PT	AU	BA	BE	GP	AF	BF	CA	TI	SO	SE	BS	LA	DT	CT	CY	CL	SP	HO	DE	ID	AB	C1	C3	RP	EM	RI	OI	FU	FP	FX	CR	NR	TC	Z9	U1	U2	PU	PI	PA	SN	EI	BN	J9	JI	PD	PY	VL	IS	PN	SU	SI	MA	BP	EP	AR	DI	DL	D2	EA	PG	WC	WE	SC	GA	PM	OA	HC	HP	DA	UT
J	Cummins, NW; Weaver, EA; May, SM; Croatt, AJ; Foreman, O; Kennedy, RB; Poland, GA; Barry, MA; Nath, KA; Badley, AD				Cummins, Nathan W.; Weaver, Eric A.; May, Shannon M.; Croatt, Anthony J.; Foreman, Oded; Kennedy, Richard B.; Poland, Gregory A.; Barry, Michael A.; Nath, Karl A.; Badley, Andrew D.			Heme oxygenase-1 regulates the immune response to influenza virus infection and vaccination in aged mice	FASEB JOURNAL			English	Article						single-nucleotide polymorphism; pathogenesis; cytokine	INFLAMMATORY RESPONSES; KIDNEY-DISEASE; HOST-DEFENSE; MCP-1; POLYMORPHISMS; ACTIVATION; HUMANS	Underlying mechanisms of individual variation in severity of influenza infection and response to vaccination are poorly understood. We investigated the effect of reduced heme oxygenase-1 (HO-1) expression on vaccine response and outcome of influenza infection. HO-1-deficient and wild-type (WT) mice (kingdom, Animalia; phylum, Chordata; genus/species, Mus musculus) were infected with influenza virus A/PR/8/34 with or without prior vaccination with an adenoviral-based influenza vaccine. A genome-wide association study evaluated the expression of single-nucleotide polymorphisms (SNPs) in the HO-1 gene and the response to influenza vaccination in healthy humans. HO-1-deficient mice had decreased survival after influenza infection compared to WT mice (median survival 5.5 vs. 6.5 d, P=0.016). HO-1-deficient mice had impaired production of antibody following influenza vaccination compared to WT mice (mean antibody titer 869 vs. 1698, P=0.02). One SNP in HO-1 and one SNP in the constitutively expressed isoform HO-2 were independently associated with decreased antibody production after influenza vaccination in healthy human volunteers (P=0.017 and 0.014, respectively). HO-1 deficient mice were paired with sex-and age-matched WT controls. HO-1 affects the immune response to both influenza infection and vaccination, suggesting that therapeutic induction of HO-1 expression may represent a novel adjuvant to enhance influenza vaccine effectiveness.-Cummins, N. W., Weaver, E. A., May, S. M., Croatt, A. J., Foreman, O., Kennedy, R. B., Poland, G. A., Barry, M. A., Nath, K. A., Badley, A. D. Heme oxygenase-1 regulates the immune response to influenza virus infection and vaccination in aged mice. FASEB J. 26, 2911-2918 (2012). www.fasebj.org	[Cummins, Nathan W.; Weaver, Eric A.; May, Shannon M.; Barry, Michael A.; Badley, Andrew D.] Mayo Clin, Dept Med, Div Infect Dis, Rochester, MN USA; [Croatt, Anthony J.; Nath, Karl A.] Mayo Clin, Dept Med, Div Nephrol & Hypertens, Rochester, MN USA; [Kennedy, Richard B.; Poland, Gregory A.] Mayo Clin, Dept Med, Vaccine Res Grp, Rochester, MN USA; [Foreman, Oded] Jackson Lab, Sacramento, CA USA	Mayo Clinic; Mayo Clinic; Mayo Clinic; Jackson Laboratory	Badley, AD (corresponding author), 200 1st St SW, Rochester, MN 55905 USA.	badley.andrew@mayo.edu	badley, andrew d/O-9022-2014	Badley, Andrew/0000-0001-7796-7680; Kennedy, Rick/0000-0001-6164-4967	U.S. National Institutes of Health [AI-40384, AI-89859Z, AR-056950-02, DK-007013-32]; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI040384, R21AI040384, R56AI040384, U01AI089859, R01AI097241] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES [T32AR056950] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [T32DK007013] Funding Source: NIH RePORTER	U.S. National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	The authors acknowledge support from the U.S. National Institutes of Health, including grants AI-40384, AI-89859Z, AR-056950-02, and DK-007013-32, for this work. All authors critically reviewed and approved the final version of the paper. Conflicts of interest: G. A. P. has offered consultative advice on novel influenza vaccine development to Merck & Co., Avianax, Theraclone Sciences (formally Spaltudaq Corporation), MedImmune LLC, Liquidia Technologies, Novavax, Novartis Vaccines and Therapeutics, and PAXVAX. All other authors declare no conflicts of interest. The authors thank Allan Ackerman for technical assistance with the study.	Abraham NG, 2008, PHARMACOL REV, V60, P79, DOI 10.1124/pr.107.07104; Bharucha AE, 2010, CLIN PHARMACOL THER, V87, P187, DOI 10.1038/clpt.2009.221; Choi AMK, 1996, AM J PHYSIOL-LUNG C, V271, pL383, DOI 10.1152/ajplung.1996.271.3.L383; Chung SW, 2008, J CLIN INVEST, V118, P239, DOI 10.1172/JCI32730; Chung SW, 2009, CELL MICROBIOL, V11, P199, DOI 10.1111/j.1462-5822.2008.01261.x; Cottey R., 2001, INFLUENZA VIRUS CURR; Exner M, 2004, FREE RADICAL BIO MED, V37, P1097, DOI 10.1016/j.freeradbiomed.2004.07.008; Hashiba T, 2001, GENE THER, V8, P1499, DOI 10.1038/sj.gt.3301540; Julkunen I, 2000, VACCINE, V19, pS32, DOI 10.1016/S0264-410X(00)00275-9; Kanakiriya SKR, 2003, AM J PHYSIOL-RENAL, V284, pF546, DOI 10.1152/ajprenal.00298.2002; Kapturczak MH, 2004, AM J PATHOL, V165, P1045, DOI 10.1016/S0002-9440(10)63365-2; Katz JM, 2004, IMMUNOL RES, V29, P113, DOI 10.1385/IR:29:1-3:113; Kennedy R, 2009, CLIN VACCINE IMMUNOL, V16, P1105, DOI 10.1128/CVI.00109-09; Li Y, 2009, CLIN EXP HYPERTENS, V31, P534, DOI 10.3109/10641960902825461; Mok H, 2005, MOL THER, V11, P66, DOI 10.1016/j.ymthe.2004.09.015; Murali NS, 2007, AM J PHYSIOL-RENAL, V292, pF837, DOI 10.1152/ajprenal.00254.2006; Nath KA, 2006, KIDNEY INT, V70, P432, DOI 10.1038/sj.ki.5001565; Nath KA, 2000, AM J PATHOL, V156, P1527, DOI 10.1016/S0002-9440(10)65024-9; Nath KA, 2001, KIDNEY INT, V59, P106, DOI 10.1046/j.1523-1755.2001.00471.x; Pittock ST, 2005, KIDNEY INT, V68, P611, DOI 10.1111/j.1523-1755.2005.00439.x; Poland GA, 2008, VACCINE, V26, pD35, DOI 10.1016/j.vaccine.2008.07.065; Sambo MR, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0011141; Saukkonen K, 2010, SHOCK, V34, P558, DOI 10.1097/SHK.0b013e3181e14de9; Sinnis P, 2008, CELL HOST MICROBE, V3, P277, DOI 10.1016/j.chom.2008.04.009; Sladkova T, 2006, ACTA VIROL, V50, P151; Tracz MJ, 2007, AM J PATHOL, V170, P1820, DOI 10.2353/ajpath.2007.061093; Tracz MJ, 2007, J AM SOC NEPHROL, V18, P414, DOI 10.1681/ASN.2006080894; Trammell RA, 2008, EXPERT REV MOL DIAGN, V8, P515, DOI 10.1586/14737159.8.4.515	28	36	39	0	9	FEDERATION AMER SOC EXP BIOL	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3998 USA	0892-6638	1530-6860		FASEB J	Faseb J.	JUL	2012	26	7					2911	2918		10.1096/fj.11-190017	http://dx.doi.org/10.1096/fj.11-190017			8	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	967MP	22490782	Green Published, Green Submitted			2022-12-25	WOS:000305912500019
J	van der Woude, AD; Sarkar, D; Bhatt, A; Sparrius, M; Raadsen, SA; Boon, L; Geurtsen, J; van der Sar, AM; Luirink, J; Houben, ENG; Besra, GS; Bitter, W				van der Woude, Aniek D.; Sarkar, Debasmita; Bhatt, Apoorva; Sparrius, Marion; Raadsen, Susanne A.; Boon, Louis; Geurtsen, Jeroen; van der Sar, Astrid M.; Luirink, Joen; Houben, Edith N. G.; Besra, Gurdyal S.; Bitter, Wilbert			Unexpected Link between Lipooligosaccharide Biosynthesis and Surface Protein Release in Mycobacterium marinum	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							GRANULOMA-FORMATION; GENE-EXPRESSION; OUTER-MEMBRANE; VII SECRETION; TUBERCULOSIS; IDENTIFICATION; MODEL; VISUALIZATION; ANTIGENS; SEQUENCE	The mycobacterial cell envelope is characterized by the presence of a highly impermeable second membrane, which is composed of mycolic acids intercalated with different unusual free lipids, such as lipooligosaccharides (LOS). Transport across this cell envelope requires a dedicated secretion system for extracellular proteins, such as PE_PGRS proteins, which are specific mycobacterial proteins with polymorphic (G) under barC-(r) under bar ich (s) under arc equence (PGRS). In this study, we set out to identify novel components involved in the secretion of PE_ PGRS proteins by screening Mycobacterium marinum transposon mutants for secretion defects. Interestingly, most mutants were not affected in secretion but in the release of PE_ PGRS proteins from the cell surface. These mutants had insertions in a gene cluster associated with LOS biosynthesis. Lipid analysis of these mutants revealed a role at different stages of LOS biosynthesis for 10 novel genes. Furthermore, we show that regulatory protein WhiB4 is involved in LOS biosynthesis. The absence of the most extended LOS molecule, i.e. LOS-IV, and a concomitant accumulation of LOS-III was already sufficient to reduce the release of PE_ PGRS proteins from the mycobacterial cell surface. A similar effect was observed for major surface protein EspE. These results show that the attachment of surface proteins is strongly influenced by the glycolipid composition of the mycobacterial cell envelope. Finally, we tested the virulence of a LOS-IV-deficient mutant in our zebrafish embryo infection model. This mutant showed a marked increase in virulence as compared with the wild-type strain, suggesting that LOS-IV plays a role in the modulation of mycobacterial virulence.	[van der Woude, Aniek D.; Sparrius, Marion; Raadsen, Susanne A.; Geurtsen, Jeroen; van der Sar, Astrid M.; Houben, Edith N. G.; Bitter, Wilbert] Vrije Univ Amsterdam, Med Ctr, Dept Med Microbiol & Infect Control, NL-1081 HV Amsterdam, Netherlands; [van der Woude, Aniek D.; Luirink, Joen; Bitter, Wilbert] Vrije Univ Amsterdam, Inst Mol Cell Biol, Dept Mol Microbiol, NL-1081 BT Amsterdam, Netherlands; [Sarkar, Debasmita; Bhatt, Apoorva] Univ Birmingham, Sch Biosci, Birmingham B15 2TT, W Midlands, England; [Boon, Louis; Besra, Gurdyal S.] Bioceros BV, NL-3584 Utrecht, Netherlands	Vrije Universiteit Amsterdam; Vrije Universiteit Amsterdam; University of Birmingham; Bioceros B.V.	Bitter, W (corresponding author), Vrije Univ Amsterdam, Dept Mol Microbiol, Boelelaan 1087, NL-1081 HV Amsterdam, Netherlands.	w.bitter@vumc.nl	Boon, Laurence/HCI-3629-2022; Bitter, Wilbert/ABG-3726-2020; Luirink, Joen/AAB-8658-2021; Houben, Edith N.G./B-2110-2015; Bitter, W/CAJ-5778-2022; Bitter, Wilbert/AAA-6872-2019; van der Sar, Astrid M/A-3698-2008	Bitter, Wilbert/0000-0001-8347-6511; Houben, Edith N.G./0000-0002-8805-2002; van der Sar, Astrid M/0000-0001-5790-5036; Besra, Gurdyal/0000-0002-5605-0395; Boon, Louis/0000-0002-0937-9171; van der Woude, Aniek/0000-0002-7786-9893; Luirink, J./0000-0001-8431-0804	Netherlands Organization for Scientific Research; Netherlands Organization for Scientific Research-VENI grant; MRC [G0600105] Funding Source: UKRI; Medical Research Council [G0600105] Funding Source: researchfish	Netherlands Organization for Scientific Research(Netherlands Organization for Scientific Research (NWO)); Netherlands Organization for Scientific Research-VENI grant; MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission)	This work was supported by an ECHO project grant from the Netherlands Organization for Scientific Research (to A. D. v. d. W.) and a Netherlands Organization for Scientific Research-VENI grant (to E. N. G. H.).	Abdallah AM, 2009, MOL MICROBIOL, V73, P329, DOI 10.1111/j.1365-2958.2009.06783.x; Abdallah AM, 2007, NAT REV MICROBIOL, V5, P883, DOI 10.1038/nrmicro1773; Abdallah AM, 2006, MOL MICROBIOL, V62, P667, DOI 10.1111/j.1365-2958.2006.05409.x; Alam MS, 2007, MOL MICROBIOL, V63, P1414, DOI 10.1111/j.1365-2958.2007.05589.x; Alderson MR, 2000, J EXP MED, V191, P551, DOI 10.1084/jem.191.3.551; ALLEN MM, 1984, ANNU REV MICROBIOL, V38, P1, DOI 10.1146/annurev.mi.38.100184.000245; BELISLE JT, 1989, J BACTERIOL, V171, P3465, DOI 10.1128/jb.171.6.3465-3470.1989; Betts JC, 2002, MOL MICROBIOL, V43, P717, DOI 10.1046/j.1365-2958.2002.02779.x; BRENNAN PJ, 1995, ANNU REV BIOCHEM, V64, P29, DOI 10.1146/annurev.bi.64.070195.000333; Brodin P, 2010, PLOS PATHOG, V6, DOI 10.1371/journal.ppat.1001100; Burguiere A, 2005, J BIOL CHEM, V280, P42124, DOI 10.1074/jbc.M507500200; Carlsson F, 2009, PLOS PATHOG, V5, DOI 10.1371/journal.ppat.1000285; Cole ST, 1998, NATURE, V393, P537, DOI 10.1038/31159; COLLINS FM, 1981, INFECT IMMUN, V32, P614, DOI 10.1128/IAI.32.2.614-624.1981; DAFFE M, 1991, BIOCHEMISTRY-US, V30, P378, DOI 10.1021/bi00216a011; Davis JM, 2002, IMMUNITY, V17, P693, DOI 10.1016/S1074-7613(02)00475-2; Etienne G, 2009, J BACTERIOL, V191, P2613, DOI 10.1128/JB.01235-08; Fuser G, 2007, MACROMOL BIOSCI, V7, P278, DOI 10.1002/mabi.200600207; Geiman DE, 2006, ANTIMICROB AGENTS CH, V50, P2836, DOI 10.1128/AAC.00295-06; Gey van Pittius NC, 2006, BMC EVOL BIOL, V6, DOI 10.1186/1471-2148-6-95; GILLERON M, 1993, J BIOL CHEM, V268, P3168; Harboe M, 1998, INFECT IMMUN, V66, P717, DOI 10.1128/IAI.66.2.717-723.1998; Hayward CMM, 1999, VACCINE, V17, P1272, DOI 10.1016/S0264-410X(98)00350-8; Hoffmann C, 2008, P NATL ACAD SCI USA, V105, P3963, DOI 10.1073/pnas.0709530105; HUNTER SW, 1983, J BIOL CHEM, V258, P481; Hwang BY, 2004, CHEM BIOL, V11, P915, DOI 10.1016/j.chembiol.2004.04.015; LEMASSU A, 1992, J GEN MICROBIOL, V138, P1535, DOI 10.1099/00221287-138-7-1535; Lesley R, 2008, CURR OPIN MICROBIOL, V11, P277, DOI 10.1016/j.mib.2008.05.013; Matsunaga I, 2004, J EXP MED, V200, P1559, DOI 10.1084/jem.20041429; Meijer AH, 2008, DEV COMP IMMUNOL, V32, P36, DOI 10.1016/j.dci.2007.04.003; Pallen MJ, 2002, TRENDS MICROBIOL, V10, P209, DOI 10.1016/S0966-842X(02)02345-4; Parish T, 1998, METH MOL B, V101, P1, DOI 10.1385/0-89603-471-2:1; POULET S, 1995, ARCH MICROBIOL, V163, P87, DOI 10.1007/s002030050176; Puttinaowarat S., 2000, Fish Veterinary Journal, P6; Rachman H, 2006, MICROBES INFECT, V8, P747, DOI 10.1016/j.micinf.2005.09.011; Ren HP, 2007, MOL MICROBIOL, V63, P1345, DOI 10.1111/j.1365-2958.2007.05603.x; Rombouts Y, 2011, J BIOL CHEM, V286, P33678, DOI 10.1074/jbc.M111.273920; Rombouts Y, 2010, J AM CHEM SOC, V132, P16073, DOI 10.1021/ja105807s; Rombouts Y, 2009, J BIOL CHEM, V284, P20975, DOI 10.1074/jbc.M109.011429; Sani M, 2010, PLOS PATHOG, V6, DOI 10.1371/journal.ppat.1000794; Sarkar D, 2011, J BACTERIOL, V193, P2336, DOI 10.1128/JB.00065-11; Sassetti CM, 2003, MOL MICROBIOL, V48, P77, DOI 10.1046/j.1365-2958.2003.03425.x; Singh A, 2009, PLOS PATHOG, V5, DOI 10.1371/journal.ppat.1000545; Stinear TP, 2008, GENOME RES, V18, P729, DOI 10.1101/gr.075069.107; Stoop EJM, 2011, DIS MODEL MECH, V4, P526, DOI 10.1242/dmm.006676; Talaat AM, 1998, INFECT IMMUN, V66, P2938, DOI 10.1128/IAI.66.6.2938-2942.1998; van der Sar AM, 2004, INFECT IMMUN, V72, P6306, DOI 10.1128/IAI.72.11.6306-6312.2004; van der Sar AM, 2003, CELL MICROBIOL, V5, P601, DOI 10.1046/j.1462-5822.2003.00303.x; VANPITTIUS NCG, 2001, GENOME BIOL, V2, DOI DOI 10.1186/GB-2001-2-10-RESEARCH0044; WHO, 2011, 2011 2012 TUB GLOB F; Zuber B, 2008, J BACTERIOL, V190, P5672, DOI 10.1128/JB.01919-07	51	37	38	0	9	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	JUN 8	2012	287	24					20417	20429		10.1074/jbc.M111.336461	http://dx.doi.org/10.1074/jbc.M111.336461			13	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	974FB	22505711	hybrid, Green Published			2022-12-25	WOS:000306414500060
J	Ma, XJ; Zhao, Y; Daaka, YH; Nie, ZZ				Ma, Xiaojie; Zhao, Yu; Daaka, Yehia; Nie, Zhongzhen			Acute Activation of beta(2)-Adrenergic Receptor Regulates Focal Adhesions through beta Arrestin2-and p115RhoGEF Protein-mediated Activation of RhoA	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							STRESS FIBER FORMATION; KINASE ACTIVATION; COUPLED RECEPTORS; CELL-MIGRATION; GROWTH-FACTOR; P115 RHOGEF; CYCLIC-AMP; GTPASE; ARRESTIN; PHOSPHORYLATION	beta(2)-Adrenergic receptors (beta(2)ARs) regulate cellular functions through G protein-transduced and beta Arrestin-transduced signals. beta(2)ARs have been shown to regulate cancer cell migration, but the underlying mechanisms are not well understood. Here, we report that beta(2)AR regulates formation of focal adhesions, whose dynamic remodeling is critical for directed cell migration. beta(2)ARs induce activation of RhoA, which is dependent on beta Arrestin2 but not G(s). beta Arrestin2 forms a complex with p115RhoGEF, a guanine nucleotide exchange factor for RhoA that is well known to be activated by G(12/13)-coupled receptors. Our results show that beta Arrestin2 forms a complex with p115RhoGEF in the cytosol in resting cells. Upon beta(2)AR activation, both beta Arrestin2 and p115RhoGEF translocate to the plasma membrane, with concomitant activation of RhoA and formation of focal adhesions and stress fibers. Activation of RhoA and focal adhesion remodeling may explain, at least in part, the role of beta(2)ARs in cell migration. These results suggest that beta Arrestin2 may serve as a convergence point for non-G(12/13) and non-G(q) protein-coupled receptors to activate RhoA.	[Ma, Xiaojie; Zhao, Yu; Daaka, Yehia; Nie, Zhongzhen] Univ Florida, Dept Urol, Gainesville, FL 32610 USA; [Ma, Xiaojie; Zhao, Yu; Daaka, Yehia; Nie, Zhongzhen] Univ Florida, Prostate Dis Ctr, Gainesville, FL 32610 USA; [Daaka, Yehia; Nie, Zhongzhen] Univ Florida, Dept Anat & Cell Biol, Gainesville, FL 32610 USA	State University System of Florida; University of Florida; State University System of Florida; University of Florida; State University System of Florida; University of Florida	Nie, ZZ (corresponding author), 2033 Mowry Rd,CGRC Rm 460, Gainesville, FL 32610 USA.	niez@ufl.edu		Zhao, Yu/0000-0002-4919-1341	National Institutes of Health [K22CA124578, R01CA129155]; NATIONAL CANCER INSTITUTE [R01CA129155, K22CA124578] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	This work was supported, in whole or in part, by National Institutes of Health Grants K22CA124578 (to Z. N.) and R01CA129155 (to Y. D.).	Anthony DF, 2011, MOL CELL BIOL, V31, P1066, DOI 10.1128/MCB.00883-10; Barnes WG, 2005, J BIOL CHEM, V280, P8041, DOI 10.1074/jbc.M412924200; Bhattacharyya R, 2003, BIOCHEM J, V371, P709, DOI 10.1042/BJ20021897; Chaffer CL, 2011, SCIENCE, V331, P1559, DOI 10.1126/science.1203543; Chen Z, 2011, PROTEIN SCI, V20, P107, DOI 10.1002/pro.542; Chikumi H, 2004, ONCOGENE, V23, P233, DOI 10.1038/sj.onc.1207012; Chow WH, 2010, NAT REV UROL, V7, P245, DOI 10.1038/nrurol.2010.46; Claing A, 2001, J BIOL CHEM, V276, P42509, DOI 10.1074/jbc.M108399200; Cotton M, 2009, CELL SIGNAL, V21, P1045, DOI 10.1016/j.cellsig.2009.02.008; Daaka Y, 1997, NATURE, V390, P88, DOI 10.1038/36362; Daher Z, 2008, CELL SIGNAL, V20, P2256, DOI 10.1016/j.cellsig.2008.08.021; Dong JM, 1998, J BIOL CHEM, V273, P22554, DOI 10.1074/jbc.273.35.22554; Dorsam RT, 2007, NAT REV CANCER, V7, P79, DOI 10.1038/nrc2069; Engers R, 2000, INT J CANCER, V88, P369, DOI 10.1002/1097-0215(20001101)88:3<369::AID-IJC8>3.0.CO;2-K; Fleming IN, 1996, J BIOL CHEM, V271, P33067, DOI 10.1074/jbc.271.51.33067; Friedl P, 2003, NAT REV CANCER, V3, P362, DOI 10.1038/nrc1075; Gardel ML, 2008, J CELL BIOL, V183, P999, DOI 10.1083/jcb.200810060; Goncharova EA, 2012, AM J RESP CELL MOL, V46, P48, DOI 10.1165/rcmb.2011-0217OC; Guilluy C, 2010, NAT MED, V16, P183, DOI 10.1038/nm.2079; Ha VL, 2008, J BIOL CHEM, V283, P14915, DOI 10.1074/jbc.M709717200; Hara MR, 2011, NATURE, V477, P349, DOI 10.1038/nature10368; Hart MJ, 1998, SCIENCE, V280, P2112, DOI 10.1126/science.280.5372.2112; Heasman SJ, 2008, NAT REV MOL CELL BIO, V9, P690, DOI 10.1038/nrm2476; Holinstat M, 2003, J BIOL CHEM, V278, P28793, DOI 10.1074/jbc.M303900200; Kasbohm EA, 2005, J BIOL CHEM, V280, P11583, DOI 10.1074/jbc.M414423200; Kenakin T, 2007, TRENDS PHARMACOL SCI, V28, P407, DOI 10.1016/j.tips.2007.06.009; Kim WJ, 2012, CANCER LETT, V320, P65, DOI 10.1016/j.canlet.2012.01.022; Kohout TA, 2001, P NATL ACAD SCI USA, V98, P1601, DOI 10.1073/pnas.041608198; Kozasa T, 1998, SCIENCE, V280, P2109, DOI 10.1126/science.280.5372.2109; Lang P, 1996, EMBO J, V15, P510, DOI 10.1002/j.1460-2075.1996.tb00383.x; Li J, 2007, J CELL BIOL, V178, P453, DOI 10.1083/jcb.200608033; Lodewyks C, 2011, HEPATOL RES, V41, P1000, DOI 10.1111/j.1872-034X.2011.00854.x; Luthy IA, 2009, CURR MED CHEM, V16, P1850, DOI 10.2174/092986709788186048; Luttrell LM, 1999, SCIENCE, V283, P655, DOI 10.1126/science.283.5402.655; Malchinkhuu E, 2009, MOL BIOL CELL, V20, P5156, DOI 10.1091/mbc.E09-08-0692; Maudsley S, 2000, J BIOL CHEM, V275, P9572, DOI 10.1074/jbc.275.13.9572; Moore CAC, 2007, ANNU REV PHYSIOL, V69, P451, DOI 10.1146/annurev.physiol.69.022405.154712; Mythreye K, 2009, CELL CYCLE, V8, P3069, DOI 10.4161/cc.8.19.9419; Noma T, 2007, J CLIN INVEST, V117, P2445, DOI 10.1172/JCI31901; Norman JC, 1998, J CELL BIOL, V143, P1981, DOI 10.1083/jcb.143.7.1981; Oakley RH, 2000, J BIOL CHEM, V275, P17201, DOI 10.1074/jbc.M910348199; Parsons JT, 2010, NAT REV MOL CELL BIO, V11, P633, DOI 10.1038/nrm2957; Perron L, 2004, CANCER CAUSE CONTROL, V15, P535, DOI 10.1023/B:CACO.0000036152.58271.5e; Premont RT, 2000, J BIOL CHEM, V275, P22373, DOI 10.1074/jbc.275.29.22373; Rajagopal S, 2010, NAT REV DRUG DISCOV, V9, P373, DOI 10.1038/nrd3024; Randazzo PA, 2000, P NATL ACAD SCI USA, V97, P4011, DOI 10.1073/pnas.070552297; Rangarajan S, 2003, J CELL BIOL, V160, P487, DOI 10.1083/jcb.200209105; Rossman KL, 2005, NAT REV MOL CELL BIO, V6, P167, DOI 10.1038/nrm1587; Sastry SK, 2000, EXP CELL RES, V261, P25, DOI 10.1006/excr.2000.5043; Schmidt A, 2002, GENE DEV, V16, P1587, DOI 10.1101/gad.1003302; Schuller HM, 2002, NAT REV CANCER, V2, P455, DOI 10.1038/nrc824; Scott MGH, 2006, MOL CELL BIOL, V26, P3432, DOI 10.1128/MCB.26.9.3432-3445.2006; Shin SY, 2010, MOL CANCER RES, V8, P507, DOI 10.1158/1541-7786.MCR-09-0454; Siehler S, 2009, BRIT J PHARMACOL, V158, P41, DOI 10.1111/j.1476-5381.2009.00121.x; Sun M, 2010, NAT REV UROL, V7, P327, DOI 10.1038/nrurol.2010.57; Thaker PH, 2006, NAT MED, V12, P939, DOI 10.1038/nm1447; Vega FM, 2008, FEBS LETT, V582, P2093, DOI 10.1016/j.febslet.2008.04.039; Webb DJ, 2002, NAT CELL BIOL, V4, pE97, DOI 10.1038/ncb0402-e97; Wisler JW, 2007, P NATL ACAD SCI USA, V104, P16657, DOI 10.1073/pnas.0707936104; Wu JJ, 2011, J BIOL CHEM, V286, P33954, DOI 10.1074/jbc.M110.187344; Yang EV, 2006, CANCER RES, V66, P10357, DOI 10.1158/0008-5472.CAN-06-2496; Yoon HY, 2006, J CELL SCI, V119, P4650, DOI 10.1242/jcs.03237; Yuan BZ, 1998, CANCER RES, V58, P2196; Zhu YJ, 2009, J BIOL CHEM, V284, P13489, DOI 10.1074/jbc.M900469200; Zoudilova M, 2007, J BIOL CHEM, V282, P20634, DOI 10.1074/jbc.M701391200	65	31	32	0	2	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JUN 1	2012	287	23					18925	18936		10.1074/jbc.M112.352260	http://dx.doi.org/10.1074/jbc.M112.352260			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	974EF	22500016	hybrid, Green Published			2022-12-25	WOS:000306411900005
J	Gao, XJ; Zhao, XJ; Zhu, Y; He, JY; Shao, J; Su, C; Zhang, Y; Zhang, W; Saarikettu, J; Silvennoinen, O; Yao, Z; Yang, J				Gao, Xingjie; Zhao, Xiujuan; Zhu, Yu; He, Jinyan; Shao, Jie; Su, Chao; Zhang, Yi; Zhang, Wei; Saarikettu, Juha; Silvennoinen, Olli; Yao, Zhi; Yang, Jie			Tudor Staphylococcal Nuclease (Tudor-SN) Participates in Small Ribonucleoprotein (snRNP) Assembly via Interacting with Symmetrically Dimethylated Sm Proteins	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							ARGININE METHYLTRANSFERASE; PROTEOMIC ANALYSIS; STRUCTURAL BASIS; BINDING PROTEIN; CAJAL BODIES; RNA; DOMAIN; P100; COACTIVATOR; METHYLATION	Human Tudor staphylococcal nuclease (Tudor-SN) is composed of four tandem repeats of staphylococcal nuclease (SN)-like domains, followed by a tudor and SN-like domain (TSN) consisting of a central tudor flanked by two partial SN-like sequences. The crystal structure of the tudor domain displays a conserved aromatic cage, which is predicted to hook methyl groups. Here, we demonstrated that the TSN domain of Tudor-SN binds to symmetrically dimethylarginine (sDMA)-modified SmB/B' and SmD1/D3 core proteins of the spliceosome. We demonstrated that this interaction ability is reduced by the methyltransferase inhibitor 5-deoxy-5-(methylthio)adenosine. Mutagenesis experiments indicated that the conserved amino acids (Phe-715, Tyr-721, Tyr-738, and Tyr-741) in the methyl-binding cage of the TSN domain are required for Tudor-SN-SmB interaction. Furthermore, depletion of Tudor-SN affects the association of Sm protein with snRNAs and, as a result, inhibits the assembly of uridine-rich small ribonucleoprotein mediated by the Sm core complex in vivo. Our results reveal the molecular basis for the involvement of Tudor-SN in regulating small nuclear ribonucleoprotein biogenesis, which provides novel insight related to the biological activity of Tudor-SN.	[Gao, Xingjie; Zhao, Xiujuan; Zhu, Yu; He, Jinyan; Shao, Jie; Su, Chao; Zhang, Yi; Zhang, Wei; Yao, Zhi; Yang, Jie] Tianjin Med Univ, Res Ctr Basic Med Sci, Sch Basic Med Sci, Dept Immunol, Tianjin 30070, Peoples R China; [Gao, Xingjie; Zhao, Xiujuan; Zhu, Yu; He, Jinyan; Shao, Jie; Su, Chao; Zhang, Yi; Zhang, Wei; Yao, Zhi; Yang, Jie] Tianjin Med Univ, Res Ctr Basic Med Sci, Sch Basic Med Sci, Dept Biochem, Tianjin 30070, Peoples R China; [Gao, Xingjie; Zhao, Xiujuan; Zhu, Yu; He, Jinyan; Shao, Jie; Su, Chao; Zhang, Yi; Zhang, Wei; Yao, Zhi; Yang, Jie] Tianjin Med Univ, Res Ctr Basic Med Sci, Tianjin Key Lab Cellular & Mol Immunol, Tianjin 30070, Peoples R China; [Gao, Xingjie; Zhao, Xiujuan; Zhu, Yu; He, Jinyan; Shao, Jie; Su, Chao; Zhang, Yi; Zhang, Wei; Yao, Zhi; Yang, Jie] Tianjin Med Univ, Res Ctr Basic Med Sci, Key Lab Educ Minist China, Tianjin 30070, Peoples R China; [Gao, Xingjie; Su, Chao; Zhang, Yi; Yang, Jie] Tianjin Med Univ, Res Ctr Basic Med Sci, Lab Mol Immunol, Tianjin 30070, Peoples R China; [Saarikettu, Juha; Silvennoinen, Olli] Univ Tampere, Tampere Univ Hosp, Inst Med Technol, FI-33014 Tampere, Finland	Tianjin Medical University; Tianjin Medical University; Tianjin Medical University; Tianjin Medical University; Tianjin Medical University; Tampere University; Tampere University Hospital	Yao, Z (corresponding author), Tianjin Med Univ, Res Ctr Basic Med Sci, Sch Basic Med Sci, Dept Immunol, Tianjin 30070, Peoples R China.	yaozhi@tijmu.edu.cn; yangj@tijmu.edu.cn	Zhang, Yi/N-2069-2018	Zhang, Yi/0000-0002-2500-680X	Project 863 of the Ministry of Science and Technology of China [2007AA02Z115]; 973 Program [2009CB918903]; Specialized Fund for the Doctoral Program of Higher Education [20091202110001]; China Postdoctoral Science Foundation [2011M500529]; Tianjin Educational Committee Foundation [2008ZD01]; Tianjin Municipal Science and Technology Commission [08ZCGHHZ01900]; NSFC [31125012, 90919032, 30970582, 30670441, 31100967, 31170830]	Project 863 of the Ministry of Science and Technology of China(National High Technology Research and Development Program of China); 973 Program(National Basic Research Program of China); Specialized Fund for the Doctoral Program of Higher Education(Specialized Research Fund for the Doctoral Program of Higher Education (SRFDP)); China Postdoctoral Science Foundation(China Postdoctoral Science Foundation); Tianjin Educational Committee Foundation; Tianjin Municipal Science and Technology Commission; NSFC(National Natural Science Foundation of China (NSFC))	This work was supported by Project 863 of the Ministry of Science and Technology of China Grants 2007AA02Z115, NSFC 31125012, 90919032, 30970582, 30670441, 31100967, and 31170830, 973 Program Grant 2009CB918903, Specialized Fund for the Doctoral Program of Higher Education Grant 20091202110001, China Postdoctoral Science Foundation Grant 2011M500529, Tianjin Educational Committee Foundation Grant 2008ZD01, and Tianjin Municipal Science and Technology Commission Grant 08ZCGHHZ01900.	Abe S, 2003, J EXP BOT, V54, P971, DOI 10.1093/jxb/erg096; Achsel T, 2001, P NATL ACAD SCI USA, V98, P3685, DOI 10.1073/pnas.071033998; ANDERSEN J, 1991, BIOESSAYS, V13, P57, DOI 10.1002/bies.950130203; Boisvert FM, 2002, J CELL BIOL, V159, P957, DOI 10.1083/jcb.200207028; Boisvert FM, 2003, MOL CELL PROTEOMICS, V2, P1319, DOI 10.1074/mcp.M300088-MCP200; Boisvert Francois-Michel, 2005, Sci STKE, V2005, pre2, DOI 10.1126/stke.2712005re2; Brahms H, 2000, J BIOL CHEM, V275, P17122, DOI 10.1074/jbc.M000300200; Brahms H, 2001, RNA, V7, P1531, DOI 10.1017/S135583820101442X; Brenner TJ, 2006, RNA, V12, P862, DOI 10.1261/rna.2319806; Broadhurst MK, 2005, BBA-GENE STRUCT EXPR, V1681, P126, DOI 10.1016/j.bbaexp.2004.10.009; Buhler D, 1999, HUM MOL GENET, V8, P2351, DOI 10.1093/hmg/8.13.2351; Caudy AA, 2003, NATURE, V425, P411, DOI 10.1038/nature01956; Chakrabarti SK, 2002, J BIOL CHEM, V277, P13286, DOI 10.1074/jbc.M111857200; Cheng DH, 2007, MOL CELL, V25, P71, DOI 10.1016/j.molcel.2006.11.019; Cote J, 2005, J BIOL CHEM, V280, P28476, DOI 10.1074/jbc.M414328200; Dong LJ, 2011, J BIOL CHEM, V286, P3451, DOI 10.1074/jbc.M110.168377; Friberg A, 2009, J MOL BIOL, V387, P921, DOI 10.1016/j.jmb.2009.02.018; Frilander MJ, 2005, MOL CELL BIOL, V25, P4813, DOI 10.1128/MCB.25.12.4813-4825.2005; Gao XJ, 2010, FEBS LETT, V584, P3525, DOI 10.1016/j.febslet.2010.07.022; Gonsalvez GB, 2007, J CELL BIOL, V178, P733, DOI 10.1083/jcb.200702147; Grainger RJ, 2005, RNA, V11, P533, DOI 10.1261/rna.2220705; Guthrie C, 2010, J BIOL CHEM, V285, P1, DOI 10.1074/jbc.X109.080580; Howard-Till RA, 2007, EUKARYOT CELL, V6, P1795, DOI 10.1128/EC.00192-07; Huang Y, 2006, SCIENCE, V312, P748, DOI 10.1126/science.1125162; Huyen Y, 2004, NATURE, V432, P406, DOI 10.1038/nature03114; Jurica MS, 2003, MOL CELL, V12, P5, DOI 10.1016/S1097-2765(03)00270-3; Kambach C, 1999, CURR OPIN STRUC BIOL, V9, P222, DOI 10.1016/S0959-440X(99)80032-3; Kambach C, 1999, CELL, V96, P375, DOI 10.1016/S0092-8674(00)80550-4; Kolb SJ, 2007, J CHILD NEUROL, V22, P990, DOI 10.1177/0883073807305666; Kotani T, 2007, J NEUROL, V254, P624, DOI 10.1007/s00415-006-0410-x; Lee JH, 2005, J BIOL CHEM, V280, P3656, DOI 10.1074/jbc.M405295200; Li CL, 2008, NUCLEIC ACIDS RES, V36, P3579, DOI 10.1093/nar/gkn236; Liu K, 2010, P NATL ACAD SCI USA, V107, P18398, DOI 10.1073/pnas.1013106107; Livak KJ, 2001, METHODS, V25, P402, DOI 10.1006/meth.2001.1262; Meister G, 2001, CURR BIOL, V11, P1990, DOI 10.1016/S0960-9822(01)00592-9; Miranda TB, 2004, BIOCHEM BIOPH RES CO, V323, P382, DOI 10.1016/j.bbrc.2004.08.107; Nagai K, 2001, BIOCHEM SOC T, V29, P15; Paukku K, 2008, NUCLEIC ACIDS RES, V36, P4474, DOI 10.1093/nar/gkn411; Pessa HKJ, 2006, RNA, V12, P1883, DOI 10.1261/rna.213906; Rodriguez L, 2007, BIOCHEM BIOPH RES CO, V356, P226, DOI 10.1016/j.bbrc.2007.02.110; Sami-Subbu R, 2001, PLANT MOL BIOL, V46, P79, DOI 10.1023/A:1010643209402; Selenko P, 2001, NAT STRUCT BIOL, V8, P27; Shaw N, 2007, NAT STRUCT MOL BIOL, V14, P779, DOI 10.1038/nsmb1269; Sleeman JE, 2001, J CELL SCI, V114, P4407; Sprangers R, 2003, J MOL BIOL, V327, P507, DOI 10.1016/S0022-2836(03)00148-7; Stark H, 2001, NATURE, V409, P539, DOI 10.1038/35054102; SUROWY CS, 1989, MOL CELL BIOL, V9, P4179, DOI 10.1128/MCB.9.10.4179; Tkacz ID, 2010, J BIOL CHEM, V285, P27982, DOI 10.1074/jbc.M109.095349; Tripsianes K, 2011, NAT STRUCT MOL BIOL, V18, P1414, DOI 10.1038/nsmb.2185; Valineva T, 2005, J BIOL CHEM, V280, P14989, DOI 10.1074/jbc.M410465200; Will CL, 2001, CURR OPIN CELL BIOL, V13, P290, DOI 10.1016/S0955-0674(00)00211-8; Yang J, 2002, EMBO J, V21, P4950, DOI 10.1093/emboj/cdf463; Yang J, 2007, NUCLEIC ACIDS RES, V35, P4485, DOI 10.1093/nar/gkm470; Zhang Z, 2008, CELL, V133, P585, DOI 10.1016/j.cell.2008.03.031; Zhao CT, 2003, FEBS LETT, V543, P190, DOI 10.1016/S0014-5793(03)00445-9; Zhou ZL, 2002, NATURE, V419, P182, DOI 10.1038/nature01031	56	42	44	1	13	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	MAY 25	2012	287	22					18130	18141		10.1074/jbc.M111.311852	http://dx.doi.org/10.1074/jbc.M111.311852			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	974EC	22493508	Green Published, hybrid			2022-12-25	WOS:000306411600021
J	Lange, A; Castaneda, C; Hoeller, D; Lancelin, JM; Fushman, D; Walker, O				Lange, Anja; Castaneda, Carlos; Hoeller, Daniela; Lancelin, Jean-Marc; Fushman, David; Walker, Olivier			Evidence for Cooperative and Domain-specific Binding of the Signal Transducing Adaptor Molecule 2 (STAM2) to Lys(63)-linked Diubiquitin	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							UBIQUITIN-INTERACTING MOTIF; POLYUBIQUITIN CHAINS; BIOLOGICAL MACROMOLECULES; RECEPTOR ENDOCYTOSIS; NMR-SPECTROSCOPY; ESCRT COMPLEXES; PROTEIN; RECOGNITION; DYNAMICS; CONFORMATION	As the upstream component of the ESCRT (endosomal sorting complexes required for transport) machinery, the ESCRT-0 complex is responsible for directing ubiquitinated membrane proteins to the multivesicular body pathway. ESCRT-0 is formed by two subunits known as Hrs (hepatocyte growth factor-regulated substrate) and STAM (signal transducing adaptor molecule), both of which harbor multiple ubiquitin-binding domains (UBDs). In particular, STAM2 possesses two UBDs, the VHS (Vps27/Hrs/Stam) and UIM (ubiquitin interacting motif) domains, connected by a 20-amino acid flexible linker. In the present study, we report the interactions of the UIM domain and VHS-UIM construct of STAM2 with monoubiquitin (Ub), Lys(48)- and Lys(63)-linked diubiquitins. Our results demonstrate that the UIM domain alone binds monoubiquitin, Lys(48)- and Lys(63)-linked diubiquitins with the same affinity and in the same binding mode. Interestingly, binding of VHS-UIM to Lys(63)-linked diubiquitin is not only avid, but also cooperative. We also show that the distal domain of Lys(63)-linked diubiquitin stabilizes the helical structure of the UIM domain and that the corresponding complex adopts a specific structural organization responsible for its greater affinity. In contrast, binding of VHS-UIM to Lys(48)-linked diubiquitin and monoubiquitin is not cooperative and does not show any avidity. These results may explain the better sorting efficiency of some cargoes polyubiquitinated with Lys(63)-linked chains over monoubiquitinated cargoes or those tagged with Lys(48)-linked chains.	[Lange, Anja; Lancelin, Jean-Marc; Walker, Olivier] Univ Lyon, CNRS, UMR 5280, Inst Sci Analyt, F-69622 Villeurbanne, France; [Castaneda, Carlos; Fushman, David] Univ Maryland, Ctr Biomol Struct & Org, Dept Chem & Biochem, College Pk, MD 20910 USA; [Hoeller, Daniela] Innsbruck Med Univ, Bioctr, Div Med Biochem, A-6020 Innsbruck, Austria	Centre National de la Recherche Scientifique (CNRS); CNRS - Institute of Chemistry (INC); University System of Maryland; University of Maryland College Park; Medical University of Innsbruck	Walker, O (corresponding author), 43 Blvd 11 Novembre 1918, F-69622 Villeurbanne, France.	olivier.walker@univ-lyon1.fr	Lancelin, Jean-marc/AAC-5686-2019; WALKER, Olivier/B-2580-2016; Hoeller, Daniela/GVT-8953-2022	WALKER, Olivier/0000-0001-7284-2555; Castaneda, Carlos/0000-0001-9634-0867	National Institutes of Health [GM065334]; National Science Foundation [DBI-0905967]; French MENRT; French Rhone Alpes region for the ExploraDoc; eNMR project (European FP7 e-Infrastructure grant) [213010]; national GRID Initiatives of Italy, Germany; Dutch BiG Grid project (Netherlands Organization for Scientific Research); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM065334] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); National Science Foundation(National Science Foundation (NSF)); French MENRT; French Rhone Alpes region for the ExploraDoc(Region Auvergne-Rhone-Alpes); eNMR project (European FP7 e-Infrastructure grant); national GRID Initiatives of Italy, Germany; Dutch BiG Grid project (Netherlands Organization for Scientific Research); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported, in whole or in part, by National Institutes of Health Grant GM065334 (to D. F.) and National Science Foundation Postdoctoral Fellowship DBI-0905967 (to C. A. C.).; Recipient of fellowships from the French MENRT and a French Rhone Alpes region for the ExploraDoc.; The eNMR project (European FP7 e-Infrastructure grant, contract no. 213010), supported by the national GRID Initiatives of Italy, Germany, and the Dutch BiG Grid project (Netherlands Organization for Scientific Research) are acknowledged for the use of web portals, computing, and storage facilities.	Acconcia F, 2009, EXP CELL RES, V315, P1610, DOI 10.1016/j.yexcr.2008.10.014; Barriere H, 2007, MOL BIOL CELL, V18, P3952, DOI 10.1091/mbc.E07-07-0678; Bilodeau PS, 2002, NAT CELL BIOL, V4, P534, DOI 10.1038/ncb815; Clague MJ, 2010, CELL, V143, P682, DOI 10.1016/j.cell.2010.11.012; Clore GM, 2009, CHEM REV, V109, P4108, DOI 10.1021/cr900033p; Datta AB, 2009, J MOL BIOL, V392, P1117, DOI 10.1016/j.jmb.2009.07.090; De Vries SJ, 2007, PROTEINS, V69, P726, DOI 10.1002/prot.21723; DELAGLIO F, 1995, J BIOMOL NMR, V6, P277, DOI 10.1007/BF00197809; Dikic I, 2009, NAT REV MOL CELL BIO, V10, P659, DOI 10.1038/nrm2767; Dominguez C, 2003, J AM CHEM SOC, V125, P1731, DOI 10.1021/ja026939x; Duncan LM, 2006, EMBO J, V25, P1635, DOI 10.1038/sj.emboj.7601056; FINKELSTEIN AV, 1989, PROTEIN ENG, V3, P1, DOI 10.1093/protein/3.1.1; Fisher RD, 2003, J BIOL CHEM, V278, P28976, DOI 10.1074/jbc.M302596200; Fushman D, 1997, J MOL BIOL, V266, P173, DOI 10.1006/jmbi.1996.0771; Garrus JE, 2001, CELL, V107, P55, DOI 10.1016/S0092-8674(01)00506-2; Goddard T. D., 2001, SPARKY 3; Grunberg R, 2006, STRUCTURE, V14, P683, DOI 10.1016/j.str.2006.01.014; GRZESIEK S, 1993, J AM CHEM SOC, V115, P12593, DOI 10.1021/ja00079a052; Haglund K, 2003, TRENDS BIOCHEM SCI, V28, P598, DOI 10.1016/j.tibs.2003.09.005; Hall JB, 2003, J BIOMOL NMR, V27, P261, DOI 10.1023/A:1025467918856; Haririnia A, 2007, J MOL BIOL, V368, P753, DOI 10.1016/j.jmb.2007.02.037; Henne WM, 2011, DEV CELL, V21, P77, DOI 10.1016/j.devcel.2011.05.015; Hicke L, 2001, NAT REV MOL CELL BIO, V2, P195, DOI 10.1038/35056583; Hicke L, 2003, ANNU REV CELL DEV BI, V19, P141, DOI 10.1146/annurev.cellbio.19.110701.154617; Hofmann K, 2001, TRENDS BIOCHEM SCI, V26, P347, DOI 10.1016/S0968-0004(01)01835-7; Hurley JH, 2008, CURR OPIN CELL BIOL, V20, P4, DOI 10.1016/j.ceb.2007.12.002; Hurley JH, 2010, CRIT REV BIOCHEM MOL, V45, P463, DOI 10.3109/10409238.2010.502516; JENCKS WP, 1981, P NATL ACAD SCI-BIOL, V78, P4046, DOI 10.1073/pnas.78.7.4046; KAY LE, 1989, BIOCHEMISTRY-US, V28, P8972, DOI 10.1021/bi00449a003; Keller R., 2004, COMPUTER AIDED RESON, V1; Lauwers E, 2010, TRENDS CELL BIOL, V20, P196, DOI 10.1016/j.tcb.2010.01.004; Lauwers E, 2009, J CELL BIOL, V185, P493, DOI 10.1083/jcb.200810114; Lim J, 2011, BIOCHEM BIOPH RES CO, V405, P24, DOI 10.1016/j.bbrc.2010.12.103; Lo YC, 2009, MOL CELL, V33, P602, DOI 10.1016/j.molcel.2009.01.012; Markin CJ, 2010, J AM CHEM SOC, V132, P11247, DOI 10.1021/ja103869x; Mayers JR, 2011, J BIOL CHEM, V286, P9636, DOI 10.1074/jbc.M110.185363; Mizuno E, 2004, J BIOCHEM, V135, P385, DOI 10.1093/jb/mvh046; Mizuno E, 2003, MOL BIOL CELL, V14, P3675, DOI 10.1091/mbc.E02-12-0823; Pervushin K, 1997, P NATL ACAD SCI USA, V94, P12366, DOI 10.1073/pnas.94.23.12366; Pickart CM, 2004, CURR OPIN CHEM BIOL, V8, P610, DOI 10.1016/j.cbpa.2004.09.009; Pickart CM, 2005, METHOD ENZYMOL, V399, P21, DOI 10.1016/S0076-6879(05)99002-2; Platta HW, 2011, CURR OPIN CELL BIOL, V23, P393, DOI 10.1016/j.ceb.2011.03.008; Rahighi S, 2009, CELL, V136, P1098, DOI 10.1016/j.cell.2009.03.007; Raiborg C, 2008, EXP CELL RES, V314, P801, DOI 10.1016/j.yexcr.2007.10.014; Ren XF, 2010, EMBO J, V29, P1045, DOI 10.1038/emboj.2010.6; Ryabov Y, 2006, PROTEINS, V63, P787, DOI 10.1002/prot.20917; SALI A, 1993, J MOL BIOL, V234, P779, DOI 10.1006/jmbi.1993.1626; Scita G, 2010, NATURE, V463, P464, DOI 10.1038/nature08910; Shields SB, 2009, J CELL BIOL, V185, P213, DOI 10.1083/jcb.200811130; Shih SC, 2002, NAT CELL BIOL, V4, P389, DOI 10.1038/ncb790; Sims JJ, 2009, MOL CELL, V33, P775, DOI 10.1016/j.molcel.2009.02.011; Slagsvold T, 2006, TRENDS CELL BIOL, V16, P317, DOI 10.1016/j.tcb.2006.04.004; Sorkin A, 2009, NAT REV MOL CELL BIO, V10, P609, DOI 10.1038/nrm2748; Swanson KA, 2003, EMBO J, V22, P4597, DOI 10.1093/emboj/cdg471; Ubbink M, 2009, FEBS LETT, V583, P1060, DOI 10.1016/j.febslet.2009.02.046; Varadan R, 2004, J BIOL CHEM, V279, P7055, DOI 10.1074/jbc.M309184200; Varadan R, 2005, METHOD ENZYMOL, V399, P177, DOI 10.1016/S0076-6879(05)99012-5; Varadan R, 2002, J MOL BIOL, V324, P637, DOI 10.1016/S0022-2836(02)01198-1; WISHART DS, 1994, J BIOMOL NMR, V4, P171; Wollert T, 2010, NATURE, V464, P864, DOI 10.1038/nature08849; Zhang D, 2008, J MOL BIOL, V377, P162, DOI 10.1016/j.jmb.2007.12.029; Zhang NX, 2009, MOL CELL, V35, P280, DOI 10.1016/j.molcel.2009.06.010; Zhou HX, 2009, CHEM REV, V109, P4092, DOI 10.1021/cr800551w; Zhou HX, 2001, J PHYS CHEM B, V105, P6763, DOI 10.1021/jp011355n	64	17	18	0	8	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAY 25	2012	287	22					18687	18699		10.1074/jbc.M111.324954	http://dx.doi.org/10.1074/jbc.M111.324954			13	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	974EC	22493438	hybrid, Green Published			2022-12-25	WOS:000306411600077
J	Narayan, SB; Master, SR; Sireci, AN; Bierl, C; Stanley, PE; Li, CH; Stanley, CA; Bennett, MJ				Narayan, Srinivas B.; Master, Stephen R.; Sireci, Anthony N.; Bierl, Charlene; Stanley, Paige E.; Li, Changhong; Stanley, Charles A.; Bennett, Michael J.			Short-Chain 3-Hydroxyacyl-Coenzyme A Dehydrogenase Associates with a Protein Super-Complex Integrating Multiple Metabolic Pathways	PLOS ONE			English	Article							CITRATE SYNTHASE; MALATE-DEHYDROGENASE; INSULIN-SECRETION; BETA-OXIDATION; MITOCHONDRIAL; HYPERINSULINISM; DEFICIENCY; ENZYMES; CELL; MUTATIONS	Proteins involved in mitochondrial metabolic pathways engage in functionally relevant multi-enzyme complexes. We previously described an interaction between short-chain 3-hydroxyacyl-coenzyme A dehydrogenase (SCHAD) and glutamate dehydrogenase (GDH) explaining the clinical phenotype of hyperinsulinism in SCHAD-deficient patients and adding SCHAD to the list of mitochondrial proteins capable of forming functional, multi-pathway complexes. In this work, we provide evidence of SCHAD's involvement in additional interactions forming tissue-specific metabolic super complexes involving both membrane-associated and matrix-dwelling enzymes and spanning multiple metabolic pathways. As an example, in murine liver, we find SCHAD interaction with aspartate transaminase (AST) and GDH from amino acid metabolic pathways, carbamoyl phosphate synthase I (CPS-1) from ureagenesis, other fatty acid oxidation and ketogenesis enzymes and fructose-bisphosphate aldolase, an extra-mitochondrial enzyme of the glycolytic pathway. Most of the interactions appear to be independent of SCHAD's role in the penultimate step of fatty acid oxidation suggesting an organizational, structural or non-enzymatic role for the SCHAD protein.	[Narayan, Srinivas B.; Stanley, Paige E.; Bennett, Michael J.] Childrens Hosp Philadelphia, Dept Pathol & Lab Med, Philadelphia, PA 19104 USA; [Master, Stephen R.; Bennett, Michael J.] Univ Penn, Dept Pathol & Lab Med, Perelman Sch Med, Philadelphia, PA 19104 USA; [Sireci, Anthony N.] Columbia Univ, Coll Phys & Surg, Dept Pathol & Cell Biol, New York, NY USA; [Bierl, Charlene] Cooper Univ Hosp, Dept Pathol, Camden, NJ USA; [Li, Changhong; Stanley, Charles A.] Childrens Hosp Philadelphia, Div Endocrinol, Philadelphia, PA 19104 USA; [Li, Changhong; Stanley, Charles A.] Univ Penn, Dept Pediat, Perelman Sch Med, Philadelphia, PA 19104 USA	University of Pennsylvania; Pennsylvania Medicine; Childrens Hospital of Philadelphia; University of Pennsylvania; Pennsylvania Medicine; Columbia University; Cooper University Hospital; University of Pennsylvania; Pennsylvania Medicine; Childrens Hospital of Philadelphia; University of Pennsylvania; Pennsylvania Medicine	Narayan, SB (corresponding author), Childrens Hosp Philadelphia, Dept Pathol & Lab Med, Philadelphia, PA 19104 USA.	bennettmi@email.chop.edu	Abed, Farook Nehad/AAV-4188-2020	Abed, Farook Nehad/0000-0003-0338-0283; Master, Stephen/0000-0002-6808-631X; STANLEY, CHARLES/0000-0003-4881-9392	 [5R01 DK053012-11]; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R37DK056268, R01DK053012] Funding Source: NIH RePORTER	; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	This work was supported by 5R01 DK053012-11, to CAS. Molecular Basis of a New Form of Hyperinsulinism. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	BEECKMANS S, 1981, EUR J BIOCHEM, V117, P527; Bennett MJ, 2006, MOL GENET METAB, V89, P74, DOI 10.1016/j.ymgme.2006.04.004; BENNETT MJ, 1994, J INHERIT METAB DIS, V17, P283, DOI 10.1007/BF00711808; BUSTAMANTE E, 1977, P NATL ACAD SCI USA, V74, P3735, DOI 10.1073/pnas.74.9.3735; Clayton PT, 2001, J CLIN INVEST, V108, P457; Cox J, 2008, NAT BIOTECHNOL, V26, P1367, DOI 10.1038/nbt.1511; Enns GM, 2000, J PEDIATR-US, V136, P251, DOI 10.1016/S0022-3476(00)70111-9; FAHIEN LA, 1985, J BIOL CHEM, V260, P6069; FAHIEN LA, 1983, ARCH BIOCHEM BIOPHYS, V220, P386, DOI 10.1016/0003-9861(83)90428-9; Genda EN, 2011, J NEUROSCI, V31, P18275, DOI 10.1523/JNEUROSCI.3305-11.2011; HALPER LA, 1977, ARCH BIOCHEM BIOPHYS, V184, P529, DOI 10.1016/0003-9861(77)90462-3; Hardy OT, 2007, MOL ENDOCRINOL, V21, P765, DOI 10.1210/me.2006-0411; Hussain K, 2005, J PEDIATR-US, V146, P706, DOI 10.1016/j.jpeds.2005.01.032; Kapoor RR, 2009, J CLIN ENDOCR METAB, V94, P2221, DOI 10.1210/jc.2009-0423; KISPAL G, 1986, J BIOL CHEM, V261, P14209; Li CH, 2010, J BIOL CHEM, V285, P31806, DOI 10.1074/jbc.M110.123638; Martens GA, 2007, J BIOL CHEM, V282, P21134, DOI 10.1074/jbc.M700083200; Molven A, 2004, DIABETES, V53, P221, DOI 10.2337/diabetes.53.1.221; Narayan SB, 2011, CLIN CHEM LAB MED, V49, P1177, DOI 10.1515/CCLM.2011.200; Olsen LF, 2009, BIOPHYS J, V96, P3850, DOI 10.1016/j.bpj.2009.02.026; Parker A, 2000, BIOCHEM J, V345, P429, DOI 10.1042/0264-6021:3450429; Pearce EL, 2009, NATURE, V460, P103, DOI 10.1038/nature08097; Pepin E, 2010, J DIABETES, V2, P157, DOI 10.1111/j.1753-0407.2010.00076.x; Stanley CA, 1998, NEW ENGL J MED, V338, P1352, DOI 10.1056/NEJM199805073381904; SUMEGI B, 1984, J BIOL CHEM, V259, P5040; Vockley J, 2000, MOL GENET METAB, V71, P10, DOI 10.1006/mgme.2000.3066; Wang YD, 2010, J BIOL CHEM, V285, P29834, DOI 10.1074/jbc.M110.139493; Wisniewski JR, 2009, NAT METHODS, V6, P359, DOI [10.1038/nmeth.1322, 10.1038/NMETH.1322]	28	14	15	1	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 9	2012	7	4							e35048	10.1371/journal.pone.0035048	http://dx.doi.org/10.1371/journal.pone.0035048			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	955JO	22496890	Green Published, gold, Green Submitted			2022-12-25	WOS:000305014500041
J	Noch, E; Sariyer, IK; Gordon, J; Khalili, K				Noch, Evan; Sariyer, Ilker Kudret; Gordon, Jennifer; Khalili, Kamel			JC Virus T-Antigen Regulates Glucose Metabolic Pathways in Brain Tumor Cells	PLOS ONE			English	Article							HUMAN-PAPILLOMAVIRUS TYPE-16; CANCER-CELLS; IN-VIVO; PYRUVATE-KINASE; DOWN-REGULATION; PROTEIN-KINASE; REPLICATION; EXPRESSION; TRANSCRIPTION; POLYOMAVIRUS	Recent studies have reported the detection of the human neurotropic virus, JCV, in a significant population of brain tumors, including medulloblastomas. Accordingly, expression of the JCV early protein, T-antigen, which has transforming activity in cell culture and in transgenic mice, results in the development of a broad range of tumors of neural crest and glial origin. Evidently, the association of T-antigen with a range of tumor-suppressor proteins, including p53 and pRb, and signaling molecules, such as b-catenin and IRS-1, plays a role in the oncogenic function of JCV T-antigen. We demonstrate that T-antigen expression is suppressed by glucose deprivation in medulloblastoma cells and in glioblastoma xenografts that both endogenously express T-antigen. Mechanistic studies indicate that glucose deprivation-mediated suppression of T-antigen is partly influenced by 5'-activated AMP kinase (AMPK), an important sensor of the AMP/ATP ratio in cells. In addition, glucose deprivation-induced cell cycle arrest in the G1 phase is blocked with AMPK inhibition, which also prevents T-antigen downregulation. Furthermore, T-antigen prevents G1 arrest and sustains cells in the G2 phase during glucose deprivation. On a functional level, T-antigen downregulation is partially dependent on reactive oxygen species (ROS) production during glucose deprivation, and T-antigen prevents ROS induction, loss of ATP production, and cytotoxicity induced by glucose deprivation. Additionally, we have found that T-antigen is downregulated by the glycolytic inhibitor, 2-deoxy-D-glucose (2-DG), and the pentose phosphate inhibitors, 6-aminonicotinamide and oxythiamine, and that T-antigen modulates expression of the glycolytic enzyme, hexokinase 2 (HK2), and the pentose phosphate enzyme, transaldolase-1 (TALDO1), indicating a potential link between T-antigen and metabolic regulation. These studies point to the possible involvement of JCV T-antigen in medulloblastoma proliferation and the metabolic phenotype and may enhance our understanding of the role of viral proteins in glycolytic tumor metabolism, thus providing useful targets for the treatment of virus-induced tumors.	[Noch, Evan] Temple Univ, Sch Med, Dept Neurosci, Philadelphia, PA 19122 USA; Temple Univ, Sch Med, Ctr Neurovirol, Philadelphia, PA 19122 USA	Pennsylvania Commonwealth System of Higher Education (PCSHE); Temple University; Pennsylvania Commonwealth System of Higher Education (PCSHE); Temple University	Noch, E (corresponding author), Temple Univ, Sch Med, Dept Neurosci, Philadelphia, PA 19122 USA.	kamel.khalili@temple.edu	Sariyer, Ilker/AAE-7677-2020		National Institutes of Health [1T32MH079785, R01NS35000]; NATIONAL INSTITUTE OF MENTAL HEALTH [P30MH092177, T32MH079785] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS035000] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF MENTAL HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))	This investigation was partiallly supported by the National Institutes of Health under Ruth L. Kirchstein National Research Service Award (1T32MH079785) providing support to EN. Additional support for this work was made possible by grant number R01NS35000 awarded by NIH to KK. The funders had no role in the study design, data collection and analysis, decision to publish or preparation of the manuscript.	Bollag B, 1996, VIROLOGY, V218, P81, DOI 10.1006/viro.1996.0168; BRAVARD A, 1992, CARCINOGENESIS, V13, P767, DOI 10.1093/carcin/13.5.767; Caldarelli-Stefano R, 2000, HUM PATHOL, V31, P394, DOI 10.1016/S0046-8177(00)80256-7; Caracciolo V, 2010, J CELL BIOCHEM, V110, P182, DOI 10.1002/jcb.22525; Cheng P, 2009, ONCOL REP, V22, P1101, DOI 10.3892/or_00000542; Christofk HR, 2008, NATURE, V452, P230, DOI 10.1038/nature06734; Davy CE, 2002, J VIROL, V76, P9806, DOI 10.1128/JVI.76.19.9806-9818.2002; Del Valle L, 2001, CANCER RES, V61, P4287; Deshmane SL, 2009, J BIOL CHEM, V284, P11364, DOI 10.1074/jbc.M809266200; Dwarakanath BS, 2009, J CANCER RES THER, V5, P21, DOI 10.4103/0973-1482.55136; Gan DD, 2004, ONCOGENE, V23, P483, DOI 10.1038/sj.onc.1207018; Gan DD, 2001, ONCOGENE, V20, P4864, DOI 10.1038/sj.onc.1204670; Gentilella A, 2009, J CELL BIOCHEM, V108, P1117, DOI 10.1002/jcb.22343; Hernlund E, 2009, MOL CANCER THER, V8, P1916, DOI 10.1158/1535-7163.MCT-09-0179; HINDS PW, 1992, CELL, V70, P993, DOI 10.1016/0092-8674(92)90249-C; Izumi T, 2010, P NATL ACAD SCI USA, V107, P20798, DOI 10.1073/pnas.1008076107; JONES JS, 1993, J VIROL, V67, P67, DOI 10.1128/JVI.67.1.67-74.1993; Kasai D, 2009, J HEPATOL, V50, P883, DOI 10.1016/j.jhep.2008.12.029; Khalili K, 2003, ONCOGENE, V22, P5181, DOI 10.1038/sj.onc.1206559; Khalili K, 2003, ANTICANCER RES, V23, P2035; KITAGAWA K, 1985, BIOCHIM BIOPHYS ACTA, V821, P63, DOI 10.1016/0005-2736(85)90153-1; Krynska B, 1999, ONCOGENE, V18, P39, DOI 10.1038/sj.onc.1202278; Krynska B, 1997, J CELL BIOCHEM, V67, P223, DOI 10.1002/(SICI)1097-4644(19971101)67:2<223::AID-JCB7>3.0.CO;2-Z; Kumar SH, 2009, J VIROL, V83, P8565, DOI 10.1128/JVI.00603-09; Lachaise F, 2001, FREE RADICAL BIO MED, V30, P1365, DOI 10.1016/S0891-5849(01)00532-9; Laderoute KR, 2006, MOL CELL BIOL, V26, P5336, DOI 10.1128/MCB.00166-06; Liu BL, 2009, CELL CYCLE, V8, P2031, DOI 10.4161/cc.8.13.8814; Maehama T, 1998, INT J CANCER, V76, P639, DOI 10.1002/(SICI)1097-0215(19980529)76:5<639::AID-IJC5>3.0.CO;2-R; Manel N, 2003, CELL, V115, P449, DOI 10.1016/S0092-8674(03)00881-X; Maschek G, 2004, CANCER RES, V64, P31, DOI 10.1158/0008-5472.CAN-03-3294; NATH KA, 1995, AM J PHYSIOL-CELL PH, V268, pC227, DOI 10.1152/ajpcell.1995.268.1.C227; Orba Y, 2010, J BIOL CHEM, V285, P1544, DOI 10.1074/jbc.M109.064311; RAJ GV, 1995, INT J ONCOL, V7, P801; Safak M, 2001, J VIROL, V75, P1476, DOI 10.1128/JVI.75.3.1476-1486.2001; SATO H, 1989, J VIROL, V63, P3555, DOI 10.1128/JVI.63.8.3555-3559.1989; Spitz DR, 2000, ANN NY ACAD SCI, V899, P349, DOI 10.1111/j.1749-6632.2000.tb06199.x; Staib C, 1996, VIROLOGY, V219, P237, DOI 10.1006/viro.1996.0241; Uleri E, GENES CANC, V2, P728; Wang W, 2002, MOL CELL BIOL, V22, P3425, DOI 10.1128/MCB.22.10.3425-3436.2002; WARBURG O, 1956, SCIENCE, V123, P309, DOI 10.1126/science.123.3191.309; WOLD WSM, 1980, J VIROL, V33, P1225, DOI 10.1128/JVI.33.3.1225-1228.1980; Yamada M, 1999, CANCER CHEMOTH PHARM, V44, P59, DOI 10.1007/s002800050945; Zhou GC, 2001, J CLIN INVEST, V108, P1167, DOI 10.1172/JCI200113505; Zhou J, 2009, ONCOGENE, V28, P1993, DOI 10.1038/onc.2009.63; Zhuang Yongxian, 2008, J Mol Signal, V3, P18, DOI 10.1186/1750-2187-3-18; Zwerschke W, 1999, P NATL ACAD SCI USA, V96, P1291, DOI 10.1073/pnas.96.4.1291	46	19	19	0	14	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 9	2012	7	4							e35054	10.1371/journal.pone.0035054	http://dx.doi.org/10.1371/journal.pone.0035054			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	955JO	22496891	gold, Green Published, Green Submitted			2022-12-25	WOS:000305014500042
J	Hao, WL; Allen, VG; Jamieson, FB; Low, DE; Alexander, DC				Hao, Weilong; Allen, Vanessa G.; Jamieson, Frances B.; Low, Donald E.; Alexander, David C.			Phylogenetic Incongruence in E. coli O104: Understanding the Evolutionary Relationships of Emerging Pathogens in the Face of Homologous Recombination	PLOS ONE			English	Article							HEMOLYTIC-UREMIC SYNDROME; COMPLETE GENOME SEQUENCE; ESCHERICHIA-COLI; MOSAIC STRUCTURE; SPECIATION; DNA; INTEGRATION; POPULATIONS; DIVERSITY; INFERENCE	Escherichia coli O104:H4 was identified as an emerging pathogen during the spring and summer of 2011 and was responsible for a widespread outbreak that resulted in the deaths of 50 people and sickened over 4075. Traditional phenotypic and genotypic assays, such as serotyping, pulsed field gel electrophoresis (PFGE), and multilocus sequence typing (MLST), permit identification and classification of bacterial pathogens, but cannot accurately resolve relationships among genotypically similar but pathotypically different isolates. To understand the evolutionary origins of E. coli O104:H4, we sequenced two strains isolated in Ontario, Canada. One was epidemiologically linked to the 2011 outbreak, and the second, unrelated isolate, was obtained in 2010. MLST analysis indicated that both isolates are of the same sequence type (ST678), but whole-genome sequencing revealed differences in chromosomal and plasmid content. Through comprehensive phylogenetic analysis of five O104:H4 ST678 genomes, we identified 167 genes in three gene clusters that have undergone homologous recombination with distantly related E. coli strains. These recombination events have resulted in unexpectedly high sequence diversity within the same sequence type. Failure to recognize or adjust for homologous recombination can result in phylogenetic incongruence. Understanding the extent of homologous recombination among different strains of the same sequence type may explain the pathotypic differences between the ON2010 and ON2011 strains and help shed new light on the emergence of this new pathogen.	[Hao, Weilong; Allen, Vanessa G.; Jamieson, Frances B.; Low, Donald E.; Alexander, David C.] Univ Toronto, Dept Lab Med & Pathobiol, Toronto, ON, Canada; [Hao, Weilong; Allen, Vanessa G.; Jamieson, Frances B.; Low, Donald E.] Mt Sinai Hosp, Toronto, ON M5G 1X5, Canada; [Hao, Weilong; Allen, Vanessa G.; Jamieson, Frances B.; Low, Donald E.; Alexander, David C.] Publ Hlth Ontario, Publ Hlth Labs, Toronto, ON, Canada	University of Toronto; University of Toronto; University Toronto Affiliates; Sinai Health System Toronto	Hao, WL (corresponding author), Wayne State Univ, Dept Biol Sci, Detroit, MI 48202 USA.	HaoW@wayne.edu	Jamieson, Frances/B-2040-2013; Hao, Weilong/C-4923-2009; Allen, Vanessa/AAE-2756-2022	Hao, Weilong/0000-0002-6337-7169; Allen, Vanessa/0000-0001-9802-9730	Public Health Ontario; Public Health Agency of Canada	Public Health Ontario; Public Health Agency of Canada	This work was supported by funding from Public Health Ontario and the Public Health Agency of Canada. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alexander DC, 2012, EMERG INFEC IN PRESS; Alikhan NF, 2011, BMC GENOMICS, V12, DOI 10.1186/1471-2164-12-402; Archer CT, 2011, BMC GENOMICS, V12, DOI 10.1186/1471-2164-12-9; Bae WK, 2006, YONSEI MED J, V47, P437, DOI 10.3349/ymj.2006.47.3.437; Bielaszewska M, 2011, LANCET INFECT DIS, V11, P671, DOI 10.1016/S1473-3099(11)70165-7; Bruen TC, 2006, GENETICS, V172, P2665, DOI 10.1534/genetics.105.048975; Brzuszkiewicz E, 2011, ARCH MICROBIOL, V193, P883, DOI 10.1007/s00203-011-0725-6; Budroni S, 2011, P NATL ACAD SCI USA, V108, P4494, DOI 10.1073/pnas.1019751108; Camacho C, 2009, BMC BIOINFORMATICS, V10, DOI 10.1186/1471-2105-10-421; Chaudhuri RR, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0008801; Daubin V, 2004, GENOME RES, V14, P1036, DOI 10.1101/gr.2231904; Didelot X, 2011, PLOS GENET, V7, DOI 10.1371/journal.pgen.1002191; Dobrindt U, 2001, CURR OPIN MICROBIOL, V4, P550, DOI 10.1016/S1369-5274(00)00250-2; DYKHUIZEN DE, 1991, J BACTERIOL, V173, P7257, DOI 10.1128/jb.173.22.7257-7268.1991; Edgar RC, 2004, NUCLEIC ACIDS RES, V32, P1792, DOI 10.1093/nar/gkh340; Falush D, 2003, GENETICS, V164, P1567; Feil EJ, 2001, P NATL ACAD SCI USA, V98, P182, DOI 10.1073/pnas.98.1.182; Felsenstein J., 1989, CLADISTICS, V5, P164, DOI DOI 10.1111/J.1096-0031.1989.TB00562.X; Gordon D, 2001, GENOME RES, V11, P614, DOI 10.1101/gr.171401; Guo H, 2009, GENOME, V52, P862, DOI [10.1139/G09-060, 10.1139/g09-060]; GUTTMAN DS, 1994, SCIENCE, V266, P1380, DOI 10.1126/science.7973728; Hacker J, 1997, MOL MICROBIOL, V23, P1089, DOI 10.1046/j.1365-2958.1997.3101672.x; Hao Weilong, 2011, Mob Genet Elements, V1, P256; Hao WL, 2011, GENOME BIOL EVOL, V3, P1406, DOI 10.1093/gbe/evr119; Hao WL, 2011, GENE, V481, P57, DOI 10.1016/j.gene.2011.04.012; Hao WL, 2010, BMC BIOINFORMATICS, V11, DOI 10.1186/1471-2105-11-114; Hao WL, 2006, GENOME RES, V16, P636, DOI 10.1101/gr.4746406; Huang XQ, 1999, GENOME RES, V9, P868, DOI 10.1101/gr.9.9.868; Jolley KA, 2010, BMC BIOINFORMATICS, V11, DOI 10.1186/1471-2105-11-595; KARLIN S, 1995, TRENDS GENET, V11, P283; Koski LB, 2001, J MOL EVOL, V52, P540, DOI 10.1007/s002390010184; Leigh JW, 2008, SYST BIOL, V57, P104, DOI 10.1080/10635150801910436; Lukjancenko O, 2010, MICROB ECOL, V60, P708, DOI 10.1007/s00248-010-9717-3; Luo CW, 2011, P NATL ACAD SCI USA, V108, P7200, DOI 10.1073/pnas.1015622108; Maiden MCJ, 1998, P NATL ACAD SCI USA, V95, P3140, DOI 10.1073/pnas.95.6.3140; Martin D, 2000, BIOINFORMATICS, V16, P562, DOI 10.1093/bioinformatics/16.6.562; MARTINEZ E, 1990, EMBO J, V9, P1275, DOI 10.1002/j.1460-2075.1990.tb08236.x; Mazel D, 1998, SCIENCE, V280, P605, DOI 10.1126/science.280.5363.605; McGraw EA, 1999, MOL BIOL EVOL, V16, P12, DOI 10.1093/oxfordjournals.molbev.a026032; Mellmann A, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0022751; Mossoro C, 2002, J CLIN MICROBIOL, V40, P3086, DOI 10.1128/JCM.40.8.3086-3088.2002; Ochman H, 1999, P NATL ACAD SCI USA, V96, P12638, DOI 10.1073/pnas.96.22.12638; Ochman H, 2000, NATURE, V405, P299, DOI 10.1038/35012500; Ogura Y, 2009, P NATL ACAD SCI USA, V106, P17939, DOI 10.1073/pnas.0903585106; Oshima K, 2008, DNA RES, V15, P375, DOI 10.1093/dnares/dsn026; Posada D, 2002, J MOL EVOL, V54, P396, DOI 10.1007/s00239-001-0034-9; Posada D, 2002, ANNU REV GENET, V36, P75, DOI 10.1146/annurev.genet.36.040202.111115; Rasko DA, 2008, J BACTERIOL, V190, P6881, DOI 10.1128/JB.00619-08; Rasko DA, 2011, NEW ENGL J MED, V365, P709, DOI 10.1056/NEJMoa1106920; Retchless AC, 2007, SCIENCE, V317, P1093, DOI 10.1126/science.1144876; Retchless AC, 2010, P NATL ACAD SCI USA, V107, P11453, DOI 10.1073/pnas.1001291107; Rocha EPC, 2006, MOL BIOL EVOL, V23, P513, DOI 10.1093/molbev/msj052; Rohde H, 2011, NEW ENGL J MED, V365, P718, DOI 10.1056/NEJMoa1107643; Rosenberg NA, 2004, MOL ECOL NOTES, V4, P137, DOI 10.1046/j.1471-8286.2003.00566.x; Rowe-Magnus DA, 2003, GENOME RES, V13, P428, DOI 10.1101/gr.617103; Sims GE, 2011, P NATL ACAD SCI USA, V108, P8329, DOI 10.1073/pnas.1105168108; Sims GE, 2009, P NATL ACAD SCI USA, V106, P2677, DOI 10.1073/pnas.0813249106; Sonnhammer ELL, 1995, GENE, V167, pGC1, DOI 10.1016/0378-1119(95)00714-8; Stamatakis A, 2006, BIOINFORMATICS, V22, P2688, DOI 10.1093/bioinformatics/btl446; STOKES HW, 1989, MOL MICROBIOL, V3, P1669, DOI 10.1111/j.1365-2958.1989.tb00153.x; Tatusov RL, 2000, NUCLEIC ACIDS RES, V28, P33, DOI 10.1093/nar/28.1.33; Thompson JR, 2005, SCIENCE, V307, P1311, DOI 10.1126/science.1106028; Touchon M, 2009, PLOS GENET, V5, DOI 10.1371/journal.pgen.1000344; Vos M, 2009, ISME J, V3, P199, DOI 10.1038/ismej.2008.93; Welch RA, 2002, P NATL ACAD SCI USA, V99, P17020, DOI 10.1073/pnas.252529799; Wirth T, 2006, MOL MICROBIOL, V60, P1136, DOI 10.1111/j.1365-2958.2006.05172.x; Yomano LP, 1998, J IND MICROBIOL BIOT, V20, P132, DOI 10.1038/sj.jim.2900496; Zhou ZM, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0008700	68	20	21	0	13	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 6	2012	7	4							e33971	10.1371/journal.pone.0033971	http://dx.doi.org/10.1371/journal.pone.0033971			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	955JA	22493677	Green Published, Green Submitted, gold			2022-12-25	WOS:000305012700019
J	Nehring, S; Budisa, N; Wiltschi, B				Nehring, Sebastian; Budisa, Nediljko; Wiltschi, Birgit			Performance Analysis of Orthogonal Pairs Designed for an Expanded Eukaryotic Genetic Code	PLOS ONE			English	Article							TRANSFER-RNA-SYNTHETASE; UNNATURAL AMINO-ACIDS; CU,ZN SUPEROXIDE-DISMUTASE; PROTEIN-COUPLED RECEPTOR; ESCHERICHIA-COLI; IN-VIVO; SACCHAROMYCES-CEREVISIAE; SUBSTRATE-SPECIFICITY; YEAST; EXPRESSION	Background: The suppression of amber stop codons with non-canonical amino acids (ncAAs) is used for the site-specific introduction of many unusual functions into proteins. Specific orthogonal aminoacyl-tRNA synthetase (o-aaRS)/amber suppressor tRNA(CUA) pairs (o-pairs) for the incorporation of ncAAs in S. cerevisiae were previously selected from an E. coli tyrosyl-tRNA synthetase/tRNA(CUA) mutant library. Incorporation fidelity relies on the specificity of the o-aaRSs for their ncAAs and the ability to effectively discriminate against their natural substrate Tyr or any other canonical amino acid. Methodology/Principal Findings: We used o-pairs previously developed for ncAAs carrying reactive alkyne-, azido-, or photocrosslinker side chains to suppress an amber mutant of human superoxide dismutase 1 in S. cerevisiae. We found worse incorporation efficiencies of the alkyne- and the photocrosslinker ncAAs than reported earlier. In our hands, amber suppression with the ncAA containing the azido group did not occur at all. In addition to the incorporation experiments in S. cerevisiae, we analyzed the catalytic properties of the o-aaRSs in vitro. Surprisingly, all o-aaRSs showed much higher preference for their natural substrate Tyr than for any of the tested ncAAs. While it is unclear why efficiently recognized Tyr is not inserted at amber codons, we speculate that metabolically inert ncAAs accumulate in the cell, and for this reason they are incorporated despite being weak substrates for the o-aaRSs. Conclusions/Significance: O-pairs have been developed for a whole plethora of ncAAs. However, a systematic and detailed analysis of their catalytic properties is still missing. Our study provides a comprehensive scrutiny of o-pairs developed for the site-specific incorporation of reactive ncAAs in S. cerevisiae. It suggests that future development of o-pairs as efficient biotechnological tools will greatly benefit from sound characterization in vivo and in vitro in parallel to monitoring intracellular ncAA levels.	[Nehring, Sebastian; Budisa, Nediljko] Tech Univ Berlin, Dept Biocatalysis, Berlin, Germany; [Wiltschi, Birgit] Univ Freiburg, BIOSS Ctr Biol Signalling Studies, D-79106 Freiburg, Germany; [Wiltschi, Birgit] Univ Freiburg, Fac Biol, D-79106 Freiburg, Germany	Technical University of Berlin; University of Freiburg; University of Freiburg	Nehring, S (corresponding author), Tech Univ Berlin, Dept Biocatalysis, Berlin, Germany.	birgit.wiltschi@acib.at	Budisa, Nediljko/AAA-4634-2022; Budisa, Nediljko/AAG-7291-2019; Budisa, Nediljko/T-4812-2017	Budisa, Nediljko/0000-0001-8437-7304; Budisa, Nediljko/0000-0001-8437-7304; Wiltschi, Birgit/0000-0001-5230-0951	Federal Ministry of Education and Research of Germany	Federal Ministry of Education and Research of Germany(Federal Ministry of Education & Research (BMBF))	The work was supported by the BioFuture Program of the Federal Ministry of Education and Research of Germany. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ai HW, 2010, ANGEW CHEM INT EDIT, V49, P935, DOI 10.1002/anie.200905590; Baruah M, 1996, SYNLETT, P1193; Beatty KE, 2008, BIOORG MED CHEM LETT, V18, P5995, DOI 10.1016/j.bmcl.2008.08.046; Beatty KE, 2006, ANGEW CHEM INT EDIT, V45, P7364, DOI 10.1002/anie.200602114; Beatty KE, 2010, CHEMBIOCHEM, V11, P2092, DOI 10.1002/cbic.201000419; Boer E, 2007, APPL MICROBIOL BIOT, V77, P513, DOI 10.1007/s00253-007-1209-0; Brustad E, 2008, BIOORG MED CHEM LETT, V18, P6004, DOI 10.1016/j.bmcl.2008.09.050; Chen HT, 2007, NAT STRUCT MOL BIOL, V14, P696, DOI 10.1038/nsmb1272; Chen PR, 2009, ANGEW CHEM INT EDIT, V48, P4052, DOI 10.1002/anie.200900683; Chen S, 2007, J MOL BIOL, V371, P112, DOI 10.1016/j.jmb.2007.05.017; Chin JW, 2003, SCIENCE, V301, P964, DOI 10.1126/science.1084772; Chin JW, 2003, CHEM BIOL, V10, P511, DOI 10.1016/S1074-5521(03)00123-6; Chin JW, 2002, J AM CHEM SOC, V124, P9026, DOI 10.1021/ja027007w; Coin I, 2011, ANGEW CHEM INT EDIT, V50, P8077, DOI 10.1002/anie.201102646; Cropp TA, 2007, NAT PROTOC, V2, P2590, DOI 10.1038/nprot.2007.378; Daggett KA, 2011, CURR OPIN CHEM BIOL, V15, P392, DOI 10.1016/j.cbpa.2011.03.010; Deiters A, 2003, J AM CHEM SOC, V125, P11782, DOI 10.1021/ja0370037; Deiters A, 2004, BIOORG MED CHEM LETT, V14, P5743, DOI 10.1016/j.bmcl.2004.09.059; Deiters A, 2006, UNNATURAL REACTIVE A; Dieterich DC, 2010, NAT NEUROSCI, V13, P897, DOI 10.1038/nn.2580; Francklyn CS, 2008, METHODS, V44, P100, DOI 10.1016/j.ymeth.2007.09.007; Furter R, 1998, PROTEIN SCI, V7, P419; Giese C, 2008, CHEMMEDCHEM, V3, P1449, DOI 10.1002/cmdc.200800108; Gietz RD, 2002, METHOD ENZYMOL, V350, P87; Grunbeck A, 2011, BIOCHEMISTRY-US, V50, P3411, DOI 10.1021/bi200214r; HAID A, 1983, METHOD ENZYMOL, V96, P192; HALLEWELL RA, 1987, BIO-TECHNOL, V5, P363, DOI 10.1038/nbt0487-363; Hans MA, 2001, APPL MICROBIOL BIOT, V56, P776, DOI 10.1007/s002530100708; Hoesl MG, 2011, CHEMBIOCHEM, V12, P552, DOI 10.1002/cbic.201000586; Huang LY, 2008, BIOCHEMISTRY-US, V47, P5638, DOI 10.1021/bi701866e; IBBA M, 1994, BIOCHEMISTRY-US, V33, P7107, DOI 10.1021/bi00189a013; IBBA M, 1995, FEBS LETT, V364, P272, DOI 10.1016/0014-5793(95)00408-2; Kamal A, 1997, CHEM COMMUN, P1015, DOI 10.1039/a701249g; KAST P, 1991, J MOL BIOL, V222, P99, DOI 10.1016/0022-2836(91)90740-W; Kiick KL, 2000, ANGEW CHEM INT EDIT, V39, P2148, DOI 10.1002/1521-3773(20000616)39:12<2148::AID-ANIE2148>3.0.CO;2-7; Kiick KL, 2000, TETRAHEDRON, V56, P9487, DOI 10.1016/S0040-4020(00)00833-4; LAEMMLI UK, 1970, NATURE, V227, P680, DOI 10.1038/227680a0; LAWRENCE F, 1973, EUR J BIOCHEM, V36, P234, DOI 10.1111/j.1432-1033.1973.tb02905.x; Lee HS, 2009, J AM CHEM SOC, V131, P12921, DOI 10.1021/ja904896s; Lepthien S, 2010, ANGEW CHEM INT EDIT, V49, P5446, DOI 10.1002/anie.201000439; Lichty JJ, 2005, PROTEIN EXPRES PURIF, V41, P98, DOI 10.1016/j.pep.2005.01.019; Lindberg MJ, 2004, P NATL ACAD SCI USA, V101, P15893, DOI 10.1073/pnas.0403979101; Link AJ, 2006, P NATL ACAD SCI USA, V103, P10180, DOI 10.1073/pnas.0601167103; Liu CC, 2010, ANNU REV BIOCHEM, V79, P413, DOI 10.1146/annurev.biochem.052308.105824; Liu DR, 1999, P NATL ACAD SCI USA, V96, P4780, DOI 10.1073/pnas.96.9.4780; Liu WS, 2007, NAT METHODS, V4, P239, DOI 10.1038/NMETH1016; Meldal M, 2008, CHEM REV, V108, P2952, DOI 10.1021/cr0783479; Merkel L, 2008, CHEMBIOCHEM, V9, P1220, DOI 10.1002/cbic.200800050; Merkel L, 2007, CHEMBIOCHEM, V8, P2227, DOI 10.1002/cbic.200700540; Miyake-Stoner SJ, 2010, BIOCHEMISTRY-US, V49, P1667, DOI 10.1021/bi901947r; Mohibullah N, 2008, GENE DEV, V22, P2994, DOI 10.1101/gad.1724408; PARGE HE, 1992, P NATL ACAD SCI USA, V89, P6109, DOI 10.1073/pnas.89.13.6109; ROMANOS MA, 1992, YEAST, V8, P423, DOI 10.1002/yea.320080602; SAMPSON JR, 1989, SCIENCE, V243, P1363; Sharma N, 2000, FEBS LETT, V467, P37, DOI 10.1016/S0014-5793(00)01120-0; Takimoto JK, 2010, CHEMBIOCHEM, V11, P2268, DOI 10.1002/cbic.201000436; Takimoto JK, 2009, MOL BIOSYST, V5, P931, DOI 10.1039/b904228h; Tanrikulu IC, 2009, P NATL ACAD SCI USA, V106, P15285, DOI 10.1073/pnas.0905735106; Tippmann EM, 2007, TETRAHEDRON, V63, P6182, DOI 10.1016/j.tet.2007.02.125; Wan W, 2010, ANGEW CHEM INT EDIT, V49, P3211, DOI 10.1002/anie.201000465; Wang F, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0009354; Wang L, 2001, SCIENCE, V292, P498, DOI 10.1126/science.1060077; Wiltschi B, 2007, APPL MICROBIOL BIOT, V74, P739, DOI 10.1007/s00253-006-0823-6; Ye SX, 2008, J BIOL CHEM, V283, P1525, DOI 10.1074/jbc.M707355200; Ye SX, 2010, NATURE, V464, P1386, DOI 10.1038/nature08948; Ye SX, 2009, NAT CHEM BIOL, V5, P397, DOI 10.1038/nchembio.167; Young DD, 2011, BIOCHEMISTRY-US, V50, P1894, DOI 10.1021/bi101929e; Young TS, 2010, J BIOL CHEM, V285, P11039, DOI 10.1074/jbc.R109.091306; Young TS, 2010, J MOL BIOL, V395, P361, DOI 10.1016/j.jmb.2009.10.030; Young TS, 2009, BIOCHEMISTRY-US, V48, P2643, DOI 10.1021/bi802178k	70	44	46	1	37	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 6	2012	7	4							e31992	10.1371/journal.pone.0031992	http://dx.doi.org/10.1371/journal.pone.0031992			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	955JA	22493661	Green Published, Green Submitted, gold			2022-12-25	WOS:000305012700003
J	Oh, J; Han, M; Peterson, BS; Jeong, J				Oh, Jihoon; Han, Mookyung; Peterson, Bradley S.; Jeong, Jaeseung			Spontaneous Eyeblinks Are Correlated with Responses during the Stroop Task	PLOS ONE			English	Article							EYE BLINKING; INTERFERENCE; FREQUENCY; WORK; GAZE; FMRI; EOG	The timing and frequency of spontaneous eyeblinking is thought to be influenced by ongoing internal cognitive or neurophysiological processes, but how precisely these processes influence the dynamics of eyeblinking is still unclear. This study aimed to better understand the functional role of eyeblinking during cognitive processes by investigating the temporal pattern of eyeblinks during the performance of attentional tasks. The timing of spontaneous eyeblinks was recorded from 28 healthy subjects during the performance of both visual and auditory versions of the Stroop task, and the temporal distributions of eyeblinks were estimated in relation to the timing of stimulus presentation and vocal response during the tasks. We found that the spontaneous eyeblink rate increased during Stroop task performance compared with the resting rate. Importantly, the subjects (17/28 during the visual Stroop, 20/28 during the auditory Stroop) were more likely to blink before a vocal response in both tasks (150-250 msec) and the remaining subjects were more likely to blink soon after the vocal response (200-300 msec), regardless of the stimulus type (congruent or incongruent) or task difficulty. These findings show that spontaneous eyeblinks are closely associated with responses during the performance of the Stroop task on a short time scale and suggest that spontaneous eyeblinks likely signal a shift in the internal cognitive or attentional state of the subjects.	[Oh, Jihoon; Han, Mookyung; Jeong, Jaeseung] Korea Adv Inst Sci & Technol, Dept Bio & Brain Engn, Taejon 305701, South Korea; [Oh, Jihoon] Catholic Univ Korea, Coll Med, Seoul, South Korea; [Peterson, Bradley S.; Jeong, Jaeseung] Columbia Univ, Coll Phys & Surg, Dept Psychiat, New York, NY USA	Korea Advanced Institute of Science & Technology (KAIST); Catholic University of Korea; Columbia University	Oh, J (corresponding author), Korea Adv Inst Sci & Technol, Dept Bio & Brain Engn, Taejon 305701, South Korea.	jsjeong@kaist.ac.kr	Jeong, Jaeseung/C-1620-2011		CHUNG Moon Soul Research Center for BioInformation and BioElectronics (CMSC) in KAIST; Korea Science and Engineering Foundation (KOSEF); Korea government (MOST) [R01-2003-000-10432-0, M10644000028-06N4400-02810]; KAIST [NNA0130]; NIMH [K02-74677]	CHUNG Moon Soul Research Center for BioInformation and BioElectronics (CMSC) in KAIST; Korea Science and Engineering Foundation (KOSEF)(Korea Science and Engineering Foundation); Korea government (MOST)(Ministry of Science & Technology (MOST), Republic of KoreaKorean Government); KAIST; NIMH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH))	This work was supported by CHUNG Moon Soul Research Center for BioInformation and BioElectronics (CMSC) in KAIST, the Korea Science and Engineering Foundation (KOSEF) grant funded by the Korea government (MOST) (No. R01-2003-000-10432-0 and No. M10644000028-06N4400-02810) and grant No. NNA0130 from the KAIST, and NIMH grant K02-74677. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bacher LF, 2004, DEV PSYCHOBIOL, V44, P95, DOI 10.1002/dev.10162; Bentivoglio AR, 1997, MOVEMENT DISORD, V12, P1028, DOI 10.1002/mds.870120629; CAPLAN R, 1994, BIOL PSYCHIAT, V35, P228, DOI 10.1016/0006-3223(94)91253-X; Chung JY, 2006, NEUROSCI LETT, V395, P196, DOI 10.1016/j.neulet.2005.10.094; COHEN JD, 1990, PSYCHOL REV, V97, P332, DOI 10.1037/0033-295X.97.3.332; Colzato LS, 2008, NEUROPSYCHOLOGIA, V46, P3179, DOI 10.1016/j.neuropsychologia.2008.07.006; Colzato LS, 2007, NEUROPSYCHOLOGIA, V45, P2387, DOI 10.1016/j.neuropsychologia.2007.03.004; Dalley, 2008, GRANTS ATLAS ANATOMY; DEJONG PJ, 1990, INT J NEUROSCI, V51, P89, DOI 10.3109/00207459009000513; Doughty MJ, 2001, OPTOMETRY VISION SCI, V78, P712, DOI 10.1097/00006324-200110000-00011; EVINGER C, 1994, EXP BRAIN RES, V100, P337; FUKUDA K, 1994, PERCEPT MOTOR SKILL, V79, P1599, DOI 10.2466/pms.1994.79.3f.1599; Fukuda K, 2001, INT J PSYCHOPHYSIOL, V40, P239, DOI 10.1016/S0167-8760(00)00192-6; HOLLAND MK, 1975, PERCEPT MOTOR SKILL, V41, P403, DOI 10.2466/pms.1975.41.2.403; Ichikawa N, 2004, PERCEPT MOTOR SKILL, V98, P131; Kaneko K, 1999, PERCEPT MOTOR SKILL, V88, P1037, DOI 10.2466/pms.1999.88.3.1037; Kaneko K, 2001, PERCEPT MOTOR SKILL, V92, P234, DOI 10.2466/PMS.92.1.234-250; KARSON CN, 1981, PSYCHIAT RES, V5, P243, DOI 10.1016/0165-1781(81)90070-6; MACLEOD CM, 1991, PSYCHOL BULL, V109, P163, DOI 10.1037/0033-2909.109.2.163; MONSTER AW, 1978, BIOTELEM PAT MON, V5, P206; ORCHARD L N, 1991, Integrative Physiological and Behavioral Science, V26, P108, DOI 10.1007/BF02691032; PIETERS JM, 1981, CORTEX, V17, P369, DOI 10.1016/S0010-9452(81)80024-X; Siegle GJ, 2008, PSYCHOPHYSIOLOGY, V45, P679, DOI 10.1111/j.1469-8986.2008.00681.x; STERN JA, 1984, PSYCHOPHYSIOLOGY, V21, P22, DOI 10.1111/j.1469-8986.1984.tb02312.x; Stroop JR, 1935, J EXP PSYCHOL, V18, P643, DOI 10.1037/h0054651; Tada H, 1978, Fukushima J Med Sci, V25, P91; VONCRAMON D, 1980, NEUROPSYCHOLOGIA, V18, P603, DOI 10.1016/0028-3932(80)90164-5; WOOD CL, 1950, AM J PSYCHOL, V63, P584, DOI 10.2307/1418873; Yoon HW, 2005, NEUROSCI LETT, V381, P26, DOI 10.1016/j.neulet.2005.01.077; ZAKAY D, 1985, CAN J PSYCHOL, V39, P414, DOI 10.1037/h0080069	30	33	33	0	14	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 6	2012	7	4							e34871	10.1371/journal.pone.0034871	http://dx.doi.org/10.1371/journal.pone.0034871			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	955JA	22493720	Green Published, gold, Green Submitted			2022-12-25	WOS:000305012700062
J	Ghosh, S; Hossain, MZ; Borges, M; Goggins, MG; Ingersoll, RG; Eshleman, JR; Klein, AP; Kern, SE				Ghosh, Soma; Hossain, M. Zulfiquer; Borges, Michael; Goggins, Michael G.; Ingersoll, Roxann G.; Eshleman, James R.; Klein, Alison P.; Kern, Scott E.			Analysis of Polymorphisms and Haplotype Structure of the Human Thymidylate Synthase Genetic Region: A Tool for Pharmacogenetic Studies	PLOS ONE			English	Article							SINGLE NUCLEOTIDE POLYMORPHISM; COLORECTAL-CANCER PATIENTS; 5-FLUOROURACIL INCORPORATION; MONONUCLEOTIDE REPEATS; POECILIA-RETICULATA; FUNCTIONAL-ANALYSIS; PREDICTS TOXICITY; DOSE ADJUSTMENT; DNA; RNA	5-fluorouracil (5FU), a widely used chemotherapeutic drug, inhibits the DNA replicative enzyme, thymidylate synthase (Tyms). Prior studies implicated a VNTR (variable numbers of tandem repeats) polymorphism in the 5'-untranslated region (5'-UTR) of the TYMS gene as a determinant of Tyms expression in tumors and normal tissues and proposed that these VNTR genotypes could help decide fluoropyrimidine dosing. Clinical associations between 5FU-related toxicity and the TYMS VNTR were reported, however, results were inconsistent, suggesting that additional genetic variation in the TYMS gene might influence Tyms expression. We thus conducted a detailed genetic analysis of this region, defining new polymorphisms in this gene including mononucleotide (poly A:T) repeats and novel single nucleotide polymorphisms (SNPs) flanking the VNTR in the TYMS genetic region. Our haplotype analysis of this region used data from both established and novel genetic variants and found nine SNP haplotypes accounting for more than 90% of the studied population. We observed non-exclusive relationships between the VNTR and adjacent SNP haplotypes, such that each type of VNTR commonly occurred on several haplotype backgrounds. Our results confirmed the expectation that the VNTR alleles exhibit homoplasy and lack the common ancestry required for a reliable marker of a linked adjacent locus that might govern toxicity. We propose that it may be necessary in a clinical trial to assay multiple types of genetic polymorphisms in the TYMS region to meaningfully model linkage of genetic markers to 5FU-related toxicity. The presence of multiple long (up to 26 nt), polymorphic monothymidine repeats in the promoter region of the sole human thymidylate synthetic enzyme is intriguing.	[Ghosh, Soma; Hossain, M. Zulfiquer; Goggins, Michael G.; Eshleman, James R.; Klein, Alison P.; Kern, Scott E.] Johns Hopkins Univ, Johns Hopkins Sch Med, Dept Oncol, Baltimore, MD 21218 USA; [Borges, Michael; Goggins, Michael G.; Eshleman, James R.; Klein, Alison P.] Johns Hopkins Univ, Johns Hopkins Sch Med, Dept Pathol, Sidney Kimmel Comprehens Canc Ctr, Baltimore, MD USA	Johns Hopkins University; Johns Hopkins Medicine; Johns Hopkins University; Johns Hopkins Medicine	Ghosh, S (corresponding author), Johns Hopkins Univ, Johns Hopkins Sch Med, Dept Oncol, Baltimore, MD 21218 USA.	sk@jhmi.edu		, Roxann/0000-0002-4266-613X	NIH [CA62924]; Everett and Marjorie Kovler Professorship in Pancreas Cancer Research; NATIONAL CANCER INSTITUTE [P50CA062924] Funding Source: NIH RePORTER	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Everett and Marjorie Kovler Professorship in Pancreas Cancer Research; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	This study was funded by NIH grant CA62924 and by the Everett and Marjorie Kovler Professorship in Pancreas Cancer Research. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	AITMAN TJ, 1991, MAMM GENOME, V1, P206, DOI 10.1007/BF00352326; Barrett JC, 2005, BIOINFORMATICS, V21, P263, DOI 10.1093/bioinformatics/bth457; Brody JR, 2009, CANCER RES, V69, P984, DOI 10.1158/0008-5472.CAN-08-3610; Brody JR, 2004, BIOTECHNIQUES, V37, P598, DOI 10.2144/04374ST04; de Bock CE, 2011, PHARMACOGENOMICS J, V11, P307, DOI 10.1038/tpj.2010.43; Fujii Ryuta, 2003, Int J Clin Oncol, V8, P72, DOI 10.1007/s101470300013; Fujishima M, 2010, ANTICANCER RES, V30, P4373; Gabriel SB, 2002, SCIENCE, V296, P2225, DOI 10.1126/science.1069424; Gamelin E, 2008, J CLIN ONCOL, V26, P2099, DOI 10.1200/JCO.2007.13.3934; Ghosh S, 2011, CANCER BIOL THER, V12, P750, DOI 10.4161/cbt.12.8.16867; Gusella M, 2009, BRIT J CANCER, V100, P1549, DOI 10.1038/sj.bjc.6605052; HEIDELBERGER C, 1957, NATURE, V179, P663, DOI 10.1038/179663a0; HORIE N, 1995, CELL STRUCT FUNCT, V20, P191, DOI 10.1247/csf.20.191; Ichikawa W, 2006, CLIN CANCER RES, V12, P3928, DOI 10.1158/1078-0432.CCR-05-2665; Kakimoto M, 2005, CANCER LETT, V223, P103, DOI 10.1016/j.canlet.2004.09.020; KANEDA S, 1987, NUCLEIC ACIDS RES, V15, P1259, DOI 10.1093/nar/15.3.1259; Kawakami K, 2003, CANCER RES, V63, P6004; Kim SR, 2010, CHEMOTHERAPY, V56, P313, DOI 10.1159/000320032; Kline CL, 2011, CANCER BIOL THER, V12, P557, DOI 10.4161/cbt.12.7.18059; Kristensen MH, 2010, J INT MED RES, V38, P484, DOI 10.1177/147323001003800212; KUFE DW, 1981, J BIOL CHEM, V256, P8885; Lecomte T, 2004, CLIN CANCER RES, V10, P5880, DOI 10.1158/1078-0432.CCR-04-0169; Li WH, MOL EVOLUTION; Longley DB, 2003, NAT REV CANCER, V3, P330, DOI 10.1038/nrc1074; Lum PY, 2004, CELL, V116, P121, DOI 10.1016/S0092-8674(03)01035-3; LYSS AP, 1993, CANCER INVEST, V11, P239, DOI 10.3109/07357909309024846; MAJOR PP, 1982, CANCER RES, V42, P3005; Mandola MV, 2003, CANCER RES, V63, P2898; Noordhuis P, 2004, ANN ONCOL, V15, P1025, DOI 10.1093/annonc/mdh264; Ohta T, 2007, GENET RES, V89, P367, DOI 10.1017/S0016672308009531; Olsen KM, 1999, MOL BIOL EVOL, V16, P1406, DOI 10.1093/oxfordjournals.molbev.a026050; PARKER WB, 1990, PHARMACOL THERAPEUT, V48, P381, DOI 10.1016/0163-7258(90)90056-8; Pullarkat S. T., 2001, Pharmacogenomics Journal, V1, P65; Purcell S, 2007, AM J HUM GENET, V81, P559, DOI 10.1086/519795; Saif MW, 2009, JNCI-J NATL CANCER I, V101, P1543, DOI 10.1093/jnci/djp328; SANTI DV, 1972, P NATL ACAD SCI USA, V69, P1855, DOI 10.1073/pnas.69.7.1855; Schwab M, 2008, J CLIN ONCOL, V26, P2131, DOI 10.1200/JCO.2006.10.4182; Schwartz S, 1999, CANCER RES, V59, P2995; Showalter SL, 2008, CANCER BIOL THER, V7, P986, DOI 10.4161/cbt.7.7.6181; Stephens M, 2005, AM J HUM GENET, V76, P449, DOI 10.1086/428594; Taylor JS, 1999, J MOL EVOL, V48, P245, DOI 10.1007/BF03356596; Taylor JS, 2000, GENETICS, V155, P1313; Ulrich CM, 2000, CANCER EPIDEM BIOMAR, V9, P1381; Vignoli M, 2011, PHARMACOL RES, V64, P242, DOI 10.1016/j.phrs.2011.04.006; Wenz HM, 1998, GENOME RES, V8, P69, DOI 10.1101/gr.8.1.69; Yawata A, 2005, CANCER CHEMOTH PHARM, V56, P465, DOI 10.1007/s00280-005-1018-z	46	7	9	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 5	2012	7	4							e34426	10.1371/journal.pone.0034426	http://dx.doi.org/10.1371/journal.pone.0034426			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	955IH	22496803	Green Published, gold, Green Submitted			2022-12-25	WOS:000305010500007
J	Bowler, MT; Buchanan-Smith, HM; Whiten, A				Bowler, Mark T.; Buchanan-Smith, Hannah M.; Whiten, Andrew			Assessing Public Engagement with Science in a University Primate Research Centre in a National Zoo	PLOS ONE			English	Article							VISITOR BEHAVIOR	Recent years have seen increasing encouragement by research institutions and funding bodies for scientists to actively engage with the public, who ultimately finance their work. Animal behaviour as a discipline possesses several features, including its inherent accessibility and appeal to the public, that may help it occupy a particularly successful niche within these developments. It has also established a repertoire of quantitative behavioural methodologies that can be used to document the public's responses to engagement initiatives. This kind of assessment is becoming increasingly important considering the enormous effort now being put into public engagement projects, whose effects are more often assumed than demonstrated. Here we report our first attempts to quantify relevant aspects of the behaviour of a sample of the hundreds of thousands of visitors who pass through the 'Living Links to Human Evolution Research Centre' in Edinburgh Zoo. This University research centre actively encourages the public to view ongoing primate research and associated science engagement activities. Focal follows of visitors and scan sampling showed substantial 'dwell times' in the Centre by common zoo standards and the addition of new engagement elements in a second year was accompanied by significantly increased overall dwell times, tripling for the most committed two thirds of visitors. Larger groups of visitors were found to spend more time in the Centre than smaller ones. Viewing live, active science was the most effective activity, shown to be enhanced by novel presentations of carefully constructed explanatory materials. The findings emphasise the importance and potential of zoos as public engagement centres for the biological sciences.	[Bowler, Mark T.; Whiten, Andrew] Univ St Andrews, Sch Psychol, Ctr Social Learning & Cognit Evolut, St Andrews, Fife, Scotland; [Bowler, Mark T.; Whiten, Andrew] Univ St Andrews, Sch Psychol, Scottish Primate Res Grp, St Andrews, Fife, Scotland; [Buchanan-Smith, Hannah M.] Univ Stirling, Sch Nat Sci, Stirling FK9 4LA, Scotland; [Buchanan-Smith, Hannah M.] Univ Stirling, Scottish Primate Res Grp, Stirling FK9 4LA, Scotland	University of St Andrews; University of St Andrews; University of Stirling; University of Stirling	Bowler, MT (corresponding author), Univ St Andrews, Sch Psychol, Ctr Social Learning & Cognit Evolut, St Andrews, Fife, Scotland.	mtb21@st-andrews.ac.uk	Buchanan-Smith, Hannah M/A-5350-2009	Buchanan-Smith, Hannah M/0000-0002-2516-7734; Whiten, Andrew/0000-0003-2426-5890; Bowler, Mark/0000-0001-5236-3477	Scottish Funding Council; Scottish Government; Wellcome Trust	Scottish Funding Council; Scottish Government; Wellcome Trust(Wellcome TrustEuropean Commission)	The Living Links to Human Evolution Research Centre was funded by a Strategic Research and Development Grant from the Scottish Funding Council. The research was funded by a Scottish Government Science Engagement Grant and a Wellcome Trust 'Investment in People' award. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ALTMANN J, 1974, BEHAVIOUR, V49, P227, DOI 10.1163/156853974X00534; Anderson US, 2003, ENVIRON BEHAV, V35, P826, DOI 10.1177/0013916503254746; Bitgood S., 2000, J INTERPRETATION RES, V5, P31, DOI [https://doi.org/10.1177/109258720000500205, DOI 10.1177/109258720000500205]; Clayton S, 2009, ZOO BIOL, V28, P377, DOI 10.1002/zoo.20186; Falk J.H., 2007, WHY ZOOS AQUARIUMS M; Francis D, 2007, J INT ZOO ED ASS, V43, P20; Hart A, NCCPE BRIEFING SERIE; Leonardi R, 2010, AM J PRIMATOL, V72, P33, DOI 10.1002/ajp.20748; Louch J, 1999, DODO, V35, P134; Macdonald C., 2011, International Zoo Yearbook, V45, P7, DOI 10.1111/j.1748-1090.2010.00120.x; Moss A., 2010, J INTERPRETATION RES, V15, P11, DOI DOI 10.1177/109258721001500203; Moss A, 2008, VISIT STUD, V11, P26, DOI 10.1080/10645570801938418; Nakamichi M, 2007, ANTHROZOOS, V20, P155, DOI 10.2752/175303707X207945; Phillpot P, 1996, DODO, V32, P193; Randler C, 2007, VISIT STUD, V10, P205, DOI 10.1080/10645570701585343; Ross S. R., 2005, VISITOR STUDIES TODA, V8, P4; Ross SR, 2009, ZOO BIOL, V28, P462, DOI 10.1002/zoo.20220; Screven C, 1990, ILVS REV, V1, P33; Serrell B, 1999, PAYING ATTENTION VIS; Stoinski TS, 1998, ZOO BIOL, V17, P167, DOI 10.1002/(SICI)1098-2361(1998)17:3<167::AID-ZOO2>3.0.CO;2-7; Tanaka M, 2010, INT PRIM SOC C 2010; Whiten A, 2005, NATURE, V437, P737, DOI 10.1038/nature04047	22	24	24	1	48	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 4	2012	7	4							e34505	10.1371/journal.pone.0034505	http://dx.doi.org/10.1371/journal.pone.0034505			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	953GO	22496822	Green Submitted, Green Published, gold			2022-12-25	WOS:000304855200059
J	Tessema, M; Yingling, CM; Grimes, MJ; Thomas, CL; Liu, YS; Leng, SG; Joste, N; Belinsky, SA				Tessema, Mathewos; Yingling, Christin M.; Grimes, Marcie J.; Thomas, Cynthia L.; Liu, Yushi; Leng, Shuguang; Joste, Nancy; Belinsky, Steven A.			Differential Epigenetic Regulation of TOX Subfamily High Mobility Group Box Genes in Lung and Breast Cancers	PLOS ONE			English	Article							ABERRANT PROMOTER METHYLATION; CPG ISLAND; COLORECTAL-CANCER; HMGB PROTEINS; HUMAN TUMORS; DNA; IDENTIFICATION; EXPRESSION; CELLS; ADENOCARCINOMAS	Aberrant cytosine methylation affects regulation of hundreds of genes during cancer development. In this study, a novel aberrantly hypermethylated CpG island in cancer was discovered within the TOX2 promoter. TOX2 was unmethylated in normal cells but 28% lung (n = 190) and 23% breast (n = 80) tumors were methylated. Expression of two novel TOX2 transcripts identified was significantly reduced in primary lung tumors than distant normal lung (p<0.05). These transcripts were silenced in methylated lung and breast cancer cells and 5-Aza-2-deoxycytidine treatment re-expressed both. Extension of these assays to TOX, TOX3, and TOX4 genes that share similar genomic structure and protein homology with TOX2 revealed distinct methylation profiles by smoking status, histology, and cancer type. TOX was almost exclusively methylated in breast (43%) than lung (5%) cancer, whereas TOX3 was frequently methylated in lung (58%) than breast (30%) tumors. TOX4 was unmethylated in all samples and showed the highest expression in normal lung. Compared to TOX4, expression of TOX, TOX2 and TOX3 in normal lung was 25, 44, and 88% lower, respectively, supporting the premise that reduced promoter activity confers increased susceptibility to methylation during lung carcinogenesis. Genome-wide assays revealed that siRNA-mediated TOX2 knockdown modulated multiple pathways while TOX3 inactivation targeted neuronal development and function. Although these knockdowns did not result in further phenotypic changes of lung cancer cells in vitro, the impact on tissue remodeling, inflammatory response, and cell differentiation pathways suggest a potential role for TOX2 in modulating tumor microenvironment.	[Tessema, Mathewos; Yingling, Christin M.; Grimes, Marcie J.; Thomas, Cynthia L.; Liu, Yushi; Leng, Shuguang; Belinsky, Steven A.] Lovelace Resp Res Inst, Lung Canc Program, Albuquerque, NM USA; [Joste, Nancy] Univ New Mexico, Dept Internal Med, Albuquerque, NM 87131 USA	Lovelace Respiratory Research Institute; University of New Mexico	Tessema, M (corresponding author), Lovelace Resp Res Inst, Lung Canc Program, Albuquerque, NM USA.	sbelinsk@LRRI.org	Liu, Yushi/A-1533-2014	Liu, Yushi/0000-0003-4185-4187	National Institutes of Health [R01ES008801, ES015262, P50 CA58184]; NATIONAL CANCER INSTITUTE [P50CA058184] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES [R01ES015262, R01ES008801] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Environmental Health Sciences (NIEHS))	This work was supported by National Institutes of Health Grant numbers [R01ES008801], [ES015262], and [P50 CA58184] to SAB. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aleman A, 2008, BRIT J CANCER, V98, P466, DOI 10.1038/sj.bjc.6604143; Alizadeh AA, 2000, NATURE, V403, P503, DOI 10.1038/35000501; Belinsky SA, 2002, CANCER RES, V62, P2370; Belinsky SA, 2011, CANCER RES, V71, P454, DOI 10.1158/0008-5472.CAN-10-3184; Bewley CA, 1998, ANNU REV BIOPH BIOM, V27, P105, DOI 10.1146/annurev.biophys.27.1.105; Chakravarty G, 2011, EXP BIOL MED, V236, P145, DOI 10.1258/ebm.2010.010086; Ching TT, 2005, NAT GENET, V37, P645, DOI 10.1038/ng1563; Chung W, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0002079; Clark SJ, 2002, ONCOGENE, V21, P5380, DOI 10.1038/sj.onc.1205598; Deloukas P, 2001, NATURE, V414, P865, DOI 10.1038/414865a; Dittmer S, 2011, J CELL SCI, V124, P252, DOI 10.1242/jcs.068759; du Puch CBM, 2011, ARCH BIOCHEM BIOPHYS, V507, P296, DOI 10.1016/j.abb.2010.12.021; Hess JL, 1998, AM J CLIN PATHOL, V109, P251, DOI 10.1093/ajcp/109.3.251; Jia XP, 2011, J MOL CELL BIOL, V3, P230, DOI 10.1093/jmcb/mjr002; Jia Y, 2010, EPIGENETICS-US, V5, P743, DOI 10.4161/epi.5.8.13104; Kajitani T, 2004, ENDOCRINOLOGY, V145, P2307, DOI 10.1210/en.2003-1343; Lander ES, 2001, NATURE, V409, P860, DOI 10.1038/35057062; Livak KJ, 2001, METHODS, V25, P402, DOI 10.1006/meth.2001.1262; Marsit CJ, 2006, CANCER RES, V66, P10621, DOI 10.1158/0008-5472.CAN-06-1687; O'Flaherty E, 2003, BMC GENOMICS, V4, DOI 10.1186/1471-2164-4-13; Oyer JA, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0004832; Palmisano WA, 2003, CANCER RES, V63, P4620; Ramirez RD, 2004, CANCER RES, V64, P9027, DOI 10.1158/0008-5472.CAN-04-3703; Shiraishi M, 1999, P NATL ACAD SCI USA, V96, P2913, DOI 10.1073/pnas.96.6.2913; Shiraishi M, 2002, ONCOGENE, V21, P3659, DOI 10.1038/sj.onc.1205453; Smith LT, 2006, P NATL ACAD SCI USA, V103, P982, DOI 10.1073/pnas.0510171102; Soullier S, 1999, J MOL EVOL, V48, P517, DOI 10.1007/PL00006495; Stros M, 2010, BBA-GENE REGUL MECH, V1799, P101, DOI 10.1016/j.bbagrm.2009.09.008; Tallini G, 1999, ADV ANAT PATHOL, V6, P237, DOI 10.1097/00125480-199909000-00001; Tessema M, 2010, ONCOGENE, V29, P5159, DOI 10.1038/onc.2010.255; Tessema M, 2012, ONCOGENE        1212, DOI 101038/onc2011577; Tessema M, 2008, CANCER RES, V68, P1707, DOI 10.1158/0008-5472.CAN-07-6325; Thomas JO, 2001, TRENDS BIOCHEM SCI, V26, P167, DOI 10.1016/S0968-0004(01)01801-1; Toyota M, 1999, CANCER RES, V59, P2307; Toyota M, 1999, P NATL ACAD SCI USA, V96, P8681, DOI 10.1073/pnas.96.15.8681; Toyota M, 1999, CANCER RES, V59, P4535; Travers AA, 2003, EMBO REP, V4, P131, DOI 10.1038/sj.embor.embor741; Treff NR, 2004, ONCOGENE, V23, P777, DOI 10.1038/sj.onc.1207167; Ueki T, 2001, CANCER RES, V61, P8540; Wilkinson B, 2002, NAT IMMUNOL, V3, P272, DOI 10.1038/ni767; Yuan FH, 2004, J BIOL CHEM, V279, P20935, DOI 10.1074/jbc.M401931200; Yuan SH, 2009, P NATL ACAD SCI USA, V106, P2909, DOI 10.1073/pnas.0805555106; Zhang W, 2008, CANCER RES, V68, P2764, DOI 10.1158/0008-5472.CAN-07-6349	43	43	44	3	17	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 4	2012	7	4							e34850	10.1371/journal.pone.0034850	http://dx.doi.org/10.1371/journal.pone.0034850			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	953GO	22496870	Green Published, Green Submitted, gold			2022-12-25	WOS:000304855200085
J	Xie, MX; Zhu, XZ; Liu, ZF; Shrubsole, M; Varma, V; Mayer, IA; Dai, Q; Chen, Q; You, SJ				Xie, Mingxuan; Zhu, Xiangzhu; Liu, Zhaofan; Shrubsole, Martha; Varma, Vijay; Mayer, Ingrid A.; Dai, Qi; Chen, Qiong; You, Shaojin			Membrane Progesterone Receptor Alpha as a Potential Prognostic Biomarker for Breast Cancer Survival: A Retrospective Study	PLOS ONE			English	Article							GROWTH-FACTOR RECEPTOR; BASAL-LIKE; AMERICAN-SOCIETY; CELLS; EXPRESSION; CAVEOLIN-1; ESTROGEN; RECOMMENDATIONS; PHENOTYPE; HORMONES	Classically, the actions of progesterone (P4) are attributed to the binding of nuclear progesterone receptor (PR) and subsequent activation of its downstream target genes. These mechanisms, however, are not applicable to PR-or basal phenotype breast cancer (BPBC) due to lack of PR in these cancers. Recently, the function of membrane progesterone receptor alpha (mPR alpha) in human BPBC cell lines was studied in our lab. We proposed that the signaling cascades of P4 -> mPR alpha pathway may play an essential role in controlling cell proliferation and epithelial mesenchymal transition (EMT) of breast cancer. Using human breast cancer tissue microarrays, we found in this study that the average intensity of mPR alpha expression, but not percentage of breast cancer with high level of mPR alpha expression (mPR alpha-HiEx), was significantly lower in the TNM stage 4 patients compared to those with TNM 1-3 patients; and both average intensities of mPR alpha expression and mPR alpha-HiEx rates were significantly higher in cancers negative for ER, as compared with those cancers with ER+. However, after adjusting for age at diagnosis and/or TNM stage, only average intensities of mPR alpha expression were associated with ER status. In addition, we found that the rates of mPR alpha-HiEx were significantly higher in cancers with epithelial growth factor receptor-1 (EGFR+) and high level of Ki67 expression, indicating positive correlation between mPR alpha over expression and EGFR or Ki67. Further analysis indicated that both mPR alpha-HiEx rate and average intensity of mPR alpha expression were significantly higher in HER2+ subtype cancers (i.e. HER2+ER-PR-) as compared to ER+ subtype cancers. These data support our hypothesis that P4 modulates the activities of the PI3K and cell proliferation pathways through the caveolar membrane bound growth factor receptors such as mPR alpha and growth factor receptors. Future large longitudinal studies with larger sample size and survival outcomes are necessary to confirm our findings.	[Xie, Mingxuan; Liu, Zhaofan; You, Shaojin] Atlanta VA Med Ctr, Atlanta Res & Educ Fdn, Histopathol Core, Decatur, GA USA; [Zhu, Xiangzhu; Shrubsole, Martha; Dai, Qi] Vanderbilt Univ, Vanderbilt Epidemiol Ctr, Div Epidemiol, Nashville, TN USA; [Varma, Vijay] Atlanta VA Med Ctr, Dept Pathol, Decatur, GA USA; [Mayer, Ingrid A.] Sch Med, Div Hematol Oncol, Nashville, TN USA; [Xie, Mingxuan; Chen, Qiong] Cent S Univ, Xiangya Hosp, Dept Geriatr, Changsha, Hunan, Peoples R China	US Department of Veterans Affairs; Veterans Health Administration (VHA); Atlanta VA Health Care System; Atlanta VA Medical Center; Vanderbilt University; US Department of Veterans Affairs; Veterans Health Administration (VHA); Atlanta VA Health Care System; Atlanta VA Medical Center; Central South University	Xie, MX (corresponding author), Atlanta VA Med Ctr, Atlanta Res & Educ Fdn, Histopathol Core, Decatur, GA USA.	qi.dai@Vanderbilt.Edu; Shaojin.You@va.gov	Shrubsole, Martha J/K-5052-2015; Zhu, Xiangzhu/ABB-5787-2021	Shrubsole, Martha J/0000-0002-5591-7575; Zhu, Xiangzhu/0000-0002-4462-8815	Atlanta Research and Education Foundation; Emory University; NATIONAL CANCER INSTITUTE [K23CA127469, R03CA112645] Funding Source: NIH RePORTER	Atlanta Research and Education Foundation; Emory University; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	This study was funded by Atlanta Research and Education Foundation Bridge Fund (SY) and Emory University Research Award (SY). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bouman A, 2005, HUM REPROD UPDATE, V11, P411, DOI 10.1093/humupd/dmi008; Cheang MCU, 2009, JNCI-J NATL CANCER I, V101, P736, DOI 10.1093/jnci/djp082; D'Eon T, 2002, J WOMEN HEALTH GEN-B, V11, P225, DOI 10.1089/152460902753668439; Dressing GE, 2007, STEROIDS, V72, P111, DOI 10.1016/j.steroids.2006.10.006; Eliakim R, 2000, J REPROD MED, V45, P781; Elsheikh SE, 2008, BRIT J CANCER, V99, P327, DOI 10.1038/sj.bjc.6604463; Fadare O, 2008, NAT CLIN PRACT ONCOL, V5, P149, DOI 10.1038/ncponc1038; Falkenstein E, 2000, PHARMACOL REV, V52, P513; Flanagan MB, 2008, MODERN PATHOL, V21, P1255, DOI 10.1038/modpathol.2008.54; Flynn JF, 2009, J ONCOL, V2009, DOI 10.1155/2009/526963; Gellersen B, 2009, HUM REPROD UPDATE, V15, P119, DOI 10.1093/humupd/dmn044; Gialeli C, 2009, CURR MED CHEM, V16, P3797, DOI 10.2174/092986709789177984; Graham JD, 1997, ENDOCR REV, V18, P502, DOI 10.1210/er.18.4.502; Harris L, 2007, J CLIN ONCOL, V25, P5287, DOI 10.1200/JCO.2007.14.2364; Karteris E, 2006, MOL ENDOCRINOL, V20, P1519, DOI 10.1210/me.2005-0243; Lange CA, 1999, MOL ENDOCRINOL, V13, P829, DOI 10.1210/me.13.6.829; Liegl B, 2005, MODERN PATHOL, V18, P1283, DOI 10.1038/modpathol.3800437; Losel R, 2005, HORM METAB RES, V37, P10, DOI 10.1055/s-2005-861023; Losel R, 2003, NAT REV MOL CELL BIO, V4, P46, DOI 10.1038/nrm1009; Mani SA, 2008, CELL, V133, P704, DOI 10.1016/j.cell.2008.03.027; McGowan EM, 2004, BREAST CANCER RES TR, V83, P211, DOI 10.1023/B:BREA.0000014041.58977.80; Medina PJ, 2008, CLIN THER, V30, P1426, DOI 10.1016/j.clinthera.2008.08.008; Morel AP, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0002888; Oettel M, 2004, Aging Male, V7, P236; Patel HH, 2008, ANNU REV PHARMACOL, V48, P359, DOI 10.1146/annurev.pharmtox.48.121506.124841; Pelekanou V, 2007, CANCER EPIDEM BIOMAR, V16, P2016, DOI 10.1158/1055-9965.EPI-06-1023; Perou CM, 2000, NATURE, V406, P747, DOI 10.1038/35021093; Quinkler M, 2003, J CLIN ENDOCR METAB, V88, P2803, DOI 10.1210/jc.2002-021970; Pinilla SMR, 2006, BREAST CANCER RES TR, V99, P85, DOI 10.1007/s10549-006-9184-1; Schuffner AA, 2002, MOL HUM REPROD, V8, P722, DOI 10.1093/molehr/8.8.722; Sen A, 2010, BREAST CANCER RES, V12, DOI 10.1186/bcr2580; Sleiter N, 2009, ENDOCRINOLOGY, V150, P3833, DOI 10.1210/en.2008-0774; Thomas P, 2008, FRONT NEUROENDOCRIN, V29, P292, DOI 10.1016/j.yfrne.2008.01.001; Thomson TA, 2010, AM J CLIN PATHOL, V133, P909, DOI 10.1309/AJCP1IU7BTSAQGYZ; Viale G, 2007, J CLIN ONCOL, V25, P3846, DOI 10.1200/JCO.2007.11.9453; Weigel MT, 2010, ENDOCR-RELAT CANCER, V17, pR245, DOI 10.1677/ERC-10-0136; Williams TM, 2005, AM J PHYSIOL-CELL PH, V288, pC494, DOI 10.1152/ajpcell.00458.2004; Wolff AC, 2007, J CLIN ONCOL, V25, P118, DOI 10.1200/JCO.2006.09.2775; You S, 2010, J MOL HISTOL    0518; Zhu Y, 2003, P NATL ACAD SCI USA, V100, P2231, DOI 10.1073/pnas.0336132100; Zlobec I, 2006, MODERN PATHOL, V19, P1236, DOI 10.1038/modpathol.3800642; Zuo LA, 2010, BREAST CANCER RES, V12, DOI 10.1186/bcr2588; Zuo L, 2009, CANCER CELL INT, V9, DOI 10.1186/1475-2867-9-8	43	27	28	0	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 4	2012	7	4							e35198	10.1371/journal.pone.0035198	http://dx.doi.org/10.1371/journal.pone.0035198			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	953GO	22496908	Green Published, gold, Green Submitted			2022-12-25	WOS:000304855200102
J	Seifert, AW; Monaghan, JR; Voss, SR; Maden, M				Seifert, Ashley W.; Monaghan, James R.; Voss, S. Randal; Maden, Malcolm			Skin Regeneration in Adult Axolotls: A Blueprint for Scar-Free Healing in Vertebrates	PLOS ONE			English	Article							EXTRACELLULAR-MATRIX; WOUND REPAIR; LIMB REGENERATION; KERATINOCYTE ACTIVATION; AMBYSTOMA-MEXICANUM; BASEMENT-MEMBRANE; FINE-STRUCTURE; FETAL; NEWT; CELL	While considerable progress has been made towards understanding the complex processes and pathways that regulate human wound healing, regenerative medicine has been unable to develop therapies that coax the natural wound environment to heal scar-free. The inability to induce perfect skin regeneration stems partly from our limited understanding of how scar-free healing occurs in a natural setting. Here we have investigated the wound repair process in adult axolotls and demonstrate that they are capable of perfectly repairing full thickness excisional wounds made on the flank. In the context of mammalian wound repair, our findings reveal a substantial reduction in hemostasis, reduced neutrophil infiltration and a relatively long delay in production of new extracellular matrix (ECM) during scar-free healing. Additionally, we test the hypothesis that metamorphosis leads to scarring and instead show that terrestrial axolotls also heal scar-free: albeit at a slower rate. Analysis of newly forming dermal ECM suggests that low levels of fibronectin and high levels of tenascin-C promote regeneration in lieu of scarring. Lastly, a genetic analysis during wound healing comparing epidermis between aquatic and terrestrial axolotls suggests that matrix metalloproteinases may regulate the fibrotic response. Our findings outline a blueprint to understand the cellular and molecular mechanisms coordinating scar-free healing that will be useful towards elucidating new regenerative therapies targeting fibrosis and wound repair.	[Seifert, Ashley W.; Monaghan, James R.; Maden, Malcolm] Univ Florida, Dept Biol, Gainesville, FL 32611 USA; [Voss, S. Randal] Univ Kentucky, Dept Biol, Lexington, KY USA; [Voss, S. Randal] Univ Kentucky, Spinal Cord & Brain Injury Res Ctr, Lexington, KY USA	State University System of Florida; University of Florida; University of Kentucky; University of Kentucky	Seifert, AW (corresponding author), Univ Florida, Dept Biol, Gainesville, FL 32611 USA.	seifert@ufl.edu		Seifert, Ashley/0000-0001-6576-3664	NIH-NCRR [R24-RR016344]; Army Research Office [MURI: W911NF-09-1-0305]; DFG Center for Regenerative Therapies; NIH-NIDCD [R01-DC005590-07S1]; National Science Foundation [DBI-0951484]; NIH [5RC2NS069480]; NIH-NIDDK [5T32DK074367]; University of Florida; NATIONAL CENTER FOR RESEARCH RESOURCES [R24RR016344] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [T32DK074367] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [RC2NS069480] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON DEAFNESS AND OTHER COMMUNICATION DISORDERS [R01DC005590] Funding Source: NIH RePORTER; OFFICE OF THE DIRECTOR, NATIONAL INSTITUTES OF HEALTH [R24OD010435] Funding Source: NIH RePORTER	NIH-NCRR(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); Army Research Office; DFG Center for Regenerative Therapies(German Research Foundation (DFG)); NIH-NIDCD(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Deafness & Other Communication Disorders (NIDCD)); National Science Foundation(National Science Foundation (NSF)); NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NIH-NIDDK(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); University of Florida(University of Florida); NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); NATIONAL INSTITUTE ON DEAFNESS AND OTHER COMMUNICATION DISORDERS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Deafness & Other Communication Disorders (NIDCD)); OFFICE OF THE DIRECTOR, NATIONAL INSTITUTES OF HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA)	The Ambystoma Affymetrix Genechips were designed from a transcript assembly funded by NIH-NCRR (R24-RR016344). Most of the transcripts were generated under the NIH-NCRR grant and an Army Research Office grant (MURI: W911NF-09-1-0305) to Ken Muneoka, David Gardiner, and SRV. Additional transcripts were provided by Elly Tanaka through funding from the DFG Center for Regenerative Therapies, and Bernd Fritsch through funding from NIH-NIDCD (R01-DC005590-07S1). The axolotls were obtained from the Ambystoma Genetic Stock Center at the University of Kentucky, which is funded by the National Science Foundation (DBI-0951484). This study was supported by NIH 5RC2NS069480 to MM and AWS is funded by NIH-NIDDK 5T32DK074367. Publication of this article was funded in part by the University of Florida Open-Access Publishing Fund. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aarabi S, 2007, PLOS MED, V4, P1464, DOI 10.1371/journal.pmed.0040234; ADZICK NS, 1985, J PEDIATR SURG, V20, P315; Adzick NS, 1992, FETAL WOUND HEALING, Vxv; Annis DS, 2006, J THROMB HAEMOST, V4, P459, DOI 10.1111/j.1538-7836.2006.01723.x; ARMSTRONG JR, 1995, DEV BIOL, V169, P242, DOI 10.1006/dbio.1995.1141; Bayat A, 2003, BRIT MED J, V326, P88, DOI 10.1136/bmj.326.7380.88; Beare AHM, 2006, J ANAT, V209, P547, DOI 10.1111/j.1469-7580.2006.00641.x; BILLINGHAM RE, 1956, NATURE, V177, P791, DOI 10.1038/177791b0; BREEDIS C, 1954, CANCER RES, V14, P575; Brown BC, 2008, J PLAST RECONSTR AES, V61, P1049, DOI 10.1016/j.bjps.2008.03.020; Bullard KM, 2003, WORLD J SURG, V27, P54, DOI 10.1007/s00268-002-6737-2; Calve S, 2010, DEV BIOL, V344, P259, DOI 10.1016/j.ydbio.2010.05.007; Clark LD, 1998, CLIN IMMUNOL IMMUNOP, V88, P35, DOI 10.1006/clin.1998.4519; Clark R. A. F, 1996, MOL CELLULAR BIOL WO; CLARK RAF, 1990, J INVEST DERMATOL, V94, pS128, DOI 10.1111/1523-1747.ep12876104; Colwell AS, 2006, WOUND REPAIR REGEN, V14, P81, DOI 10.1111/j.1524-475X.2005.00092.x; Coolen NA, 2010, ARCH DERMATOL RES, V302, P47, DOI 10.1007/s00403-009-0989-8; Coulombe PA, 1997, BIOCHEM BIOPH RES CO, V236, P231, DOI 10.1006/bbrc.1997.6945; Dang CM, 2003, PLAST RECONSTR SURG, V111, P2273, DOI 10.1097/01.PRS.0000060102.57809.DA; Davis AK, 2008, FUNCT ECOL, V22, P760, DOI 10.1111/j.1365-2435.2008.01467.x; DONALDSON DJ, 1991, ANAT REC, V230, P451, DOI 10.1002/ar.1092300403; DONALDSON DJ, 1995, ANAT REC, V241, P49, DOI 10.1002/ar.1092410108; Dovi JV, 2004, THROMB HAEMOSTASIS, V92, P275, DOI 10.1160/TH03-11-0720; Dovi JV, 2003, J LEUKOCYTE BIOL, V73, P448, DOI 10.1189/jlb.0802406; Eppley BL, 2004, PLAST RECONSTR SURG, V114, P1502, DOI 10.1097/01.PRS.0000138251.07040.51; Ferguson MWJ, 2004, PHILOS T R SOC B, V359, P839, DOI 10.1098/rstb.2004.1475; Ferguson MWJ, 1991, FETAL WOUND HEALING, P92; Ferris DR, 2010, DEV GROWTH DIFFER, V52, P715, DOI 10.1111/j.1440-169X.2010.01208.x; FRANTZ FW, 1992, J PEDIATR SURG, V27, P945, DOI 10.1016/0022-3468(92)90537-H; Gautier L, 2004, BIOINFORMATICS, V20, P307, DOI 10.1093/bioinformatics/btg405; Gentleman RC, 2004, GENOME BIOL, V5, DOI 10.1186/gb-2004-5-10-r80; Godwin JW, 2006, J ANAT, V209, P423, DOI 10.1111/j.1469-7580.2006.00626.x; GOSS RJ, 1987, NEWS PHYSIOL SCI, V2, P112, DOI 10.1152/physiologyonline.1987.2.3.112; GRINNELL F, 1992, J CELL SCI, V101, P1; GRINNELL F, 1981, J INVEST DERMATOL, V76, P181, DOI 10.1111/1523-1747.ep12525694; GRINNELL F, 1994, J CELL BIOL, V124, P401, DOI 10.1083/jcb.124.4.401; GROSS J, 1995, P NATL ACAD SCI USA, V92, P5982, DOI 10.1073/pnas.92.13.5982; Gurtner GC, 2008, NATURE, V453, P314, DOI 10.1038/nature07039; Hasegawa H, 2007, ARCH HISTOL CYTOL, V70, P255, DOI 10.1679/aohc.70.255; HEMESATH TJ, 1994, J IMMUNOL, V152, P5199; Huggins P, COMP BIOCH PHYSL C; Irizarry RA, 2003, BIOSTATISTICS, V4, P249, DOI 10.1093/biostatistics/4.2.249; Ito M, 2007, NATURE, V447, P316, DOI 10.1038/nature05766; JARIAL MS, 1989, J ANAT, V167, P95; KELLY DE, 1966, ANAT REC, V154, P685, DOI 10.1002/ar.1091540314; Kumar A, 2010, J ANAT, V217, P16, DOI 10.1111/j.1469-7580.2010.01239.x; KURKINEN M, 1980, LAB INVEST, V43, P47; Levesque M, 2010, J EXP ZOOL PART B, V314B, P684, DOI 10.1002/jez.b.21371; LIN RY, 1995, ANN SURG, V222, P146, DOI 10.1097/00000658-199508000-00006; MACKIE EJ, 1988, J CELL BIOL, V107, P2757, DOI 10.1083/jcb.107.6.2757; Martin P, 1997, SCIENCE, V276, P75, DOI 10.1126/science.276.5309.75; Martin P, 2005, TRENDS CELL BIOL, V15, P599, DOI 10.1016/j.tcb.2005.09.002; Martin P, 2003, CURR BIOL, V13, P1122, DOI 10.1016/S0960-9822(03)00396-8; MAST BA, 1992, SURG GYNECOL OBSTET, V174, P441; Mauch C, 2010, J INVEST DERMATOL, V130, P2120, DOI 10.1038/jid.2010.60; Mescher AL, 2005, ADV BIOCHEM ENG BIOT, V93, P39, DOI 10.1007/b99966; Mescher AL, 2006, THESCIENTIFICWORLDJO, V6, P1, DOI 10.1100/tsw.2006.323; Metcalfe AD, 2006, J ANAT, V209, P439, DOI 10.1111/j.1469-7580.2006.00632.x; Mori R, 2008, J EXP MED, V205, P43, DOI 10.1084/jem.20071412; Namazi MR, 2011, INT J DERMATOL, V50, P85, DOI 10.1111/j.1365-4632.2010.04678.x; Neufeld DA, 1996, ANAT RECORD, V245, P122; Neufeld DA, 1996, ANAT RECORD, V246, P155; OKADA Y, 1990, EUR J BIOCHEM, V194, P721, DOI 10.1111/j.1432-1033.1990.tb19462.x; ONDA H, 1990, DEVELOPMENT, V108, P657; Page RB, 2009, COLD SPRING HARB PRO; POLEZHAEV LV, 1972, ORGAN REGENERATION A; Rose SM, 1944, J EXP ZOOL, V95, P149, DOI 10.1002/jez.1400950202; Sanges R, 2007, BIOINFORMATICS, V23, P3406, DOI 10.1093/bioinformatics/btm469; Santosh N, 2011, DEV DYNAM, V240, P1127, DOI 10.1002/dvdy.22503; Schultz GS, 2011, WOUND REPAIR REGEN, V19, P134, DOI 10.1111/j.1524-475X.2011.00673.x; Schultz GS, 2009, WOUND REPAIR REGEN, V17, P153, DOI 10.1111/j.1524-475X.2009.00466.x; SHEEHAN HL, 1947, J PATHOL BACTERIOL, V59, P336, DOI 10.1002/path.1700590142; SIMPSON DM, 1972, J CLIN INVEST, V51, P2009, DOI 10.1172/JCI107007; Smyth G.K., 2004, STAT APPL GENET MOL, V3, DOI DOI 10.2202/1544-6115.1027; Smyth GK, 2005, BIOINFORMATICS, V21, P2067, DOI 10.1093/bioinformatics/bti270; Stramer BM, 2007, J INVEST DERMATOL, V127, P1009, DOI 10.1038/sj.jid.5700811; Sund B, 2000, NEW DEV WOUND CARE, P1; Szpaderska AM, 2003, J INVEST DERMATOL, V120, P1130, DOI 10.1046/j.1523-1747.2003.12253.x; Toriseva M, 2009, CELL MOL LIFE SCI, V66, P203, DOI 10.1007/s00018-008-8388-4; Vinarsky V, 2005, DEV BIOL, V279, P86, DOI 10.1016/j.ydbio.2004.12.003; Wallace, 1981, VERTEBRATE LIMB REGE; Werb Z, 1997, CELL, V91, P439, DOI 10.1016/S0092-8674(00)80429-8; WHITBY DJ, 1991, DEVELOPMENT, V112, P651; Yannas I.V., 2001, REGENERATION SKIN; Yannas Ioannis V., 1996, Wound Repair and Regeneration, V4, P29, DOI 10.1046/j.1524-475X.1996.40107.x	85	171	176	2	56	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 2	2012	7	4							e32875	10.1371/journal.pone.0032875	http://dx.doi.org/10.1371/journal.pone.0032875			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	952GU	22485136	Green Published, Green Submitted, gold			2022-12-25	WOS:000304780500012
J	Stathopoulou, A; Roukos, V; Petropoulou, C; Kotsantis, P; Karantzelis, N; Nishitani, H; Lygerou, Z; Taraviras, S				Stathopoulou, Athanasia; Roukos, Vassilis; Petropoulou, Chariklia; Kotsantis, Panagiotis; Karantzelis, Nickolas; Nishitani, Hideo; Lygerou, Zoi; Taraviras, Stavros			Cdt1 Is Differentially Targeted for Degradation by Anticancer Chemotherapeutic Drugs	PLOS ONE			English	Article							UBIQUITIN LIGASE; DNA-REPLICATION; TOPOISOMERASE-II; CELL-CYCLE; LICENSING FACTOR; GEMININ; CANCER; PCNA; PROTEOLYSIS; CHROMATIN	Background: Maintenance of genome integrity is crucial for the propagation of the genetic information. Cdt1 is a major component of the pre-replicative complex, which controls once per cell cycle DNA replication. Upon DNA damage, Cdt1 is rapidly targeted for degradation. This targeting has been suggested to safeguard genomic integrity and prevent re-replication while DNA repair is in progress. Cdt1 is deregulated in tumor specimens, while its aberrant expression is linked with aneuploidy and promotes tumorigenesis in animal models. The induction of lesions in DNA is a common mechanism by which many cytotoxic anticancer agents operate, leading to cell cycle arrest and apoptosis. Methodology/Principal Finding: In the present study we examine the ability of several anticancer drugs to target Cdt1 for degradation. We show that treatment of HeLa and HepG2 cells with MMS, Cisplatin and Doxorubicin lead to rapid proteolysis of Cdt1, whereas treatment with 5-Fluorouracil and Tamoxifen leave Cdt1 expression unaffected. Etoposide affects Cdt1 stability in HepG2 cells and not in HeLa cells. RNAi experiments suggest that Cdt1 proteolysis in response to MMS depends on the presence of the sliding clamp PCNA. Conclusion/Significance: Our data suggest that treatment of tumor cells with commonly used chemotherapeutic agents induces differential responses with respect to Cdt1 proteolysis. Information on specific cellular targets in response to distinct anticancer chemotherapeutic drugs in different cancer cell types may contribute to the optimization of the efficacy of chemotherapy.	[Stathopoulou, Athanasia; Petropoulou, Chariklia; Karantzelis, Nickolas; Taraviras, Stavros] Univ Patras, Sch Med, Dept Physiol, GR-26110 Patras, Greece; [Roukos, Vassilis; Kotsantis, Panagiotis; Lygerou, Zoi] Univ Patras, Sch Med, Dept Gen Biol, GR-26110 Patras, Greece; [Nishitani, Hideo] Univ Hyogo, Grad Sch Life Sci, Dept Biol Signaling, Kobe, Hyogo 6500044, Japan	University of Patras; University of Patras; University of Hyogo	Stathopoulou, A (corresponding author), Univ Patras, Sch Med, Dept Physiol, GR-26110 Patras, Greece.	taraviras@med.upatras.gr	Roukos, Vassilis/K-6248-2012; Kotsantis, Panagiotis/AGU-7131-2022; Kotsantis, Panagiotis/AGZ-3258-2022; Taraviras, Stavros/AAJ-4690-2020; Roukos, Vassilis/AAC-4827-2020	Kotsantis, Panagiotis/0000-0002-6131-4009; Kotsantis, Panagiotis/0000-0002-6131-4009; Taraviras, Stavros/0000-0002-7455-647X; Nishitani, Hideo/0000-0001-5907-9380; Karantzelis, Nikolaos/0000-0002-6582-6757; Stathopoulou, Athanasia/0000-0001-8579-7706; Roukos, Vassilis/0000-0002-5065-3937	Hellenic Anticancer Institute [11/2005]; Grants-in-Aid for Scientific Research [22019033] Funding Source: KAKEN	Hellenic Anticancer Institute; Grants-in-Aid for Scientific Research(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI))	This study was supported by research funding from the Hellenic Anticancer Institute to S. Taraviras (11/2005). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript. No additional external funding was received for this study.	Achuthan S, 2011, J BIOL CHEM, V286, P37813, DOI 10.1074/jbc.M110.200675; Arentson E, 2002, ONCOGENE, V21, P1150, DOI 10.1038/sj.onc.1205175; Arias EE, 2006, NAT CELL BIOL, V8, P84, DOI 10.1038/ncb1346; Arias EE, 2005, GENE DEV, V19, P114, DOI 10.1101/gad.1255805; Bender RP, 2008, BIOCHEMISTRY-US, V47, P4501, DOI 10.1021/bi702019z; Bravou V, 2005, INT J ONCOL, V27, P1511; Davidson IF, 2006, MOL CELL, V24, P433, DOI 10.1016/j.molcel.2006.09.010; Gasnereau I, 2007, CYTOM PART A, V71A, P1, DOI 10.1002/cyto.a.20352; Guarino E, 2011, NUCLEIC ACIDS RES, V39, P5978, DOI 10.1093/nar/gkr222; Havens CG, 2009, MOL CELL, V35, P93, DOI 10.1016/j.molcel.2009.05.012; Higa LAA, 2003, NAT CELL BIOL, V5, P1008, DOI 10.1038/ncb1061; Higa LA, 2006, CELL CYCLE, V5, P1675, DOI 10.4161/cc.5.15.3149; Hu J, 2006, J BIOL CHEM, V281, P3753, DOI 10.1074/jbc.C500464200; Hu J, 2004, NAT CELL BIOL, V6, P1003, DOI 10.1038/ncb1172; Jin JP, 2006, MOL CELL, V23, P709, DOI 10.1016/j.molcel.2006.08.010; Karakaidos P, 2004, AM J PATHOL, V165, P1351, DOI 10.1016/S0002-9440(10)63393-7; Kondo T, 2004, J BIOL CHEM, V279, P27315, DOI 10.1074/jbc.M314023200; Li XH, 2003, J BIOL CHEM, V278, P30854, DOI 10.1074/jbc.C300251200; Liontos M, 2007, CANCER RES, V67, P10899, DOI 10.1158/0008-5472.CAN-07-2837; Liu EB, 2004, J BIOL CHEM, V279, P17283, DOI 10.1074/jbc.C300549200; Maiorano D, 2000, NATURE, V404, P622, DOI 10.1038/35007104; Musch T, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0010726; Nishitani H, 2006, EMBO J, V25, P1126, DOI 10.1038/sj.emboj.7601002; Nishitani H, 2000, NATURE, V404, P625, DOI 10.1038/35007110; Nishitani H, 2001, J BIOL CHEM, V276, P44905, DOI 10.1074/jbc.M105406200; Nitiss JL, 2009, NAT REV CANCER, V9, P338, DOI 10.1038/nrc2607; Petropoulou C, 2008, FRONT BIOSCI, V13, P4485, DOI 10.2741/3018; PINES J, 1990, NATURE, V346, P760, DOI 10.1038/346760a0; Ponti D, 2005, CANCER RES, V65, P5506, DOI 10.1158/0008-5472.CAN-05-0626; Ralph E, 2006, EMBO REP, V7, P1134, DOI 10.1038/sj.embor.7400827; Sakaue-Sawano A, 2008, CELL, V132, P487, DOI 10.1016/j.cell.2007.12.033; Sansam CL, 2006, GENE DEV, V20, P3117, DOI 10.1101/gad.1482106; Senga T, 2006, J BIOL CHEM, V281, P6246, DOI 10.1074/jbc.M512705200; Seo J, 2005, ONCOGENE, V24, P8176, DOI 10.1038/sj.onc.1208881; Sharma SV, 2010, CELL, V141, P69, DOI 10.1016/j.cell.2010.02.027; Shibata E, 2011, MOL CELL BIOL, V31, P3136, DOI 10.1128/MCB.05496-11; Spella M, 2007, NEUROSCIENCE, V147, P373, DOI 10.1016/j.neuroscience.2007.03.050; Sugimoto N, 2004, J BIOL CHEM, V279, P19691, DOI 10.1074/jbc.M313175200; Tada S, 2001, NAT CELL BIOL, V3, P107, DOI 10.1038/35055000; Tatsumi Y, 2006, J CELL SCI, V119, P3128, DOI 10.1242/jcs.03031; Thomer M, 2004, DEVELOPMENT, V131, P4807, DOI 10.1242/dev.01348; Vaziri C, 2003, MOL CELL, V11, P997, DOI 10.1016/S1097-2765(03)00099-6; Wang D, 2005, NAT REV DRUG DISCOV, V4, P307, DOI 10.1038/nrd1691; Wang JZ, 2006, AM J PHYSIOL-RENAL, V291, pF1300, DOI 10.1152/ajprenal.00509.2005; Wilstermann AM, 2007, BIOCHEMISTRY-US, V46, P8217, DOI 10.1021/bi700272u; Wohlschlegel JA, 2000, SCIENCE, V290, P2309, DOI 10.1126/science.290.5500.2309; Wong PG, 2010, CELL CYCLE, V9, P4351, DOI 10.4161/cc.9.21.13596; Xouri G, 2004, EUR J BIOCHEM, V271, P3368, DOI 10.1111/j.1432-1033.2004.04271.x; Xouri G, 2007, EMBO J, V26, P1303, DOI 10.1038/sj.emboj.7601597; Zhong WW, 2003, NATURE, V423, P885, DOI 10.1038/nature01747; Zhou BBS, 2004, NAT REV CANCER, V4, P216, DOI 10.1038/nrc1296	51	23	23	0	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 30	2012	7	3							e34621	10.1371/journal.pone.0034621	http://dx.doi.org/10.1371/journal.pone.0034621			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	959UC	22479651	Green Published, gold, Green Submitted			2022-12-25	WOS:000305339100171
J	Nasr, Z; Robert, F; Porco, JA; Muller, WJ; Pelletier, J				Nasr, Z.; Robert, F.; Porco, J. A., Jr.; Muller, W. J.; Pelletier, J.			eIF4F suppression in breast cancer affects maintenance and progression	ONCOGENE			English	Article						elF4E; elF4A; PyMT mouse model; breast cancer; pulmonary metastasis	INITIATION-FACTOR 4E; MAMMARY-TUMOR PROGRESSION; CELL-GROWTH; C-MYC; THERAPEUTIC SUPPRESSION; EPITHELIAL-CELLS; MOUSE MODEL; TSC GENES; TRANSLATION; EXPRESSION	Levels of eukaryotic initiation factor 4E (eIF4E) are frequently elevated in human cancers and in some instances have been associated with poor prognosis and outcome. Here we utilize transgenic and allograft breast cancer models to demonstrate that increased mammalian target of rapamycin (mTOR) signalling can be a significant contributor to breast cancer progression in vivo. Suppressing mTOR activity, as well as levels and activity of the downstream translation regulators, elF4E and elF4A, delayed breast cancer progression, onset of associated pulmonary metastasis in vivo and breast cancer cell invasion and migration in vitro. Translation of vascular endothelial growth factor (VEGF), matrix metallopeptidase 9 (MMP9) and cyclin D1 mRNAs, which encode products associated with the metastatic phenotype, is inhibited upon eIF4E suppression. Our results indicate that the mTOR/eIF4F axis is an important contributor to tumor maintenance and progression programs in breast cancer. Targeting this pathway may be of therapeutic benefit. Oncogene (2013) 32, 861-871; doi:10.1038/onc.2012.105; published online 9 April 2012	[Nasr, Z.; Robert, F.; Muller, W. J.; Pelletier, J.] McGill Univ, Dept Biochem, Montreal, PQ H3G 1Y6, Canada; [Porco, J. A., Jr.] Boston Univ, Dept Chem, Ctr Chem Methodol & Lib Dev, Boston, MA 02215 USA; [Muller, W. J.; Pelletier, J.] McGill Univ, Rosalind & Morris Goodman Canc Res Ctr, Montreal, PQ H3G 1Y6, Canada	McGill University; Boston University; McGill University	Pelletier, J (corresponding author), McGill Univ, McIntyre Med Sci Bldg,Room 810,3655 Promenade Sir, Montreal, PQ H3G 1Y6, Canada.	jerry.pelletier@mcgill.ca			Canadian Institutes of Health Research [MOP-89791, MOP-106530]; CRC Chair in Molecular Oncology; National Institutes of Health [GM-073855]; Canadian Cancer Society Research Institute (CCSRI) [17099]; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R24GM111625, R01GM073855] Funding Source: NIH RePORTER	Canadian Institutes of Health Research(Canadian Institutes of Health Research (CIHR)); CRC Chair in Molecular Oncology; National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Canadian Cancer Society Research Institute (CCSRI)(Canadian Cancer Society (CCS)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	WJM is supported by the Canadian Institutes of Health Research (MOP-89791) and a CRC Chair in Molecular Oncology. JAP, Jr thanks the National Institutes of Health (GM-073855) for research support. This work was supported by the Canadian Institutes of Health Research (MOP-106530) and the Canadian Cancer Society Research Institute (CCSRI no. 17099) to JP.	Andrechek ER, 2000, P NATL ACAD SCI USA, V97, P3444, DOI 10.1073/pnas.050408497; Armengol G, 2007, CANCER RES, V67, P7551, DOI 10.1158/0008-5472.CAN-07-0881; Avdulov S, 2004, CANCER CELL, V5, P553, DOI 10.1016/j.ccr.2004.05.024; Benjamin D, 2011, NAT REV DRUG DISCOV, V10, P868, DOI 10.1038/nrd3531; Bordeleau ME, 2008, J CLIN INVEST, V118, P2651, DOI 10.1172/JCI34753; Bordeleau ME, 2006, NAT CHEM BIOL, V2, P213, DOI 10.1038/nchembio776; BOYDEN S, 1962, J EXP MED, V115, P453, DOI 10.1084/jem.115.3.453; Brown CJ, 2011, J MOL BIOL, V405, P736, DOI 10.1016/j.jmb.2010.10.045; Cencic R, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0005223; Chakraborty S, 2008, BMC CANCER, V8, DOI 10.1186/1471-2407-8-163; Coleman LJ, 2009, BRIT J CANCER, V100, P1393, DOI 10.1038/sj.bjc.6605044; Davie SA, 2007, TRANSGENIC RES, V16, P193, DOI 10.1007/s11248-006-9056-9; De Benedetti A, 2004, ONCOGENE, V23, P3189, DOI 10.1038/sj.onc.1207545; Dillon RL, 2010, CANCER RES, V70, P4260, DOI 10.1158/0008-5472.CAN-10-0266; Dillon RL, 2009, CANCER RES, V69, P5057, DOI 10.1158/0008-5472.CAN-08-4287; Dong K, 2009, BREAST CANCER RES TR, V113, P443, DOI 10.1007/s10549-008-9956-x; Dorrello NV, 2006, SCIENCE, V314, P467, DOI 10.1126/science.1130276; Dowling RJO, 2010, SCIENCE, V328, P1172, DOI 10.1126/science.1187532; Gingras AC, 1999, ANNU REV BIOCHEM, V68, P913, DOI 10.1146/annurev.biochem.68.1.913; Graff JR, 2008, CANCER RES, V68, P631, DOI 10.1158/0008-5472.CAN-07-5635; Graff JR, 2007, J CLIN INVEST, V117, P2638, DOI 10.1172/JCI32044; GRAFF JR, 1995, INT J CANCER, V60, P255; GUY CT, 1992, MOL CELL BIOL, V12, P954, DOI 10.1128/MCB.12.3.954; Ilic N, 2011, P NATL ACAD SCI USA, V108, pE699, DOI 10.1073/pnas.1108237108; Iliopoulos D, 2011, CANCER RES, V71, P3196, DOI 10.1158/0008-5472.CAN-10-3471; Jiang H, 2003, CANCER CELL INT, V3, DOI 10.1186/1475-2867-3-2; Jiang WG, 2005, EUR J CANCER, V41, P1628, DOI 10.1016/j.ejca.2005.03.023; Jones RM, 1996, MOL CELL BIOL, V16, P4754; Knowles MA, 2003, BIOCHEM SOC T, V31, P597, DOI 10.1042/BST0310597; Ko SY, 2009, CLIN CANCER RES, V15, P4336, DOI 10.1158/1078-0432.CCR-08-2924; Konicek BW, 2011, CANCER RES, V71, P1849, DOI 10.1158/0008-5472.CAN-10-3298; Larsson O, 2007, CANCER RES, V67, P6814, DOI 10.1158/0008-5472.CAN-07-0752; LAZARISKARATZAS A, 1990, NATURE, V345, P544, DOI 10.1038/345544a0; Li BDL, 1997, CANCER-AM CANCER SOC, V79, P2385; Lifsted T, 1998, INT J CANCER, V77, P640, DOI 10.1002/(SICI)1097-0215(19980812)77:4<640::AID-IJC26>3.0.CO;2-8; Lin CJ, 2008, CANCER RES, V68, P5326, DOI 10.1158/0008-5472.CAN-07-5876; Lin EY, 2003, AM J PATHOL, V163, P2113, DOI 10.1016/S0002-9440(10)63568-7; Liu PX, 2011, NAT MED, V17, P1116, DOI 10.1038/nm.2402; Maglione JE, 2001, CANCER RES, V61, P8298; Muellner MK, 2011, NAT CHEM BIOL, V7, P787, DOI 10.1038/nchembio.695; Podsypanina K, 2008, P NATL ACAD SCI USA, V105, P5242, DOI 10.1073/pnas.0801197105; Pons B, 2011, INT J ONCOL, V39, P1337, DOI 10.3892/ijo.2011.1118; PRICE JE, 1990, CANCER RES, V50, P717; Rosenwald IB, 1996, CANCER LETT, V102, P113, DOI 10.1016/0304-3835(96)04171-7; Ruggero D, 2004, NAT MED, V10, P484, DOI 10.1038/nm1042; Sarbassov DD, 2006, MOL CELL, V22, P159, DOI 10.1016/j.molcel.2006.03.029; Silvera D, 2010, NAT REV CANCER, V10, P254, DOI 10.1038/nrc2824; Soni A, 2008, MOL CANCER THER, V7, P1782, DOI 10.1158/1535-7163.MCT-07-2357; van Veelen W, 2011, ONCOGENE, V30, P2289, DOI 10.1038/onc.2010.630; Webster MA, 1998, MOL CELL BIOL, V18, P2344, DOI 10.1128/MCB.18.4.2344; Weigelt B, 2011, ONCOGENE, V30, P3222, DOI 10.1038/onc.2011.42; Wendel HG, 2006, CANCER RES, V66, P7639, DOI 10.1158/0008-5472.CAN-06-0419; Wendel HG, 2004, NATURE, V428, P332, DOI 10.1038/nature02369; Wienecke R, 1997, ANN NEUROL, V42, P230, DOI 10.1002/ana.410420215; Xu ZF, 2009, LEUKEMIA RES, V33, P891, DOI 10.1016/j.leukres.2009.01.041; Zhou FF, 2011, MED ONCOL, V28, P1302, DOI 10.1007/s12032-010-9630-0; Zindy P, 2011, CANCER RES, V71, P4068, DOI 10.1158/0008-5472.CAN-11-0420	57	57	63	0	17	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0950-9232			ONCOGENE	Oncogene	FEB 14	2013	32	7					861	871		10.1038/onc.2012.105	http://dx.doi.org/10.1038/onc.2012.105			11	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	112GQ	22484424	Green Accepted			2022-12-25	WOS:000316581100006
J	Mima, A; Kitada, M; Geraldes, P; Li, Q; Matsumoto, M; Mizutani, K; Qi, W; Li, CZ; Leitges, M; Rask-Madsen, C; King, GL				Mima, Akira; Kitada, Munehiro; Geraldes, Pedro; Li, Qian; Matsumoto, Motonobu; Mizutani, Koji; Qi, Weier; Li, Chenzhong; Leitges, Michael; Rask-Madsen, Christian; King, George L.			Glomerular VEGF resistance induced by PKC beta/SHP-1 activation and contribution to diabetic nephropathy	FASEB JOURNAL			English	Article						podocyte apoptosis; hyperglycemia; VEGFR-2	KINASE-C-DELTA; ENDOTHELIAL GROWTH-FACTOR; PROTEIN-KINASE; CELL APOPTOSIS; PKC-DELTA; EXPRESSION; GLUCOSE; BETA; DIFFERENTIATION; INHIBITION	This study characterizes the effect of glucose-induced activation of protein kinase C delta (PKC delta) and Src homology-2 domain-containing phosphatase-1 (SHP-1) expression on vascular endothelial growth factor (VEGF) actions in glomerular podocytes in cultures and in glomeruli of diabetic rodents. Elevation of glucose levels induced PKC delta and p38 mitogen-activated protein kinase (p38 MAPK) to increase SHP-1 expression, increased podocyte apoptosis, and inhibited VEGF activation in podocytes and glomerular endothelial cells. The adverse effects of high glucose levels can be negated by molecular inhibitors of PKC delta, p38MAPK, and SHP-1 and only partially reduced by antioxidants and nuclear factor-kappa B (NF-kappa B) inhibitor. Increased PKC delta activation and SHP-1 expression correlated with loss of VEGF signaling and podocyte numbers in the glomeruli of diabetic rats and mice. In contrast, diabetic PKC delta -knockout (Prkcd(-/-)) mice did not exhibit activation of p38 MAPK and SHP-1 or inhibition of VEGF signaling in renal glomeruli. Functionally, diabetic Prkcd(-/-) mice had decreased expressions of TGF beta, VEGF, and extracellular matrix and less albuminuria than diabetic Prkcd(+/+) mice. Hyperglycemia and diabetes can cause glomerular podocyte apoptosis and endothelial dysfunction partly due to increased PKC beta/p38 MAPK activation and the expression of SHP-1 to cause VEGF resistance, independent of NF-kappa B activation.-Mima, A., Kitada, M., Geraldes, P., Li, Q., Matsumoto, M., Mizutani, K., Qi, W., Li, C., Leitges, M., Rask-Madsen, C., King, G. L. Glomerular VEGF resistance induced by PKC delta/SHP-1 activation and contribution to diabetic nephropathy. FASEB J. 26, 2963-2974 (2012). www.fasebj.org	[King, George L.] Harvard Univ, Joslin Diabet Ctr, Div Res, Sch Med,Dianne Nunnally Hoppes Lab Diabet Complic, Boston, MA 02215 USA; [Geraldes, Pedro] Univ Sherbrooke, Dept Med, Sherbrooke, PQ J1K 2R1, Canada; [Leitges, Michael] Univ Oslo, Biotechnol Ctr Oslo, Oslo, Norway	Harvard University; Harvard Medical School; Joslin Diabetes Center, Inc.; University of Sherbrooke; University of Oslo	King, GL (corresponding author), Harvard Univ, Joslin Diabet Ctr, Div Res, Sch Med,Dianne Nunnally Hoppes Lab Diabet Complic, 1 Joslin Pl, Boston, MA 02215 USA.	george.king@joslin.harvard.edu	Leitges, Michael/AAN-1953-2021; åå, åç°/AAD-8655-2019	Leitges, Michael/0000-0003-4203-6995; Rask-Madsen, Christian/0000-0002-8548-466X	U.S. National Institutes of Health/National Eye Institute [EY016150]; Manpei Suzuki Diabetes Foundation; Kanzawa Medical Research Foundation; Novartis Foundation, Japan; Diabetes and Endocrinology Research Center [P30DK036836]; NATIONAL EYE INSTITUTE [R01EY016150] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [P30DK036836] Funding Source: NIH RePORTER	U.S. National Institutes of Health/National Eye Institute(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI)); Manpei Suzuki Diabetes Foundation; Kanzawa Medical Research Foundation(Kanzawa Medical Research Foundation); Novartis Foundation, Japan(Novartis); Diabetes and Endocrinology Research Center; NATIONAL EYE INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	The authors thank Dr. Hillary Keenan for the discussions on the statistical analysis and Ms. Patti Muehter for excellent assistance with manuscript preparation. This work is supported by grants to G. L. K. from the U.S. National Institutes of Health/National Eye Institute (EY016150). A. M. is the recipient of a Research Fellowship (Manpei Suzuki Diabetes Foundation, Kanzawa Medical Research Foundation, Novartis Foundation, Japan). This project has been supported by Diabetes and Endocrinology Research Center grant P30DK036836.	Brownlee M, 2001, NATURE, V414, P813, DOI 10.1038/414813a; Busik JV, 2008, DIABETES, V57, P1952, DOI 10.2337/db07-1520; De Vriese AS, 2001, J AM SOC NEPHROL, V12, P1734, DOI 10.1681/ASN.V1281734; Dubois MJ, 2006, NAT MED, V12, P549, DOI 10.1038/nm1397; ELLIS EN, 1987, KIDNEY INT, V32, P736, DOI 10.1038/ki.1987.268; Emoto Y, 1995, EMBO J, V14, P6148, DOI 10.1002/j.1460-2075.1995.tb00305.x; Eremina V, 2003, J CLIN INVEST, V111, P707, DOI 10.1172/JCI200317423; Eremina V, 2008, NEW ENGL J MED, V358, P1129, DOI 10.1056/NEJMoa0707330; Geraldes P, 2009, NAT MED, V15, P1298, DOI 10.1038/nm.2052; Gubler MC, 2003, J AM SOC NEPHROL, V14, pS22, DOI 10.1097/01.ASN.0000067648.75923.68; Hohenstein B, 2006, KIDNEY INT, V69, P1654, DOI 10.1038/sj.ki.5000294; Igarashi M, 1999, J CLIN INVEST, V103, P185, DOI 10.1172/JCI3326; Kim YH, 2008, DIABETES, V57, P2181, DOI 10.2337/db07-1431; Koya D, 1997, J CLIN INVEST, V100, P115, DOI 10.1172/JCI119503; Ku CH, 2008, DIABETES, V57, P2824, DOI 10.2337/db08-0647; Leitges M, 2001, J CLIN INVEST, V108, P1505; Li XN, 2010, J AM SOC NEPHROL, V21, P1115, DOI 10.1681/ASN.2009070760; Lin CL, 2006, KIDNEY INT, V69, P1593, DOI 10.1038/sj.ki.5000329; Menne J, 2004, DIABETES, V53, P2101, DOI 10.2337/diabetes.53.8.2101; Mima A, 2011, KIDNEY INT, V79, P883, DOI 10.1038/ki.2010.526; Mundel P, 1997, EXP CELL RES, V236, P248, DOI 10.1006/excr.1997.3739; Naruse K, 2006, DIABETES, V55, P691, DOI 10.2337/diabetes.55.03.06.db05-0771; Pagtalunan ME, 1997, J CLIN INVEST, V99, P342, DOI 10.1172/JCI119163; Quack I., J BIOL CHEM, V15, P12959; Remuzzi G, 2006, J CLIN INVEST, V116, P288, DOI 10.1172/JCI27699; Romeo G, 2002, DIABETES, V51, P2241, DOI 10.2337/diabetes.51.7.2241; Schrijvers BF, 2005, HORM METAB RES, V37, P21, DOI 10.1055/s-2005-861027; Shizukuda Y, 1999, CIRCULATION, V100, P1909, DOI 10.1161/01.CIR.100.18.1909; SHULTZ LD, 1993, CELL, V73, P1445, DOI 10.1016/0092-8674(93)90369-2; Sison K, 2010, J AM SOC NEPHROL, V21, P1691, DOI 10.1681/ASN.2010030295; Stadtman ER, 2006, FREE RADICAL RES, V40, P1250, DOI 10.1080/10715760600918142; Steffes MW, 2001, KIDNEY INT, V59, P2104, DOI 10.1046/j.1523-1755.2001.0590062104.x; Suzuma K, 2002, P NATL ACAD SCI USA, V99, P721, DOI 10.1073/pnas.022644499; Tanaka M, 2004, CIRCULATION, V110, pII194, DOI 10.1161/01.CIR.0000138389.22905.62; Toyoda M, 2004, KIDNEY INT, V66, P1107, DOI 10.1111/j.1523-1755.2004.00798.x; TRYGGVASON K, 1975, NEPHRON, V15, P62, DOI 10.1159/000180493; Turner RC, 1998, LANCET, V352, P837, DOI 10.1016/s0140-6736(98)07019-6; WEIBEL ER, 1962, J APPL PHYSIOL, V17, P343, DOI 10.1152/jappl.1962.17.2.343; Wilmer WA, 2001, KIDNEY INT, V60, P858, DOI 10.1046/j.1523-1755.2001.060003858.x	39	53	56	1	13	WILEY	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0892-6638	1530-6860		FASEB J	Faseb J.	JUL	2012	26	7					2963	2974		10.1096/fj.11-202994	http://dx.doi.org/10.1096/fj.11-202994			12	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	967MP	22499584	Green Published			2022-12-25	WOS:000305912500024
J	Rock, K; Meusch, M; Fuchs, N; Tigges, J; Zipper, P; Fritsche, E; Krutmann, J; Homey, B; Reifenberger, J; Fischer, JW				Roeck, Katharina; Meusch, Michael; Fuchs, Nikola; Tigges, Julia; Zipper, Petra; Fritsche, Ellen; Krutmann, Jean; Homey, Bernhard; Reifenberger, Julia; Fischer, Jens W.			Estradiol Protects Dermal Hyaluronan/Versican Matrix during Photoaging by Release of Epidermal Growth Factor from Keratinocytes	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							HORMONE REPLACEMENT THERAPY; SMOOTH-MUSCLE-CELLS; HYALURONIC-ACID; ESTROGEN-RECEPTOR; HUMAN SKIN; ACTIVATES HYALURONAN; POSTMENOPAUSAL WOMEN; PROLIFERATION; VERSICAN; FIBROBLASTS	Hyaluronan (HA) and versican are key components of the dermis and are responsive to ultraviolet (UV) B-induced remodeling. The aim of this study was to explore the molecular mechanisms mediating the effects of estrogen (E-2) on HA-rich extracellular matrix during photoaging. Hairless skh-1 mice were irradiated with UVB (three times, 1 minimal erythema dose (80 mJ/cm(2)), weekly) for 10 weeks, and endogenous sex hormone production was abrogated by ovariectomy. Subcutaneous substitution of E-2 by means of controlled-release pellets caused a strong increase in the dermal HA content in both irradiated and nonirradiated skin. The increase in dermal HA correlated with induction of HA synthase HAS3 by E-2. Expression of splice variant 2 of the HA-binding proteoglycan versican was also increased by E-2. In search of candidate mediators of these effects, it was found that E-2 strongly induced the expression of epidermal growth factor (EGF) in UVB-irradiated epidermis in vivo and in keratinocytes in vitro. EGF in turn up-regulated the expression of HAS3 and versican V2 in dermal fibroblasts. HAS3 knockdown by shRNA caused inhibition of fibroblast proliferation. Furthermore, HAS3 and versican V2 induction by E-2 correlated positively with proliferation in vivo. In addition, the accumulation of inflammatory macrophages, expression of inducible cyclooxygenase 2, as well as proinflammatory monocyte chemotactic protein 1 were decreased in response to E-2 in the dermis. Collectively, these data suggest that E-2 treatment increases the amount of dermal HA and versican V2 via paracrine release of EGF, which may be implicated in the pro-proliferative and anti-inflammatory effects of E-2 during photoaging.	[Roeck, Katharina; Meusch, Michael; Fuchs, Nikola; Fischer, Jens W.] Univ Dusseldorf, Inst Pharmakol & Klin Pharmakol, Univ Klinikum Dusseldorf, D-40225 Dusseldorf, Germany; [Tigges, Julia; Fritsche, Ellen; Krutmann, Jean] Univ Dusseldorf, IUF Leibniz Inst Environm Med, Univ Klinikum Dusseldorf, D-40225 Dusseldorf, Germany; [Zipper, Petra; Homey, Bernhard; Reifenberger, Julia] Univ Dusseldorf, Dept Dermatol, Univ Klinikum Dusseldorf, D-40225 Dusseldorf, Germany	Heinrich Heine University Dusseldorf; Heinrich Heine University Dusseldorf Hospital; Heinrich Heine University Dusseldorf; Heinrich Heine University Dusseldorf Hospital; Leibniz Institut fur Umweltmedizinische Forschung (IUF); Heinrich Heine University Dusseldorf; Heinrich Heine University Dusseldorf Hospital	Fischer, JW (corresponding author), Univ Dusseldorf, Inst Pharmakol & Klin Pharmakol, Univ Klinikum Dusseldorf, D-40225 Dusseldorf, Germany.	jens.fischer@uni-duesseldorf.de	Reifenberger, Guido/AAE-3599-2019	Tigges, Julia/0000-0002-0847-9939	Deutsche Forschungsgemeinschaft [SFB 728, TP C6, TP C1, TP C4]	Deutsche Forschungsgemeinschaft(German Research Foundation (DFG))	This work was supported by Deutsche Forschungsgemeinschaft Grants SFB 728, TP C6, C1, and C4.	Ashcroft GS, 1997, NAT MED, V3, P1209, DOI 10.1038/nm1197-1209; Averbeck M, 2007, J INVEST DERMATOL, V127, P687, DOI 10.1038/sj.jid.5700614; BENTLEY JP, 1986, J INVEST DERMATOL, V87, P668, DOI 10.1111/1523-1747.ep12456427; Bourguignon LYW, 2007, J BIOL CHEM, V282, P19426, DOI 10.1074/jbc.M610054200; Brennan M, 2003, PHOTOCHEM PHOTOBIOL, V78, P43, DOI 10.1562/0031-8655(2003)078<0043:MMITMC>2.0.CO;2; CASTELOBRANCO C, 1992, MATURITAS, V15, P113, DOI 10.1016/0378-5122(92)90245-Y; Chang MY, 2000, J BIOL CHEM, V275, P4766, DOI 10.1074/jbc.275.7.4766; Dai G, 2007, AM J PATHOL, V171, P1451, DOI 10.2353/ajpath.2007.070136; Day AJ, 2002, J BIOL CHEM, V277, P4585, DOI 10.1074/jbc.R100036200; de la Motte CA, 1999, J BIOL CHEM, V274, P30747, DOI 10.1074/jbc.274.43.30747; Dours-Zimmermann MT, 2009, J NEUROSCI, V29, P7731, DOI 10.1523/JNEUROSCI.4158-08.2009; Evanko SP, 1999, ARTERIOSCL THROM VAS, V19, P1004, DOI 10.1161/01.ATV.19.4.1004; Evanko SP, 2012, MATRIX BIOL, V31, P90, DOI 10.1016/j.matbio.2011.10.004; Fisher GJ, 1996, NATURE, V379, P335, DOI 10.1038/379335a0; Gehm BD, 2000, MOL CELL ENDOCRINOL, V159, P53, DOI 10.1016/S0303-7207(99)00195-1; GHERSETICH I, 1994, INT J DERMATOL, V33, P119, DOI 10.1111/j.1365-4362.1994.tb01540.x; GROSMAN N, 1971, ACTA PHARMACOL TOX, V30, P458; Haczynski J, 2002, INT J MOL MED, V10, P149; Hall JM, 2001, J BIOL CHEM, V276, P36869, DOI 10.1074/jbc.R100029200; IGNARTROWBRIDGE DM, 1992, P NATL ACAD SCI USA, V89, P4658, DOI 10.1073/pnas.89.10.4658; Itano N, 2002, IUBMB LIFE, V54, P195, DOI 10.1080/15216540214929; Kanda N, 2005, J DERMATOL SCI, V38, P1, DOI 10.1016/j.jdermsci.2004.10.011; Karousou E, 2010, J BIOL CHEM, V285, P23647, DOI 10.1074/jbc.M110.127050; Knott A, 2009, BIOGERONTOLOGY, V10, P181, DOI 10.1007/s10522-008-9165-3; Koshiishi I, 1999, BBA-GEN SUBJECTS, V1428, P327, DOI 10.1016/S0304-4165(99)00081-1; NELSON KG, 1991, P NATL ACAD SCI USA, V88, P21, DOI 10.1073/pnas.88.1.21; Oppermann M, 2011, BASIC RES CARDIOL, V106, P539, DOI 10.1007/s00395-011-0160-5; Papakonstantinou E, 1998, ATHEROSCLEROSIS, V138, P79, DOI 10.1016/S0021-9150(98)00006-9; Pasonen-Seppanen S, 2003, J INVEST DERMATOL, V120, P1038, DOI 10.1046/j.1523-1747.2003.12249.x; Pienimaki JP, 2001, J BIOL CHEM, V276, P20428, DOI 10.1074/jbc.M007601200; REENSTRA WR, 1993, EXP CELL RES, V209, P118, DOI 10.1006/excr.1993.1291; Sator PG, 2007, CLIMACTERIC, V10, P320, DOI 10.1080/13697130701444073; Sator PG, 2001, MATURITAS, V39, P43, DOI 10.1016/S0378-5122(00)00225-5; SCHWARTZ E, 1988, J INVEST DERMATOL, V91, P158, DOI 10.1111/1523-1747.ep12464405; Sheng W, 2005, MOL BIOL CELL, V16, P1330, DOI 10.1091/mbc.e04-04-0295; Shiraha H, 2000, J BIOL CHEM, V275, P19343, DOI 10.1074/jbc.M000008200; Simpson RML, 2010, AM J PATHOL, V176, P1215, DOI 10.2353/ajpath.2010.090802; Simpson RML, 2009, AM J PATHOL, V175, P1915, DOI 10.2353/ajpath.2009.090045; SOBEL H, 1970, STEROIDS, V16, P1, DOI 10.1016/S0039-128X(70)80090-3; Stern R, 2004, EUR J CELL BIOL, V83, P317, DOI 10.1078/0171-9335-00392; Stern R, 2008, CLIN DERMATOL, V26, P106, DOI 10.1016/j.clindermatol.2007.09.013; Takahashi Y, 1996, J DERMATOL SCI, V11, P129, DOI 10.1016/0923-1811(95)00430-0; TAMMI R, 1994, PROG HISTOCHEM CYTOC, V29, P1; Toole BP, 2004, NAT REV CANCER, V4, P528, DOI 10.1038/nrc1391; Twarock S, 2011, MOL CANCER, V10, DOI 10.1186/1476-4598-10-30; UZUKA M, 1981, BIOCHIM BIOPHYS ACTA, V673, P387, DOI 10.1016/0304-4165(81)90470-0; Varani J, 2001, AM J PATHOL, V158, P931, DOI 10.1016/S0002-9440(10)64040-0; Verdier-Sevain S, 2004, FASEB J, V18, P1252, DOI 10.1096/fj.03-1088fje; Verdier-Sevrain S, 2006, EXP DERMATOL, V15, P83, DOI 10.1111/j.1600-0625.2005.00377.x; Vickers MR, 2007, BMJ-BRIT MED J, V335, P239, DOI 10.1136/bmj.39266.425069.AD; Vigetti D, 2009, J BIOL CHEM, V284, P30684, DOI 10.1074/jbc.M109.040386; Webber J, 2009, J BIOL CHEM, V284, P9083, DOI 10.1074/jbc.M806989200; Wight TN, 2002, CURR OPIN CELL BIOL, V14, P617, DOI 10.1016/S0955-0674(02)00375-7; YONEDA M, 1988, J CELL SCI, V90, P265; Zhang B, 2001, GENE THER, V8, P1745, DOI 10.1038/sj.gt.3301587	55	37	39	0	7	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JUN 8	2012	287	24					20056	20069		10.1074/jbc.M112.353151	http://dx.doi.org/10.1074/jbc.M112.353151			14	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	974FB	22493503	Green Published, hybrid			2022-12-25	WOS:000306414500027
J	van Roermund, CWT; Ijlst, L; Majczak, W; Waterham, HR; Folkerts, H; Wanders, RJA; Hellingwerf, KJ				van Roermund, Carlo W. T.; Ijlst, Lodewijk; Majczak, Wiktor; Waterham, Hans R.; Folkerts, Hendrik; Wanders, Ronald J. A.; Hellingwerf, Klaas J.			Peroxisomal Fatty Acid Uptake Mechanism in Saccharomyces cerevisiae	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							BINDING-CASSETTE TRANSPORTER; ACYL-COA SYNTHETASE; X-LINKED ADRENOLEUKODYSTROPHY; BETA-OXIDATION; ABC TRANSPORTERS; ARABIDOPSIS-THALIANA; PLASMA-MEMBRANE; COENZYME-A; PROTEIN; METABOLISM	Peroxisomes play a major role in human cellular lipid metabolism, including fatty acid beta-oxidation. The most frequent peroxisomal disorder is X-linked adrenoleukodystrophy, which is caused by mutations in ABCD1. The biochemical hallmark of X-linked adrenoleukodystrophy is the accumulation of very long chain fatty acids (VLCFAs) due to impaired peroxisomal beta-oxidation. Although this suggests a role of ABCD1 in VLCFA import into peroxisomes, no direct experimental evidence is available to substantiate this. To unravel the mechanism of peroxisomal VLCFA transport, we use Saccharomyces cerevisiae as a model organism. Here we provide evidence that in this organism very long chain acyl-CoA esters are hydrolyzed by the Pxa1p-Pxa2p complex prior to the actual transport of their fatty acid moiety into the peroxisomes with the CoA presumably being released into the cytoplasm. The Pxa1p-Pxa2p complex functionally interacts with the acyl-CoA synthetases Faa2p and/or Fat1p on the inner surface of the peroxisomal membrane for subsequent re-esterification of the VLCFAs. Importantly, the Pxa1p-Pxa2p complex shares this molecular mechanism with HsABCD1 and HsABCD2.	[van Roermund, Carlo W. T.; Ijlst, Lodewijk; Majczak, Wiktor; Waterham, Hans R.; Folkerts, Hendrik; Wanders, Ronald J. A.] Univ Amsterdam, Acad Med Ctr, Dept Pediat, Lab Genet Metab Dis, NL-1105 AZ Amsterdam, Netherlands; [van Roermund, Carlo W. T.; Ijlst, Lodewijk; Majczak, Wiktor; Waterham, Hans R.; Folkerts, Hendrik; Wanders, Ronald J. A.] Univ Amsterdam, Acad Med Ctr, Dept Clin Chem, Lab Genet Metab Dis, NL-1105 AZ Amsterdam, Netherlands; [Hellingwerf, Klaas J.] Univ Amsterdam, Swammerdam Inst Life Sci, Fac Sci, NL-1098 XH Amsterdam, Netherlands	University of Amsterdam; Academic Medical Center Amsterdam; University of Amsterdam; Academic Medical Center Amsterdam; University of Amsterdam	van Roermund, CWT (corresponding author), Univ Amsterdam, Acad Med Ctr, Dept Pediat, Lab Genet Metab Dis, Rm F0-226,Meibergdreef 9, NL-1105 AZ Amsterdam, Netherlands.	c.vanroermund@amc.uva.nl			Europeon Leukodystrophies Association (ELA) Foundation [091564]	Europeon Leukodystrophies Association (ELA) Foundation	This work was supported by the Europeon Leukodystrophies Association (ELA) Foundation Research Grant 091564.	Agrimi G, 2012, BIOCHEM J, V443, P241, DOI 10.1042/BJ20111420; Arai R, 2001, PROTEIN ENG, V14, P529, DOI 10.1093/protein/14.8.529; Athenstaedt K, 1999, J BACTERIOL, V181, P6441, DOI 10.1128/JB.181.20.6441-6448.1999; Choi JY, 1999, J BIOL CHEM, V274, P4671, DOI 10.1074/jbc.274.8.4671; Deutscher J, 2006, MICROBIOL MOL BIOL R, V70, P939, DOI 10.1128/MMBR.00024-06; Elgersma Y, 1996, J BIOL CHEM, V271, P26375, DOI 10.1074/jbc.271.42.26375; Footitt S, 2002, EMBO J, V21, P2912, DOI 10.1093/emboj/cdf300; Fulda M, 2004, PLANT CELL, V16, P394, DOI 10.1105/tpc.019646; Fulda M, 2002, PLANT J, V32, P93, DOI 10.1046/j.1365-313X.2002.01405.x; Hayashi M, 2002, PLANT CELL PHYSIOL, V43, P1, DOI 10.1093/pcp/pcf023; Hettema EH, 1996, EMBO J, V15, P3813, DOI 10.1002/j.1460-2075.1996.tb00755.x; Hooks MA, 2007, BIOCHEM J, V406, P399, DOI 10.1042/BJ20070258; Igoillo-Esteve M, 2011, INT J PARASITOL, V41, P429, DOI 10.1016/j.ijpara.2010.11.002; KNOLL LJ, 1994, J BIOL CHEM, V269, P16348; Linton KJ, 2007, PFLUG ARCH EUR J PHY, V453, P555, DOI 10.1007/s00424-006-0126-x; Lolkema JS, 1998, CURR OPIN MICROBIOL, V1, P248, DOI 10.1016/S1369-5274(98)80018-0; Nyathi Y, 2010, J BIOL CHEM, V285, P29892, DOI 10.1074/jbc.M110.151225; Obermeyer T, 2007, J LIPID RES, V48, P2354, DOI 10.1194/jlr.M700300-JLR200; Pillai BK, 2009, J BIOL CHEM, V284, P33296, DOI 10.1074/jbc.M109.043737; Procko E, 2009, FASEB J, V23, P1287, DOI 10.1096/fj.08-121855; Rokka A, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0005090; Shani N, 1996, ANN NY ACAD SCI, V804, P770, DOI 10.1111/j.1749-6632.1996.tb18697.x; Shockey JM, 2002, PLANT PHYSIOL, V129, P1710, DOI 10.1104/pp.003269; SMITH PK, 1985, ANAL BIOCHEM, V150, P76, DOI 10.1016/0003-2697(85)90442-7; Steinberg SJ, 1999, ANN NEUROL, V46, P409, DOI 10.1002/1531-8249(199909)46:3<409::AID-ANA18>3.0.CO;2-9; Stromhaug PE, 1998, BIOCHEM J, V335, P217, DOI 10.1042/bj3350217; Swartzman EE, 1996, J CELL BIOL, V132, P549, DOI 10.1083/jcb.132.4.549; Theodoulou FL, 2006, FEBS LETT, V580, P1139, DOI 10.1016/j.febslet.2005.12.095; van Roermund CWT, 2011, BBA-MOL CELL BIOL L, V1811, P148, DOI 10.1016/j.bbalip.2010.11.010; van Roermund CWT, 2008, FASEB J, V22, P4201, DOI 10.1096/fj.08-110866; van Roermund CWT, 1999, EMBO J, V18, P5843, DOI 10.1093/emboj/18.21.5843; van Roermund CWT, 2001, MOL CELL BIOL, V21, P4321, DOI 10.1128/MCB.21.13.4321-4329.2001; Van Vlies N, 2005, BIOCHEM J, V387, P185, DOI 10.1042/BJ20041489; Verleur N, 1997, EUR J BIOCHEM, V249, P657, DOI 10.1111/j.1432-1033.1997.00657.x; Verrier PJ, 2008, TRENDS PLANT SCI, V13, P151, DOI 10.1016/j.tplants.2008.02.001; Vreken P, 1999, J INHERIT METAB DIS, V22, P302, DOI 10.1023/A:1005587617745; WANDERS RJA, 1992, BIOCHEM BIOPH RES CO, V188, P1139, DOI 10.1016/0006-291X(92)91350-Y; Wanders RJA, 2007, PFLUG ARCH EUR J PHY, V453, P719, DOI 10.1007/s00424-006-0142-x; Wanders RJA, 2006, ANNU REV BIOCHEM, V75, P295, DOI 10.1146/annurev.biochem.74.082803.133329; Watkins PA, 2000, CELL BIOCHEM BIOPHYS, V32, P333, DOI 10.1385/CBB:32:1-3:333; Wieser T, 2003, NEUROLOGY, V60, P1351, DOI 10.1212/01.WNL.0000055901.58642.48; Zolman BK, 2001, PLANT PHYSIOL, V127, P1266, DOI 10.1104/pp.010550	42	62	62	0	16	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JUN 8	2012	287	24					20144	20153		10.1074/jbc.M111.332833	http://dx.doi.org/10.1074/jbc.M111.332833			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	974FB	22493507	Green Published, hybrid			2022-12-25	WOS:000306414500035
J	Hanna, RA; Quinsay, MN; Orogo, AM; Giang, K; Rikka, S; Gustafsson, AB				Hanna, Rita A.; Quinsay, Melissa N.; Orogo, Amabel M.; Giang, Kayla; Rikka, Shivaji; Gustafsson, Asa B.			Microtubule-associated Protein 1 Light Chain 3 (LC3) Interacts with Bnip3 Protein to Selectively Remove Endoplasmic Reticulum and Mitochondria via Autophagy	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							CELL-DEATH; TRANSMEMBRANE DOMAIN; UP-REGULATION; DEGRADATION; EXPRESSION; APOPTOSIS; GABARAP; BINDS; CA2+; NIX	Autophagy plays an important role in cellular quality control and is responsible for removing protein aggregates and dysfunctional organelles. Bnip3 is an atypical BH3-only protein that is known to cause mitochondrial dysfunction and cell death. Interestingly, Bnip3 can also protect against cell death by inducing mitochondrial autophagy. The mechanism for this process, however, remains poorly understood. Bnip3 contains a C-terminal transmembrane domain that is essential for homodimerization and proapoptotic function. In this study, we show that homodimerization of Bnip3 is also a requirement for induction of autophagy. Several Bnip3 mutants that do not interfere with its mitochondrial localization but disrupt homodimerization failed to induce autophagy in cells. In addition, we discovered that endogenous Bnip3 is localized to both mitochondria and the endoplasmic reticulum (ER). To investigate the effects of Bnip3 at mitochondria or the ER on autophagy, Bnip3 was targeted specifically to each organelle by substituting the Bnip3 transmembrane domain with that of Acta or cytochrome b(5). We found that Bnip3 enhanced autophagy in cells from both sites. We also discovered that Bnip3 induced removal of both ER (ERphagy) and mitochondria (mitophagy) via autophagy. The clearance of these organelles was mediated in part via binding of Bnip3 to LC3 on the autophagosome. Although ablation of the Bnip3-LC3 interaction by mutating the LC3 binding site did not impair the prodeath activity of Bnip3, it significantly reduced both mitophagy and ERphagy. Our data indicate that Bnip3 regulates the apoptotic balance as an autophagy receptor that induces removal of both mitochondria and ER.	[Hanna, Rita A.; Quinsay, Melissa N.; Orogo, Amabel M.; Giang, Kayla; Rikka, Shivaji; Gustafsson, Asa B.] Univ Calif San Diego, Skaggs Sch Pharm & Pharmaceut Sci, La Jolla, CA 92093 USA	University of California System; University of California San Diego	Gustafsson, AB (corresponding author), Univ Calif San Diego, Skaggs Sch Pharm & Pharmaceut Sci, 9500 Gilman Dr, La Jolla, CA 92093 USA.	asag@ucsd.edu			National Institutes of Health [R01HL087023, R01HL101217]; American Heart Association; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL087023, R01HL101217] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [T32GM007752] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); American Heart Association(American Heart Association); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported by National Institutes of Health Grants R01HL087023 and R01HL101217. This work was also supported by a scientist development grant from the American Heart Association.	Azad MB, 2008, AUTOPHAGY, V4, P195, DOI 10.4161/auto.5278; Bellot G, 2009, MOL CELL BIOL, V29, P2570, DOI 10.1128/MCB.00166-09; Bernales S, 2007, AUTOPHAGY, V3, P285, DOI 10.4161/auto.3930; Bocharov EV, 2007, J BIOL CHEM, V282, P16256, DOI 10.1074/jbc.M701745200; Chen G, 1997, J EXP MED, V186, P1975, DOI 10.1084/jem.186.12.1975; Criollo A, 2007, CELL DEATH DIFFER, V14, P1029, DOI 10.1038/sj.cdd.4402099; Diwan A, 2009, J CLIN INVEST, V119, P203, DOI 10.1172/JCI36445; Erkan M, 2005, ONCOGENE, V24, P4421, DOI 10.1038/sj.onc.1208642; Fan W, 2011, P NATL ACAD SCI USA, V108, P7769, DOI 10.1073/pnas.1016472108; Foyouzi-Youssefi R, 2000, P NATL ACAD SCI USA, V97, P5723, DOI 10.1073/pnas.97.11.5723; Gao WT, 2010, J BIOL CHEM, V285, P1371, DOI 10.1074/jbc.M109.054197; Hamacher-Brady A, 2007, CELL DEATH DIFFER, V14, P146, DOI 10.1038/sj.cdd.4401936; Hamasaki M, 2005, TRAFFIC, V6, P56, DOI 10.1111/j.1600-0854.2004.00245.x; Jian BX, 2011, MOL MED, V17, P542, DOI 10.2119/molmed.2010.00195; Kabeya Y, 2004, J CELL SCI, V117, P2805, DOI 10.1242/jcs.01131; Kang R, 2011, CELL DEATH DIFFER, V18, P571, DOI 10.1038/cdd.2010.191; Kanzawa T, 2005, ONCOGENE, V24, P980, DOI 10.1038/sj.onc.1208095; Kim I, 2007, ARCH BIOCHEM BIOPHYS, V462, P245, DOI 10.1016/j.abb.2007.03.034; Kirkin V, 2009, MOL CELL, V33, P505, DOI 10.1016/j.molcel.2009.01.020; Komatsu M, 2007, CELL, V131, P1149, DOI 10.1016/j.cell.2007.10.035; Kubl DA, 2007, BIOCHEM J, V405, P407, DOI 10.1042/BJ20070319; Kubli DA, 2008, AM J PHYSIOL-HEART C, V295, pH2025, DOI 10.1152/ajpheart.00552.2008; Lee Y, 2011, AM J PHYSIOL-HEART C, V301, pH1924, DOI 10.1152/ajpheart.00368.2011; Levine B, 2004, DEV CELL, V6, P463, DOI 10.1016/S1534-5807(04)00099-1; Ma XC, 2012, AUTOPHAGY, V8, P297, DOI 10.4161/auto.18658; Monastyrska Iryna, 2006, Molecular Aspects of Medicine, V27, P483, DOI 10.1016/j.mam.2006.08.004; Murai M, 2005, CLIN CANCER RES, V11, P1021; Nakai A, 2007, NAT MED, V13, P619, DOI 10.1038/nm1574; Novak I, 2010, EMBO REP, V11, P45, DOI 10.1038/embor.2009.256; Okami J, 2004, CANCER RES, V64, P5338, DOI 10.1158/0008-5472.CAN-04-0089; Pankiv S, 2007, J BIOL CHEM, V282, P24131, DOI 10.1074/jbc.M702824200; Quinsay MN, 2010, AUTOPHAGY, V6, P855, DOI 10.4161/auto.6.7.13005; Ray R, 2000, J BIOL CHEM, V275, P1439, DOI 10.1074/jbc.275.2.1439; Regula KM, 2002, CIRC RES, V91, P226, DOI 10.1161/01.RES.0000029232.42227.16; Rikka S, 2011, CELL DEATH DIFFER, V18, P721, DOI 10.1038/cdd.2010.146; Schwarten M, 2009, AUTOPHAGY, V5, P690, DOI 10.4161/auto.5.5.8494; Schweers RL, 2007, P NATL ACAD SCI USA, V104, P19500, DOI 10.1073/pnas.0708818104; Scorrano L, 2003, SCIENCE, V300, P135, DOI 10.1126/science.1081208; Sulistijo ES, 2003, J BIOL CHEM, V278, P51950, DOI 10.1074/jbc.M308429200; Tanaka Y, 2000, NATURE, V406, P902, DOI 10.1038/35022595; Vande Velde C, 2000, MOL CELL BIOL, V20, P5454, DOI 10.1128/MCB.20.15.5454-5468.2000; Webster KA, 2005, J MOL CELL CARDIOL, V38, P35, DOI 10.1016/j.yjmcc.2004.11.007; YOSHIMORI T, 1991, J BIOL CHEM, V266, P17707; Zhang HF, 2008, J BIOL CHEM, V283, P10892, DOI 10.1074/jbc.M800102200; Zhang L, 2009, FASEB J, V23, P3405, DOI 10.1096/fj.08-124354; Zhang ZF, 2007, STROKE, V38, P1606, DOI 10.1161/STROKEAHA.106.475129	46	452	483	5	54	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JUN 1	2012	287	23					19094	19104		10.1074/jbc.M111.322933	http://dx.doi.org/10.1074/jbc.M111.322933			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	974EF	22505714	Green Published, hybrid			2022-12-25	WOS:000306411900020
J	Johnson, MA; Cartmell, J; Weisser, NE; Woods, RJ; Bundle, DR				Johnson, Margaret A.; Cartmell, Jonathan; Weisser, Nina E.; Woods, Robert J.; Bundle, David R.			Molecular Recognition of Candida albicans (1 -> 2)-beta-Mannan Oligosaccharides by a Protective Monoclonal Antibody Reveals the Immunodominance of Internal Saccharide Residues	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							NIH-B-792 STRAIN; NMR-SPECTROSCOPY; LIGAND-BINDING; COMBINING SITE; FORCE-FIELD; PHOSPHOMANNAN; DIFFERENCE; MANNAN; SEROTYPE; CELLS	A self-consistent model of beta-mannan oligosaccharides bound to a monoclonal antibody, C3.1, that protects mice against Candida albicans has been developed through chemical mapping, NMR spectroscopic, and computational studies. This antibody optimally binds di- and trisaccharide epitopes, whereas larger oligomers bind with affinities that markedly decrease with increasing chain length. The (1 -> 2)-beta-linked di-, tri-, and tetra-mannosides bind in helical conformations similar to the solution global minimum. Antibody recognition of the di- and trisaccharide is primarily dependent on the mannose unit at the reducing end, with the hydrophobic face of this sugar being tightly bound. Recognition of a tetrasaccharide involves a frameshift in the ligand interaction, shown by strong binding of the sugar adjacent to the reducing end. We show that frameshifting may also be deliberately induced by chemical modifications. Molecular recognition patterns similar to that of mAb C3.1, determined by saturation transfer difference-NMR, were also observed in polyclonal sera from rabbits immunized with a trisaccharide glycoconjugate. The latter observation points to the importance of internal residues as immunodominant epitopes in (1 -> 2)-beta-mannans and to the viability of a glycoconjugate vaccine composed of a minimal length oligosaccharide hapten.	[Johnson, Margaret A.; Cartmell, Jonathan; Bundle, David R.] Univ Alberta, Dept Chem, Edmonton, AB T6G 2G2, Canada; [Weisser, Nina E.; Woods, Robert J.] Natl Univ Ireland, Sch Chem, Galway, Ireland; [Woods, Robert J.] Univ Georgia, Complex Carbohydrate Res Ctr, Athens, GA 30602 USA	University of Alberta; Ollscoil na Gaillimhe-University of Galway; University System of Georgia; University of Georgia	Johnson, MA (corresponding author), Univ Alberta, Dept Chem, Edmonton, AB T6G 2G2, Canada.	maggie.johnson@ualberta.ca	Cartmell, Jonathan/GPS-4523-2022; Woods, Robert/F-4962-2015	Weisser, Nina/0000-0002-9903-2429; Woods, Robert/0000-0002-2400-6293	National Institutes of Health [GM094919, RR005351]; Alberta Glycomics Centre; Natural Sciences and Engineering Research Council of Canada; Science Foundation of Ireland [08/IN.1/B2070]; European Union; NATIONAL CENTER FOR RESEARCH RESOURCES [P41RR005351] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM094919, P41GM103390] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Alberta Glycomics Centre; Natural Sciences and Engineering Research Council of Canada(Natural Sciences and Engineering Research Council of Canada (NSERC)CGIAR); Science Foundation of Ireland(Science Foundation Ireland); European Union(European Commission); NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported, in whole or in part, by National Institutes of Health Grants GM094919 and RR005351 (to R. J. W. and N. E. W.). This work was also supported by the Alberta Glycomics Centre and the Natural Sciences and Engineering Research Council of Canada, the Science Foundation of Ireland (08/IN.1/B2070), and the European Union (European Regional Development Fund). D. R. B. is a co-founder and shareholder in a company attempting to advance a vaccine against C. albicans.	Bundle D. R., 2008, ACS SYM SER, V989, P163; Bundle D. R., 2012, ANTICARBOHYDRATE ANT, P121; BUNDLE DR, 1994, BIOCHEMISTRY-US, V33, P5172, DOI 10.1021/bi00183a022; BUNDLE DR, 1999, BIOORGANIC CHEM CARB, P370; Claasen B, 2005, J AM CHEM SOC, V127, P916, DOI 10.1021/ja044434w; Costello C., 2012, CARBOHYDR R IN PRESS; Cutler JE, 2005, CURR MOL MED, V5, P383, DOI 10.2174/1566524054022576; DAUBEROSGUTHORPE P, 1988, PROTEINS, V4, P31, DOI 10.1002/prot.340040106; Duan Y, 2003, J COMPUT CHEM, V24, P1999, DOI 10.1002/jcc.10349; Eisenberg D, 1997, METHOD ENZYMOL, V277, P396, DOI 10.1016/S0076-6879(97)77022-8; Fidel Paul L Jr, 2011, Curr Infect Dis Rep, V13, P102, DOI 10.1007/s11908-010-0143-y; Han Y, 1999, J INFECT DIS, V179, P1477, DOI 10.1086/314779; Han Y, 2000, INFECT IMMUN, V68, P1649, DOI 10.1128/IAI.68.3.1649-1654.2000; HAN YM, 1995, INFECT IMMUN, V63, P2714, DOI 10.1128/IAI.63.7.2714-2719.1995; Han YM, 1998, INFECT IMMUN, V66, P5771, DOI 10.1128/IAI.66.12.5771-5776.1998; Haselhorst T, 1999, BIOCHEMISTRY-US, V38, P6449, DOI 10.1021/bi982984z; HEIDELBERGER MICHAEL, 1960, FORSCHR CHEM ORG NATURSTOFFE, V18, P503; HWANG TL, 1995, J MAGN RESON SER A, V112, P275, DOI 10.1006/jmra.1995.1047; JANN K, 1975, ANTIGENS, V3, P1; Jennings H., 2012, ANTICARBOHYDRATE ANT, P55; KABAT EA, 1960, J IMMUNOL, V84, P82; Kirschner KN, 2008, J COMPUT CHEM, V29, P622, DOI 10.1002/jcc.20820; KOBAYASHI H, 1989, ARCH BIOCHEM BIOPHYS, V272, P364, DOI 10.1016/0003-9861(89)90230-0; KOBAYASHI H, 1990, ARCH BIOCHEM BIOPHYS, V278, P195, DOI 10.1016/0003-9861(90)90248-W; LASKOWSKI RA, 1993, J APPL CRYSTALLOGR, V26, P283, DOI 10.1107/S0021889892009944; MacCallum D.M., 2010, PATHOGENIC YEASTS YE, P41, DOI [10.1007/978-3-642-03150-2_3, DOI 10.1007/978-3-642-03150-2_3]; MARTIN ACR, 1989, P NATL ACAD SCI USA, V86, P9268, DOI 10.1073/pnas.86.23.9268; Mayer M, 1999, ANGEW CHEM INT EDIT, V38, P1784, DOI 10.1002/(SICI)1521-3773(19990614)38:12<1784::AID-ANIE1784>3.0.CO;2-Q; Melo F, 1998, J MOL BIOL, V277, P1141, DOI 10.1006/jmbi.1998.1665; Morrell M, 2005, ANTIMICROB AGENTS CH, V49, P3640, DOI 10.1128/AAC.49.9.3640-3645.2005; NEWMAN BA, 1985, J IMMUNOL, V135, P1220; Nitz M, 2002, J BIOL CHEM, V277, P3440, DOI 10.1074/jbc.M109274200; Nitz M, 2001, J ORG CHEM, V66, P8411, DOI 10.1021/jo010570x; Nycholat C., 2008, THESIS U ALBERTA; Nycholat CM, 2009, CARBOHYD RES, V344, P1397, DOI 10.1016/j.carres.2009.07.008; Onufriev A, 2002, J COMPUT CHEM, V23, P1297, DOI 10.1002/jcc.10126; Plum M, 2011, J BIOL CHEM, V286, P43103, DOI 10.1074/jbc.M111.291823; Poulain D, 2004, CURR OPIN MICROBIOL, V7, P342, DOI 10.1016/j.mib.2004.06.011; SHIBATA N, 1991, ARCH BIOCHEM BIOPHYS, V290, P535, DOI 10.1016/0003-9861(91)90578-7; SHIBATA N, 1986, ARCH BIOCHEM BIOPHYS, V251, P697, DOI 10.1016/0003-9861(86)90379-6; Shibata N, 2007, BIOCHEM J, V404, P365, DOI 10.1042/BJ20070081; Stronati M, 2006, Minerva Pediatr, V58, P537; Szabo EK, 2011, FEMS MICROBIOL LETT, V320, P1, DOI 10.1111/j.1574-6968.2011.02262.x; TOJO M, 1990, CARBOHYD RES, V199, P215, DOI 10.1016/0008-6215(90)84263-T; Toscano, 1999, Curr Infect Dis Rep, V1, P347, DOI 10.1007/s11908-999-0041-3; Trinel PA, 1997, FEBS LETT, V416, P203, DOI 10.1016/S0014-5793(97)01205-2; Trott O, 2010, J COMPUT CHEM, V31, P455, DOI 10.1002/jcc.21334; Vincent SJF, 1996, J BIOMOL NMR, V7, P169; Whitelegg NRJ, 2000, PROTEIN ENG, V13, P819, DOI 10.1093/protein/13.12.819; Wu XY, 2007, ORG BIOMOL CHEM, V5, P3477, DOI 10.1039/b709912f; Xin H, 2008, P NATL ACAD SCI USA, V105, P13526, DOI 10.1073/pnas.0803195105; Zhang AY, 2007, DERMATOL CLIN, V25, P165, DOI 10.1016/j.det.2007.01.002	52	34	34	2	19	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAY 25	2012	287	22					18078	18090		10.1074/jbc.M112.355578	http://dx.doi.org/10.1074/jbc.M112.355578			13	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	974EC	22493450	hybrid, Green Published			2022-12-25	WOS:000306411600017
J	Tejero, J; Basu, S; Helms, C; Hogg, N; King, SB; Kim-Shapiro, DB; Gladwin, MT				Tejero, Jesus; Basu, Swati; Helms, Christine; Hogg, Neil; King, S. Bruce; Kim-Shapiro, Daniel B.; Gladwin, Mark T.			Low NO Concentration Dependence of Reductive Nitrosylation Reaction of Hemoglobin	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							TETRAMER-DIMER EQUILIBRIUM; OXIDE SYNTHASE ACTIVITY; NITRIC-OXIDE; INOSITOL HEXAPHOSPHATE; SUBUNIT DISSOCIATION; BETA-CHAINS; DEOXYHEMOGLOBIN; KINETICS; BINDING; OXIDATION	The reductive nitrosylation of ferric (met) hemoglobin is of considerable interest and remains incompletely explained. We have previously observed that at low NO concentrations the reaction with tetrameric hemoglobin occurs with an observed rate constant that is at least 5 times faster than that observed at higher concentrations. This was ascribed to a faster reaction of NO with a methemoglobin-nitrite complex. We now report detailed studies of this reaction of low NO with methemoglobin. Nitric oxide paradoxically reacts with ferric hemoglobin with faster observed rate constants at the lower NO concentration in a manner that is not affected by changes in nitrite concentration, suggesting that it is not a competition between NO and nitrite, as we previously hypothesized. By evaluation of the fast reaction in the presence of allosteric effectors and isolated beta- and alpha-chains of hemoglobin, it appears that NO reacts with a subpopulation of beta-subunit ferric hemes whose population is influenced by quaternary state, redox potential, and hemoglobin dimerization. To further characterize the role of nitrite, we developed a system that oxidizes nitrite to nitrate to eliminate nitrite contamination. Removal of nitrite does not alter reaction kinetics, but modulates reaction products, with a decrease in the formation of S-nitrosothiols. These results are consistent with the formation of NO2/N2O3 in the presence of nitrite. The observed fast reductive nitrosylation observed at low NO concentrations may function to preserve NO bioactivity via primary oxidation of NO to form nitrite or in the presence of nitrite to form N2O3 and S-nitrosothiols.	[Basu, Swati; Helms, Christine; Kim-Shapiro, Daniel B.] Wake Forest Univ, Dept Phys, Winston Salem, NC 27109 USA; [Tejero, Jesus; Gladwin, Mark T.] Univ Pittsburgh, Vasc Med Inst, Pittsburgh, PA 15261 USA; [King, S. Bruce] Wake Forest Univ, Dept Chem, Winston Salem, NC 27109 USA; [Hogg, Neil] Med Coll Wisconsin, Dept Biophys, Milwaukee, WI 53226 USA; [Gladwin, Mark T.] Univ Pittsburgh, Dept Pulm Allergy & Crit Care Med, Pittsburgh, PA 15213 USA	Wake Forest University; Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh; Wake Forest University; Medical College of Wisconsin; Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh	Kim-Shapiro, DB (corresponding author), Wake Forest Univ, Dept Phys, Winston Salem, NC 27109 USA.	shapiro@wfu.edu; gladwinmt@upmc.edu	Kim-Shapiro, Daniel/HGA-2682-2022; Tejero, Jesus/G-3953-2017	Tejero, Jesus/0000-0003-3245-9978	National Institutes of Health [HL058091, HL098032, HL096973, DK085852]; Institute for Transfusion Medicine; Hemophilia Center of Western Pennsylvania; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL098032, R37HL058091, R01HL058091, R29HL058091, R01HL096973] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [RC1DK085852] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Institute for Transfusion Medicine; Hemophilia Center of Western Pennsylvania; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	This work was supported, in whole or in part, by National Institutes of Health Grants HL058091, HL098032, HL096973, and DK085852, and the Institute for Transfusion Medicine and the Hemophilia Center of Western Pennsylvania.	Angelo M, 2006, P NATL ACAD SCI USA, V103, P8366, DOI 10.1073/pnas.0600942103; ANTONINI E, 1971, HEMOGLOBIN MYOGLOBIN, P110; Ascenzi P, 2007, FEBS J, V274, P551, DOI 10.1111/j.1742-4658.2006.05609.x; Ascenzi P, 2010, FEBS J, V277, P2474, DOI 10.1111/j.1742-4658.2010.07662.x; Ascenzi P, 2010, BIOCHEM BIOPH RES CO, V393, P196, DOI 10.1016/j.bbrc.2010.01.092; Basu S, 2008, METHOD ENZYMOL, V440, P137, DOI 10.1016/S0076-6879(07)00808-7; Basu S, 2007, NAT CHEM BIOL, V3, P785, DOI 10.1038/nchembio.2007.46; BATIE CJ, 1986, J BIOL CHEM, V261, P1214; Brooks J, 1937, PROC R SOC SER B-BIO, V123, P368, DOI 10.1098/rspb.1937.0057; CHANCE B, 1952, J BIOL CHEM, V194, P471; CHIEN JCW, 1969, J AM CHEM SOC, V91, P2166, DOI 10.1021/ja01036a085; Cosby K, 2003, NAT MED, V9, P1498, DOI 10.1038/nm954; Daff S, 2004, BIOCHEMISTRY-US, V43, P3929, DOI 10.1021/bi0360408; DOYLE MP, 1981, J BIOL CHEM, V256, P2393; Eich RF, 1996, BIOCHEMISTRY-US, V35, P6976, DOI 10.1021/bi960442g; Fang KZ, 1998, BIOCHEM BIOPH RES CO, V252, P535, DOI 10.1006/bbrc.1998.9688; Fernandez BO, 2003, J AM CHEM SOC, V125, P10510, DOI 10.1021/ja036693b; Ford PC, 2010, INORG CHEM, V49, P6226, DOI 10.1021/ic902073z; GERACI G, 1969, J BIOL CHEM, V244, P4664; GIBSON QH, 1970, BIOCHEM BIOPH RES CO, V41, P415, DOI 10.1016/0006-291X(70)90520-6; Gladwin MT, 2009, ACCOUNTS CHEM RES, V42, P157, DOI 10.1021/ar800089j; Gladwin MT, 2000, P NATL ACAD SCI USA, V97, P9943, DOI 10.1073/pnas.180155397; GRAY RD, 1974, J BIOL CHEM, V249, P2879; GRAY RD, 1980, J BIOL CHEM, V255, P1812; GRAY RD, 1971, J BIOL CHEM, V246, P7168; Griffon N, 1998, PROTEIN SCI, V7, P673, DOI 10.1002/pro.5560070316; Han TH, 2002, P NATL ACAD SCI USA, V99, P7763, DOI 10.1073/pnas.122118299; HENSLEY P, 1975, J BIOL CHEM, V250, P9391; Herold S, 2003, J BIOL CHEM, V278, P6623, DOI 10.1074/jbc.M210275200; Hoshino M, 1996, J AM CHEM SOC, V118, P5702, DOI 10.1021/ja953311w; Huang KT, 2005, J BIOL CHEM, V280, P31126, DOI 10.1074/jbc.M501496200; Huang Z, 2005, J CLIN INVEST, V115, P2099, DOI 10.1172/JCI24650; IMAI K, 1977, BIOCHIM BIOPHYS ACTA, V490, P164, DOI 10.1016/0005-2795(77)90116-7; KEILIN D, 1958, BIOCHIM BIOPHYS ACTA, V29, P302, DOI 10.1016/0006-3002(58)90189-6; Keilin D., 1937, NATURE, V139, P548; Keszler A, 2008, J BIOL CHEM, V283, P9615, DOI 10.1074/jbc.M705630200; Kleinbongard P, 2003, FREE RADICAL BIO MED, V35, P790, DOI 10.1016/S0891-5849(03)00406-4; Lancaster JR, 2004, AM J PHYSIOL-LUNG C, V287, pL465, DOI 10.1152/ajplung.00151.2004; Lancaster JR, 1997, NITRIC OXIDE-BIOL CH, V1, P18, DOI 10.1006/niox.1996.0112; LANCASTER JR, 1994, P NATL ACAD SCI USA, V91, P8137, DOI 10.1073/pnas.91.17.8137; Lancaster JR, 1996, METHOD ENZYMOL, V268, P31; Lauer T, 2001, P NATL ACAD SCI USA, V98, P12814, DOI 10.1073/pnas.221381098; Luchsinger BP, 2003, P NATL ACAD SCI USA, V100, P461, DOI 10.1073/pnas.0233287100; Lundberg JO, 2009, NAT CHEM BIOL, V5, P865, DOI 10.1038/nchembio.260; Malatesta F, 2005, BIOPHYS CHEM, V116, P251, DOI 10.1016/j.bpc.2005.04.006; Nagababu E, 2003, J BIOL CHEM, V278, P46349, DOI 10.1074/jbc.M307572200; Nagababu E, 2006, NITRIC OXIDE-BIOL CH, V15, P20, DOI 10.1016/j.niox.2006.01.012; Nagababu E, 2007, BIOCHEMISTRY-US, V46, P11650, DOI 10.1021/bi700364e; Navati MS, 2009, J AM CHEM SOC, V131, P12273, DOI 10.1021/ja903364h; OLSON JS, 1976, J BIOL CHEM, V251, P441; OLSON JS, 1976, J BIOL CHEM, V251, P447; PARKHURST KM, 1992, INT J BIOCHEM, V24, P993, DOI 10.1016/0020-711X(92)90109-E; PHILO JS, 1988, J BIOL CHEM, V263, P682; Rifkind JM, 2011, NITRIC OXIDE-BIOL CH, V24, P102, DOI 10.1016/j.niox.2011.01.001; Roche CJ, 2010, NITRIC OXIDE-BIOL CH, V22, P180, DOI 10.1016/j.niox.2009.11.003; Saavedra JE, 1996, J MED CHEM, V39, P4361, DOI 10.1021/jm960616s; Salhany JM, 2008, BIOCHEMISTRY-US, V47, P6059, DOI 10.1021/bi8000819; SHARMA VS, 1987, BIOCHEMISTRY-US, V26, P3837, DOI 10.1021/bi00387a015; Shiva S, 2006, NAT CHEM BIOL, V2, P486, DOI 10.1038/nchembio813; WHITE SL, 1975, J BIOL CHEM, V250, P1263; WHITE SL, 1976, J BIOL CHEM, V251, P4763; WINK DA, 1993, CHEM RES TOXICOL, V6, P23, DOI 10.1021/tx00031a003; Zhang Y, 2002, FREE RADICAL BIO MED, V32, P1212, DOI 10.1016/S0891-5849(02)00829-8	63	35	35	0	13	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAY 25	2012	287	22					18262	18274		10.1074/jbc.M111.298927	http://dx.doi.org/10.1074/jbc.M111.298927			13	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	974EC	22493289	Green Published, hybrid			2022-12-25	WOS:000306411600033
J	Vastagh, C; Gardoni, F; Bagetta, V; Stanic, J; Zianni, E; Giampa, C; Picconi, B; Calabresi, P; Di Luca, M				Vastagh, Csaba; Gardoni, Fabrizio; Bagetta, Vincenza; Stanic, Jennifer; Zianni, Elisa; Giampa, Carmen; Picconi, Barbara; Calabresi, Paolo; Di Luca, Monica			N-Methyl-D-aspartate (NMDA) Receptor Composition Modulates Dendritic Spine Morphology in Striatal Medium Spiny Neurons	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							PROTEIN-KINASE-A; GLUTAMATE RECEPTORS; SYNAPTIC PLASTICITY; NUCLEUS-ACCUMBENS; NR2B SUBUNIT; DOPAMINE; TRAFFICKING; PHOSPHORYLATION; ACTIVATION; DISEASE	Dendritic spines of medium spiny neurons represent an essential site of information processing between NMDA and dopamine receptors in striatum. Even if activation of NMDA receptors in the striatum has important implications for synaptic plasticity and disease states, the contribution of specific NMDA receptor subunits still remains to be elucidated. Here, we show that treatment of corticostriatal slices with NR2A antagonist NVP-AAM077 or with NR2A blocking peptide induces a significant increase of spine head width. Sustained treatment with D1 receptor agonist (SKF38393) leads to a significant decrease of NR2A-containing NMDA receptors and to a concomitant increase of spine head width. Interestingly, co-treatment of corticostriatal slices with NR2A antagonist (NVP-AAM077) and D1 receptor agonist augmented the increase of dendritic spine head width as obtained with SKF38393. Conversely, NR2B antagonist (ifenprodil) blocked any morphological effect induced by D1 activation. These results indicate that alteration of NMDA receptor composition at the corticostriatal synapse contributes not only to the clinical features of disease states such as experimental parkinsonism but leads also to a functional and morphological outcome in dendritic spines of medium spiny neurons.	[Vastagh, Csaba; Gardoni, Fabrizio; Stanic, Jennifer; Zianni, Elisa; Di Luca, Monica] Univ Milan, Dept Pharmacol Sci, I-20133 Milan, Italy; [Bagetta, Vincenza; Giampa, Carmen; Picconi, Barbara; Calabresi, Paolo] Ist Ricovero & Cura Carattere Sci, Fdn Santa Lucia, Lab Neurofisiol, I-00143 Rome, Italy; [Calabresi, Paolo] Univ Perugia, Osped S Maria della Misericordia, I-06156 Perugia, Italy	University of Milan; IRCCS Santa Lucia; Hospital Santa Maria della Misericordia; University of Perugia	Gardoni, F (corresponding author), Univ Milan, Dept Pharmacol Sci, Via Balzaretti 9, I-20133 Milan, Italy.	fabrizio.gardoni@unimi.it	Bagetta, Vincenza/J-4248-2012; Gardoni, Fabrizio/A-3135-2009; Picconi, Barbara/G-8299-2011; Calabresi, Paolo/G-8496-2011; Di Luca, Monica/A-7632-2012	Gardoni, Fabrizio/0000-0003-4598-5563; Picconi, Barbara/0000-0001-6020-1021; Calabresi, Paolo/0000-0003-0326-5509; Di Luca, Monica/0000-0003-2298-615X; , Giampa/0000-0002-1763-5665; Stanic, Jennifer/0000-0003-1295-4568	European Community [222918, 217902, 238608]; Progetto Strategico; Progetto Giovani Ministero Sanita; Cariplo Foundation [2010-0661]	European Community(European Commission); Progetto Strategico; Progetto Giovani Ministero Sanita; Cariplo Foundation(Fondazione Cariplo)	This work was supported by European Community FP7 Contracts 222918 (REPLACES; to P. C. and M. D. L.), 217902 (cPADS; to M. D. L.), and 238608 (Symbad (to M. D. L.); Progetto Strategico 2007 (to P. C., B. P., and M. D. L.); Progetto Giovani Ministero Sanita 2008 (to B. P. and F. G.); and Cariplo Foundation Project 2010-0661 (to F. G. and B. P.).	Aarts M, 2002, SCIENCE, V298, P846, DOI 10.1126/science.1072873; Adesnik H, 2008, P NATL ACAD SCI USA, V105, P5597, DOI 10.1073/pnas.0800946105; Albers DS, 1999, NEUROSCIENCE, V89, P209, DOI 10.1016/S0306-4522(98)00328-5; Arbuthnott GW, 2000, J ANAT, V196, P587, DOI 10.1046/j.1469-7580.2000.19640587.x; Bourne JN, 2008, ANNU REV NEUROSCI, V31, P47, DOI 10.1146/annurev.neuro.31.060407.125646; Chapman DE, 2003, J NEUROPHYSIOL, V89, P69, DOI 10.1152/jn.00342.2002; Day M, 2006, NAT NEUROSCI, V9, P251, DOI 10.1038/nn1632; Di Filippo M, 2009, BEHAV BRAIN RES, V199, P108, DOI 10.1016/j.bbr.2008.09.025; Dunah AW, 2001, J NEUROSCI, V21, P5546, DOI 10.1523/JNEUROSCI.21-15-05546.2001; Dunah AW, 2003, J NEUROCHEM, V85, P935, DOI 10.1046/j.1471-4159.2003.01744.x; Dunah AW, 2004, MOL PHARMACOL, V65, P121, DOI 10.1124/mol.65.1.121; Fantin M, 2007, J NEUROCHEM, V103, P2200, DOI 10.1111/j.1471-4159.2007.04966.x; Fiala JC, 1998, J NEUROSCI, V18, P8900; Fiorentini C, 2003, J BIOL CHEM, V278, P20196, DOI 10.1074/jbc.M213140200; Gardoni F, 2006, J NEUROSCI, V26, P2914, DOI 10.1523/JNEUROSCI.5326-05.2006; Gardoni F, 2001, J BIOL CHEM, V276, P7609, DOI 10.1074/jbc.M009922200; Gardoni F., 2011, NEUROBIOL AGING; Gardoni F, 2010, PROG BRAIN RES, V183, P169, DOI 10.1016/S0079-6123(10)83009-2; Gardoni F, 2009, J NEUROSCI, V29, P669, DOI 10.1523/JNEUROSCI.3921-08.2009; Hallett PJ, 2006, J NEUROSCI, V26, P4690, DOI 10.1523/JNEUROSCI.0792-06.2006; Jocoy EL, 2011, FRONT SYST NEUROSCI, V5, DOI 10.3389/fnsys.2011.00028; Kasai H, 2003, TRENDS NEUROSCI, V26, P360, DOI 10.1016/S0166-2236(03)00162-0; Kopec CD, 2007, J NEUROSCI, V27, P13706, DOI 10.1523/JNEUROSCI.3503-07.2007; Kruusmagi M, 2009, NEUROSCIENCE, V164, P463, DOI 10.1016/j.neuroscience.2009.08.052; Lau CG, 2007, NAT REV NEUROSCI, V8, P413, DOI 10.1038/nrn2153; Lee FJS, 2002, CELL, V111, P219, DOI 10.1016/S0092-8674(02)00962-5; Lee KW, 2006, P NATL ACAD SCI USA, V103, P3399, DOI 10.1073/pnas.0511244103; Li LJ, 2004, J NEUROPHYSIOL, V92, P2738, DOI 10.1152/jn.00308.2004; Lu WY, 2001, NEURON, V29, P243, DOI 10.1016/S0896-6273(01)00194-5; Luthi A, 2001, NAT NEUROSCI, V4, P1102, DOI 10.1038/nn744; Mangiavacchi S, 2004, J NEUROCHEM, V88, P1261, DOI 10.1046/j.1471-4159.2003.02248.x; Mauceri D, 2004, J BIOL CHEM, V279, P23813, DOI 10.1074/jbc.M402796200; McAvoy T, 2009, P NATL ACAD SCI USA, V106, P3531, DOI 10.1073/pnas.0813263106; McKinney RA, 2010, J PHYSIOL-LONDON, V588, P107, DOI 10.1113/jphysiol.2009.178905; Merriam EB, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0027688; Milnerwood AJ, 2010, NEURON, V65, P178, DOI 10.1016/j.neuron.2010.01.008; Neely MD, 2009, J NEUROSCI METH, V184, P332, DOI 10.1016/j.jneumeth.2009.08.016; Paille V, 2010, J NEUROSCI, V30, P14182, DOI 10.1523/JNEUROSCI.2149-10.2010; Paoletti P, 2007, CURR OPIN PHARMACOL, V7, P39, DOI 10.1016/j.coph.2006.08.011; Price CJ, 1999, J NEUROCHEM, V73, P2441, DOI 10.1046/j.1471-4159.1999.0732441.x; Ren Z, 2010, NEUROSCIENCE, V168, P48, DOI 10.1016/j.neuroscience.2010.03.034; Schotanus SM, 2008, J NEUROCHEM, V106, P1758, DOI 10.1111/j.1471-4159.2008.05512.x; Surmeier DJ, 2007, TRENDS NEUROSCI, V30, P228, DOI 10.1016/j.tins.2007.03.008; Valjent E, 2009, TRENDS NEUROSCI, V32, P538, DOI 10.1016/j.tins.2009.06.005	44	28	29	0	10	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAY 25	2012	287	22					18103	18114		10.1074/jbc.M112.347427	http://dx.doi.org/10.1074/jbc.M112.347427			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	974EC	22493505	Green Published, hybrid			2022-12-25	WOS:000306411600019
J	de Graaf, KL; Albert, M; Weissert, R				de Graaf, Katrien L.; Albert, Monika; Weissert, Robert			Autoantigen Conformation Influences Both B- and T-cell Responses and Encephalitogenicity	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							MYELIN OLIGODENDROCYTE GLYCOPROTEIN; EXPERIMENTAL AUTOIMMUNE ENCEPHALOMYELITIS; EXPERIMENTAL ALLERGIC ENCEPHALOMYELITIS; CENTRAL-NERVOUS-SYSTEM; MULTIPLE-SCLEROSIS; MYELIN/OLIGODENDROCYTE GLYCOPROTEIN; MONOCLONAL-ANTIBODY; BASIC-PROTEIN; MICE; MOG	It has become increasingly clear that only antibodies recognizing conformation-dependent epitopes of myelin oligodendrocyte glycoprotein (MOG) have a demyelinating potential in the animal model of multiple sclerosis, experimental autoimmune encephalomyelitis (EAE). Nevertheless, for the induction of EAE, most studies to date have used MOG peptides or bacterially expressed MOG, neither of which contain the tertiary structure of the native antigen. Non-refolded recombinant human MOG does not induce EAE in DA rats. Therefore, we refolded this protein in order to assess the influence of MOG conformation on its pathogenicity in DA rats. DA rats immunized with refolded human MOG developed severe acute EAE. As expected, rats immunized with the refolded protein had a higher amount of conformational MOG antibodies present in serum. But in addition, a striking effect of MOG refolding on the generation of T-cell responses was found. Indeed, T-cell responses against the encephalitogenic MOG 91-108 epitope were greatly enhanced after refolding. Therefore, we conclude that refolding of MOG increases its pathogenicity both by generating conformation-dependent MOG antibodies and by enhancing its processing or/and presentation on MHC molecules. These data are important in regard to investigations of the pathogenic potential of many (auto)antigens.	[de Graaf, Katrien L.; Albert, Monika; Weissert, Robert] Univ Tubingen, Hertie Inst Clin Brain Res, Expt Neuroimmunol Lab, D-72076 Tubingen, Germany	Eberhard Karls University of Tubingen; Eberhard Karls University Hospital	Weissert, R (corresponding author), Univ Regensburg, Dept Neurol, Univ Str 84, D-93053 Regensburg, Germany.	robert.weissert@klinik.uni-regensburg.de	Weissert, Robert/AAA-4791-2019; Weissert, Robert/B-2585-2009	Weissert, Robert/0000-0002-1295-1271	German Research Foundation (Deutsche Forschungsgemeinschaft)	German Research Foundation (Deutsche Forschungsgemeinschaft)(German Research Foundation (DFG))	This work was supported by the German Research Foundation (Deutsche Forschungsgemeinschaft).	Adelmann M, 1995, J NEUROIMMUNOL, V63, P17, DOI 10.1016/0165-5728(95)00124-7; Allamargot C, 2007, J NEUROCHEM, V101, P298, DOI 10.1111/j.1471-4159.2006.04296.x; AMOR S, 1994, J IMMUNOL, V153, P4349; Berger T, 2003, NEW ENGL J MED, V349, P139, DOI 10.1056/NEJMoa022328; Bourquin C, 2003, J IMMUNOL, V171, P455, DOI 10.4049/jimmunol.171.1.455; Brehm U, 1999, J NEUROIMMUNOL, V97, P9, DOI 10.1016/S0165-5728(99)00010-7; Breithaupt C, 2003, P NATL ACAD SCI USA, V100, P9446, DOI 10.1073/pnas.1133443100; Breithaupt C, 2008, J IMMUNOL, V181, P1255, DOI 10.4049/jimmunol.181.2.1255; BRUNNER C, 1989, J NEUROCHEM, V52, P296, DOI 10.1111/j.1471-4159.1989.tb10930.x; Carrio MM, 2002, J BIOTECHNOL, V96, P3, DOI 10.1016/S0168-1656(02)00032-9; Delamarre L, 2006, J EXP MED, V203, P2049, DOI 10.1084/jem.20052442; Fissolo N, 2009, MOL CELL PROTEOMICS, V8, P2090, DOI 10.1074/mcp.M900001-MCP200; Gaertner S, 2004, NEUROLOGY, V63, P2381, DOI 10.1212/01.WNL.0000147259.34163.33; Genain CP, 1995, J CLIN INVEST, V96, P2966, DOI 10.1172/JCI118368; Herrmann MM, 2005, BLOOD, V106, P1875, DOI 10.1182/blood-2004-12-4607; Hjelmstrom P, 1998, J IMMUNOL, V161, P4480; Kornek B, 2000, AM J PATHOL, V157, P267, DOI 10.1016/S0002-9440(10)64537-3; Lalive PH, 2006, P NATL ACAD SCI USA, V103, P2280, DOI 10.1073/pnas.0510672103; Lampasona V, 2004, NEUROLOGY, V62, P2092, DOI 10.1212/01.WNL.0000127615.15768.AE; Linares D, 2004, PROTEIN EXPRES PURIF, V34, P249, DOI 10.1016/j.pep.2003.11.016; Lindert RB, 1999, BRAIN, V122, P2089, DOI 10.1093/brain/122.11.2089; LININGTON C, 1988, AM J PATHOL, V130, P443; LINNINGTON C, 1984, J NEUROIMMUNOL, V6, P387, DOI 10.1016/0165-5728(84)90064-X; Lyons JA, 1999, EUR J IMMUNOL, V29, P3432, DOI 10.1002/(SICI)1521-4141(199911)29:11<3432::AID-IMMU3432>3.0.CO;2-2; Lyons JA, 2002, EUR J IMMUNOL, V32, P1905, DOI 10.1002/1521-4141(200207)32:7<1905::AID-IMMU1905>3.0.CO;2-L; Marta CB, 2005, P NATL ACAD SCI USA, V102, P13992, DOI 10.1073/pnas.0504979102; Mathey E, 2004, EUR J IMMUNOL, V34, P2065, DOI 10.1002/eji.200425291; McLaughlin KA, 2009, J IMMUNOL, V183, P4067, DOI 10.4049/jimmunol.0801888; O'Connor KC, 2007, NAT MED, V13, P211, DOI 10.1038/nm1488; OETTINGER HF, 1993, J NEUROIMMUNOL, V44, P157, DOI 10.1016/0165-5728(93)90037-Y; Oliver AR, 2003, J IMMUNOL, V171, P462, DOI 10.4049/jimmunol.171.1.462; Sakuma H, 2004, BRAIN, V127, P2201, DOI 10.1093/brain/awh260; SCHLUESENER HJ, 1987, J IMMUNOL, V139, P4016; Sospedra M, 2005, ANNU REV IMMUNOL, V23, P683, DOI 10.1146/annurev.immunol.23.021704.115707; Storch MK, 1998, BRAIN PATHOL, V8, P681, DOI 10.1111/j.1750-3639.1998.tb00194.x; von Budingen HC, 2004, EUR J IMMUNOL, V34, P2072, DOI 10.1002/eji.200425050; Weissert R, 1998, J CLIN INVEST, V102, P1265, DOI 10.1172/JCI3022; Weissert R, 2001, J IMMUNOL, V166, P7588, DOI 10.4049/jimmunol.166.12.7588; Zhou D, 2006, J NEUROIMMUNOL, V178, P103	39	14	14	0	1	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAY 18	2012	287	21					17206	17213		10.1074/jbc.M111.304246	http://dx.doi.org/10.1074/jbc.M111.304246			8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	973PU	22493449	Green Published, hybrid			2022-12-25	WOS:000306373000020
J	Bronze, M; Steegen, K; Wallis, CL; De Wolf, H; Papathanasopoulos, MA; Van Houtte, M; Stevens, WS; de Wit, TR; Stuyver, LJ				Bronze, Michelle; Steegen, Kim; Wallis, Carole L.; De Wolf, Hans; Papathanasopoulos, Maria A.; Van Houtte, Margriet; Stevens, Wendy S.; de Wit, Tobias Rinke; Stuyver, Lieven J.		ART-A Consortium	HIV-1 Phenotypic Reverse Transcriptase Inhibitor Drug Resistance Test Interpretation Is Not Dependent on the Subtype of the Virus Backbone	PLOS ONE			English	Article							ANTIRETROVIRAL DRUGS; SOUTH-AFRICA; SUSCEPTIBILITY; TYPE-1; ANTIVIROGRAM; PHENOSENSE; PROTEASE; ASSAYS; TOOL	To date, the majority of HIV-1 phenotypic resistance testing has been performed with subtype B virus backbones (e. g. HXB2). However, the relevance of using this backbone to determine resistance in non-subtype B HIV-1 viruses still needs to be assessed. From 114 HIV-1 subtype C clinical samples (36 ARV-naive, 78 ARV-exposed), pol amplicons were produced and analyzed for phenotypic resistance using both a subtype B-and C-backbone in which the pol fragment was deleted. Phenotypic resistance was assessed in resulting recombinant virus stocks (RVS) for a series of antiretroviral drugs (ARV's) and expressed as fold change (FC), yielding 1660 FC comparisons. These Antivirogram (R) derived FC values were categorized as having resistant or sensitive susceptibility based on biological cut-off values (BCOs). The concordance between resistance calls obtained for the same clinical sample but derived from two different backbones (i.e. B and C) accounted for 86.1% (1429/1660) of the FC comparisons. However, when taking the assay variability into account, 95.8% (1590/1660) of the phenotypic data could be considered as being concordant with respect to their resistance call. No difference in the capacity to detect resistance associated with M184V, K103N and V106M mutations was noted between the two backbones. The following was concluded: (i) A high level of concordance was shown between the two backbone phenotypic resistance profiles; (ii) Assay variability is largely responsible for discordant results (i. e. for FC values close to BCO); (iii) Confidence intervals should be given around the BCO's, when assessing resistance in HIV-1 subtype C; (iv) No systematic resistance under-or overcalling of subtype C amplicons in the B-backbone was observed; (v) Virus backbone subtype sequence variability outside the pol region does not contribute to phenotypic FC values. In conclusion the HXB2 virus backbone remains an acceptable vector for phenotyping HIV-1 subtype C pol amplicons.	[Bronze, Michelle; Wallis, Carole L.; Papathanasopoulos, Maria A.; Stevens, Wendy S.] Univ Witwatersrand, Dept Mol Med & Haematol, Johannesburg, South Africa; [Steegen, Kim; De Wolf, Hans; Van Houtte, Margriet; Stuyver, Lieven J.] Virco BVBA, Beerse, Belgium; [de Wit, Tobias Rinke] Univ Amsterdam, Acad Med Ctr, PharmAccess Fdn, CPCD, NL-1105 AZ Amsterdam, Netherlands	University of Witwatersrand; University of Amsterdam; Academic Medical Center Amsterdam	Bronze, M (corresponding author), Univ Witwatersrand, Dept Mol Med & Haematol, Johannesburg, South Africa.	michelle.bronze@gmail.com	Steegen, K/AAF-6512-2020; Steegen, Kim/ABH-4471-2020	Steegen, Kim/0000-0003-3226-7685; Wallis, Carole/0000-0001-8408-8772	NWO/WOTRO, The Hague, The Netherlands [W.07.05.204.00]; NOW/WOTRO -NACCAP; NWO: De Nederlandse Organisatie voor Wetenschappelij_ Onderzoek (Netherlands Organisation for Scientific Research); WOTRO: Wetenschappelijk Onderzoek van de Tropen an Ontwikkelingslanden (Netherelands Foundation for the advancement of Tropical Research)	NWO/WOTRO, The Hague, The Netherlands; NOW/WOTRO -NACCAP; NWO: De Nederlandse Organisatie voor Wetenschappelij_ Onderzoek (Netherlands Organisation for Scientific Research); WOTRO: Wetenschappelijk Onderzoek van de Tropen an Ontwikkelingslanden (Netherelands Foundation for the advancement of Tropical Research)	ART-A: Consortium to develop an Affordable Resistance Test for Africa, supported by NWO/WOTRO under the Netherlands African Partnership for Capacity Development and Clinical Interventions against Poverty related Diseases (NACCAP; grant: W.07.05.204.00), The Hague, The Netherlands. NWO: De Nederlandse Organisatie voor Wetenschappelij_ Onderzoek (Netherlands Organisation for Scientific Research). WOTRO: Wetenschappelijk Onderzoek van de Tropen an Ontwikkelingslanden (Netherelands Foundation for the advancement of Tropical Research). This research was conducted in the course of the authors' PhD programme. The funders had no direct or indirect influence on the results of the research. The funders (NOW/WOTRO -NACCAP) had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Arien KK, 2005, J VIROL, V79, P8979, DOI 10.1128/JVI.79.14.8979-8990.2005; Choe S, 15 INT HIV DRUG RES; Hamers R, 2011, INT J EPIDEMIOL 0421; Hamers RL, 2008, ANTIVIR THER, V13, P625; Hamers RL, 2010, JAIDS-J ACQ IMM DEF, V55, P95, DOI 10.1097/QAI.0b013e3181e544e0; Hamers RL, 2011, LANCET INFECT DI JUL; Hemelaar J, 2011, AIDS, V25, P679, DOI 10.1097/QAD.0b013e328342ff93; Hertogs K, 1998, ANTIMICROB AGENTS CH, V42, P269, DOI 10.1093/jac/42.2.269; Hunt GM, 2011, AIDS, V25, P1461, DOI 10.1097/QAD.0b013e3283492180; Johnson Victoria A, 2010, Top HIV Med, V18, P156; Murphy RA, 2010, AIDS, V24, P1007, DOI 10.1097/QAD.0b013e3283333639; Nauwelaers D, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0019643; Ndembi N, 2011, AIDS, V25, P905, DOI 10.1097/QAD.0b013e328346260f; Petropoulos CJ, 2000, ANTIMICROB AGENTS CH, V44, P920, DOI 10.1128/AAC.44.4.920-928.2000; Price MA, 2011, AIDS RES HUM RETROV, V27, P5, DOI 10.1089/aid.2010.0030; Qari SH, 2002, J CLIN MICROBIOL, V40, P31, DOI 10.1128/JCM.40.1.31-35.2002; Rhee SY, 2003, NUCLEIC ACIDS RES, V31, P298, DOI 10.1093/nar/gkg100; Steegen K, 2010, AIDS RES THER   1015, P38; Van Houtte M, 2009, J MED VIROL, V81, P1702, DOI 10.1002/jmv.21585; van Zyl GU, 2011, J MED VIROL, V83, P1764, DOI 10.1002/jmv.22189; Vergara IA, 2008, BMC BIOINFORMATICS, V9, DOI 10.1186/1471-2105-9-265; Virco B, VIRCO BIOL CUT OFFS; Wallis CL, 2010, J VIROL METHODS, V163, P505, DOI 10.1016/j.jviromet.2009.11.011; Wang K, 2004, ANTIVIR THER, V9, P703; World Health Organization, 2010, UN ACC SCAL PRIOR HI; Zhang J, 2005, JAIDS-J ACQ IMM DEF, V38, P439, DOI 10.1097/01.qai.0000147526.64863.53	26	6	6	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 9	2012	7	4							e34708	10.1371/journal.pone.0034708	http://dx.doi.org/10.1371/journal.pone.0034708			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	955JO	22496845	gold, Green Published, Green Submitted			2022-12-25	WOS:000305014500027
J	Breen, MR; Camps, M; Carvalho-Simoes, F; Zorzano, A; Pilch, PF				Breen, Michael R.; Camps, Marta; Carvalho-Simoes, Francisco; Zorzano, Antonio; Pilch, Paul F.			Cholesterol Depletion in Adipocytes Causes Caveolae Collapse Concomitant with Proteosomal Degradation of Cavin-2 in a Switch-Like Fashion	PLOS ONE			English	Article							CONGENITAL GENERALIZED LIPODYSTROPHY; TRANSCRIPT RELEASE FACTOR; INSULIN-RESISTANCE; MICE SHOW; LIPID TRAFFICKING; PTRF MUTATIONS; ADIPOSE-TISSUE; KNOCKOUT MICE; RICH DOMAINS; POLYMERASE-I	Caveolae, little caves of cell surfaces, are enriched in cholesterol, a certain level of which is required for their structural integrity. Here we show in adipocytes that cavin-2, a peripheral membrane protein and one of 3 cavin isoforms present in caveolae from non-muscle tissue, is degraded upon cholesterol depletion in a rapid fashion resulting in collapse of caveolae. We exposed 3T3-L1 adipocytes to the cholesterol depleting agent methyl-beta-cyclodextrin, which results in a sudden and extensive degradation of cavin-2 by the proteasome and a concomitant movement of cavin-1 from the plasma membrane to the cytosol along with loss of caveolae. The recovery of cavin-2 at the plasma membrane is cholesterol-dependent and is required for the return of cavin-1 from the cytosol to the cell surface and caveolae restoration. Expression of shRNA directed against cavin-2 also results in a cytosolic distribution of cavin-1 and loss of caveolae. Taken together, these data demonstrate that cavin-2 functions as a cholesterol responsive component of caveolae that is required for cavin-1 localization to the plasma membrane, and caveolae structural integrity.	[Breen, Michael R.; Pilch, Paul F.] Boston Univ, Sch Med, Dept Biochem, Boston, MA 02118 USA; [Camps, Marta; Carvalho-Simoes, Francisco; Zorzano, Antonio] Univ Barcelona, Fac Biol, Dept Bioquim & Biol Mol, Barcelona, Spain; [Camps, Marta; Carvalho-Simoes, Francisco; Zorzano, Antonio] Inst Salud Carlos III, CIBER Diabet & Enfermedades Metab Asociadas CIBER, Barcelona, Spain; [Camps, Marta; Carvalho-Simoes, Francisco] Univ Barcelona, IBUB Inst Biomed, Barcelona, Spain; [Zorzano, Antonio] Inst Res Biomed IRB Barcelona, Barcelona, Spain; [Pilch, Paul F.] Boston Univ, Sch Med, Dept Med, Boston, MA 02118 USA	Boston University; University of Barcelona; CIBER - Centro de Investigacion Biomedica en Red; CIBERES; Instituto de Salud Carlos III; University of Barcelona; Barcelona Institute of Science & Technology; Institute for Research in Biomedicine - IRB Barcelona; Boston University	Breen, MR (corresponding author), Boston Univ, Sch Med, Dept Biochem, Boston, MA 02118 USA.	ppilch@bu.edu	Zorzano, Antonio/R-5479-2018; Camps, Marta/F-6557-2016	Camps, Marta/0000-0001-5392-1792; Pilch, Paul/0000-0003-1997-0499	U.S. National Institutes of Health [DK30425, DK56935, DK07201]; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK030425, R01DK056935, T32DK007201] Funding Source: NIH RePORTER	U.S. National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	This work was supported by grants from the U.S. National Institutes of Health DK30425 and DK56935 to PFP and training grant DK07201 to MRB. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aboulaich N, 2004, BIOCHEM J, V383, P237, DOI 10.1042/BJ20040647; Bastiani M, 2010, J CELL SCI, V123, P3831, DOI 10.1242/jcs.070102; Bastiani M, 2009, J CELL BIOL, V185, P1259, DOI 10.1083/jcb.200903053; Bickel PE, 2009, BBA-MOL CELL BIOL L, V1791, P419, DOI 10.1016/j.bbalip.2009.04.002; Cao H, 2008, LIPIDS HEALTH DIS, V7, DOI 10.1186/1476-511X-7-3; Capozza F, 2005, AM J PHYSIOL-CELL PH, V288, pC1317, DOI 10.1152/ajpcell.00489.2004; Cohen AW, 2004, PHYSIOL REV, V84, P1341, DOI 10.1152/physrev.00046.2003; Cohen AW, 2003, AM J PHYSIOL-CELL PH, V285, pC222, DOI 10.1152/ajpcell.00006.2003; Drab M, 2001, SCIENCE, V293, P2449, DOI 10.1126/science.1062688; Dwianingsih EK, 2010, MOL GENET METAB, V101, P233, DOI 10.1016/j.ymgme.2010.06.016; Epand RM, 2008, BBA-BIOMEMBRANES, V1778, P1576, DOI 10.1016/j.bbamem.2008.03.016; Epand RM, 2005, J MOL BIOL, V345, P339, DOI 10.1016/j.jmb.2004.10.064; FOLCH J, 1957, J BIOL CHEM, V226, P497; Forbes A, 2007, J BIOL CHEM, V282, DOI 10.1074/jbc.M702117200; Galbiati F, 2001, J BIOL CHEM, V276, P21425, DOI 10.1074/jbc.M100828200; GOLDSTEIN JL, 1990, NATURE, V343, P425, DOI 10.1038/343425a0; Gonzalez-Munoz E, 2009, ENDOCRINOLOGY, V150, P3493, DOI 10.1210/en.2008-1520; GREEN H, 1975, CELL, V5, P19, DOI 10.1016/0092-8674(75)90087-2; Guilherme A, 2008, NAT REV MOL CELL BIO, V9, P367, DOI 10.1038/nrm2391; Hailstones D, 1998, J LIPID RES, V39, P369; Hansen CG, 2010, TRENDS CELL BIOL, V20, P177, DOI 10.1016/j.tcb.2010.01.005; Hansen CG, 2009, NAT CELL BIOL, V11, P807, DOI 10.1038/ncb1887; Hansen CG, 2011, J CELL SCI, V124, P2777, DOI 10.1242/jcs.084319; Hayashi YK, 2009, J CLIN INVEST, V119, P2623, DOI 10.1172/JCI38660; Hayer A, 2010, J CELL BIOL, V191, P615, DOI 10.1083/jcb.201003086; Hayer A, 2010, TRAFFIC, V11, P361, DOI 10.1111/j.1600-0854.2009.01023.x; HEUSER JE, 1989, J CELL BIOL, V108, P389, DOI 10.1083/jcb.108.2.389; Hill MM, 2008, CELL, V132, P113, DOI 10.1016/j.cell.2007.11.042; Kim CA, 2008, J CLIN ENDOCR METAB, V93, P1129, DOI 10.1210/jc.2007-1328; KRAUSE BR, 1978, J LIPID RES, V19, P774; KRAUSE BR, 1984, J LIPID RES, V25, P97; Le Lay S, 2006, TRAFFIC, V7, P549, DOI 10.1111/j.1600-0854.2006.00406.x; Le Lay S, 2009, BBA-MOL CELL BIOL L, V1791, P514, DOI 10.1016/j.bbalip.2008.10.008; Liu LB, 2008, CELL METAB, V8, P310, DOI 10.1016/j.cmet.2008.07.008; Liu LB, 2008, J BIOL CHEM, V283, P4314, DOI 10.1074/jbc.M707890200; McMahon KA, 2009, EMBO J, V28, P1001, DOI 10.1038/emboj.2009.46; Meshulam T, 2006, BIOCHEMISTRY-US, V45, P2882, DOI 10.1021/bi051999b; Meshulam T, 2011, J LIPID RES, V52, P1526, DOI 10.1194/jlr.M015628; MURATA M, 1995, P NATL ACAD SCI USA, V92, P10339, DOI 10.1073/pnas.92.22.10339; Murphy S, 2009, BBA-MOL CELL BIOL L, V1791, P441, DOI 10.1016/j.bbalip.2008.07.004; Parpal S, 2001, J BIOL CHEM, V276, P9670, DOI 10.1074/jbc.M007454200; Pilch PF, 2007, J LIPID RES, V48, P2103, DOI 10.1194/jlr.R700009-JLR200; Pilch PF, 2011, TRENDS ENDOCRIN MET, V22, P318, DOI 10.1016/j.tem.2011.04.001; Pilch PF, 2011, CLIN LIPIDOL, V6, P49, DOI 10.2217/CLP.10.80; Radhakrishnan A, 2008, CELL METAB, V8, P512, DOI 10.1016/j.cmet.2008.10.008; Rajab A, 2010, PLOS GENET, V6, DOI 10.1371/journal.pgen.1000874; Razani B, 2001, J BIOL CHEM, V276, P38121; Rechsteiner M, 1996, TRENDS BIOCHEM SCI, V21, P267, DOI 10.1016/S0968-0004(96)10031-1; Ros-Baro A, 2001, P NATL ACAD SCI USA, V98, P12050, DOI 10.1073/pnas.211341698; ROTHBERG KG, 1992, CELL, V68, P673, DOI 10.1016/0092-8674(92)90143-Z; Shastry S, 2010, AM J MED GENET A, V152A, P2245, DOI 10.1002/ajmg.a.33578; Smart EJ, 2002, METHOD ENZYMOL, V353, P131; Thorn H, 2003, MOL BIOL CELL, V14, P3967, DOI 10.1091/mbc.E03-01-0050; Woodman SE, 2004, NEUROLOGY, V62, P538, DOI 10.1212/WNL.62.4.538; Zhao YY, 2002, P NATL ACAD SCI USA, V99, P11375, DOI 10.1073/pnas.172360799	55	47	48	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 6	2012	7	4							e34516	10.1371/journal.pone.0034516	http://dx.doi.org/10.1371/journal.pone.0034516			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	955JA	22493697	Green Published, Green Submitted, gold			2022-12-25	WOS:000305012700039
J	Lozano, R; Ponce, O; Ramirez, M; Mostajo, N; Orjeda, G				Lozano, Roberto; Ponce, Olga; Ramirez, Manuel; Mostajo, Nelly; Orjeda, Gisella			Genome-Wide Identification and Mapping of NBS-Encoding Resistance Genes in Solanum tuberosum Group Phureja	PLOS ONE			English	Article							MULTIPLE SEQUENCE ALIGNMENT; DISEASE RESISTANCE; DEFENSE RESPONSES; REPEAT; PROTEINS; TOMATO; DOMAIN; INFECTION; EVOLUTION; PRODUCTS	The majority of disease resistance (R) genes identified to date in plants encode a nucleotide-binding site (NBS) and leucine-rich repeat (LRR) domain containing protein. Additional domains such as coiled-coil (CC) and TOLL/interleukin-1 receptor (TIR) domains can also be present. In the recently sequenced Solanum tuberosum group phureja genome we used HMM models and manual curation to annotate 435 NBS-encoding R gene homologs and 142 NBS-derived genes that lack the NBS domain. Highly similar homologs for most previously documented Solanaceae R genes were identified. A surprising similar to 41% (179) of the 435 NBS-encoding genes are pseudogenes primarily caused by premature stop codons or frameshift mutations. Alignment of 81.80% of the 577 homologs to S. tuberosum group phureja pseudomolecules revealed non-random distribution of the R-genes; 362 of 470 genes were found in high density clusters on 11 chromosomes.	[Lozano, Roberto; Ponce, Olga; Ramirez, Manuel; Mostajo, Nelly; Orjeda, Gisella] Univ Peruana Cayetano Heredia, Genom Res Unit, Fac Sci & Philosophy, Lima, Peru	Universidad Peruana Cayetano Heredia	Lozano, R (corresponding author), Univ Peruana Cayetano Heredia, Genom Res Unit, Fac Sci & Philosophy, Lima, Peru.	gisella.orjeda@upch.edu.pe		Ponce, Olga Patricia/0000-0001-9454-5797; Lozano, Roberto/0000-0003-0760-4977; Orjeda, Gisella/0000-0003-3013-5523	FINCyT [(099-FINCyT-EQUIP-2009)/(076-FINCyT-PIN-2008)]; IADB (Interamerican Development Bank) [1663/OC-PE]; Peruvian Ministry of Agriculture-Technical Secretariat of coordination; CGIAR; Peruvian National Council of Science and Technology (CONCYTEC); Inter-American Council for Integral Development (FEMCIDI)	FINCyT; IADB (Interamerican Development Bank); Peruvian Ministry of Agriculture-Technical Secretariat of coordination; CGIAR(CGIAR); Peruvian National Council of Science and Technology (CONCYTEC); Inter-American Council for Integral Development (FEMCIDI)	The authors acknowledge the funding made available by FINCyT (099-FINCyT-EQUIP-2009)/(076-FINCyT-PIN-2008), IADB (Interamerican Development Bank) Loan No 1663/OC-PE, Peruvian Ministry of Agriculture-Technical Secretariat of coordination with the CGIAR, Peruvian National Council of Science and Technology (CONCYTEC), Special Multilateral Fund of the Inter-American Council for Integral Development (FEMCIDI). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ameline-Torregrosa C, 2008, PLANT PHYSIOL, V146, P5, DOI 10.1104/pp.107.104588; Bailey T L, 1995, Proc Int Conf Intell Syst Mol Biol, V3, P21; Ballvora A, 2002, PLANT J, V30, P361, DOI 10.1046/j.1365-313X.2001.01292.x; Belkhadir Y, 2004, CURR OPIN PLANT BIOL, V7, P391, DOI 10.1016/j.pbi.2004.05.009; BENT AF, 1994, SCIENCE, V265, P1856, DOI 10.1126/science.8091210; Dangl JL, 2001, NATURE, V411, P826, DOI 10.1038/35081161; Delorenzi M, 2002, BIOINFORMATICS, V18, P617, DOI 10.1093/bioinformatics/18.4.617; Dinesh-Kumar SP, 2000, P NATL ACAD SCI USA, V97, P1908, DOI 10.1073/pnas.020367497; Douchkov D, 2005, PLANT CELL ENVIRON, V28, P365, DOI 10.1111/j.1365-3040.2005.01273.x; Ernst K, 2002, PLANT J, V31, P127, DOI 10.1046/j.1365-313X.2002.01341.x; Fernandez D, 2004, MOL PLANT PATHOL, V5, P527, DOI [10.1111/j.1364-3703.2004.00250.x, 10.1111/J.1364-3703.2004.00250.X]; Finn RD, 2011, NUCLEIC ACIDS RES, V39, pW29, DOI 10.1093/nar/gkr367; Friedman AR, 2007, CURR OPIN GENET DEV, V17, P493, DOI 10.1016/j.gde.2007.08.014; Gassmann W, 2008, CURR TOP MICROBIOL, V326, P219; Gebhardt C, 2001, ANNU REV PHYTOPATHOL, V39, P79, DOI 10.1146/annurev.phyto.39.1.79; GRANT MR, 1995, SCIENCE, V269, P843, DOI 10.1126/science.7638602; Hirotsune S, 2003, NATURE, V423, P91, DOI 10.1038/nature01535; Hong JP, 2005, PLANTA, V220, P875, DOI 10.1007/s00425-004-1412-5; Hulbert SH, 2001, ANNU REV PHYTOPATHOL, V39, P285, DOI 10.1146/annurev.phyto.39.1.285; Kohler A, 2008, PLANT MOL BIOL, V66, P619, DOI 10.1007/s11103-008-9293-9; Kozik A, 2002, BIOINFORMATICS, V18, P335, DOI 10.1093/bioinformatics/18.2.335; Li XY, 2010, PLANT SYST EVOL, V289, P101, DOI 10.1007/s00606-010-0331-0; Liu J.-J., 2003, MGG Molecular Genetics and Genomics, V270, P432, DOI 10.1007/s00438-003-0940-1; Massa AN, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0026801; McDonnell AV, 2006, BIOINFORMATICS, V22, P356, DOI 10.1093/bioinformatics/bti797; McHale L, 2006, GENOME BIOL, V7, P212; Mestre P, 2006, PLANT CELL, V18, P491, DOI 10.1105/tpc.105.037234; Meyers BC, 2003, PLANT CELL, V15, P809, DOI 10.1105/tpc.009308; Meyers BC, 1999, PLANT J, V20, P317, DOI 10.1046/j.1365-313X.1999.t01-1-00606.x; Mlotshwa S, 2008, TRENDS PLANT SCI, V13, P375, DOI 10.1016/j.tplants.2008.04.009; Monosi B, 2004, THEOR APPL GENET, V109, P1434, DOI 10.1007/s00122-004-1758-x; Morrissey J, 2009, PLANT CELL, V21, P3326, DOI 10.1105/tpc.109.069401; Mun JH, 2009, MOL GENET GENOMICS, V282, P617, DOI 10.1007/s00438-009-0492-0; Paterson AH, 2009, NATURE, V457, P551, DOI 10.1038/nature07723; Plocik A, 2004, MOL PHYLOGENET EVOL, V31, P153, DOI 10.1016/S1055-7903(03)00274-4; Poliseno L, 2010, NATURE, V465, P1033, DOI 10.1038/nature09144; Porter BW, 2009, MOL GENET GENOMICS, V281, P609, DOI 10.1007/s00438-009-0434-x; Radwan O, 2008, MOL GENET GENOMICS, V280, P111, DOI 10.1007/s00438-008-0346-1; SAITOU N, 1987, MOL BIOL EVOL, V4, P406, DOI 10.1093/oxfordjournals.molbev.a040454; Sanseverino W, 2010, NUCLEIC ACIDS RES, V38, pD814, DOI 10.1093/nar/gkp978; Schornack S, 2004, PLANT J, V37, P46, DOI 10.1046/j.1365-313X.2003.01937.x; Schuler GD, 1997, GENOME RES, V7, P541, DOI 10.1101/gr.7.5.541; Tameling WIL, 2002, PLANT CELL, V14, P2929, DOI 10.1105/tpc.005793; Tamura K, 2007, MOL BIOL EVOL, V24, P1596, DOI 10.1093/molbev/msm092; Tan XP, 2007, BMC PLANT BIOL, V7, DOI 10.1186/1471-2229-7-56; THOMPSON JD, 1994, NUCLEIC ACIDS RES, V22, P4673, DOI 10.1093/nar/22.22.4673; TRAUT TW, 1994, EUR J BIOCHEM, V222, P9, DOI 10.1111/j.1432-1033.1994.tb18835.x; van der Biezen EA, 1998, CURR BIOL, V8, pR226, DOI 10.1016/S0960-9822(98)70145-9; van der Vossen EAG, 2005, PLANT J, V44, P208, DOI 10.1111/j.1365-313X.2005.02527.x; vanderVoort JR, 1997, THEOR APPL GENET, V95, P874, DOI 10.1007/s001220050638; Warren RF, 1998, PLANT CELL, V10, P1439, DOI 10.1105/tpc.10.9.1439; Waterhouse AM, 2009, BIOINFORMATICS, V25, P1189, DOI 10.1093/bioinformatics/btp033; Wei FS, 2002, PLANT CELL, V14, P1903, DOI 10.1105/tpc.002238; Xu X, 2011, NATURE, V475, P189, DOI 10.1038/nature10158; Yang SH, 2008, MOL GENET GENOMICS, V280, P187, DOI 10.1007/s00438-008-0355-0; Zhou T, 2004, MOL GENET GENOMICS, V271, P402, DOI 10.1007/s00438-004-0990-z	56	85	94	0	29	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 6	2012	7	4							e34775	10.1371/journal.pone.0034775	http://dx.doi.org/10.1371/journal.pone.0034775			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	955JA	22493716	gold, Green Submitted, Green Published			2022-12-25	WOS:000305012700058
J	Munoz, WA; Kloc, M; Cho, K; Lee, M; Hofmann, I; Sater, A; Vleminckx, K; McCrea, PD				Munoz, William A.; Kloc, Malgorzata; Cho, Kyucheol; Lee, Moonsup; Hofmann, Ilse; Sater, Amy; Vleminckx, Kris; McCrea, Pierre D.			Plakophilin-3 Is Required for Late Embryonic Amphibian Development, Exhibiting Roles in Ectodermal and Neural Tissues	PLOS ONE			English	Article							RHO-FAMILY GTPASES; DESMOSOMAL PLAQUE; P120 CATENIN; CELL-ADHESION; BETA-CATENIN; TRANSCRIPTION FACTOR; EPITHELIAL-CELLS; PROTEIN PLAKOPHILIN-2; ACTIN CYTOSKELETON; FRAGILITY-SYNDROME	The p120-catenin family has undergone a significant expansion during the evolution of vertebrates, resulting in varied functions that have yet to be discerned or fully characterized. Likewise, members of the plakophilins, a related catenin subfamily, are found throughout the cell with little known about their functions outside the desmosomal plaque. While the plakophilin-3 (Pkp3) knockout mouse resulted in skin defects, we find larger, including lethal effects following its depletion in Xenopus. Pkp3, unlike some other characterized catenins in amphibians, does not have significant maternal deposits of mRNA. However, during embryogenesis, two Pkp3 protein products whose temporal expression is partially complimentary become expressed. Only the smaller of these products is found in adult Xenopus tissues, with an expression pattern exhibiting distinctions as well as overlaps with those observed in mammalian studies. We determined that Xenopus Pkp3 depletion causes a skin fragility phenotype in keeping with the mouse knockout, but more novel, Xenopus tailbud embryos are hyposensitive to touch even in embryos lacking outward discernable phenotypes, and we additionally resolved disruptions in certain peripheral neural structures, altered establishment and migration of neural crest, and defects in ectodermal multiciliated cells. The use of two distinct morpholinos, as well as rescue approaches, indicated the specificity of these effects. Our results point to the requirement of Pkp3 in amphibian embryogenesis, with functional roles in a number of tissue types.	[Munoz, William A.; Kloc, Malgorzata; Cho, Kyucheol; Lee, Moonsup; McCrea, Pierre D.] Univ Texas MD Anderson Canc Ctr, Dept Biochem & Mol Biol, Houston, TX 77030 USA; [Munoz, William A.; Cho, Kyucheol; Lee, Moonsup; McCrea, Pierre D.] Univ Texas Grad Sch Biomed Sci, Program Genes & Dev, Houston, TX USA; [Kloc, Malgorzata] Methodist Hosp, Res Inst, Dept Surg, Houston, TX 77030 USA; [Hofmann, Ilse] Univ Heidelberg, DKFZ, Med Fac Mannheim, Joint Res Div Vasc Biol, D-6800 Mannheim, Germany; [Sater, Amy] Univ Houston, Dept Biol & Biochem, Houston, TX USA; [Vleminckx, Kris] Flanders Inst Biotechnol VIB, Dept Mol Biomed Res, Ghent, Belgium	University of Texas System; UTMD Anderson Cancer Center; The Methodist Hospital System; The Methodist Hospital - Houston; Helmholtz Association; German Cancer Research Center (DKFZ); Ruprecht Karls University Heidelberg; University of Houston System; University of Houston; Flanders Institute for Biotechnology (VIB)	Munoz, WA (corresponding author), Univ Texas MD Anderson Canc Ctr, Dept Biochem & Mol Biol, Houston, TX 77030 USA.	pdmccrea@mdanderson.org	Kloc, Malgorzata/AAF-6982-2020; Vleminckx, Kris/J-5699-2013		NIH [RO1GM52112]; Cancer Prevention and Research Institute of Texas [RP101502]; National Cancer Institute [CA-16672]; NATIONAL CANCER INSTITUTE [P30CA016672] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM052112] Funding Source: NIH RePORTER	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Cancer Prevention and Research Institute of Texas; National Cancer Institute(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported (P.D.M) by the NIH (RO1GM52112 and Research Supplement to Promote Diversity in Health-Related Research). W. A. M. was supported from a Cancer Prevention and Research Institute of Texas Research Training Award (RP101502). Assistance with DNA sequencing, high resolution electron microscopy and other core facilities was provided from a National Cancer Institute Core Grant (CA-16672) to MD Anderson Cancer Center. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ACHTSTATTER T, 1989, DIFFERENTIATION, V40, P129, DOI 10.1111/j.1432-0436.1989.tb00822.x; Aho S, 2002, J CELL SCI, V115, P1391; Anastasiadis PZ, 2007, BBA-MOL CELL RES, V1773, P34, DOI 10.1016/j.bbamcr.2006.08.040; Anastasiadis PZ, 2001, CURR OPIN CELL BIOL, V13, P604, DOI 10.1016/S0955-0674(00)00258-1; Anastasiadis PZ, 2000, NAT CELL BIOL, V2, P637, DOI 10.1038/35023588; Awad MM, 2008, NAT CLIN PRACT CARD, V5, P258, DOI 10.1038/ncpcardio1182; Basch ML, 2006, ADV EXP MED BIOL, V589, P24; Bass-Zubek AE, 2009, CURR OPIN CELL BIOL, V21, P708, DOI 10.1016/j.ceb.2009.07.002; Beausoleil SA, 2004, P NATL ACAD SCI USA, V101, P12130, DOI 10.1073/pnas.0404720101; Bilinski SM, 2010, METHODS, V51, P11, DOI 10.1016/j.ymeth.2009.12.003; Bonne S, 2003, J CELL BIOL, V161, P403, DOI 10.1083/jcb.200303036; Bonne S, 1999, J CELL SCI, V112, P2265; Breuninger S, 2010, AM J PATHOL, V176, P2509, DOI 10.2353/ajpath.2010.090737; Brooke MA, 2012, J PATHOL, V226, P158, DOI 10.1002/path.3027; Carnahan RH, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0015747; Chen XY, 2002, J BIOL CHEM, V277, P10512, DOI 10.1074/jbc.M108765200; Chidgey M, 2001, J CELL BIOL, V155, P821, DOI 10.1083/jcb.200105009; Christiansen JH, 2000, CURR OPIN CELL BIOL, V12, P719, DOI 10.1016/S0955-0674(00)00158-7; Ciesiolka M, 2004, J CELL SCI, V117, P4325, DOI 10.1242/jcs.01298; Clevers H, 2006, CELL, V127, P469, DOI 10.1016/j.cell.2006.10.018; Daniel JM, 1999, MOL CELL BIOL, V19, P3614; Daniel JM, 2007, BBA-MOL CELL RES, V1773, P59, DOI 10.1016/j.bbamcr.2006.08.052; DEMARAIS AA, 1992, DEV BIOL, V153, P337, DOI 10.1016/0012-1606(92)90118-Z; Demirag GG, 2011, MED ONCOL; Demirag GG, 2011, DIAGN PATHOL, V6, DOI 10.1186/1746-1596-6-1; Fang X, 2004, J CELL BIOL, V165, P87, DOI 10.1083/jcb.200307109; Franke WW, 2009, CSH PERSPECT BIOL, V1, DOI 10.1101/cshperspect.a003061; FUNAYAMA N, 1995, J CELL BIOL, V128, P959, DOI 10.1083/jcb.128.5.959; Furukawa C, 2005, CANCER RES, V65, P7102, DOI 10.1158/0008-5472.CAN-04-1877; Gerull B, 2004, NAT GENET, V36, P1162, DOI 10.1038/ng1461; Godsel LM, 2010, MOL BIOL CELL, V21, P2844, DOI 10.1091/mbc.E10-02-0131; Green KJ, 2007, J INVEST DERMATOL, V127, P2499, DOI 10.1038/sj.jid.5701015; Grosheva I, 2001, J CELL SCI, V114, P695; Grossmann KS, 2004, J CELL BIOL, V167, P149, DOI 10.1083/jcb.200402096; Gu D, 2011, J BIOL CHEM; Gu DM, 2009, J CELL SCI, V122, P4049, DOI 10.1242/jcs.031948; Hartsock A, 2008, BBA-BIOMEMBRANES, V1778, P660, DOI 10.1016/j.bbamem.2007.07.012; Hatzfeld M, 2005, EUR J CELL BIOL, V84, P205, DOI 10.1016/j.ejcb.2004.12.016; Hatzfeld M, 2000, J CELL BIOL, V149, P209, DOI 10.1083/jcb.149.1.209; Hatzfeld M, 2007, BBA-MOL CELL RES, V1773, P69, DOI 10.1016/j.bbamcr.2006.04.009; HEID HW, 1994, DIFFERENTIATION, V58, P113; Hobbs RP, 2012, J INVEST DERMATOL; Hofmann I, 2006, MOL BIOL CELL, V17, P1388, DOI 10.1091/mbc.e05-08-0708; Hofmann I, 2000, J CELL SCI, V113, P2471; Hong JY, 2010, J CELL SCI, V123, P4351, DOI 10.1242/jcs.067199; Israely I, 2004, CURR BIOL, V14, P1657, DOI 10.1016/j.cub.2004.08.065; Keil R, 2007, CELL CYCLE, V6, P122, DOI 10.4161/cc.6.2.3741; Keirsebilck A, 1998, GENOMICS, V50, P129, DOI 10.1006/geno.1998.5325; Klaus A, 2008, NAT REV CANCER, V8, P387, DOI 10.1038/nrc2389; Klymkowsky MW, 1999, MICROSC RES TECHNIQ, V45, P43, DOI 10.1002/(SICI)1097-0029(19990401)45:1<43::AID-JEMT4>3.3.CO;2-3; Kowalczyk AP, 1999, J BIOL CHEM, V274, P18145, DOI 10.1074/jbc.274.26.18145; Kundu ST, 2008, INT J CANCER, V123, P2303, DOI 10.1002/ijc.23797; Kuriyama S, 2008, PHILOS T R SOC B, V363, P1349, DOI 10.1098/rstb.2007.2252; McCrea PD, 2007, BBA-MOL CELL RES, V1773, P17, DOI 10.1016/j.bbamcr.2006.06.009; McCrea PD, 2009, CSH PERSPECT BIOL, V1, DOI 10.1101/cshperspect.a002923; McCrea PD, 2010, J CELL SCI, V123, P637, DOI 10.1242/jcs.039842; McGrath JA, 1997, NAT GENET, V17, P240, DOI 10.1038/ng1097-240; McMillan JR, 2003, J INVEST DERMATOL, V121, P96, DOI 10.1046/j.1523-1747.2003.12324.x; Mertens C, 2001, P NATL ACAD SCI USA, V98, P7795, DOI 10.1073/pnas.141219498; Mertens C, 1996, J CELL BIOL, V135, P1009, DOI 10.1083/jcb.135.4.1009; Mo YY, 1996, CANCER RES, V56, P2633; Molenaar M, 1996, CELL, V86, P391, DOI 10.1016/S0092-8674(00)80112-9; Montross WT, 2000, J CELL SCI, V113, P1759; Nekrasova OE, 2011, J CELL BIOL, V195, P1185, DOI 10.1083/jcb.201106057; Noren NK, 2000, J CELL BIOL, V150, P567, DOI 10.1083/jcb.150.3.567; North AJ, 1999, J CELL SCI, V112, P4325; Papagerakis S, 2003, HUM PATHOL, V34, P565, DOI 10.1016/S0046-8177(03)00174-6; Paulson AF, 2000, J BIOL CHEM, V275, P30124, DOI 10.1074/jbc.M003048200; Perez-Moreno M, 2003, CELL, V112, P535, DOI 10.1016/S0092-8674(03)00108-9; Rickelt S, 2011, CELL TISSUE RES, V346, P65, DOI 10.1007/s00441-011-1260-0; Roberts BJ, 2011, EXP CELL RES, V317, P2814, DOI 10.1016/j.yexcr.2011.09.003; Schmidt A, 1999, DIFFERENTIATION, V64, P291, DOI 10.1046/j.1432-0436.1999.6450291.x; Schmidt A, 1997, CELL TISSUE RES, V290, P481, DOI 10.1007/s004410050956; SCHNEIDER S, 1993, DEVELOPMENT, V118, P629; Schwarz J, 2006, HUM PATHOL, V37, P613, DOI 10.1016/j.humpath.2006.01.013; Sive Hazel L., 2000, EARLY DEV XENOPUS LA; Sklyarova T, 2008, J INVEST DERMATOL, V128, P1375, DOI 10.1038/sj.jid.5701189; Smith EA, 1998, J CELL BIOL, V141, P1229, DOI 10.1083/jcb.141.5.1229; Snider P, 2007, THESCIENTIFICWORLDJO, V7, P1090, DOI 10.1100/tsw.2007.189; Sobolik-Delmaire T, 2006, J BIOL CHEM, V281, P16962, DOI 10.1074/jbc.M600570200; Sobolik-Delmaire T, 2010, J INVEST DERMATOL, V130, P2638, DOI 10.1038/jid.2010.191; South AP, 2003, J CELL SCI, V116, P3303, DOI 10.1242/jcs.00636; Sprecher E, 2004, J INVEST DERMATOL, V122, P647, DOI 10.1111/j.0022-202X.2004.22335.x; Thomason HA, 2010, BIOCHEM J, V429, P419, DOI 10.1042/BJ20100567; Wallingford JB, 2010, COLD SPRING HARB PRO; Wolf A, 2006, NAT CELL BIOL, V8, P1432, DOI 10.1038/ncb1504; Wolf A, 2010, J CELL BIOL, V188, P463, DOI 10.1083/jcb.200908135; Yin TF, 2004, SEMIN CELL DEV BIOL, V15, P665, DOI 10.1016/j.semcdb.2004.09.005	88	12	12	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 5	2012	7	4							e34342	10.1371/journal.pone.0034342	http://dx.doi.org/10.1371/journal.pone.0034342			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	955IH	22496792	gold, Green Published, Green Submitted			2022-12-25	WOS:000305010500006
J	Gorski, L				Gorski, Lisa			Selective Enrichment Media Bias the Types of Salmonella enterica Strains Isolated from Mixed Strain Cultures and Complex Enrichment Broths	PLOS ONE			English	Article							LISTERIA-MONOCYTOGENES; SEROTYPES; SAMPLES; IDENTIFICATION; LABORATORIES; TYPHIMURIUM; DIVERSITY; TRACKING; DIFFER	For foodborne outbreak investigations it can be difficult to isolate the relevant strain from food and/or environmental sources. If the sample is contaminated by more than one strain of the pathogen the relevant strain might be missed. In this study mixed cultures of Salmonella enterica were grown in one set of standard enrichment media to see if culture bias patterns emerged. Nineteen strains representing four serogroups and ten serotypes were compared in four-strain mixtures in Salmonella-only and in cattle fecal culture enrichment backgrounds using Salmonella enrichment media. One or more strain(s) emerged as dominant in each mixture. No serotype was most fit, but strains of serogroups C2 and E were more likely to dominate enrichment culture mixtures than strains of serogroups B or C1. Different versions of Rappaport-Vassiliadis (RV) medium gave different patterns of strain dominance in both Salmonella-only and fecal enrichment culture backgrounds. The fittest strains belonged to serogroups C1, C2, and E, and included strains of S. Infantis, S. Thompson S. Newport, S. 6,8:d:-, and S. Give. Strains of serogroup B, which included serotypes often seen in outbreaks such as S. Typhimurium, S. Saintpaul, and S. Schwarzengrund were less likely to emerge as dominant strains in the mixtures when using standard RV as part of the enrichment. Using a more nutrient-rich version of RV as part of the protocol led to a different pattern of strains emerging, however some were still present in very low numbers in the resulting population. These results indicate that outbreak investigations of food and/or other environmental samples should include multiple enrichment protocols to ensure isolation of target strains of Salmonella.	ARS, Produce Safety & Microbiol Res Unit, USDA, Albany, CA USA	United States Department of Agriculture (USDA)	Gorski, L (corresponding author), ARS, Produce Safety & Microbiol Res Unit, USDA, Albany, CA USA.	lisa.gorski@ars.usda.gov		Gorski, Lisa/0000-0003-2387-1012	United States Department of Agriculture (USDA), Agricultural Research Service CRIS [5325-42000-046-00D]; National Research Initiative from the USDA National Institute of Food and Agriculture [2006-55212-16927, 2007-35212-18239]	United States Department of Agriculture (USDA), Agricultural Research Service CRIS(United States Department of Agriculture (USDA)); National Research Initiative from the USDA National Institute of Food and Agriculture	This work was supported by the United States Department of Agriculture (USDA), Agricultural Research Service CRIS project 5325-42000-046-00D and, in part, by National Research Initiative Competitive Grant numbers 2006-55212-16927 and 2007-35212-18239 from the USDA National Institute of Food and Agriculture. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Andrews W.H, 2007, SALMONELLA BACTERIOL; [Anonymous], ANONYMOUS METHOD 168; BARKER RM, 1980, J GEN MICROBIOL, V120, P21; Barkocy-Gallagher GA, 2002, J FOOD PROTECT, V65, P1527, DOI 10.4315/0362-028X-65.10.1527; Bruhn JB, 2005, APPL ENVIRON MICROB, V71, P961, DOI 10.1128/AEM.71.2.961-967.2005; CAMPOS L C, 1988, Memorias do Instituto Oswaldo Cruz, V83, P189; Carter MQ, 2011, APPL ENVIRON MICROB, V77, P3685, DOI 10.1128/AEM.02315-10; CDC, 2011, SALM ANN SUMM TABL 2; Cooley M, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0001159; Davies PR, 2000, J APPL MICROBIOL, V89, P169, DOI 10.1046/j.1365-2672.2000.01101.x; Fedorka-Cray PJ, 1998, J FOOD PROTECT, V61, P525, DOI 10.4315/0362-028X-61.5.525; Gorski L, 2006, APPL ENVIRON MICROB, V72, P776, DOI 10.1128/AEM.72.1.776-783.2006; Gorski L, 2011, APPL ENVIRON MICROB, V77, P2734, DOI 10.1128/AEM.02321-10; Haley BJ, 2009, APPL ENVIRON MICROB, V75, P1248, DOI 10.1128/AEM.01648-08; HARVEY RWS, 1967, J HYG-CAMB, V65, P423, DOI 10.1017/S0022172400045939; Hendriksen RS, 2011, FOODBORNE PATHOG DIS, V8, P887, DOI 10.1089/fpd.2010.0787; Jones TF, 2008, J INFECT DIS, V198, P109, DOI 10.1086/588823; MCGIBBON L, 1984, INT J FOOD MICROBIOL, V1, P171, DOI 10.1016/0168-1605(84)90013-8; Murray GL, 2003, MOL MICROBIOL, V47, P1395, DOI 10.1046/j.1365-2958.2003.03383.x; Palumbo JD, 2003, J CLIN MICROBIOL, V41, P564, DOI 10.1128/JCM.41.2.564-571.2003; Patankar C V, 1985, J Postgrad Med, V31, P46; Patchanee P, 2010, FOODBORNE PATHOG DIS, V7, P1113, DOI 10.1089/fpd.2010.0572; Raetz CRH, 2002, ANNU REV BIOCHEM, V71, P635, DOI 10.1146/annurev.biochem.71.110601.135414; Rostagno MH, 2005, J VET DIAGN INVEST, V17, P80, DOI 10.1177/104063870501700118; Rybolt ML, 2004, POULTRY SCI, V83, P1112, DOI 10.1093/ps/83.7.1112; Singer RS, 2009, J FOOD PROTECT, V72, P707, DOI 10.4315/0362-028X-72.4.707; VASSILIADIS P, 1983, J APPL BACTERIOL, V54, P69, DOI 10.1111/j.1365-2672.1983.tb01302.x; Voogt N, 2002, EUR J CLIN MICROBIOL, V21, P449, DOI 10.1007/s10096-002-0741-1	28	58	61	0	15	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 4	2012	7	4							e34722	10.1371/journal.pone.0034722	http://dx.doi.org/10.1371/journal.pone.0034722			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	953GO	22496847	Green Submitted, gold, Green Published			2022-12-25	WOS:000304855200070
J	Hsu, YC; Yu, L; Chen, HI; Lee, HL; Kuo, YM; Jen, CYJ				Hsu, Yuan-Chang; Yu, Lung; Chen, Hsiun-ing; Lee, Hui-Ling; Kuo, Yu-Min; Jen, Chauying J.			Blood Pressure Variations Real-Time Reflect the Conditioned Fear Learning and Memory	PLOS ONE			English	Article							SUBSTANCE-P; POTENTIATED STARTLE; AMYGDALA; HYPOTHALAMUS; BRAIN; RATS; ANXIETY; SYSTEM; CAT	The conditioned fear learning and memory occurs when a neutral conditioned stimulus (CS) is paired with an aversive unconditioned stimulus (US). This process is critically dependent on the amygdala and inevitably involves blood pressure (BP) alterations. We hypothesized that BP variations could instantaneously reveal individual steps during conditioned fear learning and memory. An implanted telemetric probe was used to monitor the BP real-time in rats during training and testing sessions of the fear-potentiated startle. Our results showed that (i) the conditioned fear learning during the training sessions was reflected by light (CS)-induced rapid BP elevations and by electric shock (US)-evoked sympathetic tone elevations; (ii) these two BP-related parameters were not only negatively correlated with each other but also coupled to each other in the training session trials; (iii) both parameters closely predicted the performance of fear-potentiated startle on the next day; and (iv) although local blocking of one of the two fear-conditioned pathways in the training session partially inhibited fear learning, the fear memory retrieval still used both pathways. Altogether, real-time blood pressure variations faithfully revealed the critical steps involved in conditioned fear learning and memory, and our results supported a coupling between the cued learning and the post-shock calmness.	[Hsu, Yuan-Chang; Chen, Hsiun-ing; Jen, Chauying J.] Natl Cheng Kung Univ, Inst Basic Med Sci, Tainan 70101, Taiwan; [Yu, Lung] Natl Cheng Kung Univ, Inst Behav Med, Tainan 70101, Taiwan; [Chen, Hsiun-ing; Jen, Chauying J.] Natl Cheng Kung Univ, Dept Physiol, Tainan 70101, Taiwan; [Lee, Hui-Ling] Natl Cheng Kung Univ, Inst Publ Hlth, Tainan 70101, Taiwan; [Kuo, Yu-Min] Natl Cheng Kung Univ, Dept Cell Biol & Anat, Tainan 70101, Taiwan	National Cheng Kung University; National Cheng Kung University; National Cheng Kung University; National Cheng Kung University; National Cheng Kung University	Hsu, YC (corresponding author), Natl Cheng Kung Univ, Inst Basic Med Sci, Tainan 70101, Taiwan.	jen@mail.ncku.edu.tw	Kuo, Yu-Min/A-9050-2013	Kuo, Yu-Min/0000-0003-4867-2482	National Science Council in Taiwan [NSC 98-2320-B-006-019-MY3, NSC 98-2320-B-006-028-MY3]	National Science Council in Taiwan(Ministry of Science and Technology, Taiwan)	This study was supported by grants from the National Science Council in Taiwan (Grant numbers NSC 98-2320-B-006-019-MY3, NSC 98-2320-B-006-028-MY3). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Blair HT, 2001, LEARN MEMORY, V8, P229, DOI 10.1101/lm.30901; CERUTTI C, 1991, AM J PHYSIOL, V261, pH1292, DOI 10.1152/ajpheart.1991.261.4.H1292; COLPAERT FC, 1976, BEHAV BIOL, V16, P117, DOI 10.1016/S0091-6773(76)91225-6; Dalgleish T, 2004, NAT REV NEUROSCI, V5, P583, DOI 10.1038/nrn1432; DAVIS M, 1992, ANNU REV NEUROSCI, V15, P353, DOI 10.1146/annurev.neuro.15.1.353; Davis M, 2006, AM PSYCHOL, V61, P741, DOI 10.1037/0003-066X.61.8.741; deOliveira L, 1997, NEUROREPORT, V8, P3489, DOI 10.1097/00001756-199711100-00015; Dielenberg RA, 2001, NEUROSCIENCE, V104, P1085, DOI 10.1016/S0306-4522(01)00150-6; Fanselow MS, 1998, NEURON, V20, P625, DOI 10.1016/S0896-6273(00)81002-8; Fanselow MS, 2005, ANNU REV PSYCHOL, V56, P207, DOI 10.1146/annurev.psych.56.091103.070213; Han YC, 1996, BRAIN RES, V716, P59, DOI 10.1016/0006-8993(95)01586-8; Harris JA, 2011, J EXP PSYCHOL-ANIM B, V37, P277, DOI 10.1037/a0023079; Harris JA, 2011, J EXP PSYCHOL ANIM B, V37, P151, DOI 10.1037/a0021883; Hsu YC, 2011, J HYPERTENS, V29, P2339, DOI 10.1097/HJH.0b013e32834c628f; ITOI K, 1991, BRAIN RES, V558, P123, DOI 10.1016/0006-8993(91)90727-D; Lang PJ, 2006, PROG BRAIN RES, V156, P3, DOI 10.1016/S0079-6123(06)56001-7; LEDOUX J E, 1992, P339; Maren S, 2004, NAT REV NEUROSCI, V5, P844, DOI 10.1038/nrn1535; Roozendaal B, 2003, PROG NEURO-PSYCHOPH, V27, P1213, DOI 10.1016/j.pnpbp.2003.09.015; Roozendaal B, 2009, NAT REV NEUROSCI, V10, P423, DOI 10.1038/nrn2651; Sah P, 2008, ANN NY ACAD SCI, V1129, P88, DOI 10.1196/annals.1417.020; Sudakov K V, 1987, Neurosci Behav Physiol, V17, P74, DOI 10.1007/BF01186811; Zhao ZW, 2009, NEUROPSYCHOPHARMACOL, V34, P331, DOI 10.1038/npp.2008.55	23	5	5	0	13	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 4	2012	7	4							e32855	10.1371/journal.pone.0032855	http://dx.doi.org/10.1371/journal.pone.0032855			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	953GO	22496737	Green Published, gold, Green Submitted			2022-12-25	WOS:000304855200006
J	Pan, IC; Liao, DC; Wu, FH; Daniell, H; Singh, ND; Chang, C; Shih, MC; Chan, MT; Lin, CS				Pan, I-Chun; Liao, Der-Chih; Wu, Fu-Huei; Daniell, Henry; Singh, Nameirakpam Dolendro; Chang, Chen; Shih, Ming-Che; Chan, Ming-Tsair; Lin, Choun-Sea			Complete Chloroplast Genome Sequence of an Orchid Model Plant Candidate: Erycina pusilla Apply in Tropical Oncidium Breeding	PLOS ONE			English	Article							COMPLETE NUCLEOTIDE-SEQUENCE; GOWER RAMSEY; PHYLOGENETIC-RELATIONSHIPS; DIFFERENTIAL EXPRESSION; MITOCHONDRIAL-DNA; GENE-SEQUENCES; NDH GENES; IDENTIFICATION; EVOLUTION; BIOTECHNOLOGY	Oncidium is an important ornamental plant but the study of its functional genomics is difficult. Erycina pusilla is a fast-growing Oncidiinae species. Several characteristics including low chromosome number, small genome size, short growth period, and its ability to complete its life cycle in vitro make E. pusilla a good model candidate and parent for hybridization for orchids. Although genetic information remains limited, systematic molecular analysis of its chloroplast genome might provide useful genetic information. By combining bacterial artificial chromosome (BAC) clones and next-generation sequencing (NGS), the chloroplast (cp) genome of E. pusilla was sequenced accurately, efficiently and economically. The cp genome of E. pusilla shares 89 and 84% similarity with Oncidium Gower Ramsey and Phalanopsis aphrodite, respectively. Comparing these 3 cp genomes, 5 regions have been identified as showing diversity. Using PCR analysis of 19 species belonging to the Epidendroideae subfamily, a conserved deletion was found in the rps15-trnN region of the Cymbidieae tribe. Because commercial Oncidium varieties in Taiwan are limited, identification of potential parents using molecular breeding method has become very important. To demonstrate the relationship between taxonomic position and hybrid compatibility of E. pusilla, 4 DNA regions of 36 tropically adapted Oncidiinae varieties have been analyzed. The results indicated that trnF-ndhJ and trnH-psbA were suitable for phylogenetic analysis. E. pusilla proved to be phylogenetically closer to Rodriguezia and Tolumnia than Oncidium, despite its similar floral appearance to Oncidium. These results indicate the hybrid compatibility of E. pusilla, its cp genome providing important information for Oncidium breeding.	[Pan, I-Chun; Chan, Ming-Tsair] Natl Cheng Kung Univ, Inst Biotechnol, Tainan 70101, Taiwan; [Pan, I-Chun; Liao, Der-Chih; Wu, Fu-Huei; Shih, Ming-Che; Chan, Ming-Tsair; Lin, Choun-Sea] Acad Sinica, Agr Biotechnol Res Ctr, Taipei 115, Taiwan; [Pan, I-Chun; Chan, Ming-Tsair] Acad Sinica Biotechnol Ctr So Taiwan, Tainan, Taiwan; [Daniell, Henry; Singh, Nameirakpam Dolendro] Univ Cent Florida, Dept Mol Biol & Microbiol, Orlando, FL 32816 USA; [Chang, Chen] Natl Chung Hsing Univ, Dept Hort, Taichung 40227, Taiwan	National Cheng Kung University; Academia Sinica - Taiwan; State University System of Florida; University of Central Florida; National Chung Hsing University	Pan, IC (corresponding author), Natl Cheng Kung Univ, Inst Biotechnol, Tainan 70101, Taiwan.	mbmtchan@gate.sinica.edu.tw; cslin99@gate.sinica.edu.tw	Daniell, Henry/L-3655-2019; Pan, I-Chun/AFP-1078-2022; Shih, Ming-Che/V-1816-2019; Chan, Ming-Tsair/L-2465-2015	Daniell, Henry/0000-0003-4485-1176; Chan, Ming-Tsair/0000-0002-1942-9160; Lin, Choun-Sea/0000-0001-9566-2952	Agricultural Biotechnology Research Center, Academia Sinica, Taipei, Taiwan; Academia Sinica Biotechnology Center in Southern Taiwan, Tainan, Taiwan; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM063879] Funding Source: NIH RePORTER	Agricultural Biotechnology Research Center, Academia Sinica, Taipei, Taiwan; Academia Sinica Biotechnology Center in Southern Taiwan, Tainan, Taiwan; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported by the Agricultural Biotechnology Research Center, Academia Sinica, Taipei, Taiwan and Academia Sinica Biotechnology Center in Southern Taiwan, Tainan, Taiwan. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	AYLIFFE MA, 1992, THEOR APPL GENET, V85, P229, DOI 10.1007/BF00222864; Bausher MG, 2006, BMC PLANT BIOL, V6, DOI 10.1186/1471-2229-6-21; Cameron KM, 2006, CLADISTICS, V22, P239, DOI 10.1111/j.1096-0031.2006.00102.x; Cameron KM, 2004, MOL PHYLOGENET EVOL, V31, P1157, DOI 10.1016/j.ympev.2003.10.010; Chang CC, 2006, MOL BIOL EVOL, V23, P279, DOI 10.1093/molbev/msj029; Chang YY, 2011, PLANT CELL PHYSIOL, V52, P1532, DOI 10.1093/pcp/pcr101; Chase MW, 2009, ANN BOT-LONDON, V104, P387, DOI 10.1093/aob/mcp067; CHASE MW, 1986, SYST BOT, V11, P477, DOI 10.2307/2419085; Chase MW, 2005, ANN BOT-LONDON, V95, P191, DOI 10.1093/aob/mci012; CHASE MW, 2003, ORCHID CONSERVATION, P69; Chen ChiaChung, 2003, Journal of Agriculture and Forestry, V52, P33; Chen YC, 2000, IN VITRO CELL DEV-PL, V36, P420; Chiou CY, 2008, PLANT MOL BIOL, V66, P379, DOI 10.1007/s11103-007-9275-3; Chiu YT, 2011, PROPAG ORNAM PLANTS, V11, P131; Chris BJ, 2011, PLANT MOL BIOL, P1; Damon Anne, 2007, Tropical Ecology, V48, P1; Daniell H, 2005, TRENDS BIOTECHNOL, V23, P238, DOI 10.1016/j.tibtech.2005.03.008; Daniell H, 2008, THEOR APPL GENET, V116, P723, DOI 10.1007/s00122-007-0706-y; DODSON C H, 1972, Phytologia, V24, P285; Felix LP, 1999, CARYOLOGIA, V52, P165, DOI 10.1080/00087114.1998.10589169; Fu CH, 2011, PLANT CELL PHYSIOL, V52, P238, DOI 10.1093/pcp/pcq201; Goremykin VV, 2009, MOL BIOL EVOL, V26, P99, DOI 10.1093/molbev/msn226; Hirai A., 1993, Plant Molecular Biology Reporter, V11, P98, DOI 10.1007/BF02670465; Hsiao YY, 2011, PLANT CELL PHYSIOL, V52, P1467, DOI 10.1093/pcp/pcr100; Hsu CT, 2011, BMC PLANT BIOL, V11, DOI 10.1186/1471-2229-11-60; Hsu HF, 2002, PLANT CELL PHYSIOL, V43, P1198, DOI 10.1093/pcp/pcf143; Jansen RK, 2008, MOL PHYLOGENET EVOL, V48, P1204, DOI 10.1016/j.ympev.2008.06.013; KERBAUY GB, 1984, PLANT SCI LETT, V35, P73, DOI 10.1016/0304-4211(84)90160-3; Kumar S, 2004, BRIEF BIOINFORM, V5, P150, DOI 10.1093/bib/5.2.150; Liao LJ, 2004, MOL BREEDING, V13, P229, DOI 10.1023/B:MOLB.0000022527.68551.30; Liau CH, 2003, PLANT CELL REP, V21, P993, DOI 10.1007/s00299-003-0614-9; Lin CS, 2011, SEED NURSERY, V13, P31; Mach JM, 2001, P NATL ACAD SCI USA, V98, P771, DOI 10.1073/pnas.021465298; Martin M, 2010, PLANT PHYSIOL BIOCH, V48, P636, DOI 10.1016/j.plaphy.2010.04.009; Mccoy SR, 2008, BMC EVOL BIOL, V8, DOI 10.1186/1471-2148-8-130; NAKAZONO M, 1993, MOL GEN GENET, V236, P341, DOI 10.1007/BF00277131; Neubig KM, 2009, PLANT SYST EVOL, V277, P75, DOI 10.1007/s00606-008-0105-0; Nock CJ, 2011, PLANT BIOTECHNOL J, V9, P328, DOI 10.1111/j.1467-7652.2010.00558.x; Pellegrino G, 2009, PLANT BIOLOGY, V11, P434, DOI 10.1111/j.1438-8677.2008.00135.x; Pinheiro F, 2010, MOL ECOL, V19, P3981, DOI 10.1111/j.1365-294X.2010.04780.x; Russell A, 2010, ANN BOT-LONDON, V106, P37, DOI 10.1093/aob/mcq092; Samson N, 2007, PLANT BIOTECHNOL J, V5, P339, DOI 10.1111/j.1467-7652.2007.00245.x; Sanjaya, 2007, ORCHID BIOTECHNOLOGY, P225; Saski C, 2005, PLANT MOL BIOL, V59, P309, DOI 10.1007/s11103-005-8882-0; Scarcelli N, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0019954; Sheu JJ, 1996, J BIOL CHEM, V271, P26998, DOI 10.1074/jbc.271.43.26998; STERN DB, 1982, NATURE, V299, P698, DOI 10.1038/299698a0; STERN DB, 1984, P NATL ACAD SCI-BIOL, V81, P1946, DOI 10.1073/pnas.81.7.1946; Su CL, 2011, PLANT CELL PHYSIOL, V52, P1501, DOI 10.1093/pcp/pcr097; Thiruvengadam M, 2009, PLANT CELL REP, V28, P1463, DOI 10.1007/s00299-009-0746-7; Thompson JD, 1997, NUCLEIC ACIDS RES, V25, P4876, DOI 10.1093/nar/25.24.4876; Tian Xin, 2002, Acta Botanica Yunnanica, V24, P170; Timmis JN, 2004, NAT REV GENET, V5, P123, DOI 10.1038/nrg1271; Verma D, 2007, PLANT PHYSIOL, V145, P1129, DOI 10.1104/pp.107.106690; WAKASUGI T, 1994, P NATL ACAD SCI USA, V91, P9794, DOI 10.1073/pnas.91.21.9794; Williams Norris H., 2001, Lindleyana, V16, P113; Wu CS, 2009, MOL PHYLOGENET EVOL, V52, P115, DOI 10.1016/j.ympev.2008.12.026; Wu FH, 2009, TREE PHYSIOL, V29, P847, DOI 10.1093/treephys/tpp015; Wu FH, 2010, BMC PLANT BIOL, V10, DOI 10.1186/1471-2229-10-68; Wyman SK, 2004, BIOINFORMATICS, V20, P3252, DOI 10.1093/bioinformatics/bth352; You SJ, 2003, PLANTA, V217, P60, DOI 10.1007/s00425-002-0970-7; Zhang Y, 2011, PLOS ONE, V6, DOI [10.1371/journal.pone.0021342, 10.1371/journal.pone.0020596]; Zhang Y, 2008, MAR BIOTECHNOL, V10, P358, DOI 10.1007/s10126-007-9071-8	63	48	49	0	49	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 4	2012	7	4							e34738	10.1371/journal.pone.0034738	http://dx.doi.org/10.1371/journal.pone.0034738			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	953GO	22496851	Green Published, gold, Green Submitted			2022-12-25	WOS:000304855200073
J	Lopez-Fernandez, H; Winemiller, KO; Montana, C; Honeycutt, RL				Lopez-Fernandez, Hernan; Winemiller, Kirk O.; Montana, Carmen; Honeycutt, Rodney L.			Diet-Morphology Correlations in the Radiation of South American Geophagine Cichlids (Perciformes: Cichlidae: Cichlinae)	PLOS ONE			English	Article							ECOMORPHOLOGICAL DIVERSIFICATION; MOLECULAR PHYLOGENY; ADAPTIVE RADIATION; ECOLOGICAL LIMITS; TELEOSTEI; EVOLUTION; GYMNOGEOPHAGUS; CONVERGENCE; MECHANICS; FISHES	Genera within the South American cichlid tribe Geophagini display specialized feeding and reproductive strategies, with some taxa specialized for both substrate sifting and mouth brooding. Several lineages within the clade also possess an epibranchial lobe (EBL), a unique pharyngeal structure that has been proposed to have a function in feeding and/or mouth brooding. A recently published genus-level phylogeny of Neotropical cichlids was used as the evolutionary framework for investigating the evolution of morphological features presumably correlated with diet and mouth brooding in the tribe Geophagini. We tested for possible associations between the geophagine epibranchial lobe and benthic feeding and mouth brooding. We also addressed whether the Eft.. may be associated with unique patterns of diversification in certain geophagine clades. Tests of binary character correlations revealed the EBL was significantly associated with mouth brooding. We also tested for a relationship between diet and morphology. We analyzed stomach contents and morphometric variation among 21 species, with data for two additional species obtained from the literature. Principal Components Analysis revealed axes of morphological variation significantly correlated with piscivory and benthivory, and both morphology and diet were significantly associated with phylogeny. These results suggest that the EBL could be an adaptation for either feeding or mouth brooding. The EBL, however, was not associated with species richness or accelerated rates of phyletic diversification.	[Lopez-Fernandez, Hernan] Royal Ontario Museum, Dept Nat Hist, Toronto, ON M5S 2C6, Canada; [Lopez-Fernandez, Hernan] Univ Toronto, Dept Ecol & Evolutionary Biol, Toronto, ON, Canada; [Winemiller, Kirk O.; Montana, Carmen] Texas A&M Univ, Dept Wildlife & Fisheries Sci, Sect Ecol Evolut & Systemat, College Stn, TX 77843 USA; [Honeycutt, Rodney L.] Pepperdine Univ, Div Nat Sci, Malibu, CA 90265 USA	Royal Ontario Museum; University of Toronto; Texas A&M University System; Texas A&M University College Station; Pepperdine University	Lopez-Fernandez, H (corresponding author), Royal Ontario Museum, Dept Nat Hist, Toronto, ON M5S 2C6, Canada.	hernanl@rom.on.ca	Montana, Carmen/H-1387-2012	Winemiller, Kirk/0000-0003-0236-5129; Lopez-Fernandez, Hernan/0000-0003-0270-1671	United States National Science Foundation [DEB 0516831]; Natural Sciences and Engineering Research Council of Canada	United States National Science Foundation(National Science Foundation (NSF)); Natural Sciences and Engineering Research Council of Canada(Natural Sciences and Engineering Research Council of Canada (NSERC)CGIAR)	Funding for this project was provided by Grant DEB 0516831 from the United States National Science Foundation (www.nsf.gov) to KOW, RLH, and HLF and by a Discovery Grant from the Natural Sciences and Engineering Research Council of Canada (http://www.nserc-crsng.gc.ca/Index_eng.asp) to HLF. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abouheif E, 1999, EVOL ECOL RES, V1, P895; Albert JS, 2011, HISTORICAL BIOGEOGRAPHY OF NEOTROPICAL FRESHWATER FISHES, P21; Albert JS, 2011, HISTORICAL BIOGEOGRAPHY OF NEOTROPICAL FRESHWATER FISHES, P3; Albert JS, 2011, HISTORICAL BIOGEOGRAPHY OF NEOTROPICAL FRESHWATER FISHES, P1; BAREL CDN, 1983, NETH J ZOOL, V33, P357; Collar DC, 2009, EVOLUTION, V63, P1557, DOI 10.1111/j.1558-5646.2009.00626.x; DRUCKER EG, 1991, J MORPHOL, V210, P267, DOI 10.1002/jmor.1052100306; ESCALANTE A H, 1984, Limnobios, V2, P562; Farias IP, 1999, J MOL EVOL, V48, P703, DOI 10.1007/PL00006514; Farias IP, 2000, J EXP ZOOL, V288, P76, DOI 10.1002/(SICI)1097-010X(20000415)288:1&lt;76::AID-JEZ8&gt;3.0.CO;2-P; FELSENSTEIN J, 1985, AM NAT, V125, P1, DOI 10.1086/284325; GARLAND T, 1992, SYST BIOL, V41, P18, DOI 10.2307/2992503; Gavrilets S, 2009, SCIENCE, V323, P732, DOI 10.1126/science.1157966; Glaser U, 1996, SOUTHAMERICAN CICHLI; GLASER U., 1996, SOUTHAMERICAN CICHLI; Glaser U, 1996, SOUTHAMERICAN CICHLI; Glor RE, 2010, ANNU REV ECOL EVOL S, V41, P251, DOI 10.1146/annurev.ecolsys.39.110707.173447; Gonzalez-Bergonzoni I, 2009, NEOTROP ICHTHYOL, V7, P19, DOI 10.1590/S1679-62252009000100003; Greenwood P.H., 1987, B BRIT MUS NAT HIST, V53, P139; Haseman JD, 1911, CARNEGIE MUS, V7, P315; Hoorn C, AMAZONIA LANDSCAPE S; Hulsey CD, 2010, BMC EVOL BIOL, V10, DOI 10.1186/1471-2148-10-279; Hulsey CD, 2004, MOL PHYLOGENET EVOL, V31, P754, DOI 10.1016/j.ympev.2003.08.024; Hulsey CD, 2005, FUNCT ECOL, V19, P487, DOI 10.1111/j.1365-2435.2005.00987.x; JACKSON DA, 1995, ECOSCIENCE, V2, P297, DOI 10.1080/11956860.1995.11682297; Kaufman L.S., 1982, Breviora, P1; Kullander S. O., 2003, CLOFFSCA CHECK LIST, P39; KULLANDER S.O., 1989, CICHLIDS SURINAM; KULLANDER SO, 1989, J NAT HIST, V23, P225, DOI 10.1080/00222938900770131; Kullander SO, 1986, CICHLID FISHES AMAZO; Kullander Sven O., 1998, P461; LAUR DR, 1983, ENVIRON BIOL FISH, V8, P217, DOI 10.1007/BF00001087; LIEM KF, 1986, COPEIA, P311, DOI 10.2307/1444992; Lopez-Fernandez H, 2005, ZOOL SCR, V34, P627, DOI 10.1111/j.1463-6409.2005.00209.x; Lopez-Fernandez H, 2005, MOL PHYLOGENET EVOL, V34, P227, DOI 10.1016/j.ympev.2004.09.004; Lopez-Fernandez H, 2004, ZOOTAXA, P1; Lopez-Fernandez H, 2011, HISTORICAL BIOGEOGRAPHY OF NEOTROPICAL FRESHWATER FISHES, P105; Lopez-Fernandez H, 2010, MOL PHYLOGENET EVOL, V55, P1070, DOI 10.1016/j.ympev.2010.02.020; Lowe-McConnell RH, 1991, CICHLID FISHES BEHAV, P62; Lundberg John G., 1998, P13; Lundberg JG, 2010, AMAZONIA: LANDSCAPE AND SPECIES EVOLUTION: A LOOK INTO THE PAST, P281; Lundberg John G., 1998, P49; Maddison, 2019, MESQUITE MODULAR SYS; Malabarba MC, 2010, J VERTEBR PALEONTOL, V30, P341, DOI 10.1080/02724631003618348; Midford P. E., 2005, PDAP PACKAGE MESQUIT; MITTER C, 1988, AM NAT, V132, P107, DOI 10.1086/284840; Montana CG, 2009, NEOTROP ICHTHYOL, V7, P267, DOI 10.1590/S1679-62252009000200019; Moreira Sandra Socorro, 2002, Acta Amazonica, V32, P691; MULLER M, 1984, Transactions of the Zoological Society of London, V37, P51; Musilova Z, 2009, J ZOOL SYST EVOL RES, V47, P234, DOI 10.1111/j.1439-0469.2009.00528.x; Musilova Z, 2008, MOL PHYLOGENET EVOL, V46, P659, DOI 10.1016/j.ympev.2007.10.011; NORTON SF, 1993, J EXP BIOL, V176, P11; PAGEL M, 1994, P ROY SOC B-BIOL SCI, V255, P37, DOI 10.1098/rspb.1994.0006; Pavoine S, 2008, THEOR POPUL BIOL, V73, P79, DOI 10.1016/j.tpb.2007.10.001; Peres-Neto PR, 2001, OECOLOGIA, V129, P169, DOI 10.1007/s004420100720; Rabosky DL, 2008, P ROY SOC B-BIOL SCI, V275, P2363, DOI 10.1098/rspb.2008.0630; Rabosky DL, 2007, P ROY SOC B-BIOL SCI, V274, P2915, DOI 10.1098/rspb.2007.0924; Rabosky DL, 2009, ECOL LETT, V12, P735, DOI 10.1111/j.1461-0248.2009.01333.x; Rabosky DL, 2009, AM NAT, V173, P662, DOI 10.1086/597378; Relyea RA, 2004, ECOLOGY, V85, P172, DOI 10.1890/03-0169; Rican O, 2008, MOL PHYLOGENET EVOL, V49, P941, DOI 10.1016/j.ympev.2008.07.022; Smith WL, 2008, CLADISTICS, V24, P625, DOI 10.1111/j.1096-0031.2008.00210.x; STIASSNY M L J, 1987, Bulletin of the Museum of Comparative Zoology, V151, P269; Wainwright PC, 2001, J EXP BIOL, V204, P3039; Wainwright PC, 2006, FISH PHYSIOL, V23, P77, DOI 10.1016/S1546-5098(05)23003-0; Weidner T., 2000, S AM EARTHEATERS; WINEMILLER KO, 1990, ECOL MONOGR, V60, P331, DOI 10.2307/1943061; WINEMILLER KO, 1991, ECOL MONOGR, V61, P343, DOI 10.2307/2937046; WINEMILLER KO, 1995, ENVIRON BIOL FISH, V44, P235, DOI 10.1007/BF00005919	69	55	55	0	32	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 2	2012	7	4							e33997	10.1371/journal.pone.0033997	http://dx.doi.org/10.1371/journal.pone.0033997			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	952GU	22485154	Green Published, Green Submitted, gold			2022-12-25	WOS:000304780500030
J	McLachlan, NM; Marco, DJT; Wilson, SJ				McLachlan, Neil M.; Marco, David J. T.; Wilson, Sarah J.			Pitch Enumeration: Failure to Subitize in Audition	PLOS ONE			English	Article							DISCRIMINATION; TONES; NUMBER; MODEL	Background. Subitizing involves recognition mechanisms that allow effortless enumeration of up to four visual objects however despite ample resolution experimental data suggest that only one pitch can be reliably enumerated. This may be due to the grouping of tones according to harmonic relationships by recognition mechanisms prior to fine pitch processing. Poorer frequency resolution of auditory information available to recognition mechanisms may lead to unrelated tones being grouped, resulting in underestimation of pitch number. Methods, Results and Conclusion; We tested whether pitch enumeration is better for chords of full harmonic complex tones, where grouping errors are less likely, than for complexes with fewer and less accurately tuned harmonics. Chords of low familiarity were used to mitigate the possibility that participants would recognize the chord itself and simply recall the number of bitches. We found that accuracy of pitch enumeration was less than the visual system overall, and underestimation of pitch number increased for stimuli containing fewer harmonics. We conclude that harmonically related tones are first grouped at the poorer frequency resolution of the auditory nerve, leading to poor enumeration of more than one pitch.	[McLachlan, Neil M.; Marco, David J. T.; Wilson, Sarah J.] Univ Melbourne, Sch Psychol Sci, Melbourne, Vic, Australia	University of Melbourne	McLachlan, NM (corresponding author), Univ Melbourne, Sch Psychol Sci, Melbourne, Vic, Australia.	mcln@unimelb.edu.au		Wilson, Professor Sarah/0000-0002-2678-1576; Marco, David/0000-0001-8634-3036	Australian Research Council [DP0665494]	Australian Research Council(Australian Research Council)	This research was funded by an Australian Research Council (http://www.arc.gov.au/) Discovery grant (DP0665494). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alain C, 2007, HEARING RES, V229, P225, DOI 10.1016/j.heares.2007.01.011; Assmann PF, 1998, J ACOUST SOC AM, V103, P1150, DOI 10.1121/1.421249; DEWITT LA, 1987, PERCEPT PSYCHOPHYS, V41, P73, DOI 10.3758/BF03208216; HOUTSMA AJM, 1990, J ACOUST SOC AM, V87, P304, DOI 10.1121/1.399297; KAUFMAN EL, 1949, AM J PSYCHOL, V62, P498, DOI 10.2307/1418556; Krumhansl C.L., 1990, COGNITIVE FDN MUSICA, P77; McLachlan N, 2003, J ACOUST SOC AM, V114, P505, DOI 10.1121/1.1575748; McLachlan N, 2010, PSYCHOL REV, V117, P175, DOI 10.1037/a0018063; McLachlan N, 2009, HEARING RES, V249, P23, DOI 10.1016/j.heares.2009.01.003; MOORE BCJ, 1973, J ACOUST SOC AM, V54, P610, DOI 10.1121/1.1913640; Moore BCJ, 1996, J ACOUST SOC AM, V99, P542, DOI 10.1121/1.414512; Parncutt R., 1989, HARMONY PSYCHOACOUST; Piazza M, 2002, NEUROIMAGE, V15, P435, DOI 10.1006/nimg.2001.0980; Seither-Preisler A, 2007, J EXP PSYCHOL HUMAN, V33, P743, DOI 10.1037/0096-1523.33.3.743; TAKEUCHI AH, 1993, PSYCHOL BULL, V113, P345, DOI 10.1037/0033-2909.113.2.345; TERHARDT E, 1974, J ACOUST SOC AM, V55, P1061, DOI 10.1121/1.1914648; THURLOW WR, 1959, J ACOUST SOC AM, V31, P1332, DOI 10.1121/1.1907630; Vetter P, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0003269; Ward R, 1954, J ACOUST SOC AM, V26, P520; Wender KF, 2000, PSYCHOL RES-PSYCH FO, V64, P81, DOI 10.1007/s004260000021	20	6	6	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 2	2012	7	4							e33661	10.1371/journal.pone.0033661	http://dx.doi.org/10.1371/journal.pone.0033661			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	952GU	22485148	Green Published, gold			2022-12-25	WOS:000304780500024
J	Schuessler, DL; Parish, T				Schuessler, Dorothee L.; Parish, Tanya			The Promoter of Rv0560c Is Induced by Salicylate and Structurally-Related Compounds in Mycobacterium tuberculosis	PLOS ONE			English	Article							INDUCIBLE GENE-REGULATION; EXPRESSION; IRON; IDENTIFICATION; SIDEROPHORE; RESISTANCE; INSIGHTS; GROWTH; TRANSPORT; VIRULENCE	Mycobacterium tuberculosis, the causative agent of tuberculosis (TB), is a major global health threat. During infection, bacteria are believed to encounter adverse conditions such as iron depletion. Mycobacteria synthesize iron-sequestering mycobactins, which are essential for survival in the host, via the intermediate salicylate. Salicylate is a ubiquitous compound which is known to induce a mild antibiotic resistance phenotype. In M. tuberculosis salicylate highly induces the expression of Rv0560c, a putative methyltransferase. We identified and characterized the promoter and regulatory elements of Rv0560c. P-Rv0560c activity was highly inducible by salicylate in a dose-dependent manner. The induction kinetics of P-Rv0560c were slow, taking several days to reach maximal activity, which was sustained over several weeks. Promoter activity could also be induced by compounds structurally related to salicylate, such as aspirin or para-aminosalicylic acid, but not by benzoate, indicating that induction is specific to a structural motif. The -10 and -35 promoter elements were identified and residues involved in regulation of Promoter activity were identified in close Proximity to an inverted repeat spanning the -35 promoter element. We conclude that Rv0560c expression is controlled by a yet unknown repressor via a highly inducible promoter.	[Schuessler, Dorothee L.; Parish, Tanya] Queen Mary Univ London, Barts & London Sch Med & Dent, London, England	University of London; Queen Mary University London	Schuessler, DL (corresponding author), MRC Natl Inst Med Res, London, England.	t.parish@qmul.ac.uk			European Union [LSHP-CT-2005-018923]	European Union(European Commission)	This work was funded by the European Union Project LSHP-CT-2005-018923. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Agarwal N, 2003, FEMS MICROBIOL LETT, V225, P75, DOI 10.1016/S0378-1097(03)00483-X; Agarwal N, 2006, MICROBIOL-SGM, V152, P2749, DOI 10.1099/mic.0.28924-0; Alekshun MN, 1997, ANTIMICROB AGENTS CH, V41, P2067, DOI 10.1128/AAC.41.10.2067; Amin AG, 2008, MICROBIOL-SGM, V154, P240, DOI 10.1099/mic.0.2007/012153-0; Bacon J, 2007, MICROBIOL-SGM, V153, P1435, DOI 10.1099/mic.0.2006/004317-0; Balazsi G, 2008, MOL SYST BIOL, V4, DOI 10.1038/msb.2008.63; BARCLAY R, 1988, J GEN MICROBIOL, V134, P771; Bashyam MD, 1998, J BACTERIOL, V180, P2568, DOI 10.1128/JB.180.9.2568-2573.1998; Blokpoel MCJ, 2005, NUCLEIC ACIDS RES, V33, DOI 10.1093/nar/gni023; Blokpoel MCJ, 2003, J MICROBIOL METH, V54, P203, DOI 10.1016/S0167-7012(03)00044-7; Carroll P, 2005, APPL ENVIRON MICROB, V71, P3077, DOI 10.1128/AEM.71.6.3077-3084.2005; Carroll P, 2008, ASSAYING PROMOTER AC, P265; Carroll P, 2011, APPL ENVIRON MICROB, V77, P5040, DOI 10.1128/AEM.02880-10; Carroll P, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0009823; Chauhan S, 2011, NUCLEIC ACIDS RES, V39, P7400, DOI 10.1093/nar/gkr375; Cole ST, 1998, NATURE, V393, P537, DOI 10.1038/31159; COLLINS MD, 1981, MICROBIOL REV, V45, P316, DOI 10.1128/MMBR.45.2.316-354.1981; COLLINS MD, 1977, J GEN MICROBIOL, V100, P221, DOI 10.1099/00221287-100-2-221; De Voss JJ, 2000, P NATL ACAD SCI USA, V97, P1252, DOI 10.1073/pnas.97.3.1252; Denkin S, 2005, ARCH MICROBIOL, V184, P152, DOI 10.1007/s00203-005-0037-9; Dussurget O, 1999, J BACTERIOL, V181, P3402, DOI 10.1128/JB.181.11.3402-3408.1999; Ehrt S, 2005, NUCLEIC ACIDS RES, V33, DOI 10.1093/nar/gni013; Fivian-Hughes AS, 2010, J BACTERIOL, V192, P4348, DOI 10.1128/JB.00454-10; Forti F, 2009, J BIOTECHNOL, V140, P270, DOI 10.1016/j.jbiotec.2009.02.001; Garbe TR, 2004, CAN J MICROBIOL, V50, P771, DOI 10.1139/W04-067; Gustafson JE, 1999, ANTIMICROB AGENTS CH, V43, P990, DOI 10.1128/AAC.43.4.990; Harrison AJ, 2006, J BACTERIOL, V188, P6081, DOI 10.1128/JB.00338-06; Honaker RW, 2010, J BACTERIOL, V192, P6447, DOI 10.1128/JB.00978-10; Hotsclaw CM, 2008, ACS CHEM BIOL, V3, P619, DOI 10.1021/cb800145r; Kurosu M, 2009, MED CHEM, V5, P197, DOI 10.2174/157340609787582882; Manganelli R, 2004, J BACTERIOL, V186, P895, DOI 10.1128/JB.186.4.895-902.2004; Miller JH, EXPT MOL GENETICS; Papavinasasundaram KG, 2001, MICROBIOL-SGM, V147, P3271, DOI 10.1099/00221287-147-12-3271; Parish T, 1998, METH MOL B, V101, P129, DOI 10.1385/0-89603-471-2:129; Pomposiello PJ, 2001, J BACTERIOL, V183, P3890, DOI 10.1128/JB.183.13.3890-3902.2001; Price CTD, 2000, INT J BIOCHEM CELL B, V32, P1029, DOI 10.1016/S1357-2725(00)00042-X; Quadri LEN, 1998, CHEM BIOL, V5, P631, DOI 10.1016/S1074-5521(98)90291-5; Ratledge C, 2004, TUBERCULOSIS, V84, P110, DOI 10.1016/j.tube.2003.08.012; RATLEDGE C, 1962, BIOCHEM J, V84, P501, DOI 10.1042/bj0840501; Ratledge C, 1996, MICROBIOL-UK, V142, P2207, DOI 10.1099/13500872-142-8-2207; RATLEDGE C, 1972, BIOCHIM BIOPHYS ACTA, V279, P58, DOI 10.1016/0304-4165(72)90241-3; Rickman L, 2005, MOL MICROBIOL, V56, P1274, DOI 10.1111/j.1365-2958.2005.04609.x; Rodriguez GM, 2002, INFECT IMMUN, V70, P3371, DOI 10.1128/IAI.70.7.3371-3381.2002; ROSNER JL, 1985, P NATL ACAD SCI USA, V82, P8771, DOI 10.1073/pnas.82.24.8771; Russell DG, 2010, SCIENCE, V328, P852, DOI 10.1126/science.1184784; Schaller A, 2002, ANTIMICROB AGENTS CH, V46, P2636, DOI 10.1128/AAC.46.8.2636-2639.2002; Schnappinger D, 2003, J EXP MED, V198, P693, DOI 10.1084/jem.20030846; Shen ZQ, 2011, APPL ENVIRON MICROB, V77, P7128, DOI 10.1128/AEM.00763-11; Starck J, 2004, MICROBIOL-SGM, V150, P3821, DOI 10.1099/mic.0.27284-0; Stcovart OR, 2005, MYCOBACTERIUM MOL MI, P245; Sun ZH, 2001, FEMS MICROBIOL LETT, V203, P211, DOI 10.1111/j.1574-6968.2001.tb10843.x; Triccas JA, 2001, MICROBIOL-SGM, V147, P1253, DOI 10.1099/00221287-147-5-1253; Ulrichs T, 2006, J PATHOL, V208, P261, DOI 10.1002/path.1906; Weinberg ED, 1999, J EUKARYOT MICROBIOL, V46, P231, DOI 10.1111/j.1550-7408.1999.tb05119.x; Weinberg ED, 2009, BBA-GEN SUBJECTS, V1790, P600, DOI 10.1016/j.bbagen.2008.07.002; Weinstein EA, 2005, P NATL ACAD SCI USA, V102, P4548, DOI 10.1073/pnas.0500469102; World Health Organization, 2009, GLOB TUB CONTR EP ST; Young M., 2005, MYCOBACTERIUM MOL MI, P265; Zwahlen J, 2007, BIOCHEMISTRY-US, V46, P954, DOI 10.1021/bi060852x	59	21	27	0	14	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 2	2012	7	4							e34471	10.1371/journal.pone.0034471	http://dx.doi.org/10.1371/journal.pone.0034471			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	952GU	22485172	Green Published, gold			2022-12-25	WOS:000304780500047
J	Palanisamy, GS; Kirk, NM; Ackart, DF; Obregon-Henao, A; Shanley, CA; Orme, IM; Basaraba, RJ				Palanisamy, Gopinath S.; Kirk, Natalie M.; Ackart, David F.; Obregon-Henao, Andres; Shanley, Crystal A.; Orme, Ian M.; Basaraba, Randall J.			Uptake and Accumulation of Oxidized Low-Density Lipoprotein during Mycobacterium tuberculosis Infection in Guinea Pigs	PLOS ONE			English	Article							SCAVENGER RECEPTOR CD36; GLYCATION END-PRODUCTS; PULMONARY TUBERCULOSIS; FOAMY MACROPHAGES; LECTIN-LIKE; MICE; ATHEROSCLEROSIS; CHOLESTEROL; LDL; FAMILY	The typical host response to infection of humans and some animals by M. tuberculosis is the accumulation of reactive oxygen species generating inflammatory cells into discrete granulomas, which frequently develop central caseous necrosis. In previous studies we showed that infection of immunologically naive guinea pigs with M. tuberculosis leads to localized and systemic oxidative stress that results in a significant depletion of serum total antioxidant capacity and the accumulation of malondialdehyde, a bi-product of lipid peroxidation. Here we show that in addition, the generation of excessive reactive oxygen species in vivo resulted in the accumulation of oxidized low density lipoproteins (OxLDL) in pulmonary and extrapulmonary granulomas, serum and lung macrophages collected by bronchoalveolar lavage. Macrophages from immunologically naive guinea pigs infected with M. tuberculosis also had increased surface expression of the type 1 scavenger receptors CD36 and LOX1, which facilitate the uptake of oxidized host macromolecules including OxLDL. Vaccination of guinea pigs with Bacillus Calmette Guerin (BCG) prior to aerosol challenge reduced the bacterial burden as well as the intracellular accumulation of OxLDL and the expression of macrophage CD36 and LOX1. In vitro loading of guinea pig lung macrophages with OxLDL resulted in enhanced replication of bacilli compared to macrophages loaded with non-oxidized LDL. Overall, this study provides additional evidence of oxidative stress in M. tuberculosis infected guinea pigs and the potential role OxLDL laden macrophages have in supporting intracellular bacilli survival and persistence.	[Palanisamy, Gopinath S.; Kirk, Natalie M.; Ackart, David F.; Obregon-Henao, Andres; Shanley, Crystal A.; Orme, Ian M.; Basaraba, Randall J.] Colorado State Univ, Dept Microbiol Immunol & Pathol, Ft Collins, CO 80523 USA	Colorado State University	Palanisamy, GS (corresponding author), Colorado State Univ, Dept Microbiol Immunol & Pathol, Ft Collins, CO 80523 USA.	Randall.Basaraba@colostate.edu			National Institutes of Health [AI070456, AI083856]; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R21AI083856, U01AI070456] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	This study was supported by National Institutes of Health grants AI070456 (RJB) and AI083856 (IMO). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Basaraba RJ, 2008, TUBERCULOSIS, V88, P69, DOI 10.1016/j.tube.2007.09.002; Canetti G., 1955, TUBERCLE BACILLUS PU; Chen MJ, 2002, PHARMACOL THERAPEUT, V95, P89, DOI 10.1016/S0163-7258(02)00236-X; Chen XP, 2008, CELL BIOCHEM FUNCT, V26, P760, DOI 10.1002/cbf.1502; D'Avila H, 2008, CELL MICROBIOL, V10, P2589, DOI 10.1111/j.1462-5822.2008.01233.x; Esterbauer H, 1996, REV PHYSIOL BIOCH P, V127, P31, DOI 10.1007/BFb0048264; Febbraio M, 2000, J CLIN INVEST, V105, P1049, DOI 10.1172/JCI9259; Febbraio M, 2001, J CLIN INVEST, V108, P785, DOI 10.1172/JCI200114006; Galkina E, 2009, ANNU REV IMMUNOL, V27, P165, DOI 10.1146/annurev.immunol.021908.132620; Gatfield J, 2000, SCIENCE, V288, P1647, DOI 10.1126/science.288.5471.1647; Hunter RL, 2007, TUBERCULOSIS, V87, P267, DOI 10.1016/j.tube.2006.11.003; Kalayoglu MV, 1998, J INFECT DIS, V177, P725, DOI 10.1086/514241; Kwiatkowska S, 1999, RESP MED, V93, P272, DOI 10.1016/S0954-6111(99)90024-0; Larnsal Madhab, 2007, Southeast Asian Journal of Tropical Medicine and Public Health, V38, P695; Lenaerts AJ, 2007, ANTIMICROB AGENTS CH, V51, P3338, DOI 10.1128/AAC.00276-07; Matsunaga I, 2009, ANAL BIOCHEM, V393, P222, DOI 10.1016/j.ab.2009.06.032; McKinney JD, 2000, NATURE, V406, P735, DOI 10.1038/35021074; McMurray David N., 1994, P135; McNamara JR, 1996, J LIPID RES, V37, P1924; Mehta JL, 2007, CIRC RES, V100, P1634, DOI 10.1161/CIRCRESAHA.107.149724; Mehta JL, 2006, CARDIOVASC RES, V69, P36, DOI 10.1016/j.cardiores.2005.09.006; Miner MD, 2009, INDIAN J EXP BIOL, V47, P407; Ohgami N, 2001, J BIOL CHEM, V276, P3195, DOI 10.1074/jbc.M006545200; Ordway D, 2005, J IMMUNOL, V175, P3873, DOI 10.4049/jimmunol.175.6.3873; Ordway D, 2008, CLIN VACCINE IMMUNOL, V15, P1248, DOI 10.1128/CVI.00019-08; Ordway DJ, 2010, ANTIMICROB AGENTS CH, V54, P1820, DOI 10.1128/AAC.01521-09; Palanisamy GS, 2008, TUBERCULOSIS, V88, P295, DOI 10.1016/j.tube.2007.12.003; Palanisamy GS, 2011, PLOS ONE UNPUB; Pandey AK, 2008, P NATL ACAD SCI USA, V105, P4376, DOI 10.1073/pnas.0711159105; Peyron P, 2008, PLOS PATHOG, V4, DOI 10.1371/journal.ppat.1000204; Philips JA, 2005, SCIENCE, V309, P1251, DOI 10.1126/science.1116006; Podrez EA, 1999, J CLIN INVEST, V103, P1547, DOI 10.1172/JCI5549; Podrez EA, 2000, J CLIN INVEST, V105, P1095, DOI 10.1172/JCI8574; Podrez EA, 2007, NAT MED, V13, P1086, DOI 10.1038/nm1626; Rachman H, 2006, PLOS ONE, V1, DOI 10.1371/journal.pone.0000029; Rhoades ER, 1997, TUBERCLE LUNG DIS, V78, P57, DOI 10.1016/S0962-8479(97)90016-2; Rodriguez IR, 2004, INVEST OPHTH VIS SCI, V45, P2830, DOI 10.1167/iovs.04-0075; Russell DG, 2009, NAT IMMUNOL, V10, P943, DOI 10.1038/ni.1781; SMITH DW, 1970, AM REV RESPIR DIS, V102, P937; Steinberg D, 2005, MOL NUTR FOOD RES, V49, P995, DOI 10.1002/mnfr.200500081; TENG B, 1983, P NATL ACAD SCI-BIOL, V80, P6662, DOI 10.1073/pnas.80.21.6662; VIRCHOW R, 1989, NUTR REV, V47, P23; Wolschendorf F, 2011, P NATL ACAD SCI USA, V108, P1621, DOI 10.1073/pnas.1009261108; World Health Organization, 2009, GLOB TUB CONTR EP ST; Yam KC, 2009, PLOS PATHOG, V5, DOI 10.1371/journal.ppat.1000344	45	29	35	1	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 30	2012	7	3							e34148	10.1371/journal.pone.0034148	http://dx.doi.org/10.1371/journal.pone.0034148			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	959UC	22493658	gold, Green Published, Green Submitted			2022-12-25	WOS:000305339100124
J	Onuma, TA; Duan, CM				Onuma, Takeshi A.; Duan, Cunming			Duplicated Kiss1 receptor genes in zebrafish: distinct gene expression patterns, different ligand selectivity, and a novel nuclear isoform with transactivating activity	FASEB JOURNAL			English	Article						alternative splicing; nuclear localization	BINDING PROTEIN-5; GNRH NEURONS; HORMONE; GPR54; KISSPEPTIN; GROWTH; ACTIVATION; IDENTIFICATION; HYPOGONADISM; REGULATOR	The kisspeptin (KISS1) and Kiss1 receptor (Kiss1r) pathway plays a central role in the neuroendocrine control of reproduction. In contrast to humans and mammals that have a single Kiss1 gene and a single Kiss1r gene, multiple Kiss ligand and receptor genes are found in nonmammalian vertebrates. Their functional relationship, however, is poorly understood. Here, we report that the duplicated zebrafish kiss1r genes have evolved a distinct gene expression pattern, different ligand selectivity, and novel nuclear isoforms. While a single kiss1ra mRNA was detected exclusively in the brain, 5 kiss1rb transcripts were found in many peripheral tissues. Functional assays showed that kiss1ra encodes a receptor activated by both Kiss1 and Kiss2, while kiss1rb encodes a receptor that has a preference for Kiss1. The four alternatively spliced kiss1rb mRNAs encoded 4 truncated isoforms, denoted kiss1rb-derived protein (KRBDP) 1-4. When their subcellular localization was examined, KRBDP3 and KRBDP4 were found in the nucleus in cultured mammalian cells and in zebrafish embryos. One-hybrid transcription activation assays revealed that KRBDP3, but not KRBDP4, possesses ligand-independent transactivation activity. These findings highlight how the duplication of Kiss1r genes may facilitate their adaptation of specialized functions. The discovery of a nuclear Kiss1r isoform raises the possibility of novel function of Kiss1r in the nucleus.-Onuma, T. A., Duan, C. Duplicated Kiss1 receptor genes in zebrafish: distinct gene expression patterns, different ligand selectivity, and a novel nuclear isoform with transactivating activity. FASEB J. 26, 2941-2950 (2012). www.fasebj.org	[Onuma, Takeshi A.; Duan, Cunming] Univ Michigan, Dept Mol Cellular & Dev Biol, Ann Arbor, MI 48109 USA	University of Michigan System; University of Michigan	Duan, CM (corresponding author), Univ Michigan, Dept Mol Cellular & Dev Biol, Ann Arbor, MI 48109 USA.	cduan@umich.edu	Onuma, Takeshi A/L-2702-2017		National Science Foundation [IOB-0543018, IOS-1051034]; Japan Society for the Promotion of Science [2009159]; Direct For Biological Sciences [1051034] Funding Source: National Science Foundation	National Science Foundation(National Science Foundation (NSF)); Japan Society for the Promotion of Science(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of Science); Direct For Biological Sciences(National Science Foundation (NSF)NSF - Directorate for Biological Sciences (BIO))	The authors thank Andrea Lynema and Sarah Gaubatz (University of Michigan) for proofreading this manuscript. The authors thank Dr. Alfonso Saera-Vila for reading and commenting on an early version of this manuscript. The authors are grateful to Drs. Pamela Mellon, (University of California-San Diego, La Jolla, CA, USA) and Jessica Schwartz (University of Michigan) for providing important reagents. This work was supported in part by National Science Foundation grants IOB-0543018 and IOS-1051034 to C. D. T.A.O. was supported in part by an Oversea Research Fellowship (#2009159) from the Japan Society for the Promotion of Science.	Abraham E, 2008, J NEUROENDOCRINOL, V20, P394, DOI 10.1111/j.1365-2826.2008.01654.x; Abraham E, 2010, ENDOCRINOLOGY, V151, P332, DOI 10.1210/en.2009-0548; Akazome Y, 2010, J FISH BIOL, V76, P161, DOI 10.1111/j.1095-8649.2009.02496.x; Apaja PM, 2006, MOL BIOL CELL, V17, P2243, DOI 10.1091/mbc.E05-09-0875; Biran J, 2008, BIOL REPROD, V79, P776, DOI 10.1095/biolreprod.107.066266; Brothers SP, 2004, MOL ENDOCRINOL, V18, P1787, DOI 10.1210/me.2004-0091; Castano JP, 2009, PEPTIDES, V30, P10, DOI 10.1016/j.peptides.2008.07.025; d'Anglemont de Tassigny X, 2007, P NATL ACAD SCI USA, V104, P10714, DOI 10.1073/pnas.0704114104; de Roux N, 2003, P NATL ACAD SCI USA, V100, P10972, DOI 10.1073/pnas.1834399100; Felip A, 2009, MOL CELL ENDOCRINOL, V312, P61, DOI 10.1016/j.mce.2008.11.017; Funes S, 2003, BIOCHEM BIOPH RES CO, V312, P1357, DOI 10.1016/j.bbrc.2003.11.066; Hauge-Evans AC, 2006, DIABETOLOGIA, V49, P2131, DOI 10.1007/s00125-006-0343-z; He XL, 2005, GENETICS, V169, P1157, DOI 10.1534/genetics.104.037051; Irwig MS, 2004, NEUROENDOCRINOLOGY, V80, P264, DOI 10.1159/000083140; Kajimura S, 2005, P NATL ACAD SCI USA, V102, P1240, DOI 10.1073/pnas.0407443102; Kitahashi T, 2009, ENDOCRINOLOGY, V150, P821, DOI 10.1210/en.2008-0940; Lapatto R, 2007, ENDOCRINOLOGY, V148, P4927, DOI 10.1210/en.2007-0078; Lee YR, 2009, ENDOCRINOLOGY, V150, P2837, DOI 10.1210/en.2008-1679; Liao JF, 1997, J BIOL CHEM, V272, P25951, DOI 10.1074/jbc.272.41.25951; Luan X, 2007, NEUROENDOCRINOLOGY, V86, P77, DOI 10.1159/000107511; Markovic D, 2007, ENDOCRINOLOGY, V148, P3205, DOI 10.1210/en.2007-0095; Markovic D, 2009, CELL MOL LIFE SCI, V66, P3337, DOI 10.1007/s00018-009-0093-4; Matsui H, 2004, BIOCHEM BIOPH RES CO, V320, P383, DOI 10.1016/j.bbrc.2004.05.185; Mayer C, 2011, NAT NEUROSCI, V14, P704, DOI 10.1038/nn.2818; McElvaine AT, 2006, ENDOCRINOLOGY, V147, P1884, DOI 10.1210/en.2005-1488; MELLON PL, 1990, NEURON, V5, P1, DOI 10.1016/0896-6273(90)90028-E; Messager S, 2005, P NATL ACAD SCI USA, V102, P1761, DOI 10.1073/pnas.0409330102; Millar RP, 2004, ENDOCR REV, V25, P235, DOI 10.1210/er.2003-0002; Nakamura Y, 2007, REPROD SCI, V14, P836, DOI 10.1177/1933719107307823; Navarro VM, 2004, J PHYSIOL-LONDON, V561, P379, DOI 10.1113/jphysiol.2004.072298; Oakley AE, 2009, ENDOCR REV, V30, P713, DOI 10.1210/er.2009-0005; Pineda R, 2010, ENDOCRINOLOGY, V151, P722, DOI 10.1210/en.2009-0803; Pisarchik A, 2001, FASEB J, V15, P2754, DOI 10.1096/fj.01-0487fje; Popa SM, 2008, ANNU REV PHYSIOL, V70, P213, DOI 10.1146/annurev.physiol.70.113006.100540; Schwartz TW, 2006, ANNU REV PHARMACOL, V46, P481, DOI 10.1146/annurev.pharmtox.46.120604.141218; Seminara SB, 2003, NEW ENGL J MED, V349, P1614, DOI 10.1056/NEJMoa035322; Servili A, 2011, ENDOCRINOLOGY, V152, P1527, DOI 10.1210/en.2010-0948; Silveira LG, 2010, J CLIN ENDOCR METAB, V95, P2276, DOI 10.1210/jc.2009-2421; Sower SA, 2009, GEN COMP ENDOCR, V161, P20, DOI 10.1016/j.ygcen.2008.11.023; Teles MG, 2008, NEW ENGL J MED, V358, P709, DOI 10.1056/NEJMoa073443; Tsutsui K, 2010, J NEUROENDOCRINOL, V22, P716, DOI 10.1111/j.1365-2826.2010.02018.x; van Aerle R, 2008, PEPTIDES, V29, P57, DOI 10.1016/j.peptides.2007.10.018; Wahab F, 2010, HORM METAB RES, V42, P570, DOI 10.1055/s-0030-1252016; Xu QJ, 2004, CIRC RES, V94, pE46, DOI 10.1161/01.RES.0000124761.62846.DF; Yi TF, 2010, J BIOL CHEM, V285, P17811, DOI 10.1074/jbc.M110.130740; Zhao Y, 2006, J BIOL CHEM, V281, P14184, DOI 10.1074/jbc.M506941200; Zmijewski MA, 2009, J CELL PHYSIOL, V218, P593, DOI 10.1002/jcp.21632; Zohar Y, 2010, GEN COMP ENDOCR, V165, P438, DOI 10.1016/j.ygcen.2009.04.017	48	21	22	0	7	FEDERATION AMER SOC EXP BIOL	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3998 USA	0892-6638	1530-6860		FASEB J	Faseb J.	JUL	2012	26	7					2941	2950		10.1096/fj.11-201095	http://dx.doi.org/10.1096/fj.11-201095			10	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	967MP	22499582	Green Submitted			2022-12-25	WOS:000305912500022
J	Okayasu, M; Nakayachi, M; Hayashida, C; Ito, J; Kaneda, T; Masuhara, M; Suda, N; Sato, T; Hakeda, Y				Okayasu, Mari; Nakayachi, Mai; Hayashida, Chiyomi; Ito, Junta; Kaneda, Toshio; Masuhara, Masaaki; Suda, Naoto; Sato, Takuya; Hakeda, Yoshiyuki			Low-density Lipoprotein Receptor Deficiency Causes Impaired Osteoclastogenesis and Increased Bone Mass in Mice because of Defect in Osteoclastic Cell-Cell Fusion	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							KAPPA-B LIGAND; COLONY-STIMULATING FACTOR; POSTMENOPAUSAL WOMEN; ENDOTHELIAL-CELLS; IN-VITRO; DC-STAMP; MEVALONATE PATHWAY; SIGNALING COMPLEX; PLASMA-MEMBRANES; FAMILY-MEMBER	Osteoporosis is associated with both atherosclerosis and vascular calcification attributed to hyperlipidemia. However, the cellular and molecular mechanisms explaining the parallel progression of these diseases remain unclear. Here, we used low-density lipoprotein receptor knockout (LDLR-/-) mice to elucidate the role of LDLR in regulating the differentiation of osteoclasts, which are responsible for bone resorption. Culturing wild-type osteoclast precursors in medium containing LDL-depleted serum decreased receptor activator of NF-kappa B ligand (RANKL)-induced osteoclast formation, and this defect was additively rescued by simultaneous treatment with native and oxidized LDLs. Osteoclast precursors constitutively expressed LDLR in a RANKL-independent manner. Osteoclast formation from LDLR-/- osteoclast precursors was delayed, and the multinucleated cells formed in culture were smaller and contained fewer nuclei than wild-type cells, implying impaired cell-cell fusion. Despite these findings, RANK signaling, including the activation of Erk and Akt, was normal in LDLR-/- preosteoclasts, and RANKL-induced expression of NFATc1 (a master regulator of osteoclastogenesis), cathepsin K, and tartrate-resistant acid phosphatase was equivalent in LDLR-null and wild-type cells. In contrast, the amounts of the osteoclast fusion-related proteins v-ATPase V-o subunit d2 and dendritic cell-specific transmembrane protein in LDLR-/- plasma membranes were reduced when compared with the wild type, suggesting a correlation with impaired cell-cell fusion, which occurs on the plasma membrane. LDLR-/- mice consistently exhibited increased bone mass in vivo. This change was accompanied by decreases in bone resorption parameters, with no changes in bone formation parameters. These findings provide a novel mechanism for osteoclast differentiation and improve the understanding of the correlation between osteoclast formation and lipids.	[Okayasu, Mari; Nakayachi, Mai; Hayashida, Chiyomi; Ito, Junta; Masuhara, Masaaki; Sato, Takuya; Hakeda, Yoshiyuki] Meikai Univ, Sch Dent, Dept Human Dev & Fostering, Div Oral Anat, Sakado, Saitama 3500283, Japan; [Okayasu, Mari; Nakayachi, Mai; Suda, Naoto] Meikai Univ, Sch Dent, Dept Human Dev & Fostering, Div Orthodont, Sakado, Saitama 3500283, Japan; [Okayasu, Mari] Tokyo Univ Hosp, Dept Sensory & Motor Syst Med, Div Oral Maxillofacial Surg Dent & Orthodont, Tokyo 1138655, Japan; [Kaneda, Toshio] Hoshi Univ, Fac Pharmaceut Sci, Tokyo 1428501, Japan; [Masuhara, Masaaki] Kagoshima Univ, Fac Dent, Dept Appl Pharmacol, Kagoshima 8908544, Japan	Meikai University; Meikai University; University of Tokyo; Hoshi University; Kagoshima University	Hakeda, Y (corresponding author), Meikai Univ, Sch Dent, Div Oral Anat, Sakado, Saitama 350283, Japan.	y-hakeda@dent.meikai.ac.jp			Japanese Ministry of Education, Science, Sports, and Culture [19592130, 21592341]	Japanese Ministry of Education, Science, Sports, and Culture(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT))	This work was supported by Japanese Ministry of Education, Science, Sports, and Culture Grants-in-aid for scientific research 19592130 and 21592341 (to Y. H.).	Anzinger JJ, 2010, ARTERIOSCL THROM VAS, V30, P2022, DOI 10.1161/ATVBAHA.110.210849; Asagiri M, 2007, BONE, V40, P251, DOI 10.1016/j.bone.2006.09.023; BANKS LM, 1994, EUR J CLIN INVEST, V24, P813, DOI 10.1111/j.1365-2362.1994.tb02024.x; Barengolts EI, 1998, CALCIFIED TISSUE INT, V62, P209, DOI 10.1007/s002239900419; Bastiaanse EML, 1997, CARDIOVASC RES, V33, P272, DOI 10.1016/S0008-6363(96)00193-9; Bergstrom JD, 2000, ARCH BIOCHEM BIOPHYS, V373, P231, DOI 10.1006/abbi.1999.1502; BROWN MS, 1980, J LIPID RES, V21, P505; Buhagiar KA, 2004, AM J PHYSIOL-CELL PH, V286, pC398, DOI 10.1152/ajpcell.00016.2003; Chiu YH, 2012, J BONE MINER RES, V27, P79, DOI 10.1002/jbmr.531; Diascro DD, 1998, J BONE MINER RES, V13, P96, DOI 10.1359/jbmr.1998.13.1.96; Fisher JE, 1999, P NATL ACAD SCI USA, V96, P133, DOI 10.1073/pnas.96.1.133; Friesen JA, 2004, GENOME BIOL, V5, DOI 10.1186/gb-2004-5-11-248; Fuller K, 1998, J EXP MED, V188, P997, DOI 10.1084/jem.188.5.997; GOLDSTEIN JL, 1990, NATURE, V343, P425, DOI 10.1038/343425a0; Goldstein JL, 2009, ARTERIOSCL THROM VAS, V29, P431, DOI 10.1161/ATVBAHA.108.179564; Grasser W. A., 2003, Journal of Musculoskeletal & Neuronal Interactions, V3, P53; Hada N, 2012, BONE, V50, P226, DOI 10.1016/j.bone.2011.10.028; Hartgers FC, 2000, EUR J IMMUNOL, V30, P3585, DOI 10.1002/1521-4141(200012)30:12<3585::AID-IMMU3585>3.0.CO;2-Y; INAOKA T, 1995, BIOCHEM BIOPH RES CO, V206, P89, DOI 10.1006/bbrc.1995.1013; ISHIBASHI S, 1993, J CLIN INVEST, V92, P883, DOI 10.1172/JCI116663; Ishida N, 2002, J BIOL CHEM, V277, P41147, DOI 10.1074/jbc.M205063200; Jobling MG, 2002, INFECT IMMUN, V70, P1260, DOI 10.1128/IAI.70.3.1260-1271.2002; Kaneda T, 2000, J IMMUNOL, V165, P4254, DOI 10.4049/jimmunol.165.8.4254; Kim T, 2009, BIOCHEM BIOPH RES CO, V390, P585, DOI 10.1016/j.bbrc.2009.10.010; KURIHARA N, 1989, BLOOD, V74, P1295; Lacey DL, 1998, CELL, V93, P165, DOI 10.1016/S0092-8674(00)81569-X; Lange Y, 2008, J BIOL CHEM, V283, P1445, DOI 10.1074/jbc.M706967200; Lee SE, 2001, J BIOL CHEM, V276, P49343, DOI 10.1074/jbc.M103642200; Lee SH, 2006, NAT MED, V12, P1403, DOI 10.1038/nm1514; Luegmayr E, 2004, CELL DEATH DIFFER, V11, pS108, DOI 10.1038/sj.cdd.4401399; Matsuo K, 2000, NAT GENET, V24, P184, DOI 10.1038/72855; Mensah KA, 2010, J CELL PHYSIOL, V223, P76, DOI 10.1002/jcp.22012; Miyamoto H., 2012, J BONE MINE IN PRESS; Miyazaki T, 2000, J CELL BIOL, V148, P333, DOI 10.1083/jcb.148.2.333; Mizukami J, 2002, MOL CELL BIOL, V22, P992, DOI 10.1128/MCB.22.4.992-1000.2002; Mouritsen OG, 2004, LIPIDS, V39, P1101, DOI 10.1007/s11745-004-1336-x; Mundy G, 1999, SCIENCE, V286, P1946, DOI 10.1126/science.286.5446.1946; Nagao T, 2007, ARTERIOSCL THROM VAS, V27, P1596, DOI 10.1161/ATVBAHA.107.145086; Pani B, 2009, CELL CALCIUM, V45, P625, DOI 10.1016/j.ceca.2009.02.009; Parhami F, 1997, ARTERIOSCL THROM VAS, V17, P680, DOI 10.1161/01.ATV.17.4.680; Parhami F, 2001, J BONE MINER RES, V16, P182, DOI 10.1359/jbmr.2001.16.1.182; PINALS RS, 1972, LANCET, V2, P929; Prieto-Sanchez RM, 2006, ONCOGENE, V25, P2961, DOI 10.1038/sj.onc.1209333; Rodal SK, 1999, MOL BIOL CELL, V10, P961, DOI 10.1091/mbc.10.4.961; Rodan SB, 1997, J ENDOCRINOL, V154, pS47; Roodman GD, 1996, ENDOCR REV, V17, P308, DOI 10.1210/er.17.4.308; RUDNEY H, 1986, ANNU REV NUTR, V6, P245, DOI 10.1146/annurev.nu.06.070186.001333; Sato R, 1995, CELL STRUCT FUNCT, V20, P421, DOI 10.1247/csf.20.421; Sato T, 1998, BONE, V23, P135, DOI 10.1016/S8756-3282(98)00082-9; Smith AN, 2005, J AM SOC NEPHROL, V16, P1245, DOI 10.1681/ASN.2004090761; SUDA T, 1995, BONE, V17, pS87, DOI 10.1016/8756-3282(95)00185-G; Syme CA, 2006, MOL ENDOCRINOL, V20, P3400, DOI 10.1210/me.2006-0178; Takahashi A, 1996, ATHEROSCLEROSIS, V120, P93, DOI 10.1016/0021-9150(95)05686-6; Takayanagi H, 2002, DEV CELL, V3, P889, DOI 10.1016/S1534-5807(02)00369-6; Tanko LB, 2003, CALCIFIED TISSUE INT, V73, P15, DOI 10.1007/s00223-002-2070-x; Teitelbaum SL, 2007, AM J PATHOL, V170, P427, DOI 10.2353/ajpath.2007.060834; Thomas CM, 2008, J CELL MOL MED, V12, P796, DOI 10.1111/j.1582-4934.2008.00295.x; THORIN E, 1995, ATHEROSCLEROSIS, V114, P185, DOI 10.1016/0021-9150(94)05482-X; Wong BR, 1999, MOL CELL, V4, P1041, DOI 10.1016/S1097-2765(00)80232-4; Woo JT, 2005, BIOCHEM PHARMACOL, V69, P87, DOI 10.1016/j.bcp.2004.08.036; Wu HP, 2009, J BONE MINER RES, V24, P871, DOI [10.1359/JBMR.081239, 10.1359/jbmr.081239]; Xu J, 2010, P NATL ACAD SCI USA, V107, P4764, DOI 10.1073/pnas.0910872107; Yagi M, 2005, J EXP MED, V202, P345, DOI 10.1084/jem.20050645; Yamaguchi T, 2002, ENDOCR J, V49, P211, DOI 10.1507/endocrj.49.211; Yasuda H, 1998, P NATL ACAD SCI USA, V95, P3597, DOI 10.1073/pnas.95.7.3597	65	41	43	0	5	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JUN 1	2012	287	23					19229	19241		10.1074/jbc.M111.323600	http://dx.doi.org/10.1074/jbc.M111.323600			13	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	974EF	22500026	Green Published, hybrid			2022-12-25	WOS:000306411900033
J	Zhao, L; Ericksen, B; Wu, XJ; Zhan, CY; Yuan, WR; Li, X; Pazgier, M; Lu, WY				Zhao, Le; Ericksen, Bryan; Wu, Xueji; Zhan, Changyou; Yuan, Weirong; Li, Xu; Pazgier, Marzena; Lu, Wuyuan			Invariant Gly Residue Is Important for alpha-Defensin Folding, Dimerization, and Function A CASE STUDY OF THE HUMAN NEUTROPHIL alpha-DEFENSIN HNP1	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							CONSERVED SALT BRIDGE; ANTIMICROBIAL PEPTIDES; MAMMALIAN DEFENSINS; MOUSE CRYPTDIN-4; HOST-DEFENSE; PANETH CELLS; BETA-BULGE; PROTEINS; TOXIN	The human alpha-defensins (HNP) are synthesized in vivo as inactive prodefensins, and contain a conserved glycine, Gly(17), which is part of a beta-bulge structure. It had previously been shown that the glycine main chain torsion angles are in a D-configuration, and that D-amino acids but not L-alanine could be substituted at that position to yield correctly folded peptides without the help of a prodomain. In this study, the glycine to L-alanine mutant defensin was synthesized in the form of a prodefensin using native chemical ligation. The ligation product folded correctly and yielded an active peptide upon CNBr cleavage. The L-Ala(17)-HNP1 crystal structure depicted a beta-bulge identical to wild-type HNP1. However, dimerization was perturbed, causing one monomer to tilt with respect to the other in a dimerization model. Inhibitory activity against the anthrax lethal factor showed a 2-fold reduction relative to wild-type HNP1 as measured by the inhibitory concentration IC50. Self-association was slightly reduced, as detected by surface plasmon resonance measurements. According to the results of the virtual colony count assay, the antibacterial activity against Escherichia coli, Staphylococcus aureus, and Bacillus cereus exhibited a less than 2-fold reduction in virtual lethal dose values. Prodefensins with two other L-amino acid substitutions, Arg and Phe, at the same position did not fold, indicating that only small side chains are tolerable. These results further elucidate the factors governing the region of the beta-bulge structure that includes Gly(17), illuminating why glycine is conserved in all mammalian alpha-defensins.	[Zhao, Le; Li, Xu; Pazgier, Marzena; Lu, Wuyuan] Xi An Jiao Tong Univ, Sch Med, Affiliated Hosp 1, Xian, Peoples R China; [Ericksen, Bryan; Wu, Xueji; Zhan, Changyou; Yuan, Weirong; Pazgier, Marzena; Lu, Wuyuan] Univ Maryland, Sch Med, Dept Biochem & Mol Biol, Baltimore, MD 21201 USA; [Ericksen, Bryan; Wu, Xueji; Zhan, Changyou; Yuan, Weirong; Pazgier, Marzena; Lu, Wuyuan] Univ Maryland, Sch Med, Inst Human Virol, Baltimore, MD 21201 USA	Xi'an Jiaotong University; University System of Maryland; University of Maryland Baltimore; University System of Maryland; University of Maryland Baltimore	Pazgier, M (corresponding author), Xi An Jiao Tong Univ, Sch Med, Affiliated Hosp 1, Xian, Peoples R China.	mpazgier@ihv.umaryland.edu; wlu@ihv.umaryland.edu	Zhan, Changyou/G-3667-2011; Lu, Wuyuan/J-8452-2017; Lu, Wuyuan/B-2268-2010	Lu, Wuyuan/0000-0003-1318-9968; Ericksen, Bryan/0000-0002-8016-8289	DOE Office of Biological and Environmental Research; National Institutes of Health [AI072732, AI061482]; National Institutes of Health, National Center for Research Resources, Biomedical Technology Program [P41RR001209]; National Institute of General Medical Sciences; Xi'an Jiaotong University School of Medicine; NATIONAL CENTER FOR RESEARCH RESOURCES [P41RR001209] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI061482, R01AI072732] Funding Source: NIH RePORTER	DOE Office of Biological and Environmental Research(United States Department of Energy (DOE)); National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); National Institutes of Health, National Center for Research Resources, Biomedical Technology Program(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); National Institute of General Medical Sciences(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); Xi'an Jiaotong University School of Medicine(Xi'an Jiaotong University); NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	We thank the X-ray Crystallography Core Facility of the University of Maryland at Baltimore for providing crystallographic equipment and resources. Portions of this research were carried out at the Stanford Synchrotron Radiation Lightsource, a Directorate of SLAC National Accelerator Laboratory and an Office of Science User Facility operated for the United States Department of Energy Office of Science by Stanford University. The SSRL Structural Molecular Biology Program is supported by the DOE Office of Biological and Environmental Research, and by National Institutes of Health, National Center for Research Resources, Biomedical Technology Program Grant P41RR001209, and the National Institute of General Medical Sciences.; This work was supported, in whole or in part, by National Institutes of Health Grants AI072732 and AI061482 (to W. L.).; Guanghua Scholar supported by Xi'an Jiaotong University School of Medicine.	Abrami L, 2005, TRENDS MICROBIOL, V13, P72, DOI 10.1016/j.tim.2004.12.004; Andersson H. S., 2012, AMINO ACIDS     0129; BAILEY S, 1994, ACTA CRYSTALLOGR D, V50, P760, DOI 10.1107/s0907444994003112; Bernard JJ, 2011, CELL MOL LIFE SCI, V68, P2189, DOI 10.1007/s00018-011-0712-8; Bevins CL, 2006, BIOCHEM SOC T, V34, P263, DOI 10.1042/BST0340263; BRUNGER AT, 1992, NATURE, V355, P472, DOI 10.1038/355472a0; CHAN AWE, 1993, PROTEIN SCI, V2, P1574, DOI 10.1002/pro.5560021004; Chen VB, 2010, ACTA CRYSTALLOGR D, V66, P12, DOI 10.1107/S0907444909042073; DAWSON PE, 1994, SCIENCE, V266, P776, DOI 10.1126/science.7973629; Dawson PE, 2000, ANNU REV BIOCHEM, V69, P923, DOI 10.1146/annurev.biochem.69.1.923; Emsley P, 2004, ACTA CRYSTALLOGR D, V60, P2126, DOI 10.1107/S0907444904019158; Ericksen B, 2005, ANTIMICROB AGENTS CH, V49, P269, DOI 10.1128/AAC.49.1.269-275.2005; Figueredo SM, 2009, J BIOL CHEM, V284, P6826, DOI 10.1074/jbc.M807024200; GABAY JE, 1989, P NATL ACAD SCI USA, V86, P5610, DOI 10.1073/pnas.86.14.5610; GANZ T, 1985, J CLIN INVEST, V76, P1427, DOI 10.1172/JCI112120; Ganz T, 2003, NAT REV IMMUNOL, V3, P710, DOI 10.1038/nri1180; HILL CP, 1991, SCIENCE, V251, P1481, DOI 10.1126/science.2006422; JONES DE, 1993, FEBS LETT, V315, P187, DOI 10.1016/0014-5793(93)81160-2; JONES DE, 1992, J BIOL CHEM, V267, P23216; Kim C, 2005, P NATL ACAD SCI USA, V102, P4830, DOI 10.1073/pnas.0500508102; Krissinel E, 2007, J MOL BIOL, V372, P774, DOI 10.1016/j.jmb.2007.05.022; Lehrer RI, 2004, NAT REV MICROBIOL, V2, P727, DOI 10.1038/nrmicro976; Lehrer RI, 2012, IMMUNOL REV, V245, P84, DOI 10.1111/j.1600-065X.2011.01082.x; LIU L, 1995, BLOOD, V85, P1095, DOI 10.1182/blood.V85.4.1095.bloodjournal8541095; Llenado RA, 2009, INFECT IMMUN, V77, P5035, DOI 10.1128/IAI.00695-09; Maemoto A, 2004, J BIOL CHEM, V279, P44188, DOI 10.1074/jbc.M406154200; MICHAELSON D, 1992, J LEUKOCYTE BIOL, V51, P634, DOI 10.1002/jlb.51.6.634; Min DH, 2004, NAT BIOTECHNOL, V22, P717, DOI 10.1038/nbt973; Mitchell JBO, 2003, PROTEINS, V50, P563, DOI 10.1002/prot.10320; Murshudov GN, 1997, ACTA CRYSTALLOGR D, V53, P240, DOI 10.1107/S0907444996012255; Otwinowski Z, 1997, METHOD ENZYMOL, V276, P307, DOI 10.1016/S0076-6879(97)76066-X; PACE CN, 1995, PROTEIN SCI, V4, P2411, DOI 10.1002/pro.5560041120; PARDI A, 1992, BIOCHEMISTRY-US, V31, P11357, DOI 10.1021/bi00161a013; Pazgier M, 2006, CELL MOL LIFE SCI, V63, P1294, DOI 10.1007/s00018-005-5540-2; Pazgier M, 2012, J BIOL CHEM, V287, P8944, DOI 10.1074/jbc.M111.332205; Rajabi M, 2008, J BIOL CHEM, V283, P21509, DOI 10.1074/jbc.M801851200; RICHARDSON JS, 1978, P NATL ACAD SCI USA, V75, P2574, DOI 10.1073/pnas.75.6.2574; Rosengren KJ, 2006, J BIOL CHEM, V281, P28068, DOI 10.1074/jbc.M604992200; Selsted ME, 2005, NAT IMMUNOL, V6, P551, DOI 10.1038/ni1206; SELSTED ME, 1985, J CLIN INVEST, V76, P1436, DOI 10.1172/JCI112121; SMITH CK, 1994, BIOCHEMISTRY-US, V33, P5510, DOI 10.1021/bi00184a020; Szyk A, 2006, PROTEIN SCI, V15, P2749, DOI 10.1110/ps.062336606; Tanabe H, 2004, J BIOL CHEM, V279, P11976, DOI 10.1074/jbc.M310251200; Valore EV, 1996, J CLIN INVEST, V97, P1624, DOI 10.1172/JCI118588; Wei G, 2010, J BIOL CHEM, V285, P16275, DOI 10.1074/jbc.M110.102749; Wei G, 2009, J BIOL CHEM, V284, P29180, DOI 10.1074/jbc.M109.018085; Wiesner J, 2010, VIRULENCE, V1, P440, DOI 10.4161/viru.1.5.12983; WILDE CG, 1989, J BIOL CHEM, V264, P11200; Wu Z, 2003, J PEPT RES, V62, P53, DOI 10.1034/j.1399-3011.2003.00068.x; Wu ZB, 2005, J BIOL CHEM, V280, P43039, DOI 10.1074/jbc.M510562200; Wu ZB, 2003, J AM CHEM SOC, V125, P2402, DOI 10.1021/ja0294257; Wu ZB, 2007, J MOL BIOL, V368, P537, DOI 10.1016/j.jmb.2007.02.040; Xie C, 2005, PEPTIDES, V26, P2377, DOI 10.1016/j.peptides.2005.06.002; Xie C, 2005, J BIOL CHEM, V280, P32921, DOI 10.1074/jbc.M503084200; Yeaman MR, 2007, NAT REV MICROBIOL, V5, P727, DOI 10.1038/nrmicro1744; Yount NY, 2004, P NATL ACAD SCI USA, V101, P7363, DOI 10.1073/pnas.0401567101; Zasloff M, 2002, NATURE, V415, P389, DOI 10.1038/415389a; Zou GZ, 2007, J BIOL CHEM, V282, P19653, DOI 10.1074/jbc.M611003200	58	18	20	0	7	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JUN 1	2012	287	23					18900	18912		10.1074/jbc.M112.355255	http://dx.doi.org/10.1074/jbc.M112.355255			13	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	974EF	22496447	Green Published, hybrid			2022-12-25	WOS:000306411900003
J	Choe, J; Oh, N; Park, S; Lee, YK; Song, OK; Locker, N; Chi, SG; Kim, YK				Choe, Junho; Oh, Nara; Park, Sungjin; Lee, Ye Kyung; Song, Ok-Kyu; Locker, Nicolas; Chi, Sung-Gil; Kim, Yoon Ki			Translation Initiation on mRNAs Bound by Nuclear Cap-binding Protein Complex CBP80/20 Requires Interaction between CBP80/20-dependent Translation Initiation Factor and Eukaryotic Translation Initiation Factor 3g	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							NONSENSE-MEDIATED DECAY; EXON JUNCTION COMPLEX; MAMMALIAN-CELLS; EIF3; SUBUNIT; SURVEILLANCE; REPRESSION; RECRUITS; REVEALS; OCCURS	In the cytoplasm of mammalian cells, either cap-binding proteins 80 and 20 (CBP80/20) or eukaryotic translation initiation factor (eIF) 4E can direct the initiation of translation. Although the recruitment of ribosomes to mRNAs during eIF4E-dependent translation (ET) is well characterized, the molecular mechanism for CBP80/20-dependent translation (CT) remains obscure. Here, we show that CBP80/20-dependent translation initiation factor (CTIF), which has been shown to be preferentially involved in CT but not ET, specifically interacts with eIF3g, a component of the eIF3 complex involved in ribosome recruitment. By interacting with eIF3g, CTIF serves as an adaptor protein to bridge the CBP80/20 and the eIF3 complex, leading to efficient ribosome recruitment during CT. Accordingly, down-regulation of CTIF using a small interfering RNA causes a redistribution of CBP80 from polysome fractions to subpoly-some fractions, without significant consequence to eIF4E distribution. In addition, down-regulation of eIF3g inhibits the efficiency of nonsense-mediated mRNA decay, which is tightly coupled to CT but not to ET. Moreover, the artificial tethering of CTIF to an intercistronic region of dicistronic mRNA results in translation of the downstream cistron in an eIF3-dependent manner. These findings support the idea that CT mechanistically differs from ET.	[Choe, Junho; Oh, Nara; Park, Sungjin; Chi, Sung-Gil; Kim, Yoon Ki] Korea Univ, Sch Life Sci & Biotechnol, Seoul 136701, South Korea; [Lee, Ye Kyung; Song, Ok-Kyu] Panbionet Corp, Pohang 790784, Kyungbuk, South Korea; [Locker, Nicolas] Univ Surrey, Dept Microbial & Cellular Sci, Guildford GU2 7HX, Surrey, England	Korea University; University of Surrey	Kim, YK (corresponding author), Korea Univ, Sch Life Sci & Biotechnol, Seoul 136701, South Korea.	yk-kim@korea.ac.kr	Choe, Junho/E-3410-2019	Choe, Junho/0000-0002-2365-3755; Kim, Yoon Ki/0000-0003-1303-072X; Locker, Nicolas/0000-0002-0053-2897	Korea Science and Engineering Foundation (KOSEF) [2009-0084897, 0001197]; Korea Government (MEST); Korea Research Foundation [KRF-2008-314-C00247]; Korean Government (MOEHRD); Seoul Science Fellowship	Korea Science and Engineering Foundation (KOSEF)(Korea Science and Engineering Foundation); Korea Government (MEST)(Ministry of Education, Science & Technology (MEST), Republic of KoreaKorean Government); Korea Research Foundation(National Research Foundation of Korea); Korean Government (MOEHRD)(Ministry of Education & Human Resources Development (MOEHRD), Republic of KoreaKorean Government); Seoul Science Fellowship	This work was supported in part by the Korea Science and Engineering Foundation (KOSEF) Grants 2009-0084897 and 0001197 funded by the Korea Government (MEST) and Korea Research Foundation Grant KRF-2008-314-C00247 funded by the Korean Government (MOEHRD).; Supported in part by a Seoul Science Fellowship.	Chin SY, 2004, GENE DEV, V18, P745, DOI 10.1101/gad.1170204; Cho H, 2009, MOL CELL, V33, P75, DOI 10.1016/j.molcel.2008.11.022; Choe J, 2011, FEBS LETT, V585, P2682, DOI 10.1016/j.febslet.2011.07.047; Choe J, 2010, EMBO REP, V11, P380, DOI 10.1038/embor.2010.44; Cuchalova L, 2010, MOL CELL BIOL, V30, P4671, DOI 10.1128/MCB.00430-10; De Gregorio E, 1999, EMBO J, V18, P4865, DOI 10.1093/emboj/18.17.4865; DOUGHERTY WG, 1988, EMBO J, V7, P1281, DOI 10.1002/j.1460-2075.1988.tb02942.x; Durand S, 2011, CELL, V145, P324, DOI 10.1016/j.cell.2011.03.038; Hershey JWB, 2010, BRAZ J MED BIOL RES, V43, P920, DOI 10.1590/S0100-879X2010001000002; Hinnebusch AG, 2006, TRENDS BIOCHEM SCI, V31, P553, DOI 10.1016/j.tibs.2006.08.005; Ishigaki Y, 2001, CELL, V106, P607, DOI 10.1016/S0092-8674(01)00475-5; Isken O, 2008, CELL, V133, P314, DOI 10.1016/j.cell.2008.02.030; Kim KM, 2009, GENE DEV, V23, P2033, DOI 10.1101/gad.1823409; Kim YK, 2005, CELL, V120, P195, DOI 10.1016/j.cell.2004.11.050; Lee HC, 2010, FEBS LETT, V584, P795, DOI 10.1016/j.febslet.2010.01.003; LeFebvre AK, 2006, J BIOL CHEM, V281, P22917, DOI 10.1074/jbc.M605418200; Lejeune F, 2004, NAT STRUCT MOL BIOL, V11, P992, DOI 10.1038/nsmb824; Lejeune F, 2002, EMBO J, V21, P3536, DOI 10.1093/emboj/cdf345; Lemay JF, 2010, RNA BIOL, V7, P291, DOI 10.4161/rna.7.3.11649; Locker N, 2011, NUCLEIC ACIDS RES, V39, P2367, DOI 10.1093/nar/gkq1118; Maquat LE, 2001, RNA, V7, P445, DOI 10.1017/S1355838201002229; Maquat LE, 2010, CELL, V142, P368, DOI 10.1016/j.cell.2010.07.022; Marin-Vinader L, 2006, BBA-GENE STRUCT EXPR, V1759, P535, DOI 10.1016/J.bbaexp.2006.10.003; Martineau Y, 2008, MOL CELL BIOL, V28, P6658, DOI 10.1128/MCB.00738-08; Masutani M, 2007, EMBO J, V26, P3373, DOI 10.1038/sj.emboj.7601765; Morris C, 2007, EMBO REP, V8, P596, DOI 10.1038/sj.embor.7400955; Neu-Yilik G, 2008, ADV GENET, V62, P185, DOI 10.1016/S0065-2660(08)00604-4; Oh N, 2007, FEBS LETT, V581, P5158, DOI 10.1016/j.febslet.2007.10.002; Oh N, 2007, BIOCHEM BIOPH RES CO, V362, P145, DOI 10.1016/j.bbrc.2007.07.169; Oh YL, 1998, BIOCHEM J, V331, P169, DOI 10.1042/bj3310169; Pisarev AV, 2007, METHOD ENZYMOL, V430, P147, DOI 10.1016/S0076-6879(07)30007-4; Sato H, 2009, GENE DEV, V23, P2537, DOI 10.1101/gad.1817109; Schoenberg DR, 2012, NAT REV GENET, V13, P246, DOI 10.1038/nrg3160; TAN RY, 1995, P NATL ACAD SCI USA, V92, P5282, DOI 10.1073/pnas.92.12.5282; Zhou M, 2008, P NATL ACAD SCI USA, V105, P18139, DOI 10.1073/pnas.0801313105	35	36	38	0	4	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAY 25	2012	287	22					18500	18509		10.1074/jbc.M111.327528	http://dx.doi.org/10.1074/jbc.M111.327528			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	974EC	22493286	hybrid, Green Published, Green Submitted			2022-12-25	WOS:000306411600056
J	Pierrat, MJ; Marsaud, V; Mauviel, A; Javelaud, D				Pierrat, Marie-Jeanne; Marsaud, Veronique; Mauviel, Alain; Javelaud, Delphine			Expression of Microphthalmia-associated Transcription Factor (MITF), Which Is Critical for Melanoma Progression, Is Inhibited by Both Transcription Factor GLI2 and Transforming Growth Factor-beta	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							IN-VIVO; GENE-EXPRESSION; TGF-BETA; STABLE OVEREXPRESSION; SKI ONCOPROTEIN; CELLS; VITRO; METASTASIS; PROTEINS; INVASION	The melanocyte-specific transcription factor M-MITF is involved in numerous aspects of melanoblast lineage biology including pigmentation, survival, and migration. It plays complex roles at all stages of melanoma progression and metastasis. We established previously that GLI2, a Kruppel-like transcription factor that acts downstream of Hedgehog signaling, is a direct transcriptional target of the TGF-beta/SMAD pathway and contributes to melanoma progression, exerting antagonistic activities against M-MITF to control melanoma cell invasiveness. Herein, we dissected the molecular mechanisms underlying both TGF-beta and GLI2-driven M-MITF gene repression. Using transient cell transfection experiments with M-MITF promoter constructs, chromatin immunoprecipitation, site-directed mutagenesis, and electrophoretic mobility shift assays, we identified a GLI2 binding site within the -334/-296 region of the M-MITF promoter, critical for GLI2-driven transcriptional repression. This region is, however, not needed for inhibition of M-MITF promoter activity by TGF-beta. We determined that TGF-beta rapidly repressed protein kinase A activity, thus reducing both phospho-cAMP-response element-binding protein (CREB) levels and CREB-dependent transcription of the M-MITF promoter. Increased GLI2 binding to its cognate cis-element, associated with reduced CREB-dependent transcription, allowed maximal inhibition of the M-MITF promoter via two distinct mechanisms.	[Mauviel, Alain] Inst Curie, Ctr Rech, INSERM, CNRS,U1021,UMR3347,Univ Ctr,Team TGP, F-91400 Orsay, France; Univ Paris 11, F-91400 Orsay, France	Centre National de la Recherche Scientifique (CNRS); CNRS - National Institute for Biology (INSB); UDICE-French Research Universities; PSL Research University Paris; UNICANCER; Institut Curie; Institut National de la Sante et de la Recherche Medicale (Inserm); Universite Paris Saclay; UDICE-French Research Universities; Universite Paris Saclay	Mauviel, A (corresponding author), Inst Curie, Ctr Rech, INSERM, CNRS,U1021,UMR3347,Univ Ctr,Team TGP, Bldg 110, F-91400 Orsay, France.	alain.mauviel@curie.fr; delphine.javelaud@curie.fr	MAUVIEL, Alain/F-6251-2013; Javelaud, Delphine/B-1129-2019	Javelaud, Delphine/0000-0002-7674-7739; Mauviel, Alain/0000-0002-0438-2793	Ligue Nationale Contre le Cancer (Equipe Labellisee LIGUE) [EL2011-AM]; INCa [PLBIO08-126]; Emile and Henriette Goutiere; Association pour la Recherche contre le Cancer; Institut Curie, INSERM; CNRS; Canceropole Ile-de-France and Fondation pour la Recherche Medicale	Ligue Nationale Contre le Cancer (Equipe Labellisee LIGUE); INCa(Institut National du Cancer (INCA) France); Emile and Henriette Goutiere; Association pour la Recherche contre le Cancer(Fondation ARC pour la Recherche sur le Cancer); Institut Curie, INSERM; CNRS(Centre National de la Recherche Scientifique (CNRS)); Canceropole Ile-de-France and Fondation pour la Recherche Medicale	This work was supported by Ligue Nationale Contre le Cancer (Equipe Labellisee LIGUE EL2011-AM), INCa (PLBIO08-126) and a donation from Emile and Henriette Goutiere (to A. M.), Association pour la Recherche contre le Cancer (to D. J.), and institutional funding from Institut Curie, INSERM, and CNRS.; Recipient of a Ph.D. scholarship awarded by Canceropole Ile-de-France and Fondation pour la Recherche Medicale.	Alexaki VI, 2008, PIGM CELL MELANOMA R, V21, P429, DOI 10.1111/j.1755-148X.2008.00466.x; Alexaki VI, 2010, JNCI-J NATL CANCER I, V102, P1148, DOI 10.1093/jnci/djq257; ANDREWS NC, 1991, NUCLEIC ACIDS RES, V19, P2499, DOI 10.1093/nar/19.9.2499; Bertolotto C, 1996, J CELL BIOL, V134, P747, DOI 10.1083/jcb.134.3.747; Bertolotto C, 1998, J CELL BIOL, V142, P827, DOI 10.1083/jcb.142.3.827; Chen DH, 2009, PIGM CELL MELANOMA R, V22, P761, DOI 10.1111/j.1755-148X.2009.00603.x; Dai P, 2002, GENE DEV, V16, P2843, DOI 10.1101/gad.1017302; Dennler S, 2007, CANCER RES, V67, P6981, DOI 10.1158/0008-5472.CAN-07-0491; Dennler S, 2009, J BIOL CHEM, V284, P31523, DOI 10.1074/jbc.M109.059964; DiVito KA, 2010, PIGM CELL MELANOMA R, V23, P795, DOI 10.1111/j.1755-148X.2010.00758.x; Hoek KS, 2010, PIGM CELL MELANOMA R, V23, P746, DOI 10.1111/j.1755-148X.2010.00757.x; Javelaud D, 2005, ONCOGENE, V24, P7624, DOI 10.1038/sj.onc.1208900; Javelaud D, 2004, INT J BIOCHEM CELL B, V36, P1161, DOI 10.1016/S1357-2725(03)00255-3; Javelaud D, 2008, PIGM CELL MELANOMA R, V21, P123, DOI 10.1111/j.1755-148X.2008.00450.x; Javelaud D, 2007, CANCER RES, V67, P2317, DOI 10.1158/0008-5472.CAN-06-3950; Javelaud D, 2011, PIGM CELL MELANOMA R, V24, P932, DOI 10.1111/j.1755-148X.2011.00893.x; Javelaud D, 2011, CANCER RES, V71, P5606, DOI 10.1158/0008-5472.CAN-11-1194; Javelaud D, 2011, MOL CANCER, V10, DOI 10.1186/1476-4598-10-2; Kump E, 2008, ONCOGENE, V27, P3856, DOI 10.1038/onc.2008.5; Levy C, 2006, TRENDS MOL MED, V12, P406, DOI 10.1016/j.molmed.2006.07.008; Luo KX, 1999, GENE DEV, V13, P2196, DOI 10.1101/gad.13.17.2196; Massague J, 2005, GENE DEV, V19, P2783, DOI 10.1101/gad.1350705; Massague J, 2008, CELL, V134, P215, DOI 10.1016/j.cell.2008.07.001; Mayr B, 2001, NAT REV MOL CELL BIO, V2, P599, DOI 10.1038/35085068; Meulmeester E, 2011, J PATHOL, V223, P205, DOI 10.1002/path.2785; Mohammad KS, 2011, CANCER RES, V71, P175, DOI 10.1158/0008-5472.CAN-10-2651; Rodeck U, 1999, CANCER RES, V59, P547; Sasaki H, 1997, DEVELOPMENT, V124, P1313; Sasaki H, 1999, DEVELOPMENT, V126, P3915; Schiller M, 2003, ONCOGENE, V22, P8881, DOI 10.1038/sj.onc.1206871; Schiller M, 2010, J BIOL CHEM, V285, P409, DOI 10.1074/jbc.M109.038620; Steingrimsson E, 2004, ANNU REV GENET, V38, P365, DOI 10.1146/annurev.genet.38.072902.092717; Sun Y, 1999, MOL CELL, V4, P499, DOI 10.1016/S1097-2765(00)80201-4; Verrecchia F, 2001, J INVEST DERMATOL, V116, P755, DOI 10.1046/j.1523-1747.2001.01326.x; Widmer DS, 2012, PIGM CELL MELANOMA R, V25, P343, DOI 10.1111/j.1755-148X.2012.00986.x	35	53	60	0	20	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAY 25	2012	287	22					17996	18004		10.1074/jbc.M112.358341	http://dx.doi.org/10.1074/jbc.M112.358341			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	974EC	22496449	hybrid, Green Published			2022-12-25	WOS:000306411600009
J	Koutinas, AA; Sypsas, V; Kandylis, P; Michelis, A; Bekatorou, A; Kourkoutas, Y; Kordulis, C; Lycourghiotis, A; Banat, IM; Nigam, P; Marchant, R; Giannouli, M; Yianoulis, P				Koutinas, Athanasios A.; Sypsas, Vasilios; Kandylis, Panagiotis; Michelis, Andreas; Bekatorou, Argyro; Kourkoutas, Yiannis; Kordulis, Christos; Lycourghiotis, Alexis; Banat, Ibrahim M.; Nigam, Poonam; Marchant, Roger; Giannouli, Myrsini; Yianoulis, Panagiotis			Nano-Tubular Cellulose for Bioprocess Technology Development	PLOS ONE			English	Article							SACCHAROMYCES-CEREVISIAE; ETHANOL-PRODUCTION; YEAST; TEMPERATURE; IMMOBILIZATION; FERMENTATION; CATALYSIS	Delignified cellulosic material has shown a significant promotional effect on the alcoholic fermentation as yeast immobilization support. However, its potential for further biotechnological development is unexploited. This study reports the characterization of this tubular/porous cellulosic material, which was done by SEM, porosimetry and X-ray powder diffractometry. The results showed that the structure of nano-tubular cellulose (NC) justifies its suitability for use in "cold pasteurization'' processes and its promoting activity in bioprocessing (fermentation). The last was explained by a glucose pump theory. Also, it was demonstrated that crystallization of viscous invert sugar solutions during freeze drying could not be otherwise achieved unless NC was present. This effect as well as the feasibility of extremely low temperature fermentation are due to reduction of the activation energy, and have facilitated the development of technologies such as wine fermentations at home scale (in a domestic refrigerator). Moreover, NC may lead to new perspectives in research such as the development of new composites, templates for cylindrical nano-particles, etc.	[Koutinas, Athanasios A.; Sypsas, Vasilios; Kandylis, Panagiotis; Michelis, Andreas; Bekatorou, Argyro] Univ Patras, Dept Chem, Food Biotechnol Grp, Patras, Greece; [Kourkoutas, Yiannis] Democritus Univ Thrace, Dept Mol Biol, Alexandroupolis, Greece; [Kordulis, Christos; Lycourghiotis, Alexis] Univ Patras, Grp Catalysis & Interfacial Chem Environm Applica, Patras, Greece; [Kordulis, Christos] Inst Chem Engn & High Temp Chem Proc FORTH ICE HT, Patras, Greece; [Banat, Ibrahim M.; Nigam, Poonam; Marchant, Roger] Univ Ulster, Sch Biomed Sci, Coleraine BT52 1SA, Londonderry, North Ireland; [Giannouli, Myrsini; Yianoulis, Panagiotis] Univ Patras, Dept Phys, GR-26110 Patras, Greece	University of Patras; Democritus University of Thrace; University of Patras; Foundation for Research & Technology - Hellas (FORTH); Institute of Chemical Engineering Sciences (ICE-HT); Ulster University; University of Patras	Koutinas, AA (corresponding author), Univ Patras, Dept Chem, Food Biotechnol Grp, Patras, Greece.	a.a.koutinas@upatras.gr	Lycourghiotis, Alexis/G-1125-2010; Kourkoutas, Yiannis/AAM-8253-2021; bekatorou, argyro/AAT-5448-2020; Kandylis, Panagiotis/M-2338-2019; Banat, Ibrahim M/C-1910-2013; NIGAM, POONAM/AAV-4816-2021; Kandylis, Panagiotis/F-4403-2012; Kordulis, Christos/F-7982-2010	Banat, Ibrahim M/0000-0001-8964-2840; NIGAM, POONAM/0000-0001-8505-5382; Kordulis, Christos/0000-0002-4259-8624; Giannouli, Myrsini/0000-0002-9134-8146; Marchant, Roger/0000-0001-5213-229X; Kandylis, Panagiotis/0000-0002-3909-2139				Arinstein A, 2007, NAT NANOTECHNOL, V2, P59, DOI 10.1038/nnano.2006.172; Balat M, 2009, APPL ENERG, V86, P2273, DOI 10.1016/j.apenergy.2009.03.015; Bardi EP, 1996, J AGR FOOD CHEM, V44, P463, DOI 10.1021/jf9501406; BARDI EP, 1994, J AGR FOOD CHEM, V42, P221, DOI 10.1021/jf00037a040; Beecher JF, 2007, NAT NANOTECHNOL, V2, P466, DOI 10.1038/nnano.2007.239; Bourikas K, 2006, CATAL REV, V48, P363, DOI 10.1080/01614940600962321; Buick R, 2008, NATURE, V455, P569; Farrauto R. J., 2003, FUNDAMENTALS IND CAT; Franken J, 2008, CURR GENET, V53, P347, DOI 10.1007/s00294-008-0191-0; Girard B, 2000, CRIT REV BIOTECHNOL, V20, P109, DOI 10.1080/07388550008984168; Gonzalez MG, 1996, J AM SOC BREW CHEM, V54, P29; Huang J, 1998, U.S. Patent, Patent No. 5853647; ICONOMOU L, 1995, J FERMENT BIOENG, V79, P294, DOI 10.1016/0922-338X(95)90621-6; KANA K, 1989, J FERMENT BIOENG, V68, P213, DOI 10.1016/0922-338X(89)90140-2; KANA K, 1989, J FERMENT BIOENG, V68, P144, DOI 10.1016/0922-338X(89)90064-0; Kandylis P, 2008, J AGR FOOD CHEM, V56, P12037, DOI 10.1021/jf802476w; Kandylis P, 2008, J AGR FOOD CHEM, V56, P3317, DOI 10.1021/jf073273n; McClory C, 2009, AUST J CHEM, V62, P762, DOI 10.1071/CH09131; Mehdaoui S, 2009, MATER CHARACT, V60, P451, DOI 10.1016/j.matchar.2008.10.003; Mihranyan A, 2004, INT J PHARMACEUT, V269, P433, DOI 10.1016/j.ijpharm.2003.09.030; Yerga RMN, 2009, CHEMSUSCHEM, V2, P471, DOI 10.1002/cssc.200900018; Palkar VR, 1999, NANOSTRUCT MATER, V11, P369, DOI 10.1016/S0965-9773(99)00053-7; Resasco DE, 2008, NAT NANOTECHNOL, V3, P708, DOI 10.1038/nnano.2008.357; Scrosati B, 2007, NAT NANOTECHNOL, V2, P598, DOI 10.1038/nnano.2007.318; Zhang YHP, 2004, BIOTECHNOL BIOENG, V88, P797, DOI 10.1002/bit.20282	25	48	49	1	16	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 9	2012	7	4							e34350	10.1371/journal.pone.0034350	http://dx.doi.org/10.1371/journal.pone.0034350			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	955JO	22496794	Green Published, gold			2022-12-25	WOS:000305014500022
J	Alvarez-Garcia, O; Garcia-Lopez, E; Loredo, V; Gil-Pena, H; Mejia-Gaviria, N; Rodriguez-Suarez, J; Ordonez, FA; Santos, F				Alvarez-Garcia, Oscar; Garcia-Lopez, Enrique; Loredo, Vanessa; Gil-Pena, Helena; Mejia-Gaviria, Natalia; Rodriguez-Suarez, Julian; Ordonez, Flor A.; Santos, Fernando			Growth Hormone Improves Growth Retardation Induced by Rapamycin without Blocking Its Antiproliferative and Antiangiogenic Effects on Rat Growth Plate	PLOS ONE			English	Article							BONE-GROWTH; YOUNG-RATS; CHONDROCYTES; SIROLIMUS; MATURATION; ALLOGRAFTS; AUTOPHAGY; KINASE	Rapamycin, an immunosuppressant agent used in renal transplantation with antitumoral properties, has been reported to impair longitudinal growth in young individuals. As growth hormone (GH) can be used to treat growth retardation in transplanted children, we aimed this study to find out the effect of GH therapy in a model of young rat with growth retardation induced by rapamycin administration. Three groups of 4-week-old rats treated with vehicle (C), daily injections of rapamycin alone (RAPA) or in combination with GH (RGH) at pharmacological doses for 1 week were compared. GH treatment caused a 20% increase in both growth velocity and body length in RGH animals when compared with RAPA group. GH treatment did not increase circulating levels of insulin-like growth factor I, a systemic mediator of GH actions. Instead, GH promoted the maturation and hypertrophy of growth plate chondrocytes, an effect likely related to AKT and ERK1/2 mediated inactivation of GSK3 beta, increase of glycogen deposits and stabilization of beta-catenin. Interestingly, GH did not interfere with the antiproliferative and antiangiogenic activities of rapamycin in the growth plate and did not cause changes in chondrocyte autophagy markers. In summary, these findings indicate that GH administration improves longitudinal growth in rapamycin-treated rats by specifically acting on the process of growth plate chondrocyte hypertrophy but not by counteracting the effects of rapamycin on proliferation and angiogenesis.	[Alvarez-Garcia, Oscar; Mejia-Gaviria, Natalia; Rodriguez-Suarez, Julian; Santos, Fernando] Univ Oviedo, Dept Pediat, Oviedo, Spain; [Alvarez-Garcia, Oscar; Santos, Fernando] Inst Univ Oncol Principado Asturias, Lab Growth & Canc, Oviedo, Asturias, Spain; [Garcia-Lopez, Enrique; Loredo, Vanessa; Gil-Pena, Helena; Rodriguez-Suarez, Julian; Ordonez, Flor A.; Santos, Fernando] Hosp Univ Cent Asturias, Dept Pediat, Oviedo, Spain	University of Oviedo; University of Oviedo; Instituto Universitario de Oncologia de Asturias; Central University Hospital Asturias	Alvarez-Garcia, O (corresponding author), Univ Oviedo, Dept Pediat, Oviedo, Spain.	fsantos@uniovi.es	Rodríguez, Julián/W-2440-2019; Rodríguez, Julián/F-5900-2019	Rodríguez, Julián/0000-0003-4621-8905; Rodríguez, Julián/0000-0003-4621-8905; Mejia Gaviria, Natalia/0000-0003-3650-2785	Fondo de Investigacion Sanitaria (FIS) [PI08-1723]; Fondo Europeo de Desarrollo Regional (FEDER); Fundacion para el Fomento en Asturias de la Investigacion Cientifica Aplicada y Tecnologia (FICYT) [PC07-004]; Instituto Universitario de Oncologia del Principado de Asturias (IUOPA); Fundacion Nutricion y Crecimiento	Fondo de Investigacion Sanitaria (FIS)(Instituto de Salud Carlos III); Fondo Europeo de Desarrollo Regional (FEDER)(European Commission); Fundacion para el Fomento en Asturias de la Investigacion Cientifica Aplicada y Tecnologia (FICYT); Instituto Universitario de Oncologia del Principado de Asturias (IUOPA); Fundacion Nutricion y Crecimiento	This study was supported by Fondo de Investigacion Sanitaria (FIS, PI08-1723), Fondo Europeo de Desarrollo Regional (FEDER), Fundacion para el Fomento en Asturias de la Investigacion Cientifica Aplicada y Tecnologia (FICYT, PC07-004), Instituto Universitario de Oncologia del Principado de Asturias (IUOPA) and Fundacion Nutricion y Crecimiento. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alvarez-Garcia O, 2007, PEDIATR NEPHROL, V22, P954, DOI 10.1007/s00467-007-0456-8; Alvarez-Garcia O, 2010, KIDNEY INT, V78, P561, DOI 10.1038/ki.2010.173; Bohensky J, 2010, PEDIATR NEPHROL, V25, P633, DOI 10.1007/s00467-009-1310-y; Cobo A, 1999, J AM SOC NEPHROL, V10, P971; Cohen P, 2001, NAT REV MOL CELL BIO, V2, P769, DOI 10.1038/35096075; Cravedi P, 2009, LANCET, V373, P1235, DOI 10.1016/S0140-6736(09)60709-1; Dharnidharka VR, 2008, PEDIATR TRANSPLANT, V12, P689, DOI 10.1111/j.1399-3046.2007.00881.x; Fine RN, 2007, NAT CLIN PRACT NEPHR, V3, P318, DOI 10.1038/ncpneph0502; Geissler EK, 2010, KIDNEY INT, V78, P1075, DOI 10.1038/ki.2010.324; Gillespie JR, 2011, ENDOCRINOLOGY, V152, P1755, DOI 10.1210/en.2010-1412; Gonzalez D, 2011, PEDIATR NEPHROL, V26, P961, DOI 10.1007/s00467-011-1811-3; Guo XZ, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0006067; Hudes G, 2007, NEW ENGL J MED, V356, P2271, DOI 10.1056/NEJMoa066838; Ibanez JP, 2005, TRANSPLANT P, V37, P682, DOI 10.1016/j.transproceed.2004.12.242; Kawasaki Y, 2008, J CLIN INVEST, V118, P2506, DOI 10.1172/JCI35243; Koehl GE, 2004, TRANSPLANTATION, V77, P1319, DOI 10.1097/00007890-200405150-00002; Le Roith D, 2001, ENDOCR REV, V22, P53, DOI 10.1210/er.22.1.53; Mizushima N, 2010, CELL, V140, P313, DOI 10.1016/j.cell.2010.01.028; Molinos I, 2006, KIDNEY INT, V70, P1955, DOI 10.1038/sj.ki.5001949; Murakami S, 2004, GENE DEV, V18, P290, DOI 10.1101/gad.1179104; Phornphutkul C, 2009, J ORTHOP RES, V27, P1157, DOI 10.1002/jor.20894; Rangel GA, 2009, PEDIATR NEPHROL, V24, P2047, DOI 10.1007/s00467-009-1215-9; Sanchez CP, 2009, BMC PEDIATR, V9, DOI 10.1186/1471-2431-9-3; Srinivas V, 2009, CELLS TISSUES ORGANS, V189, P88, DOI 10.1159/000151428; van der Eerden BCJ, 2003, ENDOCR REV, V24, P782, DOI 10.1210/er.2002-0033; Wilsman NJ, 1996, J ORTHOP RES, V14, P927, DOI 10.1002/jor.1100140613; Wullschleger S, 2006, CELL, V124, P471, DOI 10.1016/j.cell.2006.01.016	27	12	13	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 6	2012	7	4							e34788	10.1371/journal.pone.0034788	http://dx.doi.org/10.1371/journal.pone.0034788			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	955JA	22493717	gold, Green Published, Green Submitted			2022-12-25	WOS:000305012700059
J	Liang, GY; Nan, HM; Qureshi, AA; Han, JL				Liang, Geyu; Nan, Hongmei; Qureshi, Abrar A.; Han, Jiali			Pre-Diagnostic Plasma 25-Hydroxyvitamin D Levels and Risk of Non-Melanoma Skin Cancer in Women	PLOS ONE			English	Article							VITAMIN-D LEVELS; INCIDENT HYPERTENSION; POSTMENOPAUSAL WOMEN; BREAST-CANCER; UNITED-STATES; ELDERLY-MEN; BASAL-CELL; HEALTH; COHORT; 1,25-DIHYDROXYVITAMIN-D	Background: Recent reports have shown that vitamin D status was inversely associated with the risk of various cancers. However, few studies examined the association between vitamin D levels and risk of skin cancer. Methods: We prospectively evaluated the association between baseline plasma 25(OH)D levels and the risk of incident squamous cell carcinoma (SCC) and basal cell carcinoma (BCC) among 4,641 women from the Nurses' Health Study (NHS) and the NHS II with 510 incident BCC cases and 75 incident SCC cases. We used multivariate logistic regression models to calculate odds ratios (ORs) and 95% confidence intervals (CIs). Results: Plasma 25(OH)D levels were positively associated with risk of BCC after adjusting for age at blood draw, season of blood draw, lab batch, hair color, burning tendency, the number of sunburns, and ultra-violet B flux of residence at blood collection. Women in the highest quartile of 25(OH)D had more than 2-fold increased risk of BCC compared with women in the lowest quartile (OR = 2.07, 95% CI = 1.52-2.80, P for trend <0.0001). We also found a significantly positive association between plasma 25(OH)D levels and SCC risk after adjusting for the same covariates (OR, highest vs. lowest quartile = 3.77, 95% CI = 1.70-8.36, P for trend = 0.0002). Conclusion: In this prospective study of women, plasma vitamin D levels were positively associated with non-melanoma skin cancer risk. Considering that most circulating vitamin D is due to sun exposure, the positive association between plasma vitamin D and non-melanoma skin cancer is confounded by sun exposure. Our data suggest that one-time measurement of plasma vitamin D levels may reasonably reflect long-term sun exposure and predict the risk of non-melanoma skin cancer.	[Liang, Geyu] Southeast Univ, Sch Publ Hlth, Minist Educ, Key Lab Environm Med Engn, Nanjing, Jiangsu, Peoples R China; [Nan, Hongmei; Qureshi, Abrar A.; Han, Jiali] Brigham & Womens Hosp, Dept Med, Channing Lab, Boston, MA USA; [Qureshi, Abrar A.; Han, Jiali] Harvard Univ, Brigham & Womens Hosp, Sch Med, Dept Dermatol, Boston, MA 02115 USA; [Han, Jiali] Harvard Univ, Sch Publ Hlth, Dept Epidemiol, Boston, MA 02115 USA; [Nan, Hongmei] Univ Maryland, Sch Med, Dept Epidemiol & Publ Hlth, Div Canc Epidemiol, Baltimore, MD 21201 USA	Southeast University - China; Harvard University; Brigham & Women's Hospital; Harvard University; Brigham & Women's Hospital; Harvard Medical School; Harvard University; Harvard T.H. Chan School of Public Health; University System of Maryland; University of Maryland Baltimore	Liang, GY (corresponding author), Southeast Univ, Sch Publ Hlth, Minist Educ, Key Lab Environm Med Engn, Nanjing, Jiangsu, Peoples R China.	jiali.han@channing.harvard.edu			NIH [CA50385, CA67262, CA87969, CA49449]; NATIONAL CANCER INSTITUTE [R01CA050385, R01CA049449, U01CA067262, P01CA087969, U01CA049449, R01CA067262] Funding Source: NIH RePORTER	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	This work is supported by NIH grants CA50385, CA67262, CA87969, and CA49449. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ahonen MH, 2000, CANCER CAUSE CONTROL, V11, P847, DOI 10.1023/A:1008923802001; Asgari MM, 2010, J INVEST DERMATOL, V130, P1438, DOI 10.1038/jid.2009.402; Barake R, 2010, J AM COLL NUTR, V29, P25, DOI 10.1080/07315724.2010.10719813; Christenson LJ, 2005, JAMA-J AM MED ASSOC, V294, P681, DOI 10.1001/jama.294.6.681; COLDITZ GA, 1986, AM J EPIDEMIOL, V123, P894, DOI 10.1093/oxfordjournals.aje.a114319; Eide MJ, 2011, ARCH DERMATOL, V147, P1379, DOI 10.1001/archdermatol.2011.231; Eliassen AH, 2011, BREAST CANCER RES, V13, DOI 10.1186/bcr2880; Feskanich D, 2004, CANCER EPIDEM BIOMAR, V13, P1502; Forman JP, 2008, HYPERTENSION, V52, P828, DOI 10.1161/HYPERTENSIONAHA.108.117630; Forman JP, 2007, HYPERTENSION, V49, P1063, DOI 10.1161/HYPERTENSIONAHA.107.087288; Garcia VC, 2010, NUTRIENTS, V2, P426, DOI 10.3390/nu2040426; Goodwin PJ, 2009, J CLIN ONCOL, V27, P3757, DOI 10.1200/JCO.2008.20.0725; Green AK, 2010, INT J CANCER, V127, P667, DOI 10.1002/ijc.25075; Holick MF, 2010, ENDOCRIN METAB CLIN, V39, P381, DOI [10.1016/j.rdc.2012.03.013, 10.1016/j.ecl.2010.02.016]; Hollis BW, 1996, CALCIFIED TISSUE INT, V58, P4, DOI 10.1007/s002239900002; Hollis BW, 1997, METHOD ENZYMOL, V282, P174; Hunter David J., 1990, Annals of Epidemiology, V1, P13; Karohl C, 2010, AM J CLIN NUTR, V92, P1393, DOI 10.3945/ajcn.2010.30176; Kotsopoulos J, 2010, CANCER EPIDEM BIOMAR, V19, P938, DOI 10.1158/1055-9965.EPI-09-1318; Linos E, 2009, J INVEST DERMATOL, V129, P1666, DOI 10.1038/jid.2008.423; MIETTINEN OS, 1976, AM J EPIDEMIOL, V104, P609, DOI 10.1093/oxfordjournals.aje.a112339; MILLER DL, 1994, J AM ACAD DERMATOL, V30, P774, DOI 10.1016/S0190-9622(08)81509-5; Seifert M, 2004, J STEROID BIOCHEM, V89-90, P375, DOI 10.1016/j.jsbmb.2004.03.002; Skinner HG, 2006, CANCER EPIDEM BIOMAR, V15, P1688, DOI 10.1158/1055-9965.EPI-06-0206; Tang JY, 2011, J CLIN ONCOL, V29, P3078, DOI 10.1200/JCO.2011.34.5967; Tang JY, 2011, CANCER PREV RES, V4, P744, DOI 10.1158/1940-6207.CAPR-10-0285; Tang JY, 2010, CANCER CAUSE CONTROL, V21, P387, DOI 10.1007/s10552-009-9470-4; Tworoger SS, 2007, CANCER EPIDEM BIOMAR, V16, P783, DOI 10.1158/1055-9965.EPI-06-0981; Wagner D, 2009, CLIN BIOCHEM, V42, P1549, DOI 10.1016/j.clinbiochem.2009.07.013; Wang YT, 2009, AM J EPIDEMIOL, V170, P88, DOI 10.1093/aje/kwp086; Weinstein SJ, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0020796; Wu K, 2007, J NATL CANCER I, V99, P1120, DOI 10.1093/jnci/djm038; Zhou W, 2005, CANCER EPIDEM BIOMAR, V14, P2303, DOI 10.1158/1055-9965.EPI-05-0335; Zinser GM, 2002, CARCINOGENESIS, V23, P2103, DOI 10.1093/carcin/23.12.2103	34	34	34	0	19	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 6	2012	7	4							e35211	10.1371/journal.pone.0035211	http://dx.doi.org/10.1371/journal.pone.0035211			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	955JA	22493740	gold, Green Published, Green Submitted			2022-12-25	WOS:000305012700082
J	Walsh, CJ				Walsh, Charles J.			The Structure of the Mitotic Spindle and Nucleolus during Mitosis in the Amebo-Flagellate Naegleria	PLOS ONE			English	Article							GRUBERI; ACTIN; PROTEIN; CLONING	Mitosis in the amebo-flagellate Naegleria pringsheimi is acentrosomal and closed (the nuclear membrane does not break down). The large central nucleolus, which occupies about 20% of the nuclear volume, persists throughout the cell cycle. At mitosis, the nucleolus divides and moves to the poles in association with the chromosomes. The structure of the mitotic spindle and its relationship to the nucleolus are unknown. To identify the origin and structure of the mitotic spindle, its relationship to the nucleolus and to further understand the influence of persistent nucleoli on cellular division in acentriolar organisms like Naegleria, three-dimensional reconstructions of the mitotic spindle and nucleolus were carried out using confocal microscopy. Monoclonal antibodies against three different nucleolar regions and alpha-tubulin were used to image the nucleolus and mitotic spindle. Microtubules were restricted to the nucleolus beginning with the earliest prophase spindle microtubules. Early spindle microtubules were seen as short rods on the surface of the nucleolus. Elongation of the spindle microtubules resulted in a rough cage of microtubules surrounding the nucleolus. At metaphase, the mitotic spindle formed a broad band completely embedded within the nucleolus. The nucleolus separated into two discreet masses connected by a dense band of microtubules as the spindle elongated. At telophase, the distal ends of the mitotic spindle were still completely embedded within the daughter nucleoli. Pixel by pixel comparison of tubulin and nucleolar protein fluorescence showed 70% or more of tubulin co-localized with nucleolar proteins by early prophase. These observations suggest a model in which specific nucleolar binding sites for microtubules allow mitotic spindle formation and attachment. The fact that a significant mass of nucleolar material precedes the chromosomes as the mitotic spindle elongates suggests that spindle elongation drives nucleolar division.	Univ Pittsburgh, Dept Biol Sci, Pittsburgh, PA 15260 USA	Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh	Walsh, CJ (corresponding author), Univ Pittsburgh, Dept Biol Sci, Pittsburgh, PA 15260 USA.	cwalsh@pitt.edu			Department of Biological Sciences at the University of Pittsburgh	Department of Biological Sciences at the University of Pittsburgh	I am grateful to Christine Berliner, William Saunders and Betty Walsh for helpful comments on the manuscript. Tom Harper provided expert technical help with confocal microscopy. This work would not have been possible without the support of the Department of Biological Sciences at the University of Pittsburgh and the Department Chair, Professor Graham Hatfull. The expert technical help of David Salcido with this and previous work is especially appreciated.	Chung SL, 2002, GENE, V293, P77, DOI 10.1016/S0378-1119(02)00509-7; CLARK CG, 1987, MOL CELL BIOL, V7, P3027, DOI 10.1128/MCB.7.9.3027; CLARK CG, 1990, J PROTOZOOL, V37, P400, DOI 10.1111/j.1550-7408.1990.tb01164.x; De Jonckheere JF, 2004, PROTIST, V155, P89, DOI 10.1078/1434461000167; Fritz-Laylin LK, 2010, CELL, V140, P631, DOI 10.1016/j.cell.2010.01.032; FULTON C, 1971, J CELL BIOL, V51, P826, DOI 10.1083/jcb.51.3.826; Fulton C., 1970, Methods Cell Physiol., V4, P341; FULTON C, 1967, DEV BIOL, V15, P165, DOI 10.1016/0012-1606(67)90012-7; Gatlin JC, 2010, SEMIN CELL DEV BIOL, V21, P248, DOI 10.1016/j.semcdb.2010.01.015; Gonzalez-Robles A, 2009, EXP PARASITOL, V122, P212, DOI 10.1016/j.exppara.2009.03.016; Hernandez-Verdun D, 2011, NUCLEUS-PHILA, V2, P189, DOI 10.4161/nucl.2.3.16246; POMORSKI P, 1993, CELL BIOL INT, V17, P521, DOI 10.1006/cbir.1993.1093; Sandquist JC, 2011, DEV CELL, V21, P410, DOI 10.1016/j.devcel.2011.07.018; SCHUSTER FL, 1975, TISSUE CELL, V7, P1, DOI 10.1016/S0040-8166(75)80003-6; Trimbur GM, 1999, J CELL SCI, V112, P1159; TRIMBUR GM, 1993, J CELL BIOL, V122, P753, DOI 10.1083/jcb.122.4.753; TRIMBUR GM, 1992, J CELL SCI, V103, P167; Wadsworth P, 2011, PROTOPLASMA, V248, P439, DOI 10.1007/s00709-010-0205-x; WALSH C, 1984, J CELL BIOL, V98, P449, DOI 10.1083/jcb.98.2.449; Walsh CJ, 2007, EUR J CELL BIOL, V86, P85, DOI 10.1016/j.ejcb.2006.10.003	20	10	10	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 6	2012	7	4							e34763	10.1371/journal.pone.0034763	http://dx.doi.org/10.1371/journal.pone.0034763			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	955JA	22493714	Green Accepted, Green Published, gold			2022-12-25	WOS:000305012700056
J	Kao, CH; Hsiang, CY; Ho, TY				Kao, Chia-Hung; Hsiang, Chien-Yun; Ho, Tin-Yun			Assessment of Chitosan-Affected Metabolic Response by Peroxisome Proliferator-Activated Receptor Bioluminescent Imaging-Guided Transcriptomic Analysis	PLOS ONE			English	Article							HOST-BIOMATERIAL INTERACTION; MOLECULAR-WEIGHT CHITOSAN; NUCLEAR RECEPTORS; APOLIPOPROTEIN-B; PPAR-GAMMA; MICE; DISEASE; CHITIN; OLIGOSACCHARIDES; THERAPY	Chitosan has been widely used in food industry as a weight-loss aid and a cholesterol-lowering agent. Previous studies have shown that chitosan affects metabolic responses and contributes to anti-diabetic, hypocholesteremic, and blood glucose-lowering effects; however, the in vivo targeting sites and mechanisms of chitosan remain to be clarified. In this study, we constructed transgenic mice, which carried the luciferase genes driven by peroxisome proliferator-activated receptor (PPAR), a key regulator of fatty acid and glucose metabolism. Bioluminescent imaging of PPAR transgenic mice was applied to report the organs that chitosan acted on, and gene expression profiles of chitosan-targeted organs were further analyzed to elucidate the mechanisms of chitosan. Bioluminescent imaging showed that constitutive PPAR activities were detected in brain and gastrointestinal tract. Administration of chitosan significantly activated the PPAR activities in brain and stomach. Microarray analysis of brain and stomach showed that several pathways involved in lipid and glucose metabolism were regulated by chitosan. Moreover, the expression levels of metabolism-associated genes like apolipoprotein B (apoB) and ghrelin genes were down-regulated by chitosan. In conclusion, these findings suggested the feasibility of PPAR bioluminescent imaging-guided transcriptomic analysis on the evaluation of chitosan-affected metabolic responses in vivo. Moreover, we newly identified that downregulated expression of apoB and ghrelin genes were novel mechanisms for chitosan-affected metabolic responses in vivo.	[Kao, Chia-Hung] China Med Univ Hosp, Dept Nucl Med, Taichung, Taiwan; [Hsiang, Chien-Yun] China Med Univ, Dept Microbiol, Taichung, Taiwan; [Ho, Tin-Yun] China Med Univ, Grad Inst Chinese Med, Taichung, Taiwan	China Medical University Taiwan; China Medical University Hospital - Taiwan; China Medical University Taiwan; China Medical University Taiwan	Ho, TY (corresponding author), China Med Univ, Grad Inst Chinese Med, Taichung, Taiwan.	tyh@mail.cmu.edu.tw	Hsiang, Chien-Yun/O-3853-2015; Ho, Tin-Yun/O-3889-2015		National Science Council (NSC) [100-2324-B-039-001, NSC100-2320-B-039-020]; Committee on Chinese Medicine and Pharmacy at Department of Health [CCMP100-RD-048, CCMP101-RD-103]; China Medical University [CMU100-S-16, CMU100-S-34, CMU100-TS-14]	National Science Council (NSC)(Ministry of Science and Technology, Taiwan); Committee on Chinese Medicine and Pharmacy at Department of Health; China Medical University(China Medical University)	This work was supported by grants from National Science Council (NSC 100-2324-B-039-001 and NSC100-2320-B-039-020), Committee on Chinese Medicine and Pharmacy at Department of Health (CCMP100-RD-048 and CCMP101-RD-103), and China Medical University (CMU100-S-16, CMU100-S-34, and CMU100-TS-14). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Baker WL, 2009, ANN NUTR METAB, V55, P368, DOI 10.1159/000258633; Baldrick P, 2010, REGUL TOXICOL PHARM, V56, P290, DOI 10.1016/j.yrtph.2009.09.015; Benn M, 2009, ATHEROSCLEROSIS, V206, P17, DOI 10.1016/j.atherosclerosis.2009.01.004; Bensinger SJ, 2008, NATURE, V454, P470, DOI 10.1038/nature07202; Castaneda TR, 2010, FRONT NEUROENDOCRIN, V31, P44, DOI 10.1016/j.yfrne.2009.10.008; Chang CT, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0031808; Chang CT, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0023682; Cheng WY, 2009, BRIT J PHARMACOL, V157, P746, DOI 10.1111/j.1476-5381.2009.00223.x; Cho EJ, 2008, J MICROBIOL BIOTECHN, V18, P80; Cho MC, 2008, PPAR RES, V2008, DOI 10.1155/2008/679137; Ciana P, 2007, MOL ENDOCRINOL, V21, P388, DOI 10.1210/me.2006-0152; Coll Teresa, 2009, Curr Mol Pharmacol, V2, P46; Escher P, 2000, MUTAT RES-FUND MOL M, V448, P121, DOI 10.1016/S0027-5107(99)00231-6; Hayashi K, 2002, BIOL PHARM BULL, V25, P188, DOI 10.1248/bpb.25.188; Heneka MT, 2007, BBA-MOL CELL BIOL L, V1771, P1031, DOI 10.1016/j.bbalip.2007.04.016; Ho TY, 2007, BIOMATERIALS, V28, P4370, DOI 10.1016/j.biomaterials.2007.07.005; Hsiang CY, 2009, BIOMATERIALS, V30, P3042, DOI 10.1016/j.biomaterials.2009.02.016; Jarmila V, 2011, CURR PHARM DESIGN, V7, P3596; Jayakumar R, 2011, BIOTECHNOL ADV, V29, P322, DOI 10.1016/j.biotechadv.2011.01.005; Jayakumar R, 2010, CARBOHYD POLYM, V82, P227, DOI 10.1016/j.carbpol.2010.04.074; Jayakumar R, 2010, PROG MATER SCI, V55, P675, DOI 10.1016/j.pmatsci.2010.03.001; Jayakumar R, 2010, BIOTECHNOL ADV, V28, P142, DOI 10.1016/j.biotechadv.2009.11.001; Jayakumar R, 2010, CARBOHYD POLYM, V79, P1, DOI 10.1016/j.carbpol.2009.08.026; KANAUCHI O, 1995, BIOSCI BIOTECH BIOCH, V59, P786, DOI 10.1271/bbb.59.786; Kanehisa M, 2010, NUCLEIC ACIDS RES, V38, pD355, DOI 10.1093/nar/gkp896; Khor E, 2003, BIOMATERIALS, V24, P2339, DOI 10.1016/S0142-9612(03)00026-7; Kim E, 1998, J LIPID RES, V39, P703; Kojima M, 1999, NATURE, V402, P656, DOI 10.1038/45230; Kumar SG, 2009, PROTEOMICS, V9, P2149, DOI 10.1002/pmic.200800571; Kummer MP, 2008, PPAR RES, V2008, DOI 10.1155/2008/403896; LENICH C, 1988, J LIPID RES, V29, P755; Liu SH, 2010, J AGR FOOD CHEM, V58, P5795, DOI 10.1021/jf100662r; Lovett-Racke AE, 2004, J IMMUNOL, V172, P5790, DOI 10.4049/jimmunol.172.9.5790; Martin H, 2010, MUTAT RES-FUND MOL M, V690, P57, DOI 10.1016/j.mrfmmm.2009.09.009; Mhurchu CN, 2005, OBES REV, V6, P35, DOI 10.1111/j.1467-789X.2005.00158.x; Perissi V, 2005, NAT REV MOL CELL BIO, V6, P542, DOI 10.1038/nrm1680; Peters JM, 2008, CLIN SCI, V115, P107, DOI 10.1042/CS20080022; Rahman MA, 2008, PROTEOMICS, V8, P569, DOI 10.1002/pmic.200700888; Rosenson RS, 2009, ATHEROSCLEROSIS, V207, P328, DOI 10.1016/j.atherosclerosis.2009.05.020; Schintu N, 2009, EUR J NEUROSCI, V29, P954, DOI 10.1111/j.1460-9568.2009.06657.x; Shah A, 2010, ATHEROSCLEROSIS, V210, P35, DOI 10.1016/j.atherosclerosis.2009.11.010; Sniderman AD, 2005, CIRCULATION, V112, P3366, DOI 10.1161/CIRCULATIONAHA.105.583336; Sumiyoshi M, 2006, J PHARM PHARMACOL, V58, P201, DOI 10.1211/jpp.58.2.0007; Wu SL, 2009, J PHARMACOL EXP THER, V330, P370, DOI 10.1124/jpet.109.152835; Zambelli F, 2009, NUCLEIC ACIDS RES, V37, pW247, DOI 10.1093/nar/gkp464	45	13	13	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 4	2012	7	4							e34969	10.1371/journal.pone.0034969	http://dx.doi.org/10.1371/journal.pone.0034969			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	953GO	22496881	Green Submitted, gold, Green Published			2022-12-25	WOS:000304855200092
J	Karunanithi, S; Joshi, J; Chavel, C; Birkaya, B; Grell, L; Cullen, PJ				Karunanithi, Sheelarani; Joshi, Jyoti; Chavel, Colin; Birkaya, Barbara; Grell, Laura; Cullen, Paul J.			Regulation of Mat Responses by a Differentiation MAPK Pathway in Saccharomyces cerevisiae	PLOS ONE			English	Article							HAPLOID INVASIVE GROWTH; BUD-SITE-SELECTION; BIOFILM FORMATION; FILAMENTOUS GROWTH; PROTEIN-KINASE; SIGNALING SPECIFICITY; GENE DELETION; TRANSCRIPTION; FLO11; REPRESSION	Fungal species exhibit diverse behaviors when presented with extracellular challenges. Pathogenic fungi can undergo cell differentiation and biofilm formation in response to fluctuating nutrient levels, and these responses are required for virulence. In the model fungal eukaryote Saccharomyces cerevisiae, nutrient limitation induces filamentous growth and biofilm/mat formation. Both responses require the same signal transduction (MAPK) pathway and the same cell adhesion molecule (Flo11) but have been studied under different conditions. We found that filamentous growth and mat formation are aspects of a related response that is regulated by the MAPK pathway. Cells in yeast-form mats differentiated into pseudohyphae in response to nutrient limitation. The MAPK pathway regulated mat expansion (in the plane of the XY-axis) and substrate invasion (downward in the plane of the Z-axis), which optimized the mat's response to extracellular nutrient levels. The MAPK pathway also regulated an upward growth pattern (in the plane of the Z-axis) in response to nutrient limitation and changes in surface rigidity. Upward growth allowed for another level of mat responsiveness and resembled a type of colonial chemorepulsion. Together our results show that signaling pathways play critical roles in regulating social behaviors in which fungal cells participate. Signaling pathways may regulate similar processes in pathogens, whose highly nuanced responses are required for virulence.	[Karunanithi, Sheelarani; Joshi, Jyoti; Chavel, Colin; Birkaya, Barbara; Grell, Laura; Cullen, Paul J.] SUNY Buffalo, Dept Biol Sci, Buffalo, NY 14260 USA	State University of New York (SUNY) System; State University of New York (SUNY) Buffalo	Karunanithi, S (corresponding author), SUNY Buffalo, Dept Biol Sci, Buffalo, NY 14260 USA.	pjcullen@buffalo.edu			National Institutes of Health [1R03DE018425-01, GM098629, DE018425]; American Cancer Society [TBE-114083]; NATIONAL INSTITUTE OF DENTAL &CRANIOFACIAL RESEARCH [R03DE018425] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM098629] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); American Cancer Society(American Cancer Society); NATIONAL INSTITUTE OF DENTAL &CRANIOFACIAL RESEARCH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Dental & Craniofacial Research (NIDCR)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	Funding was provided by the National Institutes of Health (1R03DE018425-01, GM098629, and DE018425) and the American Cancer Society (TBE-114083). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Baillie GS, 1999, J MED MICROBIOL, V48, P671, DOI 10.1099/00222615-48-7-671; Bardwell L, 2006, BIOCHEM SOC T, V34, P837, DOI 10.1042/BST0340837; Bardwell L, 1998, P NATL ACAD SCI USA, V95, P15400, DOI 10.1073/pnas.95.26.15400; BAUDIN A, 1993, NUCLEIC ACIDS RES, V21, P3329, DOI 10.1093/nar/21.14.3329; Beauvais A, 2009, FEMS YEAST RES, V9, P411, DOI 10.1111/j.1567-1364.2009.00482.x; Blankenship JR, 2006, CURR OPIN MICROBIOL, V9, P588, DOI 10.1016/j.mib.2006.10.003; Chandra J, 2005, CURR DRUG TARGETS, V6, P887, DOI 10.2174/138945005774912762; CHANT J, 1995, J CELL BIOL, V129, P751, DOI 10.1083/jcb.129.3.751; Chavel CA, 2010, PLOS GENET, V6, DOI 10.1371/journal.pgen.1000883; Chen H, 2006, GENE DEV, V20, P1150, DOI 10.1101/gad.1411806; Cook JG, 1996, GENE DEV, V10, P2831, DOI 10.1101/gad.10.22.2831; COSTERTON JW, 1995, ANNU REV MICROBIOL, V49, P711, DOI 10.1146/annurev.mi.49.100195.003431; Csank C, 1998, INFECT IMMUN, V66, P2713, DOI 10.1128/IAI.66.6.2713-2721.1998; Cullen PJ, 2000, P NATL ACAD SCI USA, V97, P13619, DOI 10.1073/pnas.240345197; Cullen PJ, 2004, GENE DEV, V18, P1695, DOI 10.1101/gad.1178604; Cullen PJ, 2002, MOL BIOL CELL, V13, P2990, DOI 10.1091/mbc.E02-03-0151; GIMENO CJ, 1992, CELL, V68, P1077, DOI 10.1016/0092-8674(92)90079-R; Goldstein AL, 1999, YEAST, V15, P1541, DOI 10.1002/(SICI)1097-0061(199910)15:14<1541::AID-YEA476>3.3.CO;2-B; Guo B, 2000, P NATL ACAD SCI USA, V97, P12158, DOI 10.1073/pnas.220420397; Halme A, 2004, CELL, V116, P405, DOI 10.1016/S0092-8674(04)00118-7; Karunanithi S, 2010, CURR BIOL, V20, P1389, DOI 10.1016/j.cub.2010.06.033; Kumamoto CA, 2005, ANNU REV MICROBIOL, V59, P113, DOI 10.1146/annurev.micro.59.030804.121034; Kumamoto CA, 2005, P NATL ACAD SCI USA, V102, P5576, DOI 10.1073/pnas.0407097102; Laffey SF, 2005, MICROBIOL-SGM, V151, P1073, DOI 10.1099/mic.0.27739-0; Lamb TM, 2003, MOL CELL BIOL, V23, P677, DOI 10.1128/MCB.23.2.677-686.2003; Lambrechts MG, 1996, P NATL ACAD SCI USA, V93, P8419, DOI 10.1073/pnas.93.16.8419; Leberer E, 1997, EMBO J, V16, P83, DOI 10.1093/emboj/16.1.83; LIU HP, 1993, SCIENCE, V262, P1741, DOI 10.1126/science.8259520; Lo HJ, 1997, CELL, V90, P939, DOI 10.1016/S0092-8674(00)80358-X; Lo WS, 1998, MOL BIOL CELL, V9, P161, DOI 10.1091/mbc.9.1.161; Longtine MS, 1998, YEAST, V14, P953, DOI 10.1002/(SICI)1097-0061(199807)14:10<953::AID-YEA293>3.3.CO;2-L; Madhani HD, 1998, TRENDS CELL BIOL, V8, P348, DOI 10.1016/S0962-8924(98)01298-7; Madhani HD, 1997, SCIENCE, V275, P1314, DOI 10.1126/science.275.5304.1314; Madhani HD, 1997, CELL, V91, P673, DOI 10.1016/S0092-8674(00)80454-7; Malcher M, 2011, GENETICS, V187, P717, DOI 10.1534/genetics.110.125708; Martineau CN, 2007, GENETICS, V177, P1679, DOI 10.1534/genetics.107.081141; Mosch HU, 1996, P NATL ACAD SCI USA, V93, P5352, DOI 10.1073/pnas.93.11.5352; Murillo LA, 2005, EUKARYOT CELL, V4, P1562, DOI 10.1128/EC.4.9.1562-1573.2005; Nett JE, 2009, J INFECT DIS, V200, P307, DOI 10.1086/599838; Nobile CJ, 2005, CURR BIOL, V15, P1150, DOI 10.1016/j.cub.2005.05.047; Nobile CJ, 2006, EUKARYOT CELL, V5, P1604, DOI 10.1128/EC.00194-06; Nobile CJ, 2006, PLOS PATHOG, V2, P636, DOI 10.1371/journal.ppat.0020063; Norice CT, 2007, EUKARYOT CELL, V6, P2046, DOI 10.1128/EC.00314-07; O'Rourke SM, 1998, GENE DEV, V12, P2874, DOI 10.1101/gad.12.18.2874; Paramonova E, 2009, MICROBIOL-SGM, V155, P1997, DOI 10.1099/mic.0.021568-0; Parsek MR, 2005, TRENDS MICROBIOL, V13, P27, DOI 10.1016/j.tim.2004.11.007; Peter M, 1996, EMBO J, V15, P7046, DOI 10.1002/j.1460-2075.1996.tb01096.x; Ramage G, 2002, FEMS MICROBIOL LETT, V214, P95, DOI 10.1111/j.1574-6968.2002.tb11330.x; Reynolds TB, 2001, SCIENCE, V291, P878, DOI 10.1126/science.291.5505.878; Reynolds TB, 2006, EUKARYOT CELL, V5, P1266, DOI 10.1128/EC.00022-06; Richard ML, 2005, EUKARYOT CELL, V4, P1493, DOI 10.1128/EC.4.8.1493-1502.2005; ROBERTS RL, 1994, GENE DEV, V8, P2974, DOI 10.1101/gad.8.24.2974; Rose MD., 1990, METHODS YEAST GENETI; Rupp S, 1999, EMBO J, V18, P1257, DOI 10.1093/emboj/18.5.1257; Sambrook J., 1989, MOL CLONING LAB MANU, V2; Sarode N, 2011, EUKARYOT CELL, V10, P1516, DOI 10.1128/EC.05078-11; Scherz R, 2001, J BACTERIOL, V183, P5402, DOI 10.1128/JB.183.18.5402-5413.2001; Schwartz MA, 2004, ANNU REV GENET, V38, P725, DOI 10.1146/annurev.genet.39.073003.112634; Vinod PK, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0001663	60	18	18	3	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 4	2012	7	4							e32294	10.1371/journal.pone.0032294	http://dx.doi.org/10.1371/journal.pone.0032294			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	953GO	22496730	gold, Green Published, Green Submitted			2022-12-25	WOS:000304855200003
J	Al-Mousa, F; Michelangeli, F				Al-Mousa, Fawaz; Michelangeli, Francesco			Some Commonly Used Brominated Flame Retardants Cause Ca2+-ATPase Inhibition, Beta-Amyloid Peptide Release and Apoptosis in SH-SY5Y Neuronal Cells	PLOS ONE			English	Article							TETRABROMOBISPHENOL-A TBBPA; POLYCHLORINATED-BIPHENYLS; SPONTANEOUS BEHAVIOR; ALZHEIMERS-DISEASE; NEONATAL EXPOSURE; DIPHENYL ETHERS; CALCIUM; HEXABROMOCYCLODODECANE; ADULT; DYSREGULATION	Brominated flame retardants (BFRs) are chemicals commonly used to reduce the flammability of consumer products and are considered pollutants since they have become widely dispersed throughout the environment and have also been shown to bio-accumulate within animals and man. This study investigated the cytotoxicity of some of the most commonly used groups of BFRs on SH-SY5Y human neuroblastoma cells. The results showed that of the BFRs tested, hexabromocyclododecane (HBCD), tetrabromobisphenol-A (TBBPA) and decabromodiphenyl ether (DBPE), all are cytotoxic at low micromolar concentrations (LC50 being 2.7 +/- 0.7 mu M, 15 +/- 4 mu M and 28 +/- 7 mu M, respectively). They induced cell death at least in part, by apoptosis through activation of caspases. They also increased intracellular [Ca2+] levels and reactive-oxygen-species within these neuronal cells. Furthermore, these BFRs also caused rapid depolarization of the mitochondria and cytochrome c release in these neuronal cells. Elevated intracellular [Ca2+] levels appear to occur through a mechanism involving microsomal Ca2+-ATPase inhibition and this maybe responsible for Ca2+-induced mitochondria dysfunction. In addition, mu M levels of these BFRs caused beta-amyloid peptide (A beta-42) processing and release from these cells with a few hours of exposure. These results therefore shows that these pollutants are both neurotoxic and amyloidogenic in-vitro.	[Al-Mousa, Fawaz; Michelangeli, Francesco] Univ Birmingham, Sch Biosci, Birmingham, W Midlands, England	University of Birmingham	Al-Mousa, F (corresponding author), Univ Birmingham, Sch Biosci, Birmingham, W Midlands, England.	F.Michelangeli@Bham.ac.uk			Medical Faculty of the University of Birmingham; The Ministry of Health, Saudi Arabia	Medical Faculty of the University of Birmingham; The Ministry of Health, Saudi Arabia	This project was funded through a Rowbottom bequest grant from the Medical Faculty of the University of Birmingham. The Ministry of Health, Saudi Arabia is thanked for a PhD scholarship to F. Al-Mousa. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alaee M, 2002, CHEMOSPHERE, V46, P579, DOI 10.1016/S0045-6535(01)00224-7; Berger AB, 2006, CELL RES, V2006, P1; Bezprozvanny I, 2008, TRENDS NEUROSCI, V31, P454, DOI 10.1016/j.tins.2008.06.005; Bi XH, 2007, ENVIRON SCI TECHNOL, V41, P5647, DOI 10.1021/es070346a; Camandola S, 2011, BBA-MOL CELL RES, V1813, P965, DOI 10.1016/j.bbamcr.2010.10.005; Darnerud PO, 2003, ENVIRON INT, V29, P841, DOI 10.1016/S0160-4120(03)00107-7; De Strooper B, 2000, J CELL SCI, V113, P1857; de Wit CA, 2002, CHEMOSPHERE, V46, P583, DOI 10.1016/S0045-6535(01)00225-9; Demuro A, 2005, J BIOL CHEM, V280, P17294, DOI 10.1074/jbc.M500997200; Demuro A, 2010, J BIOL CHEM, V285, P12463, DOI 10.1074/jbc.R109.080895; Eriksson P, 2002, TOXICOL SCI, V67, P98, DOI 10.1093/toxsci/67.1.98; Fonnum F, 2006, J TOXICOL ENV HEAL A, V69, P21, DOI 10.1080/15287390500259020; Franklin JL, 2011, ANTIOXID REDOX SIGN, V14, P1437, DOI 10.1089/ars.2010.3596; Green KN, 2008, J CELL BIOL, V181, P1107, DOI 10.1083/jcb.200706171; Hayden RE, 2010, HAEMATOL-HEMATOL J, V95, P1889, DOI 10.3324/haematol.2010.027821; He P, 2009, NEUROTOXICOLOGY, V30, P10, DOI 10.1016/j.neuro.2008.10.004; Jennings AM, 2006, FASEB J, V20, pA1158; Koyama Y, 2008, INVEST OPHTH VIS SCI, V49, P2376, DOI 10.1167/iovs.07-1067; Lai P, 2011, FEBS LETT, V585, P2291, DOI 10.1016/j.febslet.2011.05.058; Lai P, 2009, BIOSCIENCE REP, V29, P397, DOI 10.1042/BSR20090058; Leissring MA, 1999, J BIOL CHEM, V274, P32535, DOI 10.1074/jbc.274.46.32535; Liang B, 2010, J BIOL CHEM, V285, P27737, DOI 10.1074/jbc.M110.117960; Mattson MP, 2003, CELL CALCIUM, V34, P385, DOI 10.1016/S0143-4160(03)00128-3; Mattson MP, 2004, NATURE, V430, P631, DOI 10.1038/nature02621; McStay GP, 2008, CELL DEATH DIFFER, V15, P322, DOI 10.1038/sj.cdd.4402260; Michelangeli F, 2011, BIOCHEM SOC T, V39, P789, DOI 10.1042/BST0390789; Michelangeli F, 2008, CHEM-BIOL INTERACT, V176, P220, DOI 10.1016/j.cbi.2008.08.005; Nunez G, 1998, ONCOGENE, V17, P3237, DOI 10.1038/sj.onc.1202581; Ogunbayo OA, 2008, TOXICOL IN VITRO, V22, P943, DOI 10.1016/j.tiv.2008.01.015; Ogunbayo OA, 2007, BIOCHEM J, V408, P407, DOI 10.1042/BJ20070843; Ogunbayo OA, 2007, BBA-BIOMEMBRANES, V1768, P1559, DOI 10.1016/j.bbamem.2007.03.013; Querfurth HW, 1997, J NEUROCHEM, V69, P1580; Reistad T, 2006, ARCH TOXICOL, V80, P785, DOI 10.1007/s00204-006-0099-8; Stutzmann GE, 2004, J NEUROSCI, V24, P508, DOI 10.1523/JNEUROSCI.4386-03.2004; Stutzmann GE, 2007, NEUROSCIENTIST, V13, P546, DOI 10.1177/1073858407299730; Stutzmann GE, 2006, J NEUROSCI, V26, P5180, DOI 10.1523/JNEUROSCI.0739-06.2006; Szabo DT, 2010, TOXICOL SCI, V117, P282, DOI 10.1093/toxsci/kfq183; Tesco G, 2007, NEURON, V54, P721, DOI 10.1016/j.neuron.2007.05.012; Thomsen C, 2007, ENVIRON SCI TECHNOL, V41, P5210, DOI 10.1021/es0702622; Toescu EC, 2007, AGING CELL, V6, P267, DOI 10.1111/j.1474-9726.2007.00296.x; Viberg H, 2003, TOXICOL APPL PHARM, V192, P95, DOI 10.1016/S0041-008X(03)00217-5; Viberg H, 2006, TOXICOL SCI, V92, P211, DOI 10.1093/toxsci/kfj196; Viswanath V, 2001, J NEUROSCI, V21, P9519, DOI 10.1523/JNEUROSCI.21-24-09519.2001; Walsh DM, 2007, BIOCHEM SOC T, V35, P416, DOI 10.1042/BST0350416; Yoo AS, 2000, NEURON, V27, P561, DOI 10.1016/S0896-6273(00)00066-0	45	69	74	1	44	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 2	2012	7	4							e33059	10.1371/journal.pone.0033059	http://dx.doi.org/10.1371/journal.pone.0033059			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	952GU	22485137	Green Published, Green Submitted, gold			2022-12-25	WOS:000304780500013
J	Wang, K; Bodempudi, V; Liu, ZG; Borrego-Diaz, E; Yamoutpoor, F; Meyer, A; Woo, RA; Pan, W; Dudek, AZ; Olyaee, MS; Esfandyari, T; Farassati, F				Wang, Kun; Bodempudi, Vidya; Liu, Zhengian; Borrego-Diaz, Emma; Yamoutpoor, Farnaz; Meyer, Anna; Woo, Richard A.; Pan, Weihong; Dudek, Arkadiusz Z.; Olyaee, Mojtaba S.; Esfandyari, Tuba; Farassati, Faris			Inhibition of Mesothelin as a Novel Strategy for Targeting Cancer Cells	PLOS ONE			English	Article							RAF-MEK-ERK; HUMAN LUNG-CANCER; ENDOPLASMIC-RETICULUM; PANCREATIC-CANCER; OVARIAN-CANCER; MONOCLONAL-ANTIBODY; ANTITUMOR-ACTIVITY; TUMOR PROGRESSION; IMMUNOTOXIN SS1P; HIGH-AFFINITY	Mesothelin, a differentiation antigen present in a series of malignancies such as mesothelioma, ovarian, lung and pancreatic cancer, has been studied as a marker for diagnosis and a target for immunotherapy. We, however, were interested in evaluating the effects of direct targeting of Mesothelin on the viability of cancer cells as the first step towards developing a novel therapeutic strategy. We report here that gene specific silencing for Mesothelin by distinct methods (siRNA and microRNA) decreased viability of cancer cells from different origins such as mesothelioma (H2373), ovarian cancer (Skov3 and Ovcar-5) and pancreatic cancer (Miapaca2 and Panc-1). Additionally, the invasiveness of cancer cells was also significantly decreased upon such treatment. We then investigated pro-oncogenic signaling characteristics of cells upon mesothelin-silencing which revealed a significant decrease in phospho-ERK1 and PI3K/AKT activity. The molecular mechanism of reduced invasiveness was connected to the reduced expression of beta-Catenin, an important marker of EMT (epithelial-mesenchymal transition). Ero1, a protein involved in clearing unfolded proteins and a member of the ER-Stress (endoplasmic reticulum-stress) pathway was also markedly reduced. Furthermore, Mesothelin silencing caused a significant increase in fraction of cancer cells in S-phase. In next step, treatment of ovarian cancer cells (OVca429) with a lentivirus expressing anti-mesothelin microRNA resulted in significant loss of viability, invasiveness, and morphological alterations. Therefore, we propose the inhibition of Mesothelin as a potential novel strategy for targeting human malignancies.	[Wang, Kun; Liu, Zhengian; Borrego-Diaz, Emma; Yamoutpoor, Farnaz; Pan, Weihong; Olyaee, Mojtaba S.; Esfandyari, Tuba; Farassati, Faris] Univ Kansas, Med Ctr, Dept Med, Mol Med Lab,Div Gastroenterol, Kansas City, KS 66103 USA; [Wang, Kun; Liu, Zhengian; Borrego-Diaz, Emma; Yamoutpoor, Farnaz; Pan, Weihong; Olyaee, Mojtaba S.; Esfandyari, Tuba; Farassati, Faris] Univ Kansas, Med Ctr, Div Hematol Oncol, Dept Med, Kansas City, KS 66103 USA; [Bodempudi, Vidya; Meyer, Anna; Dudek, Arkadiusz Z.] Univ Minnesota, Dept Med, Minneapolis, MN 55455 USA; [Woo, Richard A.] So Illinois Univ, Med Ctr, Springfield, IL USA	University of Kansas; University of Kansas Medical Center; University of Kansas; University of Kansas Medical Center; University of Minnesota System; University of Minnesota Twin Cities; Southern Illinois University System; Southern Illinois University	Wang, K (corresponding author), Univ Kansas, Med Ctr, Dept Med, Mol Med Lab,Div Gastroenterol, Kansas City, KS 66103 USA.	ffarassati@kumc.edu	Dudek, Arkadiusz Zbigniew/HGD-1339-2022; Wang, Kun/H-5227-2016	Dudek, Arkadiusz Zbigniew/0000-0002-9114-8945; 	Mesothelioma Applied Research Foundation (MARF); Marsha Rivkin Institute for Ovarian Cancer (MRC); Flight attendant Medical Research Institute (FAMRI); All in For Cure	Mesothelioma Applied Research Foundation (MARF); Marsha Rivkin Institute for Ovarian Cancer (MRC); Flight attendant Medical Research Institute (FAMRI); All in For Cure	Research at F. Farassati's laboratory is supported by "All in For Cure", "Mesothelioma Applied Research Foundation (MARF)", "Marsha Rivkin Institute for Ovarian Cancer (MRC)" and "Flight attendant Medical Research Institute (FAMRI)". The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abdel-Azeez HA, 2010, ASIAN PAC J CANCER P, V11, P111; Alvarado Y, 2007, EXPERT OPIN EMERG DR, V12, P271, DOI 10.1517/14728214.12.2.271; Alves CC, 2009, FRONT BIOSCI-LANDMRK, V14, P3041, DOI 10.2741/3433; Araki K, 2011, J BIOL CHEM; Baba K, 2012, J SURG ONCOL, V105, P195, DOI 10.1002/jso.22024; Banhegyi G, 2007, ANN NY ACAD SCI, V1113, P58, DOI 10.1196/annals.1391.007; Bartel DP, 2009, CELL, V136, P215, DOI 10.1016/j.cell.2009.01.002; Bera TK, 2000, MOL CELL BIOL, V20, P2902, DOI 10.1128/MCB.20.8.2902-2906.2000; Bharadwaj U, 2011, MOL CANCER, V10, DOI 10.1186/1476-4598-10-106; Bharadwaj U, 2011, CARCINOGENESIS, V32, P1013, DOI 10.1093/carcin/bgr075; Bodempudi V, 2009, MOL CELL BIOL, V29, P3964, DOI 10.1128/MCB.01153-08; Boelens J, 2007, IN VIVO, V21, P215; Bolos V, 2003, J CELL SCI, V116, P499, DOI 10.1242/jcs.00224; Breidenbach M, 2005, GENE THER, V12, P187, DOI 10.1038/sj.gt.3302404; Carthew RW, 2009, CELL, V136, P642, DOI 10.1016/j.cell.2009.01.035; Chang F, 2003, LEUKEMIA, V17, P590, DOI 10.1038/sj.leu.2402824; CHANG K, 1992, INT J CANCER, V50, P373, DOI 10.1002/ijc.2910500308; Chang K, 1996, P NATL ACAD SCI USA, V93, P136, DOI 10.1073/pnas.93.1.136; Chang MC, 2011, BIOCH J; Couto LB, 2010, CURR OPIN PHARMACOL, V10, P534, DOI 10.1016/j.coph.2010.06.007; Debacq-Chainiaux F, 2010, ADV EXP MED BIOL, V694, P126; Fan D, 2002, MOL CANCER THER, V1, P595; Glass JP, 2011, INT J SURG PATHOL; Gubbels JAA, 2006, MOL CANCER, V5, DOI 10.1186/1476-4598-5-50; Hall A, 2009, CANCER METAST REV, V28, P5, DOI 10.1007/s10555-008-9166-3; Hassan R, 1999, INT J CANCER, V80, P559, DOI 10.1002/(SICI)1097-0215(19990209)80:4<559::AID-IJC13>3.0.CO;2-Y; Hassan R, 2002, CLIN CANCER RES, V8, P3520; Hassan R, 2000, J IMMUNOTHER, V23, P473, DOI 10.1097/00002371-200007000-00011; Hassan R, 2007, CLIN CANCER RES, V13, P5144, DOI 10.1158/1078-0432.CCR-07-0869; Hassan R, 2006, CLIN CANCER RES, V12, P4983, DOI 10.1158/1078-0432.CCR-06-0441; Hassan R, 2010, CLIN CANCER RES, V16, P6132, DOI 10.1158/1078-0432.CCR-10-2275; Hellstrom Ingegerd, 2011, Expert Opin Med Diagn, V5, P227, DOI 10.1517/17530059.2011.559459; Hilger RA, 2002, ONKOLOGIE, V25, P511, DOI 10.1159/000068621; Ho M, 2007, CLIN CANCER RES, V13, P1571, DOI 10.1158/1078-0432.CCR-06-2161; Hokaiwado N, 2008, IDRUGS, V11, P274; Iacobuzio-Donahue CA, 2003, CANCER RES, V63, P8614; KARLAN BY, 1988, GYNECOL ONCOL, V31, P103, DOI 10.1016/0090-8258(88)90276-4; KOHNO K, 1993, MOL CELL BIOL, V13, P877, DOI 10.1128/MCB.13.2.877; Koumenis C, 2006, CURR MOL MED, V6, P55, DOI 10.2174/156652406775574604; Kreitman RJ, 2009, CLIN CANCER RES, V15, P5274, DOI 10.1158/1078-0432.CCR-09-0062; Lee AS, 2006, CANCER BIOL THER, V5, P721, DOI 10.4161/cbt.5.7.3120; Mak BC, 2003, J BIOL CHEM, V278, P5947, DOI 10.1074/jbc.C200473200; Micalizzi DS, 2010, J MAMMARY GLAND BIOL, V15, P117, DOI 10.1007/s10911-010-9178-9; Muminova ZE, 2004, BMC CANCER, V4, DOI 10.1186/1471-2407-4-19; Ni M, 2007, FEBS LETT, V581, P3641, DOI 10.1016/j.febslet.2007.04.045; Prieve Mary G, 2003, BMC Dev Biol, V3, P2, DOI 10.1186/1471-213X-3-2; Quintela-Fandino M, 2010, CLIN TRANSL ONCOL, V12, P662, DOI 10.1007/s12094-010-0575-8; Roberts PJ, 2007, ONCOGENE, V26, P3291, DOI 10.1038/sj.onc.1210422; Rovira C, 2010, IUBMB LIFE, V62, P859, DOI 10.1002/iub.399; Rump A, 2004, J BIOL CHEM, V279, P9190, DOI 10.1074/jbc.M312372200; Scharovsky OG, 2000, J BIOMED SCI, V7, P292, DOI 10.1007/BF02253247; Singh A, 2010, ONCOGENE, V29, P4741, DOI 10.1038/onc.2010.215; Yamada S, 2011, CLIN CHEM LAB MED; Yamashita Y, 2000, BIOCHEM BIOPH RES CO, V275, P134, DOI 10.1006/bbrc.2000.3280; Yamoutpour F, 2008, MOL CANCER THER, V7, P3586, DOI 10.1158/1535-7163.MCT-08-0653; Yilmaz M, 2009, CANCER METAST REV, V28, P15, DOI 10.1007/s10555-008-9169-0; Zebisch A, 2007, CURR MED CHEM, V14, P601, DOI 10.2174/092986707780059670	57	36	40	0	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 2	2012	7	4							e33214	10.1371/journal.pone.0033214	http://dx.doi.org/10.1371/journal.pone.0033214			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	952GU	22485139	Green Submitted, gold, Green Published			2022-12-25	WOS:000304780500015
J	Erales, J; Hoyt, MA; Troll, F; Coffino, P				Erales, Jenny; Hoyt, Martin A.; Troll, Fabian; Coffino, Philip			Functional Asymmetries of Proteasome Translocase Pore	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							MOUSE ORNITHINE-DECARBOXYLASE; REGULATORY PARTICLE; YEAST; DEGRADATION; ATPASES; ATP; ARCHITECTURE; MECHANISM; MUTANTS; SUBUNIT	Degradation by proteasomes involves coupled translocation and unfolding of its protein substrates. Six distinct but paralo-gous proteasome ATPase proteins, Rpt1 to -6, form a heterohexameric ring that acts on substrates. An axially positioned loop (Ar-Phi loop) moves in concert with ATP hydrolysis, engages substrate, and propels it into a proteolytic chamber. The aromatic (Ar) residue of the Ar-Phi loop in all six Rpts of S. cerevisiae is tyrosine; this amino acid is thought to have important functional contacts with substrate. Six yeast strains were constructed and characterized in which Tyr was individually mutated to Ala. The mutant cells were viable and had distinct phenotypes. rpt3, rpt4, and rpt5 Tyr/Ala mutants, which cluster on one side of the ATPase hexamer, were substantially impaired in their capacity to degrade substrates. In contrast, rpt1, rpt2, and rpt6 mutants equaled or exceeded wild type in degradation activity. However, rpt1 and rpt6 mutants had defects that limited cell growth or viability under conditions that stressed the ubiquitin proteasome system. In contrast, the rpt3 mutant grew faster than wild type and to a smaller size, a defect that has previously been associated with misregulation of G1 cyclins. This rpt3 phenotype probably results from altered degradation of cell cycle regulatory proteins. Finally, mutation of five of the Rpt subunits increased proteasome ATPase activity, implying bidirectional coupling between the Ar-Phi loop and the ATP hydrolysis site. The present observations assign specific functions to individual Rpt proteins and provide insights into the diverse roles of the axial loops of individual proteasome ATPases.	[Erales, Jenny; Hoyt, Martin A.; Troll, Fabian; Coffino, Philip] Univ Calif San Francisco, Dept Microbiol & Immunol, San Francisco, CA 94127 USA	University of California System; University of California San Francisco	Coffino, P (corresponding author), 513 Parnassus Ave,Rm S-430, San Francisco, CA 94143 USA.	Philip.Coffino@ucsf.edu		Coffino, Philip/0000-0003-0344-5083	National Institutes of Health [GM45335]; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM045335] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported, in whole or in part, by National Institutes of Health Grant GM45335 (to P.C.).	Crosas B, 2006, CELL, V127, P1401, DOI 10.1016/j.cell.2006.09.051; Djuranovic S, 2009, MOL CELL, V34, P580, DOI 10.1016/j.molcel.2009.04.030; Elsasser S, 2005, METHOD ENZYMOL, V398, P353, DOI 10.1016/S0076-6879(05)98029-4; Gerlinger UM, 1997, MOL BIOL CELL, V8, P2487, DOI 10.1091/mbc.8.12.2487; Glickman MH, 1998, MOL CELL BIOL, V18, P3149, DOI 10.1128/MCB.18.6.3149; Glickman MH, 1998, CELL, V94, P615, DOI 10.1016/S0092-8674(00)81603-7; Groll M, 1997, NATURE, V386, P463, DOI 10.1038/386463a0; Guthrie C., 2002, GUIDE YEAST GENETICS; Henderson A, 2011, J BIOL CHEM, V286, P17495, DOI 10.1074/jbc.M110.212027; HILT W, 1993, J BIOL CHEM, V268, P3479; Hinnerwisch J, 2005, CELL, V121, P1029, DOI 10.1016/j.cell.2005.04.012; Hoyt MA, 2003, J BIOL CHEM, V278, P12135, DOI 10.1074/jbc.M211802200; Hoyt MA, 2006, EMBO J, V25, P1720, DOI 10.1038/sj.emboj.7601058; Joly N, 2010, J BIOL CHEM, V285, P15178, DOI 10.1074/jbc.M110.103150; Jorgensen P, 2002, SCIENCE, V297, P395, DOI 10.1126/science.1070850; Kern AD, 1999, STRUCTURE, V7, P567, DOI 10.1016/S0969-2126(99)80073-2; Lander GC, 2012, NATURE, V482, P186, DOI 10.1038/nature10774; Lasker K, 2012, P NATL ACAD SCI USA, V109, P1380, DOI 10.1073/pnas.1120559109; Lee SH, 2012, J BIOL CHEM, V287, P9269, DOI 10.1074/jbc.M111.316208; Li HB, 2000, NAT STRUCT BIOL, V7, P1117; Martin A, 2008, NAT STRUCT MOL BIOL, V15, P1147, DOI 10.1038/nsmb.1503; MURAKAMI Y, 1992, NATURE, V360, P597, DOI 10.1038/360597a0; Prakash S, 2004, NAT STRUCT MOL BIOL, V11, P830, DOI 10.1038/nsmb814; Pringle J R, 1975, Methods Cell Biol, V11, P131, DOI 10.1016/S0091-679X(08)60320-9; Rubin DM, 1998, EMBO J, V17, P4909, DOI 10.1093/emboj/17.17.4909; Sambrook J, 2001, MOL CLONING LAB MANU; Sauer RT, 2011, ANNU REV BIOCHEM, V80, P587, DOI 10.1146/annurev-biochem-060408-172623; Singleton MR, 2000, CELL, V101, P589, DOI 10.1016/S0092-8674(00)80871-5; Smith DM, 2011, CELL, V144, P526, DOI 10.1016/j.cell.2011.02.005; SUDBERY PE, 1980, NATURE, V288, P401, DOI 10.1038/288401a0; Takeuchi J, 2007, EMBO J, V26, P123, DOI 10.1038/sj.emboj.7601476; Tian G, 2011, NAT STRUCT MOL BIOL, V18, P1259, DOI 10.1038/nsmb.2147; Tomko RJ, 2010, MOL CELL, V38, P393, DOI 10.1016/j.molcel.2010.02.035; WETTERS TV, 1989, MOL CELL BIOL, V9, P5484, DOI 10.1128/MCB.9.12.5484; Yu J, 2010, J MOL BIOL, V400, P186, DOI 10.1016/j.jmb.2010.05.002; Zhang F, 2009, MOL CELL, V34, P473, DOI 10.1016/j.molcel.2009.04.021; Zhang F, 2009, MOL CELL, V34, P485, DOI 10.1016/j.molcel.2009.04.022	37	35	35	0	3	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	MAY 25	2012	287	22					18535	18543		10.1074/jbc.M112.357327	http://dx.doi.org/10.1074/jbc.M112.357327			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	974EC	22493437	Green Published, hybrid			2022-12-25	WOS:000306411600059
J	Jamesdaniel, S; Coling, D; Hinduja, S; Ding, DL; Li, J; Cassidy, L; Seigel, GM; Qu, J; Salvi, R				Jamesdaniel, Samson; Coling, Donald; Hinduja, Sneha; Ding, Dalian; Li, Jun; Cassidy, Linda; Seigel, Gail M.; Qu, Jun; Salvi, Richard			Cisplatin-induced Ototoxicity Is Mediated by Nitroxidative Modification of Cochlear Proteins Characterized by Nitration of Lmo4	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							INDUCED HEARING-LOSS; TYROSINE NITRATION; INNER-EAR; PROTEOMIC ANALYSIS; SIGNAL TRANSDUCER; GUINEA-PIGS; PEROXYNITRITE; APOPTOSIS; EXPRESSION; MECHANISM	Tyrosine nitration is an important sequel of cellular signaling induced by reactive oxygen species. Cisplatin is an anti-neoplastic agent that damages the inner ear through reactive oxygen species and by the formation of DNA adducts. This study reveals a correlation between cisplatin-mediated hearing loss and nitroxidative modification of cochlear proteins and is the first to report nitration of Lmo4. Cisplatin induced a dose-dependent increase in hearing loss in Wistar rats. A 10-15-dB decrease in distortion product amplitude and massive loss of outer hair cells at the basal turn of the cochlea was observed 3 days post-treatment after a 16 mg/kg dose. Cisplatin induced nitration of cellular proteins within the organ of Corti, spiral ganglion, and stria vascularis, which are known targets of cisplatin ototoxicity. Nitration of a 76-kDa cochlear protein correlated with cisplatin dose. The nitrated protein was identified as Lmo4 (LIM domain only 4) by MALDI-TOF (matrix-assisted laser desorption/ionization time of flight) mass spectrometry and confirmed by reciprocal immunoprecipitation and immunoblotting. Co-localization of nitrotyrosine and Lmo4 was particularly high in outer hair cell nuclei after cisplatin treatment. Cochlear levels of Lmo4 were decreased in rats treated with cisplatin. In vitro studies supported the repression of Lmo4 in nitroxidative conditions and the induction of apoptosis upon repression of Lmo4. Inhibition of cochlear protein nitration prevented cisplatin-induced hearing loss. As Lmo4 is a transcriptional regulator that controls the choice between cell survival and cell death, these results support the hypothesis that nitration of Lmo4 influences cisplatin-induced ototoxicity.	[Jamesdaniel, Samson; Coling, Donald; Hinduja, Sneha; Ding, Dalian; Cassidy, Linda; Seigel, Gail M.; Salvi, Richard] SUNY Buffalo, Dept Commun Disorders & Sci, Buffalo, NY 14214 USA; [Li, Jun; Qu, Jun] SUNY Buffalo, Sch Pharm & Pharmaceut Sci, Dept Pharmaceut Sci, Buffalo, NY 14260 USA	State University of New York (SUNY) System; State University of New York (SUNY) Buffalo; State University of New York (SUNY) System; State University of New York (SUNY) Buffalo	Jamesdaniel, S (corresponding author), SUNY Buffalo, Dept Commun Disorders & Sci, 137 Cary Hall,3435 Main St, Buffalo, NY 14214 USA.	sj57@buffalo.edu	Li, Jun/N-3806-2014; Jamesdaniel, Samson/ABA-2616-2021	Li, Jun/0000-0001-9940-3421; Jamesdaniel, Samson/0000-0002-5269-9007; Coling, Donald/0000-0001-6285-5336	National Institutes of Health [1 R03 DC010225-01 (NIDCD), CA127061]; NYSTEM [C026412]; Cornell Center on the Microenvironment and Metastasis from NCI [U54CA143876]; NATIONAL CANCER INSTITUTE [R21CA127061, U54CA143876] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON DEAFNESS AND OTHER COMMUNICATION DISORDERS [R03DC010225] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NYSTEM; Cornell Center on the Microenvironment and Metastasis from NCI; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE ON DEAFNESS AND OTHER COMMUNICATION DISORDERS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Deafness & Other Communication Disorders (NIDCD))	This work was supported, in whole or in part, by National Institutes of Health Grant 1 R03 DC010225-01 (NIDCD).; Supported by the Cornell Center on the Microenvironment and Metastasis through Award U54CA143876 from the NCI, National Institutes of Health Grant CA127061 and NYSTEM C026412.	ANNIKO M, 1986, AM J OTOLARYNG, V7, P276, DOI 10.1016/S0196-0709(86)80050-3; Banfi B, 2004, J BIOL CHEM, V279, P46065, DOI 10.1074/jbc.M403046200; Berndtsson M, 2007, INT J CANCER, V120, P175, DOI 10.1002/ijc.22132; BRADFORD MM, 1976, ANAL BIOCHEM, V72, P248, DOI 10.1016/0003-2697(76)90527-3; Campbell KCM, 2007, HEARING RES, V226, P92, DOI 10.1016/j.heares.2006.11.012; Cassina P, 2002, J NEUROSCI RES, V67, P21, DOI 10.1002/jnr.10107; Charitidi K, 2010, NEUROSCIENCE, V165, P923, DOI 10.1016/j.neuroscience.2009.11.020; Chen HH, 2007, EXP CELL RES, V313, P3106, DOI 10.1016/j.yexcr.2007.04.026; COLING D, 2001, CURR PROTOC NEUROSCI, pCH2; Coling DE, 2007, HEARING RES, V226, P140, DOI 10.1016/j.heares.2006.12.017; Dehne N, 2001, TOXICOL APPL PHARM, V174, P27, DOI 10.1006/taap.2001.9171; Deng M, 2010, DEV BIOL, V338, P38, DOI 10.1016/j.ydbio.2009.11.003; Ding D., 2001, AUDITORY PSYCHOBIOLO, P189; Ding DL, 2011, HEARING RES, V282, P196, DOI 10.1016/j.heares.2011.08.002; Duan XT, 2009, J PROTEOME RES, V8, P2838, DOI 10.1021/pr900001t; Garcia-Berrocal JR, 2007, BRIT J PHARMACOL, V152, P1012, DOI 10.1038/sj.bjp.0707405; Gow AJ, 1996, FEBS LETT, V385, P63, DOI 10.1016/0014-5793(96)00347-X; Hofstetter P, 1997, HEARING RES, V112, P199, DOI 10.1016/S0378-5955(97)00123-8; HOGG N, 1994, ARCH BIOCHEM BIOPHYS, V314, P153, DOI 10.1006/abbi.1994.1423; Ischiropoulos H, 2003, BIOCHEM BIOPH RES CO, V305, P776, DOI 10.1016/S0006-291X(03)00814-3; Jamesdaniel S, 2008, J PROTEOME RES, V7, P3516, DOI 10.1021/pr8002479; Jamesdaniel S, 2009, J PROTEOME RES, V8, P3520, DOI 10.1021/pr900222c; Kelly TC, 2003, HEARING RES, V186, P10, DOI 10.1016/S0378-5955(03)00303-4; Kim JY, 2010, J BIOL CHEM, V285, P37251, DOI 10.1074/jbc.M110.142315; Kong SK, 1996, P NATL ACAD SCI USA, V93, P3377, DOI 10.1073/pnas.93.8.3377; Lee JE, 2004, ACTA OTO-LARYNGOL, V124, P1131, DOI 10.1080/00016480410017521; Lee J, 2010, CARCINOGENESIS, V31, P1991, DOI 10.1093/carcin/bgq175; Manetopoulos C, 2003, BIOCHEM BIOPH RES CO, V307, P891, DOI 10.1016/S0006-291X(03)01298-1; Maruyama J, 2008, NEUROBIOL DIS, V29, P14, DOI 10.1016/j.nbd.2007.07.026; Meech RP, 1998, HEARING RES, V124, P44, DOI 10.1016/S0378-5955(98)00116-6; Novotny-Diermayr V, 2005, J BIOL CHEM, V280, P12747, DOI 10.1074/jbc.M500175200; Radi R, 2001, FREE RADICAL BIO MED, V30, P463, DOI 10.1016/S0891-5849(00)00373-7; RAVI R, 1995, PHARMACOL TOXICOL, V76, P386, DOI 10.1111/j.1600-0773.1995.tb00167.x; Rybak LP, 2007, HEARING RES, V226, P157, DOI 10.1016/j.heares.2006.09.015; Schaffar G, 2008, J NEUROCHEM, V107, P418, DOI 10.1111/j.1471-4159.2008.05621.x; Setogawa T, 2006, BIOCHEM BIOPH RES CO, V343, P1186, DOI 10.1016/j.bbrc.2006.03.077; Singh RR, 2005, CANCER RES, V65, P10594, DOI 10.1158/0008-5472.CAN-05-2268; Souza JM, 2008, FREE RADICAL BIO MED, V45, P357, DOI 10.1016/j.freeradbiomed.2008.04.010; Sum EYM, 2002, J BIOL CHEM, V277, P7849, DOI 10.1074/jbc.M110603200; Teranishi M, 2003, INT J PEDIATR OTORHI, V67, P133, DOI 10.1016/S0165-5876(02)00353-1; Tu CJ, 2011, ANAL CHEM, V83, P4802, DOI 10.1021/ac200376m; van Ruijven MWM, 2005, HEARING RES, V205, P241, DOI 10.1016/j.heares.2005.03.023; van Ruijven MWM, 2005, HEARING RES, V203, P112, DOI 10.1016/j.heares.2004.12.007; vanderVliet A, 1997, J BIOL CHEM, V272, P7617, DOI 10.1074/jbc.272.12.7617; Wang H, 2009, J AM SOC MASS SPECTR, V20, P507, DOI 10.1016/j.jasms.2008.11.008; Wang N, 2007, ONCOGENE, V26, P6431, DOI 10.1038/sj.onc.1210465; Wang Y, 2008, PROTEIN PEPTIDE LETT, V15, P1063, DOI 10.2174/092986608786071111; Xiao T, 2003, J TOXICOL ENV HEAL A, V66, P469, DOI 10.1080/15287390306449; Xu SQ, 2006, AM J PHYSIOL-HEART C, V290, pH2220, DOI 10.1152/ajpheart.01293.2005; Yamamoto T, 2000, FEBS LETT, V486, P143, DOI 10.1016/S0014-5793(00)02296-1; Yamashita D, 2005, NEUROSCIENCE, V134, P633, DOI 10.1016/j.neuroscience.2005.04.015; Yun MH, 2009, NATURE, V459, P460, DOI 10.1038/nature07955; Zhao W, 2011, ANTI-CANCER DRUG, V22, P79, DOI 10.1097/CAD.0b013e32833f44fd	53	29	29	0	5	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAY 25	2012	287	22					18674	18686		10.1074/jbc.M111.297960	http://dx.doi.org/10.1074/jbc.M111.297960			13	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	974EC	22493493	Green Published, hybrid			2022-12-25	WOS:000306411600076
J	Goodin, P; Ciorciari, J; Baker, K; Carrey, AM; Harper, M; Kaufman, J				Goodin, Peter; Ciorciari, Joseph; Baker, Kate; Carrey, Anne-Marie; Harper, Michelle; Kaufman, Jordy			A High-Density EEG Investigation into Steady State Binaural Beat Stimulation	PLOS ONE			English	Article							FREQUENCY-FOLLOWING RESPONSE; WORKING-MEMORY; BRAIN ACTIVATION; BIPOLAR DISORDER; AUDITORY BEATS; FUNCTIONAL MRI; ENTRAINMENT; TECHNOLOGY; HUMANS; INJURY	Binaural beats are an auditory phenomenon that has been suggested to alter physiological and cognitive processes including vigilance and brainwave entrainment. Some personality traits measured by the NEO Five Factor Model have been found to alter entrainment using pulsing light stimuli, but as yet no studies have examined if this occurs using steady state presentation of binaural beats for a relatively short presentation of two minutes. This study aimed to examine if binaural beat stimulation altered vigilance or cortical frequencies and if personality traits were involved. Thirty-one participants were played binaural beat stimuli designed to elicit a response at either the Theta (7 Hz) or Beta (16 Hz) frequency bands while undertaking a zero-back vigilance task. EEG was recorded from a high-density electrode cap. No significant differences were found in vigilance or cortical frequency power during binaural beat stimulation compared to a white noise control period. Furthermore, no significant relationships were detected between the above and the Big Five personality traits. This suggests a short presentation of steady state binaural beats are not sufficient to alter vigilance or entrain cortical frequencies at the two bands examined and that certain personality traits were not more susceptible than others.	[Goodin, Peter; Ciorciari, Joseph; Baker, Kate; Carrey, Anne-Marie; Harper, Michelle; Kaufman, Jordy] Swinburne Univ Technol, Brain & Psychol Sci Res Ctr, Hawthorn, Vic 3122, Australia	Swinburne University of Technology	Goodin, P (corresponding author), Swinburne Univ Technol, Brain & Psychol Sci Res Ctr, Hawthorn, Vic 3122, Australia.	jciorciari@swin.edu.au	Kaufman, Jordy/A-5742-2008; Ciorciari, Joseph/J-9538-2012	Kaufman, Jordy/0000-0001-9881-371X; Ciorciari, Joseph/0000-0002-0751-0631; Goodin, Peter/0000-0003-1981-7363	Faculty of Life and Social Sciences	Faculty of Life and Social Sciences	This project was funded by the Faculty of Life and Social Sciences. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aiken SJ, 2008, HEARING RES, V245, P35, DOI 10.1016/j.heares.2008.08.004; Bogdan VA, 2009, J COGN BEHAV PSYCHOT, V9, P67; Brady B, 2000, AM J CLIN HYPN, V43, P53, DOI 10.1080/00029157.2000.10404255; Costa P. T. J., 1992, PSYCHOL ASSESSMENT R, V4; Dabu-Bondoc S, 2010, ANESTH ANALG, V110, P208, DOI 10.1213/ANE.0b013e3181bea424; DeYoung CG, 2010, PSYCHOL SCI, V21, P820, DOI 10.1177/0956797610370159; Fitzpatrick DC, 2009, JARO-J ASSOC RES OTO, V10, P579, DOI 10.1007/s10162-009-0177-8; GRATTON G, 1983, ELECTROEN CLIN NEURO, V55, P468, DOI 10.1016/0013-4694(83)90135-9; Gurrera RJ, 2001, BIOL PSYCHIAT, V49, P922, DOI 10.1016/S0006-3223(00)01067-2; Huang TL, 2008, ALTERN THER HEALTH M, V14, P38; Karino S, 2006, J NEUROPHYSIOL, V96, P1927, DOI 10.1152/jn.00859.2005; Kasprzak C, 2011, ACTA PHYS POL A, V119, P986, DOI 10.12693/APhysPolA.119.986; Kennerly R., 2004, J NEUROTHER, V8, P122; Krishnan A, 2004, HEARING RES, V189, P1, DOI 10.1016/S0378-5955(03)00402-7; Lane JD, 1998, PHYSIOL BEHAV, V63, P249, DOI 10.1016/S0031-9384(97)00436-8; Le Scouarnec RP, 2001, ALTERN THER HEALTH M, V7, P58; MARSH JT, 1970, SCIENCE, V169, P1222, DOI 10.1126/science.169.3951.1222; McAllister TW, 1999, NEUROLOGY, V53, P1300, DOI 10.1212/WNL.53.6.1300; MCCRAE RR, 1992, J PERS, V60, P175, DOI 10.1111/j.1467-6494.1992.tb00970.x; Monks PJ, 2004, BIPOLAR DISORD, V6, P550, DOI 10.1111/j.1399-5618.2004.00147.x; OSTER G, 1973, SCI AM, V229, P94, DOI 10.1038/scientificamerican1073-94; Persinger MA, 1997, PERCEPT MOTOR SKILL, V84, P527, DOI 10.2466/pms.1997.84.2.527; Rosenfeld JP, 1997, APPL PSYCHOPHYS BIOF, V22, P3, DOI 10.1023/A:1026233624772; Schwarz DWF, 2005, CLIN NEUROPHYSIOL, V116, P658, DOI 10.1016/j.clinph.2004.09.014; SILBERSTEIN R B, 1990, Brain Topography, V3, P337, DOI 10.1007/BF01135443; Smits M, 2009, HUM BRAIN MAPP, V30, P2789, DOI 10.1002/hbm.20709; Stevens L, 2003, AM J CLIN HYPN, V45, P295, DOI 10.1080/00029157.2003.10403543; Stough C, 2001, INT J PSYCHOPHYSIOL, V41, P87, DOI 10.1016/S0167-8760(00)00176-8; Szatkowska I, 2008, NEUROBIOL LEARN MEM, V90, P475, DOI 10.1016/j.nlm.2008.06.001; Thermenos HW, 2011, BIPOLAR DISORD, V13, P272, DOI 10.1111/j.1399-5618.2011.00920.x; von Stein A, 2000, INT J PSYCHOPHYSIOL, V38, P301, DOI 10.1016/S0167-8760(00)00172-0; Wahbeh H, 2007, J ALTERN COMPLEM MED, V13, P199, DOI 10.1089/acm.2006.6201; Wahbeh H, 2007, J ALTERN COMPLEM MED, V13, P25, DOI 10.1089/acm.2006.6196	33	40	44	4	71	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 9	2012	7	4							e34789	10.1371/journal.pone.0034789	http://dx.doi.org/10.1371/journal.pone.0034789			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	955JO	22496862	Green Published, gold			2022-12-25	WOS:000305014500030
J	Scully, ED; Hoover, K; Carlson, J; Tien, M; Geib, SM				Scully, Erin D.; Hoover, Kelli; Carlson, John; Tien, Ming; Geib, Scott M.			Analysis of Fusarium solani Isolated from the Longhorned Beetle, Anoplophora glabripennis	PLOS ONE			English	Article							AMINO-ACID-SEQUENCE; LIGNIN DEGRADATION; PHANEROCHAETE-CHRYSOSPORIUM; LIGNOCELLULOSE DEGRADATION; EXTRACELLULAR PEROXIDASE; MICROBIAL-DEGRADATION; WOOD DECAY; PROTEINS; LACCASE; GUT	Wood is a highly intractable food source, yet many insects successfully colonize and thrive in this challenging niche. Overcoming the lignin barrier of wood is a key challenge in nutrient acquisition, but full depolymerization of intact lignin polymers has only been conclusively demonstrated in fungi and is not known to occur by enzymes produced by insects or bacteria. Previous research validated that lignocellulose and hemicellulose degradation occur within the gut of the wood boring insect, Anoplophora glabripennis (Asian longhorned beetle), and that a fungal species, Fusarium solani (ATCC MYA 4552), is consistently associated with the larval stage. While the nature of this relationship is unresolved, we sought to assess this fungal isolate's ability to degrade lignocellulose and cell wall polysaccharides and to extract nutrients from woody tissue. This gut-derived fungal isolate was inoculated onto a wood-based substrate and shotgun proteomics using Multidimensional Protein Identification Technology (MudPIT) was employed to identify 400 expressed proteins. Through this approach, we detected proteins responsible for plant cell wall polysaccharide degradation, including proteins belonging to 28 glycosyl hydrolase families and several cutinases, esterases, lipases, pectate lyases, and polysaccharide deacetylases. Proteinases with broad substrate specificities and ureases were observed, indicating that this isolate has the capability to digest plant cell wall proteins and recycle nitrogenous waste under periods of nutrient limitation. Additionally, several laccases, peroxidases, and enzymes involved in extracellular hydrogen peroxide production previously implicated in lignin depolymerization were detected. In vitro biochemical assays were conducted to corroborate MudPIT results and confirmed that cellulases, glycosyl hydrolases, xylanases, laccases, and Mn- independent peroxidases were active in culture; however, lignin- nd Mn- dependent peroxidase activities were not detected While little is known about the role of filamentous fungi and their associations with insects, these findings suggest that this isolate has the endogenous potential to degrade lignocellulose and extract nutrients from woody tissue.	[Scully, Erin D.] Penn State Univ, Huck Inst Life Sci, Intercoll Program Genet, University Pk, PA 16802 USA; [Hoover, Kelli] Penn State Univ, Ctr Chem Ecol, Dept Entomol, University Pk, PA 16802 USA; [Carlson, John] Penn State Univ, Sch Forest Resources, University Pk, PA 16802 USA; [Carlson, John] Chonnam Natl Univ, World Class Univ, Dept Bioenergy Sci & Technol, Kwangju, South Korea; [Tien, Ming] Penn State Univ, Dept Biochem & Mol Biol, University Pk, PA 16802 USA; [Geib, Scott M.] USDA ARS, Trop Crop & Commod Protect Res Unit, Pacific Basin Agr Res Ctr, Hilo, HI USA	Pennsylvania Commonwealth System of Higher Education (PCSHE); Pennsylvania State University; Pennsylvania State University - University Park; Pennsylvania Commonwealth System of Higher Education (PCSHE); Pennsylvania State University; Pennsylvania State University - University Park; Pennsylvania Commonwealth System of Higher Education (PCSHE); Pennsylvania State University; Pennsylvania State University - University Park; Chonnam National University; Pennsylvania Commonwealth System of Higher Education (PCSHE); Pennsylvania State University; Pennsylvania State University - University Park; United States Department of Agriculture (USDA)	Scully, ED (corresponding author), Penn State Univ, Huck Inst Life Sci, Intercoll Program Genet, University Pk, PA 16802 USA.	scott.geib@ars.usda.gov		Geib, Scott/0000-0002-9511-5139	USDA-NRI-CRSEES [2008-35504-04464, 2009-35302-05286]; Alphawood Foundation, Chicago, Illinois; Pennsylvania State University College of Agricultural Sciences; World Class University from the Ministry of Education, Science and Technology of South Korea [R31-2009-000-20025-0]	USDA-NRI-CRSEES; Alphawood Foundation, Chicago, Illinois; Pennsylvania State University College of Agricultural Sciences; World Class University from the Ministry of Education, Science and Technology of South Korea	Funding for this project was provided by USDA-NRI-CRSEES grant 2008-35504-04464, USDA-NRI-CREES grant 2009-35302-05286, the Alphawood Foundation, Chicago, Illinois, a Seed Grant to Dr. Hoover from the Pennsylvania State University College of Agricultural Sciences. Dr. Carlson was partially supported by World Class University Project R31-2009-000-20025-0 grant from the Ministry of Education, Science and Technology of South Korea. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abbas A, 2005, CURR GENET, V47, P49, DOI 10.1007/s00294-004-0550-4; ANDER P, 1976, ARCH MICROBIOL, V109, P1, DOI 10.1007/BF00425105; Bending GD, 1997, MYCOL RES, V101, P1348, DOI 10.1017/S0953756297004140; Bendtsen JD, 2004, J MOL BIOL, V340, P783, DOI 10.1016/j.jmb.2004.05.028; Bermek H, 1998, J BIOTECHNOL, V66, P117, DOI 10.1016/S0168-1656(98)00091-1; BERNFELD P, 1955, METHOD ENZYMOL, V1, P149, DOI 10.1016/0076-6879(55)01021-5; Bollag DM, 1996, PROTEIN METHODS, Vxvi; BRADFORD MM, 1976, ANAL BIOCHEM, V72, P248, DOI 10.1016/0003-2697(76)90527-3; Bugg TDH, 2011, CURR OPIN BIOTECH, V22, P394, DOI 10.1016/j.copbio.2010.10.009; Calderon-Cortes N, 2010, INSECT MOL BIOL, V19, P323, DOI 10.1111/j.1365-2583.2010.00991.x; Camarero S, 1999, J BIOL CHEM, V274, P10324, DOI 10.1074/jbc.274.15.10324; Cantarel BL, 2009, NUCLEIC ACIDS RES, V37, pD233, DOI 10.1093/nar/gkn663; Chavez R, 2002, GENE, V293, P161, DOI 10.1016/S0378-1119(02)00720-5; Coleman JJ, 2009, PLOS GENET, V5, DOI 10.1371/journal.pgen.1000618; Colombo JC, 1996, ENVIRON POLLUT, V94, P355, DOI 10.1016/S0269-7491(96)00044-9; Coy MR, 2010, INSECT BIOCHEM MOLEC, V40, P723, DOI 10.1016/j.ibmb.2010.07.004; CRAWFORD DL, 1980, ENZYME MICROB TECH, V2, P11, DOI 10.1016/0141-0229(80)90003-4; Davison A, 2005, MOL BIOL EVOL, V22, P1273, DOI 10.1093/molbev/msi107; DEJONG E, 1992, FEBS LETT, V299, P107, DOI 10.1016/0014-5793(92)80111-S; Dillon RJ, 2004, ANNU REV ENTOMOL, V49, P71, DOI 10.1146/annurev.ento.49.061802.123416; DOWD PF, 1992, J IND MICROBIOL, V9, P149, DOI 10.1007/BF01569619; Dunwell JM, 2004, PHYTOCHEMISTRY, V65, P7, DOI 10.1016/j.phytochem.2003.08.016; FALCON MA, 1995, SOIL BIOL BIOCHEM, V27, P121, DOI 10.1016/0038-0717(94)00174-Y; Ferris MJ, 1996, APPL ENVIRON MICROB, V62, P340, DOI 10.1128/AEM.62.2.340-346.1996; Geib SM, 2008, P NATL ACAD SCI USA, V105, P12932, DOI 10.1073/pnas.0805257105; Geib Scott M., 2012, Insects, V3, P141, DOI 10.3390/insects3010141; Geib SM, 2010, INSECT SCI, V17, P253, DOI 10.1111/j.1744-7917.2010.01323.x; Geib SM, 2009, ENVIRON ENTOMOL, V38, P686, DOI 10.1603/022.038.0320; Hammer K., 1997, Plant Genetic Resources Newsletter, P33; Hanks LM, 1999, ANNU REV ENTOMOL, V44, P483, DOI 10.1146/annurev.ento.44.1.483; Harazono K, 2003, BIOSCI BIOTECH BIOCH, V67, P889, DOI 10.1271/bbb.67.889; Hemingway RW, 1992, PLANT POLYPHENOLICS; HENRISSAT B, 1991, BIOCHEM J, V280, P309, DOI 10.1042/bj2800309; Her S, 1999, LETT APPL MICROBIOL, V29, P389, DOI 10.1046/j.1472-765X.1999.00651.x; HOLTZAPPLE M, 1990, BIOTECHNOL BIOENG, V36, P275, DOI 10.1002/bit.260360310; Hu JF, 2009, AGR FOREST ENTOMOL, V11, P359, DOI 10.1111/j.1461-9563.2009.00443.x; Kajikawa H, 2000, FEMS MICROBIOL LETT, V187, P15, DOI 10.1111/j.1574-6968.2000.tb09129.x; Kato K, 1998, BIOTECHNOL LETT, V20, P459, DOI 10.1023/A:1005432027603; Ke J, 2011, INT BIODETER BIODEGR, V65, P744, DOI 10.1016/j.ibiod.2010.12.016; KELLER B, 1989, P NATL ACAD SCI USA, V86, P1529, DOI 10.1073/pnas.86.5.1529; Kersten P, 2007, FUNGAL GENET BIOL, V44, P77, DOI 10.1016/j.fgb.2006.07.007; Kinter M, 2000, PROTEIN SEQUENCING I, Vxvi; KIRK TK, 1987, ANNU REV MICROBIOL, V41, P465, DOI 10.1146/annurev.mi.41.100187.002341; KUAN IC, 1993, P NATL ACAD SCI USA, V90, P1242, DOI 10.1073/pnas.90.4.1242; KUKOR JJ, 1988, PHYSIOL ZOOL, V61, P364, DOI 10.1086/physzool.61.4.30161254; LAEMMLI UK, 1970, NATURE, V227, P680, DOI 10.1038/227680a0; Lingafelter S.W., 2002, REVISION ANOPLOPHORA; Lozovaya VV, 2006, PLANT DIS, V90, P77, DOI 10.1094/PD-90-0077; MAGNUSON TS, 1992, APPL ENVIRON MICROB, V58, P1070, DOI 10.1128/AEM.58.3.1070-1072.1992; Martinez D, 2004, NAT BIOTECHNOL, V22, P695, DOI 10.1038/nbt967; MILLER GL, 1959, ANAL CHEM, V31, P426, DOI 10.1021/ac60147a030; Morales-Ramos JA, 2000, ANN ENTOMOL SOC AM, V93, P541, DOI 10.1603/0013-8746(2000)093[0541:SRBHHC]2.0.CO;2; Morozova OV, 2007, APPL BIOCHEM MICROB, V43, P12; Nowak DJ, 2001, J ECON ENTOMOL, V94, P116, DOI 10.1603/0022-0493-94.1.116; Ohta Y, 2001, MICROBIOL-SGM, V147, P31, DOI 10.1099/00221287-147-1-31; OSullivan AC, 1997, CELLULOSE, V4, P173, DOI 10.1023/A:1018431705579; PASTI MB, 1990, APPL ENVIRON MICROB, V56, P2213, DOI 10.1128/AEM.56.7.2213-2218.1990; Pauchet Y, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0015635; Pauchet Y, 2009, INSECT BIOCHEM MOLEC, V39, P403, DOI 10.1016/j.ibmb.2009.04.001; Pazzagli L, 1999, J BIOL CHEM, V274, P24959, DOI 10.1074/jbc.274.35.24959; PETTERSEN RC, 1984, ADV CHEM SER, P57; Pinto PC, 2005, CARBOHYD POLYM, V60, P489, DOI 10.1016/j.carbpol.2005.03.001; Regalado V, 1999, APPL MICROBIOL BIOT, V51, P388, DOI 10.1007/s002530051407; REHMAN AU, 1992, J GEN MICROBIOL, V138, P1251, DOI 10.1099/00221287-138-6-1251; Rodriguez A, 1996, FEMS MICROBIOL ECOL, V21, P213, DOI 10.1016/S0168-6496(96)00057-8; Romero MC, 2002, ENVIRON POLLUT, V117, P159, DOI 10.1016/S0269-7491(01)00143-9; Sato S, 2007, MICROBIOL-SGM, V153, P3023, DOI 10.1099/mic.0.2006/000513-0; Sato S, 2009, CURR GENET, V55, P273, DOI 10.1007/s00294-009-0243-0; Scharf ME, 2008, BIOFUEL BIOPROD BIOR, V2, P540, DOI 10.1002/bbb.107; SCHWARZ WH, 1987, ANAL BIOCHEM, V164, P72, DOI 10.1016/0003-2697(87)90369-1; Shary S, 2007, APPL ENVIRON MICROB, V73, P6691, DOI 10.1128/AEM.01361-07; Soundararajan S, 2004, PLANT CELL, V16, P1564, DOI 10.1105/tpc.020677; Strope PK, 2011, BMC EVOL BIOL, V11, DOI 10.1186/1471-2148-11-80; Sun JZ, 2010, INSECT SCI, V17, P163, DOI 10.1111/j.1744-7917.2010.01348.x; SUTHERLAND JB, 1983, CAN J BOT, V61, P1194, DOI 10.1139/b83-126; TEETORBARSCH GH, 1983, MYCOPATHOLOGIA, V84, P3, DOI 10.1007/BF00436991; TIEN M, 1984, P NATL ACAD SCI-BIOL, V81, P2280, DOI 10.1073/pnas.81.8.2280; Ubiyvovk VM, 2006, CELL BIOL INT, V30, P665, DOI 10.1016/j.cellbi.2006.04.006; Varela E, 2003, ARCH MICROBIOL, V180, P251, DOI 10.1007/s00203-003-0583-y; Veignie E, 2004, ENVIRON POLLUT, V129, P1, DOI 10.1016/j.envpol.2003.11.007; Watanabe H, 2009, ANNU REV ENTOMOL, V55, P23; Willis JD, 2010, INSECT SCI, V17, P184, DOI 10.1111/j.1744-7917.2010.01322.x; Worrall JJ, 1997, MYCOLOGIA, V89, P199, DOI 10.2307/3761073; YOUN HD, 1995, FEMS MICROBIOL LETT, V132, P183, DOI 10.1111/j.1574-6968.1995.tb07831.x; ZAREMAIVAN H, 1988, MYCOLOGIA, V80, P365, DOI 10.2307/3807634; Zhang DH, 2011, INSECT BIOCHEM MOLEC, V41, P211, DOI 10.1016/j.ibmb.2010.12.006	86	31	31	0	65	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 9	2012	7	4							e32990	10.1371/journal.pone.0032990	http://dx.doi.org/10.1371/journal.pone.0032990			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	955JO	22496740	Green Published, gold, Green Submitted			2022-12-25	WOS:000305014500008
J	Thangapandian, S; John, S; Arooj, M; Lee, KW				Thangapandian, Sundarapandian; John, Shalini; Arooj, Mahreen; Lee, Keun Woo			Molecular Dynamics Simulation Study and Hybrid Pharmacophore Model Development in Human LTA4H Inhibitor Design	PLOS ONE			English	Article							LEUKOTRIENE A(4) HYDROLASE; POTENT INHIBITORS; DISCOVERY; IDENTIFICATION; DOCKING; ENZYME; ATHEROSCLEROSIS; MECHANISMS	Human leukotriene A4 hydrolase (hLTA4H) is a bi-functional enzyme catalyzes the hydrolase and aminopeptidase functions upon the fatty acid and peptide substrates, respectively, utilizing the same but overlapping binding site. Particularly the hydrolase function of this enzyme catalyzes the rate-limiting step of the leukotriene (LT) cascade that converts the LTA4 to LTB4. This product is a potent pro-inflammatory activator of inflammatory responses and thus blocking this conversion provides a valuable means to design anti-inflammatory agents. Four structurally very similar chemical compounds with highly different inhibitory profile towards the hydrolase function of hLTA4H were selected from the literature. Molecular dynamics (MD) simulations of the complexes of hLTA4H with these inhibitors were performed and the results have provided valuable information explaining the reasons for the differences in their biological activities. Binding mode analysis revealed that the additional thiophene moiety of most active inhibitor helps the pyrrolidine moiety to interact the most important R563 and K565 residues. The hLTA4H complexes with the most active compound and substrate were utilized in the development of hybrid pharmacophore models. These developed pharmacophore models were used in screening chemical databases in order to identify lead candidates to design potent hLTA4H inhibitors. Final evaluation based on molecular docking and electronic parameters has identified three compounds of diverse chemical scaffolds as potential leads to be used in novel and potent hLTA4H inhibitor design.	[Thangapandian, Sundarapandian; John, Shalini; Arooj, Mahreen; Lee, Keun Woo] Gyeongsang Natl Univ, Res Inst Nat Sci, Div Appl Life Sci, SSAC,PMBBRC,Program BK21, Jinju, South Korea	Gyeongsang National University	Thangapandian, S (corresponding author), Gyeongsang Natl Univ, Res Inst Nat Sci, Div Appl Life Sci, SSAC,PMBBRC,Program BK21, Jinju, South Korea.	kwlee@gnu.ac.kr	Arooj, Mahreen/AAC-7565-2020	Arooj, Mahreen/0000-0003-1975-5289	National Research Foundation of Korea (NRF) [2009-0073267, 2009-0081539, 2010-0029084]; Ministry of Education, Science and Technology (MEST) of Republic of Korea; Rural Development Administration (RDA) of Republic of Korea [PJ008038]	National Research Foundation of Korea (NRF)(National Research Foundation of Korea); Ministry of Education, Science and Technology (MEST) of Republic of Korea(Ministry of Education, Science & Technology (MEST), Republic of Korea); Rural Development Administration (RDA) of Republic of Korea(Rural Development Administration (RDA), Republic of Korea)	This work was supported by the Basic Science Research Program (2009-0073267), Pioneer Research Center Program (2009-0081539), and Management of Climate Change Program (2010-0029084) through the National Research Foundation of Korea (NRF) funded by the Ministry of Education, Science and Technology (MEST) of Republic of Korea. This work was also supported by the Next-Generation BioGreen 21 Program (PJ008038) from Rural Development Administration (RDA) of Republic of Korea. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Back M, 2005, P NATL ACAD SCI USA, V102, P17501, DOI 10.1073/pnas.0505845102; Barnes PJ, 2002, NAT REV DRUG DISCOV, V1, P437, DOI 10.1038/nrd820; Cheng F, 2008, PROTEINS, V70, P1228, DOI 10.1002/prot.21615; Davies DR, 2009, J MED CHEM, V52, P4694, DOI 10.1021/jm900259h; Delley B, 2000, COMP MATER SCI, V17, P122, DOI 10.1016/S0927-0256(00)00008-2; Drazen JM, 1999, NEW ENGL J MED, V340, P197, DOI 10.1056/NEJM199901213400306; Drazen JM, 1997, PHARMACOTHERAPY, V17, pS22; Enomoto H, 2009, BIOORG MED CHEM LETT, V19, P442, DOI 10.1016/j.bmcl.2008.11.042; Funk CD, 2001, SCIENCE, V294, P1871, DOI 10.1126/science.294.5548.1871; Gompertz S, 2002, CHEST, V122, P289, DOI 10.1378/chest.122.1.289; Grice CA, 2008, J MED CHEM, V51, P4150, DOI 10.1021/jm701575k; GRIFFITHS RJ, 1995, P NATL ACAD SCI USA, V92, P517, DOI 10.1073/pnas.92.2.517; Haeggstrom JZ, 2004, J BIOL CHEM, V279, P50639, DOI 10.1074/jbc.R400027200; Hess B, 2008, J CHEM THEORY COMPUT, V4, P435, DOI 10.1021/ct700301q; HOGG JH, 1995, BIOORGAN MED CHEM, V3, P1405, DOI 10.1016/0968-0896(95)00128-4; HOLMES MA, 1982, J MOL BIOL, V160, P623, DOI 10.1016/0022-2836(82)90319-9; Huey R, 2007, J COMPUT CHEM, V28, P1145, DOI 10.1002/jcc.20634; Iversen L, 1997, SKIN PHARMACOL, V10, P169, DOI 10.1159/000211501; Jiang XL, 2008, BIOORG MED CHEM LETT, V18, P6549, DOI 10.1016/j.bmcl.2008.10.044; Kirkland TA, 2008, BIOORGAN MED CHEM, V16, P4963, DOI 10.1016/j.bmc.2008.03.042; Langer T, 2004, Drug Discov Today Technol, V1, P203, DOI 10.1016/j.ddtec.2004.11.015; Lipinski CA, 2001, ADV DRUG DELIVER REV, V46, P3, DOI 10.1016/S0169-409X(00)00129-0; Meng CQ, 2006, CURR TOP MED CHEM, V6, P93, DOI 10.2174/156802606775270260; Morris GM, 1998, J COMPUT CHEM, V19, P1639, DOI 10.1002/(SICI)1096-987X(19981115)19:14<1639::AID-JCC10>3.0.CO;2-B; Penning TD, 2001, CURR PHARM DESIGN, V7, P163, DOI 10.2174/1381612013398248; Peters-Golden M, 2007, NEW ENGL J MED, V357, P1841, DOI 10.1056/NEJMra071371; Rinaldo-Matthis A, 2010, BIOCHIMIE, V92, P676, DOI 10.1016/j.biochi.2010.01.010; Rudberg PC, 2004, J BIOL CHEM, V279, P27376, DOI 10.1074/jbc.M401031200; Rudberg PC, 2002, J BIOL CHEM, V277, P1398, DOI 10.1074/jbc.M106577200; Sandanayaka V, 2010, BIOORG MED CHEM LETT, V20, P2851, DOI 10.1016/j.bmcl.2010.03.047; Sandanayaka V, 2010, J MED CHEM, V53, P573, DOI 10.1021/jm900838g; SHARON P, 1984, GASTROENTEROLOGY, V86, P453; Thangapandian S, 2011, EUR J MED CHEM, V46, P1593, DOI 10.1016/j.ejmech.2011.02.007; Thangapandian S, 2011, J CHEM INF MODEL, V51, P33, DOI 10.1021/ci1002813; Tholander F, 2005, J BIOL CHEM, V280, P33477, DOI 10.1074/jbc.M506821200; Thomsen R, 2006, J MED CHEM, V49, P3315, DOI 10.1021/jm051197e; Thunnissen MMGM, 2002, FASEB J, V16, P1648, DOI 10.1096/fj.01-1017fje; Thunnissen MMGM, 2001, NAT STRUCT BIOL, V8, P131, DOI 10.1038/84117; Tsuji F, 1998, LIFE SCI, V64, pPL51, DOI 10.1016/S0024-3205(98)00556-6; Van der Spoel D, 2005, J COMPUT CHEM, V26, P1701, DOI 10.1002/jcc.20291; Wagner AB, 2006, J CHEM INF MODEL, V46, P767, DOI 10.1021/ci050481b; Wang YL, 2010, NUCLEIC ACIDS RES, V38, pD255, DOI 10.1093/nar/gkp965; Wei DG, 2008, J MED CHEM, V51, P7882, DOI 10.1021/jm8010096	43	13	13	0	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 5	2012	7	4							e34593	10.1371/journal.pone.0034593	http://dx.doi.org/10.1371/journal.pone.0034593			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	955IH	22496831	Green Published, Green Submitted, gold			2022-12-25	WOS:000305010500019
J	Tobler, U; Borgula, A; Schmidt, BR				Tobler, Ursina; Borgula, Adrian; Schmidt, Benedikt R.			Populations of a Susceptible Amphibian Species Can Grow despite the Presence of a Pathogenic Chytrid Fungus	PLOS ONE			English	Article							EMERGING INFECTIOUS-DISEASE; BATRACHOCHYTRIUM-DENDROBATIDIS; CHYTRIDIOMYCOSIS; FROGS; DYNAMICS; SURVIVAL; EXTINCTION; VIRULENCE; DECLINE; HOST	Disease can be an important driver of host population dynamics and epizootics can cause severe host population declines. Batrachochytrium dendrobatidis (Bd), the pathogen causing amphibian chytridiomycosis, may occur epizootically or enzootically and can harm amphibian populations in many ways. While effects of Bd epizootics are well documented, the effects of enzootic Bd have rarely been described. We used a state-space model that accounts for observation error to test whether population trends of a species highly susceptible to Bd, the midwife toad Alytes obstetricans, are negatively affected by the enzootic presence of the pathogen. Unexpectedly, Bd had no negative effect on population growth rates from 2002-2008. This suggests that negative effects of disease on individuals do not necessarily translate into negative effects at the population level. Populations of amphibian species that are susceptible to the emerging disease chytridiomycosis can persist despite the enzootic presence of the pathogen under current environmental conditions.	[Tobler, Ursina; Schmidt, Benedikt R.] Univ Zurich, Inst Evolutionary Biol & Environm Studies, Zurich, Switzerland; [Borgula, Adrian] Bur Nat Schutzbiol, Luzern, Switzerland; [Schmidt, Benedikt R.] KARCH, Neuchatel, Switzerland	University of Zurich	Tobler, U (corresponding author), Univ Zurich, Inst Evolutionary Biol & Environm Studies, Zurich, Switzerland.	benedikt.schmidt@ieu.uzh.ch	Schmidt, Benedikt R./B-8491-2008	Schmidt, Benedikt R./0000-0002-4023-1001	Zoological Institute; Forschungskredit of the University of Zurich; Vontobel Stiftung; Janggen-Pohn Stiftung; Basler Stiftung fur biologische Forschung; Stiftung Dr. Joachim De Giacomi; Zoo Zurich; Grun Stadt Zurich; European Union of Aquarium Curators; Zurcher Tierschutz	Zoological Institute; Forschungskredit of the University of Zurich; Vontobel Stiftung; Janggen-Pohn Stiftung; Basler Stiftung fur biologische Forschung; Stiftung Dr. Joachim De Giacomi; Zoo Zurich; Grun Stadt Zurich; European Union of Aquarium Curators(European Commission); Zurcher Tierschutz	Funding was provided by the Zoological Institute and the Forschungskredit of the University of Zurich, Vontobel Stiftung, Janggen-Pohn Stiftung, Basler Stiftung fur biologische Forschung, Stiftung Dr. Joachim De Giacomi, Zoo Zurich, Grun Stadt Zurich, European Union of Aquarium Curators, and Zurcher Tierschutz. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Altwegg R, 2003, OECOLOGIA, V136, P46, DOI 10.1007/s00442-003-1248-x; Amt fur Natur- und Landschaftsschutz, 2000, ART GEB 2000 2009; ANDERSON RM, 1979, NATURE, V280, P361, DOI 10.1038/280361a0; Bart J, 2004, WILDLIFE SOC B, V32, P1242, DOI 10.2193/0091-7648(2004)032[1242:DEIWS]2.0.CO;2; Berven KA, 2009, COPEIA, P328, DOI 10.1643/CH-08-052; Borgula A, 2010, ARTENHILFSPROGRAMM G; Borgula Adrian, 2003, Zeitschrift fuer Feldherpetologie, V10, P11; Bosch J, 2001, BIOL CONSERV, V97, P331, DOI 10.1016/S0006-3207(00)00132-4; Bosch J, 2007, P ROY SOC B-BIOL SCI, V274, P253, DOI 10.1098/rspb.2006.3713; Boyle DG, 2004, DIS AQUAT ORGAN, V60, P141, DOI 10.3354/dao060141; Briggs CJ, 2010, P NATL ACAD SCI USA, V107, P9695, DOI 10.1073/pnas.0912886107; Briggs CJ, 2005, ECOLOGY, V86, P3149, DOI 10.1890/04-1428; BURNHAM KP, 1984, ECOLOGY, V65, P105; Conroy SDS, 2003, POPUL ECOL, V45, P105, DOI 10.1007/s10144-003-0145-9; de Castro F, 2005, ECOL LETT, V8, P117, DOI 10.1111/j.1461-0248.2004.00693.x; De Valpine P, 2002, ECOL MONOGR, V72, P57, DOI 10.1890/0012-9615(2002)072[0057:FPMIPN]2.0.CO;2; Deem Sharon L., 2008, P304; Di Minin E, 2011, ECOGRAPHY, V34, P162, DOI 10.1111/j.1600-0587.2010.06263.x; DIGIACOMO RF, 1986, J AM VET MED ASSOC, V189, P22; Ebert D, 1996, TRENDS ECOL EVOL, V11, pA79; EBERT D, 1994, SCIENCE, V265, P1084, DOI 10.1126/science.265.5175.1084; Fisher MC, 2009, ANNU REV MICROBIOL, V63, P291, DOI 10.1146/annurev.micro.091208.073435; Garner TWJ, 2005, EMERG INFECT DIS, V11, P1639; Gelman A., 2007, DATA ANAL USING REGR; Grafe TU, 2004, OECOLOGIA, V141, P40, DOI 10.1007/s00442-004-1639-7; Hels T, 2002, ECOGRAPHY, V25, P730, DOI 10.1034/j.1600-0587.2002.250609.x; Hijmans RJ, 2005, INT J CLIMATOL, V25, P1965, DOI 10.1002/joc.1276; Ibelings BW, 2004, J PHYCOL, V40, P437, DOI 10.1111/j.1529-8817.2004.03117.x; Jolles AE, 2006, AM NAT, V167, P745, DOI 10.1086/503055; Jolles AE, 2005, ECOLOGY, V86, P2358, DOI 10.1890/05-0038; Kery M, 2012, BAYESIAN POPULATION ANALYSIS USING WINBUGS: A HIERARCHICAL PERSPECTIVE, P1; Kery M, 2008, COMMUNITY ECOL, V9, P207, DOI 10.1556/ComEc.9.2008.2.10; Lampo M, 1998, ECOL APPL, V8, P388, DOI 10.2307/2641079; Laurance WF, 1996, CONSERV BIOL, V10, P406, DOI 10.1046/j.1523-1739.1996.10020406.x; Lebreton JD, 2005, AUST NZ J STAT, V47, P49, DOI 10.1111/j.1467-842X.2005.00371.x; Lips KR, 2006, P NATL ACAD SCI USA, V103, P3165, DOI 10.1073/pnas.0506889103; Longo AV, 2010, ECOHEALTH, V7, P185, DOI 10.1007/s10393-010-0327-9; Lunn DJ, 2000, STAT COMPUT, V10, P325, DOI 10.1023/A:1008929526011; Muths E, 2011, J APPL ECOL, V48, P873, DOI 10.1111/j.1365-2664.2011.02005.x; Patrick DA, 2008, ECOLOGY, V89, P2563, DOI 10.1890/07-0906.1; Peyer NF, 2010, THESIS U ZURICH ZURI; Pilliod DS, 2010, CONSERV BIOL, V24, P1259, DOI 10.1111/j.1523-1739.2010.01506.x; Puschendorf R, 2011, CONSERV BIOL, V25, P956, DOI 10.1111/j.1523-1739.2011.01728.x; R Core Team, 2022, R LANG ENV STAT COMP; Read Andrew F., 1994, Trends in Microbiology, V2, P73, DOI 10.1016/0966-842X(94)90537-1; Retallick RWR, 2004, PLOS BIOL, V2, P1965, DOI 10.1371/journal.pbio.0020351; Schmidt B.R., 2005, ROTE LISTE GEFAHRDET; SCHMIDT B. R., 2009, METHODEN FELDHERPETO, P229; Schmidt BR, 2009, AMPHIBIA-REPTILIA, V30, P313, DOI 10.1163/156853809788795245; SCHMIDT BR, 1993, TRENDS ECOL EVOL, V8, P271, DOI 10.1016/0169-5347(93)90252-K; Schmidt BR, 2005, AQUAT CONSERV, V15, P681, DOI 10.1002/aqc.740; Schmidt BR, 2004, HERPETOL J, V14, P167; Skelly D.C., 2009, AMPHIBIAN ECOLOGY CO, P55; Skerratt LF, 2007, ECOHEALTH, V4, P125, DOI 10.1007/s10393-007-0093-5; Stuart SN, 2004, SCIENCE, V306, P1783, DOI 10.1126/science.1103538; Teacher AGF, 2010, ANIM CONSERV, V13, P514, DOI 10.1111/j.1469-1795.2010.00373.x; Tobler U, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0010927; Tompkins D.M., 2001, ECOLOGY WILDLIFE DIS, P45; Tompkins DM, 1999, PARASITOL TODAY, V15, P311, DOI 10.1016/S0169-4758(99)01484-2; Vences Miguel, 2007, Zeitschrift fuer Feldherpetologie, V14, P153; Vredenburg VT, 2010, P NATL ACAD SCI USA, V107, P9689, DOI 10.1073/pnas.0914111107; Walker SF, 2010, ECOL LETT, V13, P372, DOI 10.1111/j.1461-0248.2009.01434.x; Woodhams DC, 2011, FRONT ZOOL, V8, DOI 10.1186/1742-9994-8-8	63	53	55	2	43	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 5	2012	7	4							e34667	10.1371/journal.pone.0034667	http://dx.doi.org/10.1371/journal.pone.0034667			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	955IH	22496836	Green Published, gold, Green Accepted, Green Submitted			2022-12-25	WOS:000305010500021
J	Moro, M; Crosti, M; Creo, P; Gallina, P; Curti, S; Sugliano, E; Scavelli, R; Cattaneo, D; Canidio, E; Marconi, M; Rebulla, P; Sarmientos, P; Viale, G; Pagani, M; Abrignani, S				Moro, Monica; Crosti, Mariacristina; Creo, Pasquale; Gallina, Pierangela; Curti, Serena; Sugliano, Elisa; Scavelli, Rossana; Cattaneo, Davide; Canidio, Elena; Marconi, Maurizio; Rebulla, Paolo; Sarmientos, Paolo; Viale, Giuseppe; Pagani, Massimiliano; Abrignani, Sergio			Identification of New Hematopoietic Cell Subsets with a Polyclonal Antibody Library Specific for Neglected Proteins	PLOS ONE			English	Article							GENE-EXPRESSION PROFILE; CD4(+)CD25(+) T-CELLS; B-CELLS; REGULATORY PROPERTIES; CD133(+) CELLS; BLOOD; EFFECTOR; MEMORY; DIFFERENTIATION; TRANSPLANTATION	The identification of new markers, the expression of which defines new phenotipically and functionally distinct cell subsets, is a main objective in cell biology. We have addressed the issue of identifying new cell specific markers with a reverse proteomic approach whereby approximately 1700 human open reading frames encoding proteins predicted to be transmembrane or secreted have been selected in silico for being poorly known, cloned and expressed in bacteria. These proteins have been purified and used to immunize mice with the aim of obtaining polyclonal antisera mostly specific for linear epitopes. Such a library, made of about 1600 different polyclonal antisera, has been obtained and screened by flow cytometry on cord blood derived CD34+CD45dim cells and on peripheral blood derived mature lymphocytes (PBLs). We identified three new proteins expressed by fractions of CD34+CD45dim cells and eight new proteins expressed by fractions of PBLs. Remarkably, we identified proteins the presence of which had not been demonstrated previously by transcriptomic analysis. From the functional point of view, looking at new proteins expressed on CD34+CD45dim cells, we identified one cell surface protein (MOSC-1) the expression of which on a minority of CD34+ progenitors marks those CD34+CD45dim cells that will go toward monocyte/granulocyte differentiation. In conclusion, we show a new way of looking at the membranome by assessing expression of generally neglected proteins with a library of polyclonal antisera, and in so doing we have identified new potential subsets of hematopoietic progenitors and of mature PBLs.	[Moro, Monica; Crosti, Mariacristina; Creo, Pasquale; Gallina, Pierangela; Curti, Serena; Sugliano, Elisa; Scavelli, Rossana; Abrignani, Sergio] Fdn Ist Nazl Genet Mol, INGM, Milan, Italy; [Cattaneo, Davide; Canidio, Elena; Sarmientos, Paolo; Pagani, Massimiliano; Abrignani, Sergio] PRIMM, Milan, Italy; [Marconi, Maurizio; Rebulla, Paolo; Pagani, Massimiliano; Abrignani, Sergio] IRCCS Ca Granda Osped Maggiore Policlin, Milan, Italy; [Viale, Giuseppe; Pagani, Massimiliano] IEO, Milan, Italy	IRCCS Ca Granda Ospedale Maggiore Policlinico; IRCCS European Institute of Oncology (IEO)	Moro, M (corresponding author), Fdn Ist Nazl Genet Mol, INGM, Milan, Italy.	pagani@primm.it	Creo, Pasquale/AAA-7572-2021; Viale, Giuseppe/AAE-8921-2019; Rebulla, Paolo/I-7684-2015	Creo, Pasquale/0000-0003-1545-3427; Rebulla, Paolo/0000-0002-3875-5754; Pagani, Massimiliano/0000-0002-7017-9304; Abrignani, Sergio/0000-0002-0794-3285	Italian Ministry of Health; CARIPLO Foundation [2007-5441]	Italian Ministry of Health(Ministry of Health, Italy); CARIPLO Foundation(Fondazione Cariplo)	This work was supported by the Italian Ministry of Health and partially by CARIPLO Foundation, grant no. 2007-5441. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Anantharaman V, 2002, FEMS MICROBIOL LETT, V207, P55, DOI 10.1016/S0378-1097(01)00515-8; Annunziato F, 2007, J EXP MED, V204, P1849, DOI 10.1084/jem.20070663; Annunziato F, 2009, ARTHRITIS RES THER, V11, DOI 10.1186/ar2843; BACH FH, 1968, LANCET, V2, P1364; Bick D, 2011, CURR OPIN PEDIATR, V23, P594, DOI 10.1097/MOP.0b013e32834b20ec; Bluestone JA, 2009, NAT REV IMMUNOL, V9, P811, DOI 10.1038/nri2654; Chan WL, 2003, IMMUNOL LETT, V85, P159, DOI 10.1016/S0165-2478(02)00223-7; de Bruin AM, 2011, BLOOD; Dieckmann D, 2001, J EXP MED, V193, P1303, DOI 10.1084/jem.193.11.1303; Dorner T, 2009, ARTHRITIS RES THER, V11, DOI 10.1186/ar2780; Dogan I, 2009, NAT IMMUNOL, V10, P1292, DOI 10.1038/ni.1814; Eyerich S, 2009, J CLIN INVEST, V119, P3573, DOI 10.1172/JCI40202; Fischer D, 2006, CURR OPIN STRUC BIOL, V16, P178, DOI 10.1016/j.sbi.2006.03.004; Foster LJ, 2005, STEM CELLS, V23, P1367, DOI 10.1634/stemcells.2004-0372; Gluckman E, 2005, CYTOTHERAPY, V7, P219, DOI 10.1080/14653240510027136; Gonzaga-Jauregui C, 2012, ANNU REV MED, V63, P35, DOI 10.1146/annurev-med-051010-162644; Gratwohl A, 2002, BLOOD, V100, P2374, DOI 10.1182/blood-2002-03-0675; Grifantini R, 2011, J PROTEOMICS; Gross O, 2011, IMMUNOL REV, V243, P136, DOI 10.1111/j.1600-065X.2011.01046.x; Haberkorn U, 2002, EUR J NUCL MED, V29, P115, DOI 10.1007/s00259-001-0682-4; Harari A, 2006, IMMUNOL REV, V211, P236, DOI 10.1111/j.0105-2896.2006.00395.x; Hemmoranta H, 2006, STEM CELLS DEV, V15, P839, DOI 10.1089/scd.2006.15.839; Hinz U, 2010, CELL MOL LIFE SCI, V67, P1049, DOI 10.1007/s00018-009-0229-6; Hocquette J F, 2005, J Physiol Pharmacol, V56 Suppl 3, P37; Jaatinen T, 2006, STEM CELLS, V24, P631, DOI 10.1634/stemcells.2005-0185; Jonuleit H, 2001, J EXP MED, V193, P1285, DOI 10.1084/jem.193.11.1285; Kallies A, 2008, IMMUNOL CELL BIOL, V86, P325, DOI 10.1038/icb.2008.16; Langrish CL, 2005, J EXP MED, V201, P233, DOI 10.1084/jem.20041257; LANZAVECCHIA A, 1977, B I SIEROTER MILAN, V56, P217; Lemoine S, 2009, ANN NY ACAD SCI, V1173, P260, DOI 10.1111/j.1749-6632.2009.04651.x; Liu F, 2006, PROTEOMICS, V6, P2673, DOI 10.1002/pmic.200500032; Loyet KM, 2005, J PROTEOME RES, V4, P400, DOI 10.1021/pr049810q; Lyman GH, 2006, CLIN BREAST CANCER, V7, P372, DOI 10.3816/CBC.2006.n.053; Madras N, 2002, STEM CELLS, V20, P230, DOI 10.1634/stemcells.20-3-230; Nierhoff D, 2007, HEPATOLOGY; Oh JMC, 2001, PROTEOMICS, V1, P1303, DOI 10.1002/1615-9861(200110)1:10<1303::AID-PROT1303>3.0.CO;2-2; Sanz I, 2008, SEMIN IMMUNOL, V20, P67, DOI 10.1016/j.smim.2007.12.006; Turtle CJ, 2009, IMMUNITY, V31, P834, DOI 10.1016/j.immuni.2009.09.015; Weaver CT, 2009, NAT REV IMMUNOL, V9, P883, DOI 10.1038/nri2660; Xu Cunshuan, 2004, Genomics Proteomics & Bioinformatics, V2, P109; Zhao JH, 2011, CURR PHARM BIOTECHNO, V12, P293, DOI 10.2174/138920111794295729	41	1	1	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 4	2012	7	4							e34395	10.1371/journal.pone.0034395	http://dx.doi.org/10.1371/journal.pone.0034395			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	953GO	22496798	Green Submitted, Green Published, gold			2022-12-25	WOS:000304855200045
J	Zhang, QG; Laird, MD; Han, D; Nguyen, K; Scott, E; Dong, Y; Dhandapani, KM; Brann, DW				Zhang, Quan-Guang; Laird, Melissa D.; Han, Dong; Khoi Nguyen; Scott, Erin; Dong, Yan; Dhandapani, Krishnan M.; Brann, Darrell W.			Critical Role of NADPH Oxidase in Neuronal Oxidative Damage and Microglia Activation following Traumatic Brain Injury	PLOS ONE			English	Article							CONTROLLED CORTICAL IMPACT; AMYLOID PRECURSOR PROTEIN; CENTRAL-NERVOUS-SYSTEM; SUPEROXIDE-PRODUCTION; SYNAPTIC PROTEINS; ISCHEMIA; OXYGEN; EDEMA; NEUROPROTECTION; ATTENUATION	Background: Oxidative stress is known to play an important role in the pathology of traumatic brain injury. Mitochondria are thought to be the major source of the damaging reactive oxygen species (ROS) following TBI. However, recent work has revealed that the membrane, via the enzyme NADPH oxidase can also generate the superoxide radical (O-2(-)), and thereby potentially contribute to the oxidative stress following TBI. The current study thus addressed the potential role of NADPH oxidase in TBI. Methodology/Principal Findings:The results revealed that NADPH oxidase activity in the cerebral cortex and hippocampal CA1 region increases rapidly following controlled cortical impact in male mice, with an early peak at 1 h, followed by a secondary peak from 24-96 h after TBI. In situ localization using oxidized hydroethidine and the neuronal marker, NeuN, revealed that the O-2(-) induction occurred in neurons at 1 h after TBI. Pre- or post-treatment with the NADPH oxidase inhibitor, apocynin markedly inhibited microglial activation and oxidative stress damage. Apocynin also attenuated TBI-induction of the Alzheimer's disease proteins beta-amyloid and amyloid precursor protein. Finally, both pre- and post-treatment of apocynin was also shown to induce significant neuroprotection against TBI. In addition, a NOX2-specific inhibitor, gp91ds-tat was also shown to exert neuroprotection against TBI. Conclusions/Significance: As a whole, the study demonstrates that NADPH oxidase activity and superoxide production exhibit a biphasic elevation in the hippocampus and cortex following TBI, which contributes significantly to the pathology of TBI via mediation of oxidative stress damage, microglial activation, and AD protein induction in the brain following TBI.	[Zhang, Quan-Guang; Han, Dong; Khoi Nguyen; Scott, Erin; Dong, Yan; Brann, Darrell W.] Georgia Hlth Sci Univ, Dept Neurol, Inst Mol Med & Genet, Augusta, GA USA; [Laird, Melissa D.; Dhandapani, Krishnan M.] Georgia Hlth Sci Univ, Dept Neurosurg, Augusta, GA USA	University System of Georgia; Augusta University; University System of Georgia; Augusta University	Zhang, QG (corresponding author), Georgia Hlth Sci Univ, Dept Neurol, Inst Mol Med & Genet, Augusta, GA USA.	dbrann@georgiahealth.edu		Dhandapani, Krishnan/0000-0001-7044-1117				Afanas'ev IB, 2007, MOL BIOTECHNOL, V37, P2, DOI 10.1007/s12033-007-0056-7; Ansari MA, 2008, FREE RADICAL BIO MED, V45, P443, DOI 10.1016/j.freeradbiomed.2008.04.038; Ansari MA, 2008, J NEUROTRAUM, V25, P513, DOI 10.1089/neu.2007.0451; Beauchamp K, 2008, MOL MED, V14, P731, DOI 10.2119/2008-00050.Beauchamp; Bedard K, 2007, PHYSIOL REV, V87, P245, DOI 10.1152/physrev.00044.2005; Bergamini CM, 2004, CURR PHARM DESIGN, V10, P1611, DOI 10.2174/1381612043384664; Bindokas VP, 1996, J NEUROSCI, V16, P1324; Block ML, 2008, BMC NEUROSCI, V9, DOI 10.1186/1471-2202-9-S2-S8; Bramlett HM, 1997, J NEUROPATH EXP NEUR, V56, P1132, DOI 10.1097/00005072-199710000-00007; Chen H, 2009, J CEREB BLOOD FLOW M; Chen H, 2009, J CEREBR BLOOD F MET, V29, P1262, DOI 10.1038/jcbfm.2009.47; Dohi K, 2010, J NEUROINFLAMM, V7, DOI 10.1186/1742-2094-7-41; Gaetz M, 2004, CLIN NEUROPHYSIOL, V115, P4, DOI 10.1016/S1388-2457(03)00258-X; Gilgun-Sherki Y, 2002, PHARMACOL REV, V54, P271, DOI 10.1124/pr.54.2.271; Harting MT, 2008, SURGERY, V144, P803, DOI 10.1016/j.surg.2008.05.017; Itoh T, 2009, NEUROL RES, V31, P103, DOI 10.1179/016164108X323771; Jackman KA, 2009, BRIT J PHARMACOL, V156, P680, DOI 10.1111/j.1476-5381.2008.00073.x; Jellinger KA, 2004, CURR OPIN NEUROL, V17, P719, DOI 10.1097/00019052-200412000-00012; Kelley BJ, 2007, J NEUROPATH EXP NEUR, V66, P989, DOI 10.1097/NEN.0b013e3181588245; Kiening KL, 2002, NEUROSCI LETT, V324, P105, DOI 10.1016/S0304-3940(02)00180-5; King MD, 2011, J NEUROSURG, V115, P116, DOI 10.3171/2011.2.JNS10784; Laird MD, 2010, J NEUROCHEM, V113, P637, DOI 10.1111/j.1471-4159.2010.06630.x; Lambert AJ, 2009, METHODS MOL BIOL, V554, P165, DOI 10.1007/978-1-59745-521-3_11; Lotocki G, 2009, J NEUROTRAUM, V26, P1123, DOI 10.1089/neu.2008.0802; MOUTON PR, 1994, J CHEM NEUROANAT, V7, P185, DOI 10.1016/0891-0618(94)90028-0; Murotomi K, 2011, MOL CELL NEUROSCI, V46, P681, DOI 10.1016/j.mcn.2011.01.009; Pun PBL, 2009, FREE RADICAL RES, V43, P348, DOI 10.1080/10715760902751902; Qin LY, 2002, J NEUROCHEM, V83, P973, DOI 10.1046/j.1471-4159.2002.01210.x; Raz L, 2010, PLAS ONE; Rey FE, 2001, CIRC RES, V89, P408, DOI 10.1161/hh1701.096037; Serrano F, 2003, BRAIN RES, V988, P193, DOI 10.1016/S0006-8993(03)03364-X; Sorce S, 2009, ANTIOXID REDOX SIGN, V11, P2481, DOI [10.1089/ars.2009.2578, 10.1089/ARS.2009.2578]; Tang LL, 2007, J INT MED RES, V35, P517, DOI 10.1177/147323000703500411; Toklu HZ, 2009, FREE RADICAL RES, V43, P658, DOI 10.1080/10715760902988843; Unterberg AW, 2004, NEUROSCIENCE, V129, P1021, DOI 10.1016/j.neuroscience.2004.06.046; Van Den Heuvel C, 2007, PROG BRAIN RES, V161, P303, DOI 10.1016/S0079-6123(06)61021-2; Venkatesan C, 2010, J NEUROINFLAMM, V7, DOI 10.1186/1742-2094-7-32; Wada K, 1999, NEUROSURGERY, V45, P601, DOI 10.1097/00006123-199909000-00031; Wakade C, 2010, J NEUROSURG; Wakade C, 2008, ENDOCRINOLOGY, V149, P367, DOI 10.1210/en.2007-0899; Wang R, 2009, J NEUROSCIE IN PRESS; Zhang QG, 2008, J NEUROSCI, V28, P8430, DOI 10.1523/JNEUROSCI.2752-08.2008; Zhang QG, 2009, J NEUROSCI, V29, P13823, DOI 10.1523/JNEUROSCI.3574-09.2009; Zweckberger K, 2006, J NEUROTRAUM, V23, P1083, DOI 10.1089/neu.2006.23.1083	44	157	159	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 2	2012	7	4							e34504	10.1371/journal.pone.0034504	http://dx.doi.org/10.1371/journal.pone.0034504			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	952GU	22485176	Green Published, Green Submitted, gold			2022-12-25	WOS:000304780500051
J	Gerbitz, A; Sukumar, M; Helm, F; Wilke, A; Friese, C; Fahrenwaldt, C; Lehmann, FM; Loddenkemper, C; Kammertoens, T; Mautner, J; Schmitt, CA; Blankenstein, T; Bornkamm, GW				Gerbitz, Armin; Sukumar, Madhusudhanan; Helm, Florian; Wilke, Andrea; Friese, Christian; Fahrenwaldt, Cornelia; Lehmann, Frank M.; Loddenkemper, Christoph; Kammertoens, Thomas; Mautner, Josef; Schmitt, Clemens A.; Blankenstein, Thomas; Bornkamm, Georg W.			Stromal Interferon-gamma Signaling and Cross-Presentation Are Required to Eliminate Antigen-Loss Variants of B Cell Lymphomas in Mice	PLOS ONE			English	Article							THYMIC EPITHELIAL-CELLS; NON-HODGKIN-LYMPHOMA; T-CELLS; SUPPRESSOR-CELLS; BURKITT-LYMPHOMA; TUMOR STROMA; IN-VIVO; CANCER; LYMPHOCYTES; IMMUNITY	To study mechanisms of T cell-mediated rejection of B cell lymphomas, we developed a murine lymphoma model wherein three potential rejection antigens, human c-MYC, chicken ovalbumin (OVA), and GFP are expressed. After transfer into wild-type mice 60-70% of systemically growing lymphomas expressing all three antigens were rejected; lymphomas expressing only human c-MYC protein were not rejected. OVA expressing lymphomas were infiltrated by T cells, showed MHC class I and II upregulation, and lost antigen expression, indicating immune escape. In contrast to wild-type recipients, 80-100% of STAT1-, IFN-gamma-, or IFN-gamma receptor-deficient recipients died of lymphoma, indicating that host IFN-gamma signaling is critical for rejection. Lymphomas arising in IFN-gamma- and IFN-gamma-receptor-deficient mice had invariably lost antigen expression, suggesting that poor overall survival of these recipients was due to inefficient elimination of antigen-negative lymphoma variants. Antigen-dependent eradication of lymphoma cells in wild-type animals was dependent on cross-presentation of antigen by cells of the tumor stroma. These findings provide first evidence for an important role of the tumor stroma in T cell-mediated control of hematologic neoplasias and highlight the importance of incorporating stroma-targeting strategies into future immunotherapeutic approaches.	[Gerbitz, Armin; Helm, Florian; Wilke, Andrea; Friese, Christian; Fahrenwaldt, Cornelia; Kammertoens, Thomas; Blankenstein, Thomas] Charite, Dept Immunol, Berlin, Germany; [Sukumar, Madhusudhanan; Lehmann, Frank M.; Bornkamm, Georg W.] Helmholtz Ctr Munich, Inst Clin Mol Biol & Tumor Genet, Munich, Germany; [Loddenkemper, Christoph] Charite, Dept Pathol, Berlin, Germany; [Mautner, Josef] Tech Univ TU Munich, Dept Pediat, Munich, Germany; [Mautner, Josef] Tech Univ Munich, Clin Cooperat Grp Pediat Tumor Immunol, Munich, Germany; [Mautner, Josef] Helmholtz Ctr Munich, Munich, Germany; [Gerbitz, Armin; Fahrenwaldt, Cornelia] Univ Erlangen Nurnberg, Dept Hematol & Oncol, D-91054 Erlangen, Germany; [Schmitt, Clemens A.] Charite, Dept Hematol & Oncol, Berlin, Germany; [Blankenstein, Thomas] Max Delbruck Ctr Mol Med, Berlin, Germany	Free University of Berlin; Humboldt University of Berlin; Charite Universitatsmedizin Berlin; Helmholtz Association; Helmholtz-Center Munich - German Research Center for Environmental Health; Free University of Berlin; Humboldt University of Berlin; Charite Universitatsmedizin Berlin; Technical University of Munich; Helmholtz Association; Helmholtz-Center Munich - German Research Center for Environmental Health; University of Erlangen Nuremberg; Free University of Berlin; Humboldt University of Berlin; Charite Universitatsmedizin Berlin; Helmholtz Association; Max Delbruck Center for Molecular Medicine	Gerbitz, A (corresponding author), Charite, Dept Immunol, Berlin, Germany.	armin.gerbitz@uk-erlangen.de	Schmitt, Clemens A/S-9479-2017	Schmitt, Clemens A/0000-0002-4731-2226; Lehmann, Frank Michael/0000-0002-0381-9033	Deutsche Forschungsgemeinschaft [Ge999/5-3, SFB-TR36, SFB-TR54]; Wilhelm Sander Foundation; Rudolf-Bartling-Foundation	Deutsche Forschungsgemeinschaft(German Research Foundation (DFG)); Wilhelm Sander Foundation; Rudolf-Bartling-Foundation	This work was supported by grants from the Deutsche Forschungsgemeinschaft (Ge999/5-3, SFB-TR36, SFB-TR54), the Wilhelm Sander Foundation and the Rudolf-Bartling-Foundation. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aran JM, 1998, CANCER GENE THER, V5, P195; Bhattacharya D, 2006, J EXP MED, V203, P73, DOI 10.1084/jem.20051714; Zhang B, 2008, J CLIN INVEST, V118, P1398, DOI 10.1172/JCI33522; Bosetti C, 2008, INT J CANCER, V123, P1917, DOI 10.1002/ijc.23722; Clarke SRM, 2000, IMMUNOL CELL BIOL, V78, P110, DOI 10.1046/j.1440-1711.2000.00889.x; Cloosen S, 2007, CANCER RES, V67, P3919, DOI 10.1158/0008-5472.CAN-06-2112; Derbinski J, 2001, NAT IMMUNOL, V2, P1032, DOI 10.1038/ni723; Dierks C, 2007, NAT MED, V13, P944, DOI 10.1038/nm1614; DIGHE AS, 1994, IMMUNITY, V1, P447, DOI 10.1016/1074-7613(94)90087-6; Dunn GP, 2006, NAT REV IMMUNOL, V6, P836, DOI 10.1038/nri1961; Durbin JE, 1996, CELL, V84, P443, DOI 10.1016/S0092-8674(00)81289-1; Dyer CM, 2004, BLOOD, V103, P3073, DOI 10.1182/blood-2003-07-2305; Ehst BD, 2003, AM J TRANSPLANT, V3, P1355, DOI 10.1046/j.1600-6135.2003.00246.x; FalK MH, 1998, INT J CANCER, V75, P620, DOI 10.1002/(SICI)1097-0215(19980209)75:4<620::AID-IJC21>3.0.CO;2-B; Fisher SG, 2004, ONCOGENE, V23, P6524, DOI 10.1038/sj.onc.1207843; Gabrilovich DI, 2009, NAT REV IMMUNOL, V9, P162, DOI 10.1038/nri2506; GHATTAS IR, 1991, MOL CELL BIOL, V11, P5848, DOI 10.1128/MCB.11.12.5848; Goldstone AH, 2009, BIOL BLOOD MARROW TR, V15, P7, DOI 10.1016/j.bbmt.2008.11.017; Grigg A, 2004, BIOL BLOOD MARROW TR, V10, P579, DOI 10.1016/j.bbmt.2004.05.008; Hamadani M, 2009, BIOL BLOOD MARROW TR, V15, P547, DOI 10.1016/j.bbmt.2009.01.010; Heslop HE, 1996, NAT MED, V2, P551, DOI 10.1038/nm0596-551; Heslop HE, 2009, BLOOD; Hurt EM, 2004, CANCER CELL, V5, P191, DOI 10.1016/S1535-6108(04)00019-4; Kolb HJ, 2004, BLOOD, V103, P767, DOI 10.1182/blood-2003-02-0342; KOLB HJ, 1990, BLOOD, V76, P2462, DOI 10.1182/blood.V76.12.2462.2462; Kovalchuk AL, 2000, J EXP MED, V192, P1183, DOI 10.1084/jem.192.8.1183; Kuppers R, 2009, NAT REV CANCER, V9, P15, DOI 10.1038/nrc2542; Lenz G, 2008, NEW ENGL J MED, V359, P2313, DOI 10.1056/NEJMoa0802885; Levi F, 2002, LEUKEMIA RES, V26, P903, DOI 10.1016/S0145-2126(02)00031-0; Mumberg D, 1996, Semin Immunol, V8, P289, DOI 10.1006/smim.1996.0037; Ostrand-Rosenberg S, 2009, J IMMUNOL, V182, P4499, DOI 10.4049/jimmunol.0802740; PREHN RT, 1957, J NATL CANCER I, V18, P769; Qin ZH, 2000, IMMUNITY, V12, P677, DOI 10.1016/S1074-7613(00)80218-6; Reimann M, CANC CELL, V17, P262; Schaefer BC, 2001, CELL IMMUNOL, V214, P110, DOI 10.1006/cimm.2001.1895; Schmitt CA, 2002, CELL, V109, P335, DOI 10.1016/S0092-8674(02)00734-1; Schuler T, 2003, J IMMUNOL, V170, P4427, DOI 10.4049/jimmunol.170.9.4427; Serody JS, 1999, BLOOD, V93, P43, DOI 10.1182/blood.V93.1.43.401k24_43_50; Spiotto MT, 2004, NAT MED, V10, P294, DOI 10.1038/nm999; Swift S, 2001, Curr Protoc Immunol, VChapter 10, DOI 10.1002/0471142735.im1017cs31; van Besien K, 2009, BIOL BLOOD MARROW TR, V15, P554, DOI 10.1016/j.bbmt.2009.01.012; Wagner HJ, 2004, CANCER GENE THER, V11, P81, DOI 10.1038/sj.cgt.7700664; WOLFEL T, 1995, SCIENCE, V269, P1281, DOI 10.1126/science.7652577; Zenz T, 2010, NAT REV CANCER, V10, P37, DOI 10.1038/nrc2764; Zhang B, 2008, CANCER RES, V68, P1563, DOI 10.1158/0008-5472.CAN-07-5324; Zhang B, 2007, J EXP MED, V204, P49, DOI 10.1084/jem.20062056	46	14	15	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 30	2012	7	3							e34552	10.1371/journal.pone.0034552	http://dx.doi.org/10.1371/journal.pone.0034552			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	959UC	22479645	Green Published, gold, Green Accepted			2022-12-25	WOS:000305339100168
J	Kriechbaumer, V; Nabok, A; Mustafa, MK; Al-Ammar, R; Tsargorodskaya, A; Smith, DP; Abell, BM				Kriechbaumer, Verena; Nabok, Alexei; Mustafa, Mohd K.; Al-Ammar, Rukaiah; Tsargorodskaya, Anna; Smith, David P.; Abell, Ben M.			Analysis of Protein Interactions at Native Chloroplast Membranes by Ellipsometry	PLOS ONE			English	Article							INTERNAL-REFLECTION ELLIPSOMETRY; SURFACE-PLASMON RESONANCE; RECEPTOR; IMPORT; TRANSLOCON; PRECURSOR	Membrane bound receptors play vital roles in cell signaling, and are the target for many drugs, yet their interactions with ligands are difficult to study by conventional techniques due to the technical difficulty of monitoring these interactions in lipid environments. In particular, the ability to analyse the behaviour of membrane proteins in their native membrane environment is limited. Here, we have developed a quantitative approach to detect specific interactions between low abundance chaperone receptors within native chloroplast membranes and their soluble chaperone partners. Langmuir-Schaefer film deposition was used to deposit native chloroplasts onto gold-coated glass slides, and interactions between the molecular chaperones Hsp70 and Hsp90 and their receptors in the chloroplast membranes were detected and quantified by total internal reflection ellipsometry (TIRE). We show that native chloroplast membranes deposited on gold-coated glass slides using Langmuir-Schaefer films retain functional receptors capable of binding chaperones with high specificity and affinity. Taking into account the low chaperone receptor abundance in native membranes, these binding properties are consistent with data generated using soluble forms of the chloroplast chaperone receptors, OEP61 and Toc64. Therefore, we conclude that chloroplasts have the capacity to selectively bind chaperones, consistent with the notion that chaperones play an important role in protein targeting to chloroplasts. Importantly, this method of monitoring by TIRE does not require any protein labelling. This novel combination of techniques should be applicable to a wide variety of membranes and membrane protein receptors, thus presenting the opportunity to quantify protein interactions involved in fundamental cellular processes, and to screen for drugs that target membrane proteins.	[Kriechbaumer, Verena; Smith, David P.; Abell, Ben M.] Sheffield Hallam Univ, Biomed Res Ctr, Sheffield S1 1WB, S Yorkshire, England; [Nabok, Alexei; Mustafa, Mohd K.; Al-Ammar, Rukaiah; Tsargorodskaya, Anna] Sheffield Hallam Univ, Mat & Engn Res Inst, Sheffield S1 1WB, S Yorkshire, England	Sheffield Hallam University; Sheffield Hallam University	Kriechbaumer, V (corresponding author), Sheffield Hallam Univ, Biomed Res Ctr, Sheffield S1 1WB, S Yorkshire, England.	v.kriechbaumer@shu.ac.uk	Kriechbaumer, Verena/AAW-9148-2020; Nabok, Alexei/AAW-5758-2020; ammmar, Rukaiah Al/AAB-1850-2019; Kriechbaumer, Verena/ABF-5534-2020; Mustafa, Mohd Kamarulzaki/AAO-9802-2021	Kriechbaumer, Verena/0000-0003-3782-5834; Mustafa, Mohd/0000-0003-2451-8595; Abell, Ben/0000-0002-0953-0046; Smith, David/0000-0001-5177-8574	EPSRC [EP/H000275/1, EP/I016473/1]; BBSRC [BB/E01559X/1]; Biotechnology and Biological Sciences Research Council [BB/E01559X/1] Funding Source: researchfish; Engineering and Physical Sciences Research Council [EP/I016473/1, EP/J501621/1] Funding Source: researchfish	EPSRC(UK Research & Innovation (UKRI)Engineering & Physical Sciences Research Council (EPSRC)); BBSRC(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); Biotechnology and Biological Sciences Research Council(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); Engineering and Physical Sciences Research Council(UK Research & Innovation (UKRI)Engineering & Physical Sciences Research Council (EPSRC))	This work was supported by the EPSRC( www.epsrc.ac.uk) Engineering for Life research grant ( No. EP/H000275/1), the Feasibility Study grant ( No. EP/I016473/1), and a BBSRC( www.bbsrc.ac.uk/) research grant ( No. BB/E01559X/1, awarded to Dr. Abell. Consumables and salary of Dr. Kriechbaumer were paid off these grants. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abell BM, 2007, J CELL SCI, V120, P1743, DOI 10.1242/jcs.002410; Artigues A, 2002, J BIOL CHEM, V277, P25047, DOI 10.1074/jbc.M203474200; Arwin H, 2004, APPL OPTICS, V43, P3028, DOI 10.1364/AO.43.003028; Brinker A, 2002, J BIOL CHEM, V277, P19265, DOI 10.1074/jbc.M109002200; Chew O, 2004, FEBS LETT, V557, P109, DOI 10.1016/S0014-5793(03)01457-1; Gonzalez-Maeso J, 2010, NAT NEUROSCI, V13, P524, DOI 10.1038/nn0510-524; Hernandez MP, 2002, J BIOL CHEM, V277, P38294, DOI 10.1074/jbc.M206566200; Kriechbaumer V, 2011, BIOPHYS J, V101, P504, DOI 10.1016/j.bpj.2011.06.011; Liu X, 2003, ANAL BIOCHEM, V314, P301, DOI 10.1016/S0003-2697(02)00696-6; Maynard Jennifer A., 2009, Biotechnology Journal, V4, P1542, DOI 10.1002/biot.200900195; Nabok A, 2011, SENSOR ACTUAT B-CHEM, V154, P232, DOI 10.1016/j.snb.2010.02.005; Nabok A, 2008, THIN SOLID FILMS, V516, P8993, DOI 10.1016/j.tsf.2007.11.077; Nabok AV, 2005, APPL SURF SCI, V246, P381, DOI 10.1016/j.apsusc.2004.11.084; Odunuga OO, 2003, J BIOL CHEM, V278, P6896, DOI 10.1074/jbc.M206867200; Petty M.C., 1996, LANGMUIR BLODGETT FI, DOI 10.1017/CBO9780511622519; Prasad BD, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0012761; Qbadou S, 2006, EMBO J, V25, P1836, DOI 10.1038/sj.emboj.7601091; Scheufler C, 2000, CELL, V101, P199, DOI 10.1016/S0092-8674(00)80830-2; Schleiff E, 2003, J CELL BIOL, V160, P541, DOI 10.1083/jcb.200210060; Szekacs A, 2009, APPL OPTICS, V48, pB151, DOI 10.1364/AO.48.00B151; Vojta A, 2004, J BIOL CHEM, V279, P21401, DOI 10.1074/jbc.M401968200; von Loeffelholz O, 2011, BIOCHEM J, V438, P143, DOI 10.1042/BJ20110448; Wickner W, 2005, SCIENCE, V310, P1452, DOI 10.1126/science.1113752; Woollam J. A., 2002, GUIDE USING WVASE32	24	2	2	2	19	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 29	2012	7	3							e34455	10.1371/journal.pone.0034455	http://dx.doi.org/10.1371/journal.pone.0034455			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	948SR	22479632	gold, Green Submitted, Green Published, Green Accepted			2022-12-25	WOS:000304523400085
J	Karve, TM; Rosen, EM				Karve, Tejaswita M.; Rosen, Eliot M.			B-cell Translocation Gene 2 (BTG2) Stimulates Cellular Antioxidant Defenses through the Antioxidant Transcription Factor NFE2L2 in Human Mammary Epithelial Cells	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							ESTROGEN-RECEPTOR-ALPHA; TUMOR-SUPPRESSOR GENE; NRF2 KNOCKOUT MICE; BREAST-CANCER; OXIDATIVE STRESS; SIGNALING PATHWAY; DNA-DAMAGE; EXPRESSION; PROTEIN; INHIBITION	The B-cell translocation gene 2, BTG2, a member of the BTG/TOB (B-cell translocation gene/transducers of ErbB2) gene family, has been implicated in cell cycle regulation, normal development, and possibly tumor suppression. Previously, it was shown that BTG2 expression is lost or down-regulated in human breast cancers. We now report that BTG2 protects human mammary epithelial cells from oxidative stress due to hydrogen peroxide and other oxidants. BTG2 protection against oxidative stress is BRCA1-independent but requires the antioxidant transcription factor NFE2L2 and is associated with up-regulation of the expression of antioxidant enzymes, including catalase and superoxide dismutases 1 and 2. BTG2 stimulation of antioxidant gene expression is also NFE2L2-dependent. We further demonstrate that BTG2 is a binding partner for NFE2L2 and increases its transcriptional activity. In addition, BTG2 is detectable at the antioxidant response element (ARE) of several NFE2L2-responsive genes. Finally, we show that the ability of BTG2 to associate with NFE2L2, to protect cells against oxidative stress, and to stimulate antioxidant gene expression requires box B, a short highly conserved amino acid motif characteristic of BTG2/TOB family proteins, but does not require boxes A or C. These findings suggest a novel role for BTG2 as a co-activator for NFE2L2 in up-regulating cellular antioxidant defenses.	[Rosen, Eliot M.] Georgetown Univ, Med Ctr, Dept Oncol, Washington, DC 20057 USA; [Karve, Tejaswita M.; Rosen, Eliot M.] Georgetown Univ, Med Ctr, Dept Biochem, Washington, DC 20057 USA; [Karve, Tejaswita M.; Rosen, Eliot M.] Georgetown Univ, Med Ctr, Dept Cellular & Mol Biol, Washington, DC 20057 USA	Georgetown University; Georgetown University; Georgetown University	Rosen, EM (corresponding author), Georgetown Univ, Med Ctr, Dept Oncol, 3970 Reservoir Rd NW, Washington, DC 20057 USA.	emr36@georgetown.edu			National Institutes of Health through the USPHS [RO1-CA80000, RO1-CA104546, RO1-CA150646]; Susan G. Komen for the Cure [KG110580]; Living in Pink; World Class University program; Ministry of Education, Science and Technology through the National Research Foundation of Korea [R31-10069]; NATIONAL CANCER INSTITUTE [R01CA104546, R01CA080000, R01CA150646] Funding Source: NIH RePORTER	National Institutes of Health through the USPHS; Susan G. Komen for the Cure(Susan G. Komen Breast Cancer Foundation); Living in Pink; World Class University program; Ministry of Education, Science and Technology through the National Research Foundation of Korea; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	This work was supported, in whole or in part, by National Institutes of Health Grants RO1-CA80000, RO1-CA104546 and RO1-CA150646 through the USPHS (to E. M. R.). This work was also supported by Susan G. Komen for the Cure (KG110580), and Living in Pink (to E. M. R.).; Supported by the World Class University program funded by the Ministry of Education, Science and Technology through the National Research Foundation of Korea (R31-10069). To whom correspondence should be addressed: Dept. of Oncology, Georgetown University Medical Center, 3970 Reservoir Rd., NW, Washington, D. C. 20057. Tel.: 202-687-7695; Fax: 202-687-7256; E-mail: emr36@georgetown.edu.	ARENANDER AT, 1989, J NEUROSCI RES, V23, P257, DOI 10.1002/jnr.490230303; Bae I, 2004, CANCER RES, V64, P7893, DOI 10.1158/0008-5472.CAN-04-1119; Becks L, 2010, BMC CANCER, V10, DOI 10.1186/1471-2407-10-540; Chen F, 1999, P NATL ACAD SCI USA, V96, P541, DOI 10.1073/pnas.96.2.541; Duriez C, 2002, GENE, V282, P207, DOI 10.1016/S0378-1119(01)00825-3; Duriez Cyril, 2004, Bull Cancer, V91, pE242; Fan SJ, 2009, CANCER RES, V69, P6083, DOI 10.1158/0008-5472.CAN-08-3309; Farioli-Vecchioli S, 2007, FASEB J, V21, P2215, DOI 10.1096/fj.06-7548com; Ficazzola MA, 2001, CARCINOGENESIS, V22, P1271, DOI 10.1093/carcin/22.8.1271; Fiedler F, 1998, BIOCHEM BIOPH RES CO, V249, P562, DOI 10.1006/bbrc.1998.9195; FLETCHER BS, 1991, J BIOL CHEM, V266, P14511; Giudice A, 2006, BIOESSAYS, V28, P169, DOI 10.1002/bies.20359; Guardavaccaro D, 2000, MOL CELL BIOL, V20, P1797, DOI 10.1128/MCB.20.5.1797-1815.2000; Hayashida M, 2010, NEUROREPORT, V21, P90, DOI 10.1097/WNR.0b013e328332c4d7; Iacopetti P, 1999, P NATL ACAD SCI USA, V96, P4639, DOI 10.1073/pnas.96.8.4639; Karmakar S, 2009, INT J CANCER, V124, P1841, DOI 10.1002/ijc.24133; Kaspar JW, 2009, FREE RADICAL BIO MED, V47, P1304, DOI 10.1016/j.freeradbiomed.2009.07.035; Katiyar P, 2009, MOL ENDOCRINOL, V23, P1135, DOI 10.1210/me.2008-0347; Kawakubo H, 2004, ONCOGENE, V23, P8310, DOI 10.1038/sj.onc.1208008; Kawakubo H, 2006, CANCER RES, V66, P7075, DOI 10.1158/0008-5472.CAN-06-0379; Kawamura-Tsuzuku J, 2004, ONCOGENE, V23, P6630, DOI 10.1038/sj.onc.1207890; Khor TO, 2008, CANCER PREV RES, V1, P187, DOI 10.1158/1940-6207.CAPR-08-0028; Kryston TB, 2011, MUTAT RES-FUND MOL M, V711, P193, DOI 10.1016/j.mrfmmm.2010.12.016; Kwak MK, 2002, MOL CELL BIOL, V22, P2883, DOI 10.1128/MCB.22.9.2883-2892.2002; Lin WJ, 1996, J BIOL CHEM, V271, P15034, DOI 10.1074/jbc.271.25.15034; Matsuda S, 2001, FEBS LETT, V497, P67, DOI 10.1016/S0014-5793(01)02436-X; Melamed J, 2002, TISSUE CELL, V34, P28, DOI 10.1054/tice.2001.0220; Mollerstrom E, 2010, BMC CANCER, V10, DOI 10.1186/1471-2407-10-296; Mollerstrom E, 2010, CANCER GENET CYTOGEN, V198, P79, DOI 10.1016/j.cancergencyto.2009.12.012; Montagnoli A, 1996, CELL GROWTH DIFFER, V7, P1327; Pledgie-Tracy A, 2007, MOL CANCER THER, V6, P1013, DOI 10.1158/1535-7163.MCT-06-0494; Prevot D, 2000, J BIOL CHEM, V275, P147, DOI 10.1074/jbc.275.1.147; Prevot D, 2001, J BIOL CHEM, V276, P9640, DOI 10.1074/jbc.M008201200; Rouault JP, 1996, NAT GENET, V14, P482, DOI 10.1038/ng1296-482; Ryu MS, 2004, EXP CELL RES, V299, P159, DOI 10.1016/j.yexcr.2004.05.014; Savkovic V, 2004, DIGEST DIS, V22, P239, DOI 10.1159/000082795; Slevin M, 2009, PATHOBIOLOGY, V76, P129, DOI 10.1159/000209390; Struckmann K, 2004, CANCER RES, V64, P1632, DOI 10.1158/0008-5472.CAN-03-1687; Takahashi F, 2011, ONCOGENE, V30, P3084, DOI 10.1038/onc.2011.24; Terra R, 2008, INT IMMUNOL, V20, P317, DOI 10.1093/intimm/dxm152; Tirone F, 2001, J CELL PHYSIOL, V187, P155, DOI 10.1002/jcp.1062; Tomlinson GE, 1998, CANCER RES, V58, P3237; VARNUM BC, 1994, J CELL PHYSIOL, V158, P205, DOI 10.1002/jcp.1041580125; Wheaton K, 2010, AGING CELL, V9, P747, DOI 10.1111/j.1474-9726.2010.00601.x; Xu CJ, 2006, MOL CANCER THER, V5, P1918, DOI 10.1158/1535-7163.MCT-05-0497; Yuan RQ, 2001, CANCER RES, V61, P8022; Zhang JY, 2006, MOL CELL BIOL, V26, P7942, DOI 10.1128/MCB.00700-06; Zhang ZM, 2011, CELL BIOCHEM BIOPHYS, V61, P83, DOI 10.1007/s12013-011-9164-x	48	19	19	0	8	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	SEP 7	2012	287	37					31503	31514		10.1074/jbc.M112.367433	http://dx.doi.org/10.1074/jbc.M112.367433			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	006AK	22493435	Green Published, hybrid			2022-12-25	WOS:000308791300063
J	Li, XW; Cudaback, E; Breyer, RM; Montine, KS; Keene, CD; Montine, TJ				Li, Xianwu; Cudaback, Eiron; Breyer, Richard M.; Montine, Kathleen S.; Keene, C. Dirk; Montine, Thomas J.			Eicosanoid receptor subtype-mediated opposing regulation of TLR-stimulated expression of astrocyte glial-derived neurotrophic factor	FASEB JOURNAL			English	Article						PGE(2); EP1; FP; TP; Parkinson's disease	NONSTEROIDAL ANTIINFLAMMATORY DRUGS; TOLL-LIKE RECEPTOR-3; AGED RHESUS-MONKEYS; PARKINSONS-DISEASE; DOPAMINERGIC-NEURONS; FACTOR GDNF; INTRAPUTAMENAL INFUSION; IN-VIVO; NEURODEGENERATION; RISK	A major therapeutic target for Parkinson's disease (PD) is providing increased glial-derived neurotrophic factor (GDNF) to dopaminergic neurons. We tested the hypothesis that innate immune activation increases astrocyte GDNF production and that this is regulated by specific eicosanoid receptors. Innate immune-activated primary murine astrocytes were assayed for GDNF expression and secretion. Controls were agent vehicle exposure and wild-type mice. Rank order for up to 10-fold selectively increased GDNF expression was activators of TLR3 > TLR2 or TLR4 > TLR9. TLR3 activator-stimulated GDNF expression was selectively JNK-dependent, followed cyclooxygenase (COX)-2, was coincident with membranous PGE(2) synthase, and was not significantly altered by a nonspecific COX-or a COX-2-selective inhibitor. Specific eicosanoid receptors had opposing effects on TLR3 activator-induced GDNF expression: similar to 60% enhancement by blocking or ablating of PGE(2) receptor subtype 1 (EP1), similar to 30% enhancement by activating PGF(2 alpha) receptor or thromboxane receptor, or similar to 15% enhancement by activating EP4. These results demonstrate functionally antagonistic eicosanoid receptor subtype regulation of innate immunity-induced astrocyte GDNF expression and suggest that selective inhibition of EP1 signaling might be a means to augment astrocyte GDNF secretion in the context of innate immune activation in diseased regions of brain in PD.-Li, X., Cudaback, E., Breyer, R. M., Montine, K. S., Keene, C. D., Montine, T. J. Eicosanoid receptor subtype-mediated opposing regulation of Toll-like receptor-stimulated expression of astrocyte glial-derived neurotrophic factor. FASEB J. 26, 3075-3083 (2012). www.fasebj.org	[Li, Xianwu; Cudaback, Eiron; Montine, Kathleen S.; Keene, C. Dirk; Montine, Thomas J.] Univ Washington, Dept Pathol, Seattle, WA 98104 USA; [Breyer, Richard M.] Vanderbilt Univ, Sch Med, Div Nephrol, Nashville, TN 37212 USA	University of Washington; University of Washington Seattle; Vanderbilt University	Li, XW (corresponding author), Univ Washington, Dept Pathol, Box 359645, Seattle, WA 98104 USA.	xli@u.washington.edu	Keene, Christopher D/N-1806-2015	Montine, Kathleen/0000-0003-2110-8363; Keene, Christopher/0000-0002-5291-1469	U.S. National Institutes of Health [ES16754, NS62864, AG35681, AG00258, DK37097, GM15431]; Nancy and Buster Alvord Endowment; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK037097] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES [R01ES016754] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [P01GM015431, P50GM015431] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON AGING [RC1AG035681, T32AG000258, Z01AG000258] Funding Source: NIH RePORTER	U.S. National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Nancy and Buster Alvord Endowment; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Environmental Health Sciences (NIEHS)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA))	The authors thank Meilany Wijaya for assistance with animal husbandry, Aimee Schantz and Amy Look for administrative support, and Carol Arnold for managerial support. This work was funded by the U.S. National Institutes of Health (ES16754, NS62864, AG35681, AG00258, DK37097, and GM15431) and the Nancy and Buster Alvord Endowment.	Becker C, 2011, EUR J NEUROL, V18, P1336, DOI 10.1111/j.1468-1331.2011.03399.x; Beraud D, 2011, FRONT NEUROSCI-SWITZ, V5, DOI 10.3389/fnins.2011.00080; Biju KC, 2010, MOL THER, V18, P1536, DOI 10.1038/mt.2010.107; Bornebroek M, 2007, NEUROEPIDEMIOLOGY, V28, P193, DOI 10.1159/000108110; Bsibsi M, 2006, GLIA, V53, P688, DOI 10.1002/glia.20328; Bsibsi M, 2010, J IMMUNOL, V184, P6929, DOI 10.4049/jimmunol.0902419; Carpentier PA, 2005, GLIA, V49, P360, DOI 10.1002/glia.20117; Chen HL, 2005, ANN NEUROL, V58, P963, DOI 10.1002/ana.20682; Driver JA, 2011, BMJ-BRIT MED J, V342, DOI 10.1136/bmj.d198; Eberling JL, 2009, HUM GENE THER, V20, P511, DOI 10.1089/hum.2008.201; Emborg ME, 2008, CELL TRANSPLANT, V17, P383; Furuyashiki T, 2011, NAT REV ENDOCRINOL, V7, P163, DOI 10.1038/nrendo.2010.194; Fuxe KG, 2008, BRAIN RES REV, V58, P453, DOI 10.1016/j.brainresrev.2008.04.003; Gagne JJ, 2010, NEUROLOGY, V74, P995, DOI 10.1212/WNL.0b013e3181d5a4a3; Gao XA, 2011, NEUROLOGY, V76, P863, DOI 10.1212/WNL.0b013e31820f2d79; Garbayo E, 2009, J CONTROL RELEASE, V135, P119, DOI 10.1016/j.jconrel.2008.12.010; Gill SS, 2003, NAT MED, V9, P589, DOI 10.1038/nm850; Ginsberg SD, 1998, ACTA NEUROPATHOL, V96, P487, DOI 10.1007/s004010050923; Granholm AC, 2000, J NEUROSCI, V20, P3182, DOI 10.1523/JNEUROSCI.20-09-03182.2000; Grondin R, 2003, J NEUROSCI, V23, P1974; Guan Y, 2007, J CLIN INVEST, V117, P2496, DOI 10.1172/JCI29838; Hong Murray, 2008, Expert Rev Neurother, V8, P1125, DOI 10.1586/14737175.8.7.1125; Hovland DN, 2007, TOXICOL PATHOL, V35, P1013, DOI 10.1177/01926230701481899; Kariko K, 2004, J BIOL CHEM, V279, P12542, DOI 10.1074/jbc.M310175200; KEARNS CM, 1995, BRAIN RES, V672, P104, DOI 10.1016/0006-8993(94)01366-P; Kitaoka S, 2007, J NEUROSCI, V27, P12900, DOI 10.1523/JNEUROSCI.3257-07.2007; Kordower JH, 2000, SCIENCE, V290, P767, DOI 10.1126/science.290.5492.767; Lang AE, 2006, ANN NEUROL, V59, P459, DOI 10.1002/ana.20737; Lau YS, 2011, EUR J NEUROSCI, V33, P1264, DOI 10.1111/j.1460-9568.2011.07626.x; Li XW, 2011, GLIA, V59, P569, DOI 10.1002/glia.21125; Li XZ, 2009, NEUROSCI RES, V65, P252, DOI 10.1016/j.neures.2009.07.007; Lim JE, 2011, AM J PATHOL, V179, P1095, DOI 10.1016/j.ajpath.2011.05.045; LIN LFH, 1993, SCIENCE, V260, P1130, DOI 10.1126/science.8493557; Lindvall O, 2008, EXP NEUROL, V209, P82, DOI 10.1016/j.expneurol.2007.08.019; Maswood N, 2002, NEUROBIOL AGING, V23, P881, DOI 10.1016/S0197-4580(02)00022-2; MATTAMMAL MB, 1995, J NEUROCHEM, V64, P1645; Nutt JG, 2003, NEUROLOGY, V60, P69, DOI 10.1212/WNL.60.1.69; Okun E, 2009, BRAIN RES REV, V59, P278, DOI 10.1016/j.brainresrev.2008.09.001; Pascual A, 2008, NAT NEUROSCI, V11, P755, DOI 10.1038/nn.2136; Roodveldt C, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0013481; Ros-Bernal F, 2011, P NATL ACAD SCI USA, V108, P6632, DOI 10.1073/pnas.1017820108; Saito T, 2008, J EXP MED, V205, P1523, DOI 10.1084/jem.20081210; Shie FS, 2005, GLIA, V52, P70, DOI 10.1002/glia.20220; Shiose S, 2011, J BIOL CHEM, V286, P15543, DOI 10.1074/jbc.M111.228551; Slevin JT, 2007, J NEUROSURG, V106, P614, DOI 10.3171/jns.2007.106.4.614; Soeda S, 2008, THROMB HAEMOSTASIS, V100, P1014, DOI 10.1160/TH08-04-0259; Stefanova N, 2011, AM J PATHOL, V179, P954, DOI 10.1016/j.ajpath.2011.04.013; Stone DK, 2009, ANTIOXID REDOX SIGN, V11, P2151, DOI [10.1089/ars.2009.2460, 10.1089/ARS.2009.2460]; Su XM, 2009, HUM GENE THER, V20, P1627, DOI 10.1089/hum.2009.103; Tajiri N, 2010, BRAIN RES, V1310, P200, DOI 10.1016/j.brainres.2009.10.075; Tanaka T, 2008, NEUROSCI LETT, V431, P262, DOI 10.1016/j.neulet.2007.11.051; Tanaka Y, 2009, EUR J NEUROSCI, V30, P2338, DOI 10.1111/j.1460-9568.2009.07021.x; Teismann P, 2003, P NATL ACAD SCI USA, V100, P5473, DOI 10.1073/pnas.0837397100; Thompson LH, 2009, EUR J NEUROSCI, V30, P625, DOI 10.1111/j.1460-9568.2009.06878.x; TOMAC A, 1995, NATURE, V373, P335, DOI 10.1038/373335a0; Verity AN, 1999, J NEUROSCI RES, V55, P187, DOI 10.1002/(SICI)1097-4547(19990115)55:2<187::AID-JNR6>3.0.CO;2-T; Verity AN, 1998, J NEUROCHEM, V70, P531; Wu JJ, 2010, NEUROCHEM RES, V35, P495, DOI 10.1007/s11064-009-0086-6; Yang Y, 2009, J GENE MED, V11, P899, DOI 10.1002/jgm.1377; Zigmond MJ, 2009, PARKINSONISM RELAT D, V15, pS42, DOI 10.1016/S1353-8020(09)70778-3	60	12	13	0	10	FEDERATION AMER SOC EXP BIOL	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3998 USA	0892-6638	1530-6860		FASEB J	Faseb J.	JUL	2012	26	7					3075	3083		10.1096/fj.11-200279	http://dx.doi.org/10.1096/fj.11-200279			9	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	967MP	22499581	Green Published			2022-12-25	WOS:000305912500035
J	Rybalchenko, V; Ahuja, M; Coblentz, J; Churamani, D; Patel, S; Kiselyov, K; Muallem, S				Rybalchenko, Volodymyr; Ahuja, Malini; Coblentz, Jessica; Churamani, Dev; Patel, Sandip; Kiselyov, Krill; Muallem, Shmuel			Membrane Potential Regulates Nicotinic Acid Adenine Dinucleotide Phosphate (NAADP) Dependence of the pH- and Ca2+- sensitive Organellar Two-pore Channel TPC1	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							MOBILIZES CALCIUM; RELEASE CHANNEL; MECHANISM; STORES; ROLES	Nicotinic acid adenine dinucleotide phosphate (NAADP) is a potent second messenger that mobilizes Ca2+ from the acidic endolysosomes by activation of the two-pore channels TPC1 and TPC2. The channel properties of human TPC1 have not been studied before, and its cellular function is not known. In the present study, we characterized TPC1 incorporated into lipid bilayers. The native and recombinant TPC1 channels are activated by NAADP. TPC1 activity requires acidic luminal pH and high luminal Ca2+. With Ba2+ as the permeable ion, luminal Ca2+ activates TPC1 with an apparent K-m of 180 mu M. TPC1 operates in two tightly coupled conductance states of 47 +/- 8 and 200 +/- 9 picosiemens. Importantly, opening of the large conductance markedly increases the small conductance mean open time. Changes in membrane potential from 0 to -60 mV increased linearly both the small and the large conductances and NPo, indicating that TPC1 is regulated by voltage. Intriguingly, the apparent affinity for activation of TPC1 by its ligand NAADP is not constant. Rather, hyperpolarization increases the apparent affinity of TPC1 for NAADP by 10 nM/mV. The concerted regulation of TPC1 activity by luminal Ca2+ and by membrane potential thus provides a potential mechanism to explain NAADP-induced Ca2+ oscillations. These findings reveal unique properties of TPC1 to explain its role in Ca2+ oscillations and cell function.	[Rybalchenko, Volodymyr; Ahuja, Malini; Muallem, Shmuel] NIDCR, Epithelial Signaling & Transport Sect, Mol Physiol & Therapeut Branch, NIH, Bethesda, MD 20892 USA; [Coblentz, Jessica; Kiselyov, Krill] Univ Pittsburgh, Dept Biol Sci, Pittsburgh, PA 15260 USA; [Churamani, Dev; Patel, Sandip] UCL, Dept Cell & Dev Biol, London WC1E 6BT, England	National Institutes of Health (NIH) - USA; NIH National Institute of Dental & Craniofacial Research (NIDCR); Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh; University of London; University College London	Muallem, S (corresponding author), NIDCR, Epithelial Signaling & Transport Sect, Mol Physiol & Therapeut Branch, NIH, Bethesda, MD 20892 USA.	shmuel.muallem@nih.gov	; Patel, Sandip/O-9591-2015	Kiselyov, Kirill/0000-0001-6683-2895; Rybalchenko, Volodymyr/0000-0003-4092-0779; Patel, Sandip/0000-0001-7247-2013	National Institutes of Health through the NIDCR/DIR [Z1A-DE000735, HD058577, ES01678]; Biotechnology and Biological Sciences Research Council [BB/G013721/1]; BBSRC [BB/G013721/1] Funding Source: UKRI; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT [R01HD058577] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DENTAL & CRANIOFACIAL RESEARCH [ZIADE000735] Funding Source: NIH RePORTER	National Institutes of Health through the NIDCR/DIR(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Biotechnology and Biological Sciences Research Council(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); BBSRC(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); NATIONAL INSTITUTE OF DENTAL & CRANIOFACIAL RESEARCH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Dental & Craniofacial Research (NIDCR))	This work was supported, in whole or in part, by an intramural National Institutes of Health grant (to S. M.) through the NIDCR/DIR Z1A-DE000735 and extramural Grants HD058577 and ES01678 (to K. K.). This work was also supported by Biotechnology and Biological Sciences Research Council Grant BB/G013721/1 (to S. P.).	Berridge MJ, 2003, NAT REV MOL CELL BIO, V4, P517, DOI 10.1038/nrm1155; Beyhl D, 2009, PLANT J, V58, P715, DOI 10.1111/j.1365-313X.2009.03820.x; Brailoiu E, 2010, J BIOL CHEM, V285, P38511, DOI 10.1074/jbc.M110.162073; Brailoiu E, 2010, J BIOL CHEM, V285, DOI 10.1074/jbc.C109.081943; Brailoiu E, 2009, J CELL BIOL, V186, P201, DOI 10.1083/jcb.200904073; Cai XJ, 2010, MOL BIOL EVOL, V27, P2352, DOI 10.1093/molbev/msq122; Calcraft PJ, 2009, NATURE, V459, P596, DOI 10.1038/nature08030; Cancela JM, 2000, EMBO J, V19, P2549, DOI 10.1093/emboj/19.11.2549; Churchill GC, 2001, EMBO J, V20, P2666, DOI 10.1093/emboj/20.11.2666; Churchill GC, 2002, CELL, V111, P703, DOI 10.1016/S0092-8674(02)01082-6; Furuichi T, 2001, PLANT CELL PHYSIOL, V42, P900, DOI 10.1093/pcp/pce145; Galione A, 2005, CELL CALCIUM, V38, P273, DOI 10.1016/j.ceca.2005.06.031; Guse AH, 2008, SCI SIGNAL, V1, DOI 10.1126/scisignal.144re10; Hedrich R, 2011, MOL PLANT, V4, P428, DOI 10.1093/mp/ssr017; Ishibashi K, 2000, BIOCHEM BIOPH RES CO, V270, P370, DOI 10.1006/bbrc.2000.2435; Kim HJ, 2008, EMBO J, V27, P1197, DOI 10.1038/emboj.2008.56; Kiselyov K, 2010, CELL CALCIUM, V47, P103, DOI 10.1016/j.ceca.2009.12.007; Koivusalo M, 2011, TRAFFIC, V12, P972, DOI 10.1111/j.1600-0854.2011.01215.x; LEE HC, 1995, J BIOL CHEM, V270, P2152, DOI 10.1074/jbc.270.5.2152; Lin-Moshier Y, 2012, J BIOL CHEM, V287, P2296, DOI 10.1074/jbc.M111.305813; Miedel MT, 2008, J EXP MED, V205, P1477, DOI 10.1084/jem.20072194; Patel S, 2011, CELL CALCIUM, V50, P109, DOI 10.1016/j.ceca.2011.03.009; Patel S, 2011, CELL CALCIUM, V50, P157, DOI 10.1016/j.ceca.2011.03.011; Patel S, 2010, CELL CALCIUM, V47, P480, DOI 10.1016/j.ceca.2010.05.001; Peiter E, 2005, NATURE, V434, P404, DOI 10.1038/nature03381; Petersen OH, 2004, BIOL RES, V37, P661, DOI 10.4067/s0716-97602004000400023; Pitt SJ, 2010, J BIOL CHEM, V285, P35039, DOI 10.1074/jbc.M110.156927; Pottosin I, 2004, PLANTA, V219, P1057, DOI 10.1007/s00425-004-1293-7; Pottosin II, 2007, J EXP BOT, V58, P1559, DOI 10.1093/jxb/erm035; Rietdorf K, 2011, J BIOL CHEM, V286, P37058, DOI 10.1074/jbc.C111.289835; Ruas M, 2010, CURR BIOL, V20, P703, DOI 10.1016/j.cub.2010.02.049; Schieder M, 2010, J BIOL CHEM, V285, P21219, DOI 10.1074/jbc.C110.143123; Sonawane ND, 2002, J BIOL CHEM, V277, P5506, DOI 10.1074/jbc.M110818200; Soyombo AA, 2006, J BIOL CHEM, V281, P7294, DOI 10.1074/jbc.M508211200; Steinberg BE, 2010, J CELL BIOL, V189, P1171, DOI 10.1083/jcb.200911083; Walseth TF, 2012, J BIOL CHEM, V287, P2308, DOI 10.1074/jbc.M111.306563; WARD JM, 1994, PLANT CELL, V6, P669; Weinert S, 2010, SCIENCE, V328, P1401, DOI 10.1126/science.1188072; Yamaguchi S, 2011, J BIOL CHEM, V286, P22934, DOI 10.1074/jbc.M110.210930; Zhang F, 2007, J BIOL CHEM, V282, P25259, DOI 10.1074/jbc.M701614200; Zhang F, 2009, J CELL MOL MED, V13, P3174, DOI 10.1111/j.1582-4934.2008.00486.x; Zhu Michael X., 2010, Communicative & Integrative Biology, V3, P12; Zhu MX, 2010, FEBS LETT, V584, P1966, DOI 10.1016/j.febslet.2010.02.028; Zong XG, 2009, PFLUG ARCH EUR J PHY, V458, P891, DOI 10.1007/s00424-009-0690-y	44	57	59	0	5	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JUN 8	2012	287	24					20407	20416		10.1074/jbc.M112.359612	http://dx.doi.org/10.1074/jbc.M112.359612			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	974FB	22500018	Green Published, hybrid			2022-12-25	WOS:000306414500059
J	Suzuki, H; Ikeda, A; Tsuchimoto, S; Adachi, K; Noguchi, A; Fukumori, Y; Kanemori, M				Suzuki, Hirotaka; Ikeda, Ayami; Tsuchimoto, Sachie; Adachi, Ko-ichi; Noguchi, Aki; Fukumori, Yoshihiro; Kanemori, Masaaki			Synergistic Binding of DnaJ and DnaK Chaperones to Heat Shock Transcription Factor sigma(32) Ensures Its Characteristic High Metabolic Instability IMPLICATIONS FOR HEAT SHOCK PROTEIN 70 (Hsp70)-Hsp40 MODE OF FUNCTION	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							ATP-DEPENDENT PROTEASE; ESCHERICHIA-COLI; FTSH PROTEASE; CELLULAR FUNCTIONS; HSP70 CHAPERONES; TURNOVER ELEMENT; IN-VIVO; PROTEINS; MECHANISM; DEGRADATION	Escherichia coli heat shock transcription factor sigma(32) is rapidly degraded by ATP-dependent proteases, such as FtsH and ClpYQ. Although the DnaK chaperone system (DnaK, DnaJ, and GrpE) promotes sigma(32) degradation in vivo, the precise mechanism that is involved remains unknown. Our previous results indicated that sigma(32) mutants containing amino acid substitution in the N-terminal half of Region 2.1 are markedly stabilized in vivo. Here, we report the further characterization of these mutants by examining purified sigma(32) mutants in vitro. Surprisingly, I54A sigma(32), a very stable mutant, is more susceptible to ClpYQ and FtsH proteases than wild-type sigma(32), indicating that the stability of sigma(32) does not always reflect its susceptibility to proteases. Co-precipitation and gel filtration analyses show that purified sigma(32) mutants exhibit a reduced affinity for DnaJ, leading to a marked decrease in forming a complex with DnaK in the presence of DnaJ and ATP. Other mutants with modestly increased stability (A50S sigma(32) and K51E sigma(32)) show an intermediate efficiency of complex formation with DnaK, suggesting that defects in binding to DnaK and DnaJ are well correlated with metabolic stability; effective interaction with DnaK promotes sigma(32) degradation in vivo. We argue that the stable and effective interaction of heat shock protein 70 (Hsp70) with a substrate polypeptide may generally require the simultaneous binding of heat shock protein 40 (Hsp40) to distinct sites on the substrate.	[Suzuki, Hirotaka; Ikeda, Ayami; Tsuchimoto, Sachie; Adachi, Ko-ichi; Noguchi, Aki; Fukumori, Yoshihiro; Kanemori, Masaaki] Kanazawa Univ, Coll Sci & Engn, Sch Nat Syst, Kanazawa, Ishikawa 9201192, Japan	Kanazawa University	Kanemori, M (corresponding author), Kanazawa Univ, Coll Sci & Engn, Sch Nat Syst, Kakuma Machi, Kanazawa, Ishikawa 9201192, Japan.	mkanemo@staff.kanazawa-u.ac.jp	Fukumori, Yoshihiro/J-2483-2014					AKIYAMA Y, 1990, BIOCHEM BIOPH RES CO, V167, P711, DOI 10.1016/0006-291X(90)92083-C; Blaszczak A, 1999, MOL MICROBIOL, V31, P157, DOI 10.1046/j.1365-2958.1999.01155.x; Cajo GC, 2006, J BIOL CHEM, V281, P12436, DOI 10.1074/jbc.M511192200; Gamer J, 1996, EMBO J, V15, P607, DOI 10.1002/j.1460-2075.1996.tb00393.x; GAMER J, 1992, CELL, V69, P833, DOI 10.1016/0092-8674(92)90294-M; Genevaux P, 2007, MOL MICROBIOL, V66, P840, DOI 10.1111/j.1365-2958.2007.05961.x; Gottesman S, 2003, ANNU REV CELL DEV BI, V19, P565, DOI 10.1146/annurev.cellbio.19.110701.153228; Guisbert E, 2008, MICROBIOL MOL BIOL R, V72, P545, DOI 10.1128/MMBR.00007-08; Han WJ, 2003, J BIOL CHEM, V278, P19038, DOI 10.1074/jbc.M300756200; Hartl FU, 2011, NATURE, V475, P324, DOI 10.1038/nature10317; Herman C, 2003, MOL CELL, V11, P659, DOI 10.1016/S1097-2765(03)00068-6; HERMAN C, 1995, P NATL ACAD SCI USA, V92, P3516, DOI 10.1073/pnas.92.8.3516; Horikoshi M, 2004, J BACTERIOL, V186, P7474, DOI 10.1128/JB.186.22.7474-7480.2004; ISHIAI M, 1992, J BACTERIOL, V174, P5597, DOI 10.1128/JB.174.17.5597-5603.1992; Ito K, 2005, ANNU REV MICROBIOL, V59, P211, DOI 10.1146/annurev.micro.59.030804.121316; Kampinga HH, 2010, NAT REV MOL CELL BIO, V11, P579, DOI 10.1038/nrm2941; Kanemori M, 1999, J BIOL CHEM, V274, P22002, DOI 10.1074/jbc.274.31.22002; Kanemori M, 1997, J BACTERIOL, V179, P7219, DOI 10.1128/jb.179.23.7219-7225.1997; Karata K, 1999, J BIOL CHEM, V274, P26225, DOI 10.1074/jbc.274.37.26225; Kim SY, 2002, J BIOL CHEM, V277, P44778, DOI 10.1074/jbc.M206176200; KUSUKAWA N, 1988, GENE DEV, V2, P874, DOI 10.1101/gad.2.7.874; Laufen T, 1999, P NATL ACAD SCI USA, V96, P5452, DOI 10.1073/pnas.96.10.5452; LIBEREK K, 1995, P NATL ACAD SCI USA, V92, P6224, DOI 10.1073/pnas.92.14.6224; LIBEREK K, 1993, P NATL ACAD SCI USA, V90, P11019, DOI 10.1073/pnas.90.23.11019; LIBEREK K, 1992, P NATL ACAD SCI USA, V89, P3516, DOI 10.1073/pnas.89.8.3516; Mayer MP, 2005, CELL MOL LIFE SCI, V62, P670, DOI 10.1007/s00018-004-4464-6; NAGAI H, 1994, P NATL ACAD SCI USA, V91, P10280, DOI 10.1073/pnas.91.22.10280; Obrist M, 2005, J BACTERIOL, V187, P3807, DOI 10.1128/JB.187.11.3807-3813.2005; Obrist M, 2009, FEMS MICROBIOL LETT, V290, P199, DOI 10.1111/j.1574-6968.2008.01423.x; Obrist M, 2007, MICROBIOL-SGM, V153, P2560, DOI 10.1099/mic.0.2007/007047-0; Ogura T, 2001, GENES CELLS, V6, P575, DOI 10.1046/j.1365-2443.2001.00447.x; Ogura T, 1999, MOL MICROBIOL, V31, P833, DOI 10.1046/j.1365-2958.1999.01221.x; Rodriguez F, 2008, MOL CELL, V32, P347, DOI 10.1016/j.molcel.2008.09.016; Sambrook J, 1989, MOL CLONING LAB MANU, P2; STRAUS D, 1990, GENE DEV, V4, P2202, DOI 10.1101/gad.4.12a.2202; STRAUS DB, 1989, GENE DEV, V3, P2003, DOI 10.1101/gad.3.12a.2003; Tatsuta T, 1998, MOL MICROBIOL, V30, P583, DOI 10.1046/j.1365-2958.1998.01091.x; TAURA T, 1989, BIOCHEM BIOPH RES CO, V163, P438, DOI 10.1016/0006-291X(89)92155-4; Terada K, 2010, J BIOL CHEM, V285, P16789, DOI 10.1074/jbc.M110.101501; TILLY K, 1989, J BACTERIOL, V171, P1585, DOI 10.1128/jb.171.3.1585-1589.1989; TOBE T, 1984, MOL GEN GENET, V195, P10, DOI 10.1007/BF00332716; TOMOYASU T, 1995, EMBO J, V14, P2551, DOI 10.1002/j.1460-2075.1995.tb07253.x; Yura T, 2000, BACTERIAL STRESS RESPONSES, P3; Yura T, 2007, P NATL ACAD SCI USA, V104, P17638, DOI 10.1073/pnas.0708819104	44	15	15	0	7	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JUN 1	2012	287	23					19275	19283		10.1074/jbc.M111.331470	http://dx.doi.org/10.1074/jbc.M111.331470			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	974EF	22496372	hybrid, Green Published			2022-12-25	WOS:000306411900037
J	Fujikawa, M; Imamura, H; Nakamura, J; Yoshida, M				Fujikawa, Makoto; Imamura, Hiromi; Nakamura, Junji; Yoshida, Masasuke			Assessing Actual Contribution of IF1, Inhibitor of Mitochondrial FoF1, to ATP Homeostasis, Cell Growth, Mitochondrial Morphology, and Cell Viability	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							CRISTAE MORPHOLOGY; F1F0-ATP SYNTHASE; PROTEIN IF1; COMPLEX; HEART; YEAST; OLIGOMERIZATION; ORGANIZATION; DIMERIZATION; LACKING	FoF1-ATP synthase (FoF1) synthesizes ATP in mitochondria coupled with proton flow driven by the proton motive force (pmf) across membranes. It has been known that isolated IF1, an evolutionarily well conserved mitochondrial protein, can inhibit the ATP hydrolysis activity of FoF1. Here, we generated HeLa cells with permanent IF1 knockdown (IF1-KD cells) and compared their energy metabolism with control cells. Under optimum growth conditions, IF1-KD cells have lower cellular ATP levels and generate a higher pmf and more reactive oxygen species. Nonetheless, IF1-KD cells and control cells show the same rates of cell growth, glucose consumption, and mitochondrial ATP synthesis. Furthermore, contrary to previous reports, the morphology of mitochondria in IF1-KD cells appears to be normal. When cells encounter sudden dissipation of pmf, the cytoplasmic ATP level in IF1-KD cells drops immediately (similar to 1 min), whereas it remains unchanged in the control cells, indicating occurrence of futile ATP hydrolysis by FoF1 in the absence of IF1. The lowered ATP level in IF1-KD cells then recovers gradually (similar to 10 min) to the original level by consuming more glucose than control cells. The viability of IF1-KD cells and control cells is the same in the absence of pmf. Thus, IF1 contributes to ATP homeostasis, but its deficiency does not affect the growth and survival of HeLa cells. Only when cells are exposed to chemical ischemia (no glycolysis and no respiration) or high concentrations of reactive oxygen species does IF1 exhibit its ability to alleviate cell injury.	[Yoshida, Masasuke] Kyoto Sangyo Univ, Dept Mol Biosci, Kyoto 6038555, Japan; [Fujikawa, Makoto; Nakamura, Junji; Yoshida, Masasuke] Japan Sci & Technol Agcy, ATP Synth Regulat Project, Int Cooperat Res Project ICORP, Tokyo 1350064, Japan; [Imamura, Hiromi] Tokyo Univ Sci, Fac Pharmaceut Sci, Dept Biochem, Noda, Chiba 2788510, Japan; [Imamura, Hiromi] Kyoto Univ, Hakubi Project, Kyoto 6058501, Japan	Kyoto Sangyo University; Japan Science & Technology Agency (JST); Tokyo University of Science; Kyoto University	Yoshida, M (corresponding author), Kyoto Sangyo Univ, Dept Mol Biosci, Kyoto 6038555, Japan.	masasuke.yoshida@cc.kyoto-su.ac.jp	Imamura, Hiromi/AAD-5109-2019; FUNG, John Julian/A-2679-2012	Imamura, Hiromi/0000-0002-1896-0443; FUNG, John Julian/0000-0002-3038-0441; Fujikawa, Makoto/0000-0002-8100-3718	ATP Synthesis Regulation Project (ICORP) by Japan Science and Technology Agency; Grants-in-Aid for Scientific Research [24657101] Funding Source: KAKEN	ATP Synthesis Regulation Project (ICORP) by Japan Science and Technology Agency; Grants-in-Aid for Scientific Research(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI))	This work was supported by the ATP Synthesis Regulation Project (ICORP) by the Japan Science and Technology Agency (to M. Y.).	Aggeler R, 2002, J BIOL CHEM, V277, P33906, DOI 10.1074/jbc.M204538200; Buzhynskyy N, 2007, BIOPHYS J, V93, P2870, DOI 10.1529/biophysj.107.109728; Cabezon E, 2000, J BIOL CHEM, V275, P25460, DOI 10.1074/jbc.M003859200; Cabezon E, 2003, NAT STRUCT BIOL, V10, P744, DOI 10.1038/nsb966; Campanella M, 2008, CELL METAB, V8, P13, DOI 10.1016/j.cmet.2008.06.001; Campanella M, 2009, BBA-BIOENERGETICS, V1787, P393, DOI 10.1016/j.bbabio.2009.02.023; Castillo DD, 2011, J BIOL CHEM, V286, P23911, DOI 10.1074/jbc.M111.252056; Dienhart M, 2002, J BIOL CHEM, V277, P39289, DOI 10.1074/jbc.M205720200; DUBOIS M, 1951, NATURE, V168, P167, DOI 10.1038/168167a0; Fujikawa M, 2010, BIOCHEM BIOPH RES CO, V401, P538, DOI 10.1016/j.bbrc.2010.09.089; Garcia JJ, 2006, BIOCHEMISTRY-US, V45, P12695, DOI 10.1021/bi060339j; Giraud MF, 2002, BBA-BIOENERGETICS, V1555, P174, DOI 10.1016/S0005-2728(02)00274-8; ICHIKAWA N, 1990, J BIOL CHEM, V265, P6274; Ichikawa N, 1999, BIOSCI BIOTECH BIOCH, V63, P2225, DOI 10.1271/bbb.63.2225; Imamura H, 2009, P NATL ACAD SCI USA, V106, P15651, DOI 10.1073/pnas.0904764106; Lu YM, 2001, J BIOCHEM-TOKYO, V130, P873, DOI 10.1093/oxfordjournals.jbchem.a003060; MANSOUR TE, 1968, J BIOL CHEM, V243, P2523; Minauro-Sanmiguel F, 2005, P NATL ACAD SCI USA, V102, P12356, DOI 10.1073/pnas.0503893102; Ohsakaya S, 2011, J BIOL CHEM, V286, P20292, DOI 10.1074/jbc.M110.198523; Pallotti F, 2007, METHOD CELL BIOL, V80, P3, DOI 10.1016/S0091-679X(06)80001-4; Paumard P, 2002, EMBO J, V21, P221, DOI 10.1093/emboj/21.3.221; PULLMAN ME, 1963, J BIOL CHEM, V238, P3762; Sanchez-Cenizo L, 2010, J BIOL CHEM, V285, P25308, DOI 10.1074/jbc.M110.146480; Strauss M, 2008, EMBO J, V27, P1154, DOI 10.1038/emboj.2008.35; Tomasetig L, 2002, BBA-BIOENERGETICS, V1556, P133, DOI 10.1016/S0005-2728(02)00344-4; Wittig I, 2008, BBA-BIOENERGETICS, V1777, P592, DOI 10.1016/j.bbabio.2008.04.027; Wittig I, 2010, BBA-BIOENERGETICS, V1797, P1004, DOI 10.1016/j.bbabio.2010.02.021; Yamada E, 1997, IMMUNOLOGY, V92, P571, DOI 10.1046/j.1365-2567.1997.00370.x	28	48	50	0	13	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAY 25	2012	287	22					18781	18787		10.1074/jbc.M112.345793	http://dx.doi.org/10.1074/jbc.M112.345793			7	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	974EC	22493494	hybrid, Green Published			2022-12-25	WOS:000306411600086
J	Han, WN; Ming, M; Zhao, R; Pi, JB; Wu, CL; He, YY				Han, Weinong; Ming, Mei; Zhao, Rui; Pi, Jingbo; Wu, Chunli; He, Yu-Ying			Nrf1 CNC-bZIP Protein Promotes Cell Survival and Nucleotide Excision Repair through Maintaining Glutathione Homeostasis	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							TRANSCRIPTION FACTOR; LEUCINE-ZIPPER; XERODERMA-PIGMENTOSUM; ANTIOXIDANT RESPONSE; LUNG-CANCER; SKIN-CANCER; DNA-REPAIR; MOLECULAR-CLONING; ULTRAVIOLET-B; GENE	Skin cancer is the most common cancer in the United States. Its major environmental risk factor is UVB radiation in sunlight. In response to UVB damage, epidermal keratinocytes activate a specific repair pathway, i.e. nucleotide excision repair, to remove UVB-induced DNA lesions. However, the regulation of UVB response is not fully understood. Here we show that the long isoform of the nuclear factor erythroid 2-related factor 1 (Nrf1, also called NFE2L1), a cytoprotective transcription factor critical for the expression of multiple antioxidant response element-dependent genes, plays an important role in the response of keratinocytes to UVB. Nrf1 loss sensitized keratinocytes to UVB-induced apoptosis by up-regulating the expression of the proapoptotic Bcl-2 family member Bik through reducing glutathione levels. Knocking down Bik reduced UVB-induced apoptosis in Nrf1-inhibited cells. In UVB-irradiated surviving cells, however, disruption of Nrf1 impaired nucleotide excision repair through suppressing the transcription of xeroderma pigmentosum C (XPC), a factor essential for initiating the global genome nucleotide excision repair by recognizing the DNA lesion and recruiting downstream factors. Nrf1 enhanced XPC expression by increasing glutathione availability but was independent of the transcription repressor of XPC. Adding XPC or glutathione restored the DNA repair capacity in Nrf1-inhibited cells. Finally, we demonstrate that Nrf1 levels are significantly reduced by UVB radiation in mouse skin and are lower in human skin tumors than in normal skin. These results indicate a novel role of Nrf1 in UVB-induced DNA damage repair and suggest Nrf1 as a tumor suppressor in the skin.	[Han, Weinong; Ming, Mei; Wu, Chunli; He, Yu-Ying] Univ Chicago, Dept Med, Dermatol Sect, Chicago, IL 60637 USA; [Zhao, Rui; Pi, Jingbo] Hamner Inst Hlth Sci, Div Translat Biol, Res Triangle Pk, NC 27709 USA; [Zhao, Rui] China Med Univ, Sch Forens Med, Shenyang 110001, Peoples R China; [Wu, Chunli] China Med Univ, Affiliated Hosp 4, Dept Radiat Oncol, Shenyang 110001, Peoples R China	University of Chicago; The Hamner Institutes for Health Sciences; China Medical University; China Medical University	He, YY (corresponding author), Univ Chicago, Dept Med, Dermatol Sect, 5841 S Maryland Ave, Chicago, IL 60637 USA.	yyhe@medicine.bsd.uchicago.edu	PI, JINGBO/GWC-2514-2022	PI, JINGBO/0000-0003-0227-8041	National Institutes of Health [ES016936, ES016005]; University of Chicago Comprehensive Cancer Center Pilot program [P30 CA014599]; Clinical and Translational Science Awards (National Institutes of Health) [UL1RR024999]; University of Chicago Friends of Dermatology Research Funds; NATIONAL CANCER INSTITUTE [P30CA014599] Funding Source: NIH RePORTER; NATIONAL CENTER FOR RESEARCH RESOURCES [UL1RR024999] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES [R01ES016936, R01ES016005] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); University of Chicago Comprehensive Cancer Center Pilot program; Clinical and Translational Science Awards (National Institutes of Health)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); University of Chicago Friends of Dermatology Research Funds; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Environmental Health Sciences (NIEHS))	This work was supported, in whole or in part, by National Institutes of Health Grants ES016936 (to Y. Y. H.) and ES016005 (to J. P.), the University of Chicago Comprehensive Cancer Center Pilot program (Grant P30 CA014599), and the Clinical and Translational Science Awards (National Institutes of Health Grant UL1RR024999). This work was also supported by the University of Chicago Friends of Dermatology Research Funds.	ANDREWS NC, 1993, NATURE, V362, P722, DOI 10.1038/362722a0; Avval FZ, 2009, J BIOL CHEM, V284, P8233, DOI 10.1074/jbc.M809338200; Bowden GT, 2004, NAT REV CANCER, V4, P23, DOI 10.1038/nrc1253; Cam H, 2004, MOL CELL, V16, P399, DOI 10.1016/j.molcel.2004.09.037; CHAN JY, 1993, P NATL ACAD SCI USA, V90, P11371, DOI 10.1073/pnas.90.23.11371; Chen LY, 2003, MOL CELL BIOL, V23, P4673, DOI 10.1128/MCB.23.13.4673-4686.2003; Cleaver JE, 2009, NAT REV GENET, V10, P756, DOI 10.1038/nrg2663; Cleaver JE, 2005, NAT REV CANCER, V5, P564, DOI 10.1038/nrc1652; Daniel PT, 1999, BLOOD, V94, P1100, DOI 10.1182/blood.V94.3.1100.415a16_1100_1107; Dominguez-Brauer C, 2009, EMBO REP, V10, P1036, DOI 10.1038/embor.2009.139; Hoeijmakers JHJ, 2001, NATURE, V411, P366, DOI 10.1038/35077232; Hollander MC, 2005, P NATL ACAD SCI USA, V102, P13200, DOI 10.1073/pnas.0503133102; Hu ZB, 2005, INT J CANCER, V115, P478, DOI 10.1002/ijc.20911; Jans J, 2005, CURR BIOL, V15, P105, DOI 10.1016/j.cub.2005.01.001; Johnsen O, 1998, NUCLEIC ACIDS RES, V26, P512, DOI 10.1093/nar/26.2.512; Johnson TM, 1998, J AM ACAD DERMATOL, V38, P681, DOI 10.1016/S0190-9622(98)70196-3; Kobayashi A, 1999, J BIOL CHEM, V274, P6443, DOI 10.1074/jbc.274.10.6443; Kraemer KH, 1997, P NATL ACAD SCI USA, V94, P11, DOI 10.1073/pnas.94.1.11; Lee GY, 2005, INT J CANCER, V115, P807, DOI 10.1002/ijc.20900; Leung L, 2003, J BIOL CHEM, V278, P48021, DOI 10.1074/jbc.M308439200; LUNA L, 1994, GENOMICS, V22, P553, DOI 10.1006/geno.1994.1428; Maeda T, 2001, J INVEST DERMATOL, V117, P1490, DOI 10.1046/j.0022-202x.2001.01562.x; Marin MS, 2004, CANCER EPIDEM BIOMAR, V13, P1788; Markovic J, 2007, J BIOL CHEM, V282, P20416, DOI 10.1074/jbc.M609582200; Markovic J, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0006413; Ming M, 2011, CANCER RES, V71, P5287, DOI 10.1158/0008-5472.CAN-10-4614; Ming M, 2010, P NATL ACAD SCI USA, V107, P22623, DOI 10.1073/pnas.1010377108; MOI P, 1994, P NATL ACAD SCI USA, V91, P9926, DOI 10.1073/pnas.91.21.9926; Murphy P, 2000, MECH DEVELOP, V97, P141, DOI 10.1016/S0925-4773(00)00413-5; Nioi P, 2004, MUTAT RES-FUND MOL M, V555, P149, DOI 10.1016/j.mrfmmm.2004.05.023; Ohtsuji M, 2008, J BIOL CHEM, V283, P33554, DOI 10.1074/jbc.M804597200; Oyake T, 1996, MOL CELL BIOL, V16, P6083; Pi JB, 2010, TOXICOL APPL PHARM, V244, P1, DOI 10.1016/j.taap.2010.01.005; Radhakrishnan SK, 2010, MOL CELL, V38, P17, DOI 10.1016/j.molcel.2010.02.029; Real PJ, 2006, FEBS LETT, V580, P5905, DOI 10.1016/j.febslet.2006.08.088; Riedl T, 2003, EMBO J, V22, P5293, DOI 10.1093/emboj/cdg489; Shimazu T, 2007, GENE DEV, V21, P929, DOI 10.1101/gad.1522007; Sugasawa K, 1998, MOL CELL, V2, P223, DOI 10.1016/S1097-2765(00)80132-X; Venugopal R, 1996, P NATL ACAD SCI USA, V93, P14960, DOI 10.1073/pnas.93.25.14960; Volker M, 2001, MOL CELL, V8, P213, DOI 10.1016/S1097-2765(01)00281-7; Xu ZR, 2005, P NATL ACAD SCI USA, V102, P4120, DOI 10.1073/pnas.0500660102; Yang HP, 2005, MOL CELL BIOL, V25, P5933, DOI 10.1128/MCB.25.14.5933-5946.2005; Youle RJ, 2008, NAT REV MOL CELL BIO, V9, P47, DOI 10.1038/nrm2308; Zhang DD, 2006, DRUG METAB REV, V38, P769, DOI 10.1080/03602530600971974; Zhao R, 2011, ENVIRON HEALTH PERSP, V119, P56, DOI 10.1289/ehp.1002304; Zhu YM, 2007, CARCINOGENESIS, V28, P698, DOI 10.1093/carcin/bgl201	46	31	34	0	15	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAY 25	2012	287	22					18788	18795		10.1074/jbc.M112.363614	http://dx.doi.org/10.1074/jbc.M112.363614			8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	974EC	22500024	hybrid, Green Published			2022-12-25	WOS:000306411600087
J	Ho, BT; Olson, G; Figel, S; Gelman, I; Cance, WG; Golubovskaya, VM				Ho, Baotran; Olson, Gretchen; Figel, Sheila; Gelman, Irwin; Cance, William G.; Golubovskaya, Vita M.			Nanog Increases Focal Adhesion Kinase (FAK) Promoter Activity and Expression and Directly Binds to FAK Protein to Be Phosphorylated	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							SMALL-MOLECULE INHIBITOR; DECREASES TUMOR-GROWTH; EMBRYONIC STEM-CELLS; BREAST-CANCER CELLS; N-TERMINAL DOMAIN; GENE-EXPRESSION; HUMAN NEUROBLASTOMA; CARCINOMA-CELLS; HUMAN GLIOMAS; P53	Nanog and FAK were shown to be overexpressed in cancer cells. In this report, the Nanog overexpression increased FAK expression in 293, SW480, and SW620 cancer cells. Nanog binds the FAK promoter and up-regulates its activity, whereas Nanog siRNA decreases FAK promoter activity and FAK mRNA. The FAK promoter contains four Nanog-binding sites. The site-directed mutagenesis of these sites significantly decreased up-regulation of FAK promoter activity by Nanog. EMSA showed the specific binding of Nanog to each of the four sites, and binding was confirmed by ChIP assay. Nanog directly binds the FAK protein by pulldown and immunoprecipitation assays, and proteins co-localize by confocal microscopy. Nanog binds the N-terminal domain of FAK. In addition, FAK directly phosphorylates Nanog in a dose-dependent manner by in vitro kinase assay and in cancer cells in vivo. The site-directed mutagenesis of Nanog tyrosines, Y35F and Y174F, blocked phosphorylation and binding by FAK. Moreover, overexpression of wild type Nanog increased filopodia/lamellipodia formation, whereas mutant Y35F and Y174F Nanog did not. The wild type Nanog increased cell invasion that was inhibited by the FAK inhibitor and increased by FAK more significantly than with the mutants Y35F and Y174F Nanog. Down-regulation of Nanog with siRNA decreased cell growth reversed by FAK overexpression. Thus, these data demonstrate the regulation of the FAK promoter by Nanog, the direct binding of the proteins, the phosphorylation of Nanog by FAK, and the effect of FAK and Nanog cross-regulation on cancer cell morphology, invasion, and growth that plays a significant role in carcinogenesis.	[Ho, Baotran; Olson, Gretchen; Cance, William G.; Golubovskaya, Vita M.] Roswell Pk Canc Inst, Dept Surg Oncol, Buffalo, NY 14263 USA; [Figel, Sheila; Gelman, Irwin] Roswell Pk Canc Inst, Dept Canc Genet, Buffalo, NY 14263 USA	Roswell Park Cancer Institute; Roswell Park Cancer Institute	Cance, WG (corresponding author), Roswell Pk Canc Inst, Dept Surg Oncol, Elm & Carlton St, Buffalo, NY 14263 USA.	William.Cance@Roswellpark.org; Vita.Golubovskaya@Roswellpark.org			National Institutes of Health [CA65910]; Susan Komen for the Cure Grant [BCTR0707148]; Roswell Park Cancer Institute; NCI [P30 CA016056]; NATIONAL CANCER INSTITUTE [P30CA016056, R01CA065910] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Susan Komen for the Cure Grant; Roswell Park Cancer Institute; NCI(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	This work was supported, in whole or in part, by National Institutes of Health Grant CA65910 (to W. G. C.) and Grant P30 CA016056 from NCI. This work was also supported by Susan Komen for the Cure Grant BCTR0707148 (to V. M. G.) and the Roswell Park Cancer Institute.	Afrikanova I, 2011, J BIOL CHEM, V286, P36042, DOI 10.1074/jbc.M111.290825; Ambady S, 2010, INT J DEV BIOL, V54, P1743, DOI 10.1387/ijdb.103192sa; Beierle EA, 2007, J BIOL CHEM, V282, P12503, DOI 10.1074/jbc.M701450200; Beierle EA, 2010, CELL CYCLE, V9, P1005, DOI 10.4161/cc.9.5.10936; Beviglia L, 2003, BIOCHEM J, V373, P201, DOI 10.1042/BJ20021846; Bourguignon LYW, 2008, J BIOL CHEM, V283, P17635, DOI 10.1074/jbc.M800109200; Bourguignon LYW, 2009, J BIOL CHEM, V284, P26533, DOI 10.1074/jbc.M109.027466; Cance WG, 2008, SCI SIGNAL, V1, DOI 10.1126/stke.120pe22; Chang DF, 2009, STEM CELLS, V27, P812, DOI 10.1634/stemcells.2008-0657; Chen LY, 2009, CELL RES, V19, P1052, DOI 10.1038/cr.2009.79; Fatoo A, 2011, J NEURO-ONCOL, V103, P397, DOI 10.1007/s11060-010-0406-3; Fonar Y, 2011, MOL BIOL CELL, V22, P2409, DOI 10.1091/mbc.E10-12-0932; Frame MC, 2010, NAT REV MOL CELL BIO, V11, P802, DOI 10.1038/nrm2996; Gillis AJM, 2011, INT J ANDROL, V34, pE160, DOI 10.1111/j.1365-2605.2011.01148.x; Golubovskaya V, 2004, BBA-GENE STRUCT EXPR, V1678, P111, DOI 10.1016/j.bbaexp.2004.03.002; Golubovskaya V, 2002, J BIOL CHEM, V277, P38978, DOI 10.1074/jbc.M205002200; Golubovskaya VM, 2008, MOL CARCINOGEN, V47, P373, DOI 10.1002/mc.20395; Golubovskaya VM, 2008, BIOCHEM J, V411, P151, DOI 10.1042/BJ20071657; Golubovskaya VM, 2008, MOL CARCINOGEN, V47, P222, DOI 10.1002/mc.20380; Golubovskaya VM, 2010, FRONT BIOSCI-LANDMRK, V15, P901, DOI 10.2741/3653; Golubovskaya VM, 2009, INT J CANCER, V125, P1735, DOI 10.1002/ijc.24486; Golubovskaya VM, 2009, BMC CANCER, V9, DOI 10.1186/1471-2407-9-280; Golubovskaya VM, 2008, J MED CHEM, V51, P7405, DOI 10.1021/jm800483v; Golubovskaya VM, 2005, J BIOL CHEM, V280, P25008, DOI 10.1074/jbc.M414172200; Guan JL, 2010, IUBMB LIFE, V62, P268, DOI 10.1002/iub.303; Guo Y, 2011, HISTOPATHOLOGY, V59, P763, DOI 10.1111/j.1365-2559.2011.03993.x; Guzman-Ramirez N, 2009, PROSTATE, V69, P1683, DOI 10.1002/pros.21018; Hanks SK, 1997, BIOESSAYS, V19, P137, DOI 10.1002/bies.950190208; Herberg M, 2011, CELL CYCLE, V10, P2252, DOI 10.4161/cc.10.14.16203; Hochwald SN, 2009, CELL CYCLE, V8, P2435, DOI 10.4161/cc.8.15.9145; Jauch R, 2008, J MOL BIOL, V376, P758, DOI 10.1016/j.jmb.2007.11.091; Jeter CR, 2011, ONCOGENE, V30, P3833, DOI 10.1038/onc.2011.114; Jeter CR, 2009, STEM CELLS, V27, P993, DOI 10.1002/stem.29; Kobayashi K, 2012, J CELL BIOCHEM, V113, P508, DOI 10.1002/jcb.23374; Kohler EE, 2011, BLOOD, V117, P1761, DOI 10.1182/blood-2010-07-295261; Kweh F, 2009, MOL CARCINOGEN, V48, P1005, DOI 10.1002/mc.20552; Leask A, 2008, J CELL SCI, V121, P3459, DOI 10.1242/jcs.029215; Liang J, 2008, NAT CELL BIOL, V10, P731, DOI 10.1038/ncb1736; Lim ST, 2008, MOL CELL, V29, P9, DOI 10.1016/j.molcel.2007.11.031; Lin T., 2011, MED ONCOL, V20, P2252; Lin TX, 2005, NAT CELL BIOL, V7, P165, DOI 10.1038/ncb1211; Lin YL, 2011, MOL CELL BIOCHEM, V351, P109, DOI 10.1007/s11010-011-0717-5; Meng HM, 2010, CANCER BIOL THER, V9, P295, DOI 10.4161/cbt.9.4.10666; Moretto-Zita M, 2010, P NATL ACAD SCI USA, V107, P13312, DOI 10.1073/pnas.1005847107; Niu CS, 2011, ONCOL REP, V26, P593, DOI 10.3892/or.2011.1308; Salasznyk RM, 2007, EXP CELL RES, V313, P22, DOI 10.1016/j.yexcr.2006.09.013; Schober M, 2011, P NATL ACAD SCI USA, V108, P10544, DOI 10.1073/pnas.1107807108; Shibue T, 2009, P NATL ACAD SCI USA, V106, P10290, DOI 10.1073/pnas.0904227106; Su YJ, 2011, EMBO J, V30, P3186, DOI 10.1038/emboj.2011.211; Teng BP, 2011, ANTI-CANCER AGENT ME, V11, P620; Theunissen TW, 2011, CURR BIOL, V21, P65, DOI 10.1016/j.cub.2010.11.074; Tomuleasa C, 2010, J BUON, V15, P583; Tsai LL, 2011, J ORAL PATHOL MED, V40, P621, DOI 10.1111/j.1600-0714.2011.01015.x; Tu LC, 2001, J BIOMED SCI, V8, P184, DOI 10.1007/BF02256411; Twarock S, 2010, J BIOL CHEM, V285, P23274, DOI 10.1074/jbc.M109.093146; Waldron RT, 2000, J BIOL CHEM, V275, P17114, DOI 10.1074/jbc.M908959199; Yamamoto D, 2003, CELL SIGNAL, V15, P575, DOI 10.1016/S0898-6568(02)00142-0; Zbinden M, 2010, EMBO J, V29, P2659, DOI 10.1038/emboj.2010.137; Zhao J, 2001, MOL BIOL CELL, V12, P4066, DOI 10.1091/mbc.12.12.4066; Zhao XF, 2010, J CELL BIOL, V189, P955, DOI 10.1083/jcb.200912094; Zhou X, 2011, INT J GYNECOL PATHOL, V30, P262, DOI 10.1097/PGP.0b013e3182055a1f	62	56	62	0	13	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAY 25	2012	287	22					18656	18673		10.1074/jbc.M111.322883	http://dx.doi.org/10.1074/jbc.M111.322883			18	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	974EC	22493428	Green Published, hybrid			2022-12-25	WOS:000306411600075
J	Niimi, S; Arakawa-Takeuchi, S; Uranbileg, B; Park, J; Jinno, S; Okayama, H				Niimi, Shinichiro; Arakawa-Takeuchi, Shiho; Uranbileg, Baasanjav; Park, Jun-ha; Jinno, Shigeki; Okayama, Hiroto			Cdc6 Protein Obstructs Apoptosome Assembly and Consequent Cell Death by Forming Stable Complexes with Activated Apaf-1 Molecules	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							MAMMALIAN TARGET; DEPENDENT ACTIVATION; TSC2 GENE; EKER RAT; ANCHORAGE; CASPASE-3; PATHWAY; CYCLE; REPLICATION; EXPRESSION	Cdc6 is the bifunctional AAA + ATPase that assembles prereplicative complexes on origins of replication and activates p21(CIP1)- or p27(KIP1)-bound Cdk2. During the G(1)-S transition, the Cdc6 gene essential for chromosomal replication is activated by the E2F transcriptional factor. Paradoxically, Apaf-1 encoding the central component of the apoptosome is also activated at the same time and by E2F. Consequently, genes for antipodal life and death are regulated in the same manner by the same transcriptional factor. Here we report a striking solution to this paradox. Besides performing prereplicative complex assembly and Cdk2 activation, Cdc6 obstructed apoptosome assembly by forming stable complexes very likely with a monomer of cytochrome c-activated Apaf-1 molecules. This function depended on its own ATPase domain but not on the cyclin-binding motif. In proliferating rodent fibroblasts, Cdc6 continued to block apoptosome assembly induced by a non-cytochrome c or some other mechanism, suppressing seemingly unintended apoptosis when promoting cell proliferation. Thus, Cdc6 is an AAA + ATPase with three functions, all working for life.	[Okayama, Hiroto] Univ Tokyo, Grad Sch, Dept Biochem & Mol Biol, Tokyo 1130031, Japan; Univ Tokyo, Fac Med, Tokyo 1130031, Japan	University of Tokyo; University of Tokyo	Okayama, H (corresponding author), Univ Tokyo, Grad Sch, Dept Biochem & Mol Biol, Tokyo 1130031, Japan.	okayama-tky@umin.net			Ministry of Education, Science and Culture of Japan	Ministry of Education, Science and Culture of Japan(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT))	This work was supported by grants-in-aid for scientific research (S) and the Global Center of Excellence from the Ministry of Education, Science and Culture of Japan.	Arakawa-Takeuchi S, 2010, FEBS LETT, V584, P2779, DOI 10.1016/j.febslet.2010.05.005; Boatright KM, 2003, CURR OPIN CELL BIOL, V15, P725, DOI 10.1016/j.ceb.2003.10.009; Chiarugi P, 2008, BIOCHEM PHARMACOL, V76, P1352, DOI 10.1016/j.bcp.2008.07.023; Cowling V, 2002, CELL DEATH DIFFER, V9, P1046, DOI 10.1038/sj.cdd.4401065; Dyson N, 1998, GENE DEV, V12, P2245, DOI 10.1101/gad.12.15.2245; Furukawa Y, 2002, J BIOL CHEM, V277, P39760, DOI 10.1074/jbc.M200805200; Ghosh S, 2006, CANCER CELL, V10, P215, DOI 10.1016/j.ccr.2006.08.007; Hall JR, 2007, MOL BIOL CELL, V18, P3340, DOI 10.1091/mbc.E07-02-0173; Herbig U, 1999, MOL BIOL CELL, V10, P2631, DOI 10.1091/mbc.10.8.2631; Hsu JY, 2002, NAT CELL BIOL, V4, P358, DOI 10.1038/ncb785; Jinno S, 2002, ONCOGENE, V21, P1777, DOI 10.1038/sj.onc.1205249; Kan QM, 2008, J BIOL CHEM, V283, P17864, DOI 10.1074/jbc.M802055200; Kan QM, 2008, P NATL ACAD SCI USA, V105, P4757, DOI 10.1073/pnas.0706392105; Karassek S, 2010, J BIOL CHEM, V285, P33979, DOI 10.1074/jbc.M109.095968; KERR JFR, 1972, BRIT J CANCER, V26, P239, DOI 10.1038/bjc.1972.33; KOBAYASHI T, 1995, NAT GENET, V9, P70, DOI 10.1038/ng0195-70; Malladi S, 2009, EMBO J, V28, P1916, DOI 10.1038/emboj.2009.152; Marconi A, 2004, J CELL SCI, V117, P5815, DOI 10.1242/jcs.01490; Mendez J, 2000, MOL CELL BIOL, V20, P8602, DOI 10.1128/MCB.20.22.8602-8612.2000; Muller H, 2001, GENE DEV, V15, P267, DOI 10.1101/gad.864201; Park J, 2011, J BIOL CHEM, V286, P23132, DOI 10.1074/jbc.M110.209114; Pelizon C, 2002, EMBO REP, V3, P780, DOI 10.1093/embo-reports/kvf161; Peters JM, 2006, NAT REV MOL CELL BIO, V7, P644, DOI 10.1038/nrm1988; PINES J, 1994, SEMIN CANCER BIOL, V5, P305; Riedl SJ, 2007, NAT REV MOL CELL BIO, V8, P405, DOI 10.1038/nrm2153; Rytomaa M, 1999, CURR BIOL, V9, P1043, DOI 10.1016/S0960-9822(99)80454-0; Schafer ZT, 2006, DEV CELL, V10, P549, DOI 10.1016/j.devcel.2006.04.008; Sengupta S, 2010, MOL CELL, V40, P310, DOI 10.1016/j.molcel.2010.09.026; SHERR CJ, 1995, TRENDS BIOCHEM SCI, V20, P187, DOI 10.1016/S0968-0004(00)89005-2; Slee EA, 1999, J CELL BIOL, V144, P281, DOI 10.1083/jcb.144.2.281; Srinivasula SM, 1998, MOL CELL, V1, P949, DOI 10.1016/S1097-2765(00)80095-7; Uranbileg B, 2012, J BIOL CHEM, V287, P6275, DOI 10.1074/jbc.M111.318295; Vaux DL, 1996, P NATL ACAD SCI USA, V93, P2239, DOI 10.1073/pnas.93.6.2239; Wei MC, 2001, SCIENCE, V292, P727, DOI 10.1126/science.1059108; Yan LJ, 2006, J BIOL CHEM, V281, P19793, DOI 10.1074/jbc.C600028200; Yang SH, 2006, APOPTOSIS, V11, P1987, DOI 10.1007/s10495-006-0084-y; YEUNG RS, 1994, P NATL ACAD SCI USA, V91, P11413, DOI 10.1073/pnas.91.24.11413; Youle RJ, 2008, NAT REV MOL CELL BIO, V9, P47, DOI 10.1038/nrm2308; Zou H, 1997, CELL, V90, P405, DOI 10.1016/S0092-8674(00)80501-2	39	18	19	0	4	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAY 25	2012	287	22					18573	18583		10.1074/jbc.M112.347690	http://dx.doi.org/10.1074/jbc.M112.347690			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	974EC	22493447	Green Published, hybrid			2022-12-25	WOS:000306411600063
J	Shah, CA; Bei, L; Wang, H; Platanias, LC; Eklund, EA				Shah, Chirag A.; Bei, Ling; Wang, Hao; Platanias, Leonidas C.; Eklund, Elizabeth A.			HoxA10 Protein Regulates Transcription of Gene Encoding Fibroblast Growth Factor 2 (FGF2) in Myeloid Cells	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							BONE-MARROW-CELLS; HUMAN HEMATOPOIETIC-CELLS; TGF-BETA ISOFORMS; DNA-BINDING; IN-VITRO; ACTIVATES TRANSCRIPTION; ENDOTHELIAL-CELLS; PROGENITOR CELLS; EXPRESSION; LEUKEMIA	HoxA10 is a member of a highly conserved family of homeodomain transcription factors that are involved in definitive hematopoiesis and implicated in the pathogenesis of acute myeloid leukemia (AML). During normal hematopoiesis, HoxA10 facilitates myeloid progenitor expansion and impedes myeloid differentiation. To better understand the molecular mechanisms that control these events, we have been identifying and characterizing HoxA10 target genes. In this study, we identified the gene encoding fibroblast growth factor 2 (Fgf2 or basic fibroblast growth factor) as a target gene that is relevant to the biological effects of HoxA10. We identified two cis elements in the proximal FGF2 promoter that are activated by HoxA10 in myeloid progenitor cells and differentiating phagocytes. We determined that Fgf2 expression and secretion are regulated in a HoxA10-dependent manner in these cells. We found that increased Fgf2 production by HoxA10-overexpressing myeloid progenitor cells induced a phosphoinositol 3-kinase-dependent increase in beta-catenin protein. This resulted in autocrine stimulation of proliferation in HoxA10-overexpressing cells and hypersensitivity to other cytokines that share this pathway. Therefore, these studies identified expression of Fgf2 as a mechanism by which HoxA10 controls the size of the myeloid progenitor population. These studies also suggested that aberrant production of Fgf2 may contribute to leukemogenesis in the subset of AML with dysregulated Hox expression. Therapeutic targeting of Fgf2-stimulated signaling pathways might be a rational approach to this poor prognosis subset of AML.	[Shah, Chirag A.; Bei, Ling; Wang, Hao; Platanias, Leonidas C.; Eklund, Elizabeth A.] Northwestern Univ, Feinberg Sch Med, Chicago, IL 60611 USA; [Shah, Chirag A.; Bei, Ling; Wang, Hao; Platanias, Leonidas C.; Eklund, Elizabeth A.] Northwestern Univ, Robert H Lurie Comprehens Canc Ctr, Chicago, IL 60611 USA; [Bei, Ling; Platanias, Leonidas C.; Eklund, Elizabeth A.] Jesse Brown Vet Affairs Med Ctr, Chicago, IL 60612 USA	Northwestern University; Feinberg School of Medicine; Ann & Robert H. Lurie Children's Hospital of Chicago; Northwestern University; Robert H. Lurie Comprehensive Cancer Center; US Department of Veterans Affairs; Veterans Health Administration (VHA); Jesse Brown VA Medical Center	Eklund, EA (corresponding author), Northwestern Univ, Feinberg Sch Med, 303 E Super St,Lurie 5-105, Chicago, IL 60611 USA.	e-eklund@northwestern.edu		Wang, Hao/0000-0003-2131-0377	National Institutes of Health [R01-HL87717]; Veterans Affairs Merit Review; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL087717] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Veterans Affairs Merit Review(US Department of Veterans Affairs); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))	This work was supported, in whole or in part, by National Institutes of Health Grant R01-HL87717. This work was also supported by a Veterans Affairs Merit Review.	ACAMPORA D, 1989, NUCLEIC ACIDS RES, V17, P10385, DOI 10.1093/nar/17.24.10385; Aguayo A, 2000, BLOOD, V96, P2240, DOI 10.1182/blood.V96.6.2240.h8002240_2240_2245; Armstrong SA, 2002, NAT GENET, V30, P41, DOI 10.1038/ng765; Bei L, 2007, J BIOL CHEM, V282, P16846, DOI 10.1074/jbc.M609744200; Bei L, 2011, J BIOL CHEM, V286, P19047, DOI 10.1074/jbc.M110.213983; Bjornsson JM, 2001, BLOOD, V98, P3301, DOI 10.1182/blood.V98.12.3301; Buske C, 2001, BLOOD, V97, P2286, DOI 10.1182/blood.V97.8.2286; Calvo KR, 2000, MOL CELL BIOL, V20, P3274, DOI 10.1128/MCB.20.9.3274-3285.2000; Camos M, 2006, CANCER RES, V66, P6947, DOI 10.1158/0008-5472.CAN-05-4601; CHEIFETZ S, 1990, J BIOL CHEM, V265, P20533; Davidson AJ, 2003, NATURE, V425, P300, DOI 10.1038/nature01973; DIGNAM JD, 1983, NUCLEIC ACIDS RES, V11, P1475, DOI 10.1093/nar/11.5.1475; Dubchak I, 2000, GENOME RES, V10, P1304, DOI 10.1101/gr.142200; Eklund EA, 1998, J BIOL CHEM, V273, P13957, DOI 10.1074/jbc.273.22.13957; Eklund EA, 2002, J BIOL CHEM, V277, P36878, DOI 10.1074/jbc.M203917200; Eklund EA, 2000, J BIOL CHEM, V275, P20117, DOI 10.1074/jbc.M907915199; Ernst P, 2004, CURR BIOL, V14, P2063, DOI 10.1016/j.cub.2004.11.012; Golub TR, 1999, SCIENCE, V286, P531, DOI 10.1126/science.286.5439.531; Guenther MG, 2005, P NATL ACAD SCI USA, V102, P8603, DOI 10.1073/pnas.0503072102; Henckaerts E, 2004, J IMMUNOL, V173, P2486, DOI 10.4049/jimmunol.173.4.2486; Holnthoner W, 2002, J BIOL CHEM, V277, P45847, DOI 10.1074/jbc.M209354200; Horton SJ, 2005, CANCER RES, V65, P9245, DOI 10.1158/0008-5472.CAN-05-1691; Huang WQ, 2010, MOL CELL BIOL, V30, P4575, DOI 10.1128/MCB.01595-09; Kawagoe H, 1999, LEUKEMIA, V13, P687, DOI 10.1038/sj.leu.2401410; Kroon E, 1998, EMBO J, V17, P3714, DOI 10.1093/emboj/17.13.3714; LARRICK JW, 1980, J IMMUNOL, V125, P6; Lawrence HJ, 1997, BLOOD, V89, P1922, DOI 10.1182/blood.V89.6.1922; Lindsey S, 2005, J IMMUNOL, V175, P5269, DOI 10.4049/jimmunol.175.8.5269; Loots GG, 2002, GENOME RES, V12, P832, DOI 10.1101/gr.225502; LOWNEY P, 1991, NUCLEIC ACIDS RES, V19, P3443, DOI 10.1093/nar/19.12.3443; Mayor C, 2000, BIOINFORMATICS, V16, P1046, DOI 10.1093/bioinformatics/16.11.1046; Milne TA, 2002, MOL CELL, V10, P1107, DOI 10.1016/S1097-2765(02)00741-4; Oberley MJ, 2003, METHOD ENZYMOL, V371, P577; PAREKH T, 1994, J IMMUNOL, V152, P2456; Rusnati M, 1997, MOL BIOL CELL, V8, P2449, DOI 10.1091/mbc.8.12.2449; Salzman SA, 2002, CYTOKINES CELL MOL T, V7, P31, DOI 10.1080/13684730216400; SATOKATA I, 1995, NATURE, V374, P460, DOI 10.1038/374460a0; SAUVAGEAU G, 1994, P NATL ACAD SCI USA, V91, P12223, DOI 10.1073/pnas.91.25.12223; SAUVAGEAU G, 1995, GENE DEV, V9, P1753, DOI 10.1101/gad.9.14.1753; Shah CA, 2011, J BIOL CHEM, V286, P3161, DOI 10.1074/jbc.M110.183251; Shimizu T, 2008, MOL CELL BIOL, V28, P7427, DOI 10.1128/MCB.01962-07; Szymkowiak CH, 2000, CYTOKINE, V12, P397, DOI 10.1006/cyto.1999.0572; Takagi S, 2000, ACTA HAEMATOL-BASEL, V103, P78, DOI 10.1159/000041024; Thorsteinsdottir U, 2002, BLOOD, V99, P121, DOI 10.1182/blood.V99.1.121; Thorsteinsdottir U, 2001, MOL CELL BIOL, V21, P224, DOI 10.1128/MCB.21.1.224-234.2001; Wang H, 2007, J BIOL CHEM, V282, P16164, DOI 10.1074/jbc.M610556200; Wang H, 2011, J BIOL CHEM, V286, P16832, DOI 10.1074/jbc.M110.213975; Wang H, 2009, J BIOL CHEM, V284, P2549, DOI 10.1074/jbc.M804704200; WILSON EL, 1991, BLOOD, V77, P954; Yoon SY, 2000, ACTA HAEMATOL-BASEL, V104, P151, DOI 10.1159/000046507; Zhu CL, 2004, J BIOL CHEM, V279, P50874, DOI 10.1074/jbc.M405736200	51	32	36	0	5	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAY 25	2012	287	22					18230	18248		10.1074/jbc.M111.328401	http://dx.doi.org/10.1074/jbc.M111.328401			19	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	974EC	22493287	Green Published, hybrid			2022-12-25	WOS:000306411600031
J	Kim, B; Yang, MS; Choi, D; Kim, JH; Kim, HS; Seol, W; Choi, S; Jou, I; Kim, EY; Joe, EH				Kim, Beomsue; Yang, Myung-Soon; Choi, Dongjoo; Kim, Jong-Hyeon; Kim, Hye-Sun; Seol, Wongi; Choi, Sangdun; Jou, Ilo; Kim, Eun-Young; Joe, Eun-Hye			Impaired Inflammatory Responses in Murine Lrrk2-Knockdown Brain Microglia	PLOS ONE			English	Article							NF-KAPPA-B; ACTIVATED PROTEIN-KINASE; PARKIN DEFICIENCY INCREASES; CULTURED RAT MICROGLIA; NITRIC-OXIDE SYNTHASE; TRANSCRIPTIONAL ACTIVITY; NEURONAL TOXICITY; LRRK2 EXPRESSION; DNA-BINDING; IN-VITRO	LRRK2, a Parkinson's disease associated gene, is highly expressed in microglia in addition to neurons; however, its function in microglia has not been evaluated. Using Lrrk2 knockdown (Lrrk2-KD) murine microglia prepared by lentiviral-mediated transfer of Lrrk2-specific small inhibitory hairpin RNA (shRNA), we found that Lrrk2 deficiency attenuated lipopolysaccharide (LPS)-induced mRNA and/or protein expression of inducible nitric oxide synthase, TNF-alpha, IL-1 beta and IL-6. LPS-induced phosphorylation of p38 mitogen-activated protein kinase and stimulation of NF-kappa B-responsive luciferase reporter activity was also decreased in Lrrk2-KD cells. Interestingly, the decrease in NF-kappa B transcriptional activity measured by luciferase assays appeared to reflect increased binding of the inhibitory NF-kappa B homodimer, p50/p50, to DNA. In LPS-responsive HEK293T cells, overexpression of the human LRRK2 pathologic, kinase-active mutant G2019S increased basal and LPS-induced levels of phosphorylated p38 and JNK, whereas wild-type and other pathologic (R1441C and G2385R) or artificial kinase-dead (D1994A) LRRK2 mutants either enhanced or did not change basal and LPS-induced p38 and JNK phosphorylation levels. However, wild-type LRRK2 and all LRRK2 mutant variants equally enhanced NF-kappa B transcriptional activity. Taken together, these results suggest that LRRK2 is a positive regulator of inflammation in murine microglia, and LRRK2 mutations may alter the microenvironment of the brain to favor neuroinflammation.	[Kim, Beomsue; Yang, Myung-Soon; Jou, Ilo; Joe, Eun-Hye] Ajou Univ, Sch Med, Dept Pharmacol, Suwon 441749, South Korea; [Choi, Dongjoo; Kim, Jong-Hyeon; Kim, Hye-Sun; Jou, Ilo; Kim, Eun-Young; Joe, Eun-Hye] Ajou Univ, Sch Med, Grad Program Neurosci, Suwon 441749, South Korea; [Seol, Wongi] Wonkwang Univ, Sanbon Hosp, InAm Neurosci Res Ctr, Gunpo, South Korea; [Choi, Sangdun] Ajou Univ, Sch Med, Dept Mol Sci & Technol, Suwon 441749, South Korea; [Jou, Ilo; Kim, Eun-Young; Joe, Eun-Hye] Ajou Univ, Sch Med, Chron Inflammatory Dis Res Ctr, Suwon 441749, South Korea; [Kim, Eun-Young] Ajou Univ, Sch Med, Inst Med Sci, Suwon 441749, South Korea	Ajou University; Ajou University; Wonkwang University; Ajou University; Ajou University; Ajou University	Kim, B (corresponding author), Ajou Univ, Sch Med, Dept Pharmacol, Suwon 441749, South Korea.	ehjoe@ajou.ac.kr	Kim, Beomsue/X-3045-2019	Kim, Beomsue/0000-0003-1207-7876; Choi, Dongjoo/0000-0003-3222-7130	Korea Science and Engineering Foundation National Research Laboratory [2-2008025-0]; Korean government (Ministry of Education, Science and Technology); Brain Research Center of the Twenty-First Century Frontier Research Program [M103KV010011-06K2201-01110]; Ministry of Science and Technology, Republic of Korea; Korea Science and Engineering Foundation through the Chronic Inflammatory Disease Research Center at Ajou University [R13-2003-019]; National Research Foundation of Korea (NRF) [2009-00505, NRF-2008-521-C00220, NRF-2011-0012195]; Inje FIRST (Inje University, Korea)	Korea Science and Engineering Foundation National Research Laboratory(Korea Science and Engineering Foundation); Korean government (Ministry of Education, Science and Technology)(Ministry of Education, Science & Technology (MEST), Republic of KoreaKorean Government); Brain Research Center of the Twenty-First Century Frontier Research Program; Ministry of Science and Technology, Republic of Korea(Ministry of Science & Technology (MOST), Republic of Korea); Korea Science and Engineering Foundation through the Chronic Inflammatory Disease Research Center at Ajou University(Korea Science and Engineering Foundation); National Research Foundation of Korea (NRF)(National Research Foundation of Korea); Inje FIRST (Inje University, Korea)	This work was supported by Korea Science and Engineering Foundation National Research Laboratory Program Grant 2-2008025-0, funded by the Korean government (Ministry of Education, Science and Technology), grant M103KV010011-06K2201-01110 from the Brain Research Center of the Twenty-First Century Frontier Research Program funded by the Ministry of Science and Technology, Republic of Korea, the Korea Science and Engineering Foundation through the Chronic Inflammatory Disease Research Center at Ajou University (Grant R13-2003-019) to EHJ, Global Partnership Program (2009-00505) through the National Research Foundation of Korea (NRF) and Inje FIRST program (Inje University, Korea) to WS, Basic Science Research Program (NRF-2008-521-C00220) through the National Research Foundation of Korea to EYK, and Basic Science Research Program (NRF-2011-0012195) through the National Research Foundation of Korea to BK. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ashwell JD, 2006, NAT REV IMMUNOL, V6, P532, DOI 10.1038/nri1865; Bachstetter AD, 2011, J NEUROINFLAMM, V8, DOI 10.1186/1742-2094-8-79; Barrett JC, 2008, NAT GENET, V40, P955, DOI 10.1038/ng.175; BLASI E, 1990, J NEUROIMMUNOL, V27, P229, DOI 10.1016/0165-5728(90)90073-V; Casarejos MJ, 2009, J NEUROCHEM, V110, P1523, DOI 10.1111/j.1471-4159.2009.06248.x; Chow JC, 1999, J BIOL CHEM, V274, P10689, DOI 10.1074/jbc.274.16.10689; Covy JP, 2009, MOVEMENT DISORD, V24, P32, DOI 10.1002/mds.22096; DING AH, 1988, ANAL BIOCHEM, V175, P22, DOI 10.1016/0003-2697(88)90355-7; Doyle SL, 2005, J BIOL CHEM, V280, P23496, DOI 10.1074/jbc.C500053200; Dusonchet J, 2011, J NEUROSCI, V31, P907, DOI 10.1523/JNEUROSCI.5092-10.2011; Frank-Cannon TC, 2008, J NEUROSCI, V28, P10825, DOI 10.1523/JNEUROSCI.3001-08.2008; Gardet A, 2010, J IMMUNOL, V185, P5577, DOI 10.4049/jimmunol.1000548; Gloeckner CJ, 2009, J NEUROCHEM, V109, P959, DOI 10.1111/j.1471-4159.2009.06024.x; Hamza TH, 2010, NAT GENET, V42, P781, DOI 10.1038/ng.642; Hayden MS, 2004, GENE DEV, V18, P2195, DOI 10.1101/gad.1228704; He Y, 2003, J NEUROCHEM, V86, P1338, DOI 10.1046/j.1471-4159.2003.01938.x; Heo HY, 2010, EXP CELL RES, V316, P649, DOI 10.1016/j.yexcr.2009.09.014; Hou SH, 2003, J BIOL CHEM, V278, P45994, DOI 10.1074/jbc.M307971200; Hsu CH, 2010, J NEUROCHEM, V112, P1593, DOI 10.1111/j.1471-4159.2010.06568.x; Huang B, 2010, CELL SIGNAL, V22, P1282, DOI 10.1016/j.cellsig.2010.03.017; Kang JH, 2001, NEUROSCI LETT, V299, P205, DOI 10.1016/S0304-3940(01)01515-4; Lee BD, 2010, NAT MED, V16, P998, DOI 10.1038/nm.2199; Lee SB, 2007, BIOCHEM BIOPH RES CO, V358, P534, DOI 10.1016/j.bbrc.2007.04.156; Li XT, 2010, J NEUROSCI, V30, P1788, DOI 10.1523/JNEUROSCI.5604-09.2010; Li YP, 2009, NAT NEUROSCI, V12, P826, DOI 10.1038/nn.2349; Liberatore GT, 1999, NAT MED, V5, P1403; Liou AKF, 2008, NEUROBIOL DIS, V32, P116, DOI 10.1016/j.nbd.2008.06.016; Liu B, 2006, AAPS J, V8, pE606, DOI 10.1208/aapsj080369; Liu YG, 2001, CANCER RES, V61, P5402; Livak KJ, 2001, METHODS, V25, P402, DOI 10.1006/meth.2001.1262; Madrid LV, 2001, J BIOL CHEM, V276, P18934, DOI 10.1074/jbc.M101103200; MCGEER PL, 1988, NEUROLOGY, V38, P1285, DOI 10.1212/WNL.38.8.1285; Medvedev AE, 2003, J ENDOTOXIN RES, V9, P60, DOI 10.1179/096805103125001360; Melrose HL, 2007, NEUROSCIENCE, V147, P1047, DOI 10.1016/j.neuroscience.2007.05.027; Melrose HL, 2010, NEUROBIOL DIS, V40, P503, DOI 10.1016/j.nbd.2010.07.010; Miklossy J, 2006, J NEUROPATH EXP NEUR, V65, P953, DOI 10.1097/01.jnen.0000235121.98052.54; Mutez E, 2011, NEUROBIOL AGING, V32, P1839, DOI 10.1016/j.neurobiolaging.2009.10.016; Paisan-Ruiz C, 2009, ANN HUM GENET, V73, P391, DOI 10.1111/j.1469-1809.2009.00524.x; Plowey ED, 2008, J NEUROCHEM, V105, P1048, DOI 10.1111/j.1471-4159.2008.05217.x; Potashkin J.A., 2010, PARKINSONS DIS, V2011; Godoy MCP, 2008, BRAIN, V131, P1880, DOI 10.1093/brain/awn101; Pyo H, 1998, NEUROREPORT, V9, P871, DOI 10.1097/00001756-199803300-00020; Pyo H, 1999, J BIOL CHEM, V274, P34584, DOI 10.1074/jbc.274.49.34584; Ryu J, 2002, J IMMUNOL, V168, P5805, DOI 10.4049/jimmunol.168.11.5805; Ryu J, 2000, J BIOL CHEM, V275, P29955, DOI 10.1074/jbc.M001220200; Saha RN, 2007, J IMMUNOL, V179, P7101, DOI 10.4049/jimmunol.179.10.7101; Schmidt S, 2011, HUM MOL GENET, V20, P1197, DOI 10.1093/hmg/ddq564; Shin N, 2008, EXP CELL RES, V314, P2055, DOI 10.1016/j.yexcr.2008.02.015; Smith WLW, 2006, NAT NEUROSCI, V9, P1231, DOI 10.1038/nn1776; Solano RM, 2008, J NEUROSCI, V28, P598, DOI 10.1523/JNEUROSCI.4609-07.2008; Tong YR, 2009, P NATL ACAD SCI USA, V106, P14622, DOI 10.1073/pnas.0906334106; Waak J, 2009, FASEB J, V23, P2478, DOI 10.1096/fj.08-125153; Wang L, 2010, NEUROSCI LETT, V468, P198, DOI 10.1016/j.neulet.2009.10.080; West AB, 2007, HUM MOL GENET, V16, P223, DOI 10.1093/hmg/ddl471; White LR, 2007, J NEUROSCI RES, V85, P1288, DOI 10.1002/jnr.21240; Whitton PS, 2007, BRIT J PHARMACOL, V150, P963, DOI 10.1038/sj.bjp.0707167; Wilms H, 2003, FASEB J, V17, P500, DOI 10.1096/fj.02-0314fje; Yang H, 2000, J BIOL CHEM, V275, P20861, DOI 10.1074/jbc.M002896200; Zhang FR, 2009, NEW ENGL J MED, V361, P2609, DOI 10.1056/NEJMoa0903753; Zheng Y, 2010, EUR J NEUROL; Zhong HH, 1997, CELL, V89, P413, DOI 10.1016/S0092-8674(00)80222-6	61	130	133	1	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 9	2012	7	4							e34693	10.1371/journal.pone.0034693	http://dx.doi.org/10.1371/journal.pone.0034693			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	955JO	22496842	gold, Green Published			2022-12-25	WOS:000305014500026
J	Klemm, K; Mehta, A; Stadler, PF				Klemm, Konstantin; Mehta, Anita; Stadler, Peter F.			Landscape Encodings Enhance Optimization	PLOS ONE			English	Article								Hard combinatorial optimization problems deal with the search for the minimum cost solutions (ground states) of discrete systems under strong constraints. A transformation of state variables may enhance computational tractability. It has been argued that these state encodings are to be chosen invertible to retain the original size of the state space. Here we show how redundant non-invertible encodings enhance optimization by enriching the density of low-energy states. In addition, smooth landscapes may be established on encoded state spaces to guide local search dynamics towards the ground state.	[Klemm, Konstantin; Stadler, Peter F.] Univ Leipzig, Dept Comp Sci, Bioinformat Grp, Leipzig, Germany; [Klemm, Konstantin; Stadler, Peter F.] Univ Leipzig, Interdisciplinary Ctr Bioinformat, Leipzig, Germany; [Mehta, Anita] SN Bose Natl Ctr Basic Sci, Theory Dept, Kolkata 700064, W Bengal, India; [Stadler, Peter F.] Max Planck Inst Math Sci, Leipzig, Germany; [Stadler, Peter F.] Fraunhofer Inst Zelltherapie & Immunol, Leipzig, Germany; [Stadler, Peter F.] Univ Vienna, Dept Theoret Chem, Vienna, Austria; [Stadler, Peter F.] Santa Fe Inst, Santa Fe, NM 87501 USA	Leipzig University; Leipzig University; Department of Science & Technology (India); SN Bose National Centre for Basic Science (SNBNCBS); Max Planck Society; Fraunhofer Gesellschaft; University of Vienna; The Santa Fe Institute	Klemm, K (corresponding author), Univ Leipzig, Dept Comp Sci, Bioinformat Grp, Leipzig, Germany.	klemm@bioinf.uni-leipzig.de	Klemm, Konstantin/L-8426-2018; Stadler, Peter F. F/L-7857-2015; Klemm, Konstantin/GYU-3511-2022	Stadler, Peter F. F/0000-0002-5016-5191; 	Volkswagenstiftung [85 165/85 166]	Volkswagenstiftung(Volkswagen)	Volkswagenstiftung, project 85 165/85 166, http://www.volkswagenstiftung.de/. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Applegate D.L., 2006, TRAVELING SALESMAN P, P1, DOI [10.1515/9781400841103, DOI 10.1515/9781400841103]; Banzhaf W, 2006, GENET PROGR SER, V9, P207, DOI 10.1007/0-387-28111-8_14; Bauer M, 2005, PHYS REV LETT, V95, DOI 10.1103/PhysRevLett.95.107202; Berg J, 2004, P NATL ACAD SCI USA, V101, P14689, DOI 10.1073/pnas.0305199101; BINDER K, 1986, REV MOD PHYS, V58, P801, DOI 10.1103/RevModPhys.58.801; Bollobas B., 2001, RANDOM GRAPHS; Caprara A, 1997, PROC INT C COMPUT MO, P75; Choi SS, 2008, IEEE T EVOLUT COMPUT, V12, P604, DOI 10.1109/TEVC.2007.913699; Fernandez P, 2007, J R SOC INTERFACE, V4, P41, DOI 10.1098/rsif.2006.0152; Flamm C., 2007, Foundations of Genetic Algorithms, P194; FRAENKEL AS, 1993, B MATH BIOL, V55, P1199, DOI 10.1007/BF02460704; Garey M.R., 1979, COMPUTERS INTRACTABI; HELD M, 1962, J SOC IND APPL MATH, V10, P196, DOI 10.1137/0110015; Holland JH, 1992, ADAPTATION NATURAL A, DOI DOI 10.7551/MITPRESS/1090.001.0001; Karmakar N, 1982, UCBCSD81113; KIRKPATRICK S, 1983, SCIENCE, V220, P671, DOI 10.1126/science.220.4598.671; Knowles J. D., 2002, Parallel Problem Solving from Nature - PPSN VII. 7th International Conference. Proceedings (Lecture Notes in Computer Science Vol.2439), P88; Koza JR, 1992, GENETIC PROGRAMMING; Mertens S, 1998, PHYS REV LETT, V81, P4281, DOI 10.1103/PhysRevLett.81.4281; Mezard M, 2002, SCIENCE, V297, P812, DOI 10.1126/science.1073287; Reidys C, 1997, B MATH BIOL, V59, P339, DOI 10.1016/S0092-8240(96)00089-4; Reidys CM, 2002, SIAM REV, V44, P3, DOI 10.1137/S0036144501395952; Ricci-Tersenghi F, 2010, SCIENCE, V330, P1639, DOI 10.1126/science.1189804; Rothlauf F, 2003, EVOL COMPUT, V11, P381, DOI 10.1162/106365603322519288; Rothlauf F., 2006, REPRESENTATIONS GENE; Rothlauf F, 2011, NAT COMPUT SER, P1, DOI 10.1007/978-3-540-72962-4; Ruml W, 1996, J OPTIMIZ THEORY APP, V89, P251, DOI 10.1007/BF02192530; Schulman LS, 2007, PHYS REV LETT, V98, DOI 10.1103/PhysRevLett.98.257202; SCHUSTER P, 1994, P ROY SOC B-BIOL SCI, V255, P279, DOI 10.1098/rspb.1994.0040; SHERRINGTON D, 1975, PHYS REV LETT, V35, P1792, DOI 10.1103/PhysRevLett.35.1792; Van Nimwegen E, 2000, B MATH BIOL, V62, P799, DOI 10.1006/bulm.2000.0180; YU T, 2002, LNCS, V2278, P13, DOI DOI 10.1007/3-540-45984-7_	32	5	5	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 9	2012	7	4							e34780	10.1371/journal.pone.0034780	http://dx.doi.org/10.1371/journal.pone.0034780			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	955JO	22496860	gold, Green Submitted, Green Published			2022-12-25	WOS:000305014500029
J	Saravanan, S; Schrama, JW; Figueiredo-Silva, AC; Kaushik, SJ; Verreth, JAJ; Geurden, I				Saravanan, Subramanian; Schrama, Johan W.; Figueiredo-Silva, A. Claudia; Kaushik, Sadasivam J.; Verreth, Johan A. J.; Geurden, Inge			Constraints on Energy Intake in Fish: The Link between Diet Composition, Energy Metabolism, and Energy Intake in Rainbow Trout	PLOS ONE			English	Article							EUROPEAN SEA-BASS; VOLUNTARY FEED-INTAKE; SALMON SALMO-SALAR; ONCORHYNCHUS-MYKISS; FOOD-INTAKE; DIGESTIBLE ENERGY; GROWING-PIGS; UTILIZATION EFFICIENCY; OREOCHROMIS-NILOTICUS; DICENTRARCHUS-LABRAX	The hypothesis was tested that fish fed to satiation with iso-energetic diets differing in macronutrient composition will have different digestible energy intakes (DEI) but similar total heat production. Four iso-energetic diets (2 x 2 factorial design) were formulated having a contrast in i) the ratio of protein to energy (P/E): high (H-P/E) vs. low (L-P/E) and ii) the type of nonprotein energy (NPE) source: fat vs. carbohydrate which were iso-energetically exchanged. Triplicate groups (35 fish/tank) of rainbow trout were hand-fed each diet twice daily to satiation for 6 weeks under non-limiting water oxygen conditions. Feed intake (FI), DEI (kJ kg(-0.8) d(-1)) and growth (g kg(-0.8) d(-1)) of trout were affected by the interaction between P/E ratio and NPE source of the diet (P < 0.05). Regardless of dietary P/E ratio, the inclusion of carbohydrate compared to fat as main NPE source reduced DEI and growth of trout by similar to 20%. The diet-induced differences in FI and DEI show that trout did not compensate for the dietary differences in digestible energy or digestible protein contents. Further, changes in body fat store and plasma glucose did not seem to exert a homeostatic feedback control on DEI. Independent of the diet composition, heat production of trout did not differ (P > 0.05). Our data suggest that the control of DEI in trout might be a function of heat production, which in turn might reflect a physiological limit related with oxidative metabolism.	[Saravanan, Subramanian; Schrama, Johan W.; Verreth, Johan A. J.] Wageningen Univ, WIAS, Aquaculture & Fisheries Grp, Wageningen, Netherlands; [Saravanan, Subramanian; Figueiredo-Silva, A. Claudia; Kaushik, Sadasivam J.; Geurden, Inge] INRA, UR1067, Pole Hydrobiol INRA, St Pee Sur Nivelle, France	Wageningen University & Research; INRAE; Universite de Pau et des Pays de l'Adour	Saravanan, S (corresponding author), Wageningen Univ, WIAS, Aquaculture & Fisheries Grp, Wageningen, Netherlands.	inge.geurden@st-pee.inra.fr	Kaushik, Sadasivam J/B-9824-2009; Verreth, Johan/ABD-7198-2020	Kaushik, Sadasivam J/0000-0001-7856-8374; Verreth, Johan/0000-0001-7277-5129; Schrama, Johan/0000-0001-7156-8806	INRA (Institut National de Recherche Agronomique)	INRA (Institut National de Recherche Agronomique)	This study has been funded by institutional funds from INRA (Institut National de Recherche Agronomique) in the framework of the INRA/WUR (Wageningen University Research) Aquaculture Platform. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alanara A., 1996, Aquaculture Research, V27, P479, DOI 10.1111/j.1365-2109.1996.tb01277.x; Azevedo PA, 1998, AQUAT LIVING RESOUR, V11, P227, DOI 10.1016/S0990-7440(98)89005-0; Bendiksen EA, 2002, AQUAC RES, V33, P525, DOI 10.1046/j.1365-2109.2002.00737.x; Blundell John E., 1995, Nutrition Research Reviews, V8, P225, DOI 10.1079/NRR19950014; BOUJARD T, 1994, AQUAT LIVING RESOUR, V7, P211, DOI 10.1051/alr:1994023; BROBECK JOHN R., 1957, YALE JOUR BIOL AND MED, V29, P565; BROMLEY PJ, 1980, AQUACULTURE, V19, P359, DOI 10.1016/0044-8486(80)90084-8; Bureau Dominique P., 2002, P1; Bureau DP, 2003, N AM J AQUACULT, V65, P33, DOI 10.1577/1548-8454(2003)065&lt;0033:CCAPTE&gt;2.0.CO;2; Cho C.Y., 1985, P95; CHOUBERT G, 1982, AQUACULTURE, V29, P185, DOI 10.1016/0044-8486(82)90048-5; Dias J, 1999, CYBIUM, V23, P127; Dias J, 1998, AQUAT LIVING RESOUR, V11, P219, DOI 10.1016/S0990-7440(98)89004-9; Emmans GC, 1995, LIVEST PROD SCI, V44, P189, DOI 10.1016/0301-6226(95)00073-9; Encarnacao P, 2004, AQUACULTURE, V235, P569, DOI 10.1016/j.aquaculture.2004.01.001; Ferguson NS, 1997, ANIM SCI, V64, P365, DOI 10.1017/S1357729800015939; Ferguson NS, 2002, ANIM SCI, V74, P103, DOI 10.1017/S1357729800052267; Figueiredo-Silva AC, 2012, BRIT J NUTR, V107, P1714, DOI 10.1017/S0007114511004739; FOLCH J, 1957, J BIOL CHEM, V226, P497; Friedman MI, 1998, AM J CLIN NUTR, V67, p513S, DOI 10.1093/ajcn/67.3.513S; Gelineau A, 2001, REPROD NUTR DEV, V41, P487, DOI 10.1051/rnd:2001103; Geurden I, 2006, PHYSIOL BEHAV, V88, P325, DOI 10.1016/j.physbeh.2006.03.033; Glencross B, 2008, AQUACULT NUTR, V14, P129, DOI 10.1111/j.1365-2095.2007.00512.x; Glencross BD, 2009, AQUACULT NUTR, V15, P1, DOI 10.1111/j.1365-2095.2007.00562.x; Glencross B, 2007, AQUACULTURE, V265, P218, DOI 10.1016/j.aquaculture.2007.01.040; HE EQ, 1993, T AM FISH SOC, V122, P717, DOI 10.1577/1548-8659(1993)122<0717:AEMOGE>2.3.CO;2; Helland SJ, 1998, AQUACULTURE, V162, P1, DOI 10.1016/S0044-8486(98)00206-3; HEMRE GI, 1989, AQUACULTURE, V80, P261, DOI 10.1016/0044-8486(89)90174-9; HENRY Y, 1985, LIVEST PROD SCI, V12, P339, DOI 10.1016/0301-6226(85)90133-2; Hewson-Hughes AK, 2011, J EXP BIOL, V214, P1039, DOI 10.1242/jeb.049429; ISO, 1981, 5985 ISO; ISO, 2005, 15914 ISO; Johansen SJS, 2003, AQUAC RES, V34, P317; KAUSHIK SJ, 1984, Z TIERPHYSIOL TIERER, V51, P57; KENNEDY GC, 1953, PROC R SOC SER B-BIO, V140, P578, DOI 10.1098/rspb.1953.0009; Ketelaars JJMH, 1996, J ANIM SCI, V74, P3036; KIM JD, 1992, AQUACULTURE, V106, P161, DOI 10.1016/0044-8486(92)90200-5; Koh K, 1999, BRIT POULTRY SCI, V40, P511, DOI 10.1080/00071669987287; Langhans W, 2008, APPETITE, V51, P446, DOI 10.1016/j.appet.2008.06.014; Lekva A, 2010, AQUACULTURE, V300, P169, DOI 10.1016/j.aquaculture.2010.01.001; MAYER J, 1991, NUTR REV, V49, P46; Mayntz D, 2009, ANIM BEHAV, V77, P349, DOI 10.1016/j.anbehav.2008.09.036; MCLEAN JA, 1972, BRIT J NUTR, V27, P597, DOI 10.1079/BJN19720130; MORALES AE, 1994, AQUACULTURE, V124, P117, DOI 10.1016/0044-8486(94)90367-0; Nicolaidis S, 2011, PHYSIOL BEHAV, V104, P8, DOI 10.1016/j.physbeh.2011.04.058; NRC (National Research Council), 2011, NUTR REQ FISH SHRIMP; PAGE JW, 1973, J NUTR, V103, P1339, DOI 10.1093/jn/103.9.1339; Peres H, 1999, AQUACULTURE, V179, P325, DOI 10.1016/S0044-8486(99)00168-4; Polakof S, 2008, AM J PHYSIOL-REG I, V295, pR478, DOI 10.1152/ajpregu.00176.2008; Riche M, 2004, AQUACULTURE, V234, P657, DOI 10.1016/j.aquaculture.2003.12.012; Ruohonen K, 1996, J FISH BIOL, V49, P501, DOI 10.1111/j.1095-8649.1996.tb00045.x; SHARIATMADARI F, 1993, BRIT POULTRY SCI, V34, P959, DOI 10.1080/00071669308417656; Silverstein JT, 1999, AQUACULTURE, V177, P161, DOI 10.1016/S0044-8486(99)00076-9; Sorensen A, 2008, OBESITY, V16, P566, DOI 10.1038/oby.2007.58; Stubbs RJ, 2006, BRIT J NUTR, V95, P657, DOI 10.1079/BJN20041361; Tekinay AA, 2003, TURK J VET ANIM SCI, V27, P1077; Tran-Duy A, 2008, AQUACULTURE, V277, P213, DOI 10.1016/j.aquaculture.2008.03.004; Volkoff H, 2006, ZEBRAFISH, V3, P131, DOI 10.1089/zeb.2006.3.131; Woods SC, 1998, SCIENCE, V280, P1378, DOI 10.1126/science.280.5368.1378; Woods SC, 2011, PHYSIOL BEHAV, V104, P4, DOI 10.1016/j.physbeh.2011.04.026; Yamamoto T, 2000, FISHERIES SCI, V66, P528, DOI 10.1046/j.1444-2906.2000.00083.x	61	52	52	0	25	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 9	2012	7	4							e34743	10.1371/journal.pone.0034743	http://dx.doi.org/10.1371/journal.pone.0034743			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	955JO	22496852	Green Published, gold, Green Submitted			2022-12-25	WOS:000305014500028
J	Shariati, NH; Freeman, AW				Shariati, Nastaran Hesam; Freeman, Alan W.			A Multi-Stage Model for Fundamental Functional Properties in Primary Visual Cortex	PLOS ONE			English	Article							CATS STRIATE CORTEX; LATERAL GENICULATE-NUCLEUS; CELL RECEPTIVE-FIELDS; RETINAL GANGLION-CELLS; ORIENTATION SELECTIVITY; DIRECTION SELECTIVITY; COMPLEX CELLS; SPATIOTEMPORAL ORGANIZATION; CONTRAST SENSITIVITY; SPATIAL SUMMATION	Many neurons in mammalian primary visual cortex have properties such as sharp tuning for contour orientation, strong selectivity for motion direction, and insensitivity to stimulus polarity, that are not shared with their sub-cortical counterparts. Successful models have been developed for a number of these properties but in one case, direction selectivity, there is no consensus about underlying mechanisms. We here define a model that accounts for many of the empirical observations concerning direction selectivity. The model describes a single column of cat primary visual cortex and comprises a series of processing stages. Each neuron in the first cortical stage receives input from a small number of on-centre and off-centre relay cells in the lateral geniculate nucleus. Consistent with recent physiological evidence, the off-centre inputs to cortex precede the on-centre inputs by a small (similar to 4 ms) interval, and it is this difference that confers direction selectivity on model neurons. We show that the resulting model successfully matches the following empirical data: the proportion of cells that are direction selective; tilted spatiotemporal receptive fields; phase advance in the response to a stationary contrast-reversing grating stepped across the receptive field. The model also accounts for several other fundamental properties. Receptive fields have elongated subregions, orientation selectivity is strong, and the distribution of orientation tuning bandwidth across neurons is similar to that seen in the laboratory. Finally, neurons in the first stage have properties corresponding to simple cells, and more complex-like cells emerge in later stages. The results therefore show that a simple feed-forward model can account for a number of the fundamental properties of primary visual cortex.	[Shariati, Nastaran Hesam; Freeman, Alan W.] Univ Sydney, Discipline Biomed Sci, Lidcombe, NSW, Australia	University of Sydney	Shariati, NH (corresponding author), Univ Sydney, Discipline Biomed Sci, Lidcombe, NSW, Australia.	Alan.Freeman@sydney.edu.au	Freeman, Alan/A-6613-2008	Freeman, Alan/0000-0003-0563-526X				ADELSON EH, 1985, J OPT SOC AM A, V2, P284, DOI 10.1364/JOSAA.2.000284; Alonso JM, 1998, NAT NEUROSCI, V1, P395, DOI 10.1038/1609; Alonso JM, 2001, J NEUROSCI, V21, P4002, DOI 10.1523/JNEUROSCI.21-11-04002.2001; Alonso JM, 1996, NATURE, V383, P815, DOI 10.1038/383815a0; Anderson JS, 2000, J NEUROPHYSIOL, V84, P909, DOI 10.1152/jn.2000.84.2.909; BEAULIEU C, 1983, J COMP NEUROL, V217, P337, DOI 10.1002/cne.902170308; Carandini M, 2000, J NEUROSCI, V20, P470, DOI 10.1523/JNEUROSCI.20-01-00470.2000; Chance FS, 1999, NAT NEUROSCI, V2, P277, DOI 10.1038/6381; CREUTZFELDT O, 1968, EXP BRAIN RES, V6, P324; DEAN AF, 1983, J PHYSIOL-LONDON, V344, P305, DOI 10.1113/jphysiol.1983.sp014941; DEAN AF, 1981, J PHYSIOL-LONDON, V318, P413; DEANGELIS GC, 1993, J NEUROPHYSIOL, V69, P1118, DOI 10.1152/jn.1993.69.4.1118; DEANGELIS GC, 1993, J NEUROPHYSIOL, V69, P1091, DOI 10.1152/jn.1993.69.4.1091; ENROTHCUGELL C, 1966, J PHYSIOL-LONDON, V187, P517, DOI 10.1113/jphysiol.1966.sp008107; FRISHMAN LJ, 1987, J GEN PHYSIOL, V89, P599, DOI 10.1085/jgp.89.4.599; GABBOTT PLA, 1986, EXP BRAIN RES, V61, P323; Gardner JL, 1999, VISUAL NEUROSCI, V16, P1115, DOI 10.1017/S0952523899166112; GILBERT CD, 1979, NATURE, V280, P120, DOI 10.1038/280120a0; GIZZI MS, 1990, J NEUROPHYSIOL, V63, P1529, DOI 10.1152/jn.1990.63.6.1529; HUBEL DH, 1962, J PHYSIOL-LONDON, V160, P106, DOI 10.1113/jphysiol.1962.sp006837; HUGHES A, 1976, VISION RES, V16, P149, DOI 10.1016/0042-6989(76)90091-2; Jagadeesh B, 1997, J NEUROPHYSIOL, V78, P2772, DOI 10.1152/jn.1997.78.5.2772; Jin JZ, 2011, J NEUROSCI, V31, P17471, DOI 10.1523/JNEUROSCI.2456-11.2011; Jin JZ, 2011, NAT NEUROSCI, V14, P232, DOI 10.1038/nn.2729; Jin JZ, 2008, NAT NEUROSCI, V11, P88, DOI 10.1038/nn2029; JONES JP, 1987, J NEUROPHYSIOL, V58, P1187, DOI 10.1152/jn.1987.58.6.1187; KAPLAN E, 1987, J PHYSIOL-LONDON, V391, P267, DOI 10.1113/jphysiol.1987.sp016737; Kuhlmann L, 2011, FRONT SYST NEUROSCI, V5, DOI 10.3389/fnsys.2011.00081; LUND JS, 1979, J COMP NEUROL, V184, P599, DOI 10.1002/cne.901840402; Martinez LM, 2005, NAT NEUROSCI, V8, P372, DOI 10.1038/nn1404; MOVSHON JA, 1978, J PHYSIOL-LONDON, V283, P53, DOI 10.1113/jphysiol.1978.sp012488; MOVSHON JA, 1978, J PHYSIOL-LONDON, V283, P101, DOI 10.1113/jphysiol.1978.sp012490; Murthy A, 1998, VISUAL NEUROSCI, V15, P239, DOI 10.1017/S0952523898152045; Peterson MR, 2004, J NEUROSCI, V24, P3583, DOI 10.1523/JNEUROSCI.5398-03.2004; REID RC, 1987, P NATL ACAD SCI USA, V84, P8740, DOI 10.1073/pnas.84.23.8740; REID RC, 1995, NATURE, V378, P281, DOI 10.1038/378281a0; Ringach DL, 2004, J NEUROPHYSIOL, V92, P468, DOI 10.1152/jn.01202.2003; Romo PA, 2011, J NEUROPHYSIOL, V106, P1688, DOI 10.1152/jn.00894.2010; ROSE D, 1974, EXP BRAIN RES, V20, P1; SAUL AB, 1990, J NEUROPHYSIOL, V64, P206, DOI 10.1152/jn.1990.64.1.206; SCLAR G, 1982, EXP BRAIN RES, V46, P457; SILLITO AM, 1975, J PHYSIOL-LONDON, V250, P305, DOI 10.1113/jphysiol.1975.sp011056; SOMERS DC, 1995, J NEUROSCI, V15, P5448; Sompolinsky H, 1997, CURR OPIN NEUROBIOL, V7, P514, DOI 10.1016/S0959-4388(97)80031-1; SOODAK RE, 1987, P NATL ACAD SCI USA, V84, P3936, DOI 10.1073/pnas.84.11.3936; Stein JJ, 1996, J COMP NEUROL, V372, P597, DOI 10.1002/(SICI)1096-9861(19960902)372:4<597::AID-CNE8>3.0.CO;2-#; STONE J, 1982, TRENDS NEUROSCI, V5, P441, DOI 10.1016/0166-2236(82)90237-5; TANAKA K, 1983, J NEUROPHYSIOL, V49, P1303, DOI 10.1152/jn.1983.49.6.1303; TUSA RJ, 1978, J COMP NEUROL, V177, P213, DOI 10.1002/cne.901770204; Ursino M, 2007, COMPUT BIOL MED, V37, P398, DOI 10.1016/j.compbiomed.2006.05.002; WASSLE H, 1981, PROC R SOC SER B-BIO, V212, P177, DOI 10.1098/rspb.1981.0033; WATSON AB, 1985, J OPT SOC AM A, V2, P322, DOI 10.1364/JOSAA.2.000322	52	9	9	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 9	2012	7	4							e34466	10.1371/journal.pone.0034466	http://dx.doi.org/10.1371/journal.pone.0034466			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	955JO	22496811	Green Published, Green Submitted, gold			2022-12-25	WOS:000305014500023
J	Daskalov, A; Paoletti, M; Ness, F; Saupe, SJ				Daskalov, Asen; Paoletti, Mathieu; Ness, Frederique; Saupe, Sven J.			Genomic Clustering and Homology between HET-S and the NWD2 STAND Protein in Various Fungal Genomes	PLOS ONE			English	Article							NON-SELF RECOGNITION; PROGRAMMED CELL-DEATH; PODOSPORA-ANSERINA; VEGETATIVE INCOMPATIBILITY; AMYLOID FIBRILS; PRION PROTEIN; HETEROKARYON INCOMPATIBILITY; HET-S(218-289) PRION; GENETIC-VARIATION; DOMAIN	Background: Prions are infectious proteins propagating as self-perpetuating amyloid polymers. The [Het-s] prion of Podospora anserina is involved in a cell death process associated with non-self recognition. The prion forming domain (PFD) of HET-s adopts a beta-solenoid amyloid structure characterized by the two fold repetition of an elementary triangular motif. [Het-s] induces cell death when interacting with HET-S, an allelic variant of HET-s. When templated by [Het-s], HET-S undergoes a trans-conformation, relocates to the cell membrane and induces toxicity. Methodology/Principal Findings: Here, comparing HET-s homologs from different species, we devise a consensus for the HET-s elementary triangular motif. We use this motif to screen genomic databases and find a match to the N-terminus of NWD2, a STAND protein, encoded by the gene immediately adjacent to het-S. STAND proteins are signal transducing ATPases which undergo ligand-induced oligomerisation. Homology modelling predicts that the NWD2 N-terminal region adopts a HET-s-like fold. We propose that upon NWD2 oligomerisation, these N-terminal extensions adopt the beta-solenoid fold and template HET-S to adopt the amyloid fold and trigger toxicity. We extend this model to a putative prion, the sigma infectious element in Nectria haematococca, because the s locus controlling propagation of sigma also encodes a STAND protein and displays analogous features. Comparative genomic analyses indicate evolutionary conservation of these STAND/prion-like gene pairs, identify a number of novel prion candidates and define, in addition to the HET-s PFD motif, two distinct, novel putative PFD-like motifs. Conclusions/Significance: We suggest the existence, in the fungal kingdom, of a widespread and evolutionarily conserved mode of signal transduction based on the transmission of an amyloid-fold from a NOD-like STAND receptor protein to an effector protein.	[Daskalov, Asen; Paoletti, Mathieu; Ness, Frederique; Saupe, Sven J.] Univ Bordeaux 2, CNRS, UMR 5095, Inst Biochim & Genet Cellulaire, F-33076 Bordeaux, France	Centre National de la Recherche Scientifique (CNRS); CNRS - National Institute for Biology (INSB); UDICE-French Research Universities; Universite de Bordeaux	Daskalov, A (corresponding author), Univ Bordeaux 2, CNRS, UMR 5095, Inst Biochim & Genet Cellulaire, F-33076 Bordeaux, France.	sven.saupe@ibgc.u-bordeaux2.fr		saupe, sven/0000-0002-5589-721X				Aguzzi A, 2008, ANNU REV NEUROSCI, V31, P439, DOI 10.1146/annurev.neuro.31.060407.125620; Alexandrov IM, 2008, J BIOL CHEM, V283, P15185, DOI 10.1074/jbc.M802071200; Balguerie A, 2004, J CELL SCI, V117, P2599, DOI 10.1242/jcs.01116; Balguerie A, 2003, EMBO J, V22, P2071, DOI 10.1093/emboj/cdg213; Benkemoun L, 2011, MOL MICROBI IN PRESS; Blanco LP, 2012, TRENDS MICROBIOL, V20, P66, DOI 10.1016/j.tim.2011.11.005; Bratton SB, 2010, J CELL SCI, V123, P3209, DOI 10.1242/jcs.073643; Bryant C, 2009, TRENDS CELL BIOL, V19, P455, DOI 10.1016/j.tcb.2009.06.002; Chevanne D, 2010, BMC EVOL BIOL, V10, DOI 10.1186/1471-2148-10-134; Chevanne D, 2009, CURR GENET, V55, P93, DOI 10.1007/s00294-008-0227-5; Coustou V, 1997, P NATL ACAD SCI USA, V94, P9773, DOI 10.1073/pnas.94.18.9773; Crow ET, 2011, SEMIN CELL DEV BIOL, V22, P452, DOI 10.1016/j.semcdb.2011.03.003; Dalebroux ZD, 2010, MICROBIOL MOL BIOL R, V74, P171, DOI 10.1128/MMBR.00046-09; Dalstra HJP, 2003, P NATL ACAD SCI USA, V100, P6616, DOI 10.1073/pnas.1030058100; Danot O, 2009, STRUCTURE, V17, P172, DOI 10.1016/j.str.2009.01.001; DELEU C, 1990, NUCLEIC ACIDS RES, V18, P4901, DOI 10.1093/nar/18.16.4901; DELEU C, 1993, GENETICS, V135, P45; Derkatch IL, 2001, CELL, V106, P171, DOI 10.1016/S0092-8674(01)00427-5; Espagne E, 1997, MOL GEN GENET, V256, P620, DOI 10.1007/s004380050610; Espagne E, 2002, GENETICS, V161, P71; Gazit E, 2002, FASEB J, V16, P77, DOI 10.1096/fj.01-0442hyp; Glass NL, 2006, CURR OPIN MICROBIOL, V9, P553, DOI 10.1016/j.mib.2006.09.001; Graziani S, 2004, BMC BIOL, V2, DOI 10.1186/1741-7007-2-18; Greenwald J, 2010, STRUCTURE, V18, P1244, DOI 10.1016/j.str.2010.08.009; Greenwald J, 2010, MOL CELL, V38, P889, DOI 10.1016/j.molcel.2010.05.019; Halfmann R, 2012, NATURE, V482, P363, DOI 10.1038/nature10875; Halfmann R, 2011, MOL CELL, V43, P72, DOI 10.1016/j.molcel.2011.05.013; Halfmann R, 2010, TRENDS CELL BIOL, V20, P125, DOI 10.1016/j.tcb.2009.12.003; Hou FJ, 2011, CELL, V146, P448, DOI 10.1016/j.cell.2011.06.041; Kajava AV, 2010, FASEB J, V24, P1311, DOI 10.1096/fj.09-145979; Koonin EV, 2000, TRENDS BIOCHEM SCI, V25, P223, DOI 10.1016/S0968-0004(00)01577-2; Kubicek CP, 2011, GENOME BIOL, V12, DOI 10.1186/gb-2011-12-4-r40; Lange A, 2009, CHEMBIOCHEM, V10, P1657, DOI 10.1002/cbic.200900019; Larquet E, 2004, J MOL BIOL, V343, P1159, DOI 10.1016/j.jmb.2004.09.010; Lelpe DD, 2004, J MOL BIOL, V343, P1, DOI 10.1016/j.jmb.2004.08.023; Leveau JHJ, 2008, NEW PHYTOL, V177, P859, DOI 10.1111/j.1469-8137.2007.02325.x; Li LM, 2000, SCIENCE, V287, P661, DOI 10.1126/science.287.5453.661; Liu JJ, 1999, NATURE, V400, P573, DOI 10.1038/23048; Maddelein ML, 2002, P NATL ACAD SCI USA, V99, P7402, DOI 10.1073/pnas.072199199; Marshall KE, 2011, BIOCHEMISTRY-US, V50, P2061, DOI 10.1021/bi101936c; Mathur V, 2011, MOL CELLULA IN PRESS; Mattjus P, 2009, BBA-BIOMEMBRANES, V1788, P267, DOI 10.1016/j.bbamem.2008.10.003; McGlinchey RP, 2011, P NATL ACAD SCI USA, V108, P5337, DOI 10.1073/pnas.1102762108; Mitrophanov AY, 2008, BIOESSAYS, V30, P542, DOI 10.1002/bies.20769; Mizuno N, 2011, P NATL ACAD SCI USA, V108, P3252, DOI 10.1073/pnas.1011342108; Nakayashiki T, 2005, P NATL ACAD SCI USA, V102, P10575, DOI 10.1073/pnas.0504882102; Paoletti M, 2007, EUKARYOT CELL, V6, P2001, DOI 10.1128/EC.00129-07; Paoletti M, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0000283; Paoletti M, 2009, BIOESSAYS, V31, P1201, DOI 10.1002/bies.200900085; Pinan-Lucarre B, 2007, SEMIN CANCER BIOL, V17, P101, DOI 10.1016/j.semcancer.2006.11.009; Proell M, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0002119; Prusiner SB, 1998, P NATL ACAD SCI USA, V95, P13363, DOI 10.1073/pnas.95.23.13363; Reubold TF, 2011, STRUCTURE, V19, P1074, DOI 10.1016/j.str.2011.05.013; Riedl SJ, 2005, NATURE, V434, P926, DOI 10.1038/nature03465; Riedl SJ, 2007, NAT REV MOL CELL BIO, V8, P405, DOI 10.1038/nrm2153; Ritter C, 2005, NATURE, V435, P844, DOI 10.1038/nature03793; Ross ED, 2005, NAT CELL BIOL, V7, P1039, DOI 10.1038/ncb1105-1039; SAUPE S, 1995, GENE, V162, P135, DOI 10.1016/0378-1119(95)00272-8; SAUPE S, 1994, P NATL ACAD SCI USA, V91, P5927, DOI 10.1073/pnas.91.13.5927; Saupe S. J., 2011, SEMIN CELL DEV BIOL; Saupe SJ, 2000, MICROBIOL MOL BIOL R, V64, P489, DOI 10.1128/MMBR.64.3.489-502.2000; Saupe SJ, 2011, SEMIN CELL DEV BIOL, V22, P460, DOI 10.1016/j.semcdb.2011.02.019; Sawaya MR, 2007, NATURE, V447, P453, DOI 10.1038/nature05695; Sen A, 2007, J BIOL CHEM, V282, P5545, DOI 10.1074/jbc.M611464200; Shi YG, 2006, CURR OPIN CELL BIOL, V18, P677, DOI 10.1016/j.ceb.2006.09.006; Ting JPY, 2008, NAT REV IMMUNOL, V8, P372, DOI 10.1038/nri2296; True HL, 2000, NATURE, V407, P477, DOI 10.1038/35035005; True HL, 2004, NATURE, V431, P184, DOI 10.1038/nature02885; Tsai HH, 2005, P NATL ACAD SCI USA, V102, P8174, DOI 10.1073/pnas.0408653102; Tuite MF, 2010, NAT REV MOL CELL BIO, V11, P823, DOI 10.1038/nrm3007; Van Melckebeke H, 2010, J AM CHEM SOC, V132, P13765, DOI [10.1021/ja104213J, 10.1021/ja104213j]; Van Ooijen G, 2008, J EXP BOT, V59, P1383, DOI 10.1093/jxb/ern045; Wasmer C, 2008, SCIENCE, V319, P1523, DOI 10.1126/science.1151839; Wasmer C, 2010, J MOL BIOL, V402, P311, DOI 10.1016/j.jmb.2010.06.053; Wasmer C, 2009, J MOL BIOL, V394, P119, DOI 10.1016/j.jmb.2009.09.015; WICKNER RB, 1994, SCIENCE, V264, P566, DOI 10.1126/science.7909170; Wickner RB, 1997, P NATL ACAD SCI USA, V94, P10012, DOI 10.1073/pnas.94.19.10012; Wickner RB, 2011, SEMIN CELL DEV BIOL; Yu XC, 2005, STRUCTURE, V13, P1725, DOI 10.1016/j.str.2005.09.006; Yuan SJ, 2011, STRUCTURE, V19, P1084, DOI 10.1016/j.str.2011.07.001	80	57	57	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 6	2012	7	4							e34854	10.1371/journal.pone.0034854	http://dx.doi.org/10.1371/journal.pone.0034854			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	955JA	22493719	Green Published, Green Submitted, gold			2022-12-25	WOS:000305012700061
J	Huang, T; Wang, JJ; Cai, YD; Yu, H; Chou, KC				Huang, Tao; Wang, Junjie; Cai, Yu-Dong; Yu, Hanry; Chou, Kuo-Chen			Hepatitis C Virus Network Based Classification of Hepatocellular Cirrhosis and Carcinoma	PLOS ONE			English	Article							AMINO-ACID-COMPOSITION; PROTEIN STRUCTURAL CLASSES; CHRONIC LIVER-DISEASE; GENE-EXPRESSION; SUBCELLULAR-LOCALIZATION; DRUG-TARGET; NS3 PROTEIN; PREDICTION; HCV; INFECTION	Hepatitis C virus (HCV) is a main risk factor for liver cirrhosis and hepatocellular carcinoma, particularly to those patients with chronic liver disease or injury. The similar etiology leads to a high correlation of the patients suffering from the disease of liver cirrhosis with those suffering from the disease of hepatocellular carcinoma. However, the biological mechanism for the relationship between these two kinds of diseases is not clear. The present study was initiated in an attempt to investigate into the HCV infection protein network, in hopes to find good biomarkers for diagnosing the two diseases as well as gain insights into their progression mechanisms. To realize this, two potential biomarker pools were defined: (i) the target genes of HCV, and (ii) the between genes on the shortest paths among the target genes of HCV. Meanwhile, a predictor was developed for identifying the liver tissue samples among the following three categories: (i) normal, (ii) cirrhosis, and (iii) hepatocellular carcinoma. Interestingly, it was observed that the identification accuracy was higher with the tissue samples defined by extracting the features from the second biomarker pool than that with the samples defined based on the first biomarker pool. The identification accuracy by the jackknife validation for the between-genes approach was 0.960, indicating that the novel approach holds a quite promising potential in helping find effective biomarkers for diagnosing the liver cirrhosis disease and the hepatocellular carcinoma disease. It may also provide useful insights for in-depth study of the biological mechanisms of HCV-induced cirrhosis and hepatocellular carcinoma.	[Cai, Yu-Dong] Shanghai Univ, Inst Syst Biol, Shanghai, Peoples R China; [Huang, Tao] Chinese Acad Sci, Shanghai Inst Biol Sci, Key Lab Syst Biol, Shanghai, Peoples R China; [Huang, Tao] Shanghai Ctr Bioinformat Technol, Shanghai, Peoples R China; [Huang, Tao] Chinese Acad Sci, Grad Sch, Beijing, Peoples R China; [Cai, Yu-Dong] Fudan Univ, Ctr Computat Syst Biol, Shanghai 200433, Peoples R China; [Yu, Hanry] Natl Univ Singapore, Yong Loo Lin Sch Med, Dept Physiol, Singapore 117595, Singapore; [Yu, Hanry] ASTAR, Inst Bioengn & Nanotechnol, Singapore, Singapore; [Yu, Hanry] NUS Grad Sch Integrat Sci & Engn, Ctr Life Sci, Singapore, Singapore; [Wang, Junjie; Yu, Hanry] Natl Univ Singapore, Temasek Labs, Mechanobiol Inst Singapore, Singapore 117548, Singapore; [Wang, Junjie; Yu, Hanry] Singapore MIT Alliance, Computat & Syst Biol Program, Singapore, Singapore; [Yu, Hanry] Natl Univ Singapore, DSO Labs, NUS Tissue Engn Program, Singapore 117548, Singapore; [Yu, Hanry] Singapore MIT Alliance Res & Technol, Singapore, Singapore; [Yu, Hanry] MIT, Dept Biol Engn, Cambridge, MA 02139 USA; [Cai, Yu-Dong; Chou, Kuo-Chen] Gordon Life Sci Inst, San Diego, CA USA	Shanghai University; Chinese Academy of Sciences; Shanghai Institutes for Biological Sciences, CAS; Chinese Academy of Sciences; Chinese Academy of Sciences; University of Chinese Academy of Sciences, CAS; Fudan University; National University of Singapore; Agency for Science Technology & Research (A*STAR); A*STAR - Institute of Bioengineering & Bioimaging (IBB); A*STAR - Institute of Bioengineering & Nanotechnology (IBN); National University of Singapore; National University of Singapore; Massachusetts Institute of Technology (MIT); Nanyang Technological University & National Institute of Education (NIE) Singapore; Nanyang Technological University; Singapore-MIT Alliance for Research & Technology Centre (SMART); National University of Singapore; Singapore-MIT Alliance for Research & Technology Centre (SMART); Massachusetts Institute of Technology (MIT)	Cai, YD (corresponding author), Shanghai Univ, Inst Syst Biol, Shanghai, Peoples R China.	cai_yud@yahoo.com.cn; hanry_yu@nuhs.edu.sg; kcchou@gordonlifescience.org	Yu, Hanry/L-6050-2019; Yu, Hanry/C-7375-2011; Yu, Hanry/C-1031-2013; Chou, Kuo-Chen/A-8340-2009	Yu, Hanry/0000-0002-0339-3685; Yu, Hanry/0000-0002-0339-3685; cai, yudong/0000-0001-5664-7979	National Basic Research Program of China [2011CB510102, 2011CB510101]; Shanghai Municipal Education Commission [12ZZ087]; Institute of Bioengineering and Nanotechnology [R-185-000-182-592]; Singapore-MIT Alliance Computational and Systems Biology Flagship [C-382-641-001-091]; SMART (Singapore-MIT Alliance for Research and Technology) BioSyM and Mechanobiology Institute of Singapore [R-714-001-003-271]	National Basic Research Program of China(National Basic Research Program of China); Shanghai Municipal Education Commission(Shanghai Municipal Education Commission (SHMEC)); Institute of Bioengineering and Nanotechnology(Agency for Science Technology & Research (A*STAR)); Singapore-MIT Alliance Computational and Systems Biology Flagship(Singapore-MIT Alliance for Research & Technology Centre (SMART)); SMART (Singapore-MIT Alliance for Research and Technology) BioSyM and Mechanobiology Institute of Singapore(Singapore-MIT Alliance for Research & Technology Centre (SMART))	This work was supported by grants from National Basic Research Program of China (2011CB510102, 2011CB510101) and Innovation Program of Shanghai Municipal Education Commission (12ZZ087) to YDC and the Institute of Bioengineering and Nanotechnology Jassen Cilag Grant (R-185-000-182-592), (Singapore-MIT Alliance Computational and Systems Biology Flagship Project (C-382-641-001-091), SMART (Singapore-MIT Alliance for Research and Technology) BioSyM and Mechanobiology Institute of Singapore (R-714-001-003-271) to HY. JW is SMA (Singapore-MIT Alliance) scholar. The funders had no role in study desgin, data collection and analysis, decision to publish, or preparation of the manuscript.	Abraham G, 2010, BMC BIOINFORMATICS, V11, DOI 10.1186/1471-2105-11-277; Bolstad BM, 2003, BIOINFORMATICS, V19, P185, DOI 10.1093/bioinformatics/19.2.185; Carmona-Saez P, 2007, GENOME BIOL, V8, DOI 10.1186/gb-2007-8-1-r3; Casey LM, 2006, DEV DYNAM, V235, P1830, DOI 10.1002/dvdy.20821; Chartrand G, 1992, APPL ALGORITHMIC GRA; Chen SH, 2005, CURR MED CHEM, V12, P2317, DOI 10.2174/0929867054864769; CHOU KC, 1995, CRIT REV BIOCHEM MOL, V30, P275, DOI 10.3109/10409239509083488; CHOU KC, 1995, PROTEINS, V21, P319, DOI 10.1002/prot.340210406; Chou KC, 2008, NAT PROTOC, V3, P153, DOI 10.1038/nprot.2007.494; Chou KC, 2007, ANAL BIOCHEM, V370, P1, DOI 10.1016/j.ab.2007.07.006; Chou KC, 2012, MOL BIOSYST, V8, P629, DOI 10.1039/c1mb05420a; Chou KC, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0018258; Chou KC, 2011, J THEOR BIOL, V273, P236, DOI 10.1016/j.jtbi.2010.12.024; Chou KC, 2009, CURR PROTEOMICS, V6, P262, DOI 10.2174/157016409789973707; Cook GA, 2011, BIOPOLYMERS, V96, P32, DOI 10.1002/bip.21453; COVER TM, 1967, IEEE T INFORM THEORY, V13, P21, DOI 10.1109/TIT.1967.1053964; Cubas R, 2010, MOL CANCER, V9, DOI 10.1186/1476-4598-9-253; de Chassey B, 2008, MOL SYST BIOL, V4, DOI 10.1038/msb.2008.66; De Giorgi V, 2009, J TRANSL MED, V7, DOI 10.1186/1479-5876-7-85; Deng L, 2006, J GEN VIROL, V87, P1703, DOI 10.1099/vir.0.81735-0; DENOEUX T, 1995, IEEE T SYST MAN CYB, V25, P804, DOI 10.1109/21.376493; Dijkstra E.W, 1959, NUMER MATH, V1, P269, DOI DOI 10.1007/BF01386390; El-Serag HB, 2008, GASTROENTEROLOGY, V134, P1752, DOI 10.1053/j.gastro.2008.02.090; El-Serag HB, 1999, NEW ENGL J MED, V340, P745, DOI 10.1056/NEJM199903113401001; Esmaeili M, 2010, J THEOR BIOL, V263, P203, DOI 10.1016/j.jtbi.2009.11.016; Farazi PA, 2006, NAT REV CANCER, V6, P674, DOI 10.1038/nrc1934; Frick DN, 2007, CURR ISSUES MOL BIOL, V9, P1; FRIEDMAN JH, 1975, IEEE T COMPUT, V24, P1000, DOI 10.1109/T-C.1975.224110; Gao M, 2010, NATURE, V465, P96, DOI 10.1038/nature08960; Garbi N, 2006, NAT IMMUNOL, V7, P93, DOI 10.1038/ni1288; He ZS, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0009603; Hoshida Y, 2008, NEW ENGL J MED, V359, P1995, DOI 10.1056/NEJMoa0804525; Hu LL, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0014556; Huang T, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0025297; Huang T, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0022940; Huang T, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0010972; Huang T, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0008126; Huber W, 2004, BIOINFORMATICS, V20, P1651, DOI 10.1093/bioinformatics/bth133; Irizarry RA, 2003, BIOSTATISTICS, V4, P249, DOI 10.1093/biostatistics/4.2.249; Jensen LJ, 2009, NUCLEIC ACIDS RES, V37, pD412, DOI 10.1093/nar/gkn760; Kiernan AE, 2005, DEVELOPMENT, V132, P4353, DOI 10.1242/dev.02002; Kudo M, 2011, DIGEST DIS, V29, P316, DOI 10.1159/000327568; Leiserson CE, 2001, INTRO ALGORITHMS; Lemmer ER, 2006, SEMIN LIVER DIS, V26, P373, DOI 10.1055/s-2006-951604; Lenschow DJ, 2005, J VIROL, V79, P13974, DOI 10.1128/JVI.79.22.13974-13983.2005; Lin WZ, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0024756; Mahalanobis P.C., 1936, P NATL I SCI INDIA, V2, P49, DOI DOI 10.1145/1390156.1390302; Mas VR, 2009, MOL MED, V15, P85, DOI 10.2119/molmed.2008.00110; Michiels S, 2005, LANCET, V365, P488, DOI 10.1016/S0140-6736(05)17866-0; Mohabatkar H, 2011, J THEOR BIOL, V281, P18, DOI 10.1016/j.jtbi.2011.04.017; Mousseau G, 2011, J GEN VIROL, V92, P101, DOI 10.1099/vir.0.023325-0; Nanni L, 2009, PROTEIN PEPTIDE LETT, V16, P163, DOI 10.2174/092986609787316199; Nogales-Cadenas R, 2009, NUCLEIC ACIDS RES, V37, pW317, DOI 10.1093/nar/gkp416; Nomoto S, 2010, ANN SURG ONCOL, V17, P923, DOI 10.1245/s10434-009-0790-0; Oppmann B, 2000, IMMUNITY, V13, P715, DOI 10.1016/S1074-7613(00)00070-4; Parham C, 2002, J IMMUNOL, V168, P5699, DOI 10.4049/jimmunol.168.11.5699; Peng HC, 2005, IEEE T PATTERN ANAL, V27, P1226, DOI 10.1109/TPAMI.2005.159; Pietras A, 2011, MOL CANCER RES, V9, P626, DOI 10.1158/1541-7786.MCR-10-0508; Pillai KCS, 1985, ENCY STATISTICAL SCI, P176; Piskin G, 2006, J IMMUNOL, V176, P1908, DOI 10.4049/jimmunol.176.3.1908; Romero-Gomez M, 2006, WORLD J GASTROENTERO, V12, P7075, DOI 10.3748/wjg.v12.i44.7075; Shang S, 2011, HEPATOLOGY; Shim EK, 2011, J IMMUNOL, V186, P2926, DOI 10.4049/jimmunol.1001785; Silva CM, 2004, ONCOGENE, V23, P8017, DOI 10.1038/sj.onc.1208159; Song EL, 2011, GYNECOL ONCOL, V121, P174, DOI 10.1016/j.ygyno.2010.11.004; Strosberg AD, 2010, VIRUSES-BASEL, V2, P1734, DOI 10.3390/v2081734; Su WH, 2007, NUCLEIC ACIDS RES, V35, pD727, DOI 10.1093/nar/gkl845; Tagger A, 1999, INT J CANCER, V81, P695, DOI 10.1002/(SICI)1097-0215(19990531)81:5<695::AID-IJC4>3.3.CO;2-N; TSUKUMA H, 1993, NEW ENGL J MED, V328, P1797, DOI 10.1056/NEJM199306243282501; Walker Michelle P., 2003, Antiviral Chemistry & Chemotherapy, V14, P1; Wang FJ, 2007, INT J ONCOL, V30, P33; Wang P, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0018476; Wang P, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0023505; Wang YH, 2010, DEV DYNAM, V239, P2522, DOI 10.1002/dvdy.22394; Wu TT, 1998, MOL BIOL CELL, V9, P1661, DOI 10.1091/mbc.9.7.1661; Wu ZC, 2012, PROTEIN PEPTIDE LETT, V19, P4, DOI 10.2174/092986612798472839; Wu ZC, 2011, MOL BIOSYST, V7, P3287, DOI 10.1039/c1mb05232b; Xiao X, 2011, J THEOR BIOL, V284, P42, DOI 10.1016/j.jtbi.2011.06.005; Xiao X, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0020592; Xiao XA, 2011, MOL BIOSYST, V7, P911, DOI 10.1039/c0mb00170h; Zhang LH, 2005, WORLD J GASTROENTERO, V11, P463, DOI 10.3748/wjg.v11.i4.463; Zhang ZJ, 2011, J CLIN LAB ANAL, V25, P402, DOI 10.1002/jcla.20491; Zhao C, 2005, P NATL ACAD SCI USA, V102, P10200, DOI 10.1073/pnas.0504754102	83	51	51	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 6	2012	7	4							e34460	10.1371/journal.pone.0034460	http://dx.doi.org/10.1371/journal.pone.0034460			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	955JA	22493692	Green Published, gold, Green Submitted			2022-12-25	WOS:000305012700034
J	Lv, TF; Yuan, DM; Miao, XH; Lv, YL; Zhan, P; Shen, XK; Song, Y				Lv, Tangfeng; Yuan, Dongmei; Miao, Xiaohui; Lv, Yanling; Zhan, Ping; Shen, Xiaokun; Song, Yong			Over-Expression of LSD1 Promotes Proliferation, Migration and Invasion in Non-Small Cell Lung Cancer	PLOS ONE			English	Article								Background: Lysine specific demethylase 1 (LSD1) has been identified and biochemically characterized in epigenetics, but the pathological roles of its dysfunction in lung cancer remain to be elucidated. The aim of this study was to evaluate the prognostic significance of LSD1 expression in patients with non-small cell lung cancer (NSCLC) and to define its exact role in lung cancer proliferation, migration and invasion. Methods: The protein levels of LSD1 in surgically resected samples from NSCLC patients were detected by immunohistochemistry or Western blotting. The mRNA levels of LSD1 were detected by qRT-PCR. The correlation of LSD1 expression with clinical characteristics and prognosis was determined by statistical analysis. Cell proliferation rate was assessed by MTS assay and immunofluorescence. Cell migration and invasion were detected by scratch test, matrigel assay and transwell invasion assay. Results: LSD1 expression was higher in lung cancer tissue more than in normal lung tissue. Our results showed that overexpression of LSD1 protein were associated with shorter overall survival of NSCLC patients. LSD1 was localized mainly to the cancer cell nucleus. Interruption of LSD1 using siRNA or a chemical inhibitor, pargyline, suppressed proliferation, migration and invasion of A549, H460 and 293T cells. Meanwhile, over-expression of LSD1 enhanced cell growth. Finally, LSD1 was shown to regulate epithelial-to-mesenchymal transition in lung cancer cells. Conclusions: Over-expression of LSD1 was associated with poor prognosis in NSCLC, and promoted tumor cell proliferation, migration and invasion. These results suggest that LSD1 is a tumor-promoting factor with promising therapeutic potential for NSCLC.	[Lv, Tangfeng; Yuan, Dongmei; Miao, Xiaohui; Lv, Yanling; Shen, Xiaokun; Song, Yong] Nanjing Univ, Sch Med, Jinling Hosp, Dept Resp Med, Nanjing, Jiangsu, Peoples R China; [Zhan, Ping] Nanjing Chest Hosp, Dept Resp Med 1, Nanjing, Jiangsu, Peoples R China	Nanjing University	Lv, TF (corresponding author), Nanjing Univ, Sch Med, Jinling Hosp, Dept Resp Med, Nanjing, Jiangsu, Peoples R China.	yong_song6310@yahoo.com						Best JD, 2010, DRUG DISCOV TODAY, V15, P65, DOI 10.1016/j.drudis.2009.10.010; Chen PP, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0000534; Cole PA, 2008, NAT CHEM BIOL, V4, P590, DOI 10.1038/nchembio.111; Debnath J, 2003, METHODS, V30, P256, DOI 10.1016/S1046-2023(03)00032-X; Hayami S, 2011, INT J CANCER, V128, P574, DOI 10.1002/ijc.25349; Jemal A, 2011, CA-CANCER J CLIN, V61, P133, DOI [10.3322/caac.20105, 10.3322/caac.20073]; Lim S, 2010, INT J CANCER, V127, P1991, DOI 10.1002/ijc.25538; Lim S, 2010, CARCINOGENESIS, V31, P512, DOI 10.1093/carcin/bgp324; Metzger E, 2005, NATURE, V437, P436, DOI 10.1038/nature04020; Piperi C, 2008, J CELL MOL MED, V12, P1495, DOI 10.1111/j.1582-4934.2008.00309.x; REMMELE W, 1987, PATHOLOGE, V8, P138; Risch A, 2008, INT J CANCER, V123, P1, DOI 10.1002/ijc.23605; Schulte JH, 2009, CANCER RES, V69, P2065, DOI 10.1158/0008-5472.CAN-08-1735; Scoumanne A, 2007, J BIOL CHEM, V282, P15471, DOI 10.1074/jbc.M701023200; Seligson DB, 2009, AM J PATHOL, V174, P1619, DOI 10.2353/ajpath.2009.080874; Shi Y, 2007, NAT REV GENET, V8, P829, DOI 10.1038/nrg2218; Shi YJ, 2004, CELL, V119, P941, DOI 10.1016/j.cell.2004.12.012; Suikki HE, 2010, PROSTATE, V70, P889, DOI 10.1002/pros.21123; Ueda R, 2009, J AM CHEM SOC, V131, P17536, DOI 10.1021/ja907055q; Wang JX, 2007, NATURE, V446, P882, DOI 10.1038/nature05671; Wang Y, 2009, CELL, V138, P660, DOI 10.1016/j.cell.2009.05.050; Xiang B, 2006, METHOD ENZYMOL, V406, P692, DOI 10.1016/S0076-6879(06)06054-X	22	211	249	3	45	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 6	2012	7	4							e35065	10.1371/journal.pone.0035065	http://dx.doi.org/10.1371/journal.pone.0035065			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	955JA	22493729	Green Submitted, Green Published, gold			2022-12-25	WOS:000305012700071
J	Tan, GG; Liao, WT; Dong, X; Yang, GJ; Zhu, ZY; Li, WH; Chai, YF; Lou, ZY				Tan, Guangguo; Liao, Wenting; Dong, Xin; Yang, Genjing; Zhu, Zhenyu; Li, Wuhong; Chai, Yifeng; Lou, Ziyang			Metabonomic Profiles Delineate the Effect of Traditional Chinese Medicine Sini Decoction on Myocardial Infarction in Rats	PLOS ONE			English	Article							FLIGHT MASS-SPECTROMETRY; FATTY-ACID OXIDATION; HEART-FAILURE; HPLC-MS; LIQUID-CHROMATOGRAPHY; H-1-NMR SPECTROSCOPY; SYSTEMS BIOLOGY; ISCHEMIC-HEART; FAILING HEART; HUMAN URINE	Background: In spite of great advances in target-oriented Western medicine for treating myocardial infarction (MI), it is still a leading cause of death in a worldwide epidemic. In contrast to Western medicine, Traditional Chinese medicine (TCM) uses a holistic and synergistic approach to restore the balance of Yin-Yang of body energy so the body's normal function can be restored. Sini decoction (SND) is a well-known formula of TCM which has been used to treat MI for many years. However, its holistic activity evaluation and mechanistic understanding are still lacking due to its complex components. Methodology/Principal Findings: A urinary metabonomic method based on nuclear magnetic resonance and ultra high-performance liquid chromatography coupled to mass spectrometry was developed to characterize MI-related metabolic profiles and delineate the effect of SND on MI. With Elastic Net for classification and selection of biomarkers, nineteen potential biomarkers in rat urine were screened out, primarily related to myocardial energy metabolism, including the glycolysis, citrate cycle, amino acid metabolism, purine metabolism and pyrimidine metabolism. With the altered metabolism pathways as possible drug targets, we systematically analyze the therapeutic effect of SND, which demonstrated that SND administration could provide satisfactory effect on MI through partially regulating the perturbed myocardial energy metabolism. Conclusions/Significance: Our results showed that metabonomic approach offers a useful tool to identify MI-related biomarkers and provides a new methodological cue for systematically dissecting the underlying efficacies and mechanisms of TCM in treating MI.	[Tan, Guangguo; Liao, Wenting; Dong, Xin; Yang, Genjing; Zhu, Zhenyu; Li, Wuhong; Chai, Yifeng; Lou, Ziyang] Second Mil Med Univ, Sch Pharm, Shanghai, Peoples R China; [Tan, Guangguo; Liao, Wenting; Zhu, Zhenyu; Li, Wuhong; Chai, Yifeng] Shanghai Key Lab Pharmaceut Metabolite Res, Shanghai, Peoples R China	Naval Medical University	Tan, GG (corresponding author), Second Mil Med Univ, Sch Pharm, Shanghai, Peoples R China.	louziyang@126.com			National Natural Science Fund of China [30873196]; Project of Modernization of Traditional Chinese Medicine of Shanghai [09dZ1975100]; Doctoral Innovation Foundation of Second Military Medical University	National Natural Science Fund of China(National Natural Science Foundation of China (NSFC)); Project of Modernization of Traditional Chinese Medicine of Shanghai; Doctoral Innovation Foundation of Second Military Medical University	The work was supported by the National Natural Science Fund of China (No. 30873196) and the Project of Modernization of Traditional Chinese Medicine of Shanghai (No. 09dZ1975100) as well as the Doctoral Innovation Foundation of Second Military Medical University (2011). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Asl MN, 2008, PHYTOTHER RES, V22, P709, DOI 10.1002/ptr.2362; Bauer John Anthony, 2008, Congest Heart Fail, V14, P283, DOI 10.1111/j.1751-7133.2008.00011.x; Beckonert O, 2007, NAT PROTOC, V2, P2692, DOI 10.1038/nprot.2007.376; Bijlsma S, 2006, ANAL CHEM, V78, P567, DOI 10.1021/ac051495j; Butt MS, 2011, CRIT REV FOOD SCI, V51, P383, DOI 10.1080/10408391003624848; Dyck JRB, 2004, CIRC RES, V94, pE78, DOI 10.1161/01.RES.0000129255.19569.8f; Efferth T, 2007, TRENDS MOL MED, V13, P353, DOI 10.1016/j.molmed.2007.07.001; Fiehn O, 2002, PLANT MOL BIOL, V48, P155, DOI 10.1023/A:1013713905833; Gika HG, 2007, J PROTEOME RES, V6, P3291, DOI 10.1021/pr070183p; Giovane A, 2008, J CELL BIOCHEM, V105, P648, DOI 10.1002/jcb.21875; GORDON A, 1995, CARDIOVASC RES, V30, P413, DOI 10.1016/0008-6363(95)00062-3; GUTH BD, 1990, CIRCULATION, V81, P1948, DOI 10.1161/01.CIR.81.6.1948; Han J, 2009, BIOANALYSIS, V1, P1665, DOI 10.4155/BIO.09.158; Hodson MP, 2007, ANAL BIOCHEM, V362, P182, DOI 10.1016/j.ab.2006.12.037; Holmes E, 1997, J PHARMACEUT BIOMED, V15, P1647, DOI 10.1016/S0731-7085(97)00066-6; Janis MT, 2008, EXPERT OPIN DRUG MET, V4, P665, DOI [10.1517/17425255.4.6.665 , 10.1517/17425250802095565]; Jin Minghua, 2003, Zhong Yao Cai, V26, P71; KOBAYASHI M, 1988, J PHARMACOL EXP THER, V246, P667; Lenz EM, 2005, BIOMARKERS, V10, P173, DOI 10.1080/13547500500094034; Lindon JC, 2006, PHARM RES, V23, P1075, DOI 10.1007/s11095-006-0025-z; Lv YH, 2010, J PHARMACEUT BIOMED, V52, P129, DOI 10.1016/j.jpba.2009.12.016; Maier LS, 2000, CARDIOVASC RES, V45, P913, DOI 10.1016/S0008-6363(99)00387-9; McNulty PH, 2000, METABOLISM, V49, P1365, DOI 10.1053/meta.2000.9510; Mendes-Silva W, 2003, THROMB RES, V112, P93, DOI 10.1016/j.thromres.2003.10.014; Neubauer S, 2007, NEW ENGL J MED, V356, P1140, DOI 10.1056/NEJMra063052; Nicholson JK, 1999, XENOBIOTICA, V29, P1181, DOI 10.1080/004982599238047; Nielsen S, 1997, P NATL ACAD SCI USA, V94, P5450, DOI 10.1073/pnas.94.10.5450; Pechlivanis A, 2010, J PROTEOME RES, V9, P6405, DOI 10.1021/pr100684t; Roepke TK, 2009, NAT MED, V15, P1186, DOI 10.1038/nm.2029; Sabatine MS, 2005, CIRCULATION, V112, P3868, DOI 10.1161/CIRCULATIONAHA.105.569137; Sangster T, 2006, ANALYST, V131, P1075, DOI 10.1039/b604498k; Singhuber J, 2009, J ETHNOPHARMACOL, V126, P18, DOI 10.1016/j.jep.2009.07.031; Smith CA, 2006, ANAL CHEM, V78, P779, DOI 10.1021/ac051437y; Somjen D, 2004, J STEROID BIOCHEM, V91, P147, DOI 10.1016/j.jsbmb.2004.04.003; Sreekumar A, 2009, NATURE, V457, P910, DOI 10.1038/nature07762; Stanley WC, 2005, PHYSIOL REV, V85, P1093, DOI 10.1152/physrev.00006.2004; Stanley WC, 2005, HEART FAIL REV, V10, P275, DOI 10.1007/s10741-005-7542-4; Tan GG, 2011, BIOMED CHROMATOGR, V25, P913, DOI 10.1002/bmc.1544; Theodoridis G, 2008, TRAC-TREND ANAL CHEM, V27, P251, DOI 10.1016/j.trac.2008.01.008; Torabi A, 2008, EUR HEART J, V29, P859, DOI 10.1093/eurheartj/ehn096; Trygg J, 2007, J PROTEOME RES, V6, P469, DOI 10.1021/pr060594q; Tuunanen H, 2011, CARDIOVASC RES, V90, P251, DOI 10.1093/cvr/cvr052; Verpoorte R, 2005, J ETHNOPHARMACOL, V100, P53, DOI 10.1016/j.jep.2005.05.033; Wang M, 2005, PHYTOTHER RES, V19, P173, DOI 10.1002/ptr.1624; Weir Robin A P, 2006, Curr Heart Fail Rep, V3, P175, DOI 10.1007/s11897-006-0019-5; Wen ZN, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0018278; Williams RE, 2005, MOL BIOSYST, V1, P166, DOI 10.1039/b500852b; Williams RE, 2005, J PHARMACEUT BIOMED, V38, P465, DOI 10.1016/j.jpba.2005.01.013; Wu W, 1999, Zhongguo Zhong Xi Yi Jie He Za Zhi, V19, P23; Yamaguchi F, 1997, J MOL CELL CARDIOL, V29, P753, DOI 10.1006/jmcc.1996.0319; Yaoita H, 1993, Int J Card Imaging, V9, P273, DOI 10.1007/BF01137154; YU SM, 1995, BRIT J PHARMACOL, V114, P1587, DOI 10.1111/j.1476-5381.1995.tb14943.x; Zhao MQ, 2003, ZHONGGUO ZHONG XI YI, V23, P1; Zou H, 2005, J R STAT SOC B, V67, P301, DOI 10.1111/j.1467-9868.2005.00503.x	54	76	82	2	79	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 6	2012	7	4							e34157	10.1371/journal.pone.0034157	http://dx.doi.org/10.1371/journal.pone.0034157			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	955JA	22493681	Green Published, Green Submitted, gold			2022-12-25	WOS:000305012700023
J	Long, Y; Qi, O; Wang, HL				Long Yan; Qi Ouyang; Hongli Wang			Dose-Response Aligned Circuits in Signaling Systems	PLOS ONE			English	Article							POSITIVE FEEDBACK LOOPS; NETWORK MOTIFS; YEAST; RECEPTOR; OSCILLATIONS; ROBUSTNESS; BINDING; DESIGN; CELLS; MODEL	Cells use biological signal transduction pathways to respond to environmental stimuli and the behavior of many cell types depends on precise sensing and transmission of external information. A notable property of signal transduction that was characterized in the Saccharomyces cerevisiae yeast cell and many mammalian cells is the alignment of dose-response curves. It was found that the dose response of the receptor matches closely the dose responses of the downstream. This dose-response alignment (DoRA) renders equal sensitivities and concordant responses in different parts of signaling system and guarantees a faithful information transmission. The experimental observations raise interesting questions about the nature of the information transmission through DoRA signaling networks and design principles of signaling systems with this function. Here, we performed an exhaustive computational analysis on network architectures that underlie the DoRA function in simple regulatory networks composed of two and three enzymes. The minimal circuits capable of DoRA were examined with Michaelis-Menten kinetics. Several motifs that are essential for the dynamical function of DoRA were identified. Systematic analysis of the topology space of robust DoRA circuits revealed that, rather than fine-tuning the network's parameters, the function is primarily realized by enzymatic regulations on the controlled node that are constrained in limiting regions of saturation or linearity.	[Long Yan; Qi Ouyang; Hongli Wang] Peking Univ, State Key Lab Mesoscop Phys, Beijing 100871, Peoples R China; [Long Yan; Qi Ouyang; Hongli Wang] Peking Univ, Sch Phys, Beijing 100871, Peoples R China; [Qi Ouyang; Hongli Wang] Peking Univ, Ctr Theoret Biol, Beijing 100871, Peoples R China; [Qi Ouyang] Sch Phys, Peking Tsinghua Ctr Life Sci, Beijing, Peoples R China	Peking University; Peking University; Peking University	Long, Y (corresponding author), Peking Univ, State Key Lab Mesoscop Phys, Beijing 100871, Peoples R China.	hlwang@pku.edu.cn			NSFC [10721403, 10774008, 11074009, 11174013]; MSTC [2009CB918500]	NSFC(National Natural Science Foundation of China (NSFC)); MSTC(Ministry of Science and Technology, China)	This work is partially supported by the NSFC (10721403, 10774008, 11074009, 11174013) and MSTC (2009CB918500). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alon U., 2007, INTRO SYSTEMS BIOL; Alon U, 2007, NAT REV GENET, V8, P450, DOI 10.1038/nrg2102; AMIR SM, 1973, J BIOL CHEM, V248, P4092; BLACK JW, 1983, PROC R SOC SER B-BIO, V220, P141, DOI 10.1098/rspb.1983.0093; Brandman O, 2005, SCIENCE, V310, P496, DOI 10.1126/science.1113834; Brent R, 2009, FEBS LETT, V583, P4019, DOI 10.1016/j.febslet.2009.11.029; Chang DE, 2010, P NATL ACAD SCI USA, V107, P175, DOI 10.1073/pnas.0908314107; Colman-Lerner A, 2005, NATURE, V437, P699, DOI 10.1038/nature03998; CUATRECASAS P, 1971, P NATL ACAD SCI USA, V68, P1264, DOI 10.1073/pnas.68.6.1264; Ferrell JE, 1998, SCIENCE, V280, P895, DOI 10.1126/science.280.5365.895; Goentoro L, 2009, MOL CELL, V36, P894, DOI 10.1016/j.molcel.2009.11.018; Hornung G, 2008, PLOS COMPUT BIOL, V4, DOI 10.1371/journal.pcbi.0040008; Huang CYF, 1996, P NATL ACAD SCI USA, V93, P10078, DOI 10.1073/pnas.93.19.10078; Iman R.L, 1980, LATIN HYPERCUBE SAMP; JACKSON CL, 1990, CELL, V63, P1039, DOI 10.1016/0092-8674(90)90507-B; KASAI M, 1971, J MEMBRANE BIOL, V6, P58, DOI 10.1007/BF01874114; KNAUER DJ, 1984, J BIOL CHEM, V259, P5623; LIN SY, 1970, AM J PHYSIOL, V218, P1319, DOI 10.1152/ajplegacy.1970.218.5.1319; Ma WZ, 2006, MOL SYST BIOL, V2, DOI 10.1038/msb4100111; Ma WZ, 2009, CELL, V138, P760, DOI 10.1016/j.cell.2009.06.013; Marhl M, 2006, BIOPHYS CHEM, V120, P161, DOI 10.1016/j.bpc.2005.11.005; Marhl M, 2005, FEBS LETT, V579, P5461, DOI 10.1016/j.febslet.2005.09.007; Milo R, 2002, SCIENCE, V298, P824, DOI 10.1126/science.298.5594.824; Novak B, 2008, NAT REV MOL CELL BIO, V9, P981, DOI 10.1038/nrm2530; NOVICK A, 1957, P NATL ACAD SCI USA, V43, P553, DOI 10.1073/pnas.43.7.553; SEGALL JE, 1993, P NATL ACAD SCI USA, V90, P8332, DOI 10.1073/pnas.90.18.8332; Shao DY, 2006, BIOPHYS J, V91, P3986, DOI 10.1529/biophysj.106.081661; Shen-Orr SS, 2002, NAT GENET, V31, P64, DOI 10.1038/ng881; Shoval O, 2010, P NATL ACAD SCI USA, V107, P15995, DOI 10.1073/pnas.1002352107; Wagner A, 2005, P NATL ACAD SCI USA, V102, P11775, DOI 10.1073/pnas.0501094102; Yi TM, 2003, P NATL ACAD SCI USA, V100, P10764, DOI 10.1073/pnas.1834247100; Yu RC, 2008, NATURE, V456, P755, DOI 10.1038/nature07513	32	4	4	0	17	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 5	2012	7	4							e34727	10.1371/journal.pone.0034727	http://dx.doi.org/10.1371/journal.pone.0034727			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	955IH	22496849	Green Submitted, Green Published, gold			2022-12-25	WOS:000305010500026
J	Sabatier, R; Doyen, L; Tichit, M				Sabatier, Rodolphe; Doyen, Luc; Tichit, Muriel			Action versus Result-Oriented Schemes in a Grassland Agroecosystem: A Dynamic Modelling Approach	PLOS ONE			English	Article							AGRICULTURAL WET GRASSLANDS; LAPWINGS VANELLUS-VANELLUS; AGRI-ENVIRONMENT SCHEMES; BREEDING WADERS; VIABILITY MODEL; TRADE-OFFS; CONSERVATION; PERSPECTIVES; MANAGEMENT; BIRDS	Effects of agri-environment schemes (AES) on biodiversity remain controversial. While most AES are action-oriented, result-oriented and habitat-oriented schemes have recently been proposed as a solution to improve AES efficiency. The objective of this study was to compare action-oriented, habitat-oriented and result-oriented schemes in terms of ecological and productive performance as well as in terms of management flexibility. We developed a dynamic modelling approach based on the viable control framework to carry out a long term assessment of the three schemes in a grassland agroecosystem. The model explicitly links grazed grassland dynamics to bird population dynamics. It is applied to lapwing conservation in wet grasslands in France. We ran the model to assess the three AES scenarios. The model revealed the grazing strategies respecting ecological and productive constraints specific to each scheme. Grazing strategies were assessed by both their ecological and productive performance. The viable control approach made it possible to obtain the whole set of viable grazing strategies and therefore to quantify the management flexibility of the grassland agroecosystem. Our results showed that habitat and result-oriented scenarios led to much higher ecological performance than the action-oriented one. Differences in both ecological and productive performance between the habitat and result-oriented scenarios were limited. Flexibility of the grassland agroecosystem in the result-oriented scenario was much higher than in that of habitat-oriented scenario. Our model confirms the higher flexibility as well as the better ecological and productive performance of result-oriented schemes. A larger use of result-oriented schemes in conservation may also allow farmers to adapt their management to local conditions and to climatic variations.	[Sabatier, Rodolphe; Tichit, Muriel] INRA, UMR SADAPT 1048, Paris, France; [Sabatier, Rodolphe; Tichit, Muriel] AgroParisTech, UMR SADAPT 1048, Paris, France; [Doyen, Luc] MNHN, CNRS, UMR CERSP 7204, Paris, France	AgroParisTech; INRAE; UDICE-French Research Universities; Universite Paris Saclay; AgroParisTech; UDICE-French Research Universities; Universite Paris Saclay; Centre National de la Recherche Scientifique (CNRS); Museum National d'Histoire Naturelle (MNHN)	Sabatier, R (corresponding author), INRA, UMR SADAPT 1048, Paris, France.	rodolphe.sabatier@forst.uni-goettingen.de	Doyen, Luc/GXH-3424-2022	Doyen, Luc/0000-0001-8272-6187	ANR-Agence Nationale de la Recherche - The French National Research Agency [ANR-08-STRA-007]	ANR-Agence Nationale de la Recherche - The French National Research Agency(French National Research Agency (ANR))	This work was carried out with the financial support of the "ANR-Agence Nationale de la Recherche - The French National Research Agency'' under the "SYSTERRA program - Ecosystems and Sustainable Development,'' project "ANR-08-STRA-007, FARMBIRD - Coviability models of FARMing and BIRD biodiversity.'' The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aubin J. P., 1991, VIABILITY THEORY; Baumgartner S, 2009, ECOL ECON, V68, P2008, DOI 10.1016/j.ecolecon.2009.01.016; BEINTEMA AJ, 1987, J APPL ECOL, V24, P743, DOI 10.2307/2403978; Brunner A, 2005, AGRIENVIRONMENT SCHE; De Lara M., 2008, SUSTAINABLE MANAGEME; Devereux CL, 2004, IBIS, V146, P115, DOI 10.1111/j.1474-919X.2004.00355.x; Durant D, 2008, AGR ECOSYST ENVIRON, V128, P146, DOI 10.1016/j.agee.2008.05.013; Durant D, 2008, BIODIVERS CONSERV, V17, P2275, DOI 10.1007/s10531-007-9310-3; Groot JCJ, 2007, AGR ECOSYST ENVIRON, V120, P58, DOI 10.1016/j.agee.2006.03.037; Gunderson Lance, 1999, CONSERVATION ECOLOGY, V3; Kleijn D, 2006, ECOL LETT, V9, P243, DOI 10.1111/j.1461-0248.2005.00869.x; Klimek S, 2008, BIOL CONSERV, V141, P2888, DOI 10.1016/j.biocon.2008.08.025; Martin G, 2009, AGR ECOSYST ENVIRON, V129, P508, DOI 10.1016/j.agee.2008.11.005; Matzdorf B, 2010, LAND USE POLICY, V27, P535, DOI 10.1016/j.landusepol.2009.07.011; Melman TCP, 2010, WEB BASED TOOL TAILO; Mestelan P, 2007, RENCONTRES RECHERCHE; Musters CJM, 2001, CONSERV BIOL, V15, P363, DOI 10.1046/j.1523-1739.2001.015002363.x; NEAS, 2007, EX SUMM EC EV NAT CO; Sabatier R, 2010, ECOL MODEL, V221, P1292, DOI 10.1016/j.ecolmodel.2010.02.003; Sabatier R, 2010, MULTISCALE TRADE OFF; SABATIER R., 2010, RECONCILING PRODUCTI, P10; Sabatier R., 2011, P 3 FARM SYST DES C, P54; Sabatier R, 2008, ASSESSING EFFECT STO, P213; Schwarz G., 2008, ANAL POTENTIAL EFFEC; SNH, 2005, E SCOTTL GRASSL MAN; Sokal RR, 1995, BIOMETRY; Tichit M, 2007, ECOL MODEL, V206, P277, DOI 10.1016/j.ecolmodel.2007.03.043; Tichit M, 2004, ANIM RES, V53, P405, DOI 10.1051/animres:2004024; Tichit M, 2011, LIVEST SCI, V139, P161, DOI 10.1016/j.livsci.2011.03.006; Verhulst J, 2007, J APPL ECOL, V44, P70, DOI 10.1111/j.1365-2664.2006.01238.x; Wittig B, 2006, BIOL CONSERV, V133, P186, DOI 10.1016/j.biocon.2006.06.004; Zabel A, 2008, CONSERV BIOL, V22, P247, DOI 10.1111/j.1523-1739.2008.00898.x	32	30	30	2	32	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 5	2012	7	4							e33257	10.1371/journal.pone.0033257	http://dx.doi.org/10.1371/journal.pone.0033257			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	955IH	22496746	Green Published, gold, Green Submitted			2022-12-25	WOS:000305010500001
J	Valentine, LE; Reaveley, A; Johnson, B; Fisher, R; Wilson, BA				Valentine, Leonie E.; Reaveley, Alice; Johnson, Brent; Fisher, Rebecca; Wilson, Barbara A.			Burning in Banksia Woodlands: How Does the Fire-Free Period Influence Reptile Communities?	PLOS ONE			English	Article							WILDLAND-URBAN INTERFACE; SUCCESSION; REGIMES; CONSERVATION; LIZARDS; DISTURBANCE; MANAGEMENT; DIVERSITY; AUSTRALIA; RESPONSES	Fire is an important management tool for both hazard reduction burning and maintenance of biodiversity. The impact of time since last fire on fauna is an important factor to understand as land managers often aim for prescribed burning regimes with specific fire-free intervals. However, our current understanding of the impact of time since last fire on fauna is largely unknown and likely dependent on vegetation type. We examined the responses of reptiles to fire age in banksia woodlands, and the interspersed melaleuca damplands among them, north of Perth, Western Australia, where the current prescribed burning regime is targeting a fire-free period of 8-12 years. The response of reptiles to fire was dependent on vegetation type. Reptiles were generally more abundant (e.g. Lerista elegans and Ctenophorus adelaidensis) and specious in banksia sites. Several species (e.g. Menetia greyii, Cryptoblepharus buchananii) preferred long unburnt melaleuca sites (>16 years since last fire, YSLF) compared to recently burnt sites (<12 YSLF). Several of the small elapids (e.g. the WA priority listed species Neelaps calonotus) were only detected in older-aged banksia sites (>16 YSLF). The terrestrial dragon C. adelaidensis and the skink Morethia obscura displayed a strong response to fire in banksia woodlands only. Highest abundances of the dragon were detected in the recently burnt (<7 YSLF) and long unburnt (>35 YSLF) banksia woodlands, while the skink was more abundant in older sites. Habitats from a range of fire ages are required to support the reptiles we detected, especially the longer unburnt (>16 YSLF) melaleuca habitat. Current burning prescriptions are reducing the availability of these older habitats.	[Valentine, Leonie E.] Murdoch Univ, Sch Vet & Biomed Sci, Western Australian Ctr Excellence Climate Change, Perth, WA, Australia; [Reaveley, Alice; Johnson, Brent; Wilson, Barbara A.] Gnangara Sustainabil Strategy, Dept Environm & Conservat, Perth, WA, Australia; [Fisher, Rebecca] Univ Western Australia, Oceans Inst, Perth, WA 6009, Australia	Murdoch University; University of Western Australia	Valentine, LE (corresponding author), Murdoch Univ, Sch Vet & Biomed Sci, Western Australian Ctr Excellence Climate Change, Perth, WA, Australia.	l.valentine@murdoch.edu.au	Fisher, Rebecca/C-5459-2011; Valentine, Leonie Ellen/G-9963-2012	Fisher, Rebecca/0000-0001-5148-6731; Valentine, Leonie Ellen/0000-0003-1479-0755	Government of Western Australia	Government of Western Australia	Funding for the research was via the Gnangara Sustainability Strategy, Government of Western Australia. The funders had no role in the study design, data collection and analysis, decision to publish or preparation of the manuscript.	[Anonymous], 1981, FIRE AUSTR BIOTA; BEARD JS, 1984, KWONGAN PLANT LIFE S, P1; Behn G., 2001, Australian Forestry, V64, P80; Behn G., 2009, DEV REMOTELY SENSED; Bond W. J., 1996, FIRE PLANTS, DOI DOI 10.2307/2404797; BRAITHWAITE RW, 1987, J TROP ECOL, V3, P265, DOI 10.1017/S0266467400002145; Brawn JD, 2001, ANNU REV ECOL SYST, V32, P251, DOI 10.1146/annurev.ecolsys.32.081501.114031; Burnham K.P., 2002, MODEL SELECTION MULT, DOI 10.1007/b97636; Burrows N., 2003, FIRE S W W AUSTR SYN; BURROWS ND, 1990, J ENVIRON MANAGE, V31, P229, DOI 10.1016/S0301-4797(05)80036-2; Caughley J., 1985, P31; Clarke MF, 2008, WILDLIFE RES, V35, P385, DOI 10.1071/WR07137; Colwell R. K., 2006, ESTIMATES VERSION 8; Craig MD, 2010, RESTOR ECOL, V18, P300, DOI 10.1111/j.1526-100X.2009.00526.x; Cunningham SC, 2002, BIOL CONSERV, V107, P193, DOI 10.1016/S0006-3207(02)00064-2; Dell J, 1995, BURNING OUR BUSHLAND, P35; DODD J, 1989, Journal of the Royal Society of Western Australia, V71, P89; Fernandes PM, 2003, INT J WILDLAND FIRE, V12, P117, DOI 10.1071/WF02042; Fox Barry J., 1996, P467, DOI 10.1016/B978-012178075-3/50016-7; FOX BJ, 1982, ECOLOGY, V63, P1332, DOI 10.2307/1938861; FOX BJ, 1979, AUST J BOT, V27, P157, DOI 10.1071/BT9790157; FRIEND GR, 1993, BIOL CONSERV, V65, P99, DOI 10.1016/0006-3207(93)90439-8; Galiana-Martin L, 2011, LANDSCAPE RES, V36, P151, DOI 10.1080/01426397.2010.549218; *GOV W AUSTR, 2000, BUSH FOR, V1; Government of Western Australia, 2009, GNANG SUST STRAT SIT; GREENBERG CH, 1994, CONSERV BIOL, V8, P1047, DOI 10.1046/j.1523-1739.1994.08041047.x; Hayward Matt W., 2008, Conservation Science Western Australia, V7, P35; Kitchener DJ, 1978, MAMMALS N SWAN COAST, P54; KRUSKAL JB, 1964, PSYCHOMETRIKA, V29, P1, DOI 10.1007/BF02289565; Letnic M, 2004, J ARID ENVIRON, V59, P85, DOI 10.1016/j.jaridenv.2004.01.014; Masters P, 1996, WILDLIFE RES, V23, P39, DOI 10.1071/WR9960039; Mattiske Consulting Pty Ltd, 2003, FLOR VEG STUD GNAN A; McCune B, 1999, MULTIVARIATE ANAL EC; McCune B., 2002, ANAL ECOLOGICAL COMM, DOI 10.1016/S0022-0981(03)00091-1; Mielke P.W., 1984, HDB STAT, V4, P813, DOI DOI 10.1016/S0169-7161(84)04036-0; Mitchell D, 2003, BIODIVERSITY AUDIT W; Mittermeier RA, 2004, HOTSPOTS REVISITED; Muller C, 2010, FIRE MANAGEMENT OPER; Parr CL, 2006, CONSERV BIOL, V20, P1610, DOI 10.1111/j.1523-1739.2006.00492.x; Penman TD, 2011, INT J WILDLAND FIRE, V20, P721, DOI 10.1071/WF09131; PIANKA ER, 1989, AM NAT, V134, P344, DOI 10.1086/284985; Pianka ER, 2012, AUSTRAL ECOL, V37, P1, DOI 10.1111/j.1442-9993.2010.02234.x; PIELOU EC, 1966, J THEOR BIOL, V13, P131, DOI 10.1016/0022-5193(66)90013-0; R DEVELOPMENT CORE TEAM, 2011, R LANG ENV STAT COMP; Radeloff VC, 2005, ECOL APPL, V15, P799, DOI 10.1890/04-1413; Russell-Smith J, 2003, INT J WILDLAND FIRE, V12, P283, DOI 10.1071/WF03015; SEMENIUK C A, 1990, Journal of the Royal Society of Western Australia, V72, P109; SIMPSON EH, 1949, NATURE, V163, P688, DOI 10.1038/163688a0; Storr GM, 1978, FAUNAL STUDIES NO SW, P172; Taylor JE, 2001, AUSTRAL ECOL, V26, P193, DOI 10.1046/j.1442-9993.2001.01105.x; TRAINOR CR, 1994, WILDLIFE RES, V21, P131, DOI 10.1071/WR9940131; Underwood R.J., 1985, P S FIR EC MAN W AUS, P153; Valentine LE, 2007, BIOL CONSERV, V137, P90, DOI 10.1016/j.biocon.2007.01.018; Valentine LE, 2012, AUSTRAL ECOL, V37, P23, DOI 10.1111/j.1442-9993.2011.02244.x; Wallace Jeremy, 2006, Ecological Management & Restoration, V7, pS31, DOI 10.1111/j.1442-8903.2006.00289.x; Whelan R.J.., 1995, ECOLOGY FIRE; Whelan RJ, 2002, CONSERV BIOL, V16, P1659, DOI 10.1046/j.1523-1739.2002.02091.x; Wilson BA, 2009, BIOD VAL THREAT PROC; Wilson BA, 2010, GUIDELINES ECOLOGICA; Wittkuhn RS, 2011, FOREST ECOL MANAG, V261, P965, DOI 10.1016/j.foreco.2010.10.037; Woinarski JCZ, 1999, RANGELAND J, V21, P24, DOI 10.1071/RJ9990024; Yesertener C., 2007, ASSESSMENT DECLINING; Zar JH, 1999, BIOSTATISTICAL ANAL; Zuur Alain F., 2009, P1	64	32	36	0	31	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 5	2012	7	4							e34448	10.1371/journal.pone.0034448	http://dx.doi.org/10.1371/journal.pone.0034448			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	955IH	22496806	Green Published, gold			2022-12-25	WOS:000305010500008
J	Chaix, B; Bean, K; Daniel, M; Zenk, SN; Kestens, Y; Charreire, H; Leal, C; Thomas, F; Karusisi, N; Weber, C; Oppert, JM; Simon, C; Merlo, J; Pannier, B				Chaix, Basile; Bean, Kathy; Daniel, Mark; Zenk, Shannon N.; Kestens, Yan; Charreire, Helene; Leal, Cinira; Thomas, Frederique; Karusisi, Noella; Weber, Christiane; Oppert, Jean-Michel; Simon, Chantal; Merlo, Juan; Pannier, Bruno			Associations of Supermarket Characteristics with Weight Status and Body Fat: A Multilevel Analysis of Individuals within Supermarkets (RECORD Study)	PLOS ONE			English	Article							GEOGRAPHIC LIFE ENVIRONMENTS; HEALTH-CARE UTILIZATION; FOOD ENVIRONMENT; RISK-FACTORS; CARDIOVASCULAR MORTALITY; WAIST CIRCUMFERENCE; SOCIAL-FACTORS; NEIGHBORHOOD; STORES; AVAILABILITY	Purpose: Previous research on the influence of the food environment on weight status has often used impersonal measures food environment defined for residential neighborhoods, which ignore whether people actually use the food outlets near their residence. To assess whether supermarkets are relevant contexts for interventions, the present study explored between-residential neighborhood and between-supermarket variations in body mass index (BMI) and waist circumference (WC), and investigated associations between brands and characteristics of supermarkets and BMI or WC, after adjustment for individual and residential neighborhood characteristics. Methods: Participants in the RECORD Cohort Study (Paris Region, France, 2007-2008) were surveyed on the supermarket (brand and exact location) where they conducted their food shopping. Overall, 7 131 participants shopped in 1 097 different supermarkets. Cross-classified multilevel linear models were estimated for BMI and WC. Results: Just 11.4% of participants shopped for food primarily within their residential neighborhood. After accounting for participants' residential neighborhood, people shopping in the same supermarket had a more comparable BMI and WC than participants shopping in different supermarkets. After adjustment for individual and residential neighborhood characteristics, participants shopping in specific supermarket brands, in hard discount supermarkets (especially if they had a low education), and in supermarkets whose catchment area comprised low educated residents had a higher BMI/WC. Conclusion: A public health strategy to reduce excess weight may be to intervene on specific supermarkets to change food purchasing behavior, as supermarkets are where dietary preferences are materialized into definite purchased foods.	[Chaix, Basile; Leal, Cinira; Karusisi, Noella] Univ Paris 06, UMR S 707, Paris, France; [Chaix, Basile; Leal, Cinira; Karusisi, Noella] INSERM, U707, Paris, France; [Bean, Kathy; Thomas, Frederique; Pannier, Bruno] Ctr Invest Prevent & Clin, Paris, France; [Daniel, Mark] Univ S Australia, Sansom Inst Hlth Res, Social Epidemiol & Evaluat Res Unit, Adelaide, SA 5001, Australia; [Daniel, Mark] Univ Melbourne, St Vincents Hosp, Dept Med, Fitzroy, Vic 3065, Australia; [Zenk, Shannon N.] Univ Illinois, Dept Hlth Syst Sci, Chicago, IL USA; [Kestens, Yan] Univ Montreal, Social & Prevent Med Dept, Montreal, PQ, Canada; [Charreire, Helene] Univ Paris Est, LabUrba Inst Urbanisme Paris, Creteil, France; [Leal, Cinira] EHESP Sch Publ Hlth, Rennes, France; [Weber, Christiane] Strasbourg Univ, CNRS Image ERL7230, Strasbourg, France; [Oppert, Jean-Michel] Univ Paris 13, CNAM, Inserm U557, EA3200,Inra U1125, Bobigny, France; [Oppert, Jean-Michel] Univ Paris 06, Dept Nutr, CNRH IdF, Pitie Salpetriere Hosp,AP HP, Paris, France; [Simon, Chantal] Lyon Univ, Inra U1235, Inserm U870, CRNH Rhone Alpes, Pierre Benite, France; [Merlo, Juan] Lund Univ, Clin Res Ctr, Fac Med, Unit Social Epidemiol, Malmo, Sweden	UDICE-French Research Universities; Sorbonne Universite; Institut National de la Sante et de la Recherche Medicale (Inserm); University of South Australia; St Vincent's Hospital Melbourne; University of Melbourne; University of Illinois System; University of Illinois Chicago; University of Illinois Chicago Hospital; Universite de Montreal; Universite Paris-Est-Creteil-Val-de-Marne (UPEC); UDICE-French Research Universities; Universites de Strasbourg Etablissements Associes; Universite de Strasbourg; heSam Universite; Conservatoire National Arts & Metiers (CNAM); INRAE; Institut National de la Sante et de la Recherche Medicale (Inserm); Universite Paris 13; Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Pitie-Salpetriere - APHP; UDICE-French Research Universities; Sorbonne Universite; INRAE; Institut National de la Sante et de la Recherche Medicale (Inserm); Lund University	Chaix, B (corresponding author), Univ Paris 06, UMR S 707, Paris, France.	chaix@u707.jussieu.fr	Merlo, Juan/E-2136-2011; Kestens, Yan/D-1631-2012; Chaix, Basile/B-8625-2014; , simon/B-2895-2011; Oppert, Jean-Michel/F-2810-2017; Charreire, Helene/F-3037-2017; Zennk, Shannon/D-4096-2018; Daniel, Mark/A-1151-2009	Merlo, Juan/0000-0001-8379-9708; Kestens, Yan/0000-0003-2619-5750; , simon/0000-0002-7820-3233; Charreire, Helene/0000-0002-1260-9812; Zennk, Shannon/0000-0003-2409-7022; Daniel, Mark/0000-0001-9112-134X	Institute for Public Health Research (Institut de Recherche en Sante Publique); National Institute for Prevention and Health Education (Institut National de Prevention et d'Education pour la Sante) [074/07-DAS]; National Institute of Public Health Surveillance (Institut de Veille Sanitaire); French Ministries of Research and Health (Epidemiologic Cohorts); National Health Insurance Office for Salaried Workers (Caisse Nationale d'Assurance Maladie des Travailleurs Salaries); National Research Agency (Agence Nationale de la Recherche) [00153 05]; Ile-de-France Regional Health Agency (Agence Regionale de Sante d'Ile-de-France); City of Paris (Ville de Paris); Ile-de-France Regional Council (Conseil Regional d'Ile-de-France, DIM SEnT and CODDIM); Ile-de-France Youth, Sports, and Social Cohesion Regional Direction (Direction Regionale de la Jeunesse et des Sports et de la Cohesion Sociale); Swedish Research Council; Canadian Institutes for Health Research	Institute for Public Health Research (Institut de Recherche en Sante Publique); National Institute for Prevention and Health Education (Institut National de Prevention et d'Education pour la Sante); National Institute of Public Health Surveillance (Institut de Veille Sanitaire); French Ministries of Research and Health (Epidemiologic Cohorts); National Health Insurance Office for Salaried Workers (Caisse Nationale d'Assurance Maladie des Travailleurs Salaries); National Research Agency (Agence Nationale de la Recherche)(French National Research Agency (ANR)); Ile-de-France Regional Health Agency (Agence Regionale de Sante d'Ile-de-France)(Region Ile-de-France); City of Paris (Ville de Paris)(Region Ile-de-France); Ile-de-France Regional Council (Conseil Regional d'Ile-de-France, DIM SEnT and CODDIM)(Region Ile-de-France); Ile-de-France Youth, Sports, and Social Cohesion Regional Direction (Direction Regionale de la Jeunesse et des Sports et de la Cohesion Sociale)(Region Ile-de-France); Swedish Research Council(Swedish Research CouncilEuropean Commission); Canadian Institutes for Health Research(Canadian Institutes of Health Research (CIHR))	This work, as part of the RECORD project, was supported by the Institute for Public Health Research (Institut de Recherche en Sante Publique); the National Institute for Prevention and Health Education (Institut National de Prevention et d'Education pour la Sante) (Prevention Program 2007 074/07-DAS; 2010-2011 financial support; and 2011-2013 financial support); the National Institute of Public Health Surveillance (Institut de Veille Sanitaire) (Territory and Health Program); the French Ministries of Research and Health (Epidemiologic Cohorts Grant 2008); the National Health Insurance Office for Salaried Workers (Caisse Nationale d'Assurance Maladie des Travailleurs Salaries); the National Research Agency (Agence Nationale de la Recherche) (Health-Environment Program 2005 #00153 05); the Ile-de-France Regional Health Agency (Agence Regionale de Sante d'Ile-de-France); the City of Paris (Ville de Paris); the Ile-de-France Regional Council (Conseil Regional d'Ile-de-France, DIM SEnT and CODDIM); and the Ile-de-France Youth, Sports, and Social Cohesion Regional Direction (Direction Regionale de la Jeunesse et des Sports et de la Cohesion Sociale). The project was also supported by the Swedish Research Council (to JM), by the Canadian Institutes for Health Research (to YK), and by ANR-PNRA (to JMO). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	[Anonymous], 2009, PRODUITS BAS PRIX QU, P470; Beckman A, 2006, BMC PUBLIC HEALTH, V6, DOI 10.1186/1471-2458-6-71; Benetos A, 2008, AM J CARDIOL, V102, P188, DOI 10.1016/j.amjcard.2008.03.037; Chaix B, 2008, J EPIDEMIOL COMMUN H, V62, P62, DOI 10.1136/jech.2006.056960; Chaix B, 2005, J EPIDEMIOL COMMUN H, V59, P517, DOI 10.1136/jech.2004.025478; Chaix B, 2005, AM J EPIDEMIOL, V162, P171, DOI 10.1093/aje/kwi175; Chaix B, 2012, INT J EPIDEMIOL, V41, P1283, DOI 10.1093/ije/dyr107; Chaix B, 2011, EPIDEMIOLOGY, V22, P18, DOI 10.1097/EDE.0b013e3181fd2961; Chaix B, 2010, HYPERTENSION, V55, P769, DOI 10.1161/HYPERTENSIONAHA.109.143206; Chaix B, 2010, EPIDEMIOLOGY, V21, P124, DOI 10.1097/EDE.0b013e3181c04e70; Chaix B, 2009, ANNU REV PUBL HEALTH, V30, P81, DOI 10.1146/annurev.publhealth.031308.100158; CNA, 2010, 67 CNA AV; Darmon N, 2009, PUBLIC HEALTH NUTR, V12, P808, DOI 10.1017/S1368980008003157; Drewnowski A, 2007, J AM DIET ASSOC, V107, P1028, DOI 10.1016/j.jada.2007.03.013; Farley TA, 2009, J URBAN HEALTH, V86, P672, DOI 10.1007/s11524-009-9390-3; Franco M, 2008, AM J PREV MED, V35, P561, DOI 10.1016/j.amepre.2008.07.003; Gittelsohn J, 2010, HEALTH EDUC BEHAV, V37, P390, DOI 10.1177/1090198109343886; Glanz K, 2005, AM J HEALTH PROMOT, V19, P330, DOI 10.4278/0890-1171-19.5.330; Glanz K, 2007, AM J PREV MED, V32, P282, DOI 10.1016/j.amepre.2006.12.019; Glanz K, 2009, AM J PREV MED, V36, pS93, DOI 10.1016/j.amepre.2009.01.010; Havard S, 2011, OCCUP ENVIRON MED, V68, P366, DOI 10.1136/oem.2010.060640; Inagami S, 2006, AM J PREV MED, V31, P10, DOI 10.1016/j.amepre.2006.03.019; Jeffery RW, 2006, INT J BEHAV NUTR PHY, V3, DOI 10.1186/1479-5868-3-2; Leal C, 2011, OBES REV, V12, P217, DOI 10.1111/j.1467-789X.2010.00726.x; Leal C, 2011, EPIDEMIOLOGY, V22, P694, DOI 10.1097/EDE.0b013e3182257784; Li F, 2009, AM J EPIDEMIOL, V169, P401, DOI 10.1093/aje/kwn398; Lytle LA, 2009, AM J PREV MED, V36, pS134, DOI 10.1016/j.amepre.2009.01.018; McKinnon RA, 2009, AM J PREV MED, V36, pS124, DOI 10.1016/j.amepre.2009.01.012; Mehta NK, 2008, AM J PREV MED, V34, P127, DOI 10.1016/j.amepre.2007.09.031; Michels S, 1995, LETT IFN, V35, P1; Morland K, 2006, AM J PREV MED, V30, P333, DOI 10.1016/j.amepre.2005.11.003; Mujahid MS, 2007, AM J EPIDEMIOL, V165, P858, DOI 10.1093/aje/kwm040; Muntaner C, 2006, HEALTH PLACE, V12, P688, DOI 10.1016/j.healthplace.2005.09.004; Oqali, 2010, RAPP ACT 2009; Powell LM, 2007, AM J PREV MED, V33, pS301, DOI 10.1016/j.amepre.2007.07.007; Rosmond R, 1996, INT J OBESITY, V20, P599; Roux AVD, 2003, J URBAN HEALTH, V80, P569, DOI 10.1093/jurban/jtg065; Thomas F, 2005, HYPERTENSION, V46, P654, DOI 10.1161/01.HYP.0000184282.51550.00; United Nations Development Programme, 2008, HUM DEV REP 2007 200; Wang MC, 2007, J EPIDEMIOL COMMUN H, V61, P491, DOI 10.1136/jech.2006.051680; Zenk SN, 2005, AM J PREV MED, V29, P1, DOI 10.1016/j.amepre.2005.03.002	41	63	63	1	18	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 4	2012	7	4							e32908	10.1371/journal.pone.0032908	http://dx.doi.org/10.1371/journal.pone.0032908			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	953GO	22496738	Green Accepted, Green Published, gold			2022-12-25	WOS:000304855200007
J	Chevalier, N; Vega, A; Bouskine, A; Siddeek, B; Michiels, JF; Chevallier, D; Fenichel, P				Chevalier, Nicolas; Vega, Aurelie; Bouskine, Adil; Siddeek, Benazir; Michiels, Jean-Francois; Chevallier, Daniel; Fenichel, Patrick			GPR30, the Non-Classical Membrane G Protein Related Estrogen Receptor, Is Overexpressed in Human Seminoma and Promotes Seminoma Cell Proliferation	PLOS ONE			English	Article							BREAST-CANCER CELLS; COUPLED RECEPTOR; OVARIAN-CANCER; ER-BETA; EXPRESSION; 17-BETA-ESTRADIOL; LINE; GPER; IDENTIFICATION; CONNEXIN-43	Background: Testicular germ cell tumours are the most frequent cancer of young men with an increasing incidence all over the world. Pathogenesis and reasons of this increase remain unknown but epidemiological and clinical data have suggested that fetal exposure to environmental endocrine disruptors (EEDs) with estrogenic effects, could participate to testicular germ cell carcinogenesis. However, these EEDs (like bisphenol A) are often weak ligands for classical nuclear estrogen receptors. Several research groups recently showed that the non classical membrane G-protein coupled estrogen receptor (GPER/GPR30) mediates the effects of estrogens and several xenoestrogens through rapid non genomic activation of signal transduction pathways in various human estrogen dependent cancer cells (breast, ovary, endometrium). The aim of this study was to demonstrate that GPER was overexpressed in testicular tumours and was able to trigger JKT-1 seminoma cell proliferation. Results: We report here for the first time a complete morphological and functional characterization of GPER in normal and malignant human testicular germ cells. In normal adult human testes, GPER was expressed by somatic (Sertoli cells) and germ cells (spermatogonia and spermatocytes). GPER was exclusively overexpressed in seminomas, the most frequent testicular germ cell cancer, localized at the cell membrane and triggered a proliferative effect on JKT-1 cells in vitro, which was completely abolished by G15 (a GPER selective antagonist) and by siRNA invalidation. Conclusion: These results demonstrate that GPER is expressed by human normal adult testicular germ cells, specifically overexpressed in seminoma tumours and able to trigger seminoma cell proliferation in vitro. It should therefore be considered rather than classical ERs when xeno-estrogens or other endocrine disruptors are assessed in testicular germ cell cancers. It may also represent a prognosis marker and/or a therapeutic target for seminomas.	[Chevalier, Nicolas; Vega, Aurelie; Bouskine, Adil; Siddeek, Benazir; Fenichel, Patrick] Ctr Mediterrane Med Mol C3M, UNS, INSERM,UMR 1065, Equipe Environm Reprod & Canc Hormonodependants 5, Nice, France; [Chevalier, Nicolas; Vega, Aurelie; Bouskine, Adil; Siddeek, Benazir; Fenichel, Patrick] Univ Nice Sophia Antipolis, Fac Med, Inst Signalisat & Pathol IFR 50, Nice, France; [Chevalier, Nicolas; Vega, Aurelie; Bouskine, Adil; Siddeek, Benazir; Fenichel, Patrick] Ctr Hosp Univ Nice, Hop Archet, Serv Endocrinol Diabet & Med Reprod, Nice, France; [Michiels, Jean-Francois] Ctr Hosp Univ Nice, Hop Pasteur, Lab Anat & Cytol Pathol, Nice, France; [Chevallier, Daniel] Ctr Hosp Univ Nice, Hop Pasteur, Serv Urol, Nice, France	Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Universite Cote d'Azur; UDICE-French Research Universities; Universite Cote d'Azur; CHU Nice; CHU Nice; CHU Nice	Chevalier, N (corresponding author), Ctr Mediterrane Med Mol C3M, UNS, INSERM,UMR 1065, Equipe Environm Reprod & Canc Hormonodependants 5, Nice, France.	fenichel.p@chu-nice.fr	VEGA, Aurelie/X-9434-2019	VEGA, Aurelie/0000-0002-9693-2173; , benazir/0000-0003-2764-6656; CHEVALIER, Nicolas/0000-0001-7160-4301; Patrick, FENICHEL/0000-0003-0509-175X				Albanito L, 2008, ENDOCRINOLOGY, V149, P3799, DOI 10.1210/en.2008-0117; Albanito L, 2007, CANCER RES, V67, P1859, DOI 10.1158/0008-5472.CAN-06-2909; Bourdon V, 1998, BIOL REPROD, V58, P591, DOI 10.1095/biolreprod58.2.591; Bouskine A, 2008, ENDOCRINOLOGY, V149, P565, DOI 10.1210/en.2007-1318; Bouskine A, 2010, INT J ANDROL, V33, P54, DOI 10.1111/j.1365-2605.2009.00950.x; Bouskine A, 2009, ENVIRON HEALTH PERSP, V117, P1053, DOI 10.1289/ehp.0800367; Carreau S, 2002, MOL CELL ENDOCRINOL, V193, P137, DOI 10.1016/S0303-7207(02)00107-7; Chang EC, 2006, ENDOCRINOLOGY, V147, P4831, DOI 10.1210/en.2006-0563; Cheng SB, 2011, STEROIDS, V76, P892, DOI 10.1016/j.steroids.2011.02.018; Chevalier N, 2012, INT J CANCER, V130, P241, DOI 10.1002/ijc.25972; Chimento A, 2010, MOL CELL ENDOCRINOL, V320, P136, DOI 10.1016/j.mce.2010.01.035; Dennis MK, 2009, NAT CHEM BIOL, V5, P421, DOI 10.1038/nchembio.168; Esteller M, 2008, NEW ENGL J MED, V358, P1148, DOI 10.1056/NEJMra072067; Esteller M, 2007, NAT REV GENET, V8, P286, DOI 10.1038/nrg2005; Filardo EJ, 2006, CLIN CANCER RES, V12, P6359, DOI 10.1158/1078-0432.CCR-06-0860; Filardo EJ, 2002, J STEROID BIOCHEM, V80, P231, DOI 10.1016/S0960-0760(01)00190-X; Filardo EJ, 2002, MOL ENDOCRINOL, V16, P70, DOI 10.1210/me.16.1.70; Franco R, 2011, CANCER BIOL THER, V11, P609, DOI 10.4161/cbt.11.6.14672; Giess M, 2010, J STEROID BIOCHEM, V118, P7, DOI 10.1016/j.jsbmb.2009.09.001; Hardell L, 2006, INT J ANDROL, V29, P228, DOI 10.1111/j.1365-2605.2005.00622.x; Iacobuzio-Donahue CA, 2009, ANNU REV PATHOL-MECH, V4, P229, DOI 10.1146/annurev.pathol.3.121806.151442; Jones MEE, 2000, BEST PRACT RES CL EN, V14, P505, DOI 10.1053/beem.2000.0094; Kang LG, 2010, MOL ENDOCRINOL, V24, P709, DOI 10.1210/me.2009-0317; Kinugawa K, 1998, Int J Urol, V5, P282, DOI 10.1111/j.1442-2042.1998.tb00604.x; Konstantinopoulos PA, 2003, EUR J CANCER, V39, P1251, DOI 10.1016/S0959-8049(03)00239-9; Lablack A, 1998, CELL TISSUE RES, V294, P279, DOI 10.1007/s004410051178; Langer G, 2010, STEROIDS, V75, P603, DOI 10.1016/j.steroids.2009.12.006; Lazennec G, 2001, ENDOCRINOLOGY, V142, P4120, DOI 10.1210/en.142.9.4120; Liu XC, 2009, BIOL REPROD, V80, P1253, DOI 10.1095/biolreprod.108.070250; Loomis AK, 2000, BIOL REPROD, V62, P995, DOI 10.1095/biolreprod62.4.995; Lucas TFG, 2010, BIOL REPROD, V83, P307, DOI 10.1095/biolreprod.110.084160; Maggiolini M, 2010, J ENDOCRINOL, V204, P105, DOI 10.1677/JOE-09-0242; Prossnitz ER, 2008, ANNU REV PHYSIOL, V70, P165, DOI 10.1146/annurev.physiol.70.113006.100518; Rago V, 2011, REPROD BIOL ENDOCRIN, V9, DOI 10.1186/1477-7827-9-135; Revankar CM, 2005, SCIENCE, V307, P1625, DOI 10.1126/science.1106943; Roger C, 2005, J MOL ENDOCRINOL, V35, P191, DOI 10.1677/jme.1.01704; Roger C, 2004, J PATHOL, V202, P241, DOI 10.1002/path.1509; Sirianni R, 2008, ENDOCRINOLOGY, V149, P5043, DOI 10.1210/en.2007-1593; Skakkebaek NE, 1998, APMIS, V106, P3, DOI 10.1111/j.1699-0463.1998.tb01314.x; Smith HO, 2009, GYNECOL ONCOL, V114, P465, DOI 10.1016/j.ygyno.2009.05.015; Teng J, 2008, ENDOCRINOLOGY, V149, P4024, DOI 10.1210/en.2007-1669; Thomas P, 2006, STEROIDS, V71, P310, DOI 10.1016/j.steroids.2005.09.015; Thomas P, 2005, ENDOCRINOLOGY, V146, P624, DOI 10.1210/en.2004-1064; Thomas P, 2010, STEROIDS, V75, P595, DOI 10.1016/j.steroids.2009.11.005; Thomas P, 2006, J STEROID BIOCHEM, V102, P175, DOI 10.1016/j.jsbmb.2006.09.017; Vivacqua A, 2006, MOL ENDOCRINOL, V20, P631, DOI 10.1210/me.2005-0280; Zhao Chunyan, 2008, Nucl Recept Signal, V6, pe003, DOI 10.1621/nrs.06003	47	75	79	0	21	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 4	2012	7	4							e34672	10.1371/journal.pone.0034672	http://dx.doi.org/10.1371/journal.pone.0034672			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	953GO	22496838	Green Published, gold, Green Submitted			2022-12-25	WOS:000304855200067
J	De Marco, D; Clementi, N; Mancini, N; Solforosi, L; Moreno, GJ; Sun, XJ; Tumpey, TM; Gubareva, LV; Mishin, V; Clementi, M; Burioni, R				De Marco, Donata; Clementi, Nicola; Mancini, Nicasio; Solforosi, Laura; Moreno, Guisella J.; Sun, Xiangjie; Tumpey, Terrence M.; Gubareva, Larisa V.; Mishin, Vasiliy; Clementi, Massimo; Burioni, Roberto			A Non-VH1-69 Heterosubtypic Neutralizing Human Monoclonal Antibody Protects Mice against H1N1 and H5N1 Viruses	PLOS ONE			English	Article							INFLUENZA-A; OSELTAMIVIR; HEMAGGLUTININ; RESISTANCE; EPITOPE; IDENTIFICATION; IMMUNIZATION; STRAIN	Influenza viruses are among the most important human pathogens and are responsible for annual epidemics and sporadic, potentially devastating pandemics. The humoral immune response plays an important role in the defense against these viruses, providing protection mainly by producing antibodies directed against the hemagglutinin (HA) glycoprotein. However, their high genetic variability allows the virus to evade the host immune response and the potential protection offered by seasonal vaccines. The emergence of resistance to antiviral drugs in recent years further limits the options available for the control of influenza. The development of alternative strategies for influenza prophylaxis and therapy is therefore urgently needed. In this study, we describe a human monoclonal antibody (PN-SIA49) that recognizes a highly conserved epitope located on the stem region of the HA and able to neutralize a broad spectrum of influenza viruses belonging to different subtypes (H1, H2 and H5). Furthermore, we describe its protective activity in mice after lethal challenge with H1N1 and H5N1 viruses suggesting a potential application in the treatment of influenza virus infections.	[De Marco, Donata; Clementi, Nicola; Mancini, Nicasio; Solforosi, Laura; Moreno, Guisella J.; Clementi, Massimo; Burioni, Roberto] Univ Vita Salute San Raffaele, Lab Microbiol & Virol, Milan, Italy; [Sun, Xiangjie; Tumpey, Terrence M.; Gubareva, Larisa V.; Mishin, Vasiliy] Ctr Dis Control & Prevent, Influenza Div, Natl Ctr Immunizat & Resp Dis, Atlanta, GA USA	Vita-Salute San Raffaele University; Centers for Disease Control & Prevention - USA	De Marco, D (corresponding author), Univ Vita Salute San Raffaele, Lab Microbiol & Virol, Milan, Italy.	burioni.roberto@hsr.it	Burioni, Roberto/F-2396-2012; Clementi, Nicola/G-8545-2014; Clementi, Massimo/F-6646-2013; Sun, Xiangjie/AAP-5409-2020; Mancini, Nicasio/AAN-6203-2020	Clementi, Nicola/0000-0002-1822-9861; Clementi, Massimo/0000-0002-7461-5898; MANCINI, Nicasio/0000-0003-0637-0910	UNIFLUVAC [10DF]	UNIFLUVAC	This study was supported by the Italian Minister of Health Universal Influenza Vaccine, UNIFLUVAC, grant n. 10DF. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Smith Nicole M., 2006, Morbidity and Mortality Weekly Report, V55, P1; Bright RA, 2006, JAMA-J AM MED ASSOC, V295, P891, DOI 10.1001/jama.295.8.joc60020; Burioni R, 2010, VIROLOGY, V399, P144, DOI 10.1016/j.virol.2009.12.014; Burioni R, 2009, NEW MICROBIOL, V32, P319; Burioni R, 2009, LANCET, V374, P1417, DOI 10.1016/S0140-6736(09)61853-5; Cheng PKC, 2009, EMERG INFECT DIS, V15, P966, DOI 10.3201/eid1506.081357; Clementi N, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0028001; Collins PJ, 2008, NATURE, V453, P1258, DOI 10.1038/nature06956; Corti D, 2010, J CLIN INVEST, V120, P1663, DOI 10.1172/JCI41902; CUNNINGHAM BC, 1989, SCIENCE, V244, P1081, DOI 10.1126/science.2471267; de Jong MD, 2005, NEW ENGL J MED, V353, P2667, DOI 10.1056/NEJMoa054512; Ekiert DC, 2011, SCIENCE, V333, P843, DOI 10.1126/science.1204839; Enserink M, 2009, SCIENCE, V323, P1162, DOI 10.1126/science.323.5918.1162; Ramirez-Gonzalez JE, 2011, EMERG INFECT DIS, V17, P283, DOI 10.3201/eid1702.100897; Fraser C, 2009, SCIENCE, V324, P1557, DOI 10.1126/science.1176062; Friesen RHE, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0009106; Hanson BJ, 2006, RESP RES, V7, DOI 10.1186/1465-9921-7-126; He GM, 2008, ANTIVIR RES, V77, P72, DOI 10.1016/j.antiviral.2007.08.007; Kashyap AK, 2010, PLOS PATHOG, V6, DOI 10.1371/journal.ppat.1000990; KRYSTAL M, 1982, P NATL ACAD SCI-BIOL, V79, P4800, DOI 10.1073/pnas.79.15.4800; LAMARRE A, 1995, J IMMUNOL, V154, P3975; MA JKC, 1990, INFECT IMMUN, V58, P3407, DOI 10.1128/IAI.58.10.3407-3414.1990; Matthews BW, 1996, FASEB J, V10, P35, DOI 10.1096/fasebj.10.1.8566545; Monto AS, 2009, VACCINE, V27, P5043, DOI 10.1016/j.vaccine.2009.06.032; Moscona A, 2008, ANNU REV MED, V59, P397, DOI 10.1146/annurev.med.59.061506.213121; Moscona A, 2009, NEW ENGL J MED, V360, P953, DOI 10.1056/NEJMp0900648; Murphy Trudy V., 2008, Morbidity and Mortality Weekly Report, V57, P1; OKUNO Y, 1993, J VIROL, V67, P2552, DOI 10.1128/JVI.67.5.2552-2558.1993; Palese P, 2004, NAT MED, V10, pS82, DOI 10.1038/nm1141; Perotti M, 2008, J VIROL, V82, P1047, DOI 10.1128/JVI.01986-07; Sui JH, 2009, NAT STRUCT MOL BIOL, V16, P265, DOI 10.1038/nsmb.1566; Thompson WW, 2004, JAMA-J AM MED ASSOC, V292, P1333, DOI 10.1001/jama.292.11.1333; Throsby M, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0003942; Trifonov V, 2009, NEW ENGL J MED, V361, P115, DOI 10.1056/NEJMp0904572; Webster RG, 1999, P NATL ACAD SCI USA, V96, P1164, DOI 10.1073/pnas.96.4.1164; Weiss GA, 2000, P NATL ACAD SCI USA, V97, P8950, DOI 10.1073/pnas.160252097; WHO, 2002, GLOB SOL UV IND PRAC; YODEN S, 1985, ARCH VIROL, V85, P209, DOI 10.1007/BF01314232; Zhang MY, 2004, J VIROL, V78, P9233, DOI 10.1128/JVI.78.17.9233-9242.2004	39	46	49	0	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 4	2012	7	4							e34415	10.1371/journal.pone.0034415	http://dx.doi.org/10.1371/journal.pone.0034415			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	953GO	22496802	Green Published, gold, Green Submitted			2022-12-25	WOS:000304855200049
J	Han, Y; Hou, GY; Jiang, WM; Han, CH; Liu, S; Chen, J; Li, JP; Zhang, P; Huang, BX; Liu, YH; Chen, JM				Han, Yan; Hou, Guangyu; Jiang, Wenming; Han, Chunhua; Liu, Shuo; Chen, Jie; Li, Jinping; Zhang, Peng; Huang, Baoxu; Liu, Yuehuan; Chen, Jiming			A Survey of Avian Influenza in Tree Sparrows in China in 2011	PLOS ONE			English	Article							WILD BIRDS; VIRUS SURVEILLANCE; PASSER-DOMESTICUS; EUROPEAN-UNION; H5N1; EPIDEMIOLOGY; GENERATION; POULTRY	Tree sparrows (Passer montanus) are widely distributed in all seasons in many countries. In this study, a survey and relevant experiments on avian influenza (AI) in tree sparrows were conducted. The results suggested that the receptor for avian influenza viruses (AIVs), SA alpha 2,3Gal,is abundant in the respiratory tract of tree sparrows, and most of the tree sparrows infected experimentally with two H5 subtype highly pathogenic avian influenza ( HPAI) viruses died within five days after inoculation. Furthermore, no AIVs were isolated from the rectum eluate of 1300 tree sparrows, but 94 serological positives of AI were found in 800 tree sparrows. The serological positives were more prevalent for H5 subtype HPAI (94/800) than for H7 subtype AI (0/800), more prevalent for clade 2.3.2.1 H5 subtype HPAI (89/800) than for clade 2.3.4 (1/800) and clade 7.2 (4/800) H5 subtype HPAI, more prevalent for clade 2.3.2.1 H5 subtype HPAI in a city in southern China (82/800) than in a city in northern China (8/800). The serological data are all consistent with the distribution of the subtypes or clades of AI in poultry in China. Previously, sparrows or other passerine birds were often found to be pathogenically negative for AIVs, except when an AIV was circulating in the local poultry, or the tested passerine birds were from a region near waterfowl-rich bodies of water. Taken together, the data suggest that tree sparrows are susceptible to infection of AIVs, and surveys targeting sparrows can provide good serological data about the circulation of AIVs in relevant regions.	[Han, Yan; Hou, Guangyu; Jiang, Wenming; Liu, Shuo; Chen, Jie; Li, Jinping; Zhang, Peng; Huang, Baoxu; Chen, Jiming] China Anim Hlth & Epidemiol Ctr, Qingdao, Peoples R China; [Han, Yan; Zhang, Peng] Qingdao Agr Univ, Coll Anim Sci & Vet Med, Qingdao, Peoples R China; [Han, Chunhua; Liu, Yuehuan] Beijing Acad Agr & Forestry Sci, Inst Anim & Husb Med, Beijing, Peoples R China	China Animal Health & Epidemiology Center; Qingdao Agricultural University; Beijing Academy of Agriculture & Forestry	Han, Y (corresponding author), China Anim Hlth & Epidemiol Ctr, Qingdao, Peoples R China.	jmchen66@yahoo.cn	Chen, Ji-Ming/AHD-7398-2022; Chen, Jiming/AAA-3575-2020	Chen, Jiming/0000-0003-3155-3145; Chen, Jiming/0000-0002-0404-0830	Ministry of Agriculture of People's Republic of China	Ministry of Agriculture of People's Republic of China	This work was supported by the Avian Influenza Surveillance Program of the Ministry of Agriculture of People's Republic of China. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alexander DJ, 2007, AVIAN DIS, V51, P161, DOI 10.1637/7602-041306R.1; Barbour Elie K, 2007, Vet Ital, V43, P33; Boon ACM, 2007, EMERG INFECT DIS, V13, P1720, DOI 10.3201/eid1311.070114; Boyce WM, 2009, COMP IMMUNOL MICROB, V32, P275, DOI 10.1016/j.cimid.2008.01.002; Breed AC, 2010, AVIAN DIS, V54, P399, DOI 10.1637/8950-053109-Reg.1; Brown JD, 2009, J VET DIAGN INVEST, V21, P437, DOI 10.1177/104063870902100404; Capua I, 2000, VET REC, V147, P640; Chen JM, 2007, AM J INFECT CONTROL, V35, P351, DOI 10.1016/j.ajic.2006.07.016; Dalessi S, 2007, AVIAN DIS, V51, P355, DOI 10.1637/7580-040106R.1; De Marco MA, 2003, VET RES COMMUN, V27, P107, DOI 10.1023/B:VERC.0000014126.72654.22; Forrest HL, 2010, J VIROL, V84, P3718, DOI 10.1128/JVI.02017-09; Fouchier RAM, 2009, REV SCI TECH OIE, V28, P49, DOI 10.20506/rst.28.1.1863; Fouchier RAM, 2003, AVIAN DIS, V47, P857, DOI 10.1637/0005-2086-47.s3.857; Gutierrez RA, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0028609; Hesterberg U, 2009, INFLUENZA OTHER RESP, V3, P1, DOI 10.1111/j.1750-2659.2008.00058.x; Hoffmann E, 2001, ARCH VIROL, V146, P2275, DOI 10.1007/s007050170002; Hoffmann E, 2002, VACCINE, V20, P3165, DOI 10.1016/S0264-410X(02)00268-2; Hoye BJ, 2010, EMERG INFECT DIS, V16, P1827, DOI 10.3201/eid1612.100589; Ito T, 1998, J VIROL, V72, P7367, DOI 10.1128/JVI.72.9.7367-7373.1998; Jiang WM, 2010, J GEN VIROL, V91, P2491, DOI 10.1099/vir.0.023168-0; Kang HM, 2010, J WILDLIFE DIS, V46, P878, DOI 10.7589/0090-3558-46.3.878; Kou Z, 2005, J VIROL, V79, P15460, DOI 10.1128/JVI.79.24.15460-15466.2005; Kou Z, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0006926; Krauss S, 2010, AVIAN DIS, V54, P394, DOI 10.1637/8703-031609-Review.1; Li YB, 2006, VIRUS GENES, V33, P117, DOI 10.1007/s11262-005-0042-8; Liu QF, 2010, VIRUS RES, V147, P25, DOI 10.1016/j.virusres.2009.09.014; Liu S, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0005022; Liu YH, 2009, AVIAN PATHOL, V38, P263, DOI 10.1080/03079450903055363; Lvov DK, 2010, AVIAN DIS, V54, P483, DOI 10.1637/8893-042509-Review.1; Martin V, 2011, PLOS PATHOG, V7, DOI 10.1371/journal.ppat.1001308; Morishita TY, 1999, AVIAN DIS, V43, P549, DOI 10.2307/1592655; Nemeth NM, 2010, AVIAN PATHOL, V39, P411, DOI 10.1080/03079457.2010.513043; NESTOROWICZ A, 1987, VIROLOGY, V160, P411, DOI 10.1016/0042-6822(87)90012-2; OIE (World Organization for Animal Health), 2011, TERR AN HLTH COD; Perez-Ramirez E, 2010, VET MICROBIOL, V146, P200, DOI 10.1016/j.vetmic.2010.05.008; Peterson AT, 2008, EMERG INFECT DIS, V14, P1644, DOI 10.3201/eid1410.080169; Poetranto ED, 2011, MICROBIOL IMMUNOL, V55, P666, DOI 10.1111/j.1348-0421.2011.00361.x; Samaan G, 2011, PREV VET MED, V100, P71, DOI 10.1016/j.prevetmed.2011.03.003; SIDORENKO EV, 1985, VOP VIRUSOL+, P657; Smith GJD, 2012, INFLUENZA OTHER RESP, V6, P1, DOI 10.1111/j.1750-2659.2011.00298.x; Summers-Smith JD, 2009, HDB BIRDS WORLD, V14, P759	42	11	12	1	25	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 4	2012	7	4							e33092	10.1371/journal.pone.0033092	http://dx.doi.org/10.1371/journal.pone.0033092			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	953GO	22496742	Green Submitted, gold, Green Published			2022-12-25	WOS:000304855200009
J	Kehn-Hall, K; Narayanan, A; Lundberg, L; Sampey, G; Pinkham, C; Guendel, I; Van Duyne, R; Senina, S; Schultz, KL; Stavale, E; Aman, MJ; Bailey, C; Kashanchi, F				Kehn-Hall, Kylene; Narayanan, Aarthi; Lundberg, Lindsay; Sampey, Gavin; Pinkham, Chelsea; Guendel, Irene; Van Duyne, Rachel; Senina, Svetlana; Schultz, Kimberly L.; Stavale, Eric; Aman, M. Javad; Bailey, Charles; Kashanchi, Fatah			Modulation of GSK-3 beta Activity in Venezuelan Equine Encephalitis Virus Infection	PLOS ONE			English	Article							GLYCOGEN-SYNTHASE KINASE-3; SMALL-MOLECULE INHIBITORS; DEPENDENT RNA-POLYMERASE; BLOOD-BRAIN-BARRIER; SIGNALING PATHWAYS; PROTEIN NSP2; MICE; CELLS; REPLICATION; GSK3-BETA	Alphaviruses, including Venezuelan Equine Encephalitis Virus (VEEV), cause disease in both equine and humans that exhibit overt encephalitis in a significant percentage of cases. Features of the host immune response and tissue-specific responses may contribute to fatal outcomes as well as the development of encephalitis. It has previously been shown that VEEV infection of mice induces transcription of pro-inflammatory cytokines genes (e. g., IFN-gamma, IL-6, IL-12, iNOS and TNF-alpha) within 6 h. GSK-3 beta is a host protein that is known to modulate pro-inflammatory gene expression and has been a therapeutic target in neurodegenerative disorders such as Alzheimer's. Hence inhibition of GSK-3 beta in the context of encephalitic viral infections has been useful in a neuroprotective capacity. Small molecule GSK-3 beta inhibitors and GSK-3 beta siRNA experiments indicated that GSK-3 beta was important for VEEV replication. Thirty-eight second generation BIO derivatives were tested and BIOder was found to be the most potent inhibitor, with an IC50 of similar to 0.5 mu M and a CC50 of >100 mu M. BIOder was a more potent inhibitor of GSK-3 beta than BIO, as demonstrated through in vitro kinase assays from uninfected and infected cells. Size exclusion chromatography experiments demonstrated that GSK-3 beta is found in three distinct complexes in VEEV infected cells, whereas GSK-3 beta is only present in one complex in uninfected cells. Cells treated with BIOder demonstrated an increase in the anti-apoptotic gene, survivin, and a decrease in the pro-apoptotic gene, BID, suggesting that modulation of pro-and anti-apoptotic genes contributes to the protective effect of BIOder treatment. Finally, BIOder partially protected mice from VEEV induced mortality. Our studies demonstrate the utility of GSK-3 beta inhibitors for modulating VEEV infection.	[Kehn-Hall, Kylene; Narayanan, Aarthi; Lundberg, Lindsay; Sampey, Gavin; Pinkham, Chelsea; Guendel, Irene; Van Duyne, Rachel; Senina, Svetlana; Bailey, Charles; Kashanchi, Fatah] George Mason Univ, Natl Ctr Biodef & Infect Dis, Manassas, VA USA; [Van Duyne, Rachel] George Washington Univ, Dept Microbiol Immunol & Trop Med, Washington, DC USA; [Schultz, Kimberly L.] Johns Hopkins Bloomberg Sch Publ Hlth, W Harry Feinstone Dept Mol Microbiol & Immunol, Baltimore, MD USA; [Stavale, Eric; Aman, M. Javad] Integrated Biotherapeut Inc, Gaithersburg, MD USA	George Mason University; George Washington University; Johns Hopkins University; Johns Hopkins Bloomberg School of Public Health	Kehn-Hall, K (corresponding author), George Mason Univ, Natl Ctr Biodef & Infect Dis, Manassas, VA USA.	fkashanc@gmu.edu	Van Duyne, Rachel/I-7365-2019; Kehn-Hall, Kylene/I-5752-2013; Van Duyne, Rachel/ABI-2429-2020	Van Duyne, Rachel/0000-0003-2914-6874; Kehn-Hall, Kylene/0000-0001-8036-7213	National Institutes of Health (NIH) [AI0078859, AI0074410, NS070740]; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R21AI074410, R21AI078859] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R21NS070740] Funding Source: NIH RePORTER	National Institutes of Health (NIH)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))	This work was supported by National Institutes of Health (NIH) grants AI0078859, AI0074410 and NS070740 to FK. The content is solely the responsibility of the authors and does not necessarily represent the official views of the NIH. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Agrawal S, 2006, J EXP MED, V203, P1007, DOI 10.1084/jem.20051342; Aguilar PV, 2004, EMERG INFECT DIS, V10, P880, DOI 10.3201/eid1005.030634; Amanchy R, 2007, NAT BIOTECHNOL, V25, P285, DOI 10.1038/nbt0307-285; Atasheva S, 2008, J VIROL, V82, P4028, DOI 10.1128/JVI.02330-07; Atasheva S, 2010, J VIROL, V84, P4158, DOI 10.1128/JVI.02554-09; BERGE TO, 1961, AM J HYG, V73, P209, DOI 10.1093/oxfordjournals.aje.a120178; Beurel E, 2006, PROG NEUROBIOL, V79, P173, DOI 10.1016/j.pneurobio.2006.07.006; Beurel E, 2011, BIOL PSYCHIAT, V69, p34S; BEYAERT R, 1989, P NATL ACAD SCI USA, V86, P9494, DOI 10.1073/pnas.86.23.9494; Charles PC, 2001, VIROLOGY, V284, P190, DOI 10.1006/viro.2001.0878; CHARLES PC, 1995, VIROLOGY, V208, P662, DOI 10.1006/viro.1995.1197; Charvet C, 2011, MOL CELL, V42, P584, DOI 10.1016/j.molcel.2011.03.033; Chin PC, 2005, MOL BRAIN RES, V137, P193, DOI 10.1016/j.molbrainres.2005.03.004; Coghlan MP, 2000, CHEM BIOL, V7, P793, DOI 10.1016/S1074-5521(00)00025-9; Cross DAE, 2001, J NEUROCHEM, V77, P94, DOI 10.1046/j.1471-4159.2001.00251.x; de Cedron MG, 1999, FEBS LETT, V448, P19, DOI 10.1016/S0014-5793(99)00321-X; Ding QQ, 2007, MOL CELL BIOL, V27, P4006, DOI 10.1128/MCB.00620-06; Dolan PJ, 2010, CURR OPIN DRUG DISC, V13, P595; Eugenin EA, 2003, METHODS, V29, P351, DOI 10.1016/S1046-2023(02)00359-6; Frame S, 2001, BIOCHEM J, V359, P1, DOI 10.1042/0264-6021:3590001; Garmashova N, 2007, J VIROL, V81, P13552, DOI 10.1128/JVI.01576-07; Gould TD, 2006, CURR DRUG TARGETS, V7, P1399, DOI 10.2174/1389450110607011399; Griffin D, 1997, IMMUNOL REV, V159, P155, DOI 10.1111/j.1600-065X.1997.tb01013.x; Gubler DJ, 2002, ARCH MED RES, V33, P330, DOI 10.1016/S0188-4409(02)00378-8; Hanger DP, 2009, TRENDS MOL MED, V15, P112, DOI 10.1016/j.molmed.2009.01.003; Hoeflich KP, 2000, NATURE, V406, P86, DOI 10.1038/35017574; Huang WC, 2009, IMMUNOLOGY, V128, pe275, DOI 10.1111/j.1365-2567.2008.02959.x; Jackson AC, 1997, ACTA NEUROPATHOL, V93, P349, DOI 10.1007/s004010050626; JACKSON AC, 1991, VET PATHOL, V28, P410, DOI 10.1177/030098589102800509; Julander JG, 2008, ANTIVIR RES, V78, P230, DOI 10.1016/j.antiviral.2008.01.007; Kehn-Hall K, 2011, VIROLOGY, V415, P56, DOI 10.1016/j.virol.2011.03.025; KINNEY RM, 1993, J VIROL, V67, P1269, DOI 10.1128/JVI.67.3.1269-1277.1993; Konig R, 2010, NATURE, V463, P813, DOI 10.1038/nature08699; Kulasegaran-Shylini R, 2009, VIROLOGY, V387, P211, DOI 10.1016/j.virol.2009.02.027; LEON CA, 1975, INT J EPIDEMIOL, V4, P131, DOI 10.1093/ije/4.2.131; Li MT, 2000, MOL CELL BIOL, V20, P9356, DOI 10.1128/MCB.20.24.9356-9363.2000; Ludwig George V., 2001, American Journal of Tropical Medicine and Hygiene, V64, P49; MacAulay K, 2003, EUR J BIOCHEM, V270, P3829, DOI 10.1046/j.1432-1033.2003.03777.x; Magiatis P, 2010, NEUROTOXICOL TERATOL, V32, P212, DOI 10.1016/j.ntt.2009.12.005; Martin M, 2005, NAT IMMUNOL, V6, P777, DOI 10.1038/ni1221; Maurer MH, 2007, J PROTEOME RES, V6, P1198, DOI 10.1021/pr0605825; Maurer U, 2006, MOL CELL, V21, P749, DOI 10.1016/j.molcel.2006.02.009; Meijer L, 2003, CHEM BIOL, V10, P1255, DOI 10.1016/j.chembiol.2003.11.010; Morel C, 2009, MOL CELL BIOL, V29, P3845, DOI 10.1128/MCB.00279-09; Muehlenbein MP, 2006, VIROL J, V3, DOI 10.1186/1743-422X-3-19; Olival KJ, 2005, J NEUROVIROL, V11, P441, DOI 10.1080/13550280591002450; PARDIGON N, 1993, J VIROL, V67, P5003, DOI 10.1128/JVI.67.8.5003-5011.1993; Ramirez SH, 2010, AM J PATHOL, V176, P881, DOI 10.2353/ajpath.2010.090671; Reichert E, 2009, BIOSECUR BIOTERROR, V7, P413, DOI 10.1089/bsp.2009.0032; RIKKONEN M, 1994, J VIROL, V68, P5804, DOI 10.1128/JVI.68.9.5804-5810.1994; Rosenberg GA, 2002, NEUROSCIENTIST, V8, P586, DOI 10.1177/1073858402238517; Rubach JK, 2009, VIROLOGY, V384, P201, DOI 10.1016/j.virol.2008.10.030; Ryzhikov AB, 1995, ARCH VIROL, V140, P2243, DOI 10.1007/BF01323243; Schafer A, 2011, J VIROL, V85, P10682, DOI 10.1128/JVI.05032-11; Schafer A, 2009, J VIROL, V83, P4275, DOI 10.1128/JVI.02383-08; Schoneboom BA, 2000, J INTERF CYTOK RES, V20, P205, DOI 10.1089/107999000312621; Schoneboom BA, 2000, J NEUROIMMUNOL, V109, P132, DOI 10.1016/S0165-5728(00)00290-3; SHIRAKO Y, 1994, J VIROL, V68, P1874, DOI 10.1128/JVI.68.3.1874-1885.1994; Stamatovic SM, 2005, J CEREBR BLOOD F MET, V25, P593, DOI 10.1038/sj.jcbfm.9600055; Steele KE, 2010, VET PATHOL, V47, P790, DOI 10.1177/0300985810372508; Steele KE, 1998, VET PATHOL, V35, P386, DOI 10.1177/030098589803500508; STRAUSS JH, 1994, MICROBIOL REV, V58, P491, DOI 10.1128/MMBR.58.3.491-562.1994; Sutherland C., 2011, INT J ALZHEIMERS DIS, V2011; Thal MA, 2007, VIROLOGY, V358, P221, DOI 10.1016/j.virol.2006.08.022; Wang HZ, 2011, J IMMUNOL, V186, P5217, DOI 10.4049/jimmunol.1002513; Wang HZ, 2011, CYTOKINE, V53, P130, DOI 10.1016/j.cyto.2010.10.009; Weaver SC, 2004, ANNU REV ENTOMOL, V49, P141, DOI 10.1146/annurev.ento.49.061802.123422; Weaver SC, 1996, LANCET, V348, P436, DOI 10.1016/S0140-6736(96)02275-1; Zacks MA, 2010, VET MICROBIOL, V140, P281, DOI 10.1016/j.vetmic.2009.08.023	69	43	45	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 4	2012	7	4							e34761	10.1371/journal.pone.0034761	http://dx.doi.org/10.1371/journal.pone.0034761			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	953GO	22496857	Green Published, Green Submitted, gold			2022-12-25	WOS:000304855200078
J	Padmanabhan, K; Wang, KY; Samatova, NF				Padmanabhan, Kanchana; Wang, Kuangyu; Samatova, Nagiza F.			Functional Annotation of Hierarchical Modularity	PLOS ONE			English	Article							GENE-EXPRESSION DATA; OXIDATIVE-STRESS; SACCHAROMYCES-CEREVISIAE; PROTEIN COMPLEXES; PLASMA-MEMBRANE; ONTOLOGY TERMS; YEAST RVS161; MODULES; TOOL; INFORMATION	In biological networks of molecular interactions in a cell, network motifs that are biologically relevant are also functionally coherent, or form functional modules. These functionally coherent modules combine in a hierarchical manner into larger, less cohesive subsystems, thus revealing one of the essential design principles of system-level cellular organization and function-hierarchical modularity. Arguably, hierarchical modularity has not been explicitly taken into consideration by most, if not all, functional annotation systems. As a result, the existing methods would often fail to assign a statistically significant functional coherence score to biologically relevant molecular machines. We developed a methodology for hierarchical functional annotation. Given the hierarchical taxonomy of functional concepts (e.g., Gene Ontology) and the association of individual genes or proteins with these concepts (e. g., GO terms), our method will assign a Hierarchical Modularity Score (HMS) to each node in the hierarchy of functional modules; the HMS score and its p-value measure functional coherence of each module in the hierarchy. While existing methods annotate each module with a set of "enriched'' functional terms in a bag of genes, our complementary method provides the hierarchical functional annotation of the modules and their hierarchically organized components. A hierarchical organization of functional modules often comes as a bi-product of cluster analysis of gene expression data or protein interaction data. Otherwise, our method will automatically build such a hierarchy by directly incorporating the functional taxonomy information into the hierarchy search process and by allowing multi-functional genes to be part of more than one component in the hierarchy. In addition, its underlying HMS scoring metric ensures that functional specificity of the terms across different levels of the hierarchical taxonomy is properly treated. We have evaluated our method using Saccharomyces cerevisiae data from KEGG and MIPS databases and several other computationally derived and curated datasets. The code and additional supplemental files can be obtained from http://code.google.com/p/functional-annotation-of-hierarchical-modularity/ (Accessed 2012 March 13).	[Padmanabhan, Kanchana; Samatova, Nagiza F.] N Carolina State Univ, Dept Comp Sci, Raleigh, NC 27695 USA; [Wang, Kuangyu] N Carolina State Univ, Bioinformat Res Ctr, Raleigh, NC 27695 USA; [Padmanabhan, Kanchana; Samatova, Nagiza F.] Oak Ridge Natl Lab, Oak Ridge, TN USA	University of North Carolina; North Carolina State University; University of North Carolina; North Carolina State University; United States Department of Energy (DOE); Oak Ridge National Laboratory	Padmanabhan, K (corresponding author), N Carolina State Univ, Dept Comp Sci, Raleigh, NC 27695 USA.	Samatova@csc.ncsu.edu			U.S. Department of Energy (DOE), Office of Science; Office of Advanced Scientific Computing Research (ASCR); Office of Biological and Environmental Research (BER); U.S. National Science Foundation (Expeditions in Computing); UT-Battelle for the LLC U.S. DOE [DEAC05-00OR22725]	U.S. Department of Energy (DOE), Office of Science(United States Department of Energy (DOE)); Office of Advanced Scientific Computing Research (ASCR)(Czech Academy of Sciences); Office of Biological and Environmental Research (BER); U.S. National Science Foundation (Expeditions in Computing)(National Science Foundation (NSF)NSF - Directorate for Computer & Information Science & Engineering (CISE)); UT-Battelle for the LLC U.S. DOE(United States Department of Energy (DOE))	This work was supported in part by the U.S. Department of Energy (DOE), Office of Science, the Office of Advanced Scientific Computing Research (ASCR) and the Office of Biological and Environmental Research (BER) and the U.S. National Science Foundation (Expeditions in Computing). Oak Ridge National Laboratory is managed by UT-Battelle for the LLC U.S. DOE under contract no. DEAC05-00OR22725. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Al-Shahrour F, 2004, BIOINFORMATICS, V20, P578, DOI 10.1093/bioinformatics/btg455; Alexa A, 2006, BIOINFORMATICS, V22, P1600, DOI 10.1093/bioinformatics/btl140; Apostolico A, 2006, LECT NOTES COMPUTER, V3909, P85; Ashburner M, 2000, NAT GENET, V25, P25, DOI 10.1038/75556; Bauer S, 2008, BIOINFORMATICS, V24, P1650, DOI 10.1093/bioinformatics/btn250; Beissbarth T, 2004, BIOINFORMATICS, V20, P1464, DOI 10.1093/bioinformatics/bth088; Berriz GF, 2003, BIOINFORMATICS, V19, P2502, DOI 10.1093/bioinformatics/btg363; BEZDEK JC, 1984, COMPUT GEOSCI, V10, P191, DOI 10.1016/0098-3004(84)90020-7; Boyle EI, 2004, BIOINFORMATICS, V20, P3710, DOI 10.1093/bioinformatics/bth456; Breton AM, 2001, YEAST, V18, P1053, DOI 10.1002/yea.755; Budanitsky Alexander, 2001, WORKSH WORDNET OTH L, V2, P2; Carmona-Saez P, 2007, GENOME BIOL, V8, DOI 10.1186/gb-2007-8-1-r3; Castillo-Davis CI, 2003, BIOINFORMATICS, V19, P891, DOI 10.1093/bioinformatics/btg114; Chagoyen M, 2008, BMC BIOINFORMATICS, V9, DOI 10.1186/1471-2105-9-444; Chen JC, 2006, BIOINFORMATICS, V22, P2283, DOI 10.1093/bioinformatics/btl370; DURRENS P, 1995, CURR GENET, V27, P213, DOI 10.1007/BF00326151; GARCIARUIZ C, 1995, MOL PHARMACOL, V48, P825; Gavin AC, 2002, NATURE, V415, P141, DOI 10.1038/415141a; GERRITY JP, 1992, MON WEATHER REV, V120, P2709, DOI 10.1175/1520-0493(1992)120<2709:ANOGAM>2.0.CO;2; Geva AB, 1999, IEEE T FUZZY SYST, V7, P723, DOI 10.1109/91.811242; GRUNE T, 1995, J BIOL CHEM, V270, P2344, DOI 10.1074/jbc.270.5.2344; Guldener U, 2006, NUCLEIC ACIDS RES, V34, pD436, DOI 10.1093/nar/gkj003; Gulshan K, 2004, EUKARYOT CELL, V3, P318, DOI 10.1128/EC.3.2.318-330.2004; Hach A, 1999, MOL CELL BIOL, V19, P4324; Hand RA, 2003, EUKARYOT CELL, V2, P306, DOI 10.1128/EC.2.2.306-317.2003; Hartwell LH, 1999, NATURE, V402, pC47, DOI 10.1038/35011540; Heidke P., 1926, GEOGR ANN, V8; Ho Y, 2002, NATURE, V415, P180, DOI 10.1038/415180a; Horng YJ, 2005, IEEE T FUZZY SYST, V13, P216, DOI 10.1109/TFUZZ.2004.840134; Hosack DA, 2003, GENOME BIOL, V4, DOI 10.1186/gb-2003-4-10-r70; Huang DW, 2009, NAT PROTOC, V4, P44, DOI 10.1038/nprot.2008.211; Huang DW, 2009, NUCLEIC ACIDS RES, V37, P1, DOI 10.1093/nar/gkn923; Jensen LJ, 2009, NUCLEIC ACIDS RES, V37, pD412, DOI 10.1093/nar/gkn760; Jiang J.J., 1997, P INT C RES COMP LIN, P19; JOHNSTON M, 1987, MICROBIOL REV, V51, P458, DOI 10.1128/MMBR.51.4.458-476.1987; Jupiter D, 2010, INFORMS J COMPUT, V22, P210, DOI 10.1287/ijoc.1090.0356; Kanehisa M, 2000, NUCLEIC ACIDS RES, V28, P27, DOI 10.1093/nar/28.1.27; Kanehisa M, 2010, NUCLEIC ACIDS RES, V38, pD355, DOI 10.1093/nar/gkp896; Kanehisa M, 2006, NUCLEIC ACIDS RES, V34, pD354, DOI 10.1093/nar/gkj102; KIKUCHI Y, 1994, MOL GEN GENET, V245, P107, DOI 10.1007/BF00279756; Kobayashi A, 2006, MOL CELL BIOL, V26, P221, DOI 10.1128/MCB.26.1.221-229.2006; Krogan NJ, 2004, MOL CELL, V13, P225, DOI 10.1016/S1097-2765(04)00003-6; LANCE GN, 1967, COMPUT J, V9, P373, DOI 10.1093/comjnl/9.4.373; Lavoie H, 2010, PLOS BIOL, V8, DOI 10.1371/journal.pbio.1000329; Lin D., 1998, Machine Learning. Proceedings of the Fifteenth International Conference (ICML'98), P296; Liu L, 2003, J BIOL CHEM, V278, P31998, DOI 10.1074/jbc.M303553200; Luo F, 2009, BMC BIOINFORMATICS, V10, DOI 10.1186/1471-2105-10-S4-S8; Ma HW, 2004, BMC BIOINFORMATICS, V5, DOI 10.1186/1471-2105-5-199; Maere S, 2005, BIOINFORMATICS, V21, P3448, DOI 10.1093/bioinformatics/bti551; Masseroli M, 2004, NUCLEIC ACIDS RES, V32, pW293, DOI 10.1093/nar/gkh432; Milo R, 2002, SCIENCE, V298, P824, DOI 10.1126/science.298.5594.824; Mistry M, 2008, BMC BIOINFORMATICS, V9, DOI 10.1186/1471-2105-9-327; MUNN AL, 1995, MOL BIOL CELL, V6, P1721, DOI 10.1091/mbc.6.12.1721; Myer VE, 1998, J BIOL CHEM, V273, P27757, DOI 10.1074/jbc.273.43.27757; North BV, 2002, AM J HUM GENET, V71, P439, DOI 10.1086/341527; Pandey J, 2008, BIOINFORMATICS, V24, pI28, DOI 10.1093/bioinformatics/btn296; Pandey J, 2010, BMC BIOINFORMATICS, V11, DOI 10.1186/1471-2105-11-S1-S35; Peirce C S, 1884, Science, V4, P453, DOI 10.1126/science.ns-4.93.453-a; Pilauri V, 2005, GENETICS, V169, P1903, DOI 10.1534/genetics.104.036723; Platt A, 1998, EMBO J, V17, P4086, DOI 10.1093/emboj/17.14.4086; Pu SY, 2009, NUCLEIC ACIDS RES, V37, P825, DOI 10.1093/nar/gkn1005; Quinn J., 2008, STRESS YEASTS FILAME, P67; Ravasz E, 2002, SCIENCE, V297, P1551, DOI 10.1126/science.1073374; Raychaudhuri S, 2003, BIOINFORMATICS, V19, P396, DOI 10.1093/bioinformatics/btg002; Raychaudhuri S, 2002, GENOME RES, V12, P1582, DOI 10.1101/gr.116402; Resnik P, 1999, J ARTIF INTELL RES, V11, P95, DOI 10.1613/jair.514; Rey FE, 2007, APPL ENVIRON MICROB, V73, P1665, DOI 10.1128/AEM.02565-06; Ruepp A, 2004, NUCLEIC ACIDS RES, V32, P5539, DOI 10.1093/nar/gkh894; Ruths T, 2009, BIOINFORMATICS, V25, P1178, DOI 10.1093/bioinformatics/btp128; Sallusto F, 2009, EUR J IMMUNOL, V39, P2076, DOI 10.1002/eji.200939722; Schaffrath R, 2000, FUNGAL GENET BIOL, V30, P173, DOI 10.1006/fgbi.2000.1221; SCHLESSER A, 1988, J BIOL CHEM, V263, P19480; SELLECK SB, 1987, MOL CELL BIOL, V7, P3260, DOI 10.1128/MCB.7.9.3260; Shah NH, 2004, BIOINFORMATICS, V20, P1196, DOI 10.1093/bioinformatics/bth056; SIVADON P, 1995, MOL GEN GENET, V246, P485, DOI 10.1007/BF00290452; Spirin V, 2003, P NATL ACAD SCI USA, V100, P12123, DOI 10.1073/pnas.2032324100; Stevens SW, 1999, P NATL ACAD SCI USA, V96, P7226, DOI 10.1073/pnas.96.13.7226; Tachihara K, 2005, J BIOL CHEM, V280, P12637, DOI 10.1074/jbc.M410778200; Tai SL, 2007, MOL BIOL CELL, V18, P5100, DOI 10.1091/mbc.E07-02-0131; Tsekouras G, 2005, FUZZY SET SYST, V150, P245, DOI 10.1016/j.fss.2004.04.013; Wang QQ, 2002, P NATL ACAD SCI USA, V99, P12853, DOI 10.1073/pnas.202115499; Wu CY, 2009, J BIOL CHEM, V284, P27544, DOI 10.1074/jbc.M109.042036; Young A, 2005, BIOINFORMATICS, V21, P275, DOI 10.1093/bioinformatics/bth495; Zeeberg BR, 2003, GENOME BIOL, V4, DOI 10.1186/gb-2003-4-4-r28; Zhang B, 2004, BMC BIOINFORMATICS, V5, DOI 10.1186/1471-2105-5-16; Zheng B, 2007, GENOME BIOL, V8; Zhou H, 2006, YEAST PROTEIN PROTEI	88	3	3	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 4	2012	7	4							e33744	10.1371/journal.pone.0033744	http://dx.doi.org/10.1371/journal.pone.0033744			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	953GO	22496762	Green Submitted, Green Published, gold			2022-12-25	WOS:000304855200021
J	Wu, MY; Jiang, M; Zhai, XD; Beaudet, AL; Wu, RC				Wu, Mei-Yi; Jiang, Ming; Zhai, Xiaodong; Beaudet, Arthur L.; Wu, Ray-Chang			An Unexpected Function of the Prader-Willi Syndrome Imprinting Center in Maternal Imprinting in Mice	PLOS ONE			English	Article							ANGELMAN-SYNDROME; NECDIN GENE; ANTISENSE TRANSCRIPT; DNA METHYLATION; MURINE UBE3A; MOUSE MODEL; SNRPN GENE; MUTATIONS; DELETION; LETHALITY	Genomic imprinting is a phenomenon that some genes are expressed differentially according to the parent of origin. Prader-Willi syndrome (PWS) and Angelman syndrome (AS) are neurobehavioral disorders caused by deficiency of imprinted gene expression from paternal and maternal chromosome 15q11-q13, respectively. Imprinted genes at the PWS/AS domain are regulated through a bipartite imprinting center, the PWS-IC and AS-IC. The PWS-IC activates paternal-specific gene expression and is responsible for the paternal imprint, whereas the AS-IC functions in the maternal imprint by allele-specific repression of the PWS-IC to prevent the paternal imprinting program. Although mouse chromosome 7C has a conserved PWS/AS imprinted domain, the mouse equivalent of the human AS-IC element has not yet been identified. Here, we suggest another dimension that the PWS-IC also functions in maternal imprinting by negatively regulating the paternally expressed imprinted genes in mice, in contrast to its known function as a positive regulator for paternal-specific gene expression. Using a mouse model carrying a 4.8-kb deletion at the PWS-IC, we demonstrated that maternal transmission of the PWS-IC deletion resulted in a maternal imprinting defect with activation of the paternally expressed imprinted genes and decreased expression of the maternally expressed imprinted gene on the maternal chromosome, accompanied by alteration of the maternal epigenotype toward a paternal state spread over the PWS/AS domain. The functional significance of this acquired paternal pattern of gene expression was demonstrated by the ability to complement PWS phenotypes by maternal inheritance of the PWS-IC deletion, which is in stark contrast to paternal inheritance of the PWS-IC deletion that resulted in the PWS phenotypes. Importantly, low levels of expression of the paternally expressed imprinted genes are sufficient to rescue postnatal lethality and growth retardation in two PWS mouse models. These findings open the opportunity for a novel approach to the treatment of PWS.	[Wu, Mei-Yi; Jiang, Ming; Wu, Ray-Chang] George Washington Univ, Dept Biochem & Mol Biol, Washington, DC 20052 USA; [Zhai, Xiaodong; Beaudet, Arthur L.] Baylor Coll Med, Dept Mol & Human Genet, Houston, TX 77030 USA	George Washington University; Baylor College of Medicine	Wu, MY (corresponding author), George Washington Univ, Dept Biochem & Mol Biol, Washington, DC 20052 USA.	bcmmxw@gwumc.edu; bcmrxw@gwumc.edu	Wu, Ray-chang/X-2018-2019		George Washington University; National Institutes of Health [HD037283]; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT [R01HD037283] Funding Source: NIH RePORTER	George Washington University; National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD))	This work was supported by a startup fund from George Washington University (to RW) and by a research grant HD037283 from the National Institutes of Health (to ALB). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bielinska B, 2000, NAT GENET, V25, P74, DOI 10.1038/75629; Bischof JM, 2007, HUM MOL GENET, V16, P2713, DOI 10.1093/hmg/ddm225; Bressler J, 2001, NAT GENET, V28, P232, DOI 10.1038/90067; Buiting K, 2010, AM J MED GENET C, V154C, P365, DOI 10.1002/ajmg.c.30273; Cattanach BM, 1997, MAMM GENOME, V8, P472, DOI 10.1007/s003359900479; Chamberlain SJ, 2001, GENOMICS, V73, P316, DOI 10.1006/geno.2001.6543; Chamberlain SJ, 2010, NEUROBIOL DIS, V39, P13, DOI 10.1016/j.nbd.2010.03.011; de Smith AJ, 2009, HUM MOL GENET, V18, P3257, DOI 10.1093/hmg/ddp263; Dindot SV, 2009, GENOME RES, V19, P1374, DOI 10.1101/gr.089185.108; Ding F, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0001709; Dittrich B, 1996, NAT GENET, V14, P163, DOI 10.1038/ng1096-163; Dubose AJ, 2011, HUM MOL GENET; DUKER AL, 2010, EUR J HUM GENET; Farber C, 1999, HUM MOL GENET, V8, P337, DOI 10.1093/hmg/8.2.337; Gabriel JM, 1998, MAMM GENOME, V9, P788, DOI 10.1007/s003359900868; Gerard M, 1999, NAT GENET, V23, P199, DOI 10.1038/13828; Gray TA, 1999, P NATL ACAD SCI USA, V96, P5616, DOI 10.1073/pnas.96.10.5616; Hanel ML, 2001, MOL CELL BIOL, V21, P2384, DOI 10.1128/MCB.21.7.2384-2392.2001; Hershko A, 1999, GENE, V234, P323, DOI 10.1016/S0378-1119(99)00192-4; Horsthemke B, 2008, AM J MED GENET A, V146A, P2041, DOI 10.1002/ajmg.a.32364; Jay P, 1997, NAT GENET, V17, P357, DOI 10.1038/ng1197-357; Jiang YH, 1998, NEURON, V21, P799, DOI 10.1016/S0896-6273(00)80596-6; Johnstone KA, 2006, HUM MOL GENET, V15, P393, DOI 10.1093/hmg/ddi456; Kishino T, 1997, NAT GENET, V15, P70, DOI 10.1038/ng0197-70; Landers M, 2004, NUCLEIC ACIDS RES, V32, P3480, DOI 10.1093/nar/gkh670; Lau JCY, 2004, NUCLEIC ACIDS RES, V32, P3376, DOI 10.1093/nar/gkh671; MacDonald HR, 1997, HUM MOL GENET, V6, P1873, DOI 10.1093/hmg/6.11.1873; Matsuura T, 1997, NAT GENET, V15, P74, DOI 10.1038/ng0197-74; Muscatelli F, 2000, HUM MOL GENET, V9, P3101, DOI 10.1093/hmg/9.20.3101; Ohta T, 1999, AM J HUM GENET, V64, P385, DOI 10.1086/302232; Peery EG, 2007, MAMM GENOME, V18, P255, DOI 10.1007/s00335-007-9019-3; Perk J, 2002, EMBO J, V21, P5807, DOI 10.1093/emboj/cdf570; Relkovic D, 2011, BRAIN RES B; Rougeulle C, 1998, NAT GENET, V19, P15, DOI 10.1038/ng0598-15; Runte M, 2001, HUM MOL GENET, V10, P2687, DOI 10.1093/hmg/10.23.2687; Sahoo T, 2008, NAT GENET, V40, P719, DOI 10.1038/ng.158; Schaller F, 2010, HUM MOL GENET, V19, P4895, DOI 10.1093/hmg/ddq424; Shemer R, 2000, NAT GENET, V26, P440, DOI 10.1038/82571; Shemer R, 1997, P NATL ACAD SCI USA, V94, P10267, DOI 10.1073/pnas.94.19.10267; Skryabin BV, 2007, PLOS GENET, V3, P2529, DOI 10.1371/journal.pgen.0030235; Tsai TF, 1999, NAT GENET, V22, P15, DOI 10.1038/8722; Tsai TF, 1999, HUM MOL GENET, V8, P1357, DOI 10.1093/hmg/8.8.1357; Weber M, 2005, NAT GENET, V37, P853, DOI 10.1038/ng1598; Wu MY, 2006, GENESIS, V44, P12, DOI 10.1002/gene.20179; Yang T, 1998, NAT GENET, V19, P25, DOI 10.1038/ng0598-25	45	13	13	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 4	2012	7	4							e34348	10.1371/journal.pone.0034348	http://dx.doi.org/10.1371/journal.pone.0034348			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	953GO	22496793	Green Submitted, gold, Green Published			2022-12-25	WOS:000304855200041
J	Gong, Y; Li, YL; Abdolmaleky, HM; Li, LL; Zhou, JR				Gong, Yi; Li, Yanli; Abdolmaleky, Hamid M.; Li, Linglin; Zhou, Jin-Rong			Tanshinones Inhibit the Growth of Breast Cancer Cells through Epigenetic Modification of Aurora A Expression and Function	PLOS ONE			English	Article							TANDEM MASS-SPECTROMETRY; PROSTATE-CANCER; SALVIA-MILTIORRHIZA; KINASE INHIBITORS; CYCLE ARREST; RAT PLASMA; IIA; APOPTOSIS; CRYPTOTANSHINONE; CYTOTOXICITY	The objectives of this study were to evaluate the effects of tanshinones from a Chinese herb Salvia Miltiorrhiza on the growth of breast cancer cells, and to elucidate cellular and molecular mechanisms of action. Tanshinones showed the dose-dependent effect on the growth inhibition of breast cancer cells in vitro, with tanshinone I (T1) the most potent agent. T1 was also the only tanshinone to have potent activity in inhibiting the growth of the triple-negative breast cancer cell line MDA-MB231. T1 caused cell cycle arrests of both estrogen-dependent and estrogen-independent cell lines associated with alterations of cyclinD, CDK4 and cyclinB, and induced breast cancer cell apoptosis associated with upregulation of c-PARP and downregulation of survivin and Aurora A. Among these associated biomarkers, Aurora A showed the most consistent pattern with the anti-growth activity of tanshinones. Overexpression of Aurora A was also verified in breast tumors. The gene function assay showed that knockdown of Aurora A by siRNA dramatically reduced the growth-inhibition and apoptosis-induction activities of T1, suggesting Aurora A as an important functional target of T1 action. On the other hand, tanshinones had much less adverse effects on normal mammary epithelial cells. Epigenetic mechanism studies showed that overexpression of Aurora A gene in breast cancer cells was not regulated by gene promoter DNA methylation, but by histone acetylation. T1 treatment significantly reduced acetylation levels of histone H3 associated with Aurora A gene. Our results supported the potent activity of T1 in inhibiting the growth of breast cancer cells in vitro in part by downregulation of Aurora A gene function. Our previous studies also demonstrated that T1 had potent anti-angiogenesis activity and minimal side effects in vivo. Altogether, this study warrants further investigation to develop T1 as an effective and safe agent for the therapy and prevention of breast cancer.	[Gong, Yi; Li, Yanli; Abdolmaleky, Hamid M.; Li, Linglin; Zhou, Jin-Rong] Harvard Univ, Sch Med, Dept Surg, Nutr Metab Lab,Beth Israel Deaconess Med, Boston, MA 02115 USA; [Li, Yanli; Zhou, Jin-Rong] E China Normal Univ, Inst Mol & Expt Therapeut, Shanghai 200062, Peoples R China	Harvard University; Beth Israel Deaconess Medical Center; Harvard Medical School; East China Normal University	Gong, Y (corresponding author), Harvard Univ, Sch Med, Dept Surg, Nutr Metab Lab,Beth Israel Deaconess Med, Boston, MA 02115 USA.	jrzhou@bidmc.harvard.edu	li, yanli/AAT-2012-2021	li, yanli/0000-0002-2936-0339; Mostafavi Abdolmaleky, Hamid/0000-0002-8872-5174	National Cancer Institute [R21 CA133865]; Department of Defense [PC073988]; NATIONAL CANCER INSTITUTE [R21CA133865] Funding Source: NIH RePORTER	National Cancer Institute(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); Department of Defense(United States Department of Defense); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	This work was supported in part by grants to JRZ from the National Cancer Institute (R21 CA133865) and the Department of Defense (PC073988). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abdolmaleky Hamid Mostafavi, 2008, V448, P187, DOI 10.1007/978-1-59745-205-2_9; American Cancer Society, 2010, OV BREST CANC MAN WO; Banerjee HN, 2009, BIOMARK MED, V3, P397, DOI 10.2217/BMM.09.26; Bi HC, 2007, BIOMED CHROMATOGR, V21, P473, DOI 10.1002/bmc.778; Buschhorn HM, 2005, PROSTATE, V64, P341, DOI 10.1002/pros.20247; Comperat E, 2007, VIRCHOWS ARCH, V450, P419, DOI 10.1007/s00428-007-0383-x; Comperat E, 2008, UROLOGY, V72, P873, DOI 10.1016/j.urology.2007.12.026; Cui Y, 2008, LIFE SCI, V82, P247, DOI 10.1016/j.lfs.2007.11.013; Dar AA, 2010, MOL CANCER THER, V9, P268, DOI 10.1158/1535-7163.MCT-09-0765; Davie JR, 2003, J NUTR, V133, p2485S, DOI 10.1093/jn/133.7.2485S; Dworkin AM, 2009, SEMIN CANCER BIOL, V19, P165, DOI 10.1016/j.semcancer.2009.02.007; Fang MZ, 2007, J NUTR, V137, p223S, DOI 10.1093/jn/137.1.223S; Giet R, 1999, J CELL SCI, V112, P3591; Gorgun G, 2010, BLOOD, V115, P5202, DOI 10.1182/blood-2009-12-259523; Gong Y, 2011, INT J CANCER, V129, P1042, DOI 10.1002/ijc.25678; Hao HP, 2006, J PHARMACEUT BIOMED, V40, P382, DOI 10.1016/j.jpba.2005.07.029; Kaestner P, 2009, MOL CANCER THER, V8, P2046, DOI 10.1158/1535-7163.MCT-09-0323; Keen N, 2004, NAT REV CANCER, V4, P927, DOI 10.1038/nrc1502; Lea MA, 2002, NUTR CANCER, V43, P90, DOI 10.1207/S15327914NC431_11; Lee CY, 2008, MOL CANCER THER, V7, P3527, DOI 10.1158/1535-7163.MCT-07-2288; Lee ECY, 2006, CANCER RES, V66, P4996, DOI 10.1158/0008-5472.CAN-05-2796; Lee WYW, 2008, FOOD CHEM TOXICOL, V46, P328, DOI 10.1016/j.fct.2007.08.013; Lentini L, 2008, ONCOL RES, V17, P115, DOI 10.3727/096504008785055521; Li DH, 2003, CLIN CANCER RES, V9, P991; Li J, 2005, J CHROMATOGR B, V826, P26, DOI 10.1016/j.jchromb.2005.07.048; Li Y, 2012, MOL CARCINO IN PRESS; Lima SC, 2010, CURR OPIN MOL THER, V12, P316; Liu JJ, 2009, ONCOL REP, V21, P1075, DOI 10.3892/or_00000326; Mai ZM, 2007, CARCINOGENESIS, V28, P1217, DOI 10.1093/carcin/bgm004; Marumoto T, 2005, NAT REV CANCER, V5, P42, DOI 10.1038/nrc1526; Matarasso N, 2007, NEOPLASIA, V9, P707, DOI 10.1593/neo.07322; Meraldi P, 2004, CURR OPIN GENET DEV, V14, P29, DOI 10.1016/j.gde.2003.11.006; Mosaddik MA, 2003, PHYTOMEDICINE, V10, P682, DOI 10.1078/0944-7113-00321; Nizamutdinova IT, 2008, CARCINOGENESIS, V29, P1885, DOI 10.1093/carcin/bgn151; Nizamutdinova IT, 2008, INT J ONCOL, V33, P485, DOI 10.3892/ijo_00000031; Qu Y, 2008, CANCER GENE THER, V15, P517, DOI 10.1038/cgt.2008.22; Qu Yi, 2008, Sichuan Da Xue Xue Bao Yi Xue Ban, V39, P1; Singh AV, 2006, CANCER RES, V66, P1851, DOI 10.1158/0008-5472.CAN-05-1332; Song M, 2005, J CHROMATOGR B, V827, P205, DOI 10.1016/j.jchromb.2005.09.014; Staff S, 2010, ONCOL REP, V23, P307, DOI 10.3892/or_00000637; Su CC, 2008, INT J MOL MED, V22, P357, DOI 10.3892/ijmm_00000030; Vankayalapati H, 2003, MOL CANCER THER, V2, P283; Veeck J, 2010, J MAMMARY GLAND BIOL, V15, P5, DOI 10.1007/s10911-010-9165-1; Wang J, 2007, J NEURO-ONCOL, V82, P11, DOI 10.1007/s11060-006-9242-x; Wang X, 1996, Zhonghua Zhong Liu Za Zhi, V18, P412; Wang XJ, 2005, INT J CANCER, V116, P799, DOI 10.1002/ijc.20880; Yuan S, 2002, HUA XI YI KE DA XUE, V33, P90; Yuan SL, 2004, WORLD J GASTROENTERO, V10, P2024, DOI 10.3748/wjg.v10.i14.2024; Yuan Shulan, 2002, Journal of West China University of Medical Sciences, V33, P84; Zhang P, 1999, Zhongguo Zhong Xi Yi Jie He Za Zhi, V19, P103	50	50	51	3	30	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 2	2012	7	4							e33656	10.1371/journal.pone.0033656	http://dx.doi.org/10.1371/journal.pone.0033656			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	952GU	22485147	Green Submitted, Green Published, gold			2022-12-25	WOS:000304780500023
J	Mondal, A; Roy, A; Sarkar, S; Mukherjee, J; Ganguly, T; Chattopadhyay, D				Mondal, Arindam; Roy, Arunava; Sarkar, Sandipto; Mukherjee, Jishnu; Ganguly, Tridib; Chattopadhyay, Dhrubajyoti			Interaction of Chandipura Virus N and P Proteins: Identification of Two Mutually Exclusive Domains of N Involved in Interaction with P	PLOS ONE			English	Article							VESICULAR-STOMATITIS-VIRUS; NUCLEOCAPSID PROTEIN; PHOSPHOPROTEIN NS; COMPLEX-FORMATION; RNA-SYNTHESIS; LEADER RNA; BINDING; NUCLEOPROTEIN; TRANSCRIPTION; CHAPERONE	The nucleocapsid protein (N) and the phosphoprotein (P) of nonsegmented negative-strand (NNS) RNA viruses interact with each other to accomplish two crucial events necessary for the viral replication cycle. First, the P protein binds to the aggregation prone nascent N molecules maintaining them in a soluble monomeric (N-0) form (N-0-P complex). It is this form that is competent for specific encapsidation of the viral genome. Second, the P protein binds to oligomeric N in the nucleoprotein complex (N-RNA-P complex), and thereby facilitates the recruitment of the viral polymerase (L) onto its template. All previous attempts to study these complexes relied on co-expression of the two proteins in diverse systems. In his study, we have characterised these different modes of N-P interaction in detail and for the first time have been able to reconstitute these complexes individually in vitro in the chandipura virus (CHPV), a human pathogenic NNS RNA virus. Using a battery of truncated mutants of the N protein, we have been able to identify two mutually exclusive domains of N involved in differential interaction with the P protein. An unique N-terminal binding site, comprising of amino acids (aa) 1-180 form the N-0-P interacting region, whereas, C-terminal residues spanning aa 320-390 is instrumental in N-RNA-P interactions. Significantly, the ex-vivo data also supports these observations. Based on these results, we suggest that the P Protein acts as N-specific chaperone and thereby Partially masking the N-N self-association region, which leads to the specific recognition of viral genome RNA by N-0.	[Mondal, Arindam; Roy, Arunava; Sarkar, Sandipto; Mukherjee, Jishnu; Chattopadhyay, Dhrubajyoti] Univ Calcutta, Dept Biotechnol, Kolkata, W Bengal, India; [Mondal, Arindam; Roy, Arunava; Sarkar, Sandipto; Mukherjee, Jishnu; Chattopadhyay, Dhrubajyoti] Univ Calcutta, Dr BC Guha Ctr Genet Engn & Biotechnol, Kolkata, W Bengal, India; [Ganguly, Tridib] IISER, Dept Biol Sci, Kolkata, W Bengal, India	University of Calcutta; University of Calcutta; Indian Institute of Science Education & Research (IISER) - Kolkata	Mondal, A (corresponding author), Univ Virginia, Dept Pathol, Hlth Syst, Charlottesville, VA 22903 USA.	djcbcg@caluniv.ac.in	Roy, Arunava/T-9494-2019; Mondal, Arindam/AAQ-5734-2021; ganguly, tridib/H-8767-2019	Roy, Arunava/0000-0002-8486-0539; ganguly, tridib/0000-0002-5283-5689; Mondal, Arindam/0000-0001-7991-5809	Department of Science and Technology, Ministry of Science and Technology, Government of India [SR/SO/BB-67/2008]; University Grants Commission CAS in the Department of Biochemistry	Department of Science and Technology, Ministry of Science and Technology, Government of India(Department of Science & Technology (India)); University Grants Commission CAS in the Department of Biochemistry	This work was supported by a research grant (SR/SO/BB-67/2008) from the Department of Science and Technology, Ministry of Science and Technology, Government of India and the University Grants Commission CAS programme in the Department of Biochemistry. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Albertini AAV, 2006, SCIENCE, V313, P360, DOI 10.1126/science.1125280; Basak S, 2004, J MOL BIOL, V339, P1089, DOI 10.1016/j.jmb.2004.03.081; Basak S, 2003, VIROLOGY, V307, P372, DOI 10.1016/S0042-6822(02)00093-4; Basak S, 2007, BIOSCIENCE REP, V27, P275, DOI 10.1007/s10540-007-9054-z; BHATT PN, 1967, INDIAN J MED RES, V55, P1295; Bhattacharya R, 2006, VIROLOGY, V349, P197, DOI 10.1016/j.virol.2006.01.017; BLUMBERG BM, 1981, CELL, V23, P837, DOI 10.1016/0092-8674(81)90448-7; Chadha MS, 2005, AM J TROP MED HYG, V73, P566, DOI 10.4269/ajtmh.2005.73.566; Chattopadhyay D, 1997, VIROLOGY, V239, P11, DOI 10.1006/viro.1997.8838; CHATTOPADHYAY D, 1994, CELL MOL BIOL RES, V40, P693; Chen MZ, 2007, J VIROL, V81, P13478, DOI 10.1128/JVI.01244-07; CURRAN J, 1995, J VIROL, V69, P849, DOI 10.1128/JVI.69.2.849-855.1995; DAS T, 1993, VIROLOGY, V193, P340, DOI 10.1006/viro.1993.1130; DAVIS NL, 1986, J VIROL, V59, P751, DOI 10.1128/JVI.59.3.751-754.1986; DE BP, 1985, BIOCHEM BIOPH RES CO, V126, P40, DOI 10.1016/0006-291X(85)90568-6; De BP, 2000, J VIROL, V74, P5886, DOI 10.1128/JVI.74.13.5886-5895.2000; EMERSON SU, 1972, J VIROL, V10, P297, DOI 10.1128/JVI.10.2.297-309.1972; EMERSON SU, 1987, P NATL ACAD SCI USA, V84, P5655, DOI 10.1073/pnas.84.16.5655; EMERSON SU, 1975, J VIROL, V15, P1348, DOI 10.1128/JVI.15.6.1348-1356.1975; Green TJ, 2000, J VIROL, V74, P9515, DOI 10.1128/JVI.74.20.9515-9524.2000; Green TJ, 2006, SCIENCE, V313, P357, DOI 10.1126/science.1126953; Green TJ, 2009, P NATL ACAD SCI USA, V106, P11713, DOI 10.1073/pnas.0903228106; Gurav YK, 2010, INDIAN J MED RES, V132, P395; HOWARD M, 1989, J GEN VIROL, V70, P2683, DOI 10.1099/0022-1317-70-10-2683; Iseni F, 1998, J GEN VIROL, V79, P2909, DOI 10.1099/0022-1317-79-12-2909; Ivanov I, 2011, VIRUS RES, V162, P126, DOI 10.1016/j.virusres.2011.09.025; LAFERLA FM, 1989, J VIROL, V63, P3852, DOI 10.1128/JVI.63.9.3852-3857.1989; Leyrat C, 2011, PLOS PATHOG, V7, DOI 10.1371/journal.ppat.1002248; Leyrat C, 2011, PROTEIN SCI, V20, P542, DOI 10.1002/pro.587; Majumdar A, 2004, BIOCHEMISTRY-US, V43, P2863, DOI 10.1021/bi035793r; Majumder A, 2001, J BIOL CHEM, V276, P30948, DOI 10.1074/jbc.M011705200; MASTERS PS, 1988, J VIROL, V62, P2658, DOI 10.1128/JVI.62.8.2658-2664.1988; MASTERS PS, 1988, J VIROL, V62, P2651, DOI 10.1128/JVI.62.8.2651-2657.1988; Mavrakis M, 2003, VIROLOGY, V305, P406, DOI 10.1006/viro.2002.1748; Mavrakis M, 2006, VIROLOGY, V349, P422, DOI 10.1016/j.virol.2006.01.030; Mondal A, 2010, VIROLOGY, V407, P33, DOI 10.1016/j.virol.2010.07.032; Omi-Furutani M, 2010, J VIROL, V84, P9793, DOI 10.1128/JVI.00339-10; PERLMAN SM, 1973, J VIROL, V12, P1395, DOI 10.1128/JVI.12.6.1395-1400.1973; Rao BL, 2004, LANCET, V364, P869, DOI 10.1016/S0140-6736(04)16982-1; Rao SN, 2008, J TROP PEDIATRICS, V54, P25, DOI 10.1093/tropej/fmm078; RODRIGUES JJ, 1983, INDIAN J MED RES, V77, P303; SORIA M, 1973, J MOL BIOL, V77, P449, DOI 10.1016/0022-2836(73)90450-6; TAKACS AM, 1993, P NATL ACAD SCI USA, V90, P10375, DOI 10.1073/pnas.90.21.10375; THORNTON GB, 1983, BIOCHEM BIOPH RES CO, V116, P1160, DOI 10.1016/S0006-291X(83)80264-2; WERTZ GW, 1973, J VIROL, V12, P253, DOI 10.1128/JVI.12.2.253-264.1973; Zhang X, 2008, J VIROL, V82, P674, DOI 10.1128/JVI.00935-07	46	28	29	0	0	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 2	2012	7	4							e34623	10.1371/journal.pone.0034623	http://dx.doi.org/10.1371/journal.pone.0034623			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	952GU	22485180	gold, Green Published, Green Submitted			2022-12-25	WOS:000304780500055
J	Nanbara, H; Wara-aswapati, N; Nagasawa, T; Yoshida, Y; Yashiro, R; Bando, Y; Kobayashi, H; Khongcharoensuk, J; Hormdee, D; Pitiphat, W; Boch, JA; Izumi, Y				Nanbara, Hiromi; Wara-aswapati, Nawarat; Nagasawa, Toshiyuki; Yoshida, Yasuhiro; Yashiro, Reiko; Bando, Yukiko; Kobayashi, Hiroaki; Khongcharoensuk, Janjura; Hormdee, Doosadee; Pitiphat, Waranuch; Boch, Jason A.; Izumi, Yuichi			Modulation of Wnt5a Expression by Periodontopathic Bacteria	PLOS ONE			English	Article							OSTEOCLAST DIFFERENTIATION; PORPHYROMONAS-GINGIVALIS; OSTEOPROTEGERIN LIGAND; GENE-EXPRESSION; RHEUMATOID-ARTHRITIS; STEM-CELLS; PERIODONTITIS; ACTIVATION; WINGLESS; PROLIFERATION	Wingless proteins, termed Wnt, are involved in embryonic development, blood cell differentiation, and tumorigenesis. In mammalian hematopoiesis, Wnt signaling is essential for stem-cell homeostasis and lymphocyte differentiation. Recent studies have suggested that these molecules are associated with cardiovascular diseases, rheumatoid arthritis, and osteoarthritis. Furthermore, Wnt5a signaling is essential for the general inflammatory response of human macrophages. Periodontitis is a chronic inflammatory disease caused by gram-negative periodontopathic bacteria and the resultant host immune response. Periodontitis is characterized by loss of tooth-supporting structures and alveolar bone resorption. There have been no previous reports on Wnt5a expression in periodontitis tissue, and only few study reported the molecular mechanisms of Wnt5a expression in LPS-stimulated monocytic cells. Using RT-PCR, we demonstrated that Wnt5a mRNA expression was up-regulated in chronic periodontitis tissue as compared to healthy control tissue. P. gingivalis LPS induced Wnt5a mRNA in the human monocytic cell line THP-1 with a peak at 4 hrs after stimulation. P. gingivalis LPS induced higher up-regulation of Wnt5a mRNA than E. coli LPS. The LPS receptors TLR2 and TLR4 were equally expressed on the surface of THP-1 cells. P. gingivalis LPS induced l kappa B alpha degradation and was able to increase the NF-kappa B binding activity to DNA. P. gingivalis LPS-induced Wnt5a expression was inhibited by NF-kappa B inhibitors, suggesting NF-kappa B involvement. Furthermore, IFN-gamma synergistically enhanced the P. gingivalis LPS-induced production of Wnt5a. Pharmacological investigation and siRNA experiments showed that STAT1 was important for P. gingivalis LPS-induced Wnt5a expression. These results suggest that the modulation of Wnt5a expression by P. gingivalis may play an important role in the periodontal inflammatory process and serve a target for the development of new therapies.	[Nanbara, Hiromi; Nagasawa, Toshiyuki; Yashiro, Reiko; Bando, Yukiko; Kobayashi, Hiroaki; Izumi, Yuichi] Tokyo Med & Dent Univ, Dept Periodontol, Tokyo, Japan; [Nanbara, Hiromi; Izumi, Yuichi] Tokyo Med & Dent Univ, Global Ctr Excellence Program, Int Res Ctr Mol Sci Tooth & Bone Dis, Tokyo, Japan; [Wara-aswapati, Nawarat; Khongcharoensuk, Janjura; Hormdee, Doosadee] Khon Kaen Univ, Fac Dent, Dept Periodontol, Khon Kaen, Thailand; [Yoshida, Yasuhiro] Univ Occupat & Environm Hlth, Sch Med, Dept Immunol, Fukuoka, Japan; [Pitiphat, Waranuch] Khon Kaen Univ, Fac Dent, Dept Community Dent, Khon Kaen, Thailand; [Boch, Jason A.] Harvard Univ, Sch Dent Med, Dept Oral Med Infect & Immun, Boston, MA 02115 USA	Tokyo Medical & Dental University (TMDU); Tokyo Medical & Dental University (TMDU); Khon Kaen University; University of Occupational & Environmental Health - Japan; Khon Kaen University; Harvard University; Harvard School of Dental Medicine	Nanbara, H (corresponding author), Tokyo Med & Dent Univ, Dept Periodontol, Tokyo, Japan.	freude@med.uoeh-u.ac.jp	Kobayashi, Hiroaki/AAG-6812-2019	Pitiphat, Waranuch/0000-0001-6628-0306; /0000-0003-1658-3119	Ministry of Education, Culture, Sports, Science, and Technology of Japan [21390553]; National Research Council of Thailand (NRCT); Japan Society for the Promotion of Science (JSPS); Khon Kaen University; Grants-in-Aid for Scientific Research [21390553] Funding Source: KAKEN	Ministry of Education, Culture, Sports, Science, and Technology of Japan(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)); National Research Council of Thailand (NRCT)(National Research Council of Thailand (NRCT)); Japan Society for the Promotion of Science (JSPS)(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of Science); Khon Kaen University; Grants-in-Aid for Scientific Research(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI))	This study was supported by Grant-in-Aid for Scientific Research 21390553, grant from Global Center of Excellence (GCOE) Program, International Research Center for Molecular Science in Tooth and Bone Diseases Program, from the Ministry of Education, Culture, Sports, Science, and Technology of Japan; the National Research Council of Thailand (NRCT); Japan Society for the Promotion of Science (JSPS) grant, JSPS Invitation Fellowship for Research in Japan (NW), and Khon Kaen University grant. http://www.mext.go.jp/. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Armitage G C, 1999, Ann Periodontol, V4, P1, DOI 10.1902/annals.1999.4.1.1; Bansal K, 2011, J BIOL CHEM, V286, P37032, DOI 10.1074/jbc.M111.260414; Bickel M, 2001, J CLIN PERIODONTOL, V28, P840, DOI 10.1034/j.1600-051x.2001.028009840.x; Blumenthal A, 2006, BLOOD, V108, P965, DOI 10.1182/blood-2005-12-5046; Burgess TL, 1999, J CELL BIOL, V145, P527, DOI 10.1083/jcb.145.3.527; Cheng CW, 2008, BIOCHEM BIOPH RES CO, V365, P285, DOI 10.1016/j.bbrc.2007.10.166; Christman MA, 2008, AM J PHYSIOL-HEART C, V294, pH2864, DOI 10.1152/ajpheart.00982.2007; Costerton JW, 1999, SCIENCE, V284, P1318, DOI 10.1126/science.284.5418.1318; Darveau RP, 2002, INFECT IMMUN, V70, P1867, DOI 10.1128/IAI.70.4.1867-1873.2002; Dissanayake SK, 2008, CANCER RES, V68, P10205, DOI 10.1158/0008-5472.CAN-08-2149; Frank DA, 1999, NAT MED, V5, P444, DOI 10.1038/7445; Fujio Y, 2004, FEBS LETT, V573, P202, DOI 10.1016/j.febslet.2004.07.082; GAVIN BJ, 1992, MOL CELL BIOL, V12, P2418, DOI 10.1128/MCB.12.5.2418; Hofbauer LC, 1999, BONE, V25, P255, DOI 10.1016/S8756-3282(99)00162-3; Holt SC, 2005, PERIODONTOL 2000, V38, P72, DOI 10.1111/j.1600-0757.2005.00113.x; Hsu HL, 1999, P NATL ACAD SCI USA, V96, P3540, DOI 10.1073/pnas.96.7.3540; JAHNKE A, 1994, FEBS LETT, V354, P220, DOI 10.1016/0014-5793(94)01130-3; Kanaya S, 2004, EUR J IMMUNOL, V34, P1451, DOI 10.1002/eji.200324549; Katoh M, 2007, INT J MOL MED, V19, P273; KLINGENSMITH J, 1994, DEV BIOL, V166, P396, DOI 10.1006/dbio.1994.1325; Lacey DL, 1998, CELL, V93, P165, DOI 10.1016/S0092-8674(00)81569-X; Loesche WJ, 2001, CLIN MICROBIOL REV, V14, P727, DOI 10.1128/CMR.14.4.727-752.2001; LOWENSTEIN CJ, 1993, P NATL ACAD SCI USA, V90, P9730, DOI 10.1073/pnas.90.20.9730; Masckauchan TNH, 2006, MOL BIOL CELL, V17, P5163, DOI 10.1091/mbc.E06-04-0320; Matsuzaki K, 1998, BIOCHEM BIOPH RES CO, V246, P199, DOI 10.1006/bbrc.1998.8586; Medzhitov R, 2001, NAT REV IMMUNOL, V1, P135, DOI 10.1038/35100529; Nakashima T, 2000, BIOCHEM BIOPH RES CO, V275, P768, DOI 10.1006/bbrc.2000.3379; Nusse R, 2005, CELL RES, V15, P28, DOI 10.1038/sj.cr.7290260; Ohmori Y, 2001, J LEUKOCYTE BIOL, V69, P598; Pereira C, 2008, ARTERIOSCL THROM VAS, V28, P504, DOI 10.1161/ATVBAHA.107.157438; Plosker GL, 2003, DRUGS, V63, P2317, DOI 10.2165/00003495-200363210-00004; Pulendran B, 2001, J IMMUNOL, V167, P5067, DOI 10.4049/jimmunol.167.9.5067; Rasmussen L, 2000, J CLIN PERIODONTOL, V27, P41, DOI 10.1034/j.1600-051x.2000.027001041.x; Reya T, 2003, NATURE, V423, P409, DOI 10.1038/nature01593; Reya T, 2000, IMMUNITY, V13, P15, DOI 10.1016/S1074-7613(00)00004-2; Sen M, 2000, P NATL ACAD SCI USA, V97, P2791, DOI 10.1073/pnas.050574297; SHARMA RP, 1976, DEV BIOL, V48, P461, DOI 10.1016/0012-1606(76)90108-1; Staal FJT, 2003, CURR OPIN IMMUNOL, V15, P204, DOI 10.1016/S0952-7915(03)00003-7; Wang D, 2005, ORAL MICROBIOL IMMUN, V20, P172, DOI 10.1111/j.1399-302X.2005.00208.x; Yang DH, 2009, CIRC RES, V104, P372, DOI 10.1161/CIRCRESAHA.108.185405; Yoshida Y, 2004, J BIOL CHEM, V279, P1768, DOI 10.1074/jbc.M311498200	41	43	47	0	22	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 2	2012	7	4							e34434	10.1371/journal.pone.0034434	http://dx.doi.org/10.1371/journal.pone.0034434			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	952GU	22485170	Green Published, Green Submitted, gold			2022-12-25	WOS:000304780500045
J	Pays, O; Fortin, D; Gassani, J; Duchesne, J				Pays, Olivier; Fortin, Daniel; Gassani, Jean; Duchesne, Jean			Group Dynamics and Landscape Features Constrain the Exploration of Herds in Fusion-Fission Societies: The Case of European Roe Deer	PLOS ONE			English	Article							ELK CERVUS-ELAPHUS; FRAGMENTED LANDSCAPE; SEXUAL SEGREGATION; GROUP-SIZE; SELECTION; AGGRESSION; BEHAVIOR; FOOD; CONNECTIVITY; INTENSITY	Despite the large number of movement studies, the constraints that grouping imposes on movement decisions remain essentially unexplored, even for highly social species. Such constraints could be key, however, to understanding the dynamics and spatial organisation of species living in group fusion-fission systems. We investigated the winter movements (speed and diffusion coefficient) of groups of free-ranging roe deer (Capreolus capreolus), in an agricultural landscape characterised by a mosaic of food and foodless patches. Most groups were short-lived units that merged and split up frequently during the course of a day. Deer groups decreased their speed and diffusion rate in areas where food patches were abundant, as well as when travelling close to main roads and crest lines and far from forests. While accounting for these behavioural adjustments to habitat features, our study revealed some constraints imposed by group foraging: large groups reached the limit of their diffusion rate faster than small groups. The ability of individuals to move rapidly to new foraging locations following patch depression thus decreases with group size. Our results highlight the importance of considering both habitat heterogeneity and group dynamics when predicting the movements of individuals in group fusion-fission societies. Further, we provide empirical evidence that group cohesion can restrain movement and, therefore, the speed at which group members can explore their environment. When maintaining cohesion reduces foraging gains because of movement constraints, leaving the group may become a fitness-rewarding decision, especially when individuals can join other groups located nearby, which would tend to maintain highly dynamical group fusion-fission systems. Our findings also provide the basis for new hypotheses explaining a broad range of ecological patterns, such as the broader diet and longer residency time reported for larger herbivore groups.	[Pays, Olivier] Univ Angers, Grp Ecol & Conservat, Angers, France; [Pays, Olivier] Univ Reims, Ctr Rech & Format Ecoethol, Boult Aux Bois, France; [Pays, Olivier] INRA, Comportement & Ecol Faune Sauvage, F-31326 Castanet Tolosan, France; [Fortin, Daniel] Univ Laval, Dept Biol, Quebec City, PQ G1K 7P4, Canada; [Gassani, Jean] Univ Djibouti, Djibouti, Djibouti; [Duchesne, Jean] Agrocampus Ouest, Unite Rech Paysage, Angers, France	Universite d'Angers; Universite de Reims Champagne-Ardenne; INRAE; Laval University; University Djibouti; Institut Agro; Agrocampus Ouest	Pays, O (corresponding author), Univ Angers, Grp Ecol & Conservat, Angers, France.	olivier.pays@univ-angers.fr	Fortin, Daniel/ABG-3554-2020		Communaute de Communes de l'Argonne Ardennaise; Conseil Regional de Champagne Ardenne	Communaute de Communes de l'Argonne Ardennaise(Region Grand-Est); Conseil Regional de Champagne Ardenne(Region Grand-Est)	The 'Communaute de Communes de l'Argonne Ardennaise' and the 'Conseil Regional de Champagne Ardenne,' provided financial supports to conduct the study. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Anderson DP, 2005, LANDSCAPE ECOL, V20, P257, DOI 10.1007/s10980-005-0062-8; Babin JS, 2011, ECOLOGY, V92, P240, DOI 10.1890/10-0252.1; Cargnelutti B, 2002, REV ECOL-TERRE VIE, V57, P29; Casellas E, 2008, J THEOR BIOL, V250, P424, DOI 10.1016/j.jtbi.2007.10.011; Coulon A, 2004, MOL ECOL, V13, P2841, DOI 10.1111/j.1365-294X.2004.02253.x; Farnsworth KD, 1998, FUNCT ECOL, V12, P74, DOI 10.1046/j.1365-2435.1998.00163.x; Fortin D, 2002, ECOLOGY, V83, P970, DOI 10.1890/0012-9658(2002)083[0970:TTSOFD]2.0.CO;2; Fortin D, 2008, J APPL ECOL, V45, P1392, DOI 10.1111/j.1365-2664.2008.01542.x; Fortin D, 2009, ECOLOGY, V90, P2480, DOI 10.1890/08-0345.1; Frair JL, 2008, J APPL ECOL, V45, P1504, DOI 10.1111/j.1365-2664.2008.01526.x; FREELAND WJ, 1990, ECOLOGY, V71, P589, DOI 10.2307/1940312; Frid A, 1997, ANIM BEHAV, V53, P799, DOI 10.1006/anbe.1996.0345; Goldberg JL, 2001, BEHAV ECOL, V12, P490, DOI 10.1093/beheco/12.4.490; GRANT JWA, 1993, MAR BEHAV PHYSIOL, V23, P137, DOI 10.1080/10236249309378862; Haskell DG, 1997, BEHAV ECOL, V8, P448, DOI 10.1093/beheco/8.4.448; Hebblewhite M, 2008, J APPL ECOL, V45, P834, DOI 10.1111/j.1365-2664.2008.01466.x; Houle M, 2010, LANDSCAPE ECOL, V25, P419, DOI 10.1007/s10980-009-9420-2; Johnson CA, 2004, BEHAV ECOL, V15, P412, DOI 10.1093/beheco/arh026; Kie JG, 2005, LANDSCAPE ECOL, V20, P289, DOI 10.1007/s10980-005-3165-3; Kie JG, 2002, ECOLOGY, V83, P530, DOI 10.1890/0012-9658(2002)083[0530:LHADSE]2.0.CO;2; Kutner M. H., 2004, APPL LINEAR REGRESSI; Laurian C, 2008, J WILDLIFE MANAGE, V72, P1550, DOI 10.2193/2008-063; Maindonald J, 2007, DATA ANAL GRAPHICS U; Marchal C, 1998, REV ECOL-TERRE VIE, V53, P59; Martin P., 1993, MEASURING BEHAV; McLoughlin PD, 2006, P ROY SOC B-BIOL SCI, V273, P1449, DOI 10.1098/rspb.2006.3486; Michelena P, 2004, ANIM BEHAV, V68, P1371, DOI 10.1016/j.anbehav.2004.04.008; MONAGHAN P, 1985, ANIM BEHAV, V33, P993, DOI 10.1016/S0003-3472(85)80033-6; Myers J.P., 1981, P135; Ramp D, 2002, OIKOS, V98, P393, DOI 10.1034/j.1600-0706.2002.980304.x; Robb SE, 1998, ANIM BEHAV, V56, P29, DOI 10.1006/anbe.1998.0735; Roever CL, 2010, ECOGRAPHY, V33, P1113, DOI 10.1111/j.1600-0587.2010.06077.x; Ruckstuhl KE, 2002, BIOL REV, V77, P77, DOI 10.1017/S1464793101005814; Ruckstuhl KE, 2002, ANIM BEHAV, V64, P909, DOI 10.1006/anbe.2002.2015; SMITH JNM, 1974, BEHAVIOUR, V49, P1, DOI 10.1163/156853974X00390; Stephens D.W., 1986, pi; Sueur C, 2011, OIKOS, V120, P1608, DOI 10.1111/j.1600-0706.2011.19685.x; Villerette N, 2006, CAN J ZOOL, V84, P787, DOI 10.1139/Z06-052; Wall J, 2006, CURR BIOL, V16, pR527, DOI 10.1016/j.cub.2006.06.049	39	20	20	0	64	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 30	2012	7	3							e34678	10.1371/journal.pone.0034678	http://dx.doi.org/10.1371/journal.pone.0034678			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	959UC	22479652	gold, Green Published, Green Submitted			2022-12-25	WOS:000305339100172
J	Posner, M; Kiss, AJ; Skiba, J; Drossman, A; Dolinska, MB; Hejtmancik, JF; Sergeev, YV				Posner, Mason; Kiss, Andor J.; Skiba, Jackie; Drossman, Amy; Dolinska, Monika B.; Hejtmancik, J. Fielding; Sergeev, Yuri V.			Functional Validation of Hydrophobic Adaptation to Physiological Temperature in the Small Heat Shock Protein alpha A-crystallin	PLOS ONE			English	Article							CHAPERONE-LIKE ACTIVITY; ZEBRAFISH DANIO-RERIO; TOOTHFISH DISSOSTICHUS-MAWSONI; DIFFERENT THERMAL ENVIRONMENTS; EYE LENS CRYSTALLINS; B-CRYSTALLIN; PHYLOGENETIC ANALYSIS; MOLECULAR CHAPERONE; MAXIMUM-LIKELIHOOD; SUBUNIT EXCHANGE	Small heat shock proteins (sHsps) maintain cellular homeostasis by preventing stress and disease-induced protein aggregation. While it is known that hydrophobicity impacts the ability of sHsps to bind aggregation-prone denaturing proteins, the complex quaternary structure of globular sHsps has made understanding the significance of specific changes in hydrophobicity difficult. Here we used recombinant protein of the lenticular sHsp alpha A-crystallin from six teleost fishes environmentally adapted to temperatures ranging from -2 degrees C to 40 degrees C to identify correlations between physiological temperature, protein stability and chaperone-like activity. Using sequence and structural modeling analysis we identified specific amino acid differences between the warm adapted zebrafish and cold adapted Antarctic toothfish that could contribute to these correlations and validated the functional consequences of three specific hydrophobicity-altering amino acid substitutions in alpha A-crystallin. Site directed mutagenesis of three residues in the zebrafish (V62T, C143S, T147V) confirmed that each impacts either protein stability or chaperone-like activity or both, with the V62T substitution having the greatest impact. Our results indicate a role for changing hydrophobicity in the thermal adaptation of alpha A-crystallin and suggest ways to produce sHsp variants with altered chaperone-like activity. These data also demonstrate that a comparative approach can provide new information about sHsp function and evolution.	[Posner, Mason; Skiba, Jackie; Drossman, Amy] Ashland Univ, Dept Biol, Ashland, OH USA; [Kiss, Andor J.] Miami Univ, Dept Zool, Oxford, OH 45056 USA; [Dolinska, Monika B.; Hejtmancik, J. Fielding; Sergeev, Yuri V.] NEI, Ophthalm Genet & Visual Funct Branch, NIH, Bethesda, MD 20892 USA	Ashland University; University System of Ohio; Miami University; National Institutes of Health (NIH) - USA; NIH National Eye Institute (NEI)	Posner, M (corresponding author), Ashland Univ, Dept Biol, Ashland, OH USA.	mposner@ashland.edu	Posner, Mason/J-9759-2019; Kiss, Andor J/E-9863-2016	Posner, Mason/0000-0003-2817-3395; Kiss, Andor J/0000-0002-7508-0485	National Eye Institute at the National Institutes of Health [R15 EY13535]; NATIONAL EYE INSTITUTE [R15EY013535, ZIAEY000272, ZIAEY000476, ZIAEY000281] Funding Source: NIH RePORTER	National Eye Institute at the National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI)); NATIONAL EYE INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI))	This research was funded by grant R15 EY13535 from the National Eye Institute at the National Institutes of Health. http://grants.nih.gov/grants/funding/area.htm. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abgar S, 2000, EUR J BIOCHEM, V267, P5916, DOI 10.1046/j.1432-1327.2000.01646.x; Aquilina JA, 2005, J BIOL CHEM, V280, P14485, DOI 10.1074/jbc.M500135200; Bagneris C, 2009, J MOL BIOL, V392, P1242, DOI 10.1016/j.jmb.2009.07.069; Benesch JLP, 2008, J BIOL CHEM, V283, P28513, DOI 10.1074/jbc.M804729200; Bhat SP, 1999, EUR J CELL BIOL, V78, P143, DOI 10.1016/S0171-9335(99)80016-8; BHAT SP, 1989, BIOCHEM BIOPH RES CO, V158, P319, DOI 10.1016/S0006-291X(89)80215-3; Bova MP, 1997, J BIOL CHEM, V272, P29511, DOI 10.1074/jbc.272.47.29511; Campbell KL, 2010, NAT GENET, V42, P536, DOI 10.1038/ng.574; Cheng C, 2010, J BIOL CHEM, V285, P41187, DOI 10.1074/jbc.M110.154534; Dahlman JM, 2005, MOL VIS, V11, P88; Derham BK, 2001, EUR J BIOCHEM, V268, P713, DOI 10.1046/j.1432-1327.2001.01929.x; Dong YW, 2009, J EXP BIOL, V212, P169, DOI 10.1242/jeb.024505; DUBIN RA, 1989, MOL CELL BIOL, V9, P1083, DOI 10.1128/MCB.9.3.1083; Eifert C, 2005, BBA-PROTEINS PROTEOM, V1748, P146, DOI 10.1016/j.bbapap.2004.12.015; Eyles SJ, 2010, P NATL ACAD SCI USA, V107, P2727, DOI 10.1073/pnas.0915160107; Gangadhariah MH, 2010, BBA-MOL BASIS DIS, V1802, P432, DOI 10.1016/j.bbadis.2010.01.010; Gangalum RK, 2009, INVEST OPHTH VIS SCI, V50, P3283, DOI 10.1167/iovs.08-3052; Geffeney SL, 2005, NATURE, V434, P759, DOI 10.1038/nature03444; Ghosh JG, 2007, INT J BIOCHEM CELL B, V39, P1804, DOI 10.1016/j.biocel.2007.04.027; GRAVES JE, 1982, EVOLUTION, V36, P97, DOI 10.1111/j.1558-5646.1982.tb05014.x; HallBarry G, PHYLOGENETIC TREES M; Hayes VH, 2008, J BIOL CHEM, V283, P10500, DOI 10.1074/jbc.M706453200; Hochachka PW, BIOCH ADAPTATION MEC; Holland LZ, 1997, BIOCHEMISTRY-US, V36, P3207, DOI 10.1021/bi962664k; HORWITZ J, 1992, P NATL ACAD SCI USA, V89, P10449, DOI 10.1073/pnas.89.21.10449; Horwitz J, 1998, METHOD ENZYMOL, V290, P365, DOI 10.1016/S0076-6879(98)90032-5; Horwitz J, 2009, EXP EYE RES, V88, P190, DOI 10.1016/j.exer.2008.07.007; IWAKI T, 1989, CELL, V57, P71, DOI 10.1016/0092-8674(89)90173-6; Jaenicke R, 2000, P NATL ACAD SCI USA, V97, P2962, DOI 10.1073/pnas.97.7.2962; Jaya N, 2009, P NATL ACAD SCI USA, V106, P15604, DOI 10.1073/pnas.0902177106; Kiss AJ, 2004, J EXP BIOL, V207, P4633, DOI 10.1242/jeb.01312; Kiss AJ, 2008, COMP BIOCHEM PHYS D, V3, P155, DOI 10.1016/j.cbd.2008.02.002; KLEMENZ R, 1991, P NATL ACAD SCI USA, V88, P3652, DOI 10.1073/pnas.88.9.3652; Kumar MS, 2005, J BIOL CHEM, V280, P21726, DOI 10.1074/jbc.M500405200; Laganowsky A, 2010, PROTEIN SCI, V19, P1978, DOI 10.1002/pro.471; Laganowsky A, 2010, PROTEIN SCI, V19, P1031, DOI 10.1002/pro.380; LASKOWSKI RA, 1993, J APPL CRYSTALLOGR, V26, P283, DOI 10.1107/S0021889892009944; LEE C, 1991, J MOL BIOL, V217, P373, DOI 10.1016/0022-2836(91)90550-P; LEE C, 1994, J MOL BIOL, V236, P918, DOI 10.1006/jmbi.1994.1198; Letunic I, 2009, NUCLEIC ACIDS RES, V37, pD229, DOI 10.1093/nar/gkn808; LEVITT M, 1992, J MOL BIOL, V226, P507, DOI 10.1016/0022-2836(92)90964-L; Liang JJN, 2000, MOL VIS, V6, P10; McClellan DA, 2005, MOL BIOL EVOL, V22, P437, DOI 10.1093/molbev/msi028; MCFALLNGAI MJ, 1990, EXP EYE RES, V50, P703, DOI 10.1016/0014-4835(90)90117-D; Mchaourab HS, 2009, BIOCHEMISTRY-US, V48, P3828, DOI 10.1021/bi900212j; Mchaourab HS, 2002, J BIOL CHEM, V277, P40557, DOI 10.1074/jbc.M206250200; NEEDLEMAN SB, 1970, J MOL BIOL, V48, P443, DOI 10.1016/0022-2836(70)90057-4; Nylander JAA, 2004, MRMODELTEST PROGRAM; Ousman SS, 2007, NATURE, V448, P474, DOI 10.1038/nature05935; PAULING L, 1949, SCIENCE, V110, P543, DOI 10.1126/science.110.2865.543; Pettersen EF, 2004, J COMPUT CHEM, V25, P1605, DOI 10.1002/jcc.20084; Posner M, 1999, BBA-GENE STRUCT EXPR, V1447, P271, DOI 10.1016/S0167-4781(99)00155-4; Posner M, 2008, MOL VIS, V14, P806; Reddy GB, 2006, IUBMB LIFE, V58, P632, DOI 10.1080/15216540601010096; Reddy GB, 2000, J BIOL CHEM, V275, P4565, DOI 10.1074/jbc.275.7.4565; Runkle S, 2002, MOL VIS, V8, P45; Schrank TP, 2009, P NATL ACAD SCI USA, V106, P16984, DOI 10.1073/pnas.0906510106; Schultz J, 1998, P NATL ACAD SCI USA, V95, P5857, DOI 10.1073/pnas.95.11.5857; Schymkowitz J, 2005, NUCLEIC ACIDS RES, V33, pW382, DOI 10.1093/nar/gki387; Schymkowitz JWH, 2005, P NATL ACAD SCI USA, V102, P10147, DOI 10.1073/pnas.0501980102; Smith AA, 2006, FEBS J, V273, P481, DOI 10.1111/j.1742-4658.2005.05080.x; Stegh AH, 2008, P NATL ACAD SCI USA, V105, P10703, DOI 10.1073/pnas.0712034105; Stengel F, 2010, P NATL ACAD SCI USA, V107, P2007, DOI 10.1073/pnas.0910126107; Sun Y, 2005, CELL MOL LIFE SCI, V62, P2460, DOI 10.1007/s00018-005-5190-4; THOMPSON JD, 1994, NUCLEIC ACIDS RES, V22, P4673, DOI 10.1093/nar/22.22.4673; Treweek TM, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0001046; Vicart P, 1998, NAT GENET, V20, P92, DOI 10.1038/1765; Waddell PJ, 1997, MOL PHYLOGENET EVOL, V8, P398, DOI 10.1006/mpev.1997.0452; Woolley S, 2003, BIOINFORMATICS, V19, P671, DOI 10.1093/bioinformatics/btg043; Yang ZH, 1997, COMPUT APPL BIOSCI, V13, P555; Yang ZH, 2007, MOL BIOL EVOL, V24, P1586, DOI 10.1093/molbev/msm088	71	16	17	0	14	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 29	2012	7	3							e34438	10.1371/journal.pone.0034438	http://dx.doi.org/10.1371/journal.pone.0034438			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	948SR	22479631	Green Published, Green Submitted, gold			2022-12-25	WOS:000304523400084
J	Bui, C; Barter, MJ; Scott, JL; Xu, YB; Galler, M; Reynard, LN; Rowan, AD; Young, DA				Bui, Catherine; Barter, Matt J.; Scott, Jenny L.; Xu, Yaobo; Galler, Martin; Reynard, Louise N.; Rowan, Andrew D.; Young, David A.			cAMP response element-binding (CREB) recruitment following a specific CpG demethylation leads to the elevated expression of the matrix metalloproteinase 13 in human articular chondrocytes and osteoarthritis	FASEB JOURNAL			English	Article						transcription; cartilage; collagenase; epigenetic	ENDOCHONDRAL BONE-DEVELOPMENT; GENE-EXPRESSION; DNA METHYLATION; RHEUMATOID-ARTHRITIS; COLLAGENASE EXPRESSION; INFLAMMATORY CYTOKINES; TRANSCRIPTION FACTORS; 13-DEFICIENT MICE; CARTILAGE; PROTEIN	Osteoarthritis is a degenerative joint disease characterized by a progressive and irreversible loss of the articular cartilage, due in main part to the cleavage of type II collagen within the matrix by the enzyme matrix metalloproteinase (MMP)13. Here, we examined the methylation status of MMP13 promoter and report the demethylation of specific CpG dinucleotides within its promoter in osteoarthritic compared to normal cartilage, which correlates with increased MMP13 expression. Of the promoter CpG sites examined, the -104 CpG was consistently demethylated following treatment of human articular chondrocytes with 10 mu M DNA-methyltransferase inhibitor 5-aza-2'-deoxycytidine, again correlating with increased MMP13 expression. Methylation of the -104 CpG site resulted in reduced promoter activity in the chondrosarcoma cell line SW1353 as shown by CpG-free luciferase reporter. Using electrophoretic mobility shift assays, we identified CREB as the regulating factor able to only bind to the MMP13 promoter when the -104 CpG is demethylated, and confirmed this binding by chromatin immunoprecipitation. Finally, we demonstrated that CREB induces MMP13 expression only following treatment of SW1353 with 0.5 mu M Ca2+ ionophore A23187. In summary, the -104 CpG is demethylated in osteoarthritic cartilage, correlating with the elevated MMP13 expression and cartilage destruction, providing a highly novel link between epigenetic status and arthritic disease.-Bui, C., Barter, M. J., Scott, J. L., Xu, Y., Galler, M., Reynard, L. N., Rowan, A. D., Young, D. A. cAMP response element-binding (CREB) recruitment following a specific CpG demethylation leads to the elevated expression of the matrix metalloproteinase 13 in human articular chondrocytes and osteoarthritis. FASEB J. 26, 3000-3011 (2012). www.fasebj.org	[Bui, Catherine; Barter, Matt J.; Scott, Jenny L.; Xu, Yaobo; Galler, Martin; Reynard, Louise N.; Rowan, Andrew D.; Young, David A.] Newcastle Univ, Sch Med, Inst Cellular Med, Musculoskeletal Res Grp, Newcastle Upon Tyne NE2 4HH, Tyne & Wear, England	Newcastle University - UK	Young, DA (corresponding author), Newcastle Univ, Sch Med, Inst Cellular Med, Musculoskeletal Res Grp, Newcastle Upon Tyne NE2 4HH, Tyne & Wear, England.	d.a.young@ncl.ac.uk	Young, David/GOV-5677-2022	Young, David/0000-0002-7078-6745; Reynard, Louise/0000-0002-6613-1797	Arthritis Research UK [18726, 19485]; J. G. W. Patterson Foundation; Newcastle University Hospitals Special Trustees, UK; UK National Institute for Health Research Biomedical Research Centre for Aging and Age Related Disease; Northumberland, Tyne; Wear Comprehensive Local Research Network; Versus Arthritis [18746] Funding Source: researchfish	Arthritis Research UK(Versus Arthritis); J. G. W. Patterson Foundation; Newcastle University Hospitals Special Trustees, UK; UK National Institute for Health Research Biomedical Research Centre for Aging and Age Related Disease; Northumberland, Tyne; Wear Comprehensive Local Research Network; Versus Arthritis(Versus Arthritis)	The authors thank Maja Klug and Michael Rehli (University Hospital, Regensburg, Germany) for the kind donation of the pCpGL vector. This work was supported by Arthritis Research UK grants 18726 and 19485, the J. G. W. Patterson Foundation, the Newcastle University Hospitals Special Trustees, UK and the UK National Institute for Health Research Biomedical Research Centre for Aging and Age Related Disease award to the Newcastle on Tyne Hospitals National Health Service Foundation Trust. Clinical and translational research in the Musculoskeletal Research Group is supported by the Northumberland, Tyne, and Wear Comprehensive Local Research Network.	Billinghurst RC, 1997, J CLIN INVEST, V99, P1534, DOI 10.1172/JCI119316; Bock C, 2005, BIOINFORMATICS, V21, P4067, DOI 10.1093/bioinformatics/bti652; Boileau C, 2005, ARTHRITIS RHEUM-US, V52, P488, DOI 10.1002/art.20809; Chan HM, 2001, J CELL SCI, V114, P2363; CHRIVIA JC, 1993, NATURE, V365, P855, DOI 10.1038/365855a0; Dreier R, 2010, ARTHRITIS RES THER, V12, DOI 10.1186/ar3117; Gentleman RC, 2004, GENOME BIOL, V5, DOI 10.1186/gb-2004-5-10-r80; Goldring MB, 2007, J CELL PHYSIOL, V213, P626, DOI 10.1002/jcp.21258; Hansen KD, 2012, BIOSTATISTICS, V13, P204, DOI 10.1093/biostatistics/kxr054; Hashimoto K, 2009, ARTHRITIS RHEUM-US, V60, P3303, DOI 10.1002/art.24882; Iliopoulos D, 2007, ANN RHEUM DIS, V66, P1616, DOI 10.1136/ard.2007.069377; Imagawa K, 2011, BIOCHEM BIOPH RES CO, V405, P362, DOI 10.1016/j.bbrc.2011.01.007; Inada M, 2004, P NATL ACAD SCI USA, V101, P17192, DOI 10.1073/pnas.0407788101; Irizarry RA, 2009, NAT GENET, V41, P178, DOI 10.1038/ng.298; Kasper LH, 2010, EMBO J, V29, P3660, DOI 10.1038/emboj.2010.235; Kent WJ, 2002, GENOME RES, V12, P996, DOI 10.1101/gr.229102; Kevorkian L, 2004, ARTHRITIS RHEUM-US, V50, P131, DOI 10.1002/art.11433; Klug M, 2006, EPIGENETICS-US, V1, P127, DOI 10.4161/epi.1.3.3327; Knauper V, 1996, J BIOL CHEM, V271, P1544, DOI 10.1074/jbc.271.3.1544; Li YW, 2011, DEVELOPMENT, V138, P359, DOI 10.1242/dev.052324; Litherland GJ, 2008, J BIOL CHEM, V283, P14221, DOI 10.1074/jbc.M710136200; Little CB, 2009, ARTHRITIS RHEUM-US, V60, P3723, DOI 10.1002/art.25002; Long FX, 2001, DEVELOPMENT, V128, P541; Mancini DN, 1998, ONCOGENE, V16, P1161, DOI 10.1038/sj.onc.1201630; Matsuo N, 2006, J BIOL CHEM, V281, P5445, DOI 10.1074/jbc.M509923200; McKay JA, 2011, GENES NUTR, V6, P189, DOI 10.1007/s12263-010-0199-1; Miranda TB, 2007, J CELL PHYSIOL, V213, P384, DOI 10.1002/jcp.21224; Murphy G, 2008, NAT CLIN PRACT RHEUM, V4, P128, DOI 10.1038/ncprheum0727; Nile CJ, 2008, ARTHRITIS RHEUM, V58, P2686, DOI 10.1002/art.23758; Ooi SKT, 2008, CELL, V133, P1145, DOI 10.1016/j.cell.2008.06.009; Portela A, 2010, NAT BIOTECHNOL, V28, P1057, DOI 10.1038/nbt.1685; Ramage L, 2009, SCAND J MED SCI SPOR, V19, P457, DOI 10.1111/j.1600-0838.2009.00912.x; Reynard LN, 2011, HUM MOL GENET, V20, P3450, DOI 10.1093/hmg/ddr253; Roach HI, 2005, ARTHRITIS RHEUM-US, V52, P3110, DOI 10.1002/art.21300; Robinson MD, 2010, BIOINFORMATICS, V26, P139, DOI 10.1093/bioinformatics/btp616; Rowan AD, 2001, ARTHRITIS RHEUM-US, V44, P1620, DOI 10.1002/1529-0131(200107)44:7<1620::AID-ART285>3.0.CO;2-B; Rowan AD, 2007, FRONT BIOSCI-LANDMRK, V12, P536, DOI 10.2741/2080; Sato K, 2006, NAT MED, V12, P1410, DOI 10.1038/nm1515; Schmucker AC, 2012, J BIOL CHEM, V287, P1189, DOI 10.1074/jbc.M111.264077; SHENG M, 1990, NEURON, V4, P571, DOI 10.1016/0896-6273(90)90115-V; Stickens D, 2004, DEVELOPMENT, V131, P5883, DOI 10.1242/dev.01461; Sun PQ, 1996, J BIOL CHEM, V271, P3066, DOI 10.1074/jbc.271.6.3066; Takami N, 2006, ARTHRITIS RHEUM-US, V54, P779, DOI 10.1002/art.21637; Takeda H, 2007, BRAIN RES, V1184, P306, DOI 10.1016/j.brainres.2007.09.055; TATE PH, 1993, CURR OPIN GENET DEV, V3, P226, DOI 10.1016/0959-437X(93)90027-M; Tsuda M, 2003, J BIOL CHEM, V278, P27224, DOI 10.1074/jbc.M303471200; Vincenti MP, 2002, ARTHRITIS RES, V4, P157, DOI 10.1186/ar401; Visse R, 2003, CIRC RES, V92, P827, DOI 10.1161/01.RES.0000070112.80711.3D; Whitmarsh AJ, 1996, J MOL MED-JMM, V74, P589, DOI 10.1007/s001090050063; Wu XL, 2001, J BIOL CHEM, V276, P1735, DOI 10.1074/jbc.M006727200; Yano S, 2003, J IMMUNOL, V171, P2510, DOI 10.4049/jimmunol.171.5.2510; Young DA, 2005, ARTHRITIS RES THER, V7, pR503, DOI 10.1186/ar1702; Young DA, 2002, BIOCHEM J, V364, P89, DOI 10.1042/bj3640089; Zhang Q, 2008, ANN RHEUM DIS, V67, P1633, DOI 10.1136/ard.2007.079574	54	84	86	1	14	FEDERATION AMER SOC EXP BIOL	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3998 USA	0892-6638			FASEB J	Faseb J.	JUL	2012	26	7					3000	3011		10.1096/fj.12-206367	http://dx.doi.org/10.1096/fj.12-206367			12	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	967MP	22505473				2022-12-25	WOS:000305912500027
J	Aleshin, AE; DiScipio, RG; Stec, B; Liddington, RC				Aleshin, Alexander E.; DiScipio, Richard G.; Stec, Boguslaw; Liddington, Robert C.			Crystal Structure of C5b-6 Suggests Structural Basis for Priming Assembly of the Membrane Attack Complex	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							FACTOR-I MODULES; PAROXYSMAL-NOCTURNAL HEMOGLOBINURIA; RHEUMATOID-ARTHRITIS; ALTERNATIVE-PATHWAY; PLASMA-PROTEINS; BINDING-SITES; ACTIVATION; C5; COMPONENTS; DOMAINS	The complement membrane attack complex ( MAC) forms transmembrane pores in pathogen membranes. The first step in MAC assembly is cleavage of C5 to generate metastable C5b, which forms a stable complex with C6, termed C5b-6. C5b-6 initiates pore formation via the sequential recruitment of homologous proteins: C7, C8, and 12-18 copies of C9, each of which comprises a central MAC-perforin domain flanked by auxiliary domains. We recently proposed a model of pore assembly, in which the auxiliary domains play key roles, both in stabilizing the closed conformation of the protomers and in driving the sequential opening of the MAC-perforin beta-sheet of each new recruit to the growing pore. Here, we describe an atomic model of C5b-6 at 4.2 angstrom resolution. We show that C5b provides four interfaces for the auxiliary domains of C6. The largest interface is created by the insertion of an interdomain linker from C6 into a hydrophobic groove created by a major reorganization of the alpha-helical domain of C5b. In combination with the rigid body docking of N-terminal elements of both proteins, C5b becomes locked into a stable conformation. Both C6 auxiliary domains flanking the linker pack tightly against C5b. The net effect is to induce the clockwise rigid body rotation of four auxiliary domains, as well as the opening/twisting of the central beta-sheet of C6, in the directions predicted by our model to activate or prime C6 for the subsequent steps in MAC assembly. The complex also suggests novel small molecule strategies for modulating pathological MAC assembly.	[Aleshin, Alexander E.; Stec, Boguslaw; Liddington, Robert C.] Sanford Burnham Med Res Inst, Program Infect Dis, La Jolla, CA 92037 USA; [DiScipio, Richard G.] Torrey Pines Inst Mol Studies, San Diego, CA 92121 USA	Sanford Burnham Prebys Medical Discovery Institute; Torrey Pines Institute for Molecular Studies, California	Liddington, RC (corresponding author), Sanford Burnham Med Res Inst, Program Infect Dis, 10901 N Torrey Pines Rd, La Jolla, CA 92037 USA.	rlidding@sanfordburnham.org		Stec, Boguslaw/0000-0002-8696-0349	National Institutes of Health [AI055789, AI055860]; United States Army Medical Research and Materiel Command [DAMD17-03-2-0038]; Multiple Sclerosis National Research Institute [4061]; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [P01AI055789, R01AI055860] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); United States Army Medical Research and Materiel Command(United States Department of DefenseUnited States ArmyU.S. Army Medical Research & Materiel Command (USAMRMC)); Multiple Sclerosis National Research Institute; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	This work was supported, in whole or in part, by National Institutes of Health Grants AI055789 and AI055860 (to R. C. L.). This work was also supported by United States Army Medical Research and Materiel Command Grant DAMD17-03-2-0038 (to R. C. L.) and Multiple Sclerosis National Research Institute Grant 4061 (to R. G. D.).	Aleshin AE, 2012, J BIOL CHEM, V287, P10210, DOI 10.1074/jbc.M111.327809; Banyai L, 1999, PROTEIN SCI, V8, P1636, DOI 10.1110/ps.8.8.1636; BENNETT MJ, 1994, P NATL ACAD SCI USA, V91, P3127, DOI 10.1073/pnas.91.8.3127; CAMUSSI G, 1985, J IMMUNOL, V135, P2409; COOPER NR, 1970, J EXP MED, V132, P775, DOI 10.1084/jem.132.4.775; Daha MR, 2010, CRIT REV IMMUNOL, V30, P47, DOI 10.1615/CritRevImmunol.v30.i1.30; Dinu V, 2007, GENET EPIDEMIOL, V31, P224, DOI 10.1002/gepi.20204; DiScipio R. G, 1998, COMPLEMENT SYSTEM, P50; DISCIPIO RG, 1992, J BIOL CHEM, V267, P17087; DiScipio RG, 1999, J BIOL CHEM, V274, P31811, DOI 10.1074/jbc.274.45.31811; DISCIPIO RG, 1983, J BIOL CHEM, V258, P629; DISCIPIO RG, 1981, BIOCHEM J, V199, P497, DOI 10.1042/bj1990497; DISCIPIO RG, 1994, PROTEIN EXPRES PURIF, V5, P170, DOI 10.1006/prep.1994.1027; EHRENGRUBER MU, 1994, FEBS LETT, V346, P181, DOI 10.1016/0014-5793(94)00463-3; Emsley P, 2010, ACTA CRYSTALLOGR D, V66, P486, DOI 10.1107/S0907444910007493; FERNANDEZ HN, 1978, J BIOL CHEM, V253, P6955; Forneris F, 2010, SCIENCE, V330, P1816, DOI 10.1126/science.1195821; Fraser DA, 2003, J BIOL CHEM, V278, P48921, DOI 10.1074/jbc.M302598200; Fredslund F, 2008, NAT IMMUNOL, V9, P753, DOI 10.1038/ni.1625; Garcia BL, 2010, J MOL BIOL, V402, P17, DOI 10.1016/j.jmb.2010.07.029; Gronenborn AM, 2009, CURR OPIN STRUC BIOL, V19, P39, DOI 10.1016/j.sbi.2008.12.002; Guo RF, 2005, ANNU REV IMMUNOL, V23, P821, DOI 10.1146/annurev.immunol.23.021704.115835; Ingram G, 2009, CLIN EXP IMMUNOL, V155, P128, DOI 10.1111/j.1365-2249.2008.03830.x; Janssen BJC, 2006, NATURE, V444, P213, DOI 10.1038/nature05172; Katschke KJ, 2009, J BIOL CHEM, V284, P10473, DOI 10.1074/jbc.M809106200; KOLB WP, 1972, J EXP MED, V135, P549, DOI 10.1084/jem.135.3.549; KOSKI CL, 1987, J CLIN INVEST, V80, P1492, DOI 10.1172/JCI113231; Laursen NS, 2011, EMBO J, V30, P606, DOI 10.1038/emboj.2010.341; Laursen NS, 2010, P NATL ACAD SCI USA, V107, P3681, DOI 10.1073/pnas.0910565107; Lee M., 2012, NEUROBIOL AGING; Liu Y, 2002, PROTEIN SCI, V11, P1285, DOI 10.1110/ps.0201402; Manthey HD, 2009, INT J BIOCHEM CELL B, V41, P2114, DOI 10.1016/j.biocel.2009.04.005; McCoy AJ, 2007, ACTA CRYSTALLOGR D, V63, P32, DOI 10.1107/S0907444906045975; MCGEER PL, 1989, NEUROSCI LETT, V107, P341, DOI 10.1016/0304-3940(89)90843-4; McKeage K, 2011, DRUGS, V71, P2327, DOI 10.2165/11208300-000000000-00000; MULLEREBERHARD HJ, 1986, ANNU REV IMMUNOL, V4, P503, DOI 10.1146/annurev.iy.04.040186.002443; Murshudov GN, 2011, ACTA CRYSTALLOGR D, V67, P355, DOI 10.1107/S0907444911001314; Nishida N, 2006, P NATL ACAD SCI USA, V103, P19737, DOI 10.1073/pnas.0609791104; Nozaki M, 2006, P NATL ACAD SCI USA, V103, P2328, DOI 10.1073/pnas.0408835103; Okroj M, 2007, ANN MED, V39, P517, DOI 10.1080/07853890701477546; Phelan MM, 2009, J BIOL CHEM, V284, P19637, DOI 10.1074/jbc.M901993200; PODACK ER, 1980, J EXP MED, V151, P301, DOI 10.1084/jem.151.2.301; PODACK ER, 1979, P NATL ACAD SCI USA, V76, P897, DOI 10.1073/pnas.76.2.897; Qiao F, 2006, AM J PATHOL, V169, P1039, DOI 10.2353/ajpath.2006.060248; Ricklin D, 2007, NAT BIOTECHNOL, V25, P1265, DOI 10.1038/nbt1342; Rooijakkers SHM, 2009, NAT IMMUNOL, V10, P721, DOI 10.1038/ni.1756; ROSS GD, 1985, J IMMUNOL, V135, P2005; ROSS GD, 1983, J EXP MED, V158, P334, DOI 10.1084/jem.158.2.334; Rother RP, 2007, NAT BIOTECHNOL, V25, P1256, DOI 10.1038/nbt1344; Stahl AL, 2009, MOL IMMUNOL, V46, P2236, DOI 10.1016/j.molimm.2009.04.012; Thai CT, 2005, J IMMUNOL, V174, P6227, DOI 10.4049/jimmunol.174.10.6227; Thai CT, 2004, J IMMUNOL, V173, P4547, DOI 10.4049/jimmunol.173.7.4547; Thai CT, 2003, J IMMUNOL, V171, P6565, DOI 10.4049/jimmunol.171.12.6565; TSCHOPP J, 1984, J BIOL CHEM, V259, P1922; TSCHOPP J, 1982, NATURE, V298, P534, DOI 10.1038/298534a0; Turnberg D, 2004, AM J PATHOL, V165, P825, DOI 10.1016/S0002-9440(10)63345-7; Welch TR, 2001, FRONT BIOSCI, V6, pD898, DOI 10.2741/Welch; WHALEY K, 1997, COMPLEMENT PRACTICAL, P19; Wiesmann C, 2006, NATURE, V444, P217, DOI 10.1038/nature05263; Williams AS, 2004, ARTHRITIS RHEUM-US, V50, P3035, DOI 10.1002/art.20478; Wu J, 2009, NAT IMMUNOL, V10, P728, DOI 10.1038/ni.1755	61	46	47	1	7	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JUN 1	2012	287	23					19642	19652		10.1074/jbc.M112.361121	http://dx.doi.org/10.1074/jbc.M112.361121			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	974EF	22500023	Green Published, hybrid			2022-12-25	WOS:000306411900075
J	Mallipattu, SK; Liu, RJ; Zheng, F; Narla, G; Ma'ayan, A; Dikman, S; Jain, MK; Saleem, M; D'Agati, V; Klotman, P; Chuang, PY; He, JC				Mallipattu, Sandeep K.; Liu, Ruijie; Zheng, Feng; Narla, Goutham; Ma'ayan, Avi; Dikman, Steven; Jain, Mukesh K.; Saleem, Moin; D'Agati, Vivette; Klotman, Paul; Chuang, Peter Y.; He, John C.			Kruppel-like Factor 15 (KLF15) Is a Key Regulator of Podocyte Differentiation	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							HIV-ASSOCIATED NEPHROPATHY; FOCAL SEGMENTAL GLOMERULOSCLEROSIS; GLOMERULAR PODOCYTES; TRANSGENIC MICE; IN-VIVO; EXPRESSION; PROLIFERATION; RETINOIDS; KIDNEY; PATHOGENESIS	Podocyte injury resulting from a loss of differentiation is the hallmark of many glomerular diseases. We previously showed that retinoic acid (RA) induces podocyte differentiation via stimulation of the cAMP pathway. However, many podocyte maturity markers lack binding sites for RA-response element or cAMP-response element (CREB) in their promoter regions. We hypothesized that transcription factors induced by RA and downstream of CREB mediate podocyte differentiation. We performed microarray gene expression studies in human podocytes treated with and without RA to identify differentially regulated genes. In comparison with known CREB target genes, we identified Kruppel-like factor 15 (KLF15), a kidney-enriched nuclear transcription factor, that has been previously shown to mediate cell differentiation. We confirmed that RA increased KLF15 expression in both murine and human podocytes. Overexpression of KLF15 stimulated expression of differentiation markers in both wild-type and HIV-1-infected podocytes. Also, KLF15 binding to the promoter regions of nephrin and podocin was increased in RA-treated podocytes. Although KLF15(-/-) mice at base line had minimal phenotype, lipopolysaccharide or adriamycin-treated KLF15(-/-) mice had a significant increase in proteinuria and podocyte foot process effacement with a reduction in the expression of podocyte differentiation markers as compared with the wild-type treated mice. Finally, KLF15 expression was reduced in glomeruli isolated from HIV transgenic mice as well as in kidney biopsies from patients with HIV-associated nephropathy and idiopathic focal segmental glomerulosclerosis. These results indicate a critical role of KLF15 in mediating podocyte differentiation and in protecting podocytes against injury.	[Mallipattu, Sandeep K.; Chuang, Peter Y.; He, John C.] Mt Sinai Sch Med, Dept Med, Div Nephrol, New York, NY 10029 USA; [Liu, Ruijie; He, John C.] James J Peters Vet Affairs Med Ctr, Renal Sect, New York, NY 10468 USA; [Zheng, Feng] Mt Sinai Sch Med, Dept Geriatr, Div Geriatr, New York, NY 10029 USA; [Narla, Goutham] Mt Sinai Sch Med, Dept Genet & Genom Sci, New York, NY 10029 USA; [Ma'ayan, Avi; He, John C.] Mt Sinai Sch Med, Dept Pharmacol & Syst Therapeut, New York, NY 10029 USA; [Dikman, Steven] Mt Sinai Sch Med, Dept Pathol, New York, NY 10029 USA; [Jain, Mukesh K.] Case Western Reserve Univ, Case Cardiovasc Inst, Dept Med, Res Inst, Cleveland, OH 44106 USA; [Saleem, Moin] Univ Bristol, Southmead Hosp, Childrens Renal Unit, Bristol BS10 5NB, Avon, England; [Saleem, Moin] Univ Bristol, Southmead Hosp, Acad Renal Unit, Bristol BS10 5NB, Avon, England; [Klotman, Paul] Baylor Coll Med, Houston, TX 77030 USA; [D'Agati, Vivette] Columbia Univ, Dept Pathol, New York, NY 10032 USA	Icahn School of Medicine at Mount Sinai; Icahn School of Medicine at Mount Sinai; Icahn School of Medicine at Mount Sinai; Icahn School of Medicine at Mount Sinai; Icahn School of Medicine at Mount Sinai; Case Western Reserve University; Southmead Hospital; University of Bristol; Southmead Hospital; University of Bristol; Baylor College of Medicine; Columbia University	He, JC (corresponding author), Mt Sinai Sch Med, Dept Med Nephrol, 1 Gustave L Levy Pl,Box 1243, New York, NY 10029 USA.	cijiang.he@mssm.edu	Mallipattu, Sandeep/M-7009-2014; Narla, Goutham/AAZ-5710-2020; Ma'ayan, Avi/AAG-3131-2019	Narla, Goutham/0000-0003-4098-4203; Ma'ayan, Avi/0000-0002-6904-1017; Saleem, Moin/0000-0002-9808-4518	National Institutes of Health from NIDDK [1R01DK078897-01, R01HL084154, P01DK056492, T32 DK07757-12, 5K08DK082760]; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL084154] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [F32DK094635, P01DK056492, K08DK082760, R01DK078897, T32DK007757] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [P50GM071558, R01GM098316] Funding Source: NIH RePORTER	National Institutes of Health from NIDDK; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported, in whole or in part, by National Institutes of Health Grants 1R01DK078897-01 (to J. H.), R01HL084154 (to M. K. J.), P01DK056492 (to P. K.), 5K08DK082760 (to P. Y. C.), and T32 DK07757-12 (to S. K. M.) from NIDDK.	Barisoni L, 1999, J AM SOC NEPHROL, V10, P51; Barisoni L, 2000, KIDNEY INT, V58, P173, DOI 10.1046/j.1523-1755.2000.00152.x; Bruggeman LA, 1997, J CLIN INVEST, V100, P84, DOI 10.1172/JCI119525; Bruggeman LA, 2001, KIDNEY INT, V59, P2174, DOI 10.1046/j.1523-1755.2001.0590062174.x; Cohen CD, 2006, P NATL ACAD SCI USA, V103, P5682, DOI 10.1073/pnas.0511257103; de Lema GP, 2004, KIDNEY INT, V66, P1018, DOI 10.1111/j.1523-1755.2004.00850.x; DICKIE P, 1991, VIROLOGY, V185, P109, DOI 10.1016/0042-6822(91)90759-5; Eaton SA, 2008, J BIOL CHEM, V283, P26937, DOI 10.1074/jbc.M804831200; Evans TRJ, 1999, BRIT J CANCER, V80, P1, DOI 10.1038/sj.bjc.6690312; Feinberg MW, 2004, TRENDS CARDIOVAS MED, V14, P241, DOI 10.1016/j.tcm.2004.06.005; Feng XB, 2009, J AM SOC NEPHROL, V20, P2138, DOI 10.1681/ASN.2008080879; Fisch S, 2007, P NATL ACAD SCI USA, V104, P7074, DOI 10.1073/pnas.0701981104; Gassmann M, 2009, ELECTROPHORESIS, V30, P1845, DOI 10.1002/elps.200800720; He JCJ, 2004, J CLIN INVEST, V114, P643, DOI 10.1172/JCI200421004; He JCJ, 2007, J AM SOC NEPHROL, V18, P93, DOI 10.1681/ASN.2006070727; Husain M, 2002, J AM SOC NEPHROL, V13, DOI 10.1097/01.ASN.0000019642.55998.69; Katsuya K, 2006, KIDNEY INT, V69, P2101, DOI 10.1038/sj.ki.5000398; Koop K, 2003, J AM SOC NEPHROL, V14, P2063, DOI 10.1097/01.ASN.0000078803.53165.C9; Kriz W, 1998, KIDNEY INT, V54, P687, DOI 10.1046/j.1523-1755.1998.00044.x; Lee TI, 2006, NAT PROTOC, V1, P729, DOI 10.1038/nprot.2006.98; Lee VWS, 2011, NEPHROLOGY, V16, P30, DOI 10.1111/j.1440-1797.2010.01383.x; Lehrke I, 2002, AM J PHYSIOL-RENAL, V282, pF741, DOI 10.1152/ajprenal.00026.2001; Lu TC, 2008, MOL CELL BIOL, V28, P5785, DOI 10.1128/MCB.00245-08; Mori T, 2005, J BIOL CHEM, V280, P12867, DOI 10.1074/jbc.M410515200; Palmer RE, 2001, CURR BIOL, V11, P1805, DOI 10.1016/S0960-9822(01)00560-7; Pearson R, 2008, INT J BIOCHEM CELL B, V40, P1996, DOI 10.1016/j.biocel.2007.07.018; Potapova TA, 2011, MOL BIOL CELL, V22, P1191, DOI 10.1091/mbc.E10-07-0599; Reiser J, 2004, J AM SOC NEPHROL, V15, P2246, DOI 10.1097/01.ASN.0000136312.46464.33; Ross MJ, 2006, JAIDS-J ACQ IMM DEF, V42, P1, DOI 10.1097/01.qai.0000218353.60099.4f; Ross MJ, 2005, J AM SOC NEPHROL, V16, P2403, DOI 10.1681/ASN.2004121101; Schwartz EJ, 2001, J AM SOC NEPHROL, V12, P1677, DOI 10.1681/ASN.V1281677; Sun Y, 2009, AM J NEPHROL, V29, P558, DOI 10.1159/000191469; Suzuki A, 2003, J AM SOC NEPHROL, V14, P981, DOI 10.1097/01.ASN.0000057857.66268.8F; Takemoto M, 2002, AM J PATHOL, V161, P799, DOI 10.1016/S0002-9440(10)64239-3; Tsui CC, 2006, J AM SOC NEPHROL, V17, P1543, DOI 10.1681/ASN.2005080835; Vaughan MR, 2005, KIDNEY INT, V68, P133, DOI 10.1111/j.1523-1755.2005.00387.x; White JT, 2010, DEVELOPMENT, V137, P1863, DOI 10.1242/dev.042887; Wolf G, 2005, DIABETES, V54, P1626, DOI 10.2337/diabetes.54.6.1626; Xu Q, 2004, KIDNEY INT, V66, P2119, DOI 10.1111/j.1523-1755.2004.66002.x	39	76	82	0	8	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JUN 1	2012	287	23					19122	19135		10.1074/jbc.M112.345983	http://dx.doi.org/10.1074/jbc.M112.345983			14	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	974EF	22493483	Green Published, hybrid			2022-12-25	WOS:000306411900023
J	Lee, J; Kim, JCK; Lee, SE; Quinley, C; Kim, H; Herdman, S; Corr, M; Raz, E				Lee, Jongdae; Kim, Joanna C. K.; Lee, Shee-Eun; Quinley, Christine; Kim, HyeRi; Herdman, Scott; Corr, Maripat; Raz, Eyal			Signal Transducer and Activator of Transcription 3 (STAT3) Protein Suppresses Adenoma-to-carcinoma Transition in Apc(min/+) Mice via Regulation of Snail-1 (SNAI) Protein Stability	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							GLYCOGEN-SYNTHASE KINASE-3; HUMAN COLORECTAL ADENOCARCINOMA; INTESTINAL EPITHELIAL-CELLS; TAU PHOSPHORYLATION; TUMOR PROGRESSION; CANCER; TUMORIGENESIS; EXPRESSION; INCREASES; RECEPTOR	STAT3 was recently reported to suppress tumor invasion in Apc(min/+) mice. We investigated the mechanisms by which STAT3 inhibits intestinal epithelial tumors using Apc(min/+)/Stat3(IEC-KO) mice (intestinal epithelial cell (IEC)-specific deletion of STAT3 in the Apc(min/+) background) to determine the role of STAT3 in carcinogenesis in vivo as well as colorectal cancer cell lines in vitro. To inhibit invasion of IEC tumors, STAT3 functions as a molecular adaptor rather than a transcription factor. Accordingly, the tumors in Apc(min/+)/Stat3(IEC-KO) mice undergo adenoma-to-carcinoma transition and acquire an invasive phenotype. Similarly, STAT3 knockdown in a colorectal cell line enhances IEC invasion. We demonstrate that STAT3 down-regulates SNAI (Snail-1) expression levels and hence suppresses epithelial-mesenchymal transition of colorectal cancer cells. Mechanistically, STAT3 facilitates glycogen synthase kinase (GSK) 3 beta-mediated degradation of SNAI by regulating phosphorylation of GSK3 beta. Our data identified a new role for STAT3 in the adenoma-to-carcinoma sequence of intestinal tumors.	[Lee, Jongdae; Kim, Joanna C. K.; Lee, Shee-Eun; Quinley, Christine; Kim, HyeRi; Herdman, Scott; Corr, Maripat; Raz, Eyal] Univ Calif San Diego, Dept Med, La Jolla, CA 92093 USA	University of California System; University of California San Diego	Lee, J (corresponding author), 9500 Gilman Dr, La Jolla, CA 92093 USA.	j142lee@ucsd.edu; eraz@ucsd.edu		Lee, Jongdae/0000-0002-6270-4658	National Institutes of Health [A1068685, A1095623, DK35108, DK080506]; Crohns and Colitis Foundation of America; National Institutes of Health through the NINDS [P30 NS047101]; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI068685, U01AI095623] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [P01DK035108, R24DK080506] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [P30NS047101] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Crohns and Colitis Foundation of America; National Institutes of Health through the NINDS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))	This work was supported, in whole or in part, by National Institutes of Health Grants A1068685, A1095623, DK35108, and DK080506. This work was also supported by a grant from Crohns and Colitis Foundation of America.; We thank Jennifer Meerloo for assistance in confocal imaging at the University of California at San Diego Neuroscience Microscopy Shared Facility funded by National Institutes of Health Grant P30 NS047101 through the NINDS.	Batlle E, 2005, NATURE, V435, P1126, DOI 10.1038/nature03626; Bilger A, 1996, SEMIN CANCER BIOL, V7, P249, DOI 10.1006/scbi.1996.0033; Bollrath J, 2009, CANCER CELL, V15, P91, DOI 10.1016/j.ccr.2009.01.002; Carrozzino F, 2005, AM J PHYSIOL-CELL PH, V289, pC1002, DOI 10.1152/ajpcell.00175.2005; Catlett-Falcone R, 1999, IMMUNITY, V10, P105, DOI 10.1016/S1074-7613(00)80011-4; Chan KS, 2004, J CLIN INVEST, V114, P720, DOI 10.1172/JCI200421032; Chiarle R, 2005, NAT MED, V11, P623, DOI 10.1038/nm1249; CROSS DAE, 1995, NATURE, V378, P785, DOI 10.1038/378785a0; FEARON ER, 1990, CELL, V61, P759, DOI 10.1016/0092-8674(90)90186-I; Fearon ER, 2011, ANNU REV PATHOL-MECH, V6, P479, DOI 10.1146/annurev-pathol-011110-130235; Grivennikov S, 2009, CANCER CELL, V15, P103, DOI 10.1016/j.ccr.2009.01.001; Grivennikov SI, 2010, CYTOKINE GROWTH F R, V21, P11, DOI 10.1016/j.cytogfr.2009.11.005; Halberg RB, 2000, P NATL ACAD SCI USA, V97, P3461, DOI 10.1073/pnas.050585597; Hartigan JA, 1999, J BIOL CHEM, V274, P21395, DOI 10.1074/jbc.274.30.21395; Hotary KB, 2003, CELL, V114, P33, DOI 10.1016/S0092-8674(03)00513-0; Ikenouchi J, 2003, J CELL SCI, V116, P1959, DOI 10.1242/jcs.00389; Kessenbrock K, 2010, CELL, V141, P52, DOI 10.1016/j.cell.2010.03.015; Kinoshita E, 2011, PROTEOMICS, V11, P319, DOI 10.1002/pmic.201000472; Kobayashi M, 2003, J CLIN INVEST, V111, P1297, DOI 10.1172/JCI200317085; Kusaba T, 2005, J CLIN PATHOL, V58, P833, DOI 10.1136/jcp.2004.023416; Lee J, 2006, NAT CELL BIOL, V8, P1327, DOI 10.1038/ncb1500; Lee SH, 2010, NAT MED, V16, P665, DOI 10.1038/nm.2143; Lesort M, 1999, J NEUROCHEM, V72, P576, DOI 10.1046/j.1471-4159.1999.0720576.x; Liu L, 2005, P NATL ACAD SCI USA, V102, P8150, DOI 10.1073/pnas.0501643102; Martinez-Estrada OM, 2006, BIOCHEM J, V394, P449, DOI 10.1042/BJ20050591; Musteanu M, 2010, GASTROENTEROLOGY, V138, P1003, DOI 10.1053/j.gastro.2009.11.049; Ng DCH, 2006, J CELL BIOL, V172, P245, DOI 10.1083/jcb.200503021; Ota I, 2009, P NATL ACAD SCI USA, V106, P20318, DOI 10.1073/pnas.0910962106; Park JK, 2008, ONCOL REP, V20, P597, DOI 10.3892/or_00000047; PEIFER M, 1994, DEV BIOL, V166, P543, DOI 10.1006/dbio.1994.1336; Peinado H, 2007, NAT REV CANCER, V7, P415, DOI 10.1038/nrc2131; Pfeffer LM, 1997, SCIENCE, V276, P1418, DOI 10.1126/science.276.5317.1418; Pilati C, 2011, J EXP MED, V208, P1359, DOI 10.1084/jem.20110283; PLYTE SE, 1992, BIOCHIM BIOPHYS ACTA, V1114, P147, DOI 10.1016/0304-419X(92)90012-N; Rivat C, 2004, ONCOGENE, V23, P3317, DOI 10.1038/sj.onc.1207437; Schaffer B, 2003, GENE, V302, P73, DOI 10.1016/S0378-1119(02)01092-2; Takaku K, 1998, CELL, V92, P645, DOI 10.1016/S0092-8674(00)81132-0; Thornton TM, 2008, SCIENCE, V320, P667, DOI 10.1126/science.1156037; Yost C, 1996, GENE DEV, V10, P1443, DOI 10.1101/gad.10.12.1443; Yu H, 2009, NAT REV CANCER, V9, P798, DOI 10.1038/nrc2734; Zhou BHP, 2004, NAT CELL BIOL, V6, P931, DOI 10.1038/ncb1173; Zucker S, 2004, CANCER METAST REV, V23, P101, DOI 10.1023/A:1025867130437	42	53	54	1	16	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAY 25	2012	287	22					18182	18189		10.1074/jbc.M111.328831	http://dx.doi.org/10.1074/jbc.M111.328831			8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	974EC	22496368	Green Published, hybrid			2022-12-25	WOS:000306411600026
J	Fieder, M; Huber, S				Fieder, Martin; Huber, Susanne			The Association between Pro-Social Attitude and Reproductive Success Differs between Men and Women	PLOS ONE			English	Article							STRONG RECIPROCITY; RURAL GAMBIA; FERTILITY; HUMANS; COOPERATION; REPUTATION; EVOLUTION; WORK; LIFE; KIN	The evolution of pro-social attitude and cooperation in humans is under debate. Most of the knowledge on human cooperation results from laboratory experiments and theoretic modeling. Evolutionary explanations, however, rest upon fitness consequences. We therefore examined fitness correlates of pro-social behavior in a real life setting, analyzing data from the Wisconsin Longitudinal Study (n = 2545 men, 2967 women). We investigated whether pro-social attitude, proxied by self reported voluntary work, is associated with lifetime reproductive success. We find a sex difference in the association between pro-social attitude and offspring number. In men, a pro-social attitude was associated with higher offspring number, whereas in women, it was associated with lower offspring count. To our knowledge, this is the first study to demonstrate fitness consequences of pro-social behavior towards strangers. We conclude that analysing real life settings may help to explain the evolutionary forces leading to pro-social behavior in humans and speculate that these factors might differ between the sexes.	[Fieder, Martin; Huber, Susanne] Univ Vienna, Dept Anthropol, Vienna, Austria; [Huber, Susanne] Univ Vet Med Vienna, Res Inst Wildlife Ecol, Vienna, Austria	University of Vienna; University of Veterinary Medicine Vienna	Fieder, M (corresponding author), Univ Vienna, Dept Anthropol, Vienna, Austria.	martin.fieder@univie.ac.at			National Institute on Aging [AG-9775 AG-21079, AG-033285]; Vilas Estate Trust; National Science Foundation; Spencer Foundation; Graduate School of the University of Wisconsin-Madison; NATIONAL INSTITUTE ON AGING [R01AG009775, R01AG033285, P01AG021079] Funding Source: NIH RePORTER	National Institute on Aging(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA)); Vilas Estate Trust; National Science Foundation(National Science Foundation (NSF)); Spencer Foundation; Graduate School of the University of Wisconsin-Madison; NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA))	Since 1991, the WLS has been supported principally by the National Institute on Aging (AG-9775 AG-21079 and AG-033285), with additional support from the Vilas Estate Trust, the National Science Foundation, the Spencer Foundation, and the Graduate School of the University of Wisconsin-Madison. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bereczkei T, 1998, EVOL HUM BEHAV, V19, P283, DOI 10.1016/S1090-5138(98)00027-0; Bereczkei T, 2007, EVOL HUM BEHAV, V28, P277, DOI 10.1016/j.evolhumbehav.2007.04.002; Bereczkei T, 2010, EVOL HUM BEHAV, V31, P95, DOI 10.1016/j.evolhumbehav.2009.07.004; Bernhard H, 2006, NATURE, V442, P912, DOI 10.1038/nature04981; Bowles S, 2004, THEOR POPUL BIOL, V65, P17, DOI 10.1016/j.tpb.2003.07.001; Crawley MJ, R BOOK JOHN; Day KM, 1997, APPL ECON, V29, P707, DOI 10.1080/000368497326642; Draper P, 2000, HUM NATURE-INT BIOS, V11, P117, DOI 10.1007/s12110-000-1016-0; Fehr E, 2002, HUM NATURE-INT BIOS, V13, P1, DOI 10.1007/s12110-002-1012-7; Fieder M, 2005, ETHOLOGY, V111, P940, DOI 10.1111/j.1439-0310.2005.01129.x; Fieder M, 2011, HUM NAT IN PRESS; Fieder M, 2007, EVOL HUM BEHAV, V28, P392, DOI 10.1016/j.evolhumbehav.2007.05.004; Gurven M, 2000, EVOL HUM BEHAV, V21, P263, DOI 10.1016/S1090-5138(00)00032-5; Gurven M, 2004, BEHAV BRAIN SCI, V27, P543, DOI 10.1017/S0140525X04000123; Hawkes K, 2002, EVOL ANTHROPOL, V11, P58, DOI 10.1002/evan.20005; Hopcroft RL, 2006, EVOL HUM BEHAV, V27, P104, DOI 10.1016/j.evolhumbehav.2005.07.004; Milinski M, 2002, P ROY SOC B-BIOL SCI, V269, P881, DOI 10.1098/rspb.2002.1964; Nettle D, 2008, AM NAT, V172, P658, DOI 10.1086/591690; O'Hara RB, 2010, METHODS ECOL EVOL, V1, P118, DOI 10.1111/j.2041-210X.2010.00021.x; Sear R, 2003, EVOL HUM BEHAV, V24, P25, DOI 10.1016/S1090-5138(02)00105-8; Sear R, 2002, DEMOGRAPHY, V39, P43, DOI 10.1353/dem.2002.0010; Sosis R, 2000, EVOL HUM BEHAV, V21, P223, DOI 10.1016/S1090-5138(00)00030-1; West SA, 2011, EVOL HUM BEHAV, V32, P231, DOI 10.1016/j.evolhumbehav.2010.08.001	23	3	3	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 9	2012	7	4							e33489	10.1371/journal.pone.0033489	http://dx.doi.org/10.1371/journal.pone.0033489			3	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	955JO	22496750	Green Published, gold			2022-12-25	WOS:000305014500011
J	Oster, M; Murani, E; Metges, CC; Ponsuksili, S; Wimmers, K				Oster, Michael; Murani, Eduard; Metges, Cornelia C.; Ponsuksili, Siriluck; Wimmers, Klaus			A Gestational High Protein Diet Affects the Abundance of Muscle Transcripts Related to Cell Cycle Regulation throughout Development in Porcine Progeny	PLOS ONE			English	Article							FOLIC-ACID SUPPLEMENTATION; POLO-LIKE KINASES; SKELETAL-MUSCLE; GENE-EXPRESSION; GLUCOCORTICOID-RECEPTOR; GROWTH; RESTRICTION; FETAL; ALTERS; PERFORMANCE	Background: In various animal models pregnancy diets have been shown to affect offspring phenotype. Indeed, the underlying programming of development is associated with modulations in birth weight, body composition, and continual diet-dependent modifications of offspring metabolism until adulthood, producing the hypothesis that the offspring's transcriptome is permanently altered depending on maternal diet. Methodology/Principal Findings: To assess alterations of the offspring's transcriptome due to gestational protein supply, German Landrace sows were fed isoenergetic diets containing protein levels of either 30% (high protein - HP) or 12% (adequate protein - AP) throughout their pregnancy. Offspring muscle tissue (M. longissimus dorsi) was collected at 94 days post conception (dpc), and 1, 28, and 188 days post natum (dpn) for use with Affymetrix GeneChip Porcine Genome Arrays and subsequent statistical and Ingenuity pathway analyses. Numerous transcripts were found to have altered abundance at 94 dpc and 1 dpn; at 28 dpn no transcripts were altered, and at 188 dpn only a few transcripts showed a different abundance between diet groups. However, when assessing transcriptional changes across developmental time points, marked differences were obvious among the dietary groups. Depending on the gestational dietary exposure, short- and long-term effects were observed for mRNA expression of genes related to cell cycle regulation, energy metabolism, growth factor signaling pathways, and nucleic acid metabolism. In particular, the abundance of transcripts related to cell cycle remained divergent among the groups during development. Conclusion: Expression analysis indicates that maternal protein supply induced programming of the offspring's genome; early postnatal compensation of the slight growth retardation obvious at birth in HP piglets resulted, as did a permanently different developmental alteration and responsiveness to the common environment of the transcriptome. The transcriptome modulations are interpreted as the molecular equivalent of developmental plasticity of the offspring that necessitates adaptation and maintenance of the organismal phenotype.	[Oster, Michael; Murani, Eduard; Wimmers, Klaus] Leibniz Inst Farm Anim Biol FBN, Res Unit Mol Biol, Dummerstorf, Germany; [Metges, Cornelia C.] Leibniz Inst Farm Anim Biol FBN, Res Unit Nutr Physiol, Dummerstorf, Germany; [Ponsuksili, Siriluck] Leibniz Inst Farm Anim Biol FBN, Res Grp Funct Genom, Dummerstorf, Germany	Forschungsinstitut fur Nutztierbiologie (FBN); Forschungsinstitut fur Nutztierbiologie (FBN); Forschungsinstitut fur Nutztierbiologie (FBN)	Oster, M (corresponding author), Leibniz Inst Farm Anim Biol FBN, Res Unit Mol Biol, Dummerstorf, Germany.	wimmers@fbn-dummerstorf.de	Wimmers, Klaus/AAF-9434-2020	Wimmers, Klaus/0000-0002-9523-6790	German Federal Ministry of Education and Research, Bonn, Germany [FKZ 0315132A]	German Federal Ministry of Education and Research, Bonn, Germany	The study was part of the project FEPROeXPRESS (FUGATO plus, FKZ 0315132A) funded by the German Federal Ministry of Education and Research, Bonn, Germany. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bertram C, 2001, ENDOCRINOLOGY, V142, P2841, DOI 10.1210/en.142.7.2841; Borengasser SJ, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0024068; Ciciarello M, 2007, CELL MOL LIFE SCI, V64, P1891, DOI 10.1007/s00018-007-6568-2; Coupe B, 2009, AM J PHYSIOL-REG I, V297, pR813, DOI 10.1152/ajpregu.00201.2009; D'Andrea M, 2011, ANIM GENET, V42, P501, DOI 10.1111/j.1365-2052.2010.02164.x; Desai M, 1996, BRIT J NUTR, V76, P591, DOI 10.1079/BJN19960065; Gallou-Kabani C, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0014398; Glover DM, 1998, GENE DEV, V12, P3777, DOI 10.1101/gad.12.24.3777; Gondret F, 2005, LIVEST PROD SCI, V93, P137, DOI 10.1016/j.livprodsci.2004.09.009; Jorgensen P, 2004, CURR BIOL, V14, pR1014, DOI 10.1016/j.cub.2004.11.027; Karunaratne J. F., 2006, Archiv fur Tierzucht, V49, P19; Karunaratne JF, 2005, J ANAT, V207, P763, DOI 10.1111/j.1469-7580.2005.00494.x; Li MZ, 2010, PLOS ONE, V5, DOI [10.1371/journal.pone.0015168, 10.1371/journal.pone.0011541]; Lillycrop KA, 2005, J NUTR, V135, P1382, DOI 10.1093/jn/135.6.1382; Lillycrop KA, 2007, BRIT J NUTR, V97, P1064, DOI 10.1017/S000711450769196X; Lillycrop KA, 2010, BRIT J NUTR, V103, P1711, DOI 10.1017/S0007114509993795; MAHAN DC, 1977, J ANIM SCI, V45, P1061, DOI 10.2527/jas1977.4551061x; Maloney CA, 2005, BRIT J NUTR, V94, P12, DOI 10.1079/BJN20051447; Metges CC, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0031390; Metzler-Zebeli B, 2012, BR J NUTR UNPUB; Micke GC, 2011, MOL CELL ENDOCRINOL, V332, P234, DOI 10.1016/j.mce.2010.10.018; Micke GC, 2011, REPRODUCTION, V141, P697, DOI 10.1530/REP-10-0332; Mortensen OH, 2010, J BIOMED SCI, V17, DOI 10.1186/1423-0127-17-S1-S38; Murani E, 2007, BMC DEV BIOL, V7, DOI 10.1186/1471-213X-7-109; Naraballobh W, 2010, ARCH TIERZUCHT, V53, P230, DOI 10.5194/aab-53-230-2010; Nigg EA, 1998, CURR OPIN CELL BIOL, V10, P776, DOI 10.1016/S0955-0674(98)80121-X; Oster M, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0021691; Petrik J, 1999, ENDOCRINOLOGY, V140, P4861, DOI 10.1210/en.140.10.4861; Rehfeldt C, 2006, J Anim Sci, V84 Suppl, pE113; Rehfeldt C, 2012, J ANIM SCI, V90, P184, DOI 10.2527/jas.2011-4234; Rehfeldt C, 2011, J ANIM SCI, V89, P329, DOI 10.2527/jas.2010-2970; Rehfeldt C, 2011, EUR J NUTR; Ren J, 2010, J MOL MED, V88, P993, DOI 10.1007/s00109-010-0663-9; Ristow M, 2010, EXP GERONTOL, V45, P410, DOI 10.1016/j.exger.2010.03.014; Selak MA, 2003, AM J PHYSIOL-ENDOC M, V285, pE130, DOI 10.1152/ajpendo.00322.2002; Skulachev Vladimir P., 1999, Molecular Aspects of Medicine, V20, P139, DOI 10.1016/S0098-2997(99)00008-4; Sparre T, 2003, DIABETOLOGIA, V46, P1497, DOI 10.1007/s00125-003-1208-3; Storey JD, 2003, P NATL ACAD SCI USA, V100, P9440, DOI 10.1073/pnas.1530509100; Theil PK, 2011, J ANIM SCI, V89, P1805, DOI 10.2527/jas.2010-2856; Theys N, 2011, J NUTR BIOCHEM, V22, P985, DOI 10.1016/j.jnutbio.2010.08.015; Theys N, 2009, AM J PHYSIOL-REG I, V297, pR1516, DOI 10.1152/ajpregu.00280.2009; Towler MC, 2007, CIRC RES, V100, P328, DOI 10.1161/01.RES.0000256090.42690.05; Tzur A, 2009, SCIENCE, V325, P167, DOI 10.1126/science.1174294; Wallace DC, 2010, MITOCHONDRION, V10, P12, DOI 10.1016/j.mito.2009.09.006; Watkins AJ, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0028745; Wu G, 2006, J ANIM SCI, V84, P2316, DOI 10.2527/jas.2006-156; Zhu MJ, 2004, BIOL REPROD, V71, P1968, DOI 10.1095/biolreprod.104.034561	47	9	9	0	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 9	2012	7	4							e34519	10.1371/journal.pone.0034519	http://dx.doi.org/10.1371/journal.pone.0034519			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	955JO	22496824	gold, Green Submitted, Green Published			2022-12-25	WOS:000305014500024
J	Bosiger, YJ; Lonnstedt, OM; McCormick, MI; Ferrari, MCO				Bosiger, Yoland J.; Lonnstedt, Oona M.; McCormick, Mark I.; Ferrari, Maud C. O.			Learning Temporal Patterns of Risk in a Predator-Diverse Environment	PLOS ONE			English	Article							CHEMICAL ALARM CUES; PREY INTERACTIONS; BEHAVIOR; MORTALITY; THREAT; RECOGNITION; AVOIDANCE; INTENSITY; ABUNDANCE; DYNAMICS	Predation plays a major role in shaping prey behaviour. Temporal patterns of predation risk have been shown to drive daily activity and foraging patterns in prey. Yet the ability to respond to temporal patterns of predation risk in environments inhabited by highly diverse predator communities, such as rainforests and coral reefs, has received surprisingly little attention. In this study, we investigated whether juvenile marine fish, Pomacentrus moluccensis (lemon damselfish), have the ability to learn to adjust the intensity of their antipredator response to match the daily temporal patterns of predation risk they experience. Groups of lemon damselfish were exposed to one of two predictable temporal risk patterns for six days. "Morning risk" treatment prey were exposed to the odour of Cephalopholis cyanostigma (rockcod) paired with conspecific chemical alarm cues (simulating a rockcod present and feeding) during the morning, and rockcod odour only in the evening (simulating a rockcod present but not feeding). "Evening risk" treatment prey had the two stimuli presented to them in the opposite order. When tested individually for their response to rockcod odour alone, lemon damselfish from the morning risk treatment responded with a greater antipredator response intensity in the morning than in the evening. In contrast, those lemon damselfish previously exposed to the evening risk treatment subsequently responded with a greater antipredator response when tested in the evening. The results of this experiment demonstrate that P. moluccensis have the ability to learn temporal patterns of predation risk and can adjust their foraging patterns to match the threat posed by predators at a given time of day. Our results provide the first experimental demonstration of a mechanism by which prey in a complex, multi-predator environment can learn and respond to daily patterns of predation risk.	[Bosiger, Yoland J.; Lonnstedt, Oona M.; McCormick, Mark I.] James Cook Univ, ARC Ctr Excellence Coral Reef Studies, Townsville, Qld 4811, Australia; [Bosiger, Yoland J.; Lonnstedt, Oona M.; McCormick, Mark I.] James Cook Univ, Sch Marine & Trop Biol, Townsville, Qld 4811, Australia; [Ferrari, Maud C. O.] Univ Saskatchewan, WCVM, Dept Biomed Sci, Saskatoon, SK, Canada	James Cook University; James Cook University; University of Saskatchewan	Bosiger, YJ (corresponding author), James Cook Univ, ARC Ctr Excellence Coral Reef Studies, Townsville, Qld 4811, Australia.	yoland.bosiger@my.jcu.edu.au	McCormick, Mark I/J-8301-2014	McCormick, Mark I/0000-0001-9289-1645	ARC Centre of Excellence for Coral Reef Studies [DP0985015]	ARC Centre of Excellence for Coral Reef Studies(Australian Research Council)	The work was supported by ARC Centre of Excellence for Coral Reef Studies Grant number: DP0985015. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Almany GR, 2006, CORAL REEFS, V25, P19, DOI 10.1007/s00338-005-0044-y; Beukers JS, 1998, OECOLOGIA, V114, P50, DOI 10.1007/s004420050419; Beukers-Stewart BD, 2004, J EXP MAR BIOL ECOL, V299, P155, DOI 10.1016/j.jembe.2003.08.015; Brown GE, 2003, FISH FISH, V4, P227, DOI 10.1046/j.1467-2979.2003.00132.x; Chivers DP, 1998, ECOSCIENCE, V5, P338, DOI 10.1080/11956860.1998.11682471; CLARKE JA, 1983, BEHAV ECOL SOCIOBIOL, V13, P205, DOI 10.1007/BF00299924; Danilowicz BS, 1999, MAR BIOL, V133, P337, DOI 10.1007/s002270050472; Doherty PJ, 2004, ECOLOGY, V85, P2422, DOI 10.1890/04-0366; DOMM SB, 1973, PAC SCI, V27, P128; FEENER DH, 1988, BEHAV ECOL SOCIOBIOL, V22, P421, DOI 10.1007/BF00294980; Ferrari MCO, 2008, BEHAV ECOL, V19, P980, DOI 10.1093/beheco/arn056; Ferrari MCO, 2008, ETHOLOGY, V114, P238, DOI 10.1111/j.1439-0310.2007.01468.x; Ferrari MCO, 2006, ANIM BEHAV, V72, P927, DOI 10.1016/j.anbehav.2006.03.001; Ferrari MCO, 2010, CAN J ZOOL, V88, P698, DOI 10.1139/Z10-029; Ferrari MCO, 2010, BIOL LETTERS, V6, P308, DOI 10.1098/rsbl.2009.0798; Ferrari MCO, 2010, BEHAV ECOL SOCIOBIOL, V64, P549, DOI 10.1007/s00265-009-0870-y; Ferrari MCO, 2009, ANIM BEHAV, V78, P11, DOI 10.1016/j.anbehav.2009.03.016; GLADFELTER WB, 1979, MAR BIOL, V50, P109, DOI 10.1007/BF00397815; Green SJ, 2011, MAR ECOL PROG SER, V433, P159, DOI 10.3354/meps09208; HELFMAN G S, 1978, Environmental Biology of Fishes, V3, P129, DOI 10.1007/BF00006313; Helfman G.S., 1993, BEHAV TELEOST FISHES, P479, DOI DOI 10.1007/978-94-011-1578-0; HELFMAN GS, 1982, ANIM BEHAV, V30, P317, DOI 10.1016/S0003-3472(82)80042-0; HELFMAN GS, 1989, BEHAV ECOL SOCIOBIOL, V24, P47, DOI 10.1007/BF00300117; Hixon M.A., 1991, P475; Hobson E. S., 1965, Copeia, V1965, P291, DOI 10.2307/1440790; Holbrook SJ, 2002, ECOLOGY, V83, P2855, DOI 10.2307/3072021; Holmes TH, 2010, BEHAV PROCESS, V83, P299, DOI 10.1016/j.beproc.2010.01.013; Holmes TH, 2010, MAR ECOL PROG SER, V399, P273, DOI 10.3354/meps08337; Kelley JL, 2003, FISH FISH, V4, P216, DOI 10.1046/j.1467-2979.2003.00126.x; Kotler BP, 2002, EVOL ECOL RES, V4, P495; Kronfeld-Schor N, 2003, ANNU REV ECOL EVOL S, V34, P153, DOI 10.1146/annurev.ecolsys.34.011802.132435; Kusch RC, 2004, BEHAV ECOL SOCIOBIOL, V55, P551, DOI 10.1007/s00265-003-0743-8; Leis Jeffrey L., 2002, P171, DOI 10.1016/B978-012615185-5/50011-6; Lima SL, 1999, AM NAT, V153, P649, DOI 10.1086/303202; Lima SL, 2002, TRENDS ECOL EVOL, V17, P70, DOI 10.1016/S0169-5347(01)02393-X; LIMA SL, 1990, CAN J ZOOL, V68, P619, DOI 10.1139/z90-092; Lonnstedt OM, 2011, ANIM BEHAV, V82, P213, DOI 10.1016/j.anbehav.2011.04.015; Mapstone BD, 1988, THESIS U SYDNEY SYDN; MATHIS A, 1993, ANIM BEHAV, V46, P645, DOI 10.1006/anbe.1993.1241; Milinski Manfred, 1993, Fish and Fisheries Series, V7, P285; Mitchell MD, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0015764; MUNZ FW, 1973, VISION RES, V13, P1829, DOI 10.1016/0042-6989(73)90060-6; Randall JE, 1997, FISHES GREAT BARRER; Reebs SG, 1999, ETHOLOGY, V105, P361, DOI 10.1046/j.1439-0310.1999.00390.x; Roth TC, 2007, AM NAT, V169, P264, DOI 10.1086/510605; SHPIGEL M, 1989, ENVIRON BIOL FISH, V24, P67, DOI 10.1007/BF00001611; SIH A, 1980, SCIENCE, V210, P1041, DOI 10.1126/science.210.4473.1041; SLOBODKIN LB, 1974, Q REV BIOL, V49, P181, DOI 10.1086/408082; Smith R. Jan F., 1997, P163; Sokal RR, 2003, BIOMETRY PRINCIPLES; Stephens DW, 1991, BEHAV ECOL, V2, P77, DOI 10.1093/beheco/2.1.77; Stewart BD, 2001, MAR BIOL, V138, P383, DOI 10.1007/s002270000468; SUBOSKI MD, 1990, PSYCHOL REV, V97, P271, DOI 10.1037/0033-295X.97.2.271; WATANUKI Y, 1986, AUK, V103, P14, DOI 10.1093/auk/103.1.14	54	23	23	0	40	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 6	2012	7	4							e34535	10.1371/journal.pone.0034535	http://dx.doi.org/10.1371/journal.pone.0034535			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	955JA	22493699	gold, Green Submitted, Green Published, Green Accepted			2022-12-25	WOS:000305012700041
J	Breheny, P; Chalise, P; Batzler, A; Wang, LW; Fridley, BL				Breheny, Patrick; Chalise, Prabhakar; Batzler, Anthony; Wang, Liewei; Fridley, Brooke L.			Genetic Association Studies of Copy-Number Variation: Should Assignment of Copy Number States Precede Testing?	PLOS ONE			English	Article							GENOME-WIDE ASSOCIATION; CIRCULAR BINARY SEGMENTATION; STRUCTURAL VARIATION; FINE-SCALE; CGH DATA; DISCOVERY; PHARMACOGENOMICS; CYTOTOXICITY; POLYMORPHISM; GEMCITABINE	Recently, structural variation in the genome has been implicated in many complex diseases. Using genomewide single nucleotide polymorphism (SNP) arrays, researchers are able to investigate the impact not only of SNP variation, but also of copy-number variants (CNVs) on the phenotype. The most common analytic approach involves estimating, at the level of the individual genome, the underlying number of copies present at each location. Once this is completed, tests are performed to determine the association between copy number state and phenotype. An alternative approach is to carry out association testing first, between phenotype and raw intensities from the SNP array at the level of the individual marker, and then aggregate neighboring test results to identify CNVs associated with the phenotype. Here, we explore the strengths and weaknesses of these two approaches using both simulations and real data from a pharmacogenomic study of the chemotherapeutic agent gemcitabine. Our results indicate that pooled marker-level testing is capable of offering a dramatic increase in power (>12-fold) over CNV-level testing, particularly for small CNVs. However, CNV-level testing is superior when CNVs are large and rare; understanding these tradeoffs is an important consideration in conducting association studies of structural variation.	[Breheny, Patrick] Univ Kentucky, Dept Biostat, Lexington, KY 40506 USA; [Chalise, Prabhakar] Univ Kansas, Med Ctr, Dept Biostat, Kansas City, KS 66103 USA; [Batzler, Anthony; Fridley, Brooke L.] Mayo Clin, Dept Hlth Sci Res, Rochester, MN USA; [Wang, Liewei] Mayo Clin, Dept Mol Pharmacol & Expt Therapeut, Rochester, MN USA	University of Kentucky; University of Kansas; University of Kansas Medical Center; Mayo Clinic; Mayo Clinic	Breheny, P (corresponding author), Univ Kentucky, Dept Biostat, Lexington, KY 40506 USA.	patrick.breheny@uky.edu	Fridley, Brooke L/D-8315-2015	Fridley, Brooke L/0000-0001-7739-7956; Breheny, Patrick/0000-0002-0650-1119	National Institutes of Health [GM86689, CA140879, CA130828, CA138461, GM61388]; Minnesota Partnership for Biotechnology and Medical Genomics grant; Mayo Foundation; NATIONAL CANCER INSTITUTE [R21CA140879, K22CA130828, R01CA138461] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R21GM086689, U19GM061388, U01GM061388] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Minnesota Partnership for Biotechnology and Medical Genomics grant; Mayo Foundation; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This research was supported by the National Institutes of Health (GM86689, CA140879, CA130828, CA138461, GM61388), Minnesota Partnership for Biotechnology and Medical Genomics grant, and the Mayo Foundation. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aguirre AJ, 2004, P NATL ACAD SCI USA, V101, P9067, DOI 10.1073/pnas.0402932101; Baladandayuthapani V, 2010, J AM STAT ASSOC, V105, P1358, DOI 10.1198/jasa.2010.ap09250; Barnes C, 2008, NAT GENET, V40, P1245, DOI 10.1038/ng.206; BENJAMINI Y, 1995, J R STAT SOC B, V57, P289, DOI 10.1111/j.2517-6161.1995.tb02031.x; Bentley DR, 2008, NATURE, V456, P53, DOI 10.1038/nature07517; CLEVELAND WS, 1979, J AM STAT ASSOC, V74, P829, DOI 10.2307/2286407; Conrad DF, 2010, NATURE, V464, P704, DOI 10.1038/nature08516; Davidian M., 1995, NONLINEAR MODELS REP; de Smith AJ, 2007, HUM MOL GENET, V16, P2783, DOI 10.1093/hmg/ddm208; Diskin SJ, 2008, NUCLEIC ACIDS RES, V36, DOI 10.1093/nar/gkn556; Efron B, 2011, BIOMETRIKA, V98, P251, DOI 10.1093/biomet/asr018; Fellermann K, 2006, AM J HUM GENET, V79, P439, DOI 10.1086/505915; Fridlyand J, 2004, J MULTIVARIATE ANAL, V90, P132, DOI 10.1016/j.jmva.2004.02.008; Hollox EJ, 2008, NAT GENET, V40, P23, DOI 10.1038/ng.2007.48; Iafrate AJ, 2004, NAT GENET, V36, P949, DOI 10.1038/ng1416; Ju YS, 2010, NUCLEIC ACIDS RES, V38, DOI 10.1093/nar/gkq730; Kalari KR, 2010, BMC GENOMICS, V11, DOI 10.1186/1471-2164-11-357; Kidd JM, 2008, NATURE, V453, P56, DOI 10.1038/nature06862; Lai WR, 2005, BIOINFORMATICS, V21, P3763, DOI 10.1093/bioinformatics/bti611; LEHMANN E. L., 2005, TESTING STAT HYPOTHE; Li L, 2008, CANCER RES, V68, P7050, DOI 10.1158/0008-5472.CAN-08-0405; Li L, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0007765; Marenne G, 2011, HUM MUTAT, V32, P240, DOI 10.1002/humu.21398; Marioni JC, 2007, GENOME BIOL, V8, DOI 10.1186/gb-2007-8-10-r228; Matsuzaki H, 2009, GENOME BIOL, V10, DOI 10.1186/gb-2009-10-11-r125; McCarroll SA, 2006, NAT GENET, V38, P86, DOI 10.1038/ng1696; McKernan KJ, 2009, GENOME RES, V19, P1527, DOI 10.1101/gr.091868.109; Mills RE, 2006, GENOME RES, V16, P1182, DOI 10.1101/gr.4565806; Moreno De Luca D, 2011, AM J HUM GENET, V88, P121; Nadaraya E. A., 1964, THEOR PROBAB APPL, V9, P141, DOI [DOI 10.1137/1109020, 10.1137/1110024]; Niu NF, 2010, GENOME RES, V20, P1482, DOI 10.1101/gr.107672.110; Nowak G, 2011, BIOSTATISTICS, V12, P776, DOI 10.1093/biostatistics/kxr012; Olshen AB, 2004, BIOSTATISTICS, V5, P557, DOI 10.1093/biostatistics/kxh008; Pang AW, 2010, GENOME BIOL, V11, DOI 10.1186/gb-2010-11-5-r52; Peiffer DA, 2006, GENOME RES, V16, P1136, DOI 10.1101/gr.5402306; Perry GH, 2008, AM J HUM GENET, V82, P685, DOI 10.1016/j.ajhg.2007.12.010; Pinto D, 2007, HUM MOL GENET, V16, pR168, DOI 10.1093/hmg/ddm241; Pinto D, 2011, NAT BIOTECHNOL, V29, P512, DOI 10.1038/nbt.1852; Price AL, 2006, NAT GENET, V38, P904, DOI 10.1038/ng1847; Redon R, 2006, NATURE, V444, P444, DOI 10.1038/nature05329; Sebat J, 2004, SCIENCE, V305, P525, DOI 10.1126/science.1098918; Sebat J, 2007, SCIENCE, V316, P445, DOI 10.1126/science.1138659; Shaikh TH, 2009, GENOME RES, V19, P1682, DOI 10.1101/gr.083501.108; Steemers FJ, 2006, NAT METHODS, V3, P31, DOI 10.1038/NMETH842; Storey JD, 2003, P NATL ACAD SCI USA, V100, P9440, DOI 10.1073/pnas.1530509100; Tibshirani R, 2005, J R STAT SOC B, V67, P91, DOI 10.1111/j.1467-9868.2005.00490.x; Tibshirani R, 2008, BIOSTATISTICS, V9, P18, DOI 10.1093/biostatistics/kxm013; Tuzun E, 2005, NAT GENET, V37, P727, DOI 10.1038/ng1562; Venkatraman ES, 2007, BIOINFORMATICS, V23, P657, DOI 10.1093/bioinformatics/btl646; Walsh T, 2008, SCIENCE, V320, P539, DOI 10.1126/science.1155174; Wang K, 2007, AM J HUM GENET, V81, P1278, DOI 10.1086/522374; Wang K, 2007, GENOME RES, V17, P1665, DOI 10.1101/gr.6861907; Watson G., 1964, SANKHYA A, V26, P359, DOI DOI 10.2307/25049340; Willenbrock H, 2005, BIOINFORMATICS, V21, P4084, DOI 10.1093/bioinformatics/bti677; Wong KK, 2007, AM J HUM GENET, V80, P91, DOI 10.1086/510560; Yang HC, 2008, GENETICS, V179, P1057, DOI 10.1534/genetics.107.084616; Zaykin DV, 2002, GENET EPIDEMIOL, V22, P170, DOI 10.1002/gepi.0042	57	6	7	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 6	2012	7	4							e34262	10.1371/journal.pone.0034262	http://dx.doi.org/10.1371/journal.pone.0034262			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	955JA	22493684	Green Published, gold, Green Submitted			2022-12-25	WOS:000305012700026
J	Danko, MJ; Kozlowski, J; Vaupel, JW; Baudisch, A				Danko, Maciej Jan; Kozlowski, Jan; Vaupel, James Walton; Baudisch, Annette			Mutation Accumulation May Be a Minor Force in Shaping Life History Traits	PLOS ONE			English	Article							OPTIMAL ALLOCATION; GENE-EXPRESSION; AGE; EVOLUTION; GROWTH; SENESCENCE; MORTALITY; OPTIMIZATION; REPRODUCTION; PATTERNS	Is senescence the adaptive result of tradeoffs between younger and older ages or the nonadaptive burden of deleterious mutations that act at older ages? To shed new light on this unresolved question we combine adaptive and nonadaptive processes in a single model. Our model uses Penna's bit-strings to capture different age-specific mutational patterns. Each pattern represents a genotype and for each genotype we find the life history strategy that maximizes fitness. Genotypes compete with each other and are subject to selection and to new mutations over generations until equilibrium in gene-frequencies is reached. The mutation-selection equilibrium provides information about mutational load and the differential effects of mutations on a life history trait - the optimal age at maturity. We find that mutations accumulate only at ages with negligible impact on fitness and that mutation accumulation has very little effect on the optimal age at maturity. These results suggest that life histories are largely determined by adaptive processes. The non-adaptive process of mutation accumulation seems to be unimportant at evolutionarily relevant ages.	[Danko, Maciej Jan; Vaupel, James Walton; Baudisch, Annette] Max Planck Inst Demog Res, Rostock, Germany; [Kozlowski, Jan] Jagiellonian Univ, Inst Environm Sci, Krakow, Poland	Max Planck Society; Jagiellonian University	Danko, MJ (corresponding author), Max Planck Inst Demog Res, Rostock, Germany.	danko@demogr.mpg.de	Dańko, Maciej J./W-3099-2019; Baudisch, Annette/ABA-2290-2020; Kozlowski, Jan/K-5549-2012	Dańko, Maciej J./0000-0002-7924-9022; Kozlowski, Jan/0000-0002-7084-2030; Baudisch, Annette/0000-0002-4202-089X; Vaupel, James/0000-0003-0783-3905	Max Planck Institute for Demographic Research; Jagiellonian University [DS/WBiNoZ/INoS 757/08]	Max Planck Institute for Demographic Research; Jagiellonian University	MJD, AB and JWV are funded by Max Planck Institute for Demographic Research and JK is funded by Jagiellonian University (DS/WBiNoZ/INoS 757/08). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Baudisch A, 2005, P NATL ACAD SCI USA, V102, P8263, DOI 10.1073/pnas.0502155102; Baudisch A, 2011, METHODS ECOLOGY EVOL, V2; Brown JH, 2006, P NATL ACAD SCI USA, V103, P17595, DOI 10.1073/pnas.0608522103; CHARLESWORTH B, 1990, EVOLUTION, V44, P520, DOI 10.1111/j.1558-5646.1990.tb05936.x; Charlesworth B, 1996, P NATL ACAD SCI USA, V93, P6140, DOI 10.1073/pnas.93.12.6140; Charlesworth B, 2001, J THEOR BIOL, V210, P47, DOI 10.1006/jtbi.2001.2296; Charnov EL, 2004, EVOL ECOL RES, V6, P307; CHARNOV EL, 1991, P NATL ACAD SCI USA, V88, P1134, DOI 10.1073/pnas.88.4.1134; Charnov EL, 2001, P NATL ACAD SCI USA, V98, P9460, DOI 10.1073/pnas.161294498; Charnov Eric L., 1993, P1; Cichon M, 2000, EVOL ECOL RES, V2, P857; Cichon M, 1999, ACTA OECOL, V20, P25, DOI 10.1016/S1146-609X(99)80012-5; Cooper VS, 2000, NATURE, V407, P736, DOI 10.1038/35037572; CROW J F, 1970, P591, DOI 10.1093/bioinformatics/btr330; de Magalhaes JP, 2009, BIOINFORMATICS, V25, P875, DOI 10.1093/bioinformatics/btp073; Drake JW, 1999, ANN NY ACAD SCI, V870, P100, DOI 10.1111/j.1749-6632.1999.tb08870.x; Drake JW, 1998, GENETICS, V148, P1667; Flatt T, 2007, SCIENCE, V318, P1255, DOI 10.1126/science.1147491; Gibbs RA, 2004, NATURE, V428, P493, DOI 10.1038/nature02426; Golden TR, 2004, AGING CELL, V3, P111, DOI 10.1111/j.1474-9728.2004.00095.x; Gong Y, 2006, J GERONTOL A-BIOL, V61, P1246, DOI 10.1093/gerona/61.12.1246; GUSTAFSSON L, 1990, NATURE, V347, P279, DOI 10.1038/347279a0; HAMILTON WD, 1966, J THEOR BIOL, V12, P12, DOI 10.1016/0022-5193(66)90184-6; KAWECKI TJ, 1993, EVOL ECOL, V7, P155, DOI 10.1007/BF01239386; KIRKWOOD TBL, 1977, NATURE, V270, P301, DOI 10.1038/270301a0; KOZLOWSKI J, 1992, TRENDS ECOL EVOL, V7, P15, DOI 10.1016/0169-5347(92)90192-E; Kozlowski J, 2004, INTEGR COMP BIOL, V44, P480, DOI 10.1093/icb/44.6.480; KOZLOWSKI J, 1993, TRENDS ECOL EVOL, V8, P84, DOI 10.1016/0169-5347(93)90056-U; Kozlowski J, 1999, EVOL ECOL RES, V1, P423; KOZLOWSKI J, 1986, THEOR POPUL BIOL, V29, P16, DOI 10.1016/0040-5809(86)90003-1; Kozlowski J, 2006, POL J ECOL, V54, P585; McCarroll SA, 2004, NAT GENET, V36, P197, DOI 10.1038/ng1291; Medawar P., 1952, UNSOLVED PROBLEM BIO; Moorad JA, 2008, GENETICS, V179, P2061, DOI 10.1534/genetics.108.088526; Moorad JA, 2009, P ROY SOC B-BIOL SCI, V276, P2271, DOI 10.1098/rspb.2009.0183; Nekrutenko A, 2004, MOL BIOL EVOL, V21, P1278, DOI 10.1093/molbev/msh125; Nussey DH, 2008, P ROY SOC B-BIOL SCI, V275, P745, DOI 10.1098/rspb.2007.0986; Nussey DH, 2006, ECOL LETT, V9, P1342, DOI 10.1111/j.1461-0248.2006.00989.x; PARTRIDGE L, 1993, NATURE, V362, P305, DOI 10.1038/362305a0; PENNA TJP, 1995, J STAT PHYS, V78, P1629, DOI 10.1007/BF02180147; Pletcher SD, 2002, CURR BIOL, V12, P712, DOI 10.1016/S0960-9822(02)00808-4; Pletcher SD, 1998, GENETICS, V148, P287; Reid JM, 2003, J ANIM ECOL, V72, P765, DOI 10.1046/j.1365-2656.2003.00750.x; ROSE M, 1980, NATURE, V287, P141, DOI 10.1038/287141a0; Rose M.R., 1991, EVOLUTIONARY BIOL AG; Snoke MS, 2003, HEREDITY, V91, P546, DOI 10.1038/sj.hdy.6800353; Spencer CC, 2005, J HERED, V96, P513, DOI 10.1093/jhered/esi071; Stauffer D, 2007, ARXIV07063101V1; Stearns S.C., 1992, pi; Wachter KW, 2008, ARXIV08070483; WILLIAMS GC, 1957, EVOLUTION, V11, P398, DOI 10.1111/j.1558-5646.1957.tb02911.x; Yampolsky LY, 2000, GENETICA, V110, P11, DOI 10.1023/A:1017582625191; ZIOLKO M, 1983, MATH BIOSCI, V64, P127, DOI 10.1016/0025-5564(83)90032-9	54	14	14	0	16	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 6	2012	7	4							e34146	10.1371/journal.pone.0034146	http://dx.doi.org/10.1371/journal.pone.0034146			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	955JA	22493680	Green Published, Green Submitted, gold			2022-12-25	WOS:000305012700022
J	Nicol, AF; Silva, JRLE; Cunha, CB; Amaro, SM; Oliveira, N; Grinsztejn, B; Khalil, R; Russomano, F; Pires, A; Golub, JE; Nuovo, GJ				Nicol, Alcina F.; Lapa e Silva, Jose R.; Cunha, Cynthia B.; Amaro-Filho, Sergio M.; Oliveira, Nathalia; Grinsztejn, Beatriz; Khalil, Ruth; Russomano, Fabio; Pires, Andrea; Golub, Jonathan E.; Nuovo, Gerard J.			Evaluation of MCM-2 Expression in TMA Cervical Specimens	PLOS ONE			English	Article							MINICHROMOSOME MAINTENANCE PROTEINS; HIV-POSITIVE MEN; INTRAEPITHELIAL NEOPLASIA; UTERINE CERVIX; HIV/HPV COINFECTION; CELL-CYCLE; BIOMARKERS; DYSPLASIA; MARKERS	Background: Minichromosome maintenance proteins (MCM) are highly expressed in actively replicating cells. The need for biological markers for cervical carcinoma and its precursor lesions is emerging. Our main aim was to determine the immunohistochemical expression of MCM-2 in HIV-positive and -negative dysplastic cervical specimens. Methods: Immunohistochemical analysis of MCM-2 was performed in a total of 352 cervical TMA specimens of normal control, low-grade CIN, high-grade CIN and invasive tumor. 38 specimens were from HIV-positive women. A receiver operating characteristic (ROC) curve was constructed to determine the best cutoff to diagnose high-grade CIN and invasive cervical cancer. Results: In the progression from normal epithelium to high-grade CIN and invasive tumor we found significant differences in the MCM-2 expression (p<0.05). Based on the ROC curve of 80% with an area under the curve (AUC) of 0.78, expression of MCM-2 to diagnose high-grade CIN and invasive tumor resulted in sensitivity of 81%, specificity of 66%, a positive predictive value (PPV) of 86% and a negative predictive value (NPV) of 57%. HIV-positive cervices revealed a decreasing expression of MCM-2 in both LGCIN and HGCIN compared with HIV-negative specimens (p<0.0001). Conclusions: The present study suggests that immunohistochemical MCM-2 may not be a promising biomarker for diagnosing high-grade CIN and invasive cancer.	[Nicol, Alcina F.; Amaro-Filho, Sergio M.; Oliveira, Nathalia] Inst Oswaldo Cruz, Lab Interdisciplinary Med Res, BR-20001 Rio De Janeiro, Brazil; [Lapa e Silva, Jose R.] Univ Fed Rio de Janeiro, Clementino Fraga Filho Univ Hosp, Lab Multidisciplinar, Rio De Janeiro, Brazil; [Cunha, Cynthia B.; Grinsztejn, Beatriz; Khalil, Ruth] Fundacao Oswaldo Cruz, Evandro Chagas Clin Res Inst, Dept Infect Dis, Rio De Janeiro, Brazil; [Russomano, Fabio] Fundacao Oswaldo Cruz, Fernandes Figueira Inst, Dept Cerv Pathol, Rio De Janeiro, Brazil; [Pires, Andrea] Fonte Med Diagnost Lab, Niteroi, RJ, Brazil; [Pires, Andrea] Univ Fed Fluminense, Niteroi, RJ, Brazil; [Golub, Jonathan E.] Johns Hopkins Bloomberg Sch Publ Hlth, Baltimore, MD USA; [Golub, Jonathan E.] Johns Hopkins Sch Med, Baltimore, MD USA; [Nuovo, Gerard J.] Ohio State Univ, Ctr Comprehens Canc, Columbus, OH 43210 USA	Fundacao Oswaldo Cruz; Universidade Federal do Rio de Janeiro; Fundacao Oswaldo Cruz; Fundacao Oswaldo Cruz; Universidade Federal Fluminense; Johns Hopkins University; Johns Hopkins Bloomberg School of Public Health; Johns Hopkins University; Johns Hopkins Medicine; James Cancer Hospital & Solove Research Institute; University System of Ohio; Ohio State University	Nicol, AF (corresponding author), Inst Oswaldo Cruz, Lab Interdisciplinary Med Res, BR-20001 Rio De Janeiro, Brazil.	nicol@ioc.fiocruz.br	Oliveira, Nathália/M-8830-2019; Lapa e Silva, Jose R./AAS-4793-2020	Oliveira, Nathália/0000-0003-3733-0022; Lapa e Silva, Jose R./0000-0003-3116-0253; Amaro-Filho, Sergio/0000-0002-7374-4081	Fogarty International Center, National Institutes of Health [2 D 43 TW000010-23-AITRP]; Laboratory of Interdisciplinary Medical Research, Instituto Oswaldo Cruz, Brazil; Lewis Foundation (Dr. Gerard J Nuovo Laboratory); FOGARTY INTERNATIONAL CENTER [D43TW000010] Funding Source: NIH RePORTER	Fogarty International Center, National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Fogarty International Center (FIC)); Laboratory of Interdisciplinary Medical Research, Instituto Oswaldo Cruz, Brazil; Lewis Foundation (Dr. Gerard J Nuovo Laboratory); FOGARTY INTERNATIONAL CENTER(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Fogarty International Center (FIC))	AFN and SAF were scholars in the International AIDS Research and Training Program, supported by the Fogarty International Center, National Institutes of Health Research Grant 2 D 43 TW000010-23-AITRP. NO was a scholar in the Fundacao Carlos Chagas Filho de Amparo a Pesquisa do Estado do Rio de Janeiro. This work was supported in part by grants from the Laboratory of Interdisciplinary Medical Research, Instituto Oswaldo Cruz, Brazil, and the Lewis Foundation (from the Dr. Gerard J Nuovo Laboratory). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Benevolo M, 2010, HISTOPATHOLOGY, V57, P580, DOI 10.1111/j.1365-2559.2010.03674.x; Pires ARC, 2006, DIAGN PATHOL, V1, DOI 10.1186/1746-1596-1-14; Eng J, 2005, ACAD RADIOL, V12, P909, DOI 10.1016/j.acra.2005.04.005; Fan Jerome, 2006, CJEM, V8, P19; Freeman A, 1999, CLIN CANCER RES, V5, P2121; Galgano MT, 2010, AM J SURG PATHOL, V34, P1077, DOI 10.1097/PAS.0b013e3181e8b2c4; Giaginis C, 2010, HISTOL HISTOPATHOL, V25, P351, DOI 10.14670/HH-25.351; Gupta N, 2010, DIAGN CYTOPATHOL, V38, P618, DOI 10.1002/dc.21270; Kreuter A, 2008, J INVEST DERMATOL, V128, P2316, DOI 10.1038/jid.2008.72; Kreuter A, 2010, J AM ACAD DERMATOL, V63, P490, DOI 10.1016/j.jaad.2009.08.043; Mukherjee G, 2007, BRIT J CANCER, V96, P1107, DOI 10.1038/sj.bjc.6603679; Nicol AF, 2008, J CLIN PATHOL, V61, P84, DOI 10.1136/jcp.2007.047290; Nicol AF, DIAGN MOL PATHOL, V14, P39; Nicol AF, 2008, BMC CANCER, V8, DOI 10.1186/1471-2407-8-289; Nuovo GJ, 2010, METHODS, V52, P307, DOI 10.1016/j.ymeth.2010.08.009; Scarpini C, 2008, CANCER EPIDEM BIOMAR, V17, P2855, DOI 10.1158/1055-9965.EPI-08-0288; Tachibana KEK, 2005, J PATHOL, V205, P123, DOI 10.1002/path.1708	17	7	8	0	0	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 6	2012	7	4							e32936	10.1371/journal.pone.0032936	http://dx.doi.org/10.1371/journal.pone.0032936			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	955JA	22493662	gold, Green Published, Green Submitted			2022-12-25	WOS:000305012700004
J	Njie, EG; Kantorovich, S; Astary, GW; Green, C; Zheng, T; Semple-Rowland, SL; Steindler, DA; Sarntinoranont, M; Streit, WJ; Borchelt, DR				Njie, EMalick G.; Kantorovich, Svetlana; Astary, Garrett W.; Green, Cameron; Zheng, Tong; Semple-Rowland, Susan L.; Steindler, Dennis A.; Sarntinoranont, Malisa; Streit, Wolfgang J.; Borchelt, David R.			A Preclinical Assessment of Neural Stem Cells as Delivery Vehicles for Anti-Amyloid Therapeutics	PLOS ONE			English	Article							ADULT HUMAN BRAIN; ALZHEIMER-DISEASE; PROGENITOR CELLS; RAT HIPPOCAMPUS; GAMMA-SECRETASE; IMPROVE MEMORY; NEURONAL LOSS; GENE-THERAPY; MOUSE MODEL; IN-VIVO	Transplantation of neural stems cells (NSCs) could be a useful means to deliver biologic therapeutics for late-stage Alzheimer's disease (AD). In this study, we conducted a small preclinical investigation of whether NSCs could be modified to express metalloproteinase 9 (MMP9), a secreted protease reported to degrade aggregated Ab peptides that are the major constituents of the senile plaques. Our findings illuminated three issues with using NSCs as delivery vehicles for this particular application. First, transplanted NSCs generally failed to migrate to amyloid plaques, instead tending to colonize white matter tracts. Second, the final destination of these cells was highly influenced by how they were delivered. We found that our injection methods led to cells largely distributing to white matter tracts, which are anisotropic conduits for fluids that facilitate rapid distribution within the CNS. Third, with regard to MMP9 as a therapeutic to remove senile plaques, we observed high concentrations of endogenous metalloproteinases around amyloid plaques in the mouse models used for these preclinical tests with no evidence that the NSC-delivered enzymes elevated these activities or had any impact. Interestingly, MMP9-expressing NSCs formed substantially larger grafts. Overall, we observed long-term survival of NSCs in the brains of mice with high amyloid burden. Therefore, we conclude that such cells may have potential in therapeutic applications in AD but improved targeting of these cells to disease-specific lesions may be required to enhance efficacy.	[Njie, EMalick G.; Kantorovich, Svetlana; Green, Cameron; Semple-Rowland, Susan L.; Streit, Wolfgang J.; Borchelt, David R.] Univ Florida, Dept Neurosci, McKnight Brain Inst, Gainesville, FL 32610 USA; [Astary, Garrett W.] Univ Florida, Dept Biomed Engn, Gainesville, FL USA; [Zheng, Tong; Steindler, Dennis A.] Univ Florida, Dept Neurosurg, Gainesville, FL USA; [Sarntinoranont, Malisa] Univ Florida, Dept Mech & Aerosp Engn, Gainesville, FL USA; [Borchelt, David R.] Univ Florida, SantaFe HealthCare Alzheimers Res Ctr, Gainesville, FL USA; [Borchelt, David R.] Univ Florida, Ctr Translat Res Neurodegenerat Dis, Gainesville, FL USA	State University System of Florida; University of Florida; State University System of Florida; University of Florida; State University System of Florida; University of Florida; State University System of Florida; University of Florida; State University System of Florida; University of Florida; State University System of Florida; University of Florida	Njie, EG (corresponding author), Columbia Univ, Dept Biol Sci, New York, NY 10027 USA.	borchelt@mbi.ufl.edu	Steindler, Dennis/AAJ-5811-2020	Njie, eMalick/0000-0002-7171-9237	National Institute of Aging National Research Service [T32 AG000196-16A1]; National Institutes of Health [NS047225, AG023665, NS055165, NS063360]; Johnnie B. Byrd Sr Alzheimer's Center and Research Institute; SantaFe Health Care Alzheimer's Disease Research Center; NATIONAL EYE INSTITUTE [P30EY021721] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS063360, R01NS047225] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON AGING [T32AG000196, R01AG023665] Funding Source: NIH RePORTER	National Institute of Aging National Research Service; National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Johnnie B. Byrd Sr Alzheimer's Center and Research Institute; SantaFe Health Care Alzheimer's Disease Research Center; NATIONAL EYE INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA))	This study was supported by the National Institute of Aging National Research Service Award Training Grant [T32 AG000196-16A1 to Dr. Njie], National Institutes of Health [grant numbers NS047225 to Dr. Borchelt, AG023665 to Dr. Streit, NS055165 to Dr. Steindler, NS063360 to Dr. Sarntinoranont], a grant from the Johnnie B. Byrd Sr Alzheimer's Center and Research Institute [to Dr. Njie, Dr. Zheng, Dr. Steindler and Dr. Borchelt], and the SantaFe Health Care Alzheimer's Disease Research Center [Dr. Njie and Dr. Borchelt]. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	[Anonymous], 2008, SURG RADIOL ANAT, V30, P131, DOI 10.1007/s00276-007-0293-2; Arvidsson A, 2002, NAT MED, V8, P963, DOI 10.1038/nm747; Astary GW, 2010, J NEUROSCI METH, V187, P129, DOI 10.1016/j.jneumeth.2010.01.002; Blurton-Jones M, 2009, P NATL ACAD SCI USA, V106, P13594, DOI 10.1073/pnas.0901402106; Braak H, 1996, NEUROSCI LETT, V210, P87, DOI 10.1016/0304-3940(96)12668-9; Dolev I, 2004, P NATL ACAD SCI USA, V101, P13909, DOI 10.1073/pnas.0404458101; Dull T, 1998, J VIROL, V72, P8463, DOI 10.1128/JVI.72.11.8463-8471.1998; Englund U, 2002, DEV BRAIN RES, V134, P123, DOI 10.1016/S0165-3806(01)00330-3; GAGE FH, 1995, P NATL ACAD SCI USA, V92, P11879, DOI 10.1073/pnas.92.25.11879; Golde TE, 2011, NEURON, V69, P203, DOI 10.1016/j.neuron.2011.01.002; Hemming ML, 2007, PLOS MED, V4, P1405, DOI 10.1371/journal.pmed.0040262; Hyman BT, 1997, J NEUROPATH EXP NEUR, V56, P1095, DOI 10.1097/00005072-199710000-00002; Imitola J, 2004, P NATL ACAD SCI USA, V101, P18117, DOI 10.1073/pnas.0408258102; Itoh T, 2009, NEUROL RES, V31, P90, DOI 10.1179/174313208X332995; Jankowsky JL, 2005, PLOS MED, V2, P1318, DOI 10.1371/journal.pmed.0020355; Jankowsky JL, 2004, HUM MOL GENET, V13, P159, DOI 10.1093/hmg/ddh019; Mazel T, 1998, NEUROREPORT, V9, P1299; Njie EG, 2012, NEUROBIOL AGING, V33, DOI 10.1016/j.neurobiolaging.2010.05.008; Ohab JJ, 2006, J NEUROSCI, V26, P13007, DOI 10.1523/JNEUROSCI.4323-06.2006; Olstorn H, 2007, NEUROSURGERY, V60, P1089, DOI 10.1227/01.NEU.0000255461.91892.0D; Park KI, 2006, EXP NEUROL, V199, P179, DOI 10.1016/j.expneurol.2006.03.016; Pichavant Christophe, 2011, PLoS Curr, V3, pRRN1275, DOI 10.1371/currents.RRN1275; REYNOLDS BA, 1992, SCIENCE, V255, P1707, DOI 10.1126/science.1553558; Ryu JK, 2009, J NEUROINFLAMM, V6, DOI 10.1186/1742-2094-6-39; Semple-Rowland SL, 2007, MOL VIS, V13, P2001; Shagin DA, 2004, MOL BIOL EVOL, V21, P841, DOI 10.1093/molbev/msh079; Shankar GM, 2008, NAT MED, V14, P837, DOI 10.1038/nm1782; Tang J, 2008, NEUROSCI RES, V62, P86, DOI 10.1016/j.neures.2008.06.005; Tuszynski MH, 2005, NAT MED, V11, P551, DOI 10.1038/nm1239; Vorisek I, 1997, J NEUROPHYSIOL, V78, P912, DOI 10.1152/jn.1997.78.2.912; Walton NM, 2006, GLIA, V54, P815, DOI 10.1002/glia.20419; Walton NM, 2006, DEVELOPMENT, V133, P3671, DOI 10.1242/dev.02541; Wang A, 2011, J NEUROSCI, V31, P4124, DOI 10.1523/JNEUROSCI.5077-10.2011; Wong GT, 2004, J BIOL CHEM, V279, P12876, DOI 10.1074/jbc.M311652200; Yamasaki TR, 2007, J NEUROSCI, V27, P11925, DOI 10.1523/JNEUROSCI.1627-07.2007; Yan P, 2006, J BIOL CHEM, V281, P24566, DOI 10.1074/jbc.M602440200; Yin KJ, 2006, J NEUROSCI, V26, P10939, DOI 10.1523/JNEUROSCI.2085-06.2006; Yushkevich PA, 2006, NEUROIMAGE, V31, P1116, DOI 10.1016/j.neuroimage.2006.01.015; Zheng T, 2006, NEUROSCIENCE, V142, P175, DOI 10.1016/j.neuroscience.2006.05.051	39	17	18	0	25	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 4	2012	7	4							e34097	10.1371/journal.pone.0034097	http://dx.doi.org/10.1371/journal.pone.0034097			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	953GO	22496779	Green Published, gold, Green Submitted			2022-12-25	WOS:000304855200031
J	Prina, AM; Deeg, D; Brayne, C; Beekman, A; Huisman, M				Prina, A. Matthew; Deeg, Dorly; Brayne, Carol; Beekman, Aartjan; Huisman, Martijn			The Association between Depressive Symptoms and Non-Psychiatric Hospitalisation in Older Adults	PLOS ONE			English	Article							MYOCARDIAL-INFARCTION; PHYSICAL HEALTH; LATER-LIFE; CES-D; RISK; ONSET; DISABILITY; VALIDITY; OUTCOMES; DISEASE	Background: It is known that people who suffer from depression are more likely to have other physical illnesses, but the extent of the association between depression and non-psychiatric hospitalisation episodes has never been researched in great depth. We therefore aimed to investigate whether depressed middle-aged and older people were more likely to be hospitalised for causes other than mental illnesses, and whether the outcomes for this group of people were less favourable. Methods & Findings: Hospital events from 1995 to 2006 were obtained from the Dutch National Medical Register and linked to participants of the Longitudinal Aging Study Amsterdam (LASA). Linkage was accomplished in 97% of the LASA sample by matching gender, year of birth and postal code. Depression was measured at each wave point of the LASA study using the Centre for Epidemiologic Studies Depression (CES-D). Hospital outcomes including admission, length of stay, readmission and death while in hospital were recorded at 6, 12 and 24 months intervals after each LASA interview. Generalised Estimating Equation models were also used to investigate potential confounders. After 12 months, 14% of depressed people were hospitalised compared to 10% of non-depressed individuals. There was a 2-fold increase in deaths while in hospital amongst the depressed (0.8% vs 0.4%), who also had longer total length of stay (2.6 days vs 1.4 days). Chronic illnesses and functional limitations had major attenuating effects, but depression was found to be an independent risk factor for length of stay after full adjustment (OR = 1.33, 95% CI: 1.22-1.46 after 12 months). Conclusions: Depression in middle and old age is associated with non-psychiatric hospitalisation, longer length of stay and higher mortality in clinical settings. Targeting of this high-risk group could reduce the financial, medical and social burden related to hospital admission.	[Prina, A. Matthew; Brayne, Carol] Univ Cambridge, Inst Publ Hlth, Dept Publ Hlth & Primary Care, Cambridge, England; [Deeg, Dorly; Beekman, Aartjan; Huisman, Martijn] Vrije Univ Amsterdam, Med Ctr, Dept Epidemiol & Biostat, Amsterdam, Netherlands; [Deeg, Dorly; Beekman, Aartjan; Huisman, Martijn] Vrije Univ Amsterdam, Med Ctr, EMGO Inst Hlth & Care Res, Amsterdam, Netherlands; [Deeg, Dorly; Beekman, Aartjan; Huisman, Martijn] Vrije Univ Amsterdam, Med Ctr, Dept Psychiat, Amsterdam, Netherlands; [Huisman, Martijn] Vrije Univ Amsterdam, Dept Sociol, Amsterdam, Netherlands	University of Cambridge; Vrije Universiteit Amsterdam; Vrije Universiteit Amsterdam; Vrije Universiteit Amsterdam; Vrije Universiteit Amsterdam	Prina, AM (corresponding author), Univ Cambridge, Inst Publ Hlth, Dept Publ Hlth & Primary Care, Cambridge, England.	amp68@medschl.cam.ac.uk	Prina, Matthew/B-4188-2013; Brayne, Carol/AAA-4285-2020; Huisman, Martijn/G-2873-2010	Prina, Matthew/0000-0001-6698-3263; Brayne, Carol/0000-0001-5307-663X; 	Ministry of Health, Welfare and Sports; National Institute for Health Research [NF-SI-0611-10084] Funding Source: researchfish	Ministry of Health, Welfare and Sports; National Institute for Health Research(National Institute for Health Research (NIHR))	The LASA study was primarily funded by the Ministry of Health, Welfare and Sports (to The Longitudinal Aging Study Amsterdam). The funders had no role in the study design, data collection, analysis, decision to publish or preparation of the manuscript. No additional external funding was received for this study.	American Psychiatric Association, 1994, DIAGN STAT MAN MENT, V4th ed.; Beekman A T, 1994, Tijdschr Gerontol Geriatr, V25, P95; Beekman ATF, 1997, PSYCHOL MED, V27, P231, DOI 10.1017/S0033291796003510; Beekman ATF, 1997, PSYCHOL MED, V27, P1397, DOI 10.1017/S0033291797005734; BERKMAN LF, 1986, AM J EPIDEMIOL, V124, P372, DOI 10.1093/oxfordjournals.aje.a114408; Braam AW, 2005, BRIT J PSYCHIAT, V187, P35, DOI 10.1192/bjp.187.1.35; Bromet E, 2011, BMC MED, V9, DOI 10.1186/1741-7015-9-90; (CBS) CBoS, 1993, STAT YB; Covinsky KE, 2010, J AM GERIATR SOC, V58, P551, DOI 10.1111/j.1532-5415.2010.02723.x; Deeg D., 2003, AUTONOMY WELL BEING; Department of Health, 2010, HOSP EP STAT HES; desBruin A., 2004, STAT J UN EC COMM EU, V21, P23; Eisner MD, 2005, ANN ALLERG ASTHMA IM, V94, P566, DOI 10.1016/S1081-1206(10)61135-0; FOELKER GA, 1992, J AM GERIATR SOC, V40, P259, DOI 10.1111/j.1532-5415.1992.tb02079.x; Frasure-Smith N, 2000, J PSYCHOSOM RES, V48, P471, DOI 10.1016/S0022-3999(99)00088-4; Garretsen H, PROBLEEMDRINKEN PREV; Hertzog C., 1990, PSYCHOL ASSESSMENT, V2, P64, DOI DOI 10.1037/1040-3590.2.1.64; HIMMELFARB S, 1983, J GERONTOL, V38, P333, DOI 10.1093/geronj/38.3.333; Hosaka T, 1999, PSYCHIAT CLIN NEUROS, V53, P491, DOI 10.1046/j.1440-1819.1999.00580.x; Huisman M, 2011, INT J EPIDEMIOL; Kato Naoko, 2009, J Card Fail, V15, P912, DOI 10.1016/j.cardfail.2009.06.442; Katon Wayne J, 2011, Dialogues Clin Neurosci, V13, P7; Knol MJ, 2006, DIABETOLOGIA, V49, P837, DOI 10.1007/s00125-006-0159-x; Kriegsman DMW, 1996, J CLIN EPIDEMIOL, V49, P1407, DOI 10.1016/S0895-4356(96)00274-0; Kronish IM, 2006, J GEN INTERN MED, V21, P1178, DOI 10.1111/j.1525-1497.2006.00586.x; LIANG KY, 1993, ANNU REV PUBL HEALTH, V14, P43, DOI 10.1146/annurev.pu.14.050193.000355; Lopez AD, 2006, LANCET, V367, P1747, DOI 10.1016/S0140-6736(06)68770-9; Ormel J, 1999, PSYCHOL MED, V29, P847, DOI 10.1017/S0033291799008600; Paas G, 2002, RES VALIDITY LMR; Penninx BWJH, 2000, J AFFECT DISORDERS, V61, P1, DOI 10.1016/S0165-0327(00)00152-X; RADLOFF L S, 1986, Clinical Gerontologist, V5, P119; Seedat S, 2009, ARCH GEN PSYCHIAT, V66, P785, DOI 10.1001/archgenpsychiatry.2009.36; Smits CHM, 1997, J AGING HEALTH, V9, P204, DOI 10.1177/089826439700900204; Turner A, 2010, AUST NZ J PSYCHIAT, V44, P658, DOI 10.3109/00048671003646751; Twisk JWR, 1997, INT J SPORTS MED, V18, pS216, DOI 10.1055/s-2007-972718; van Sonsbeek JLA., 1988, MAANDBERICHT GEZONDH, V88, P4; Wolkowitz Owen M, 2011, Dialogues Clin Neurosci, V13, P25; Wulsin LR, 2003, PSYCHOSOM MED, V65, P201, DOI 10.1097/01.PSY.0000058371.50240.E3; Ziegelstein RC, 2000, ARCH INTERN MED, V160, P1818, DOI 10.1001/archinte.160.12.1818	39	37	39	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 4	2012	7	4							e34821	10.1371/journal.pone.0034821	http://dx.doi.org/10.1371/journal.pone.0034821			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	953GO	22496867	Green Published, gold			2022-12-25	WOS:000304855200083
J	Regev, L; Meningher, T; Hindiyeh, M; Mendelson, E; Mandelboim, M				Regev, Liora; Meningher, Tal; Hindiyeh, Musa; Mendelson, Ella; Mandelboim, Michal			Increase Human Metapneumovirus Mediated Morbidity following Pandemic Influenza Infection	PLOS ONE			English	Article							RESPIRATORY SYNCYTIAL VIRUS; GENETIC-VARIABILITY; TRACT INFECTIONS; CHILDREN; IMPACT	Human metapneumovirus (hMPV) is a recently discovered respiratory pathogen, infecting mainly young children. The infected patients suffer from influenza like symptoms (ILS). In Israel the virus is mainly circulating in February to March. Here we report on an increased rate of hMPV infection in the winter season of 2009-10. The 2009-10 infection had several unique characteristics when compared to previous seasons; it started around January and a large number of infants were infected by the virus. Genetic analysis based on the viral L and F genes of hMPV showed that only subtypes A2 and B2 circulated in Israel. Additionally, we have identified a novel variant of hMPV within subgroup A2b, which subdivide it into A2b1 and A2b2. Finally, we showed that the hMPV infection was detected in the country soon after the infection with the pandemic influenza virus had declined, that infection with the pandemic influenza virus was dominant and that it interfered with the infection of other respiratory viruses. Thus, we suggest that the unusual increase in hMPV infection observed in 2009-10 was due to the appearance of the pandemic influenza virus in the winter season prior to 2009-10.	[Regev, Liora; Meningher, Tal; Hindiyeh, Musa; Mendelson, Ella; Mandelboim, Michal] Chaim Sheba Med Ctr, Minist Hlth, Cent Virol Lab, Ramat Gan, Israel; [Meningher, Tal] Bar Ilan Univ, Fac Life Sci, Ramat Gan, Israel; [Mendelson, Ella] Tel Aviv Univ, Sackler Fac Med, Sch Publ Hlth, Dept Epidemiol & Prevent Med, IL-69978 Tel Aviv, Israel	Chaim Sheba Medical Center; Bar Ilan University; Tel Aviv University; Sackler Faculty of Medicine	Regev, L (corresponding author), Chaim Sheba Med Ctr, Minist Hlth, Cent Virol Lab, Ramat Gan, Israel.	michalman@sheba.health.gov.il						Aberle JH, 2010, PEDIATR INFECT DIS J, V29, P1016, DOI 10.1097/INF.0b013e3181e3331a; Agrawal AS, 2011, VIROL J, V8, DOI 10.1186/1743-422X-8-67; Arnott A, 2011, INFECT GENET EVOL; Bach N, 2004, ARCH PEDIATRIE, V11, P212, DOI 10.1016/j.arcped.2003.12.009; Bastien N, 2003, J CLIN MICROBIOL, V41, P4642, DOI 10.1128/JCM.41.10.4642-4646.2003; Biacchesi S, 2003, VIROLOGY, V315, P1, DOI 10.1016/S0042-6822(03)00528-2; Boivin G, 2003, EMERG INFECT DIS, V9, P634; Boivin G, 2002, J INFECT DIS, V186, P1330, DOI 10.1086/344319; Bosis S, 2005, J MED VIROL, V75, P101, DOI 10.1002/jmv.20243; Cane PA, 2003, BONE MARROW TRANSPL, V31, P309, DOI 10.1038/sj.bmt.1703849; Carr MJ, 2008, J MED VIROL, V80, P510, DOI 10.1002/jmv.21081; Engelhard D, 2011, EMERG INFECT DIS, V17, P1740, DOI 10.3201/eid1709.102022; Esper F, 2003, PEDIATRICS, V111, P1407, DOI 10.1542/peds.111.6.1407; Falsey AR, 2003, J INFECT DIS, V187, P785, DOI 10.1086/367901; Gaunt ER, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0017427; Heim A, 2003, J MED VIROL, V70, P228, DOI 10.1002/jmv.10382; Hindiyeh M, 2010, J CLIN MICROBIOL, V48, P1884, DOI 10.1128/JCM.02540-09; Hu AZ, 2003, J CLIN MICROBIOL, V41, P149, DOI 10.1128/JCM.41.1.149-154.2003; Huck B, 2006, EMERG INFECT DIS, V12, P147, DOI 10.3201/eid1201.050772; Lazar I, 2004, EMERG INFECT DIS, V10, P1318, DOI 10.3201/eid1007.030983; Legrand L, 2011, J MED VIROL, V83, P517, DOI 10.1002/jmv.22002; Mackie P L, 2003, Paediatr Respir Rev, V4, P84, DOI 10.1016/S1526-0542(03)00031-9; Mammas IN, 2011, MOL MED REP, V4, P267, DOI 10.3892/mmr.2011.416; Matsuzaki Y, 2008, J MED VIROL, V80, P1084, DOI 10.1002/jmv.21194; O'Gorman C, 2006, EUR J CLIN MICROBIOL, V25, P190, DOI 10.1007/s10096-006-0116-0; Pabbaraju K, 2007, J CLIN VIROL, V40, P186, DOI 10.1016/j.jcv.2007.08.004; Peret TCT, 2004, J GEN VIROL, V85, P679, DOI 10.1099/vir.0.19504-0; Rafiefard F, 2008, J MED VIROL, V80, P1631, DOI 10.1002/jmv.21242; Regev L, 2006, J CLIN MICROBIOL, V44, P1484, DOI 10.1128/JCM.44.4.1484-1489.2006; Schildgen V, 2011, CLIN MICROBIOL REV, V24, P734, DOI 10.1128/CMR.00015-11; Shahda S, 2011, TRANSPL INFECT DIS, V13, P324, DOI 10.1111/j.1399-3062.2010.00575.x; Sumino KC, 2005, J INFECT DIS, V192, P1052, DOI 10.1086/432728; van den Hoogen BG, 2004, EMERG INFECT DIS, V10, P658, DOI 10.3201/eid1004.030393; Wang HC, 2008, ARCH VIROL, V153, P2207, DOI 10.1007/s00705-008-0242-3; Xiao NG, 2010, PEDIATR INFECT DIS J, V29, P131, DOI 10.1097/INF.0b013e3181b56009	35	13	13	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 4	2012	7	4							e34750	10.1371/journal.pone.0034750	http://dx.doi.org/10.1371/journal.pone.0034750			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	953GO	22496855	Green Submitted, Green Published, gold			2022-12-25	WOS:000304855200076
J	Lagadec, C; Dekmezian, C; Bauche, L; Pajonk, F				Lagadec, Chann; Dekmezian, Carmen; Bauche, Lucile; Pajonk, Frank			Oxygen Levels Do Not Determine Radiation Survival of Breast Cancer Stem Cells	PLOS ONE			English	Article							IN-VITRO PROPAGATION; INITIATING CELLS; TUMOR HYPOXIA; RADIOTHERAPY; HEAD; NECK; PREDICTOR; CARCINOMA; IMPACT; ALDH1	For more than a century oxygen has been known to be one of the most powerful radiosensitizers. However, despite decades of preclinical and clinical research aimed at overcoming tumor hypoxia, little clinical progress has been made so far. Ionizing radiation damages DNA through generation of free radicals. In the presence of oxygen these lesions are chemically modified, and thus harder to repair while hypoxia protects cells from radiation (Oxygen enhancement ratio (OER)). Breast cancer stem cells (BSCSs) are protected from radiation by high levels of free radical scavengers even in the presence of oxygen. This led us to hypothesize that BCSCs exhibit an OER of 1. Using four established breast cancer cell lines (MCF-7, T47D, MDA-MB-231, SUM159PT) and primary breast cancer samples, we determined the number of BCSCs using cancer stem cell markers (ALDH1, low proteasome activity), compared radiation clonogenic survival and mammosphere formation under normoxic and hypoxic conditions, and correlated these results to the expression levels of key members of the free radical scavenging systems. The number of BCSCs increased with increased aggressiveness of the cancer. This correlated with increased radioresistance (SF8Gy), and decreasing OERs. When cultured as mammospheres, breast cancer cell lines and primary samples were highly radioresistant and not further protected by hypoxia (OER similar to 1). We conclude that because BCSCs are protected from radiation through high expression levels of free radical scavengers, hypoxia does not lead to additional radioprotection of BCSCs.	[Lagadec, Chann; Dekmezian, Carmen; Bauche, Lucile; Pajonk, Frank] Univ Calif Los Angeles, David Geffen Sch Med, Dept Radiat Oncol, Los Angeles, CA 90095 USA; [Pajonk, Frank] Univ Calif Los Angeles, Jonsson Comprehens Canc Ctr, Los Angeles, CA 90095 USA	University of California System; University of California Los Angeles; University of California Los Angeles Medical Center; David Geffen School of Medicine at UCLA; UCLA Jonsson Comprehensive Cancer Center; University of California System; University of California Los Angeles	Lagadec, C (corresponding author), Univ Calif Los Angeles, David Geffen Sch Med, Dept Radiat Oncol, Los Angeles, CA 90095 USA.	fpajonk@mednet.ucla.edu	Lagadec, chann/E-4250-2010	Lagadec, chann/0000-0002-5182-2069	California Breast Cancer Research Program [15NB-0153]; National Cancer Institute [RO1 CA137110]; Army Medical Research and Material Command's Prostate Cancer Research Program [W81XWH-07-1-0065]; Ward Family Foundation; NATIONAL CANCER INSTITUTE [R01CA137110] Funding Source: NIH RePORTER	California Breast Cancer Research Program; National Cancer Institute(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); Army Medical Research and Material Command's Prostate Cancer Research Program; Ward Family Foundation; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	FP was supported by grants from the California Breast Cancer Research Program (15NB-0153), the National Cancer Institute (RO1 CA137110) and the Army Medical Research and Material Command's Prostate Cancer Research Program (W81XWH-07-1-0065). CL was supported by an award from the Ward Family Foundation. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript. No additional external funding was received for this study.	Al-Hajj M, 2003, P NATL ACAD SCI USA, V100, P3983, DOI 10.1073/pnas.0530291100; Brizel DM, 1997, INT J RADIAT ONCOL, V38, P285, DOI 10.1016/S0360-3016(97)00101-6; Chen FH, 2009, CLIN CANCER RES, V15, P1721, DOI 10.1158/1078-0432.CCR-08-1471; De Bels D, 2011, NEW ENGL J MED, V365, P1845, DOI 10.1056/NEJMc1110602; Dewhirst MW, 2009, RADIAT RES, V172, P653, DOI 10.1667/RR1926.1; Dontu G, 2003, GENE DEV, V17, P1253, DOI 10.1101/gad.1061803; ELFadl D, 2011, BREAST, V20, P334, DOI 10.1016/j.breast.2011.02.017; Epperly MW, 2003, RADIAT RES, V160, P568, DOI 10.1667/RR3081; Fillmore CM, 2008, BREAST CANCER RES, V10, DOI 10.1186/bcr1982; Frommhold H, 1998, STRAHLENTHER ONKOL, V174, P31; Fyles A, 2002, J CLIN ONCOL, V20, P680, DOI 10.1200/JCO.20.3.680; Ginestier C, 2007, CELL STEM CELL, V1, P555, DOI 10.1016/j.stem.2007.08.014; Heddleston JM, 2009, CELL CYCLE, V8, P3274, DOI 10.4161/cc.8.20.9701; Hemmati HD, 2003, P NATL ACAD SCI USA, V100, P15178, DOI 10.1073/pnas.2036535100; Henke M, 2003, LANCET, V362, P1255, DOI 10.1016/S0140-6736(03)14567-9; Hoff CM, 2011, ACTA ONCOL, V50, P1006, DOI 10.3109/0284186X.2011.592650; KONERDING MA, 1989, STRAHLENTHER ONKOL, V165, P503; Lagadec C, 2012, STEM CELLS IN PRESS; Lagadec C, 2010, BREAST CANCER RES, V12, DOI 10.1186/bcr2479; Overgaard J, 2011, RADIOTHER ONCOL, V100, P22, DOI 10.1016/j.radonc.2011.03.004; Phillips TM, 2006, JNCI-J NATL CANCER I, V98, P1777, DOI 10.1093/jnci/djj495; Ponti D, 2005, CANCER RES, V65, P5506, DOI 10.1158/0008-5472.CAN-05-0626; Reya T, 2001, NATURE, V414, P105, DOI 10.1038/35102167; Ricardo S, 2011, J CLIN PATHOL, V64, P937, DOI 10.1136/jcp.2011.090456; Schwarz G, 1906, MUENCHNER MED WOCHEN, V56, P1217; TEICHER BA, 1981, CANCER RES, V41, P73; van Putten L M, 1968, Eur J Cancer, V4, P172; Vaupel P, 2002, Wien Med Wochenschr, V152, P334; Vlashi E, 2011, P NATL ACAD SCI USA, V108, P16062, DOI 10.1073/pnas.1106704108; Vlashi E, 2009, JNCI-J NATL CANCER I, V101, P350, DOI 10.1093/jnci/djn509; Woodward WA, 2007, P NATL ACAD SCI USA, V104, P618, DOI 10.1073/pnas.0606599104	31	27	28	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 29	2012	7	3							e34545	10.1371/journal.pone.0034545	http://dx.doi.org/10.1371/journal.pone.0034545			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	948SR	22479642	Green Published, gold, Green Submitted			2022-12-25	WOS:000304523400087
J	Rangarajan, ES; Izard, T				Rangarajan, Erumbi S.; Izard, Tina			The Cytoskeletal Protein alpha-Catenin Unfurls upon Binding to Vinculin	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							CELL-CELL ADHESION; BETA-CATENIN; CRYSTAL-STRUCTURE; ACTIVATE VINCULIN; TALIN ROD; F-ACTIN; STRUCTURAL BASIS; N-CADHERIN; COMPLEX; SITES	Adherens junctions (AJs) are essential for cell-cell contacts, morphogenesis, and the development of all higher eukaryotes. AJs are formed by calcium-dependent homotypic interactions of the ectodomains of single membrane-pass cadherin family receptors. These homotypic interactions in turn promote binding of the intracellular cytoplasmic tail domains of cadherin receptors with beta-catenin, a multifunctional protein that plays roles in both transcription and AJs. The cadherin receptor-beta-catenin complex binds to the cytoskeletal protein alpha-catenin, which is essential for both the formation and the stabilization of these junctions. Precisely how alpha-catenin contributes to the formation and stabilization of AJs is hotly debated, although the latter is thought to involve its interactions with the cytoskeletal protein vinculin. Here we report the crystal structure of the vinculin binding domain (VBD) of alpha-catenin in complex with the vinculin head domain (Vh1). This structure reveals that alpha-catenin is in a unique unfurled mode allowing dimer formation when bound to vinculin. Finally, binding studies suggest that vinculin must be in an activated state to bind to alpha-catenin and that this interaction is stabilized by the formation of a ternary alpha-catenin-vinculin-F-actin complex, which can be formed via the F-actin binding domain of either protein. We propose a feed-forward model whereby alpha-catenin-vinculin interactions promote their binding to the actin cytoskeleton to stabilize AJs.	[Rangarajan, Erumbi S.; Izard, Tina] Scripps Res Inst, Dept Canc Biol, Cell Adhes Lab, Jupiter, FL 33458 USA	Scripps Research Institute	Izard, T (corresponding author), Scripps Res Inst, Dept Canc Biol, Cell Adhes Lab, Jupiter, FL 33458 USA.	mkernick@scripps.edu			National Institutes of Health; State of Florida; Scripps Florida; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM094483] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); State of Florida; Scripps Florida; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	Supported by National Institutes of Health grants and by start-up funds provided to Scripps Florida from the State of Florida. To whom correspondence should be addressed.; We are indebted to our colleagues at Scripps Florida: John Cleveland for discussions and critical review of the manuscript, Zhen Wu and Philippe Bois for sequencing, and Philippe Bois for fruitful discussions. V. Nayak generated the alpha-catenin 82-906, 144-906, and 277-382 constructs, and HaJeung Park and Ewa Folta-Stogniew (Yale) provided SLS data. We are grateful to the staff at the SER-CAT (beamline BM22) for synchrotron support.	Abe K, 2008, P NATL ACAD SCI USA, V105, P13, DOI 10.1073/pnas.0710504105; Bakolitsa C, 2004, NATURE, V430, P583, DOI 10.1038/nature02610; Benjamin JM, 2010, J CELL BIOL, V189, P339, DOI 10.1083/jcb.200910041; Bois PRJ, 2005, MOL CELL BIOL, V25, P6112, DOI 10.1128/MCB.25.14.6112-6122.2005; Bois PRJ, 2006, J BIOL CHEM, V281, P7228, DOI 10.1074/jbc.M510397200; Borgon RA, 2004, STRUCTURE, V12, P1189, DOI 10.1016/j.str.2004.05.009; Braga VMM, 2004, SEMIN CELL DEV BIOL, V15, P631, DOI 10.1016/j.semcdb.2004.09.009; Brault V, 2001, DEVELOPMENT, V128, P1253; Bricogne G., 2011, BUSTER; Chen VB, 2010, ACTA CRYSTALLOGR D, V66, P12, DOI 10.1107/S0907444909042073; Clevers H, 2006, CELL, V127, P469, DOI 10.1016/j.cell.2006.10.018; Cohen DM, 2005, J BIOL CHEM, V280, P17109, DOI 10.1074/jbc.M414704200; del Rio A, 2009, SCIENCE, V323, P638, DOI 10.1126/science.1162912; Drees F, 2005, CELL, V123, P903, DOI 10.1016/j.cell.2005.09.021; Emsley P, 2004, ACTA CRYSTALLOGR D, V60, P2126, DOI 10.1107/S0907444904019158; Evans P, 2006, ACTA CRYSTALLOGR D, V62, P72, DOI 10.1107/S0907444905036693; Fillingham I, 2005, STRUCTURE, V13, P65, DOI 10.1016/j.str.2004.11.006; Folta-Stogniew E, 1999, J Biomol Tech, V10, P51; Gingras AR, 2005, J BIOL CHEM, V280, P37217, DOI 10.1074/jbc.M508060200; HAEGEL H, 1995, DEVELOPMENT, V121, P3529; Huelsken J, 2001, CELL, V105, P533, DOI 10.1016/S0092-8674(01)00336-1; Imamura Y, 1999, J CELL BIOL, V144, P1311, DOI 10.1083/jcb.144.6.1311; Izard T, 2004, J BIOL CHEM, V279, P27667, DOI 10.1074/jbc.M403076200; Izard T, 2004, NATURE, V427, P171, DOI 10.1038/nature02281; Izard T, 2006, J CELL BIOL, V175, P465, DOI 10.1083/jcb.200605091; Janssen MEW, 2006, MOL CELL, V21, P271, DOI 10.1016/j.molcel.2005.11.020; KABSCH W, 1993, J APPL CRYSTALLOGR, V26, P795, DOI 10.1107/S0021889893005588; Kelley LA, 2009, NAT PROTOC, V4, P363, DOI 10.1038/nprot.2009.2; LAWRENCE MC, 1993, J MOL BIOL, V234, P946, DOI 10.1006/jmbi.1993.1648; Lecuit T, 2010, NAT CELL BIOL, V12, P522, DOI 10.1038/ncb2066; Maddugoda MP, 2007, J CELL BIOL, V178, P529, DOI 10.1083/jcb.200612042; MATTHEWS BW, 1968, J MOL BIOL, V33, P491, DOI 10.1016/0022-2836(68)90205-2; Pappas DJ, 2006, CELL COMMUN ADHES, V13, P151, DOI 10.1080/15419060600726142; Park H, 2011, J BIOL CHEM, V286, P35096, DOI 10.1074/jbc.M111.263855; Park H, 2011, J BIOL CHEM, V286, P23214, DOI 10.1074/jbc.M110.184283; Park H, 2010, ACTA CRYSTALLOGR F, V66, P595, DOI 10.1107/S1744309110011875; Peng X, 2012, J BIOL CHEM, V287, P7728, DOI 10.1074/jbc.M111.297481; Pokutta S, 2000, MOL CELL, V5, P533, DOI 10.1016/S1097-2765(00)80447-5; Pokutta S, 2002, CURR OPIN STRUC BIOL, V12, P255, DOI 10.1016/S0959-440X(02)00318-4; Pokutta S, 2002, J BIOL CHEM, V277, P18868, DOI 10.1074/jbc.M201463200; Pokutta S, 2008, BIOCHEM SOC T, V36, P141, DOI 10.1042/BST0360141; Radice GL, 1997, DEV BIOL, V181, P64, DOI 10.1006/dbio.1996.8443; RIMM DL, 1995, P NATL ACAD SCI USA, V92, P8813, DOI 10.1073/pnas.92.19.8813; Vagin A, 1997, J APPL CRYSTALLOGR, V30, P1022, DOI 10.1107/S0021889897006766; Van Nhieu GT, 2007, EMBO J, V26, P4588; Vasioukhin V, 2000, CELL, V100, P209, DOI 10.1016/S0092-8674(00)81559-7; Vonrhein C, 2011, ACTA CRYSTALLOGR D, V67, P293, DOI 10.1107/S0907444911007773; Wahl JK, 2003, J BIOL CHEM, V278, P17269, DOI 10.1074/jbc.M211452200; Weis WI, 2006, J BIOL CHEM, V281, P35593, DOI 10.1074/jbc.R600027200; Weiss EE, 1998, J CELL BIOL, V141, P755, DOI 10.1083/jcb.141.3.755; Yamada S, 2005, CELL, V123, P889, DOI 10.1016/j.cell.2005.09.020; Yang J, 2001, EMBO J, V20, P3645, DOI 10.1093/emboj/20.14.3645; Ylanne J, 2001, STRUCTURE, V9, P597, DOI 10.1016/S0969-2126(01)00619-0; Yogesha SD, 2012, PROTEIN SCI, V21, P583, DOI 10.1002/pro.2041; Yogesha SD, 2011, PROTEIN SCI, V20, P1471, DOI 10.1002/pro.671; Yonemura S, 2010, NAT CELL BIOL, V12, P533, DOI 10.1038/ncb2055	56	62	63	1	9	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAY 25	2012	287	22					18492	18499		10.1074/jbc.M112.351023	http://dx.doi.org/10.1074/jbc.M112.351023			8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	974EC	22493458	Green Published, hybrid			2022-12-25	WOS:000306411600055
J	van Meeteren, LA; Thorikay, M; Bergqvist, S; Pardali, E; Stampino, CG; Hu-Lowe, D; Goumans, MJ; ten Dijke, P				van Meeteren, Laurens A.; Thorikay, Midory; Bergqvist, Simon; Pardali, Evangelia; Stampino, Corrado Gallo; Hu-Lowe, Dana; Goumans, Marie-Jose; ten Dijke, Peter			Anti-human Activin Receptor-like Kinase 1 (ALK1) Antibody Attenuates Bone Morphogenetic Protein 9 (BMP9)-induced ALK1 Signaling and Interferes with Endothelial Cell Sprouting	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							GROWTH-FACTOR-BETA; ANGIOGENESIS; EXPRESSION; ENDOGLIN; IDENTIFICATION; ACTIVATION; PATHWAYS; BINDS; BMP-9; GENE	Genetic and molecular studies suggest that activin receptor-like kinase 1 (ALK1), a transforming growth factor beta (TGF-beta) type I receptor, and endoglin, a TGF-beta co-receptor, play an essential role in vascular development and pathological angiogenesis. Several agents that interfere with ALK1 and endoglin function are currently in clinical trials for antiangiogenic activity in cancer therapy. One of these agents, PF-03446962 (anti-hALK1 antibody), shows promising results in the clinic. However, its effects on endothelial cell function and mechanism of action are unclear. Here we demonstrate that anti-hALK1 antibody selectively recognizes human ALK1. The anti-hALK1 antibody interfered with bone morphogenetic protein 9 (BMP9)-induced signaling in endothelial cells. Consistent with this notion, anti-hALK1 antibody was found to compete highly efficiently with the binding of the ALK1 ligand BMP9 and TGF-beta to ALK1. Moreover, it prevented BMP9-dependent recruitment of co-receptor endoglin into this angiogenesis-mediating signaling complex. In addition, we demonstrated that anti-hALK1 antibody inhibited endothelial cell sprouting but did not directly interfere with vascular endothelial growth factor (VEGF) signaling, VEGF-induced proliferation, and migration of endothelial cells. Finally, we demonstrated that BMP9 in serum is essential for endothelial sprouting and that anti-hALK1 antibody inhibits this potently. Our data suggest that both the VEGF/VEGF receptor and the BMP9/ALK1 pathways are essential for stimulating angiogenesis, and targeting both pathways simultaneously may be an attractive strategy to overcome resistance to antiangiogenesis therapy.	[van Meeteren, Laurens A.; Thorikay, Midory; Goumans, Marie-Jose; ten Dijke, Peter] Leiden Univ, Med Ctr, Dept Mol Cell Biol, NL-2300 RC Leiden, Netherlands; [van Meeteren, Laurens A.; Thorikay, Midory; Goumans, Marie-Jose; ten Dijke, Peter] Leiden Univ, Med Ctr, Ctr Biomed Genet, NL-2300 RC Leiden, Netherlands; [Bergqvist, Simon; Hu-Lowe, Dana] Pfizer Inc, Oncol Res Unit, San Diego, CA 92121 USA; [Pardali, Evangelia] Univ Munster, Dept Cardiol & Angiol, D-48149 Munster, Germany; [Stampino, Corrado Gallo] Pfizer Italia Srl, Clin Oncol, I-20152 Milan, Italy	Leiden University; Leiden University Medical Center (LUMC); Leiden University - Excl LUMC; Leiden University; Leiden University Medical Center (LUMC); Leiden University - Excl LUMC; Pfizer; University of Munster; Pfizer	van Meeteren, LA (corresponding author), Leiden Univ, Med Ctr, Dept Mol Cell Biol, Postzone S-1-P,Postbus 9600, NL-2300 RC Leiden, Netherlands.	L.A.van_Meeteren@lumc.nl; p.ten_dijke@lumc.nl	Van Meeteren, Laurens A./AGQ-6139-2022; Goumans, Marie-José/AAG-4994-2021; Dijke, Peter ten/AAG-4660-2021; van Meeteren, Laurens/A-9890-2008; Goumans, Marie Jose/U-1455-2019	Dijke, Peter ten/0000-0002-7234-342X; van Meeteren, Laurens/0000-0001-9885-0668; Goumans, Marie Jose/0000-0001-9344-6746	Dutch Cancer Society; Pfizer Inc.; Le Ducq Foundation; Centre for Biomedical Genetics	Dutch Cancer Society(KWF Kankerbestrijding); Pfizer Inc.(Pfizer); Le Ducq Foundation(Leducq Foundation); Centre for Biomedical Genetics	This work was supported by the Dutch Cancer Society (to L.A.v.M.), Pfizer Inc., the Le Ducq Foundation, and the Centre for Biomedical Genetics. D. Hu-Lowe and S. Bergqvist are full-time Pfizer Inc. employees and own Pfizer Inc. stock. P. ten Dijke has received research funding from Pfizer Inc.	Blanco FJ, 2005, J CELL PHYSIOL, V204, P574, DOI 10.1002/jcp.20311; Brown MA, 2005, J BIOL CHEM, V280, P25111, DOI 10.1074/jbc.M503328200; Carmeliet P, 2011, NATURE, V473, P298, DOI 10.1038/nature10144; Castonguay R, 2011, J BIOL CHEM, V286, P30034, DOI 10.1074/jbc.M111.260133; Cunha SI, 2010, J EXP MED, V207, P85, DOI 10.1084/jem.20091309; David L, 2008, CIRC RES, V102, P914, DOI 10.1161/CIRCRESAHA.107.165530; David L, 2007, BLOOD, V109, P1953, DOI 10.1182/blood-2006-07-034124; Ebisawa T, 1999, J CELL SCI, V112, P3519; FROLIK CA, 1984, J BIOL CHEM, V259, P995; Goff LW, 2010, J CLIN ONCOL, V28, DOI 10.1200/jco.2010.28.15_suppl.3034; Goumans MJ, 2002, EMBO J, V21, P1743, DOI 10.1093/emboj/21.7.1743; Goumans MJ, 2003, MOL CELL, V12, P817, DOI 10.1016/S1097-2765(03)00386-1; Hu-Lowe D., 2009, P 100 ANN M AM ASS C; Hughes Christopher C W, 2007, J Vis Exp, P175, DOI 10.3791/175; Johnson DW, 1996, NAT GENET, V13, P189, DOI 10.1038/ng0696-189; Kellermann SA, 2002, CURR OPIN BIOTECH, V13, P593, DOI 10.1016/S0958-1669(02)00354-3; Korchynskyi O, 2002, J BIOL CHEM, V277, P4883, DOI 10.1074/jbc.M111023200; Larrivee B, 2012, DEV CELL, V22, P489, DOI 10.1016/j.devcel.2012.02.005; Mancuso P, 2009, J CLIN ONCOL, V27; MCALLISTER KA, 1994, NAT GENET, V8, P345, DOI 10.1038/ng1294-345; Mitchell D, 2010, MOL CANCER THER, V9, P379, DOI 10.1158/1535-7163.MCT-09-0650; Nakatsu Martin N, 2007, J Vis Exp, P186, DOI 10.3791/186; Niessen K, 2010, BLOOD, V115, P1654, DOI 10.1182/blood-2009-07-235655; NORTH MA, 2007, Patent No. 2007040912; Oh SP, 2000, P NATL ACAD SCI USA, V97, P2626, DOI 10.1073/pnas.97.6.2626; Park SO, 2009, J CLIN INVEST, V119, P3487, DOI 10.1172/JCI39482; Persson U, 1998, FEBS LETT, V434, P83, DOI 10.1016/S0014-5793(98)00954-5; Roelen BAJ, 1997, DEV DYNAM, V209, P418, DOI 10.1002/(SICI)1097-0177(199708)209:4<418::AID-AJA9>3.0.CO;2-L; Roman BL, 2002, DEVELOPMENT, V129, P3009; Scharpfenecker M, 2007, J CELL SCI, V120, P964, DOI 10.1242/jcs.002949; Scotti C, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0026431; SEEHRA J, 2009, Patent No. 2009139891; Seki T, 2006, LAB INVEST, V86, P116, DOI 10.1038/labinvest.3700376; Suzuki Y, 2010, J CELL SCI, V123, P1684, DOI 10.1242/jcs.061556; Urness LD, 2000, NAT GENET, V26, P328, DOI 10.1038/81634; Valdimarsdottir G, 2002, CIRCULATION, V106, P2263, DOI 10.1161/01.CIR.0000033830.36431.46; van Meeteren LA, 2011, CURR PHARM BIOTECHNO, V12, P2108; van Meeteren LA, 2012, CELL TISSUE RES, V347, P177, DOI 10.1007/s00441-011-1222-6; WU XY, 1995, BIOCHEM BIOPH RES CO, V216, P78, DOI 10.1006/bbrc.1995.2594; YAMASHITA H, 1995, J CELL BIOL, V130, P217, DOI 10.1083/jcb.130.1.217	40	73	74	2	10	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAY 25	2012	287	22					18551	18561		10.1074/jbc.M111.338103	http://dx.doi.org/10.1074/jbc.M111.338103			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	974EC	22493445	Green Published, hybrid			2022-12-25	WOS:000306411600061
J	Zhang, YM; Jiang, DS; Zhang, Y; Jiang, XH; Wang, F; Tao, J				Zhang, Yiming; Jiang, Dongsheng; Zhang, Yuan; Jiang, Xinghong; Wang, Fen; Tao, Jin			Neuromedin U Type 1 Receptor Stimulation of A-type K+ Current Requires the beta gamma Subunits of G(o) Protein, Protein Kinase A, and Extracellular Signal-regulated Kinase 1/2 (ERK1/2) in Sensory Neurons	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							DORSAL-ROOT GANGLION; INACTIVATING POTASSIUM CURRENT; CENTRAL-NERVOUS-SYSTEM; PYRAMIDAL NEURONS; ENHANCED EXCITABILITY; ADENYLYL-CYCLASE; CALCIUM-CHANNELS; DOWN-REGULATION; HORN NEURONS; RAT	Although neuromedin U (NMU) has been implicated in analgesia, the detailed mechanisms still remain unclear. In this study, we identify a novel functional role of NMU type 1 receptor (NMUR1) in regulating the transient outward K+ currents (I-A) in small dorsal root ganglion (DRG) neurons. We found that NMU reversibly increased I-A in a dose-dependent manner, instead the sustained delayed rectifier K+ current (I-DR) was not affected. This NMU-induced I-A increase was pertussis toxin-sensitive and was totally reversed by NMUR1 knockdown. Intracellular application of GDP beta S (guanosine 5'-O-(2-thiodiphosphate)), QEHA peptide, or a selective antibody raised against the G alpha(o) or G beta blocked the stimulatory effects of NMU. Pretreatment of the cells with the protein kinase A (PKA) inhibitor or ERK inhibitor abolished the NMU-induced I-A response, whereas inhibition of phosphatidylinositol 3-kinase or PKC had no such effects. Exposure of DRG neurons to NMU markedly induced the phosphorylation of ERK (p-ERK), whereas p-JNK or p-p38 was not affected. Moreover, the NMU-induced p-ERK increase was attenuated by PKA inhibition and activation of PKA by foskolin would mimic the NMU-induced I-A increase. Functionally, we observed a significant decrease of the firing rate of neuronal action potential induced by NMU and pretreatment of DRG neurons with 4-AP could abolish this effect. In summary, these results suggested that NMU increases I-A via activation of NMUR1 that couples sequentially to the down-stream activities of G beta gamma of the G(o) protein, PKA, and ERK, which could contribute to its physiological functions including neuronal hypoexcitability in DRG neurons.	[Zhang, Yiming; Zhang, Yuan; Jiang, Xinghong; Wang, Fen; Tao, Jin] Soochow Univ, Coll Med, Key Lab Pain Res & Therapy, Dept Neurobiol, Suzhou 215123, Peoples R China; [Jiang, Dongsheng] Univ Ulm, Dept Dermatol & Allerg Dis, D-89081 Ulm, Germany; [Zhang, Yuan] Soochow Univ, Affiliated Hosp 2, Dept Neurol, Suzhou 215004, Peoples R China	Soochow University - China; Ulm University; Soochow University - China	Tao, J (corresponding author), 199 Ren Ai Rd, Suzhou 215123, Peoples R China.	taoj@suda.edu.cn	Zhang, Yiming/HGB-7344-2022; Jiang, Dongsheng/AAG-1284-2020	Jiang, Dongsheng/0000-0003-0961-2671; Tao, Jin/0000-0002-8481-3732	National Natural Science Foundation of China [30900437, 81171056]; Natural Science Funding of Jiangsu Province [BK2009118, BK2011440]; Natural Science Funding for Colleges and Universities in Jiangsu Province [09KJB18000]; Scientific Research Foundation for the Returned Overseas Chinese Scholars of State Education Ministry; Soochow University [Q4134901]; Priority Academic Program Development of Jiangsu Higher Education Institutions	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Natural Science Funding of Jiangsu Province(Natural Science Foundation of Jiangsu Province); Natural Science Funding for Colleges and Universities in Jiangsu Province; Scientific Research Foundation for the Returned Overseas Chinese Scholars of State Education Ministry(Scientific Research Foundation for the Returned Overseas Chinese Scholars); Soochow University; Priority Academic Program Development of Jiangsu Higher Education Institutions	This work was supported by National Natural Science Foundation of China Grants 30900437 and 81171056, Natural Science Funding of Jiangsu Province Grants BK2009118 and BK2011440, Natural Science Funding for Colleges and Universities in Jiangsu Province Grant 09KJB180008, a grant from the Scientific Research Foundation for the Returned Overseas Chinese Scholars of State Education Ministry (to J. T.), Start-up Funding of Soochow University Grant Q4134901, and Dong-Wu Scholar Funding of Soochow University (to J. T.), and a project funded by the Priority Academic Program Development of Jiangsu Higher Education Institutions.	Abdulla FA, 2001, J NEUROPHYSIOL, V85, P630, DOI 10.1152/jn.2001.85.2.630; AKINS PT, 1993, NEUROSCIENCE, V56, P759, DOI 10.1016/0306-4522(93)90372-M; Anderson D, 2010, NAT NEUROSCI, V13, P333, DOI 10.1038/nn.2493; Andrade A, 2010, NAT NEUROSCI, V13, P1249, DOI 10.1038/nn.2643; AvidorReiss T, 1996, J BIOL CHEM, V271, P21309, DOI 10.1074/jbc.271.35.21309; Bailey TW, 2002, J NEUROSCI, V22, P8230; Brighton PJ, 2004, PHARMACOL REV, V56, P231, DOI 10.1124/pr.56.2.3; Budhiraja S, 2009, FUND CLIN PHARMACOL, V23, P149, DOI 10.1111/j.1472-8206.2009.00667.x; CARDENAS CG, 1995, J NEUROPHYSIOL, V74, P1870, DOI 10.1152/jn.1995.74.5.1870; Chien LY, 2007, J NEUROSCI, V27, P9855, DOI 10.1523/JNEUROSCI.0604-07.2007; Choi S, 2006, ARCH PHARM RES, V29, P998, DOI 10.1007/BF02969284; Chung JJ, 2009, FEBS J, V276, P5547, DOI 10.1111/j.1742-4658.2009.07241.x; Dong Y, 2003, J NEUROSCI, V23, P2686; Fujii R, 2000, J BIOL CHEM, V275, P21068, DOI 10.1074/jbc.M001546200; Gold MS, 1996, NEUROSCIENCE, V71, P265, DOI 10.1016/0306-4522(95)00433-5; Hoffman DA, 1998, J NEUROSCI, V18, P3521; Howard AD, 2000, NATURE, V406, P70, DOI 10.1038/35017610; Hu CL, 2008, J NEUROCHEM, V106, P1125, DOI 10.1111/j.1471-4159.2008.05449.x; Hu HJ, 2003, J NEUROPHYSIOL, V90, P1671, DOI 10.1152/jn.00340.2003; Hu HJ, 2006, NEURON, V50, P89, DOI 10.1016/j.neuron.2006.03.010; Kim DS, 2002, MOL BRAIN RES, V105, P146, DOI 10.1016/S0169-328X(02)00388-1; Mitchell JD, 2009, BRIT J PHARMACOL, V158, P87, DOI 10.1111/j.1476-5381.2009.00252.x; Moriyama M, 2004, J PHYSIOL-LONDON, V559, P707, DOI 10.1113/jphysiol.2004.070110; NISENBAUM ES, 1994, J NEUROPHYSIOL, V71, P1174, DOI 10.1152/jn.1994.71.3.1174; Ocana M, 2004, EUR J PHARMACOL, V500, P203, DOI 10.1016/j.ejphar.2004.07.026; Passmore GM, 2003, J NEUROSCI, V23, P7227, DOI 10.1523/JNEUROSCI.23-18-07227.2003; PETERSEN M, 1991, BRAIN RES, V561, P20, DOI 10.1016/0006-8993(91)90744-G; Petruska JC, 2000, J NEUROPHYSIOL, V84, P2365, DOI 10.1152/jn.2000.84.5.2365; Pongs O, 1999, FEBS LETT, V452, P31, DOI 10.1016/S0014-5793(99)00535-9; Raddatz R, 2000, J BIOL CHEM, V275, P32452, DOI 10.1074/jbc.M004613200; Ramakers GMJ, 2002, P NATL ACAD SCI USA, V99, P10144, DOI 10.1073/pnas.152620399; Rasband MN, 2001, DEV BIOL, V236, P5, DOI 10.1006/dbio.2001.0326; Schrader LA, 2006, AM J PHYSIOL-CELL PH, V290, pC852, DOI 10.1152/ajpcell.00358.2005; Shan LX, 2000, J BIOL CHEM, V275, P39482, DOI 10.1074/jbc.C000522200; Shen YR, 2006, J NEUROSCI, V26, P10690, DOI 10.1523/JNEUROSCI.2093-06.2006; Szekeres PG, 2000, J BIOL CHEM, V275, P20247, DOI 10.1074/jbc.C000244200; TANG WJ, 1991, SCIENCE, V254, P1500, DOI 10.1126/science.1962211; Tao J, 2008, MOL PHARMACOL, V73, P1596, DOI 10.1124/mol.107.043612; Tao J, 2009, CELL SIGNAL, V21, P1436, DOI 10.1016/j.cellsig.2009.05.002; Tao J, 2009, CELL CALCIUM, V45, P133, DOI 10.1016/j.ceca.2008.07.004; Tolhurst DJ, 2009, J NEUROSCI, V29, P2355, DOI 10.1523/JNEUROSCI.3869-08.2009; Van Hoorick D, 2003, MOL CELL NEUROSCI, V24, P357, DOI 10.1016/S1044-7431(03)00174-X; Vydyanathan A, 2005, J NEUROPHYSIOL, V93, P3401, DOI 10.1152/jn.01267.2004; Wang F, 2011, CELL CALCIUM, V49, P12, DOI 10.1016/j.ceca.2010.11.002; Watanabe S, 2002, P NATL ACAD SCI USA, V99, P8366, DOI 10.1073/pnas.122210599; Waxman SG, 1999, PAIN, pS133, DOI 10.1016/S0304-3959(99)00147-5; Westfall TD, 2002, J PHARMACOL EXP THER, V301, P987, DOI 10.1124/jpet.301.3.987; Wolfe JT, 2003, NATURE, V424, P209, DOI 10.1038/nature01772; Won JH, 2008, CELL SIGNAL, V20, P884, DOI 10.1016/j.cellsig.2007.12.022; Xu GY, 2006, AM J PHYSIOL-GASTR L, V291, pG424, DOI 10.1152/ajpgi.00560.2005; Yang EK, 2004, NEUROSCIENCE, V123, P867, DOI 10.1016/j.neuroscience.2003.11.014; Yoshimura N, 1996, J PHYSIOL-LONDON, V494, P1; Yu XH, 2003, NEUROSCIENCE, V120, P467, DOI 10.1016/S0306-4522(03)00300-2; Zhang JM, 1999, J NEUROPHYSIOL, V82, P3359, DOI 10.1152/jn.1999.82.6.3359; Zhang YM, 2011, CELL SIGNAL, V23, P1057, DOI 10.1016/j.cellsig.2011.02.001; Zhang YA, 2010, CELL SIGNAL, V22, P1660, DOI 10.1016/j.cellsig.2010.06.006	56	27	27	0	2	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAY 25	2012	287	22					18562	18572		10.1074/jbc.M111.322271	http://dx.doi.org/10.1074/jbc.M111.322271			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	974EC	22493291	Green Published, hybrid			2022-12-25	WOS:000306411600062
J	Ehlen, A; Rossello, CA; von Stedingk, K; Hoog, G; Nilsson, E; Pettersson, HM; Jirstrom, K; Alvarado-Kristensson, M				Ehlen, Asa; Rossello, Catalina A.; von Stedingk, Kristoffer; Hoog, Greta; Nilsson, Elise; Pettersson, Helen M.; Jirstrom, Karin; Alvarado-Kristensson, Maria			Tumors with Nonfunctional Retinoblastoma Protein Are Killed by Reduced gamma-Tubulin Levels	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							CANCER-CELL-LINES; COPY NUMBER; EXPRESSION; TRANSCRIPTION; E2F; PHOSPHORYLATION; NEUROBLASTOMA; PROGNOSIS; BINDING; ROLES	In various tumors inactivation of growth control is achieved by interfering with the RB1 signaling pathway. Here, we describe that RB1 and gamma-tubulin proteins moderate each other's expression by binding to their respective gene promoters. Simultaneous reduction of RB1 and gamma-tubulin protein levels results in an E2F1-dependent up-regulation of apoptotic genes such as caspase 3. We report that in various tumors types, there is an inverse correlation between the expression levels of gamma-tubulin and RB1 and that in tumor cell lines with a nonfunctioning RB1, reduction of gamma-tubulin protein levels leads to induction of apoptosis. Thus, the RB1/gamma- tubulin signal network can be considered as a new target for cancer treatment.	[Ehlen, Asa; Rossello, Catalina A.; von Stedingk, Kristoffer; Hoog, Greta; Nilsson, Elise; Pettersson, Helen M.; Alvarado-Kristensson, Maria] Lund Univ, Skane Univ Hosp, Dept Lab Med, Ctr Mol Pathol, SE-20502 Malmo, Sweden; [Jirstrom, Karin] Lund Univ, Skane Univ Hosp, Dept Clin Sci, SE-22185 Lund, Sweden	Lund University; Skane University Hospital; Lund University; Skane University Hospital	Alvarado-Kristensson, M (corresponding author), Lund Univ, SUS, Ctr Mol Pathol, Entrance 78,Floor 2, SE-20502 Malmo, Sweden.	maria.alvarado-kristensson@med.lu.se	Castillo, Catalina Ana Rosselló/L-6477-2014; Castillo, Catalina Ana Rosselló/R-9426-2019; Alvarado-Kristensson, Maria T./C-4543-2014	Castillo, Catalina Ana Rosselló/0000-0002-8977-607X; Castillo, Catalina Ana Rosselló/0000-0002-8977-607X; Eklund, Greta/0000-0002-2498-7765; Alvarado Kristensson, Maria Teresa/0000-0003-0598-7986	Swedish Research Council; Swedish Cancer Society; Royal Physiographic Society in Lund; Gyllenstiernska Krapperupsstiftelsen; Skane University Hospital in Malmo Cancer Research Fund; Per-Eric and Ulla Schyberg Foundation; Cradfoord Foundation; Gunnar Nilsson, H. Foundation; G. Jeanssons Foundation; O. and E. Ericsson Foundation	Swedish Research Council(Swedish Research CouncilEuropean Commission); Swedish Cancer Society(Swedish Cancer Society); Royal Physiographic Society in Lund; Gyllenstiernska Krapperupsstiftelsen; Skane University Hospital in Malmo Cancer Research Fund; Per-Eric and Ulla Schyberg Foundation; Cradfoord Foundation; Gunnar Nilsson, H. Foundation; G. Jeanssons Foundation; O. and E. Ericsson Foundation	This work was supported by the Swedish Research Council, the Swedish Cancer Society, the Royal Physiographic Society in Lund, Per-Eric and Ulla Schyberg, Cradfoord, Gunnar Nilsson, H. and G. Jeanssons and O. and E. Ericsson Foundations; Gyllenstiernska Krapperupsstiftelsen; and the Skane University Hospital in Malmo Cancer Research Fund.	Adams PD, 2001, BBA-REV CANCER, V1471, pM123, DOI 10.1016/S0304-419X(01)00019-1; Alvarado-Kristensson M, 2004, J EXP MED, V199, P449, DOI 10.1084/jem.20031771; Alvarado-Kristensson M, 2009, NAT CELL BIOL, V11, P1081, DOI 10.1038/ncb1921; Biswas AK, 2012, CANCER RES, V72, P13, DOI 10.1158/0008-5472.CAN-11-2196; Chen HZ, 2009, NAT REV CANCER, V9, P785, DOI 10.1038/nrc2696; De Preter K, 2002, MODERN PATHOL, V15, P159, DOI 10.1038/modpathol.3880508; Ehlen A, 2010, J TRANSL MED, V8, DOI 10.1186/1479-5876-8-78; Elkabets M, 2011, J CLIN INVEST, V121, P784, DOI 10.1172/JCI43757; Gaber A, 2009, BRIT J CANCER, V100, P1540, DOI 10.1038/sj.bjc.6605047; Hanahan D, 2000, CELL, V100, P57, DOI 10.1016/S0092-8674(00)81683-9; Harbour JW, 2000, GENE DEV, V14, P2393, DOI 10.1101/gad.813200; Hoog G, 2011, FASEB J, V25, P3815, DOI 10.1096/fj.11-187484; Kononen J, 1998, NAT MED, V4, P844, DOI 10.1038/nm0798-844; LEE EYHP, 1988, P NATL ACAD SCI USA, V85, P6017, DOI 10.1073/pnas.85.16.6017; Mizuarai S, 2011, MOL CANCER, V10, DOI 10.1186/1476-4598-10-31; Molenaar JJ, 2008, CANCER RES, V68, P2599, DOI 10.1158/0008-5472.CAN-07-5032; Nahle Z, 2002, NAT CELL BIOL, V4, P859, DOI 10.1038/ncb868; NYGREN P, 1991, BRIT J CANCER, V64, P1011, DOI 10.1038/bjc.1991.456; Persson MM, 2012, AM J PATHOL, V180, P494, DOI 10.1016/j.ajpath.2011.10.014; QIN XQ, 1994, P NATL ACAD SCI USA, V91, P10918, DOI 10.1073/pnas.91.23.10918; Sellers WR, 1998, GENE DEV, V12, P95, DOI 10.1101/gad.12.1.95; Stransky N, 2006, NAT GENET, V38, P1386, DOI 10.1038/ng1923; Svensson KJ, 2011, INT J ONCOL, V39, P1421, DOI 10.3892/ijo.2011.1164; Zhang JH, 2011, BLOOD, V118, P3080, DOI 10.1182/blood-2011-03-341412	24	24	24	1	3	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAY 18	2012	287	21					17241	17247		10.1074/jbc.M112.357038	http://dx.doi.org/10.1074/jbc.M112.357038			7	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	973PU	22493456	hybrid, Green Published			2022-12-25	WOS:000306373000024
J	Hojo, H; Ohba, S; Yano, F; Saito, T; Ikeda, T; Nakajima, K; Komiyama, Y; Nakagata, N; Suzuki, K; Takato, T; Kawaguchi, H; Chung, U				Hojo, Hironori; Ohba, Shinsuke; Yano, Fumiko; Saito, Taku; Ikeda, Toshiyuki; Nakajima, Keiji; Komiyama, Yuske; Nakagata, Naomi; Suzuki, Kentaro; Takato, Tsuyoshi; Kawaguchi, Hiroshi; Chung, Ung-il			Gli1 Protein Participates in Hedgehog-mediated Specification of Osteoblast Lineage during Endochondral Ossification	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							REQUIRES ADDITIONAL EFFECTORS; BONE-FORMATION; DIFFERENTIATION; IHH; EXPRESSION; GROWTH; CANCER; GENES; RUNX2	With regard to Hedgehog signaling in mammalian development, the majority of research has focused on Gli2 and Gli3 rather than Gli1. This is because Gli1(-/-) mice do not show any gross abnormalities in adulthood, and no detailed analyses of fetal Gli1(-/-) mice are available. In this study, we investigated the physiological role of Gli1 in osteogenesis. Histological analyses revealed that bone formation was impaired in Gli1(-/-) fetuses compared with WT fetuses. Gli1(-/-) perichondrial cells expressed neither runt-related transcription factor 2 (Runx2) nor osterix, master regulators of osteogenesis, in contrast to WT cells. In vitro analyses showed that overexpression of Gli1 up-regulated early osteogenesis-related genes in both WT and Runx2(-/-) perichondrial cells, and Gli1 activated transcription of those genes via its association with their 5'-regulatory regions, underlying the function of Gli1 in the perichondrium. Moreover, Gli1(-/-);Gli2(-/-) mice showed more severe phenotypes of impaired bone formation than either Gli1(-/-) or Gli2(-/-) mice, and osteoblast differentiation was impaired in Gli1(-/-);Gli3(-/-) perichondrial cells compared with Gli3(-/-) cells in vitro. These data suggest that Gli1 itself can induce early osteoblast differentiation, at least to some extent, in a Runx2-independent manner. It also plays a redundant role with Gli2 and is involved in the repressor function of Gli3 in osteogenesis. On the basis of these findings, we propose that upon Hedgehog input, Gli1 functions collectively with Gli2 and Gli3 in osteogenesis.	[Hojo, Hironori] Univ Tokyo, Ctr Dis Biol & Integrat Med, Bunkyo Ku, Tokyo 1130033, Japan; [Hojo, Hironori; Yano, Fumiko; Saito, Taku; Ikeda, Toshiyuki; Nakajima, Keiji; Komiyama, Yuske; Takato, Tsuyoshi; Kawaguchi, Hiroshi] Univ Tokyo, Dept Sensory & Motor Syst Med, Tokyo 1130033, Japan; [Nakagata, Naomi; Suzuki, Kentaro] Kumamoto Univ, CARD, Kumamoto 8600811, Japan	University of Tokyo; University of Tokyo; Kumamoto University	Hojo, H (corresponding author), Univ Tokyo, Ctr Dis Biol & Integrat Med, Bunkyo Ku, 7-3-1 Hongo, Tokyo 1130033, Japan.	hojo@bmw.t.u-tokyo.ac.jp; soba@bmw.t.u-tokyo.ac.jp	Ikeda, Toshiyuki/GVS-5588-2022	Ohba, Shinsuke/0000-0002-6874-8539; Hojo, Hironori/0000-0003-2245-6853; Nakagata, Naomi/0000-0002-5737-9993	Japan Society for the Promotion of Science (JSPS); Center for NanoBio Integration; Center for Medical System Innovation; Funding Program for World-Leading Innovative R&D on Science and Technology (FIRST program)	Japan Society for the Promotion of Science (JSPS)(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of Science); Center for NanoBio Integration; Center for Medical System Innovation; Funding Program for World-Leading Innovative R&D on Science and Technology (FIRST program)(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of Science)	This work was supported in part by grants-in-aid for scientific research from the Japan Society for the Promotion of Science (JSPS) and by the Center for NanoBio Integration, the Center for Medical System Innovation, and the Funding Program for World-Leading Innovative R&D on Science and Technology (FIRST program).	Arai F, 2002, J EXP MED, V195, P1549, DOI 10.1084/jem.20011700; Bai CB, 2002, DEVELOPMENT, V129, P4753; Bai CYB, 2001, DEVELOPMENT, V128, P5161; Chung UI, 2001, J CLIN INVEST, V107, P295, DOI 10.1172/JCI11706; DIGNAM JD, 1983, NUCLEIC ACIDS RES, V11, P1475, DOI 10.1093/nar/11.5.1475; Drakopoulou E, 2010, CELL CYCLE, V9, P4144, DOI 10.4161/cc.9.20.13453; Ducy P, 1997, CELL, V89, P747, DOI 10.1016/S0092-8674(00)80257-3; Hilton MJ, 2005, DEVELOPMENT, V132, P4339, DOI 10.1242/dev.02025; Hojo H, 2010, J BONE MINER METAB, V28, P627, DOI 10.1007/s00774-010-0179-y; Hu HL, 2005, DEVELOPMENT, V132, P49, DOI 10.1242/dev.01564; Ingham PW, 2001, GENE DEV, V15, P3059, DOI 10.1101/gad.938601; Jacob J, 2003, EMBO REP, V4, P761, DOI 10.1038/sj.embor.embor896; Jiang J, 2008, DEV CELL, V15, P801, DOI 10.1016/j.devcel.2008.11.010; Joeng KS, 2009, DEVELOPMENT, V136, P4177, DOI 10.1242/dev.041624; Karlstrom RO, 2003, DEVELOPMENT, V130, P1549, DOI 10.1242/dev.00364; Kimura H, 2005, ONCOGENE, V24, P4026, DOI 10.1038/sj.onc.1208567; Komori T, 1997, CELL, V89, P755, DOI 10.1016/S0092-8674(00)80258-5; Koziel L, 2005, DEVELOPMENT, V132, P5249, DOI 10.1242/dev.02097; Kronenberg HM, 2003, NATURE, V423, P332, DOI 10.1038/nature01657; Long FX, 2012, NAT REV MOL CELL BIO, V13, P27, DOI 10.1038/nrm3254; Long FX, 2004, DEVELOPMENT, V131, P1309, DOI 10.1242/dev.01006; Mak KK, 2008, DEV CELL, V14, P674, DOI 10.1016/j.devcel.2008.02.003; Merchant A, 2010, BLOOD, V115, P2391, DOI 10.1182/blood-2009-09-241703; Mo R, 1997, DEVELOPMENT, V124, P113; Nakashima K, 2002, CELL, V108, P17, DOI 10.1016/S0092-8674(01)00622-5; Ohba S, 2008, DEV CELL, V14, P689, DOI 10.1016/j.devcel.2008.03.007; Park HL, 2000, DEVELOPMENT, V127, P1593; Saito T, 2010, NAT MED, V16, P678, DOI 10.1038/nm.2146; Shimoyama A, 2007, MOL BIOL CELL, V18, P2411, DOI 10.1091/mbc.E06-08-0743; St-Jacques B, 1999, GENE DEV, V13, P2072, DOI 10.1101/gad.13.16.2072; Stecca B, 2010, J MOL CELL BIOL, V2, P84, DOI 10.1093/jmcb/mjp052; Tu XL, 2012, DEV BIOL, V362, P76, DOI 10.1016/j.ydbio.2011.11.013; Vokes SA, 2008, GENE DEV, V22, P2651, DOI 10.1101/gad.1693008	33	64	69	0	10	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAY 18	2012	287	21					17860	17869		10.1074/jbc.M112.347716	http://dx.doi.org/10.1074/jbc.M112.347716			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	973PU	22493482	hybrid, Green Published			2022-12-25	WOS:000306373000083
J	Blackler, R; Syer, S; Bolla, M; Ongini, E; Wallace, JL				Blackler, Rory; Syer, Stephanie; Bolla, Manlio; Ongini, Ennio; Wallace, John L.			Gastrointestinal-Sparing Effects of Novel NSAIDs in Rats with Compromised Mucosal Defence	PLOS ONE			English	Article							NONSTEROIDAL ANTIINFLAMMATORY DRUGS; ENTERIC-COATED ASPIRIN; PROTON PUMP INHIBITORS; SMALL-BOWEL INJURY; HYDROGEN-SULFIDE; NITRIC-OXIDE; GASTRIC-ULCERATION; CYCLOOXYGENASE 1; NO-NAPROXEN; ULCERS	Nonsteroidal antiand/orinflammatory drugs are among the most commonly used prescription and over-the-counter medications, but they often produce significant gastrointestinal ulceration and bleeding, particularly in elderly patients and patients with certain co-morbidities. Novel anti-inflammatory drugs are seldom tested in animal models that mimic the high risk human users, leading to an underestimate of the true toxicity of the drugs. In the present study we examined the effects of two novel NSAIDs and two commonly used NSAIDs in models in which mucosal defence was expected to be impaired. Naproxen, celecoxib, ATB-346 (a hydrogen sulfide- and naproxen-releasing compound) and NCX 429 (a nitric oxide- and naproxen-releasing compound) were evaluated in healthy, arthritic, obese, and hypertensive rats and in rats of advanced age (19 months) and rats co-administered low-dose aspirin and/or omeprazole. In all models except hypertension, greater gastric and/or intestinal damage was observed when naproxen was administered in these models than in healthy rats. Celecoxib-induced damage was significantly increased when co-administered with low-dose aspirin and/or omeprazole. In contrast, ATB-346 and NCX 429, when tested at doses that were as effective as naproxen and celecoxib in reducing inflammation and inhibiting cyclooxygenase activity, did not produce significant gastric or intestinal damage in any of the models. These results demonstrate that animal models of human co-morbidities display the same increased susceptibility to NSAID-induced gastrointestinal damage as observed in humans. Moreover, two novel NSAIDs that release mediators of mucosal defence (hydrogen sulfide and nitric oxide) do not induce significant gastrointestinal damage in these models of impaired mucosal defence.	[Blackler, Rory; Syer, Stephanie; Wallace, John L.] McMaster Univ, Farncombe Family Digest Hlth Res Inst, Hamilton, ON, Canada; [Bolla, Manlio; Ongini, Ennio] NicOx Res Inst, Milan, Italy	McMaster University	Blackler, R (corresponding author), McMaster Univ, Farncombe Family Digest Hlth Res Inst, Hamilton, ON, Canada.	jwalla@mcmaster.ca	Wallace, John/AAL-3763-2021		Canadian Institutes of Health Research	Canadian Institutes of Health Research(Canadian Institutes of Health Research (CIHR))	This work was supported by a grant from the Canadian Institutes of Health Research. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aro P, 2006, AM J EPIDEMIOL, V163, P1025, DOI 10.1093/aje/kwj129; Augstein P, 2009, METHODS MOL BIOL, V560, P159, DOI 10.1007/978-1-59745-448-3_12; BJARNASON I, 1993, GASTROENTEROLOGY, V104, P1832, DOI 10.1016/0016-5085(93)90667-2; Brzozowski T, 2000, DIGEST LIVER DIS, V32, P583, DOI 10.1016/S1590-8658(00)80840-3; Cicala C, 2000, BRIT J PHARMACOL, V130, P1399, DOI 10.1038/sj.bjp.0703449; Davies NM, 1997, ALIMENT PHARM THER, V11, P69, DOI 10.1046/j.1365-2036.1997.115286000.x; Elliott SN, 1998, AM J PHYSIOL-GASTR L, V275, pG425, DOI 10.1152/ajpgi.1998.275.3.G425; ELLIOTT SN, 1995, GASTROENTEROLOGY, V109, P524, DOI 10.1016/0016-5085(95)90341-0; Fiorucci S, 2005, GASTROENTEROLOGY, V129, P1210, DOI 10.1053/j.gastro.2005.07.060; Fiorucci S, 2002, GASTROENTEROLOGY, V123, P1598, DOI 10.1053/gast.2002.36558; Fujimori S, 2010, EUR J CLIN INVEST, V40, P504, DOI 10.1111/j.1365-2362.2010.02290.x; Goldstein JL, 2005, CLIN GASTROENTEROL H, V3, P133, DOI 10.1016/S1542-3565(04)00619-6; Goto H, 2001, CLIN EXP PHARMACOL P, V28, P659, DOI 10.1046/j.1440-1681.2001.03497.x; Graham DY, 2011, AM J MED SCI, V342, P356, DOI 10.1097/MAJ.0b013e3182113658; Graham DY, 2005, CLIN GASTROENTEROL H, V3, P55, DOI 10.1016/S1542-3565(04)00603-2; Hernandez-Diaz S, 2002, J CLIN EPIDEMIOL, V55, P157, DOI 10.1016/S0895-4356(01)00461-9; Kearney PM, 2006, BMJ-BRIT MED J, V332, P1302, DOI 10.1136/bmj.332.7553.1302; KENT TH, 1969, AM J PATHOL, V54, P237; Laine L, 2004, GASTROENTEROLOGY, V127, P395, DOI 10.1053/j.gastro.2004.05.001; Maiden L, 2005, GASTROENTEROLOGY, V128, P1172, DOI 10.1053/j.gastro.2005.03.020; MCCAFFERTY DM, 1995, GASTROENTEROLOGY, V109, P1173, DOI 10.1016/0016-5085(95)90576-6; MIURA S, 1991, AM J PHYSIOL, V261, pG213, DOI 10.1152/ajpgi.1991.261.2.G213; Poullis A, 2003, EUR J GASTROEN HEPAT, V15, P573, DOI 10.1097/01.meg.0000059108.41030.23; PURKERSON ML, 1986, HYPERTENSION, V8, P1113, DOI 10.1161/01.HYP.8.12.1113; Reuter BK, 1997, GASTROENTEROLOGY, V112, P109, DOI 10.1016/S0016-5085(97)70225-7; Scheiman JM, 2006, AM J GASTROENTEROL, V101, P701, DOI 10.1111/j.1572-0241.2006.00499.x; Solomon DH, 1997, AM J MED, V102, P208; Uejima M, 1996, MICROBIOL IMMUNOL, V40, P553, DOI 10.1111/j.1348-0421.1996.tb01108.x; Vogiagis D, 2000, AM J PHYSIOL-GASTR L, V278, pG820, DOI 10.1152/ajpgi.2000.278.5.G820; Waldram A, 2009, J PROTEOME RES, V8, P2361, DOI 10.1021/pr8009885; WALLACE JL, 1990, AM J PHYSIOL, V259, pG462, DOI 10.1152/ajpgi.1990.259.3.G462; WALLACE JL, 1993, CAN J PHYSIOL PHARM, V71, P98, DOI 10.1139/y93-014; Wallace JL, 1998, GASTROENTEROLOGY, V115, P101, DOI 10.1016/S0016-5085(98)70370-1; Wallace JL, 2000, GASTROENTEROLOGY, V119, P512, DOI 10.1053/gast.2000.9304; Wallace JL, 2000, GASTROENTEROLOGY, V119, P706, DOI 10.1053/gast.2000.16510; Wallace JL, 2003, FUND CLIN PHARMACOL, V17, P11, DOI 10.1046/j.1472-8206.2003.00125.x; Wallace JL, 2008, PHYSIOL REV, V88, P1547, DOI 10.1152/physrev.00004.2008; Wallace JL, 2007, FASEB J, V21, P4070, DOI 10.1096/fj.07-8669com; Wallace JL, 2007, TRENDS PHARMACOL SCI, V28, P501, DOI 10.1016/j.tips.2007.09.003; Wallace JL, 2007, GASTROENTEROLOGY, V132, P261, DOI 10.1053/j.gastro.2006.11.042; Wallace JL, 2012, BRIT J PHARMACOL, V165, P67, DOI 10.1111/j.1476-5381.2011.01509.x; Wallace JL, 2011, GASTROENTEROLOGY, V141, P1314, DOI 10.1053/j.gastro.2011.06.075; Wallace JL, 2010, BRIT J PHARMACOL, V159, P1236, DOI 10.1111/j.1476-5381.2009.00611.x; Watanabe T, 2008, CLIN GASTROENTEROL H, V6, P1279, DOI 10.1016/j.cgh.2008.06.021; Zanardo RCO, 2006, FASEB J, V20, P2118, DOI 10.1096/fj.06-6270fje; ZUCKER LM, 1972, ENDOCRINOLOGY, V90, P1320, DOI 10.1210/endo-90-5-1320	46	32	34	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 9	2012	7	4							e35196	10.1371/journal.pone.0035196	http://dx.doi.org/10.1371/journal.pone.0035196			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	955JO	22496907	Green Submitted, Green Published, gold			2022-12-25	WOS:000305014500049
J	Gish, M; Dafni, A; Inbar, M				Gish, Moshe; Dafni, Amots; Inbar, Moshe			Young Aphids Avoid Erroneous Dropping when Evading Mammalian Herbivores by Combining Input from Two Sensory Modalities	PLOS ONE			English	Article							ACYRTHOSIPHON-PISUM HARRIS; PEA APHID; ANTIPREDATOR BEHAVIOR; ESCAPE BEHAVIOR; PREDATOR AVOIDANCE; ALARM PHEROMONE; RESPONSES; RISK; CUES; COSTS	Mammalian herbivores may incidentally ingest plant-dwelling insects while foraging. Adult pea aphids (Acyrthosiphon pisum) avoid this danger by dropping off their host plant after sensing the herbivore's warm and humid breath and the vibrations it causes while feeding. Aphid nymphs may also drop (to escape insect enemies), but because of their slow movement, have a lower chance of finding a new plant. We compared dropping rates of first-instar nymphs with those of adults, after exposing pea aphids to different combinations of simulated mammalian breath and vibrations. We hypothesized that nymphs would compensate for the greater risk they face on the ground by interpreting more conservatively the mammalian herbivore cues they perceive. Most adults dropped in response to breath alone, but nymphs rarely did so. Breath stimulus accompanied by one concurrent vibrational stimulus, caused a minor rise in adult dropping rates. Adding a second vibration during breath had no additional effect on adults. The nymphs, however, relied on a combination of the two types of stimuli, with a threefold increase in dropping rates when the breath was accompanied by one vibration, and a further doubling of dropping rates when the second vibration was added. The age-specificity of the aphids' herbivore detection mechanism is probably an adaptation to the different cost of dropping for the different age groups. Relying on a combination of stimuli from two sensory modalities enables the vulnerable nymphs to avoid costly mistakes. Our findings emphasize the importance of the direct trophic effect of mammalian herbivory for plant-dwelling insects.	[Gish, Moshe; Dafni, Amots; Inbar, Moshe] Univ Haifa, Dept Evolutionary & Environm Biol, IL-31999 Haifa, Israel	University of Haifa	Gish, M (corresponding author), Univ Haifa, Dept Evolutionary & Environm Biol, IL-31999 Haifa, Israel.	minbar@research.haifa.ac.il		Inbar, Moshe/0000-0002-4707-9508	Israel Science Foundation [940/08]; Henk and Dorothy Schussheim Fund for Ecological Research in Mount Carmel	Israel Science Foundation(Israel Science Foundation); Henk and Dorothy Schussheim Fund for Ecological Research in Mount Carmel	This work was partly supported by the Israel Science Foundation (Grant Number 940/08 to MI) and by the Henk and Dorothy Schussheim Fund for Ecological Research in Mount Carmel. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript. No additional external funding was received for this study.	Amo L, 2004, ANIM BEHAV, V67, P647, DOI 10.1016/j.anbehav.2003.08.005; Aoki S., 2010, Psyche: A Journal of Entomology, V2010, P380351, DOI 10.1155/2010/380351; Bernasconi ML, 1998, ENTOMOL EXP APPL, V87, P133, DOI 10.1023/A:1003200108763; Bouwma P, 2001, ANIM BEHAV, V61, P771, DOI 10.1006/anbe.2000.1649; Braam J, 2005, NEW PHYTOL, V165, P373, DOI 10.1111/j.1469-8137.2004.01263.x; BROADBENT L, 1951, ANN APPL BIOL, V38, P577, DOI 10.1111/j.1744-7348.1951.tb07829.x; Broom, 1981, BIOL BEHAV MECH FUNC; Caro Tim, 2005, pXIII; Castellanos I, 2006, ANIM BEHAV, V72, P461, DOI 10.1016/j.anbehav.2006.02.005; CLEGG JM, 1982, CAN J ZOOL, V60, P2245, DOI 10.1139/z82-289; Cooper WE, 1998, CAN J ZOOL, V76, P1507; Cromarty SI, 2000, BIOL BULL-US, V199, P265, DOI 10.2307/1543183; Dicke M, 2010, TRENDS PLANT SCI, V15, P167, DOI 10.1016/j.tplants.2009.12.002; DILL LM, 1990, OECOLOGIA, V83, P473, DOI 10.1007/BF00317197; DIXON A. F. G., 1958, TRANS ROY ENTOMOL SOC LONDON, V110, P319; FITZGIBBON CD, 1990, ANIM BEHAV, V40, P846, DOI 10.1016/S0003-3472(05)80985-6; Francke DL, 2008, ENTOMOL EXP APPL, V127, P118, DOI 10.1111/j.1570-7458.2008.00678.x; Frazer B.D., 1988, P217; FRAZER B D, 1976, Journal of the Entomological Society of British Columbia, V73, P33; Gish M, 2006, J INSECT BEHAV, V19, P143, DOI 10.1007/s10905-005-9009-9; Gish M, 2011, NATURWISSENSCHAFTEN, V98, P731, DOI 10.1007/s00114-011-0819-7; Gish M, 2010, CURR BIOL, V20, pR628, DOI 10.1016/j.cub.2010.06.065; Harrewijn, 1987, APHIDS THEIR BIOL A, V2A, P269; Hartbauer M, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0010417; Heil M, 2004, J CHEM ECOL, V30, P1289, DOI 10.1023/B:JOEC.0000030299.59863.69; HELFMAN GS, 1989, BEHAV ECOL SOCIOBIOL, V24, P47, DOI 10.1007/BF00300117; Kim JW, 2009, J FISH BIOL, V74, P1280, DOI 10.1111/j.1095-8649.2009.02199.x; Kunert G, 2010, ECOL ENTOMOL, V35, P147, DOI 10.1111/j.1365-2311.2009.01146.x; LANG F, 1977, SCIENCE, V197, P682, DOI 10.1126/science.197.4304.682; Levri EP, 1998, CAN J ZOOL, V76, P1878, DOI 10.1139/cjz-76-10-1878; Losey JE, 1998, ECOL ENTOMOL, V23, P53, DOI 10.1046/j.1365-2311.1998.00102.x; Losey JE, 1998, OECOLOGIA, V115, P245, DOI 10.1007/s004420050513; Martin J, 2005, CAN J ZOOL, V83, P1189, DOI 10.1139/Z05-114; MCALLISTER MK, 1987, NATURE, V328, P797, DOI 10.1038/328797b0; MONTGOMERY ME, 1978, ANN ENTOMOL SOC AM, V71, P788, DOI 10.1093/aesa/71.5.788; Nelson EH, 2007, OECOLOGIA, V151, P22, DOI 10.1007/s00442-006-0573-2; ODE PR, 1993, FRESHWATER BIOL, V30, P351, DOI 10.1111/j.1365-2427.1993.tb00819.x; Pavlovic A, 2010, ANN BOT-LONDON, V105, P37, DOI 10.1093/aob/mcp269; Peccoud J, 2009, P NATL ACAD SCI USA, V106, P7495, DOI 10.1073/pnas.0811117106; POLIS GA, 1989, ANNU REV ECOL SYST, V20, P297, DOI 10.1146/annurev.es.20.110189.001501; ROITBERG BD, 1978, J APPL ECOL, V15, P775, DOI 10.2307/2402774; ROITBERG BD, 1979, J ANIM ECOL, V48, P111, DOI 10.2307/4104; ROITBERG BD, 1978, CAN J ZOOL, V56, P103, DOI 10.1139/z78-014; ROITBERG BD, 1979, CAN ENTOMOL, V111, P515, DOI 10.4039/Ent111515-4; Roth ED, 2004, BEHAV ECOL, V15, P365, DOI 10.1093/beheco/arh024; SCHULTZ JC, 1981, EVOLUTION, V35, P175, DOI 10.1111/j.1558-5646.1981.tb04870.x; Shine R, 2002, COPEIA, P843; SOLUK DA, 1993, ECOLOGY, V74, P219, DOI 10.2307/1939516; Tokunaga E, 2008, POPUL ECOL, V50, P45, DOI 10.1007/s10144-007-0065-1; Volkov AG, 2011, J PLANT PHYSIOL, V168, P109, DOI 10.1016/j.jplph.2010.06.007; Warkentin KM, 2005, ANIM BEHAV, V70, P59, DOI 10.1016/j.anbehav.2004.09.019; Yamazaki K, 2008, NATURWISSENSCHAFTEN, V95, P263, DOI 10.1007/s00114-007-0318-z; ZAMORA R, 1993, OIKOS, V66, P223, DOI 10.2307/3544808	53	19	19	1	20	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 9	2012	7	4							e32706	10.1371/journal.pone.0032706	http://dx.doi.org/10.1371/journal.pone.0032706			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	955JO	22496734	Green Published, gold, Green Submitted			2022-12-25	WOS:000305014500005
J	Yuan, K; Lian, ZR; Sun, B; Clayton, MM; Ng, IOL; Feitelson, MA				Yuan, Ke; Lian, Zhaorui; Sun, Bill; Clayton, Marcia M.; Ng, Irene O. L.; Feitelson, Mark A.			Role of miR-148a in Hepatitis B Associated Hepatocellular Carcinoma	PLOS ONE			English	Article							VIRUS-X-PROTEIN; TUMOR-SUPPRESSOR GENE; NF-KAPPA-B; LIVER-CANCER; TRANSCRIPTIONAL ACTIVATION; DNA METHYLTRANSFERASE-1; NUCLEAR RECEPTOR; TARGETING PTEN; CELL-SURVIVAL; BETA-CATENIN	Hepatitis B virus encoded X antigen (HBx) is a trans-regulatory protein that alters the activity of selected transcription factors and cytoplasmic signal transduction pathways. HBx transcriptionally up-regulates the expression of a unique gene, URG11, which in turn transcriptionally up-regulates beta-catenin, thereby contributing importantly to hepatocarcinogenesis. HBx and URG11 also alter the expression of multiple microRNAs, and by miRNA array analysis, both were shown to promote the expression of miR-148a. Elevated miR-148a was also seen in HBx positive liver samples from infected patients. To study the function of miR-148a, anti-148a was introduced into HepG2 and Hep3B cells stably expressing HBx or stably over-expressing URG11. Anti-miR-148a suppressed cell proliferation, cell cycle progression, cell migration, anchorage independent growth in soft agar and subcutaneous tumor formation in SCID mice. Introduction of anti-miR-148a increased PTEN protein and mRNA expression, suggesting that PTEN was targeted by miR-148a. Anti-miR-148a failed to suppress PTEN expression when co-transfected with reporter gene mutants in the 3'UTR of PTEN mRNA. Introduction of anti-miR-148a also resulted in depressed Akt signaling by HBx and URG11, resulting in decreased expression of beta-catenin. Thus, miR-148a may play a central role in HBx/URG11 mediated HCC, and may be an early diagnostic marker and/or therapeutic target associated with this tumor type.	[Yuan, Ke; Lian, Zhaorui; Sun, Bill; Clayton, Marcia M.; Feitelson, Mark A.] Temple Univ, Dept Biol, Coll Sci & Technol, Philadelphia, PA 19122 USA; [Feitelson, Mark A.] Temple Univ, Ctr Biotechnol, Sbarro Hlth Res Org, Coll Sci & Technol, Philadelphia, PA 19122 USA; [Ng, Irene O. L.] Univ Hong Kong, Queen Mary Hosp, Dept Pathol, Pokfulam, Hong Kong, Peoples R China	Pennsylvania Commonwealth System of Higher Education (PCSHE); Temple University; Pennsylvania Commonwealth System of Higher Education (PCSHE); Temple University; University of Hong Kong	Yuan, K (corresponding author), Temple Univ, Dept Biol, Coll Sci & Technol, Philadelphia, PA 19122 USA.	feitelso@temple.edu	Lian, Zhaorui/AAW-2379-2020	Feitelson, Mark/0000-0002-4904-0498; Ng, Irene Oi-lin/0000-0001-7532-2029	National Institutes of Health [5R01CA104025, 5R01CA111427]; NATIONAL CANCER INSTITUTE [R01CA111427, R01CA104025] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	This work was supported by National Institutes of Health grants 5R01CA104025 and 5R01CA111427. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Baldus CD, 2003, BLOOD, V102, P1613, DOI 10.1182/blood-2003-02-0359; BENN J, 1994, P NATL ACAD SCI USA, V91, P10350, DOI 10.1073/pnas.91.22.10350; Blumberg B, 1998, GENE DEV, V12, P3195, DOI 10.1101/gad.12.20.3195; Braconi C, 2010, HEPATOLOGY, V51, P881, DOI 10.1002/hep.23381; Budhu A, 2008, HEPATOLOGY, V47, P897, DOI 10.1002/hep.22160; Calin GA, 2005, NEW ENGL J MED, V353, P1793, DOI 10.1056/NEJMoa050995; Calin GA, 2004, P NATL ACAD SCI USA, V101, P11755, DOI 10.1073/pnas.0404432101; Carruba G, 1999, ANN NY ACAD SCI, V886, P212, DOI 10.1111/j.1749-6632.1999.tb09419.x; Chalhoub N, 2009, ANNU REV PATHOL-MECH, V4, P127, DOI 10.1146/annurev.pathol.4.110807.092311; Cheng AM, 2005, NUCLEIC ACIDS RES, V33, P1290, DOI 10.1093/nar/gki200; Chirillo P, 1996, J VIROL, V70, P641, DOI 10.1128/JVI.70.1.641-646.1996; Chung TW, 2003, CANCER RES, V63, P3453; Cully M, 2006, NAT REV CANCER, V6, P184, DOI 10.1038/nrc1819; Duursma AM, 2008, RNA, V14, P872, DOI 10.1261/rna.972008; Fabregat I, 2007, LIVER INT, V27, P155, DOI 10.1111/j.1478-3231.2006.01409.x; FEITELSON MA, 1993, ONCOGENE, V8, P1109; Feitelson MA, 1997, AM J PATHOL, V150, P1141; Feitelson MA, 2009, CANCER LETT, V286, P69, DOI 10.1016/j.canlet.2008.12.010; Goodwin B, 1999, MOL PHARMACOL, V56, P1329, DOI 10.1124/mol.56.6.1329; Gramantieri L, 2007, CANCER RES, V67, P6092, DOI 10.1158/0008-5472.CAN-06-4607; Gramantieri L, 2008, J CELL MOL MED, V12, P2189, DOI 10.1111/j.1582-4934.2008.00533.x; He HL, 2005, P NATL ACAD SCI USA, V102, P19075, DOI 10.1073/pnas.0509603102; He L, 2005, NATURE, V435, P828, DOI 10.1038/nature03552; Henkler F, 1996, J VIRAL HEPATITIS, V3, P109, DOI 10.1111/j.1365-2893.1996.tb00001.x; Jung JK, 2007, CANCER RES, V67, P5771, DOI 10.1158/0008-5472.CAN-07-0529; Kato M, 2009, NAT CELL BIOL, V11, P881, DOI 10.1038/ncb1897; Korkaya H, 2009, PLOS BIOL, V7, DOI 10.1371/journal.pbio.1000121; Lagos-Quintana M, 2001, SCIENCE, V294, P853, DOI 10.1126/science.1064921; Lee RC, 2001, SCIENCE, V294, P862, DOI 10.1126/science.1065329; Lehmann JM, 1998, J CLIN INVEST, V102, P1016, DOI 10.1172/JCI3703; Lian ZR, 2006, HEPATOLOGY, V43, P415, DOI 10.1002/hep.21053; Lian ZR, 2003, NEOPLASIA, V5, P229, DOI 10.1016/S1476-5586(03)80055-6; Lian ZR, 1999, ONCOGENE, V18, P1677, DOI 10.1038/sj.onc.1202470; Liu CG, 2004, P NATL ACAD SCI USA, V101, P9740, DOI 10.1073/pnas.0403293101; Lu J, 2005, NATURE, V435, P834, DOI 10.1038/nature03702; LUCITO R, 1992, J VIROL, V66, P983, DOI 10.1128/JVI.66.2.983-991.1992; Lujambio A, 2008, P NATL ACAD SCI USA, V105, P13556, DOI 10.1073/pnas.0803055105; MAGUIRE HF, 1991, SCIENCE, V252, P842, DOI 10.1126/science.1827531; Meng FY, 2007, GASTROENTEROLOGY, V133, P647, DOI 10.1053/j.gastro.2007.05.022; Murakami Y, 2006, ONCOGENE, V25, P2537, DOI 10.1038/sj.onc.1209283; Nijhara R, 2001, J VIROL, V75, P10348, DOI 10.1128/JVI.75.21.10348-10358.2001; Oishi N, 2007, CANCER SCI, V98, P1540, DOI 10.1111/j.1349-7006.2007.00579.x; Parkin DM, 2005, CA-CANCER J CLIN, V55, P74, DOI 10.3322/canjclin.55.2.74; QADRI I, 1995, P NATL ACAD SCI USA, V92, P1003, DOI 10.1073/pnas.92.4.1003; SETO E, 1990, NATURE, V344, P72, DOI 10.1038/344072a0; Shih WL, 2000, J BIOL CHEM, V275, P25858, DOI 10.1074/jbc.M003578200; Stambolic V, 2001, MOL CELL, V8, P317, DOI 10.1016/S1097-2765(01)00323-9; Sun BS, 1998, HEPATOLOGY, V27, P228, DOI 10.1002/hep.510270135; Szmuness W, 1978, Prog Med Virol, V24, P40; Takagi S, 2008, J BIOL CHEM, V283, P9674, DOI 10.1074/jbc.M709382200; Tang H, 2006, CANCER SCI, V97, P977, DOI 10.1111/j.1349-7006.2006.00299.x; Tanner SM, 2001, P NATL ACAD SCI USA, V98, P13901, DOI 10.1073/pnas.241525498; TIOLLAIS P, 1985, NATURE, V317, P489, DOI 10.1038/317489a0; UEDA H, 1995, NAT GENET, V9, P41, DOI 10.1038/ng0195-41; Volinia S, 2006, P NATL ACAD SCI USA, V103, P2257, DOI 10.1073/pnas.0510565103; WANG XW, 1994, P NATL ACAD SCI USA, V91, P2230, DOI 10.1073/pnas.91.6.2230; Wen SH, 2001, P NATL ACAD SCI USA, V98, P4622, DOI 10.1073/pnas.081063798; Wu RC, 2000, MOL CELL BIOCHEM, V203, P59, DOI 10.1023/A:1007024624967; Yang H, 2008, CANCER RES, V68, P425, DOI 10.1158/0008-5472.CAN-07-2488	59	82	90	0	13	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 9	2012	7	4							e35331	10.1371/journal.pone.0035331	http://dx.doi.org/10.1371/journal.pone.0035331			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	955JO	22496917	Green Published, gold, Green Submitted			2022-12-25	WOS:000305014500055
J	Wang, M; Wang, QL; Wang, BM				Wang, Min; Wang, Qinglian; Wang, Baomin			Identification and Characterization of MicroRNAs in Asiatic Cotton (Gossypium arboreum L.)	PLOS ONE			English	Article							COMPUTATIONAL IDENTIFICATION; PLANT MICRORNA; TARGET GENES; CONSERVATION; RESISTANCE; EXPRESSION; SEQUENCE; HIRSUTUM; TIME	To date, no miRNAs have been identified in the important diploid cotton species although there are several reports on miRNAs in upland cotton. In this study, we identified 73 miRNAs, belonging to 49 families, from Asiatic cotton using a well-developed comparative genome-based homologue search. Several of the predicted miRNAs were validated using quantitative real time PCR (qRT-PCR). The length of miRNAs varied from 18 to 22 nt with an average of 20 nt. The length of miRNA precursors also varied from 46 to 684 nt with an average of 138 +/- 120 nt. For a majority of Asiatic cotton miRNAs, there is only one member per family; however, multiple members were identified for miRNA 156, 414, 837, 838, 1044, 1533, 2902, 2868, 5021 and 5142 families. Nucleotides A and U were dominant, accounted for 62.95%, in the Asiatic cotton pre-miRNAs. The Asiatic cotton pre-miRNAs had high negative minimal folding free energy (MFE) and adjusted MFE (AMFE) and high MFE index (MFEI). Many miRNAs identified in Asiatic cotton suggest that miRNAs also play a similar regulatory mechanism in diploid cotton.	[Wang, Min; Wang, Baomin] China Agr Univ, Coll Agron & Biotechnol, Beijing 100094, Peoples R China; [Wang, Qinglian] Henan Inst Sci & Technol, Xingxiang, Henan, Peoples R China	China Agricultural University; Henan Institute of Science & Technology	Wang, M (corresponding author), China Agr Univ, Coll Agron & Biotechnol, Beijing 100094, Peoples R China.	wangql@hist.edu.cn; wbaomin@263.net			National Natural Science Foundation of China [31170263]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC))	This project is partially support by the grants from National Natural Science Foundation of China (31170263). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Akhtar KP, 2010, ANN APPL BIOL, V157, P135, DOI 10.1111/j.1744-7348.2010.00416.x; Altuvia Y, 2005, NUCLEIC ACIDS RES, V33, P2697, DOI 10.1093/nar/gki567; Aukerman MJ, 2003, PLANT CELL, V15, P2730, DOI 10.1105/tpc.016238; Bartel DP, 2009, CELL, V136, P215, DOI 10.1016/j.cell.2009.01.002; Chen CF, 2005, NUCLEIC ACIDS RES, V33, DOI 10.1093/nar/gni178; Chen R, 2009, J INTEGR PLANT BIOL, V51, P1071, DOI 10.1111/j.1744-7909.2009.00887.x; Chen XM, 2004, SCIENCE, V303, P2022, DOI 10.1126/science.1088060; DHAWAN A K, 1991, Journal of Research Punjab Agricultural University, V28, P57; Frazier TP, 2010, PLANTA, V232, P1289, DOI 10.1007/s00425-010-1255-1; Glazinska P, 2009, J PLANT PHYSIOL, V166, P1801, DOI 10.1016/j.jplph.2009.05.011; Gleave AP, 2008, TREE GENET GENOMES, V4, P343, DOI 10.1007/s11295-007-0113-1; Griffiths-Jones S, 2008, NUCLEIC ACIDS RES, V36, pD154, DOI 10.1093/nar/gkm952; Han YS, 2009, SCI CHINA SER C, V52, P1091, DOI 10.1007/s11427-009-0144-y; Kwak PB, 2009, BMC GENOMICS, V10, DOI 10.1186/1471-2164-10-457; Liu DQ, 2006, GENET RESOUR CROP EV, V53, P1145, DOI 10.1007/s10722-005-1304-y; Maqbool A, 2010, BIOTECHNOL PROGR, V26, P21, DOI 10.1002/btpr.306; Mlotshwa S, 2006, PLANT MOL BIOL, V61, P781, DOI 10.1007/s11103-006-0049-0; Nibouche S, 2008, PLANT BREEDING, V127, P376, DOI 10.1111/j.1439-0523.2008.01499.x; Pang MX, 2009, GENOME BIOL, V10, DOI 10.1186/gb-2009-10-11-r122; Pasquinelli AE, 2000, NATURE, V408, P86, DOI 10.1038/35040556; Pasquinelli AE, 2003, EVOL DEV, V5, P372, DOI 10.1046/j.1525-142X.2003.03044.x; Qiu CX, 2007, GENE, V395, P49, DOI 10.1016/j.gene.2007.01.034; Song CN, 2009, PLANTA, V230, P671, DOI 10.1007/s00425-009-0971-x; Tahir MS, 2011, CYTOLOGIA, V76, P193, DOI 10.1508/cytologia.76.193; Wheeler TA, 1999, PLANT DIS, V83, P831, DOI 10.1094/PDIS.1999.83.9.831; Xie FL, 2007, FEBS LETT, V581, P1464, DOI 10.1016/j.febslet.2007.02.074; Xie FL, 2011, GENE, V473, P8, DOI 10.1016/j.gene.2010.09.007; Xie FL, 2010, PLANTA, V232, P417, DOI 10.1007/s00425-010-1182-1; Yin ZJ, 2008, GENE, V414, P60, DOI 10.1016/j.gene.2008.02.007; Zhang BH, 2007, GENE, V397, P26, DOI 10.1016/j.gene.2007.03.020; Zhang BH, 2006, COMPUT BIOL CHEM, V30, P395, DOI 10.1016/j.compbiolchem.2006.08.006; Zhang BH, 2007, J CELL PHYSIOL, V210, P279, DOI 10.1002/jcp.20869; Zhang BH, 2006, FEBS LETT, V580, P3753, DOI 10.1016/j.febslet.2006.05.063; Zhang BH, 2009, MOL BIOTECHNOL, V42, P269, DOI 10.1007/s12033-009-9163-y; Zhang BH, 2008, PLANTA, V229, P161, DOI 10.1007/s00425-008-0818-x; Zhang BH, 2006, CELL MOL LIFE SCI, V63, P246, DOI 10.1007/s00018-005-5467-7; Zhang BH, 2006, DEV BIOL, V289, P3, DOI 10.1016/j.ydbio.2005.10.036; Zhang BH, 2005, CELL RES, V15, P336, DOI 10.1038/sj.cr.7290302; Zhang BH, 2006, PLANT J, V46, P243, DOI 10.1111/j.1365-313X.2006.02697.X; Zhang WW, 2009, COMPUT BIOL CHEM, V33, P84, DOI 10.1016/j.compbiolchem.2008.07.006	40	34	39	0	13	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 6	2012	7	4							e33696	10.1371/journal.pone.0033696	http://dx.doi.org/10.1371/journal.pone.0033696			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	955JA	22493671	gold, Green Published, Green Submitted			2022-12-25	WOS:000305012700013
J	Ma, SS; Liu, SJ; Huang, QY; Xie, B; Lai, BQ; Wang, C; Song, B; Li, MT				Ma, Shanshan; Liu, Shaojun; Huang, Qiaoying; Xie, Bo; Lai, Bingquan; Wang, Chong; Song, Bin; Li, Mingtao			Site-specific Phosphorylation Protects Glycogen Synthase Kinase-3 beta from Calpain-mediated Truncation of Its N and C Termini	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							CEREBELLAR GRANULE NEURONS; POTASSIUM DEPRIVATION; KINASE 3-BETA; APOPTOSIS; INHIBITION; CLEAVAGE; SURVIVAL; GSK-3; EXPRESSION; GSK3-BETA	Glycogen synthase kinase-3 beta (GSK-3 beta), a key regulator of neuronal apoptosis, is inhibited by the phosphorylation of Ser-9/Ser-389 and was recently shown to be cleaved by calpain at the N terminus, leading to its subsequent activation. In this study calpain was found to cleave GSK-3 beta not only at the N terminus but also at the C terminus, and cleavage sites were identified at residues Thr-38-Thr-39 and Ile-384-Gln-385. Furthermore, the cleavage of GSK-3 beta occurred in tandem with Ser-9 dephosphorylation during cerebellar granule neuron apoptosis. Increasing Ser-9 phosphorylation of GSK-3 beta by inhibiting phosphatase 1/2A or pretreating with purified active Akt inhibited calpain-mediated cleavage of GSK-3 beta at both N and C termini, whereas non-phosphorylatable mutant GSK-3 beta S9A facilitated its cleavage. In contrast, Ser-389 phosphorylation selectively inhibited the cleavage of GSK-3 beta at the C terminus but not the N terminus. Calpain-mediated cleavage resulted in three truncated products, all of which contained an intact kinase domain: Delta N-GSK-3 beta (amino acids 39-420), Delta C-GSK-3 beta (amino acids 1-384), and Delta N/Delta C-GSK-3 beta (amino acids 39-384). All three truncated products showed increased kinase and pro-apoptotic activity, with Delta N/Delta C-GSK-3 beta being the most active form. This observation suggests that the GSK-3 beta C terminus acts as an autoinhibitory domain similar to the N terminus. Taken together, these findings demonstrate that calpain-mediated cleavage activates GSK-3 beta by removing its N- and C-terminal autoinhibitory domains and that Ser-9 phosphorylation inhibits the cleavage of GSK-3 beta at both termini. In contrast, Ser-389 phosphorylation inhibits only C-terminal cleavage but not N-terminal cleavage. These findings also identify a mechanism by which site-specific phosphorylation and calpain-mediated cleavage operate in concert to regulate GSK-3 beta activity.	[Li, Mingtao] Sun Yat Sen Univ, Zhongshan Sch Med, Dept Pharmacol, Guangzhou 510080, Guangdong, Peoples R China; Sun Yat Sen Univ, Zhongshan Sch Med, Prote Ctr, Guangzhou 510080, Guangdong, Peoples R China	Sun Yat Sen University; Sun Yat Sen University	Li, MT (corresponding author), Sun Yat Sen Univ, Zhongshan Sch Med, Dept Pharmacol, 74 Zhongshan Rd 2, Guangzhou 510080, Guangdong, Peoples R China.	limt@mail.sysu.edu.cn		Liu, Shaojun/0000-0001-7895-5577; Ma, Shanshan/0000-0002-3004-9468; Huang, Qiaoying/0000-0001-6643-2509	National Basic Research Program of China 973 Program [2011CB504105]; National Natural Science Foundation of China [81030024]; Natural Science Foundation of Guangdong Province China [9351008901000003]; Key Program for Scientific and Technological Innovations of Higher Education Institutes in Guangdong Province China [cxzd1002]	National Basic Research Program of China 973 Program(National Basic Research Program of China); National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Natural Science Foundation of Guangdong Province China(National Natural Science Foundation of Guangdong Province); Key Program for Scientific and Technological Innovations of Higher Education Institutes in Guangdong Province China	This work was supported by National Basic Research Program of China 973 Program Grant 2011CB504105, National Natural Science Foundation of China Grant 81030024, Natural Science Foundation of Guangdong Province China Grant 9351008901000003, and Key Program for Scientific and Technological Innovations of Higher Education Institutes in Guangdong Province China Grant cxzd1002.	Alvira D, 2007, NEUROSCIENCE, V146, P350, DOI 10.1016/j.neuroscience.2007.01.042; Bano D, 2005, CELL, V120, P275, DOI 10.1016/j.cell.2004.11.049; Bax B, 2001, STRUCTURE, V9, P1143, DOI 10.1016/S0969-2126(01)00679-7; Beurel E, 2006, PROG NEUROBIOL, V79, P173, DOI 10.1016/j.pneurobio.2006.07.006; Chen G, 2004, FASEB J, V18, P1162, DOI 10.1096/fj.04-1551fje; Chin PC, 2005, MOL BRAIN RES, V137, P193, DOI 10.1016/j.molbrainres.2005.03.004; Crespo-Biel N, 2010, HIPPOCAMPUS, V20, P962, DOI 10.1002/hipo.20691; CROSS DAE, 1995, NATURE, V378, P785, DOI 10.1038/378785a0; D'MELLO SR, 1993, P NATL ACAD SCI USA, V90, P10989, DOI 10.1073/pnas.90.23.10989; Dajani R, 2001, CELL, V105, P721, DOI 10.1016/S0092-8674(01)00374-9; Dunker A K, 1998, Pac Symp Biocomput, P473; Dyson HJ, 2005, NAT REV MOL CELL BIO, V6, P197, DOI 10.1038/nrm1589; Fink AL, 2005, CURR OPIN STRUC BIOL, V15, P35, DOI 10.1016/j.sbi.2005.01.002; Goni-Oliver P, 2007, J BIOL CHEM, V282, P22406, DOI 10.1074/jbc.M702793200; Goni-Oliver P, 2011, NEUROCHEM INT, V59, P97, DOI 10.1016/j.neuint.2011.03.021; Goni-Oliver P, 2009, J ALZHEIMERS DIS, V18, P843, DOI 10.3233/JAD-2009-1190; Goni-Oliver P, 2009, J NEUROSCI RES, V87, P1156, DOI 10.1002/jnr.21932; Hernandez F, 2010, MOL CELL BIOCHEM, V344, P211, DOI 10.1007/s11010-010-0544-0; Hernandez F, 2009, BRAIN RES BULL, V80, P248, DOI 10.1016/j.brainresbull.2009.05.017; Hetman M, 2000, J NEUROSCI, V20, P2567; Iakoucheva LM, 2004, NUCLEIC ACIDS RES, V32, P1037, DOI 10.1093/nar/gkh253; Kamei H, 2007, J BIOL CHEM, V282, P1687, DOI 10.1074/jbc.M610541200; Kwok JBJ, 2005, ANN NEUROL, V58, P829, DOI 10.1002/ana.20691; Leroy K, 1999, J CHEM NEUROANAT, V16, P279, DOI 10.1016/S0891-0618(99)00012-5; Li MT, 2000, MOL CELL BIOL, V20, P9356, DOI 10.1128/MCB.20.24.9356-9363.2000; Liu W, 2009, PROTEOMICS, V9, P3712, DOI 10.1002/pmic.200800979; Ma C, 2007, J BIOL CHEM, V282, P30901, DOI 10.1074/jbc.M608694200; Miller TM, 1996, J NEUROSCI, V16, P7487; Pap M, 1998, J BIOL CHEM, V273, P19929, DOI 10.1074/jbc.273.32.19929; Prakash S, 2004, NAT STRUCT MOL BIOL, V11, P830, DOI 10.1038/nsmb814; SAKAI K, 1987, J BIOCHEM-TOKYO, V101, P911, DOI 10.1093/oxfordjournals.jbchem.a121959; Salas TR, 2003, J BIOL CHEM, V278, P41338, DOI 10.1074/jbc.M302972200; Song B, 2010, J BIOL CHEM, V285, P41122, DOI 10.1074/jbc.M110.130351; Takashima A, 2006, J ALZHEIMERS DIS, V9, P309; Thornton TM, 2008, SCIENCE, V320, P667, DOI 10.1126/science.1156037; Vosler PS, 2008, MOL NEUROBIOL, V38, P78, DOI 10.1007/s12035-008-8036-x; Wang WY, 2007, NEUROPHARMACOLOGY, V52, P1678, DOI 10.1016/j.neuropharm.2007.03.017; Ward JJ, 2004, BIOINFORMATICS, V20, P2138, DOI 10.1093/bioinformatics/bth195; WOODGETT JR, 1990, EMBO J, V9, P2431, DOI 10.1002/j.1460-2075.1990.tb07419.x; Xie B, 2011, J NEUROSCI, V31, P5032, DOI 10.1523/JNEUROSCI.5504-10.2011; Yuan ZM, 2009, MOL CELL BIOL, V29, P2431, DOI 10.1128/MCB.01344-08; Yuen EY, 2007, J BIOL CHEM, V282, P16434, DOI 10.1074/jbc.M701283200	42	20	21	0	9	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JUN 29	2012	287	27					22521	22532		10.1074/jbc.M111.321349	http://dx.doi.org/10.1074/jbc.M111.321349			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	975GB	22496446	hybrid, Green Published			2022-12-25	WOS:000306495000010
J	Wratting, D; Thistlethwaite, A; Harris, M; Zeef, LAH; Millar, CB				Wratting, Daniel; Thistlethwaite, Angela; Harris, Michael; Zeef, Leo A. H.; Millar, Catherine B.			A Conserved Function for the H2A.Z C Terminus	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							HISTONE H2A.Z; SACCHAROMYCES-CEREVISIAE; DOCKING DOMAIN; VARIANT; GENOME; ACETYLATION; REGIONS; YEAST; HETEROCHROMATIN; EUCHROMATIN	Histone H2A variants generate diversity in chromatin structure and functions, as nucleosomes containing variant H2A histones have altered physical, chemical, and biological properties. H2A.Z is an evolutionarily ancient and highly conserved H2A variant that regulates processes ranging from gene expression to the DNA damage response. Here we find that the unstructured portion of the C-terminal tail of H2A.Z is required for the normal functions of this histone variant in budding yeast. We have also identified a novel splice isoform of the human H2A.Z-2 gene that encodes a C-terminally truncated H2A.Z protein that is similar to the truncation mutants we identified in yeast. The short forms of H2A.Z in both yeast and human cells are more loosely associated with chromatin than the full-length proteins, indicating a conserved function for the H2A.Z C-terminal tail in regulating the association of H2A.Z with nucleosomes.	[Wratting, Daniel; Thistlethwaite, Angela; Harris, Michael; Zeef, Leo A. H.; Millar, Catherine B.] Univ Manchester, Fac Life Sci, Manchester M13 9PT, Lancs, England	University of Manchester	Millar, CB (corresponding author), Univ Manchester, Fac Life Sci, Michael Smith Bldg, Manchester M13 9PT, Lancs, England.	catherine.millar@manchester.ac.uk		Millar, Catherine/0000-0002-8649-5408	Wellcome Trust; BBSRC	Wellcome Trust(Wellcome TrustEuropean Commission); BBSRC(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC))	This work was supported by a Wellcome Trust Career Development Fellowship (to C. B. M.) and a BBSRC Doctoral Training Studentship (to D. W.).	Albert I, 2007, NATURE, V446, P572, DOI 10.1038/nature05632; Ausio J, 2002, BIOCHEMISTRY-US, V41, P5945, DOI 10.1021/bi020059d; Barski A, 2007, CELL, V129, P823, DOI 10.1016/j.cell.2007.05.009; Bolstad BM, 2003, BIOINFORMATICS, V19, P185, DOI 10.1093/bioinformatics/19.2.185; Clarkson MJ, 1999, NATURE, V399, P694, DOI 10.1038/21436; Collins SR, 2007, NATURE, V446, P806, DOI 10.1038/nature05649; Creyghton MP, 2008, CELL, V135, P649, DOI 10.1016/j.cell.2008.09.056; EICKBUSH TH, 1988, J BIOL CHEM, V263, P18972; Eirin-Lopez JM, 2009, BMC EVOL BIOL, V9, DOI 10.1186/1471-2148-9-31; Gevry N, 2007, GENE DEV, V21, P1869, DOI 10.1101/gad.1545707; Gevry N, 2009, GENE DEV, V23, P1522, DOI 10.1101/gad.1787109; Guillemette B, 2005, PLOS BIOL, V3, P2100, DOI 10.1371/journal.pbio.0030384; Ikura T, 2007, MOL CELL BIOL, V27, P7028, DOI 10.1128/MCB.00579-07; Jackson JD, 2000, NUCLEIC ACIDS RES, V28, P3811, DOI 10.1093/nar/28.19.3811; Jensen K, 2011, MOL GENET GENOMICS, V285, P287, DOI 10.1007/s00438-011-0604-5; Jin CY, 2009, NAT GENET, V41, P941, DOI 10.1038/ng.409; Kalocsay M, 2009, MOL CELL, V33, P335, DOI 10.1016/j.molcel.2009.01.016; Karaczyn AA, 2003, CHEM RES TOXICOL, V16, P1555, DOI 10.1021/tx0300277; Karaczyn AA, 2009, ANN CLIN LAB SCI, V39, P251; Kimura A, 2002, NAT GENET, V32, P370, DOI 10.1038/ng993; Kobor MS, 2004, PLOS BIOL, V2, P587, DOI 10.1371/journal.pbio.0020131; Longtine MS, 1998, YEAST, V14, P953, DOI 10.1002/(SICI)1097-0061(199807)14:10<953::AID-YEA293>3.3.CO;2-L; Luger K, 1997, NATURE, V389, P251, DOI 10.1038/38444; Mavrich TN, 2008, NATURE, V453, P358, DOI 10.1038/nature06929; Meneghini MD, 2003, CELL, V112, P725, DOI 10.1016/S0092-8674(03)00123-5; Millar CB, 2006, GENE DEV, V20, P711, DOI 10.1101/gad.1395506; Mizuguchi G, 2004, SCIENCE, V303, P343, DOI 10.1126/science.1090701; Ogawa Y, 2005, BIOCHEM BIOPH RES CO, V336, P204, DOI 10.1016/j.bbrc.2005.08.046; Papamichos-Chronakis M, 2011, CELL, V144, P200, DOI 10.1016/j.cell.2010.12.021; Raisner RM, 2005, CELL, V123, P233, DOI 10.1016/j.cell.2005.10.002; Ruthenburg AJ, 2007, NAT REV MOL CELL BIO, V8, P983, DOI 10.1038/nrm2298; Santisteban MS, 2000, CELL, V103, P411, DOI 10.1016/S0092-8674(00)00133-1; Sarcinella E, 2007, MOL CELL BIOL, V27, P6457, DOI 10.1128/MCB.00241-07; Shia WJ, 2006, GENE DEV, V20, P2507, DOI 10.1101/gad.1439206; Shukla MS, 2011, NUCLEIC ACIDS RES, V39, P2559, DOI 10.1093/nar/gkq1174; Su AI, 2004, P NATL ACAD SCI USA, V101, P6062, DOI 10.1073/pnas.0400782101; Suka N, 2002, NAT GENET, V32, P378, DOI 10.1038/ng1017; Talbert PB, 2010, NAT REV MOL CELL BIO, V11, P264, DOI 10.1038/nrm2861; Thambirajah AA, 2009, BIOCHEM CELL BIOL, V87, P7, DOI 10.1139/O08-103; Tighe A, 2004, J CELL SCI, V117, P6339, DOI 10.1242/jcs.01556; Van Doninck K, 2009, PLOS GENET, V5, DOI 10.1371/journal.pgen.1000401; Vissers JHA, 2008, CELL DIV, V3, DOI 10.1186/1747-1028-3-8; Vogler C, 2010, PLOS GENET, V6, DOI 10.1371/journal.pgen.1001234; Wang AY, 2011, MOL CELL BIOL, V31, P3871, DOI 10.1128/MCB.05182-11; Whittle CM, 2008, PLOS GENET, V4, DOI 10.1371/journal.pgen.1000187; Wu WH, 2005, NAT STRUCT MOL BIOL, V12, P1064, DOI 10.1038/nsmb1023; Xi YX, 2011, GENOME RES, V21, P718, DOI 10.1101/gr.117101.110; Zhang HY, 2005, CELL, V123, P219, DOI 10.1016/j.cell.2005.08.036; Zilberman D, 2008, NATURE, V456, P125, DOI 10.1038/nature07324	49	19	20	0	8	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JUN 1	2012	287	23					19148	19157		10.1074/jbc.M111.317990	http://dx.doi.org/10.1074/jbc.M111.317990			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	974EF	22493515	Green Published, hybrid			2022-12-25	WOS:000306411900025
J	Fu, W; Ruangkittisakul, A; MacTavish, D; Shi, JY; Ballanyi, K; Jhamandas, JH				Fu, Wen; Ruangkittisakul, Araya; MacTavish, David; Shi, Jenny Y.; Ballanyi, Klaus; Jhamandas, Jack H.			Amyloid beta (A beta) Peptide Directly Activates Amylin-3 Receptor Subtype by Triggering Multiple Intracellular Signaling Pathways	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							ACTIVITY-MODIFYING PROTEINS; CALCITONIN RECEPTOR; ALZHEIMERS-DISEASE; DIABETES-MELLITUS; COUPLED RECEPTORS; TOXICITY; NEURONS; PHARMACOLOGY; PATHOLOGY; ISOFORM	The two age-prevalent diseases Alzheimer disease and type 2 diabetes mellitus share many common features including the deposition of amyloidogenic proteins, amyloid beta protein (A beta) and amylin (islet amyloid polypeptide), respectively. Recent evidence suggests that both A beta and amylin may express their effects through the amylin receptor, although the precise mechanisms for this interaction at a cellular level are unknown. Here, we studied this by generating HEK293 cells with stable expression of an isoform of the amylin receptor family, amylin receptor-3 (AMY3). A beta 1-42 and human amylin (hAmylin) increase cytosolic cAMP and Ca2+, trigger multiple pathways involving the signal transduction mediators protein kinase A, MAPK, Akt, and cFos. A beta 1-42 and hAmylin also induce cell death during exposure for 24-48 h at low micromolar concentrations. In the presence of hAmylin, A beta 1-42 effects on HEK293-AMY3-expressing cells are occluded, suggesting a shared mechanism of action between the two peptides. Amylin receptor antagonist AC253 blocks increases in intracellular Ca2+, activation of protein kinase A, MAPK, Akt, cFos, and cell death, which occur upon AMY3 activation with hAmylin, A beta 1-42, or their co-application. Our data suggest that AMY3 plays an important role by serving as a receptor target for actions A beta and thus may represent a novel therapeutic target for development of compounds to treat neurodegenerative conditions such as Alzheimer disease.	[Fu, Wen; MacTavish, David; Shi, Jenny Y.; Jhamandas, Jack H.] Univ Alberta, Centres Neurosci & Prions & Prot Folding Dis, Dept Med, Div Neurol, Edmonton, AB T6G 2S2, Canada; [Ruangkittisakul, Araya; Ballanyi, Klaus] Univ Alberta, Dept Physiol, Edmonton, AB T6G 2S2, Canada	University of Alberta; University of Alberta	Jhamandas, JH (corresponding author), Univ Alberta, Heritage Med Res Ctr 530, Dept Med Neurol, Edmonton, AB T6G 2S2, Canada.	jack.jhamandas@ualberta.ca	Ungpakawa, Araya/J-3849-2013	Ungpakawa, Araya/0000-0002-9606-8557	Canadian Institutes of Health Research [CIHR MOP 93601]; Canada Foundation of Innovation; Alberta-Heritage Foundation for Medical Research	Canadian Institutes of Health Research(Canadian Institutes of Health Research (CIHR)); Canada Foundation of Innovation(Canada Foundation for Innovation); Alberta-Heritage Foundation for Medical Research(Alberta Heritage Foundation for Medical Research)	This work was supported by Canadian Institutes of Health Research Grant CIHR MOP 93601 (to J. H. J.), the Canada Foundation of Innovation, and a scientist award from the Alberta-Heritage Foundation for Medical Research (to K. B.).	Ahtiluoto S, 2010, NEUROLOGY, V75, P1195, DOI 10.1212/WNL.0b013e3181f4d7f8; Akter K, 2011, BRIT J CLIN PHARMACO, V71, P365, DOI 10.1111/j.1365-2125.2010.03830.x; Andreetto E, 2011, CHEMBIOCHEM, V12, P1313, DOI 10.1002/cbic.201100192; Ballard C, 2011, LANCET, V377, P1019, DOI 10.1016/S0140-6736(10)61349-9; Beeley NRA, 1996, EXPERT OPIN THER PAT, V6, P555; Berridge MJ, 2000, NAT REV MOL CELL BIO, V1, P11, DOI 10.1038/35036035; BHOGAL R, 1992, ENDOCRINOLOGY, V130, P906, DOI 10.1210/en.130.2.906; Castellani RJ, 2010, DM-DIS MON, V56, P484, DOI 10.1016/j.disamonth.2010.06.001; Chiti F, 2006, ANNU REV BIOCHEM, V75, P333, DOI 10.1146/annurev.biochem.75.101304.123901; Christopoulos G, 1999, MOL PHARMACOL, V56, P235, DOI 10.1124/mol.56.1.235; Drisaldi B, 2004, J BIOL CHEM, V279, P55443, DOI 10.1074/jbc.M404794200; Enns LC, 2010, AGEING RES REV, V9, P269, DOI 10.1016/j.arr.2010.02.004; Franke TF, 2008, ONCOGENE, V27, P6473, DOI 10.1038/onc.2008.313; Glabe CG, 2006, NEUROBIOL AGING, V27, P570, DOI 10.1016/j.neurobiolaging.2005.04.017; Gotz J, 2009, CELL MOL LIFE SCI, V66, P1321, DOI 10.1007/s00018-009-9070-1; Haass C, 2007, NAT REV MOL CELL BIO, V8, P101, DOI 10.1038/nrm2101; Hay DL, 2005, MOL PHARMACOL, V67, P1655, DOI 10.1124/mol.104.008615; Hebda JA, 2009, ANNU REV BIOPHYS, V38, P125, DOI 10.1146/annurev.biophys.050708.133622; Hoppener JWM, 2000, NEW ENGL J MED, V343, P411; Huang X, 2010, NEUROSCIENCE, V165, P1429, DOI 10.1016/j.neuroscience.2009.11.063; Jhamandas JH, 2011, AM J PATHOL, V178, P140, DOI 10.1016/j.ajpath.2010.11.022; Jhamandas JH, 2004, J NEUROSCI, V24, P5579, DOI 10.1523/JNEUROSCI.1051-04.2004; Kuwasako K, 2004, MOL PHARMACOL, V65, P207, DOI 10.1124/mol.65.1.207; Lappano R, 2011, NAT REV DRUG DISCOV, V10, P47, DOI 10.1038/nrd3320; Lim YA, 2010, PROTEOMICS, V10, P1621, DOI 10.1002/pmic.200900651; Morfis M, 2008, ENDOCRINOLOGY, V149, P5423, DOI 10.1210/en.2007-1735; Poyner DR, 2002, PHARMACOL REV, V54, P233, DOI 10.1124/pr.54.2.233; Purdue BW, 2002, RECEPTOR CHANNEL, V8, P243, DOI 10.1080/10606820213681; Quinn JMW, 1999, BONE, V25, P1, DOI 10.1016/S8756-3282(99)00094-0; Raggatt LJ, 2000, J ENDOCRINOL, V167, P93, DOI 10.1677/joe.0.1670093; Rezaei-Ghaleh N, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0020289; Ruangkittisakul A, 2006, J NEUROSCI, V26, P11870, DOI 10.1523/JNEUROSCI.3357-06.2006; Stine WB, 2003, J BIOL CHEM, V278, P11612, DOI 10.1074/jbc.M210207200; Subramaniam S, 2010, FEBS J, V277, P22, DOI 10.1111/j.1742-4658.2009.07367.x; Thathiah A, 2011, NAT REV NEUROSCI, V12, P73, DOI 10.1038/nrn2977; Tilakaratne N, 2000, J PHARMACOL EXP THER, V294, P61; Walker CS, 2010, TRENDS PHARMACOL SCI, V31, P476, DOI 10.1016/j.tips.2010.06.006	37	79	80	1	15	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAY 25	2012	287	22					18820	18830		10.1074/jbc.M111.331181	http://dx.doi.org/10.1074/jbc.M111.331181			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	974EC	22500019	Green Published, hybrid			2022-12-25	WOS:000306411600090
J	Hudson, PN; Self, J; Weiss, S; Braden, Z; Xiao, YH; Girgis, NM; Emerson, G; Hughes, C; Sammons, SA; Isaacs, SN; Damon, IK; Olson, VA				Hudson, Paul N.; Self, Joshua; Weiss, Sonja; Braden, Zachary; Xiao, Yuhong; Girgis, Natasha M.; Emerson, Ginny; Hughes, Christine; Sammons, Scott A.; Isaacs, Stuart N.; Damon, Inger K.; Olson, Victoria A.			Elucidating the Role of the Complement Control Protein in Monkeypox Pathogenicity	PLOS ONE			English	Article							ENHANCED NEUTRALIZATION; SMALLPOX INHIBITOR; IMMUNE-RESPONSES; ENZYMES SPICE; VIRUS; VACCINIA; ACTIVATION; CONGO; TRANSMISSION; EXPRESSION	Monkeypox virus (MPXV) causes a smallpox-like disease in humans. Clinical and epidemiological studies provide evidence of pathogenicity differences between two geographically distinct monkeypox virus clades: the West African and Congo Basin. Genomic analysis of strains from both clades identified a similar to 10 kbp deletion in the less virulent West African isolates sequenced to date. One absent open reading frame encodes the monkeypox virus homologue of the complement control protein (CCP). This modulatory protein prevents the initiation of both the classical and alternative pathways of complement activation. In monkeypox virus, CCP, also known as MOPICE, is a similar to 24 kDa secretory protein with sequence homology to this superfamily of proteins. Here we investigate CCP expression and its role in monkeypox virulence and pathogenesis. CCP was incorporated into the West African strain and removed from the Congo Basin strain by homologous recombination. CCP expression phenotypes were confirmed for both wild type and recombinant monkeypox viruses and CCP activity was confirmed using a C4b binding assay. To characterize the disease, prairie dogs were intranasally infected and disease progression was monitored for 30 days. Removal of CCP from the Congo Basin strain reduced monkeypox disease morbidity and mortality, but did not significantly decrease viral load. The inclusion of CCP in the West African strain produced changes in disease manifestation, but had no apparent effect on disease-associated mortality. This study identifies CCP as an important immuno-modulatory protein in monkeypox pathogenesis but not solely responsible for the increased virulence seen within the Congo Basin clade of monkeypox virus.	[Hudson, Paul N.; Self, Joshua; Weiss, Sonja; Braden, Zachary; Emerson, Ginny; Hughes, Christine; Sammons, Scott A.; Damon, Inger K.; Olson, Victoria A.] Ctr Dis Control & Prevent, Poxvirus & Rabies Branch, DHCPP, Atlanta, GA 30333 USA; [Hudson, Paul N.; Self, Joshua; Weiss, Sonja; Braden, Zachary; Emerson, Ginny; Hughes, Christine; Sammons, Scott A.; Damon, Inger K.; Olson, Victoria A.] Ctr Dis Control & Prevent, Biotechnol Core Facil Branch, DSR, NCEZID, Atlanta, GA USA; [Xiao, Yuhong; Girgis, Natasha M.; Isaacs, Stuart N.] Univ Penn, Sch Med, Dept Med, Div Infect Dis, Philadelphia, PA 19104 USA	Centers for Disease Control & Prevention - USA; Centers for Disease Control & Prevention - USA; University of Pennsylvania	Hudson, PN (corresponding author), Ctr Dis Control & Prevent, Poxvirus & Rabies Branch, DHCPP, Atlanta, GA 30333 USA.	fst6@cdc.gov	Isaacs, Stuart/HGA-3405-2022		NIH [U01 AI066333]; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [U01AI066333] Funding Source: NIH RePORTER	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	This work was funded by NIH grant U01 AI066333. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Benhnia MREI, 2009, J VIROL, V83, P1201, DOI 10.1128/JVI.01797-08; Bernet J, 2004, J VIROL, V78, P9446, DOI 10.1128/JVI.78.17.9446-9457.2004; Bernet J, 2003, J BIOSCIENCES, V28, P249, DOI 10.1007/BF02970145; BOONE RF, 1977, J VIROL, V21, P475, DOI 10.1128/JVI.21.2.475-483.1977; BOYLE DB, 1988, GENE, V65, P123, DOI 10.1016/0378-1119(88)90424-6; Chakrabarti S, 1997, BIOTECHNIQUES, V23, P1094, DOI 10.2144/97236st07; Chen NH, 2005, VIROLOGY, V340, P46, DOI 10.1016/j.virol.2005.05.030; DeHaven BC, 2010, J VIROL, V84, P11245, DOI 10.1128/JVI.00372-10; Estep RD, 2011, J VIROL, V85, P9527, DOI 10.1128/JVI.00199-11; FALKNER FG, 1988, J VIROL, V62, P1849, DOI 10.1128/JVI.62.6.1849-1854.1988; Girgis NM, 2011, J VIROL, V85, P2547, DOI 10.1128/JVI.01474-10; Girgis NM, 2010, J VIROL; Guarner J, 2004, EMERG INFECT DIS, V10, P426, DOI 10.3201/eid1003.030878; HRUBY DE, 1979, J VIROL, V29, P705, DOI 10.1128/JVI.29.2.705-715.1979; Hutson CL, 2007, AM J TROP MED HYG, V76, P757, DOI 10.4269/ajtmh.2007.76.757; Hutson CL, 2009, J GEN VIROL, V90, P323, DOI 10.1099/vir.0.005108-0; Hutson CL, 2010, VIROLOGY; ISAACS SN, 1992, P NATL ACAD SCI USA, V89, P628, DOI 10.1073/pnas.89.2.628; Isaacs SN, 2003, J VIROL, V77, P8256, DOI 10.1128/JVI.77.15.8256-8262.2003; JEZEK Z, 1987, J INFECT DIS, V156, P293, DOI 10.1093/infdis/156.2.293; Jezek Z., 1988, MONOGRAPHS VIROLOGY; KOTWAL GJ, 1988, NATURE, V335, P176, DOI 10.1038/335176a0; KOTWAL GJ, 1990, SCIENCE, V250, P827, DOI 10.1126/science.2237434; Learned LA, 2005, AM J TROP MED HYG, V73, P428, DOI 10.4269/ajtmh.2005.73.428; Lehmann EL, 1975, NONPARAMETRICS STAT, pxvi; Leite JA, 2011, ARCH VIROL, V156, P617, DOI 10.1007/s00705-010-0900-0; Li Y, 2006, J CLIN VIROL, V36, P194, DOI 10.1016/j.jcv.2006.03.012; Likos AM, 2005, J GEN VIROL, V86, P2661, DOI 10.1099/vir.0.81215-0; Liszewski MK, 2008, J IMMUNOL, V181, P4199, DOI 10.4049/jimmunol.181.6.4199; Liszewski MK, 2006, J IMMUNOL, V176, P3725, DOI 10.4049/jimmunol.176.6.3725; Liszewski MK, 2009, J IMMUNOL, V183, P3150, DOI 10.4049/jimmunol.0901366; MCKENZIE R, 1992, J INFECT DIS, V166, P1245, DOI 10.1093/infdis/166.6.1245; Mehlhop E, 2006, J EXP MED, V203, P1371, DOI 10.1084/jem.20052388; Miller CG, 1997, VIROLOGY, V229, P126, DOI 10.1006/viro.1996.8396; Moulton EA, 2008, PLOS PATHOG, V4, DOI 10.1371/journal.ppat.1000249; Mullick J, 2005, J VIROL, V79, P12382, DOI 10.1128/JVI.79.19.12382-12393.2005; Mullick J, 2003, TRENDS IMMUNOL, V24, P500, DOI 10.1016/S1471-4906(03)00207-2; PATEL DD, 1986, VIROLOGY, V149, P174, DOI 10.1016/0042-6822(86)90119-4; Reed KD, 2004, NEW ENGL J MED, V350, P342, DOI 10.1056/NEJMoa032299; Rimoin AW, 2010, P NATL ACAD SCI USA, V107, P16262, DOI 10.1073/pnas.1005769107; Rosengard AM, 1999, MOL IMMUNOL, V36, P685, DOI 10.1016/S0161-5890(99)00081-4; Rosengard AM, 2002, P NATL ACAD SCI USA, V99, P8808, DOI 10.1073/pnas.112220499; Sfyroera G, 2005, J IMMUNOL, V174, P2143, DOI 10.4049/jimmunol.174.4.2143; Toapanta FR, 2006, IMMUNOL RES, V36, P197, DOI 10.1385/IR:36:1:197; Xu RH, 2008, J EXP MED, V205, P981, DOI 10.1084/jem.20071854	45	22	22	3	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 9	2012	7	4							e35086	10.1371/journal.pone.0035086	http://dx.doi.org/10.1371/journal.pone.0035086			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	955JO	22496894	gold, Green Submitted, Green Published			2022-12-25	WOS:000305014500044
J	Lim, S; Choi, SH; Shin, H; Cho, BJ; Park, HS; Ahn, BY; Kang, SM; Yoon, JW; Jang, HC; Kim, YB; Park, KS				Lim, Soo; Choi, Sung Hee; Shin, Hayley; Cho, Bong Jun; Park, Ho Seon; Ahn, Byung Yong; Kang, Seon Mee; Yoon, Ji Won; Jang, Hak Chul; Kim, Young-Bum; Park, Kyong Soo			Effect of a Dipeptidyl Peptidase-IV Inhibitor, Des-Fluoro-Sitagliptin, on Neointimal Formation after Balloon Injury in Rats	PLOS ONE			English	Article							GLUCAGON-LIKE PEPTIDE-1; MONOCYTE CHEMOATTRACTANT PROTEIN-1; CORONARY-ARTERY-DISEASE; SMOOTH-MUSCLE-CELLS; MATRIX METALLOPROTEINASES; DIABETIC-PATIENTS; GROWTH-FACTOR; DPP-IV; HYPERPLASIA; MECHANISMS	Background: Recently, it has been suggested that enhancement of incretin effect improves cardiac function. We investigated the effect of a DPP-IV inhibitor, des-fluoro-sitagliptin, in reducing occurrence of restenosis in carotid artery in response to balloon injury and the related mechanisms. Methods and Findings: Otsuka Long-Evans Tokushima Fatty rats were grouped into four: control (normal saline) and sitagliptin 100, 250 and 500 mg/kg per day (n = 10 per group). Sitagliptin or normal saline were given orally from 1 week before to 2 weeks after carotid injury. After 3 weeks of treatment, sitagliptin treatment caused a significant and dose-dependent reduction in intima-media ratio (IMR) in obese diabetic rats. This effect was accompanied by improved glucose homeostasis, decreased circulating levels of high-sensitivity C-reactive protein (hsCRP) and increased adiponectin level. Moreover, decreased IMR was correlated significantly with reduced hsCRP, tumor necrosis factor-alpha and monocyte chemoattractant protein-1 levels and plasminogen activator inhibitor-1 activity. In vitro evidence with vascular smooth muscle cells (VSMCs) demonstrated that proliferation and migration were decreased significantly after sitagliptin treatment. In addition, sitagliptin increased caspase-3 activity and decreased monocyte adhesion and NF kappa B activation in VSMCs. Conclusions: Sitagliptin has protective properties against restenosis after carotid injury and therapeutic implications for treating macrovascular complications of diabetes.	[Lim, Soo; Choi, Sung Hee; Cho, Bong Jun; Kang, Seon Mee; Yoon, Ji Won; Jang, Hak Chul] Seoul Natl Univ, Bundang Hosp, Dept Internal Med, Songnam, South Korea; [Lim, Soo; Choi, Sung Hee; Park, Ho Seon; Ahn, Byung Yong; Kang, Seon Mee; Yoon, Ji Won; Jang, Hak Chul; Park, Kyong Soo] Seoul Natl Univ, Coll Med, Dept Internal Med, Seoul 151, South Korea; [Shin, Hayley] Johns Hopkins Bloomberg Sch Publ Hlth, Baltimore, MD USA; [Kim, Young-Bum] Beth Israel Deaconess Med Ctr, Dept Med, Div Endocrinol Diabet & Metab, Boston, MA 02215 USA; [Kim, Young-Bum] Harvard Univ, Sch Med, Boston, MA USA; [Park, Kyong Soo] Seoul Natl Univ, Grad Sch Convergence Sci & Technol, Dept Mol Med & Biopharmaceut Sci, Seoul, South Korea	Seoul National University (SNU); Seoul National University (SNU); Johns Hopkins University; Johns Hopkins Bloomberg School of Public Health; Harvard University; Beth Israel Deaconess Medical Center; Harvard University; Harvard Medical School; Seoul National University (SNU)	Lim, S (corresponding author), Seoul Natl Univ, Bundang Hosp, Dept Internal Med, Songnam, South Korea.	kspark@snu.ac.kr	Jang, Hak Chul/D-9637-2012; Park, Kyong Soo/C-2265-2008; Ahn, Byungyong/AHB-6077-2022; Choi, Sung-hee/J-5689-2012; Lim, Soo/AAU-8107-2020	Jang, Hak Chul/0000-0002-4188-6536; Park, Kyong Soo/0000-0003-3597-342X; Lim, Soo/0000-0002-4137-1671; CHOI, SUNG HEE/0000-0003-0740-8116; Ahn, Byungyong/0000-0002-9871-5180; Park, Ho Seon/0000-0003-1200-4626	American Diabetes Association [1-09-RA-87]; Ministry of Education, Science and Technology; Korea Science and Engineering Foundation [R31-2008-000-10103-0]; Merck	American Diabetes Association(American Diabetes Association); Ministry of Education, Science and Technology(Ministry of Education, Science & Technology (MEST), Republic of Korea); Korea Science and Engineering Foundation(Korea Science and Engineering Foundation); Merck(Merck & Company)	This work was supported by research grant from the American Diabetes Association (1-09-RA-87), the World Class University project of the Ministry of Education, Science and Technology and the Korea Science and Engineering Foundation (R31-2008-000-10103-0) and the investigator initiated studies programs of Merck. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; This work was partly supported by the investigator initiated studies programs of Merck. The sitagliptin used in this study is a Merck product. There are no patents, products in development or other marketed products to declare. This does not alter the authors' adherence to all the PLoS ONE policies on sharing data and materials.	Ahren B, 2004, J CLIN ENDOCR METAB, V89, P2078, DOI 10.1210/jc.2003-031907; ANSARI B, 1993, J PATHOL, V170, P1, DOI 10.1002/path.1711700102; BENDECK MP, 1994, CIRC RES, V75, P539, DOI 10.1161/01.RES.75.3.539; Buteau J, 2004, DIABETOLOGIA, V47, P806, DOI 10.1007/s00125-004-1379-6; Buteau J, 2003, DIABETES, V52, P124, DOI 10.2337/diabetes.52.1.124; CLOWES AW, 1983, LAB INVEST, V49, P327; Cooper ME, 2001, AM J HYPERTENS, V14, P475, DOI 10.1016/S0895-7061(00)01323-6; Derosa G, 2007, DIABETES METAB, V33, P129, DOI 10.1016/j.diabet.2006.11.008; Drucker DJ, 2003, DIABETES CARE, V26, P2929, DOI 10.2337/diacare.26.10.2929; Drucker DJ, 2003, EXPERT OPIN INV DRUG, V12, P87, DOI 10.1517/13543784.12.1.87; Egashira K, 2002, CIRC RES, V90, P1167, DOI 10.1161/01.RES.0000020561.03244.7E; FALK E, 1995, CIRCULATION, V92, P657, DOI 10.1161/01.CIR.92.3.657; Ferns GAA, 2000, INT J EXP PATHOL, V81, P63, DOI 10.1046/j.1365-2613.2000.00143.x; GALIS ZS, 1994, CIRC RES, V75, P181, DOI 10.1161/01.RES.75.1.181; GALIS ZS, 1994, J CLIN INVEST, V94, P2493, DOI 10.1172/JCI117619; Holst JJ, 2003, ADV EXP MED BIOL, V524, P263; Klonoff DC, 2008, CURR MED RES OPIN, V24, P275, DOI 10.1185/030079908X253870; Lambeir AM, 2003, CRIT REV CL LAB SCI, V40, P209, DOI 10.1080/713609354; Lavrik IN, 2005, J CLIN INVEST, V115, P2665, DOI 10.1172/JCI26252; Li-Saw-Hee FL, 2000, INT J CARDIOL, V75, P43, DOI 10.1016/S0167-5273(00)00274-6; Liu HB, 2008, J ENDOCRINOL, V196, P57, DOI 10.1677/JOE-07-0387; Mari A, 2005, J CLIN ENDOCR METAB, V90, P4888, DOI 10.1210/jc.2004-2460; Marx N, 2003, ARTERIOSCL THROM VAS, V23, P283, DOI 10.1161/01.ATV.0000054195.35121.5E; Maxwell PR, 2001, DIABETIC MED, V18, P777, DOI 10.1046/j.1464-5491.2001.00542.x; Moreno PR, 1996, CIRCULATION, V94, P3098, DOI 10.1161/01.CIR.94.12.3098; Moreno PR, 1999, J AM COLL CARDIOL, V34, P1045, DOI 10.1016/S0735-1097(99)00338-1; Mori E, 2002, CIRCULATION, V105, P2905, DOI 10.1161/01.CIR.0000018603.67989.71; Nagase H, 1999, J BIOL CHEM, V274, P21491, DOI 10.1074/jbc.274.31.21491; Newby AC, 2000, J PATHOL, V190, P300, DOI 10.1002/(SICI)1096-9896(200002)190:3<300::AID-PATH596>3.0.CO;2-I; Nystrom T, 2005, REGUL PEPTIDES, V125, P173, DOI 10.1016/j.regpep.2004.08.024; Nystrom T, 2004, AM J PHYSIOL-ENDOC M, V287, pE1209, DOI 10.1152/ajpendo.00237.2004; Ohnuma K, 2007, J BIOL CHEM, V282, P10117, DOI 10.1074/jbc.M609157200; Pasceri V, 2000, CIRCULATION, V102, P2165; Petroff MGV, 2001, CIRC RES, V89, P445, DOI 10.1161/hh1701.095716; Pischon T, 2004, JAMA-J AM MED ASSOC, V291, P1730, DOI 10.1001/jama.291.14.1730; Read PA, 2010, DPP 4 INHIBITION SIT; Ristic S, 2005, DIABETES OBES METAB, V7, P692, DOI 10.1111/j.1463-1326.2005.00539.x; Rodriguez AE, 2007, EUR HEART J, V28, P2118, DOI 10.1093/eurheartj/ehm297; Rogers C, 1996, ARTERIOSCL THROM VAS, V16, P1312, DOI 10.1161/01.ATV.16.10.1312; Schulze MB, 2005, DIABETES, V54, P534, DOI 10.2337/diabetes.54.2.534; Song HK, 2008, AM J PHYSIOL-RENAL, V295, pF1485, DOI 10.1152/ajprenal.90231.2008; Tanaka H, 1996, ARTERIOSCL THROM VAS, V16, P12, DOI 10.1161/01.ATV.16.1.12; Welt FGP, 2000, ARTERIOSCL THROM VAS, V20, P2553, DOI 10.1161/01.ATV.20.12.2553; Yoon JS, 2011, DIABETES METAB J, V35, P437, DOI 10.4093/dmj.2011.35.5.437; Yu Y, 2004, J AM COLL CARDIOL, V44, P904, DOI 10.1016/j.jacc.2004.04.050	45	47	49	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 6	2012	7	4							e35007	10.1371/journal.pone.0035007	http://dx.doi.org/10.1371/journal.pone.0035007			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	955JA	22493727	Green Published, Green Submitted, gold			2022-12-25	WOS:000305012700069
J	Shen, B; Han, XQ; Zhang, JP; Rossiter, SJ; Zhang, SY				Shen, Bin; Han, Xiuqun; Zhang, Junpeng; Rossiter, Stephen J.; Zhang, Shuyi			Adaptive Evolution in the Glucose Transporter 4 Gene Slc2a4 in Old World Fruit Bats (Family: Pteropodidae)	PLOS ONE			English	Article							DETECTING POSITIVE SELECTION; AMINO-ACID SITES; PARACELLULAR ABSORPTION; INSULIN-RESISTANCE; NATURAL-SELECTION; GLUCOSE; INFERENCE; MUSCLE; FUEL; ALGORITHM	Frugivorous and nectarivorous bats are able to ingest large quantities of sugar in a short time span while avoiding the potentially adverse side-effects of elevated blood glucose. The glucose transporter 4 protein (GLUT4) encoded by the Slc2a4 gene plays a critical role in transmembrane skeletal muscle glucose uptake and thus glucose homeostasis. To test whether the Slc2a4 gene has undergone adaptive evolution in bats with carbohydrate-rich diets in relation to their insect-eating sister taxa, we sequenced the coding region of the Slc2a4 gene in a number of bat species, including four Old World fruit bats (Pteropodidae) and three New World fruit bats (Phyllostomidae). Our molecular evolutionary analyses revealed evidence that Slc2a4 has undergone a change in selection pressure in Old World fruit bats with 11 amino acid substitutions detected on the ancestral branch, whereas, no positive selection was detected in the New World fruit bats. We noted that in the former group, amino acid replacements were biased towards either Serine or Isoleucine, and, of the 11 changes, six were specific to Old World fruit bats (A133S, A164S, V377F, V386I, V441I and G459S). Our study presents preliminary evidence that the Slc2a4 gene has undergone adaptive changes in Old World fruit bats in relation to their ability to meet the demands of a high sugar diet.	[Shen, Bin; Han, Xiuqun; Zhang, Junpeng; Zhang, Shuyi] E China Normal Univ, Inst Adv Interdisciplinary Res, Inst Mol Ecol & Evolut, Shanghai 200062, Peoples R China; [Rossiter, Stephen J.] Queen Mary Univ London, Sch Biol & Chem Sci, London, England	East China Normal University; University of London; Queen Mary University London	Shen, B (corresponding author), E China Normal Univ, Inst Adv Interdisciplinary Res, Inst Mol Ecol & Evolut, Shanghai 200062, Peoples R China.	syzhang@bio.ecnu.edu.cn	Rossiter, Stephen J/E-2111-2011	Rossiter, Stephen/0000-0002-3881-4515	Key Construction Program of the National "985" Project; "211" Project; Royal Society; Biotechnology and Biological Sciences Research Council (BBSRC)	Key Construction Program of the National "985" Project; "211" Project(Anhui UniversityMinistry of Education, China); Royal Society(Royal Society of London); Biotechnology and Biological Sciences Research Council (BBSRC)(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC))	This study was supported by grants awarded by the Key Construction Program of the National "985" Project and "211" Project to SZ. SJR was supported by a Royal Society Research Fellowship and a Biotechnology and Biological Sciences Research Council (BBSRC) Chinese Partnering award. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abel ED, 2001, NATURE, V409, P729, DOI 10.1038/35055575; Altringham J D, 1996, BATS BIOL BEHAV, P2; Amitai O, 2010, J EXP BIOL, V213, P2693, DOI 10.1242/jeb.043505; Anisimova M, 2002, MOL BIOL EVOL, V19, P950, DOI 10.1093/oxfordjournals.molbev.a004152; Betts M.J., 2007, BIOINFORMATICS GENET, DOI [10.1002/9780470059180.ch13, DOI 10.1002/0470867302.CH14]; Bielawski JP, 2003, J STRUCT FUNCT GENOM, V3, P201, DOI DOI 10.1007/978-94-010-0263-9_20; Brunner Y, 2009, J PROTEOMICS, V71, P576, DOI 10.1016/j.jprot.2008.10.002; Caviedes-Vidal E, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0001425; Caviedes-Vidal E, 2007, P NATL ACAD SCI USA, V104, P19132, DOI 10.1073/pnas.0703159104; Datzmann T, 2010, BMC EVOL BIOL, V10, DOI 10.1186/1471-2148-10-165; Davies K T J, 2012, Heredity (Edinb), V108, P480, DOI 10.1038/hdy.2011.119; Ding KY, 2005, MOL BIOL EVOL, V22, P148, DOI 10.1093/molbev/msh266; Haygood R, 2007, NAT GENET, V39, P1140, DOI 10.1038/ng2104; Huang SH, 2007, CELL METAB, V5, P237, DOI 10.1016/j.cmet.2007.03.006; Huelsenbeck JP, 2001, BIOINFORMATICS, V17, P754, DOI 10.1093/bioinformatics/17.8.754; Kawahito S, 2009, WORLD J GASTROENTERO, V15, P4137, DOI 10.3748/wjg.15.4137; KEEGAN DJ, 1977, COMP BIOCHEM PHYS A, V58, P349, DOI 10.1016/0300-9629(77)90153-0; Kelm DH, 2011, P ROY SOC B-BIOL SCI, V278, P3490, DOI 10.1098/rspb.2011.0465; Klip A, 2009, APPL PHYSIOL NUTR ME, V34, P481, DOI 10.1139/H09-047; LASKA M, 1990, Z SAUGETIERKD, V55, P49; Li G, 2008, P NATL ACAD SCI USA, V105, P13959, DOI 10.1073/pnas.0802097105; Liu Y, 2011, MOL BIOL EV IN PRESS; Liu Y, 2012, MOL BIOL EVOL, V29, P1507, DOI 10.1093/molbev/mss013; Liu Y, 2010, CURR BIOL, V20, P1834, DOI 10.1016/j.cub.2010.09.008; Maddison, 2019, MESQUITE MODULAR SYS; Michelmore AJ, 1998, GEN COMP ENDOCR, V110, P319, DOI 10.1006/gcen.1998.7077; Murphy WJ, 2001, SCIENCE, V294, P2348, DOI 10.1126/science.1067179; Pond SLK, 2006, BIOINFORMATICS, V22, P3096, DOI 10.1093/bioinformatics/btl474; Pond SLK, 2011, MOL BIOL EVOL, V28, P3033, DOI 10.1093/molbev/msr125; Pond SLK, 2005, MOL BIOL EVOL, V22, P478, DOI 10.1093/molbev/msi031; Pond SLK, 2005, BIOINFORMATICS, V21, P676, DOI 10.1093/bioinformatics/bti079; Posada D, 2008, MOL BIOL EVOL, V25, P1253, DOI 10.1093/molbev/msn083; Protzek AOP, 2010, COMP BIOCHEM PHYS A, V157, P142, DOI 10.1016/j.cbpa.2010.05.016; Salas-Burgos A, 2004, BIOPHYS J, V87, P2990, DOI 10.1529/biophysj.104.047886; Shepherd PR, 1999, NEW ENGL J MED, V341, P248, DOI 10.1056/NEJM199907223410406; Suarez RK, 2009, COMP BIOCHEM PHYS A, V153, P136, DOI 10.1016/j.cbpa.2009.01.015; Tamura K, 2007, MOL BIOL EVOL, V24, P1596, DOI 10.1093/molbev/msm092; Tarazona-Santos E, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0009827; Teeling EC, 2005, SCIENCE, V307, P580, DOI 10.1126/science.1105113; Thompson JD, 1997, NUCLEIC ACIDS RES, V25, P4876, DOI 10.1093/nar/25.24.4876; Thong FSL, 2005, PHYSIOLOGY, V20, P271, DOI 10.1152/physiol.00017.2005; Tracy CR, 2007, J EXP BIOL, V210, P1726, DOI 10.1242/jeb.02766; Voigt CC, 2007, FUNCT ECOL, V21, P913, DOI 10.1111/j.1365-2435.2007.01321.x; Welch KC, 2008, J EXP BIOL, V211, P310, DOI 10.1242/jeb.012252; Yang J, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0001472; Yang ZH, 2005, MOL BIOL EVOL, V22, P1107, DOI 10.1093/molbev/msi097; YANG ZH, 1995, GENETICS, V141, P1641; Yang ZH, 2000, TRENDS ECOL EVOL, V15, P496, DOI 10.1016/S0169-5347(00)01994-7; Yang ZH, 1998, MOL BIOL EVOL, V15, P568, DOI 10.1093/oxfordjournals.molbev.a025957; Yang ZH, 2007, MOL BIOL EVOL, V24, P1586, DOI 10.1093/molbev/msm088; Yuan LH, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0027189; Zisman A, 2000, NAT MED, V6, P924, DOI 10.1038/78693	52	19	22	1	26	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 6	2012	7	4							e33197	10.1371/journal.pone.0033197	http://dx.doi.org/10.1371/journal.pone.0033197			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	955JA	22493665	gold, Green Published			2022-12-25	WOS:000305012700007
J	Zhou, J; Ju, WQ; Wang, DP; Wu, LW; Zhu, XF; Guo, ZY; He, XS				Zhou, Jian; Ju, Weiqiang; Wang, Dongping; Wu, Linwei; Zhu, Xiaofeng; Guo, Zhiyong; He, Xiaoshun			Down-Regulation of microRNA-26a Promotes Mouse Hepatocyte Proliferation during Liver Regeneration	PLOS ONE			English	Article							PARTIAL-HEPATECTOMY; STEM-CELLS; TARGETS; CANCER; TUMORIGENESIS; EXPRESSION; REPAIR; CYCLE	Background: Inadequate liver regeneration (LR) is still an unsolved problem in major liver resection and small-for-size syndrome post-living donor liver transplantation. A number of microRNAs have been shown to play important roles in cell proliferation. Herein, we investigated the role of miR-26a as a pivotal regulator of hepatocyte proliferation in LR. Methodology/Principal Findings: Adult male C57BL/6J mice, undergoing 70% partial hepatectomy (PH), were treated with Ad5-anti-miR-26a-LUC or Ad5-miR-26a-LUC or Ad5-LUC vector via portal vein. The animals were subjected to in vivo bioluminescence imaging. Serum and liver samples were collected to test liver function, calculate liver-to-body weight ratio (LBWR), document hepatocyte proliferation (Ki-67 staining), and investigate potential targeted gene expression of miR-26a by quantitative real-time PCR and Western blot. The miR-26a level declined during LR after 70% PH. Down-regulation of miR-26a by anti-miR-26a expression led to enhanced proliferation of hepatocytes, and both LBWR and hepatocyte proliferation (Ki-67(+) cells %) showed an increased tendency, while liver damage, indicated by aspartate aminotransferase (AST), alanine aminotransferase (ALT) and total bilirubin (T-Bil), was reduced. Furthermore, CCND2 and CCNE2, as possible targeted genes of miR-26a, were up-regulated. In addition, miR-26a over-expression showed converse results. Conclusions/Significance: MiR-26a plays crucial role in regulating the proliferative phase of LR, probably by repressing expressions of cell cycle proteins CCND2 and CCNE2. The current study reveals a novel miRNA-mediated regulation pattern during the proliferative phase of LR.	[Zhou, Jian; Ju, Weiqiang; Wang, Dongping; Wu, Linwei; Zhu, Xiaofeng; Guo, Zhiyong; He, Xiaoshun] Sun Yat Sen Univ, Organ Transplant Ctr, Affiliated Hosp 1, Guangzhou 510275, Guangdong, Peoples R China	Sun Yat Sen University	Zhou, J (corresponding author), Sun Yat Sen Univ, Organ Transplant Ctr, Affiliated Hosp 1, Guangzhou 510275, Guangdong, Peoples R China.	rockyucsf1981@126.com; gdtrc@126.com			National High Technology Research and Development Program of China (863 Program) [2012AA021008]; Ministry of Health [2010159, 201002004]; National Natural Science Foundation of China [30972951, 81170448]	National High Technology Research and Development Program of China (863 Program)(National High Technology Research and Development Program of China); Ministry of Health; National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC))	This study was supported by the National High Technology Research and Development Program of China (863 Program) (2012AA021008), the Key Clinical Project from the Ministry of Health (2010159), National Natural Science Foundation of China (30972951 and 81170448), and special fund for science research by Ministry of Health (201002004). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bergmann A, 2010, SCI SIGNAL, V3, DOI 10.1126/scisignal.3145re8; Betel D, 2008, NUCLEIC ACIDS RES, V36, pD149, DOI 10.1093/nar/gkm995; Bockhorn M, 2007, J SURG RES, V138, P291, DOI 10.1016/j.jss.2006.07.027; Chang TC, 2008, NAT GENET, V40, P43, DOI 10.1038/ng.2007.30; Chen H, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0020238; Duncan AW, 2009, GASTROENTEROLOGY, V137, P466, DOI 10.1053/j.gastro.2009.05.044; Fausto N, 2004, HEPATOLOGY, V39, P1477, DOI 10.1002/hep.20214; Geng Y, 2003, CELL, V114, P431, DOI 10.1016/S0092-8674(03)00645-7; Grimson A, 2007, MOL CELL, V27, P91, DOI 10.1016/j.molcel.2007.06.017; Hammond SM, 2006, TRENDS MOL MED, V12, P99, DOI 10.1016/j.molmed.2006.01.004; Hardy J, 2004, SCIENCE, V303, P851, DOI 10.1126/science.1092712; He L, 2004, NAT REV GENET, V5, P522, DOI 10.1038/nrg1379; Jung J, 2011, INT IMMUNOPHARMACOL, V11, P976, DOI 10.1016/j.intimp.2011.02.012; Karp SJ, 2009, AM J TRANSPLANT, V9, P1973, DOI 10.1111/j.1600-6143.2009.02731.x; Kota J, 2009, CELL, V137, P1005, DOI 10.1016/j.cell.2009.04.021; Krek A, 2005, NAT GENET, V37, P495, DOI 10.1038/ng1536; Kuramitsu K, 2011, HEPATOLOGY, V53, P2016, DOI 10.1002/hep.24317; Leeper NJ, 2011, J CELL PHYSIOL, V226, P1035, DOI 10.1002/jcp.22422; Livak KJ, 2001, METHODS, V25, P402, DOI 10.1006/meth.2001.1262; Lu JA, 2011, CANCER RES, V71, P225, DOI 10.1158/0008-5472.CAN-10-1850; Luker GD, 2011, METHODS MOL BIOL, V680, P29, DOI 10.1007/978-1-60761-901-7_2; Lynn FC, 2009, TRENDS ENDOCRIN MET, V20, P452, DOI 10.1016/j.tem.2009.05.007; Malumbres M, 2009, NAT REV CANCER, V9, P153, DOI 10.1038/nrc2602; Marquez RT, 2010, AM J PHYSIOL-GASTR L, V298, pG535, DOI 10.1152/ajpgi.00338.2009; Matsuo R, 2011, ANN SURG, V253, P759, DOI 10.1097/SLA.0b013e318211caf8; Michalopoulos GK, 2007, J CELL PHYSIOL, V213, P286, DOI 10.1002/jcp.21172; Mitchell C, 2008, NAT PROTOC, V3, P1167, DOI 10.1038/nprot.2008.80; Ohtake Y, 2008, CELL BIOCHEM FUNCT, V26, P359, DOI 10.1002/cbf.1451; Pager CT, 2009, PROG MOL BIOL TRANSL, V90, P187, DOI 10.1016/S1877-1173(09)90005-9; Port JD, 2010, J CARDIOVASC PHARM, V56, P444, DOI 10.1097/FJC.0b013e3181f605b6; Shu JM, 2011, HEPATOLOGY, V54, P609, DOI 10.1002/hep.24421; Song GS, 2010, HEPATOLOGY, V51, P1735, DOI 10.1002/hep.23547; Sun SC, 2008, NEUROL INDIA, V56, P52; van der Meel R, 2010, DRUG DISCOV TODAY, V15, P102, DOI 10.1016/j.drudis.2009.12.003; Vermeulen K, 2003, CELL PROLIFERAT, V36, P131, DOI 10.1046/j.1365-2184.2003.00266.x; Weissleder R, 2008, NATURE, V452, P580, DOI 10.1038/nature06917; Wong CF, 2008, J BIOL CHEM, V283, P9836, DOI 10.1074/jbc.M709614200; Yang JD, 2010, WOUND REPAIR REGEN, V18, P524, DOI 10.1111/j.1524-475X.2010.00614.x; Yuan B, 2011, FEBS LETT, V585, P927, DOI 10.1016/j.febslet.2011.02.031; Zhang B, 2011, CARCINOGENESIS, V32, P2, DOI 10.1093/carcin/bgq209; Zhang N, 2004, BLOOD, V103, P617, DOI 10.1182/blood-2003-06-1820; Zimmermann A, 2004, NEPHROL DIAL TRANSPL, V19, P6, DOI 10.1093/ndt/gfh1034; Zinn KR, 2008, ILAR J, V49, P103, DOI 10.1093/ilar.49.1.103	43	55	64	0	17	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 4	2012	7	4							e33577	10.1371/journal.pone.0033577	http://dx.doi.org/10.1371/journal.pone.0033577			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	953GO	22496754	Green Submitted, Green Published, gold			2022-12-25	WOS:000304855200017
J	da Costa, LS; da Silva, APP; Da Poian, AT; El-Bacha, T				da Costa, Leandro Silva; Pereira da Silva, Ana Paula; Da Poian, Andrea T.; El-Bacha, Tatiana			Mitochondrial Bioenergetic Alterations in Mouse Neuroblastoma Cells Infected with Sindbis Virus: Implications to Viral Replication and Neuronal Death	PLOS ONE			English	Article							AGE-DEPENDENT RESISTANCE; OXIDATIVE STRESS; INDUCED APOPTOSIS; ACTIVATION; IDENTIFICATION; ENCEPHALITIS; DYSFUNCTION; RESPIRATION; INHIBITION; CALCIUM	The metabolic resources crucial for viral replication are provided by the host. Details of the mechanisms by which viruses interact with host metabolism, altering and recruiting high free-energy molecules for their own replication, remain unknown. Sindbis virus, the prototype of and most widespread alphavirus, causes outbreaks of arthritis in humans and serves as a model for the study of the pathogenesis of neurological diseases induced by alphaviruses in mice. In this work, respirometric analysis was used to evaluate the effects of Sindbis virus infection on mitochondrial bioenergetics of a mouse neuroblastoma cell lineage, Neuro 2a. The modulation of mitochondria] functions affected cellular ATP content and this was synchronous with Sindbis virus replication cycle and cell death. At 15 h, irrespective of effects on cell viability, viral replication induced a decrease in oxygen consumption uncoupled to ATP synthesis and a 36% decrease in maximum uncoupled respiration, which led to an increase of 30% in the fraction of oxygen consumption used for ATP synthesis. Decreased proton leak associated to complex I respiration contributed to the apparent improvement of mitochondrial function. Cellular ATP content was not affected by infection. After 24 h, mitochondria dysfunction was clearly observed as maximum uncoupled respiration reduced 65%, along with a decrease in the fraction of oxygen consumption used for ATP synthesis. Suppressed respiration driven by complexes I- and II-related substrates seemed to play a role in mitochondrial dysfunction. Despite the increase in glucose uptake and glycolytic flux, these changes were followed by a 30% decrease in ATP content and neuronal death. Taken together, mitochondrial bioenergetics is modulated during Sindbis virus infection in such a way as to favor ATP synthesis required to support active viral replication. These early changes in metabolism of Neuro 2a cells may form the molecular basis of neuronal dysfunction and Sindbis virus-induced encephalitis.	[da Costa, Leandro Silva; Pereira da Silva, Ana Paula; Da Poian, Andrea T.; El-Bacha, Tatiana] Univ Fed Rio de Janeiro, Inst Bioquim Med, Rio De Janeiro, Brazil; [Pereira da Silva, Ana Paula] Univ Fed Rio de Janeiro, Inst Ciencias Exatas, Dept Quim, Setor Bioquim, Rio De Janeiro, Brazil	Universidade Federal do Rio de Janeiro; Universidade Federal do Rio de Janeiro	da Costa, LS (corresponding author), Univ Fed Rio de Janeiro, Inst Bioquim Med, Cidade Univ, Rio De Janeiro, Brazil.	elbachat@gmail.com	da Costa, Leandro Silva/X-9504-2019; da Silva, Ana/GXH-4851-2022; Da Poian, Andrea T./V-1699-2019; El-Bacha, Tatiana/ABH-1287-2020	da Costa, Leandro Silva/0000-0001-9697-4894; El-Bacha, Tatiana/0000-0003-0809-0218; Da Poian, Andrea/0000-0002-3969-704X	Conselho Nacional de Desenvolvimento Cientifico e Tecnologico-Brazilian Ministry of Science and Technology (CNPq); Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior (CAPES); Fundacao Carlos Chagas Filho de Amparo a Pesquisa do Estado do Rio de Janeiro (FAPERJ); CNPq	Conselho Nacional de Desenvolvimento Cientifico e Tecnologico-Brazilian Ministry of Science and Technology (CNPq)(Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPQ)); Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior (CAPES)(Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior (CAPES)); Fundacao Carlos Chagas Filho de Amparo a Pesquisa do Estado do Rio de Janeiro (FAPERJ)(Fundacao Carlos Chagas Filho de Amparo a Pesquisa do Estado do Rio De Janeiro (FAPERJ)); CNPq(Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPQ))	This work was supported by the Conselho Nacional de Desenvolvimento Cientifico e Tecnologico-Brazilian Ministry of Science and Technology (CNPq), Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior (CAPES) and Fundacao Carlos Chagas Filho de Amparo a Pesquisa do Estado do Rio de Janeiro (FAPERJ). L.S.C. is a recipient of a scholarship of CNPq. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	AKAMATSU Y, 1994, YAKUGAKU ZASSHI, V114, P863, DOI 10.1248/yakushi1947.114.11_863; Andersen JK, 2004, NAT MED, V10, pS18, DOI 10.1038/nrn1434; Balachandran S, 2000, J VIROL, V74, P1513, DOI 10.1128/JVI.74.3.1513-1523.2000; Blas-Garcia A, 2010, HEPATOLOGY, V52, P115, DOI 10.1002/hep.23647; Brand MD, 2011, BIOCHEM J, V435, P297, DOI 10.1042/BJ20110162; Caro C, 1998, INT J BIOCHEM CELL B, V30, P1031, DOI 10.1016/S1357-2725(98)00061-2; CHANCE B, 1956, ADV ENZYMOL REL S BI, V17, P65; Chapplain JM, 2011, HIV CLIN TRIALS, V12, P54, DOI 10.1310/hct1201-54; Chen HK, 2011, J BIOL CHEM, V286, P5215, DOI 10.1074/jbc.M110.151084; Despres P, 1996, J VIROL, V70, P4090; Einsiedel L, 2010, MITOCHONDRION, V10, P534, DOI 10.1016/j.mito.2010.05.010; El-Bacha T, 2004, MOL CELL BIOCHEM, V266, P191, DOI 10.1023/B:MCBI.0000049154.17866.00; El-Bacha T, 2007, BBA-MOL BASIS DIS, V1772, P1158, DOI 10.1016/j.bbadis.2007.08.003; Everett H, 2001, VIROLOGY, V288, P1, DOI 10.1006/viro.2001.1081; Fukui H, 2008, TRENDS NEUROSCI, V31, P251, DOI 10.1016/j.tins.2008.02.008; Galluzzi L, 2008, PLOS PATHOG, V4, DOI 10.1371/journal.ppat.1000018; GARRY RF, 1986, VIROLOGY, V155, P378, DOI 10.1016/0042-6822(86)90201-1; Garry RF, 1994, J GEN VIROL 2, V75, P411; Gnaiger E, 2001, RESP PHYSIOL, V128, P277, DOI 10.1016/S0034-5687(01)00307-3; Gnaiger E, 2009, INT J BIOCHEM CELL B, V41, P1837, DOI 10.1016/j.biocel.2009.03.013; GRAY MA, 1983, J GEN VIROL, V64, P1449, DOI 10.1099/0022-1317-64-7-1449; Griffin DE, 2005, CURR TOP MICROBIOL, V289, P57; Griffin DE, 1997, ANNU REV MICROBIOL, V51, P565, DOI 10.1146/annurev.micro.51.1.565; Griffin DE, 2010, IMMUNOL RES, V47, P123, DOI 10.1007/s12026-009-8143-4; Halliwell B, 2006, J NEUROCHEM, V97, P1634, DOI 10.1111/j.1471-4159.2006.03907.x; Huang D, 2003, J CHROMATOGR B, V784, P101, DOI 10.1016/S1570-0232(02)00780-8; Hutter E, 2004, BIOCHEM J, V380, P919, DOI 10.1042/BJ20040095; JOHNSON RT, 1972, J INFECT DIS, V125, P257, DOI 10.1093/infdis/125.3.257; Kapadia SB, 2005, P NATL ACAD SCI USA, V102, P2561, DOI 10.1073/pnas.0409834102; Kowaltowski AJ, 1999, FREE RADICAL BIO MED, V26, P463, DOI 10.1016/S0891-5849(98)00216-0; Kowaltowski AJ, 2009, FREE RADICAL BIO MED, V47, P333, DOI 10.1016/j.freeradbiomed.2009.05.004; Labrada L, 2002, J VIROL, V76, P11688, DOI 10.1128/JVI.76.22.11688-11703.2002; Laine M, 2004, J INTERN MED, V256, P457, DOI 10.1111/j.1365-2796.2004.01413.x; LEVINE B, 1993, NATURE, V361, P739, DOI 10.1038/361739a0; Lewis J, 1999, NAT MED, V5, P832, DOI 10.1038/10556; Liang XH, 1998, J VIROL, V72, P8586, DOI 10.1128/JVI.72.11.8586-8596.1998; LIN KI, 1995, J CELL BIOL, V131, P1149, DOI 10.1083/jcb.131.5.1149; Lu TH, 2011, TOXICOL LETT, V204, P71, DOI 10.1016/j.toxlet.2011.04.013; Maity R, 2010, J CELL BIOCHEM, V109, P933, DOI 10.1002/jcb.22469; Maynard ND, 2010, BIOTECHNOL J, V5, P686, DOI 10.1002/biot.201000080; Munger J, 2008, NAT BIOTECHNOL, V26, P1179, DOI 10.1038/nbt.1500; Munger J, 2006, PLOS PATHOG, V2, P1165, DOI 10.1371/journal.ppat.0020132; Nagley R, 2009, BIOCHIM BIOPHYS ACTA, V1802, P167; Nicholls DG, 2008, ANN NY ACAD SCI, V1147, P53, DOI 10.1196/annals.1427.002; Ohta A, 2011, MITOCHONDRION, V11, P1, DOI 10.1016/j.mito.2010.08.006; Orvedahl A, 2010, CELL HOST MICROBE, V7, P115, DOI 10.1016/j.chom.2010.01.007; Parquet MD, 2001, FEBS LETT, V500, P17, DOI 10.1016/S0014-5793(01)02573-X; da Silva APP, 2009, BIOCHEM J, V417, P717, DOI 10.1042/BJ20080805; PETERHANS E, 1979, J VIROL, V29, P143, DOI 10.1128/JVI.29.1.143-152.1979; Renner K, 2003, BBA-MOL CELL RES, V1642, P115, DOI 10.1016/S0167-4889(03)00105-8; Ripoli M, 2010, J VIROL, V84, P647, DOI 10.1128/JVI.00769-09; Rodgers MA, 2009, J AM CHEM SOC, V131, P5030, DOI 10.1021/ja809949r; Rolfe DFS, 1997, PHYSIOL REV, V77, P731, DOI 10.1152/physrev.1997.77.3.731; SAWICKI DL, 1990, VIROLOGY, V174, P43, DOI 10.1016/0042-6822(90)90052-S; Scherbik SV, 2010, J VIROL, V84, P8721, DOI 10.1128/JVI.00144-10; Simmons JD, 2010, J VIROL, V84, P11429, DOI 10.1128/JVI.00577-10; Skulachev VP, 2006, APOPTOSIS, V11, P473, DOI 10.1007/s10495-006-5881-9; Sorbara LR, 1996, J VIROL, V70, P7275, DOI 10.1128/JVI.70.10.7275-7279.1996; Sumpter R, 2011, AUTOPHAGY, V7, P260, DOI 10.4161/auto.7.3.14281; Ubol S, 1996, J VIROL, V70, P2215, DOI 10.1128/JVI.70.4.2215-2220.1996; Vastag L, 2011, PLOS PATHOG, V7, DOI 10.1371/journal.ppat.1002124; Verrier F, 2003, ANN NY ACAD SCI, V1010, P126, DOI 10.1196/annals.1299.022; WIDNELL CC, 1990, FASEB J, V4, P1634, DOI 10.1096/fasebj.4.6.2156742; Wishart DS, 2007, NUCLEIC ACIDS RES, V35, pD521, DOI 10.1093/nar/gkl923; Wojda U, 2008, IUBMB LIFE, V60, P575, DOI 10.1002/iub.91	65	30	30	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 2	2012	7	4							e33871	10.1371/journal.pone.0033871	http://dx.doi.org/10.1371/journal.pone.0033871			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	952GU	22485151	Green Submitted, gold, Green Published			2022-12-25	WOS:000304780500027
J	Valdez, G; Tapia, JC; Lichtman, JW; Fox, MA; Sanes, JR				Valdez, Gregorio; Tapia, Juan C.; Lichtman, Jeff W.; Fox, Michael A.; Sanes, Joshua R.			Shared Resistance to Aging and ALS in Neuromuscular Junctions of Specific Muscles	PLOS ONE			English	Article							AMYOTROPHIC-LATERAL-SCLEROSIS; FRONTOTEMPORAL LOBAR DEGENERATION; AGE-RELATED-CHANGES; NEURODEGENERATIVE DISEASES; EXTRAOCULAR-MUSCLES; SUPEROXIDE-DISMUTASE; AXONAL-TRANSPORT; TRANSGENIC MICE; MOTOR-NEURONS; ONUFS NUCLEUS	Normal aging and neurodegenerative diseases both lead to structural and functional alterations in synapses. Comparison of synapses that are generally similar but respond differently to insults could provide the basis for discovering mechanisms that underlie susceptibility or resistance to damage. Here, we analyzed skeletal neuromuscular junctions (NMJs) in 16 mouse muscles to seek such differences. We find that muscles respond in one of three ways to aging. In some, including most limb and trunk muscles, age-related alterations to NMJs are progressive and extensive during the second postnatal year. NMJs in other muscles, such as extraocular muscles, are strikingly resistant to change. A third set of muscles, including several muscles of facial expression and the external anal sphinter, succumb to aging but not until the third postnatal year. We asked whether susceptible and resistant muscles differed in rostrocaudal or proximodistal position, source of innervation, motor unit size, or fiber type composition. Of these factors, muscle innervation by brainstem motor neurons correlated best with resistance to age-related decline. Finally, we compared synaptic alterations in normally aging muscles to those in a mouse model of amyotrophic lateral sclerosis (ALS). Patterns of resistance and susceptibility were strikingly correlated in the two conditions. Moreover, damage to NMJs in aged muscles correlated with altered expression and distribution of CRMP4a and TOP-43, which are both altered in motor neurons affected by ALS. Together, these results reveal novel structural regional and molecular parallels between aging and ALS.	[Valdez, Gregorio; Tapia, Juan C.; Lichtman, Jeff W.; Fox, Michael A.; Sanes, Joshua R.] Harvard Univ, Dept Mol & Cellular Biol, Cambridge, MA 02138 USA; [Valdez, Gregorio; Tapia, Juan C.; Lichtman, Jeff W.; Fox, Michael A.; Sanes, Joshua R.] Harvard Univ, Ctr Brain Sci, Cambridge, MA 02138 USA; [Fox, Michael A.] Virginia Commonwealth Univ, Dept Anat & Neurobiol, Richmond, VA USA	Harvard University; Harvard University; Virginia Commonwealth University	Valdez, G (corresponding author), Harvard Univ, Dept Mol & Cellular Biol, Cambridge, MA 02138 USA.	sanesj@mcb.harvard.edu		Fox, Michael/0000-0002-1649-7782	NIH [R01AG032322]; NRSA from NINDS/NIH; NATIONAL INSTITUTE ON AGING [R01AG032322] Funding Source: NIH RePORTER	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NRSA from NINDS/NIH; NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA))	This work was supported by grant R01AG032322 from the NIH to J.R.S. and J.W.L. G.V. was supported by a NRSA Postdoctoral Fellowship from NINDS/NIH. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Andersen BB, 2003, J COMP NEUROL, V466, P356, DOI 10.1002/cne.10884; Arai T, 2006, BIOCHEM BIOPH RES CO, V351, P602, DOI 10.1016/j.bbrc.2006.10.093; Atkin JD, 2005, NEUROMUSCULAR DISORD, V15, P377, DOI 10.1016/j.nmd.2005.02.005; BERGMANN M, 1995, J NEUROL SCI, V129, P141, DOI 10.1016/0022-510X(94)00263-N; Briggs MM, 2002, J EXP BIOL, V205, P3133; Burke SN, 2010, TRENDS NEUROSCI, V33, P153, DOI 10.1016/j.tins.2009.12.003; Burke SN, 2006, NAT REV NEUROSCI, V7, P30, DOI 10.1038/nrn1809; Chakkalakal JV, 2010, DEVELOPMENT, V137, P3489, DOI 10.1242/dev.053348; Cohen TJ, 2011, TRENDS MOL MED, V17, P659, DOI 10.1016/j.molmed.2011.06.004; De Vos KJ, 2008, ANNU REV NEUROSCI, V31, P151, DOI 10.1146/annurev.neuro.31.061307.090711; Deschenes MR, 2011, CURR AGING SCI; Duan HL, 2003, CEREB CORTEX, V13, P950, DOI 10.1093/cercor/13.9.950; Duplan L, 2010, J NEUROSCI, V30, P785, DOI 10.1523/JNEUROSCI.5411-09.2010; ELKERDANY MK, 1993, ANAT REC, V237, P291, DOI 10.1002/ar.1092370215; FAHIM MA, 1983, J NEUROCYTOL, V12, P13, DOI 10.1007/BF01148085; Feng GP, 2000, NEURON, V28, P41, DOI 10.1016/S0896-6273(00)00084-2; Fischer LR, 2004, EXP NEUROL, V185, P232, DOI 10.1016/j.expneurol.2003.10.004; Fox MA, 2011, J COMP NEUROL, V519, P2907, DOI 10.1002/cne.22700; Frolkis VV, 1997, EXP GERONTOL, V32, P441, DOI 10.1016/S0531-5565(96)00168-4; Goldberg SJ, 1999, PROG BRAIN RES, V123, P221, DOI 10.1016/S0079-6123(08)62859-9; GURNEY ME, 1994, SCIENCE, V264, P1772, DOI 10.1126/science.8209258; Hegedus J, 2007, NEUROBIOL DIS, V28, P154, DOI 10.1016/j.nbd.2007.07.003; Hof PR, 2004, TRENDS NEUROSCI, V27, P607, DOI 10.1016/j.tins.2004.07.013; KAMINSKI HJ, 1992, ANN NEUROL, V32, P586, DOI 10.1002/ana.410320418; KELLER EL, 1971, J NEUROPHYSIOL, V34, P908, DOI 10.1152/jn.1971.34.5.908; Keller-Peck CR, 2001, NEURON, V31, P381, DOI 10.1016/S0896-6273(01)00383-X; Kihira T, 1997, J NEUROL SCI, V147, P81, DOI 10.1016/S0022-510X(96)05313-0; LEXELL J, 1995, J GERONTOL A-BIOL, V50, P11; MANNEN T, 1982, ACTA NEUROPATHOL, V58, P255, DOI 10.1007/BF00688606; Mehler MF, 2000, TRENDS NEUROSCI, V23, P599, DOI 10.1016/S0166-2236(00)01705-7; Morrison BM, 1998, ANN NEUROL, V44, pS32, DOI 10.1002/ana.410440706; Mosier DR, 2000, NEUROLOGY, V54, P252, DOI 10.1212/WNL.54.1.252; Murray LM, 2008, HUM MOL GENET, V17, P949, DOI 10.1093/hmg/ddm367; Neumann M, 2006, SCIENCE, V314, P130, DOI 10.1126/science.1134108; Page TL, 2002, NEUROSCI LETT, V317, P37, DOI 10.1016/S0304-3940(01)02428-4; PARDO CA, 1995, P NATL ACAD SCI USA, V92, P954, DOI 10.1073/pnas.92.4.954; Pette D, 2000, MICROSC RES TECHNIQ, V50, P500, DOI 10.1002/1097-0029(20000915)50:6<500::AID-JEMT7>3.0.CO;2-7; Porter JD, 2002, ANN NY ACAD SCI, V956, P7, DOI 10.1111/j.1749-6632.2002.tb02804.x; PORTER JD, 1989, INVEST OPHTH VIS SCI, V30, P1894; Prakash YS, 1998, MUSCLE NERVE, V21, P887, DOI 10.1002/(SICI)1097-4598(199807)21:7<887::AID-MUS6>3.0.CO;2-2; REINER A, 1995, EXP NEUROL, V131, P239, DOI 10.1016/0014-4886(95)90046-2; ROSEN DR, 1993, NATURE, V362, P59, DOI 10.1038/362059a0; Ryan S, 2007, ANAT SCI INT, V82, P1, DOI 10.1111/j.1447-073x.2006.00154.x; SARTORE S, 1987, J MUSCLE RES CELL M, V8, P161, DOI 10.1007/BF01753992; Saxena S, 2011, NEURON, V71, P35, DOI 10.1016/j.neuron.2011.06.031; Schaefer AM, 2005, J COMP NEUROL, V490, P209, DOI 10.1002/cne.20620; Schiaffino S, 2011, PHYSIOL REV, V91, P1447, DOI 10.1152/physrev.00031.2010; Stokin GB, 2006, ANNU REV BIOCHEM, V75, P607, DOI 10.1146/annurev.biochem.75.103004.142637; Valdez G, 2010, P NATL ACAD SCI USA, V107, P14863, DOI 10.1073/pnas.1002220107; Vandervoort AA, 2002, MUSCLE NERVE, V25, P17, DOI 10.1002/mus.1215; von Bohlen und Halbach O, 2006, J NEUROSCI RES, V83, P525, DOI 10.1002/jnr.20759; Wegorzewska I, 2009, P NATL ACAD SCI USA, V106, P18809, DOI 10.1073/pnas.0908767106; WIECZOREK DF, 1985, J CELL BIOL, V101, P618, DOI 10.1083/jcb.101.2.618	53	144	146	0	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 2	2012	7	4							e34640	10.1371/journal.pone.0034640	http://dx.doi.org/10.1371/journal.pone.0034640			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	952GU	22485182	Green Published, gold			2022-12-25	WOS:000304780500057
J	Barbera-Cremades, M; Baroja-Mazo, A; Gomez, AI; Machado, F; Di Virgilio, F; Pelegrin, P				Barbera-Cremades, Maria; Baroja-Mazo, Alberto; Gomez, Ana I.; Machado, Francisco; Di Virgilio, Francesco; Pelegrin, Pablo			P2X7 receptor-stimulation causes fever via PGE2 and IL-1 beta release	FASEB JOURNAL			English	Article						inflammation; pyrogen; macrophages; purinergic receptors; in vivo bioluminescence	ACTIVATED PROTEIN-KINASE; P2X(7) RECEPTOR; EXTRACELLULAR ATP; ANTIINFLAMMATORY DRUGS; PROSTAGLANDIN E-2; MESSENGER-RNA; MOUSE MODEL; INFLAMMATION; CYCLOOXYGENASE-2; MACROPHAGES	Prostaglandins (PGs) are important lipid mediators involved in the development of inflammatory associated pain and fever. PGE2 is a well-established endogenous pyrogen activated by proinflammatory cytokine interleukin (IL)-1 beta. P2X7 receptors (P2X7Rs) expressed by inflammatory cells are stimulated by the danger signal extracellular ATP to activate the inflammasome and release IL-1 beta. Here we show that P2X7R activation is required for the release of PGE2 and other autacoids independent of inflammasome activation, with an ATP EC50 for PGE2 and IL-1 beta release of 1.58 and 1.23 mM, respectively. Furthermore, lack of P2X7R or specific antagonism of P2X7R decreased the febrile response in mice triggered after intraperitoneal LPS or IL-1 beta inoculation. Accordingly, LPS inoculation caused intraperitoneal ATP accumulation. Therefore, P2X7R antagonists emerge as novel therapeutics for the treatment for acute inflammation, pain and fever, with wider anti-inflammatory activity than currently used cyclooxygenase inhibitors.-Barbera-Cremades, M., Baroja-Mazo, A., Gomez, A. I., Machado, F., Di Virgilio, F., Pelegrin, P. P2X7 receptor-stimulation causes fever via PGE2 and IL-1 beta release. FASEB J. 26, 2951-2962 (2012). www.fasebj.org	[Barbera-Cremades, Maria; Baroja-Mazo, Alberto; Gomez, Ana I.; Pelegrin, Pablo] Univ Hosp Virgen, Inflammat & Expt Surg Unit, Arrixaca Fdn Formac Invest Sanit Reg Murcia FFIS, Ctr Invest Biomed Red Enfermedades Hepat & Digest, Murcia 30120, Spain; [Machado, Francisco] Univ Hosp Virgen, Dept Gynecol & Obstet, Arrixaca Fdn Formac Invest Sanit Reg Murcia FFIS, Murcia 30120, Spain; [Di Virgilio, Francesco] Univ Ferrara, Sect Gen Pathol, Dept Expt & Diagnost Med, I-44100 Ferrara, Italy	CIBER - Centro de Investigacion Biomedica en Red; CIBEREHD; University of Ferrara	Pelegrin, P (corresponding author), Univ Hosp Virgen, Inflammat & Expt Surg Unit, Arrixaca Fdn Formac Invest Sanit Reg Murcia FFIS, Ctr Invest Biomed Red Enfermedades Hepat & Digest, Carretera Madrid Cartagena S-N, Murcia 30120, Spain.	pablo.pelegrin@ffis.es	Di Virgilio, Francesco/J-3754-2018; Pelegrin, Pablo/M-2007-2014; DI VIRGILIO, Francesco/O-4634-2019; Baroja-Mazo, Alberto/E-6270-2016; Machado, Francisco/B-6098-2011	Di Virgilio, Francesco/0000-0003-3566-1362; Pelegrin, Pablo/0000-0002-9688-1804; DI VIRGILIO, Francesco/0000-0003-3566-1362; Baroja-Mazo, Alberto/0000-0001-5212-5006; Machado, Francisco/0000-0001-9852-8089	Instituto Salud Carlos III-FEDER [EMER07/049, PI09/0120]; Fundacion Seneca [11922/PI/09]; Italian Association for Cancer Research (AIRC)	Instituto Salud Carlos III-FEDER; Fundacion Seneca(Fundacion Seneca); Italian Association for Cancer Research (AIRC)(Fondazione AIRC per la ricerca sul cancro)	The authors thank Francois Rassendren (Institut de Genomique Fonctionnelle, Montpellier, France) for P2X4 deficient mice bone marrow and helpful discussion; Alexij Verkhratsky (University of Manchester, Manchester, UK) for P2X7 receptor-deficient mice used for in vitro experiments; L. Martinez-Alarcon for human blood extraction; G. Lopez-Castejon for help with in vitro culture/stimulation of P2X4-and P2X7-deficient BMDMs; J. Sim for animal handling; M. C. Banos for cellular technical assistance; and V. Mulero for helpful discussion. This work was supported by grants from PN I+D+I 2008-2011-Instituto Salud Carlos III-FEDER (EMER07/049 and PI09/0120), Fundacion Seneca (11922/PI/09), managed by Fundacion Formacion Investigacion Sanitaria Region de Murcia (FFIS), and from the Italian Association for Cancer Research (AIRC). M. B-C. executed and analyzed experiments from all figures. A. B-M. performed flow cytometry experiments with macrophages, and A. I. G. plated human macrophages and performed some of the cell stimulation and IL-1 beta ELISAs. F. M. collected human peritoneal lavage. F. D. V. provided the pmeLUC-HEK probe and helped with in vivo ATP determination experiments. P. P. conceived, designed, and supervised this study, analyzed and interpreted experiments, and wrote the final manuscript with contributions from the other authors.	Alzola E, 1998, J BIOL CHEM, V273, P30208, DOI 10.1074/jbc.273.46.30208; Anrather J, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0025916; Armstrong S, 2009, J CELL SCI, V122, P136, DOI 10.1242/jcs.031534; Arulkumaran N, 2011, EXPERT OPIN INV DRUG, V20, P897, DOI 10.1517/13543784.2011.578068; Bartfai T, 2010, THESCIENTIFICWORLDJO, V10, P490, DOI 10.1100/tsw.2010.50; Bertolini A, 2002, CURR MED CHEM, V9, P1033, DOI 10.2174/0929867024606650; Brough D, 2003, J IMMUNOL, V170, P3029, DOI 10.4049/jimmunol.170.6.3029; Cao CY, 1996, BRAIN RES, V733, P263, DOI 10.1016/0006-8993(96)00575-6; Chessell IP, 2005, PAIN, V114, P386, DOI 10.1016/j.pain.2005.01.002; Costa HM, 2011, PURINERG SIGNAL, V7, P381, DOI 10.1007/s11302-011-9255-6; Coutinho-Silva R, 2003, IMMUNITY, V19, P403, DOI 10.1016/S1074-7613(03)00235-8; Davidson J, 2001, PFLUG ARCH EUR J PHY, V442, P526; DINARELLO CA, 1986, J CLIN INVEST, V77, P1734, DOI 10.1172/JCI112495; Donnelly-Roberts D, 2008, J PHARMACOL EXP THER, V324, P409, DOI 10.1124/jpet.106.105890; Donnelly-Roberts DL, 2004, J PHARMACOL EXP THER, V308, P1053, DOI 10.1124/jpet.103.059600; EGUCHI N, 1992, J PHARMACOL EXP THER, V262, P1110; Ferrari D, 2006, J IMMUNOL, V176, P3877, DOI 10.4049/jimmunol.176.7.3877; Gijon MA, 2000, J BIOL CHEM, V275, P20146, DOI 10.1074/jbc.M908941199; GOPPELTSTRUEBE M, 1995, PROSTAG LEUKOTR ESS, V52, P213, DOI 10.1016/0952-3278(95)90039-X; Gourine AV, 2005, BRIT J PHARMACOL, V146, P139, DOI 10.1038/sj.bjp.0706287; Gudipaty L, 2001, AM J PHYSIOL-CELL PH, V280, pC943, DOI 10.1152/ajpcell.2001.280.4.C943; Honore P, 2006, J PHARMACOL EXP THER, V319, P1376, DOI 10.1124/jpet.106.111559; Honore P, 2009, BEHAV BRAIN RES, V204, P77, DOI 10.1016/j.bbr.2009.05.018; Hunot S, 2004, P NATL ACAD SCI USA, V101, P665, DOI 10.1073/pnas.0307453101; Idzko M, 2007, NAT MED, V13, P913, DOI 10.1038/nm1617; Itoh K, 2011, NEUROSCIENCE, V192, P721, DOI 10.1016/j.neuroscience.2011.06.083; Ivanov AI, 2004, FRONT BIOSCI-LANDMRK, V9, P1977, DOI 10.2741/1383; Jiang H, 2007, BRIT J PHARMACOL, V151, P1033, DOI 10.1038/sj.bjp.0707311; Keating C, 2011, J IMMUNOL, V187, P1467, DOI 10.4049/jimmunol.1100423; King BF, 2007, BRIT J PHARMACOL, V151, P565, DOI 10.1038/sj.bjp.0707266; Kuroda E, 2011, IMMUNITY, V34, P514, DOI 10.1016/j.immuni.2011.03.019; Lenertz LY, 2011, IMMUNOL RES, V50, P22, DOI 10.1007/s12026-011-8203-4; Li S, 2001, BRAIN RES, V910, P163, DOI 10.1016/S0006-8993(01)02707-X; Lopez-Castejon G, 2010, J IMMUNOL, V185, P2611, DOI 10.4049/jimmunol.1000436; Mackenzie AB, 2005, J BIOL CHEM, V280, P33968, DOI 10.1074/jbc.M502705200; Moore SF, 2009, J IMMUNOL, V183, P3302, DOI 10.4049/jimmunol.0900394; Netea MG, 2009, BLOOD, V113, P2324, DOI 10.1182/blood-2008-03-146720; Nieminen R, 2006, INT IMMUNOPHARMACOL, V6, P987, DOI 10.1016/j.intimp.2006.01.009; North RA, 2002, PHYSIOL REV, V82, P1013, DOI 10.1152/physrev.00015.2002; Panupinthu N, 2008, J CELL BIOL, V181, P859, DOI 10.1083/jcb.200708037; Pelegrin P, 2008, J IMMUNOL, V180, P7147, DOI 10.4049/jimmunol.180.11.7147; Pelegrin P, 2011, PROG INFLAMM RES SER, P101, DOI 10.1007/978-3-0348-0148-5_7; Pelegrin P, 2008, DRUG NEWS PERSPECT, V21, P424, DOI 10.1358/dnp.2008.21.8.1265800; Pellegatti P, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0002599; Portanova JP, 1996, J EXP MED, V184, P883, DOI 10.1084/jem.184.3.883; Rainsford K. D., 2007, V42, P3; Riteau N, 2010, AM J RESP CRIT CARE, V182, P774, DOI 10.1164/rccm.201003-0359OC; Roger S, 2010, J BIOL CHEM, V285, P17514, DOI 10.1074/jbc.M109.053082; Royle SJ, 2005, J CELL SCI, V118, P3073, DOI 10.1242/jcs.02451; Sakata D, 2010, J PHARMACOL SCI, V112, P1, DOI 10.1254/jphs.09R03CP; Samad TA, 2002, TRENDS MOL MED, V8, P390, DOI 10.1016/S1471-4914(02)02383-3; Shiratori M, 2010, J NEUROCHEM, V114, P810, DOI 10.1111/j.1471-4159.2010.06809.x; Solle M, 2001, J BIOL CHEM, V276, P125, DOI 10.1074/jbc.M006781200; Ulmann L, 2008, J NEUROSCI, V28, P11263, DOI 10.1523/JNEUROSCI.2308-08.2008; Ulmann L, 2010, EMBO J, V29, P2290, DOI 10.1038/emboj.2010.126; von Kugelgen I, 2006, PHARMACOL THERAPEUT, V110, P415, DOI 10.1016/j.pharmthera.2005.08.014; Weber FC, 2010, J EXP MED, V207, P2609, DOI 10.1084/jem.20092489; Wilhelm K, 2010, NAT MED, V16, P1434, DOI 10.1038/nm.2242; Williams CS, 1999, ONCOGENE, V18, P7908, DOI 10.1038/sj.onc.1203286; Xia MS, 2011, GLIA, V59, P664, DOI 10.1002/glia.21138; Yip L, 2009, FASEB J, V23, P1685, DOI 10.1096/fj.08-126458	61	111	112	0	11	FEDERATION AMER SOC EXP BIOL	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3998 USA	0892-6638	1530-6860		FASEB J	Faseb J.	JUL	2012	26	7					2951	2962		10.1096/fj.12-205765	http://dx.doi.org/10.1096/fj.12-205765			12	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	967MP	22490780				2022-12-25	WOS:000305912500023
J	Valley, CC; Lewis, AK; Mudaliar, DJ; Perlmutter, JD; Braun, AR; Karim, CB; Thomas, DD; Brody, JR; Sachs, JN				Valley, Christopher C.; Lewis, Andrew K.; Mudaliar, Deepti J.; Perlmutter, Jason D.; Braun, Anthony R.; Karim, Christine B.; Thomas, David D.; Brody, Jonathan R.; Sachs, Jonathan N.			Tumor Necrosis Factor-related Apoptosis-inducing Ligand (TRAIL) Induces Death Receptor 5 Networks That Are Highly Organized	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							P75 NEUROTROPHIN RECEPTOR; DR5 MONOCLONAL-ANTIBODY; TUMORICIDAL ACTIVITY; CRYSTAL-STRUCTURE; CANCER-CELLS; TRANSMEMBRANE HELICES; FUNCTIONAL-ANALYSIS; REGULATORY COMPLEX; TARGETING DEATH; SOLID TUMORS	Recent evidence suggests that TNF-related apoptosis-inducing ligand (TRAIL), a death-inducing cytokine with anti-tumor potential, initiates apoptosis by re-organizing TRAIL receptors into large clusters, although the structure of these clusters and the mechanism by which they assemble are unknown. Here, we demonstrate that TRAIL receptor 2 (DR5) forms receptor dimers in a ligand-dependent manner at endogenous receptor levels, and these receptor dimers exist within high molecular weight networks. Using mutational analysis, FRET, fluorescence microscopy, synthetic biochemistry, and molecular modeling, we find that receptor dimerization relies upon covalent and noncovalent interactions between membrane-proximal residues. Additionally, by using FRET, we show that the oligomeric structure of two functional isoforms of DR5 is indistinguishable. The resulting model of DR5 activation should revise the accepted architecture of the functioning units of DR5 and the structurally homologous TNF receptor superfamily members.	[Valley, Christopher C.; Lewis, Andrew K.; Mudaliar, Deepti J.; Perlmutter, Jason D.; Braun, Anthony R.; Sachs, Jonathan N.] Univ Minnesota, Dept Biomed Engn, Minneapolis, MN 55455 USA; [Karim, Christine B.; Thomas, David D.] Univ Minnesota, Dept Biochem Mol Biol & Biophys, Minneapolis, MN 55455 USA; [Brody, Jonathan R.] Thomas Jefferson Univ, Jefferson Med Coll, Div Surg Res, Dept Surg, Philadelphia, PA 19107 USA	University of Minnesota System; University of Minnesota Twin Cities; University of Minnesota System; University of Minnesota Twin Cities; Jefferson University	Sachs, JN (corresponding author), Univ Minnesota, Dept Biomed Engn, Rm 7-105 NHH,312 Church St SE, Minneapolis, MN 55455 USA.	jnsachs@umn.edu		Thomas, David D./0000-0002-8822-2040; Braun, Anthony/0000-0002-9942-3390; Perlmutter, Jason/0000-0003-2855-2360; Karim, Christine/0000-0002-7321-7695	NIH [R21 CA152668, GM27906]; ACS [IRG-58-001-49 IRG 49-28]; NATIONAL CANCER INSTITUTE [R21CA152668] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM027906] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON AGING [R37AG026160] Funding Source: NIH RePORTER	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); ACS(American Cancer Society); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA))	This research was supported in part by grants to J. N. S. (NIH R21 CA152668 and ACS IRG-58-001-49 IRG 49-28) and to D. D. T. (NIH GM27906).	Adams C, 2008, CELL DEATH DIFFER, V15, P751, DOI 10.1038/sj.cdd.4402306; Algeciras-Schimnich A, 2002, MOL CELL BIOL, V22, P207, DOI 10.1128/MCB.22.1.207-220.2002; Arai T, 1998, CANCER LETT, V133, P197, DOI 10.1016/S0304-3835(98)00230-4; Ashkenazi A, 2002, NAT REV CANCER, V2, P420, DOI 10.1038/nrc821; Ashkenazi A, 2008, J CLIN ONCOL, V26, P3621, DOI 10.1200/JCO.2007.15.7198; Autry JM, 2011, J BIOL CHEM, V286, P31697, DOI 10.1074/jbc.M111.246843; BANNER DW, 1993, CELL, V73, P431, DOI 10.1016/0092-8674(93)90132-A; Baritaki S, 2007, MOL CANCER THER, V6, P1387, DOI 10.1158/1535-7163.MCT-06-0521; Bhatia S, 2005, P NATL ACAD SCI USA, V102, P15569, DOI 10.1073/pnas.0507257102; Bin L, 2007, J BIOL CHEM, V282, P28189, DOI 10.1074/jbc.M704210200; Blanchard H, 1999, STRUCTURE, V7, P1125, DOI 10.1016/S0969-2126(99)80179-8; Boatright KM, 2003, MOL CELL, V11, P529, DOI 10.1016/S1097-2765(03)00051-0; BROOKS BR, 1983, J COMPUT CHEM, V4, P187, DOI 10.1002/jcc.540040211; Camidge DR, 2008, EXPERT OPIN BIOL TH, V8, P1167, DOI 10.1517/14712598.8.8.1167 ; Cha SS, 2000, J BIOL CHEM, V275, P31171, DOI 10.1074/jbc.M004414200; Chan FKM, 2000, SCIENCE, V288, P2351, DOI 10.1126/science.288.5475.2351; Chan FKM, 2001, CYTOMETRY, V44, P361, DOI 10.1002/1097-0320(20010801)44:4<361::AID-CYTO1128>3.0.CO;2-3; Chan FKM, 2007, CYTOKINE, V37, P101, DOI 10.1016/j.cyto.2007.03.005; Clancy L, 2005, P NATL ACAD SCI USA, V102, P18099, DOI 10.1073/pnas.0507329102; Donepudi M, 2003, MOL CELL, V11, P543, DOI 10.1016/S1097-2765(03)00059-5; Feig M, 2004, J MOL GRAPH MODEL, V22, P377, DOI 10.1016/j.jmgm.2003.12.005; Fesik SW, 2005, NAT REV CANCER, V5, P876, DOI 10.1038/nrc1736; Guo YB, 2005, J BIOL CHEM, V280, P41940, DOI 10.1074/jbc.M503621200; Hartman NC, 2011, CURR OPIN CELL BIOL, V23, P370, DOI 10.1016/j.ceb.2011.05.003; Henkler F, 2005, J CELL BIOL, V168, P1087, DOI 10.1083/jcb.200501048; Hou ZJ, 2008, J BIOL CHEM, V283, P28996, DOI 10.1074/jbc.M804782200; Hou ZJ, 2010, J MOL BIOL, V402, P210, DOI 10.1016/j.jmb.2010.07.023; Hymowitz SG, 2000, BIOCHEMISTRY-US, V39, P633, DOI 10.1021/bi992242l; Hymowitz SG, 1999, MOL CELL, V4, P563, DOI 10.1016/S1097-2765(00)80207-5; Ichikawa K, 2001, NAT MED, V7, P954, DOI 10.1038/91000; Im W, 2003, BIOPHYS J, V85, P2900, DOI 10.1016/S0006-3495(03)74712-2; Im WP, 2003, J COMPUT CHEM, V24, P1691, DOI 10.1002/jcc.10321; Jin H, 2004, CANCER RES, V64, P4900, DOI 10.1158/0008-5472.CAN-04-0408; Kelley SK, 2004, CURR OPIN PHARMACOL, V4, P333, DOI 10.1016/j.coph.2004.02.006; Kohlhaas SL, 2007, J BIOL CHEM, V282, P12831, DOI 10.1074/jbc.M700438200; Li E, 2006, J MOL BIOL, V356, P600, DOI 10.1016/j.jmb.2005.11.077; Li E, 2006, BIOCHEMISTRY-US, V45, P6241, DOI 10.1021/bi060609y; Li J, 2008, DRUG DEVELOP RES, V69, P69, DOI 10.1002/ddr.20229; Li RH, 2001, P NATL ACAD SCI USA, V98, P12462, DOI 10.1073/pnas.221463098; Mackerell AD, 2004, J COMPUT CHEM, V25, P1400, DOI 10.1002/jcc.20065; MacKerell AD, 1998, J PHYS CHEM B, V102, P3586, DOI 10.1021/jp973084f; Mahalingam D, 2011, CURR DRUG TARGETS, V12, P2079, DOI 10.2174/138945011798829357; Mahalingam D, 2009, CANCER TREAT REV, V35, P280, DOI 10.1016/j.ctrv.2008.11.006; Manza BN, 2011, P NATL ACAD SCI USA, V108, P9089, DOI 10.1073/pnas.1018771108; Mongkolsapaya J, 1999, NAT STRUCT BIOL, V6, P1048; NAISMITH JH, 1995, J BIOL CHEM, V270, P13303, DOI 10.1074/jbc.270.22.13303; Ozsoy HZ, 2008, J BIOL CHEM, V283, P23419, DOI 10.1074/jbc.M802967200; Pan GH, 1997, SCIENCE, V277, P815, DOI 10.1126/science.277.5327.815; Pan GH, 1997, SCIENCE, V276, P111, DOI 10.1126/science.276.5309.111; Pavet V, 2010, CANCER RES, V70, P1101, DOI 10.1158/0008-5472.CAN-09-2889; Raghunathan A, 2001, EXP CELL RES, V268, P230, DOI 10.1006/excr.2001.5290; Ranzinger J, 2009, NANO LETT, V9, P4240, DOI 10.1021/nl902429b; Robia SL, 2007, CIRC RES, V101, P1123, DOI 10.1161/CIRCRESAHA.107.159947; Rosevear HM, 2010, CURR OPIN INVEST DR, V11, P688; Schneider P, 2000, METHOD ENZYMOL, V322, P325; Screaton GR, 1997, CURR BIOL, V7, P693, DOI 10.1016/S0960-9822(06)00297-1; Senes A, 2000, J MOL BIOL, V296, P921, DOI 10.1006/jmbi.1999.3488; Shanker A, 2008, JNCI-J NATL CANCER I, V100, P649, DOI 10.1093/jnci/djn113; Siegel RM, 2000, SCIENCE, V288, P2354, DOI 10.1126/science.288.5475.2354; Siegel RM, 2004, J CELL BIOL, V167, P735, DOI 10.1083/jcb.200406101; Sugita Y, 1999, CHEM PHYS LETT, V314, P141, DOI 10.1016/S0009-2614(99)01123-9; Thomas LR, 2004, J BIOL CHEM, V279, P52479, DOI 10.1074/jbc.M409578200; Thorburn A, 2007, J THORAC ONCOL, V2, P461, DOI 10.1097/JTO.0b013e31805fea64; Vilar M, 2009, J CELL SCI, V122, P3351, DOI 10.1242/jcs.055061; Vilar M, 2009, NEURON, V62, P72, DOI 10.1016/j.neuron.2009.02.020; Wagner KW, 2007, NAT MED, V13, P1070, DOI 10.1038/nm1627; Walczak H, 1997, EMBO J, V16, P5386, DOI 10.1093/emboj/16.17.5386; Watt W, 1999, STRUCTURE, V7, P1135, DOI 10.1016/S0969-2126(99)80180-4; Wiley SR, 1995, IMMUNITY, V3, P673, DOI 10.1016/1074-7613(95)90057-8; Wilson NS, 2011, CANCER CELL, V19, P101, DOI 10.1016/j.ccr.2010.11.012; Yasuda T, 2008, MOL CANCER RES, V6, P1852, DOI 10.1158/1541-7786.MCR-08-0012; Zacharias DA, 2002, SCIENCE, V296, P913, DOI 10.1126/science.1068539; Zhu H, 2010, J MOL BIOL, V401, P882, DOI 10.1016/j.jmb.2010.06.062	73	53	57	0	18	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JUN 15	2012	287	25					21265	21278		10.1074/jbc.M111.306480	http://dx.doi.org/10.1074/jbc.M111.306480			14	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	974FQ	22496450	hybrid, Green Published			2022-12-25	WOS:000306416800046
J	Tiwari, MK; Singh, RK; Singh, R; Jeya, M; Zhao, HM; Lee, JK				Tiwari, Manish Kumar; Singh, Raushan Kumar; Singh, Ranjitha; Jeya, Marimuthu; Zhao, Huimin; Lee, Jung-Kul			Role of Conserved Glycine in Zinc-dependent Medium Chain Dehydrogenase/Reductase Superfamily	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							L-ARABINITOL 4-DEHYDROGENASE; ARCHAEON HALOFERAX-MEDITERRANEI; DENSITY-FUNCTIONAL THEORY; HUMAN SERUM TRANSFERRIN; METAL-BINDING SITES; ALCOHOL-DEHYDROGENASE; GLUCOSE-DEHYDROGENASE; TRIGONAL-PLANAR; LIGAND-BINDING; ACTIVE-SITE	The medium-chain dehydrogenase/reductase (MDR) superfamily consists of a large group of enzymes with a broad range of activities. Members of this superfamily are currently the subject of intensive investigation, but many aspects, including the zinc dependence of MDR superfamily proteins, have not yet have been adequately investigated. Using a density functional theory-based screening strategy, we have identified a strictly conserved glycine residue (Gly) in the zinc-dependent MDR superfamily. To elucidate the role of this conserved Gly in MDR, we carried out a comprehensive structural, functional, and computational analysis of four MDR enzymes through a series of studies including site-directed mutagenesis, isothermal titration calorimetry, electron paramagnetic resonance (EPR), quantum mechanics, and molecular mechanics analysis. Gly substitution by other amino acids posed a significant threat to the metal binding affinity and activity of MDR superfamily enzymes. Mutagenesis at the conserved Gly resulted in alterations in the coordination of the catalytic zinc ion, with concomitant changes in metal-ligand bond length, bond angle, and the affinity (K-d) toward the zinc ion. The Gly mutants also showed different spectroscopic properties in EPR compared with those of the wild type, indicating that the binding geometries of the zinc to the zinc binding ligands were changed by the mutation. The present results demonstrate that the conserved Gly in the GHE motif plays a role in maintaining the metal binding affinity and the electronic state of the catalytic zinc ion during catalysis of the MDR superfamily enzymes.	[Zhao, Huimin] Univ Illinois, Dept Chem & Biomol Engn, Urbana, IL 61801 USA; [Tiwari, Manish Kumar; Singh, Raushan Kumar; Singh, Ranjitha; Jeya, Marimuthu; Lee, Jung-Kul] Konkuk Univ, Dept Chem Engn, Seoul 143701, South Korea	University of Illinois System; University of Illinois Urbana-Champaign; Konkuk University	Zhao, HM (corresponding author), Univ Illinois, Dept Chem & Biomol Engn, 600 S Mathews Ave, Urbana, IL 61801 USA.	zhao5@illinois.edu; jkrhee@konkuk.ac.kr	Ramakrishnan, Ranjitha/D-9087-2011; Jeya, Marimuthu/D-9063-2011; Ramakrishnan, Ranjitha/K-7554-2019; Lee, Jungkukl/D-9104-2011; Tiwari, Manish K./D-9034-2011	Ramakrishnan, Ranjitha/0000-0001-9697-9070; Jeya, Marimuthu/0000-0001-6730-4074; Ramakrishnan, Ranjitha/0000-0001-9697-9070; Tiwari, Manish K./0000-0002-4667-1112; Singh, Raushan Kumar/0000-0001-8031-1041	National Research Foundation of Korea; Ministry of Education, Science and Technology [2011-50210]; 21C Frontier Microbial Genomics and Applications Center Program.	National Research Foundation of Korea(National Research Foundation of Korea); Ministry of Education, Science and Technology(Ministry of Education, Science & Technology (MEST), Republic of Korea); 21C Frontier Microbial Genomics and Applications Center Program.(Ministry of Education, Science & Technology (MEST), Republic of Korea)	This research was supported by the Converging Research Center Program through the National Research Foundation of Korea, funded by the Ministry of Education, Science and Technology (Grant 2011-50210). This study also was supported by the 21C Frontier Microbial Genomics and Applications Center Program.	Alberts IL, 1998, PROTEIN SCI, V7, P1700, DOI 10.1002/pro.5560070805; [Anonymous], 2006, ACC MAT STUD; [Anonymous], 2003, DMOL US GUID S D; Auld DS, 2008, CELL MOL LIFE SCI, V65, P3961, DOI 10.1007/s00018-008-8593-1; Auld DS, 2001, BIOMETALS, V14, P271, DOI 10.1023/A:1012976615056; Bae B, 2010, J MOL BIOL, V402, P230, DOI 10.1016/j.jmb.2010.07.033; Baker PJ, 2009, P NATL ACAD SCI USA, V106, P779, DOI 10.1073/pnas.0807529106; BECKE AD, 1988, J CHEM PHYS, V88, P2547, DOI 10.1063/1.454033; Bonete MJ, 1996, FEBS LETT, V383, P227, DOI 10.1016/0014-5793(96)00235-9; BRADFORD MM, 1976, ANAL BIOCHEM, V72, P248, DOI 10.1016/0003-2697(76)90527-3; Anota EC, 2010, PHYS STATUS SOLIDI C, V7, DOI 10.1002/pssc.200983909; CHRISTIANSON DW, 1991, ADV PROTEIN CHEM, V42, P281; Darensbourg DJ, 1999, INORG CHEM, V38, P1356, DOI 10.1021/ic9805325; de Azevedo WF, 2008, CURR DRUG TARGETS, V9, P1031, DOI 10.2174/138945008786949405; DELLEY B, 1990, J CHEM PHYS, V92, P508, DOI 10.1063/1.458452; DiTusa CA, 2001, BIOCHEMISTRY-US, V40, P5338, DOI 10.1021/bi001731e; Dudev T, 2000, J AM CHEM SOC, V122, P11146, DOI 10.1021/ja0010296; Dudev T, 2003, CHEM REV, V103, P773, DOI 10.1021/cr020467n; Dudev T, 2003, J AM CHEM SOC, V125, P3168, DOI 10.1021/ja0209722; Dudev T, 2002, J AM CHEM SOC, V124, P6759, DOI 10.1021/ja012620l; Dudev T, 1999, J AM CHEM SOC, V121, P7665, DOI 10.1021/ja984470t; EKLUND H, 1979, J BIOL CHEM, V254, P3458; EKLUND H, 1981, J MOL BIOL, V146, P561, DOI 10.1016/0022-2836(81)90047-4; Fox S, 2011, J CHEM THEORY COMPUT, V7, P1102, DOI 10.1021/ct100706u; Gonzalez-Duarte R, 2005, HEREDITY, V95, P184, DOI 10.1038/sj.hdy.6800723; GRADY JK, 1995, BIOCHEM J, V309, P403, DOI 10.1042/bj3090403; GRUFF ES, 1989, J AM CHEM SOC, V111, P8762, DOI 10.1021/ja00205a052; Harding MM, 1999, ACTA CRYSTALLOGR D, V55, P1432, DOI 10.1107/S0907444999007374; He QY, 1998, J BIOL CHEM, V273, P17018, DOI 10.1074/jbc.273.27.17018; HOAGSTROM CW, 1969, J BIOL CHEM, V244, P5967; Hullme EC, 2007, BIOCHEM SOC T, V35, P742, DOI 10.1042/BST0350742; Idupulapati NB, 2010, J PHYS CHEM A, V114, P1887, DOI 10.1021/jp9083025; KIEFER LL, 1995, J AM CHEM SOC, V117, P6831, DOI 10.1021/ja00131a004; KLAMT A, 1995, J PHYS CHEM-US, V99, P2224, DOI 10.1021/j100007a062; Krezel A, 2008, J BIOL INORG CHEM, V13, P401, DOI 10.1007/s00775-007-0330-y; Kuo JM, 1997, BIOCHEMISTRY-US, V36, P1982, DOI 10.1021/bi962099l; LEE CT, 1988, PHYS REV B, V37, P785, DOI 10.1103/PhysRevB.37.785; Lee YM, 2008, J MOL BIOL, V379, P545, DOI 10.1016/j.jmb.2008.04.004; LESBURG CA, 1995, J AM CHEM SOC, V117, P6838, DOI 10.1021/ja00131a005; Li KY, 2006, J PHYS CHEM A, V110, P11332, DOI 10.1021/jp062886k; Liang JA, 2010, ANGEW CHEM INT EDIT, V49, P7710, DOI 10.1002/anie.201002853; Lipscomb WN, 1996, CHEM REV, V96, P2375, DOI 10.1021/cr950042j; Lu Y, 2001, CHEM REV, V101, P3047, DOI 10.1021/cr0000574; Lyons TJ, 1996, P NATL ACAD SCI USA, V93, P12240, DOI 10.1073/pnas.93.22.12240; MAKINEN MW, 1983, P NATL ACAD SCI-BIOL, V80, P2584, DOI 10.1073/pnas.80.9.2584; Maniccia Anna Wilkins, 2009, PMC Biophys, V2, P11, DOI 10.1186/1757-5036-2-11; MARET W, 1988, BIOCHEMISTRY-US, V27, P1622, DOI 10.1021/bi00405a035; Maret W, 2009, CHEM REV, V109, P4682, DOI 10.1021/cr800556u; Marino SF, 1999, CHEM BIOL, V6, P649, DOI 10.1016/S1074-5521(99)80116-1; Matzapetakis M, 2005, J AM CHEM SOC, V127, P18229, DOI 10.1021/ja055433m; Maynard AT, 2001, J AM CHEM SOC, V123, P1047, DOI 10.1021/ja0011616; MCDONALD IK, 1994, J MOL BIOL, V238, P777, DOI 10.1006/jmbi.1994.1334; Mertz P, 1997, J BIOL CHEM, V272, P21296, DOI 10.1074/jbc.272.34.21296; Morrison KL, 2001, CURR OPIN CHEM BIOL, V5, P302, DOI 10.1016/S1367-5931(00)00206-4; Mulliken R., 1935, J CHEM PHYS, V3; PARR RG, 1983, J AM CHEM SOC, V105, P7512, DOI 10.1021/ja00364a005; PEARSON RG, 1986, P NATL ACAD SCI USA, V83, P8440, DOI 10.1073/pnas.83.22.8440; PEARSON RG, 1963, J AM CHEM SOC, V85, P3533, DOI 10.1021/ja00905a001; PERDEW JP, 1992, PHYS REV B, V45, P13244, DOI 10.1103/PhysRevB.45.13244; Persson B, 2008, CELL MOL LIFE SCI, V65, P3879, DOI 10.1007/s00018-008-8587-z; Pire C, 2001, FEMS MICROBIOL LETT, V200, P221, DOI 10.1111/j.1574-6968.2001.tb10719.x; RAO ST, 1973, J MOL BIOL, V76, P241, DOI 10.1016/0022-2836(73)90388-4; Richard P, 2001, J BIOL CHEM, V276, P40631, DOI 10.1074/jbc.M104022200; Ryde U, 1999, BIOPHYS J, V77, P2777, DOI 10.1016/S0006-3495(99)77110-9; SALI A, 1993, J MOL BIOL, V234, P779, DOI 10.1006/jmbi.1993.1626; Sullivan R, 2007, APPL MICROBIOL BIOT, V77, P845, DOI 10.1007/s00253-007-1225-0; Tiwari M, 2010, J MOL GRAPH MODEL, V28, P707, DOI 10.1016/j.jmgm.2010.01.004; Tiwari MK, 2010, APPL MICROBIOL BIOT, V87, P571, DOI 10.1007/s00253-010-2478-6; Vipond IB, 1996, BIOCHEMISTRY-US, V35, P1712, DOI 10.1021/bi9523926; Weiss GA, 2000, P NATL ACAD SCI USA, V97, P8950, DOI 10.1073/pnas.160252097; White CE, 2010, J PHYS CHEM A, V114, P4988, DOI 10.1021/jp911108d; White DJ, 2001, BIOCHEMISTRY-US, V40, P8918, DOI 10.1021/bi010637a; Yan BX, 1997, J BIOL CHEM, V272, P3190, DOI 10.1074/jbc.272.6.3190; Zhan CG, 2003, J PHYS CHEM A, V107, P4184, DOI 10.1021/jp0225774	74	30	32	2	22	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JUN 1	2012	287	23					19429	19439		10.1074/jbc.M111.335752	http://dx.doi.org/10.1074/jbc.M111.335752			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	974EF	22500022	hybrid, Green Published			2022-12-25	WOS:000306411900057
J	Danciu, TE; Chupreta, S; Cruz, O; Fox, JE; Whitman, M; Iniguez-Lluhi, JA				Danciu, Theodora E.; Chupreta, Sergey; Cruz, Osvaldo; Fox, Jennifer E.; Whitman, Malcolm; Iniguez-Lluhi, Jorge A.			Small Ubiquitin-like Modifier (SUMO) Modification Mediates Function of the Inhibitory Domains of Developmental Regulators FOXC1 and FOXC2	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							HELIX TRANSCRIPTION FACTORS; AXENFELD-RIEGER-SYNDROME; CARDIOVASCULAR DEVELOPMENT; MISSENSE MUTATIONS; CONJUGATING ENZYME; STRUCTURAL BASIS; BOND FORMATION; DNA-BINDING; HEAT-SHOCK; GENE	FOXC1 and FOXC2 are forkhead transcription factors that play essential roles during development and physiology. Despite their critical role, the mechanisms that regulate the function of these factors remain poorly understood. We have identified conserved motifs within a previously defined N-terminal negative regulatory region of FOXC1/C2 that conforms to the definition of synergy control or SC motifs. Because such motifs inhibit the activity of transcription factors by serving as sites of post-translational modification by small ubiquitin-like modifier (SUMO), we have examined whether FOXC1/C2 are targets of SUMOylation and probed the functional significance of this modification. We find that endogenous FOXC1 forms modified by SUMO2/3 can be detected. Moreover, in cell culture, all three SUMO isoforms are readily conjugated to FOXC1 and FOXC2. The modification can be reconstituted in vitro with purified components and can be reversed in vitro by treatment with the SUMO protease SENP2. SUMOylation of FOXC1 and FOXC2 occurs primarily on one consensus synergy control motif with minor contributions of a second, more degenerate site. Notably, although FOXC1 is also phosphorylated at multiple sites, disruption of sites immediately downstream of the SC motifs does not influence SUMOylation. Consistent with a negative functional role, SUMOylation-deficient mutants displayed higher transcriptional activity when compared with wild type forms despite comparable protein levels and subcellular localization. Thus, the findings demonstrate that SC motifs mediate the inhibitory function of this region by serving as sites for SUMOylation and reveal a novel mechanism for acute and reversible regulation of FOXC1/C2 function.	[Danciu, Theodora E.; Fox, Jennifer E.] Univ Michigan, Sch Dent, Dept Periodont & Oral Med, Ann Arbor, MI 48109 USA; [Chupreta, Sergey; Cruz, Osvaldo; Iniguez-Lluhi, Jorge A.] Univ Michigan, Sch Med, Dept Pharmacol, Ann Arbor, MI 48109 USA; [Whitman, Malcolm] Harvard Univ, Sch Dent Med, Dept Dev Biol, Boston, MA 02115 USA	University of Michigan System; University of Michigan; University of Michigan System; University of Michigan; Harvard University; Harvard School of Dental Medicine	Danciu, TE (corresponding author), Univ Michigan, Sch Dent, Dept Periodont & Oral Med, Ann Arbor, MI 48109 USA.	tdanciu@umich.edu; iniguez@umich.edu		Iniguez-Lluhi, Jorge/0000-0001-7010-089X	National Institutes of Health from the USPHS [R56 DK061656]; National Institutes of Health from the NIDCR [K22DE016614]; National Institutes of Health [P60 DK20572]; NATIONAL INSTITUTE OF DENTAL &CRANIOFACIAL RESEARCH [K22DE016614] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [P60DK020572, R56DK061656] Funding Source: NIH RePORTER	National Institutes of Health from the USPHS; National Institutes of Health from the NIDCR; National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF DENTAL &CRANIOFACIAL RESEARCH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Dental & Craniofacial Research (NIDCR)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	This work was supported, in whole or in part, by National Institutes of Health Grant R56 DK061656 from the USPHS (to J. A. I.) and National Institutes of Health Grant K22DE016614 from the NIDCR (to T. E. D.).; We thank Dr. Ormond A. MacDougald for valuable discussions and suggestions and Yana Kamberov for initial SUMOylation discussions. Core facility use was also provided through Grant P60 DK20572 from the National Institutes of Health.	Alkuraya FS, 2006, SCIENCE, V313, P1751, DOI 10.1126/science.1128406; Andreou AM, 2007, AM J HUM GENET, V81, P700, DOI 10.1086/521033; Benson MD, 2007, P NATL ACAD SCI USA, V104, P1805, DOI 10.1073/pnas.0606702104; Bernier-Villamor V, 2002, CELL, V108, P345, DOI 10.1016/S0092-8674(02)00630-X; Berry FB, 2006, J BIOL CHEM, V281, P10098, DOI 10.1074/jbc.M513629200; Berry FB, 2006, HUM MOL GENET, V15, P905, DOI 10.1093/hmg/ddl008; Berry FB, 2002, J BIOL CHEM, V277, P10292, DOI 10.1074/jbc.M110266200; Bohren KM, 2004, J BIOL CHEM, V279, P27233, DOI 10.1074/jbc.M402273200; Carlsson P, 2002, DEV BIOL, V250, P1, DOI 10.1006/dbio.2002.0780; Chupreta S, 2007, J BIOL CHEM, V282, P36155, DOI 10.1074/jbc.M708130200; Danciu TE, 2010, J CELL BIOCHEM, V109, P417, DOI 10.1002/jcb.22415; Dotzlaw H, 2002, MOL ENDOCRINOL, V16, P661, DOI 10.1210/me.16.4.661; Faber J., 1994, NORMAL TABLE XENOPUS, P2; Fujita H, 2006, CIRC RES, V98, P626, DOI 10.1161/01.RES.0000207407.51752.3c; Gareau JR, 2010, NAT REV MOL CELL BIO, V11, P861, DOI 10.1038/nrm3011; Gerin I, 2009, J BIOL CHEM, V284, P10755, DOI 10.1074/jbc.M809115200; Ghioni P, 2005, CELL CYCLE, V4, P183, DOI 10.4161/cc.4.1.1359; Hayashi H, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0002401; Hiemisch H, 1998, GENE, V220, P77, DOI 10.1016/S0378-1119(98)00409-0; Holmstrom S, 2003, P NATL ACAD SCI USA, V100, P15758, DOI 10.1073/pnas.2136933100; Holmstrom SR, 2008, MOL ENDOCRINOL, V22, P2061, DOI 10.1210/me.2007-0581; Hong HK, 1999, HUM MOL GENET, V8, P625, DOI 10.1093/hmg/8.4.625; Huang YP, 2004, CELL CYCLE, V3, P1587, DOI 10.4161/cc.3.12.1290; Iida K, 1997, DEVELOPMENT, V124, P4627; Iniguez-Lluhi JA, 2000, MOL CELL BIOL, V20, P6040, DOI 10.1128/MCB.20.16.6040-6050.2000; Iniguez-Lluhi JA, 2009, SUMO REGULATION OF CELLULAR PROCESSES, P13, DOI 10.1007/978-90-481-2649-1_2; IniguezLluhi JA, 1997, J BIOL CHEM, V272, P4149, DOI 10.1074/jbc.272.7.4149; Johnson ES, 1997, J BIOL CHEM, V272, P26799, DOI 10.1074/jbc.272.43.26799; Kaestner KH, 2000, GENE DEV, V14, P142; Kume T, 2001, GENE DEV, V15, P2470, DOI 10.1101/gad.907301; Kume T, 1998, CELL, V93, P985, DOI 10.1016/S0092-8674(00)81204-0; Kume T, 2008, TRENDS CARDIOVAS MED, V18, P224, DOI 10.1016/j.tcm.2008.11.003; Lehmann OJ, 2000, AM J HUM GENET, V67, P1129; Lin DY, 2006, MOL CELL, V24, P341, DOI 10.1016/j.molcel.2006.10.019; Makarova O, 2000, BIOTECHNIQUES, V29, P970, DOI 10.2144/00295bm08; Mani SA, 2007, P NATL ACAD SCI USA, V104, P10069, DOI 10.1073/pnas.0703900104; Obenauer JC, 2003, NUCLEIC ACIDS RES, V31, P3635, DOI 10.1093/nar/gkg584; Olsen SK, 2010, NATURE, V463, P906, DOI 10.1038/nature08765; Owerbach D, 2005, BIOCHEM BIOPH RES CO, V337, P517, DOI 10.1016/j.bbrc.2005.09.090; Palvimo JJ, 2007, BIOCHEM SOC T, V35, P1405, DOI 10.1042/BST0351405; Pauws E, 2009, SUMO REGULATION OF CELLULAR PROCESSES, P301, DOI 10.1007/978-90-481-2649-1_17; PIERROU S, 1995, ANAL BIOCHEM, V229, P99, DOI 10.1006/abio.1995.1384; Poukka H, 2000, P NATL ACAD SCI USA, V97, P14145, DOI 10.1073/pnas.97.26.14145; Reverter D, 2006, NAT STRUCT MOL BIOL, V13, P1060, DOI 10.1038/nsmb1168; Rice R, 2005, DEV DYNAM, V233, P847, DOI 10.1002/dvdy.20430; Rice R, 2003, DEV BIOL, V262, P75, DOI 10.1016/S0012-1606(03)00355-5; Rosendorff A, 2006, P NATL ACAD SCI USA, V103, P5308, DOI 10.1073/pnas.0601066103; Saitoh H, 2000, J BIOL CHEM, V275, P6252, DOI 10.1074/jbc.275.9.6252; Saleem RA, 2001, AM J HUM GENET, V68, P627, DOI 10.1086/318792; Stielow B, 2008, EMBO REP, V9, P899, DOI 10.1038/embor.2008.127; Su HL, 2002, GENE, V296, P65, DOI 10.1016/S0378-1119(02)00843-0; Subramanian L, 2003, J BIOL CHEM, V278, P9134, DOI 10.1074/jbc.M210440200; Tamimi Y, 2006, HUM MOL GENET, V15, P3229, DOI 10.1093/hmg/ddl400; Tamini Y, 2004, INVEST OPHTH VIS SCI, V45, P3904, DOI 10.1167/iovs.04-0628; Tumer Z, 2009, EUR J HUM GENET, V17, P1527, DOI 10.1038/ejhg.2009.93; WALSH DA, 1987, TERATOLOGY, V36, P181, DOI 10.1002/tera.1420360205; Watanabe M, 1999, DEVELOPMENT, V126, P5621; Winnier GE, 1999, DEV BIOL, V213, P418, DOI 10.1006/dbio.1999.9382; Yang SH, 2006, EMBO J, V25, P5083, DOI 10.1038/sj.emboj.7601383; Yang WH, 2009, MOL CELL BIOL, V29, P613, DOI 10.1128/MCB.00295-08; Yeh ETH, 2009, J BIOL CHEM, V284, P8223, DOI 10.1074/jbc.R800050200; Zhang FP, 2008, MOL CELL BIOL, V28, P5381, DOI 10.1128/MCB.00651-08	62	21	25	1	8	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAY 25	2012	287	22					18318	18329		10.1074/jbc.M112.339424	http://dx.doi.org/10.1074/jbc.M112.339424			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	974EC	22493429	Green Published, hybrid			2022-12-25	WOS:000306411600038
J	Berquist, RM; Gledhill, KM; Peterson, MW; Doan, AH; Baxter, GT; Yopak, KE; Kang, N; Walker, HJ; Hastings, PA; Frank, LR				Berquist, Rachel M.; Gledhill, Kristen M.; Peterson, Matthew W.; Doan, Allyson H.; Baxter, Gregory T.; Yopak, Kara E.; Kang, Ning; Walker, H. J.; Hastings, Philip A.; Frank, Lawrence R.			The Digital Fish Library: Using MRI to Digitize, Database, and Document the Morphological Diversity of Fish	PLOS ONE			English	Article							MAGNETIC-RESONANCE MICROSCOPY; HIGH-RESOLUTION; DIFFUSION PROPERTIES; COMPUTED-TOMOGRAPHY; CRANIAL ENDOTHERMY; VIRTUAL HISTOLOGY; MOUSE ATLAS; TISSUE; PHYLOGENY; TOOLS	Museum fish collections possess a wealth of anatomical and morphological data that are essential for documenting and understanding biodiversity. Obtaining access to specimens for research, however, is not always practical and frequently conflicts with the need to maintain the physical integrity of specimens and the collection as a whole. Non-invasive three-dimensional (3D) digital imaging therefore serves a critical role in facilitating the digitization of these specimens for anatomical and morphological analysis as well as facilitating an efficient method for online storage and sharing of this imaging data. Here we describe the development of the Digital Fish Library (DFL, http://www.digitalfishlibrary.org), an online digital archive of high-resolution, high-contrast, magnetic resonance imaging (MRI) scans of the soft tissue anatomy of an array of fishes preserved in the Marine Vertebrate Collection of Scripps Institution of Oceanography. We have imaged and uploaded MRI data for over 300 marine and freshwater species, developed a data archival and retrieval system with a web-based image analysis and visualization tool, and integrated these into the public DFL website to disseminate data and associated metadata freely over the web. We show that MRI is a rapid and powerful method for accurately depicting the in-situ soft-tissue anatomy of preserved fishes in sufficient detail for large-scale comparative digital morphology. However these 3D volumetric data require a sophisticated computational and archival infrastructure in order to be broadly accessible to researchers and educators.	[Berquist, Rachel M.; Gledhill, Kristen M.; Peterson, Matthew W.; Doan, Allyson H.; Baxter, Gregory T.; Yopak, Kara E.; Kang, Ning; Frank, Lawrence R.] Univ Calif San Diego, Ctr Sci Computat Imaging, La Jolla, CA 92093 USA; [Walker, H. J.; Hastings, Philip A.] Univ Calif San Diego, Scripps Inst Oceanog, Marine Vertebrate Collect & Marine Biol Res Div, La Jolla, CA 92093 USA; [Frank, Lawrence R.] Univ Calif San Diego, Ctr Funct Magnet Resonance Imaging, La Jolla, CA 92093 USA	University of California System; University of California San Diego; University of California System; University of California San Diego; Scripps Institution of Oceanography; University of California System; University of California San Diego	Berquist, RM (corresponding author), Univ Calif San Diego, Ctr Sci Computat Imaging, La Jolla, CA 92093 USA.	lfrank@ucsd.edu	Yopak, Kara E/A-5549-2012	Yopak, Kara E/0000-0002-7870-9066; Hastings, Philip/0000-0002-9867-6601	National Science Foundation (NSF) [DBI-0446389, EF-0850369]; Division Of Earth Sciences [0948842] Funding Source: National Science Foundation; Emerging Frontiers [0850369] Funding Source: National Science Foundation	National Science Foundation (NSF)(National Science Foundation (NSF)); Division Of Earth Sciences(National Science Foundation (NSF)NSF - Directorate for Geosciences (GEO)); Emerging Frontiers(National Science Foundation (NSF)NSF - Directorate for Biological Sciences (BIO))	The DFL received its primary funding from the Biological Infrastructure Program (Grant DBI-0446389) of the National Science Foundation (NSF: http://www.nsf.gov/div/index.jsp?div=DBI) with additional funding provided by NSF award EF-0850369. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Basser PJ, 1996, J MAGN RESON SER B, V111, P209, DOI [10.1006/jmrb.1996.0086, 10.1016/j.jmr.2011.09.022]; Bernstein M.A., 2004, HDB MRI PULSE SEQUEN, DOI 10.1016/B978-012092861-3/50021-2; Betz O, 2007, J MICROSC-OXFORD, V227, P51, DOI 10.1111/j.1365-2818.2007.01785.x; BLACKBAND SJ, 1990, MAGN RESON IMAGING, V8, P191, DOI 10.1016/0730-725X(90)90253-X; Blits KC, 1999, ANAT REC, V257, P58; Bock C, 2002, MAGN RESON IMAGING, V20, P165, DOI 10.1016/S0730-725X(02)00482-4; Bookstein FL, 1996, B MATH BIOL, V58, P313, DOI 10.1016/0092-8240(95)00329-0; Bryson-Richardson RJ, 2007, BMC BIOL, V5, DOI 10.1186/1741-7007-5-34; Callaghan P., 1991, PRINCIPLES NUCL MAGN; Chakrabarty P, 2011, J MORPHOL, V272, P704, DOI 10.1002/jmor.10941; Chanet B, 2007, CYBIUM, V31, P107; Chanet B, 2009, CR BIOL, V332, P413, DOI 10.1016/j.crvi.2008.12.002; Clabaut C, 2007, EVOLUTION, V61, P560, DOI 10.1111/j.1558-5646.2007.00045.x; Cleary JO, 2011, NEUROIMAGE, V54, P769, DOI 10.1016/j.neuroimage.2010.07.039; CLOUTIER R, 1988, ENVIRON BIOL FISH, V23, P281, DOI 10.1007/BF00005239; Cnudde V, 2008, J MICROSC-OXFORD, V232, P476, DOI 10.1111/j.1365-2818.2008.02142.x; Corfield JR, 2008, NAT PROTOC, V3, P597, DOI 10.1038/nprot.2008.17; De Groof G, 2006, NEUROIMAGE, V29, P754, DOI 10.1016/j.neuroimage.2005.09.022; Dhenain M, 2001, DEV BIOL, V232, P458, DOI 10.1006/dbio.2001.0189; Dickinson ME, 2006, DEV DYNAM, V235, P2386, DOI 10.1002/dvdy.20889; Dinley J, 2010, J MICROSC-OXFORD, V238, P123, DOI 10.1111/j.1365-2818.2009.03335.x; Dogdas B, 2007, PHYS MED BIOL, V52, P577, DOI 10.1088/0031-9155/52/3/003; Driehuys B, 2008, ILAR J, V49, P35, DOI 10.1093/ilar.49.1.35; Fishbein KW, 2007, MAGN RESON MED, V57, P866, DOI 10.1002/mrm.21189; FISHELSON L, 1991, JPN J ICHTHYOL, V38, P17, DOI 10.1007/BF02910104; Forbes JG, 2006, MAGN RESON IMAGING, V24, P321, DOI 10.1016/j.mri.2005.10.036; Giribet G, 2010, ACTA ZOOL-STOCKHOLM, V91, P11, DOI 10.1111/j.1463-6395.2009.00420.x; Hart AG, 2003, J INSECT SCI, V3, DOI 10.1093/jis/3.1.5; Hastings PA, 2011, ZOOTAXA, P57, DOI 10.11646/zootaxa.2946.1.12; Hayat M. A, 1970, PRINCIPLES TECHNIQUE, V1; Heemskerk AM, 2007, CURR MED IMAGING REV, V3, P152, DOI 10.2174/157340507781386988; Herberholz J, 2004, J EXP BIOL, V207, P4543, DOI 10.1242/jeb.01328; Houle D, 2010, P NATL ACAD SCI USA, V107, P1793, DOI 10.1073/pnas.0906195106; Jacobs RE, 2003, NAT CELL BIOL, pSS10, DOI 10.1038/nrm1195; Jiang Y, 2004, MAGN RESON MED, V52, P453, DOI 10.1002/mrm.20191; Johnston P, 2011, J MORPHOL, V272, P1492, DOI 10.1002/jmor.10998; Kalat TM, 2010, APPL MAGN RESON, V38, P361, DOI 10.1007/s00723-010-0122-3; Kherlopian AR, 2008, BMC SYST BIOL, V2, DOI 10.1186/1752-0509-2-74; Lauridsen H, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0017879; LIEM KF, 1991, AM ZOOL, V31, P759; Liste F, 2006, VET RADIOL ULTRASOUN, V47, P453, DOI 10.1111/j.1740-8261.2006.00167.x; Mathiassen JR, 2011, TRENDS FOOD SCI TECH, V22, P257, DOI 10.1016/j.tifs.2011.03.006; Metscher BD, 2009, DEV DYNAM, V238, P632, DOI 10.1002/dvdy.21857; MOK HK, 1982, JPN J ICHTHYOL, V29, P43; MOK HK, 1981, JPN J ICHTHYOL, V27, P281; Nelson JS, 1984, FISHES WORLD; Newman JD, 2009, BRAIN RES REV, V62, P1, DOI 10.1016/j.brainresrev.2009.09.001; Nott KP, 1999, FOOD SCI TECHNOL-LEB, V32, P261; Nott KP, 1999, MAGN RESON IMAGING, V17, P445, DOI 10.1016/S0730-725X(98)00189-1; Pena H, 2008, ICES J MAR SCI, V65, P1751, DOI 10.1093/icesjms/fsn190; Peng HC, 2010, NAT BIOTECHNOL, V28, P348, DOI 10.1038/nbt.1612; Perry CN, 2007, J MORPHOL, V268, P284, DOI 10.1002/jmor.10516; Petiet A, 2007, J MAGN RESON IMAGING, V25, P1192, DOI 10.1002/jmri.20932; Petiet AE, 2008, P NATL ACAD SCI USA, V105, P12331, DOI 10.1073/pnas.0805747105; Plyusnin I, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0001742; Prager RW, 2010, P I MECH ENG H, V224, P193, DOI 10.1243/09544119JEIM586; Prieto-Marquez A, 2007, J MORPHOL, V268, P1120; Pyle RL, 2008, ZOOTAXA, P3, DOI 10.11646/zootaxa.1671.1.2; Richtarski U, 2000, J FISH BIOL, V56, P22, DOI 10.1006/jfbi.1999.1137; Rogers BL, 2008, CAN J FISH AQUAT SCI, V65, P1245, DOI 10.1139/F08-102; Rowe T, 1999, J VERTEBR PALEONTOL, V19, P1, DOI 10.1080/02724634.1999.10011200; Rowe T, 2011, SCIENCE, V331, P712, DOI 10.1126/science.1202828; Ruffins SW, 2007, THESCIENTIFICWORLDJO, V7, P592, DOI 10.1100/tsw.2007.125; Runcie RM, 2009, J EXP BIOL, V212, P461, DOI 10.1242/jeb.022814; SCHULTZE HP, 1991, ENVIRON BIOL FISH, V32, P159, DOI 10.1007/BF00007451; Scotland RW, 2003, SYST BIOL, V52, P539, DOI 10.1080/10635150390223613; Seltman K, 2007, J MORPHOL, V268, P1132; Sepulveda CA, 2007, J FISH BIOL, V70, P1720, DOI 10.1111/j.1095-8649.2007.01446.x; Sharpe J, 2002, SCIENCE, V296, P541, DOI 10.1126/science.1068206; Shen L, 2009, EVOLUTION, V63, P1003, DOI 10.1111/j.1558-5646.2008.00557.x; Shepherd TM, 2009, MAGN RESON MED, V62, P26, DOI 10.1002/mrm.21977; SMEETS WJAJ, 1976, J COMP NEUROL, V165, P333, DOI 10.1002/cne.901650305; Sparks JS, 2008, B AM MUS NAT HIST, P5; Strijkers GJ, 2007, ANTI-CANCER AGENT ME, V7, P291, DOI 10.2174/187152007780618135; Suarez AV, 2004, BIOSCIENCE, V54, P66, DOI 10.1641/0006-3568(2004)054[0066:TVOMCF]2.0.CO;2; Taylor W. R., 1967, Proceedings of the United States National Museum, V122, P1; Thacker PD, 2003, BIOSCIENCE, V53, P544, DOI 10.1641/0006-3568(2003)053[0544:MTSOTT]2.0.CO;2; The Digital Fish Library Earthguide Module, DES DEEP FISH; Thelwall PE, 2006, MAGN RESON MED, V56, P282, DOI 10.1002/mrm.20962; THICKMAN DI, 1983, RADIOLOGY, V148, P183, DOI 10.1148/radiology.148.1.6856832; Tyszka JM, 2006, NEUROIMAGE, V29, P1058, DOI 10.1016/j.neuroimage.2005.08.037; Tyszka JM, 2005, CURR OPIN BIOTECH, V16, P93, DOI 10.1016/j.copbio.2004.11.004; Ullmann JFP, 2010, J MORPHOL, V271, P1446, DOI 10.1002/jmor.10887; Ullmann JFP, 2010, NMR BIOMED, V23, P341, DOI 10.1002/nbm.1465; Ullmann JFP, 2010, NEUROIMAGE, V51, P76, DOI 10.1016/j.neuroimage.2010.01.086; Van der Linden A, 2007, NMR BIOMED, V20, P522, DOI 10.1002/nbm.1131; Vasquez SX, 2008, ANAT REC, V291, P475, DOI 10.1002/ar.20670; Veliyulin E, 2006, MOD MAGN RESON, V1, P959, DOI [10.1007/1-4020-3910-7_111, DOI 10.1007/1-4020-3910-7_111]; Waller G, 1996, NATURE, V380, P209, DOI 10.1038/380209a0; WALLER GNH, 1994, MAGN RESON IMAGING, V12, P535, DOI 10.1016/0730-725X(94)92548-8; Walter T, 2010, NAT METHODS, V7, pS26, DOI [10.1038/nmeth.1431, 10.1038/NMETH.1431]; Weinmann HJ, 2003, EUR J RADIOL, V46, P33, DOI 10.1016/S0720-048X(02)00332-7; Westneat MW, 2008, ANNU REV PHYSIOL, V70, P119, DOI 10.1146/annurev.physiol.70.113006.100434; Winston JE, 2007, ZOOTAXA, P47, DOI 10.11646/zootaxa.1668.1.6; WINTERBOTTOM R, 1974, P ACAD NAT SCI PHILA, V125, P225; Yopak KE, 2009, BRAIN BEHAV EVOLUT, V74, P121, DOI 10.1159/000235962; Yopak KE, 2007, BRAIN BEHAV EVOLUT, V70, P210; Yushkevich PA, 2006, NEUROIMAGE, V31, P1116, DOI 10.1016/j.neuroimage.2006.01.015; Ziegler A, COMP MORPHOLOGY AXIA; Ziegler A, 2011, ZOOMORPHOLOGY, V130, P227, DOI 10.1007/s00435-011-0138-8; Ziegler A, 2011, METHODS MOL BIOL, V771, P633, DOI 10.1007/978-1-61779-219-9_32; Ziegler A, 2010, BIOL DIRECT, V5, DOI 10.1186/1745-6150-5-45; Ziegler A, 2008, BMC BIOL, V6, DOI 10.1186/1741-7007-6-33	103	41	43	1	52	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 6	2012	7	4							e34499	10.1371/journal.pone.0034499	http://dx.doi.org/10.1371/journal.pone.0034499			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	955JA	22493695	gold, Green Submitted, Green Published			2022-12-25	WOS:000305012700037
J	Jenq, RR; Curran, MA; Goldberg, GL; Liu, C; Allison, JP; van den Brink, MRM				Jenq, Robert R.; Curran, Michael A.; Goldberg, Gabrielle L.; Liu, Chen; Allison, James P.; van den Brink, Marcel R. M.			Repertoire Enhancement with Adoptively Transferred Female Lymphocytes Controls the Growth of Pre-Implanted Murine Prostate Cancer	PLOS ONE			English	Article							VERSUS-HOST-DISEASE; BONE-MARROW-TRANSPLANTATION; ANDROGEN-REGULATED GENES; TRAMP MODEL; DONOR AGE; ANTIGEN; CELLS; EXPRESSION; BLOCKADE; RISK	Background: In prostate cancer, genes encoding androgen-regulated, Y-chromosome-encoded, and tissue-specific antigens may all be overexpressed. In the adult male host, however, most high affinity T cells targeting these potential tumor rejection antigens will be removed during negative selection. In contrast, the female mature T-cell repertoire should contain abundant precursors capable of recognizing these classes of prostate cancer antigens and mediating effective anti-tumor immune responses. Methodology/Principal Findings: We find that syngeneic TRAMP-C2 prostatic adenocarcinoma cells are spontaneously rejected in female hosts. Adoptive transfer of naive female lymphocytes to irradiated male hosts bearing pre-implanted TRAMP-C2 tumor cells slows tumor growth and mediates tumor rejection in some animals. The success of this adoptive transfer was dependent on the transfer of female CD4 T cells and independent of the presence of CD25-expressing regulatory T cells in the transferred lymphocytes. We identify in female CD4 T cells stimulated with TRAMP-C2 a dominant MHC II-restricted response to the Y-chromosome antigen DBY. Furthermore, CD8 T cell responses in female lymphocytes to the immunodominant MHC I-restricted antigen SPAS-1 are markedly increased compared to male mice. Finally, we find no exacerbation of graft-versus-host disease in either syngeneic or minor-antigen mismatched allogeneic lymphocyte adoptive transfer models by using female into male versus male into male cells. Conclusions/Significance: This study shows that adoptively transferred female lymphocytes, particularly CD4 T cells, can control the outgrowth of pre-implanted prostatic adenocarcinoma cells. This approach does not significantly worsen graft-versus-host responses suggesting it may be viable in the clinic. Further, enhancing the available immune repertoire with female-derived T cells may provide an excellent pool of prostate cancer reactive T cells for further augmentation by combination with either vaccination or immune regulatory blockade strategies.	[Jenq, Robert R.; Goldberg, Gabrielle L.; van den Brink, Marcel R. M.] Mem Sloan Kettering Canc Ctr, Dept Immunol & Med, New York, NY 10021 USA; [Jenq, Robert R.] Weill Cornell Med Coll, New York, NY USA; [Curran, Michael A.; Allison, James P.] Mem Sloan Kettering Canc Ctr, Dept Immunol, Howard Hughes Med Inst, New York, NY 10021 USA; [Liu, Chen] Univ Florida, Coll Med, Dept Pathol Immunol & Lab Med, Gainesville, FL USA	Memorial Sloan Kettering Cancer Center; Cornell University; Howard Hughes Medical Institute; Memorial Sloan Kettering Cancer Center; State University System of Florida; University of Florida	Jenq, RR (corresponding author), Mem Sloan Kettering Canc Ctr, Dept Immunol & Med, 1275 York Ave, New York, NY 10021 USA.	vandenbm@mskcc.org	van den Brink, Marcel R. M./HGB-9434-2022	Allison, James/0000-0001-8980-5697; Jenq, Robert/0000-0002-5434-439X; Curran, Michael/0000-0003-4996-7207	National Institutes of Health [R01-HL069929, R01-CA107096, R01-AI080455]; United States Department of Defense: USAMRAA [W81XWH-09-1-0294]; Radiation Effects Research Foundation (RERF-NIAID); Experimental Therapeutics Center of Memorial Sloan-Kettering Cancer Center; Lymphoma Foundation; Alex's Lemonade Stand; Geoffrey Beene Cancer Research Center at Memorial Sloan-Kettering Cancer Center; Peter Solomon Fund, Research and Therapeutics Program in Prostate Cancer; NATIONAL CANCER INSTITUTE [P30CA008748, R01CA107096] Funding Source: NIH RePORTER; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL069929] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI080455] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); United States Department of Defense: USAMRAA; Radiation Effects Research Foundation (RERF-NIAID); Experimental Therapeutics Center of Memorial Sloan-Kettering Cancer Center; Lymphoma Foundation; Alex's Lemonade Stand; Geoffrey Beene Cancer Research Center at Memorial Sloan-Kettering Cancer Center; Peter Solomon Fund, Research and Therapeutics Program in Prostate Cancer; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	This research was supported by National Institutes of Health award numbers R01-HL069929 (MvdB), R01-CA107096 (MvdB), R01-AI080455 (MvdB). The content is solely the responsibility of the authors and does not necessarily represent the official views of the National Institutes of Health. Support was also received from the United States Department of Defense: USAMRAA Award W81XWH-09-1-0294 (MvdB), the Radiation Effects Research Foundation (RERF-NIAID) (MvdB), The Experimental Therapeutics Center of Memorial Sloan-Kettering Cancer Center funded by Mr. William H. Goodwin and Mrs. Alice Goodwin, The Lymphoma Foundation, Alex's Lemonade Stand, The Geoffrey Beene Cancer Research Center at Memorial Sloan-Kettering Cancer Center, The Peter Solomon Fund, Research and Therapeutics Program in Prostate Cancer. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ATKINSON K, 1986, BRIT J HAEMATOL, V63, P231; Barrett AJ, 2008, BRIT J HAEMATOL, V142, P877, DOI 10.1111/j.1365-2141.2008.07260.x; Chen H, 2009, P NATL ACAD SCI USA, V106, P2729, DOI 10.1073/pnas.0813175106; Cooke KR, 1996, BLOOD, V88, P3230, DOI 10.1182/blood.V88.8.3230.bloodjournal8883230; Curran MA, 2010, P NATL ACAD SCI USA, V107, P4275, DOI 10.1073/pnas.0915174107; Curran MA, 2009, CANCER RES, V69, P7747, DOI 10.1158/0008-5472.CAN-08-3289; Dasari VK, 2001, J UROLOGY, V165, P1335, DOI 10.1016/S0022-5347(01)69895-1; Fasso M, 2008, P NATL ACAD SCI USA, V105, P3509, DOI 10.1073/pnas.0712269105; FLOWERS MED, 1990, BRIT J HAEMATOL, V74, P492, DOI 10.1111/j.1365-2141.1990.tb06340.x; Fong L, 2009, CANCER RES, V69, P609, DOI 10.1158/0008-5472.CAN-08-3529; Foster BA, 1997, CANCER RES, V57, P3325; Garcia-Hernandez MDL, 2007, CANCER RES, V67, P1344, DOI 10.1158/0008-5472.CAN-06-2996; Gingrich JR, 1997, CANCER RES, V57, P4687; Gregory CW, 1998, CANCER RES, V58, P5718; Hill GR, 1997, BLOOD, V90, P3204, DOI 10.1182/blood.V90.8.3204; Hodi FS, 2010, NEW ENGL J MED, V363, P711, DOI 10.1056/NEJMoa1003466; Hurwitz Arthur A, 2001, Curr Protoc Immunol, VChapter 20, DOI 10.1002/0471142735.im2005s45; Jenq RR, 2009, BLOOD, V113, P1574, DOI 10.1182/blood-2008-05-155697; Kantoff PW, 2010, NEW ENGL J MED, V363, P411, DOI 10.1056/NEJMoa1001294; Kolb HJ, 2008, BLOOD, V112, P4371, DOI 10.1182/blood-2008-03-077974; Kollman C, 2001, BLOOD, V98, P2043, DOI 10.1182/blood.V98.7.2043; Kumar A, 2011, P NATL ACAD SCI USA, V108, P17087, DOI 10.1073/pnas.1108745108; Mapara MY, 2002, BLOOD, V100, P1903, DOI 10.1182/blood-2002-01-0023; Na IK, 2010, J CLIN INVEST, V120, P343, DOI 10.1172/JCI39395; Peggs KS, 2008, IMMUNOL REV, V224, P141, DOI 10.1111/j.1600-065X.2008.00649.x; Perez-Diez A, 2007, BLOOD, V109, P5346, DOI 10.1182/blood-2006-10-051318; SYKES M, 1988, BONE MARROW TRANSPL, V3, P379; Turcotte Simon, 2011, Adv Surg, V45, P341; Xu LL, 2001, INT J CANCER, V92, P322, DOI 10.1002/ijc.1196; Yanagisawa S, 1997, INT IMMUNOL, V9, P227, DOI 10.1093/intimm/9.2.227; Yi HF, 2011, CANCER IMMUNOL IMMUN, V60, P349, DOI 10.1007/s00262-010-0939-5	31	5	5	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 6	2012	7	4							e35222	10.1371/journal.pone.0035222	http://dx.doi.org/10.1371/journal.pone.0035222			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	955JA	22493742	Green Submitted, Green Published, gold			2022-12-25	WOS:000305012700084
J	Kipfer, T; Wohlgemuth, T; van der Heijden, MGA; Ghazoul, J; Egli, S				Kipfer, Tabea; Wohlgemuth, Thomas; van der Heijden, Marcel G. A.; Ghazoul, Jaboury; Egli, Simon			Growth Response of Drought-Stressed Pinus sylvestris Seedlings to Single- and Multi-Species Inoculation with Ectomycorrhizal Fungi	PLOS ONE			English	Article							MYCORRHIZAL ASSOCIATIONS; ECOSYSTEM FUNCTION; ENZYME-ACTIVITIES; DIVERSITY; PRODUCTIVITY; BIODIVERSITY; PLANTS; RESISTANCE; SECRETION; NUTRITION	Many trees species form symbiotic associations with ectomycorrhizal (ECM) fungi, which improve nutrient and water acquisition of their host. Until now it is unclear whether the species richness of ECM fungi is beneficial for tree seedling performance, be it during moist conditions or drought. We performed a pot experiment using Pinus sylvestris seedlings inoculated with four selected ECM fungi (Cenococcum geophilum, Paxillus involutus, Rhizopogon roseolus and Suillus granulatus) to investigate (i) whether these four ECM fungi, in monoculture or in species mixtures, affect growth of P. sylvestris seedlings, and (ii) whether this effect can be attributed to species number per se or to species identity. Two different watering regimes (moist vs. dry) were applied to examine the context-dependency of the results. Additionally, we assessed the activity of eight extracellular enzymes in the root tips. Shoot growth was enhanced in the presence of S. granulatus, but not by any other ECM fungal species. The positive effect of S. granulatus on shoot growth was more pronounced under moist (threefold increase) than under dry conditions (twofold increase), indicating that the investigated ECM fungi did not provide additional support during drought stress. The activity of secreted extracellular enzymes was higher in S. granulatus than in any other species. In conclusion, our findings suggest that ECM fungal species composition may affect seedling performance in terms of aboveground biomass.	[Kipfer, Tabea; Wohlgemuth, Thomas; Egli, Simon] Swiss Fed Res Inst WSL, Birmensdorf, Switzerland; [Kipfer, Tabea; Ghazoul, Jaboury] ETH, Inst Terr Ecosyst, Zurich, Switzerland; [van der Heijden, Marcel G. A.] Agroscope Reckenholz Tanikon, Ecol Farming Syst, Zurich, Switzerland; [van der Heijden, Marcel G. A.] Univ Zurich, Inst Evolutionary Biol & Environm Studies, Zurich, Switzerland; [van der Heijden, Marcel G. A.] Univ Utrecht, Fac Sci, Inst Environm Biol, Utrecht, Netherlands	Swiss Federal Institutes of Technology Domain; Swiss Federal Institute for Forest, Snow & Landscape Research; Swiss Federal Institutes of Technology Domain; ETH Zurich; Swiss Federal Research Station Agroscope; University of Zurich; Utrecht University	Kipfer, T (corresponding author), Swiss Fed Res Inst WSL, Birmensdorf, Switzerland.	tabea.kipfer@alumni.ethz.ch	van der Heijden, Marcel/AAY-1593-2021; Wohlgemuth, Thomas/E-6588-2016; van der Heijden, Marcel G.A./H-5243-2011; Ghazoul, Jaboury/B-2121-2018	Wohlgemuth, Thomas/0000-0002-4623-0894; van der Heijden, Marcel/0000-0001-7040-1924	Swiss National Foundation [31003A_118002]	Swiss National Foundation(Swiss National Science Foundation (SNSF))	This study was supported by the Swiss National Foundation grant no. 31003A_118002. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ABUZINADAH RA, 1989, NEW PHYTOL, V112, P55, DOI 10.1111/j.1469-8137.1989.tb00308.x; Agerer R, 2001, MYCORRHIZA, V11, P107, DOI 10.1007/s005720100108; Baxter JW, 2001, NEW PHYTOL, V152, P139, DOI 10.1046/j.0028-646x.2001.00245.x; Brundrett MC, 2009, PLANT SOIL, V320, P37, DOI 10.1007/s11104-008-9877-9; Cairney JWG, 2007, CAN J FOREST RES, V37, P207, DOI 10.1139/X06-190; Chambers SM, 1999, ECTOMYCORRHIZAL FUNGI: KEY GENERA IN PROFILE, P1; Colpaert JV, 1999, NEW PHYTOL, V143, P589, DOI 10.1046/j.1469-8137.1999.00471.x; Courty PE, 2011, J EXP BOT, V62, P249, DOI 10.1093/jxb/erq274; Courty PE, 2005, NEW PHYTOL, V167, P309, DOI 10.1111/j.1469-8137.2005.01401.x; Courty PE, 2007, SOIL BIOL BIOCHEM, V39, P1655, DOI 10.1016/j.soilbio.2007.01.017; Crawley M. J., 2008, R BOOK; Cullings K, 2008, OECOLOGIA, V158, P77, DOI 10.1007/s00442-008-1119-6; DOSSKEY MG, 1991, NEW PHYTOL, V117, P327, DOI 10.1111/j.1469-8137.1991.tb04914.x; Dunabeitia MK, 2004, MYCORRHIZA, V14, P11, DOI 10.1007/s00572-003-0270-5; Erland S, 2002, ECOL STU AN, V157, P163; Fransson PMA, 2001, NEW PHYTOL, V152, P431, DOI 10.1046/j.0028-646X.2001.00276.x; Garbaye J, 2000, OUTLOOK AGR, V29, P63, DOI 10.5367/000000000101293068; Hector A, 1999, SCIENCE, V286, P1123, DOI 10.1126/science.286.5442.1123; Hector A, 1998, OIKOS, V82, P597, DOI 10.2307/3546380; Hooper DU, 2005, ECOL MONOGR, V75, P3, DOI 10.1890/04-0922; Huston MA, 1997, OECOLOGIA, V110, P449, DOI 10.1007/s004420050180; Johnson NC, 1997, NEW PHYTOL, V135, P575, DOI 10.1046/j.1469-8137.1997.00729.x; Jones MD, 2004, CAN J BOT, V82, P1089, DOI [10.1139/B04-110, 10.1139/b04-110]; Jones MD, 2009, FUNGAL ECOL, V2, P110, DOI [10.1016/j.funeco.2009.02.002, 10.1016/j.funeco.2008.09.003]; Jonsson LM, 2001, OIKOS, V93, P353, DOI 10.1034/j.1600-0706.2001.930301.x; Kennedy PG, 2007, PLANT SOIL, V291, P155, DOI 10.1007/s11104-006-9183-3; Kipfer T, 2011, OECOLOGIA, V167, P219, DOI 10.1007/s00442-011-1981-5; Koide RT, 2000, NEW PHYTOL, V147, P233, DOI 10.1046/j.1469-8137.2000.00710.x; LAMHAMEDI MS, 1992, TREE PHYSIOL, V10, P231, DOI 10.1093/treephys/10.3.231; Lehto T, 2011, MYCORRHIZA, V21, P71, DOI 10.1007/s00572-010-0348-9; Maherali H, 2007, SCIENCE, V316, P1746, DOI 10.1126/science.1143082; MARX DH, 1969, PHYTOPATHOLOGY, V59, P153; Molina R., 1992, Mycorrhizal functioning: an integrative plant-fungal process., P357; Morte A, 2001, BIOL PLANTARUM, V44, P263, DOI 10.1023/A:1010207610974; Moser B, 2010, EUR J FOREST RES, V129, P625, DOI 10.1007/s10342-010-0363-6; PARKE JL, 1983, NEW PHYTOL, V95, P83, DOI 10.1111/j.1469-8137.1983.tb03471.x; Parrent JL, 2006, ECOLOGY, V87, P2278, DOI 10.1890/0012-9658(2006)87[2278:CANAAE]2.0.CO;2; Peter M, 2001, NEW PHYTOL, V149, P311, DOI 10.1046/j.1469-8137.2001.00030.x; PIGOTT CD, 1982, NEW PHYTOL, V92, P513, DOI 10.1111/j.1469-8137.1982.tb03409.x; Pritsch K, 2011, ANN FOREST SCI, V68, P25, DOI 10.1007/s13595-010-0004-8; Simard SW, 1997, NATURE, V388, P579, DOI 10.1038/41557; Smith S.E., 2008, MYCORRHIZAL SYMBIOSI, V3rd ed; Tilman D, 2001, SCIENCE, V294, P843, DOI 10.1126/science.1060391; Trappe JM., 1962, THESIS U WASHINGTON; van der Heijden MGA, 1998, NATURE, V396, P69, DOI 10.1038/23932; Vogelsang KM, 2006, NEW PHYTOL, V172, P554, DOI 10.1111/j.1469-8137.2006.01854.x; Wagg C, 2011, ECOL LETT, V14, P1001, DOI 10.1111/j.1461-0248.2011.01666.x; Wardle DA, 1999, OIKOS, V87, P403, DOI 10.2307/3546757; Zhang BC, 2016, J BASIC MICROB, V56, P670, DOI 10.1002/jobm.201500751	49	46	52	6	100	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 5	2012	7	4							e35275	10.1371/journal.pone.0035275	http://dx.doi.org/10.1371/journal.pone.0035275			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	955IH	22496914	Green Published, Green Accepted, Green Submitted, gold			2022-12-25	WOS:000305010500036
J	Burchell, L; Chaugule, VK; Walden, H				Burchell, Lynn; Chaugule, Viduth K.; Walden, Helen			Small, N-Terminal Tags Activate Parkin E3 Ubiquitin Ligase Activity by Disrupting Its Autoinhibited Conformation	PLOS ONE			English	Article							RECESSIVE JUVENILE PARKINSONISM; PROTEIN LIGASE; PATHOGENIC MUTATIONS; DISEASE; MITOPHAGY; PINK1; GENE; PHOSPHORYLATION; MITOCHONDRIA; CELLS	Parkin is an E3 ubiquitin ligase, mutations in which cause Autosomal Recessive Parkinson's Disease. Many studies aimed at understanding Parkin function, regulation and dysfunction are performed using N-terminal epitope tags. We report here that the use of small tags such as FLAG, cMyc and HA, influence the physical stability and activity of Parkin in and out of cells, perturbing the autoinhibited native state of Parkin, resulting in an active-for-autoubiquitination species.	[Burchell, Lynn; Chaugule, Viduth K.; Walden, Helen] London Res Inst Canc Res UK, Lincolns Inn Fields Labs, Prot Struct & Funct Lab, London, England	University of London; Institute of Cancer Research - UK	Burchell, L (corresponding author), London Res Inst Canc Res UK, Lincolns Inn Fields Labs, Prot Struct & Funct Lab, London, England.	Helen.walden@cancer.org.uk	Chaugule, Viduth K./AAG-2753-2019	Chaugule, Viduth K./0000-0001-7814-5865	Cancer Research UK	Cancer Research UK(Cancer Research UK)	This work was funded by Cancer Research UK. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Biasini E, 2004, J NEUROCHEM, V88, P545, DOI 10.1046/j.1471-4159.2003.02152.x; Bonifati Vincenzo, 2012, Parkinsonism Relat Disord, V18 Suppl 1, pS4, DOI 10.1016/S1353-8020(11)70004-9; Chaugule VK, 2011, EMBO J, V30, P2853, DOI 10.1038/emboj.2011.204; Chew KCM, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0019720; Cooper HJ, 2004, ANAL CHEM, V76, P6982, DOI 10.1021/ac0401063; Corti O, 2007, DRUG DISCOV TODAY, V4, P121; Dawson TM, 2010, MOVEMENT DISORD, V25, pS32, DOI 10.1002/mds.22798; Durcan TM, 2012, J BIOL CHEM, V287, P531, DOI 10.1074/jbc.M111.288449; Durcan TM, 2011, HUM MOL GENET, V20, P141, DOI 10.1093/hmg/ddq452; Finney N, 2003, J BIOL CHEM, V278, P16054, DOI 10.1074/jbc.C300051200; Gegg ME, 2010, HUM MOL GENET, V19, P4861, DOI 10.1093/hmg/ddq419; Geisler S, 2010, NAT CELL BIOL, V12, P119, DOI 10.1038/ncb2012; Hardy J, 2010, NEURON, V68, P201, DOI 10.1016/j.neuron.2010.10.014; Henn IH, 2005, J NEUROCHEM, V92, P114, DOI 10.1111/j.1471-4159.2004.02854.x; Imai Y, 2000, J BIOL CHEM, V275, P35661, DOI 10.1074/jbc.C000447200; Imai Y, 2011, CURR OPIN NEUROBIOL, V21, P935, DOI 10.1016/j.conb.2011.10.016; Joch M, 2007, MOL BIOL CELL, V18, P3105, DOI 10.1091/mbc.E05-11-1027; Kitada T, 1998, NATURE, V392, P605, DOI 10.1038/33416; Ko HS, 2010, P NATL ACAD SCI USA, V107, P16691, DOI 10.1073/pnas.1006083107; LaVoie MJ, 2005, NAT MED, V11, P1214, DOI 10.1038/nm1314; Lucking CB, 1998, LANCET, V352, P1355, DOI 10.1016/S0140-6736(05)60746-5; Martin I, 2011, ANNU REV GENOM HUM G, V12, P301, DOI 10.1146/annurev-genom-082410-101440; Matsuda N, 2006, J BIOL CHEM, V281, P3204, DOI 10.1074/jbc.M510393200; Matsuda N, 2010, J CELL BIOL, V189, P211, DOI 10.1083/jcb.200910140; Rakovic A, 2010, HUM MOL GENET, V19, P3124, DOI 10.1093/hmg/ddq215; Rankin Carolyn A, 2011, Open Biochem J, V5, P9, DOI 10.2174/1874091X01105010009; Ren Y, 2011, HUM MOL GENET, V20, P1074, DOI 10.1093/hmg/ddq550; de la Torre ER, 2011, CURR MED CHEM, V18, P2477, DOI 10.2174/092986711795843254; Schlossmacher MG, 2002, AM J PATHOL, V160, P1655, DOI 10.1016/S0002-9440(10)61113-3; Sha D, 2010, HUM MOL GENET, V19, P352, DOI 10.1093/hmg/ddp501; Shimura H, 2000, NAT GENET, V25, P302, DOI 10.1038/77060; Shin JH, 2011, CELL, V144, P689, DOI 10.1016/j.cell.2011.02.010; Van Humbeeck C, 2008, EUR J NEUROSCI, V27, P284, DOI 10.1111/j.1460-9568.2007.06000.x; Vives-Bauza C, 2010, P NATL ACAD SCI USA, V107, P378, DOI 10.1073/pnas.0911187107; Wenzel DM, 2011, NATURE, V474, P105, DOI 10.1038/nature09966; West AB, 2003, NEUROSCI LETT, V341, P139, DOI 10.1016/S0304-3940(03)00188-5; Yao DD, 2004, P NATL ACAD SCI USA, V101, P10810, DOI 10.1073/pnas.0404161101; Youle RJ, 2011, NAT REV MOL CELL BIO, V12, P9, DOI 10.1038/nrm3028; Zhang Y, 2000, P NATL ACAD SCI USA, V97, P13354, DOI 10.1073/pnas.240347797	39	26	26	2	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 4	2012	7	4							e34748	10.1371/journal.pone.0034748	http://dx.doi.org/10.1371/journal.pone.0034748			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	953GO	22496854	Green Submitted, Green Published, gold			2022-12-25	WOS:000304855200075
J	Munemasa, Y; Chang, CS; Kwong, JMK; Kyung, H; Kitaoka, Y; Caprioli, J; Piri, N				Munemasa, Yasunari; Chang, Chang-Sheng; Kwong, Jacky M. K.; Kyung, Haksu; Kitaoka, Yasushi; Caprioli, Joseph; Piri, Natik			The Neuronal EGF-Related Gene Nell2 Interacts with Macf1 and Supports Survival of Retinal Ganglion Cells after Optic Nerve Injury	PLOS ONE			English	Article							IN-VIVO ELECTROPORATION; LONG-TERM POTENTIATION; GROWTH-FACTOR; PROTEIN; PROTECTION; MORPHOLOGY; GLAUCOMA; NUCLEUS; ACTIN; TRANSECTION	Nell2 is a neuron-specific protein containing six epidermal growth factor-like domains. We have identified Nell2 as a retinal ganglion cell (RGC)-expressed gene by comparing mRNA profiles of control and RGC-deficient rat retinas. The aim of this study was to analyze Nell2 expression in wild-type and optic nerve axotomized retinas and evaluate its potential role in RGCs. Nell2-positive in situ and immunohistochemical signals were localized to irregularly shaped cells in the ganglion cell layer (GCL) and colocalized with retrogradely-labeled RGCs. No Nell2-positive cells were detected in 2 weeks optic nerve transected (ONT) retinas characterized with approximately 90% RGC loss. RT-PCR analysis showed a dramatic decrease in the Nell2 mRNA level after ONT compared to the controls. Immunoblot analysis of the Nell2 expression in the retina revealed the presence of two proteins with approximate MW of 140 and 90 kDa representing glycosylated and non-glycosylated Nell2, respectively. Both products were almost undetectable in retinal protein extracts two weeks after ONT. Proteome analysis of Nell2-interacting proteins carried out with MALDI-TOF MS (MS) identified microtubule-actin crosslinking factor 1 (Macf1), known to be critical in CNS development. Strong Macf1 expression was observed in the inner plexiform layer and GCL where it was colocalizied with Thy-1 staining. Since Nell2 has been reported to increase neuronal survival of the hippocampus and cerebral cortex, we evaluated the effect of Nell2 overexpression on RGC survival. RGCs in the nasal retina were consistently more efficiently transfected than in other areas (49% vs. 13%; n = 5, p<0.05). In non-transfected or pEGFP-transfected ONT retinas, the loss of RGCs was approximately 90% compared to the untreated control. In the nasal region, Nell2 transfection led to the preservation of approximately 58% more cells damaged by axotomy compared to non-transfected (n = 5, p<0.01) or pEGFP-transfected controls (n = 5, p<0.01).	[Munemasa, Yasunari; Chang, Chang-Sheng; Kwong, Jacky M. K.; Kyung, Haksu; Caprioli, Joseph; Piri, Natik] Univ Calif Los Angeles, Jules Stein Eye Inst, Los Angeles, CA 90024 USA; [Caprioli, Joseph; Piri, Natik] Univ Calif Los Angeles, Brain Res Inst, Los Angeles, CA 90024 USA; [Munemasa, Yasunari; Kitaoka, Yasushi] St Marianna Univ, Sch Med, Dept Ophthalmol, Kawasaki, Kanagawa, Japan	University of California System; University of California Los Angeles; University of California System; University of California Los Angeles; Saint Marianna University	Munemasa, Y (corresponding author), Univ Calif Los Angeles, Jules Stein Eye Inst, Los Angeles, CA 90024 USA.	piri@jsei.ucla.edu		Caprioli, Joseph/0000-0002-2383-7263	National Institutes of Health (NIH) [EY018644]; NATIONAL EYE INSTITUTE [R01EY018644] Funding Source: NIH RePORTER	National Institutes of Health (NIH)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL EYE INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI))	This work was supported by the National Institutes of Health (NIH; http://www.nih.gov/) Grant EY018644 (NP). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aihara K, 2003, MOL BRAIN RES, V116, P86, DOI 10.1016/S0169-328X(03)00256-0; Chen HJ, 2006, GENE DEV, V20, P1933, DOI 10.1101/gad.1411206; Choi EJ, 2010, J BIOL CHEM, V285, P25074, DOI 10.1074/jbc.M110.100545; DACEY DM, 1992, P NATL ACAD SCI USA, V89, P9666, DOI 10.1073/pnas.89.20.9666; Dacey DM, 1999, PROG RETIN EYE RES, V18, P737, DOI 10.1016/S1350-9462(98)00013-5; DACEY DM, 1993, J NEUROSCI, V13, P5334, DOI 10.1523/JNEUROSCI.13-12-05334.1993; DAVIS C G, 1990, New Biologist, V2, P410; Dezawa M, 2002, MICRON, V33, P1, DOI 10.1016/S0968-4328(01)00002-6; GLOVINSKY Y, 1991, INVEST OPHTH VIS SCI, V32, P484; Goryunov D, 2010, MOL CELL NEUROSCI, V44, P1, DOI 10.1016/j.mcn.2010.01.010; Haefliger IO, 1999, SURV OPHTHALMOL, V43, pS51, DOI 10.1016/S0039-6257(99)00026-0; Hwang EM, 2007, BIOCHEM BIOPH RES CO, V353, P805, DOI 10.1016/j.bbrc.2006.12.115; Ishii Y, 2003, INVEST OPHTH VIS SCI, V44, P1982, DOI 10.1167/iovs.02-0912; Ishikawa H, 2005, GENE THER, V12, P289, DOI 10.1038/sj.gt.3302277; Jeong JK, 2008, J NEUROCHEM, V106, P1604, DOI 10.1111/j.1471-4159.2008.05505.x; Jiang YL, 2009, MOL CELL NEUROSCI, V41, P113, DOI 10.1016/j.mcn.2009.02.006; Kielczewski JL, 2005, INVEST OPHTH VIS SCI, V46, P3188, DOI 10.1167/iovs.05-0321; Kim H, 2002, J NEUROCHEM, V83, P1389, DOI 10.1046/j.1471-4159.2002.01245.x; KIMURA H, 1993, P NATL ACAD SCI USA, V90, P2165, DOI 10.1073/pnas.90.6.2165; Kuroda S, 1999, BIOCHEM BIOPH RES CO, V265, P79, DOI 10.1006/bbrc.1999.1638; Leung CL, 1999, J CELL BIOL, V147, P1275, DOI 10.1083/jcb.147.6.1275; Martin KRG, 2003, INVEST OPHTH VIS SCI, V44, P4357, DOI 10.1167/iovs.02-1332; MATSUHASHI S, 1995, DEV DYNAM, V203, P212, DOI 10.1002/aja.1002030209; Matsuyama S, 2004, NEUROREPORT, V15, P417, DOI 10.1097/00001756-200403010-00007; Mo XF, 2002, INVEST OPHTH VIS SCI, V43, P2401; Munemasa Y, 2009, GENE THER, V16, P17, DOI 10.1038/gt.2008.126; Munemasa Y, 2008, INVEST OPHTH VIS SCI, V49, P3535, DOI 10.1167/iovs.08-1716; Munemasa Y, 2009, INVEST OPHTH VIS SCI, V50, P3869, DOI 10.1167/iovs.08-3138; Nelson BR, 2004, DEV BIOL, V270, P322, DOI 10.1016/j.ydbio.2004.03.004; Oyasu M, 2000, MOL BRAIN RES, V76, P151, DOI 10.1016/S0169-328X(99)00342-3; Paquet-Durand F, 2007, J NEUROSCI RES, V85, P693, DOI 10.1002/jnr.21151; Piri N, 2006, MOL VIS, V12, P1660; QUIGLEY HA, 1988, OPHTHALMOLOGY, V95, P357; RODIECK RW, 1993, J COMP NEUROL, V338, P289, DOI 10.1002/cne.903380211; Rosenblum K, 2002, J NEUROSCI, V22, P5432; SCHILLER PH, 1978, J NEUROPHYSIOL, V41, P788, DOI 10.1152/jn.1978.41.3.788; Schori H, 2001, P NATL ACAD SCI USA, V98, P3398, DOI 10.1073/pnas.041609498; SOMMER A, 1991, ARCH OPHTHALMOL-CHIC, V109, P77, DOI 10.1001/archopht.1991.01080010079037; Sonnenberg A, 2007, EXP CELL RES, V313, P2189, DOI 10.1016/j.yexcr.2007.03.039; Spencer AG, 1998, J BIOL CHEM, V273, P9886, DOI 10.1074/jbc.273.16.9886; Tahzib NG, 2004, BRAIN RES BULL, V62, P491, DOI 10.1016/S0361-9230(03)00083-2; Vereker E, 2000, J NEUROSCI, V20, P6811, DOI 10.1523/JNEUROSCI.20-18-06811.2000; Wang X, 2005, J NEUROSCI RES, V82, P674, DOI 10.1002/jnr.20679; Watanabe TK, 1996, GENOMICS, V38, P273, DOI 10.1006/geno.1996.0628; Yamada ES, 2001, VISION RES, V41, P119, DOI 10.1016/S0042-6989(00)00244-3	45	20	22	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 4	2012	7	4							e34810	10.1371/journal.pone.0034810	http://dx.doi.org/10.1371/journal.pone.0034810			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	953GO	22496866	Green Published, gold, Green Submitted			2022-12-25	WOS:000304855200082
J	Sharma, VK; Kumar, N; Prakash, T; Taylor, TD				Sharma, Vineet K.; Kumar, Naveen; Prakash, Tulika; Taylor, Todd D.			Fast and Accurate Taxonomic Assignments of Metagenomic Sequences Using MetaBin	PLOS ONE			English	Article							PHYLOGENETIC CLASSIFICATION; GENOME; GUT; FRAGMENTS	Taxonomic assignment of sequence reads is a challenging task in metagenomic data analysis, for which the present methods mainly use either composition- or homology-based approaches. Though the homology-based methods are more sensitive and accurate, they suffer primarily due to the time needed to generate the Blast alignments. We developed the MetaBin program and web server for better homology-based taxonomic assignments using an ORF-based approach. By implementing Blat as the faster alignment method in place of Blastx, the analysis time has been reduced by severalfold. It is benchmarked using both simulated and real metagenomic datasets, and can be used for both single and paired-end sequence reads of varying lengths (>= 45 bp). To our knowledge, MetaBin is the only available program that can be used for the taxonomic binning of short reads (<100 bp) with high accuracy and high sensitivity using a homology-based approach. The MetaBin web server can be used to carry out the taxonomic analysis, by either submitting reads or Blastx output. It provides several options including construction of taxonomic trees, creation of a composition chart, functional analysis using COGs, and comparative analysis of multiple metagenomic datasets. MetaBin web server and a standalone version for high-throughput analysis are available freely at http://metabin.riken.jp/.	[Sharma, Vineet K.; Kumar, Naveen; Prakash, Tulika; Taylor, Todd D.] RIKEN, Lab MetaSyst Res, Quantitat Biol Ctr, Yokohama, Kanagawa, Japan; [Sharma, Vineet K.] Indian Inst Sci Educ & Res, Dept Biol Sci, Bhopal, Madhya Pradesh, India	RIKEN; Indian Institute of Science Education & Research (IISER) - Bhopal	Sharma, VK (corresponding author), RIKEN, Lab MetaSyst Res, Quantitat Biol Ctr, Yokohama, Kanagawa, Japan.	taylor@riken.jp	Taylor, Todd/A-7121-2009	Taylor, Todd/0000-0003-4247-6253; Kumar, Naveen/0000-0001-7364-6601; K. Sharma, Vineet/0000-0002-2958-6215	RIKEN	RIKEN	This work was supported by the operational expenditure fund of RIKEN. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Brady A, 2009, NAT METHODS, V6, P673, DOI [10.1038/NMETH.1358, 10.1038/nmeth.1358]; Diaz NN, 2009, BMC BIOINFORMATICS, V10, DOI 10.1186/1471-2105-10-56; Gerlach W, 2009, BMC BIOINFORMATICS, V10, DOI 10.1186/1471-2105-10-430; Green Tringe Susannah, 2005, Nature Reviews Genetics, V6, P805, DOI 10.1038/nrg1709; Haque MM, 2009, BIOINFORMATICS, V25, P1722, DOI 10.1093/bioinformatics/btp317; Hongoh Y, 2008, SCIENCE, V322, P1108, DOI 10.1126/science.1165578; Hongoh Y, 2008, P NATL ACAD SCI USA, V105, P5555, DOI 10.1073/pnas.0801389105; Huson DH, 2007, GENOME RES, V17, P377, DOI 10.1101/gr.5969107; Kent WJ, 2002, GENOME RES, V12, P656, DOI 10.1101/gr.229202; Kurokawa K, 2007, DNA RES, V14, P169, DOI 10.1093/dnares/dsm018; McHardy AC, 2007, NAT METHODS, V4, P63, DOI 10.1038/NMETH976; Qin JJ, 2010, NATURE, V464, P59, DOI 10.1038/nature08821; Richter DC, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0003373; Rosen GL, 2011, BIOINFORMATICS, V27, P127, DOI 10.1093/bioinformatics/btq619; Sayers EW, 2011, NUCLEIC ACIDS RES, V39, pD38, DOI 10.1093/nar/gkq1172; Sharma VK, 2010, NUCLEIC ACIDS RES, V38, pD468, DOI 10.1093/nar/gkp1001; Teeling H, 2004, BMC BIOINFORMATICS, V5, DOI 10.1186/1471-2105-5-163; Venter JC, 2004, SCIENCE, V304, P66, DOI 10.1126/science.1093857	18	17	17	0	17	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 4	2012	7	4							e34030	10.1371/journal.pone.0034030	http://dx.doi.org/10.1371/journal.pone.0034030			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	953GO	22496776	gold, Green Published, Green Submitted			2022-12-25	WOS:000304855200029
J	Nakao, T; Tsujikawa, M; Notomi, S; Ikeda, Y; Nishida, K				Nakao, Takeshi; Tsujikawa, Motokazu; Notomi, Shoji; Ikeda, Yasuhiro; Nishida, Kohji			The Role of Mislocalized Phototransduction in Photoreceptor Cell Death of Retinitis Pigmentosa	PLOS ONE			English	Article							BARDET-BIEDL-SYNDROME; RETINAL DEGENERATION; ADENYLYL-CYCLASE; BETA-SUBUNIT; GENE; RHODOPSIN; MUTATIONS; PROTEIN; MOUSE; LIGHT	Most of inherited retinal diseases such as retinitis pigmentosa (RP) cause photoreceptor cell death resulting in blindness. RP is a large family of diseases in which the photoreceptor cell death can be caused by a number of pathways. Among them, light exposure has been reported to induce photoreceptor cell death. However, the detailed mechanism by which photoreceptor cell death is caused by light exposure is unclear. In this study, we have shown that even a mild light exposure can induce ectopic phototransduction and result in the acceleration of rod photoreceptor cell death in some vertebrate models. In ovl, a zebrafish model of outer segment deficiency, photoreceptor cell death is associated with light exposure. The ovl larvae show ectopic accumulation of rhodopsin and knockdown of ectopic rhodopsin and transducin rescue rod photoreceptor cell death. However, knockdown of phosphodiesterase, the enzyme that mediates the next step of phototransduction, does not. So, ectopic phototransduction activated by light exposure, which leads to rod photoreceptor cell death, is through the action of transducin. Furthermore, we have demonstrated that forced activation of adenylyl cyclase in the inner segment leads to rod photoreceptor cell death. For further confirmation, we have also generated a transgenic fish which possesses a human rhodopsin mutation, Q344X. This fish and rd10 model mice show photoreceptor cell death caused by adenylyl cyclase. In short, our study indicates that in some RP, adenylyl cyclase is involved in photoreceptor cell death pathway; its inhibition is potentially a logical approach for a novel RP therapy.	[Nakao, Takeshi; Tsujikawa, Motokazu; Nishida, Kohji] Osaka Univ, Dept Ophthalmol, Grad Sch Med, Suita, Osaka, Japan; [Notomi, Shoji; Ikeda, Yasuhiro] Kyushu Univ, Dept Ophthalmol, Grad Sch Med Sci, Fukuoka 812, Japan	Osaka University; Kyushu University	Nakao, T (corresponding author), Osaka Univ, Dept Ophthalmol, Grad Sch Med, Suita, Osaka, Japan.	moto@ophthal.med.osaka-u.ac.jp		Nishida, Kohji/0000-0001-9069-3610	Ministry of Education, Culture, Sports, Science, and Technology	Ministry of Education, Culture, Sports, Science, and Technology(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT))	These studies were supported by Grants-in-Aid from the Ministry of Education, Culture, Sports, Science, and Technology (MT). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alfinito PD, 2002, P NATL ACAD SCI USA, V99, P5655, DOI 10.1073/pnas.072557799; Allagnat F, 2008, J BIOL CHEM, V283, P5226, DOI 10.1074/jbc.M708181200; Azadi S, 2006, MOL CELL NEUROSCI, V31, P759, DOI 10.1016/j.mcn.2006.01.001; Azadi S, 2007, BRAIN RES, V1129, P116, DOI 10.1016/j.brainres.2006.10.031; Barhoum R, 2008, NEUROSCIENCE, V155, P698, DOI 10.1016/j.neuroscience.2008.06.042; Beales PL, 1999, J MED GENET, V36, P437; Berson EL, 1996, P NATL ACAD SCI USA, V93, P4526, DOI 10.1073/pnas.93.10.4526; BERSON EL, 1993, INVEST OPHTH VIS SCI, V34, P1659; Brand M, 1996, DEVELOPMENT, V123, P129; Chang B, 2007, VISION RES, V47, P624, DOI 10.1016/j.visres.2006.11.020; Chang B, 2002, VISION RES, V42, P517, DOI 10.1016/S0042-6989(01)00146-8; Concepcion F, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0010904; Defer N, 2000, AM J PHYSIOL-RENAL, V279, pF400, DOI 10.1152/ajprenal.2000.279.3.F400; Deretic D, 1998, P NATL ACAD SCI USA, V95, P10620, DOI 10.1073/pnas.95.18.10620; Deretic D, 1996, J BIOL CHEM, V271, P2279, DOI 10.1074/jbc.271.4.2279; DEVRIES GW, 1982, J NEUROCHEM, V38, P759; Doerre G, 2002, MECH DEVELOP, V110, P125, DOI 10.1016/S0925-4773(01)00571-8; Fariss RN, 1997, J COMP NEUROL, V387, P148, DOI 10.1002/(SICI)1096-9861(19971013)387:1<148::AID-CNE12>3.0.CO;2-Q; FARRAR GJ, 1991, NATURE, V354, P478, DOI 10.1038/354478a0; FEINSTEIN PG, 1991, P NATL ACAD SCI USA, V88, P10173, DOI 10.1073/pnas.88.22.10173; Gargini C, 2007, J COMP NEUROL, V500, P222, DOI 10.1002/cne.21144; GREEN JS, 1989, NEW ENGL J MED, V321, P1002, DOI 10.1056/NEJM198910123211503; Hamaoka T, 2002, GENESIS, V34, P215, DOI 10.1002/gene.10155; Hao WS, 2002, NAT GENET, V32, P254, DOI 10.1038/ng984; Hartong DT, 2006, LANCET, V368, P1795, DOI 10.1016/S0140-6736(06)69740-7; Hauck SM, 2006, MOL CELL PROTEOMICS, V5, P324, DOI 10.1074/mcp.M500217-MCP200; JACOBSON SG, 1991, AM J OPHTHALMOL, V112, P256, DOI 10.1016/S0002-9394(14)76726-1; Janssen S, 2011, HUM GENET, V129, P79, DOI 10.1007/s00439-010-0902-8; Johnson LE, 2005, CELL TISSUE RES, V320, P213, DOI 10.1007/s00441-004-1046-8; Johnson PT, 2003, INVEST OPHTH VIS SCI, V44, P4481, DOI 10.1167/iovs.03-0436; KIMMEL CB, 1995, DEV DYNAM, V203, P253, DOI 10.1002/aja.1002030302; Kremmer S, 1997, GRAEF ARCH CLIN EXP, V235, P575, DOI 10.1007/BF00947087; Ludwig MG, 2002, J RECEPT SIGNAL TR R, V22, P79, DOI 10.1081/RRS-120014589; Malicki J, 1999, METHODS CELL BIOL, V59, P273; Malicki J, 2002, METHODS, V28, P427, DOI 10.1016/S1046-2023(02)00262-1; MCLAUGHLIN ME, 1993, NAT GENET, V4, P130, DOI 10.1038/ng0693-130; Nir I, 2001, EXP EYE RES, V73, P265, DOI 10.1006/exer.2001.1037; Paquet-Durand F, 2006, J NEUROCHEM, V96, P802, DOI 10.1111/j.1471-4159.2005.03628.x; Pazour GJ, 2000, J CELL BIOL, V151, P709, DOI 10.1083/jcb.151.3.709; Pierce EA, 1999, NAT GENET, V22, P248, DOI 10.1038/10305; Pujic Z, 2001, DEV BIOL, V234, P454, DOI 10.1006/dbio.2001.0251; Ravary A, 2003, J NEUROSCI, V23, P2228; Reme CE, 1998, PROG RETIN EYE RES, V17, P443, DOI 10.1016/S1350-9462(98)00009-3; Rex TS, 2004, MOL THER, V10, P855, DOI 10.1016/j.ymthe.2004.07.027; ROSENFELD PJ, 1992, NAT GENET, V1, P209, DOI 10.1038/ng0692-209; Smith LEH, 2004, J CLIN INVEST, V114, P755, DOI 10.1172/JCI200422930; Sohocki MM, 2001, HUM MUTAT, V17, P42, DOI 10.1002/1098-1004(2001)17:1<42::AID-HUMU5>3.0.CO;2-K; Sun ZX, 2004, DEVELOPMENT, V131, P4085, DOI 10.1242/dev.01240; SUNG CH, 1994, J NEUROSCI, V14, P5818; Tam BM, 2006, J NEUROSCI, V26, P203, DOI 10.1523/JNEUROSCI.3849-05.2006; Tam BM, 2000, J CELL BIOL, V151, P1369, DOI 10.1083/jcb.151.7.1369; Tan E, 2001, INVEST OPHTH VIS SCI, V42, P589; Tsujikawa M, 2004, NEURON, V42, P703, DOI 10.1016/S0896-6273(04)00268-5; Tsujikawa M, 2008, ARCH OPHTHALMOL-CHIC, V126, P337, DOI 10.1001/archopht.126.3.337; Wang M, 1997, VISUAL NEUROSCI, V14, P55, DOI 10.1017/S0952523800008750; WEISS ER, 1995, BIOCHEM BIOPH RES CO, V216, P755, DOI 10.1006/bbrc.1995.2686; Zaghloul NA, 2010, P NATL ACAD SCI USA, V107, P10602, DOI 10.1073/pnas.1000219107; Zhang LZ, 2004, J BIOL CHEM, V279, P20858, DOI 10.1074/jbc.M310643200; Zhang X, 2000, INVEST OPHTH VIS SCI, V41, P998	59	33	34	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 2	2012	7	4							e32472	10.1371/journal.pone.0032472	http://dx.doi.org/10.1371/journal.pone.0032472			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	952GU	22485131	Green Submitted, gold, Green Published			2022-12-25	WOS:000304780500007
J	Yanaba, K; Asano, Y; Tada, Y; Sugaya, M; Kadono, T; Sato, S				Yanaba, Koichi; Asano, Yoshihide; Tada, Yayoi; Sugaya, Makoto; Kadono, Takafumi; Sato, Shinichi			Proteasome Inhibitor Bortezomib Ameliorates Intestinal Injury in Mice	PLOS ONE			English	Article							INFLAMMATORY-BOWEL-DISEASE; ULCERATIVE-COLITIS; MURINE COLITIS; CELL-CYCLE; KAPPA-B; CYCLOSPORINE; APOPTOSIS; 20S	Background: Bortezomib is a proteasome inhibitor that has shown impressive efficacy in the treatment of multiple myeloma. In mice, the addition of dextran sulfate sodium (DSS) to drinking water leads to acute colitis that can serve as an experimental animal model for human ulcerative colitis. Methodology/Principal Findings: Bortezomib treatment was shown to potently inhibit murine DSS-induced colitis. The attenuation of DSS-induced colitis was associated with decreased inflammatory cell infiltration in the colon. Specifically, bortezomib-treated mice showed significantly decreased numbers of CD4(+) and CD8(+) T cells in the colon and mesenteric lymph nodes. Bortezomib treatment significantly diminished interferon (IFN)-gamma expression in the colon and mesenteric lymph nodes. Furthermore, cytoplasmic IFN-gamma production by CD4(+) and CD8(+) T cells in mesenteric lymph nodes was substantially decreased by bortezomib treatment. Notably, bortezomib enhanced T cell apoptosis by inhibiting nuclear factor-kappa B activation during DSS-induced colitis. Conclusions/Significance: Bortezomib treatment is likely to induce T cell death, thereby suppressing DSS-induced colitis by reducing IFN-gamma production.	[Yanaba, Koichi; Asano, Yoshihide; Tada, Yayoi; Sugaya, Makoto; Kadono, Takafumi; Sato, Shinichi] Univ Tokyo, Fac Med, Dept Dermatol, Tokyo 113, Japan	University of Tokyo	Yanaba, K (corresponding author), Univ Tokyo, Fac Med, Dept Dermatol, Tokyo 113, Japan.	yanabak-der@h.u-tokyo.ac.jp	菅谷, 誠/GWC-3786-2022		Research on Intractable Diseases from the Ministry of Health, Labor and Welfare of Japan	Research on Intractable Diseases from the Ministry of Health, Labor and Welfare of Japan	This work was supported by a grant of Research on Intractable Diseases from the Ministry of Health, Labor and Welfare of Japan. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adams J, 2004, NAT REV CANCER, V4, P349, DOI 10.1038/nrc1361; Baumeister W, 1998, CELL, V92, P367, DOI 10.1016/S0092-8674(00)80929-0; Blanco B, 2006, BLOOD, V107, P3575, DOI 10.1182/blood-2005-05-2118; Ciechanover A, 1998, P NATL ACAD SCI USA, V95, P2727, DOI 10.1073/pnas.95.6.2727; COOPER HS, 1993, LAB INVEST, V69, P238; Coux O, 1996, ANNU REV BIOCHEM, V65, P801, DOI 10.1146/annurev.bi.65.070196.004101; Egger B, 2000, DIGESTION, V62, P240, DOI 10.1159/000007822; Elliott PJ, 1999, J ALLERGY CLIN IMMUN, V104, P294, DOI 10.1016/S0091-6749(99)70369-6; Fiocchi C, 1998, GASTROENTEROLOGY, V115, P182, DOI 10.1016/S0016-5085(98)70381-6; Fissolo N, 2008, EUR J IMMUNOL, V38, P2401, DOI 10.1002/eji.200838413; Hibi T, 2006, J GASTROENTEROL, V41, P10, DOI 10.1007/s00535-005-1744-3; King RW, 1996, SCIENCE, V274, P1652, DOI 10.1126/science.274.5293.1652; Luo HY, 2001, TRANSPLANTATION, V72, P196, DOI 10.1097/00007890-200107270-00005; Meijerink J, 2001, J MOL DIAGN, V3, P55, DOI 10.1016/S1525-1578(10)60652-6; Melgar S, 2005, AM J PHYSIOL-GASTR L, V288, pG1328, DOI 10.1152/ajpgi.00467.2004; MURTHY SNS, 1993, DIGEST DIS SCI, V38, P1722, DOI 10.1007/BF01303184; Naujokat C, 2003, BIOCHEM BIOPH RES CO, V310, P347, DOI 10.1016/j.bbrc.2003.08.141; Naujokat C, 2002, LAB INVEST, V82, P965, DOI 10.1097/01.LAB.0000022226.23741.37; Neubert K, 2008, NAT MED, V14, P748, DOI 10.1038/nm1763; Obeng EA, 2006, BLOOD, V107, P4907, DOI 10.1182/blood-2005-08-3531; OKAYASU I, 1990, GASTROENTEROLOGY, V98, P694, DOI 10.1016/0016-5085(90)90290-H; Palombella VJ, 1998, P NATL ACAD SCI USA, V95, P15671, DOI 10.1073/pnas.95.26.15671; Richardson Paul G, 2003, Cancer Control, V10, P361; Sands BE, 2007, J GASTROENTEROL, V42, P16, DOI 10.1007/s00535-006-1995-7; Sato S, 1996, J IMMUNOL, V157, P4371; Schmidt N, 2010, GUT, V59, P896, DOI 10.1136/gut.2009.203554; Sun K, 2004, P NATL ACAD SCI USA, V101, P8120, DOI 10.1073/pnas.0401563101; Vanderlugt CL, 2000, J AUTOIMMUN, V14, P205, DOI 10.1006/jaut.2000.0370; Visekruna A, 2006, J CLIN INVEST, V116, P3195, DOI 10.1172/JCI28804; Visekruna A, 2009, INFLAMM BOWEL DIS, V15, P526, DOI 10.1002/ibd.20805; Wirtz S, 2007, NAT PROTOC, V2, P541, DOI 10.1038/nprot.2007.41; Yanaba K, 2010, J LEUKOCYTE BIOL, V88, P117, DOI 10.1189/jlb.1009666	32	11	11	0	0	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 30	2012	7	3							e34587	10.1371/journal.pone.0034587	http://dx.doi.org/10.1371/journal.pone.0034587			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	959UC	22479648	Green Published, Green Submitted			2022-12-25	WOS:000305339100170
J	Lee, HD; Koo, BH; Kim, YH; Jeon, OH; Kim, DS				Lee, Hee Doo; Koo, Bon-Hun; Kim, Yeon Hyang; Jeon, Ok-Hee; Kim, Doo-Sik			Exosome release of ADAM15 and the functional implications of human macrophage-derived ADAM15 exosomes	FASEB JOURNAL			English	Article						disintegrin; microvesicles; antitumor immunity	HUMAN ALVEOLAR MACROPHAGES; PROTEIN-KINASE-C; MEMBRANE-VESICLES; TUMORICIDAL PROPERTIES; DISINTEGRIN DOMAIN; CELL-PROLIFERATION; RECEPTOR; DIFFERENTIATION; MECHANISM; ACTIVATION	A disintegrin and metalloproteinase 15 (ADAM15), the only ADAM protein containing an Arg-Gly-Asp (RGD) motif in its disintegrin-like domain, is a widely expressed membrane protein that is involved in tumor progression and suppression. However, the underlying mechanism of ADAM15-mediated tumor suppression is not clearly understood. This study demonstrates that ADAM15 is released as an exosomal component, and ADAM15 exosomes exert tumor suppressive activities. We found that exosomal ADAM15 release is stimulated by phorbol 12-myristate 13-acetate, a typical protein kinase C activator, in various tumor cell types, and this results in a corresponding decrease in plasma membrane-associated ADAM15. Exosomes rich in ADAM15 display enhanced binding affinity for integrin alpha v beta 3 in an RGD-dependent manner and suppress vitronectin-and fibronectin-induced cell adhesion, growth, and migration, as well as in vivo tumor growth. Exosomal ADAM15 is released from human macrophages, and macrophage-derived ADAM15 exosomes have tumor inhibitory effects. This work suggests a primary role of ADAM15 for exosome-mediated tumor suppression, as well as functional significance of exosomal ADAM protein in antitumor immunity.-Lee, H. D., Koo, B.-H., Kim, Y. H., Jeon, O.-H., Kim, D.-S. Exosome release of ADAM15 and the functional implications of human macrophage-derived ADAM15 exosomes. FASEB J. 26, 3084-3095 (2012). www.fasebj.org	[Lee, Hee Doo; Koo, Bon-Hun; Kim, Yeon Hyang; Jeon, Ok-Hee; Kim, Doo-Sik] Yonsei Univ, Coll Life Sci & Biotechnol, Dept Biochem, Seoul 120749, South Korea	Yonsei University	Kim, DS (corresponding author), Yonsei Univ, Coll Life Sci & Biotechnol, Dept Biochem, Seoul 120749, South Korea.	dskim@yonsei.ac.kr		Lee, Heedoo/0000-0001-7652-3930	National Research Foundation of Korea; Ministry of Education, Science, and Technology [2009-0081760]	National Research Foundation of Korea(National Research Foundation of Korea); Ministry of Education, Science, and Technology(Ministry of Education, Science & Technology (MEST), Republic of Korea)	This work was supported by the Future-based Technology Development Program through the National Research Foundation of Korea, funded by the Ministry of Education, Science, and Technology (2009-0081760).	Abache T, 2007, J CELL BIOCHEM, V102, P650, DOI 10.1002/jcb.21318; AIHARA H, 1991, P NATL ACAD SCI USA, V88, P11062, DOI 10.1073/pnas.88.24.11062; Anand Paras K, 2010, Commun Integr Biol, V3, P405, DOI 10.4161/cib.3.5.12474; Arribas J, 2002, CHEM REV, V102, P4627, DOI 10.1021/cr010202t; BRAUN DP, 1993, CANCER RES, V53, P3362; Chairoungdua A, 2010, J CELL BIOL, V190, P1079, DOI 10.1083/jcb.201002049; Chen Q, 2008, INT J BIOCHEM CELL B, V40, P2164, DOI 10.1016/j.biocel.2008.02.021; Choi SH, 2006, CANCER RES, V66, P7261, DOI 10.1158/0008-5472.CAN-05-4177; Cocucci E, 2009, TRENDS CELL BIOL, V19, P43, DOI 10.1016/j.tcb.2008.11.003; Daigneault M, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0008668; Gutwein P, 2005, CLIN CANCER RES, V11, P2492, DOI 10.1158/1078-0432.CCR-04-1688; Hawari FI, 2004, P NATL ACAD SCI USA, V101, P1297, DOI 10.1073/pnas.0307981100; Herren B, 2001, EXP CELL RES, V271, P152, DOI 10.1006/excr.2001.5353; HIBBS JB, 1982, ADV EXP MED BIOL, V146, P315; Higginbotham JN, 2011, CURR BIOL, V21, P779, DOI 10.1016/j.cub.2011.03.043; Landen CN, 2008, NEOPLASIA, V10, P1259, DOI 10.1593/neo.08740; LEMARBRE P, 1980, BLOOD, V55, P612; LINDEN DJ, 1991, SCIENCE, V254, P1656, DOI 10.1126/science.1721243; Lynch S, 2009, J IMMUNOL, V183, P1884, DOI 10.4049/jimmunol.0900798; Mathivanan S, 2009, PROTEOMICS, V9, P4997, DOI 10.1002/pmic.200900351; McLane Mary Ann, 2004, Current Drug Targets - Cardiovascular & Haematological Disorders, V4, P327, DOI 10.2174/1568006043335880; Monick MM, 1998, AM J PHYSIOL-LUNG C, V275, pL389, DOI 10.1152/ajplung.1998.275.2.L389; Najy AJ, 2008, J BIOL CHEM, V283, P18393, DOI 10.1074/jbc.M801329200; Najy AJ, 2008, CANCER RES, V68, P1092, DOI 10.1158/0008-5472.CAN-07-2432; Schafer B, 2004, J BIOL CHEM, V279, P47929, DOI 10.1074/jbc.M400129200; Schafer B, 2004, ONCOGENE, V23, P991, DOI 10.1038/sj.onc.1207278; Segura E, 2007, J IMMUNOL, V179, P1489, DOI 10.4049/jimmunol.179.3.1489; SONE S, 1981, CELL IMMUNOL, V57, P42, DOI 10.1016/0008-8749(81)90118-0; SONE S, 1984, CANCER RES, V44, P646; SONE S, 1982, CANCER RES, V42, P2227; Sun CX, 2010, CARDIOVASC RES, V87, P348, DOI 10.1093/cvr/cvq060; Takagi J, 2004, BIOCHEM SOC T, V32, P403, DOI 10.1042/BST0320403; Takeda S, 2006, EMBO J, V25, P2388, DOI 10.1038/sj.emboj.7601131; Thery C, 2001, J IMMUNOL, V166, P7309, DOI 10.4049/jimmunol.166.12.7309; Thery C, 2009, NAT REV IMMUNOL, V9, P581, DOI 10.1038/nri2567; Toquet C, 2012, INT J CANCER, V130, P278, DOI 10.1002/ijc.25891; Trochon-Joseph V, 2004, CANCER RES, V64, P2062, DOI 10.1158/0008-5472.CAN-03-3272; Ungerer C, 2010, BIOCHEM BIOPH RES CO, V401, P363, DOI 10.1016/j.bbrc.2010.09.055; Valadi H, 2007, NAT CELL BIOL, V9, P654, DOI 10.1038/ncb1596; van Kilsdonk JWJ, 2010, EUR J CELL BIOL, V89, P415, DOI 10.1016/j.ejcb.2009.11.026; Vecchi M, 1996, J BIOL CHEM, V271, P18989, DOI 10.1074/jbc.271.31.18989; Whatling C, 2004, J LIPID RES, V45, P1768, DOI 10.1194/jlr.M400195-JLR200; WOLFSBERG TG, 1995, J CELL BIOL, V131, P275, DOI 10.1083/jcb.131.2.275; Wu J, 2008, ONCOL REP, V20, P669, DOI 10.3892/or_00000058; Zeelenberg IS, 2008, CANCER RES, V68, P1228, DOI 10.1158/0008-5472.CAN-07-3163; Zhang XP, 1998, J BIOL CHEM, V273, P7345, DOI 10.1074/jbc.273.13.7345	46	35	35	0	20	FEDERATION AMER SOC EXP BIOL	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3998 USA	0892-6638	1530-6860		FASEB J	Faseb J.	JUL	2012	26	7					3084	3095		10.1096/fj.11-201681	http://dx.doi.org/10.1096/fj.11-201681			12	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	967MP	22505472				2022-12-25	WOS:000305912500036
J	Troxell, B; Xu, HJ; Yang, XF				Troxell, Bryan; Xu, Haijun; Yang, X. Frank			Borrelia burgdorferi, a Pathogen That Lacks Iron, Encodes Manganese-dependent Superoxide Dismutase Essential for Resistance to Streptonigrin	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							LYME-DISEASE SPIROCHETE; ESCHERICHIA-COLI; PSEUDOMONAS-AERUGINOSA; HYDROGEN-PEROXIDE; FREE-RADICALS; VIRULENCE; OXYGEN; TOXICITY; PARAQUAT; LIFE	Borrelia burgdorferi, the causative agent of Lyme disease, exists in nature through a complex life cycle involving ticks of the Ixodes genus and mammalian hosts. During its life cycle, B. burgdorferi experiences fluctuations in oxygen tension and may encounter reactive oxygen species (ROS). The key metalloenzyme to degrade ROS in B. burgdorferi is SodA. Although previous work suggests that B. burgdorferi SodA is an iron-dependent superoxide dismutase (SOD), later work demonstrates that B. burgdorferi is unable to transport iron and contains an extremely low intracellular concentration of iron. Consequently, the metal cofactor for SodA has been postulated to be manganese. However, experimental evidence to support this hypothesis remains lacking. In this study, we provide biochemical and genetic data showing that SodA is a manganese-dependent enzyme. First, B. burgdorferi contained SOD activity that is resistant to H2O2 and NaCN, characteristics associated with Mn-SODs. Second, the addition of manganese to the Chelex-treated BSK-II enhanced SodA expression. Third, disruption of the manganese transporter gene bmtA, which significantly lowers the intracellular manganese, greatly reduced SOD activity and SodA expression, suggesting that manganese regulates the level of SodA. In addition, we show that B. burgdorferi is resistant to streptonigrin, a metal-dependent redox cycling compound that produces ROS, and that SodA plays a protective role against the streptonigrin. Taken together, our data demonstrate the Lyme disease spirochete encodes a manganese-dependent SOD that contributes to B. burgdorferi defense against intracellular superoxide.	[Troxell, Bryan; Yang, X. Frank] Indiana Univ Sch Med, Dept Immunol & Microbiol, Indianapolis, IN 46202 USA; [Xu, Haijun] Zhejiang Univ, Inst Insect Sci, Hangzhou 310029, Zhejiang, Peoples R China	Indiana University System; Indiana University Bloomington; Zhejiang University	Yang, XF (corresponding author), Indiana Univ Sch Med, Dept Immunol & Microbiol, Indianapolis, IN 46202 USA.	xfyang@iupui.edu		Xu, Hai-Jun/0000-0002-7314-377X; Troxell, Bryan/0000-0002-0533-6721	National Institutes of Health [R01 AI083640, 5T32AI060519]; Indiana University; Lilly Endowment, Inc.; National Center for Research Resources, National Institutes of Health [C06 RR015481-01]; NATIONAL CENTER FOR RESEARCH RESOURCES [C06RR015481] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [T32AI060519, R01AI083640] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Indiana University; Lilly Endowment, Inc.; National Center for Research Resources, National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	This work was supported, in whole or in part, by National Institutes of Health Grant R01 AI083640 (to X. F. Y.). This work was also supported by Indiana INGEN and METACyt grants from Indiana University, funded by the Lilly Endowment, Inc. (to X. F. Y.) and in part by Grant C06 RR015481-01 from National Center for Research Resources, National Institutes of Health.; Supported by National Institutes of Health T32 Training Grant 5T32AI060519.	Allison KR, 2011, NATURE, V473, P216, DOI 10.1038/nature10069; Anjem A, 2009, MOL MICROBIOL, V72, P844, DOI 10.1111/j.1365-2958.2009.06699.x; ASADA K, 1975, J BIOL CHEM, V250, P2801; AUSTIN FE, 1981, INFECT IMMUN, V33, P372, DOI 10.1128/IAI.33.2.372-379.1981; BACHUR NR, 1979, P NATL ACAD SCI USA, V76, P954, DOI 10.1073/pnas.76.2.954; BARBOUR AG, 1984, YALE J BIOL MED, V57, P521; Barriere C, 2001, J APPL MICROBIOL, V91, P514, DOI 10.1046/j.1365-2672.2001.01411.x; Barriere C, 2001, APPL ENVIRON MICROB, V67, P4096, DOI 10.1128/AEM.67.9.4096-4104.2001; BEAUCHAM.C, 1971, ANAL BIOCHEM, V44, P276, DOI 10.1016/0003-2697(71)90370-8; Benov L, 1999, J BIOL CHEM, V274, P4202, DOI 10.1074/jbc.274.7.4202; BENOV LT, 1994, J BIOL CHEM, V269, P25310; BERNOFSKY C, 1973, ANAL BIOCHEM, V53, P452, DOI 10.1016/0003-2697(73)90094-8; Boylan JA, 2008, MOL MICROBIOL, V68, P786, DOI 10.1111/j.1365-2958.2008.06204.x; BURGDORFER W, 1982, SCIENCE, V216, P1317, DOI 10.1126/science.7043737; CARLIOZ A, 1986, EMBO J, V5, P623, DOI 10.1002/j.1460-2075.1986.tb04256.x; Casjens S, 2000, MOL MICROBIOL, V35, P490, DOI 10.1046/j.1365-2958.2000.01698.x; Chang SK, 1997, APPL ENVIRON MICROB, V63, P3732, DOI 10.1128/AEM.63.9.3732-3735.1997; COHEN MS, 1987, ANTIMICROB AGENTS CH, V31, P1507, DOI 10.1128/AAC.31.10.1507; CONE R, 1976, CAN J BIOCHEM CELL B, V54, P219, DOI 10.1139/o76-034; de Paiva SR, 2003, MEM I OSWALDO CRUZ, V98, P959, DOI 10.1590/S0074-02762003000700017; Elias AF, 2002, INFECT IMMUN, V70, P2139, DOI 10.1128/IAI.70.4.2139-2150.2002; Esteve-Gassent MD, 2009, MOL MICROBIOL, V71, P594, DOI 10.1111/j.1365-2958.2008.06549.x; Fraser CM, 1997, NATURE, V390, P580, DOI 10.1038/37551; GARDNER PR, 1991, J BIOL CHEM, V266, P19328; GARDNER PR, 1991, J BIOL CHEM, V266, P1478; GREGORY EM, 1973, J BACTERIOL, V115, P987, DOI 10.1128/JB.115.3.987-991.1973; GREGORY EM, 1973, J BACTERIOL, V114, P1193, DOI 10.1128/JB.114.3.1193-1197.1973; GREGORY EM, 1978, APPL ENVIRON MICROB, V35, P988, DOI 10.1128/AEM.35.5.988-991.1978; GUTTERIDGE JMC, 1984, BIOCHEM PHARMACOL, V33, P3059, DOI 10.1016/0006-2952(84)90609-9; HASSAN HM, 1977, J BACTERIOL, V129, P1574, DOI 10.1128/JB.129.3.1574-1583.1977; HASSAN HM, 1978, J BIOL CHEM, V253, P8143; HASSAN HM, 1979, ARCH BIOCHEM BIOPHYS, V196, P385, DOI 10.1016/0003-9861(79)90289-3; HASSETT DJ, 1992, INFECT IMMUN, V60, P328, DOI 10.1128/IAI.60.2.328-336.1992; HASSETT DJ, 1987, J BIOL CHEM, V262, P13404; Inbaraj JJ, 2004, CHEM RES TOXICOL, V17, P55, DOI 10.1021/tx034132s; Jewett MW, 2007, MOL MICROBIOL, V66, P975, DOI 10.1111/j.1365-2958.2007.05969.x; KAO SM, 1985, J BIOL CHEM, V260, P478; KEELE BB, 1970, J BIOL CHEM, V245, P6176; Leonardo MR, 1996, J BACTERIOL, V178, P6013, DOI 10.1128/jb.178.20.6013-6018.1996; MARTIN ME, 1986, J BIOL CHEM, V261, P9361; MCCORD JM, 1969, J BIOL CHEM, V244, P6049; Narasimhan S, 2007, CELL HOST MICROBE, V2, P7, DOI 10.1016/j.chom.2007.06.001; Ngok-Ngam P, 2009, J BACTERIOL, V191, P2083, DOI 10.1128/JB.01380-08; Nowalk AJ, 2006, PROTEOMICS, V6, P2121, DOI 10.1002/pmic.200500187; Ouyang ZM, 2009, P NATL ACAD SCI USA, V106, P3449, DOI 10.1073/pnas.0812999106; Posey JE, 2000, SCIENCE, V288, P1651, DOI 10.1126/science.288.5471.1651; Price-Whelan A, 2007, J BACTERIOL, V189, P6372, DOI 10.1128/JB.00505-07; PRIVALLE CT, 1993, J BIOL CHEM, V268, P5178; Radolf JD, 2012, NAT REV MICROBIOL, V10, P87, DOI 10.1038/nrmicro2714; Samuels D S, 1995, Methods Mol Biol, V47, P253; Sha SH, 1999, HEARING RES, V128, P112, DOI 10.1016/S0378-5955(98)00200-7; Steere AC, 2004, J CLIN INVEST, V113, P1093, DOI [10.1172/JCI200421681, 10.1172/JCI21681]; WHITE HL, 1968, MOL PHARMACOL, V4, P549; WHITE JR, 1982, BIOCHEM BIOPH RES CO, V106, P407, DOI 10.1016/0006-291X(82)91125-1; WHITE JR, 1977, BIOCHEM BIOPH RES CO, V77, P387, DOI 10.1016/S0006-291X(77)80209-X; Whitehouse CA, 1997, INFECT IMMUN, V65, P4865, DOI 10.1128/IAI.65.11.4865-4868.1997; Yang XFF, 2004, J EXP MED, V199, P641, DOI 10.1084/jem.20031960; YEOWELL HN, 1982, ANTIMICROB AGENTS CH, V22, P961, DOI 10.1128/AAC.22.6.961; YOST FJ, 1973, J BIOL CHEM, V248, P4905; Youn HD, 1996, BIOCHEM J, V318, P889, DOI 10.1042/bj3180889	60	46	46	1	23	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JUN 1	2012	287	23					19284	19293		10.1074/jbc.M112.344903	http://dx.doi.org/10.1074/jbc.M112.344903			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	974EF	22500025	hybrid, Green Published			2022-12-25	WOS:000306411900038
J	Kligys, KR; Wu, Y; Hopkinson, SB; Kaur, S; Platanias, LC; Jones, JCR				Kligys, Kristina R.; Wu, Yvonne; Hopkinson, Susan B.; Kaur, Surinder; Platanias, Leonidas C.; Jones, Jonathan C. R.			alpha 6 beta 4 Integrin, a Master Regulator of Expression of Integrins in Human Keratinocytes	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							JUNCTIONAL EPIDERMOLYSIS-BULLOSA; ALPHA-3-BETA-1 INTEGRIN; PEMPHIGOID ANTIGEN; MESSENGER-RNA; ALPHA(6)BETA(4) INTEGRIN; EPIDERMAL-GROWTH; PYLORIC ATRESIA; CARCINOMA CELLS; GENE ITGB4; TRANSLATION	Three major laminin and collagen-binding integrins in skin (alpha 6 beta 4, alpha 3 beta 1, and alpha 2 beta 1) are involved in keratinocyte adhesion to the dermis and dissemination of skin cells during wound healing and/or tumorigenesis. Knockdown of alpha 6 integrin in keratinocytes not only results in motility defects but also leads to decreased surface expression of the alpha 2, alpha 3, and beta 4 integrin subunits. Whereas alpha 2 integrin mRNA levels are decreased in alpha 6 integrin knockdown cells, alpha 3 and beta 4 integrin mRNAs levels are unaffected. Expression of either alpha 6 or alpha 3 integrin in alpha 6 integrin knockdown cells restores alpha 2 integrin mRNA levels. Moreover, re-expression of alpha 6 integrin increases beta 4 integrin protein at the cell surface, which results in an increase in alpha 3 integrin expression via activation of initiation factor 4E-binding protein 1. Our data indicate that the alpha 6 beta 4 integrin is a master regulator of transcription and translation of other integrin subunits and underscore its pivotal role in wound healing and cancer.	[Kligys, Kristina R.; Wu, Yvonne; Hopkinson, Susan B.; Jones, Jonathan C. R.] Northwestern Univ, Feinberg Sch Med, Dept Cell & Mol Biol, Chicago, IL 60611 USA; [Kaur, Surinder; Platanias, Leonidas C.] Northwestern Univ, Robert H Lurie Comprehens Canc Ctr, Div Hematol Oncol, Chicago, IL 60611 USA	Northwestern University; Feinberg School of Medicine; Ann & Robert H. Lurie Children's Hospital of Chicago; Northwestern University; Robert H. Lurie Comprehensive Cancer Center	Jones, JCR (corresponding author), Northwestern Univ, Feinberg Sch Med, Dept Cell & Mol Biol, 303 E Chicago Ave, Chicago, IL 60611 USA.	j-jones3@northwestern.edu	Jones, Jonathan C R/T-9467-2017	Jones, Jonathan C R/0000-0002-1496-4922	National Institutes of Health [RO1 AR054184, RO1 CA77816]; Northwestern University Flow Cytometry and Cell Imaging Facilities through Cancer Center [CA060553]	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Northwestern University Flow Cytometry and Cell Imaging Facilities through Cancer Center	This work was supported, in whole or in part, by National Institutes of Health Grants RO1 AR054184 (to J. C. R. J.) and RO1 CA77816 (to L. P.). This work was also supported by the Northwestern University Flow Cytometry and Cell Imaging Facilities through Cancer Center Support Grant CA060553.	Allegra M, 2003, J INVEST DERMATOL, V121, P1336, DOI 10.1111/j.1523-1747.2003.12625.x; Brakebusch C, 2000, EMBO J, V19, P3990, DOI 10.1093/emboj/19.15.3990; Choma DP, 2007, J INVEST DERMATOL, V127, P31, DOI 10.1038/sj.jid.5700505; Chung J, 2002, J CELL BIOL, V158, P165, DOI 10.1083/jcb.200112015; DiPersio CM, 2000, J CELL SCI, V113, P3051; Dowling J, 1996, J CELL BIOL, V134, P559, DOI 10.1083/jcb.134.2.559; Frank DE, 2004, J CELL SCI, V117, P1351, DOI 10.1242/jcs.01003; GeorgesLabouesse E, 1996, NAT GENET, V13, P370, DOI 10.1038/ng0796-370; Gingras AC, 2001, GENE DEV, V15, P2852; Goldfinger LE, 1999, J CELL SCI, V112, P2615; Gonzalez AM, 2002, P NATL ACAD SCI USA, V99, P16075, DOI 10.1073/pnas.252649399; Hamill KJ, 2012, J INVEST DERMATOL, V132, P448, DOI 10.1038/jid.2011.297; Hamill KJ, 2011, J BIOL CHEM, V286, P26768, DOI 10.1074/jbc.M110.203646; Hamill KJ, 2009, MOL BIOL CELL, V20, P2954, DOI 10.1091/mbc.E09-01-0051; Hintermann E, 2005, J BIOL CHEM, V280, P8004, DOI 10.1074/jbc.M406301200; HOGERVORST F, 1991, EUR J BIOCHEM, V199, P425, DOI 10.1111/j.1432-1033.1991.tb16140.x; HOPKINSON SB, 1992, J INVEST DERMATOL, V99, P264, DOI 10.1111/1523-1747.ep12616615; Iyer V, 2005, J CELL SCI, V118, P1185, DOI 10.1242/jcs.01708; JONES JCR, 1991, CELL REGUL, V2, P427, DOI 10.1091/mbc.2.6.427; Kaur S, 2008, P NATL ACAD SCI USA, V105, P4808, DOI 10.1073/pnas.0710907105; KLATTE DH, 1994, J INVEST DERMATOL, V102, P39, DOI 10.1111/1523-1747.ep12371728; Kligys K, 2007, J BIOL CHEM, V282, P32520, DOI 10.1074/jbc.M707041200; Lamar JM, 2008, CANCER RES, V68, P7371, DOI 10.1158/0008-5472.CAN-08-1080; LANGHOFER M, 1993, J CELL SCI, V105, P753; LEE EC, 1992, J CELL BIOL, V117, P671, DOI 10.1083/jcb.117.3.671; Litjens SHM, 2006, TRENDS CELL BIOL, V16, P376, DOI 10.1016/j.tcb.2006.05.004; Lochter A, 1999, MOL BIOL CELL, V10, P271, DOI 10.1091/mbc.10.2.271; Margadant C, 2009, J CELL SCI, V122, P278, DOI 10.1242/jcs.029108; McKendrick L, 1999, INT J BIOCHEM CELL B, V31, P31, DOI 10.1016/S1357-2725(98)00129-0; Mitchell K, 2009, J CELL SCI, V122, P1778, DOI 10.1242/jcs.040956; Nikolopoulos SN, 2005, MOL CELL BIOL, V25, P6090, DOI 10.1128/MCB.25.14.6090-6102.2005; Pulkkinen L, 1998, AM J HUM GENET, V63, P1376, DOI 10.1086/302116; Pulkkinen L, 1998, AM J PATHOL, V152, P157; Pulkkinen L, 1997, HUM MOL GENET, V6, P669, DOI 10.1093/hmg/6.5.669; Pulkkinen L, 1997, LAB INVEST, V76, P823; Pulkkinen L, 1998, EXP DERMATOL, V7, P46, DOI 10.1111/j.1600-0625.1998.tb00304.x; Pulkkinen L, 1998, AM J PATHOL, V152, P935; Raymond K, 2005, J CELL SCI, V118, P1045, DOI 10.1242/jcs.01689; Reynolds LE, 2008, J CLIN INVEST, V118, P965, DOI 10.1172/JCI33538; Rodius S, 2007, J CELL PHYSIOL, V212, P439, DOI 10.1002/jcp.21040; Russell AJ, 2003, J CELL SCI, V116, P3543, DOI 10.1242/jcs.00663; Ruzzi L, 1997, J CLIN INVEST, V99, P2826, DOI 10.1172/JCI119474; Santoro MM, 2003, DEV CELL, V5, P257, DOI 10.1016/S1534-5807(03)00201-6; Sehgal BU, 2006, J BIOL CHEM, V281, P35487, DOI 10.1074/jbc.M606317200; Tsuruta D, 2003, J BIOL CHEM, V278, P38707, DOI 10.1074/jbc.M301637200; vanderNeut R, 1996, NAT GENET, V13, P366, DOI 10.1038/ng0796-366; VIDAL F, 1995, NAT GENET, V10, P229, DOI 10.1038/ng0695-229; Watt FM, 2002, EMBO J, V21, P3919, DOI 10.1093/emboj/cdf399; Wen TT, 2010, WOUND REPAIR REGEN, V18, P325, DOI 10.1111/j.1524-475X.2010.00590.x; Yoon SO, 2006, CANCER RES, V66, P2732, DOI 10.1158/0008-5472.CAN-05-2941; Zhang K, 1996, EXP CELL RES, V227, P309, DOI 10.1006/excr.1996.0280; ZUTTER MM, 1995, P NATL ACAD SCI USA, V92, P7411, DOI 10.1073/pnas.92.16.7411	52	39	40	0	8	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	MAY 25	2012	287	22					17975	17984		10.1074/jbc.M111.310458	http://dx.doi.org/10.1074/jbc.M111.310458			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	974EC	22493440	hybrid, Green Published			2022-12-25	WOS:000306411600007
J	Thapa, A; Morris, L; Xu, JH; Ma, HW; Michalakis, S; Biel, M; Ding, XQ				Thapa, Arjun; Morris, Lynsie; Xu, Jianhua; Ma, Hongwei; Michalakis, Stylianos; Biel, Martin; Ding, Xi-Qin			Endoplasmic Reticulum Stress-associated Cone Photoreceptor Degeneration in Cyclic Nucleotide-gated Channel Deficiency	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							APOPTOSIS-INDUCING FACTOR; RETINAL DEGENERATION; CELL-DEATH; CROSS-TALK; SUBUNIT STOICHIOMETRY; MULTIPLE PATHWAYS; TRANSGENIC RATS; MICE LACKING; ACTIVATION; MUTATIONS	Cyclic nucleotide-gated (CNG) channels play a pivotal role in phototransduction. Mutations in the cone CNG channel subunits CNGA3 and CNGB3 account for >70% of all known cases of achromatopsia. Cones degenerate in achromatopsia patients and in CNGA3(-/-) and CNGB3(-/-) mice. This work investigates the molecular basis of cone degeneration in CNG channel deficiency. As cones comprise only 2-3% of the total photoreceptor population in the wild-type mouse retina, we generated mouse lines with CNG channel deficiency on a cone-dominant background, i.e. CNGA3(-/-)/Nrl(-/-) and CNGB3(-/-)/Nrl(-/-) mice. The retinal phenotype and potential cell death pathways were examined by functional, biochemical, and immunohistochemical approaches. CNGA3(-/-)/Nrl(-/-) and CNGB3(-/-)/Nrl(-/-) mice showed impaired cone function, opsin mislocalization, and cone degeneration similar to that in the single knock-out mice. The endoplasmic reticulum stress marker proteins, including Grp78/Bip, phospho-eIF2 alpha, phospho-IP3R, and CCAAT/enhancer-binding protein homologous protein, were elevated significantly in CNGA3(-/-)/Nrl(-/-) and CNGB3(-/-)/Nrl(-/-) retinas, compared with the age-matched (postnatal 30 days) Nrl(-/-) controls. Along with these, up-regulation of the cysteine protease calpains and cleavage of caspase-12 and caspase-7 were found in the channel-deficient retinas, suggesting an endoplasmic reticulum stress-associated apoptosis. In addition, we observed a nuclear translocation of apoptosis-inducing factor (AIF) and endonuclease G in CNGA3(-/-)/Nrl(-/-) and CNGB3(-/-)/Nrl(-/-) retinas, implying a mitochondrial insult in the endoplasmic reticulum stress-activated cell death process. Taken together, our findings suggest a crucial role of endoplasmic reticulum stress in cone degeneration associated with CNG channel deficiency.	[Thapa, Arjun; Morris, Lynsie; Xu, Jianhua; Ma, Hongwei; Ding, Xi-Qin] Univ Oklahoma, Hlth Sci Ctr, Dept Cell Biol, Oklahoma City, OK 73104 USA; [Michalakis, Stylianos; Biel, Martin] Univ Munich, Munich Ctr Integrated Prot Sci CIPSM, Ctr Drug Res, Dept Pharm, D-81377 Munich, Germany	University of Oklahoma System; University of Oklahoma Health Sciences Center; University of Munich	Ding, XQ (corresponding author), Univ Oklahoma, Hlth Sci Ctr, Dept Cell Biol, 940 Stanton L Young Blvd,BMSB 553, Oklahoma City, OK 73104 USA.	xi-qin-ding@ouhsc.edu	Biel, Martin/G-1175-2014; Michalakis, Stylianos/W-2094-2018; Michalakis, Stylianos/M-4677-2019	Biel, Martin/0000-0002-9974-3052; Michalakis, Stylianos/0000-0001-5092-9238; Michalakis, Stylianos/0000-0001-5092-9238	NEI, National Institutes of Health [P30EY12190, R01EY019490]; National Center for Research Resources [P20RR017703]; American Health Assistance Foundation; Oklahoma Center for the Advancement of Science Technology; Deutsche Forschungsgemeinschaft; NATIONAL CENTER FOR RESEARCH RESOURCES [P20RR017703] Funding Source: NIH RePORTER; NATIONAL EYE INSTITUTE [P30EY021725, R01EY019490, P30EY012190] Funding Source: NIH RePORTER	NEI, National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI)); National Center for Research Resources(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); American Health Assistance Foundation(BrightFocus Foundation); Oklahoma Center for the Advancement of Science Technology; Deutsche Forschungsgemeinschaft(German Research Foundation (DFG)); NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL EYE INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI))	This work was supported, in whole or in part, by NEI, National Institutes of Health Grants P30EY12190 and R01EY019490. This work was also supported by grants from the National Center for Research Resources (P20RR017703), the American Health Assistance Foundation, the Oklahoma Center for the Advancement of Science & Technology, and the Deutsche Forschungsgemeinschaft.	Biel M, 1999, P NATL ACAD SCI USA, V96, P7553, DOI 10.1073/pnas.96.13.7553; Bode C, 2003, MOL VIS, V9, P144; Daniele LL, 2005, INVEST OPHTH VIS SCI, V46, P2156, DOI 10.1167/iovs.04-1427; Ding XQ, 2009, HUM MOL GENET, V18, P4770, DOI 10.1093/hmg/ddp440; Doonan F, 2005, INVEST OPHTH VIS SCI, V46, P3530, DOI 10.1167/iovs.05-0248; Doonan F, 2003, J NEUROSCI, V23, P5723; Duricka DL, 2012, BIOCHEM J, V441, P685, DOI 10.1042/BJ20111004; Faillace MP, 2004, J BIOL CHEM, V279, P22643, DOI 10.1074/jbc.M400035200; Farjo R, 2006, J CELL BIOL, V173, P59, DOI 10.1083/jcb.200509036; Fujita E, 2002, CELL DEATH DIFFER, V9, P1108, DOI 10.1038/sj.cdd.4401080; Genead MA, 2011, INVEST OPHTH VIS SCI, V52, P7298, DOI 10.1167/iovs.11-7762; Gerstner A, 2000, J NEUROSCI, V20, P1324; Gorbatyuk MS, 2010, P NATL ACAD SCI USA, V107, P5961, DOI 10.1073/pnas.0911991107; Griciuc A, 2010, PLOS GENET, V6, DOI 10.1371/journal.pgen.1001075; Griciuc A, 2010, BBA-MOL CELL RES, V1803, P424, DOI 10.1016/j.bbamcr.2010.01.008; Kaupp UB, 2002, PHYSIOL REV, V82, P769, DOI 10.1152/physrev.00008.2002; Kohl S, 2000, HUM MOL GENET, V9, P2107, DOI 10.1093/hmg/9.14.2107; Kunchithapautham K, 2009, INVEST OPHTH VIS SCI, V50, P4858, DOI 10.1167/iovs.08-3008; Li JZ, 2006, J BIOL CHEM, V281, P7260, DOI 10.1074/jbc.M509868200; Li LY, 2001, NATURE, V412, P95, DOI 10.1038/35083620; Liu CD, 1999, J NEUROSCI, V19, P4778; Liu H, 2010, EYE, V24, P137, DOI 10.1038/eye.2009.20; Matveev AV, 2008, J NEUROCHEM, V106, P2042, DOI 10.1111/j.1471-4159.2008.05548.x; Matveev AV, 2010, BIOCHEMISTRY-US, V49, P1628, DOI 10.1021/bi901960u; Mears AJ, 2001, NAT GENET, V29, P447, DOI 10.1038/ng774; Mendes CS, 2009, EMBO J, V28, P1296, DOI 10.1038/emboj.2009.76; Michalakis S, 2005, INVEST OPHTH VIS SCI, V46, P1516, DOI 10.1167/iovs.04-1503; Michalakis S, 2010, MOL THER, V18, P2057, DOI 10.1038/mt.2010.149; Mizukoshi S, 2010, EXP EYE RES, V91, P353, DOI 10.1016/j.exer.2010.06.004; Murakami Y, 2007, J BIOCHEM, V141, P401, DOI 10.1093/jb/mvm044; Nakagawa T, 2000, NATURE, V403, P98, DOI 10.1038/47513; Nakagawa T, 2000, J CELL BIOL, V150, P887, DOI 10.1083/jcb.150.4.887; Nishiguchi KM, 2005, HUM MUTAT, V25, P248, DOI 10.1002/humu.20142; Olshevskaya EV, 2002, MOL CELL BIOCHEM, V230, P139, DOI 10.1023/A:1014248208584; Palmer AE, 2004, P NATL ACAD SCI USA, V101, P17404, DOI 10.1073/pnas.0408030101; Paquet-Durand F, 2006, J NEUROCHEM, V96, P802, DOI 10.1111/j.1471-4159.2005.03628.x; Patel KA, 2005, INVEST OPHTH VIS SCI, V46, P2282, DOI 10.1167/iovs.05-0179; PEACHEY NS, 1993, NEUROSCI LETT, V162, P9, DOI 10.1016/0304-3940(93)90547-X; Polster BM, 2005, J BIOL CHEM, V280, P6447, DOI 10.1074/jbc.M413269200; Rao RV, 2001, J BIOL CHEM, V276, P33869, DOI 10.1074/jbc.M102225200; Reme CE, 1998, PROG RETIN EYE RES, V17, P443, DOI 10.1016/S1350-9462(98)00009-3; Reuter P, 2008, HUM MUTAT, V29, P1228, DOI 10.1002/humu.20790; Saini RV, 2011, J IMMUNOL, V186, P3497, DOI 10.4049/jimmunol.1003409; Sanges D, 2006, APOPTOSIS, V11, P1629, DOI 10.1007/s10495-006-9006-2; Sanges D, 2006, P NATL ACAD SCI USA, V103, P17366, DOI 10.1073/pnas.0606276103; Sano Y, 2006, AM J PATHOL, V169, P132, DOI 10.2353/ajpath.2006.060085; Shuart NG, 2011, NAT COMMUN, V2, DOI 10.1038/ncomms1466; Szegezdi E, 2006, EMBO REP, V7, P880, DOI 10.1038/sj.embor.7400779; Tam BM, 2006, INVEST OPHTH VIS SCI, V47, P3234, DOI 10.1167/iovs.06-0213; Tam BM, 2006, J NEUROSCI, V26, P203, DOI 10.1523/JNEUROSCI.3849-05.2006; Thiadens AAHJ, 2010, INVEST OPHTH VIS SCI, V51, P5952, DOI 10.1167/iovs.10-5680; Varsanyi B, 2007, INVEST OPHTH VIS SCI, V48, P2249, DOI 10.1167/iovs.06-1173; Wang X, 2011, CELL DEATH DIFFER, V18, P38, DOI 10.1038/cdd.2010.68; Wang XZ, 1996, MOL CELL BIOL, V16, P4273; Weitz D, 2002, NEURON, V36, P881, DOI 10.1016/S0896-6273(02)01098-X; Wenzel A, 2005, PROG RETIN EYE RES, V24, P275, DOI 10.1016/j.preteyeres.2004.08.002; Wissinger B, 2001, AM J HUM GENET, V69, P722, DOI 10.1086/323613; Xu JH, 2011, INVEST OPHTH VIS SCI, V52, P3557, DOI 10.1167/iovs.10-6358; Yang LP, 2007, INVEST OPHTH VIS SCI, V48, P5191, DOI 10.1167/iovs.07-0512; Zhang T, 2011, P NATL ACAD SCI USA, V108, P8879, DOI 10.1073/pnas.1017127108; Zheng J, 2002, NEURON, V36, P891, DOI 10.1016/S0896-6273(02)01099-1; Zhong HM, 2002, NATURE, V420, P193, DOI 10.1038/nature01201; Zhu XM, 2003, J NEUROSCI, V23, P6152, DOI 10.1523/JNEUROSCI.23-14-06152.2003	63	42	44	0	6	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAY 25	2012	287	22					18018	18029		10.1074/jbc.M112.342220	http://dx.doi.org/10.1074/jbc.M112.342220			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	974EC	22493484	Green Published, hybrid			2022-12-25	WOS:000306411600011
J	Caserta, S; Nausch, N; Sawtell, A; Drummond, R; Barr, T; MacDonald, AS; Mutapi, F; Zamoyska, R				Caserta, Stefano; Nausch, Norman; Sawtell, Amy; Drummond, Rebecca; Barr, Tom; MacDonald, Andrew S.; Mutapi, Francisca; Zamoyska, Rose			Chronic Infection Drives Expression of the Inhibitory Receptor CD200R, and Its Ligand CD200, by Mouse and Human CD4 T Cells	PLOS ONE			English	Article							NEGLECTED TROPICAL DISEASES; SCHISTOSOMA-HAEMATOBIUM; SALMONELLA-TYPHIMURIUM; INFLUENZA INFECTION; MYELOID CELLS; IFN-GAMMA; IN-VIVO; RESPONSES; MICE; IMMUNITY	Certain parasites have evolved to evade the immune response and establish chronic infections that may persist for many years. T cell responses in these conditions become muted despite ongoing infection. Upregulation of surface receptors with inhibitory properties provides an immune cell-intrinsic mechanism that, under conditions of chronic infection, regulates immune responses and limits cellular activation and associated pathology. The negative regulator, CD200 receptor, and its ligand, CD200, have been shown to regulate macrophage activation and reduce pathology following infection. We show that CD4 T cells also increase expression of inhibitory CD200 receptors (CD200R) in response to chronic infection. CD200R was upregulated on murine effector T cells in response to infection with bacterial, Salmonella enterica, or helminth, Schistosoma mansoni, pathogens that respectively drive predominant Th1- or Th2-responses. In vitro chronic and prolonged stimuli were required for the sustained upregulation of CD200R, and its expression coincided with loss of multifunctional potential in T effector cells during infection. Importantly, we show an association between IL-4 production and CD200R expression on T effector cells from humans infected with Schistosoma haematobium that correlated effectively with egg burden and, thus infection intensity. Our results indicate a role of CD200R: CD200 in T cell responses to helminths which has diagnostic and prognostic relevance as a marker of infection for chronic schistosomiasis in mouse and man.	[Caserta, Stefano; Nausch, Norman; Sawtell, Amy; Drummond, Rebecca; Barr, Tom; MacDonald, Andrew S.; Mutapi, Francisca; Zamoyska, Rose] Univ Edinburgh, Inst Immunol & Infect Res, Edinburgh, Midlothian, Scotland	University of Edinburgh	Caserta, S (corresponding author), Univ Edinburgh, Inst Immunol & Infect Res, Edinburgh, Midlothian, Scotland.	rose.zamoyska@ed.ac.uk	Nausch, Norman/L-9276-2013; Drummond, Rebecca/I-3155-2019; Caserta, Stefano/AAP-5616-2020; Nausch, Norman/M-4526-2019	Nausch, Norman/0000-0002-9704-2148; Drummond, Rebecca/0000-0001-5424-7074; Caserta, Stefano/0000-0002-3674-2837; Nausch, Norman/0000-0002-9704-2148; Zamoyska, Rose/0000-0001-9816-2638; Mutapi, Francisca/0000-0002-2537-3466	Cancer Research UK [A8429]; Medical Research Council [G0701437]; Wellcome Trust [WT082028MA, WT082814]; MRC [G0701437] Funding Source: UKRI	Cancer Research UK(Cancer Research UK); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Wellcome Trust(Wellcome Trust); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC))	Cancer Research UK (grant A8429) (SC RZ); Medical Research Council(grant G0701437) (ASM); The Wellcome Trust (grant WT082028MA) (NN FM) and (grant WT082814) (TB). The funders had no role in study design, data collection and analysis, decision to publish or preparation of the manuscript.	Barclay AN, 2002, TRENDS IMMUNOL, V23, P285, DOI 10.1016/S1471-4906(02)02223-8; Barr TA, 2010, J IMMUNOL, V185, P2783, DOI 10.4049/jimmunol.1001431; Caserta S, 2008, CANCER RES, V68, P3010, DOI 10.1158/0008-5472.CAN-07-5796; Caserta S, 2010, J IMMUNOL, V185, P6545, DOI 10.4049/jimmunol.1001867; Crompton DWT, 2002, ANNU REV NUTR, V22, P35, DOI 10.1146/annurev.nutr.22.120501.134539; Fife BT, 2008, IMMUNOL REV, V224, P166, DOI 10.1111/j.1600-065X.2008.00662.x; Han S, 2010, P NATL ACAD SCI USA, V107, P20453, DOI 10.1073/pnas.1008437107; Harari A, 2006, IMMUNOL REV, V211, P236, DOI 10.1111/j.0105-2896.2006.00395.x; Hess J, 1996, J IMMUNOL, V156, P3321; Hoek RM, 2000, SCIENCE, V290, P1768, DOI 10.1126/science.290.5497.1768; HOISETH SK, 1981, NATURE, V291, P238, DOI 10.1038/291238a0; Hotez PJ, 2008, J CLIN INVEST, V118, P1311, DOI 10.1172/JCI34261; Kawasaki BT, 2008, TRENDS IMMUNOL, V29, P464, DOI 10.1016/j.it.2008.07.005; Kretz-Rommel A, 2007, J IMMUNOL, V178, P5595, DOI 10.4049/jimmunol.178.9.5595; Kretz-Ronlmel A, 2008, J IMMUNOL, V180, P699, DOI 10.4049/jimmunol.180.2.699; LUCAS B, 1993, J IMMUNOL, V151, P4574; Mathers CD, 2007, PLOS NEGLECT TROP D, V1, DOI 10.1371/journal.pntd.0000114; Mihrshahi R, 2010, J IMMUNOL, V185, P7216, DOI 10.4049/jimmunol.1002858; Mihrshahi R, 2009, J IMMUNOL, V183, P4879, DOI 10.4049/jimmunol.0901531; Milner T, 2010, PARASITE IMMUNOL, V32, P710, DOI 10.1111/j.1365-3024.2010.01235.x; Mohrs M, 2001, IMMUNITY, V15, P303, DOI 10.1016/S1074-7613(01)00186-8; Murphy E, 1996, J EXP MED, V183, P901, DOI 10.1084/jem.183.3.901; MURPHY KM, 1990, SCIENCE, V250, P1720, DOI 10.1126/science.2125367; Mutapi F, 2002, LANCET INFECT DIS, V2, P219, DOI 10.1016/S1473-3099(02)00240-2; Mutapi F, 2007, BMC INFECT DIS, V7, DOI 10.1186/1471-2334-7-139; Nishimura H, 1999, IMMUNITY, V11, P141, DOI 10.1016/S1074-7613(00)80089-8; Pearce EJ, 2002, NAT REV IMMUNOL, V2, P499, DOI 10.1038/nri843; Phythian-Adams AT, 2010, J EXP MED, V207, P2089, DOI 10.1084/jem.20100734; Rijkers ESK, 2008, MOL IMMUNOL, V45, P1126, DOI 10.1016/j.molimm.2007.07.013; Rygiel TP, 2009, J IMMUNOL, V183, P1990, DOI 10.4049/jimmunol.0900252; Snelgrove RJ, 2008, NAT IMMUNOL, V9, P1074, DOI 10.1038/ni.1637; Sprent J, 2002, ANNU REV IMMUNOL, V20, P551, DOI 10.1146/annurev.immunol.20.100101.151926; Taylor JJ, 2009, J CLIN INVEST, V119, P1019, DOI 10.1172/JCI36534; TIVOL EA, 1995, IMMUNITY, V3, P541, DOI 10.1016/1074-7613(95)90125-6; Vella A, 1997, J EXP MED, V186, P325, DOI 10.1084/jem.186.2.325; Wang J, 2005, P NATL ACAD SCI USA, V102, P11823, DOI 10.1073/pnas.0505497102; WATERHOUSE P, 1995, SCIENCE, V270, P985, DOI 10.1126/science.270.5238.985; WEBB M, 1984, J NEUROCHEM, V43, P1061, DOI 10.1111/j.1471-4159.1984.tb12844.x; Woolhouse MEJ, 1997, P NATL ACAD SCI USA, V94, P338, DOI 10.1073/pnas.94.1.338; Wright GJ, 2003, J IMMUNOL, V171, P3034, DOI 10.4049/jimmunol.171.6.3034; Wright GJ, 2001, IMMUNOLOGY, V102, P173, DOI 10.1046/j.1365-2567.2001.01163.x	41	30	31	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 9	2012	7	4							e35466	10.1371/journal.pone.0035466	http://dx.doi.org/10.1371/journal.pone.0035466			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	955JO	22496920	Green Published, Green Accepted, Green Submitted, gold			2022-12-25	WOS:000305014500058
J	Jauhiainen, A; Thomsen, C; Strombom, L; Grundevik, P; Andersson, C; Danielsson, A; Andersson, MK; Nerman, O; Rorkvist, L; Stahlberg, A; Aman, P				Jauhiainen, Alexandra; Thomsen, Christer; Strombom, Linda; Grundevik, Pernilla; Andersson, Carola; Danielsson, Anna; Andersson, Mattias K.; Nerman, Olle; Rorkvist, Linda; Stahlberg, Anders; Aman, Pierre			Distinct Cytoplasmic and Nuclear Functions of the Stress Induced Protein DDIT3/CHOP/GADD153	PLOS ONE			English	Article							ENDOPLASMIC-RETICULUM STRESS; C/EBP-HOMOLOGOUS PROTEIN; TRANSCRIPTION FACTOR CHOP; PANCREATIC BETA-CELLS; AMINO-ACID LIMITATION; MYXOID LIPOSARCOMA; BINDING-PROTEIN; GENE-EXPRESSION; IN-VITRO; INDUCED APOPTOSIS	DDIT3, also known as GADD153 or CHOP, encodes a basic leucine zipper transcription factor of the dimer forming C/EBP family. DDIT3 is known as a key regulator of cellular stress response, but its target genes and functions are not well characterized. Here, we applied a genome wide microarray based expression analysis to identify DDIT3 target genes and functions. By analyzing cells carrying tamoxifen inducible DDIT3 expression constructs we show distinct gene expression profiles for cells with cytoplasmic and nuclear localized DDIT3. Of 175 target genes identified only 3 were regulated by DDIT3 in both cellular localizations. More than two thirds of the genes were downregulated, supporting a role for DDIT3 as a dominant negative factor that could act by either cytoplasmic or nuclear sequestration of dimer forming transcription factor partners. Functional annotation of target genes showed cell migration, proliferation and apoptosis/survival as the most affected categories. Cytoplasmic DDIT3 affected more migration associated genes, while nuclear DDIT3 regulated more cell cycle controlling genes. Cell culture experiments confirmed that cytoplasmic DDIT3 inhibited migration, while nuclear DDIT3 caused a G1 cell cycle arrest. Promoters of target genes showed no common sequence motifs, reflecting that DDIT3 forms heterodimers with several alternative transcription factors that bind to different motifs. We conclude that expression of cytoplasmic DDIT3 regulated 94 genes. Nuclear translocation of DDIT3 regulated 81 additional genes linked to functions already affected by cytoplasmic DDIT3. Characterization of DDIT3 regulated functions helps understanding its role in stress response and involvement in cancer and degenerative disorders.	[Jauhiainen, Alexandra] Karolinska Inst, Dept Med Epidemiol & Biostat, Stockholm, Sweden; [Thomsen, Christer; Strombom, Linda; Grundevik, Pernilla; Andersson, Carola; Andersson, Mattias K.; Rorkvist, Linda; Stahlberg, Anders; Aman, Pierre] Univ Gothenburg, Dept Pathol, Sahlgrenska Canc Ctr, Gothenburg, Sweden; [Danielsson, Anna] Univ Gothenburg, Sahlgrenska Univ Hosp, Inst Clin Sci, Dept Oncol, Gothenburg, Sweden; [Nerman, Olle] Chalmers, Dept Math Stat, S-41296 Gothenburg, Sweden; [Nerman, Olle] Univ Gothenburg, Dept Math Stat, Gothenburg, Sweden	Karolinska Institutet; University of Gothenburg; Sahlgrenska University Hospital; University of Gothenburg; Chalmers University of Technology; University of Gothenburg	Jauhiainen, A (corresponding author), Karolinska Inst, Dept Med Epidemiol & Biostat, Stockholm, Sweden.	pierre.aman@llcr.med.gu.se		Stahlberg, Anders/0000-0003-4243-0191; Aman, Pierre/0000-0002-1482-8875; Danielsson, Anna/0000-0002-2827-7429	Swedish Cancer Society; Assar Gabrielssons Research Foundation; Johan Jansson Foundation for Cancer Research; Swedish Children's Cancer Society; University of Gothenburg; Wilhelm and Martina Lundgren Foundation for Scientific Research; Swedish Research Council; Gothenburg Stochastic Centre; Gothenburg Mathematical Modeling Centre; Swedish Foundation for Strategic Research	Swedish Cancer Society(Swedish Cancer Society); Assar Gabrielssons Research Foundation; Johan Jansson Foundation for Cancer Research; Swedish Children's Cancer Society; University of Gothenburg; Wilhelm and Martina Lundgren Foundation for Scientific Research; Swedish Research Council(Swedish Research CouncilEuropean Commission); Gothenburg Stochastic Centre; Gothenburg Mathematical Modeling Centre; Swedish Foundation for Strategic Research(Swedish Foundation for Strategic Research)	This work was supported by grants from the Swedish Cancer Society, Assar Gabrielssons Research Foundation, Johan Jansson Foundation for Cancer Research, Swedish Children's Cancer Society, BioCARE National Strategic Research Program at University of Gothenburg, Wilhelm and Martina Lundgren Foundation for Scientific Research, the Swedish Research Council, the Gothenburg Stochastic Centre, Gothenburg Mathematical Modeling Centre, and the Swedish Foundation for Strategic Research. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adamson ED, 2002, TUMOR BIOL, V23, P93, DOI 10.1159/000059711; Agresti A, 2002, CATEGORICAL DATA ANA, Vxv; Andersson MK, 2008, BMC CELL BIOL, V9, DOI 10.1186/1471-2121-9-37; Araki E, 2003, EXP BIOL MED, V228, P1213, DOI 10.1177/153537020322801018; BARONE MV, 1994, GENE DEV, V8, P453, DOI 10.1101/gad.8.4.453; BATCHVAROVA N, 1995, EMBO J, V14, P4654, DOI 10.1002/j.1460-2075.1995.tb00147.x; Bento C, 2009, BMC CELL BIOL, V10, DOI 10.1186/1471-2121-10-89; Chen BPC, 1996, MOL CELL BIOL, V16, P1157, DOI 10.1128/mcb.16.3.1157; Chen ZD, 1998, NUCLEIC ACIDS RES, V26, P1126, DOI 10.1093/nar/26.4.1126; Chiribau CB, 2010, MOL CELL BIOL, V30, P3722, DOI 10.1128/MCB.01507-09; CROZAT A, 1993, NATURE, V363, P640, DOI 10.1038/363640a0; Cui KY, 2000, J BIOL CHEM, V275, P7591, DOI 10.1074/jbc.275.11.7591; Diakogiannaki E, 2007, J ENDOCRINOL, V194, P283, DOI 10.1677/JOE-07-0082; Engstrom K, 2006, AM J PATHOL, V168, P1642, DOI 10.2353/ajpath.2006.050872; Fawcett TW, 1999, BIOCHEM J, V339, P135, DOI 10.1042/0264-6021:3390135; Gachon F, 2001, FEBS LETT, V502, P57, DOI 10.1016/S0014-5793(01)02646-1; GATELY DP, 1994, BRIT J CANCER, V70, P1102, DOI 10.1038/bjc.1994.455; Gentleman RC, 2004, GENOME BIOL, V5, DOI 10.1186/gb-2004-5-10-r80; Goransson M, 2005, INT J CANCER, V115, P556, DOI 10.1002/ijc.20893; Goransson M, 2009, ONCOGENE, V28, P270, DOI 10.1038/onc.2008.378; Gotoh T, 2002, J BIOL CHEM, V277, P12343, DOI 10.1074/jbc.M107988200; Ishikawa F, 2009, J BIOCHEM, V146, P123, DOI 10.1093/jb/mvp052; JACKMAN J, 1994, CANCER RES, V54, P5656; Jousse C, 2001, NUCLEIC ACIDS RES, V29, P4341, DOI 10.1093/nar/29.21.4341; Jousse C, 1999, FEBS LETT, V448, P211, DOI 10.1016/S0014-5793(99)00373-7; Kel AE, 2003, NUCLEIC ACIDS RES, V31, P3576, DOI 10.1093/nar/gkg585; Krones-Herzig A, 2005, CANCER RES, V65, P5133, DOI 10.1158/0008-5472.CAN-04-3742; Li Y, 2008, J BIOL CHEM, V283, P22443, DOI 10.1074/jbc.M801046200; LITTLEWOOD TD, 1995, NUCLEIC ACIDS RES, V23, P1686, DOI 10.1093/nar/23.10.1686; Liu T, 2007, CELL DEATH DIFFER, V14, P411, DOI 10.1038/sj.cdd.4402022; Lorz C, 2004, J AM SOC NEPHROL, V15, P380, DOI 10.1097/01.ASN.0000111289.91206.B0; LUETHY JD, 1992, CANCER RES, V52, P5; Ma YJ, 2002, J MOL BIOL, V318, P1351, DOI 10.1016/S0022-2836(02)00234-6; Marciniak SJ, 2004, GENE DEV, V18, P3066, DOI 10.1101/gad.1250704; Matys V, 2006, NUCLEIC ACIDS RES, V34, pD108, DOI 10.1093/nar/gkj143; Maytin EV, 2001, EXP CELL RES, V267, P193, DOI 10.1006/excr.2001.5248; Mihailidou C, 2010, CELL PHYSIOL BIOCHEM, V25, P761, DOI 10.1159/000315096; Newman JRS, 2003, SCIENCE, V300, P2097, DOI 10.1126/science.1084648; Oyadomari S, 2004, CELL DEATH DIFFER, V11, P381, DOI 10.1038/sj.cdd.4401373; Oyadomari S, 2002, J CLIN INVEST, V109, P525, DOI 10.1172/JCI200214550; Pan YX, 2007, BIOCHEM J, V401, P299, DOI 10.1042/BJ20061261; Pereira RC, 2006, J CELL BIOCHEM, V97, P633, DOI 10.1002/jcb.20660; Persson F, 2008, CANCER LETT, V260, P37, DOI 10.1016/j.canlet.2007.10.032; RON D, 1992, GENE DEV, V6, P439, DOI 10.1101/gad.6.3.439; Shirakawa K, 2006, MOL CELL BIOL, V26, P6105, DOI 10.1128/MCB.02429-05; Singh VK, 2008, J MOL BIOL, V380, P313, DOI 10.1016/j.jmb.2008.04.069; Sok J, 1999, MOL CELL BIOL, V19, P495; Su N, 2008, J BIOL CHEM, V283, P35106, DOI 10.1074/jbc.M806874200; Tang JR, 2002, BIOCHEM BIOPH RES CO, V290, P1255, DOI 10.1006/bbrc.2002.6336; Thelin-Jarnum S, 2002, INT J CANCER, V97, P446, DOI 10.1002/ijc.1632; Thorp E, 2009, CELL METAB, V9, P474, DOI 10.1016/j.cmet.2009.03.003; Ubeda M, 1996, MOL CELL BIOL, V16, P1479; Vandesompele J, 2002, GENOME BIOL, V3, DOI 10.1186/gb-2002-3-7-research0034; Wang XZ, 1998, EMBO J, V17, P3619, DOI 10.1093/emboj/17.13.3619; WEDEL A, 1995, IMMUNOBIOLOGY, V193, P171, DOI 10.1016/S0171-2985(11)80541-3; Yu J, 2007, CELL DEATH DIFFER, V14, P436, DOI 10.1038/sj.cdd.4402029; Zinszner H, 1998, GENE DEV, V12, P982, DOI 10.1101/gad.12.7.982	57	71	78	6	19	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 9	2012	7	4							e33208	10.1371/journal.pone.0033208	http://dx.doi.org/10.1371/journal.pone.0033208			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	955JO	22496745	gold, Green Published			2022-12-25	WOS:000305014500010
J	Ojuromi, OT; Izquierdo, F; Fenoy, S; Fagbenro-Beyioku, A; Oyibo, W; Akanmu, A; Odunukwe, N; Henriques-Gil, N; del Aguila, C				Ojuromi, Oladele Teslim; Izquierdo, Fernando; Fenoy, Soledad; Fagbenro-Beyioku, Adetayo; Oyibo, Wellington; Akanmu, Alani; Odunukwe, Nkiruka; Henriques-Gil, Nuno; del Aguila, Carmen			Identification and Characterization of Microsporidia from Fecal Samples of HIV-Positive Patients from Lagos, Nigeria	PLOS ONE			English	Article							POLYMERASE-CHAIN-REACTION; ENTEROCYTOZOON-BIENEUSI GENOTYPES; VIRUS-INFECTED PATIENTS; INTESTINAL MICROSPORIDIOSIS; ENCEPHALITOZOON-INTESTINALIS; SEPTATA-INTESTINALIS; NEGATIVE PATIENTS; PERSISTENT DIARRHEA; BIOPSY SPECIMENS; STOOL SAMPLES	Background: Microsporidia are obligate intracellular parasites that infect a broad range of vertebrates and invertebrates. They have been increasingly recognized as human pathogens in AIDS patients, mainly associated with a life-threatening chronic diarrhea and systemic disease. However, to date the global epidemiology of human microsporidiosis is poorly understood, and recent data suggest that the incidence of these pathogens is much higher than previously reported and may represent a neglected etiological agent of more common diseases indeed in immunocompetent individuals. To contribute to the knowledge of microsporidia molecular epidemiology in HIV-positive patients in Nigeria, the authors tested stool samples proceeding from patients with and without diarrhea. Methodology/Principal Findings: Stool samples from 193 HIV-positive patients with and without diarrhea (67 and 126 respectively) from Lagos (Nigeria) were investigated for the presence of microsporidia and Cryptosporidium using Weber's Chromotrope-based stain, Kinyoun stain, IFAT and PCR. The Weber stain showed 45 fecal samples (23.3%) with characteristic microsporidia spores, and a significant association of microsporidia with diarrhea was observed (O.R. = 18.2; CI: 95%). A similar result was obtained using Kinyoun stain, showing 44 (31,8%) positive samples with structures morphologically compatible with Cryptosporidium sp, 14 (31.8%) of them with infection mixed with microsporidia. The characterization of microsporidia species by IFAT and PCR allowed identification of Enterocytozoon bieneusi, Encephalitozoon intestinalis and E. cuniculi in 5, 2 and 1 samples respectively. The partial sequencing of the ITS region of the rRNA genes showed that the three isolates of E. bieneusi studied are included in Group I, one of which bears the genotype B. Conclusions/Significance: To our knowledge, this is the first report of microsporidia characterization in fecal samples from HIV-positive patients from Lagos, Nigeria. These results focus attention on the need to include microsporidial diagnosis in the management of HIV/AIDS infection in Nigeria, at the very least when other more common pathogens have not been detected.	[Ojuromi, Oladele Teslim] Lagos State Univ, Fac Sci, Dept Zool, Lagos, Nigeria; [Izquierdo, Fernando; Fenoy, Soledad; Henriques-Gil, Nuno; del Aguila, Carmen] CEU San Pablo, Fac Farm, Madrid, Spain; [Ojuromi, Oladele Teslim; Fagbenro-Beyioku, Adetayo; Oyibo, Wellington] Univ Lagos, Coll Med, Dept Med Microbiol & Parasitol, Lagos, Nigeria; [Akanmu, Alani] Univ Lagos, Coll Med, Dept Hematol, Lagos, Nigeria; [Odunukwe, Nkiruka] Nigerian Inst Med Res, Div Clin Res, Lagos, Nigeria	Lagos State University; San Pablo CEU University; University of Lagos; University of Lagos	Ojuromi, OT (corresponding author), Lagos State Univ, Fac Sci, Dept Zool, Lagos, Nigeria.	cagupue@ceu.es	del Aguila, Carmen/A-6063-2016; Arias, Fernando Izquierdo/AAE-3073-2019; Fenoy, Soledad/A-9633-2016	del Aguila, Carmen/0000-0003-0063-7899; Arias, Fernando Izquierdo/0000-0003-0367-007X; Fenoy, Soledad/0000-0002-5218-6308; Akanmu, Alani Sulaimon/0000-0001-7424-6060; Oyibo, Wellington/0000-0002-5730-5396	Fundacion San Pablo-CEU [USP-PC03/08]	Fundacion San Pablo-CEU	This work was supported by a grant from Fundacion San Pablo-CEU USP-PC03/08, and Lagos State University, Ojo, Nigeria, assisted for the visit of OTO to Spain. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Accoceberry I, 1999, J CLIN MICROBIOL, V37, P4107, DOI 10.1128/JCM.37.12.4107-4112.1999; ALDRAS AM, 1994, J CLIN MICROBIOL, V32, P608, DOI 10.1128/JCM.32.3.608-612.1994; Ayinmode A. B., 2011, Journal of Parasitology Research, V2011, P129542, DOI 10.1155/2011/129542; Bandelt HJ, 1999, MOL BIOL EVOL, V16, P37, DOI 10.1093/oxfordjournals.molbev.a026036; Bern C, 2005, J INFECT DIS, V191, P1658, DOI 10.1086/429674; BOOM R, 1990, J CLIN MICROBIOL, V28, P495, DOI 10.1128/JCM.28.3.495-503.1990; Bornay-Llinares FJ, 1998, J INFECT DIS, V178, P820, DOI 10.1086/515356; BRETAGNE S, 1993, B SOC PATHOL EXOT, V86, P351; Breton J, 2007, J CLIN MICROBIOL, V45, P2580, DOI 10.1128/JCM.02554-06; Carlson James R, 2004, Arch Pathol Lab Med, V128, pe41; Carville A, 1997, CLIN DIAGN LAB IMMUN, V4, P405, DOI 10.1128/CDLI.4.4.405-408.1997; Cegielski JP, 1999, CLIN INFECT DIS, V28, P314, DOI 10.1086/515131; Chabchoub N, 2009, AM J TROP MED HYG, V80, P24, DOI 10.4269/ajtmh.2009.80.24; Cisse OA, 2002, J CLIN MICROBIOL, V40, P1715, DOI 10.1128/JCM.40.5.1715-1718.2002; DaSilva AJ, 1996, J CLIN MICROBIOL, V34, P986, DOI 10.1128/JCM.34.4.986-987.1996; DaSilva AJ, 1997, MOL DIAGN, V2, P47, DOI 10.1016/S1084-8592(97)80010-0; Del Aguila C, 1999, J EUKARYOT MICROBIOL, V46, p8S; del Aguila C, 2001, J CLIN MICROBIOL, V39, P1105, DOI 10.1128/JCM.39.3.1105-1108.2001; Del Aguila C, 1997, J EUKARYOT MICROBIOL, V44, p84S, DOI 10.1111/j.1550-7408.1997.tb05798.x; delAguila C, 1997, J CLIN MICROBIOL, V35, P1862, DOI 10.1128/JCM.35.7.1862-1866.1997; Didier ES, 2005, ACTA TROP, V94, P61, DOI 10.1016/j.actatropica.2005.01.010; Didier ES, 2004, VET PARASITOL, V126, P145, DOI 10.1016/j.vetpar.2004.09.006; Endeshaw T, 2006, JPN J INFECT DIS, V59, P306; Espern A, 2007, J CLIN MICROBIOL, V45, P2999, DOI 10.1128/JCM.00684-07; FEDORKO DP, 1995, J CLIN MICROBIOL, V33, P1739, DOI 10.1128/JCM.33.7.1739-1741.1995; Ferreira FMB, 2001, MICROBES INFECT, V3, P1015, DOI 10.1016/S1286-4579(01)01465-4; Foster P, 2001, MOL BIOL EVOL, V18, P1864; Franzen C, 1999, CLIN MICROBIOL REV, V12, P243, DOI 10.1128/CMR.12.2.243; Gainzarain JC, 1998, CLIN INFECT DIS, V27, P394, DOI 10.1086/514660; GARCIA LS, 1994, J CLIN MICROBIOL, V32, P1739, DOI 10.1128/JCM.32.7.1739-1741.1994; Garcia LS, 2007, DIAGNOSTIC MED PARAS, V5th; Gumbo T, 1999, AIDS, V13, P819, DOI 10.1097/00002030-199905070-00011; Hall T.A., 1999, NUCL ACIDS S SERIES, V41, P95, DOI [DOI 10.1021/BK-1999-0734.CH008, citeulike-article-id:691774, 10.12691/ajmr-6-4-3]; Haro M, 2005, APPL ENVIRON MICROB, V71, P3153, DOI 10.1128/AEM.71.6.3153-3157.2005; Haro M, 2003, J CLIN MICROBIOL, V41, P4166, DOI 10.1128/JCM.41.9.4166-4171.2003; Haro M, 2006, J EUKARYOT MICROBIOL, V53, pS58, DOI 10.1111/j.1550-7408.2006.00173.x; Henriques-Gil N, APPL ENV MICROBIOL, V76, P3333; Henriques-Gil N, 2010, APPL ENVIRON MICROB, V76, P3333, DOI 10.1128/AEM.03026-09; Ikeh E I, 2007, Niger Postgrad Med J, V14, P290; KELLY P, 1994, LANCET, V344, P271, DOI 10.1016/S0140-6736(94)93039-2; Kucerova-Pospisilova Z, 1998, FOLIA PARASIT, V45, P108; Latib MA, 2001, TRANSPLANT INT, V14, P274, DOI 10.1111/j.1432-2277.2001.tb00058.x; Lebbad M, 2001, ACTA TROP, V80, P45, DOI 10.1016/S0001-706X(01)00142-5; Leelayoova S, 2006, J CLIN MICROBIOL, V44, P3001, DOI 10.1128/JCM.00945-06; Liguory O, 1997, AIDS, V11, P723, DOI 10.1097/00002030-199706000-00004; Lores B, 2002, CLIN INFECT DIS, V34, P918, DOI 10.1086/339205; Lobo ML, 2006, APPL ENVIRON MICROB, V72, P7380, DOI 10.1128/AEM.01394-06; Maiga I, 1997, Sante, V7, P257; Mathis A, 1999, PARASITE, V6, P189, DOI 10.1051/parasite/1999062189; Metge S, 2000, EUR J CLIN MICROBIOL, V19, P221, DOI 10.1007/s100960050463; Mohindra A R, 2002, Transpl Infect Dis, V4, P102, DOI 10.1034/j.1399-3062.2002.01011.x; Mor SM, 2009, EMERG INFECT DIS, V15, P49, DOI 10.3201/eid1501.071536; MORALES MAG, 1995, TROP MED PARASITOL, V46, P109; Muller A, 2001, J CLIN MICROBIOL, V39, P1630, DOI 10.1128/JCM.39.4.1630-1632.2001; Nkinin SW, 2007, J CLIN MICROBIOL, V45, P2841, DOI 10.1128/JCM.00328-07; Notermans DW, 2005, J CLIN MICROBIOL, V43, P610, DOI 10.1128/JCM.43.2.610-614.2005; Okewole EA, 2008, ONDERSTEPOORT J VET, V75, P33; Rozas J, 2003, BIOINFORMATICS, V19, P2496, DOI 10.1093/bioinformatics/btg359; Sadler F, 2002, J INFECTION, V44, P39, DOI 10.1053/jinf.2001.0934; Sak B, 2011, PLOS NEGLECT TROP D, V5, DOI 10.1371/journal.pntd.0001162; Samie A, 2007, T ROY SOC TROP MED H, V101, P547, DOI 10.1016/j.trstmh.2007.02.005; Santin M, 2005, PARASITOL RES, V97, P535, DOI 10.1007/s00436-005-1482-8; Santin M, 2009, J EUKARYOT MICROBIOL, V56, P34, DOI 10.1111/j.1550-7408.2008.00380.x; Sarfati C, 2006, AM J TROP MED HYG, V74, P162, DOI 10.4269/ajtmh.2006.74.162; SERWADDA D, 1985, LANCET, V2, P849, DOI 10.1016/S0140-6736(85)90122-9; Sianongo S, 2001, T ROY SOC TROP MED H, V95, P605, DOI 10.1016/S0035-9203(01)90093-8; Sing A, 2001, J CLIN MICROBIOL, V39, P2371, DOI 10.1128/JCM.39.6.2371-2372.2001; Stark D, 2009, CLIN MICROBIOL REV, V22, P634, DOI 10.1128/CMR.00017-09; Subrungruang I, 2004, J CLIN MICROBIOL, V42, P3490, DOI 10.1128/JCM.42.8.3490-3494.2004; Sulaiman IM, 2003, J EUKARYOT MICROBIOL, V50, P591, DOI 10.1111/j.1550-7408.2003.tb00642.x; Ten Hove RJ, 2009, J EUKARYOT MICROBIOL, V56, P388, DOI 10.1111/j.1550-7408.2009.00393.x; THOMPSON JD, 1994, NUCLEIC ACIDS RES, V22, P4673, DOI 10.1093/nar/22.22.4673; Tumwine JK, 2005, AM J TROP MED HYG, V73, P921, DOI 10.4269/ajtmh.2005.73.921; Tumwine JK, 2002, AM J TROP MED HYG, V67, P299, DOI 10.4269/ajtmh.2002.67.299; VANGOOL T, 1995, T ROY SOC TROP MED H, V89, P478, DOI 10.1016/0035-9203(95)90073-X; vanGool T, 1997, J INFECT DIS, V175, P1020, DOI 10.1086/513963; VISVESVARA GS, 1994, J CLIN MICROBIOL, V32, P2760, DOI 10.1128/JCM.32.11.2760-2768.1994; WEBER R, 1992, NEW ENGL J MED, V326, P161, DOI 10.1056/NEJM199201163260304; WEBER R, 1993, CLIN INFECT DIS, V17, P480, DOI 10.1093/clinids/17.3.480; Xiao L, 2004, SE ASIAN J TROP MED, V35, P40	80	34	35	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 9	2012	7	4							e35239	10.1371/journal.pone.0035239	http://dx.doi.org/10.1371/journal.pone.0035239			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	955JO	22496910	Green Published, Green Submitted, gold			2022-12-25	WOS:000305014500050
J	Arun, P; Oguntayo, S; Alamneh, Y; Honnold, C; Wang, Y; Valiyaveettil, M; Long, JB; Nambiar, MP				Arun, Peethambaran; Oguntayo, Samuel; Alamneh, Yonas; Honnold, Cary; Wang, Ying; Valiyaveettil, Manojkumar; Long, Joseph B.; Nambiar, Madhusoodana P.			Rapid Release of Tissue Enzymes into Blood after Blast Exposure: Potential Use as Biological Dosimeters	PLOS ONE			English	Article							TRAUMATIC BRAIN-INJURY; LITHOTRIPTER SHOCK-WAVES; EXPLOSIVE BLAST; RATS; DAMAGE; PERMEABILIZATION; OVERPRESSURE; AFGHANISTAN; MEMBRANE; PROTEINS	Explosive blast results in multiple organ injury and polytrauma, the intensity of which varies with the nature of the exposure, orientation, environment and individual resilience. Blast overpressure alone may not precisely indicate the level of body or brain injury after blast exposure. Assessment of the extent of body injury after blast exposure is important, since polytrauma and systemic factors significantly contribute to blast-induced traumatic brain injury. We evaluated the activity of plasma enzymes including aspartate aminotransferase (AST), alanine aminotransferase (ALT), lactate dehydrogenase (LDH) and creatine kinase (CK) at different time points after blast exposure using a mouse model of single and repeated blast exposures to assess the severity of injury. Our data show that activities of all the enzymes in the plasma were significantly increased as early as 1 h after blast exposure. The elevated enzyme activity remained up to 6 h in an overpressure dose-dependent manner and returned close to normal levels at 24 h. Head-only blast exposure with body protection showed no increase in the enzyme activities suggesting that brain injury alone does not contribute to the systemic increase. In contrast to plasma increase, AST, ALT and LDH activity in the liver and CK in the skeletal muscle showed drastic decrease at 6 h after blast exposures. Histopathology showed mild necrosis at 6 h and severe necrosis at 24 h after blast exposures in liver and no changes in the skeletal muscle suggesting that the enzyme release from the tissue to plasma is probably triggered by transient cell membrane disruption from shockwave and not due to necrosis. Overpressure dependent transient release of tissue enzymes and elevation in the plasma after blast exposure suggest that elevated enzyme activities in the blood can be potentially used as a biological dosimeter to assess the severity of blast injury.	[Arun, Peethambaran; Oguntayo, Samuel; Alamneh, Yonas; Wang, Ying; Valiyaveettil, Manojkumar; Long, Joseph B.; Nambiar, Madhusoodana P.] Walter Reed Army Inst Res, Blast Induced Neurotrauma Branch, Ctr Mil Psychiat & Neurosci, Silver Spring, MD USA; [Honnold, Cary] Walter Reed Army Inst Res, Vet Serv Program, Div Pathol, Silver Spring, MD USA	United States Department of Defense; United States Army; Walter Reed Army Institute of Research (WRAIR); United States Department of Defense; United States Army; Walter Reed Army Institute of Research (WRAIR)	Arun, P (corresponding author), Walter Reed Army Inst Res, Blast Induced Neurotrauma Branch, Ctr Mil Psychiat & Neurosci, Silver Spring, MD USA.	madhusoodana.nambiar@amedd.army.mil			Congressionally Directed Medical Research Programs grant [W81XWH-08-2-0017]	Congressionally Directed Medical Research Programs grant	The study was supported by Congressionally Directed Medical Research Programs grant (Award Number W81XWH-08-2-0017) to JBL. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Armonda RA, 2006, NEUROSURGERY, V59, P1215, DOI 10.1227/01.NEU.0000249190.46033.94; Arun P, 2011, NEUROREPORT, V22, P379, DOI 10.1097/WNR.0b013e328346b138; Avidan V, 2005, AM J SURG, V190, P927, DOI 10.1016/j.amjsurg.2005.08.022; Bassit RA, 2010, EUR J APPL PHYSIOL, V108, P945, DOI 10.1007/s00421-009-1305-1; Bauman RA, 2009, J NEUROTRAUM, V26, P841, DOI [10.1089/neu.2008.0898, 10.1089/neu.2009-0898]; Bell RS, 2010, NEUROSURG FOCUS, V28, DOI 10.3171/2010.2.FOCUS1025; Cernak Ibolja, 2010, Front Neurol, V1, P151, DOI 10.3389/fneur.2010.00151; Chavko M, 2008, J TRAUMA, V65, P1140, DOI 10.1097/TA.0b013e3181870a8c; Chavko M, 2011, J NEUROSCI METH, V195, P61, DOI 10.1016/j.jneumeth.2010.11.019; Chavko M, 2009, SHOCK, V32, P325, DOI 10.1097/SHK.0b013e31819c38f1; Courtney AC, 2009, MED HYPOTHESES, V72, P76, DOI 10.1016/j.mehy.2008.08.015; Courtney MW, 2011, NEUROIMAGE, V54, pS55, DOI 10.1016/j.neuroimage.2010.05.025; Cullen DK, 2011, NEUROIMAGE, V54, pS37, DOI 10.1016/j.neuroimage.2010.10.076; Delius M, 1999, CANCER RES, V59, P5227; DePalma RG, 2005, NEW ENGL J MED, V352, P1335, DOI 10.1056/NEJMra042083; Devarajan P, 2011, CURR OPIN PEDIATR, V23, P194, DOI 10.1097/MOP.0b013e328343f4dd; DOUKAS AG, 1993, ULTRASOUND MED BIOL, V19, P137, DOI 10.1016/0301-5629(93)90006-A; Elsayed NM, 2000, TOXICOLOGY, V155, P91, DOI 10.1016/S0300-483X(00)00281-X; GAMBIHLER S, 1994, J MEMBRANE BIOL, V141, P267; GAMBIHLER S, 1992, NATURWISSENSCHAFTEN, V79, P328, DOI 10.1007/BF01138714; Garner Jeff, 2007, Anesthesiol Clin, V25, P147; Gorbunov NV, 2006, EXP MOL PATHOL, V80, P11, DOI 10.1016/j.yexmp.2005.06.007; Jeyaseelan K, 2008, STROKE, V39, P959, DOI 10.1161/STROKEAHA.107.500736; Kodama T, 2000, BIOPHYS J, V79, P1821, DOI 10.1016/S0006-3495(00)76432-0; Koliatsos VE, 2011, J NEUROPATH EXP NEUR, V70, P399, DOI 10.1097/NEN.0b013e3182189f06; Laterza OF, 2009, CLIN CHEM, V55, P1977, DOI 10.1373/clinchem.2009.131797; Ling G, 2009, J NEUROTRAUM, V26, P815, DOI 10.1089/neu.2007.0484; Long JB, 2009, J NEUROTRAUM, V26, P827, DOI 10.1089/neu.2008.0748; Morochovic R, 2009, EUR J NEUROL, V16, P1112, DOI 10.1111/j.1468-1331.2009.02653.x; Nakagawa A, 2011, J NEUROTRAUM, V28, P1101, DOI 10.1089/neu.2010.1442; Pun Pamela B L, 2011, Front Neurol, V2, P19, DOI 10.3389/fneur.2011.00019; Reagan WJ, 2010, TOXICOL PATHOL, V38, P1134, DOI 10.1177/0192623310382438; Redell JB, 2010, J NEUROTRAUM, V27, P2147, DOI 10.1089/neu.2010.1481; Shahshahani MM, 2011, J DERMATOL, V38, P1153, DOI 10.1111/j.1346-8138.2011.01278.x; Singab ANB, 2005, ARCH PHARM RES, V28, P791, DOI 10.1007/BF02977344; Sorichter S, 1999, EXERC IMMUNOL REV, V5, P5; Wallace D, 2009, AUSTRALAS PSYCHIATRY, V17, P218, DOI 10.1080/10398560902878679; Wang Y, 2011, J NEUROTRAUM, V28, P2171, DOI 10.1089/neu.2011.1990; Warden D, 2006, J HEAD TRAUMA REHAB, V21, P398, DOI 10.1097/00001199-200609000-00004; Wightman JM, 2001, ANN EMERG MED, V37, P664, DOI 10.1067/mem.2001.114906; Yamaguchi M, 2002, MOL CELL BIOCHEM, V241, P61, DOI 10.1023/A:1020822610085; Zurek J, 2012, ACTA NEUROCHIR, V154, P93, DOI 10.1007/s00701-011-1175-2	42	20	22	0	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 6	2012	7	4							e33798	10.1371/journal.pone.0033798	http://dx.doi.org/10.1371/journal.pone.0033798			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	955JA	22493674	Green Published, gold, Green Submitted			2022-12-25	WOS:000305012700016
J	Cui, L; Li, T; Liu, YY; Zhou, L; Li, PH; Xu, BL; Huang, LF; Chen, Y; Liu, YZ; Tian, XY; Jee, WSS; Wu, T				Cui, Liao; Li, Ting; Liu, Yuyu; Zhou, Le; Li, Pinghua; Xu, Bilian; Huang, Lianfang; Chen, Yan; Liu, Yanzhi; Tian, Xiaoyan; Jee, Webster S. S.; Wu, Tie			Salvianolic Acid B Prevents Bone Loss in Prednisone-Treated Rats through Stimulation of Osteogenesis and Bone Marrow Angiogenesis	PLOS ONE			English	Article							TRABECULAR BONE; DIFFERENTIATION; OSTEOBLASTS; MILTIORRHIZA; CELLS; EXPRESSION; BEAGLE; HISTOMORPHOMETRY; GLUCOCORTICOIDS; OSTEONECROSIS	Glucocorticoid (GC) induced osteoporosis (GIO) is caused by the long-term use of GC for treatment of autoimmune and inflammatory diseases. The GC related disruption of bone marrow microcirculation and increased adipogenesis contribute to GIO development. However, neither currently available anti-osteoporosis agent is completely addressed to microcirculation and bone marrow adipogenesis. Salvianolic acid B (Sal B) is a polyphenolic compound from a Chinese herbal medicine, Salvia miltiorrhiza Bunge. The aim of this study was to determine the effects of Sal B on osteoblast bone formation, angiogenesis and adipogenesis-associated GIO by performing marrow adipogenesis and microcirculation dilation and bone histomorphometry analyses. (1) In vivo study: Bone loss in GC treated rats was confirmed by significantly decreased BMD, bone strength, cancellous bone mass and architecture, osteoblast distribution, bone formation, marrow microvessel density and diameter along with down-regulation of marrow BMPs expression and increased adipogenesis. Daily treatment with Sal B (40 mg/kg/d) for 12 weeks in GC male rats prevented GC-induced cancellous bone loss and increased adipogenesis while increasing cancellous bone formation rate with improved local microcirculation by capillary dilation. Treatment with Sal B at a higher dose (80 mg/kg/d) not only prevented GC-induced osteopenia, but also increased cancellous bone mass and thickness, associated with increase of marrow BMPs expression, inhibited adipogenesis and further increased microvessel diameters. (2) In vitro study: In concentration from 10(-6) mol/L to 10(-7) mol/L, Sal B stimulated bone marrow stromal cell (MSC) differentiation to osteoblast and increased osteoblast activities, decreased GC associated adipogenic differentiation by down-regulation of PPAR gamma mRNA expression, increased Runx2 mRNA expression without osteoblast inducement, and, furthermore, Sal B decreased Dickkopf-1 and increased beta-catenin mRNA expression with or without adipocyte inducement in MSC. We conclude that Sal B prevented bone loss in GC-treated rats through stimulation of osteogenesis, bone marrow angiogenesis and inhibition of adipogenesis.	[Cui, Liao; Li, Ting; Liu, Yuyu; Zhou, Le; Li, Pinghua; Xu, Bilian; Huang, Lianfang; Chen, Yan; Liu, Yanzhi; Wu, Tie] Guangdong Med Coll, Guangdong Key Lab Res & Dev Nat Drug, Dept Pharmacol, Zhanjiang City, Guangdong, Peoples R China; [Cui, Liao; Tian, Xiaoyan; Jee, Webster S. S.] Univ Utah, Sch Med, Div Radiobiol, Salt Lake City, UT 84112 USA	Guangdong Medical University; Utah System of Higher Education; University of Utah	Cui, L (corresponding author), Guangdong Med Coll, Guangdong Key Lab Res & Dev Nat Drug, Dept Pharmacol, Zhanjiang City, Guangdong, Peoples R China.	wutie2@163.com	Liu, Yanzhi/P-6387-2014; Li, Ping/GYV-4914-2022		National Science Foundation of China [30672470, 30973574]	National Science Foundation of China(National Natural Science Foundation of China (NSFC))	This work was supported by grants from the National Science Foundation of China (No: 30672470 and No: 30973574). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adams James David, 2006, Chin Med, V1, P3, DOI 10.1186/1749-8546-1-3; Baron R, 1983, BONE HISTOMORPHOMETR, P22; Blair HC, 2007, ANN NY ACAD SCI, V1116, P165, DOI 10.1196/annals.1402.029; Brandi ML, 2006, J BONE MINER RES, V21, P183, DOI 10.1359/JBMR.050917; Branemark PI, 1958, SCAND J CLIN LAB S38, V11, P1; Canalis Ernesto, 2005, Curr Osteoporos Rep, V3, P98, DOI 10.1007/s11914-005-0017-7; Chinese Pharmacopoeia Commission, 2005, PHARM PEOPL REP CH 1; Cui L, 2001, ACTA PHARMACOL SIN, V22, P428; Cui L, 2009, ACTA PHARMACOL SIN, V30, P321, DOI 10.1038/aps.2009.9; Das A, 2011, TISSUE ENG PART B-RE, V17, P403, DOI [10.1089/ten.teb.2011.0190, 10.1089/ten.TEB.2011.0190]; Day TF, 2005, DEV CELL, V8, P739, DOI 10.1016/j.devcel.2005.03.016; Eghbali-Fatourechi GZ, 2005, NEW ENGL J MED, V352, P1959, DOI 10.1056/NEJMoa044264; Eriksen EF, 2007, J BONE MINER RES, V22, P1, DOI 10.1359/JBMR.060910; Ersoy A, 2006, NEPHROL DIAL TRANSPL, V21, P1452, DOI 10.1093/ndt/gfi342; Hamidouche Z, 2008, FASEB J, V22, P3813, DOI 10.1096/fj.08-106302; Hauge EM, 2001, J BONE MINER RES, V16, P1575, DOI 10.1359/jbmr.2001.16.9.1575; He HB, 2008, PHARMACOL REP, V60, P369; [胡长根 Hu Changgen], 2004, [中华骨科杂志, Chinese Journal of Orthopedics], V24, P359; Ito S, 2007, BONE, V40, P84, DOI 10.1016/j.bone.2006.07.012; Jee WSS, 1997, HDB BONE MORPHOLOGY, P87; Ji XY, 2000, ACTA PHARMACOL SIN, V21, P1089; Kang DG, 2003, PHYTOTHER RES, V17, P917, DOI 10.1002/ptr.1250; Kerachian MA, 2009, J STEROID BIOCHEM, V114, P121, DOI 10.1016/j.jsbmb.2009.02.007; Khan E, 2003, J LAB CLIN MED, V142, P29, DOI 10.1016/S0022-2143(03)00058-1; Kitajima M, 2007, MED MOL MORPHOL, V40, P150, DOI 10.1007/s00795-007-0367-6; Kuznetsov SA, 2001, J CELL BIOL, V153, P1133, DOI 10.1083/jcb.153.5.1133; Lam FFY, 2006, EUR J PHARMACOL, V553, P240, DOI 10.1016/j.ejphar.2006.09.030; Li GS, 2009, TOXICOL MECH METHOD, V19, P441, DOI 10.1080/15376510903150623; Li YG, 2009, J CHROMATOGR A, V1216, P1941, DOI 10.1016/j.chroma.2008.12.032; Liebschner MAK, 2005, ANN BIOMED ENG, V33, P26, DOI 10.1007/s10439-005-8960-0; Lu BY, 2010, CELL BIOL INT, V34, P1063, DOI 10.1042/CBI20090126; Luppen CA, 2008, GROWTH FACTORS, V26, P226, DOI 10.1080/08977190802277880; Marx N, 1998, CIRC RES, V83, P1097, DOI 10.1161/01.RES.83.11.1097; Miyanishi K, 2002, BONE, V30, P185, DOI 10.1016/S8756-3282(01)00663-9; Nakashima K, 2002, CELL, V108, P17, DOI 10.1016/S0092-8674(01)00622-5; Ohnaka K, 2004, BIOCHEM BIOPH RES CO, V318, P259, DOI 10.1016/j.bbrc.2004.04.025; Ohnaka Keizo, 2006, Clin Calcium, V16, P1812; Padro T, 2000, BLOOD, V95, P2637, DOI 10.1182/blood.V95.8.2637.008k07_2637_2644; Parfitt AM, 1998, BONE, V23, P491, DOI 10.1016/S8756-3282(98)00140-9; PARFITT AM, 1987, J BONE MINER RES, V2, P595, DOI 10.1002/jbmr.5650020617; PARFITT AM, 1995, CALCIFIED TISSUE INT, V56, pS5, DOI 10.1007/BF03354639; Partfitt AM, 2008, OSTEOPOROSIS, P71; REEVE J, 1988, J CLIN ENDOCR METAB, V66, P1124, DOI 10.1210/jcem-66-6-1124; Shah SK, 2006, J AM OSTEOPATH ASSOC, V106, P653; Sun Yu, 2008, Zhongguo Yaolixue Tongbao, V24, P377; Tian XY, 2010, BONE, V47, P529, DOI 10.1016/j.bone.2010.05.032; VAN DYKE DONALD, 1967, CLIN ORTHOP RELATED RES, V52, P37; [汪红 Wang Hong], 2002, [中国药科大学学报, Journal of China Pharmaceutical University], V33, P219; WEIDNER N, 1995, BREAST CANCER RES TR, V36, P169, DOI 10.1007/BF00666038; Weinstein RS, 2010, BONE, V46, P564, DOI 10.1016/j.bone.2009.06.030; WRONSKI TJ, 1981, CALCIFIED TISSUE INT, V33, P583, DOI 10.1007/BF02409495; WRONSKI TJ, 1980, RADIAT RES, V83, P74, DOI 10.2307/3575260; Yin L, 2006, CHINESE MED J-PEKING, V119, P581, DOI 10.1097/00029330-200604010-00012; Zhong Jing, 2007, Yaoxue Xuebao, V42, P716; Zhou LM, 2005, J CLIN PHARMACOL, V45, P1345, DOI 10.1177/0091270005282630	55	90	100	2	31	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 6	2012	7	4							e34647	10.1371/journal.pone.0034647	http://dx.doi.org/10.1371/journal.pone.0034647			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	955JA	22493705	Green Published, gold, Green Submitted			2022-12-25	WOS:000305012700047
J	Gibson, NJ; Tolbert, LP; Oland, LA				Gibson, Nicholas J.; Tolbert, Leslie P.; Oland, Lynne A.			Activation of Glial FGFRs Is Essential in Glial Migration, Proliferation, and Survival and in Glia-Neuron Signaling during Olfactory System Development	PLOS ONE			English	Article							FIBROBLAST-GROWTH-FACTOR; MOTH MANDUCA-SEXTA; HEPARAN-SULFATE PROTEOGLYCANS; SENSORY AXON GUIDANCE; FACTOR RECEPTOR; ANTENNAL LOBES; EMBRYONIC-DEVELOPMENT; CELL-PROLIFERATION; NEURITE OUTGROWTH; NERVOUS-SYSTEM	Development of the adult olfactory system of the moth Manduca sexta depends on reciprocal interactions between olfactory receptor neuron (ORN) axons growing in from the periphery and centrally-derived glial cells. Early-arriving ORN axons induce a subset of glial cells to proliferate and migrate to form an axon-sorting zone, in which later-arriving ORN axons will change their axonal neighbors and change their direction of outgrowth in order to travel with like axons to their target areas in the olfactory (antennal) lobe. These newly fasciculated axon bundles will terminate in protoglomeruli, the formation of which induces other glial cells to migrate to surround them. Glial cells do not migrate unless ORN axons are present, axons fail to fasciculate and target correctly without sufficient glial cells, and protoglomeruli are not maintained without a glial surround. We have shown previously that Epidermal Growth Factor receptors and the IgCAMs Neuroglian and Fasciclin II play a role in the ORN responses to glial cells. In the present work, we present evidence for the importance of glial Fibroblast Growth Factor receptors in glial migration, proliferation, and survival in this developing pathway. We also report changes in growth patterns of ORN axons and of the dendrites of olfactory (antennal lobe) neurons following blockade of glial FGFR activation that suggest that glial FGFR activation is important in reciprocal communication between neurons and glial cells.	[Gibson, Nicholas J.; Tolbert, Leslie P.; Oland, Lynne A.] Univ Arizona, Dept Neurosci, Tucson, AZ 85721 USA	University of Arizona	Gibson, NJ (corresponding author), Univ Arizona, Dept Neurosci, Tucson, AZ 85721 USA.	njgibson@neurobio.arizona.edu			National Institutes of Health [DC008597]; NATIONAL INSTITUTE ON DEAFNESS AND OTHER COMMUNICATION DISORDERS [R01DC008597] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE ON DEAFNESS AND OTHER COMMUNICATION DISORDERS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Deafness & Other Communication Disorders (NIDCD))	This work was supported by National Institutes of Health DC008597 (http://nih.gov/). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Auld V, 1999, CELL MOL LIFE SCI, V55, P1377, DOI 10.1007/s000180050378; Bashaw GJ, 2010, CSH PERSPECT BIOL, V2, DOI 10.1101/cshperspect.a001941; Baumann PM, 1996, J COMP NEUROL, V373, P118; Beiman M, 1996, GENE DEV, V10, P2993, DOI 10.1101/gad.10.23.2993; Biscardi JS, 1999, J BIOL CHEM, V274, P8335, DOI 10.1074/jbc.274.12.8335; Bryant MR, 2009, GLIA, V57, P935, DOI 10.1002/glia.20818; Chotard C, 2004, TRENDS NEUROSCI, V27, P655, DOI 10.1016/j.tins.2004.09.001; Chotard C, 2007, NEURON GLIA BIOL, V3, P17, DOI 10.1017/S1740925X07000592; Combet C, 2000, TRENDS BIOCHEM SCI, V25, P147, DOI 10.1016/S0968-0004(99)01540-6; Condron B, 1999, DEVELOPMENT, V126, P4635; Doherty P, 1996, MOL CELL NEUROSCI, V8, P99, DOI 10.1006/mcne.1996.0049; Dossenbach C, 2001, DEVELOPMENT, V128, P4563; EMORI Y, 1993, FEBS LETT, V332, P111, DOI 10.1016/0014-5793(93)80494-F; Eswarakumar VP, 2005, CYTOKINE GROWTH F R, V16, P139, DOI 10.1016/j.cytogfr.2005.01.001; Forni JJ, 2004, MOL CELL NEUROSCI, V26, P282, DOI 10.1016/j.mcn.2004.02.003; Franzdottir SR, 2009, NATURE, V460, P758, DOI 10.1038/nature08167; Freeman MR, 2006, CURR OPIN NEUROBIOL, V16, P119, DOI 10.1016/j.conb.2005.12.004; Garcia-Alonso L, 2000, NEURON, V28, P741, DOI 10.1016/S0896-6273(00)00150-1; Gdalyahu A, 2004, EMBO J, V23, P823, DOI 10.1038/sj.emboj.7600079; Gibson NJ, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0007222; Gibson NJ, 2006, J COMP NEUROL, V495, P554, DOI 10.1002/cne.20890; Gibson NJ, 2001, DEV BIOL, V240, P326, DOI 10.1006/dbio.2001.0463; Gibson NJ, 2004, J COMP NEUROL, V476, P1, DOI 10.1002/cne.20178; Gisselbrecht S, 1996, GENE DEV, V10, P3003, DOI 10.1101/gad.10.23.3003; Gryzik T, 2004, CURR BIOL, V14, P659, DOI 10.1016/j.cub.2004.03.058; HAYASHI JH, 1990, J NEUROSCI, V10, P848; Heil JE, 2007, EUR J NEUROSCI, V26, P1227, DOI 10.1111/j.1460-9568.2007.05756.x; Hendzel MJ, 1997, CHROMOSOMA, V106, P348, DOI 10.1007/s004120050256; Hidalgo A, 2003, BIOCHEM SOC T, V31, P50, DOI 10.1042/bst0310050; Higgins MR, 2002, DEV BIOL, V244, P134, DOI 10.1006/dbio.2002.0583; Islam R, 2004, MOL BIOL CELL, V15, P2003, DOI 10.1091/mbc.e03-05-0333; Kadam S, 2009, DEVELOPMENT, V136, P739, DOI 10.1242/dev.027904; KADMON G, 1990, J CELL BIOL, V110, P193, DOI 10.1083/jcb.110.1.193; Kaneko M, 2003, J NEUROSCI, V23, P11523; Katsuma S, 2006, J VIROL, V80, P5474, DOI 10.1128/JVI.00248-06; KIRSCHENBAUM SR, 1995, J NEUROBIOL, V28, P234, DOI 10.1002/neu.480280209; Klambt C, 2009, NAT REV NEUROSCI, V10, P769, DOI 10.1038/nrn2720; KLAMBT C, 1992, GENE DEV, V6, P1668, DOI 10.1101/gad.6.9.1668; Klingseisen A, 2009, DEVELOPMENT, V136, P2393, DOI 10.1242/dev.035451; Kolodkin AL, 2010, CSH PERSPECT BIOL, V2; Kristiansen LV, 2005, MOL CELL NEUROSCI, V28, P141, DOI 10.1016/j.mcn.2004.09.003; LaVallee TM, 1998, J CELL BIOL, V141, P1647, DOI 10.1083/jcb.141.7.1647; Leadbeater WE, 2006, J NEUROCHEM, V96, P1189, DOI 10.1111/j.1471-4159.2005.03632.x; Lemke G, 2001, ANNU REV NEUROSCI, V24, P87, DOI 10.1146/annurev.neuro.24.1.87; Lin XH, 2000, MATRIX BIOL, V19, P303, DOI 10.1016/S0945-053X(00)00073-1; Lin XH, 1999, DEVELOPMENT, V126, P3715; Lohr C, 2005, GLIA, V50, P198, DOI 10.1002/glia.20163; Maher PA, 1996, J CELL BIOL, V134, P529, DOI 10.1083/jcb.134.2.529; Meaburn KJ, 2007, NATURE, V445, P379, DOI 10.1038/445379a; Michelson AM, 1998, DEV GENET, V22, P212, DOI 10.1002/(SICI)1520-6408(1998)22:3<212::AID-DVG4>3.0.CO;2-9; Mitra SK, 2005, NAT REV MOL CELL BIO, V6, P56, DOI 10.1038/nrm1549; Mohammadi M, 1998, EMBO J, V17, P5896, DOI 10.1093/emboj/17.20.5896; Niethammer P, 2002, J CELL BIOL, V157, P521, DOI 10.1083/jcb.200109059; OLAND LA, 1988, J NEUROSCI, V8, P353; OLAND LA, 1989, GLIA, V2, P10, DOI 10.1002/glia.440020103; OLAND LA, 1987, J COMP NEUROL, V255, P196, DOI 10.1002/cne.902550204; Oland LA, 2003, ANNU REV ENTOMOL, V48, P89, DOI 10.1146/annurev.ento.48.091801.112654; OLAND LA, 1988, J COMP NEUROL, V278, P377, DOI 10.1002/cne.902780307; Oland LA, 1998, J NEUROBIOL, V36, P41, DOI 10.1002/(SICI)1097-4695(199807)36:1<41::AID-NEU4>3.0.CO;2-A; Oland LA, 2011, GLIA IN PRESS; Ornitz DM, 2000, BIOESSAYS, V22, P108, DOI 10.1002/(SICI)1521-1878(200002)22:2<108::AID-BIES2>3.0.CO;2-M; Richardson TP, 2001, J CELL SCI, V114, P1613; Rossler W, 1999, J NEUROSCI, V19, P9865; Saffell JL, 1997, NEURON, V18, P231, DOI 10.1016/S0896-6273(00)80264-0; SANES JR, 1976, DEV BIOL, V51, P282, DOI 10.1016/0012-1606(76)90144-5; Schlessinger J, 2003, SCIENCE, V300, P750, DOI 10.1126/science.1082024; Sen A, 2005, BMC DEV BIOL, V5, DOI 10.1186/1471-213X-5-25; Sepp KJ, 2003, J NEUROSCI, V23, P8221; Shishido E, 1997, DEVELOPMENT, V124, P2119; SHISHIDO E, 1993, DEVELOPMENT, V117, P751; Silies M, 2010, NAT NEUROSCI, V13, P1357, DOI 10.1038/nn.2656; Skaper SD, 2000, J NEUROCHEM, V75, P1520, DOI 10.1046/j.1471-4159.2000.0751520.x; Stachowiak EK, 1997, ONCOGENE, V14, P2201, DOI 10.1038/sj.onc.1201057; Stachowiak MK, 2003, J CELL BIOCHEM, V90, P662, DOI 10.1002/jcb.10606; Stathopoulos A, 2004, GENE DEV, V18, P687, DOI 10.1101/gad.1166404; Thisse B, 2005, DEV BIOL, V287, P390, DOI 10.1016/j.ydbio.2005.09.011; THOMPSON JD, 1994, NUCLEIC ACIDS RES, V22, P4673, DOI 10.1093/nar/22.22.4673; TOLBERT LP, 1990, J COMP NEUROL, V298, P69, DOI 10.1002/cne.902980106; TOLBERT LP, 1981, PROC R SOC SER B-BIO, V213, P279, DOI 10.1098/rspb.1981.0067; TOLBERT LP, 1983, J NEUROSCI, V3, P1158; Tolbert LP, 2004, PROG NEUROBIOL, V73, P73, DOI 10.1016/j.pneurobio.2004.04.004; Tsai LH, 2005, NEURON, V46, P383, DOI 10.1016/j.neuron.2005.04.013; WILLIAMS EJ, 1994, NEURON, V13, P583, DOI 10.1016/0896-6273(94)90027-2; Wright JW, 1999, DEVELOPMENT, V126, P3217; Xian W, 2007, MOL ENDOCRINOL, V21, P987, DOI 10.1210/me.2006-0518	85	16	16	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 6	2012	7	4							e33828	10.1371/journal.pone.0033828	http://dx.doi.org/10.1371/journal.pone.0033828			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	955JA	22493675	Green Published, Green Submitted, gold			2022-12-25	WOS:000305012700017
J	Schmidt, C; Wiener, E; Hoffmann, J; Klingebiel, R; Schmidt, F; Hofmann, T; Harms, L; Kunte, H				Schmidt, Christoph; Wiener, Edzard; Hoffmann, Jan; Klingebiel, Randolf; Schmidt, Felix; Hofmann, Tobias; Harms, Lutz; Kunte, Hagen			Structural Olfactory Nerve Changes in Patients Suffering from Idiopathic Intracranial Hypertension	PLOS ONE			English	Article							QUALITY-OF-LIFE; BULB VOLUME; PENNSYLVANIA SMELL; DISORDERS; IDENTIFICATION; RHINORRHEA; UNIVERSITY	Background: Complications of idiopathic intracranial hypertension (IIH) are usually caused by elevated intracranial pressure (ICP). In a similar way as in the optic nerve, elevated ICP could also compromise the olfactory nerve system. On the other side, there is growing evidence that an extensive lymphatic network system around the olfactory nerves could be disturbed in cerebrospinal fluid disorders like IIH. The hypothesis that patients with IIH suffer from hyposmia has been suggested in the past. However, this has not been proven in clinical studies yet. This pilot study investigates whether structural changes of the olfactory nerve system can be detected in patients with IIH. Methodology/Principal Findings: Twenty-three patients with IIH and 23 matched controls were included. Olfactory bulb volume (OBV) and sulcus olfactorius (OS) depth were calculated by magnetic resonance techniques. While mean values of total OBV (128.7 +/- 38.4 vs. 130.0 +/- 32.6 mm(3), p = 0.90) and mean OS depth (8.5 +/- 1.2 vs. 8.6 +/- 1.1 mm, p = 0.91) were similar in both groups, Pearson correlation showed that patients with a shorter medical history IIH revealed a smaller OBV (r = 0.53, p<0.01). In untreated symptomatic patients (n = 7), the effect was greater (r = 0.76, p<0.05). Patients who suffered from IIH for less than one year (n = 8), total OBV was significantly smaller than in matched controls (116.6 +/- 24.3 vs. 149.3 +/- 22.2 mm(3), p = 0.01). IIH patients with visual disturbances (n = 21) revealed a lower OS depth than patients without (8.3 +/- 0.9 vs. 10.8 +/- 1.0 mm, p<0.01). Conclusions/Significance: The results suggest that morphological changes of the olfactory nerve system could be present in IIH patients at an early stage of disease.	[Schmidt, Christoph; Wiener, Edzard; Klingebiel, Randolf] Charite, Inst Radiol, D-13353 Berlin, Germany; [Hoffmann, Jan; Schmidt, Felix; Harms, Lutz; Kunte, Hagen] Charite, Dept Neurol, D-13353 Berlin, Germany; [Hofmann, Tobias] Charite, Dept Psychosomat Med, D-13353 Berlin, Germany	Free University of Berlin; Humboldt University of Berlin; Charite Universitatsmedizin Berlin; Free University of Berlin; Humboldt University of Berlin; Charite Universitatsmedizin Berlin; Free University of Berlin; Humboldt University of Berlin; Charite Universitatsmedizin Berlin	Schmidt, C (corresponding author), Charite, Inst Radiol, D-13353 Berlin, Germany.	hagen.kunte@charite.de	Hoffmann, Jan/AAP-8376-2020	Hofmann, Tobias/0000-0002-4002-3552; Csapo-Schmidt, Christoph/0000-0002-9021-8227				Abolmaali ND, 2002, AM J NEURORADIOL, V23, P157; Ball AK, 2006, LANCET NEUROL, V5, P433, DOI 10.1016/S1474-4422(06)70442-2; BRISMAN R, 1970, ARCH NEUROL-CHICAGO, V22, P245, DOI 10.1001/archneur.1970.00480210055007; Buschuter D, 2008, NEUROIMAGE, V42, P498, DOI 10.1016/j.neuroimage.2008.05.004; CLARK D, 1994, J NEUROL NEUROSUR PS, V57, P847, DOI 10.1136/jnnp.57.7.847; Curtis MA, 2007, SCIENCE, V315, P1243, DOI 10.1126/science.1136281; DEEMS DA, 1991, ARCH OTOLARYNGOL, V117, P519; Dhungana S, 2010, ACTA NEUROL SCAND, V121, P71, DOI 10.1111/j.1600-0404.2009.01172.x; DOTY RL, 1984, LARYNGOSCOPE, V94, P176, DOI 10.1288/00005537-198402000-00004; Duprez TP, 2010, EUR J RADIOL, V74, P288, DOI 10.1016/j.ejrad.2009.05.065; Friedman DI, 2002, NEUROLOGY, V59, P1492, DOI 10.1212/01.WNL.0000029570.69134.1B; GIUSEFFI V, 1991, NEUROLOGY, V41, P239, DOI 10.1212/WNL.41.2_Part_1.239; Goektas O, 2009, EUR J RADIOL, V71, P469, DOI 10.1016/j.ejrad.2008.10.039; Gomez C, 2006, NEUROSCIENCE, V141, P2117, DOI 10.1016/j.neuroscience.2006.05.046; Hummel T, 2005, ACTA OTO-LARYNGOL, V125, P116, DOI 10.1080/00016480410022787; Hummel T, 1997, CHEM SENSES, V22, P39, DOI 10.1093/chemse/22.1.39; Johnston Miles, 2004, Cerebrospinal Fluid Res, V1, P2, DOI 10.1186/1743-8454-1-2; Kapoor KG, 2008, MED HYPOTHESES, V71, P816, DOI 10.1016/j.mehy.2008.04.023; Miwa T, 2001, ARCH OTOLARYNGOL, V127, P497, DOI 10.1001/archotol.127.5.497; Rombaux P, 2010, EUR ARCH OTO-RHINO-L, V267, P1551, DOI 10.1007/s00405-010-1230-2; Rombaux P, 2009, RHINOLOGY, V47, P3; Schwob James E., 2002, Anatomical Record, V269, P33, DOI 10.1002/ar.10047; Sinclair AJ, 2008, J NEUROIMMUNOL, V201, P212, DOI 10.1016/j.jneuroim.2008.06.029; Temmel AFP, 2002, ARCH OTOLARYNGOL, V128, P635, DOI 10.1001/archotol.128.6.635; Wang J, 2011, AM J NEURORADIOL, V32, P677, DOI 10.3174/ajnr.A2350	25	26	27	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 6	2012	7	4							e35221	10.1371/journal.pone.0035221	http://dx.doi.org/10.1371/journal.pone.0035221			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	955JA	22493741	Green Submitted, gold, Green Published			2022-12-25	WOS:000305012700083
J	Song, YT; Gunnarson, E				Song, Yutong; Gunnarson, Eli			Potassium Dependent Regulation of Astrocyte Water Permeability Is Mediated by cAMP Signaling	PLOS ONE			English	Article							CENTRAL-NERVOUS-SYSTEM; RETINAL MULLER CELLS; PROTEIN-KINASE-A; SPREADING DEPRESSION; EXTRACELLULAR POTASSIUM; HIPPOCAMPAL ASTROCYTES; GLUTAMATE UPTAKE; CALCIUM INFLUX; GLIAL-CELLS; CHANNELS	Astrocytes express potassium and water channels to support dynamic regulation of potassium homeostasis. Potassium kinetics can be modulated by aquaporin-4 (AQP4), the essential water channel for astrocyte water permeability regulation. We investigated whether extracellular potassium ([K+](o)) can regulate astrocyte water permeability and the mechanisms of such an effect. Studies were performed on rat primary astrocytes and a rat astrocyte cell line transfected with AQP4. We found that 10mM [K+](o) caused an immediate, more than 40%, increase in astrocyte water permeability which was sustained in 5min. The water channel AQP4 was a target for this regulation. Potassium induced a significant increase in intracellular cAMP as measured with a FRET based method and with enzyme immunoassay. We found that protein kinase A (PKA) could phosphorylate AQP4 in vitro. Further elevation of [K+](o) to 35mM induced a global intracellular calcium response and a transient water permeability increase that was abolished in 5min. When inwardly rectifying potassium (Kir)-channels were blocked, 10mM [K+](o) also induced a calcium increase and the water permeability increase no longer persisted. In conclusion, we find that elevation of extracellular potassium regulates AQP4 and astrocyte water permeability via intracellular signaling involving cAMP. A prolonged increase of astrocyte water permeability is Kir-channel dependent and this response can be impeded by intracellular calcium signaling. Our results support the concept of coupling between AQP4 and potassium handling in astrocytes.	[Song, Yutong; Gunnarson, Eli] Karolinska Inst, Dept Womens & Childrens Hlth, Astrid Lindgren Childrens Hosp, Stockholm, Sweden	Karolinska Institutet	Song, YT (corresponding author), Karolinska Inst, Dept Womens & Childrens Hlth, Astrid Lindgren Childrens Hosp, Stockholm, Sweden.	eli.gunnarson@ki.se			Jeanssons Stiftelse; Stiftelsen Frimurare Barnhuset i Stockholm; Sallskapet Barnavard	Jeanssons Stiftelse; Stiftelsen Frimurare Barnhuset i Stockholm; Sallskapet Barnavard	This work was supported by Jeanssons Stiftelse, Stiftelsen Frimurare Barnhuset i Stockholm, Sallskapet Barnavard, and the regional agreement on medical training and clinical research (ALF) between Stockholm County Council and Karolinska Institutet. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Amiry-Moghaddam M, 2003, NAT REV NEUROSCI, V4, P991, DOI 10.1038/nrn1252; Amiry-Moghaddam M, 2003, P NATL ACAD SCI USA, V100, P13615, DOI 10.1073/pnas.2336064100; Binder DK, 2006, GLIA, V53, P631, DOI 10.1002/glia.20318; Bolton S, 2006, GLIA, V54, P316, DOI 10.1002/glia.20384; BOURKE RS, 1983, NEUROCHEM RES, V8, P5, DOI 10.1007/BF00965650; Butt AM, 2006, J CELL MOL MED, V10, P33, DOI 10.1111/j.1582-4934.2006.tb00289.x; Chever O, 2010, J NEUROSCI, V30, P15769, DOI 10.1523/JNEUROSCI.2078-10.2010; COGHLAN VM, 1995, SCIENCE, V267, P108, DOI 10.1126/science.7528941; Daly J W, 1977, Int Rev Neurobiol, V20, P105, DOI 10.1016/S0074-7742(08)60652-2; Djukic B, 2007, J NEUROSCI, V27, P11354, DOI 10.1523/JNEUROSCI.0723-07.2007; DUFFY S, 1994, NEUROSCIENCE, V61, P51, DOI 10.1016/0306-4522(94)90059-0; Duffy S, 1996, J NEUROSCI, V16, P71; Fort PE, 2008, GLIA, V56, P597, DOI 10.1002/glia.20633; Gunnarson E, 2005, NEUROSCIENCE, V136, P105, DOI 10.1016/j.neuroscience.2005.07.027; Gunnarson E, 2008, GLIA, V56, P587, DOI 10.1002/glia.20627; HENN FA, 1972, BRAIN RES, V43, P437, DOI 10.1016/0006-8993(72)90399-X; HERTZ L, 1965, NATURE, V206, P1091, DOI 10.1038/2061091a0; Hertz L, 1981, Prog Clin Biol Res, V59A, P45; Kang SJ, 2008, MOL CELLS, V25, P124; Klarenbeek JB, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0019170; Kofuji P, 2004, NEUROSCIENCE, V129, P1045, DOI 10.1016/j.neurscience.2004.06.008; Kucheryavykh YV, 2007, GLIA, V55, P274, DOI 10.1002/glia.20455; Leis JA, 2005, GLIA, V50, P407, DOI 10.1002/glia.20145; Lian XY, 2004, BRAIN RES, V1012, P177, DOI 10.1016/j.brainres.2004.04.011; MACVICAR BA, 1991, GLIA, V4, P448, DOI 10.1002/glia.440040504; MACVICAR BA, 1984, SCIENCE, V226, P1345, DOI 10.1126/science.6095454; Nagelhus EA, 1999, GLIA, V26, P47, DOI 10.1002/(SICI)1098-1136(199903)26:1<47::AID-GLIA5>3.0.CO;2-5; Olsen ML, 2008, J NEUROCHEM, V107, P589, DOI 10.1111/j.1471-4159.2008.05615.x; Paluzzi S, 2007, J NEUROCHEM, V103, P1196, DOI 10.1111/j.1471-4159.2007.04826.x; Risher WC, 2009, GLIA, V57, P207, DOI 10.1002/glia.20747; Ruiz-Ederra J, 2007, J BIOL CHEM, V282, P21866, DOI 10.1074/jbc.M703236200; Rutledge EM, 1996, J NEUROSCI, V16, P7803; SOMJEN GG, 1979, ANNU REV PHYSIOL, V41, P159, DOI 10.1146/annurev.ph.41.030179.001111; Strohschein S, 2011, GLIA, V59, P973, DOI 10.1002/glia.21169; Vinade L, 1997, DEV BRAIN RES, V104, P11, DOI 10.1016/S0165-3806(97)00114-4; VYSKOCIL F, 1972, BRAIN RES, V39, P255, DOI 10.1016/0006-8993(72)90802-5; WALZ W, 1983, PROG NEUROBIOL, V20, P133, DOI 10.1016/0301-0082(83)90013-8; Walz W, 2000, NEUROCHEM INT, V36, P291, DOI 10.1016/S0197-0186(99)00137-0; Zelenina M, 2000, EUR BIOPHYS J BIOPHY, V29, P165, DOI 10.1007/PL00006645; Zhang H, 2008, MOL CELL NEUROSCI, V37, P1, DOI 10.1016/j.mcn.2007.08.007; Zhou N, 2010, CEREB CORTEX, V20, P2614, DOI 10.1093/cercor/bhq018	41	32	35	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 6	2012	7	4							e34936	10.1371/journal.pone.0034936	http://dx.doi.org/10.1371/journal.pone.0034936			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	955JA	22493723	Green Published, Green Submitted, gold			2022-12-25	WOS:000305012700065
J	Dai, JY; Wan, SG; Zhou, F; Myers, RE; Guo, X; Li, BS; Fu, XY; Palazzo, JP; Dou, KF; Yang, HS; Xing, JL				Dai, Jingyao; Wan, Shaogui; Zhou, Feng; Myers, Ronald E.; Guo, Xu; Li, Bingshan; Fu, Xiaoying; Palazzo, Juan P.; Dou, Kefeng; Yang, Hushan; Xing, Jinliang			Genetic Polymorphism in a VEGF-Independent Angiogenesis Gene ANGPT1 and Overall Survival of Colorectal Cancer Patients after Surgical Resection	PLOS ONE			English	Article							ENDOTHELIAL-GROWTH-FACTOR; TUMOR ANGIOGENESIS; TIE2 RECEPTOR; IN-VIVO; ANGIOPOIETIN-1; RISK; CHEMOTHERAPY; EXPRESSION; RS6983267; PATHWAYS	Background: The VEGF-independent angiogenic signaling plays an important role in the development of colorectal cancer (CRC). However, its implication in the clinical outcome of CRC has not been reported. This study aimed to investigate the association between genetic variations in several major VEGF-independent signaling pathway genes and the overall survival of CRC patients. Methods: Seven single nucleotide polymorphisms (SNPs) in four important VEGF-independent angiogenic genes (ANGPT1, AMOT, DLL4 and ENG) were genotyped in a Chinese population with 408 CRC patients. Results: One SNP, rs1954727 in ANGPT1, was significantly associated with CRC overall survival. Compared to patients with the homozygous wild-type genotype of rs1954727, those with heterozygous and homozygous variant genotypes exhibited a favorable overall survival with a hazard ratio (HR) of 0.89 (95% confidence interval [CI] 0.55-1.43, P = 0.623), and 0.32 (95% CI 0.15-0.71, P = 0.005), respectively (P trend = 0.008). In stratified analysis, this association remained significant in patients receiving chemotherapy (P trend = 0.012), but not in those without chemotherapy. We further evaluated the effects of chemotherapy on CRC survival that was stratified by rs1954727 genotypes. We found that chemotherapy resulted in a significantly better overall survival in the CRC patients (HR = 0.44, 95%CI 0.26-0.75, P = 0.002), which was especially prominent in those patients with the heterozygous genotype of rs1954727 (HR = 0.45, 95% CI 0.22-0.92, P = 0.028). Conclusion: Our data suggest that rs1954727 in ANGPT1 gene might be a prognostic biomarker for the overall survival of CRC patients, especially in those receiving chemotherapy, a finding that warrants validation in larger independent populations.	[Dai, Jingyao; Dou, Kefeng] Fourth Mil Med Univ, Xijing Hosp, Dept Hepatobiliary Surg, Xian 710032, Peoples R China; [Wan, Shaogui; Myers, Ronald E.; Fu, Xiaoying; Yang, Hushan] Thomas Jefferson Univ, Kimmel Canc Ctr, Dept Med Oncol, Div Populat Sci, Philadelphia, PA 19107 USA; [Zhou, Feng] Fourth Mil Med Univ, Tangdu Hosp, Dept Gen Surg, Xian 710032, Peoples R China; [Guo, Xu; Xing, Jinliang] Fourth Mil Med Univ, Cell Engn Res Ctr, State Key Lab Canc Biol, Xian 710032, Peoples R China; [Guo, Xu; Xing, Jinliang] Fourth Mil Med Univ, Dept Cell Biol, Xian 710032, Peoples R China; [Li, Bingshan] Vanderbilt Univ, Dept Mol Physiol & Biophys, Ctr Human Genet Res, Nashville, TN 37232 USA; [Palazzo, Juan P.] Thomas Jefferson Univ, Dept Pathol, Philadelphia, PA 19107 USA	Air Force Military Medical University; Jefferson University; Air Force Military Medical University; Air Force Military Medical University; Air Force Military Medical University; Vanderbilt University; Jefferson University	Dai, JY (corresponding author), Fourth Mil Med Univ, Xijing Hosp, Dept Hepatobiliary Surg, Xian 710032, Peoples R China.	hushan.yang@jefferson.edu; xingjl@fmmu.edu.cn	Wan, Shaogui/I-5047-2013; Li, Bingshan/H-1944-2011	Myers, Ronald E./0000-0002-8059-7390	Thomas Jefferson University; National Natural Science Foundation of China [30872927]; National Basic Research Program of China [2009CB521704]; NATIONAL CANCER INSTITUTE [R03CA162201] Funding Source: NIH RePORTER	Thomas Jefferson University; National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); National Basic Research Program of China(National Basic Research Program of China); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	The work reported here is supported by a start-up grant from Thomas Jefferson University, grant 2009CB521704 from The National Basic Research Program of China, and grant 30872927 from National Natural Science Foundation of China. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Asahara T, 1998, CIRC RES, V83, P233, DOI 10.1161/01.RES.83.3.233; Bao L, 2007, NUCLEIC ACIDS RES, V35, pD51, DOI 10.1093/nar/gkl797; Bergers G, 2008, NAT REV CANCER, V8, P592, DOI 10.1038/nrc2442; Cai J, 2011, FRONT BIOSCI-LANDMRK, V16, P803, DOI 10.2741/3721; Castro FA, 2011, EUR J CANCER, V47, P1203, DOI 10.1016/j.ejca.2010.12.011; Chen JF, 2009, CANCER BIOL THER, V8, P1424, DOI 10.4161/cbt.8.14.8889; Dassoulas K, 2009, MOL CARCINOGEN, V48, P563, DOI 10.1002/mc.20495; Dufraine J, 2008, ONCOGENE, V27, P5132, DOI 10.1038/onc.2008.227; El-Gohary YM, 2007, AM J CLIN PATHOL, V127, P572, DOI 10.1309/X6NXYE57DLUE2NQ8; Ferlay J, 2010, INT J CANCER, V127, P2893, DOI 10.1002/ijc.25516; Ferrari P, 2007, INT J CANCER, V121, P2065, DOI 10.1002/ijc.22966; Goel A, 2010, CURR OPIN GASTROEN, V26, P47, DOI 10.1097/MOG.0b013e328332b850; Hansen TF, 2010, J CANCER RES CLIN, V136, P751, DOI 10.1007/s00432-009-0714-1; Hawighorst T, 2002, AM J PATHOL, V160, P1381, DOI 10.1016/S0002-9440(10)62565-5; Hayes AJ, 2000, BRIT J CANCER, V83, P1154, DOI 10.1054/bjoc.2000.1437; Hofmann G, 2008, J CANCER RES CLIN, V134, P591, DOI 10.1007/s00432-007-0322-x; Holash J, 1999, SCIENCE, V284, P1994, DOI 10.1126/science.284.5422.1994; Huang HH, 2010, NAT REV CANCER, V10, P575, DOI 10.1038/nrc2894; Koukourakis MI, 2004, LUNG CANCER, V46, P293, DOI 10.1016/j.lungcan.2004.04.037; Levchenko T, 2008, FASEB J, V22, P880, DOI 10.1096/fj.07-9509com; Loughna S, 2001, MATRIX BIOL, V20, P319, DOI 10.1016/S0945-053X(01)00149-4; Maisonpierre PC, 1997, SCIENCE, V277, P55, DOI 10.1126/science.277.5322.55; Mita AC, 2010, CLIN CANCER RES, V16, P3044, DOI 10.1158/1078-0432.CCR-09-3368; Papapetropoulos A, 2000, J BIOL CHEM, V275, P9102, DOI 10.1074/jbc.275.13.9102; Pomerantz MM, 2009, NAT GENET, V41, P882, DOI 10.1038/ng.403; Renner W, 2000, J VASC RES, V37, P443, DOI 10.1159/000054076; Rmali KA, 2007, COLORECTAL DIS, V9, P3, DOI 10.1111/j.1463-1318.2006.01089.x; Roberts KE, 2009, AM J RESP CRIT CARE, V179, P835, DOI 10.1164/rccm.200809-1472OC; Shibuya M, 2008, BMB REP, V41, P278, DOI 10.5483/BMBRep.2008.41.4.278; Shim WSN, 2007, MOL CANCER RES, V5, P655, DOI 10.1158/1541-7786.MCR-07-0072; Stoeltzing O, 2003, CANCER RES, V63, P3370; Thompson SD, 2010, ARTHRITIS RHEUM-US, V62, P3265, DOI 10.1002/art.27688; Tuupanen S, 2009, NAT GENET, V41, P885, DOI 10.1038/ng.406; Ulrich CM, 2003, NAT REV CANCER, V3, P912, DOI 10.1038/nrc1233; Xing JL, 2011, EUR J CANCER, V47, P1699, DOI 10.1016/j.ejca.2011.02.004; Yancopoulos GD, 2000, NATURE, V407, P242, DOI 10.1038/35025215; Yang BM, 2003, J DIABETES COMPLICAT, V17, P1, DOI 10.1016/S1056-8727(02)00181-2; Yu Q, 2001, AM J PATHOL, V158, P563, DOI 10.1016/S0002-9440(10)63998-3	38	14	14	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 4	2012	7	4							e34758	10.1371/journal.pone.0034758	http://dx.doi.org/10.1371/journal.pone.0034758			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	953GO	22496856	Green Published, gold			2022-12-25	WOS:000304855200077
J	Misu, H; Ishikura, K; Kurita, S; Takeshita, Y; Ota, T; Saito, Y; Takahashi, K; Kaneko, S; Takamura, T				Misu, Hirofumi; Ishikura, Kazuhide; Kurita, Seiichiro; Takeshita, Yumie; Ota, Tsuguhito; Saito, Yoshiro; Takahashi, Kazuhiko; Kaneko, Shuichi; Takamura, Toshinari			Inverse Correlation between Serum Levels of Selenoprotein P and Adiponectin in Patients with Type 2 Diabetes	PLOS ONE			English	Article							INSULIN-RESISTANCE; DEFICIENT MICE; SELENIUM; PLASMA; SENSITIVITY; OBESITY; ATHEROSCLEROSIS; PHOSPHORYLATION; EXPRESSION; DISEASE	Background: We recently identified selenoprotein P (SeP) as a liver-derived secretory protein that causes insulin resistance in the liver and skeletal muscle; however, it is unknown whether and, if so, how SeP acts on adipose tissue. The present study tested the hypothesis that SeP is related to hypoadiponectinemia in patients with type 2 diabetes. Methodology/Principal Findings: We compared serum levels of SeP with those of adiponectin and other clinical parameters in 36 patients with type 2 diabetes. We also measured levels of blood adiponectin in SeP knockout mice. Circulating SeP levels were positively correlated with fasting plasma glucose (r = 0.35, P = 0.037) and negatively associated with both total and high-molecular adiponectin in patients with type 2 diabetes (r = -0.355, P = 0.034; r = -0.367, P = 0.028). SeP was a predictor of both total and high-molecular adiponectin, independently of age, body weight, and quantitative insulin sensitivity index (beta = -0.343, P = 0.022; beta = -0.357, P = 0.017). SeP knockout mice exhibited an increase in blood adiponectin levels when fed regular chow or a high sucrose, high fat diet. Conclusions/Significance: These results suggest that overproduction of liver-derived secretory protein SeP is connected with hypoadiponectinemia in patients with type 2 diabetes.	[Misu, Hirofumi; Ishikura, Kazuhide; Kurita, Seiichiro; Takeshita, Yumie; Ota, Tsuguhito; Kaneko, Shuichi; Takamura, Toshinari] Kanazawa Univ, Grad Sch Med Sci, Dept Dis Control & Homeostasis, Kanazawa, Ishikawa, Japan; [Saito, Yoshiro] Doshisha Univ, Fac Med & Life Sci, Dept Med Life Syst, Kyoto 602, Japan; [Takahashi, Kazuhiko] Hokkaido Pharmaceut Univ, Dept Nutr Biochem, Otaru, Hokkaido, Japan	Kanazawa University; Doshisha University	Misu, H (corresponding author), Kanazawa Univ, Grad Sch Med Sci, Dept Dis Control & Homeostasis, Kanazawa, Ishikawa, Japan.	ttakamura@m-kanazawa.jp	Saito, Yoshiro/H-4597-2019	Saito, Yoshiro/0000-0002-0559-5889	Ministry of Education, Culture, Sports, Science, and Technology of Japan [C-23591301, B-23791022]; Grants-in-Aid for Scientific Research [23591301] Funding Source: KAKEN	Ministry of Education, Culture, Sports, Science, and Technology of Japan(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)); Grants-in-Aid for Scientific Research(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI))	This work was supported in part by Grants-in-Aid for Scientific Research (C-23591301 to TT), and a Grant-in-aid for Young Scientists (B-23791022 to HM) from the Ministry of Education, Culture, Sports, Science, and Technology of Japan. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript. No additional external funding was received for this study.	Andoh A, 2005, NUTRITION, V21, P574, DOI 10.1016/j.nut.2004.08.025; Burk RF, 2005, ANNU REV NUTR, V25, P215, DOI 10.1146/annurev.nutr.24.012003.132120; Carlson BA, 2004, J BIOL CHEM, V279, P8011, DOI 10.1074/jbc.M310470200; Hill KE, 2003, J BIOL CHEM, V278, P13640, DOI 10.1074/jbc.M300755200; Hill KE, 1996, J NUTR, V126, P138, DOI 10.1093/jn/126.1.138; Iwaki M, 2003, DIABETES, V52, P1655, DOI 10.2337/diabetes.52.7.1655; Katz A, 2000, J CLIN ENDOCR METAB, V85, P2402, DOI 10.1210/jc.85.7.2402; Kern PA, 2003, DIABETES, V52, P1779, DOI 10.2337/diabetes.52.7.1779; Kubota N, 2006, J BIOL CHEM, V281, P8748, DOI 10.1074/jbc.M505649200; Lumeng CN, 2011, J CLIN INVEST, V121, P2111, DOI 10.1172/JCI57132; Maeda N, 2002, NAT MED, V8, P731, DOI 10.1038/nm724; Misu H, 2007, DIABETOLOGIA, V50, P268, DOI 10.1007/s00125-006-0489-8; Misu H, 2010, CELL METAB, V12, P483, DOI 10.1016/j.cmet.2010.09.015; Nakashima R, 2006, J CLIN ENDOCR METAB, V91, P3873, DOI 10.1210/jc.2006-1158; Okamoto Y, 2002, CIRCULATION, V106, P2767, DOI 10.1161/01.CIR.0000042707.50032.19; Pajvani UB, 2003, J BIOL CHEM, V278, P9073, DOI 10.1074/jbc.M207198200; Persson-Moschos M, 1998, EUR J CLIN NUTR, V52, P363, DOI 10.1038/sj.ejcn.1600565; Pischon T, 2004, JAMA-J AM MED ASSOC, V291, P1730, DOI 10.1001/jama.291.14.1730; Saito Y, 2001, J HEALTH SCI, V47, P346, DOI 10.1248/jhs.47.346; Schoenmakers E, 2010, J CLIN INVEST, V120, P4220, DOI 10.1172/JCI43653; Schomburg L, 2003, BIOCHEM J, V370, P397, DOI 10.1042/BJ20021853; Schulze MB, 2005, DIABETES, V54, P534, DOI 10.2337/diabetes.54.2.534; Speckmann B, 2008, HEPATOLOGY, V48, P1998, DOI 10.1002/hep.22526; Stefan N, 2002, DIABETES, V51, P1884, DOI 10.2337/diabetes.51.6.1884; Tschritter O, 2003, DIABETES, V52, P239, DOI 10.2337/diabetes.52.2.239; Waki H, 2003, J BIOL CHEM, V278, P40352, DOI 10.1074/jbc.M300365200; Walter PL, 2008, BIOCHEM BIOPH RES CO, V365, P316, DOI 10.1016/j.bbrc.2007.10.171; Weyer C, 2001, J CLIN ENDOCR METAB, V86, P1930, DOI 10.1210/jc.86.5.1930; Yamauchi T, 2003, J BIOL CHEM, V278, P2461, DOI 10.1074/jbc.M209033200; Yamauchi T, 2001, NAT MED, V7, P941, DOI 10.1038/90984; YANG JG, 1989, J NUTR, V119, P1010, DOI 10.1093/jn/119.7.1010; Yang SJ, 2011, J CLIN ENDOCR METAB, V96, pE1325, DOI 10.1210/jc.2011-0620	32	79	81	0	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 4	2012	7	4							e34952	10.1371/journal.pone.0034952	http://dx.doi.org/10.1371/journal.pone.0034952			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	953GO	22496878	Green Submitted, Green Published, gold			2022-12-25	WOS:000304855200089
J	Wuebben, EL; Mallanna, SK; Cox, JL; Rizzino, A				Wuebben, Erin L.; Mallanna, Sunil K.; Cox, Jesse L.; Rizzino, Angie			Musashi2 Is Required for the Self-Renewal and Pluripotency of Embryonic Stem Cells	PLOS ONE			English	Article							RNA-BINDING PROTEIN; MYELOID-LEUKEMIA; EXPRESSION; DIFFERENTIATION; MOUSE; REGULATOR; SCREEN; ROLES; MSI2; GENE	Recent studies have shown that the RNA binding protein Musashi 2 (Msi2) plays important roles during development. Msi2 has also been shown to be elevated in several leukemias and its elevated expression has been linked with poorer prognosis in these cancers. Additionally, in embryonic stem cells (ESC) undergoing the early stages of differentiation, Msi2 has been shown to associate with the transcription factor Sox2, which is required for the self-renewal of ESC. These findings led us to examine the effects of Msi2 on the behavior of ESC. We determined that ESC express two isoforms of Msi2, the larger canonical isoform (isoform 1) and a shorter, splice-variant isoform (isoform 2). Using multiple shRNA lentiviral vectors, we determined that knockdown of Msi2 disrupts the self-renewal of ESC and promotes their differentiation into cells that express markers associated with mesoderm, ectoderm, and trophectoderm. Moreover, our studies indicate that the extent of differentiation and the loss of self-renewal capacity correlate with the levels to which Msi2 levels were decreased. We extended these findings by engineering ESC to inducibly express either Msi2 isoform1 or isoform 2. We determined that ectopic expression of Msi2 isoform 1, but not isoform 2, enhances the cloning efficiency of ESC. In addition, we examined how Msi2 isoform 1 and isoform 2 affect the differentiation of ESC. Interestingly, ectopic expression of either Msi2 isoform 1 or isoform 2 does not affect the pattern of differentiation induced by retinoic acid. Finally, we show that ectopic expression of either isoform 1 or isoform 2 is not sufficient to block the differentiation that results from the knockdown of both isoforms of Msi2. Thus, it appears that both isoforms of Msi2 are required for the self-renewal of ESC.	[Wuebben, Erin L.; Mallanna, Sunil K.; Cox, Jesse L.; Rizzino, Angie] Univ Nebraska Med Ctr, Eppley Inst Res Canc & Allied Dis, Omaha, NE USA	University of Nebraska System; University of Nebraska Medical Center	Wuebben, EL (corresponding author), Univ Nebraska Med Ctr, Eppley Inst Res Canc & Allied Dis, Omaha, NE USA.	arizzino@unmc.edu			National Institutes of Health [GM 080751]; National Cancer Institute [CA009476]; NATIONAL CANCER INSTITUTE [T32CA009476] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM080751] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); National Cancer Institute(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported by a grant from National Institutes of Health (GM 080751); EW was supported by an National Cancer Institute training grant (CA009476). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Barbouti A, 2003, CANCER RES, V63, P1202; Boer B, 2007, NUCLEIC ACIDS RES, V35, P1773, DOI 10.1093/nar/gkm059; Cox JL, 2011, J CELL SCI, V124, P2654, DOI 10.1242/jcs.083238; de Andres-Aguayo L, 2011, BLOOD, V118, P554, DOI 10.1182/blood-2010-12-322081; DOETSCHMAN TC, 1985, J EMBRYOL EXP MORPH, V87, P27; Gao Z, 2012, J BIOL CHEM IN PRESS; Hope KJ, 2010, CELL STEM CELL, V7, P101, DOI 10.1016/j.stem.2010.06.007; Huang DW, 2009, NAT PROTOC, V4, P44, DOI 10.1038/nprot.2008.211; Huang DW, 2009, NUCLEIC ACIDS RES, V37, P1, DOI 10.1093/nar/gkn923; Imai T, 2001, MOL CELL BIOL, V21, P3888, DOI 10.1128/MCB.21.12.3888-3900.2001; Ito T, 2010, NATURE, V466, P765, DOI 10.1038/nature09171; Kharas MG, 2010, NAT MED, V16, P903, DOI 10.1038/nm.2187; Kopp JL, 2008, STEM CELLS, V26, P903, DOI 10.1634/stemcells.2007-0951; Mallanna SK, 2010, STEM CELLS, V28, P1715, DOI 10.1002/stem.494; Niwa H, 2000, NAT GENET, V24, P372, DOI 10.1038/74199; Sakakibara S, 2002, P NATL ACAD SCI USA, V99, P15194, DOI 10.1073/pnas.232087499; Sakakibara S, 2001, J NEUROSCI, V21, P8091, DOI 10.1523/JNEUROSCI.21-20-08091.2001; Varum S, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0020914; Viswanathan SR, 2008, SCIENCE, V320, P97, DOI 10.1126/science.1154040	19	35	39	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 4	2012	7	4							e34827	10.1371/journal.pone.0034827	http://dx.doi.org/10.1371/journal.pone.0034827			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	953GO	22496868	Green Submitted, Green Published, gold			2022-12-25	WOS:000304855200084
J	Badea, CT; Athreya, KK; Espinosa, G; Clark, D; Ghafoori, AP; Li, YF; Kirsch, DG; Johnson, GA; Annapragada, A; Ghaghada, KB				Badea, Cristian T.; Athreya, Khannan K.; Espinosa, Gabriela; Clark, Darin; Ghafoori, A. Paiman; Li, Yifan; Kirsch, David G.; Johnson, G. Allan; Annapragada, Ananth; Ghaghada, Ketan B.			Computed Tomography Imaging of Primary Lung Cancer in Mice Using a Liposomal-Iodinated Contrast Agent	PLOS ONE			English	Article							PULMONARY NODULES; CT; ALGORITHM	Purpose: To investigate the utility of a liposomal-iodinated nanoparticle contrast agent and computed tomography (CT) imaging for characterization of primary nodules in genetically engineered mouse models of non-small cell lung cancer. Methods: Primary lung cancers with mutations in K-ras alone (Kras(LA1)) or in combination with p53 (LSL-Kras(G12D);p53(FL/FL)) were generated. A liposomal-iodine contrast agent containing 120 mg Iodine/mL was administered systemically at a dose of 16 mu l/gm body weight. Longitudinal micro-CT imaging with cardio-respiratory gating was performed pre-contrast and at 0 hr, day 3, and day 7 post-contrast administration. CT-derived nodule sizes were used to assess tumor growth. Signal attenuation was measured in individual nodules to study dynamic enhancement of lung nodules. Results: A good correlation was seen between volume and diameter-based assessment of nodules (R-2>0.8) for both lung cancer models. The LSL-Kras(G12D);p53(FL/FL) model showed rapid growth as demonstrated by systemically higher volume changes compared to the lung nodules in Kras(LA1) mice (p<0.05). Early phase imaging using the nanoparticle contrast agent enabled visualization of nodule blood supply. Delayed-phase imaging demonstrated significant differential signal enhancement in the lung nodules of LSL-Kras(G12D);p53(FL/FL) mice compared to nodules in Kras(LA1) mice (p<0.05) indicating higher uptake and accumulation of the nanoparticle contrast agent in rapidly growing nodules. Conclusions: The nanoparticle iodinated contrast agent enabled visualization of blood supply to the nodules during the early-phase imaging. Delayed-phase imaging enabled characterization of slow growing and rapidly growing nodules based on signal enhancement. The use of this agent could facilitate early detection and diagnosis of pulmonary lesions as well as have implications on treatment response and monitoring.	[Badea, Cristian T.; Clark, Darin; Johnson, G. Allan] Duke Univ, Med Ctr, Ctr Vivo Microscopy, Durham, NC 27706 USA; [Athreya, Khannan K.] Univ Texas Hlth Sci Ctr Houston, Univ Texas, Med Sch Houston, Houston, TX USA; [Espinosa, Gabriela; Annapragada, Ananth; Ghaghada, Ketan B.] Texas Childrens Hosp, Edward B Singleton Dept Pediat Radiol, Houston, TX 77030 USA; [Espinosa, Gabriela] Univ Texas Hlth Sci Ctr Houston, Sch Biomed Informat, Houston, TX USA; [Ghafoori, A. Paiman; Li, Yifan; Kirsch, David G.] Duke Univ, Med Ctr, Dept Radiat Oncol, Durham, NC USA; [Kirsch, David G.] Duke Univ, Med Ctr, Dept Pharmacol & Canc Biol, Durham, NC USA	Duke University; University of Texas System; University of Texas Health Science Center Houston; Baylor College of Medicine; University of Texas System; University of Texas Health Science Center Houston; Duke University; Duke University	Badea, CT (corresponding author), Duke Univ, Med Ctr, Ctr Vivo Microscopy, Durham, NC 27706 USA.	cristian.badea@duke.edu; kbghagha@texaschildrens.org	Badea, Cristian T/M-3323-2019; Annapragada, Ananth/GOK-1576-2022; Ghaghada, Ketan/F-6825-2012; Badea, Cristian/B-6681-2011	Badea, Cristian T/0000-0002-1850-2522; Badea, Cristian/0000-0002-1850-2522; Annapragada, Ananth/0000-0002-3156-9617; Johnson, G.Allan/0000-0002-7606-5447	NIH/NCRR National Biomedical Technology Resource Center [P41 RR005959, NCI U24 CA092656]; Marval Biosciences Inc.; American Society of Clinical Oncology; NCI [K08 CA 114176]; NATIONAL CANCER INSTITUTE [K08CA114176, U24CA092656] Funding Source: NIH RePORTER; NATIONAL CENTER FOR RESEARCH RESOURCES [P41RR005959] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [K02AI093866] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF BIOMEDICAL IMAGING AND BIOENGINEERING [P41EB015897] Funding Source: NIH RePORTER	NIH/NCRR National Biomedical Technology Resource Center(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Marval Biosciences Inc.; American Society of Clinical Oncology; NCI(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF BIOMEDICAL IMAGING AND BIOENGINEERING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Biomedical Imaging & Bioengineering (NIBIB))	This work was supported in part by NIH/NCRR National Biomedical Technology Resource Center grants (P41 RR005959, NCI U24 CA092656) (CTB, GAJ). Part of this work was supported by funding from Marval Biosciences Inc. (AA, KBG), American Society of Clinical Oncology, Young Investigator Award (APG) and NCI K08 CA 114176 (DGK). No additional external funding was received for this study. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	[Anonymous], 2011, NEW ENGLAND J MED, V365, P395; Badea C, 2004, MED PHYS, V31, P3324, DOI 10.1118/1.1812604; Badea C. T., 2011, MED IMAGING 2011 PHY, P7961; Baden C, 2008, DUAL MICROCT SYSTEM; Boone John M, 2004, Mol Imaging, V3, P149, DOI 10.1162/1535350042380326; FELDKAMP LA, 1984, J OPT SOC AM A, V1, P612, DOI 10.1364/JOSAA.1.000612; Freedman M, 2009, ACAD RADIOL, V16, P627, DOI 10.1016/j.acra.2008.12.002; Garbow JR, 2004, CANCER RES, V64, P2740, DOI 10.1158/0008-5472.CAN-03-3258; Ghaghada KB, 2011, ACAD RADIOL, V18, P20, DOI 10.1016/j.acra.2010.09.003; Hallouard F, 2010, BIOMATERIALS, V31, P6249, DOI 10.1016/j.biomaterials.2010.04.066; Jackson EL, 2005, CANCER RES, V65, P10280, DOI 10.1158/0008-5472.CAN-05-2193; Jemal A, 2008, JNCI-J NATL CANCER I, V100, P1672, DOI 10.1093/jnci/djn389; Johnson L, 2001, NATURE, V410, P1111, DOI 10.1038/35074129; Johnston SM, 2010, MED IMAGING 2010 PHY, P7622; Kamba T, 2006, AM J PHYSIOL-HEART C, V290, pH560, DOI 10.1152/ajpheart.00133.2005; Karathanasis E, 2009, RADIOLOGY, V250, P398, DOI 10.1148/radiol.2502080801; Kim YR, 2000, ACCURATE MEASUREMENT; Kirsch DG, 2010, INT J RADIAT ONCOL, V76, P973, DOI 10.1016/j.ijrobp.2009.11.038; Klerk CPW, 2007, BIOTECHNIQUES, V43, P7, DOI 10.2144/000112515; MacMahon H, 2005, RADIOLOGY, V237, P395, DOI 10.1148/radiol.2372041887; Mozley PD, 2010, ANN ONCOL, V21, P1751, DOI 10.1093/annonc/mdq051; Niedre MJ, 2008, P NATL ACAD SCI USA, V105, P19126, DOI 10.1073/pnas.0804798105; Oliver TG, 2010, GENE DEV, V24, P837, DOI 10.1101/gad.1897010; Petkovska I, 2006, EUR J RADIOL, V59, P244, DOI 10.1016/j.ejrad.2006.03.005; Phillips WT, 2009, WIRES NANOMED NANOBI, V1, P69, DOI 10.1002/wnan.3; Quan E, 2009, PHYS MED BIOL, V54, P1061, DOI 10.1088/0031-9155/54/4/016; Rygh CB, 2011, CLIN CANCER RES, V17, P550, DOI 10.1158/1078-0432.CCR-10-2049; Samei E, 2009, INT J NANOMED, V4, P277; Schraufnagel DE, BREATHING AM DIS PRO; Strijkers GJ, 2010, ANGIOGENESIS, V13, P161, DOI 10.1007/s10456-010-9165-1; Turetschek K, 2004, J MAGN RESON IMAGING, V20, P138, DOI 10.1002/jmri.20049; X He, 2011, NOVEL PEPTIDE PROBE, pnull; Yi CA, 2004, RADIOLOGY, V233, P191, DOI 10.1148/radiol.2331031535; Zheng JZ, 2010, CONTRAST MEDIA MOL I, V5, P147, DOI 10.1002/cmmi.378	34	44	46	1	19	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 2	2012	7	4							e34496	10.1371/journal.pone.0034496	http://dx.doi.org/10.1371/journal.pone.0034496			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	952GU	22485175	Green Submitted, Green Published, gold			2022-12-25	WOS:000304780500050
J	Iamarino, A; de Melo, FL; Braconi, CT; Zanotto, PMD				Iamarino, Atila; de Melo, Fernando Lucas; Braconi, Carla Torres; de Andrade Zanotto, Paolo Marinho			BF Integrase Genes of HIV-1 Circulating in Sao Paulo, Brazil, with a Recurrent Recombination Region	PLOS ONE			English	Article							DRUG-RESISTANCE; PATIENTS NAIVE; SUBTYPE-B; VIRUS; IDENTIFICATION; INHIBITORS; JPHMM	Although some studies have shown diversity in HIV integrase (IN) genes, none has focused particularly on the gene evolving in epidemics in the context of recombination. The IN gene in 157 HIV-1 integrase inhibitor-naive patients from the Sao Paulo State, Brazil, were sequenced tallying 128 of subtype B (23 of which were found in non-B genomes), 17 of subtype F (8 of which were found in recombinant genomes), 11 integrases were BF recombinants, and 1 from subtype C. Crucially, we found that 4 BF recombinant viruses shared a recurrent recombination breakpoint region between positions 4900 and 4924 (relative to the HXB2) that includes 2 gRNA loops, where the RT may stutter. Since these recombinants had independent phylogenetic origin, we argue that these results suggest a possible recombination hotspot not observed so far in BF CRF in particular, or in any other HIV-1 CRF in general. Additionally, 40% of the drug-naive and 45% of the drug-treated patients had at least 1 raltegravir (RAL) or elvitegravir (EVG) resistance-associated amino acid change, but no major resistance mutations were found, in line with other studies. Importantly, V151I was the most common minor resistance mutation among B, F and BF IN genes. Most codon sites of the IN genes had higher rates of synonymous substitutions (dS) indicative of a strong negative selection. Nevertheless, several codon sites mainly in the subtype B were found under positive selection. Consequently, we observed a higher genetic diversity in the B portions of the mosaics, possibly due to the more recent introduction of subtype F on top of an ongoing subtype B epidemics and a fast spread of subtype F alleles among the B population.	[Iamarino, Atila; de Melo, Fernando Lucas; Braconi, Carla Torres; de Andrade Zanotto, Paolo Marinho] Univ Sao Paulo, Lab Mol Evolut & Bioinformat, Dept Microbiol, Biomed Sci Inst ICB 2, Sao Paulo, Brazil	Universidade de Sao Paulo	Iamarino, A (corresponding author), Univ Sao Paulo, Lab Mol Evolut & Bioinformat, Dept Microbiol, Biomed Sci Inst ICB 2, Sao Paulo, Brazil.	pzanotto@usp.br	Melo, Fernando Lucas/U-6535-2017; Braconi, Carla/B-3320-2014; de A. Zanotto, Paolo M./B-9286-2019	Melo, Fernando Lucas/0000-0002-9591-0239; Braconi, Carla/0000-0002-5370-8980; de A. Zanotto, Paolo M./0000-0002-8167-0625; Iamarino, Atila/0000-0003-3904-0248	Fundacao de Amparo a Pesquisa do Estado de Sao Paulo (FAPESP) [10/19341-4, 00/04205-6, 08/58559-5, 07/01554-9, 09/16740-8]; CNPq	Fundacao de Amparo a Pesquisa do Estado de Sao Paulo (FAPESP)(Fundacao de Amparo a Pesquisa do Estado de Sao Paulo (FAPESP)); CNPq(Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPQ))	This study was funded by Fundacao de Amparo a Pesquisa do Estado de Sao Paulo (FAPESP; projects #10/19341-4, 00/04205-6 [VGDN program], 08/58559-5 [AI], 07/01554-9 [FLM], and 09/16740-8 [CTB]). PMAZ holds a CNPq-PQ scholarship. The funders had no role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Arruda LB, 2010, AIDS RES HUM RETROV, V26, P105, DOI 10.1089/aid.2009.0179; Bello G, 2006, AIDS, V20, P763, DOI 10.1097/01.aids.0000216377.84313.52; Passaes CPB, 2009, AIDS RES HUM RETROV, V25, P1339, DOI 10.1089/aid.2009.0167; Bouyac-Bertoia M, 2001, MOL CELL, V7, P1025, DOI 10.1016/S1097-2765(01)00240-4; Bruselles A, 2009, AIDS RES HUM RETROV, V25, P937, DOI 10.1089/aid.2009.0083; Ceccherini-Silberstein F, 2009, AIDS REV, V11, P17; Pardini MI, 2008, PLOS BIOL, V6, P428, DOI 10.1371/journal.pbio.0060057; De Sa DJ, 2005, AIDS RES HUM RETROV, V21, P145, DOI 10.1089/aid.2005.21.145; De Sa DJ, 2006, AIDS RES HUM RETROV, V22, P1; DeJesus E, 2006, JAIDS-J ACQ IMM DEF, V43, P1, DOI 10.1097/01.qai.0000233308.82860.2f; ENGELMAN A, 1992, J VIROL, V66, P6361, DOI 10.1128/JVI.66.11.6361-6369.1992; Gonsalez CR, 2007, VIRUS RES, V129, P87, DOI 10.1016/j.virusres.2007.06.021; Grinsztejn B, 2007, LANCET, V369, P1261, DOI 10.1016/S0140-6736(07)60597-2; Pond SLK, 2006, MOL BIOL EVOL, V23, P1891, DOI 10.1093/molbev/msl051; KULKOSKY J, 1992, MOL CELL BIOL, V12, P2331, DOI 10.1128/MCB.12.5.2331; Lataillade M, 2007, ANTIVIR THER, V12, P563; Maertens GN, 2010, NATURE, V468, P326, DOI 10.1038/nature09517; Magiorkinis G, 2003, J GEN VIROL, V84, P2715, DOI 10.1099/vir.0.19180-0; Malet I, 2008, ANTIMICROB AGENTS CH, V52, P1351, DOI 10.1128/AAC.01228-07; de Souza ACMF, 2008, AIDS RES HUM RETROV, V24, P1521, DOI 10.1089/aid.2008.0089; McCutchan FE, 1999, EVOLUTION OF HIV, P41; Ministerio da Saude do Brasil Secretaria de Vigilancia em Saude Programa Nacional de DST e AIDS, 2010, MIN SAUD BRAS B EP, VVII; Pommier Y, 2005, NAT REV DRUG DISCOV, V4, P236, DOI 10.1038/nrd1660; Sanabani S, 2006, AIDS RES HUM RETROV, V22, P171, DOI 10.1089/aid.2006.22.171; Sanabani S, 2006, INFECT GENET EVOL, V6, P368, DOI 10.1016/j.meegid.2006.01.003; Schultz AK, 2006, BMC BIOINFORMATICS, V7, DOI 10.1186/1471-2105-7-265; Schultz AK, 2009, NUCLEIC ACIDS RES, V37, pW647, DOI 10.1093/nar/gkp371; Shafer RW, 2006, J INFECT DIS, V194, pS51, DOI 10.1086/505356; Thomson MM, 2005, AIDS REV, V7, P210; Van Laethem K, 2008, J VIROL METHODS, V153, P176, DOI 10.1016/j.jviromet.2008.07.008; Watts JM, 2009, NATURE, V460, P711, DOI 10.1038/nature08237; Zhang M, 2006, NUCLEIC ACIDS RES, V34, pW463, DOI 10.1093/nar/gkl255; Zhang M, 2010, RETROVIROLOGY, V7, DOI 10.1186/1742-4690-7-25; Zwickl D., 2006, GARLI GENETIC ALGORI	34	3	3	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 2	2012	7	4							e34324	10.1371/journal.pone.0034324	http://dx.doi.org/10.1371/journal.pone.0034324			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	952GU	22485165	gold, Green Published, Green Submitted			2022-12-25	WOS:000304780500040
J	Rau, C; Hwang, M; Lee, WK; Richter, CP				Rau, Christoph; Hwang, Margaret; Lee, Wah-Keat; Richter, Claus-Peter			Quantitative X-ray Tomography of the Mouse Cochlea	PLOS ONE			English	Article							OPTICAL COHERENCE TOMOGRAPHY; TEMPORAL BONE; INNER-EAR; MICROSCOPY; MORPHOLOGY; MEMBRANE; TISSUE; MICE; MAP	Imaging with hard X-rays allows visualizing cochlear structures while maintaining intrinsic qualities of the tissue, including structure and size. With coherent X-rays, soft tissues, including membranes, can be imaged as well as cells making use of the so-called in-line phase contrast. In the present experiments, partially coherent synchrotron radiation has been used for micro-tomography. Three-dimensional reconstructions of the mouse cochlea have been created using the EM3D software and the volume has been segmented in the Amira Software Suite. The structures that have been reconstructed include scala tympani, scala media, scala vestibuli Reissner's membrane, basilar membrane, tectorial membrane, organ of Corti, spiral limbus, spiral ganglion and cochlear nerve. Cross-sectional areas of the scalae were measured. The results provide a realistic and quantitative reconstruction of the cochlea.	[Rau, Christoph] Diamond Light Source Ltd, Didcot, Oxon, England; [Rau, Christoph; Hwang, Margaret; Richter, Claus-Peter] Northwestern Univ, Dept Otolaryngol, Feinberg Sch Med, Chicago, IL 60611 USA; [Lee, Wah-Keat] Argonne Natl Lab, Adv Photon Source, Argonne, IL 60439 USA; [Richter, Claus-Peter] Northwestern Univ, Dept Biomed Engn, Evanston, IL 60208 USA; [Richter, Claus-Peter] Northwestern Univ, Dept Commun Sci & Disorders, Hugh Knowles Ctr, Evanston, IL USA	Diamond Light Source; Northwestern University; Feinberg School of Medicine; United States Department of Energy (DOE); Argonne National Laboratory; Northwestern University; Northwestern University	Rau, C (corresponding author), Diamond Light Source Ltd, Diamond House,Harwell Sci & Innovat Campus, Didcot, Oxon, England.	cri529@northwestern.edu	Lee, Wah-Keat/GRR-9734-2022		NSF [IBN-0415901]; Hugh Knowles Foundation; United States Department of Energy, Office of Science, Office of Basic Energy Sciences [DE-AC02-06CH11357]	NSF(National Science Foundation (NSF)); Hugh Knowles Foundation; United States Department of Energy, Office of Science, Office of Basic Energy Sciences(United States Department of Energy (DOE))	CPR has been supported by a grant from the NSF (IBN-0415901) and the Hugh Knowles Foundation. Use of the Advanced Photon Source at Argonne National Laboratory was supported by the United States Department of Energy, Office of Science, Office of Basic Energy Sciences, under Contract No. DE-AC02-06CH11357. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Brunschwig AS, 1997, HEARING RES, V114, P62, DOI 10.1016/S0378-5955(97)00153-6; BURDA H, 1988, J MORPHOL, V198, P269, DOI 10.1002/jmor.1051980303; BURDA H, 1988, HEARING RES, V36, P97, DOI 10.1016/0378-5955(88)90140-2; Choudhury N, 2006, HEARING RES, V220, P1, DOI 10.1016/j.heares.2006.06.006; Czerny C, 2003, RADIOLOGE, V43, P200, DOI 10.1007/s00117-003-0867-x; Dodt HU, 2007, NAT METHODS, V4, P331, DOI 10.1038/NMETH1036; Edge RM, 1998, HEARING RES, V124, P1, DOI 10.1016/S0378-5955(98)00090-2; EHRET G, 1977, J COMP PHYSIOL, V122, P65, DOI 10.1007/BF00611249; Fuchs E, 2002, OPT EXPRESS, V10, P145, DOI 10.1364/OE.10.000145; Glueckert R, 2010, AM J MED GENET A, V152A, P665, DOI 10.1002/ajmg.a.33321; Hallpike C S, 1938, Proc R Soc Med, V31, P1317; Huisken J, 2004, SCIENCE, V305, P1007, DOI 10.1126/science.1100035; Johnson SB, 2011, HEARING RES, V278, P34, DOI 10.1016/j.heares.2011.02.008; Keiler S, 2001, HEARING RES, V162, P91, DOI 10.1016/S0378-5955(01)00374-4; Lareida A, 2009, J MICROSC-OXFORD, V234, P95, DOI 10.1111/j.1365-2818.2009.03143.x; Lee CF, 2010, ANN BIOMED ENG, V38, P1719, DOI 10.1007/s10439-010-9961-1; LIM DJ, 1972, ARCHIV OTOLARYNGOL, V96, P199; Lin J, 2008, ANN OTO RHINOL LARYN, V117, P341, DOI 10.1177/000348940811700503; Muller M, 2005, HEARING RES, V202, P63, DOI 10.1016/j.heares.2004.08.011; Ou HC, 2000, HEARING RES, V145, P123, DOI 10.1016/S0378-5955(00)00082-4; Pau HW, 2008, LARYNGO RHINO OTOL, V87, P641, DOI 10.1055/s-2007-995725; Pau HW, 2007, ACTA OTO-LARYNGOL, V127, P907, DOI 10.1080/00016480601089408; Rau C, 2006, MICROSC RES TECHNIQ, V69, P660, DOI 10.1002/jemt.20336; Rau C, 2007, NIMB, DOI [10.1016/j.nimb.2007.1003.1053, DOI 10.1016/J.NIMB.2007.1003.1053]; Rau C, 2007, MICRO NANO IN PRESS; Rau C, 2006, SPIE, V6078; Reisser C, 1996, AM J OTOL, V17, P473; Richter CP, 2009, MICROSC RES TECHNIQ, V72, P902, DOI 10.1002/jemt.20728; Santi PA, 2011, J HISTOCHEM CYTOCHEM, V59, P129, DOI 10.1369/0022155410394857; Santi PA, 2009, BIOTECHNIQUES, V46, P287, DOI 10.2144/000113087; Siedentopf H, 1902, ANN PHYS, V315, P1, DOI [10.1002/andp.19023150102, DOI 10.1002/ANDP.19023150102]; Steel KP, 1996, CURR OPIN NEUROBIOL, V6, P520, DOI 10.1016/S0959-4388(96)80059-6; Subhash HM, 2010, J BIOMED OPT, V15, DOI 10.1117/1.3456554; Thorne M, 1999, LARYNGOSCOPE, V109, P1661, DOI 10.1097/00005537-199910000-00021; Vogel U, 1999, ORL-J OTO-RHIN-LARYN, V61, P259, DOI 10.1159/000027683; VOIE AH, 1993, J MICROSC-OXFORD, V170, P229, DOI 10.1111/j.1365-2818.1993.tb03346.x; Voie AH, 1995, COMPUT MED IMAG GRAP, V19, P377, DOI 10.1016/0895-6111(95)00034-8; Voie AH, 2002, HEARING RES, V171, P119, DOI 10.1016/S0378-5955(02)00493-8; Wong BJF, 2000, J BIOMED OPT, V5, P367, DOI 10.1117/1.1310165; Wong BJF, 2004, OTOLARYNG HEAD NECK, V130, P334, DOI 10.1016/j.otohns.2003.11.007; Zheng QY, 1999, HEARING RES, V130, P94, DOI 10.1016/S0378-5955(99)00003-9	41	25	27	0	15	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 2	2012	7	4							e33568	10.1371/journal.pone.0033568	http://dx.doi.org/10.1371/journal.pone.0033568			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	952GU	22485145	Green Published, Green Submitted, gold			2022-12-25	WOS:000304780500021
J	Belforte, N; Sande, PH; de Zavalia, N; Dorfman, D; Rosenstein, RE				Belforte, Nicolas; Sande, Pablo H.; de Zavalia, Nuria; Dorfman, Damian; Rosenstein, Ruth E.			Therapeutic Benefit of Radial Optic Neurotomy in a Rat Model of Glaucoma	PLOS ONE			English	Article							CENTRAL RETINAL VEIN; RETROGRADE AXOPLASMIC-TRANSPORT; GANGLION-CELL FATE; NERVE HEAD; LAMINA-CRIBROSA; INTRAOCULAR-PRESSURE; OCCLUSION; MONKEY; DEFORMATION; TISSUE	Radial optic neurotomy (RON) has been proposed as a surgical treatment to alleviate the neurovascular compression and to improve the venous outflow in patients with central retinal vein occlusion. Glaucoma is characterized by specific visual field defects due to the loss of retinal ganglion cells and damage to the optic nerve head (ONH). One of the clinical hallmarks of glaucomatous neuropathy is the excavation of the ONH. The aim of this work was to analyze the effect of RON in an experimental model of glaucoma in rats induced by intracameral injections of chondroitin sulfate (CS). For this purpose, Wistar rats were bilaterally injected with vehicle or CS in the eye anterior chamber, once a week, for 10 weeks. At 3 or 6 weeks of a treatment with vehicle or CS, RON was performed by a single incision in the edge of the neuro-retinal ring at the nasal hemisphere of the optic disk in one eye, while the contralateral eye was submitted to a sham procedure. Electroretinograms (ERGs) were registered under scotopic conditions and visual evoked potentials (VEPs) were registered with skull-implanted electrodes. Retinal and optic nerve morphology was examined by optical microscopy. RON did not affect the ocular hypertension induced by CS. In eyes injected with CS, a significant decrease of retinal (ERG a- and b- wave amplitude) and visual pathway (VEP N2-P2 component amplitude) function was observed, whereas RON reduced these functional alterations in hypertensive eyes. Moreover, a significant loss of cells in the ganglion cell layer, and Thy-1-, NeuN- and Brn3a- positive cells was observed in eyes injected with CS, whereas RON significantly preserved these parameters. In addition, RON preserved the optic nerve structure in eyes with chronic ocular hypertension. These results indicate that RON reduces functional and histological alterations induced by experimental chronic ocular hypertension.	[Belforte, Nicolas; Sande, Pablo H.; de Zavalia, Nuria; Dorfman, Damian; Rosenstein, Ruth E.] Univ Buenos Aires, Lab Retinal Neurochem & Expt Ophthalmol, Dept Human Biochem, Sch Med CEFyBO,CONICET, Buenos Aires, DF, Argentina	Consejo Nacional de Investigaciones Cientificas y Tecnicas (CONICET); University of Buenos Aires	Belforte, N (corresponding author), Univ Buenos Aires, Lab Retinal Neurochem & Expt Ophthalmol, Dept Human Biochem, Sch Med CEFyBO,CONICET, Buenos Aires, DF, Argentina.	ruthr@fmed.uba.ar		Belforte, Nicolas/0000-0001-5857-8006	Agencia Nacional de Promocion Cientifica y Tecnologica [PICT 1623]; University of Buenos Aires [M062]; Consejo Nacional de Investigaciones Cientificas y Tecnicas (CONICET), Argentina [PIP 1911]	Agencia Nacional de Promocion Cientifica y Tecnologica(ANPCyT); University of Buenos Aires(University of Buenos Aires); Consejo Nacional de Investigaciones Cientificas y Tecnicas (CONICET), Argentina(Consejo Nacional de Investigaciones Cientificas y Tecnicas (CONICET))	This research was supported by grants from the Agencia Nacional de Promocion Cientifica y Tecnologica (PICT 1623), the University of Buenos Aires (M062), and Consejo Nacional de Investigaciones Cientificas y Tecnicas (CONICET) (PIP 1911), Argentina. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Arevalo JF, 2008, RETINA-J RET VIT DIS, V28, P1044, DOI 10.1097/IAE.0b013e3181744153; BARNSTABLE CJ, 1984, NEUROSCIENCE, V11, P847, DOI 10.1016/0306-4522(84)90195-7; Belforte N, 2010, INVEST OPHTH VIS SCI, V51, P5768, DOI 10.1167/iovs.10-5660; Belforte NA, 2011, RETINA-J RET VIT DIS, V31, P2115, DOI 10.1097/IAE.0b013e31820f4bcb; Bellezza AJ, 2003, INVEST OPHTH VIS SCI, V44, P623, DOI 10.1167/iovs.01-1282; Buckingham BP, 2008, J NEUROSCI, V28, P2735, DOI 10.1523/JNEUROSCI.4443-07.2008; Burgoyne CF, 2005, PROG RETIN EYE RES, V24, P39, DOI 10.1016/j.preteyeres.2004.06.001; Burgoyne CF, 2004, INVEST OPHTH VIS SCI, V45, P4388, DOI 10.1167/iovs.04-0022; Canola K, 2007, INVEST OPHTH VIS SCI, V48, P446, DOI 10.1167/iovs.06-0190; Dijk F, 2007, EXP EYE RES, V84, P858, DOI 10.1016/j.exer.2007.01.006; Downs JC, 2008, OPTOMETRY VISION SCI, V85, P425, DOI 10.1097/OPX.0b013e31817841cb; ERNEST JT, 1968, AM J OPHTHALMOL, V66, P373, DOI 10.1016/0002-9394(68)91520-1; Feltgen N, 2005, OPHTHALMOLOGE, V102, P802, DOI 10.1007/s00347-004-1060-y; Garcia-Arumi J, 2003, ARCH OPHTHALMOL-CHIC, V121, P1385, DOI 10.1001/archopht.121.10.1385; Hayreh SS, 2004, ARCH OPHTHALMOL-CHIC, V122, P1572, DOI 10.1001/archopht.122.10.1572-b; Horio N, 2005, AM J OPHTHALMOL, V139, P926, DOI 10.1016/j.ajo.2004.10.053; JOHANSSON JO, 1983, INVEST OPHTH VIS SCI, V24, P1552; Maia M, 2007, CLIN EXP OPHTHALMOL, V35, P672, DOI 10.1111/j.1442-9071.2007.01568.x; Martinez-Jardon CS, 2005, BRIT J OPHTHALMOL, V89, P558, DOI 10.1136/bjo.2004.048181; May CA, 2002, INVEST OPHTH VIS SCI, V43, P2206; May CA, 2008, OPEN OPHTHALMOL J, V2, P94, DOI 10.2174/1874364100802010094; MINCKLER DS, 1977, INVEST OPHTH VIS SCI, V16, P426; Moreno MC, 2004, FREE RADICAL BIO MED, V37, P803, DOI 10.1016/j.freeradbiomed.2004.06.001; MORRISON J, 1995, EXP EYE RES, V60, P127, DOI 10.1016/S0014-4835(95)80002-6; Opremcak EM, 2006, RETINA-J RET VIT DIS, V26, P297, DOI 10.1097/00006982-200603000-00008; Opremcak EM, 2001, RETINA-J RET VIT DIS, V21, P408, DOI 10.1097/00006982-200110000-00002; Pease ME, 2000, INVEST OPHTH VIS SCI, V41, P764; QUIGLEY HA, 1981, ARCH OPHTHALMOL-CHIC, V99, P635, DOI 10.1001/archopht.1981.03930010635009; Quina LA, 2005, J NEUROSCI, V25, P11595, DOI 10.1523/JNEUROSCI.2837-05.2005; Raymond ID, 2008, MOL VIS, V14, P1559; Roberts MD, 2010, INVEST OPHTH VIS SCI, V51, P5675, DOI 10.1167/iovs.10-5411; Samuel MA, 2003, RETINA-J RET VIT DIS, V23, P580, DOI 10.1097/00006982-200308000-00033; Schneider U, 2005, RETINA-J RET VIT DIS, V25, P704, DOI 10.1097/00006982-200509000-00004; Sigal IA, 2009, EXP EYE RES, V88, P799, DOI 10.1016/j.exer.2009.02.003; Soheilian M, 2010, OPHTHAL SURG LAS IM, V41, P157, DOI 10.3928/15428877-20100303-02; Wax MB, 2009, EXP EYE RES, V88, P825, DOI 10.1016/j.exer.2009.02.005; Weis E, 2008, CAN J OPHTHALMOL, V43, P73, DOI 10.3129/i07-180; Weizer JS, 2003, AM J OPHTHALMOL, V136, P814, DOI 10.1016/S0002-9394(03)00698-6; Williamson TH, 2003, BRIT J OPHTHALMOL, V87, P1126, DOI 10.1136/bjo.87.9.1126; Wolf HK, 1996, J HISTOCHEM CYTOCHEM, V44, P1167, DOI 10.1177/44.10.8813082; Yamamoto S, 2005, AM J OPHTHALMOL, V139, P206, DOI 10.1016/j.ajo.2004.07.031; Yamamoto T, 2009, RETINA-J RET VIT DIS, V29, P1167, DOI 10.1097/IAE.0b013e3181a46a5e; YAN DB, 1994, BRIT J OPHTHALMOL, V78, P643, DOI 10.1136/bjo.78.8.643; Yang HL, 2007, INVEST OPHTH VIS SCI, V48, P4597, DOI 10.1167/iovs.07-0349; Yang HL, 2011, INVEST OPHTH VIS SCI, V52, P345, DOI 10.1167/iovs.09-5122	45	4	4	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 29	2012	7	3							e34574	10.1371/journal.pone.0034574	http://dx.doi.org/10.1371/journal.pone.0034574			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	948SR	22479647	Green Published, Green Submitted, gold			2022-12-25	WOS:000304523400089
J	Dubut, V; Fouquet, A; Voisin, A; Costedoat, C; Chappaz, R; Gilles, A				Dubut, Vincent; Fouquet, Antoine; Voisin, Adrien; Costedoat, Caroline; Chappaz, Remi; Gilles, Andre			From Late Miocene to Holocene: Processes of Differentiation within the Telestes Genus (Actinopterygii: Cyprinidae)	PLOS ONE			English	Article							POPULATION GENETIC-STRUCTURE; MICROSATELLITE NULL ALLELES; VAIRONE LEUCISCUS-SOUFFIA; MULTILOCUS GENOTYPE DATA; BULLHEAD COTTUS-GOBIO; MUTICELLUS TELEOSTEI; EUROPEAN CYPRINIDS; COMPLEX TELEOSTEI; COMPUTER-PROGRAM; COUNTING ALLELES	Investigating processes and timing of differentiation of organisms is critical in the understanding of the evolutionary mechanisms involved in microevolution, speciation, and macroevolution that generated the extant biodiversity. From this perspective, the Telestes genus is of special interest: the Telestes species have a wide distribution range across Europe (from the Danubian district to Mediterranean districts) and have not been prone to translocation. Molecular data (mtDNA: 1,232 bp including the entire Cyt b gene; nuclear genome: 11 microsatellites) were gathered from 34 populations of the Telestes genus, almost encompassing the entire geographic range. Using several phylogenetic and molecular dating methods interpreted in conjunction with paleoclimatic and geomorphologic evidence, we investigated the processes and timing of differentiation of the Telestes lineages. The observed genetic structure and diversity were largely congruent between mtDNA and microsatellites. The Messinian Salinity Crisis (Late Miocene) seems to have played a major role in the speciation processes of the genus. Focusing on T. souffia, a species occurring in the Danube and Rhone drainages, we were able to point out several specific events from the Pleistocene to the Holocene that have likely driven the differentiation and the historical demography of this taxon. This study provides support for an evolutionary history of dispersal and vicariance with unprecedented resolution for any freshwater fish in this region.	[Dubut, Vincent; Fouquet, Antoine; Voisin, Adrien; Costedoat, Caroline; Chappaz, Remi; Gilles, Andre] Aix Marseille Univ, CNRS, Equipe Evolut Genome Environm, Ctr St Charles,IRD,UMR IMBE 7263, Marseille, France; [Fouquet, Antoine] CNRS Guyane, USR 3456, CNRS, Cayenne, French Guiana	UDICE-French Research Universities; Aix-Marseille Universite; Centre National de la Recherche Scientifique (CNRS); Institut de Recherche pour le Developpement (IRD)	Dubut, V (corresponding author), Aix Marseille Univ, CNRS, Equipe Evolut Genome Environm, Ctr St Charles,IRD,UMR IMBE 7263, Case 36, Marseille, France.	v.dubut@gmail.com		Dubut, Vincent/0000-0002-5619-6909; Fouquet, Antoine/0000-0003-4060-0281				AKAIKE H, 1974, IEEE T AUTOMAT CONTR, VAC19, P716, DOI 10.1109/TAC.1974.1100705; Avise JC, 1998, P ROY SOC B-BIOL SCI, V265, P1707, DOI 10.1098/rspb.1998.0492; Banarescu P., 1990, ZOOGEOGRAPHY FRESH W, V1; Banarescu PM, 1989, FRESHWATER FISHES EU, P88; Bandelt HJ, 1999, MOL BIOL EVOL, V16, P37, DOI 10.1093/oxfordjournals.molbev.a026036; Belkhir K, 2004, GENETIX 4 05 LOGICIE; BENJAMINI Y, 1995, J R STAT SOC B, V57, P289, DOI 10.1111/j.2517-6161.1995.tb02031.x; Bernatchez L, 1998, MOL ECOL, V7, P431, DOI 10.1046/j.1365-294x.1998.00319.x; Bianco P.G., 1990, Ichthyological Exploration of Freshwaters, V1, P167; BIANCO PG, 1988, J FISH BIOL, V32, P1, DOI 10.1111/j.1095-8649.1988.tb05331.x; Brito RM, 1997, MOL PHYLOGENET EVOL, V8, P435, DOI 10.1006/mpev.1997.0429; Bryja J, 2010, MOL ECOL, V19, P4708, DOI 10.1111/j.1365-294X.2010.04844.x; Burridge CP, 2008, MOL BIOL EVOL, V25, P624, DOI 10.1093/molbev/msm271; Campana MG, 2011, MOL ECOL RESOUR, V11, P349, DOI 10.1111/j.1755-0998.2010.02917.x; Carlsson J, 2008, J HERED, V99, P616, DOI 10.1093/jhered/esn048; CAVALLISFORZA LL, 1967, AM J HUM GENET, V19, P233, DOI 10.2307/2406616; CHANGEUX T, 1995, BIOL CONSERV, V72, P137, DOI 10.1016/0006-3207(94)00077-4; Chapuis MP, 2008, MOL ECOL, V17, P3640, DOI 10.1111/j.1365-294X.2008.03869.x; Chapuis MP, 2007, MOL BIOL EVOL, V24, P621, DOI 10.1093/molbev/msl191; Clark PU, 2009, SCIENCE, V325, P710, DOI 10.1126/science.1172873; Clebert JP, 1991, DURANCE; Clement M, 2000, MOL ECOL, V9, P1657, DOI 10.1046/j.1365-294x.2000.01020.x; Cornuet JM, 1996, GENETICS, V144, P2001; Cortey M, 2009, BIOL J LINN SOC, V97, P904, DOI 10.1111/j.1095-8312.2009.01220.x; Costedoat C, 2006, MOL PHYLOGENET EVOL, V41, P127, DOI 10.1016/j.ympev.2006.04.022; Costedoat Caroline, 2009, Open Conservation Biology Journal, V3, P36, DOI 10.2174/1874839200903010036; Coyne JA, 2004, SPECIATION, V37; CRACRAFT J, 1982, AM ZOOL, V22, P411; Dermitzakis M.D., 1991, Accademia Nazionale dei Lincei Atti Convegni Lincei (Rome), V85, P263; DIRIENZO A, 1994, P NATL ACAD SCI USA, V91, P3166, DOI 10.1073/pnas.91.8.3166; DOWLING TE, 1993, NATURE, V362, P444, DOI 10.1038/362444a0; Drummond AJ, 2005, MOL BIOL EVOL, V22, P1185, DOI [10.1093/molbev/msi103, 10.1093/molbev/mss075]; Drummond AJ, 2007, BMC EVOL BIOL, V7, DOI 10.1186/1471-2148-7-214; Dubut Vincent, 2010, BMC Res Notes, V3, P135, DOI 10.1186/1756-0500-3-135; Dubut V, 2009, MOL ECOL RESOUR, V9, P1001, DOI 10.1111/j.1755-0998.2009.02539.x; Evanno G, 2005, MOL ECOL, V14, P2611, DOI 10.1111/j.1365-294X.2005.02553.x; EWENS WJ, 1972, THEOR POPUL BIOL, V3, P87, DOI 10.1016/0040-5809(72)90035-4; Excoffier L, 2008, TRENDS ECOL EVOL, V23, P347, DOI 10.1016/j.tree.2008.04.004; Excoffier L, 2005, EVOL BIOINFORM, V1, P47, DOI 10.1177/117693430500100003; Falush D, 2003, GENETICS, V164, P1567; Falush D, 2007, MOL ECOL NOTES, V7, P574, DOI 10.1111/j.1471-8286.2007.01758.x; FELSENSTEIN J, 1985, EVOLUTION, V39, P783, DOI 10.1111/j.1558-5646.1985.tb00420.x; Fogelqvist J, 2010, MOL ECOL RESOUR, V10, P314, DOI 10.1111/j.1755-0998.2009.02756.x; Forster P, 1996, AM J HUM GENET, V59, P935; Fu YX, 1997, GENETICS, V147, P915; Garcia-Castellanos D, 2009, NATURE, V462, P778, DOI 10.1038/nature08555; GIBBARD P.L., 2005, GEOLOGIC TIME SCALE, P441, DOI DOI 10.1017/CBO9780511536045.023; GIBBARD PL, 1988, PHILOS T ROY SOC B, V318, P559, DOI 10.1098/rstb.1988.0024; Gilles A, 1998, MOL PHYLOGENET EVOL, V10, P132, DOI 10.1006/mpev.1997.0480; Gilles A, 1998, CAN J FISH AQUAT SCI, V55, P2341, DOI 10.1139/cjfas-55-10-2341; Gilles A, 2010, ZOOL SCR, V39, P225, DOI 10.1111/j.1463-6409.2010.00417.x; Guinand B, 1996, BIOL J LINN SOC, V58, P173, DOI 10.1111/j.1095-8312.1996.tb01430.x; Head MJ, 2005, GEOL SOC SPEC PUBL, V247, P1, DOI 10.1144/GSL.SP.2005.247.01.01; Helgason A, 2003, ANN HUM GENET, V67, P281, DOI 10.1046/j.1469-1809.2003.00046.x; Hewitt G, 2000, NATURE, V405, P907, DOI 10.1038/35016000; Hoffmann R.C., 1995, GUELPH ICHTHYOLOGY R, V3, P57; Hofreiter M, 2009, CURR BIOL, V19, pR584, DOI 10.1016/j.cub.2009.06.030; HSU KJ, 1977, NATURE, V267, P399, DOI 10.1038/267399a0; Hubisz MJ, 2009, MOL ECOL RESOUR, V9, P1322, DOI 10.1111/j.1755-0998.2009.02591.x; Huelsenbeck JP, 2001, BIOINFORMATICS, V17, P754, DOI 10.1093/bioinformatics/17.8.754; Kalinowski ST, 2011, HEREDITY, V106, P625, DOI 10.1038/hdy.2010.95; Kalinowski ST, 2004, CONSERV GENET, V5, P539, DOI 10.1023/B:COGE.0000041021.91777.1a; Ketmaier V, 2004, MOL PHYLOGENET EVOL, V32, P1061, DOI 10.1016/j.ympev.2004.04.008; KIMURA M, 1964, GENETICS, V49, P725; KIMURA M, 1978, P NATL ACAD SCI USA, V75, P2868, DOI 10.1073/pnas.75.6.2868; Krijgsman W, 1999, NATURE, V400, P652, DOI 10.1038/23231; Lajbner Z, 2011, EVOL APPL, V4, P545, DOI 10.1111/j.1752-4571.2010.00174.x; Levy A, 2009, J BIOGEOGR, V36, P55, DOI 10.1111/j.1365-2699.2008.01969.x; Loczy D, 2008, LARGE RIVERS GEOMORP, P235; Machordom A, 2001, MOL PHYLOGENET EVOL, V18, P252, DOI 10.1006/mpev.2000.0876; MANTEL N, 1967, CANCER RES, V27, P209; Marchetto F, 2010, BMC EVOL BIOL, V10, DOI 10.1186/1471-2148-10-111; Muenzel FM, 2007, MOL ECOL NOTES, V7, P1048, DOI 10.1111/j.1471-8286.2007.01772.x; Muscheler R, 2008, NAT GEOSCI, V1, P263, DOI 10.1038/ngeo128; NEI M, 1975, EVOLUTION, V29, P1, DOI 10.2307/2407137; Nei M., 1987, MOL EVOLUTIONARY GEN; NELVA A, 1988, Cybium, V12, P287; Nelva A, 1997, B FR PECHE PISCIC, V344/345, P253; Neuenschwander S, 2008, MOL ECOL, V17, P757, DOI 10.1111/j.1365-294X.2007.03621.x; Olivier JM, 2009, RIVERS OF EUROPE, 1ST EDITION, P247, DOI 10.1016/B978-0-12-369449-2.00007-2; Otto-Bliesner BL, 2006, SCIENCE, V311, P1751, DOI 10.1126/science.1120808; PENNY D, 1985, SYST ZOOL, V34, P75, DOI 10.2307/2413347; Perea S, 2010, BMC EVOL BIOL, V10, DOI 10.1186/1471-2148-10-265; Petit RJ, 1998, CONSERV BIOL, V12, P844, DOI 10.1046/j.1523-1739.1998.96489.x; Piry S, 1999, J HERED, V90, P502, DOI 10.1093/jhered/90.4.502; Posada D, 1998, BIOINFORMATICS, V14, P817, DOI 10.1093/bioinformatics/14.9.817; Prichard J.K., 2010, DOCUMENTATION STRUCT; Pritchard JK, 2000, GENETICS, V155, P945; Provan J, 2008, TRENDS ECOL EVOL, V23, P564, DOI 10.1016/j.tree.2008.06.010; Rab P, 2008, CHROMOSOME RES, V16, P863, DOI 10.1007/s10577-008-1245-3; Rambaut A, 2007, TRACER VERSION 1 2; Reyjol Y, 2007, GLOBAL ECOL BIOGEOGR, V16, P65, DOI 10.1111/j.1466-8238.2006.00264.x; Rousset F, 1997, GENETICS, V145, P1219; Rousset F, 2008, MOL ECOL RESOUR, V8, P103, DOI 10.1111/j.1471-8286.2007.01931.x; Rull V, 2009, J BIOGEOGR, V36, P481, DOI 10.1111/j.1365-2699.2008.02023.x; Saillard J, 2000, AM J HUM GENET, V67, P718, DOI 10.1086/303038; Salzburger W, 2003, MOL ECOL, V12, P2371, DOI 10.1046/j.1365-294X.2003.01911.x; Sastre C, 1997, B FR PECHE PISCIC, V344/345, P9; Schwarz M, 1998, BIOL MENACES PROTECT; Sediva A, 2008, MOL ECOL, V17, P1277, DOI 10.1111/j.1365-294X.2007.03656.x; Sirocko F, 2005, NATURE, V436, P833, DOI 10.1038/nature03905; Societe du Canal de Provence (SCP), 1995, CART AM HYDR; Solar II, 2009, REV AQUACULT, V1, P174, DOI 10.1111/j.1753-5131.2009.01013.x; Sommerwerk N, 2009, RIVERS OF EUROPE, 1ST EDITION, P59, DOI 10.1016/B978-0-12-369449-2.00003-5; Stepien CA, 2009, MOL ECOL, V18, P3411, DOI 10.1111/j.1365-294X.2009.04291.x; Szpiech ZA, 2008, BIOINFORMATICS, V24, P2498, DOI 10.1093/bioinformatics/btn478; TAJIMA F, 1989, GENETICS, V123, P585; TAJIMA F, 1983, GENETICS, V105, P437; TEMPLETON AR, 1992, GENETICS, V132, P619; Tishkoff SA, 2009, SCIENCE, V324, P1035, DOI 10.1126/science.1172257; Tougard C, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0003532; Uehlinger U, 2009, RIVERS OF EUROPE, 1ST EDITION, P199, DOI 10.1016/B978-0-12-369449-2.00006-0; Van Oosterhout C, 2004, MOL ECOL NOTES, V4, P535, DOI 10.1111/j.1471-8286.2004.00684.x; Volckaert FAM, 2002, J EVOLUTION BIOL, V15, P930, DOI 10.1046/j.1420-9101.2002.00469.x; Vonlanthen P, 2007, MOL ECOL, V16, P4572, DOI 10.1111/j.1365-294X.2007.03531.x; WATTERSON GA, 1975, THEOR POPUL BIOL, V7, P256, DOI 10.1016/0040-5809(75)90020-9; Weir BS, 2002, ANNU REV GENET, V36, P721, DOI 10.1146/annurev.genet.36.050802.093940; WILGENBUSCH JC, 2004, AWTY SYSTEM GRAPHICA; Wocher H, 2006, ARCH HYDROBIOL, V165, P77, DOI 10.1127/0003-9136/2006/0165-0077; Won H, 2006, SYST BIOL, V55, P610, DOI 10.1080/10635150600812619; Zaccara S, 2007, ZOOL SCR, V36, P443, DOI 10.1111/j.1463-6409.2007.00294.x; Zardoya R, 1999, J MOL EVOL, V49, P227, DOI 10.1007/PL00006545	122	23	24	1	35	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 29	2012	7	3							e34423	10.1371/journal.pone.0034423	http://dx.doi.org/10.1371/journal.pone.0034423			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	948SR	22479629	Green Published, gold			2022-12-25	WOS:000304523400082
J	Bulmer, JN; Innes, BA; Levey, J; Robson, SC; Lash, GE				Bulmer, Judith N.; Innes, Barbara A.; Levey, Joanne; Robson, Stephen C.; Lash, Gendie E.			The role of vascular smooth muscle cell apoptosis and migration during uterine spiral artery remodeling in normal human pregnancy	FASEB JOURNAL			English	Article						trophoblast; protease; angiogenic growth factor	NATURAL-KILLER-CELLS; EXTRAVILLOUS TROPHOBLAST; UTEROPLACENTAL ARTERIES; GROWTH-FACTORS; PLACENTAL BED; GUINEA-PIG; LIGAND; TRANSFORMATION; EXPRESSION; CYTOKINE	During human uterine spiral artery (SpA) remodeling, vascular smooth muscle cells (VSMCs) are lost and replaced by fibrinoid, incorporating extravillous trophoblast (EVT) cells. The aim of the current study was to determine the relative contributions of apoptosis and migration to VSMC loss during SpA remodeling. Immunohistochemistry (Apoptag, active caspase 3, lamin) of placental bed biopsies (8-20 wk gestation) demonstrated apoptotic cells in all samples; double immunolabeling identified these as trophoblasts, leukocytes, and endothelial cells. In total, 294 SpAs were studied, and only one apoptotic VSMC was identified. H-caldesmon-immunopositive VSMCs were observed surrounding and separate from SpA walls in partially remodeled vessels; the highest level of VSMC migration was observed in vessels with associated EVT cells (number of migrated cells 6.4 +/- 1.2; distance migrated 3.5 +/- 0.3 pixels) compared with those without (number of migrated cells 3.6 +/- 0.5, P<0.001; distance migrated 2.8 +/- 0.1 pixels, P<0.0001). VEGF-A, VEGF-C, TGF-beta 1, and Ang-2 all stimulated human aorta VSMC invasion in vitro, although EVT cell culture supernatants did not. In summary, apoptosis is unlikely to play a major role in loss of VSMCs from SpAs during remodeling in normal pregnancy, but VSMCs appear to migrate away from the wall of the SpA, an effect enhanced by the presence of EVT cells.-Bulmer, J. N., Innes, B. A., Levey, J., Robson, S. C., Lash, G. E. The role of vascular smooth muscle cell apoptosis and migration during uterine spiral artery remodeling in normal human pregnancy. FASEB J. 26, 2975-2985 (2012). www.fasebj.org	[Bulmer, Judith N.; Innes, Barbara A.; Levey, Joanne; Robson, Stephen C.; Lash, Gendie E.] Newcastle Univ, Inst Cellular Med, Reprod & Vasc Biol Grp, Newcastle Upon Tyne NE2 4HH, Tyne & Wear, England	Newcastle University - UK	Lash, GE (corresponding author), Newcastle Univ, Inst Cellular Med, Reprod & Vasc Biol Grp, 3rd Floor,William Leech Bldg, Newcastle Upon Tyne NE2 4HH, Tyne & Wear, England.	g.e.lash@ncl.ac.uk	Lash, Gendie/AAI-4116-2021	Lash, Gendie/0000-0002-3606-1361	Wellcome Trust [069939]; UK Biotechnology and Biological Sciences Research Council [BB/E016790/1]; BBSRC [BB/E016790/1] Funding Source: UKRI; Biotechnology and Biological Sciences Research Council [BB/E016790/1] Funding Source: researchfish	Wellcome Trust(Wellcome TrustEuropean Commission); UK Biotechnology and Biological Sciences Research Council(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); BBSRC(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); Biotechnology and Biological Sciences Research Council(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC))	The authors acknowledge the staff at the Royal Victoria Infirmary (Newcastle upon Tyne, UK) for their assistance in sample collection. This project was supported by funding from The Wellcome Trust (069939) and from the UK Biotechnology and Biological Sciences Research Council (BB/E016790/1).	Ball E, 2006, J PATHOL, V208, P535, DOI 10.1002/path.1927; Cohen GM, 1997, BIOCHEM J, V326, P1, DOI 10.1042/bj3260001; Gerthoffer WT, 2007, CIRC RES, V100, P607, DOI 10.1161/01.RES.0000258492.96097.47; Harris LK, 2006, AM J PATHOL, V169, P1863, DOI 10.2353/ajpath.2006.060265; Harris LK, 2010, AM J PATHOL, V177, P2103, DOI 10.2353/ajpath.2010.100182; Keogh RJ, 2007, CIRC RES, V100, P834, DOI 10.1161/01.RES.0000261352.81736.37; KHONG TY, 1986, BRIT J OBSTET GYNAEC, V93, P1049, DOI 10.1111/j.1471-0528.1986.tb07830.x; Kim YM, 2003, AM J OBSTET GYNECOL, V189, P1063, DOI 10.1067/S0002-9378(03)00838-X; Korshunov VA, 2008, CURR OPIN HEMATOL, V15, P250, DOI 10.1097/MOH.0b013e3282f97d71; Lash GE, 2007, PLACENTA, V28, P390, DOI 10.1016/j.placenta.2006.06.001; Lash GE, 2010, PLACENTA, V31, pS87, DOI 10.1016/j.placenta.2009.12.022; Lash GE, 2010, PLACENTA, V31, P545, DOI 10.1016/j.placenta.2010.02.020; Lash GE, 2011, HUM REPROD, V26, P2289, DOI 10.1093/humrep/der198; Lash GE, 2006, J LEUKOCYTE BIOL, V80, P572, DOI 10.1189/jlb.0406250; Loro LL, 2003, J ORAL PATHOL MED, V32, P125, DOI 10.1034/j.1600-0714.2003.00052.x; NANAEV A, 1995, CELL TISSUE RES, V282, P407, DOI 10.1007/s004410050492; Nanaev AK, 2000, PLACENTA, V21, P306, DOI 10.1053/plac.1999.0490; Naruse K, 2009, HUM REPROD, V24, P553, DOI 10.1093/humrep/den408; Pijnenborg R, 2006, PLACENTA, V27, P939, DOI 10.1016/j.placenta.2005.12.006; PIJNENBORG R, 1991, BRIT J OBSTET GYNAEC, V98, P648, DOI 10.1111/j.1471-0528.1991.tb13450.x; Pongcharoen S, 2004, PLACENTA, V25, P321, DOI 10.1016/j.placenta.2003.08.020; Rakesh K, 2005, INT IMMUNOPHARMACOL, V5, P1487, DOI 10.1016/j.intimp.2005.05.003; Red-Horse K, 2006, J CLIN INVEST, V116, P2643, DOI 10.1172/JC127306; Robson SC, 2002, AM J OBSTET GYNECOL, V187, P1349, DOI 10.1067/mob.2002.126866; Smith SD, 2009, AM J PATHOL, V174, P1959, DOI 10.2353/ajpath.2009.080995; Stadelmann C, 2000, CELL TISSUE RES, V301, P19, DOI 10.1007/s004410000203; Tarrade A, 2001, LAB INVEST, V81, P1199, DOI 10.1038/labinvest.3780334; Vassiliadou N, 1998, BIOL REPROD, V58, P982, DOI 10.1095/biolreprod58.4.982; Whitley GSJ, 2010, PLACENTA, V31, P465, DOI 10.1016/j.placenta.2010.03.002; Whitley GSJ, 2009, J ANAT, V215, P21, DOI 10.1111/j.1469-7580.2008.01039.x	30	52	53	1	12	FEDERATION AMER SOC EXP BIOL	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3998 USA	0892-6638	1530-6860		FASEB J	Faseb J.	JUL	2012	26	7					2975	2985		10.1096/fj.12-203679	http://dx.doi.org/10.1096/fj.12-203679			11	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	967MP	22499583				2022-12-25	WOS:000305912500025
J	Koike, A; Kato, T; Sugiura, R; Ma, Y; Tabata, Y; Ohmoto, K; Sio, SO; Kuno, T				Koike, Atsushi; Kato, Toshiaki; Sugiura, Reiko; Ma, Yan; Tabata, Yuki; Ohmoto, Koji; Sio, Susie O.; Kuno, Takayoshi			Genetic Screening for Regulators of Prz1, a Transcriptional Factor Acting Downstream of Calcineurin in Fission Yeast	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							ZINC-FINGER PROTEIN; NUCLEAR EXPORT; PHOSPHORYLATION; PATHWAY; BINDING; SIGNAL; IDENTIFICATION; ACTIVATION; HOMOLOG; ENCODES	Calcineurin phosphatase plays crucial roles in a wide variety of cell types and organisms. Dephosphorylation of the nuclear factor of activated T-cell (NFAT) family of transcriptional factors by calcineurin is essential for activating immune-responsive genes in mammals. NFAT activity is also regulated by diverse signaling pathways, which affect NFAT kinases and nuclear partner proteins. In fission yeast, calcineurin dephosphorylates and activates Prz1, a C2H2-type zinc finger transcriptional factor. Calcineurin-Prz1 signaling regulates the expression of the Pmc1 Ca2+ pump. Prz1-overexpressing cells showed extremely slow growth and high transcriptional activity of Prz1 in the absence of stimulation. Here, we isolated seven genes as dosage-dependent suppressors of this slow growth phenotype. These seven genes encode Rad24, Rad25, Pka1, Msn5 (SPAC328.01c), Pac1, Ape2, and Tfs1. All of them decreased the high transcriptional activity caused by Prz1 overexpression. Overexpression of Pka1, Rad24, and Rad25 also repressed the Ca2+-induced transcriptional activity in cells with Prz1 expressed at wild-type levels. Knock-out of rad24 or rad25 significantly enhanced the transcriptional activity of Prz1, whereas knock-out or mutation of other genes did not enhance the activity. The 14-3-3 proteins, Rad24 and Rad25, bound Prz1 and the Rad24-binding site located at residues 421-426 of Prz1. In msn5 deletion mutants, GFP-Prz1 localized at nucleus in the absence of Ca2+ stimulation, suggesting that Msn5 functions as an exportin for Prz1. In summary, our data suggest that Rad24 and Rad25 negatively regulate Prz1 and that Pka1, Msn5, Pac1, Tfs1, and Ape2 also regulate Prz1.	[Koike, Atsushi; Kato, Toshiaki; Ma, Yan; Tabata, Yuki; Ohmoto, Koji; Kuno, Takayoshi] Kobe Univ, Grad Sch Med, Dept Biochem & Mol Biol, Div Mol Pharmacol & Pharmacogen,Chuo Ku, Kobe, Hyogo 6500017, Japan; [Koike, Atsushi] Osaka Univ Pharmaceut Sci, Lab Biodef & Regulat, Takatsuki, Osaka 5691094, Japan; [Sugiura, Reiko] Kinki Univ, Sch Pharmaceut Sci, Lab Mol Pharmacogen, Higashiosaka, Osaka 5778502, Japan; [Sio, Susie O.] Univ Philippines, Coll Med, Dept Pharmacol & Toxicol, Manila 1000, Philippines	Kobe University; Osaka University of Pharmaceutical Sciences; Kindai University (Kinki University); University of the Philippines System; University of the Philippines Manila	Koike, A (corresponding author), Kobe Univ, Grad Sch Med, Dept Biochem & Mol Biol, Div Mol Pharmacol & Pharmacogen,Chuo Ku, Kusunoki Cho 6-5-1, Kobe, Hyogo 6500017, Japan.	koike@gly.oups.ac.jp			Ministry of Education, Culture, Sports, Science and Technology of Japan	Ministry of Education, Culture, Sports, Science and Technology of Japan(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT))	This work was supported by research grants from the Ministry of Education, Culture, Sports, Science and Technology of Japan.	[Anonymous], 1992, NATURE, V357, P2; Beals CR, 1997, SCIENCE, V275, P1930, DOI 10.1126/science.275.5308.1930; Boustany LM, 2002, GENE DEV, V16, P608, DOI 10.1101/gad.967602; Chow CW, 1997, SCIENCE, V278, P1638, DOI 10.1126/science.278.5343.1638; CLIPSTONE NA, 1992, NATURE, V357, P695, DOI 10.1038/357695a0; Crabtree GR, 2001, J BIOL CHEM, V276, P2313, DOI 10.1074/jbc.R000024200; del Arco PG, 2000, J BIOL CHEM, V275, P13872, DOI 10.1074/jbc.275.18.13872; Deng L, 2006, MOL BIOL CELL, V17, P4790, DOI 10.1091/mbc.E06-06-0526; FORD JC, 1994, SCIENCE, V265, P533, DOI 10.1126/science.8036497; Graef IA, 2001, CELL, V105, P863, DOI 10.1016/S0092-8674(01)00396-8; Gwack Y, 2006, NATURE, V441, P646, DOI 10.1038/nature04631; HENDEY B, 1992, SCIENCE, V258, P296, DOI 10.1126/science.1384129; Herrmann A, 2007, J CELL SCI, V120, P3249, DOI 10.1242/jcs.03482; Hirayama S, 2003, J BIOL CHEM, V278, P18078, DOI 10.1074/jbc.M212900200; Kafadar KA, 2004, EUKARYOT CELL, V3, P1147, DOI 10.1128/EC.3.5.1147-1153.2004; Kehlenbach RH, 1998, J CELL BIOL, V141, P863, DOI 10.1083/jcb.141.4.863; Kim DU, 2010, NAT BIOTECHNOL, V28, P617, DOI 10.1038/nbt.1628; Kim JS, 2007, J BIOL CHEM, V282, P34787, DOI 10.1074/jbc.M704754200; Kunitomo H, 2000, MOL BIOL CELL, V11, P3205, DOI 10.1091/mbc.11.9.3205; Ma Y, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0022421; Mansuy IM, 1998, CELL, V92, P39, DOI 10.1016/S0092-8674(00)80897-1; MAUNDRELL K, 1993, GENE, V123, P127, DOI 10.1016/0378-1119(93)90551-D; Molkentin JD, 1998, CELL, V93, P215, DOI 10.1016/S0092-8674(00)81573-1; MORENO S, 1991, METHOD ENZYMOL, V194, P795; Palmer D, 2007, J BIOL CHEM, V282, P9411, DOI 10.1074/jbc.M606936200; Parua PK, 2010, MOL CELL BIOL, V30, P5273, DOI 10.1128/MCB.00715-10; ROTHSTEIN RJ, 1983, METHOD ENZYMOL, V101, P202; Rotondo G, 1997, RNA, V3, P1182; Shen YH, 2003, MOL BIOL CELL, V14, P4721, DOI 10.1091/mbc.E02-12-0821; Sio SO, 2005, J BIOL CHEM, V280, P12231, DOI 10.1074/jbc.M414234200; Toda T, 1996, MOL CELL BIOL, V16, P6752; Wang HG, 1999, SCIENCE, V284, P339, DOI 10.1126/science.284.5412.339; Williams LA, 1996, YEAST, V12, P227, DOI 10.1002/(SICI)1097-0061(19960315)12:3<227::AID-YEA905>3.3.CO;2-0; Xiao Z, 2003, J BIOL CHEM, V278, P34245, DOI 10.1074/jbc.M301596200; Yaffe MB, 1997, CELL, V91, P961, DOI 10.1016/S0092-8674(00)80487-0; Zhou DW, 1999, RNA, V5, P1083, DOI 10.1017/S1355838299990726; Zhou X, 2010, J BIOL CHEM, V285, P32818, DOI 10.1074/jbc.M110.135764; Zhu JY, 1998, CELL, V93, P851, DOI 10.1016/S0092-8674(00)81445-2	38	15	16	0	2	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JUN 1	2012	287	23					19294	19303		10.1074/jbc.M111.310615	http://dx.doi.org/10.1074/jbc.M111.310615			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	974EF	22496451	Green Published, hybrid			2022-12-25	WOS:000306411900039
J	Mo, C; Dai, YM; Kang, N; Cui, LX; He, W				Mo, Chen; Dai, Yumei; Kang, Ning; Cui, Lianxian; He, Wei			Ectopic Expression of Human MutS Homologue 2 on Renal Carcinoma Cells Is Induced by Oxidative Stress with Interleukin-18 Promotion via p38 Mitogen-activated Protein Kinase (MAPK) and c-Jun N-terminal Kinase (JNK) Signaling Pathways	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							DELTA-T-CELLS; DNA MISMATCH REPAIR; 1-METHYLPROPYL 2-IMIDAZOLYL DISULFIDE; PRO-INFLAMMATORY CYTOKINES; PEROXIDE-INDUCED APOPTOSIS; MICROSATELLITE INSTABILITY; TRANSCRIPTION FACTOR-3; ADOPTIVE IMMUNOTHERAPY; PERIPHERAL-BLOOD; EPITHELIAL-CELLS	Human MutS homologue 2 (hMSH2), a crucial element of the highly conserved DNA mismatch repair system, maintains genetic stability in the nucleus of normal cells. Our previous studies indicate that hMSH2 is ectopically expressed on the surface of epithelial tumor cells and recognized by both T cell receptor gamma delta (TCR gamma delta) and natural killer group 2 member D (NKG2D) on V delta 2 T cells. Ectopically expressed hMSH2 could trigger a gamma delta T cell-mediated cytolysis. In this study, we showed that oxidative stress induced ectopic expression of hMSH2 on human renal carcinoma cells. Under oxidative stress, both p38 mitogen-activated protein kinase (MAPK) and c-Jun N-terminal kinase (JNK) pathways have been confirmed to mediate the ectopic expression of hMSH2 through the apoptosis-signaling kinase 1 (ASK1) upstream and activating transcription factor 3 (ATF3) downstream of both pathways. Moreover, renal carcinoma cell-derived interleukin (IL)-18 in oxidative stress was a prominent stimulator for ectopically induced expression of hMSH2, which was promoted by interferon (IFN)-gamma as well. Finally, oxidative stress or pretreatment with IL-18 and IFN-gamma enhanced gamma delta T cell-mediated cytolysis of renal carcinoma cells. Our results not only establish a mechanism of ectopic hMSH2 expression in tumor cells but also find a biological linkage between ectopic expression of hMSH2 and activation of gamma delta T cells in stressful conditions. Because gamma delta T cells play an important role in the early stage of innate anti-tumor response, gamma delta T cell activation triggered by ectopically expressed hMSH2 may be an important event in immunosurveillance for carcinogenesis.	[Mo, Chen; Dai, Yumei; Kang, Ning; Cui, Lianxian; He, Wei] Chinese Acad Med Sci, Inst Basic Med Sci, Dept Immunol, Beijing 100005, Peoples R China; [He, Wei] Sch Peking Union Med Coll, Natl Key Lab Med Mol Biol, Beijing 100005, Peoples R China	Chinese Academy of Medical Sciences - Peking Union Medical College; Institute of Basic Medical Sciences - CAMS; Chinese Academy of Medical Sciences - Peking Union Medical College; Peking Union Medical College	He, W (corresponding author), Chinese Acad Med Sci, Inst Basic Med Sci, Dept Immunol, 5 Dong Dan San Tiao, Beijing 100005, Peoples R China.	hewei@moh.gov.cn			National Natural Science Foundation of China [30930083]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC))	This work was supported by National Natural Science Foundation of China Grant 30930083.	Acharya S, 1996, P NATL ACAD SCI USA, V93, P13629, DOI 10.1073/pnas.93.24.13629; AHN YS, 1994, TOXICOL PATHOL, V22, P415, DOI 10.1177/019262339402200407; Altavilla G, 2010, ONCOL REP, V24, P927, DOI 10.3892/or_00000938; Bachmann M, 2007, MOL CANCER THER, V6, P723, DOI 10.1158/1535-7163.MCT-06-0505; Campregher C, 2008, GUT, V57, P780, DOI 10.1136/gut.2007.141556; Castrilli G, 2002, J ORAL PATHOL MED, V31, P234, DOI 10.1034/j.1600-0714.2002.310407.x; Chaum E, 2009, J CELL BIOCHEM, V108, P1280, DOI 10.1002/jcb.22358; Chen H, 2008, J BIOL CHEM, V283, P12528, DOI 10.1074/jbc.M708067200; Chen L, 2008, FREE RADICAL BIO MED, V45, P1035, DOI 10.1016/j.freeradbiomed.2008.07.011; Cho ES, 2008, MUTAT RES-FUND MOL M, V640, P123, DOI 10.1016/j.mrfmmm.2007.12.012; Choi TG, 2011, BBA-MOL CELL RES, V1813, P1412, DOI 10.1016/j.bbamcr.2011.04.001; Ciucci A, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0023766; Dai YM, 2012, J BIOL CHEM, V287, P16812, DOI 10.1074/jbc.M111.327650; Davis RJ, 2000, CELL, V103, P239, DOI 10.1016/S0092-8674(00)00116-1; Dostert C, 2008, SCIENCE, V320, P674, DOI 10.1126/science.1156995; Eagle RA, 2007, NAT REV IMMUNOL, V7, P737, DOI 10.1038/nri2144; Filen S, 2010, J IMMUNOL, V184, P4990, DOI 10.4049/jimmunol.0903106; FISHEL R, 1993, CELL, V75, P1027, DOI 10.1016/0092-8674(93)90546-3; Frederiks WM, 2010, ACTA HISTOCHEM, V112, P364, DOI 10.1016/j.acthis.2009.03.003; Gao YF, 2003, J EXP MED, V198, P433, DOI 10.1084/jem.20030584; Geller SF, 2003, ADV EXP MED BIOL, V533, P249; Goldman EH, 2004, J BIOL CHEM, V279, P10442, DOI 10.1074/jbc.M311129200; Hamid AA, 2002, CANCER, V94, P997, DOI 10.1002/cncr.10341.abs; Harfe BD, 2000, ANNU REV GENET, V34, P359, DOI 10.1146/annurev.genet.34.1.359; Hess J, 2004, J CELL SCI, V117, P5965, DOI 10.1242/jcs.01589; Ho TC, 2006, APOPTOSIS, V11, P1899, DOI 10.1007/s10495-006-9403-6; Hussein MR, 2006, INT J EXP PATHOL, V87, P297, DOI 10.1111/j.1365-2613.2006.00482.x; Hussein MR, 2002, MOL CARCINOGEN, V34, P35, DOI 10.1002/mc.10047; Ichijo H, 1997, SCIENCE, V275, P90, DOI 10.1126/science.275.5296.90; Ichijo H, 1999, ONCOGENE, V18, P6087, DOI 10.1038/sj.onc.1203129; Jordan BF, 2005, CLIN CANCER RES, V11, P529; Kang N, 2009, CANCER BIOL THER, V8, P1540, DOI 10.4161/cbt.8.16.8950; Kastrinos F, 2008, CANCER EPIDEM BIOMAR, V17, P2044, DOI 10.1158/1055-9965.EPI-08-0301; Khanna A, 2011, TRANSPLANTATION, V91, P590, DOI 10.1097/TP.0b013e31820d3b82; Kiersnowska-Rogowska Beata, 2005, Przegl Lek, V62, P772; Kondo M, 2008, CYTOTHERAPY, V10, P842, DOI 10.1080/14653240802419328; Kunzmann V, 2005, LEUKEMIA LYMPHOMA, V46, P671, DOI 10.1080/10428190500051893; Kyriakis JM, 2001, PHYSIOL REV, V81, P807, DOI 10.1152/physrev.2001.81.2.807; LEE JC, 1994, NATURE, V372, P739, DOI 10.1038/372739a0; Lee SF, 2011, METHOD CELL BIOL, V103, P99, DOI 10.1016/B978-0-12-385493-3.00005-X; Lee YJ, 2002, MOL PHARMACOL, V62, P1409, DOI 10.1124/mol.62.6.1409; Li GM, 2008, CELL RES, V18, P85, DOI 10.1038/cr.2007.115; Li W, 2010, J IMMUNOTHER, V33, P287, DOI 10.1097/CJI.0b013e3181c80ffa; Liu T, 2010, METHODS MOL BIOL, V653, P193, DOI 10.1007/978-1-60761-759-4_11; Maddux BA, 2001, DIABETES, V50, P404, DOI 10.2337/diabetes.50.2.404; Maheshwari A, 2009, FEBS J, V276, P870, DOI 10.1111/j.1742-4658.2008.06831.x; Maroney AC, 1998, J NEUROSCI, V18, P104; Martin SA, 2010, CLIN CANCER RES, V16, P5107, DOI 10.1158/1078-0432.CCR-10-0821; Martin SA, 2009, EMBO MOL MED, V1, P323, DOI 10.1002/emmm.200900040; Martinon F, 2010, EUR J IMMUNOL, V40, P616, DOI 10.1002/eji.200940168; Matzinger P, 2002, SCIENCE, V296, P301, DOI 10.1126/science.1071059; Miyazaki K, 2009, NUCLEIC ACIDS RES, V37, P1438, DOI 10.1093/nar/gkn1082; Nijhawan D, 2000, ANNU REV NEUROSCI, V23, P73, DOI 10.1146/annurev.neuro.23.1.73; Ogata Atsushi, 2004, Mod Rheumatol, V14, P267, DOI 10.1007/s10165-004-0306-5; Park S, 2009, LEUKEMIA RES, V33, P315, DOI 10.1016/j.leukres.2008.08.001; Pljesa-Ercegovac M, 2008, UROL ONCOL-SEMIN ORI, V26, P175, DOI 10.1016/j.urolonc.2007.02.007; Qi XF, 2011, J CELL PHYSIOL, V226, P58, DOI 10.1002/jcp.22303; RAINGEAUD J, 1995, J BIOL CHEM, V270, P7420, DOI 10.1074/jbc.270.13.7420; Rosin DL, 2011, J AM SOC NEPHROL, V22, P416, DOI 10.1681/ASN.2010040430; Rudich A, 1998, DIABETES, V47, P1562, DOI 10.2337/diabetes.47.10.1562; Saitoh A, 2008, MED ONCOL, V25, P137, DOI 10.1007/s12032-007-9004-4; Scherer SJ, 2000, J BIOL CHEM, V275, P37469, DOI 10.1074/jbc.M006990200; Son YO, 2009, MOL CELLS, V28, P545, DOI 10.1007/s10059-009-0149-1; Son YO, 2009, APOPTOSIS, V14, P796, DOI 10.1007/s10495-009-0353-7; Song H, 2008, IMMUNOL LETT, V120, P103, DOI 10.1016/j.imlet.2008.07.007; Srivastava T, 2004, J NEURO-ONCOL, V66, P51, DOI 10.1023/B:NEON.0000013482.99032.b0; St Germain C, 2010, NEOPLASIA, V12, P527, DOI 10.1593/neo.92048; Talotta F, 2010, ONCOGENE, V29, P4732, DOI 10.1038/onc.2010.211; Todaro M, 2009, J IMMUNOL, V182, P7287, DOI 10.4049/jimmunol.0804288; Venkataraman GM, 2007, J IMMUNOL, V178, P961, DOI 10.4049/jimmunol.178.2.961; Venkatesan B, 2009, AM J PHYSIOL-HEART C, V297, pH874, DOI 10.1152/ajpheart.00311.2009; Wang M, 2009, J PATHOL, V218, P95, DOI 10.1002/path.2521; Welsh SJ, 2003, MOL CANCER THER, V2, P235; Wilhelm M, 2003, BLOOD, V102, P200, DOI 10.1182/blood-2002-12-3665; Wyman TH, 2002, J LEUKOCYTE BIOL, V72, P401; Yang D, 2007, EXP EYE RES, V85, P462, DOI 10.1016/j.exer.2007.06.013; Zlatanou A, 2011, MOL CELL, V43, P649, DOI 10.1016/j.molcel.2011.06.023	77	26	35	0	3	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JUN 1	2012	287	23					19242	19254		10.1074/jbc.M112.349936	http://dx.doi.org/10.1074/jbc.M112.349936			13	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	974EF	22493490	Green Published, hybrid			2022-12-25	WOS:000306411900034
J	Nunes-Tavares, N; Santos, LE; Stutz, B; Brito-Moreira, J; Klein, WL; Ferreira, ST; de Mello, FG				Nunes-Tavares, Nilson; Santos, Luis Eduardo; Stutz, Bernardo; Brito-Moreira, Jordano; Klein, William L.; Ferreira, Sergio T.; de Mello, Fernando G.			Inhibition of Choline Acetyltransferase as a Mechanism for Cholinergic Dysfunction Induced by Amyloid-beta Peptide Oligomers	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							RECEPTOR-DEPENDENT MECHANISM; EMBRYONIC AVIAN RETINA; CENTRAL-NERVOUS-SYSTEM; D-ASPARTATE RECEPTOR; A-BETA; ALZHEIMERS-DISEASE; HIPPOCAMPAL-NEURONS; OXIDATIVE STRESS; CHICKEN RETINA; ACTIVATION	Dysregulated cholinergic signaling is an early hallmark of Alzheimer disease (AD), usually ascribed to degeneration of cholinergic neurons induced by the amyloid-beta peptide (A beta). It is now generally accepted that neuronal dysfunction and memory deficits in the early stages of AD are caused by the neuronal impact of soluble A beta oligomers (A beta Os). A beta Os build up in AD brain and specifically attach to excitatory synapses, leading to synapse dysfunction. Here, we have investigated the possibility that A beta Os could impact cholinergic signaling. The activity of choline acetyltransferase (ChAT, the enzyme that carries out ACh production) was inhibited by similar to 50% in cultured cholinergic neurons exposed to low nanomolar concentrations of A beta Os. 3-(4,5-Dimethylthiazol-2-yl)-2,5-di-phenyltetrazoliumbromide (MTT) reduction, lactatedehydrogenase release, and [H-3] choline uptake assays showed no evidence of neuronal damage or loss of viability that could account for reduced ChAT activity under these conditions. Glutamate receptor antagonists fully blocked ChAT inhibition and oxidative stress induced by A beta Os. Antioxidant polyunsaturated fatty acids had similar effects, indicating that oxidative damage may be involved in ChAT inhibition. Treatment with insulin, previously shown to down-regulate neuronal A beta O binding sites, fully prevented A beta O-induced inhibition of ChAT. Interestingly, we found that A beta Os selectively bind to similar to 50% of cultured cholinergic neurons, suggesting that ChAT is fully inhibited in A beta O-targeted neurons. Reduction in ChAT activity instigated by A beta Os may thus be a relevant event in early stage AD pathology, preceding the loss of cholinergic neurons commonly observed in AD brains.	[Nunes-Tavares, Nilson; Santos, Luis Eduardo; Stutz, Bernardo; de Mello, Fernando G.] Univ Fed Rio de Janeiro, Inst Biofis Carlos Chagas Filho, BR-21944590 Rio De Janeiro, RJ, Brazil; [Brito-Moreira, Jordano; Ferreira, Sergio T.] Univ Fed Rio de Janeiro, Inst Bioquim Med, BR-21944590 Rio De Janeiro, RJ, Brazil; [Klein, William L.] Northwestern Univ, Evanston, IL 60208 USA	Universidade Federal do Rio de Janeiro; Universidade Federal do Rio de Janeiro; Northwestern University	de Mello, FG (corresponding author), Univ Fed Rio de Janeiro, Inst Biofis Carlos Chagas Filho, BR-21944590 Rio De Janeiro, RJ, Brazil.	fgmello@biof.ufrj.br	Ferreira, Sergio/AAZ-1576-2020; Santos, Luís/B-4961-2015; Neurociencia, Inct/I-1011-2013	Ferreira, Sergio/0000-0001-7160-9866; Santos, Luís/0000-0002-0694-733X; 	Conselho Nacional de Desenvolvi-mento Cientifico e Tecnologico; Fundacao de Amparo a Pesquisa do Estado do Rio de Janeiro; National Institute of Translational Neuroscience	Conselho Nacional de Desenvolvi-mento Cientifico e Tecnologico(Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPQ)); Fundacao de Amparo a Pesquisa do Estado do Rio de Janeiro(Fundacao Carlos Chagas Filho de Amparo a Pesquisa do Estado do Rio De Janeiro (FAPERJ)); National Institute of Translational Neuroscience	This work was supported by grants from Conselho Nacional de Desenvolvi-mento Cientifico e Tecnologico, Fundacao de Amparo a Pesquisa do Estado do Rio de Janeiro, and National Institute of Translational Neuroscience (to F.G.d.M. and S.T.F.).	Abramoff MD, 2004, BIOPHOTONICS INT, V11, P36, DOI DOI 10.1117/1.3589100; BARTUS RT, 1982, SCIENCE, V217, P408, DOI 10.1126/science.7046051; Bate C, 2010, NEUROTOX RES, V17, P203, DOI 10.1007/s12640-009-9093-2; BAUGHMAN RW, 1977, BRAIN RES, V138, P469, DOI 10.1016/0006-8993(77)90684-9; Bazan NG, 2007, CURR OPIN CLIN NUTR, V10, P136, DOI 10.1097/MCO.0b013e32802b7030; Blasina MF, 2000, CELL TISSUE RES, V299, P173, DOI 10.1007/s004419900117; BRADFORD MM, 1976, ANAL BIOCHEM, V72, P248, DOI 10.1016/0003-2697(76)90527-3; Brito-Moreira J, 2011, CURR ALZHEIMER RES, V8, P552, DOI 10.2174/156720511796391917; Contestabile A, 2011, BEHAV BRAIN RES, V221, P334, DOI 10.1016/j.bbr.2009.12.044; De Felice FG, 2007, J BIOL CHEM, V282, P11590, DOI 10.1074/jbc.M607483200; De Felice FG, 2009, P NATL ACAD SCI USA, V106, P1971, DOI 10.1073/pnas.0809158106; Decker H, 2010, J NEUROCHEM, V115, P1520, DOI 10.1111/j.1471-4159.2010.07058.x; Decker H, 2010, J NEUROSCI, V30, P9166, DOI 10.1523/JNEUROSCI.1074-10.2010; DEMELLO FG, 1991, CELL MOL NEUROBIOL, V11, P485, DOI 10.1007/BF00734811; DEMELLO FG, 1990, J NEUROCHEM, V54, P886, DOI 10.1111/j.1471-4159.1990.tb02334.x; ELLMAN GL, 1961, BIOCHEM PHARMACOL, V7, P88, DOI 10.1016/0006-2952(61)90145-9; Ferreira ST, 2007, IUBMB LIFE, V59, P332, DOI 10.1080/15216540701283882; Ferreira ST, 2011, NEUROBIOL LEARN MEM, V96, P529, DOI 10.1016/j.nlm.2011.08.003; FONNUM F, 1975, J NEUROCHEM, V24, P407, DOI 10.1111/j.1471-4159.1975.tb11895.x; HANSEN MB, 1989, J IMMUNOL METHODS, V119, P203, DOI 10.1016/0022-1759(89)90397-9; Jurgensen S, 2011, J BIOL CHEM, V286, P3270, DOI 10.1074/jbc.M110.177790; Kim SJ, 2010, NEUROSCI LETT, V479, P292, DOI 10.1016/j.neulet.2010.05.083; Klein WL, 2002, NEUROCHEM INT, V41, P345, DOI 10.1016/S0197-0186(02)00050-5; Lacor PN, 2007, J NEUROSCI, V27, P796, DOI 10.1523/JNEUROSCI.3501-06.2007; Lambert MP, 2007, J NEUROCHEM, V100, P23, DOI 10.1111/j.1471-4159.2006.04157.x; Lambert MP, 1998, P NATL ACAD SCI USA, V95, P6448, DOI 10.1073/pnas.95.11.6448; Li SM, 2011, J NEUROSCI, V31, P6627, DOI 10.1523/JNEUROSCI.0203-11.2011; Loureiro-dos-Santos NE, 2002, CELL MOL NEUROBIOL, V22, P727, DOI 10.1023/A:1021809124814; Loureiro-dos-Santos NE, 2001, J NEUROCHEM, V77, P1136, DOI 10.1046/j.1471-4159.2001.00330.x; Louzada PR, 2004, FASEB J, V18, P511, DOI 10.1096/fj.03-0739com; Louzada PR, 2001, NEUROSCI LETT, V301, P59, DOI 10.1016/S0304-3940(01)01585-3; LOWRY OH, 1951, J BIOL CHEM, V193, P265; MASLAND R H, 1980, Neurochemistry International, V1, P501, DOI 10.1016/0197-0186(80)90083-2; Pacher P, 2007, PHYSIOL REV, V87, P315, DOI 10.1152/physrev.00029.2006; Paula-Lima AC, 2011, ANTIOXID REDOX SIGN, V14, P1209, DOI 10.1089/ars.2010.3287; Renner M, 2010, NEURON, V66, P739, DOI 10.1016/j.neuron.2010.04.029; Saraiva LM, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0015230; Schliebs R, 2011, BEHAV BRAIN RES, V221, P555, DOI 10.1016/j.bbr.2010.11.058; Shankar GM, 2007, J NEUROSCI, V27, P2866, DOI 10.1523/JNEUROSCI.4970-06.2007; SPIRA AW, 1987, J COMP NEUROL, V260, P526, DOI 10.1002/cne.902600406; STRADA O, 1992, P NATL ACAD SCI USA, V89, P9549, DOI 10.1073/pnas.89.20.9549; VANDERKLOOT W, 1994, PHYSIOL REV, V74, P899, DOI 10.1152/physrev.1994.74.4.899; Viola KL, 2008, J NUTR HEALTH AGING, V12, p51S, DOI 10.1007/BF02982587; Wilcox KC, 2011, CELL MOL NEUROBIOL, V31, P939, DOI 10.1007/s10571-011-9691-4; WILLIAMS K, 1993, MOL PHARMACOL, V44, P851; Xia P, 2010, J NEUROSCI, V30, P11246, DOI 10.1523/JNEUROSCI.2488-10.2010; Zhao WQ, 2010, J BIOL CHEM, V285, P7619, DOI 10.1074/jbc.M109.057182	47	66	66	0	5	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JUN 1	2012	287	23					19377	19385		10.1074/jbc.M111.321448	http://dx.doi.org/10.1074/jbc.M111.321448			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	974EF	22505713	Green Published, hybrid			2022-12-25	WOS:000306411900052
J	Pino, E; Wang, H; McDonald, ME; Qiang, L; Farmer, SR				Pino, Elizabeth; Wang, Hong; McDonald, Meghan E.; Qiang, Li; Farmer, Stephen R.			Roles for Peroxisome Proliferator-activated Receptor gamma (PPAR gamma) and PPAR gamma Coactivators 1 alpha and 1 beta in Regulating Response of White and Brown Adipocytes to Hypoxia	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							INDUCIBLE FACTOR 1-ALPHA; ADIPOSE-TISSUE; CELL-METABOLISM; OBESITY; INFLAMMATION; DYSFUNCTION; ANGIOGENESIS; PGC-1-ALPHA; OXYGENATION; EXPRESSION	Obese white adipose tissue is hypoxic but is incapable of inducing compensatory angiogenesis. Brown adipose tissue is highly vascularized, facilitating delivery of nutrients to brown adipocytes for heat production. In this study, we investigated the mechanisms by which white and brown adipocytes respond to hypoxia. Brown adipocytes produced lower amounts of hypoxia-inducible factor 1 alpha (HIF-1 alpha) than white adipocytes in response to low O-2 but induced higher levels of hypoxia-associated genes. The response of white adipocytes to hypoxia required HIF-1 alpha, but its presence alone was incapable of inducing target gene expression under normoxic conditions. In addition to the HIF-1 alpha targets, hypoxia also induced many inflammatory genes. Exposure of white adipocytes to a peroxisome proliferator-activated receptor gamma (PPAR gamma) ligand (troglitazone) attenuated induction of these genes but enhanced expression of the HIF-1 alpha targets. Knockdown of PPAR gamma in mature white adipocytes prevented the usual robust induction of HIF-1 alpha targets in response to hypoxia. Similarly, knockdown of PPAR gamma coactivator (PGC) 1 beta in PGC-1 alpha-deficient brown adipocytes eliminated their response to hypoxia. These data demonstrate that the response of white adipocytes requires HIF-1 alpha but also depends on PPAR gamma in white cells and the PPAR gamma cofactors PGC-1 alpha and PGC-1 beta in brown cells.	[Pino, Elizabeth; Wang, Hong; McDonald, Meghan E.; Qiang, Li; Farmer, Stephen R.] Boston Univ, Sch Med, Dept Biochem, Boston, MA 02118 USA	Boston University	Farmer, SR (corresponding author), Boston Univ, Sch Med, Dept Biochem, 715 Albany St, Boston, MA 02118 USA.	sfarmer@bu.edu	Qiang, Li/C-9560-2012	Pino, Elizabeth/0000-0003-0626-5221; Farmer, Stephen/0000-0003-2483-2795; Qiang, Li/0000-0001-8322-1797	United States Public Health Service [DK51586, DK58825, DK086629]; National Institutes of Health [5T32AG000115]; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [RC1DK086629, R56DK058825, R56DK051586, R01DK058825, R01DK051586] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON AGING [T32AG000115] Funding Source: NIH RePORTER	United States Public Health Service(United States Department of Health & Human ServicesUnited States Public Health Service); National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA))	This work was supported by United States Public Health Service Grants DK51586, DK58825, and DK086629 (to S. R. F.) and National Institutes of Health Training Grant 5T32AG000115-24 (to E. P.).	Arany Z, 2008, NATURE, V451, P1008, DOI 10.1038/nature06613; Bell EL, 2011, ONCOGENE, V30, P2986, DOI 10.1038/onc.2011.37; Boulahbel H, 2009, BIOCHEM SOC T, V37, P291, DOI 10.1042/BST0370291; Choi JH, 2010, NATURE, V466, P451, DOI 10.1038/nature09291; Deng T, 2011, J BIOL CHEM, V286, P30723, DOI 10.1074/jbc.M111.251926; Divoux A, 2011, OBES REV, V12, pe494, DOI 10.1111/j.1467-789X.2010.00811.x; Divoux A, 2010, DIABETES, V59, P2817, DOI 10.2337/db10-0585; Finley LWS, 2011, CANCER CELL, V19, P416, DOI 10.1016/j.ccr.2011.02.014; Giralt A, 2011, J BIOL CHEM, V286, P16958, DOI 10.1074/jbc.M110.202390; Halberg N, 2009, MOL CELL BIOL, V29, P4467, DOI 10.1128/MCB.00192-09; King A, 2006, ONCOGENE, V25, P4675, DOI 10.1038/sj.onc.1209594; Marxsen JH, 2004, BIOCHEM J, V381, P761, DOI 10.1042/BJ20040620; Maxwell PH, 2005, EXP PHYSIOL, V90, P791, DOI 10.1113/expphysiol.2005.030924; O'Hagan KA, 2009, P NATL ACAD SCI USA, V106, P2188, DOI 10.1073/pnas.0808801106; Ouchi N, 2011, NAT REV IMMUNOL, V11, P85, DOI 10.1038/nri2921; Pasarica M, 2010, J CLIN ENDOCR METAB, V95, P4052, DOI 10.1210/jc.2009-2377; Pasarica M, 2009, DIABETES, V58, P718, DOI 10.2337/db08-1098; Rutkowski JM, 2009, FEBS J, V276, P5738, DOI 10.1111/j.1742-4658.2009.07303.x; Selak MA, 2005, CANCER CELL, V7, P77, DOI 10.1016/j.ccr.2004.11.022; Semenza GL, 2001, CELL, V107, P1, DOI 10.1016/S0092-8674(01)00518-9; SEMENZA GL, 2007, SCI STKE, pCM8, DOI DOI 10.1126/STKE.4072007CM8; Semenza GL, 2007, SCIENCE, V318, P62, DOI 10.1126/science.1147949; Trayhurn P, 2008, BRIT J NUTR, V100, P227, DOI 10.1017/S0007114508971282; Trujillo ME, 2006, ENDOCR REV, V27, P798, DOI 10.1210/er.2006-0033; Uldry M, 2006, CELL METAB, V3, P333, DOI 10.1016/j.cmet.2006.04.002; Vernochet C, 2009, MOL CELL BIOL, V29, P4714, DOI 10.1128/MCB.01899-08; Wang H, 2008, MOL CELL BIOL, V28, P188, DOI 10.1128/MCB.00992-07; Wood IS, 2009, P NUTR SOC, V68, P370, DOI 10.1017/S0029665109990206; Xue Y, 2009, CELL METAB, V9, P99, DOI 10.1016/j.cmet.2008.11.009; Ye JP, 2007, AM J PHYSIOL-ENDOC M, V293, pE1118, DOI 10.1152/ajpendo.00435.2007	30	25	27	0	3	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAY 25	2012	287	22					18351	18358		10.1074/jbc.M112.350918	http://dx.doi.org/10.1074/jbc.M112.350918			8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	974EC	22493496	Green Published, hybrid			2022-12-25	WOS:000306411600041
J	Takeda, T; Fujii, M; Taura, J; Ishii, Y; Yamada, H				Takeda, Tomoki; Fujii, Misaki; Taura, Junki; Ishii, Yuji; Yamada, Hideyuki			Dioxin Silences Gonadotropin Expression in Perinatal Pups by Inducing Histone Deacetylases A NEW INSIGHT INTO THE MECHANISM FOR THE IMPRINTING OF SEXUAL IMMATURITY BY DIOXIN	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							BETA-SUBUNIT GENES; MATERNAL EXPOSURE; ARYL-HYDROCARBON; CROSS-TALK; 2,3,7,8-TETRACHLORODIBENZO-P-DIOXIN TCDD; PITUITARY GONADOTROPIN; FETAL RATS; RECEPTOR; RESPONSIVENESS; HORMONE	Maternal exposure to 2,3,7,8-tetrachlorodibenzo-p-dioxin (TCDD) causes the impairment of reproduction and development in the pups. Our previous studies have revealed that maternal treatment with TCDD attenuates the fetal production of pituitary gonadotropins (luteinizing hormone (LH) and follicle-stimulating hormone) at gestational day (GD) 20, leading to the impairment of sexual behavior in adulthood. However, the mechanism underlying such a reduction has remained unknown until now. When pregnant rats at GD15 were given an oral dose of TCDD (1 mu g/kg), the testicular expression of steroidogenic proteins was reduced between GD20 and postnatal days (PND) 2. In accordance with this, the pituitary expression of gonadotropin beta-subunit and serum gonadotropin were also attenuated from GD20 to PND0 in a pup-specific fashion. To identify the target genes linked to a fetal reduction in gonadotropin beta-subunit, we performed a DNA microarray analysis using the fetal pituitary and its regulatory organ, the hypothalamus. The results obtained showed that TCDD induced histone deacetylases (HDACs) in the fetal pituitary. In support with this, TCDD markedly deacetylated histones H3 and H4 twined around the promoter of the fetal LH beta gene. This effect was fetus- and LH beta-specific, and this was not observed in the maternal pituitary or for other pituitary hormone genes. Finally, an LH beta reduction caused by TCDD was completely restored by maternal co-treatment with valproic acid, an HDAC inhibitor. These results strongly suggest that the increased deacetylation of histone owing to HDAC induction plays a critical role in the TCDD-induced reduction in LH beta in the fetal pituitary.	[Takeda, Tomoki; Fujii, Misaki; Taura, Junki; Ishii, Yuji; Yamada, Hideyuki] Kyushu Univ, Grad Sch Pharmaceut Sci, Higashi Ku, Fukuoka 8128582, Japan	Kyushu University	Yamada, H (corresponding author), Kyushu Univ, Grad Sch Pharmaceut Sci, Higashi Ku, 3-1-1 Maidashi, Fukuoka 8128582, Japan.	hyamada@phar.kyushu-u.ac.jp	Ishii, Yuji/AAU-3300-2021		Ministry of Health, Labor, and Welfare, Japan [H21-Kagaku-Ippan-005, H21-Shokuhin-Ippan-014]	Ministry of Health, Labor, and Welfare, Japan(Ministry of Health, Labour and Welfare, Japan)	This work was supported by a grant from the Ministry of Health, Labor, and Welfare, Japan: Research on Risk of Chemical Substances (Project No: H21-Kagaku-Ippan-005), and Research on Food Safety (Project No: H21-Shokuhin-Ippan-014).	Abe T, 2004, INT J DEV BIOL, V48, P327, DOI 10.1387/ijdb.041838ta; Badawi AF, 2000, CARCINOGENESIS, V21, P1593, DOI 10.1093/carcin/21.8.1593; Bernard DJ, 2010, FERTIL STERIL, V93, P2465, DOI 10.1016/j.fertnstert.2010.03.034; Bolstad BM, 2003, BIOINFORMATICS, V19, P185, DOI 10.1093/bioinformatics/19.2.185; Burger LL, 2004, J MOL ENDOCRINOL, V33, P559, DOI 10.1677/jme.1.01600; FernandezSalguero PM, 1996, TOXICOL APPL PHARM, V140, P173, DOI 10.1006/taap.1996.0210; FROMMER M, 1992, P NATL ACAD SCI USA, V89, P1827, DOI 10.1073/pnas.89.5.1827; FUJISAWASEHARA A, 1987, NUCLEIC ACIDS RES, V15, P4179, DOI 10.1093/nar/15.10.4179; Gentleman RC, 2004, GENOME BIOL, V5, DOI 10.1186/gb-2004-5-10-r80; Hashimoto K, 2007, EPIGENETICS-US, V2, P86, DOI 10.4161/epi.2.2.4203; Jorgensen JS, 2004, ENDOCR REV, V25, P521, DOI 10.1210/er.2003-0029; Khan S, 2006, MOL ENDOCRINOL, V20, P2199, DOI 10.1210/me.2006-0100; Kharat I, 1996, J BIOL CHEM, V271, P10533, DOI 10.1074/jbc.271.18.10533; KIM DS, 1994, MOL ENDOCRINOL, V8, P528, DOI 10.1210/me.8.4.528; Larsen JC, 2006, MOL NUTR FOOD RES, V50, P885, DOI 10.1002/mnfr.200500247; Lim S, 2007, MOL CELL BIOL, V27, P4105, DOI 10.1128/MCB.00248-07; MACLUSKY NJ, 1981, SCIENCE, V211, P1294, DOI 10.1126/science.6163211; Manna PR, 2009, MOL HUM REPROD, V15, P321, DOI 10.1093/molehr/gap025; MARSHALL JC, 1986, NEW ENGL J MED, V315, P1459; Matsumoto Y, 2010, J TOXICOL SCI, V35, P365, DOI 10.2131/jts.35.365; Mayer C, 2011, NAT NEUROSCI, V14, P704, DOI 10.1038/nn.2818; Mccarthy MM, 2008, PHYSIOL REV, V88, P91, DOI 10.1152/physrev.00010.2007; Melamed P, 2006, MOL CELL ENDOCRINOL, V252, P167, DOI 10.1016/j.mce.2006.03.024; Melamed P, 2008, TRENDS ENDOCRIN MET, V19, P25, DOI 10.1016/j.tem.2007.10.008; Mimura J, 1997, GENES CELLS, V2, P645, DOI 10.1046/j.1365-2443.1997.1490345.x; Mimura J, 2003, BBA-GEN SUBJECTS, V1619, P263, DOI 10.1016/S0304-4165(02)00485-3; Moran FM, 2000, BIOL REPROD, V62, P1102, DOI 10.1095/biolreprod62.4.1102; Mutoh J, 2006, ENDOCRINOLOGY, V147, P927, DOI 10.1210/en.2005-1125; Ohsako S, 2001, TOXICOL SCI, V60, P132, DOI 10.1093/toxsci/60.1.132; Ohtake F, 2007, NATURE, V446, P562, DOI 10.1038/nature05683; PENNATHUR S, 1993, MOL ENDOCRINOL, V7, P797, DOI 10.1210/me.7.6.797; PETERSON RE, 1993, CRIT REV TOXICOL, V23, P283, DOI 10.3109/10408449309105013; Phiel CJ, 2001, J BIOL CHEM, V276, P36734, DOI 10.1074/jbc.M101287200; POLAND A, 1982, ANNU REV PHARMACOL, V22, P517, DOI 10.1146/annurev.pa.22.040182.002505; Ruf F, 2004, TRENDS ENDOCRIN MET, V15, P331, DOI 10.1016/j.tem.2004.07.008; Schecter A, 2006, ENVIRON RES, V101, P419, DOI 10.1016/j.envres.2005.12.003; Smyth GK, 2005, STAT BIOL HEALTH, P397, DOI 10.1007/0-387-29362-0_23; Takeda T, 2011, J TOXICOL SCI, V36, P221, DOI 10.2131/jts.36.221; Takeda T, 2009, J PHARMACOL EXP THER, V329, P1091, DOI 10.1124/jpet.109.151282; Taketoh J, 2007, LIFE SCI, V80, P1259, DOI 10.1016/j.lfs.2006.12.029; Wang Y, 2010, J MOL ENDOCRINOL, V44, P349, DOI 10.1677/JME-09-0142; Wen SP, 2010, P NATL ACAD SCI USA, V107, P16372, DOI 10.1073/pnas.1000423107	42	26	32	0	6	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	MAY 25	2012	287	22					18440	18450		10.1074/jbc.M111.335158	http://dx.doi.org/10.1074/jbc.M111.335158			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	974EC	22493514	Green Published, hybrid			2022-12-25	WOS:000306411600050
J	Kittilsen, S; Johansen, IB; Braastad, BO; Overli, O				Kittilsen, Silje; Johansen, Ida Beitnes; Braastad, Bjarne Olai; Overli, Oyvind			Pigments, Parasites and Personalitiy: Towards a Unifying Role for Steroid Hormones?	PLOS ONE			English	Article							SALMON SALMO-SALAR; BRAIN MONOAMINERGIC ACTIVITY; TROUT ONCORHYNCHUS-MYKISS; ATLANTIC SALMON; RAINBOW-TROUT; LEPEOPHTHEIRUS-SALMONIS; SEA LICE; COHO SALMON; EXPERIMENTAL-INFECTION; STRESS RESPONSIVENESS	A surging interest in the evolution of consistent trait correlations has inspired research on pigment patterns as a correlate of behavioural syndromes, or "animal personalities". Associations between pigmentation, physiology and health status are less investigated as potentially conserved trait clusters. In the current study, lice counts performed on farmed Atlantic salmon Salmo salar naturally infected with ectoparasitic sea lice Lepeophtheirus salmonis showed that individual fish with high incidence of black melanin-based skin spots harboured fewer female sea lice carrying egg sacs, compared to less pigmented fish. There was no significant association between pigmentation and lice at other developmental stages, suggesting that host factors associated with melanin-based pigmentation may modify ectoparasite development to a larger degree than settlement. In a subsequent laboratory experiment a strong negative correlation between skin spots and post-stress cortisol levels was revealed, with less pigmented individuals showing a more pronounced cortisol response to acute stress. The observation that lice prevalence was strongly increased on a fraction of sexually mature male salmon which occurred among the farmed fish further supports a role for steroid hormones as mediators of reduced parasite resistance. The data presented here propose steroid hormones as a proximate cause for the association between melanin-based pigmentation and parasites. Possible fundamental and applied implications are discussed.	[Kittilsen, Silje; Braastad, Bjarne Olai; Overli, Oyvind] Norwegian Univ Life Sci, Dept Anim & Aquacultural Sci, As, Norway; [Johansen, Ida Beitnes] Univ Oslo, Dept Mol Biosci, Oslo, Norway	Norwegian University of Life Sciences; University of Oslo	Kittilsen, S (corresponding author), Norwegian Univ Life Sci, Dept Anim & Aquacultural Sci, As, Norway.	oyvind.overli@umb.no	Johansen, Ida Beitnes/W-3766-2019		Research Council of Norway [172609]	Research Council of Norway(Research Council of Norway)	Funding provided by the Research Council of Norway (www.rcn.no). Project no. 172609: Selection for reduced stress responsiveness in Atlantic salmon (Salmo salar). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Almasi B, 2010, J EVOLUTION BIOL, V23, P987, DOI 10.1111/j.1420-9101.2010.01969.x; Bakke TA, 1998, CAN J FISH AQUAT SCI, V55, P247, DOI 10.1139/cjfas-55-S1-247; Barber I, 2010, PHILOS T R SOC B, V365, P4077, DOI 10.1098/rstb.2010.0182; BISBAL GA, 1991, J FISH BIOL, V39, P421, DOI 10.1111/j.1095-8649.1991.tb04373.x; Cesarini JP, 1996, ADV SPACE RES, V18, P35, DOI 10.1016/0273-1177(96)00025-7; Chakarov N, 2008, FUNCT ECOL, V22, P1062, DOI 10.1111/j.1365-2435.2008.01460.x; Clotfelter ED, 2007, BEHAV ECOL, V18, P1139, DOI 10.1093/beheco/arm090; Costello MJ, 2006, TRENDS PARASITOL, V22, P475, DOI 10.1016/j.pt.2006.08.006; Costello MJ, 2009, P ROY SOC B-BIOL SCI, V276, P3385, DOI 10.1098/rspb.2009.0771; Da Silva JAP, 1999, ANN NY ACAD SCI, V876, P102; Dawson LHJ, 1997, ICES J MAR SCI, V54, P1129, DOI 10.1016/S1054-3139(97)80018-5; Ruiz-Gomez MD, 2011, PHYSIOL BEHAV, V102, P317, DOI 10.1016/j.physbeh.2010.11.023; Denholm I, 2002, PEST MANAG SCI, V58, P528, DOI 10.1002/ps.482; DiBattista JD, 2005, J EXP BIOL, V208, P2707, DOI 10.1242/jeb.01690; Ducrest AL, 2008, TRENDS ECOL EVOL, V23, P502, DOI 10.1016/j.tree.2008.06.001; Fast MD, 2006, FISH SHELLFISH IMMUN, V21, P228, DOI 10.1016/j.fsi.2005.11.010; Fast MD, 2002, DIS AQUAT ORGAN, V52, P57, DOI 10.3354/dao052057; FITZPATRICK MS, 1986, GEN COMP ENDOCR, V62, P437, DOI 10.1016/0016-6480(86)90054-7; FOLSTAD I, 1992, AM NAT, V139, P603, DOI 10.1086/285346; Galeotti P, 2003, J ZOOL, V261, P91, DOI 10.1017/S0952836903003960; Garcia de Leaniz C, 2007, BIOL REV, V82, P173, DOI 10.1111/j.1469-185X.2006.00004.x; Gasparini J, 2009, J ANIM ECOL, V78, P608, DOI 10.1111/j.1365-2656.2008.01521.x; Gjerde B, 2011, AQUACULTURE, V314, P66, DOI 10.1016/j.aquaculture.2011.01.026; Harris J, 2000, VET IMMUNOL IMMUNOP, V77, P163, DOI 10.1016/S0165-2427(00)00235-X; HILL HZ, 1992, BIOESSAYS, V14, P49, DOI 10.1002/bies.950140111; Hoglund E, 2000, J EXP BIOL, V203, P1711; Horth L, 2003, P ROY SOC B-BIOL SCI, V270, P1033, DOI 10.1098/rspb.2003.2348; Hutchings JA, 1998, CAN J FISH AQUAT SCI, V55, P22, DOI 10.1139/cjfas-55-S1-22; Jacquin L, 2011, J AVIAN BIOL, V42, P11, DOI 10.1111/j.1600-048X.2010.05120.x; JARVI T, 1984, ANIM BEHAV, V32, P590, DOI 10.1016/S0003-3472(84)80296-1; Jawor JM, 2003, AUK, V120, P249, DOI 10.1642/0004-8038(2003)120[0249:MOHASS]2.0.CO;2; Johnson PTJ, 2007, P NATL ACAD SCI USA, V104, P15781, DOI 10.1073/pnas.0707763104; JOHNSON SC, 1991, CAN J ZOOL, V69, P929, DOI 10.1139/z91-138; JOHNSON SC, 1992, DIS AQUAT ORGAN, V14, P195, DOI 10.3354/dao014195; JOHNSON SC, 1992, DIS AQUAT ORGAN, V14, P179, DOI 10.3354/dao014179; Jones SRM, 2007, DIS AQUAT ORGAN, V75, P229, DOI 10.3354/dao075229; Kittilsen S, 2009, HORM BEHAV, V56, P292, DOI 10.1016/j.yhbeh.2009.06.006; Klein SL, 2004, PARASITE IMMUNOL, V26, P247, DOI 10.1111/j.0141-9838.2004.00710.x; Koolhaas JM, 1999, NEUROSCI BIOBEHAV R, V23, P925, DOI 10.1016/S0149-7634(99)00026-3; Korte SM, 2005, NEUROSCI BIOBEHAV R, V29, P3, DOI 10.1016/j.neubiorev.2004.08.009; Kortet R, 2010, ECOL LETT, V13, P1449, DOI 10.1111/j.1461-0248.2010.01536.x; Krkosek M, 2007, SCIENCE, V318, P1772, DOI 10.1126/science.1148744; Leclercq E, 2010, FISH FISH, V11, P159, DOI 10.1111/j.1467-2979.2009.00346.x; Lees F, 2008, J FISH DIS, V31, P947, DOI 10.1111/j.1365-2761.2008.00969.x; MacKinnon BM, 1998, ICES J MAR SCI, V55, P188, DOI 10.1006/jmsc.1997.0361; Mackintosh JA, 2001, J THEOR BIOL, V211, P101, DOI 10.1006/jtbi.2001.2331; Mafli A, 2011, ANIM BEHAV, V81, P859, DOI 10.1016/j.anbehav.2011.01.025; Maule AG, 1996, FISH SHELLFISH IMMUN, V6, P221, DOI 10.1006/fsim.1996.0022; MCBRIDE JR, 1986, J FISH BIOL, V29, P153, DOI 10.1111/j.1095-8649.1986.tb04934.x; McEwen BS, 1997, BRAIN RES REV, V23, P79, DOI 10.1016/S0165-0173(96)00012-4; McGraw KJ, 2008, PIGM CELL MELANOMA R, V21, P133, DOI 10.1111/j.1755-148X.2008.00454.x; McGraw KJ, 2003, AM NAT, V162, P704, DOI 10.1086/378904; McKenzie VJ, 2007, ECOHEALTH, V4, P384, DOI 10.1007/s10393-007-0131-3; McKinnon JS, 2010, MOL ECOL, V19, P5101, DOI 10.1111/j.1365-294X.2010.04846.x; Mommsen TP, 1999, REV FISH BIOL FISHER, V9, P211, DOI 10.1023/A:1008924418720; MOSER M, 1991, J PARASITOL, V77, P551, DOI 10.2307/3283158; NAPPI AJ, 1993, PIGM CELL RES, V6, P117, DOI 10.1111/j.1600-0749.1993.tb00590.x; Overli O, 2006, PHYSIOL BEHAV, V87, P506, DOI 10.1016/j.physbeh.2005.11.012; Overli O, 2002, J EXP BIOL, V205, P391; Overli O, 2002, HORM BEHAV, V42, P53, DOI 10.1006/hbeh.2002.1796; Overli O, 2001, BRAIN BEHAV EVOLUT, V57, P214, DOI 10.1159/000047238; Overli O, 2007, NEUROSCI BIOBEHAV R, V31, P396, DOI 10.1016/j.neubiorev.2006.10.006; Parejo D, 2011, J AVIAN BIOL, V42, P49, DOI 10.1111/j.1600-048X.2010.05235.x; Pfaff DW, 2009, HORMONES, BRAIN AND BEHAVIOR, VOLS 1-5, 2ND EDITION, P1; Pottinger TG, 1999, GEN COMP ENDOCR, V116, P122, DOI 10.1006/gcen.1999.7355; Pottinger TG, 2001, HORM BEHAV, V40, P419, DOI 10.1006/hbeh.2001.1707; Roulin A, 2001, BEHAV ECOL, V12, P103, DOI 10.1093/oxfordjournals.beheco.a000371; Roulin A, 2008, BEHAV ECOL SOCIOBIOL, V62, P507, DOI 10.1007/s00265-007-0475-2; Roulin A, 2004, BIOL REV, V79, P815, DOI 10.1017/S1464793104006487; Ruiz-Gomez MD, 2008, HORM BEHAV, V54, P534, DOI 10.1016/j.yhbeh.2008.05.005; Schjolden J, 2007, BRAIN BEHAV EVOLUT, V70, P227, DOI 10.1159/000105486; Schoech SJ, 2011, CURR ZOOL, V57, P514, DOI 10.1093/czoolo/57.4.514; Siva-Jothy MT, 2000, P ROY SOC B-BIOL SCI, V267, P2523, DOI 10.1098/rspb.2000.1315; Skugor S, 2008, BMC GENOMICS, V9, DOI 10.1186/1471-2164-9-498; Tadiso TM, 2011, BMC GENOMICS, V12, DOI 10.1186/1471-2164-12-141; Taranger GL, 2010, GEN COMP ENDOCR, V165, P483, DOI 10.1016/j.ygcen.2009.05.004; Thorpe JE, 2007, MAR ECOL PROG SER, V335, P285, DOI 10.3354/meps335285; Tobler M, 2008, ENVIRON BIOL FISH, V81, P29, DOI 10.1007/s10641-006-9153-x; TULLY O, 1993, FISH RES, V17, P187, DOI 10.1016/0165-7836(93)90018-3; Vinkler M, 2010, NATURWISSENSCHAFTEN, V97, P19, DOI 10.1007/s00114-009-0595-9; von Schantz T, 1999, P ROY SOC B-BIOL SCI, V266, P1, DOI 10.1098/rspb.1999.0597; Wedekind C, 2008, P ROY SOC B-BIOL SCI, V275, P1737, DOI 10.1098/rspb.2008.0072; West PM, 2002, SCIENCE, V297, P1339, DOI 10.1126/science.1073257; Weyts FAA, 1999, FISH SHELLFISH IMMUN, V9, P1, DOI 10.1006/fsim.1998.0170; YOUNGSON AF, 1988, AQUACULTURE, V69, P145, DOI 10.1016/0044-8486(88)90193-7	85	42	43	1	66	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 6	2012	7	4							e34281	10.1371/journal.pone.0034281	http://dx.doi.org/10.1371/journal.pone.0034281			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	955JA	22493685	Green Published, gold, Green Submitted			2022-12-25	WOS:000305012700027
J	Lahnakoski, JM; Salmi, J; Jaaskelainen, IP; Lampinen, J; Glerean, E; Tikka, P; Sams, M				Lahnakoski, Juha M.; Salmi, Juha; Jaaskelainen, Iiro P.; Lampinen, Jouko; Glerean, Enrico; Tikka, Pia; Sams, Mikko			Stimulus-Related Independent Component and Voxel-Wise Analysis of Human Brain Activity during Free Viewing of a Feature Film	PLOS ONE			English	Article							AUDITORY-CORTEX; NATURAL STIMULI; MOTION; PERCEPTION; NETWORKS; PREMOTOR; LANGUAGE; VISION; SYSTEM; ROBUST	Understanding how the brain processes stimuli in a rich natural environment is a fundamental goal of neuroscience. Here, we showed a feature film to 10 healthy volunteers during functional magnetic resonance imaging (fMRI) of hemodynamic brain activity. We then annotated auditory and visual features of the motion picture to inform analysis of the hemodynamic data. The annotations were fitted to both voxel-wise data and brain network time courses extracted by independent component analysis (ICA). Auditory annotations correlated with two independent components (IC) disclosing two functional networks, one responding to variety of auditory stimulation and another responding preferentially to speech but parts of the network also responding to non-verbal communication. Visual feature annotations correlated with four ICs delineating visual areas according to their sensitivity to different visual stimulus features. In comparison, a separate voxel-wise general linear model based analysis disclosed brain areas preferentially responding to sound energy, speech, music, visual contrast edges, body motion and hand motion which largely overlapped the results revealed by ICA. Differences between the results of IC- and voxel-based analyses demonstrate that thorough analysis of voxel time courses is important for understanding the activity of specific sub-areas of the functional networks, while ICA is a valuable tool for revealing novel information about functional connectivity which need not be explained by the predefined model. Our results encourage the use of naturalistic stimuli and tasks in cognitive neuroimaging to study how the brain processes stimuli in rich natural environments.	[Lahnakoski, Juha M.; Salmi, Juha; Jaaskelainen, Iiro P.; Lampinen, Jouko; Glerean, Enrico; Sams, Mikko] Aalto Univ, Sch Sci, Dept BECS, Brain & Mind Lab, Espoo, Finland; [Lahnakoski, Juha M.] Aalto Univ, Sch Sci, AMI Ctr, Espoo, Finland; [Tikka, Pia] Aalto Univ, Sch Arts Design & Architecture, Dept Mot Picture Televis & Prod Design, Helsinki, Finland	Aalto University; Aalto University; Aalto University	Lahnakoski, JM (corresponding author), Aalto Univ, Sch Sci, Dept BECS, Brain & Mind Lab, Espoo, Finland.	juha.lahnakoski@aalto.fi	Jaaskelainen, Iiro P/C-7392-2012; Lahnakoski, Juha/G-2072-2012; Salmi, Juha/G-7049-2012; Lahnakoski, Juha/AAB-1850-2022; Lampinen, Jouko/D-3927-2014; Tikka, Pia/J-1907-2012; Sams, Mikko E/G-7060-2012; Glerean, Enrico/C-6384-2011	Jaaskelainen, Iiro P/0000-0001-6001-6950; Lahnakoski, Juha/0000-0002-5223-7822; Salmi, Juha/0000-0001-5623-6598; Lahnakoski, Juha/0000-0002-5223-7822; Glerean, Enrico/0000-0003-0624-675X	Aalto University; Academy of Finland [129670, 130412, 138145]	Aalto University; Academy of Finland(Academy of Finland)	This work is supported by aivoAALTO research project of Aalto University (http://neuro.hut.fi/aivoaalto/contact.html), and Academy of Finland [grant numbers 129670, 130412, 138145] (http://www.aka.fi/eng). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bartels A, 2008, CEREB CORTEX, V18, P705, DOI 10.1093/cercor/bhm107; Bartels A, 2004, NEUROIMAGE, V22, P419, DOI 10.1016/j.neuroimage.2004.01.007; BELL AJ, 1995, NEURAL COMPUT, V7, P1129, DOI 10.1162/neco.1995.7.6.1129; Brown S, 2008, CEREB CORTEX, V18, P837, DOI 10.1093/cercor/bhm131; Brown S, 2007, BRAIN COGNITION, V63, P59, DOI 10.1016/j.bandc.2006.08.006; Buccino G, 2004, BRAIN LANG, V89, P370, DOI 10.1016/S0093-934X(03)00356-0; Buccino G, 2001, EUR J NEUROSCI, V13, P400, DOI 10.1046/j.1460-9568.2001.01385.x; Calhoun VD, 2001, HUM BRAIN MAPP, V13, P43, DOI 10.1002/hbm.1024; Corbetta M, 2008, NEURON, V58, P306, DOI 10.1016/j.neuron.2008.04.017; Damoiseaux JS, 2006, P NATL ACAD SCI USA, V103, P13848, DOI 10.1073/pnas.0601417103; David SV, 2009, J NEUROSCI, V29, P3374, DOI 10.1523/JNEUROSCI.5249-08.2009; Hari R, 2009, PHYSIOL REV, V89, P453, DOI 10.1152/physrev.00041.2007; Hart HC, 2002, HEARING RES, V171, P177, DOI 10.1016/S0378-5955(02)00498-7; Hasson U, 2004, SCIENCE, V303, P1634, DOI 10.1126/science.1089506; Hasson U, 2010, TRENDS COGN SCI, V14, P40, DOI 10.1016/j.tics.2009.10.011; Himberg J, 2003, 2003 IEEE XIII WORKSHOP ON NEURAL NETWORKS FOR SIGNAL PROCESSING - NNSP'03, P259, DOI 10.1109/NNSP.2003.1318025; Himberg J, 2004, NEUROIMAGE, V22, P1214, DOI 10.1016/j.neuroimage.2004.03.027; Hyvarinen A, 2000, NEURAL NETWORKS, V13, P411, DOI 10.1016/S0893-6080(00)00026-5; Jaaskelainen Iiro P, 2008, Open Neuroimag J, V2, P14, DOI 10.2174/1874440000802010014; Jenkinson M, 2002, NEUROIMAGE, V17, P825, DOI 10.1006/nimg.2002.1132; Kauppi J- P, 2010, INF TECHN APPL BIOM, P1, DOI [10.1109/ITAB.2010.5687650, DOI 10.1109/ITAB.2010.5687650]; Lartillot O., 2007, INT C DIG AUD EFF, P237; Lerner Y, 2011, J NEUROSCI, V31, P2906, DOI 10.1523/JNEUROSCI.3684-10.2011; Peeters R, 2009, J NEUROSCI, V29, P11523, DOI 10.1523/JNEUROSCI.2040-09.2009; Rauschecker JP, 2009, NAT NEUROSCI, V12, P718, DOI 10.1038/nn.2331; Salmi J, 2009, BRAIN RES, V1286, P155, DOI 10.1016/j.brainres.2009.06.083; Saur D, 2008, P NATL ACAD SCI USA, V105, P18035, DOI 10.1073/pnas.0805234105; Schon D, 2010, NEUROIMAGE, V51, P450, DOI 10.1016/j.neuroimage.2010.02.023; Schultz J, 2009, EXP BRAIN RES, V194, P465, DOI 10.1007/s00221-009-1721-9; Scott SK, 2003, TRENDS NEUROSCI, V26, P100, DOI 10.1016/S0166-2236(02)00037-1; Smith SM, 2002, HUM BRAIN MAPP, V17, P143, DOI 10.1002/hbm.10062; Smith SM, 2004, NEUROIMAGE, V23, pS208, DOI 10.1016/j.neuroimage.2004.07.051; Spiers HJ, 2007, TRENDS COGN SCI, V11, P356, DOI 10.1016/j.tics.2007.06.002; Stephens GJ, 2010, P NATL ACAD SCI USA, V107, P14425, DOI 10.1073/pnas.1008662107; Woolrich MW, 2009, NEUROIMAGE, V45, pS173, DOI 10.1016/j.neuroimage.2008.10.055; Ylipaavalniemi J, 2009, NEUROIMAGE, V48, P176, DOI 10.1016/j.neuroimage.2009.03.056	36	41	41	3	25	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 5	2012	7	4							e35215	10.1371/journal.pone.0035215	http://dx.doi.org/10.1371/journal.pone.0035215			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	955IH	22496909	Green Published, gold, Green Submitted			2022-12-25	WOS:000305010500034
J	Li, BQ; Huang, T; Liu, L; Cai, YD; Chou, KC				Li, Bi-Qing; Huang, Tao; Liu, Lei; Cai, Yu-Dong; Chou, Kuo-Chen			Identification of Colorectal Cancer Related Genes with mRMR and Shortest Path in Protein-Protein Interaction Network	PLOS ONE			English	Article							AMINO-ACID-COMPOSITION; HUMAN TISSUE KALLIKREINS; GENOME-WIDE ASSOCIATION; SUBCELLULAR-LOCALIZATION; TRANSCRIPTION FACTOR; PREDICTION; EXPRESSION; ENZYME; COLON; BETA	One of the most important and challenging problems in biomedicine and genomics is how to identify the disease genes. In this study, we developed a computational method to identify colorectal cancer-related genes based on (i) the gene expression profiles, and (ii) the shortest path analysis of functional protein association networks. The former has been used to select differentially expressed genes as disease genes for quite a long time, while the latter has been widely used to study the mechanism of diseases. With the existing protein-protein interaction data from STRING (Search Tool for the Retrieval of Interacting Genes), a weighted functional protein association network was constructed. By means of the mRMR (Maximum Relevance Minimum Redundancy) approach, six genes were identified that can distinguish the colorectal tumors and normal adjacent colonic tissues from their gene expression profiles. Meanwhile, according to the shortest path approach, we further found an additional 35 genes, of which some have been reported to be relevant to colorectal cancer and some are very likely to be relevant to it. Interestingly, the genes we identified from both the gene expression profiles and the functional protein association network have more cancer genes than the genes identified from the gene expression profiles alone. Besides, these genes also had greater functional similarity with the reported colorectal cancer genes than the genes identified from the gene expression profiles alone. All these indicate that our method as presented in this paper is quite promising. The method may become a useful tool, or at least plays a complementary role to the existing method, for identifying colorectal cancer genes. It has not escaped our notice that the method can be applied to identify the genes of other diseases as well.	[Li, Bi-Qing; Huang, Tao; Liu, Lei] Chinese Acad Sci, Key Lab Syst Biol, Shanghai Inst Biol Sci, Shanghai, Peoples R China; [Li, Bi-Qing; Huang, Tao; Liu, Lei] Shanghai Ctr Bioinformat Technol, Shanghai, Peoples R China; [Cai, Yu-Dong] Shanghai Univ, Inst Syst Biol, Shanghai, Peoples R China; [Cai, Yu-Dong] Fudan Univ, Ctr Computat Syst Biol, Shanghai 200433, Peoples R China; [Cai, Yu-Dong; Chou, Kuo-Chen] Gordon Life Sci Inst, San Diego, CA USA	Chinese Academy of Sciences; Shanghai Institutes for Biological Sciences, CAS; Chinese Academy of Sciences; Shanghai University; Fudan University	Li, BQ (corresponding author), Chinese Acad Sci, Key Lab Syst Biol, Shanghai Inst Biol Sci, Shanghai, Peoples R China.	liulei@sibs.ac.cn; cai_yud@yahoo.com.cn	Chou, Kuo-Chen/A-8340-2009	cai, yudong/0000-0001-5664-7979	National Basic Research Program of China [2011CB510102, 2011CB510101, 2011CB910200, 2010CB912702]; Natural Science Foundation of China [90913009]; Chinese Academy of Sciences [KSCX2-EW-R-04]; National High Tech Program [2012AA022802]; Innovation Program of Shanghai Municipal Education Commission [12ZZ087]	National Basic Research Program of China(National Basic Research Program of China); Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Chinese Academy of Sciences(Chinese Academy of Sciences); National High Tech Program; Innovation Program of Shanghai Municipal Education Commission(Innovation Program of Shanghai Municipal Education Commission)	This work was supported by grants from the National Basic Research Program of China (2011CB510102, 2011CB510101, 2011CB910200 and 2010CB912702), the Natural Science Foundation of China (90913009), the Chinese Academy of Sciences (KSCX2-EW-R-04), a National High Tech Program Grant 2012AA022802 and the Innovation Program of Shanghai Municipal Education Commission (12ZZ087). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Allen WL, 2010, BMC CANCER, V10, DOI 10.1186/1471-2407-10-687; ALTHAUS IW, 1993, J BIOL CHEM, V268, P14875; Andraos J, 2008, CAN J CHEM, V86, P342, DOI 10.1139/V08-020; Bakall B, 2008, INVEST OPHTH VIS SCI, V49, P1563, DOI 10.1167/iovs.07-1338; Benjamini Y, 2001, ANN STAT, V29, P1165; Bogdanov P, 2010, IEEE ACM T COMPUT BI, V7, P208, DOI 10.1109/TCBB.2009.81; Borgono CA, 2004, NAT REV CANCER, V4, P876, DOI 10.1038/nrc1474; Cai Y., 2011, AMINO ACIDS; Castagnetta L, 2002, ANN NY ACAD SCI, V963, P322; Catalano MG, 2000, INT J CANCER, V86, P325, DOI 10.1002/(SICI)1097-0215(20000501)86:3<325::AID-IJC4>3.0.CO;2-G; Chen L, 2013, CURR BIOINFORM, V8, P200, DOI 10.2174/1574893611308020008; Chen L, 2012, PROTEIN PEPTIDE LETT, V19, P99, DOI 10.2174/092986612798472857; Chou K.C., 2011, NATUR SCI, V3, P862, DOI [10.4236/ns.2011.310111, DOI 10.4236/NS.2011.310111]; CHOU KC, 1994, ANAL BIOCHEM, V221, P217, DOI 10.1006/abio.1994.1405; CHOU KC, 1980, BIOCHEM J, V187, P829, DOI 10.1042/bj1870829; CHOU KC, 1989, J BIOL CHEM, V264, P12074; CHOU KC, 1990, BIOPHYS CHEM, V35, P1, DOI 10.1016/0301-4622(90)80056-D; CHOU KC, 1995, CRIT REV BIOCHEM MOL, V30, P275, DOI 10.3109/10409239509083488; Chou KC, 2008, NAT PROTOC, V3, P153, DOI 10.1038/nprot.2007.494; Chou KC, 2007, ANAL BIOCHEM, V370, P1, DOI 10.1016/j.ab.2007.07.006; Chou KC, 2012, MOL BIOSYST, V8, P629, DOI 10.1039/c1mb05420a; Chou KC, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0018258; Chou KC, 2011, J THEOR BIOL, V273, P236, DOI 10.1016/j.jtbi.2010.12.024; Chou KC, 2010, CURR DRUG METAB, V11, P369, DOI 10.2174/138920010791514261; Christensen BC, 2011, JNCI-J NATL CANCER I, V103, DOI 10.1093/jnci/djq497; Cui JA, 2011, NUCLEIC ACIDS RES, V39, P1197, DOI 10.1093/nar/gkq960; DENOEUX T, 1995, IEEE T SYST MAN CYB, V25, P804, DOI 10.1109/21.376493; Deves C, 2011, VIRCHOWS ARCH, V458, P421, DOI 10.1007/s00428-011-1053-6; Diamandis EP, 2002, CLIN CHEM, V48, P1198; DIAMANDIS EP, 1995, J CLIN ENDOCR METAB, V80, P1515, DOI 10.1210/jc.80.5.1515; Dijkstra E.W, 1959, NUMER MATH, V1, P269, DOI DOI 10.1007/BF01386390; Esmaeili M, 2010, J THEOR BIOL, V263, P203, DOI 10.1016/j.jtbi.2009.11.016; FRIEDMAN JH, 1975, IEEE T COMPUT, V24, P1000, DOI 10.1109/T-C.1975.224110; Gayther SA, 2000, NAT GENET, V24, P300, DOI 10.1038/73536; Georgiou DN, 2009, J THEOR BIOL, V257, P17, DOI 10.1016/j.jtbi.2008.11.003; Gu Q, 2010, PROTEIN PEPTIDE LETT, V17, P559, DOI 10.2174/092986610791112693; Hibi K, 2009, ANTICANCER RES, V29, P2215; Hinoue T., 2011, GENOME RES; Hiranuma C, 2004, INT J MOL MED, V13, P413; Hoeft B, 2010, CARCINOGENESIS, V31, P466, DOI 10.1093/carcin/bgp325; Howe GR, 1997, CANCER CAUSE CONTROL, V8, P215, DOI 10.1023/A:1018476414781; Hu LL, 2011, PROTEIN PEPTIDE LETT, V18, P552, DOI 10.2174/092986611795222795; Hu LL, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0014556; Huang DW, 2009, NAT PROTOC, V4, P44, DOI 10.1038/nprot.2008.211; Huang T, 2011, PROTEIN PEPTIDE LETT; Huang T, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0016036; Huang T, 2011, NEUROCOMPUTING, V74, P3677, DOI 10.1016/j.neucom.2011.07.019; Huang T, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0025297; Huang T, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0022940; Huang T, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0010972; Huang T, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0008126; Huang T, 2009, BIOCHEM BIOPH RES CO, V390, P1111, DOI 10.1016/j.bbrc.2009.08.131; Huret JL, 2003, NUCLEIC ACIDS RES, V31, P272, DOI 10.1093/nar/gkg126; Imai K, 2008, CLIN CANCER RES, V14, P6487, DOI 10.1158/1078-0432.CCR-08-1086; Irizarry RA, 2009, NAT GENET, V41, P178, DOI 10.1038/ng.298; Johnson SAS, 2003, MOL CELL BIOL, V23, P3043, DOI 10.1128/MCB.23.9.3043-3051.2003; Jones S, 2008, SCIENCE, V321, P1801, DOI 10.1126/science.1164368; Karaoz U, 2004, P NATL ACAD SCI USA, V101, P2888, DOI 10.1073/pnas.0307326101; Katoh M, 2004, INT J ONCOL, V25, P1495; Kim IJ, 2006, CARCINOGENESIS, V27, P392, DOI 10.1093/carcin/bgi237; Kim MS, 2011, HISTOPATHOLOGY, V58, P660, DOI 10.1111/j.1365-2559.2011.03819.x; Kourmpetis YAI, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0009293; Lagger G, 2003, MOL CELL BIOL, V23, P2669, DOI 10.1128/MCB.23.8.2669-2679.2003; Landi D, 2008, CARCINOGENESIS, V29, P579, DOI 10.1093/carcin/bgm304; Letovsky S, 2003, BIOINFORMATICS, V19, pi197, DOI 10.1093/bioinformatics/btg1026; LEVESQUE M, 1995, J CLIN LAB ANAL, V9, P123, DOI 10.1002/jcla.1860090209; Li JM, 2010, BREAST CANCER RES, V12, DOI 10.1186/bcr2772; Lipkin SM, 2010, CANCER PREV RES, V3, P597, DOI 10.1158/1940-6207.CAPR-10-0007; Liu DJ, 2009, ANTICANCER RES, V29, P3777; Liu Q, 2010, BMC BIOINFORMATICS, V11, DOI 10.1186/1471-2105-11-S11-S5; MacLean HE, 1997, J STEROID BIOCHEM, V62, P233, DOI 10.1016/S0960-0760(97)00049-6; Medina MW, 2010, DISCOV MED, V9, P495; Menendez D, 2009, NAT REV CANCER, V9, P724, DOI 10.1038/nrc2730; Mohabatkar H, 2011, J THEOR BIOL, V281, P18, DOI 10.1016/j.jtbi.2011.04.017; Mohabatkar H, 2010, PROTEIN PEPTIDE LETT, V17, P1207, DOI 10.2174/092986610792231564; Morikawa T, 2011, JAMA-J AM MED ASSOC, V305, P1685, DOI 10.1001/jama.2011.513; Nabieva E, 2005, BIOINFORMATICS, V21, pI302, DOI 10.1093/bioinformatics/bti1054; Nagaraj SH, 2011, BMC SYST BIOL, V5, DOI 10.1186/1752-0509-5-35; Ng KL, 2010, COMPUT BIOL MED, V40, P300, DOI 10.1016/j.compbiomed.2010.01.001; Niittymaki I, 2011, BMC MED GENET, V12, DOI 10.1186/1471-2350-12-23; OHKUBO I, 1995, INT J BIOCHEM CELL B, V27, P603, DOI 10.1016/1357-2725(95)00021-G; Parsons DW, 2008, SCIENCE, V321, P1807, DOI 10.1126/science.1164382; Peng HC, 2005, IEEE T PATTERN ANAL, V27, P1226, DOI 10.1109/TPAMI.2005.159; Polakis P, 2000, GENE DEV, V14, P1837; Prasad TSK, 2009, NUCLEIC ACIDS RES, V37, pD767, DOI 10.1093/nar/gkn892; Reeves JR, 2005, BIOCHEM J, V385, P105, DOI 10.1042/BJ20040290; Sabates-Beliver J, 2007, MOL CANCER RES, V5, P1263, DOI 10.1158/1541-7786.MCR-07-0267; Sharan R, 2007, MOL SYST BIOL, V3, DOI 10.1038/msb4100129; Slattery ML, 2005, CANCER EPIDEM BIOMAR, V14, P2936, DOI 10.1158/1055-9965.EPI-05-0514; Stohr H, 2002, EUR J HUM GENET, V10, P281, DOI 10.1038/sj.ejhg.5200796; Szklarczyk D, 2011, NUCLEIC ACIDS RES, V39, pD561, DOI 10.1093/nar/gkq973; Talieri M, 2009, THROMB HAEMOSTASIS, V101, P741, DOI 10.1160/TH08-07-0471; Team RDC, 2019, R LANG ENV STAT COMP; Thangaraju M, 2009, BIOCHEM J, V417, P379, DOI 10.1042/BJ20081132; Thomas G, 2008, NAT GENET, V40, P310, DOI 10.1038/ng.91; Tsukahara H, 2001, PEDIATR INT, V43, P267, DOI 10.1046/j.1442-200x.2001.01393.x; van Criekinge W, 2007, International Application No: PCT/US2007/013803., Patent No. 2007013803; Wood LD, 2007, SCIENCE, V318, P1108, DOI 10.1126/science.1145720; Wu ZC, 2011, MOL BIOSYST, V7, P3287, DOI 10.1039/c1mb05232b; Xiao X, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0020592; Yang XY, 2010, PROTEIN PEPTIDE LETT, V17, P899, DOI 10.2174/092986610791306670; Yi XF, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0012495; Yu K, 2010, J CLIN INVEST, V120, P1722, DOI 10.1172/JCI41129; ZHOU GP, 1984, BIOCHEM J, V222, P169, DOI 10.1042/bj2220169; Zhou GP, 2011, PROTEIN PEPTIDE LETT, V18, P966, DOI 10.2174/0929866511107010966; Zhou GP, 2011, J THEOR BIOL, V284, P142, DOI 10.1016/j.jtbi.2011.06.006	106	155	157	1	33	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 4	2012	7	4							e33393	10.1371/journal.pone.0033393	http://dx.doi.org/10.1371/journal.pone.0033393			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	953GO	22496748	gold, Green Published, Green Submitted			2022-12-25	WOS:000304855200012
J	Redmond, WL; Triplett, T; Floyd, K; Weinberg, AD				Redmond, William L.; Triplett, Todd; Floyd, Kevin; Weinberg, Andrew D.			Dual Anti-OX40/IL-2 Therapy Augments Tumor Immunotherapy via IL-2R-Mediated Regulation of OX40 Expression	PLOS ONE			English	Article							T-CELL RESPONSES; IN-VIVO; SELECTIVE STIMULATION; COMPETITIVE FITNESS; ANTITUMOR IMMUNITY; EFFECTOR FUNCTION; GENE-EXPRESSION; RECEPTOR; COSTIMULATION; INTERLEUKIN-2	The provision of T cell co-stimulation via members of the TNFR super-family, including OX40 (CD134) and 4-1BB (CD137), provides critical signals that promote T cell survival and differentiation. Recent studies have demonstrated that ligation of OX40 can augment T cell-mediated anti-tumor immunity in pre-clinical models and more importantly, OX40 agonists are under clinical development for cancer immunotherapy. OX40 is of particular interest as a therapeutic target as it is not expressed on naive T cells but rather, is transiently up-regulated following TCR stimulation. Although TCR engagement is necessary for inducing OX40 expression, the downstream signals that regulate OX40 itself remain unclear. In this study, we demonstrate that OX40 expression is regulated through a TCR and common gamma chain cytokine-dependent signaling cascade that requires JAK3-mediated activation of the downstream transcription factors STAT3 and STAT5. Furthermore, combined treatment with an agonist anti-OX40 mAb and IL-2 augmented tumor immunotherapy against multiple tumor types. Dual therapy was also able to restore the function of anergic tumor-reactive CD8 T cells in mice with long-term well-established (>5 wks) tumors, leading to increased survival of the tumor-bearing hosts. Together, these data reveal the ability of TCR/common gamma chain cytokine signaling to regulate OX40 expression and demonstrate a novel means of augmenting cancer immunotherapy by providing dual anti-OX40/common gamma chain cytokine-directed therapy.	[Redmond, William L.; Triplett, Todd; Floyd, Kevin; Weinberg, Andrew D.] Providence Portland Med Ctr, Earle A Chiles Res Inst, Robert W Franz Canc Res Ctr, Portland, OR USA; [Triplett, Todd; Weinberg, Andrew D.] Oregon Hlth & Sci Univ, Dept Mol Microbiol & Immunol, Portland, OR 97201 USA	Providence Portland Medical Center; Oregon Health & Science University	Redmond, WL (corresponding author), Providence Portland Med Ctr, Earle A Chiles Res Inst, Robert W Franz Canc Res Ctr, Portland, OR USA.	william.redmond@providence.org	triplett, todd/AAY-1204-2020	triplett, todd/0000-0001-5494-6510; Redmond, William/0000-0002-2572-1731	Providence Portland Medical Foundation; Safeway Foundation; American Cancer Society; Prostate Cancer Foundation; National Institute of Health (NIH) [4R00CA136678-02]; NATIONAL CANCER INSTITUTE [R01CA102577, R00CA136678] Funding Source: NIH RePORTER	Providence Portland Medical Foundation; Safeway Foundation; American Cancer Society(American Cancer Society); Prostate Cancer Foundation; National Institute of Health (NIH)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	This work was supported by the Providence Portland Medical Foundation, the Safeway Foundation, an American Cancer Society Sam E. and Kathleen Henry post-doctoral fellowship; a Prostate Cancer Foundation Young Investigator Award; a National Institute of Health (NIH) Pathway to Independence Award (4R00CA136678-02; WLR); and grants from the NIH (ADW). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Akiba H, 1999, J IMMUNOL, V162, P7058; Basham B, 2008, NUCLEIC ACIDS RES, V36, P3802, DOI 10.1093/nar/gkn271; Boyman O, 2006, SCIENCE, V311, P1924, DOI 10.1126/science.1122927; Changelian PS, 2008, BLOOD, V111, P2155, DOI 10.1182/blood-2007-09-115030; Croft M, 2003, NAT REV IMMUNOL, V3, P609, DOI 10.1038/nri1148; Croft M, 2010, ANNU REV IMMUNOL, V28, P57, DOI 10.1146/annurev-immunol-030409-101243; Evans DE, 2001, J IMMUNOL, V167, P6804, DOI 10.4049/jimmunol.167.12.6804; Gadina M, 2000, J BIOL CHEM, V275, P26959; Gaffen SL, 2001, CYTOKINE, V14, P63, DOI 10.1006/cyto.2001.0862; Gramaglia I, 1998, J IMMUNOL, V161, P6510; Gramaglia I, 2000, J IMMUNOL, V165, P3043, DOI 10.4049/jimmunol.165.6.3043; John S, 1999, MOL CELL BIOL, V19, P1910; Joshi NS, 2007, IMMUNITY, V27, P281, DOI 10.1016/j.immuni.2007.07.010; Kamimura D, 2007, J EXP MED, V204, P1803, DOI 10.1084/jem.20070543; Kish DD, 2007, J LEUKOCYTE BIOL, V82, P85, DOI 10.1189/jlb.0207089; Kitamura N, 2009, INT J CANCER, V125, P630, DOI 10.1002/ijc.24435; Klinger M, 2009, J IMMUNOL, V182, P4581, DOI 10.4049/jimmunol.0900010; Kovanen PE, 2004, IMMUNOL REV, V202, P67, DOI 10.1111/j.0105-2896.2004.00203.x; Krieg C, 2010, P NATL ACAD SCI USA, V107, P11906, DOI 10.1073/pnas.1002569107; Lathrop SK, 2004, J IMMUNOL, V172, P6735, DOI 10.4049/jimmunol.172.11.6735; Lees JR, 2006, IMMUNOLOGY, V117, P248, DOI 10.1111/j.1365-2567.2005.02293.x; Lenschow DJ, 1996, ANNU REV IMMUNOL, V14, P233, DOI 10.1146/annurev.immunol.14.1.233; Leonard WJ, 1998, ANNU REV IMMUNOL, V16, P293, DOI 10.1146/annurev.immunol.16.1.293; Lu LF, 2009, IMMUNITY, V30, P80, DOI 10.1016/j.immuni.2008.11.010; Moroz A, 2004, J IMMUNOL, V173, P900, DOI 10.4049/jimmunol.173.2.900; Nelson BH, 1998, ADV IMMUNOL, V70, P1, DOI 10.1016/S0065-2776(08)60386-7; Niedbala W, 2007, P NATL ACAD SCI USA, V104, P15478, DOI 10.1073/pnas.0703725104; Piconese S, 2010, EUR J IMMUNOL, V40, P2902, DOI 10.1002/eji.201040505; Rabinovich GA, 2007, ANNU REV IMMUNOL, V25, P267, DOI 10.1146/annurev.immunol.25.022106.141609; Redmond WL, 2007, J IMMUNOL, V179, P7244, DOI 10.4049/jimmunol.179.11.7244; Redmond WL, 2009, EUR J IMMUNOL, V39, P2184, DOI 10.1002/eji.200939348; Redmond WL, 2009, CRIT REV IMMUNOL, V29, P187, DOI 10.1615/CritRevImmunol.v29.i3.10; Rochman Y, 2009, NAT REV IMMUNOL, V9, P480, DOI 10.1038/nri2580; Rogers PR, 2001, IMMUNITY, V15, P445, DOI 10.1016/S1074-7613(01)00191-1; Sarkar S, 2008, J EXP MED, V205, P625, DOI 10.1084/jem.20071641; Shimoda M, 2006, J IMMUNOL, V176, P6503, DOI 10.4049/jimmunol.176.11.6503; SPIESS PJ, 1987, JNCI-J NATL CANCER I, V79, P1067; Srinivas S, 2001, BMC Dev Biol, V1, P4, DOI 10.1186/1471-213X-1-4; Takeda I, 2004, J IMMUNOL, V172, P3580, DOI 10.4049/jimmunol.172.6.3580; Taraban VY, 2002, EUR J IMMUNOL, V32, P3617, DOI 10.1002/1521-4141(200212)32:12<3617::AID-IMMU3617>3.0.CO;2-M; Teglund S, 1998, CELL, V93, P841, DOI 10.1016/S0092-8674(00)81444-0; Toennies HM, 2004, J LEUKOCYTE BIOL, V75, P350, DOI 10.1189/jlb.0803401; Tone Y, 2007, J IMMUNOL, V179, P1760, DOI 10.4049/jimmunol.179.3.1760; Verdeil G, 2008, P NATL ACAD SCI US; Verdeil G, 2006, J IMMUNOL, V176, P4834, DOI 10.4049/jimmunol.176.8.4834; Walker LSK, 1999, J EXP MED, V190, P1115, DOI 10.1084/jem.190.8.1115; Watts TH, 2005, ANNU REV IMMUNOL, V23, P23, DOI 10.1146/annurev.immunol.23.021704.115839; Webster KE, 2009, J EXP MED, V206, P751, DOI 10.1084/jem.20082824; Weinberg AD, 2000, J IMMUNOL, V164, P2160, DOI 10.4049/jimmunol.164.4.2160; Williams CA, 2007, J IMMUNOL, V178, P7694, DOI 10.4049/jimmunol.178.12.7694; Xiao X, 2012, J IMMUNOL, V188, P892, DOI 10.4049/jimmunol.1101373; Yu CR, 1998, J LEUKOCYTE BIOL, V64, P245, DOI 10.1002/jlb.64.2.245	52	37	41	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 4	2012	7	4							e34467	10.1371/journal.pone.0034467	http://dx.doi.org/10.1371/journal.pone.0034467			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	953GO	22496812	Green Submitted, Green Published, gold			2022-12-25	WOS:000304855200054
J	Srinivasan, VB; Vaidyanathan, V; Mondal, A; Rajamohan, G				Srinivasan, Vijaya Bharathi; Vaidyanathan, Vasanth; Mondal, Amitabha; Rajamohan, Govindan			Role of the Two Component Signal Transduction System CpxAR in Conferring Cefepime and Chloramphenicol Resistance in Klebsiella pneumoniae NTUH-K2044	PLOS ONE			English	Article							BIOFILM FORMATION; ESCHERICHIA-COLI; LIVER-ABSCESS; EFFLUX PUMP; COLONIZATION; VIRULENCE; PATHWAY; KINASE; GENE	Background: Klebsiella pneumoniae is a Gram-negative, non-motile, facultative anaerobe belonging to the Enterobacteriaceae family of the gamma-Proteobacteria class in the phylum Proteobacteria. Multidrug resistant K. pneumoniae have caused major therapeutic problems worldwide due to emergence of extended-spectrum beta-lactamase producing strains. Two-component systems serve as a basic stimulus-response coupling mechanism to allow organisms to sense and respond to changes in many different environmental conditions including antibiotic stress. Principal Findings: In the present study, we investigated the role of an uncharacterized cpxAR operon in bacterial physiology and antimicrobial resistance by generating isogenic mutant (Delta cpxAR) deficient in the CpxA/CpxR component derived from the hyper mucoidal K1 strain K. pneumoniae NTUH-K2044. The behaviour of DcpxAR was determined under hostile conditions, reproducing stresses encountered in the gastrointestinal environment and deletion resulted in higher sensitivity to bile, osmotic and acid stresses. The Delta cpxAR was more susceptible to beta-lactams and chloramphenicol than the wild-type strain, and complementation restored the altered phenotypes. The relative change in expression of acrB, acrD, eefB efflux genes were decreased in cpxAR mutant as evidenced by qRT-PCR. Comparison of outer membrane protein profiles indicated a conspicuous difference in the knock out background. Gel shift assays demonstrated direct binding of CpxR(KP) to promoter region of ompC(KP) in a concentration dependent manner. Conclusions and Significance: The Cpx envelope stress response system is known to be activated by alterations in pH, membrane composition and misfolded proteins, and this systematic investigation reveals its direct involvement in conferring antimicrobial resistance against clinically significant antibiotics for the very first time. Overall results displayed in this report reflect the pleiotropic role of the CpxAR signaling system and diversity of the antibiotic resistome in hyper virulent K1 serotype K. pneumoniae NTUH-K2044.	[Srinivasan, Vijaya Bharathi; Vaidyanathan, Vasanth; Mondal, Amitabha; Rajamohan, Govindan] Inst Microbial Technol, Council Sci Ind Res, Chandigarh, India	Council of Scientific & Industrial Research (CSIR) - India; CSIR - Institute of Microbial Technology (IMTECH)	Srinivasan, VB (corresponding author), Inst Microbial Technol, Council Sci Ind Res, Sect 39 A, Chandigarh, India.	rmohan@imtech.res.in		Govindan, Rajamohan/0000-0002-0208-3546	Department of Biotechnology (DBT), Government of India; University Grants Commission (UGC); Council of Scientific and Industrial Research (CSIR), Diamond Jubilee scheme, Government of India; CSIR-Institute of Microbial Technology, India	Department of Biotechnology (DBT), Government of India(Department of Biotechnology (DBT) India); University Grants Commission (UGC)(University Grants Commission, India); Council of Scientific and Industrial Research (CSIR), Diamond Jubilee scheme, Government of India; CSIR-Institute of Microbial Technology, India	VBS, W, and AM are grateful to Department of Biotechnology (DBT), Innovative Young Biotechnologist Award, Government of India, University Grants Commission (UGC), and Council of Scientific and Industrial Research (CSIR), Diamond Jubilee scheme, Government of India, respectively, for their fellowships. The work was supported by CSIR-Institute of Microbial Technology, India; and a grant provided by Department of Biotechnology, Government of India. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Altschul SF, 1997, NUCLEIC ACIDS RES, V25, P3389, DOI 10.1093/nar/25.17.3389; Arnold RS, 2011, SOUTH MED J, V104, P40, DOI 10.1097/SMJ.0b013e3181fd7d5a; Chaba R, 2002, EUR J BIOCHEM, V269, P1078, DOI 10.1046/j.1432-1033.2002.02778.x; Chen JH, 2010, J ANTIMICROB CHEMOTH, V65, P986, DOI 10.1093/jac/dkq056; Cheng HY, 2010, J BACTERIOL, V192, P3144, DOI 10.1128/JB.00031-10; Clinical and Laboratory Standards Institute, 2010, M100S20U CLSI; Coudeyras S, 2008, INFECT IMMUN, V76, P4633, DOI 10.1128/IAI.00356-08; De Wulf P, 2000, J BACTERIOL, V182, P1423, DOI 10.1128/JB.182.5.1423-1426.2000; Di Martino P, 2003, RES MICROBIOL, V154, P9, DOI 10.1016/S0923-2508(02)00004-9; DiGiuseppe PA, 2003, J BACTERIOL, V185, P2432, DOI 10.1128/JB.185.8.2432-2440.2003; Dorel C, 2006, RES MICROBIOL, V157, P306, DOI 10.1016/j.resmic.2005.12.003; Fang CT, 2004, J EXP MED, V199, P697, DOI 10.1084/jem.20030857; Gunn JS, 2000, MICROBES INFECT, V2, P907, DOI 10.1016/S1286-4579(00)00392-0; Hennequin C, 2009, INFECT IMMUN, V77, P5449, DOI 10.1128/IAI.00837-09; Hirakawa H, 2003, J BACTERIOL, V185, P1851, DOI 10.1128/JB.185.6.1851-1856.2003; Hu WS, 2011, ANTIMICROB AGENTS CH, V55, P3829, DOI 10.1128/AAC.00216-11; Imlay JA, 2003, ANNU REV MICROBIOL, V57, P395, DOI 10.1146/annurev.micro.57.030502.090938; MacRitchie DM, 2008, ADV EXP MED BIOL, V631, P80, DOI 10.1007/978-0-387-78885-2_6; Maroncle N, 2002, INFECT IMMUN, V70, P4729, DOI 10.1128/IAI.70.8.4729-4734.2002; Pages JM, 2008, NAT REV MICROBIOL, V6, P893, DOI 10.1038/nrmicro1994; Piddock LJV, 2006, CLIN MICROBIOL REV, V19, P382, DOI 10.1128/CMR.19.2.382-402.2006; Podschun R, 1998, CLIN MICROBIOL REV, V11, P589, DOI 10.1128/CMR.11.4.589; Price NL, 2009, J BACTERIOL, V191, P1798, DOI 10.1128/JB.00798-08; Raffa RG, 2002, MOL MICROBIOL, V45, P1599, DOI 10.1046/j.1365-2958.2002.03112.x; Raivio TL, 2005, MOL MICROBIOL, V56, P1119, DOI 10.1111/j.1365-2958.2005.04625.x; Rajamohan G, 2010, J ANTIMICROB CHEMOTH, V65, P1919, DOI 10.1093/jac/dkq195; Shemesh M, 2010, J BACTERIOL, V192, P6352, DOI 10.1128/JB.01025-10; Stock AM, 2000, ANNU REV BIOCHEM, V69, P183, DOI 10.1146/annurev.biochem.69.1.183; Tran EEH, 2009, APPL ENVIRON MICROB, V75, P4007, DOI 10.1128/AEM.02658-08; Tsai YK, 2011, ANTIMICROB AGENTS CH, V55, P1485, DOI 10.1128/AAC.01275-10; Wu KM, 2009, J BACTERIOL, V191, P4492, DOI 10.1128/JB.00315-09	31	55	59	4	16	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 4	2012	7	4							e33777	10.1371/journal.pone.0033777	http://dx.doi.org/10.1371/journal.pone.0033777			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	953GO	22496764	Green Published, Green Submitted, gold			2022-12-25	WOS:000304855200023
J	Fong, B; Jin, R; Wang, XY; Safaee, M; Lisiero, DN; Yang, I; Li, G; Liau, LM; Prins, RM				Fong, Brendan; Jin, Richard; Wang, Xiaoyan; Safaee, Michael; Lisiero, Dominique N.; Yang, Isaac; Li, Gang; Liau, Linda M.; Prins, Robert M.			Monitoring of Regulatory T Cell Frequencies and Expression of CTLA-4 on T Cells, before and after DC Vaccination, Can Predict Survival in GBM Patients	PLOS ONE			English	Article							PULSED DENDRITIC CELLS; GLIOMA PATIENTS; ADJUVANT TEMOZOLOMIDE; RECURRENT GLIOMA; IMMUNE-RESPONSES; CD127 EXPRESSION; MURINE GLIOMA; SIPULEUCEL-T; GLIOBLASTOMA; IMMUNOTHERAPY	Purpose:Dendritic cell (DC) vaccines have recently emerged as an innovative therapeutic option for glioblastoma patients. To identify novel surrogates of anti-tumor immune responsiveness, we studied the dynamic expression of activation and inhibitory markers on peripheral blood lymphocyte (PBL) subsets in glioblastoma patients treated with DC vaccination at UCLA. Experimental Design: Pre-treatment and post-treatment PBL from 24 patients enrolled in two Phase I clinical trials of dendritic cell immunotherapy were stained and analyzed using flow cytometry. A univariate Cox proportional hazards model was utilized to investigate the association between continuous immune monitoring variables and survival. Finally, the immune monitoring variables were dichotomized and a recursive partitioning survival tree was built to obtain cut-off values predictive of survival. Results: The change in regulatory T cell (CD3(+)CD4(+)CD25(+)CD127(low)) frequency in PBL was significantly associated with survival (p = 0.0228; hazard ratio = 3.623) after DC vaccination. Furthermore, the dynamic expression of the negative co-stimulatory molecule, CTLA-4, was also significantly associated with survival on CD3(+)CD4(+) T cells (p =0.0191; hazard ratio = 2.840) and CD3(+)CD8(+) T cells (p = 0.0273; hazard ratio = 2.690), while that of activation markers (CD25, CD69) was not. Finally, a recursive partitioning tree algorithm was utilized to dichotomize the post/pre fold change immune monitoring variables. The resultant cut-off values from these immune monitoring variables could effectively segregate these patients into groups with significantly different overall survival curves. Conclusions: Our results suggest that monitoring the change in regulatory T cell frequencies and dynamic expression of the negative co-stimulatory molecules on peripheral blood T cells, before and after DC vaccination, may predict survival. The cut-off point generated from these data can be utilized in future prospective immunotherapy trials to further evaluate its predictive validity.	[Fong, Brendan; Jin, Richard; Safaee, Michael; Lisiero, Dominique N.; Yang, Isaac; Liau, Linda M.; Prins, Robert M.] Univ Calif Los Angeles, David Geffen Sch Med, Dept Neurosurg, Los Angeles, CA 90095 USA; [Wang, Xiaoyan; Li, Gang] Univ Calif Los Angeles, David Geffen Sch Med, Dept Biostat, Los Angeles, CA 90095 USA; [Yang, Isaac] Univ Calif Los Angeles, David Geffen Sch Med, Jonsson Comprehens Canc Ctr, Los Angeles, CA 90095 USA; [Liau, Linda M.; Prins, Robert M.] Univ Calif Los Angeles, David Geffen Sch Med, Brain Res Inst, Los Angeles, CA 90095 USA; [Prins, Robert M.] Univ Calif Los Angeles, David Geffen Sch Med, Inst Mol Med, Los Angeles, CA 90095 USA	University of California System; University of California Los Angeles; University of California Los Angeles Medical Center; David Geffen School of Medicine at UCLA; University of California System; University of California Los Angeles; University of California Los Angeles Medical Center; David Geffen School of Medicine at UCLA; UCLA Jonsson Comprehensive Cancer Center; University of California System; University of California Los Angeles; University of California Los Angeles Medical Center; David Geffen School of Medicine at UCLA; University of California System; University of California Los Angeles; University of California Los Angeles Medical Center; David Geffen School of Medicine at UCLA; University of California System; University of California Los Angeles; University of California Los Angeles Medical Center; David Geffen School of Medicine at UCLA	Fong, B (corresponding author), Univ Calif Los Angeles, David Geffen Sch Med, Dept Neurosurg, Los Angeles, CA 90095 USA.	rprins@mednet.ucla.edu	Yang, Isaac/AAT-5897-2020; Prins, Robert/AAX-1155-2021	Yang, Isaac/0000-0002-5176-5615; Prins, Robert/0000-0002-6282-6583; Jin, Richard/0000-0002-1316-814X; Liau, Linda/0000-0002-4053-0052	NIH/NCI [K01-CA111402, RO1-CA123396, R01 CA 112358]; Brad Kaminsky Foundation; Cranium Crusaders; Miles for Hope Foundation; Northwest Biotherapeutics, Inc.; Eli & Edyth Broad Center of Regenerative Medicine and Stem Cell Research at UCLA; STOP Cancer Foundation; Ben & Catherine Ivy Foundation; American Brain Tumor Association; NIH [CA16042]; NATIONAL CANCER INSTITUTE [R01CA112358, R01CA123396, K01CA111402, P30CA016042] Funding Source: NIH RePORTER; NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCES [UL1TR000124] Funding Source: NIH RePORTER; NATIONAL CENTER FOR RESEARCH RESOURCES [UL1RR033176] Funding Source: NIH RePORTER	NIH/NCI(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); Brad Kaminsky Foundation; Cranium Crusaders; Miles for Hope Foundation; Northwest Biotherapeutics, Inc.; Eli & Edyth Broad Center of Regenerative Medicine and Stem Cell Research at UCLA; STOP Cancer Foundation; Ben & Catherine Ivy Foundation; American Brain Tumor Association; NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Advancing Translational Sciences (NCATS)); NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR))	This work was supported in part by NIH/NCI grants K01-CA111402 and RO1-CA123396 (to RMP), R01 CA 112358 (to LML), the Brad Kaminsky Foundation, Cranium Crusaders, the Miles for Hope Foundation, Northwest Biotherapeutics, Inc., the Eli & Edyth Broad Center of Regenerative Medicine and Stem Cell Research at UCLA (to RMP and LML), the STOP Cancer Foundation (RMP), the Ben & Catherine Ivy Foundation (to RMP), and the American Brain Tumor Association (to LL and BF). Flow cytometry was performed at the UCLA Jonsson Comprehensive Cancer Center (JCCC) Core Facility, which is supported by the NIH award CA16042. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ardon H, 2010, J IMMUNOL METHODS, V352, P169, DOI 10.1016/j.jim.2009.10.007; Ardon H, 2010, J NEURO-ONCOL, V99, P261, DOI 10.1007/s11060-010-0131-y; Burton E C, 2000, Curr Treat Options Oncol, V1, P459, DOI 10.1007/s11864-000-0073-2; Cheever MA, 2011, CLIN CANCER RES, V17, P3520, DOI 10.1158/1078-0432.CCR-10-3126; Curran MA, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0019499; Curtin JF, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0001983; De Vleeschouwer S, 2008, CLIN CANCER RES, V14, P3098, DOI 10.1158/1078-0432.CCR-07-4875; El Andaloussi A, 2006, NEURO-ONCOLOGY, V8, P234, DOI 10.1215/15228517-2006-006; El Andaloussi A, 2007, J NEURO-ONCOL, V83, P145, DOI 10.1007/s11060-006-9314-y; El Andaloussi A, 2006, J NEUROSURG, V105, P430, DOI 10.3171/jns.2006.105.3.430; Fecci PE, 2007, CLIN CANCER RES, V13, P2158, DOI 10.1158/1078-0432.CCR-06-2070; Fecci PE, 2006, CLIN CANCER RES, V12, P4294, DOI 10.1158/1078-0432.CCR-06-0053; Grauer OM, 2008, INT J CANCER, V122, P1794, DOI 10.1002/ijc.23284; Grauer OM, 2007, INT J CANCER, V121, P95, DOI 10.1002/ijc.22607; Heimberger AB, 2008, NEURO-ONCOLOGY, V10, P98, DOI 10.1215/15228517-2007-046; Hodi FS, 2010, NEW ENGL J MED, V363, P711, DOI 10.1056/NEJMoa1003466; Jackson C, 2011, CLIN DEV IMMUNOL, DOI 10.1155/2011/732413; Kantoff PW, 2010, NEW ENGL J MED, V363, P411, DOI 10.1056/NEJMoa1001294; Kikuchi T, 2004, J IMMUNOTHER, V27, P452, DOI 10.1097/00002371-200411000-00005; Lee AW, 2002, VACCINE, V20, pA8, DOI 10.1016/S0264-410X(02)00382-1; Liau LM, 2005, CLIN CANCER RES, V11, P5515, DOI 10.1158/1078-0432.CCR-05-0464; Liu WH, 2006, J EXP MED, V203, P1701, DOI 10.1084/jem.20060772; Maes W, 2009, NEURO-ONCOLOGY, V11, P529, DOI 10.1215/15228517-2009-004; Mitchell DA, 2011, BLOOD; Nieder C, 2002, J CLIN ONCOL, V20, P3179, DOI 10.1200/JCO.2002.20.14.3179; Okada H, 2011, J CLIN ONCOL, V29, P330, DOI 10.1200/JCO.2010.30.7744; Pedicord VA, 2011, P NATL ACAD SCI USA, V108, P266, DOI 10.1073/pnas.1016791108; Peggs KS, 2009, J EXP MED, V206, P1717, DOI 10.1084/jem.20082492; Prins RM, 2008, NEW ENGL J MED, V359, P539, DOI 10.1056/NEJMc0804818; Prins RM, 2011, CLIN CANCER RES, V17, P1603, DOI 10.1158/1078-0432.CCR-10-2563; Quezada SA, 2008, J EXP MED, V205, P2125, DOI 10.1084/jem.20080099; Quezada SA, 2011, IMMUNOL REV, V241, P104, DOI 10.1111/j.1600-065X.2011.01007.x; Salama AK, 2011, CLIN CANC RES; Stupp R, 2005, NEW ENGL J MED, V352, P987, DOI 10.1056/NEJMoa043330; Stupp R, 2009, LANCET ONCOL, V10, P459, DOI 10.1016/S1470-2045(09)70025-7; Surawicz TS, 1998, J NEURO-ONCOL, V40, P151, DOI 10.1023/A:1006091608586; Traynor K, 2011, AM J HEALTH-SYST PH, V68, P768, DOI 10.2146/news110025; Wainwright DA, 2011, NEUROONCOLOGY; Walker DG, 2008, J CLIN NEUROSCI, V15, P114, DOI 10.1016/j.jocn.2007.08.007; Wheeler CJ, 2008, CANCER RES, V68, P5955, DOI 10.1158/0008-5472.CAN-07-5973; Yamanaka R, 2003, BRIT J CANCER, V89, P1172, DOI 10.1038/sj.bjc.6601268; Yamanaka R, 2005, CLIN CANCER RES, V11, P4160, DOI 10.1158/1078-0432.CCR-05-0120; Yang Meng-Yin, 2006, Expert Rev Neurother, V6, P1481, DOI 10.1586/14737175.6.10.1481; Yu JS, 2001, CANCER RES, V61, P842; Yu JS, 2004, CANCER RES, V64, P4973, DOI 10.1158/0008-5472.CAN-03-3505; Yuan J, 2011, CANC IMMUNOL IMMUNOT	46	71	78	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 2	2012	7	4							e32614	10.1371/journal.pone.0032614	http://dx.doi.org/10.1371/journal.pone.0032614			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	952GU	22485134	gold, Green Published, Green Submitted			2022-12-25	WOS:000304780500010
J	Liang, ZX; Zhan, WQ; Zhu, AZ; Yoon, Y; Lin, SB; Sasaki, M; Klapproth, JMA; Yang, H; Grossniklaus, HE; Xu, JG; Rojas, M; Voll, RJ; Goodman, MM; Arrendale, RF; Liu, J; Yun, CC; Snyder, JP; Liotta, DC; Shim, H				Liang, Zhongxing; Zhan, Weiqiang; Zhu, Aizhi; Yoon, Younghyoun; Lin, Songbai; Sasaki, Maiko; Klapproth, Jan-Michael A.; Yang, Hua; Grossniklaus, Hans E.; Xu, Jianguo; Rojas, Mauricio; Voll, Ronald J.; Goodman, Mark M.; Arrendale, Richard F.; Liu, Jin; Yun, C. Chris; Snyder, James P.; Liotta, Dennis C.; Shim, Hyunsuk			Development of a Unique Small Molecule Modulator of CXCR4	PLOS ONE			English	Article							BREAST-CANCER METASTASIS; CHEMOKINE RECEPTOR; ACCURATE DOCKING; NECK-CANCER; STEM-CELLS; INVOLVEMENT; ANTAGONIST; ACTIVATION; EXPRESSION; AMD3100	Background: Metastasis, the spread and growth of tumor cells to distant organ sites, represents the most devastating attribute and plays a major role in the morbidity and mortality of cancer. Inflammation is crucial for malignant tumor transformation and survival. Thus, blocking inflammation is expected to serve as an effective cancer treatment. Among anti-inflammation therapies, chemokine modulation is now beginning to emerge from the pipeline. CXC chemokine receptor-4 (CXCR4) and its ligand stromal cell-derived factor-1 (CXCL12) interaction and the resulting cell signaling cascade have emerged as highly relevant targets since they play pleiotropic roles in metastatic progression. The unique function of CXCR4 is to promote the homing of tumor cells to their microenvironment at the distant organ sites. Methodology/Principal Findings: We describe the actions of N,N'-(1,4-phenylenebis(methylene))dipyrimidin-2-amine (designated MSX-122), a novel small molecule and partial CXCR4 antagonist with properties quite unlike that of any other reported CXCR4 antagonists, which was prepared in a single chemical step using a reductive amination reaction. Its specificity toward CXCR4 was tested in a binding affinity assay and a ligand competition assay using F-18-labeled MSX-122. The potency of the compound was determined in two functional assays, Matrigel invasion assay and cAMP modulation. The therapeutic potential of MSX-122 was evaluated in three different murine models for inflammation including an experimental colitis, carrageenan induced paw edema, and bleomycin induced lung fibrosis and three different animal models for metastasis including breast cancer micrometastasis in lung, head and neck cancer metastasis in lung, and uveal melanoma micrometastasis in liver in which CXCR4 was reported to play crucial roles. Conclusions/Significance: We developed a novel small molecule, MSX-122, that is a partial CXCR4 antagonist without mobilizing stem cells, which can be safer for long-term blockade of metastasis than other reported CXCR4 antagonists.	[Liang, Zhongxing; Zhu, Aizhi; Yoon, Younghyoun; Voll, Ronald J.; Goodman, Mark M.; Shim, Hyunsuk] Emory Univ, Dept Radiol & Imaging Sci, Atlanta, GA 30322 USA; [Zhan, Weiqiang; Liu, Jin; Snyder, James P.; Liotta, Dennis C.] Emory Univ, Dept Chem, Atlanta, GA 30322 USA; [Lin, Songbai; Sasaki, Maiko; Klapproth, Jan-Michael A.; Xu, Jianguo; Rojas, Mauricio; Yun, C. Chris] Emory Univ, Dept Med, Atlanta, GA 30322 USA; [Yang, Hua; Grossniklaus, Hans E.] Emory Univ, Dept Ophthalmol, Atlanta, GA 30322 USA; [Goodman, Mark M.; Liotta, Dennis C.; Shim, Hyunsuk] Emory Univ, Winship Canc Inst, Atlanta, GA 30322 USA; [Arrendale, Richard F.; Snyder, James P.; Liotta, Dennis C.] Emory Univ, Emory Inst Drug Discovery, Atlanta, GA 30322 USA	Emory University; Emory University; Emory University; Emory University; Emory University; Emory University	Liang, ZX (corresponding author), Emory Univ, Dept Radiol & Imaging Sci, Atlanta, GA 30322 USA.	jsnyder@emory.edu; dliotta@emory.edu; hshim@emory.edu			United States National Institutes of Health; NATIONAL CANCER INSTITUTE [R01CA165306] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK071597] Funding Source: NIH RePORTER	United States National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	All the studies were funded by the United States National Institutes of Health. The NIH had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	AbdelMagid AF, 1996, J ORG CHEM, V61, P3849, DOI 10.1021/jo960057x; Andres PG, 2000, J IMMUNOL, V164, P6303, DOI 10.4049/jimmunol.164.12.6303; Balkwill F, 2004, SEMIN CANCER BIOL, V14, P171, DOI 10.1016/j.semcancer.2003.10.003; Boudeau J, 1999, INFECT IMMUN, V67, P4499, DOI 10.1128/IAI.67.9.4499-4509.1999; Calandra G, 2010, CURR TOP MICROBIOL, V341, P173, DOI 10.1007/82_2010_26; Castaneda FE, 2005, GASTROENTEROLOGY, V129, P1991, DOI 10.1053/j.gastro.2005.09.017; Crump MP, 1997, EMBO J, V16, P6996, DOI 10.1093/emboj/16.23.6996; Davis CB, 1997, J EXP MED, V186, P1793, DOI 10.1084/jem.186.10.1793; De Clercq E, 2003, NAT REV DRUG DISCOV, V2, P581, DOI 10.1038/nrd1134; Dorsam RT, 2007, NAT REV CANCER, V7, P79, DOI 10.1038/nrc2069; Feng Y, 1996, SCIENCE, V272, P872, DOI 10.1126/science.272.5263.872; Fricker SP, 2006, BIOCHEM PHARMACOL, V72, P588, DOI 10.1016/j.bcp.2006.05.010; Friesner RA, 2004, J MED CHEM, V47, P1739, DOI 10.1021/jm0306430; Furusato B, 2010, PATHOL INT, V60, P497, DOI 10.1111/j.1440-1827.2010.02548.x; Gao C, 2007, TRANSPL P, V39, P268, DOI 10.1016/j.transproceed.2006.10.020; Graves AP, 2008, J MOL BIOL, V377, P914, DOI 10.1016/j.jmb.2008.01.049; Guimaraes CRW, 2008, J CHEM INF MODEL, V48, P958, DOI 10.1021/ci800004w; Gupta SK, 2001, IMMUNOL LETT, V78, P29, DOI 10.1016/S0165-2478(01)00228-0; Halgren TA, 2004, J MED CHEM, V47, P1750, DOI 10.1021/jm030644s; Imitola J, 2004, P NATL ACAD SCI USA, V101, P18117, DOI 10.1073/pnas.0408258102; Kajiyama H, 2007, CELL TISSUE RES, V330, P221, DOI 10.1007/s00441-007-0455-x; Kalatskaya I, 2009, MOL PHARMACOL, V75, P1240, DOI 10.1124/mol.108.053389; Kang YB, 2003, CANCER CELL, V3, P537, DOI 10.1016/S1535-6108(03)00132-6; Kilkenny C, 2010, PLOS BIOL, V8, DOI 10.1371/journal.pbio.1000412; Kofuku Y, 2009, J BIOL CHEM, V284, P35240, DOI 10.1074/jbc.M109.024851; Kucia M, 2005, STEM CELLS, V23, P879, DOI 10.1634/stemcells.2004-0342; Lazennec G, 2010, TRENDS MOL MED, V16, P133, DOI 10.1016/j.molmed.2010.01.003; Liang Z, 2007, BIOCHEM BIOPH RES CO, V359, P716, DOI 10.1016/j.bbrc.2007.05.182; Liang ZX, 2004, CANCER RES, V64, P4302, DOI 10.1158/0008-5472.CAN-03-3958; Lin SB, 2010, GASTROENTEROLOGY, V138, P649, DOI 10.1053/j.gastro.2009.09.055; Liotta LA, 2001, NATURE, V411, P375, DOI 10.1038/35077241; Mikami S, 2008, J PHARMACOL EXP THER, V327, P383, DOI 10.1124/jpet.108.141085; Moyer RA, 2007, LAB INVEST, V87, P807, DOI 10.1038/labinvest.3700595; Muller A, 2001, NATURE, V410, P50, DOI 10.1038/35065016; Porta C, 2010, CANC LETT; Sanchez X, 1997, J BIOL CHEM, V272, P27529, DOI 10.1074/jbc.272.44.27529; Sasaki T, 2007, BIOL PHARM BULL, V30, P1599, DOI 10.1248/bpb.30.1599; Schiffer D, 2010, ANTICANCER RES, V30, P1977; Sherman W, 2006, J MED CHEM, V49, P534, DOI 10.1021/jm050540c; Shim H, 2009, SEMIN CANCER BIOL, V19, P123, DOI 10.1016/j.semcancer.2008.11.004; Strieter RM, 2009, J LEUKOCYTE BIOL, V86, P1111, DOI 10.1189/jlb.0309132; Thelen M, 2008, J NEUROIMMUNOL, V198, P9, DOI 10.1016/j.jneuroim.2008.04.020; Wang J, 2005, ONCOGENE, V24, P5897, DOI 10.1038/sj.onc.1208740; Wang JH, 2008, J BIOL CHEM, V283, P4283, DOI 10.1074/jbc.M707465200; Weinberg RA, 2007, BIOL CANC; Wu BL, 2010, SCIENCE, V330, P1066, DOI 10.1126/science.1194396; Xia XM, 2010, WORLD J GASTROENTERO, V16, P2873, DOI 10.3748/wjg.v16.i23.2873; Xui J, 2007, AM J RESP CELL MOL B; Yang H, 2008, MELANOMA RES, V18, P95, DOI 10.1097/CMR.0b013e3282f628df; Yang H, 2006, CURR EYE RES, V31, P557, DOI 10.1080/02713680600718962; Yoon Y, 2007, CANCER RES, V67, P7518, DOI 10.1158/0008-5472.CAN-06-2263; Zaitseva M, 1997, NAT MED, V3, P1369, DOI 10.1038/nm1297-1369; Zhan WQ, 2007, J MED CHEM, V50, P5655, DOI 10.1021/jm070679i; Zhu AZ, 2010, J MED CHEM, V53, P8556, DOI 10.1021/jm100786g; Zlotnik A, 2006, CONTRIB MICROBIOL, V13, P191, DOI 10.1159/000092973	55	96	106	1	29	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 2	2012	7	4							e34038	10.1371/journal.pone.0034038	http://dx.doi.org/10.1371/journal.pone.0034038			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	952GU	22485156	Green Submitted, Green Published, gold			2022-12-25	WOS:000304780500032
J	Naydenov, NG; Brown, B; Harris, G; Dohn, MR; Morales, VM; Baranwal, S; Reynolds, AB; Ivanov, AI				Naydenov, Nayden G.; Brown, Bryan; Harris, Gianni; Dohn, Michael R.; Morales, Victor M.; Baranwal, Somesh; Reynolds, Albert B.; Ivanov, Andrei I.			A Membrane Fusion Protein alpha SNAP Is a Novel Regulator of Epithelial Apical Junctions	PLOS ONE			English	Article							NUCLEOTIDE-EXCHANGE PROTEIN; CELL-CELL CONTACTS; E-CADHERIN; ENDOPLASMIC-RETICULUM; PLASMA-MEMBRANE; TIGHT JUNCTIONS; BARRIER FUNCTION; SECRETORY PATHWAY; ARF FAMILY; MDCK CELLS	Tight junctions (TJs) and adherens junctions (AJs) are key determinants of the structure and permeability of epithelial barriers. Although exocytic delivery to the cell surface is crucial for junctional assembly, little is known about the mechanisms controlling TJ and AJ exocytosis. This study was aimed at investigating whether a key mediator of exocytosis soluble N-ethylmaleimide sensitive factor (NSF) attachment protein alpha (alpha SNAP), regulates epithelial junctions. alpha SNAP was enriched at apical junctions in SK-CO15 and T84 colonic epithelial cells and in normal human intestinal mucosa. siRNA-mediated knockdown of alpha SNAP inhibited AJ/TJ assembly and establishment of the paracellular barrier in SK-CO15 cells which was accompanied by a significant down-regulation of p120-catenin and E-cadherin expression. A selective depletion of p120 catenin effectively disrupted AJ and TJ structure and compromised the epithelial barrier. However, overexpression of p120 catenin did not rescue the defects of junctional structure and permeability caused by alpha SNAP knockdown thereby suggesting the involvement of additional mechanisms. Such mechanisms did not depend on NSF functions or induction of cell death, but were associated with disruption of the Golgi complex and down regulation of a Golgi-associated guanidine nucleotide exchange factor, GBF1. These findings suggest novel roles for alpha SNAP in promoting the formation of epithelial AJs and TJs by controlling Golgi-dependent expression and trafficking of junctional proteins.	[Naydenov, Nayden G.; Brown, Bryan; Harris, Gianni; Morales, Victor M.; Baranwal, Somesh; Ivanov, Andrei I.] Univ Rochester, Dept Med, Rochester, NY 14627 USA; [Dohn, Michael R.; Reynolds, Albert B.] Vanderbilt Univ, Dept Canc Biol, Nashville, TN USA	University of Rochester; Vanderbilt University	Naydenov, NG (corresponding author), Univ Rochester, Dept Med, Rochester, NY 14627 USA.	Andrei_Ivanov@urmc.rochester.edu	Ivanov, Andrei/V-1672-2019; Baranwal, Somesh/F-4824-2012		National Institute of Health [RO1 DK083968, R01 DK084953, R01 CA111947, RO1 CA055724, P50 CA95103]; NATIONAL CANCER INSTITUTE [P50CA095103, R01CA055724, R01CA111947] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK084953, R01DK083968] Funding Source: NIH RePORTER	National Institute of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	This work was supported by National Institute of Health grants RO1 DK083968, R01 DK084953 to All and R01 CA111947, RO1 CA055724, P50 CA95103 to ABR. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Anderson JM, 2009, CSH PERSPECT BIOL, V1, DOI 10.1101/cshperspect.a002584; Andreeva AV, 2006, EXPERT OPIN THER TAR, V10, P723, DOI 10.1517/14728222.10.5.723; Andreeva AV, 2005, J BIOL CHEM, V280, P30376, DOI 10.1074/jbc.M502844200; Aoki T, 2008, BIOCHEM J, V410, P93, DOI 10.1042/BJ20071304; Barnard RJO, 1997, J CELL BIOL, V139, P875, DOI 10.1083/jcb.139.4.875; Bonifacino JS, 2004, CELL, V116, P153, DOI 10.1016/S0092-8674(03)01079-1; Bryant DM, 2004, TRENDS CELL BIOL, V14, P427, DOI 10.1016/j.tcb.2004.07.007; Burgoyne RD, 1998, BIOESSAYS, V20, P328, DOI 10.1002/(SICI)1521-1878(199804)20:4<328::AID-BIES9>3.0.CO;2-L; BURGOYNE RD, 1993, BIOCHEM J, V293, P305, DOI 10.1042/bj2930305; Capaldo CT, 2007, MOL BIOL CELL, V18, P189, DOI 10.1091/mbc.E06-05-0471; Chae TH, 2004, NAT GENET, V36, P264, DOI 10.1038/ng1302; Citterio C, 2008, P NATL ACAD SCI USA, V105, P2877, DOI 10.1073/pnas.0712224105; Dancourt J, 2010, ANNU REV BIOCHEM, V79, P777, DOI 10.1146/annurev-biochem-061608-091319; Davis MA, 2006, DEV CELL, V10, P21, DOI 10.1016/j.devcel.2005.12.004; Davis MA, 2003, J CELL BIOL, V163, P525, DOI 10.1083/jcb.200307111; Delva E, 2009, TRAFFIC, V10, P259, DOI 10.1111/j.1600-0854.2008.00862.x; Diaz F, 2009, P NATL ACAD SCI USA, V106, P11143, DOI 10.1073/pnas.0811227106; Donaldson JG, 2005, BIOCHEM SOC T, V33, P639, DOI 10.1042/BST0330639; Ducharme NA, 2006, MOL BIOL CELL, V17, P3625, DOI 10.1091/mbc.E05-08-0736; Giepmans BNG, 2009, BBA-BIOMEMBRANES, V1788, P820, DOI 10.1016/j.bbamem.2008.07.015; Gillingham AK, 2007, ANNU REV CELL DEV BI, V23, P579, DOI 10.1146/annurev.cellbio.23.090506.123209; Gonzalez-Mariscal L, 2008, BBA-BIOMEMBRANES, V1778, P729, DOI 10.1016/j.bbamem.2007.08.018; Green KJ, 2010, CSH PERSPECT BIOL, V2, DOI 10.1101/cshperspect.a000125; Hartsock A, 2008, BBA-BIOMEMBRANES, V1778, P660, DOI 10.1016/j.bbamem.2007.07.012; Hong WJ, 2005, BBA-MOL CELL RES, V1744, P120, DOI 10.1016/j.bbamcr.2005.03.014; Hu W, 2005, MOL BIOL CELL, V16, P1555, DOI 10.1091/mbc.E04-07-0594; Ireton RC, 2002, J CELL BIOL, V159, P465, DOI 10.1083/jcb.200205115; Ivanov AI, 2005, BIOESSAYS, V27, P356, DOI 10.1002/bies.20203; Ivanov AI, 2004, MOL BIOL CELL, V15, P176, DOI 10.1091/mbc.E03-05-0319; Ivanov AI, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0000658; Ivanov AI, 2010, AM J PATHOL, V177, P512, DOI 10.2353/ajpath.2010.100168; Ivanov AI, 2010, AM J PATHOL, V176, P134, DOI 10.2353/ajpath.2010.090220; Jackson C L, 2000, Subcell Biochem, V34, P233; Jahn R, 2006, NAT REV MOL CELL BIO, V7, P631, DOI 10.1038/nrm2002; Kawamoto K, 2002, TRAFFIC, V3, P483, DOI 10.1034/j.1600-0854.2002.30705.x; LATTERICH M, 1995, CELL, V82, P885, DOI 10.1016/0092-8674(95)90268-6; Laukoetter MG, 2007, J EXP MED, V204, P3067, DOI 10.1084/jem.20071416; Le TL, 1999, J CELL BIOL, V146, P219, DOI 10.1083/jcb.146.1.219; LEBIVIC A, 1989, P NATL ACAD SCI USA, V86, P9313; Lin Y, 2005, J BIOL CHEM, V280, P12799, DOI 10.1074/jbc.M413968200; Lipschutz JH, 2003, J BIOL CHEM, V278, P20954, DOI 10.1074/jbc.M213210200; Lock JG, 2005, TRAFFIC, V6, P1142, DOI 10.1111/j.1600-0854.2005.00349.x; LOUVARD D, 1980, P NATL ACAD SCI-BIOL, V77, P4132, DOI 10.1073/pnas.77.7.4132; Low SH, 1998, J CELL BIOL, V141, P1503, DOI 10.1083/jcb.141.7.1503; Malsam J, 2008, CELL MOL LIFE SCI, V65, P2814, DOI 10.1007/s00018-008-8352-3; Marsden M, 2003, CURR BIOL, V13, P1182, DOI 10.1016/S0960-9822(03)00433-0; Martin HGS, 2006, J CELL BIOCHEM, V99, P1203, DOI 10.1002/jcb.20998; Martinez-Rico C, 2010, J CELL SCI, V123, P712, DOI 10.1242/jcs.047878; McCarter SD, 2010, TRAFFIC, V11, P856, DOI 10.1111/j.1600-0854.2010.01052.x; McNeil E, 2006, MOL BIOL CELL, V17, P1922, DOI 10.1091/mbc.E05-07-0650; Morimoto S, 2005, J BIOL CHEM, V280, P2220, DOI 10.1074/jbc.M406906200; Morinaga N, 1996, P NATL ACAD SCI USA, V93, P12856, DOI 10.1073/pnas.93.23.12856; Nakajima K, 2004, EMBO J, V23, P3216, DOI 10.1038/sj.emboj.7600333; Naydenov NG, 2010, MOL BIOL CELL, V21, P3506, DOI 10.1091/mbc.E10-03-0259; Nejsum LN, 2007, J CELL BIOL, V178, P323, DOI 10.1083/jcb.200705094; Niessen CM, 2008, BBA-BIOMEMBRANES, V1778, P562, DOI 10.1016/j.bbamem.2007.12.015; Niu TK, 2005, MOL BIOL CELL, V16, P1213, DOI 10.1091/mbc.E04-07-0599; Paris L, 2008, BBA-BIOMEMBRANES, V1778, P646, DOI 10.1016/j.bbamem.2007.08.004; Perez-Moreno M, 2006, CELL, V124, P631, DOI 10.1016/j.cell.2005.11.043; Peter F, 1998, J CELL SCI, V111, P2625; Pochec E, 2006, EUR J CELL BIOL, V85, P47, DOI 10.1016/j.ejcb.2005.08.010; Pokutta S, 2007, ANNU REV CELL DEV BI, V23, P237, DOI 10.1146/annurev.cellbio.22.010305.104241; Polishchuk R, 2004, NAT CELL BIOL, V6, P297, DOI 10.1038/ncb1109; Pulvirenti T, 2008, NAT CELL BIOL, V10, P912, DOI 10.1038/ncb1751; Rabouille C, 1998, CELL, V92, P603, DOI 10.1016/S0092-8674(00)81128-9; REYNOLDS AB, 1994, MOL CELL BIOL, V14, P8333, DOI 10.1128/MCB.14.12.8333; Reynolds AB, 2007, BBA-MOL CELL RES, V1773, P2, DOI 10.1016/j.bbamcr.2006.09.019; RIPLEY CR, 1993, J BIOL CHEM, V268, P3677; Rodriguez-Boulan E, 2005, NAT REV MOL CELL BIO, V6, P233, DOI 10.1038/nrm1593; Saenz JB, 2009, NAT CHEM BIOL, V5, P157, DOI 10.1038/nchembio.144; Sharma N, 2006, J CELL BIOL, V173, P937, DOI 10.1083/jcb.200603132; Sheen VL, 2004, NAT GENET, V36, P69, DOI 10.1038/ng1276; Shen L, 2006, AM J PHYSIOL-GASTR L, V290, pG577, DOI 10.1152/ajpgi.00439.2005; Smalley-Freed WG, 2010, J CLIN INVEST, V120, P1824, DOI 10.1172/JCI41414; Spang A, 2009, CURR OPIN CELL BIOL, V21, P531, DOI 10.1016/j.ceb.2009.03.003; Taulet N, 2009, J BIOL CHEM, V284, P23137, DOI 10.1074/jbc.M109.017665; Troyanovsky RB, 2006, MOL BIOL CELL, V17, P3484, DOI 10.1091/mbc.E06-03-0190; Tsukita S, 2001, NAT REV MOL CELL BIO, V2, P285, DOI 10.1038/35067088; Turner JR, 2009, NAT REV IMMUNOL, V9, P799, DOI 10.1038/nri2653; Ungar D, 2003, ANNU REV CELL DEV BI, V19, P493, DOI 10.1146/annurev.cellbio.19.110701.155609; Verrier SE, 2008, EUR J CELL BIOL, V87, P863, DOI 10.1016/j.ejcb.2008.07.003; Wang YZ, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0001647; Whiteheart SW, 2001, INT REV CYTOL, V207, P71; Winter U, 2009, J BIOL CHEM, V284, P31817, DOI 10.1074/jbc.M109.045286; Wirtz-Peitz F, 2009, CURR OPIN GENET DEV, V19, P350, DOI 10.1016/j.gde.2009.04.011; Wu J, 1998, HYBRIDOMA, V17, P175, DOI 10.1089/hyb.1998.17.175; Yamamoto Y, 2003, BIOCHEM BIOPH RES CO, V308, P270, DOI 10.1016/S0006-291X(03)01358-5; Yan HHN, 2008, CURR TOP DEV BIOL, V80, P57, DOI 10.1016/S0070-2153(07)80002-0; Yano T, 2011, J CELL BIOL, V193, P319, DOI 10.1083/jcb.201009100; Yap AS, 2007, CURR OPIN CELL BIOL, V19, P508, DOI 10.1016/j.ceb.2007.09.008; Zerial M, 2001, NAT REV MOL CELL BIO, V2, P107, DOI 10.1038/35052055	91	28	29	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 2	2012	7	4							e34320	10.1371/journal.pone.0034320	http://dx.doi.org/10.1371/journal.pone.0034320			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	952GU	22485163	gold, Green Published, Green Submitted			2022-12-25	WOS:000304780500038
J	Opitz, SEW; Boeve, JL; Nagy, ZT; Sonet, G; Koch, F; Muller, C				Opitz, Sebastian E. W.; Boeve, Jean-Luc; Nagy, Zoltan Tamas; Sonet, Gontran; Koch, Frank; Mueller, Caroline			Host Shifts from Lamiales to Brassicaceae in the Sawfly Genus Athalia	PLOS ONE			English	Article							INSECT PLANT INTERACTIONS; MOLECULAR PHYLOGENY; CHEMICAL DEFENSE; ROSAE-RUFICORNIS; HYMENOPTERA; EVOLUTION; SEQUESTRATION; SPECIALIZATION; CLERODENDRINS; LEPIDOPTERA	Plant chemistry can be a key driver of host shifts in herbivores. Several species in the salwfly genus Athalia are important economic Pests on Brassicaceae, whereas other Athalia species are specialized on Lamiales. These host. plants have glucosides in common which are sequestered by larvae. To disentangle the possible direction of host shifts in this genus, we examined the sequestration specificity and feeding deterrence of iridoid glucosides (IGs) and glucosinolates (GSs) in larvae of five species which either naturally sequester IGs from their hosts within the Plantaginaceae (Lamiales) or GSs from Brassicaceae, respectively. Furthermore, adults were tested for feeding stimulation by a neo-clerodane diterpenoid which occurs in Lamiales. Larvae of the Plantaginaceae-feeders did not sequester artificially administered p-hydroxybenzylGS and were more deterred by GSs than Brassicaceae-feeders were by IGs. In contrast, larvae of Brassicaceae-feeders were able to sequester artificially administered catalpol (IG), which points to an ancestral association with Lamiales. In line with this finding, adults of all tested species were stimulated by the neo-clerodarie diterpenoid. Finally, in a phylogenetic tree inferred from genetic marker sequences of 21 Athalia Species, the sister species of all remaining 20 Athalia species also turned out to be a Lamiales-feeder. Fundamental physiological pre-adaptations, such as the establishment of a glucoside transporter, and mechanisms to circumvent activation of glucosides by glucosidases are therefore necessary prerequisites for successful host shifts between Lamiales and Brassicaceae.	[Opitz, Sebastian E. W.; Mueller, Caroline] Univ Bielefeld, Dept Chem Ecol, D-33615 Bielefeld, Germany; [Boeve, Jean-Luc; Nagy, Zoltan Tamas; Sonet, Gontran] Royal Belgian Inst Nat Sci, IRSNB KBIN, Brussels, Belgium; [Koch, Frank] Humboldt Univ, Museum Nat Kunde, Leibniz Inst Evolut & Biodiversitatsforsch, D-10099 Berlin, Germany	University of Bielefeld; Royal Belgian Institute of Natural Sciences; Humboldt University of Berlin; Leibniz Institut fur Evolutions und Biodiversitatsforschung	Opitz, SEW (corresponding author), Univ Bielefeld, Dept Chem Ecol, D-33615 Bielefeld, Germany.	caroline.mueller@uni-bielefeld.de	Nagy, Zoltan T./C-6737-2011; Muller, Caroline/G-5073-2011; Opitz, Sebastian Ed Wieland/AAG-2898-2022; Opitz, Sebastian Ed Wieland/AFK-4118-2022	Nagy, Zoltan T./0000-0002-8455-040X; Muller, Caroline/0000-0002-8447-534X; 	Deutsche Forschungsgemeinschaft [MU1829/1-1]; Joint Experimental Molecular Unit, Belgian Science Policy Office; Belgian Directorate-General for Development Cooperation	Deutsche Forschungsgemeinschaft(German Research Foundation (DFG)); Joint Experimental Molecular Unit, Belgian Science Policy Office; Belgian Directorate-General for Development Cooperation	This work was funded mainly by the grant MU1829/1-1 of the Deutsche Forschungsgemeinschaft. The phylogenetic analyses were supported by the Joint Experimental Molecular Unit that is supported by the Belgian Science Policy Office. Athalia specimens from Ethiopia were collected in the frame of a Global Taxonomy Initiative project in collaboration with S. Mengistou (2437FRK2_T1_GTI-01_Boeve&Pauly_2010) and supported financially by the Belgian Directorate-General for Development Cooperation. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ABE M, 1988, Esakia, P91; Amano T, 1999, CHEMOECOLOGY, V9, P145, DOI 10.1007/s000490050046; Benson RB, 1962, B BRIT MUS NAT HIST, V11, P334; Berenbaum MR, 2001, ANN MO BOT GARD, V88, P45, DOI 10.2307/2666131; BERNAYS E, 1988, ECOLOGY, V69, P886, DOI 10.2307/1941237; Bernays E. A., 1994, Host-plant selection by phytophagous insects.; Byng JW, 2016, BOT J LINN SOC, V181, P1, DOI 10.1111/boj.12385; CHEVIN H, 1969, ANN SOC ENTOMOL FR, V5, P825; Dobler S, 2001, BASIC APPL ECOL, V2, P15, DOI 10.1078/1439-1791-00032; Dobler S, 1996, EVOLUTION, V50, P2373, DOI [10.2307/2410706, 10.1111/j.1558-5646.1996.tb03625.x]; Dobler S, 2011, PHYTOCHEMISTRY, V72, P1593, DOI 10.1016/j.phytochem.2011.04.015; Drummond A. J., 2009, TRACER MCMC TRACE AN; EHRLICH PR, 1964, EVOLUTION, V18, P586, DOI 10.2307/2406212; FARRELL B, 1990, EVOLUTION, V44, P1389, DOI 10.1111/j.1558-5646.1990.tb03834.x; Folmer O., 1994, Molecular Marine Biology and Biotechnology, V3, P294; Fordyce JA, 2010, P ROY SOC B-BIOL SCI, V277, P3735, DOI 10.1098/rspb.2010.0211; Futuyma DJ, 1996, PHILOS T R SOC B, V351, P1361, DOI 10.1098/rstb.1996.0119; FUTUYMA DJ, 1990, EVOLUTION, V44, P1885, DOI 10.1111/j.1558-5646.1990.tb04298.x; FUTUYMA DJ, 1992, HERBIVORES THEIR INT, P439; Futuyma DJ, 2009, P NATL ACAD SCI USA, V106, P18054, DOI 10.1073/pnas.0904106106; HANAZAWA M, 1995, DISCRETE APPL MATH, V56, P245, DOI 10.1016/0166-218X(94)00089-V; Huelsenbeck JP, 2001, BIOINFORMATICS, V17, P754, DOI 10.1093/bioinformatics/17.8.754; JAENIKE J, 1990, ANNU REV ECOL SYST, V21, P243, DOI 10.1146/annurev.ecolsys.21.1.243; Jahner JP, 2011, EVOLUTION, V65, P2719, DOI 10.1111/j.1558-5646.2011.01310.x; Janz N, 2001, EVOLUTION, V55, P783, DOI 10.1554/0014-3820(2001)055[0783:EDOHPS]2.0.CO;2; Janz N, 1998, EVOLUTION, V52, P486, DOI [10.2307/2411084, 10.1111/j.1558-5646.1998.tb01648.x]; Janz N, 2008, SPECIALIZATION, SPECIATION, AND RADIATION: THE EVOLUTIONARY BIOLOGY OF HERBIVOROUS INSECTS, P203; Katoh K, 2002, NUCLEIC ACIDS RES, V30, P3059, DOI 10.1093/nar/gkf436; Katoh K, 2008, BMC BIOINFORMATICS, V9, DOI 10.1186/1471-2105-9-212; Kim H, 2011, PLOS ONE, V6, DOI [10.1371/journal.pone.0024749, 10.1371/journal.pone.0019867]; Koch Frank, 2006, P297; Koch Frank, 2007, Mitteilungen Muenchener Entomologischen Gesellschaft, V97, P81; Lacourt Jean, 1999, Memoires de la SEF, V3, P1; Lauber K., 2007, FLORA HELVETICA; Malakov PY, 1998, PHYTOCHEMISTRY, V49, P811, DOI 10.1016/S0031-9422(97)01027-3; Menken SBJ, 1998, ENDLESS FORMS, P145; MERRITT AT, 1992, NAT PROD REP, V9, P243, DOI 10.1039/np9920900243; MITTER C, 1991, TRENDS ECOL EVOL, V6, P290, DOI 10.1016/0169-5347(91)90007-K; Morant AV, 2008, PHYTOCHEMISTRY, V69, P1795, DOI 10.1016/j.phytochem.2008.03.006; Muller C, 2009, PHYTOCHEM REV, V8, P121, DOI 10.1007/s11101-008-9115-3; Muller C, 2001, J CHEM ECOL, V27, P2505, DOI 10.1023/A:1013631616141; Murphy SM, 2004, P NATL ACAD SCI USA, V101, P18048, DOI 10.1073/pnas.0406490102; Narushima H, 1997, DISCRETE APPL MATH, V80, P231, DOI 10.1016/S0166-218X(97)00088-7; Nishida R, 2004, BIOCHEM SYST ECOL, V32, P15, DOI 10.1016/S0305-1978(03)00160-1; NISHIDA R, 1990, J CHEM ECOL, V16, P151, DOI 10.1007/BF01021276; NISHIDA R, 1989, AGR BIOL CHEM TOKYO, V53, P1641, DOI 10.1080/00021369.1989.10869500; Normark BB, 1999, P ROY SOC B-BIOL SCI, V266, P2253, DOI 10.1098/rspb.1999.0916; Nylin S, 2009, EVOL ECOL, V23, P137, DOI 10.1007/s10682-007-9205-5; Nyman T, 2006, SYST ENTOMOL, V31, P569, DOI 10.1111/j.1365-3113.2006.00336.x; Nyman T, 2010, BMC EVOL BIOL, V10, DOI 10.1186/1471-2148-10-266; Opitz SEW, 2011, CHEMBIOCHEM, V12, P1252, DOI 10.1002/cbic.201100053; Opitz SEW, 2010, J CHEM ECOL, V36, P148, DOI 10.1007/s10886-010-9740-3; Opitz SEW, 2009, CHEMOECOLOGY, V19, P117, DOI 10.1007/s00049-009-0018-6; Opitz SEW, 2011, THESIS BIELEFELD U G; Paradis E, 2004, BIOINFORMATICS, V20, P289, DOI 10.1093/bioinformatics/btg412; Posada D, 2008, MOL BIOL EVOL, V25, P1253, DOI 10.1093/molbev/msn083; Schmidt S, 2006, ORG DIVERS EVOL, V6, P127, DOI 10.1016/j.ode.2005.07.002; SCHULTZ JC, 1988, ECOLOGY, V69, P896, DOI 10.2307/1941239; Speyer W., 1954, HDB PFLANZENKRANKHEI, P270; Swofford DL, 2001, PAUP PHYLOGENETIC AN; Taeger A., 1998, PFLANZENWESPEN DEUTS, P49; Taeger A, 2010, ZOOTAXA, P1, DOI 10.11646/zootaxa.2580.1.1; Termonia A, 2002, P ROY SOC B-BIOL SCI, V269, P1, DOI 10.1098/rspb.2001.1859; Termonia A, 2001, P NATL ACAD SCI USA, V98, P3909, DOI 10.1073/pnas.061034598; Turner H, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0009933; Winkler IS, 2008, SPECIALIZATION, SPECIATION, AND RADIATION: THE EVOLUTIONARY BIOLOGY OF HERBIVOROUS INSECTS, P240; Winkler IS, 2009, P NATL ACAD SCI USA, V106, P18103, DOI 10.1073/pnas.0904852106	67	18	18	0	27	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 2	2012	7	4							e33649	10.1371/journal.pone.0033649	http://dx.doi.org/10.1371/journal.pone.0033649			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	952GU	22485146	Green Published, gold			2022-12-25	WOS:000304780500022
J	Halpern, KB; Veprik, A; Rubins, N; Naaman, O; Walker, MD				Halpern, Keren Bahar; Veprik, Anna; Rubins, Nir; Naaman, Orly; Walker, Michael D.			GPR41 Gene Expression Is Mediated by Internal Ribosome Entry Site (IRES)-dependent Translation of Bicistronic mRNA Encoding GPR40 and GPR41 Proteins	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							CHAIN FATTY-ACIDS; PANCREATIC BETA-CELLS; COUPLED RECEPTOR; INSULIN-SECRETION; ENTEROENDOCRINE CELLS; TRANSCRIPTION; STIMULATION; INITIATION; INTESTINE; REGION	GPR41 is a G protein-coupled receptor activated by short chain fatty acids. The gene encoding GPR41 is located immediately downstream of a related gene encoding GPR40, a receptor for long chain fatty acids. Expression of GPR41 has been reported in a small number of cell types, including gut enteroendocrine cells and sympathetic ganglia, where it may play a role in the maintenance of metabolic homeostasis. We now demonstrate that GPR41, like GPR40, is expressed in pancreatic beta cells. Surprisingly, we found no evidence for transcriptional control elements or transcriptional initiation in the intergenic GPR40-GPR41 region. Rather, using 5'-rapid amplification of cDNA ends analysis, we demonstrated that GPR41 is transcribed from the promoter of the GPR40 gene. We confirmed this finding by generating bicistronic luciferase reporter plasmids, and we were able to map a potential internal ribosome entry site-containing region to a 2474-nucleotide region of the intergenic sequence. Consistent with this, we observed m(7)G cap-independent reporter gene expression upon transfection of RNA containing this region. Thus, GPR41 expression is mediated via an internal ribosome entry site located in the intergenic region of a bicistronic mRNA. This novel sequence organization may be utilized to permit coordinated regulation of the fatty acid receptors GPR40 and GPR41.	[Halpern, Keren Bahar; Veprik, Anna; Rubins, Nir; Naaman, Orly; Walker, Michael D.] Weizmann Inst Sci, Dept Biol Chem, IL-76100 Rehovot, Israel	Weizmann Institute of Science	Walker, MD (corresponding author), Weizmann Inst Sci, Dept Biol Chem, IL-76100 Rehovot, Israel.	m.walker@weizmann.ac.il		Veprik, Anna/0000-0002-3904-7151	Israel Science Foundation; Benjamin and Seema Pulier Charitable Foundation; Florence Blau, Morris Blau, and Rose Patterson Fund	Israel Science Foundation(Israel Science Foundation); Benjamin and Seema Pulier Charitable Foundation; Florence Blau, Morris Blau, and Rose Patterson Fund	This work was supported in part by grants from the Israel Science Foundation, the Benjamin and Seema Pulier Charitable Foundation, and the Florence Blau, Morris Blau, and Rose Patterson Fund.	Bartoov-Shifman R, 2007, J BIOL CHEM, V282, P23561, DOI 10.1074/jbc.M702115200; BERGMAN EN, 1990, PHYSIOL REV, V70, P567, DOI 10.1152/physrev.1990.70.2.567; Briscoe CP, 2003, J BIOL CHEM, V278, P11303, DOI 10.1074/jbc.M211495200; Brown AJ, 2003, J BIOL CHEM, V278, P11312, DOI 10.1074/jbc.M211609200; Chakrabarti SK, 2003, TRENDS ENDOCRIN MET, V14, P78, DOI 10.1016/S1043-2760(02)00039-5; CUMMINGS JH, 1987, GUT, V28, P1221, DOI 10.1136/gut.28.10.1221; Edfalk S, 2008, DIABETES, V57, P2280, DOI 10.2337/db08-0307; Elroy-Stein O., 2007, TRANSLATIONAL CONTRO, P155; GERMAN M, 1995, DIABETES, V44, P1002, DOI 10.2337/diab.44.8.1002; Gray TA, 1999, P NATL ACAD SCI USA, V96, P5616, DOI 10.1073/pnas.96.10.5616; Halban PA, 2001, DIABETES, V50, P2181, DOI 10.2337/diabetes.50.10.2181; Hellen CUT, 2001, GENE DEV, V15, P1593, DOI 10.1101/gad.891101; Henis-Korenblit S, 2002, P NATL ACAD SCI USA, V99, P5400, DOI 10.1073/pnas.082102499; Henquin JC, 2003, EUR J CLIN INVEST, V33, P742, DOI 10.1046/j.1365-2362.2003.01207.x; Hui DW, 2009, J BIOL CHEM, V284, P2245, DOI 10.1074/jbc.M807063200; Itoh Y, 2003, NATURE, V422, P173, DOI 10.1038/nature01478; JACOB F, 1961, J MOL BIOL, V3, P318, DOI 10.1016/S0022-2836(61)80072-7; JANG SK, 1988, J VIROL, V62, P2636, DOI 10.1128/JVI.62.8.2636-2643.1988; Karaki S, 2006, CELL TISSUE RES, V324, P353, DOI 10.1007/s00441-005-0140-x; Kimura I, 2011, P NATL ACAD SCI USA, V108, P8030, DOI 10.1073/pnas.1016088108; Kimura M, 2001, J BIOL CHEM, V276, P26453, DOI 10.1074/jbc.M101289200; Kozak M, 1999, GENE, V234, P187, DOI 10.1016/S0378-1119(99)00210-3; KOZAK M, 1989, J CELL BIOL, V108, P229, DOI 10.1083/jcb.108.2.229; Latour MG, 2007, DIABETES, V56, P1087, DOI 10.2337/db06-1532; Li DS, 2009, NAT PROTOC, V4, P1649, DOI 10.1038/nprot.2009.150; Livak KJ, 2001, METHODS, V25, P402, DOI 10.1006/meth.2001.1262; Ohneda K, 2000, SEMIN CELL DEV BIOL, V11, P227, DOI 10.1006/scdb.2000.0171; PELLETIER J, 1988, NATURE, V334, P320, DOI 10.1038/334320a0; Plank TDM, 2012, WIRES RNA, V3, P195, DOI 10.1002/wrna.1105; Samuel BS, 2008, P NATL ACAD SCI USA, V105, P16767, DOI 10.1073/pnas.0808567105; Sawzdargo M, 1997, BIOCHEM BIOPH RES CO, V239, P543, DOI 10.1006/bbrc.1997.7513; Shapiro H, 2005, BIOCHEM BIOPH RES CO, V335, P97, DOI 10.1016/j.bbrc.2005.07.042; STEINER DF, 1985, ANNU REV GENET, V19, P463, DOI 10.1146/annurev.ge.19.120185.002335; Steneberg R, 2005, CELL METAB, V1, P245, DOI 10.1016/j.cmet.2005.03.007; Tolhurst G, 2012, DIABETES, V61, P364, DOI 10.2337/db11-1019; WALKER MD, 1983, NATURE, V306, P557, DOI 10.1038/306557a0; WIGLER M, 1979, P NATL ACAD SCI USA, V76, P1373, DOI 10.1073/pnas.76.3.1373; Xiong YM, 2004, P NATL ACAD SCI USA, V101, P1045, DOI 10.1073/pnas.2637002100; Yaney GC, 2003, DIABETOLOGIA, V46, P1297, DOI 10.1007/s00125-003-1207-4; Zraika S, 2002, Obes Rev, V3, P103, DOI 10.1046/j.1467-789X.2002.00062.x	40	32	33	0	5	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JUN 8	2012	287	24					20154	20163		10.1074/jbc.M112.358887	http://dx.doi.org/10.1074/jbc.M112.358887			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	974FB	22493486	hybrid, Green Published			2022-12-25	WOS:000306414500036
J	Yao, Y; Bellon, M; Shelton, SN; Nicot, C				Yao, Yuan; Bellon, Marcia; Shelton, Shary N.; Nicot, Christophe			Tumor Suppressors p53, p63TA alpha, p63TAy, p73 alpha, and p73 beta Use Distinct Pathways to Repress Telomerase Expression	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							REVERSE-TRANSCRIPTASE GENE; CATALYTIC SUBUNIT HTERT; CELL-CYCLE ARREST; C-MYC; DOWN-REGULATION; CANCER-CELLS; P73 GENE; NF-Y; PROMOTER; ACTIVATION	The promoter of the telomerase catalytic subunit (TERT) is subject to tight regulation and remains repressed in somatic cells to ensure their limited life span and to prevent tumor initiation. Here we report that the hTERT promoter is strongly repressed by p53 and the related family members p63 and p73. We found that p53-mediated repression was different in human and mouse cells and occurred through p53-dependent transcription inhibition of c-Myc or through E-box/E2F pathways, respectively. Although p63TA alpha-mediated repression occurred through SP1, p63TAy-mediated repression occurred through E2F signaling. Finally, p73 alpha- and p73 beta-mediated repression occurred through NF-YB2. Our results show a complex multifactorial mechanism used by p53 and its family members to keep hTERT expression under tight control. .	[Nicot, Christophe] Univ Kansas, Med Ctr, Ctr Viral Oncol, Kansas City, KS 66160 USA; Univ Kansas, Med Ctr, Dept Pathol & Lab Med, Kansas City, KS 66160 USA	University of Kansas; University of Kansas Medical Center; University of Kansas; University of Kansas Medical Center	Nicot, C (corresponding author), Univ Kansas, Med Ctr, Ctr Viral Oncol, Kansas City, KS 66160 USA.	cnicot@kumc.edu			National Institutes of Health [CA106258, CA115398]; NATIONAL CANCER INSTITUTE [R01CA115398, R01CA106258] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	This work was supported, in whole or in part, by National Institutes of Health Grants CA106258 and CA115398.	Artandi SE, 2010, CARCINOGENESIS, V31, P9, DOI 10.1093/carcin/bgp268; Beitzinger M, 2006, ONCOGENE, V25, P813, DOI 10.1038/sj.onc.1209125; Bellon M, 2008, BLOOD, V112, P2946, DOI 10.1182/blood-2008-01-134692; Bellon M, 2008, JNCI-J NATL CANCER I, V100, P98, DOI 10.1093/jnci/djm269; Benatti P, 2008, NUCLEIC ACIDS RES, V36, P1415, DOI 10.1093/nar/gkm1046; Bouwman P, 2000, EMBO J, V19, P655, DOI 10.1093/emboj/19.4.655; BRADFORD MM, 1976, ANAL BIOCHEM, V72, P248, DOI 10.1016/0003-2697(76)90527-3; Chebel A, 2009, J BIOL CHEM, V284, P35725, DOI 10.1074/jbc.M109.009183; Cong YS, 2002, MICROBIOL MOL BIOL R, V66, P407, DOI 10.1128/MMBR.66.3.407-425.2002; Cong YS, 1999, HUM MOL GENET, V8, P137, DOI 10.1093/hmg/8.1.137; Cong YS, 2000, J BIOL CHEM, V275, P35665, DOI 10.1074/jbc.C000637200; Corn PG, 1999, CANCER RES, V59, P3352; Crowe DL, 2001, NUCLEIC ACIDS RES, V29, P2789, DOI 10.1093/nar/29.13.2789; Datta A, 2006, BLOOD, V108, P1021, DOI 10.1182/blood-2006-01-0067; Deng YB, 2008, NAT REV CANCER, V8, P450, DOI 10.1038/nrc2393; Dietz S, 2002, FEBS LETT, V525, P93, DOI 10.1016/S0014-5793(02)03093-4; Dyson N, 1998, GENE DEV, V12, P2245, DOI 10.1101/gad.12.15.2245; Fujiki T, 2007, ONCOGENE, V26, P5258, DOI 10.1038/sj.onc.1210331; Giono LE, 2006, J CELL PHYSIOL, V209, P13, DOI 10.1002/jcp.20689; Glasspool RM, 2005, NEOPLASIA, V7, P614, DOI 10.1593/neo.04766; Gollahon LS, 1996, ONCOGENE, V12, P715; Goueli BS, 2003, ONCOGENE, V22, P8042, DOI 10.1038/sj.onc.1206847; Greenberg RA, 1999, ONCOGENE, V18, P1219, DOI 10.1038/sj.onc.1202669; Gunes C, 2000, CANCER RES, V60, P2116; Guo Z, 2003, J BIOL CHEM, V278, P23570, DOI 10.1074/jbc.M303431200; Hackzell A, 2002, J BIOL CHEM, V277, P39769, DOI 10.1074/jbc.M204483200; HARLEY CB, 1994, COLD SPRING HARB SYM, V59, P307, DOI 10.1101/SQB.1994.059.01.035; Hashimoto M, 2008, INT J ONCOL, V33, P333, DOI 10.3892/ijo_00000013; Ho JSL, 2005, MOL CELL BIOL, V25, P7423, DOI 10.1128/MCB.25.17.7423-7431.2005; Horikawa I, 2004, CYTOTECHNOLOGY, V45, P23, DOI 10.1007/s10616-004-5122-4; Horikawa I, 2002, MOL BIOL CELL, V13, P2585, DOI 10.1091/mbc.E01-11-0107; Horikawa I, 1999, CANCER RES, V59, P826; Jost CA, 1997, NATURE, V389, P191, DOI 10.1038/38298; Kanaya T, 2000, CLIN CANCER RES, V6, P1239; Kirschner RD, 2008, NUCLEIC ACIDS RES, V36, P2969, DOI 10.1093/nar/gkn132; Kusumoto M, 1999, CLIN CANCER RES, V5, P2140; Kyo S, 2000, NUCLEIC ACIDS RES, V28, P669, DOI 10.1093/nar/28.3.669; Lansdorp PM, 2008, BLOOD, V111, P1759, DOI 10.1182/blood-2007-09-084913; Li H, 2007, ANN NY ACAD SCI, V1114, P56, DOI 10.1196/annals.1396.016; Li H, 2006, J BIOL CHEM, V281, P25588, DOI 10.1074/jbc.M602381200; Lohr K, 2003, J BIOL CHEM, V278, P32507, DOI 10.1074/jbc.M212517200; MOBERG KH, 1992, J CELL BIOCHEM, V49, P208, DOI 10.1002/jcb.240490213; Moll UM, 2004, MOL CANCER RES, V2, P371; Nakatake M, 2007, CELL CYCLE, V6, P1496; Oh S, 2000, ONCOGENE, V19, P1485, DOI 10.1038/sj.onc.1203439; Oh S, 1999, J BIOL CHEM, V274, P37473, DOI 10.1074/jbc.274.52.37473; Pei JH, 2011, TUMOR BIOL, V32, P1133, DOI 10.1007/s13277-011-0215-0; Racek T, 2005, J BIOL CHEM, V280, P40402, DOI 10.1074/jbc.C500193200; Shats I, 2004, J BIOL CHEM, V279, P50976, DOI 10.1074/jbc.M402502200; Sinha-Datta U, 2004, BLOOD, V104, P2523, DOI 10.1182/blood-2003-12-4251; Sitaram RT, 2010, BRIT J CANCER, V103, P1255, DOI 10.1038/sj.bjc.6605878; Takakura M, 1999, CANCER RES, V59, P551; Watanabe T, 2002, ACTA NEUROPATHOL, V104, P357, DOI 10.1007/s00401-002-0549-1; Xu DW, 2000, ONCOGENE, V19, P5123, DOI 10.1038/sj.onc.1203890	54	12	15	0	4	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JUN 8	2012	287	24					20737	20747		10.1074/jbc.M111.319236	http://dx.doi.org/10.1074/jbc.M111.319236			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	974FB	22496369	Green Published, hybrid			2022-12-25	WOS:000306414500092
J	Ai, LB; Skehan, RR; Saydi, J; Lin, T; Brown, KD				Ai, Lingbao; Skehan, Ryan R.; Saydi, John; Lin, Tong; Brown, Kevin D.			Ataxia-Telangiectasia, Mutated (ATM)/Nuclear Factor kappa Light Chain Enhancer of Activated B Cells (NF kappa B) Signaling Controls Basal and DNA Damage-induced Transglutaminase 2 Expression	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							RESISTANT BREAST-CANCER; TISSUE TRANSGLUTAMINASE; CROSS-LINKING; CONSTITUTIVE ACTIVATION; DRUG-SENSITIVITY; OXIDATIVE STRESS; GENOTOXIC STRESS; IKK ACTIVATION; TUMOR-CELLS; KINASE ATM	Transglutaminase 2 (TG2) is a ubiquitously expressed enzyme that cross-links proteins and its overexpression, linked to a drug resistant phenotype, is commonly observed in cancer cells. Further, up-regulation of TG2 expression occurs during response to various forms of cell stress; however, the molecular mechanisms that drive inducible expression of the TG2 gene (TGM2) require elucidation. Here we show that genotoxic stress induces TG2 expression through the Ataxia-Telangiectasia, Mutated (ATM)/Nuclear Factor kappa light chain enhancer of activated B cells (NF kappa B) signaling pathway. We further document that NF kappa B is both necessary and sufficient to drive constitutive TG2 expression in cultured cell lines. Additionally, shRNA-mediated knockdown or pharmacological inhibition of the ATM kinase results in reduced constitutive TG2 expression and NF kappa B transcriptional activity. We document that the NF kappa B subunit p65 (RelA) interacts with two independent consensus NF kappa B binding sites within the TGM2 promoter, that mutation of either site or pharmacological inhibition of NF kappa B reduces TGM2 promoter activity, and genotoxic stress drives heightened association of p65 with the TGM2 promoter. Finally, we observed that knockdown of either p65 or ATM in MDA-MB-468 breast cancer cells expressing recombinant TG2 partially reduces resistance to doxorubicin, indicating that the drug resistance linked to overexpression of TG2 functions, in part, through p65 and ATM. This work establishes a novel ATM-dependent signaling loop where TG2 and NF kappa B activate each other resulting in sustained activation of NF kappa B and acquisition of a drug-resistant phenotype.	[Brown, Kevin D.] Univ Florida, Coll Med, Dept Biochem & Mol Biol, Gainesville, FL 32610 USA; Univ Florida, Coll Med, UF Shands Canc Ctr, Gainesville, FL 32610 USA	State University System of Florida; University of Florida; State University System of Florida; University of Florida	Brown, KD (corresponding author), Univ Florida, Coll Med, Dept Biochem & Mol Biol, Box 100245, Gainesville, FL 32610 USA.	kdbrown1@ufl.edu	Lin, Tong/G-4105-2012		National Institutes of Health [R01-CA102289]; Ocala Royal Dames for Cancer Research; Florida Department of Health; NATIONAL CANCER INSTITUTE [R01CA102289] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Ocala Royal Dames for Cancer Research; Florida Department of Health; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	This work was supported, in whole or in part, by grants from the National Institutes of Health (R01-CA102289), the Ocala Royal Dames for Cancer Research, and the Florida Department of Health (to K. D. B.).	Adamson AW, 2002, J BIOL CHEM, V277, P38222, DOI 10.1074/jbc.M204409200; Aeschlimann D, 2000, CONNECT TISSUE RES, V41, P1, DOI 10.3109/03008200009005638; Ai LB, 2008, CARCINOGENESIS, V29, P510, DOI 10.1093/carcin/bgm280; Antonyak MA, 2009, J BIOL CHEM, V284, P17914, DOI 10.1074/jbc.M109.013037; Bartkova J, 2005, NATURE, V434, P864, DOI 10.1038/nature03482; Baskaran R, 1997, NATURE, V387, P516, DOI 10.1038/387516a0; Bensimon A., FEBS LETT, V585, P1625; Budillon A., 2011, AMINO ACIDS IN PRESS; Bunz F, 1998, SCIENCE, V282, P1497, DOI 10.1126/science.282.5393.1497; Caccamo D, 2005, J NEUROSCI RES, V82, P858, DOI 10.1002/jnr.20683; Cao LY, 2008, CARCINOGENESIS, V29, P1893, DOI 10.1093/carcin/bgn158; Chen JSK, 1999, INT J BIOCHEM CELL B, V31, P817, DOI 10.1016/S1357-2725(99)00045-X; Chen JSK, 2002, BREAST CANCER RES TR, V71, P237, DOI 10.1023/A:1014461832403; Dyer LM, 2011, J NEURO-ONCOL, V101, P429, DOI 10.1007/s11060-010-0277-7; Fesus L, 2005, FEBS LETT, V579, P3297, DOI 10.1016/j.febslet.2005.03.063; Fok JY, 2006, MOL CANCER THER, V5, P1493, DOI 10.1158/1535-7163.MCT-06-0083; Grosjean-Raillard J, 2009, ONCOGENE, V28, P1099, DOI 10.1038/onc.2008.457; Guo Z, 2010, SCIENCE, V330, P517, DOI 10.1126/science.1192912; Han JA, 1999, J CANCER RES CLIN, V125, P89, DOI 10.1007/s004320050247; Herman JF, 2006, ONCOGENE, V25, P3049, DOI 10.1038/sj.onc.1209324; Hettasch JM, 1996, LAB INVEST, V75, P637; Hickson I, 2004, CANCER RES, V64, P9152, DOI 10.1158/0008-5472.CAN-04-2727; Ientile R, 2007, AMINO ACIDS, V33, P385, DOI 10.1007/s00726-007-0517-0; Jang GY, 2010, ONCOGENE, V29, P356, DOI 10.1038/onc.2009.342; Janssens S, 2006, CELL DEATH DIFFER, V13, P773, DOI 10.1038/sj.cdd.4401843; Johnson KA, 2003, J BIOL CHEM, V278, P18824, DOI 10.1074/jbc.M301055200; Kang SK, 2004, FEBS LETT, V577, P361, DOI 10.1016/j.febslet.2004.10.031; Karin M, 2002, NAT REV CANCER, V2, P301, DOI 10.1038/nrc780; Kim DS, 2006, CANCER RES, V66, P10936, DOI 10.1158/0008-5472.CAN-06-1521; KUNSCH C, 1992, MOL CELL BIOL, V12, P4412, DOI 10.1128/MCB.12.10.4412; Lee JM, 2004, J BIOL CHEM, V279, P53725, DOI 10.1074/jbc.M407627200; Li NX, 2001, J BIOL CHEM, V276, P8898, DOI 10.1074/jbc.M009809200; Lim CA, 2007, MOL CELL, V27, P622, DOI 10.1016/j.molcel.2007.06.038; LORAND L, 1984, MOL CELL BIOCHEM, V58, P9, DOI 10.1007/BF00240602; Lorand L, 2003, NAT REV MOL CELL BIO, V4, P140, DOI 10.1038/nrm1014; LU S, 1995, J BIOL CHEM, V270, P9748, DOI 10.1074/jbc.270.17.9748; Luo J, 2009, CELL, V136, P823, DOI 10.1016/j.cell.2009.02.024; Mann AP, 2006, CANCER RES, V66, P8788, DOI 10.1158/0008-5472.CAN-06-1457; Mehta K, 2004, CLIN CANCER RES, V10, P8068, DOI 10.1158/1078-0432.CCR-04-1107; MEHTA K, 1994, INT J CANCER, V58, P400, DOI 10.1002/ijc.2910580316; Mirza A, 1997, AM J PHYSIOL-GASTR L, V272, pG281, DOI 10.1152/ajpgi.1997.272.2.G281; Pierce JW, 1997, J BIOL CHEM, V272, P21096, DOI 10.1074/jbc.272.34.21096; Reed JC, 1999, J CLIN ONCOL, V17, P2941, DOI 10.1200/JCO.1999.17.9.2941; Rodolfo C, 2004, J BIOL CHEM, V279, P54783, DOI 10.1074/jbc.M410938200; SZATROWSKI TP, 1991, CANCER RES, V51, P794; Tanaka T, 2006, CELL CYCLE, V5, P878, DOI 10.4161/cc.5.8.2681; Telci D, 2006, FRONT BIOSCI-LANDMRK, V11, P867, DOI 10.2741/1843; TOYOKUNI S, 1995, FEBS LETT, V358, P1, DOI 10.1016/0014-5793(94)01368-B; Verma A, 2007, DRUG RESIST UPDATE, V10, P144, DOI 10.1016/j.drup.2007.06.002; Verma A, 2006, CANCER RES, V66, P10525, DOI 10.1158/0008-5472.CAN-06-2387; Veuger SJ, 2011, DNA REPAIR, V10, P235, DOI 10.1016/j.dnarep.2010.11.005; Willis SN, 2005, CURR OPIN CELL BIOL, V17, P617, DOI 10.1016/j.ceb.2005.10.001; Wu ZH, 2006, SCIENCE, V311, P1141, DOI 10.1126/science.1121513; Wu ZH, 2007, J MOL MED, V85, P1187, DOI 10.1007/s00109-007-0227-9; Wu ZH, 2010, MOL CELL, V40, P75, DOI 10.1016/j.molcel.2010.09.010; Yamaguchi H, 2006, MOL CELL BIOL, V26, P569, DOI 10.1128/MCB.26.2.569-579.2006; Yuan L, 2007, ONCOGENE, V26, P2563, DOI 10.1038/sj.onc.1210048; Yuan L, 2005, MOL CANCER THER, V4, P1293, DOI 10.1158/1535-7163.MCT-04-0328; Zemskov EA, 2006, FRONT BIOSCI-LANDMRK, V11, P1057, DOI 10.2741/1863; Zhou Y, 2005, ENDOCR-RELAT CANCER, V12, pS37, DOI 10.1677/erc.1.00977	60	25	25	0	1	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAY 25	2012	287	22					18330	18341		10.1074/jbc.M112.339317	http://dx.doi.org/10.1074/jbc.M112.339317			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	974EC	22493284	Green Published, hybrid			2022-12-25	WOS:000306411600039
J	Ochs, SM; Thumann, S; Richau, R; Weirauch, MT; Lowe, TM; Thomm, M; Hausner, W				Ochs, Simon M.; Thumann, Sybille; Richau, Renate; Weirauch, Matt T.; Lowe, Todd M.; Thomm, Michael; Hausner, Winfried			Activation of Archaeal Transcription Mediated by Recruitment of Transcription Factor B	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							CELL-FREE TRANSCRIPTION; TATA-BINDING PROTEIN; RNA-POLYMERASE; PYROCOCCUS-FURIOSUS; SULFOLOBUS-SOLFATARICUS; PREINITIATION COMPLEX; INITIATION COMPLEX; STRUCTURAL BASIS; TFIIE-ALPHA; DNA-BINDING	Archaeal promoters consist of a TATA box and a purine-rich adjacent upstream sequence (transcription factor B (TFB)-responsive element (BRE)), which are bound by the transcription factors TATA box-binding protein (TBP) and TFB. Currently, only a few activators of archaeal transcription have been experimentally characterized. The best studied activator, Ptr2, mediates activation by recruitment of TBP. Here, we present a detailed biochemical analysis of an archaeal transcriptional activator, PF1088, which was identified in Pyrococcus furiosus by a bioinformatic approach. Operon predictions suggested that an upstream gene, pf1089, is polycistronically transcribed with pf1088. We demonstrate that PF1088 stimulates in vitro transcription by up to 7-fold when the pf1089 promoter is used as a template. By DNase I and hydroxyl radical footprinting experiments, we show that the binding site of PF1088 is located directly upstream of the BRE of pf1089. Mutational analysis indicated that activation requires the presence of the binding site for PF1088. Furthermore, we show that activation of transcription by PF1088 is dependent upon the presence of an imperfect BRE and is abolished when the pf1089 BRE is replaced with a BRE from a strong archaeal promoter. Gel shift experiments showed that TFB recruitment to the pf1089 operon is stimulated by PF1088, and TFB seems to stabilize PF1088 operator binding even in the absence of TBP. Taken together, these results represent the first biochemical evidence for a transcriptional activator working as a TFB recruitment factor in Archaea, for which the designation TFB-RF1 is suggested.	[Ochs, Simon M.; Thumann, Sybille; Richau, Renate; Thomm, Michael; Hausner, Winfried] Univ Regensburg, Lehrstuhl Mikrobiol, D-93053 Regensburg, Germany; [Weirauch, Matt T.; Lowe, Todd M.] Univ Calif Santa Cruz, Dept Biomol Engn, Santa Cruz, CA 95064 USA	University of Regensburg; University of California System; University of California Santa Cruz	Hausner, W (corresponding author), Univ Regensburg, Lehrstuhl Mikrobiol, Univ Str 31, D-93053 Regensburg, Germany.	winfried.hausner@biologie.uni-regensburg.de	Lowe, Todd Michael/ABJ-5261-2022		Deutsche Forschungsgemeinschaft [TH 422/13-1]	Deutsche Forschungsgemeinschaft(German Research Foundation (DFG))	This work was supported by Deutsche Forschungsgemeinschaft Grant TH 422/13-1.	Aravind L, 1999, NUCLEIC ACIDS RES, V27, P4658, DOI 10.1093/nar/27.23.4658; Bartlett MS, 2005, CURR OPIN MICROBIOL, V8, P677, DOI 10.1016/j.mib.2005.10.016; Bartlett MS, 2004, J BIOL CHEM, V279, P5894, DOI 10.1074/jbc.M311429200; Bell SD, 2005, TRENDS MICROBIOL, V13, P262, DOI 10.1016/j.tim.2005.03.015; Bell SD, 1999, P NATL ACAD SCI USA, V96, P13662, DOI 10.1073/pnas.96.24.13662; Bell SD, 2001, CURR OPIN MICROBIOL, V4, P208, DOI 10.1016/S1369-5274(00)00190-9; Bell SD, 2001, EMBO REP, V2, P133, DOI 10.1093/embo-reports/kve021; Brinkman AB, 2002, J BIOL CHEM, V277, P29537, DOI 10.1074/jbc.M203528200; Geiduschek EP, 2005, MOL MICROBIOL, V56, P1397, DOI 10.1111/j.1365-2958.2005.04627.x; Grohmann D, 2009, BIOCHEM SOC T, V37, P12, DOI 10.1042/BST0370012; Grunberg S, 2007, J BIOL CHEM, V282, P35482, DOI 10.1074/jbc.M707371200; HAIN J, 1992, NUCLEIC ACIDS RES, V20, P5423, DOI 10.1093/nar/20.20.5423; Hanzelka BL, 2001, J BACTERIOL, V183, P1813, DOI 10.1128/JB.183.5.1813-1818.2001; HAUSNER W, 1991, J MOL BIOL, V222, P495, DOI 10.1016/0022-2836(91)90492-O; Hausner W, 1996, J BIOL CHEM, V271, P30144, DOI 10.1074/jbc.271.47.30144; Hethke C, 1999, GENETICS, V152, P1325; Kanai T, 2007, J BIOL CHEM, V282, DOI 10.1074/jbc.M703424200; Kostrewa D, 2009, NATURE, V462, P323, DOI 10.1038/nature08548; Lee SJ, 2008, ARCH MICROBIOL, V190, P247, DOI 10.1007/s00203-008-0378-2; Lipscomb GL, 2009, MOL MICROBIOL, V71, P332, DOI 10.1111/j.1365-2958.2008.06525.x; Littlefield O, 1999, P NATL ACAD SCI USA, V96, P13668, DOI 10.1073/pnas.96.24.13668; Liu W, 2007, J MOL BIOL, V369, P474, DOI 10.1016/j.jmb.2007.03.044; Okada U, 2006, PROTEINS, V63, P1084, DOI 10.1002/prot.20913; Osman D, 2010, NAT PROD REP, V27, P668, DOI 10.1039/b906682a; Ouhammouch M, 2005, MOL MICROBIOL, V56, P625, DOI 10.1111/j.1365-2958.2005.04563.x; Ouhammouch M, 2003, P NATL ACAD SCI USA, V100, P5097, DOI 10.1073/pnas.0837150100; Peeters E, 2010, ARCHAEA, V2010, DOI 10.1155/2010/750457; Peeters E, 2009, MOL MICROBIOL, V71, P972, DOI 10.1111/j.1365-2958.2008.06578.x; Peng N, 2009, MOL MICROBIOL, V74, P928, DOI 10.1111/j.1365-2958.2009.06908.x; Qureshi SA, 1997, EMBO J, V16, P2927, DOI 10.1093/emboj/16.10.2927; Qureshi SA, 1998, MOL CELL, V1, P389, DOI 10.1016/S1097-2765(00)80039-8; Renfrow MB, 2004, J BIOL CHEM, V279, P2825, DOI 10.1074/jbc.M311433200; Spitalny P, 2003, J BIOL CHEM, V278, P30497, DOI 10.1074/jbc.M303633200; Teufel K, 2010, ARCH MICROBIOL, V192, P143, DOI 10.1007/s00203-009-0537-0; Thomm M., 2007, ARCHAEA EVOLUTION PH, P185; Thomm M, 2007, ARCHAEA: MOLECULAR AND CELLULAR BIOLOGY, P139; Tsai FTF, 2000, EMBO J, V19, P25, DOI 10.1093/emboj/19.1.25; TULLIUS TD, 1987, METHOD ENZYMOL, V155, P537; van de Werken HJG, 2006, FEMS MICROBIOL LETT, V260, P69, DOI 10.1111/j.1574-6968.2006.00292.x; Waege I, 2010, APPL ENVIRON MICROB, V76, P3308, DOI 10.1128/AEM.01951-09; Weidenbach K, 2010, FEBS J, V277, P4398, DOI 10.1111/j.1742-4658.2010.07821.x	41	26	26	0	3	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAY 25	2012	287	22					18863	18871		10.1074/jbc.M112.365742	http://dx.doi.org/10.1074/jbc.M112.365742			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	974EC	22496454	hybrid, Green Published			2022-12-25	WOS:000306411600094
J	Panina, S; Stephan, A; la Cour, JM; Jacobsen, K; Kallerup, LK; Bumbuleviciute, R; Knudsen, KVK; Sanchez-Gonzalez, P; Villalobo, A; Olesen, UH; Berchtold, MW				Panina, Svetlana; Stephan, Alexander; la Cour, Jonas M.; Jacobsen, Kivin; Kallerup, Line K.; Bumbuleviciute, Rasita; Knudsen, Kristoffer V. K.; Sanchez-Gonzalez, Pablo; Villalobo, Antonio; Olesen, Uffe H.; Berchtold, Martin W.			Significance of Calcium Binding, Tyrosine Phosphorylation, and Lysine Trimethylation for the Essential Function of Calmodulin in Vertebrate Cells Analyzed in a Novel Gene Replacement System	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							GROWTH-FACTOR RECEPTOR; TARGET RECOGNITION; CYCLE PROGRESSION; ACTIVATION; KINASE; PROTEIN; STIMULATION; MECHANISMS; 3-KINASE; TISSUE	Calmodulin (CaM) was shown to be essential for survival of lower eukaryotes by gene deletion experiments. So far, no CaM gene deletion was reported in higher eukaryotes. In vertebrates, CaM is expressed from several genes, which encode an identical protein, making it difficult to generate a model system to study the effect of CaM gene deletion. Here, we present a novel genetic system based on the chicken DT40 cell line, in which the two functional CaM genes were deleted and one allele replaced with a CaM transgene that can be artificially regulated. We show that CaM is essential for survival of vertebrate cells as they die in the absence of CaM expression. Reversal of CaM repression or ectopic expression of HA-tagged CaM rescued the cells. Cells exclusively expressing HA-CaM with impaired individual calcium binding domains as well as HA-CaM lacking the ability to be phosphorylated at residues Tyr(99)/Tyr(138) or trimethylated at Lys(115) survived and grew well. CaM mutated at both Ca2+ binding sites 3 and 4 as well as at both sites 1 and 2, but to a lesser degree, showed decreased ability to support cell growth. Cells expressing CaM with all calcium binding sites impaired died with kinetics similar to that of cells expressing no CaM. This system offers a unique opportunity to analyze CaM structure-function relationships in vivo without the use of pharmacological inhibitors and to analyze the function of wild type and mutated CaM in modulating the activity of different target systems without interference of endogenous CaM.	[Berchtold, Martin W.] Univ Copenhagen, Dept Biol, Bioctr, DK-2200 Copenhagen, Denmark; [Sanchez-Gonzalez, Pablo; Villalobo, Antonio] CSIC, Inst Invest Biomed, Dept Canc Biol, E-28029 Madrid, Spain	University of Copenhagen; Consejo Superior de Investigaciones Cientificas (CSIC); CSIC - Instituto de Investigaciones Biomedicas Alberto Sols (IIBM)	Berchtold, MW (corresponding author), Univ Copenhagen, Dept Biol, Bioctr, DK-2200 Copenhagen, Denmark.	mabe@bio.ku.dk	Vitting-Seerup, Kristoffer/AAE-4069-2021; Villalobo, Antonio/O-9621-2019; Vitting-Seerup, Kristoffer/C-9008-2015; Berchtold, Martin/L-1695-2014; Villalobo, Antonio/K-2902-2017; la Cour, Jonas/M-5088-2016	Villalobo, Antonio/0000-0002-4200-374X; Vitting-Seerup, Kristoffer/0000-0002-6450-0608; Berchtold, Martin/0000-0001-8995-9047; Sanhez, Pablo/0000-0002-2844-6843; la Cour, Jonas/0000-0002-1588-0608; Olesen, Uffe Hogh/0000-0002-4578-684X	Danish Research Council; Lundbeeck Foundation; AP Moller Fonden; Dagmar Marshall Fonden; Willumsen Fonden; Danielsen Fonden; Wedell Wedellsborg Fonden; Fraenkels Mindefond; Hansen Fonden; Danish Cancer Society [R2-A183]; Junta de Ampliacion de Estudios; Consejo Superior de Investigaciones Cientificas; Ministerio de Ciencia e Innovacion [SAF2008-00986, SAF2011-23494]; Consejeria de Educacion de la Comunidad de Madrid [S2011/BMD-2349]; European Commission [ITN 289033]	Danish Research Council(Det Frie Forskningsrad (DFF)); Lundbeeck Foundation; AP Moller Fonden; Dagmar Marshall Fonden; Willumsen Fonden; Danielsen Fonden; Wedell Wedellsborg Fonden; Fraenkels Mindefond; Hansen Fonden; Danish Cancer Society(Danish Cancer Society); Junta de Ampliacion de Estudios; Consejo Superior de Investigaciones Cientificas; Ministerio de Ciencia e Innovacion(Ministry of Science and Innovation, Spain (MICINN)Instituto de Salud Carlos IIISpanish Government); Consejeria de Educacion de la Comunidad de Madrid; European Commission(European CommissionEuropean Commission Joint Research Centre)	This work was supported by grants from the Danish Research Council, the Lundbeeck Foundation, AP Moller Fonden, Dagmar Marshall Fonden, Willumsen Fonden, Danielsen Fonden, and Wedell Wedellsborg Fonden, Fraenkels Mindefond, Hansen Fonden (to M. W. B.).; Supported by the Danish Cancer Society (R2-A183).; Supported by a predoctoral fellowship from the Junta de Ampliacion de Estudios, Consejo Superior de Investigaciones Cientificas.; Supported by the Ministerio de Ciencia e Innovacion (SAF2008-00986 and SAF2011-23494), the Consejeria de Educacion de la Comunidad de Madrid (S2011/BMD-2349), and the European Commission (Contract ITN 289033).	Benaim G, 2002, EUR J BIOCHEM, V269, P3619, DOI 10.1046/j.1432-1033.2002.03038.x; BERCHTOLD MW, 1993, GENOMICS, V16, P461, DOI 10.1006/geno.1993.1211; Berridge MJ, 2003, NAT REV MOL CELL BIO, V4, P517, DOI 10.1038/nrm1155; Briggs MW, 2003, EMBO REP, V4, P571, DOI 10.1038/sj.embor.embor867; Chin D, 2000, TRENDS CELL BIOL, V10, P322, DOI 10.1016/S0962-8924(00)01800-6; Choi J, 2006, CELL CYCLE, V5, P2183, DOI 10.4161/cc.5.19.3265; Dagher R, 2011, BBA-MOL CELL RES, V1813, P1059, DOI 10.1016/j.bbamcr.2010.11.004; Deb TB, 2004, J BIOL CHEM, V279, P38903, DOI 10.1074/jbc.M405314200; DEISS LP, 1995, GENE DEV, V9, P15, DOI 10.1101/gad.9.1.15; FARNSWORTH CL, 1995, NATURE, V376, P524, DOI 10.1038/376524a0; Fischer R, 1998, FEBS LETT, V425, P175, DOI 10.1016/S0014-5793(98)00225-7; GEISER JR, 1991, CELL, V65, P949, DOI 10.1016/0092-8674(91)90547-C; GREGORI L, 1985, J BIOL CHEM, V260, P5232; Harding SA, 1997, EMBO J, V16, P1137, DOI 10.1093/emboj/16.6.1137; Hoeflich KP, 2002, CELL, V108, P739, DOI 10.1016/S0092-8674(02)00682-7; Hook SS, 2001, ANNU REV PHARMACOL, V41, P471, DOI 10.1146/annurev.pharmtox.41.1.471; Joseph JD, 2002, EUKARYOT CELL, V1, P119, DOI 10.1128/EC.01.1.119-125.2002; Joyal JL, 1997, J BIOL CHEM, V272, P28183, DOI 10.1074/jbc.272.45.28183; Jurado LA, 1999, PHYSIOL REV, V79, P661, DOI 10.1152/physrev.1999.79.3.661; Kahl CR, 2003, ENDOCR REV, V24, P719, DOI 10.1210/er.2003-0008; KLEE CB, 1982, ADV PROTEIN CHEM, V35, P213, DOI 10.1016/S0065-3233(08)60470-2; Klee CB, 1998, J BIOL CHEM, V273, P13367, DOI 10.1074/jbc.273.22.13367; la Cour JM, 2003, AM J PATHOL, V163, P81, DOI 10.1016/S0002-9440(10)63632-2; Li HB, 2012, J BIOL CHEM, V287, P3273, DOI 10.1074/jbc.M111.317529; LU KP, 1993, ENDOCR REV, V14, P40, DOI 10.1210/er.14.1.40; Machaca K, 2010, CELL CALCIUM, V48, P243, DOI 10.1016/j.ceca.2010.10.003; Magnani R, 2010, NAT COMMUN, V1, DOI 10.1038/ncomms1044; Maier LS, 2002, J MOL CELL CARDIOL, V34, P919, DOI 10.1006/jmcc.2002.2038; MEANS AR, 1994, FEBS LETT, V347, P1, DOI 10.1016/0014-5793(94)00492-7; MEYERS MB, 1995, FEBS LETT, V357, P230, DOI 10.1016/0014-5793(94)01338-2; MOSER MJ, 1995, J BIOL CHEM, V270, P20643, DOI 10.1074/jbc.270.35.20643; O'Day DH, 2003, CELL SIGNAL, V15, P347, DOI 10.1016/S0898-6568(02)00116-X; Roberts DM, 1996, MED VET ENTOMOL, V10, P137, DOI 10.1111/j.1365-2915.1996.tb00719.x; Salas V, 2005, PROTEIN EXPRES PURIF, V41, P384, DOI 10.1016/j.pep.2005.01.004; SANJOSE E, 1992, J BIOL CHEM, V267, P15237; Schmalzigaug R, 2001, IMMUNOLOGY, V103, P332, DOI 10.1046/j.1365-2567.2001.01259.x; Swindells MB, 1996, NAT STRUCT BIOL, V3, P501, DOI 10.1038/nsb0696-501; TAKUWA N, 1995, CELL SIGNAL, V7, P93, DOI 10.1016/0898-6568(94)00074-L; TAKUWA N, 1993, J BIOL CHEM, V268, P138; Tarabykina S, 2000, J BIOL CHEM, V275, P10514, DOI 10.1074/jbc.275.14.10514; Winding P, 2001, J IMMUNOL METHODS, V249, P1, DOI 10.1016/S0022-1759(00)00333-1; Xia Y, 1998, J BIOL CHEM, V273, P25804, DOI 10.1074/jbc.273.40.25804; Yap Kyoko L., 2000, Journal of Structural and Functional Genomics, V1, P8, DOI 10.1023/A:1011320027914	43	17	17	0	7	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAY 25	2012	287	22					18173	18181		10.1074/jbc.M112.339382	http://dx.doi.org/10.1074/jbc.M112.339382			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	974EC	22493455	Green Published, hybrid			2022-12-25	WOS:000306411600025
J	Pertusa, M; Madrid, R; Morenilla-Palao, C; Belmonte, C; Viana, F				Pertusa, Maria; Madrid, Rodolfo; Morenilla-Palao, Cruz; Belmonte, Carlos; Viana, Felix			N-Glycosylation of TRPM8 Ion Channels Modulates Temperature Sensitivity of Cold Thermoreceptor Neurons	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							MENTHOL RECEPTOR TRPM8; SODIUM-CHANNELS; VANILLOID RECEPTOR-1; POTASSIUM CHANNELS; SURFACE-CHARGE; SENSATION; RESIDUES; REVEALS; ACID; SITE	TRPM8 is a member of the transient receptor potential ion channel superfamily, which is expressed in sensory neurons and is activated by cold and cooling compounds, such as menthol. Activation of TRPM8 by agonists takes place through shifts in its voltage activation curve, allowing channel opening at physiological membrane potentials. Here, we studied the role of the N-glycosylation occurring at the pore loop of TRPM8 on the function of the channel. Using heterologous expression of recombinant channels in HEK293 cells we found that the unglycosylated TRPM8 mutant (N934Q) displays marked functional differences compared with the wild type channel. These differences include a shift in the threshold of temperature activation and a reduced response to menthol and cold stimuli. Biophysical analysis indicated that these modifications are due to a shift in the voltage dependence of TRPM8 activation toward more positive potentials. By using tunicamycin, a drug that prevents N-glycosylation of proteins, we also evaluated the effect of the N-glycosylation on the responses of trigeminal sensory neurons expressing TRPM8. These experiments showed that the lack of N-glycosylation affects the function of native TRPM8 ion channels in a similar way to heterologously expressed ones, causing an important shift of the temperature threshold of cold-sensitive thermoreceptor neurons. Altogether, these results indicate that post-translational modification of TRPM8 is an important mechanism modulating cold thermoreceptor function, explaining the marked differences in temperature sensitivity observed between recombinant and native TRPM8 ion channels.	[Pertusa, Maria; Madrid, Rodolfo; Morenilla-Palao, Cruz; Belmonte, Carlos; Viana, Felix] Univ Miguel Hernandez, Consejo Super Invest Cient, Inst Neurociencias Alicante, Alicante 03550, Spain; [Pertusa, Maria; Madrid, Rodolfo] Univ Santiago Chile, Fac Quim & Biol, Dept Biol, Santiago 9160000, Chile	Consejo Superior de Investigaciones Cientificas (CSIC); Universidad Miguel Hernandez de Elche; CSIC-UMH - Instituto de Neurociencias de Alicante (IN); Universidad de Santiago de Chile	Viana, F (corresponding author), Univ Miguel Hernandez, Consejo Super Invest Cient, Inst Neurociencias Alicante, Alicante 03550, Spain.	felix.viana@umh.es	Viana, Felix/U-8533-2017	Viana, Felix/0000-0003-1439-949X; Morenilla-Palao, Cruz/0000-0002-8159-1206; Pertusa, Maria/0000-0003-3856-9019; Madrid, Rodolfo/0000-0002-8623-5761	Spanish MICIIN [SAF2010-14990]; CONSOLIDER-INGENIO [CSD2007-00023]; Spanish Ministry of Education and Science; FONDECYT [3110128, 1100983]; Spanish Fundacion Marcelino Botin	Spanish MICIIN(Spanish Government); CONSOLIDER-INGENIO(Ministry of Science and Innovation, Spain (MICINN)Spanish Government); Spanish Ministry of Education and Science(Spanish Government); FONDECYT(Comision Nacional de Investigacion Cientifica y Tecnologica (CONICYT)CONICYT FONDECYT); Spanish Fundacion Marcelino Botin	This work was supported in part by Spanish MICIIN Projects SAF2010-14990 (to F.V.) and CONSOLIDER-INGENIO CSD2007-00023 (to C.B.).; Supported by a predoctoral fellowship from the Spanish Ministry of Education and Science and FONDECYT Grant 3110128.; Supported by a postdoctoral fellowship of the Spanish Fundacion Marcelino Botin and FONDECYT Grant 1100983.	Alvarez O, 2002, ADV PHYSIOL EDUC, V26, P327, DOI 10.1152/advan.00006.2002; Bandell M, 2006, NAT NEUROSCI, V9, P493, DOI 10.1038/nn1665; Bautista DM, 2007, NATURE, V448, P204, DOI 10.1038/nature05910; Bennett E, 1997, J GEN PHYSIOL, V109, P327, DOI 10.1085/jgp.109.3.327; Bernstein JG, 2012, CURR OPIN NEUROBIOL, V22, P61, DOI 10.1016/j.conb.2011.10.023; Brauchi S, 2006, J NEUROSCI, V26, P4835, DOI 10.1523/JNEUROSCI.5080-05.2006; Brauchi S, 2004, P NATL ACAD SCI USA, V101, P15494, DOI 10.1073/pnas.0406773101; Chang Q, 2005, SCIENCE, V310, P490, DOI 10.1126/science.1114245; Cohen DM, 2006, SEMIN CELL DEV BIOL, V17, P630, DOI 10.1016/j.semcdb.2006.11.007; Colburn RW, 2007, NEURON, V54, P379, DOI 10.1016/j.neuron.2007.04.017; de la Pena E., 2005, J PHYSL, V567, P415; Dhaka A, 2007, NEURON, V54, P371, DOI 10.1016/j.neuron.2007.02.024; Dhaka A, 2006, ANNU REV NEUROSCI, V29, P135, DOI 10.1146/annurev.neuro.29.051605.112958; Dietrich A, 2003, J BIOL CHEM, V278, P47842, DOI 10.1074/jbc.M302983200; Dragoni I, 2006, J BIOL CHEM, V281, P37353, DOI 10.1074/jbc.M607227200; Erler I, 2006, J BIOL CHEM, V281, P38396, DOI 10.1074/jbc.M607756200; Freeman LC, 2000, J MEMBRANE BIOL, V177, P65, DOI 10.1007/s002320001100; Hensel H, 1981, Monogr Physiol Soc, V38, P1; HILLE B, 1975, PHILOS T R SOC B, V270, P301, DOI 10.1098/rstb.1975.0011; HSIEH P, 1983, J BIOL CHEM, V258, P2548; Jahnel R, 2001, EUR J BIOCHEM, V268, P5489, DOI 10.1046/j.1432-1033.2001.02500.x; Johnson D, 2008, PFLUG ARCH EUR J PHY, V456, P393, DOI 10.1007/s00424-007-0378-0; Jordt SE, 2000, P NATL ACAD SCI USA, V97, P8134, DOI 10.1073/pnas.100129497; Jung S, 2003, J BIOL CHEM, V278, P3562, DOI 10.1074/jbc.M211484200; Kedei N, 2001, J BIOL CHEM, V276, P28613, DOI 10.1074/jbc.M103272200; KLAUSNER RD, 1992, J CELL BIOL, V116, P1071, DOI 10.1083/jcb.116.5.1071; Liu D, 2005, J BIOL CHEM, V280, P20691, DOI 10.1074/jbc.M414072200; Madrid R, 2006, J NEUROSCI, V26, P12512, DOI 10.1523/JNEUROSCI.3752-06.2006; Madrid R, 2009, J NEUROSCI, V29, P3120, DOI 10.1523/JNEUROSCI.4778-08.2009; Mahieu F, 2010, J PHYSIOL-LONDON, V588, P315, DOI 10.1113/jphysiol.2009.183582; MAHONEY WC, 1979, J BIOL CHEM, V254, P6572; Malkia A, 2007, J PHYSIOL-LONDON, V581, P155, DOI 10.1113/jphysiol.2006.123059; McKemy DD, 2005, MOL PAIN, V1, DOI 10.1186/1744-8069-1-16; McKemy DD, 2002, NATURE, V416, P52, DOI 10.1038/nature719; Morenilla-Palao C, 2009, J BIOL CHEM, V284, P9215, DOI 10.1074/jbc.M807228200; Nilius B, 2006, EMBO J, V25, P467, DOI 10.1038/sj.emboj.7600963; Owsianik G, 2006, ANNU REV PHYSIOL, V68, P685, DOI 10.1146/annurev.physiol.68.040204.101406; Parra A, 2010, NAT MED, V16, P1396, DOI 10.1038/nm.2264; Peier AM, 2002, CELL, V108, P705, DOI 10.1016/S0092-8674(02)00652-9; RECIOPINTO E, 1990, NEURON, V5, P675, DOI 10.1016/0896-6273(90)90221-Z; Rho SH, 2000, FEBS LETT, V478, P246, DOI 10.1016/S0014-5793(00)01863-9; Semtner M, 2007, J BIOL CHEM, V282, P33868, DOI 10.1074/jbc.M702577200; Thornhill WB, 1996, J BIOL CHEM, V271, P19093, DOI 10.1074/jbc.271.32.19093; Tsuzuki K, 2004, J NEUROSCI, V24, P762, DOI 10.1523/JNEUROSCI.4658-03.2004; Tyrrell L, 2001, J NEUROSCI, V21, P9629, DOI 10.1523/JNEUROSCI.21-24-09629.2001; Ufret-Vincenty CA, 2001, J BIOL CHEM, V276, P28197, DOI 10.1074/jbc.M102548200; Valero M, 2011, PFLUG ARCH EUR J PHY, V461, P99, DOI 10.1007/s00424-010-0895-0; Vannier B, 1998, J BIOL CHEM, V273, P8675, DOI 10.1074/jbc.273.15.8675; Varki A., 1999, ESSENTIALS GLYCOBIOL; Viana F, 2002, NAT NEUROSCI, V5, P254, DOI 10.1038/nn809; Voets T, 2004, NATURE, V430, P748, DOI 10.1038/nature02732; Watanabe I, 2003, J PHYSIOL-LONDON, V550, P51, DOI 10.1113/jphysiol.2003.040337; Wirkner K, 2005, NEUROREPORT, V16, P997, DOI 10.1097/00001756-200506210-00023; Xia R, 2008, J BIOL CHEM, V283, P27426, DOI 10.1074/jbc.M801049200; Xu HS, 2006, AM J PHYSIOL-RENAL, V290, pF1103, DOI 10.1152/ajprenal.00245.2005; Zhang Y, 1999, J MEMBRANE BIOL, V171, P195, DOI 10.1007/s002329900571	56	51	53	1	11	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAY 25	2012	287	22					18218	18229		10.1074/jbc.M111.312645	http://dx.doi.org/10.1074/jbc.M111.312645			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	974EC	22493431	Green Published, hybrid			2022-12-25	WOS:000306411600030
J	Yoshizawa, T; Shimizu, T; Hirano, H; Sato, M; Hashimoto, H				Yoshizawa, Takuya; Shimizu, Toshiyuki; Hirano, Hisashi; Sato, Mamoru; Hashimoto, Hiroshi			Structural Basis for Inhibition of Xyloglucan-specific Endo-beta-1,4-glucanase (XEG) by XEG-Protein Inhibitor	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							ENDO-BETA-GLUCANASE; X-RAY-DIFFRACTION; ASPERGILLUS-ACULEATUS; CELL-WALL; GLYCOPROTEIN; CARROT; ENDOGLUCANASE; PURIFICATION; COMPLEXES; XYLANASE	Microorganisms such as plant pathogens secrete glycoside hydrolases (GHs) to digest the polysaccharide chains of plant cell walls. The degradation of cell walls by these enzymes is a crucial step for nutrition and invasion. To protect the cell wall from these enzymes, plants secrete glycoside hydrolase inhibitor proteins (GHIPs). Xyloglucan-specific endo-beta-1,4-glucanase (XEG), a member of GH family 12 (GH12), could be a great threat to many plants because xyloglucan is a major component of the cell wall in most plants. Understanding the inhibition mechanism of XEG by GHIP is therefore of great importance in the field of plant defense, but to date the mechanism and specificity of GHIPs remain unclear. We have determined the crystal structure of XEG in complex with extracellular dermal glycoprotein (EDGP), a carrot GHIP that inhibits XEG. The structure reveals that the conserved arginines of EDGP intrude into the active site of XEG and interact with the catalytic glutamates of the enzyme. We have also determined the crystal structure of the XEG-xyloglucan complex. These structures show that EDGP closely mimics the XEG-xyloglucan interaction. Although EDGP shares structural similarity to a wheat GHIP (Triticum aestivum xylanase inhibitor-IA (TAXI-IA)) that inhibits GH11 family xylanases, the arrangement of GH and GHIP in the XEG-EDGP complex is distinct from that in the xylanase-TAXI-IA complex. Our findings imply that plants have evolved structures of GHIPs to inhibit different GH family members that attack their cell walls.	[Yoshizawa, Takuya; Hirano, Hisashi; Sato, Mamoru; Hashimoto, Hiroshi] Yokohama City Univ, Grad Sch Nanobiosci, Tsurumi Ku, Yokohama, Kanagawa 2300045, Japan; [Shimizu, Toshiyuki] Univ Tokyo, Grad Sch Pharmaceut Sci, Bunkyo Ku, Tokyo 1130033, Japan	Yokohama City University; University of Tokyo	Hashimoto, H (corresponding author), Yokohama City Univ, Grad Sch Nanobiosci, Tsurumi Ku, 1-7-29 Suehiro Cho, Yokohama, Kanagawa 2300045, Japan.	hash@tsurumi.yokohama-cu.ac.jp		Hashimoto, Hiroshi/0000-0003-1503-6789	National Project on Protein Structural and Functional Analyses Protein 3000 Project; Ministry of Education, Culture, Sports, Science, and Technology in Japan (MEXT)	National Project on Protein Structural and Functional Analyses Protein 3000 Project; Ministry of Education, Culture, Sports, Science, and Technology in Japan (MEXT)(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT))	This work was supported by a Grant-in-Aid for Scientific Research (KAKENHI), the National Project on Protein Structural and Functional Analyses Protein 3000 Project, and the Targeted Proteins Research Program from Ministry of Education, Culture, Sports, Science, and Technology in Japan (MEXT) (to T. S., M. S., and H. H.).	BROWNER MF, 1995, BIOCHEMISTRY-US, V34, P6602, DOI 10.1021/bi00020a004; Brunger AT, 1998, ACTA CRYSTALLOGR D, V54, P905, DOI 10.1107/S0907444998003254; Emsley P, 2004, ACTA CRYSTALLOGR D, V60, P2126, DOI 10.1107/S0907444904019158; Fierens K, 2005, FEBS J, V272, P5872, DOI 10.1111/j.1742-4658.2005.04987.x; Gebruers K, 2004, BBA-PROTEINS PROTEOM, V1696, P213, DOI 10.1016/j.bbapap.2003.08.013; Gloster TM, 2007, J BIOL CHEM, V282, P19177, DOI 10.1074/jbc.M700224200; HAYASHI T, 1989, ANNU REV PLANT PHYS, V40, P139, DOI 10.1146/annurev.pp.40.060189.001035; HENRISSAT B, 1991, BIOCHEM J, V280, P309, DOI 10.1042/bj2800309; Hoover DM, 2002, NUCLEIC ACIDS RES, V30, DOI 10.1093/nar/30.10.e43; Juge N, 2006, TRENDS PLANT SCI, V11, P359, DOI 10.1016/j.tplants.2006.05.006; KANDA T, 1976, J BIOCHEM, V79, P997, DOI 10.1093/oxfordjournals.jbchem.a131167; Lagaert S, 2009, SEMIN CELL DEV BIOL, V20, P1064, DOI 10.1016/j.semcdb.2009.05.008; LASKOWSKI RA, 1993, J APPL CRYSTALLOGR, V26, P283, DOI 10.1107/S0021889892009944; LEVER M, 1972, ANAL BIOCHEM, V47, P273, DOI 10.1016/0003-2697(72)90301-6; Martinez-Fleites C, 2006, J BIOL CHEM, V281, P24922, DOI 10.1074/jbc.M603583200; Miyatake H, 2006, ACTA CRYSTALLOGR D, V62, P280, DOI 10.1107/S0907444905041909; Murshudov GN, 1997, ACTA CRYSTALLOGR D, V53, P240, DOI 10.1107/S0907444996012255; Naqvi SMS, 2005, PLANT PHYSIOL, V139, P1389, DOI 10.1104/pp.105.065227; Otwinowski Z, 1997, METHOD ENZYMOL, V276, P307, DOI 10.1016/S0076-6879(97)76066-X; Pauly M, 1999, GLYCOBIOLOGY, V9, P93, DOI 10.1093/glycob/9.1.93; Payan F, 2004, J BIOL CHEM, V279, P36029, DOI 10.1074/jbc.M404225200; Qin Q, 2003, PLANT J, V34, P327, DOI 10.1046/j.1365-313X.2003.01726.x; Sandgren M, 2005, PROG BIOPHYS MOL BIO, V89, P246, DOI 10.1016/j.pbiomolbio.2004.11.002; Sansen S, 2004, J BIOL CHEM, V279, P36022, DOI 10.1074/jbc.M404212200; Shang CW, 2005, BIOCHEM BIOPH RES CO, V328, P144, DOI 10.1016/j.bbrc.2004.12.166; Shang CW, 2004, BIOCHEMISTRY-US, V43, P6281, DOI 10.1021/bi036160f; Terwilliger T, 2004, J SYNCHROTRON RADIAT, V11, P49, DOI 10.1107/S0909049503023938; TORRONEN A, 1994, EMBO J, V13, P2493, DOI 10.1002/j.1460-2075.1994.tb06536.x; Vagin A, 1997, J APPL CRYSTALLOGR, V30, P1022, DOI 10.1107/S0021889897006766; Yoshizawa T, 2011, ACTA CRYSTALLOGR F, V67, P830, DOI 10.1107/S1744309111020045; Yoshizawa T, 2011, FEBS J, V278, P1944, DOI 10.1111/j.1742-4658.2011.08111.x	31	43	44	1	19	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAY 25	2012	287	22					18710	18716		10.1074/jbc.M112.350520	http://dx.doi.org/10.1074/jbc.M112.350520			7	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	974EC	22496365	Green Published, hybrid			2022-12-25	WOS:000306411600079
J	Xiang, LS; Xie, GF; Ou, JJ; Wei, X; Pan, F; Liang, HJ				Xiang, Lisha; Xie, Ganfeng; Ou, Juanjuan; Wei, Xing; Pan, Feng; Liang, Houjie			The Extra Domain A of Fibronectin Increases VEGF-C Expression in Colorectal Carcinoma Involving the PI3K/AKT Signaling Pathway	PLOS ONE			English	Article							GROWTH-FACTOR-C; LYMPHATIC VESSEL DENSITY; TUMOR-METASTASIS; NODE METASTASIS; CANCER-CELLS; IN-VIVO; LYMPHANGIOGENESIS; MECHANISMS; ADENOCARCINOMA; VASCULATURE	The extra domain A (EDA)-containing fibronectin (EDA-FN), an alternatively spliced form of the extracellular matrix protein fibronectin, is predominantly expressed in various malignancies but not in normal tissues. In the present study, we investigated the potential pro-lymphangiogenesis effects of extra domain A (EDA)-mediated vascular endothelial growth factor-C (VEGF-C) secretion in colorectal carcinoma (CRC). We detected the expressions of EDA and VEGF-C in 52 human colorectal tumor tissues and their surrounding mucosae by immunohistochemical analysis, and further tested the correlation between the expressions of these two proteins in aforementioned CRC tissues. Both EDA and VEGF-C were abundantly expressed in the specimens of human CRC tissues. And VEGF-C was associated with increased expression of EDA in human CRC according to linear regression analysis. Besides, EDA expression was significantly correlated with lymph node metastasis, tumor differentiation and clinical stage by clinicopathological analysis of tissue microarrays containing tumor tissues of 115 CRC patients. Then, human CRC cell SW480 was transfected with lentivectors to elicit expression of shRNA against EDA (shRNA-EDA), and SW620 was transfected with a lentiviral vector to overexpress EDA (pGC-FU-EDA), respectively. We confirmed that VEGF-C was upregulated in EDA-overexpressed cells, and downregulated in shRNA-EDA cells. Moreover, a PI3K-dependent signaling pathway was found to be involved in EDA-mediated VEGF-C secretion. The in vivo result demonstrated that EDA could promote tumor growth and tumor-induced lymphangiogenesis in mouse xenograft models. Our findings provide evidence that EDA could play a role in tumor-induced lymphangiogenesis via upregulating autocrine secretion of VEGF-C in colorectal cancer, which is associated with the PI3K/Akt-dependent pathway.	[Xiang, Lisha] Third Mil Med Univ, Southwest Hosp, Dept Oncol, Chongqing, Peoples R China; Third Mil Med Univ, Southwest Hosp, SW Canc Ctr, Chongqing, Peoples R China	Army Medical University; Army Medical University	Xiang, LS (corresponding author), Third Mil Med Univ, Southwest Hosp, Dept Oncol, Chongqing, Peoples R China.	lianghoujie@sina.com						Achen MG, 2005, CANCER CELL, V7, P121, DOI 10.1016/j.ccr.2005.01.017; Avraamides CJ, 2008, NAT REV CANCER, V8, P604, DOI 10.1038/nrc2353; Bahram Fuad, 2010, Pathophysiology, V17, P253, DOI 10.1016/j.pathophys.2009.10.004; Barresi V, 2011, J CLIN PATHOL, V64, P6, DOI 10.1136/jcp.2010.083550; Beasley NJP, 2002, CANCER RES, V62, P1315; Caunt M, 2008, CANCER CELL, V13, P331, DOI 10.1016/j.ccr.2008.01.029; Chang L, 2002, ANN NY ACAD SCI, V979, P111, DOI 10.1111/j.1749-6632.2002.tb04872.x; Clasper S, 2008, CANCER RES, V68, P7293, DOI 10.1158/0008-5472.CAN-07-6506; Duan Guang-Jie, 2004, Zhonghua Bing Li Xue Za Zhi, V33, P518; Duff SE, 2003, INT J ONCOL, V22, P339; Enholm B, 1997, ONCOGENE, V14, P2475, DOI 10.1038/sj.onc.1201090; Girling JE, 2009, REPRODUCTION, V138, P883, DOI 10.1530/REP-09-0147; Goc A, 2011, INT J ONCOL, V38, P267, DOI 10.3892/ijo_00000847; Karpanen T, 2001, CANCER RES, V61, P1786; Kim JG, 2008, CLIN CANCER RES, V14, P62, DOI 10.1158/1078-0432.CCR-07-1537; Krishnan J, 2003, CANCER RES, V63, P713; Liu HT, 2009, INT J SURG PATHOL, V17, P426, DOI 10.1177/1066896909337505; Mandriota SJ, 2001, EMBO J, V20, P672, DOI 10.1093/emboj/20.4.672; McFadden JP, 2010, BRIT J DERMATOL, V163, P5, DOI 10.1111/j.1365-2133.2010.09737.x; Oliver G, 2002, GENE DEV, V16, P773, DOI 10.1101/gad.975002; Ou JJ, 2010, CANCER BIOL THER, V9, P186, DOI 10.4161/cbt.9.3.10651; Parr C, 2003, INT J ONCOL, V23, P533; Pepper MS, 2001, CLIN CANCER RES, V7, P462; Romberger DJ, 1997, INT J BIOCHEM CELL B, V29, P939, DOI 10.1016/S1357-2725(96)00172-0; Royston D, 2009, J PATHOL, V217, P608, DOI 10.1002/path.2517; Saad RS, 2009, AM J CLIN PATHOL, V131, P92, DOI 10.1309/AJCPKWUQSIPVG90H; Saintigny P, 2007, LUNG CANCER, V58, P205, DOI 10.1016/j.lungcan.2007.06.021; Saji M, 2010, MOL CELL ENDOCRINOL, V321, P20, DOI 10.1016/j.mce.2009.10.016; Skinner HD, 2004, J BIOL CHEM, V279, P45643, DOI 10.1074/jbc.M404097200; Su JL, 2008, CANCER CELL, V13, P557, DOI 10.1016/j.ccr.2008.04.021; Sundlisxter E, 2007, INT J CANCER, V121, P1401, DOI 10.1002/ijc.22996; Tammela T, 2010, CELL, V140, P460, DOI 10.1016/j.cell.2010.01.045; Tang YC, 2003, CANCER RES, V63, P1166; van der Straaten HM, 2004, J INVEST DERMATOL, V123, P1057, DOI 10.1111/j.0022-202X.2004.23474.x; Villa A, 2008, INT J CANCER, V122, P2405, DOI 10.1002/ijc.23408; West KA, 2002, DRUG RESIST UPDATE, V5, P234, DOI 10.1016/S1368-7646(02)00120-6	36	43	47	0	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 9	2012	7	4							e35378	10.1371/journal.pone.0035378	http://dx.doi.org/10.1371/journal.pone.0035378			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	955JO	22496919	Green Published, gold, Green Submitted			2022-12-25	WOS:000305014500057
J	Chen, H; Gao, N; Fan, DY; Wu, JM; Zhu, JP; Li, JQ; Wang, J; Chen, YL; An, J				Chen, Hui; Gao, Na; Fan, Dongying; Wu, Jiangman; Zhu, Junping; Li, Jieqiong; Wang, Juan; Chen, Yanlei; An, Jing			Suppressive Effects on the Immune Response and Protective Immunity to a JEV DNA Vaccine by Co-administration of a GM-CSF-Expressing Plasmid in Mice	PLOS ONE			English	Article							COLONY-STIMULATING FACTOR; REGULATORY T-CELLS; TOLEROGENIC DENDRITIC CELLS; JAPANESE ENCEPHALITIS-VIRUS; AUTOIMMUNE-THYROIDITIS; RANDOMIZED-TRIAL; CANCER-PATIENTS; IN-VIVO; ANTIGEN; CYTOKINES	As a potential cytokine adjuvant of DNA vaccines, granulocyte-macrophage colony-stimulating factor (GM-CSF) has received considerable attention due to its essential role in the recruitment of antigen-presenting cells, differentiation and maturation of dendritic cells. However, in our recent study of a Japanese encephalitis virus (JEV) DNA vaccine, co-inoculation of a GM-CSF plasmid dramatically suppressed the specific IgG response and resulted in decreased protection against JEV challenge. It is known that GM-CSF has been used in clinic to treat neutropenia for repopulating myeloid cells, and as an adjuvant in vaccine studies; it has shown various effects on the immune response. Therefore, in this study, we characterized the suppressive effects on the immune response to a JEV DNA vaccine by the co-administration of the GM-CSF-expressing plasmid and clarified the underlying mechanisms of the suppression in mice. Our results demonstrated that co-immunization with GM-CSF caused a substantial dampening of the vaccine-induced antibody responses. The suppressive effect was dose-and timing-dependent and likely related to the immunogenicity of the antigen. The suppression was associated with the induction of immature dendritic cells and the expansion of regulatory T cells but not myeloid-derived suppressor cells. Collectively, our findings not only provide valuable information for the application of GM-CSF in clinic and using as a vaccine adjuvant but also offer further insight into the understanding of the complex roles of GM-CSF.	[Chen, Hui; Gao, Na; Fan, Dongying; Wu, Jiangman; Zhu, Junping; Li, Jieqiong; Wang, Juan; Chen, Yanlei; An, Jing] Capital Med Univ, Sch Basic Med Sci, Dept Microbiol, Beijing, Peoples R China	Capital Medical University	Chen, H (corresponding author), Capital Med Univ, Sch Basic Med Sci, Dept Microbiol, Beijing, Peoples R China.	anjing@ccmu.edu.cn	Li, jie/GXG-4583-2022		National Key Programs on Basic Research of China [2011CB504703]; National Natural Science Foundation of China [30872227]; Jurisdiction of Beijing Municipality [20090616119, 200907112]	National Key Programs on Basic Research of China; National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Jurisdiction of Beijing Municipality	This work was supported by grants from the National Key Programs on Basic Research of China (2011CB504703, http://www.973.gov.cn/English/Index.aspx), the National Natural Science Foundation of China (30872227, http://www.nsfc.gov.cn/) and the Funding Project for Academic Human Resources Development in Institutions of Higher Learning Under the Jurisdiction of Beijing Municipality (20090616119, 200907112, http://www.bjedu.gov.cn/). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abaitua F, 2006, VIRUS RES, V116, P11, DOI 10.1016/j.virusres.2005.08.008; Banchereau J, 1998, NATURE, V392, P245, DOI 10.1038/32588; Chakrabarti R, 2005, VACCINE, V23, P4553, DOI 10.1016/j.vaccine.2005.05.002; Chakrabarti R, 2004, VACCINE, V22, P1199, DOI 10.1016/j.vaccine.2003.09.023; Chang SY, 2004, INT J CANCER, V111, P86, DOI 10.1002/ijc.20232; Chen HW, 1999, J VIROL, V73, P10137, DOI 10.1128/JVI.73.12.10137-10145.1999; Chen HW, 2001, J IMMUNOL, V166, P7419, DOI 10.4049/jimmunol.166.12.7419; Dolcetti L, 2010, EUR J IMMUNOL, V40, P22, DOI 10.1002/eji.200939903; Ganesh BB, 2009, INT IMMUNOL, V21, P269, DOI 10.1093/intimm/dxn147; Gangi E, 2005, J IMMUNOL, V174, P7006, DOI 10.4049/jimmunol.174.11.7006; Gao N, 2010, IMMUNOL LETT, V129, P23, DOI 10.1016/j.imlet.2009.12.023; Gaudreau S, 2007, J IMMUNOL, V179, P3638, DOI 10.4049/jimmunol.179.6.3638; Gillessen S, 2003, P NATL ACAD SCI USA, V100, P8874, DOI 10.1073/pnas.1033098100; Grcevic D, 2006, CLIN EXP IMMUNOL, V146, P146, DOI 10.1111/j.1365-2249.2006.03181.x; Hirota K, 2010, SEMIN IMMUNOPATHOL, V32, P3, DOI 10.1007/s00281-009-0187-y; Jonuleit H, 2000, J EXP MED, V192, P1213, DOI 10.1084/jem.192.9.1213; Kared H, 2008, BLOOD, V112, P2575, DOI 10.1182/blood-2008-02-140681; Kaufman HL, 2002, VACCINE, V20, P1862, DOI 10.1016/S0264-410X(02)00032-4; Kusakabe K, 2000, J IMMUNOL, V164, P3102, DOI 10.4049/jimmunol.164.6.3102; Lahoud MH, 2006, J IMMUNOL, V177, P372, DOI 10.4049/jimmunol.177.1.372; Loudon PT, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0011021; Lutz MB, 2002, TRENDS IMMUNOL, V23, P445, DOI 10.1016/S1471-4906(02)02281-0; Mach N, 2000, CANCER RES, V60, P3239; Mahnke K, 2002, IMMUNOL CELL BIOL, V80, P477, DOI 10.1046/j.1440-1711.2002.01115.x; Mahnke K, 2007, CELL IMMUNOL, V250, P1, DOI 10.1016/j.cellimm.2008.01.004; Maldonado RA, 2010, ADV IMMUNOL, V108, P111, DOI [10.1016/B978-0-12-380995-7.00004-5, 10.1016/S0065-2776(10)08004_1]; Morales JK, 2010, BREAST CANCER RES TR, V123, P39, DOI 10.1007/s10549-009-0622-8; Nemunaitis J, 2005, EXPERT REV VACCINES, V4, P259, DOI 10.1586/14760584.4.3.259; Nimal S, 2006, VACCINE, V24, P3298, DOI 10.1016/j.vaccine.2006.01.020; NIWA H, 1991, GENE, V108, P193, DOI 10.1016/0378-1119(91)90434-D; Parmiani G, 2007, ANN ONCOL, V18, P226, DOI 10.1093/annonc/mdl158; Qin L, 2007, J VIROL, V81, P10606, DOI 10.1128/JVI.01000-07; Ramanathan RK, 2002, J CLIN ONCOL, V20, P4313, DOI 10.1200/JCO.2002.02.041; Rutella S, 2004, IMMUNOL LETT, V94, P11, DOI 10.1016/j.imlet.2004.04.015; Serafini P, 2004, CANCER RES, V64, P6337, DOI 10.1158/0008-5472.CAN-04-0757; Serafini P, 2004, CANCER IMMUNOL IMMUN, V53, P64, DOI 10.1007/s00262-003-0443-2; Sheng JR, 2006, J IMMUNOL, V177, P5296, DOI 10.4049/jimmunol.177.8.5296; Shi YF, 2006, CELL RES, V16, P126, DOI 10.1038/sj.cr.7310017; Slingluff CL, 2009, CLIN CANCER RES, V15, P7036, DOI 10.1158/1078-0432.CCR-09-1544; Song XQ, 2009, VACCINE, V27, P690, DOI 10.1016/j.vaccine.2008.11.090; Wallet MA, 2005, CLIN MED RES, V3, P166, DOI 10.3121/cmr.3.3.166; Xu R, 2008, VACCINE, V26, P4819, DOI 10.1016/j.vaccine.2008.06.103; Yang B, 2008, VACCINE, V26, P5477, DOI 10.1016/j.vaccine.2008.07.060; Zhang XZ, 2007, VACCINE, V25, P1342, DOI 10.1016/j.vaccine.2006.09.089; Zheng Q, 2011, VACCINE, V29, P763, DOI 10.1016/j.vaccine.2010.11.014	45	13	14	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 6	2012	7	4							e34602	10.1371/journal.pone.0034602	http://dx.doi.org/10.1371/journal.pone.0034602			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	955JA	22493704	Green Published, Green Submitted, gold			2022-12-25	WOS:000305012700046
J	Li, JM; Jin, ZX; Song, WJ				Li, Junmin; Jin, Zexin; Song, Wenjing			Do Native Parasitic Plants Cause More Damage to Exotic Invasive Hosts Than Native Non-Invasive Hosts? An Implication for Biocontrol	PLOS ONE			English	Article							MIKANIA-MICRANTHA; SURFACE-AREA; RESISTANCE; IMPACTS; TRAITS; GROWTH; CARBON; ROOTS	Field studies have shown that native, parasitic plants grow vigorously on invasive plants and can cause more damage to invasive plants than native plants. However, no empirical test has been conducted and the mechanism is still unknown. We conducted a completely randomized greenhouse experiment using 3 congeneric pairs of exotic, invasive and native, non-invasive herbaceous plant species to quantify the damage caused by parasitic plants to hosts and its correlation with the hosts' growth rate and resource use efficiency. The biomass of the parasitic plants on exotic, invasive hosts was significantly higher than on congeneric native, non-invasive hosts. Parasites caused more damage to exotic, invasive hosts than to congeneric, native, non-invasive hosts. The damage caused by parasites to hosts was significantly positively correlated with the biomass of parasitic plants. The damage of parasites to hosts was significantly positively correlated with the relative growth rate and the resource use efficiency of its host plants. It may be the mechanism by which parasitic plants grow more vigorously on invasive hosts and cause more damage to exotic, invasive hosts than to native, non-invasive hosts. These results suggest a potential biological control effect of native, parasitic plants on invasive species by reducing the dominance of invasive species in the invaded community.	[Li, Junmin; Jin, Zexin; Song, Wenjing] Taizhou Univ, Inst Ecol, Linhai, Zhejiang, Peoples R China	Taizhou University	Li, JM (corresponding author), Taizhou Univ, Inst Ecol, Linhai, Zhejiang, Peoples R China.	lijmtzc@126.com	李, 钧敏/L-7390-2019		National Natural Science Foundation of China [30800133]; China Postdoctoral Science Foundation [20080440557]; National Natural Science Foundation of Zhejiang Province [Y5090253, Y5110227]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); China Postdoctoral Science Foundation(China Postdoctoral Science Foundation); National Natural Science Foundation of Zhejiang Province	Support for the project was provided through funding from the National Natural Science Foundation of China (No. 30800133), China Postdoctoral Science Foundation (No. 20080440557) and National Natural Science Foundation of Zhejiang Province (No. Y5090253; Y5110227). The funders had no role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aritua V, 1998, ANN APPL BIOL, V132, P399, DOI 10.1111/j.1744-7348.1998.tb05217.x; Barton KE, 2008, OIKOS, V117, P917, DOI 10.1111/j.0030-1299.2008.16324.x; Callaway RM, 2006, TRENDS ECOL EVOL, V21, P369, DOI 10.1016/j.tree.2006.04.008; Callaway RM, 2003, ECOLOGY, V84, P1115, DOI 10.1890/0012-9658(2003)084[1115:PPAIAP]2.0.CO;2; Callaway RM, 1999, ECOLOGY, V80, P1196, DOI 10.1890/0012-9658(1999)080[1196:BCHMIC]2.0.CO;2; Cogni R, 2010, BIOTROPICA, V42, P188, DOI 10.1111/j.1744-7429.2009.00570.x; Colautti RI, 2004, ECOL LETT, V7, P721, DOI 10.1111/j.1461-0248.2004.00616.x; Drenovsky RE, 2008, AM J BOT, V95, P681, DOI 10.3732/ajb.2007408; Edit Committee of Flora of China Chinese Academy of Science, 1985, FLORA CHINA, V14, P72; Egilla JN, 2001, PLANT SOIL, V229, P213, DOI 10.1023/A:1004883032383; EISSENSTAT DM, 1992, J PLANT NUTR, V15, P763, DOI 10.1080/01904169209364361; Elton C. S., 1958, ECOLOGY INVASIONS AN; Fu Gai-lan, 2007, Shengtaixue Zazhi, V26, P1590; Funk JL, 2007, NATURE, V446, P1079, DOI 10.1038/nature05719; Grime J. P., 1991, Plant root growth: an ecological perspective., P381; Gonzalez-Santana IH, 2012, PHYSIOL PLANTARUM, V144, P134, DOI 10.1111/j.1399-3054.2011.01527.x; Himmelbauer ML, 2004, PLANT SOIL, V260, P111, DOI 10.1023/B:PLSO.0000030171.28821.55; Jackson RB, 1997, P NATL ACAD SCI USA, V94, P7362, DOI 10.1073/pnas.94.14.7362; JESCHKE WD, 1994, J EXP BOT, V45, P801, DOI 10.1093/jxb/45.6.801; [郝建华 Jianhua Hao], 2009, [植物学报, Chinese Bulletin of Botany], V44, P656; Jogesh T, 2008, BIOL INVASIONS, V10, P797, DOI 10.1007/s10530-008-9236-z; Keane RM, 2002, TRENDS ECOL EVOL, V17, P164, DOI 10.1016/S0169-5347(02)02499-0; Kourtev PS, 2003, SOIL BIOL BIOCHEM, V35, P895, DOI 10.1016/S0038-0717(03)00120-2; Li YL, 2005, BOT BULL ACAD SINICA, V46, P127; NORBY RJ, 1994, PLANT SOIL, V165, P9, DOI 10.1007/BF00009958; Parker IM, 2007, ECOLOGY, V88, P1210, DOI 10.1890/06-1377; Pennings SC, 2002, OECOLOGIA, V131, P479, DOI 10.1007/s00442-002-0923-7; Press MC, 2005, NEW PHYTOL, V166, P737, DOI 10.1111/j.1469-8137.2005.01358.x; Prider J, 2009, ANN BOT-LONDON, V103, P107, DOI 10.1093/aob/mcn214; RAABE ZDZISLAW, 1965, ACTA PROTOZOOL, V3, P311; Reich PB, 1997, P NATL ACAD SCI USA, V94, P13730, DOI 10.1073/pnas.94.25.13730; Shen XY, 2011, BIOL INVASIONS, V13, P869, DOI 10.1007/s10530-010-9875-8; Suetsugu K, 2008, ANN BOT-LONDON, V102, P49, DOI 10.1093/aob/mcn065; van Kleunen M, 2010, ECOL LETT, V13, P235, DOI 10.1111/j.1461-0248.2009.01418.x; Vila M, 2004, OIKOS, V105, P229, DOI 10.1111/j.0030-1299.2004.12682.x; Wang Hui, 2008, Wuhan Zhiwuxue Yanjiu, V26, P134; Wang RK, 2012, ACTA ECOLOG IN PRESS, V6; Wang ZY, 2010, BMC GENOMICS, V11, DOI 10.1186/1471-2164-11-726; Weiher E, 1999, J VEG SCI, V10, P609, DOI 10.2307/3237076; Wijesundara D. S. A., 2001, Annals of the Sri Lanka Department of Agriculture, V3, P343; Wu JR, 2006, ALLELOPATHY J, V17, P279; Yu H, 2008, BIOL CONSERV, V141, P2653, DOI 10.1016/j.biocon.2008.08.002; Yu H, 2011, BIOL INVASIONS, V13, P747, DOI 10.1007/s10530-010-9865-x; [昝启杰 Zan Qijie], 2002, [中山大学学报. 自然科学版, Acta Scientiarum Naturalium Universitatis Sunyatseni], V41, P60; Zhang LY, 2004, WEED RES, V44, P42, DOI 10.1111/j.1365-3180.2003.00371.x	45	23	26	3	48	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 6	2012	7	4							e34577	10.1371/journal.pone.0034577	http://dx.doi.org/10.1371/journal.pone.0034577			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	955JA	22493703	Green Published, Green Submitted, gold			2022-12-25	WOS:000305012700045
J	Hughes, S; Welsh, L; Katti, C; Gonzalez-Menendez, I; Turton, M; Halford, S; Sekaran, S; Peirson, SN; Hankins, MW; Foster, RG				Hughes, Steven; Welsh, Laura; Katti, Christiana; Gonzalez-Menendez, Irene; Turton, Michael; Halford, Stephanie; Sekaran, Sumathi; Peirson, Stuart N.; Hankins, Mark W.; Foster, Russell G.			Differential Expression of Melanopsin Isoforms Opn4L and Opn4S during Postnatal Development of the Mouse Retina	PLOS ONE			English	Article							GANGLION-CELL PHOTORECEPTORS; MAMMALIAN RETINA; DOPAMINE; PROJECTIONS; DIVERSITY; BIPOLAR; MICE; ROD	Photosensitive retinal ganglion cells (pRGCs) respond to light from birth and represent the earliest known light detection system to develop in the mouse retina. A number of morphologically and functionally distinct subtypes of pRGCs have been described in the adult retina, and have been linked to different physiological roles. We have previously identified two distinct isoforms of mouse melanopsin, Opn4L and Opn4S, which are generated by alternate splicing of the Opn4 locus. These isoforms are differentially expressed in pRGC subtypes of the adult mouse retina, with both Opn4L and Opn4S detected in M1 type pRGCs, and only Opn4L detected in M2 type pRGCs. Here we investigate the developmental expression of Opn4L and Opn4S and show a differential profile of expression during postnatal development. Opn4S mRNA is detected at relatively constant levels throughout postnatal development, with levels of Opn4S protein showing a marked increase between P0 and P3, and then increasing progressively over time until adult levels are reached by P10. By contrast, levels of Opn4L mRNA and protein are low at birth and show a marked increase at P14 and P30 compared to earlier time points. We suggest that these differing profiles of expression are associated with the functional maturation of M1 and M2 subtypes of pRGCs. Based upon our data, Opn4S expressing M1 type pRGCs mature first and are the dominant pRGC subtype in the neonate retina, whereas increased expression of Opn4L and the maturation of M2 type pRGCs occurs later, between P10 and P14, at a similar time to the maturation of rod and cone photoreceptors. We suggest that the distinct functions associated with these cell types will develop at different times during postnatal development.	[Hughes, Steven; Welsh, Laura; Katti, Christiana; Turton, Michael; Halford, Stephanie; Sekaran, Sumathi; Peirson, Stuart N.; Hankins, Mark W.; Foster, Russell G.] Univ Oxford, Nuffield Lab Ophthalmol, Oxford OX2 6AW, England; [Gonzalez-Menendez, Irene] Univ Oviedo, Dept Morfol & Biol Celular, E-33006 Oviedo, Spain	University of Oxford; University of Oviedo	Hughes, S (corresponding author), Univ Oxford, Nuffield Lab Ophthalmol, Walton St, Oxford OX2 6AW, England.	mark.hankins@eye.ox.ac.uk; russell.foster@eye.ox.ac.uk	Halford, Stephanie/AAJ-1375-2020	Halford, Stephanie/0000-0003-2179-907X; FOSTER, RUSSELL/0000-0001-6055-2067	Wellcome Trust; BBSRC (Biotechnology and Biological Sciences Research Council); BBSRC [BB/G003602/1] Funding Source: UKRI; Biotechnology and Biological Sciences Research Council [BB/G003602/1] Funding Source: researchfish	Wellcome Trust(Wellcome TrustEuropean Commission); BBSRC (Biotechnology and Biological Sciences Research Council)(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); BBSRC(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); Biotechnology and Biological Sciences Research Council(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC))	This work was funded by a Wellcome Trust Programme Grant awarded to RGF, MWH, SNP, SH, SS. CK was funded by a BBSRC (Biotechnology and Biological Sciences Research Council) grant awarded to SS. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Baver SB, 2008, EUR J NEUROSCI, V27, P1763, DOI 10.1111/j.1460-9568.2008.06149.x; Belenky MA, 2003, J COMP NEUROL, V460, P380, DOI 10.1002/cne.10652; Berson DM, 2010, J COMP NEUROL, V518, P2405, DOI 10.1002/cne.22381; Cameron MA, 2009, EUR J NEUROSCI, V29, P761, DOI 10.1111/j.1460-9568.2009.06631.x; Chen SK, 2011, NATURE, V476, P92, DOI 10.1038/nature10206; Coombs JL, 2007, J COMP NEUROL, V503, P803, DOI 10.1002/cne.21429; Do MTH, 2010, PHYSIOL REV, V90, P1547, DOI 10.1152/physrev.00013.2010; Ecker JL, 2010, NEURON, V67, P49, DOI 10.1016/j.neuron.2010.05.023; Freedman MS, 1999, SCIENCE, V284, P502, DOI 10.1126/science.284.5413.502; Gonzalez-Menendez I, 2011, BRAIN RES; Gonzalez-Menendez I, 2009, FRONT CELL NEUROSCI, V3, DOI 10.3389/neuro.03.003.2009; Hankins MW, 2008, TRENDS NEUROSCI, V31, P27, DOI 10.1016/j.tins.2007.11.002; Hannibal J, 2004, CELL TISSUE RES, V316, P99, DOI 10.1007/s00441-004-0858-x; Hannibal L, 2005, J MOL NEUROSCI, V27, P147, DOI 10.1385/JMN:27:02:147; Hattar S, 2002, SCIENCE, V295, P1065, DOI 10.1126/science.1069609; Hattar S, 2006, J COMP NEUROL, V497, P326, DOI 10.1002/cne.20970; Johnson J, 2010, P NATL ACAD SCI USA, V107, P17374, DOI 10.1073/pnas.1008533107; Li YC, 2012, CELL SIGNAL, V24, P685, DOI 10.1016/j.cellsig.2011.10.017; Mathes A, 2007, J NEUROENDOCRINOL, V19, P952, DOI 10.1111/j.1365-2826.2007.01608.x; McNeill DS, 2011, NEURAL DEV, V6, DOI 10.1186/1749-8104-6-8; NIR I, 1993, MOL BRAIN RES, V19, P47, DOI 10.1016/0169-328X(93)90147-H; Ostergaard J, 2007, INVEST OPHTH VIS SCI, V48, P3812, DOI 10.1167/iovs.06-1322; Pires SS, 2009, J NEUROSCI, V29, P12332, DOI 10.1523/JNEUROSCI.2036-09.2009; Provencio I, 2002, NATURE, V415, P493, DOI 10.1038/415493a; Ruan GX, 2006, P NATL ACAD SCI USA, V103, P9703, DOI 10.1073/pnas.0601940103; Sakamoto K, 2005, EUR J NEUROSCI, V22, P3129, DOI 10.1111/j.1460-9568.2005.04512.x; Schmidt TM, 2008, J NEUROPHYSIOL, V100, P371, DOI 10.1152/jn.00062.2008; Schmidt TM, 2011, TRENDS NEUROSCI, V34, P572, DOI 10.1016/j.tins.2011.07.001; Schmidt TM, 2011, J COMP NEUROL, V519, P1492, DOI 10.1002/cne.22579; Schmidt TM, 2010, J NEUROSCI, V30, P16262, DOI 10.1523/JNEUROSCI.3656-10.2010; Schmidt TM, 2009, J NEUROSCI, V29, P476, DOI 10.1523/JNEUROSCI.4117-08.2009; Sekaran S, 2005, CURR BIOL, V15, P1099, DOI 10.1016/j.cub.2005.05.053; Takada Y, 2004, INVEST OPHTH VIS SCI, V45, P3302, DOI 10.1167/iovs.04-0156; Tarttelin EE, 2003, EXP EYE RES, V76, P393, DOI 10.1016/S0014-4835(02)00300-7; Tian N, 2003, NEURON, V39, P85, DOI 10.1016/S0896-6273(03)00389-1; Tu DC, 2005, NEURON, V48, P987, DOI 10.1016/j.neuron.2005.09.031; Vandesompele J, 2002, GENOME BIOL, V3, DOI 10.1186/gb-2002-3-7-research0034; Viney TJ, 2007, CURR BIOL, V17, P981, DOI 10.1016/j.cub.2007.04.058; Vugler AA, 2007, J CHEM NEUROANAT, V33, P9, DOI 10.1016/j.jchemneu.2006.10.004; Vugler AA, 2007, EXP NEUROL, V205, P26, DOI 10.1016/j.expneurol.2007.01.032; Wong KY, 2007, J PHYSIOL-LONDON, V582, P279, DOI 10.1113/jphysiol.2007.133751; YOUNG RW, 1985, DEV BRAIN RES, V21, P229, DOI 10.1016/0165-3806(85)90211-1	42	26	28	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 5	2012	7	4							e34531	10.1371/journal.pone.0034531	http://dx.doi.org/10.1371/journal.pone.0034531			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	955IH	22496826	Green Submitted, Green Published, gold			2022-12-25	WOS:000305010500016
J	Huang, Y; Zheng, LS; Gong, XH; Jia, XL; Song, W; Liu, ML; Fan, YB				Huang, Yan; Zheng, Lisha; Gong, Xianghui; Jia, Xiaoling; Song, Wei; Liu, Meili; Fan, Yubo			Effect of Cyclic Strain on Cardiomyogenic Differentiation of Rat Bone Marrow Derived Mesenchymal Stem Cells	PLOS ONE			English	Article							STROMAL CELLS; IN-VITRO; MECHANICAL STRAIN; ENDOTHELIAL-CELLS; GROWTH-FACTORS; SHEAR-STRESS; CARDIOMYOCYTES; PROLIFERATION; EXPRESSION; STRETCH	Mesenchymal stem cells (MSCs) are a potential source of material for the generation of tissue-engineered cardiac grafts because of their ability to transdifferentiate into cardiomyocytes after chemical treatments or co-culture with cardiomyocytes. Cardiomyocytes in the body are subjected to cyclic strain induced by the rhythmic heart beating. Whether cyclic strain could regulate rat bone marrow derived MSC (rBMSC) differentiation into cardiomyocyte-like lineage was investigated in this study. A stretching device was used to generate the cyclic strain for rBMSCs. Cardiomyogenic differentiation was evaluated using quantitative real-time reverse transcription polymerase chain reaction (RT-PCR), immunocytochemistry and western-blotting. The results demonstrated that appropriate cyclic strain treatment alone could induce cardiomyogenic differentiation of rBMSCs, as confirmed by the expression of cardiomyocyte-related markers at both mRNA and protein levels. Furthermore, rBMSCs exposed to the strain stimulation expressed cardiomyocyte-related markers at a higher level than the shear stimulation. In addition, when rBMSCs were exposed to both strain and 5-azacytidine (5-aza), expression levels of cardiomyocyte-related markers significantly increased to a degree suggestive of a synergistic interaction. These results suggest that cyclic strain is an important mechanical stimulus affecting the cardiomyogenic differentiation of rBMSCs. This provides a new avenue for mechanistic studies of stem cell differentiation and a new approach to obtain more committed differentiated cells.	[Huang, Yan; Zheng, Lisha; Gong, Xianghui; Jia, Xiaoling; Song, Wei; Liu, Meili; Fan, Yubo] Beihang Univ, Sch Biol Sci & Med Engn, Minist Educ, Key Lab Biomech & Mechanobiol, Beijing, Peoples R China	Beihang University	Huang, Y (corresponding author), Beihang Univ, Sch Biol Sci & Med Engn, Minist Educ, Key Lab Biomech & Mechanobiol, Beijing, Peoples R China.	yubofan@buaa.edu.cn	Gong, Xianghui/AAW-1133-2020	Gong, Xianghui/0000-0002-6411-4272	National Basic Research Program of China (973 Program) [2011CB710901]; National Natural Science Foundation of China [10925208]; Specialized Research Fund for the Doctoral Program of Higher Education of China [20091102110031]	National Basic Research Program of China (973 Program)(National Basic Research Program of China); National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Specialized Research Fund for the Doctoral Program of Higher Education of China(Specialized Research Fund for the Doctoral Program of Higher Education (SRFDP))	This project was supported by the National Basic Research Program of China (973 Program, No. 2011CB710901, www.most.gov.cn), the National Natural Science Foundation of China (No. 10925208, www.nsfc.gov.cn), and the Specialized Research Fund for the Doctoral Program of Higher Education of China (No. 20091102110031, www.cutech.edu.cn). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abi-Char J, 2007, J PHYSIOL-LONDON, V582, P1205, DOI 10.1113/jphysiol.2007.134809; Amado LC, 2005, P NATL ACAD SCI USA, V102, P11474, DOI 10.1073/pnas.0504388102; Antonitsis Polychronis, 2007, Interact Cardiovasc Thorac Surg, V6, P593, DOI 10.1510/icvts.2007.157875; Arminan A, 2009, STEM CELLS DEV, V18, P907, DOI 10.1089/scd.2008.0292; Bai K, 2010, J BIOMECH, V43, P1176, DOI 10.1016/j.jbiomech.2009.11.030; Bartunek J, 2007, AM J PHYSIOL-HEART C, V292, pH1095, DOI 10.1152/ajpheart.01009.2005; Brand NJ, 2006, INT J BIOCHEM CELL B, V38, P30, DOI 10.1016/j.biocel.2005.06.018; BRAUNWALD E, 1988, HEART DISEASE, P383; Burlacu A, 2008, EUR J CELL BIOL, V87, P173, DOI 10.1016/j.ejcb.2007.09.003; Engler AJ, 2006, CELL, V126, P677, DOI 10.1016/j.cell.2006.06.044; Feng C, 2009, EXP CELL RES, V315, P3044, DOI 10.1016/j.yexcr.2009.05.005; Fink C, 2000, FASEB J, V14, P669, DOI 10.1096/fasebj.14.5.669; Gomes ME, 2006, TISSUE ENG, V12, P177, DOI 10.1089/ten.2006.12.177; Gwak SJ, 2008, BIOMATERIALS, V29, P844, DOI 10.1016/j.biomaterials.2007.10.050; Hamilton DW, 2004, TISSUE ENG, V10, P361, DOI 10.1089/107632704323061726; Huang Y, 2010, ARCH MED RES, V41, P497, DOI 10.1016/j.arcmed.2010.10.002; Hwang NS, 2008, ADV DRUG DELIVER REV, V60, P199, DOI 10.1016/j.addr.2007.08.036; Inuernicia G, 2008, EXP CELL RES, V314, P366, DOI 10.1016/j.yexcr.2007.08.006; Jacot JG, 2010, J BIOMECH, V43, P93, DOI 10.1016/j.jbiomech.2009.09.014; Jang JY, 2011, J BIOMED BIOTECHNOL, DOI 10.1155/2011/860652; Kablar B, 2003, DEV BIOL, V258, P307, DOI 10.1016/S0012-1606(03)00139-8; Kasper G, 2007, STEM CELLS, V25, P903, DOI 10.1634/stemcells.2006-0432; Koike M, 2005, J BONE MINER METAB, V23, P219, DOI 10.1007/s00774-004-0587-y; Kreke MR, 2008, TISSUE ENG PT A, V14, P529, DOI 10.1089/tea.2007.0068; Kreke MR, 2005, BONE, V36, P1047, DOI 10.1016/j.bone.2005.03.008; Kreke MR, 2004, TISSUE ENG, V10, P780, DOI 10.1089/1076327041348455; Kurpinski K, 2006, P NATL ACAD SCI USA, V103, P16095, DOI 10.1073/pnas.0604182103; Lattanzi L, 1998, J CLIN INVEST, V101, P2119, DOI 10.1172/JCI1505; Li X, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0026029; Li XH, 2007, J MOL CELL CARDIOL, V42, P295, DOI 10.1016/j.yjmcc.2006.07.002; Martin-Rendon E, 2008, VOX SANG, V95, P137, DOI 10.1111/j.1423-0410.2008.01076.x; Martinez EC, 2011, J MOL CELL CARDIOL, V50, P312, DOI 10.1016/j.yjmcc.2010.08.009; McCloskey KE, 2006, J VASC RES, V43, P411, DOI 10.1159/000094791; Mouw JK, 2007, STEM CELLS, V25, P655, DOI 10.1634/stemcells.2006-0435; O'Cearbhaill ED, 2008, BIOMATERIALS, V29, P1610, DOI 10.1016/j.biomaterials.2007.11.042; Park JS, 2007, FRONT BIOSCI-LANDMRK, V12, P5098, DOI 10.2741/2551; Park JS, 2004, BIOTECHNOL BIOENG, V88, P359, DOI 10.1002/bit.20250; Pfaffl MW, 2001, NUCLEIC ACIDS RES, V29, DOI 10.1093/nar/29.9.e45; Quinlan AMT, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0023272; Riddle RC, 2006, AM J PHYSIOL-CELL PH, V290, pC776, DOI 10.1152/ajpcell.00082.2005; SADOSHIMA J, 1992, J BIOL CHEM, V267, P10551; Saha S, 2006, J CELL PHYSIOL, V206, P126, DOI 10.1002/jcp.20441; Schmelter M, 2006, FASEB J, V20, P1182, DOI 10.1096/fj.05-4723fje; Shim WSN, 2004, BIOCHEM BIOPH RES CO, V324, P481, DOI 10.1016/j.bbrc.2004.09.087; Shimko VF, 2008, TISSUE ENG PT A, V14, P49, DOI 10.1089/ten.a.2007.0092; Simmons CA, 2003, J BIOMECH, V36, P1087, DOI 10.1016/S0021-9290(03)00110-6; Toma C, 2002, CIRCULATION, V105, P93, DOI 10.1161/hc0102.101442; Vandenburgh HH, 1996, AM J PHYSIOL-CELL PH, V270, pC1284, DOI 10.1152/ajpcell.1996.270.5.C1284; Wang FW, 2009, NEUROSCIENCE, V160, P319, DOI 10.1016/j.neuroscience.2009.02.068; Wang TZ, 2006, INT J CARDIOL, V109, P74, DOI 10.1016/j.ijcard.2005.05.072; Xie XJ, 2006, ACTA PHARMACOL SIN, V27, P1153, DOI 10.1111/j.1745-7254.2006.00436.x; Yamada K, 2005, CIRC RES, V97, P346, DOI 10.1161/01.RES.0000178788.76568.8a; Yang MC, 2009, BIOMATERIALS, V30, P3757, DOI 10.1016/j.biomaterials.2009.03.057; Zeng LF, 2006, J CELL BIOL, V174, P1059, DOI 10.1083/jcb.200605113	54	64	72	0	50	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 4	2012	7	4							e34960	10.1371/journal.pone.0034960	http://dx.doi.org/10.1371/journal.pone.0034960			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	953GO	22496879	Green Published, gold, Green Submitted			2022-12-25	WOS:000304855200090
J	Khakhalin, AS; Aizenman, CD				Khakhalin, Arseny S.; Aizenman, Carlos D.			GABAergic Transmission and Chloride Equilibrium Potential Are Not Modulated by Pyruvate in the Developing Optic Tectum of Xenopus laevis Tadpoles	PLOS ONE			English	Article							IN-VIVO; INTRINSIC EXCITABILITY; KETONE-BODIES; NEURONS; EXCITATION; CIRCUIT; GABA; AVAILABILITY; INHIBITION; METABOLISM	In the developing mammalian brain, gamma-aminobutyric acid (GABA) is thought to play an excitatory rather than an inhibitory role due to high levels of intracellular Cl- in immature neurons. This idea, however, has been questioned by recent studies which suggest that glucose-based artificial cerebrospinal fluid (ACSF) may be inadequate for experiments on immature and developing brains. These studies suggest that immature neurons may require alternative energy sources, such as lactate or pyruvate. Lack of these other energy sources is thought to result in artificially high intracellular Cl- concentrations, and therefore a more depolarized GABA receptor (GABAR) reversal potential. Since glucose metabolism can vary widely among different species, it is important to test the effects of these alternative energy sources on different experimental preparations. We tested whether pyruvate affects GABAergic transmission in isolated brains of developing wild type Xenopus tadpoles in vitro by recording the responsiveness of tectal neurons to optic nerve stimulation, and by measuring currents evoked by local GABA application in a gramicidin perforated patch configuration. We found that, in contrast with previously reported results, the reversal potential for GABAR-mediated currents does not change significantly between developmental stages 45 and 49. Partial substitution of glucose by pyruvate had only minor effects on both the GABA reversal potential, and the responsiveness of tectal neurons at stages 45 and 49. Total depletion of energy sources from the ACSF did not affect neural responsiveness. We also report a strong spatial gradient in GABA reversal potential, with immature cells adjacent to the lateral and caudal proliferative zones having more positive reversal potentials. We conclude that in this experimental preparation standard glucose-based ACSF is an appropriate extracellular media for in vitro experiments.	[Khakhalin, Arseny S.; Aizenman, Carlos D.] Brown Univ, Dept Neurosci, Providence, RI 02912 USA	Brown University	Khakhalin, AS (corresponding author), Brown Univ, Dept Neurosci, Providence, RI 02912 USA.	Carlos_Aizenman@brown.edu		Khakhalin, Arseny/0000-0002-0429-1728	National Eye Institute of the NIH [5R01 EYO19578-02]; NATIONAL EYE INSTITUTE [R01EY019578] Funding Source: NIH RePORTER	National Eye Institute of the NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI)); NATIONAL EYE INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI))	This work was supported by grant 5R01 EYO19578-02, from the National Eye Institute of the NIH [http://www.nei.nih.gov/]. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aizenman CD, 2007, J NEUROPHYSIOL, V97, P2949, DOI 10.1152/jn.00452.2006; Aizenman CD, 2003, NEURON, V39, P831, DOI 10.1016/S0896-6273(03)00527-0; Akerman CJ, 2007, TRENDS NEUROSCI, V30, P382, DOI 10.1016/j.tins.2007.06.002; Akerman CJ, 2006, J NEUROSCI, V26, P5117, DOI 10.1523/JNEUROSCI.0319-06.2006; Ben-Ari Y, 2007, PHYSIOL REV, V87, P1215, DOI 10.1152/physrev.00017.2006; Brumberg JC, 2000, J NEUROSCI, V20, P4829; Canepari M, 1997, BIOL CYBERN, V77, P153, DOI 10.1007/s004220050376; Casey JR, 2010, NAT REV MOL CELL BIO, V11, P50, DOI 10.1038/nrm2820; Church J, 1998, J PHYSIOL-LONDON, V511, P119, DOI 10.1111/j.1469-7793.1998.119bi.x; Clements JD, 1997, BIOPHYS J, V73, P220, DOI 10.1016/S0006-3495(97)78062-7; Dong W, 2009, J NEUROPHYSIOL, V101, P803, DOI 10.1152/jn.90848.2008; Dzhala VI, 2005, NAT MED, V11, P1205, DOI 10.1038/nm1301; Faber J., 1994, NORMAL TABLE XENOPUS, P2; Hahn G, 2010, J NEUROPHYSIOL, V104, P3312, DOI 10.1152/jn.00953.2009; Holmgren CD, 2010, J NEUROCHEM, V112, P900, DOI 10.1111/j.1471-4159.2009.06506.x; Juge N, 2010, NEURON, V68, P99, DOI 10.1016/j.neuron.2010.09.002; Khakhalin AS, 2011, J NEUROPHYSIOL, V106, P1065, DOI 10.1152/jn.00293.2011; Kirmse K, 2010, J NEUROSCI, V30, P16002, DOI 10.1523/JNEUROSCI.2534-10.2010; Kudela P, 2003, BIOL CYBERN, V88, P276, DOI 10.1007/s00422-002-0381-7; KYROZIS A, 1995, J NEUROSCI METH, V57, P27, DOI 10.1016/0165-0270(94)00116-X; LAZAR G, 1973, J ANAT, V116, P347; MERKLE S, 1988, COMP BIOCHEM PHYS B, V89, P719, DOI 10.1016/0305-0491(88)90314-8; Mukhtarov Marat, 2011, J Neurochem, V116, P316, DOI 10.1111/j.1471-4159.2010.07111.x; Nehlig A, 2004, PROSTAG LEUKOTR ESS, V70, P265, DOI 10.1016/j.plefa.2003.07.006; Pouille F, 2009, NAT NEUROSCI, V12, P1577, DOI 10.1038/nn.2441; Pratt KG, 2008, NAT NEUROSCI, V11, P467, DOI 10.1038/nn2076; Pratt KG, 2007, J NEUROSCI, V27, P8268, DOI 10.1523/JNEUROSCI.1738-07.2007; Pratt KG, 2009, J NEUROPHYSIOL, V102, P399, DOI 10.1152/jn.91317.2008; Rheims S, 2009, J NEUROCHEM, V110, P1330, DOI 10.1111/j.1471-4159.2009.06230.x; Richards Blake A, 2010, Front Synaptic Neurosci, V2, P7, DOI 10.3389/fnsyn.2010.00007; Ruusuvuori E, 2010, J NEUROSCI, V30, P15638, DOI 10.1523/JNEUROSCI.3355-10.2010; Schulz DJ, 2006, J EXP BIOL, V209, P4821, DOI 10.1242/jeb.02567; Simmons A, 2004, J COMP PHYSIOL A, V190, P747, DOI 10.1007/s00359-004-0534-3; Tyzio R, 2011, J NEUROSCI, V31, P34, DOI 10.1523/JNEUROSCI.3314-10.2011; Wright R, 2011, NEURAL PLAST, V2011, DOI 10.1155/2011/728395; Wu GY, 1996, SCIENCE, V274, P972, DOI 10.1126/science.274.5289.972; Zhang LI, 1998, NATURE, V395, P37, DOI 10.1038/25665; Zilberter Y, 2010, TRENDS PHARMACOL SCI, V31, P394, DOI 10.1016/j.tips.2010.06.005	38	16	16	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 4	2012	7	4							e34446	10.1371/journal.pone.0034446	http://dx.doi.org/10.1371/journal.pone.0034446			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	953GO	22496804	Green Published, Green Submitted, gold			2022-12-25	WOS:000304855200050
J	Sato, M; Kojima, K; Sakuma, C; Murakami, M; Aratani, E; Takenouchi, T; Tamada, Y; Kitani, H				Sato, Mitsuru; Kojima, Katsura; Sakuma, Chisato; Murakami, Maria; Aratani, Eriko; Takenouchi, Takato; Tamada, Yasushi; Kitani, Hiroshi			Production of scFv-Conjugated Affinity Silk Powder by Transgenic Silkworm Technology	PLOS ONE			English	Article							WISKOTT-ALDRICH-SYNDROME; RECOMBINANT PROTEINS; CELL LINES; FIBROIN; ANTIBODY; DIFFERENTIATION; NANOPARTICLES; GENERATION; SCAFFOLDS; SYSTEM	Bombyx mori (silkworm) silk proteins are being utilized as unique biomaterials for medical applications. Chemical modification or post-conjugation of bioactive ligands expand the applicability of silk proteins; however, the processes are elaborate and costly. In this study, we used transgenic silkworm technology to develop single-chain variable fragment (scFv)-conjugated silk fibroin. The cocoons of the transgenic silkworm contain fibroin L-chain linked with scFv as a fusion protein. After dissolving the cocoons in lithium bromide, the silk solution was dialyzed, concentrated, freeze-dried, and crushed into powder. Immunoprecipitation analyses demonstrate that the scFv domain retains its specific binding activity to the target molecule after multiple processing steps. These results strongly suggest the promise of scFv-conjugated silk fibroin as an alternative affinity reagent, which can be manufactured using transgenic silkworm technology at lower cost than traditional affinity carriers.	[Sato, Mitsuru; Sakuma, Chisato; Takenouchi, Takato; Kitani, Hiroshi] Natl Inst Agrobiol Sci, Anim Immune & Cell Biol Res Unit, Tsukuba, Ibaraki, Japan; [Kojima, Katsura; Murakami, Maria; Aratani, Eriko; Tamada, Yasushi] Natl Inst Agrobiol Sci, Silk Mat Res Unit, Tsukuba, Ibaraki, Japan	National Institute of Agrobiological Sciences - Japan; National Institute of Agrobiological Sciences - Japan	Sato, M (corresponding author), Natl Inst Agrobiol Sci, Anim Immune & Cell Biol Res Unit, Tsukuba, Ibaraki, Japan.	kitani@affrc.go.jp			Program for Promotion of Basic and Applied Research for Innovations in Bio-oriented Industry	Program for Promotion of Basic and Applied Research for Innovations in Bio-oriented Industry	This work was supported by the Program for Promotion of Basic and Applied Research for Innovations in Bio-oriented Industry (http://brain.naro.affrc.go.jp/index-e.html). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	BIRD RE, 1988, SCIENCE, V242, P423, DOI 10.1126/science.3140379; Davies J, 1996, PROTEIN ENG, V9, P531, DOI 10.1093/protein/9.6.531; DERRY JMJ, 1994, CELL, V78, P635, DOI 10.1016/0092-8674(94)90528-2; Gotoh Y, 1997, BIOMATERIALS, V18, P267, DOI 10.1016/S0142-9612(96)00137-8; Gupta V, 2009, INT J NANOMED, V4, P115; Hino R, 2006, BIOMATERIALS, V27, P5715, DOI 10.1016/j.biomaterials.2006.07.028; HUSTON JS, 1988, P NATL ACAD SCI USA, V85, P5879, DOI 10.1073/pnas.85.16.5879; Iizuka M, 2009, FEBS J, V276, P5806, DOI 10.1111/j.1742-4658.2009.07262.x; Inoue S, 2005, INSECT BIOCHEM MOLEC, V35, P51, DOI 10.1016/j.ibmb.2004.10.002; Karageorgiou V, 2004, J BIOMED MATER RES A, V71A, P528, DOI 10.1002/jbm.a.30186; Kim UJ, 2004, BIOMACROMOLECULES, V5, P786, DOI 10.1021/bm0345460; Kojima K, 2007, BIOSCI BIOTECH BIOCH, V71, P2943, DOI 10.1271/bbb.70353; Mathur AB, 2010, NANOMEDICINE-UK, V5, P807, DOI [10.2217/nnm.10.51, 10.2217/NNM.10.51]; Meinel L, 2004, J BIOMED MATER RES A, V71A, P25, DOI 10.1002/jbm.a.30117; Murphy AR, 2008, BIOMATERIALS, V29, P2829, DOI 10.1016/j.biomaterials.2008.03.039; Nazarov R, 2004, BIOMACROMOLECULES, V5, P718, DOI 10.1021/bm034327e; Ogawa S, 2007, J BIOTECHNOL, V128, P531, DOI 10.1016/j.jbiotec.2006.10.019; RALPH P, 1977, J IMMUNOL, V119, P950; RASCHKE WC, 1978, CELL, V15, P261, DOI 10.1016/0092-8674(78)90101-0; Rockwood DN, 2011, NAT PROTOC, V6, P1612, DOI 10.1038/nprot.2011.379; Sato M, 2005, FEBS J, V272, P6131, DOI 10.1111/j.1742-4658.2005.05011.x; Sato M, 2001, J IMMUNOL, V167, P4701, DOI 10.4049/jimmunol.167.8.4701; Sofia S, 2001, J BIOMED MATER RES, V54, P139, DOI 10.1002/1097-4636(200101)54:1<139::AID-JBM17>3.0.CO;2-7; Tamada Y, 2005, BIOMACROMOLECULES, V6, P3100, DOI 10.1021/bm050431f; Tamada Y, 2004, BIOMATERIALS, V25, P377, DOI 10.1016/S0142-9612(03)00533-7; Tamura T, 2000, NAT BIOTECHNOL, V18, P81, DOI 10.1038/71978; Thrasher AJ, 2002, NAT REV IMMUNOL, V2, P635, DOI 10.1038/nri884; WINTER G, 1991, NATURE, V349, P293, DOI 10.1038/349293a0	28	17	19	0	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 4	2012	7	4							e34632	10.1371/journal.pone.0034632	http://dx.doi.org/10.1371/journal.pone.0034632			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	953GO	22496833	gold, Green Submitted, Green Published			2022-12-25	WOS:000304855200064
J	Fischedick, G; Klein, DC; Wu, GM; Esch, D; Hoing, S; Han, DW; Reinhardt, P; Hergarten, K; Tapia, N; Scholer, HR; Sterneckert, JL				Fischedick, Gerrit; Klein, Diana C.; Wu, Guangming; Esch, Daniel; Hoeing, Susanne; Han, Dong Wook; Reinhardt, Peter; Hergarten, Kerstin; Tapia, Natalia; Schoeler, Hans R.; Sterneckert, Jared L.			Zfp296 Is a Novel, Pluripotent-Specific Reprogramming Factor	PLOS ONE			English	Article							NEURAL STEM-CELLS; ES; CONVERSION; CLONING; CYCLE	Expression of the four transcription factors Oct4, Sox2, Klf4, and c-Myc (OSKM) is sufficient to reprogram somatic cells into induced pluripotent stem (iPSCs). However, this process is slow and inefficient compared with the fusion of somatic cells with embryonic stem cells (ESCs), indicating that ESCs express additional factors that can enhance the efficiency of reprogramming We had previously developed a method to detect and isolate early neural induction intermediates during the differentiation of mouse ESCs. Using the gene expression profiles of these intermediates, we identified 23 ESC-specific transcripts and tested each for the ability to enhance iPSC formation. Of the tested factors, zinc finger protein 296 (Zfp296) led to the largest increase in mouse iPSC formation. We confirmed that Zfp296 was specifically expressed in pluripotent stem cells and germ cells. Zfp296 in combination with OSKM induced iPSC formation earlier and more efficiently than OSKM alone. Through mouse chimera and teratoma formation, we demonstrated that the resultant iPSCs were pluripotent. We showed that Zfp296 activates transcription of the Oct4 gene via the germ cell specific conserved region 4 (CR4), and when overexpressed in mouse ESCs leads to upregulation of Nanog expression and downregulation of the expression of differentiation markers, including Sox17, Eomes, and T, which is consistent with the observation that Zfp296 enhances the efficiency of reprogramming. In contrast, knockdown of Zfp296 in ESCs leads to the expression of differentiation markers. Finally, we demonstrated that expression of Zfp296 in ESCs inhibits, but does not block, differentiation into neural cells.	[Fischedick, Gerrit; Klein, Diana C.; Wu, Guangming; Esch, Daniel; Hoeing, Susanne; Reinhardt, Peter; Hergarten, Kerstin; Tapia, Natalia; Schoeler, Hans R.; Sterneckert, Jared L.] Max Planck Inst Mol Biomed, Dept Cell & Dev Biol, Munster, Germany; [Han, Dong Wook] Konkuk Univ, Dept Stem Cell Biol, Sch Med, Seoul, South Korea; [Schoeler, Hans R.] Univ Munster, Fac Med, Munster, Germany	Max Planck Society; Konkuk University; Konkuk University Medical Center; University of Munster	Fischedick, G (corresponding author), Max Planck Inst Mol Biomed, Dept Cell & Dev Biol, Munster, Germany.	office@mpi-muenster.mpg.de	Sterneckert, Jared/E-6802-2015; , HS/AAB-4434-2019; Tapia, Natalia/H-5500-2012	, HS/0000-0003-2643-5136; Sterneckert, Jared/0000-0002-7688-3124; Tapia, Natalia/0000-0003-0226-1952; Klein, Diana/0000-0002-1770-443X	Deutsche Forschungsgemeinschaft (DFG) [SCHO340/5-1, SPP 1356]	Deutsche Forschungsgemeinschaft (DFG)(German Research Foundation (DFG))	This work was generously supported by grant (SCHO340/5-1) from the Deutsche Forschungsgemeinschaft (DFG) Priority Program: Pluripotency and Cellular Reprogramming (SPP 1356). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aasen T, 2008, NAT BIOTECHNOL, V26, P1276, DOI 10.1038/nbt.1503; Anastassiadis K, 2002, GENE, V298, P159, DOI 10.1016/S0378-1119(02)00979-4; Bhutani N, 2010, NATURE, V463, P1042, DOI 10.1038/nature08752; Boland MJ, 2009, NATURE, V461, P91, DOI 10.1038/nature08310; Chambers SM, 2009, NAT BIOTECHNOL, V27, P275, DOI 10.1038/nbt.1529; Cowan CA, 2004, NEW ENGL J MED, V350, P1353, DOI 10.1056/NEJMsr040330; Dear TN, 2000, MAMM GENOME, V11, P1037, DOI 10.1007/s003350010182; Do JT, 2006, STEM CELL REV, V2, P257, DOI 10.1007/BF02698052; Eminli S, 2009, NAT GENET, V41, P968, DOI 10.1038/ng.428; Han DW, 2008, STEM CELLS, V26, P445, DOI 10.1634/stemcells.2007-0553; Han DW, 2011, NAT CELL BIOL, V13, P66, DOI 10.1038/ncb2136; Hanna J, 2008, CELL, V133, P250, DOI 10.1016/j.cell.2008.03.028; HOGAN B, 1986, MANIPULATING MOUSE E; Ito S, 2010, NATURE, V466, P1129, DOI 10.1038/nature09303; Kang L, 2009, CELL STEM CELL, V5, P135, DOI 10.1016/j.stem.2009.07.001; Kim JB, 2008, NATURE, V454, P646, DOI 10.1038/nature07061; Kim JB, 2009, CELL, V136, P411, DOI 10.1016/j.cell.2009.01.023; Kitamura T, 2003, EXP HEMATOL, V31, P1007, DOI 10.1016/j.exphem.2003.07.005; Ko K, 2009, CELL STEM CELL, V5, P87, DOI 10.1016/j.stem.2009.05.025; Nagy A, 1993, GENE TARGETING PRACT; Nordhoff V, 2001, MAMM GENOME, V12, P309, DOI 10.1007/s003350010279; Okita K, 2007, NATURE, V448, P313, DOI 10.1038/nature05934; Palermo A, 2009, FASEB J, V23, P1431, DOI 10.1096/fj.08-122903; Sebastiano V, 2010, DEVELOPMENT, V137, P3551, DOI 10.1242/dev.047027; Sterneckert J, 2010, STEM CELLS, V28, P1772, DOI 10.1002/stem.498; Takahashi K, 2006, CELL, V126, P663, DOI 10.1016/j.cell.2006.07.024; Tang FC, 2009, NAT METHODS, V6, P377, DOI [10.1038/NMETH.1315, 10.1038/nmeth.1315]; Wernig M, 2007, NATURE, V448, P318, DOI 10.1038/nature05944; Wu GM, 2011, PLOS BIOL, V9, DOI 10.1371/journal.pbio.1001099; Yeom YI, 1996, DEVELOPMENT, V122, P881; Zhao XY, 2009, NATURE, V461, P86, DOI 10.1038/nature08267	31	26	26	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 2	2012	7	4							e34645	10.1371/journal.pone.0034645	http://dx.doi.org/10.1371/journal.pone.0034645			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	952GU	22485183	Green Published, gold, Green Submitted			2022-12-25	WOS:000304780500058
J	Lee, J; Sung, CO; Lee, EJ; Do, IG; Kim, HC; Yoon, SH; Lee, WY; Chun, HK; Kim, KM; Park, YS				Lee, Jeeyun; Sung, Chang Ohk; Lee, Eui J.; Do, In-Gu; Kim, Hee-Cheol; Yoon, Seong Hyeon; Lee, Woo Yong; Chun, Ho Kyung; Kim, Kyoung-Mee; Park, Young Suk			Metastasis of Neuroendocrine Tumors Are Characterized by Increased Cell Proliferation and Reduced Expression of the ATM Gene	PLOS ONE			English	Article							BREAST-CANCER PATIENTS; DNA-DAMAGE RESPONSE; ATAXIA-TELANGIECTASIA; CARCINOID-TUMORS; ENDOCRINE TUMORS; RISK; LYMPHOMA; RECTUM; LINES; RADIOSENSITIVITY	Purpose: Gastroenteropancreatic neuroendocrine tumors (GEP-NETs) are rare group of tumors with a wide spectrum of clinical behavior. However, there are no known clinically relevant biomarkers to predict metastasis. Experimental Design: To investigate differential gene expression signatures of metastatic vs non-metastatic NETs, we studied cell cycle regulatory genes in 19 metastatic and 22 non-metastatic colorectal NETs by PCR arrays. Immunohistochemistry (IHC) and quantitative real-time RT-PCR were performed to verify the results and another set of 38 GEP-NETs were further studied for validation. Results: We first delineated six candidate genes for metastasis including ATM, CCND2, RBL2, CDKN3, CCNB1, and GTSE1. ATM was negatively correlated with metastatic NETs (p<0.001) with more than 2-fold change compared to non-metastatic NETs. Overexpression of ATM protein by IHC was strongly correlated with high ATM mRNA levels and low Ki-67 labeling index. Patients with ATM-negativity by IHC showed significantly decreased overall survival than patients with ATM-positivity (median OS, metastatic vs non-metastatic NETs; 2.7 years vs not reached; p = 0.003) and 85.7% of metastatic NETs were ATM-negative. In another validation set of GEP-NETs, decreased mRNA of ATM gene was associated with metastasis and remained significant (p = 0.023). Conclusions: ATM down-regulation was strongly associated with metastatic NETs when compared with non-metastatic NETs and ATM may be a potential predictive marker for metastasis as well as a novel target in metastatic GEP-NETs.	[Lee, Jeeyun; Park, Young Suk] Sungkyunkwan Univ, Sch Med, Dept Med, Div Hematol Oncol, Seoul, South Korea; [Lee, Eui J.] Catholic Univ Korea, Incheon St Mary Hosp, Res Inst, Seoul, South Korea; [Do, In-Gu] Sungkyunkwan Univ, Sch Med, Samsung Canc Res Inst, Seoul, South Korea; [Kim, Hee-Cheol; Yoon, Seong Hyeon; Lee, Woo Yong; Chun, Ho Kyung] Sungkyunkwan Univ, Sch Med, Samsung Med Ctr, Seoul, South Korea	Sungkyunkwan University (SKKU); Catholic University of Korea; Samsung; Sungkyunkwan University (SKKU); Sungkyunkwan University (SKKU); Samsung Medical Center	Lee, J (corresponding author), Sungkyunkwan Univ, Sch Med, Dept Med, Div Hematol Oncol, Seoul, South Korea.	kkmkys@skku.edu; pys27hmo@skku.edu	Lee, Jee Yun/C-9646-2011; Lee, Jeeyun/I-7171-2015	Sung, Chang Ohk/0000-0002-8567-456X				Ai LB, 2004, CANCER EPIDEM BIOMAR, V13, P150, DOI 10.1158/1055-9965.EPI-082-3; Atencio DP, 2001, ENVIRON MOL MUTAGEN, V38, P200, DOI 10.1002/em.1072; Bartek J, 2011, MOL ONCOL, V5, P303, DOI 10.1016/j.molonc.2011.07.006; Bartkova J, 2005, NATURE, V434, P864, DOI 10.1038/nature03482; Chan JA, 2011, CURR TREAT OPTIONS O; COLE J, 1988, INT J RADIAT BIOL, V54, P929, DOI 10.1080/09553008814552331; Dahlberg WK, 1995, CLIN CANCER RES, V1, P785; De Falco G, 2007, BLOOD, V110, P1301, DOI 10.1182/blood-2006-12-064865; Fahy BN, 2007, ANN SURG ONCOL, V14, P1735, DOI 10.1245/s10434-006-9311-6; Gatti RA, 1999, MOL GENET METAB, V68, P419, DOI 10.1006/mgme.1999.2942; Hauso O, 2008, CANCER, V113, P2655, DOI 10.1002/cncr.23883; Hemminki K, 2001, CANCER, V92, P2204, DOI 10.1002/1097-0142(20011015)92:8&lt;2204::AID-CNCR1564&gt;3.0.CO;2-R; Iannuzzi CM, 2002, INT J RADIAT ONCOL, V52, P606, DOI 10.1016/S0360-3016(01)02684-0; Indra DM, 2011, HUM GENET, V130, P735, DOI 10.1007/s00439-011-1015-8; Ito T, 2010, J GASTROENTEROL, V45, P234, DOI 10.1007/s00535-009-0194-8; Khanna KK, 2000, JNCI-J NATL CANCER I, V92, P795, DOI 10.1093/jnci/92.10.795; Kim WJ, 2002, ONCOGENE, V21, P3864, DOI 10.1038/sj.onc.1205485; Klimstra DS, 2010, AM J SURG PATHOL, V34, P300, DOI 10.1097/PAS.0b013e3181ce1447; Kloppel G, 2004, ANN NY ACAD SCI, V1014, P13, DOI 10.1196/annals.1294.002; Koura AN, 1997, CANCER, V79, P1294, DOI 10.1002/(SICI)1097-0142(19970401)79:7<1294::AID-CNCR4>3.0.CO;2-H; Lavin MF, 2008, NAT REV MOL CELL BIO, V9, P759, DOI 10.1038/nrm2514; Lee SW, 2000, MOL CELL BIOL, V20, P1723, DOI 10.1128/MCB.20.5.1723-1732.2000; Lepage C, 2007, GASTROENTEROLOGY, V132, P899, DOI 10.1053/j.gastro.2007.01.006; Lobrich M, 2007, NAT REV CANCER, V7, P861, DOI 10.1038/nrc2248; Matsuoka S, 1998, SCIENCE, V282, P1893, DOI 10.1126/science.282.5395.1893; Mitui M, 2009, HUM MUTAT, V30, P12, DOI 10.1002/humu.20805; Modlin IM, 2003, CANCER-AM CANCER SOC, V97, P934, DOI 10.1002/cncr.11105; Schaffner C, 2000, P NATL ACAD SCI USA, V97, P2773, DOI 10.1073/pnas.050400997; Shields CJ, 2010, ANN SURG, V252, P750, DOI 10.1097/SLA.0b013e3181fb8df6; Soga J, 1998, J EXP CLIN CANC RES, V17, P139; Solcia EKG, 2000, WHO INT HISTOLOGICAL; Sterner JM, 1998, MOL CELL BIOL, V18, P2748, DOI 10.1128/MCB.18.5.2748; Stoppa-Lyonnet D, 1998, BLOOD, V91, P3920, DOI 10.1182/blood.V91.10.3920.3920_3920_3926; SWIFT M, 1991, NEW ENGL J MED, V325, P1831, DOI 10.1056/NEJM199112263252602; Taylor AMR, 2005, J CLIN PATHOL, V58, P1009, DOI 10.1136/jcp.2005.026062; Vorechovsky I, 1996, CANCER RES, V56, P2726; Weston VJ, 2010, BLOOD, V116, P4578, DOI 10.1182/blood-2010-01-265769; Williams GT, 2007, HISTOPATHOLOGY, V50, P30, DOI 10.1111/j.1365-2559.2006.02570.x; Williamson CT, 2010, MOL CANCER THER, V9, P347, DOI 10.1158/1535-7163.MCT-09-0872; Xie P, 2011, BIOCHEM BIOPH RES CO, V404, P413, DOI 10.1016/j.bbrc.2010.11.135; Yao JC, 2008, J CLIN ONCOL, V26, P3063, DOI 10.1200/JCO.2007.15.4377; Yao JC, 2011, NEW ENGL J MED, V364, P514, DOI 10.1056/NEJMoa1009290; Zhang L, 2004, MUTAT RES-GEN TOX EN, V557, P41, DOI 10.1016/j.mrgentox.2003.09.012; Zhang PL, 2003, CANCER BIOL THER, V2, P87	44	22	30	0	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 2	2012	7	4							e34456	10.1371/journal.pone.0034456	http://dx.doi.org/10.1371/journal.pone.0034456			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	952GU	22485171	gold, Green Submitted, Green Published			2022-12-25	WOS:000304780500046
J	Yi, YJ; Sutovsky, M; Kennedy, C; Sutovsky, P				Yi, Young-Joo; Sutovsky, Miriam; Kennedy, Chelsey; Sutovsky, Peter			Identification of the Inorganic Pyrophosphate Metabolizing, ATP Substituting Pathway in Mammalian Spermatozoa	PLOS ONE			English	Article							EXTRACELLULAR ADENOSINE 5'-TRIPHOSPHATE; CORTICAL GRANULE EXOCYTOSIS; PIG OOCYTES; MOUSE SPERMATOZOA; BOAR SPERMATOZOA; IN-VITRO; PROTEIN; FERTILIZATION; PHOSPHORYLATION; ANK	Inorganic pyrophosphate (PPi) is generated by ATP hydrolysis in the cells and also present in extracellular matrix, cartilage and bodily fluids. Fueling an alternative pathway for energy production in cells, PPi is hydrolyzed by inorganic pyrphosphatase (PPA1) in a highly exergonic reaction that can under certain conditions substitute for ATP-derived energy. Recombinant PPA1 is used for energy-regeneration in the cell-free systems used to study the zymology of ATP-dependent ubiquitin-proteasome system, including the role of sperm-borne proteasomes in mammalian fertilization. Inspired by an observation of reduced in vitro fertilization (IVF) rates in the presence of external, recombinant PPA1, this study reveals, for the first time, the presence of PPi, PPA1 and PPi transporter, progressive ankylosis protein ANKH in mammalian spermatozoa. Addition of PPi during porcine IVF increased fertilization rates significantly and in a dose-dependent manner. Fluorometric assay detected high levels of PPi in porcine seminal plasma, oviductal fluid and spermatozoa. Immunofluorescence detected PPA1 in the postacrosomal sheath (PAS) and connecting piece of boar spermatozoa; ANKH was present in the sperm head PAS and equatorial segment. Both ANKH and PPA1 were also detected in human and mouse spermatozoa, and in porcine spermatids. Higher proteasomal-proteolytic activity, indispensable for fertilization, was measured in spermatozoa preserved with PPi. The identification of an alternative, PPi dependent pathway for ATP production in spermatozoa elevates our understanding of sperm physiology and sets the stage for the improvement of semen extenders, storage media and IVF media for animal biotechnology and human assisted reproductive therapies.	[Yi, Young-Joo; Sutovsky, Miriam; Kennedy, Chelsey; Sutovsky, Peter] Univ Missouri, Div Anim Sci, Columbia, MO 65211 USA; [Sutovsky, Peter] Univ Missouri, Dept Obstet, Columbia, MO USA; [Sutovsky, Peter] Univ Missouri, Dept Gynecol, Columbia, MO USA; [Sutovsky, Peter] Univ Missouri, Dept Womens Hlth, Columbia, MO USA	University of Missouri System; University of Missouri Columbia; University of Missouri System; University of Missouri Columbia; University of Missouri System; University of Missouri Columbia; University of Missouri System; University of Missouri Columbia	Yi, YJ (corresponding author), Univ Missouri, Div Anim Sci, Columbia, MO 65211 USA.	yiyo@missouri.edu		Sutovsky, Peter/0000-0002-9231-2823	University of Missouri-Columbia; United States Department of Agriculture (USDA) National Institute of Food and Agriculture [2007-35203-18274, 2011-67015-20025]	University of Missouri-Columbia; United States Department of Agriculture (USDA) National Institute of Food and Agriculture(United States Department of Agriculture (USDA))	This work was supported by funding from the Food for the 21st Century Program of the University of Missouri-Columbia, and the Competitive Grants no. 2007-35203-18274 and no. 2011-67015-20025 from the United States Department of Agriculture (USDA) National Institute of Food and Agriculture, to P.S. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abeydeera LR, 1998, BIOL REPROD, V58, P1316, DOI 10.1095/biolreprod58.5.1316; Baykov A A, 1999, Prog Mol Subcell Biol, V23, P127; Carr G, 2009, CELL PHYSIOL BIOCHEM, V24, P595, DOI 10.1159/000257515; CHEN J, 1990, J BACTERIOL, V172, P5686, DOI 10.1128/jb.172.10.5686-5689.1990; Chi A, 2000, J BIOL CHEM, V275, P35677, DOI 10.1074/jbc.C000581200; DASILVA LP, 1991, BIOCHEM BIOPH RES CO, V178, P1359, DOI 10.1016/0006-291X(91)91043-C; DAVIDSON AM, 1988, BIOCHEM J, V254, P379, DOI 10.1042/bj2540379; Edwards SE, 2007, REPROD SCI, V14, P655, DOI 10.1177/1933719107306227; Fairchild TA, 1999, BBA-GENE STRUCT EXPR, V1447, P133, DOI 10.1016/S0167-4781(99)00175-X; FLEISCH H, 1966, NATURE, V212, P901, DOI 10.1038/212901a0; FLEISCH H, 1962, AM J PHYSIOL, V203, P671, DOI 10.1152/ajplegacy.1962.203.4.671; GARNER DL, 1994, J ANDROL, V15, P620; Gurley KA, 2006, AM J HUM GENET, V79, P1017, DOI 10.1086/509881; Ho AM, 2000, SCIENCE, V289, P265, DOI 10.1126/science.289.5477.265; Hoelzle K, 2010, BMC MICROBIOL, V10, DOI 10.1186/1471-2180-10-194; Islam MK, 2005, INFECT IMMUN, V73, P1995, DOI 10.1128/IAI.73.4.1995-2004.2005; Johnson K, 2000, ARTHRITIS RHEUM-US, V43, P1560, DOI 10.1002/1529-0131(200007)43:7<1560::AID-ANR21>3.3.CO;2-J; Johnson K, 1999, ARTHRITIS RHEUM-US, V42, P1986, DOI 10.1002/1529-0131(199909)42:9<1986::AID-ANR26>3.0.CO;2-O; Johnson LA, 2000, ANIM REPROD SCI, V62, P143, DOI 10.1016/S0378-4320(00)00157-3; KANO K, 1994, THERIOGENOLOGY, V42, P1061, DOI 10.1016/0093-691X(94)90128-6; Kim JC, 2008, MOL CELLS, V26, P558; Kim NH, 1996, J REPROD FERTIL, V107, P79, DOI 10.1530/jrf.0.1070079; LAHTI R, 1983, MICROBIOL REV, V47, P169, DOI 10.1128/MMBR.47.2.169-178.1983; LUNDIN M, 1991, J BIOL CHEM, V266, P12168; LUNDIN M, 1992, BIOCHIM BIOPHYS ACTA, V1098, P217, DOI 10.1016/S0005-2728(05)80339-1; Mohanty JG, 1997, J IMMUNOL METHODS, V202, P133, DOI 10.1016/S0022-1759(96)00244-X; Ozgocmen S, 2002, UROLOGY, V59, P919, DOI 10.1016/S0090-4295(02)01557-1; PELLER L, 1976, BIOCHEMISTRY-US, V15, P141, DOI 10.1021/bi00646a021; PEREIRADASILVA L, 1993, ARCH BIOCHEM BIOPHYS, V304, P310, DOI 10.1006/abbi.1993.1355; PURSEL VG, 1975, J ANIM SCI, V40, P99, DOI 10.2527/jas1975.40199x; Rodriguez-Miranda E, 2008, BIOL REPROD, V79, P164, DOI 10.1095/biolreprod.107.065565; Rosen F, 1997, ARTHRITIS RHEUM-US, V40, P1275, DOI 10.1002/art.12; Rosenthal AK, 1999, J RHEUMATOL, V26, P395; Rosenthal AK, 1996, CALCIFIED TISSUE INT, V59, P128, DOI 10.1007/s002239900099; Rossato M, 1999, HUM REPROD, V14, P694, DOI 10.1093/humrep/14.3.694; RUSSELL RGG, 1971, J CLIN INVEST, V50, P961, DOI 10.1172/JCI106589; Ryan LM, 1999, ARTHRITIS RHEUM, V42, P555, DOI 10.1002/1529-0131(199904)42:3<555::AID-ANR21>3.0.CO;2-Z; Sivula T, 1999, FEBS LETT, V454, P75, DOI 10.1016/S0014-5793(99)00779-6; SONNEWALD U, 1992, PLANT J, V2, P571; Sutovsky P, 2011, REPRODUCTION, V142, P1, DOI 10.1530/REP-11-0041; Terkeltaub RA, 2001, AM J PHYSIOL-CELL PH, V281, pC1, DOI 10.1152/ajpcell.2001.281.1.C1; VISCONTI PE, 1995, DEVELOPMENT, V121, P1139; VISCONTI PE, 1995, DEVELOPMENT, V121, P1129; Wang J, 2007, EXP CELL RES, V313, P4120, DOI 10.1016/j.yexcr.2007.09.008; Wang WH, 1997, J REPROD FERTIL, V109, P247, DOI 10.1530/jrf.0.1090247; Wang WH, 2003, MICROSC RES TECHNIQ, V61, P335, DOI 10.1002/jemt.10346; Wu ATH, 2007, DEV BIOL, V312, P471, DOI 10.1016/j.ydbio.2007.08.051; YANG ZH, 1992, J BIOL CHEM, V267, P24634; Yepes M, 2003, LAB INVEST, V83, P1025, DOI 10.1097/01.LAB.0000075640.49586.E6; Yi XJ, 2011, INT J ANDROL, DOI [10.111141365-2605.2011.01217.x, DOI 10.1111/J.1365.2011.01217.X]; Yi YJ, 2010, CELL TISSUE RES, V341, P325, DOI 10.1007/s00441-010-0988-2; Yi YJ, 2010, J REPROD IMMUNOL, V84, P154, DOI 10.1016/j.jri.2009.11.002; Yi YJ, 2009, SYST BIOL REPROD MED, V55, P85, DOI 10.1080/19396360802699074; Zhou MJ, 1997, ANAL BIOCHEM, V253, P162, DOI 10.1006/abio.1997.2391	54	27	29	1	19	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 2	2012	7	4							e34524	10.1371/journal.pone.0034524	http://dx.doi.org/10.1371/journal.pone.0034524			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	952GU	22485177	Green Submitted, Green Published, gold			2022-12-25	WOS:000304780500052
J	Bao, F; Wu, P; Xiao, N; Qiu, F; Zeng, QP				Bao, Fei; Wu, Pei; Xiao, Na; Qiu, Frank; Zeng, Qing-Ping			Nitric Oxide-Driven Hypoxia Initiates Synovial Angiogenesis, Hyperplasia and Inflammatory Lesions in Mice	PLOS ONE			English	Article							NECROSIS-FACTOR-ALPHA; RHEUMATOID-ARTHRITIS; MODEL; RESPONSES; SYNTHASE; STRESS; TARGET	Background: Rheumatoid arthritis (RA) is an inflammatory articular disease with cartilage and bone damage due to hyperplasic synoviocyte invasion and subsequent matrix protease digestion. Although monoclonal antibodies against tumor necrosis factor alpha (TNF alpha) have been approved for clinical use in patients with RA, desired therapeutic regimens suitable for non-responders are still unavailable because etiological initiators leading to RA remain enigmatic and unidentified. Methodology/Principal Findings: Bacteria-induced arthritis (BIA) that simulates collagen-induced arthritis (CIA) is developed in mice upon daily live bacterial feeding. The morphological lesions of paw erythema and edema together with the histological alterations of synovial hyperplasia and lymphocytic infiltration emerge as the early-phase manifestations of BIA and CIA. Bacteria- or collagen-mediated global upregulation of pro-inflammatory cytokines is accompanied by the burst of nitric oxide (NO). Elevation of the serum NO level is correlated with decline of the blood oxygen saturation percentage (SpO2), reflecting a hypoxic consequence during development towards arthritis. NO-driven hypoxia is further evident from a positive relationship between NO and lactic acid (LA), an end product from glycolysis. Upregulation of hypoxia inducible factor 1 alpha (HIF-1 alpha) and vascular endothelial growth factor (VEGF) validates hypoxia-induced angiogenesis in the inflamed synovium of modeling mice. Administration of the NO donor compound sodium nitroprusside (SNP) causes articular inflammation by inducing synovial hypoxia. Anti-bacteria by the antibiotic cefotaxime and/or the immunosuppressant rapamycin or artesunate that also inhibits nitric oxide synthase (NOS) can abrogate NO production, mitigate hypoxia, and considerably ameliorate or even completely abort synovitis, hence highlighting that NO may serve as an initiator of inflammatory arthritis. Conclusions/Significance: Like collagen, bacteria also enable synovial lesions via upregulating pro-inflammatory cytokines, triggering NO production, driving hypoxic responses, and inducing synovial angiogenesis and hyperplasia, suggesting that sustained infection might be, in part, responsible for the onset of synovitis and arthritis in mice.	[Bao, Fei; Wu, Pei; Xiao, Na; Zeng, Qing-Ping] Guangzhou Univ Chinese Med, Inst Trop Med, Guangzhou, Guangdong, Peoples R China; [Qiu, Frank] Simplex Biotechnol LLC, Clinton, NJ USA	Guangzhou University of Chinese Medicine	Bao, F (corresponding author), Guangzhou Univ Chinese Med, Inst Trop Med, Guangzhou, Guangdong, Peoples R China.	qpzeng@163.com			National Project for Talent Overseas Chinese Scholars; Guangdong Provincial Natural Science Foundation [9145624536-4000003]	National Project for Talent Overseas Chinese Scholars; Guangdong Provincial Natural Science Foundation(National Natural Science Foundation of Guangdong Province)	This work was supported by the National Project for Talent Overseas Chinese Scholars (2009) and Guangdong Provincial Natural Science Foundation (No. 9145624536-4000003). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abramson SB, 2004, J RHEUMATOL, V31, P70, DOI 10.1097/BOR.0b013e328349c2b1; Biniecka M, 2011, ARTHRITIS RES THER, V13, DOI 10.1186/ar3424; Brand DD, 2007, NAT PROTOC, V2, P1269, DOI 10.1038/nprot.2007.173; Bredt DS, 1999, FREE RADICAL RES, V31, P577, DOI 10.1080/10715769900301161; Cannon GW, 1996, ARTHRITIS RHEUM-US, V39, P1677, DOI 10.1002/art.1780391010; Cejka D, 2010, ARTHRITIS RHEUM-US, V62, P2294, DOI 10.1002/art.27504; COURTENAY JS, 1980, NATURE, V283, P666, DOI 10.1038/283666a0; Cua DJ, 2011, NAT MED, V17, P1055, DOI 10.1038/nm0911-1055; Eckmann L, 2005, SPRINGER SEMIN IMMUN, V27, P181, DOI 10.1007/s00281-005-0207-5; FARRELL AJ, 1992, ANN RHEUM DIS, V51, P1219, DOI 10.1136/ard.51.11.1219; Fermor B, 2007, EUR CELLS MATER, V13, P56, DOI 10.22203/eCM.v013a06; Gowers IR, 2010, RHEUMATOLOGY, V42, P508; Han TH, 2003, P NATL ACAD SCI USA, V100, P12504, DOI 10.1073/pnas.2133409100; Hultqvist M, 2006, PLOS MED, V3, P1625, DOI 10.1371/journal.pmed.0030348; Humby F, 2009, PLOS MED, V6, P59, DOI 10.1371/journal.pmed.0060001; Kasuno K, 2004, J BIOL CHEM, V279, P2550, DOI 10.1074/jbc.M308197200; Kelly D, 2012, IMMUNOL REV, V245, P27, DOI 10.1111/j.1600-065X.2011.01079.x; Kennedy A, 2010, ARTHRITIS RHEUM-US, V62, P711, DOI 10.1002/art.27287; Keunen O, 2011, P NATL ACAD SCI USA, V108, P3749, DOI 10.1073/pnas.1014480108; Lala PK, 2001, LANCET ONCOL, V2, P149, DOI 10.1016/S1470-2045(00)00256-4; Laragione T, 2010, MOL MED, V16, P352, DOI 10.2119/molmed.2010.00049; Luross JA, 2001, IMMUNOLOGY, V103, P407, DOI 10.1046/j.1365-2567.2001.01267.x; McDevitt H, 2000, ARTHRITIS RES, V2, P85, DOI 10.1186/ar72; Muntane J, 2010, WORLD J HEPATOL, V2, P337, DOI 10.4254/wjh.v2.i9.337; Nagy G, 2008, IMMUNOL LETT, V118, P55, DOI 10.1016/j.imlet.2008.02.009; Nagy G, 2010, ARTHRITIS RES THER, V12, DOI 10.1186/ar3045; Nagy G, 2007, IMMUNOL LETT, V111, P1, DOI 10.1016/j.imlet.2007.04.013; Natarajan R, 2003, FEBS LETT, V549, P99, DOI 10.1016/S0014-5793(03)00798-1; Ng CT, 2010, ANN RHEUM DIS, V69, P1389, DOI 10.1136/ard.2009.119776; Nisoli E, 2006, J CELL SCI, V119, P2855, DOI 10.1242/jcs.03062; Olson N, 2011, NITRIC OXIDE-BIOL CH, V25, P125, DOI 10.1016/j.niox.2010.12.010; Perkins DJ, 1998, ARTHRITIS RHEUM, V41, P2205, DOI 10.1002/1529-0131(199812)41:12<2205::AID-ART16>3.3.CO;2-H; Rahman Masmudur M, 2006, PLoS Pathog, V2, pe4; Sanchez-Pernaute O, 2003, ANN RHEUM DIS, V62, P1135, DOI 10.1136/ard.2003.011767; Schett G, 2011, ARTHRITIS RES THER, V13, DOI [10.1186/1478-6354-13-S1-S4, 10.1186/ar3095]; Sherbet G. V., 2009, British Journal of Medical Practitioners, V2, P6; Smith HS, 2011, PAIN PHYSICIAN, V14, pE427; Smith MM, 2008, RHEUMATOLOGY, V47, P1172, DOI 10.1093/rheumatology/ken219; Smolen JS, 2007, LANCET, V370, P1861, DOI 10.1016/S0140-6736(07)60784-3; Song XR, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0023453; Tak PP, 2011, ARTHRITIS RES THER, V13, DOI [10.1186/ar3096, 10.1186/1478-6354-13-S1-S5]; Tang W, 2011, SCIENCE, V332, P478, DOI 10.1126/science.1199214; Teachey DT, 2009, BRIT J HAEMATOL, V145, P101, DOI 10.1111/j.1365-2141.2009.07595.x; Toes REM, 2009, PLOS MED, V6, P15, DOI 10.1371/journal.pmed.1000009; van Zonneveld AJ, 2010, ANN RHEUM DIS, V69, P57, DOI 10.1136/ard.2009.119495; WALSH LJ, 1991, P NATL ACAD SCI USA, V88, P4220, DOI 10.1073/pnas.88.10.4220; Wang B, 2004, ARTHRITIS RHEUM-US, V50, P2995, DOI 10.1002/art.20459; Wang JX, 2008, BRIT J PHARMACOL, V153, P1303, DOI 10.1038/bjp.2008.11; Wheeler MA, 1997, J CLIN INVEST, V99, P110, DOI 10.1172/JCI119121; Wilder RL, 2002, ANN RHEUM DIS, V61, P96, DOI 10.1136/ard.61.suppl_2.ii96; Witthoft T, 1998, AM J PHYSIOL-GASTR L, V275, pG564, DOI 10.1152/ajpgi.1998.275.3.G564; Wu HJ, 2010, IMMUNITY, V32, P815, DOI 10.1016/j.immuni.2010.06.001; Xu WM, 2005, CELL RES, V15, P63, DOI 10.1038/sj.cr.7290267	53	16	19	0	16	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 30	2012	7	3							e34494	10.1371/journal.pone.0034494	http://dx.doi.org/10.1371/journal.pone.0034494			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	959UC	22479635	gold, Green Published			2022-12-25	WOS:000305339100161
J	Bailey, CK; Mittal, MK; Misra, S; Chaudhuri, G				Bailey, Charvann K.; Mittal, Mukul K.; Misra, Smita; Chaudhuri, Gautam			High Motility of Triple-negative Breast Cancer Cells Is Due to Repression of Plakoglobin Gene by Metastasis Modulator Protein SLUG	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							EPITHELIAL-MESENCHYMAL TRANSITION; E-CADHERIN; DECOY OLIGONUCLEOTIDES; TRANSCRIPTION FACTORS; AFRICAN-AMERICAN; CARCINOMA CELLS; IN-VIVO; EXPRESSION; ACTIVATION; ADHESION	One of highly pathogenic breast cancer cell types are the triple negative (negative in the expression of estrogen, progesterone, and ERBB2 receptors) breast cancer cells. These cells are highly motile and metastatic and are characterized by high levels of the metastasis regulator protein SLUG. Using isogenic breast cancer cell systems we have shown here that high motility of these cells is directly correlated with the levels of the SLUG in these cells. Because epithelial/mesenchymal cell motility is known to be negatively regulated by the catenin protein plakoglobin, we postulated that the transcriptional repressor protein SLUG increases the motility of the aggressive breast cancer cells through the knockdown of the transcription of the plakoglobin gene. We found that SLUG inhibits the expression of plakoglobin gene directly in these cells. Overexpression of SLUG in the SLUG-deficient cancer cells significantly decreased the levels of mRNA and protein of plakoglobin. On the contrary, knockdown of SLUG in SLUG-high cancer cells elevated the levels of plakoglobin. Blocking of SLUG function with a double-stranded DNA decoy that competes with the E2-box binding of SLUG also increased the levels of plakoglobin mRNA, protein, and promoter activity in the SLUG-high triple negative breast cancer cells. Overexpression of SLUG in the SLUG-deficient cells elevated the motility of these cells. Knockdown of plakoglobin in these low motility non-invasive breast cancer cells rearranged the actin filaments and increased the motility of these cells. Forced expression of plakoglobin in SLUG-high cells had the reverse effects on cellular motility. This study thus implicates SLUG-induced repression of plakoglobin as a motility determinant in highly disseminating breast cancer.	[Mittal, Mukul K.; Misra, Smita; Chaudhuri, Gautam] Meharry Med Coll, Dept Microbiol & Immunol, Nashville, TN 37208 USA; [Bailey, Charvann K.] Meharry Med Coll, Dept Biochem & Canc Biol, Nashville, TN 37208 USA	Meharry Medical College; Meharry Medical College	Chaudhuri, G (corresponding author), Meharry Med Coll, Dept Microbiol & Immunol, 1005 DB Todd,Jr Blvd, Nashville, TN 37208 USA.	gchaudhuri@mmc.edu		Mittal, Mukul/0000-0002-9795-7372	National Institutes of Health [1U54RR026140-01, R25GM059993, T32HL007737, T32HL007735, U01NS041071, U54RR026140, U54CA091408, S10RR0254970]; Department of Defense Congressionally Directed Medical Research Program [W81XWH-06-1-0466, BC103645, W81XWH-09-1-0676]; Center for Research Resources, National Institutes of Health [UL1 RR024975]; NATIONAL CANCER INSTITUTE [U54CA091408] Funding Source: NIH RePORTER; NATIONAL CENTER FOR RESEARCH RESOURCES [UL1RR024975, U54RR026140] Funding Source: NIH RePORTER; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [T32HL007737, T32HL007735] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [U01NS041071] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Department of Defense Congressionally Directed Medical Research Program(United States Department of Defense); Center for Research Resources, National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))	This work was supported, in whole or in part, by National Institutes of Health Grants 1U54RR026140-01 (to S. M.) and R25GM059993, T32HL007737, and T32HL007735 (graduate student fellowships to C. K. B.). This work was also supported in part by Department of Defense Congressionally Directed Medical Research Program Grants W81XWH-06-1-0466, BC103645, and W81XWH-09-1-0676 (to G. C.); Confocal microscopy was performed through the use of the Meharry Medical College Morphology Core, which was supported in part by National Institutes of Health grants U01NS041071, U54RR026140, U54CA091408, and S10RR0254970. Other Core facility research was supported in part by Vanderbilt Clinical and Translational Science Awards Grant UL1 RR024975 from the Center for Research Resources, National Institutes of Health.	Alves CC, 2009, FRONT BIOSCI-LANDMRK, V14, P3041, DOI 10.2741/3433; Amirikia KC, 2011, CANCER-AM CANCER SOC, V117, P2747, DOI 10.1002/cncr.25862; Anastassiou D, 2011, BMC CANCER, V11, DOI 10.1186/1471-2407-11-529; Anders CK, 2009, CLIN BREAST CANCER, V9, pS73, DOI 10.3816/CBC.2009.s.008; Bailey CK, 2007, BIOCHEM BIOPH RES CO, V353, P661, DOI 10.1016/j.bbrc.2006.12.097; Cabrini G, 2010, CURR MED CHEM, V17, P4392, DOI 10.2174/092986710793361243; Caca K, 1999, CELL GROWTH DIFFER, V10, P369; Chen HM, 2009, CANCER RES, V69, P9228, DOI 10.1158/0008-5472.CAN-09-1950; Chinnadurai G, 2007, INT J BIOCHEM CELL B, V39, P1593, DOI 10.1016/j.biocel.2007.01.025; Chinnadurai G, 2009, CANCER RES, V69, P731, DOI 10.1158/0008-5472.CAN-08-3349; Coates JC, 2003, TRENDS CELL BIOL, V13, P463, DOI 10.1016/S0962-8924(03)00167-3; De Stefano D, 2010, CURR OPIN MOL THER, V12, P203; Destaing O, 2011, CURR OPIN CELL BIOL, V23, P597, DOI 10.1016/j.ceb.2011.04.002; Gambari R, 2010, BIOCHEM PHARMACOL, V80, P1887, DOI 10.1016/j.bcp.2010.06.047; Guo WJ, 2012, CELL, V148, P1015, DOI 10.1016/j.cell.2012.02.008; Hajra KM, 2002, CANCER RES, V62, P1613; Huang H, 2008, CELL MOTIL CYTOSKEL, V65, P964, DOI 10.1002/cm.20319; Huo DZ, 2009, J CLIN ONCOL, V27, P4515, DOI 10.1200/JCO.2008.19.6873; Katafiasz D, 2011, CELL ADHES MIGR, V5, P315, DOI 10.4161/cam.5.4.17040; Lehmann BD, 2011, J CLIN INVEST, V121, P2750, DOI 10.1172/JCI45014; Leong KG, 2007, J EXP MED, V204, P2935, DOI 10.1084/jem.20071082; Li YF, 2010, MOL CANCER RES, V8, P1579, DOI 10.1158/1541-7786.MCR-10-0081; McConkey DJ, 2009, CANCER METAST REV, V28, P335, DOI 10.1007/s10555-009-9194-7; Misra S, 2010, MOL CANCER, V9, DOI 10.1186/1476-4598-9-50; Mittal MK, 2008, BIOCHEM BIOPH RES CO, V372, P30, DOI 10.1016/j.bbrc.2008.04.187; Mittal MK, 2011, J BIOL CHEM, V286, P469, DOI 10.1074/jbc.M110.164384; Murphy DA, 2011, NAT REV MOL CELL BIO, V12, P413, DOI 10.1038/nrm3141; Nieto MA, 2002, NAT REV MOL CELL BIO, V3, P155, DOI 10.1038/nrm757; O'Brien KM, 2010, CLIN CANCER RES, V16, P6100, DOI 10.1158/1078-0432.CCR-10-1533; Pan HJ, 2007, CANCER BIOL THER, V6, P1638, DOI 10.4161/cbt.6.10.4904; Penolazzi L, 2007, MOL PHARMACOL, V71, P1457, DOI 10.1124/mol.107.034561; Piva R, 2006, ANN NY ACAD SCI, V1091, P509, DOI 10.1196/annals.1378.092; Piva R, 2002, TECHNOL CANCER RES T, V1, P405, DOI 10.1177/153303460200100512; Ridley AJ, 2011, CELL, V145, P1012, DOI 10.1016/j.cell.2011.06.010; Rieger-Christ KM, 2005, BRIT J CANCER, V92, P2153, DOI 10.1038/sj.bjc.6602651; Shafiei F, 2008, ONCOGENE, V27, P2602, DOI 10.1038/sj.onc.1210917; Shair KHY, 2008, CANCER RES, V68, P6997, DOI 10.1158/0008-5472.CAN-08-1178; Shirley SH, 2010, MOL CARCINOGEN, V49, P851, DOI 10.1002/mc.20674; Storci G, 2008, J PATHOL, V214, P25, DOI 10.1002/path.2254; Tawfik O, 2010, ANN CLIN LAB SCI, V40, P315; Todorovic V, 2010, J CELL SCI, V123, P3576, DOI 10.1242/jcs.070391; Tripathi MK, 2005, J BIOL CHEM, V280, P17163, DOI 10.1074/jbc.M501375200; Tripathi MK, 2005, BIOCHEM BIOPH RES CO, V329, P508, DOI 10.1016/j.bbrc.2005.02.006; Wei SS, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0028797; Wels C, 2011, J INVEST DERMATOL, V131, P1877, DOI 10.1038/jid.2011.142; Wu WS, 2005, CELL, V123, P641, DOI 10.1016/j.cell.2005.09.029; Yang AD, 2006, CANCER RES, V66, P46, DOI 10.1158/0008-5472.CAN-05-3086; Yin TF, 2005, P NATL ACAD SCI USA, V102, P5420, DOI 10.1073/pnas.0501676102; Zilfou JT, 2005, CELL, V123, P545, DOI 10.1016/j.cell.2005.11.003	49	30	30	1	6	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JUN 1	2012	287	23					19472	19486		10.1074/jbc.M112.345728	http://dx.doi.org/10.1074/jbc.M112.345728			15	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	974EF	22496452	hybrid, Green Published			2022-12-25	WOS:000306411900061
J	Chanoux, RA; Robay, A; Shubin, CB; Kebler, C; Suaud, L; Rubenstein, RC				Chanoux, Rebecca A.; Robay, Amal; Shubin, Calla B.; Kebler, Catherine; Suaud, Laurence; Rubenstein, Ronald C.			Hsp70 Promotes Epithelial Sodium Channel Functional Expression by Increasing Its Association with Coat Complex II and Its Exit from Endoplasmic Reticulum	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							TRANSMEMBRANE CONDUCTANCE REGULATOR; BIP ATPASE MUTANTS; NA+ CHANNEL; CYSTIC-FIBROSIS; LIDDLES-SYNDROME; MOLECULAR CHAPERONES; PROTEASE ACTIVATION; SURFACE EXPRESSION; GAMMA-SUBUNIT; BETA-SUBUNIT	The epithelial sodium channel(ENaC) plays an important role in the homeostasis of blood pressure and of the airway surface liquid, and inappropriate regulation of ENaC results in refractory hypertension (in Liddle syndrome) and impaired mucociliary clearance (in cystic fibrosis). The regulation of ENaC by molecular chaperones, such as the 70-kDa heat shock protein Hsp70, is not completely understood. Building on the previous suggestion by our group that Hsp70 promotes ENaC functional and surface expression in Xenopus oocytes, we investigated the mechanism by which Hsp70 acts upon ENaC in epithelial cells. In Madin-Darby canine kidney cells stably expressing epitope-tagged alpha beta gamma-ENaC and with tetracycline-inducible overexpression of Hsp70, treatment with 1 or 2 mu g/ml doxycycline increased total Hsp70 expression similar to 2-fold and ENaC functional expression similar to 1.4-fold. This increase in ENaC functional expression corresponded to an increase in ENaC expression at the apical surface of the cells and was not present when an ATPase-deficient Hsp70 was similarly over expressed. The increase in functional expression was not due to a change in the rate at which ENaC was retrieved from the apical membrane. Instead, Hsp70 overexpression increased the association of ENaC with the Sec24D cargo recognition component of coat complex II, which carries protein cargo from the endoplasmic reticulum to the Golgi. These data support the hypothesis that Hsp70 promotes ENaC biogenesis and trafficking to the apical surface of epithelial cells.	[Chanoux, Rebecca A.; Robay, Amal; Shubin, Calla B.; Kebler, Catherine; Suaud, Laurence; Rubenstein, Ronald C.] Childrens Hosp Philadelphia, Div Pulm Med, Philadelphia, PA 19104 USA; [Chanoux, Rebecca A.; Robay, Amal; Shubin, Calla B.; Kebler, Catherine; Suaud, Laurence; Rubenstein, Ronald C.] Childrens Hosp Philadelphia, Cyst Fibrosis Ctr, Philadelphia, PA 19104 USA; [Rubenstein, Ronald C.] Univ Penn, Perelman Sch Med, Dept Pediat, Philadelphia, PA 19104 USA	University of Pennsylvania; Childrens Hospital of Philadelphia; University of Pennsylvania; Childrens Hospital of Philadelphia; University of Pennsylvania	Rubenstein, RC (corresponding author), Childrens Hosp Philadelphia, Div Pulm Med, Abramson 410C,34th St & Civ Ctr Blvd, Philadelphia, PA 19104 USA.	rrubenst@mail.med.upenn.edu		Shubin, Calla/0000-0002-4618-2722; Rubenstein, Ronald/0000-0002-3138-4006	National Institutes of Health [T32 DK07748, R01 DK58046, R01 DK73185]; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK058046, T32DK007748, R01DK073185] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	This work was supported, in whole or in part, by National Institutes of Health Grants T32 DK07748 (to R. A. C.), R01 DK58046, (to R. C. R.), and R01 DK73185 (to R. C. R.).	ABRAVAYA K, 1992, GENE DEV, V6, P1153, DOI 10.1101/gad.6.7.1153; Adebamiro A, 2005, J GEN PHYSIOL, V126, P339, DOI 10.1085/jgp.200509285; Barlowe C, 2002, CURR OPIN CELL BIOL, V14, P417, DOI 10.1016/S0955-0674(02)00348-4; Bruns JB, 2007, J BIOL CHEM, V282, P6153, DOI 10.1074/jbc.M610636200; Caldwell RA, 2005, AM J PHYSIOL-LUNG C, V288, pL813, DOI 10.1152/ajplung.00435.2004; Caldwell RA, 2004, AM J PHYSIOL-CELL PH, V286, pC190, DOI 10.1152/ajpcell.00342.2003; CANESSA CM, 1994, NATURE, V367, P463, DOI 10.1038/367463a0; CANESSA CM, 1994, AM J PHYSIOL-CELL PH, V267, pC1682, DOI 10.1152/ajpcell.1994.267.6.C1682; Choo-Kang LR, 2001, AM J PHYSIOL-LUNG C, V281, pL58, DOI 10.1152/ajplung.2001.281.1.L58; Dieter M, 2004, OBES RES, V12, P862, DOI 10.1038/oby.2004.104; Firsov D, 1996, P NATL ACAD SCI USA, V93, P15370, DOI 10.1073/pnas.93.26.15370; Goldfarb SB, 2006, P NATL ACAD SCI USA, V103, P5817, DOI 10.1073/pnas.0507903103; Hanwell D, 2002, J BIOL CHEM, V277, P9772, DOI 10.1074/jbc.M110904200; Hendershot L, 1996, P NATL ACAD SCI USA, V93, P5269, DOI 10.1073/pnas.93.11.5269; HENDERSHOT LM, 1995, MOL BIOL CELL, V6, P283, DOI 10.1091/mbc.6.3.283; Hughey RP, 2004, J BIOL CHEM, V279, P48491, DOI 10.1074/jbc.C400460200; Hughey RP, 2004, J BIOL CHEM, V279, P18111, DOI 10.1074/jbc.C400080200; Hummler E, 2003, CURR HYPERTENS REP, V5, P11, DOI 10.1007/s11906-003-0005-1; Jasti J, 2007, NATURE, V449, P316, DOI 10.1038/nature06163; Jovov B, 2002, J BIOL CHEM, V277, P4134, DOI 10.1074/jbc.M108354200; Kamynina E, 2001, KIDNEY INT, V60, P466, DOI 10.1046/j.1523-1755.2001.060002466.x; Kamynina E, 2001, FASEB J, V15, P204, DOI 10.1096/fj.00-0191com; Kashlan OB, 2007, J BIOL CHEM, V282, P28149, DOI 10.1074/jbc.M703409200; Kaufman RJ, 2002, J CLIN INVEST, V110, P1389, DOI 10.1172/JC1200216886; Knight KK, 2006, P NATL ACAD SCI USA, V103, P2805, DOI 10.1073/pnas.0511184103; Lang F, 2003, CELL PHYSIOL BIOCHEM, V13, P41, DOI 10.1159/000070248; Laroia G, 1999, SCIENCE, V284, P499, DOI 10.1126/science.284.5413.499; Lu C, 2007, TRAFFIC, V8, P1246, DOI 10.1111/j.1600-0854.2007.00602.x; Matsui H, 1998, CELL, V95, P1005, DOI 10.1016/S0092-8674(00)81724-9; Miller E, 2002, EMBO J, V21, P6105, DOI 10.1093/emboj/cdf605; Miller EA, 2003, CELL, V114, P497, DOI 10.1016/S0092-8674(03)00609-3; Morris RG, 2002, J GEN PHYSIOL, V120, P71, DOI 10.1085/jgp.20018547; Mueller GM, 2007, J BIOL CHEM, V282, DOI 10.1074/jbc.M707339200; Nishikawa S, 2005, J BIOCHEM, V137, P551, DOI 10.1093/jb/mvi068; Pradervand S, 2003, J AM SOC NEPHROL, V14, P2219, DOI 10.1097/01.ASN.0000080204.65527.E6; Pruliere-Escabasse V, 2007, J BIOL CHEM, V282, P34048, DOI 10.1074/jbc.M702384200; Rossi E, 2008, J HYPERTENS, V26, P921, DOI 10.1097/HJH.0b013e3282f85dfe; Rossier BC, 2002, ANNU REV PHYSIOL, V64, P877, DOI 10.1146/annurev.physiol.64.082101.143243; Rossier Bernard C, 2004, Proc Am Thorac Soc, V1, P4, DOI 10.1513/pats.2306007; Rubenstein RC, 1997, J CLIN INVEST, V100, P2457, DOI 10.1172/JCI119788; Sato JD, 2007, CELL PHYSIOL BIOCHEM, V20, P91, DOI 10.1159/000104157; Shi YH, 1998, GENE DEV, V12, P654, DOI 10.1101/gad.12.5.654; Staub O, 1997, EMBO J, V16, P6325, DOI 10.1093/emboj/16.21.6325; Stewart AP, 2011, J BIOL CHEM, V286, P31944, DOI 10.1074/jbc.M111.275289; Suaud L, 2011, J BIOL CHEM, V286, P45083, DOI 10.1074/jbc.M111.293282; Valentijn JA, 1998, J BIOL CHEM, V273, P30344, DOI 10.1074/jbc.273.46.30344; Wagner CA, 2001, CELL PHYSIOL BIOCHEM, V11, P209, DOI 10.1159/000051935; Wang XD, 2004, J CELL BIOL, V167, P65, DOI 10.1083/jcb.200401035; Wilson GM, 2001, J BIOL CHEM, V276, P44450, DOI 10.1074/jbc.M108521200	50	18	18	0	1	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JUN 1	2012	287	23					19255	19265		10.1074/jbc.M112.357756	http://dx.doi.org/10.1074/jbc.M112.357756			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	974EF	22496374	Green Published, hybrid			2022-12-25	WOS:000306411900035
J	Campbell, ZT; Menichelli, E; Friend, K; Wu, J; Kimble, J; Williamson, JR; Wickens, M				Campbell, Zachary T.; Menichelli, Elena; Friend, Kyle; Wu, Joann; Kimble, Judith; Williamson, James R.; Wickens, Marvin			Identification of a Conserved Interface between PUF and CPEB Proteins	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							B1 MESSENGER-RNA; PUMILIO-HOMOLOGY DOMAIN; TRANSLATIONAL CONTROL; C-ELEGANS; CYTOPLASMIC POLYADENYLATION; CAENORHABDITIS-ELEGANS; BINDING PROTEIN; OOCYTE MATURATION; XENOPUS PUMILIO; BRAIN-TUMOR	Members of the PUF ((Pu) under bar milio and (F) under bar BF) and CPEB ((c) under bar ytoplasmic (p) under bar olyadenylation (e) under bar lement-(b) under bar inding) protein families collaborate to regulate mRNA expression throughout eukaryotes. Here, we focus on the physical interactions between members of these two families, concentrating on Caenorhabditis elegans FBF-2 and CPB-1. To localize the site of interaction on FBF-2, we identified conserved amino acids within C. elegans PUF proteins. Deletion of an extended loop containing several conserved residues abolished binding to CPB-1. We analyzed alanine substitutions at 13 individual amino acids in FBF-2, each identified via its conservation. Multiple single point mutations disrupted binding to CPB-1 but not to RNA. Position Tyr-479 was particularly critical as multiple substitutions to other amino acids at this position did not restore binding. The complex of FBF-2 and CPB-1 repressed translation of an mRNA containing an FBF binding element. Repression required both proteins and was disrupted by FBF-2 alleles that failed to bind CPB-1 or RNA. The equivalent loop in human PUM2 is required for binding to human CPEB3 in vitro, although the primary sequences of the human and C. elegans PUF proteins have diverged in that region. Our findings define a key region in PUF/CPEB interactions and imply a conserved platform through which PUF proteins interact with their protein partners.	[Campbell, Zachary T.; Friend, Kyle; Kimble, Judith; Wickens, Marvin] Univ Wisconsin, Dept Biochem, Madison, WI 53706 USA; [Kimble, Judith] Univ Wisconsin, Howard Hughes Med Inst, Madison, WI 53706 USA; [Menichelli, Elena; Wu, Joann; Williamson, James R.] Scripps Res Inst, Dept Mol Biol, La Jolla, CA 92037 USA; [Menichelli, Elena; Wu, Joann; Williamson, James R.] Scripps Res Inst, Skaggs Inst Chem Biol, La Jolla, CA 92037 USA	University of Wisconsin System; University of Wisconsin Madison; Howard Hughes Medical Institute; University of Wisconsin System; University of Wisconsin Madison; Scripps Research Institute; Scripps Research Institute	Wickens, M (corresponding author), Univ Wisconsin, Dept Biochem, 433 Babcock Dr, Madison, WI 53706 USA.	wickens@biochem.wisc.edu	Williamson, James R/B-2891-2009; Williamson, James/AAL-2104-2021	Williamson, James R/0000-0002-8772-468X; Williamson, James/0000-0002-8772-468X; Campbell, Zachary/0000-0002-3768-6996	National Institutes of Health [F32 GM095169, GM069454, GM53320, GM031892, GM050942]; American Cancer Society [PF-10-127-01-DDC]; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM069454, F32GM095169, R37GM031892, R01GM031892, R01GM050942, R01GM053320] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); American Cancer Society(American Cancer Society); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	Supported by National Institutes of Health Grant F32 GM095169.; Supported by Grant PF-10-127-01-DDC from the American Cancer Society.; An Investigator of the Howard Hughes Medical Institute. Supported by National Institutes of Health Grant GM069454.; Supported by National Institutes of Health Grant GM53320.; Supported by National Institutes of Health Grants GM031892 and GM050942. To whom correspondence should be addressed: Dept. of Biochemistry, University of Wisconsin-Madison, 433 Babcock Dr., Madison, WI 53706. Tel.: 608-263-0858; Fax 608-262-9108; E-mail: wickens@biochem. wisc.edu.	Ariz M, 2009, DEV BIOL, V326, P295, DOI 10.1016/j.ydbio.2008.11.024; Barnard DC, 2004, CELL, V119, P641, DOI 10.1016/j.cell.2004.10.029; Besse F, 2008, NAT REV MOL CELL BIO, V9, P971, DOI 10.1038/nrm2548; Burns DM, 2008, GENE DEV, V22, P3449, DOI 10.1101/gad.1697808; Cho S, 2007, CURR BIOL, V17, P203, DOI 10.1016/j.cub.2006.12.027; Chritton JJ, 2010, RNA, V16, P1217, DOI 10.1261/rna.2070110; Costa-Mattioli M, 2009, NEURON, V61, P10, DOI 10.1016/j.neuron.2008.10.055; Crittenden SL, 2002, NATURE, V417, P660, DOI 10.1038/nature754; Dubnau J, 2003, CURR BIOL, V13, P286, DOI 10.1016/S0960-9822(03)00064-2; Eckmann CR, 2004, GENETICS, V168, P147, DOI 10.1534/genetics.104.029264; Edwards TA, 2003, GENE DEV, V17, P2508, DOI 10.1101/gad.1119403; Edwards TA, 2001, CELL, V105, P281, DOI 10.1016/S0092-8674(01)00318-X; Friend K, 2012, NAT STRUCT MOL BIOL, V19, P176, DOI 10.1038/nsmb.2214; Gebauer F, 2004, NAT REV MOL CELL BIO, V5, P827, DOI 10.1038/nrm1488; Goldstrohm AC, 2008, NAT REV MOL CELL BIO, V9, P337, DOI 10.1038/nrm2370; Goldstrohm AC, 2007, J BIOL CHEM, V282, P109, DOI 10.1074/jbc.M609413200; Groisman I, 2000, CELL, V103, P435, DOI 10.1016/S0092-8674(00)00135-5; Haag ES, 2007, GENETICA, V129, P45, DOI 10.1007/s10709-006-0032-3; Haag ES, 2005, EVOLUTION, V59, P1620, DOI 10.1111/j.0014-3820.2005.tb01813.x; Hake LE, 1998, MOL CELL BIOL, V18, P685, DOI 10.1128/MCB.18.2.685; Hook BA, 2007, J BIOL CHEM, V282, P15430, DOI 10.1074/jbc.M611253200; Houshmandi SS, 2005, RNA, V11, P1655, DOI 10.1261/rna.2168505; Huang YS, 2006, EMBO J, V25, P4865, DOI 10.1038/sj.emboj.7601322; HULSKAMP M, 1989, NATURE, V338, P629, DOI 10.1038/338629a0; IRISH V, 1989, NATURE, V338, P646, DOI 10.1038/338646a0; Kadyrova LY, 2007, DEVELOPMENT, V134, P1519, DOI 10.1242/dev.002212; Kaye JA, 2009, NEURON, V61, P57, DOI 10.1016/j.neuron.2008.11.012; Lu G, 2011, STRUCTURE, V19, P361, DOI 10.1016/j.str.2010.12.019; Luitjens C, 2000, GENE DEV, V14, P2596, DOI 10.1101/gad.831700; Mendez R, 2000, NATURE, V404, P302, DOI 10.1038/35005126; Mendez R, 2001, NAT REV MOL CELL BIO, V2, P521, DOI 10.1038/35080081; Minshall N, 2007, J BIOL CHEM, V282, P37389, DOI 10.1074/jbc.M704629200; Nakahata S, 2003, MECH DEVELOP, V120, P865, DOI 10.1016/S0925-4773(03)00160-6; Nakahata S, 2001, J BIOL CHEM, V276, P20945, DOI 10.1074/jbc.M010528200; Olivas W, 2000, EMBO J, V19, P6602, DOI 10.1093/emboj/19.23.6602; Ortiz-Zapater E, 2012, NAT MED, V18, P83, DOI 10.1038/nm.2540; Osborne H B, 1997, Prog Mol Subcell Biol, V18, P173; Pique M, 2008, CELL, V132, P434, DOI 10.1016/j.cell.2007.12.038; Radford HE, 2008, BBA-GENE REGUL MECH, V1779, P217, DOI 10.1016/j.bbagrm.2008.02.002; Rajagopalan Lavanya, 2009, V493, P287, DOI 10.1007/978-1-59745-523-7_17; Richter JD, 2007, TRENDS BIOCHEM SCI, V32, P279, DOI 10.1016/j.tibs.2007.04.004; Richter JD, 2011, CSH PERSPECT BIOL, V3, DOI 10.1101/cshperspect.a002758; Sonoda J, 1999, GENE DEV, V13, P2704, DOI 10.1101/gad.13.20.2704; Sonoda J, 2001, GENE DEV, V15, P762, DOI 10.1101/gad.870801; Standart N, 2008, BIOCHEM SOC T, V36, P671, DOI 10.1042/BST0360671; Suh N, 2009, GENETICS, V181, P1249, DOI 10.1534/genetics.108.099440; Tay J, 2000, DEV BIOL, V221, P1, DOI 10.1006/dbio.2000.9669; Theis M, 2003, P NATL ACAD SCI USA, V100, P9602, DOI 10.1073/pnas.1133424100; Valencia-Sanchez MA, 2006, GENE DEV, V20, P515, DOI 10.1101/gad.1399806; Wang XQ, 2002, CELL, V110, P501, DOI 10.1016/S0092-8674(02)00873-5; Wang XQ, 2001, MOL CELL, V7, P855, DOI 10.1016/S1097-2765(01)00229-5; Wang YM, 2009, P NATL ACAD SCI USA, V106, P20186, DOI 10.1073/pnas.0812076106; WHARTON RP, 1991, CELL, V67, P955, DOI 10.1016/0092-8674(91)90368-9; Wickens M, 2002, TRENDS GENET, V18, P150, DOI 10.1016/S0168-9525(01)02616-6; Wickens M., 1996, TRANSLATIONAL CONTRO, P411; Wreden C, 1997, DEVELOPMENT, V124, P3015; Zhang BL, 1997, NATURE, V390, P477, DOI 10.1038/37297; Zhu DY, 2009, P NATL ACAD SCI USA, V106, P20192, DOI 10.1073/pnas.0812079106	58	29	31	0	6	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAY 25	2012	287	22					18854	18862		10.1074/jbc.M112.352815	http://dx.doi.org/10.1074/jbc.M112.352815			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	974EC	22496444	hybrid, Green Published			2022-12-25	WOS:000306411600093
J	Illingworth, RS; Botting, CH; Grimes, GR; Bickmore, WA; Eskeland, R				Illingworth, Robert S.; Botting, Catherine H.; Grimes, Graeme R.; Bickmore, Wendy A.; Eskeland, Ragnhild			PRC1 and PRC2 Are Not Required for Targeting of H2A.Z to Developmental Genes in Embryonic Stem Cells	PLOS ONE			English	Article							HISTONE VARIANT H2A.Z; POLYCOMB GROUP; CHROMATIN-STRUCTURE; DNA METHYLATION; GROUP PROTEINS; COMPLEX; RING1B; TRANSCRIPTION; PURIFICATION; REGULATORS	The essential histone variant H2A.Z localises to both active and silent chromatin sites. In embryonic stem cells (ESCs), H2A.Z is also reported to co-localise with polycomb repressive complex 2 (PRC2) at developmentally silenced genes. The mechanism of H2A.Z targeting is not clear, but a role for the PRC2 component Suz12 has been suggested. Given this association, we wished to determine if polycomb functionally directs H2A.Z incorporation in ESCs. We demonstrate that the PRC1 component Ring1B interacts with multiple complexes in ESCs. Moreover, we show that although the genomic distribution of H2A.Z co-localises with PRC2, Ring1B and with the presence of CpG islands, H2A.Z still blankets polycomb target loci in the absence of Suz12, Eed (PRC2) or Ring1B (PRC1). Therefore we conclude that H2A.Z accumulates at developmentally silenced genes in ESCs in a polycomb independent manner.	[Illingworth, Robert S.; Grimes, Graeme R.; Bickmore, Wendy A.; Eskeland, Ragnhild] Univ Edinburgh, MRC Human Genet Unit, MRC Inst Genet & Mol Med, Edinburgh, Midlothian, Scotland; [Botting, Catherine H.] Univ St Andrews, BMS Mass Spectrometry & Prote Facil, St Andrews, Fife, Scotland	University of Edinburgh; University of St Andrews	Illingworth, RS (corresponding author), Univ Edinburgh, MRC Human Genet Unit, MRC Inst Genet & Mol Med, Edinburgh, Midlothian, Scotland.	W.Bickmore@hgu.mrc.ac.uk; Ragnhild.Eskeland@imbv.uio.no	Eskeland, Ragnhild/AFM-2892-2022; Eskeland, Ragnhild/GSN-9383-2022; Eskeland, Ragnhild/K-7018-2014; Bickmore, Wendy/C-7314-2013	Eskeland, Ragnhild/0000-0003-2789-3171; Eskeland, Ragnhild/0000-0003-2789-3171; Illingworth, Rob/0000-0001-9275-1933; Bickmore, Wendy/0000-0001-6660-7735	Medical Research Council, UK; BBSRC [BB/H008500/1]; MRC [MC_PC_U127527202] Funding Source: UKRI; Biotechnology and Biological Sciences Research Council [BB/H008500/1] Funding Source: researchfish; Medical Research Council [MC_PC_U127527202] Funding Source: researchfish	Medical Research Council, UK(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); BBSRC(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Biotechnology and Biological Sciences Research Council(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission)	This work was supported by the Medical Research Council, UK and by grant BB/H008500/1 from the BBSRC. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Azuara V, 2006, NAT CELL BIOL, V8, P532, DOI 10.1038/ncb1403; Barski A, 2007, CELL, V129, P823, DOI 10.1016/j.cell.2007.05.009; Bernstein BE, 2006, CELL, V125, P315, DOI 10.1016/j.cell.2006.02.041; Boyer LA, 2006, NATURE, V441, P349, DOI 10.1038/nature04733; Buchwald G, 2006, EMBO J, V25, P2465, DOI 10.1038/sj.emboj.7601144; Chamberlain SJ, 2008, STEM CELLS, V26, P1496, DOI 10.1634/stemcells.2008-0102; Conerly ML, 2010, GENOME RES, V20, P1383, DOI 10.1101/gr.106542.110; Creyghton MP, 2008, CELL, V135, P649, DOI 10.1016/j.cell.2008.09.056; Dou YL, 2005, CELL, V121, P873, DOI 10.1016/j.cell.2005.04.031; Elderkin S, 2007, MOL CELL, V28, P107, DOI 10.1016/j.molcel.2007.08.009; Endoh M, 2008, DEVELOPMENT, V135, P1513, DOI 10.1242/dev.014340; Eskeland R, 2004, BIOCHEMISTRY-US, V43, P3740, DOI 10.1021/bi035964s; Eskeland R, 2010, MOL CELL, V38, P452, DOI 10.1016/j.molcel.2010.02.032; Fan JY, 2004, MOL CELL, V16, P655, DOI 10.1016/j.molcel.2004.10.023; Fazzio TG, 2008, CELL, V134, P162, DOI 10.1016/j.cell.2008.05.031; Fischle W, 2003, GENE DEV, V17, P1870, DOI 10.1101/gad.1110503; Fouse SD, 2008, CELL STEM CELL, V2, P160, DOI 10.1016/j.stem.2007.12.011; Fuchs M, 2001, CELL, V106, P297, DOI 10.1016/S0092-8674(01)00450-0; Gambetta MC, 2009, SCIENCE, V325, P93, DOI 10.1126/science.1169727; Garrick D, 2008, BLOOD, V112, P3889, DOI 10.1182/blood-2008-06-161901; Gearhart MD, 2006, MOL CELL BIOL, V26, P6880, DOI 10.1128/MCB.00630-06; Gevry N, 2007, GENE DEV, V21, P1869, DOI 10.1101/gad.1545707; Gevry N, 2009, GENE DEV, V23, P1522, DOI 10.1101/gad.1787109; Kim J, 2010, CELL, V143, P313, DOI 10.1016/j.cell.2010.09.010; Ku M, 2008, PLOS GENET, V4, DOI 10.1371/journal.pgen.1000242; Lee TI, 2006, CELL, V125, P301, DOI 10.1016/j.cell.2006.02.043; Leeb M, 2007, J CELL BIOL, V178, P219, DOI 10.1083/jcb.200612127; Leeb M, 2010, GENE DEV, V24, P265, DOI 10.1101/gad.544410; Levine SS, 2002, MOL CELL BIOL, V22, P6070, DOI 10.1128/MCB.22.17.6070-6078.2002; Lu JR, 2007, P NATL ACAD SCI USA, V104, P9381, DOI 10.1073/pnas.0610279104; Lu PYT, 2009, BIOCHEM CELL BIOL, V87, P799, DOI 10.1139/O09-062; Luger K, 1999, METH MOL B, V119, P1; Lynch MD, 2012, EMBO J, V31, P317, DOI 10.1038/emboj.2011.399; Margueron R, 2011, NATURE, V469, P343, DOI 10.1038/nature09784; Martinato F, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0003650; Mavrich TN, 2008, NATURE, V453, P358, DOI 10.1038/nature06929; Mendenhall EM, 2010, PLOS GENET, V6, DOI 10.1371/journal.pgen.1001244; Meneghini MD, 2003, CELL, V112, P725, DOI 10.1016/S0092-8674(03)00123-5; Myers SA, 2011, P NATL ACAD SCI US; Negishi M, 2007, BIOCHEM BIOPH RES CO, V353, P992, DOI 10.1016/j.bbrc.2006.12.166; Ogawa H, 2002, SCIENCE, V296, P1132, DOI 10.1126/science.1069861; Ollinger R, 2008, PLOS GENET, V4, DOI 10.1371/journal.pgen.1000199; Pasini D, 2007, MOL CELL BIOL, V27, P3769, DOI 10.1128/MCB.01432-06; Raisner RM, 2005, CELL, V123, P233, DOI 10.1016/j.cell.2005.10.002; Rangasamy D, 2003, EMBO J, V22, P1599, DOI 10.1093/emboj/cdg160; Ruhf ML, 2001, DEVELOPMENT, V128, P1429; Ruhl DD, 2006, BIOCHEMISTRY-US, V45, P5671, DOI 10.1021/bi060043d; Sanchez C, 2007, MOL CELL PROTEOMICS, V6, P820, DOI 10.1074/mcp.M600275-MCP200; Sarcinella E, 2007, MOL CELL BIOL, V27, P6457, DOI 10.1128/MCB.00241-07; Shevchenko A, 1996, BIOCHEM SOC T, V24, P893, DOI 10.1042/bst0240893; Shia WJ, 2006, GENE DEV, V20, P2507, DOI 10.1101/gad.1439206; Simon JA, 2009, NAT REV MOL CELL BIO, V10, P697, DOI 10.1038/nrm2763; Sinclair DAR, 2009, P NATL ACAD SCI USA, V106, P13427, DOI 10.1073/pnas.0904638106; Stock JK, 2007, NAT CELL BIOL, V9, P1428, DOI 10.1038/ncb1663; Straub T, 2008, PLOS GENET, V4, DOI 10.1371/journal.pgen.1000302; Strubbe G, 2011, P NATL ACAD SCI USA, V108, P5572, DOI 10.1073/pnas.1007916108; Swaminathan J, 2005, GENE DEV, V19, P65, DOI 10.1101/gad.1259105; Talbert PB, 2010, NAT REV MOL CELL BIO, V11, P264, DOI 10.1038/nrm2861; Trojer P, 2011, MOL CELL, V42, P438, DOI 10.1016/j.molcel.2011.04.004; van den Berg DLC, 2010, CELL STEM CELL, V6, P369, DOI 10.1016/j.stem.2010.02.014; Vidal M, 2009, INT J DEV BIOL, V53, P355, DOI 10.1387/ijdb.082690mv; Vogler C, 2010, PLOS GENET, V6, DOI 10.1371/journal.pgen.1001234; Wamstad JA, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0002814; Wang HB, 2004, NATURE, V431, P873, DOI 10.1038/nature02985; Wang L, 2004, MOL CELL, V14, P637, DOI 10.1016/j.molcel.2004.05.009; Wright KJ, 2006, P NATL ACAD SCI USA, V103, P12347, DOI 10.1073/pnas.0605499103; Wynder C, 2005, NAT CELL BIOL, V7, P1113, DOI 10.1038/ncb1312; Zilberman D, 2008, NATURE, V456, P125, DOI 10.1038/nature07324; Zlatanova J, 2008, STRUCTURE, V16, P166, DOI 10.1016/j.str.2007.12.008	69	33	35	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 9	2012	7	4							e34848	10.1371/journal.pone.0034848	http://dx.doi.org/10.1371/journal.pone.0034848			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	955JO	22496869	Green Published, Green Submitted, gold			2022-12-25	WOS:000305014500033
J	Carter, S; Miard, S; Roy-Bellavance, C; Boivin, L; Li, Z; Pibarot, P; Mathieu, P; Picard, F				Carter, Sophie; Miard, Stephanie; Roy-Bellavance, Catherine; Boivin, Louise; Li, Zhuo; Pibarot, Philippe; Mathieu, Patrick; Picard, Frederic			Sirt1 Inhibits Resistin Expression in Aortic Stenosis	PLOS ONE			English	Article							INCREASES LIPID-ACCUMULATION; VALVE STENOSIS; TRANSCRIPTIONAL ACTIVITY; SCAVENGER RECEPTOR; INSULIN-RESISTANCE; PPAR-GAMMA; TNF-ALPHA; MACROPHAGES; ATHEROSCLEROSIS; INFLAMMATION	The development of human calcified aortic stenosis (AS) includes age-dependent processes that have been involved in atherosclerosis, such as infiltration of macrophages in aortic valves, which then promote production of many pro-inflammatory cytokines, including resistin. However, the molecular mechanisms contributing to these processes are not established. Since Sirt1 has been shown to modulate macrophage biology and inflammation, we examined its levels in human AS and tested its impact on resistin expression. Sirt1 mRNA (p = 0.01) and protein (p < 0.05) levels were reduced in explanted valves from AS patients (n = 51) compared to those from control (n = 11) patients. Sirt1 mRNA levels were negatively associated with resistin mRNA levels quantified in AS valves (p = 0.02). Stimulation of Sirt1 by resveratrol or virus-driven overexpression robustly diminished resistin mRNA and protein expression in macrophages, whereas down-regulation of Sirt1 triggered a large increase in resistin expression. These effects were direct, as chromatin immunoprecipitation assays showed that Sirt1 physically interacted with the resistin promoter region at an AP-1 response element. Moreover, Sirt1 blocked c-jun-induced resistin transactivation in gene reporter assays. These findings demonstrate that, in calcified AS, levels of Sirt1 are reduced whereas those of resistin are increased within aortic valve leaflets. Our results also suggest that this loss of Sirt1 expression alleviates its inhibition of resistin transcription in macrophages. Although the overall contribution of this process to the underlying mechanisms for AS disease development remains unresolved, these observations suggest that modification of Sirt1 expression and/or activity could represent a novel approach against inflammation in AS.	[Carter, Sophie; Miard, Stephanie; Roy-Bellavance, Catherine; Boivin, Louise; Li, Zhuo; Pibarot, Philippe; Mathieu, Patrick; Picard, Frederic] Univ Laval, Quebec Heart & Lung Res Ctr, Quebec City, PQ, Canada	Laval University; Quebec Heart & Lung Institute	Carter, S (corresponding author), Univ Laval, Quebec Heart & Lung Res Ctr, Quebec City, PQ, Canada.	Frederic.Picard@criucpq.ulaval.ca	Pibarot, Philippe/ABD-5300-2021	Carter, Sophie/0000-0002-9817-0029	Institut de cardiologie et de pneumologie de Quebec (IUCPQ) Foundation; Canadian Institutes for Health Research (CIHR); International Chair on Cardiometabolic Risk; FRSQ	Institut de cardiologie et de pneumologie de Quebec (IUCPQ) Foundation; Canadian Institutes for Health Research (CIHR)(Canadian Institutes of Health Research (CIHR)); International Chair on Cardiometabolic Risk; FRSQ(Fonds de la Recherche en Sante du Quebec)	This project was supported by grants from Institut de cardiologie et de pneumologie de Quebec (IUCPQ) Foundation and the Canadian Institutes for Health Research (CIHR). FP is a Junior 2 Investigator of the Fonds pour la recherche en sante du Quebec (FRSQ). SC was a recipient of a studentship from the International Chair on Cardiometabolic Risk and now holds a FRSQ PhD studentship. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abdelmohsen K, 2007, MOL CELL, V25, P543, DOI 10.1016/j.molcel.2007.01.011; Agmon Y, 2001, J AM COLL CARDIOL, V38, P827, DOI 10.1016/S0735-1097(01)01422-X; Bosse Y, 2009, CIRC-CARDIOVASC GENE, V2, P489, DOI 10.1161/CIRCGENETICS.108.820795; Charest A, 2006, HEART, V92, P1844, DOI 10.1136/hrt.2005.086595; Chawla A, 2010, CIRC RES, V106, P1559, DOI 10.1161/CIRCRESAHA.110.216523; Cote C, 2008, HEART, V94, P1175, DOI 10.1136/hrt.2007.125740; de Kreutzenberg SV, 2010, DIABETES, V59, P1006, DOI 10.2337/db09-1187; Derbali H, 2010, AM J PATHOL, V176, P2638, DOI 10.2353/ajpath.2010.090541; Gao ZG, 2008, BIOCHEM BIOPH RES CO, V376, P793, DOI 10.1016/j.bbrc.2008.09.079; Guarente L, 2005, CELL, V120, P473, DOI 10.1016/j.cell.2005.01.029; Guarente L, 2011, NEW ENGL J MED, V364, P2235, DOI 10.1056/NEJMra1100831; Helske S, 2007, CURR OPIN LIPIDOL, V18, P483, DOI 10.1097/MOL.0b013e3282a66099; Hess J, 2004, J CELL SCI, V117, P5965, DOI 10.1242/jcs.01589; Hopkins RA, 2006, CIRCULATION, V114, P261, DOI 10.1161/CIRCULATIONAHA.106.639005; Jung HS, 2006, CARDIOVASC RES, V69, P76, DOI 10.1016/j.cardiores.2005.09.015; Kunnari AM, 2009, REGUL PEPTIDES, V157, P57, DOI 10.1016/j.regpep.2009.05.002; Lee TS, 2009, LIFE SCI, V84, P97, DOI 10.1016/j.lfs.2008.11.004; Lehrke M, 2004, PLOS MED, V1, P161, DOI 10.1371/journal.pmed.0010045; Li X, 2007, MOL CELL, V28, P91, DOI 10.1016/j.molcel.2007.07.032; LINDROOS M, 1993, J AM COLL CARDIOL, V21, P1220, DOI 10.1016/0735-1097(93)90249-Z; Liu K, 2010, BIOCHIMIE, V92, P789, DOI 10.1016/j.biochi.2010.02.024; Lorenzi I, 2008, J MOL MED, V86, P171, DOI 10.1007/s00109-007-0267-1; Lu SC, 2002, FEBS LETT, V530, P158, DOI 10.1016/S0014-5793(02)03450-6; Mathieu P, 2005, J HEART VALVE DIS, V14, P353; Mathieu P, 2006, VASC HEALTH RISK MAN, V2, P285, DOI 10.2147/vhrm.2006.2.3.285; Mercader J, 2011, J NUTR BIOCHEM, V22, P828, DOI 10.1016/j.jnutbio.2010.07.007; Miller JD, 2008, J AM COLL CARDIOL, V52, P843, DOI 10.1016/j.jacc.2008.05.043; Mohty D, 2010, INT J CARDIOL, V142, P126, DOI 10.1016/j.ijcard.2008.12.068; Nakamaru Y, 2009, FASEB J, V23, P2810, DOI 10.1096/fj.08-125468; Nollert G, 2003, J THORAC CARDIOV SUR, V126, P965, DOI 10.1016/S0022-5223(02)73619-2; Ohmori R, 2005, J AM COLL CARDIOL, V46, P379, DOI 10.1016/j.jacc.2005.04.022; Patel SD, 2004, SCIENCE, V304, P1154, DOI 10.1126/science.1093466; Picard F, 2004, NATURE, V429, P771, DOI 10.1038/nature02583; Picard F, 2002, CELL, V111, P931, DOI 10.1016/S0092-8674(02)01169-8; Rae C, 2006, DIABETOLOGIA, V49, P1112, DOI 10.1007/s00125-006-0187-6; Reilly MP, 2005, CIRCULATION, V111, P932, DOI 10.1161/01.CIR.0000155620.10387.43; Schwartz DR, 2011, TRENDS ENDOCRIN MET, V22, P259, DOI 10.1016/j.tem.2011.03.005; Shen Z, 2009, AM J PHYSIOL-GASTR L, V296, pG1047, DOI 10.1152/ajpgi.00016.2009; Shetty R, 2009, EUR J CLIN INVEST, V39, P471, DOI 10.1111/j.1365-2362.2009.02132.x; Shyu KG, 2009, J BIOMED SCI, V16, DOI 10.1186/1423-0127-16-50; Singh AK, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0009912; Stein S, 2010, EUR HEART J, V31, P2301, DOI 10.1093/eurheartj/ehq107; Takemura A, 2011, ARTERIOSCL THROM VAS, V31, P2054, DOI 10.1161/ATVBAHA.110.216739; Xu WB, 2006, BIOCHEM BIOPH RES CO, V351, P376, DOI 10.1016/j.bbrc.2006.10.051; Yetkin E, 2009, INT J CARDIOL, V135, P4, DOI 10.1016/j.ijcard.2009.03.108; Yoshizaki T, 2010, AM J PHYSIOL-ENDOC M, V298, pE419, DOI 10.1152/ajpendo.00417.2009; Zhang QJ, 2008, CARDIOVASC RES, V80, P191, DOI 10.1093/cvr/cvn224; Zhang R, 2010, J BIOL CHEM, V285, P7097, DOI 10.1074/jbc.M109.038604	48	23	24	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 6	2012	7	4							e35110	10.1371/journal.pone.0035110	http://dx.doi.org/10.1371/journal.pone.0035110			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	955JA	22493735	Green Published, Green Submitted, gold			2022-12-25	WOS:000305012700077
J	Chua, AC; Leo, YS; Cavailler, P; Chu, C; Ng, A; Ng, OT; Krishnan, P				Chua, Arlene C.; Leo, Yee Sin; Cavailler, Philippe; Chu, Christine; Aloysius Ng; Oon Tek Ng; Krishnan, Prabha			Opt-out of Voluntary HIV Testing: A Singapore Hospital's Experience	PLOS ONE			English	Article							UNITED-STATES	Introduction: Since 2008, the Singapore Ministry of Health (MOH) has expanded HIV testing by increasing anonymous HIV test sites, as well as issuing a directive to hospitals to offer routine voluntary opt out inpatient HIV testing. We reviewed this program implemented at the end of 2008 at Tan Tock Seng Hospital (TTSH), the second largest acute care general hospital in Singapore. Methods and Findings: From January 2009 to December 2010, all inpatients aged greater or equal than 21 years were screened for HIV unless they declined or were not eligible for screening. We reviewed the implementation of the Opt Out testing policy. There were a total of 93,211 admissions; 41,543 patients were included based on HIV screening program eligibility criteria. Among those included, 79% (n = 32,675) opted out of HIV screening. The overall acceptance rate was 21%. Majority of eligible patients who were tested (63%) were men. The mean age of tested patients was 52 years. The opt out rate was significantly higher among females (OR: 1.5, 95% CI: 1.4-1.6), aged >60 years (OR: 2.3, 95% CI: 2.2-2.4) and Chinese ethnicity (OR: 1.7, 95% CI:1.6-1.8). The false positive rate of the HIV screening test is 0.56%. The proportion of patients with HIV infection among those who underwent HIV screening is 0.18%. All16 confirmed HIV patients were linked to care. Conclusion: The default opt-in rate of inpatient HIV testing was low at Tan Tock Seng Hospital, Singapore. Efforts to address individual HIV risk perception and campaigns against HIV stigma are needed to encourage more individuals to be tested for HIV.	[Chua, Arlene C.; Leo, Yee Sin; Oon Tek Ng] Tan Tock Seng Hosp, Dept Infect Dis, Singapore, Singapore; [Cavailler, Philippe] Reg Emerging Dis Intervent Ctr, Dept Epidemiol Res, Singapore, Singapore; [Chu, Christine; Aloysius Ng; Krishnan, Prabha] Tan Tock Seng Hosp, Dept Lab Med, Singapore, Singapore	Tan Tock Seng Hospital; Tan Tock Seng Hospital	Chua, AC (corresponding author), Tan Tock Seng Hosp, Dept Infect Dis, Singapore, Singapore.	Arlene_CHUA@ttsh.com.sg	Cavailler, Philippe/G-4138-2017	Chua, Arlene/0000-0001-6428-9083	Ministry of Health	Ministry of Health	This is a Ministry of Health funded screening program. The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Action For AIDS, 2011, AFA AN TEST SIT PREV; Smith Nicole M., 2006, Morbidity and Mortality Weekly Report, V55, P1; [Anonymous], 2006, STRAITS TIMES; Calderon Y, 2011, CROI 2011; Health Promotion Board, 2007, NAT BEH SUR SURV 200; Mills CW, 2011, SEX TRANSM DIS, V38, P715, DOI 10.1097/OLQ.0b013e31820ead73; Ministry of Health, 2010, UPD HIV AIDS SIT SIN; Paltiel AD, 2006, ANN INTERN MED, V145, P797, DOI 10.7326/0003-4819-145-11-200612050-00004; Paltiel AD, 2005, NEW ENGL J MED, V352, P586, DOI 10.1056/NEJMsa042088; Sanders GD, 2005, NEW ENGL J MED, V352, P570, DOI 10.1056/NEJMsa042657; Siegel M, 2010, JAIDS-J ACQ IMM DEF, V55, P205, DOI 10.1097/QAI.0b013e3181e15bf4; WHO, 2008, EP FACT SHEET HIV AI; World Health Organization and the Joint United Nations Programme on HIV and AIDS (UNAIDS), 2011, UNGASS COUNTR PROGR	13	20	20	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 6	2012	7	4							e34663	10.1371/journal.pone.0034663	http://dx.doi.org/10.1371/journal.pone.0034663			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	955JA	22493708	Green Submitted, gold, Green Published			2022-12-25	WOS:000305012700050
J	Duan, FB; Chapeau-Blondeau, F; Abbott, D				Duan, Fabing; Chapeau-Blondeau, Francois; Abbott, Derek			Fisher Information as a Metric of Locally Optimal Processing and Stochastic Resonance	PLOS ONE			English	Article							NON-GAUSSIAN NOISE; SYSTEMS; SIGNALS; DETECTORS; DISORDER	The origins of Fisher information are in its use as a performance measure for parametric estimation. We augment this and show that the Fisher information can characterize the performance in several other significant signal processing operations. For processing of a weak signal in additive white noise, we demonstrate that the Fisher information determines (i) the maximum output signal-to-noise ratio for a periodic signal; (ii) the optimum asymptotic efficacy for signal detection; (iii) the best cross-correlation coefficient for signal transmission; and (iv) the minimum mean square error of an unbiased estimator. This unifying picture, via inequalities on the Fisher information, is used to establish conditions where improvement by noise through stochastic resonance is feasible or not.	[Duan, Fabing] Qingdao Univ, Coll Automat Engn, Qingdao 266071, Peoples R China; [Chapeau-Blondeau, Francois] Univ Angers, LISA, Angers, France; [Abbott, Derek] Univ Adelaide, Sch Elect & Elect Engn, Adelaide, SA, Australia; [Abbott, Derek] Univ Adelaide, Ctr Biomed Engn CBME, Adelaide, SA, Australia	Qingdao University; Universite d'Angers; University of Adelaide; University of Adelaide	Duan, FB (corresponding author), Qingdao Univ, Coll Automat Engn, Qingdao 266071, Peoples R China.	fabing.duan@gmail.com	Abbott, Derek/E-8352-2011	Abbott, Derek/0000-0002-0945-2674; CHAPEAU-BLONDEAU, Francois/0000-0003-0536-7146	NSF of Shandong Province, China [ZR2010FM006]	NSF of Shandong Province, China	This work is sponsored by the NSF of Shandong Province, China (No. ZR2010FM006). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	BENZI R, 1981, J PHYS A-MATH GEN, V14, pL453, DOI 10.1088/0305-4470/14/11/006; Bezrukov SM, 1997, NATURE, V385, P319, DOI 10.1038/385319a0; BROWN L. D., 1982, STAT PROBABILITY ESS, P141; CAPON J, 1961, IRE T INFORM THEOR, V7, P67, DOI 10.1109/TIT.1961.1057628; Chapeau-Blondeau F, 2009, J STAT MECH-THEORY E, V1; ChapeauBlondeau F, 1997, PHYS REV E, V55, P1478, DOI 10.1103/PhysRevE.55.1478; Chen HO, 2007, IEEE T SIGNAL PROCES, V55, P3172, DOI 10.1109/TSP.2007.893757; COLLINS JJ, 1995, NATURE, V376, P236, DOI 10.1038/376236a0; Cover TM, 1991, ELEMENTS INFORM THEO; DEWEESE M, 1995, NUOVO CIMENTO D, V17, P733, DOI 10.1007/BF02451830; Duan FB, 2011, PHYS REV E, V84, DOI 10.1103/PhysRevE.84.051107; Dykman MI, 1998, NATURE, V391, P344, DOI 10.1038/34812; Gammaitoni L, 1998, REV MOD PHYS, V70, P223, DOI 10.1103/RevModPhys.70.223; Gan CB, 2010, CHINESE PHYS B, V19, DOI 10.1088/1674-1056/19/4/040508; Gosak M, 2012, MOL CRYST LIQ CRYST, V553, P13, DOI 10.1080/15421406.2011.609343; Greenwood PE, 2004, PHYS REV E, V70, DOI 10.1103/PhysRevE.70.051110; HANGGI P, 1993, J STAT PHYS, V70, P25, DOI 10.1007/BF01053952; Kassam S. A., 1988, SIGNAL DETECTION NON; Kay S, 2000, IEEE SIGNAL PROC LET, V7, P8, DOI 10.1109/97.809511; Kay S. M., 1998, FUNDAMENTALS STAT SI; LU NH, 1981, IEEE T INFORM THEORY, V27, P755, DOI 10.1109/TIT.1981.1056414; McDonnell MD, 2009, PLOS COMPUT BIOL, V5, DOI 10.1371/journal.pcbi.1000348; Perc M, 2007, PHYS REV E, V76, DOI 10.1103/PhysRevE.76.066203; Perc M, 2008, SOFT MATTER, V4, P1861, DOI 10.1039/b804566f; Perc M, 2008, PHYS REV E, V78, DOI 10.1103/PhysRevE.78.036105; POOR HV, 1978, J ACOUST SOC AM, V63, P75, DOI 10.1121/1.381698; SONG I, 1990, IEEE T INFORM THEORY, V36, P516, DOI 10.1109/18.54900; Stocks NG, 2000, PHYS REV LETT, V84, P2310, DOI 10.1103/PhysRevLett.84.2310; Wang QY, 2009, CHAOS, V19, DOI 10.1063/1.3133126; Ward LM, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0014371; Zaikin AA, 2000, PHYS REV LETT, V85, P227, DOI 10.1103/PhysRevLett.85.227; Zeng LZ, 2011, FLUCT NOISE LETT, V10, P223, DOI 10.1142/S0219477511000508; Zozor S, 2003, IEEE T SIGNAL PROCES, V51, P3177, DOI 10.1109/TSP.2003.818905	34	15	15	1	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 6	2012	7	4							e34282	10.1371/journal.pone.0034282	http://dx.doi.org/10.1371/journal.pone.0034282			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	955JA	22493686	Green Published, gold, Green Submitted			2022-12-25	WOS:000305012700028
J	Kox, M; Vaneker, M; van der Hoeven, JG; Scheffer, GJ; Hoedemaekers, CW; Pickkers, P				Kox, Matthijs; Vaneker, Michiel; van der Hoeven, Johannes G.; Scheffer, Gert-Jan; Hoedemaekers, Cornelia W.; Pickkers, Peter			Effects of Vagus Nerve Stimulation and Vagotomy on Systemic and Pulmonary Inflammation in a Two-Hit Model in Rats	PLOS ONE			English	Article							INDUCED LUNG INJURY; CHOLINERGIC ANTIINFLAMMATORY PATHWAY; VENTILATOR-INDUCED INJURY; MECHANICAL VENTILATION; IMPROVES SURVIVAL; HEALTHY MICE; IN-VIVO; SEPSIS; ENDOTOXEMIA; SUSCEPTIBILITY	Pulmonary inflammation contributes to ventilator-induced lung injury. Sepsis-induced pulmonary inflammation (first hit) may be potentiated by mechanical ventilation (MV, second hit). Electrical stimulation of the vagus nerve has been shown to attenuate inflammation in various animal models through the cholinergic anti-inflammatory pathway. We determined the effects of vagotomy (VGX) and vagus nerve stimulation (VNS) on systemic and pulmonary inflammation in a two-hit model. Male Sprague-Dawley rats were i.v. administered lipopolysaccharide (LPS) and subsequently underwent VGX, VNS or a sham operation. 1 hour following LPS, MV with low (8 mL/kg) or moderate (15 mL/kg) tidal volumes was initiated, or animals were left breathing spontaneously (SP). After 4 hours of MV or SP, rats were sacrificed. Cytokine and blood gas analysis was performed. MV with 15, but not 8 mL/kg, potentiated the LPS-induced pulmonary pro-inflammatory cytokine response (TNF-alpha, IL-6, KC: p<0.05 compared to LPS-SP), but did not affect systemic inflammation or impair oxygenation. VGX enhanced the LPS-induced pulmonary, but not systemic pro-inflammatory cytokine response in spontaneously breathing, but not in MV animals (TNF-alpha, IL-6, KC: p<0.05 compared to SHAM), and resulted in decreased pO(2) (p<0.05 compared to sham-operated animals). VNS did not affect any of the studied parameters in both SP and MV animals. In conclusion, MV with moderate tidal volumes potentiates the pulmonary inflammatory response elicited by systemic LPS administration. No beneficial effects of vagus nerve stimulation performed following LPS administration were found. These results questions the clinical applicability of stimulation of the cholinergic anti-inflammatory pathway in systemically inflamed patients admitted to the ICU where MV is initiated.	[Kox, Matthijs; van der Hoeven, Johannes G.; Hoedemaekers, Cornelia W.; Pickkers, Peter] Radboud Univ Nijmegen, Med Ctr, Dept Intens Care Med, NL-6525 ED Nijmegen, Netherlands; [Kox, Matthijs; Vaneker, Michiel; Scheffer, Gert-Jan] Radboud Univ Nijmegen, Med Ctr, Dept Anesthesiol, NL-6525 ED Nijmegen, Netherlands; [Kox, Matthijs; van der Hoeven, Johannes G.; Pickkers, Peter] Nijmegen Inst Infect Inflammat & Immun N4i, Nijmegen, Netherlands	Radboud University Nijmegen; Radboud University Nijmegen; Radboud University Nijmegen	Kox, M (corresponding author), Radboud Univ Nijmegen, Med Ctr, Dept Intens Care Med, NL-6525 ED Nijmegen, Netherlands.	m.kox@ic.umcn.nl	Scheffer, G.J./H-8086-2014; van der Hoeven, J.G./H-8048-2014; Hoedemaekers, C.W.E./L-4375-2015; Vaneker, M./L-4702-2015; Pickkers, P./H-8080-2014; Kox, Matthijs/L-4454-2015	Pickkers, P./0000-0002-1104-4303; 				Altemeier WA, 2004, AM J PHYSIOL-LUNG C, V287, pL533, DOI 10.1152/ajplung.00004.2004; Bernik TR, 2002, J EXP MED, V195, P781, DOI 10.1084/jem.20011714; Boland C, 2011, INFLAMMATION, V34, P29, DOI 10.1007/s10753-010-9204-5; Borovikova LV, 2000, NATURE, V405, P458, DOI 10.1038/35013070; Bregeon F, 2005, ANESTHESIOLOGY, V102, P331; Bregeon F, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0022386; Crimi E, 2006, AM J RESP CRIT CARE, V174, P178, DOI 10.1164/rccm.200507-1178OC; de Jonge WJ, 2005, NAT IMMUNOL, V6, P844, DOI 10.1038/ni1229; dos Santos CC, 2005, CRIT CARE, V9, P280, DOI 10.1186/cc3022; dos Santos CC, 2011, AM J RESP CRIT CARE, V183, P471, DOI 10.1164/rccm.201002-0314OC; Gattinoni L, 2010, CRIT CARE MED, V38, pS539, DOI 10.1097/CCM.0b013e3181f1fcf7; Guarini S, 2003, CIRCULATION, V107, P1189, DOI 10.1161/01.CIR.0000050627.90734.ED; Hofer S, 2008, CRIT CARE MED, V36, P404, DOI 10.1097/01.CCM.0B013E31816208B3; Hudson LD, 1999, JAMA-J AM MED ASSOC, V282, P77, DOI 10.1001/jama.282.1.77; Huston JM, 2007, CRIT CARE MED, V35, P2762, DOI 10.1097/01.CCM.0000288102.15975.BA; Huston JM, 2006, J EXP MED, V203, P1623, DOI 10.1084/jem.20052362; Imai Y, 1999, J APPL PHYSIOL, V87, P510, DOI 10.1152/jappl.1999.87.2.510; Jerng JS, 2007, THORAX, V62, P527, DOI 10.1136/thx.2006.061945; Jiang JS, 2010, RESPIRATION, V80, P246, DOI 10.1159/000279438; Karzai W, 2005, ANESTHESIOLOGY, V103, P996, DOI 10.1097/00000542-200511000-00014; Kox M, 2011, BR J ANAESTH; Lang JD, 2005, CLIN EXP IMMUNOL, V141, P211, DOI 10.1111/j.1365-2249.2005.02853.x; Lin SM, 2007, SHOCK, V28, P453, DOI 10.1097/shk.0b013e3180487fb5; Liu YY, 2008, CRIT CARE, V12, DOI 10.1186/cc6982; Niederbichler AD, 2009, BURNS, V35, P783, DOI 10.1016/j.burns.2008.08.023; Opal SM, 2010, INT J ANTIMICROB AG, V36, pS70, DOI 10.1016/j.ijantimicag.2010.11.008; Plotz FB, 2004, INTENS CARE MED, V30, P1865, DOI 10.1007/s00134-004-2363-9; Rieger-Fackeldey E, 2008, RESP PHYSIOL NEUROBI, V160, P341, DOI 10.1016/j.resp.2007.10.017; Rosas-Ballina M, 2008, P NATL ACAD SCI USA, V105, P11008, DOI 10.1073/pnas.0803237105; Schreiber T, 2006, ANESTHESIOLOGY, V104, P133, DOI 10.1097/00000542-200601000-00019; Sevransky Jonathan E, 2004, Crit Care Med, V32, pS548, DOI 10.1097/01.CCM.0000145947.19077.25; Terragni PP, 2009, ANESTHESIOLOGY, V111, P826, DOI 10.1097/ALN.0b013e3181b764d2; Tracey KJ, 2002, NATURE, V420, P853, DOI 10.1038/nature01321; Tremblay LN, 1998, P ASSOC AM PHYSICIAN, V110, P482; Vaneker M, 2007, ANESTHESIOLOGY, V107, P419, DOI 10.1097/01.anes.0000278908.22686.01; Wang H, 2003, NATURE, V421, P384, DOI 10.1038/nature01339; Wolthuis EK, 2009, CRIT CARE, V13, DOI 10.1186/cc7688; Wosten-van Asperen RM, 2010, AM J PATHOL, V176, P2219, DOI 10.2353/ajpath.2010.090565	38	34	36	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 6	2012	7	4							e34431	10.1371/journal.pone.0034431	http://dx.doi.org/10.1371/journal.pone.0034431			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	955JA	22493690	Green Published, gold			2022-12-25	WOS:000305012700032
J	Krawczyk, SA; Haller, JF; Ferrante, T; Zoeller, RA; Corkey, BE				Krawczyk, Sarah A.; Haller, Jorge F.; Ferrante, Tom; Zoeller, Raphael A.; Corkey, Barbara E.			Reactive Oxygen Species Facilitate Translocation of Hormone Sensitive Lipase to the Lipid Droplet During Lipolysis in Human Differentiated Adipocytes	PLOS ONE			English	Article							DEPENDENT PROTEIN-KINASE; INSULIN-RESISTANT MICE; OXIDATIVE STRESS; ADIPOSE-TISSUE; IN-VITRO; NATRIURETIC PEPTIDES; NERVOUS-SYSTEM; CYCLIC-AMP; FAT-CELLS; PHOSPHORYLATION	In obesity, there is an increase in reactive oxygen species (ROS) within adipose tissue caused by increases in inflammation and overnutrition. Hormone sensitive lipase (HSL) is part of the canonical lipolytic pathway and critical for complete lipolysis. This study hypothesizes that ROS is a signal that integrates regulation of lipolysis by targeting HSL. Experiments were performed with human differentiated adipocytes from the subcutaneous depot. Antioxidants were employed as a tool to decrease ROS, and it was found that scavenging ROS with diphenyliodonium, N-acetyl cysteine, or resveratrol decreased lipolysis in adipocytes. HSL phosphorylation of a key serine residue, Ser552, as well as translocation of this enzyme from the cytosol to the lipid droplet upon lipolytic stimulation were both abrogated by scavenging ROS. The phosphorylation status of other serine residues on HSL were not affected. These findings are significant because they document that ROS contributes to the physiological regulation of lipolysis via an effect on translocation. Such regulation could be useful in developing new obesity therapies.	[Krawczyk, Sarah A.; Ferrante, Tom; Corkey, Barbara E.] Boston Univ, Sch Med, Dept Med, Boston, MA 02118 USA; [Krawczyk, Sarah A.; Ferrante, Tom; Corkey, Barbara E.] Boston Univ, Sch Med, Dept Biochem, Boston, MA 02118 USA; [Haller, Jorge F.; Zoeller, Raphael A.] Boston Univ, Sch Med, Dept Physiol & Biophys, Boston, MA 02118 USA	Boston University; Boston University; Boston University	Krawczyk, SA (corresponding author), Boston Univ, Sch Med, Dept Med, Boston, MA 02118 USA.	krawczyk@bu.edu		Zoeller, Raphael/0000-0002-6560-0993	National Institutes of Heatlh [DK056690, DK46200]; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK035914, R01DK056690, P30DK046200] Funding Source: NIH RePORTER	National Institutes of Heatlh; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	Funding through the National Institutes of Heatlh, grants DK056690 and DK46200. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Akassoglou K, 2005, MOL PHARMACOL, V68, P952, DOI 10.1124/mol.105.017277; Anthonsen MW, 1998, J BIOL CHEM, V273, P215, DOI 10.1074/jbc.273.1.215; Babich H, 2009, IN VITRO CELL DEV-AN, V45, P226, DOI 10.1007/s11626-008-9168-z; CAMPBELL PJ, 1994, AM J PHYSIOL, V266, pE600, DOI 10.1152/ajpendo.1994.266.4.E600; Contreras JA, 1998, PROTEIN EXPRES PURIF, V12, P93, DOI 10.1006/prep.1997.0821; Csaki LS, 2010, ANNU REV NUTR, V30, P257, DOI 10.1146/annurev.nutr.012809.104729; D'Autreaux B, 2007, NAT REV MOL CELL BIO, V8, P813, DOI 10.1038/nrm2256; Feil R, 2005, REV NEUROSCIENCE, V16, P23; Fischer-Posovszky P, 2001, AM J CLIN NUTR, V92, P5; Fiscus RR, 2002, NEUROSIGNALS, V11, P175, DOI 10.1159/000065431; Furukawa S, 2004, J CLIN INVEST, V114, P1752, DOI [10.1172/JCI20042162S, 10.1172/JCI21625]; Galitzky J, 2001, J LIPID RES, V42, P536; Gaudiot N, 2000, AM J PHYSIOL-CELL PH, V279, pC1603, DOI 10.1152/ajpcell.2000.279.5.C1603; Gauthier MS, 2008, J BIOL CHEM, V283, P16514, DOI 10.1074/jbc.M708177200; GREENBERG AS, 1991, J BIOL CHEM, V266, P11341; Haemmerle G, 2006, SCIENCE, V312, P734, DOI 10.1126/science.1123965; Harada K, 2003, AM J PHYSIOL-ENDOC M, V285, pE1182, DOI 10.1152/ajpendo.00259.2003; Houslay MD, 2003, BIOCHEM J, V370, P1, DOI 10.1042/BJ20021698; KHOO JC, 1974, J CLIN INVEST, V53, P1124, DOI 10.1172/JCI107650; Krintel C, 2009, FEBS J, V276, P4752, DOI 10.1111/j.1742-4658.2009.07172.x; Krintel C, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0003756; Lampidonis AD, GENE, V477, P1; Lampidonis AD, 2011, GENE, V477, P1, DOI 10.1016/j.gene.2011.01.007; Martin S, 2009, J BIOL CHEM, V284, P32097, DOI 10.1074/jbc.M109.002675; Miyoshi H, 2006, J BIOL CHEM, V281, P15837, DOI 10.1074/jbc.M601097200; Peyot ML, 2004, DIABETES, V53, P1733, DOI 10.2337/diabetes.53.7.1733; Pi JB, 2007, DIABETES, V56, P1783, DOI 10.2337/db06-1601; Sekiya M, 2004, J BIOL CHEM, V279, P15084, DOI 10.1074/jbc.M310985200; Sengenes C, 2002, INT J OBESITY, V26, P24, DOI 10.1038/sj.ijo.0801845; Sengenes C, 2002, AM J PHYSIOL-REG I, V283, pR257, DOI 10.1152/ajpregu.00453.2001; Sengenes C, 2000, FASEB J, V14, P1345, DOI 10.1096/fj.14.10.1345; SENGUPTA K, 1981, J PHARMACOL EXP THER, V218, P128; Smith AJ, 2008, J BIOL CHEM, V283, P33536, DOI 10.1074/jbc.M806732200; Souza SC, 2002, J BIOL CHEM, V277, P8267, DOI 10.1074/jbc.M108329200; STRALFORS P, 1983, J BIOL CHEM, V258, P5146; STRALFORS P, 1984, P NATL ACAD SCI-BIOL, V81, P3317, DOI 10.1073/pnas.81.11.3317; Su CL, 2003, J BIOL CHEM, V278, P43615, DOI 10.1074/jbc.M301809200; Talior I, 2005, AM J PHYSIOL-ENDOC M, V288, pE405, DOI 10.1152/ajpendo.00378.2004; Talior I, 2003, AM J PHYSIOL-ENDOC M, V285, pE295, DOI 10.1152/ajpendo.00044.2003; Talmud PJ, 2001, BBA-MOL BASIS DIS, V1537, P239, DOI 10.1016/S0925-4439(01)00076-X; Wang T, 2010, OBESITY, V18, P1493, DOI 10.1038/oby.2009.456; Wang YL, 2004, OBES RES, V12, P1781, DOI 10.1038/oby.2004.221; Watt MJ, 2006, AM J PHYSIOL-ENDOC M, V290, pE500, DOI 10.1152/ajpendo.00361.2005; WOLFE RR, 1987, AM J PHYSIOL, V252, pE189, DOI 10.1152/ajpendo.1987.252.2.E189; Zhong J, 2010, J PROTEOME RES, V9, P5228, DOI 10.1021/pr100521c; Zimmermann R, 2004, SCIENCE, V306, P1383, DOI 10.1126/science.1100747	46	39	40	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 6	2012	7	4							e34904	10.1371/journal.pone.0034904	http://dx.doi.org/10.1371/journal.pone.0034904			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	955JA	22493722	gold, Green Submitted, Green Published			2022-12-25	WOS:000305012700064
J	Ogata, N; Yokoyama, T; Iwabuchi, K				Ogata, Norichika; Yokoyama, Takeshi; Iwabuchi, Kikuo			Transcriptome Responses of Insect Fat Body Cells to Tissue Culture Environment	PLOS ONE			English	Article							DIFFERENTIAL EXPRESSION ANALYSIS; RNA-SEQ; BOMBYX-MORI; SILKWORM; REVEALS; INVITRO; GROWTH; MOTH	Tissue culture is performed to maintain isolated portions of multicellular organisms in an artificial milieu that is outside the individual organism and for considerable periods of time; cells derived from cultured explants are, in general, different from cells of the corresponding tissue in a living organism. The changes in cultured tissues that precede and often explain the subsequent cell proliferation of explant-derived cells have been partially studied, but little is known about the molecular and genomic basis of these changes. Comparative transcriptomics of intact and cultured (90 hours in MGM-450 insect medium) Bombyx mori tissues revealed that fewer genes represented a larger portion of the transcriptome of intact fat body tissues than of cultured fat body tissues. This analysis also indicated that expression of genes encoding sugar transporters and immune response proteins increased during culture and that expression of genes encoding lipoproteins and cuticle proteins decreased during culture. These results provide support for hypotheses that cultured tissues respond immunologically to surgery, adapt to the medium by accelerating sugar uptake, and terminate their identity as part of an intact organism by becoming independent of that organism.	[Ogata, Norichika; Iwabuchi, Kikuo] Tokyo Univ Agr & Technol, Fac Agr, Appl Entomol Lab, Tokyo, Japan; [Yokoyama, Takeshi] Tokyo Univ Agr & Technol, Fac Agr, Sericultural Sci Lab, Tokyo, Japan	Tokyo University of Agriculture & Technology; Tokyo University of Agriculture & Technology	Ogata, N (corresponding author), Tokyo Univ Agr & Technol, Fac Agr, Appl Entomol Lab, Tokyo, Japan.	kikkuo@cc.tuat.ac.jp	Yokoyama, Takeshi/C-3854-2013; Iwabuchi, Kikuo/I-7530-2012	Ogata, Norichika/0000-0002-6856-6655				Anders S, 2010, GENOME BIOL, V11, DOI 10.1186/gb-2010-11-10-r106; Bentley DR, 2008, NATURE, V456, P53, DOI 10.1038/nature07517; Carleton HM, 1923, BR J EXP BIOL, V1, P131; Celniker SE, 2009, NATURE, V459, P927, DOI 10.1038/459927a; Cherbas L, 2011, GENOME RES, V21, P301, DOI 10.1101/gr.112961.110; Conesa A, 2005, BIOINFORMATICS, V21, P3674, DOI 10.1093/bioinformatics/bti610; Couble P, 2008, INSECT BIOCHEM MOLEC, V38, P1035, DOI [10.1016/j.ibmb.2009.01.004, 10.1016/j.ibmb.2008.11.004]; Eppler A, 1980, INVERTEBRATE SYSTEMS, P59; Freshney R.I., 2005, CULTURE ANIMAL CELLS, DOI [10.1002/0471747599.CAC022, DOI 10.1002/0471747599.CAC022]; GRACE TDC, 1962, NATURE, V195, P788, DOI 10.1038/195788a0; GRACE TDC, 1959, ANN NY ACAD SCI, V77, P275, DOI 10.1111/j.1749-6632.1959.tb36908.x; Hosseini Parsa, 2010, BMC Res Notes, V3, P183, DOI 10.1186/1756-0500-3-183; IMANISHI S, 1992, JARQ-JPN AGR RES Q, V26, P196; IMANISHI S, 1988, Journal of Sericultural Science of Japan, V57, P184; Jing Tian-zhong, 2006, Journal of Forestry Research (Harbin), V17, P129, DOI 10.1007/s11676-006-0030-4; KURTTI TJ, 1975, IN VITRO CELL DEV B, V11, P274; Kurtti TJ, INSECT MITE NUTR, P387; Langmead B, 2009, GENOME BIOL, V10, DOI 10.1186/gb-2009-10-3-r25; Lynn DE, 2001, IN VITRO CELL DEV-AN, V37, P319, DOI 10.1007/BF02577564; Marioni JC, 2008, GENOME RES, V18, P1509, DOI 10.1101/gr.079558.108; MITSUHASHI J, 1988, APPL ENTOMOL ZOOL, V23, P488, DOI 10.1303/aez.23.488; Mortazavi A, 2008, NAT METHODS, V5, P621, DOI 10.1038/nmeth.1226; Nordman J, 2011, GENOME RES, V21, P175, DOI 10.1101/gr.114611.110; R DEVELOPMENT CORE TEAM, 2011, R LANG ENV STAT COMP; Robinson MD, 2010, GENOME BIOL, V11, DOI 10.1186/gb-2010-11-3-r25; SATO G, 1960, P NATL ACAD SCI USA, V46, P963, DOI 10.1073/pnas.46.7.963; SHANNON CE, 1948, BELL SYST TECH J, V27, P379, DOI 10.1002/j.1538-7305.1948.tb01338.x; Shimomura M, 2009, BMC GENOMICS, V10, DOI 10.1186/1471-2164-10-486; Shinoda T, 2003, P NATL ACAD SCI USA, V100, P11986, DOI 10.1073/pnas.2134232100; Stief P, 2006, J COMP PHYSIOL B, V176, P673, DOI 10.1007/s00360-006-0090-y; Tanaka H, 2008, INSECT BIOCHEM MOLEC, V38, P1087, DOI 10.1016/j.ibmb.2008.09.001; Trapnell C, 2010, NAT BIOTECHNOL, V28, P511, DOI 10.1038/nbt.1621; Trapnell C, 2009, BIOINFORMATICS, V25, P1105, DOI 10.1093/bioinformatics/btp120; WEISS SA, 1982, BIOTECHNOL BIOENG, V24, P1145, DOI 10.1002/bit.260240511; WYATT GR, 1956, J GEN PHYSIOL, V39, P853, DOI 10.1085/jgp.39.6.853; Xiang H, 2010, NAT BIOTECHNOL, V28, P516, DOI 10.1038/nbt.1626; Yamashita M, 2001, J INSECT PHYSIOL, V47, P325, DOI 10.1016/S0022-1910(00)00144-X; Zhang JY, 2010, BMC GENOMICS, V11, DOI 10.1186/1471-2164-11-611	38	10	11	2	25	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 6	2012	7	4							e34940	10.1371/journal.pone.0034940	http://dx.doi.org/10.1371/journal.pone.0034940			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	955JA	22493724	gold, Green Published, Green Submitted			2022-12-25	WOS:000305012700066
J	Hundahl, CA; Fahrenkrug, J; Hay-Schmidt, A; Georg, B; Faltoft, B; Hannibal, J				Hundahl, Christian A.; Fahrenkrug, Jan; Hay-Schmidt, Anders; Georg, Birgitte; Faltoft, Birgitte; Hannibal, Jens			Circadian Behaviour in Neuroglobin Deficient Mice	PLOS ONE			English	Article							GASTRIN-RELEASING-PEPTIDE; SUPRACHIASMATIC NUCLEUS; MESSENGER-RNA; PROTEIN EXPRESSION; GENE-EXPRESSION; PHASE-SHIFT; C-FOS; CLOCK; RECEPTOR; LIGHT	Neuroglobin (Ngb), a neuron-specific oxygen-binding globin with an unknown function, has been proposed to play a key role in neuronal survival. We have previously shown Ngb to be highly expressed in the rat suprachiasmatic nucleus (SCN). The present study addresses the effect of Ngb deficiency on circadian behavior. Ngb-deficient and wild-type (wt) mice were placed in running wheels and their activity rhythms, endogenous period and response to light stimuli were investigated. The effect of Ngb deficiency on the expression of Period1 (Per1) and the immediate early gene Fos was determined after light stimulation at night and the neurochemical phenotype of Ngb expressing neurons in wt mice was characterized. Loss of Ngb function had no effect on overall circadian entrainment, but resulted in a significantly larger phase delay of circadian rhythm upon light stimulation at early night. A light-induced increase in Per1, but not Fos, gene expression was observed in Ngb-deficient mice. Ngb expressing neurons which co-stored Gastrin Releasing Peptide (GRP) and were innervated from the eye and the geniculo-hypothalamic tract expressed FOS after light stimulation. No PER1 expression was observed in Ngb-positive neurons. The present study demonstrates for the first time that the genetic elimination of Ngb does not affect core clock function but evokes an increased behavioural response to light concomitant with increased Per1 gene expression in the SCN at early night.	[Hundahl, Christian A.; Fahrenkrug, Jan; Georg, Birgitte; Faltoft, Birgitte; Hannibal, Jens] Univ Copenhagen, Bispebjerg Hosp, Fac Hlth Sci, Dept Clin Biochem, Copenhagen, Denmark; [Hay-Schmidt, Anders] Univ Copenhagen, Panum Inst, Dept Neurosci & Pharmacol, DK-2200 Copenhagen, Denmark	University of Copenhagen; Bispebjerg Hospital; University of Copenhagen	Hundahl, CA (corresponding author), Univ Copenhagen, Bispebjerg Hosp, Fac Hlth Sci, Dept Clin Biochem, Copenhagen, Denmark.	j.hannibal@dadlnet.dk	Hannibal, Jens/H-5482-2019; Hundahl, Christian Ansgar/H-3938-2015	Hannibal, Jens/0000-0001-9416-0125; 	Lundbeck Foundation [R44-A4267]; NOVO-Nordisk Foundation; King Christian the Xth Foundation; Foundation for Providing Medical Research; Danish Biotechnology Center for Cellular Communication; Lundbeck Foundation [R77-2010-7108] Funding Source: researchfish	Lundbeck Foundation(Lundbeckfonden); NOVO-Nordisk Foundation(Novo Nordisk Foundation); King Christian the Xth Foundation; Foundation for Providing Medical Research; Danish Biotechnology Center for Cellular Communication; Lundbeck Foundation(Lundbeckfonden)	This work was supported by the Lundbeck Foundation (R44-A4267), the NOVO-Nordisk Foundation, the King Christian the Xth Foundation, the Foundation for Providing Medical Research, and the Danish Biotechnology Center for Cellular Communication. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aida R, 2002, MOL PHARMACOL, V61, P26, DOI 10.1124/mol.61.1.26; Albrecht U, 1997, CELL, V91, P1055, DOI 10.1016/S0092-8674(00)80495-X; Antle MC, 2005, J NEUROSCI, V25, P2447, DOI 10.1523/JNEUROSCI.4696-04.2005; Antle MC, 2009, REV ENDOCR METAB DIS, V10, P279, DOI 10.1007/s11154-009-9116-6; Aton SJ, 2005, NAT NEUROSCI, V8, P476, DOI 10.1038/nn1419; Brewer JM, 2002, J BIOL RHYTHM, V17, P28, DOI 10.1177/074873002129002311; Brown TM, 2005, J NEUROSCI, V25, P11155, DOI 10.1523/JNEUROSCI.3821-05.2005; Brunori M, 2007, CELL MOL LIFE SCI, V64, P1259, DOI 10.1007/s00018-007-7090-2; Burmester T, 2000, NATURE, V407, P520, DOI 10.1038/35035093; DAAN S, 1976, J COMP PHYSIOL, V106, P253, DOI 10.1007/BF01417857; Dewilde S, 2001, J BIOL CHEM, V276, P38949, DOI 10.1074/jbc.M106438200; Fago A, 2004, J BIOL CHEM, V279, P44417, DOI 10.1074/jbc.M407126200; FAHRENKRUG J, 1995, REGUL PEPTIDES, V58, P89, DOI 10.1016/0167-0115(95)00052-D; Fahrenkrug J, 2006, ENDOCRINOLOGY, V147, P3769, DOI 10.1210/en.2006-0305; Gamble KL, 2007, J NEUROSCI, V27, P12078, DOI 10.1523/JNEUROSCI.1109-07.2007; Gamble KL, 2011, J BIOL RHYTHM, V26, P99, DOI 10.1177/0748730410396678; Georg B, 2007, BRAIN RES, V1135, P52, DOI 10.1016/j.brainres.2006.12.001; Golombek DA, 2010, PHYSIOL REV, V90, P1063, DOI 10.1152/physrev.00009.2009; Hannibal J, 2001, J NEUROSCI, V21, P4883, DOI 10.1523/JNEUROSCI.21-13-04883.2001; HANNIBAL J, 2006, ADV ANAT EMBRYOL CEL, V182, P1; Hannibal J, 2008, AM J PHYSIOL-REG I, V295, pR2050, DOI 10.1152/ajpregu.90563.2008; Harmar AJ, 2002, CELL, V109, P497, DOI 10.1016/S0092-8674(02)00736-5; Hundahl CA, 2010, J COMP NEUROL, V518, P1556, DOI 10.1002/cne.22290; Hundahl C, 2006, BRAIN RES, V1085, P19, DOI 10.1016/j.brainres.2006.02.040; Hundahl CA, 2008, NEUROENDOCRINOLOGY, V88, P183, DOI 10.1159/000135617; Hundahl CA, 2008, NEUROENDOCRINOLOGY, V88, P173, DOI 10.1159/000129698; Hundahl CA, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0028160; Hundahl CA, 2010, BRAIN RES, V1331, P58, DOI 10.1016/j.brainres.2010.03.056; Kallingal GJ, 2007, NEUROSCI LETT, V422, P59, DOI 10.1016/j.neulet.2007.06.003; Kallingal GJ, 2006, EUR J NEUROSCI, V24, P2853, DOI 10.1111/j.1460-9568.2006.05165.x; KNIGGE U, 1984, J CLIN ENDOCR METAB, V59, P310, DOI 10.1210/jcem-59-2-310; KORNHAUSER JM, 1990, NEURON, V5, P127, DOI 10.1016/0896-6273(90)90303-W; Kriegsfeld LJ, 2008, EUR J NEUROSCI, V27, P2907, DOI 10.1111/j.1460-9568.2008.06239.x; Maywood ES, 2007, COLD SPRING HARB SYM, V72, P85, DOI 10.1101/sqb.2007.72.005; Maywood ES, 2006, CURR BIOL, V16, P599, DOI 10.1016/j.cub.2006.02.023; Mohawk JA, 2011, TRENDS NEUROSCI; Morin LP, 2006, BRAIN RES REV, V51, P1, DOI 10.1016/j.brainresrev.2005.08.003; PIGGINS HD, 1995, J NEUROSCI, V15, P5612; Piggins HD, 2005, NEUROSCI LETT, V384, P205, DOI 10.1016/j.neulet.2005.03.072; Reppert SM, 2001, ANNU REV PHYSIOL, V63, P647, DOI 10.1146/annurev.physiol.63.1.647; Schwenk F, 1995, NUCLEIC ACIDS RES, V23, P5080, DOI 10.1093/nar/23.24.5080; Shigeyoshi Y, 1997, CELL, V91, P1043, DOI 10.1016/S0092-8674(00)80494-8; Stadler F, 2010, CHRONOBIOL INT, V27, P68, DOI 10.3109/07420521003648554; Yan LL, 2004, EUR J NEUROSCI, V19, P1105, DOI 10.1111/j.1460-9568.2004.03189.x; Yannielli PC, 2001, J NEUROSCI, V21, P5367, DOI 10.1523/JNEUROSCI.21-14-05367.2001	45	28	28	0	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 5	2012	7	4							e34462	10.1371/journal.pone.0034462	http://dx.doi.org/10.1371/journal.pone.0034462			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	955IH	22496809	Green Published, Green Submitted, gold			2022-12-25	WOS:000305010500010
J	Lotsch, J; Walter, C; Felden, L; Noth, U; Deichmann, R; Oertel, BG				Loetsch, Joern; Walter, Carmen; Felden, Lisa; Noeth, Ulrike; Deichmann, Ralf; Oertel, Bruno G.			The Human Operculo-Insular Cortex Is Pain-Preferentially but Not Pain-Exclusively Activated by Trigeminal and Olfactory Stimuli	PLOS ONE			English	Article							EVENT-RELATED POTENTIALS; SENSORY DECISION-THEORY; HUMAN BRAIN; NASAL-MUCOSA; CORTICAL NETWORK; CO2 STIMULATION; FMRI; RESPONSES; PERCEPTION; SALIENCE	Increasing evidence about the central nervous representation of pain in the brain suggests that the operculo-insular cortex is a crucial part of the pain matrix. The pain-specificity of a brain region may be tested by administering nociceptive stimuli while controlling for unspecific activations by administering non-nociceptive stimuli. We applied this paradigm to nasal chemosensation, delivering trigeminal or olfactory stimuli, to verify the pain-specificity of the operculo-insular cortex. In detail, brain activations due to intranasal stimulation induced by non-nociceptive olfactory stimuli of hydrogen sulfide (5 ppm) or vanillin (0.8 ppm) were used to mask brain activations due to somatosensory, clearly nociceptive trigeminal stimulations with gaseous carbon dioxide (75% v/v). Functional magnetic resonance (fMRI) images were recorded from 12 healthy volunteers in a 3T head scanner during stimulus administration using an event-related design. We found that significantly more activations following nociceptive than non-nociceptive stimuli were localized bilaterally in two restricted clusters in the brain containing the primary and secondary somatosensory areas and the insular cortices consistent with the operculo-insular cortex. However, these activations completely disappeared when eliminating activations associated with the administration of olfactory stimuli, which were small but measurable. While the present experiments verify that the operculo-insular cortex plays a role in the processing of nociceptive input, they also show that it is not a pain-exclusive brain region and allow, in the experimental context, for the interpretation that the operculo-insular cortex splay a major role in the detection of and responding to salient events, whether or not these events are nociceptive or painful.	[Loetsch, Joern; Walter, Carmen; Felden, Lisa; Oertel, Bruno G.] Goethe Univ Frankfurt, Inst Clin Pharmacol, Pharmazentrum Frankfurt ZAFES, Frankfurt, Germany; [Noeth, Ulrike; Deichmann, Ralf] Goethe Univ Frankfurt, Brain Imaging Ctr, Frankfurt, Germany	Goethe University Frankfurt; Goethe University Frankfurt	Lotsch, J (corresponding author), Goethe Univ Frankfurt, Inst Clin Pharmacol, Pharmazentrum Frankfurt ZAFES, Frankfurt, Germany.	j.loetsch@em.uni-frankfurt.de		Lotsch, Jorn/0000-0002-5818-6958	Deutsche Forschungsgemeinschaft, DFG [Lo 612/10-1]; Bundesministerium fur Bildung und Forschung [DLR 01GO0203]	Deutsche Forschungsgemeinschaft, DFG(German Research Foundation (DFG)); Bundesministerium fur Bildung und Forschung(Federal Ministry of Education & Research (BMBF))	Deutsche Forschungsgemeinschaft, DFG Lo 612/10-1, for study support (JL), and Bundesministerium fur Bildung und Forschung (DLR 01GO0203; RD) for support of the fMRI equipment. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Albrecht J, 2010, BRAIN RES REV, V62, P183, DOI 10.1016/j.brainresrev.2009.11.001; Andersson JLR, 2001, NEUROIMAGE, V13, P903, DOI 10.1006/nimg.2001.0746; Apkarian AV, 2005, EUR J PAIN, V9, P463, DOI 10.1016/j.ejpain.2004.11.001; Baliki MN, 2009, J NEUROPHYSIOL, V101, P875, DOI 10.1152/jn.91100.2008; Baumgartner U, 2010, J NEUROPHYSIOL, V104, P2863, DOI 10.1152/jn.00253.2010; Bingel U, 2008, PHYSIOLOGY, V23, P371, DOI 10.1152/physiol.00024.2008; Boly M, 2007, P NATL ACAD SCI USA, V104, P12187, DOI 10.1073/pnas.0611404104; Bornhovd K, 2002, BRAIN, V125, P1326, DOI 10.1093/brain/awf137; Boyle JA, 2007, NEUROSCIENCE, V149, P223, DOI 10.1016/j.neuroscience.2007.06.045; Boyle JA, 2007, CHEM SENSES, V32, P343, DOI 10.1093/chemse/bjm004; Brand G, 2006, NEUROSCI BIOBEHAV R, V30, P908, DOI 10.1016/j.neubiorev.2006.01.002; Bushnell MC, 1999, P NATL ACAD SCI USA, V96, P7705, DOI 10.1073/pnas.96.14.7705; CASEY KL, 1994, J NEUROPHYSIOL, V71, P802, DOI 10.1152/jn.1994.71.2.802; COGHILL RC, 1994, J NEUROSCI, V14, P4095; Coghill RC, 1999, J NEUROPHYSIOL, V82, P1934, DOI 10.1152/jn.1999.82.4.1934; CRAIG KD, 1978, J PERS SOC PSYCHOL, V36, P805, DOI 10.1037/0022-3514.36.8.805; Derbyshire SWG, 1997, PAIN, V73, P431, DOI 10.1016/S0304-3959(97)00138-3; DOTY RL, 1978, PHYSIOL BEHAV, V20, P175, DOI 10.1016/0031-9384(78)90070-7; Downar J, 2003, NEUROIMAGE, V20, P1540, DOI 10.1016/S1053-8119(03)00407-5; Downar J, 2002, J NEUROPHYSIOL, V87, P615, DOI 10.1152/jn.00636.2001; Downar J, 2000, NAT NEUROSCI, V3, P277, DOI 10.1038/72991; Eickhoff SB, 2006, CEREB CORTEX, V16, P254, DOI 10.1093/cercor/bhi105; Eickhoff SB, 2005, NEUROIMAGE, V25, P1325, DOI 10.1016/j.neuroimage.2004.12.034; Eickhoff SB, 2007, NEUROIMAGE, V36, P511, DOI 10.1016/j.neuroimage.2007.03.060; Eickhoff SB, 2006, NEUROIMAGE, V32, P570, DOI 10.1016/j.neuroimage.2006.04.204; FORMAN SD, 1995, MAGNET RESON MED, V33, P636, DOI 10.1002/mrm.1910330508; Frasnelli J, 2007, CEREB CORTEX, V17, P2268, DOI 10.1093/cercor/bhl135; FRIEDMAN DP, 1986, J COMP NEUROL, V252, P323, DOI 10.1002/cne.902520304; Friston K. J., 1995, HUMAN BRAIN MAPPING, V2, P189, DOI DOI 10.1002/HBM.460020402; Friston KJ, 1998, NEUROIMAGE, V7, P30, DOI 10.1006/nimg.1997.0306; Frot M, 2007, CEREB CORTEX, V17, P610, DOI 10.1093/cercor/bhk007; Garcia-Larrea L, 2010, BRAIN, V133, P2528, DOI 10.1093/brain/awq220; Geyer S, 1999, NEUROIMAGE, V10, P63, DOI 10.1006/nimg.1999.0440; Glascher J, 2009, NEUROINFORMATICS, V7, P73, DOI 10.1007/s12021-008-9042-x; Gluscher J., 2008, CONTRAST WEIGHTS FLE; Griswold MA, 2002, MAGN RESON MED, V47, P1202, DOI 10.1002/mrm.10171; Hari R, 1997, PAIN, V72, P145, DOI 10.1016/S0304-3959(97)00023-7; Howard JD, 2009, NAT NEUROSCI, V12, P932, DOI 10.1038/nn.2324; Hummel T, 2005, CHEM SENSES, V30, pI205, DOI 10.1093/chemse/bjh186; HUMMEL T, 1994, ELECTROEN CLIN NEURO, V92, P426, DOI 10.1016/0168-5597(94)90020-5; Hummel T, 2003, INT J PSYCHOPHYSIOL, V47, P147, DOI 10.1016/S0167-8760(02)00150-2; Hummel T, 2011, INT J PSYCHOPHYSIOL, V80, P69, DOI 10.1016/j.ijpsycho.2011.01.012; Hutton C, 2002, NEUROIMAGE, V16, P217, DOI 10.1006/nimg.2001.1054; HUTTUNEN J, 1986, ELECTROEN CLIN NEURO, V64, P347, DOI 10.1016/0013-4694(86)90159-8; Iannilli E, 2008, PAIN, V139, P376, DOI 10.1016/j.pain.2008.05.007; Iannilli E, 2007, BRAIN RES, V1139, P235, DOI 10.1016/j.brainres.2006.12.082; Ibanez A, 2010, BRAIN STRUCT FUNCT, V214, P397, DOI 10.1007/s00429-010-0256-y; KOBAL G, 1989, EXPERIENTIA, V45, P130, DOI 10.1007/BF01954845; KOBAL G, 1985, PAIN, V22, P151, DOI 10.1016/0304-3959(85)90175-7; Kobal G., 1996, Rhinology (Utrecht), V34, P222; Kobal G, 1998, LARYNGOSCOPE, V108, P1033, DOI 10.1097/00005537-199807000-00015; Kobal G, 1981, ELEKTROPHYSIOLOGISCH; Legrain V, 2003, PAIN, V103, P237, DOI 10.1016/S0304-3959(02)00451-7; Legrain V, 2002, PAIN, V99, P21, DOI 10.1016/S0304-3959(02)00051-9; Legrain V, 2011, PROG NEUROBIOL, V93, P111, DOI 10.1016/j.pneurobio.2010.10.005; Loring DW, 2002, EPILEPSY BEHAV, V3, P539, DOI 10.1016/S1525-5050(02)00558-9; Lotsch J, 2011, SOCIAL COGNITIVE AFF; Lui F, 2008, PAIN, V138, P362, DOI 10.1016/j.pain.2008.01.010; MALOW RM, 1989, PAIN, V38, P35, DOI 10.1016/0304-3959(89)90070-5; MALOW RM, 1987, J ABNORM PSYCHOL, V96, P184, DOI 10.1037/0021-843X.96.3.184; Mazzola L, 2006, CEREB CORTEX, V16, P960, DOI 10.1093/cercor/bhj038; Mazzola L, 2009, PAIN, V146, P99, DOI 10.1016/j.pain.2009.07.014; Menon V, 2010, BRAIN STRUCT FUNCT, V214, P655, DOI 10.1007/s00429-010-0262-0; MESULAM MM, 1982, J COMP NEUROL, V212, P38, DOI 10.1002/cne.902120104; Mouraux A, 2009, J NEUROPHYSIOL, V101, P3258, DOI 10.1152/jn.91181.2008; Mouraux A, 2011, NEUROIMAGE, V54, P2237, DOI 10.1016/j.neuroimage.2010.09.084; MUFSON EJ, 1981, NEUROSCIENCE, V6, P1231, DOI 10.1016/0306-4522(81)90184-6; MUGLER JP, 1991, JMRI-J MAGN RESON IM, V1, P561, DOI 10.1002/jmri.1880010509; Oertel BG, 2011, HUMAN BRAIN MAPPING; Peyron R, 2000, NEUROPHYSIOL CLIN, V30, P263, DOI 10.1016/S0987-7053(00)00227-6; Peyron R, 2002, NEUROIMAGE, V17, P1336, DOI 10.1006/nimg.2002.1315; Price DD, 2000, SCIENCE, V288, P1769, DOI 10.1126/science.288.5472.1769; Reeh P W, 2001, Curr Opin Pharmacol, V1, P45, DOI 10.1016/S1471-4892(01)00014-5; Schweinhardt P, 2006, NMR BIOMED, V19, P702, DOI 10.1002/nbm.1076; Starr CJ, 2009, J NEUROSCI, V29, P2684, DOI 10.1523/JNEUROSCI.5173-08.2009; STEEN KH, 1992, J NEUROSCI, V12, P86; TALBOT JD, 1991, SCIENCE, V251, P1355, DOI 10.1126/science.2003220; Tarun AS, 2003, CHEM SENSES, V28, P621, DOI 10.1093/chemse/bjg054; Tolle TR, 1999, ANN NEUROL, V45, P40, DOI 10.1002/1531-8249(199901)45:1<40::AID-ART8>3.0.CO;2-L; Treede RD, 1999, PAIN, V79, P105, DOI 10.1016/S0304-3959(98)00184-5; Tzourio-Mazoyer N, 2002, NEUROIMAGE, V15, P273, DOI 10.1006/nimg.2001.0978; Wang YYY, 2010, J NEUROSCI, V30, P12958, DOI 10.1523/JNEUROSCI.2715-10.2010; Weiskopf N, 2006, NEUROIMAGE, V33, P493, DOI 10.1016/j.neuroimage.2006.07.029; Wiech K, 2010, J NEUROSCI, V30, P16324, DOI 10.1523/JNEUROSCI.2087-10.2010; WORSLEY KJ, 1995, NEUROIMAGE, V2, P173, DOI 10.1006/nimg.1995.1023; WORSLEY KJ, 1994, ADV APPL PROBAB, V26, P13, DOI 10.2307/1427576; Wright IC, 1995, NEUROIMAGE, V2, P244, DOI 10.1006/nimg.1995.1032; YANG JC, 1985, PSYCHOSOM MED, V47, P461, DOI 10.1097/00006842-198509000-00006	88	24	27	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 5	2012	7	4							e34798	10.1371/journal.pone.0034798	http://dx.doi.org/10.1371/journal.pone.0034798			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	955IH	22496865	gold, Green Submitted, Green Published			2022-12-25	WOS:000305010500027
J	Bae, J; Sung, BH; Cho, IH; Song, WK				Bae, Jeomil; Sung, Bong Hwan; Cho, In Ha; Song, Woo Keun			F-Actin-Dependent Regulation of NESH Dynamics in Rat Hippocampal Neurons	PLOS ONE			English	Article							LONG-TERM POTENTIATION; DENDRITIC SPINES; SYNAPTIC PLASTICITY; EXCITATORY SYNAPSES; PROTEIN FAMILY; TRANSLOCATION; MECHANISMS; BRAIN; CELLS; LTP	Synaptic plasticity is an important feature of neurons essential for learning and memory. Postsynaptic organization and composition are dynamically remodeled in response to diverse synaptic inputs during synaptic plasticity. During this process, the dynamics and localization of postsynaptic proteins are also precisely regulated. NESH/Abi-3 is a member of the Abl interactor (Abi) protein family. Overexpression of NESH is associated with reduced cell motility and tumor metastasis. Strong evidence of a close relationship between NESH and the actin cytoskeleton has been documented. Although earlier studies have shown that NESH is prominently expressed in the brain, its function and characteristics are yet to be established. Data from the present investigation suggest that synaptic localization of NESH in hippocampal neurons is regulated in an F-actin-dependent manner. The dynamic fraction of NESH in the dendritic spine was analyzed using FRAP (fluorescence recovery after photobleaching). Interestingly, F-actin stabilization and disruption significantly affected the mobile fraction of NESH, possibly through altered interactions of NESH with the F-actin. In addition, NESH was synaptically targeted from the dendritic shaft to spine after induction of chemical LTP (long-term potentiation) and the translocation was dependent on F-actin. Our data collectively support the significance of the F-actin cytoskeleton in synaptic targeting of NESH as well as its dynamics.	[Bae, Jeomil; Cho, In Ha; Song, Woo Keun] Gwangju Inst Sci & Technol, Sch Life Sci, Cell Dynam & Bioimaging Res Ctr, Kwangju, South Korea; [Sung, Bong Hwan] Vanderbilt Univ, Med Ctr, Dept Canc Biol, Nashville, TN USA	Gwangju Institute of Science & Technology (GIST); Vanderbilt University	Bae, J (corresponding author), Gwangju Inst Sci & Technol, Sch Life Sci, Cell Dynam & Bioimaging Res Ctr, Kwangju, South Korea.	wksong@gist.ac.kr		Bae, Jeomil/0000-0001-9374-6802	Cell Dynamics and Bioimaging Research Center [20110001155]; Conversing Research Center [2011K000690]; Mid-Career Research Program [20110000095]; National Research Foundation of Korea	Cell Dynamics and Bioimaging Research Center; Conversing Research Center; Mid-Career Research Program; National Research Foundation of Korea(National Research Foundation of Korea)	This research was supported by grants from the Cell Dynamics and Bioimaging Research Center (20110001155), Conversing Research Center Program (2011K000690), Mid-Career Research Program (20110000095), and funding from the National Research Foundation of Korea. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bockers TM, 2001, J BIOL CHEM, V276, P40104, DOI 10.1074/jbc.M102454200; Bourne JN, 2008, ANNU REV NEUROSCI, V31, P47, DOI 10.1146/annurev.neuro.31.060407.125646; Ehrlich I, 2004, J NEUROSCI, V24, P916, DOI 10.1523/JNEUROSCI.4733-03.2004; Fortin DA, 2010, J NEUROSCI, V30, P11565, DOI 10.1523/JNEUROSCI.1746-10.2010; Fukazawa' Y, 2003, NEURON, V38, P447, DOI 10.1016/S0896-6273(03)00206-X; Hering H, 2003, J NEUROSCI, V23, P11759; Hirao N, 2006, FEBS LETT, V580, P6464, DOI 10.1016/j.febslet.2006.10.065; Holtmaat A, 2009, NAT REV NEUROSCI, V10, P647, DOI 10.1038/nrn2699; Hori K, 2005, J NEUROSCI, V25, P2670, DOI 10.1523/JNEUROSCI.3638-04.2005; Ichigotani Y, 2002, CANCER RES, V62, P2215; Innocenti M, 2005, NAT CELL BIOL, V7, P969, DOI 10.1038/ncb1304; Kasai H, 2003, TRENDS NEUROSCI, V26, P360, DOI 10.1016/S0166-2236(03)00162-0; Kasai H, 2010, TRENDS NEUROSCI, V33, P121, DOI 10.1016/j.tins.2010.01.001; Kopec CD, 2007, J NEUROSCI, V27, P13706, DOI 10.1523/JNEUROSCI.3503-07.2007; Kuriu T, 2006, J NEUROSCI, V26, P7693, DOI 10.1523/JNEUROSCI.0522-06.2006; Matsuda S, 2008, ANN ONCOL, V19, P1356, DOI 10.1093/annonc/mdn293; Matsuzaki M, 2004, NATURE, V429, P761, DOI 10.1038/nature02617; McGee AW, 2003, CURR OPIN NEUROBIOL, V13, P111, DOI 10.1016/S0959-4388(03)00008-4; Okamoto KI, 2004, NAT NEUROSCI, V7, P1104, DOI 10.1038/nn1311; Pak DTS, 2001, NEURON, V31, P289, DOI 10.1016/S0896-6273(01)00355-5; Renner M, 2008, CURR OPIN NEUROBIOL, V18, P532, DOI 10.1016/j.conb.2008.09.009; Riedl J, 2008, NAT METHODS, V5, P605, DOI 10.1038/nmeth.1220; Shen K, 1999, SCIENCE, V284, P162, DOI 10.1126/science.284.5411.162; Sheng M, 2002, SCIENCE, V298, P776, DOI 10.1126/science.1075333; Sheng M, 2007, ANNU REV BIOCHEM, V76, P823, DOI 10.1146/annurev.biochem.76.060805.160029; Shiraishi Y, 1999, J NEUROSCI, V19, P8389; Stein V, 2003, J NEUROSCI, V23, P5503; Stradal T, 2001, CURR BIOL, V11, P891, DOI 10.1016/S0960-9822(01)00239-1; Toni N, 1999, NATURE, V402, P421, DOI 10.1038/46574; Yang YL, 2008, J NEUROSCI, V28, P5740, DOI 10.1523/JNEUROSCI.3998-07.2008; Yuste R, 2001, ANNU REV NEUROSCI, V24, P1071, DOI 10.1146/annurev.neuro.24.1.1071	31	14	14	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 4	2012	7	4							e34514	10.1371/journal.pone.0034514	http://dx.doi.org/10.1371/journal.pone.0034514			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	953GO	22496823	Green Published, Green Submitted, gold			2022-12-25	WOS:000304855200060
J	Kayeyi, N; Fylkesnes, K; Michelo, C; Makasa, M; Sandoy, I				Kayeyi, Nkomba; Fylkesnes, Knut; Michelo, Charles; Makasa, Mpundu; Sandoy, Ingvild			Decline in HIV Prevalence among Young Women in Zambia: National-Level Estimates of Trends Mask Geographical and Socio-Demographic Differences	PLOS ONE			English	Article							POPULATION-BASED SURVEYS; TO-CHILD TRANSMISSION; SENTINEL SURVEILLANCE; PREVENTION; EPIDEMIC; PEOPLE; EXPERIENCE; MORTALITY; INFECTION; PATTERNS	Background: A decline in HIV incidence has been reported in Zambia and a number of other sub-Saharan countries. The trend of HIV prevalence among young people is a good marker of HIV incidence. In this study, different data sources are used to examine geographical and sub-population group differentials in HIV prevalence trends among men and women aged 15-24 years in Zambia. Design and Methods: We analysed ANC data for women aged 15-24 years from 22 sentinel sites consistently covered in the period 1994-2008, and HIV data for young men and women aged 15-24 years from the ZDHS 2001/2 and 2007. In addition, we systematically reviewed peer-reviewed articles that have reported findings on HIV prevalence and incidence among young people. Findings: Overall trends of the ANC surveillance data indicated a substantial HIV prevalence decline among young women in both urban and rural areas. However, provincial declines differed substantially, i.e. between 10% and 68% among urban women, and from stability to 86% among rural women. Prevalence declines were steeper among those with the highest educational attainments than among the least educated. The ZDHS data indicated a significant reduction in prevalence between the two survey rounds among young women only. Provincial-level ZDHS changes were difficult to assess because the sample sizes were small. ANC-based trend patterns were consistent with those observed in PMTCT-based data (2002-2006), whereas population-based surveys in a selected urban community (1995-2003) suggested that the ANC-based data underestimated the prevalence declines in the general populations of both young both men and women. Conclusion: The overall HIV prevalence declined substantially among young women in Zambia and this is interpreted as indicating a decline in HIV incidence. It is noteworthy that overall national trends masked substantial differences by place and by educational attainment, demonstrating critical limitations in the current focus on overall country-level trends in epidemiological reports.	[Kayeyi, Nkomba; Fylkesnes, Knut; Makasa, Mpundu; Sandoy, Ingvild] Univ Bergen, Ctr Int Hlth, Bergen, Norway; [Kayeyi, Nkomba; Michelo, Charles] Univ Zambia, Sch Med, Dept Publ Hlth, Lusaka, Zambia; [Makasa, Mpundu] Minist Hlth, Lusaka, Zambia	University of Bergen; University of Zambia	Kayeyi, N (corresponding author), Univ Bergen, Ctr Int Hlth, Bergen, Norway.	nkayeyi@yahoo.co.uk	Sandøy, Ingvild Fossgard/ABD-3557-2020	Kayeyi, Nkomba/0000-0002-4043-5872; Sandoy, Ingvild/0000-0001-5567-4588	Norwegian programme for development, research and education (NUFU); Norwegian Agency for Development Cooperation (NORAD); Swedish International Cooperation Agency (SIDA); Centers for Disease Control and Prevention (CDC); Demographic and Health Survey (DHS)	Norwegian programme for development, research and education (NUFU); Norwegian Agency for Development Cooperation (NORAD); Swedish International Cooperation Agency (SIDA); Centers for Disease Control and Prevention (CDC)(United States Department of Health & Human ServicesCenters for Disease Control & Prevention - USA); Demographic and Health Survey (DHS)	The authors would like to acknowledge the Norwegian programme for development, research and education (NUFU) for financing this study. Further acknowledgement is made to the funders of the surveys, in particular the ANC sentinel surveillance, which has been funded over the years by the Norwegian Agency for Development Cooperation (NORAD), the Swedish International Cooperation Agency (SIDA) and the Centers for Disease Control and Prevention (CDC). Other organisations include MEASURE DHS, which funds the Demographic and Health Survey (DHS). The funders of this study had no role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Barnighausen T, 2011, EPIDEMIOLOGY, V22, P27, DOI 10.1097/EDE.0b013e3181ffa201; Bello GA, 2006, SEX TRANSM INFECT, V82, pI9, DOI 10.1136/sti.2005.016030; Bond V, 2002, EVAL PROGRAM PLANN, V25, P347, DOI 10.1016/S0149-7189(02)00046-0; Bonell CP, 2007, AIDS S7, V21; Buve A, 2002, LANCET, V359, P2011, DOI 10.1016/S0140-6736(02)08823-2; Buve A, 2001, AIDS, V15, pS5, DOI 10.1097/00002030-200108004-00002; Central Statistical Office (CSO) [Zambia] Central Board of Health [Zambia] and ORC Macro, 2003, ZAMB DEM HLTH SURV 2; Chanem KG, 2008, AIDS, V22, P1145, DOI 10.1097/QAD.0b013e32830184df; Cheluget B, 2006, SEX TRANSM INFECT, V82, pI21, DOI 10.1136/sti.2005.015990; CSO MOH TDRC University of Zambia, 2009, ZAMB DEM HLTH SURV 2; Doherty T, 2006, B WORLD HEALTH ORGAN, V84, P90, DOI 10.2471/BLT.04.019448; Dzekedzeke K, 2006, BMC PUBLIC HLTH, V6; Fylkesnes K, 1997, AIDS, V11, P339, DOI 10.1097/00002030-199703110-00012; Fylkesnes K, 2001, AIDS, V15, P907, DOI 10.1097/00002030-200105040-00011; Fylkesnes K, 1998, AIDS, V12, P1227, DOI 10.1097/00002030-199810000-00015; Ghys DP, 2005, SEX TRANSM INFECT, V82, pi52; Glynn JR, 2001, AIDS, V15, P1717, DOI 10.1097/00002030-200109070-00016; Gouws E, 2010, EPI ALERT METHODS ES; Gouws E, 2008, AIDS, V22, pS5, DOI 10.1097/01.aids.0000341773.86500.9d; Hallett TB, 2010, AIDS, V24, P147, DOI 10.1097/QAD.0b013e32833062dc; Hargreaves JR, 2008, AIDS, V22, P403, DOI 10.1097/QAD.0b013e3282f2aac3; Hargreaves JR, 2010, AIDS, V24, P754, DOI 10.1097/QAD.0b013e328336672e; Hargrove JW, 2008, AIDS, V22, P511, DOI 10.1097/QAD.0b013e3282f2a960; Heffron R, 2011, LANCET          1004; Hladik W, 2006, SEX TRANSM INFECT, V82, pI32, DOI 10.1136/sti.2005.016592; Hladik W, 2005, AIDS, V19, pS19, DOI 10.1097/01.aids.0000172873.82509.5e; Janssen RS, 1998, JAMA-J AM MED ASSOC, V280, P42, DOI 10.1001/jama.280.1.42; Joesoef MR, 2003, INT J STD AIDS, V14, P193, DOI 10.1258/095646203762869214; Kapina M, 2010, SEX TRANSM DIS; Kayeyi N, 2009, BMC PUBLIC HEALTH, V9, DOI 10.1186/1471-2458-9-310; Lopman B, 2008, INT J EPIDEMIOL, V37, P88, DOI 10.1093/ije/dym255; Mahomva A, 2006, SEX TRANSM INFECT, V82, pI42, DOI 10.1136/sti.2005.019174; Makasa M, 2011, SEX TRANSM DIS; Michelo C, 2008, TROP MED INT HEALTH, V13, P171, DOI 10.1111/j.1365-3156.2007.01987.x; Michelo C, 2006, BMC PUBLIC HEALTH, V6, DOI 10.1186/1471-2458-6-279; Michelo C, 2006, AIDS, V20, P1031, DOI 10.1097/01.aids.0000222076.91114.95; Mishra V, 2006, B WORLD HEALTH ORGAN, V84, P537, DOI 10.2471/BLT.05.029520; MOH CBOH GRZ, 2005, ZAMB ANT CLIN SENT S; Mpairwe H, 2005, JAIDS-J ACQ IMM DEF, V39, P354, DOI 10.1097/01.qai.0000148081.38331.92; Myer L, 2010, PLOS MED, V7, DOI 10.1371/journal.pmed.1000229; NAC, 2009, ZAMB HIV PREV RESP M; NAC TDRC SIDA CDC, 2003, ZAMB ANT CLIN SENT S; Nyirenda M, 2007, AIDS, V21, pS73, DOI 10.1097/01.aids.0000299413.82893.2b; Ramjee G, 2008, JAIDS-J ACQ IMM DEF, V47, P93, DOI 10.1097/QAI.0b013e31815c71f7; Sandoy IF, 2007, BMC PUBLIC HEALTH, V7, DOI 10.1186/1471-2458-7-60; Sandoy IF, 2006, TROP MED INT HEALTH, V11, P917, DOI 10.1111/j.1365-3156.2006.01629.x; Seguy N, 2006, CAN DATA PROGRAMS PR, P121; Smith J, 2007, AIDS, V21, pS81, DOI 10.1097/01.aids.0000299414.60022.1b; Stoneburner RL, 2004, SCIENCE, V304, P714, DOI 10.1126/science.1093166; Stringer ME, 2008, B WHO, V89; UNAIDS WHO, 2011, GLOB REP 2011 UNAIDS; Zaba B, 2000, AIDS, V14, P1633, DOI 10.1097/00002030-200007280-00020	52	18	18	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 4	2012	7	4							e33652	10.1371/journal.pone.0033652	http://dx.doi.org/10.1371/journal.pone.0033652			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	953GO	22496759	Green Submitted, Green Published, gold			2022-12-25	WOS:000304855200019
J	Carilli, J; Donner, SD; Hartmann, AC				Carilli, Jessica; Donner, Simon D.; Hartmann, Aaron C.			Historical Temperature Variability Affects Coral Response to Heat Stress	PLOS ONE			English	Article							THERMAL TOLERANCE; OXIDATIVE STRESS; REEF; GROWTH; PORITES; SUSCEPTIBILITY; ADAPTATION; ANNULARIS; MORTALITY; PATTERNS	Coral bleaching is the breakdown of symbiosis between coral animal hosts and their dinoflagellate algae symbionts in response to environmental stress. On large spatial scales, heat stress is the most common factor causing bleaching, which is predicted to increase in frequency and severity as the climate warms. There is evidence that the temperature threshold at which bleaching occurs varies with local environmental conditions and background climate conditions. We investigated the influence of past temperature variability on coral susceptibility to bleaching, using the natural gradient in peak temperature variability in the Gilbert Islands, Republic of Kiribati. The spatial pattern in skeletal growth rates and partial mortality scars found in massive Porites sp. across the central and northern islands suggests that corals subject to larger year-to-year fluctuations in maximum ocean temperature were more resistant to a 2004 warm-water event. In addition, a subsequent 2009 warm event had a disproportionately larger impact on those corals from the island with lower historical heat stress, as indicated by lower concentrations of triacylglycerol, a lipid utilized for energy, as well as thinner tissue in those corals. This study indicates that coral reefs in locations with more frequent warm events may be more resilient to future warming, and protection measures may be more effective in these regions.	[Carilli, Jessica] Australian Nucl Sci & Technol Org, Inst Environm Res, Lucas Heights, NSW, Australia; [Donner, Simon D.] Univ British Columbia, Dept Geog, Vancouver, BC, Canada; [Hartmann, Aaron C.] Univ Calif San Diego, Scripps Inst Oceanog, La Jolla, CA 92093 USA	Australian Nuclear Science & Technology Organisation; University of British Columbia; University of California System; University of California San Diego; Scripps Institution of Oceanography	Carilli, J (corresponding author), Australian Nucl Sci & Technol Org, Inst Environm Res, Lucas Heights, NSW, Australia.	jcarilli@gmail.com			Natural Sciences and Engineering Research Council of Canada; Australian Nuclear Science and Technology Organization; United States National Science Foundation	Natural Sciences and Engineering Research Council of Canada(Natural Sciences and Engineering Research Council of Canada (NSERC)CGIAR); Australian Nuclear Science and Technology Organization; United States National Science Foundation(National Science Foundation (NSF))	This work was supported by a Natural Sciences and Engineering Research Council of Canada Discovery Grant (SDD; www.nserc-crsng.gc.ca), an Australian Nuclear Science and Technology Organization Postdoctoral Fellowship (JC; ansto.gov.au), and a United States National Science Foundation Graduate Research Fellowship (ACH; www.nsf.gov). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Anthony KRN, 2008, P NATL ACAD SCI USA, V105, P17442, DOI 10.1073/pnas.0804478105; Anthony KRN, 2007, LIMNOL OCEANOGR, V52, P716, DOI 10.4319/lo.2007.52.2.0716; Anthony KRN, 2006, MAR ECOL PROG SER, V319, P111, DOI 10.3354/meps319111; BARNES DJ, 1992, J EXP MAR BIOL ECOL, V159, P113, DOI 10.1016/0022-0981(92)90261-8; Baskett ML, 2009, ECOL APPL, V19, P3, DOI 10.1890/08-0139.1; Benson AA, 1972, P BIOCH SOC, V128, P1; Berkelmans R, 1999, CORAL REEFS, V18, P219, DOI 10.1007/s003380050186; Berkelmans R, 2006, P ROY SOC B-BIOL SCI, V273, P2305, DOI 10.1098/rspb.2006.3567; Brown BE, 2002, CORAL REEFS, V21, P119, DOI 10.1007/s00338-002-0215-z; Brown BE, 1997, CORAL REEFS, V16, pS129, DOI 10.1007/s003380050249; Brown BE, 2002, MAR ECOL PROG SER, V242, P119, DOI 10.3354/meps242119; BUDDEMEIER RW, 1993, BIOSCIENCE, V43, P320, DOI 10.2307/1312064; Cantin NE, 2010, SCIENCE, V329, P322, DOI 10.1126/science.1190182; Carilli JE, 2010, B MAR SCI, V86, P709; Carilli JE, 2010, GLOBAL CHANGE BIOL, V16, P1247, DOI 10.1111/j.1365-2486.2009.02043.x; Carilli JE, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0006324; Castillo KD, 2005, MAR BIOL, V148, P261, DOI 10.1007/s00227-005-0046-x; Coles SL, 2003, ADV MAR BIOL, V46, P183, DOI 10.1016/S0065-2881(03)46004-5; Donner SD, 2005, GLOBAL CHANGE BIOL, V11, P2251, DOI 10.1111/j.1365-2486.2005.01073.x; Donner SD, 2010, ATOLL RES B, P587; Donner SD, 2011, ECOL APPL, V21, P1718, DOI 10.1890/10-0107.1; Donner SD, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0005712; Downs CA, 2002, FREE RADICAL BIO MED, V33, P533, DOI 10.1016/S0891-5849(02)00907-3; Eakin CM, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0013969; Fitt WK, 2001, CORAL REEFS, V20, P51, DOI 10.1007/s003380100146; GOREAU TJ, 1994, AMBIO, V23, P176; Halley R, 2007, GEOLOGICAL APPROACHE; Harvell CD, 1999, SCIENCE, V285, P1505, DOI 10.1126/science.285.5433.1505; Hoegh-Guldberg O, 1999, MAR FRESHWATER RES, V50, P839, DOI 10.1071/MF99078; Jones AM, 2008, P ROY SOC B-BIOL SCI, V275, P1359, DOI 10.1098/rspb.2008.0069; LEDER JJ, 1991, CORAL REEFS, V10, P19, DOI 10.1007/BF00301902; Lesser MP, 1997, CORAL REEFS, V16, P187, DOI 10.1007/s003380050073; Lough JM, 2000, GEOPHYS RES LETT, V27, P3901, DOI 10.1029/2000GL011715; Lough JM, 2000, J EXP MAR BIOL ECOL, V245, P225, DOI 10.1016/S0022-0981(99)00168-9; Loya Y, 2001, ECOL LETT, V4, P122, DOI 10.1046/j.1461-0248.2001.00203.x; Marshall PA, 2000, CORAL REEFS, V19, P155, DOI 10.1007/s003380000086; Maynard JA, 2008, MAR BIOL, V155, P173, DOI 10.1007/s00227-008-1015-y; McWilliams JP, 2005, ECOLOGY, V86, P2055, DOI 10.1890/04-1657; Middlebrook R, 2008, J EXP BIOL, V211, P1050, DOI 10.1242/jeb.013284; Oliver TA, 2011, CORAL REEFS, V30, P429, DOI 10.1007/s00338-011-0721-y; Rodrigues L, 2005, THESIS U PENNSYLVANI; Rodrigues LJ, 2008, J EXP MAR BIOL ECOL, V358, P136, DOI 10.1016/j.jembe.2008.02.004; Rowan R, 2004, NATURE, V430, P742, DOI 10.1038/430742a; Salih A, 2000, NATURE, V408, P850, DOI 10.1038/35048564; Sampayo EM, 2008, P NATL ACAD SCI USA, V105, P10444, DOI 10.1073/pnas.0708049105; Strong A.E., 1997, P 8 INT COR REEF S, V2, P1495; Strong AE, 2004, B MAR SCI, V75, P259; Suzuki A, 2003, CORAL REEFS, V22, P357, DOI 10.1007/s00338-003-0323-4; Thompson DM, 2009, P ROY SOC B-BIOL SCI, V276, P2893, DOI 10.1098/rspb.2009.0591; Williams GJ, 2010, MAR POLLUT BULL, V60, P1467, DOI 10.1016/j.marpolbul.2010.05.009; Wooldridge SA, 2009, MAR POLLUT BULL, V58, P745, DOI 10.1016/j.marpolbul.2008.12.013; Yee SH, 2008, ECOL MODEL, V218, P162, DOI 10.1016/j.ecolmodel.2008.06.037	52	100	103	0	93	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 30	2012	7	3							e34418	10.1371/journal.pone.0034418	http://dx.doi.org/10.1371/journal.pone.0034418			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	959UC	22479626	gold, Green Submitted, Green Published			2022-12-25	WOS:000305339100156
J	Yoshimura, M; Fisher, BL				Yoshimura, Masashi; Fisher, Brian L.			A Revision of Male Ants of the Malagasy Amblyoponinae (Hymenoptera: Formicidae) with Resurrections of the Genera Stigmatomma and Xymmer	PLOS ONE			English	Article							GENUS; DIVERSIFICATION; SYSTEMATICS; PHYLOGENY; TAXONOMY	In a male-based revision of ants of the subfamily Amblyoponinae from the Southwest Indian Ocean islands (SWIO: Comoros, Madagascar, Mauritius, Mayotte, Reunion, and Seychelles), we explore and reconsider male morphological characters that distinguish genera within the group. Our investigation redefines Amblyopone Erichson sensu Brown (1960), here referred to as Amblyopone sensu lato, into three genera: Xymmer Santschi stat. rev., Amblyopone sensu stricto, Stigmatomma Roger stat. rev. All species names under Amblyopone s. l. reassign into Xymmer and Amblyopone s. s., which are small, well-defined genera, and Stigmatomma, a large group with a generic delimitation that still needs further refinement. Based on a study of male mandible characters and our scenario for mandibular evolution of the worker caste within Amblyopone s. l, we conclude that Amblyopone s. s. nests outside of XMAS (Xymmer+Mystrium+Adetomyrma+Stigmatomma) clade. The following names are transferred from Amblyopone s. l. to Xymmer as comb. rev.: muticus. The following names are transferred from Amblyopone s. l. to Stigmatomma as comb. rev.: amblyops, armigerum, bellii, bierigi, bruni, celata, chilense, denticulatum, elongatum, emeryi, feae, impressifrons, luzonicum, minuta, normandi, oregonense, pallipes, quadratum, reclinatum, rothneyi, santschii, saundersi, silvestrii, zwaluwenburgi; as comb. nov.: agostii, annae, besucheti, boltoni, caliginosum, cleae, crenatum, degeneratum, egregium, electrinum, eminia, exiguum, falcatum, ferrugineum, fulvidum, gaetulicum, gingivalis, glauerti, gnoma, gracile, groehni, heraldoi, lucidum, lurilabes, monrosi, mystriops, noonadan, octodentatum, ophthalmicum, orizabanum, papuanum, pertinax, pluto, punctulatum, rubiginoum, sakaii, smithi, trigonignathum, trilobum, wilsoni, zaojun, and testaceum. A male-based key to the genera of Malagasy amblyoponine ants, their diagnoses, and a discussion of the evolution of the morphological character of males in the subfamily are given, and the distinguishing characters of each are illustrated. In addition, our results predict that Paraprionopelta belongs in the XMAS clade and that Concoctio should have males with two mandibular teeth.	[Yoshimura, Masashi; Fisher, Brian L.] Calif Acad Sci, Dept Entomol, San Francisco, CA 94118 USA	California Academy of Sciences	Yoshimura, M (corresponding author), Calif Acad Sci, Dept Entomol, San Francisco, CA 94118 USA.	myoshimura@ant-database.org; bfisher@calacademy.org	Fisher, Brian L./S-9374-2019; Yoshimura, Masashi/D-5096-2009	Fisher, Brian/0000-0002-4653-3270; Yoshimura, Masashi/0000-0003-1468-5541	National Science Foundation [DEB-0842395]; Division Of Environmental Biology [0842395] Funding Source: National Science Foundation	National Science Foundation(National Science Foundation (NSF)); Division Of Environmental Biology(National Science Foundation (NSF)NSF - Directorate for Biological Sciences (BIO))	This work was supported by the National Science Foundation under grant no. DEB-0842395 (http://www.nsf.gov/funding/). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	BINGHAM CT, 2003, FAUNA BRIT INDIA INC, V2; BOLTON B, 1990, J NAT HIST, V24, P53, DOI 10.1080/00222939000770051; Bolton B., 1994, Identification guide to the ant genera of the world.; Bolton Barry, 2003, Memoirs of the American Entomological Institute (Gainesville), V71, P1; Bolton Barry, 1995, P1; Brady SG, 2006, P NATL ACAD SCI USA, V103, P18172, DOI 10.1073/pnas.0605858103; Brown W. L jr., 1950, Transactions of the American Entomological Society, V75, P113; BROWN WILLIAM L., 1960, BULL MUS COMP ZOOL HARVARD UNIV, V122, P143; BROWN WILLIAM L., 1949, PSYCHE, V56, P81, DOI 10.1155/1949/67378; Clark J., 1934, Memoirs of the National Museum Melbourne, Vno. 8, P21; Clark J., 1928, Journal Royal Soc W Aust Sydney, V14, P29; Eguchi K, 2006, ZOOTAXA, P1; Emery C., 1919, Annales de la Societe Entomologique de Belgique Bruxelles, V59; ERICHSON WF, 1842, ARCH NATURGESCH, V8, P83, DOI DOI 10.5962/BHL.PART.21657; FISHER BL, 2005, P CALIFORNIA ACAD SC, V56, P78; Fisher BL, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0001787; Gauld I. D., 1988, HYMENOPTERA; Gotwald Jr WH, 1969, MEMOIR CORNELL U AGR; GOTWALD WH, 1972, ANN ENTOMOL SOC AM, V65, P383, DOI 10.1093/aesa/65.2.383; Huber John T., 1993, Agriculture Canada Publication, V1894E, P13; Hymenoptera Emery C, FAM FORMICIDAE SUBFA, P1; International Commision on Zoological Nomenclature, 1999, INT COD ZOOL NOM; Kusnezov N., 1955, Zoologischer Anzeiger Leipzig, V154, P268; Mann W. M., 1919, Bulletin of the Museum at Harvard College, V63; Moreau CS, 2006, SCIENCE, V312, P101, DOI 10.1126/science.1124891; Nichols SW, TORRE BUENO GLOSSARY; OGATA K, 1987, Esakia, P97; Ouellette GD, 2006, MOL PHYLOGENET EVOL, V40, P359, DOI 10.1016/j.ympev.2006.03.017; Provancher L., 1881, NAT CAN, V12, P193; Roger J, 1859, BERL ENTOMOL Z, V3, P225; Santschi F., 1914, B LAB ZOOLOGIA GEN A, V8, P309, DOI DOI 10.5281/ZENODO.14385; Saux C, 2004, MOL PHYLOGENET EVOL, V33, P457, DOI 10.1016/j.ympev.2004.06.017; Serna F, 2010, J INSECT SCI, V10, DOI 10.1673/031.010.11101; Serna F, 2011, ZOOTAXA, P67, DOI 10.11646/zootaxa.2923.1.5; Smith Marion R., 1943, AMER MIDLAND NAT, V30, P273, DOI 10.2307/2421283; SNODGRASS R. E., 1941, SMITHSONIAN MISC COLL, V99, P1; SNODGRASS R. E., 1957, SMITHSONIAN MISC COLL, V135, P1; Snodgrass RE., 1935, PRINCIPLES INSECT MO, P1; Ward PS, 2011, MYRMECOL NEWS, V15, P21; WARD PS, 1994, SYST ENTOMOL, V19, P159, DOI 10.1111/j.1365-3113.1994.tb00585.x; Wheeler W. M., 1922, Bulletin of the American Museum of Natural History, V45, P631; Wheeler WM, 1927, P AM ACAD ARTS SCI, V62, P1, DOI 10.2307/25130101; WOOTTON RJ, 1979, SYST ENTOMOL, V4, P81, DOI 10.1111/j.1365-3113.1979.tb00614.x; Yoshimura M, 2007, ZOOTAXA, P21, DOI 10.11646/zootaxa.1654.1.2; Yoshimura M, 2011, ZOOTAXA, P1; Yoshimura M, 2009, ZOOTAXA, P1	46	64	70	1	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 29	2012	7	3							e33325	10.1371/journal.pone.0033325	http://dx.doi.org/10.1371/journal.pone.0033325			23	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	948SR	22496722	Green Published, gold, Green Submitted			2022-12-25	WOS:000304523400020
J	Campbell, HG; Mehta, R; Neumann, AA; Rubio, C; Baird, M; Slatter, TL; Braithwaite, AW				Campbell, H. G.; Mehta, R.; Neumann, A. A.; Rubio, C.; Baird, M.; Slatter, T. L.; Braithwaite, A. W.			Activation of p53 following ionizing radiation, but not other stressors, is dependent on the proline-rich domain (PRD)	ONCOGENE			English	Article						p53; apoptosis; DNA repair	LI-FRAUMENI-SYNDROME; FUNCTIONAL DOMAIN; TUMOR-SUPPRESSOR; MICE LACKING; APOPTOSIS; E1A; TRANSACTIVATION; PROTEINS; REGION; CELLS	The tumor suppressor protein, p53 is one of the most important cellular defences against malignant transformation. In response to cellular stressors p53 can induce apoptosis, cell cycle arrest or senescence as well as aid in DNA repair. Which p53 function is required for tumor suppression is unclear. The proline-rich domain (PRD) of p53 (residues 58-101) has been reported to be essential for the induction of apoptosis. To determine the importance of the PRD in tumor suppression in vivo we previously generated a mouse containing a 33-amino-acid deletion (residues 55-88) in p53 (m Delta pro). We showed that m Delta pro mice are protected from T-cell tumors but not late-onset B-cell tumors. Here, we characterize the functionality of the PRD and show that it is important for mediating the p53 response to DNA damage induced by gamma-radiation, but not the p53-mediated responses to Ha-Ras expression or oxidative stress. We conclude that the PRD is important for receiving incoming activating signals. Failure of PRD mutants to respond to the activating signaling produced by DNA damage leads to impaired downstream signaling, accumulation of mutations, which potentially leads to late-onset tumors. Oncogene (2013) 32, 827-836; doi:10.1038/onc.2012.102; published online 9 April 2012	[Campbell, H. G.; Mehta, R.; Neumann, A. A.; Rubio, C.; Braithwaite, A. W.] Univ Sydney, Childrens Med Res Inst, Sydney, NSW 2006, Australia; [Baird, M.] Univ Otago, Dept Microbiol & Immunol, Sch Med Sci, Dunedin, New Zealand; [Slatter, T. L.; Braithwaite, A. W.] Univ Otago, Sch Med, Dept Pathol, Dunedin, New Zealand	Children's Medical Research Institute - Australia; University of Sydney; University of Otago; University of Otago	Braithwaite, AW (corresponding author), Childrens Med Res Inst, Cell Transformat Unit, Locked Bag 23, Wentworthville, NSW 2145, Australia.	abraithwaite@cmri.org.au						Baptiste N, 2002, ONCOGENE, V21, P9, DOI 10.1038/sj/onc/1205015; Braithwaite AW, 2005, CARCINOGENESIS, V26, P1161, DOI 10.1093/carcin/bgi091; BRAITHWAITE AW, 1983, J VIROL, V45, P192, DOI 10.1128/JVI.45.1.192-199.1983; Cordenonsi M, 2007, SCIENCE, V315, P840, DOI 10.1126/science.1135961; DENG CX, 1995, CELL, V82, P675, DOI 10.1016/0092-8674(95)90039-X; DONEHOWER LA, 1992, NATURE, V356, P215, DOI 10.1038/356215a0; Edwards SJ, 2003, ONCOGENE, V22, P4517, DOI 10.1038/sj.onc.1206726; Hammond EM, 2002, MOL CELL BIOL, V22, P1834, DOI 10.1128/MCB.22.6.1834-1843.2002; Hansen RS, 1996, ONCOGENE, V13, P995; Haupt Y, 1997, NATURE, V387, P296, DOI 10.1038/387296a0; HOLLSTEIN M, 1991, SCIENCE, V253, P49, DOI 10.1126/science.1905840; HORN PL, 1984, J CELL PHYSIOL, V121, P309, DOI 10.1002/jcp.1041210207; JACKS T, 1994, CURR BIOL, V4, P1, DOI 10.1016/S0960-9822(00)00002-6; Khanna KK, 1998, NAT GENET, V20, P398, DOI 10.1038/3882; LANE DP, 1992, NATURE, V358, P15, DOI 10.1038/358015a0; Lang GA, 2004, CELL, V119, P861, DOI 10.1016/j.cell.2004.11.006; Lee JH, 2004, SCIENCE, V304, P93, DOI 10.1126/science.1091496; LOWE SW, 1993, GENE DEV, V7, P535, DOI 10.1101/gad.7.4.535; MALKIN D, 1990, SCIENCE, V250, P1233, DOI 10.1126/science.1978757; Michalak EM, 2008, CELL DEATH DIFFER, V15, P1019, DOI 10.1038/cdd.2008.16; Olive KP, 2004, CELL, V119, P847, DOI 10.1016/j.cell.2004.11.004; Parrinello S, 2003, NAT CELL BIOL, V5, P741, DOI 10.1038/ncb1024; Rogakou EP, 1998, J BIOL CHEM, V273, P5858, DOI 10.1074/jbc.273.10.5858; Sakamuro D, 1997, ONCOGENE, V15, P887, DOI 10.1038/sj.onc.1201263; Salvador JM, 2002, IMMUNITY, V16, P499, DOI 10.1016/S1074-7613(02)00302-3; Samuelson AV, 1997, P NATL ACAD SCI USA, V94, P12094, DOI 10.1073/pnas.94.22.12094; SCHEFFNER M, 1990, CELL, V63, P1129, DOI 10.1016/0092-8674(90)90409-8; Serrano M, 1997, CELL, V88, P593, DOI 10.1016/S0092-8674(00)81902-9; Slatter TL, 2010, CELL DEATH DIFFER, V17, P540, DOI 10.1038/cdd.2009.136; TEODORO JG, 1995, ONCOGENE, V11, P467; Toledo F, 2006, CANCER CELL, V9, P273, DOI 10.1016/j.ccr.2006.03.014; Toledo F, 2007, MOL CELL BIOL, V27, P1425, DOI 10.1128/MCB.00999-06; Venot C, 1998, EMBO J, V17, P4668, DOI 10.1093/emboj/17.16.4668; Vousden KH, 2007, NAT REV MOL CELL BIO, V8, P275, DOI 10.1038/nrm2147; Walker KK, 1996, P NATL ACAD SCI USA, V93, P15335, DOI 10.1073/pnas.93.26.15335; WHYTE P, 1988, NATURE, V334, P124, DOI 10.1038/334124a0; Xu J., 2001, PREPARATION CULTURE	37	10	10	0	5	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0950-9232			ONCOGENE	Oncogene	FEB 14	2013	32	7					827	836		10.1038/onc.2012.102	http://dx.doi.org/10.1038/onc.2012.102			10	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	112GQ	22484427				2022-12-25	WOS:000316581100003
J	Bett, C; Fernandez-Borges, N; Kurt, TD; Lucero, M; Nilsson, KPR; Castilla, J; Sigurdson, CJ				Bett, Cyrus; Fernandez-Borges, Natalia; Kurt, Timothy D.; Lucero, Melanie; Nilsson, K. Peter R.; Castilla, Joaquin; Sigurdson, Christina J.			Structure of the beta 2-alpha 2 loop and interspecies prion transmission	FASEB JOURNAL			English	Article						amyloid; TSE; transmissible spongiform encephalopathy; neurodegeneration	CREUTZFELDT-JAKOB-DISEASE; SPONGIFORM ENCEPHALOPATHY; NMR STRUCTURE; AMINO-ACID; IN-VITRO; SPECIES BARRIER; PROTEIN; PRP; VARIANT; PROPAGATION	Prions are misfolded, aggregated conformers of the prion protein that can be transmitted between species. The precise determinants of interspecies transmission remain unclear, although structural similarity between the infectious prion and host prion protein is required for efficient conversion to the misfolded conformer. The beta 2-alpha 2 loop region of endogenous prion protein, PrPC, has been implicated in barriers to prion transmission. We recently discovered that conversion was efficient when incoming and host prion proteins had similar beta 2-alpha 2 loop structures; however, the roles of primary vs. secondary structural homology could not be distinguished. Here we uncouple the effect of primary and secondary structural homology of the beta 2-alpha 2 loop on prion conversion. We inoculated prions from animals having a disordered or an ordered beta 2-alpha 2 loop into mice having a disordered loop or an ordered loop due to a single residue substitution (D167S). We found that prion conversion was driven by a homologous primary structure and occurred independently of a homologous secondary structure. Similarly, cell-free conversion using PrPC from mice with disordered or ordered loops and prions from 5 species correlated with primary but not secondary structural homology of the loop. Thus, our findings support a model in which efficient interspecies prion conversion is determined by small stretches of the primary sequence rather than the secondary structure of PrP.-Bett, C., Fernandez-Borges, N., Kurt, T. D., Lucero, M., Nilsson, K. P. R., Castilla, J., Sigurdson, C. J. Structure of the beta 2-alpha 2 loop and interspecies prion transmission. FASEB J. 26, 2868-2876 (2012). www.fasebj.org	[Bett, Cyrus; Kurt, Timothy D.; Lucero, Melanie; Sigurdson, Christina J.] Univ Calif San Diego, Dept Pathol, La Jolla, CA 92093 USA; [Bett, Cyrus; Kurt, Timothy D.; Lucero, Melanie; Sigurdson, Christina J.] Univ Calif San Diego, Dept Med, La Jolla, CA 92093 USA; [Fernandez-Borges, Natalia; Castilla, Joaquin] Ctr Cooperat Res Biosci CIC bioGUNE, Derio, Spain; [Nilsson, K. Peter R.] Linkoping Univ, Dept Phys Chem & Biol, Linkoping, Sweden; [Castilla, Joaquin] Basque Fdn Sci IkerBasque, Bilbao, Spain; [Sigurdson, Christina J.] Univ Calif Davis, Dept Pathol Microbiol & Immunol, Davis, CA 95616 USA	University of California System; University of California San Diego; University of California System; University of California San Diego; CIC bioGUNE; Linkoping University; Basque Foundation for Science; University of California System; University of California Davis	Sigurdson, CJ (corresponding author), Univ Calif San Diego, Dept Pathol, San Diego, CA 92103 USA.	csigurdson@ucsd.edu	Castilla, Joaquin/D-5261-2011; Castilla, Joaquín/J-8414-2019; Fernández-Borges, Natalia/H-1875-2012	Castilla, Joaquin/0000-0002-2216-1361; Castilla, Joaquín/0000-0002-2216-1361; Fernandez-Borges, Natalia/0000-0001-6274-0096	U.S. National Institutes of Health [NS055116, NS069566, U54AI0359]; national grant from Spain [AGL2009-11553-C02-01]; Basque government grant [PI2010-18]; IKERBasque Foundation; Department of Industry, Tourism, and Trade of the Government of the Autonomous Community of the Basque Country; Innovation Technology Department of Bizkaia County; Swedish Foundation for International Cooperation in Research and Higher Education (STINT); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS069566, R01NS076896, R21NS055116] Funding Source: NIH RePORTER	U.S. National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); national grant from Spain; Basque government grant(Basque Government); IKERBasque Foundation; Department of Industry, Tourism, and Trade of the Government of the Autonomous Community of the Basque Country; Innovation Technology Department of Bizkaia County; Swedish Foundation for International Cooperation in Research and Higher Education (STINT); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))	The authors thank Dr. Adriano Aguzzi (Institute of Neuropathology, University Hospital Zurich, Zurich, Switzerland) and Dr. Charles Weissmann (The Scripps Research Institute Florida, Jupiter, FL, USA) for kindly providing the anti-PrP POM antibodies and the CAD-RML cells, respectively; Mona Farahi, Rozalyn Simon, and Karin Magnusson for excellent technical support; and Drs. David Eisenberg and Michael Sawaya for helpful discussions. The authors also thank the animal caretakers at the University of California, San Diego, and CIC bioGUNE and Drs. Jean E. Jewell (University ofWyoming, Laramie, WY, USA) and Tomas Mayoral (Central Veterinary Laboratory, Madrid, Spain) for the CWD and BSE brain samples. This study was supported by the U.S. National Institutes of Health (NS055116, NS069566, and U54AI0359; C.J.S.); a national grant from Spain (AGL2009-11553-C02-01); a Basque government grant (PI2010-18); the IKERBasque Foundation; the Department of Industry, Tourism, and Trade of the Government of the Autonomous Community of the Basque Country (Etortek Research Programs 2011/2013); the Innovation Technology Department of Bizkaia County; and an Institutional Grant for Younger Researchers from the Swedish Foundation for International Cooperation in Research and Higher Education (STINT; C.J.S., K.P.R.N.).	Barron RM, 2001, EMBO J, V20, P5070, DOI 10.1093/emboj/20.18.5070; Bett C, 2012, PLOS PATHOG, V8, DOI 10.1371/journal.ppat.1002522; Billeter M, 1997, P NATL ACAD SCI USA, V94, P7281, DOI 10.1073/pnas.94.14.7281; Bruce KL, 2011, SEMIN CELL DEV BIOL, V22, P444, DOI 10.1016/j.semcdb.2011.03.005; Bruce ME, 1997, NATURE, V389, P498, DOI 10.1038/39057; Castilla J, 2005, CELL, V121, P195, DOI 10.1016/j.cell.2005.02.011; Castilla J, 2008, EMBO J, V27, P2557, DOI 10.1038/emboj.2008.181; Castilla J, 2008, CELL, V134, P757, DOI 10.1016/j.cell.2008.07.030; Castilla J, 2006, METHOD ENZYMOL, V412, P3, DOI 10.1016/s0076-6879(06)12001-7; Chang HY, 2008, P NATL ACAD SCI USA, V105, P13345, DOI 10.1073/pnas.0802215105; Chien P, 2003, NATURE, V424, P948, DOI 10.1038/nature01894; Christen B, 2008, J MOL BIOL, V383, P306, DOI 10.1016/j.jmb.2008.08.045; Collinge J, 1996, NATURE, V383, P685, DOI 10.1038/383685a0; Collinge J, 2007, SCIENCE, V318, P930, DOI 10.1126/science.1138718; Ding L, 2000, SYNTHETIC MET, V110, P133, DOI 10.1016/S0379-6779(99)00284-2; Gossert AD, 2005, P NATL ACAD SCI USA, V102, P646, DOI 10.1073/pnas.0409008102; Green KM, 2008, PLOS PATHOG, V4, DOI 10.1371/journal.ppat.1000139; Ho HA, 2002, ANGEW CHEM INT EDIT, V41, P1548, DOI 10.1002/1521-3773(20020503)41:9<1548::AID-ANIE1548>3.0.CO;2-I; Kaneko K, 1997, P NATL ACAD SCI USA, V94, P10069, DOI 10.1073/pnas.94.19.10069; KIRKWOOD JK, 1993, VET REC, V133, P360, DOI 10.1136/vr.133.15.360; KIRKWOOD JK, 1994, VET REC, V135, P296, DOI 10.1136/vr.135.13.296; KOCISKO DA, 1995, P NATL ACAD SCI USA, V92, P3923, DOI 10.1073/pnas.92.9.3923; Kurt TD, 2011, J VIROL, V85, P8528, DOI 10.1128/JVI.00809-11; Kurt TD, 2009, VIROLOGY, V387, P235, DOI 10.1016/j.virol.2009.02.025; Lau AL, 2007, P NATL ACAD SCI USA, V104, P11551, DOI 10.1073/pnas.0704260104; Peretz D, 2002, NEURON, V34, P921, DOI 10.1016/S0896-6273(02)00726-2; Perez DR, 2010, J MOL BIOL, V400, P121, DOI 10.1016/j.jmb.2010.04.066; Piening N, 2006, J BIOL CHEM, V281, P9373, DOI 10.1074/jbc.M512239200; Polymenidou M, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0003872; PRIOLA SA, 1995, J VIROL, V69, P7754, DOI 10.1128/JVI.69.12.7754-7758.1995; PRUSINER SB, 1991, SCIENCE, V252, P1515, DOI 10.1126/science.1675487; PRUSINER SB, 1982, SCIENCE, V216, P136, DOI 10.1126/science.6801762; PRUSINER SB, 1990, CELL, V63, P673, DOI 10.1016/0092-8674(90)90134-Z; Qi YP, 1997, J NEUROSCI, V17, P1217; Riek R, 1997, FEBS LETT, V413, P282, DOI 10.1016/S0014-5793(97)00920-4; Riek R, 1996, NATURE, V382, P180, DOI 10.1038/382180a0; Ryder SJ, 2001, VET REC, V148, P437, DOI 10.1136/vr.148.14.437; Saa Paula, 2004, V299, P53; Sawaya MR, 2007, NATURE, V447, P453, DOI 10.1038/nature05695; Schatzl HM, 1997, J MOL BIOL, V265, P257, DOI 10.1006/jmbi.1996.0791; SCOTT M, 1993, CELL, V73, P979, DOI 10.1016/0092-8674(93)90275-U; Scott MR, 1997, P NATL ACAD SCI USA, V94, P14279, DOI 10.1073/pnas.94.26.14279; Sigurdson CJ, 2007, NAT METHODS, V4, P1023, DOI 10.1038/nmeth1131; Sigurdson CJ, 2006, J VIROL, V80, P12303, DOI 10.1128/JVI.01120-06; Sigurdson CJ, 2011, J NEUROSCI, V31, P13840, DOI 10.1523/JNEUROSCI.3504-11.2011; Sigurdson CJ, 2010, J CLIN INVEST, V120, P2590, DOI 10.1172/JCI42051; Tessier PM, 2007, NATURE, V447, P556, DOI 10.1038/nature05848; Verges KJ, 2011, NAT STRUCT MOL BIOL, V18, P493, DOI 10.1038/nsmb.2030; Vorberg I, 2003, J VIROL, V77, P2003, DOI 10.1128/JVI.77.3.2003-2009.2003; Wadsworth JDF, 2001, LANCET, V358, P171, DOI 10.1016/S0140-6736(01)05403-4; WELLS GAH, 1995, BRAIN PATHOL, V5, P91, DOI 10.1111/j.1750-3639.1995.tb00580.x; Will RG, 1996, LANCET, V347, P921, DOI 10.1016/S0140-6736(96)91412-9; Wiltzius JJW, 2009, NAT STRUCT MOL BIOL, V16, P973, DOI 10.1038/nsmb.1643	53	27	27	0	9	WILEY	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0892-6638	1530-6860		FASEB J	Faseb J.	JUL	2012	26	7					2868	2876		10.1096/fj.11-200923	http://dx.doi.org/10.1096/fj.11-200923			9	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	967MP	22490928	Green Published			2022-12-25	WOS:000305912500015
J	Mizumoto, S; Takahashi, J; Sugahara, K				Mizumoto, Shuji; Takahashi, Jun; Sugahara, Kazuyuki			Receptor for Advanced Glycation End Products (RAGE) Functions as Receptor for Specific Sulfated Glycosaminoglycans, and Anti-RAGE Antibody or Sulfated Glycosaminoglycans Delivered in Vivo Inhibit Pulmonary Metastasis of Tumor Cells	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							HERPES-SIMPLEX-VIRUS; GROWTH-FACTOR BINDING; EMBRYONIC PIG BRAIN; CHONDROITIN-SULFATE; HEPARAN-SULFATE; CARCINOMA-CELLS; GEL DIGESTION; HYBRID CHAINS; P-SELECTIN; CANCER	Altered expression of chondroitin sulfate (CS) and heparan sulfate (HS) at the surfaces of tumor cells plays a key role in malignant transformation and tumor metastasis. Previously we demonstrated that a Lewis lung carcinoma (LLC)-derived tumor cell line with high metastatic potential had a higher proportion of E-disaccharide units, GlcUA-GalNAc(4,6-O-disulfate), in CS chains than low metastatic LLC cells and that such CS chains are involved in the metastatic process. The metastasis was markedly inhibited by the pre-administration of CS-E from squid cartilage rich in E units or by preincubation with a phage display antibody specific for CS-E. However, the molecular mechanism of the inhibition remains to be investigated. In this study the receptor molecule for CS chains containing E-disaccharides expressed on LLC cells was revealed to be receptor for advanced glycation end products (RAGE), which is a member of the immunoglobulin superfamily predominantly expressed in the lung. Interestingly, RAGE bound strongly to not only E-disaccharide, but also HS-expressing LLC cells. Furthermore, the colonization of the lungs by LLC cells was effectively inhibited by the blocking of CS or HS chains at the tumor cell surface with an anti-RAGE antibody through intravenous injections in a dose-dependent manner. These results provide the clear evidence that RAGE is at least one of the critical receptors for CS and HS chains expressed at the tumor cell surface and involved in experimental lung metastasis and that CS/HS and RAGE are potential molecular targets in the treatment of pulmonary metastasis.	[Sugahara, Kazuyuki] Hokkaido Univ, Grad Sch Life Sci, Frontier Res Ctr Postgenom Sci & Technol, Lab Proteoglycan Signaling & Therapeut,Kita Ku, Sapporo, Hokkaido 0010021, Japan	Hokkaido University	Sugahara, K (corresponding author), Hokkaido Univ, Grad Sch Life Sci, Frontier Res Ctr Postgenom Sci & Technol, Lab Proteoglycan Signaling & Therapeut,Kita Ku, West 11,North 21, Sapporo, Hokkaido 0010021, Japan.	k-sugar@sci.hokudai.ac.jp	Mizumoto, Shuji/F-8313-2018	Mizumoto, Shuji/0000-0002-4641-1505	Ministry of Education, Culture, Sports, Science, and Technology, Japan (MEXT) [23390016, 23790066]	Ministry of Education, Culture, Sports, Science, and Technology, Japan (MEXT)(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT))	This work was supported in part by Grant-in-aid for Scientific Research (B) 23390016 (to K. S.), Future Drug Discovery and Medical Care Innovation Program (to K. S.) and Young Scientists (B) 23790066 (to S. M.) from The Ministry of Education, Culture, Sports, Science, and Technology, Japan (MEXT).	BANFIELD BW, 1995, J VIROL, V69, P3290, DOI 10.1128/JVI.69.6.3290-3298.1995; Bao XF, 2005, J BIOL CHEM, V280, P9180, DOI 10.1074/jbc.M413423200; Bao XF, 2004, J BIOL CHEM, V279, P9765, DOI 10.1074/jbc.M310877200; Basappa, 2009, GLYCOBIOLOGY, V19, P735, DOI 10.1093/glycob/cwp041; Beauvais DeannaLee M, 2004, Reprod Biol Endocrinol, V2, P3, DOI 10.1186/1477-7827-2-3; Beauvais DLM, 2004, J CELL BIOL, V167, P171, DOI 10.1083/jcb.200404171; Bergefall K, 2005, J BIOL CHEM, V280, P32193, DOI 10.1074/jbc.M503645200; Bishop JR, 2007, NATURE, V446, P1030, DOI 10.1038/nature05817; Buckley ST, 2010, J BIOMED BIOTECHNOL, DOI 10.1155/2010/917108; Deepa SS, 2007, BIOCHEMISTRY-US, V46, P2453, DOI 10.1021/bi602374m; Deepa SS, 2002, J BIOL CHEM, V277, P43707, DOI 10.1074/jbc.M207105200; Eccles SA, 2007, LANCET, V369, P1742, DOI 10.1016/S0140-6736(07)60781-8; Englert JM, 2008, PROTEIN EXPRES PURIF, V61, P99, DOI 10.1016/j.pep.2008.05.004; FAASSEN AE, 1992, J CELL BIOL, V116, P521, DOI 10.1083/jcb.116.2.521; Fidler IJ, 2003, NAT REV CANCER, V3, P453, DOI 10.1038/nrc1098; Frame MC, 2010, NAT REV MOL CELL BIO, V11, P802, DOI 10.1038/nrm2996; FUNAHASHI M, 1982, ANAL BIOCHEM, V126, P414, DOI 10.1016/0003-2697(82)90537-1; Fuster MM, 2005, NAT REV CANCER, V5, P526, DOI 10.1038/nrc1649; GRUENHEID S, 1993, J VIROL, V67, P93, DOI 10.1128/JVI.67.1.93-100.1993; GUNTHERT U, 1991, CELL, V65, P13, DOI 10.1016/0092-8674(91)90403-L; Hanford LE, 2004, J BIOL CHEM, V279, P50019, DOI 10.1074/jbc.M409782200; HELLMAN U, 1995, ANAL BIOCHEM, V224, P451, DOI 10.1006/abio.1995.1070; Iida J, 1996, SEMIN CANCER BIOL, V7, P155, DOI 10.1006/scbi.1996.0021; Kawashima H, 2002, J BIOL CHEM, V277, P12921, DOI 10.1074/jbc.M200396200; Kim S, 2009, NATURE, V457, P102, DOI 10.1038/nature07623; Kinoshita A, 1997, J BIOL CHEM, V272, P19656, DOI 10.1074/jbc.272.32.19656; Kinoshita A, 1999, ANAL BIOCHEM, V269, P367, DOI 10.1006/abio.1999.4027; KLOMPMAKERS AA, 1986, ANAL BIOCHEM, V153, P80, DOI 10.1016/0003-2697(86)90064-3; Koch M, 2010, STRUCTURE, V18, P1342, DOI 10.1016/j.str.2010.05.017; LANKES WT, 1991, P NATL ACAD SCI USA, V88, P8297, DOI 10.1073/pnas.88.19.8297; Li F, 2008, J BIOL CHEM, V283, P34294, DOI 10.1074/jbc.M806015200; Mikami T, 2009, J BIOL CHEM, V284, P4494, DOI 10.1074/jbc.M809227200; Monzavi-Karbassi B, 2007, INT J CANCER, V120, P1179, DOI 10.1002/ijc.22424; NEEPER M, 1992, J BIOL CHEM, V267, P14998; Ohyama C, 1999, EMBO J, V18, P1516, DOI 10.1093/emboj/18.6.1516; Park H, 2010, J BIOL CHEM, V285, P40762, DOI 10.1074/jbc.M110.169276; Rao NV, 2010, AM J PHYSIOL-CELL PH, V299, pC97, DOI 10.1152/ajpcell.00009.2010; ROSENFELD J, 1992, ANAL BIOCHEM, V203, P173, DOI 10.1016/0003-2697(92)90061-B; Sasisekharan R, 2002, NAT REV CANCER, V2, P521, DOI 10.1038/nrc842; Sims GP, 2010, ANNU REV IMMUNOL, V28, P367, DOI 10.1146/annurev.immunol.021908.132603; Srikrishna G, 2002, J NEUROCHEM, V80, P998, DOI 10.1046/j.0022-3042.2002.00796.x; Sugahara K, 2003, CURR OPIN STRUC BIOL, V13, P612, DOI 10.1016/j.sbi.2003.09.011; Sugahara KN, 2008, CANCER RES, V68, P7191, DOI 10.1158/0008-5472.CAN-07-6198; Sugahara K, 2007, CURR OPIN STRUC BIOL, V17, P536, DOI 10.1016/j.sbi.2007.08.015; ten Dam GB, 2007, AM J PATHOL, V171, P1324, DOI 10.2353/ajpath.2007.070111; Timar J, 2002, SEMIN CANCER BIOL, V12, P173, DOI 10.1016/S1044-579X(02)00021-4; Uyama T, 2006, J BIOL CHEM, V281, P38668, DOI 10.1074/jbc.M609320200; Xu D, 2011, J BIOL CHEM, V286, P41736, DOI 10.1074/jbc.M111.299685; Zhou Z, 2006, J EXP MED, V203, P1067, DOI 10.1084/jem.20051947	49	73	76	1	17	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JUN 1	2012	287	23					18985	18994		10.1074/jbc.M111.313437	http://dx.doi.org/10.1074/jbc.M111.313437			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	974EF	22493510	Green Published, hybrid			2022-12-25	WOS:000306411900010
J	Saxena, A; Banasavadi-Siddegowda, YK; Fan, YF; Bhattacharya, S; Roy, G; Giovannucci, DR; Frizzell, RA; Wang, XD				Saxena, Anita; Banasavadi-Siddegowda, Yeshavanth K.; Fan, Yifei; Bhattacharya, Sumit; Roy, Gargi; Giovannucci, David R.; Frizzell, Raymond A.; Wang, Xiaodong			Human Heat Shock Protein 105/110 kDa (Hsp105/110) Regulates Biogenesis and Quality Control of Misfolded Cystic Fibrosis Transmembrane Conductance Regulator at Multiple Levels	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							DISEASE-ASSOCIATED MUTATIONS; DELTA-F508 CFTR TRAFFICKING; CHLORIDE CHANNEL ACTIVITY; ENDOPLASMIC-RETICULUM; EPITHELIAL-CELLS; INTRACELLULAR-TRANSPORT; CO-CHAPERONE; CONFORMATIONAL MATURATION; PROTEASOMAL DEGRADATION; HSP90 COCHAPERONE	Heat shock protein 105/110-kDa (Hsp105/110), a member of the Hsp70 super family of molecular chaperones, serves as a nucleotide exchange factor for Hsc70, independently prevents the aggregation of misfolded proteins, and functionally relates to Hsp90. We investigated the roles of human Hsp105 alpha, the constitutively expressed isoform, in the biogenesis and quality control of the cystic fibrosis transmembrane conductance regulator (CFTR). In the endoplasmic reticulum (ER), Hsp105 facilitates CFTR quality control at an early stage in its biosynthesis but promotes CFTR post-translational folding. Deletion of Phe-508 (Delta F508), the most prevalent mutation causing cystic fibrosis, interferes with de novo folding of CFTR, impairing its export from the ER and accelerating its clearance in the ER and post-Golgi compartments. We show that Hsp105 preferentially associates with and stabilizes Delta F508 CFTR at both levels. Introduction of the Hsp105 substrate binding domain potently increases the steady state level of Delta F508 CFTR by reducing its early-stage degradation. This in turn dramatically enhances Delta F508 CFTR cell surface functional expression in cystic fibrosis airway epithelial cells. Although other Hsc70 nucleotide exchange factors such as HspBP1 and BAG-2 inhibit CFTR post-translational degradation in the ER through cochaperone CHIP, Hsp105 has a primary role promoting CFTR quality control at an earlier stage. The Hsp105-mediated multilevel regulation of Delta F508 CFTR folding and quality control provides new opportunities to understand how chaperone machinery regulates the homeostasis and functional expression of misfolded proteins in the cell. Future studies in this direction will inform therapeutics development for cystic fibrosis and other protein misfolding diseases.	[Saxena, Anita; Banasavadi-Siddegowda, Yeshavanth K.; Fan, Yifei; Roy, Gargi; Wang, Xiaodong] Univ Toledo, Coll Med, Dept Physiol & Pharmacol, Toledo, OH 43614 USA; [Bhattacharya, Sumit; Giovannucci, David R.] Univ Toledo, Coll Med, Dept Neurosci, Toledo, OH 43614 USA; [Frizzell, Raymond A.] Univ Pittsburgh, Sch Med, Dept Cell Biol & Physiol, Pittsburgh, PA 15261 USA	University System of Ohio; University of Toledo; University System of Ohio; University of Toledo; Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh	Wang, XD (corresponding author), 3000 Arlington Ave,Mail Stop 1008, Toledo, OH 43614 USA.	xiaodong.wang@utoledo.edu	Giovannucci, David R/A-5657-2018	/0000-0002-4730-6918	Cystic Fibrosis Foundation; University of Toledo Health Science Campus; National Institutes of Health [DE14756, DK68196]; NATIONAL INSTITUTE OF DENTAL & CRANIOFACIAL RESEARCH [R01DE014756] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DENTAL &CRANIOFACIAL RESEARCH [R56DE014756] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK068196] Funding Source: NIH RePORTER	Cystic Fibrosis Foundation(Italian Cystic Fibrosis Research Foundation); University of Toledo Health Science Campus; National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF DENTAL & CRANIOFACIAL RESEARCH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Dental & Craniofacial Research (NIDCR)); NATIONAL INSTITUTE OF DENTAL &CRANIOFACIAL RESEARCH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Dental & Craniofacial Research (NIDCR)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	This work was primarily supported by the Cystic Fibrosis Foundation and the University of Toledo Health Science Campus (both to X. W.). This work was also supported in part by National Institutes of Health Grants DE14756 (to D. R. G.) and DK68196 (to R. A. F.).	Albanese V, 2006, CELL, V124, P75, DOI 10.1016/j.cell.2005.11.039; Alberti S, 2004, MOL BIOL CELL, V15, P4003, DOI 10.1091/mbc.E04-04-0293; Aridor M, 2000, TRAFFIC, V1, P836, DOI 10.1034/j.1600-0854.2000.011104.x; Arndt V, 2005, MOL BIOL CELL, V16, P5891, DOI 10.1091/mbc.E05-07-0660; Ballinger CA, 1999, MOL CELL BIOL, V19, P4535; Banasavadi-Siddegowda YK, 2011, J BIOL CHEM, V286, P43071, DOI 10.1074/jbc.M111.269993; Carlile GW, 2007, CHEMBIOCHEM, V8, P1012, DOI 10.1002/cbic.200700027; Cebotaru L, 2008, J BIOL CHEM, V283, P21926, DOI 10.1074/jbc.M709156200; CHAPPELL TG, 1986, CELL, V45, P3, DOI 10.1016/0092-8674(86)90532-5; CHENG SH, 1990, CELL, V63, P827, DOI 10.1016/0092-8674(90)90148-8; Choo-Kang LR, 2001, AM J PHYSIOL-LUNG C, V281, pL58, DOI 10.1152/ajplung.2001.281.1.L58; Clain J, 2005, HUM MUTAT, V25, P360, DOI 10.1002/humu.20156; Clancy JP, 2012, THORAX, V67, P12, DOI 10.1136/thoraxjnl-2011-200393; Connell P, 2001, NAT CELL BIOL, V3, P93, DOI 10.1038/35050618; Cormet-Boyaka E, 2004, P NATL ACAD SCI USA, V101, P8221, DOI 10.1073/pnas.0400459101; DENNING GM, 1992, NATURE, V358, P761, DOI 10.1038/358761a0; Dragovic Z, 2006, EMBO J, V25, P2519, DOI 10.1038/sj.emboj.7601138; Du K, 2005, NAT STRUCT MOL BIOL, V12, P17, DOI 10.1038/nsmb882; Du K, 2009, MOL BIOL CELL, V20, P1903, DOI 10.1091/mbc.E08-09-0950; Farinha CM, 2002, BIOCHEM J, V366, P797, DOI 10.1042/BJ20011717; Goeckeler JL, 2002, MOL BIOL CELL, V13, P2760, DOI 10.1091/mbc.02-04-0051; Grove DE, 2011, MOL BIOL CELL, V22, P301, DOI 10.1091/mbc.E10-09-0760; Hatayama T, 1998, BIOCHEM BIOPH RES CO, V248, P395, DOI 10.1006/bbrc.1998.8979; He LH, 2010, FASEB J, V24, P3103, DOI 10.1096/fj.09-141788; Henderson MJ, 2010, J BIOL CHEM, V285, P11314, DOI 10.1074/jbc.M109.044057; Hrizo SL, 2007, J BIOL CHEM, V282, P32665, DOI 10.1074/jbc.M705216200; Hutt DM, 2010, NAT CHEM BIOL, V6, P25, DOI [10.1038/NCHEMBIO.275, 10.1038/nchembio.275]; JENSEN TJ, 1995, CELL, V83, P129, DOI 10.1016/0092-8674(95)90241-4; LEEYOON D, 1995, J BIOL CHEM, V270, P15725, DOI 10.1074/jbc.270.26.15725; Liu XD, 1999, J BIOL CHEM, V274, P26654, DOI 10.1074/jbc.274.38.26654; Loo MA, 1998, EMBO J, V17, P6879, DOI 10.1093/emboj/17.23.6879; LUKACS GL, 1994, EMBO J, V13, P6076, DOI 10.1002/j.1460-2075.1994.tb06954.x; LUKACS GL, 1993, J BIOL CHEM, V268, P21592; Mandal AK, 2010, MOL BIOL CELL, V21, P1439, DOI 10.1091/mbc.E09-09-0779; Marozkina NV, 2010, P NATL ACAD SCI USA, V107, P11393, DOI 10.1073/pnas.0909128107; Meacham GC, 1999, EMBO J, V18, P1492, DOI 10.1093/emboj/18.6.1492; Meacham GC, 2001, NAT CELL BIOL, V3, P100, DOI 10.1038/35050509; Munkonge Felix, 2004, J Cyst Fibros, V3 Suppl 2, P171, DOI 10.1016/j.jcf.2004.05.036; Oberdorf J, 2005, J BIOL CHEM, V280, P38193, DOI 10.1074/jbc.M504200200; Oh HJ, 1999, J BIOL CHEM, V274, P15712, DOI 10.1074/jbc.274.22.15712; Oh HJ, 1997, J BIOL CHEM, V272, P31636, DOI 10.1074/jbc.272.50.31636; Okiyoneda T, 2010, SCIENCE, V329, P805, DOI 10.1126/science.1191542; Ostedgaard LS, 1999, J CELL SCI, V112, P2091; Pedemonte N, 2005, J CLIN INVEST, V115, P2564, DOI 10.1172/JCI24898; Raviol H, 2006, EMBO J, V25, P2510, DOI 10.1038/sj.emboj.7601139; RIORDAN JR, 1989, SCIENCE, V245, P1066; Roy G, 2010, MOL BIOL CELL, V21, P597, DOI 10.1091/mbc.E09-05-0427; Rubenstein RC, 1997, J CLIN INVEST, V100, P2457, DOI 10.1172/JCI119788; SCHMID SL, 1985, J BIOL CHEM, V260, P10050; Schuermann JP, 2008, MOL CELL, V31, P232, DOI 10.1016/j.molcel.2008.05.006; Seibert FS, 1997, BIOCHEMISTRY-US, V36, P11966, DOI 10.1021/bi9712652; Seibert FS, 1996, J BIOL CHEM, V271, P15139, DOI 10.1074/jbc.271.25.15139; Shaner L, 2004, J BIOL CHEM, V279, P21992, DOI 10.1074/jbc.M313739200; Shaner L, 2005, J BIOL CHEM, V280, P41262, DOI 10.1074/jbc.M503614200; Silvis MR, 2003, J BIOL CHEM, V278, P11554, DOI 10.1074/jbc.M212843200; Singh OV, 2008, MOL CELL PROTEOMICS, V7, P1099, DOI 10.1074/mcp.M700303-MCP200; SMIT LS, 1995, HUM MOL GENET, V4, P269, DOI 10.1093/hmg/4.2.269; Stothard P, 2000, BIOTECHNIQUES, V28, P1102, DOI 10.2144/00286ir01; Sun F, 2008, FASEB J, V22, P3255, DOI 10.1096/fj.07-105338; Sun F, 2006, J BIOL CHEM, V281, P36856, DOI 10.1074/jbc.M607085200; Swiatecka-Urban A, 2005, J BIOL CHEM, V280, P36762, DOI 10.1074/jbc.M508944200; Van Goor F, 2006, AM J PHYSIOL-LUNG C, V290, pL1117, DOI 10.1152/ajplung.00169.2005; Van Goor F, 2011, P NATL ACAD SCI USA, V108, P18843, DOI 10.1073/pnas.1105787108; Vankeerberghen A, 1998, HUM MOL GENET, V7, P1761, DOI 10.1093/hmg/7.11.1761; Vij N, 2006, J BIOL CHEM, V281, P17369, DOI 10.1074/jbc.M600509200; Wang XD, 2004, J CELL BIOL, V167, P65, DOI 10.1083/jcb.200401035; Wang XD, 2008, TRAFFIC, V9, P1878, DOI 10.1111/j.1600-0854.2008.00806.x; Wang XD, 2006, CELL, V127, P803, DOI 10.1016/j.cell.2006.09.043; WARD CL, 1995, CELL, V83, P121, DOI 10.1016/0092-8674(95)90240-6; Yam AYW, 2005, J BIOL CHEM, V280, P41252, DOI 10.1074/jbc.M503615200; Yamagishi N, 2004, J BIOL CHEM, V279, P41727, DOI 10.1074/jbc.M407947200; Yamagishi N, 2010, EXP CELL RES, V316, P2424, DOI 10.1016/j.yexcr.2010.06.003; YANG YP, 1993, P NATL ACAD SCI USA, V90, P9480, DOI 10.1073/pnas.90.20.9480; YASUDA K, 1995, J BIOL CHEM, V270, P29718, DOI 10.1074/jbc.270.50.29718; Younger JM, 2006, CELL, V126, P571, DOI 10.1016/j.cell.2006.06.041; Zaman K, 2006, MOL PHARMACOL, V70, P1435, DOI 10.1124/mol.106.023242; ZEITLIN PL, 1991, AM J RESP CELL MOL, V4, P313, DOI 10.1165/ajrcmb/4.4.313; Zhang F, 1998, NAT STRUCT BIOL, V5, P180, DOI 10.1038/nsb0398-180; Zhang H, 2006, J BIOL CHEM, V281, P11312, DOI 10.1074/jbc.M512013200; Zhou ZF, 1998, J BIOL CHEM, V273, P21061, DOI 10.1074/jbc.273.33.21061	80	33	33	0	5	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JUN 1	2012	287	23					19158	19170		10.1074/jbc.M111.297580	http://dx.doi.org/10.1074/jbc.M111.297580			13	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	974EF	22505710	hybrid, Green Published			2022-12-25	WOS:000306411900026
J	Chen, YJ; Hsieh, MY; Chang, MY; Chen, HC; Jan, MS; Maa, MC; Leu, TH				Chen, Yen-Jen; Hsieh, Ming-Yu; Chang, Miao Ying; Chen, Hui-Chen; Jan, Ming-Shiou; Maa, Ming-Chei; Leu, Tzeng-Horng			Eps8 Protein Facilitates Phagocytosis by Increasing TLR4-MyD88 Protein Interaction in Lipopolysaccharide-stimulated Macrophages	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							TOLL-LIKE RECEPTORS; SRC-MEDIATED TRANSFORMATION; FOCAL ADHESION KINASE; NITRIC-OXIDE; C-SRC; ACTIVATION; EXPRESSION; RAC; INVOLVEMENT; IMMUNITY	Toll-like receptors (TLRs) are crucial in macrophage phagocytosis, which is pivotal in host innate immune response. However, the detailed mechanism is not fully defined. Here, we demonstrated that the induction of Src and Eps8 in LPS-treated macrophages was TLR4- and MyD88-dependent, and their attenuation reduced LPS-promoted phagocytosis. Confocal microscopy indicated the colocalization of Eps8 and TLR4 in the cytosol and at the phagosome. Consistently, both Eps8 and TLR4 were present in the same immunocomplex regard-less of LPS stimulation. Inhibition of this complex formation by eps8 siRNA or overexpression of pleckstrin homology domain-truncated Eps8 (i.e. 261-p97(Eps8)) decreased LPS-induced TLR4-MyD88 interaction and the following activation of Src, focal adhesion kinase, and p38 MAPK. Importantly, attenuation of Eps8 impaired the bacterium-killing ability of macrophages. Thus, Eps8 is a key regulator of the LPS-stimulated TLR4-MyD88 interaction and contributes to macrophage phagocytosis.	[Chen, Hui-Chen; Maa, Ming-Chei] China Med Univ, Grad Inst Basic Med Sci, Taichung 40402, Taiwan; [Chen, Yen-Jen; Hsieh, Ming-Yu; Leu, Tzeng-Horng] Natl Cheng Kung Univ, Inst Basic Med Sci, Tainan 70101, Taiwan; [Chen, Yen-Jen; Hsieh, Ming-Yu; Leu, Tzeng-Horng] Natl Cheng Kung Univ, Coll Med, Dept Pharmacol, Tainan 70101, Taiwan; [Leu, Tzeng-Horng] Natl Cheng Kung Univ, Ctr Infect Dis & Signaling Res, Tainan 70101, Taiwan; [Chang, Miao Ying] China Med Univ Hosp, Dept Med Res, Taichung 40402, Taiwan; [Maa, Ming-Chei] China Med Univ, Inst Mol Syst Biomed, Taichung 40402, Taiwan; [Jan, Ming-Shiou] Chung Shan Med Univ, Coll Med, Inst Microbiol & Immunol, Taichung 40201, Taiwan	China Medical University Taiwan; National Cheng Kung University; National Cheng Kung University; National Cheng Kung University; China Medical University Taiwan; China Medical University Hospital - Taiwan; China Medical University Taiwan; Chung Shan Medical University	Maa, MC (corresponding author), China Med Univ, Grad Inst Basic Med Sci, Taichung 40402, Taiwan.	mcmaa@mail.cmu.edu.tw; tzengleu@mail.ncku.edu.tw	Chen, Hui-Chen/L-8149-2013	Chen, Hui-Chen/0000-0001-9751-5729	National Health Research Institute [NHRI-EX101-10131BI]; National Science Council [NSC100-2325-B-006-011, NSC98-2311-B-039-002-MY3]; Comprehensive Cancer Center in Southern Taiwan [DOH100-TD-C-111-003]; Taiwan Department of Health Clinical Trial and Research Center of Excellence [DOH101-TD-B-111-004]; China Medical University [CMU97-193]; National Research Program for Genomic Medicine, National Science Council [NSC94-3112-B-001-003, NSC94-3112-B-001-018-Y]	National Health Research Institute(National Health Research Institutes - Taiwan); National Science Council(Ministry of Science and Technology, Taiwan); Comprehensive Cancer Center in Southern Taiwan; Taiwan Department of Health Clinical Trial and Research Center of Excellence; China Medical University(China Medical University); National Research Program for Genomic Medicine, National Science Council(Ministry of Science and Technology, Taiwan)	This work was supported in part by National Health Research Institute Grant NHRI-EX101-10131BI (to T.-H. L.); National Science Council Grants NSC100-2325-B-006-011 (to T.-H. L.) and NSC98-2311-B-039-002-MY3 (to M.-C. M.); Comprehensive Cancer Center in Southern Taiwan Grant DOH100-TD-C-111-003 (to T.-H. L.), Taiwan Department of Health Clinical Trial and Research Center of Excellence Grant DOH101-TD-B-111-004 (to M.-C. M.), and China Medical University Grant CMU97-193 (to M.-C. M.).; We thank Dr. C. H. A. Cheung for critical comments on the manuscript. The lentivirus encoding luciferase siRNA or eps8 siRNA-503 and the DNA constructs of pLKO.1-shLuc, pLKO.1-meps8-503, pLKO.1-meps8-1847, pLKO.1-mfak-1, pLKO.1-mfak-2, pLKO.1-mmyd88-1, and pLKO.1-mmyd88-2 were provided by the National RNAi Core Facility located at the Institute of Molecular Biology/Genomic Research Center, Academia Sinica, supported by National Research Program for Genomic Medicine, National Science Council Grants NSC94-3112-B-001-003 and NSC94-3112-B-001-018-Y.	Abou Kheir W, 2005, J CELL SCI, V118, P5369, DOI 10.1242/jcs.02638; Abou-Kheir W, 2008, J CELL SCI, V121, P379, DOI 10.1242/jcs.010272; Aderem A, 1999, ANNU REV IMMUNOL, V17, P593, DOI 10.1146/annurev.immunol.17.1.593; ALLEN LAH, 1995, J EXP MED, V182, P829, DOI 10.1084/jem.182.3.829; Beutler B, 2002, CURR OPIN HEMATOL, V9, P2, DOI 10.1097/00062752-200201000-00002; Blander JM, 2004, SCIENCE, V304, P1014, DOI 10.1126/science.1096158; BROWN EJ, 1995, BIOESSAYS, V17, P109, DOI 10.1002/bies.950170206; Chen YJ, 2008, MOL CANCER THER, V7, P1376, DOI 10.1158/1535-7163.MCT-07-2388; Cote-Velez MJA, 2001, IMMUNOL LETT, V78, P189, DOI 10.1016/S0165-2478(01)00251-6; Croce A, 2004, NAT CELL BIOL, V6, P1173, DOI 10.1038/ncb1198; Defilippi P, 2006, TRENDS CELL BIOL, V16, P257, DOI 10.1016/j.tcb.2006.03.003; Di Fiore PP, 2002, INT J BIOCHEM CELL B, V34, P1178, DOI 10.1016/S1357-2725(02)00064-X; Disanza A, 2004, NAT CELL BIOL, V6, P1180, DOI 10.1038/ncb1199; Doyle SE, 2004, J EXP MED, V199, P81, DOI 10.1084/jem.20031237; Duong LT, 2001, J BIOL CHEM, V276, P7484, DOI 10.1074/jbc.M008368200; FAZIOLI F, 1993, EMBO J, V12, P3799, DOI 10.1002/j.1460-2075.1993.tb06058.x; Finnemann SC, 2003, EMBO J, V22, P4143, DOI 10.1093/emboj/cdg416; Frittoli E, 2011, IMMUNITY, V35, P388, DOI 10.1016/j.immuni.2011.07.007; Funato Y, 2004, CANCER RES, V64, P5237, DOI 10.1158/0008-5472.CAN-04-0327; Gillespie JP, 1997, ANNU REV ENTOMOL, V42, P611, DOI 10.1146/annurev.ento.42.1.611; Greenberg S, 2002, CURR OPIN IMMUNOL, V14, P136, DOI 10.1016/S0952-7915(01)00309-0; Jones GE, 2002, INT J BIOCHEM CELL B, V34, P806, DOI 10.1016/S1357-2725(01)00162-5; Kawai T, 2009, INT IMMUNOL, V21, P317, DOI 10.1093/intimm/dxp017; Kong L, 2008, CELL RES, V18, P745, DOI 10.1038/cr.2008.65; Lakkakorpi PT, 2003, J BIOL CHEM, V278, P11502, DOI 10.1074/jbc.M206579200; Leu TH, 2006, MOL IMMUNOL, V43, P308, DOI 10.1016/j.molimm.2005.03.015; Leu TH, 2004, J BIOL CHEM, V279, P9875, DOI 10.1074/jbc.M309884200; Liu PS, 2010, ONCOGENE, V29, P3977, DOI 10.1038/onc.2010.144; Maa MC, 1998, BIOCHEM BIOPH RES CO, V251, P344, DOI 10.1006/bbrc.1998.9464; Maa MC, 1999, BBA-MOL CELL RES, V1450, P341, DOI 10.1016/S0167-4889(99)00069-5; Maa MC, 2001, ONCOGENE, V20, P106, DOI 10.1038/sj.onc.1204069; Maa MC, 2008, J BIOL CHEM, V283, P31408, DOI 10.1074/jbc.M801158200; Maa MC, 2007, J BIOL CHEM, V282, P19399, DOI 10.1074/jbc.M610280200; Maa MC, 2011, BBA-MOL CELL RES, V1813, P136, DOI 10.1016/j.bbamcr.2010.09.004; Massol P, 1998, EMBO J, V17, P6219, DOI 10.1093/emboj/17.21.6219; May RC, 2000, NAT CELL BIOL, V2, P246, DOI 10.1038/35008673; Metheniti A, 2001, FEBS LETT, V496, P55, DOI 10.1016/S0014-5793(01)02405-X; Owen KA, 2007, CELL MICROBIOL, V9, P596, DOI 10.1111/j.1462-5822.2006.00811.x; Poltorak A, 1998, SCIENCE, V282, P2085, DOI 10.1126/science.282.5396.2085; Schnare M, 2001, NAT IMMUNOL, V2, P947, DOI 10.1038/ni712; Scita G, 1999, NATURE, V401, P290, DOI 10.1038/45822; Scita G, 2001, J CELL BIOL, V154, P1031, DOI 10.1083/jcb.200103146; Takenawa T, 2007, NAT REV MOL CELL BIO, V8, P37, DOI 10.1038/nrm2069; Takeuchi O, 2010, CELL, V140, P805, DOI 10.1016/j.cell.2010.01.022; Underhill DM, 2004, MICROBES INFECT, V6, P1368, DOI 10.1016/j.micinf.2004.08.016; Underhill DM, 2002, ANNU REV IMMUNOL, V20, P825, DOI 10.1146/annurev.immunol.20.103001.114744; Watters TM, 2007, IMMUNOL CELL BIOL, V85, P411, DOI 10.1038/sj.icb.7100095; Wiedemann A, 2001, CELL MICROBIOL, V3, P693, DOI 10.1046/j.1462-5822.2001.00149.x; Xi CX, 2010, J LEUKOCYTE BIOL, V87, P415, DOI 10.1189/jlb.0309125	49	35	36	2	5	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAY 25	2012	287	22					18806	18819		10.1074/jbc.M112.340935	http://dx.doi.org/10.1074/jbc.M112.340935			14	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	974EC	22493489	hybrid, Green Published			2022-12-25	WOS:000306411600089
J	Monet, M; Francoeur, N; Boulay, G				Monet, Michael; Francoeur, Nancy; Boulay, Guylain			Involvement of Phosphoinositide 3-Kinase and PTEN Protein in Mechanism of Activation of TRPC6 Protein in Vascular Smooth Muscle Cells	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							PULMONARY ARTERIAL-HYPERTENSION; PLASMA-MEMBRANE; CALCIUM-ENTRY; INTRACELLULAR TRAFFICKING; CHANNEL ACTIVATION; TUMOR-SUPPRESSOR; PROSTATE-CANCER; CA2+ ENTRY; RECEPTOR; PATHWAY	TRPC6 is a cation channel in the plasma membrane that plays a role in Ca2+ entry after the stimulation of a G(q)-protein-coupled or tyrosine-kinase receptor. TRPC6 translocates to the plasma membrane upon stimulation and remains there as long as the stimulus is present. However, the mechanism that regulates the trafficking and activation of TRPC6 are unclear. In this study we showed phosphoinositide 3-kinase and its antagonistic phosphatase, PTEN, are involved in the activation of TRPC6. The inhibition of PI3K by PIK-93, LY294002, or wortmannin decreased carbachol-induced translocation of TRPC6 to the plasma membrane and carbachol-induced net Ca2+ entry into T6.11 cells. Conversely, a reduction of PTEN expression did not affect carbachol-induced externalization of TRPC6 but increased Ca2+ entry through TRPC6 in T6.11 cells. We also showed that the PI3K/PTEN pathway regulates vasopressin-induced translocation of TRPC6 to the plasma membrane and vasopressin-induced Ca2+ entry into A7r5 cells, which endogenously express TRPC6. In summary, we provided evidence that the PI3K/PTEN pathway plays an important role in the translocation of TRPC6 to the plasma membrane and may thus have a significant impact on Ca2+ signaling in cells that endogenously express TRPC6.	[Monet, Michael; Francoeur, Nancy; Boulay, Guylain] Univ Sherbrooke, Fac Med & Hlth Sci, Dept Pharmacol, Sherbrooke, PQ J1H 5N4, Canada	University of Sherbrooke	Boulay, G (corresponding author), Univ Sherbrooke, Fac Med & Hlth Sci, Dept Pharmacol, 3001-12E Ave Nord, Sherbrooke, PQ J1H 5N4, Canada.	Guylain.Boulay@USherbrooke.ca	Boulay, Guylain/D-9773-2010	MONET, Michael/0000-0002-7864-862X	Canadian Institutes of Health Research; Natural Sciences and Engineering Research Council of Canada; Quebec Heart and Stroke Foundation; Centre de Recherche en Pharmacologie Structurale de l'Universite de Sherbrooke; Institut de Pharmacologie de Sherbrooke; Fonds de Recherche en Sante du Quebec	Canadian Institutes of Health Research(Canadian Institutes of Health Research (CIHR)); Natural Sciences and Engineering Research Council of Canada(Natural Sciences and Engineering Research Council of Canada (NSERC)CGIAR); Quebec Heart and Stroke Foundation; Centre de Recherche en Pharmacologie Structurale de l'Universite de Sherbrooke; Institut de Pharmacologie de Sherbrooke; Fonds de Recherche en Sante du Quebec(Fonds de la Recherche en Sante du Quebec)	This work was supported by grants from the Canadian Institutes of Health Research, the Natural Sciences and Engineering Research Council of Canada, and the Quebec Heart and Stroke Foundation.; Recipient of a fellowship from the Centre de Recherche en Pharmacologie Structurale de l'Universite de Sherbrooke and the Institut de Pharmacologie de Sherbrooke.; Recipient of a scholarship from the Fonds de Recherche en Sante du Quebec.	Albert AP, 2008, J PHYSIOL-LONDON, V586, P3087, DOI 10.1113/jphysiol.2008.153676; Andrews S., 2007, SCI STKE 2007; Balla A, 2006, TRENDS CELL BIOL, V16, P351, DOI 10.1016/j.tcb.2006.05.003; Balla A, 2008, MOL BIOL CELL, V19, P711, DOI 10.1091/mbc.E07-07-0713; Berridge MJ, 2000, NAT REV MOL CELL BIO, V1, P11, DOI 10.1038/35036035; BERRIDGE MJ, 1986, J EXP BIOL, V124, P323; Berridge MJ, 1998, NATURE, V395, P645, DOI 10.1038/27094; Bezzerides VJ, 2004, NAT CELL BIOL, V6, P709, DOI 10.1038/ncb1150; Bohnacker T, 2009, SCI SIGNAL, V2, DOI 10.1126/scisignal.2000259; Bousquet SM, 2010, J BIOL CHEM, V285, P40534, DOI 10.1074/jbc.M110.160051; Brooks CL, 2011, FEBS LETT, V585, P2803, DOI 10.1016/j.febslet.2011.05.022; Cantley LC, 1999, P NATL ACAD SCI USA, V96, P4240, DOI 10.1073/pnas.96.8.4240; Cayouette S, 2007, CELL CALCIUM, V42, P225, DOI 10.1016/j.ceca.2007.01.014; Cayouette S, 2010, BBA-MOL CELL RES, V1803, P805, DOI 10.1016/j.bbamcr.2010.03.010; Dewitt S, 2006, J CELL SCI, V119, P443, DOI 10.1242/jcs.02756; Dominguez V, 2011, J BIOL CHEM, V286, P4216, DOI 10.1074/jbc.M110.200295; Downing GJ, 1996, BIOCHEMISTRY-US, V35, P3587, DOI 10.1021/bi9517493; El Boustany C, 2008, HEPATOLOGY, V47, P2068, DOI 10.1002/hep.22263; Elsasser S, 2005, NAT CELL BIOL, V7, P742, DOI 10.1038/ncb0805-742; Gottlieb TM, 2002, ONCOGENE, V21, P1299, DOI 10.1038/sj.onc.1205181; Gradilone SA, 2005, BIOL CELL, V97, P831, DOI 10.1042/BC20040115; GRYNKIEWICZ G, 1985, J BIOL CHEM, V260, P3440; Helms MN, 2005, J BIOL CHEM, V280, P40885, DOI 10.1074/jbc.M509646200; Jung S, 2002, AM J PHYSIOL-CELL PH, V282, pC347, DOI 10.1152/ajpcell.00283.2001; Katso R, 2001, ANNU REV CELL DEV BI, V17, P615, DOI 10.1146/annurev.cellbio.17.1.615; Kawanabe Y, 2003, AM J PHYSIOL-CELL PH, V284, pC506, DOI 10.1152/ajpcell.00384.2002; Kini V, 2010, J BIOL CHEM, V285, P33082, DOI 10.1074/jbc.M110.142034; Knight ZA, 2006, CELL, V125, P733, DOI 10.1016/j.cell.2006.03.035; Kwon Y, 2007, MOL CELL, V25, P491, DOI 10.1016/j.molcel.2007.01.021; Lee JO, 1999, CELL, V99, P323, DOI 10.1016/S0092-8674(00)81663-3; Li AG, 2006, MOL CELL, V23, P575, DOI 10.1016/j.molcel.2006.06.028; Li J, 1997, SCIENCE, V275, P1943, DOI 10.1126/science.275.5308.1943; Lian LR, 2005, BLOOD, V106, P110, DOI 10.1182/blood-2004-05-2005; Lindmo K, 2006, J CELL SCI, V119, P605, DOI 10.1242/jcs.02855; Liu DY, 2008, ARTERIOSCL THROM VAS, V28, P746, DOI 10.1161/ATVBAHA.108.162222; MacDonald PE, 2009, ISLETS, V1, P266, DOI 10.4161/isl.1.3.9678; Mani BK, 2009, CELL CALCIUM, V45, P400, DOI 10.1016/j.ceca.2009.01.004; Mayo LD, 2001, P NATL ACAD SCI USA, V98, P11598, DOI 10.1073/pnas.181181198; Meunier FA, 2005, MOL BIOL CELL, V16, P4841, DOI 10.1091/mbc.E05-02-0171; Monet M, 2009, BBA-MOL CELL RES, V1793, P528, DOI 10.1016/j.bbamcr.2009.01.003; MUALLEM S, 1989, ANNU REV PHYSIOL, V51, P83; Pedersen SF, 2005, CELL CALCIUM, V38, P233, DOI 10.1016/j.ceca.2005.06.028; Pigeau GM, 2009, DIABETES, V58, P2084, DOI 10.2337/db08-1371; Reiser J, 2005, NAT GENET, V37, P739, DOI 10.1038/ng1592; Saleh SN, 2009, J PHYSIOL-LONDON, V587, P5361, DOI 10.1113/jphysiol.2009.180331; SCHU PV, 1993, SCIENCE, V260, P88, DOI 10.1126/science.8385367; Shen B, 2011, J BIOL CHEM, V286, P19439, DOI 10.1074/jbc.M110.210294; Soboloff J, 2005, J BIOL CHEM, V280, P39786, DOI 10.1074/jbc.M506064200; STEPHENS L, 1994, CELL, V77, P83, DOI 10.1016/0092-8674(94)90237-2; Stephens LR, 1997, CELL, V89, P105, DOI 10.1016/S0092-8674(00)80187-7; STOYANOV B, 1995, SCIENCE, V269, P690, DOI 10.1126/science.7624799; Taylor CW, 2002, CELL, V111, P767, DOI 10.1016/S0092-8674(02)01197-2; Tseng PH, 2004, BIOCHEMISTRY-US, V43, P11701, DOI 10.1021/bi049349f; Vanhaesebroeck B, 1999, EXP CELL RES, V253, P239, DOI 10.1006/excr.1999.4701; Vanhaesebroeck B, 2001, ANNU REV BIOCHEM, V70, P535, DOI 10.1146/annurev.biochem.70.1.535; Vazquez F, 2000, BBA-REV CANCER, V1470, pM21, DOI 10.1016/S0304-419X(99)00032-3; Vazquez G, 2004, BBA-MOL CELL RES, V1742, P21, DOI 10.1016/j.bbamcr.2004.08.015; Vecchione C, 2005, J EXP MED, V201, P1217, DOI 10.1084/jem.20040995; Viard P, 2004, NAT NEUROSCI, V7, P939, DOI 10.1038/nn1300; Vivanco I, 2002, NAT REV CANCER, V2, P489, DOI 10.1038/nrc839; Winn MP, 2005, SCIENCE, V308, P1801, DOI 10.1126/science.1106215; Wu GS, 2007, J NEUROSCI, V27, P7447, DOI 10.1523/JNEUROSCI.4266-06.2007; Yu Y, 2004, P NATL ACAD SCI USA, V101, P13861, DOI 10.1073/pnas.0405908101; Yu Y, 2009, CIRCULATION, V119, P2313, DOI 10.1161/CIRCULATIONAHA.108.782458; Zhou BHP, 2001, NAT CELL BIOL, V3, P973, DOI 10.1038/ncb1101-973; Zhu X, 1996, CELL, V85, P661, DOI 10.1016/S0092-8674(00)81233-7	66	36	37	0	5	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAY 18	2012	287	21					17672	17681		10.1074/jbc.M112.341354	http://dx.doi.org/10.1074/jbc.M112.341354			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	973PU	22493444	Green Published, hybrid			2022-12-25	WOS:000306373000066
J	Pokrishevsky, E; Grad, LI; Yousefi, M; Wang, J; Mackenzie, IR; Cashman, NR				Pokrishevsky, Edward; Grad, Leslie I.; Yousefi, Masoud; Wang, Jing; Mackenzie, Ian R.; Cashman, Neil R.			Aberrant Localization of FUS and TDP43 Is Associated with Misfolding of SOD1 in Amyotrophic Lateral Sclerosis	PLOS ONE			English	Article							FRONTOTEMPORAL LOBAR DEGENERATION; TDP-43; ALS; MUTATIONS; PROTEIN; DISEASE; RNA; MUTANTS; NEURONS; NUCLEAR	Background: Amyotrophic lateral sclerosis (ALS) is incurable and characterized by progressive paralysis of the muscles of the limbs, speech and swallowing, and respiration due to the progressive degeneration of voluntary motor neurons. Clinically indistinguishable ALS can be caused by genetic mutations of Cu/Zn superoxide dismutase (SOD1), TAR-DNA binding protein 43 (TDP43), or fused in sarcoma/translocated in liposarcoma (FUS/TLS), or can occur in the absence of known mutation as sporadic disease. In this study, we tested the hypothesis that FUS/TLS and TDP43 gain new pathogenic functions upon aberrant accumulation in the cytosol that directly or indirectly include misfolding of SOD1. Methodology/Principal Findings: Patient spinal cord necropsy immunohistochemistry with SOD1 misfolding-specific antibodies revealed misfolded SOD1 in perikarya and motor axons of SOD1-familial ALS (SOD1-FALS), and in motor axons of R521C-FUS FALS and sporadic ALS (SALS) with cytoplasmic TDP43 inclusions. SOD1 misfolding and oxidation was also detected using immunocytochemistry and quantitative immunoprecipitation of human neuroblastoma SH-SY5Y cells as well as cultured murine spinal neural cells transgenic for human wtSOD1, which were transiently transfected with human cytosolic mutant FUS or TDP43, or wtTDP43. Conclusion/Significance: We conclude that cytosolic mislocalization of FUS or TDP43 in vitro and ALS in vivo may kindle wtSOD1 misfolding in non-SOD1 FALS and SALS. The lack of immunohistochemical compartmental co-localization of misfolded SOD1 with cytosolic TDP43 or FUS suggests an indirect induction of SOD1 misfolding followed by propagation through template directed misfolding beyond its site of inception. The identification of a final common pathway in the molecular pathogenesis of ALS provides a treatment target for this devastating disease.	[Pokrishevsky, Edward; Grad, Leslie I.; Yousefi, Masoud; Wang, Jing; Cashman, Neil R.] Univ British Columbia, Brain Res Ctr, Vancouver, BC V5Z 1M9, Canada; [Mackenzie, Ian R.] Univ British Columbia, Dept Pathol & Lab Med, Vancouver, BC V5Z 1M9, Canada	University of British Columbia; University of British Columbia	Pokrishevsky, E (corresponding author), Univ British Columbia, Brain Res Ctr, Vancouver, BC V5Z 1M9, Canada.	neil.cashman@vch.ca			Allen T. Lambert Neural Research Fund; PrioNet Canada; Canadian Institutes of Health Research (CIHR) [74580]; Pacific Alzheimer Research Foundation	Allen T. Lambert Neural Research Fund; PrioNet Canada; Canadian Institutes of Health Research (CIHR)(Canadian Institutes of Health Research (CIHR)); Pacific Alzheimer Research Foundation	NRC is supported by donations from the Allen T. Lambert Neural Research Fund, as well as by grants from PrioNet Canada (http://www.prionetcanada.ca). EP receives the Frederick Banting and Charles Best Canada Graduate Award from Canadian Institutes of Health Research (CIHR) (http://www.cihr-irsc.gc.ca). IRM is supported by grants from CIHR (grant number 74580, IM) and the Pacific Alzheimer Research Foundation (IM; http://www.parf.ca). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Anderson KN, 2004, BRAIN RES PROTOC, V12, P132, DOI 10.1016/j.brainresprot.2003.10.001; Ash PEA, 2010, HUM MOL GENET, V19, P3206, DOI 10.1093/hmg/ddq230; Banci L, 2009, P NATL ACAD SCI USA, V106, P6980, DOI 10.1073/pnas.0809845106; Barmada SJ, 2010, J NEUROSCI, V30, P639, DOI 10.1523/JNEUROSCI.4988-09.2010; Bosco DA, 2010, NAT NEUROSCI, V13, P1396, DOI 10.1038/nn.2660; Bosco DA, 2010, HUM MOL GENET, V19, P4160, DOI 10.1093/hmg/ddq335; Boyault C, 2007, GENE DEV, V21, P2172, DOI 10.1101/gad.436407; Braun RJ, 2011, J BIOL CHEM, V286, P19958, DOI 10.1074/jbc.M110.194852; Cleveland DW, 1999, NEURON, V24, P515, DOI 10.1016/S0896-6273(00)81108-3; Crippa V, 2010, HUM MOL GENET, V19, P3440, DOI 10.1093/hmg/ddq257; Crow JP, 1997, J NEUROCHEM, V69, P1936; Dormann D, 2010, EMBO J, V29, P2841, DOI 10.1038/emboj.2010.143; Forsberg K, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0011552; Grad LI, 2011, P NATL ACAD SCI USA, V108, P16398, DOI 10.1073/pnas.1102645108; Guest WC, 2011, J TOXICOL ENV HEAL A, V74, P1433, DOI 10.1080/15287394.2011.618967; HUA XX, 1995, J BIOL CHEM, V270, P29422, DOI 10.1074/jbc.270.49.29422; Huang C, 2011, PLOS GENET, V7, DOI 10.1371/journal.pgen.1002011; Ilieva H, 2009, J CELL BIOL, V187, P761, DOI 10.1083/jcb.200908164; Israelson A, 2010, NEURON, V67, P575, DOI 10.1016/j.neuron.2010.07.019; Keohane C., 1999, Clinical and Experimental Pathology, V47, P125; Kim SH, 2010, J BIOL CHEM, V285, P34097, DOI 10.1074/jbc.M110.154831; Koyama S, 2006, BIOCHEM BIOPH RES CO, V343, P719, DOI 10.1016/j.bbrc.2006.02.170; Kwiatkowski TJ, 2009, SCIENCE, V323, P1205, DOI 10.1126/science.1166066; Kwong LK, 2008, NEUROSIGNALS, V16, P41, DOI 10.1159/000109758; Lagier-Tourenne C, 2010, HUM MOL GENET, V19, pR46, DOI 10.1093/hmg/ddq137; Lagier-Tourenne C, 2009, CELL, V136, P1001, DOI 10.1016/j.cell.2009.03.006; Liu-Yesucevitz L, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0013250; Mackenzie IRA, 2010, LANCET NEUROL, V9, P995, DOI 10.1016/S1474-4422(10)70195-2; Moisse K, 2009, BRAIN RES, V1249, P202, DOI 10.1016/j.brainres.2008.10.021; Munch C, 2011, P NATL ACAD SCI USA, V108, P3548, DOI 10.1073/pnas.1017275108; Munoz DG, 2010, NEUROLOGY, V75, P584, DOI 10.1212/WNL.0b013e3181ed9ee4; Neumann M, 2006, SCIENCE, V314, P130, DOI 10.1126/science.1134108; Neumann M, 2009, BRAIN, V132, P2922, DOI 10.1093/brain/awp214; Pesiridis GS, 2009, HUM MOL GENET, V18, pR156, DOI 10.1093/hmg/ddp303; PRUSINER SB, 1982, SCIENCE, V216, P136, DOI 10.1126/science.6801762; Rakhit R, 2007, NAT MED, V13, P754, DOI 10.1038/nm1559; Selkoe DJ, 2003, NATURE, V426, P900, DOI 10.1038/nature02264; Seyfried NT, 2010, MOL CELL PROTEOMICS, V9, P705, DOI 10.1074/mcp.M800390-MCP200; Vance C, 2009, SCIENCE, V323, P1208, DOI 10.1126/science.1165942; Ve Velde C., 2008, P NATL ACAD SCI USA, V105, P4022, DOI [DOI 10.1073/PNAS.0712209105, 10.1073/pnas.0712209105]; Wilson AC, 2011, INT J CLIN EXP PATHO, V4, P147; Winton MJ, 2008, J BIOL CHEM, V283, P13302, DOI 10.1074/jbc.M800342200; Xu YF, 2010, J NEUROSCI, V30, P10851, DOI 10.1523/JNEUROSCI.1630-10.2010	43	129	134	0	22	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 6	2012	7	4							e35050	10.1371/journal.pone.0035050	http://dx.doi.org/10.1371/journal.pone.0035050			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	955JA	22493728	Green Published, Green Submitted, gold			2022-12-25	WOS:000305012700070
J	Sturdivant, SK; Diaz, RJ; Cutter, GR				Sturdivant, S. Kersey; Diaz, Robert J.; Cutter, George R.			Bioturbation in a Declining Oxygen Environment, in situ Observations from Wormcam	PLOS ONE			English	Article							BEHAVIORAL-RESPONSES; RAPPAHANNOCK RIVER; DEPOSIT-FEEDERS; REACTION-RATES; SEDIMENT; HYPOXIA; DEPLETION; BAY; ADAPTATIONS; POLYCHAETA	Bioturbation, the displacement and mixing of sediment particles by fauna or flora, facilitates life supporting processes by increasing the quality of marine sediments. In the marine environment bioturbation is primarily mediated by infaunal organisms, which are susceptible to perturbations in their surrounding environment due to their sedentary life history traits. Of particular concern is hypoxia, dissolved oxygen (DO) concentrations <= 2.8 mg l(-1), a prevalent and persistent problem that affects both pelagic and benthic fauna. A benthic observing system (Wormcam) consisting of a buoy, telemetering electronics, sediment profile camera, and water quality datasonde was developed and deployed in the Rappahannock River, VA, USA, in an area known to experience seasonal hypoxia from early spring to late fall. Wormcam transmitted a time series of in situ images and water quality data, to a website via wireless internet modem, for 5 months spanning normoxic and hypoxic periods. Hypoxia was found to significantly reduce bioturbation through reductions in burrow lengths, burrow production, and burrowing depth. Although infaunal activity was greatly reduced during hypoxic and near anoxic conditions, some individuals remained active. Low concentrations of DO in the water column limited bioturbation by infaunal burrowers and likely reduced redox cycling between aerobic and anaerobic states. This study emphasizes the importance of in situ observations for understanding how components of an ecosystem respond to hypoxia.	[Sturdivant, S. Kersey; Diaz, Robert J.] Coll William & Mary, Virginia Inst Marine Sci, Gloucester Pt, VA USA; [Sturdivant, S. Kersey] NOAA, Cordell Bank Natl Marine Sanctuaries Program, Point Reyes Stn, CA USA; [Cutter, George R.] NOAA, SW Fisheries Sci Ctr, La Jolla, CA USA	William & Mary; Virginia Institute of Marine Science; National Oceanic Atmospheric Admin (NOAA) - USA; National Oceanic Atmospheric Admin (NOAA) - USA	Sturdivant, SK (corresponding author), Coll William & Mary, Virginia Inst Marine Sci, Gloucester Pt, VA USA.	kersey.sturdivant@noaa.gov			National Science Foundation [0536572]; National Oceanic and Atmospheric Administration [NA05NOS4781202]	National Science Foundation(National Science Foundation (NSF)); National Oceanic and Atmospheric Administration(National Oceanic Atmospheric Admin (NOAA) - USA)	Supported in part by funding from National Science Foundation award 0536572 and National Oceanic and Atmospheric Administration Coastal Hypoxia Research Program grant NA05NOS4781202. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript. No additional external funding received for this study.	Aller RC, 1998, J MAR RES, V56, P905, DOI 10.1357/002224098321667413; ALLER RC, 1994, CHEM GEOL, V114, P331, DOI 10.1016/0009-2541(94)90062-0; ALLER RC, 1985, J MAR RES, V43, P615, DOI 10.1357/002224085788440349; ALLER RC, 1978, AM J SCI, V278, P1185, DOI 10.2475/ajs.278.9.1185; Andersen Frede Ostergaard, 1991, V63, P69; BAGARINAO T, 1992, AQUAT TOXICOL, V24, P21, DOI 10.1016/0166-445X(92)90015-F; Bartolomaeus Thomas, 1994, Microfauna Marina, V9, P171; Bernhard JM, 2000, NATURE, V403, P77, DOI 10.1038/47476; Childress JJ, 1998, J EXP BIOL, V201, P1223; DABORN GR, 1993, LIMNOL OCEANOGR, V38, P225; DAUER DM, 1985, MAR BIOL, V85, P143, DOI 10.1007/BF00397433; de Deckere EMGT, 2001, ESTUAR COAST SHELF S, V53, P665, DOI 10.1006/ecss.2001.0811; Diaz RJ, 1995, OCEANOGR MAR BIOL, V33, P245; Diaz RJ, 2001, BEL BAR LIB, P19; Diaz RJ, 2008, SCIENCE, V321, P926, DOI 10.1126/science.1156401; Dorgan KM, 2006, OCEANOGR MAR BIOL, V44, P85; FENCHEL T, 1969, Ophelia, V6, P1; Francois F, 2002, MAR ECOL PROG SER, V229, P127, DOI 10.3354/meps229127; Furukawa Y, 2001, J MAR RES, V59, P417, DOI 10.1357/002224001762842262; GILBERT F, 1994, CHEMOSPHERE, V29, P1, DOI 10.1016/0045-6535(94)90084-1; Gonzalez RR, 2000, ESTUAR COAST SHELF S, V51, P507, DOI 10.1006/ecss.2000.0693; Graco M, 2001, LIMNOL OCEANOGR, V46, P821, DOI 10.4319/lo.2001.46.4.0821; GRAF G, 1992, OCEANOGR MAR BIOL, V30, P149; GUINASSO NL, 1975, J GEOPHYS RES-OC ATM, V80, P3032, DOI 10.1029/JC080i021p03032; JORGENSEN BB, 1974, MAR BIOL, V24, P189, DOI 10.1007/BF00391893; JORGENSEN BB, 1980, OIKOS, V34, P68, DOI 10.2307/3544551; KUO AY, 1987, ESTUARIES, V10, P277, DOI 10.2307/1351884; Lamont PA, 2000, DEEP-SEA RES PT II, V47, P9, DOI 10.1016/S0967-0645(99)00102-2; Levin LA, 2003, OCEANOGR MAR BIOL, V41, P1; LLANSO RJ, 1992, ESTUAR COAST SHELF S, V35, P491, DOI 10.1016/S0272-7714(05)80027-7; Lohrer AM, 2004, NATURE, V431, P1092, DOI 10.1038/nature03042; MANGUM C, 1970, AM SCI, V58, P641; Meysman FJR, 2006, TRENDS ECOL EVOL, V21, P688, DOI 10.1016/j.tree.2006.08.002; NELSON DC, 1986, APPL ENVIRON MICROB, V52, P225, DOI 10.1128/AEM.52.2.225-233.1986; Nilsson HC, 2000, MAR ECOL PROG SER, V197, P139, DOI 10.3354/meps197139; Park KO, 1996, ESTUAR COAST SHELF S, V42, P563, DOI 10.1006/ecss.1996.0037; Pearson T.H., 1978, Oceanography and Marine Biology an Annual Review, V16, P229; RHOADS DC, 1971, LIMNOL OCEANOGR, V16, P110, DOI 10.4319/lo.1971.16.1.0110; Rhodes D., 1982, ANIMAL SEDIMENT RELA, P3, DOI DOI 10.1007/978-1-4757-1317-6; Riedel B, 2008, J EXP MAR BIOL ECOL, V367, P17, DOI 10.1016/j.jembe.2008.08.007; Rosenberg R, 2001, SCI MAR, V65, P107, DOI 10.3989/scimar.2001.65s2107; ROSENBERG R, 1991, MAR ECOL PROG SER, V79, P127, DOI 10.3354/meps079127; Rowden AA, 1998, CONT SHELF RES, V18, P1365, DOI 10.1016/S0278-4343(98)00048-X; Skipper M, 2010, NATURE, V465, P703, DOI 10.1038/465703a; SNELGROVE PVR, 1994, OCEANOGR MAR BIOL, V32, P111; Solan M, 2002, MAR ECOL PROG SER, V228, P179, DOI 10.3354/meps228179; THEEDE H, 1973, Netherlands Journal of Sea Research, V7, P244, DOI 10.1016/0077-7579(73)90048-3; Tyson RV, 1991, MODERN ANCIENT CONTI, P27; Van ENGEL W. A., 1958, COMMERCIAL FISH REV, V20, P6; Vaquer-Sunyer R, 2008, P NATL ACAD SCI USA, V105, P15452, DOI 10.1073/pnas.0803833105; Vinebrooke RD, 2004, OIKOS, V104, P451, DOI 10.1111/j.0030-1299.2004.13255.x; VISMANN B, 1990, MAR ECOL PROG SER, V59, P229, DOI 10.3354/meps059229; WEIGELT M, 1986, MEERESFORSCHUNG, V31, P124; WENNER C A, 1975, Chesapeake Science, V16, P62, DOI 10.2307/1351085	54	48	50	1	45	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 6	2012	7	4							e34539	10.1371/journal.pone.0034539	http://dx.doi.org/10.1371/journal.pone.0034539			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	955JA	22493701	Green Submitted, Green Published, gold			2022-12-25	WOS:000305012700043
J	Taylor, JE; Swiderska, A; Artero, JB; Callow, P; Kneale, G				Taylor, James E.; Swiderska, Anna; Artero, Jean-Baptiste; Callow, Philip; Kneale, Geoff			Structural and Functional Analysis of the Symmetrical Type I Restriction Endonuclease R.EcoR124I(NT)	PLOS ONE			English	Article							DNA METHYLTRANSFERASE; MODIFICATION ENZYME; MODIFICATION METHYLASE; SCATTERING DATA; HSDR SUBUNIT; SYSTEMS; TRANSLOCATION; ORGANIZATION; RECOGNITION; EXPRESSION	Type I restriction-modification (RM) systems are comprised of two multi-subunit enzymes, the methyltransferase (similar to 160 kDa), responsible for methylation of DNA, and the restriction endonuclease (similar to 400 kDa), responsible for DNA cleavage. Both enzymes share a number of subunits. An engineered RM system, EcoR124I(NT), based on the N-terminal domain of the specificity subunit of EcoR124I was constructed that recognises the symmetrical sequence GAAN(7)TTC and is active as a methyltransferase. Here, we investigate the restriction endonuclease activity of R.EcoR124I(NT) in vitro and the subunit assembly of the multi-subunit enzyme. Finally, using small-angle neutron scattering and selective deuteration, we present a low-resolution structural model of the endonuclease and locate the motor subunits within the multi-subunit enzyme. We show that the covalent linkage between the two target recognition domains of the specificity subunit is not required for subunit assembly or enzyme activity, and discuss the implications for the evolution of Type I enzymes.	[Taylor, James E.; Swiderska, Anna; Kneale, Geoff] Univ Portsmouth, Inst Biomed & Biomol Sci, Portsmouth, Hants, England; [Artero, Jean-Baptiste; Callow, Philip] Inst Max Von Laue Paul Langevin, F-38042 Grenoble, France; [Artero, Jean-Baptiste] Keele Univ, Macromol Struct Res Grp, Keele, Staffs, England	University of Portsmouth; Institut Laue-Langevin (ILL); Keele University	Taylor, JE (corresponding author), Univ Portsmouth, Inst Biomed & Biomol Sci, Portsmouth, Hants, England.	geoff.kneale@port.ac.uk		Taylor, James/0000-0003-4285-6985	Wellcome Trust [080304/Z/06/Z]	Wellcome Trust(Wellcome TrustEuropean Commission)	This work was funded by the Wellcome Trust (grant number 080304/Z/06/Z awarded to GK). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	BICKLE TA, 1993, MICROBIOL REV, V57, P434, DOI 10.1128/MMBR.57.2.434-450.1993; Calisto RM, 2005, J MOL BIOL, V351, P749, DOI 10.1016/j.jmb.2005.06.050; Callow P, 2007, J MOL BIOL, V369, P177, DOI 10.1016/j.jmb.2007.03.012; DeLano W.L., 2002, PYMOL MOL GRAPHICS S; Firman K, 2000, EMBO J, V19, P2094, DOI 10.1093/emboj/19.9.2094; FOURNET G, 1950, J PHYS-PARIS, V11, P516, DOI 10.1051/jphysrad:01950001108-9051600; Gao P, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0017346; Janscak P, 1996, J MOL BIOL, V257, P977, DOI 10.1006/jmbi.1996.0217; Kennaway CK, 2012, GENE DEV, V26, P92, DOI 10.1101/gad.179085.111; Kennaway CK, 2009, NUCLEIC ACIDS RES, V37, P762, DOI 10.1093/nar/gkn988; Kim JS, 2005, P NATL ACAD SCI USA, V102, P3248, DOI 10.1073/pnas.0409851102; Konarev PV, 2003, J APPL CRYSTALLOGR, V36, P1277, DOI 10.1107/S0021889803012779; Konarev PV, 2001, J APPL CRYSTALLOGR, V34, P527, DOI 10.1107/S0021889801006100; Lapkouski M, 2009, NAT STRUCT MOL BIOL, V16, P94, DOI 10.1038/nsmb.1523; Laue T.M., 1992, ANAL ULTRACENTRIFUGA, P90; Mernagh DR, 1998, BIOL CHEM, V379, P497, DOI 10.1515/bchm.1998.379.4-5.497; Murray NE, 2000, MICROBIOL MOL BIOL R, V64, P412, DOI 10.1128/MMBR.64.2.412-434.2000; Obarska-Kosinska A, 2008, J MOL BIOL, V376, P438, DOI 10.1016/j.jmb.2007.11.024; Orthaber D, 2000, J APPL CRYSTALLOGR, V33, P218, DOI 10.1107/S0021889899015216; PATEL J, 1992, GENE, V112, P21, DOI 10.1016/0378-1119(92)90298-4; PRICE C, 1987, EMBO J, V6, P1493, DOI 10.1002/j.1460-2075.1987.tb02391.x; Schuck P, 2000, BIOPHYS J, V78, P1606, DOI 10.1016/S0006-3495(00)76713-0; Seidel R, 2004, NAT STRUCT MOL BIOL, V11, P838, DOI 10.1038/nsmb816; Smith MA, 2001, J MOL BIOL, V314, P41, DOI 10.1006/jmbi.2001.5123; Smith MA, 1998, BIOL CHEM, V379, P505, DOI 10.1515/bchm.1998.379.4-5.505; Svergun DI, 2000, J BIOL CHEM, V275, P14432, DOI 10.1074/jbc.275.19.14432; SVERGUN DI, 1992, J APPL CRYSTALLOGR, V25, P495, DOI 10.1107/S0021889892001663; Szczelkun MD, 1997, J MOL BIOL, V271, P112, DOI 10.1006/jmbi.1997.1172; TAYLOR I, 1993, NUCLEIC ACIDS RES, V21, P4929, DOI 10.1093/nar/21.21.4929; TAYLOR I, 1992, NUCLEIC ACIDS RES, V20, P179, DOI 10.1093/nar/20.2.179; Taylor JE, 2010, J MOL BIOL, V398, P391, DOI 10.1016/j.jmb.2010.03.008; Uyen NT, 2009, NUCLEIC ACIDS RES, V37, P6960, DOI 10.1093/nar/gkp603; Whitten AE, 2008, J APPL CRYSTALLOGR, V41, P222, DOI 10.1107/S0021889807055136; WILSON GG, 1991, NUCLEIC ACIDS RES, V19, P2539, DOI 10.1093/nar/19.10.2539	34	8	8	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 6	2012	7	4							e35263	10.1371/journal.pone.0035263	http://dx.doi.org/10.1371/journal.pone.0035263			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	955JA	22493743	Green Published, Green Submitted, Green Accepted, gold			2022-12-25	WOS:000305012700085
J	Van Dongen, S; Sprengers, E; Helle, S				Van Dongen, Stefan; Sprengers, Ellen; Helle, Samuli			Hand Asymmetry Does Not Relate to Key Life History Traits in Post-Menopausal Contemporary Finnish Women	PLOS ONE			English	Article							FLUCTUATING ASYMMETRY; NATURAL-SELECTION; FACIAL ATTRACTIVENESS; BREAST ASYMMETRY; QUALITY; HUMANS; RATIO; SEX; 2ND	Associations between fluctuating asymmetry (FA, a putative marker of developmental instability, DI) and life history traits have received a great deal of attention in the non-human literature. However, the patterns found are very heterogeneous and generalizations are difficult to make. In humans, only a few studies have related FA to life histories and fitness. In this paper we study such relationships using hand FA and several key life history traits in 209 post-menopausal Finnish women born between 1946 and 1958. Asymmetry measurements were based on scans of the hands and the life histories of these women were collected using questionnaires. No significant associations were detected and trends were opposite to expectations. We did find evidence for directional asymmetry, as traits in the right hand were larger on average. This may be due to handedness, questioning the usefulness of hand FA as a measure of DI. We conclude that future studies in humans should carefully examine the usefulness of traits as measures of DI.	[Van Dongen, Stefan; Sprengers, Ellen] Univ Antwerp, Evolutionary Ecol Grp, Dept Biol, B-2020 Antwerp, Belgium; [Helle, Samuli] Univ Turku, Dept Biol, Sect Ecol, SF-20500 Turku, Finland	University of Antwerp; University of Turku	Van Dongen, S (corresponding author), Univ Antwerp, Evolutionary Ecol Grp, Dept Biol, B-2020 Antwerp, Belgium.	stefan.vandongen@ua.ac.be			research Foundation - Flanders (FWO) [G.0025.07]; Academy of Finland	research Foundation - Flanders (FWO)(FWO); Academy of Finland(Academy of Finland)	This study was supported by Research program G.0025.07 of the research Foundation - Flanders (FWO) and Academy of Finland. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bridges Patricia S., 1995, Evolutionary Anthropology, V4, P112, DOI 10.1002/evan.1360040403; Byars SG, 2010, P NATL ACAD SCI USA, V107, P1787, DOI 10.1073/pnas.0906199106; Cochran C., 2009, 10000 YEAR EXPLOSION; Dongen SV, 2006, J EVOLUTION BIOL, V19, P1727, DOI 10.1111/j.1420-9101.2006.01175.x; Furlow FB, 1997, P ROY SOC B-BIOL SCI, V264, P823, DOI 10.1098/rspb.1997.0115; Gibson MA, 2003, P ROY SOC B-BIOL SCI, V270, pS108, DOI 10.1098/rsbl.2003.0031; Helle S, 2005, P ROY SOC B-BIOL SCI, V272, P29, DOI 10.1098/rspb.2004.2944; Helle S, 2008, AM J HUM BIOL, V20, P700, DOI 10.1002/ajhb.20796; Helle S, 2009, ARCH SEX BEHAV, V38, P1, DOI 10.1007/s10508-008-9419-9; Hume DK, 2001, EVOL HUM BEHAV, V22, P93, DOI 10.1016/S1090-5138(00)00065-9; Kirk KM, 2001, EVOLUTION, V55, P423; Klingenberg Christian Peter, 2003, P427; Kravdal O, 2008, AM SOCIOL REV, V73, P854, DOI 10.1177/000312240807300508; Manning JT, 1998, HUM REPROD, V13, P3000, DOI 10.1093/humrep/13.11.3000; Manning JT, 1997, EVOL HUM BEHAV, V18, P223, DOI 10.1016/S0162-3095(97)00002-0; Manning JT, P ROYAL SOC LONDON B, V255, P189; Milne BJ, 2003, EVOL HUM BEHAV, V24, P53, DOI 10.1016/S1090-5138(02)00120-4; MOLLER AP, 1995, ETHOL SOCIOBIOL, V16, P207, DOI 10.1016/0162-3095(95)00002-3; Pettay JE, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0000606; Rasband W.S., 1997, IMAGE J; Scheib JE, 1999, P ROY SOC B-BIOL SCI, V266, P1913, DOI 10.1098/rspb.1999.0866; Van Dongen S, 2009, J EVOLUTION BIOL, V22, P612, DOI 10.1111/j.1420-9101.2008.01667.x; Van Dongen S, 2011, EVOLUTION H IN PRESS; Van Dongen S, ANN HUMAN BIOL, V38, P317; Whitlock M, 1998, P ROY SOC B-BIOL SCI, V265, P1429, DOI 10.1098/rspb.1998.0453; Zeller R, 2010, CURR OPIN GENET DEV, V20, P384, DOI 10.1016/j.gde.2010.04.014	26	1	1	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 6	2012	7	4							e34661	10.1371/journal.pone.0034661	http://dx.doi.org/10.1371/journal.pone.0034661			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	955JA	22493707	Green Published, gold			2022-12-25	WOS:000305012700049
J	Villareal, TA; Brown, CG; Brzezinski, MA; Krause, JW; Wilson, C				Villareal, Tracy A.; Brown, Colbi G.; Brzezinski, Mark A.; Krause, Jeffrey W.; Wilson, Cara			Summer Diatom Blooms in the North Pacific Subtropical Gyre: 2008-2009	PLOS ONE			English	Article							SEA-SURFACE TEMPERATURE; ANNUAL SILICA CYCLE; RICHELIA-INTRACELLULARIS; CHLOROPHYLL BLOOMS; FIXATION; DIAZOTROPHS; FRONTS; OCEAN; ZONE; EDDY	The summertime North Pacific subtropical gyre has widespread phytoplankton blooms between Hawaii and the subtropical front (similar to 30 degrees N) that appear as chlorophyll (chl) increases in satellite ocean color data. Nitrogen-fixing diatom symbioses (diatom-diazotroph associations: DDAs) often increase 10(2)-10(3) fold in these blooms and contribute to elevated export flux. In 2008 and 2009, two cruises targeted satellite chlorophyll blooms to examine DDA species abundance, chlorophyll concentration, biogenic silica concentration, and hydrography. Generalized observations that DDA blooms occur when the mixed layer depth is < 70 m are supported, but there is no consistent relationship between mixed layer depth, bloom intensity, or composition; regional blooms between 22-34 degrees N occur within a broader temperature range (21-26 degrees C) than previously reported. In both years, the Hemiaulus-Richelia and Rhizosolenia-Richelia DDAs increased 10(2)-10(3) over background concentrations within satellite-defined bloom features. The two years share a common trend of Hemiaulus dominance of the DDAs and substantial increases in the >10 mu m chl a fraction (similar to 40-90+% of total chl a). Integrated diatom abundance varied 10-fold over <10 km. Biogenic silica concentration tracked diatom abundance, was dominated by the >10 mu m size fraction, and increased up to 5-fold in the blooms. The two years differed in the magnitude of the surface chl a increase (2009>2008), the abundance of pennate diatoms within the bloom (2009>2008), and the substantially greater mixed layer depth in 2009. Only the 2009 bloom had sufficient chl a in the >10 mu m fraction to produce the observed ocean color chl increase. Blooms had high spatial variability; ocean color images likely average over numerous small events over time and space scales that exceed the individual event scale. Summertime DDA export flux noted at the Hawaii time-series Sta. ALOHA is probably a generalized feature of the eastern N. Pacific north to the subtropical front.	[Villareal, Tracy A.; Brown, Colbi G.] Univ Texas Austin, Inst Marine Sci, Port Aransas, TX USA; [Villareal, Tracy A.; Brown, Colbi G.] Univ Texas Austin, Dept Marine Sci, Port Aransas, TX USA; [Brzezinski, Mark A.; Krause, Jeffrey W.] Univ Calif Santa Barbara, Inst Marine Sci, Santa Barbara, CA 93106 USA; [Brzezinski, Mark A.] Univ Calif Santa Barbara, Dept Ecol Evolut & Marine Biol, Santa Barbara, CA 93106 USA; [Wilson, Cara] NOAA NMFS SW Fisheries Sci Ctr, Div Environm Res, Pacific Grove, CA USA	University of Texas System; University of Texas Austin; University of Texas System; University of Texas Austin; University of California System; University of California Santa Barbara; University of California System; University of California Santa Barbara; National Oceanic Atmospheric Admin (NOAA) - USA	Villareal, TA (corresponding author), Univ Texas Austin, Inst Marine Sci, Port Aransas, TX USA.	t.villareal@mail.utexas.edu	Villareal, Tracy A/I-9462-2012; Wilson, Cara/A-8816-2009	Villareal, Tracy A/0000-0002-5717-8163; Wilson, Cara/0000-0001-9318-2322	National Science Foundation (NSF) [OCE-0726726, OCE-9414372, OCE-0094591, OCE-0648130]	National Science Foundation (NSF)(National Science Foundation (NSF))	This work was funded by National Science Foundation (NSF) (www.nsf.gov) grants OCE-0726726, OCE-9414372, and OCE-0094591 awarded to TAV and OCE, and OCE-0648130 to MAB. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Brown SL, 2008, DEEP SEA RES 2, V55, P1133; Brzezinski MA, 1998, MAR ECOL PROG SER, V167, P89, DOI 10.3354/meps167089; BRZEZINSKI MA, 1995, DEEP-SEA RES PT I, V42, P1215, DOI 10.1016/0967-0637(95)93592-3; Brzezinski MA, 2011, DEEP-SEA RES PT I, V58, P988, DOI 10.1016/j.dsr.2011.08.001; Calil PHR, 2010, J GEOPHYS RES-OCEANS, V115, DOI 10.1029/2009JC005360; Calil PHR, 2011, J GEOPHYS RES-OCEANS, V116, DOI 10.1029/2010JC006704; Carpenter EJ, 1999, MAR ECOL PROG SER, V185, P273, DOI 10.3354/meps185273; Casey KS, 1999, J CLIMATE, V12, P1848, DOI 10.1175/1520-0442(1999)012<1848:ACOSAI>2.0.CO;2; Church MJ, 2009, GLOBAL BIOGEOCHEM CY, V23, DOI 10.1029/2008GB003418; Dore JE, 2008, PROG OCEANOGR, V76, P2, DOI 10.1016/j.pocean.2007.10.002; Fiore CL, 2010, TRENDS MICROBIOL, V18, P455, DOI 10.1016/j.tim.2010.07.001; Fong AA, 2008, ISME J, V2, P663, DOI 10.1038/ismej.2008.22; Foster RA, 2006, ENVIRON MICROBIOL, V8, P1913, DOI 10.1111/j.1462-2920.2006.01068.x; Foster RA, 2008, NITROGEN IN THE MARINE ENVIRONMENT, 2ND EDITION, P1197, DOI 10.1016/B978-0-12-372522-6.00027-X; Foster RA, 2009, ENVIRON MICROBIOL, V11, P741, DOI 10.1111/j.1462-2920.2008.01796.x; Fryxell GA, 2000, DIATOM RES, V15, P43; Gomez F, 2005, J PLANKTON RES, V27, P323, DOI 10.1093/plankt/fbi007; Hasle G.R., 1978, PHYTOPLANKTON MANUAL, VVolume 6, P88; HEINBOKEL JF, 1986, J PHYCOL, V22, P399, DOI 10.1111/j.1529-8817.1986.tb00043.x; Karl D, 2002, BIOGEOCHEMISTRY, V57, P47, DOI 10.1023/A:1015798105851; Karl DM, 2012, P NATL ACAD SCI USA, V109, P1842, DOI 10.1073/pnas.1120312109; Kilpatrick KA, 2001, J GEOPHYS RES-OCEANS, V106, P9179, DOI 10.1029/1999JC000065; Krause JW, 2010, LIMNOL OCEANOGR, V55, P2608, DOI 10.4319/lo.2010.55.6.2608; Levitus S, 1983, EOS T AM GEOPHYS UNI, V64, P962; LYNN RJ, 1986, J PHYS OCEANOGR, V16, P209, DOI 10.1175/1520-0485(1986)016<0209:TSANSF>2.0.CO;2; Mahaffey C, 2005, AM J SCI, V305, P546, DOI 10.2475/ajs.305.6-8.546; Montoya JP, 2004, NATURE, V430, P1027, DOI 10.1038/nature02824; Rii YM, 2008, DEEP-SEA RES PT II, V55, P1275, DOI 10.1016/j.dsr2.2008.01.013; RODEN GI, 1975, J PHYS OCEANOGR, V5, P557, DOI 10.1175/1520-0485(1975)005<0557:ONPTSS>2.0.CO;2; RODEN GI, 1980, J PHYS OCEANOGR, V10, P342, DOI 10.1175/1520-0485(1980)010<0342:OTSFZN>2.0.CO;2; Scharek R, 1999, MAR ECOL PROG SER, V182, P55, DOI 10.3354/meps182055; Scharek R, 1999, DEEP-SEA RES PT I, V46, P1051, DOI 10.1016/S0967-0637(98)00102-2; Sohm JA, 2011, J GEOPHYS RES-BIOGEO, V116, DOI 10.1029/2010JG001513; Throndsen J., 1978, PHYTOPLANKTON MANUAL, P69; Vaillancourt RD, 2003, DEEP-SEA RES PT I, V50, P829, DOI 10.1016/S0967-0637(03)00059-1; VENRICK EL, 1974, LIMNOL OCEANOGR, V19, P437, DOI 10.4319/lo.1974.19.3.0437; VENRICK EL, 1988, J PLANKTON RES, V10, P987, DOI 10.1093/plankt/10.5.987; VILLAREAL TA, 1992, NATO ADV SCI I C-MAT, V362, P163; VILLAREAL TA, 1990, MAR ECOL-P S Z N I, V11, P117, DOI 10.1111/j.1439-0485.1990.tb00233.x; VILLAREAL TA, 1994, B MAR SCI, V54, P1; Villareal TA, 2007, DEEP-SEA RES PT I, V54, P1273, DOI 10.1016/j.dsr.2007.04.018; Villareal TA, 2011, J GEOPHYS RES-OCEANS, V116, DOI 10.1029/2010JC006268; Watkins-Brandt KS, 2011, MAR ECOL PROG SER, V432, P17, DOI 10.3354/meps09147; WELSCHMEYER NA, 1994, LIMNOL OCEANOGR, V39, P1985, DOI 10.4319/lo.1994.39.8.1985; White AE, 2007, J GEOPHYS RES-OCEANS, V112, DOI 10.1029/2007JC004129; Wilson C, 2003, GEOPHYS RES LETT, V30, DOI 10.1029/2003GL017770; Wilson C, 2011, GEOPHYS RES LETT, V38, P6, DOI [10.1029/2011GL1020, DOI 10.1029/2011GL1020]; Wilson C, 2008, PROG OCEANOGR, V78, P107, DOI 10.1016/j.pocean.2008.05.002; Wilson C, 2008, J MARINE SYST, V69, P164, DOI 10.1016/j.jmarsys.2005.09.018	49	49	50	2	42	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 6	2012	7	4							e33109	10.1371/journal.pone.0033109	http://dx.doi.org/10.1371/journal.pone.0033109			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	955JA	22493663	Green Published, gold, Green Submitted			2022-12-25	WOS:000305012700005
J	Bernabe-Ortiz, A; Benziger, CP; Gilman, RH; Smeeth, L; Miranda, JJ				Bernabe-Ortiz, Antonio; Pastorius Benziger, Catherine; Gilman, Robert H.; Smeeth, Liam; Jaime Miranda, J.			Sex Differences in Risk Factors for Cardiovascular Disease: The PERU MIGRANT Study	PLOS ONE			English	Article							METABOLIC SYNDROME; PREVALENCE; MIGRATION; OBESITY; ASSOCIATION; URBAN	Introduction: Although men and women have similar risk factors for cardiovascular disease, many social behaviors in developing countries differ by sex. Rural-to-urban migrants have different cardiovascular risk profiles than rural or urban dwellers. The objective of this study was to evaluate the sex differences with specific cardiovascular risk factors in rural-to-urban migrants. Methods and Results: We used the rural-to-urban migrant group of the PERU MIGRANT cross-sectional study to investigate the sex differences in specific cardiovascular risk factors: obesity, hypertension, metabolic syndrome, as well as exposures of socioeconomic status, acculturation surrogates and behavioral characteristics. Logistic regression analysis was used to characterize strength of association between sex and our outcomes adjusting for potential confounders. The sample of migrants was 589 (mean age 46.5 years) and 52.4% were female. In the adjusted models, women were more likely to be obese (OR = 5.97; 95% CI: 3.21-11) and have metabolic syndrome (OR = 2.22; 95% CI: 1.39-3.55) than men, explaining the greatest variability for obesity and metabolic syndrome but not for hypertension. Conclusions: Our results suggest that interventions for CVD in Peru should be sex-specific and address the unique health needs of migrant populations living in urban shantytowns since the risk factors for obesity and metabolic syndrome differ between males and females.	[Bernabe-Ortiz, Antonio; Pastorius Benziger, Catherine; Gilman, Robert H.; Smeeth, Liam; Jaime Miranda, J.] Univ Peruana Cayetano Heredia, CRONICAS Ctr Excellence Chron Dis, Lima, Peru; [Bernabe-Ortiz, Antonio] Univ Peruana Cayetano Heredia, Sch Publ Hlth & Adm, Epidemiol Unit, Lima, Peru; [Pastorius Benziger, Catherine] Univ Minnesota, Sch Med, Minneapolis, MN 55455 USA; [Gilman, Robert H.] Johns Hopkins Bloomberg Sch Publ Hlth, Dept Int Hlth, Baltimore, MD USA; [Gilman, Robert H.] AB PRISMA, Area Invest & Desarrollo, Lima, Peru; [Smeeth, Liam; Jaime Miranda, J.] London Sch Hyg & Trop Med, Fac Epidemiol & Populat Hlth, London WC1, England; [Jaime Miranda, J.] Univ Peruana Cayetano Heredia, Sch Med, Dept Med, Lima, Peru	Universidad Peruana Cayetano Heredia; Universidad Peruana Cayetano Heredia; University of Minnesota System; University of Minnesota Twin Cities; Johns Hopkins University; Johns Hopkins Bloomberg School of Public Health; University of London; London School of Hygiene & Tropical Medicine; Universidad Peruana Cayetano Heredia	Bernabe-Ortiz, A (corresponding author), Univ Peruana Cayetano Heredia, CRONICAS Ctr Excellence Chron Dis, Lima, Peru.	Jaime.Miranda@upch.pe	Miranda, J. Jaime/A-8482-2008; Benziger, Catherine/AAN-3344-2021; Smeeth, Liam/X-5862-2018	Miranda, J. Jaime/0000-0002-4738-5468; Benziger, Catherine/0000-0002-8992-6197; Smeeth, Liam/0000-0002-9168-6022; Bernabe-Ortiz, Antonio/0000-0002-6834-1376	National Heart, Lung and Blood Institute (NHLBI), National Institutes of Health, Department of Health and Human Services [HHSN268200900033C]; National Institutes of Health; Fogarty International Center through Vanderbilt University [R24 TW007988]; Wellcome Trust [GR074833MA]; National Institute for Health Research [NF-SI-0510-10090] Funding Source: researchfish; FOGARTY INTERNATIONAL CENTER [R24TW007988] Funding Source: NIH RePORTER	National Heart, Lung and Blood Institute (NHLBI), National Institutes of Health, Department of Health and Human Services(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Fogarty International Center through Vanderbilt University(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Fogarty International Center (FIC)); Wellcome Trust(Wellcome TrustEuropean Commission); National Institute for Health Research(National Institute for Health Research (NIHR)); FOGARTY INTERNATIONAL CENTER(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Fogarty International Center (FIC))	ABO, RHG, JJM and the CRONICAS Center of Excellence in Chronic Diseases at UPCH is funded by the National Heart, Lung and Blood Institute (NHLBI), National Institutes of Health, Department of Health and Human Services, under contract no. HHSN268200900033C. CPB was supported by the National Institutes of Health and Fogarty International Center through the International Clinical Research Fellows Program at Vanderbilt University (R24 TW007988). The PERU MIGRANT Study was funded by a Wellcome Trust Masters Research Training Fellowship and a Wellcome Trust PhD Studentship to JJM (GR074833MA). LS is supported by a Wellcome Trust Senior Research Fellowship in Clinical Science. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Anonymous, 2006, Metabolic Syndrome and Related Disorders, V4, P1, DOI 10.1089/met.2006.4.1; Baracco Rossana, 2007, Metabolic Syndrome and Related Disorders, V5, P55, DOI 10.1089/met.2006.0019; Bautista LE, 2009, OBES REV, V10, P364, DOI 10.1111/j.1467-789X.2009.00591.x; Bernabe-Ortiz A, 2010, OBESITY, V18, P2199, DOI 10.1038/oby.2010.92; Quintana HC, 2009, REV ESP SALUD PUBLIC, V83, P257, DOI 10.1590/s1135-57272009000200009; Castanho VS, 2001, BMC PUBLIC HEALTH, V1, DOI 10.1186/1471-2458-1-3; Cecchini M, 2010, LANCET, V376, P1775, DOI 10.1016/S0140-6736(10)61514-0; Chobanian AV, 2003, HYPERTENSION, V42, P1206, DOI 10.1161/01.HYP.0000107251.49515.c2; Ebrahim S, 2010, PLOS MED, V7, DOI 10.1371/journal.pmed.1000268; Epping-Jordan JE, 2005, LANCET, V366, P1667, DOI 10.1016/S0140-6736(05)67342-4; Escobedo J, 2009, CARDIOVASC DIABETOL, V8, DOI 10.1186/1475-2840-8-52; Filozof C, 2001, Obes Rev, V2, P99, DOI 10.1046/j.1467-789x.2001.00029.x; HE J, 1991, AM J EPIDEMIOL, V134, P1085, DOI 10.1093/oxfordjournals.aje.a116012; Hernandez AV, 2011, HEART; Herrera VM, 2009, INT J OBESITY, V33, P568, DOI 10.1038/ijo.2009.35; International Diabetes Federation, 2006, IDF CONS WORLDW DEF; Miranda JJ, 2011, HEART, V97, P787, DOI 10.1136/hrt.2010.218537; Málaga Germán, 2010, Rev. perú. med. exp. salud publica, V27, P557; Mancia G, 2007, EUR HEART J, V28, P1462, DOI [10.1093/eurheartj/ehm236, 10.1093/eurheartj/eht151]; Medina-Lezama J, 2007, DIABETES RES CLIN PR, V78, P270, DOI 10.1016/j.diabres.2007.04.004; Miranda JJ, 2009, BMC CARDIOVASC DISOR, V9, DOI 10.1186/1471-2261-9-23; Pastorius Benziger Catherine, 2011, Crit Pathw Cardiol, V10, P99, DOI 10.1097/HPC.0b013e318223e375; Patel RB, 2009, NEW ENGL J MED, V361, P741, DOI 10.1056/NEJMp0810878; Pedersen D, 2008, SOC SCI MED, V67, P205, DOI 10.1016/j.socscimed.2008.03.040; Pischon T, 2008, NEW ENGL J MED, V359, P2105, DOI 10.1056/NEJMoa0801891; POULTER NR, 1990, BMJ-BRIT MED J, V300, P967, DOI 10.1136/bmj.300.6730.967; SchenckGustafsson K, 1996, EUR HEART J, V17, P2, DOI 10.1093/eurheartj/17.suppl_D.2; Sokka T, 2008, CLIN EXP RHEUMATOL, V26, pS35, DOI 10.1161/CIRCULATIONAHA.109.192644; Takenaka A, 2010, LAT AM PERSPECT, V37, P29, DOI 10.1177/0094582X10379106; UNFPA, 2007, STAT WORLD POP 2007; Van Ginkel H., 2008, NATURE, V456, P32, DOI DOI 10.1038/TWAS08.32A; Wenger NK, 1995, AM J HYPERTENS, V8, pS94, DOI 10.1016/0895-7061(95)99306-1; WHO, 2011, GLOB STAT REP NONC D; WHO, 2002, RED RISKS PROM HLTH	34	20	21	0	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 5	2012	7	4							e35127	10.1371/journal.pone.0035127	http://dx.doi.org/10.1371/journal.pone.0035127			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	955IH	22496899	Green Published, Green Submitted, gold, Green Accepted			2022-12-25	WOS:000305010500030
J	Fruhwirth, S; Teich, K; Klug, G				Fruehwirth, Sebastian; Teich, Kristin; Klug, Gabriele			Effects of the Cryptochrome CryB from Rhodobacter sphaeroides on Global Gene Expression in the Dark or Blue Light or in the Presence of Singlet Oxygen	PLOS ONE			English	Article							PHOTOOXIDATIVE STRESS; HYDROGEN-PEROXIDE; PHOTOLYASE; DNA; PROTEIN; APPA; PUF; TRANSCRIPTOME; CAPSULATUS; MICROARRAY	Several regulators are controlling the formation of the photosynthetic apparatus in the facultatively photosynthetic bacterium Rhodobacter sphaeroides. Among the proteins affecting photosynthesis gene expression is the blue light photoreceptor cryptochrome CryB. This study addresses the effect of CryB on global gene expression. The data reveal that CryB does not only influence photosynthesis gene expression but also genes for the non-photosynthetic energy metabolism like citric acid cycle and oxidative phosphorylation. In addition several genes involved in RNA processing and in transcriptional regulation are affected by a cryB deletion. Although CryB was shown to undergo a photocycle it does not only affect gene expression in response to blue light illumination but also in response to singlet oxygen stress conditions. While there is a large overlap in these responses, some CryB-dependent effects are specific for blue-light or photooxidative stress. In addition to protein-coding genes some genes for sRNAs show CryB-dependent expression. These findings give new insight into the function of bacterial cryptochromes and demonstrate for the first time a function in the oxidative stress response.	[Fruehwirth, Sebastian; Teich, Kristin; Klug, Gabriele] Univ Giessen, Inst Mikrobiol & Mol Biol, Giessen, Germany	Justus Liebig University Giessen	Fruhwirth, S (corresponding author), Univ Giessen, Inst Mikrobiol & Mol Biol, Giessen, Germany.	Gabriele.Klug@mikro.bio.uni-giessen.de	Klug, Gabriele/K-5322-2014	Klug, Gabriele/0000-0002-3527-5093	Deutsche Forschungsgemeinschaft [Kl563/22-1]	Deutsche Forschungsgemeinschaft(German Research Foundation (DFG))	This work was supported by Deutsche Forschungsgemeinschaft (Kl563/22-1). The funders had no role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Berghoff BA, 2011, MOL MICROBIOL, V80, P1479, DOI 10.1111/j.1365-2958.2011.07658.x; Berghoff BA, 2009, MOL MICROBIOL, V74, P1497, DOI 10.1111/j.1365-2958.2009.06949.x; Braatsch S, 2004, PHOTOSYNTH RES, V79, P45, DOI 10.1023/B:PRES.0000011924.89742.f9; Braatsch S, 2002, MOL MICROBIOL, V45, P827, DOI 10.1046/j.1365-2958.2002.03058.x; Brennan RG, 2007, CURR OPIN MICROBIOL, V10, P125, DOI 10.1016/j.mib.2007.03.015; Brudler R, 2003, MOL CELL, V11, P59, DOI 10.1016/S1097-2765(03)00008-X; Chaves I, 2011, ANNU REV PLANT BIOL, V62, P335, DOI 10.1146/annurev-arplant-042110-103759; Devlin PF, 2000, PLANT CELL, V12, P2499, DOI 10.1105/tpc.12.12.2499; Drews G, 1983, MIKROBIOLOGISCHES PR; ERASO JM, 1994, J BACTERIOL, V176, P32, DOI 10.1128/JB.176.1.32-43.1994; Evguenieva-Hackenberg E, 2009, PROG MOL BIOL TRANSL, V85, P275, DOI 10.1016/S0079-6603(08)00807-6; Geisselbrecht Y, 2012, EMBO REPORT IN PRESS; Glaeser J, 2005, MICROBIOL-SGM, V151, P1927, DOI 10.1099/mic.0.27789-0; Glaeser J, 2011, ADV MICROB PHYSIOL, V58, P141, DOI 10.1016/B978-0-12-381043-4.00004-0; Glaeser J, 2007, J PROTEOME RES, V6, P2460, DOI 10.1021/pr060624p; Gomelsky M, 2002, TRENDS BIOCHEM SCI, V27, P497, DOI 10.1016/S0968-0004(02)02181-3; Gomelsky M, 2011, TRENDS MICROBIOL, V19, P441, DOI 10.1016/j.tim.2011.05.002; Griffin EA, 1999, SCIENCE, V286, P768, DOI 10.1126/science.286.5440.768; Han YC, 2007, MOL MICROBIOL, V64, P1090, DOI 10.1111/j.1365-2958.2007.05724.x; Happ HN, 2005, MOL MICROBIOL, V58, P903, DOI 10.1111/j.1365-2958.2005.04882.x; Heck C, 1999, J BACTERIOL, V181, P7621, DOI 10.1128/JB.181.24.7621-7625.1999; Hendrischk AK, 2007, MICROBIOL-SGM, V153, P1842, DOI 10.1099/mic.0.2006/004390-0; Hendrischk AK, 2009, MOL MICROBIOL, V74, P990, DOI 10.1111/j.1365-2958.2009.06912.x; Hitomi K, 2000, NUCLEIC ACIDS RES, V28, P2353, DOI 10.1093/nar/28.12.2353; Jager S, 2001, NUCLEIC ACIDS RES, V29, P4581, DOI 10.1093/nar/29.22.4581; JANZON L, 1986, FEMS MICROBIOL LETT, V33, P193; KLUG G, 1992, GENE, V121, P95, DOI 10.1016/0378-1119(92)90166-M; LEE JK, 1992, J BACTERIOL, V174, P1146, DOI 10.1128/jb.174.4.1146-1157.1992; Li QH, 2007, PHOTOCHEM PHOTOBIOL, V83, P94, DOI 10.1562/2006-02-28-IR-826; Lin CT, 2005, GENOME BIOL, V6, DOI 10.1186/gb-2005-6-5-220; Liu HT, 2011, TRENDS PLANT SCI, V16, P684, DOI 10.1016/j.tplants.2011.09.002; Lopez L, 2011, PLANT CELL ENV, pno; Losi A, 2008, PHOTOCH PHOTOBIO SCI, V7, P1168, DOI 10.1039/b802472c; Losi A, 2007, PHOTOCHEM PHOTOBIOL, V83, P1283, DOI 10.1111/j.1751-1097.2007.00196.x; Mao LY, 2005, MICROBIOL-SGM, V151, P3197, DOI 10.1099/mic.0.28167-0; Metz S, 2010, PHOTOCHEM PHOTOBIOL, V86, P882, DOI 10.1111/j.1751-1097.2010.00749.x; Metz S, 2009, J BACTERIOL, V191, P4473, DOI 10.1128/JB.00262-09; Moon K, 2011, MOL MICROBIOL, V82, P1545, DOI 10.1111/j.1365-2958.2011.07907.x; Moskvin OV, 2007, J BIOL CHEM, V282, P28740, DOI 10.1074/jbc.M703261200; Moskvin OV, 2005, J BACTERIOL, V187, P2148, DOI 10.1128/JB.187.6.2148-2156.2005; Nuss AM, 2010, J BACTERIOL, V192, P2613, DOI 10.1128/JB.01605-09; Oberpichler I, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0026775; Pokorny R, 2008, P NATL ACAD SCI USA, V105, P21023, DOI 10.1073/pnas.0805830106; Purcell EB, 2008, CURR OPIN MICROBIOL, V11, P168, DOI 10.1016/j.mib.2008.02.014; Ritchie ME, 2007, BIOINFORMATICS, V23, P2700, DOI 10.1093/bioinformatics/btm412; Selby CP, 2006, P NATL ACAD SCI USA, V103, P17696, DOI 10.1073/pnas.0607993103; SHIMADA H, 1992, PLANT CELL PHYSIOL, V33, P471; Silva IJ, 2011, WIRES RNA, V2, P818, DOI 10.1002/wrna.94; Smyth G.K., 2004, STAT APPL GENET MOL, V3, DOI DOI 10.2202/1544-6115.1027; Smyth GK, 2005, STAT BIOL HEALTH, P397, DOI 10.1007/0-387-29362-0_23; Smyth GK, 2003, METHODS, V31, P265, DOI 10.1016/S1046-2023(03)00155-5; Somers DE, 1998, SCIENCE, V282, P1488, DOI 10.1126/science.282.5393.1488; Todo T, 1999, MUTAT RES-DNA REPAIR, V434, P89, DOI 10.1016/S0921-8777(99)00013-0; van der Horst GTJ, 1999, NATURE, V398, P627, DOI 10.1038/19323; Waters LS, 2009, CELL, V136, P615, DOI 10.1016/j.cell.2009.01.043; Zeller T, 2005, J BACTERIOL, V187, P7232, DOI 10.1128/JB.187.21.7232-7242.2005; Zeller T, 2007, J BACTERIOL, V189, P3784, DOI 10.1128/JB.01795-06	57	14	14	0	16	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 5	2012	7	4							e33791	10.1371/journal.pone.0033791	http://dx.doi.org/10.1371/journal.pone.0033791			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	955IH	22496766	Green Published, Green Submitted, gold			2022-12-25	WOS:000305010500002
J	Ma, LN; Huang, WW; Guo, CY; Wang, RZ; Xiao, CW				Ma, Linna; Huang, Wenwen; Guo, Chengyuan; Wang, Renzhong; Xiao, Chunwang			Soil Microbial Properties and Plant Growth Responses to Carbon and Water Addition in a Temperate Steppe: The Importance of Nutrient Availability	PLOS ONE			English	Article							ORGANIC-MATTER; COMMUNITY STRUCTURE; BACTERIAL BIOMASS; CLIMATE-CHANGE; NITROGEN LIMITATION; GRASSLAND; FUNGAL; MINERALIZATION; DECOMPOSITION; DYNAMICS	Background: Global climatic change is generally expected to stimulate net primary production, and consequently increase soil carbon (C) input. The enhanced C input together with potentially increased precipitation may affect soil microbial processes and plant growth. Methodology/Principal Findings: To examine the effects of C and water additions on soil microbial properties and plant growth, we conducted an experiment lasting two years in a temperate steppe of northeastern China. We found that soil C and water additions significantly affected microbial properties and stimulated plant growth. Carbon addition significantly increased soil microbial biomass and activity but had a limited effect on microbial community structure. Water addition significantly increased soil microbial activity in the first year but the response to water decreased in the second year. The water-induced changes of microbial activity could be ascribed to decreased soil nitrogen (N) availability and to the shift in soil microbial community structure. However, no water effect on soil microbial activity was visible under C addition during the two years, likely because C addition alleviated nutrient limitation of soil microbes. In addition, C and water additions interacted to affect plant functional group composition. Water addition significantly increased the ratio of grass to forb biomass in C addition plots but showed only minor effects under ambient C levels. Our results suggest that soil microbial activity and plant growth are limited by nutrient (C and N) and water availability, and highlight the importance of nutrient availability in modulating the responses of soil microbes and plants to potentially increased precipitation in the temperate steppe. Conclusions/Significance: Increased soil C input and precipitation would show significant effects on soil microbial properties and plant growth in the temperate steppe. These findings will improve our understanding of the responses of soil microbes and plants to the indirect and direct climate change effects.	[Ma, Linna; Huang, Wenwen; Guo, Chengyuan; Wang, Renzhong; Xiao, Chunwang] Chinese Acad Sci, Inst Bot, State Key Lab Vegetat & Environm Change, Beijing, Peoples R China; [Ma, Linna; Huang, Wenwen; Guo, Chengyuan] Chinese Acad Sci, Grad Sch, Beijing, Peoples R China	Chinese Academy of Sciences; Institute of Botany, CAS; Chinese Academy of Sciences; University of Chinese Academy of Sciences, CAS	Ma, LN (corresponding author), Chinese Acad Sci, Inst Bot, State Key Lab Vegetat & Environm Change, Beijing, Peoples R China.	wangrz@ibcas.ac.cn; cwxiao@ibcas.ac.cn	huang, wen/GXW-0661-2022; Huang, WW/GXH-0977-2022		State Key Laboratory of Vegetation and Environmental Change, Institute of Botany, Chinese Academy of Sciences (VEWALNE)	State Key Laboratory of Vegetation and Environmental Change, Institute of Botany, Chinese Academy of Sciences (VEWALNE)	This study was financially supported by the State Key Laboratory of Vegetation and Environmental Change, Institute of Botany, Chinese Academy of Sciences (VEWALNE-project). The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alden L, 2001, APPL ENVIRON MICROB, V67, P1830, DOI 10.1128/AEM.67.4.1830-1838.2001; Avrahami S, 2003, ENVIRON MICROBIOL, V5, P691, DOI 10.1046/j.1462-2920.2003.00457.x; Balser TC, 2005, BIOGEOCHEMISTRY, V73, P395, DOI 10.1007/s10533-004-0372-y; Bardgett RD, 1999, FUNCT ECOL, V13, P650, DOI 10.1046/j.1365-2435.1999.00362.x; Bardgett RD, 1999, OIKOS, V85, P193, DOI 10.2307/3546486; Bossio DA, 1998, MICROBIAL ECOL, V35, P265, DOI 10.1007/s002489900082; Bossuyt H, 2001, APPL SOIL ECOL, V16, P195, DOI 10.1016/S0929-1393(00)00116-5; Bremner J. M., 1982, Methods of soil analysis. Part 2. Chemical and microbiological properties, P595; Busse MD, 2009, SOIL BIOL BIOCHEM, V41, P220, DOI 10.1016/j.soilbio.2008.10.012; Collins SL, 2008, J ECOL, V96, P413, DOI 10.1111/j.1365-2745.2008.01362.x; Drenovsky RE, 2004, MICROB ECOL, V48, P424, DOI 10.1007/s00248-003-1063-2; Elser JJ, 2007, ECOL LETT, V10, P1135, DOI 10.1111/j.1461-0248.2007.01113.x; Fierer N, 2003, SOIL BIOL BIOCHEM, V35, P167, DOI 10.1016/S0038-0717(02)00251-1; Frostegard A, 1996, BIOL FERT SOILS, V22, P59, DOI 10.1007/BF00384433; FROSTEGARD A, 1993, SOIL BIOL BIOCHEM, V25, P723, DOI 10.1016/0038-0717(93)90113-P; Gao XJ, 2001, ADV ATMOS SCI, V18, P1224; GONCALVES JLM, 1994, SOIL BIOL BIOCHEM, V26, P1557, DOI 10.1016/0038-0717(94)90098-1; Goyal S, 1999, BIOL FERT SOILS, V29, P196, DOI 10.1007/s003740050544; Harpole WS, 2007, GLOBAL CHANGE BIOL, V13, P2341, DOI 10.1111/j.1365-2486.2007.01447.x; Hol WHG, 2010, ECOL LETT, V13, P292, DOI 10.1111/j.1461-0248.2009.01424.x; Hooper DU, 1999, BIOGEOCHEMISTRY, V46, P247, DOI 10.1007/BF01007582; Houghton J. T., 2001, CLIMATE CHANGE 2001; Hu S, 2001, NATURE, V409, P188, DOI 10.1038/35051576; Hu S, 1997, MICROBIAL ECOL, V33, P134, DOI 10.1007/s002489900015; Jastrow JD, 1998, SOIL BIOL BIOCHEM, V30, P905, DOI 10.1016/S0038-0717(97)00207-1; Jin HM, 2010, J PLANT ECOL, V3, P209, DOI 10.1093/jpe/rtq001; Jones C, 2005, GLOBAL CHANGE BIOL, V11, P154, DOI 10.1111/j.1365-2486.2004.00885.x; Kim DG, 2011, BIOGEOSCIENCES, V8, P9847, DOI DOI 10.5194/BGD-8-9847-2011; Klanderud K, 2005, ECOLOGY, V86, P2047, DOI 10.1890/04-1563; Leiros MC, 1999, SOIL BIOL BIOCHEM, V31, P327, DOI 10.1016/S0038-0717(98)00129-1; Liski J, 2003, GLOBAL CHANGE BIOL, V9, P575, DOI 10.1046/j.1365-2486.2003.00605.x; LOVELL RD, 1995, SOIL BIOL BIOCHEM, V27, P969, DOI 10.1016/0038-0717(94)00241-R; LUND V, 1980, MICROBIAL ECOL, V6, P115, DOI 10.1007/BF02010550; Ma LN, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0027645; Marschner P, 2004, BIOL FERT SOILS, V40, P1, DOI 10.1007/s00374-004-0736-4; McIntyre RES, 2009, SOIL BIOL BIOCHEM, V41, P92, DOI 10.1016/j.soilbio.2008.09.021; Morris SJ, 1999, SOIL BIOL BIOCHEM, V31, P887, DOI 10.1016/S0038-0717(99)00002-4; Nelson D. W., 1996, Methods of soil analysis. Part 3 - chemical methods., P961; Nemani RR, 2003, SCIENCE, V300, P1560, DOI 10.1126/science.1082750; Ni J, 2000, J ARID ENVIRON, V46, P313, DOI 10.1006/jare.2000.0667; Olsson PA, 1998, PLANT SOIL, V201, P9, DOI 10.1023/A:1004379404220; Panikov NS, 1999, APPL SOIL ECOL, V11, P161, DOI 10.1016/S0929-1393(98)00143-7; Peacock AD, 2001, SOIL BIOL BIOCHEM, V33, P1011, DOI 10.1016/S0038-0717(01)00004-9; Rodrigo A, 1997, ECOL MODEL, V102, P325, DOI 10.1016/S0304-3800(97)00067-7; SAKAMOTO K, 1994, BIOL FERT SOILS, V17, P39, DOI 10.1007/BF00418670; Schmidt MWI, 2011, NATURE, V478, P49, DOI 10.1038/nature10386; Shaver GR, 2000, BIOSCIENCE, V50, P871, DOI 10.1641/0006-3568(2000)050[0871:GWATEA]2.0.CO;2; Smith RS, 2003, J APPL ECOL, V40, P51, DOI 10.1046/j.1365-2664.2003.00780.x; Solomon S, 2007, AR4 CLIMATE CHANGE 2007: THE PHYSICAL SCIENCE BASIS, P1; SPARLING GP, 1995, AUST J SOIL RES, V33, P961, DOI 10.1071/SR9950961; Sylvia DM, 1999, PRINCIPLES APPL SOIL; Trujillo W, 2006, SOIL TILL RES, V87, P28, DOI 10.1016/j.still.2005.02.038; Tu C, 2006, SOIL BIOL BIOCHEM, V38, P247, DOI 10.1016/j.soilbio.2005.05.002; VANCE ED, 1987, SOIL BIOL BIOCHEM, V19, P703, DOI 10.1016/0038-0717(87)90052-6; Wardle DA, 1995, SOIL BIOL BIOCHEM, V27, P1601, DOI 10.1016/0038-0717(95)00093-T; Xiao CW, 2007, NEW PHYTOL, V174, P835, DOI 10.1111/j.1469-8137.2007.02054.x; Yang HJ, 2011, GLOBAL CHANGE BIOL, V17, P2936, DOI 10.1111/j.1365-2486.2011.02423.x; Yuan ZY, 2005, PLANT SOIL, V273, P257, DOI 10.1007/s11104-004-7941-7	58	40	47	11	90	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 5	2012	7	4							e35165	10.1371/journal.pone.0035165	http://dx.doi.org/10.1371/journal.pone.0035165			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	955IH	22496905	gold, Green Published, Green Submitted			2022-12-25	WOS:000305010500032
J	Park, HW; Cho, JS; Park, CK; Jung, SJ; Park, CH; Lee, SJ; Oh, SB; Park, YS; Chang, MS				Park, Hwan-Woo; Cho, Jung-Sun; Park, Chul-Kyu; Jung, Sung Jun; Park, Chang-Hwan; Lee, Shin-Jae; Oh, Seog Bae; Park, Young-Seok; Chang, Mi-Sook			Directed Induction of Functional Motor Neuron-Like Cells from Genetically Engineered Human Mesenchymal Stem Cells	PLOS ONE			English	Article							MARROW STROMAL CELLS; ADENOSINE-MONOPHOSPHATE STIMULATION; SPINAL-CORD-INJURY; BONE-MARROW; TRANSCRIPTION FACTORS; DIFFERENTIATION PROTOCOLS; AXONAL ELONGATION; SUBTYPE IDENTITY; IN-VITRO; SPECIFICATION	Cell replacement using stem cells is a promising therapeutic approach to treat degenerative motor neuron (MN) disorders, such as amyotrophic lateral sclerosis and spinal cord injury. Human bone marrow-derived mesenchymal stem cells (hMSCs) are a desirable cell source for autologous cell replacement therapy to treat nervous system injury due to their plasticity, low immunogenicity, and a lower risk of tumor formation than embryonic stem cells. However, hMSCs are inefficient with regards to differentiating into MN-like cells. To solve this limitation, we genetically engineered hMSCs to express MN-associated transcription factors, Olig2 and Hb9, and then treat the hMSCs expressing Olig2 and Hb9 with optimal MN induction medium (MNIM). This method of induction led to higher expression (>30% of total cells) of MN markers. Electrophysiological data revealed that the induced hMSCs had the excitable properties of neurons and were able to form functional connections with muscle fibers in vitro. Furthermore, when the induced hMSCs were transplanted into an injured organotypic rat spinal cord slice culture, an ex vivo model of spinal cord injury, they exhibited characteristics of MNs. The data strongly suggest that induced Olig2/Hb9-expressing hMSCs were clearly reprogrammed and directed toward a MN-like lineage. We propose that methods to induce Olig2 and Hb9, followed by further induction with MNIM have therapeutic potential for autologous cell replacement therapy to treat degenerative MN disorders.	[Park, Hwan-Woo; Cho, Jung-Sun; Park, Young-Seok; Chang, Mi-Sook] Seoul Natl Univ, Dent Res Inst, Dept Oral Anat, Seoul, South Korea; [Park, Hwan-Woo; Cho, Jung-Sun; Park, Chul-Kyu; Lee, Shin-Jae; Oh, Seog Bae; Park, Young-Seok; Chang, Mi-Sook] Seoul Natl Univ, Sch Dent, Seoul, South Korea; [Park, Chul-Kyu; Oh, Seog Bae] Seoul Natl Univ, Dent Res Inst, Dept Physiol, Seoul, South Korea; [Jung, Sung Jun] Hanyang Univ, Coll Med, Dept Physiol, Seoul 133791, South Korea; [Park, Chang-Hwan] Hanyang Univ, Coll Med, Grad Sch Biomed Sci & Engn, Seoul 133791, South Korea; [Park, Chang-Hwan] Hanyang Univ, Coll Med, Dept Microbiol, Seoul 133791, South Korea; [Lee, Shin-Jae] Seoul Natl Univ, Dent Res Inst, Dept Orthodont, Seoul, South Korea; [Chang, Mi-Sook] Seoul Natl Univ, Neurosci Res Inst, Seoul, South Korea	Seoul National University (SNU); Seoul National University (SNU); Seoul National University (SNU); Hanyang University; Hanyang University; Hanyang University; Seoul National University (SNU); Seoul National University (SNU)	Park, HW (corresponding author), Seoul Natl Univ, Dent Res Inst, Dept Oral Anat, Seoul, South Korea.	mschang@snu.ac.kr	Park, Hwan-Woo/D-2358-2014; Park, Young-Seok/D-5762-2012; OH, Seog Bae/AAQ-2478-2020; Lee, Shin-Jae/D-5883-2012	Park, Hwan-Woo/0000-0001-8029-2004; Lee, Shin-Jae/0000-0003-1861-1400; Oh, Seog Bae/0000-0001-7975-6895; Chang, Mi-Sook/0000-0002-4379-204X	National Research Foundation of Korea (NRF); Ministry of Education, Science and Technology [2011-0003075]; Ministry of Health & Welfare, Republic of Korea [A100823]	National Research Foundation of Korea (NRF)(National Research Foundation of Korea); Ministry of Education, Science and Technology(Ministry of Education, Science & Technology (MEST), Republic of Korea); Ministry of Health & Welfare, Republic of Korea(Ministry of Health & Welfare (MOHW), Republic of Korea)	This research was supported by a grant from the Basic Science Research Program through the National Research Foundation of Korea (NRF) funded by the Ministry of Education, Science and Technology (M-SC, 2011-0003075) and a grant from the Korea Health Technology R&D Project, Ministry of Health & Welfare (M-SC, A100823), Republic of Korea. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Barzilay R, 2008, STEM CELLS DEV, V17, P547, DOI 10.1089/scd.2007.0172; Bianco P, 2001, STEM CELLS, V19, P180, DOI 10.1634/stemcells.19-3-180; Bohl D, 2008, STEM CELLS, V26, P2564, DOI 10.1634/stemcells.2008-0371; Boillee S, 2006, NEURON, V52, P39, DOI 10.1016/j.neuron.2006.09.018; Brejot T, 2006, EXP NEUROL, V198, P167, DOI 10.1016/j.expneurol.2005.11.026; Briscoe J, 2008, PHILOS T R SOC B, V363, P57, DOI 10.1098/rstb.2006.2012; Cho JS, 2009, NEUROSCI LETT, V454, P43, DOI 10.1016/j.neulet.2009.02.024; Cleveland DW, 2001, NAT REV NEUROSCI, V2, P806, DOI 10.1038/35097565; Diez del Corral R, 2003, NEURON, V40, P65; Ericson J, 1997, CELL, V90, P169, DOI 10.1016/S0092-8674(00)80323-2; Helmy KY, 2010, THER DELIV, V1, P693, DOI [10.4155/tde.10.57, 10.4155/TDE.10.57]; Lee SK, 2003, NEURON, V38, P731, DOI 10.1016/S0896-6273(03)00296-4; LEFEBVRE S, 1995, CELL, V80, P155, DOI 10.1016/0092-8674(95)90460-3; Li JY, 2008, TRENDS NEUROSCI, V31, P146, DOI 10.1016/j.tins.2007.12.001; Li XJ, 2005, NAT BIOTECHNOL, V23, P215, DOI 10.1038/nbt1063; Maden M, 2002, NAT REV NEUROSCI, V3, P843, DOI 10.1038/nrn963; Miles GB, 2004, J NEUROSCI, V24, P7848, DOI 10.1523/JNEUROSCI.1972-04.2004; Morrison SJ, 1999, CELL, V96, P737, DOI 10.1016/S0092-8674(00)80583-8; Munoz-Elias G, 2003, STEM CELLS, V21, P437, DOI 10.1634/stemcells.21-4-437; Nagoshi N, 2008, CELL STEM CELL, V2, P392, DOI 10.1016/j.stem.2008.03.005; Nayak MS, 2006, BBA-MOL BASIS DIS, V1762, P1128, DOI 10.1016/j.bbadis.2006.06.004; Neuhuber B, 2004, J NEUROSCI RES, V77, P192, DOI 10.1002/jnr.20147; Novitch BG, 2003, NEURON, V40, P81, DOI 10.1016/j.neuron.2003.08.006; Novitch BG, 2001, NEURON, V31, P773, DOI 10.1016/S0896-6273(01)00407-X; Nussbaum J, 2007, FASEB J, V21, P1345, DOI 10.1096/fj.06-6769com; Pang ZPP, 2011, NATURE, V476, P220, DOI 10.1038/nature10202; Park HW, 2010, GLIA, V58, P1118, DOI 10.1002/glia.20992; Pittenger MF, 1999, SCIENCE, V284, P143, DOI 10.1126/science.284.5411.143; Prockop DJ, 1997, SCIENCE, V276, P71, DOI 10.1126/science.276.5309.71; Rameshwar P, 2009, MOL THER, V17, P216, DOI 10.1038/mt.2008.296; Reyes M, 2001, BLOOD, V98, P2615, DOI 10.1182/blood.V98.9.2615; ROELINK H, 1995, CELL, V81, P445, DOI 10.1016/0092-8674(95)90397-6; ROISEN FJ, 1972, SCIENCE, V175, P73, DOI 10.1126/science.175.4017.73; ROISEN FJ, 1972, SCIENCE, V177, P809, DOI 10.1126/science.177.4051.809; Sanchez-Ramos J, 2000, EXP NEUROL, V164, P247, DOI 10.1006/exnr.2000.7389; Sanes JR, 1999, ANNU REV NEUROSCI, V22, P389, DOI 10.1146/annurev.neuro.22.1.389; Shah NM, 1996, CELL, V85, P331, DOI 10.1016/S0092-8674(00)81112-5; Sherman LS, 2011, CTS-CLIN TRANSL SCI, V4, P380, DOI 10.1111/j.1752-8062.2011.00283.x; Shirasaki R, 2002, ANNU REV NEUROSCI, V25, P251, DOI 10.1146/annurev.neuro.25.112701.142916; Sockanathan S, 2003, NEURON, V40, P97, DOI 10.1016/S0896-6273(03)00532-4; Sockanathan S, 1998, CELL, V94, P503, DOI 10.1016/S0092-8674(00)81591-3; Takashima Y, 2007, CELL, V129, P1377, DOI 10.1016/j.cell.2007.04.028; Thaler JP, 2004, NEURON, V41, P337, DOI 10.1016/S0896-6273(04)00011-X; Thuret S, 2006, NAT REV NEUROSCI, V7, P628, DOI 10.1038/nrn1955; Trzaska KA, 2007, STEM CELLS, V25, P2797, DOI 10.1634/stemcells.2007-0212; Wichterle H, 2002, CELL, V110, P385, DOI 10.1016/S0092-8674(02)00835-8; Woodbury D, 2000, J NEUROSCI RES, V61, P364, DOI 10.1002/1097-4547(20000815)61:4<364::AID-JNR2>3.0.CO;2-C; Zhang XD, 2006, STEM CELLS, V24, P434, DOI 10.1634/stemcells.2005-0171	48	11	13	0	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 5	2012	7	4							e35244	10.1371/journal.pone.0035244	http://dx.doi.org/10.1371/journal.pone.0035244			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	955IH	22496912	gold, Green Published			2022-12-25	WOS:000305010500035
J	Enea-Drapeau, C; Carlier, M; Huguet, P				Enea-Drapeau, Claire; Carlier, Michele; Huguet, Pascal			Tracking Subtle Stereotypes of Children with Trisomy 21: From Facial-Feature-Based to Implicit Stereotyping	PLOS ONE			English	Article							DOWN-SYNDROME; ASSOCIATION TEST; INDIVIDUAL-DIFFERENCES; INTERGROUP CONTACT; SOCIAL COGNITION; RACIAL-ATTITUDES; THREAT; DISABILITIES; PERFORMANCE; PREJUDICE	Background: Stigmatization is one of the greatest obstacles to the successful integration of people with Trisomy 21 (T21 or Down syndrome), the most frequent genetic disorder associated with intellectual disability. Research on attitudes and stereotypes toward these people still focuses on explicit measures subjected to social-desirability biases, and neglects how variability in facial stigmata influences attitudes and stereotyping. Methodology/Principal Findings: The participants were 165 adults including 55 young adult students, 55 non-student adults, and 55 professional caregivers working with intellectually disabled persons. They were faced with implicit association tests (IAT), a well-known technique whereby response latency is used to capture the relative strength with which some groups of people-here photographed faces of typically developing children and children with T21-are automatically (without conscious awareness) associated with positive versus negative attributes in memory. Each participant also rated the same photographed faces (consciously accessible evaluations). We provide the first evidence that the positive bias typically found in explicit judgments of children with T21 is smaller for those whose facial features are highly characteristic of this disorder, compared to their counterparts with less distinctive features and to typically developing children. We also show that this bias can coexist with negative evaluations at the implicit level (with large effect sizes), even among professional caregivers. Conclusion: These findings support recent models of feature-based stereotyping, and more importantly show how crucial it is to go beyond explicit evaluations to estimate the true extent of stigmatization of intellectually disabled people.	[Enea-Drapeau, Claire] Aix Marseille Univ, Lab Psychol Cognit, Marseille, France; CNRS, Marseille, France	UDICE-French Research Universities; Aix-Marseille Universite; Centre National de la Recherche Scientifique (CNRS)	Enea-Drapeau, C (corresponding author), Aix Marseille Univ, Lab Psychol Cognit, Marseille, France.	claire.enea-drapeau@univ-amu.fr		Huguet, Pascal/0000-0002-0707-7655	Aix-Marseille University; Centre National de la Recherche Scientifique; "Fondation Jerome Lejeune" (France)	Aix-Marseille University; Centre National de la Recherche Scientifique(Centre National de la Recherche Scientifique (CNRS)); "Fondation Jerome Lejeune" (France)	Support for this research was provided by Aix-Marseille University, the Centre National de la Recherche Scientifique, and the "Fondation Jerome Lejeune" (France). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ambady N, 2001, PSYCHOL SCI, V12, P385, DOI 10.1111/1467-9280.00371; Bargh JA, 2006, CURR DIR PSYCHOL SCI, V15, P1, DOI 10.1111/j.0963-7214.2006.00395.x; Blair IV, 2004, J PERS SOC PSYCHOL, V87, P763, DOI 10.1037/0022-3514.87.6.763; Blair IV, 2002, J PERS SOC PSYCHOL, V83, P5, DOI 10.1037/0022-3514.83.1.5; Blair IV, 2004, PSYCHOL SCI, V15, P674, DOI 10.1111/j.0956-7976.2004.00739.x; Bodenhausen GV, 1997, ADV SOCIAL COGNITION, P1; Borthwick C, 1996, DISABIL SOC, V11, P403, DOI 10.1080/09687599627688; Brewer M.B., 1988, ADV SOCIAL COGNITION, P1, DOI DOI 10.2307/1423264; Carlier M., 2007, DEFICIENCES INTELLEC; Croizet JC, 1998, PERS SOC PSYCHOL B, V24, P588, DOI 10.1177/0146167298246003; Croizet JC, 2004, PERS SOC PSYCHOL B, V30, P721, DOI 10.1177/0146167204263961; Cunningham C., 2004, INT J DISABIL DEV ED, V51, P335, DOI [10.1080/1034912042000295017., DOI 10.1080/1034912042000295017]; Dasgupta N, 2000, J EXP SOC PSYCHOL, V36, P316, DOI 10.1006/jesp.1999.1418; DEVINE PG, 1989, J PERS SOC PSYCHOL, V56, P5, DOI 10.1037/0022-3514.56.5.680; Fidler DJ, 1999, AM J MENT RETARD, V104, P410, DOI 10.1352/0895-8017(1999)104<0410:CMAPPI>2.0.CO;2; Finlay WML, 2000, BRIT J SOC PSYCHOL, V39, P129, DOI 10.1348/014466600164372; FISKE ST, 1993, ANNU REV PSYCHOL, V44, P155, DOI 10.1146/annurev.psych.44.1.155; FISKE ST, 1990, ADV EXP SOC PSYCHOL, V23, P1, DOI 10.1016/S0065-2601(08)60317-2; Gilmore L., 2003, INT J DISABIL DEV ED, V50, P65, DOI [10.1080/1034912032000053340, DOI 10.1080/1034912032000053340]; Glenn S., 2004, INT J DISABIL DEV ED, V51, P363, DOI [10.1080/1034912042000295026., DOI 10.1080/1034912042000295026]; GREENWALD AG, 1995, PSYCHOL REV, V102, P4, DOI 10.1037/0033-295X.102.1.4; Greenwald AG, 1998, J PERS SOC PSYCHOL, V74, P1464, DOI 10.1037/0022-3514.74.6.1464; Greenwald AG, 2003, J PERS SOC PSYCHOL, V85, P197, DOI 10.1037/0022-3514.85.2.197; Greenwald AG, 2006, CALIF LAW REV, V94, P945, DOI 10.2307/20439056; Henry PJ, 2006, PSYCHOL SCI, V17, P862, DOI 10.1111/j.1467-9280.2006.01795.x; Huguet P, 2007, J EDUC PSYCHOL, V99, P545, DOI 10.1037/0022-0663.99.3.545; Huguet P, 2009, J EXP SOC PSYCHOL, V45, P1024, DOI 10.1016/j.jesp.2009.04.029; JULIANREYNIER C, 1995, J MED GENET, V32, P597, DOI 10.1136/jmg.32.8.597; Lawson KL, 2010, J APPL SOC PSYCHOL, V40, P554, DOI 10.1111/j.1559-1816.2010.00587.x; LEVY JM, 1993, J REHABIL, V59, P49; Maras P, 1996, J APPL SOC PSYCHOL, V26, P2113, DOI 10.1111/j.1559-1816.1996.tb01790.x; Mason MF, 2006, SOC COGNITION, V24, P540, DOI 10.1521/soco.2006.24.5.540; Mazerolles M, 2012, PSYCHOL SCI IN PRESS; McConnell AR, 2001, J EXP SOC PSYCHOL, V37, P435, DOI 10.1006/jesp.2000.1470; McKown C, 2003, CHILD DEV, V74, P498, DOI 10.1111/1467-8624.7402012; MENOLASCINO FJ, 1965, AM J MENT DEF, V69, P653; Mepsted J, 1988, SPECIAL CHILDREN, V17, P14; Morris JK, 2009, BRIT MED J, V339, DOI 10.1136/bmj.b3794; Murthy SK, 2007, MED PRIN PRACT, V16, P25, DOI 10.1159/000096136; Nosek BA, 2009, P NATL ACAD SCI USA, V106, P10593, DOI 10.1073/pnas.0809921106; Olsen CL, 2003, HUM BIOL, V75, P503, DOI 10.1353/hub.2003.0059; Pace JE, 2010, AM J MED GENET A, V152A, P2185, DOI 10.1002/ajmg.a.33595; Peris TS, 2008, J NERV MENT DIS, V196, P752, DOI 10.1097/NMD.0b013e3181879dfd; Prestwich A, 2008, BRIT J SOC PSYCHOL, V47, P575, DOI 10.1348/014466607X267470; Regner I, 2010, PSYCHOL SCI, V21, P1646, DOI 10.1177/0956797610386619; Richetin J, 2007, INT J PSYCHOL, V42, P166, DOI 10.1080/00207590601067078; Robey KL, 2006, J DEV PHYS DISABIL, V18, P441, DOI 10.1007/s10882-006-9027-3; Rojahn J, 2008, J DEV PHYS DISABIL, V20, P389, DOI 10.1007/s10882-008-9108-6; Sirlopu D, 2008, J APPL SOC PSYCHOL, V38, P2710, DOI 10.1111/j.1559-1816.2008.00411.x; STEELE CM, 1995, J PERS SOC PSYCHOL, V69, P797, DOI 10.1037/0022-3514.69.5.797; Thomas A, 2007, J REHABIL, V73, P3; Turner RN, 2010, BRIT J SOC PSYCHOL, V49, P129, DOI 10.1348/014466609X419901; Unger D. D., 2002, FOCUS AUTISM DEV DIS, V17, P2, DOI [10.1177/108835760201700101, DOI 10.1177/108835760201700101]; White MJ, 2006, J REHABIL, V72, P33; Wilson TD, 2000, PSYCHOL REV, V107, P101, DOI 10.1037/0033-295X.107.1.101; Wishart JG, 1996, J INTELL DISABIL RES, V40, P56, DOI 10.1111/j.1365-2788.1996.tb00603.x	56	31	31	1	41	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 4	2012	7	4							e34369	10.1371/journal.pone.0034369	http://dx.doi.org/10.1371/journal.pone.0034369			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	953GO	22496796	gold, Green Published			2022-12-25	WOS:000304855200043
J	Khrameeva, EE; Mironov, AA; Fedonin, GG; Khaitovich, P; Gelfand, MS				Khrameeva, Ekaterina E.; Mironov, Andrey A.; Fedonin, Gennady G.; Khaitovich, Philipp; Gelfand, Mikhail S.			Spatial Proximity and Similarity of the Epigenetic State of Genome Domains	PLOS ONE			English	Article							INTEGRATIVE ANALYSIS; SEMANTIC SIMILARITY; CHROMATIN; MONOMETHYLATION; DISCOVERY	Recent studies demonstrate that the organization of the chromatin within the nuclear space might play a crucial role in the regulation of gene expression. The ongoing progress in determination of the 3D structure of the nuclear chromatin allows one to study correlations between spatial proximity of genome domains and their epigenetic state. We combined the data on three-dimensional architecture of the whole human genome with results of high-throughput studies of the chromatin functional state and observed that fragments of different chromosomes that are spatially close tend to have similar patterns of histone modifications, methylation state, DNAse sensitivity, expression level, and chromatin states in general. Moreover, clustering of genome regions by spatial proximity produced compact clusters characterized by the high level of histone modifications and DNAse sensitivity and low methylation level, and loose clusters with the opposite characteristics. We also associated the spatial proximity data with previously detected chimeric transcripts and the results of RNA-seq experiments and observed that the frequency of formation of chimeric transcripts from fragments of two different chromosomes is higher among spatially proximal genome domains. A fair fraction of these chimeric transcripts seems to arise post-transcriptionally via trans-splicing.	[Khrameeva, Ekaterina E.; Mironov, Andrey A.; Fedonin, Gennady G.; Gelfand, Mikhail S.] Russian Acad Sci, Inst Informat Transmiss Problems, Moscow, Russia; [Khrameeva, Ekaterina E.; Mironov, Andrey A.; Gelfand, Mikhail S.] Moscow MV Lomonosov State Univ, Fac Bioengn & Bioinformat, Moscow, Russia; [Khaitovich, Philipp] Shanghai Inst Biol Sci, Partner Inst Computat Biol, Shanghai, Peoples R China; [Khaitovich, Philipp] Max Planck Inst Evolutionary Anthropol, Leipzig, Germany	Kharkevich Institute for Information Transmission Problems of the RAS; Russian Academy of Sciences; Lomonosov Moscow State University; Chinese Academy of Sciences; Shanghai Institutes for Biological Sciences, CAS; Max Planck Society	Khrameeva, EE (corresponding author), Russian Acad Sci, Inst Informat Transmiss Problems, Moscow, Russia.	khrameeva@genebee.msu.ru	Khrameeva, Ekaterina/I-3620-2015; Fedonin, Gennady/M-5786-2014; Gelfand, Mikhail S/F-3425-2012; Khaitovich, Philipp/HGC-8520-2022; Mironov, Andrey/C-8024-2012	Khrameeva, Ekaterina/0000-0001-6188-9139; Fedonin, Gennady/0000-0002-9427-8083; Gelfand, Mikhail/0000-0003-4181-0846	Russian Foundation of Basic Research [10-04-00783, 09-04-92745, 09-04-92742]; Russian Academy of Sciences;  [07.514.11.4007];  [14.740.11.0003]	Russian Foundation of Basic Research(Russian Foundation for Basic Research (RFBR)); Russian Academy of Sciences(Russian Academy of Sciences); ; 	This work was supported by State contracts [07.514.11.4007, 14.740.11.0003]; the Russian Foundation of Basic Research [10-04-00783 to EK, 09-04-92745 to MG, and 09-04-92742 to AM]; and the Russian Academy of Sciences ["Molecular and Cellular Biology", "Basic Science for Medicine"]. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	[Anonymous], 2010, R LANG ENV STAT COMP; Berger MF, 2010, GENOME RES, V20, P413, DOI 10.1101/gr.103697.109; Bernstein BE, 2007, CELL, V128, P669, DOI 10.1016/j.cell.2007.01.033; Bock C, 2008, BIOINFORMATICS, V24, P1, DOI 10.1093/bioinformatics/btm546; Camacho C, 2009, BMC BIOINFORMATICS, V10, DOI 10.1186/1471-2105-10-421; Cocquet J, 2006, GENOMICS, V88, P127, DOI 10.1016/j.ygeno.2005.12.013; CREMER T, 1982, HUM GENET, V60, P46, DOI 10.1007/BF00281263; Dekker J, 2002, SCIENCE, V295, P1306, DOI 10.1126/science.1067799; Denoeud F, 2007, GENOME RES, V17, P746, DOI 10.1101/gr.5660607; Dorigo B, 2003, J MOL BIOL, V327, P85, DOI 10.1016/S0022-2836(03)00025-1; Ernst J, 2010, NAT BIOTECHNOL, V28, P817, DOI 10.1038/nbt.1662; Feingold EA, 2004, SCIENCE, V306, P636, DOI 10.1126/science.1105136; Gerstein MB, 2010, SCIENCE, V330, P1775, DOI 10.1126/science.1196914; Gingeras TR, 2009, NATURE, V461, P206, DOI 10.1038/nature08452; Houston SI, 2008, J BIOL CHEM, V283, P19478, DOI 10.1074/jbc.M710579200; Hubner MR, 2010, ANNU REV BIOPHYS, V39, P471, DOI 10.1146/annurev.biophys.093008.131348; Karolchik D, 2003, NUCLEIC ACIDS RES, V31, P51, DOI 10.1093/nar/gkg129; Kidd JM, 2008, NATURE, V453, P56, DOI 10.1038/nature06862; Kim P, 2010, NUCLEIC ACIDS RES, V38, pD81, DOI 10.1093/nar/gkp982; Kouzarides T, 2007, CELL, V128, P693, DOI 10.1016/j.cell.2007.02.005; Li RQ, 2008, BIOINFORMATICS, V24, P713, DOI 10.1093/bioinformatics/btn025; Li X, 2009, J MOL EVOL, V68, P56, DOI 10.1007/s00239-008-9187-0; Li ZF, 2011, P NATL ACAD SCI USA, V108, P3116, DOI 10.1073/pnas.1009353108; Lieberman-Aiden E, 2009, SCIENCE, V326, P289, DOI 10.1126/science.1181369; Liu W, 2010, NATURE, V466, P508, DOI 10.1038/nature09272; Lowe CB, 2007, P NATL ACAD SCI USA, V104, P8005, DOI 10.1073/pnas.0611223104; Maher CA, 2009, P NATL ACAD SCI USA, V106, P12353, DOI 10.1073/pnas.0904720106; Maher CA, 2009, NATURE, V458, P97, DOI 10.1038/nature07638; McManus CJ, 2010, P NATL ACAD SCI USA, V107, P12975, DOI 10.1073/pnas.1007586107; Obayashi T, 2011, NUCLEIC ACIDS RES, V39, pD1016, DOI 10.1093/nar/gkq1147; Roy S, 2010, SCIENCE, V330, P1787, DOI 10.1126/science.1198374; Schones DE, 2008, NAT REV GENET, V9, P179, DOI 10.1038/nrg2270; Schotta G, 2008, GENE DEV, V22, P2048, DOI 10.1101/gad.476008; Talasz H, 2005, J BIOL CHEM, V280, P38814, DOI 10.1074/jbc.M505563200; Tikhonov A. N., 1943, DOKL AKAD NAUK SSSR, V39, P195; Vakoc CR, 2006, MOL CELL BIOL, V26, P9185, DOI 10.1128/MCB.01529-06; Wang JZ, 2007, BIOINFORMATICS, V23, P1274, DOI 10.1093/bioinformatics/btm087; WARD JH, 1963, J AM STAT ASSOC, V58, P236, DOI 10.2307/2282967; Williams A, 2010, TRENDS GENET, V26, P188, DOI 10.1016/j.tig.2010.01.007; Xu AG, 2010, PLOS COMPUT BIOL, V6, DOI 10.1371/journal.pcbi.1000843; Yaffe E, 2011, NAT GENET, V43, P1059, DOI 10.1038/ng.947; Yu GC, 2010, BIOINFORMATICS, V26, P976, DOI 10.1093/bioinformatics/btq064; Yu H, 2008, GENOME RES, V18, P1314, DOI 10.1101/gr.073080.107	43	10	13	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 4	2012	7	4							e33947	10.1371/journal.pone.0033947	http://dx.doi.org/10.1371/journal.pone.0033947			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	953GO	22496774	Green Published, gold, Green Submitted			2022-12-25	WOS:000304855200027
J	Pryor, S; McCaffrey, G; Young, LR; Grimes, ML				Pryor, Shona; McCaffrey, Gretchen; Young, Lindsay R.; Grimes, Mark L.			NGF Causes TrkA to Specifically Attract Microtubules to Lipid Rafts	PLOS ONE			English	Article							NERVE GROWTH-FACTOR; P75 NEUROTROPHIN RECEPTOR; SIGNALING ENDOSOMES; PC12 CELLS; ENDOCYTIC PATHWAY; POSTTRANSLATIONAL MODIFICATIONS; MEMBRANE TRAFFICKING; NEURONAL APOPTOSIS; TYROSINE KINASE; PLASMA-MEMBRANE	Membrane protein sorting is mediated by interactions between proteins and lipids. One mechanism that contributes to sorting involves patches of lipids, termed lipid rafts, which are different from their surroundings in lipid and protein composition. Although the nerve growth factor (NGF) receptors, TrkA and p75(NTR) collaborate with each other at the plasma membrane to bind NGF, these two receptors are endocytosed separately and activate different cellular responses. We hypothesized that receptor localization in membrane rafts may play a role in endocytic sorting. TrkA and p75(NTR) both reside in detergent-resistant membranes (DRMs), yet they responded differently to a variety of conditions. The ganglioside, GM1, caused increased association of NGF, TrkA, and microtubules with DRMs, but a decrease in p75(NTR). When microtubules were induced to polymerize and attach to DRMs by in vitro reactions, TrkA, but not p75(NTR), was bound to microtubules in DRMs and in a detergent-resistant endosomal fraction. NGF enhanced the interaction between TrkA and microtubules in DRMs, yet tyrosine phosphorylated TrkA was entirely absent in DRMs under conditions where activated TrkA was detected in detergent-sensitive membranes and endosomes. These data indicate that TrkA and p75(NTR) partition into membrane rafts by different mechanisms, and that the fraction of TrkA that associates with DRMs is internalized but does not directly form signaling endosomes. Rather, by attracting microtubules to lipid rafts, TrkA may mediate other processes such as axon guidance.	[Pryor, Shona; Young, Lindsay R.] Massey Univ, Inst Mol Biosci, Palmerston North, New Zealand; [McCaffrey, Gretchen; Young, Lindsay R.; Grimes, Mark L.] Univ Montana, Div Biol Sci, Missoula, MT 59812 USA; [Grimes, Mark L.] Univ Montana, Ctr Struct & Funct Neurosci, Missoula, MT 59812 USA	Massey University; University of Montana System; University of Montana; University of Montana System; University of Montana	Pryor, S (corresponding author), AgResearch Ltd, Ruakura Res Ctr, Hamilton, New Zealand.	Mark.Grimes@mso.umt.edu			Whitehall Foundation; NIH [NS070746-01, NS061303-01]; NIH COBRE NCRR [P20 RR015583]; NIH BRIN NCRR [PR-16455-02]; Health Research Council; Cancer Society; Neurological Foundation; Lottery Health; Real Kids Trust; Palmerston North Medical Research Foundation; Massey University; Lottery Science; NATIONAL CENTER FOR RESEARCH RESOURCES [P20RR015583] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R15NS070746, R15NS061303] Funding Source: NIH RePORTER	Whitehall Foundation; NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NIH COBRE NCRR; NIH BRIN NCRR; Health Research Council; Cancer Society; Neurological Foundation; Lottery Health; Real Kids Trust; Palmerston North Medical Research Foundation; Massey University; Lottery Science; NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))	MG was supported by the Whitehall Foundation (www.whitehall.org/), NIH NS070746-01, NS061303-01, NIH COBRE NCRR Grant # P20 RR015583, NIH BRIN NCRR Grant #PR-16455-02 and New Zealand Funding from: Health Research Council, Cancer Society, Neurological Foundation, Lottery Health, Lottery Science, Real Kids Trust, Palmerston North Medical Research Foundation, and Massey University. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aguilar RC, 2005, P NATL ACAD SCI USA, V102, P2679, DOI 10.1073/pnas.0500213102; Bamji SX, 1998, J CELL BIOL, V140, P911, DOI 10.1083/jcb.140.4.911; BANDTLOW C, 2004, SCI STKE, pPE24, DOI DOI 10.1126/STKE.2352004PE24; Bartheld von CS, 2011, PROG NEUROBIOL, DOI [10.1016/j.pneurobio.2011.01.003, DOI 10.1016/J.PNEUROBI0.2011.01.003]; Beattie EC, 2000, J NEUROSCI, V20, P7325; Bilderback TR, 1999, J BIOL CHEM, V274, P257, DOI 10.1074/jbc.274.1.257; Bronfman FC, 2003, J NEUROSCI, V23, P3209; Canossa M, 1996, EMBO J, V15, P3369, DOI 10.1002/j.1460-2075.1996.tb00702.x; Chen H, 2005, P NATL ACAD SCI USA, V102, P2766, DOI 10.1073/pnas.0409719102; de Pablo Y, 2008, J NEUROCHEM, V104, P124, DOI 10.1111/j.1471-4159.2007.05027.x; Dechant G, 2002, NAT NEUROSCI, V5, P1131, DOI 10.1038/nn1102-1131; Deinhardt K, 2007, TRAFFIC, V8, P1736, DOI 10.1111/j.1600-0854.2007.00645.x; del Pozo MA, 2004, SCIENCE, V303, P839, DOI 10.1126/science.1092571; Dixon SJ, 2006, BBA-MOL CELL RES, V1763, P366, DOI 10.1016/j.bbamcr.2006.02.009; DRUBIN D, 1988, J CELL BIOL, V106, P1583, DOI 10.1083/jcb.106.5.1583; DRUBIN DG, 1985, J CELL BIOL, V101, P1799, DOI 10.1083/jcb.101.5.1799; Esposito D, 2001, J BIOL CHEM, V276, P32687, DOI 10.1074/jbc.M011674200; Farooqui T, 1997, J NEUROCHEM, V68, P2348; FERRARI G, 1995, J BIOL CHEM, V270, P3074, DOI 10.1074/jbc.270.7.3074; Francois F, 2001, MOL CELL NEUROSCI, V18, P347, DOI 10.1006/mcne.2001.1035; Fukushima N, 2009, J NEUROCHEM, V109, P683, DOI 10.1111/j.1471-4159.2009.06013.x; Galjart N, 2003, CURR OPIN CELL BIOL, V15, P48, DOI 10.1016/S0955-0674(02)00007-8; Geetha T, 2008, TRAFFIC, V9, P1146, DOI 10.1111/j.1600-0854.2008.00751.x; Glebov OO, 2006, NAT CELL BIOL, V8, P46, DOI 10.1038/ncb1342; GREENE LA, 1987, METHOD ENZYMOL, V147, P207; Grimes ML, 1997, P NATL ACAD SCI USA, V94, P9909, DOI 10.1073/pnas.94.18.9909; Grimes ML, 1996, J NEUROSCI, V16, P7950; Grimes ML, 2003, J NEUROCHEM, V84, P905, DOI 10.1046/j.1471-4159.2003.01603.x; Haglund K, 2003, NAT CELL BIOL, V5, P461, DOI 10.1038/ncb983; HANTZOPOULOS PA, 1994, NEURON, V13, P187, DOI 10.1016/0896-6273(94)90469-3; Harrington AW, 2011, CELL, V146, P421, DOI 10.1016/j.cell.2011.07.008; Head BP, 2006, J BIOL CHEM, V281, P26391, DOI 10.1074/jbc.M602577200; Hibbert AP, 2006, MOL CELL NEUROSCI, V32, P387, DOI 10.1016/j.mcn.2006.06.001; Higuchi H, 2003, EMBO J, V22, P1790, DOI 10.1093/emboj/cdg177; Hoeller D, 2005, CURR OPIN CELL BIOL, V17, P107, DOI 10.1016/j.ceb.2005.01.001; Howe CL, 2001, NEURON, V32, P801, DOI 10.1016/S0896-6273(01)00526-8; Hryciw T, 2010, J NEUROCHEM, V112, P924, DOI 10.1111/j.1471-4159.2009.06503.x; Huang C, 1999, J BIOL CHEM, V274, P36707, DOI 10.1074/jbc.274.51.36707; HUBER LJ, 1995, J NEUROSCI RES, V40, P557, DOI 10.1002/jnr.490400415; Ibanez CF, 2004, NEURON, V42, P3, DOI 10.1016/S0896-6273(04)00194-1; Kamiguchi H, 2006, J NEUROCHEM, V98, P330, DOI 10.1111/j.1471-4159.2006.03888.x; Lakadamyali M, 2006, CELL, V124, P997, DOI 10.1016/j.cell.2005.12.038; Lasiecka ZM, 2011, MOL CELL NEUROSCI, V48, P278, DOI 10.1016/j.mcn.2011.06.013; Lingwood D, 2010, SCIENCE, V327, P46, DOI 10.1126/science.1174621; MacCormick M, 2005, BIOCHEM J, V387, P155, DOI 10.1042/BJ20040272; Madshus IH, 2006, TRAFFIC, V7, P258, DOI 10.1111/j.1600-0854.2006.00393.x; Makkerh JPS, 2005, EMBO REP, V6, P936, DOI 10.1038/sj.embor.7400503; McCaffrey G, 2009, TRAFFIC, V10, P938, DOI 10.1111/j.1600-0854.2009.00909.x; Miller FD, 2001, CELL MOL LIFE SCI, V58, P1045, DOI 10.1007/PL00000919; MUTOH T, 1995, P NATL ACAD SCI USA, V92, P5087, DOI 10.1073/pnas.92.11.5087; Neumann-Giesen C, 2007, J CELL SCI, V120, P395, DOI 10.1242/jcs.03336; Nichols BJ, 2003, CURR BIOL, V13, P686, DOI 10.1016/S0960-9822(03)00209-4; Nishio M, 2004, J BIOL CHEM, V279, P33368, DOI 10.1074/jbc.M403816200; Palazzo AF, 2004, SCIENCE, V303, P836, DOI 10.1126/science.1091325; Paratcha G, 2002, CURR OPIN NEUROBIOL, V12, P542, DOI 10.1016/S0959-4388(02)00363-X; Perret E, 2005, CURR OPIN CELL BIOL, V17, P423, DOI 10.1016/j.ceb.2005.06.008; Philippidou P, 2011, P NATL ACAD SCI USA, V108, P852, DOI 10.1073/pnas.1015981108; Pike LJ, 2003, J LIPID RES, V44, P655, DOI 10.1194/jlr.R200021-JLR200; Polo S, 2006, CELL, V124, P897, DOI 10.1016/j.cell.2006.02.025; Polo S, 2002, NATURE, V416, P451, DOI 10.1038/416451a; RABIN SJ, 1995, J NEUROCHEM, V65, P347; Sadowski L, 2009, EXP CELL RES, V315, P1601, DOI 10.1016/j.yexcr.2008.09.021; Saxena S, 2005, MOL CELL NEUROSCI, V28, P571, DOI 10.1016/j.mcn.2004.11.011; Schwarz LA, 2012, MOL CELL NEUROSCI, V49, P387, DOI 10.1016/j.mcn.2011.08.006; Shao YF, 2002, J CELL BIOL, V157, P679, DOI 10.1083/jcb.200201063; Sigismund S, 2005, P NATL ACAD SCI USA, V102, P2760, DOI 10.1073/pnas.0409817102; Simons K, 2000, NAT REV MOL CELL BIO, V1, P31, DOI 10.1038/35036052; Simons K, 2010, NAT REV MOL CELL BIO, V11, P688, DOI 10.1038/nrm2977; Suzuki S, 2004, J CELL BIOL, V167, P1205, DOI 10.1083/jcb.200404106; Tsui-Pierchala BA, 2002, TRENDS NEUROSCI, V25, P412, DOI 10.1016/S0166-2236(02)02215-4; Ueda A, 2010, MOL CELL NEUROSCI, V45, P355, DOI 10.1016/j.mcn.2010.07.008; Valdez G, 2005, J NEUROSCI, V25, P5236, DOI 10.1523/JNEUROSCI.5104-04.2005; Valdez G, 2007, P NATL ACAD SCI USA, V104, P12270, DOI 10.1073/pnas.0702819104; Winckler B, 2011, TRAFFIC, V12, P1099, DOI 10.1111/j.1600-0854.2011.01213.x; Wloga D, 2010, J CELL SCI, V123, P3447, DOI 10.1242/jcs.063727; Wu CB, 2007, TRAFFIC, V8, P1503, DOI 10.1111/j.1600-0854.2007.00636.x; Yamashita T, 2005, MOL NEUROBIOL, V32, P105, DOI 10.1385/MN:32:2:105; Yu WY, 2004, FEBS LETT, V577, P87, DOI 10.1016/j.febslet.2004.09.068; Zheng J, 2008, J BIOL CHEM, V283, P13280, DOI 10.1074/jbc.M709930200; Zhou FQ, 2006, J CELL SCI, V119, P2787, DOI 10.1242/jcs.03016; Zhou FQ, 2004, NEURON, V42, P897, DOI 10.1016/j.neuron.2004.05.011; Zweifel LS, 2005, NAT REV NEUROSCI, V6, P615, DOI 10.1038/nrn1727	82	22	22	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 4	2012	7	4							e35163	10.1371/journal.pone.0035163	http://dx.doi.org/10.1371/journal.pone.0035163			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	953GO	22496904	Green Published, Green Submitted, gold			2022-12-25	WOS:000304855200101
J	Rahman, S; Quann, K; Pandya, D; Singh, S; Khan, ZK; Jain, P				Rahman, Saifur; Quann, Kevin; Pandya, Devanshi; Singh, Shruti; Khan, Zafar K.; Jain, Pooja			HTLV-1 Tax Mediated Downregulation of miRNAs Associated with Chromatin Remodeling Factors in T Cells with Stably Integrated Viral Promoter	PLOS ONE			English	Article							VIRUS TYPE-I; MYELOPATHY/TROPICAL SPASTIC PARAPARESIS; CENTRAL-NERVOUS-SYSTEM; LONG TERMINAL REPEAT; TYPE-1 TAX; TRANSCRIPTIONAL ACTIVATION; HISTONE ACETYLTRANSFERASE; ASYMPTOMATIC CARRIERS; 21-BASE-PAIR REPEATS; BASAL TRANSCRIPTION	RNA interference (RNAi) is a natural cellular mechanism to silence gene expression and is predominantly mediated by microRNAs (miRNAs) that target messenger RNA. Viruses can manipulate the cellular processes necessary for their replication by targeting the host RNAi machinery. This study explores the effect of human T-cell leukemia virus type 1 (HTLV-1) transactivating protein Tax on the RNAi pathway in the context of a chromosomally integrated viral long terminal repeat (LTR) using a CD4(+) T-cell line, Jurkat. Transcription factor profiling of the HTLV-1 LTR stably integrated T-cell clone transfected with Tax demonstrates increased activation of substrates and factors associated with chromatin remodeling complexes. Using a miRNA microarray and bioinformatics experimental approach, Tax was also shown to downregulate the expression of miRNAs associated with the translational regulation of factors required for chromatin remodeling. These observations were validated with selected miRNAs and an HTLV-1 infected T cells line, MT-2. miR-149 and miR-873 were found to be capable of directly targeting p300 and p/CAF, chromatin remodeling factors known to play critical role in HTLV-1 pathogenesis. Overall, these results are first in line establishing HTLV-1/Tax-miRNA-chromatin concept and open new avenues toward understanding retroviral latency and/or replication in a given cell type.	[Rahman, Saifur; Quann, Kevin; Pandya, Devanshi; Singh, Shruti; Khan, Zafar K.; Jain, Pooja] Drexel Univ, Coll Med, Drexel Inst Biotechnol & Virol Res, Dept Microbiol & Immunol, Philadelphia, PA 19104 USA	Drexel University	Rahman, S (corresponding author), Drexel Univ, Coll Med, Drexel Inst Biotechnol & Virol Res, Dept Microbiol & Immunol, Philadelphia, PA 19104 USA.	pjain@drexelmed.edu	Rahman, Saifur/D-8569-2012		United States Public Health Service/National Institutes of Health [AI077414, AI093172]; NATIONAL CANCER INSTITUTE [R01CA054559] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI077414, R21AI093172, R56AI077414] Funding Source: NIH RePORTER	United States Public Health Service/National Institutes of Health(United States Department of Health & Human ServicesUnited States Public Health ServiceNational Institutes of Health (NIH) - USA); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	These studies were supported by the United States Public Health Service/National Institutes of Health grants: AI077414 to Dr. Jain and AI093172 to Dr. Khan. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ADYA N, 1995, J VIROL, V69, P1834, DOI 10.1128/JVI.69.3.1834-1841.1995; Azran Inbal, 2004, Retrovirology, V1, P20; Bangham CRM, 2003, J GEN VIROL, V84, P3177, DOI 10.1099/vir.0.19334-0; Bantignies F, 1996, MOL CELL BIOL, V16, P2174; Barnhart MK, 1997, J VIROL, V71, P337, DOI 10.1128/JVI.71.1.337-344.1997; Bartel DP, 2004, CELL, V116, P281, DOI 10.1016/S0092-8674(04)00045-5; BEIMLING P, 1992, ONCOGENE, V7, P257; Belandia B, 2003, CELL, V114, P277, DOI 10.1016/S0092-8674(03)00599-3; Bellon M, 2009, BLOOD, V113, P4914, DOI 10.1182/blood-2008-11-189845; Benkirane M, 1998, J BIOL CHEM, V273, P24898, DOI 10.1074/jbc.273.38.24898; Bennasser Y, 2005, IMMUNITY, V22, P607, DOI 10.1016/j.immuni.2005.03.010; Bennasser Yamina, 2004, Retrovirology, V1, P43, DOI 10.1186/1742-4690-1-43; Bodor J, 1995, FEBS LETT, V377, P413, DOI 10.1016/0014-5793(95)01299-0; Bogenberger JM, 2008, RETROVIROLOGY, V5, DOI 10.1186/1742-4690-5-9; Cullen BR, 2006, NAT GENET, V38, pS25, DOI 10.1038/ng1793; de Vries W, 2008, GENE THER, V15, P545, DOI 10.1038/gt.2008.12; Derse D, 2007, J VIROL, V81, P6731, DOI 10.1128/JVI.02752-06; Doi K, 2005, BLOOD, V106, P1048, DOI 10.1182/blood-2004-11-4350; Doucas V, 1999, P NATL ACAD SCI USA, V96, P2633, DOI 10.1073/pnas.96.6.2633; Easley R, 2010, J VIROL, V84, P4755, DOI 10.1128/JVI.00851-09; Edlich RF, 2000, J EMERG MED, V18, P109, DOI 10.1016/S0736-4679(99)00173-0; El Kharroubi A, 1998, MOL CELL BIOL, V18, P2535, DOI 10.1128/MCB.18.5.2535; Elgin SCR, 1990, CURR OPIN CELL BIOL, V2, P437, DOI 10.1016/0955-0674(90)90125-X; Fazi F, 2007, CANCER CELL, V12, P457, DOI 10.1016/j.ccr.2007.09.020; Gallo RC, 2005, RETROVIROLOGY, V2, DOI 10.1186/1742-4690-2-17; GESSAIN A, 1985, LANCET, V2, P407; Grant C, 2002, J CELL PHYSIOL, V190, P133, DOI 10.1002/JCP.10053; Grant C, 2006, J LEUKOCYTE BIOL, V80, P640, DOI 10.1189/jlb.1205723; Hakim ST, 2008, BIOCHEM BIOPH RES CO, V369, P357, DOI 10.1016/j.bbrc.2008.02.025; Harrod R, 2000, J BIOL CHEM, V275, P11852, DOI 10.1074/jbc.275.16.11852; Harrod R, 1998, MOL CELL BIOL, V18, P5052, DOI 10.1128/MCB.18.9.5052; Hayashi D, 2008, J NEUROVIROL, V14, P459, DOI 10.1080/13550280802178538; Hobert O, 2008, SCIENCE, V319, P1785, DOI 10.1126/science.1151651; HOLLSBERG P, 1993, NEW ENGL J MED, V328, P1173, DOI 10.1056/NEJM199304223281608; Huang JL, 2007, NAT MED, V13, P1241, DOI 10.1038/nm1639; Igakura T, 2003, SCIENCE, V299, P1713, DOI 10.1126/science.1080115; Jiang H, 1999, MOL CELL BIOL, V19, P8136; Johnnidis JB, 2008, NATURE, V451, P1125, DOI 10.1038/nature06607; Jones KS, 2008, NAT MED, V14, P429, DOI 10.1038/nm1745; Jopling CL, 2005, SCIENCE, V309, P1577, DOI 10.1126/science.1113329; Kashanchi F, 1998, J BIOL CHEM, V273, P34646, DOI 10.1074/jbc.273.51.34646; Kishimoto M, 2006, ENDOCR J, V53, P157, DOI 10.1507/endocrj.53.157; KIYOKAWA T, 1984, GANN, V75, P747; Koszewski NJ, 2003, J STEROID BIOCHEM, V87, P223, DOI 10.1016/j.jsbmb.2003.09.006; Kwok RPS, 1996, NATURE, V380, P642, DOI 10.1038/380642a0; Lecellier CH, 2005, SCIENCE, V308, P557, DOI 10.1126/science.1108784; LEHKY TJ, 1995, ANN NEUROL, V37, P167, DOI 10.1002/ana.410370206; Lenzmeier BA, 1998, MOL CELL BIOL, V18, P721, DOI 10.1128/MCB.18.2.721; Lin J, 2007, J VIROL, V81, P12218, DOI 10.1128/JVI.01390-07; Marzio G, 2001, P NATL ACAD SCI USA, V98, P6342, DOI 10.1073/pnas.111031498; Matsuoka M, 2007, NAT REV CANCER, V7, P270, DOI 10.1038/nrc2111; Meekings KN, 2008, PLOS PATHOG, V4, DOI 10.1371/journal.ppat.1000027; Merkenschlager M, 2008, CURR OPIN IMMUNOL; Nagai M, 1998, J NEUROVIROL, V4, P586, DOI 10.3109/13550289809114225; Nagai M, 2001, BLOOD, V98, P1858, DOI 10.1182/blood.V98.6.1858; Newbound GC, 1996, J VIROL, V70, P2101, DOI 10.1128/JVI.70.4.2101-2106.1996; Nie ZQ, 2000, MOL CELL BIOL, V20, P8879, DOI 10.1128/MCB.20.23.8879-8888.2000; Okada M, 2002, J VIROL, V76, P12564, DOI 10.1128/JVI.76.24.12564-12573.2002; OSAME M, 1986, LANCET, V1, P1031; PACAUCCARALERTKUN S, 1994, MOL CELL BIOL, V14, P456, DOI 10.1128/MCB.14.1.456; Pais-Correia AM, 2010, NAT MED, V16, P83, DOI 10.1038/nm.2065; PALUTKE M, 1977, AM J CLIN PATHOL, V68, P429; Pandya D, 2007, FUTURE VIROL, V2, P481, DOI 10.2217/17460794.2.5.481; Persaud D, 2003, J VIROL, V77, P1659, DOI 10.1128/JVI.77.3.1659-1665.2003; Pichler K, 2008, RETROVIROLOGY, V5, DOI 10.1186/1742-4690-5-100; POIESZ BJ, 1980, P NATL ACAD SCI-BIOL, V77, P7415, DOI 10.1073/pnas.77.12.7415; Quivy Vincent, 2007, Subcell Biochem, V41, P371; Richardson JH, 1997, BLOOD, V89, P3303, DOI 10.1182/blood.V89.9.3303; Rossi C, 1999, J MED VIROL, V58, P264, DOI 10.1002/(SICI)1096-9071(199907)58:3<264::AID-JMV12>3.0.CO;2-V; Rusinov V, 2005, NUCLEIC ACIDS RES, V33, pW696, DOI 10.1093/nar/gki364; SCHECHTER GP, 1977, BLOOD, V49, P651; Scoggin KES, 2001, MOL CELL BIOL, V21, P5520, DOI 10.1128/MCB.21.16.5520-5530.2001; SHINZATO O, 1991, BLOOD, V78, P2082; Silva MTT, 2007, CLIN INFECT DIS, V44, P689, DOI 10.1086/510679; SODROSKI JG, 1984, SCIENCE, V225, P381, DOI 10.1126/science.6330891; SUZUKI T, 1993, ONCOGENE, V8, P2391; Takatsuki K, 2005, RETROVIROLOGY, V2, DOI 10.1186/1742-4690-2-16; TATENO M, 1984, J EXP MED, V159, P1105, DOI 10.1084/jem.159.4.1105; Tie F, 1996, J VIROL, V70, P8368, DOI 10.1128/JVI.70.12.8368-8374.1996; TOMITA M, 2009, INT J CANC; Triboulet R, 2007, SCIENCE, V315, P1579, DOI 10.1126/science.1136319; Uchiyama T, 1997, ANNU REV IMMUNOL, V15, P15, DOI 10.1146/annurev.immunol.15.1.15; Ureta-Vidal A, 2001, J INFECT DIS, V183, P857, DOI 10.1086/319264; Waziri A, 2000, J VIROL, V74, P2178, DOI 10.1128/JVI.74.5.2178-2185.2000; Yeung ML, 2008, CANCER RES, V68, P8976, DOI 10.1158/0008-5472.CAN-08-0769; Yeung ML, 2005, RETROVIROLOGY, V2, DOI 10.1186/1742-4690-2-81; ZHAO LJ, 1992, P NATL ACAD SCI USA, V89, P7070, DOI 10.1073/pnas.89.15.7070	87	26	28	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 4	2012	7	4							e34490	10.1371/journal.pone.0034490	http://dx.doi.org/10.1371/journal.pone.0034490			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	953GO	22496815	Green Published, gold			2022-12-25	WOS:000304855200056
J	Brasme, JF; Grill, J; Doz, F; Lacour, B; Valteau-Couanet, D; Gaillard, S; Delalande, O; Aghakhani, N; Puget, S; Chalumeau, M				Brasme, Jean-Francois; Grill, Jacques; Doz, Francois; Lacour, Brigitte; Valteau-Couanet, Dominique; Gaillard, Stephan; Delalande, Olivier; Aghakhani, Nozar; Puget, Stephanie; Chalumeau, Martin			Long Time to Diagnosis of Medulloblastoma in Children Is Not Associated with Decreased Survival or with Worse Neurological Outcome	PLOS ONE			English	Article							HIGH-DOSE CHEMOTHERAPY; BRAIN-TUMORS; CHILDHOOD-CANCER; SYMPTOM ONSET; RISK MEDULLOBLASTOMA; DELAY; FRANCE; CLASSIFICATION; REGISTRIES; INTERVAL	Background: The long time to diagnosis of medulloblastoma, one of the most frequent brain tumors in children, is the source of painful remorse and sometimes lawsuits. We analyzed its consequences for tumor stage, survival, and sequelae. Patients and Methods: This retrospective population-based cohort study included all cases of pediatric medulloblastoma from a region of France between 1990 and 2005. We collected the demographic, clinical, and tumor data and analyzed the relations between the interval from symptom onset until diagnosis, initial disease stage, survival, and neuropsychological and neurological outcome. Results:The median interval from symptom onset until diagnosis for the 166 cases was 65 days (interquartile range 31-121, range 3-457). A long interval (defined as longer than the median) was associated with a lower frequency of metastasis in the univariate and multivariate analyses and with a larger tumor volume, desmoplastic histology, and longer survival in the univariate analysis, but not after adjustment for confounding factors. The time to diagnosis was significantly associated with IQ score among survivors. No significant relation was found between the time to diagnosis and neurological disability. In the 62 patients with metastases, a long prediagnosis interval was associated with a higher T stage, infiltration of the fourth ventricle floor, and incomplete surgical resection; it nonetheless did not influence survival significantly in this subgroup. Conclusions: We found complex and often inverse relations between time to diagnosis of medulloblastoma in children and initial severity factors, survival, and neuropsychological and neurological outcome. This interval appears due more to the nature of the tumor and its progression than to parental or medical factors. These conclusions should be taken into account in the information provided to parents and in expert assessments produced for malpractice claims.	[Brasme, Jean-Francois; Grill, Jacques; Valteau-Couanet, Dominique] Inst Gustave Roussy, Dept Pediat & Adolescent Oncol, Villejuif, France; [Brasme, Jean-Francois; Grill, Jacques; Valteau-Couanet, Dominique; Aghakhani, Nozar] Univ Paris Sud, Le Kremlin Bicetre, France; [Brasme, Jean-Francois; Grill, Jacques; Valteau-Couanet, Dominique; Aghakhani, Nozar] Hop St Vincent de Paul, INSERM, U953, Epidemiol Res Unit Perinatal Hlth & Womens & Chil, F-75674 Paris, France; [Doz, Francois] Inst Curie, Dept Pediat & Adolescent Oncol, Paris, France; [Doz, Francois; Puget, Stephanie; Chalumeau, Martin] Univ Paris 05, Paris, France; [Lacour, Brigitte] CHU Nancy, French Natl Registry Childhood Solid Tumors, Vandoeuvre Les Nancy, France; [Gaillard, Stephan] Hop Foch, Dept Neurosurg, Suresnes, France; [Gaillard, Stephan] Univ Paris Ile de France Ouest, Guyancourt, France; [Delalande, Olivier] Fdn Adolphe De Rothschild, Dept Pediat Neurosurg, Paris, France; [Aghakhani, Nozar] Ctr Hosp Bicetre, AP HP, Dept Neurosurg, Le Kremlin Bicetre, France; [Puget, Stephanie] Hop Necker Enfants Malad, AP HP, Dept Pediat Neurosurg, Paris, France; [Chalumeau, Martin] Hop Necker Enfants Malad, AP HP, Dept Pediat, Paris, France	UNICANCER; Gustave Roussy; UDICE-French Research Universities; Universite Paris Saclay; Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Cochin - APHP; Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Universite Paris Cite; UDICE-French Research Universities; PSL Research University Paris; UNICANCER; Institut Curie; UDICE-French Research Universities; Universite Paris Cite; CHU de Nancy; Hospital Foch; Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Bicetre - APHP; Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Necker-Enfants Malades - APHP; UDICE-French Research Universities; Universite Paris Cite; Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Necker-Enfants Malades - APHP; UDICE-French Research Universities; Universite Paris Cite	Brasme, JF (corresponding author), Inst Gustave Roussy, Dept Pediat & Adolescent Oncol, Villejuif, France.	jfbrasme@gmail.com	Doz, Francois P/K-8616-2012; aghakhani, nozar/ABF-7908-2021; Grill, Jacques/R-8093-2019; Chalumeau, Martin/F-4293-2017	Chalumeau, Martin/0000-0001-8175-3706; BRASME, jean-francois/0000-0003-1330-396X; aghakhani, nozar/0000-0001-8389-8167; Doz, Francois/0000-0001-9286-4831				Alston RD, 2003, DEV MED CHILD NEUROL, V45, P308, DOI 10.1017/S0012162203000586; Brasme JF, 2012, EUR J PEDIATR, V171, P25, DOI 10.1007/s00431-011-1480-z; CHANG CH, 1969, RADIOLOGY, V93, P1351, DOI 10.1148/93.6.1351; D'Agostino RB, 2007, CIRCULATION, V115, P2340, DOI 10.1161/CIRCULATIONAHA.105.594952; Dang-Tan T, 2008, PEDIATR BLOOD CANCER, V51, P468, DOI 10.1002/pbc.21600; Dang-Tan T, 2007, CANCER-AM CANCER SOC, V110, P703, DOI 10.1002/cncr.22849; Desandes E, 2004, PEDIATR BLOOD CANCER, V43, P749, DOI 10.1002/pbc.20148; Desandes E, 2008, EUR J CANCER, V44, P205, DOI 10.1016/j.ejca.2007.11.016; Dixon-Woods M, 2001, LANCET, V357, P670, DOI 10.1016/S0140-6736(00)04130-1; Dobrovoljac M, 2002, EUR J PEDIATR, V161, P663, DOI 10.1007/s00431-002-1088-4; Dufour C, 2008, NEURO-ONCOLOGY, V10, P488; Dufour C, 2008, NEURO-ONCOLOGY, V10, P423; Edgeworth J, 1996, ARCH DIS CHILD, V74, P148, DOI 10.1136/adc.74.2.148; FLORES LE, 1986, AM J DIS CHILD, V140, P684, DOI 10.1001/archpedi.1986.02140210082031; Frange P, 2009, J NEURO-ONCOL, V95, P271, DOI 10.1007/s11060-009-9927-z; Grill J, 1999, INT J RADIAT ONCOL, V45, P137, DOI 10.1016/S0360-3016(99)00177-7; Grill J, 2005, LANCET ONCOL, V6, P573, DOI 10.1016/S1470-2045(05)70252-7; Haimi M, 2004, PEDIATR HEMAT ONCOL, V21, P37, DOI 10.1080/08880010490263579; Halperin EC, 2001, CANCER, V91, P1444, DOI 10.1002/1097-0142(20010415)91:8<1444::AID-CNCR1151>3.0.CO;2-U; HARISIADIS L, 1977, INT J RADIAT ONCOL, V2, P833, DOI 10.1016/0360-3016(77)90181-X; Hoven E, 2008, J PEDIAT HEMATOL ONC, V30, P807, DOI 10.1097/MPH.0b013e31818a9553; Keene DL, 1999, PEDIATR NEUROL, V20, P198, DOI 10.1016/S0887-8994(98)00139-8; KLEIHUES P, 1993, BRAIN PATHOL, V3, P255, DOI 10.1111/j.1750-3639.1993.tb00752.x; Kleihues P, 2000, CANCER, V88, P2887, DOI 10.1002/1097-0142(20000615)88:12<2887::AID-CNCR32>3.0.CO;2-F; Klein-Geltink J, 2006, J PEDIAT HEMATOL ONC, V28, P433, DOI 10.1097/01.mph.0000212945.20480.26; Kukal K, 2009, EUR J PEDIATR, V168, P303, DOI 10.1007/s00431-008-0755-5; Lacour B, 2010, EUR J CANCER PREV, V19, P173, DOI 10.1097/CEJ.0b013e32833876c0; Lannering B, 2010, PEDIAT BLOOD CANC, V55; Loh AHP, 2009, J PEDIAT HEMATOL ONC, V31, P734, DOI 10.1097/MPH.0b013e3181b78725; Mehta V, 2002, NEUROSURGERY, V51, P365, DOI 10.1227/01.NEU.0000019779.27789.AC; Najaf-Zadeh A, 2011, ARCH DIS CHILD, V96, P127, DOI 10.1136/adc.2010.189209; Northcott PA, 2011, J CLIN ONCOL, V29, P1408, DOI 10.1200/JCO.2009.27.4324; Oyharcabal-Bourden V, 2005, J CLIN ONCOL, V23, P4726, DOI 10.1200/JCO.2005.00.760; POLLOCK BH, 1991, J PEDIATR-US, V119, P725, DOI 10.1016/S0022-3476(05)80287-2; Reulecke BC, 2008, J CHILD NEUROL, V23, P178, DOI 10.1177/0883073807308692; SAHA V, 1993, ARCH DIS CHILD, V68, P771, DOI 10.1136/adc.68.6.771; Sommelet D, 2005, ARCH PEDIATRIE, V12, P814, DOI 10.1016/j.arcped.2005.04.039; Thulesius H, 2000, ACTA ONCOL, V39, P873, DOI 10.1080/028418600750063640; Verlooy J, 2006, EUR J CANCER, V42, P3004, DOI 10.1016/j.ejca.2006.02.026; Wilne SH, 2006, ARCH DIS CHILD, V91, P502, DOI 10.1136/adc.2005.090266	40	27	27	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 2	2012	7	4							e33415	10.1371/journal.pone.0033415	http://dx.doi.org/10.1371/journal.pone.0033415			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	952GU	22485143	Green Published, gold, Green Submitted			2022-12-25	WOS:000304780500019
J	Michels, L; Martin, E; Klaver, P; Edden, R; Zelaya, F; Lythgoe, DJ; Luchinger, R; Brandeis, D; O'Gorman, RL				Michels, Lars; Martin, Ernst; Klaver, Peter; Edden, Richard; Zelaya, Fernando; Lythgoe, David J.; Luechinger, Rafael; Brandeis, Daniel; O'Gorman, Ruth L.			Frontal GABA Levels Change during Working Memory	PLOS ONE			English	Article							MAGNETIC-RESONANCE-SPECTROSCOPY; DORSOLATERAL PREFRONTAL CORTEX; HUMAN VISUAL-CORTEX; SHORT-TERM-MEMORY; IN-VIVO; NEURONAL-ACTIVITY; OXIDATIVE-METABOLISM; NMDA CHANNELS; BRAIN; STIMULATION	Functional neuroimaging metrics are thought to reflect changes in neurotransmitter flux, but changes in neurotransmitter levels have not been demonstrated in humans during a cognitive task, and the relationship between neurotransmitter dynamics and hemodynamic activity during cognition has not yet been established. We evaluate the concentration of the major inhibitory (GABA) and excitatory (glutamate + glutamine: Glx) neurotransmitters and the cerebral perfusion at rest and during a prolonged delayed match-to-sample working memory task. Resting GABA levels in the dorsolateral prefrontal cortex correlated positively with the resting perfusion and inversely with the change in perfusion during the task. Further, only GABA increased significantly during the first working memory run and then decreased continuously across subsequent task runs. The decrease of GABA over time was paralleled by a trend towards decreased reaction times and higher task accuracy. These results demonstrate a link between neurotransmitter dynamics and hemodynamic activity during working memory, indicating that functional neuroimaging metrics depend on the balance of excitation and inhibition required for cognitive processing.	[Michels, Lars; Martin, Ernst; Klaver, Peter; O'Gorman, Ruth L.] Univ Childrens Hosp, Ctr MR Res, Zurich, Switzerland; [Michels, Lars] Univ Zurich Hosp, Inst Neuroradiol, CH-8091 Zurich, Switzerland; [Martin, Ernst; Klaver, Peter; Brandeis, Daniel] Zurich Ctr Integrat Human Physiol, Zurich, Switzerland; [Klaver, Peter] Univ Zurich, Div Abnormal Psychol & Clin Intervent, Inst Psychol, Zurich, Switzerland; [Edden, Richard] Johns Hopkins Univ, Sch Med, Russell H Morgan Dept Radiol & Radiol Sci, Baltimore, MD USA; [Edden, Richard] Kennedy Krieger Inst, FM Kirby Ctr Funct Brain Imaging, Baltimore, MD USA; [Zelaya, Fernando; Lythgoe, David J.] Kings Coll London, Ctr Neuroimaging Sci, Inst Psychiat, London WC2R 2LS, England; [Luechinger, Rafael; Brandeis, Daniel] Univ Zurich, Dept Child & Adolescent Psychiat, Zurich, Switzerland; [Brandeis, Daniel] Heidelberg Univ, Dept Child & Adolescent Psychiat & Psychotherapy, Cent Inst Mental Hlth, Med Fac Mannheim, D-6800 Mannheim, Germany	University Children's Hospital Zurich; University of Zurich; University Zurich Hospital; University of Zurich; Zurich Center Integrative Human Physiology (ZIHP); University of Zurich; Johns Hopkins University; Kennedy Krieger Institute; University of London; King's College London; University of Zurich; Central Institute of Mental Health; Ruprecht Karls University Heidelberg	Michels, L (corresponding author), Univ Childrens Hosp, Ctr MR Res, Zurich, Switzerland.	lars.michels@kispi.uzh.ch	Zelaya, Fernando O/I-3125-2012; Edden, Richard A/G-5538-2012; Klaver, Peter/G-7988-2011; Michels, Lars/X-6939-2018; Klaver, Peter/M-9506-2019; Lythgoe, David J/E-5275-2010	Zelaya, Fernando O/0000-0002-9525-1560; Klaver, Peter/0000-0002-6541-9975; Klaver, Peter/0000-0002-6541-9975; O'Gorman, Ruth/0000-0001-5932-7786; Lythgoe, David/0000-0002-5078-9025; Michels, Lars/0000-0003-3750-1100; Edden, Richard/0000-0002-0671-7374	University of Zurich; Wellcome Trust	University of Zurich; Wellcome Trust(Wellcome Trust)	This work was supported by the University Research Priority Program "Integrative Human Physiology" at the University of Zurich. The authors also thank the Wellcome Trust for support to neuroimaging at the Centre for Neuroimaging Sciences. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Altamura M, 2007, PSYCHIAT RES-NEUROIM, V154, P103, DOI 10.1016/j.pscychresns.2006.08.002; Attwell D, 2010, NATURE, V468, P232, DOI 10.1038/nature09613; Baddeley A, 1996, PHILOS T ROY SOC B, V351, P1461; Buzsaki G, 2007, NEURON, V56, P771, DOI 10.1016/j.neuron.2007.11.008; Compte A, 2000, CEREB CORTEX, V10, P910, DOI 10.1093/cercor/10.9.910; Cowan N, 2001, BEHAV BRAIN SCI, V24, P87, DOI 10.1017/S0140525X01003922; D'Esposito M, 2000, EXP BRAIN RES, V133, P3, DOI 10.1007/s002210000395; Dalby NO, 2001, CURR OPIN NEUROL, V14, P187, DOI 10.1097/00019052-200104000-00009; Donahue MJ, 2010, NEUROIMAGE; Edden RAE, 2007, MAGN RESON MED, V58, P1276, DOI 10.1002/mrm.21383; Evans CJ, 2011, REGIONAL VARIATIONS; Floyer-Lea A, 2006, J NEUROPHYSIOL, V95, P1639, DOI 10.1152/jn.00346.2005; Fox MD, 2007, NAT REV NEUROSCI, V8, P700, DOI 10.1038/nrn2201; Frahm J, 1996, MAGNET RESON MED, V35, P143, DOI 10.1002/mrm.1910350202; FUSTER JM, 1982, J NEUROSCI, V2, P361; FUSTER JM, 1982, EXP NEUROL, V77, P679, DOI 10.1016/0014-4886(82)90238-2; Fuster JM, 2001, NEURON, V30, P319, DOI 10.1016/S0896-6273(01)00285-9; FUSTER JM, 1990, PROG BRAIN RES, V85, P313; GOLDMANRAKIC PS, 1995, NEURON, V14, P477, DOI 10.1016/0896-6273(95)90304-6; Gussew A, 2010, NEUROIMAGE, V49, P1895, DOI 10.1016/j.neuroimage.2009.09.007; Hyder F, 2001, NMR BIOMED, V14, P413, DOI 10.1002/nbm.733; Jansma JM, 2001, J COGNITIVE NEUROSCI, V13, P730, DOI 10.1162/08989290152541403; Jensen JE, 2005, NMR BIOMED, V18, P570, DOI 10.1002/nbm.994; Jensen O, 1996, LEARN MEMORY, V3, P264, DOI 10.1101/lm.3.2-3.264; Jensen O, 2002, EUR J NEUROSCI, V15, P1395, DOI 10.1046/j.1460-9568.2002.01975.x; Jensen O, 1996, LEARN MEMORY, V3, P243, DOI 10.1101/lm.3.2-3.243; Jentsch JD, 2009, NEUROPSYCHOPHARMACOL, V34, P2601, DOI 10.1038/npp.2009.90; JONIDES J, 1993, NATURE, V363, P623, DOI 10.1038/363623a0; Kegeles LS, 2007, P INT SOC MAG RESON; Kehrer C, 2008, FRONT MOL NEUROSCI, V1, DOI 10.3389/neuro.02/006.2008; Levy R, 1999, J NEUROSCI, V19, P5149; Levy R, 2000, EXP BRAIN RES, V133, P23, DOI 10.1007/s002210000397; Magistretti PJ, 1999, SCIENCE, V283, P496, DOI 10.1126/science.283.5401.496; Mangia S, 2007, J NEUROSCI RES, V85, P3340, DOI 10.1002/jnr.21371; Mangia S, 2007, J CEREBR BLOOD F MET, V27, P1055, DOI 10.1038/sj.jcbfm.9600401; Markram H, 2004, NAT REV NEUROSCI, V5, P793, DOI 10.1038/nrn1519; McCarthy G, 1996, CEREB CORTEX, V6, P600, DOI 10.1093/cercor/6.4.600; Mescher M, 1998, NMR BIOMED, V11, P266, DOI 10.1002/(SICI)1099-1492(199810)11:6<266::AID-NBM530>3.0.CO;2-J; Michels L, 2008, NEUROIMAGE, V40, P1296, DOI 10.1016/j.neuroimage.2007.12.048; Michels L, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0010298; Morellini F, 2010, CEREB CORTEX, V20, P2712, DOI 10.1093/cercor/bhq017; MORRIS RGM, 1986, NATURE, V319, P774, DOI 10.1038/319774a0; Mullins PG, 2005, NEUROIMAGE, V26, P642, DOI 10.1016/j.neuroimage.2005.02.001; Muthukumaraswamy SD, 2009, P NATL ACAD SCI USA, V106, P8356, DOI 10.1073/pnas.0900728106; Northoff G, 2007, NAT NEUROSCI, V10, P1515, DOI 10.1038/nn2001; OLIVER MW, 1990, INT J DEV NEUROSCI, V8, P417, DOI 10.1016/0736-5748(90)90074-C; Owen AM, 1996, CEREB CORTEX, V6, P31, DOI 10.1093/cercor/6.1.31; Pang KC, 2011, HIPPOCAMPUS; Patel AB, 2005, P NATL ACAD SCI USA, V102, P5588, DOI 10.1073/pnas.0501703102; Peterson DA, 2002, NEUROSCI LETT, V328, P17, DOI 10.1016/S0304-3940(02)00429-9; Petrides M, 1996, PHILOS T ROY SOC B, V351, P1455, DOI 10.1098/rstb.1996.0130; Postle BR, 2005, J COGNITIVE NEUROSCI, V17, P1679, DOI 10.1162/089892905774589208; PRICHARD J, 1991, P NATL ACAD SCI USA, V88, P5829, DOI 10.1073/pnas.88.13.5829; PROVENCHER SW, 1993, MAGNET RESON MED, V30, P672, DOI 10.1002/mrm.1910300604; Puts NAJ, 2011, PROGR NUCL IN PRESS; Rothman DL, 1999, PHILOS T R SOC B, V354, P1165, DOI 10.1098/rstb.1999.0472; Rothman DL, 2003, ANNU REV PHYSIOL, V65, P401, DOI 10.1146/annurev.physiol.65.092101.142131; Rothman DL, 2002, IN VIVO MAGNETIC RES; Russell V, 2000, BEHAV BRAIN RES, V117, P69, DOI 10.1016/S0166-4328(00)00291-6; Rypma B, 2003, COGNITIVE BRAIN RES, V16, P162, DOI 10.1016/S0926-6410(02)00247-1; SAPPEYMARINIER D, 1992, J CEREBR BLOOD F MET, V12, P584, DOI 10.1038/jcbfm.1992.82; SAWAGUCHI T, 1988, BEHAV BRAIN RES, V31, P193, DOI 10.1016/0166-4328(88)90023-X; SHARMA AC, 1990, METHOD FIND EXP CLIN, V12, P175; Shulman RG, 2001, AM J PSYCHIAT, V158, P11, DOI 10.1176/appi.ajp.158.1.11; Sibson NR, 1998, P NATL ACAD SCI USA, V95, P316, DOI 10.1073/pnas.95.1.316; Smith EE, 1996, CEREB CORTEX, V6, P11, DOI 10.1093/cercor/6.1.11; Somogyi P, 1998, BRAIN RES REV, V26, P113, DOI 10.1016/S0165-0173(97)00061-1; SPEHLMANN R, 1976, LANCET, V1, P724; Stagg CJ, 2009, J NEUROPHYSIOL, V101, P2872, DOI 10.1152/jn.91060.2008; Stagg CJ, 2009, J NEUROSCI, V29, P5202, DOI 10.1523/JNEUROSCI.4432-08.2009; Thompson RB, 1998, MAGNET RESON MED, V39, P762, DOI 10.1002/mrm.1910390514; Waagepetersen H, 2007, HDB NEUROCHEMISTRY M; Wong EC, 1998, MAGNET RESON MED, V39, P702, DOI 10.1002/mrm.1910390506; Zahr NM, 2008, CEREB CORTEX, V18, P2241, DOI 10.1093/cercor/bhm250; Zhang JX, 2003, NEUROIMAGE, V20, P1531, DOI 10.1016/j.neuroimage.2003.07.016; Zhu H, 2011, MAGN RESON MED, V65, P603, DOI 10.1002/mrm.22671	76	75	76	0	24	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 2	2012	7	4							e31933	10.1371/journal.pone.0031933	http://dx.doi.org/10.1371/journal.pone.0031933			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	952GU	22485128	Green Submitted, gold, Green Published, Green Accepted			2022-12-25	WOS:000304780500004
J	Passot, JB; Sheynikhovich, D; Duvelle, E; Arleo, A				Passot, Jean-Baptiste; Sheynikhovich, Denis; Duvelle, Eleonore; Arleo, Angelo			Contribution of Cerebellar Sensorimotor Adaptation to Hippocampal Spatial Memory	PLOS ONE			English	Article							NMDA RECEPTOR-ACTIVITY; MORRIS WATER MAZE; PATH-INTEGRATION; PURKINJE-CELLS; PLACE CELLS; COGNITIVE MECHANISMS; DECLARATIVE MEMORY; VESTIBULAR NUCLEI; INTERNAL-MODEL; NAVIGATION	Complementing its primary role in motor control, cerebellar learning has also a bottom-up influence on cognitive functions where high-level representations build up from elementary sensorimotor memories. In this paper we examine the cerebellar contribution to both procedural and declarative components of spatial cognition. To do so, we model a functional interplay between the cerebellum and the hippocampal formation during goal-oriented navigation. We reinterpret and complete existing genetic behavioural observations by means of quantitative accounts that cross-link synaptic plasticity mechanisms, single cell and population coding properties, and behavioural responses. In contrast to earlier hypotheses positing only a purely procedural impact of cerebellar adaptation deficits, our results suggest a cerebellar involvement in high-level aspects of behaviour. In particular, we propose that cerebellar learning mechanisms may influence hippocampal place fields, by contributing to the path integration process. Our simulations Predict differences in place-cell discharge properties between normal mice and L7-PKCl mutant mice lacking long-term depression at cerebellar parallel fibre-Purkinje cell synapses. On the behavioural level, these results suggest that, by influencing the accuracy of hippocampal spatial codes, cerebellar deficits may impact the exploration-exploitation balance during spatial navigation.	[Passot, Jean-Baptiste; Sheynikhovich, Denis; Duvelle, Eleonore; Arleo, Angelo] Univ Paris 06, CNRS, Lab Neurobiol Adapt Proc, UMR 7102, Paris, France	Centre National de la Recherche Scientifique (CNRS); UDICE-French Research Universities; Sorbonne Universite	Passot, JB (corresponding author), Univ Paris 06, CNRS, Lab Neurobiol Adapt Proc, UMR 7102, Paris, France.	angelo.arleo@upmc.fr	Arleo, Angelo/N-9255-2019; Sheynikhovich, Denis/K-3776-2013; Duvelle, Éléonore/ABC-1541-2020	Arleo, Angelo/0000-0002-1990-1971; Sheynikhovich, Denis/0000-0001-7737-8907; Duvelle, Éléonore/0000-0002-3514-8801	French Ministry of Higher Education and Research; French Defense Procurement Agency (DGA); French National Research Agency (ANR) [ANR-09-EMER-005-01]	French Ministry of Higher Education and Research; French Defense Procurement Agency (DGA); French National Research Agency (ANR)(French National Research Agency (ANR))	This manuscript was granted by the French Ministry of Higher Education and Research, the French Defense Procurement Agency (DGA), and the French National Research Agency (ANR) Project EvoNeuro, ANR-09-EMER-005-01. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ALBUS J S, 1971, Mathematical Biosciences, V10, P25, DOI 10.1016/0025-5564(71)90051-4; Angelaki DE, 2010, CEREBELLUM, V9, P174, DOI 10.1007/s12311-009-0147-z; Arleo A, 2000, BIOL CYBERN, V83, P287, DOI 10.1007/s004220000171; Arleo A, 2004, IEEE T NEURAL NETWOR, V15, P639, DOI 10.1109/TNN.2004.826221; Arleo Angelo, 2007, Journal of Integrative Neuroscience, V6, P327, DOI 10.1142/S0219635207001593; Attwell PJE, 2002, NEURON, V34, P1011, DOI 10.1016/S0896-6273(02)00719-5; Bell C, 1997, BRAIN BEHAV EVOLUT, V50, P17, DOI 10.1159/000113352; Bosco G, 2001, PHYSIOL REV, V81, P539, DOI 10.1152/physrev.2001.81.2.539; Brun VH, 2002, SCIENCE, V296, P2243, DOI 10.1126/science.1071089; Burgess N, 2002, NEURON, V35, P625, DOI 10.1016/S0896-6273(02)00830-9; Burguiere E, 2005, NAT NEUROSCI, V8, P1292, DOI 10.1038/nn1532; Cain DP, 1996, REV NEUROSCIENCE, V7, P215; Chadderton P, 2004, NATURE, V428, P856, DOI 10.1038/nature02442; Compoint C, 1997, NEUROSCI LETT, V238, P91, DOI 10.1016/S0304-3940(97)00864-1; D'Angelo E, 2009, TRENDS NEUROSCI, V32, P30, DOI 10.1016/j.tins.2008.09.007; DAHHAOUI M, 1992, BEHAV NEURAL BIOL, V58, P180, DOI 10.1016/0163-1047(92)90440-F; De Zeeuw CI, 1998, NEURON, V20, P495, DOI 10.1016/S0896-6273(00)80990-3; Eccles JC, 1967, CEREBELLUM NEURONAL; EICHENBAUM H, 1992, J COGNITIVE NEUROSCI, V4, P217, DOI 10.1162/jocn.1992.4.3.217; Eichenbaum H, 2001, BEHAV BRAIN RES, V127, P199, DOI 10.1016/S0166-4328(01)00365-5; EICHENBAUM H, 1990, J NEUROSCI, V10, P3531; Eichenbaum H, 1999, NEURON, V23, P209, DOI 10.1016/S0896-6273(00)80773-4; Ekstrom AD, 2003, NATURE, V425, P184, DOI 10.1038/nature01964; Etienne AS, 1998, NATURE, V396, P161, DOI 10.1038/24151; Etienne AS, 2004, HIPPOCAMPUS, V14, P180, DOI 10.1002/hipo.10173; Federico F, 2006, BRAIN RES BULL, V70, P356, DOI 10.1016/j.brainresbull.2006.06.005; Fonio E, 2009, P NATL ACAD SCI USA, V106, P21335, DOI 10.1073/pnas.0812513106; Foti F, 2010, CEREBELLUM, V9, P29, DOI 10.1007/s12311-009-0134-4; FUJITA M, 1982, BIOL CYBERN, V45, P195, DOI 10.1007/BF00336192; Fuster JM, 2001, NEURON, V30, P319, DOI 10.1016/S0896-6273(01)00285-9; Fyhn M, 2004, SCIENCE, V305, P1258, DOI 10.1126/science.1099901; Gandhi CC, 2000, BEHAV BRAIN RES, V109, P37, DOI 10.1016/S0166-4328(99)00160-6; GEORGOPOULOS AP, 1986, SCIENCE, V233, P1416, DOI 10.1126/science.3749885; Ghez C, 2000, CEREBELLUM, P832; Glickstein M, 2007, CURR BIOL, V17, pR824, DOI 10.1016/j.cub.2007.08.009; Glickstein M, 2008, CEREBELLUM, V7, P589, DOI 10.1007/s12311-008-0074-4; HARTIGAN JA, 1985, ANN STAT, V13, P70, DOI 10.1214/aos/1176346577; Hilber P, 1998, BEHAV GENET, V28, P299, DOI 10.1023/A:1021675514883; Hoh T, 1999, J Neurosci, V19, pRC2; Hok V, 2005, P NATL ACAD SCI USA, V102, P4602, DOI 10.1073/pnas.0407332102; Holmes G, 1939, BRAIN, V62, P1, DOI 10.1093/brain/62.1.1; Imamizu H, 2000, NATURE, V403, P192, DOI 10.1038/35003194; Ito M, 2005, PROG BRAIN RES, V148, P95, DOI 10.1016/S0079-6123(04)48009-1; Ito M, 1998, TRENDS COGN SCI, V2, P313, DOI 10.1016/S1364-6613(98)01222-4; ITO M, 1982, NEUROSCI LETT, V33, P253, DOI 10.1016/0304-3940(82)90380-9; ITO M, 1970, INT J NEUROL, V7, P162; Ito M, 1984, CEREBELLUM NEURAL CO; Ito M, 1974, CONTROL MECH CEREBEL, P293; Ito M, 2006, PROG NEUROBIOL, V78, P272, DOI 10.1016/j.pneurobio.2006.02.006; JAKAB RL, 1988, ANAT EMBRYOL, V179, P81, DOI 10.1007/BF00305102; Joyal CC, 2001, BEHAV BRAIN RES, V122, P131, DOI 10.1016/S0166-4328(00)00390-9; KAWATO M, 1987, BIOL CYBERN, V57, P169, DOI 10.1007/BF00364149; Koekkoek SKE, 2003, SCIENCE, V301, P1736, DOI 10.1126/science.1088383; KOLB B, 1983, BEHAV NEUROSCI, V97, P13, DOI 10.1037/0735-7044.97.1.13; Korelusova I, 2007, Prague Med Rep, V108, P37; KOTCHABHAKDI N, 1978, EXP BRAIN RES, V31, P591; LALONDE R, 1988, BRAIN RES, V455, P24, DOI 10.1016/0006-8993(88)90109-6; LALONDE R, 1987, J NEUROGENET, V4, P285, DOI 10.3109/01677068709102349; LALONDE R, 1986, BRAIN RES, V398, P175, DOI 10.1016/0006-8993(86)91264-3; Leggio MG, 2006, BRAIN RES BULL, V70, P347, DOI 10.1016/j.brainresbull.2006.06.006; Leggio MG, 1999, EXP BRAIN RES, V127, P1, DOI 10.1007/s002210050768; Lev-Ram V, 2002, P NATL ACAD SCI USA, V99, P8389, DOI 10.1073/pnas.122206399; Mandolesi L, 2003, EUR J NEUROSCI, V18, P2618, DOI 10.1046/j.1460-9568.2003.02990.x; Mandolesi L, 2001, EUR J NEUROSCI, V14, P2011, DOI 10.1046/j.0953-816x.2001.01819.x; MARR D, 1969, J PHYSIOL-LONDON, V202, P437, DOI 10.1113/jphysiol.1969.sp008820; Martinet LE, 2011, PLOS COMPUT BIOL, V7, DOI 10.1371/journal.pcbi.1002045; MCCORMICK DA, 1984, SCIENCE, V223, P296, DOI 10.1126/science.6701513; MCDONALD RJ, 1994, BEHAV NEURAL BIOL, V61, P260, DOI 10.1016/S0163-1047(05)80009-3; MCDONALD RJ, 1993, BEHAV NEUROSCI, V107, P3, DOI 10.1037/0735-7044.107.1.3; McNaughton BL, 2006, NAT REV NEUROSCI, V7, P663, DOI 10.1038/nrn1932; Medina JF, 2000, NAT NEUROSCI, V3, P1205, DOI 10.1038/81486; Medina JF, 2002, NAT REV NEUROSCI, V3, P122, DOI 10.1038/nrn728; Miall RC, 2007, PLOS BIOL, V5, P2733, DOI 10.1371/journal.pbio.0050316; Miall RC, 1998, NOVART FDN SYMP, V218, P272; Miall RC, 2001, NAT NEUROSCI, V4, P638, DOI 10.1038/88465; Michel O., 2004, International Journal of Advanced Robotic Systems, V1, P39; MITTELSTAEDT ML, 1980, NATURWISSENSCHAFTEN, V67, P566, DOI 10.1007/BF00450672; MORRIS R, 1984, J NEUROSCI METH, V11, P47, DOI 10.1016/0165-0270(84)90007-4; MORRIS RGM, 1982, NATURE, V297, P681, DOI 10.1038/297681a0; Moser EI, 2008, ANNU REV NEUROSCI, V31, P69, DOI 10.1146/annurev.neuro.31.061307.090723; Mulliken GH, 2008, P NATL ACAD SCI USA, V105, P8170, DOI 10.1073/pnas.0802602105; OKEEFE J, 1978, EXP BRAIN RES, V31, P573; Packard MG, 1996, NEUROBIOL LEARN MEM, V65, P65, DOI 10.1006/nlme.1996.0007; Pasalar S, 2006, NAT NEUROSCI, V9, P1404, DOI 10.1038/nn1783; Petrosini L, 1998, PROG NEUROBIOL, V56, P191, DOI 10.1016/S0301-0082(98)00036-7; Petrosini L, 1996, EUR J NEUROSCI, V8, P1882, DOI 10.1111/j.1460-9568.1996.tb01332.x; Rochefort C, 2011, SCIENCE, V334, P385, DOI 10.1126/science.1207403; Rondi-Reig L, 2006, J NEUROSCI, V26, P4071, DOI 10.1523/JNEUROSCI.3408-05.2006; Rondi-Reig L, 2005, PROG BRAIN RES, V148, P201, DOI 10.1016/S0079-6123(04)48017-0; Safo P, 2008, NEUROPHARMACOLOGY, V54, P213, DOI 10.1016/j.neuropharm.2007.05.029; Schonewille M, 2010, NEURON, V67, P618, DOI 10.1016/j.neuron.2010.07.009; Schonewille M, 2011, NEURON, V70, P43, DOI 10.1016/j.neuron.2011.02.044; Schweighofer N, 1998, EUR J NEUROSCI, V10, P95, DOI 10.1046/j.1460-9568.1998.00007.x; Schweighofer N, 1996, BIOL CYBERN, V75, P29, DOI 10.1007/BF00238737; Shadmehr R, 2010, ANNU REV NEUROSCI, V33, P89, DOI 10.1146/annurev-neuro-060909-153135; Shaikh AG, 2004, J NEUROSCI, V24, P4491, DOI 10.1523/JNEUROSCI.0109-04.2004; Sheynikhovich D, 2009, PSYCHOL REV, V116, P540, DOI 10.1037/a0016170; Strick PL, 2009, ANNU REV NEUROSCI, V32, P413, DOI 10.1146/annurev.neuro.31.060407.125606; Thach WT, 1998, TRENDS COGN SCI, V2, P331, DOI 10.1016/S1364-6613(98)01223-6; THACH WT, 1992, ANNU REV NEUROSCI, V15, P403, DOI 10.1146/annurev.neuro.15.1.403; Timmann D, 2007, CEREBELLUM, V6, P159, DOI 10.1080/14734220701496448; TOLMAN EC, 1948, PSYCHOL REV, V55, P189, DOI 10.1037/h0061626; Wang YT, 2000, NEURON, V25, P635, DOI 10.1016/S0896-6273(00)81066-1; WHISHAW IQ, 1986, J COMP PSYCHOL, V100, P422, DOI 10.1037/0735-7036.100.4.422; WHISHAW IQ, 1991, Q J EXP PSYCHOL-B, V43, P83; WHISHAW IQ, 1985, BEHAV NEUROSCI, V99, P979, DOI 10.1037/0735-7044.99.5.979; White NM, 2002, NEUROBIOL LEARN MEM, V77, P125, DOI 10.1006/nlme.2001.4008; Wiener JM, 2011, EXP BRAIN RES, V208, P61, DOI 10.1007/s00221-010-2460-7; WILSON MA, 1993, SCIENCE, V261, P1055, DOI 10.1126/science.8351520; Wolpert DM, 1998, NEURAL NETWORKS, V11, P1317, DOI 10.1016/S0893-6080(98)00066-5; Wolpert DM, 1998, TRENDS COGN SCI, V2, P338, DOI 10.1016/S1364-6613(98)01221-2; Yakusheva TA, 2007, NEURON, V54, P973, DOI 10.1016/j.neuron.2007.06.003; Yin HH, 2006, NAT REV NEUROSCI, V7, P464, DOI 10.1038/nrn1919	114	23	25	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 2	2012	7	4							e32560	10.1371/journal.pone.0032560	http://dx.doi.org/10.1371/journal.pone.0032560			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	952GU	22485133	Green Published, Green Submitted, gold			2022-12-25	WOS:000304780500009
J	Leskov, I; Pallasch, CP; Drake, A; Iliopoulou, BP; Souza, A; Shen, CH; Schweighofer, CD; Abruzzo, L; Frenzel, LP; Wendtner, CM; Hemann, MT; Chen, J				Leskov, I.; Pallasch, C. P.; Drake, A.; Iliopoulou, B. P.; Souza, A.; Shen, C-H; Schweighofer, C. D.; Abruzzo, L.; Frenzel, L. P.; Wendtner, C. M.; Hemann, M. T.; Chen, J.			Rapid generation of human B-cell lymphomas via combined expression of Myc and Bc12 and their use as a preclinical model for biological therapies	ONCOGENE			English	Article						humanized mouse model; MYC; BCL2; double-hit lymphoma; antibody	SCID IL2R-GAMMA(NULL) MICE; HEMATOPOIETIC STEM-CELLS; CD34(+) CELLS; C-MYC; IN-VIVO; ENFORCED EXPRESSION; BURKITTS-LYMPHOMA; TRANSGENIC MICE; SELF-RENEWAL; BCL-2	Although numerous mouse models of B-cell malignancy have been developed via the enforced expression of defined oncogenic lesions, the feasibility of generating lineage-defined human B-cell malignancies using mice reconstituted with modified human hematopoietic stem cells (HSCs) remains unclear. In fact, whether human cells can be transformed as readily as murine cells by simple oncogene combinations is a subject of considerable debate. Here, we describe the development of humanized mouse model of MYC/BCL2-driven 'double-hit' lymphoma. By engrafting human HSCs transduced with the oncogene combination into immunodeficient mice, we generate a fatal B malignancy with complete penetrance. This humanized-MYC/BCL2-model (hMB) accurately recapitulates the histopathological and clinical aspects of steroid-, chemotherapy- and rituximab-resistant human 'double-hit' lymphomas that involve the MYC and BCL2 loci. Notably, this model can serve as a platform for the evaluation of antibody-based therapeutics. As a proof of principle, we used this model to show that the anti-CD52 antibody alemtuzumab effectively eliminates lymphoma cells from the spleen, liver and peripheral blood, but not from the brain. The hMB humanized mouse model underscores the synergy of MYC and BCL2 in 'double-hit' lymphomas in human patients. Additionally, our findings highlight the utility of humanized mouse models in interrogating therapeutic approaches, particularly human-specific monoclonal antibodies. Oncogene (2013) 32, 1066-1072; doi: 10.1038/onc.2012.117; published online 9 April 2012	[Leskov, I.; Pallasch, C. P.; Drake, A.; Iliopoulou, B. P.; Souza, A.; Shen, C-H; Hemann, M. T.; Chen, J.] MIT, Koch Inst Integrat Canc Res, Dept Biol, Cambridge, MA 02139 USA; [Pallasch, C. P.; Schweighofer, C. D.; Frenzel, L. P.; Wendtner, C. M.] Univ Cologne, Dept Internal Med 1, Ctr Integrated Oncol, D-50931 Cologne, Germany; [Pallasch, C. P.; Abruzzo, L.; Frenzel, L. P.; Wendtner, C. M.] Univ Cologne, Cluster Excellence Cellular Stress Response Aging, D-50931 Cologne, Germany; [Schweighofer, C. D.] UT MD Anderson Canc Ctr Houston, Dept Hematopathol, Houston, TX USA	Massachusetts Institute of Technology (MIT); University of Cologne; University of Cologne; University of Texas System; UTMD Anderson Cancer Center	Hemann, MT (corresponding author), MIT, Koch Inst Integrat Canc Res, Dept Biol, 77 Massachusetts Ave,76-310, Cambridge, MA 02139 USA.	hemann@mit.edu; jchen@mit.edu	Pallasch, Christian Philipp/T-3088-2018	Pallasch, Christian P./0000-0001-5675-6905	Marble Family Foundation; Singapore-MIT Alliance for Research and Technology; NIH [R01-CA128803]; German Research foundation; MIT School of Science Cancer Research Fellowship; Ludwig Academic Graduate Fellowship; Medical Scientist Training Program from the National Institute Of General Medical Sciences [T32GM007753]; NATIONAL CANCER INSTITUTE [P30CA014051, R01CA128803] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [T32GM007753] Funding Source: NIH RePORTER	Marble Family Foundation; Singapore-MIT Alliance for Research and Technology; NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); German Research foundation(German Research Foundation (DFG)); MIT School of Science Cancer Research Fellowship; Ludwig Academic Graduate Fellowship; Medical Scientist Training Program from the National Institute Of General Medical Sciences; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	We thank P Bak and Herman Eisen for helpful discussions and the Swanson Biotechnology Center for excellent technical support. This work was partly supported by grants from the Marble Family Foundation (to JC and MTH), Singapore-MIT Alliance for Research and Technology (to JC) and the NIH (R01-CA128803 to MTH). CPP is supported by a research fellowship of the German Research foundation. IL was supported in part by the MIT School of Science Cancer Research Fellowship, the Ludwig Academic Graduate Fellowship and the Medical Scientist Training Program (Grant Number T32GM007753 from the National Institute Of General Medical Sciences). The content is solely the responsibility of the authors and does not necessarily represent the official views of the National Institute Of General Medical Sciences or the National Institutes of Health.	Aukema SM, 2011, BLOOD, V117, P2319, DOI 10.1182/blood-2010-09-297879; Bacher U, 2011, GENE CHROMOSOME CANC, V50, P43, DOI 10.1002/gcc.20831; Barabe F, 2007, SCIENCE, V316, P600, DOI 10.1126/science.1139851; Basecke J, 2005, LEUKEMIA LYMPHOMA, V46, P265, DOI 10.1080/10428190400010767; BHATIA K, 1993, NAT GENET, V5, P56, DOI 10.1038/ng0993-56; Buske C, 2001, BLOOD, V97, P2286, DOI 10.1182/blood.V97.8.2286; Chung KY, 2006, CANCER RES, V66, P11781, DOI 10.1158/0008-5472.CAN-06-0706; Chung KY, 2005, BLOOD, V105, P77, DOI 10.1182/blood-2003-12-4445; Gallamini A, 2007, BLOOD, V110, P2316, DOI 10.1182/blood-2007-02-074641; Giassi LJ, 2008, EXP BIOL MED, V233, P997, DOI 10.3181/0802-RM-70; GU W, 1994, SCIENCE, V264, P251, DOI 10.1126/science.8146655; Harrington AM, 2011, AM J CLIN PATHOL, V135, P649, DOI 10.1309/AJCPL11MAHISIJBQ; Hasserjian Robert P, 2009, J Hematop, V2, P89, DOI 10.1007/s12308-009-0039-7; Hu YP, 2009, IMMUNOLOGY, V128, P260, DOI 10.1111/j.1365-2567.2009.03115.x; Johnson NA, 2009, BLOOD, V114, P2273, DOI 10.1182/blood-2009-03-212191; Kelly PN, 2007, BLOOD, V109, P4907, DOI 10.1182/blood-2006-10-051847; Li S., 2011, MODERN PATHOL, V25, P145; MCDONNELL TJ, 1989, CELL, V57, P79, DOI 10.1016/0092-8674(89)90174-8; Montes R, 2011, BLOOD, V117, P4746, DOI 10.1182/blood-2010-12-322230; Moreau T, 2004, MOL THER, V10, P45, DOI 10.1016/j.ymthe.2004.04.005; Prendergast GC, 1999, ONCOGENE, V18, P2967, DOI 10.1038/sj.onc.1202727; Rangarajan A, 2004, CANCER CELL, V6, P171, DOI 10.1016/j.ccr.2004.07.009; Schmitt CA, 2001, BLOOD CELL MOL DIS, V27, P206, DOI 10.1006/bcmd.2000.0372; Schuringa JJ, 2004, J EXP MED, V200, P623, DOI 10.1084/jem.20041024; Shultz LD, 2005, J IMMUNOL, V174, P6477, DOI 10.4049/jimmunol.174.10.6477; SmithSorensen B, 1996, J BIOL CHEM, V271, P5513, DOI 10.1074/jbc.271.10.5513; Snuderl M, 2010, AM J SURG PATHOL, V34, P327, DOI 10.1097/PAS.0b013e3181cd3aeb; Stern P, 2008, P NATL ACAD SCI USA, V105, P13895, DOI 10.1073/pnas.0806907105; STRASSER A, 1990, NATURE, V348, P331, DOI 10.1038/348331a0; Tomita N, 2011, J CLIN EXP HEMATOP, V51, P7, DOI 10.3960/jslrt.51.7; VAUX DL, 1988, NATURE, V335, P440, DOI 10.1038/335440a0; Wendtner CM, 2004, LEUKEMIA, V18, P1093, DOI 10.1038/sj.leu.2403354; Wu D, 2010, AM J CLIN PATHOL, V134, P258, DOI 10.1309/AJCP7YLDTJPLCE5F; Wunderlich M, 2006, BLOOD, V108, P1690, DOI 10.1182/blood-2005-12-012773; Zhang CC, 2008, BLOOD, V111, P3415, DOI 10.1182/blood-2007-11-122119	35	35	41	0	8	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0950-9232			ONCOGENE	Oncogene	FEB 21	2013	32	8					1066	1072		10.1038/onc.2012.117	http://dx.doi.org/10.1038/onc.2012.117			7	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	111LQ	22484426	Green Accepted, Green Submitted			2022-12-25	WOS:000316523200014
J	Schulte, JH; Lindner, S; Bohrer, A; Maurer, J; De Preter, K; Lefever, S; Heukamp, L; Schulte, S; Molenaar, J; Versteeg, R; Thor, T; Kunkele, A; Vandesompele, J; Speleman, F; Schorle, H; Eggert, A; Schramm, A				Schulte, J. H.; Lindner, S.; Bohrer, A.; Maurer, J.; De Preter, K.; Lefever, S.; Heukamp, L.; Schulte, S.; Molenaar, J.; Versteeg, R.; Thor, T.; Kuenkele, A.; Vandesompele, J.; Speleman, F.; Schorle, H.; Eggert, A.; Schramm, A.			MYCN and ALKF1174L are sufficient to drive neuroblastoma development from neural crest progenitor cells	ONCOGENE			English	Article						neuroblastoma; MYCN; neural crest progenitor cell	EXPRESSION; MEDULLOBLASTOMA; ORIGIN	Neuroblastonna is an embryonal tumor with a heterogeneous clinical course. The tumor is presumed to be derived from the neural crest, but the cells of origin remain to be determined. To date, few recurrent genetic changes contributing to neuroblastoma formation, such as amplification of the MYCN oncogene and activating mutations of the ALK oncogene, have been identified. The possibility to model neuroblastoma in mice allows investigation of the cell of origin hypothesis in further detail. Here we present the evidence that murine neural crest progenitor cells can give rise to neuroblastonna upon transformation with MYCN or ALK(F1174L). For this purpose we used JoMa1, a multipotent neural crest progenitor cell line, which is kept in a viable and undifferentiated state by a tamoxifen-activated c-Myc transgene (c-MycER(T)). Expression of MYCN or ALK(F1174L), one of the oncogenic ALK variants identified in primary neuroblastomas, enabled these cells to grow independently of c-MycER(T) activity in vitro and caused formation of neuroblastoma-like tumors in vivo in contrast to parental JoMa1 cells and JoMa1 cells-expressing TrkA or GFP. Tumorigenicity was enhanced upon serial transplantation of tumor-derived cells, and tumor cells remained susceptible to the MYC-inhibitor, NBT-272, indicating that cell growth depended on functional MYCN. Our findings support neural crest progenitor cells as the precursor cells of neuroblastoma, and indicate that neuroblastomas arise as their malignant progeny. Oncogene (2013) 32, 1059-1065; doi:10.1038/onc.2012.106; published online 9 April 2012	[Schulte, J. H.; Lindner, S.; Bohrer, A.; Schulte, S.; Thor, T.; Kuenkele, A.; Eggert, A.; Schramm, A.] Univ Childrens Hosp Essen, Dept Pediat Oncol & Haematol, D-45122 Essen, Germany; [Maurer, J.; Schorle, H.] Univ Bonn, Inst Pathol, Dept Dev Pathol, Bonn, Germany; [De Preter, K.; Lefever, S.; Vandesompele, J.; Speleman, F.] Ghent Univ Hosp, CMGG, Ghent, Belgium; [Heukamp, L.] Univ Bonn, Dept Pathol, Bonn, Germany; [Molenaar, J.; Versteeg, R.] Univ Amsterdam, Acad Med Ctr, Dept Human Genet, NL-1105 AZ Amsterdam, Netherlands	University of Duisburg Essen; University of Bonn; Ghent University; Ghent University Hospital; University of Bonn; University of Amsterdam; Academic Medical Center Amsterdam	Schulte, JH (corresponding author), Univ Childrens Hosp Essen, Dept Pediat Oncol & Haematol, Hufelandstr 55, D-45122 Essen, Germany.	Johannes.schulte@uni-due.de	Schorle, Hubert/M-5001-2016; speleman, frank/AAR-5184-2020; Heukamp, Lukas C/A-8338-2013; Eggert, Angelika/AAE-6907-2022; Vandesompele, Jo/W-3411-2018; Versteeg, Rogier/AAQ-1765-2020; Maurer, Jochen/G-4832-2018; Schorle, Hubert/S-1713-2019; Schulte, Johannes H./V-2474-2018; Schulte, Johannes H/G-3981-2010; Schramm, Alexander/G-5688-2010; De Preter, Katleen/I-7135-2013; Heukamp, Lukas/G-9967-2012	Schorle, Hubert/0000-0001-8272-0076; speleman, frank/0000-0002-6628-8559; Eggert, Angelika/0000-0003-3476-8184; Vandesompele, Jo/0000-0001-6274-0184; Maurer, Jochen/0000-0003-3962-3128; Schramm, Alexander/0000-0001-7670-7529; De Preter, Katleen/0000-0002-7726-5096; Kunkele, Annette/0000-0002-8406-5412; Heukamp, Lukas/0000-0002-3388-3482; Versteeg, Rogier/0000-0001-7172-0388; Schulte, Johannes Hubertus/0000-0003-0671-1201	German National Genome Research Network (NGFN) [PKN-01GS0894-6]; German Cancer Aid [108941]	German National Genome Research Network (NGFN); German Cancer Aid(Deutsche Krebshilfe)	We thank E Mahlow, 5 Dreesmann, A Odersky and M Baumann for their excellent technical assistance and K Astrahantseff for proof reading the manuscript. This work was supported by the German National Genome Research Network (NGFN plus grant no. PKN-01GS0894-6 to JHS, AE and AS) and by the German Cancer Aid (grant no. 108941 to JHS and AE).	Barker N, 2009, NATURE, V457, P608, DOI 10.1038/nature07602; BECKWITH JB, 1963, AM J PATHOL, V43, P1089; Bonnet D, 1997, NAT MED, V3, P730, DOI 10.1038/nm0797-730; De Preter K, 2006, GENOME BIOL, V7, DOI 10.1186/gb-2006-7-9-r84; Gibson P, 2010, NATURE, V468, P1095, DOI 10.1038/nature09587; Hata K, 2007, LIVER TRANSPLANT, V13, P114, DOI 10.1002/lt.20957; Jager R, 2004, GENESIS, V38, P145, DOI 10.1002/gene.20014; Johnson RA, 2010, NATURE, V466, P632, DOI 10.1038/nature09173; Maris JM, 2010, NEW ENGL J MED, V362, P2202, DOI 10.1056/NEJMra0804577; MARTINZANCA D, 1989, MOL CELL BIOL, V9, P24, DOI 10.1128/MCB.9.1.24; Maurer J, 2007, DIFFERENTIATION, V75, P580, DOI 10.1111/j.1432-0436.2007.00164.x; Pajtler K, 2010, J VIS EXP; Riggi N, 2008, CANCER RES, V68, P2176, DOI 10.1158/0008-5472.CAN-07-1761; Schulte JH, 2005, ONCOGENE, V24, P165, DOI 10.1038/sj.onc.1208000; Schulte JH, 2010, INT J CANCER, V127, P2374, DOI 10.1002/ijc.25436; Schulte JH, 2009, INT J CANCER, V124, P2488, DOI 10.1002/ijc.24204; Schulte JH, 2009, CANCER RES, V69, P2065, DOI 10.1158/0008-5472.CAN-08-1735; Soucek L, 2008, NATURE, V455, P679, DOI 10.1038/nature07260; Swartling FJ, 2010, GENE DEV, V24, P1059, DOI 10.1101/gad.1907510; von Bueren AO, 2007, BMC CANCER, V7, DOI 10.1186/1471-2407-7-19; Weiss WA, 1997, EMBO J, V16, P2985, DOI 10.1093/emboj/16.11.2985; Zender L, 2008, CELL, V135, P852, DOI 10.1016/j.cell.2008.09.061	22	69	71	0	18	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0950-9232	1476-5594		ONCOGENE	Oncogene	FEB 21	2013	32	8					1059	1065		10.1038/onc.2012.106	http://dx.doi.org/10.1038/onc.2012.106			7	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	111LQ	22484425				2022-12-25	WOS:000316523200013
J	Kwak, D; Choi, S; Jeong, H; Jang, JH; Lee, Y; Jeon, H; Lee, MN; Noh, J; Cho, K; Yoo, JS; Hwang, D; Suh, PG; Ryu, SH				Kwak, Dongoh; Choi, Sunkyu; Jeong, Heeyoon; Jang, Jin-Hyeok; Lee, Youngmi; Jeon, Hyeona; Lee, Mi Nam; Noh, Jungeun; Cho, Kun; Yoo, Jong Shin; Hwang, Daehee; Suh, Pann-Ghill; Ryu, Sung Ho			Osmotic Stress Regulates Mammalian Target of Rapamycin (mTOR) Complex 1 via c-Jun N-terminal Kinase (JNK)-mediated Raptor Protein Phosphorylation	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							SIGNAL-TRANSDUCTION; CELL-GROWTH; S6 KINASE; ACTIVATION; PATHWAY; TOR; PHOSPHATASE; MECHANISMS; INTERACTS; P70(S6K)	mTOR complex 1 (mTORC1) is a multiprotein complex that integrates diverse signals including growth factors, nutrients, and stress to control cell growth. Raptor is an essential component of mTORC1 that functions to recruit specific substrates. Recently, Raptor was suggested to be a key target of regulation of mTORC1. Here, we show that Raptor is phosphorylated by JNK upon osmotic stress. We identified that osmotic stress induces the phosphorylation of Raptor at Ser-696, Thr-706, and Ser-863 using liquid chromatography-tandem mass spectrometry. We found that JNK is responsible for the phosphorylation. The inhibition of JNK abolishes the phosphorylation of Raptor induced by osmotic stress in cells. Furthermore, JNK physically associates with Raptor and phosphorylates Raptor in vitro, implying that JNK is responsible for the phosphorylation of Raptor. Finally, we found that osmotic stress activates mTORC1 kinase activity in a JNK-dependent manner. Our findings suggest that the molecular link between JNK and Raptor is a potential mechanism by which stress regulates the mTORC1 signaling pathway.	[Kwak, Dongoh; Choi, Sunkyu; Jeong, Heeyoon; Jeon, Hyeona; Lee, Mi Nam; Noh, Jungeun; Ryu, Sung Ho] Pohang Univ Sci & Technol POSTECH, Div Mol & Life Sci, Pohang 790784, Kyungbuk, South Korea; [Jang, Jin-Hyeok; Lee, Youngmi; Hwang, Daehee; Ryu, Sung Ho] Pohang Univ Sci & Technol POSTECH, Sch Interdisciplinary Biosci & Bioengn, Pohang 790784, Kyungbuk, South Korea; [Ryu, Sung Ho] Pohang Univ Sci & Technol POSTECH, Div Integrat Biosci & Biotechnol, Pohang 790784, Kyungbuk, South Korea; [Cho, Kun; Yoo, Jong Shin] Korea Basic Sci Inst, Mass Spectrometry Res Ctr, Cheong Won 363883, Chungbuk, South Korea; [Suh, Pann-Ghill] Ulsan Natl Inst Sci & Technol, Sch Nanobiosci & Chem Engn, Ulsan 689798, South Korea	Pohang University of Science & Technology (POSTECH); Pohang University of Science & Technology (POSTECH); Pohang University of Science & Technology (POSTECH); Korea Basic Science Institute (KBSI); Ulsan National Institute of Science & Technology (UNIST)	Ryu, SH (corresponding author), Pohang Univ Sci & Technol POSTECH, Div Mol & Life Sci, Pohang 790784, Kyungbuk, South Korea.	sungho@postech.ac.kr	Cho, Kun/B-9319-2012; Suh, Pann-Ghill/F-3610-2010	Cho, Kun/0000-0003-1154-4065; Ryu, Sung Ho/0000-0003-0913-3048	Global Frontier Project [NRF-MI-AXA002-2010-0029764]; Global Research Network [KRF-2008-220-C00036]	Global Frontier Project; Global Research Network	This work was supported by the Global Frontier Project (Grant NRF-MI-AXA002-2010-0029764) and Global Research Network Program (Grant KRF-2008-220-C00036).	Carriere A, 2008, CURR BIOL, V18, P1269, DOI 10.1016/j.cub.2008.07.078; Carriere A, 2011, J BIOL CHEM, V286, P567, DOI 10.1074/jbc.M110.159046; Choo AY, 2010, MOL CELL, V38, P487, DOI 10.1016/j.molcel.2010.05.007; Foster KG, 2010, J BIOL CHEM, V285, P80, DOI 10.1074/jbc.M109.029637; Fujishita T, 2011, GASTROENTEROLOGY, V140, P1556, DOI 10.1053/j.gastro.2011.02.007; Go WY, 2004, P NATL ACAD SCI USA, V101, P10673, DOI 10.1073/pnas.0403139101; Gual P, 2003, J BIOL CHEM, V278, P26550, DOI 10.1074/jbc.M212273200; Guertin DA, 2007, CANCER CELL, V12, P9, DOI 10.1016/j.ccr.2007.05.008; Gwinn DM, 2008, MOL CELL, V30, P214, DOI 10.1016/j.molcel.2008.03.003; Gwinn DM, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0009197; Hara K, 2002, CELL, V110, P177, DOI 10.1016/S0092-8674(02)00833-4; Ho SN, 2006, J CELL PHYSIOL, V206, P9, DOI 10.1002/jcp.20445; Huang CS, 2002, CANCER RES, V62, P5689; Huang J, 2008, BIOCHEM J, V412, P179, DOI 10.1042/BJ20080281; HuangFu WC, 2006, J BIOL CHEM, V281, P28802, DOI 10.1074/jbc.M603627200; Inoki K, 2003, GENE DEV, V17, P1829, DOI 10.1101/gad.1110003; Jacinto E, 2003, NAT REV MOL CELL BIO, V4, P117, DOI 10.1038/nrm1018; Kim DH, 2002, CELL, V110, P163, DOI 10.1016/S0092-8674(02)00808-5; Lee CH, 2007, EMBO J, V26, P4812, DOI 10.1038/sj.emboj.7601900; Lei K, 2002, MOL CELL BIOL, V22, P4929, DOI 10.1128/MCB.22.13.4929-4942.2002; Long X, 2005, CURR BIOL, V15, P702, DOI 10.1016/j.cub.2005.02.053; Ma XJM, 2009, NAT REV MOL CELL BIO, V10, P307, DOI 10.1038/nrm2672; Parrott LA, 1999, J BIOL CHEM, V274, P24731, DOI 10.1074/jbc.274.35.24731; Peterson RT, 1999, P NATL ACAD SCI USA, V96, P4438, DOI 10.1073/pnas.96.8.4438; Ramirez-Valle F, 2010, MOL CELL BIOL, V30, P3151, DOI 10.1128/MCB.00322-09; Reiling JH, 2006, ONCOGENE, V25, P6373, DOI 10.1038/sj.onc.1209889; Sancak Y, 2007, MOL CELL, V25, P903, DOI 10.1016/j.molcel.2007.03.003; Schaim SS, 2003, CURR BIOL, V13, P797, DOI 10.1016/S0960-9822(03)00329-4; Sengupta S, 2010, MOL CELL, V40, P310, DOI 10.1016/j.molcel.2010.09.026; Weston CR, 2007, CURR OPIN CELL BIOL, V19, P142, DOI 10.1016/j.ceb.2007.02.001; Wu XN, 2011, J BIOL CHEM, V286, P31501, DOI 10.1074/jbc.M111.233122; Wullschleger S, 2006, CELL, V124, P471, DOI 10.1016/j.cell.2006.01.016; Zhang YG, 2001, J BIOL CHEM, V276, P20913, DOI 10.1074/jbc.M009047200; Zheng CJ, 1999, J BIOL CHEM, V274, P28966, DOI 10.1074/jbc.274.41.28966; Zoncu R, 2011, NAT REV MOL CELL BIO, V12, P21, DOI 10.1038/nrm3025	35	32	35	0	3	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAY 25	2012	287	22					18398	18407		10.1074/jbc.M111.326538	http://dx.doi.org/10.1074/jbc.M111.326538			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	974EC	22493283	hybrid, Green Published			2022-12-25	WOS:000306411600046
J	Lee, SY; Kim, JR; Hu, YY; Khan, R; Kim, SJ; Bharadwaj, KG; Davidson, MM; Choi, CS; Shin, KO; Lee, YM; Park, WJ; Park, IS; Jiang, XC; Goldberg, IJ; Park, TS				Lee, Su-Yeon; Kim, Jung Ran; Hu, Yunying; Khan, Raffay; Kim, Su-Jung; Bharadwaj, Kalyani G.; Davidson, Mercy M.; Choi, Cheol-Soo; Shin, Kyong-Oh; Lee, Yong-Moon; Park, Woo-Jin; Park, In-Sun; Jiang, Xian-Cheng; Goldberg, Ira J.; Park, Tae-Sik			Cardiomyocyte Specific Deficiency of Serine Palmitoyltransferase Subunit 2 Reduces Ceramide but Leads to Cardiac Dysfunction	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							PALMITOYL-COA TRANSFERASE; SPHINGOLIPID METABOLISM; HEART-FAILURE; FATTY-ACIDS; INSULIN-RESISTANCE; KEY ENZYME; SYNTHASE 2; IN-VIVO; SPHINGOMYELIN; ACTIVATION	The role of serine palmitoyltransferase (SPT) and de novo ceramide biosynthesis in cardiac ceramide and sphingomyelin metabolism is unclear. To determine whether the de novo synthetic pathways, rather than ceramide uptake from circulating lipoproteins, is important for heart ceramide levels, we created cardiomyocyte-specific deficiency of Sptlc2, a subunit of SPT. Heart-specific Sptlc2-deficient (hSptlc2 KO) mice had a >35% reduction in ceramide, which was limited to C18:0 and very long chain ceramides. Sphingomyelinase expression, and levels of sphingomyelin and diacylglycerol were unchanged. But surprisingly phospholipids and acyl CoAs contained increased saturated long chain fatty acids. hSptlc2 KO mice had decreased fractional shortening and thinning of the cardiac wall. While the genes regulating glucose and fatty acid metabolism were not changed, expression of cardiac failure markers and the genes involved in the formation of extracellular matrices were up-regulated in hSptlc2 KO hearts. In addition, ER-stress markers were up-regulated leading to increased apoptosis. These results suggest that Sptlc2-mediated de novo ceramide synthesis is an essential source of C18:0 and very long chain, but not of shorter chain, ceramides in the heart. Changes in heart lipids other than ceramide levels lead to cardiac toxicity.	[Lee, Su-Yeon; Kim, Jung Ran; Kim, Su-Jung; Park, Tae-Sik] Gachon Univ, Dept Life Sci, Songnam 461701, Gyeonggi Do, South Korea; [Hu, Yunying; Khan, Raffay; Bharadwaj, Kalyani G.; Goldberg, Ira J.] Columbia Univ, Dept Med, New York, NY 10032 USA; [Davidson, Mercy M.] Columbia Univ, Dept Radiat Oncol, New York, NY 10032 USA; [Choi, Cheol-Soo] Gachon Univ, Lee Gil Ya Canc & Diabet Inst, Inchon 406840, South Korea; [Shin, Kyong-Oh; Lee, Yong-Moon] Chungbuk Natl Univ, Coll Pharm, Chonju 361763, South Korea; [Shin, Kyong-Oh; Lee, Yong-Moon] Chungbuk Natl Univ, MRC, Chonju 361763, South Korea; [Park, Woo-Jin] Gwangju Inst Sci & Technol, Dept Life Sci, Kwangju 500712, South Korea; [Park, In-Sun] Inha Univ, Coll Med, Dept Anat, Inchon 402751, South Korea; [Jiang, Xian-Cheng] State Univ New York Downstate Med Ctr, Dept Cell Biol, Brooklyn, NY 11203 USA	Gachon University; Columbia University; Columbia University; Gachon University; Chungbuk National University; Chungbuk National University; Gwangju Institute of Science & Technology (GIST); Inha University; State University of New York (SUNY) System; State University of New York (SUNY) Downstate Medical Center	Park, TS (corresponding author), Gachon Univ, Dept Life Sci, Songnam 461701, Gyeonggi Do, South Korea.	tspark@gachon.ac.kr	Lorkiewicz, Pawel/A-2126-2011	Lorkiewicz, Pawel/0000-0002-1755-9826	National Research Foundation of Korea (NRF); Ministry of Education, Science, and Technology [NRF-2010-0000590, NRF2011-0025903, HL73029, HL45095]; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL073029, R37HL045095, R01HL045095] Funding Source: NIH RePORTER	National Research Foundation of Korea (NRF)(National Research Foundation of Korea); Ministry of Education, Science, and Technology(Ministry of Education, Science & Technology (MEST), Republic of Korea); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))	This research was supported by Basic Science Research Program through the National Research Foundation of Korea (NRF) funded by the Ministry of Education, Science, and Technology NRF-2010-0000590, NRF2011-0025903)(to T.S.P.) and HL73029 and HL45095 (to I.J.G.).	Ananthakrishnan R, 2005, MOL CELL BIOCHEM, V268, P103, DOI 10.1007/s11010-005-3699-3; Augustus AS, 2006, J BIOL CHEM, V281, P8716, DOI 10.1074/jbc.M509890200; Banerjee I, 2007, AM J PHYSIOL-HEART C, V293, pH1883, DOI 10.1152/ajpheart.00514.2007; Bartke N, 2009, J LIPID RES, V50, pS91, DOI 10.1194/jlr.R800080-JLR200; BLIGH EG, 1959, CAN J BIOCHEM PHYS, V37, P911; Borradaile NM, 2006, J LIPID RES, V47, P2726, DOI 10.1194/jlr.M600299-JLR200; Chavez JA, 2003, ARCH BIOCHEM BIOPHYS, V419, P101, DOI 10.1016/j.abb.2003.08.020; Cole LK, 2011, CIRC RES, V108, P686, DOI 10.1161/CIRCRESAHA.110.238691; Davidson MM, 2005, J MOL CELL CARDIOL, V39, P133, DOI 10.1016/j.yjmcc.2005.03.003; Han G, 2009, P NATL ACAD SCI USA, V106, P8186, DOI 10.1073/pnas.0811269106; Han GS, 2006, J BIOL CHEM, V281, P9210, DOI 10.1074/jbc.M600425200; Hanada K, 2003, BBA-MOL CELL BIOL L, V1632, P16, DOI 10.1016/S1388-1981(03)00059-3; Haq S, 2001, CIRCULATION, V103, P670; Haughey NJ, 2010, BBA-MOL CELL BIOL L, V1801, P878, DOI 10.1016/j.bbalip.2010.05.003; Hojjati MR, 2005, BBA-MOL CELL BIOL L, V1737, P44, DOI 10.1016/j.bbalip.2005.08.006; Holland WL, 2008, ENDOCR REV, V29, P381, DOI 10.1210/er.2007-0025; Holland WL, 2007, CELL METAB, V5, P167, DOI 10.1016/j.cmet.2007.01.002; Hornemann T, 2007, BIOCHEM J, V405, P157, DOI 10.1042/BJ20070025; Hornemann T, 2006, J BIOL CHEM, V281, P37275, DOI 10.1074/jbc.M608066200; Li ZY, 2006, CELL METAB, V3, P321, DOI 10.1016/j.cmet.2006.03.007; Li ZQ, 2009, J BIOL CHEM, V284, P27010, DOI 10.1074/jbc.M109.042028; Lightle S, 2003, ARCH BIOCHEM BIOPHYS, V419, P120, DOI 10.1016/j.abb.2003.08.031; Linn SC, 2006, FEBS LETT, V580, P6217, DOI 10.1016/j.febslet.2006.10.025; Listenberger LL, 2003, P NATL ACAD SCI USA, V100, P3077, DOI 10.1073/pnas.0630588100; Magnes C, 2005, ANAL CHEM, V77, P2889, DOI 10.1021/ac048314i; Matsui T, 2006, AM J PHYSIOL-ENDOC M, V290, pE789, DOI 10.1152/ajpendo.00564.2004; Maxfield FR, 2010, CURR OPIN CELL BIOL, V22, P422, DOI 10.1016/j.ceb.2010.05.004; McCampbell A, 2005, HUM MOL GENET, V14, P3507, DOI 10.1093/hmg/ddi380; Mesicek J, 2010, CELL SIGNAL, V22, P1300, DOI 10.1016/j.cellsig.2010.04.006; Milhas D, 2010, FEBS LETT, V584, P1887, DOI 10.1016/j.febslet.2009.10.058; Mullen TD, 2011, J BIOL CHEM, V286, DOI 10.1074/jbc.M111.230870; Oskouian B, 2010, ADV EXP MED BIOL, V688, P185; Ostrander DB, 2001, J BIOL CHEM, V276, P38061; Park TS, 2008, J LIPID RES, V49, P2101, DOI 10.1194/jlr.M800147-JLR200; Park TS, 2004, CIRCULATION, V110, P3465, DOI 10.1161/01.CIR.0000148370.60535.22; Pettus BJ, 2002, BBA-MOL CELL BIOL L, V1585, P114, DOI 10.1016/S1388-1981(02)00331-1; Pewzner-Jung Y, 2010, J BIOL CHEM, V285, P10911, DOI 10.1074/jbc.M109.077610; Pewzner-Jung Y, 2010, J BIOL CHEM, V285, P10902, DOI 10.1074/jbc.M109.077594; Rotthier A, 2010, AM J HUM GENET, V87, P513, DOI 10.1016/j.ajhg.2010.09.010; Saini-Chohan HK, 2009, J LIPID RES, V50, P1600, DOI 10.1194/jlr.M800561-JLR200; Saito H, 2000, BBA-MOL CELL BIOL L, V1486, P312, DOI 10.1016/S1388-1981(00)00071-8; Shimabukuro M, 1998, J BIOL CHEM, V273, P32487, DOI 10.1074/jbc.273.49.32487; Wang CY, 2002, CIRCULATION, V105, P1609, DOI 10.1161/01.CIR.0000013022.11250.30; Weiss B, 1997, EUR J BIOCHEM, V249, P239, DOI 10.1111/j.1432-1033.1997.00239.x; Wolfe RR, 1992, RADIOACTIVE STABLE I; Yoo HH, 2006, J CHROMATOGR B, V843, P327, DOI 10.1016/j.jchromb.2006.06.025; Yoshimura A, 2005, ACTA PHYSIOL SCAND, V185, P41, DOI 10.1111/j.1365-201X.2005.01455.x; Yu CL, 2002, J BIOL CHEM, V277, P50230, DOI 10.1074/jbc.M200958200	48	50	51	0	8	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAY 25	2012	287	22					18429	18439		10.1074/jbc.M111.296947	http://dx.doi.org/10.1074/jbc.M111.296947			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	974EC	22493506	Green Published, hybrid			2022-12-25	WOS:000306411600049
J	Nishiwaki, T; Kondo, T				Nishiwaki, Taeko; Kondo, Takao			Circadian Autodephosphorylation of Cyanobacterial Clock Protein KaiC Occurs via Formation of ATP as Intermediate	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							KINETIC-DATA; PHOSPHORYLATION; PHOSPHATASES; OSCILLATION; EXPLORER; PROGRAM; SYSTEM; RHYTHM	The cyanobacterial circadian oscillator can be reconstituted in vitro; mixing three clock proteins (KaiA, KaiB, and KaiC) with ATP results in an oscillation of KaiC phosphorylation with a periodicity of similar to 24 h. The hexameric ATPase KaiC hydrolyzes ATP bound at subunit interfaces. KaiC also exhibits autokinase and autophosphatase activities, the latter of which is particularly noteworthy because KaiC is phylogenetically distinct from typical protein phosphatases. To examine this activity, we performed autodephosphorylation assays using P-32-labeled KaiC. The residual radioactive ATP bound to subunit interfaces was removed using a newly established method, which included the dissociation of KaiC hexamers into monomers and the reconstitution of KaiC hexamers with nonradioactive ATP. This approach ensured that only the signals derived from P-32-labeled KaiC were examined. We detected the transient formation of [P-32] ATP preceding the accumulation of P-32(i). Together with kinetic analyses, our data demonstrate that KaiC undergoes dephosphorylation via a mechanism that differs from those of conventional protein phosphatases. A phosphate group at a phosphorylation site is first transferred to KaiC-bound ADP to form ATP as an intermediate, which can be regarded as a reversal of the autophosphorylation reaction. Subsequently, the ATP molecule is hydrolyzed to form P-i. We propose that the ATPase active site mediates not only ATP hydrolysis but also the bidirectional transfer of the phosphate between phosphorylation sites and the KaiC-bound nucleotide. On the basis of these findings, we can now dissect the dynamics of the KaiC phosphorylation cycle relative to ATPase activity.	[Kondo, Takao] Nagoya Univ, Grad Sch Sci, Div Biol Sci, Nagoya, Aichi 4648602, Japan; Japan Sci & Technol Agcy JST, CREST, Chikusa Ku, Nagoya, Aichi 4648602, Japan	Nagoya University; Japan Science & Technology Agency (JST)	Kondo, T (corresponding author), Nagoya Univ, Grad Sch Sci, Div Biol Sci, Furo Cho, Nagoya, Aichi 4648602, Japan.	kondo@bio.nagoya-u.ac.jp			Ministry of Education, Culture, Sports, Science and Technology of Japan [21570037, 23118708]	Ministry of Education, Culture, Sports, Science and Technology of Japan(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT))	This work was supported in part by Grants-in-Aid 21570037 and 23118708 from the Ministry of Education, Culture, Sports, Science and Technology of Japan (to T. N.).	Hayashi F, 2003, GENES CELLS, V8, P287, DOI 10.1046/j.1365-2443.2003.00633.x; Hayashi F, 2006, BIOCHEM BIOPH RES CO, V348, P864, DOI 10.1016/j.bbrc.2006.07.143; Ito H, 2007, NAT STRUCT MOL BIOL, V14, P1084, DOI 10.1038/nsmb1312; Iwasaki H, 2002, P NATL ACAD SCI USA, V99, P15788, DOI 10.1073/pnas.222467299; Iwasaki H, 1999, EMBO J, V18, P1137, DOI 10.1093/emboj/18.5.1137; Johnson KA, 2009, ANAL BIOCHEM, V387, P30, DOI 10.1016/j.ab.2008.12.025; Johnson KA, 2009, ANAL BIOCHEM, V387, P20, DOI 10.1016/j.ab.2008.12.024; Kim YI, 2008, P NATL ACAD SCI USA, V105, P12825, DOI 10.1073/pnas.0800526105; Kitayama Y, 2003, EMBO J, V22, P2127, DOI 10.1093/emboj/cdg212; Lakin-Thomas PL, 2006, J BIOL RHYTHM, V21, P83, DOI 10.1177/0748730405286102; LAPORTE DC, 1989, BIOCHIMIE, V71, P1051, DOI 10.1016/0300-9084(89)90110-7; Leipe DD, 2003, J MOL BIOL, V333, P781, DOI 10.1016/j.jmb.2003.08.040; Nakajima M, 2005, SCIENCE, V308, P414, DOI 10.1126/science.1108451; Nishiwaki T, 2004, P NATL ACAD SCI USA, V101, P13927, DOI 10.1073/pnas.0403906101; Nishiwaki T, 2000, P NATL ACAD SCI USA, V97, P495, DOI 10.1073/pnas.97.1.495; Nishiwaki T, 2007, EMBO J, V26, P4029, DOI 10.1038/sj.emboj.7601832; O'Neill JS, 2011, NATURE, V469, P498, DOI 10.1038/nature09702; O'Neill JS, 2011, NATURE, V469, P554, DOI 10.1038/nature09654; Pattanayek R, 2004, MOL CELL, V15, P375, DOI 10.1016/j.molcel.2004.07.013; Rust MJ, 2007, SCIENCE, V318, P809, DOI 10.1126/science.1148596; Rust MJ, 2011, SCIENCE, V331, P220, DOI 10.1126/science.1197243; Shi YG, 2009, CELL, V139, P468, DOI 10.1016/j.cell.2009.10.006; Tabernero L, 2008, FEBS J, V275, P867, DOI 10.1111/j.1742-4658.2008.06251.x; Terauchi K, 2007, P NATL ACAD SCI USA, V104, P16377, DOI 10.1073/pnas.0706292104; Xu Y, 2004, P NATL ACAD SCI USA, V101, P13933, DOI 10.1073/pnas.0404768101; Xu Y, 2003, EMBO J, V22, P2117, DOI 10.1093/emboj/cdg168; Yegutkin GG, 2006, J BIOL CHEM, V281, P29441, DOI 10.1074/jbc.M602480200	27	57	59	1	10	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAY 25	2012	287	22					18030	18035		10.1074/jbc.M112.350660	http://dx.doi.org/10.1074/jbc.M112.350660			6	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	974EC	22493509	Green Published, hybrid			2022-12-25	WOS:000306411600012
J	Li, YH; Liu, SY; Zhang, ZY; Xu, QB; Xie, FK; Wang, JJ; Ping, SN; Li, C; Wang, ZJ; Zhang, M; Huang, JT; Chen, DD; Hu, LP; Li, CH				Li, Yuhuang; Liu, Shuying; Zhang, Zhengyu; Xu, Qingbo; Xie, Fukang; Wang, Jingjing; Ping, Suning; Li, Chen; Wang, Zhaojing; Zhang, Min; Huang, Jintao; Chen, Dadi; Hu, Liping; Li, Chaohong			RAGE Mediates Accelerated Diabetic Vein Graft Atherosclerosis Induced by Combined Mechanical Stress and AGEs via Synergistic ERK Activation	PLOS ONE			English	Article							GLYCATION END-PRODUCTS; SMOOTH-MUSCLE-CELLS; NEOINTIMAL FORMATION; NULL MICE; SIGNALING PATHWAY; OXIDATIVE STRESS; ANGIOTENSIN-II; BYPASS GRAFTS; RECEPTOR; ARTERIAL	Aims/Hypothesis: Diabetes with hypertension rapidly accelerates vascular disease, but the underlying mechanism remains unclear. We evaluated the hypothesis that the receptor of advanced glycation end products (RAGE) might mediate combined signals initiated by diabetes-related AGEs and hypertension-induced mechanical stress as a common molecular sensor. Methods: In vivo surgical vein grafts created by grafting vena cava segments from C57BL/6J mice into the common carotid arteries of streptozotocin (STZ)-treated and untreated isogenic mice for 4 and 8 weeks were analyzed using morphometric and immunohistochemical techniques. In vitro quiescent mouse vascular smooth muscle cells (VSMCs) with either knockdown or overexpression of RAGE were subjected to cyclic stretching with or without AGEs. Extracellular signal-regulated kinase (ERK) phosphorylation and Ki-67 expression were investigated. Results: Significant increases in neointimal formation, AGE deposition, Ki-67 expression, and RAGE were observed in the vein grafts of STZ-induced diabetic mice. The highest levels of ERK phosphorylation and Ki-67 expression in VSMCs were induced by simultaneous stretch stress and AGE exposure. The synergistic activation of ERKs and Ki-67 in VSMCs was significantly inhibited by siRNA-RAGE treatment and enhanced by over-expression of RAGE. Conclusion: RAGE may mediate synergistically increased ERK activation and VSMC proliferation induced by mechanical stretching with and without AGEs. It may serve as a common molecular bridge between the two, accelerating vascular remodeling. This study provides potential drug targets and novel therapeutic strategies for the treatment of vascular diseases resulting from diabetes with hypertension.	[Li, Yuhuang; Liu, Shuying; Zhang, Zhengyu; Xie, Fukang; Wang, Jingjing; Ping, Suning; Li, Chen; Wang, Zhaojing; Zhang, Min; Huang, Jintao; Chen, Dadi; Hu, Liping; Li, Chaohong] Sun Yat Sen Univ, Dept Histol & Embryol, Zhongshan Sch Med, Guangzhou 510275, Guangdong, Peoples R China; [Xu, Qingbo] Kings Coll London, British Heart Fdn Ctr, Div Cardiovasc, London WC2R 2LS, England	Sun Yat Sen University; University of London; King's College London	Li, YH (corresponding author), Sun Yat Sen Univ, Dept Histol & Embryol, Zhongshan Sch Med, Guangzhou 510275, Guangdong, Peoples R China.	lichaohongzq@yahoo.com	Zhang, Zhengyu/AAJ-3821-2020	Li, Chaohong/0000-0002-7979-1639	National Natural Science Foundation of China [30570762, 30871023, 81070124]; Natural Science Foundation of Guangdong Province [8151008901000044]; Doctoral Foundation of the Chinese Ministry of Education [20090171110049]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Natural Science Foundation of Guangdong Province(National Natural Science Foundation of Guangdong Province); Doctoral Foundation of the Chinese Ministry of Education	This work was supported by grants 30570762, 30871023, and 81070124 from the National Natural Science Foundation of China, grant 8151008901000044 from the Natural Science Foundation of Guangdong Province, and grant 20090171110049 from the Doctoral Foundation of the Chinese Ministry of Education. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aronson D, 2003, J HYPERTENS, V21, P3, DOI 10.1097/00004872-200301000-00002; BENES AJ, 1985, J CELL SCI, V75, P35; Bierhaus A, 2009, DIABETOLOGIA, V52, P2251, DOI 10.1007/s00125-009-1458-9; BROWNLEE M, 1995, ANNU REV MED, V46, P223, DOI 10.1146/annurev.med.46.1.223; Bu DX, 2010, CIRC RES, V106, P1040, DOI 10.1161/CIRCRESAHA.109.201103; Bucciarelli LG, 2002, CIRCULATION, V106, P2827, DOI 10.1161/01.CIR.0000039325.03698.36; Cheng ZJ, 2007, J HUAZHONG U SCI-MED, V27, P393, DOI 10.1007/s11596-007-0411-8; Chien S, 2007, AM J PHYSIOL-HEART C, V292, pH1209, DOI 10.1152/ajpheart.01047.2006; Cooper ME, 2001, DIABETOLOGIA, V44, P1957, DOI 10.1007/s001250100000; Cooper SA, 2007, AM J PHYSIOL-HEART C, V293, pH2009, DOI 10.1152/ajpheart.00522.2007; DOBRIN PB, 1995, HYPERTENSION, V26, P38, DOI 10.1161/01.HYP.26.1.38; Galler A, 2003, DIABETES CARE, V26, P2609, DOI 10.2337/diacare.26.9.2609; Hilker M, 2002, CARDIOVASC PATHOL, V11, P284, DOI 10.1016/S1054-8807(02)00113-8; Hu YH, 2004, J CLIN INVEST, V113, P1258, DOI 10.1172/JCI200419628; Hu YH, 1998, FASEB J, V12, P1135, DOI 10.1096/fasebj.12.12.1135; Kim JY, 2008, INT J ONCOL, V33, P493, DOI 10.3892/ijo_00000032; Koka V, 2006, CIRCULATION, V113, P1353, DOI 10.1161/CIRCULATIONAHA.105.575589; Leitges M, 2001, J CLIN INVEST, V108, P1505; Lewko B, 2009, J CELL PHYSIOL, V221, P288, DOI 10.1002/jcp.21856; Li CH, 2000, CELL SIGNAL, V12, P435, DOI 10.1016/S0898-6568(00)00096-6; Li CH, 1999, J BIOL CHEM, V274, P25273, DOI 10.1074/jbc.274.36.25273; Li JH, 2004, AM J PATHOL, V164, P1389, DOI 10.1016/S0002-9440(10)63225-7; LOMBARD JH, 1990, AM J PHYSIOL, V259, pH29, DOI 10.1152/ajpheart.1990.259.1.H29; LOOP FD, 1986, NEW ENGL J MED, V314, P1, DOI 10.1056/NEJM198601023140101; Mayr U, 2002, CIRC RES, V90, P197, DOI 10.1161/hh0202.103715; Meloche J, 2011, ARTERIOSCL THROM VAS, V31, P2114, DOI 10.1161/ATVBAHA.111.230573; Nilsson PM, 2011, DIABETES CARE, V34, pS109, DOI 10.2337/dc11-s204; Park' L, 1998, NAT MED, V4, P1025, DOI 10.1038/2012; Prado CM, 2006, J HYPERTENS, V24, P503, DOI 10.1097/01.hjh.0000209987.51606.23; Rosen P, 2001, DIABETES-METAB RES, V17, P189, DOI 10.1002/dmrr.196; Sakaguchi T, 2003, J CLIN INVEST, V111, P959, DOI 10.1172/JCI200317115; Salzberg SP, 2006, CIRCULATION, V114, pI302, DOI 10.1161/CIRCULATIONAHA.105.001339; Schmidt AM, 1999, CIRC RES, V84, P489, DOI 10.1161/01.RES.84.5.489; Shi Y, 1996, CIRCULATION, V94, P1655, DOI 10.1161/01.CIR.94.7.1655; Soro-Paavonen A, 2008, DIABETES, V57, P2461, DOI 10.2337/db07-1808; Villacorta L, 2007, AM J PHYSIOL-HEART C, V293, pH770, DOI 10.1152/ajpheart.00261.2007; VLASSARA H, 1995, MOL MED, V1, P447, DOI 10.1007/BF03401582; Vlassara H, 2002, J INTERN MED, V251, P87, DOI 10.1046/j.1365-2796.2002.00932.x; Williams B, 1998, J HYPERTENS, V16, P1921, DOI 10.1097/00004872-199816121-00011; Yamagishi S, 2011, EXP GERONTOL, V46, P217, DOI 10.1016/j.exger.2010.11.007; Zauli G, 2010, DIABETES, V59, P1261, DOI 10.2337/db09-1771; Zhou ZM, 2003, CIRCULATION, V107, P2238, DOI 10.1161/01.CIR.0000063577.32819.23; Zou YP, 1998, AM J PATHOL, V153, P1301, DOI 10.1016/S0002-9440(10)65675-1; Zou YZ, 2004, NAT CELL BIOL, V6, P499, DOI 10.1038/ncb1137	44	37	43	1	13	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 9	2012	7	4							e35016	10.1371/journal.pone.0035016	http://dx.doi.org/10.1371/journal.pone.0035016			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	955JO	22496883	gold, Green Published, Green Submitted			2022-12-25	WOS:000305014500038
J	Peng, F; Xu, ZM; Wang, J; Chen, YY; Li, Q; Zuo, YF; Chen, J; Hu, X; Zhou, QC; Wang, Y; Ma, HL; Bao, Y; Chen, M				Peng, Fang; Xu, Zumin; Wang, Jin; Chen, Yuanyuan; Li, Qiang; Zuo, Yufang; Chen, Jing; Hu, Xiao; Zhou, Qichao; Wang, Yan; Ma, Honglian; Bao, Yong; Chen, Ming			Recombinant Human Endostatin Normalizes Tumor Vasculature and Enhances Radiation Response in Xenografted Human Nasopharyngeal Carcinoma Models	PLOS ONE			English	Article							TYROSINE KINASE INHIBITOR; ENDOTHELIAL GROWTH-FACTOR; EPITHELIUM-DERIVED FACTOR; VESSEL NORMALIZATION; MATRIX METALLOPROTEINASES; ANTIANGIOGENIC THERAPY; LYMPHATIC METASTASIS; ANTI-ANGIOGENESIS; CANCER-THERAPY; SOLID TUMORS	Background: Hypoxic tumor cells can reduce the efficacy of radiation. Antiangiogenic therapy may transiently "normalize'' the tumor vasculature to make it more efficient for oxygen delivery. The aim of this study is to investigate whether the recombinant human endostatin (endostar) can create a "vascular normalization window'' to alleviate hypoxia and enhance the inhibitory effects of radiation therapy in human nasopharyngeal carcinoma (NPC) in mice. Methodology/Principal Findings: Transient changes in morphology of tumor vasculature and hypoxic tumor cell fraction in response to endostar were detected in mice bearing CNE-2 and 5-8F human NPC xenografts. Various treatment schedules were tested to assess the influence of endostar on the effect of radiation therapy. Several important factors relevant to the angiogenesis were identified through immunohistochemical staining. During endostar treatment, tumor vascularity decreased, while the basement membrane and pericyte coverage associated with endothelial cells increased, which supported the idea of vessel normalization. Hypoxic tumor cell fraction also decreased after the treatment. The transient modulation of tumor physiology caused by endostar improved the effect of radiation treatment compared with other treatment schedules. The expressions of vascular endothelial growth factor (VEGF), matrix metalloproteinase-2 (MMP-2), MMP-9, and MMP-14 decreased, while the level of pigment epithelium-derived factor (PEDF) increased. Conclusions: Endostar normalized tumor vasculature, which alleviated hypoxia and significantly sensitized the function of radiation in anti-tumor in human NPC. The results provide an important experimental basis for combining endostar with radiation therapy in human NPC.	[Peng, Fang; Xu, Zumin; Wang, Jin; Chen, Yuanyuan; Hu, Xiao; Zhou, Qichao; Wang, Yan; Ma, Honglian; Bao, Yong; Chen, Ming] Sun Yat Sen Univ, Ctr Canc, Dept Radiat Oncol, Guangzhou 510275, Guangdong, Peoples R China; [Peng, Fang; Xu, Zumin; Wang, Jin; Chen, Yuanyuan; Hu, Xiao; Zhou, Qichao; Wang, Yan; Ma, Honglian; Bao, Yong; Chen, Ming] State Key Lab Oncol S China, Guangzhou, Guangdong, Peoples R China; [Xu, Zumin; Zuo, Yufang] Guangdong Med Coll, Affiliated Hosp, Ctr Canc, Zhanjiang, Peoples R China; [Li, Qiang] Sun Yat Sen Univ, Affiliated Hosp 1, Organ Transplantat Ctr, Guangzhou 510275, Guangdong, Peoples R China; [Chen, Jing] Guangzhou Mil Command, Guangzhou Gen Hosp, Guangzhou, Guangdong, Peoples R China	Sun Yat Sen University; Guangdong Medical University; Sun Yat Sen University; Southern Theater Command General Hospital	Peng, F (corresponding author), Sun Yat Sen Univ, Ctr Canc, Dept Radiat Oncol, Guangzhou 510275, Guangdong, Peoples R China.	baoyong@sysucc.org.cn; chenming@sysucc.org.cn	Chen, Ming/GVU-8412-2022; Chen, Yuanyuan/GXG-2130-2022; Chen, Ming/GYE-1379-2022; zuo, yufang/AAH-7155-2021	Chen, Ming/0000-0001-5041-9342; 	National Natural Science Foundation of China [30872974, 81172116]; Science and Technology Planning Project of Guangdong Province, China [2009B030801154]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Science and Technology Planning Project of Guangdong Province, China	This work was supported in part by National Natural Science Foundation of China (No. 30872974, 81172116) and Science and Technology Planning Project of Guangdong Province, China (No. 2009B030801154). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript. No additional external funding was received for this study.	Brown JM, 1999, CANCER RES, V59, P5863; Brown JM, 2004, NAT REV CANCER, V4, P437, DOI 10.1038/nrc1367; Brown JM, 1998, CANCER RES, V58, P1408; Cao RH, 2004, CANCER CELL, V6, P333, DOI 10.1016/j.ccr.2004.08.034; Carmeliet P, 2000, NATURE, V407, P249, DOI 10.1038/35025220; Carmeliet P, 2011, NAT REV DRUG DISCOV, V10, P417, DOI 10.1038/nrd3455; Cerniglia GJ, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0006539; Chae SS, 2010, CLIN CANCER RES, V16, P3618, DOI 10.1158/1078-0432.CCR-09-3073; Chung YL, 2000, CLIN CANCER RES, V6, P1452; Dawson DW, 1999, SCIENCE, V285, P245, DOI 10.1126/science.285.5425.245; Dings RPM, 2007, CLIN CANCER RES, V13, P3395, DOI 10.1158/1078-0432.CCR-06-2441; Dvorak HF, 2002, J CLIN ONCOL, V20, P4368, DOI 10.1200/JCO.2002.10.088; Ek ETH, 2006, TRENDS MOL MED, V12, P497, DOI 10.1016/j.molmed.2006.08.009; Ferrara N, 2005, NATURE, V438, P967, DOI 10.1038/nature04483; FOLKMAN J, 1972, ANN SURG, V175, P409, DOI 10.1097/00000658-197203000-00014; Fukumura D, 2007, MICROVASC RES, V74, P72, DOI 10.1016/j.mvr.2007.05.003; Gao GQ, 2002, J BIOL CHEM, V277, P9492, DOI 10.1074/jbc.M108004200; Hardee M, 2009, CANCER CHEMOTH PHARM, V63, P219, DOI 10.1007/s00280-008-0729-3; Hedlund EM, 2009, P NATL ACAD SCI USA, V106, P17505, DOI 10.1073/pnas.0908026106; Jain RK, 2007, CANCER RES, V67, P2729, DOI 10.1158/0008-5472.CAN-06-4102; Jain Rakesh K., 2008, P261; Jain RK, 2001, NAT MED, V7, P987, DOI 10.1038/nm0901-987; Jain RK, 2005, SCIENCE, V307, P58, DOI 10.1126/science.1104819; Kessenbrock K, 2010, CELL, V141, P52, DOI 10.1016/j.cell.2010.03.015; Lee AWM, 2011, EUR J CANCER, V47, P656, DOI 10.1016/j.ejca.2010.10.026; Lee NY, 2011, J CLIN ONCOL, V29, P5516; Liang Y, 2010, J BIOL CHEM, V285, P4931, DOI 10.1074/jbc.M109.048397; Ling Y, 2007, BIOCHEM BIOPH RES CO, V361, P79, DOI 10.1016/j.bbrc.2007.06.155; Lu N, 2008, EXP BIOL MED, V233, P1013, DOI 10.3181/0801-RM-7; Maione F, 2009, J CLIN INVEST, V119, P3356, DOI 10.1172/JCI36308; McGee MC, 2010, INT J RADIAT ONCOL, V76, P1537, DOI 10.1016/j.ijrobp.2009.12.010; Ni QG, 2009, EUR J PHARMACOL, V614, P1, DOI 10.1016/j.ejphar.2009.04.032; Nissen LJ, 2007, J CLIN INVEST, V117, P2766, DOI 10.1172/JCI32479; Ohta M, 2009, SURG TODAY, V39, P1046, DOI 10.1007/s00595-009-4020-y; OReilly MS, 1997, CELL, V88, P277, DOI 10.1016/S0092-8674(00)81848-6; Page-McCaw A, 2007, NAT REV MOL CELL BIO, V8, P221, DOI 10.1038/nrm2125; Song LB, 2006, CANCER RES, V66, P6225, DOI 10.1158/0008-5472.CAN-06-0094; Sun Y, 2005, J CLIN ONCOL, V23, p654S; Taguchi E, 2008, CANCER SCI, V99, P623, DOI 10.1111/j.1349-7006.2007.00724.x; Winkler F, 2004, CANCER CELL, V6, P553, DOI 10.1016/S1535-6108(04)00305-8; Yang S, 2010, CURR CANCER DRUG TAR, V10, P611, DOI 10.2174/156800910791859506; ZHANG SH, 1983, INT J CANCER, V31, P587, DOI 10.1002/ijc.2910310509; Zhou QY, 2008, CLIN CANCER RES, V14, P1540, DOI 10.1158/1078-0432.CCR-07-4544	43	53	72	2	26	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 9	2012	7	4							e34646	10.1371/journal.pone.0034646	http://dx.doi.org/10.1371/journal.pone.0034646			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	955JO	22496834	gold, Green Published, Green Submitted			2022-12-25	WOS:000305014500025
J	Tsukada, S; Nakashima, H; Torimitsu, K				Tsukada, Shingo; Nakashima, Hiroshi; Torimitsu, Keiichi			Conductive Polymer Combined Silk Fiber Bundle for Bioelectrical Signal Recording	PLOS ONE			English	Article							PEDOT; FIBROIN; TISSUE	Electrode materials for recording biomedical signals, such as electrocardiography (ECG), electroencephalography (EEG) and evoked potentials data, are expected to be soft, hydrophilic and electroconductive to minimize the stress imposed on living tissue, especially during long-term monitoring. We have developed and characterized string-shaped electrodes made from conductive polymer with silk fiber bundles (thread), which offer a new biocompatible stress free interface with living tissue in both wet and dry conditions. An electroconductive polyelectrolyte, poly(3,4-ethylenedioxythiophene) -poly(styrenesulfonate) (PEDOT-PSS) was electrochemically combined with silk thread made from natural Bombyx mori. The polymer composite 280 mu m thread exhibited a conductivity of 0.00117 S/cm (which corresponds to a DC resistance of 2.62 Mohm/cm). The addition of glycerol to the PEDOT-PSS silk thread improved the conductivity to 0.102 S/cm (20.6 kohm/cm). The wettability of PEDOT-PSS was controlled with glycerol, which improved its durability in water and washing cycles. The glycerol treated PEDOT-PSS silk thread showed a tensile strength of 1000 cN in both wet and dry states. Without using any electrolytes, pastes or solutions, the thread directly collects electrical signals from living tissue and transmits them through metal cables. ECG, EEG, and sensory evoked potential (SEP) signals were recorded from experimental animals by using this thread placed on the skin. PEDOT-PSS silk glycerol composite thread offers a new class of biocompatible electrodes in the field of biomedical and health promotion that does not induce stress in the subjects.	[Tsukada, Shingo; Nakashima, Hiroshi; Torimitsu, Keiichi] NTT Corp, NTT Basic Res Labs, Mat Sci Lab, Atsugi, Kanagawa, Japan	Nippon Telegraph & Telephone Corporation	Tsukada, S (corresponding author), NTT Corp, NTT Basic Res Labs, Mat Sci Lab, Atsugi, Kanagawa, Japan.	tsukada.shingo@lab.ntt.co.jp	Torimitsu, Keiichi/A-3078-2011; TORIMITSU, KEIICHI/GQR-2299-2022; Torimitsu, Keiichi/AAE-4333-2019		Nippon Telegraph and Telephone Corporation (NTT)	Nippon Telegraph and Telephone Corporation (NTT)	The authors have read the journal's policy and have the following conflicts. The authors, ST, HN and KT are employees at Basic Research Laboratory, which is a research institute funded by Nippon Telegraph and Telephone Corporation (NTT). The authors have been filing an application for a patent regarding this study. This does not alter the authors' adherence to all the PLoS ONE policies on sharing data and materials.	Fabretto M, 2008, MACROMOL RAPID COMM, V29, P1403, DOI 10.1002/marc.200800270; Fabretto M, 2011, THIN SOLID FILMS, V519, P2544, DOI 10.1016/j.tsf.2010.12.016; Fabretto M, 2009, MACROMOL RAPID COMM, V30, P1846, DOI 10.1002/marc.200900371; Fabretto M, 2009, J MATER CHEM, V19, P7871, DOI 10.1039/b912324e; Fung MK, 2002, APPL PHYS LETT, V81, P1497, DOI 10.1063/1.1499519; Granlund T, 2001, J APPL PHYS, V89, P5897, DOI 10.1063/1.1350998; HEYWANG G, 1992, ADV MATER, V4, P116, DOI 10.1002/adma.19920040213; Jin HJ, 2003, NATURE, V424, P1057, DOI 10.1038/nature01809; Kim DH, 2010, NAT MATER, V9, P511, DOI [10.1038/NMAT2745, 10.1038/nmat2745]; Kim Dong-Hwan, 2008, P177; Kim JY, 2002, SYNTHETIC MET, V126, P311, DOI 10.1016/S0379-6779(01)00576-8; Kim WH, 2002, APPL PHYS LETT, V80, P3844, DOI 10.1063/1.1480100; Kim YH, 2011, ADV FUNCT MATER, V21, P1076, DOI 10.1002/adfm.201002290; Lang U, 2009, SYNTHETIC MET, V159, P473, DOI 10.1016/j.synthmet.2008.11.005; Lofhede J., 2010, P 10 IEEE INT C INF, P1; Marozas V, 2011, J ELECTROCARDIOL, V44, P189, DOI 10.1016/j.jelectrocard.2010.12.004; Marquez JC, 2009, IEEE ENG MED BIO, P4816, DOI 10.1109/IEMBS.2009.5332631; Miller K, 2002, J BIOMECH, V35, P483, DOI 10.1016/S0021-9290(01)00234-2; Muller C, 2011, ADV MATER, V23, P898, DOI 10.1002/adma.201003601; Muller C, 2011, J MATER CHEM, V21, P2909, DOI 10.1039/c0jm03270k; Nyberg T, 2007, J NEUROSCI METH, V160, P16, DOI 10.1016/j.jneumeth.2006.08.008; Okuzaki H, 2003, MACROMOL RAPID COMM, V24, P261, DOI 10.1002/marc.200390038; Richardson-Burns SM, 2007, BIOMATERIALS, V28, P1539, DOI 10.1016/j.biomaterials.2006.11.026; Serban MA, 2011, J BIOMED MATER RES A, V98A, P567, DOI 10.1002/jbm.a.33149; Winther-Jensen B, 2011, MACROMOL MATER ENG, V296, P185, DOI 10.1002/mame.201000292; Zhang FL, 2002, ADV MATER, V14, P662, DOI 10.1002/1521-4095(20020503)14:9<662::AID-ADMA662>3.0.CO;2-N	26	96	97	5	115	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 6	2012	7	4							e33689	10.1371/journal.pone.0033689	http://dx.doi.org/10.1371/journal.pone.0033689			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	955JA	22493670	Green Published, gold, Green Submitted			2022-12-25	WOS:000305012700012
J	Disanto, G; Morahan, JM; Lacey, MV; DeLuca, GC; Giovannoni, G; Ebers, GC; Ramagopalan, SV				Disanto, Giulio; Morahan, Julia M.; Lacey, Melanie V.; DeLuca, Gabriele C.; Giovannoni, Gavin; Ebers, George C.; Ramagopalan, Sreeram V.			Seasonal Distribution of Psychiatric Births in England	PLOS ONE			English	Article							BIPOLAR DISORDER; NORTHERN-HEMISPHERE; ADULT DISEASE; SCHIZOPHRENIA; RISK; POPULATION; SIBLINGS; SUICIDE; ORIGINS	There is general consensus that season of birth influences the risk of developing psychiatric conditions later in life. We aimed to investigate whether the risk of schizophrenia (SC), bipolar affective disorder (BAD) and recurrent depressive disorder (RDD) is influenced by month of birth in England to a similar extent as other countries using the largest cohort of English patients collected to date (n = 57,971). When cases were compared to the general English population (n = 29,183,034) all diseases showed a seasonal distribution of births (SC p = 2.48E-05; BAD p = 0.019; RDD p = 0.015). This data has implications for future strategies of disease prevention.	[Disanto, Giulio; Morahan, Julia M.; DeLuca, Gabriele C.; Ebers, George C.; Ramagopalan, Sreeram V.] Univ Oxford, Wellcome Trust Ctr Human Genet, Oxford, England; [Disanto, Giulio; Morahan, Julia M.; DeLuca, Gabriele C.; Ebers, George C.; Ramagopalan, Sreeram V.] Univ Oxford, Dept Clin Neurol, Oxford, England; [Lacey, Melanie V.; Ramagopalan, Sreeram V.] London Sch Hyg & Trop Med, London WC1, England; [Giovannoni, Gavin; Ramagopalan, Sreeram V.] Queen Mary Univ London, Barts & London Sch Med & Dent, Blizard Inst Cell & Mol Sci, London, England	University of Oxford; Wellcome Centre for Human Genetics; University of Oxford; University of London; London School of Hygiene & Tropical Medicine; University of London; Queen Mary University London	Disanto, G (corresponding author), Univ Oxford, Wellcome Trust Ctr Human Genet, Oxford, England.	s.ramagopalan@qmul.ac.uk		Ebers, George/0000-0003-4771-4177; De Luca, Gabriele/0000-0003-0342-5197; Morahan, Julia/0000-0001-9278-0603; McKeating, Jane/0000-0002-7229-5886	Medical Research Council [G0801976]; Wellcome Trust [075491/Z/04]; MRC [G0801976] Funding Source: UKRI	Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Wellcome Trust(Wellcome Trust); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC))	This work was funded by the Medical Research Council [GRANT NUMBER G0801976] and the Wellcome Trust [075491/Z/04]. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript. All authors state that this research was carried out independently of the influence of funding bodies.	ADAMS W, 1993, BRIT J PSYCHIAT, V163, P522, DOI 10.1192/bjp.163.4.522; BARKER DJP, 1995, P ROY SOC B-BIOL SCI, V262, P37, DOI 10.1098/rspb.1995.0173; BUCK C, 1978, BRIT J PSYCHIAT, V133, P358, DOI 10.1192/bjp.133.4.358; Cohen AS, 2011, J PSYCHIATR RES, V45, P955, DOI 10.1016/j.jpsychires.2010.12.006; Davies G, 2003, SCHIZOPHRENIA BULL, V29, P587, DOI 10.1093/oxfordjournals.schbul.a007030; Disanto G, 2011, BRIT J PSYCHIAT, V198, P404, DOI 10.1192/bjp.bp.110.085944; Dome P, 2010, BIOL PSYCHIAT, V68, P148, DOI 10.1016/j.biopsych.2010.03.005; HARE EH, 1976, BRIT J PSYCHIAT, V129, P49, DOI 10.1192/bjp.129.1.49; Hoffman S, 2007, NEUROEPIDEMIOLOGY, V29, P89, DOI 10.1159/000109502; Joiner TE, 2002, PSYCHIAT RES, V112, P89, DOI 10.1016/S0165-1781(02)00183-X; Langley-Evans SC, 2010, MED PRIN PRACT, V19, P87, DOI 10.1159/000273066; Lichtenstein P, 2009, LANCET, V373, P234, DOI 10.1016/S0140-6736(09)60072-6; McGrath JJ, 2010, SCHIZOPHRENIA BULL, V36, P1073, DOI 10.1093/schbul/sbq101; McGrath JJ, 2010, ARCH GEN PSYCHIAT, V67, P889, DOI 10.1001/archgenpsychiatry.2010.110; Potash JB, 2009, NAT REV NEUROL, V5, P299, DOI 10.1038/nrneurol.2009.71; PULVER AE, 1992, BRIT J PSYCHIAT, V160, P71, DOI 10.1192/bjp.160.1.71; Purcell SM, 2009, NATURE, V460, P748, DOI 10.1038/nature08185; Rihmer Z, 2011, J AFFECT DISORDERS, V132, P64, DOI 10.1016/j.jad.2011.01.015; Rothwell PM, 1999, BRIT MED J, V319, P887, DOI 10.1136/bmj.319.7214.887; Salib E, 2006, BRIT J PSYCHIAT, V188, P416, DOI 10.1192/bjp.bp.105.009118; Schwartz PJ, 2011, MED HYPOTHESES, V76, P785, DOI 10.1016/j.mehy.2011.02.019; Suvisaari JM, 2001, AM J PSYCHIAT, V158, P754, DOI 10.1176/appi.ajp.158.5.754; Torrey EF, 1996, SCHIZOPHR RES, V21, P141; Torrey EF, 1997, SCHIZOPHR RES, V28, P1, DOI 10.1016/S0920-9964(97)00092-3; Tsuchiya KJ, 2003, BIPOLAR DISORD, V5, P231, DOI 10.1034/j.1399-5618.2003.00038.x; WALTER SD, 1975, BRIT J PREV SOC MED, V29, P18	26	36	37	0	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 4	2012	7	4							e34866	10.1371/journal.pone.0034866	http://dx.doi.org/10.1371/journal.pone.0034866			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	953GO	22496872	gold, Green Published			2022-12-25	WOS:000304855200086
J	Gong, L; Ramm, G; Devenish, RJ; Prescott, M				Gong, Lan; Ramm, Georg; Devenish, Rodney J.; Prescott, Mark			HcRed, a Genetically Encoded Fluorescent Binary Cross-Linking Agent for Cross-Linking of Mitochondrial ATP Synthase in Saccharomyces cerevisiae	PLOS ONE			English	Article							F1F0-ATP SYNTHASE; IN-VIVO; MEMBRANE-PROTEIN; YEAST; IDENTIFICATION; COMPLEXES; DIMER; OSCP	Genetically encoded fluorescent cross-linking agents represent powerful tools useful both for visualising and modulating protein interactions in living cells. The far-red fluorescent protein HcRed, which is fluorescent only in a dimer form, can be used to promote the homo-dimerisation of target proteins, and thereby yield useful information about biological processes. We have in yeast cells expressed HcRed fused to a subunit of mitochondrial ATP synthase (mtATPase). This resulted in cross-linking of the large multi-subunit mtATPase complex within the inner-membrane of the mitochondrion. Fluorescence microscopy revealed aberrant mitochondrial morphology, and mtATPase complexes isolated from mitochondria were recovered as fluorescent dimers under conditions where complexes from control mitochondria were recovered as monomers. When viewed by electron microscopy normal cristae were absent from mitochondria in cells in which mATPase complexes were cross-linked. mtATPase dimers are believed to be the building blocks that are assembled into supramolecular mtATPase ribbons that promote the formation of mitochondrial cristae. We propose that HcRed cross-links mATPase complexes in the mitochondrial membrane hindering the normal assembly/disassembly of the supramolecular forms of mtATPase.	[Gong, Lan; Ramm, Georg; Devenish, Rodney J.; Prescott, Mark] Monash Univ, Dept Biochem & Mol Biol, Clayton, Vic 3800, Australia; [Gong, Lan; Devenish, Rodney J.] Monash Univ, ARC Ctr Excellence Struct & Funct Microbial Genom, Clayton, Vic 3800, Australia	Monash University; Monash University	Gong, L (corresponding author), Monash Univ, Dept Biochem & Mol Biol, Clayton Campus, Clayton, Vic 3800, Australia.	Mark.Prescott@monash.edu	Gong, Lan/J-6368-2016; Gong, Lan/O-7886-2019	Gong, Lan/0000-0003-3136-1565; Gong, Lan/0000-0003-3136-1565; Ramm, Georg/0000-0003-3596-2288	Monash University; Australian Research Council	Monash University(Monash University); Australian Research Council(Australian Research Council)	This work was supported by Monash University (http://www.monash.edu.au/) and the Australian Research Council (http://www.arc.gov.au/). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ALLEN RD, 1989, J CELL BIOL, V108, P2233, DOI 10.1083/jcb.108.6.2233; Arnold I, 1998, EMBO J, V17, P7170, DOI 10.1093/emboj/17.24.7170; Arnold I, 1998, J BIOL CHEM, V273, P1469, DOI 10.1074/jbc.273.3.1469; Bateson M, 1999, J BIOL CHEM, V274, P7462, DOI 10.1074/jbc.274.11.7462; Bevis BJ, 2002, NAT BIOTECHNOL, V20, P83, DOI 10.1038/nbt0102-83; Boyle GM, 1999, EUR J BIOCHEM, V262, P315, DOI 10.1046/j.1432-1327.1999.00345.x; Campbell RE, 2002, P NATL ACAD SCI USA, V99, P7877, DOI 10.1073/pnas.082243699; Chudakov DM, 2010, PHYSIOL REV, V90, P1103, DOI 10.1152/physrev.00038.2009; Couoh-Cardel SJ, 2010, J BIOL CHEM, V285, P36447, DOI 10.1074/jbc.M110.144907; Davies KM, 2011, P NATL ACAD SCI USA, V108, P14121, DOI 10.1073/pnas.1103621108; Devenish RJ, 2008, INT REV CEL MOL BIO, V267, P1, DOI 10.1016/S1937-6448(08)00601-1; Fenno L, 2011, ANNU REV NEUROSCI, V34, P389, DOI 10.1146/annurev-neuro-061010-113817; Fradkov AF, 2002, BIOCHEM J, V368, P17, DOI 10.1042/BJ20021191; Gavin P, 2002, BIOCHEM BIOPH RES CO, V298, P707, DOI 10.1016/S0006-291X(02)02552-4; Gavin PD, 2005, J BIOENERG BIOMEMBR, V37, P55, DOI 10.1007/s10863-005-4128-8; Gavin PD, 2004, J CELL SCI, V117, P2333, DOI 10.1242/jcs.01074; Gietz RD, 2007, NAT PROTOC, V2, P31, DOI 10.1038/nprot.2007.13; Griffith J, 2008, TRAFFIC, V9, P1060, DOI 10.1111/j.1600-0854.2008.00753.x; Gurskaya NG, 2001, FEBS LETT, V507, P16, DOI 10.1016/S0014-5793(01)02930-1; Liou W, 1996, HISTOCHEM CELL BIOL, V106, P41, DOI 10.1007/BF02473201; Lukyanov KA, 2005, NAT REV MOL CELL BIO, V6, P885, DOI 10.1038/nrm1741; Pastuszka MK, 2010, J DRUG DELIV SCI TEC, V20, P163, DOI 10.1016/S1773-2247(10)50025-X; Paumard P, 2002, EMBO J, V21, P221, DOI 10.1093/emboj/21.3.221; Prescott M, 2003, J BIOL CHEM, V278, P251, DOI 10.1074/jbc.M204556200; Prescott M, 1997, FEBS LETT, V411, P97, DOI 10.1016/S0014-5793(97)00670-4; Rosado CJ, 2008, AUTOPHAGY, V4, P205, DOI 10.4161/auto.5331; SCHAGGER H, 1994, ANAL BIOCHEM, V217, P220, DOI 10.1006/abio.1994.1112; Seelert H, 2011, BBA-BIOENERGETICS, V1807, P1185, DOI 10.1016/j.bbabio.2011.05.023; Stock D, 1999, SCIENCE, V286, P1700, DOI 10.1126/science.286.5445.1700; Straffon AFL, 1998, BBA-BIOMEMBRANES, V1371, P157, DOI 10.1016/S0005-2736(98)00034-0; Wilmann PG, 2005, J MOL BIOL, V349, P223, DOI 10.1016/j.jmb.2005.03.020	31	1	2	1	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 4	2012	7	4							e35095	10.1371/journal.pone.0035095	http://dx.doi.org/10.1371/journal.pone.0035095			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	953GO	22496895	gold, Green Published, Green Submitted			2022-12-25	WOS:000304855200099
J	Higaki, T; Higaki, S; Hirota, M; Akita, K; Hasezawa, S				Higaki, Takumi; Higaki, Shogo; Hirota, Masahiro; Akita, Kae; Hasezawa, Seiichiro			Radionuclide Analysis on Bamboos following the Fukushima Nuclear Accident	PLOS ONE			English	Article							RADIOCESIUM; SOIL	In response to contamination from the recent Fukushima nuclear accident, we conducted radionuclide analysis on bamboos sampled from six sites within a 25 to 980 km radius of the Fukushima Daiichi nuclear power plant. Maximum activity concentrations of radiocesium Cs-134 and Cs-137 in samples from Fukushima city, 65 km away from the Fukushima Daiichi plant, were in excess of 71 and 79 kBq/kg, dry weight (DW), respectively. In Kashiwa city, 195 km away from the Fukushima Daiichi, the sample concentrations were in excess of 3.4 and 4.3 kBq/kg DW, respectively. In Toyohashi city, 440 km away from the Fukushima Daiichi, the concentrations were below the measurable limits of up to 4.5 Bq/kg DW. In the radiocesium contaminated samples, the radiocesium activity was higher in mature and fallen leaves than in young leaves, branches and culms.	[Higaki, Takumi; Akita, Kae; Hasezawa, Seiichiro] Univ Tokyo, Grad Sch Frontier Sci, Dept Integrated Biosci, Kashiwa, Chiba, Japan; [Higaki, Takumi; Hasezawa, Seiichiro] Japan Sci & Technol Agcy, Adv Measurement & Anal, Chiyoda Ku, Tokyo, Japan; [Higaki, Shogo] Univ Tokyo, Radioisotope Ctr, Bunkyo Ku, Tokyo, Japan; [Hirota, Masahiro] Univ Tokyo, Dept Nucl Engn & Management, Bunkyo Ku, Tokyo, Japan	University of Tokyo; Japan Science & Technology Agency (JST); University of Tokyo; University of Tokyo	Higaki, T (corresponding author), Univ Tokyo, Grad Sch Frontier Sci, Dept Integrated Biosci, Kashiwa, Chiba, Japan.	takumi.higaki@gmail.com	Higaki, Shogo/N-8792-2019; Higaki, Shogo/G-5100-2013; Higaki, Takumi/N-1216-2015	Higaki, Shogo/0000-0002-5098-6475; Higaki, Shogo/0000-0002-5098-6475; 	Japanese Ministry of Education, Science, Culture, Sports and Technology [21027009]; Grants-in-Aid for Scientific Research [24114001] Funding Source: KAKEN	Japanese Ministry of Education, Science, Culture, Sports and Technology(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)); Grants-in-Aid for Scientific Research(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI))	This work was financially supported in part by a Grant-in-Aid for Scientific Research on Priority Areas to SH (No. 21027009) from the Japanese Ministry of Education, Science, Culture, Sports and Technology. No additional external funding received for this study. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bolsunovsky A, 2011, J ENVIRON RADIOACTIV, V102, P1062, DOI 10.1016/j.jenvrad.2011.06.007; Bowyer TW, 2011, J ENVIRON RADIOACTIV, V102, P681, DOI 10.1016/j.jenvrad.2011.04.009; Isagi Y, 1997, PLANT ECOL, V130, P41, DOI 10.1023/A:1009711814070; Lozano RL, 2011, ENVIRON INT, V37, P1259, DOI 10.1016/j.envint.2011.06.001; Manolopoulou M, 2011, J ENVIRON RADIOACTIV, V102, P796, DOI 10.1016/j.jenvrad.2011.04.010; Pittauerova D, 2011, J ENVIRON RADIOACTIV, V102, P877, DOI 10.1016/j.jenvrad.2011.06.003; Sinclair LE, 2011, J ENVIRON RADIOACTIV, V102, P1018, DOI 10.1016/j.jenvrad.2011.06.008; Smolders Erik, 2011, Integrated Environmental Assessment and Management, V7, P379, DOI 10.1002/ieam.236; Tagami K, 2011, J ENV RADIO IN PRESS; Tsukada H, 2002, ENVIRON POLLUT, V117, P403, DOI 10.1016/S0269-7491(01)00199-3	10	10	10	0	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 4	2012	7	4							e34766	10.1371/journal.pone.0034766	http://dx.doi.org/10.1371/journal.pone.0034766			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	953GO	22496858	Green Published, Green Submitted, gold			2022-12-25	WOS:000304855200079
J	Roy, S; Morse, D				Roy, Sougata; Morse, David			A Full Suite of Histone and Histone Modifying Genes Are Transcribed in the Dinoflagellate Lingulodinium	PLOS ONE			English	Article							PERIDINIUM-BALTICUM; DNA-REPLICATION; S-PHASE; CRYPTHECODINIUM-COHNII; PHYLOGENETIC ANALYSIS; GYRODINIUM-COHNII; NUCLEAR IMPORT; CELL-CYCLE; CHROMATIN; PROTEIN	Background: Dinoflagellates typically lack histones and nucleosomes are not observed in DNA spreads. However, recent studies have shown the presence of core histone mRNA sequences scattered among different dinoflagellate species. To date, the presence of all components required for manufacturing and modifying nucleosomes in a single dinoflagellate species has not been confirmed. Methodology and Results: Analysis of a Lingulodinium transcriptome obtained by Illumina sequencing of mRNA shows several different copies of each of the four core histones as well as a suite of histone modifying enzymes and histone chaperone proteins. Phylogenetic analysis shows one of each Lingulodinium histone copies belongs to the dinoflagellate clade while the second is more divergent and does not share a common ancestor. All histone mRNAs are in low abundance (roughly 25 times lower than higher plants) and transcript levels do not vary over the cell cycle. We also tested Lingulodinium extracts for histone proteins using immunoblotting and LC-MS/MS, but were unable to confirm histone expression at the protein level. Conclusion: We show that all core histone sequences are present in the Lingulodinium transcriptome. The conservation of these sequences, even though histone protein accumulation remains below currently detectable levels, strongly suggests dinoflagellates possess histones.	[Roy, Sougata; Morse, David] Univ Montreal, Dept Sci Biol, Inst Rech Biol Vegetale, Montreal, PQ H3C 3J7, Canada	Universite de Montreal	Roy, S (corresponding author), Univ Montreal, Dept Sci Biol, Inst Rech Biol Vegetale, CP 6128, Montreal, PQ H3C 3J7, Canada.	david.morse@umontreal.ca		Roy, Sougata/0000-0003-0168-5737; Morse, David/0000-0003-4131-4367; Roy, Sougata/0000-0001-9718-873X	National Science and Engineering Research Council of Canada [171382-03]	National Science and Engineering Research Council of Canada(Natural Sciences and Engineering Research Council of Canada (NSERC))	Research support from the National Science and Engineering Research Council of Canada to DM (Grant number 171382-03) is gratefully acknowledged. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	AZEVEDO C, 1989, J PARASITOL, V75, P627, DOI 10.2307/3282915; Bannister AJ, 2011, CELL RES, V21, P381, DOI 10.1038/cr.2011.22; Baxevanis AD, 1996, NUCLEIC ACIDS RES, V24, P245, DOI 10.1093/nar/24.1.245; Bertomeu T, 2007, BIOL CELL, V99, P531, DOI 10.1042/BC20070018; BODANSKY S, 1979, BIOCHEM BIOPH RES CO, V88, P1329, DOI 10.1016/0006-291X(79)91126-4; Canela N, 2003, J BIOL CHEM, V278, P1158, DOI 10.1074/jbc.M207497200; Chan YH, 2007, NUCLEIC ACIDS RES, V35, P2573, DOI 10.1093/nar/gkm165; Chavez-Blanco A, 2005, MOL CANCER, V4, DOI 10.1186/1476-4598-4-22; Chow MH, 2010, EUKARYOT CELL, V9, P1577, DOI 10.1128/EC.00026-10; Chudnovsky Y, 2002, J PHYCOL, V38, P543, DOI 10.1046/j.1529-8817.2002.t01-1-01186.x; Costas E, 2005, CYTOGENET GENOME RES, V109, P268, DOI 10.1159/000082409; Dagenais-Bellefeuille S, 2008, J BIOL RHYTHM, V23, P400, DOI 10.1177/0748730408321749; de la Espina SMD, 2005, EUR J CELL BIOL, V84, P137, DOI 10.1016/j.ejcb.2005.01.002; Dereeper A, 2008, NUCLEIC ACIDS RES, V36, pW465, DOI 10.1093/nar/gkn180; Dhillon N, 2006, MOL CELL BIOL, V26, P489, DOI 10.1128/MCB.26.2.489-501.2006; EHINGER A, 1990, MOL GEN GENET, V222, P416, DOI 10.1007/BF00633848; Frenkiel-Krispin D, 2001, EMBO J, V20, P1184, DOI 10.1093/emboj/20.5.1184; Fries T, 2007, J BIOL CHEM, V282, P19292, DOI 10.1074/jbc.M700217200; Frye RA, 2000, BIOCHEM BIOPH RES CO, V273, P793, DOI 10.1006/bbrc.2000.3000; Glozak MA, 2005, GENE, V363, P15, DOI 10.1016/j.gene.2005.09.010; GUILLARD RR, 1962, CAN J MICROBIOL, V8, P229, DOI 10.1139/m62-029; Hackett JD, 2005, BMC GENOMICS, V6, DOI 10.1186/1471-2164-6-80; HEINTZ N, 1983, MOL CELL BIOL, V3, P539, DOI 10.1128/MCB.3.4.539; HERZOG M, 1981, EUR J CELL BIOL, V23, P295; HOLMHANSEN O, 1969, SCIENCE, V163, P87, DOI 10.1126/science.163.3862.87; KAPROS T, 1995, PLANT MOL BIOL, V28, P901, DOI 10.1007/BF00042074; KELLOGG DR, 1995, J CELL BIOL, V130, P661, DOI 10.1083/jcb.130.3.661; KELLOGG DR, 1995, J CELL BIOL, V130, P675, DOI 10.1083/jcb.130.3.675; Krude T, 1999, EUR J BIOCHEM, V263, P1, DOI 10.1046/j.1432-1327.1999.00508.x; LaJeunesse TC, 2005, MOL BIOL EVOL, V22, P570, DOI 10.1093/molbev/msi042; Levi-Setti R, 2008, EUR J CELL BIOL, V87, P963, DOI 10.1016/j.ejcb.2008.06.002; Lin SJ, 2010, P NATL ACAD SCI USA, V107, P20033, DOI 10.1073/pnas.1007246107; LIVOLANT F, 1984, TISSUE CELL, V16, P535, DOI 10.1016/0040-8166(84)90029-6; Margueron R, 2005, CURR OPIN GENET DEV, V15, P163, DOI 10.1016/j.gde.2005.01.005; Martzen MR, 1999, SCIENCE, V286, P1153, DOI 10.1126/science.286.5442.1153; Mosammaparast N, 2002, J BIOL CHEM, V277, P862, DOI 10.1074/jbc.M106845200; Mosammaparast N, 2001, J CELL BIOL, V153, P251, DOI 10.1083/jcb.153.2.251; Okamoto OK, 2003, GENE, V321, P73, DOI 10.1016/j.gene.2003.07.003; Park YJ, 2006, P NATL ACAD SCI USA, V103, P1248, DOI 10.1073/pnas.0508002103; Pennini ME, 2010, PLOS PATHOG, V6, DOI 10.1371/journal.ppat.1000995; Postberg J, 2010, BMC EVOL BIOL, V10, DOI 10.1186/1471-2148-10-259; RILL RL, 1989, CHROMOSOMA, V98, P280, DOI 10.1007/BF00327314; RIZZO PJ, 1981, BIOSYSTEMS, V14, P433, DOI 10.1016/0303-2647(81)90048-4; RIZZO PJ, 1972, SCIENCE, V176, P796, DOI 10.1126/science.176.4036.796; RIZZO PJ, 1982, BIOSYSTEMS, V15, P27, DOI 10.1016/0303-2647(82)90014-4; Rizzo PJ, 2003, CELL RES, V13, P215, DOI 10.1038/sj.cr.7290166; RIZZO PJ, 1977, SCIENCE, V198, P1258, DOI 10.1126/science.563104; ROBBINS E, 1967, P NATL ACAD SCI USA, V57, P409, DOI 10.1073/pnas.57.2.409; Robin P, 2007, GENOME BIOL, V8, DOI 10.1186/gb-2007-8-12-r270; Rogakou EP, 1998, J BIOL CHEM, V273, P5858, DOI 10.1074/jbc.273.10.5858; Saldarriaga JF, 2003, INT J SYST EVOL MICR, V53, P355, DOI 10.1099/ijs.0.02328-0; Shechter D, 2007, NAT PROTOC, V2, P1445, DOI 10.1038/nprot.2007.202; SHUPE K, 1983, J PROTOZOOL, V30, P599, DOI 10.1111/j.1550-7408.1983.tb01429.x; Starai VJ, 2002, SCIENCE, V298, P2390, DOI 10.1126/science.1077650; Suganuma T, 2010, ANN REV BIOCH; TANIMOTO EY, 1993, PLANT PHYSIOL, V103, P1291, DOI 10.1104/pp.103.4.1291; Taoka K, 1998, PLANT CELL PHYSIOL, V39, P294, DOI 10.1093/oxfordjournals.pcp.a029370; THATCHER TH, 1994, NUCLEIC ACIDS RES, V22, P174, DOI 10.1093/nar/22.2.174; TOMAS RN, 1973, J PHYCOL, V9, P91, DOI 10.1111/j.0022-3646.1973.00091.x; Trievel RC, 2002, CELL, V111, P91, DOI 10.1016/S0092-8674(02)01000-0; VAQUERO A, 2003, SCI AGING KNOWLEDGE, pRE4, DOI DOI 10.1126/SAGEKE.2003.14.RE4; Velculescu VE, 1997, CELL, V88, P243, DOI 10.1016/S0092-8674(00)81845-0; Verdin E, 2003, TRENDS GENET, V19, P286, DOI 10.1016/S0168-9525(03)00073-8; VERNET G, 1990, BIOCHIM BIOPHYS ACTA, V1048, P281, DOI 10.1016/0167-4781(90)90068-D; WEST MHP, 1980, BIOCHEMISTRY-US, V19, P3238, DOI 10.1021/bi00555a022; WU RS, 1981, CELL, V27, P321, DOI 10.1016/0092-8674(81)90415-3; Zhang H, 2007, P NATL ACAD SCI USA, V104, P4618, DOI 10.1073/pnas.0700258104	67	42	43	1	19	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 4	2012	7	4							e34340	10.1371/journal.pone.0034340	http://dx.doi.org/10.1371/journal.pone.0034340			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	953GO	22496791	Green Published, gold, Green Submitted			2022-12-25	WOS:000304855200040
J	Vallejos, M; Carvajal, F; Pino, K; Navarrete, C; Ferres, M; Huidobro-Toro, JP; Sargueil, B; Lopez-Lastra, M				Vallejos, Maricarmen; Carvajal, Felipe; Pino, Karla; Navarrete, Camilo; Ferres, Marcela; Pablo Huidobro-Toro, Juan; Sargueil, Bruno; Lopez-Lastra, Marcelo			Functional and Structural Analysis of the Internal Ribosome Entry Site Present in the mRNA of Natural Variants of the HIV-1	PLOS ONE			English	Article							CAP-INDEPENDENT TRANSLATION; PROTEIN-SYNTHESIS; 5-UNTRANSLATED REGION; PROMOTES TRANSLATION; VIRUS LEADER; INITIATION; IRES; SEGMENT; EXPRESSION; MECHANISM	The 5'untranslated regions (UTR) of the full length mRNA of the HIV-1 proviral clones pNL4.3 and pLAI, harbor an internal ribosomal entry site (IRES). In this study we extend this finding by demonstrating that the mRNA 5'UTRs of natural variants of HIV-1 also exhibit IRES-activity. Cap-independent translational activity was demonstrated using bicistronic mRNAs in HeLa cells and in Xenopus laevis oocytes. The possibility that expression of the downstream cistron in these constructs was due to alternative splicing or to cryptic promoter activity was ruled out. The HIV-1 variants exhibited significant 5'UTR nucleotide diversity with respect to the control sequence recovered from pNL4.3. Interestingly, translational activity from the 5'UTR of some of the HIV-1 variants was enhanced relative to that observed for the 5'UTR of pNL4.3. In an attempt to explain these findings we probed the secondary structure of the variant HIV-1 5'UTRs using enzymatic and chemical approaches. Yet subsequent structural analyses did not reveal significant variations when compared to the pNL4.3-5'UTR. Thus, the increased IRES-activity observed for some of the HIV-1 variants cannot be ascribed to a specific structural modification. A model to explain these findings is proposed.	[Vallejos, Maricarmen; Carvajal, Felipe; Pino, Karla; Lopez-Lastra, Marcelo] Pontificia Univ Catolica Chile, Escuela Med, Inst Milenio Inmunol & Inmunoterapia, Lab Virol Mol,Ctr Invest Med, Santiago, Chile; [Navarrete, Camilo; Pablo Huidobro-Toro, Juan] Pontificia Univ Catolica Chile, Fac Ciencias Biol, Dept Fisiol, Ctr Envejecimiento & Regenerac,CARE, Santiago, Chile; [Ferres, Marcela] Univ Chile, Fac Med, Lab Infectol, Santiago 7, Chile; [Sargueil, Bruno] Univ Paris 05, CNRS, UMR 8015, Lab Cristallog & RMN Biol, Paris, France	Pontificia Universidad Catolica de Chile; Pontificia Universidad Catolica de Chile; Universidad de Chile; Centre National de la Recherche Scientifique (CNRS); CNRS - National Institute for Biology (INSB); UDICE-French Research Universities; Universite Paris Cite	Vallejos, M (corresponding author), Pontificia Univ Catolica Chile, Escuela Med, Inst Milenio Inmunol & Inmunoterapia, Lab Virol Mol,Ctr Invest Med, Alameda 340, Santiago, Chile.	malopez@med.puc.cl	Lopez-Lastra, Marcelo/HHM-9832-2022	sargueil, bruno/0000-0003-4483-355X; Carvajal Diaz, Felipe/0000-0002-4576-9310; Lopez-Lastra, Marcelo/0000-0002-7936-8478	Fondo Nacional de Ciencia y Tecnologia del Gobierno de Chile (FONDECYT) [1090318, 1110672]; Proyecto [P09/016-F]; de la Iniciativa Cientifica Milenio del Ministerio de Economia; Fomento y Turismo [PFB 12/2007]; SIDACTION [AI20-1-01577]; Agence Nationale de Recherche sur le Sida (ANRS) [2011-11188]; Centre National de la Recherche Scientifique (CNRS)-France [5283]; Comision Nacional de Investigacion Cientofica y Tecnologica (CONICYT)-Chile [5283]; Pontificia Universidad Catolica de Chile [PMD 10/09]; CONICYT	Fondo Nacional de Ciencia y Tecnologia del Gobierno de Chile (FONDECYT)(Comision Nacional de Investigacion Cientifica y Tecnologica (CONICYT)CONICYT FONDECYT); Proyecto; de la Iniciativa Cientifica Milenio del Ministerio de Economia; Fomento y Turismo; SIDACTION; Agence Nationale de Recherche sur le Sida (ANRS)(ANRSFrench National Research Agency (ANR)); Centre National de la Recherche Scientifique (CNRS)-France(Centre National de la Recherche Scientifique (CNRS)); Comision Nacional de Investigacion Cientofica y Tecnologica (CONICYT)-Chile(Comision Nacional de Investigacion Cientifica y Tecnologica (CONICYT)); Pontificia Universidad Catolica de Chile; CONICYT(Comision Nacional de Investigacion Cientifica y Tecnologica (CONICYT))	This study was supported by the Fondo Nacional de Ciencia y Tecnologia del Gobierno de Chile (FONDECYT 1090318) and Proyecto P09/016-F, de la Iniciativa Cientifica Milenio del Ministerio de Economia, Fomento y Turismo to MLL, PFB 12/2007, grants from SIDACTION (AI20-1-01577) and the Agence Nationale de Recherche sur le Sida (ANRS 2011-11188) to BS, and partial support from FONDECYT 1110672 to JPH-T, grant Projet International de Cooperation Scientifique (PICS 5283) between the Centre National de la Recherche Scientifique (CNRS)-France and the Comision Nacional de Investigacion Cientofica y Tecnologica (CONICYT)-Chile to BS and MLL, and funding from the Programa de Doctorado en Ciencias Medicas, Escuela de Medicina de la Pontificia Universidad Catolica de Chile (PMD 10/09) to MV. During her work on this project MV was supported by a CONICYT doctoral fellowship.	Acuna-Castillo C, 2002, BRIT J PHARMACOL, V136, P510, DOI 10.1038/sj.bjp.0704747; Altafaj Xavier, 2006, V322, P55; Alvarez E, 2006, BIOCHEM J, V396, P219, DOI 10.1042/BJ20060108; Attal J, 1996, FEBS LETT, V392, P220, DOI 10.1016/0014-5793(96)00815-0; Baird SD, 2006, RNA, V12, P1755, DOI 10.1261/rna.157806; Balvay L, 2007, NAT REV MICROBIOL, V5, P128, DOI 10.1038/nrmicro1599; Belsham GJ, 2000, TRENDS MICROBIOL, V8, P330, DOI 10.1016/S0966-842X(00)01788-1; Berkhout B, 1996, PROG NUCLEIC ACID RE, V54, P1, DOI 10.1016/S0079-6603(08)60359-1; Berkhout B., 2011, NUCL ACIDS IN PRESS; Berkhout B, 2011, NUCLEIC ACIDS RES, V39, P5232, DOI 10.1093/nar/gkr113; BERLIOZ C, 1995, J VIROL, V69, P6400, DOI 10.1128/JVI.69.10.6400-6407.1995; BERLIOZ C, 1995, J VIROL, V69, P2214, DOI 10.1128/JVI.69.4.2214-2222.1995; Bolinger C, 2010, NUCLEIC ACIDS RES, V38, P1686, DOI 10.1093/nar/gkp1075; Brasey A, 2003, J VIROL, V77, P3939, DOI 10.1128/JVI.77.7.3939-3949.2003; Buck CB, 2001, J VIROL, V75, P181, DOI 10.1128/JVI.75.1.181-191.2001; Cai A, 1999, BIOCHEMISTRY-US, V38, P8538, DOI 10.1021/bi9830213; Camerini V, 2008, J VIROL, V82, P3574, DOI 10.1128/JVI.02038-07; CARBERRY SE, 1989, BIOCHEMISTRY-US, V28, P8078, DOI 10.1021/bi00446a017; CARBERRY SE, 1990, BIOCHEMISTRY-US, V29, P3337, DOI 10.1021/bi00465a027; Castello A, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0007997; Chamond N, 2010, BIOCHEM SOC T, V38, P1548, DOI 10.1042/BST0381548; Charnay N, 2009, RETROVIROLOGY, V6, DOI 10.1186/1742-4690-6-74; Cochrane A, 2009, RNA BIOL, V6, P169, DOI 10.4161/rna.6.2.8095; Cochrane AW, 2006, RETROVIROLOGY, V3, DOI 10.1186/1742-4690-3-18; Damgaard CK, 2004, J MOL BIOL, V336, P369, DOI 10.1016/j.jmb.2003.12.010; DARZYNKIEWICZ E, 1988, NUCLEIC ACIDS RES, V16, P8953, DOI 10.1093/nar/16.18.8953; Deffaud C, 2000, J VIROL, V74, P11581, DOI 10.1128/JVI.74.24.11581-11588.2000; Fitzgerald KD, 2009, BBA-GENE REGUL MECH, V1789, P518, DOI 10.1016/j.bbagrm.2009.07.004; Gamarnik Andrea V., 2006, V322, P367; Gamarnik AV, 1996, EMBO J, V15, P5988, DOI 10.1002/j.1460-2075.1996.tb00985.x; Gendron K, 2011, NUCLEIC ACIDS RES, V39, P902, DOI 10.1093/nar/gkq885; Han BG, 2002, MOL CELL BIOL, V22, P7372, DOI 10.1128/MCB.22.21.7372-7384.2002; Herbreteau CH, 2005, NAT STRUCT MOL BIOL, V12, P1001, DOI 10.1038/nsmb1011; Barria MI, 2009, NUCLEIC ACIDS RES, V37, P957, DOI 10.1093/nar/gkn1022; Jackson RJ, 2010, NAT REV MOL CELL BIO, V11, P113, DOI 10.1038/nrm2838; Jackson RJ, 1995, CURR TOP MICROBIOL, V203, P1; James L, 2008, NUCLEIC ACIDS RES, V36, P4653, DOI 10.1093/nar/gkn447; Kazadi K, 2008, NUCLEIC ACIDS RES, V36, P6918, DOI 10.1093/nar/gkn812; Keiper BD, 1997, NUCLEIC ACIDS RES, V25, P395, DOI 10.1093/nar/25.2.395; Kieft JS, 2008, TRENDS BIOCHEM SCI, V33, P274, DOI 10.1016/j.tibs.2008.04.007; Kozak M, 2003, GENE, V318, P1, DOI 10.1016/S0378-1119(03)00774-1; Liu JF, 2011, J NEUROIMMUNE PHARM, V6, P308, DOI 10.1007/s11481-011-9265-8; Locker N, 2011, NUCLEIC ACIDS RES, V39, P2367, DOI 10.1093/nar/gkq1118; Lopez-Lastra M, 2005, BIOL RES, V38, P121, DOI 10.4067/S0716-97602005000200003; Lopez-Lastra M, 1999, J VIROL, V73, P8393; Lopez-Lastra M, 2010, REV MED VIROL, V20, P177, DOI 10.1002/rmv.649; LopezLastra M, 1997, HUM GENE THER, V8, P1855, DOI 10.1089/hum.1997.8.16-1855; Meignin C, 2003, MOL CELL BIOL, V23, P8246, DOI 10.1128/MCB.23.22.8246-8254.2003; Monette A, 2009, J BIOL CHEM, V284, P31350, DOI 10.1074/jbc.M109.048736; Ohlmann T, 2002, J MOL BIOL, V318, P9, DOI 10.1016/S0022-2836(02)00070-0; Ohlmann T, 2000, J BIOL CHEM, V275, P11899, DOI 10.1074/jbc.275.16.11899; Ooms M, 2004, J VIROL, V78, P10814, DOI 10.1128/JVI.78.19.10814-10819.2004; Paillart JC, 2004, J BIOL CHEM, V279, P48397, DOI 10.1074/jbc.M408294200; Perales C, 2003, FEBS LETT, V533, P89, DOI 10.1016/S0014-5793(02)03764-X; Pfingsten JS, 2006, SCIENCE, V314, P1450, DOI 10.1126/science.1133281; Ricci EP, 2008, BIOCHEM SOC T, V36, P690, DOI 10.1042/BST0360690; Rivas-Aravena A, 2009, VIROLOGY, V392, P178, DOI 10.1016/j.virol.2009.06.050; Ronfort C, 2004, RNA, V10, P504, DOI 10.1261/rna.5185604; Rutkowska-Wlodarczyk I, 2008, BIOCHEMISTRY-US, V47, P2710, DOI 10.1021/bi701168z; Semler BL, 2008, TRENDS MICROBIOL, V16, P1, DOI 10.1016/j.tim.2007.11.001; Silvera D, 2009, NAT CELL BIOL, V11, P903, DOI 10.1038/ncb1900; Sonenberg N, 2009, CELL, V136, P731, DOI 10.1016/j.cell.2009.01.042; Thierry S, 2004, J VIROL, V78, P12198, DOI 10.1128/JVI.78.22.12198-12206.2004; VAGNER S, 1995, J BIOL CHEM, V270, P20376, DOI 10.1074/jbc.270.35.20376; Vallejos M, 2011, NUCLEIC ACIDS RES, V39, P6186, DOI 10.1093/nar/gkr189; Vallejos M, 2010, NUCLEIC ACIDS RES, V38, P618, DOI 10.1093/nar/gkp890; Ventoso I, 2001, P NATL ACAD SCI USA, V98, P12966, DOI 10.1073/pnas.231343498; Vopalensky V, 2008, RNA, V14, P1720, DOI 10.1261/rna.831808; Weill L, 2010, NUCLEIC ACIDS RES, V38, P1367, DOI 10.1093/nar/gkp1109; Wilkinson KA, 2008, PLOS BIOL, V6, P883, DOI 10.1371/journal.pbio.0060096; Wilson JE, 2000, MOL CELL BIOL, V20, P4990, DOI 10.1128/MCB.20.14.4990-4999.2000; Yedavalli VSRK, 2010, P NATL ACAD SCI USA, V107, P14787, DOI 10.1073/pnas.1009490107	72	29	29	1	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 4	2012	7	4							e35031	10.1371/journal.pone.0035031	http://dx.doi.org/10.1371/journal.pone.0035031			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	953GO	22496887	Green Published, Green Submitted, gold			2022-12-25	WOS:000304855200096
J	Burton-Chellew, MN; West, SA				Burton-Chellew, Maxwell N.; West, Stuart A.			Correlates of Cooperation in a One-Shot High-Stakes Televised Prisoners' Dilemma	PLOS ONE			English	Article							MEASURING SOCIAL PREFERENCES; EVOLUTION; BEHAVIOR; PEOPLE; GAME; RECIPROCITY; REPUTATION; ECONOMICS; LAUGHTER; MARKET	Explaining cooperation between non-relatives is a puzzle for both evolutionary biology and the social sciences. In humans cooperation is often studied in a laboratory setting using economic games such as the prisoners dilemma. However, such experiments are sometimes criticized for being played for low stakes and by misrepresentative student samples. Golden balls is a televised game show that uses the prisoners' dilemma, with a diverse range of participants, often playing for very large stakes. We use this non-experimental dataset to investigate the factors that influence cooperation when "playing" for considerably larger stakes than found in economic experiments. The game show has earlier stages that allow for an analysis of lying and voting decisions. We found that contestants were sensitive to the stakes involved, cooperating less when the stakes were larger in both absolute and relative terms. We also found that older contestants were more likely to cooperate, that liars received less cooperative behavior, but only if they told a certain type of lie, and that physical contact was associated with reduced cooperation, whereas laughter and promises were reliable signals or cues of cooperation, but were not necessarily detected.	[Burton-Chellew, Maxwell N.; West, Stuart A.] Univ Oxford, Dept Zool, Oxford OX1 3PS, England	University of Oxford	Burton-Chellew, MN (corresponding author), Univ Oxford, Dept Zool, S Parks Rd, Oxford OX1 3PS, England.	max.burton@zoo.ox.ac.uk	West, Stuart A/M-3608-2014; Burton-Chellew, Max/G-2760-2010	West, Stuart A/0000-0003-2152-3153; Burton-Chellew, Max/0000-0002-5330-0379	European Research Council [ATRQBY0]	European Research Council(European Research Council (ERC)European Commission)	This work was funded by the European Research Council Grant: ATRQBY0. http://erc.europa.eu/. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	AKAIKE H, 1974, IEEE T AUTOMAT CONTR, VAC19, P716, DOI 10.1109/TAC.1974.1100705; Alexander R., 2008, ESSAYS PEDAGOGY; ANDREONI J, 1993, ECON J, V103, P570, DOI 10.2307/2234532; Ariely Daniel, 2008, PREDICTABLY IRRATION; AXELROD R, 1981, SCIENCE, V211, P1390, DOI 10.1126/science.7466396; Belot M, 2010, J ECON BEHAV ORGAN, V73, P396, DOI 10.1016/j.jebo.2010.01.001; Benz M, 2008, EXP ECON, V11, P268, DOI 10.1007/s10683-007-9192-y; Bolton GE, 2000, AM ECON REV, V90, P166, DOI 10.1257/aer.90.1.166; Boone C, 1999, J ECON PSYCHOL, V20, P343, DOI 10.1016/S0167-4870(99)00012-4; Boone RT, 2003, J NONVERBAL BEHAV, V27, P163, DOI 10.1023/A:1025341931128; Bshary R, 2008, J EVOLUTION BIOL, V21, P405, DOI 10.1111/j.1420-9101.2007.01482.x; Camerer C.F., 2003, BEHAV GAME THEORY EX, DOI 10.1257/jep.9.2.209; Cameron LA, 1999, ECON INQ, V37, P47, DOI 10.1111/j.1465-7295.1999.tb01415.x; Carpenter J, 2005, ECON LETT, V86, P393, DOI 10.1016/j.econlet.2004.08.007; Charness G, 2002, Q J ECON, V117, P817, DOI 10.1162/003355302760193904; Clutton-Brock T, 2009, NATURE, V462, P51, DOI 10.1038/nature08366; Cooper R, 1996, GAME ECON BEHAV, V12, P187, DOI 10.1006/game.1996.0013; Crawley MJ., 2007, R BOOK; DANHEISER PR, 1982, J PERS SOC PSYCHOL, V42, P497, DOI 10.1037/0022-3514.42.3.497; dos Santos M, 2011, P ROY SOC B-BIOL SCI, V278, P371, DOI 10.1098/rspb.2010.1275; Dunbar RIM, 2010, NEUROSCI BIOBEHAV R, V34, P260, DOI 10.1016/j.neubiorev.2008.07.001; Fehr E, 2004, TRENDS COGN SCI, V8, P185, DOI 10.1016/j.tics.2004.02.007; Fehr E, 1999, Q J ECON, V114, P817, DOI 10.1162/003355399556151; Gachter S, 2009, PHILOS T R SOC B, V364, P791, DOI 10.1098/rstb.2008.0275; Gardner A, 2010, EVOLUTION, V64, P25, DOI 10.1111/j.1558-5646.2009.00842.x; GRAFEN A, 1990, J THEOR BIOL, V144, P517, DOI 10.1016/S0022-5193(05)80088-8; Hagen EH, 2006, THEOR POPUL BIOL, V69, P339, DOI 10.1016/j.tpb.2005.09.005; HAMILTON WD, 1963, AM NAT, V97, P354, DOI 10.1086/497114; HAMILTON WD, 1970, NATURE, V228, P1218, DOI 10.1038/2281218a0; HAMILTON WD, 1964, J THEOR BIOL, V7, P1, DOI 10.1016/0022-5193(64)90039-6; HARDIN G, 1968, SCIENCE, V162, P1243, DOI 10.1126/science.162.3859.1243; Henrich J, 2010, BEHAV BRAIN SCI, V33, P111, DOI 10.1017/S0140525X10000725; Henrich J, 2010, NATURE, V466, P29, DOI 10.1038/466029a; Kocher MG, 2008, ECON LETT, V99, P508, DOI 10.1016/j.econlet.2007.09.048; Krebs JR, 1993, INTRO BEHAV ECOLOGY; Kummerli R, 2010, P NATL ACAD SCI USA, V107, P10125, DOI 10.1073/pnas.1000829107; Ledyard J., 1995, HDB EXPT EC, P253; Levitt SD, 2008, SCIENCE, V319, P909, DOI 10.1126/science.1153640; Levitt SD, 2007, J ECON PERSPECT, V21, P153, DOI 10.1257/jep.21.2.153; Levitt SD, 2007, CAN J ECON, V40, P347, DOI 10.1111/j.1365-2966.2007.00412.x; Liberman V, 2004, PERS SOC PSYCHOL B, V30, P1175, DOI 10.1177/0146167204264004; List JA, 2006, J POLIT ECON, V114, P1, DOI 10.1086/498587; Loewenstein G, 1999, ECON J, V109, pF25, DOI 10.1111/1468-0297.00400; Lusk JL, 2006, ECON LETT, V93, P285, DOI 10.1016/j.econlet.2006.05.016; MAYNARD-SMITH J., 2003, ANIMAL SIGNALS; Mehu M, 2008, FOLIA PRIMATOL, V79, P269, DOI 10.1159/000126928; Mehu M, 2007, EVOL HUM BEHAV, V28, P415, DOI 10.1016/j.evolhumbehav.2007.05.010; Mehu M, 2008, BEHAVIOUR, V145, P1747, DOI 10.1163/156853908786279619; Miller L, 2011, JENA EC RES PAPERS, V18, P1; Oda R, 2009, BIOL LETTERS, V5, P752, DOI 10.1098/rsbl.2009.0332; Oda R, 2009, HUM NATURE-INT BIOS, V20, P331, DOI 10.1007/s12110-009-9070-8; Owren MJ, 2001, EMO SOC BEH, P152; RAPOPORT A, 1988, J CONFLICT RESOLUT, V32, P457, DOI 10.1177/0022002788032003003; Sachs JL, 2004, Q REV BIOL, V79, P135, DOI 10.1086/383541; SALLY D, 1995, RATION SOC, V7, P58, DOI 10.1177/1043463195007001004; Schug J, 2010, EVOL HUM BEHAV, V31, P87, DOI 10.1016/j.evolhumbehav.2009.09.006; Slonim R, 1998, ECONOMETRICA, V66, P569, DOI 10.2307/2998575; SPENCE M, 1973, Q J ECON, V87, P355, DOI 10.2307/1882010; Szathmary E, 1995, MAJOR TRANSITIONS EV; van den Assem MJ, MANAGEMENT IN PRESS; WEISFELD GE, 1993, ETHOL SOCIOBIOL, V14, P141, DOI 10.1016/0162-3095(93)90012-7; West SA, 2007, CURR BIOL, V17, pR661, DOI 10.1016/j.cub.2007.06.004; West SA, 2010, SCIENCE, V327, P1341, DOI 10.1126/science.1178332; ZAHAVI A, 1975, J THEOR BIOL, V53, P205, DOI 10.1016/0022-5193(75)90111-3	64	8	8	0	14	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 2	2012	7	4							e33344	10.1371/journal.pone.0033344	http://dx.doi.org/10.1371/journal.pone.0033344			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	952GU	22485141	Green Published, gold			2022-12-25	WOS:000304780500017
J	Doerks, T; van Noort, V; Minguez, P; Bork, P				Doerks, Tobias; van Noort, Vera; Minguez, Pablo; Bork, Peer			Annotation of the M. tuberculosis Hypothetical Orfeome: Adding Functional Information to More than Half of the Uncharacterized Proteins	PLOS ONE			English	Article							MYCOBACTERIUM-TUBERCULOSIS; ESCHERICHIA-COLI; COMPLETE GENOMES; GENE; DATABASE; PREDICTION; NETWORKS; SEQUENCE; TARGETS	The genome of Mycobacterium tuberculosis (H37Rv) contains 4,019 protein coding genes, of which more than thousand have been categorized as 'hypothetical' implying that for these not even weak functional associations could be identified so far. We here predict reliable functional indications for half of this large hypothetical orfeome: 497 genes can be annotated based on orthology, and another 125 can be linked to interacting proteins via integrated genomic context analysis and literature mining. The assignments include newly identified clusters of interacting proteins, hypothetical genes that are associated to well known pathways and putative disease-relevant targets. All together, we have raised the fraction of the proteome with at least some functional annotation to 88% which should considerably enhance the interpretation of large-scale experiments targeting this medically important organism.	[Doerks, Tobias; van Noort, Vera; Minguez, Pablo; Bork, Peer] European Mol Biol Lab, Heidelberg, Germany; [Bork, Peer] Max Delbrueck Ctr, Berlin, Germany	European Molecular Biology Laboratory (EMBL); Helmholtz Association; Max Delbruck Center for Molecular Medicine	Doerks, T (corresponding author), European Mol Biol Lab, Heidelberg, Germany.	doerks@embl.de	van Noort, Vera/E-1053-2011; Miguez, Pablo/D-4822-2013; van Noort, Vera/GWZ-9038-2022; Bork, Peer/F-1813-2013	van Noort, Vera/0000-0002-8436-6602; Miguez, Pablo/0000-0003-4099-9421; Bork, Peer/0000-0002-2627-833X; Ranganathan, Shoba/0000-0002-8290-813X	European Union (SysteMTb) [241587]	European Union (SysteMTb)	This work was supported by the European Union FP7 program (SysteMTb 241587). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Anishetty S, 2005, COMPUT BIOL CHEM, V29, P368, DOI 10.1016/j.compbiolchem.2005.07.001; Beloqui A, 2006, J BIOL CHEM, V281, P22933, DOI 10.1074/jbc.M600577200; Bork P, 1998, NAT GENET, V18, P313, DOI 10.1038/ng0498-313; Boyle DS, 1997, MOL MICROBIOL, V24, P1263, DOI 10.1046/j.1365-2958.1997.4091773.x; Camus JC, 2002, MICROBIOL-SGM, V148, P2967, DOI 10.1099/00221287-148-10-2967; Cole ST, 1998, NATURE, V393, P537, DOI 10.1038/31159; Dandekar T, 1998, TRENDS BIOCHEM SCI, V23, P324, DOI 10.1016/S0968-0004(98)01274-2; Date SV, 2003, NAT BIOTECHNOL, V21, P1055, DOI 10.1038/nbt861; Doerks T, 2004, TRENDS GENET, V20, P126, DOI 10.1016/j.tig.2004.01.006; Eisen JA, 1998, GENOME RES, V8, P163, DOI 10.1101/gr.8.3.163; Enright AJ, 1999, NATURE, V402, P86, DOI 10.1038/47056; Galperin MY, 2004, NUCLEIC ACIDS RES, V32, P5452, DOI 10.1093/nar/gkh885; Goulding CW, 2005, J MOL BIOL, V349, P61, DOI 10.1016/j.jmb.2005.03.023; Honrubia MP, 2001, MOL GENET GENOMICS, V265, P1022, DOI 10.1007/s004380100497; Huynen M, 2000, GENOME RES, V10, P1204, DOI 10.1101/gr.10.8.1204; Huynen MA, 2003, CURR OPIN CELL BIOL, V15, P191, DOI 10.1016/S0955-0674(03)00009-7; Huynen MA, 1998, P NATL ACAD SCI USA, V95, P5849, DOI 10.1073/pnas.95.11.5849; Jackson M, 2000, J BIOL CHEM, V275, P30092, DOI 10.1074/jbc.M004658200; Kanehisa M, 2010, NUCLEIC ACIDS RES, V38, pD355, DOI 10.1093/nar/gkp896; Koonin EV, 2005, ANNU REV GENET, V39, P309, DOI 10.1146/annurev.genet.39.073003.114725; Kumar V., 2007, ROBBINS BASIC PATHOL, P516; Lew JM, 2011, TUBERCULOSIS, V91, P1, DOI 10.1016/j.tube.2010.09.008; Marcotte EM, 1999, NATURE, V402, P83, DOI 10.1038/47048; Mazandu GK, 2011, INFECT GENET EVOL; Mellor JC, 2002, NUCLEIC ACIDS RES, V30, P306, DOI 10.1093/nar/30.1.306; Muller J, 2010, NUCLEIC ACIDS RES, V38, pD190, DOI 10.1093/nar/gkp951; Overbeek R, 1999, P NATL ACAD SCI USA, V96, P2896, DOI 10.1073/pnas.96.6.2896; Pellegrini M, 1999, P NATL ACAD SCI USA, V96, P4285, DOI 10.1073/pnas.96.8.4285; Roberts RJ, 2004, PLOS BIOL, V2, P293, DOI 10.1371/journal.pbio.0020042; Roberts SA, 2002, P NATL ACAD SCI USA, V99, P2766, DOI 10.1073/pnas.052710499; Southwick F., 2007, INFECT DIS CLIN SHOR; Spraggon G, 2004, PROTEIN SCI, V13, P3187, DOI 10.1110/ps.04939904; Szklarczyk D, 2011, NUCLEIC ACIDS RES, V39, pD561, DOI 10.1093/nar/gkq973; Tatusov RL, 2001, NUCLEIC ACIDS RES, V29, P22, DOI 10.1093/nar/29.1.22; von Mering C, 2003, P NATL ACAD SCI USA, V100, P15428, DOI 10.1073/pnas.2136809100; von Mering C, 2003, NUCLEIC ACIDS RES, V31, P258, DOI 10.1093/nar/gkg034; White EL, 2007, J BIOMOL SCREEN, V12, P100, DOI 10.1177/1087057106296484; *WHO, TUB FACT SHEET 104	38	42	42	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 2	2012	7	4							e34302	10.1371/journal.pone.0034302	http://dx.doi.org/10.1371/journal.pone.0034302			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	952GU	22485162	gold, Green Published, Green Accepted, Green Submitted			2022-12-25	WOS:000304780500037
J	Li, JG; Ren, LL; Guo, L; Xiang, ZC; Paranhos-Baccala, G; Vernet, G; Wang, JW				Li, Jianguo; Ren, Lili; Guo, Li; Xiang, Zichun; Paranhos-Baccala, Glaucia; Vernet, Guy; Wang, Jianwei			Evolutionary Dynamics Analysis of Human Metapneumovirus Subtype A2: Genetic Evidence for Its Dominant Epidemic	PLOS ONE			English	Article							RESPIRATORY SYNCYTIAL VIRUS; CIRCULATION PATTERNS; NATURAL-SELECTION; YOUNG-CHILDREN; VARIABILITY; INFECTION; TRACT; DIVERSITY; GENOTYPE; STRAINS	Human metapneumovirus (hMPV) is a respiratory viral pathogen in children worldwide. hMPV is divided into four subtypes: hMPV_A1, hMPV_A2, hMPV_B1, and hMPV_B2. hMPV_A2 can be further divided into hMPV_A2a and A2b based on phylogenetic analysis. The typical prevalence pattern of hMPV involves a shift of the predominant subtype within one or two years. However, hMPV_A2, in particular hMPV_A2b, has circulated worldwide with a several years long term high epidemic. To study this distinct epidemic behavior of hMPV_A2, we analyzed 294 sequences of partial G genes of the virus from different countries. Molecular evolutionary data indicates that hMPV_A2 evolved toward heterogeneity faster than the other subtypes. Specifically, a Bayesian skyline plot analysis revealed that hMPV_A2 has undergone a generally upward fluctuation since 1997, whereas the other subtypes experienced only one upward fluctuation. Although hMPV_A2 showed a lower value of mean dN/dS than the other subtypes, it had the largest number of positive selection sites. Meanwhile, various styles of mutation were observed in the mutation hotspots of hMPV_A2b. Bayesian phylogeography analysis also revealed two fusions of diffusion routes of hMPV_A2b in India (June 2006) and Beijing, China (June 2008). Sequences of hMPV_A2b retrieved from GenBank boosted simultaneously with the two fusions respectively, indicating that fusion of genetic transmission routes from different regions improved survival of hMPV_A2. Epidemic and evolutionary dynamics of hMPV_A2b were similar to those of hMPV_A2. Overall, our findings provide important molecular insights into hMPV epidemics and viral variation, and explain the occurrence of an atypical epidemic of hMPV_A2, particularly hMPV_A2b.	[Li, Jianguo; Ren, Lili; Guo, Li; Xiang, Zichun; Wang, Jianwei] Peking Union Med Coll, MOH Key Lab Syst Biol Pathogens, Beijing 100021, Peoples R China; [Li, Jianguo; Ren, Lili; Guo, Li; Xiang, Zichun; Wang, Jianwei] Peking Union Med Coll, Christophe Merieux Lab, IPB, CAMS Fdn Merieux, Beijing 100021, Peoples R China; [Li, Jianguo; Ren, Lili; Guo, Li; Xiang, Zichun; Wang, Jianwei] Chinese Acad Med Sci, Beijing 100730, Peoples R China; [Paranhos-Baccala, Glaucia; Vernet, Guy] Fdn Merieux, Lyon, France	Chinese Academy of Medical Sciences - Peking Union Medical College; Peking Union Medical College; Chinese Academy of Medical Sciences - Peking Union Medical College; Institute of Pathogen Biology - CAMS; Peking Union Medical College; Chinese Academy of Medical Sciences - Peking Union Medical College	Li, JG (corresponding author), Peking Union Med Coll, MOH Key Lab Syst Biol Pathogens, Beijing 100021, Peoples R China.	wangjw28@163.com	Li, Jianguo/T-3372-2019; Wang, Jianwei/W-5916-2019; Wang, Jianwei/AAW-9499-2020	Li, Jianguo/0000-0002-2251-8308; Wang, Jianwei/0000-0002-1116-4559	International Science and Technology Cooperation Program of China [2010DFB33270]; National Major Science & Technology Project for Control and Prevention of Major Infectious Diseases of China [2009ZX10004-206]	International Science and Technology Cooperation Program of China; National Major Science & Technology Project for Control and Prevention of Major Infectious Diseases of China	This study was supported in part by the International Science and Technology Cooperation Program of China (2010DFB33270) (http://www.cistc.gov.cn) and National Major Science & Technology Project for Control and Prevention of Major Infectious Diseases of China (2009ZX10004-206) (http://www.nmp.gov.cn/). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript. No additional external funding was received for this study.	Agapov E, 2006, J INFECT DIS, V193, P396, DOI 10.1086/499310; Ahumada-Ruiz S, 2008, AIDS RES HUM RETROV, V24, P1461, DOI 10.1089/aid.2008.0153; Bastien N, 2003, VIRUS RES, V93, P51, DOI 10.1016/S0168-1702(03)00065-0; Biacchesi S, 2005, J VIROL, V79, P12608, DOI 10.1128/JVI.79.19.12608-12613.2005; Biacchesi S, 2004, J VIROL, V78, P12877, DOI 10.1128/JVI.78.23.12877-12887.2004; Caracciolo S, 2008, PEDIATR INFECT DIS J, V27, P406, DOI 10.1097/INF.0b013e318162a164; Chung JY, 2008, J MED VIROL, V80, P902, DOI 10.1002/jmv.21129; de Graaf M, 2008, J GEN VIROL, V89, P2933, DOI 10.1099/vir.0.2008/006957-0; Dolz R, 2008, VIROLOGY, V374, P50, DOI 10.1016/j.virol.2007.12.020; Drummond AJ, 2007, BMC EVOL BIOL, V7, DOI 10.1186/1471-2148-7-214; Gerna G, 2005, ARCH VIROL, V150, P2365, DOI 10.1007/s00705-005-0581-2; Holmes EC, 2009, PLOS COMPUT BIOL, V5, DOI 10.1371/journal.pcbi.1000505; Huck B, 2006, EMERG INFECT DIS, V12, P147, DOI 10.3201/eid1201.050772; Ishiguro N, 2004, J CLIN MICROBIOL, V42, P3406, DOI 10.1128/JCM.42.8.3406-3414.2004; Kahn JS, 2006, CLIN MICROBIOL REV, V19, P546, DOI 10.1128/CMR.00014-06; Lemey P, 2009, PLOS COMPUT BIOL, V5, DOI 10.1371/journal.pcbi.1000520; Liao YC, 2008, BIOINFORMATICS, V24, P505, DOI 10.1093/bioinformatics/btm638; Ludewick HP, 2005, EMERG INFECT DIS, V11, P1074, DOI 10.3201/eid1107.050050; Mackay IM, 2006, J INFECT DIS, V193, P1630, DOI 10.1086/504260; Noyola DE, 2005, J MED MICROBIOL, V54, P969, DOI 10.1099/jmm.0.46052-0; Oliveira DBL, 2009, J MED VIROL, V81, P915, DOI 10.1002/jmv.21436; Padhi A, 2008, VIRUS RES, V131, P121, DOI 10.1016/j.virusres.2007.08.014; Pan K, 2011, J R SOC INTERFACE, V8, P1644, DOI 10.1098/rsif.2011.0105; Peret TCT, 2004, J GEN VIROL, V85, P679, DOI 10.1099/vir.0.19504-0; Peret TCT, 1998, J GEN VIROL, V79, P2221, DOI 10.1099/0022-1317-79-9-2221; Peret TCT, 2000, J INFECT DIS, V181, P1891, DOI 10.1086/315508; Pond SLK, 2005, BIOINFORMATICS, V21, P676, DOI 10.1093/bioinformatics/bti079; Posada D, 1998, BIOINFORMATICS, V14, P817, DOI 10.1093/bioinformatics/14.9.817; Pybus OG, 2009, NAT REV GENET, V10, P540, DOI 10.1038/nrg2583; Ren L, 2009, CLIN MICROBIOL INFEC, V15, P1146, DOI 10.1111/j.1469-0691.2009.02746.x; Ren LL, 2008, J CLIN VIROL, V43, P330, DOI 10.1016/j.jcv.2008.08.003; Sarasini A, 2006, J CLIN VIROL, V35, P59, DOI 10.1016/j.jcv.2005.05.010; Sloots TP, 2006, EMERG INFECT DIS, V12, P1263, DOI 10.3201/eid1708.051239; Tamura K, 2007, MOL BIOL EVOL, V24, P1596, DOI 10.1093/molbev/msm092; Tee KK, 2010, J VIROL, V84, P3339, DOI 10.1128/JVI.01019-09; van den Hoogen BG, 2001, NAT MED, V7, P719, DOI 10.1038/89098; Wilgenbusch James C, 2003, Curr Protoc Bioinformatics, VChapter 6, DOI 10.1002/0471250953.bi0604s00; Wolf Yuri I, 2010, PLoS Curr, V2, pRRN1200, DOI 10.1371/currents.RRN1200; Yang ZH, 2007, MOL BIOL EVOL, V24, P1586, DOI 10.1093/molbev/msm088; Zaki ME, 2009, MICROBIOL IMMUNOL, V53, P603, DOI 10.1111/j.1348-0421.2009.00162.x; Zehender G, 2011, INFECT GENET EVOL, V11, P646, DOI 10.1016/j.meegid.2011.02.003	41	3	5	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 30	2012	7	3							e34544	10.1371/journal.pone.0034544	http://dx.doi.org/10.1371/journal.pone.0034544			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	959UC	22479641	gold, Green Published, Green Submitted			2022-12-25	WOS:000305339100166
J	Williams, CM; Marshall, KE; MacMillan, HA; Dzurisin, JDK; Hellmann, JJ; Sinclair, BJ				Williams, Caroline M.; Marshall, Katie E.; MacMillan, Heath A.; Dzurisin, Jason D. K.; Hellmann, Jessica J.; Sinclair, Brent J.			Thermal Variability Increases the Impact of Autumnal Warming and Drives Metabolic Depression in an Overwintering Butterfly	PLOS ONE			English	Article							CLIMATE-CHANGE; TEMPERATURE; RANGE; SIZE; POPULATIONS; PERFORMANCE; COLEOPTERA; ALLOCATION; EVOLUTION; SURVIVAL	Increases in thermal variability elevate metabolic rate due to Jensen's inequality, and increased metabolic rate decreases the fitness of dormant ectotherms by increasing consumption of stored energy reserves. Theory predicts that ectotherms should respond to increased thermal variability by lowering the thermal sensitivity of metabolism, which will reduce the impact of the warm portion of thermal variability. We examined the thermal sensitivity of metabolic rate of overwintering Erynnis propertius (Lepidoptera: Hesperiidae) larvae from a stable or variable environment reared in the laboratory in a reciprocal common garden design, and used these data to model energy use during the winters of 1973-2010 using meteorological data to predict the energetic outcomes of metabolic compensation and phenological shifts. Larvae that experienced variable temperatures had decreased thermal sensitivity of metabolic rate, and were larger than those reared at stable temperatures, which could partially compensate for the increased energetic demands. Even with depressed thermal sensitivity, the variable environment was more energy-demanding than the stable, with the majority of this demand occurring in autumn. Autumn phenology changes thus had disproportionate influence on energy consumption in variable environments, and variable-reared larvae were most susceptible to overwinter energy drain. Therefore the energetic impacts of the timing of entry into winter dormancy will strongly influence ectotherm fitness in northern temperate environments. We conclude that thermal variability drives the expression of metabolic suppression in this species; that phenological shifts will have a greater impact on ectotherms in variable thermal environments; and that E. propertius will be more sensitive to shifts in phenology in autumn than in spring. This suggests that increases in overwinter thermal variability and/or extended, warm autumns, will negatively impact all non-feeding dormant ectotherms which lack the ability to suppress their overwinter metabolic thermal sensitivity.	[Williams, Caroline M.; Marshall, Katie E.; MacMillan, Heath A.; Sinclair, Brent J.] Univ Western Ontario, Dept Biol, London, ON, Canada; [Dzurisin, Jason D. K.; Hellmann, Jessica J.] Univ Notre Dame, Dept Biol Sci, South Bend, IN USA	Western University (University of Western Ontario); University of Notre Dame	Williams, CM (corresponding author), Univ Florida, Dept Entomol & Nematol, Gainesville, FL 32611 USA.	bsincla7@uwo.ca	MacMillan, Heath/J-6943-2012; Williams, Caroline/B-4001-2012; Marshall, Katie/A-8200-2013	MacMillan, Heath/0000-0001-7598-3273; Williams, Caroline/0000-0003-3112-0286; Marshall, Katie/0000-0002-6991-4957; Sinclair, Brent/0000-0002-8191-9910	NSERC (Natural Sciences and Engineering Research Council of Canada); Canadian Foundation for Innovation; Ontario Ministry for Research and Innovation; U.S. Department of Energy Office of Science [DE-FG02-05ER]; Ontario NSERC	NSERC (Natural Sciences and Engineering Research Council of Canada)(Natural Sciences and Engineering Research Council of Canada (NSERC)); Canadian Foundation for Innovation(Canada Foundation for Innovation); Ontario Ministry for Research and Innovation(Ministry of Research and Innovation, Ontario); U.S. Department of Energy Office of Science(United States Department of Energy (DOE)); Ontario NSERC	This study was supported by Ontario and NSERC (Natural Sciences and Engineering Research Council of Canada) Graduate Scholarships to C.M.W., H.A.M., and K.E.M.; grants from NSERC (Discovery), the Canadian Foundation for Innovation and Ontario Ministry for Research and Innovation to B.J.S; and U.S. Department of Energy Office of Science (Biological and Environmental Research) Grant no. DE-FG02-05ER to J.J.H. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Angilletta MJ, 2006, J THERM BIOL, V31, P541, DOI 10.1016/j.jtherbio.2006.06.002; Angilletta MJ, 2009, BIO HABIT, P1, DOI 10.1093/acprof:oso/9780198570875.001.1; Boggs CL, 2009, FUNCT ECOL, V23, P27, DOI 10.1111/j.1365-2435.2009.01527.x; Bosch J, 2010, J INSECT PHYSIOL, V56, P1949, DOI 10.1016/j.jinsphys.2010.08.017; Chippindale AK, 1996, EVOLUTION, V50, P753, DOI [10.2307/2410848, 10.1111/j.1558-5646.1996.tb03885.x]; Clarke A, 2004, FUNCT ECOL, V18, P252, DOI 10.1111/j.0269-8463.2004.00842.x; Crawley MJ., 2007, R BOOK; Crozier L, 2004, ECOLOGY, V85, P231, DOI 10.1890/02-0607; Davidowitz G, 2004, INTEGR COMP BIOL, V44, P443, DOI 10.1093/icb/44.6.443; Dillon ME, 2010, NATURE, V467, P704, DOI 10.1038/nature09407; Estay SA, 2011, POPUL ECOL, V53, P53, DOI 10.1007/s10144-010-0216-7; Gillooly JF, 2001, SCIENCE, V293, P2248, DOI 10.1126/science.1061967; Hahn DA, 2011, ANNU REV ENTOMOL, V56, P103, DOI 10.1146/annurev-ento-112408-085436; Han EN, 1998, ECOL ENTOMOL, V23, P160, DOI 10.1046/j.1365-2311.1998.00111.x; Hellmann JJ, 2008, OECOLOGIA, V157, P583, DOI 10.1007/s00442-008-1112-0; Hochachka P. W., 2002, BIOCH ADAPTATION; Irwin JT, 2003, OIKOS, V100, P71, DOI 10.1034/j.1600-0706.2003.11738.x; Ishihara M, 2006, ENVIRON ENTOMOL, V35, P524, DOI 10.1603/0046-225X-35.2.524; Jepsen JU, 2008, J ANIM ECOL, V77, P257, DOI 10.1111/j.1365-2656.2007.01339.x; Kingsolver JG, 2009, EVOLUTION, V63, P537, DOI 10.1111/j.1558-5646.2008.00568.x; Makarieva AM, 2006, FUNCT ECOL, V20, P83, DOI 10.1111/j.1365-2435.2006.01070.x; Marshall KE, 2012, NATURWISSENSCHAFTEN, V99, P33, DOI 10.1007/s00114-011-0866-0; Nespolo RF, 2007, BIOL RES, V40, P5, DOI 10.4067/S0716-97602007000100001; Niehaus AC, 2011, J EXP BIOL, V214, P1965, DOI 10.1242/jeb.054478; NIJHOUT HF, 1975, BIOL BULL, V149, P214, DOI 10.2307/1540491; O'Brien DM, 2002, P NATL ACAD SCI USA, V99, P4413, DOI 10.1073/pnas.072346699; Paaijmans KP, 2010, P NATL ACAD SCI USA, V107, P15135, DOI 10.1073/pnas.1006422107; Pachauri Rajendra, 2007, AR4 CLIMATE CHANGE 2; Parajulee MN, 1997, ENVIRON ENTOMOL, V26, P135, DOI 10.1093/ee/26.2.135; Parmesan C, 2003, NATURE, V421, P37, DOI 10.1038/nature01286; Pasztor L, 2000, TRENDS ECOL EVOL, V15, P117, DOI 10.1016/S0169-5347(99)01801-7; Pelini SL, 2009, P NATL ACAD SCI USA, V106, P11160, DOI 10.1073/pnas.0900284106; Pinheiro J., 2019, NLME LINEAR NONLINEA; Pinheiro J, 2001, MIXED EFFECTS MODELS; Prior KM, 2009, CAN ENTOMOL, V141, P161, DOI 10.4039/n08-019; R Core Development Team, 2009, R LANG ENV STAT COMP; Ruel JJ, 1999, TRENDS ECOL EVOL, V14, P361, DOI 10.1016/S0169-5347(99)01664-X; Schlenker W, 2009, P NATL ACAD SCI USA, V106, P15594, DOI 10.1073/pnas.0906865106; Schmidt Nielsen K, 1990, ANIMAL PHYSL ADAPTAT; Sunday JM, 2011, P ROY SOC B-BIOL SCI, V278, P1823, DOI 10.1098/rspb.2010.1295; Thackeray SJ, 2010, GLOBAL CHANGE BIOL, V16, P3304, DOI 10.1111/j.1365-2486.2010.02165.x; van Asch M, 2007, GLOBAL CHANGE BIOL, V13, P1596, DOI 10.1111/j.1365-2486.2007.01400.x; Williams CM, 2011, J INSECT PHYSIOL, V57, P1602, DOI 10.1016/j.jinsphys.2011.08.008; Williams CM, 2010, BIOL LETTERS, V6, P274, DOI 10.1098/rsbl.2009.0803; Zhang TJ, 2005, REV GEOPHYS, V43, DOI 10.1029/2004RG000157	45	93	94	0	70	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 30	2012	7	3							e34470	10.1371/journal.pone.0034470	http://dx.doi.org/10.1371/journal.pone.0034470			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	959UC	22479634	Green Submitted, gold, Green Published			2022-12-25	WOS:000305339100160
J	Zabransky, DJ; Nirschl, CJ; Durham, NM; Park, B; Ceccato, CM; Bruno, TC; Tam, AJ; Getnet, D; Drake, CG				Zabransky, Daniel J.; Nirschl, Christopher J.; Durham, Nicholas M.; Park, Ben V.; Ceccato, Christina M.; Bruno, Tullia C.; Tam, Ada J.; Getnet, Derese; Drake, Charles G.			Phenotypic and Functional Properties of Helios(+) Regulatory T Cells	PLOS ONE			English	Article							EXPRESSION; TOLERANCE; CD25(+); SELF; IMMUNITY	Helios, an Ikaros family transcription factor, is preferentially expressed at the mRNA and protein level in regulatory T cells. Helios expression previously appeared to be restricted to thymic-derived Treg. Consistent with recent data, we show here that Helios expression is inducible in vitro under certain conditions. To understand phenotypic and functional differences between Helios(+) and Helios(-) Treg, we profiled cell-surface markers of FoxP3(+) Treg using unmanipulated splenocytes. We found that CD103 and GITR are expressed at high levels on a subset of Helios(+) Treg and that a Helios(+) Treg population could be significantly enriched by FACS sorting using these two markers. Quantitative real-time PCR (qPCR) analysis revealed increased TGF-beta message in Helios(+) Treg, consistent with the possibility that this population possesses enhanced regulatory potential. In tumor-bearing mice, we found that Helios(+) Treg were relatively over-represented in the tumor-mass, and BrdU studies showed that, in vivo, Helios(+) Treg proliferated more than Helios(-) Treg. We hypothesized that Helios-enriched Treg might exert increased suppressive effects. Using in vitro suppression assays, we show that Treg function correlates with the absolute number of Helios(+) cells in culture. Taken together, these data show that Helios(+) Treg represent a functional subset with associated CD103 and GITR expression.	[Zabransky, Daniel J.; Nirschl, Christopher J.; Durham, Nicholas M.; Park, Ben V.; Ceccato, Christina M.; Bruno, Tullia C.; Tam, Ada J.; Getnet, Derese; Drake, Charles G.] Johns Hopkins Univ, Dept Oncol, Baltimore, MD 21218 USA; [Drake, Charles G.] James Buchanan Brady Urol Inst, Baltimore, MD USA	Johns Hopkins University	Zabransky, DJ (corresponding author), Johns Hopkins Univ, Dept Oncol, Baltimore, MD 21218 USA.	cdrake@jhmi.edu		Zabransky, Daniel/0000-0002-8184-3346; Nirschl, Christopher/0000-0002-7333-2757	National Institutes of Health [R01 CA127153, 1P50CA58236-15]; Patrick C. Walsh Fund; OneInSix Foundation; Prostate Cancer Foundation; NATIONAL CANCER INSTITUTE [P50CA058236, R01CA127153] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [T32AI007247] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Patrick C. Walsh Fund; OneInSix Foundation; Prostate Cancer Foundation; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	This work was supported by the National Institutes of Health R01 CA127153 and 1P50CA58236-15, the Patrick C. Walsh Fund (http://prostatecancerprogram.onc.jhmi.edu/PCW/), the OneInSix Foundation (www.oneinsix.org), and the Prostate Cancer Foundation (www.pcf.org). CGD is a Damon Runyon-Lilly Clinical Investigator. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alinikula J, 2010, EUR J IMMUNOL, V40, P2599, DOI 10.1002/eji.200940002; Anz D, 2011, INT J CANC IN PRESS; Belkaid Y, 2006, IMMUNOL REV, V212, P287, DOI 10.1111/j.0105-2896.2006.00409.x; Cai Q, 2009, J IMMUNOL, V183, P2303, DOI 10.4049/jimmunol.0901407; Chen X, 2008, J IMMUNOL, V180, P6467, DOI 10.4049/jimmunol.180.10.6467; Curiel TJ, 2008, CURR OPIN IMMUNOL, V20, P241, DOI 10.1016/j.coi.2008.04.008; Feuerer M, 2010, P NATL ACAD SCI USA, V107, P5919, DOI 10.1073/pnas.1002006107; Fontenot JD, 2005, IMMUNITY, V22, P329, DOI 10.1016/j.immuni.2005.01.016; Getnet D, 2010, MOL IMMUNOL, V47, P1595, DOI 10.1016/j.molimm.2010.02.001; Getnet D, 2009, J IMMUNOL, V182, P4675, DOI 10.4049/jimmunol.0803400; Haribhai D, 2009, J IMMUNOL, V182, P3461, DOI 10.4049/jimmunol.0802535; Horwitz DA, 2008, TRENDS IMMUNOL, V29, P429, DOI 10.1016/j.it.2008.06.005; Huang CT, 2004, IMMUNITY, V21, P503, DOI 10.1016/j.immuni.2004.08.010; Huehn J, 2004, J EXP MED, V199, P303, DOI 10.1084/jem.20031562; Kronenberg M, 2005, NATURE, V435, P598, DOI 10.1038/nature03725; Lehmann J, 2002, P NATL ACAD SCI USA, V99, P13031, DOI 10.1073/pnas.192162899; Lin W, 2007, NAT IMMUNOL, V8, P359, DOI 10.1038/ni1445; Malek TR, 2004, NAT REV IMMUNOL, V4, P665, DOI 10.1038/nri1435; McHugh RS, 2002, IMMUNITY, V16, P311, DOI 10.1016/S1074-7613(02)00280-7; Sakaguchi S, 2005, NAT IMMUNOL, V6, P345, DOI 10.1038/ni1178; Sakaguchi S, 2008, CELL, V133, P775, DOI 10.1016/j.cell.2008.05.009; Schon MP, 1999, J IMMUNOL, V162, P6641; Shevach EM, 2004, ARTHRITIS RHEUM, V50, P2721, DOI 10.1002/art.20500; Sugimoto N, 2006, INT IMMUNOL, V18, P1197, DOI 10.1093/intimm/dxl060; Thornton AM, 2004, J IMMUNOL, V172, P6519, DOI 10.4049/jimmunol.172.11.6519; Thornton AM, 2010, J IMMUNOL, V184, P3433, DOI 10.4049/jimmunol.0904028; Verhagen J, 2010, J IMMUNOL, V185, P7129, DOI 10.4049/jimmunol.1090105; Vignali DAA, 2008, NAT REV IMMUNOL, V8, P523, DOI 10.1038/nri2343; Zheng Y, 2007, NAT IMMUNOL, V8, P457, DOI 10.1038/ni1455	29	117	123	1	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 30	2012	7	3							e34547	10.1371/journal.pone.0034547	http://dx.doi.org/10.1371/journal.pone.0034547			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	959UC	22479644	gold, Green Published, Green Submitted			2022-12-25	WOS:000305339100167
J	Santa-Maria, I; Varghese, M; Ksiezak-Reding, H; Dzhun, A; Wang, J; Pasinetti, GM				Santa-Maria, Ismael; Varghese, Merina; Ksiezak-Reding, Hanna; Dzhun, Anastasiya; Wang, Jun; Pasinetti, Giulio M.			Paired Helical Filaments from Alzheimer Disease Brain Induce Intracellular Accumulation of Tau Protein in Aggresomes	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							PROGRESSIVE SUPRANUCLEAR PALSY; SEED POLYPHENOLIC EXTRACT; NEURONAL CELLS; NEUROFIBRILLARY DEGENERATION; NEURODEGENERATIVE DISEASES; EXTRACELLULAR TAU; ALPHA-SYNUCLEIN; EXOSOMES; TAUOPATHY; MODEL	Abnormal folding of tau protein leads to the generation of paired helical filaments (PHFs) and neurofibrillary tangles, a key neuropathological feature in Alzheimer disease and tauopathies. A specific anatomical pattern of pathological changes developing in the brain suggests that once tau pathology is initiated it propagates between neighboring neuronal cells, possibly spreading along the axonal network. We studied whether PHFs released from degenerating neurons could be taken up by surrounding cells and promote spreading of tau pathology. Neuronal and non-neuronal cells overexpressing green fluorescent protein-tagged tau (GFP-Tau) were treated with isolated fractions of human Alzheimer disease-derived PHFs for 24 h. We found that cells internalized PHFs through an endocytic mechanism and developed intracellular GFP-Tau aggregates with attributes of aggresomes. This was particularly evident by the perinuclear localization of aggregates and redistribution of the vimentin intermediate filament network and retrograde motor protein dynein. Furthermore, the content of Sarkosyl-insoluble tau, a measure of abnormal tau aggregation, increased 3-fold in PHF-treated cells. An exosome-related mechanism did not appear to be involved in the release of GFP-Tau from untreated cells. The evidence that cells can internalize PHFs, leading to formation of aggresome-like bodies, opens new therapeutic avenues to prevent propagation and spreading of tau pathology.	[Santa-Maria, Ismael; Varghese, Merina; Ksiezak-Reding, Hanna; Dzhun, Anastasiya; Wang, Jun; Pasinetti, Giulio M.] Mt Sinai Sch Med, Ctr Excellence Res Complementary & Alternat Med A, Ctr Excellence Novel Approaches Neurodiagnost & N, Brain Inst,Dept Neurol, New York, NY 10029 USA; [Varghese, Merina; Ksiezak-Reding, Hanna; Dzhun, Anastasiya; Pasinetti, Giulio M.] James J Peters Vet Affairs Med Ctr, Geriatr Res Educ & Clin Ctr, Bronx, NY 10468 USA; [Santa-Maria, Ismael] Queen Sofia Fdn, Ctr Invest Enfermedades Neurol Fdn, Alzheimer Dis Res Unit, Madrid 28031, Spain	Icahn School of Medicine at Mount Sinai; Geriatric Research Education & Clinical Center; US Department of Veterans Affairs; Veterans Health Administration (VHA); James J. Peters VA Medical Center	Pasinetti, GM (corresponding author), Mt Sinai Sch Med, Ctr Excellence Res Complementary & Alternat Med A, Ctr Excellence Novel Approaches Neurodiagnost & N, Brain Inst,Dept Neurol, 1 Gustave L Levy Pl,Box 1137, New York, NY 10029 USA.	giulio.pasinetti@mssm.edu	Santa-Maria, Ismael/AAI-7630-2020; Varghese, Merina/H-5472-2019	Varghese, Merina/0000-0002-1517-3903; Pasinetti, Giulio/0000-0002-1524-5196; Santa-Maria Perez, Ismael/0000-0003-2801-5020	NCI, National Institutes of Health [5R24 CA095823-04, PO1 AT004511]; National Institutes of Health Shared Instrumentation [1 S10 RR0 9145-01]; Society for Progressive Supranuclear Palsy; Veterans Affairs merit review grant; National Science Foundation Major Research Instrumentation [DBI-9724504]; NATIONAL CANCER INSTITUTE [R24CA095823] Funding Source: NIH RePORTER; NATIONAL CENTER FOR COMPLEMENTARY & ALTERNATIVE MEDICINE [P01AT004511] Funding Source: NIH RePORTER	NCI, National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); National Institutes of Health Shared Instrumentation(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Society for Progressive Supranuclear Palsy; Veterans Affairs merit review grant(US Department of Veterans Affairs); National Science Foundation Major Research Instrumentation(National Science Foundation (NSF)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL CENTER FOR COMPLEMENTARY & ALTERNATIVE MEDICINE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Complementary & Alternative Medicine)	Confocal laser scanning microscopy was performed at the James J. Peters Veteran Affairs Medical Center and conventional fluorescence microscopy was performed at the Mount Sinai School of Medicine Microscopy Shared Resource Facility supported with funding from NCI, National Institutes of Health Shared Resource Grant 5R24 CA095823-04, National Science Foundation Major Research Instrumentation Grant DBI-9724504, and National Institutes of Health Shared Instrumentation Grant 1 S10 RR0 9145-01. We thank Jesus Avila (Universidad Auto noma de Madrid, Madrid, Spain) for help with preparing GFP and GFP-Tau plasmids. We also thank Miguel Gama-Sosa (Mount Sinai School of Medicine, New York, NY) for lending his expertise in confocal microscopy.; This work was supported, in whole or in part, by National Institutes of Health Grant PO1 AT004511 (to G. M. P.). This work was also supported by the Society for Progressive Supranuclear Palsy and in part by Veterans Affairs merit review grant (to G. M. P.). Dr. Pasinetti has filed a patent application (pending) through Mount Sinai School of Medicine related to grape seed polyphenolic extract. In the event that the pending patent is licensed, Dr. Pasinetti would be entitled to a share of any proceeds Mount Sinai School of Medicine receives from the license.	Abrahamsen H, 2010, CURR BIOL, V20, pR415, DOI 10.1016/j.cub.2010.03.011; ARRIAGADA PV, 1992, NEUROLOGY, V42, P631, DOI 10.1212/WNL.42.3.631; Avila J, 2004, PHYSIOL REV, V84, P361, DOI 10.1152/physrev.00024.2003; Ballatore C, 2007, NAT REV NEUROSCI, V8, P663, DOI 10.1038/nrn2194; Bandyopadhyay B, 2007, J BIOL CHEM, V282, P16454, DOI 10.1074/jbc.M700192200; BIEDLER JL, 1978, CANCER RES, V38, P3751; BONDAREFF W, 1989, NEUROBIOL AGING, V10, P709, DOI 10.1016/0197-4580(89)90007-9; BRAAK H, 1991, ACTA NEUROPATHOL, V81, P261, DOI 10.1007/BF00305867; Brunden KR, 2010, EXP NEUROL, V223, P304, DOI 10.1016/j.expneurol.2009.08.031; Carrettiero DC, 2009, J NEUROSCI, V29, P2151, DOI 10.1523/JNEUROSCI.4660-08.2009; Clavaguera F, 2009, NAT CELL BIOL, V11, P909, DOI 10.1038/ncb1901; Congdon EE, 2008, J BIOL CHEM, V283, P13806, DOI 10.1074/jbc.M800247200; David DC, 2002, J NEUROCHEM, V83, P176, DOI 10.1046/j.1471-4159.2002.01137.x; de Calignon A, 2012, NEURON, V73, P685, DOI 10.1016/j.neuron.2011.11.033; Emmanouilidou E, 2010, J NEUROSCI, V30, P6838, DOI 10.1523/JNEUROSCI.5699-09.2010; Faure J, 2006, MOL CELL NEUROSCI, V31, P642, DOI 10.1016/j.mcn.2005.12.003; Ferruzzi MG, 2009, J ALZHEIMERS DIS, V18, P113, DOI 10.3233/JAD-2009-1135; Fevrier B, 2004, P NATL ACAD SCI USA, V101, P9683, DOI 10.1073/pnas.0308413101; Friedhoff P, 1998, P NATL ACAD SCI USA, V95, P15712, DOI 10.1073/pnas.95.26.15712; Frost B, 2009, J BIOL CHEM, V284, P12845, DOI 10.1074/jbc.M808759200; Gomez-Ramos A, 2008, MOL CELL NEUROSCI, V37, P673, DOI 10.1016/j.mcn.2007.12.010; Gomez-Ramos A, 2006, FEBS LETT, V580, P4842, DOI 10.1016/j.febslet.2006.07.078; Guo JL, 2011, J BIOL CHEM, V286, P15317, DOI 10.1074/jbc.M110.209296; Guthrie CR, 2011, J MOL NEUROSCI, V45, P32, DOI 10.1007/s12031-011-9502-x; Hamano T, 2009, INT J CLIN EXP PATHO, V2, P561; Hansen CG, 2009, J CELL SCI, V122, P1713, DOI 10.1242/jcs.033951; Hernandez F, 2007, CELL MOL LIFE SCI, V64, P2219, DOI 10.1007/s00018-007-7220-x; Ho L, 2009, J ALZHEIMERS DIS, V16, P433, DOI 10.3233/JAD-2009-0969; Hwang IK, 2004, LIFE SCI, V75, P1989, DOI 10.1016/j.lfs.2004.05.013; Johnston JA, 1998, J CELL BIOL, V143, P1883, DOI 10.1083/jcb.143.7.1883; Keck S, 2003, J NEUROCHEM, V85, P115, DOI 10.1046/j.1471-4159.2003.01642.x; Kim W, 2010, FEBS LETT, V584, P3085, DOI 10.1016/j.febslet.2010.05.042; King ME, 2001, AM J PATHOL, V158, P1481, DOI 10.1016/S0002-9440(10)64099-0; Kopito RR, 2000, TRENDS CELL BIOL, V10, P524, DOI 10.1016/S0962-8924(00)01852-3; Ksiezak-Reding H, 2012, NEUROBIOL AGING, V33, P1427, DOI 10.1016/j.neurobiolaging.2010.11.006; KSIEZAKREDING H, 1994, NEUROBIOL AGING, V15, P11, DOI 10.1016/0197-4580(94)90140-6; Lee HJ, 2008, INT J BIOCHEM CELL B, V40, P1835, DOI 10.1016/j.biocel.2008.01.017; Li Z., 2012, INT J ALZHEIMERS DIS; Liu L, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0031302; Magalhaes AC, 2005, J NEUROSCI, V25, P5207, DOI 10.1523/JNEUROSCI.0653-05.2005; Mathivanan S, 2010, J PROTEOMICS, V73, P1907, DOI 10.1016/j.jprot.2010.06.006; McNaught KSP, 2002, EUR J NEUROSCI, V16, P2136, DOI 10.1046/j.1460-9568.2002.02301.x; Nickel W, 2010, CURR OPIN BIOTECH, V21, P621, DOI 10.1016/j.copbio.2010.06.004; Olzmann JA, 2008, CURR MED CHEM, V15, P47; Pasinetti GM, 2010, J NEUROCHEM, V114, P1557, DOI 10.1111/j.1471-4159.2010.06875.x; Perez M, 2009, J NEUROCHEM, V109, P1756, DOI 10.1111/j.1471-4159.2009.06102.x; Porto-Carreiro I, 2005, BLOOD CELL MOL DIS, V35, P143, DOI 10.1016/j.bcmd.2005.06.013; Rajendran L, 2006, P NATL ACAD SCI USA, V103, P11172, DOI 10.1073/pnas.0603838103; Raju I, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0019876; Ren PH, 2009, NAT CELL BIOL, V11, P219, DOI 10.1038/ncb1830; Rodriguez-Gonzalez A, 2008, CANCER RES, V68, P2557, DOI 10.1158/0008-5472.CAN-07-5989; Saman S, 2012, J BIOL CHEM, V287, P3842, DOI 10.1074/jbc.M111.277061; Santa-Maria I, 2008, J ALZHEIMERS DIS, V13, P177; Santa-Maria I, 2012, NEUROBIOL AGING, V33, P2072, DOI 10.1016/j.neurobiolaging.2011.09.027; Sergeant N, 1999, J NEUROCHEM, V72, P1243, DOI 10.1046/j.1471-4159.1999.0721243.x; Simon D, 2012, FEBS LETT, V586, P47, DOI 10.1016/j.febslet.2011.11.022; Simpson RJ, 2008, PROTEOMICS, V8, P4083, DOI 10.1002/pmic.200800109; Takahashi M, 2002, J NEUROPATH EXP NEUR, V61, P33, DOI 10.1093/jnen/61.1.33; Thery Clotilde, 2006, Curr Protoc Cell Biol, VChapter 3, DOI 10.1002/0471143030.cb0322s30; Upadhya SC, 2007, BMC BIOCHEM, V8, DOI 10.1186/1471-2091-8-S1-S12; Vella LJ, 2008, EUR BIOPHYS J BIOPHY, V37, P323, DOI 10.1007/s00249-007-0246-z; Vingtdeux V, 2007, J BIOL CHEM, V282, P18197, DOI 10.1074/jbc.M609475200; Wang J, 2012, J NEUROSCI, V32, P5144, DOI 10.1523/JNEUROSCI.6437-11.2012; Wang J, 2010, J ALZHEIMERS DIS, V22, P653, DOI 10.3233/JAD-2010-101074; Wong ESP, 2008, HUM MOL GENET, V17, P2570, DOI 10.1093/hmg/ddn157; Yamada K, 2011, J NEUROSCI, V31, P13110, DOI 10.1523/JNEUROSCI.2569-11.2011; Zhao Z, 2003, MOL CELL NEUROSCI, V24, P367, DOI 10.1016/S1044-7431(03)00175-1	67	91	95	0	16	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JUN 8	2012	287	24					20522	20533		10.1074/jbc.M111.323279	http://dx.doi.org/10.1074/jbc.M111.323279			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	974FB	22496370	hybrid, Green Published			2022-12-25	WOS:000306414500073
J	Bui, SH; McLean, KJ; Cheesman, MR; Bradley, JM; Rigby, SEJ; Levy, CW; Leys, D; Munro, AW				Bui, Soi H.; McLean, Kirsty J.; Cheesman, Myles R.; Bradley, Justin M.; Rigby, Stephen E. J.; Levy, Colin W.; Leys, David; Munro, Andrew W.			Unusual Spectroscopic and Ligand Binding Properties of the Cytochrome P450-Flavodoxin Fusion Enzyme XplA	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							MAGNETIC CIRCULAR-DICHROISM; MYCOBACTERIUM-TUBERCULOSIS; FLAVOCYTOCHROME P450BM3; HEXAHYDRO-1,3,5-TRINITRO-1,3,5-TRIAZINE RDX; BIOPHYSICAL CHARACTERIZATION; REDUCTIVE DECHLORINATION; CRYSTAL-STRUCTURE; SELF-SUFFICIENT; HEME; DEGRADATION	The Rhodococcus rhodochrous strain 11Y XplA enzyme is an unusual cytochrome P450-flavodoxin fusion enzyme that catalyzes reductive denitration of the explosive hexahydro-1,3,5-trinitro-1,3,5-triazene (RDX). We show by light scattering that XplA is a monomeric enzyme. XplA has high affinity for imidazole (K-d = 1.6 mu M), explaining previous reports of a red-shifted XplA Soret band in pure enzyme. The true Soret maximum of XplA is at 417 nm. Similarly, unusually weak XplA flavodoxin FMN binding (K-d = 1.09 mu M) necessitates its purification in the presence of the cofactor to produce hallmark flavin contributions absent in previously reported spectra. Structural and ligand-binding data reveal a constricted active site able to accommodate RDX and small inhibitory ligands (e.g. 4-phenylimidazole and morpholine) while discriminating against larger azole drugs. The crystal structure also identifies a high affinity imidazole binding site, consistent with its low K-d, and shows active site penetration by PEG, perhaps indicative of an evolutionary lipid-metabolizing function for XplA. EPR studies indicate heterogeneity in binding mode for RDX and other ligands. The substrate analog trinitrobenzene does not induce a substrate-like type I optical shift but creates a unique low spin EPR spectrum due to influence on structure around the distal water heme ligand. The substrate-free heme iron potential (-268mV versus NHE) is positive for a low spin P450, and the elevated potential of the FMN semiquinone/hydroquinone couple (-172 mV) is also an adaptation that may reflect (along with the absence of a key Thr/Ser residue conserved in oxygen-activating P450s) the evolution of XplA as a specialized RDX reductase catalyst.	[Bui, Soi H.; McLean, Kirsty J.; Rigby, Stephen E. J.; Levy, Colin W.; Leys, David; Munro, Andrew W.] Univ Manchester, Fac Life Sci, Manchester Interdisciplinary Bioctr, Manchester M1 7DN, Lancs, England; [Cheesman, Myles R.; Bradley, Justin M.] Univ E Anglia, Sch Chem Sci, Norwich NR4 7TJ, Norfolk, England	University of Manchester; University of East Anglia	Munro, AW (corresponding author), Univ Manchester, Fac Life Sci, Manchester Interdisciplinary Bioctr, 131 Princess St, Manchester M1 7DN, Lancs, England.	Andrew.Munro@Manchester.ac.uk	Munro, Andrew/G-5639-2019; McLean, Kirsty J/GXI-2853-2022	Munro, Andrew/0000-0002-4642-180X; McLean, Kirsty/0000-0002-7193-5044	United Kingdom Biotechnology and Biological Sciences Research Council; Biotechnology and Biological Sciences Research Council; Biotechnology and Biological Sciences Research Council [BB/E013252/1, BB/E013007/1] Funding Source: researchfish; BBSRC [BB/E013252/1, BB/E013007/1] Funding Source: UKRI	United Kingdom Biotechnology and Biological Sciences Research Council(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); Biotechnology and Biological Sciences Research Council(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); Biotechnology and Biological Sciences Research Council(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); BBSRC(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC))	This work was supported by the United Kingdom Biotechnology and Biological Sciences Research Council.; Supported by a Biotechnology and Biological Sciences Research Council Ph.D. studentship.	Aliverti A, 1999, METH MOL B, V131, P9; Andeer PF, 2009, APPL ENVIRON MICROB, V75, P3258, DOI 10.1128/AEM.02396-08; Ayoub K, 2010, J HAZARD MATER, V178, P10, DOI 10.1016/j.jhazmat.2010.02.042; BAILEY S, 1994, ACTA CRYSTALLOGR D, V50, P760, DOI 10.1107/s0907444994003112; Barr I, 2011, J BIOL CHEM, V286, P16716, DOI 10.1074/jbc.M110.180844; BERRY EA, 1987, ANAL BIOCHEM, V161, P1, DOI 10.1016/0003-2697(87)90643-9; Bhushan B, 2003, APPL ENVIRON MICROB, V69, P1347, DOI 10.1128/AEM.69.3.1347-1351.2003; BOHAN TL, 1977, J MAGN RESON, V26, P109, DOI 10.1016/0022-2364(77)90240-2; Cargill R., 1990, CARBON MONOXIDE, V43, P5; Chang FC, 1999, BIOCHEMISTRY-US, V38, P7168, DOI 10.1021/bi982203u; CHEESMAN MR, 1991, ADV INORG CHEM, V36, P201, DOI 10.1016/S0898-8838(08)60040-9; Clark JP, 2006, J INORG BIOCHEM, V100, P1075, DOI 10.1016/j.jinorgbio.2005.11.020; CUPPVICKERY JR, 1995, NAT STRUCT BIOL, V2, P144, DOI 10.1038/nsb0295-144; Cutter LA, 2001, ENVIRON MICROBIOL, V3, P699, DOI 10.1046/j.1462-2920.2001.00246.x; Daff SN, 1997, BIOCHEMISTRY-US, V36, P13816, DOI 10.1021/bi971085s; Denisov IG, 2005, CHEM REV, V105, P2253, DOI 10.1021/cr0307143; Driscoll MD, 2010, J BIOL CHEM, V285, P38270, DOI 10.1074/jbc.M110.164293; Dutton P L, 1978, Methods Enzymol, V54, P411; Field JA, 2008, ENVIRON POLLUT, V155, P1, DOI 10.1016/j.envpol.2007.10.016; French CE, 1999, NAT BIOTECHNOL, V17, P491, DOI 10.1038/8673; Furukawa K, 2000, CURR OPIN BIOTECH, V11, P244, DOI 10.1016/S0958-1669(00)00091-4; Gillam EMJ, 1999, BIOCHEM BIOPH RES CO, V265, P469, DOI 10.1006/bbrc.1999.1702; Girvan HM, 2010, BIOCHEM J, V427, P455, DOI 10.1042/BJ20091603; Girvan HM, 2004, J BIOL CHEM, V279, P23274, DOI 10.1074/jbc.M401716200; Glieder A, 2002, NAT BIOTECHNOL, V20, P1135, DOI 10.1038/nbt744; Hannemann F, 2007, BBA-GEN SUBJECTS, V1770, P330, DOI 10.1016/j.bbagen.2006.07.017; HARTLINE RA, 1971, J BACTERIOL, V106, P468, DOI 10.1128/JB.106.2.468-478.1971; Hawkes DB, 2010, CHEMBIOCHEM, V11, P1107, DOI 10.1002/cbic.201000119; Jackson CJ, 2002, J BIOL CHEM, V277, P46959, DOI 10.1074/jbc.M203523200; Jackson RG, 2007, P NATL ACAD SCI USA, V104, P16822, DOI 10.1073/pnas.0705110104; KABSCH W, 1988, J APPL CRYSTALLOGR, V21, P916, DOI 10.1107/S0021889888007903; Kammer FVD, 2005, ANAL CHIM ACTA, V552, P166, DOI 10.1016/j.aca.2005.07.049; KEITH LH, 1979, ENVIRON SCI TECHNOL, V13, P416, DOI 10.1021/es60152a601; Kurumata M, 2005, Z NATURFORSCH C, V60, P272; Lachance B, 1999, MUTAT RES-GEN TOX EN, V444, P25, DOI 10.1016/S1383-5718(99)00073-X; Lawson RJ, 2004, BIOCHEMISTRY-US, V43, P12410, DOI 10.1021/bi049132l; Lawson RJ, 2004, BIOCHEMISTRY-US, V43, P12390, DOI 10.1021/bi049131t; Lederer F, 1999, METH MOL B, V131, P149; Martinis SA, 1996, BIOCHEMISTRY-US, V35, P14530, DOI 10.1021/bi961511u; McCarthy AA, 2002, BIOCHEMISTRY-US, V41, P10950, DOI 10.1021/bi020225h; McLean KJ, 2006, BIOCHEMISTRY-US, V45, P8427, DOI 10.1021/bi0601609; McLean KJ, 2008, J BIOL CHEM, V283, P33406, DOI 10.1074/jbc.M802115200; MILES JS, 1992, BIOCHEM J, V288, P503, DOI 10.1042/bj2880503; Munro AW, 2007, NAT PROD REP, V24, P585, DOI 10.1039/b604190f; Munro AW, 2007, BBA-GEN SUBJECTS, V1770, P345, DOI 10.1016/j.bbagen.2006.08.018; Munro AW, 1996, BBA-PROTEIN STRUCT M, V1296, P127, DOI 10.1016/0167-4838(96)00061-1; Munro AW, 2002, TRENDS BIOCHEM SCI, V27, P250, DOI 10.1016/S0968-0004(02)02086-8; Munro AW, 1996, MOL MICROBIOL, V20, P1115, DOI 10.1111/j.1365-2958.1996.tb02632.x; Neeli R, 2005, FEBS LETT, V579, P5582, DOI 10.1016/j.febslet.2005.09.023; Noble MA, 1998, BIOCHEMISTRY-US, V37, P15799, DOI 10.1021/bi980462d; Okeke BC, 2001, CAN J MICROBIOL, V47, P448; OMURA T, 1964, J BIOL CHEM, V239, P2370; Ortiz de Montellano P.R., 2005, CYTOCHROME P450 STRU, P183, DOI [10.1007/b139087, DOI 10.1007/B139087]; Ost TWB, 2001, BIOCHEMISTRY-US, V40, P13421, DOI 10.1021/bi010716m; RAAG R, 1991, BIOCHEMISTRY-US, V30, P11420, DOI 10.1021/bi00112a008; RUX JJ, 1991, FEBS LETT, V290, P49, DOI 10.1016/0014-5793(91)81222-T; Rylott EL, 2006, NAT BIOTECHNOL, V24, P216, DOI 10.1038/nbt1184; Rylott EL, 2011, BBA-PROTEINS PROTEOM, V1814, P230, DOI 10.1016/j.bbapap.2010.07.004; Sabbadin F, 2009, J BIOL CHEM, V284, P28467, DOI 10.1074/jbc.M109.031559; Seth-Smith HMB, 2008, APPL ENVIRON MICROB, V74, P4550, DOI 10.1128/AEM.00391-08; Seth-Smith HMB, 2002, APPL ENVIRON MICROB, V68, P4764, DOI 10.1128/AEM.68.10.4764-4771.2002; Seward HE, 2006, J BIOL CHEM, V281, P39437, DOI 10.1074/jbc.M607665200; Shao ZQ, 1996, APPL ENVIRON MICROB, V62, P403, DOI 10.1128/AEM.62.2.403-407.1996; SLIGAR SG, 1976, BIOCHEMISTRY-US, V15, P5399, DOI 10.1021/bi00669a029; SONO M, 1982, J BIOL CHEM, V257, P8308; SONO M, 1982, J BIOL CHEM, V257, P5496; Thompson KT, 2005, APPL ENVIRON MICROB, V71, P8265, DOI 10.1128/AEM.71.12.8265-8272.2005; ULLRICH V, 1975, BIOCHEM SOC T, V3, P803, DOI 10.1042/bst0030803; Van Aken B, 2009, CURR OPIN BIOTECH, V20, P231, DOI 10.1016/j.copbio.2009.01.011; Warman AJ, 2005, BIOCHEM SOC T, V33, P747, DOI 10.1042/BST0330747; Warman AJ, 2012, FEBS J, V279, P1675, DOI 10.1111/j.1742-4658.2012.08543.x	71	23	23	2	36	ELSEVIER	AMSTERDAM	RADARWEG 29, 1043 NX AMSTERDAM, NETHERLANDS		1083-351X		J BIOL CHEM	J. Biol. Chem.	JUN 1	2012	287	23					19699	19714		10.1074/jbc.M111.319202	http://dx.doi.org/10.1074/jbc.M111.319202			16	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	974EF	22500029	Green Published, hybrid			2022-12-25	WOS:000306411900080
J	Garcia-Ruiz, I; Solis-Munoz, P; Gomez-Izquierdo, E; Munoz-Yague, MT; Valverde, AM; Solis-Herruzo, JA				Garcia-Ruiz, Inmaculada; Solis-Munoz, Pablo; Gomez-Izquierdo, Erica; Teresa Munoz-Yaguee, Maria; Valverde, Angela M.; Solis-Herruzo, Jose A.			Protein-tyrosine Phosphatases Are Involved in Interferon Resistance Associated with Insulin Resistance in HepG2 Cells and Obese Mice	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							CHRONIC HEPATITIS-C; NECROSIS-FACTOR-ALPHA; METALLOPROTEINASE-13 GENE-EXPRESSION; STIMULATED JAK/STAT PATHWAY; NEGATIVE REGULATOR; PLUS RIBAVIRIN; OB/OB MICE; METFORMIN; RECEPTOR; PTP1B	Insulin resistance is a risk factor for non-response to interferon/ribavirin therapy in patients with chronic hepatitis C. The aim of this study was to determine the role played by protein-tyrosine phosphatases (PTPs) in the absence of interferon-alpha (IFN alpha) response associated with insulin resistance. We induced insulin resistance by silencing IRS-2 or by treating HepG2 cells with tumor necrosis factor-alpha (TNF alpha) and analyzed insulin response by evaluating Akt phosphorylation and IFN alpha response by measuring Stat-1 tyrosine phosphorylation and 2',5'-oligoadenylate synthase and myxovirus resistance gene expression. The response to IFN alpha was also measured in insulin-resistant obese mice (high fat diet and ob/ob mice) untreated and treated with metformin. Silencing IRS-2 mRNA induces insulin resistance and inhibits IFN alpha response. Likewise, TNF alpha suppresses insulin and IFN alpha response. Treatment of cells with pervanadate and knocking down PTP-1B restores insulin and IFN alpha response. Both silencing IRS-2 and TNF alpha treatment increase PTP and PTP-1B activity. Metformin inhibits PTP and improves IFN alpha response in insulin-resistant cells. Insulin-resistant ob/ob mice have increased PTP-1B gene expression and activity in the liver and do not respond to IFN alpha administration. Treatment with metformin improves this response. In HepG2 cells, insulin resistance provokes IFN alpha resistance, which is associated with an increased PTP-1B activity in the liver. Inhibition of PTP-1B activity with pervanadate and metformin or knocking down PTP-1B reestablishes IFN alpha response. Likewise, metformin decreases PTP-1B activity and improves response to IFN alpha in insulin-resistant obese mice. The use of PTP-1B inhibitors may improve the response to IFN alpha/ribavirin therapy.	[Garcia-Ruiz, Inmaculada; Gomez-Izquierdo, Erica; Teresa Munoz-Yaguee, Maria; Solis-Herruzo, Jose A.] Univ Complutense, Res Inst, Univ Hosp 12 Octubre, Sch Med, Madrid 28041, Spain; [Solis-Munoz, Pablo] Kings Coll Hosp London, Inst Liver Studies, London SE5 9RS, England; [Valverde, Angela M.] Inst Salud Carlos III, Ctr Invest Biomed Red Diabet & Enfermedad Metab A, Madrid 28029, Spain; [Valverde, Angela M.] Univ Autonoma Madrid, Inst Invest Biomed Alberto Sols, Consejo Super Invest Cient, Madrid 28029, Spain	Complutense University of Madrid; Hospital Universitario 12 de Octubre; King's College Hospital NHS Foundation Trust; King's College Hospital; University of London; King's College London; CIBER - Centro de Investigacion Biomedica en Red; CIBERDEM; Instituto de Salud Carlos III; Autonomous University of Madrid; Consejo Superior de Investigaciones Cientificas (CSIC); CSIC - Instituto de Investigaciones Biomedicas Alberto Sols (IIBM)	Solis-Herruzo, JA (corresponding author), Hosp 12 Octubre, Ctr Invest, Ave Cordoba S-N, E-28041 Madrid, Spain.	jsolis.hdoc@salud.madrid.org	Solis-Muñoz, Pablo/N-5955-2017; García-Ruiz, Inmaculada/G-8204-2015	Solis-Muñoz, Pablo/0000-0002-5550-1350; García-Ruiz, Inmaculada/0000-0003-4185-8524; Martinez Valverde, Angela/0000-0003-1192-9045	Fundacion Mutua Madrilena; "Fondo de Investigacion Sanitaria", Spain [PI07/0052;PI10/0312]	Fundacion Mutua Madrilena(Instituto de Salud Carlos III); "Fondo de Investigacion Sanitaria", Spain(Instituto de Salud Carlos III)	This study was supported in part by Grants from the "Fundacion Mutua Madrilena" and from the "Fondo de Investigacion Sanitaria" (PI07/0052; PI10/0312), Spain.	AHMAD F, 1995, METABOLISM, V44, P1175, DOI 10.1016/0026-0495(95)90012-8; Andujar-Plata P, 2012, DIABETES RES CLIN PR, V95, P1, DOI 10.1016/j.diabres.2011.09.022; Bernsmeier C, 2008, J HEPATOL, V49, P429, DOI 10.1016/j.jhep.2008.04.007; Brackett CC, 2010, J AM PHARM ASSOC, V50, P407, DOI 10.1331/JAPhA.2010.08090; Bressler BL, 2003, HEPATOLOGY, V38, P639, DOI 10.1053/jhep.2003.50350; CHEN J, 1994, J BIOL CHEM, V269, P7957; Chua SC, 1996, SCIENCE, V271, P994, DOI 10.1126/science.271.5251.994; DAVID M, 1995, MOL CELL BIOL, V15, P7050; Diaz-Sanjuan T, 2009, J HEPATOL, V50, P128, DOI 10.1016/j.jhep.2008.07.034; Duong FHT, 2006, HEPATOLOGY, V43, P796, DOI 10.1002/hep.21116; Elchebly M, 1999, SCIENCE, V283, P1544, DOI 10.1126/science.283.5407.1544; Emanuelli B, 2001, J BIOL CHEM, V276, P47944, DOI 10.1074/jbc.M104602200; Emslie-Smith AM, 2001, DIABETIC MED, V18, P483, DOI 10.1046/j.1464-5491.2001.00509.x; Franceschini L, 2011, HEPATOLOGY, V54, P484, DOI 10.1002/hep.24394; Garcia-Ruiz I, 2006, HEPATOLOGY, V44, P581, DOI 10.1002/hep.21313; GIN H, 1985, METABOLISM, V34, P923, DOI 10.1016/0026-0495(85)90139-8; Gonzalez-Rodriguez A, 2007, ENDOCRINOLOGY, V148, P594, DOI 10.1210/en.2006-0644; Gonzalez-Rodriguez A, 2010, DIABETES, V59, P588, DOI 10.2337/db09-0796; Gum RJ, 2003, DIABETES, V52, P21, DOI 10.2337/diabetes.52.1.21; Gunton JE, 2003, J CLIN ENDOCR METAB, V88, P1323, DOI 10.1210/jc.2002-021394; Holland W, 2004, BIOCHEM PHARMACOL, V67, P2081, DOI 10.1016/j.bcp.2004.02.016; Hong F, 2001, FASEB J, V15, P1595, DOI 10.1096/fj.00-0908fje; Huyer G, 1997, J BIOL CHEM, V272, P843, DOI 10.1074/jbc.272.2.843; Jacobson IM, 2007, HEPATOLOGY, V46, P971, DOI 10.1002/hep.21932; Kenner KA, 1996, J BIOL CHEM, V271, P19810, DOI 10.1074/jbc.271.33.19810; Lang A, 2000, AM J PHYSIOL-GASTR L, V279, pG1333, DOI 10.1152/ajpgi.2000.279.6.G1333; Larrea E, 1996, HEPATOLOGY, V23, P210, DOI 10.1002/hep.510230203; Liu B, 2004, NAT IMMUNOL, V5, P891, DOI 10.1038/ni1104; Lu XQ, 2008, BLOOD, V112, P4098, DOI 10.1182/blood-2008-03-148726; Mashimo T, 2003, GENOMICS, V82, P537, DOI 10.1016/S0888-7543(03)00176-9; Meyer T, 2004, EUR J BIOCHEM, V271, P4606, DOI 10.1111/j.1432-1033.2004.04423.x; Myers MP, 2001, J BIOL CHEM, V276, P47771, DOI 10.1074/jbc.C100583200; Nieto-Vazquez I, 2007, DIABETES, V56, P404, DOI 10.2337/db06-0989; O'Shea JJ, 2002, CELL, V109, pS121, DOI 10.1016/S0092-8674(02)00701-8; Peraldi P, 1998, MOL CELL BIOCHEM, V182, P169, DOI 10.1023/A:1006865715292; Ravichandran LV, 2001, MOL ENDOCRINOL, V15, P1768, DOI 10.1210/me.15.10.1768; Romero-Gomez M, 2005, GASTROENTEROLOGY, V128, P636, DOI 10.1053/j.gastro.2004.12.049; Romero-Gomez M, 2009, HEPATOLOGY, V50, P1702, DOI 10.1002/hep.23206; Sakai I, 2002, BLOOD, V100, P2926, DOI 10.1182/blood-2002-01-0073; Solis-Herruzo JA, 1999, J BIOL CHEM, V274, P30919, DOI 10.1074/jbc.274.43.30919; Song MM, 1998, J BIOL CHEM, V273, P35056, DOI 10.1074/jbc.273.52.35056; Stith BJ, 1996, ENDOCRINOLOGY, V137, P2990, DOI 10.1210/en.137.7.2990; Taguchi A, 2008, ANNU REV PHYSIOL, V70, P191, DOI 10.1146/annurev.physiol.70.113006.100533; Valverde AM, 2003, DIABETES, V52, P2239, DOI 10.2337/diabetes.52.9.2239; Walsh MJ, 2006, GUT, V55, P529, DOI 10.1136/gut.2005.069674; Xu HM, 2008, MOL IMMUNOL, V45, P3545, DOI 10.1016/j.molimm.2008.05.006; You M, 1999, MOL CELL BIOL, V19, P2416, DOI 10.1128/mcb.19.3.2416; Zabolotny JM, 2008, J BIOL CHEM, V283, P14230, DOI 10.1074/jbc.M800061200; ZHANG ZY, 1993, ANAL BIOCHEM, V211, P7, DOI 10.1006/abio.1993.1224	49	15	15	1	19	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JUN 1	2012	287	23					19564	19573		10.1074/jbc.M112.342709	http://dx.doi.org/10.1074/jbc.M112.342709			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	974EF	22493491	Green Published, hybrid			2022-12-25	WOS:000306411900068
J	Jang, SY; Kang, HT; Hwang, ES				Jang, So-young; Kang, Hyun Tae; Hwang, Eun Seong			Nicotinamide-induced Mitophagy EVENT MEDIATED BY HIGH NAD(+)/NADH RATIO AND SIRT1 PROTEIN ACTIVATION	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							SMALL-MOLECULE ACTIVATORS; LIFE-SPAN; CALORIE RESTRICTION; MITOCHONDRIAL BIOGENESIS; CELLULAR SENESCENCE; AMPK ACTIVATION; HUMAN-CELLS; AUTOPHAGY; FUSION; METABOLISM	Active autophagy coupled with rapid mitochondrial fusion and fission constitutes an important mitochondrial quality control mechanism and is critical to cellular health. In our previous studies, we found that exposure of cells to nicotinamide causes a decrease in mitochondrial content and an increase in mitochondrial membrane potential (MMP) by activating autophagy and inducing mitochondrial fragmentation. Here, we present evidence to show that the effect of nicotinamide is mediated through an increase of the [NAD(+)]/[NADH] ratio and the activation of SIRT1, an NAD(+)-dependent deacetylase that plays a role in autophagy flux. The [NAD(+)]/[NADH] ratio was inversely correlated with the mitochondrial content, and an increase in the ratio by the mobilization of the malate-aspartate shuttle resulted in autophagy activation and mitochondrial transformation from lengthy filaments to short dots. Furthermore, treatment of cells with SIRT1 activators, fisetin or SRT1720, induced similar changes in the mitochondrial content. Importantly, the activators induced mitochondrial fragmentation only when SIRT1 expression was intact. Meanwhile, MMP did not increase when the cells were treated with the activators, suggesting that the change in MMP is not induced by the mitochondrial turnover per se and that elevation of the [NAD(+)]/[NADH] ratio may activate additional mechanisms that cause MMP augmentation. Together, our results indicate that a metabolic state resulting in an elevated [NAD(+)]/[NADH] ratio can modulate mitochondrial quantity and quality via pathways that may include SIRT1-mediated mitochondrial autophagy.	[Jang, So-young; Kang, Hyun Tae; Hwang, Eun Seong] Univ Seoul, Dept Life Sci, Seoul 130743, South Korea	University of Seoul	Hwang, ES (corresponding author), Univ Seoul, Dept Life Sci, Seoul 130743, South Korea.	eshwang@uos.ac.kr		Hwang, Eun Seong/0000-0001-8580-8444	Mid-career Researcher Program NRF [2009-0086432]; MEST	Mid-career Researcher Program NRF(National Research Foundation of Korea); MEST(Ministry of Education, Science & Technology (MEST), Republic of Korea)	This work was supported by Mid-career Researcher Program NRF Grant 2009-0086432 funded by the MEST.	Bach D, 2003, J BIOL CHEM, V278, P17190, DOI 10.1074/jbc.M212754200; Baur JA, 2010, BBA-PROTEINS PROTEOM, V1804, P1626, DOI 10.1016/j.bbapap.2009.10.025; Bitterman KJ, 2002, J BIOL CHEM, V277, P45099, DOI 10.1074/jbc.M205670200; Blander G, 2004, ANNU REV BIOCHEM, V73, P417, DOI 10.1146/annurev.biochem.73.011303.073651; Brunk UT, 2002, EUR J BIOCHEM, V269, P1996, DOI 10.1046/j.1432-1033.2002.02869.x; Burnett C, 2011, NATURE, V477, P482, DOI 10.1038/nature10296; Chen CJ, 2009, BIOCHEM BIOPH RES CO, V378, P389, DOI 10.1016/j.bbrc.2008.11.110; Chen HC, 2010, CELL, V141, P280, DOI 10.1016/j.cell.2010.02.026; Frank S, 2001, DEV CELL, V1, P515, DOI 10.1016/S1534-5807(01)00055-7; Fu XA, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0002009; Funk JA, 2010, J PHARMACOL EXP THER, V333, P593, DOI 10.1124/jpet.109.161992; Giannakou ME, 2004, TRENDS CELL BIOL, V14, P408, DOI 10.1016/j.tcb.2004.07.006; Gomes LC, 2011, NAT CELL BIOL, V13, P589, DOI 10.1038/ncb2220; Guarente L, 2008, CELL, V132, P171, DOI 10.1016/j.cell.2008.01.007; Hariharan N, 2010, CIRC RES, V107, P1470, DOI 10.1161/CIRCRESAHA.110.227371; Hasmann M, 2003, CANCER RES, V63, P7436; Herranz D, 2010, NAT REV CANCER, V10, P819, DOI 10.1038/nrc2962; Howitz KT, 2003, NATURE, V425, P191, DOI 10.1038/nature01960; Humphries KM, 2006, FREE RADICAL RES, V40, P1239, DOI 10.1080/10715760600913184; Hwang ES, 2009, CELL MOL LIFE SCI, V66, P2503, DOI 10.1007/s00018-009-0034-2; Imai S, 2009, CURR PHARM DESIGN, V15, P20, DOI 10.2174/138161209787185814; Ishihara N, 2004, J CELL SCI, V117, P6535, DOI 10.1242/jcs.01565; JACKSON TM, 1995, J NUTR, V125, P1455; Jendrach M, 2005, MECH AGEING DEV, V126, P813, DOI 10.1016/j.mad.2005.03.002; Kang HT, 2006, AGING CELL, V5, P423, DOI 10.1111/j.1474-9726.2006.00234.x; Kang HT, 2009, AGING CELL, V8, P426, DOI 10.1111/j.1474-9726.2009.00487.x; Kloting N, 2005, EXP GERONTOL, V40, P878, DOI 10.1016/j.exger.2005.07.004; Kume S, 2010, J CLIN INVEST, V120, P1043, DOI 10.1172/JCI41376; Lagouge M, 2006, CELL, V127, P1109, DOI 10.1016/j.cell.2006.11.013; Lee HC, 2002, J BIOMED SCI, V9, P517, DOI 10.1007/BF02254978; Lee IH, 2008, P NATL ACAD SCI USA, V105, P3374, DOI 10.1073/pnas.0712145105; Lee S, 2007, J BIOL CHEM, V282, P22977, DOI 10.1074/jbc.M700679200; Liesa M, 2009, PHYSIOL REV, V89, P799, DOI 10.1152/physrev.00030.2008; Lin SJ, 2004, GENE DEV, V18, P12, DOI 10.1101/gad.1164804; Liu YB, 2002, J NEUROCHEM, V80, P780, DOI 10.1046/j.0022-3042.2002.00744.x; Maiese K, 2009, MOLECULES, V14, P3446, DOI 10.3390/molecules14093446; Milne JC, 2007, NATURE, V450, P712, DOI 10.1038/nature06261; Milner J, 2009, CURR PHARM DESIGN, V15, P39, DOI 10.2174/138161209787185841; Morselli E, 2011, J CELL BIOL, V192, P615, DOI 10.1083/jcb.201008167; Morselli E, 2010, AUTOPHAGY, V6, P186, DOI 10.4161/auto.6.1.10817; Nelson D. L., 2000, LEHNINGER PRINCIPLES, P685; Ong SB, 2010, CARDIOVASC RES, V88, P16, DOI 10.1093/cvr/cvq237; Park JW, 1998, INT J CARDIOL, V65, P139, DOI 10.1016/S0167-5273(98)00117-X; Puissant A, 2010, CANCER RES, V70, P1042, DOI 10.1158/0008-5472.CAN-09-3537; Rodgers JT, 2005, NATURE, V434, P113, DOI 10.1038/nature03354; Rongvaux A, 2003, BIOESSAYS, V25, P683, DOI 10.1002/bies.10297; Salminen A, 2009, CELL SIGNAL, V21, P1356, DOI 10.1016/j.cellsig.2009.02.014; Sauve AA, 2006, ANNU REV BIOCHEM, V75, P435, DOI 10.1146/annurev.biochem.74.082803.133500; Simonsen A, 2008, AUTOPHAGY, V4, P176, DOI 10.4161/auto.5269; Tanno M, 2007, J BIOL CHEM, V282, P6823, DOI 10.1074/jbc.M609554200; Twig G, 2008, EMBO J, V27, P433, DOI 10.1038/sj.emboj.7601963; Vaziri H, 2001, CELL, V107, P149, DOI 10.1016/S0092-8674(01)00527-X; WILLIAMSON DH, 1967, BIOCHEM J, V103, P514, DOI 10.1042/bj1030514; Yoon YS, 2006, J CELL PHYSIOL, V209, P468, DOI 10.1002/jcp.20753; Yoon YS, 2005, ONCOGENE, V24, P1895, DOI 10.1038/sj.onc.1208262; Zhang T, 2009, J BIOL CHEM, V284, P20408, DOI 10.1074/jbc.M109.016469	56	163	169	1	21	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JUN 1	2012	287	23					19304	19314		10.1074/jbc.M112.363747	http://dx.doi.org/10.1074/jbc.M112.363747			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	974EF	22493485	Green Published, hybrid			2022-12-25	WOS:000306411900040
J	Sharotri, V; Collier, DM; Olson, DR; Zhou, RF; Snyder, PM				Sharotri, Vikas; Collier, Daniel M.; Olson, Diane R.; Zhou, Ruifeng; Snyder, Peter M.			Regulation of Epithelial Sodium Channel Trafficking by Proprotein Convertase Subtilisin/Kexin Type 9 (PCSK9)	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							SURFACE LIQUID VOLUME; NA+ CHANNEL; GAMMA-SUBUNIT; CYSTIC-FIBROSIS; CELL-SURFACE; SELF-INHIBITION; SECRETED PCSK9; LDL RECEPTOR; ENAC; DEGRADATION	The epithelial Na+ channel (ENaC) is critical for Na+ homeostasis and blood pressure control. Defects in its regulation cause inherited forms of hypertension and hypotension. Previous work found that ENaC gating is regulated by proteases through cleavage of the extracellular domains of the alpha and gamma subunits. Here we tested the hypothesis that ENaC is regulated by proprotein convertase subtilisin/kexin type 9 (PCSK9), a protease that modulates the risk of cardiovascular disease. PCSK9 reduced ENaC current in Xenopus oocytes and in epithelia. This occurred through a decrease in ENaC protein at the cell surface and in the total cellular pool, an effect that did not require the catalytic activity of PCSK9. PCSK9 interacted with all three ENaC subunits and decreased their trafficking to the cell surface by increasing proteasomal degradation. In contrast to its previously reported effects on the LDL receptor, PCSK9 did not alter ENaC endocytosis or degradation of the pool of ENaC at the cell surface. These results support a role for PCSK9 in the regulation of ENaC trafficking in the biosynthetic pathway, likely by increasing endoplasmic reticulum-associated degradation. By reducing ENaC channel number, PCSK9 could modulate epithelial Na+ absorption, a major contributor to blood pressure control.	[Snyder, Peter M.] Univ Iowa, Carver Coll Med, Dept Internal Med, Iowa City, IA 52242 USA; Univ Iowa, Carver Coll Med, Dept Mol Physiol & Biophys, Iowa City, IA 52242 USA	University of Iowa; University of Iowa	Snyder, PM (corresponding author), Univ Iowa, Carver Coll Med, Dept Internal Med, 371 EMRB, Iowa City, IA 52242 USA.	peter-snyder@uiowa.edu	Collier, Daniel/GVU-0199-2022		National Institutes of Health [HL058812]; American Heart Association; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [T32HL007121, R29HL058812, R01HL058812] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); American Heart Association(American Heart Association); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))	This work was supported, in whole or in part, by National Institutes of Health Grant HL058812 (to P. M. S.). This work was also supported by fellowship grants from the American Heart Association (to V. S. and D. M. C.).	Adebamiro A, 2007, J GEN PHYSIOL, V130, P611, DOI 10.1085/jgp.200709781; Benjannet S, 2004, J BIOL CHEM, V279, P48865, DOI 10.1074/jbc.M409699200; Bruns JB, 2007, J BIOL CHEM, V282, P6153, DOI 10.1074/jbc.M610636200; Caldwell RA, 2005, AM J PHYSIOL-LUNG C, V288, pL813, DOI 10.1152/ajplung.00435.2004; Chang SS, 1996, NAT GENET, V12, P248, DOI 10.1038/ng0396-248; Chraibi A, 2002, J GEN PHYSIOL, V120, P133, DOI 10.1085/jgp.20028612; Cohen JC, 2006, NEW ENGL J MED, V354, P1264, DOI 10.1056/NEJMoa054013; Collier DM, 2011, J BIOL CHEM, V286, P6027, DOI 10.1074/jbc.M110.198127; Collier DM, 2009, J BIOL CHEM, V284, P29320, DOI 10.1074/jbc.M109.046771; Collier DM, 2009, J BIOL CHEM, V284, P792, DOI 10.1074/jbc.M806954200; Essalmani R, 2011, J BIOL CHEM, V286, P4257, DOI 10.1074/jbc.M110.192104; Firsov D, 1996, P NATL ACAD SCI USA, V93, P15370, DOI 10.1073/pnas.93.26.15370; Frindt G, 2001, AM J PHYSIOL-RENAL, V280, pF112, DOI 10.1152/ajprenal.2001.280.1.F112; Horton JD, 2007, TRENDS BIOCHEM SCI, V32, P71, DOI 10.1016/j.tibs.2006.12.008; Hughey RP, 2003, J BIOL CHEM, V278, P37073, DOI 10.1074/jbc.M307003200; Kabra R, 2008, J BIOL CHEM, V283, P6033, DOI 10.1074/jbc.M708555200; Kleyman TR, 2009, J BIOL CHEM, V284, P20447, DOI 10.1074/jbc.R800083200; Knight KK, 2006, P NATL ACAD SCI USA, V103, P2805, DOI 10.1073/pnas.0511184103; Knight KK, 2008, J BIOL CHEM, V283, P27477, DOI 10.1074/jbc.M804176200; Kwon HJ, 2008, P NATL ACAD SCI USA, V105, P1820, DOI 10.1073/pnas.0712064105; Lagace TA, 2006, J CLIN INVEST, V116, P2995, DOI 10.1172/JCI29383; Lifton RP, 1996, SCIENCE, V272, P676, DOI 10.1126/science.272.5262.676; Mall M, 2004, NAT MED, V10, P487, DOI 10.1038/nm1028; Masilamani S, 1999, J CLIN INVEST, V104, pR19, DOI 10.1172/JCI7840; Maxwell KN, 2005, CURR OPIN LIPIDOL, V16, P167, DOI 10.1097/01.mol.0000162321.31925.a3; Maxwell KN, 2005, P NATL ACAD SCI USA, V102, P2069, DOI 10.1073/pnas.0409736102; MCDONALD FJ, 1994, AM J PHYSIOL, V266, pL728, DOI 10.1152/ajplung.1994.266.6.L728; MCDONALD FJ, 1995, AM J PHYSIOL-CELL PH, V268, pC1157, DOI 10.1152/ajpcell.1995.268.5.C1157; McNutt MC, 2007, J BIOL CHEM, V282, P20799, DOI 10.1074/jbc.C700095200; Myerburg MM, 2006, J BIOL CHEM, V281, P27942, DOI 10.1074/jbc.M606449200; Nassoury N, 2007, TRAFFIC, V8, P718, DOI 10.1111/j.1600-0854.2007.00562.x; Park SW, 2004, J BIOL CHEM, V279, P50630, DOI 10.1074/jbc.M410077200; Passero CJ, 2008, J BIOL CHEM, V283, P36586, DOI 10.1074/jbc.M805676200; Poirier S, 2008, J BIOL CHEM, V283, P2363, DOI 10.1074/jbc.M708098200; Poirier S, 2009, J BIOL CHEM, V284, P28856, DOI 10.1074/jbc.M109.037085; Schild L, 2004, REV PHYSIOL BIOCH P, V151, P93, DOI 10.1007/s10254-004-0023-7; Seidah NG, 2008, INT J BIOCHEM CELL B, V40, P1111, DOI 10.1016/j.biocel.2008.01.030; Seidah NG, 2007, J MOL MED, V85, P685, DOI 10.1007/s00109-007-0172-7; Seidah NG, 2003, P NATL ACAD SCI USA, V100, P928, DOI 10.1073/pnas.0335507100; Snyder PM, 2009, SCI SIGNAL, V2, DOI 10.1126/scisignal.279pe41; Snyder PM, 2005, ENDOCRINOLOGY, V146, P5079, DOI 10.1210/en.2005-0894; Snyder PM, 2004, J BIOL CHEM, V279, P45753, DOI 10.1074/jbc.M407858200; Snyder PM, 1999, J BIOL CHEM, V274, P28484, DOI 10.1074/jbc.274.40.28484; Snyder PM, 2000, J CLIN INVEST, V105, P45, DOI 10.1172/JCI7869; SNYDER PM, 1995, CELL, V83, P969, DOI 10.1016/0092-8674(95)90212-0; Snyder PM, 2000, J GEN PHYSIOL, V116, P781, DOI 10.1085/jgp.116.6.781; Svenningsen P, 2009, J AM SOC NEPHROL, V20, P299, DOI 10.1681/ASN.2008040364; SWICK AG, 1992, P NATL ACAD SCI USA, V89, P1812, DOI 10.1073/pnas.89.5.1812; Tarran R, 2006, J GEN PHYSIOL, V127, P591, DOI 10.1085/jgp.200509468; Vallet V, 1997, NATURE, V389, P607, DOI 10.1038/39329; Yamamoto T, 2011, J BIOL CHEM, V286, P5464, DOI 10.1074/jbc.M110.199042; Zhang DW, 2007, J BIOL CHEM, V282, P18602, DOI 10.1074/jbc.M702027200; Zhou RF, 2007, J BIOL CHEM, V282, P20207, DOI 10.1074/jbc.M611329200	53	70	75	0	3	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JUN 1	2012	287	23					19266	19274		10.1074/jbc.M112.363382	http://dx.doi.org/10.1074/jbc.M112.363382			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	974EF	22493497	Green Published, hybrid			2022-12-25	WOS:000306411900036
J	Greve, C; Gimnich, F; Hutterer, R; Misof, B; Haase, M				Greve, Carola; Gimnich, France; Hutterer, Rainer; Misof, Bernhard; Haase, Martin			Radiating on Oceanic Islands: Patterns and Processes of Speciation in the Land Snail Genus Theba (Risso 1826)	PLOS ONE			English	Article							MULTILOCUS GENOTYPE DATA; PHYLOGENETIC ANALYSIS; SYMPATRIC SPECIATION; TERRESTRIAL FAUNA; CANARY-ISLANDS; DIVERSIFICATION; INFERENCE; EVOLUTION; AFLP; COLONIZATION	Island radiations have played a major role in shaping our current understanding of allopatric, sympatric and parapatric speciation. However, the fact that species divergence correlates with island size emphasizes the importance of geographic isolation (allopatry) in speciation. Based on molecular and morphological data, we investigated the diversification of the land snail genus Theba on the two Canary Islands of Lanzarote and Fuerteventura. Due to the geological history of both islands, this study system provides ideal conditions to investigate the interplay of biogeography, dispersal ability and differentiation in generating species diversity. Our analyses demonstrated extensive cryptic diversification of Theba on these islands, probably driven mainly by non-adaptive allopatric differentiation and secondary gene flow. In a few cases, we observed a complete absence of gene flow among sympatrically distributed forms suggesting an advanced stage of speciation. On the Jandia peninsula genome scans suggested genotype-environment associations and potentially adaptive diversification of two closely related Theba species to different ecological environments. We found support for the idea that genetic differentiation was enhanced by divergent selection in different environments. The diversification of Theba on both islands is therefore best explained by a mixture of non-adaptive and adaptive speciation, promoted by ecological and geomorphological factors.	[Greve, Carola; Gimnich, France; Hutterer, Rainer; Misof, Bernhard] Zool Forsch Museum Alexander Koenig, Bonn, Germany; [Haase, Martin] Univ Greifswald, Inst Zool, Greifswald, Germany	Zoologisches Forschungsmuseum Alexander Koenig (ZFMK); Ernst Moritz Arndt Universitat Greifswald	Greve, C (corresponding author), Zool Forsch Museum Alexander Koenig, Bonn, Germany.	c.greve@uni-bonn.de	Haase, Martin/G-5034-2012	Haase, Martin/0000-0002-9281-8752	Deutsche Forschungsgemeinschaft (DFG) [MI 649/7-1, HU 430/2-2]; Alexander Koenig Gesellschaft (AKG)	Deutsche Forschungsgemeinschaft (DFG)(German Research Foundation (DFG)); Alexander Koenig Gesellschaft (AKG)	This work was financially supported by grants of the Deutsche Forschungsgemeinschaft (DFG MI 649/7-1 and DFG HU 430/2-2) and the Alexander Koenig Gesellschaft (AKG). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Acosta J, 2003, MAR GEOPHYS RES, V24, P1, DOI 10.1007/s11001-004-1513-3; Bank RA, 2002, COLLECTANEA MALACOLO, P89; Beaumont MA, 2004, MOL ECOL, V13, P969, DOI 10.1111/j.1365-294X.2004.02125.x; Bierne N, 2011, MOL ECOL, V20, P2044, DOI 10.1111/j.1365-294X.2011.05080.x; Bonin A, 2007, MOL ECOL, V16, P3737, DOI 10.1111/j.1365-294X.2007.03435.x; Bonin A, 2004, MOL ECOL, V13, P3261, DOI 10.1111/j.1365-294X.2004.02346.x; Bonnet E, 2002, J STAT SOFTW, V7, P1, DOI DOI 10.18637/JSS.V007.I10; Bookstein F.L., 1991, MORPHOMETRIC TOOLS L; Butlin RK, 2010, GENETICA, V138, P409, DOI 10.1007/s10709-008-9321-3; Carracedo JC, 2002, CLASSIC GEOLOGY EURO; Carracedo JC, VOLCANES ISLAS CANAR; COELLO J, 1992, J VOLCANOL GEOTH RES, V53, P251, DOI 10.1016/0377-0273(92)90085-R; Cowie RH, 2008, PHILOS T R SOC B, V363, P3363, DOI 10.1098/rstb.2008.0061; Coyne JA, 2004, SPECIATION; Davison A, 2000, BIOL J LINN SOC, V70, P697, DOI 10.1006/bijl.1999.0426; Dayrat B, 2011, MOL PHYLOGENET EVOL, V59, P425, DOI 10.1016/j.ympev.2011.02.014; Dyer RJ, 2004, MOL ECOL, V13, P1713, DOI 10.1111/j.1365-294X.2004.02177.x; Ehrich D, 2006, MOL ECOL NOTES, V6, P603, DOI 10.1111/j.1471-8286.2006.01380.x; Emerson BC, 2002, MOL ECOL, V11, P951, DOI 10.1046/j.1365-294X.2002.01507.x; Evanno G, 2005, MOL ECOL, V14, P2611, DOI 10.1111/j.1365-294X.2005.02553.x; Excoffier L, 2010, MOL ECOL RESOUR, V10, P564, DOI 10.1111/j.1755-0998.2010.02847.x; Falush D, 2003, GENETICS, V164, P1567; Falush D, 2007, MOL ECOL NOTES, V7, P574, DOI 10.1111/j.1471-8286.2007.01758.x; FERNANDEZPALACIOS JM, 1993, ECOGRAPHY, V16, P31, DOI 10.1111/j.1600-0587.1993.tb00056.x; Foll M, 2008, GENETICS, V180, P977, DOI 10.1534/genetics.108.092221; Folmer O., 1994, Molecular Marine Biology and Biotechnology, V3, P294; Gavrilets Sergey, 2004, P1; GITTENBERGER E, 1991, BIOL J LINN SOC, V43, P263, DOI 10.1111/j.1095-8312.1991.tb00598.x; Gittenberger E, 1987, ZOOLOGISCHE VERHANDE, V241, P3; Glor RE, 2003, EVOLUTION, V57, P2383; Greve C, 2010, MOL PHYLOGENET EVOL, V57, P572, DOI 10.1016/j.ympev.2010.08.021; Haase M, 2009, J ZOOL SYST EVOL RES, V47, P105, DOI 10.1111/j.1439-0469.2008.00488.x; Hall T.A., 1999, NUCL ACIDS S SERIES, V41, P95, DOI [DOI 10.1021/BK-1999-0734.CH008, citeulike-article-id:691774, 10.12691/ajmr-6-4-3]; Hammer Oyvind, 2001, Palaeontologia Electronica, V4, pUnpaginated; Hebert PDN, 2003, P ROY SOC B-BIOL SCI, V270, pS96, DOI 10.1098/rsbl.2003.0025; Hendry AP, 2007, FUNCT ECOL, V21, P455, DOI 10.1111/j.1365-2435.2007.01240.x; Herder F, 2008, EVOLUTION, V62, P2178, DOI 10.1111/j.1558-5646.2008.00447.x; Hey J, 2004, MOL ECOL, V13, P909, DOI 10.1046/j.1365-294X.2003.02031.x; Huelsenbeck JP, 2001, BIOINFORMATICS, V17, P754, DOI 10.1093/bioinformatics/17.8.754; Hutterer R, 1997, HELDIA 4 SONDERH, V5, P72; Juan C, 1998, P ROY SOC B-BIOL SCI, V265, P135, DOI 10.1098/rspb.1998.0274; Juan C, 2000, TRENDS ECOL EVOL, V15, P104, DOI 10.1016/S0169-5347(99)01776-0; Koopman WJM, 2005, SYST BIOL, V54, P197, DOI 10.1080/10635150590924181; Kozak KH, 2006, P ROY SOC B-BIOL SCI, V273, P539, DOI 10.1098/rspb.2005.3326; Losos JB, 2009, NATURE, V457, P830, DOI 10.1038/nature07893; Luikart G, 2003, NAT REV GENET, V4, P981, DOI 10.1038/nrg1226; MANTEL N, 1967, CANCER RES, V27, P209; Meco J, 2007, GLOBAL PLANET CHANGE, V57, P222, DOI 10.1016/j.gloplacha.2006.11.040; Meier R, 2006, SYST BIOL, V55, P715, DOI 10.1080/10635150600969864; Meudt HM, 2007, TRENDS PLANT SCI, V12, P106, DOI 10.1016/j.tplants.2007.02.001; NEI M, 1979, P NATL ACAD SCI USA, V76, P5269, DOI 10.1073/pnas.76.10.5269; Nosil P, 2008, EVOLUTION, V62, P316, DOI 10.1111/j.1558-5646.2007.00299.x; Nylander J. A. A., 2004, MRMODELTEST V2; Parent CE, 2008, PHILOS T R SOC B, V363, P3347, DOI 10.1098/rstb.2008.0118; Parent CE, 2006, EVOLUTION, V60, P2311, DOI 10.1554/06-366.1; Perez-Figueroa A, 2010, J EVOLUTION BIOL, V23, P2267, DOI 10.1111/j.1420-9101.2010.02093.x; Pfenninger M, 2002, EVOLUTION, V56, P1776, DOI 10.1111/j.0014-3820.2002.tb00191.x; Pompanon F, 2005, NAT REV GENET, V6, P847, DOI 10.1038/nrg1707; Pritchard JK, 2000, GENETICS, V155, P945; Rambaut A, 2008, TRACER V1 4 1; Risso A, 1826, HIST NATURELLE PRIN; Rohlf FJ, 2004, TPSDIG DIGITIZE LAND; Rohlf FJ, 2004, TPSUTIL FILE UTILITY; Rundell RJ, 2009, TRENDS ECOL EVOL, V24, P394, DOI 10.1016/j.tree.2009.02.007; Schilthuizen M, 2010, J ZOOL, V282, P191, DOI 10.1111/j.1469-7998.2010.00729.x; Schluter D, 2009, SCIENCE, V323, P737, DOI 10.1126/science.1160006; SIMON C, 1994, ANN ENTOMOL SOC AM, V87, P651, DOI 10.1093/aesa/87.6.651; Stamatakis A, 2008, SYST BIOL, V57, P758, DOI 10.1080/10635150802429642; Stamatakis A, 2006, BIOINFORMATICS, V22, P2688, DOI 10.1093/bioinformatics/btl446; SWOFFORD DL, 2002, PAUP PHYLOGENETIC AN; Thompson JD, 2002, CURR PROTOC BIOINFOR, DOI DOI 10.1002/0471250953.BI0203S00; Via S, 2001, TRENDS ECOL EVOL, V16, P381, DOI 10.1016/S0169-5347(01)02188-7; Via S, 2009, P NATL ACAD SCI USA, V106, P9939, DOI 10.1073/pnas.0901397106; VOS P, 1995, NUCLEIC ACIDS RES, V23, P4407, DOI 10.1093/nar/23.21.4407; WRIGHT S, 1978, P580; Zelditch ML, 2004, GEOMETRIC MORPHOMETR	76	21	21	0	39	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 6	2012	7	4							e34339	10.1371/journal.pone.0034339	http://dx.doi.org/10.1371/journal.pone.0034339			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	955JA	22493687	Green Published, gold, Green Submitted			2022-12-25	WOS:000305012700029
J	Silva-Rocha, R; de Lorenzo, V				Silva-Rocha, Rafael; de Lorenzo, Victor			A GFP-lacZ Bicistronic Reporter System for Promoter Analysis in Environmental Gram-Negative Bacteria	PLOS ONE			English	Article							STOCHASTIC GENE-EXPRESSION; PSEUDOMONAS-PUTIDA; TRANSCRIPTIONAL REGULATORS; CHROMOSOMAL INSERTION; NOISE-PROPAGATION; TOL PLASMID; BISTABILITY; DEGRADATION; NETWORKS; PATHWAYS	Here, we describe a bicistronic reporter system for the analysis of promoter activity in a variety of Gram-negative bacteria at both the population and single-cell levels. This synthetic genetic tool utilizes an artificial operon comprising the gfp and lacZ genes that are assembled in a suicide vector, which is integrated at specific sites within the chromosome of the target bacterium, thereby creating a monocopy reporter system. This tool was instrumental for the complete in vivo characterization of two promoters, Pb and Pc, that drive the expression of the benzoate and catechol degradation pathways, respectively, of the soil bacterium Pseudomonas putida KT2440. The parameterization of these promoters in a population (using beta-galactosidase assays) and in single cells (using flow cytometry) was necessary to examine the basic numerical features of these systems, such as the basal and maximal levels and the induction kinetics in response to an inducer (benzoate). Remarkably, GFP afforded a view of the process at a much higher resolution compared with standard lacZ tests; changes in fluorescence faithfully reflected variations in the transcriptional regimes of individual bacteria. The broad host range of the vector/reporter platform is an asset for the characterization of promoters in different bacteria, thereby expanding the diversity of genomic chasses amenable to Synthetic Biology methods.	[Silva-Rocha, Rafael; de Lorenzo, Victor] CSIC, Ctr Nacl Biotecnol, Syst Biol Program, Madrid, Spain	Consejo Superior de Investigaciones Cientificas (CSIC); CSIC - Centro Nacional de Biotecnologia (CNB)	Silva-Rocha, R (corresponding author), CSIC, Ctr Nacl Biotecnol, Syst Biol Program, Madrid, Spain.	vdlorenzo@cnb.csic.es	Silva-Rocha, Rafael/H-4929-2012	Silva-Rocha, Rafael/0000-0001-6319-631X; de Lorenzo, Victor/0000-0002-6041-2731	Spanish Ministry of Science and Innovation (MICINN); EU; Autonomous Community of Madrid	Spanish Ministry of Science and Innovation (MICINN)(Ministry of Science and Innovation, Spain (MICINN)Spanish Government); EU(European Commission); Autonomous Community of Madrid	This work was funded by BIO and FEDER CONSOLIDER-INGENIO Program of the Spanish Ministry of Science and Innovation (MICINN), the BACSINE, MICROME and ST-FLOW Contracts of the EU, and the PROMT Program of the Autonomous Community of Madrid. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Balleza E, 2009, FEMS MICROBIOL REV, V33, P133, DOI 10.1111/j.1574-6976.2008.00145.x; Becskei A, 2000, NATURE, V405, P590, DOI 10.1038/35014651; Cagatay T, 2009, CELL, V139, P512, DOI 10.1016/j.cell.2009.07.046; Cases I, 2003, TRENDS MICROBIOL, V11, P248, DOI 10.1016/S0966-842X(03)00103-3; Choi KH, 2005, NAT METHODS, V2, P443, DOI 10.1038/NMETH765; Cowles CE, 2000, J BACTERIOL, V182, P6339, DOI 10.1128/JB.182.22.6339-6346.2000; de las Heras A, 2010, FEMS MICROBIOL REV, V34, P842, DOI 10.1111/j.1574-6976.2010.00238.x; de Lorenzo V, 1992, Curr Opin Biotechnol, V3, P227, DOI 10.1016/0958-1669(92)90097-3; de Lorenzo V, 2008, CURR OPIN BIOTECH, V19, P579, DOI 10.1016/j.copbio.2008.10.004; DELORENZO V, 1991, EMBO J, V10, P1159, DOI 10.1002/j.1460-2075.1991.tb08056.x; DELORENZO V, 1993, J BACTERIOL, V175, P6902, DOI 10.1128/jb.175.21.6902-6907.1993; DELORENZO V, 1990, J BACTERIOL, V172, P6568, DOI 10.1128/jb.172.11.6568-6572.1990; DELORENZO V, 1994, METHOD ENZYMOL, V235, P386; Dublanche Y, 2006, MOL SYST BIOL, V2, DOI 10.1038/msb4100081; Dubnau D, 2006, MOL MICROBIOL, V61, P564, DOI 10.1111/j.1365-2958.2006.05249.x; Elowitz MB, 2002, SCIENCE, V297, P1183, DOI 10.1126/science.1070919; Elowitz MB, 2000, NATURE, V403, P335, DOI 10.1038/35002125; Galvao TC, 2006, CURR OPIN BIOTECH, V17, P34, DOI 10.1016/j.copbio.2005.12.002; Gardner TS, 2000, NATURE, V403, P339, DOI 10.1038/35002131; Graumann PL, 2006, MOL MICROBIOL, V61, P560, DOI 10.1111/j.1365-2958.2006.05264.x; Harwood CS, 1996, ANNU REV MICROBIOL, V50, P553, DOI 10.1146/annurev.micro.50.1.553; Hasty J, 2002, NATURE, V420, P224, DOI 10.1038/nature01257; HERRERO M, 1990, J BACTERIOL, V172, P6557, DOI 10.1128/jb.172.11.6557-6567.1990; Hooshangi S, 2005, P NATL ACAD SCI USA, V102, P3581, DOI 10.1073/pnas.0408507102; Itzkovitz S, 2006, BMC GENOMICS, V7, DOI 10.1186/1471-2164-7-239; Jimenez JI, 2002, ENVIRON MICROBIOL, V4, P824, DOI 10.1046/j.1462-2920.2002.00370.x; KESSLER B, 1992, MOL GEN GENET, V233, P293, DOI 10.1007/BF00587591; KING JMH, 1990, SCIENCE, V249, P778, DOI 10.1126/science.249.4970.778; Konstantinidis KT, 2004, P NATL ACAD SCI USA, V101, P3160, DOI 10.1073/pnas.0308653100; KRISTENSEN CS, 1995, J BACTERIOL, V177, P52, DOI 10.1128/jb.177.1.52-58.1995; KUO MS, 1986, CARBOHYD RES, V156, P173, DOI 10.1016/S0008-6215(00)90109-5; Maamar H, 2005, MOL MICROBIOL, V56, P615, DOI 10.1111/j.1365-2958.2005.04592.x; Martin L, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0007569; Martinez-Antonio A, 2003, CURR OPIN MICROBIOL, V6, P482, DOI 10.1016/j.mib.2003.09.002; McAdams HH, 1999, TRENDS GENET, V15, P65, DOI 10.1016/S0168-9525(98)01659-X; McAdams HH, 2004, NAT REV GENET, V5, P169, DOI 10.1038/nrg1292; McAdams HH, 1997, P NATL ACAD SCI USA, V94, P814, DOI 10.1073/pnas.94.3.814; Miller WG, 1997, GENE, V191, P149, DOI 10.1016/S0378-1119(97)00051-6; Oppenheim AB, 2005, ANNU REV GENET, V39, P409, DOI 10.1146/annurev.genet.39.073003.113656; PARSEK MR, 1992, J BACTERIOL, V174, P7798, DOI 10.1128/JB.174.23.7798-7806.1992; PARSEK MR, 1995, MOL MICROBIOL, V15, P819, DOI 10.1111/j.1365-2958.1995.tb02352.x; Pedraza JM, 2005, SCIENCE, V307, P1965, DOI 10.1126/science.1109090; PEREZMARTIN J, 1995, J BACTERIOL, V177, P3758, DOI 10.1128/jb.177.13.3758-3763.1995; Qazi SNA, 2004, J BACTERIOL, V186, P1065, DOI 10.1128/JB.186.4.1065-1077.2004; Raj A, 2008, CELL, V135, P216, DOI 10.1016/j.cell.2008.09.050; Sambrook J., 1989, MOL CLONING LAB MANU, V2; Santos PM, 2004, PROTEOMICS, V4, P2640, DOI 10.1002/pmic.200300793; Silva-Rocha R, 2010, ANNU REV MICROBIOL, V64, P257, DOI 10.1146/annurev.micro.091208.073229; Sprinzak D, 2005, NATURE, V438, P443, DOI 10.1038/nature04335; Teichmann SA, 2004, NAT GENET, V36, P492, DOI 10.1038/ng1340; Thieffry D, 1998, BIOESSAYS, V20, P433, DOI 10.1002/(SICI)1521-1878(199805)20:5<433::AID-BIES10>3.0.CO;2-2; Tropel D, 2004, MICROBIOL MOL BIOL R, V68, P474, DOI 10.1128/MMBR.68.3.474-500.2004; Visca P, 2002, MOL MICROBIOL, V45, P1177, DOI 10.1046/j.1365-2958.2002.03088.x; Voigt CA, 2006, CURR OPIN BIOTECH, V17, P548, DOI 10.1016/j.copbio.2006.09.001	54	16	16	2	32	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 6	2012	7	4							e34675	10.1371/journal.pone.0034675	http://dx.doi.org/10.1371/journal.pone.0034675			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	955JA	22493710	Green Published, gold, Green Submitted			2022-12-25	WOS:000305012700052
J	Kuykendall, LD; Shao, JY; Hartung, JS				Kuykendall, L. David; Shao, Jonathan Y.; Hartung, John S.			Conservation of Gene Order and Content in the Circular Chromosomes of 'Candidatus Liberibacter asiaticus' and Other Rhizobiales	PLOS ONE			English	Article							GREENING DISEASE; PCR DETECTION; SPECIES TREE; CITRUS; IDENTIFICATION; COLONIZATION; EVOLUTIONARY; BACTERIUM; SEQUENCE; REVEALS	'Ca. Liberibacter asiaticus,' an insect-vectored, obligate intracellular bacterium associated with citrus-greening disease, also called "HLB," is a member of the Rhizobiales along with nitrogen-fixing microsymbionts Sinorhizobium meliloti and Bradyrhizobium japonicum, plant pathogen Agrobacterium tumefaciens and facultative intracellular mammalian pathogen Bartonella henselae. Comparative analyses of their circular chromosomes identified 514 orthologous genes shared among all five species. Shared among all five species are 50 identical blocks of microsyntenous orthologous genes (MOGs), containing a total of 283 genes. While retaining highly conserved genomic blocks of microsynteny, divergent evolution, horizontal gene transfer and niche specialization have disrupted macrosynteny among the five circular chromosomes compared. Highly conserved microsyntenous gene clusters help define the Rhizobiales, an order previously defined by 16S RNA gene similarity and herein represented by the three families: Bartonellaceae, Bradyrhizobiaceae and Rhizobiaceae. Genes without orthologs in the other four species help define individual species. The circular chromosomes of each of the five Rhizobiales species examined had genes lacking orthologs in the other four species. For example, 63 proteins are encoded by genes of 'Ca. Liberibacter asiaticus' not shared with other members of the Rhizobiales. Of these 63 proteins, 17 have predicted functions related to DNA replication or RNA transcription, and some of these may have roles related to low genomic GC content. An additional 17 proteins have predicted functions relevant to cellular processes, particularly modifications of the cell surface. Seventeen unshared proteins have specific metabolic functions including a pathway to synthesize cholesterol encoded by a seven-gene operon. The remaining 12 proteins encoded by 'Ca. Liberibacter asiaticus' genes not shared with other Rhizobiales are of bacteriophage origin. 'Ca. Liberibacter asiaticus' shares 11 genes with only Sinorhizobium meliloti and 12 genes are shared with only Bartonella henselae.	[Kuykendall, L. David; Shao, Jonathan Y.; Hartung, John S.] ARS, Mol Plant Pathol Lab, USDA, Beltsville, MD USA	United States Department of Agriculture (USDA)	Kuykendall, LD (corresponding author), ARS, Mol Plant Pathol Lab, USDA, Beltsville, MD USA.	John.Hartung@ars.usda.gov			United States Department of Agriculture	United States Department of Agriculture(United States Department of Agriculture (USDA))	This research was supported by intramural United States Department of Agriculture Funds funds. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alsmark CM, 2004, P NATL ACAD SCI USA, V101, P9716, DOI 10.1073/pnas.0305659101; Ballouz S, 2010, PLOS COMPUT BIOL, V6, DOI 10.1371/journal.pcbi.1000672; Bateman A, 2004, NUCLEIC ACIDS RES, V32, pD138, DOI [10.1093/nar/gkt1223, 10.1093/nar/gkp985, 10.1093/nar/gkr1065]; Bove JM, 2006, J PLANT PATHOL, V88, P7; Carvalho FM, 2010, BMC MICROBIOL, V10, DOI 10.1186/1471-2180-10-37; Castillo-Ramirez S, 2008, BMC EVOL BIOL, V8, DOI 10.1186/1471-2148-8-300; Chen J, 2011, [植物病理学报, Acta Phytopathologica Sinica], V41, P113; Da Graca J, 2004, DIS FRUITS VEGETABLE, VI, P229, DOI DOI 10.1007/1-4020-2606-4_4; Davis MJ, 2008, PLANT DIS, V92, P1547, DOI 10.1094/PDIS-92-11-1547; Dillingham MS, 1999, NUCLEIC ACIDS RES, V27, P3310, DOI 10.1093/nar/27.16.3310; Duan YP, 2009, MOL PLANT MICROBE IN, V22, P1011, DOI 10.1094/MPMI-22-8-1011; Durr H, 2006, NUCLEIC ACIDS RES, V34, P4160, DOI 10.1093/nar/gkl540; Engel P, 2009, GENOME DYNAM, V6, P158, DOI 10.1159/000235769; Flaus A, 2006, NUCLEIC ACIDS RES, V34, P2887, DOI 10.1093/nar/gkl295; Garnett HM, 1984, CITRUS SUBTROP FRUIT, V611, P4; GHOSH SK, 1971, CURR SCI INDIA, V40, P299; Guerrero G, 2005, BMC EVOL BIOL, V5, DOI 10.1186/1471-2148-5-55; Hamon MA, 2008, CELL HOST MICROBE, V4, P100, DOI 10.1016/j.chom.2008.07.009; Hartung JS, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0023289; Hartung JS, 2010, PHYTOPATHOLOGY, V100, P756, DOI 10.1094/PHYTO-100-8-0756; Husain M. A., 1927, MEMOIRS DEP AGR INDI, V10, P1; JAGOUEIX S, 1994, INT J SYST BACTERIOL, V44, P379, DOI 10.1099/00207713-44-3-379; Jagoueix S, 1996, MOL CELL PROBE, V10, P43, DOI 10.1006/mcpr.1996.0006; Jagoueix S, 1997, INT J SYST BACTERIOL, V47, P224, DOI 10.1099/00207713-47-1-224; Jones KM, 2007, NAT REV MICROBIOL, V5, P619, DOI 10.1038/nrmicro1705; Kida Y, 2007, INFECT IMMUN, V75, P164, DOI 10.1128/IAI.01239-06; Kim JS, 2009, PHYTOPATHOLOGY, V99, P50, DOI 10.1094/PHYTO-99-1-0050; Konstantinidis KT, 2004, P NATL ACAD SCI USA, V101, P3160, DOI 10.1073/pnas.0308653100; Kuykendall L., 2006, INT J SYST EVOL MICR, V56, P1; Kuykendall L. D., 2005, BERGEYS MANUAL SYSTE, V2, P324; Kuykendall LD, PREDICTED ROLE UNPUB; Li WB, 2006, J MICROBIOL METH, V66, P104, DOI 10.1016/j.mimet.2005.10.018; Li WB, 2009, PHYTOPATHOLOGY, V99, P139, DOI 10.1094/PHYTO-99-2-0139; Li YX, 2007, MICROBIOL-SGM, V153, P719, DOI 10.1099/mic.0.2006/002311-0; LIN K. -H., 1956, Acta Phytopathologica Sinica, V2, P1; Merhej V, 2009, BIOL DIRECT, V4, DOI 10.1186/1745-6150-4-13; Moran NA, 2002, CELL, V108, P583, DOI 10.1016/S0092-8674(02)00665-7; Newman KL, 2004, P NATL ACAD SCI USA, V101, P1737, DOI 10.1073/pnas.0308399100; Newman KL, 2003, APPL ENVIRON MICROB, V69, P7319, DOI 10.1128/AEM.69.12.7319-7327.2003; Rocha EPC, 2002, TRENDS GENET, V18, P291, DOI 10.1016/S0168-9525(02)02690-2; Sechler A, 2009, PHYTOPATHOLOGY, V99, P480, DOI 10.1094/PHYTO-99-5-0480; Tatineni S, 2008, PHYTOPATHOLOGY, V98, P592, DOI 10.1094/PHYTO-98-5-0592; Teixeira DD, 2005, MOL CELL PROBE, V19, P173, DOI 10.1016/j.mcp.2004.011.002; Tyler HL, 2009, MOL PLANT MICROBE IN, V22, P1624, DOI 10.1094/MPMI-22-12-1624; Williams KP, 2007, J BACTERIOL, V189, P4578, DOI 10.1128/JB.00269-07; Wu H, 2005, P 2005 IEEE COMP SYS; Zhang SJ, 2011, MOL PLANT MICROBE IN, V24, P458, DOI 10.1094/MPMI-11-10-0256	47	10	10	0	13	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 4	2012	7	4							e34673	10.1371/journal.pone.0034673	http://dx.doi.org/10.1371/journal.pone.0034673			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	953GO	22496839	gold, Green Submitted, Green Published			2022-12-25	WOS:000304855200068
J	Lim, S; MacIntyre, DA; Lee, YS; Khanjani, S; Terzidou, V; Teoh, TG; Bennett, PR				Lim, Sheri; MacIntyre, David A.; Lee, Yun S.; Khanjani, Shirin; Terzidou, Vasso; Teoh, T. G.; Bennett, Phillip R.			Nuclear Factor Kappa B Activation Occurs in the Amnion Prior to Labour Onset and Modulates the Expression of Numerous Labour Associated Genes	PLOS ONE			English	Article							HUMAN-FETAL MEMBRANES; ARACHIDONIC-ACID METABOLISM; EPIDERMAL GROWTH-FACTOR; OXYTOCIN RECEPTORS; HUMAN PARTURITION; PRETERM LABOR; EXPORT SIGNAL; RABBIT AMNION; CELLS; TERM	Background: Prior to the onset of human labour there is an increase in the synthesis of prostaglandins, cytokines and chemokines in the fetal membranes, particular the amnion. This is associated with activation of the transcription factor nuclear factor kappa B (NF kappa B). In this study we characterised the level of NF kappa B activity in amnion epithelial cells as a measure of amnion activation in samples collected from women undergoing caesarean section at 39 weeks gestation prior to the onset of labour. Methodology/Principal Findings: We found that a proportion of women exhibit low or moderate NF kappa B activity while other women exhibit high levels of NF kappa B activity (n=12). This activation process does not appear to involve classical pathways of NF kappa B activation but rather is correlated with an increase in nuclear p65-Rel-B dimers. To identify the full range of genes upregulated in association with amnion activation, microarray analysis was performed on carefully characterised non-activated amnion (n=3) samples and compared to activated samples (n=3). A total of 919 genes were upregulated in response to amnion activation including numerous inflammatory genes such cyclooxygenase-2 (COX-2, 44-fold), interleukin 8 (IL-8, 6-fold), IL-1 receptor accessory protein (IL-1 RAP, 4.5-fold), thrombospondin 1 (TSP-1, 3-fold) and, unexpectedly, oxytocin receptor (OTR, 24-fold). Ingenuity Pathway Analysis of the microarray data reveal the two main gene networks activated concurrently with amnion activation are i) cell death, cancer and morphology and ii) cell cycle, embryonic development and tissue development. Conclusions/Significance: Our results indicate that assessment of amnion NF kappa B activation is critical for accurate sample classification and subsequent interpretation of data. Collectively, our data suggest amnion activation is largely an inflammatory event that occurs in the amnion epithelial layer as a prelude to the onset of labour.	[Lim, Sheri; MacIntyre, David A.; Lee, Yun S.; Khanjani, Shirin; Terzidou, Vasso; Bennett, Phillip R.] Univ London Imperial Coll Sci Technol & Med, Inst Reprod & Dev Biol, Imperial Coll Parturit Res Grp, London, England; [Teoh, T. G.] St Marys Hosp, Dept Obstet & Gynaecol, London, England	Imperial College London; Imperial College London	Lim, S (corresponding author), Univ London Imperial Coll Sci Technol & Med, Inst Reprod & Dev Biol, Imperial Coll Parturit Res Grp, London, England.	pbennett@imperial.ac.uk	MacIntyre, David A/D-9267-2012	Bennett, Phillip/0000-0002-6253-4919; MacIntyre, David/0000-0002-4186-5567	Genesis Research Trust; National Institute for Health Research [ACF-2012-21-018] Funding Source: researchfish	Genesis Research Trust; National Institute for Health Research(National Institute for Health Research (NIHR))	This study was supported by funding from Genesis Research Trust. The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ackerman VE, 2004, BIOL REPROD, V71, P2079, DOI 10.1095/biolreprod.104.030841; Allport VC, 2001, MOL HUM REPROD, V7, P581, DOI 10.1093/molehr/7.6.581; Belt AR, 1999, AM J OBSTET GYNECOL, V181, P359, DOI 10.1016/S0002-9378(99)70562-4; BENNETT PR, 1987, AM J OBSTET GYNECOL, V156, P649, DOI 10.1016/0002-9378(87)90070-6; BENNETT PR, 1992, PROSTAGLANDINS, V43, P87, DOI 10.1016/0090-6980(92)90068-5; BENNETT PR, 1993, BRIT J OBSTET GYNAEC, V100, P1037, DOI 10.1111/j.1471-0528.1993.tb15143.x; Blanks AM, 2003, J CLIN ENDOCR METAB, V88, P3392, DOI 10.1210/jc.2002-021212; BROCKMAN JA, 1995, MOL CELL BIOL, V15, P2809; CHIBBAR R, 1993, J CLIN INVEST, V91, P185, DOI 10.1172/JCI116169; CONNOLLY JM, 1991, PROSTATE, V19, P173, DOI 10.1002/pros.2990190210; CONNOLLY JM, 1990, PROSTATE, V16, P209, DOI 10.1002/pros.2990160304; CROSTON GE, 1995, J BIOL CHEM, V270, P16514, DOI 10.1074/jbc.270.28.16514; Elliott CL, 2001, MOL HUM REPROD, V7, P787, DOI 10.1093/molehr/7.8.787; Elliott CL, 2001, AM J REPROD IMMUNOL, V46, P260, DOI 10.1034/j.1600-0897.2001.d01-11.x; FAN CM, 1991, NATURE, V354, P395, DOI 10.1038/354395a0; FUCHS AR, 1982, SCIENCE, V215, P1396, DOI 10.1126/science.6278592; HINKO A, 1992, ENDOCRINOLOGY, V130, P3547, DOI 10.1210/en.130.6.3547; Hsu CD, 2000, AM J REPROD IMMUNOL, V43, P255, DOI 10.1111/j.8755-8920.2000.430502.x; HSU HL, 1995, CELL, V81, P495, DOI 10.1016/0092-8674(95)90070-5; Huang TT, 2000, P NATL ACAD SCI USA, V97, P1014, DOI 10.1073/pnas.97.3.1014; Huang TT, 2001, MOL CELL BIOL, V21, P4737, DOI 10.1128/MCB.21.14.4737-4747.2001; Hughes TR, 2000, CELL, V102, P109, DOI 10.1016/S0092-8674(00)00015-5; Ishikawa H, 1998, J EXP MED, V187, P985, DOI 10.1084/jem.187.7.985; JUNQUEIRA LCU, 1980, AM J OBSTET GYNECOL, V138, P273, DOI 10.1016/0002-9378(80)90248-3; Karin M, 2002, NAT IMMUNOL, V3, P221, DOI 10.1038/ni0302-221; Kumagai K, 2001, MOL HUM REPROD, V7, P681, DOI 10.1093/molehr/7.7.681; Lee SH, 2002, J BIOL CHEM, V277, P23358, DOI 10.1074/jbc.M111559200; Lee Y, 2003, MOL HUM REPROD, V9, P213, DOI 10.1093/molehr/gag026; Lindstrom TM, 2005, REPRODUCTION, V130, P569, DOI 10.1530/rep.1.00197; Meteoglu I, 2008, J EXP CLIN CANC RES, V27, DOI 10.1186/1756-9966-27-53; OKITA JR, 1982, J BIOL CHEM, V257, P4029; OKITA JR, 1983, IN VITRO CELL DEV B, V19, P117; OSMERS R, 1992, AM J OBSTET GYNECOL, V166, P1455, DOI 10.1016/0002-9378(92)91619-L; RUBEN SM, 1992, GENE DEV, V6, P745, DOI 10.1101/gad.6.5.745; Sadovsky Y, 2000, AM J OBSTET GYNECOL, V182, P370, DOI 10.1016/S0002-9378(00)70226-2; SANGHA RK, 1994, J CLIN ENDOCR METAB, V78, P982, DOI 10.1210/jc.78.4.982; Sawdy RJ, 2000, PLACENTA, V21, P54, DOI 10.1053/plac.1999.0438; Slater D, 1999, J MOL ENDOCRINOL, V22, P125, DOI 10.1677/jme.0.0220125; SLATER DM, 1995, AM J OBSTET GYNECOL, V172, P77, DOI 10.1016/0002-9378(95)90087-X; SOLOFF MS, 1993, ANN NY ACAD SCI, V689, P207, DOI 10.1111/j.1749-6632.1993.tb55549.x; Terzidou V, 2011, BIOL REPROD, V84, P546, DOI 10.1095/biolreprod.110.086785; Thomson AJ, 1999, HUM REPROD, V14, P229, DOI 10.1093/humrep/14.1.229; WEIH F, 1994, ONCOGENE, V9, P3289; Xia YY, 1997, AM J PATHOL, V151, P375; Zanetti M, 2003, ANN NY ACAD SCI, V987, P249, DOI 10.1111/j.1749-6632.2003.tb06056.x	45	43	43	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 2	2012	7	4							e34707	10.1371/journal.pone.0034707	http://dx.doi.org/10.1371/journal.pone.0034707			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	952GU	22485186	gold, Green Published, Green Submitted			2022-12-25	WOS:000304780500061
J	Wasling, P; Strandberg, J; Hanse, E				Wasling, Pontus; Strandberg, Joakim; Hanse, Eric			AMPA Receptor Activation Causes Silencing of AMPA Receptor-Mediated Synaptic Transmission in the Developing Hippocampus	PLOS ONE			English	Article							LONG-TERM POTENTIATION; IONOTROPIC GLUTAMATE RECEPTORS; PYRAMIDAL NEURONS; DENDRITIC SPINES; CA1 REGION; SYNAPSES; PLASTICITY; DEPRESSION; LTP; TRAFFICKING	Agonist-induced internalization of transmembrane receptors is a widespread biological phenomenon that also may serve as a mechanism for synaptic plasticity. Here we show that the agonist AMPA causes a depression of AMPA receptor (AMPAR) signaling at glutamate synapses in the CA1 region of the hippocampus in slices from developing, but not from mature, rats. This developmentally restricted agonist-induced synaptic depression is expressed as a total loss of AMPAR signaling, without affecting NMDA receptor (NMDAR) signaling, in a large proportion of the developing synapses, thus creating AMPAR silent synapses. The AMPA-induced AMPAR silencing is induced independently of activation of mGluRs and NMDARs, and it mimics and occludes stimulus-induced depression, suggesting that this latter form of synaptic plasticity is expressed as agonist-induced removal of AMPARs. Induction of long-term potentiation (LTP) rendered the developing synapses resistant to the AMPA-induced depression, indicating that LTP contributes to the maturation-related increased stability of these synapses. Our study shows that agonist binding to AMPARs is a sufficient triggering stimulus for the creation of AMPAR silent synapses at developing glutamate synapses.	[Wasling, Pontus; Strandberg, Joakim; Hanse, Eric] Univ Gothenburg, Sahlgrenska Acad, Dept Physiol, Inst Neurosci & Physiol, Gothenburg, Sweden	University of Gothenburg	Wasling, P (corresponding author), Univ Gothenburg, Sahlgrenska Acad, Dept Physiol, Inst Neurosci & Physiol, Gothenburg, Sweden.	pontus.wasling@physiol.gu.se	Strandberg, Joakim/B-4371-2009	Strandberg, Joakim/0000-0003-1483-6581	Swedish research council [12600, 01580]; Swedish Alzheimer foundation [2009-3033]; foundation of Wilhelm and Martina Lundgren [vet2-29/2010]	Swedish research council(Swedish Research CouncilEuropean Commission); Swedish Alzheimer foundation; foundation of Wilhelm and Martina Lundgren	This study was supported by the Swedish research council project nr 12600 and 01580 (www.vr.se), the Swedish Alzheimer foundation project nr 2009-3033 (www.alzheimerfonden.se), and the foundation of Wilhelm and Martina Lundgren project nr vet2-29/2010 (www.wmlundgren.se). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abrahamsson T, 2005, J PHYSIOL-LONDON, V569, P737, DOI 10.1113/jphysiol.2005.097725; Abrahamsson T, 2008, J NEUROPHYSIOL, V100, P2605, DOI 10.1152/jn.90476.2008; Abrahamsson T, 2007, J NEUROPHYSIOL, V98, P2604, DOI 10.1152/jn.00602.2007; Carroll RC, 1999, P NATL ACAD SCI USA, V96, P14112, DOI 10.1073/pnas.96.24.14112; Collingridge GL, 2010, NAT REV NEUROSCI, V11, P459, DOI 10.1038/nrn2867; Derkach VA, 2007, NAT REV NEUROSCI, V8, P101, DOI 10.1038/nrn2055; Durand GM, 1996, NATURE, V381, P71, DOI 10.1038/381071a0; Ehlers MD, 2000, NEURON, V28, P511, DOI 10.1016/S0896-6273(00)00129-X; Groc L, 2006, TRENDS NEUROSCI, V29, P132, DOI 10.1016/j.tins.2006.01.005; Groc L, 2002, J NEUROSCI, V22, P5552; Hall BJ, 2008, TRENDS NEUROSCI, V31, P82, DOI 10.1016/j.tins.2007.11.010; Hanse E, 2009, TRENDS NEUROSCI, V32, P532, DOI 10.1016/j.tins.2009.07.003; Hsia AY, 1998, J NEUROPHYSIOL, V79, P2013, DOI 10.1152/jn.1998.79.4.2013; Hua JYY, 2004, NAT NEUROSCI, V7, P327, DOI 10.1038/nn1218; ISAAC JTR, 1995, NEURON, V15, P427, DOI 10.1016/0896-6273(95)90046-2; Jensen V, 2003, J PHYSIOL-LONDON, V553, P843, DOI 10.1113/jphysiol.2003.053637; Katz LC, 1996, SCIENCE, V274, P1133, DOI 10.1126/science.274.5290.1133; Kennedy MJ, 2006, ANNU REV NEUROSCI, V29, P325, DOI 10.1146/annurev.neuro.29.051605.112808; Kerchner GA, 2008, NAT REV NEUROSCI, V9, P813, DOI 10.1038/nrn2501; Lendvai B, 2000, NATURE, V404, P876, DOI 10.1038/35009107; LIAO DZ, 1995, NATURE, V375, P400, DOI 10.1038/375400a0; Lin JW, 2000, NAT NEUROSCI, V3, P1282, DOI 10.1038/81814; Lissin DV, 1999, J NEUROSCI, V19, P1263; Luscher C, 1999, NEURON, V24, P649, DOI 10.1016/S0896-6273(00)81119-8; Malinow R, 2002, ANNU REV NEUROSCI, V25, P103, DOI 10.1146/annurev.neuro.25.112701.142758; Meng K, 2010, NEUROSCIENCE, V165, P684, DOI 10.1016/j.neuroscience.2009.11.030; Montgomery JM, 2002, NEURON, V33, P765, DOI 10.1016/S0896-6273(02)00606-2; Morimoto-Tomita M, 2009, NEURON, V61, P101, DOI 10.1016/j.neuron.2008.11.009; Nishimune A, 1998, NEURON, V21, P87, DOI 10.1016/S0896-6273(00)80517-6; Park M, 2006, NEURON, V52, P817, DOI 10.1016/j.neuron.2006.09.040; Passafaro M, 2001, NAT NEUROSCI, V4, P917, DOI 10.1038/nn0901-917; Penzes P, 2011, NAT NEUROSCI, V14, P285, DOI 10.1038/nn.2741; RAKIC P, 1986, SCIENCE, V232, P232, DOI 10.1126/science.3952506; Riebe I, 2009, EUR J NEUROSCI, V29, P1870, DOI 10.1111/j.1460-9568.2009.06734.x; Scholz R, 2010, NEURON, V66, P768, DOI 10.1016/j.neuron.2010.05.003; Shi SH, 2001, CELL, V105, P331, DOI 10.1016/S0092-8674(01)00321-X; Strandberg J, 2011, NEUROSCIENCE, V192, P54, DOI 10.1016/j.neuroscience.2011.06.081; Strandberg J, 2009, J NEUROPHYSIOL, V101, P2252, DOI 10.1152/jn.91210.2008; Tardin C, 2003, EMBO J, V22, P4656, DOI 10.1093/emboj/cdg463; Verhage M, 2000, SCIENCE, V287, P864, DOI 10.1126/science.287.5454.864; Xiao MY, 2004, NAT NEUROSCI, V7, P236, DOI 10.1038/nn1196; Yashiro K, 2008, NEUROPHARMACOLOGY, V55, P1081, DOI 10.1016/j.neuropharm.2008.07.046; Yasuda H, 2003, NAT NEUROSCI, V6, P15, DOI 10.1038/nn985	43	7	7	2	13	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 2	2012	7	4							e34474	10.1371/journal.pone.0034474	http://dx.doi.org/10.1371/journal.pone.0034474			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	952GU	22485173	gold, Green Published, Green Submitted			2022-12-25	WOS:000304780500048
J	Zhu, GJ; Wang, F; Chen, C; Xu, L; Zhang, WC; Fan, C; Peng, YJ; Chen, J; He, WQ; Guo, SY; Zuo, J; Gao, X; Zhu, MS				Zhu, Guang-Jie; Wang, Fang; Chen, Chen; Xu, Lin; Zhang, Wen-Cheng; Fan, Chi; Peng, Ya-Jing; Chen, Jie; He, Wei-Qi; Guo, Shi-Ying; Zuo, Jian; Gao, Xia; Zhu, Min-Sheng			Myosin Light-Chain Kinase Is Necessary for Membrane Homeostasis in Cochlear Inner Hair Cells	PLOS ONE			English	Article							SMOOTH-MUSCLE CONTRACTION; HEARING-LOSS; IN-VIVO; DEAFNESS; GENE; IDENTIFICATION; MUTATIONS; BINDING; MICE; EAR	The structural homeostasis of the cochlear hair cell membrane is critical for all aspects of sensory transduction, but the regulation of its maintenance is not well understood. In this report, we analyzed the cochlear hair cells of mice with specific deletion of myosin light chain kinase (MLCK) in inner hair cells. MLCK-deficient mice showed impaired hearing, with a 5- to 14-dB rise in the auditory brainstem response (ABR) thresholds to clicks and tones of different frequencies and a significant decrease in the amplitude of the ABR waves. The mutant inner hair cells produced several ball-like structures around the hair bundles in vivo, indicating impaired membrane stability. Inner hair cells isolated from the knockout mice consistently displayed less resistance to hypoosmotic solution and less membrane F-actin. Myosin light-chain phosphorylation was also reduced in the mutated inner hair cells. Our results suggest that MLCK is necessary for maintaining the membrane stability of inner hair cells.	[Zhu, Guang-Jie; Wang, Fang; Chen, Chen; Xu, Lin; Zhang, Wen-Cheng; Fan, Chi; Peng, Ya-Jing; Chen, Jie; He, Wei-Qi; Guo, Shi-Ying; Gao, Xia; Zhu, Min-Sheng] Nanjing Univ, Nanjing Drum Tower Hosp, MOE Key Lab Model Anim & Dis Studies, Nanjing, Jiangsu, Peoples R China; [Zhu, Guang-Jie; Wang, Fang; Chen, Chen; Xu, Lin; Zhang, Wen-Cheng; Fan, Chi; Peng, Ya-Jing; Chen, Jie; He, Wei-Qi; Guo, Shi-Ying; Gao, Xia; Zhu, Min-Sheng] Nanjing Univ, Model Anim Res Ctr, Nanjing, Jiangsu, Peoples R China; [Zhang, Wen-Cheng; Zhu, Min-Sheng] Wenzhou Med Coll, Sch Life Sci, Zhejiang Prov Key Lab Technol & Applicat Model Or, University Pk, Wenzhou, Peoples R China; [Zuo, Jian] St Jude Childrens Res Hosp, Dept Dev Neurobiol, Memphis, TN 38105 USA	Nanjing University; Nanjing University; Wenzhou Medical University; St Jude Children's Research Hospital	Zhu, GJ (corresponding author), Nanjing Univ, Nanjing Drum Tower Hosp, MOE Key Lab Model Anim & Dis Studies, Nanjing, Jiangsu, Peoples R China.	xiagao213@yahoo.com.cn; zhums@nju.edu.cn	Zhang, Wencheng/AAO-8445-2020; He, Weiqi/I-7935-2013; He, Weiqi/L-2502-2019	He, Weiqi/0000-0003-3137-8420; He, Weiqi/0000-0003-3137-8420; Chen, Chen/0000-0001-7075-8501	National Natural Science Funding of China [30973302]; National Basic Research Program of China (973) [2009CB942602, 2007CB947100]; Medically Important Development Project of Nanjing [ZKZ06019]; Medically Important People Project of Jiangsu Province [RC2007010]	National Natural Science Funding of China(National Natural Science Foundation of China (NSFC)); National Basic Research Program of China (973)(National Basic Research Program of China); Medically Important Development Project of Nanjing; Medically Important People Project of Jiangsu Province	This work was supported by the National Natural Science Funding of China (grant number 30973302), the National Basic Research Program of China (973) (grant numbers 2009CB942602, and 2007CB947100), the Medically Important Development Project of Nanjing (ZKZ06019) and the Medically Important People Project of Jiangsu Province (RC2007010). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ashmore JF, 2000, P NATL ACAD SCI USA, V97, P11759, DOI 10.1073/pnas.97.22.11759; Bao R, 2008, J GEN PHYSIOL, V132, P145, DOI 10.1085/jgp.200709933; Bekesy G., 1960, EXPT HEARING; Belyantseva IA, 2003, P NATL ACAD SCI USA, V100, P13958, DOI 10.1073/pnas.2334417100; Breckenridge MT, 2009, MOL BIOL CELL, V20, P338, DOI 10.1091/mbc.E08-04-0372; BROWNELL WE, 1990, EAR HEARING, V11, P82, DOI 10.1097/00003446-199004000-00003; Cai S, 1998, AM J PHYSIOL-CELL PH, V275, pC1349, DOI 10.1152/ajpcell.1998.275.5.C1349; Clayburgh DR, 2004, J BIOL CHEM, V279, P55506, DOI 10.1074/jbc.M408822200; Ding HL, 2009, J BIOL CHEM, V284, P15541, DOI 10.1074/jbc.M900888200; Donaudy F, 2004, AM J HUM GENET, V74, P770, DOI 10.1086/383285; Etournay R, 2007, J CELL SCI, V120, P2838, DOI 10.1242/jcs.002568; Ferrari MB, 1998, J CELL BIOL, V141, P1349, DOI 10.1083/jcb.141.6.1349; Frolenkov GI, 2004, NAT REV GENET, V5, P489, DOI 10.1038/nrg1377; GOECKELER ZM, 1995, J CELL BIOL, V130, P613, DOI 10.1083/jcb.130.3.613; Grimm M, 2006, BRIT J PHARMACOL, V148, P991, DOI 10.1038/sj.bjp.0706803; Grimsley-Myers CM, 2009, J NEUROSCI, V29, P15859, DOI 10.1523/JNEUROSCI.3998-09.2009; He DZZ, 2000, HEARING RES, V145, P156, DOI 10.1016/S0378-5955(00)00084-8; He WQ, 2008, GASTROENTEROLOGY, V135, P610, DOI 10.1053/j.gastro.2008.05.032; He WQ, 2011, AM J PHYSIOL-HEART C, V301, pH584, DOI 10.1152/ajpheart.01212.2010; Heath KE, 2001, AM J HUM GENET, V69, P1033, DOI 10.1086/324267; Ingber DE, 2006, FASEB J, V20, P811, DOI 10.1096/fj.05-5424rev; Ishmael JE, 2008, ACTA HISTOCHEM, V110, P172, DOI 10.1016/j.acthis.2007.08.005; Jiang H, 2006, J NEUROSCI RES, V83, P1544, DOI 10.1002/jnr.20833; Judice TN, 2002, BRAIN RES PROTOC, V9, P65, DOI 10.1016/S1385-299X(01)00138-6; Kamm KE, 2001, J BIOL CHEM, V276, P4527, DOI 10.1074/jbc.R000028200; Kharkovets T, 2000, P NATL ACAD SCI USA, V97, P4333, DOI 10.1073/pnas.97.8.4333; Krendel M, 2005, PHYSIOLOGY, V20, P239, DOI 10.1152/physiol.00014.2005; Kudryashov DS, 1999, FEBS LETT, V463, P67, DOI 10.1016/S0014-5793(99)01591-4; Lalwani AK, 2000, AM J HUM GENET, V67, P1121, DOI 10.1016/S0002-9297(07)62942-5; Li J, 2001, J BIOL CHEM, V276, P31233, DOI 10.1074/jbc.M104368200; Li MY, 2004, GENESIS, V39, P173, DOI 10.1002/gene.20040; Li ZW, 2002, BIOPHYS J, V82, P1386, DOI 10.1016/S0006-3495(02)75493-3; LIM DJ, 1980, J ACOUST SOC AM, V67, P1686, DOI 10.1121/1.384295; Liu XZ, 1997, NAT GENET, V16, P188, DOI 10.1038/ng0697-188; Lynch ED, 1997, SCIENCE, V278, P1315, DOI 10.1126/science.278.5341.1315; Mermall V, 1998, SCIENCE, V279, P527, DOI 10.1126/science.279.5350.527; Mizuno Y, 2008, AM J PHYSIOL-CELL PH, V295, pC358, DOI 10.1152/ajpcell.90645.2007; Morton CC, 2002, HUM MOL GENET, V11, P1229, DOI 10.1093/hmg/11.10.1229; Nadol JB, 2001, INT J PEDIATR OTORHI, V61, P1, DOI 10.1016/S0165-5876(01)00546-8; Parker LL, 2006, BRAIN RES, V1091, P235, DOI 10.1016/j.brainres.2006.03.032; Parving A, 1999, ACTA PAEDIATR, V88, P69, DOI 10.1080/080352599750029439; Probst FJ, 1998, SCIENCE, V280, P1444, DOI 10.1126/science.280.5368.1444; ROBERTS WM, 1988, ANNU REV CELL BIOL, V4, P63, DOI 10.1146/annurev.cellbio.4.1.63; Seri M, 2002, HUM GENET, V110, P182, DOI 10.1007/s00439-001-0659-1; Smith L, 1999, J BIOL CHEM, V274, P29433, DOI 10.1074/jbc.274.41.29433; Smith L, 2002, J BIOL CHEM, V277, P35597, DOI 10.1074/jbc.M206483200; Somlyo AP, 2003, PHYSIOL REV, V83, P1325, DOI 10.1152/physrev.00023.2003; Takizawa N, 2007, J CELL SCI, V120, P3792, DOI 10.1242/jcs.008219; Willems PJ, 2000, NEW ENGL J MED, V342, P1101, DOI 10.1056/NEJM200004133421506; Wilson SM, 2001, GENOMICS, V74, P228, DOI 10.1006/geno.2001.6554; Yamamoto N, 2009, DEVELOPMENT, V136, P1977, DOI 10.1242/dev.030718; Yang CX, 2006, CELL RES, V16, P367, DOI 10.1038/sj.cr.7310047; Yang T, 2005, AM J MED GENET A, V139A, P9, DOI 10.1002/ajmg.a.30989; Zhang WC, 2008, FEBS J, V275, P2489, DOI 10.1111/j.1742-4658.2008.06393.x; Zhang WC, 2010, J BIOL CHEM, V285, P5522, DOI 10.1074/jbc.M109.062836	55	5	6	0	15	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 2	2012	7	4							e34894	10.1371/journal.pone.0034894	http://dx.doi.org/10.1371/journal.pone.0034894			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	952GU	22485190	Green Published, Green Submitted, gold			2022-12-25	WOS:000304780500064
J	Branagan, AM; Maher, RL; Morrical, SW				Branagan, Amy M.; Maher, Robyn L.; Morrical, Scott W.			Assembly and Dynamics of Gp59-Gp32-Single-stranded DNA (ssDNA), a DNA Helicase Loading Complex Required for Recombination-dependent Replication in Bacteriophage T4	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							GENE 59 PROTEIN; LEADING-STRAND SYNTHESIS; VIROLOGY JOURNAL SERIES; BINDING-PROTEIN; T4 HELICASE; UVSX RECOMBINASE; SINGLE-MOLECULE; POLYMERASE GP43; NUCLEIC-ACIDS; GP59	The Gp59 protein of bacteriophage T4 plays critical roles in recombination-dependent DNA replication and repair by correctly loading the replicative helicase, Gp41, onto recombination intermediates. Previous work demonstrated that Gp59 is required to load helicase onto single-stranded DNA that is saturated with Gp32, the T4 single-stranded DNA (ssDNA)-binding protein. Gp59 and Gp32 bind simultaneously to ssDNA, forming a Gp59-Gp32-ssDNA complex that is a key intermediate in helicase loading. Here we characterize the assembly and dynamics of this helicase loading complex (HLC) through changes in the fluorescent states of Gp32F, a fluorescein-Gp32 conjugate. Results show that HLC formation requires a minimum Gp32-ssDNA cluster size and that Gp59 co-localizes with Gp32-ssDNA clusters in the presence of excess free ssDNA. These and other results indicate that Gp59 targets helicase assembly onto Gp32-ssDNA clusters that form on the displaced strand of D-loops, which suggests a mechanism for the rapid initiation of recombination-dependent DNA replication. Helicase loading at the HLC requires ATP binding (not hydrolysis) by Gp41 and results in local remodeling of Gp32 within the HLC. Subsequent ATPase-driven translocation of Gp41 progressively disrupts Gp32-ssDNA interactions. Evidence suggests that Gp59 from the HLC is recycled to promote multiple rounds of helicase assembly on Gp32-ssDNA, a capability that could be important for the restart of stalled replication forks.	[Branagan, Amy M.; Maher, Robyn L.; Morrical, Scott W.] Univ Vermont, Coll Med, Dept Biochem, Burlington, VT 05405 USA	University of Vermont	Morrical, SW (corresponding author), Univ Vermont, Coll Med, Dept Biochem, B407 Given Bldg,89 Beaumont Ave, Burlington, VT 05405 USA.	smorrica@uvm.edu			National Institutes of Health [R01GM48847, T32ES07122]; American Cancer Society [PF-09-254-01-DMC]; NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES [T32ES007122] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM048847] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); American Cancer Society(American Cancer Society); NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Environmental Health Sciences (NIEHS)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported, in whole or in part, by National Institutes of Health Grant R01GM48847 (to S. W. M.) and Training Grant T32ES07122 (to A. M. B.).; Supported by Postdoctoral Fellowship PF-09-254-01-DMC from the American Cancer Society.	Alberts B.M., 1971, METHODS ENZYMOL, V21, P198; ALBERTS BM, 1987, PHILOS T ROY SOC B, V317, P395, DOI 10.1098/rstb.1987.0068; Arumugam SR, 2009, J BIOL CHEM, V284, P29283, DOI 10.1074/jbc.M109.029926; BARRY J, 1994, J BIOL CHEM, V269, P33049; Bleuit JS, 2001, P NATL ACAD SCI USA, V98, P8298, DOI 10.1073/pnas.131007498; Chastain PD, 2003, J BIOL CHEM, V278, P21276, DOI 10.1074/jbc.M301573200; Delagoutte E, 2005, J MOL BIOL, V347, P257, DOI 10.1016/j.jmb.2005.01.036; FORMOSA T, 1986, CELL, V47, P793, DOI 10.1016/0092-8674(86)90522-2; GIEDROC DP, 1990, J BIOL CHEM, V265, P11444; GILL SC, 1989, ANAL BIOCHEM, V182, P319, DOI 10.1016/0003-2697(89)90602-7; Ishmael FT, 2002, J BIOL CHEM, V277, P20555, DOI 10.1074/jbc.M111951200; Ishmael FT, 2001, J BIOL CHEM, V276, P25236, DOI 10.1074/jbc.M100783200; Jones CE, 2004, J BIOL CHEM, V279, P12067, DOI 10.1074/jbc.M313840200; Jones CE, 2001, P NATL ACAD SCI USA, V98, P8312, DOI 10.1073/pnas.121009398; Jones CE, 2000, J BIOL CHEM, V275, P27145; Jones JM, 2000, MOL MICROBIOL, V36, P519, DOI 10.1046/j.1365-2958.2000.01888.x; Kadyrov FA, 2004, J BIOL CHEM, V279, P35735, DOI 10.1074/jbc.M403942200; Kadyrov FA, 2003, J BIOL CHEM, V278, P25247, DOI 10.1074/jbc.M302564200; KODADEK T, 1990, J BIOL CHEM, V265, P20966; KOWALCZYKOWSKI SC, 1981, J MOL BIOL, V145, P75, DOI 10.1016/0022-2836(81)90335-1; KOWALCZYKOWSKI SC, 1990, LANDOLTBORNSTEIN NUM, P244; Kreuzer KN, 2010, VIROL J, V7, DOI 10.1186/1743-422X-7-358; Lefebvre SD, 1997, J MOL BIOL, V272, P312, DOI 10.1006/jmbi.1997.1264; Lefebvre SD, 1999, J BIOL CHEM, V274, P22830, DOI 10.1074/jbc.274.32.22830; Liu J, 2006, J BIOL CHEM, V281, P26308, DOI 10.1074/jbc.M604349200; Liu J, 2010, VIROL J, V7, DOI 10.1186/1743-422X-7-357; LONBERG N, 1981, J MOL BIOL, V145, P123, DOI 10.1016/0022-2836(81)90337-5; Ma YJ, 2004, J BIOL CHEM, V279, P19035, DOI 10.1074/jbc.M311738200; Maher RL, 2011, J CELL BIOCHEM, V112, P2672, DOI 10.1002/jcb.23211; Morrical S., 2009, U. S. Patent, Patent No. [7,544,469 B2, 7544469]; MORRICAL SW, 1994, J BIOL CHEM, V269, P33069; MORRICAL SW, 1990, J BIOL CHEM, V265, P15096; MORRICAL SW, 1991, J BIOL CHEM, V266, P14031; Morrical SW, 1996, J BIOL CHEM, V271, P20198, DOI 10.1074/jbc.271.33.20198; Mueser TC, 2000, J MOL BIOL, V296, P597, DOI 10.1006/jmbi.1999.3438; Mueser TC, 2010, VIROL J, V7, DOI 10.1186/1743-422X-7-359; Nelson SW, 2006, J BIOL CHEM, V281, P8697, DOI 10.1074/jbc.M512185200; Pant K, 2005, J MOL BIOL, V349, P317, DOI 10.1016/j.jmb.2005.03.065; Schrock RD, 1996, J BIOL CHEM, V271, P16678, DOI 10.1074/jbc.271.28.16678; SPACCIAPOLI P, 1994, J BIOL CHEM, V269, P447; VILLEMAIN JL, 1993, BIOCHEMISTRY-US, V32, P11235, DOI 10.1021/bi00092a038; Xi J, 2005, BIOCHEMISTRY-US, V44, P7747, DOI 10.1021/bi047296w; Xi J, 2005, BIOCHEMISTRY-US, V44, P2305, DOI 10.1021/bi0479508; Xu H, 2001, BIOCHEMISTRY-US, V40, P7651, DOI 10.1021/bi010116n; YONESAKI T, 1994, J BIOL CHEM, V269, P1284; Zhang ZQ, 2005, P NATL ACAD SCI USA, V102, P3254, DOI 10.1073/pnas.0500327102	46	5	5	0	4	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JUN 1	2012	287	23					19070	19081		10.1074/jbc.M112.343830	http://dx.doi.org/10.1074/jbc.M112.343830			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	974EF	22500043	Green Published, hybrid			2022-12-25	WOS:000306411900018
J	Gagnon, KT; Biswas, S; Zhang, XX; Brown, BA; Wollenzien, P; Mattos, C; Maxwell, ES				Gagnon, Keith T.; Biswas, Shyamasri; Zhang, Xinxin; Brown, Bernard A., II; Wollenzien, Paul; Mattos, Carla; Maxwell, E. Stuart			Structurally Conserved Nop56/58 N-terminal Domain Facilitates Archaeal Box C/D Ribonucleoprotein-guided Methyltransferase Activity	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							RIBOSE METHYLATION; RNA; PROTEIN; SRNP; 2'-O-METHYLATION; COMPLEXES	Box C/D RNA-protein complexes (RNPs) guide the 2'-O-methylation of nucleotides in both archaeal and eukaryotic ribosomal RNAs. The archaeal box C/D and C'/D' RNP subcomplexes are each assembled with three sRNP core proteins. The archaeal Nop56/58 core protein mediates crucial protein-protein interactions required for both sRNP assembly and the methyltransferase reaction by bridging the L7Ae and fibrillarin core proteins. The interaction of Methanocaldococcus jannaschii (Mj) Nop56/58 with the methyltransferase fibrillarin has been investigated using site-directed mutagenesis of specific amino acids in the N-terminal domain of Nop56/58 that interacts with fibrillarin. Extensive mutagenesis revealed an unusually strong Nop56/58-fibrillarin interaction. Only deletion of the NTD itself prevented dimerization with fibrillarin. The extreme stability of the Nop56/58-fibrillarin heterodimer was confirmed in both chemical and thermal denaturation analyses. However, mutations that did not affect Nop56/58 binding to fibrillarin or sRNP assembly nevertheless disrupted sRNP-guided nucleotide modification, revealing a role for Nop56/58 in methyltransferase activity. This conclusion was supported with the cross-linking of Nop56/58 to the target RNA substrate. The Mj Nop56/58 NTD was further characterized by solving its three-dimensional crystal structure to a resolution of 1.7 angstrom. Despite low primary sequence conservation among the archaeal Nop56/58 homologs, the overall structure of the archaeal NTD domain is very well conserved. In conclusion, the archaeal Nop56/58 NTD exhibits a conserved domain structure whose exceptionally stable interaction with fibrillarin plays a role in both RNP assembly and methyltransferase activity.	[Gagnon, Keith T.; Biswas, Shyamasri; Zhang, Xinxin; Brown, Bernard A., II; Wollenzien, Paul; Mattos, Carla; Maxwell, E. Stuart] N Carolina State Univ, Dept Mol & Struct Biochem, Raleigh, NC 27695 USA	University of North Carolina; North Carolina State University	Maxwell, ES (corresponding author), 128 Polk Hall, Raleigh, NC 27695 USA.	stu_maxwell@ncsu.edu			National Institutes of Health [GM069699, 1F32HD060377-01A1]; National Science Foundation [MCB 0543741]; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT [F32HD060377] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM069699] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); National Science Foundation(National Science Foundation (NSF)); EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported, in whole or in part, by National Institutes of Health Grants GM069699 (to B. A. B.) and 1F32HD060377-01A1 (to K. T. G.) and National Science Foundation Grant MCB 0543741 (to E. S. M.).	Adams PD, 2010, ACTA CRYSTALLOGR D, V66, P213, DOI 10.1107/S0907444909052925; Aittaleb M, 2003, NAT STRUCT BIOL, V10, P256, DOI 10.1038/nsb905; Appel CD, 2007, RNA, V13, P899, DOI 10.1261/rna.517307; Balakin AG, 1996, CELL, V86, P823, DOI 10.1016/S0092-8674(00)80156-7; Bleichert F, 2009, SCIENCE, V325, P1384, DOI 10.1126/science.1176099; Darzacq X, 2002, EMBO J, V21, P2746, DOI 10.1093/emboj/21.11.2746; Davis IW, 2007, NUCLEIC ACIDS RES, V35, pW375, DOI 10.1093/nar/gkm216; Dennis PP, 2005, CURR OPIN MICROBIOL, V8, P685, DOI 10.1016/j.mib.2005.10.013; Emsley P, 2010, ACTA CRYSTALLOGR D, V66, P486, DOI 10.1107/S0907444910007493; Gagnon K, 2008, RNA DNA EDITING MOL, P313; Gagnon KT, 2006, J MOL BIOL, V362, P1025, DOI 10.1016/j.jmb.2006.07.091; Gagnon KT, 2010, BIOCHEMISTRY-US, V49, P10166, DOI 10.1021/bi101208k; Gautier T, 1997, MOL CELL BIOL, V17, P7088, DOI 10.1128/MCB.17.12.7088; Holm L, 2000, BIOINFORMATICS, V16, P566, DOI 10.1093/bioinformatics/16.6.566; Kishore S, 2006, SCIENCE, V311, P230, DOI 10.1126/science.1118265; KissLaszlo Z, 1996, CELL, V85, P1077, DOI 10.1016/S0092-8674(00)81308-2; Klein DJ, 2001, EMBO J, V20, P4214, DOI 10.1093/emboj/20.15.4214; Kleywegt GJ, 1999, ACTA CRYSTALLOGR D, V55, P1878, DOI 10.1107/S0907444999010495; Kortemme T, 2002, P NATL ACAD SCI USA, V99, P14116, DOI 10.1073/pnas.202485799; Kuhn JF, 2002, NUCLEIC ACIDS RES, V30, P931, DOI 10.1093/nar/30.4.931; LASKOWSKI RA, 1993, J APPL CRYSTALLOGR, V26, P283, DOI 10.1107/S0021889892009944; Lin JZ, 2011, NATURE, V469, P559, DOI 10.1038/nature09688; Mccoy AJ, 2007, J APPL CRYSTALLOGR, V40, P658, DOI 10.1107/S0021889807021206; Nanda K, 2004, BIOCHEMISTRY-US, V43, P8923, DOI 10.1021/bi049702h; Newman DR, 2000, RNA, V6, P861, DOI 10.1017/S1355838200992446; Nolivos S, 2005, NUCLEIC ACIDS RES, V33, P6507, DOI 10.1093/nar/gki962; Omer AD, 2000, SCIENCE, V288, P517, DOI 10.1126/science.288.5465.517; Omer AD, 2002, P NATL ACAD SCI USA, V99, P5289, DOI 10.1073/pnas.082101999; Oruganti S, 2007, J MOL BIOL, V371, P1141, DOI 10.1016/j.jmb.2007.06.029; Otwinowski Z, 1997, METHOD ENZYMOL, V276, P307, DOI 10.1016/S0076-6879(97)76066-X; Sanjay KS, 2004, J BIOL CHEM, V279, P47661, DOI 10.1074/jbc.M408868200; Tran E, 2005, RNA, V11, P285, DOI 10.1261/rna.7223405; Tran E, 2004, TRENDS BIOCHEM SCI, V29, P343, DOI 10.1016/j.tibs.2004.05.001; Tran EJ, 2003, EMBO J, V22, P3930, DOI 10.1093/emboj/cdg368; VANDUYNE GD, 1993, J MOL BIOL, V229, P105, DOI 10.1006/jmbi.1993.1012; Xue S, 2010, MOL CELL, V39, P939, DOI 10.1016/j.molcel.2010.08.022; Ye KQ, 2009, P NATL ACAD SCI USA, V106, P13808, DOI 10.1073/pnas.0905128106; Zhang XX, 2006, RNA, V12, P1092, DOI 10.1261/rna.2230106	38	8	8	0	4	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JUN 1	2012	287	23					19418	19428		10.1074/jbc.M111.323253	http://dx.doi.org/10.1074/jbc.M111.323253			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	974EF	22496443	Green Published, hybrid			2022-12-25	WOS:000306411900056
J	Kwon, YH; Jung, SY; Kim, JW; Lee, SH; Lee, JH; Lee, BY; Kwon, SM				Kwon, Yi-Hong; Jung, Seok-Yun; Kim, Jae-Won; Lee, Sang-Hun; Lee, Jun-Hee; Lee, Boo-Yong; Kwon, Sang-Mo			Phloroglucinol Inhibits the Bioactivities of Endothelial Progenitor Cells and Suppresses Tumor Angiogenesis in LLC-Tumor-Bearing Mice	PLOS ONE			English	Article							GROWTH-FACTOR PATHWAY; IN-VITRO; ANTIANGIOGENIC THERAPY; ANTICANCER AGENTS; OXIDATIVE STRESS; VEGF EXPRESSION; METASTASIS; CARCINOMA; CANCER; VIVO	Background: There is increasing evidence that phloroglucinol, a compound from Ecklonia cava, induces the apoptosis of cancer cells, eventually suppressing tumor angiogenesis. Methodology/Principal Findings: This is the first report on phloroglucinol's ability to potentially inhibit the functional bioactivities of endothelial progenitor cells (EPCs) and thereby attenuate tumor growth and angiogenesis in the Lewis lung carcinoma (LLC)-tumor-bearing mouse model. Although Phloroglucinol did not affect their cell toxicity, it specifically inhibited vascular endothelial growth factor (VEGF) dependent migration and capillary-like tube formation of EPCs. Our matrigel plug assay clearly indicated that orally injected phloroglucinol effectively disrupts VEGF-induced neovessel formation. Moreover, we demonstrated that when phloroglucinol is orally administered, it significantly inhibits tumor growth and angiogenesis as well as CD45(-)/CD34(+) progenitor mobilization into peripheral blood in vivo in the LLC-tumor-bearing mouse model. Conclusions/Significance: These results suggest a novel role for phloroglucinol: Phloroglucinol might be a modulator of circulating EPC bioactivities, eventually suppressing tumorigenesis. Therefore, phloroglucinol might be a candidate compound for biosafe drugs that target tumor angiogenesis.	[Kwon, Yi-Hong; Kim, Jae-Won; Lee, Boo-Yong] CHA Univ, Dept Food Sci & Biotechnol, Lab Funct Foods & Nutrigenom, Dept Biomed Sci, Kyunggido, South Korea; [Jung, Seok-Yun; Lee, Sang-Hun; Lee, Jun-Hee; Kwon, Sang-Mo] Pusan Natl Univ, Med Res Inst, Sch Med, Lab Vasc Med & Stem Cell Biol,Dept Physiol, Gyeongsangnam Do, South Korea	Pochon Cha University; Pusan National University	Kwon, YH (corresponding author), CHA Univ, Dept Food Sci & Biotechnol, Lab Funct Foods & Nutrigenom, Dept Biomed Sci, Kyunggido, South Korea.	bylee@cha.ac.kr; smkwon323@pusan.ac.kr	lee, sang hun/Q-4650-2019	lee, sang hun/0000-0002-9005-5966; Lee, Junhee/0000-0001-6897-2824	National Research Foundation; Korea government [2010-0020260]; Ministry of Health and Welfare, Republic of Korea [A100322]	National Research Foundation; Korea government(Korean Government); Ministry of Health and Welfare, Republic of Korea(Ministry of Health & Welfare (MOHW), Republic of Korea)	This work was supported by a National Research Foundation grant funded by the Korea government (2010-0020260) and a grant of the Korean Health Technology R&D Project, Ministry of Health and Welfare, Republic of Korea (A100322). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Asahara T, 1999, CIRC RES, V85, P221, DOI 10.1161/01.RES.85.3.221; Asahara T, 1999, EMBO J, V18, P3964, DOI 10.1093/emboj/18.14.3964; BANAI S, 1994, CIRCULATION, V89, P2183, DOI 10.1161/01.CIR.89.5.2183; Beckermann BM, 2008, BRIT J CANCER, V99, P622, DOI 10.1038/sj.bjc.6604508; Carmeliet P, 2000, NATURE, V407, P249, DOI 10.1038/35025220; Cooney MM, 2006, NAT CLIN PRACT ONCOL, V3, P682, DOI 10.1038/ncponc0663; Cragg GM, 2005, J ETHNOPHARMACOL, V100, P72, DOI 10.1016/j.jep.2005.05.011; Deryugina EI, 2006, CANCER METAST REV, V25, P9, DOI 10.1007/s10555-006-7886-9; Dome B, 2006, CANCER RES, V66, P7341, DOI 10.1158/0008-5472.CAN-05-4654; Dona M, 2004, CANCER RES, V64, P6225, DOI 10.1158/0008-5472.CAN-04-0280; Ebos JML, 2009, CANCER CELL, V15, P232, DOI 10.1016/j.ccr.2009.01.021; Eccles SA, 1996, CANCER RES, V56, P2815; Fang J, 2007, CARCINOGENESIS, V28, P858, DOI 10.1093/carcin/bgl205; Fang ST, 2011, J MOL CELL CARDIOL, V50, P290, DOI 10.1016/j.yjmcc.2010.10.024; Gao DC, 2009, BBA-REV CANCER, V1796, P33, DOI 10.1016/j.bbcan.2009.05.001; Gupta P, 2010, BIOORG MED CHEM LETT, V20, P4427, DOI 10.1016/j.bmcl.2010.06.057; Hicklin DJ, 2005, J CLIN ONCOL, V23, P1011, DOI 10.1200/JCO.2005.06.081; Ho JWY, 2006, HEPATOLOGY, V44, P836, DOI 10.1002/hep.21353; Ingram DA, 2004, BLOOD, V104, P2752, DOI 10.1182/blood-2004-04-1396; Jung MH, 2009, CARCINOGENESIS, V30, P655, DOI 10.1093/carcin/bgp039; Kang KA, 2006, J CELL BIOCHEM, V97, P609, DOI 10.1002/jcb.20668; Kim MM, 2010, FOOD CHEM TOXICOL, V48, P2925, DOI 10.1016/j.fct.2010.07.029; Kwon SM, 2009, CIRC RES, V104, P969, DOI 10.1161/CIRCRESAHA.108.192856; Li Y, 2009, BIOORGAN MED CHEM, V17, P1963, DOI 10.1016/j.bmc.2009.01.031; LIOTTA LA, 1991, CELL, V64, P327, DOI 10.1016/0092-8674(91)90642-C; Lyden D, 2001, NAT MED, V7, P1194, DOI 10.1038/nm1101-1194; Napoli C, 2011, INT J CANCER, V128, P1505, DOI 10.1002/ijc.25743; Oh HK, 2007, CANCER RES, V67, P4851, DOI 10.1158/0008-5472.CAN-06-2979; OREILLY MS, 1994, CELL, V79, P315, DOI 10.1016/0092-8674(94)90200-3; Orimo A, 2005, CELL, V121, P335, DOI 10.1016/j.cell.2005.02.034; Paez-Ribes M, 2009, CANCER CELL, V15, P220, DOI 10.1016/j.ccr.2009.01.027; Patyna S, 2009, Birth Defects Res B Dev Reprod Toxicol, V86, P204, DOI 10.1002/bdrb.20194; Porta C, 2007, CLIN EXP MED, V7, P127, DOI 10.1007/s10238-007-0145-8; Rothley M, 2009, INT J CANCER, V125, P34, DOI 10.1002/ijc.24295; Schempp CM, 2005, PLANTA MED, V71, P999, DOI 10.1055/s-2005-871303; Singh IP, 2009, EXPERT OPIN THER PAT, V19, P847, DOI 10.1517/13543770902916614; Takahashi T, 1999, NAT MED, V5, P434, DOI 10.1038/7434; Tamaskar I, 2008, J UROLOGY, V179, P81, DOI 10.1016/j.juro.2007.08.127; Tonra JR, 2007, IMMUNOL INVEST, V36, P3, DOI 10.1080/08820130600991794; Yi TF, 2008, MOL CANCER THER, V7, P1789, DOI 10.1158/1535-7163.MCT-08-0124; Zhu W, 2006, EXP MOL PATHOL, V80, P267, DOI 10.1016/j.yexmp.2005.07.004	41	20	21	1	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 9	2012	7	4							e33618	10.1371/journal.pone.0033618	http://dx.doi.org/10.1371/journal.pone.0033618			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	955JO	22496756	gold, Green Published, Green Submitted			2022-12-25	WOS:000305014500012
J	Liberman, AC; Antunica-Noguerol, M; Ferraz-de-Paula, V; Palermo-Neto, J; Castro, CN; Druker, J; Holsboer, F; Perone, MJ; Gerlo, S; De Bosscher, K; Haegeman, G; Arzt, E				Liberman, Ana C.; Antunica-Noguerol, Maria; Ferraz-de-Paula, Viviane; Palermo-Neto, Joao; Castro, Carla N.; Druker, Jimena; Holsboer, Florian; Perone, Marcelo J.; Gerlo, Sarah; De Bosscher, Karolien; Haegeman, Guy; Arzt, Eduardo			Compound A, a Dissociated Glucocorticoid Receptor Modulator, Inhibits T-bet (Th1) and Induces GATA-3 (Th2) Activity in Immune Cells	PLOS ONE			English	Article							NF-KAPPA-B; ACTIVATED PROTEIN-KINASE; TRANSCRIPTION FACTOR; DNA-BINDING; IN-VIVO; LINEAGE COMMITMENT; REGULATORY REGION; GENE-EXPRESSION; IL-5 PROMOTER; PLANT-ORIGIN	Background: Compound A (CpdA) is a dissociating non-steroidal glucocorticoid receptor (GR) ligand which has anti-inflammatory properties exerted by down-modulating proinflammatory gene expression. By favouring GR monomer formation, CpdA does not enhance glucocorticoid (GC) response element-driven gene expression, resulting in a reduced side effect profile as compared to GCs. Considering the importance of Th1/Th2 balance in the final outcome of immune and inflammatory responses, we analyzed how selective GR modulation differentially regulates the activity of T-bet and GATA-3, master drivers of Th1 and Th2 differentiation, respectively. Results: Using Western analysis and reporter gene assays, we show in murine T cells that, similar to GCs, CpdA inhibits T-bet activity via a transrepressive mechanism. Different from GCs, CpdA induces GATA-3 activity by p38 MAPK-induction of GATA-3 phosphorylation and nuclear translocation. CpdA effects are reversed by the GR antagonist RU38486, proving the involvement of GR in these actions. ELISA assays demonstrate that modulation of T-bet and GATA-3 impacts on cytokine production shown by a decrease in IFN-gamma and an increase in IL-5 production, respectively. Conclusions: Taken together, through their effect favoring Th2 over Th1 responses, particular dissociated GR ligands, for which CpdA represents a paradigm, hold potential for the application in Th1-mediated immune disorders.	[Liberman, Ana C.; Antunica-Noguerol, Maria; Castro, Carla N.; Druker, Jimena; Perone, Marcelo J.; Arzt, Eduardo] Univ Buenos Aires, Fac Ciencias Exactas & Nat, Lab Fisiol & Biol Mol, Dept Fisiol & Biol Mol & Celular, Buenos Aires, DF, Argentina; [Liberman, Ana C.; Antunica-Noguerol, Maria; Castro, Carla N.; Druker, Jimena; Perone, Marcelo J.; Arzt, Eduardo] Consejo Nacl Invest Cient & Tecn, Partner Inst Max Planck Soc, Inst Invest Biomed Buenos Aires IBioBA, RA-1033 Buenos Aires, DF, Argentina; [Ferraz-de-Paula, Viviane; Palermo-Neto, Joao] FMVZ USP, Neuroimmunomodulat Res Grp, Sao Paulo, Brazil; [Holsboer, Florian; Arzt, Eduardo] Max Planck Inst Psychiat, D-80804 Munich, Germany; [Gerlo, Sarah; De Bosscher, Karolien; Haegeman, Guy] Univ Ghent, Lab Eukaryot Gene Express & Signal Transduct, B-9000 Ghent, Belgium; [Gerlo, Sarah; De Bosscher, Karolien] UGent, VIB Dept Med Prot Res, Ghent, Belgium	University of Buenos Aires; Consejo Nacional de Investigaciones Cientificas y Tecnicas (CONICET); Max Planck Society; Universidade de Sao Paulo; Max Planck Society; Ghent University; Flanders Institute for Biotechnology (VIB); Ghent University	Liberman, AC (corresponding author), Univ Buenos Aires, Fac Ciencias Exactas & Nat, Lab Fisiol & Biol Mol, Dept Fisiol & Biol Mol & Celular, Buenos Aires, DF, Argentina.	earzt@fbmc.fcen.uba.ar		De Bosscher, Karolien/0000-0001-5059-9718; Castro, Carla Noemi/0000-0002-2689-9072	Max Planck Society, Germany; University of Buenos Aires (UBA); CONICET; Agencia Nacional de Promocion Cientifica y Tecnologica, Argentina; FWO Vlaanderen	Max Planck Society, Germany(Max Planck Society); University of Buenos Aires (UBA)(University of Buenos Aires); CONICET(Consejo Nacional de Investigaciones Cientificas y Tecnicas (CONICET)); Agencia Nacional de Promocion Cientifica y Tecnologica, Argentina(ANPCyT); FWO Vlaanderen(FWO)	This work was supported by Grants from the Max Planck Society, Germany; the University of Buenos Aires (UBA), the CONICET and Agencia Nacional de Promocion Cientifica y Tecnologica, Argentina; and the bilateral program of FWO Vlaanderen. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abbas AK, 1996, NATURE, V383, P787, DOI 10.1038/383787a0; Beck IM, 2008, EMBO J, V27, P1682, DOI 10.1038/emboj.2008.95; Blaustein M, 2004, J BIOL CHEM, V279, P21029, DOI 10.1074/jbc.M314260200; Brancho D, 2003, GENE DEV, V17, P1969, DOI 10.1101/gad.1107303; Chen CH, 2000, J IMMUNOL, V165, P5597, DOI 10.4049/jimmunol.165.10.5597; DAY RN, 1989, J BIOL CHEM, V264, P431; De Bosscher K, 2005, P NATL ACAD SCI USA, V102, P15827, DOI 10.1073/pnas.0505554102; De Bosscher K, 2010, CURR OPIN PHARMACOL, V10, P497, DOI 10.1016/j.coph.2010.04.007; Dewint P, 2008, J IMMUNOL, V180, P2608, DOI 10.4049/jimmunol.180.4.2608; FOX HS, 1991, J IMMUNOL, V146, P4362; GIGUERE V, 1986, CELL, V46, P645, DOI 10.1016/0092-8674(86)90339-9; HECK S, 1994, EMBO J, V13, P4087, DOI 10.1002/j.1460-2075.1994.tb06726.x; HO IC, 1991, EMBO J, V10, P1187, DOI 10.1002/j.1460-2075.1991.tb08059.x; Hwang ES, 2005, SCIENCE, V307, P430, DOI 10.1126/science.1103336; Hwang ES, 2002, J IMMUNOL, V169, P248, DOI 10.4049/jimmunol.169.1.248; Kleiman A, 2007, MOL CELL ENDOCRINOL, V275, P98, DOI 10.1016/j.mce.2007.05.009; Klein-Hessling S, 2003, J IMMUNOL, V170, P2956, DOI 10.4049/jimmunol.170.6.2956; Klein-Hessling S, 2008, J BIOL CHEM, V283, P31030, DOI 10.1074/jbc.M805929200; LEE HJ, 1993, J IMMUNOL, V151, P6135; Liberman AC, 2007, FASEB J, V21, P1177, DOI 10.1096/fj.06-7452com; Liberman AC, 2007, CYTOKINE GROWTH F R, V18, P45, DOI 10.1016/j.cytogfr.2007.01.005; Liberman AC, 2009, FASEB J, V23, P1558, DOI 10.1096/fj.08-121236; Louw A, 1997, BIOCHEM PHARMACOL, V53, P189, DOI 10.1016/S0006-2952(96)00661-2; Maneechotesuwan K, 2007, J IMMUNOL, V178, P2491, DOI 10.4049/jimmunol.178.4.2491; Maneechotesuwan K, 2009, PLOS MED, V6, DOI 10.1371/journal.pmed.1000076; Mosmann TR, 1996, IMMUNOL TODAY, V17, P138, DOI 10.1016/0167-5699(96)80606-2; MOSMANN TR, 1989, ANNU REV IMMUNOL, V7, P145, DOI 10.1146/annurev.immunol.7.1.145; Mullen AC, 2001, SCIENCE, V292, P1907, DOI 10.1126/science.1059835; Nawijn MC, 2001, J IMMUNOL, V167, P724, DOI 10.4049/jimmunol.167.2.724; Neurath MF, 2002, J EXP MED, V195, P1129, DOI 10.1084/jem.20011956; Ouyang WJ, 2000, IMMUNITY, V12, P27, DOI 10.1016/S1074-7613(00)80156-9; Peng SL, 2006, CELL MOL IMMUNOL, V3, P87; Plaisance S, 1997, MOL CELL BIOL, V17, P3733, DOI 10.1128/MCB.17.7.3733; Quan A, 2001, J ALLERGY CLIN IMMUN, V108, P340; Rauch A, 2011, FASEB J, V25, P1323, DOI 10.1096/fj.10-173393; Reichardt HM, 1998, CELL, V93, P531, DOI 10.1016/S0092-8674(00)81183-6; Reichardt HM, 2001, EMBO J, V20, P7168, DOI 10.1093/emboj/20.24.7168; Robertson S, 2010, J BIOL CHEM, V285, P8061, DOI 10.1074/jbc.M109.087866; RUPPRECHT R, 1993, MOL ENDOCRINOL, V7, P597, DOI 10.1210/me.7.4.597; Szabo SJ, 2000, CELL, V100, P655, DOI 10.1016/S0092-8674(00)80702-3; Szabo SJ, 2002, SCIENCE, V295, P338, DOI 10.1126/science.1065543; Takemoto N, 2000, J IMMUNOL, V165, P6687, DOI 10.4049/jimmunol.165.12.6687; Tanos T, 2005, J BIOL CHEM, V280, P18842, DOI 10.1074/jbc.M500620200; Tao YX, 2001, J BIOL CHEM, V276, P2329, DOI 10.1074/jbc.C000526200; Usui T, 2006, J EXP MED, V203, P755, DOI 10.1084/jem.20052165; van Loo G, 2010, MOL ENDOCRINOL, V24, P310, DOI 10.1210/me.2009-0236; Wang XS, 1997, J BIOL CHEM, V272, P23668, DOI 10.1074/jbc.272.38.23668; Wust S, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0008202; Zhang DH, 1998, J IMMUNOL, V161, P3817; Zhang ZR, 2009, J IMMUNOL, V183, P3081, DOI 10.4049/jimmunol.0901088; Zhou M, 2003, IMMUNOL RES, V28, P25, DOI 10.1385/IR:28:1:25; Zhu JF, 2006, CELL RES, V16, P3, DOI 10.1038/sj.cr.7310002	52	31	32	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 9	2012	7	4							e35155	10.1371/journal.pone.0035155	http://dx.doi.org/10.1371/journal.pone.0035155			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	955JO	22496903	Green Published, gold, Green Submitted			2022-12-25	WOS:000305014500048
J	Loetscher, Y; Wieser, A; Lengefeld, J; Kaiser, P; Schubert, S; Heikenwalder, M; Hardt, WD; Stecher, B				Loetscher, Yvonne; Wieser, Andreas; Lengefeld, Jette; Kaiser, Patrick; Schubert, Soeren; Heikenwalder, Mathias; Hardt, Wolf-Dietrich; Stecher, Baerbel			Salmonella Transiently Reside in Luminal Neutrophils in the Inflamed Gut	PLOS ONE			English	Article							SEROVAR TYPHIMURIUM COLITIS; GREEN FLUORESCENT PROTEIN; IDENTIFICATION; RESISTANCE; MICROBIOTA; PATHOLOGY; DISRUPTS; PROVIDES; DISEASE; TRACT	Background: Enteric pathogens need to grow efficiently in the gut lumen in order to cause disease and ensure transmission. The interior of the gut forms a complex environment comprising the mucosal surface area and the inner gut lumen with epithelial cell debris and food particles. Recruitment of neutrophils to the intestinal lumen is a hallmark of non-typhoidal Salmonella enterica infections in humans. Here, we analyzed the interaction of gut luminal neutrophils with S. enterica serovar Typhimurium (S. Tm) in a mouse colitis model. Results: Upon S. Tm-wt infection, neutrophils transmigrate across the mucosa into the intestinal lumen. We detected a majority of pathogens associated with luminal neutrophils 20 hours after infection. Neutrophils are viable and actively engulf S. Tm, as demonstrated by live microscopy. Using S. Tm mutant strains defective in tissue invasion we show that pathogens are mostly taken up in the gut lumen at the epithelial barrier by luminal neutrophils. In these luminal neutrophils, S. Tm induces expression of genes typically required for its intracellular lifestyle such as siderophore production iroBCDE and the Salmonella pathogenicity island 2 encoded type three secretion system (TTSS-2). This shows that S. Tm at least transiently survives and responds to engulfment by gut luminal neutrophils. Gentamicin protection experiments suggest that the life-span of luminal neutrophils is limited and that S. Tm is subsequently released into the gut lumen. This "fast cycling" through the intracellular compartment of gut luminal neutrophils would explain the high fraction of TTSS-2 and iroBCDE expressing intra- and extracellular bacteria in the lumen of the infected gut. Conclusion: In conclusion, live neutrophils recruited during acute S. Tm colitis engulf pathogens in the gut lumen and may thus actively engage in shaping the environment of pathogens and commensals in the inflamed gut.	[Loetscher, Yvonne; Lengefeld, Jette; Kaiser, Patrick; Hardt, Wolf-Dietrich; Stecher, Baerbel] ETH, Inst Microbiol, CH-8092 Zurich, Switzerland; [Wieser, Andreas; Schubert, Soeren; Stecher, Baerbel] Univ Munich, Max Von Pettenkofer Inst, Munich, Germany; [Heikenwalder, Mathias] Tech Univ Munich, Helmholtz Ctr Munich, Inst Virol, Munich, Germany	Swiss Federal Institutes of Technology Domain; ETH Zurich; University of Munich; Helmholtz Association; Helmholtz-Center Munich - German Research Center for Environmental Health; Technical University of Munich	Loetscher, Y (corresponding author), ETH, Inst Agr Sci, Zurich, Switzerland.	stecher@mvp.uni-muenchen.de	Heikenwalder, Mathias/AAA-2269-2020; Stecher, Barbel/B-9940-2019; Stecher, Bärbel/A-2911-2015	Stecher, Bärbel/0000-0002-7445-5193; Hardt, Wolf-Dietrich/0000-0002-9892-6420; Lengfeld, Jette/0000-0001-6021-7613	UBS AG (Zurich); Swiss National Science Foundation (SNF) [310030-132997/1]; 17 DFG [STE 1971/2-1]	UBS AG (Zurich); Swiss National Science Foundation (SNF)(Swiss National Science Foundation (SNSF)); 17 DFG(German Research Foundation (DFG))	This work was supported by the UBS AG (Zurich) on behalf of a customer 16 (WDH), the Swiss National Science Foundation (SNF, 310030-132997/1 to WDH) and the 17 DFG (STE 1971/2-1 to BS). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bachman MA, 2009, PLOS PATHOG, V5, DOI 10.1371/journal.ppat.1000622; Barman M, 2008, INFECT IMMUN, V76, P907, DOI 10.1128/IAI.01432-07; Barthel M, 2003, INFECT IMMUN, V71, P2839, DOI 10.1128/IAI.71.5.2839-2858.2003; Baumler AJ, 1996, GENE, V183, P207, DOI 10.1016/S0378-1119(96)00560-4; Bongaerts RJM, 2002, METHOD ENZYMOL, V358, P43; BOYD JF, 1985, GUT, V26, P935, DOI 10.1136/gut.26.9.935; Brinkmann V, 2004, SCIENCE, V303, P1532, DOI 10.1126/science.1092385; DAY DW, 1978, HISTOPATHOLOGY, V2, P117, DOI 10.1111/j.1365-2559.1978.tb01700.x; Faust N, 2000, BLOOD, V96, P719; Geddes K, 2007, PLOS PATHOG, V3, P2017, DOI 10.1371/journal.ppat.0030196; Hapfelmeier S, 2005, J IMMUNOL, V174, P1675, DOI 10.4049/jimmunol.174.3.1675; Hapfelmeier S, 2004, INFECT IMMUN, V72, P795, DOI 10.1128/IAI.72.2.795-809.2004; HAPFELMEIER S, 2005, TRENDS MICROBIOL; HOISETH SK, 1981, NATURE, V291, P238, DOI 10.1038/291238a0; JONES PW, 1988, VET REC, V123, P536, DOI 10.1136/vr.123.21.536; KJELDSEN L, 1994, BLOOD, V83, P799; LAWLEY TD, 2009, INFECT IMMUN; Luo Y, 1997, CURRENT PROTOCOLS IM, P32021; Lupp C, 2007, CELL HOST MICROBE, V2, P119, DOI 10.1016/j.chom.2007.06.010; MCGOVERN VJ, 1979, AM J SURG PATHOL, V3, P483, DOI 10.1097/00000478-197912000-00001; Pillay J, 2010, BLOOD, V116, P625, DOI 10.1182/blood-2010-01-259028; Raffatellu M, 2009, CELL HOST MICROBE, V5, P476, DOI 10.1016/j.chom.2009.03.011; Rollenhagen C, 2006, INFECT IMMUN, V74, P1649, DOI 10.1128/IAI.74.3.1649-1660.2006; SACHDEV HPS, 1993, J PEDIATR GASTR NUTR, V16, P33, DOI 10.1097/00005176-199301000-00006; Santos RL, 2009, TRENDS MICROBIOL, V17, P498, DOI 10.1016/j.tim.2009.08.008; Santos RL, 2001, MICROBES INFECT, V3, P1335, DOI 10.1016/S1286-4579(01)01495-2; Segal AW, 2005, ANNU REV IMMUNOL, V23, P197, DOI 10.1146/annurev.immunol.23.021704.115653; Sekirov I, 2010, GUT MICROBES, V1, P30, DOI 10.4161/gmic.1.1.10950; Stecher B, 2004, INFECT IMMUN, V72, P4138, DOI 10.1128/IAI.72.7.4138-4150.2004; Stecher B, 2010, CURR OPIN MICROBIOL; Stecher B, 2008, TRENDS MICROBIOL, V16, P107, DOI 10.1016/j.tim.2007.12.008; Stecher B, 2008, CELL MICROBIOL, V10, P1166, DOI 10.1111/j.1462-5822.2008.01118.x; Stecher B, 2007, PLOS BIOL, V5, P2177, DOI 10.1371/journal.pbio.0050244; Stecher B, 2006, INFECT IMMUN, V74, P5047, DOI 10.1128/IAI.00072-06; Stelter C, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0020749; Taylor CM, 2009, MICROB PATHOGENESIS, V46, P114, DOI 10.1016/j.micpath.2008.11.001; VANDERWAAIJ D, 1971, J HYG-CAMB, V69, P405, DOI 10.1017/S0022172400021653; Vijay-Kumar M, 2006, AM J PATHOL, V169, P1686, DOI 10.2353/ajpath.2006.060345; Wieser A, 2011, CELL MICROBIOL, V13, P742, DOI 10.1111/j.1462-5822.2011.01573.x; Winter SE, 2010, NATURE, V467, P426, DOI 10.1038/nature09415	40	43	43	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 6	2012	7	4							e34812	10.1371/journal.pone.0034812	http://dx.doi.org/10.1371/journal.pone.0034812			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	955JA	22493718	gold, Green Published, Green Submitted			2022-12-25	WOS:000305012700060
J	Pritchard, L; Holden, NJ; Bielaszewska, M; Karch, H; Toth, IK				Pritchard, Leighton; Holden, Nicola J.; Bielaszewska, Martina; Karch, Helge; Toth, Ian K.			Alignment-Free Design of Highly Discriminatory Diagnostic Primer Sets for Escherichia coli O104:H4 Outbreak Strains	PLOS ONE			English	Article							POLYMERASE-CHAIN-REACTION; PCR; IDENTIFICATION; PATHOGENS	Background:An Escherichia coli O104:H4 outbreak in Germany in summer 2011 caused 53 deaths, over 4000 individual infections across Europe, and considerable economic, social and political impact. This outbreak was the first in a position to exploit rapid, benchtop high-throughput sequencing (HTS) technologies and crowdsourced data analysis early in its investigation, establishing a new paradigm for rapid response to disease threats. We describe a novel strategy for design of diagnostic PCR primers that exploited this rapid draft bacterial genome sequencing to distinguish between E. coli O104:H4 outbreak isolates and other pathogenic E. coli isolates, including the historical haemolytic uraemic syndrome (HUSEC) E. coli HUSEC041 O104:H4 strain, which possesses the same serotype as the outbreak isolates. Methodology/Principal Findings: Primers were designed using a novel alignment-free strategy against eleven draft whole genome assemblies of E. coli O104:H4 German outbreak isolates from the E. coli O104:H4 Genome Analysis Crowd-Sourcing Consortium website, and a negative sequence set containing 69 E. coli chromosome and plasmid sequences from public databases. Validation in vitro against 21 'positive' E. coli O104:H4 outbreak and 32 'negative' non-outbreak EHEC isolates indicated that individual primer sets exhibited 100% sensitivity for outbreak isolates, with false positive rates of between 9% and 22%. A minimal combination of two primers discriminated between outbreak and non-outbreak E. coli isolates with 100% sensitivity and 100% specificity. Conclusions/Significance: Draft genomes of isolates of disease outbreak bacteria enable high throughput primer design and enhanced diagnostic performance in comparison to traditional molecular assays. Future outbreak investigations will be able to harness HTS rapidly to generate draft genome sequences and diagnostic primer sets, greatly facilitating epidemiology and clinical diagnostics. We expect that high throughput primer design strategies will enable faster, more precise responses to future disease outbreaks of bacterial origin, and help to mitigate their societal impact.	[Pritchard, Leighton; Holden, Nicola J.; Toth, Ian K.] James Hutton Inst, Dundee, Scotland; [Bielaszewska, Martina; Karch, Helge] Univ Munster, Inst Hyg, Munster, Germany; [Bielaszewska, Martina; Karch, Helge] Univ Munster, Natl Consulting Lab Haemolyt Uraem Syndrome, Munster, Germany	James Hutton Institute; University of Munster; University of Munster	Pritchard, L (corresponding author), James Hutton Inst, Dundee, Scotland.	leighton.pritchard@hutton.ac.uk	Pritchard, Leighton/A-7331-2008; Holden, Nicola/B-3038-2009; Holden, Nicola/L-1653-2019; Bielaszewska, Martina/AAC-9812-2022	Pritchard, Leighton/0000-0002-8392-2822; Holden, Nicola/0000-0002-7904-4529; Holden, Nicola/0000-0002-7904-4529; 	Scottish Government Rural and Environment Science and Analytical Services Division (RESAS)	Scottish Government Rural and Environment Science and Analytical Services Division (RESAS)	This work was supported by the Scottish Government Rural and Environment Science and Analytical Services Division (RESAS). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Altschul SF, 1997, NUCLEIC ACIDS RES, V25, P3389, DOI 10.1093/nar/25.17.3389; [Anonymous], NCBI BACT GEN SEQ FT; [Anonymous], NCBI REFSEQ DAT NCBI; [Anonymous], E COL O104 PCR PRIM; [Anonymous], E COL O104 H4 GEN AN; Bielaszewska M, 2011, LANCET INFECT DIS, V11, P671, DOI 10.1016/S1473-3099(11)70165-7; Campagna D, 2009, BIOINFORMATICS, V25, P967, DOI 10.1093/bioinformatics/btp087; Cheung Man Kit, 2011, BMC Res Notes, V4, P533, DOI 10.1186/1756-0500-4-533; Grisham MP, 2007, PLANT DIS, V91, P430, DOI 10.1094/PDIS-91-4-0430; Gurtler V, 2001, INT J SYST EVOL MICR, V51, P3; Ho CC, 2011, J CLIN MICROBIOL, V49, P3714, DOI 10.1128/JCM.05062-11; Holden N, 2009, FEMS MICROBIOL REV, V33, P689, DOI 10.1111/j.1574-6976.2008.00153.x; Homer N, 2009, PLOS ONE, V4, pA95, DOI 10.1371/journal.pone.0007767; Hyatt D, 2010, BMC BIOINFORMATICS, V11, DOI 10.1186/1471-2105-11-119; Li RQ, 2009, BIOINFORMATICS, V25, P1966, DOI 10.1093/bioinformatics/btp336; Lindstedt BA, 2003, J CLIN MICROBIOL, V41, P1469, DOI 10.1128/JCM.41.4.1469-1479.2003; Maiden MCJ, 2006, ANNU REV MICROBIOL, V60, P561, DOI 10.1146/annurev.micro.59.030804.121325; Mellmann A, 2008, EMERG INFECT DIS, V14, P1287, DOI 10.3201/eid1408.071082; Mellmann A, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0022751; *NCBI, NCBI REF SEQ REFSEQ; Pallen MJ, 2007, NATURE, V449, P835, DOI 10.1038/nature06248; Phillippy AM, 2007, PLOS COMPUT BIOL, V3, P887, DOI 10.1371/journal.pcbi.0030098; Phillippy AM, 2009, NUCLEIC ACIDS RES, V37, pW229, DOI 10.1093/nar/gkp286; Rasko DA, 2011, NEW ENGL J MED, V365, P709, DOI 10.1056/NEJMoa1106920; Reinhardt JA, 2009, GENOME RES, V19, P294, DOI 10.1101/gr.083311.108; Rice P, 2000, TRENDS GENET, V16, P276, DOI 10.1016/S0168-9525(00)02024-2; Rohde H, 2011, NEW ENGL J MED, V365, P718, DOI 10.1056/NEJMoa1107643; Rozen S, 2000, Methods Mol Biol, V132, P365; Satya RV, 2010, BMC BIOINFORMATICS, V11, DOI 10.1186/1471-2105-11-340; Satya RV, 2008, BMC GENOMICS, V9, DOI 10.1186/1471-2164-9-496; Schaad N, 2007, PLANT PATHOL; Schaad NW, 2002, PHYTOPATHOLOGY, V92, P721, DOI 10.1094/PHYTO.2002.92.7.721; Slezak Tom, 2003, Briefings in Bioinformatics, V4, P133, DOI 10.1093/bib/4.2.133; Tibayrenc M, 2009, METHODS MOL BIOL, V551, P13, DOI 10.1007/978-1-60327-999-4_2; Toth IK, 2006, ANNU REV PHYTOPATHOL, V44, P305, DOI 10.1146/annurev.phyto.44.070505.143444; Tsen HY, 1998, J APPL MICROBIOL, V84, P585, DOI 10.1046/j.1365-2672.1998.00385.x; Zhang DD, 2010, J FOOD SAFETY, V30, P832, DOI 10.1111/j.1745-4565.2010.00245.x; Zhu DS, 2009, J RAPID METH AUT MIC, V17, P67, DOI 10.1111/j.1745-4581.2009.00158.x	38	30	31	0	24	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 5	2012	7	4							e34498	10.1371/journal.pone.0034498	http://dx.doi.org/10.1371/journal.pone.0034498			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	955IH	22496820	Green Published, gold, Green Accepted, Green Submitted			2022-12-25	WOS:000305010500014
J	Maddox, SM; Coburn, PS; Shankar, N; Conway, T				Maddox, Scott M.; Coburn, Phillip S.; Shankar, Nathan; Conway, Tyrrell			Transcriptional Regulator PerA Influences Biofilm-Associated, Platelet Binding, and Metabolic Gene Expression in Enterococcus faecalis	PLOS ONE			English	Article							BIOSYNTHESIS-ACTIVATING PHEROMONE; SURFACE PROTEIN; AGGREGATION SUBSTANCE; STAPHYLOCOCCUS-AUREUS; PATHOGENICITY ISLAND; STREPTOCOCCUS-MITIS; SERINE-PROTEASE; PILUS LOCUS; VIRULENCE; ENDOCARDITIS	Enterococcus faecalis is an opportunistic pathogen and a leading cause of nosocomial infections, traits facilitated by the ability to quickly acquire and transfer virulence determinants. A 150 kb pathogenicity island (PAI) comprised of genes contributing to virulence is found in many enterococcal isolates and is known to undergo horizontal transfer. We have shown that the PAI-encoded transcriptional regulator PerA contributes to pathogenicity in the mouse peritonitis infection model. In this study, we used whole-genome microarrays to determine the PerA regulon. The PerA regulon is extensive, as transcriptional analysis showed 151 differentially regulated genes. Our findings reveal that PerA coordinately regulates genes important for metabolism, amino acid degradation, and pathogenicity. Further transcriptional analysis revealed that PerA is influenced by bicarbonate. Additionally, PerA influences the ability of E. faecalis to bind to human platelets. Our results suggest that PerA is a global transcriptional regulator that coordinately regulates genes responsible for enterococcal pathogenicity.	[Maddox, Scott M.; Conway, Tyrrell] Univ Oklahoma, Adv Ctr Genome Technol, Norman, OK 73019 USA; [Coburn, Phillip S.; Shankar, Nathan] Univ Oklahoma, Hlth Sci Ctr, Dept Pharmaceut Sci, Oklahoma City, OK USA	University of Oklahoma System; University of Oklahoma - Norman; University of Oklahoma System; University of Oklahoma Health Sciences Center	Maddox, SM (corresponding author), Univ Oklahoma, Adv Ctr Genome Technol, Norman, OK 73019 USA.	nathan-shankar@ouhsc.edu	Coburn, Phillip/V-6698-2019	Coburn, Phillip/0000-0003-3799-5251	National Institutes of Health [AI48945, GM095370]; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI048945, R56AI048945] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM095370] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported by grants AI48945 and GM095370 from the National Institutes of Health (nih.gov). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abe H, 2002, INFECT IMMUN, V70, P3500, DOI 10.1128/IAI.70.7.3500-3509.2002; Abe H, 2008, DNA RES, V15, P25, DOI 10.1093/dnares/dsm033; Abuaita BH, 2009, INFECT IMMUN, V77, P4111, DOI 10.1128/IAI.00409-09; Allen A, 2005, AM J PHYSIOL-CELL PH, V288, pC1, DOI 10.1152/ajpcell.00102.2004; Baldassarri L, 2005, J INFECT DIS, V191, P1253, DOI 10.1086/428778; Barcelona-Andres B, 2002, J BACTERIOL, V184, P6289, DOI 10.1128/JB.184.22.6289-6300.2002; Bensing BA, 2001, INFECT IMMUN, V69, P1373, DOI 10.1128/IAI.69.3.1373-1380.2001; Booth MC, 1996, MOL MICROBIOL, V21, P1175, DOI 10.1046/j.1365-2958.1996.831449.x; Bourgogne A, 2006, J BACTERIOL, V188, P2875, DOI 10.1128/JB.188.8.2875-2884.2006; Bourgogne A, 2007, J BACTERIOL, V189, P6490, DOI 10.1128/JB.00594-07; Bourgogne A, 2010, BMC MICROBIOL, V10, DOI 10.1186/1471-2180-10-17; Bustamante VH, 2008, P NATL ACAD SCI USA, V105, P14591, DOI 10.1073/pnas.0801205105; Chaussee MS, 2003, J BACTERIOL, V185, P6016, DOI 10.1128/JB.185.20.6016-6024.2003; CHOW JW, 1993, ANTIMICROB AGENTS CH, V37, P2474, DOI 10.1128/AAC.37.11.2474; Coburn PS, 2008, INFECT IMMUN, V76, P5668, DOI 10.1128/IAI.00930-08; Coburn PS, 2007, MOL MICROBIOL, V63, P530, DOI 10.1111/j.1365-2958.2006.05520.x; Coburn PS, 2010, PLASMID, V64, P18, DOI 10.1016/j.plasmid.2010.03.001; Coburn PS, 2004, SCIENCE, V306, P2270, DOI 10.1126/science.1103996; Coburn PS, 2003, CELL MICROBIOL, V5, P661, DOI 10.1046/j.1462-5822.2003.00310.x; Condon C, 2010, RNA BIOL, V7, P316, DOI 10.4161/rna.7.3.11913; COQUE TM, 1995, J INFECT DIS, V171, P1223, DOI 10.1093/infdis/171.5.1223; COSTERTON JW, 1987, ANNU REV MICROBIOL, V41, P435, DOI 10.1146/annurev.mi.41.100187.002251; CUNIN R, 1986, MICROBIOL REV, V50, P314, DOI 10.1128/MMBR.50.3.314-352.1986; Detmers FJM, 2001, RES MICROBIOL, V152, P245, DOI 10.1016/S0923-2508(01)01196-2; DURACK DT, 1975, J PATHOL, V115, P81, DOI 10.1002/path.1711150204; Edmond MB, 1999, CLIN INFECT DIS, V29, P239, DOI 10.1086/520192; Even S, 2005, NUCLEIC ACIDS RES, V33, P2141, DOI 10.1093/nar/gki505; Fitzgerald JR, 2006, NAT REV MICROBIOL, V4, P445, DOI 10.1038/nrmicro1425; Gallegos MT, 1997, MICROBIOL MOL BIOL R, V61, P393, DOI 10.1128/.61.4.393-410.1997; Gao P, 2010, J BACTERIOL, V192, P5489, DOI 10.1128/JB.00725-10; Garsin DA, 2001, P NATL ACAD SCI USA, V98, P10892, DOI 10.1073/pnas.191378698; GILMORE MS, 1994, J BACTERIOL, V176, P7335, DOI 10.1128/JB.176.23.7335-7344.1994; Griffith KL, 2002, J MOL BIOL, V322, P237, DOI 10.1016/S0022-2836(02)00782-9; HACKER J, 1983, J BACTERIOL, V154, P1145, DOI 10.1128/JB.154.3.1145-1152.1983; Hacker J, 2000, ANNU REV MICROBIOL, V54, P641, DOI 10.1146/annurev.micro.54.1.641; Hancock LE, 2004, J BACTERIOL, V186, P5629, DOI 10.1128/JB.186.17.5629-5639.2004; Hegstad K, 2010, CLIN MICROBIOL INFEC, V16, P541, DOI 10.1111/j.1469-0691.2010.03226.x; Hidalgo E, 1998, EMBO J, V17, P2629, DOI 10.1093/emboj/17.9.2629; Hills GM, 1940, BIOCHEM J, V34, P1057, DOI 10.1042/bj0341057; IKE Y, 1984, INFECT IMMUN, V45, P528, DOI 10.1128/IAI.45.2.528-530.1984; Irizarry RA, 2003, BIOSTATISTICS, V4, P249, DOI 10.1093/biostatistics/4.2.249; Kaunitz JD, 2006, ALIMENT PHARM THER, V24, P169, DOI 10.1111/j1365-2036.2006.00041.x; KREFT B, 1992, INFECT IMMUN, V60, P25, DOI 10.1128/IAI.60.1.25-30.1992; LOW D, 1984, INFECT IMMUN, V43, P353, DOI 10.1128/IAI.43.1.353-358.1984; Maccallum W G, 1899, J Exp Med, V4, P521, DOI 10.1084/jem.4.5-6.521; Mace C, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0003897; Mathy N, 2007, CELL, V129, P681, DOI 10.1016/j.cell.2007.02.051; McBride SM, 2009, J BACTERIOL, P00031; MEGRAN DW, 1992, CLIN INFECT DIS, V15, P63, DOI 10.1093/clinids/15.1.63; Mitchell J, 2007, MOL MICROBIOL, V64, P844, DOI 10.1111/j.1365-2958.2007.05703.x; Mohamed JA, 2007, J MED MICROBIOL, V56, P1581, DOI 10.1099/jmm.0.47331-0; MORISHITA T, 1981, J BACTERIOL, V148, P64, DOI 10.1128/JB.148.1.64-71.1981; Nakayama J, 2001, MOL MICROBIOL, V41, P145, DOI 10.1046/j.1365-2958.2001.02486.x; Nakayama J, 2006, J BACTERIOL, V188, P8321, DOI 10.1128/JB.00865-06; Nallapareddy SR, 2006, J CLIN INVEST, V116, P2799, DOI 10.1172/JCI29021; Nallapareddy SR, 2011, INFECT IMMUN, V79, P2911, DOI 10.1128/IAI.00039-11; OLMSTED SB, 1991, J BACTERIOL, V173, P7665, DOI 10.1128/jb.173.23.7665-7672.1991; OLMSTED SB, 1994, J INFECT DIS, V170, P1549, DOI 10.1093/infdis/170.6.1549; Palmer KL, 2010, MBIO, V1, DOI 10.1128/mBio.00227-10; Palmer KL, 2010, CURR OPIN MICROBIOL, V13, P632, DOI 10.1016/j.mib.2010.08.004; Paulsen IT, 2003, SCIENCE, V299, P2071, DOI 10.1126/science.1080613; Qin X, 2000, INFECT IMMUN, V68, P2579, DOI 10.1128/IAI.68.5.2579-2586.2000; Qin X, 2001, J BACTERIOL, V183, P3372, DOI 10.1128/JB.183.11.3372-3382.2001; Rasmussen M, 2010, MICROBES INFECT, V12, P295, DOI 10.1016/j.micinf.2010.01.005; Riboulet-Bisson E, 2008, INFECT IMMUN, V76, P3064, DOI 10.1128/IAI.00161-08; Richards MJ, 2000, INFECT CONT HOSP EP, V21, P510, DOI 10.1086/501795; Seo HS, 2010, PLOS PATHOG, V6, DOI 10.1371/journal.ppat.1001047; Shankar N, 2002, NATURE, V417, P746, DOI 10.1038/nature00802; Shankar N, 2001, INFECT IMMUN, V69, P4366, DOI 10.1128/IAI.69.7.4366-4372.2001; Shankar V, 1999, INFECT IMMUN, V67, P193, DOI 10.1128/IAI.67.1.193-200.1999; Shepard BD, 2002, INFECT IMMUN, V70, P4344, DOI 10.1128/IAI.70.8.4344-4352.2002; Singh KV, 2007, J INFECT DIS, V195, P1671, DOI 10.1086/517524; SLADE HD, 1952, J BACTERIOL, V64, P455, DOI 10.1128/JB.64.4.455-466.1952; Sullam PM, 1996, INFECT IMMUN, V64, P4915, DOI 10.1128/IAI.64.12.4915-4921.1996; Sussmuth SD, 2000, INFECT IMMUN, V68, P4900; Tendolkar PM, 2006, J BACTERIOL, V188, P2063, DOI 10.1128/JB.188.6.2063-2072.2006; Tendolkar PM, 2004, INFECT IMMUN, V72, P6032, DOI 10.1128/IAI.72.10.6032-6039.2004; Toledo-Arana A, 2001, APPL ENVIRON MICROB, V67, P4538, DOI 10.1128/AEM.67.10.4538-4545.2001; Traxler MF, 2008, MOL MICROBIOL, V68, P1128, DOI 10.1111/j.1365-2958.2008.06229.x; van Schaik W, 2010, CLIN MICROBIOL INFEC, V16, P527, DOI 10.1111/j.1469-0691.2010.03201.x; Waters CM, 2001, J BACTERIOL, V183, P5659, DOI 10.1128/JB.183.19.5659-5667.2001; Wren JD, 2006, OMICS, V10, P15, DOI 10.1089/omi.2006.10.15; Yang J, 2008, MOL MICROBIOL, V68, P314, DOI 10.1111/j.1365-2958.2008.06171.x; Yasmin A, 2010, J BACTERIOL, V192, P1122, DOI 10.1128/JB.01293-09; Zhu Y, 2007, INFECT IMMUN, V75, P4219, DOI 10.1128/IAI.00509-07	85	8	8	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 4	2012	7	4							e34398	10.1371/journal.pone.0034398	http://dx.doi.org/10.1371/journal.pone.0034398			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	953GO	22496800	Green Published, gold, Green Submitted			2022-12-25	WOS:000304855200047
J	Ribas, VT; Goncalves, BS; Linden, R; Chiarini, LB				Ribas, Vinicius Toledo; Goncalves, Bruno Souza; Linden, Rafael; Chiarini, Luciana Barreto			Activation of c-Jun N-Terminal Kinase (JNK) during Mitosis in Retinal Progenitor Cells	PLOS ONE			English	Article							PROTEIN-KINASE; NH2-TERMINAL KINASE; INHIBITOR SP600125; CYCLE PROGRESSION; NERVOUS-SYSTEM; GANGLION-CELL; NEURAL-TUBE; PHOSPHORYLATION; APOPTOSIS; PROLIFERATION	Most studies of c-Jun N-terminal Kinase (JNK) activation in retinal tissue were done in the context of neurodegeneration. In this study, we investigated the behavior of JNK during mitosis of progenitor cells in the retina of newborn rats. Retinal explants from newborn rats were kept in vitro for 3 hours and under distinct treatments. Sections of retinal explants or freshly fixed retinal tissue were used to detect JNK phosphorylation by immunohistochemistry, and were examined through both fluorescence and confocal microscopy. Mitotic cells were identified by chromatin morphology, histone-H3 phosphorylation, and location in the retinal tissue. The subcellular localization of proteins was analyzed by double staining with both a DNA marker and an antibody to each protein. Phosphorylation of JNK was also examined by western blot. The results showed that in the retina of newborn rats (P1), JNK is phosphorylated during mitosis of progenitor cells, mainly during the early stages of mitosis. JNK1 and/or JNK2 were preferentially phosphorylated in mitotic cells. Inhibition of JNK induced cell cycle arrest, specifically in mitosis. Treatment with the JNK inhibitor decreased the number of cells in anaphase, but did not alter the number of cells in either prophase/prometaphase or metaphase. Moreover, cells with aberrant chromatin morphology were found after treatment with the JNK inhibitor. The data show, for the first time, that JNK is activated in mitotic progenitor cells of developing retinal tissue, suggesting a new role of JNK in the control of progenitor cell proliferation in the retina.	[Ribas, Vinicius Toledo; Goncalves, Bruno Souza; Linden, Rafael; Chiarini, Luciana Barreto] Univ Fed Rio de Janeiro, Inst Biofis Carlos Chagas Filho, Rio de Janeiro, Brazil	Universidade Federal do Rio de Janeiro	Ribas, VT (corresponding author), Univ Fed Rio de Janeiro, Inst Biofis Carlos Chagas Filho, Rio de Janeiro, Brazil.	chiarini@biof.ufrj.br	de Toledo Ribas, Vinicius/I-5780-2014; Ribas, Vinicius/ABG-2706-2020; Linden, Rafael/F-2275-2011; Chiarini, Luciana B/J-3644-2015; de Toledo Ribas, Vinicius/AAX-8713-2021	de Toledo Ribas, Vinicius/0000-0001-8161-786X; Ribas, Vinicius/0000-0001-8161-786X; Linden, Rafael/0000-0003-3287-336X; de Toledo Ribas, Vinicius/0000-0001-8161-786X	Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPq); Fundacao de Amparo a Pesquisa do Estado do Rio de Janeiro (FAPERJ); Programa de Apoio a Nucleos de Excelencia-Rio (PRONEX-Rio); Pensa Rio	Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPq)(Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPQ)); Fundacao de Amparo a Pesquisa do Estado do Rio de Janeiro (FAPERJ)(Fundacao Carlos Chagas Filho de Amparo a Pesquisa do Estado do Rio De Janeiro (FAPERJ)); Programa de Apoio a Nucleos de Excelencia-Rio (PRONEX-Rio); Pensa Rio	This study was supported by grants from Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPq - www.cnpq.br), Fundacao de Amparo a Pesquisa do Estado do Rio de Janeiro (FAPERJ - www.faperj.br), Programa de Apoio a Nucleos de Excelencia-Rio (PRONEX-Rio), and Pensa Rio. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adler R, 2000, PROG RETIN EYE RES, V19, P529, DOI 10.1016/S1350-9462(00)00008-2; Araujo Elizabeth Giestal De, 1993, European Journal of Neuroscience, V5, P1181, DOI 10.1111/j.1460-9568.1993.tb00972.x; Bennett BL, 2001, P NATL ACAD SCI USA, V98, P13681, DOI 10.1073/pnas.251194298; Bode AM, 2007, MOL CARCINOGEN, V46, P591, DOI 10.1002/mc.20348; Campos CBL, 2002, NEUROSCIENCE, V112, P583, DOI 10.1016/S0306-4522(02)00096-9; Chang LF, 2001, NATURE, V410, P37, DOI 10.1038/35065000; Chang LF, 2003, DEV CELL, V4, P521, DOI 10.1016/S1534-5807(03)00094-7; Chen X, 2010, NEUROSCIENCE, V165, P705, DOI 10.1016/j.neuroscience.2009.11.007; Chuang JY, 2008, MOL BIOL CELL, V19, P1139, DOI 10.1091/mbc.E07-09-0881; Crocker SJ, 2006, J NEUROCHEM, V96, P489, DOI 10.1111/j.1471-4159.2005.03568.x; DEBRABANDER M, 1981, CELL BIOL INT REP, V5, P913, DOI 10.1016/0309-1651(81)90206-X; DERIJARD B, 1994, CELL, V76, P1025, DOI 10.1016/0092-8674(94)90380-8; Du LH, 2004, J BIOL CHEM, V279, P11957, DOI 10.1074/jbc.M304935200; Giasson BI, 1997, J NEUROSCI, V17, P9466; Go HS, 2009, NEUROIMMUNOMODULAT, V16, P365, DOI 10.1159/000228911; Goss VL, 2003, CELL SIGNAL, V15, P709, DOI 10.1016/S0898-6568(03)00009-3; Gupta S, 1996, EMBO J, V15, P2760, DOI 10.1002/j.1460-2075.1996.tb00636.x; Gutierrez GJ, 2010, NAT CELL BIOL, V12, P686, DOI 10.1038/ncb2071; Gutierrez GJ, 2010, J BIOL CHEM, V285, P14217, DOI 10.1074/jbc.M110.121848; Hayes NL, 2000, DEV NEUROSCI-BASEL, V22, P44, DOI 10.1159/000017426; Hendzel MJ, 1997, CHROMOSOMA, V106, P348, DOI 10.1007/s004120050256; Hess P, 2002, NAT GENET, V32, P201, DOI 10.1038/ng946; Huang EJ, 2001, ANNU REV NEUROSCI, V24, P677, DOI 10.1146/annurev.neuro.24.1.677; Hunot S, 2004, P NATL ACAD SCI USA, V101, P665, DOI 10.1073/pnas.0307453101; Kallunki T, 1996, CELL, V87, P929, DOI 10.1016/S0092-8674(00)81999-6; KALLUNKI T, 1994, GENE DEV, V8, P2996, DOI 10.1101/gad.8.24.2996; Kennedy NJ, 2003, CELL CYCLE, V2, P199, DOI 10.4161/cc.2.3.388; Kuan CY, 2003, P NATL ACAD SCI USA, V100, P15184, DOI 10.1073/pnas.2336254100; Kuan CY, 1999, NEURON, V22, P667, DOI 10.1016/S0896-6273(00)80727-8; Kuntzen C, 2005, CANCER RES, V65, P6780, DOI 10.1158/0008-5472.CAN-04-2618; Kwong JMK, 2006, EXP EYE RES, V82, P576, DOI 10.1016/j.exer.2005.08.017; KYRIAKIS JM, 1994, NATURE, V369, P156, DOI 10.1038/369156a0; Kyriakis JM, 2001, PHYSIOL REV, V81, P807, DOI 10.1152/physrev.2001.81.2.807; Kyriakis JM, 1996, J BIOL CHEM, V271, P24313, DOI 10.1074/jbc.271.40.24313; Lee K, 2008, CELL CYCLE, V7, P216, DOI 10.4161/cc.7.2.5155; Levikocitch-Verbin H, 2007, EXP EYE RES, V85, P250; Linden R, 1999, PROG RETIN EYE RES, V18, P133, DOI 10.1016/S1350-9462(98)00020-2; MacCorkle RA, 2004, J BIOL CHEM, V279, P40112, DOI 10.1074/jbc.M405481200; Mielke K, 2000, PROG NEUROBIOL, V61, P45, DOI 10.1016/S0301-0082(99)00042-8; Mingo-Sion AM, 2004, ONCOGENE, V23, P596, DOI 10.1038/sj.onc.1207147; MOHIT AA, 1995, NEURON, V14, P67, DOI 10.1016/0896-6273(95)90241-4; Moon DO, 2009, EXP MOL MED, V41, P665, DOI 10.3858/emm.2009.41.9.073; Moon SW, 2009, BIOCHEM BIOPH RES CO, V388, P167, DOI 10.1016/j.bbrc.2009.07.144; Munemasa Y, 2005, BRAIN RES, V1044, P227, DOI 10.1016/j.brainres.2005.03.014; Nishina H, 2004, J BIOCHEM, V136, P123, DOI 10.1093/jb/mvh117; PERRY VH, 1983, J COMP NEUROL, V219, P356, DOI 10.1002/cne.902190309; Putcha GV, 2003, NEURON, V38, P899, DOI 10.1016/S0896-6273(03)00355-6; REESE BE, 1992, NEUROSCIENCE, V46, P419, DOI 10.1016/0306-4522(92)90062-7; Rehen SK, 1996, DEVELOPMENT, V122, P1439; Rehen SK, 1999, EUR J NEUROSCI, V11, P4349, DOI 10.1046/j.1460-9568.1999.00868.x; Ribas VT, 2011, NEUROSCIENCE, V180, P64, DOI 10.1016/j.neuroscience.2011.01.059; Ries V, 2008, J NEUROCHEM, V107, P1578, DOI 10.1111/j.1471-4159.2008.05713.x; Rusan NM, 2009, TRAFFIC, V10, P472, DOI 10.1111/j.1600-0854.2009.00880.x; Sabapathy K, 1999, MECH DEVELOP, V89, P115, DOI 10.1016/S0925-4773(99)00213-0; Sabapathy K, 2004, MOL CELL, V15, P713, DOI 10.1016/j.molcel.2004.08.028; Sakurai T, 2006, P NATL ACAD SCI USA, V103, P10544, DOI 10.1073/pnas.0603499103; Sauer FC, 1935, J COMP NEUROL, V62, P377, DOI 10.1002/cne.900620207; Tatebayashi Y, 2006, FASEB J, V20, P762, DOI 10.1096/fj.05-4362fje; Tezel G, 2004, BRAIN RES, V996, P202, DOI 10.1016/j.brainres.2003.10.029; Uhlirova M, 2005, P NATL ACAD SCI USA, V102, P13123, DOI 10.1073/pnas.0504170102; Wada T, 2004, NAT CELL BIOL, V6, P215, DOI 10.1038/ncb1098; Wang M, 2009, J PATHOL, V218, P95, DOI 10.1002/path.2521; Weston CR, 2004, P NATL ACAD SCI USA, V101, P14114, DOI 10.1073/pnas.0406061101; Yamamoto K, 1999, MOL CELL BIOL, V19, P8469; Yang DD, 1997, NATURE, V389, P865, DOI 10.1038/39899	65	9	9	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 4	2012	7	4							e34483	10.1371/journal.pone.0034483	http://dx.doi.org/10.1371/journal.pone.0034483			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	953GO	22496813	Green Published, Green Submitted, gold			2022-12-25	WOS:000304855200055
J	Flo, E; Pallesen, S; Mageroy, N; Moen, BE; Gronli, J; Nordhus, IH; Bjorvatn, B				Flo, Elisabeth; Pallesen, Stale; Mageroy, Nils; Moen, Bente Elisabeth; Gronli, Janne; Nordhus, Inger Hilde; Bjorvatn, Bjorn			Shift Work Disorder in Nurses - Assessment, Prevalence and Related Health Problems	PLOS ONE			English	Article							HOSPITAL ANXIETY; DEPRESSION SCALE; SLEEP DISORDERS; FATIGUE; POPULATION; VALIDATION	Background: This study investigates the prevalence of symptoms of shift work disorder in a sample of nurses, and its association to individual, health and work variables. Methodology/Principal Findings: We investigated three different shift work disorder assessment procedures all based on current diagnostic criteria and employing symptom based questions. Crude and adjusted logistic regression analyses were performed with symptoms of shift work disorder as the dependent variable. Participants (n=1968) reported age, gender, work schedule, commuting time, weekly work hours, children in household, number of nights and number of shifts separated by less than 11 hours worked the last year, use of bright light therapy, melatonin and sleep medication, and completed the Bergen Insomnia Scale, Epworth Sleepiness Scale, Global Sleep Assessment Questionnaire, Diurnal Scale, Revised Circadian Type Inventory, Dispositional Resilience (Hardiness) Scale - Revised, Fatigue Questionnaire, questions about alcohol and caffeine consumption, as well as the Hospital Anxiety and Depression Scale. Conclusions/Significance: Prevalence rates of symptoms of shift work disorder varied from 32.4-37.6% depending on the assessment method and from 4.8-44.3% depending on the work schedule. Associations were found between symptoms of shift work disorder and age, gender, circadian type, night work, number of shifts separated by less than 11 hours and number of nights worked the last year, insomnia and anxiety. The different assessment procedures yielded similar results (prevalence and logistic regression analyses). The prevalence of symptoms indicative of shift work disorder was high. We argue that three symptom-based questions used in the present study adequately assess shift work disorder in epidemiological studies.	[Flo, Elisabeth; Pallesen, Stale; Gronli, Janne; Nordhus, Inger Hilde; Bjorvatn, Bjorn] Haukeland Hosp, Norwegian Competence Ctr Sleep Disorders, N-5021 Bergen, Norway; [Flo, Elisabeth; Pallesen, Stale] Univ Bergen, Dept Psychosocial Sci, Bergen, Norway; [Mageroy, Nils] Uni Hlth, Occupat & Environm Med, Bergen, Norway; [Mageroy, Nils; Moen, Bente Elisabeth] Haukeland Hosp, Dept Occupat Med, N-5021 Bergen, Norway; [Moen, Bente Elisabeth; Bjorvatn, Bjorn] Univ Bergen, Dept Publ Hlth & Primary Hlth Care, Bergen, Norway; [Gronli, Janne] Univ Bergen, Dept Biol & Med Psychol, Bergen, Norway; [Nordhus, Inger Hilde] Univ Bergen, Dept Clin Psychol, Bergen, Norway	University of Bergen; Haukeland University Hospital; University of Bergen; University of Bergen; Haukeland University Hospital; University of Bergen; University of Bergen; University of Bergen	Flo, E (corresponding author), Haukeland Hosp, Norwegian Competence Ctr Sleep Disorders, N-5021 Bergen, Norway.	elisabeth.flo@psykp.uib.no	Moen, BE/P-9329-2017	Flo, Elisabeth/0000-0003-4312-3855	Western Norway Regional Health Authority [911386, 911540]; Norwegian Nurses Organisation	Western Norway Regional Health Authority; Norwegian Nurses Organisation	The project generating the data analyzed in the present study received a grant for practical administration and data collection from The Western Norway Regional Health Authority (no personal payment/salary). Grant number 911386. Elisabeth Flo received a PhD grant from The Western Norway Regional Health Authority, committing her to write three peer reviewed articles. Grant number 911540. The Western Norway Regional Health Authority webpage: http://helse-vest.no/english/Sider/side.aspx. Economic support (minor amount) was also received from The Norwegian Nurses Organisation for postal services related to mailing of questionnaires (no personal payment/salary). The funders (The Western Norway Regional Health Authority) had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	*AASM, 2005, INT CLASS SLEEP DIS; Akerstedt T, 2010, CHRONOBIOL INT, V27, P975, DOI 10.3109/07420528.2010.489001; American Psychiatric Association (APA), 2000, DIAGN STAT MAN MENT; Bartone TP, 1989, J OCCUP ENVIRON MED, V31, P657; Baruch Y, 1999, HUM RELAT, V52, P421, DOI 10.1023/A:1016905407491; Bjelland I, 2002, J PSYCHOSOM RES, V52, P69, DOI 10.1016/S0022-3999(01)00296-3; Bush K, 1998, ARCH INTERN MED, V158, P1789, DOI 10.1001/archinte.158.16.1789; CHALDER T, 1993, J PSYCHOSOM RES, V37, P147, DOI 10.1016/0022-3999(93)90081-P; Di Milia L, 2005, PERS INDIV DIFFER, V39, P1293, DOI 10.1016/j.paid.2005.04.012; Dijk DJ, 1999, J PHYSIOL-LONDON, V516, P611, DOI 10.1111/j.1469-7793.1999.0611v.x; Drake CL, 2004, SLEEP, V27, P1453, DOI 10.1093/sleep/27.8.1453; Harma M, 2010, SCAND J WORK ENV HEA, V36, P81; Hystad SW, 2010, SCAND J PSYCHOL, V51, P237, DOI 10.1111/j.1467-9450.2009.00759.x; JOHNS NJ, 1991, SLEEP, V14, P540; Knudsen AK, 2010, AM J EPIDEMIOL, V172, P1306, DOI 10.1093/aje/kwq257; Kober T, 2010, ARBEIDSTID BLANT HEL; Loge JH, 1998, J PSYCHOSOM RES, V45, P53, DOI 10.1016/S0022-3999(97)00291-2; Munakata M, 2001, HYPERTENS RES, V24, P25, DOI 10.1291/hypres.24.25; Pallesen S, 2007, SLEEP, V30, P619, DOI 10.1093/sleep/30.5.619; Pallesen S, 2008, PERCEPT MOTOR SKILL, V107, P691, DOI 10.2466/PMS.107.3.691-706; Parent-Thirion A., 2007, 4 EUROPEAN WORKING C; Roth T, 2002, SLEEP MED, V3, P99, DOI 10.1016/S1389-9457(01)00131-9; Sack RL, 2007, SLEEP, V30, P1460, DOI 10.1093/sleep/30.11.1460; Saksvik IB, 2011, SLEEP MED REV, V15, P221, DOI 10.1016/j.smrv.2010.07.002; Shen JH, 2006, J SLEEP RES, V15, P1, DOI 10.1111/j.1365-2869.2006.00493.x; TORSVALL L, 1980, SCAND J WORK ENV HEA, V6, P283, DOI 10.5271/sjweh.2608; Waage S, 2009, SLEEP, V32, P558, DOI 10.1093/sleep/32.4.558; ZIGMOND AS, 1983, ACTA PSYCHIAT SCAND, V67, P361, DOI 10.1111/j.1600-0447.1983.tb09716.x	28	162	166	2	69	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 2	2012	7	4							e33981	10.1371/journal.pone.0033981	http://dx.doi.org/10.1371/journal.pone.0033981			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	952GU	22485153	gold, Green Published, Green Submitted, Green Accepted			2022-12-25	WOS:000304780500029
J	Hysom, DA; Naraghi-Arani, P; Elsheikh, M; Carrillo, AC; Williams, PL; Gardner, SN				Hysom, David A.; Naraghi-Arani, Pejman; Elsheikh, Maher; Carrillo, A. Celena; Williams, Peter L.; Gardner, Shea N.			Skip the Alignment: Degenerate, Multiplex Primer and Probe Design Using K-mer Matching Instead of Alignments	PLOS ONE			English	Article							SOFTWARE	PriMux is a new software package for selecting multiplex compatible, degenerate primers and probes to detect diverse targets such as viruses. It requires no multiple sequence alignment, instead applying k-mer algorithms, hence it scales well for large target sets and saves user effort from curating sequences into alignable groups. PriMux has the capability to predict degenerate primers as well as probes suitable for TaqMan or other primer/probe triplet assay formats, or simply probes for microarray or other single-oligo assay formats. PriMux employs suffix array methods for efficient calculations on oligos 10-similar to 100 nt in length. TaqMan (R) primers and probes for each segment of Rift Valley fever virus were designed using PriMux, and lab testing comparing signatures designed using PriMux versus those designed using traditional methods demonstrated equivalent or better sensitivity for the PriMux-designed signatures compared to traditional signatures. In addition, we used PriMux to design TaqMan (R) primers and probes for unalignable or poorly alignable groups of targets: that is, all segments of Rift Valley fever virus analyzed as a single target set of 198 sequences, or all 2863 Dengue virus genomes for all four serotypes available at the time of our analysis. The PriMux software is available as open source from http:/sourceforge.net/projects/PriMux.	[Hysom, David A.; Naraghi-Arani, Pejman; Elsheikh, Maher; Carrillo, A. Celena; Gardner, Shea N.] Lawrence Livermore Natl Lab, Livermore, CA USA; [Williams, Peter L.] Lawrence Berkeley Natl Lab, Joint Genome Inst, Walnut Creek, CA USA	United States Department of Energy (DOE); Lawrence Livermore National Laboratory; United States Department of Energy (DOE); Joint BioEnergy Institute - JBEI; Joint Genome Institute - JGI; Lawrence Berkeley National Laboratory	Hysom, DA (corresponding author), Lawrence Livermore Natl Lab, Livermore, CA USA.	gardner26@LLNL.gov			U.S. Department of Energy by Lawrence Livermore National Laboratory [DE-AC52-07NA27344]; Laboratory Directed Research and Development from Lawrence Livermore National Laboratory [08-SI-002]; Department of Homeland Security, Science and Technology Directorate [HSHQDC-07-X-00933]	U.S. Department of Energy by Lawrence Livermore National Laboratory(United States Department of Energy (DOE)); Laboratory Directed Research and Development from Lawrence Livermore National Laboratory; Department of Homeland Security, Science and Technology Directorate(United States Department of Homeland Security (DHS))	This work performed under the auspices of the U.S. Department of Energy by Lawrence Livermore National Laboratory under Contract DE-AC52-07NA27344. This work was supported by Laboratory Directed Research and Development grant number 08-SI-002 from Lawrence Livermore National Laboratory (https://www.llnl.gov/) and by the Department of Homeland Security, Science and Technology Directorate grant number HSHQDC-07-X-00933. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Edgar RC, 2004, NUCLEIC ACIDS RES, V32, P1792, DOI 10.1093/nar/gkh340; Gardner SN, 2009, NUCLEIC ACIDS RES, V37, P6291, DOI 10.1093/nar/gkp659; Gardner SN, 2004, J CLIN MICROBIOL, V42, P5472, DOI 10.1128/JCM.42.12.5472-5476.2004; Gardner SN, 2003, J CLIN MICROBIOL, V41, P2417, DOI 10.1128/JCM.41.6.2417-2427.2003; Jabado OJ, 2006, NUCLEIC ACIDS RES, V34, P6605, DOI 10.1093/nar/gkl966; Lemmon Gordon H, 2008, Ann Clin Microbiol Antimicrob, V7, P18, DOI 10.1186/1476-0711-7-18; Linhart Chaim, 2002, Bioinformatics, V18 Suppl 1, pS172; Mahony JO, 2000, INT J FOOD MICROBIOL, V61, P177, DOI 10.1016/S0168-1605(00)00378-0; Mandell R. B., 2011, Journal of Bioterrorism and Biodefense, V2, P108; Markham Nicholas R., 2008, V453, P3, DOI 10.1007/978-1-60327-429-6_1; MOE JB, 1981, J CLIN MICROBIOL, V13, P791, DOI 10.1128/JCM.13.4.791-793.1981; Najafabadi HS, 2008, BMC BIOINFORMATICS, V9, DOI 10.1186/1471-2105-9-55; Slezak Tom, 2003, Briefings in Bioinformatics, V4, P133, DOI 10.1093/bib/4.2.133; Souvenir R, 2003, LECT N BIOINFORMAT, V2812, P512; Victoria JG, 2010, J VIROL; Wagner EK, 2004, BASIC VIROLOGY, P136; Weidmann M, 2011, VIROL J, V8, DOI 10.1186/1743-422X-8-81	17	22	25	1	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 2	2012	7	4							e34560	10.1371/journal.pone.0034560	http://dx.doi.org/10.1371/journal.pone.0034560			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	952GU	22485178	Green Published, Green Submitted, gold			2022-12-25	WOS:000304780500053
J	Lin, MH; Shu, JC; Huang, HY; Cheng, YC				Lin, Mei-Hui; Shu, Jwu-Ching; Huang, Hsiu-Yun; Cheng, Yi-Ching			Involvement of Iron in Biofilm Formation by Staphylococcus aureus	PLOS ONE			English	Article							POLYSACCHARIDE INTERCELLULAR ADHESIN; PSEUDOMONAS-AERUGINOSA; CELLS; EPIDERMIDIS; ICA; AGGREGATION; ACQUISITION; LACTOFERRIN; MECHANISMS; EXPRESSION	Staphylococcus aureus is a human pathogen that forms biofilm on catheters and medical implants. The authors' earlier study established that 1,2,3,4,6-penta-O-galloyl-beta-D-glucopyranose (PGG) inhibits biofilm formation by S. aureus by preventing the initial attachment of the cells to a solid surface and reducing the production of polysaccharide intercellular adhesin (PIA). Our cDNA microarray and MALDI-TOF mass spectrometric studies demonstrate that PGG treatment causes the expression of genes and proteins that are normally expressed under iron-limiting conditions. A chemical assay using ferrozine verifies that PGG is a strong iron chelator that depletes iron from the culture medium. This study finds that adding FeSO4 to a medium that contains PGG restores the biofilm formation and the production of PIA by S. aureus SA113. The requirement of iron for biofilm formation by S. aureus SA113 can also be verified using a semi-defined medium, BM, that contains an iron chelating agent, 2,2'-dipyridyl (2-DP). Similar to the effect of PGG, the addition of 2-DP to BM medium inhibits biofilm formation and adding FeSO4 to BM medium that contains 2-DP restores biofilm formation. This study reveals an important mechanism of biofilm formation by S. aureus SA113.	[Lin, Mei-Hui; Shu, Jwu-Ching; Huang, Hsiu-Yun; Cheng, Yi-Ching] Chang Gung Univ, Dept Med Biotechnol, Tao Yuan, Taiwan; [Lin, Mei-Hui; Shu, Jwu-Ching; Huang, Hsiu-Yun; Cheng, Yi-Ching] Chang Gung Univ, Lab Sci, Tao Yuan, Taiwan; [Lin, Mei-Hui; Shu, Jwu-Ching] Chang Gung Univ, Res Ctr Pathogen Bacteria, Tao Yuan, Taiwan	Chang Gung University; Chang Gung University; Chang Gung University	Lin, MH (corresponding author), Chang Gung Univ, Dept Med Biotechnol, Tao Yuan, Taiwan.	thea@mail.cgu.edu.tw		Shu, Jwu-Ching/0000-0003-4862-6056; Lin, Mei-Hui/0000-0002-3498-9377	Chang Gung Memorial Hospital [CMRPD1B0101]; National Science Council of the Republic of China, Taiwan [NSC-99-2320-B-182-013-MY3]	Chang Gung Memorial Hospital(Chang Gung Memorial Hospital); National Science Council of the Republic of China, Taiwan(Ministry of Science and Technology, Taiwan)	This work was supported by grants from the Chang Gung Memorial Hospital (grant number CMRPD1B0101) and from the National Science Council of the Republic of China, Taiwan (grant number NSC-99-2320-B-182-013-MY3). (The funders' websites: http://web1.nsc.gov.tw/mp.aspx?mp = 7, http://www.cgmh.org.tw/eng2002/index.asp.) The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Agladze K, 2005, J BACTERIOL, V187, P8237, DOI 10.1128/JB.187.24.8237-8246.2005; Ardehali R, 2002, ARTIF ORGANS, V26, P512, DOI 10.1046/j.1525-1594.2002.06923.x; Banin E, 2005, P NATL ACAD SCI USA, V102, P11076, DOI 10.1073/pnas.0504266102; Banin E, 2006, APPL ENVIRON MICROB, V72, P2064, DOI 10.1128/AEM.72.3.2064-2069.2006; Barasch J, 2004, NATURE, V432, P811, DOI 10.1038/432811a; Berlutti F, 2005, INT J IMMUNOPATH PH, V18, P661, DOI 10.1177/039463200501800407; Berlutti F, 2004, BIOMETALS, V17, P271; Cramton SE, 1999, INFECT IMMUN, V67, P5427, DOI 10.1128/IAI.67.10.5427-5433.1999; Cramton SE, 2001, INFECT IMMUN, V69, P4079, DOI 10.1128/IAI.69.6.4079-4085.2001; Donlan RM, 2002, CLIN MICROBIOL REV, V15, P167, DOI 10.1128/CMR.15.2.167-193.2002; Fitzpatrick F, 2005, J CLIN MICROBIOL, V43, P1973, DOI 10.1128/JCM.43.4.1973-1976.2005; Foster TJ, 1998, TRENDS MICROBIOL, V6, P484, DOI 10.1016/S0966-842X(98)01400-0; Gotz F, 2002, MOL MICROBIOL, V43, P1367, DOI 10.1046/j.1365-2958.2002.02827.x; Hall-Stoodley L, 2002, CURR OPIN BIOTECH, V13, P228, DOI 10.1016/S0958-1669(02)00318-X; Hindre T, 2008, MICROBIOL-SGM, V154, P30, DOI 10.1099/mic.0.2007/008698-0; IORDANESCU S, 1976, J GEN MICROBIOL, V96, P277, DOI 10.1099/00221287-96-2-277; Johnson M, 2005, J BACTERIOL, V187, P8211, DOI 10.1128/JB.187.23.8211-8215.2005; Johnson M, 2008, INFECT IMMUN, V76, P1756, DOI 10.1128/IAI.01635-07; Lin MH, 2011, ANTIMICROB AGENTS CH, V55, P1021, DOI 10.1128/AAC.00843-10; Lyte M, 2003, LANCET, V361, P130, DOI 10.1016/S0140-6736(03)12231-3; Maresso AW, 2006, BIOMETALS, V19, P193, DOI 10.1007/s10534-005-4863-7; Martin-Lopez JV, 2002, J CLIN MICROBIOL, V40, P1569, DOI 10.1128/JCM.40.4.1569-1570.2002; Mazmanian SK, 2003, SCIENCE, V299, P906, DOI 10.1126/science.1081147; Mey AR, 2005, INFECT IMMUN, V73, P5706, DOI 10.1128/IAI.73.9.5706-5719.2005; Miethke M, 2007, MICROBIOL MOL BIOL R, V71, P413, DOI 10.1128/MMBR.00012-07; Mladenka P, 2011, J INORG BIOCHEM, V105, P693, DOI 10.1016/j.jinorgbio.2011.02.003; Moreau-Marquis S, 2009, AM J RESP CELL MOL, V41, P305, DOI 10.1165/rcmb.2008-0299OC; O'Neill E, 2009, J MED MICROBIOL, V58, P399, DOI 10.1099/jmm.0.005504-0; Rachid S, 2000, ANTIMICROB AGENTS CH, V44, P3357, DOI 10.1128/AAC.44.12.3357-3363.2000; Ratledge C, 2000, ANNU REV MICROBIOL, V54, P881, DOI 10.1146/annurev.micro.54.1.881; Resch A, 2006, PROTEOMICS, V6, P1867, DOI 10.1002/pmic.200500531; Schaible ME, 2004, NAT REV MICROBIOL, V2, P946, DOI 10.1038/nrmicro1046; Shevchenko A, 1996, ANAL CHEM, V68, P850, DOI 10.1021/ac950914h; Singh PK, 2004, BIOMETALS, V17, P267, DOI 10.1023/B:BIOM.0000027703.77456.27; Thompson KM, 2010, FEMS MICROBIOL LETT, V305, P143, DOI 10.1111/j.1574-6968.2010.01918.x; Wu Y, 2009, J BACTERIOL, V191, P1248, DOI 10.1128/JB.01086-08; Yang L, 2007, MICROBIOL-SGM, V153, P1318, DOI 10.1099/mic.0.2006/004911-0; Ymele-Leki P, 2007, APPL ENVIRON MICROB, V73, P1834, DOI 10.1128/AEM.01319-06	38	65	70	0	29	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 27	2012	7	3							e34388	10.1371/journal.pone.0034388	http://dx.doi.org/10.1371/journal.pone.0034388			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	940MY	22479621	Green Published, gold, Green Submitted			2022-12-25	WOS:000303894900089
J	Hu, C; Zhang, SP; Gao, X; Gao, XJ; Xu, XH; Lv, Y; Zhang, Y; Zhu, ZH; Zhang, CQ; Li, Q; Wong, JM; Cui, YP; Zhang, W; Ma, L; Wang, CG				Hu, Chen; Zhang, Shengping; Gao, Xuan; Gao, Xiaojing; Xu, Xiaohong; Lv, Ya; Zhang, Yan; Zhu, Zhenhong; Zhang, Changqing; Li, Qiao; Wong, Jiemin; Cui, Yongping; Zhang, Wen; Ma, Lin; Wang, Chuangui			Roles of Kruppel-associated Box (KRAB)-associated Co-repressor KAP1 Ser-473 Phosphorylation in DNA Damage Response	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							ZINC FINGER PROTEINS; DOUBLE-STRAND BREAKS; CHECKPOINT KINASE; CHK2 KINASE; CELL-CYCLE; COREPRESSOR; ATM; E2F1; P53; TARGET	The Kruppel-associated box (KRAB)-associated co-repressor KAP1 is an essential nuclear co-repressor for the KRAB zinc finger protein superfamily of transcriptional factors. Ataxia telangiectasia mutated (ATM)-Chk2 and ATM- and Rad3-related (ATR)-Chk1 are two primary kinase signaling cascades activated in response to DNA damage. A growing body of evidence suggests that ATM and ATR phosphorylate KAP1 at Ser-824 in response to DNA damage and regulate KAP1-dependent chromatin condensation, DNA repair, and gene expression. Here, we show that, depending on the type of DNA damage that occurs, KAP1 Ser-473 can be phosphorylated by ATM-Chk2 or ATR-Chk1 kinases. Phosphorylation of KAP1 at Ser-473 attenuated its binding to the heterochromatin protein 1 family proteins and inhibited its transcriptional repression of KRAB-zinc finger protein (KRAB-ZFP) target genes. Moreover, KAP1 Ser-473 phosphorylation induced by DNA damage stimulated KAP1-E2F1 binding. Overexpression of heterochromatin protein 1 significantly inhibited E2F1-KAP1 binding. Elimination of KAP1 Ser-473 phosphorylation increased E2F1-targeted proapoptotic gene expression and E2F1-induced apoptosis in response to DNA damage. Furthermore, loss of phosphorylation of KAP1 Ser-473 led to less BRCA1 focus formation and slower kinetics of loss of gamma H2AX foci after DNA damage. KAP1 Ser-473 phosphorylation was required for efficient DNA repair and cell survival in response to DNA damage. Our studies reveal novel functions of KAP1 Ser-473 phosphorylation under stress.	[Hu, Chen; Zhang, Shengping; Gao, Xuan; Gao, Xiaojing; Xu, Xiaohong; Lv, Ya; Wong, Jiemin; Ma, Lin; Wang, Chuangui] E China Normal Univ, Inst Biomed Sci, Shanghai Key Lab Regulatory Biol, Shanghai 200241, Peoples R China; [Hu, Chen; Zhang, Shengping; Gao, Xuan; Gao, Xiaojing; Xu, Xiaohong; Lv, Ya; Wong, Jiemin; Ma, Lin; Wang, Chuangui] E China Normal Univ, Coll Life Sci, Shanghai 200241, Peoples R China; [Zhang, Wen] E China Normal Univ, Dept Chem, Shanghai 200241, Peoples R China; [Zhang, Yan] Chinese Acad Sci, Inst Pasteur Shanghai, Shanghai 200025, Peoples R China; [Zhu, Zhenhong; Zhang, Changqing] Shanghai Jiao Tong Univ, Shanghai Peoples Hosp 6, Dept Orthoped, Shanghai 200233, Peoples R China; [Li, Qiao] Univ Ottawa, Fac Med, Dept Pathol & Lab Med, Ottawa, ON K1H 8M5, Canada; [Cui, Yongping] Shanxi Med Univ, Minist Educ, Key Lab Cellular Physiol, Taiyuan 030001, Shanxi, Peoples R China	East China Normal University; East China Normal University; East China Normal University; Chinese Academy of Sciences; Shanghai Institutes for Biological Sciences, CAS; Le Reseau International des Instituts Pasteur (RIIP); Shanghai Jiao Tong University; University of Ottawa; Shanxi Medical University	Wang, CG (corresponding author), E China Normal Univ, Inst Biomed Sci, Shanghai Key Lab Regulatory Biol, Shanghai 200241, Peoples R China.	cgwang@bio.ecnu.edu.cn		Li, Qiao/0000-0002-5941-1985; Zhu, Zhen-Hong/0000-0002-2292-949X; Wong, Jiemin/0000-0002-5311-842X; zhang, changqing/0000-0002-7408-4126	National Natural Science Foundation of China [31071248, 31171361]; National Basic Research Program of China [2009CB918401]; program for New Century Excellent Talents in University [NCET-08-0194]; Science and Technology Commission of Shanghai Municipality [11DZ2260300]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); National Basic Research Program of China(National Basic Research Program of China); program for New Century Excellent Talents in University(Program for New Century Excellent Talents in University (NCET)); Science and Technology Commission of Shanghai Municipality(Science & Technology Commission of Shanghai Municipality (STCSM))	This work was supported by the National Natural Science Foundation of China (Grants 31071248 and 31171361), the National Basic Research Program of China (Grant 2009CB918401), the program for New Century Excellent Talents in University (Grant NCET-08-0194), and the Science and Technology Commission of Shanghai Municipality (Grant 11DZ2260300) (to C. W.).	Adams CJ, 2008, EMBO REP, V9, P1222, DOI 10.1038/embor.2008.186; Ahn J, 2002, J BIOL CHEM, V277, P48418, DOI 10.1074/jbc.M208321200; Antoni L, 2007, NAT REV CANCER, V7, P925, DOI 10.1038/nrc2251; Arienti KL, 2005, J MED CHEM, V48, P1873, DOI 10.1021/jm0495935; Banath JP, 2004, CANCER RES, V64, P7144, DOI 10.1158/0008-5472.CAN-04-1433; Bartek J, 2001, NAT REV MOL CELL BIO, V2, P877, DOI 10.1038/35103059; Beausoleil SA, 2004, P NATL ACAD SCI USA, V101, P12130, DOI 10.1073/pnas.0404720101; Bennetzen MV, 2010, MOL CELL PROTEOMICS, V9, P1314, DOI 10.1074/mcp.M900616-MCP200; Blasius M, 2011, GENOME BIOL, V12, DOI 10.1186/gb-2011-12-8-r78; Cammas F, 2000, DEVELOPMENT, V127, P2955; Chang CW, 2008, BMC MOL BIOL, V9, DOI 10.1186/1471-2199-9-61; Durocher D, 2001, CURR OPIN CELL BIOL, V13, P225, DOI 10.1016/S0955-0674(00)00201-5; Friedman JR, 1996, GENE DEV, V10, P2067, DOI 10.1101/gad.10.16.2067; Frietze S, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0015082; Gebelein B, 2001, MOL CELL BIOL, V21, P928, DOI 10.1128/MCB.21.3.928-939.2001; Goodarzi AA, 2008, MOL CELL, V31, P167, DOI 10.1016/j.molcel.2008.05.017; Goodarzi AA, 2011, NAT STRUCT MOL BIOL, V18, P831, DOI 10.1038/nsmb.2077; HALL TJ, 1995, CALCIFIED TISSUE INT, V56, P336, DOI 10.1007/BF00318056; Hirao A, 2002, MOL CELL BIOL, V22, P6521, DOI 10.1128/MCB.22.18.6521-6532.2002; Ivanov AV, 2007, MOL CELL, V28, P823, DOI 10.1016/j.molcel.2007.11.012; Iyengar S, 2011, J BIOL CHEM, V286, P26267, DOI 10.1074/jbc.R111.252569; Kherrouche Z, 2006, BIOCHEM J, V396, P547, DOI 10.1042/BJ20051981; Kim ST, 1999, J BIOL CHEM, V274, P37538, DOI 10.1074/jbc.274.53.37538; Krum SA, 2010, J NUCLEIC ACIDS, V2010, DOI 10.4061/2010/801594; Lechner MS, 2000, MOL CELL BIOL, V20, P6449, DOI 10.1128/MCB.20.17.6449-6465.2000; Lee YK, 2007, J BIOL CHEM, V282, P1595, DOI 10.1074/jbc.M606306200; Li X, 2007, J BIOL CHEM, V282, P36177, DOI 10.1074/jbc.M706912200; Lin WC, 2001, GENE DEV, V15, P1833; Lobrich M, 2010, CELL CYCLE, V9, P662, DOI 10.4161/cc.9.4.10764; Manke IA, 2005, MOL CELL, V17, P37, DOI 10.1016/j.molcel.2004.11.021; Mascle XH, 2007, J BIOL CHEM, V282, P10190, DOI 10.1074/jbc.M611429200; Nahle Z, 2002, NAT CELL BIOL, V4, P859, DOI 10.1038/ncb868; Noon AT, 2010, NAT CELL BIOL, V12, P177, DOI 10.1038/ncb2017; O'Geen H, 2007, PLOS GENET, V3, P916, DOI 10.1371/journal.pgen.0030089; Okamoto K, 2006, BIOCHEM BIOPH RES CO, V351, P216, DOI 10.1016/j.bbrc.2006.10.022; Pediconi N, 2003, NAT CELL BIOL, V5, P552, DOI 10.1038/ncb998; Peng HZ, 2000, J MOL BIOL, V295, P1139, DOI 10.1006/jmbi.1999.3402; Rothkamm K, 2003, MOL CELL BIOL, V23, P5706, DOI 10.1128/MCB.23.16.5706-5715.2003; Roy A, 2010, NAT PROTOC, V5, P725, DOI 10.1038/nprot.2010.5; Ryan RF, 1999, MOL CELL BIOL, V19, P4366; Schultz DC, 2001, GENE DEV, V15, P428, DOI 10.1101/gad.869501; Shieh SY, 2000, GENE DEV, V14, P289; Sripathy SP, 2006, MOL CELL BIOL, V26, P8623, DOI 10.1128/MCB.00487-06; Stevens C, 2003, NAT CELL BIOL, V5, P401, DOI 10.1038/ncb974; Stiewe T, 2000, NAT GENET, V26, P464, DOI 10.1038/82617; Tian C, 2009, NAT CELL BIOL, V11, P580, DOI 10.1038/ncb1864; Wang CG, 2005, EMBO J, V24, P3279, DOI 10.1038/sj.emboj.7600791; Wang CG, 2005, J BIOL CHEM, V280, P12339, DOI 10.1074/jbc.C400536200; Wang CG, 2007, J BIOL CHEM, V282, P29902, DOI 10.1074/jbc.M704757200; Wang CG, 2006, NAT CELL BIOL, V8, P1025, DOI 10.1038/ncb1468; Weber P, 2002, DEVELOPMENT, V129, P2329; White DE, 2006, CANCER RES, V66, P11594, DOI 10.1158/0008-5472.CAN-06-4138; Wu XL, 2001, J BIOL CHEM, V276, P2971, DOI 10.1074/jbc.M009727200; WU XW, 1994, P NATL ACAD SCI USA, V91, P3602, DOI 10.1073/pnas.91.9.3602; Zhao Y, 2005, P NATL ACAD SCI USA, V102, P16090, DOI 10.1073/pnas.0505585102; Ziv Y, 2006, NAT CELL BIOL, V8, P870, DOI 10.1038/ncb1446	56	54	57	0	25	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JUN 1	2012	287	23					18937	18952		10.1074/jbc.M111.313262	http://dx.doi.org/10.1074/jbc.M111.313262			16	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	974EF	22496453	hybrid, Green Published			2022-12-25	WOS:000306411900006
J	Eggers, CM; Kline, ER; Zhong, DS; Zhou, W; Marcus, AI				Eggers, Carrie M.; Kline, Erik R.; Zhong, Diansheng; Zhou, Wei; Marcus, Adam I.			STE20-related Kinase Adaptor Protein alpha (STRAD alpha) Regulates Cell Polarity and Invasion through PAK1 Signaling in LKB1-null Cells	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							PEUTZ-JEGHERS-SYNDROME; LUNG-CANCER; LKB1-STRAD-MO25 COMPLEX; C. ELEGANS; LKB1; ACTIVATION; MUTATIONS; PATHWAYS; CDC42; ADENOCARCINOMAS	LKB1 is a Ser/Thr kinase, and its activity is regulated by the pseudokinase, STE20-related adaptor alpha (STRAD alpha). The STRAD alpha-LKB1 pathway plays critical roles in epithelial cell polarity, neuronal polarity, and cancer metastasis. Though much attention is given to the STRAD alpha-LKB1 pathway, the function of STRAD alpha itself, including a role outside of the LKB1 pathway, has not been well-studied. Data in Caenorhabditis elegans suggest that STRAD alpha has an LKB1-independent role in regulating cell polarity, and therefore we tested the hypothesis that STRAD alpha regulates cancer cell polarity and motility when wild-type LKB1 is absent. These results show that STRAD alpha protein is reduced in LKB1-null cell lines (mutation or homozygous deletion) and this partial degradation occurs through the Hsp90-dependent proteasome pathway. The remaining STRAD alpha participates in cell polarity and invasion, such that STRAD alpha depletion results in misaligned lamellipodia, improper Golgi positioning, and reduced invasion. To probe the molecular basis of this defect, we show that STRAD alpha associates in a complex with PAK1, and STRAD alpha loss disrupts PAK1 activity via Thr(423) PAK1 phosphorylation. When STRAD alpha is depleted, PAK1-induced invasion could not occur, suggesting that STRAD alpha is necessary for PAK1 to drive motility. Furthermore, STRAD alpha overexpression caused increased activity of the PAK1-activating protein, rac1, and a constitutively active rac1 mutant (Q61L) rescued pPAK(Thr423) and STRAD alpha invasion defects. Taken together, these results show that a STRAD alpha-rac1-PAK1 pathway regulates cell polarity and invasion in LKB1-null cells. It also suggests that while the function of LKB1 and STRAD alpha undoubtedly overlap, they may also have mutually exclusive roles.	[Eggers, Carrie M.; Kline, Erik R.; Zhong, Diansheng; Zhou, Wei; Marcus, Adam I.] Emory Univ, Winship Canc Inst, Dept Hematol & Oncol, Atlanta, GA 30322 USA	Emory University	Marcus, AI (corresponding author), Emory Univ, Winship Canc Inst, Dept Hematol & Oncol, 1365C Clifton Rd, Atlanta, GA 30322 USA.	aimarcu@emory.edu			American Cancer Society [RSG-08-035-01-CSM]; National Lung Cancer Partnership; Lung Cancer Program Project [5P01 CA116676];  [R01 (1R01CA142858)]; NATIONAL CANCER INSTITUTE [P01CA116676, R01CA142858] Funding Source: NIH RePORTER	American Cancer Society(American Cancer Society); National Lung Cancer Partnership; Lung Cancer Program Project; ; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	This work was supported by an American Cancer Society Research Scholar Award (RSG-08-035-01-CSM), the National Lung Cancer Partnership, and an R01 (1R01CA142858) (to A. I. M.). This work was also supported by a Lung Cancer Program Project Grant (5P01 CA116676) (to A. I. M. and W. Z.).	Alessi DR, 2006, ANNU REV BIOCHEM, V75, P137, DOI 10.1146/annurev.biochem.75.103004.142702; Baas AF, 2004, CELL, V116, P457, DOI 10.1016/S0092-8674(04)00114-X; Baas AF, 2003, EMBO J, V22, P3062, DOI 10.1093/emboj/cdg292; Bokoch GM, 2003, ANNU REV BIOCHEM, V72, P743, DOI 10.1146/annurev.biochem.72.121801.161742; Boudeau J, 2004, J CELL SCI, V117, P6365, DOI 10.1242/jcs.01571; Boudeau J, 2003, EMBO J, V22, P5102, DOI 10.1093/emboj/cdg490; Boudeau J, 2003, BIOCHEM J, V370, P849, DOI 10.1042/BJ20021813; Carretero J, 2004, ONCOGENE, V23, P4037, DOI 10.1038/sj.onc.1207502; Chacko AD, 2005, J PATHOL, V206, P458, DOI 10.1002/path.1794; Contreras CM, 2008, CANCER RES, V68, P759, DOI 10.1158/0008-5472.CAN-07-5014; Deguchi A, 2010, J BIOL CHEM, V285, P18283, DOI 10.1074/jbc.M109.079137; Ding L, 2008, NATURE, V455, P1069, DOI 10.1038/nature07423; Dorfman J, 2008, MOL BIOL CELL, V19, P1614, DOI 10.1091/mbc.E07-05-0454; Dummler B, 2009, CANCER METAST REV, V28, P51, DOI 10.1007/s10555-008-9168-1; Edwards DC, 1999, NAT CELL BIOL, V1, P253, DOI 10.1038/12963; Etienne-Manneville S, 2008, ONCOGENE, V27, P6970, DOI 10.1038/onc.2008.347; Etienne-Manneville S, 2001, CELL, V106, P489, DOI 10.1016/S0092-8674(01)00471-8; Hawley Simon A, 2003, J Biol, V2, P28, DOI 10.1186/1475-4924-2-28; Herbst RS, 2008, NEW ENGL J MED, V359, P1367, DOI 10.1056/NEJMra0802714; Ikediobi ON, 2006, MOL CANCER THER, V5, P2606, DOI 10.1158/1535-7163.MCT-06-0433; Jenne DE, 1998, NAT GENET, V18, P38, DOI 10.1038/ng0198-38; Ji HB, 2007, NATURE, V448, P807, DOI 10.1038/nature06030; Jiang P, 2009, CANCER LETT, V284, P122, DOI 10.1016/j.canlet.2009.02.034; Kim AS, 2000, NATURE, V404, P151, DOI 10.1038/35004513; Kim JSM, 2010, DEVELOPMENT, V137, P93, DOI 10.1242/dev.041459; Kline ER, 2011, HEAD NECK-J SCI SPEC, V33, P1501, DOI 10.1002/hed.21638; Kumar A, 2009, J CELL BIOCHEM, V107, P579, DOI 10.1002/jcb.22159; Lei M, 2000, CELL, V102, P387, DOI 10.1016/S0092-8674(00)00043-X; Lucas ME, 2009, J BIOL CHEM, V284, P14698, DOI 10.1074/jbc.M901104200; MANSER E, 1994, NATURE, V367, P40, DOI 10.1038/367040a0; Marcus AI, 2010, J THORAC ONCOL, V5, P1883, DOI 10.1097/JTO.0b013e3181fbc28a; McCabe MT, 2010, CANCER GENET CYTOGEN, V197, P130, DOI 10.1016/j.cancergencyto.2009.11.017; Narbonne P, 2010, DEVELOPMENT, V137, P661, DOI 10.1242/dev.042044; Nony P, 2003, ONCOGENE, V22, P9165, DOI 10.1038/sj.onc.1207179; Roberts AB, 2003, P NATL ACAD SCI USA, V100, P8621, DOI 10.1073/pnas.1633291100; Sanchez-Cespedes M, 2002, CANCER RES, V62, P3659; Sells MA, 1997, CURR BIOL, V7, P202, DOI 10.1016/S0960-9822(97)70091-5; Sells MA, 2000, J CELL BIOL, V151, P1449, DOI 10.1083/jcb.151.7.1449; Wingo SN, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0005137; Zeqiraj E, 2009, SCIENCE, V326, P1707, DOI 10.1126/science.1178377; Zhang SM, 2008, CANCER RES, V68, P740, DOI 10.1158/0008-5472.CAN-07-2989; Zhong DS, 2006, LUNG CANCER, V53, P285, DOI 10.1016/j.lungcan.2006.05.018	42	14	16	0	6	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAY 25	2012	287	22					18758	18768		10.1074/jbc.M111.316422	http://dx.doi.org/10.1074/jbc.M111.316422			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	974EC	22493453	hybrid, Green Published			2022-12-25	WOS:000306411600084
J	Kesic, MJ; Meyer, M; Bauer, R; Jaspers, I				Kesic, Matthew J.; Meyer, Megan; Bauer, Rebecca; Jaspers, Ilona			Exposure to Ozone Modulates Human Airway Protease/Antiprotease Balance Contributing to Increased Influenza A Infection	PLOS ONE			English	Article							BRONCHIAL EPITHELIAL-CELLS; SECRETORY LEUKOPROTEASE INHIBITOR; TRANSMEMBRANE SERINE PROTEASES; SOUTHWEST MEXICO-CITY; OXIDATIVE STRESS; CIGARETTE-SMOKE; VIRAL-INFECTION; ALPHA(1)-PROTEINASE INHIBITOR; INFLAMMATORY RESPONSE; GENE-EXPRESSION	Exposure to oxidant air pollution is associated with increased respiratory morbidities and susceptibility to infections. Ozone is a commonly encountered oxidant air pollutant, yet its effects on influenza infections in humans are not known. The greater Mexico City area was the primary site for the spring 2009 influenza A H1N1 pandemic, which also coincided with high levels of environmental ozone. Proteolytic cleavage of the viral membrane protein hemagglutinin (HA) is essential for influenza virus infectivity. Recent studies suggest that HA cleavage might be cell-associated and facilitated by the type II transmembrane serine proteases (TTSPs) human airway trypsin-like protease (HAT) and transmembrane protease, serine 2 (TMPRSS2), whose activities are regulated by antiproteases, such as secretory leukocyte protease inhibitor (SLPI). Based on these observations, we sought to determine how acute exposure to ozone may modulate cellular protease/antiprotease expression and function, and to define their roles in a viral infection. We utilized our in vitro model of differentiated human nasal epithelial cells (NECs) to determine the effects of ozone on influenza cleavage, entry, and replication. We show that ozone exposure disrupts the protease/antiprotease balance within the airway liquid. We also determined that functional forms of HAT, TMPRSS2, and SLPI are secreted from human airway epithelium, and acute exposure to ozone inversely alters their expression levels. We also show that addition of antioxidants significantly reduces virus replication through the induction of SLPI. In addition, we determined that ozone-induced cleavage of the viral HA protein is not cell-associated and that secreted endogenous proteases are sufficient to activate HA leading to a significant increase in viral replication. Our data indicate that pre-exposure to ozone disrupts the protease/antiprotease balance found in the human airway, leading to increased influenza susceptibility.	[Kesic, Matthew J.; Meyer, Megan; Bauer, Rebecca; Jaspers, Ilona] Univ N Carolina, Ctr Environm Med Asthma & Lung Biol, Chapel Hill, NC 27515 USA; [Bauer, Rebecca; Jaspers, Ilona] Univ N Carolina, Curriculum Toxicol, Chapel Hill, NC 27515 USA; [Jaspers, Ilona] Univ N Carolina, Dept Pediat, Chapel Hill, NC 27515 USA; [Meyer, Megan; Jaspers, Ilona] Univ N Carolina, Dept Microbiol & Immunol, Chapel Hill, NC 27515 USA	University of North Carolina; University of North Carolina Chapel Hill; University of North Carolina; University of North Carolina Chapel Hill; University of North Carolina; University of North Carolina Chapel Hill; University of North Carolina; University of North Carolina Chapel Hill	Kesic, MJ (corresponding author), Univ N Carolina, Ctr Environm Med Asthma & Lung Biol, Chapel Hill, NC 27515 USA.	kesic@email.unc.edu	Jaspers, Ilona/AAZ-5035-2020		National Heart, Lung, and Blood Institute (NHLBI), National Institutes of Health [HL095163]; Flight Attendant Medical Research Institute (FAMRI); Environmental Protection Agency [CR829522]; National Institute of Environmental Health Sciences [T32 ES007126-26]; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL095163] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES [R01ES013611, T32ES007126, P30ES010126] Funding Source: NIH RePORTER	National Heart, Lung, and Blood Institute (NHLBI), National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); Flight Attendant Medical Research Institute (FAMRI); Environmental Protection Agency(United States Environmental Protection Agency); National Institute of Environmental Health Sciences(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Environmental Health Sciences (NIEHS)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Environmental Health Sciences (NIEHS))	The project described was in part supported by grant number HL095163 from the National Heart, Lung, and Blood Institute (NHLBI), National Institutes of Health, a grant from the Flight Attendant Medical Research Institute (FAMRI), as well as a grant from the Environmental Protection Agency (CR829522) (all to IJ). This research was also supported by grant number T32 ES007126-26 National Institute of Environmental Health Sciences Curriculum of Toxicology Training Grant. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abboud RT, 2008, INT J TUBERC LUNG D, V12, P361; Becker S, 1998, ENVIRON TOXICOL PHAR, V6, P257, DOI 10.1016/S1382-6689(98)00043-X; Bertram S, 2011, J VIROL, V85, P13363, DOI 10.1128/JVI.05300-11; Bertram S, 2010, J VIROL, V84, P10016, DOI 10.1128/JVI.00239-10; Bottcher-Friebertshauser E, 2011, J VIROL, V85, P1554, DOI 10.1128/JVI.01294-10; Bottcher-Friebertshauser E, 2010, J VIROL, V84, P5605, DOI 10.1128/JVI.00140-10; Bogadel'nikov I V, 1990, Pediatriia, P17; Borja-Aburto VH, 1998, ENVIRON HEALTH PERSP, V106, P849, DOI 10.2307/3434129; Bottcher E, 2006, J VIROL, V80, P9896, DOI 10.1128/JVI.01118-06; Cannell JJ, 2008, VIROL J, V5, DOI 10.1186/1743-422X-5-29; Cavarra E, 2001, AM J PHYSIOL-LUNG C, V281, pL412, DOI 10.1152/ajplung.2001.281.2.L412; Cavarra E, 2001, AM J RESP CRIT CARE, V164, P886, DOI 10.1164/ajrccm.164.5.2010032; Chandran K, 2005, SCIENCE, V308, P1643, DOI 10.1126/science.1110656; Cho HY, 2005, FREE RADICAL BIO MED, V38, P325, DOI 10.1016/j.freeradbiomed.2004.10.013; Cho HY, 2010, TOXICOL APPL PHARM, V244, P43, DOI 10.1016/j.taap.2009.07.024; Cho HY, 2009, AM J RESP CRIT CARE, V179, P138, DOI 10.1164/rccm.200804-535OC; Chowell G, 2011, PLOS MED, V8, DOI 10.1371/journal.pmed.1000436; Ciriolo MR, 1997, J BIOL CHEM, V272, P2700, DOI 10.1074/jbc.272.5.2700; Dawood FS, 2009, NEW ENGL J MED, V360, P2605, DOI 10.1056/NEJMoa0903810; DILLARD GHL, 1949, CANCER RES, V9, P665; FARAGMAHMOD FI, 1988, VACCINE, V6, P262, DOI 10.1016/0264-410X(88)90222-8; Fischer BM, 2011, INT J CHRONIC OBSTR, V6, P413, DOI 10.2147/COPD.S10770; Fraser C, 2009, SCIENCE, V324, P1557, DOI 10.1126/science.1176062; FRIEDMAN M, 1992, ENVIRON HEALTH PERSP, V97, P95, DOI 10.2307/3431335; GABRIELSON EW, 1994, ENVIRON HEALTH PERSP, V102, P972, DOI 10.2307/3431921; Gagneux P, 2003, J BIOL CHEM, V278, P48245, DOI 10.1074/jbc.M309813200; Garcia-Sastre A, 2011, VIRUS RES, V162, P12, DOI 10.1016/j.virusres.2011.10.017; Garcia-Suastegui WA, 2011, MUTAGENESIS, V26, P385, DOI 10.1093/mutage/geq104; Gold DR, 1999, EPIDEMIOLOGY, V10, P8, DOI 10.1097/00001648-199901000-00004; HENNET T, 1992, J GEN VIROL, V73, P39, DOI 10.1099/0022-1317-73-1-39; Hernandez ML, 2010, J ALLERGY CLIN IMMUN, V126, P537, DOI 10.1016/j.jaci.2010.06.043; Hernandez ML, 2010, INHAL TOXICOL, V22, P648, DOI 10.3109/08958371003610966; Hooper JD, 2001, J BIOL CHEM, V276, P857, DOI 10.1074/jbc.R000020200; Iizuka T, 2005, GENES CELLS, V10, P1113, DOI 10.1111/j.1365-2443.2005.00905.x; Ishii Y, 2005, J IMMUNOL, V175, P6968, DOI 10.4049/jimmunol.175.10.6968; JAKAB GJ, 1995, ENVIRON HEALTH PERSP, V103, P77, DOI 10.2307/3432454; JAKAB GJ, 1990, AM REV RESPIR DIS, V141, P1307, DOI 10.1164/ajrccm/141.5_Pt_1.1307; Jaspers I, 2007, FREE RADICAL BIO MED, V42, P1826, DOI 10.1016/j.freeradbiomed.2007.03.017; Jaspers I, 2005, TOXICOL SCI, V85, P990, DOI 10.1093/toxsci/kfi141; Keller JN, 2006, ANTIOXID REDOX SIGN, V8, P119, DOI 10.1089/ars.2006.8.119; Kesic MJ, 2011, FREE RADICAL BIO MED, V51, P444, DOI 10.1016/j.freeradbiomed.2011.04.027; Kido H, 1999, BIOPOLYMERS, V51, P79, DOI 10.1002/(SICI)1097-0282(1999)51:1<79::AID-BIP9>3.0.CO;2-W; KIDO H, 1992, J BIOL CHEM, V267, P13573; Kido H, 2007, CURR PHARM DESIGN, V13, P405, DOI 10.2174/138161207780162971; Lambert LC, 2010, NEW ENGL J MED, V363, P2036, DOI 10.1056/NEJMra1002842; Liu CK, 1998, J VIROL, V72, P4643, DOI 10.1128/JVI.72.6.4643-4649.1998; Manicassamy B, 2009, VIROL J, V6, DOI 10.1186/1743-422X-6-75; Marsh GA, 2007, J VIROL, V81, P9727, DOI 10.1128/JVI.01144-07; Matsuyama S, 2010, J VIROL, V84, P12658, DOI 10.1128/JVI.01542-10; Matsuyama S, 2009, J VIROL, V83, P11133, DOI 10.1128/JVI.00959-09; Mauad T, 2010, AM J RESP CRIT CARE, V181, P72, DOI 10.1164/rccm.200909-1420OC; Mikerov AN, 2008, AM J PHYSIOL-LUNG C, V294, pL121, DOI 10.1152/ajplung.00288.2007; Monto AS, 2004, PEDIATR INFECT DIS J, V23, pS58, DOI 10.1097/01.inf.0000108193.91607.34; Mukhopadhyay S, 2010, AM J CLIN PATHOL, V133, P380, DOI 10.1309/AJCPXY17SULQKSWK; Na HK, 2008, FOOD CHEM TOXICOL, V46, P1271, DOI 10.1016/j.fct.2007.10.006; Nair S, 2010, ACTA PHARMACOL SIN, V31, P1223, DOI 10.1038/aps.2010.147; NAKAYAMA M, 1993, ANTIVIR RES, V21, P289, DOI 10.1016/0166-3542(93)90008-7; Neumann G, 1999, P NATL ACAD SCI USA, V96, P9345, DOI 10.1073/pnas.96.16.9345; NIWA H, 1991, GENE, V108, P193, DOI 10.1016/0378-1119(91)90434-D; O'Neill MS, 2004, J EXPO ANAL ENV EPID, V14, P429, DOI 10.1038/sj.jea.7500341; PRYOR WA, 1995, FREE RADICAL BIO MED, V19, P935, DOI 10.1016/0891-5849(95)02033-7; PURVIS MR, 1961, J INFECT DIS, V109, P238, DOI 10.1093/infdis/109.3.238; Qu F, 2009, CHEM-BIOL INTERACT, V179, P219, DOI 10.1016/j.cbi.2008.10.059; Quinlivan M, 2005, J VIROL, V79, P8431, DOI 10.1128/JVI.79.13.8431-8439.2005; Razani-Boroujerdi S, 2004, CELL IMMUNOL, V230, P1, DOI 10.1016/j.cellimm.2004.07.007; REDDEL RR, 1988, CANCER RES, V48, P1904; Reddy NM, 2007, AM J RESP CELL MOL, V37, P3, DOI 10.1165/rcmb.2007-0004RC; Reed KL, 1996, BIOL REPROD, V55, P469, DOI 10.1095/biolreprod55.2.469; SAKAI K, 1993, J HISTOCHEM CYTOCHEM, V41, P89, DOI 10.1177/41.1.8380186; Schwarz KB, 1996, FREE RADICAL BIO MED, V21, P641, DOI 10.1016/0891-5849(96)00131-1; Shinkai Y, 2006, FEBS LETT, V580, P1771, DOI 10.1016/j.febslet.2006.02.031; Shulla A, 2011, J VIROL, V85, P873, DOI 10.1128/JVI.02062-10; Simmons G, 2004, P NATL ACAD SCI USA, V101, P4240, DOI 10.1073/pnas.0306446101; Skrzydlewska E, 1997, Postepy Hig Med Dosw, V51, P443; Szabo R, 2003, THROMB HAEMOSTASIS, V90, P185, DOI 10.1160/TH03-02-0071; Thompson WW, 2003, JAMA-J AM MED ASSOC, V289, P179, DOI 10.1001/jama.289.2.179; Thompson WW, 2004, JAMA-J AM MED ASSOC, V292, P1333, DOI 10.1001/jama.292.11.1333; Cox LA, 2009, RISK ANAL, V29, P576, DOI 10.1111/j.1539-6924.2008.01152.x; Torres-Jardon R, 2009, J AIR WASTE MANAGE, V59, P1155, DOI 10.3155/1047-3289.59.10.1155; Van Amelsvoort JMM, 2001, XENOBIOTICA, V31, P891, DOI 10.1080/00498250110079149; Venkatasamy Radhakrishnan, 2007, Expert Rev Clin Immunol, V3, P365, DOI 10.1586/1744666X.3.3.365; Vogelmeier C, 1997, EUR RESPIR J, V10, P2114, DOI 10.1183/09031936.97.10092114; Wu CC, 2006, LIFE SCI, V78, P2889, DOI 10.1016/j.lfs.2005.11.013; Wu WD, 2011, FREE RADICAL BIO MED, V51, P522, DOI 10.1016/j.freeradbiomed.2011.05.006; Yasuoka S, 1997, AM J RESP CELL MOL, V16, P300, DOI 10.1165/ajrcmb.16.3.9070615; Ye LX, 2002, CLIN CHIM ACTA, V316, P43, DOI 10.1016/S0009-8981(01)00727-6; Ying QL, 2000, AM J RESP CELL MOL, V23, P506, DOI 10.1165/ajrcmb.23.4.3939; Zhu H, 2008, EXP BIOL MED, V233, P463, DOI 10.3181/0711-RM-304; Zhu M, 2000, PLANTA MED, V66, P444, DOI 10.1055/s-2000-8599	89	65	66	0	16	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 9	2012	7	4							e35108	10.1371/journal.pone.0035108	http://dx.doi.org/10.1371/journal.pone.0035108			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	955JO	22496898	Green Published, Green Submitted, gold			2022-12-25	WOS:000305014500046
J	Yogo, K; Ogawa, T; Hayashi, M; Harada, Y; Nishizaka, T; Kinosita, K				Yogo, Katsunori; Ogawa, Taisaku; Hayashi, Masahito; Harada, Yoshie; Nishizaka, Takayuki; Kinosita, Kazuhiko, Jr.			Direct Observation of Strand Passage by DNA-Topoisomerase and Its Limited Processivity	PLOS ONE			English	Article							SINGLE-MOLECULE; II-ALPHA; SUPERCOILED DNA; MECHANISM; REPLICATION; TOPOLOGY	Type-II DNA topoisomerases resolve DNA entanglements such as supercoils, knots and catenanes by passing one segment of DNA duplex through a transient enzyme-bridged double-stranded break in another segment. The ATP-dependent passage reaction has previously been demonstrated at the single-molecule level, showing apparent processivity at saturating ATP. Here we directly observed the strand passage by human topoisomerase II alpha, after winding a pair of fluorescently stained DNA molecules with optical tweezers for 30 turns into an X-shaped braid. On average 0.51+/-0.33 mu m (11+/-6 turns) of a braid was unlinked in a burst of reactions taking 8+/-4 s, the unlinked length being essentially independent of the enzyme concentration between 0.25-37 pM. The time elapsed before the start of processive unlinking decreased with the enzyme concentration, being similar to 100 s at 3.7 pM. These results are consistent with a scenario where the enzyme binds to one DNA for a period of similar to 10 s, waiting for multiple diffusional encounters with the other DNA to transport it across the break similar to 10 times, and then dissociates from the binding site without waiting for the exhaustion of transportable DNA segments.	[Yogo, Katsunori; Ogawa, Taisaku; Kinosita, Kazuhiko, Jr.] Waseda Univ, Dept Phys, Fac Sci & Engn, Tokyo 169, Japan; [Hayashi, Masahito] KAST, Yasuda On Chip Mol Cell Phen Project, Kawasaki, Kanagawa, Japan; [Harada, Yoshie] Kyoto Univ, Inst Integrated Cell Mat Sci iCeMS, Kyoto, Japan; [Nishizaka, Takayuki] Gakushuin Univ, Dept Phys, Tokyo 171, Japan	Waseda University; Kanagawa Academy Science & Technology; Kyoto University; Gakushuin University	Yogo, K (corresponding author), Waseda Univ, Dept Phys, Fac Sci & Engn, Tokyo 169, Japan.	kazuhiko@waseda.jp		Yogo, Katsunori/0000-0001-9555-2147	Ministry of Education, Culture, Sports, Science and Technology of Japan [16002013, 21000011]; Grants-in-Aid for Scientific Research [21000011] Funding Source: KAKEN	Ministry of Education, Culture, Sports, Science and Technology of Japan(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)); Grants-in-Aid for Scientific Research(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI))	This work was supported by Grants-in-Aid for Specially Promoted Research (grant numbers 16002013, 21000011 to KK) from the Ministry of Education, Culture, Sports, Science and Technology of Japan. The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Arai Y, 1999, NATURE, V399, P446, DOI 10.1038/20894; Bromberg KD, 2003, J BIOL CHEM, V278, P7406, DOI 10.1074/jbc.M212056200; BROWN PO, 1979, SCIENCE, V206, P1081, DOI 10.1126/science.227059; BUSTAMANTE C, 1994, SCIENCE, V265, P1599, DOI 10.1126/science.8079175; Charvin G, 2003, P NATL ACAD SCI USA, V100, P9820, DOI 10.1073/pnas.1631550100; Harada Y, 2001, NATURE, V409, P113, DOI 10.1038/35051126; Hayashi M, 2007, NUCLEIC ACIDS RES, V35, DOI 10.1093/nar/gkm529; Koster DA, 2006, P NATL ACAD SCI USA, V103, P1750, DOI 10.1073/pnas.0510509103; LIU LF, 1979, NATURE, V281, P456, DOI 10.1038/281456a0; Marko JF, 1997, PHYS REV E, V55, P1758, DOI 10.1103/PhysRevE.55.1758; McClendon AK, 2005, J BIOL CHEM, V280, P39337, DOI 10.1074/jbc.M503320200; MIZUUCHI K, 1980, P NATL ACAD SCI-BIOL, V77, P1847, DOI 10.1073/pnas.77.4.1847; Mueller-Planitz F, 2008, J BIOL CHEM, V283, P17463, DOI 10.1074/jbc.M710014200; Nollmann M, 2007, NAT STRUCT MOL BIOL, V14, P264, DOI 10.1038/nsmb1213; Renodon-Corniere A, 2002, BIOCHEMISTRY-US, V41, P13395, DOI 10.1021/bi0263614; Schoeffler AJ, 2008, Q REV BIOPHYS, V41, P41, DOI 10.1017/S003358350800468X; Smiley RD, 2007, P NATL ACAD SCI USA, V104, P4840, DOI 10.1073/pnas.0700342104; Stone MD, 2003, P NATL ACAD SCI USA, V100, P8654, DOI 10.1073/pnas.1133178100; Strick TR, 2000, NATURE, V404, P901, DOI 10.1038/35009144; Strick TR, 1998, BIOPHYS J, V74, P2016, DOI 10.1016/S0006-3495(98)77908-1; TANABE K, 1991, CANCER RES, V51, P4903; Wang JC, 1998, Q REV BIOPHYS, V31, P107, DOI 10.1017/S0033583598003424; Yasuda R, 2001, NATURE, V410, P898, DOI 10.1038/35073513; ZECHIEDRICH EL, 1990, EMBO J, V9, P4555, DOI 10.1002/j.1460-2075.1990.tb07908.x	24	14	14	0	13	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 9	2012	7	4							e34920	10.1371/journal.pone.0034920	http://dx.doi.org/10.1371/journal.pone.0034920			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	955JO	22496876	gold, Green Published, Green Submitted			2022-12-25	WOS:000305014500036
J	Arjomandi, M; Haight, T; Sadeghi, N; Redberg, R; Gold, WM				Arjomandi, Mehrdad; Haight, Thaddeus; Sadeghi, Nasrat; Redberg, Rita; Gold, Warren M.			Reduced Exercise Tolerance and Pulmonary Capillary Recruitment with Remote Secondhand Smoke Exposure	PLOS ONE			English	Article							CABIN AIR-QUALITY; ENVIRONMENTAL TOBACCO-SMOKE; ACUTE CORONARY SYNDROMES; DIFFUSING-CAPACITY; SINGLE EXHALATION; DISEASE; HEALTH; ASSOCIATION; DIAGNOSIS; COTININE	Rationale: Flight attendants who worked on commercial aircraft before the smoking ban in flights (pre-ban FAs) were exposed to high levels of secondhand smoke (SHS). We previously showed never-smoking pre-ban FAs to have reduced diffusing capacity (Dco) at rest. Methods: To determine whether pre-ban FAs increase their Dco and pulmonary blood flow ((Q) over dotc) during exercise, we administered a symptom-limited supine-posture progressively increasing cycle exercise test to determine the maximum work (watts) and oxygen uptake ((V) over doto(2)) achieved by FAs. After 30 min rest, we then measured Dco and (Q) over dotc at 20, 40, 60, and 80 percent of maximum observed work. Results: The FAs with abnormal resting Dco achieved a lower level of maximum predicted work and (V) over doto(2) compared to those with normal resting Dco (mean +/- SEM; 88.7 +/- 2.9 vs. 102.5 +/- 3.1% predicted (V) over doto(2); p = 0.001). Exercise limitation was associated with the FAs' FEV1 (r = 0.33; p = 0.003). The Dco increased less with exercise in those with abnormal resting Dco (mean +/- SEM: 1.36 +/- 0.16 vs. 1.90 +/- 0.16 ml/min/mmHg per 20% increase in predicted watts; p = 0.020), and amongst all FAs, the increase with exercise seemed to be incrementally lower in those with lower resting Dco. Exercise-induced increase in (Q) over dotc was not different in the two groups. However, the FAs with abnormal resting Dco had less augmentation of their Dco with increase in (Q) over dotc during exercise (mean +/- SEM: 0.93 +/- 0.06 vs. 1.47 +/- 0.09 ml/min/mmHg per L/min; p<0.0001). The Dco during exercise was inversely associated with years of exposure to SHS in those FAs with >= 10 years of pre-ban experience (r = -0.32; p = 0.032). Conclusions: This cohort of never-smoking FAs with SHS exposure showed exercise limitation based on their resting Dco. Those with lower resting Dco had reduced pulmonary capillary recruitment. Exposure to SHS in the aircraft cabin seemed to be a predictor for lower Dco during exercise.	[Arjomandi, Mehrdad; Redberg, Rita; Gold, Warren M.] Univ Calif San Francisco, Flight Attendants Med Res Inst, Ctr Excellence, San Francisco, CA 94143 USA; [Gold, Warren M.] Univ Calif San Francisco, Cardiovasc Res Inst, San Francisco, CA 94143 USA; [Arjomandi, Mehrdad; Gold, Warren M.] Univ Calif San Francisco, Dept Med, San Francisco, CA USA; [Arjomandi, Mehrdad; Redberg, Rita] San Francisco VA Med Ctr, San Francisco, CA USA; [Haight, Thaddeus] Univ Calif Berkeley, Sch Publ Hlth, Berkeley, CA 94720 USA; [Sadeghi, Nasrat] Radboud Univ Nijmegen, Med Ctr, NL-6525 ED Nijmegen, Netherlands	University of California System; University of California San Francisco; University of California System; University of California San Francisco; University of California System; University of California San Francisco; US Department of Veterans Affairs; Veterans Health Administration (VHA); San Francisco VA Medical Center; University of California System; University of California Berkeley; Radboud University Nijmegen	Arjomandi, M (corresponding author), Univ Calif San Francisco, Flight Attendants Med Res Inst, Ctr Excellence, San Francisco, CA 94143 USA.	mehrdad.arjomandi@ucsf.edu	Arjomandi, Mehrdad/ABB-4327-2021	Arjomandi, Mehrdad/0000-0002-0116-9217	The Flight Attendants Medical Research Institute; The National Institutes of Health [K23 HL083099]; Northern California Institute for Research and Education; University of California San Francisco Cardiovascular Research Institute; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [K23HL083099] Funding Source: NIH RePORTER	The Flight Attendants Medical Research Institute; The National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Northern California Institute for Research and Education; University of California San Francisco Cardiovascular Research Institute(University of California System); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))	Funding provided by The Flight Attendants Medical Research Institute, The National Institutes of Health (K23 HL083099), Northern California Institute for Research and Education and the University of California San Francisco Cardiovascular Research Institute Faculty Development Funds. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Arjomandi M, 2009, J OCCUP ENVIRON MED, V51, P639, DOI 10.1097/JOM.0b013e3181a7f048; BELMAN MJ, 1991, CHEST, V99, P566, DOI 10.1378/chest.99.3.566; Benowitz NL, 2009, AM J EPIDEMIOL, V169, P236, DOI 10.1093/aje/kwn301; BORG GAV, 1982, MED SCI SPORT EXER, V14, P377, DOI 10.1249/00005768-198205000-00012; Celli BR, 2004, EUR RESPIR J, V23, P932, DOI 10.1183/09031936.04.00014304; COHEN J, 1992, PSYCHOL BULL, V112, P155, DOI 10.1037/0033-2909.112.1.155; CRAPO RO, 1981, AM REV RESPIR DIS, V123, P659; Eisner MD, 2007, ANN EPIDEMIOL, V17, P364, DOI 10.1016/j.annepidem.2006.10.008; Eisner Mark D, 2005, Environ Health, V4, P7, DOI 10.1186/1476-069X-4-7; Eisner MD, 2005, THORAX, V60, P814, DOI 10.1136/thx.2004.037283; First M, 1985, CONSTITUTENTS SIDEST, P195; Franciosi LG, 2006, PULM PHARMACOL THER, V19, P189, DOI 10.1016/j.pupt.2005.05.001; Gelb AF, 1996, CHEST, V109, P353, DOI 10.1378/chest.109.2.353; Goniewicz ML, 2011, NICOTINE TOB RES, V13, P202, DOI 10.1093/ntr/ntq237; Goniewicz Maciej Lukasz, 2009, Central European Journal of Public Health, V17, P220; HAMMOND SK, 1995, JAMA-J AM MED ASSOC, V274, P956, DOI 10.1001/jama.274.12.956; Hammond SK, 1999, ENVIRON HEALTH PERSP, V107, P329, DOI 10.2307/3434425; HUANG YCT, 1994, CHEST, V105, P501, DOI 10.1378/chest.105.2.501; Huang YCT, 2002, CHEST, V122, P177, DOI 10.1378/chest.122.1.177; Kawachi I, 1997, CIRCULATION, V95, P2374, DOI 10.1161/01.CIR.95.10.2374; Lam TH, 2005, TOB CONTROL, V14, P307, DOI 10.1136/tc.2005.011775; Lindgren T, 2000, AVIAT SPACE ENVIR MD, V71, P774; MARTONEN TB, 1982, J MATH BIOL, V14, P203, DOI 10.1007/BF01832845; Neilsen K, 2004, TOB CONTROL, V13, P20, DOI 10.1136/tc.2003.004721; NEWTH CJL, 1977, J APPL PHYSIOL, V43, P617, DOI 10.1152/jappl.1977.43.4.617; Nishimura K, 2002, CHEST, V121, P1434, DOI 10.1378/chest.121.5.1434; Pitsavos C, 2002, HEART VESSELS, V16, P127; Pitsavos C, 2002, TOB CONTROL, V11, P220, DOI 10.1136/tc.11.3.220; Rabe KF, 2007, AM J RESP CRIT CARE, V176, P532, DOI 10.1164/rccm.200703-456SO; RAMAGE JE, 1987, CHEST, V92, P44, DOI 10.1378/chest.92.1.44; Rayman RB, 2002, AVIAT SPACE ENVIR MD, V73, P211; Repace J, 2004, TOB CONTROL, V13, P8, DOI 10.1136/tc.2003.003111; SAMET JM, 1987, AM REV RESPIR DIS, V136, P1486, DOI 10.1164/ajrccm/136.6.1486; SPENGLER JD, 1981, ATMOS ENVIRON, V15, P23, DOI 10.1016/0004-6981(81)90121-9; STOKES DL, 1981, J APPL PHYSIOL, V51, P858, DOI 10.1152/jappl.1981.51.4.858; TAYLOR AE, 1992, CIRCULATION, V86, P699, DOI 10.1161/01.CIR.86.2.699; Wan ES, 2011, AM J RESP CRIT CARE, V184, P57, DOI 10.1164/rccm.201101-0021OC; Wasserman K, 1999, PRINCIPLES EXERCISE; WILSON AF, 1994, THORAX, V49, P1121, DOI 10.1136/thx.49.11.1121	39	10	10	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 6	2012	7	4							e34393	10.1371/journal.pone.0034393	http://dx.doi.org/10.1371/journal.pone.0034393			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	955JA	22493689	Green Published, Green Submitted, gold			2022-12-25	WOS:000305012700031
J	Nordlund, J; Milani, L; Lundmark, A; Lonnerholm, G; Syvanen, AC				Nordlund, Jessica; Milani, Lili; Lundmark, Anders; Lonnerholm, Gudmar; Syvanen, Ann-Christine			DNA Methylation Analysis of Bone Marrow Cells at Diagnosis of Acute Lymphoblastic Leukemia and at Remission	PLOS ONE			English	Article							ABERRANT METHYLATION; GENE-EXPRESSION; PREDICTION; MECHANISMS; CANCER; CLASSIFICATION; SUBTYPE; DISEASE; DBC1; MLL	To detect genes with CpG sites that display methylation patterns that are characteristic of acute lymphoblastic leukemia (ALL) cells, we compared the methylation patterns of cells taken at diagnosis from 20 patients with pediatric ALL to the methylation patterns in mononuclear cells from bone marrow of the same patients during remission and in non-leukemic control cells from bone marrow or blood. Using a custom-designed assay, we measured the methylation levels of 1,320 CpG sites in regulatory regions of 413 genes that were analyzed because they display allele-specific gene expression (ASE) in ALL cells. The rationale for our selection of CpG sites was that ASE could be the result of allele-specific methylation in the promoter regions of the genes. We found that the ALL cells had methylation profiles that allowed distinction between ALL cells and control cells. Using stringent criteria for calling differential methylation, we identified 28 CpG sites in 24 genes with recurrent differences in their methylation levels between ALL cells and control cells. Twenty of the differentially methylated genes were hypermethylated in the ALL cells, and as many as nine of them (AMICA1, CPNE7, CR1, DBC1, EYA4, LGALS8, RYR3, UQCRFS1, WDR35) have functions in cell signaling and/or apoptosis. The methylation levels of a subset of the genes were consistent with an inverse relationship with the mRNA expression levels in a large number of ALL cells from published data sets, supporting a potential biological effect of the methylation signatures and their application for diagnostic purposes.	[Nordlund, Jessica; Milani, Lili; Lundmark, Anders; Syvanen, Ann-Christine] Uppsala Univ, Dept Med Sci, Uppsala, Sweden; [Lonnerholm, Gudmar] Uppsala Univ, Dept Womens & Childrens Hlth, Uppsala, Sweden	Uppsala University; Uppsala University	Nordlund, J (corresponding author), Uppsala Univ, Dept Med Sci, Uppsala, Sweden.	Ann-Christine.Syvanen@medsci.uu.se	Nordlund, Jessica/A-9627-2011; Milani, Lili/C-8759-2011; Milani, Lili/N-1097-2019	Milani, Lili/0000-0002-5323-3102; Milani, Lili/0000-0002-5323-3102; Nordlund, Jessica/0000-0001-8699-9959	Swedish Foundation for Strategic Research [RBc08-008]; Swedish Cancer Society; Swedish Childhood Cancer Foundation; Swedish Research Council for Science and Technology [90559401]	Swedish Foundation for Strategic Research(Swedish Foundation for Strategic Research); Swedish Cancer Society(Swedish Cancer Society); Swedish Childhood Cancer Foundation(European Commission); Swedish Research Council for Science and Technology(Swedish Research Council)	This work was supported by grants from the Swedish Foundation for Strategic Research (#RBc08-008), the Swedish Cancer Society, the Swedish Childhood Cancer Foundation, and the Swedish Research Council for Science and Technology (#90559401). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Agrawal S, 2007, CANCER RES, V67, P1370, DOI 10.1158/0008-5472.CAN-06-1681; Andersson A, 2007, LEUKEMIA, V21, P1198, DOI 10.1038/sj.leu.2404688; Berdasco M, 2010, DEV CELL, V19, P698, DOI 10.1016/j.devcel.2010.10.005; Broske AM, 2009, NAT GENET, V41, P1207, DOI 10.1038/ng.463; Cerveira N, 2010, BMC CANCER, V10, DOI 10.1186/1471-2407-10-518; Chung W, 2011, CANCER EPIDEM BIOMAR, V20, P1483, DOI 10.1158/1055-9965.EPI-11-0067; Cleaver AL, 2010, MOL CANCER, V9, DOI 10.1186/1476-4598-9-105; Haferlach T, 2010, J CLIN ONCOL, V28, P2529, DOI 10.1200/JCO.2009.23.4732; Hansen KD, 2011, NAT GENET; Hogan LE, 2011, BLOOD; Issa JPJ, 2007, CLIN CANCER RES, V13, P1634, DOI 10.1158/1078-0432.CCR-06-2076; Izumi H, 2005, HUM MOL GENET, V14, P997, DOI 10.1093/hmg/ddi092; Jaenisch R, 2003, NAT GENET, V33, P245, DOI 10.1038/ng1089; Jones PA, 2007, CELL, V128, P683, DOI 10.1016/j.cell.2007.01.029; Li YR, 2010, PLOS BIOL, V8, DOI 10.1371/journal.pbio.1000533; McCabe MT, 2009, CLIN CANCER RES, V15, P3927, DOI 10.1158/1078-0432.CCR-08-2784; Meyer C, 2009, LEUKEMIA, V23, P1490, DOI 10.1038/leu.2009.33; Milani L, 2010, BLOOD, V115, P1214, DOI 10.1182/blood-2009-04-214668; Milani L, 2009, GENOME RES, V19, P1, DOI 10.1101/gr.083931.108; Narayan G, 2011, GENE CHROMOSOME CANC; Osborn NK, 2006, CLIN GASTROENTEROL H, V4, P212, DOI 10.1016/j.cgh.2005.11.009; Pui C, 2004, NEW ENGL J MED, V350, P1535, DOI 10.1056/NEJMra023001; Pui CH, 2011, J CLIN ONCOL, V29, P551, DOI 10.1200/JCO.2010.30.7405; San Jose-Eneriz E, 2006, BRIT J HAEMATOL, V134, P137, DOI 10.1111/j.1365-2141.2006.06131.x; Schmiegelow K, 2010, LEUKEMIA, V24, P345, DOI 10.1038/leu.2009.251; Taylor KH, 2007, CANCER RES, V67, P2617, DOI 10.1158/0008-5472.CAN-06-3993; Testa U, 2011, ANN HEMATOL, V90, P245, DOI 10.1007/s00277-010-1118-7; Vilas-Zornoza A, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0017012; Wang MX, 2010, INT J CLIN EXP PATHO, V3, P265; Yeoh EJ, 2002, CANCER CELL, V1, P133, DOI 10.1016/S1535-6108(02)00032-6; Zou HZ, 2005, INT J CANCER, V116, P584, DOI 10.1002/ijc.21045	31	30	32	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 6	2012	7	4							e34513	10.1371/journal.pone.0034513	http://dx.doi.org/10.1371/journal.pone.0034513			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	955JA	22493696	Green Published, Green Submitted, gold			2022-12-25	WOS:000305012700038
J	Chang, JH; Paik, SY; Mao, L; Eisner, W; Flannery, PJ; Wang, LM; Tang, YP; Mattocks, N; Hadjadj, S; Goujon, JM; Ruiz, P; Gurley, SB; Spurney, RF				Chang, Jae-Hyung; Paik, Seung-Yeol; Mao, Lan; Eisner, William; Flannery, Patrick J.; Wang, Liming; Tang, Yuping; Mattocks, Natalie; Hadjadj, Samy; Goujon, Jean-Michel; Ruiz, Phillip; Gurley, Susan B.; Spurney, Robert F.			Diabetic Kidney Disease in FVB/NJ Akita Mice: Temporal Pattern of Kidney Injury and Urinary Nephrin Excretion	PLOS ONE			English	Article							GLOMERULAR PODOCYTES; MOUSE; SUSCEPTIBILITY; NEPHROPATHY; EXPRESSION; APOPTOSIS; PROTEIN; NUMBER; GENE; CALCINEURIN	Akita mice are a genetic model of type 1 diabetes. In the present studies, we investigated the phenotype of Akita mice on the FVB/NJ background and examined urinary nephrin excretion as a marker of kidney injury. Male Akita mice were compared with non-diabetic controls for functional and structural characteristics of renal and cardiac disease. Podocyte number and apoptosis as well as urinary nephrin excretion were determined in both groups. Male FVB/NJ Akita mice developed sustained hyperglycemia and albuminuria by 4 and 8 weeks of age, respectively. These abnormalities were accompanied by a significant increase in systolic blood pressure in 10-week old Akita mice, which was associated with functional, structural and molecular characteristics of cardiac hypertrophy. By 20 weeks of age, Akita mice developed a 10-fold increase in albuminuria, renal and glomerular hypertrophy and a decrease in the number of podocytes. Mild-to-moderate glomerular mesangial expansion was observed in Akita mice at 30 weeks of age. In 4-week old Akita mice, the onset of hyperglycemia was accompanied by increased podocyte apoptosis and enhanced excretion of nephrin in urine before the development of albuminuria. Urinary nephrin excretion was also significantly increased in albuminuric Akita mice at 16 and 20 weeks of age and correlated with the albumin excretion rate. These data suggest that: 1. FVB/NJ Akita mice have phenotypic characteristics that may be useful for studying the mechanisms of kidney and cardiac injury in diabetes, and 2. Enhanced urinary nephrin excretion is associated with kidney injury in FVB/NJ Akita mice and is detectable early in the disease process.	[Chang, Jae-Hyung; Eisner, William; Flannery, Patrick J.; Wang, Liming; Tang, Yuping; Mattocks, Natalie; Gurley, Susan B.; Spurney, Robert F.] Duke Univ, Dept Med, Div Nephrol, Durham, NC 27706 USA; [Chang, Jae-Hyung; Eisner, William; Flannery, Patrick J.; Wang, Liming; Tang, Yuping; Mattocks, Natalie; Gurley, Susan B.; Spurney, Robert F.] Durham VA Med Ctr, Durham, NC USA; [Paik, Seung-Yeol] Chung Ang Univ, Sch Med, Seoul 156756, South Korea; [Mao, Lan] Duke Univ, Med Ctr, Dept Med, Div Cardiol, Durham, NC 27710 USA; [Goujon, Jean-Michel] CHU Poitiers, Pathol Unit, Poitiers, France; [Hadjadj, Samy; Goujon, Jean-Michel] INSERM, U927, Poitiers, France; [Hadjadj, Samy; Goujon, Jean-Michel] INSERM, CIC 0802, Poitiers, France; [Ruiz, Phillip] Univ Miami, Dept Surg & Pathol, Miami, FL USA	Duke University; US Department of Veterans Affairs; Veterans Health Administration (VHA); Durham VA Medical Center; Chung Ang University; Chung Ang University Hospital; Duke University; CHU Poitiers; Universite de Poitiers; Institut National de la Sante et de la Recherche Medicale (Inserm); Universite de Poitiers; Institut National de la Sante et de la Recherche Medicale (Inserm); Universite de Poitiers; University of Miami	Chang, JH (corresponding author), Duke Univ, Dept Med, Div Nephrol, Durham, NC 27706 USA.	robert.spurney@dm.duke.edu			National Institutes of Health, National Institute of Diabetes, Digestive and Kidney Diseases [RO1-DK075688, 3R01DK075688-01A2S1]; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK087707, R01DK075688] Funding Source: NIH RePORTER; Veterans Affairs [I01BX000791] Funding Source: NIH RePORTER	National Institutes of Health, National Institute of Diabetes, Digestive and Kidney Diseases(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); Veterans Affairs(US Department of Veterans Affairs)	These studies were supported by grants RO1-DK075688 (to RFS) and 3R01DK075688-01A2S1 (to RFS) from the National Institutes of Health, National Institute of Diabetes, Digestive and Kidney Diseases. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aaltonen P, 2001, LAB INVEST, V81, P1185, DOI 10.1038/labinvest.3780332; Breyer MD, 2005, J AM SOC NEPHROL, V16, P27, DOI [10.1681/ASN.2009070721, 10.1681/ASN.2004080648]; Brosius FC, 2010, KIDNEY INT, V78, P431, DOI 10.1038/ki.2010.199; Brosius FC, 2009, J AM SOC NEPHROL, V20, P2503, DOI 10.1681/ASN.2009070721; Centers for Disease Control and Prevention, 2008, NAT DIAB FACT SHEET; Chua S, 2010, KIDNEY INT, V78, P453, DOI 10.1038/ki.2010.160; DEFRONZO RA, 2004, ELLENBERG RIFKINS DI, P723; Donoviel DB, 2001, MOL CELL BIOL, V21, P4829, DOI 10.1128/MCB.21.14.4829-4836.2001; Eisner C, 2010, KIDNEY INT, V77, P519, DOI 10.1038/ki.2009.501; Esposito G, 2000, AM J PHYSIOL-HEART C, V279, pH3101, DOI 10.1152/ajpheart.2000.279.6.H3101; Gooch JL, 2003, AM J PHYSIOL-RENAL, V284, pF144, DOI 10.1152/ajprenal.00158.2002; Gurley SB, 2006, AM J PHYSIOL-RENAL, V290, pF214, DOI 10.1152/ajprenal.00204.2005; Gurley SB, 2007, SEMIN NEPHROL, V27, P144, DOI 10.1016/j.semnephrol.2007.01.009; Gurley SB, 2010, AM J PHYSIOL-RENAL, V298, pF788, DOI 10.1152/ajprenal.90515.2008; Haseyama T, 2002, TOHOKU J EXP MED, V198, P233, DOI 10.1620/tjem.198.233; Hem A, 1998, LAB ANIM-UK, V32, P364, DOI 10.1258/002367798780599866; Holzman LB, 1999, KIDNEY INT, V56, P1481, DOI 10.1046/j.1523-1755.1999.00719.x; Hong EG, 2007, AM J PHYSIOL-ENDOC M, V293, pE1687, DOI 10.1152/ajpendo.00256.2007; Kestila M, 1998, MOL CELL, V1, P575, DOI 10.1016/S1097-2765(00)80057-X; Kim JJ, 2007, J AM SOC NEPHROL, V18, P2303, DOI 10.1681/ASN.2006101145; Kriz W, 1998, KIDNEY INT, V54, P687, DOI 10.1046/j.1523-1755.1998.00044.x; LANE PH, 1992, KIDNEY INT, V41, P1085, DOI 10.1038/ki.1992.165; Meyer TW, 1999, DIABETOLOGIA, V42, P1341, DOI 10.1007/s001250051447; Mundel P, 2002, J AM SOC NEPHROL, V13, P3005, DOI 10.1097/01.ASN.0000039661.06947.FD; Pagtalunan ME, 1997, J CLIN INVEST, V99, P342, DOI 10.1172/JCI119163; Patari A, 2003, DIABETES, V52, P2969, DOI 10.2337/diabetes.52.12.2969; Petermann AT, 2004, NEPHRON EXP NEPHROL, V98, pE114, DOI 10.1159/000081555; Qi ZH, 2005, DIABETES, V54, P2628, DOI 10.2337/diabetes.54.9.2628; Qi ZH, 2004, AM J PHYSIOL-RENAL, V286, pF590, DOI 10.1152/ajprenal.00324.2003; Ramage IJ, 2002, KIDNEY INT, V62, P895, DOI 10.1046/j.1523-1755.2002.00527.x; Rantanen M, 2002, J AM SOC NEPHROL, V13, DOI 10.1097/01.ASN.0000016142.29721.22; Ruotsalainen V, 1999, P NATL ACAD SCI USA, V96, P7962, DOI 10.1073/pnas.96.14.7962; Steffes MW, 2001, KIDNEY INT, V59, P2104, DOI 10.1046/j.1523-1755.2001.0590062104.x; Susztak K, 2006, DIABETES, V55, P225, DOI 10.2337/diabetes.55.01.06.db05-0894; TAKETO M, 1991, P NATL ACAD SCI USA, V88, P2065, DOI 10.1073/pnas.88.6.2065; *US REN DAT SYST, 2007, ANN DAT REP ATL CHRO; Verzola D, 2007, KIDNEY INT, V72, P1262, DOI 10.1038/sj.ki.5002531; WALLENSTEIN S, 1980, CIRC RES, V47, P1, DOI 10.1161/01.RES.47.1.1; Wang G, 2008, EUR J ENDOCRINOL, V158, P317, DOI 10.1530/EJE-07-0708; Wang LM, 2008, KIDNEY BLOOD PRESS R, V31, P111, DOI 10.1159/000121531; Wang LM, 2011, MOL ENDOCRINOL, V25, P1376, DOI 10.1210/me.2011-0029; Wang LM, 2005, J AM SOC NEPHROL, V16, P3611, DOI 10.1681/ASN.2005020167; White KE, 2002, DIABETES, V51, P3083, DOI 10.2337/diabetes.51.10.3083; Whitesall SE, 2004, AM J PHYSIOL-HEART C, V286, pH2408, DOI 10.1152/ajpheart.01089.2003; Wiggins RC, 2007, KIDNEY INT, V71, P1205, DOI 10.1038/sj.ki.5002222; Wolf G, 2005, DIABETES, V54, P1626, DOI 10.2337/diabetes.54.6.1626; Xu JX, 2010, AM J PHYSIOL-RENAL, V299, pF487, DOI 10.1152/ajprenal.00018.2010; Yoshioka M, 1997, DIABETES, V46, P887, DOI 10.2337/diabetes.46.5.887	48	31	33	0	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 4	2012	7	4							e33942	10.1371/journal.pone.0033942	http://dx.doi.org/10.1371/journal.pone.0033942			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	953GO	22496773	Green Published, Green Submitted, gold			2022-12-25	WOS:000304855200026
J	Lethbridge, R; Hou, QL; Harley, CW; Yuan, Q				Lethbridge, Rebecca; Hou, Qinlong; Harley, Carolyn W.; Yuan, Qi			Olfactory Bulb Glomerular NMDA Receptors Mediate Olfactory Nerve Potentiation and Odor Preference Learning in the Neonate Rat	PLOS ONE			English	Article							LONG-TERM POTENTIATION; MITRAL CELLS; SYNAPTIC PLASTICITY; YOUNG-RATS; POSTNATAL-DEVELOPMENT; VISUAL-CORTEX; ACTIVATION; RESPONSES; SYNAPSES; MEMORY	Rat pup odor preference learning follows pairing of bulbar beta-adrenoceptor activation with olfactory input. We hypothesize that NMDA receptor (NMDAR)-mediated olfactory input to mitral cells is enhanced during training, such that increased calcium facilitates and shapes the critical cAMP pattern. Here, we demonstrate, in vitro, that olfactory nerve stimulation, at sniffing frequencies, paired with beta-adrenoceptor activation, potentiates olfactory nerve-evoked mitral cell firing. This potentiation is blocked by a NMDAR antagonist and by increased inhibition. Glomerular dishinhibtion also induces NMDAR-sensitive potentiation. In vivo, in parallel, behavioral learning is prevented by glomerular infusion of an NMDAR antagonist or a GABA(A) receptor agonist. A glomerular GABA(A) receptor antagonist paired with odor can induce NMDAR-dependent learning. The NMDA GluN1 subunit is phosphorylated in odor-specific glomeruli within 5 min of training suggesting early activation, and enhanced calcium entry, during acquisition. The GluN1 subunit is down-regulated 3 h after learning; and at 24 h post-training the GluN2B subunit is down-regulated. These events may assist memory stability. Ex vivo experiments using bulbs from trained rat pups reveal an increase in the AMPA/NMDA EPSC ratio post-training, consistent with an increase in AMPA receptor insertion and/or the decrease in NMDAR subunits. These results support a model of a cAMP/NMDA interaction in generating rat pup odor preference learning.	[Lethbridge, Rebecca; Hou, Qinlong; Yuan, Qi] Mem Univ Newfoundland, Fac Med, St John, NF, Canada; [Harley, Carolyn W.] Mem Univ Newfoundland, Dept Psychol, Fac Sci, St John, NF, Canada	Memorial University Newfoundland; Memorial University Newfoundland	Lethbridge, R (corresponding author), Mem Univ Newfoundland, Fac Med, St John, NF, Canada.	qi.yuan@med.mun.ca		Harley, Carolyn/0000-0001-8641-7998	Canadian Institutes of Health Research [MOP-102624]	Canadian Institutes of Health Research(Canadian Institutes of Health Research (CIHR))	The work was supported by a Canadian Institutes of Health Research operating grant to QY (MOP-102624). http://www.cihr-irsc.gc.ca/e/193.html. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Apicella A, 2010, J NEUROSCI, V30, P14255, DOI 10.1523/JNEUROSCI.2747-10.2010; Aroniadou-Anderjaska V, 1999, J NEUROPHYSIOL, V82, P489, DOI 10.1152/jn.1999.82.1.489; AroniadouAnderjaska V, 1997, NEUROSCIENCE, V79, P425, DOI 10.1016/S0306-4522(96)00706-3; Carlson GC, 2000, J NEUROSCI, V20, P2011; COOPERSMITH R, 1986, BRAIN RES, V371, P400, DOI 10.1016/0006-8993(86)90384-7; Cui W, 2007, LEARN MEMORY, V14, P126, DOI 10.1101/lm.496007; Cui W, 2011, LEARN MEMORY, V18, P283, DOI 10.1101/lm.1987711; Debanne D, 1996, REV NEUROSCIENCE, V7, P29; Egger V, 2007, J PHYSIOL-LONDON, V582, P7, DOI 10.1113/jphysiol.2007.136036; Ennis M, 1998, ANN NY ACAD SCI, V855, P457, DOI 10.1111/j.1749-6632.1998.tb10606.x; Flint AC, 1997, J NEUROSCI, V17, P2469; Franks KM, 2005, NEURON, V47, P101, DOI 10.1016/j.neuron.2005.05.024; Gire DH, 2008, J NEUROPHYSIOL, V99, P2021, DOI 10.1152/jn.01324.2007; Gire DH, 2009, J NEUROSCI, V29, P13454, DOI 10.1523/JNEUROSCI.2368-09.2009; Giustetto M, 1997, NEUROSCIENCE, V76, P787; Grimes MT, 2011, NEUROBIOL LEARN MEM, V95, P385, DOI 10.1016/j.nlm.2011.01.012; Grubb MS, 2008, J NEUROSCI, V28, P2919, DOI 10.1523/JNEUROSCI.5550-07.2008; GUTHRIE KM, 1993, P NATL ACAD SCI USA, V90, P3329, DOI 10.1073/pnas.90.8.3329; Hayar A, 2001, J NEUROPHYSIOL, V86, P2173, DOI 10.1152/jn.2001.86.5.2173; HOLLINGSWORTH EB, 1985, J NEUROSCI, V5, P2240; Ikegaya Y, 2004, SCIENCE, V304, P559, DOI 10.1126/science.1093173; Isaacson JS, 1998, NEURON, V20, P749, DOI 10.1016/S0896-6273(00)81013-2; JOHANSON IB, 1980, BEHAV NEURAL BIOL, V29, P132, DOI 10.1016/S0163-1047(80)92596-0; Johnson BA, 1996, J COMP NEUROL, V376, P557, DOI 10.1002/(SICI)1096-9861(19961223)376:4<557::AID-CNE5>3.0.CO;2-0; JOHNSON BA, 1995, BRAIN RES, V699, P192, DOI 10.1016/0006-8993(95)00896-X; KENDRICK KM, 1992, SCIENCE, V256, P833, DOI 10.1126/science.1589766; Kepecs A, 2006, CHEM SENSES, V31, P167, DOI 10.1093/chemsce/bjj016; Lin BJ, 2007, J PHYSIOL-LONDON, V582, P163, DOI 10.1113/jphysiol.2006.125963; Liu XB, 2004, J NEUROSCI, V24, P8885, DOI 10.1523/JNEUROSCI.2476-04.2004; Matsumoto H, 2009, J NEUROPHYSIOL, V101, P1890, DOI 10.1152/jn.91019.2008; McLean JH, 1999, LEARN MEMORY, V6, P608, DOI 10.1101/lm.6.6.608; MONYER H, 1992, SCIENCE, V256, P1217, DOI 10.1126/science.256.5060.1217; Mutoh H, 2005, J NEUROSCI, V25, P4252, DOI 10.1523/JNEUROSCI.4721-04.2005; Okutani F, 1999, NEUROSCIENCE, V93, P1297, DOI 10.1016/S0306-4522(99)00224-9; Quinlan EM, 2004, NEURON, V41, P185, DOI 10.1016/S0896-6273(03)00874-2; Quinlan EM, 1999, P NATL ACAD SCI USA, V96, P12876, DOI 10.1073/pnas.96.22.12876; Raineki C, 2010, BRAZ J MED BIOL RES, V43, P914, DOI 10.1590/S0100-879X2010001000001; Raman IM, 1996, NEURON, V16, P415, DOI 10.1016/S0896-6273(00)80059-8; Saint Jan DD, 2005, J NEUROSCI, V25, P2917, DOI 10.1523/JNEUROSCI.5042-04.2005; Satou M, 2006, J COMP PHYSIOL A, V192, P135, DOI 10.1007/s00359-005-0056-7; Satou M, 2005, J COMP PHYSIOL A, V191, P421, DOI 10.1007/s00359-005-0600-5; Schoppa NE, 1998, J NEUROSCI, V18, P6790; Sullivan RM, 2000, BEHAV NEUROSCI, V114, P957, DOI 10.1037/0735-7044.114.5.957; SULLIVAN RM, 1986, DEV BRAIN RES, V27, P278, DOI 10.1016/0165-3806(86)90256-7; SULLIVAN RM, 1991, DEV BRAIN RES, V60, P219, DOI 10.1016/0165-3806(91)90050-S; SULLIVAN RM, 1988, DEV PSYCHOBIOL, V21, P215, DOI 10.1002/dev.420210303; SULLIVAN RM, 1989, J NEUROSCI, V9, P3998; SULLIVAN RM, 1987, DEV BRAIN RES, V35, P307, DOI 10.1016/0165-3806(87)90056-3; Williams JM, 2003, NEUROSCIENCE, V118, P1003, DOI 10.1016/S0306-4522(03)00028-9; WILSON DA, 1988, J NEUROPHYSIOL, V59, P1770, DOI 10.1152/jn.1988.59.6.1770; Wilson DA, 1996, BRAIN RES, V719, P62, DOI 10.1016/0006-8993(96)00083-2; WOO CC, 1987, J COMP NEUROL, V263, P113, DOI 10.1002/cne.902630110; WOO CC, 1995, J COMP NEUROL, V352, P1, DOI 10.1002/cne.903520102; YOVELL Y, 1992, P NATL ACAD SCI USA, V89, P6526, DOI 10.1073/pnas.89.14.6526; Yuan Q, 2003, J NEUROSCI, V23, P4760; Yuan Q, 2006, J NEUROPHYSIOL, V95, P2417, DOI 10.1152/jn.00964.2005; Yuan Q, 2002, J NEUROPHYSIOL, V87, P3156, DOI 10.1152/jn.00917.2001; Yuan Q, 2003, LEARN MEMORY, V10, P5, DOI 10.1101/lm.54803; Yuan Q, 2000, LEARN MEMORY, V7, P413, DOI 10.1101/lm.35900; Yuan Q, 2012, LEARN MEMORY, V19, P50, DOI 10.1101/lm.024844.111; Yuan Q, 2009, LEARN MEMORY, V16, P676, DOI 10.1101/lm.1569309	61	31	31	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 4	2012	7	4							e35024	10.1371/journal.pone.0035024	http://dx.doi.org/10.1371/journal.pone.0035024			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	953GO	22496886	Green Accepted, Green Published, gold			2022-12-25	WOS:000304855200095
J	Payton, CA; Wilson, DA; Wesson, DW				Payton, Colleen A.; Wilson, Donald A.; Wesson, Daniel W.			Parallel Odor Processing by Two Anatomically Distinct Olfactory Bulb Target Structures	PLOS ONE			English	Article							PIRIFORM CORTEX; TUFTED CELLS; TUBERCLE; SYSTEM; RAT; ORGANIZATION; CONNECTIONS; INFORMATION; PROJECTIONS; ATTRACTION	The olfactory cortex encompasses several anatomically distinct regions each hypothesized to provide differential representation and processing of specific odors. Studies exploring whether or not the diversity of olfactory bulb input to olfactory cortices has functional meaning, however, are lacking. Here we tested whether two anatomically major olfactory cortical structures, the olfactory tubercle (OT) and piriform cortex (PCX), differ in their neural representation and processing dynamics of a small set of diverse odors by performing in vivo extracellular recordings from the OT and PCX of anesthetized mice. We found a wealth of similarities between structures, including odor-evoked response magnitudes, breadth of odor tuning, and odor-evoked firing latencies. In contrast, only few differences between structures were found, including spontaneous activity rates and odor signal-to-noise ratios. These results suggest that despite major anatomical differences in innervation by olfactory bulb mitral/tufted cells, the basic features of odor representation and processing, at least within this limited odor set, are similar within the OT and PCX. We predict that the olfactory code follows a distributed processing stream in transmitting behaviorally and perceptually-relevant information from low-level stations.	[Payton, Colleen A.; Wesson, Daniel W.] Case Western Reserve Univ, Sch Med, Dept Neurosci, Cleveland, OH 44106 USA; [Wilson, Donald A.; Wesson, Daniel W.] Nathan S Kline Inst Psychiat Res, Emot Brain Inst, Orangeburg, NY 10962 USA; [Wilson, Donald A.; Wesson, Daniel W.] NYU, Sch Med, Dept Child & Adolescent Psychiat, New York, NY USA	Case Western Reserve University; Nathan Kline Institute for Psychiatric Research; New York University	Payton, CA (corresponding author), Case Western Reserve Univ, Sch Med, Dept Neurosci, Cleveland, OH 44106 USA.	dww53@case.edu	Wesson, Daniel/AAJ-6719-2020; Payton, Colleen/AAS-9587-2020	Wesson, Daniel/0000-0002-3192-3866; Payton, Colleen/0000-0003-1398-6211	National Science Foundation [IOS-1121471]; National Institutes of Health [DC003906]; NATIONAL INSTITUTE ON AGING [R01AG037693] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON DEAFNESS AND OTHER COMMUNICATION DISORDERS [R01DC003906] Funding Source: NIH RePORTER	National Science Foundation(National Science Foundation (NSF)); National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA)); NATIONAL INSTITUTE ON DEAFNESS AND OTHER COMMUNICATION DISORDERS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Deafness & Other Communication Disorders (NIDCD))	This work was supported by National Science Foundation grant IOS-1121471 to D.W.W. and D.A.W. and DC003906 to D.A.W. from the National Institutes of Health. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ALHEID GF, 1988, NEUROSCIENCE, V27, P1, DOI 10.1016/0306-4522(88)90217-5; Barnes DC, 2008, NAT NEUROSCI, V11, P1378, DOI 10.1038/nn.2217; Baum MJ, 2002, HORM BEHAV, V41, P213, DOI 10.1006/hbeh.2001.1749; Brennan PA, 2006, PHILOS T R SOC B, V361, P2061, DOI 10.1098/rstb.2006.1931; Brunjes PC, 2005, BRAIN RES REV, V50, P305, DOI 10.1016/j.brainresrev.2005.08.005; Carriero G, 2009, J NEUROPHYSIOL, V101, P1613, DOI 10.1152/jn.90792.2008; Chapuis J, 2012, NAT NEUROSCI, V15, P155, DOI 10.1038/nn.2966; Cury KM, 2010, NEURON, V68, P570, DOI 10.1016/j.neuron.2010.09.040; Davison IG, 2011, NEURON, V70, P82, DOI 10.1016/j.neuron.2011.02.047; Fallon JH, 1983, BRAIN RES B, V10, P179; Galizia CG, 2010, ANNU REV ENTOMOL, V55, P399, DOI 10.1146/annurev-ento-112408-085442; GERVAIS R, 1979, ELECTROEN CLIN NEURO, V46, P665, DOI 10.1016/0013-4694(79)90104-4; Ghosh S, 2011, NATURE, V472, P217, DOI 10.1038/nature09945; GILBERT CD, 1983, PROG BRAIN RES, V58, P209, DOI 10.1016/S0079-6123(08)60022-9; Gollisch T, 2008, SCIENCE, V319, P1108, DOI 10.1126/science.1149639; Gottfried JA, 2006, NEURON, V49, P467, DOI 10.1016/j.neuron.2006.01.007; HABERLY LB, 1978, J COMP NEUROL, V178, P711, DOI 10.1002/cne.901780408; HABERLY LB, 1977, BRAIN RES, V129, P152, DOI 10.1016/0006-8993(77)90978-7; Haberly LB, 1998, SYNAPTIC ORG BRAIN, P377; Heimer L, 1975, SUBCORTICAL PROJECTI; Howard JD, 2009, NAT NEUROSCI, V12, P932, DOI 10.1038/nn.2324; Ikemoto S, 2007, BRAIN RES REV; Imamura F, 2011, NAT NEUROSCI; Irvine DRF, AUDITORY BRAINSTEM, P1; Kadohisa M, 2006, P NATL ACAD SCI USA, V103, P15206, DOI 10.1073/pnas.0604313103; Kang N, 2009, EUR J NEUROSCI, V29, P624, DOI 10.1111/j.1460-9568.2009.06638.x; Kay LM, 1999, NAT NEUROSCI, V2, P1003, DOI 10.1038/14801; Lakatos P, 2008, SCIENCE, V320, P110, DOI 10.1126/science.1154735; Levy F, 2009, BEHAV BRAIN RES, V200, P336, DOI 10.1016/j.bbr.2008.12.017; Litaudon P, 2003, EUR J NEUROSCI, V17, P2457, DOI 10.1046/j.1460-9568.2003.02654.x; LUSKIN MB, 1983, J COMP NEUROL, V216, P292, DOI 10.1002/cne.902160306; Martel KL, 2007, EUR J NEUROSCI, V26, P463, DOI 10.1111/j.1460-9568.2007.05651.x; McNamara AM, 2004, CHEM SENSES, V29, P225, DOI 10.1093/chemse/bjh027; Miyamichi K, 2011, NATURE, V472, P191, DOI 10.1038/nature09714; Mombaerts P, 1999, ANNU REV NEUROSCI, V22, P487, DOI 10.1146/annurev.neuro.22.1.487; MOZELL MM, 1964, NATURE, V203, P1181, DOI 10.1038/2031181a0; Nagayama S, 2004, J NEUROPHYSIOL, V91, P2532, DOI 10.1152/jn.01266.2003; Nagayama S, 2010, FRONT NEURAL CIRCUIT, V4, DOI 10.3389/fncir.2010.00120; Neville K.R., 2004, SYNAPTIC ORG BRAIN, P415, DOI DOI 10.1093/ACPR0F:0S0/9780195159561.003.0010; Paxinos G, 2000, MOUSE BRAIN STEREOTA; PFAFF D, 1973, J COMP NEUROL, V151, P121, DOI 10.1002/cne.901510204; PFAFF DW, 1968, EXPERIENTIA, V24, P958, DOI 10.1007/BF02138682; PFAFFMANN C, 1959, AM PSYCHOL, V14, P226, DOI 10.1037/h0049324; PRICE JL, 1973, J COMP NEUROL, V150, P87, DOI 10.1002/cne.901500105; Rennaker RL, 2007, J NEUROSCI, V27, P1534, DOI 10.1523/JNEUROSCI.4072-06.2007; Rinberg D, 2006, J NEUROSCI, V26, P8857, DOI 10.1523/JNEUROSCI.0884-06.2006; SCHOENBAUM G, 1995, J NEUROPHYSIOL, V74, P733, DOI 10.1152/jn.1995.74.2.733; SCHWOB JE, 1984, J COMP NEUROL, V223, P177, DOI 10.1002/cne.902230204; SCOTT JW, 1986, EXPERIENTIA, V42, P223, DOI 10.1007/BF01942502; SCOTT JW, 1980, J COMP NEUROL, V194, P519, DOI 10.1002/cne.901940304; SCOTT JW, 1981, J NEUROPHYSIOL, V46, P918, DOI 10.1152/jn.1981.46.5.918; Shepherd G.M., 2004, SYNAPTIC ORG BRAIN, DOI [DOI 10.1093/ACPROF:OSO/9780195159561.001.1, 10.1093/acprof:oso/9780195159561.001.1]; SHIPLEY MT, 1984, BRAIN RES BULL, V12, P669, DOI 10.1016/0361-9230(84)90148-5; Sosulski DL, 2011, NATURE, V472, P213, DOI 10.1038/nature09868; Wesson DW, 2008, PLOS BIOL, V6, P717, DOI 10.1371/journal.pbio.0060082; Wesson DW, 2006, HORM BEHAV, V49, P580, DOI 10.1016/j.yhbeh.2005.12.013; Wesson DW, 2011, NEUROSCI BIOBEHAV R, V35, P655, DOI 10.1016/j.neubiorev.2010.08.004; WHITE LE, 1965, ANAT RECORD, V152, P465, DOI 10.1002/ar.1091520406; Wilson DA, 1998, J NEUROPHYSIOL, V79, P1425, DOI 10.1152/jn.1998.79.3.1425; Wilson DA, 2011, NEURON, V72, P506, DOI 10.1016/j.neuron.2011.10.027; YIN TCT, 1990, J NEUROPHYSIOL, V64, P465, DOI 10.1152/jn.1990.64.2.465	61	28	28	0	16	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 4	2012	7	4							e34926	10.1371/journal.pone.0034926	http://dx.doi.org/10.1371/journal.pone.0034926			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	953GO	22496877	Green Published, gold, Green Submitted			2022-12-25	WOS:000304855200088
J	Tsai, HY; Huang, YW				Tsai, Hung-Yin; Huang, Yen-Wen			Image Tracking Study on Courtship Behavior of Drosophila	PLOS ONE			English	Article							SLEEP ONSET; MAINTENANCE	Background: In recent years, there have been extensive studies aimed at decoding the DNA. Identifying the genetic cause of specific changes in a simple organism like Drosophila may help scientists recognize how multiple gene interactions may make some people more susceptible to heart disease or cancer. Investigators have devised experiments to observe changes in the gene networks in mutant Drosophila that responds differently to light, or have lower or higher locomotor activity. However, these studies focused on the behavior of the individual fly or on pair-wise interactions in the study of aggression or courtship. The behavior of these activities has been captured on film and inspected by a well-trained researcher after repeatedly watching the recorded film. Some studies also focused on ways to reduce the inspection time and increase the accuracy of the behavior experiment. Methodology: In this study, the behavior of drosophila during courtship was analyzed automatically by machine vision. We investigated the position and behavior discrimination during courtship using the captured images. Identification of the characteristics of drosophila, including sex, size, heading direction, and wing angles, can be computed using image analysis techniques that employ the Gaussian mixture model. The behavior of multiple drosophilae can also be analyzed simultaneously using the motion-prediction model and the variation constraint of heading direction. Conclusions: The overlapped fruit flies can be identified based on the relationship between body centers. Moreover, the behaviors and profiles can be correctly recognized by image processing based on the constraints of the wing angle and the size of the body. Therefore, the behavior of the male fruit flies can be discriminated when two or three fruit flies form a close cluster. In this study, the courtship behavior, including wing songs and attempts, can currently be distinguished with accuracies of 95.8% and 90%, respectively.	[Tsai, Hung-Yin; Huang, Yen-Wen] Natl Tsing Hua Univ, Dept Power Mech Engn, Hsinchu, Taiwan	National Tsing Hua University	Tsai, HY (corresponding author), Natl Tsing Hua Univ, Dept Power Mech Engn, Hsinchu, Taiwan.	hytsai@pme.nthu.edu.tw			National Science Council [NSC-98-2221-E-007-005-MY3]	National Science Council(Ministry of Science and Technology, Taiwan)	The authors would like to thank the National Science Council for supporting the research project under the contract No. NSC-98-2221-E-007-005-MY3 (http://www.nsc.gov.tw). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Agosto J, 2008, NAT NEUROSCI, V11, P354, DOI 10.1038/nn2046; Branson K, 2009, NAT METHODS, V6, P451, DOI [10.1038/nmeth.1328, 10.1038/NMETH.1328]; Dankert H, 2009, NAT METHODS, V6, P297, DOI [10.1038/NMETH.1310, 10.1038/nmeth.1310]; Dickson BJ, 2008, SCIENCE, V322, P904, DOI 10.1126/science.1159276; Greenspan RJ, 2001, TRENDS NEUROSCI, V24, P142, DOI 10.1016/S0166-2236(00)01719-7; Lin HH, 2007, CELL, V128, P1205, DOI 10.1016/j.cell.2007.03.006; Liu T, 2008, J NEUROSCI, V28, P5539, DOI 10.1523/JNEUROSCI.5290-07.2008; Liu WJ, 2008, BIOCHEM BIOPH RES CO, V372, P798, DOI 10.1016/j.bbrc.2008.05.119; Martin JR, 2004, BEHAV PROCESS, V67, P207, DOI 10.1016/j.beproc.2004.04.003; Ramazani RB, 2007, J NEUROSCI METH, V162, P171, DOI 10.1016/j.jneumeth.2007.01.005	10	10	10	0	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 4	2012	7	4							e34784	10.1371/journal.pone.0034784	http://dx.doi.org/10.1371/journal.pone.0034784			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	953GO	22496861	gold, Green Published, Green Submitted			2022-12-25	WOS:000304855200081
J	Crumbley, C; Wang, YJ; Banerjee, S; Burris, TP				Crumbley, Christine; Wang, Yongjun; Banerjee, Subhashis; Burris, Thomas P.			Regulation of Expression of Citrate Synthase by the Retinoic Acid Receptor-Related Orphan Receptor alpha (ROR alpha)	PLOS ONE			English	Article							NUCLEAR RECEPTOR; GENE-EXPRESSION; TRANSCRIPTIONAL REGULATION; LIGAND; CHOLESTEROL; METABOLISM; COMPONENT	The retinoic acid receptor-related orphan receptor alpha (ROR alpha) is a member of the nuclear receptor superfamily of transcription factors that Plays an important role in regulation of the circadian rhythm and metabolism. Mice lacking a functional ROR alpha display a range of metabolic abnormalities including decreased serum cholesterol and plasma triglycerides. Citrate synthase (CS) is a key enzyme of the citric acid cycle that provides energy for cellular function. Additionally, CS plays a critical role in providing citrate derived acetyl-CoA for lipogenesis and cholesterologenesis. Here, we identified a functional ROR alpha response element (RORE) in the promoter of the CS gene. ChIP analysis demonstrates ROR alpha occupancy of the CS promoter and a putative RORE binds to ROR alpha effectively in an electrophoretic mobility shift assay and confers ROR alpha responsiveness to a reporter gene in a cotransfection assay. We also observed a decrease in CS gene expression and CS enzymatic activity in the staggerer mouse, which has a mutation of in the Rora gene resulting in nonfunctional ROR alpha. protein. Furthermore, we found that SR1001 a ROR alpha inverse agonist eliminated the circadian pattern of expression of CS mRNA in mice. These data suggest that CS is a direct ROR alpha target gene and one mechanism by which ROR alpha regulates lipid metabolism is via regulation of CS expression.	[Crumbley, Christine] Scripps Res Inst, Dept Mol Therapeut, Jupiter, FL USA; Scripps Res Inst, Ctr Diabet & Metab Dis, Jupiter, FL USA	Scripps Research Institute; Scripps Research Institute	Crumbley, C (corresponding author), Scripps Res Inst, Dept Mol Therapeut, Jupiter, FL USA.	tburris@scripps.edu	Burris, Thomas P/B-3886-2016	Burris, Thomas P/0000-0003-2922-4449	National Institutes of Health [DK080201, MH092769]; American Heart Association [10PRE4330013]; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK080201] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF MENTAL HEALTH [R01MH092769] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); American Heart Association(American Heart Association); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NATIONAL INSTITUTE OF MENTAL HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH))	This work was supported by National Institutes of Health grants (DK080201 and MH092769 to TPB) and the American Heart Association (10PRE4330013 to CC). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bass J, 2010, SCIENCE, V330, P1349, DOI 10.1126/science.1195027; Burris TP, 2008, MOL ENDOCRINOL, V22, P1509, DOI 10.1210/me.2007-0519; Chen YP, 2009, J PHARMACOL EXP THER, V329, P192, DOI 10.1124/jpet.108.148916; Chopra AR, 2008, SCIENCE, V322, P1395, DOI 10.1126/science.1164847; Crumbley C, 2010, J BIOL CHEM, V285, P35386, DOI 10.1074/jbc.M110.129288; GLATZ JFC, 1984, J BIOL CHEM, V259, P4295; Green CB, 2008, CELL, V134, P728, DOI 10.1016/j.cell.2008.08.022; Jetten Anton M, 2009, Nucl Recept Signal, V7, pe003, DOI 10.1621/nrs.07003; Kallen J, 2004, J BIOL CHEM, V279, P14033, DOI 10.1074/jbc.M400302200; Kallen JA, 2002, STRUCTURE, V10, P1697, DOI 10.1016/S0969-2126(02)00912-7; Kraft CS, 2006, AM J PHYSIOL-CELL PH, V290, pC1119, DOI 10.1152/ajpcell.00463.2005; Kumar N, 2011, ACS CHEM BIOL, V6, P218, DOI 10.1021/cb1002762; Kumar N, 2010, MOL PHARMACOL, V77, P228, DOI 10.1124/mol.109.060905; Lau P, 2008, J BIOL CHEM, V283, P18411, DOI 10.1074/jbc.M710526200; Mamontova A, 1998, CIRCULATION, V98, P2738, DOI 10.1161/01.CIR.98.24.2738; Ovcharenko I, 2004, NUCLEIC ACIDS RES, V32, pW280; Raspe E, 2001, J BIOL CHEM, V276, P2865, DOI 10.1074/jbc.M004982200; Sato TK, 2004, NEURON, V43, P527, DOI 10.1016/j.neuron.2004.07.018; Solt LA, 2011, NATURE, V472, P491, DOI 10.1038/nature10075; Solt LA, 2011, FUTURE MED CHEM, V3, P623, DOI [10.4155/FMC.11.9, 10.4155/fmc.11.9]; Takeda Y, 2011, NUCLEIC ACIDS RES, V39, P4769, DOI 10.1093/nar/gkq1335; VuDac N, 1997, J BIOL CHEM, V272, P22401, DOI 10.1074/jbc.272.36.22401; Wada T, 2008, EXP BIOL MED, V233, P1191, DOI 10.3181/0802-MR-50; Wang YJ, 2010, ACS CHEM BIOL, V5, P1029, DOI 10.1021/cb100223d; Wang YJ, 2010, BBA-MOL CELL BIOL L, V1801, P917, DOI 10.1016/j.bbalip.2010.02.012; Wang YJ, 2010, J BIOL CHEM, V285, P15668, DOI 10.1074/jbc.M110.102160; Wang YJ, 2010, J BIOL CHEM, V285, P5013, DOI 10.1074/jbc.M109.080614	27	18	18	1	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 2	2012	7	4							e33804	10.1371/journal.pone.0033804	http://dx.doi.org/10.1371/journal.pone.0033804			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	952GU	22485150	Green Published, gold			2022-12-25	WOS:000304780500026
J	St Gelais, C; Coleman, CM; Wang, JH; Wu, L				St Gelais, Corine; Coleman, Christopher M.; Wang, Jian-Hua; Wu, Li			HIV-1 Nef Enhances Dendritic Cell-Mediated Viral Transmission to CD4(+) T Cells and Promotes T-Cell Activation	PLOS ONE			English	Article							HUMAN-IMMUNODEFICIENCY-VIRUS; DC-SIGN; PRIMATE LENTIVIRUSES; TYPE-1 REPLICATION; DOWN-REGULATION; ANTIGEN PRESENTATION; TRANS-ENHANCEMENT; INFECTION; PROTEIN; LYMPHOCYTES	HIV-1 Nef enhances dendritic cell (DC)-mediated viral transmission to CD4(+) T cells, but the underlying mechanism is not fully understood. It is also unknown whether HIV-1 infected DCs play a role in activating CD4(+) T cells and enhancing DC-mediated viral transmission. Here we investigated the role of HIV-1 Nef in DC-mediated viral transmission and HIV-1 infection of primary CD4(+) T cells using wild-type HIV-1 and Nef-mutated viruses. We show that HIV-1 Nef facilitated DC-mediated viral transmission to activated CD4(+) T cells. HIV-1 expressing wild-type Nef enhanced the activation and proliferation of primary resting CD4(+) T cells. However, when co-cultured with HIV-1-infected autologous DCs, there was no significant trend for infection- or Nef-dependent proliferation of resting CD4(+) T cells. Our results suggest an important role of Nef in DC-mediated transmission of HIV-1 to activated CD4(+) T cells and in the activation and proliferation of resting CD4(+) T cells, which likely contribute to viral pathogenesis.	[St Gelais, Corine; Coleman, Christopher M.; Wu, Li] Ohio State Univ, Ctr Retrovirus Res, Dept Vet Biosci, Columbus, OH 43210 USA; [Wang, Jian-Hua] Chinese Acad Sci, Key Lab Mol Virol & Immunol, Inst Pasteur Shanghai, Shanghai Inst Biol Sci, Shanghai, Peoples R China; [Wu, Li] Ohio State Univ, Med Ctr, Dept Microbial Infect & Immun, Columbus, OH 43210 USA	University System of Ohio; Ohio State University; Chinese Academy of Sciences; Shanghai Institutes for Biological Sciences, CAS; Le Reseau International des Instituts Pasteur (RIIP); University System of Ohio; Ohio State University	St Gelais, C (corresponding author), Ohio State Univ, Ctr Retrovirus Res, Dept Vet Biosci, Columbus, OH 43210 USA.	wu.840@osu.edu	Wu, Li/ABB-2813-2020; Wu, Li/E-4330-2011	Wu, Li/0000-0002-5468-2487; Wu, Li/0000-0002-5468-2487; Coleman, Christopher/0000-0002-7306-8407	National Institutes of Health (NIH) [AI068493, AI078762, R21AI098524]; Public Health Preparedness for Infectious Diseases of The Ohio State University; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI068493, R21AI078762, R21AI102822, R21AI098524] Funding Source: NIH RePORTER	National Institutes of Health (NIH)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Public Health Preparedness for Infectious Diseases of The Ohio State University; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	This work was supported by a grant (AI068493) to LW from the National Institutes of Health (NIH) and by the program of Public Health Preparedness for Infectious Diseases of The Ohio State University. LW was supported in part by grants AI078762 and R21AI098524 from the NIH. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	AIKEN C, 1995, J VIROL, V69, P5048, DOI 10.1128/JVI.69.8.5048-5056.1995; Arhel NJ, 2009, CURR TOP MICROBIOL, V339, P147, DOI 10.1007/978-3-642-02175-6_8; Arrighi JF, 2004, J EXP MED, V200, P1279, DOI 10.1084/jem.20041356; Baribaud F, 2001, VIROLOGY, V286, P1, DOI 10.1006/viro.2001.0975; Boggiano C, 2007, J VIROL, V81, P2519, DOI 10.1128/JVI.01661-06; Brenchley JM, 2006, NAT MED, V12, P1365, DOI 10.1038/nm1511; Burleigh L, 2006, J VIROL, V80, P2949, DOI 10.1128/JVI.80.6.2949-2957.2006; Coleman CM, 2011, RETROVIROLOGY, V8, DOI 10.1186/1742-4690-8-26; Coleman CM, 2009, RETROVIROLOGY, V6, DOI 10.1186/1742-4690-6-51; CONNOR RI, 1995, VIROLOGY, V206, P935, DOI 10.1006/viro.1995.1016; DANIEL MD, 1992, SCIENCE, V258, P1938, DOI 10.1126/science.1470917; DEACON NJ, 1995, SCIENCE, V270, P988, DOI 10.1126/science.270.5238.988; Dong CS, 2007, J VIROL, V81, P11352, DOI 10.1128/JVI.01081-07; ENGLUND G, 1995, J VIROL, V69, P3216, DOI 10.1128/JVI.69.5.3216-3219.1995; Fackler OT, 2007, NAT REV IMMUNOL, V7, P310, DOI 10.1038/nri2041; Fackler OT, 2001, CURR BIOL, V11, P1294, DOI 10.1016/S0960-9822(01)00373-6; Finzi D, 1998, CELL, V93, P665, DOI 10.1016/S0092-8674(00)81427-0; Foskett SM, 2001, J VIROL, V75, P1220, DOI 10.1128/JVI.75.3.1220-1228.2001; Foster JL, 2008, RETROVIROLOGY, V5, DOI 10.1186/1742-4690-5-84; Geijtenbeek TBH, 2000, CELL, V100, P587, DOI 10.1016/S0092-8674(00)80694-7; Geyer M, 2001, EMBO REP, V2, P580, DOI 10.1093/embo-reports/kve141; Gummuluru S, 2003, J VIROL, V77, P12865, DOI 10.1128/JVI.77.23.12865-12874.2003; Gummuluru S, 2002, J VIROL, V76, P10692, DOI 10.1128/JVI.76.21.10692-10701.2002; Gurney KB, 2005, J VIROL, V79, P5762, DOI 10.1128/JVI.79.9.5762-5773.2005; Hrecka K, 2011, NATURE, V474, P658, DOI 10.1038/nature10195; Izquierdo-Useros N, 2007, J VIROL, V81, P7559, DOI 10.1128/JVI.02572-06; KESTLER HW, 1991, CELL, V65, P651, DOI 10.1016/0092-8674(91)90097-I; Kirchhoff F, 2008, CELL MOL LIFE SCI, V65, P2621, DOI 10.1007/s00018-008-8094-2; KIRCHHOFF F, 1995, NEW ENGL J MED, V332, P228, DOI 10.1056/NEJM199501263320405; Kirchhoff F, 2010, CELL HOST MICROBE, V8, P55, DOI 10.1016/j.chom.2010.06.004; Kwon DS, 2002, IMMUNITY, V16, P135, DOI 10.1016/S1074-7613(02)00259-5; Laguette N, 2011, NATURE, V474, P654, DOI 10.1038/nature10117; Lama J, 2000, J VIROL, V74, P9396, DOI 10.1128/JVI.74.20.9396-9402.2000; Lore K, 2005, J EXP MED, V201, P2023, DOI 10.1084/jem.20042413; Lundquist CA, 2004, J VIROL, V78, P6287, DOI 10.1128/JVI.78.12.6287-6296.2004; Lundquist CA, 2002, J VIROL, V76, P4625, DOI 10.1128/JVI.76.9.4625-4633.2002; Manel N, 2010, NATURE, V467, P214, DOI 10.1038/nature09337; McDonald D, 2003, SCIENCE, V300, P1295, DOI 10.1126/science.1084238; Messmer D, 2002, J IMMUNOL, V169, P4172, DOI 10.4049/jimmunol.169.8.4172; Messmer D, 2002, AIDS RES HUM RETROV, V18, P1043, DOI 10.1089/08892220260235407; Michel N, 2005, CURR BIOL, V15, P714, DOI 10.1016/j.cub.2005.02.058; Moris A, 2006, BLOOD, V108, P1643, DOI 10.1182/blood-2006-02-006361; Muratori C, 2009, CELL HOST MICROBE, V6, P218, DOI 10.1016/j.chom.2009.06.009; Neri F, 2011, VIROLOGY, V410, P316, DOI 10.1016/j.virol.2010.11.018; Nobile C, 2005, J VIROL, V79, P5386, DOI 10.1128/JVI.79.9.5386-5399.2005; Petit C, 2001, VIROLOGY, V286, P225, DOI 10.1006/viro.2001.0984; Piguet V, 1999, IMMUNOL REV, V168, P51, DOI 10.1111/j.1600-065X.1999.tb01282.x; Piguet V, 2007, TRENDS IMMUNOL, V28, P503, DOI 10.1016/j.it.2007.07.010; Ruiz A, 2010, CURR HIV RES, V8, P240, DOI 10.2174/157016210791111124; Sanders RW, 2002, J VIROL, V76, P7812, DOI 10.1128/JVI.76.15.7812-7821.2002; Schindler M, 2006, CELL, V125, P1055, DOI 10.1016/j.cell.2006.04.033; Schwartz O, 1996, NAT MED, V2, P338, DOI 10.1038/nm0396-338; Shen L, 2008, J ALLERGY CLIN IMMUN, V122, P22, DOI 10.1016/j.jaci.2008.05.033; Smed-Sorensen A, 2005, J VIROL, V79, P8861, DOI 10.1128/JVI.79.14.8861-8869.2005; Sol-Foulon N, 2002, IMMUNITY, V16, P145, DOI 10.1016/S1074-7613(02)00260-1; St Gelais C, 2011, RETROVIROLOGY, V8, DOI 10.1186/1742-4690-8-55; Stumptner-Cuvelette P, 2001, P NATL ACAD SCI USA, V98, P12144, DOI 10.1073/pnas.221256498; Swigut T, 2001, EMBO J, V20, P1593, DOI 10.1093/emboj/20.7.1593; Trumpfheller C, 2003, INT IMMUNOL, V15, P289, DOI 10.1093/intimm/dxg030; Turville SG, 2004, BLOOD, V103, P2170, DOI 10.1182/blood-2003-09-3129; Unutmaz D, 1999, J EXP MED, V189, P1735, DOI 10.1084/jem.189.11.1735; Wang JH, 2007, J VIROL, V81, P8933, DOI 10.1128/JVI.00878-07; Wang JH, 2007, J VIROL, V81, P2497, DOI 10.1128/JVI.01970-06; Wu L, 2004, VIROLOGY, V318, P17, DOI 10.1016/j.virol.2003.09.028; Wu L, 2002, P NATL ACAD SCI USA, V99, P1568, DOI 10.1073/pnas.032654399; Wu L, 2002, J VIROL, V76, P5905, DOI 10.1128/JVI.76.12.5905-5914.2002; Wu L, 2008, CURR OPIN HIV AIDS, V3, P534, DOI 10.1097/COH.0b013e32830634c6; Wu L, 2006, NAT REV IMMUNOL, V6, P859, DOI 10.1038/nri1960; Wu YT, 2001, SCIENCE, V293, P1503, DOI 10.1126/science.1061548; Zhou J, 2001, J VIROL, V75, P5851, DOI 10.1128/JVI.75.13.5851-5859.2001; ZIEGLER SF, 1994, STEM CELLS, V12, P456, DOI 10.1002/stem.5530120502	71	16	16	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 30	2012	7	3							e34521	10.1371/journal.pone.0034521	http://dx.doi.org/10.1371/journal.pone.0034521			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	959UC	22479639	Green Published, Green Submitted, gold			2022-12-25	WOS:000305339100164
J	Vella, LJ; Cappai, R				Vella, Laura J.; Cappai, Roberto			Identification of a novel amyloid precursor protein processing pathway that generates secreted N-terminal fragments	FASEB JOURNAL			English	Article						Alzheimer's disease; alpha-secretase; beta-secretase; developmental regulation	ALZHEIMERS-DISEASE; KINASE-C; ALPHA-SECRETASE; BETA-SECRETASE; RETINOIC ACID; BINDING DOMAIN; SOLUBLE FORM; EXPRESSION; APP; RAT	Alzheimer's disease (AD) is a neurodegenerative disorder of the central nervous system. The proteolytic processing of the amyloid precursor protein (APP) into the beta-amyloid (A beta) peptide is a central event in AD. While the pathway that generates A beta is well described, many questions remain concerning general APP metabolism and its metabolites. It is becoming clear that the amino-terminal region of APP can be processed to release small N-terminal fragments (NTFs). The purpose of this study was to investigate the occurrence and generation of APP NTFs in vivo and in cell culture (SH-SY5Y) in order to delineate the cellular pathways implicated in their generation. We were able to detect 17- to 28-kDa APP NTFs in human and mouse brain tissue that are distinct from N-APP fragments previously reported. We show that the 17- to 28-kDa APP NTFs were highly expressed in mice from the age of 2 wk to adulthood. SH-SY5Y studies indicate the generation of APP NTFs involves a novel APP processing pathway, regulated by protein kinase C, but independent of alpha-secretase or beta-secretase 1 (BACE) activity. These results identify a novel, developmentally regulated APP processing pathway that may play an important role in the physiological function of APP.-Vella, L. J., Cappai, R. Identification of a novel amyloid precursor protein processing pathway that generates secreted N-terminal fragments. FASEB J. 26, 2930-2940 (2012). www.fasebj.org	[Cappai, Roberto] Univ Melbourne, Dept Pathol, Melbourne, Vic 3010, Australia; Univ Melbourne, Mol Sci & Biotechnol Inst Bio21, Melbourne, Vic 3010, Australia	University of Melbourne; University of Melbourne	Cappai, R (corresponding author), Univ Melbourne, Dept Pathol, Melbourne, Vic 3010, Australia.	r.cappai@unimelb.edu.au	Vella, laura/N-2733-2017; Cappai, Roberto/B-3347-2010	Vella, laura/0000-0002-1869-6291; Cappai, Roberto/0000-0002-9505-8496	Alzheimer's Australia Research Viertel Fellowship; NHMRC; Australian Research Council	Alzheimer's Australia Research Viertel Fellowship; NHMRC(National Health and Medical Research Council (NHMRC) of Australia); Australian Research Council(Australian Research Council)	The authors thank Giuseppe Ciccotosto and Andrea Connor (Department of Pathology, University of Melbourne) for assistance in providing the mouse and human brain tissue respectively. We thank the National Neural Tissue Resource Centre for the human brain tissues. L.J.V. is an Alzheimer's Australia Research Viertel Fellowship recipient. R. C. is an Australia National Health and Medical Research Council (NHMRC) Senior Research Fellow. Funding was provided by the NHMRC and the Australian Research Council to R.C.	ARAI H, 1994, BRAIN RES, V642, P132, DOI 10.1016/0006-8993(94)90914-8; Arai Y, 1997, BRAIN DEV-JPN, V19, P290, DOI 10.1016/S0387-7604(97)00559-7; Argellati F, 2009, FASEB J, V23, P1246, DOI 10.1096/fj.08-119263; Barnham KJ, 2003, J BIOL CHEM, V278, P17401, DOI 10.1074/jbc.M300629200; BUSCIGLIO J, 1993, P NATL ACAD SCI USA, V90, P2092, DOI 10.1073/pnas.90.5.2092; Caille I, 2004, DEVELOPMENT, V131, P2173, DOI 10.1242/dev.01103; CAPORASO GL, 1992, P NATL ACAD SCI USA, V89, P3055, DOI 10.1073/pnas.89.7.3055; Chen ST, 1997, NEUROREPORT, V8, P713, DOI 10.1097/00001756-199702100-00027; CLARRIS HJ, 1995, DEV BRAIN RES, V88, P87, DOI 10.1016/0165-3806(95)00083-P; Constantinescu R, 2007, J NEURAL TRANSM-SUPP, P17; Corrigan F, 2011, BRAIN RES, V1378, P137, DOI 10.1016/j.brainres.2010.12.077; Dahms SO, 2010, P NATL ACAD SCI USA, V107, P5381, DOI 10.1073/pnas.0911326107; DAIGLE I, 1993, P NATL ACAD SCI USA, V90, P12045, DOI 10.1073/pnas.90.24.12045; De Chiara G, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0013989; Encinas M, 1999, J NEUROCHEM, V73, P1409, DOI 10.1046/j.1471-4159.1999.0731409.x; Endres K, 2005, FEBS J, V272, P5808, DOI 10.1111/j.1742-4658.2005.04976.x; Esh C, 2005, BIOCHEMISTRY-US, V44, P13807, DOI 10.1021/bi051213+; Fahrenholz F, 2010, NEURODEGENER DIS, V7, P190, DOI 10.1159/000295662; GABUZDA D, 1993, J NEUROCHEM, V61, P2326, DOI 10.1111/j.1471-4159.1993.tb07479.x; Gage FH, 2002, J NEUROSCI, V22, P612, DOI 10.1523/JNEUROSCI.22-03-00612.2002; GOLDE TE, 1992, SCIENCE, V255, P728, DOI 10.1126/science.1738847; Govoni S, 1996, ANN NY ACAD SCI, V777, P332, DOI 10.1111/j.1749-6632.1996.tb34442.x; GRUBER JR, 1995, EXP CELL RES, V221, P377, DOI 10.1006/excr.1995.1388; HAASS C, 1993, J BIOL CHEM, V268, P3021; HAYASHI Y, 1994, BIOCHEM BIOPH RES CO, V205, P936, DOI 10.1006/bbrc.1994.2755; HESSE L, 1994, FEBS LETT, V349, P109, DOI 10.1016/0014-5793(94)00658-X; Hoe HS, 2009, J NEUROSCI, V29, P7459, DOI 10.1523/JNEUROSCI.4872-08.2009; Holback S, 2005, J NEUROCHEM, V95, P1059, DOI 10.1111/j.1471-4159.2005.03440.x; Hoshino M, 2003, NEUROSCI LETT, V353, P135, DOI 10.1016/j.neulet.2003.09.030; HUNG AY, 1992, P NATL ACAD SCI USA, V89, P9439, DOI 10.1073/pnas.89.20.9439; Jacobsen KT, 2010, J BIOL CHEM, V285, P10223, DOI 10.1074/jbc.M109.038224; Jefferson T, 2011, J BIOL CHEM, V286, P27741, DOI 10.1074/jbc.M111.252718; Jolly-Tornetta C, 2000, BIOCHEMISTRY-US, V39, P15282, DOI 10.1021/bi001723y; Kaden D, 2008, J BIOL CHEM, V283, P7271, DOI 10.1074/jbc.M708046200; KANG J, 1987, NATURE, V325, P733, DOI 10.1038/325733a0; Kuhn PH, 2010, EMBO J, V29, P3020, DOI 10.1038/emboj.2010.167; Lane RF, 2010, MOL NEURODEGENER, V5, DOI 10.1186/1750-1326-5-62; LeBlanc AC, 1998, J NEUROSCI, V18, P2907; Lichtenthaler SF, 2011, J NEUROCHEM, V116, P10, DOI 10.1111/j.1471-4159.2010.07081.x; LOFFLER J, 1992, J NEUROCHEM, V59, P1316, DOI 10.1111/j.1471-4159.1992.tb08443.x; Lopez-Andreo MJ, 2005, BIOCHEMISTRY-US, V44, P11353, DOI 10.1021/bi0504862; Lyckman AW, 1998, J BIOL CHEM, V273, P11100, DOI 10.1074/jbc.273.18.11100; Mattson MP, 1997, PHYSIOL REV, V77, P1081, DOI 10.1152/physrev.1997.77.4.1081; Mellor H, 1998, BIOCHEM J, V332, P281, DOI 10.1042/bj3320281; Meziane H, 1998, P NATL ACAD SCI USA, V95, P12683, DOI 10.1073/pnas.95.21.12683; Mok SS, 1997, FEBS LETT, V415, P303, DOI 10.1016/S0014-5793(97)01146-0; Mok SS, 1997, BIOCHEMISTRY-US, V36, P156, DOI 10.1021/bi961848w; Morimoto T, 1998, J NEUROSCI, V18, P9386; MOYA KL, 1994, DEV BIOL, V161, P597, DOI 10.1006/dbio.1994.1055; Needham BE, 2008, J PATHOL, V215, P155, DOI 10.1002/path.2343; Nikolaev A, 2009, NATURE, V457, P981, DOI 10.1038/nature07767; NORDSTEDT C, 1994, J BIOL CHEM, V269, P9805; Ohsawa I, 1999, EUR J NEUROSCI, V11, P1907, DOI 10.1046/j.1460-9568.1999.00601.x; Ohsawa I, 2001, J NEUROCHEM, V76, P1411, DOI 10.1046/j.1471-4159.2001.00144.x; OHTA M, 1993, DEV BRAIN RES, V75, P151, DOI 10.1016/0165-3806(93)90019-7; PALMERT MR, 1989, P NATL ACAD SCI USA, V86, P6338, DOI 10.1073/pnas.86.16.6338; Periz G, 2004, J NEUROSCI RES, V77, P309, DOI 10.1002/jnr.20203; Portelius E, 2010, EXP NEUROL, V223, P351, DOI 10.1016/j.expneurol.2009.06.011; ROCH JM, 1994, P NATL ACAD SCI USA, V91, P7450, DOI 10.1073/pnas.91.16.7450; Rossjohn J, 1999, NAT STRUCT BIOL, V6, P327; Ruiz-Leon Y, 2001, J NEUROCHEM, V79, P278, DOI 10.1046/j.1471-4159.2001.00547.x; SALBAUM JM, 1994, J EXP ZOOL, V269, P116, DOI 10.1002/jez.1402690205; Scheuermann S, 2001, J BIOL CHEM, V276, P33923, DOI 10.1074/jbc.M105410200; SCHUBERT W, 1991, BRAIN RES, V563, P184, DOI 10.1016/0006-8993(91)91532-6; SELKOE DJ, 1994, ANNU REV CELL BIOL, V10, P373, DOI 10.1146/annurev.cb.10.110194.002105; Skovronsky DM, 2000, J BIOL CHEM, V275, P2568, DOI 10.1074/jbc.275.4.2568; SMALL DH, 1994, J NEUROSCI, V14, P2117; Soba P, 2005, EMBO J, V24, P3624, DOI 10.1038/sj.emboj.7600824; Tyler SJ, 2002, BIOCHEM BIOPH RES CO, V299, P373, DOI 10.1016/S0006-291X(02)02635-9; vanSetten GB, 1996, INVEST OPHTH VIS SCI, V37, P2585; Vassar R, 1999, SCIENCE, V286, P735, DOI 10.1126/science.286.5440.735; Von Koch CS, 1997, NEUROBIOL AGING, V18, P661, DOI 10.1016/S0197-4580(97)00151-6; White AR, 1999, J NEUROSCI, V19, P9170; White AR, 1999, BRAIN RES, V842, P439, DOI 10.1016/S0006-8993(99)01861-2; Yasuoka K, 2004, J ANAT, V205, P135, DOI 10.1111/j.0021-8782.2004.00320.x	75	20	21	0	5	FEDERATION AMER SOC EXP BIOL	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3998 USA	0892-6638	1530-6860		FASEB J	Faseb J.	JUL	2012	26	7					2930	2940		10.1096/fj.11-200295	http://dx.doi.org/10.1096/fj.11-200295			11	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	967MP	22490781				2022-12-25	WOS:000305912500021
J	Barker, KD; Barkovits, K; Wilks, A				Barker, Kylie D.; Barkovits, Katalin; Wilks, Angela			Metabolic Flux of Extracellular Heme Uptake in Pseudomonas aeruginosa Is Driven by the Iron-regulated Heme Oxygenase (HemO)	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							GRAM-NEGATIVE BACTERIA; BINDING PROTEIN PHUS; TRAFFICKING PROTEIN; OUTER-MEMBRANE; SYSTEM; TRANSPORT; IDENTIFICATION; RECOMBINATION; ACQUISITION; VIRULENCE	Heme utilization by Pseudomonas aeruginosa involves several proteins required for internalization and degradation of heme. In the following report we provide the first direct in vivo evidence for the specific degradation of extracellular heme to biliverdin (BV) by the iron-regulated HemO. Moreover, through isotopic labeling (C-13-heme) and electrospray ionization-MS analysis we have confirmed the regioselectivity and ratio of C-13-delta and beta-BV IX (70:30) is identical in vivo to that previously observed for the purified protein. Furthermore, the C-13-BV IX delta and BV IX beta products are effluxed from the cell by an as yet unidentified transporter. Conversion of extracellular heme to BV is dependent solely on the iron-regulated HemO as evidenced by the lack of BV production in the P. aeruginosa hemO deletion strain. Complementation of P. aeruginosa Delta hemO with a plasmid expressing either the wild type HemO or alpha-regioselective HemO mutant restored extracellular heme uptake and degradation. In contrast deletion of the gene encoding the cytoplasmic heme-binding protein, PhuS, homologs of which have been proposed to be heme oxygenases, did not eliminate C-13-BV IX delta and IX beta production. In conclusion the metabolic flux of extracellular heme as a source of iron is driven by the catalytic action of HemO.	[Barker, Kylie D.; Barkovits, Katalin; Wilks, Angela] Univ Maryland, Sch Pharm, Dept Pharmaceut Sci, Baltimore, MD 21201 USA	University System of Maryland; University of Maryland Baltimore	Wilks, A (corresponding author), HSF 2,20 Penn St, Baltimore, MD 21201 USA.	awilks@rx.umaryland.edu		Barkovits, Katalin/0000-0003-2554-8796	National Institutes of Health [AI-55912, AI-85535]; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R56AI055912, R01AI055912, R01AI085535] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	This work was supported, in whole or in part, by National Institutes of Health Grants AI-55912 and AI-85535 (to A. W.).	Beare PA, 2003, MOL MICROBIOL, V47, P195, DOI 10.1046/j.1365-2958.2003.03288.x; Block DR, 2007, BIOCHEMISTRY-US, V46, P14391, DOI 10.1021/bi701509n; Bonnett R, 1973, J Chem Soc Perkin 1, V9, P881; Caignan GA, 2002, J AM CHEM SOC, V124, P14879, DOI 10.1021/ja0274960; Cescau S, 2007, BIOMETALS, V20, P603, DOI 10.1007/s10534-006-9050-y; DELORENZO V, 1994, METHOD ENZYMOL, V235, P386; Friedman J, 2004, BIOCHEMISTRY-US, V43, P5239, DOI 10.1021/bi049687g; Fuhrop J. H., 1975, PORPHYRINS METALLOPO; Hoang TT, 1998, GENE, V212, P77, DOI 10.1016/S0378-1119(98)00130-9; HOLLOWAY BW, 1955, J GEN MICROBIOL, V13, P572, DOI 10.1099/00221287-13-3-572; Kaur AP, 2009, J BIOL CHEM, V284, P56, DOI 10.1074/jbc.M806068200; Krieg S, 2009, P NATL ACAD SCI USA, V106, P1045, DOI 10.1073/pnas.0809406106; Lansky IB, 2006, J BIOL CHEM, V281, P13652, DOI 10.1074/jbc.M600824200; Letoffe S, 2001, MOL MICROBIOL, V41, P439, DOI 10.1046/j.1365-2958.2001.02530.x; Ochsner UA, 2000, MICROBIOL-UK, V146, P185, DOI 10.1099/00221287-146-1-185; Oglesby-Sherrouse AG, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0009930; Ratliff M, 2001, J BACTERIOL, V183, P6394, DOI 10.1128/JB.183.21.6394-6403.2001; RIVERA M, 1995, ANAL BIOCHEM, V230, P295, DOI 10.1006/abio.1995.1477; Sambrook J., 1989, MOL CLONING LAB MANU, V2; Schuller DJ, 2001, BIOCHEMISTRY-US, V40, P11552, DOI 10.1021/bi0110239; STOJILJKOVIC I, 1994, MOL MICROBIOL, V13, P719, DOI 10.1111/j.1365-2958.1994.tb00465.x; Suits MDL, 2005, P NATL ACAD SCI USA, V102, P16955, DOI 10.1073/pnas.0504289102; Wegele R, 2004, J BIOL CHEM, V279, P45791, DOI 10.1074/jbc.M408303200; Wilks A, 1998, J BIOL CHEM, V273, P837, DOI 10.1074/jbc.273.2.837; Wilks A, 2007, NAT PROD REP, V24, P511, DOI 10.1039/b604193k; Wilks A, 2011, HANDB PORPHYR SCI, V15, P357; Wyckoff EE, 2005, J BACTERIOL, V187, P5658, DOI 10.1128/JB.187.16.5658-5664.2005	27	41	42	0	7	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAY 25	2012	287	22					18342	18350		10.1074/jbc.M112.359265	http://dx.doi.org/10.1074/jbc.M112.359265			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	974EC	22493498	Green Published, hybrid			2022-12-25	WOS:000306411600040
J	Behrens, DT; Villone, D; Koch, M; Brunner, G; Sorokin, L; Robenek, H; Bruckner-Tuderman, L; Bruckner, P; Hansen, U				Behrens, Daniel Timo; Villone, Daniela; Koch, Manuel; Brunner, Georg; Sorokin, Lydia; Robenek, Horst; Bruckner-Tuderman, Leena; Bruckner, Peter; Hansen, Uwe			The Epidermal Basement Membrane Is a Composite of Separate Laminin- or Collagen IV-containing Networks Connected by Aggregated Perlecan, but Not by Nidogens	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							HEPARAN-SULFATE PROTEOGLYCAN; VII COLLAGEN; BINDING; PROTEIN; SKIN; CHAINS	The basement membrane between the epidermis and the dermis is indispensable for normal skin functions. It connects, and functionally separates, the epidermis and the dermis. To understand the suprastructural and functional basis of these connections, heterotypic supramolecular aggregates were isolated from the dermal-epidermal junction zone of human skin. Individual suprastructures were separated and purified by immunomagnetic beads, each recognizing a specific, molecular component of the aggregates. The molecular compositions of the suprastructures were determined by immunogold electron microscopy and immunoblotting. A composite of two networks was obtained from fibril-free suspensions by immunobeads recognizing either laminin 332 or collagen IV. After removal of perlecan-containing suprastructures or after enzyme digestion of heparan sulfate chains, a distinct network with a diffuse electron-optical appearance was isolated with magnetic beads coated with antibodies to collagen IV. The second network was more finely grained and comprised laminin 332 and laminins with alpha 5-chains. The core protein of perlecan was an exclusive component of this network whereas its heparan sulfate chains were integrated into the collagen IV-containing network. Nidogens 1 and 2 occurred in both networks but did not form strong molecular cross-bridges. Their incorporation into one network appeared to be masked after their incorporation into the other one. We conclude that the epidermal basement membrane is a composite of two structurally independent networks that are tightly connected in a spot-welding-like manner by perlecan-containing aggregates.	[Behrens, Daniel Timo; Villone, Daniela; Sorokin, Lydia; Bruckner, Peter; Hansen, Uwe] Munster Univ Hosp, Inst Physiol Chem & Pathobiochem, D-48149 Munster, Germany; [Koch, Manuel] Univ Cologne, Ctr Biochem, Inst Dent Res & Musculoskeletal Biol, D-50931 Cologne, Germany; [Brunner, Georg] Fachklin Hornheide, Dept Tumor Res, D-48157 Munster, Germany; [Robenek, Horst] Leibniz Inst Arteriosclerosis Res, D-48149 Munster, Germany; [Bruckner-Tuderman, Leena] Univ Med Ctr, Dept Dermatol, D-79104 Freiburg, Germany	University of Munster; University of Cologne; University of Freiburg	Bruckner, P (corresponding author), Munster Univ Hosp, Inst Physiol Chem & Pathobiochem, Waldeyerstr 15, D-48149 Munster, Germany.	peter.bruckner@uni-muenster.de	Koch, Manuel/AAG-9914-2021; Bruckner, Peter/F-4817-2019	Koch, Manuel/0000-0002-2962-7814; Bruckner, Peter/0000-0002-5566-5611; Sorokin, Lydia/0000-0001-7704-7921	Deutsche Forschungsgemeinschaft Collaborative Research Centre [A2]; Collaborative Research Centre [A2]; German Federal Ministry of Science and Technology, Network on rare diseases: Epidermolysis Bullosa	Deutsche Forschungsgemeinschaft Collaborative Research Centre(German Research Foundation (DFG)); Collaborative Research Centre; German Federal Ministry of Science and Technology, Network on rare diseases: Epidermolysis Bullosa	This work was supported by the Deutsche Forschungsgemeinschaft Collaborative Research Centre 492 Project A2 (to P. B.), Collaborative Research Centre 829 Project A2 (to M. K.), and the German Federal Ministry of Science and Technology, Network on rare diseases: Epidermolysis Bullosa.	AUMAILLEY M, 1993, KIDNEY INT, V43, P7, DOI 10.1038/ki.1993.3; AUMAILLEY M, 1989, EUR J BIOCHEM, V184, P241, DOI 10.1111/j.1432-1033.1989.tb15013.x; BATTAGLIA C, 1992, EUR J BIOCHEM, V208, P359, DOI 10.1111/j.1432-1033.1992.tb17195.x; Bose K, 2006, J BIOL CHEM, V281, P39620, DOI 10.1074/jbc.M607886200; Breitkreutz D, 2009, HISTOCHEM CELL BIOL, V132, P1, DOI 10.1007/s00418-009-0586-0; Brittingham R, 2006, BIOCHEM BIOPH RES CO, V343, P692, DOI 10.1016/j.bbrc.2006.03.034; BRUCKNERTUDERMAN L, 1987, EUR J BIOCHEM, V165, P607, DOI 10.1111/j.1432-1033.1987.tb11483.x; Durbeej M, 2010, CELL TISSUE RES, V339, P259, DOI 10.1007/s00441-009-0838-2; FOX JW, 1991, EMBO J, V10, P3137, DOI 10.1002/j.1460-2075.1991.tb04875.x; GAMMON WR, 1984, J AM ACAD DERMATOL, V11, P820, DOI 10.1016/S0190-9622(84)80459-4; Hansen U, 2006, MATRIX BIOL, V25, P252, DOI 10.1016/j.matbio.2006.01.005; Hasegawa H, 2007, ARCH HISTOL CYTOL, V70, P255, DOI 10.1679/aohc.70.255; Ho MSP, 2008, MICROSC RES TECHNIQ, V71, P387, DOI 10.1002/jemt.20567; Hudson BG, 2003, NEW ENGL J MED, V348, P2543, DOI 10.1056/NEJMra022296; Kassner A, 2003, MATRIX BIOL, V22, P131, DOI 10.1016/S0945-053X(03)00008-8; KEENE DR, 1987, J CELL BIOL, V104, P611, DOI 10.1083/jcb.104.3.611; Khoshnoodi J, 2008, MICROSC RES TECHNIQ, V71, P357, DOI 10.1002/jemt.20564; MARINKOVICH MP, 1992, J BIOL CHEM, V267, P17900; MAYER U, 1995, EUR J BIOCHEM, V227, P681, DOI 10.1111/j.1432-1033.1995.tb20188.x; Mayer U, 1998, ANN NY ACAD SCI, V857, P130, DOI 10.1111/j.1749-6632.1998.tb10113.x; MAYER U, 1993, EMBO J, V12, P1879, DOI 10.1002/j.1460-2075.1993.tb05836.x; Mokkapati S, 2008, J INVEST DERMATOL, V128, P2259, DOI 10.1038/jid.2008.65; Salmivirta K, 2002, EXP CELL RES, V279, P188, DOI 10.1006/excr.2002.5611; Timpl R, 1996, BIOESSAYS, V18, P123, DOI 10.1002/bies.950180208; Van Agtmael T, 2010, CELL TISSUE RES, V339, P167, DOI 10.1007/s00441-009-0866-y; Villone D, 2008, J BIOL CHEM, V283, P24506, DOI 10.1074/jbc.M802415200; YURCHENCO PD, 1987, J BIOL CHEM, V262, P17668; Yurchenco PD, 2011, CSH PERSPECT BIOL, V3, DOI 10.1101/cshperspect.a004911	28	104	105	0	20	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAY 25	2012	287	22					18700	18709		10.1074/jbc.M111.336073	http://dx.doi.org/10.1074/jbc.M111.336073			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	974EC	22493504	Green Published, hybrid			2022-12-25	WOS:000306411600078
J	He, P; Ng, BG; Losfeld, ME; Zhu, WH; Freeze, HH				He, Ping; Ng, Bobby G.; Losfeld, Marie-Estelle; Zhu, Wenhong; Freeze, Hudson H.			Identification of Intercellular Cell Adhesion Molecule 1 (ICAM-1) as a Hypoglycosylation Marker in Congenital Disorders of Glycosylation Cells	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							NF-KAPPA-B; MASS-SPECTROMETRY; QUALITY-CONTROL; AMINO-ACIDS; EXPRESSION; PROTEINS; DOLICHOL; CULTURE; SURFACE; GOLGI	Many human inherited disorders cause protein N-glycosylation defects, but there are few cellular markers to test gene complementation for such defects. Plasma membrane glycoproteins are potential biomarkers because they may be reduced or even absent in plasma membranes of glycosylation-deficient cells. We combined stable isotope labeling by amino acids in cell culture (SILAC) with linear ion trap mass spectrometry (LTQ Orbitrap (TM)) to identify and quantify membrane proteins from wild-type CHO and glycosylation-deficient CHO (Lec9) cells. We identified 165 underrepresented proteins from 1447 unique quantified proteins, including 18 N-glycosylated plasma membrane proteins. Using various methods, we found that intercellular cell adhesion molecule 1 (ICAM-1) was reduced in Lec9 cells and in fibroblasts from 31 congenital disorder of glycosylation (CDG) patients compared with normal controls. Mannose supplementation of phosphomannose isomerase-deficient CDG-Ib (MPI-CDG) cells and complementation with PMM2 in PMM2-deficient CDG-Ia (PMM2-CDG) cells partially corrected hypoglycosylation based on increased ICAM-1 presence on the plasma membrane. These data indicate that ICAM-1 could be a useful hypoglycosylation biomarker to assess gene complementation of CDG-I patient cells and to monitor improved glycosylation in response to therapeutic drugs.	[Zhu, Wenhong; Freeze, Hudson H.] NCI, Ctr Prote Facil, Sanford Burnham Med Res Inst, La Jolla, CA 92037 USA; [He, Ping; Ng, Bobby G.; Losfeld, Marie-Estelle; Freeze, Hudson H.] Sanford Childrens Hlth Res Ctr, Genet Dis Program, La Jolla, CA 92037 USA	National Institutes of Health (NIH) - USA; NIH National Cancer Institute (NCI); Sanford Burnham Prebys Medical Discovery Institute; Sanford Burnham Prebys Medical Discovery Institute	Freeze, HH (corresponding author), NCI, Ctr Prote Facil, Sanford Burnham Med Res Inst, 10901 N Torrey Pines Rd, La Jolla, CA 92037 USA.	hudson@sanfordburnham.org		Freeze, Hudson/0000-0001-6316-0501	National Institutes of Health [R01 DK55615]; Rocket Fund; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK055615] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Rocket Fund; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	This work was supported, in whole or in part, by National Institutes of Health Grant R01 DK55615. This work was also supported by the Rocket Fund.	Blonder J, 2002, J PROTEOME RES, V1, P351, DOI 10.1021/pr0255248; Cantagrel V, 2010, CELL, V142, P203, DOI 10.1016/j.cell.2010.06.001; Dhawan S, 1997, BLOOD, V90, P1535; Ellgaard L, 2001, CURR OPIN CELL BIOL, V13, P431, DOI 10.1016/S0955-0674(00)00233-7; Freeze HH, 2007, CURR MOL MED, V7, P389, DOI 10.2174/156652407780831548; Freeze HH, 2006, NAT REV GENET, V7, P537, DOI 10.1038/nrg1894; Freeze HH, 2010, SEMIN CELL DEV BIOL, V21, P655, DOI 10.1016/j.semcdb.2010.03.011; Fujita N, 2008, FEBS J, V275, P788, DOI 10.1111/j.1742-4658.2008.06246.x; HORIKOSHI T, 1995, FEBS LETT, V363, P141, DOI 10.1016/0014-5793(95)00299-O; Jones MA, 2012, AM J HUM GENET, V90, P363, DOI 10.1016/j.ajhg.2011.12.024; Lubke T, 1999, J BIOL CHEM, V274, P25986, DOI 10.1074/jbc.274.37.25986; Marklova E, 2007, CLIN CHIM ACTA, V385, P6, DOI 10.1016/j.cca.2007.07.002; Ong SE, 2002, MOL CELL PROTEOMICS, V1, P376, DOI 10.1074/mcp.M200025-MCP200; Otto VI, 2006, GLYCOBIOLOGY, V16, P1033, DOI 10.1093/glycob/cwl032; Papi A, 1999, J BIOL CHEM, V274, P9707, DOI 10.1074/jbc.274.14.9707; Peanne R, 2011, GLYCOBIOLOGY, V21, P864, DOI 10.1093/glycob/cwq176; Pino M, 2009, REPRODUCTION, V138, P837, DOI 10.1530/REP-09-0196; Prokhorova TA, 2009, MOL CELL PROTEOMICS, V8, P959, DOI 10.1074/mcp.M800287-MCP200; ROSENWALD AG, 1990, J LIPID RES, V31, P523; Roth J, 2002, CHEM REV, V102, P285, DOI 10.1021/cr000423j; SCHMID I, 1991, CYTOMETRY, V12, P279, DOI 10.1002/cyto.990120312; Smith MH, 2011, SCIENCE, V334, P1086, DOI 10.1126/science.1209235; Srikrishna G, 2005, J IMMUNOL, V175, P5412, DOI 10.4049/jimmunol.175.8.5412; Van Geet C, 2001, J INHERIT METAB DIS, V24, P477, DOI 10.1023/A:1010581613821; Westphal V, 2003, HUM MUTAT, V22, P1, DOI 10.1002/humu.9195; Xu X, 2011, NAT BIOTECHNOL, V29, P735, DOI 10.1038/nbt.1932; Zdebska E, 2003, PEDIATR RES, V54, P224, DOI 10.1203/01.PDR.0000072327.55955.F7; Zhang GA, 2011, J PROTEOME RES, V10, P2546, DOI 10.1021/pr200016n	28	26	27	0	4	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAY 25	2012	287	22					18210	18217		10.1074/jbc.M112.355677	http://dx.doi.org/10.1074/jbc.M112.355677			8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	974EC	22496445	Green Published, hybrid			2022-12-25	WOS:000306411600029
J	Sir, D; Kuo, CF; Tian, YJ; Liu, HM; Huang, EJ; Jung, JU; Machida, K; Ou, JHJ				Sir, Donna; Kuo, Cheng-fu; Tian, Yongjun; Liu, Helene Minyi; Huang, Eric J.; Jung, Jae U.; Machida, Keigo; Ou, Jing-hsiung James			Replication of Hepatitis C Virus RNA on Autophagosomal Membranes	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							VIRAL REPLICATION; PROTEIN; COMPLEX; INDUCTION; PATHWAY	Previous studies indicated that hepatitis C virus (HCV) perturbs the autophagic pathway to induce the accumulation of autophagosomes in cells. To understand the role of autophagosomes in the HCV life cycle, we established a stable Huh7 hepatoma cell line that contained an HCV subgenomic RNA replicon and also expressed a GFP-LC3 fusion protein. The GFP-LC3 protein is localized to autophagosomes during autophagy and served as a convenient marker for autophagosomes. Our results indicate that the silencing of the expression of LC3 or Atg7, two protein factors critical for the formation of autophagosomes, suppresses the replication of HCV RNA. Confocal microscopy studies revealed the localization of HCV NS5A and NS5B proteins, which are two important components of the HCV RNA replication complex, and nascent HCV RNA to autophagosomes. The association of the HCV RNA replication complex with the autophagosomal membranes was further confirmed by co-immunoprecipitation and immunoelectron microscopy studies. Interestingly, inhibition of Class III PI3K activity had no effect on the autophagosomes induced by HCV. These results indicate that HCV induces autophagosomes via a Class III PI3K-independent pathway and uses autophagosomal membranes as sites for its RNA replication.	[Sir, Donna; Kuo, Cheng-fu; Tian, Yongjun; Liu, Helene Minyi; Jung, Jae U.; Machida, Keigo; Ou, Jing-hsiung James] Univ So Calif, Keck Sch Med, Dept Mol Microbiol & Immunol, Los Angeles, CA 90033 USA; [Huang, Eric J.] Univ Calif San Francisco, Dept Pathol, San Francisco, CA 94143 USA; [Huang, Eric J.] Vet Affairs Med Ctr, Pathol Serv, San Francisco, CA 94121 USA	University of Southern California; University of California System; University of California San Francisco; US Department of Veterans Affairs; Veterans Health Administration (VHA)	Ou, JHJ (corresponding author), Univ So Calif, Keck Sch Med, Dept Mol Microbiol & Immunol, 2011 Zonal Ave,HMR 401, Los Angeles, CA 90033 USA.	jamesou@hsc.usc.edu	Liu, Helene Minyi/Y-1834-2019; Huang, Eric J./AAH-7997-2019; Tian, Yongjun/F-8007-2011	Liu, Helene Minyi/0000-0003-4837-5373; Huang, Eric J./0000-0002-5381-3801; Kuo, Cheng-Fu/0000-0002-8933-0799	National Institutes of Health [AI083025, DK094652, CA123328]; NATIONAL CANCER INSTITUTE [R01CA031363, P01CA123328] Funding Source: NIH RePORTER; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL110609] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [U19AI083025] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK094652] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	This work was supported, in whole or in part, by National Institutes of Health Grants AI083025, DK094652, and CA123328.	Ait-Goughoulte M, 2008, J VIROL, V82, P2241, DOI 10.1128/JVI.02093-07; Chaumorcel M, 2008, AUTOPHAGY, V4, P46, DOI 10.4161/auto.5184; Choi JN, 2004, HEPATOLOGY, V39, P81, DOI 10.1002/hep.20001; Dreux M, 2009, P NATL ACAD SCI USA, V106, P14046, DOI 10.1073/pnas.0907344106; Egger D, 2002, J VIROL, V76, P5974, DOI 10.1128/JVI.76.12.5974-5984.2002; Ferraris P, 2010, J GEN VIROL, V91, P2230, DOI 10.1099/vir.0.022186-0; Funderburk SF, 2010, TRENDS CELL BIOL, V20, P355, DOI 10.1016/j.tcb.2010.03.002; Gosert R, 2003, J VIROL, V77, P5487, DOI 10.1128/JVI.77.9.5487-5492.2003; Guevin C, 2010, VIROLOGY, V405, P1, DOI 10.1016/j.virol.2010.05.032; Guo JT, 2001, J VIROL, V75, P8516, DOI 10.1128/JVI.75.18.8516-8523.2001; Jager S, 2004, J CELL SCI, V117, P4837, DOI 10.1242/jcs.01370; Ke PY, 2011, J CLIN INVEST, V121, P37, DOI 10.1172/JCI41474; Lee JS, 2009, NAT CELL BIOL, V11, P1355, DOI 10.1038/ncb1980; LEMON SM, 2007, FIELDS VIROLOGY, P1253; Levine B, 2008, CELL, V132, P27, DOI 10.1016/j.cell.2007.12.018; Liu HM, 2009, VIROLOGY, V386, P249, DOI 10.1016/j.virol.2009.01.018; Manna D, 2010, VIROLOGY, V398, P21, DOI 10.1016/j.virol.2009.11.034; Mizui T, 2010, J GASTROENTEROL, V45, P195, DOI 10.1007/s00535-009-0132-9; Orvedahl A, 2007, CELL HOST MICROBE, V1, P23, DOI 10.1016/j.chom.2006.12.001; Sir D, 2008, HEPATOLOGY, V48, P1054, DOI 10.1002/hep.22464; Sir D, 2008, AUTOPHAGY, V4, P830, DOI 10.4161/auto.6566; Sir D, 2010, MOL CELLS, V29, P1, DOI 10.1007/s10059-010-0014-2; Sir D, 2010, P NATL ACAD SCI USA, V107, P4383, DOI 10.1073/pnas.0911373107; Tanida I, 2009, AUTOPHAGY, V5, P937, DOI 10.4161/auto.5.7.9243; Tassa A, 2003, BIOCHEM J, V376, P577, DOI 10.1042/BJ20030826; Taylor MP, 2007, J VIROL, V81, P12543, DOI 10.1128/JVI.00755-07; Zhu JH, 2007, AM J PATHOL, V170, P75, DOI 10.2353/ajpath.2007.060524	27	127	132	0	8	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	MAY 25	2012	287	22					18036	18043		10.1074/jbc.M111.320085	http://dx.doi.org/10.1074/jbc.M111.320085			8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	974EC	22496373	hybrid, Green Published			2022-12-25	WOS:000306411600013
J	Akhtar, MW; Kim, MS; Adachi, M; Morris, MJ; Qi, XX; Richardson, JA; Bassel-Duby, R; Olson, EN; Kavalali, ET; Monteggia, LM				Akhtar, M. Waseem; Kim, Mi-Sung; Adachi, Megumi; Morris, Michael J.; Qi, Xiaoxia; Richardson, James A.; Bassel-Duby, Rhonda; Olson, Eric N.; Kavalali, Ege T.; Monteggia, Lisa M.			In Vivo Analysis of MEF2 Transcription Factors in Synapse Regulation and Neuronal Survival	PLOS ONE			English	Article							ACTIVITY-DEPENDENT REGULATION; MATURATION; PROTEIN; MICE; DIFFERENTIATION; EXPRESSION; PLASTICITY; SYSTEM; SWITCH; GENES	MEF2 (A-D) transcription factors govern development, differentiation and maintenance of various cell types including neurons. The role of MEF2 isoforms in the brain has been studied using in vitro manipulations with only MEF2C examined in vivo. In order to understand specific as well as redundant roles of the MEF2 isoforms, we generated brain-specific deletion of MEF2A and found that Mef2aKO mice show normal behavior in a range of paradigms including learning and memory. We next generated Mef2a and Mef2d brain-specific double KO (Mef2a/dDKO) mice and observed deficits in motor coordination and enhanced hippocampal short-term synaptic plasticity, however there were no alterations in learning and memory, Schaffer collateral pathway long-term potentiation, or the number of dendritic spines. Since previous work has established a critical role for MEF2C in hippocampal plasticity, we generated a Mef2a, Mef2c and Mef2d brain-specific triple KO (Mef2a/c/dTKO). Mef2a/c/d TKO mice have early postnatal lethality with increased neuronal apoptosis, indicative of a redundant role for the MEF2 factors in neuronal survival. We examined synaptic plasticity in the intact neurons in the Mef2a/c/d TKO mice and found significant impairments in short-term synaptic plasticity suggesting that MEF2C is the major isoform involved in hippocampal synaptic function. Collectively, these data highlight the key in vivo role of MEF2C isoform in the brain and suggest that MEF2A and MEF2D have only subtle roles in regulating hippocampal synaptic function.	[Akhtar, M. Waseem; Adachi, Megumi; Morris, Michael J.; Monteggia, Lisa M.] Univ Texas SW Med Ctr Dallas, Dept Psychiat, Dallas, TX 75390 USA; [Kim, Mi-Sung; Qi, Xiaoxia; Bassel-Duby, Rhonda; Olson, Eric N.] Univ Texas SW Med Ctr Dallas, Dept Mol Biol, Dallas, TX 75390 USA; [Richardson, James A.] Univ Texas SW Med Ctr Dallas, Dept Pathol, Dallas, TX 75390 USA; [Kavalali, Ege T.] Univ Texas SW Med Ctr Dallas, Dept Neurosci, Dallas, TX 75390 USA; [Kavalali, Ege T.] Univ Texas SW Med Ctr Dallas, Dept Neurosci, Dallas, TX 75390 USA	University of Texas System; University of Texas Southwestern Medical Center Dallas; University of Texas System; University of Texas Southwestern Medical Center Dallas; University of Texas System; University of Texas Southwestern Medical Center Dallas; University of Texas System; University of Texas Southwestern Medical Center Dallas; University of Texas System; University of Texas Southwestern Medical Center Dallas	Akhtar, MW (corresponding author), Univ Texas SW Med Ctr Dallas, Dept Psychiat, Dallas, TX 75390 USA.	lisa.monteggia@utsouthwestern.edu	Adachi, Megumi/M-7746-2017	Adachi, Megumi/0000-0003-3404-6640	National Institutes of Health [MH081060, MH066198]; NATIONAL INSTITUTE OF MENTAL HEALTH [R01MH066198, R01MH081060] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF MENTAL HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH))	This work was supported by National Institutes of Health grants MH081060 (L. M. M.) and MH066198 (E. T. K.). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Akhtar MW, 2009, J NEUROSCI, V29, P8288, DOI 10.1523/JNEUROSCI.0097-09.2009; Barbosa AC, 2008, P NATL ACAD SCI USA, V105, P9391, DOI 10.1073/pnas.0802679105; Dittgen T, 2004, P NATL ACAD SCI USA, V101, P18206, DOI 10.1073/pnas.0407976101; Fernandez-Chacon R, 2004, NEURON, V42, P237, DOI 10.1016/S0896-6273(04)00190-4; Flavell SW, 2008, NEURON, V60, P1022, DOI 10.1016/j.neuron.2008.11.029; Flavell SW, 2006, SCIENCE, V311, P1008, DOI 10.1126/science.1122511; Kavalali ET, 1999, P NATL ACAD SCI USA, V96, P12893, DOI 10.1073/pnas.96.22.12893; Kim Y, 2008, J CLIN INVEST, V118, P124, DOI 10.1172/JCI33255; Li H, 2008, P NATL ACAD SCI USA, V105, P9397, DOI 10.1073/pnas.0802876105; LYONS GE, 1995, J NEUROSCI, V15, P5727, DOI 10.1523/jneurosci.15-08-05727.1995; Mao ZX, 1999, SCIENCE, V286, P785, DOI 10.1126/science.286.5440.785; Monteggia LM, 2004, P NATL ACAD SCI USA, V101, P10827, DOI 10.1073/pnas.0402141101; Naya FJ, 2002, NAT MED, V8, P1303, DOI 10.1038/nm789; Nelson ED, 2006, CURR BIOL, V16, P710, DOI 10.1016/j.cub.2006.02.062; Pfeiffer BE, 2010, NEURON, V66, P191, DOI 10.1016/j.neuron.2010.03.017; Potthoff MJ, 2007, DEVELOPMENT, V134, P4131, DOI 10.1242/dev.008367; Pulipparacharuvil S, 2008, NEURON, V59, P621, DOI 10.1016/j.neuron.2008.06.020; Shalizi A, 2006, SCIENCE, V311, P1012, DOI 10.1126/science.1122513; Shelton JM, 2000, J LIPID RES, V41, P532; Zhuo L, 2001, GENESIS, V31, P85, DOI 10.1002/gene.10008; Zucker RS, 2002, ANNU REV PHYSIOL, V64, P355, DOI 10.1146/annurev.physiol.64.092501.114547	21	75	76	0	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 9	2012	7	4							e34863	10.1371/journal.pone.0034863	http://dx.doi.org/10.1371/journal.pone.0034863			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	955JO	22496871	Green Published, Green Submitted, gold			2022-12-25	WOS:000305014500034
J	Xu, YL; Liu, LZ; Zhang, LF; Fu, S; Hu, YX; Wang, YJ; Fu, HR; Wu, KN; Xiao, HW; Liu, SQ; Yu, XH; Zheng, WY; Feng, B; Huang, H				Xu, Yulin; Liu, Lizhen; Zhang, Lifei; Fu, Shan; Hu, Yongxian; Wang, Yingjia; Fu, Huarui; Wu, Kangni; Xiao, Haowen; Liu, Senquan; Yu, Xiaohong; Zheng, Weiyan; Feng, Bo; Huang, He			Efficient Commitment to Functional CD34+Progenitor Cells from Human Bone Marrow Mesenchymal Stem-Cell-Derived Induced Pluripotent Stem Cells	PLOS ONE			English	Article							HEMATOPOIETIC DIFFERENTIATION; HUMAN FIBROBLASTS; STROMAL CELLS; GROWTH-FACTOR; TRANSPLANTATION; GENERATION; COCULTURE	The efficient commitment of a specialized cell type from induced pluripotent stem cells (iPSCs) without contamination from unknown substances is crucial to their use in clinical applications. Here, we propose that CD34+ progenitor cells, which retain hematopoietic and endothelial cell potential, could be efficiently obtained from iPSCs derived from human bone marrow mesenchymal stem cells (hBMMSC-iPSCs) with defined factors. By treatment with a cocktail containing mesodermal, hematopoietic, and endothelial inducers (BMP4, SCF, and VEGF, respectively) for 5 days, hBMMSC-iPSCs expressed the mesodermal transcription factors Brachyury and GATA-2 at higher levels than untreated groups (P<0.05). After culturing with another hematopoietic and endothelial inducer cocktail, including SCF, Flt3L, VEGF and IL-3, for an additional 7-9 days, CD34+ progenitor cells, which were undetectable in the initial iPSC cultures, reached nearly 20% of the total culture. This was greater than the relative number of progenitor cells produced from human-skin-fibroblast-derived iPSCs (hFib-iPSCs) or from the spontaneous differentiation groups (P<0.05), as assessed by flow cytometry analysis. These induced cells expressed hematopoietic transcription factors TAL-1 and SCL. They developed into various hematopoietic colonies when exposed to semisolid media with hematopoietic cytokines such as EPO and G-CSF. Hematopoietic cell lineages were identified by phenotype analysis with Wright-Giemsa staining. The endothelial potential of the cells was also verified by the confirmation of the formation of vascular tube-like structures and the expression of endothelial-specific markers CD31 and VE-CADHERIN. Efficient induction of CD34+ progenitor cells, which retain hematopoietic and endothelial cell potential with defined factors, provides an opportunity to obtain patient-specific cells for iPSC therapy and a useful model for the study of the mechanisms of hematopoiesis and drug screening.	[Xu, Yulin; Liu, Lizhen; Zhang, Lifei; Fu, Shan; Hu, Yongxian; Wang, Yingjia; Fu, Huarui; Wu, Kangni; Xiao, Haowen; Liu, Senquan; Yu, Xiaohong; Zheng, Weiyan; Huang, He] Zhejiang Univ, Sch Med, Affiliated Hosp 1, Bone Marrow Transplantat Ctr, Hangzhou 310003, Zhejiang, Peoples R China; [Feng, Bo] Chinese Univ Hong Kong, Sch Biomed Sci, Hong Kong, Hong Kong, Peoples R China	Zhejiang University; Chinese University of Hong Kong	Xu, YL (corresponding author), Zhejiang Univ, Sch Med, Affiliated Hosp 1, Bone Marrow Transplantat Ctr, Hangzhou 310003, Zhejiang, Peoples R China.	hehuang.zju@gmail.com	Feng, Bo/D-7831-2014	Feng, Bo/0000-0002-4018-3257	National Post Doctor Science Fund of China [20100471736]; Major Program of Technology Research and International co-operative research of Zhejiang Province [2009C14011]; Zhejiang Provincial Key Medical Discipline (Medical Tissue Engineering)	National Post Doctor Science Fund of China; Major Program of Technology Research and International co-operative research of Zhejiang Province; Zhejiang Provincial Key Medical Discipline (Medical Tissue Engineering)	This study was supported by research funding from National Post Doctor Science Fund of China to YX [20100471736], from Major Program of Technology Research and International co-operative research of Zhejiang Province to WZ (2009C14011) and from Zhejiang Provincial Key Medical Discipline (Medical Tissue Engineering) to HH. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Cerdan C, 2004, BLOOD, V103, P2504, DOI 10.1182/blood-2003-07-2563; Chadwick K, 2003, BLOOD, V102, P906, DOI 10.1182/blood-2003-03-0832; Chicha L, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0014733; Choi KD, 2009, STEM CELLS, V27, P559, DOI 10.1634/stemcells.2008-0922; Copelan EA, 2006, NEW ENGL J MED, V354, P1813, DOI 10.1056/NEJMra052638; Feng Q, 2010, STEM CELLS, V28, P704, DOI 10.1002/stem.321; Grewal SS, 2003, BLOOD, V101, P4233, DOI 10.1182/blood-2002-08-2510; Hassan HT, 1996, ACTA HAEMATOL-BASEL, V95, P257; Hinterberger W, 2002, BONE MARROW TRANSPL, V30, P753, DOI 10.1038/sj.bmt.1703686; Kaufman DS, 2001, P NATL ACAD SCI USA, V98, P10716, DOI 10.1073/pnas.191362598; KELLER G, 1993, MOL CELL BIOL, V13, P473, DOI 10.1128/MCB.13.1.473; Kennedy M, 2007, BLOOD, V109, P2679, DOI 10.1182/blood-2006-09-047704; Korbling M, 2001, BLOOD, V98, P2900, DOI 10.1182/blood.V98.10.2900; Le Blanc K, 2005, CYTOTHERAPY, V7, P36, DOI 10.1080/14653240510018118; Ledran MH, 2008, CELL STEM CELL, V3, P85, DOI 10.1016/j.stem.2008.06.001; Leger CS, 2004, CAN MED ASSOC J, V170, P1569, DOI 10.1503/cmaj.1011625; Lengerke C, 2009, ANN NY ACAD SCI, V1176, P219, DOI 10.1111/j.1749-6632.2009.04606.x; Lerou PH, 2005, BLOOD REV, V19, P321, DOI 10.1016/j.blre.2005.01.005; Lu M, 2009, EXP HEMATOL, V37, P924, DOI 10.1016/j.exphem.2009.05.007; LYMAN SD, 1993, CELL, V75, P1157, DOI 10.1016/0092-8674(93)90325-K; Murdoch B, 2002, EXP HEMATOL, V30, P598, DOI 10.1016/S0301-472X(02)00793-2; Nakano T, 1996, SCIENCE, V272, P722, DOI 10.1126/science.272.5262.722; Niibe K, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0017610; Okita K, 2007, NATURE, V448, P313, DOI 10.1038/nature05934; Park SW, 2010, BLOOD, V116, P5762, DOI 10.1182/blood-2010-04-280719; Pick M, 2007, STEM CELLS, V25, P2206, DOI 10.1634/stemcells.2006-0713; Pittenger MF, 1999, SCIENCE, V284, P143, DOI 10.1126/science.284.5411.143; Qiu CH, 2005, EXP HEMATOL, V33, P1450, DOI 10.1016/j.exphem.2005.09.003; Seiler K, 2011, STEM CELLS DEV, V20, P1131, DOI 10.1089/scd.2010.0391; Szabo E, 2010, NATURE, V468, P521, DOI 10.1038/nature09591; Takahashi K, 2007, CELL, V131, P861, DOI 10.1016/j.cell.2007.11.019; Takahashi K, 2006, CELL, V126, P663, DOI 10.1016/j.cell.2006.07.024; Thomson JA, 1998, SCIENCE, V282, P1145, DOI 10.1126/science.282.5391.1145; Tian XH, 2004, EXP HEMATOL, V32, P1000, DOI 10.1016/j.exphem.2004.06.013; Vodyanik MA, 2005, BLOOD, V105, P617, DOI 10.1182/blood-2004-04-1649; Wang Y, 2005, P NATL ACAD SCI USA, V102, P19081, DOI 10.1073/pnas.0506127102; Woods NB, 2011, STEM CELLS, V29, P1158, DOI 10.1002/stem.657; Yu JY, 2007, SCIENCE, V318, P1917, DOI 10.1126/science.1151526; Zambidis ET, 2005, BLOOD, V106, P860, DOI 10.1182/blood-2004-11-4522; Zhao YM, 2008, BIOCHEM BIOPH RES CO, V369, P1114, DOI 10.1016/j.bbrc.2008.03.011	40	33	34	0	0	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 9	2012	7	4							e34321	10.1371/journal.pone.0034321	http://dx.doi.org/10.1371/journal.pone.0034321			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	955JO	22496789	Green Published, gold, Green Submitted			2022-12-25	WOS:000305014500021
J	Hovatta, I; de Mello, VDF; Kananen, L; Lindstrom, J; Eriksson, JG; Ilanne-Parikka, P; Keinanen-Kiukaanniemi, S; Peltonen, M; Tuomilehto, J; Uusitupa, M				Hovatta, Iiris; de Mello, Vanessa D. F.; Kananen, Laura; Lindstrom, Jaana; Eriksson, Johan G.; Ilanne-Parikka, Pirjo; Keinanen-Kiukaanniemi, Sirkka; Peltonen, Markku; Tuomilehto, Jaakko; Uusitupa, Matti			Leukocyte Telomere Length in the Finnish Diabetes Prevention Study	PLOS ONE			English	Article							IMPAIRED GLUCOSE-TOLERANCE; LIFE-STYLE; ASSOCIATION; MELLITUS; OBESITY; DISEASE	Leukocyte telomere length (TL) is considered a biomarker for biological aging. Shortened TL has been observed in many complex diseases, including type 2 diabetes (T2DM). Lifestyle intervention studies, e. g. the Diabetes Prevention Study (DPS), have shown a decrease in the incidence of T2DM by promoting healthy lifestyles in individuals with impaired glucose tolerance (IGT). Our aim was to study in the DPS the influence of the lifestyle intervention on TL. TL was measured by quantitative PCR-based method at two time points (N = 334 and 343) on average 4.5 years apart during the active intervention and post-intervention follow-up. TL inversely correlated with age. Our main finding was that TL increased in about two thirds of the individuals both in the intervention and in the control groups during follow-up; TL increased most in individuals with the shortest TL at the first measurement. TL was not associated with development of T2DM, nor did lifestyle intervention have an effect on TL. No association between insulin secretion or insulin resistance indices and TL was observed. We did not detect an association between TL and development of T2DM in the DPS participants. It could be due to all participants being overweight and having IGT at baseline, both of which have been found to be independently associated with shorter leukocyte TL in some earlier studies. TL had no substantial role in worsening of glucose tolerance in people with IGT. Our study confirms that leukocyte TL can increase with time even in obese people with impaired glucose metabolism.	[Hovatta, Iiris; Kananen, Laura] Univ Helsinki, Res Programs Unit, Biomedicum Helsinki, Helsinki, Finland; [Hovatta, Iiris; Kananen, Laura] Univ Helsinki, Dept Med Genet, Haartman Inst, Helsinki, Finland; [Hovatta, Iiris] Natl Inst Hlth & Welf, Mental Hlth Serv, Helsinki, Finland; [de Mello, Vanessa D. F.; Uusitupa, Matti] Univ Eastern Finland, Inst Publ Hlth & Clin Nutr, Kuopio, Finland; [Lindstrom, Jaana; Eriksson, Johan G.; Tuomilehto, Jaakko] Natl Inst Hlth & Welf, Dept Hlth Promot & Chron Dis Prevent, Helsinki, Finland; [Eriksson, Johan G.] Univ Helsinki, Dept Gen Practice & Primary Hlth Care, Helsinki, Finland; [Eriksson, Johan G.] Folkhalsan Res Ctr, Helsinki, Finland; [Eriksson, Johan G.] Univ Helsinki, Cent Hosp, Unit Gen Practice, Helsinki, Finland; [Eriksson, Johan G.] Vaasa Cent Hosp, Vaasa, Finland; [Ilanne-Parikka, Pirjo] Finnish Diabet Assoc, Ctr Diabet, Tampere, Finland; [Ilanne-Parikka, Pirjo] Tampere Univ Hosp, Pirkanmaa Hosp Dist, Ctr Sci, Tampere, Finland; [Keinanen-Kiukaanniemi, Sirkka] Univ Oulu, Inst Hlth Sci, Oulu, Finland; [Keinanen-Kiukaanniemi, Sirkka] Oulu Univ Hosp, Unit Gen Practice, Oulu, Finland; [Keinanen-Kiukaanniemi, Sirkka] Oulu Hlth Ctr, Oulu, Finland; [Peltonen, Markku] Natl Inst Hlth & Welf, Diabet Prevent Unit, Helsinki, Finland; [Tuomilehto, Jaakko] S Ostrobothnia Cent Hosp, Seinajoki, Finland; [Tuomilehto, Jaakko] Danube Univ Krems, Ctr Vasc Prevent, Krems, Austria; [Uusitupa, Matti] Kuopio Univ Hosp, Res Unit, SF-70210 Kuopio, Finland; [Hovatta, Iiris] Natl Inst Hlth & Welf, Substance Abuse Serv, Helsinki, Finland	University of Helsinki; University of Helsinki; Finland National Institute for Health & Welfare; University of Eastern Finland; Finland National Institute for Health & Welfare; University of Helsinki; Folkhalsan Research Center; University of Helsinki; Helsinki University Central Hospital; Vaasa Central Hospital; Pirkanmaa Hospital District; Tampere University; Tampere University Hospital; University of Oulu; University of Oulu; Finland National Institute for Health & Welfare; Danube University Krems; Kuopio University Hospital; University of Eastern Finland; Finland National Institute for Health & Welfare	Hovatta, I (corresponding author), Univ Helsinki, Res Programs Unit, Biomedicum Helsinki, Helsinki, Finland.	iiris.hovatta@helsinki.fi	Peltonen, Markku/F-3037-2015; Hovatta, Iiris/D-6871-2012; Uusitupa, Matti Ilmari Julius/AAX-4929-2020	Peltonen, Markku/0000-0002-3767-4223; Hovatta, Iiris/0000-0002-5990-7892; Eriksson, Johan/0000-0002-2516-2060; Kananen, Laura/0000-0003-3742-8927; Lindstrom, Jaana/0000-0001-9255-020X; de Mello, Vanessa/0000-0003-3414-6983	Academy of Finland; Peter and Patricia Gruber Foundation; Juho Vainio Foundation; Novo Nordisk Foundation; Kuopio University Hospital [5106, 5168, 5254]; Ministry of Education of Finland; Finnish Diabetes Research Foundation; Sigrid Juselius Foundation	Academy of Finland(Academy of Finland); Peter and Patricia Gruber Foundation; Juho Vainio Foundation; Novo Nordisk Foundation(Novo Nordisk FoundationNovocure Limited); Kuopio University Hospital; Ministry of Education of Finland; Finnish Diabetes Research Foundation; Sigrid Juselius Foundation(Sigrid Juselius Foundation)	Academy of Finland (IH, VDFM, JL, JGE, JT, MU, and SKK) www.aka.fi, Rosalind Franklin Young Investigator Award from the Peter and Patricia Gruber Foundation (IH) http://www.gruberprizes.org/, Juho Vainio Foundation (JL) http://www.juhovainionsaatio.fi, Novo Nordisk Foundation (JL) http://www.novonordiskfonden.dk/en/, EVO-fund of Kuopio University Hospital (5106, 5168, 5254 [MU]) www.kuh.fi, Ministry of Education of Finland (MU) www.minedu.fi, Finnish Diabetes Research Foundation (MU) www.diabetes.fi, and Sigrid Juselius Foundation (MU) www.sigridjuselius.fi. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adaikalakoteswari A, 2007, ATHEROSCLEROSIS, V195, P83, DOI 10.1016/j.atherosclerosis.2006.12.003; Al-Attas OS, 2010, EUR J ENDOCRINOL, V163, P601, DOI 10.1530/EJE-10-0241; Aviv A, 2009, AM J EPIDEMIOL, V169, P323, DOI 10.1093/aje/kwn338; Bakaysa SL, 2007, AGING CELL, V6, P769, DOI 10.1111/j.1474-9726.2007.00340.x; Benetos A, 2001, HYPERTENSION, V37, P381, DOI 10.1161/01.HYP.37.2.381; Bischoff C, 2005, TWIN RES HUM GENET, V8, P433, DOI 10.1375/twin.8.5.433; Blasco MA, 2005, NAT REV GENET, V6, P611, DOI 10.1038/nrg1656; Cawthon RM, 2002, NUCLEIC ACIDS RES, V30, DOI 10.1093/nar/30.10.e47; Cherkas LF, 2008, ARCH INTERN MED, V168, P154, DOI 10.1001/archinternmed.2007.39; Clarke PM, 2004, DIABETOLOGIA, V47, P1747, DOI 10.1007/s00125-004-1527-z; Codd V, 2010, NAT GENET, V42, P197, DOI 10.1038/ng.532; de Mello VDF, 2012, DIABETES CARE, V35, P211, DOI 10.2337/dc11-1272; Fitzpatrick AL, 2007, AM J EPIDEMIOL, V165, P14, DOI [10.1093/aje/kw346, 10.1093/aje/kwj346]; Franco OH, 2007, ARCH INTERN MED, V167, P1145, DOI 10.1001/archinte.167.11.1145; Kananen L, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0010826; KAPRIO J, 1992, DIABETOLOGIA, V35, P1060, DOI 10.1007/BF02221682; Kim SM, 2009, CANCER EPIDEM BIOMAR, V18, P816, DOI 10.1158/1055-9965.EPI-08-0935; Kimura M, 2008, AM J EPIDEMIOL, V167, P799, DOI 10.1093/aje/kwm380; Kuhlow D, 2010, AGING-US, V2, P650, DOI 10.18632/aging.100200; Lindstrom J, 2003, DIABETES CARE, V26, P3230, DOI 10.2337/diacare.26.12.3230; Lindstrom J, 2006, LANCET, V368, P1673, DOI 10.1016/S0140-6736(06)69701-8; Nordfjall K, 2008, OBESITY, V16, P2682, DOI 10.1038/oby.2008.413; Nordfjall K, 2009, PLOS GENET, V5, DOI 10.1371/journal.pgen.1000375; Olivieri F, 2009, ATHEROSCLEROSIS, V206, P588, DOI 10.1016/j.atherosclerosis.2009.03.034; Ornish D, 2008, LANCET ONCOL, V9, P1048, DOI 10.1016/S1470-2045(08)70234-1; Paulweber B, 2010, HORM METAB RES, V42, pS3, DOI 10.1055/s-0029-1240928; Salpea KD, 2010, ATHEROSCLEROSIS, V209, P42, DOI 10.1016/j.atherosclerosis.2009.09.070; Salpea KD, 2010, ATHEROSCLEROSIS, V209, P35, DOI 10.1016/j.atherosclerosis.2009.12.021; Sampson MJ, 2006, DIABETES CARE, V29, P283, DOI 10.2337/diacare.29.02.06.dc05-1715; SLAGBOOM PE, 1994, AM J HUM GENET, V55, P876; Svenson U, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0021485; Tentolouris N, 2007, DIABETES CARE, V30, P2909, DOI 10.2337/dc07-0633; Tuomilehto J, 2001, NEW ENGL J MED, V344, P1343, DOI 10.1056/NEJM200105033441801; Valdes AM, 2005, LANCET, V366, P662, DOI 10.1016/S0140-6736(05)66630-5; Vasa-Nicotera M, 2005, AM J HUM GENET, V76, P147, DOI 10.1086/426734; von Zglinicki T, 2005, CURR MOL MED, V5, P197; Zee RYL, 2010, TRANSL RES, V155, P166, DOI 10.1016/j.trsl.2009.09.012	37	67	69	0	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 6	2012	7	4							e34948	10.1371/journal.pone.0034948	http://dx.doi.org/10.1371/journal.pone.0034948			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	955JA	22493726	gold, Green Published, Green Submitted			2022-12-25	WOS:000305012700068
J	Kang, SH; Jeong, SJ; Kim, SH; Kim, JH; Jung, JH; Koh, W; Kim, JH; Kim, DK; Chen, CY; Kim, SH				Kang, Sang-Hun; Jeong, Soo-Jin; Kim, Sun-Hee; Kim, Ji-Hyun; Jung, Ji Hoon; Koh, Wonil; Kim, Jung Hyo; Kim, Dae Keun; Chen, Chang-Yan; Kim, Sung-Hoon			Icariside II Induces Apoptosis in U937 Acute Myeloid Leukemia Cells: Role of Inactivation of STAT3-Related Signaling	PLOS ONE			English	Article							TYROSINE-PHOSPHATASE SHP-1; STAT3 ACTIVATION; INHIBITION; PATHWAY	Background: The aim of this study is to determine anti-cancer effect of Icariside II purified from the root of Epimedium koreanum Nakai on human acute myeloid leukemia (AML) cell line U937. Methodology/Principal Findings: Icariside II blocked the growth U937 cells in a dose- and time-dependent manner. In this anti-proliferation process, this herb compound rendered the cells susceptible to apoptosis, manifested by enhanced accumulation of sub-G1 cell population and increased the terminal deoxynucleotidyl transferase dUTP nick end labeling (TUNEL)-positive cells. Icariside II was able to activate caspase-3 and cleaved poly (ADP-ribose) polymerase (PARP) in a time-dependent manner. Concurrently, the anti-apoptotic proteins, such as bcl-x(L) and survivin in U937 cells, were downregulated by Icariside II. In addition, Icariside II could inhibit STAT3 phosphorylation and function and subsequently suppress the activation of Janus activated kinase 2 (JAK2), the upstream activators of STAT3, in a dose- and time-dependent manner. Icariside II also enhanced the expression of protein tyrosine phosphatase (PTP) SH2 domain-containing phosphatase (SHP)-1, and the addition of sodium pervanadate (a PTP inhibitor) prevented Icariside II-induced apoptosis as well as STAT3 inactivation in STAT3 positive U937 cells. Furthermore, silencing SHP-1 using its specific siRNA significantly blocked STAT3 inactivation and apoptosis induced by Icariside II in U937 cells. Conclusions/Significance: Our results demonstrated that via targeting STAT3-related signaling, Icariside II sensitizes U937 cells to apoptosis and perhaps serves as a potent chemotherapeutic agent for AML.	[Kang, Sang-Hun; Jeong, Soo-Jin; Kim, Sun-Hee; Kim, Ji-Hyun; Jung, Ji Hoon; Koh, Wonil; Kim, Sung-Hoon] Kyung Hee Univ, Coll Oriental Med, Seoul, South Korea; [Jeong, Soo-Jin] Korea Inst Oriental Med, Basic Herbal Res Grp, Taejon, South Korea; [Kim, Jung Hyo] Chosun Nursing Coll, Kwangju, South Korea; [Kim, Dae Keun] Woosuk Univ, Coll Pharm, Wonju, South Korea; [Chen, Chang-Yan] Harvard Univ, Beth Israel Deaconess Med Ctr, Sch Med, Boston, MA 02215 USA	Kyung Hee University; Korea Institute of Oriental Medicine (KIOM); Chosun University; Woosuk University; Harvard University; Beth Israel Deaconess Medical Center; Harvard Medical School	Kang, SH (corresponding author), Kyung Hee Univ, Coll Oriental Med, Seoul, South Korea.	sungkim7@khu.ac.kr; sungkim7@khu.ac.kr	Kim, Sun/GSN-4867-2022; Jung, Jihoon/HHY-7803-2022	kim, sunghoon/0000-0002-1570-3230	Korea Science and Engineering Foundation (KOSEF); Korea government (MEST) [2011-0063466]	Korea Science and Engineering Foundation (KOSEF)(Korea Science and Engineering Foundation); Korea government (MEST)(Ministry of Education, Science & Technology (MEST), Republic of KoreaKorean Government)	This work was supported by the Korea Science and Engineering Foundation (KOSEF) grant funded by the Korea government (MEST) (No. 2011-0063466). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ahn KS, 2008, CANCER RES, V68, P4406, DOI 10.1158/0008-5472.CAN-07-6696; Bishop JF, 1997, SEMIN ONCOL, V24, P57; Choi HJ, 2008, EUR J PHARMACOL, V579, P58, DOI 10.1016/j.ejphar.2007.10.010; Choi HJ, 2010, EUR J PHARMACOL, V636, P28, DOI 10.1016/j.ejphar.2010.03.023; Chung BH, 2008, BIOCHEM BIOPH RES CO, V376, P404, DOI 10.1016/j.bbrc.2008.09.001; Gao Z, 2007, J BIOL CHEM, V282, P30718, DOI 10.1074/jbc.M705258200; Han YJ, 2006, BLOOD, V108, P2796, DOI 10.1182/blood-2006-04-017434; Hassan HT, 2004, LEUKEMIA RES, V28, P667, DOI 10.1016/j.leukres.2003.10.008; Huang ST, 2010, PHYTOMEDICINE, V17, P47, DOI 10.1016/j.phymed.2009.06.005; JACOBSON MD, 1994, BIOCHEM SOC T, V22, P600, DOI 10.1042/bst0220600; Kee CH, 2000, PHARM CHINESE HERBS, P106; Kim H, 1999, MOL CELL BIOL, V19, P5326; Kim SH, 2011, EUR J PHARMACOL, V654, P10, DOI 10.1016/j.ejphar.2010.11.032; Kothakota S, 1997, SCIENCE, V278, P294, DOI 10.1126/science.278.5336.294; Lee JC, 2011, J CELL BIOCHEM, V112, P1552, DOI 10.1002/jcb.23077; Lee KS, 2009, CANCER LETT, V280, P93, DOI 10.1016/j.canlet.2009.02.024; Lund IK, 2005, J MOL ENDOCRINOL, V34, P339, DOI 10.1677/jme.1.01694; Mallick S, 2010, CANCER CHEMOTH PHARM, V66, P709, DOI 10.1007/s00280-009-1214-3; Oh MH, 2004, PHYTOMEDICINE, V11, P544, DOI 10.1016/j.phymed.2004.03.001; Park S, 2011, FOOD CHEM TOXICOL, V49, P1367, DOI 10.1016/j.fct.2011.03.021; Pathak AK, 2007, MOL CANCER RES, V5, P943, DOI 10.1158/1541-7786.MCR-06-0348; Redell MS, 2011, BLOOD, V117, P5701, DOI 10.1182/blood-2010-04-280123; Seki E, 2008, J HEPATOL, V48, P237, DOI 10.1016/j.jhep.2007.08.020; Sun S, 2002, J GEN VIROL, V83, P1651, DOI 10.1099/0022-1317-83-7-1651; Tenev T, 2000, EUR J CELL BIOL, V79, P261, DOI 10.1078/S0171-9335(04)70029-1; Thornberry NA, 1998, SCIENCE, V281, P1312, DOI 10.1126/science.281.5381.1312; Yamamoto T, 2002, BIOCHEM BIOPH RES CO, V297, P811, DOI 10.1016/S0006-291X(02)02291-X; Zhang Y, 2000, J BIOL CHEM, V275, P24935, DOI 10.1074/jbc.M002383200; Zhao W, 2011, ANTI-CANCER DRUG, V22, P79, DOI 10.1097/CAD.0b013e32833f44fd	29	70	73	2	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 6	2012	7	4							e28706	10.1371/journal.pone.0028706	http://dx.doi.org/10.1371/journal.pone.0028706			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	955JA	22493659	Green Submitted, Green Published, gold			2022-12-25	WOS:000305012700001
J	Kirchberg, J; Buttner, D; Thiemer, B; Sawers, RG				Kirchberg, Janine; Buettner, Daniela; Thiemer, Barbara; Sawers, R. Gary			Aconitase B Is Required for Optimal Growth of Xanthomonas campestris pv. vesicatoria in Pepper Plants	PLOS ONE			English	Article							ESCHERICHIA-COLI ACONITASES; BACILLUS-SUBTILIS; POSTTRANSCRIPTIONAL REGULATION; OXIDATIVE STRESS; GENE-EXPRESSION; III SECRETION; RNA-BINDING; PATHOGENICITY; IRON; PROTEINS	The aerobic plant pathogenic bacterium Xanthomonas campestris pv. vesicatoria (Xcv) colonizes the intercellular spaces of pepper and tomato. One enzyme that might contribute to the successful proliferation of Xcv in the host is the iron-sulfur protein aconitase, which catalyzes the conversion of citrate to isocitrate in the tricarboxylic acid (TCA) cycle and might also sense reactive oxygen species (ROS) and changes in cellular iron levels. Xcv contains three putative aconitases, two of which, acnA and acnB, are encoded by a single chromosomal locus. The focus of this study is aconitase B (AcnB). acnB is co-transcribed with two genes, XCV1925 and XCV1926, encoding putative nucleic acid-binding proteins. In vitro growth of acnB mutants was like wild type, whereas in planta growth and symptom formation in pepper plants were impaired. While acnA, XCV1925 or XCV1926 mutants showed a wild-type phenotype with respect to bacterial growth and in planta symptom formation, proliferation of the acnB mutant in susceptible pepper plants was significantly impaired. Furthermore, the deletion of acnB led to reduced HR induction in resistant pepper plants and an increased susceptibility to the superoxide-generating compound menadione. As AcnB complemented the growth deficiency of an Escherichia coli aconitase mutant, it is likely to be an active aconitase. We therefore propose that optimal growth and survival of Xcv in pepper plants depends on AcnB, which might be required for the utilization of citrate as carbon source and could also help protect the bacterium against oxidative stress.	[Kirchberg, Janine; Thiemer, Barbara; Sawers, R. Gary] Univ Halle Wittenberg, Dept Microbiol, Inst Biol, Halle, Saale, Germany; [Buettner, Daniela] Univ Halle Wittenberg, Dept Genet, Inst Biol, Halle, Saale, Germany	Martin Luther University Halle Wittenberg; Martin Luther University Halle Wittenberg	Kirchberg, J (corresponding author), Univ Halle Wittenberg, Dept Microbiol, Inst Biol, Halle, Saale, Germany.	gary.sawers@mikrobiologie.uni-halle.de			Deutsche Forschungsgemeinschaft ['Sonderforschungsbereich' SFB 648]	Deutsche Forschungsgemeinschaft(German Research Foundation (DFG))	This work was supported by the Deutsche Forschungsgemeinschaft as part of a 'Sonderforschungsbereich' SFB 648 "Molecular Mechanisms of Information Transfer in Plants''. No official grant numbers exist but both DB and GS were recipients of grants providing financial support for their respective subprojects and the work described herein. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Arcus VL, 2011, PROTEIN ENG DES SEL, V24, P33, DOI 10.1093/protein/gzq081; Ausubel FM., 1992, CURRENT PROTOCOLS MO, V3; Banerjee S, 2007, J BACTERIOL, V189, P4046, DOI 10.1128/JB.00026-07; BONAS U, 1989, MOL GEN GENET, V218, P127, DOI 10.1007/BF00330575; BONAS U, 1991, MOL PLANT MICROBE IN, V4, P81, DOI 10.1094/MPMI-4-081; Buttner D, 2010, FEMS MICROBIOL REV, V34, P107, DOI 10.1111/j.1574-6976.2009.00192.x; Buttner D, 2002, EMBO J, V21, P5313, DOI 10.1093/emboj/cdf536; Canteros BI, 1990, THESIS U FLA GAINESV; Cornelis P, 2011, METALLOMICS, V3, P540, DOI 10.1039/c1mt00022e; Craig JE, 1997, J BACTERIOL, V179, P7351, DOI 10.1128/jb.179.23.7351-7359.1997; Cunningham L, 1997, MICROBIOL-UK, V143, P3795, DOI 10.1099/00221287-143-12-3795; DANIELS MJ, 1984, EMBO J, V3, P3323, DOI 10.1002/j.1460-2075.1984.tb02298.x; Escolar L, 2001, MOL PLANT PATHOL, V2, P287, DOI 10.1046/j.1464-6722.2001.00077.x; FIGURSKI DH, 1979, P NATL ACAD SCI USA, V76, P1648, DOI 10.1073/pnas.76.4.1648; GARDNER PR, 1991, J BIOL CHEM, V266, P1478; Ghosh P, 2004, MICROBIOL MOL BIOL R, V68, P771, DOI 10.1128/MMBR.68.4.771-795.2004; Gruer MJ, 1997, MICROBIOL-UK, V143, P1837, DOI 10.1099/00221287-143-6-1837; Guo W, 2012, MICROBIOL-SGM, V158, P505, DOI 10.1099/mic.0.050419-0; Huguet E, 1998, MOL MICROBIOL, V29, P1379, DOI 10.1046/j.1365-2958.1998.01019.x; Jittawuttipoka T, 2010, ARCH MICROBIOL, V192, P331, DOI 10.1007/s00203-010-0558-8; Jittawuttipoka T, 2009, J BACTERIOL, V191, P7372, DOI 10.1128/JB.00788-09; Jones JDG, 2006, NATURE, V444, P323, DOI 10.1038/nature05286; Kitphati W, 2007, APPL ENVIRON MICROB, V73, P4760, DOI 10.1128/AEM.00531-07; Koebnik R, 2006, J BACTERIOL, V188, P7652, DOI 10.1128/JB.00795-06; Kousik CS, 1998, PLANT DIS, V82, P181, DOI 10.1094/PDIS.1998.82.2.181; LAEMMLI UK, 1970, NATURE, V227, P680, DOI 10.1038/227680a0; LEYNS F, 1984, BOT REV, V50, P308, DOI 10.1007/BF02862635; Lorenz C, 2009, J BACTERIOL, V191, P1414, DOI 10.1128/JB.01446-08; LOWRY OH, 1951, J BIOL CHEM, V193, P265; MENARD R, 1993, J BACTERIOL, V175, P5899; MINSAVAGE GV, 1990, MOL PLANT MICROBE IN, V3, P41, DOI 10.1094/MPMI-3-041; Murray EJ, 2009, J BACTERIOL, V191, P6822, DOI 10.1128/JB.00618-09; Noel L, 2001, MOL MICROBIOL, V41, P1271, DOI 10.1046/j.1365-2958.2001.02567.x; Potnis N, 2011, BMC GENOMICS, V12, DOI 10.1186/1471-2164-12-146; Qian W, 2005, GENOME RES, V15, P757, DOI 10.1101/gr.3378705; Rico A, 2008, MOL PLANT MICROBE IN, V21, P269, DOI 10.1094/MPMI-21-2-0269; Ronald P C, 1988, Mol Plant Microbe Interact, V1, P191, DOI 10.1094/MPMI-1-191; Rouault TA, 2006, NAT CHEM BIOL, V2, P406, DOI 10.1038/nchembio807; Ryan RP, 2011, NAT REV MICROBIOL, V9, P344, DOI 10.1038/nrmicro2558; Schmidtke C, 2012, NUCLEIC ACIDS RES, V40, P2020, DOI 10.1093/nar/gkr904; Somerville GA, 2002, INFECT IMMUN, V70, P6373, DOI 10.1128/IAI.70.11.6373-6382.2002; STRAUCH MA, 1989, EMBO J, V8, P1615, DOI 10.1002/j.1460-2075.1989.tb03546.x; STRAUCH MA, 1993, MOL MICROBIOL, V7, P337, DOI 10.1111/j.1365-2958.1993.tb01125.x; Sullivan DM, 2008, STRUCTURE, V16, P1702, DOI 10.1016/j.str.2008.08.014; Szczesny R, 2010, NEW PHYTOL, V187, P983, DOI 10.1111/j.1469-8137.2010.03312.x; Tamir-Ariel D, 2007, J BACTERIOL, V189, P6359, DOI 10.1128/JB.00320-07; Tamir-Ariel D, 2011, MOL PLANT PATHOL, V12, P57, DOI 10.1111/j.1364-3703.2010.00652.x; Tang Y, 1999, MICROBIOL-SGM, V145, P3069, DOI 10.1099/00221287-145-11-3069; Tang Y, 2005, MOL MICROBIOL, V56, P1149, DOI 10.1111/j.1365-2958.2005.04610.x; Tang Y, 2002, MICROBIOL-SGM, V148, P1027, DOI 10.1099/00221287-148-4-1027; Thieme F, 2005, J BACTERIOL, V187, P7254, DOI 10.1128/JB.187.21.7254-7266.2005; TOWBIN H, 1979, P NATL ACAD SCI USA, V76, P4350, DOI 10.1073/pnas.76.9.4350; Tsuchiya D, 2009, BIOCHEM BIOPH RES CO, V379, P485, DOI 10.1016/j.bbrc.2008.12.096; Varghese S, 2003, J BACTERIOL, V185, P221, DOI 10.1128/JB.185.1.221-230.2003; Walden WE, 2006, SCIENCE, V314, P1903, DOI 10.1126/science.1133116; Wengelnik K, 1999, J BACTERIOL, V181, P6828, DOI 10.1128/JB.181.21.6828-6831.1999; Wengelnik K, 1996, J BACTERIOL, V178, P3462, DOI 10.1128/jb.178.12.3462-3469.1996; Williams CH, 2002, NAT STRUCT BIOL, V9, P447, DOI 10.1038/nsb801; Wilson TJG, 1998, MOL MICROBIOL, V28, P961, DOI 10.1046/j.1365-2958.1998.00852.x; Winther KS, 2011, P NATL ACAD SCI USA, V108, P7403, DOI 10.1073/pnas.1019587108; Xu XQ, 2000, MOL MICROBIOL, V35, P407, DOI 10.1046/j.1365-2958.2000.01709.x	61	10	10	0	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 6	2012	7	4							e34941	10.1371/journal.pone.0034941	http://dx.doi.org/10.1371/journal.pone.0034941			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	955JA	22493725	Green Submitted, Green Published, gold			2022-12-25	WOS:000305012700067
J	Pancsa, R; Tompa, P				Pancsa, Rita; Tompa, Peter			Structural Disorder in Eukaryotes	PLOS ONE			English	Article							INTRINSICALLY UNSTRUCTURED PROTEINS; AMINO-ACID-COMPOSITION; PREDICTION; REGIONS; EVOLUTION; SCAFFOLD; DOMAINS	Based on early bioinformatic studies on a handful of species, the frequency of structural disorder of proteins is generally thought to be much higher in eukaryotes than in prokaryotes. To refine this view, we present here a comparative prediction study and analysis of 194 fully described eukaryotic proteomes and 87 reference prokaryotes for structural disorder. We found that structural disorder does distinguish eukaryotes from prokaryotes, but its frequency spans a very wide range in the two superkingdoms that largely overlap. The number of disordered binding regions and different Pfam domain types also contribute to distinguish eukaryotes from prokaryotes. Unexpectedly, the highest levels - and highest variability - of predicted disorder is found in protists, i.e. single-celled eukaryotes, often surpassing more complex eukaryote organisms, plants and animals. This trend contrasts with that of the number of domain types, which increases rather monotonously toward more complex organisms. The level of structural disorder appears to be strongly correlated with lifestyle, because some obligate intracellular parasites and endosymbionts have the lowest levels, whereas host-changing parasites have the highest level of predicted disorder. We conclude that protists have been the evolutionary hot-bed of experimentation with structural disorder, in a period when structural disorder was actively invented and the major functional classes of disordered proteins established.	[Pancsa, Rita; Tompa, Peter] Vrije Univ Brussel VIB, Dept Biol Struct, B-1050 Brussels, Belgium; [Tompa, Peter] Hungarian Acad Sci, Inst Enzymol, Budapest, Hungary	Flanders Institute for Biotechnology (VIB); Vrije Universiteit Brussel; Eotvos Lorand Research Network; Hungarian Academy of Sciences; Hungarian Research Centre for Natural Sciences	Pancsa, R (corresponding author), Vrije Univ Brussel VIB, Dept Biol Struct, B-1050 Brussels, Belgium.	ptompa@vub.ac.be		Tompa, Peter/0000-0001-8042-9939	The Research Foundation-Flanders Odysseus [G.0029.12]	The Research Foundation-Flanders Odysseus	This work was supported by the The Research Foundation-Flanders Odysseus grant G.0029.12. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Apweiler R, 2011, NUCLEIC ACIDS RES, V39, pD214, DOI 10.1093/nar/gkq1020; Balazs A, 2009, FEBS J, V276, P3744, DOI 10.1111/j.1742-4658.2009.07090.x; Brown CJ, 2011, CURR OPIN STRUC BIOL, V21, P441, DOI 10.1016/j.sbi.2011.02.005; Burra PV, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0012069; Csizmok V, 2005, BIOCHEMISTRY-US, V44, P3955, DOI 10.1021/bi047817f; Dafforn TR, 2004, EMBO REP, V5, P1046, DOI 10.1038/sj.embor.7400276; Davey NE, 2011, TRENDS BIOCHEM SCI, V36, P159, DOI 10.1016/j.tibs.2010.10.002; Diella F, 2008, FRONT BIOSCI-LANDMRK, V13, P6580, DOI 10.2741/3175; Dosztanyi Z, 2005, BIOINFORMATICS, V21, P3433, DOI 10.1093/bioinformatics/bti541; Dosztanyi Z, 2005, J MOL BIOL, V347, P827, DOI 10.1016/j.jmb.2005.01.071; Dosztanyi Z, 2007, CURR PROTEIN PEPT SC, V8, P161, DOI 10.2174/138920307780363406; Dosztanyi Z, 2006, J PROTEOME RES, V5, P2985, DOI 10.1021/pr060171o; Dosztanyi Zsuzsanna, 2008, V426, P103, DOI 10.1007/978-1-60327-058-8_6; Dunker A K, 2000, Genome Inform Ser Workshop Genome Inform, V11, P161; Dyson HJ, 2005, NAT REV MOL CELL BIO, V6, P197, DOI 10.1038/nrm1589; Feng ZP, 2006, MOL BIOCHEM PARASIT, V150, P256, DOI 10.1016/j.molbiopara.2006.08.011; Ferron F, 2006, PROTEINS, V65, P1, DOI 10.1002/prot.21075; Finn RD, 2010, NUCLEIC ACIDS RES, V38, pD211, DOI 10.1093/nar/gkp985; Fuxreiter M, 2007, BIOINFORMATICS, V23, P950, DOI 10.1093/bioinformatics/btm035; Goh GKM, 2009, VIROL J, V6, DOI 10.1186/1743-422X-6-69; Haynes C, 2006, PLOS COMPUT BIOL, V2, P890, DOI 10.1371/journal.pcbi.0020100; HERNANDEZ MA, 1986, EUR J BIOCHEM, V154, P41, DOI 10.1111/j.1432-1033.1986.tb09356.x; Li WZ, 2006, BIOINFORMATICS, V22, P1658, DOI 10.1093/bioinformatics/btl158; Lu X, 2009, BIOCHEMISTRY-US, V48, P164, DOI 10.1021/bi801636y; Mark WY, 2005, J MOL BIOL, V345, P275, DOI 10.1016/j.jmb.2004.10.045; McCutcheon JP, 2012, NAT REV MICROBIOL, V10, P13, DOI 10.1038/nrmicro2670; Meszaros B, 2009, PLOS COMPUT BIOL, V5, DOI 10.1371/journal.pcbi.1000376; Minezaki Y, 2007, J MOL BIOL, V368, P902, DOI 10.1016/j.jmb.2007.02.033; Minezaki Y, 2006, J MOL BIOL, V359, P1137, DOI 10.1016/j.jmb.2006.04.016; Mohan A, 2008, MOL BIOSYST, V4, P328, DOI 10.1039/b719168e; Patel SS, 2007, CELL, V129, P83, DOI 10.1016/j.cell.2007.01.044; Pavlovic-Lazetic GM, 2011, BMC BIOINFORMATICS, V12, DOI 10.1186/1471-2105-12-66; Pruitt KD, 2009, NUCLEIC ACIDS RES, V37, pD32, DOI 10.1093/nar/gkn721; Rantalainen KI, 2011, J VIROL, V85, P2449, DOI 10.1128/JVI.02051-10; Renault L, 2008, TRENDS CELL BIOL, V18, P494, DOI 10.1016/j.tcb.2008.07.008; Schad E, 2011, GENOME BIOL, V12, DOI 10.1186/gb-2011-12-12-r120; Schlessinger A, 2011, CURR OPIN STRUC BIOL, V21, P412, DOI 10.1016/j.sbi.2011.03.014; Sgarra R, 2009, BIOCHIM BIOPHYS ACTA, P37; Shoemaker BA, 2000, P NATL ACAD SCI USA, V97, P8868, DOI 10.1073/pnas.160259697; Singh GP, 2007, PROTEINS, V66, P761, DOI 10.1002/prot.21281; Szollosi E, 2008, J PROTEOME RES, V7, P2291, DOI 10.1021/pr700720c; Tompa P, 2005, TRENDS BIOCHEM SCI, V30, P484, DOI 10.1016/j.tibs.2005.07.008; Tompa P, 2003, BIOESSAYS, V25, P847, DOI 10.1002/bies.10324; Tompa P, 2011, CURR OPIN STRUC BIOL, V21, P419, DOI 10.1016/j.sbi.2011.03.012; Tompa P, 2010, J MOL BIOL, V403, P346, DOI 10.1016/j.jmb.2010.07.044; Tompa P, 2009, BIOESSAYS, V31, P328, DOI 10.1002/bies.200800151; Uversky VN, 2008, ANNU REV BIOPHYS, V37, P215, DOI 10.1146/annurev.biophys.37.032807.125924; Uversky VN, 2010, BBA-PROTEINS PROTEOM, V1804, P1231, DOI 10.1016/j.bbapap.2010.01.017; Vogel C, 2004, CURR OPIN STRUC BIOL, V14, P208, DOI 10.1016/j.sbi.2004.03.011; Vogel C, 2006, PLOS COMPUT BIOL, V2, P370, DOI 10.1371/journal.pcbi.0020048; Vucetic S, 2003, PROTEINS, V52, P573, DOI 10.1002/prot.10437; Ward JJ, 2004, J MOL BIOL, V337, P635, DOI 10.1016/j.jmb.2004.02.002; Wright PE, 2009, CURR OPIN STRUC BIOL, V19, P31, DOI 10.1016/j.sbi.2008.12.003; Xue B, 2010, BMC SYST BIOL, V4, DOI 10.1186/1752-0509-4-S1-S1	54	131	130	0	84	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 5	2012	7	4							e34687	10.1371/journal.pone.0034687	http://dx.doi.org/10.1371/journal.pone.0034687			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	955IH	22496841	Green Published, gold			2022-12-25	WOS:000305010500022
J	Clerc, P; Polster, BM				Clerc, Pascaline; Polster, Brian M.			Investigation of Mitochondrial Dysfunction by Sequential Microplate-Based Respiration Measurements from Intact and Permeabilized Neurons	PLOS ONE			English	Article							NEURODEGENERATIVE DISEASES; GLUTAMATE EXCITOTOXICITY; OXIDATIVE STRESS; COMPLEX I; MECHANISMS; APOPTOSIS; CAPACITY; SUSCEPTIBILITY; RESPIROMETRY; INHIBITION	Mitochondrial dysfunction is a component of many neurodegenerative conditions. Measurement of oxygen consumption from intact neurons enables evaluation of mitochondrial bioenergetics under conditions that are more physiologically realistic compared to isolated mitochondria. However, mechanistic analysis of mitochondrial function in cells is complicated by changing energy demands and lack of substrate control. Here we describe a technique for sequentially measuring respiration from intact and saponin-permeabilized cortical neurons on single microplates. This technique allows control of substrates to individual electron transport chain complexes following permeabilization, as well as side-by-side comparisons to intact cells. To illustrate the utility of the technique, we demonstrate that inhibition of respiration by the drug KB-R7943 in intact neurons is relieved by delivery of the complex II substrate succinate, but not by complex I substrates, via acute saponin permeabilization. In contrast, methyl succinate, a putative cell permeable complex II substrate, failed to rescue respiration in intact neurons and was a poor complex II substrate in permeabilized cells. Sequential measurements of intact and permeabilized cell respiration should be particularly useful for evaluating indirect mitochondrial toxicity due to drugs or cellular signaling events which cannot be readily studied using isolated mitochondria.	[Clerc, Pascaline] Univ Maryland, Sch Med, Dept Anesthesiol, Baltimore, MD 21201 USA; Univ Maryland, Sch Med, Ctr Shock Trauma & Anesthesiol Res, Baltimore, MD 21201 USA	University System of Maryland; University of Maryland Baltimore; University System of Maryland; University of Maryland Baltimore	Clerc, P (corresponding author), Univ Maryland, Sch Med, Dept Anesthesiol, Baltimore, MD 21201 USA.	bpolster@anes.umm.edu		Polster, Brian/0000-0003-2571-7510	National Institutes of Health [R01NS064978, P01HD016596]; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT [P01HD016596] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS064978] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))	This study was supported by National Institutes of Health grants R01NS064978 and P01HD016596. (http://grants.nih.gov/grants/oer.htm). The funders had no role in study design, data collection and analysis.	Abramov AY, 2008, BBA-BIOENERGETICS, V1777, P953, DOI 10.1016/j.bbabio.2008.04.017; Almeida A, 1997, BRAIN RES, V764, P167, DOI 10.1016/S0006-8993(97)00453-8; Brand MD, 2011, BIOCHEM J, V435, P297, DOI 10.1042/BJ20110162; Brustovetsky T, 2011, BRIT J PHARMACOL, V162, P255, DOI 10.1111/j.1476-5381.2010.01054.x; Brustovetsky T, 2009, CELL CALCIUM, V46, P18, DOI 10.1016/j.ceca.2009.03.017; Chalmers S, 2003, J BIOL CHEM, V278, P19062, DOI 10.1074/jbc.M212661200; Dranka BP, 2010, FREE RADICAL BIO MED, V48, P905, DOI 10.1016/j.freeradbiomed.2010.01.015; FISKUM G, 1980, P NATL ACAD SCI-BIOL, V77, P3430, DOI 10.1073/pnas.77.6.3430; Fiskum G, 1999, J CEREBR BLOOD F MET, V19, P351, DOI 10.1097/00004647-199904000-00001; Gerencser AA, 2009, ANAL CHEM, V81, P6868, DOI 10.1021/ac900881z; Gerencser AA, 2009, J NEUROCHEM, V110, P990, DOI 10.1111/j.1471-4159.2009.06194.x; Iwamoto T, 1998, AM J PHYSIOL-CELL PH, V275, pC423, DOI 10.1152/ajpcell.1998.275.2.C423; Jones TT, 2010, BBA-BIOENERGETICS, V1797, P167, DOI 10.1016/j.bbabio.2009.09.009; Kristian T, 2006, J NEUROSCI METH, V152, P136, DOI 10.1016/j.jneumeth.2005.08.018; Kuznetsov AV, 2008, NAT PROTOC, V3, P965, DOI 10.1038/nprot.2008.61; Lin MT, 2006, NATURE, V443, P787, DOI 10.1038/nature05292; MACDONALD MJ, 1989, ARCH BIOCHEM BIOPHYS, V269, P400, DOI 10.1016/0003-9861(89)90123-9; Nicholls DG, 2009, BIOCHEM SOC T, V37, P1385, DOI 10.1042/BST0371385; NICHOLLS DG, 1980, BIOCHEM J, V186, P833, DOI 10.1042/bj1860833; Patton C, 2004, CELL CALCIUM, V35, P427, DOI 10.1016/j.ceca.2003.10.006; Picard M, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0018317; Picard Martin, 2010, Aging Cell, V9, P1032, DOI 10.1111/j.1474-9726.2010.00628.x; Polster BM, 2004, J NEUROCHEM, V90, P1281, DOI 10.1111/j.1471-4159.2004.02572.x; Polster BM, 2001, J BIOL CHEM, V276, P37887; Safiulina D, 2004, J NEUROSCI METH, V137, P87, DOI 10.1016/j.jneumeth.2004.02.027; Santo-Domingo J, 2007, BRIT J PHARMACOL, V151, P647, DOI 10.1038/sj.bjp.0707260; Sauerbeck A, 2011, J NEUROSCI METH, V198, P36, DOI 10.1016/j.jneumeth.2011.03.007; Schuh RA, 2011, J NEUROSCI RES, V89, P1979, DOI 10.1002/jnr.22650; Sims NR, 2008, NAT PROTOC, V3, P1228, DOI 10.1038/nprot.2008.105; Stoica BA, 2005, MOL CELL NEUROSCI, V29, P355, DOI 10.1016/j.mcn.2005.02.009; Wu M, 2007, AM J PHYSIOL-CELL PH, V292, pC125, DOI 10.1152/ajpcell.00247.2006; Yakovlev AG, 2001, J NEUROSCI, V21, P7439, DOI 10.1523/JNEUROSCI.21-19-07439.2001	32	46	48	2	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 4	2012	7	4							e34465	10.1371/journal.pone.0034465	http://dx.doi.org/10.1371/journal.pone.0034465			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	953GO	22496810	Green Submitted, Green Published, gold			2022-12-25	WOS:000304855200053
J	Goel, M; Sienkiewicz, AE; Picciani, R; Wang, JH; Lee, RK; Bhattacharya, SK				Goel, Manik; Sienkiewicz, Adam E.; Picciani, Renata; Wang, Jianhua; Lee, Richard K.; Bhattacharya, Sanjoy K.			Cochlin, Intraocular Pressure Regulation and Mechanosensing	PLOS ONE			English	Article							TRABECULAR MESHWORK CELLS; VON-WILLEBRAND-FACTOR; CHANNEL TREK-1; AQUEOUS-HUMOR; PROFILIN-I; GLAUCOMA; OUTFLOW; EXPRESSION; MOUSE; MECHANOTRANSDUCTION	Fluid shear modulates many biological properties. How shear mechanosensing occurs in the extracellular matrix (ECM) and is transduced into cytoskeletal change remains unknown. Cochlin is an ECM protein of unknown function. Our investigation using a comprehensive spectrum of cutting-edge techniques has resulted in following major findings: (1) over-expression and down-regulation of cochlin increase and decrease intraocular pressure (IOP), respectively. The overexpression was achieved in DBA/2J-Gpnmb(+)/SjJ using lentiviral vectors, down-regulation was achieved in glaucomatous DBA/2J mice using targeted disruption (cochlin-null mice) and also using lentiviral vector mediated shRNA against cochlin coding region; (2) reintroduction of cochlin in cochlin-null mice increases IOP; (3) injection of exogenous cochlin also increased IOP; (4) increasing perfusion rates increased cochlin multimerization, which reduced the rate of cochlin proteolysis by trypsin and proteinase K; The cochlin multimerization in response to shear stress suggests its potential mechanosensing. Taken together with previous studies, we show cochlin is involved in regulation of intraocular pressure in DBA/2J potentially through mechanosensing of the shear stress.	[Goel, Manik; Sienkiewicz, Adam E.; Picciani, Renata; Wang, Jianhua; Lee, Richard K.; Bhattacharya, Sanjoy K.] Univ Miami, Bascom Palmer Eye Inst, Miami, FL USA	Bascom Palmer Eye Institute; University of Miami	Goel, M (corresponding author), Univ Miami, Bascom Palmer Eye Inst, Miami, FL USA.	Sbhattacharya@med.miami.edu			United States National Institute of Health [R01 EY016112, EY015266, EY021012, EY016775, EY014801]; Research to Prevent Blindness; NATIONAL EYE INSTITUTE [R01EY016112, K08EY016775, R21EY021012, R03EY015266, P30EY014801] Funding Source: NIH RePORTER	United States National Institute of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Research to Prevent Blindness(Research to Prevent Blindness (RPB)); NATIONAL EYE INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI))	This work was funded by United States National Institute of Health Grants R01 EY016112, EY015266, EY021012, EY016775, and EY014801 (www.nei.nih.gov); a career development and an unrestricted grant to the University of Miami from Research to Prevent Blindness (http://www.rpbusa.org/rpb/). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of this manuscript.	Anderson Douglas R, 2003, Curr Opin Ophthalmol, V14, P86; Asrani S, 2000, J GLAUCOMA, V9, P134; Bhattacharya SK, 2009, INVEST OPHTH VIS SCI, V50, P551, DOI 10.1167/iovs.08-2632; Bhattacharya SK, 2005, EXP EYE RES, V80, P741, DOI 10.1016/j.exer.2005.01.028; Bhattacharya SK, 2005, J BIOL CHEM, V280, P6080, DOI 10.1074/jbc.M411233200; Borras T, 2003, PROG RETIN EYE RES, V22, P435, DOI 10.1016/S1350-9462(03)00018-1; Chemin J, 2005, EMBO J, V24, P44, DOI 10.1038/sj.emboj.7600494; Chow J, 2007, MOL VIS, V13, P1926; Fujiwara K, 2006, J INTERN MED, V259, P373, DOI 10.1111/j.1365-2796.2006.01623.x; Gabelt BT, 2005, PROG RETIN EYE RES, V24, P612, DOI 10.1016/j.preteyeres.2004.10.003; Geiger B, 2001, NAT REV MOL CELL BIO, V2, P793, DOI 10.1038/35099066; Goel M, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0023070; Gomez-Cabrero A, 2005, MOL VIS, V11, P1071; Gong HY, 2009, EXP EYE RES, V88, P729, DOI 10.1016/j.exer.2009.01.015; Heys JJ, 2001, J BIOMECH ENG-T ASME, V123, P540, DOI 10.1115/1.1411972; Janmey PA, 2004, TRENDS BIOCHEM SCI, V29, P364, DOI 10.1016/j.tibs.2004.05.003; John SWM, 1997, INVEST OPHTH VIS SCI, V38, P249; Kommareddi PK, 2007, JARO-J ASSOC RES OTO, V8, P435, DOI 10.1007/s10162-007-0099-2; Kung C, 2005, NATURE, V436, P647, DOI 10.1038/nature03896; Lambrechts A, 2006, J CELL SCI, V119, P1570, DOI 10.1242/jcs.02884; LARSSON LI, 1995, ARCH OPHTHALMOL-CHIC, V113, P283, DOI 10.1001/archopht.1995.01100030037018; Lauritzen I, 2005, EMBO REP, V6, P642, DOI 10.1038/sj.embor.7400449; Lee ES, 2010, INVEST OPHTH VIS SCI, V51, P2060, DOI 10.1167/iovs.09-4521; Lesage F, 2000, AM J PHYSIOL-RENAL, V279, pF793, DOI 10.1152/ajprenal.2000.279.5.F793; Libby RT, 2005, VISUAL NEUROSCI, V22, P637, DOI 10.1017/S0952523805225130; MAEPEA O, 1992, EXP EYE RES, V54, P879, DOI 10.1016/0014-4835(92)90151-H; Morales M, 2007, EUR J PHARMACOL, V567, P145, DOI 10.1016/j.ejphar.2007.04.020; Morrison JC, 2005, PROG RETIN EYE RES, V24, P217, DOI 10.1016/j.preteyeres.2004.08.003; Morrison JC, 2003, GLAUCOMA SCI PRACTIC; Patel AJ, 2001, CURR OPIN CELL BIOL, V13, P422, DOI 10.1016/S0955-0674(00)00231-3; Picciani R, 2007, PROG RETIN EYE RES, V26, P453, DOI 10.1016/j.preteyeres.2007.06.002; Quigley HA, 2006, BRIT J OPHTHALMOL, V90, P262, DOI 10.1136/bjo.2005.081224; Robertson NG, 2008, HUM MOL GENET, V17, P3426, DOI 10.1093/hmg/ddn236; Rodriguez CI, 2004, ENDOCRINOLOGY, V145, P1410, DOI 10.1210/en.2003-1361; Shankaran H, 2003, BLOOD, V101, P2637, DOI 10.1182/blood-2002-05-1550; Sharif-Naeini R, 2009, CELL, V139, P587, DOI 10.1016/j.cell.2009.08.045; Sit AJ, 2008, INVEST OPHTH VIS SCI, V49, P1473, DOI 10.1167/iovs.07-1139; Syriani E, 2008, FASEB J, V22, P1581, DOI 10.1096/fj.06-7654com; Tian B, 2009, EXP EYE RES, V88, P713, DOI 10.1016/j.exer.2008.08.008; Vass C., 2004, INVEST OPHTHALMOL VI, V45, P5030; Vogel V, 2006, ANNU REV BIOPH BIOM, V35, P459, DOI 10.1146/annurev.biophys.35.040405.102013; Wang J, 2010, EYE CONTACT IN PRESS; WuDunn D, 2009, EXP EYE RES, V88, P718, DOI 10.1016/j.exer.2008.11.008; Zhang YY, 2009, EXP EYE RES, V89, P748, DOI 10.1016/j.exer.2009.06.015	44	32	34	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 4	2012	7	4							e34309	10.1371/journal.pone.0034309	http://dx.doi.org/10.1371/journal.pone.0034309			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	953GO	22496787	Green Published, Green Submitted, gold			2022-12-25	WOS:000304855200038
J	Noh, NA; Fuggetta, G; Manganotti, P; Fiaschi, A				Noh, Nor Azila; Fuggetta, Giorgio; Manganotti, Paolo; Fiaschi, Antonio			Long Lasting Modulation of Cortical Oscillations after Continuous Theta Burst Transcranial Magnetic Stimulation	PLOS ONE			English	Article							HIGH-FREQUENCY; MOTOR CORTEX; THALAMOCORTICAL DYSRHYTHMIA; SYNAPTIC PLASTICITY; EEG; TMS; SYNCHRONIZATION; EXCITABILITY; SYSTEMS; TASK	Transcranial magnetic theta burst stimulation (TBS) differs from other high-frequency rTMS protocols because it induces plastic changes up to an hour despite lower stimulus intensity and shorter duration of stimulation. However, the effects of TBS on neuronal oscillations remain unclear. In this study, we used electroencephalography (EEG) to investigate changes of neuronal oscillations after continuous TBS (cTBS), the protocol that emulates long-term depression (LTD) form of synaptic plasticity. We randomly divided 26 healthy humans into two groups receiving either Active or Sham cTBS as control over the left primary motor cortex (M1). Post-cTBS aftereffects were assessed with behavioural measurements at rest using motor evoked potentials (MEPs) and at active state during the execution of a choice reaction time (RT) task in combination with continuous electrophysiological recordings. The cTBS-induced EEG oscillations were assessed using event-related power (ERPow), which reflected regional oscillatory activity of neural assemblies of theta (4-7.5 Hz), low alpha (8-9.5 Hz), mu (10-12.5 Hz), low beta (13-19.5 Hz), and high beta (20-30 Hz) brain rhythms. Results revealed 20-min suppression of MEPs and at least 30-min increase of ERPow modulation, suggesting that besides MEPs, EEG has the potential to provide an accurate cortical readout to assess cortical excitability and to investigate the interference of cortical oscillations in the human brain post-cTBS. We also observed a predominant modulation of beta frequency band, supporting the hypothesis that cTBS acts more on cortical level. Theta oscillations were also modulated during rest implying the involvement of independent cortical theta generators over the motor network post cTBS. This work provided more insights into the underlying mechanisms of cTBS, providing a possible link between synchronised neural oscillations and LTD in humans.	[Noh, Nor Azila; Fuggetta, Giorgio] Univ Leicester, Sch Psychol, Coll Med Biol Sci & Psychol, Leicester, Leics, England; [Noh, Nor Azila] USIM, Fac Med & Hlth Sci, Dept Basic Med Sci 1, Persiaran MPAJ, Kuala Lumpur, Malaysia; [Fuggetta, Giorgio; Manganotti, Paolo; Fiaschi, Antonio] Univ Verona, Dept Neurol Neuropsychol Morphol & Movement Sci, Sect Clin Neurol, GB Rossi Hosp, I-37100 Verona, Italy	University of Leicester; Universiti Sains Islam Malaysia; University of Verona; Azienda Ospedaliera Universitaria Integrata Verona	Noh, NA (corresponding author), Univ Leicester, Sch Psychol, Coll Med Biol Sci & Psychol, Leicester, Leics, England.	g.fuggetta@le.ac.uk	Manganotti, Paolo/L-1763-2018	Manganotti, Paolo/0000-0001-5305-6268				Aydin-Abidin S, 2008, EXP BRAIN RES, V188, P249, DOI 10.1007/s00221-008-1356-2; Azila Noh N, 2011, HUM BRAIN MAPP; Brignani D, 2008, HUM BRAIN MAPP, V29, P603, DOI 10.1002/hbm.20423; Caplan JB, 2001, J NEUROPHYSIOL, V86, P368, DOI 10.1152/jn.2001.86.1.368; Cardenas-Morales L, 2010, BRAIN TOPOGR, V22, P294, DOI 10.1007/s10548-009-0084-7; Di Lazzaro V, 2008, J PHYSIOL-LONDON, V586, P3871, DOI 10.1113/jphysiol.2008.152736; Di Lazzaro V, 2005, J PHYSIOL-LONDON, V565, P945, DOI 10.1113/jphysiol.2005.087288; Dutilh G, 2009, PSYCHON B REV, V16, P1026, DOI 10.3758/16.6.1026; Formaggio E, 2008, BRAIN TOPOGR, V21, P100, DOI 10.1007/s10548-008-0058-1; Fuggetta G, 2008, HUM BRAIN MAPP, V29, P1, DOI 10.1002/hbm.20371; Grossheinrich N, 2009, BIOL PSYCHIAT, V65, P778, DOI 10.1016/j.biopsych.2008.10.029; Hallett M, 2007, NEURON, V55, P187, DOI 10.1016/j.neuron.2007.06.026; Hernandez RV, 2005, BRAIN RES PROTOC, V15, P6, DOI 10.1016/j.brainresprot.2005.02.003; Huang CC, 2008, NEUROPHARMACOLOGY, V54, P1071, DOI 10.1016/j.neuropharm.2008.02.013; Huang YZ, 2008, CEREB CORTEX, V18, P563, DOI 10.1093/cercor/bhm087; Huang YZ, 2007, CLIN NEUROPHYSIOL, V118, P1028, DOI 10.1016/j.clinph.2007.01.021; Huang YZ, 2005, NEURON, V45, P201, DOI 10.1016/j.neuron.2004.12.033; Huerta PT, 2009, J NEUROENG REHABIL, V6, DOI 10.1186/1743-0003-6-7; Iyer MB, 2003, J NEUROSCI, V23, P10867; Jeanmonod D, 2003, NEUROSURG CLIN N AM, V14, P251, DOI 10.1016/S1042-3680(02)00116-X; Jurcak V, 2007, NEUROIMAGE, V34, P1600, DOI 10.1016/j.neuroimage.2006.09.024; Kahana MJ, 2001, CURR OPIN NEUROBIOL, V11, P739, DOI 10.1016/S0959-4388(01)00278-1; Komssi S, 2006, BRAIN RES REV, V52, P183, DOI 10.1016/j.brainresrev.2006.01.008; LEUNG LWS, 1987, BRAIN RES, V407, P68, DOI 10.1016/0006-8993(87)91220-0; Llinas R, 2005, TRENDS NEUROSCI, V28, P325, DOI 10.1016/j.tins.2005.04.006; Llinas RR, 1999, P NATL ACAD SCI USA, V96, P15222, DOI 10.1073/pnas.96.26.15222; Makeig S, 2002, SCIENCE, V295, P690, DOI 10.1126/science.1066168; Maki H, 2010, CLIN NEUROPHYSIOL, V121, P492, DOI 10.1016/j.clinph.2009.11.078; McAllister SM, 2011, EUR J NEUROSCI, V33, P1916, DOI 10.1111/j.1460-9568.2011.07673.x; Miniussi C, 2010, BRAIN TOPOGR, V22, P249, DOI 10.1007/s10548-009-0083-8; Mochizuki H, 2005, EXP BRAIN RES, V167, P414, DOI 10.1007/s00221-005-0047-5; Mochizuki H, 2007, EXP BRAIN RES, V180, P667, DOI 10.1007/s00221-007-0884-5; Niedermeyer E, 2004, CLIN EEG NEUROSCI, V35, P84, DOI 10.1177/155005940403500206; Nyffeler T, 2006, NEUROSCI LETT, V409, P57, DOI 10.1016/j.neulet.2006.09.011; Okamoto M, 2004, NEUROIMAGE, V21, P99, DOI 10.1016/j.neuroimage.2003.08.026; OLDFIELD RC, 1971, NEUROPSYCHOLOGIA, V9, P97, DOI 10.1016/0028-3932(71)90067-4; Pareti G, 2004, NEUROL SCI, V25, P41, DOI 10.1007/s10072-004-0235-2; Paulus W, 2005, NEURON, V45, P181, DOI 10.1016/j.neuron.2005.01.008; Perfetti B, 2011, J NEUROPHYSIOL, V105, P18, DOI 10.1152/jn.00778.2010; Pfurtscheller G, 2006, NEUROIMAGE, V31, P153, DOI 10.1016/j.neuroimage.2005.12.003; Pfurtscheller G, 1999, CLIN NEUROPHYSIOL, V110, P1842, DOI 10.1016/S1388-2457(99)00141-8; Pineda JA, 2005, BRAIN RES REV, V50, P57, DOI 10.1016/j.brainresrev.2005.04.005; Raghavachari S, 2006, J NEUROPHYSIOL, V95, P1630, DOI 10.1152/jn.00409.2005; Rengachary J, 2011, FRONT HUM NEUROSCI, V5, DOI [10.3389/fnhum.2011.00029, 10.3389/fnhum.2011.00069]; Ridding MC, 2007, NAT REV NEUROSCI, V8, P559, DOI 10.1038/nrn2169; Rosanova M, 2009, J NEUROSCI, V29, P7679, DOI 10.1523/JNEUROSCI.0445-09.2009; Rossi S, 2009, CLIN NEUROPHYSIOL, V120, P2008, DOI 10.1016/j.clinph.2009.08.016; Salenius S, 2003, CURR OPIN NEUROBIOL, V13, P678, DOI 10.1016/j.conb.2003.10.008; Sauseng P, 2008, NEUROSCI BIOBEHAV R, V32, P1001, DOI 10.1016/j.neubiorev.2008.03.014; Schindler K, 2008, NEUROSCI LETT, V436, P31, DOI 10.1016/j.neulet.2008.02.052; Siebner HR, 2003, EXP BRAIN RES, V148, P1, DOI 10.1007/s00221-002-1234-2; SILVA LR, 1991, SCIENCE, V251, P432, DOI 10.1126/science.1824881; Stefan K, 2008, NEUROIMAGE, V40, P265, DOI 10.1016/j.neuroimage.2007.11.037; Stinear CM, 2009, BRAIN STIMUL, V2, P152, DOI 10.1016/j.brs.2009.01.001; Suppa A, 2008, J PHYSIOL-LONDON, V586, P4489, DOI 10.1113/jphysiol.2008.156596; Taylor PCJ, 2008, BEHAV BRAIN RES, V191, P141, DOI 10.1016/j.bbr.2008.03.033; Thickbroom GW, 2007, EXP BRAIN RES, V180, P583, DOI 10.1007/s00221-007-0991-3; Thut G, 2010, BRAIN TOPOGR, V22, P219, DOI 10.1007/s10548-009-0115-4; Thut G, 2010, BRAIN TOPOGR, V22, P215, DOI 10.1007/s10548-009-0128-z; Thut G, 2009, TRENDS COGN SCI, V13, P182, DOI 10.1016/j.tics.2009.01.004; Trippe J, 2009, EXP BRAIN RES, V199, P411, DOI 10.1007/s00221-009-1961-8; Veniero D, 2011, PSYCHOPHYSIOLOGY, V48, P1381, DOI 10.1111/j.1469-8986.2011.01218.x; Zhang YC, 2009, FRONT NEURAL CIRCUIT, V3, DOI 10.3389/neuro.04.020.2009; Ziemann U, 2011, NEUROSCIENTIST, V17, P368, DOI 10.1177/1073858410390225	64	55	56	0	16	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 4	2012	7	4							e35080	10.1371/journal.pone.0035080	http://dx.doi.org/10.1371/journal.pone.0035080			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	953GO	22496893	Green Submitted, Green Published, gold			2022-12-25	WOS:000304855200098
J	Popic, J; Pesic, V; Milanovic, D; Todorovic, S; Kanazir, S; Jevtovic-Todorovic, V; Ruzdijic, S				Popic, Jelena; Pesic, Vesna; Milanovic, Desanka; Todorovic, Smilja; Kanazir, Selma; Jevtovic-Todorovic, Vesna; Ruzdijic, Sabera			Propofol-Induced Changes in Neurotrophic Signaling in the Developing Nervous System In Vivo	PLOS ONE			English	Article							PROTEIN-KINASE-B; GABA(A) RECEPTOR; NEONATAL EXPOSURE; CELL-DEATH; RAT-BRAIN; BDNF; ERK; ACTIVATION; INHIBITION; PHOSPHORYLATION	Several studies have revealed a role for neurotrophins in anesthesia-induced neurotoxicity in the developing brain. In this study we monitored the spatial and temporal expression of neurotrophic signaling molecules in the brain of 14-day-old (PND14) Wistar rats after the application of a single propofol dose (25 mg/kg i.p). The structures of interest were the cortex and thalamus as the primary areas of anesthetic actions. Changes of the protein levels of the brain-derived neurotrophic factor (BDNF) and nerve growth factor (NGF), their activated receptors tropomyosin-related kinase (TrkA and TrkB) and downstream kinases Akt and the extracellular signal regulated kinase (ERK) were assessed by Western immunoblot analysis at different time points during the first 24 h after the treatment, as well as the expression of cleaved caspase-3 fragment. Fluoro-Jade B staining was used to follow the appearance of degenerating neurons. The obtained results show that the treatment caused marked alterations in levels of the examined neurotrophins, their receptors and downstream effector kinases. However, these changes were not associated with increased neurodegeneration in either the cortex or the thalamus. These results indicate that in the brain of PND14 rats, the interaction between Akt/ERK signaling might be one of important part of endogenous defense mechanisms, which the developing brain utilizes to protect itself from potential anesthesia-induced damage. Elucidation of the underlying molecular mechanisms will improve our understanding of the age-dependent component of anesthesia-induced neurotoxicity.	[Popic, Jelena; Pesic, Vesna; Milanovic, Desanka; Todorovic, Smilja; Kanazir, Selma; Ruzdijic, Sabera] Univ Belgrade, Inst Biol Res, Dept Neurobiol, Belgrade, Serbia; [Milanovic, Desanka; Jevtovic-Todorovic, Vesna] Univ Virginia Hlth Syst, Dept Anesthesiol, Charlottesville, VA USA	University of Belgrade; University of Virginia	Popic, J (corresponding author), Univ Belgrade, Inst Biol Res, Dept Neurobiol, Belgrade, Serbia.	sabir@ibiss.bg.ac.rs	Kanazir, Selma/E-5495-2015	Kanazir, Selma/0000-0002-7229-5296; Pesic, Vesna/0000-0002-1415-5834; Milanovic, Desanka/0000-0001-9799-0335; Todorovic, Smilja/0000-0001-7155-4914; Popic, Jelena/0000-0002-0959-3856	Ministry of Education and Science of the Republic of Serbia [ON173056]	Ministry of Education and Science of the Republic of Serbia(Ministry of Education, Science & Technological Development, Serbia)	This work was suported by grant no. ON173056 from the Ministry of Education and Science of the Republic of Serbia. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alessi DR, 1996, EMBO J, V15, P6541, DOI 10.1002/j.1460-2075.1996.tb01045.x; Altar CA, 1998, TRENDS NEUROSCI, V21, P433, DOI 10.1016/S0166-2236(98)01273-9; BARBACID M, 1994, J NEUROBIOL, V25, P1386, DOI 10.1002/neu.480251107; Ben-Ari Y, 2010, TRENDS NEUROSCI, V33, P485, DOI 10.1016/j.tins.2010.08.005; Bjornstrom K, 2008, J PHYSIOL PHARMACOL, V59, P617; Blum R, 2005, PHYSIOLOGY, V20, P70, DOI 10.1152/physiol.00042.2004; Briner A, 2010, ANESTHESIOLOGY, V112, P546, DOI 10.1097/ALN.0b013e3181cd7942; Cardone MH, 1998, SCIENCE, V282, P1318, DOI 10.1126/science.282.5392.1318; Cheung Eric C C, 2004, Sci STKE, V2004, pPE45; CURTIS R, 1995, NEURON, V14, P1201, DOI 10.1016/0896-6273(95)90267-8; DOBBING J, 1979, EARLY HUM DEV, V3, P79, DOI 10.1016/0378-3782(79)90022-7; Dolcet X, 1999, J NEUROCHEM, V73, P521, DOI 10.1046/j.1471-4159.1999.0730521.x; Dummler B, 2007, BIOCHEM SOC T, V35, P231, DOI 10.1042/BST0350231; Engelhard K, 2004, ANESTHESIOLOGY, V101, P912, DOI 10.1097/00000542-200410000-00016; Fredriksson A, 2007, ANESTHESIOLOGY, V107, P427, DOI 10.1097/01.anes.0000278892.62305.9c; Galetic I, 2003, J BIOL CHEM, V278, P4416, DOI 10.1074/jbc.M210578200; Gilman CP, 2002, NEUROMOL MED, V2, P197, DOI 10.1385/NMM:2:2:197; Grewal SS, 1999, CURR OPIN NEUROBIOL, V9, P544, DOI 10.1016/S0959-4388(99)00010-0; Hartmann M, 2001, EMBO J, V20, P5887, DOI 10.1093/emboj/20.21.5887; HEMPSTEAD BL, 1992, NEURON, V9, P883, DOI 10.1016/0896-6273(92)90241-5; Huang EJ, 2001, ANNU REV NEUROSCI, V24, P677, DOI 10.1146/annurev.neuro.24.1.677; JENSEN AG, 1994, ANESTHESIOLOGY, V81, P1220, DOI 10.1097/00000542-199411000-00016; Kaplan DR, 2000, CURR OPIN NEUROBIOL, V10, P381, DOI 10.1016/S0959-4388(00)00092-1; Kidambi Srivatsan, 2010, BMC Res Notes, V3, P201, DOI 10.1186/1756-0500-3-201; Kozinn J, 2006, ANESTHESIOLOGY, V105, P1182, DOI 10.1097/00000542-200612000-00018; Krasowski MD, 1999, CELL MOL LIFE SCI, V55, P1278, DOI 10.1007/s000180050371; Lewin GR, 1996, ANNU REV NEUROSCI, V19, P289, DOI 10.1146/annurev.ne.19.030196.001445; Liao Y, 2010, AM J TRANSL RES, V2, P19; Lu LX, 2006, APOPTOSIS, V11, P1603, DOI 10.1007/s10495-006-8762-3; Lu S, 2011, TOXICOLOGY, V279, P189, DOI 10.1016/j.tox.2010.10.011; Manning BD, 2007, CELL, V129, P1261, DOI 10.1016/j.cell.2007.06.009; Marik PE, 2004, CURR PHARM DESIGN, V10, P3639, DOI 10.2174/1381612043382846; Muller DL, 2004, J PHARMACOL EXP THER, V310, P774, DOI 10.1124/jpet.104.066548; Nakao S, 2003, ACTA ANAESTH SCAND, V47, P284, DOI 10.1034/j.1399-6576.2003.00040.x; Nicholson KM, 2002, CELL SIGNAL, V14, P381, DOI 10.1016/S0898-6568(01)00271-6; Oscarsson A, 2007, ACTA ANAESTH SCAND, V51, P1184, DOI 10.1111/j.1399-6576.2007.01388.x; Pesic V, 2009, INT J DEV NEUROSCI, V27, P279, DOI 10.1016/j.ijdevneu.2008.12.005; Ponten E, 2011, BEHAV BRAIN RES, V223, P75, DOI 10.1016/j.bbr.2011.04.019; QIU MS, 1992, NEURON, V9, P705, DOI 10.1016/0896-6273(92)90033-A; Rajagopal R, 2004, J NEUROSCI, V24, P6650, DOI 10.1523/JNEUROSCI.0010-04.2004; Riccio A, 1997, SCIENCE, V277, P1097, DOI 10.1126/science.277.5329.1097; Riedl SJ, 2001, CELL, V104, P791, DOI 10.1016/S0092-8674(02)02036-6; Rommel C, 1999, SCIENCE, V286, P1738, DOI 10.1126/science.286.5445.1738; SEGER R, 1995, FASEB J, V9, P726, DOI 10.1096/fasebj.9.9.7601337; Tao X, 1998, NEURON, V20, P709, DOI 10.1016/S0896-6273(00)81010-7; Tsui-Pierchala BA, 1999, J NEUROSCI, V19, P8207; Turina D, 2008, BRIT J ANAESTH, V101, P374, DOI 10.1093/bja/aen185; Varju P, 2001, CELL TISSUE RES, V305, P239, DOI 10.1007/s004410100356; Vutskits L, 2005, ANESTHESIOLOGY, V102, P970, DOI 10.1097/00000542-200505000-00016; Wang C, 2002, DEV BRAIN RES, V139, P59, DOI 10.1016/S0165-3806(02)00536-9; Watson FL, 1999, J NEUROSCI, V19, P7889; Yang J, 2002, MOL CELL, V9, P1227, DOI 10.1016/S1097-2765(02)00550-6; Yon JH, 2005, NEUROSCIENCE, V135, P815, DOI 10.1016/j.neuroscience.2005.03.064; Zhang YY, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0027019; Zhang YZ, 2000, J NEUROSCI, V20, P5671, DOI 10.1523/JNEUROSCI.20-15-05671.2000	55	46	48	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 4	2012	7	4							e34396	10.1371/journal.pone.0034396	http://dx.doi.org/10.1371/journal.pone.0034396			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	953GO	22496799	Green Published, gold, Green Submitted			2022-12-25	WOS:000304855200046
J	Shah, NR; Braverman, ER				Shah, Nirav R.; Braverman, Eric R.			Measuring Adiposity in Patients: The Utility of Body Mass Index (BMI), Percent Body Fat, and Leptin	PLOS ONE			English	Article							BASE-LINE LEPTIN; SARCOPENIC OBESITY; WEIGHT; PREVALENCE; WOMEN; RESISTANCE; GHRELIN; TRENDS; AGE; OSTEOPOROSIS	Background:Obesity is a serious disease that is associated with an increased risk of diabetes, hypertension, heart disease, stroke, and cancer, among other diseases. The United States Centers for Disease Control and Prevention (CDC) estimates a 20% obesity rate in the 50 states, with 12 states having rates of over 30%. Currently, the body mass index (BMI) is most commonly used to determine adiposity. However, BMI presents as an inaccurate obesity classification method that underestimates the epidemic and contributes to failed treatment. In this study, we examine the effectiveness of precise biomarkers and duel-energy x-ray absorptiometry (DXA) to help diagnose and treat obesity. Methodology/Principal Findings: A cross-sectional study of adults with BMI, DXA, fasting leptin and insulin results were measured from 1998-2009. Of the participants, 63% were females, 37% were males, 75% white, with a mean age = 51.4 (SD = 14.2). Mean BMI was 27.3 (SD = 5.9) and mean percent body fat was 31.3% (SD = 9.3). BMI characterized 26% of the subjects as obese, while DXA indicated that 64% of them were obese. 39% of the subjects were classified as non-obese by BMI, but were found to be obese by DXA. BMI misclassified 25% men and 48% women. Meanwhile, a strong relationship was demonstrated between increased leptin and increased body fat. Conclusions/Significance: Our results demonstrate the prevalence of false-negative BMIs, increased misclassifications in women of advancing age, and the reliability of gender-specific revised BMI cutoffs. BMI underestimates obesity prevalence, especially in women with high leptin levels (>30 ng/mL). Clinicians can use leptin-revised levels to enhance the accuracy of BMI estimates of percentage body fat when DXA is unavailable.	[Shah, Nirav R.] NYU, Sch Med, Dept Med, New York, NY 10003 USA; [Braverman, Eric R.] PATH Fdn NY, New York, NY USA; [Braverman, Eric R.] Weill Cornell Med Coll, Dept Neurosurg, New York, NY USA	New York University; Cornell University	Shah, NR (corresponding author), NYU, Sch Med, Dept Med, New York, NY 10003 USA.	info@pathfounationny.org	Braverman, Eric new/ABC-1152-2021; Shah, Nirav R./B-6622-2008	Shah, Nirav R./0000-0003-2044-7865	Life Extension Foundation; PATH Foundation; NRS [1 R01 HS01 8589-01]; AGENCY FOR HEALTHCARE RESEARCH AND QUALITY [R01HS018589] Funding Source: NIH RePORTER	Life Extension Foundation; PATH Foundation; NRS; AGENCY FOR HEALTHCARE RESEARCH AND QUALITY(United States Department of Health & Human ServicesAgency for Healthcare Research & Quality)	The authors are grateful to the Life Extension Foundation for their generous financial support to PATH Foundation NY. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; The authors have read the journal's policy and have the following conflicts: This work was supported by a research grant from the PATH Foundation. All research and financial support for this article preceded NRS's joining the New York State Department of Health. Similarly, except for minor editorial changes, the article was completed before that time. The views expressed in this article are solely those of the authors as individuals and do not represent the views or policies of the State of New York or the New York State Department of Health. During the period when the work was completed, NRS was also supported by grant 1 R01 HS01 8589-01. All authors have completed the Unified Competing Interest form at www.icmje.org/coi_disclosure.pdf (available on request from the corresponding author and declare that (1) NRS has received grants from the PATH Foundation for the submitted work; ERB has received no personal compensation for the submitted work; (2) NRS has relationships with AstraZeneca, Pfizer, Merck, Ortho-McNeil, Roche, Shering-Plough, GlaxoSmithKline, Novartis, Partners Healthcare, Bellevue Hospital Association, NIH, AHRQ, CDC, Robert Wood Johnson Foundation, Cerner LifeSciences, Vemco MedEd, FAIR Health, Venebio Group, LLC, American Academy of Neurology, Pinnacle Health Geisinger Health System, MetaResearch, LLC, Johnson & Johnson, Takeda, Xcenda, Engage Healthcare, Medical Learning Institute, American Health & Drug Benefits, Center of Excellence Media LLC, Nassau University Medical Center, National Institute for Quality Improvement and Education and St. John's Episcopal Hospital. ERB has relationships with PATH Medical, Total Health Nutrients, Inc. and LLC, Life Extension Foundation, Weill-Cornell Medical College, the Stanley and Fiona Druckenmiller Fund, the American Academy of Anti-aging Medicine Fellowship in Anti-Aging, Regenerative, and Functional Medicine: Master's Degree in Metabolic & Nutritional Medicine in conjunction with the University of South Florida Medical School; the American Academy of Anti-aging Medicine Tarsus Medical Conference; and Douglas Labs, Life Extension Magazine; and has authored a book on weight loss; (3) Their spouses, partners, or children have no financial relationships that may be relevant to the submitted work; and (4) NRS and ERB have no non-financial interests that may be relevant to the submitted work. This does not alter the authors' adherence to all the PLoS ONE policies on sharing data and materials.	Blew RM, 2002, OBES RES, V10, P799, DOI 10.1038/oby.2002.108; Chen K, 2006, NAT MED, V12, P425, DOI 10.1038/nm1372; Crujeiras AB, 2010, J CLIN ENDOCR METAB, V95, P5037, DOI 10.1210/jc.2009-2566; Danaei G, 2011, LANCET, V378, P31, DOI 10.1016/S0140-6736(11)60679-X; de Gonzalez AB, 2010, NEW ENGL J MED, V363, P2211, DOI 10.1056/NEJMoa1000367; De Lorenzo A, 2007, AM J CLIN NUTR, V85, P40, DOI 10.1093/ajcn/85.1.40; Di Monaco M, 2011, ARCH GERONTOL GERIAT, V52, P71, DOI 10.1016/j.archger.2010.02.002; FerroLuzzi A, 1995, WHO TECH REP SER, V854, P1; Flegal KM, 2010, INT J EPIDEMIOL, V39, P963, DOI 10.1093/ije/dyq124; Flegal KM, 2010, JAMA-J AM MED ASSOC, V303, P235, DOI 10.1001/jama.2009.2014; Flegal KM, 2009, AM J CLIN NUTR, V89, P500, DOI 10.3945/ajcn.2008.26847; Fleming TR, 1996, ANN INTERN MED, V125, P605, DOI 10.7326/0003-4819-125-7-199610010-00011; Gallagher D, 1996, AM J EPIDEMIOL, V143, P228, DOI 10.1093/oxfordjournals.aje.a008733; Gomez-Ambrosi J, 2011, OBESITY, V19, P1439, DOI 10.1038/oby.2011.36; Jia HM, 2010, AM J PREV MED, V38, P138, DOI 10.1016/j.amepre.2009.09.043; Kelesidis T, 2010, ANN INTERN MED, V152, P93, DOI 10.7326/0003-4819-152-2-201001190-00008; Koh KK, 2008, CIRCULATION, V117, P3238, DOI 10.1161/CIRCULATIONAHA.107.741645; Labayen I, 2011, J CLIN ENDOCR METAB, V96, pE996, DOI 10.1210/jc.2010-3006; Labruna G, 2011, OBESITY, V19, P1492, DOI 10.1038/oby.2010.309; Malnick SDH, 2006, QJM-INT J MED, V99, P565, DOI 10.1093/qjmed/hcl085; Mantzoros CS, 1999, ANN INTERN MED, V130, P671, DOI 10.7326/0003-4819-130-8-199904200-00014; Martin SS, 2008, J AM COLL CARDIOL, V52, P1201, DOI 10.1016/j.jacc.2008.05.060; *NHLBI, 1998, NIH PUBL; Okorodudu DO, 2010, INT J OBESITY, V34, P791, DOI 10.1038/ijo.2010.5; Prado CMM, 2008, LANCET ONCOL, V9, P629, DOI 10.1016/S1470-2045(08)70153-0; Rahman M, 2010, OBSTET GYNECOL, V115, P982, DOI 10.1097/AOG.0b013e3181da9423; Razak F, 2007, CIRCULATION, V115, P2111, DOI 10.1161/CIRCULATIONAHA.106.635011; Romero-Corral A, 2008, INT J OBESITY, V32, P959, DOI 10.1038/ijo.2008.11; Romero-Corral A, 2010, EUR HEART J, V31, P737, DOI 10.1093/eurheartj/ehp487; RUIZ JR, 2008, BMJ-BRIT MED J, V337, P439; Shea JL, 2011, NUTR METAB CARDIOVAS; Stenholm S, 2008, CURR OPIN CLIN NUTR, V11, P693, DOI 10.1097/MCO.0b013e328312c37d; Sun Q, 2010, AM J EPIDEMIOL, V172, P1442, DOI 10.1093/aje/kwq306; Sun Q, 2009, BRIT MED J, V339, DOI 10.1136/bmj.b3796; Ursavas A, 2010, ANN THORAC MED, V5, P161, DOI 10.4103/1817-1737.65050; Walsh MC, 2006, OSTEOPOROSIS INT, V17, P61, DOI 10.1007/s00198-005-1900-x; Wormser D, 2011, LANCET, V377, P1085, DOI 10.1016/S0140-6736(11)60105-0; Zimmet P, 1996, BRIT MED J, V313, P965, DOI 10.1136/bmj.313.7063.965	38	327	337	6	56	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 2	2012	7	4							e33308	10.1371/journal.pone.0033308	http://dx.doi.org/10.1371/journal.pone.0033308			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	952GU	22485140	Green Published, gold			2022-12-25	WOS:000304780500016
J	Huang, DW				Huang, Danwei			Threatened Reef Corals of the World	PLOS ONE			English	Article							PHYLOGENETIC DIVERSITY; CONSERVATION PRIORITIES; BIODIVERSITY HOTSPOTS; SCLERACTINIAN CORALS; EVOLUTIONARY HISTORY; EXTINCTION RISK; CLIMATE-CHANGE; PHASE-SHIFTS; MATRIX REPRESENTATION; STONY CORALS	A substantial proportion of the world's living species, including one-third of the reef-building corals, are threatened with extinction and in pressing need of conservation action. In order to reduce biodiversity loss, it is important to consider species' contribution to evolutionary diversity along with their risk of extinction for the purpose of setting conservation priorities. Here I reconstruct the most comprehensive tree of life for the order Scleractinia (1,293 species) that includes all 837 living reef species, and employ a composite measure of phylogenetic distinctiveness and extinction risk to identify the most endangered lineages that would not be given top priority on the basis of risk alone. The preservation of these lineages, not just the threatened species, is vital for safeguarding evolutionary diversity. Tests for phylogeny-associated patterns show that corals facing elevated extinction risk are not clustered on the tree, but species that are susceptible, resistant or resilient to impacts such as bleaching and disease tend to be close relatives. Intensification of these threats or extirpation of the endangered lineages could therefore result in disproportionate pruning of the coral tree of life.	[Huang, Danwei] Univ Calif San Diego, Scripps Inst Oceanog, La Jolla, CA 92093 USA; [Huang, Danwei] Natl Univ Singapore, Dept Biol Sci, Singapore 117548, Singapore	University of California System; University of California San Diego; Scripps Institution of Oceanography; National University of Singapore	Huang, DW (corresponding author), Univ Calif San Diego, Scripps Inst Oceanog, La Jolla, CA 92093 USA.	huangdanwei@nus.edu.sg	Huang, Danwei/C-4525-2016		Ah Meng Memorial Conservation Fund (Wildlife Reserves Singapore); Friends of the International Center Scholarship (University of California San Diego)	Ah Meng Memorial Conservation Fund (Wildlife Reserves Singapore); Friends of the International Center Scholarship (University of California San Diego)	This work was supported by the Ah Meng Memorial Conservation Fund (Wildlife Reserves Singapore) and the Friends of the International Center Scholarship (University of California San Diego). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Agnarsson I, 2010, MOL PHYLOGENET EVOL, V54, P726, DOI 10.1016/j.ympev.2009.10.033; Almany GR, 2009, CORAL REEFS, V28, P339, DOI 10.1007/s00338-009-0484-x; ALTSCHUL SF, 1990, NATURE, V348, P493, DOI 10.1038/348493c0; BAUM BR, 1992, TAXON, V41, P3, DOI 10.2307/1222480; Beger M, 2003, BIOL CONSERV, V111, P53, DOI 10.1016/S0006-3207(02)00249-5; Bellwood DR, 2004, NATURE, V429, P827, DOI 10.1038/nature02691; Bellwood DR, 2001, SCIENCE, V292, P1532, DOI 10.1126/science.1058635; Benzoni F, 2007, CONTRIB ZOOL, V76, P35, DOI 10.1163/18759866-07601004; Benzoni F, 2010, ZOOL J LINN SOC-LOND, V160, P421, DOI 10.1111/j.1096-3642.2010.00622.x; Bininda-Emonds ORP, 2005, SYST BIOL, V54, P668, DOI 10.1080/10635150590947113; Bininda-Emonds ORP, 2004, TRENDS ECOL EVOL, V19, P315, DOI 10.1016/j.tree.2004.03.015; Bininda-Emonds ORP, 2002, ANNU REV ECOL SYST, V33, P265, DOI 10.1146/annurev.ecolsys.33.010802.150511; Blomberg SP, 2003, EVOLUTION, V57, P717, DOI 10.1111/j.0014-3820.2003.tb00285.x; Blum MGB, 2006, SYST BIOL, V55, P685, DOI 10.1080/10635150600889625; Borel Best M., 1987, Zoologische Mededelingen (Leiden), V61, P387; Brandt ME, 2009, ECOLOGY, V90, P2859, DOI 10.1890/08-0445.1; Bruno JF, 2007, PLOS BIOL, V5, P1220, DOI 10.1371/journal.pbio.0050124; Bruno JF, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0000711; Budd AF, 2005, PALEONTOLOGICAL SOC, V11, P103; Budd AF, 2010, INTEGR COMP BIOL, V50, P411, DOI 10.1093/icb/icq062; Cadotte MW, 2008, P NATL ACAD SCI USA, V105, P17012, DOI 10.1073/pnas.0805962105; Cadotte MW, 2010, DIVERS DISTRIB, V16, P376, DOI 10.1111/j.1472-4642.2010.00650.x; Cadotte MW, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0005695; Cairns S. D., 2009, COLD WATER CORALS BI; Cairns S. D., 1997, SMITHSONIAN CONTRIBU, V591, P1, DOI DOI 10.5479/SI.00810282.591; Cairns Stephen D., 2001, Smithsonian Contributions to Zoology, V615, P1; Carpenter KE, 2008, SCI E LETT; Carpenter KE, 2008, SCIENCE, V321, P560, DOI 10.1126/science.1159196; Carpenter Kent E., 2011, Journal of Marine Biology, V2011, P1; Chevalier JP, 1971, EXPEDITION FRANCAISE, V5, P1; Claereboudt M., 1990, Galaxea, V9, P1; Claereboudt MR, 2004, ZOOTAXA, P1; Collen B, 2011, PHILOS T R SOC B, V366, P2611, DOI 10.1098/rstb.2011.0109; Colless D.H., 1982, SYST ZOOL, V31, P100, DOI DOI 10.2307/2413420; Connolly J, 2011, ECOLOGY, V92, P1385, DOI 10.1890/10-2270.1; Daly M, 2003, ZOOL J LINN SOC-LOND, V139, P419, DOI 10.1046/j.1096-3642.2003.00084.x; Davies TJ, 2008, P NATL ACAD SCI USA, V105, P11556, DOI 10.1073/pnas.0801917105; De Queiroz K, 2011, BIOL J LINN SOC, V103, P19, DOI 10.1111/j.1095-8312.2011.01634.x; De'ath G, 2009, SCIENCE, V323, P116, DOI 10.1126/science.1165283; Diaz M, 2011, CORAL REEFS, V30, P73, DOI 10.1007/s00338-010-0668-4; Ditlev H., 2003, Zoologische Mededelingen (Leiden), V77, P193; Fabricius KE, 2011, NAT CLIM CHANGE, V1, P165, DOI 10.1038/NCLIMATE1122; Faith DP, 2010, CURR OPIN ENV SUST, V2, P66, DOI 10.1016/j.cosust.2010.04.002; Faith DP, 2008, CONSERV BIOL, V22, P1461, DOI 10.1111/j.1523-1739.2008.01068.x; FAITH DP, 1992, BIOL CONSERV, V61, P1, DOI 10.1016/0006-3207(92)91201-3; FELSENSTEIN J, 1985, AM NAT, V125, P1, DOI 10.1086/284325; FENNER DP, 1993, B MAR SCI, V53, P1099; Flynn DFB, 2011, ECOLOGY, V92, P1573, DOI 10.1890/10-1245.1; Forsman ZH, 2009, ZOOTAXA, P51; Fritz SA, 2010, CONSERV BIOL, V24, P1042, DOI 10.1111/j.1523-1739.2010.01455.x; Fritz SA, 2010, P ROY SOC B-BIOL SCI, V277, P2435, DOI 10.1098/rspb.2010.0030; Fukami H, 2004, NATURE, V427, P832, DOI 10.1038/nature02339; Fukami H, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0003222; Gittenberger A, 2011, CONTRIB ZOOL, V80, P107, DOI 10.1163/18759866-08002002; HEAD SM, 1983, J NAT HIST, V17, P419, DOI 10.1080/00222938300770281; Heard SB, 2000, P ROY SOC B-BIOL SCI, V267, P613, DOI 10.1098/rspb.2000.1046; Hoegh-Guldberg O, 2007, SCIENCE, V318, P1737, DOI 10.1126/science.1152509; Hoeksema B. W., 1993, Zoologische Mededelingen (Leiden), V67, P639; Hoeksema BW, 2009, RAFFLES B ZOOL, P81; Hoeksema BW, 1989, ZOOLOGISCHE VERHANDE, V254, P1; Hoffmann M., 2008, Endangered Species Research, V6, P113, DOI 10.3354/esr00087; Huang DW, 2011, BMC EVOL BIOL, V11, DOI 10.1186/1471-2148-11-37; Hughes TP, 2007, CURR BIOL, V17, P360, DOI 10.1016/j.cub.2006.12.049; Hughes TP, 2003, SCIENCE, V301, P929, DOI 10.1126/science.1085046; Hughes TP, 2002, ECOL LETT, V5, P775, DOI 10.1046/j.1461-0248.2002.00383.x; HUGHES TP, 1994, SCIENCE, V265, P1547, DOI 10.1126/science.265.5178.1547; *INT UN CONS NAT, 2012, IUCN RED LIST CAT CR; Isaac NJB, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0000296; Jones KE, 2005, EVOLUTION, V59, P2243, DOI 10.1111/j.0014-3820.2005.tb00932.x; Katoh K, 2002, NUCLEIC ACIDS RES, V30, P3059, DOI 10.1093/nar/gkf436; Katoh K, 2008, BRIEF BIOINFORM, V9, P286, DOI 10.1093/bib/bbn013; Kembel SW, 2010, BIOINFORMATICS, V26, P1463, DOI 10.1093/bioinformatics/btq166; Kerr AM, 2005, BIOL REV, V80, P543, DOI 10.1017/S1464793105006780; Kitahara MV, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0011490; Knowlton N, 2008, SCI E LETT; Knowlton N, 2008, PLOS BIOL, V6, P215, DOI 10.1371/journal.pbio.0060054; Kuntner M, 2011, ZOOL SCR, V40, P1, DOI 10.1111/j.1463-6409.2010.00452.x; Lin MF, 2011, ZOOL STUD, V50, P513; Locke JM, 2007, P BIOL SOC WASH, V120, P214, DOI 10.2988/0006-324X(2007)120[214:ANDSOM]2.0.CO;2; Loya Y, 2001, ECOL LETT, V4, P122, DOI 10.1046/j.1461-0248.2001.00203.x; Mace GM, 2008, CONSERV BIOL, V22, P1424, DOI 10.1111/j.1523-1739.2008.01044.x; Mace GM, 2003, SCIENCE, V300, P1707, DOI 10.1126/science.1085510; Maddison W. P., 2007, TUATARA CONSERVATION; Maherali H, 2007, SCIENCE, V316, P1746, DOI 10.1126/science.1143082; Margules CR, 2000, NATURE, V405, P243, DOI 10.1038/35012251; Marshall PA, 2000, CORAL REEFS, V19, P155, DOI 10.1007/s003380000086; MAY RM, 1990, NATURE, V347, P129, DOI 10.1038/347129a0; May-Collado LJ, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0022562; Maynard JA, 2008, CORAL REEFS, V27, P745, DOI 10.1007/s00338-008-0432-1; McCook LJ, 1999, CORAL REEFS, V18, P357, DOI 10.1007/s003380050213; McKinney ML, 1997, ANNU REV ECOL SYST, V28, P495, DOI 10.1146/annurev.ecolsys.28.1.495; Miller J, 2006, CORAL REEFS, V25, P418, DOI 10.1007/s00338-006-0125-6; Miller M. A., 2010, GAT COMP ENV WORKSH, P1, DOI DOI 10.1109/GCE.2010.5676129; MOLL H, 1984, Zoologische Mededelingen (Leiden), V58, P47; Mooers AO, 1997, Q REV BIOL, V72, P31, DOI 10.1086/419657; MOOERS AO, 1995, EVOLUTION, V49, P379, DOI [10.2307/2410349, 10.1111/j.1558-5646.1995.tb02251.x]; Mooers AO, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0003700; Murdoch W, 2007, BIOL CONSERV, V139, P375, DOI 10.1016/j.biocon.2007.07.011; Myers Norman, 2000, Nature (London), V403, P853, DOI 10.1038/35002501; Nee S, 1997, SCIENCE, V278, P692, DOI 10.1126/science.278.5338.692; Nystrom M, 2008, CORAL REEFS, V27, P795, DOI 10.1007/s00338-008-0426-z; Orme D., 2008, CAIC COMP ANAL USING; Palmer CV, 2010, FASEB J, V24, P1935, DOI 10.1096/fj.09-152447; Pandolfi JM, 2005, SCIENCE, V308, P1742; PANDOLFI JM, 1992, J BIOGEOGR, V19, P593, DOI 10.2307/2845703; Pandolfi JM, 2011, SCIENCE, V333, P418, DOI 10.1126/science.1204794; Paradis E, 2004, BIOINFORMATICS, V20, P289, DOI 10.1093/bioinformatics/btg412; Parhar RK, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0023528; Pavoine S, 2005, ECOL LETT, V8, P579, DOI 10.1111/j.1461-0248.2005.00752.x; Pires D.O., 1997, P1581; Polidoro Beth A., 2011, Journal of Marine Biology, V2011, P1, DOI 10.1155/2011/247030; Purvis A, 2000, SCIENCE, V288, P328, DOI 10.1126/science.288.5464.328; Purvis A, 2002, SYST BIOL, V51, P844, DOI 10.1080/10635150290155809; Purvis A, 2011, PHILOS T R SOC B, V366, P2462, DOI 10.1098/rstb.2011.0025; Purvis A, 2008, ANNU REV ECOL EVOL S, V39, P301, DOI 10.1146/annurev-ecolsys-063008-102010; Ragan MA, 1992, MOL PHYLOGENET EVOL, V1, P53, DOI 10.1016/1055-7903(92)90035-F; Redding DW, 2008, J THEOR BIOL, V251, P606, DOI 10.1016/j.jtbi.2007.12.006; Redding DW, 2006, CONSERV BIOL, V20, P1670, DOI 10.1111/j.1523-1739.2006.00555.x; Redding DW, 2010, CONSERV BIOL, V24, P1052, DOI 10.1111/j.1523-1739.2010.01532.x; Roberts CM, 2002, SCIENCE, V295, P1280, DOI 10.1126/science.1067728; Rodolfo-Metalpa R, 2011, NAT CLIM CHANGE, V1, P308, DOI 10.1038/NCLIMATE1200; Rodrigues ASL, 2006, TRENDS ECOL EVOL, V21, P71, DOI 10.1016/j.tree.2005.10.010; Rodrigues ASL, 2004, BIOSCIENCE, V54, P1092, DOI 10.1641/0006-3568(2004)054[1092:GGAPRF]2.0.CO;2; Romano SL, 1997, J MOL EVOL, V45, P397, DOI 10.1007/PL00006245; Romano SL, 2000, B MAR SCI, V67, P1043; Romano SL, 1996, SCIENCE, V271, P640, DOI 10.1126/science.271.5249.640; Russell GJ, 1998, CONSERV BIOL, V12, P1365, DOI 10.1046/j.1523-1739.1998.96332.x; Scheer G., 1983, Zoologica (Stuttgart), P1; Stamatakis A, 2008, SYST BIOL, V57, P758, DOI 10.1080/10635150802429642; Stamatakis A, 2006, BIOINFORMATICS, V22, P2688, DOI 10.1093/bioinformatics/btl446; Steel M, 2007, EVOL BIOINFORM, V3, P237; Swofford D.L., 2002, PAUP PHYLOGENETIC AN; van Woesik R, 2011, MAR ECOL PROG SER, V434, P67, DOI 10.3354/meps09203; VANEWRIGHT RI, 1991, BIOL CONSERV, V55, P235, DOI 10.1016/0006-3207(91)90030-D; Vaughan TW, 1901, B US FISH COMMISS, V2, P289; Veron, 2002, NEW SPECIES DESCRIBE; VERON J E N, 1990, Galaxea, V9, P95; Veron JEN, 2009, MAR POLLUT BULL, V58, P1428, DOI 10.1016/j.marpolbul.2009.09.009; Veron J.E.N., 2000, CORALS WORLD, V1-3; Veron J.E.N., 1986, CORALS AUSTR INDOPAC; Veron JEN, 2009, GALAXEA J CORAL REEF, V11, P91, DOI DOI 10.3755/GALAXEA.11.91; Veron JEN, 1980, SCLERACTINIA E AUS 3; Veron JEN, 1977, SCLERACTINIA E AUS 2; Wallace CC, 2007, CORAL REEFS, V26, P231, DOI 10.1007/s00338-007-0203-4; Wallace C.C., 1999, STAGHORN CORALS WORL, DOI 10.1071/9780643101388; Wallace CC, 2011, J NAT HIST, V45, P1905, DOI 10.1080/00222933.2011.573098; Weitzman ML, 1998, ECONOMETRICA, V66, P1279, DOI 10.2307/2999617; Wells J. W., 1937, Journal of Paleontology Menasha, V11, P73; WIJSMAN-BEST M, 1972, Bijdragen tot de Dierkunde, V42, P3; WITTING L, 1995, BIOL CONSERV, V71, P205, DOI 10.1016/0006-3207(94)00041-N; YABE HISAKATSU, 1941, SCI REPTS TOHOKU IMP UNIV SER 2 GEOL SPECIAL VOL, V2, P67; Yee SH, 2011, ECOL MODEL, V222, P1323, DOI 10.1016/j.ecolmodel.2011.01.009	152	92	94	1	109	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 30	2012	7	3							e34459	10.1371/journal.pone.0034459	http://dx.doi.org/10.1371/journal.pone.0034459			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	959UC	22479633	Green Published, Green Submitted, gold			2022-12-25	WOS:000305339100159
J	Khairallah, RJ; Kim, J; O'Shea, KM; O'Connell, KA; Brown, BH; Galvao, T; Daneault, C; Des Rosiers, C; Polster, BM; Hoppel, CL; Stanley, WC				Khairallah, Ramzi J.; Kim, Junhwan; O'Shea, Karen M.; O'Connell, Kelly A.; Brown, Bethany H.; Galvao, Tatiana; Daneault, Caroline; Des Rosiers, Christine; Polster, Brian M.; Hoppel, Charles L.; Stanley, William C.			Improved Mitochondrial Function with Diet-Induced Increase in Either Docosahexaenoic Acid or Arachidonic Acid in Membrane Phospholipids	PLOS ONE			English	Article							EICOSAPENTAENOIC ACID; FISH-OIL; PERMEABILITY TRANSITION; FATTY-ACIDS; CARDIOLIPIN; CHROMATOGRAPHY; ACTIVATION; LIPIDS; N-3	Mitochondria can depolarize and trigger cell death through the opening of the mitochondrial permeability transition pore (MPTP). We recently showed that an increase in the long chain n3 polyunsaturated fatty acids (PUFA) docosahexaenoic acid (DHA; 22:6n3) and depletion of the n6 PUFA arachidonic acid (ARA; 20:4n6) in mitochondrial membranes is associated with a greater Ca2+ load required to induce MPTP opening. Here we manipulated mitochondrial phospholipid composition by supplementing the diet with DHA, ARA or combined DHA+ARA in rats for 10 weeks. There were no effects on cardiac function, or respiration of isolated mitochondria. Analysis of mitochondrial phospholipids showed DHA supplementation increased DHA and displaced ARA in mitochondrial membranes, while supplementation with ARA or DHA+ARA increased ARA and depleted linoleic acid (18:2n6). Phospholipid analysis revealed a similar pattern, particularly in cardiolipin. Tetralinoleoyl cardiolipin was depleted by 80% with ARA or DHA+ARA supplementation, with linoleic acid side chains replaced by ARA. Both the DHA and ARA groups had delayed Ca2+-induced MPTP opening, but the DHA+ARA group was similar to the control diet. In conclusion, alterations in mitochondria membrane phospholipid fatty acid composition caused by dietary DHA or ARA was associated with a greater cumulative Ca2+ load required to induced MPTP opening. Further, high levels of tetralinoleoyl cardiolipin were not essential for normal mitochondrial function if replaced with very-long chain n3 or n6 PUFAs.	[Khairallah, Ramzi J.; O'Shea, Karen M.; O'Connell, Kelly A.; Brown, Bethany H.; Galvao, Tatiana; Stanley, William C.] Univ Maryland, Dept Med, Div Cardiol, Baltimore, MD 21201 USA; [Kim, Junhwan; Hoppel, Charles L.] Case Western Reserve Univ, Dept Med & Pharmacol, Cleveland, OH 44106 USA; [Daneault, Caroline; Des Rosiers, Christine] Univ Montreal, Dept Nutr, Montreal, PQ H3C 3J7, Canada; [Daneault, Caroline; Des Rosiers, Christine] Univ Montreal, Montreal Heart Inst, Montreal, PQ, Canada; [Polster, Brian M.] Univ Maryland, Dept Anesthesiol, Baltimore, MD 21201 USA; [Polster, Brian M.] Univ Maryland, Shock Trauma & Anesthesiol Res STAR Ctr, Baltimore, MD 21201 USA	University System of Maryland; University of Maryland Baltimore; Case Western Reserve University; Universite de Montreal; Universite de Montreal; University System of Maryland; University of Maryland Baltimore; University System of Maryland; University of Maryland Baltimore	Khairallah, RJ (corresponding author), Univ Maryland, Dept Med, Div Cardiol, Baltimore, MD 21201 USA.	wstanley@medicine.umaryland.edu	Rosiers, Christine Des/O-6285-2014	Polster, Brian/0000-0003-2571-7510; Kim, Junhwan/0000-0002-1162-8616	National Institutes of Health [HL074237, HL091307, HL101434]; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R21HL091307, P01HL074237, P20HL101434] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))	This work was supported by National Institutes of Health grants HL074237, HL091307 and HL101434. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ABEYWARDENA MY, 1991, AM J CLIN NUTR, V53, pS1039, DOI 10.1093/ajcn/53.4.1039S; ABEYWARDENA MY, 1991, AM J PHYSIOL, V260, pH379, DOI 10.1152/ajpheart.1991.260.2.H379; CHRISTIANSEN K, 1975, ANAL BIOCHEM, V66, P93, DOI 10.1016/0003-2697(75)90728-9; Duda MK, 2009, CARDIOVASC RES, V81, P319, DOI 10.1093/cvr/cvn310; Farina EK, 2011, J NUTR, V141, P1146, DOI 10.3945/jn.110.133728; Gelinas R, 2011, AM J PHYSIOL-HEART C, V301, pH813, DOI 10.1152/ajpheart.01275.2010; Halestrap AP, 2010, BIOCHEM SOC T, V38, P841, DOI 10.1042/BST0380841; INGALLS ST, 1993, J CHROMATOGR-BIOMED, V619, P9, DOI 10.1016/0378-4347(93)80441-6; Kawabata T, 2011, PROSTAG LEUKOTR ESS, V84, P131, DOI 10.1016/j.plefa.2011.01.001; Khairallah RJ, 2010, J PHARMACOL EXP THER, V335, P155, DOI 10.1124/jpet.110.170605; Khairallah RJ, 2010, BBA-BIOENERGETICS, V1797, P1555, DOI 10.1016/j.bbabio.2010.05.007; Kinsey GR, 2007, J PHARMACOL EXP THER, V321, P707, DOI 10.1124/jpet.107.119545; MCMILLIN JB, 1992, AM J PHYSIOL, V263, pH1479, DOI 10.1152/ajpheart.1992.263.5.H1479; Minkler PE, 2010, J LIPID RES, V51, P856, DOI 10.1194/jlr.D002857; Nodari S, 2011, J AM COLL CARDIOL, V57, P870, DOI 10.1016/j.jacc.2010.11.017; O'Shea KM, 2009, J MOL CELL CARDIOL, V47, P819, DOI 10.1016/j.yjmcc.2009.08.014; PALMER JW, 1977, J BIOL CHEM, V252, P8731; Penzo D, 2004, J BIOL CHEM, V279, P25219, DOI 10.1074/jbc.M310381200; Pepe S, 1999, AM J PHYSIOL-HEART C, V276, pH149, DOI 10.1152/ajpheart.1999.276.1.H149; Pompeia C, 2003, CELL BIOCHEM FUNCT, V21, P97, DOI 10.1002/cbf.1012; Ricchelli F, 2011, BBA-BIOENERGETICS, V1807, P482, DOI 10.1016/j.bbabio.2011.02.012; Rosca M, 2011, BBA-BIOENERGETICS, V1807, P1373, DOI 10.1016/j.bbabio.2011.02.003; Russo GL, 2009, BIOCHEM PHARMACOL, V77, P937, DOI 10.1016/j.bcp.2008.10.020; Schlame M, 2003, J AM COLL CARDIOL, V42, P1994, DOI 10.1016/j.jacc.2003.06.015; Schlame M, 2002, ANN NEUROL, V51, P634, DOI 10.1002/ana.10176; Schmitz G, 2008, PROG LIPID RES, V47, P147, DOI 10.1016/j.plipres.2007.12.004; Scorrano L, 2001, J BIOL CHEM, V276, P12035, DOI 10.1074/jbc.M010603200; SEYBERTH HW, 1975, CLIN PHARMACOL THER, V18, P521; Sparagna GC, 2009, J CARDIOVASC PHARM, V53, P290, DOI 10.1097/FJC.0b013e31819b5461; Tavazzi L, 2008, LANCET, V372, P1223, DOI 10.1016/S0140-6736(08)61239-8; Williams SD, 2002, BIOCHEM J, V362, P23, DOI 10.1042/bj3620023	31	66	68	0	18	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 30	2012	7	3							e34402	10.1371/journal.pone.0034402	http://dx.doi.org/10.1371/journal.pone.0034402			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	959UC	22479624	gold, Green Published, Green Submitted			2022-12-25	WOS:000305339100155
J	Popi, AF; Osugui, L; Perez, KR; Longo-Maugeri, IM; Mariano, M				Popi, Ana Flavia; Osugui, Lika; Perez, Katia Regina; Longo-Maugeri, Ieda Maria; Mariano, Mario			Could a B-1 Cell Derived Phagocyte "Be One" of the Peritoneal Macrophages during LPS-Driven Inflammation?	PLOS ONE			English	Article							COLONY-STIMULATING FACTOR; BIPHENOTYPIC B/MACROPHAGE CELLS; TRANSCRIPTION FACTOR PU.1; MONONUCLEAR PHAGOCYTE; B-LYMPHOCYTES; DIFFERENTIATION; MOUSE; MICE; OSTEOPETROSIS; POPULATIONS	The inflammatory response is driven by signals that recruit and elicit immune cells to areas of tissue damage or infection. The concept of a mononuclear phagocyte system postulates that monocytes circulating in the bloodstream are recruited to inflamed tissues where they give rise to macrophages. A recent publication demonstrated that the large increase in the macrophages observed during infection was the result of the multiplication of these cells rather than the recruitment of blood monocytes. We demonstrated previously that B-1 cells undergo differentiation to acquire a mononuclear phagocyte phenotype in vitro (B-1CDP), and we propose that B-1 cells could be an alternative origin for peritoneal macrophages. A number of recent studies that describe the phagocytic and microbicidal activity of B-1 cells in vitro and in vivo support this hypothesis. Based on these findings, we further investigated the differentiation of B-1 cells into phagocytes in vivo in response to LPS-induced inflammation. Therefore, we investigated the role of B-1 cells in the composition of the peritoneal macrophage population after LPS stimulation using osteopetrotic mice, BALB/Xid mice and the depletion of monocytes/macrophages by clodronate treatment. We show that peritoneal macrophages appear in op/op((-/-)) mice after LPS stimulation and exhibit the same Ig gene rearrangement (VH11) that is often found in B-1 cells. These results strongly suggest that op/op((-/-)) peritoneal "macrophages" are B-1CDP. Similarly, the LPS-induced increase in the macrophage population was observed even following monocyte/macrophage depletion by clodronate. After monocyte/macrophage depletion by clodronate, LPS-elicited macrophages were observed in BALB/Xid mice only following the transfer of B-1 cells. Based on these data, we confirmed that B-1 cell differentiation into phagocytes also occurs in vivo. In conclusion, the results strongly suggest that B-1 cell derived phagocytes are a component of the LPS-elicited peritoneal macrophage population.	[Popi, Ana Flavia; Osugui, Lika; Longo-Maugeri, Ieda Maria; Mariano, Mario] Univ Fed Sao Paulo, UNIFESP, Discipline Immunol, Dept Microbiol Immunol & Parasitol, Sao Paulo, Brazil; [Perez, Katia Regina] Univ Fed Sao Paulo, Dept Biophys, Sao Paulo, Brazil; [Mariano, Mario] Univ Estadual Paulista, Lab Mol & Cellular Biol, UNIP, Sao Paulo, Brazil	Universidade Federal de Sao Paulo (UNIFESP); Universidade Federal de Sao Paulo (UNIFESP); Universidade Estadual Paulista; Universidade Paulista	Popi, AF (corresponding author), Univ Fed Sao Paulo, UNIFESP, Discipline Immunol, Dept Microbiol Immunol & Parasitol, Sao Paulo, Brazil.	afpopi@unifesp.br	Popi, Ana Flavia/V-4437-2019; Popi, Ana/C-8828-2012; Perez, Katia/J-2312-2016; Mariano, Mario/L-2557-2015; Osugui, Lika/AFV-5288-2022; Longo-Maugeri, Ieda M/B-9764-2012	Popi, Ana Flavia/0000-0001-9814-4181; Popi, Ana/0000-0001-9814-4181; Osugui, Lika/0000-0002-2755-3487; Longo-Maugeri, Ieda M/0000-0003-4184-8414; Perez, Katia Regina/0000-0001-9612-1816	FAPESP - Fundacao de Amparo a Pesquisa do Estado de Sao Paulo [2002/01354-6, 2008/55526-9]	FAPESP - Fundacao de Amparo a Pesquisa do Estado de Sao Paulo(Fundacao de Amparo a Pesquisa do Estado de Sao Paulo (FAPESP))	This research was supported by FAPESP - Fundacao de Amparo a Pesquisa do Estado de Sao Paulo (2002/01354-6 and 2008/55526-9). The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abrahao TB, 2003, IMMUNOBIOLOGY, V208, P401, DOI 10.1078/0171-2985-00287; Almeida SR, 2001, INT IMMUNOL, V13, P1193, DOI 10.1093/intimm/13.9.1193; Anderson KL, 1998, BLOOD, V91, P3702, DOI 10.1182/blood.V91.10.3702; Anthony RM, 2006, NAT MED, V12, P955, DOI 10.1038/nm1451; Bertrand JY, 2005, BLOOD, V106, P3004, DOI 10.1182/blood-2005-02-0461; Borrello MA, 1999, J IMMUNOL, V163, P3605; Borrello MA, 1996, IMMUNOL TODAY, V17, P471, DOI 10.1016/0167-5699(96)20031-B; BORRELLO MA, 1995, J IMMUNOL, V155, P4155; Getts DR, 2008, J EXP MED, V205, P2319, DOI 10.1084/jem.20080421; Graf BA, 1999, EUR J IMMUNOL, V29, P3793, DOI 10.1002/(SICI)1521-4141(199911)29:11<3793::AID-IMMU3793>3.0.CO;2-3; Hardy R R, 1992, Int Rev Immunol, V8, P189, DOI 10.3109/08830189209055573; HAYAKAWA K, 1985, J EXP MED, V161, P1554, DOI 10.1084/jem.161.6.1554; Jenkins SJ, 2011, SCIENCE, V332, P1284, DOI 10.1126/science.1204351; KANTOR AB, 1995, INT IMMUNOL, V7, P55, DOI 10.1093/intimm/7.1.55; KANTOR AB, 1992, P NATL ACAD SCI USA, V89, P3320, DOI 10.1073/pnas.89.8.3320; Katoh S, 1990, Dev Immunol, V1, P113, DOI 10.1155/1990/28760; Lepique AP, 2009, CLIN CANCER RES, V15, P4391, DOI 10.1158/1078-0432.CCR-09-0489; Li J, 2006, NAT IMMUNOL, V7, P1116, DOI 10.1038/ni1389; Lichanska AM, 1999, BLOOD, V94, P127, DOI 10.1182/blood.V94.1.127.413k07_127_138; McKercher SR, 1996, EMBO J, V15, P5647, DOI 10.1002/j.1460-2075.1996.tb00949.x; NAITO M, 1991, AM J PATHOL, V139, P657; Nakayama KI, 1997, INT J EXP PATHOL, V78, P245, DOI 10.1046/j.1365-2613.1997.250358.x; Novaes e Brito R.R., 2010, IMMUNOL IMMUNOGENETI, V2, P31; Ogiku M, 2009, J SURG RES; Parra D, 2011, J LEUKOC BIOL   1104; Plytycz B, 1997, IMMUNOL TODAY, V18, P505, DOI 10.1016/S0167-5699(97)82523-6; Popi AF, 2009, IMMUNOBIOLOGY, V214, P664, DOI 10.1016/j.imbio.2008.12.007; Popi AF, 2009, IMMUNOLOGY, V126, P114, DOI 10.1111/j.1365-2567.2008.02883.x; SCOTT EW, 1994, SCIENCE, V265, P1573, DOI 10.1126/science.8079170; Shepard JL, 2000, CURR OPIN HEMATOL, V7, P3, DOI 10.1097/00062752-200001000-00002; Smith P, 2007, J IMMUNOL, V178, P4557, DOI 10.4049/jimmunol.178.7.4557; SODHI A, 1993, INT J IMMUNOPHARMACO, V15, P327, DOI 10.1016/0192-0561(93)90043-X; Takahashi K, 1998, AM J PATHOL, V152, P445; Takahashi K, 1996, PATHOL INT, V46, P473, DOI 10.1111/j.1440-1827.1996.tb03641.x; Umeda S, 1996, AM J PATHOL, V149, P559; VANFURTH R, 1972, B WORLD HEALTH ORGAN, V46, P845; WIKTORJEDRZEJCZAK W, 1982, J EXP MED, V156, P1516, DOI 10.1084/jem.156.5.1516; WIKTORJEDRZEJCZAK W, 1992, EXP HEMATOL, V20, P1004; Yamashiro S, 1998, INT ARCH ALLERGY IMM, V115, P15, DOI 10.1159/000023825	39	30	30	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 30	2012	7	3							e34570	10.1371/journal.pone.0034570	http://dx.doi.org/10.1371/journal.pone.0034570			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	959UC	22479646	Green Submitted, Green Published, gold			2022-12-25	WOS:000305339100169
J	Hu, D; Tateno, H; Kuno, A; Yabe, R; Hirabayashi, J				Hu, Dan; Tateno, Hiroaki; Kuno, Atsushi; Yabe, Rikio; Hirabayashi, Jun			Directed Evolution of Lectins with Sugar-binding Specificity for 6-Sulfo-galactose	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							EARTHWORM LUMBRICUS-TERRESTRIS; KERATAN SULFATE GAL-6-SULFOTRANSFERASE; L-SELECTIN; LEWIS-X; GALACTOSE; LIGAND; DOMAIN; MICROARRAY; PROTEINS; OLIGOSACCHARIDES	6-sulfo-galactose (6S-Gal) is a prevalent motif observed in highly sulfated keratan sulfate, which is closely associated with the glioblastoma malignancy while acting as a critical determinant for endogenous lectins. However, facile detection of this unique glycoepitope is greatly hampered because of a lack of appropriate probes. We have previously reported tailoring an alpha 2-6-linked sialic acid-binding lectin from a ricin-B chain-like galactose-binding protein, EW29Ch, by a reinforced ribosome display system following an error-prone PCR. In this study, we challenged the creation of novel lectins to recognize 6S-Gal-terminated glycans by incorporating a high-throughput screening system with a glycoconjugate microarray. After two rounds of selection procedures, 20 mutants were obtained and 12 were then successfully expressed in Escherichia coli, 8 of which showed a significant affinity for 6'-Sulfo-LN (6-O-sulfo-Gal beta 1-4GlcNAc), which the parental EW29Ch lacked. Analysis of two representative mutants by frontal affinity chromatography revealed a substantial affinity (K-d similar to 3 mu M) for a 6S-Gal-terminated glycan. On the basis of the observation that all eight mutants have a common mutation at Glu-20 to Lys, site-directed mutagenesis experiments were performed focusing on this aspect. The results clearly indicated that the E20K mutation is necessary and sufficient to acquire the specificity for 6S-Gal. We also confirmed a difference in binding between E20K and EW29Ch to CHO cells, in which enzymes to catalyze the synthesis of 6S-Gal were overexpressed. The results clearly demonstrate that these mutants have potential to distinguish between cells containing different amounts of 6S-Gal-terminated glycans. This new technology will be used to provide novel tools essential for sulfoglycomics.	[Hu, Dan; Tateno, Hiroaki; Kuno, Atsushi; Yabe, Rikio; Hirabayashi, Jun] Natl Inst Adv Ind Sci & Technol, Res Ctr Med Glycosci, Tsukuba, Ibaraki 3058568, Japan	National Institute of Advanced Industrial Science & Technology (AIST)	Hirabayashi, J (corresponding author), Natl Inst Adv Ind Sci & Technol, Res Ctr Stem Cell Engn, Cent 2,1-1-1 Umezono, Tsukuba, Ibaraki 3058568, Japan.	jun-hirabayashi@aist.go.jp	Kuno, Atsushi/M-2151-2018; Hirabayashi, Jun/M-3998-2018; Tateno, Hiroaki/M-2706-2018	Kuno, Atsushi/0000-0002-6147-6171; Hirabayashi, Jun/0000-0002-8571-359X; Tateno, Hiroaki/0000-0003-3006-1659	Japan Society for the Promotion of Science Scholarship; Grants-in-Aid for Scientific Research [10F00218] Funding Source: KAKEN	Japan Society for the Promotion of Science Scholarship(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of Science); Grants-in-Aid for Scientific Research(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI))	This study was supported in part by the Japan Society for the Promotion of Science Scholarship.	Akama TO, 2002, J BIOL CHEM, V277, P42505, DOI 10.1074/jbc.M207412200; Bochner BS, 2005, J BIOL CHEM, V280, P4307, DOI 10.1074/jbc.M412378200; Fukushima K, 2010, GLYCOBIOLOGY, V20, P452, DOI 10.1093/glycob/cwp197; Fukuta M, 1997, J BIOL CHEM, V272, P32321, DOI 10.1074/jbc.272.51.32321; Hayatsu N, 2008, BIOCHEM BIOPH RES CO, V368, P217, DOI 10.1016/j.bbrc.2008.01.058; HEMMERICH S, 1995, J BIOL CHEM, V270, P12035, DOI 10.1074/jbc.270.20.12035; Hemmi H, 2009, FEBS J, V276, P2095, DOI 10.1111/j.1742-4658.2009.06944.x; Hirabayashi J, 1998, J BIOL CHEM, V273, P14450, DOI 10.1074/jbc.273.23.14450; Hu D, 2009, GLYCOBIOLOGY, V19, P1127, DOI 10.1093/glycob/cwp104; Kaji H, 2003, NAT BIOTECHNOL, V21, P667, DOI 10.1038/nbt829; Kaku H, 1996, J BIOL CHEM, V271, P1480, DOI 10.1074/jbc.271.3.1480; Kannagi R, 2009, GLYCOCONJUGATE J, V26, P923, DOI 10.1007/s10719-008-9122-z; Kato Y, 2008, BIOCHEM BIOPH RES CO, V369, P1041, DOI 10.1016/j.bbrc.2008.02.130; Kuno A, 2005, NAT METHODS, V2, P851, DOI 10.1038/NMETH803; MEHMET H, 1986, EUR J BIOCHEM, V157, P385, DOI 10.1111/j.1432-1033.1986.tb09680.x; Mitsuoka C, 1998, J BIOL CHEM, V273, P11225, DOI 10.1074/jbc.273.18.11225; Nakamura S, 2005, FEBS J, V272, P2784, DOI 10.1111/j.1742-4658.2005.04698.x; Pilobello KT, 2007, P NATL ACAD SCI USA, V104, P11534, DOI 10.1073/pnas.0704954104; Seko A, 2012, GLYCOBIOLOGY, V22, P181, DOI 10.1093/glycob/cwr118; SHIBUYA N, 1987, J BIOL CHEM, V262, P1596; Suzuki R, 2009, ACTA CRYSTALLOGR D, V65, P49, DOI 10.1107/S0907444908037451; Tabata N, 2009, NUCLEIC ACIDS RES, V37, DOI 10.1093/nar/gkp184; Tateno H, 2005, GLYCOBIOLOGY, V15, P1125, DOI 10.1093/glycob/cwi097; Tateno H, 2008, GLYCOBIOLOGY, V18, P789, DOI 10.1093/glycob/cwn068; Tateno H, 2007, NAT PROTOC, V2, P2529, DOI 10.1038/nprot.2007.357; Tateno H, 2007, GLYCOBIOLOGY, V17, P1138, DOI 10.1093/glycob/cwm084; Tateno H, 2010, J BIOL CHEM, V285, P6390, DOI 10.1074/jbc.M109.041863; Torii T, 2000, GLYCOBIOLOGY, V10, P203, DOI 10.1093/glycob/10.2.203; Wang YF, 2011, FEBS LETT, V585, P3927, DOI 10.1016/j.febslet.2011.10.035; Yabe R, 2007, J BIOCHEM, V141, P389, DOI 10.1093/jb/mvm043; YAMASHITA K, 1992, BIOCHEMISTRY-US, V31, P11647, DOI 10.1021/bi00161a052	31	36	36	0	16	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JUN 8	2012	287	24					20313	20320		10.1074/jbc.M112.351965	http://dx.doi.org/10.1074/jbc.M112.351965			8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	974FB	22493425	hybrid, Green Published			2022-12-25	WOS:000306414500051
J	Garcia-Tardon, N; Gonzalez-Gonzalez, IM; Martinez-Villarreal, J; Fernandez-Sanchez, E; Gimenez, C; Zafra, F				Garcia-Tardon, Noemi; Gonzalez-Gonzalez, Inmaculada M.; Martinez-Villarreal, Jaime; Fernandez-Sanchez, Enrique; Gimenez, Cecilio; Zafra, Francisco			Protein Kinase C (PKC)-promoted Endocytosis of Glutamate Transporter GLT-1 Requires Ubiquitin Ligase Nedd4-2-dependent Ubiquitination but Not Phosphorylation	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							EPITHELIAL NA+ CHANNEL; CELL-SURFACE EXPRESSION; DOPAMINE TRANSPORTER; DEPENDENT ENDOCYTOSIS; DIFFERENTIAL REGULATION; WW DOMAINS; NEDD4-2; DEGRADATION; SERUM; INTERNALIZATION	Glutamate transporter-1 (GLT-1) is the main glutamate transporter in the central nervous system, and its concentration severely decreases in neurodegenerative diseases. The number of transporters in the plasma membrane reflects the balance between their insertion and removal, and it has been reported that the regulated endocytosis of GLT-1 depends on its ubiquitination triggered by protein kinase C (PKC) activation. Here, we identified serine 520 of GLT-1 as the primary target for PKC-dependent phosphorylation, although elimination of this serine did not impair either GLT-1 ubiquitination or endocytosis in response to phorbol esters. In fact, we present evidence indicating that the ubiquitin ligase Nedd4-2 mediates the PKC-dependent ubiquitination and down-regulation of GLT-1. Overexpression of Nedd4-2 increased the ubiquitination of the transporter and promoted its degradation. Moreover, phorbol myristate acetate enhanced Nedd4-2 phosphorylation and the formation of GLT-1.Nedd4-2 complexes, whereas siRNA knockdown of Nedd4-2 prevented ubiquitination, endocytosis, and the concomitant decrease in GLT-1 activity triggered by PKC activation. These results indicate that GLT-1 endocytosis is independent of its phosphorylation and that Nedd4-2 mediates PKC-dependent down-regulation of the transporter.	[Zafra, Francisco] Univ Autonoma Madrid, Ctr Biol Mol Severo Ochoa, Consejo Super Invest Cient, E-28049 Madrid, Spain; Univ Autonoma Madrid, Dept Biol Mol, Consejo Super Invest Cient, E-28049 Madrid, Spain; CIBERER, Madrid 28049, Spain; Inst Salud Carlos III, Inst Invest Hosp Univ La Paz, Madrid 28049, Spain	Autonomous University of Madrid; Consejo Superior de Investigaciones Cientificas (CSIC); CSIC - Centro de Biologia Molecular Severo Ochoa (CBM); Autonomous University of Madrid; Consejo Superior de Investigaciones Cientificas (CSIC); CIBER - Centro de Investigacion Biomedica en Red; CIBERER; Hospital Universitario La Paz; Instituto de Salud Carlos III	Zafra, F (corresponding author), Univ Autonoma Madrid, Ctr Biol Mol Severo Ochoa, Consejo Super Invest Cient, C Nicolas Cabrera 1, E-28049 Madrid, Spain.	fzafra@cbm.uam.es	Zafra, Francisco/A-6121-2008; Gimenez, Cecilio/K-8027-2014	Zafra, Francisco/0000-0003-3801-3109; Gimenez, Cecilio/0000-0001-6726-8405; Martinez Villarreal, Jaime/0000-0002-3003-7766; Gonzalez-Gonzalez, Maria Inmaculada/0000-0001-9888-0760	Spanish Direccion General de Investigacion Cientifica y Tecnica [SAF2011-29961]; Fondo de Investigaciones Sanitarias (CIBERER); Comunidad Autonoma de Madrid; Fundacion Ramon Areces	Spanish Direccion General de Investigacion Cientifica y Tecnica(Spanish Government); Fondo de Investigaciones Sanitarias (CIBERER)(Instituto de Salud Carlos III); Comunidad Autonoma de Madrid(Comunidad de Madrid); Fundacion Ramon Areces	This work was supported by Spanish Direccion General de Investigacion Cientifica y Tecnica Grant SAF2011-29961, grants from Fondo de Investigaciones Sanitarias (CIBERER) and Comunidad Autonoma de Madrid, and an institutional grant from the Fundacion Ramon Areces.	Abe F, 2003, MOL CELL BIOL, V23, P7566, DOI 10.1128/MCB.23.21.7566-7584.2003; Bhalla V, 2006, J BIOL CHEM, V281, P26159, DOI 10.1074/jbc.M606045200; Blom N, 1999, J MOL BIOL, V294, P1351, DOI 10.1006/jmbi.1999.3310; Boehmer C, 2006, J NEUROCHEM, V97, P911, DOI 10.1111/j.1471-4159.2006.03629.x; Boehmer C, 2003, J NEUROCHEM, V86, P1181, DOI 10.1046/j.1471-4159.2003.01937.x; CASADO M, 1993, J BIOL CHEM, V268, P27313; Chan W, 2009, J BIOL CHEM, V284, P8185, DOI 10.1074/jbc.M806877200; Cremona ML, 2011, NAT NEUROSCI, V14, P469, DOI 10.1038/nn.2781; Danbolt NC, 2001, PROG NEUROBIOL, V65, P1, DOI 10.1016/S0301-0082(00)00067-8; Debonneville C, 2001, EMBO J, V20, P7052, DOI 10.1093/emboj/20.24.7052; Embark HM, 2004, KIDNEY INT, V66, P1918, DOI 10.1111/j.1523-1755.2004.00966.x; Fotia AB, 2002, FASEB J, V16, P70, DOI 10.1096/fj.02-0497fje; Gonzalez MI, 2005, J NEUROCHEM, V94, P1180, DOI 10.1111/j.1471-4159.2005.03330.x; Gonzalez MI, 2004, MOL INTERV, V4, P48, DOI 10.1124/mi.4.1.48; Gonzalez-Gonzalez IM, 2008, GLIA, V56, P963, DOI 10.1002/glia.20670; Granas C, 2003, J BIOL CHEM, V278, P4990, DOI 10.1074/jbc.M205058200; Guillet BA, 2005, NEUROCHEM INT, V46, P337, DOI 10.1016/j.neuint.2004.10.006; Hatanaka T, 2006, J BIOL CHEM, V281, P35922, DOI 10.1074/jbc.M606577200; Jespersen T, 2007, CARDIOVASC RES, V74, P64, DOI 10.1016/j.cardiores.2007.01.008; Kalandadze A, 2002, J BIOL CHEM, V277, P45741, DOI 10.1074/jbc.M203771200; Kanelis V, 1998, BIOCHEM CELL BIOL, V76, P341, DOI 10.1139/bcb-76-2-3-341; Konstas AA, 2002, J BIOL CHEM, V277, P29406, DOI 10.1074/jbc.M203018200; Lin CH, 2008, CELL, V135, P714, DOI 10.1016/j.cell.2008.09.025; Miranda M, 2005, J BIOL CHEM, V280, P35617, DOI 10.1074/jbc.M506618200; Miranda M, 2007, MOL BIOL CELL, V18, P313, DOI 10.1091/mbc.E06-08-0704; Nguyen AW, 2005, NAT BIOTECHNOL, V23, P355, DOI 10.1038/nbt1066; Pak Y, 2006, J CELL BIOL, V175, P631, DOI 10.1083/jcb.200603001; Palmada M, 2004, AM J PHYSIOL-GASTR L, V287, pG143, DOI 10.1152/ajpgi.00121.2003; Persaud A, 2009, MOL SYST BIOL, V5, DOI 10.1038/msb.2009.85; Robinson MB, 2006, HANDB EXP PHARM, V175, P251; Rotin D, 2009, NAT REV MOL CELL BIO, V10, P398, DOI 10.1038/nrm2690; Sattler R, 2006, HANDB EXP PHARM, V175, P277; Sheldon AL, 2008, NEUROCHEM INT, V53, P296, DOI 10.1016/j.neuint.2008.07.010; Snyder PM, 2009, SCI SIGNAL, V2, DOI 10.1126/scisignal.279pe41; Sorkina T, 2006, J NEUROSCI, V26, P8195, DOI 10.1523/JNEUROSCI.1301-06.2006; Springael JY, 1998, MOL BIOL CELL, V9, P1253, DOI 10.1091/mbc.9.6.1253; Staub O, 1996, EMBO J, V15, P2371, DOI 10.1002/j.1460-2075.1996.tb00593.x; Sullivan JA, 2007, MOL BIOL CELL, V18, P2429, DOI 10.1091/mbc.e07-01-0011; Susarla BTS, 2008, NEUROCHEM INT, V52, P709, DOI 10.1016/j.neuint.2007.08.020; Tanaka K, 1997, SCIENCE, V276, P1699, DOI 10.1126/science.276.5319.1699; Traub LM, 2007, J CELL SCI, V120, P543, DOI 10.1242/jcs.03385; Trotti D, 1998, TRENDS PHARMACOL SCI, V19, P328, DOI 10.1016/S0165-6147(98)01230-9; TROTTI D, 1995, J BIOL CHEM, V270, P9890, DOI 10.1074/jbc.270.17.9890; Tzingounis AV, 2007, NAT REV NEUROSCI, V8, P935, DOI 10.1038/nrn2274; Vina-Vilaseca A, 2011, J BIOL CHEM, V286, P8697, DOI 10.1074/jbc.M110.186858; Zeng FH, 2009, FASEB J, V23, P1935, DOI 10.1096/fj.08-121947; Zhou JZ, 2004, J NEUROSCI, V24, P6301, DOI 10.1523/JNEUROSCI.1404-04.2004	47	73	73	0	9	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	JUN 1	2012	287	23					19177	19187		10.1074/jbc.M112.355909	http://dx.doi.org/10.1074/jbc.M112.355909			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	974EF	22505712	Green Published, hybrid			2022-12-25	WOS:000306411900028
J	Lee, KN; Jang, WG; Kim, EJ; Oh, SH; Son, HJ; Kim, SH; Franceschi, R; Zhang, XK; Lee, SE; Koh, JT				Lee, Kkot-Nim; Jang, Won-Gu; Kim, Eun-Jung; Oh, Sin-Hye; Son, Hye-Ju; Kim, Sun-Hun; Franceschi, Renny; Zhang, Xiao-Kun; Lee, Shee-Eun; Koh, Jeong-Tae			Orphan Nuclear Receptor Chicken Ovalbumin Upstream Promoter-Transcription Factor II (COUP-TFII) Protein Negatively Regulates Bone Morphogenetic Protein 2-induced Osteoblast Differentiation through Suppressing Runt-related Gene 2 (Runx2) Activity	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							RETINOIC ACID RECEPTOR; OSTEOCALCIN GENE; THYROID-HORMONE; EXPRESSION; CELLS; TRANSACTIVATION; ADIPOGENESIS; INHIBITION; ACTIVATION; INDUCTION	Chicken ovalbumin upstream promoter-transcription factor II (COUP-TFII) is an orphan nuclear receptor of the steroid-thyroid hormone receptor superfamily. COUP-TFII is widely expressed in multiple tissues and organs throughout embryonic development and has been shown to regulate cellular growth, differentiation, and organ development. However, the role of COUP-TFII in osteoblast differentiation has not been systematically evaluated. In the present study, COUP-TFII was strongly expressed in multipotential mesenchymal cells, and the endogenous expression level decreased during osteoblast differentiation. Overexpression of COUP-TFII inhibited bone morphogenetic protein 2 (BMP2)-induced osteoblastic gene expression. The results of alkaline phosphatase, Alizarin Red staining, and osteocalcin production assay showed that COUP-TFII overexpression blocks BMP2-induced osteoblast differentiation. In contrast, the down-regulation of COUP-TFII synergistically induced the expression of BMP2-induced osteoblastic genes and osteoblast differentiation. Furthermore, the immunoprecipitation assay showed that COUP-TFII and Runx2 physically interacted and COUP-TFII significantly impaired the Runx2-dependent activation of the osteocalcin promoter. From the ChIP assay, we found that COUP-TFII repressed DNA binding of Runx2 to the osteocalcin gene, whereas Runx2 inhibited COUP-TFII expression via direct binding to the COUP-TFII promoter. Taken together, these findings demonstrate that COUP-TFII negatively regulates osteoblast differentiation via interaction with Runx2, and during the differentiation state, BMP2-induced Runx2 represses COUP-TFII expression and promotes osteoblast differentiation.	[Lee, Kkot-Nim; Jang, Won-Gu; Kim, Eun-Jung; Oh, Sin-Hye; Son, Hye-Ju; Kim, Sun-Hun; Lee, Shee-Eun; Koh, Jeong-Tae] Chonnam Natl Univ, Sch Dent, Dent Sci Res Inst, Med Res Ctr Biomineralizat Disorders, Kwangju 500757, South Korea; [Lee, Kkot-Nim; Jang, Won-Gu; Kim, Eun-Jung; Oh, Sin-Hye; Son, Hye-Ju; Kim, Sun-Hun; Lee, Shee-Eun; Koh, Jeong-Tae] Chonnam Natl Univ, Sch Dent, Med Res Ctr Biomineralizat Disorders, Project BK21, Kwangju 500757, South Korea; [Franceschi, Renny] Univ Michigan, Sch Dent, Dept Periodont & Oral Med, Ann Arbor, MI 48109 USA; [Zhang, Xiao-Kun] Sanford Burnham Med Res Inst, Ctr Canc, La Jolla, CA 92037 USA	Chonnam National University; Chonnam National University; University of Michigan System; University of Michigan; Sanford Burnham Prebys Medical Discovery Institute	Koh, JT (corresponding author), Chonnam Natl Univ, Sch Dent, Dent Sci Res Inst, Med Res Ctr Biomineralizat Disorders, Kwangju 500757, South Korea.	jtkoh@chonnam.ac.kr			National Research Foundation of Korea [2011-0010666, 2011-0030759]; Korea government (Ministry of Education, Science and Technology, MEST)	National Research Foundation of Korea(National Research Foundation of Korea); Korea government (Ministry of Education, Science and Technology, MEST)(Ministry of Education, Science & Technology (MEST), Republic of KoreaKorean Government)	This work was supported by the National Research Foundation of Korea Grants 2011-0010666 and 2011-0030759 funded by the Korea government (Ministry of Education, Science and Technology, MEST).	Aslam F, 1999, ENDOCRINOLOGY, V140, P63, DOI 10.1210/en.140.1.63; Bailey P, 1998, NUCLEIC ACIDS RES, V26, P5501, DOI 10.1093/nar/26.23.5501; Banerjee C, 1997, J CELL BIOCHEM, V66, P1, DOI 10.1002/(SICI)1097-4644(19970701)66:1<1::AID-JCB1>3.0.CO;2-V; COONEY AJ, 1992, MOL CELL BIOL, V12, P4153, DOI 10.1128/MCB.12.9.4153; Diez H, 2007, EXP CELL RES, V313, P1, DOI 10.1016/j.yexcr.2006.09.009; Ducy P, 1997, CELL, V89, P747, DOI 10.1016/S0092-8674(00)80257-3; Enmark E, 1996, MOL ENDOCRINOL, V10, P1293, DOI 10.1210/me.10.11.1293; Harada H, 1999, J BIOL CHEM, V274, P6972, DOI 10.1074/jbc.274.11.6972; Huang W, 2007, FRONT BIOSCI-LANDMRK, V12, P3068, DOI 10.2741/2296; Javed A, 2000, J CELL SCI, V113, P2221; Javed A, 2008, J BIOL CHEM, V283, P8412, DOI 10.1074/jbc.M705578200; Jeong BC, 2010, J BONE MINER RES, V25, P262, DOI 10.1359/jbmr.090718; Kruse SW, 2008, PLOS BIOL, V6, P2002, DOI 10.1371/journal.pbio.0060227; Lee YS, 2008, BIOCHEM J, V413, P559, DOI 10.1042/BJ20071637; Lian JB, 1999, VITAM HORM, V55, P443; Lin BZ, 2000, MOL CELL BIOL, V20, P957, DOI 10.1128/MCB.20.3.957-970.2000; Lin F, 2002, J BIOL CHEM, V277, P21414, DOI 10.1074/jbc.M201885200; Livak KJ, 2001, METHODS, V25, P402, DOI 10.1006/meth.2001.1262; MANOLAGAS SC, 1981, J BIOL CHEM, V256, P7115; Okamura M, 2009, P NATL ACAD SCI USA, V106, P5819, DOI 10.1073/pnas.0901676106; Park Joo-In, 2003, Keio Journal of Medicine, V52, P174; Pereira FA, 2000, CELL MOL LIFE SCI, V57, P1388, DOI 10.1007/PL00000624; Pereira FA, 1999, GENE DEV, V13, P1037, DOI 10.1101/gad.13.8.1037; PEREIRA FA, 1995, J STEROID BIOCHEM, V53, P503, DOI 10.1016/0960-0760(95)00097-J; QIU YH, 1994, TRENDS ENDOCRIN MET, V5, P234, DOI 10.1016/1043-2760(94)P3081-H; SAGAMI I, 1986, MOL CELL BIOL, V6, P4259, DOI 10.1128/MCB.6.12.4259; Shi YH, 2007, DRUG DISCOV TODAY, V12, P440, DOI 10.1016/j.drudis.2007.04.006; Shibata H, 1997, MOL ENDOCRINOL, V11, P714, DOI 10.1210/me.11.6.714; Sierra J, 2003, MOL CELL BIOL, V23, P3339, DOI 10.1128/MCB.23.9.3339-3351.2003; Takamoto N, 2005, DEVELOPMENT, V132, P2179, DOI 10.1242/dev.01808; Tsai SY, 1997, ENDOCR REV, V18, P229, DOI 10.1210/er.18.2.229; Warnecke M, 2005, GENE DEV, V19, P614, DOI 10.1101/gad.317905; WOZNEY JM, 1988, SCIENCE, V242, P1528, DOI 10.1126/science.3201241; Xu Z, 2008, P NATL ACAD SCI USA, V105, P2421, DOI 10.1073/pnas.0707082105; Zhang R, 1997, J BIOL CHEM, V272, P110, DOI 10.1074/jbc.272.1.110	35	23	24	0	7	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JUN 1	2012	287	23					18888	18899		10.1074/jbc.M111.311878	http://dx.doi.org/10.1074/jbc.M111.311878			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	974EF	22493443	hybrid, Green Published			2022-12-25	WOS:000306411900002
J	Nixon, BR; Thawornkaiwong, A; Jin, J; Brundage, EA; Little, SC; Davis, JP; Solaro, RJ; Biesiadecki, BJ				Nixon, Benjamin R.; Thawornkaiwong, Ariyoporn; Jin, Janel; Brundage, Elizabeth A.; Little, Sean C.; Davis, Jonathan P.; Solaro, R. John; Biesiadecki, Brandon J.			AMP-activated Protein Kinase Phosphorylates Cardiac Troponin I at Ser-150 to Increase Myofilament Calcium Sensitivity and Blunt PKA-dependent Function	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							N-TERMINAL EXTENSION; THIN-FILAMENTS; HEART; RABBIT; MUSCLE; MICE; CARDIOMYOPATHY; MYOCARDIUM; DYNAMICS; SUBUNITS	AMP-activated protein kinase (AMPK) is an energy-sensing enzyme central to the regulation of metabolic homeostasis. In the heart AMPK is activated during cardiac stress-induced ATP depletion and functions to stimulate metabolic pathways that restore the AMP/ATP balance. Recently it was demonstrated that AMPK phosphorylates cardiac troponin I (cTnI) at Ser-150 in vitro. We sought to determine if the metabolic regulatory kinase AMPK phosphorylates cTnI at Ser-150 in vivo to alter cardiac contractile function directly at the level of the myofilament. Rabbit cardiac myofibrils separated by two-dimensional isoelectric focusing subjected to a Western blot with a cTnI phosphorylation-specific antibody demonstrates that cTnI is endogenously phosphorylated at Ser-150 in the heart. Treatment of myofibrils with the AMPK holoenzyme increased cTnI Ser-150 phosphorylation within the constraints of the muscle lattice. Compared with controls, cardiac fiber bundles exchanged with troponin containing cTnI pseudo-phosphorylated at Ser-150 demonstrate increased sensitivity of calcium-dependent force development, blunting of both PKA-dependent calcium desensitization, and PKA-dependent increases in length dependent activation. Thus, in addition to the defined role of AMPK as a cardiac metabolic energy gauge, these data demonstrate AMPK Ser-150 phosphorylation of cTnI directly links the regulation of cardiac metabolic demand to myofilament contractile energetics. Furthermore, the blunting effect of cTnI Ser-150 phosphorylation cross-talk can uncouple the effects of myofilament PKA-dependent phosphorylation from beta-adrenergic signaling as a novel thin filament contractile regulatory signaling mechanism.	[Nixon, Benjamin R.; Brundage, Elizabeth A.; Little, Sean C.; Davis, Jonathan P.; Biesiadecki, Brandon J.] Ohio State Univ, Dept Physiol & Cell Biol, Columbus, OH 43210 USA; [Nixon, Benjamin R.; Brundage, Elizabeth A.; Little, Sean C.; Davis, Jonathan P.; Biesiadecki, Brandon J.] Ohio State Univ, Davis Heart & Lung Res Inst, Columbus, OH 43210 USA; [Thawornkaiwong, Ariyoporn; Jin, Janel; Solaro, R. John] Univ Illinois, Cardiovasc Res Ctr, Chicago, IL 60614 USA; [Thawornkaiwong, Ariyoporn; Jin, Janel; Solaro, R. John] Univ Illinois, Dept Physiol & Biophys, Chicago, IL 60614 USA	University System of Ohio; Ohio State University; University System of Ohio; Ohio State University; University of Illinois System; University of Illinois Chicago; University of Illinois Chicago Hospital; University of Illinois System; University of Illinois Chicago; University of Illinois Chicago Hospital	Biesiadecki, BJ (corresponding author), Ohio State Univ, Dept Physiol & Cell Biol, 1645 Neil Ave,304 Hamilton Hall, Columbus, OH 43210 USA.	biesiadecki.1@osu.edu	Brundage, Elizabeth/AAY-9819-2020	Nixon, Benjamin/0000-0003-1840-0179	NICHD, National Institutes of Health; National Institutes of Health [T32 007692, HL 091986, HL 062426, HL 091056]; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R56HL091986, R01HL091986, R01HL022231, P01HL062426, K99HL091056, R00HL091056] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [T32NS077984] Funding Source: NIH RePORTER	NICHD, National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))	The CT3 monoclonal antibody developed by J. J.-C. Lin was obtained from the Developmental Studies Hybridoma Bank developed under the auspices of the NICHD, National Institutes of Health, and maintained by the University of Iowa Dept. of Biology, IA City, IA 52242.; This work was supported, in whole or in part, by National Institutes of Health Grant T32 007692.; Supported by National Institutes of Health Grant HL 091986.; Supported by National Institutes of Health Grant HL 062426.; Supported by National Institutes of Health Grant HL 091056. To whom correspondence should be addressed: Dept. of Physiology and Cell Biology, The Ohio State University, 1645 Neil Ave., 304 Hamilton Hall, Columbus, OH. Tel.: 614-247-4091; Fax: 614-292-4888; E-mail: biesiadecki.1@osu.edu.	Abbott MB, 2001, BIOCHEMISTRY-US, V40, P5992, DOI 10.1021/bi0100642; Arad M, 2007, CIRC RES, V100, P474, DOI 10.1161/01.RES.0000258446.23525.37; Arteaga GM, 2000, J PHYSIOL-LONDON, V526, P541, DOI 10.1111/j.1469-7793.2000.t01-1-00541.x; Ayaz-Guner S, 2009, BIOCHEMISTRY-US, V48, P8161, DOI 10.1021/bi900739f; Behunin S. M., 2012, BIOPHYS J; Biesiadecki BJ, 2007, CIRC RES, V100, P1486, DOI 10.1161/01.RES.0000267744.92677.7f; Biesiadecki BJ, 2010, J BIOL CHEM, V285, P19688, DOI 10.1074/jbc.M109.086892; Birnbaum MJ, 2005, MOL CELL, V19, P289, DOI 10.1016/j.molcel.2005.07.012; Buscemi N, 2002, CIRC RES, V91, P509, DOI 10.1161/01.RES.0000035246.27856.53; Davis JP, 2008, CARDIOVASC RES, V77, P619, DOI 10.1093/cvr/cvm098; Davis JP, 2007, BIOPHYS J, V92, P3195, DOI 10.1529/biophysj.106.095406; Djouder N, 2010, EMBO J, V29, P469, DOI 10.1038/emboj.2009.339; Dyck JRB, 2006, J PHYSIOL-LONDON, V574, P95, DOI 10.1113/jphysiol.2006.109389; Hardie DG, 1997, EUR J BIOCHEM, V246, P259, DOI 10.1111/j.1432-1033.1997.00259.x; Heller WT, 2003, BIOCHEMISTRY-US, V42, P7790, DOI 10.1021/bi0341509; Howarth JW, 2007, J MOL BIOL, V373, P706, DOI 10.1016/j.jmb.2007.08.035; Hurley RL, 2006, J BIOL CHEM, V281, P36662, DOI 10.1074/jbc.M606676200; Ke YB, 2004, CIRC RES, V94, P194, DOI 10.1161/01.RES.0000111522.02730.56; Kirk JA, 2009, CIRC RES, V105, P1232, DOI 10.1161/CIRCRESAHA.109.205427; Kobayashi T, 2005, ANNU REV PHYSIOL, V67, P39, DOI 10.1146/annurev.physiol.67.040403.114025; Konhilas JP, 2003, J PHYSIOL-LONDON, V547, P951, DOI 10.1113/jphysiol.2002.038117; Li MX, 2003, BIOCHEMISTRY-US, V42, P14460, DOI 10.1021/bi035408y; Li MX, 1999, BIOCHEMISTRY-US, V38, P8289, DOI 10.1021/bi9901679; Lu QW, 2010, J BIOL CHEM, V285, P11810, DOI 10.1074/jbc.M109.055657; Malik FI, 2011, SCIENCE, V331, P1439, DOI 10.1126/science.1200113; MOIR AJG, 1977, BIOCHEM J, V167, P333, DOI 10.1042/bj1670333; Murphy AM, 2000, SCIENCE, V287, P488, DOI 10.1126/science.287.5452.488; Oliveira S. M., 2007, J MUSCLE RES CELL M, V28, P445; Ouyang YX, 2010, J MOL BIOL, V400, P1036, DOI 10.1016/j.jmb.2010.06.007; Perry SV, 1999, MOL CELL BIOCHEM, V190, P9, DOI 10.1023/A:1006939307715; Ramirez-Correa GA, 2008, CIRC RES, V103, P1354, DOI 10.1161/CIRCRESAHA.108.184978; SOLARO RJ, 1976, NATURE, V262, P615, DOI 10.1038/262615a0; Solis RS, 2011, PROTEIN SCI, V20, P894, DOI 10.1002/pro.623; Sumandea MP, 2003, J BIOL CHEM, V278, P35135, DOI 10.1074/jbc.M306325200; SYSKA H, 1976, BIOCHEM J, V153, P375, DOI 10.1042/bj1530375; Taglieri DM, 2011, J MOL CELL CARDIOL, V51, P988, DOI 10.1016/j.yjmcc.2011.09.016; Tardiff JC, 1998, J CLIN INVEST, V101, P2800, DOI 10.1172/JCI2389; Warren CM, 2009, J BIOL CHEM, V284, P14258, DOI 10.1074/jbc.M807621200; Wolska BM, 1999, CIRC RES, V84, P745; Young LH, 2005, TRENDS CARDIOVAS MED, V15, P110, DOI 10.1016/j.tcm.2005.04.005; Zakhary DR, 1999, CIRCULATION, V99, P505, DOI 10.1161/01.CIR.99.4.505; Zhang JA, 2010, J AM SOC MASS SPECTR, V21, P940, DOI 10.1016/j.jasms.2010.02.005	42	55	56	0	2	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JUN 1	2012	287	23					19136	19147		10.1074/jbc.M111.323048	http://dx.doi.org/10.1074/jbc.M111.323048			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	974EF	22493448	hybrid, Green Published			2022-12-25	WOS:000306411900024
J	Gesto, M; Castro, LFC; Reis-Henriques, MA; Santos, MM				Gesto, Manuel; Castro, L. Filipe C.; Reis-Henriques, Maria Armanda; Santos, Miguel Machado			Retinol Metabolism in the Mollusk Osilinus lineatus Indicates an Ancient Origin for Retinyl Ester Storage Capacity	PLOS ONE			English	Article							ENDOGENOUS RETINOIDS; HALOCYNTHIA-RORETZI; SIGNALING PATHWAYS; MASS-SPECTROMETRY; ACID; TISSUES; ADULT	Although retinoids have been reported to be present and active in vertebrates and invertebrates, the presence of mechanisms for retinoid storage in the form of retinyl esters, a key feature to maintain whole-organism retinoid homeostasis, have been considered to date a vertebrate innovation. Here we demonstrate for the first time the presence of retinol and retinyl esters in an invertebrate lophotrochozoan species, the gastropod mollusk Osilinus lineatus. Furthermore, through a pharmacological approach consisting of intramuscular injections of different retinoid precursors, we also demonstrate that the retinol esterification pathway is active in vivo in this species. Interestingly, retinol and retinyl esters were only detected in males, suggesting a gender-specific role for these compounds in the testis. Females, although lacking detectable levels of retinol or retinyl esters, also have the biochemical capacity to esterify retinol, but at a lower rate than males. The occurrence of retinyl ester storage capacity, together with the presence in males and females of active retinoids, i.e., retinoic acid isomers, indicates that O. lineatus has a well developed retinoid system. Hence, the present data strongly suggest that the capacity to maintain retinoid homeostasis has arisen earlier in Bilateria evolution than previously thought.	[Gesto, Manuel; Castro, L. Filipe C.; Reis-Henriques, Maria Armanda; Santos, Miguel Machado] Univ Porto, Interdisciplinary Ctr Marine & Environm Res, CIMAR CIIMAR, P-4100 Oporto, Portugal; [Santos, Miguel Machado] Univ Porto, Fac Sci, Dept Biol, P-4100 Oporto, Portugal	Universidade do Porto; Universidade do Porto	Gesto, M (corresponding author), Univ Vigo, Fac Biol, Dept Biol Func & Ciencias Saude, Vigo 36310, Spain.	manuelgesto@uvigo.es; filipe.castro@ciimar.up.pt; santos@ciimar.up.pt	Castro, Filipe/AAA-2197-2022; Gesto, Manuel/G-1032-2018; Santos, Miguel M./AAD-9267-2021	Castro, Filipe/0000-0001-7697-386X; Gesto, Manuel/0000-0002-9136-7857; Santos, Miguel/0000-0001-7347-0546; Reis Henriques, Maria Armanda/0000-0001-7602-9641	Fundacao para a Ciencia e a Tecnologia (Portugal) [PTDC/MAR/68106/2006, SFRH/BPD/47572/2008]; Xunta de Galicia (Spain) [IN809A 2010/360]	Fundacao para a Ciencia e a Tecnologia (Portugal)(Portuguese Foundation for Science and Technology); Xunta de Galicia (Spain)(Xunta de Galicia)	This work was supported by the project PTDC/MAR/68106/2006 from Fundacao para a Ciencia e a Tecnologia (Portugal, www.fct.pt). MG was the recipient of post-doctoral fellowships from Fundacao para a Ciencia e a Tecnologia (Portugal, SFRH/BPD/47572/2008) and Xunta de Galicia (Spain, Angeles Alvarino program, www.xunta.es), and a research grant (IN809A 2010/360, partly funded by European Social Fund) from Xunta de Galicia (Spain). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Albalat R, 2011, GENOME BIOL EVOL, V3, P985, DOI 10.1093/gbe/evr084; Albalat R, 2009, MOL CELL ENDOCRINOL, V313, P23, DOI 10.1016/j.mce.2009.08.029; Albalat R, 2009, CHEM-BIOL INTERACT, V178, P188, DOI 10.1016/j.cbi.2008.09.017; Alsop D, 2007, AQUAT TOXICOL, V82, P281, DOI 10.1016/j.aquatox.2007.03.001; BIESALSKI HK, 1992, ONCOGENE, V7, P1765; Blomhoff R, 2006, J NEUROBIOL, V66, P606, DOI 10.1002/neu.20242; Campo-Paysaa F, 2008, GENESIS, V46, P640, DOI 10.1002/dvg.20444; Castro LFC, 2007, AQUAT TOXICOL, V85, P57, DOI 10.1016/j.aquatox.2007.07.016; CRETON R, 1993, DEV GROWTH DIFFER, V35, P357; Crothers J. H., 2001, Field Studies, V10, P115; Dalfo D, 2002, DEV GENES EVOL, V212, P388, DOI 10.1007/s00427-002-0254-z; Desai B. N., 1966, Proceedings of the Malacological Society of London, V37, P1; Dmetrichuk JM, 2008, J NEUROSCI, V28, P13014, DOI 10.1523/JNEUROSCI.3192-08.2008; Gesto M, 2012, COMP BIOCHEM PHYS B, V161, P69, DOI 10.1016/j.cbpb.2011.09.006; Gundersen TE, 2007, RAPID COMMUN MASS SP, V21, P1176, DOI 10.1002/rcm.2946; Hopkins PM, 2008, COMP BIOCHEM PHYS A, V151, P602, DOI 10.1016/j.cbpa.2008.07.021; Irie T, 2004, COMP BIOCHEM PHYS B, V139, P597, DOI 10.1016/j.cbpc.2004.07.014; Irie T, 2003, COMP BIOCHEM PHYS B, V134, P221, DOI 10.1016/S1096-4959(02)00251-8; Irie T, 2010, COMP BIOCHEM PHYS B, V157, P113, DOI 10.1016/j.cbpb.2010.05.009; Kane MA, 2008, ANAL BIOCHEM, V378, P71, DOI 10.1016/j.ab.2008.03.038; KAWAMURA K, 1993, DEVELOPMENT, V117, P835; KURLANDSKY SB, 1995, J BIOL CHEM, V270, P17850, DOI 10.1074/jbc.270.30.17850; LEID M, 1992, TRENDS BIOCHEM SCI, V17, P427, DOI 10.1016/0968-0004(92)90014-Z; Malik MA, 2000, J NUTR BIOCHEM, V11, P2, DOI 10.1016/S0955-2863(99)00066-2; Marletaz F, 2006, INT J BIOL SCI, V2, P38; Nowickyj SM, 2008, P NATL ACAD SCI USA, V105, P9540, DOI 10.1073/pnas.0712132105; Ogino Y, 2001, ANN NY ACAD SCI, V948, P13; Romero R, 2001, INT J DEV BIOL, V45, P669; Simoes-Costa MS, 2008, J EXP ZOOL PART B, V310B, P54, DOI 10.1002/jez.b.21139; Suh MJ, 2006, ANAL CHEM, V78, P5719, DOI 10.1021/ac060492j; Theodosiou M, 2010, CELL MOL LIFE SCI, V67, P1423, DOI 10.1007/s00018-010-0268-z; Vernet N, 2006, ENDOCRINOLOGY, V147, P96, DOI 10.1210/en.2005-0953; Wingerath T, 1995, ARCH BIOCHEM BIOPHYS, V324, P385, DOI 10.1006/abbi.1995.0052; Wong CK, 2003, CHEMOSPHERE, V52, P1633, DOI 10.1016/S0045-6535(03)00503-4; Zega G, 2009, AQUAT TOXICOL, V91, P255, DOI 10.1016/j.aquatox.2008.11.015	35	19	19	0	14	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 6	2012	7	4							e35138	10.1371/journal.pone.0035138	http://dx.doi.org/10.1371/journal.pone.0035138			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	955JA	22493737	Green Published, Green Submitted, gold			2022-12-25	WOS:000305012700079
J	Liu, G; Lei, B; Li, Y; Tong, KY; Ding, Y; Luo, LF; Xia, XY; Jiang, SW; Deng, CY; Xiong, YZ; Li, FG				Liu, Gang; Lei, Bin; Li, Yan; Tong, Keya; Ding, Yi; Luo, Lifan; Xia, Xuanyan; Jiang, Siwen; Deng, Changyan; Xiong, Yuanzhu; Li, Fenge			Discovery of Potential piRNAs from Next Generation Sequences of the Sexually Mature Porcine Testes	PLOS ONE			English	Article							SMALL RNAS; SPERMATOGENIC CELLS; GENE-EXPRESSION; NUAGE FORMATION; NONCODING RNAS; PIWI; MICRORNAS; GERMLINE; GENOME; IDENTIFICATION	Piwi-interacting RNAs (piRNAs), a new class of small RNAs discovered from mammalian testes, are involved in transcriptional silencing of retrotransposons and other genetic elements in germ line cells. In order to identify a full transcriptome set of piRNAs expressed in the sexually mature porcine testes, small RNA fractions were extracted and were subjected to a Solexa deep sequencing. We cloned 6,913,561 clean reads of Sus Scrofa small RNAs (18-30 nt) and performed functional characterization. Sus Scrofa small RNAs showed a bimodal length distribution with two peaks at 21 nt and 29 nt. Then from 938,328 deep-sequenced small RNAs (26-30 nt), 375,195 piRNAs were identified by a k-mer scheme and 326 piRNAs were identified by homology searches. All piRNAs predicted by the k-mer scheme were then mapped to swine genome by Short Oligonucleotide Analysis Package (SOAP), and 81.61% of all uniquely mapping piRNAs (197,673) were located to 1124 defined genomic regions (5.85 Mb). Within these regions, 536 and 501 piRNA clusters generally distributed across only minus or plus genomic strand, 48 piRNA clusters distributed on two strands but in a divergent manner, and 39 piRNA clusters distributed on two strands in an overlapping manner. Furthermore, expression pattern of 7 piRNAs identified by homology searches showed 5 piRNAs displayed a ubiquitous expression pattern, although 2 piRNAs were specifically expressed in the testes. Overall, our results provide new information of porcine piRNAs and their specific expression pattern in porcine testes suggests that piRNAs have a role in regulating spermatogenesis.	[Liu, Gang; Lei, Bin; Li, Yan; Tong, Keya; Ding, Yi; Luo, Lifan; Jiang, Siwen; Deng, Changyan; Xiong, Yuanzhu; Li, Fenge] Huazhong Agr Univ, Minist Agr, Key Lab Pig Genet & Breeding, Wuhan, Peoples R China; [Liu, Gang; Lei, Bin; Li, Yan; Tong, Keya; Ding, Yi; Luo, Lifan; Jiang, Siwen; Deng, Changyan; Xiong, Yuanzhu; Li, Fenge] Huazhong Agr Univ, Minist Educ, Key Lab Agr Anim Genet Breeding & Reprod, Wuhan, Peoples R China; [Xia, Xuanyan] Huazhong Agr Univ, Coll Sci, Wuhan, Peoples R China	Huazhong Agricultural University; Ministry of Agriculture & Rural Affairs; Huazhong Agricultural University; Huazhong Agricultural University	Liu, G (corresponding author), Huazhong Agr Univ, Minist Agr, Key Lab Pig Genet & Breeding, Wuhan, Peoples R China.	lifener@mail.hzau.edu.cn	Ding, Yi/U-3314-2019	Li, Yan/0000-0003-4537-7672	National Natural Science Foundation of China [31072011]; Trans-gene Key Project of China [2009ZX08009-148B]; Natural Science Foundation of Hubei Province of China [2009CDA127]; Fundamental Research Funds for the Central Universities [2011PY074]; Chinese education ministry [IRT-0831]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Trans-gene Key Project of China; Natural Science Foundation of Hubei Province of China(Natural Science Foundation of Hubei Province); Fundamental Research Funds for the Central Universities(Fundamental Research Funds for the Central Universities); Chinese education ministry(Ministry of Education, China)	This work was supported financially by the National Natural Science Foundation of China (31072011), Trans-gene Key Project of China (2009ZX08009-148B), Natural Science Foundation of Hubei Province of China (2009CDA127), the Fundamental Research Funds for the Central Universities (2011PY074) and the creative team project of Chinese education ministry (IRT-0831). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aravin A, 2006, NATURE, V442, P203, DOI 10.1038/nature04916; Aravin AA, 2007, SCIENCE, V316, P744, DOI 10.1126/science.1142612; Aravin AA, 2011, DEV CELL, V20, P287, DOI 10.1016/j.devcel.2011.03.003; Aravin AA, 2009, PLOS GENET, V5, DOI 10.1371/journal.pgen.1000764; Brennecke J, 2007, CELL, V128, P1089, DOI 10.1016/j.cell.2007.01.043; Chen CF, 2005, NUCLEIC ACIDS RES, V33, DOI 10.1093/nar/gni178; Chen X, 2009, GENOME BIOL, V10, DOI 10.1186/gb-2009-10-7-r78; Cheng J, 2012, CANCER LETT, V315, P12, DOI 10.1016/j.canlet.2011.10.004; de Kretser DM, 1998, HUM REPROD, V13, P1; Drabent B, 1997, BIOL REPROD, V57, P1375, DOI 10.1095/biolreprod57.6.1375; Esposito T, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0022727; Ghildiyal M, 2009, NAT REV GENET, V10, P94, DOI 10.1038/nrg2504; Girard A, 2006, NATURE, V442, P199, DOI 10.1038/nature04917; Grivna ST, 2006, P NATL ACAD SCI USA, V103, P13415, DOI 10.1073/pnas.0605506103; Grivna ST, 2006, GENE DEV, V20, P1709, DOI 10.1101/gad.1434406; Happel N, 2008, EXP GERONTOL, V43, P184, DOI 10.1016/j.exger.2007.11.008; HARAYAMA H, 1991, THERIOGENOLOGY, V36, P637, DOI 10.1016/0093-691X(91)90401-X; He ZP, 2009, REPRODUCTION, V137, P901, DOI 10.1530/REP-08-0494; Hochereau-de Reviers MT, 1999, REPROD DOMEST ANIM, V34, P213, DOI 10.1111/j.1439-0531.1999.tb01243.x; Houwing S, 2007, CELL, V129, P69, DOI 10.1016/j.cell.2007.03.026; Huang DW, 2009, NAT PROTOC, V4, P44, DOI 10.1038/nprot.2008.211; Huang HY, 2011, DEV CELL, V20, P376, DOI 10.1016/j.devcel.2011.01.004; Iguchi N, 2007, ANN NY ACAD SCI, V1120, P84, DOI 10.1196/annals.1411.002; Kawaoka S, 2011, RNA, V17, P1401, DOI 10.1261/rna.2709411; Klattenhoff C, 2009, CELL, V138, P1137, DOI 10.1016/j.cell.2009.07.014; Kleene KC, 2001, MECH DEVELOP, V106, P3, DOI 10.1016/S0925-4773(01)00413-0; Lakshmi SS, 2008, NUCLEIC ACIDS RES, V36, pD173, DOI 10.1093/nar/gkm696; Lau NC, 2006, SCIENCE, V313, P363, DOI 10.1126/science.1130164; Lee EJ, 2011, RNA, V17, P1090, DOI 10.1261/rna.2565011; LENNOX RW, 1984, DEV BIOL, V103, P80, DOI 10.1016/0012-1606(84)90009-5; Luo LF, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0011744; Ma L, 2009, PLOS GENET, V5, DOI 10.1371/journal.pgen.1000635; Pang KC, 2007, NUCLEIC ACIDS RES, V35, pD178, DOI 10.1093/nar/gkl926; Papaioannou MD, 2010, J ANDROL, V31, P26, DOI 10.2164/jandrol.109.008128; Ro S, 2007, RNA, V13, P1693, DOI 10.1261/rna.640307; Rouget C, 2010, NATURE, V467, P1128, DOI 10.1038/nature09465; Saito K, 2006, GENE DEV, V20, P2214, DOI 10.1101/gad.1454806; Siomi MC, 2011, NAT REV MOL CELL BIO, V12, P246, DOI 10.1038/nrm3089; Sun XJ, 2011, BMC GENOMICS, V12, DOI 10.1186/1471-2164-12-111; Watanabe T, 2011, DEV CELL, V20, P364, DOI 10.1016/j.devcel.2011.01.005; Wei LQ, 2011, GENOME BIOL, V12, DOI 10.1186/gb-2011-12-6-r53; Xie SS, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0016235; Zamore PD, 2010, EMBO J, V29, P3219, DOI 10.1038/emboj.2010.232; Zhang Y, 2011, BIOINFORMATICS, V27, P771, DOI 10.1093/bioinformatics/btr016; Zhou XA, 2010, GENETICS, V186, P1175, DOI 10.1534/genetics.110.122234	45	16	17	0	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 6	2012	7	4							e34770	10.1371/journal.pone.0034770	http://dx.doi.org/10.1371/journal.pone.0034770			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	955JA	22493715	Green Published, gold, Green Submitted			2022-12-25	WOS:000305012700057
J	Li, J; Guo, YF; Pei, YF; Deng, HW				Li, Jian; Guo, Yan-fang; Pei, Yufang; Deng, Hong-Wen			The Impact of Imputation on Meta-Analysis of Genome-Wide Association Studies	PLOS ONE			English	Article							DIABETES RISK LOCI; SUSCEPTIBILITY LOCI; GENOTYPES; DATASETS; DISEASE; TRAITS	Genotype imputation is often used in the meta-analysis of genome-wide association studies (GWAS), for combining data from different studies and/or genotyping platforms, in order to improve the ability for detecting disease variants with small to moderate effects. However, how genotype imputation affects the performance of the meta-analysis of GWAS is largely unknown. In this study, we investigated the effects of genotype imputation on the performance of meta-analysis through simulations based on empirical data from the Framingham Heart Study. We found that when fix-effects models were used, considerable between-study heterogeneity was detected when causal variants were typed in only some but not all individual studies, resulting in up to similar to 25% reduction of detection power. For certain situations, the power of the meta-analysis can be even less than that of individual studies. Additional analyses showed that the detection power was slightly improved when between-study heterogeneity was partially controlled through the random-effects model, relative to that of the fixed-effects model. Our study may aid in the planning, data analysis, and interpretation of GWAS meta-analysis results when genotype imputation is necessary.	[Li, Jian; Pei, Yufang; Deng, Hong-Wen] Tulane Univ, Sch Publ Hlth & Trop Med, New Orleans, LA 70118 USA; [Guo, Yan-fang] So Med Univ, Sch Biomed Engn, Guangzhou, Guangdong, Peoples R China; [Pei, Yufang; Deng, Hong-Wen] Shanghai Univ Sci & Technol, Ctr Syst Biomed Sci, Shanghai 201800, Peoples R China; [Deng, Hong-Wen] Hunan Normal Univ, Coll Life Sci, Minist Educ, Lab Mol & Stat Genet, Changsha, Hunan, Peoples R China; [Deng, Hong-Wen] Hunan Normal Univ, Coll Life Sci, Minist Educ, Key Lab Prot Chem & Dev Biol, Changsha, Hunan, Peoples R China	Tulane University; Southern Medical University - China; University of Shanghai for Science & Technology; Hunan Normal University; Hunan Normal University	Li, J (corresponding author), Tulane Univ, Sch Publ Hlth & Trop Med, New Orleans, LA 70118 USA.	hdeng2@tulane.edu	Li, Jian/G-4445-2015	Deng, Hong-Wen/0000-0002-0387-8818	National Institutes of Health [P50AR055081, R01AG026564, R01AR050496, RC2DE020756, R01AR057049, R03TW008221]; Tulane University; Shanghai Leading Academic Discipline Project [S30501]; University of Shanghai for Science and Technology; National Heart, Lung, and Blood Institute (NHLBI); Boston University [N01-HC-25195]; DIVISION OF EPIDEMIOLOGY AND CLINICAL APPLICATIONS [N01HC025195] Funding Source: NIH RePORTER; FOGARTY INTERNATIONAL CENTER [R03TW008221] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES [P50AR055081, R01AR057049, R01AR050496] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DENTAL &CRANIOFACIAL RESEARCH [RC2DE020756] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON AGING [R01AG026564] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Tulane University; Shanghai Leading Academic Discipline Project(Shanghai Leading Academic Discipline Project); University of Shanghai for Science and Technology; National Heart, Lung, and Blood Institute (NHLBI)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); Boston University; DIVISION OF EPIDEMIOLOGY AND CLINICAL APPLICATIONS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI)); FOGARTY INTERNATIONAL CENTER(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Fogarty International Center (FIC)); NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS)); NATIONAL INSTITUTE OF DENTAL &CRANIOFACIAL RESEARCH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Dental & Craniofacial Research (NIDCR)); NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA))	The investigators of this work were partially supported by grants from the National Institutes of Health (http://www.nih.gov) (P50AR055081, R01AG026564, R01AR050496, RC2DE020756, R01AR057049, and R03TW008221). The study was also partially supported by a startup fund from Tulane University and by the Shanghai Leading Academic Discipline Project (S30501) and a startup fund from the University of Shanghai for Science and Technology. The Framingham Heart Study is conducted and supported by the National Heart, Lung, and Blood Institute (NHLBI) in collaboration with Boston University. This manuscript was not prepared in collaboration with investigators of the Framingham Heart Study and does not necessarily reflect the opinions or views of the Framingham Heart Study, Boston University, or the NHLBI. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; We thank the reviewers' valuable comments to make the manuscript better. The Framingham Heart Study is conducted and supported by the National Heart, Lung, and Blood Institute (NHLBI) in collaboration with Boston University (Contract No. N01-HC-25195). This manuscript was not prepared in collaboration with investigators of the Framingham Heart Study and does not necessarily reflect the opinions or views of the Framingham Heart Study, Boston University, or NHLBI.	Anderson CA, 2008, AM J HUM GENET, V83, P112, DOI 10.1016/j.ajhg.2008.06.008; COCHRAN WG, 1954, BIOMETRICS, V10, P101, DOI 10.2307/3001666; Cooper JD, 2008, NAT GENET, V40, P1399, DOI 10.1038/ng.249; de Bakker PIW, 2008, HUM MOL GENET, V17, pR122, DOI 10.1093/hmg/ddn288; Evangelou E, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0000196; Ferreira MAR, 2008, NAT GENET, V40, P1056, DOI 10.1038/ng.209; Houlston RS, 2008, NAT GENET, V40, P1426, DOI 10.1038/ng.262; Iles MM, 2008, PLOS GENET, V4, DOI 10.1371/journal.pgen.0040033; Li MX, 2009, BIOINFORMATICS, V25, P1449, DOI 10.1093/bioinformatics/btp183; Marchini J, 2007, NAT GENET, V39, P906, DOI 10.1038/ng2088; McCarthy MI, 2008, NAT REV GENET, V9, P356, DOI 10.1038/nrg2344; McCarthy MI, 2008, HUM MOL GENET, V17, pR156, DOI 10.1093/hmg/ddn289; Pei YF, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0010827; Raychaudhuri S, 2008, NAT GENET, V40, P1216, DOI 10.1038/ng.233; Sanghera DK, 2009, J HUM GENET, V54, P162, DOI 10.1038/jhg.2009.7; Staiger H, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0003019; Su Z, 2011, BIOINFORMATICS, V27, P2304, DOI 10.1093/bioinformatics/btr341; Xavier RJ, 2008, NAT REV IMMUNOL, V8, P631, DOI 10.1038/nri2361; Xiong DH, 2009, AM J HUM GENET, V84, P388, DOI 10.1016/j.ajhg.2009.01.025; Zeggini E, 2009, PHARMACOGENOMICS, V10, P191, DOI 10.2217/14622416.10.2.191; Zeggini E, 2008, NAT GENET, V40, P638, DOI 10.1038/ng.120; Zhao ZM, 2008, BMC GENET, V9, DOI 10.1186/1471-2156-9-85	23	11	11	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 5	2012	7	4							e34486	10.1371/journal.pone.0034486	http://dx.doi.org/10.1371/journal.pone.0034486			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	955IH	22496814	Green Published, Green Submitted, gold			2022-12-25	WOS:000305010500011
J	Bae, J; Sung, BH; Cho, IH; Kim, SM; Song, WK				Bae, Jeomil; Sung, Bong Hwan; Cho, In Ha; Kim, Seon-Myung; Song, Woo Keun			NESH Regulates Dendritic Spine Morphology and Synapse Formation	PLOS ONE			English	Article							N-WASP; ACTIN POLYMERIZATION; POSTSYNAPTIC DENSITY; ALZHEIMERS-DISEASE; MENTAL-RETARDATION; BINDING PARTNER; ARP2/3 COMPLEX; MORPHOGENESIS; PROTEIN; PLASTICITY	Background: Dendritic spines are small membranous protrusions on the neuronal dendrites that receive synaptic input from axon terminals. Despite their importance for integrating the enormous information flow in the brain, the molecular mechanisms regulating spine morphogenesis are not well understood. NESH/Abi-3 is a member of the Abl interactor (Abi) protein family, and its overexpression is known to reduce cell motility and tumor metastasis. NESH is prominently expressed in the brain, but its function there remains unknown. Methodology/Principal Findings: NESH was strongly expressed in the hippocampus and moderately expressed in the cerebral cortex, cerebellum and striatum, where it co-localized with the postsynaptic proteins PSD95, SPIN90 and F-actin in dendritic spines. Overexpression of NESH reduced numbers of mushroom-type spines and synapse density but increased thin, filopodia-like spines and had no effect on spine density. siRNA knockdown of NESH also reduced mushroom spine numbers and inhibited synapse formation but it increased spine density. The N-terminal region of NESH co-sedimented with filamentous actin (F-actin), which is an essential component of dendritic spines, suggesting this interaction is important for the maturation of dendritic spines. Conclusions/Significance: NESH is a novel F-actin binding protein that likely plays important roles in the regulation of dendritic spine morphogenesis and synapse formation.	[Bae, Jeomil; Cho, In Ha; Song, Woo Keun] Gwangju Inst Sci & Technol, Sch Life Sci, Cell Dynam & Bioimaging Res Ctr, Kwangju, South Korea; [Sung, Bong Hwan] Vanderbilt Univ, Med Ctr, Dept Canc Biol, Nashville, TN USA; [Kim, Seon-Myung] Emory Univ, Sch Med, Dept Cell Biol & Neurol, Ctr Neurodegenerat Dis, Atlanta, GA USA	Gwangju Institute of Science & Technology (GIST); Vanderbilt University; Emory University	Bae, J (corresponding author), Gwangju Inst Sci & Technol, Sch Life Sci, Cell Dynam & Bioimaging Res Ctr, Kwangju, South Korea.	wksong@gist.ac.kr		Bae, Jeomil/0000-0001-9374-6802	Cell Dynamics and Bioimaging Research Center [20110001155]; Conversing Research Center [2011K000690]; Mid-Career Research Program [20110000095]; National Research Foundation of Korea	Cell Dynamics and Bioimaging Research Center; Conversing Research Center; Mid-Career Research Program; National Research Foundation of Korea(National Research Foundation of Korea)	This research was supported by grants from the Cell Dynamics and Bioimaging Research Center (20110001155), Conversing Research Center Program (2011K000690), Mid-Career Research Program (20110000095), and funding from the National Research Foundation of Korea. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Allen KM, 1998, NAT GENET, V20, P25, DOI 10.1038/1675; Boda B, 2008, HIPPOCAMPUS, V18, P857, DOI 10.1002/hipo.20451; Bourne JN, 2008, ANNU REV NEUROSCI, V31, P47, DOI 10.1146/annurev.neuro.31.060407.125646; Cheng DM, 2006, MOL CELL PROTEOMICS, V5, P1158, DOI 10.1074/mcp.D500009-MCP200; Cingolani LA, 2008, NAT REV NEUROSCI, V9, P344, DOI 10.1038/nrn2373; Craig AM, 2006, TRENDS NEUROSCI, V29, P8, DOI 10.1016/j.tins.2005.11.002; DAI ZH, 1995, GENE DEV, V9, P2569, DOI 10.1101/gad.9.21.2569; Durand CM, 2007, NAT GENET, V39, P25, DOI 10.1038/ng1933; Ethell IM, 2005, PROG NEUROBIOL, V75, P161, DOI 10.1016/j.pneurobio.2005.02.003; Fischer M, 2000, NAT NEUROSCI, V3, P887, DOI 10.1038/78791; Glantz LA, 2000, ARCH GEN PSYCHIAT, V57, P65, DOI 10.1001/archpsyc.57.1.65; Grove M, 2004, MOL CELL BIOL, V24, P10905, DOI 10.1128/MCB.24.24.10905-10922.2004; Haeckel A, 2008, J NEUROSCI, V28, P10031, DOI 10.1523/JNEUROSCI.0336-08.2008; Halpain S, 2000, TRENDS NEUROSCI, V23, P141, DOI 10.1016/S0166-2236(00)01576-9; Hering H, 2003, J NEUROSCI, V23, P11759; Hirao N, 2006, FEBS LETT, V580, P6464, DOI 10.1016/j.febslet.2006.10.065; Holtmaat A, 2009, NAT REV NEUROSCI, V10, P647, DOI 10.1038/nrn2699; Hotulainen P, 2009, J CELL BIOL, V185, P323, DOI 10.1083/jcb.200809046; Hutsler JJ, 2010, BRAIN RES, V1309, P83, DOI 10.1016/j.brainres.2009.09.120; HUTTNER WB, 1983, J CELL BIOL, V96, P1374, DOI 10.1083/jcb.96.5.1374; Ichigotani Y, 2002, CANCER RES, V62, P2215; Ichigotani Y, 2002, INT J MOL MED, V9, P591; Innocenti M, 2005, NAT CELL BIOL, V7, P969, DOI 10.1038/ncb1304; Ivanov A, 2009, J CELL SCI, V122, P524, DOI 10.1242/jcs.033464; Kasai H, 2003, TRENDS NEUROSCI, V26, P360, DOI 10.1016/S0166-2236(03)00162-0; Kasai H, 2010, TRENDS NEUROSCI, V33, P121, DOI 10.1016/j.tins.2010.01.001; Kim DJ, 2006, J BIOL CHEM, V281, P617, DOI 10.1074/jbc.M504450200; Kim SM, 2011, EXP CELL RES, V317, P2276, DOI 10.1016/j.yexcr.2011.06.018; Kim SM, 2009, J NEUROCHEM, V109, P1106, DOI 10.1111/j.1471-4159.2009.06039.x; Knobloch M, 2008, MOL NEUROBIOL, V37, P73, DOI 10.1007/s12035-008-8018-z; Lee S, 2006, EMBO J, V25, P4983, DOI 10.1038/sj.emboj.7601349; Liebau S, 2011, STARCH, V6; Matsuda S, 2008, ANN ONCOL, V19, P1356, DOI 10.1093/annonc/mdn293; Meng YH, 2002, NEURON, V35, P121, DOI 10.1016/S0896-6273(02)00758-4; Miyazaki K, 2000, BBA-GENE STRUCT EXPR, V1493, P237, DOI 10.1016/S0167-4781(00)00158-5; Newey SE, 2005, J NEUROBIOL, V64, P58, DOI 10.1002/neu.20153; Newpher TM, 2009, TRENDS CELL BIOL, V19, P218, DOI 10.1016/j.tcb.2009.02.004; Nimchinsky EA, 2002, ANNU REV PHYSIOL, V64, P313, DOI 10.1146/annurev.physiol.64.081501.160008; Okamoto KI, 2004, NAT NEUROSCI, V7, P1104, DOI 10.1038/nn1311; Pinyol R, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0000400; Proepper C, 2007, EMBO J, V26, P1397, DOI 10.1038/sj.emboj.7601569; Qualmann B, 2004, J NEUROSCI, V24, P2481, DOI 10.1523/JNEUROSCI.5479-03.2004; Renner M, 2008, CURR OPIN NEUROBIOL, V18, P532, DOI 10.1016/j.conb.2008.09.009; Schubert V, 2007, J CELL SCI, V120, P205, DOI 10.1242/jcs.03337; Sheng M, 2007, ANNU REV BIOCHEM, V76, P823, DOI 10.1146/annurev.biochem.76.060805.160029; Soderling SH, 2007, J NEUROSCI, V27, P355, DOI 10.1523/JNEUROSCI.3209-06.2006; Star EN, 2002, NAT NEUROSCI, V5, P239, DOI 10.1038/nn811; Stradal T, 2001, CURR BIOL, V11, P891, DOI 10.1016/S0960-9822(01)00239-1; Sudhof TC, 2008, NATURE, V455, P903, DOI 10.1038/nature07456; Tackenberg C, 2009, CURR ALZHEIMER RES, V6, P261, DOI 10.2174/156720509788486554; Terry-Lorenzo RT, 2005, MOL BIOL CELL, V16, P2349, DOI 10.1091/mbc.E04-12-1054; Yoshihara Y, 2009, CURR OPIN NEUROBIOL, V19, P146, DOI 10.1016/j.conb.2009.05.013; Yuste R, 2001, ANNU REV NEUROSCI, V24, P1071, DOI 10.1146/annurev.neuro.24.1.1071; Zhang HY, 2005, J NEUROSCI, V25, P3379, DOI 10.1523/JNEUROSCI.3553-04.2005	54	19	19	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 2	2012	7	4							e34677	10.1371/journal.pone.0034677	http://dx.doi.org/10.1371/journal.pone.0034677			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	952GU	22485184	gold, Green Submitted, Green Published			2022-12-25	WOS:000304780500059
J	Bojang, P; Gregg, RG				Bojang, Pasano, Jr.; Gregg, Ronald G.			Topological Analysis of Small Leucine-Rich Repeat Proteoglycan Nyctalopin	PLOS ONE			English	Article							STATIONARY NIGHT BLINDNESS; ROD BIPOLAR CELLS; SIGNAL-ANCHOR PROTEINS; GROWTH-FACTOR RECEPTOR; MEMBRANE-PROTEINS; CRYSTAL-STRUCTURE; SYNAPTIC-TRANSMISSION; GLUTAMATE RECEPTORS; SPLIT-UBIQUITIN; RAT RETINA	Nyctalopin is a small leucine rich repeat proteoglycan (SLRP) whose function is critical for normal vision. The absence of nyctalopin results in the complete form of congenital stationary night blindness. Normally, glutamate released by Photoreceptors binds to the metabotropic glutamate receptor type 6(GRM6), which through a G-protein cascade closes the non-specific cation channel, TRPM1, on the dendritic tips of depolarizing bipolar cells (DBCs) in the retina. Nyctalopin has been shown to interact with TRPM1 and expression of TRPM1 on the dendritic tips of the DBCs is dependent on nyctalopin expression. In the current study, we used yeast two hybrid and biochemical approaches to investigate whether murine nyctalopin was membrane bound, and if so by what mechanism, and also whether the functional form was as a homodimer. Our results show that murine nyctalopin is anchored to the plasma membrane by a single transmembrane domain, such that the LRR domain is located in the extracellular space.	[Bojang, Pasano, Jr.; Gregg, Ronald G.] Univ Louisville, Dept Biochem & Mol Biol, Louisville, KY 40292 USA	University of Louisville	Bojang, P (corresponding author), Univ Louisville, Dept Biochem & Mol Biol, Louisville, KY 40292 USA.	ron.gregg@louisville.edu		Gregg, Ronald/0000-0001-5805-224X	United States National Institutes of Health [R01EY12354]; NATIONAL EYE INSTITUTE [R01EY012354] Funding Source: NIH RePORTER	United States National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL EYE INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI))	This research was supported by grant R01EY12354 from the United States National Institutes of Health. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Appenzeller-Herzog C, 2006, J CELL SCI, V119, P2173, DOI 10.1242/jcs.03019; Bech-Hansen NT, 2000, NAT GENET, V26, P319, DOI 10.1038/81619; Bella J, 2008, CELL MOL LIFE SCI, V65, P2307, DOI 10.1007/s00018-008-8019-0; Brandan E, 2008, MATRIX BIOL, V27, P700, DOI 10.1016/j.matbio.2008.07.004; Brandstatter JH, 1997, J NEUROSCI, V17, P9298; Cao Y, 2011, J NEUROSCI, V31, P11521, DOI 10.1523/JNEUROSCI.1682-11.2011; Cheng W, 2010, PROTEIN CELL, V1, P802, DOI 10.1007/s13238-010-0108-9; CLAROS MG, 1994, COMPUT APPL BIOSCI, V10, P685; Cserzo M, 1997, PROTEIN ENG, V10, P673, DOI 10.1093/protein/10.6.673; Dalbey RE, 2011, ANNU REV BIOCHEM, V80, P161, DOI 10.1146/annurev-biochem-060409-092524; Dancourt J, 2010, ANNU REV BIOCHEM, V79, P777, DOI 10.1146/annurev-biochem-061608-091319; De Matteis MA, 2008, NAT REV MOL CELL BIO, V9, P273, DOI 10.1038/nrm2378; Denzer AJ, 1995, EMBO J, V14, P6311, DOI 10.1002/j.1460-2075.1995.tb00321.x; DeVries SH, 1999, NATURE, V397, P157, DOI 10.1038/16462; Egea PF, 2005, CURR OPIN STRUC BIOL, V15, P213, DOI 10.1016/j.sbi.2005.03.007; Eisenhaber B, 1999, J MOL BIOL, V292, P741, DOI 10.1006/jmbi.1999.3069; Felkl M, 2008, NEUROSCIENCE, V156, P344, DOI 10.1016/j.neuroscience.2008.07.033; Garnier C, 1996, MOL MICROBIOL, V21, P1061, DOI 10.1046/j.1365-2958.1996.621430.x; Gregg RG, 2003, INVEST OPHTH VIS SCI, V44, P378, DOI 10.1167/iovs.02-0501; Gregg RG, 2007, J NEUROPHYSIOL, V98, P3023, DOI 10.1152/jn.00608.2007; Hack I, 1999, P NATL ACAD SCI USA, V96, P14130, DOI 10.1073/pnas.96.24.14130; Hirokawa T, 1998, BIOINFORMATICS, V14, P378, DOI 10.1093/bioinformatics/14.4.378; HOFMANN K, 1993, BIOL CHEM HOPPESEYLE, V374, P166, DOI DOI 10.1515/BCHM3.1993.374.1-6.143; Iozzo RV, 1999, J BIOL CHEM, V274, P4489, DOI 10.1074/jbc.274.8.4489; Jiang LH, 2007, BIOCHEM SOC T, V35, P86, DOI 10.1042/BST0350086; JOHNSSON N, 1994, P NATL ACAD SCI USA, V91, P10340, DOI 10.1073/pnas.91.22.10340; Kobe B, 1996, J MOL BIOL, V264, P1028, DOI 10.1006/jmbi.1996.0694; Koike C, 2010, P NATL ACAD SCI USA, V107, P332, DOI 10.1073/pnas.0912730107; Krogh A, 2001, J MOL BIOL, V305, P567, DOI 10.1006/jmbi.2000.4315; Le Goff MM, 2003, J BIOL CHEM, V278, P45280, DOI 10.1074/jbc.M303117200; Lee JCM, 2004, BLOOD, V103, P1912, DOI 10.1182/blood-2003-03-0928; LIU J, 1994, J BIOL CHEM, V269, P28366; MEADOWS LA, 1994, J CELL SCI, V107, P321; Morgans CW, 2009, P NATL ACAD SCI USA, V106, P19174, DOI 10.1073/pnas.0908711106; NAWY S, 1991, NEURON, V7, P677, DOI 10.1016/0896-6273(91)90380-I; NOMURA A, 1994, CELL, V77, P361, DOI 10.1016/0092-8674(94)90151-1; O'Connor E, 2005, HUM MOL GENET, V14, P1877, DOI 10.1093/hmg/ddi194; Pearring JN, 2011, J NEUROSCI, V31, P10060, DOI 10.1523/JNEUROSCI.1014-11.2011; Perrimon N, 2001, SEMIN CELL DEV BIOL, V12, P65, DOI 10.1006/scdb.2000.0237; Pierleoni A, 2011, NUCLEIC ACIDS RES, V39, pW375, DOI 10.1093/nar/gkr282; Pusch CM, 2000, NAT GENET, V26, P324, DOI 10.1038/81627; SAKAGUCHI M, 1992, P NATL ACAD SCI USA, V89, P16, DOI 10.1073/pnas.89.1.16; Saraogi I, 2011, TRAFFIC, V12, P535, DOI 10.1111/j.1600-0854.2011.01171.x; Schaefer L, 2008, J BIOL CHEM, V283, P21305, DOI 10.1074/jbc.R800020200; Scott PG, 2006, J BIOL CHEM, V281, P13324, DOI 10.1074/jbc.M513470200; Scott PG, 2004, P NATL ACAD SCI USA, V101, P15633, DOI 10.1073/pnas.0402976101; Scott PG, 2003, J BIOL CHEM, V278, P18353, DOI 10.1074/jbc.M211936200; Shen Y, 2009, J NEUROSCI, V29, P6088, DOI 10.1523/JNEUROSCI.0132-09.2009; SHIELLS RA, 1990, P ROY SOC B-BIOL SCI, V242, P91, DOI 10.1098/rspb.1990.0109; Stagljar I, 1998, P NATL ACAD SCI USA, V95, P5187, DOI 10.1073/pnas.95.9.5187; Stagljar Igor, 2003, Sci STKE, V2003, ppe56; TAKAHASHI N, 1985, P NATL ACAD SCI USA, V82, P1906, DOI 10.1073/pnas.82.7.1906; TEHEESEN S, 1994, EUR J BIOCHEM, V224, P71, DOI 10.1111/j.1432-1033.1994.tb19996.x; Tusnady GE, 2001, BIOINFORMATICS, V17, P849, DOI 10.1093/bioinformatics/17.9.849; Vardi N, 1997, VISUAL NEUROSCI, V14, P789, DOI 10.1017/S0952523800012736; Wahlberg JM, 1997, J CELL BIOL, V137, P555, DOI 10.1083/jcb.137.3.555; WINDISCH JM, 1995, J BIOL CHEM, V270, P28133; YAMASHITA M, 1991, J NEUROSCI, V11, P2372; Zeitz C, 2003, INVEST OPHTH VIS SCI, V44, P4184, DOI 10.1167/iovs.03-0251; Zhu JX, 2005, J BIOL CHEM, V280, P32468, DOI 10.1074/jbc.M503833200	60	7	7	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 2	2012	7	4							e33137	10.1371/journal.pone.0033137	http://dx.doi.org/10.1371/journal.pone.0033137			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	952GU	22485138	Green Published, Green Submitted, gold			2022-12-25	WOS:000304780500014
J	Palmberger, D; Wilson, IBH; Berger, I; Grabherr, R; Rendic, D				Palmberger, Dieter; Wilson, Iain B. H.; Berger, Imre; Grabherr, Reingard; Rendic, Dubravko			SweetBac: A New Approach for the Production of Mammalianised Glycoproteins in Insect Cells	PLOS ONE			English	Article							N-GLYCOSYLATION PATHWAY; BACULOVIRUS EXPRESSION SYSTEM; LEPIDOPTERA-NOCTUIDAE; PROTEIN; BETA-1,4-GALACTOSYLTRANSFERASE; GLYCOSYLTRANSFERASES; ANTIBODIES; VECTORS; GLYCANS; LINE	Recombinant production of therapeutically active proteins has become a central focus of contemporary life science research. These proteins are often produced in mammalian cells, in order to obtain products with post-translational modifications similar to their natural counterparts. However, in cases where a fast and flexible system for recombinant production of proteins is needed, the use of mammalian cells is limited. The baculoviral insect cell system has proven to be a powerful alternative for the expression of a wide range of recombinant proteins in short time frames. The major drawback of baculoviral systems lies in the inability to perform mammalian-like glycosylation required for the production of therapeutic glycoproteins. In this study we integrated sequences encoding Caenorhabditis elegans N-acetylglucosaminyltransferase II and bovine beta 1,4-galactosyltransferase I into the backbone of a baculovirus genome. The thereby generated SweetBac virus was subsequently used for the production of the human HIV anti-gp41 antibody 3D6 by integrating heavy and light chain open reading frames into the SweetBac genome. The parallel expression of target genes and glycosyltransferases reduced the yield of secreted antibody. However, the overall expression rate, especially in the recently established Tnao38 cell line, was comparable to that of transient expression in mammalian cells. In order to evaluate the ability of SweetBac to generate mammalian-like N-glycan structures on 3D6 antibody, we performed SDS-PAGE and tested for the presence of terminal galactose using Riccinus communis agglutinin I. The mammalianised variants of 3D6 showed highly specific binding to the lectin, indicating proper functionality. To confirm these results, PNGase A released N-glycans were analyzed by MALDI-TOF-MS and shown to contain structures with mainly one or two terminal galactose residues. Since the presence of specific N-glycans has an impact on antibodies ability to exert different effector functions, we tested the binding to human Fc gamma receptor I present on U937 cells.	[Palmberger, Dieter; Wilson, Iain B. H.; Grabherr, Reingard; Rendic, Dubravko] Univ Nat Resources & Life Sci, Vienna Inst BioTechnol VIBT, Vienna, Austria; [Berger, Imre] European Mol Biol Lab, F-38042 Grenoble, France	University of Natural Resources & Life Sciences, Vienna; European Molecular Biology Laboratory (EMBL)	Palmberger, D (corresponding author), Univ Nat Resources & Life Sci, Vienna Inst BioTechnol VIBT, Vienna, Austria.	reingard.grabherr@boku.ac.at	Rendic, Dubravko/A-9368-2010; Wilson, Iain/B-3326-2009	Grabherr, Reingard/0000-0002-4501-927X; Wilson, Iain/0000-0001-8996-1518; Palmberger, Dieter/0000-0002-2086-0396; Berger, Imre/0000-0001-7518-9045	Austrian Science Fund, FWF [TRP127-B11]; Austrian Science Fund (FWF) [TRP 127] Funding Source: researchfish	Austrian Science Fund, FWF(Austrian Science Fund (FWF)); Austrian Science Fund (FWF)(Austrian Science Fund (FWF))	This work was funded by the Austrian Science Fund, FWF (TRP127-B11), in the name of Austrian Ministry for Transport, Innovation and Technology. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Altmann F, 1999, GLYCOCONJUGATE J, V16, P109, DOI 10.1023/A:1026488408951; Aumiller JJ, 2003, GLYCOBIOLOGY, V13, P497, DOI 10.1093/glycob/cwg051; Aumiller JJ, 2012, GLYCOBIOLOGY; Berger I, 2004, NAT BIOTECHNOL, V22, P1583, DOI 10.1038/nbt1036; Bieniossek Christoph, 2008, Curr Protoc Protein Sci, VChapter 5, DOI 10.1002/0471140864.ps0520s51; Birch JR, 2006, ADV DRUG DELIVER REV, V58, P671, DOI 10.1016/j.addr.2005.12.006; Breitbach K, 2001, BIOTECHNOL BIOENG, V74, P230, DOI 10.1002/bit.1112; Chang GD, 2003, J BIOTECHNOL, V102, P61, DOI 10.1016/S0168-1656(02)00364-4; Chung CH, 2008, NEW ENGL J MED, V358, P1109, DOI 10.1056/NEJMoa074943; FELGENHAUER M, 1990, NUCLEIC ACIDS RES, V18, P4927, DOI 10.1093/nar/18.16.4927; Fitzgerald DJ, 2006, NAT METHODS, V3, P1021, DOI 10.1038/nmeth983; Hashimoto Y, 2010, BMC BIOTECHNOL, V10, DOI 10.1186/1472-6750-10-50; Hollister J, 2002, BIOCHEMISTRY-US, V41, P15093, DOI 10.1021/bi026455d; Hollister JR, 1998, GLYCOBIOLOGY, V8, P473, DOI 10.1093/glycob/8.5.473; Hollister JR, 2001, GLYCOBIOLOGY, V11, P1; Huang LH, 2006, ANAL BIOCHEM, V349, P197, DOI 10.1016/j.ab.2005.11.012; Iskratsch T, 2009, ANAL BIOCHEM, V386, P133, DOI 10.1016/j.ab.2008.12.005; Jarvis DL, 1996, NAT BIOTECHNOL, V14, P1288, DOI 10.1038/nbt1096-1288; Jefferis R, 2009, TRENDS PHARMACOL SCI, V30, P356, DOI 10.1016/j.tips.2009.04.007; Kanda Y, 2007, GLYCOBIOLOGY, V17, P104, DOI 10.1093/glycob/cwl057; Kelley B, 2009, MABS-AUSTIN, V1, P443, DOI 10.4161/mabs.1.5.9448; Krammer F, 2010, MOL BIOTECHNOL, V45, P226, DOI 10.1007/s12033-010-9268-3; LAEMMLI UK, 1970, NATURE, V227, P680, DOI 10.1038/227680a0; Palmberger D, 2011, J BIOTECHNOL; Rendic D, 2007, ELECTROPHORESIS, V28, P4484, DOI 10.1002/elps.200700098; Sambrook J., 2002, MOL CLONING LAB MANU; Schiller JT, 2008, VACCINE, V26, pK53, DOI 10.1016/j.vaccine.2008.06.002; Summers MD, 1987, TEXAS AGR EXPT STATI; Trowitzsch S, 2010, J STRUCT BIOL, V172, P45, DOI 10.1016/j.jsb.2010.02.010; VAUGHN JL, 1977, IN VITRO CELL DEV B, V13, P213; Wagner R, 1996, GLYCOBIOLOGY, V6, P165, DOI 10.1093/glycob/6.2.165; WICKHAM TJ, 1993, BIOTECHNOL PROGR, V9, P25, DOI 10.1021/bp00019a004	32	59	63	1	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 2	2012	7	4							e34226	10.1371/journal.pone.0034226	http://dx.doi.org/10.1371/journal.pone.0034226			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	952GU	22485160	Green Published, Green Submitted, gold			2022-12-25	WOS:000304780500035
J	Puppala, M; Ponder, J; Suryanarayana, P; Reddy, GB; Petrash, JM; LaBarbera, DV				Puppala, Muthenna; Ponder, Jessica; Suryanarayana, Palla; Reddy, Geereddy Bhanuprakash; Petrash, J. Mark; LaBarbera, Daniel V.			The Isolation and Characterization of beta-Glucogallin as a Novel Aldose Reductase Inhibitor from Emblica officinalis	PLOS ONE			English	Article							DIABETIC-RETINOPATHY; TRANSGENIC MICE; KETO REDUCTASES; RAT RETINA; COMPLICATIONS; CATARACT; TANNINS; LENS; ACCUMULATION; DEFICIENCY	Diabetes mellitus is recognized as a leading cause of new cases of blindness. The prevalence of diabetic eye disease is expected to continue to increase worldwide as a result of the dramatic increase in the number of people with diabetes. At present, there is no medical treatment to delay or prevent the onset and progression of cataract or retinopathy, the most common causes of vision loss in diabetics. The plant Emblica officinalis (gooseberry) has been used for thousands of years as a traditional Indian Ayurvedic preparation for the treatment of diabetes in humans. Extracts from this plant have been shown to be efficacious against the progression of cataract in a diabetic rat model. Aldose reductase (ALR2) is implicated in the development of secondary complications of diabetes including cataract and, therefore, has been a major drug target for the development of therapies to treat diabetic disease. Herein, we present the bioassay-guided isolation and structure elucidation of 1-O-galloy1-beta-D-glucose (beta-glucogallin), a major component from the fruit of the gooseberry that displays selective as well as relatively potent inhibition (IC50=17 mu M) of AKR1B1 in vitro. Molecular modeling demonstrates that this inhibitor is able to favorably bind in the active site. Further, we show that beta-glucogallin effectively inhibits sorbitol accumulation by 73% at 30 mu M under hyperglycemic conditions in an ex-vivo organ culture model of lenses excised from transgenic mice overexpressing human ALR2 in the lens. This study supports the continued development of natural products such as beta-glucogallin as therapeutic leads in the development of novel therapies to treat diabetic complications such as cataract.	[Puppala, Muthenna; Suryanarayana, Palla; Reddy, Geereddy Bhanuprakash] Natl Inst Nutr, Dept Biochem, Hyderabad 500007, Andhra Pradesh, India; [Ponder, Jessica; Petrash, J. Mark; LaBarbera, Daniel V.] Univ Colorado, Skaggs Sch Pharm & Pharmaceut Sci, Dept Pharmaceut Sci, Aurora, CO USA; [Petrash, J. Mark] Univ Colorado, Dept Ophthalmol, Sch Med, Aurora, CO USA	Indian Council of Medical Research (ICMR); ICMR - National Institute of Nutrition (NIN); University of Colorado System; University of Colorado Anschutz Medical Campus; University of Colorado System; University of Colorado Anschutz Medical Campus	Puppala, M (corresponding author), Natl Inst Nutr, Dept Biochem, Hyderabad 500007, Andhra Pradesh, India.	daniel.labarbera@ucdenver.edu	Reddy, G Bhanuprakash/AAJ-3494-2020; Puppala, Muthenna/R-9629-2017	Reddy, G Bhanuprakash/0000-0003-4787-3944; Puppala, Muthenna/0000-0002-7035-749X	Department of Biotechnology; Life Sciences Research Board of Defense Research; Development Organization, Government of India (GBR); National Institutes of Health [EY005856, EY021498]; Skaggs School of Pharmacy and Pharmaceutical Sciences; University Grants Commission, India; BOYSCAST from the Department of Science and Technology, New Delhi, India; NATIONAL EYE INSTITUTE [R55EY005856, R01EY021498, R23EY005856, R01EY005856] Funding Source: NIH RePORTER	Department of Biotechnology; Life Sciences Research Board of Defense Research; Development Organization, Government of India (GBR); National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Skaggs School of Pharmacy and Pharmaceutical Sciences; University Grants Commission, India(University Grants Commission, India); BOYSCAST from the Department of Science and Technology, New Delhi, India; NATIONAL EYE INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI))	This work was funded in part by grants from the Department of Biotechnology (under 7th FP of Indo-EU collaborative program on functional foods) and Life Sciences Research Board of Defense Research and Development Organization, Government of India (GBR), National Institutes of Health grants EY005856 (JMP) and EY021498 (DVL and JMP), and through Skaggs School of Pharmacy and Pharmaceutical Sciences start up funds (DVL). MP was supported by a Senior Research Fellowship from the University Grants Commission, India. PS was supported by a BOYSCAST fellowship from the Department of Science and Technology, New Delhi, India. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aiello LP, 1998, DIABETES CARE, V21, P143, DOI 10.2337/diacare.21.1.143; Brooks BR, 2009, J COMPUT CHEM, V30, P1545, DOI 10.1002/jcc.21287; Brownlee M, 2001, NATURE, V414, P813, DOI 10.1038/414813a; Cheung AKH, 2005, DIABETES, V54, P3119, DOI 10.2337/diabetes.54.11.3119; DAS B, 1985, DIABETES, V34, P1145, DOI 10.2337/diabetes.34.11.1145; Diabetes Control and Complications Trial, 1995, ARCH OPHTHALMOL, V113, P36; EHRIG T, 1994, BIOCHEMISTRY-US, V33, P7157, DOI 10.1021/bi00189a019; El-Kabbani O, 2000, PROTEINS, V41, P407, DOI 10.1002/1097-0134(20001115)41:3<407::AID-PROT120>3.0.CO;2-9; El-Remessy AB, 2003, INVEST OPHTH VIS SCI, V44, P3135, DOI 10.1167/iovs.02-1022; ENGERMAN RL, 1993, DIABETES, V42, P820, DOI 10.2337/diabetes.42.6.820; Fischer E, 1918, BER DTSCH CHEM GES, V51, P45, DOI 10.1002/cber.19180510108; Ghosal S, 1996, INDIAN J CHEM B, V35, P941; Giannoukakis N, 2008, EXPERT OPIN INV DRUG, V17, P575, DOI [10.1517/13543784.17.4.575, 10.1517/13543784.17.4.575 ]; Gross G., 1999, COMPREHENSIVE NATURA; Gross GG, 1992, PLANT POLYHENOLS SYN; Haslam E, 2007, PHYTOCHEMISTRY, V68, P2713, DOI 10.1016/j.phytochem.2007.09.009; HAYMAN S, 1965, J BIOL CHEM, V240, P877; KADOR PF, 1985, J MED CHEM, V28, P841, DOI 10.1021/jm00145a001; KASHIWADA Y, 1984, CHEM PHARM BULL, V32, P3461; Klebe G, 2004, CELL MOL LIFE SCI, V61, P783, DOI 10.1007/s00018-003-3406-z; Latte KP, 2000, PHYTOCHEMISTRY, V54, P701, DOI 10.1016/S0031-9422(00)00176-X; LEE AYW, 1995, P NATL ACAD SCI USA, V92, P2780, DOI 10.1073/pnas.92.7.2780; Levin DS, 2007, J AM SOC MASS SPECTR, V18, P502, DOI 10.1016/j.jasms.2006.10.008; Montes M, 2007, PROTEINS, V68, P712, DOI 10.1002/prot.21405; Murata M, 2002, J DIABETES COMPLICAT, V16, P363, DOI 10.1016/S1056-8727(01)00171-4; Neuhauser W, 1997, BIOCHEM J, V326, P683, DOI 10.1042/bj3260683; Oates, 1999, Expert Opin Investig Drugs, V8, P2095, DOI 10.1517/13543784.8.12.2095; Penning TM, 2007, ARCH BIOCHEM BIOPHYS, V464, P241, DOI 10.1016/j.abb.2007.04.024; PETRASH JM, 1992, J BIOL CHEM, V267, P24833; Petrash JM, 2004, CELL MOL LIFE SCI, V61, P737, DOI 10.1007/s00018-003-3402-3; Quideau, 2009, CHEM BIOL ELLAGITANN; Quin GJ, 2007, PROTEOMICS, V7, P2636, DOI 10.1002/pmic.200600486; RAO PV, 1989, NUTR RES, V9, P1143, DOI 10.1016/S0271-5317(89)80049-1; Reddy GB, 2008, MOL VIS, V14, P593; Reddy GB, 2011, PYLLANTHUS SPECIES S, P235; ROBISON WG, 1990, EXP EYE RES, V50, P355, DOI 10.1016/0014-4835(90)90136-I; SARGES R, 1986, METABOLISM, V35, P101, DOI 10.1016/0026-0495(86)90196-4; Scartezzini P, 2000, J ETHNOPHARMACOL, V71, P23, DOI 10.1016/S0378-8741(00)00213-0; Shen Y, 2011, CHEM-BIOL INTERACT, V191, P192, DOI 10.1016/j.cbi.2011.02.004; Song ZT, 2003, MOL CELL NEUROSCI, V23, P638, DOI 10.1016/S1044-7431(03)00096-4; Suryanarayana P, 2007, MOL VIS, V13, P1291; Suryanarayana P, 2004, MOL VIS, V10, P148; Urzhumtsev A, 1997, STRUCTURE, V5, P601, DOI 10.1016/S0969-2126(97)00216-5; YAMAOKA T, 1995, DIABETOLOGIA, V38, P255, DOI 10.1007/s001250050278	44	65	68	0	14	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 2	2012	7	4							e31399	10.1371/journal.pone.0031399	http://dx.doi.org/10.1371/journal.pone.0031399			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	952GU	22485126	Green Published, gold, Green Submitted			2022-12-25	WOS:000304780500002
J	Garcia-Lastra, R; Leginagoikoa, I; Plazaola, JM; Ocabo, B; Aduriz, G; Nunes, T; Juste, RA				Garcia-Lastra, Rodrigo; Leginagoikoa, Iratxe; Plazaola, Jose M.; Ocabo, Blanca; Aduriz, Gorka; Nunes, Telmo; Juste, Ramon A.			Bluetongue Virus Serotype 1 Outbreak in the Basque Country (Northern Spain) 2007-2008. Data Support a Primary Vector Windborne Transport	PLOS ONE			English	Article							BREVITARSIS KIEFFER DIPTERA; CULICOIDES-IMICOLA; ARBOVIRUS VECTOR; RECENT EMERGENCE; AIR STREAMS; EUROPE; SPREAD; CERATOPOGONIDAE; DISPERSAL; DISEASE	Background: Bluetongue (BT) is a vector-borne disease of ruminants that has expanded its traditional global distribution in the last decade. Recently, BTV-1 emerged in Southern Spain and caused several outbreaks in livestock reaching the north of the country. The aim of this paper was to review the emergence of BTV-1 in the Basque Country (Northern Spain) during 2007 and 2008 analyzing the possibility that infected Culicoides were introduced into Basque Country by winds from the infected areas of Southern Spain. Methodology/Principal Findings: We use a complex HYSPLIT (Hybrid Single-Particle Lagrangian Integrated Trajectory) model to draw wind roses and backward wind trajectories. The analysis of winds showed September 28 to October 2 as the only period for the introduction of infected midges in the Basque Country. These wind trajectories crossed through the areas affected by serotype 1 on those dates in the South of the Iberian Peninsula. Additionally meteorological data, including wind speed and humidity, and altitude along the trajectories showed suitable conditions for Culicoides survival and dispersion. Conclusions/Significance: An active infection in medium-long distance regions, wind with suitable speed, altitude and trajectory, and appropriate weather can lead to outbreaks of BTV-1 by transport of Culicoides imicola, not only over the sea (as reported previously) but also over the land. This shows that an additional factor has to be taken into account for the control of the disease which is currently essentially based on the assumption that midges will only spread the virus in a series of short hops. Moreover, the epidemiological and serological data cannot rule out the involvement of other Culicoides species in the spread of the infection, especially at a local level.	[Garcia-Lastra, Rodrigo; Leginagoikoa, Iratxe; Aduriz, Gorka; Juste, Ramon A.] NEIKER Tecnalia, Dept Anim Hlth, Derio, Bizkaia, Spain; [Plazaola, Jose M.] Diputac Foral Gipuzkoa, Dept Desarrollo Rural, Donostia San Sebastian, Gipuzkoa, Spain; [Ocabo, Blanca] Diputac Foral Bizkaia, Dept Agr, Bilbao, Bizkaia, Spain; [Nunes, Telmo] Univ Tecn Lisboa, Fac Med Vet, Lisbon, Portugal	Universidade de Lisboa	Garcia-Lastra, R (corresponding author), NEIKER Tecnalia, Dept Anim Hlth, Derio, Bizkaia, Spain.	rjuste@neiker.net	Juste, Ramon A./C-3570-2008	Juste, Ramon A./0000-0001-6037-5873; LEGINAGOIKOA, IRATXE/0000-0002-4887-7472; Nunes, Telmo/0000-0003-4388-5366	Direccion de Agricultura of the Departmento de Medio Ambiente, Planificacion Territorial, Agricultura y Pesca of the Basque Governement	Direccion de Agricultura of the Departmento de Medio Ambiente, Planificacion Territorial, Agricultura y Pesca of the Basque Governement	Funding for this work has been provided by the Direccion de Agricultura of the Departmento de Medio Ambiente, Planificacion Territorial, Agricultura y Pesca of the Basque Governement. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Agren ECC, 2010, VET REC, V167, P484, DOI 10.1136/vr.c3961; Alba A, 2004, VET REC, V155, P460, DOI 10.1136/vr.155.15.460; Allepuz A, 2010, PREV VET MED, V96, P263, DOI 10.1016/j.prevetmed.2010.06.005; Bishop AL, 2000, PREV VET MED, V47, P243, DOI 10.1016/S0167-5877(00)00175-6; Bishop AL, 2004, PREV VET MED, V65, P135, DOI 10.1016/j.prevetmed.2004.06.011; Braverman Y, 1996, REV SCI TECH OIE, V15, P1037, DOI 10.20506/rst.15.3.968; Burgin L, 2008, METEOROLOGICAL ANAL; Calvete C, 2008, MED VET ENTOMOL, V22, P124, DOI 10.1111/j.1365-2915.2008.00728.x; Calvete C, 2008, VET REC, V162, P255, DOI 10.1136/vr.162.8.255; Darpel KE, 2007, VET REC, V161, P253, DOI 10.1136/vr.161.8.253; Draxier RR, 1998, AUST METEOROL MAG, V47, P295; Ducheyne E, 2011, PREV VET MED, V99, P48, DOI 10.1016/j.prevetmed.2011.01.003; EUSKALMET, 2011, AG MET EUSK DAT EST; Feng HQ, 2007, AGR FOREST ENTOMOL, V9, P103, DOI 10.1111/j.1461-9563.2007.00326.x; Foxi C, 2010, MED VET ENTOMOL, V24, P199, DOI 10.1111/j.1365-2915.2010.00861.x; Gloster J, 2007, VET REC, V160, P54, DOI 10.1136/vr.160.2.54; Goldarazena A, 2008, VET REC, V162, P820, DOI 10.1136/vr.162.25.820; Hendrickx G, 2008, PREV VET MED, V87, P162, DOI 10.1016/j.prevetmed.2008.06.009; Hess GD, 2008, ENVIRON MODEL ASSESS, V13, P209, DOI 10.1007/s10666-007-9097-3; HYSPLIT, 2011, HYSPLIT HYBR SINGL P; Kedmi M, 2010, PREV VET MED, V96, P152, DOI 10.1016/j.prevetmed.2010.06.008; Lee LYL, 2004, ATMOS ENVIRON, V38, P7033, DOI 10.1016/j.atmosenv.2003.11.045; Lucientes J, 2008, 33 JORN CIENT 12 INT; Maan S, 2011, EMERG INFECT DIS, V17, P886, DOI 10.3201/eid1705.101742; Maclachlan NJ, 2009, J COMP PATHOL, V141, P1, DOI 10.1016/j.jcpa.2009.04.003; Maclachlan NJ, 2010, VET CLIN N AM-FOOD A, V26, P163, DOI 10.1016/j.cvfa.2009.10.012; Mehlhorn H, 2008, PARASITOL RES, V103, pS79, DOI 10.1007/s00436-008-1100-7; Mehlhorn H, 2009, PARASITOL RES, V105, P313, DOI 10.1007/s00436-009-1416-y; Meiswinkel R, 2008, PREV VET MED, V87, P55, DOI 10.1016/j.prevetmed.2008.06.005; Mellor PS, 2008, PREV VET MED, V87, P4, DOI 10.1016/j.prevetmed.2008.06.002; PERSSON C, 2009, 20092 SMHI; Polymenakou PN, 2008, ENVIRON HEALTH PERSP, V116, P292, DOI 10.1289/ehp.10684; Purse BV, 2005, NAT REV MICROBIOL, V3, P171, DOI 10.1038/nrmicro1090; Querol X, 1998, ATMOS ENVIRON, V32, P1963, DOI 10.1016/S1352-2310(97)00504-9; RASVE, 2011, INF LENG AZ AN 2009; Reynolds DR, 2006, ADV VIRUS RES, V67, P453, DOI 10.1016/S0065-3527(06)67012-7; Saegerman C, 2008, EMERG INFECT DIS, V14, P539, DOI 10.3201/eid1404.071441; Sellers R. F., 1992, Bluetongue, African horse sickness, and related orbiviruses: Proceedings of the Second International Symposium., P284; SELLERS RF, 1978, J HYG-CAMBRIDGE, V81, P189, DOI 10.1017/S0022172400025018; SELLERS RF, 1991, CAN J VET RES, V55, P367; SELLERS RF, 1989, CAN J VET RES, V53, P100; Sorooshian A, 2008, ATMOS CHEM PHYS, V8, P5489, DOI 10.5194/acp-8-5489-2008; Szmaragd C, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0007741; Westbrook JK, 2011, INT J BIOMETEOROL, V55, P585, DOI 10.1007/s00484-010-0359-4; Wilson A, 2009, PARASITOL RES, V104, P489, DOI 10.1007/s00436-008-1314-8; Yerramilli A, 2012, AIR QUAL ATMOS HLTH, V5, P401, DOI 10.1007/s11869-010-0132-1	46	33	33	0	16	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 30	2012	7	3							e34421	10.1371/journal.pone.0034421	http://dx.doi.org/10.1371/journal.pone.0034421			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	959UC	22479628	Green Published, Green Submitted, gold			2022-12-25	WOS:000305339100158
J	Swindell, WR; Xing, XY; Stuart, PE; Chen, CS; Aphale, A; Nair, RP; Voorhees, JJ; Elder, JT; Johnston, A; Gudjonsson, JE				Swindell, William R.; Xing, Xianying; Stuart, Philip E.; Chen, Cynthia S.; Aphale, Abhishek; Nair, Rajan P.; Voorhees, John J.; Elder, James T.; Johnston, Andrew; Gudjonsson, Johann E.			Heterogeneity of Inflammatory and Cytokine Networks in Chronic Plaque Psoriasis	PLOS ONE			English	Article							PERSONALIZED MEDICINE; EXPRESSION; INTERLEUKIN-13; SKIN; PHARMACOKINETICS; MECHANISMS; REVEALS; IL-13; KERATINOCYTES; EXACERBATION	The clinical features of psoriasis, characterized by sharply demarcated scaly erythematous plaques, are typically so distinctive that a diagnosis can easily be made on these grounds alone. However, there is great variability in treatment response between individual patients, and this may reflect heterogeneity of inflammatory networks driving the disease. In this study, whole-genome transcriptional profiling was used to characterize inflammatory and cytokine networks in 62 lesional skin samples obtained from patients with stable chronic plaque psoriasis. We were able to stratify lesions according to their inflammatory gene expression signatures, identifying those associated with strong (37% of patients), moderate (39%) and weak inflammatory infiltrates (24%). Additionally, we identified differences in cytokine signatures with heightened cytokine-response patterns in one sub-group of lesions (IL-13-strong; 50%) and attenuation of these patterns in a second sub-group (IL-13-weak; 50%). These sub-groups correlated with the composition of the inflammatory infiltrate, but were only weakly associated with increased risk allele frequency at some psoriasis susceptibility loci (e.g., REL, TRAF3IP2 and NOS2). Our findings highlight variable points in the inflammatory and cytokine networks known to drive chronic plaque psoriasis. Such heterogeneous aspects may shape clinical course and treatment responses, and can provide avenues for development of personalized treatments.	[Swindell, William R.] Harvard Univ, Sch Med, Dept Genet, Boston, MA 02115 USA; [Xing, Xianying; Stuart, Philip E.; Chen, Cynthia S.; Aphale, Abhishek; Nair, Rajan P.; Voorhees, John J.; Elder, James T.; Johnston, Andrew; Gudjonsson, Johann E.] Univ Michigan, Sch Med, Dept Dermatol, Ann Arbor, MI USA	Harvard University; Harvard Medical School; University of Michigan System; University of Michigan	Swindell, WR (corresponding author), Harvard Univ, Sch Med, Dept Genet, Boston, MA 02115 USA.	johanng@med.umich.edu	Johnston, Andrew/I-7904-2014; Voorhees, John/AAM-9966-2020	Johnston, Andrew/0000-0002-1313-9402; Voorhees, John/0000-0003-1856-785X	National Institutes of Health (NIH) [R01 AR054966]; Babcock Endowment Fund; NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES [R01AR054966, R01AR042742] Funding Source: NIH RePORTER	National Institutes of Health (NIH)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Babcock Endowment Fund; NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS))	This work was supported by R01 AR054966 (JTE) from the National Institutes of Health (NIH) and the Babcock Endowment Fund. JEG has received support from the Dermatology Foundation and American Skin Association and is the Frances and Kenneth Eisenberg Emerging Scholar of the Taubman Medical Research Institute. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Al-Hoqail IA, 2010, CURR VASC PHARMACOL, V8, P432; Balato N, 2009, J RHEUMATOL, V36, P24, DOI 10.3899/jrheum.090216; Bowcock AM, 2001, HUM MOL GENET, V10, P1793, DOI 10.1093/hmg/10.17.1793; Bowes J, 2011, ANN RHEUM DIS, V70, P1016, DOI 10.1136/ard.2010.143123; Cancino-Diaz JC, 2002, J INVEST DERMATOL, V119, P1114, DOI 10.1046/j.1523-1747.2002.19509.x; Chiricozzi A, 2011, J INVEST DERMATOL, V131, P677, DOI 10.1038/jid.2010.340; Di Cesare A, 2009, J INVEST DERMATOL, V129, P1339, DOI 10.1038/jid.2009.59; Duarte GV, 2010, AN BRAS DERMATOL, V85, P355, DOI 10.1590/S0365-05962010000300009; Duffin KC, 2009, J INVEST DERMATOL, V129, P2777, DOI 10.1038/jid.2009.169; Elewski B, 2007, BRIT J DERMATOL, V156, P138, DOI 10.1111/j.1365-2133.2006.07585.x; Filzmoser P, 2005, COMPUT GEOSCI-UK, V31, P579, DOI 10.1016/j.cageo.2004.11.013; Furlanut M, 1996, THER DRUG MONIT, V18, P544, DOI 10.1097/00007691-199610000-00004; Griffiths CEM, 2010, J EUR ACAD DERMATOL, V24, P10, DOI 10.1111/j.1468-3083.2010.03831.x; GRUBBS FE, 1950, ANN MATH STAT, V21, P27, DOI 10.1214/aoms/1177729885; Gudjonsson JE, 2004, CLIN EXP IMMUNOL, V135, P1, DOI 10.1111/j.1365-2249.2004.02310.x; Gudjonsson JE, 2010, J INVEST DERMATOL, V130, P1829, DOI 10.1038/jid.2010.36; Gudjonsson JE, 2009, J INVEST DERMATOL, V129, P2795, DOI 10.1038/jid.2009.173; Haider AS, 2008, J INVEST DERMATOL, V128, P606, DOI 10.1038/sj.jid.5701067; Hamid Q, 1996, J ALLERGY CLIN IMMUN, V98, P225, DOI 10.1016/S0091-6749(96)70246-4; HUFFMAN DH, 1973, CLIN PHARMACOL THER, V14, P572; Irizarry RA, 2003, NUCLEIC ACIDS RES, V31, DOI 10.1093/nar/gng015; Itoh K, 2005, EXP DERMATOL, V14, P667, DOI 10.1111/j.0906-6705.2005.00338.x; Joham E, 2007, FITZPATRICKS DERMATO, P169; Joshi A, 2006, J CLIN PHARMACOL, V46, P10, DOI 10.1177/0091270005283282; Klotz U, 2007, CLIN PHARMACOKINET, V46, P645, DOI 10.2165/00003088-200746080-00002; Kulski JK, 2005, J MOL MED, V83, P964, DOI 10.1007/s00109-005-0721-x; LAMBERT WE, 1994, ACTA DERM-VENEREOL, V74, P122; Liu GY, 2003, NUCLEIC ACIDS RES, V31, P82, DOI 10.1093/nar/gkg121; Lowes MA, 2007, NATURE, V445, P866, DOI 10.1038/nature05663; Nair RP, 2009, NAT GENET, V41, P199, DOI 10.1038/ng.311; Nestle FO, 2009, NEW ENGL J MED, V361, P496, DOI 10.1056/NEJMra0804595; Papp K, 2011, BRIT J DERMATOL, V164, P434, DOI 10.1111/j.1365-2133.2010.10139.x; Papp KA, 2012, J AM ACAD DERMATOL, V67, pE11, DOI 10.1016/j.jaad.2011.02.032; R Development Core Team, 2010, R R LANG ENV STAT CO; ROUSSEEUW PJ, 1987, J COMPUT APPL MATH, V20, P53, DOI 10.1016/0377-0427(87)90125-7; Schinke-Braun Martina, 2007, Methods Mol Biol, V366, P13; Shimoni Y, 2010, PLOS COMPUT BIOL, V6, DOI 10.1371/journal.pcbi.1000828; Smyth G.K., 2004, STAT APPL GENET MOL, V3, DOI DOI 10.2202/1544-6115.1027; Spadaro A, 2002, ANN RHEUM DIS, V61, P174, DOI 10.1136/ard.61.2.174; Suarez-Farinas M, 2010, BMC DERMATOL, V10, DOI 10.1186/1471-5945-10-1; Suarez-Farinas M, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0010247; Swindell WR, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0011861; Torii K, 2011, EXP DERMATOL, V20, P371, DOI 10.1111/j.1600-0625.2010.01224.x; van de Kerkhof PCM, 2009, J DERMATOL TREAT, V20, P253, DOI 10.1080/09546630903283352; VanderPloeg I, 1997, CLIN EXP IMMUNOL, V109, P526, DOI 10.1046/j.1365-2249.1997.4671365.x; Viguier M, 2009, EXPERT REV CLIN IMMU, V5, P421, DOI [10.1586/eci.09.18, 10.1586/ECI.09.18]; Wendling D, 2008, JOINT BONE SPINE, V75, P315, DOI 10.1016/j.jbspin.2007.06.011; Wongpiyabovorn J, 2003, J DERMATOL SCI, V33, P31, DOI 10.1016/S0923-1811(03)00148-8; Woolf RT, 2010, EXPERT REV CLIN IMMU, V6, P957, DOI 10.1586/ECI.10.74; Yao YH, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0002737; Zhou XH, 2003, PHYSIOL GENOMICS, V13, P69, DOI 10.1152/physiolgenomics.00157.2002; Zhu YW, 2009, J CLIN PHARMACOL, V49, P162, DOI 10.1177/0091270008329556; ZURAWSKI G, 1994, IMMUNOL TODAY, V15, P19, DOI 10.1016/0167-5699(94)90021-3	53	55	57	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 29	2012	7	3							e34594	10.1371/journal.pone.0034594	http://dx.doi.org/10.1371/journal.pone.0034594			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	948SR	22479649	gold, Green Submitted, Green Published			2022-12-25	WOS:000304523400090
J	Lafargue, M; Xu, LJ; Carles, M; Serve, E; Anjum, N; Iles, KE; Xiong, XX; Giffard, R; Pittet, JF				Lafargue, Mathieu; Xu, Lijun; Carles, Michel; Serve, Emilie; Anjum, Naseem; Iles, Karen E.; Xiong, Xiaoxing; Giffard, Rona; Pittet, Jean-Francois			Stroke-induced activation of the alpha 7 nicotinic receptor increases Pseudomonas aeruginosa lung injury	FASEB JOURNAL			English	Article						vagus nerve; pneumonia	FOCAL CEREBRAL-ISCHEMIA; ACETYLCHOLINE-RECEPTORS; MEDICAL COMPLICATIONS; GENDER-DIFFERENCES; FLUID BALANCE; BRAIN-INJURY; MICE; PNEUMONIA; INFECTION; MELANOCORTINS	Infectious complications, predominantly pneumonia, are the most common cause of death in the postacute phase of stroke, although the mechanisms underlying the corresponding immunosuppression are not fully understood. We tested the hypothesis that activation of the alpha 7 nicotinic acetylcholine receptor (alpha 7nAChR) pathway is important in the stroke-induced increase in lung injury caused by Pseudomonas aeruginosa pneumonia in mice. Prior stroke increased lung vascular permeability caused by P. aeruginosa pneumonia and was associated with decreased lung neutrophil recruitment and bacterial clearance in mice. Pharmacologic inhibition (methyllycaconitine IC50: 0.2-0.6 nM) or genetic deletion of the alpha 7nAChR significantly (P<0.05) attenuates the effect of prior stroke on lung injury and mortality caused by P. aeruginosa pneumonia in mice. Finally, pretreatment with PNU-282987, a pharmacologic activator of the alpha 7nAChR (EC50: 0.2 mu M), significantly (P<0.05) increased lung injury caused by P. aeruginosa pneumonia, significantly (P<0.05) decreased the release of KC, a major neutrophil chemokine, and significantly (P<0.05) decreased intracellular bacterial killing by a mouse alveolar macrophage cell line and primary mouse neutrophils. In summary, the alpha 7 nicotinic cholinergic pathway plays an important role in mediating the systemic immunosuppression observed after stroke and directly contributes to more severe lung damage induced by P. aeruginosa.-Lafargue, M., Xu, L., Carles, M., Serve, E., Anjum, N., Iles, K. E., Xiong, X., Giffard, R., Pittet, J.-F. Stroke-induced activation of the alpha 7 nicotinic receptor increases Pseudomonas aeruginosa lung injury. FASEB J. 26, 2919-2929 (2012). www.fasebj.org	[Serve, Emilie; Anjum, Naseem; Iles, Karen E.; Pittet, Jean-Francois] Univ Alabama Birmingham, Dept Anesthesiol, Birmingham, AL 35249 USA; [Lafargue, Mathieu] Univ Calif San Francisco, Dept Anesthesia, San Francisco, CA 94143 USA; [Xu, Lijun; Xiong, Xiaoxing; Giffard, Rona] Stanford Univ, Sch Med, Dept Anesthesia, Palo Alto, CA 94304 USA; [Carles, Michel] Univ Nice Sophia Antipolis, Dept Anesthesia, Nice, France	University of Alabama System; University of Alabama Birmingham; University of California System; University of California San Francisco; Stanford University; UDICE-French Research Universities; Universite Cote d'Azur	Pittet, JF (corresponding author), Univ Alabama Birmingham, Dept Anesthesiol, 619 S 19th St,JT926, Birmingham, AL 35249 USA.	pittetj@uab.edu	Carles, Michel/CAH-0065-2022	Giffard, Rona/0000-0003-2173-4436; CARLES, MICHEL/0000-0001-5485-1511; Xiong, Xiaoxing/0000-0001-6983-8547	U.S. National Institutes of Health [RO1 GM-62188, RO1 GM-49831]; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM049831, R01GM062188] Funding Source: NIH RePORTER	U.S. National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported, in part, by the U.S. National Institutes of Health, grants RO1 GM-62188 (J.F.P.) and RO1 GM-49831 (R.G.).	BERTRAND N, 1993, J CEREBR BLOOD F MET, V13, P789, DOI 10.1038/jcbfm.1993.100; Bertrand N, 1996, NEUROCHEM INT, V28, P293, DOI 10.1016/0197-0186(95)00086-0; Brea D, 2009, CEREBROVASC DIS, V27, P48, DOI 10.1159/000200441; Carles M, 2010, ANESTHESIOLOGY, V113, P1134, DOI 10.1097/ALN.0b013e3181f4171b; Chamorro A, 2006, J NEUROL NEUROSUR PS, V77, P1279, DOI 10.1136/jnnp.2006.100800; Chamorro A, 2005, STROKE, V36, P1495, DOI 10.1161/01.STR.0000170644.15504.49; Chamorro A, 2007, STROKE, V38, P1097, DOI 10.1161/01.STR.0000258346.68966.9d; Cheyuo C, 2011, SHOCK, V35, P258, DOI 10.1097/SHK.0b013e3181f48a37; CZLONKOWSKA A, 1979, J NEUROL SCI, V43, P455, DOI 10.1016/0022-510X(79)90024-8; dos Santos CC, 2011, AM J RESP CRIT CARE, V183, P471, DOI 10.1164/rccm.201002-0314OC; Fukuda M, 2009, INTERNAL MED, V48, P967, DOI 10.2169/internalmedicine.48.1757; Gibson CL, 2011, BRAIN, V134, P2125, DOI 10.1093/brain/awr132; Giebelen IAJ, 2009, EUR RESPIR J, V33, P375, DOI 10.1183/09031936.00103408; Giebelen IAJ, 2007, SHOCK, V28, P700, DOI 10.1097/shk.0b013e318054dd89; Giebelen IAJ, 2008, J INFECT DIS, V198, P750, DOI 10.1086/590432; Giuliani D, 2007, EUR J PHARMACOL, V570, P57, DOI 10.1016/j.ejphar.2007.05.025; Han RQ, 2009, ANESTH ANALG, V108, P280, DOI 10.1213/ane.0b013e318187ba6b; HENON H, 1995, STROKE, V26, P392, DOI 10.1161/01.STR.26.3.392; Hilker R, 2003, STROKE, V34, P975, DOI 10.1161/01.STR.0000063373.70993.CD; KALRA L, 1995, STROKE, V26, P990, DOI 10.1161/01.STR.26.6.990; Kim JS, 2010, J CLIN NEUROL, V6, P183, DOI 10.3988/jcn.2010.6.4.183; Langhorne P, 2000, STROKE, V31, P1223, DOI 10.1161/01.STR.31.6.1223; Matsunaga K, 2001, J IMMUNOL, V167, P6518, DOI 10.4049/jimmunol.167.11.6518; McAuley Danny F, 2005, Treat Respir Med, V4, P297, DOI 10.2165/00151829-200504050-00001; Minnerup J, 2010, J NEUROL NEUROSUR PS, V81, P198, DOI 10.1136/jnnp.2009.182394; Offner H, 2006, J IMMUNOL, V176, P6523, DOI 10.4049/jimmunol.176.11.6523; Ottani A, 2009, J CEREBR BLOOD F MET, V29, P512, DOI 10.1038/jcbfm.2008.140; Prass K, 2003, J EXP MED, V198, P725, DOI 10.1084/jem.20021098; Prass K, 2006, STROKE, V37, P2607, DOI 10.1161/01.STR.0000240409.68739.2b; Robriquet L, 2011, EXP LUNG RES, V37, P453, DOI 10.3109/01902148.2011.593092; Rosas-Ballina M, 2009, NEURON, V64, P28, DOI 10.1016/j.neuron.2009.09.039; Rothwell PM, 2011, LANCET, V377, P1681, DOI 10.1016/S0140-6736(11)60516-3; Roux J, 2010, J BIOL CHEM, V285, P4278, DOI 10.1074/jbc.M109.036731; Schulte-Herbruggen O, 2006, NEUROIMMUNOMODULAT, V13, P13, DOI 10.1159/000092109; Su X, 2006, AM J PHYSIOL-LUNG C, V290, pL769, DOI 10.1152/ajplung.00334.2005; Su X, 2007, AM J RESP CELL MOL, V37, P186, DOI 10.1165/rcmb.2006-0240OC; Su X, 2010, J IMMUNOL, V184, P401, DOI 10.4049/jimmunol.0901808; SWANSON RA, 1990, J CEREBR BLOOD F MET, V10, P290, DOI 10.1038/jcbfm.1990.47; Tadie JM, 2012, AM J PHYSIOL-CELL PH, V302, pC249, DOI 10.1152/ajpcell.00302.2011; Vida G, 2011, J IMMUNOL, V186, P4340, DOI 10.4049/jimmunol.1003722; Xiong XX, 2011, STROKE, V42, P2026, DOI 10.1161/STROKEAHA.110.593772; Yamaguchi H, 2003, INFECT IMMUN, V71, P3645, DOI 10.1128/IAI.71.6.3645-3647.2003; YANG GY, 1994, STROKE, V25, P165, DOI 10.1161/01.STR.25.1.165	43	36	37	0	7	FEDERATION AMER SOC EXP BIOL	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3998 USA	0892-6638			FASEB J	Faseb J.	JUL	2012	26	7					2919	2929		10.1096/fj.11-197384	http://dx.doi.org/10.1096/fj.11-197384			11	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	967MP	22490926	Green Published			2022-12-25	WOS:000305912500020
J	Zhang, QH; Yu, DH; Seo, SJ; Stone, EM; Sheffield, VC				Zhang, Qihong; Yu, Dahai; Seo, Seongjin; Stone, Edwin M.; Sheffield, Val C.			Intrinsic Protein-Protein Interaction-mediated and Chaperonin-assisted Sequential Assembly of Stable Bardet-Biedl Syndrome Protein Complex, the BBSome	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							E3 UBIQUITIN LIGASE; COUPLED-RECEPTORS; 20S PROTEASOME; MOUSE MODEL; GENE; OBESITY; CILIA; TRANSPORT; TRIM32; IDENTIFICATION	The pleiotropic features of obesity, retinal degeneration, polydactyly, kidney abnormalities, cognitive impairment, hypertension, and diabetes found in Bardet-Biedl syndrome (BBS) make this disorder an important model disorder for identifying molecular mechanisms involved in common human diseases. To date, 16 BBS genes have been reported, seven of which (BBS1, 2, 4, 5, 7, 8, and 9) code for proteins that form a complex known as the BBSome. The function of the BBSome involves ciliary membrane biogenesis. Three additional BBS genes (BBS6, BBS10, and BBS12) have homology to type II chaperonins and interact with CCT/TRiC proteins and BBS7 to form a complex termed the BBS-chaperonin complex. This complex is required for BBSome assembly. Little is known about the process and the regulation of BBSome formation. We utilized point mutations and null alleles of BBS proteins to disrupt assembly of the BBSome leading to the accumulation of BBSome assembly intermediates. By characterizing BBSome assembly intermediates, we show that the BBS-chaperonin complex plays a role in BBS7 stability. BBS7 interacts with BBS2 and becomes part of a BBS7-BBS2-BBS9 assembly intermediate referred to as the BBSome core complex because it forms the core of the BBSome. BBS1, BBS5, BBS8, and finally BBS4 are added to the BBSome core to form the complete BBSome.	[Zhang, Qihong; Yu, Dahai; Seo, Seongjin; Sheffield, Val C.] Univ Iowa, Howard Hughes Med Inst, Dept Pediat, Div Med Genet, Iowa City, IA 52242 USA; [Stone, Edwin M.] Univ Iowa, Howard Hughes Med Inst, Dept Ophthalmol & Visual Sci, Iowa City, IA 52242 USA; [Yu, Dahai] China Med Univ, Key Lab Med Cell Biol, Res Ctr Med Genom, Shenyang 110001, Peoples R China	Howard Hughes Medical Institute; University of Iowa; Howard Hughes Medical Institute; University of Iowa; China Medical University	Sheffield, VC (corresponding author), Univ Iowa, Howard Hughes Med Inst, Dept Pediat, Div Med Genet, 4181 MERF, Iowa City, IA 52242 USA.	val-sheffield@uiowa.edu		Sheffield, Val/0000-0002-6282-0835; Stone, Edwin M./0000-0003-3343-4414; Seo, Seongjin/0000-0002-7908-3210	National Institutes of Health [R01EY110298, R01EY017168]; NATIONAL EYE INSTITUTE [R01EY017168] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS083543] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL EYE INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))	This work was supported, in whole or in part, by National Institutes of Health Grants R01EY110298 and R01EY017168 (to V.C.S).	Benzinou M, 2006, DIABETES, V55, P2876, DOI 10.2337/db06-0337; Berbari NF, 2008, MOL BIOL CELL, V19, P1540, DOI 10.1091/mbc.E07-09-0942; Berbari NF, 2008, P NATL ACAD SCI USA, V105, P4242, DOI 10.1073/pnas.0711027105; Beyer AM, 2010, AM J PHYSIOL-HEART C, V299, pH1902, DOI 10.1152/ajpheart.00336.2010; Blacque OE, 2006, CELL MOL LIFE SCI, V63, P2145, DOI 10.1007/s00018-006-6180-x; Chiang AP, 2006, P NATL ACAD SCI USA, V103, P6287, DOI 10.1073/pnas.0600158103; Chiang AP, 2004, AM J HUM GENET, V75, P475, DOI 10.1086/423903; Davis RE, 2007, P NATL ACAD SCI USA, V104, P19422, DOI 10.1073/pnas.0708571104; Deveault C, 2011, HUM MUTAT, V32, P610, DOI 10.1002/humu.21480; Fan YL, 2004, NAT GENET, V36, P989, DOI 10.1038/ng1414; Fath MA, 2005, HUM MOL GENET, V14, P1109, DOI 10.1093/hmg/ddi123; Feuillan PP, 2011, J CLIN ENDOCR METAB, V96, pE528, DOI 10.1210/jc.2010-2290; Hirano Y, 2008, EMBO J, V27, P2204, DOI 10.1038/emboj.2008.148; Jin H, 2010, CELL, V141, P1208, DOI 10.1016/j.cell.2010.05.015; Kim JC, 2005, J CELL SCI, V118, P1007, DOI 10.1242/jcs.01676; Kim JC, 2004, NAT GENET, V36, P462, DOI 10.1038/ng1352; Kudryashova E, 2005, J MOL BIOL, V354, P413, DOI 10.1016/j.jmb.2005.09.068; Li X, 2007, EMBO J, V26, P2339, DOI 10.1038/sj.emboj.7601681; Locke M, 2009, HUM MOL GENET, V18, P2344, DOI 10.1093/hmg/ddp167; Loktev AV, 2008, DEV CELL, V15, P854, DOI 10.1016/j.devcel.2008.11.001; Lucker BF, 2010, J BIOL CHEM, V285, P21508, DOI 10.1074/jbc.M110.106997; Lucker BF, 2005, J BIOL CHEM, V280, P27688, DOI 10.1074/jbc.M505062200; Marion V, 2009, P NATL ACAD SCI USA, V106, P1820, DOI 10.1073/pnas.0812518106; Mykytyn K, 2004, TRENDS MOL MED, V10, P106, DOI 10.1016/j.molmed.2004.01.003; Nachury MV, 2007, CELL, V129, P1201, DOI 10.1016/j.cell.2007.03.053; Nishimura DY, 2004, P NATL ACAD SCI USA, V101, P16588, DOI 10.1073/pnas.0405496101; Oeffinger M, 2007, NAT METHODS, V4, P951, DOI 10.1038/NMETH1101; Putoux A, 2012, PEDIATR NEPHROL, V27, P7, DOI 10.1007/s00467-010-1751-3; Rahmouni K, 2008, J CLIN INVEST, V118, P1458, DOI 10.1172/JCI32357; Sahasranaman A, 2011, EMBO J, V30, P4020, DOI 10.1038/emboj.2011.338; Sattar S, 2011, DEV MED CHILD NEUROL, V53, P793, DOI 10.1111/j.1469-8749.2011.04021.x; Seo S, 2011, PLOS GENET, V7, DOI 10.1371/journal.pgen.1002358; Seo S, 2010, P NATL ACAD SCI USA, V107, P1488, DOI 10.1073/pnas.0910268107; Seo SJ, 2009, HUM MOL GENET, V18, P1323, DOI 10.1093/hmg/ddp031; Slavotinek AM, 2002, HUM GENET, V110, P561, DOI 10.1007/s00439-002-0733-3; Stoetzel C, 2006, NAT GENET, V38, P521, DOI 10.1038/ng1771; Stoetzel C, 2007, AM J HUM GENET, V80, P1, DOI 10.1086/510256; Zhang QH, 2012, HUM MOL GENET, V21, P1945, DOI 10.1093/hmg/dds004; Zhang QH, 2011, P NATL ACAD SCI USA, V108, P20678, DOI 10.1073/pnas.1113220108	39	116	118	0	22	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JUN 8	2012	287	24					20625	20635		10.1074/jbc.M112.341487	http://dx.doi.org/10.1074/jbc.M112.341487			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	974FB	22500027	hybrid, Green Published			2022-12-25	WOS:000306414500082
J	Sanz-Salvador, L; Andres-Borderia, A; Ferrer-Montiel, A; Planells-Cases, R				Sanz-Salvador, Lucia; Andres-Borderia, Amparo; Ferrer-Montiel, Antonio; Planells-Cases, Rosa			Agonist- and Ca2+-dependent Desensitization of TRPV1 Channel Targets the Receptor to Lysosomes for Degradation	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							DEPENDENT PROTEIN-KINASE; CLATHRIN-INDEPENDENT ENDOCYTOSIS; VANILLOID RECEPTOR; PLASMA-MEMBRANE; CAPSAICIN; PATHWAY; PHOSPHORYLATION; TRAFFICKING; NEURONS; CELLS	TRPV1 receptor agonists such as the vanilloid capsaicin and the potent analog resiniferatoxin are well known potent analgesics. Depending on the vanilloid, dose, and administration site, nociceptor refractoriness may last from minutes up to months, suggesting the contribution of different cellular mechanisms ranging from channel receptor desensitization to Ca2+ cytotoxicity of TRPV1-expressing neurons. The molecular mechanisms underlying agonist-induced TRPV1 desensitization and/or tachyphylaxis are still incompletely understood. Here, we report that prolonged exposure of TRPV1 to agonists induces rapid receptor endocytosis and lysosomal degradation in both sensory neurons and recombinant systems. Agonist-induced receptor internalization followed a clathrin- and dynamin-independent endocytic route, triggered by TRPV1 channel activation and Ca2+ influx through the receptor. This process appears strongly modulated by PKA-dependent phosphorylation. Taken together, these findings indicate that TRPV1 agonists induce long-term receptor down-regulation by modulating the expression level of the channel through a mechanism that promotes receptor endocytosis and degradation and lend support to the notion that cAMP signaling sensitizes nociceptors through several mechanisms.	[Sanz-Salvador, Lucia; Andres-Borderia, Amparo; Planells-Cases, Rosa] Ctr Invest Principe Felipe, Valencia 46012, Spain; [Ferrer-Montiel, Antonio] Univ Miguel Hernandez Elche, Inst Biol Mol & Celular, Elche 03202, Spain	Prince Felipe Research Center; Universidad Miguel Hernandez de Elche	Planells-Cases, R (corresponding author), Univ Miguel Hernandez, Inst Biol Mol & Celular, Av Univ S-N, Alicante 03202, Spain.	rosamplanells@gmail.com	Ferrer-Montiel, Antonio/C-3072-2015; Borderia, Amparo Andres/AAH-6525-2021	Ferrer-Montiel, Antonio/0000-0002-2973-6607; Borderia, Amparo Andres/0000-0003-2864-5444	Spanish Ministry of Science and Innovation [SAF2007-63193, SAF2010-17045, BFU2009-08346, PROMETEO/2010/046]; Consolider-Ingenio [CSD2008-00005]; Formacion del Profesorado Universitario (FPU) (Spanish Education Ministry)	Spanish Ministry of Science and Innovation(Ministry of Science and Innovation, Spain (MICINN)Spanish Government); Consolider-Ingenio(Ministry of Science and Innovation, Spain (MICINN)Spanish Government); Formacion del Profesorado Universitario (FPU) (Spanish Education Ministry)(German Research Foundation (DFG))	This work was supported by Spanish Ministry of Science and Innovation Grants SAF2007-63193 and SAF2010-17045 (to R. P. C.), BFU2009-08346 and PROMETEO/2010/046 (to A. F. M.), and Consolider-Ingenio 2010 CSD2008-00005 (to R. P. C. and A. F. M.).; Supported by an Formacion del Profesorado Universitario (FPU) Fellowship (Spanish Education Ministry).	Akopian AN, 2007, J PHYSIOL-LONDON, V583, P175, DOI 10.1113/jphysiol.2007.133231; BEVAN S, 1992, BRIT J PHARMACOL, V107, P544, DOI 10.1111/j.1476-5381.1992.tb12781.x; Bhave G, 2002, NEURON, V35, P721, DOI 10.1016/S0896-6273(02)00802-4; Bode AM, 2009, CANCER RES, V69, P905, DOI 10.1158/0008-5472.CAN-08-3263; Camprubi-Robles M, 2009, FASEB J, V23, P3722, DOI 10.1096/fj.09-134346; Caudle RM, 2003, NEUROTOXICOLOGY, V24, P895, DOI 10.1016/S0161-813X(03)00146-3; Chaudhury S, 2011, MOL PAIN, V7, DOI 10.1186/1744-8069-7-34; Cinar H, 2001, BIOCHEMISTRY-US, V40, P14030, DOI 10.1021/bi011025t; Cortright DN, 2009, CURR PHARM DESIGN, V15, P1736, DOI 10.2174/138161209788186308; Cortright DN, 2004, EUR J BIOCHEM, V271, P1814, DOI 10.1111/j.1432-1033.2004.04082.x; Fourgeaud L, 2003, J BIOL CHEM, V278, P12222, DOI 10.1074/jbc.M205663200; Garcia-Sanz N, 2004, J NEUROSCI, V24, P5307, DOI 10.1523/JNEUROSCI.0202-04.2004; Grampp T, 2007, J BIOL CHEM, V282, P24157, DOI 10.1074/jbc.M702626200; Hammond RS, 2008, J NEUROSCI, V28, P7513, DOI 10.1523/JNEUROSCI.1951-08.2008; Ji RR, 2003, TRENDS NEUROSCI, V26, P696, DOI 10.1016/j.tins.2003.09.017; Ji RR, 2001, NEUROBIOL DIS, V8, P1, DOI 10.1006/nbdi.2000.0360; Jiang M, 2009, J NEUROSCI, V29, P8063, DOI 10.1523/JNEUROSCI.6139-08.2009; Jung JY, 2004, J BIOL CHEM, V279, P7048, DOI 10.1074/jbc.M311448200; Koplas PA, 1997, J NEUROSCI, V17, P3525; Lainez S, 2010, FASEB J, V24, P1958, DOI 10.1096/fj.09-151472; Lishko PV, 2007, NEURON, V54, P905, DOI 10.1016/j.neuron.2007.05.027; Liu BY, 2005, J NEUROSCI, V25, P4835, DOI 10.1523/JNEUROSCI.1296-05.2005; Lukacs V, 2007, J NEUROSCI, V27, P7070, DOI 10.1523/JNEUROSCI.1866-07.2007; Man HY, 2007, P NATL ACAD SCI USA, V104, P3579, DOI 10.1073/pnas.0611698104; Mizushima N, 2007, AUTOPHAGY, V3, P542, DOI 10.4161/auto.4600; Mohapatra DP, 2005, J BIOL CHEM, V280, P13424, DOI 10.1074/jbc.M410917200; Mohapatra DP, 2003, J BIOL CHEM, V278, P50080, DOI 10.1074/jbc.M306619200; Morenilla-Palao C, 2004, J BIOL CHEM, V279, P25665, DOI 10.1074/jbc.M311515200; Moser E, 2010, PHARMACOLOGY, V86, P22, DOI 10.1159/000314161; Murphy JE, 2009, P NATL ACAD SCI USA, V106, P17615, DOI 10.1073/pnas.0906541106; Numazaki M, 2003, P NATL ACAD SCI USA, V100, P8002, DOI 10.1073/pnas.1337252100; Planells-Cases R, 2005, PFLUG ARCH EUR J PHY, V451, P151, DOI 10.1007/s00424-005-1423-5; Planells-Cases R, 2011, ADV EXP MED BIOL, V704, P491, DOI 10.1007/978-94-007-0265-3_27; Ricks TK, 2009, J BIOL CHEM, V284, P34444, DOI 10.1074/jbc.M109.048942; Roseberry AG, 2001, J CELL SCI, V114, P739; Rosenbaum T, 2004, J GEN PHYSIOL, V123, P53, DOI 10.1085/jgp.200308906; Sigismund S, 2005, P NATL ACAD SCI USA, V102, P2760, DOI 10.1073/pnas.0409817102; Stein AT, 2006, J GEN PHYSIOL, V128, P509, DOI 10.1085/jgp.200609576; Toth A, 2005, LIFE SCI, V76, P2921, DOI 10.1016/j.lfs.2004.10.056; Vetter I, 2006, MOL PAIN, V2, DOI 10.1186/1744-8069-2-22; WANG LH, 1993, J CELL BIOL, V123, P1107, DOI 10.1083/jcb.123.5.1107; Williams A, 2008, NAT CHEM BIOL, V4, P295, DOI 10.1038/nchembio.79; Yao J, 2009, PLOS BIOL, V7, P350, DOI 10.1371/journal.pbio.1000046; Zhang XM, 2005, EMBO J, V24, P4211, DOI 10.1038/sj.emboj.7600893	44	91	95	0	6	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JUN 1	2012	287	23					19462	19471		10.1074/jbc.M111.289751	http://dx.doi.org/10.1074/jbc.M111.289751			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	974EF	22493457	Green Published, hybrid			2022-12-25	WOS:000306411900060
J	Guturi, KKN; Mandal, T; Chatterjee, A; Sarkar, M; Bhattacharya, S; Chatterjee, U; Ghosh, MK				Guturi, Kiran Kumar Naidu; Mandal, Tapashi; Chatterjee, Anirban; Sarkar, Moumita; Bhattacharya, Seemana; Chatterjee, Uttara; Ghosh, Mrinal K.			Mechanism of beta-Catenin-mediated Transcriptional Regulation of Epidermal Growth Factor Receptor Expression in Glycogen Synthase Kinase 3 beta-inactivated Prostate Cancer Cells	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							ANDROGEN-INDEPENDENCE; ABERRANT EXPRESSION; PROTEIN-KINASE; COLON-CANCER; PATHWAY; PHOSPHORYLATION; ACTIVATION; MUTATIONS; TARGET; GENE	Wnt/beta-catenin and EGFR pathways are important in cancer development and often aberrantly activated in human cancer. However, it is very important to understand the mechanism responsible for this activation and the relation between them. Here, we report the mechanism of EGFR expression by transcriptionally active beta-catenin in GSK3 beta-inactivated prostate cancer cells that eventually leads to its enhanced proliferation and survival. Expressions of beta-catenin and EGFR are elevated in various cancers specifically in prostate cancer cells, DU145. When GSK3 beta is inactivated in these cells, beta-catenin gets stabilized, phosphorylated at Ser-552 by protein kinase A, accumulates in the nucleus, and regulates the expression of its target genes that include EGFR. Chromatin immunoprecipitation (ChIP) and promoter analysis revealed that the EGFR promoter gets occupied by transcriptionally active beta-catenin when elevated in GSK3 beta-inactivated cells. This phenomenon not only leads to increased expression of EGFR but also initiates the activation of its downstream molecules such as ERK1/2 and Stat3, ultimately resulting in up-regulation of multiple genes involved in cell proliferation and survival.	[Guturi, Kiran Kumar Naidu; Mandal, Tapashi; Chatterjee, Anirban; Sarkar, Moumita; Bhattacharya, Seemana; Ghosh, Mrinal K.] Indian Inst Chem Biol, Council Sci & Ind Res, Signal Transduct Canc & Stem Cells Lab, Kolkata 700032, W Bengal, India; [Chatterjee, Uttara] Inst Postgrad Med Educ & Res Hosp, Kolkata, India; [Chatterjee, Uttara] Inst Postgrad Med Educ & Res, Dept Pathol, Kolkata, India	Council of Scientific & Industrial Research (CSIR) - India; CSIR - Indian Institute of Chemical Biology (IICB); Institute of Post Graduate Medical Education & Research (IPGMER), Kolkata; Institute of Post Graduate Medical Education & Research (IPGMER), Kolkata	Ghosh, MK (corresponding author), Indian Inst Chem Biol, Council Sci & Ind Res, Signal Transduct Canc & Stem Cells Lab, 4 Raja SC Mullick Rd, Kolkata 700032, W Bengal, India.	mrinal.res@gmail.com		Chatterjee, Anirban/0000-0002-9082-2221	Department of Science Technology [SR/SO/HS-0126/2007]; Council of Scientific and Industrial Research (EMPOWER) [OLP-2]	Department of Science Technology(Department of Science & Technology (India)); Council of Scientific and Industrial Research (EMPOWER)	This work was supported by grants provided by Department of Science & Technology (SR/SO/HS-0126/2007) and Council of Scientific and Industrial Research (EMPOWER: OLP-2) (to M. K. G.).	Bandapalli OR, 2009, J PATHOL, V218, P370, DOI 10.1002/path.2539; Beurel E, 2006, PROG NEUROBIOL, V79, P173, DOI 10.1016/j.pneurobio.2006.07.006; Bierie B, 2003, ONCOGENE, V22, P3875, DOI 10.1038/sj.onc.1206426; Bottomly D, 2010, NUCLEIC ACIDS RES, V38, P5735, DOI 10.1093/nar/gkq363; Chesire DR, 2002, ONCOGENE, V21, P8453, DOI 10.1038/sj.onc.1206049; Chesire DR, 2000, PROSTATE, V45, P323, DOI 10.1002/1097-0045(20001201)45:4<323::AID-PROS7>3.0.CO;2-W; CONNOLLY JM, 1991, PROSTATE, V19, P173, DOI 10.1002/pros.2990190210; Das T, 2010, MOL CELL BIOCHEM, V336, P85, DOI 10.1007/s11010-009-0269-0; Daugherty RL, 2007, PHYSIOLOGY, V22, P303, DOI 10.1152/physiol.00020.2007; Di Lorenzo G, 2002, CLIN CANCER RES, V8, P3438; DIFIORE PP, 1987, CELL, V51, P1063, DOI 10.1016/0092-8674(87)90592-7; DIFIORE PP, 1987, SCIENCE, V237, P178, DOI 10.1126/science.2885917; Djakiew D, 2000, PROSTATE, V42, P150, DOI 10.1002/(SICI)1097-0045(20000201)42:2<150::AID-PROS10>3.0.CO;2-H; Fang DX, 2007, J BIOL CHEM, V282, P11221, DOI 10.1074/jbc.M611871200; Festuccia C, 2005, ENDOCR-RELAT CANCER, V12, P983, DOI 10.1677/erc.1.00986; Gerstein AV, 2002, GENE CHROMOSOME CANC, V34, P9, DOI 10.1002/gcc.10037; Ghosh MK, 2003, MOL CELL, V12, P255, DOI 10.1016/S1097-2765(03)00225-9; Ghosh MK, 2005, ONCOGENE, V24, P7290, DOI 10.1038/sj.onc.1208894; GULLICK WJ, 1991, BRIT MED BULL, V47, P87, DOI 10.1093/oxfordjournals.bmb.a072464; Hatzis P, 2008, MOL CELL BIOL, V28, P2732, DOI 10.1128/MCB.02175-07; He XC, 2007, NAT GENET, V39, P189, DOI 10.1038/ng1928; Hu TH, 2010, MOL CANCER, V9, DOI 10.1186/1476-4598-9-236; Huber AH, 2001, CELL, V105, P391, DOI 10.1016/S0092-8674(01)00330-0; Huelsken J, 2002, J CELL SCI, V115, P3977, DOI 10.1242/jcs.00089; Jaggi M, 2005, UROL ONCOL-SEMIN ORI, V23, P402, DOI 10.1016/j.urolonc.2005.03.024; Jemal A, 2008, CA-CANCER J CLIN, V58, P71, DOI 10.3322/CA.2007.0010; Li QJ, 2004, GENOMICS, V83, P231, DOI 10.1016/j.ygeno.2003.08.004; Lorenzo Giuseppe Di, 2003, Clin Prostate Cancer, V2, P50; Lu ZM, 2004, CELL CYCLE, V3, P571; Luwor R., 2008, NATURE PRECEDIN 0123; Mishra R, 2010, MOL CANCER, V9, DOI 10.1186/1476-4598-9-144; Moore MJ, 2002, J BIOL CHEM, V277, P47878, DOI 10.1074/jbc.M204970200; Morin PJ, 1997, SCIENCE, V275, P1787, DOI 10.1126/science.275.5307.1787; Musgrove EA, 2004, BREAST CANCER RES, V6, P65, DOI 10.1186/bcr737; O'Brien WT, 2009, BIOCHEM SOC T, V37, P1133, DOI 10.1042/BST0371133; OZAWA M, 1989, EMBO J, V8, P1711, DOI 10.1002/j.1460-2075.1989.tb03563.x; Saia G, 2007, CURR CANCER THER REV, V3, P25, DOI 10.2174/157339407780126647; Sarbassov DD, 2005, J BIOL CHEM, V280, P39505, DOI 10.1074/jbc.M506096200; Schlomm T, 2007, CLIN CANCER RES, V13, P6579, DOI 10.1158/1078-0432.CCR-07-1257; Sha JF, 2010, J VIROL, V84, P4050, DOI 10.1128/JVI.02131-09; Shah RB, 2006, PROSTATE, V66, P1437, DOI 10.1002/pros.20460; Siddique HR, 2011, CLIN CANCER RES, V17, P5379, DOI 10.1158/1078-0432.CCR-11-0916; Tan XP, 2005, GASTROENTEROLOGY, V129, P285, DOI 10.1053/j.gastro.2005.04.013; Taurin S, 2006, J BIOL CHEM, V281, P9971, DOI 10.1074/jbc.M508778200; Verheyen EM, 2010, DEV DYNAM, V239, P34, DOI 10.1002/dvdy.22019; Voeller HJ, 1998, CANCER RES, V58, P2520; Wang Q, 2006, ONCOGENE, V25, P43, DOI 10.1038/sj.onc.1209004; Whitaker HC, 2008, PROSTATE, V68, P1196, DOI 10.1002/pros.20780; Xu C, 2009, CELL CYCLE, V8, P4032, DOI 10.4161/cc.8.24.10111; Yardy GW, 2005, PROSTATE CANCER P D, V8, P119, DOI 10.1038/sj.pcan.4500794; Yu H, 2004, NAT REV CANCER, V4, P97, DOI 10.1038/nrc1275; Zhao JX, 2010, BIOCHEM BIOPH RES CO, V395, P146, DOI 10.1016/j.bbrc.2010.03.161	52	48	51	1	3	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAY 25	2012	287	22					18287	18296		10.1074/jbc.M111.324798	http://dx.doi.org/10.1074/jbc.M111.324798			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	974EC	22493441	Green Published, hybrid			2022-12-25	WOS:000306411600035
J	Chowdhary, R; Tan, SL; Zhang, JF; Karnik, S; Bajic, VB; Liu, JS				Chowdhary, Rajesh; Tan, Sin Lam; Zhang, Jinfeng; Karnik, Shreyas; Bajic, Vladimir B.; Liu, Jun S.			Context-Specific Protein Network Miner - An Online System for Exploring Context-Specific Protein Interaction Networks from the Literature	PLOS ONE			English	Article							FILAGGRIN MUTATIONS; HAY-FEVER; GENE; KNOWLEDGE; ASTHMA; IDENTIFICATION; ONTOLOGY; DATABASE; LIBRARY; ECZEMA	Background: Protein interaction networks (PINs) specific within a particular context contain crucial information regarding many cellular biological processes. For example, PINs may include information on the type and directionality of interaction (e.g. phosphorylation), location of interaction (i.e. tissues, cells), and related diseases. Currently, very few tools are capable of deriving context-specific PINs for conducting exploratory analysis. Results: We developed a literature-base d online system, Context-specific Protein Network Miner (CPNM), which derives context-specific PINs in real-time from the PubMed database based on a set of user-input keywords and enhanced PubMed query system. CPNM reports enriched information on protein interactions (with type and directionality), their network topology with summary statistics (e.g. most densely connected proteins in the network; most densely connected protein-pairs; and proteins connected by most inbound/outbound links) that can be explored via a user-friendly interface. Some of the novel features of the CPNM system include PIN generation, ontology-based PubMed query enhancement, real-time, user-queried, up-to-date PubMed document processing, and prediction of PIN directionality. Conclusions: CPNM provides a tool for biologists to explore PINs. It is freely accessible at http://www.biotextminer.com/CPNM/.	[Chowdhary, Rajesh; Tan, Sin Lam; Karnik, Shreyas] Marshfield Clin Res Fdn, Biomed Informat Res Ctr, Marshfield Clin, Marshfield Ctr, Marshfield, WI USA; [Zhang, Jinfeng] Florida State Univ, Dept Stat, Tallahassee, FL 32306 USA; [Bajic, Vladimir B.] KAUST, Computat Biosci Res Ctr, Thuwal, Saudi Arabia; [Liu, Jun S.] Harvard Univ, Dept Stat, Cambridge, MA 02138 USA	Marshfield Clinic; State University System of Florida; Florida State University; King Abdullah University of Science & Technology; Harvard University	Chowdhary, R (corresponding author), Marshfield Clin Res Fdn, Biomed Informat Res Ctr, Marshfield Clin, Marshfield Ctr, Marshfield, WI USA.	chowdhary.rajesh@mcrf.mfldclin.edu	Bajic, Vladimir/D-2810-2009	Bajic, Vladimir/0000-0001-5435-4750				Agarwal S, 2010, BIOCREATIVE, V46-51; Apweiler R, 2004, NUCLEIC ACIDS RES, V32, pD115, DOI 10.1093/nar/gkh131; Aranda B, 2010, NUCLEIC ACIDS RES, V38, pD525, DOI 10.1093/nar/gkp878; Ashburner M, 2000, NAT GENET, V25, P25, DOI 10.1038/75556; Barbosa-Silva A, 2010, BMC BIOINFORMATICS, V11, DOI 10.1186/1471-2105-11-70; Beuming T, 2005, BIOINFORMATICS, V21, P827, DOI 10.1093/bioinformatics/bti098; Bjorne J, 2010, BIOINFORMATICS, V26, pi382, DOI 10.1093/bioinformatics/btq180; Bui QC, 2011, BIOINFORMATICS, V27, P259, DOI 10.1093/bioinformatics/btq620; Bunescu R, 2005, ARTIF INTELL MED, V33, P139, DOI 10.1016/j.artmed.2004.07.016; Ceol A, 2010, NUCLEIC ACIDS RES, V38, pD532, DOI 10.1093/nar/gkp983; Chowdhary R, 2011, INT J DATA IN PRESS; Chowdhary R, 2009, BIOINFORMATICS, V25, P1536, DOI 10.1093/bioinformatics/btp245; Croft D, 2011, NUCLEIC ACIDS RES, V39, pD691, DOI 10.1093/nar/gkq1018; Dogan RI, 2010, P BIOCR 3 WORKSH BET, P61; Du P, 2009, BIOINFORMATICS, V25, pI63, DOI 10.1093/bioinformatics/btp193; Fontaine JF, 2010, P BIOCR 3 WORKSH BET, P67; Gerner M., 2010, P WORKSH BIOM NAT LA, P72; Gremse M, 2011, NUCLEIC ACIDS RES, V39, pD507, DOI 10.1093/nar/gkq968; Hakenberg J, 2008, BIOINFORMATICS, V24, pI126, DOI 10.1093/bioinformatics/btn299; Hakenberg J, 2011, BIOINFORMATICS, V27, P2769, DOI 10.1093/bioinformatics/btr455; Hanisch D, 2005, BMC BIOINFORMATICS, V6, DOI 10.1186/1471-2105-6-S1-S14; Heguy A, 2006, J MOL MED, V84, P318, DOI 10.1007/s00109-005-0008-2; Hirschman L, 2005, BMC BIOINFORMATICS, V6, DOI 10.1186/1471-2105-6-S1-S11; Hoffmann R, 2004, NAT GENET, V36, P664, DOI 10.1038/ng0704-664; Huang ML, 2011, BIOINFORMATICS, V27, P1032, DOI 10.1093/bioinformatics/btr042; Hunter L, 2008, BMC BIOINFORMATICS, V9, DOI 10.1186/1471-2105-9-78; Iossifov I, 2009, PLOS COMPUT BIOL, V5, DOI 10.1371/journal.pcbi.1000559; Kanehisa M, 2012, NUCLEIC ACIDS RES, V40, pD109, DOI 10.1093/nar/gkr988; Kim S, 2010, P BIOCR 3 13 15 SEPT, P83; Kim S, 2008, NUCLEIC ACIDS RES, V36, pW411, DOI 10.1093/nar/gkn281; Krallinger M, 2011, BMC BIOINFO IN PRESS; Kuhn M, 2008, NUCLEIC ACIDS RES, V36, pD684, DOI 10.1093/nar/gkm795; Leaman R, 2010, P BIOCR 3 WORKSH BET, P99; Leaman Robert, 2008, Pac Symp Biocomput, P652; Liu HF, 2006, BIOINFORMATICS, V22, P103, DOI 10.1093/bioinformatics/bti749; Lopes CT, 2010, BIOINFORMATICS, V26, P2347, DOI 10.1093/bioinformatics/btq430; Lourenco A, 2010, P BIOCR 3 WORKSH BET, P113; Maglott D, 2007, NUCLEIC ACIDS RES, V35, pD26, DOI 10.1093/nar/gkl993; Matos S, 2010, P BIOCR 3 WORKSH BET, P119; Mika S, 2004, NUCLEIC ACIDS RES, V32, pW634, DOI 10.1093/nar/gkh427; Morgan AA, 2008, GENOME BIOL, V9, DOI 10.1186/gb-2008-9-S2-S3; Natale DA, 2007, BMC BIOINFORMATICS, V8, DOI 10.1186/1471-2105-8-S9-S1; Neves ML, 2010, BMC BIOINFORMATICS, V11, DOI 10.1186/1471-2105-11-157; Okazaki N, 2010, P BIOCREATIVE, P125; Pagel P, 2005, BIOINFORMATICS, V21, P832, DOI 10.1093/bioinformatics/bti115; Palmer CNA, 2007, J ALLERGY CLIN IMMUN, V120, P64, DOI 10.1016/j.jaci.2007.04.001; Poninska J, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0016933; Prasad TSK, 2009, NUCLEIC ACIDS RES, V37, pD767, DOI 10.1093/nar/gkn892; Rebholz-Schuhmann D, 2008, BIOINFORMATICS, V24, P296, DOI 10.1093/bioinformatics/btm557; Rogers AJ, 2007, J ALLERGY CLIN IMMUN, V120, P1332, DOI 10.1016/j.jaci.2007.09.037; Rzhetsky A, 2008, CELL, V134, P9, DOI 10.1016/j.cell.2008.06.029; Saetre R., 2008, P 2 INT S LANG BIOL; Saetre R, 2010, IEEE ACM T COMPUT BI, V7, P442, DOI 10.1109/TCBB.2010.46; Sayers EW, 2010, NUCLEIC ACIDS RES, V38, P5, DOI DOI 10.1093/NAR/GKP967; Schaefer CF, 2009, NUCLEIC ACIDS RES, V37, pD674, DOI 10.1093/nar/gkn653; Schuttelaar MLA, 2009, ALLERGY, V64, P1758, DOI 10.1111/j.1398-9995.2009.02080.x; Smith B, 2007, NAT BIOTECHNOL, V25, P1251, DOI 10.1038/nbt1346; Smith L, 2008, GENOME BIOL, V9, DOI 10.1186/gb-2008-9-S2-S2; Solt I, 2010, BIOCREATIVE 3 WORKSH, P143; Stark C, 2006, NUCLEIC ACIDS RES, V34, pD535, DOI 10.1093/nar/gkj109; Szklarczyk D, 2011, NUCLEIC ACIDS RES, V39, pD561, DOI 10.1093/nar/gkq973; Tikk D, 2010, PLOS COMPUT BIOL, V6, DOI 10.1371/journal.pcbi.1000837; Tsuruoka Y, 2005, ADV INFORM; Wei CH, 2009, 2009 9 IEEE INT C BI, P461; Weidinger S, 2008, J ALLERGY CLIN IMMUN, V121, P1203, DOI 10.1016/j.jaci.2008.02.014; Wermter J, 2009, BIOINFORMATICS, V25, P815, DOI 10.1093/bioinformatics/btp071; Wong LS, 2010, J COMPUT SCI TECH-CH, V25, P124, DOI 10.1007/s11390-010-9310-8; Wren JD, 2004, BIOINFORMATICS, V20, P389, DOI 10.1093/bioinformatics/btg421; Xu H, 2007, BIOINFORMATICS, V23, P1015, DOI 10.1093/bioinformatics/btm056; Yu N, 2012, NUCLEIC ACIDS RES, V40, pD797, DOI 10.1093/nar/gkr1127; Zhou S, 2011, P NATL ACAD SCI USA, V108, P2100, DOI 10.1073/pnas.1014792108	71	20	20	1	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 6	2012	7	4							e34480	10.1371/journal.pone.0034480	http://dx.doi.org/10.1371/journal.pone.0034480			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	955JA	22493694	Green Published, Green Submitted, gold			2022-12-25	WOS:000305012700036
J	Knights, AM; Firth, LB; Walters, K				Knights, Antony M.; Firth, Louise B.; Walters, Keith			Interactions between Multiple Recruitment Drivers: Post-Settlement Predation Mortality and Flow-Mediated Recruitment	PLOS ONE			English	Article							LARVAL DISPERSAL; MARINE ECOLOGY; LIMITATION; CONSEQUENCES; COMPETITION; COMPLEXITY; STRESSORS; ABUNDANCE; SELECTION; BEHAVIOR	Background: Dispersal is a primary driver in shaping the future distribution of species in both terrestrial and marine systems. Physical transport by advection can regulate the distance travelled and rate of propagule supply to a habitat but post-settlement processes such as predation can decouple supply from recruitment. The effect of flow-mediated recruitment and predation on the recruitment success of an intertidal species, the eastern oyster Crassostrea virginica was evaluated in two-replicated field experiments. Two key crab species were manipulated to test predator identity effects on oyster mortality. Findings: Recruitment was similar to 58% higher in high flow compared to low flow, but predation masked those differences. Predation mortality was primarily attributed to the blue crab Callinectes sapidus, whilst the mud crab Panopeus herbstii had no effect on recruit mortality. Recruit mortality from predation was high when recruit densities were high, but when recruit density was low, predation effects were not seen. Under high recruitment (supply), predation determined maximum population size and in low flow environments, recruitment success is likely determined by a combination of recruitment and resource limitation but not predation. Conclusions: Four processes are demonstrated: (1) Increases in flow rate positively affect recruitment success; (2) In high flow (recruitment) environments, resource availability is less important than predation; (3) predation is an important source of recruit mortality, but is dependent upon recruit density; and (4) recruitment and/or resource limitation is likely a major driver of population structure and functioning, modifying the interaction between predators and prey. Simultaneous testing of flow-mediated recruitment and predation was required to differentiate between the role of each process in determining population size. Our results reinforce the importance of propagule pressure, predation and post-settlement mortality as important determinants of population growth and persistence, but demonstrate that they should not be considered mutually exclusive.	[Knights, Antony M.; Firth, Louise B.; Walters, Keith] Coastal Carolina Univ, Dept Marine Sci, Conway, SC USA; [Knights, Antony M.] Univ Liverpool, Sch Environm Sci, Liverpool L69 3BX, Merseyside, England; [Firth, Louise B.] Natl Univ Ireland Galway, Ryan Inst, Dept Zool, Galway, Ireland	Coastal Carolina University; University of Liverpool; Ollscoil na Gaillimhe-University of Galway	Knights, AM (corresponding author), Coastal Carolina Univ, Dept Marine Sci, Conway, SC USA.	a.knights@liv.ac.uk	Walters, Keith/AAE-4802-2020	Walters, Keith/0000-0001-8709-9768; Knights, Antony/0000-0002-0916-3469	National Fish and Wildlife Foundation	National Fish and Wildlife Foundation	This study was funded by a grant from the National Fish and Wildlife Foundation through the Savannah-Pee Dee Resource Protection Fund to K. Walters and L. D. Coen. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bertness MD, 2002, ECOLOGY, V83, P3434, DOI 10.1890/0012-9658(2002)083[3434:DASCSE]2.0.CO;2; Blackburn TM, 2011, BIODIVERS CONSERV, V20, P2189, DOI 10.1007/s10531-011-0081-5; Boesch D, 2001, SCIENCE, V293, P1589; Bricker M, 2010, ECOLOGY, V91, P85, DOI 10.1890/08-1773.1; Burgess SC, 2011, J ANIM ECOL, V80, P681, DOI 10.1111/j.1365-2656.2010.01802.x; Caley MJ, 1996, ANNU REV ECOL SYST, V27, P477, DOI 10.1146/annurev.ecolsys.27.1.477; CONNELL JH, 1961, ECOL MONOGR, V31, P61, DOI 10.2307/1950746; CONNELL JH, 1961, ECOLOGY, V42, P710, DOI 10.2307/1933500; Cowen RK, 2006, SCIENCE, V311, P522, DOI 10.1126/science.1122039; Cowen RK, 2009, ANNU REV MAR SCI, V1, P443, DOI 10.1146/annurev.marine.010908.163757; Darling ES, 2008, ECOL LETT, V11, P1278, DOI 10.1111/j.1461-0248.2008.01243.x; Denny M. W., 1988, BIOL MECH WAVE SWEPT; DOHERTY P, 1994, SCIENCE, V263, P935, DOI 10.1126/science.263.5149.935; Ferner MC, 2009, MAR ECOL PROG SER, V374, P13, DOI 10.3354/meps07764; Finelli CM, 2000, ECOLOGY, V81, P784, DOI 10.1890/0012-9658(2000)081[0784:PCOEPA]2.0.CO;2; Firth LB, 2009, J EXP MAR BIOL ECOL, V375, P70, DOI 10.1016/j.jembe.2009.05.011; FRECHETTE M, 1989, LIMNOL OCEANOGR, V34, P19, DOI 10.4319/lo.1989.34.1.0019; Gaines SD, 2007, OCEANOGRAPHY, V20, P90, DOI 10.5670/oceanog.2007.32; GOTELLI NJ, 1991, AM NAT, V138, P768, DOI 10.1086/285249; Grabowski JH, 2005, ECOLOGY, V86, P1926, DOI 10.1890/04-0690; HOLLING C. S., 1959, CANADIAN ENT, V91, P293; HOLLING C. S., 1966, Memoirs of the Entomology Society of Canada; Holling C. S., 1965, Mem ent Soc Canada Ottawa, Vno. 45, P1; HUGHES RN, 1981, MAR ECOL PROG SER, V6, P83, DOI 10.3354/meps006083; Jackson JL, 2007, LIMNOL OCEANOGR, V52, P1883, DOI 10.4319/lo.2007.52.5.1883; Jenkins SR, 2005, J ANIM ECOL, V74, P893, DOI 10.1111/j.1365-2656.2005.00985.x; Knights AM, 2010, MAR ECOL PROG SER, V404, P79, DOI 10.3354/meps08480; Kritzer JP, 2004, FISH FISH, V5, P131, DOI 10.1111/j.1467-2979.2004.00131.x; Leonard GH, 1998, ECOLOGY, V79, P1395; Liu H, 2002, DATA MIN KNOWL DISC, V6, P393, DOI 10.1023/A:1016304305535; Lopez-Urrutia A, 2007, ECOLOGY, V88, P817, DOI 10.1890/06-1641; Miller LP, 2007, J EXP MAR BIOL ECOL, V344, P215, DOI 10.1016/j.jembe.2007.01.005; MORGAN S, 1995, ECOLOGY MARINE INVER; Morin X, 2009, ECOLOGY, V90, P1301, DOI 10.1890/08-0134.1; Nathan R, 2011, THEOR ECOL-NETH, V4, P113, DOI 10.1007/s12080-011-0115-3; O'Connor MI, 2007, P NATL ACAD SCI USA, V104, P1266, DOI 10.1073/pnas.0603422104; O'Connor NE, 2008, ECOLOGY, V89, P428, DOI 10.1890/06-2029.1; Oberle B, 2011, P NATL ACAD SCI USA, V108, P5655, DOI 10.1073/pnas.1012302108; OLAFSSON EB, 1994, OCEANOGR MAR BIOL, V32, P65; PAINE RT, 1966, AM NAT, V100, P65, DOI 10.1086/282400; PAWLIK JR, 1992, OCEANOGR MAR BIOL, V30, P273; Pernet F, 2003, MAR ECOL PROG SER, V260, P125, DOI 10.3354/meps260125; PIANKA ER, 1974, P NATL ACAD SCI USA, V71, P2141, DOI 10.1073/pnas.71.5.2141; Pineda J, 2007, OCEANOGRAPHY, V20, P22, DOI 10.5670/oceanog.2007.27; Porter ET, 2000, LIMNOL OCEANOGR, V45, P145, DOI 10.4319/lo.2000.45.1.0145; R Core Team, 2022, R LANG ENV STAT COMP; Regan HM, 2001, AM NAT, V157, P1, DOI 10.1086/317005; Roughgarden J., 1987, P491; Schmitz OJ, 2000, AM NAT, V155, P141, DOI 10.1086/303311; Shurin JB, 2002, ECOL LETT, V5, P785, DOI 10.1046/j.1461-0248.2002.00381.x; Silliman BR, 2004, ESTUARIES, V27, P188, DOI 10.1007/BF02803375; Smee DL, 2010, ECOLOGY, V91, P1391, DOI 10.1890/09-0017.1; Sokal RR, 1995, BIOMETRY; THOMPSON TL, 1994, LIMNOL OCEANOGR, V39, P1768, DOI 10.4319/lo.1994.39.7.1768; Tilman D, 1997, ECOLOGY, V78, P81, DOI 10.1890/0012-9658(1997)078[0081:CIRLAG]2.0.CO;2; Underwood A.J., 1998, GEN MODEL ANAL VARIA; Underwood A.J., 1997, EXPT ECOLOGY THEIR L, DOI DOI 10.1017/CBO9780511806407; UNDERWOOD AJ, 1989, TRENDS ECOL EVOL, V4, P16, DOI 10.1016/0169-5347(89)90008-6; Vitousek PM, 2010, ECOL APPL, V20, P5, DOI 10.1890/08-0127.1; WEISSBURG MJ, 1993, ECOLOGY, V74, P1428, DOI 10.2307/1940072; White JW, 2010, MAR ECOL PROG SER, V398, P49, DOI 10.3354/meps08327	61	32	32	0	46	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 6	2012	7	4							e35096	10.1371/journal.pone.0035096	http://dx.doi.org/10.1371/journal.pone.0035096			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	955JA	22493734	Green Published, gold, Green Submitted			2022-12-25	WOS:000305012700076
J	Van den Bergh, R; Morin, S; Sass, HJ; Grzesiek, S; Vekemans, M; Florence, E; Huyen, TTT; Imiru, RG; Heyndrickx, L; Vanham, G; De Baetselier, P; Raes, G				Van den Bergh, Rafael; Morin, Sebastien; Sass, Hans Juergen; Grzesiek, Stephan; Vekemans, Marc; Florence, Eric; Huyen Thanh Thi Tran; Imiru, Rosina Gabriel; Heyndrickx, Leo; Vanham, Guido; De Baetselier, Patrick; Raes, Geert			Monocytes Contribute to Differential Immune Pressure on R5 versus X4 HIV through the Adipocytokine Visfatin/NAMPT	PLOS ONE			English	Article							HUMAN-IMMUNODEFICIENCY-VIRUS; T-CELLS; EVOLUTIONARY DYNAMICS; BIOSENSOR TECHNOLOGY; REPLICATIVE FITNESS; CORECEPTOR SWITCH; TYPE-1 INFECTION; IN-VITRO; MACROPHAGES; TRANSMISSION	Background: The immune system exerts a diversifying selection pressure on HIV through cellular, humoral and innate mechanisms. This pressure drives viral evolution throughout infection. A better understanding of the natural immune pressure on the virus during infection is warranted, given the clinical interest in eliciting and sustaining an immune response to HIV which can help to control the infection. We undertook to evaluate the potential of the novel HIV-induced, monocyte-derived factor visfatin to modulate viral infection, as part of the innate immune pressure on viral populations. Results: We show that visfatin is capable of selectively inhibiting infection by R5 HIV strains in macrophages and resting PBMC in vitro, while at the same time remaining indifferent to or even favouring infection by X4 strains. Furthermore, visfatin exerts a direct effect on the relative fitness of R5 versus X4 infections in a viral competition setup. Direct interaction of visfatin with the CCR5 receptor is proposed as a putative mechanism for this differential effect. Possible in vivo relevance of visfatin induction is illustrated by its association with the dominance of CXCR4-using HIV in the plasma. Conclusions: As an innate factor produced by monocytes, visfatin is capable of inhibiting infections by R5 but not X4 strains, reflecting a potential selective pressure against R5 viruses.	[Van den Bergh, Rafael; Huyen Thanh Thi Tran; Imiru, Rosina Gabriel; De Baetselier, Patrick; Raes, Geert] VIB, Dept Mol & Cellular Interact, Brussels, Belgium; [Van den Bergh, Rafael; Huyen Thanh Thi Tran; Imiru, Rosina Gabriel; De Baetselier, Patrick; Raes, Geert] Vrije Univ Brussel, Lab Cellular & Mol Immunol, Brussels, Belgium; [Morin, Sebastien; Sass, Hans Juergen; Grzesiek, Stephan] Univ Basel, Div Struct Biol, Biozentrum, Basel, Switzerland; [Vekemans, Marc; Florence, Eric] Inst Trop Med, Dept Clin Sci, HIV STD Unit, B-2000 Antwerp, Belgium; [Imiru, Rosina Gabriel; Heyndrickx, Leo; Vanham, Guido] Inst Trop Med, Dept Microbiol, HIV Virol Unit, B-2000 Antwerp, Belgium; [Vanham, Guido] Vrije Univ Brussel, Fac Med & Pharm, Brussels, Belgium; [Vanham, Guido] Univ Antwerp, Dept Biomed Sci, Fac Pharmaceut Biomed & Vet Sci, B-2020 Antwerp, Belgium	Flanders Institute for Biotechnology (VIB); Vrije Universiteit Brussel; University of Basel; Institute of Tropical Medicine (ITM); Institute of Tropical Medicine (ITM); Vrije Universiteit Brussel; University of Antwerp	Van den Bergh, R (corresponding author), VIB, Dept Mol & Cellular Interact, Brussels, Belgium.	rvdbergh@vub.ac.be	De Baetselier, Patrick/D-3866-2014; Raes, Geert M/H-5185-2013	Raes, Geert M/0000-0002-9065-1549; Grzesiek, Stephan/0000-0003-1998-4225; Florence, Eric/0000-0002-7004-9120; Van den Bergh, Rafael/0000-0001-6277-8713; Morin, Sebastien/0000-0003-4426-326X	Institute for the Promotion of Innovation through Science and Technology in Flanders (IWT-Vlaanderen) [IWT SB474]; European Molecular Biology Organization (EMBO)	Institute for the Promotion of Innovation through Science and Technology in Flanders (IWT-Vlaanderen)(Institute for the Promotion of Innovation by Science and Technology in Flanders (IWT)); European Molecular Biology Organization (EMBO)(European Molecular Biology Organization (EMBO))	This work was supported in part by a grant of the Institute for the Promotion of Innovation through Science and Technology in Flanders (IWT-Vlaanderen) to RVdB (IWT SB474). The European Molecular Biology Organization (EMBO) is acknowledged for a postdoctoral fellowship to SM. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aquaro S, 2002, J MED VIROL, V68, P479, DOI 10.1002/jmv.10245; Arien KK, 2006, VIROLOGY, V347, P65, DOI 10.1016/j.virol.2005.11.045; Beirnaert E, 1998, J VIROL METHODS, V73, P65, DOI 10.1016/S0166-0934(98)00044-5; Bewick S, 2011, B MATH BIOL; Carr JM, 1999, VIROLOGY, V265, P319, DOI 10.1006/viro.1999.0047; CROWE S, 1987, AIDS RES HUM RETROV, V3, P135, DOI 10.1089/aid.1987.3.135; Friebe D, 2011, DIABETOLOGIA, V54, P1200, DOI 10.1007/s00125-010-2042-z; Gordon SB, 2002, BRIT MED BULL, V61, P45, DOI 10.1093/bmb/61.1.45; GRAHAM FL, 1977, J GEN VIROL, V36, P59, DOI 10.1099/0022-1317-36-1-59; Hartley O, 2005, AIDS RES HUM RETROV, V21, P171, DOI 10.1089/aid.2005.21.171; Jiang SB, 2004, ANTIMICROB AGENTS CH, V48, P4349, DOI 10.1128/AAC.48.11.4349-4359.2004; Jones G, 2006, NEUROBIOL DIS, V21, P1, DOI 10.1016/j.nbd.2005.07.018; Jones KL, 2010, J BIOL CHEM, V285, P18603, DOI 10.1074/jbc.M109.090126; Kamp C, 2009, BMC EVOL BIOL, V9, DOI 10.1186/1471-2148-9-274; Kawashima Y, 2009, NATURE, V458, P641, DOI 10.1038/nature07746; Kedzierska K, 2002, CURR MED CHEM, V9, P1893, DOI 10.2174/0929867023368935; Korner A, 2007, J CLIN ENDOCR METAB, V92, P4783, DOI 10.1210/jc.2007-1304; Lemey P, 2006, AIDS REV, V8, P125; McMichael AJ, 1997, ANNU REV IMMUNOL, V15, P271, DOI 10.1146/annurev.immunol.15.1.271; Moncunill G, 2008, AIDS, V22, P23, DOI 10.1097/QAD.0b013e3282f303e6; Montaner LJ, 2006, J LEUKOCYTE BIOL, V80, P961, DOI 10.1189/jlb.0806488; Moore CB, 2002, SCIENCE, V296, P1439, DOI 10.1126/science.1069660; Moore JP, 2004, AIDS RES HUM RETROV, V20, P111, DOI 10.1089/088922204322749567; Moschen AR, 2010, CURR PHARM DESIGN, V16, P1913, DOI 10.2174/138161210791208947; Navratilova I, 2005, ANAL BIOCHEM, V339, P271, DOI 10.1016/j.ab.2004.12.017; Navratilova I, 2006, ANAL BIOCHEM, V355, P132, DOI 10.1016/j.ab.2006.04.021; Nisius L, 2008, PROTEIN EXPRES PURIF, V61, P155, DOI 10.1016/j.pep.2008.06.001; Oswald-Richter K, 2007, PLOS PATHOG, V3, P553, DOI 10.1371/journal.ppat.0030058; Pillai S, 2003, AIDS RES HUM RETROV, V19, P145, DOI 10.1089/088922203762688658; REED L. J., 1938, AMER JOUR HYG, V27, P493; Regoes RR, 2005, TRENDS MICROBIOL, V13, P269, DOI 10.1016/j.tim.2005.04.005; Richman DD, 2003, P NATL ACAD SCI USA, V100, P4144, DOI 10.1073/pnas.0630530100; Sguanci L, 2007, BMC EVOL BIOL, V7, DOI 10.1186/1471-2148-7-S2-S5; SMITH SD, 1984, CANCER RES, V44, P5657; Sonoli SS, 2011, EUR REV MED PHARMACO, V15, P9; Van den Bergh R, 2010, RETROVIROLOGY, V7, DOI 10.1186/1742-4690-7-53; Van Herrewege Y, 2002, AIDS RES HUM RETROV, V18, P1091, DOI 10.1089/088922202320567833; Van Herrewege Y, 2008, J ANTIMICROB CHEMOTH, V61, P818, DOI 10.1093/jac/dkn042; Vyakarnam A, 2001, AIDS, V15, P1613, DOI 10.1097/00002030-200109070-00003; Wahl SM, 1997, J LEUKOCYTE BIOL, V62, P67, DOI 10.1002/jlb.62.1.67; Weber J, 2006, J VIROL METHODS, V136, P102, DOI 10.1016/j.jviromet.2006.04.004; Wei XP, 2003, NATURE, V422, P307, DOI 10.1038/nature01470; WEISS A, 1984, J IMMUNOL, V133, P123; WILEY CA, 1986, P NATL ACAD SCI USA, V83, P7089, DOI 10.1073/pnas.83.18.7089	44	21	21	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 6	2012	7	4							e35074	10.1371/journal.pone.0035074	http://dx.doi.org/10.1371/journal.pone.0035074			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	955JA	22493731	Green Submitted, Green Published, gold			2022-12-25	WOS:000305012700073
J	Anton, K; Banerjee, D; Glod, J				Anton, Kevin; Banerjee, Debabrata; Glod, John			Macrophage-Associated Mesenchymal Stem Cells Assume an Activated, Migratory, Pro-Inflammatory Phenotype with Increased IL-6 and CXCL10 Secretion	PLOS ONE			English	Article							MONOCYTE CHEMOTACTIC PROTEIN-1; BONE-MARROW; TUMOR STROMA; DELIVERY VEHICLES; TARGETED-DELIVERY; INFILTRATION; CANCER; KINASE; DIFFERENTIATION; PROLIFERATION	Mesenchymal stem cells (MSCs) exhibit tropism for sites of tissue injury and tumors. However, the influence of the microenvironment on MSC phenotype and localization remains incompletely characterized. In this study, we begin to define a macrophage-induced MSC phenotype. These MSCs secrete interleukin-6 (IL-6), CCL5, and interferon gamma-induced protein-10 (CXCL10) and exhibit increased mobility in response to multiple soluble factors produced by macrophages including IL-8, CCL2, and CCL5. The pro-migratory phenotype is dependent on activation of a c-Jun N-terminal kinase (JNK) pathway. This work begins to identify the influence of macrophages on MSC biology. These interactions are likely to play an important role in the tissue inflammatory response and may provide insight into the migratory potential of MSCs in inflammation and tissue injury.	[Anton, Kevin; Banerjee, Debabrata; Glod, John] Univ Med & Dent New Jersey, Robert Wood Johnson Med Sch, Canc Inst New Jersey, Dept Pharmacol, New Brunswick, NJ USA; [Banerjee, Debabrata] Univ Med & Dent New Jersey, Robert Wood Johnson Med Sch, Dept Med, Canc Inst New Jersey, New Brunswick, NJ 08903 USA; [Glod, John] Univ Med & Dent New Jersey, Robert Wood Johnson Med Sch, Dept Pediat, Canc Inst New Jersey, New Brunswick, NJ 08903 USA	Rutgers State University New Brunswick; Rutgers State University Medical Center; Rutgers Cancer Institute of New Jersey; Rutgers State University New Brunswick; Rutgers State University Medical Center; Rutgers Cancer Institute of New Jersey; Rutgers State University New Brunswick; Rutgers State University Medical Center; Rutgers Cancer Institute of New Jersey	Anton, K (corresponding author), Univ Med & Dent New Jersey, Robert Wood Johnson Med Sch, Canc Inst New Jersey, Dept Pharmacol, New Brunswick, NJ USA.	glodjo@umdnj.edu	Anton, Kevin/P-1329-2018; Glod, John/U-9925-2019; Anton, Kevin/M-3147-2019	Anton, Kevin/0000-0003-1278-4626; Anton, Kevin/0000-0003-1278-4626	New Jersey Commission on Cancer Research [09-1959-CCR-E0]	New Jersey Commission on Cancer Research	This work was supported by a grant from the New Jersey Commission on Cancer Research (09-1959-CCR-E0. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adamson R, 2009, J Wound Care, V18, P349; Angst E, 2008, SURGERY, V144, P57, DOI 10.1016/j.surg.2008.03.024; Anton K, 2009, CURR PHARM BIOTECHNO, V10, P185, DOI 10.2174/138920109787315088; Arenberg DA, 2000, CANCER IMMUNOL IMMUN, V49, P63, DOI 10.1007/s002620050603; Bak XY, 2011, HUM GENE THER, V22, P1365, DOI 10.1089/hum.2010.212; Caplan AI, 2007, J CELL PHYSIOL, V213, P341, DOI 10.1002/jcp.21200; Chiou WF, 2011, EVID-BASED COMPL ALT, V2011, P1, DOI 10.1093/ecam/nep140; Delavary BM, 2011, IMMUNOBIOLOGY, V216, P753, DOI 10.1016/j.imbio.2011.01.001; Dwyer RM, 2007, CLIN CANCER RES, V13, P5020, DOI 10.1158/1078-0432.CCR-07-0731; Fong ELS, 2011, BIOMATERIALS, V32, P395, DOI 10.1016/j.biomaterials.2010.08.101; Forte G, 2006, STEM CELLS, V24, P23, DOI 10.1634/stemcells.2004-0176; FREI K, 1992, J IMMUNOL, V148, P3140; FRIEDENSTEIN AJ, 1968, TRANSPLANTATION, V6, P230, DOI 10.1097/00007890-196803000-00009; Fu XB, 2009, WOUND REPAIR REGEN, V17, P185, DOI 10.1111/j.1524-475X.2009.00454.x; Hata N, 2010, NEUROSURGERY, V66, P144, DOI 10.1227/01.NEU.0000363149.58885.2E; Hedges JC, 1999, J BIOL CHEM, V274, P24211, DOI 10.1074/jbc.274.34.24211; Herrera MB, 2007, KIDNEY INT, V72, P430, DOI 10.1038/sj.ki.5002334; Heuertz RM, 1999, J BIOL CHEM, V274, P17968, DOI 10.1074/jbc.274.25.17968; Hsieh HL, 2010, J NEUROINFLAMM, V7, DOI 10.1186/1742-2094-7-88; Huang C, 2004, J CELL SCI, V117, P4619, DOI 10.1242/jcs.01481; Kanehira M, 2007, CANCER GENE THER, V14, P894, DOI 10.1038/sj.cgt.7701079; Karnoub AE, 2007, NATURE, V449, P557, DOI 10.1038/nature06188; Kim J, 2009, EXP HEMATOL, V37, P1445, DOI 10.1016/j.exphem.2009.09.004; Klemke RL, 1997, J CELL BIOL, V137, P481, DOI 10.1083/jcb.137.2.481; Leek RD, 1996, CANCER RES, V56, P4625; Loebinger MR, 2009, CANCER RES, V69, P8862, DOI 10.1158/0008-5472.CAN-09-1912; Maggini J, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0009252; Mendes KN, 2010, INT J ONCOL, V37, P143, DOI 10.3892/ijo_00000662; Menon LG, 2007, STEM CELLS, V25, P520, DOI 10.1634/stemcells.2006-0257; Meriane M, 2006, STEM CELLS, V24, P2557, DOI 10.1634/stemcells.2006-0209; Mishra PJ, 2008, CANCER RES, V68, P4331, DOI 10.1158/0008-5472.CAN-08-0943; Mishra PJ, 2011, METHODS MOL BIOL, V717, P245, DOI 10.1007/978-1-61779-024-9_14; Mosser DM, 2008, NAT REV IMMUNOL, V8, P958, DOI 10.1038/nri2448; Nakamizo A, 2005, CANCER RES, V65, P3307, DOI 10.1158/0008-5472.CAN-04-1874; Novo E, 2011, J HEPATOL, V54, P964, DOI 10.1016/j.jhep.2010.09.022; Ren GW, 2008, CELL STEM CELL, V2, P141, DOI 10.1016/j.stem.2007.11.014; Romieu-Mourez R, 2009, J IMMUNOL, V182, P7963, DOI 10.4049/jimmunol.0803864; Russo FP, 2006, GASTROENTEROLOGY, V130, P1807, DOI 10.1053/j.gastro.2006.01.036; Ryu CH, 2011, HUM GENE THER, V22, P733, DOI 10.1089/hum.2010.187; Ryu CH, 2010, BIOCHEM BIOPH RES CO, V398, P105, DOI 10.1016/j.bbrc.2010.06.043; Shin EY, 2001, EXP MOL MED, V33, P276, DOI 10.1038/emm.2001.45; Spaeth E, 2008, GENE THER, V15, P730, DOI 10.1038/gt.2008.39; Studeny M, 2004, JNCI-J NATL CANCER I, V96, P1593, DOI 10.1093/jnci/djh299; Takanami I, 1999, ONCOLOGY-BASEL, V57, P138, DOI 10.1159/000012021; Varney ML, 2005, MELANOMA RES, V15, P417, DOI 10.1097/00008390-200510000-00010; Wang L, 2002, EXP HEMATOL, V30, P831, DOI 10.1016/S0301-472X(02)00829-9; Waterman RS, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0010088; Wei L, 2010, AM J PHYSIOL-LUNG C, V298, pL863, DOI 10.1152/ajplung.00281.2009; Wu S, 2011, BIOMATERIALS, V32, P7524, DOI 10.1016/j.biomaterials.2011.06.050; Xu F, 2010, ONCOL REP, V23, P1561, DOI 10.3892/or_00000796; Yan XL, 2011, DEV DYNAM, V240, P65, DOI 10.1002/dvdy.22490; Yang BJ, 2009, NEUROSURGERY, V65, P610, DOI 10.1227/01.NEU.0000350227.61132.A7; Yeh MC, 2010, J LEUKOCYTE BIOL, V87, P925, DOI 10.1189/jlb.0609399	53	97	107	0	27	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 4	2012	7	4							e35036	10.1371/journal.pone.0035036	http://dx.doi.org/10.1371/journal.pone.0035036			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	953GO	22496888	Green Published, gold, Green Submitted			2022-12-25	WOS:000304855200097
J	Leermakers, ETM; Taal, HR; Bakker, R; Steegers, EAP; Hofman, A; Jaddoe, VWV				Leermakers, Elisabeth T. M.; Taal, H. Rob; Bakker, Rachel; Steegers, Eric A. P.; Hofman, Albert; Jaddoe, Vincent W. V.			A Common Genetic Variant at 15q25 Modifies the Associations of Maternal Smoking during Pregnancy with Fetal Growth: The Generation R Study	PLOS ONE			English	Article							DIFFERENT PERIODS; BIRTH-WEIGHT; LUNG-CANCER; COTININE; ULTRASOUND; EXPOSURE; LENGTH; WOMEN; HEAD	Objective: Maternal smoking during pregnancy is associated with fetal growth retardation. We examined whether a common genetic variant at chromosome 15q25 (rs1051730), which is known to be involved in nicotine metabolism, modifies the associations of maternal smoking with fetal growth characteristics. Methods: This study was performed in 3,563 European mothers participating in a population-based prospective cohort study from early pregnancy onwards. Smoking was assessed by postal questionnaires and fetal growth characteristics were measured by ultrasound examinations in each trimester of pregnancy. Results: Among mothers who did not smoke during pregnancy (82.9%), maternal rs1051730 was not consistently associated with any fetal growth characteristic. Among mothers who continued smoking during pregnancy (17.1%), maternal rs1051730 was not associated with head circumference. The T-allele of maternal rs1051730 was associated with a smaller second and third trimester fetal femur length [differences -0.23 mm (95% CI -0.45 to -0.00) and -0.41 mm (95% CI -0.69 to -0.13), respectively] and a smaller birth length [difference -2.61 mm (95% CI -5.32 to 0.11)]. The maternal T-allele of rs1051730 was associated with a lower third trimester estimated fetal weight [difference -33 grams (95% CI -55 to -10)], and tended to be associated with birth weight [difference -38 grams (95% CI -89 to 13)]. This association persisted after adjustment for smoking quantity. Conclusions: Our results suggest that maternal rs1051730 genotype modifies the associations of maternal smoking during pregnancy with impaired fetal growth in length and weight. These results should be considered as hypothesis generating and indicate the need for large-scale genome wide association studies focusing on gene - fetal smoke exposure interactions.	[Leermakers, Elisabeth T. M.; Taal, H. Rob; Bakker, Rachel; Jaddoe, Vincent W. V.] Erasmus MC, Generat R Study Grp, Rotterdam, Netherlands; [Leermakers, Elisabeth T. M.; Taal, H. Rob; Hofman, Albert; Jaddoe, Vincent W. V.] Erasmus MC, Dept Epidemiol, Rotterdam, Netherlands; [Leermakers, Elisabeth T. M.; Taal, H. Rob; Jaddoe, Vincent W. V.] Erasmus MC, Dept Paediat, Rotterdam, Netherlands; [Bakker, Rachel; Steegers, Eric A. P.] Erasmus MC, Dept Obstet & Gynaecol, Rotterdam, Netherlands	Erasmus University Rotterdam; Erasmus MC; Erasmus University Rotterdam; Erasmus MC; Erasmus University Rotterdam; Erasmus MC; Erasmus University Rotterdam; Erasmus MC	Leermakers, ETM (corresponding author), Erasmus MC, Generat R Study Grp, Rotterdam, Netherlands.	v.jaddoe@erasmusmc.nl	Taal, Hendrik R/B-4847-2018		Erasmus Medical Center Rotterdam; Erasmus University Rotterdam; Netherlands Organization for Health Research and Development (ZonMw) [90700303, 916.10159]; Dutch Kidney Foundation [C08.2251]	Erasmus Medical Center Rotterdam; Erasmus University Rotterdam; Netherlands Organization for Health Research and Development (ZonMw)(Netherlands Organization for Health Research and Development); Dutch Kidney Foundation	This work was supported by the Erasmus Medical Center Rotterdam, the Erasmus University Rotterdam and the Netherlands Organization for Health Research and Development (ZonMw), who financially supported the first phase of the Generation R Study. Additional grants were received from the Netherlands Organization for Health Research and Development (ZonMw) [90700303, 916.10159 to V.W.V.J.]; and the Dutch Kidney Foundation [C08.2251 to H. R. T.] The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	[Anonymous], 1995, MULTILEVEL STAT METH; Ay L, 2009, BJOG-INT J OBSTET GY, V116, P953, DOI 10.1111/j.1471-0528.2009.02143.x; Bakker R, 2011, J NUTR, V141, P2172, DOI 10.3945/jn.111.142976; Breton CV, 2009, AM J RESP CRIT CARE, V180, P462, DOI 10.1164/rccm.200901-0135OC; Freathy RM, 2010, NAT GENET, V42, P430, DOI 10.1038/ng.567; Freathy RM, 2009, HUM MOL GENET, V18, P2922, DOI 10.1093/hmg/ddp216; Freathy RM, 2011, ULTRASOUND OBST GYN, V8, P178; Furberg H, 2010, NAT GENET, V42, P441, DOI 10.1038/ng.571; Geelhoed JJM, 2011, BJOG-INT J OBSTET GY, V118, P755, DOI 10.1111/j.1471-0528.2011.02900.x; HADDOW JE, 1987, BRIT J OBSTET GYNAEC, V94, P678, DOI 10.1111/j.1471-0528.1987.tb03174.x; HADLOCK FP, 1984, RADIOLOGY, V150, P535, DOI 10.1148/radiology.150.2.6691115; HEBEL JR, 1988, J CLIN EPIDEMIOL, V41, P483, DOI 10.1016/0895-4356(88)90050-9; Jaddoe VWV, 2007, EUR J EPIDEMIOL, V22, P917, DOI 10.1007/s10654-007-9209-z; Jaddoe VWV, 2008, PAEDIATR PERINAT EP, V22, P162, DOI 10.1111/j.1365-3016.2007.00916.x; Jaddoe VWV, 2007, AM J EPIDEMIOL, V165, P1207, DOI 10.1093/aje/kwm014; Jaddoe VWV, 2010, EUR J EPIDEMIOL, V25, P823, DOI 10.1007/s10654-010-9516-7; Klebanoff MA, 2001, PAEDIATR PERINAT EP, V15, P140, DOI 10.1046/j.1365-3016.2001.00321.x; Le Marchand L, 2008, CANCER RES, V68, P9137, DOI 10.1158/0008-5472.CAN-08-2271; NIKLASSON A, 1991, ACTA PAEDIATR SCAND, V80, P756, DOI 10.1111/j.1651-2227.1991.tb11945.x; Royal College of Obstetricians and Gynaecologists, 2000, ROUT ULTR SCREEN PRE; Timofeeva MN, 2011, CANCER EPIDEM BIOMAR, V20, P2250, DOI 10.1158/1055-9965.EPI-11-0496; Tunon K, 1996, ULTRASOUND OBST GYN, V8, P178, DOI 10.1046/j.1469-0705.1996.08030178.x; Varvarigou AA, 2010, J PERINAT MED, V38, P683, DOI [10.1515/JPM.2010.101, 10.1515/jpm.2010.101]; Verburg BO, 2008, ULTRASOUND OBST GYN, V31, P388, DOI 10.1002/uog.5225; Verburg BO, 2008, PRENATAL DIAG, V28, P323, DOI 10.1002/pd.1972; Wang XB, 1997, INT J EPIDEMIOL, V26, P978, DOI 10.1093/ije/26.5.978	26	6	6	0	0	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 4	2012	7	4							e34584	10.1371/journal.pone.0034584	http://dx.doi.org/10.1371/journal.pone.0034584			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	953GO	22496830	Green Published, Green Submitted, gold			2022-12-25	WOS:000304855200063
J	Son, S; Kang, AR; Kim, HC; Kwon, T; Park, J; Kim, HK				Son, Seokshin; Kang, Ah Reum; Kim, Hyun-chul; Kwon, Taekyoung; Park, Juyong; Kim, Huy Kang			Analysis of Context Dependence in Social Interaction Networks of a Massively Multiplayer Online Role-Playing Game	PLOS ONE			English	Article								Rapid advances in modern computing and information technology have enabled millions of people to interact online via various social network and gaming services. The widespread adoption of such online services have made possible analysis of large-scale archival data containing detailed human interactions, presenting a very promising opportunity to understand the rich and complex human behavior. In collaboration with a leading global provider of Massively Multiplayer Online Role-Playing Games (MMORPGs), here we present a network science-based analysis of the interplay between distinct types of user interaction networks in the virtual world. We find that their properties depend critically on the nature of the context-interdependence of the interactions, highlighting the complex and multilayered nature of human interactions, a robust understanding of which we believe may prove instrumental in the designing of more realistic future virtual arenas as well as provide novel insights to the science of collective human behavior.	[Son, Seokshin] Seoul Natl Univ, Multimedia & Mobile Commun Lab, Sch Comp Sci & Engn, Seoul, South Korea; [Kang, Ah Reum; Kim, Huy Kang] Korea Univ, Grad Sch Informat Secur, Seoul, South Korea; [Kim, Hyun-chul] Sangmyung Univ, Dept Comp Software Engn, Cheonan, South Korea; [Kwon, Taekyoung; Park, Juyong] Kyung Hee Univ, Dept Phys, Seoul, South Korea	Seoul National University (SNU); Korea University; Sang Myung University; Kyung Hee University	Son, S (corresponding author), Seoul Natl Univ, Multimedia & Mobile Commun Lab, Sch Comp Sci & Engn, Seoul, South Korea.	perturbation@gmail.com; cenda@korea.ac.kr	Park, Juyong/I-2290-2012; Kim, Huy Kang/R-5779-2016	Kim, Huy Kang/0000-0002-0760-8807; Kang, Ah Reum/0000-0002-0732-5313	Kyung Hee University [KHU-20110088]; National Research Foundation of Korea [KRF-20110005409]; Ministry of Knowledge Economy of Korea [NIPA-2012-C1090-1101-0004]; NAP of Korean Research Council of Fundamental Science and Technology	Kyung Hee University; National Research Foundation of Korea(National Research Foundation of Korea); Ministry of Knowledge Economy of Korea(Ministry of Trade, Industry & Energy (MOTIE), Republic of Korea); NAP of Korean Research Council of Fundamental Science and Technology	Funding provided by Kyung Hee University (www.khu.ac.kr): KHU-20110088, National Research Foundation of Korea (www.nrf.re.kr) KRF-20110005409, Ministry of Knowledge Economy of Korea (www.mke.go.kr) NIPA-2012-C1090-1101-0004 and NAP of Korean Research Council of Fundamental Science and Technology (http://www.fif.kr/home.php). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ahnert SE, 2008, PHYS REV E, V78, DOI 10.1103/PhysRevE.78.036112; Albert R, 2002, REV MOD PHYS, V74, P47, DOI 10.1103/RevModPhys.74.47; [Anonymous], 2008, NATURE, V455, P1, DOI 10.1038/455001a; Cook K. S., 1991, MACROMICRO LINKAGES, P29; COOK KS, 1983, AM J SOCIOL, V89, P275, DOI 10.1086/227866; COOK KS, 1984, RES SOCIOLOGY ORG, V3, P1; Fortunato S, 2010, PHYS REP, V486, P75, DOI 10.1016/j.physrep.2009.11.002; Kang A, 2011, ADV COMP SC IN PRESS; Kwak H, 2009, IMC'09: PROCEEDINGS OF THE 2009 ACM SIGCOMM INTERNET MEASUREMENT CONFERENCE, P301; Milo R, 2002, SCIENCE, V298, P824, DOI 10.1126/science.298.5594.824; Newman M.E.J., 2010, NETWORKS INTRO; Newman MEJ, 2003, PHYS REV E, V68, DOI 10.1103/PhysRevE.68.036122; Newman MEJ, 2003, SIAM REV, V45, P167, DOI 10.1137/S003614450342480; Onnela JP, 2007, P NATL ACAD SCI USA, V104, P7332, DOI 10.1073/pnas.0610245104; Park JY, 2007, P NATL ACAD SCI USA, V104, P17916, DOI 10.1073/pnas.0705081104; Son S, 2011, ACM SIGCOMM COMP COM, V41, P414, DOI 10.1145/2043164.2018496; Szell M, 2010, SOC NETWORKS, V32, P313, DOI 10.1016/j.socnet.2010.06.001; Szell M, 2010, P NATL ACAD SCI USA, V107, P13636, DOI 10.1073/pnas.1004008107; Wasserman S., 1994, SOCIAL NETWORK ANAL, DOI DOI 10.1017/CBO9780511815478	19	21	21	1	27	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 4	2012	7	4							e33918	10.1371/journal.pone.0033918	http://dx.doi.org/10.1371/journal.pone.0033918			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	953GO	22496771	Green Submitted, gold, Green Published			2022-12-25	WOS:000304855200025
J	Gelebart, P; Zak, Z; Anand, M; Belch, A; Lai, R				Gelebart, Pascal; Zak, Zoulika; Anand, Mona; Belch, Andrew; Lai, Raymond			Blockade of Fatty Acid Synthase Triggers Significant Apoptosis in Mantle Cell Lymphoma	PLOS ONE			English	Article							NF-KAPPA-B; PROSTATE-CANCER; LIPID-METABOLISM; ACTIVATION; INHIBITION; ONCOGENE; PATHWAYS; SURVIVAL; OVEREXPRESSION; PALMITOYLATION	Fatty acid synthase (FASN), a key player in the de novo synthetic pathway of long-chain fatty acids, has been shown to contribute to the tumorigenesis in various types of solid tumors. We here report that FASN is highly and consistently expressed in mantle cell lymphoma (MCL), an aggressive form of B-cell lymphoid malignancy. Specifically, the expression of FASN was detectable in all four MCL cell lines and 15 tumors examined. In contrast, benign lymphoid tissues and peripheral blood mononuclear cells from normal donors were negative. Treatment of MCL cell lines with orlistat, a FASN inhibitor, resulted in significant apoptosis. Knockdown of FASN expression using siRNA, which also significantly decreased the growth of MCL cells, led to a dramatic decrease in the cyclin D1 level. beta-catenin, which has been previously reported to be upregulated in a subset of MCL tumors, contributed to the high level of FASN in MCL cells, Interesting, siRNA knock-down of FASN in turn down-regulated beta-catenin. In conclusion, our data supports the concept that FASN contributes to the pathogenesis of MCL, by collaborating with beta-catenin. In view of its high and consistent expression in MCL, FASN inhibitors may hold promises for treating MCL.	[Gelebart, Pascal; Zak, Zoulika; Anand, Mona; Lai, Raymond] Univ Alberta, Dept Lab Med & Pathol, Edmonton, AB, Canada; [Gelebart, Pascal; Zak, Zoulika; Anand, Mona; Belch, Andrew; Lai, Raymond] Cross Canc Inst, Edmonton, AB T6G 1Z2, Canada; [Belch, Andrew; Lai, Raymond] Univ Alberta, Dept Oncol, Edmonton, AB, Canada	University of Alberta; University of Alberta; University of Alberta	Gelebart, P (corresponding author), Univ Alberta, Dept Lab Med & Pathol, Edmonton, AB, Canada.	rlai@ualberta.ca	Gelebart, Pascal/AAI-1439-2020	Gelebart, Pascal/0000-0003-2434-8987	Canadian Institute of Health Research; Alberta Cancer Foundation; Canadian Cancer Society Research Institute	Canadian Institute of Health Research(Canadian Institutes of Health Research (CIHR)); Alberta Cancer Foundation; Canadian Cancer Society Research Institute(Canadian Cancer Society (CCS))	This study is supported by operating research grants from the Canadian Institute of Health Research, Alberta Cancer Foundation and the Canadian Cancer Society Research Institute. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Amin HM, 2003, ARCH PATHOL LAB MED, V127, P424; Baron A, 2004, J CELL BIOCHEM, V91, P47, DOI 10.1002/jcb.10708; Cerne D, 2010, ARCH MED RES, V41, P405, DOI 10.1016/j.arcmed.2010.08.007; Delsol G, 2008, ANAPLASTIC LARGE CEL, V4th; Fiorentino M, 2008, LAB INVEST, V88, P1340, DOI 10.1038/labinvest.2008.97; Fu LC, 2006, BLOOD, V107, P4540, DOI 10.1182/blood-2005-10-4042; Gansler TS, 1997, HUM PATHOL, V28, P686, DOI 10.1016/S0046-8177(97)90177-5; Gelebart P, 2008, BLOOD, V112, P5171, DOI 10.1182/blood-2008-02-139212; Ghielmini M, 2009, BLOOD; Graner E, 2004, CANCER CELL, V5, P253, DOI 10.1016/S1535-6108(04)00055-8; Jares P, 2007, NAT REV CANCER, V7, P750, DOI 10.1038/nrc2230; JAYAKUMAR A, 1995, P NATL ACAD SCI USA, V92, P8695, DOI 10.1073/pnas.92.19.8695; Jin QR, 2010, BREAST CANCER RES, V12, DOI 10.1186/bcr2777; Kridel SJ, 2004, CANCER RES, V64, P2070, DOI 10.1158/0008-5472.can-03-3645; Kridel SJ, 2007, EXPERT OPIN INV DRUG, V16, P1817, DOI 10.1517/13543784.16.11.1817; Kusakabe T, 2000, J HISTOCHEM CYTOCHEM, V48, P613, DOI 10.1177/002215540004800505; Kusakabe T, 2002, HISTOPATHOLOGY, V40, P71, DOI 10.1046/j.1365-2559.2002.01289.x; Maier T, 2010, Q REV BIOPHYS, V43, P373, DOI 10.1017/S0033583510000156; Martinez N, 2003, CANCER RES, V63, P8226; Mashima T, 2009, BRIT J CANCER, V100, P1369, DOI 10.1038/sj.bjc.6605007; Menendez JA, 2004, P NATL ACAD SCI USA, V101, P10715, DOI 10.1073/pnas.0403390101; Menendez JA, 2007, NAT REV CANCER, V7, P763, DOI 10.1038/nrc2222; Migita T, 2009, JNCI-J NATL CANCER I, V101, P519, DOI 10.1093/jnci/djp030; Pallasch CP, 2008, LEUKEMIA, V22, P585, DOI 10.1038/sj.leu.2405058; Pham LV, 2003, J IMMUNOL, V171, P88, DOI 10.4049/jimmunol.171.1.88; Rizzatti EG, 2008, LEUKEMIA LYMPHOMA, V49, P798, DOI 10.1080/10428190801910912; Rizzatti EG, 2005, BRIT J HAEMATOL, V130, P516, DOI 10.1111/j.1365-2141.2005.05630.x; Rudelius M, 2006, BLOOD, V108, P1668, DOI 10.1182/blood-2006-04-015586; Sandilands E, 2007, J CELL SCI, V120, P2555, DOI 10.1242/jcs.003657; SEMENKOVICH CF, 1995, J LIPID RES, V36, P1507; Shishodia S, 2005, BIOCHEM PHARMACOL, V70, P700, DOI 10.1016/j.bcp.2005.04.043; Smith MR, 2008, CURR OPIN HEMATOL, V15, P415, DOI 10.1097/MOH.0b013e328302c9c5; Swerdlow S, 2001, WHO CLASSIFICATION T; Tucker CA, 2008, MOL CANCER THER, V7, P749, DOI 10.1158/1535-7163.MCT-07-0302; Uddin S, 2008, J CLIN ENDOCR METAB, V93, P4088, DOI 10.1210/jc.2008-0503; Uddin S, 2010, MOL CANCER THER, V9, P1244, DOI 10.1158/1535-7163.MCT-09-1061; Wang WQ, 2008, J ZHEJIANG UNIV-SC B, V9, P441, DOI 10.1631/jzus.B0740640; Yoon S, 2007, J BIOL CHEM, V282, P26122, DOI 10.1074/jbc.M702854200	38	37	39	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 2	2012	7	4							e33738	10.1371/journal.pone.0033738	http://dx.doi.org/10.1371/journal.pone.0033738			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	952GU	22485149	Green Submitted, Green Published, gold			2022-12-25	WOS:000304780500025
J	Creighton, CJ; Hernandez-Herrera, A; Jacobsen, A; Levine, DA; Mankoo, P; Schultz, N; Du, Y; Zhang, YQ; Larsson, E; Sheridan, R; Xiao, WM; Spellman, PT; Getz, G; Wheeler, DA; Perou, CM; Gibbs, RA; Sander, C; Hayes, DN; Gunaratne, PH				Creighton, Chad J.; Hernandez-Herrera, Anadulce; Jacobsen, Anders; Levine, Douglas A.; Mankoo, Parminder; Schultz, Nikolaus; Du, Ying; Zhang, Yiqun; Larsson, Erik; Sheridan, Robert; Xiao, Weimin; Spellman, Paul T.; Getz, Gad; Wheeler, David A.; Perou, Charles M.; Gibbs, Richard A.; Sander, Chris; Hayes, D. Neil; Gunaratne, Preethi H.		Canc Genome Atlas Res Network	Integrated Analyses of microRNAs Demonstrate Their Widespread Influence on Gene Expression in High-Grade Serous Ovarian Carcinoma	PLOS ONE			English	Article							MESSENGER-RNAS; TARGETS; CANCER; PROFILES; REVEALS; SIGNATURES; 5'-UTR; MIRNAS; DICER	Background: The Cancer Genome Atlas (TCGA) Network recently comprehensively catalogued the molecular aberrations in 487 high-grade serous ovarian cancers, with much remaining to be elucidated regarding the microRNAs (miRNAs). Here, using TCGA ovarian data, we surveyed the miRNAs, in the context of their predicted gene targets. Methods and Results: Integration of miRNA and gene patterns yielded evidence that proximal pairs of miRNAs are processed from polycistronic primary transcripts, and that intronic miRNAs and their host gene mRNAs derive from common transcripts. Patterns of miRNA expression revealed multiple tumor subtypes and a set of 34 miRNAs predictive of overall patient survival. In a global analysis, miRNA:mRNA pairs anti-correlated in expression across tumors showed a higher frequency of in silico predicted target sites in the mRNA 3'-untranslated region (with less frequency observed for coding sequence and 5'-untranslated regions). The miR-29 family and predicted target genes were among the most strongly anti-correlated miRNA:mRNA pairs; over-expression of miR-29a in vitro repressed several anti-correlated genes (including DNMT3A and DNMT3B) and substantially decreased ovarian cancer cell viability. Conclusions: This study establishes miRNAs as having a widespread impact on gene expression programs in ovarian cancer, further strengthening our understanding of miRNA biology as it applies to human cancer. As with gene transcripts, miRNAs exhibit high diversity reflecting the genomic heterogeneity within a clinically homogeneous disease population. Putative miRNA:mRNA interactions, as identified using integrative analysis, can be validated. TCGA data are a valuable resource for the identification of novel tumor suppressive miRNAs in ovarian as well as other cancers.	[Creighton, Chad J.; Zhang, Yiqun] Baylor Coll Med, Dan L Duncan Canc Ctr, Houston, TX 77030 USA; [Creighton, Chad J.] Baylor Coll Med, Dept Med, Houston, TX 77030 USA; [Levine, Douglas A.] Mem Sloan Kettering Canc Ctr, Dept Surg, Gynecol Serv, New York, NY 10021 USA; [Jacobsen, Anders; Mankoo, Parminder; Schultz, Nikolaus; Larsson, Erik; Sheridan, Robert; Sander, Chris] Mem Sloan Kettering Canc Ctr, Computat Biol Ctr, New York, NY 10021 USA; [Du, Ying; Perou, Charles M.; Hayes, D. Neil] Univ N Carolina, Lineberger Comprehens Canc Ctr, Chapel Hill, NC 27599 USA; [Hayes, D. Neil] Univ N Carolina, Div Med Oncol, Dept Internal Med, Chapel Hill, NC USA; [Spellman, Paul T.] Univ Calif Berkeley, Lawrence Berkeley Natl Lab, Div Life Sci, Berkeley, CA 94720 USA; [Getz, Gad] Broad Inst MIT & Harvard, Cambridge, MA USA; [Wheeler, David A.; Gibbs, Richard A.] Baylor Coll Med, Dept Mol & Human Genet, Houston, TX 77030 USA; [Gunaratne, Preethi H.] Baylor Coll Med, Dept Pathol, Houston, TX 77030 USA; [Hernandez-Herrera, Anadulce; Xiao, Weimin; Gunaratne, Preethi H.] Univ Houston, Dept Biol & Biochem, Houston, TX USA	Baylor College of Medicine; Baylor College of Medicine; Memorial Sloan Kettering Cancer Center; Memorial Sloan Kettering Cancer Center; University of North Carolina; University of North Carolina Chapel Hill; University of North Carolina; University of North Carolina Chapel Hill; United States Department of Energy (DOE); Lawrence Berkeley National Laboratory; University of California System; University of California Berkeley; Harvard University; Massachusetts Institute of Technology (MIT); Broad Institute; Baylor College of Medicine; Baylor College of Medicine; University of Houston System; University of Houston	Creighton, CJ (corresponding author), Baylor Coll Med, Dan L Duncan Canc Ctr, Houston, TX 77030 USA.	creighto@bcm.edu; phgunaratne@uh.edu	Perou, Charles M/H-9934-2014; Larsson Lekholm, Erik/HDM-8032-2022; Wheeler, David A/M-9740-2018; Larsson Lekholm, Erik/AHE-0932-2022; Skanderup, Anders Jacobsen/K-1081-2013; Schultz, Nikolaus/ABE-6347-2020; Zhang, YiQun/HCI-2427-2022	Perou, Charles M/0000-0001-9827-2247; Larsson Lekholm, Erik/0000-0003-1400-0119; Wheeler, David A/0000-0002-9056-6299; Larsson Lekholm, Erik/0000-0003-1400-0119; Skanderup, Anders Jacobsen/0000-0001-6847-4980; Hayes, D. Neil/0000-0001-6203-7771; Schultz, Nikolaus/0000-0002-0131-4904; Levine, Douglas/0000-0003-1038-8232	Ovarian Cancer Research Fund; National Institutes of Health (NIH) [P30CA125123]; TCGA GCC at Baylor: National Cancer Institue (NCI) [U24CA143843]; TCGA GCC at University of North Carolina [NCI-U24CA143848]; TCGA GDAC at Memorial Sloan-Kettering Cancer Center [NCI-U24CA143840]; Cullen Foundation; Mexican National Council for Science and Technology (CONACyT); Danish Research Council;  [CPRIT-RP110355]; NATIONAL CANCER INSTITUTE [P30CA016086, U24CA143840, U24CA143843, U24CA143848, P30CA125123] Funding Source: NIH RePORTER; NATIONAL HUMAN GENOME RESEARCH INSTITUTE [U54HG003273] Funding Source: NIH RePORTER	Ovarian Cancer Research Fund; National Institutes of Health (NIH)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); TCGA GCC at Baylor: National Cancer Institue (NCI); TCGA GCC at University of North Carolina; TCGA GDAC at Memorial Sloan-Kettering Cancer Center; Cullen Foundation; Mexican National Council for Science and Technology (CONACyT)(Consejo Nacional de Ciencia y Tecnologia (CONACyT)); Danish Research Council(Det Frie Forskningsrad (DFF)); ; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL HUMAN GENOME RESEARCH INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Human Genome Research Institute (NHGRI))	This work was supported in part by the Ovarian Cancer Research Fund (CJC, PHG), National Institutes of Health (NIH) grant P30CA125123 (CJC, YZ), TCGA GCC at Baylor: National Cancer Institue (NCI) grant U24CA143843 (CJC, DAW, RAG), TCGA GCC at University of North Carolina: NCI-U24CA143848 (YD, CMP, DNH), TCGA GDAC at Memorial Sloan-Kettering Cancer Center: NCI-U24CA143840 (AJ, PM, NS, EL, RS, CS), CPRIT-RP110355 (PHG), a Cullen Foundation Grant (PHG), the Mexican National Council for Science and Technology (CONACyT) (AH), and the Danish Research Council (AJ). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Baskerville S, 2005, RNA, V11, P241, DOI 10.1261/rna.7240905; Bearfoot JL, 2008, CLIN CANCER RES, V14, P7246, DOI 10.1158/1078-0432.CCR-08-1348; Bell D, 2011, NATURE, V474, P609, DOI 10.1038/nature10166; Betel D, 2008, NUCLEIC ACIDS RES, V36, pD149, DOI 10.1093/nar/gkm995; Creighton CJ, 2008, RNA, V14, P2290, DOI 10.1261/rna.1188208; Creighton CJ, 2010, CANCER RES, V70, P1906, DOI 10.1158/0008-5472.CAN-09-3875; Fabbri M, 2007, P NATL ACAD SCI USA, V104, P15805, DOI 10.1073/pnas.0707628104; Forman JJ, 2008, P NATL ACAD SCI USA, V105, P14879, DOI 10.1073/pnas.0803230105; Friedman RC, 2009, GENOME RES, V19, P92, DOI 10.1101/gr.082701.108; Garzon R, 2009, BLOOD, V113, P6411, DOI 10.1182/blood-2008-07-170589; Guo HL, 2010, NATURE, V466, P835, DOI 10.1038/nature09267; Iorio MV, 2007, CANCER RES, V67, P8699, DOI 10.1158/0008-5472.CAN-07-1936; Iorio MV, 2009, J CLIN ONCOL, V27, P5848, DOI 10.1200/JCO.2009.24.0317; Jacobsen A, 2010, GENOME RES, V20, P1010, DOI 10.1101/gr.103259.109; John B, 2004, PLOS BIOL, V2, P1862, DOI 10.1371/journal.pbio.0020363; Lee I, 2009, GENOME RES, V19, P1175, DOI 10.1101/gr.089367.108; Lewis BP, 2003, CELL, V115, P787, DOI 10.1016/S0092-8674(03)01018-3; Liang Y, 2007, BMC GENOMICS, V8, DOI 10.1186/1471-2164-8-166; Liu XX, 2011, FEBS LETT, V585, P1363, DOI 10.1016/j.febslet.2011.04.018; Lytle JR, 2007, P NATL ACAD SCI USA, V104, P9667, DOI 10.1073/pnas.0703820104; Mankoo PK, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0024709; Merritt WM, 2008, NEW ENGL J MED, V359, P2641, DOI 10.1056/NEJMoa0803785; Nam EJ, 2008, CLIN CANCER RES, V14, P2690, DOI 10.1158/1078-0432.CCR-07-1731; Perou CM, 2000, NATURE, V406, P747, DOI 10.1038/35021093; Pollack JR, 2002, P NATL ACAD SCI USA, V99, P12963, DOI 10.1073/pnas.162471999; Rajewsky N, 2006, NAT GENET S, V38; Saldanha AJ, 2004, BIOINFORMATICS, V20, P3246, DOI 10.1093/bioinformatics/bth349; Shih KK, 2011, GYNECOL ONCOL, V121, P444, DOI 10.1016/j.ygyno.2011.01.025; Tay Y, 2008, NATURE, V455, P1124, DOI 10.1038/nature07299; Verhaak RGW, 2010, CANCER CELL, V17, P98, DOI 10.1016/j.ccr.2009.12.020; Wang YP, 2009, BMC GENOMICS, V10, DOI 10.1186/1471-2164-10-218; Wu L, 2008, MOL CELL, V29, P1, DOI 10.1016/j.molcel.2007.12.010; Wyman SK, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0005311; Zhang L, 2008, P NATL ACAD SCI USA, V105, P7004, DOI 10.1073/pnas.0801615105; Zhou X, 2011, ONCOL REP	35	93	96	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 29	2012	7	3							e34546	10.1371/journal.pone.0034546	http://dx.doi.org/10.1371/journal.pone.0034546			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	948SR	22479643	gold, Green Published, Green Submitted			2022-12-25	WOS:000304523400088
J	Simone-Finstrom, MD; Spivak, M				Simone-Finstrom, Michael D.; Spivak, Marla			Increased Resin Collection after Parasite Challenge: A Case of Self-Medication in Honey Bees?	PLOS ONE			English	Article							APIS-MELLIFERA; BRAZILIAN PROPOLIS; CHIMPANZEES; ANTIBACTERIAL; RESISTANCE; PATHOGEN; COLONIES; BEHAVIOR; DEFENSE; DISEASE	The constant pressure posed by parasites has caused species throughout the animal kingdom to evolve suites of mechanisms to resist infection. Individual barriers and physiological defenses are considered the main barriers against parasites in invertebrate species. However, behavioral traits and other non-immunological defenses can also effectively reduce parasite transmission and infection intensity. In social insects, behaviors that reduce colony-level parasite loads are termed "social immunity.'' One example of a behavioral defense is resin collection. Honey bees forage for plant-produced resins and incorporate them into their nest architecture. This use of resins can reduce chronic elevation of an individual bee's immune response. Since high activation of individual immunity can impose colony-level fitness costs, collection of resins may benefit both the individual and colony fitness. However the use of resins as a more direct defense against pathogens is unclear. Here we present evidence that honey bee colonies may self-medicate with plant resins in response to a fungal infection. Self-medication is generally defined as an individual responding to infection by ingesting or harvesting non-nutritive compounds or plant materials. Our results show that colonies increase resin foraging rates after a challenge with a fungal parasite (Ascophaera apis: chalkbrood or CB). Additionally, colonies experimentally enriched with resin had decreased infection intensities of this fungal parasite. If considered self-medication, this is a particularly unique example because it operates at the colony level. Most instances of self-medication involve pharmacophagy, whereby individuals change their diet in response to direct infection with a parasite. In this case with honey bees, resins are not ingested but used within the hive by adult bees exposed to fungal spores. Thus the colony, as the unit of selection, may be responding to infection through self-medication by increasing the number of individuals that forage for resin.	[Simone-Finstrom, Michael D.] N Carolina State Univ, Dept Entomol, Raleigh, NC 27695 USA; [Spivak, Marla] Univ Minnesota, Dept Entomol, St Paul, MN USA	University of North Carolina; North Carolina State University; University of Minnesota System; University of Minnesota Twin Cities	Simone-Finstrom, MD (corresponding author), N Carolina State Univ, Dept Entomol, Raleigh, NC 27695 USA.	mdsimone@ncsu.edu	Simone-Finstrom, Michael/D-3624-2012; Spivak, Marla/AAI-5088-2020	Simone-Finstrom, Michael/0000-0003-2938-9788	National Science Foundation [IOS-0717530]	National Science Foundation(National Science Foundation (NSF))	This research was supported by a grant from the National Science Foundation (IOS-0717530) awarded to MS and an NSF Graduate Student fellowship awarded to MSF. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Antunez K, 2008, VET MICROBIOL, V131, P324, DOI 10.1016/j.vetmic.2008.04.011; Aronstein KA, 2010, J INVERTEBR PATHOL, V103, pS20, DOI 10.1016/j.jip.2009.06.018; Bastos EMAF, 2008, J INVERTEBR PATHOL, V97, P273, DOI 10.1016/j.jip.2007.10.007; Bernays EA, 2005, NATURE, V436, P476, DOI 10.1038/436476a; BOPPRE M, 1984, J CHEM ECOL, V10, P1151, DOI 10.1007/BF00987520; Castella G, 2008, ECOL ENTOMOL, V33, P408, DOI 10.1111/j.1365-2311.2007.00983.x; Castella G, 2008, ANIM BEHAV, V75, P1591, DOI 10.1016/j.anbehav.2007.10.014; Chapuisat M, 2007, P ROY SOC B-BIOL SCI, V274, P2013, DOI 10.1098/rspb.2007.0531; Choe DH, 2007, ANN ENTOMOL SOC AM, V100, P320, DOI 10.1603/0013-8746(2007)100[320:UOPRBA]2.0.CO;2; Christe P, 2003, ECOL LETT, V6, P19, DOI 10.1046/j.1461-0248.2003.00395.x; Crane E., 1990, BEES BEEKEEPING, V1st; Cremer S, 2007, CURR BIOL, V17, pR693, DOI 10.1016/j.cub.2007.06.008; Evans JD, 2006, INSECT MOL BIOL, V15, P645, DOI 10.1111/j.1365-2583.2006.00682.x; Evans JD, 2010, J INVERTEBR PATHOL, V103, pS62, DOI 10.1016/j.jip.2009.06.019; Evans JD, 2005, EVOLUTION, V59, P2270, DOI 10.1111/j.0014-3820.2005.tb00935.x; Fearnley J., 2001, BEE PROPOLIS NATURAL; Fowler A, 2007, PRIMATES, V48, P73, DOI 10.1007/s10329-006-0001-6; GHISALBERTI EL, 1979, BEE WORLD, V60, P59, DOI 10.1080/0005772X.1979.11097738; GILLIAM M, 1988, J INVERTEBR PATHOL, V52, P314, DOI 10.1016/0022-2011(88)90141-3; GLINSKI Z., 2001, APIACATA, V36, P12, DOI DOI 10.1016/J.JACI.2016.04.024; GOMPPER ME, 1993, J TROP ECOL, V9, P533, DOI 10.1017/S0266467400007616; Gwinner H, 2000, ANIM BEHAV, V59, P301, DOI 10.1006/anbe.1999.1306; Huffman MA, 1996, INT J PRIMATOL, V17, P475, DOI 10.1007/BF02735188; Huffman MA, 2010, ANIM COGN, V13, P871, DOI 10.1007/s10071-010-0335-8; Hutchings MR, 2003, P NUTR SOC, V62, P361, DOI 10.1079/PNS2003243; Kanga LHB, 2003, J ECON ENTOMOL, V96, P1091, DOI 10.1603/0022-0493-96.4.1091; KONIG B, 1988, ENTOMOL GEN, V14, P145; Kujumgiev A, 1999, J ETHNOPHARMACOL, V64, P235, DOI 10.1016/S0378-8741(98)00131-7; Lee KP, 2006, P ROY SOC B-BIOL SCI, V273, P823, DOI 10.1098/rspb.2005.3385; Lozano GA, 1998, ADV STUD BEHAV, V27, P291; Manson JS, 2010, OECOLOGIA, V162, P81, DOI 10.1007/s00442-009-1431-9; Mennerat A, 2009, ANIM BEHAV, V77, P569, DOI 10.1016/j.anbehav.2008.11.008; Morse R.A., 1997, HONEY BEE PESTS PRED; Nakamura J, 2006, BEHAV ECOL SOCIOBIOL, V60, P339, DOI 10.1007/s00265-006-0170-8; Parker BJ, 2011, TRENDS ECOL EVOL, V26, P242, DOI 10.1016/j.tree.2011.02.005; Santos FA, 2003, PHYTOTHER RES, V17, P285, DOI 10.1002/ptr.1117; Schmid-Hempel P., 1998, Parasites in social insects.; Seeley TD, 1997, AM NAT, V150, pS22, DOI 10.1086/286048; SEELEY TD, 1989, AM SCI, V77, P546; SEELEY TD, 1976, INSECT SOC, V23, P495, DOI 10.1007/BF02223477; Simone M, 2009, EVOLUTION, V63, P3016, DOI 10.1111/j.1558-5646.2009.00772.x; Simone-Finstrom M, 2010, BEHAV ECOL SOCIOBIOL, V64, P1609, DOI 10.1007/s00265-010-0974-4; Simone-Finstrom M, 2010, APIDOLOGIE, V41, P295, DOI 10.1051/apido/2010016; Singer MS, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0004796; Smilanich AM, 2011, OECOLOGIA, V165, P995, DOI 10.1007/s00442-010-1803-1; Spivak M, 2001, APIDOLOGIE, V32, P555, DOI 10.1051/apido:2001103; Strand Michael R., 2008, Insect Science, V15, P1, DOI 10.1111/j.1744-7917.2008.00183.x; Swanson JAI, 2009, J CHEM ECOL, V35, P1108, DOI 10.1007/s10886-009-9683-8; Villalba JJ, 2006, ANIM BEHAV, V71, P1131, DOI 10.1016/j.anbehav.2005.09.012; Winston M. L. L., 1991, BIOL HONEY BEE; WRANGHAM RW, 1995, AM J PRIMATOL, V37, P297, DOI 10.1002/ajp.1350370404	51	121	124	2	124	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 29	2012	7	3							e34601	10.1371/journal.pone.0034601	http://dx.doi.org/10.1371/journal.pone.0034601			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	948SR	22479650	Green Published, Green Submitted, gold			2022-12-25	WOS:000304523400091
J	Mangeat, B; Cavagliotti, L; Lehmann, M; Gers-Huber, G; Kaur, I; Thomas, Y; Kaiser, L; Piguet, V				Mangeat, Bastien; Cavagliotti, Lorris; Lehmann, Martin; Gers-Huber, Gustavo; Kaur, Inderdeep; Thomas, Yves; Kaiser, Laurent; Piguet, Vincent			Influenza Virus Partially Counteracts Restriction Imposed by Tetherin/BST-2	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							A-VIRUS; NS1 PROTEIN; GENE-EXPRESSION; CELL-SURFACE; HIV-1 VPU; CYTOKINE RESPONSES; PARTICLE RELEASE; EPITHELIAL-CELLS; APICAL MEMBRANE; INHIBITS HIV-1	Influenza virus infections lead to a burst of type I interferon (IFN) in the human respiratory tract, which most probably accounts for a rapid control of the virus. Although in mice, IFN-induced Mx1 factor mediates a major part of this response, the situation is less clear in humans. Interestingly, a recently identified IFN-induced cellular protein, tetherin (also known as CD317, BST-2, or HM1.24), exerts potent antiviral activity against a broad range of retroviruses, as well as several other enveloped viruses, by impeding the release of newly generated viral particles from the cell surface. Here we show that influenza virus belongs to the targets of this potent antiviral factor. Ectopic expression of tetherin strongly inhibited fully replicative influenza virus. In addition, depleting endogenous tetherin increased viral production of influenza virions, both in cells constitutively expressing tetherin and upon its induction by IFN. We further demonstrate, by biochemical and morphological means, that tetherin exerts its antiviral action by tethering newly budded viral particles, a mechanism similar to the one that operates against HIV-1. In addition, we determined that the magnitude of tetherin antiviral activity is comparable with or higher than the one of several previously identified anti-influenza cellular factors, such as MxA, ADAR1, ISG15, and viperin. Finally, we demonstrate that influenza virus reduces the impact of tetherin-mediated restriction on its replication by several mechanisms. First, the influenza virus NS1 protein impedes IFN-mediated tetherin induction. Second, influenza infection leads to a decrease of tetherin steady state levels, and the neuraminidase surface protein partly counteracts its activity. Overall, our study helps to delineate the intricate molecular battle taking place between influenza virus and its host cells.	[Mangeat, Bastien; Piguet, Vincent] Cardiff Univ, Inst Infect & Immun, Dept Dermatol & Wound Healing, Sch Med, Cardiff CF14 4XN, S Glam, Wales; [Mangeat, Bastien; Cavagliotti, Lorris; Lehmann, Martin; Gers-Huber, Gustavo; Kaur, Inderdeep; Piguet, Vincent] Univ Geneva, Univ Hosp & Med Sch Geneva, Dept Microbiol & Mol Med, CH-1211 Geneva, Switzerland; [Thomas, Yves] Univ Geneva, Univ Hosp & Med Sch Geneva, Virol Lab, CH-1211 Geneva, Switzerland; [Kaiser, Laurent] Univ Geneva, Univ Hosp & Med Sch Geneva, Swiss Natl Reference Ctr Influenza, CH-1211 Geneva, Switzerland; [Kaiser, Laurent] Univ Geneva, Univ Hosp & Med Sch Geneva, Div Infect Dis, CH-1211 Geneva, Switzerland	Cardiff University; University of Geneva; University of Geneva; University of Geneva; University of Geneva	Piguet, V (corresponding author), Cardiff Univ, Inst Infect & Immun, Dept Dermatol & Wound Healing, Sch Med, Heath Pk, Cardiff CF14 4XN, S Glam, Wales.	piguetv@cardiff.ac.uk		Mangeat, Bastien/0000-0003-2592-0236; Kaiser, Laurent/0000-0002-0857-2252; Piguet, Vincent/0000-0001-6079-4517	Swiss National Science Foundation grant; Cardiff University School of Medicine	Swiss National Science Foundation grant(Swiss National Science Foundation (SNSF)); Cardiff University School of Medicine	This work was supported by a Swiss National Science Foundation grant (to V. P.). This work was also supported by Cardiff University School of Medicine (to V. P. and B. M.).	ARNHEITER H, 1990, CELL, V62, P51, DOI 10.1016/0092-8674(90)90239-B; Blasius AL, 2006, J IMMUNOL, V177, P3260, DOI 10.4049/jimmunol.177.5.3260; Brass AL, 2009, CELL, V139, P1243, DOI 10.1016/j.cell.2009.12.017; CALIGUIRI LA, 1979, VIROLOGY, V92, P15, DOI 10.1016/0042-6822(79)90211-3; CHARNEAU P, 1994, J MOL BIOL, V241, P651, DOI 10.1006/jmbi.1994.1542; Chen BJ, 2007, J VIROL, V81, P7111, DOI 10.1128/JVI.00361-07; Chen ZY, 1999, EMBO J, V18, P2273, DOI 10.1093/emboj/18.8.2273; Diebold SS, 2004, SCIENCE, V303, P1529, DOI 10.1126/science.1093616; Douglas JL, 2010, PLOS PATHOG, V6, DOI 10.1371/journal.ppat.1000913; Erikson E, 2011, P NATL ACAD SCI USA, V108, P13688, DOI 10.1073/pnas.1101684108; Ferko B, 2004, J VIROL, V78, P13037, DOI 10.1128/JVI.78.23.13037-13045.2004; Garcia-Sastre A, 1998, J VIROL, V72, P8550; Habermann A, 2010, J VIROL, V84, P4646, DOI 10.1128/JVI.02421-09; Hale BG, 2008, J GEN VIROL, V89, P2359, DOI 10.1099/vir.0.2008/004606-0; Haller O, 2007, CYTOKINE GROWTH F R, V18, P425, DOI 10.1016/j.cytogfr.2007.06.001; Hammonds J, 2012, J VIROL, V86, P2259, DOI 10.1128/JVI.05906-11; Hammonds J, 2010, PLOS PATHOG, V6, DOI 10.1371/journal.ppat.1000749; Hauser H, 2010, RETROVIROLOGY, V7, DOI 10.1186/1742-4690-7-51; Hayashi S, 2008, RESPIROLOGY, V13, P203, DOI 10.1111/j.1440-1843.2007.01204.x; Hayden FG, 1998, J CLIN INVEST, V101, P643, DOI 10.1172/JCI1355; Henkel JR, 2000, J CELL BIOL, V148, P495, DOI 10.1083/jcb.148.3.495; Hinz A, 2010, CELL HOST MICROBE, V7, P314, DOI 10.1016/j.chom.2010.03.005; Huang Q, 2001, SCIENCE, V294, P870, DOI 10.1126/science.294.5543.870; ISHIKAWA J, 1995, GENOMICS, V26, P527, DOI 10.1016/0888-7543(95)80171-H; Jouvenet N, 2009, J VIROL, V83, P1837, DOI 10.1128/JVI.02211-08; Kaiser L, 2001, J MED VIROL, V64, P262, DOI 10.1002/jmv.1045; Kaletsky RL, 2009, P NATL ACAD SCI USA, V106, P2886, DOI 10.1073/pnas.0811014106; Kato H, 2006, NATURE, V441, P101, DOI 10.1038/nature04734; Kawada J, 2006, J GEN VIROL, V87, P1677, DOI 10.1099/vir.0.81670-0; Kochs G, 2007, J VIROL, V81, P7011, DOI 10.1128/JVI.02581-06; Kupzig S, 2003, TRAFFIC, V4, P694, DOI 10.1034/j.1600-0854.2003.00129.x; Lambert LC, 2010, NEW ENGL J MED, V363, P2036, DOI 10.1056/NEJMra1002842; Le Tortorec A, 2009, J VIROL, V83, P11966, DOI 10.1128/JVI.01515-09; Lehmann M, 2011, PLOS PATHOG, V7, DOI 10.1371/journal.ppat.1002456; Lenschow DJ, 2007, P NATL ACAD SCI USA, V104, P1371, DOI 10.1073/pnas.0607038104; Lowen AC, 2009, J VIROL, V83, P2803, DOI 10.1128/JVI.02424-08; Malim MH, 2008, CELL HOST MICROBE, V3, P388, DOI 10.1016/j.chom.2008.04.008; Mangeat B, 2009, PLOS PATHOG, V5, DOI 10.1371/journal.ppat.1000574; McNatt MW, 2009, PLOS PATHOG, V5, DOI 10.1371/journal.ppat.1000300; Mibayashi M, 2007, J VIROL, V81, P514, DOI 10.1128/JVI.01265-06; Miyagi E, 2009, P NATL ACAD SCI USA, V106, P2868, DOI 10.1073/pnas.0813223106; Moltedo B, 2009, J IMMUNOL, V183, P3569, DOI 10.4049/jimmunol.0900091; Naldini L, 1996, SCIENCE, V272, P263, DOI 10.1126/science.272.5259.263; Neil SJD, 2008, NATURE, V451, P425, DOI 10.1038/nature06553; Neil SJD, 2007, CELL HOST MICROBE, V2, P193, DOI 10.1016/j.chom.2007.08.001; Neuzil KM, 2002, J INFECT DIS, V185, P147, DOI 10.1086/338363; Okumura A, 2008, P NATL ACAD SCI USA, V105, P3974, DOI 10.1073/pnas.0710629105; Ozaki S, 1997, BLOOD, V90, P3179, DOI 10.1182/blood.V90.8.3179; Pardieu C, 2010, PLOS PATHOG, V6, DOI 10.1371/journal.ppat.1000843; Perez-Caballero D, 2009, CELL, V139, P499, DOI 10.1016/j.cell.2009.08.039; Quinlivan M, 2005, J VIROL, V79, P8431, DOI 10.1128/JVI.79.13.8431-8439.2005; Ramilo O, 2007, BLOOD, V109, P2066, DOI 10.1182/blood-2006-02-002477; RICHMAN DD, 1976, J CLIN MICROBIOL, V3, P223; Rollason R, 2007, J CELL SCI, V120, P3850, DOI 10.1242/jcs.003343; Sakuma T, 2009, J VIROL, V83, P2382, DOI 10.1128/JVI.01607-08; Salvatore M, 2002, J VIROL, V76, P1206, DOI 10.1128/JVI.76.3.1206-1212.2002; Schoggins JW, 2011, NATURE, V472, P481, DOI 10.1038/nature09907; Taubenberger JK, 2010, CELL HOST MICROBE, V7, P440, DOI 10.1016/j.chom.2010.05.009; Tong HH, 2004, MICROB PATHOGENESIS, V37, P193, DOI 10.1016/j.micpath.2004.06.012; TOOHEY K, 1995, VIROLOGY, V213, P70, DOI 10.1006/viro.1995.1547; Van Damme N, 2008, CELL HOST MICROBE, V3, P245, DOI 10.1016/j.chom.2008.03.001; Vidal-Laliena M, 2005, CELL IMMUNOL, V236, P6, DOI 10.1016/j.cellimm.2005.08.002; Wang XY, 2007, CELL HOST MICROBE, V2, P96, DOI 10.1016/j.chom.2007.06.009; Ward SV, 2011, P NATL ACAD SCI USA, V108, P331, DOI 10.1073/pnas.1017241108; Watanabe R, 2011, VIROLOGY, V417, P50, DOI 10.1016/j.virol.2011.05.006; Wolff T, 2009, J INTERF CYTOK RES, V29, P549, DOI 10.1089/jir.2009.0066; Xu WL, 2006, J INTERF CYTOK RES, V26, P609, DOI 10.1089/jir.2006.26.609; Yondola MA, 2011, J VIROL, V85, P2480, DOI 10.1128/JVI.02188-10	68	58	61	0	6	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JUN 22	2012	287	26					22015	22029		10.1074/jbc.M111.319996	http://dx.doi.org/10.1074/jbc.M111.319996			15	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	974GH	22493439	Green Published, hybrid			2022-12-25	WOS:000306418600040
J	Li, C; Zhang, Y; Vankemmelbeke, M; Hecht, O; Aleanizy, FS; Macdonald, C; Moore, GR; James, R; Penfold, CN				Li, Chan; Zhang, Ying; Vankemmelbeke, Mireille; Hecht, Oliver; Aleanizy, Fadilah Sfouq; Macdonald, Colin; Moore, Geoffrey R.; James, Richard; Penfold, Christopher N.			Structural Evidence That Colicin A Protein Binds to a Novel Binding Site of TolA Protein in Escherichia coli Periplasm	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							C-TERMINAL DOMAIN; FILAMENTOUS PHAGE INFECTION; OUTER-MEMBRANE; TRANSLOCATION DOMAIN; COMPETITIVE RECRUITMENT; CRYSTAL-STRUCTURE; CELL-ENVELOPE; PAL PROTEINS; IMPORT; RECOGNITION	The Tol assembly of proteins is an interacting network of proteins located in the Escherichia coli cell envelope that transduces energy and contributes to cell integrity. TolA is central to this network linking the inner and outer membranes by interactions with TolQ, TolR, TolB, and Pal. Group A colicins, such as ColA, parasitize the Tol network through interactions with TolA and/or TolB to facilitate translocation through the cell envelope to reach their cytotoxic site of action. We have determined the first structure of the C-terminal domain of TolA (TolAIII) bound to an N-terminal ColA polypeptide (TA(53-107)). The interface region of the TA(53-107)-TolAIII complex consists of polar contacts linking residues Arg-92 to Arg-96 of ColA with residues Leu-375-Pro-380 of TolA, which constitutes a beta-strand addition commonly seen in more promiscuous protein-protein contacts. The interface region also includes three cation-pi interactions (Tyr-58-Lys-368, Tyr-90-Lys-379, Phe-94-Lys-396), which have not been observed in any other colicin-Tol protein complex. Mutagenesis of the interface residues of ColA or TolA revealed that the effect on the interaction was cumulative; single mutations of either partner had no effect on ColA activity, whereas mutations of three or more residues significantly reduced ColA activity. Mutagenesis of the aromatic ring component of the cation-pi interacting residues showed Tyr-58 of ColA to be essential for the stability of complex formation. TA(53-107) binds on the opposite side of TolAIII to that used by g3p, ColN, or TolB, illustrating the flexible nature of TolA as a periplasmic hub protein.	[Li, Chan; Zhang, Ying; Vankemmelbeke, Mireille; Aleanizy, Fadilah Sfouq; James, Richard; Penfold, Christopher N.] Univ Nottingham, Sch Mol Med Sci, Ctr Biomol Sci, Nottingham NG7 2RD, England; [Hecht, Oliver; Macdonald, Colin; Moore, Geoffrey R.] Univ E Anglia, Sch Chem Sci, Ctr Mol & Struct Biochem, Norwich NR4 7TJ, Norfolk, England	University of Nottingham; University of East Anglia	Penfold, CN (corresponding author), Univ Nottingham, Sch Mol Med Sci, Ctr Biomol Sci, Univ Pk, Nottingham NG7 2RD, England.	chris.penfold@nottingham.ac.uk	Aleanizy, Fadilah Sfouq/AAL-6436-2020; James, Richard/B-2252-2009; zhang, ying/E-2718-2017	Aleanizy, Fadilah Sfouq/0000-0002-6161-3121; Zhang, Ying/0000-0003-3074-9998; Vankemmelbeke, Mireille/0000-0002-8100-813X; James, Richard/0000-0002-5086-788X; Penfold, Christopher/0000-0003-3251-5650	Biotechnology and Biological Sciences Research Council; Wolfson Foundation; Wellcome Trust	Biotechnology and Biological Sciences Research Council(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); Wolfson Foundation; Wellcome Trust(Wellcome TrustEuropean Commission)	This work was supported by the Biotechnology and Biological Sciences Research Council, the Wolfson Foundation, and The Wellcome Trust.	Bahadur RP, 2008, CELL MOL LIFE SCI, V65, P1059, DOI 10.1007/s00018-007-7451-x; BAILEY S, 1994, ACTA CRYSTALLOGR D, V50, P760, DOI 10.1107/s0907444994003112; BATY D, 1990, EUR J BIOCHEM, V189, P409, DOI 10.1111/j.1432-1033.1990.tb15503.x; Bernadac A, 1998, J BACTERIOL, V180, P4872, DOI 10.1128/JB.180.18.4872-4878.1998; Bonsor DA, 2007, J AM CHEM SOC, V129, P4800, DOI 10.1021/ja070153n; Bonsor DA, 2009, EMBO J, V28, P2846, DOI 10.1038/emboj.2009.224; Bonsor DA, 2008, BIOCHEM SOC T, V36, P1409, DOI 10.1042/BST0361409; Bouveret E, 1998, MOL MICROBIOL, V27, P143, DOI 10.1046/j.1365-2958.1998.00667.x; BOUVERET E, 1995, J BIOL CHEM, V270, P11071, DOI 10.1074/jbc.270.19.11071; Cascales E, 2002, J BACTERIOL, V184, P754, DOI 10.1128/JB.184.3.754-759.2002; Cascales E, 2001, MOL MICROBIOL, V42, P795, DOI 10.1046/j.1365-2958.2001.02673.x; Cascales E, 2000, MOL MICROBIOL, V38, P904, DOI 10.1046/j.1365-2958.2000.02190.x; Collins ES, 2002, J MOL BIOL, V318, P787, DOI 10.1016/S0022-2836(02)00036-0; Cowtan K, 1999, ACTA CRYSTALLOGR D, V55, P1555, DOI 10.1107/S0907444999007416; Cowtan K, 2006, ACTA CRYSTALLOGR D, V62, P1002, DOI 10.1107/S0907444906022116; DELAGLIO F, 1995, J BIOMOL NMR, V6, P277, DOI 10.1007/BF00197809; DeLano W. L., 2010, PYMOL MOL GRAPHICS S; Deprez C, 2005, J MOL BIOL, V346, P1047, DOI 10.1016/j.jmb.2004.12.028; Deprez C, 2002, BIOCHEMISTRY-US, V41, P2589, DOI 10.1021/bi0157262; Dubuisson JF, 2002, J BACTERIOL, V184, P4620, DOI 10.1128/JB.184.16.4620-4625.2002; Emsley P, 2004, ACTA CRYSTALLOGR D, V60, P2126, DOI 10.1107/S0907444904019158; Evans P, 2006, ACTA CRYSTALLOGR D, V62, P72, DOI 10.1107/S0907444905036693; Evans PR, 1997, JOINT CCP4 ESF EACBM, V33, P22; Gallivan JP, 1999, P NATL ACAD SCI USA, V96, P9459, DOI 10.1073/pnas.96.17.9459; Gerding MA, 2007, MOL MICROBIOL, V63, P1008, DOI 10.1111/j.1365-2958.2006.05571.x; Germon P, 2001, J BACTERIOL, V183, P4110, DOI 10.1128/JB.183.14.4110-4114.2001; Goemaere EL, 2007, J MOL BIOL, V366, P1424, DOI 10.1016/j.jmb.2006.12.020; Gokce I, 2000, J MOL BIOL, V304, P621, DOI 10.1006/jmbi.2000.4232; Goldschmidt L, 2007, PROTEIN SCI, V16, P1569, DOI 10.1110/ps.072914007; Hands SL, 2005, J BACTERIOL, V187, P6733, DOI 10.1128/JB.187.19.6733-6741.2005; Hecht O, 2008, FEBS LETT, V582, P2673, DOI 10.1016/j.febslet.2008.06.022; Hecht O, 2010, FEBS LETT, V584, P2249, DOI 10.1016/j.febslet.2010.04.061; Housden NG, 2010, P NATL ACAD SCI USA, V107, P21412, DOI 10.1073/pnas.1010780107; Hu PZ, 2009, PLOS BIOL, V7, P929, DOI 10.1371/journal.pbio.1000096; Hubbard S.J.a.J.T., 1996, NACCESS; Journet L, 2001, MOL MICROBIOL, V42, P331, DOI 10.1046/j.1365-2958.2001.02592.x; Kleanthous C, 2010, NAT REV MICROBIOL, V8, P843, DOI 10.1038/nrmicro2454; Krachler AM, 2010, J MOL BIOL, V403, P270, DOI 10.1016/j.jmb.2010.08.050; Krantz BA, 2005, SCIENCE, V309, P777, DOI 10.1126/science.1113380; LAWRENCE MC, 1993, J MOL BIOL, V234, P946, DOI 10.1006/jmbi.1993.1648; LEE B, 1971, J MOL BIOL, V55, P379, DOI 10.1016/0022-2836(71)90324-X; LESLIE AGW, 1992, JOINT CCP4 ESF EACMB, V26; Lloubes R, 2001, RES MICROBIOL, V152, P523, DOI 10.1016/S0923-2508(01)01226-8; Lo Conte L, 1999, J MOL BIOL, V285, P2177; Loftus SR, 2006, P NATL ACAD SCI USA, V103, P12353, DOI 10.1073/pnas.0603433103; Lubkowski J, 1999, STRUCTURE, V7, P711, DOI 10.1016/S0969-2126(99)80092-6; Macdonald CJ, 2004, J BIOMOL NMR, V30, P81, DOI 10.1023/B:JNMR.0000042963.71790.19; Mccoy AJ, 2007, J APPL CRYSTALLOGR, V40, P658, DOI 10.1107/S0021889807021206; Murshudov GN, 1997, ACTA CRYSTALLOGR D, V53, P240, DOI 10.1107/S0907444996012255; Painter J, 2006, J APPL CRYSTALLOGR, V39, P109, DOI 10.1107/S0021889805038987; Papadakos G, 2012, J MOL BIOL, V418, P269, DOI 10.1016/j.jmb.2012.01.039; Patil A, 2010, INT J MOL SCI, V11, P1930, DOI 10.3390/ijms11041930; Pommier S, 2005, J BACTERIOL, V187, P7526, DOI 10.1128/JB.187.21.7526-7534.2005; Raggett EM, 1998, MOL MICROBIOL, V28, P1335, DOI 10.1046/j.1365-2958.1998.00899.x; Rayment I, 1997, METHOD ENZYMOL, V276, P171, DOI 10.1016/S0076-6879(97)76058-0; Remaut H, 2006, TRENDS BIOCHEM SCI, V31, P436, DOI 10.1016/j.tibs.2006.06.007; Riechmann L, 1997, CELL, V90, P351, DOI 10.1016/S0092-8674(00)80342-6; Schendel SL, 1997, J BACTERIOL, V179, P3683, DOI 10.1128/jb.179.11.3683-3690.1997; Stirnimann CU, 2006, CELL MOL LIFE SCI, V63, P1642, DOI 10.1007/s00018-006-6055-1; Sturgis JN, 2001, J MOL MICROB BIOTECH, V3, P113; Terwilliger TC, 1999, ACTA CRYSTALLOGR D, V55, P849, DOI 10.1107/S0907444999000839; Tozawa K, 2005, BIOCHEMISTRY-US, V44, P11496, DOI 10.1021/bi0503596; Walburger A, 2002, MOL MICROBIOL, V44, P695, DOI 10.1046/j.1365-2958.2002.02895.x; Walter TS, 2006, STRUCTURE, V14, P1617, DOI 10.1016/j.str.2006.09.005; WEBSTER RE, 1991, MOL MICROBIOL, V5, P1005, DOI 10.1111/j.1365-2958.1991.tb01873.x; Witty M, 2002, EMBO J, V21, P4207, DOI 10.1093/emboj/cdf417; Yang ZR, 2005, BIOINFORMATICS, V21, P3369, DOI 10.1093/bioinformatics/bti534; Zhang Y, 2010, MOL MICROBIOL, V75, P623, DOI 10.1111/j.1365-2958.2009.06808.x	68	13	13	0	17	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	JUN 1	2012	287	23					19048	19057		10.1074/jbc.M112.342246	http://dx.doi.org/10.1074/jbc.M112.342246			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	974EF	22493500	Green Published, hybrid, Green Accepted			2022-12-25	WOS:000306411900016
J	Margalith, I; Suter, C; Ballmer, B; Schwarz, P; Tiberi, C; Sonati, T; Falsig, J; Nystrom, S; Hammarstrom, P; Aslund, A; Nilsson, KPR; Yam, A; Whitters, E; Hornemann, S; Aguzzi, A				Margalith, Ilan; Suter, Carlo; Ballmer, Boris; Schwarz, Petra; Tiberi, Cinzia; Sonati, Tiziana; Falsig, Jeppe; Nystrom, Sofie; Hammarstrom, Per; Aslund, Andreas; Nilsson, K. Peter R.; Yam, Alice; Whitters, Eric; Hornemann, Simone; Aguzzi, Adriano			Polythiophenes Inhibit Prion Propagation by Stabilizing Prion Protein (PrP) Aggregates	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							SENSITIVE OPTICAL PROBES; AMYLOID-BETA PEPTIDE; CONGO RED; PENTOSAN POLYSULFATE; CONJUGATED POLYELECTROLYTES; CONFORMATIONAL STATES; SECONDARY STRUCTURE; INCUBATION PERIOD; FIBRIL FORMATION; CULTURED-CELLS	Luminescent conjugated polymers (LCPs) interact with ordered protein aggregates and sensitively detect amyloids of many different proteins, suggesting that they may possess antiprion properties. Here, we show that a variety of anionic, cationic, and zwitterionic LCPs reduced the infectivity of prion-containing brain homogenates and of prion-infected cerebellar organotypic cultured slices and decreased the amount of scrapie isoform of PrPC (PrPSc) oligomers that could be captured in an avidity assay. Paradoxically, treatment enhanced the resistance of PrPSc to proteolysis, triggered the compaction, and enhanced the resistance to proteolysis of recombinant mouse PrP(23-231) fibers. These results suggest that LCPs act as antiprion agents by transitioning PrP aggregates into structures with reduced frangibility. Moreover, ELISA on cerebellar organotypic cultured slices and in vitro conversion assays with mouse PrP(23-231) indicated that poly(thiophene-3-acetic acid) may additionally interfere with the generation of PrPSc by stabilizing the conformation of PrPC or of a transition intermediate. Therefore, LCPs represent a novel class of antiprion agents whose mode of action appears to rely on hyperstabilization, rather than destabilization, of PrPSc deposits.	[Margalith, Ilan; Suter, Carlo; Ballmer, Boris; Schwarz, Petra; Tiberi, Cinzia; Sonati, Tiziana; Falsig, Jeppe; Hornemann, Simone; Aguzzi, Adriano] Univ Zurich Hosp, Inst Neuropathol, CH-8091 Zurich, Switzerland; [Nystrom, Sofie; Hammarstrom, Per; Aslund, Andreas; Nilsson, K. Peter R.] Linkoping Univ, IFM Dept Chem, SE-58183 Linkoping, Sweden; [Yam, Alice; Whitters, Eric] Novartis Diagnost, Emeryville, CA 94608 USA	University of Zurich; University Zurich Hospital; Linkoping University; Novartis	Hornemann, S (corresponding author), Univ Zurich Hosp, Inst Neuropathol, CH-8091 Zurich, Switzerland.	Simone.Hornemann@usz.ch; Adriano.Aguzzi@usz.ch	Aguzzi, Adriano/A-3351-2008; Aslund, Andreas/H-4721-2013; Åslund, Andreas/M-4483-2019	Aslund, Andreas/0000-0001-5222-9307; Åslund, Andreas/0000-0001-5222-9307; Aguzzi, Adriano/0000-0002-0344-6708; Nystrom, Sofie/0000-0002-4303-4783	European Union P-7 Health; Swiss National Foundation; Novartis Research Foundation; European Research Council; Swedish Foundation for Strategic Research [FFL-4]	European Union P-7 Health; Swiss National Foundation(Swiss National Science Foundation (SNSF)); Novartis Research Foundation; European Research Council(European Research Council (ERC)European Commission); Swedish Foundation for Strategic Research(Swedish Foundation for Strategic Research)	This work was supported in part by grants from the European Union P-7 Health (project acronym LUPAS), the Swiss National Foundation, and the Novartis Research Foundation.; Supported by European Research Council Starting Independent Researcher Grant (Project MUMID) from the European Research Council and Grant FFL-4 from the Swedish Foundation for Strategic Research.	Abelein A, 2012, BIOCHEMISTRY-US, V51, P126, DOI 10.1021/bi201745g; Aguzzi A, 2004, CELL, V116, P313, DOI 10.1016/S0092-8674(03)01031-6; Aguzzi A, 2009, PHYSIOL REV, V89, P1105, DOI 10.1152/physrev.00006.2009; Aguzzi A, 2009, NATURE, V459, P924, DOI 10.1038/459924a; Almstedt K, 2009, PRION, V3, P224, DOI 10.4161/pri.3.4.10112; Apetri AC, 2005, BIOCHEMISTRY-US, V44, P15880, DOI 10.1021/bi051455+; Appleby BS, 2011, EXPERT OPIN PHARMACO, V12, P1, DOI 10.1517/14656566.2010.514903; Aslund A, 2007, BIOCONJUGATE CHEM, V18, P1860, DOI 10.1021/bc700180g; Aslund Andreas, 2009, J Chem Biol, V2, P161, DOI 10.1007/s12154-009-0024-8; Aslund A, 2009, ACS CHEM BIOL, V4, P673, DOI 10.1021/cb900112v; Barron RM, 2007, J BIOL CHEM, V282, P35878, DOI 10.1074/jbc.M704329200; Benito-Leon J, 2004, CLIN NEUROPHARMACOL, V27, P201, DOI 10.1097/01.wnf.0000134853.36429.0e; Bokvist M, 2004, J MOL BIOL, V335, P1039, DOI 10.1016/j.jmb.2003.11.046; Breyer J, 2012, VET MICROBIOL, V157, P23, DOI 10.1016/j.vetmic.2011.12.008; Brown LR, 2003, J NEUROCHEM, V87, P353, DOI 10.1046/j.1471-4159.2003.01996.x; Caspi S, 1998, J BIOL CHEM, V273, P3484, DOI 10.1074/jbc.273.6.3484; Caughey B, 2003, ANNU REV NEUROSCI, V26, P267, DOI 10.1146/annurev.neuro.26.010302.081142; Chiesa R, 2003, J VIROL, V77, P7611, DOI 10.1128/JVI.77.13.7611-7622.2003; Collinge J, 2009, LANCET NEUROL, V8, P334, DOI 10.1016/S1474-4422(09)70049-3; Ding L, 2000, SYNTHETIC MET, V110, P133, DOI 10.1016/S0379-6779(99)00284-2; Edgeworth JA, 2010, P NATL ACAD SCI USA, V107, P14402, DOI 10.1073/pnas.1004036107; Enari M, 2001, P NATL ACAD SCI USA, V98, P9295, DOI 10.1073/pnas.151242598; Falsig J, 2008, NAT PROTOC, V3, P555, DOI 10.1038/nprot.2008.13; Falsig J, 2008, NAT NEUROSCI, V11, P109, DOI 10.1038/nn2028; Fischer M, 1996, EMBO J, V15, P1255, DOI 10.1002/j.1460-2075.1996.tb00467.x; GABIZON R, 1987, P NATL ACAD SCI USA, V84, P4017, DOI 10.1073/pnas.84.12.4017; Gottlieb HE, 1997, J ORG CHEM, V62, P7512, DOI 10.1021/jo971176v; Haybaeck J, 2011, PLOS PATHOG, V7, DOI 10.1371/journal.ppat.1001257; Herland A, 2005, J AM CHEM SOC, V127, P2317, DOI 10.1021/ja045835e; Hijazi N, 2003, BRAIN RES, V993, P192, DOI 10.1016/j.brainres.2003.09.014; Ho HA, 2002, ANGEW CHEM INT EDIT, V41, P1548, DOI 10.1002/1521-3773(20020503)41:9<1548::AID-ANIE1548>3.0.CO;2-I; Hornemann S, 2009, FEBS J, V276, P2359, DOI 10.1111/j.1742-4658.2009.06968.x; HSIAO KK, 1994, P NATL ACAD SCI USA, V91, P9126, DOI 10.1073/pnas.91.19.9126; INGROSSO L, 1995, J VIROL, V69, P506, DOI 10.1128/JVI.69.1.506-508.1995; Klohn PC, 2003, P NATL ACAD SCI USA, V100, P11666, DOI 10.1073/pnas.1834432100; Knowles TPJ, 2009, SCIENCE, V326, P1533, DOI 10.1126/science.1178250; Korth C, 2001, P NATL ACAD SCI USA, V98, P9836, DOI 10.1073/pnas.161274798; Kranich J, 2010, J EXP MED, V207, P2271, DOI 10.1084/jem.20092401; Lasmezas CI, 1997, SCIENCE, V275, P402, DOI 10.1126/science.275.5298.402; Lau AL, 2007, P NATL ACAD SCI USA, V104, P11551, DOI 10.1073/pnas.0704260104; Lendel C, 2010, BIOCHEMISTRY-US, V49, P1358, DOI 10.1021/bi902005t; Lysek DA, 2004, BIOCHEMISTRY-US, V43, P10393, DOI 10.1021/bi0494828; MACGREGOR IR, 1985, THROMB HAEMOSTASIS, V53, P411; Martinez-Lage JF, 2005, SURG NEUROL, V64, P542, DOI 10.1016/j.surneu.2005.03.035; Mastrianni JA, 2010, GENET MED, V12, P187, DOI 10.1097/GIM.0b013e3181cd7374; Milhavet O, 2000, J NEUROCHEM, V74, P222, DOI 10.1046/j.1471-4159.2000.0740222.x; Nilsson KPR, 2007, ACS CHEM BIOL, V2, P553, DOI 10.1021/cb700116u; Nilsson KPR, 2006, CHEMBIOCHEM, V7, P1096, DOI 10.1002/cbic.200500550; Nilsson KPR, 2010, AM J PATHOL, V176, P563, DOI 10.2353/ajpath.2010.080797; Nilsson KPR, 2005, BIOCHEMISTRY-US, V44, P3718, DOI 10.1021/bi047402u; Nilsson KPR, 2003, P NATL ACAD SCI USA, V100, P10170, DOI 10.1073/pnas.1834422100; Nilsson KPR, 2003, NAT MATER, V2, P419, DOI 10.1038/nmat899; Otzen DE, 2010, CURR PROTEIN PEPT SC, V11, P355; Ouidja MO, 2007, BIOCHEM BIOPH RES CO, V363, P95, DOI 10.1016/j.bbrc.2007.08.113; Pauly PC, 1998, J BIOL CHEM, V273, P33107, DOI 10.1074/jbc.273.50.33107; Peretz D, 2001, NATURE, V412, P739, DOI 10.1038/35089090; Peretz D, 2001, PROTEIN SCI, V10, P854, DOI 10.1110/ps.39201; Perrier V, 2004, J NEUROCHEM, V89, P454, DOI 10.1111/j.1471-4159.2004.02356.x; Piccardo P, 2007, P NATL ACAD SCI USA, V104, P4712, DOI 10.1073/pnas.0609241104; POCCHIARI M, 1987, J GEN VIROL, V68, P219, DOI 10.1099/0022-1317-68-1-219; Polymenidou M, 2011, BRAIN PATHOL, V21, P209, DOI 10.1111/j.1750-3639.2010.00439.x; Polymenidou M, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0003872; Prusiner SB, 1998, P NATL ACAD SCI USA, V95, P13363, DOI 10.1073/pnas.95.23.13363; Rangachari V, 2006, BIOCHEMISTRY-US, V45, P8639, DOI 10.1021/bi060323t; Shaked GM, 1999, J BIOL CHEM, V274, P17981, DOI 10.1074/jbc.274.25.17981; SHYNG SL, 1995, J BIOL CHEM, V270, P30221; Sigurdson CJ, 2007, NAT METHODS, V4, P1023, DOI 10.1038/nmeth1131; Silveira JR, 2005, NATURE, V437, P257, DOI 10.1038/nature03989; SKLAVIADIS TK, 1989, J VIROL, V63, P1212, DOI 10.1128/JVI.63.3.1212-1222.1989; Supattapone S, 2009, CNS NEUROL DISORD-DR, V8, P323, DOI 10.2174/187152709789541952; Tagliavini F, 1997, SCIENCE, V276, P1119, DOI 10.1126/science.276.5315.1119; Terada T, 2010, ACTA NEUROL SCAND, V121, P127, DOI 10.1111/j.1600-0404.2009.01272.x; TERZI E, 1995, J MOL BIOL, V252, P633, DOI 10.1006/jmbi.1995.0525; Tew DJ, 2008, BIOPHYS J, V94, P2752, DOI 10.1529/biophysj.107.119909; Tixador P, 2010, PLOS PATHOG, V6, DOI 10.1371/journal.ppat.1000859; Tsuboi Y, 2009, NEUROPATHOLOGY, V29, P632, DOI 10.1111/j.1440-1789.2009.01058.x; Wahlstrom A, 2008, FEBS J, V275, P5117, DOI 10.1111/j.1742-4658.2008.06643.x; Wang YQ, 2011, J BIOL CHEM, V286, DOI 10.1074/jbc.M110.208934; Weissmann C, 2004, NAT REV MICROBIOL, V2, P861, DOI 10.1038/nrmicro1025; Weissmann C, 2002, J INFECT DIS, V186, pS157, DOI 10.1086/344575; Zahn R, 2000, P NATL ACAD SCI USA, V97, P145, DOI 10.1073/pnas.97.1.145	81	52	52	0	29	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JUN 1	2012	287	23					18872	18887		10.1074/jbc.M112.355958	http://dx.doi.org/10.1074/jbc.M112.355958			16	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	974EF	22493452	Green Published, Green Accepted, Green Submitted, hybrid			2022-12-25	WOS:000306411900001
J	Osipiuk, J; Mulligan, R; Bargassa, M; Hamilton, JE; Cunningham, MA; Joachimiak, A				Osipiuk, Jerzy; Mulligan, Rory; Bargassa, Monireh; Hamilton, John E.; Cunningham, Mark A.; Joachimiak, Andrzej			Characterization of Member of DUF1888 Protein Family, Self-cleaving and Self-assembling Endopeptidase	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							MOLECULAR-DYNAMICS; AUTOCATALYTIC CLEAVAGE; ASPARTIC PROTEINASES; MATURATION CLEAVAGE; HIGH-THROUGHPUT; LOW PH; SIMULATIONS; SEQUENCE; DATABASE; CLONING	The crystal structure of SO1698 protein from Shewanella oneidensis was determined by a SAD method and refined to 1.57 angstrom. The structure is a beta sandwich that unexpectedly consists of two polypeptides; the N-terminal fragment includes residues 1-116, and the C-terminal one includes residues 117-125. Electron density also displayed the Lys-98 side chain covalently linked to Asp-116. The putative active site residues involved in self-cleavage were identified; point mutants were produced and characterized structurally and in a biochemical assay. Numerical simulations utilizing molecular dynamics and hybrid quantum/classical calculations suggest a mechanism involving activation of a water molecule coordinated by a catalytic aspartic acid.	[Hamilton, John E.; Cunningham, Mark A.] Univ Texas Pan Amer, Dept Phys & Geol, Edinburg, TX 78539 USA; [Osipiuk, Jerzy; Mulligan, Rory; Bargassa, Monireh; Joachimiak, Andrzej] Argonne Natl Lab, Midwest Ctr Struct Genom, Argonne, IL 60439 USA; [Osipiuk, Jerzy; Mulligan, Rory; Bargassa, Monireh; Joachimiak, Andrzej] Argonne Natl Lab, Struct Biol Ctr, Argonne, IL 60439 USA	University of Texas System; University of Texas Rio Grande Valley; United States Department of Energy (DOE); Argonne National Laboratory; United States Department of Energy (DOE); Argonne National Laboratory	Cunningham, MA (corresponding author), Univ Texas Pan Amer, Dept Phys & Geol, 1201 W Univ Dr, Edinburg, TX 78539 USA.	cunningham@utpa.edu; andrzejj@anl.gov		Joachimiak, Andrzej/0000-0003-2535-6209	National Institutes of Health [GM074942]; United States Department of Energy, Office of Biological and Environmental Research [DE-AC02-06CH11357]; United States Department of Energy Office of Science laboratory [DE-AC02-06CH11357]; National Science Foundation [HRD-0703584]; Midwest Center for Structural Biology; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [U54GM094585, U54GM074942] Funding Source: NIH RePORTER; Division Of Computer and Network Systems [1040430] Funding Source: National Science Foundation	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); United States Department of Energy, Office of Biological and Environmental Research(United States Department of Energy (DOE)); United States Department of Energy Office of Science laboratory(United States Department of Energy (DOE)); National Science Foundation(National Science Foundation (NSF)); Midwest Center for Structural Biology; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); Division Of Computer and Network Systems(National Science Foundation (NSF)NSF - Directorate for Computer & Information Science & Engineering (CISE))	This work was supported, in whole or in part, by National Institutes of Health Grant GM074942. This work was also supported by the United States Department of Energy, Office of Biological and Environmental Research, under Contract DE-AC02-06CH11357. This work has been created by UChicago Argonne, LLC, Operator of Argonne National Laboratory ("Argonne"). Argonne, a United States Department of Energy Office of Science laboratory, is operated under Contract DE-AC02-06CH11357.; Supported by National Science Foundation FaST program Grant HRD-0703584, administered by the Department of Educational Programs at Argonne National Laboratory.; We thank the members of the Midwest Center for Structural Biology for support, in particular Frank Collart, James Adbullah, and Garrett Cobb for efforts in cloning proteins, and Marat Valiev at Pacific Northwest National Laboratory for help with NWChem. We acknowledge the Texas Advanced Computing Center at the University of Texas at Austin for providing high performance computing resources that have contributed to the research results reported within this paper.	ALTSCHUL SF, 1990, J MOL BIOL, V215, P403, DOI 10.1016/S0022-2836(05)80360-2; BAILEY S, 1994, ACTA CRYSTALLOGR D, V50, P760, DOI 10.1107/s0907444994003112; BECKE AD, 1988, PHYS REV A, V38, P3098, DOI 10.1103/PhysRevA.38.3098; Bruice TC, 2000, BIOCHEMISTRY-US, V39, P6267, DOI 10.1021/bi0003689; BRUNGER A, 1984, CHEM PHYS LETT, V105, P495, DOI 10.1016/0009-2614(84)80098-6; Cooper JB, 2002, CURR DRUG TARGETS, V3, P155, DOI 10.2174/1389450024605382; DAVIES DR, 1990, ANNU REV BIOPHYS BIO, V19, P189, DOI 10.1146/annurev.bb.19.060190.001201; Dieckman L, 2002, PROTEIN EXPRES PURIF, V25, P1, DOI 10.1006/prep.2001.1602; Dunn BM, 2002, CHEM REV, V102, P4431, DOI 10.1021/cr010167q; Emsley P, 2004, ACTA CRYSTALLOGR D, V60, P2126, DOI 10.1107/S0907444904019158; ESSMANN U, 1995, J CHEM PHYS, V103, P8577, DOI 10.1063/1.470117; FELLER SE, 1995, J CHEM PHYS, V103, P4613, DOI 10.1063/1.470648; GALLAGHER TM, 1988, J VIROL, V62, P3399, DOI 10.1128/JVI.62.9.3399-3406.1988; Gouet P, 1999, BIOINFORMATICS, V15, P305, DOI 10.1093/bioinformatics/15.4.305; Heidelberg JF, 2002, NAT BIOTECHNOL, V20, P1118, DOI 10.1038/nbt749; Holm L, 2010, NUCLEIC ACIDS RES, V38, pW545, DOI 10.1093/nar/gkq366; HOOVER WG, 1986, PHYS REV A, V34, P2499, DOI 10.1103/PhysRevA.34.2499; HOOVER WG, 1985, PHYS REV A, V31, P1695, DOI 10.1103/PhysRevA.31.1695; Humphrey W, 1996, J MOL GRAPH MODEL, V14, P33, DOI 10.1016/0263-7855(96)00018-5; Kendall RA, 2000, COMPUT PHYS COMMUN, V128, P260, DOI 10.1016/S0010-4655(00)00065-5; Kim Youngchang, 2004, Journal of Structural and Functional Genomics, V5, P111, DOI 10.1023/B:JSFG.0000029206.07778.fc; Laskowski RA, 1996, J BIOMOL NMR, V8, P477, DOI 10.1007/BF00228148; Lesnyak DV, 2007, J BIOL CHEM, V282, P5880, DOI 10.1074/jbc.M608214200; Lidell ME, 2003, J BIOL CHEM, V278, P13944, DOI 10.1074/jbc.M210069200; MacKerell AD, 1998, J PHYS CHEM B, V102, P3586, DOI 10.1021/jp973084f; Morris RJ, 2003, METHOD ENZYMOL, V374, P229, DOI 10.1016/S0076-6879(03)74011-7; Mulder NJ, 2003, NUCLEIC ACIDS RES, V31, P315, DOI 10.1093/nar/gkg046; Murshudov GN, 1997, ACTA CRYSTALLOGR D, V53, P240, DOI 10.1107/S0907444996012255; Osicka R, 2004, J BIOL CHEM, V279, P24944, DOI 10.1074/jbc.M314013200; Otwinowski Z, 2003, ACTA CRYSTALLOGR A, V59, P228, DOI 10.1107/S0108767303005488; Phillips JC, 2005, J COMPUT CHEM, V26, P1781, DOI 10.1002/jcc.20289; Rawlings ND, 2010, NUCLEIC ACIDS RES, V38, pD227, DOI 10.1093/nar/gkp971; SCHNEEMANN A, 1992, J VIROL, V66, P6728, DOI 10.1128/JVI.66.11.6728-6734.1992; Schneider TR, 2002, ACTA CRYSTALLOGR D, V58, P1772, DOI 10.1107/S0907444902011678; Stols L, 2002, PROTEIN EXPRES PURIF, V25, P8, DOI 10.1006/prep.2001.1603; Terwilliger TC, 2003, METHOD ENZYMOL, V374, P22, DOI 10.1016/S0076-6879(03)74002-6; Thuveson M, 2000, J BIOL CHEM, V275, P30996, DOI 10.1074/jbc.M002399200; Valiev M, 2007, J PHYS CHEM B, V111, P13455, DOI 10.1021/jp074853q; Walsh MA, 1999, ACTA CRYSTALLOGR D, V55, P1168, DOI 10.1107/S0907444999003698; WERY JP, 1994, J MOL BIOL, V235, P565, DOI 10.1006/jmbi.1994.1014	40	4	5	0	4	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JUN 1	2012	287	23					19452	19461		10.1074/jbc.M112.358069	http://dx.doi.org/10.1074/jbc.M112.358069			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	974EF	22493430	Green Published, hybrid			2022-12-25	WOS:000306411900059
J	Bai, VU; Hwang, O; Divine, GW; Barrack, ER; Menon, M; Reddy, GPV; Hwang, C				Bai, V. Uma; Hwang, Ok; Divine, George W.; Barrack, Evelyn R.; Menon, Mani; Reddy, G. Prem-Veer; Hwang, Clara			Averaged Differential Expression for the Discovery of Biomarkers in the Blood of Patients with Prostate Cancer	PLOS ONE			English	Article							AMYOTROPHIC-LATERAL-SCLEROSIS; DORFIN LOCALIZES; GENE-EXPRESSION; LEWY BODIES; CELL-DEATH; SYNPHILIN-1; MORTALITY; SURVIVAL; PATHWAY; ANTIGEN	Background: The identification of a blood-based diagnostic marker is a goal in many areas of medicine, including the early diagnosis of prostate cancer. We describe the use of averaged differential display as an efficient mechanism for biomarker discovery in whole blood RNA. The process of averaging reduces the problem of clinical heterogeneity while simultaneously minimizing sample handling. Methodology/Principal Findings: RNA was isolated from the blood of prostate cancer patients and healthy controls. Samples were pooled and subjected to the averaged differential display process. Transcripts present at different levels between patients and controls were purified and sequenced for identification. Transcript levels in the blood of prostate cancer patients and controls were verified by quantitative RT-PCR. Means were compared using a t-test and a receiver-operating curve was generated. The Ring finger protein 19A (RNF19A) transcript was identified as having higher levels in prostate cancer patients compared to healthy men through the averaged differential display process. Quantitative RT-PCR analysis confirmed a more than 2-fold higher level of RNF19A mRNA levels in the blood of patients with prostate cancer than in healthy controls (p = 0.0066). The accuracy of distinguishing cancer patients from healthy men using RNF19A mRNA levels in blood as determined by the area under the receiving operator curve was 0.727. Conclusions/Significance: Averaged differential display offers a simplified approach for the comprehensive screening of body fluids, such as blood, to identify biomarkers in patients with prostate cancer. Furthermore, this proof-of-concept study warrants further analysis of RNF19A as a clinically relevant biomarker for prostate cancer detection.	[Bai, V. Uma; Barrack, Evelyn R.; Menon, Mani; Reddy, G. Prem-Veer] Henry Ford Hlth Syst, Dept Urol, Detroit, MI USA; [Bai, V. Uma; Barrack, Evelyn R.; Menon, Mani; Reddy, G. Prem-Veer] Henry Ford Hlth Syst, Vattikuti Inst Urol, Detroit, MI USA; [Hwang, Ok; Hwang, Clara] Henry Ford Hlth Syst, Dept Internal Med, Detroit, MI USA; [Divine, George W.] Henry Ford Hlth Syst, Dept Publ Hlth Sci, Detroit, MI USA; [Bai, V. Uma; Hwang, Ok; Divine, George W.; Barrack, Evelyn R.; Menon, Mani; Reddy, G. Prem-Veer; Hwang, Clara] Henry Ford Hlth Syst, Josephine Ford Canc Ctr, Detroit, MI USA	Henry Ford Health System; Henry Ford Hospital; Henry Ford Health System; Henry Ford Hospital; Henry Ford Health System; Henry Ford Hospital; Henry Ford Health System; Henry Ford Hospital; Henry Ford Health System; Henry Ford Hospital	Bai, VU (corresponding author), Henry Ford Hlth Syst, Dept Urol, Detroit, MI USA.	chwang2@hfhs.org	Hwang, Clara/AFJ-8520-2022; Hwang, Clara/AAF-5302-2022	Hwang, Clara/0000-0002-0998-323X; Hwang, Clara/0000-0002-0998-323X	Vattikuti Urology Institute	Vattikuti Urology Institute	This study was funded by the Vattikuti Urology Institute. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Andriole GL, 2009, NEW ENGL J MED, V360, P1310, DOI 10.1056/NEJMoa0810696; Bai VU, 2007, P NATL ACAD SCI USA, V104, P2343, DOI 10.1073/pnas.0610504104; Bhusari SS, 2010, EPIGENETICS-US, V5, P402, DOI 10.4161/epi.5.5.11853; Bill-Axelson A, 2011, NEW ENGL J MED, V364, P1708, DOI 10.1056/NEJMoa1011967; Bostwick DG, 2000, CANCER, V89, P123, DOI 10.1002/1097-0142(20000701)89:1<123::AID-CNCR17>3.0.CO;2-9; Catalona WJ, 1998, J UROLOGY, V160, P2428, DOI 10.1016/S0022-5347(01)62204-3; Dayyani F, 2011, JNCI-J NATL CANCER I, V103, P1665, DOI 10.1093/jnci/djr362; Eyre SJ, 2009, J UROLOGY, V182, P2653, DOI 10.1016/j.juro.2009.08.056; Giaime E, 2006, J BIOL CHEM, V281, P11515, DOI 10.1074/jbc.M508619200; Hishikawa N, 2003, AM J PATHOL, V163, P609, DOI 10.1016/S0002-9440(10)63688-7; Ito T, 2003, J BIOL CHEM, V278, P29106, DOI 10.1074/jbc.M302763200; Lee G, 2002, J NEUROCHEM, V83, P346, DOI 10.1046/j.1471-4159.2002.01136.x; Liang P, 2003, NAT REV CANCER, V3, P869, DOI 10.1038/nrc1214; LIANG P, 1994, METH MOL G, V5, P3; Livak KJ, 2001, METHODS, V25, P402, DOI 10.1006/meth.2001.1262; Niwa J, 2002, J BIOL CHEM, V277, P36793, DOI 10.1074/jbc.M206559200; Ozsolak F, 2011, NAT REV GENET, V12, P87, DOI 10.1038/nrg2934; Parekh DJ, 2006, UROLOGY, V68, P1152, DOI 10.1016/j.urology.2006.10.022; Schroeder FH, 2009, NEW ENGL J MED, V360, P1320, DOI 10.1056/NEJMoa0810084; Shipley WU, 1999, JAMA-J AM MED ASSOC, V281, P1598, DOI 10.1001/jama.281.17.1598; Siegel R, 2012, CA-CANCER J CLIN, V62, P10, DOI 10.3322/caac.20138; Takeuchi H, 2004, J NEUROCHEM, V89, P64, DOI 10.1046/j.1471-4159.2003.02289.x; Thompson IM, 2004, NEW ENGL J MED, V350, P2239, DOI 10.1056/NEJMoa031918; Thompson IM, 2005, JAMA-J AM MED ASSOC, V294, P66, DOI 10.1001/jama.294.1.66; Walsh P C, 1994, Important Adv Oncol, P211; Xu KX, 2009, CANCER CELL, V15, P270, DOI 10.1016/j.ccr.2009.02.021	26	11	11	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 6	2012	7	4							e34875	10.1371/journal.pone.0034875	http://dx.doi.org/10.1371/journal.pone.0034875			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	955JA	22493721	Green Published, gold, Green Submitted			2022-12-25	WOS:000305012700063
J	Liu, Y; Pan, SD; Liu, L; Zhai, XJ; Liu, JB; Wen, J; Zhang, YX; Chen, JG; Shen, HB; Hu, ZB				Liu, Yao; Pan, Shandong; Liu, Li; Zhai, Xiangjun; Liu, Jibin; Wen, Juan; Zhang, Yixin; Chen, Jianguo; Shen, Hongbing; Hu, Zhibin			A Genetic Variant in Long Non-Coding RNA HULC Contributes to Risk of HBV-Related Hepatocellular Carcinoma in a Chinese Population	PLOS ONE			English	Article							CANCER; TRANSLOCATION	Background: Recently, several studies have demonstrated that two long non-coding RNAs (lncRNAs), HULC and MALAT1, may participate in hepatocellular carcinoma (HCC) development and progression. However, genetic variations in the two lncRNAs and their associations with HCC susceptibility have not been reported. In this study, we hypothesized that single nucleotide polymorphisms (SNPs) in HULC and MALAT1 may contribute to HCC risk. Methods: We conducted a case-control study and genotyped two SNPs, rs7763881 in HULC and rs619586 in MALAT1, in 1300 HBV positive HCC patients, 1344 HBV persistent carriers and 1344 subjects with HBV natural clearance to test the associations between the two SNPs and susceptibility to HCC and HBV chronic infection. Results: The variant genotypes of rs7763881 were significantly associated with decreased HCC risk in a dominant genetic model [AC/CC vs. AA: adjusted odds ration (OR) = 0.81, 95% confidence intervals (CIs) = 0.68-0.97, P = 0.022]. Furthermore, the variant genotypes of rs619586 was associated with decreased HCC risk with a borderline significance (AG/GG vs. AA: adjusted OR = 0.81, 95% CIs = 0.65-1.01, P = 0.057). However, no significant association was found between the two SNPs and HBV clearance. Conclusions: The variant genotypes of rs7763881 in HULC may contribute to decreased susceptibility to HCC in HBV persistent carriers.	[Liu, Yao; Pan, Shandong; Wen, Juan; Shen, Hongbing; Hu, Zhibin] Nanjing Med Univ, Sch Publ Hlth, MOE Key Lab Modern Toxicol, Dept Epidemiol & Biostat, Nanjing, Jiangsu, Peoples R China; [Liu, Li; Liu, Jibin; Zhang, Yixin] Nantong Tumor Hosp, Dept Hepatobiliary Surg, Nantong, Peoples R China; [Liu, Li] Nanjing Med Univ, Affiliated Hosp 2, Inst Digest Endoscopy, Nanjing, Jiangsu, Peoples R China; [Liu, Li] Nanjing Med Univ, Affiliated Hosp 2, Med Ctr Digest Dis, Nanjing, Jiangsu, Peoples R China; [Zhai, Xiangjun] Jiangsu Prov Ctr Dis Prevent & Control, Dept Infect Dis, Nanjing, Jiangsu, Peoples R China; [Chen, Jianguo] Qidong Liver Canc Res Inst, Qidong, Peoples R China; [Shen, Hongbing; Hu, Zhibin] Nanjing Med Univ, Ctr Canc, Jiangsu Key Lab Canc Biomarkers Prevent & Treatme, Clin Epidemiol Sect, Nanjing, Jiangsu, Peoples R China; [Shen, Hongbing; Hu, Zhibin] Nanjing Med Univ, State Key Lab Reprod Med, Nanjing, Jiangsu, Peoples R China	Nanjing Medical University; Nanjing Medical University; Nanjing Medical University; Nanjing Medical University; Nanjing Medical University	Liu, Y (corresponding author), Nanjing Med Univ, Sch Publ Hlth, MOE Key Lab Modern Toxicol, Dept Epidemiol & Biostat, Nanjing, Jiangsu, Peoples R China.	zhibin_hu@njmu.edu.cn	, 雷克思/ABG-3956-2020	, 雷克思/0000-0003-4102-8934	Priority Academic Program Development of Jiangsu Higher Education Institutions; Foundation for the Author of National Excellent Doctoral Dissertation [201081]; National Natural Science Foundation of China [30800946, 81072344]; Natural Science Foundation Jiangsu Ministry of Health [H200957]; Program for New Century Excellent Talents in University [NCET-10-0178]; National Major ST Projects [2011ZX10004-902]	Priority Academic Program Development of Jiangsu Higher Education Institutions; Foundation for the Author of National Excellent Doctoral Dissertation(Foundation for the Author of National Excellent Doctoral Dissertation of China); National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Natural Science Foundation Jiangsu Ministry of Health; Program for New Century Excellent Talents in University(Program for New Century Excellent Talents in University (NCET)); National Major ST Projects	This work was supported in part by Priority Academic Program Development of Jiangsu Higher Education Institutions, Foundation for the Author of National Excellent Doctoral Dissertation (grant no.: 201081), National Natural Science Foundation of China (grant nos.: 30800946, 81072344), Natural Science Foundation Jiangsu Ministry of Health (grant no.: H200957), the Program for New Century Excellent Talents in University (NCET-10-0178) and National Major S&T Projects (grant no.: 2011ZX10004-902). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bernard D, 2010, EMBO J, V29, P3082, DOI 10.1038/emboj.2010.199; Chuang SC, 2009, CANCER LETT, V286, P9, DOI 10.1016/j.canlet.2008.10.040; Davis IJ, 2003, P NATL ACAD SCI USA, V100, P6051, DOI 10.1073/pnas.0931430100; Ferlay J, 2010, INT J CANCER, V127, P2893, DOI 10.1002/ijc.25516; Guffanti A, 2009, BMC GENOMICS, V10, DOI 10.1186/1471-2164-10-163; Guttman M, 2009, NATURE, V458, P223, DOI 10.1038/nature07672; Hu L., 2011, HEPATOLOGY; Hutchinson JN, 2007, BMC GENOMICS, V8, DOI 10.1186/1471-2164-8-39; Jin G, 2011, CARCINOGENESIS; Lin CP, 2010, WORLD J HEPATOL, V2, P16, DOI 10.4254/wjh.v2.i1.16; Lin R, 2007, ONCOGENE, V26, P851, DOI 10.1038/sj.onc.1209846; Matouk IJ, 2009, EUR J GASTROEN HEPAT, V21, P688, DOI 10.1097/MEG.0b013e328306a3a2; Panzitt K, 2007, GASTROENTEROLOGY, V132, P330, DOI 10.1053/j.gastro.2006.08.026; Parkin DM, 2005, CA-CANCER J CLIN, V55, P74, DOI 10.3322/canjclin.55.2.74; Ponting CP, 2009, CELL, V136, P629, DOI 10.1016/j.cell.2009.02.006; Rajaram V, 2007, GENE CHROMOSOME CANC, V46, P508, DOI 10.1002/gcc.20437; Song Il Han, 2009, Korean J Hepatol, V15 Suppl 6, pS50, DOI 10.3350/kjhep.2009.15.S6.S50; Tripathi V, 2010, MOL CELL, V39, P925, DOI 10.1016/j.molcel.2010.08.011; Walter SR, 2011, J GASTROENTEROL HEPA; Wang Y, 2011, EXPERT REV ANTI-INFE, V9, P21, DOI [10.1586/eri.10.143, 10.1586/ERI.10.143]; Yang JD, 2010, NAT REV GASTRO HEPAT, V7, P448, DOI 10.1038/nrgastro.2010.100; Zhang S, 2010, INT J GYNECOL OBSTET, V109, P194, DOI 10.1016/j.ijgo.2010.01.002	22	146	158	0	31	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 6	2012	7	4							e35145	10.1371/journal.pone.0035145	http://dx.doi.org/10.1371/journal.pone.0035145			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	955JA	22493738	gold, Green Published, Green Submitted			2022-12-25	WOS:000305012700080
J	Marconi, E; Nieus, T; Maccione, A; Valente, P; Simi, A; Messa, M; Dante, S; Baldelli, P; Berdondini, L; Benfenati, F				Marconi, Emanuele; Nieus, Thierry; Maccione, Alessandro; Valente, Pierluigi; Simi, Alessandro; Messa, Mirko; Dante, Silvia; Baldelli, Pietro; Berdondini, Luca; Benfenati, Fabio			Emergent Functional Properties of Neuronal Networks with Controlled Topology	PLOS ONE			English	Article							READILY RELEASABLE POOL; HIPPOCAMPAL-NEURONS; CONNECTIVITY; IDENTIFICATION; VESICLES; CIRCUIT; MODELS; MEA	The interplay between anatomical connectivity and dynamics in neural networks plays a key role in the functional properties of the brain and in the associated connectivity changes induced by neural diseases. However, a detailed experimental investigation of this interplay at both cellular and population scales in the living brain is limited by accessibility. Alternatively, to investigate the basic operational principles with morphological, electrophysiological and computational methods, the activity emerging from large in vitro networks of primary neurons organized with imposed topologies can be studied. Here, we validated the use of a new bio-printing approach, which effectively maintains the topology of hippocampal cultures in vitro and investigated, by patch-clamp and MEA electrophysiology, the emerging functional properties of these grid-confined networks. In spite of differences in the organization of physical connectivity, our bio-patterned grid networks retained the key properties of synaptic transmission, short-term plasticity and overall network activity with respect to random networks. Interestingly, the imposed grid topology resulted in a reinforcement of functional connections along orthogonal directions, shorter connectivity links and a greatly increased spiking probability in response to focal stimulation. These results clearly demonstrate that reliable functional studies can nowadays be performed on large neuronal networks in the presence of sustained changes in the physical network connectivity.	[Marconi, Emanuele; Nieus, Thierry; Maccione, Alessandro; Valente, Pierluigi; Simi, Alessandro; Messa, Mirko; Dante, Silvia; Baldelli, Pietro; Berdondini, Luca; Benfenati, Fabio] Fdn Ist Italiano Tecnol, Dept Neurosci & Brain Technol, Genoa, Italy; [Dante, Silvia] Fdn Ist Italiano Tecnol, Dept Nanophys, Genoa, Italy; [Marconi, Emanuele; Baldelli, Pietro; Benfenati, Fabio] Univ Genoa, Dept Expt Med, Physiol Sect, Genoa, Italy	Istituto Italiano di Tecnologia - IIT; Istituto Italiano di Tecnologia - IIT; University of Genoa	Marconi, E (corresponding author), Fdn Ist Italiano Tecnol, Dept Neurosci & Brain Technol, Genoa, Italy.	thierry.nieus@iit.it	Baldelli, Pietro/AAH-2493-2021; Berdondini, Luca/O-3201-2013; Valente, Pierluigi/AAF-2802-2021; dante, silvia/J-2996-2012; Baldelli, Pietro/AAA-6298-2020	Berdondini, Luca/0000-0001-9521-2812; maccione, alessandro/0000-0002-5044-9899; Dante, Silvia/0000-0001-6906-8482; Nieus, Thierry/0000-0001-8708-1015; Baldelli, Pietro/0000-0001-9599-3436; Simi, Alessandro/0000-0002-0427-8523	Italian Ministry of University and Research; Italian Ministry of Health Progetto Giovani Ricercatori; Compagnia di San Paolo, Torino; Telethon-Italy [GGP09134, GGP09066]	Italian Ministry of University and Research(Ministry of Education, Universities and Research (MIUR)); Italian Ministry of Health Progetto Giovani Ricercatori(Ministry of Health, Italy); Compagnia di San Paolo, Torino(Compagnia di San Paolo); Telethon-Italy(Fondazione Telethon)	This study was supported by research grants from the Italian Ministry of University and Research (PRIN to F. B.), the Italian Ministry of Health Progetto Giovani Ricercatori (to P. B.) and the Compagnia di San Paolo, Torino (to F. B. and P. B.). The support of Telethon-Italy (Grant GGP09134 to F. B. and GGP09066 to P. B.) is also acknowledged. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Arenas A, 2008, PHYS REP, V469, P93, DOI 10.1016/j.physrep.2008.09.002; Baldelli P, 2005, J NEUROSCI, V25, P3358, DOI 10.1523/JNEUROSCI.4227-04.2005; Baldelli P, 2007, J NEUROSCI, V27, P13520, DOI 10.1523/JNEUROSCI.3151-07.2007; BANKER G, 1998, CULTURING NERVE CELL; BEKKERS JM, 1991, P NATL ACAD SCI USA, V88, P7834, DOI 10.1073/pnas.88.17.7834; Berdondini L, 2006, SENSOR ACTUAT B-CHEM, V114, P530, DOI 10.1016/j.snb.2005.04.042; Berdondini L, 2009, LAB CHIP, V9, P2644, DOI 10.1039/b907394a; Binzegger T, 2004, J NEUROSCI, V24, P8441, DOI 10.1523/JNEUROSCI.1400-04.2004; Binzegger T, 2009, NEURAL NETWORKS, V22, P1071, DOI 10.1016/j.neunet.2009.07.011; Bologna LL, 2010, NEUROSCIENCE, V165, P692, DOI 10.1016/j.neuroscience.2009.11.018; Bonifazi P, 2005, EUR J NEUROSCI, V22, P2953, DOI 10.1111/j.1460-9568.2005.04464.x; Bonifazi P, 2009, SCIENCE, V326, P1419, DOI 10.1126/science.1175509; Buibas M, 2011, NEURAL COMPUT, V23, P183, DOI 10.1162/NECO_a_00065; Bullmore ET, 2009, NAT REV NEUROSCI, V10, P186, DOI 10.1038/nrn2575; Buzsaki G, 2004, TRENDS NEUROSCI, V27, P186, DOI 10.1016/j.tins.2004.02.007; Chang JC, 2003, BIOMATERIALS, V24, P2863, DOI 10.1016/S0142-9612(03)00116-9; Chiappalone M, 2006, BRAIN RES, V1093, P41, DOI 10.1016/j.brainres.2006.03.049; Chiu DT, 2000, P NATL ACAD SCI USA, V97, P2408, DOI 10.1073/pnas.040562297; COREY JM, 1991, J NEUROSCI RES, V30, P300, DOI 10.1002/jnr.490300204; DULCEY CS, 1991, SCIENCE, V252, P551, DOI 10.1126/science.2020853; Erickson J, 2008, J NEUROSCI METH, V175, P1, DOI 10.1016/j.jneumeth.2008.07.023; Feinerman O, 2008, NAT PHYS, V4, P967, DOI 10.1038/nphys1099; Ferreira A, 2002, CELL MOL LIFE SCI, V59, P589, DOI 10.1007/s00018-002-8451-5; Garofalo M, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0006482; Grinstein G, 2005, P NATL ACAD SCI USA, V102, P9948, DOI 10.1073/pnas.0504127102; Grun S, 2010, SPRINGER SERIES COMP, V7, P443; Ivenshitz M, 2010, J NEUROPHYSIOL, V104, P1052, DOI 10.1152/jn.00914.2009; Jones E., 2001, LEAST SQUARE REGRESS; Jun SB, 2007, J NEUROSCI METH, V160, P317, DOI 10.1016/j.jneumeth.2006.09.009; Jungblut M, 2009, BIOMED MICRODEVICES, V11, P1269, DOI 10.1007/s10544-009-9346-0; Kitano K, 2007, J COMPUT NEUROSCI, V23, P237, DOI 10.1007/s10827-007-0030-1; KLEINFELD D, 1988, J NEUROSCI, V8, P4098; Liao DH, 1999, NAT NEUROSCI, V2, P37, DOI 10.1038/4540; Lichtman JW, 2000, NEURON, V25, P269, DOI 10.1016/S0896-6273(00)80893-4; Linkert M, 2010, J CELL BIOL, V189, P777, DOI 10.1083/jcb.201004104; Liu HS, 2009, J NEUROSCI, V29, P7395, DOI 10.1523/JNEUROSCI.1341-09.2009; Maccione A., 2010, FRONTIERS NEUROENGIN, V3, P12; Maccione A, 2009, J NEUROSCI METH, V177, P241, DOI 10.1016/j.jneumeth.2008.09.026; Mai J, 2009, J NEUROSCI, V29, P7450, DOI 10.1523/JNEUROSCI.1121-09.2009; Maiorano G, 2010, ACS NANO, V4, P7481, DOI 10.1021/nn101557e; MALLART A, 1967, J PHYSIOL-LONDON, V193, P679, DOI 10.1113/jphysiol.1967.sp008388; Morin F, 2006, BIOSENS BIOELECTRON, V21, P1093, DOI 10.1016/j.bios.2005.04.020; Muller-Linow M, 2008, PLOS COMPUT BIOL, V4, DOI 10.1371/journal.pcbi.1000190; Nam Y, 2006, BIOSENS BIOELECTRON, V22, P589, DOI 10.1016/j.bios.2006.01.027; Netoff TI, 2004, J NEUROSCI, V24, P8075, DOI 10.1523/JNEUROSCI.1509-04.2004; Rasband W, IMAGEJ; Rosenmund C, 1996, NEURON, V16, P1197, DOI 10.1016/S0896-6273(00)80146-4; Roupioz Y, 2009, SMALL, V5, P1493, DOI 10.1002/smll.200801941; Sanz-Arigita EJ, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0013788; Schneggenburger R, 2002, TRENDS NEUROSCI, V25, P206, DOI 10.1016/S0166-2236(02)02139-2; Shein Idelson M, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0014443; Silberberg G, 2005, TRENDS NEUROSCI, V28, P541, DOI 10.1016/j.tins.2005.08.004; Sokal RR, BIOMETRY PRINCIPLES; Sporns O, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0001049; Stenger DA, 1998, J NEUROSCI METH, V82, P167, DOI 10.1016/S0165-0270(98)00047-8; Stevenson IH, 2008, CURR OPIN NEUROBIOL, V18, P582, DOI 10.1016/j.conb.2008.11.005; Suzuki I, 2007, BIOCHEM BIOPH RES CO, V356, P470, DOI 10.1016/j.bbrc.2007.03.006; Taylor AM, 2005, NAT METHODS, V2, P599, DOI 10.1038/NMETH777; Vogt AK, 2005, BIOMATERIALS, V26, P2549, DOI 10.1016/j.biomaterials.2004.07.031; Watts DJ, 1998, NATURE, V393, P440, DOI 10.1038/30918; Wesseling JF, 2002, J NEUROSCI, V22, P9708; Wheeler BC, 2010, P IEEE, V98, P398, DOI 10.1109/JPROC.2009.2039029; Xu JT, 2004, BIOMED MICRODEVICES, V6, P117, DOI 10.1023/B:BMMD.0000031748.13353.10	63	83	84	0	36	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 6	2012	7	4							e34648	10.1371/journal.pone.0034648	http://dx.doi.org/10.1371/journal.pone.0034648			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	955JA	22493706	Green Submitted, Green Published, gold			2022-12-25	WOS:000305012700048
J	Riou, M; Stroebel, D; Edwardson, JM; Paoletti, P				Riou, Morgane; Stroebel, David; Edwardson, J. Michael; Paoletti, Pierre			An Alternating GluN1-2-1-2 Subunit Arrangement in Mature NMDA Receptors	PLOS ONE			English	Article							CELL-SURFACE EXPRESSION; D-ASPARTATE RECEPTOR; DISULFIDE BONDS; TERMINAL DOMAIN; NR1 SUBUNIT; INHIBITION; ACTIVATION; MECHANISM; PROTEINS; PORE	NMDA receptors (NMDARs) form glutamate-gated ion channels that play a critical role in CNS physiology and pathology. Together with AMPA and kainate receptors, NMDARs are known to operate as tetrameric complexes with four membrane-embedded subunits associating to form a single central ion-conducting pore. While AMPA and some kainate receptors can function as homomers, NMDARs are obligatory heteromers composed of homologous but distinct subunits, most usually of the GluN1 and GluN2 types. A fundamental structural feature of NMDARs, that of the subunit arrangement around the ion pore, is still controversial. Thus, in a typical NMDAR associating two GluN1 and two GluN2 subunits, there is evidence for both alternating 1/2/1/2 and non-alternating 1/1/2/2 arrangements. Here, using a combination of electrophysiological and cross-linking experiments, we provide evidence that functional GluN1/GluN2A receptors adopt the 1/2/1/2 arrangement in which like subunits are diagonal to one another. Moreover, based on the recent crystal structure of an AMPA receptor, we show that in the agonist-binding and pore regions, the GluN1 subunits occupy a "proximal" position, closer to the central axis of the channel pore than that of GluN2 subunits. Finally, results obtained with reducing agents that differ in their membrane permeability indicate that immature (intracellular) and functional (plasma-membrane inserted) pools of NMDARs can adopt different subunit arrangements, thus stressing the importance of discriminating between the two receptor pools in assembly studies. Elucidating the quaternary arrangement of NMDARs helps to define the interface between the subunits and to understand the mechanism and pharmacology of these key signaling receptors.	[Riou, Morgane; Stroebel, David; Paoletti, Pierre] Ecole Normale Super, Inst Biol ENS, IBENS, F-75231 Paris, France; [Riou, Morgane; Stroebel, David; Paoletti, Pierre] INSERM, U1024, Paris, France; [Edwardson, J. Michael] Univ Cambridge, Dept Pharmacol, Cambridge CB2 1QJ, England; [Riou, Morgane; Stroebel, David; Paoletti, Pierre] CNRS, UMR 8197, Paris, France	UDICE-French Research Universities; PSL Research University Paris; Ecole Normale Superieure (ENS); Institut National de la Sante et de la Recherche Medicale (Inserm); University of Cambridge; Centre National de la Recherche Scientifique (CNRS); CNRS - National Institute for Biology (INSB)	Riou, M (corresponding author), Ecole Normale Super, Inst Biol ENS, IBENS, 24 Rue Lhomond, F-75231 Paris, France.	pierre.paoletti@ens.fr	Paoletti, Pierre/L-7358-2013	Paoletti, Pierre/0000-0002-3681-4845	Wellcome Trust; Central National de la Recherche Scientifique (CNRS); Institut National de la Sante et de la Recherche Medicale (INSERM); Fondation pour la Recherche Medicale (FRM, Equipe FRM); Direction Generale de l'Armement	Wellcome Trust(Wellcome TrustEuropean Commission); Central National de la Recherche Scientifique (CNRS)(Centre National de la Recherche Scientifique (CNRS)); Institut National de la Sante et de la Recherche Medicale (INSERM)(Institut National de la Sante et de la Recherche Medicale (Inserm)); Fondation pour la Recherche Medicale (FRM, Equipe FRM); Direction Generale de l'Armement	This work supported by Wellcome Trust, Central National de la Recherche Scientifique (CNRS), Institut National de la Sante et de la Recherche Medicale (INSERM), Fondation pour la Recherche Medicale (FRM, Equipe FRM), and Direction Generale de l'Armement. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Banke TG, 2003, NAT NEUROSCI, V6, P144, DOI 10.1038/nn1000; Blanke ML, 2008, MOL PHARMACOL, V74, P454, DOI 10.1124/mol.107.044115; Chang HR, 2008, J NEUROSCI, V28, P1546, DOI 10.1523/JNEUROSCI.3485-07.2008; Das U, 2010, P NATL ACAD SCI USA, V107, P8463, DOI 10.1073/pnas.1000838107; Farina AN, 2011, J NEUROSCI, V31, P3565, DOI 10.1523/JNEUROSCI.6041-10.2011; Furukawa H, 2005, NATURE, V438, P185, DOI 10.1038/nature04089; Gielen M, 2008, NEURON, V57, P80, DOI 10.1016/j.neuron.2007.11.021; Gielen M, 2009, NATURE, V459, P703, DOI 10.1038/nature07993; GLUSKER JP, 1991, ADV PROTEIN CHEM, V42, P1; HAZES B, 1988, PROTEIN ENG, V2, P119, DOI 10.1093/protein/2.2.119; Horak M, 2009, J BIOL CHEM, V284, P9683, DOI 10.1074/jbc.M807050200; Inanobe A, 2005, NEURON, V47, P71, DOI 10.1016/j.neuron.2005.05.022; Karakas E, 2011, NATURE, V475, P249, DOI 10.1038/nature10180; Krovetz HS, 1997, BIOPHYS J, V72, P117, DOI 10.1016/S0006-3495(97)78651-X; Kussius CL, 2009, NAT NEUROSCI, V12, P1114, DOI 10.1038/nn.2361; Lee CH, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0019180; Mayer ML, 2011, STRUCTURE, V19, P1370, DOI 10.1016/j.str.2011.08.009; Mayer ML, 2006, NATURE, V440, P456, DOI 10.1038/nature04709; McIlhinney RAJ, 1998, NEUROPHARMACOLOGY, V37, P1355, DOI 10.1016/S0028-3908(98)00121-X; Mony L, 2011, EMBO J, V30, P3134, DOI 10.1038/emboj.2011.203; Okabe S, 1999, J NEUROSCI, V19, P7781; Paoletti P, 1997, J NEUROSCI, V17, P5711; Paoletti P, 2011, EUR J NEUROSCI, V33, P1351, DOI 10.1111/j.1460-9568.2011.07628.x; Qiu S, 2005, J BIOL CHEM, V280, P24923, DOI 10.1074/jbc.M413915200; Rambhadran A, 2010, J BIOL CHEM, V285, P15296, DOI 10.1074/jbc.M109.085035; Salussolia CL, 2011, J NEUROSCI, V31, P11295, DOI 10.1523/JNEUROSCI.5612-10.2011; Schorge S, 2003, J NEUROSCI, V23, P1151, DOI 10.1523/JNEUROSCI.23-04-01151.2003; Sobolevsky AI, 2007, J GEN PHYSIOL, V129, P509, DOI 10.1085/jgp.200609718; Sobolevsky AI, 2009, NATURE, V462, P745, DOI 10.1038/nature08624; Stroebel D, 2011, NEUROPHARMACOLOGY, V60, P151, DOI 10.1016/j.neuropharm.2010.07.003; Traynelis SF, 2010, PHARMACOL REV, V62, P405, DOI 10.1124/pr.109.002451; VIELES P, 1972, J CHIM PHYS PCB, V69, P869, DOI 10.1051/jcp/1972690869	33	28	28	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 6	2012	7	4							e35134	10.1371/journal.pone.0035134	http://dx.doi.org/10.1371/journal.pone.0035134			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	955JA	22493736	Green Published, Green Submitted, gold			2022-12-25	WOS:000305012700078
J	Valentinova, L; Beer, NL; Stanik, J; Tribble, ND; van de Bunt, M; Huckova, M; Barrett, A; Klimes, I; Gasperikova, D; Gloyn, AL				Valentinova, Lucia; Beer, Nicola L.; Stanik, Juraj; Tribble, Nicholas D.; van de Bunt, Martijn; Huckova, Miroslava; Barrett, Amy; Klimes, Iwar; Gasperikova, Daniela; Gloyn, Anna L.			Identification and Functional Characterisation of Novel Glucokinase Mutations Causing Maturity-Onset Diabetes of the Young in Slovakia	PLOS ONE			English	Article							BETA-CELL GLUCOKINASE; HYPERINSULINEMIC HYPOGLYCEMIA; GCK GENE; MODY; HYPERGLYCEMIA; GLUCOSE; DIAGNOSIS; CHILDREN; HETEROGENEITY; HNF-1-ALPHA	Heterozygous glucokinase (GCK) mutations cause a subtype of maturity-onset diabetes of the young (GCK-MODY). Over 600 GCK mutations have been reported of which similar to 65% are missense. In many cases co-segregation has not been established and despite the importance of functional studies in ascribing pathogenicity for missense variants these have only been performed for <10% of mutations. The aim of this study was to determine the minimum prevalence of GCK-MODY amongst diabetic subjects in Slovakia by sequencing GCK in 100 Slovakian probands with a phenotype consistent with GCK-MODY and to explore the pathogenicity of identified variants through family and functional studies. Twenty-two mutations were identified in 36 families (17 missense) of which 7 (I110N, V200A, N204D, G258R, F419S, c.580-2A>C, c.1113-1114delGC) were novel. Parental DNA was available for 22 probands (covering 14/22 mutations) and co-segregation established in all cases. Bioinformatic analysis predicted all missense mutations to be damaging. Nine (I110N, V200A, N204D, G223S, G258R, F419S, V244G, L315H, I436N) mutations were functionally evaluated. Basic kinetic analysis explained pathogenicity for 7 mutants which showed reduced glucokinase activity with relative activity indices (RAI) between 0.6 to <0.001 compared to wild-type GCK (1.0). For the remaining 2 mutants additional molecular mechanisms were investigated. Differences in glucokinase regulatory protein (GKRP) -mediated-inhibition of GCK were observed for both L315H & I436N when compared to wild type (IC50 14.6 +/- 0.1 mM & 20.3 +/- 1.6 mM vs. 13.36 +/- 0.1 mM respectively [p<0.03]). Protein instability as assessed by thermal lability studies demonstrated that both L315H and I436N show marked thermal instability compared to wild-type GCK (RAI at 55 degrees C 8.8 +/- 0.8% & 3.1 +/- 0.4% vs. 42.56 +/- 3.9% respectively [p<0.001]). The minimum prevalence of GCK-MODY amongst Slovakian patients with diabetes was 0.03%. In conclusion, we have identified 22 GCK mutations in 36 Slovakian probands and demonstrate that combining family, bioinformatic and functional studies can aid the interpretation of variants identified by molecular diagnostic screening.	[Valentinova, Lucia; Stanik, Juraj; Huckova, Miroslava; Klimes, Iwar; Gasperikova, Daniela] Slovak Acad Sci, Inst Expt Endocrinol, Bratislava, Slovakia; [Valentinova, Lucia; Beer, Nicola L.; Tribble, Nicholas D.; van de Bunt, Martijn; Barrett, Amy; Gloyn, Anna L.] Univ Oxford, Oxford Ctr Diabet Endocrinol & Metab, Oxford, England; [Stanik, Juraj] Comenius Univ, Children Diabet Ctr, Dept Paediat 1, Bratislava, Slovakia; [Huckova, Miroslava; Klimes, Iwar; Gasperikova, Daniela] Slovak Acad Sci, Ctr Mol Med, Bratislava, Slovakia; [Gloyn, Anna L.] NIHR Oxford Biomed Res Ctr, Oxford, England	Slovak Academy of Sciences; University of Oxford; Comenius University Bratislava; Slovak Academy of Sciences; University of Oxford	Valentinova, L (corresponding author), Slovak Acad Sci, Inst Expt Endocrinol, Bratislava, Slovakia.	anna.gloyn@drl.ox.ac.uk	Stanik, Juraj/AAQ-6217-2021; Gasperikova, Daniela/E-7824-2018	Stanik, Juraj/0000-0002-0538-1274; Gasperikova, Daniela/0000-0002-5725-6424; van de Bunt, Martijn/0000-0002-6744-6125; Gloyn, Anna/0000-0003-1205-1844	Oxford by the Medical Research Council [81696]; European Foundation for the Study of Diabetes; Wellcome Trust [095101/Z/10/Z]; European Community [223211, CEED3]; Slovakia by the Slovak Diabetes Association; Scientific Grant Agency of the Ministry of Education, Science, Research and Sports of the Slovak Republic; Slovak Academy of Sciences [VEGA2/0151/11]; Research & Development Operational Programme [TRANSENDOGEN/26240220051]; European Regional Development Fund ERDF; Medical Research Council [G0700222] Funding Source: researchfish; MRC [G0700222] Funding Source: UKRI	Oxford by the Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); European Foundation for the Study of Diabetes; Wellcome Trust(Wellcome TrustEuropean Commission); European Community(European Commission); Slovakia by the Slovak Diabetes Association; Scientific Grant Agency of the Ministry of Education, Science, Research and Sports of the Slovak Republic; Slovak Academy of Sciences(Slovak Academy of Sciences); Research & Development Operational Programme; European Regional Development Fund ERDF(European Commission); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC))	This work was funded in Oxford by the Medical Research Council (81696), the European Foundation for the Study of Diabetes (Albert Renold Travel Fellowship awarded to LV), and the Wellcome Trust (095101/Z/10/Z). The research leading to these results has also received funding from the European Community's Seventh Framework Programme (FP7/2007-2013) under grant agreement no223211, CEED3. ALG is a Wellcome Trust Senior Fellow in Basic and Biomedical Science. This work was funded in Slovakia by the Slovak Diabetes Association and the Scientific Grant Agency of the Ministry of Education, Science, Research and Sports of the Slovak Republic, and the Slovak Academy of Sciences VEGA2/0151/11. This publication is also the result of the project implementation TRANSENDOGEN/26240220051/supported by the Research & Development Operational Programme funded by the European Regional Development Fund ERDF. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Arden C, 2007, DIABETES, V56, P1773, DOI 10.2337/db06-1151; Beer NL, 2011, J BIOL CHEM, V286, P19118, DOI 10.1074/jbc.M111.223362; Beer NL, 2009, HUM MOL GENET, V18, P4081, DOI 10.1093/hmg/ddp357; Boutin P, 2001, DIABETOLOGIA, V44, P775, DOI 10.1007/s001250051687; Brocklehurst KJ, 2004, BIOCHEM J, V378, P693, DOI 10.1042/BJ20031414; Burke CV, 1999, BIOCHEM J, V342, P345, DOI 10.1042/0264-6021:3420345; BYRNE MM, 1994, J CLIN INVEST, V93, P1120, DOI 10.1172/JCI117064; Costa A, 2000, EUR J ENDOCRINOL, V142, P380, DOI 10.1530/eje.0.1420380; Davis EA, 1999, DIABETOLOGIA, V42, P1175, DOI 10.1007/s001250051289; Ellard S, 2008, DIABETOLOGIA, V51, P546, DOI 10.1007/s00125-008-0942-y; Estalella I, 2007, CLIN ENDOCRINOL, V67, P538, DOI 10.1111/j.1365-2265.2007.02921.x; Feigerlova E, 2006, EUR J PEDIATR, V165, P446, DOI 10.1007/s00431-006-0106-3; FROGUEL P, 1992, NATURE, V356, P162, DOI 10.1038/356162a0; FROGUEL P, 1993, NEW ENGL J MED, V328, P697, DOI 10.1056/NEJM199303113281005; Gasperikova D, 2009, DIABETES, V58, P1929, DOI 10.2337/db09-0070; Gloyn AL, 2009, DIABETOLOGIA, V52, P172, DOI 10.1007/s00125-008-1188-4; Gloyn AL, 2004, FRONT DIABETES, V16, P92; Gloyn AL, 2005, J BIOL CHEM, V280, P14105, DOI 10.1074/jbc.M413146200; HAGER J, 1994, DIABETES, V43, P730, DOI 10.2337/diabetes.43.5.730; Johansen A, 2005, J CLIN ENDOCR METAB, V90, P4607, DOI 10.1210/jc.2005-0196; Kamata K, 2004, STRUCTURE, V12, P429, DOI 10.1016/j.str.2004.02.005; Kesavan P, 1997, BIOCHEM J, V322, P57, DOI 10.1042/bj3220057; Kropff J, 2011, DIABETOLOGIA, V54, P1261, DOI 10.1007/s00125-011-2090-z; LIANG Y, 1995, BIOCHEM J, V309, P167, DOI 10.1042/bj3090167; Lorini R, 2009, DIABETES CARE, V32, P1864, DOI 10.2337/dc08-2018; Mantovani Vilma, 2003, Hum Mutat, V22, P338, DOI 10.1002/humu.9179; Massa O, 2001, DIABETOLOGIA, V44, P898; Matschinsky FM, 2002, DIABETES, V51, pS394, DOI 10.2337/diabetes.51.2007.S394; Murphy R, 2008, NAT CLIN PRACT ENDOC, V4, P200, DOI 10.1038/ncpendmet0778; Ng PC, 2001, GENOME RES, V11, P863, DOI 10.1101/gr.176601; Osbak KK, 2009, HUM MUTAT, V30, P1512, DOI 10.1002/humu.21110; Pinterova D, 2007, CLIN GENET, V71, P95, DOI 10.1111/j.1399-0004.2006.00729.x; Pruhova S, 2003, DIABETOLOGIA, V46, P291, DOI 10.1007/s00125-002-1010-7; Pruhova S, 2010, PEDIATR DIABETES, V11, P529, DOI 10.1111/j.1399-5448.2010.00646.x; Ramensky V, 2002, NUCLEIC ACIDS RES, V30, P3894, DOI 10.1093/nar/gkf493; Sagen JV, 2008, PEDIATR DIABETES, V9, P442, DOI 10.1111/j.1399-5448.2008.00399.x; Sagen JV, 2006, DIABETES, V55, P1713, DOI 10.2337/db05-1513; Schober E, 2009, DIABETIC MED, V26, P466, DOI 10.1111/j.1464-5491.2009.02720.x; Schwarz JM, 2010, NAT METHODS, V7, P575, DOI 10.1038/nmeth0810-575; Shields BM, 2010, DIABETOLOGIA, V53, P2504, DOI 10.1007/s00125-010-1799-4; Shields BM, 2012, DIABET IN PRESS 0105; Steele AM, 2011, DIABETOLOGIA; STOFFEL M, 1992, P NATL ACAD SCI USA, V89, P7698, DOI 10.1073/pnas.89.16.7698; Stride A, 2002, DIABETOLOGIA, V45, P427, DOI 10.1007/s00125-001-0770-9; TAKEDA J, 1993, J BIOL CHEM, V268, P15200; Thomson K L, 2003, Hum Mutat, V22, P417, DOI 10.1002/humu.9186; Wabitsch M, 2007, DIABETIC MED, V24, P1393, DOI 10.1111/j.1464-5491.2007.02285.x; Ziemssen F, 2002, DIABETOLOGIA, V45, P286, DOI 10.1007/s00125-001-0738-9	48	15	15	0	18	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 6	2012	7	4							e34541	10.1371/journal.pone.0034541	http://dx.doi.org/10.1371/journal.pone.0034541			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	955JA	22493702	gold, Green Submitted, Green Published			2022-12-25	WOS:000305012700044
J	Pinjari, AB; Novikov, B; Rezenom, YH; Russell, DH; Wales, ME; Siddavattam, D				Pinjari, Aleem Basha; Novikov, Boris; Rezenom, Yohannes H.; Russell, David H.; Wales, Melinda E.; Siddavattam, Dayananda			Mineralization of Acephate, a Recalcitrant Organophosphate Insecticide Is Initiated by a Pseudomonad in Environmental Samples	PLOS ONE			English	Article							UNITED-STATES; P-NITROPHENOL; BIODEGRADATION; METHAMIDOPHOS; DEGRADATION; HYDROLYSIS; PARATHION; TOXICITY; EXPOSURE; SULFUR	An aerobic bacterium capable of breaking down the pesticide acephate (O, S-dimethyl acetyl phosphoramidothioic acid) was isolated from activated sludge collected from a pesticide manufacturing facility. A phylogenetic tree based on the 16 S rRNA gene sequence determined that the isolate lies within the Pseudomonads. The isolate was able to grow in the presence of acephate at concentrations up to 80 mM, with maximum growth at 40 mM. HPLC and LC-MS/MS analysis of spent medium from growth experiments and a resting cell assay detected the accumulation of methamidophos and acetate, suggesting initial hydrolysis of the amide linkage found between these two moieties. As expected, the rapid decline in acephate was coincident with the accumulation of methamidophos. Methamidophos concentrations were maintained over a period of days, without evidence of further metabolism or cell growth by the cultures. Considering this limitation, strains such as described in this work can promote the first step of acephate mineralization in soil microbial communities.	[Pinjari, Aleem Basha; Siddavattam, Dayananda] Univ Hyderabad, Sch Life Sci, Dept Anim Sci, Hyderabad 500134, Andhra Pradesh, India; [Novikov, Boris; Wales, Melinda E.] Texas A&M Univ, Dept Biochem & Biophys, College Stn, TX 77843 USA; [Rezenom, Yohannes H.; Russell, David H.] Texas A&M Univ, Dept Chem, College Stn, TX 77843 USA	University of Hyderabad; Texas A&M University System; Texas A&M University College Station; Texas A&M University System; Texas A&M University College Station	Pinjari, AB (corresponding author), Univ Hyderabad, Sch Life Sci, Dept Anim Sci, Hyderabad 500134, Andhra Pradesh, India.	sdsl@uohyd.ernet.in	Russell, David H/C-3618-2015	Russell, David H/0000-0003-0830-3914	DST, New Delhi [DST/INT/US/RPO-156/04]; National Science Foundation, USA (NSF OISE) [INT-0424002]	DST, New Delhi(Department of Science & Technology (India)); National Science Foundation, USA (NSF OISE)	DST, New Delhi (DST/INT/US/RPO-156/04) and National Science Foundation, USA (NSF OISE Grant, INT-0424002 to JRW) supported travel grant while executing the collaborative research work. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ANDO M, 1985, ARCH ENVIRON CON TOX, V14, P535, DOI 10.1007/BF01055382; ANTONIOUS GF, 1994, B ENVIRON CONTAM TOX, V52, P141, DOI 10.1007/BF00197370; Battu RS, 2009, B ENVIRON CONTAM TOX, V82, P124, DOI 10.1007/s00128-008-9541-3; Blondell JM, 2007, CLIN TOXICOL, V45, P589, DOI 10.1080/15563650701397035; BOUCHARD DC, 1982, J ECON ENTOMOL, V75, P921, DOI 10.1093/jee/75.5.921; Bronstein AC, 2010, CLIN TOXICOL, V48, P979, DOI 10.3109/15563650.2010.543906; Buckley NA, 2004, BMJ-BRIT MED J, V329, P1231, DOI 10.1136/bmj.329.7476.1231; Calvert GM, 2008, AM J IND MED, V51, P883, DOI 10.1002/ajim.20623; CHAE MY, 1994, BIOORG MED CHEM LETT, V4, P1473, DOI 10.1016/S0960-894X(01)80516-3; Chai LK, 2010, CHEMOSPHERE, V79, P434, DOI 10.1016/j.chemosphere.2010.01.046; FAO, 2004, PEST RES FOOD 2003 1, V177; Farag AT, 2000, REPROD TOXICOL, V14, P241, DOI 10.1016/S0890-6238(00)00074-5; GARRETT NE, 1986, MUTAT RES, V168, P301, DOI 10.1016/0165-1110(86)90024-2; Graetz D. A., 1970, WATER POLLUT CONTROL, V42, pR76; Harari R, 2010, ENVIRON HEALTH PERSP, V118, P890, DOI 10.1289/ehp.0901582; Imhoff JF, 1998, INT J SYST BACTERIOL, V48, P1129, DOI 10.1099/00207713-48-4-1129; Jokanovic M, 2011, CLIN NEUROL NEUROSUR, V113, P7, DOI 10.1016/j.clineuro.2010.08.015; Kumar S, 1996, CRIT REV MICROBIOL, V22, P1, DOI 10.3109/10408419609106454; LAI K, 1995, ARCH BIOCHEM BIOPHYS, V318, P59, DOI 10.1006/abbi.1995.1204; Lee Hyun-Ho, 2002, Biotechnology and Bioprocess Engineering, V7, P375, DOI 10.1007/BF02933525; Litchfield Melville H, 2005, Toxicol Rev, V24, P271, DOI 10.2165/00139709-200524040-00006; Mahajna M, 1997, CHEM RES TOXICOL, V10, P64, DOI 10.1021/tx9601420; Mulet M, 2010, ENVIRON MICROBIOL, V12, P1513, DOI 10.1111/j.1462-2920.2010.02181.x; MUNNECKE DM, 1974, APPL MICROBIOL, V28, P212, DOI 10.1128/AEM.28.2.212-217.1974; Pakala SB, 2007, APPL MICROBIOL BIOT, V73, P1452, DOI 10.1007/s00253-006-0595-z; Prendergast MA, 1998, NEUROTOXICOL TERATOL, V20, P115, DOI 10.1016/S0892-0362(97)00098-6; Ragnarsdottir KV, 2000, J GEOL SOC LONDON, V157, P859, DOI 10.1144/jgs.157.4.859; ROSENBERG A, 1979, APPL ENVIRON MICROB, V37, P886, DOI 10.1128/AEM.37.5.886-891.1979; Schafer H, 2010, J EXP BOT, V61, P315, DOI 10.1093/jxb/erp355; SINGH AK, 1987, ENVIRON RES, V43, P342, DOI 10.1016/S0013-9351(87)80034-8; Singh BK, 2004, APPL ENVIRON MICROB, V70, P4855, DOI 10.1128/AEM.70.8.4855-4863.2004; Singh BK, 2009, NAT REV MICROBIOL, V7, P156, DOI 10.1038/nrmicro2050; Sudakin DL, 2007, J TOXICOL ENV HEAL A, V70, P141, DOI 10.1080/15287390600755224; SZETO SY, 1979, J ENVIRON SCI HEAL B, V14, P635, DOI 10.1080/03601237909372157; Tamura K, 2007, MOL BIOL EVOL, V24, P1596, DOI 10.1093/molbev/msm092; Tao CJ, 2010, ENVIRON MONIT ASSESS, V165, P685, DOI 10.1007/s10661-009-0979-5; Thundiyil JG, 2008, B WORLD HEALTH ORGAN, V86, P205, DOI [10.2471/BLT.08.041814, 10.2471/BLT.07.041814]; Wang L, 2011, CURR MICROBIOL, V62, P289, DOI 10.1007/s00284-010-9707-1; Wang L, 2010, BIODEGRADATION, V21, P513, DOI 10.1007/s10532-009-9320-9; Yen JH, 2000, ECOTOX ENVIRON SAFE, V45, P79, DOI 10.1006/eesa.1999.1846; Zhao RB, 2010, AGR SCI CHINA, V9, P695, DOI 10.1016/S1671-2927(09)60145-0	41	17	17	1	17	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 4	2012	7	4							e31963	10.1371/journal.pone.0031963	http://dx.doi.org/10.1371/journal.pone.0031963			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	953GO	22496729	Green Submitted, Green Published, gold			2022-12-25	WOS:000304855200002
J	Singh, VK; Rahman, MN; Munro, K; Uversky, VN; Smith, SP; Jia, ZC				Singh, Vinay K.; Rahman, Mona N.; Munro, Kim; Uversky, Vladimir N.; Smith, Steven P.; Jia, Zongchao			Free Cysteine Modulates the Conformation of Human C/EBP Homologous Protein	PLOS ONE			English	Article							ENDOPLASMIC-RETICULUM STRESS; INTRINSICALLY DISORDERED PROTEINS; NATIVELY UNFOLDED PROTEINS; TRANSCRIPTION FACTOR CHOP; REDOX STATE; UNSTRUCTURED PROTEINS; OXIDATIVE STRESS; CELL-DEATH; MOLECULAR RECOGNITION; INDUCED APOPTOSIS	The C/EBP Homologous Protein (CHOP) is a nuclear protein that is integral to the unfolded protein response culminating from endoplasmic reticulum stress. Previously, CHOP was shown to comprise extensive disordered regions and to self-associate in solution. In the current study, the intrinsically disordered nature of this protein was characterized further by comprehensive in silico analyses. Using circular dichroism, differential scanning calorimetry and nuclear magnetic resonance, we investigated the global conformation and secondary structure of CHOP and demonstrated, for the first time, that conformational changes in this protein can be induced by the free amino acid L-cysteine. Addition of L-cysteine caused a significant dose-dependent decrease in the protein helicity - dropping from 69.1% to 23.8% in the presence of 1 mM of L-cysteine - and a sequential transition to a more disordered state, unlike that caused by thermal denaturation. Furthermore, the presence of small amounts of free amino acid (80 mu M, an 8: 1 cysteine: CHOP ratio) during CHOP thermal denaturation altered the molecular mechanism of its melting process, leading to a complex, multi-step transition. On the other hand, high levels (4 mM) of free L-cysteine seemed to cause a complete loss of rigid cooperatively melting structure. These results suggested a potential regulatory function of L-cysteine which may lead to changes in global conformation of CHOP in response to the cellular redox state and/or endoplasmic reticulum stress.	[Singh, Vinay K.; Rahman, Mona N.; Munro, Kim; Smith, Steven P.; Jia, Zongchao] Queens Univ, Dept Biomed & Mol Sci, Kingston, ON, Canada; [Uversky, Vladimir N.] Univ S Florida, Dept Mol Med, Tampa, FL USA; [Uversky, Vladimir N.] Russian Acad Sci, Inst Biol Instrumentat, Pushchino 142292, Moscow Region, Russia	Queens University - Canada; State University System of Florida; University of South Florida; Russian Academy of Sciences	Singh, VK (corresponding author), Queens Univ, Dept Biomed & Mol Sci, Kingston, ON, Canada.	jia@queensu.ca	Rahman, Mona/GRF-6475-2022; Uversky, Vladimir N./F-4515-2011	Uversky, Vladimir N./0000-0002-4037-5857; Smith, Steven/0000-0003-2710-4400; Rahman, Mona Naeema/0000-0002-9782-0173	Canadian Institute of Health Research [MOP-77810]	Canadian Institute of Health Research(Canadian Institutes of Health Research (CIHR))	This research was supported by Canadian Institute of Health Research (Grant #: MOP-77810, www.cihr-irsc.gc.ca). ZJ is a Killam Research Fellow and holds a Canada Research Chair in Structural Biology. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alter J, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0029498; Anderson CL, 2007, AM J PHYSIOL-REG I, V293, pR1069, DOI 10.1152/ajpregu.00195.2007; Aridor M, 1999, NAT MED, V5, P745, DOI 10.1038/10466; Babu MM, 2011, CURR OPIN STRUC BIOL, V21, P432, DOI 10.1016/j.sbi.2011.03.011; Banjac A, 2008, ONCOGENE, V27, P1618, DOI 10.1038/sj.onc.1210796; Bates CJ, 2002, BRIT J NUTR, V87, P71, DOI 10.1079/BJN2001479; BOHM G, 1992, PROTEIN ENG, V5, P191, DOI 10.1093/protein/5.3.191; Bourhis JM, 2007, CURR PROTEIN PEPT SC, V8, P135, DOI 10.2174/138920307780363451; Bracken C, 2004, CURR OPIN STRUC BIOL, V14, P570, DOI 10.1016/j.sbi.2004.08.003; Bruhat A, 2002, J BIOL CHEM, V277, P48107, DOI 10.1074/jbc.M206149200; Bruylants G, 2005, CURR MED CHEM, V12, P2011, DOI 10.2174/0929867054546564; Bushmarina NA, 2001, CHEMBIOCHEM, V2, P813, DOI 10.1002/1439-7633(20011105)2:11<813::AID-CBIC813>3.0.CO;2-W; Campen A, 2008, PROTEIN PEPTIDE LETT, V15, P956, DOI 10.2174/092986608785849164; Chakravarthi S, 2006, EMBO REP, V7, P271, DOI 10.1038/sj.embor.7400645; Chigurupati S, 2009, J BIOL CHEM, V284, P18323, DOI 10.1074/jbc.M109.020891; Chiribau CB, 2010, MOL CELL BIOL, V30, P3722, DOI 10.1128/MCB.01507-09; Cunnea P, 2011, MULT SCLER J, V17, P808, DOI 10.1177/1352458511399114; D'Amico S, 2001, J BIOL CHEM, V276, P25791, DOI 10.1074/jbc.M102741200; DAUGHDRILL GW, 2004, HDB PROTEIN FOLDING, P271; DELAGLIO F, 1995, J BIOMOL NMR, V6, P277, DOI 10.1007/BF00197809; Demchenko AP, 2001, J MOL RECOGNIT, V14, P42, DOI 10.1002/1099-1352(200101/02)14:1<42::AID-JMR518>3.0.CO;2-8; Dosztanyi Z, 2005, BIOINFORMATICS, V21, P3433, DOI 10.1093/bioinformatics/bti541; Dosztanyi Zsuzsanna, 2008, V426, P103, DOI 10.1007/978-1-60327-058-8_6; Dunker AK, 2008, NAT CHEM BIOL, V4, P229, DOI 10.1038/nchembio0408-229; Dunker AK, 2005, FEBS J, V272, P5129, DOI 10.1111/j.1742-4658.2005.04948.x; Dunker AK, 2001, NAT BIOTECHNOL, V19, P805, DOI 10.1038/nbt0901-805; Dunker AK, 2002, ADV PROTEIN CHEM, V62, P25; Dunker AK, 2002, BIOCHEMISTRY-US, V41, P6573, DOI 10.1021/bi012159+; Dunker AK, 2001, J MOL GRAPH MODEL, V19, P26, DOI 10.1016/S1093-3263(00)00138-8; Dyson HJ, 2005, NAT REV MOL CELL BIO, V6, P197, DOI 10.1038/nrm1589; Dyson HJ, 2002, CURR OPIN STRUC BIOL, V12, P54, DOI 10.1016/S0959-440X(02)00289-0; Eizirik DL, 2008, ENDOCR REV, V29, P42, DOI 10.1210/er.2007-0015; Ferron F, 2006, PROTEINS, V65, P1, DOI 10.1002/prot.21075; Fink AL, 2005, CURR OPIN STRUC BIOL, V15, P35, DOI 10.1016/j.sbi.2005.01.002; Gogia R, 1998, CURR EYE RES, V17, P257, DOI 10.1076/ceyr.17.3.257.5213; Gow A, 2009, CURR OPIN NEUROBIOL, V19, P505, DOI 10.1016/j.conb.2009.08.007; Gsponer J, 2009, PROG BIOPHYS MOL BIO, V99, P94, DOI 10.1016/j.pbiomolbio.2009.03.001; Gunasekaran K, 2003, TRENDS BIOCHEM SCI, V28, P81, DOI 10.1016/S0968-0004(03)00003-3; He B, 2009, CELL RES, V19, P929, DOI 10.1038/cr.2009.87; HWANG C, 1992, SCIENCE, V257, P1496, DOI 10.1126/science.1523409; Iakoucheva LM, 2002, J MOL BIOL, V323, P573, DOI 10.1016/S0022-2836(02)00969-5; Iyer SS, 2009, AM J RESP CELL MOL, V40, P90, DOI 10.1165/rcmb.2007-0447OC; JOHNSON BA, 1994, J BIOMOL NMR, V4, P603, DOI 10.1007/BF00404272; Jones DP, 2004, FASEB J, V18, P1246, DOI 10.1096/fj.03-0971fje; Jones DP, 2002, FREE RADICAL BIO MED, V33, P1290, DOI 10.1016/S0891-5849(02)01040-7; Kaufman RJ, 2010, DIABETES OBES METAB, V12, P99, DOI 10.1111/j.1463-1326.2010.01281.x; Kumar A, 2006, BIOCHEM J, V396, P61, DOI 10.1042/BJ20051411; Kuznetsova IM, 2004, J PROTEOME RES, V3, P485, DOI 10.1021/pr034094y; Kuznetsova IM, 2002, BBA-PROTEIN STRUCT M, V1596, P138, DOI 10.1016/S0167-4838(02)00212-1; Li, 1999, Genome Inform Ser Workshop Genome Inform, V10, P30; Liu JG, 2006, BIOCHEMISTRY-US, V45, P6873, DOI 10.1021/bi0602718; Malhotra JD, 2007, SEMIN CELL DEV BIOL, V18, P716, DOI 10.1016/j.semcdb.2007.09.003; MATHEWSROTH MM, 1994, PHOTODERMATOL PHOTO, V10, P244; Matsumoto M, 1996, FEBS LETT, V395, P143, DOI 10.1016/0014-5793(96)01016-2; Maytin EV, 2001, EXP CELL RES, V267, P193, DOI 10.1006/excr.2001.5248; McCullough KD, 2001, MOL CELL BIOL, V21, P1249, DOI 10.1128/MCB.21.4.1249-1259.2001; Meares GP, 2011, EXP CELL RES, V317, P1621, DOI 10.1016/j.yexcr.2011.02.012; Miyazaki Y, 2011, ARTERIOSCL THROM VAS, V31, P1124, DOI 10.1161/ATVBAHA.111.224519; Moriarty SE, 2003, FREE RADICAL BIO MED, V35, P1582, DOI 10.1016/j.freeradbiomed.2003.09.006; Namba K, 2001, GENES CELLS, V6, P1, DOI 10.1046/j.1365-2443.2001.00384.x; Obeid OA, 2004, EUR J CLIN NUTR, V58, P105, DOI 10.1038/sj.ejcn.1601755; Ohoka N, 2005, EMBO J, V24, P1243, DOI 10.1038/sj.emboj.7600596; Oldfield CJ, 2008, BMC GENOMICS, V9, DOI 10.1186/1471-2164-9-S1-S1; Oldfield CJ, 2005, BIOCHEMISTRY-US, V44, P12454, DOI 10.1021/bi050736e; Oyadomari S, 2004, CELL DEATH DIFFER, V11, P381, DOI 10.1038/sj.cdd.4401373; Oyadomari S, 2002, J CLIN INVEST, V109, P525, DOI 10.1172/JCI200214550; Park SH, 2010, J BIOL CHEM, V285, P35330, DOI 10.1074/jbc.M110.136259; Peng K, 2006, BMC BIOINFORMATICS, V7, DOI 10.1186/1471-2105-7-208; PERMYAKOV EA, 1980, EUR J BIOCHEM, V109, P307, DOI 10.1111/j.1432-1033.1980.tb04796.x; Prilusky J, 2005, BIOINFORMATICS, V21, P3435, DOI 10.1093/bioinformatics/bti537; Radivojac P, 2007, BIOPHYS J, V92, P1439, DOI 10.1529/biophysj.106.094045; Radivojac Predrag, 2003, Pac Symp Biocomput, P216; Romero P, 2001, PROTEINS, V42, P38, DOI 10.1002/1097-0134(20010101)42:1<38::AID-PROT50>3.0.CO;2-3; RON D, 1992, GENE DEV, V6, P439, DOI 10.1101/gad.6.3.439; Ron D, 2007, NAT REV MOL CELL BIO, V8, P519, DOI 10.1038/nrm2199; Schafer FQ, 2001, FREE RADICAL BIO MED, V30, P1191, DOI 10.1016/S0891-5849(01)00480-4; Schroder M, 2008, CELL MOL LIFE SCI, V65, P862, DOI 10.1007/s00018-007-7383-5; Schulz GE, 1979, MOL MECH BIOL RECOGN, P79; Shao CL, 2010, J BIOL CHEM, V285, P19710, DOI 10.1074/jbc.M109.087486; Singh VK, 2008, J MOL BIOL, V380, P313, DOI 10.1016/j.jmb.2008.04.069; Tabas I, 2011, NAT CELL BIOL, V13, P184, DOI 10.1038/ncb0311-184; Tompa P, 2002, TRENDS BIOCHEM SCI, V27, P527, DOI 10.1016/S0968-0004(02)02169-2; Tsukano H, 2010, ARTERIOSCL THROM VAS, V30, P1925, DOI 10.1161/ATVBAHA.110.206094; Turoverov KK, 2010, PROG BIOPHYS MOL BIO, V102, P73, DOI 10.1016/j.pbiomolbio.2010.01.003; Ubeda M, 1996, MOL CELL BIOL, V16, P1479; Uversky VN, 2008, SCIENCE, V322, P1340, DOI 10.1126/science.1167453; Uversky VN, 2008, ANNU REV BIOPHYS, V37, P215, DOI 10.1146/annurev.biophys.37.032807.125924; Uversky VN, 2011, INT J BIOCHEM CELL B, V43, P1090, DOI 10.1016/j.biocel.2011.04.001; Uversky VN, 2011, BBA-PROTEINS PROTEOM, V1814, P693, DOI 10.1016/j.bbapap.2011.03.010; Uversky VN, 2010, BBA-PROTEINS PROTEOM, V1804, P1231, DOI 10.1016/j.bbapap.2010.01.017; Uversky VN, 2002, EUR J BIOCHEM, V269, P2, DOI 10.1046/j.0014-2956.2001.02649.x; Uversky VN, 2003, CELL MOL LIFE SCI, V60, P1852, DOI 10.1007/s00018-003-3096-6; Uversky VN, 1996, J MOL BIOL, V255, P215, DOI 10.1006/jmbi.1996.0018; Uversky VN, 2000, PROTEINS, V41, P415, DOI 10.1002/1097-0134(20001115)41:3<415::AID-PROT130>3.3.CO;2-Z; Uversky VN, 2002, PROTEIN SCI, V11, P739, DOI 10.1110/ps.4210102; Uversky VN, 2005, J MOL RECOGNIT, V18, P343, DOI 10.1002/jmr.747; Van Der Goot Francoise G., 1992, Trends in Cell Biology, V2, P343; Wang XZ, 1996, SCIENCE, V272, P1347, DOI 10.1126/science.272.5266.1347; Wang XZ, 1996, MOL CELL BIOL, V16, P4273; Wei YS, 2003, BIOPOLYMERS, V72, P345, DOI 10.1002/bip.10436; Xue B, 2010, BBA-PROTEINS PROTEOM, V1804, P996, DOI 10.1016/j.bbapap.2010.01.011; Xue B, 2009, FEBS LETT, V583, P1469, DOI 10.1016/j.febslet.2009.03.070; Yamaguchi H, 2004, J BIOL CHEM, V279, P45495, DOI 10.1074/jbc.M406933200; Yeh MY, 2007, AM J RESP CRIT CARE, V176, P270, DOI 10.1164/rccm.200611-1722OC; Yoshida H, 2007, FEBS J, V274, P630, DOI 10.1111/j.1742-4658.2007.05639.x; Zinszner H, 1998, GENE DEV, V12, P982, DOI 10.1101/gad.12.7.982; Zou W, 2008, CANCER RES, V68, P7484, DOI 10.1158/0008-5472.CAN-08-1318	107	4	4	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 4	2012	7	4							e34680	10.1371/journal.pone.0034680	http://dx.doi.org/10.1371/journal.pone.0034680			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	953GO	22496840	Green Published, gold, Green Submitted			2022-12-25	WOS:000304855200069
J	Priyadarsini, RV; Kumar, N; Khan, I; Thiyagarajan, P; Kondaiah, P; Nagini, S				Priyadarsini, Ramamurthi Vidya; Kumar, Neeraj; Khan, Imran; Thiyagarajan, Paranthaman; Kondaiah, Paturu; Nagini, Siddavaram			Gene Expression Signature of DMBA-Induced Hamster Buccal Pouch Carcinomas: Modulation by Chlorophyllin and Ellagic Acid	PLOS ONE			English	Article							NF-KAPPA-B; GROWTH-FACTOR-BETA; THERAPEUTIC TARGET; DNA-DAMAGE; CANCER; CARCINOGENESIS; INHIBITION; MATRIX-METALLOPROTEINASE-9; RAT; ANTICARCINOGENS	Chlorophyllin (CHL), a water-soluble, semi synthetic derivative of chlorophyll and ellagic acid (EA), a naturally occurring polyplienolic compound in berries, grapes, and nuts have been reported to exert anticancer effects in various human cancer cell lines and in animal tumour models. The present study was undertaken to examine the mechanism underlying chemoprevention and changes in gene expression pattern induced by dietary supplementation of chlorophyllin and ellagic acid in the 7,12-diniethylbenz[a]anthracene (DMBA)-induced hamster buccal pouch (HBP) carcinogenesis model by whole genome profiling using pangenomic microarrays. In hamsters painted with DMBA, the expression of 1,700 genes was found to be altered significantly relative to control Dietary supplementation of chlorophyllin and ellagic acid modulated the expression profiles of 104 and 37 genes respectively. Microarray analysis also revealed changes in the expression of TGF beta receptors, NF-kappa B, cyclin D1, and matrix metalloproteinases (MMPs) that may play a crucial role in the transformation of the normal buccal pouch to a malignant phenotype. This gene expression signature was altered on treatment with chlorophyllin and ellagic acid. Our study has also revealed patterns of gene expression signature specific for chlorophyllin and ellagic acid exposure. Thus dietary chlorophyllin and ellagic acid that can reverse gene expression signature associated with carcinogenesis are novel candidates for cancer prevention and therapy.	[Priyadarsini, Ramamurthi Vidya; Thiyagarajan, Paranthaman; Nagini, Siddavaram] Annamalai Univ, Fac Sci, Dept Biochem & Biotechnol, Annamalainagar 608002, Tamil Nadu, India; [Kumar, Neeraj; Khan, Imran; Kondaiah, Paturu] Indian Inst Sci, Bengaluru, India	Annamalai University; Indian Institute of Science (IISC) - Bangalore	Priyadarsini, RV (corresponding author), Annamalai Univ, Fac Sci, Dept Biochem & Biotechnol, Annamalainagar 608002, Tamil Nadu, India.	s_nagini@yahoo.com	khan, imran/K-9921-2013	khan, imran/0000-0001-6888-7347	Department of Biotechnology, New Delhi, India, under Indo-EU	Department of Biotechnology, New Delhi, India, under Indo-EU	This work was supported by a grant from the Department of Biotechnology, New Delhi, India, under the 7th FP of the Indo-EU Joint Collaborative Project on 'FUNCFOOD'. The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aiyer HS, 2010, CANCER PREV RES, V3, P727, DOI 10.1158/1940-6207.CAPR-09-0260; Anitha P, 2011, EUR J NUTR IN PRESS; Baud V, 2009, NAT REV DRUG DISCOV, V8, P33, DOI 10.1038/nrd2781; Beltran E, 2011, P NATL ACAD SCI USA, V108, P12461, DOI 10.1073/pnas.1018941108; Binker MG, 2011, BIOCHEM BIOPH RES CO, V405, P140, DOI 10.1016/j.bbrc.2011.01.023; Carter O, 2004, J NUTR, V134, p3441S, DOI 10.1093/jn/134.12.3441S; Chaturvedi MM, 2011, ONCOGENE, V30, P1615, DOI 10.1038/onc.2010.566; Chiu LCM, 2005, INT J MOL MED, V16, P735; Chiu LCM, 2003, INT J ONCOL, V23, P729; Dashwood R, 1998, MUTAT RES-FUND MOL M, V399, P245, DOI 10.1016/S0027-5107(97)00259-5; Dashwood RH, 1997, INT J ONCOL, V10, P721; DIXIT R, 1986, P NATL ACAD SCI USA, V83, P8039, DOI 10.1073/pnas.83.21.8039; Egner PA, 2001, P NATL ACAD SCI USA, V98, P14601, DOI 10.1073/pnas.251536898; Elahi M, 2012, BIOMARKERS, V17, P21, DOI 10.3109/1354750X.2011.635804; Fujiwara Y, 2011, J HEPATO-BIL-PAN SCI, V18, P731, DOI 10.1007/s00534-011-0390-9; Gialeli C, 2011, FEBS J, V278, P16, DOI 10.1111/j.1742-4658.2010.07919.x; Gonzalez-Sarrias A, 2009, MOL NUTR FOOD RES, V53, P686, DOI 10.1002/mnfr.200800150; Gradecka-Meesters D, 2011, FOOD CHEM TOXICOL, V49, P1674, DOI 10.1016/j.fct.2011.02.021; Gupta SC, 2010, CANCER METAST REV, V29, P405, DOI 10.1007/s10555-010-9235-2; Hagiwara Y, 2010, INT J HEMATOL, V92, P136, DOI 10.1007/s12185-010-0627-4; Hawinkels LJAC, 2011, GROWTH FACTORS, V29, P140, DOI 10.3109/08977194.2011.595411; Hsieh HL, 2010, J NEUROINFLAMM, V7, DOI 10.1186/1742-2094-7-88; Hua H, 2011, CELL MOL LIFE SCI, V68, P3853, DOI 10.1007/s00018-011-0763-x; Huber MA, 2004, J CLIN INVEST, V114, P569, DOI 10.1172/JCI200421358; Kelly RJ, 2010, J IMMUNOTOXICOL, V7, P15, DOI 10.3109/15476910903389920; Lagerqvist A, 2011, FOOD CHEM TOXICOL, V49, P879, DOI 10.1016/j.fct.2010.12.011; LESCA P, 1983, CARCINOGENESIS, V4, P1651, DOI 10.1093/carcin/4.12.1651; Luqman S, 2010, PHYTOTHER RES, V24, P949, DOI 10.1002/ptr.3171; MadrigalBujaidar E, 1997, MUTAT RES-GEN TOX EN, V388, P79, DOI 10.1016/S1383-5718(96)00139-8; MANDAL S, 1987, CARCINOGENESIS, V8, P1651, DOI 10.1093/carcin/8.11.1651; Meulmeester E, 2011, J PATHOL, V223, P205, DOI 10.1002/path.2785; MUKHTAR H, 1986, CANCER RES, V46, P2262; Musgrove EA, 2011, NAT REV CANCER, V11, P558, DOI 10.1038/nrc3090; Nagini S, 2009, ANTI-CANCER AGENT ME, V9, P843, DOI 10.2174/187152009789124619; Nagini S, 2009, ORAL ONCOL, V45, pE31, DOI 10.1016/j.oraloncology.2009.01.006; Osowski A, 2010, J TOXICOL ENV HEAL A, V73, P1141, DOI 10.1080/15287394.2010.491044; Priyadarsini RV, 2012, CURR PHARM BIOTECHNO, V13, P125; Priyadarsini RV, 2011, NUTR CANCER, V63, P218, DOI 10.1080/01635581.2011.523503; Santibanez JF, 2011, CLIN SCI, V121, P233, DOI 10.1042/CS20110086; Simonich MT, 2008, FOOD CHEM TOXICOL, V46, P1014, DOI 10.1016/j.fct.2007.10.034; SINGLETARY K, 1989, In Vivo (Attiki), V3, P173; TANAKA T, 1993, CARCINOGENESIS, V14, P1321, DOI 10.1093/carcin/14.7.1321; TEEL RW, 1986, CANCER LETT, V30, P329, DOI 10.1016/0304-3835(86)90058-3; Tobar N, 2010, MOL CELL BIOCHEM, V340, P195, DOI 10.1007/s11010-010-0418-5; Umesalma S, 2010, BASIC CLIN PHARMACOL, V107, P650, DOI 10.1111/j.1742-7843.2010.00565.x; Wang R, 2006, MUTAT RES-FUND MOL M, V601, P11, DOI 10.1016/j.mrfmmm.2006.05.026; Witzel II, 2010, BIOCHEM SOC T, V38, P217, DOI 10.1042/BST0380217; Yang K, 2010, ONCOL REP, V23, P1619, DOI 10.3892/or_00000803; Yee JC, 2008, BIOTECHNOL BIOENG, V101, P1359, DOI 10.1002/bit.21984	49	26	27	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 2	2012	7	4							e34628	10.1371/journal.pone.0034628	http://dx.doi.org/10.1371/journal.pone.0034628			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	952GU	22485181	Green Published, gold, Green Submitted			2022-12-25	WOS:000304780500056
J	Zhou, CQ; Kandemir, I; Walsh, DB; Zalom, FG; Lavine, LC				Zhou, Changqing; Kandemir, Irfan; Walsh, Douglas B.; Zalom, Frank G.; Lavine, Laura Corley			Identification of Lygus hesperus by DNA Barcoding Reveals Insignificant Levels of Genetic Structure among Distant and Habitat Diverse Populations	PLOS ONE			English	Article							PLANT BUG HETEROPTERA; MIRIDAE; RESISTANCE; SOFTWARE	Background: The western tarnished plant bug Lygus hesperus is an economically important pest that belongs to a complex of morphologically similar species that makes identification problematic. The present study provides evidence for the use of DNA barcodes from populations of L. hesperus from the western United States of America for accurate identification. Methodology/Principal Findings: This study reports DNA barcodes for 134 individuals of the western tarnished plant bug from alfalfa and strawberry agricultural fields in the western United States of America. Sequence divergence estimates of <3% reveal that morphologically variable individuals presumed to be L. hesperus were accurately identified. Paired estimates of F-st and subsequent estimates of gene flow show that geographically distinct populations of L. hesperus are genetically similar. Therefore, our results support and reinforce the relatively recent (<100 years) migration of the western tarnished plant bug into agricultural habitats across the western United States. Conclusions/Significance: This study reveals that despite wide host plant usage and phenotypically plastic morphological traits, the commonly recognized western tarnished plant bug belongs to a single species, Lygus hesperus. In addition, no significant genetic structure was found for the geographically diverse populations of western tarnished plant bug used in this study.	[Zhou, Changqing; Walsh, Douglas B.; Lavine, Laura Corley] Washington State Univ, Dept Entomol, Pullman, WA 99164 USA; [Kandemir, Irfan] Ankara Univ, Dept Biol, TR-06100 Ankara, Turkey; [Walsh, Douglas B.] Irrigated Agr Res & Extens Ctr, Prosser, WA USA; [Zalom, Frank G.] Univ Calif Davis, Dept Entomol, Davis, CA 95616 USA	Washington State University; Ankara University; University of California System; University of California Davis	Zhou, CQ (corresponding author), Washington State Univ, Dept Entomol, Pullman, WA 99164 USA.	lavine@wsu.edu	kandemir, irfan/L-3944-2019	kandemir, irfan/0000-0002-2888-1044; Lavine, Laura/0000-0002-0262-359X	Washington Alfalfa Seed Commission; Washington State Commission on Pesticide Registration; California Strawberry Commission; WSU Department of Entomology	Washington Alfalfa Seed Commission; Washington State Commission on Pesticide Registration; California Strawberry Commission; WSU Department of Entomology	Funding for this study (covering collection and sequencing costs) was provided by the Washington Alfalfa Seed Commission (http://apps.leg.wa.gov/wac/default.aspx?cite = 16-529&full = true) and the Washington State Commission on Pesticide Registration (http://wscpr.org/) to DBW, California Strawberry Commission (http://www.calstrawberry.com/) to FGZ, and WSU Department of Entomology research and travel scholarships to CZ. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Armstrong K., 2010, Bulletin OEPP, V40, P91, DOI 10.1111/j.1365-2338.2009.02358.x; Bandelt HJ, 1999, MOL BIOL EVOL, V16, P37, DOI 10.1093/oxfordjournals.molbev.a026036; BUTTS RA, 1991, J ECON ENTOMOL, V84, P1591, DOI 10.1093/jee/84.5.1591; Clement M, 2000, MOL ECOL, V9, P1657, DOI 10.1046/j.1365-294x.2000.01020.x; Excoffier L, 2005, EVOL BIOINFORM, V1, P47, DOI 10.1177/117693430500100003; Galloway D, 1999, 1182 US GEOL SURV; Geisler M, 2011, COMMODITY STRAWBERRY; Goodell PB, 2009, PEST MANAG SCI, V65, P1293, DOI 10.1002/ps.1859; Guindon S, 2003, SYST BIOL, V52, P696, DOI 10.1080/10635150390235520; Hebert PDN, 2004, P NATL ACAD SCI USA, V101, P14812, DOI 10.1073/pnas.0406166101; Hebert PDN, 2003, P ROY SOC B-BIOL SCI, V270, pS96, DOI 10.1098/rsbl.2003.0025; Jung S, 2011, MOL ECOL RESOUR, V11, P266, DOI 10.1111/j.1755-0998.2010.02945.x; Kelly LJ, 2010, TAXON, V59, P251, DOI 10.1002/tax.591023; Kumar S, 2008, BRIEF BIOINFORM, V9, P299, DOI 10.1093/bib/bbn017; LEIGH TF, 1970, CALIF AGR, V24, P12; Mueller SC, 2003, U CA AGR NATURAL RES; Park DS, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0018749; Posada D, 2008, MOL BIOL EVOL, V25, P1253, DOI 10.1093/molbev/msn083; Putnam D, 1996, P 27 NAT ALF S 26 CA; Ronquist F, 2005, MRBAYES 3 1; Savolainen V, 2005, PHILOS T R SOC B, V360, P1805, DOI 10.1098/rstb.2005.1730; Schreiber AS, ALFALFA ALFALFA SEED; Schwartz M. D., 1998, Memoirs on Entomology, International, V10; Scott D.R., 1977, Bulletin Ent Soc Amer, V23, P19; Snodgrass GL, 1996, J ECON ENTOMOL, V89, P783, DOI 10.1093/jee/89.4.783; Snodgrass GL, 2000, J ECON ENTOMOL, V93, P441, DOI 10.1603/0022-0493-93.2.441; TEMPLETON AR, 1992, GENETICS, V132, P619; Waters TD, 2009, THESIS WASHINGTON ST; ZALOM FG, 1990, MONITORING AND INTEGRATED MANAGEMENT OF ARTHROPOD PESTS OF SMALL FRUIT CROPS, P239; Zalom FG, 2006, ENCY PEST MANAGEMENT, DOI 10.1081/E-EPM-120041243	30	13	13	0	13	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 30	2012	7	3							e34528	10.1371/journal.pone.0034528	http://dx.doi.org/10.1371/journal.pone.0034528			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	959UC	22479640	Green Published, gold, Green Submitted			2022-12-25	WOS:000305339100165
J	Waters, KM; Liu, T; Quesenberry, RD; Willse, AR; Bandyopadhyay, S; Kathmann, LE; Weber, TJ; Smith, RD; Wiley, HS; Thrall, BD				Waters, Katrina M.; Liu, Tao; Quesenberry, Ryan D.; Willse, Alan R.; Bandyopadhyay, Somnath; Kathmann, Loel E.; Weber, Thomas J.; Smith, Richard D.; Wiley, H. Steven; Thrall, Brian D.			Network Analysis of Epidermal Growth Factor Signaling Using Integrated Genomic, Proteomic and Phosphorylation Data	PLOS ONE			English	Article							MAMMARY EPITHELIAL-CELLS; CYSTEINYL-PEPTIDE ENRICHMENT; PROTEIN-INTERACTION NETWORK; GENE-EXPRESSION PATTERNS; HIGH-THROUGHPUT DATA; MICROARRAY TECHNOLOGY; MASS-SPECTROMETRY; SYSTEMS BIOLOGY; FACTOR RECEPTOR; QUANTITATIVE-ANALYSIS	To understand how integration of multiple data types can help decipher cellular responses at the systems level, we analyzed the mitogenic response of human mammary epithelial cells to epidermal growth factor (EGF) using whole genome microarrays, mass spectrometry-based proteomics and large-scale western blots with over 1000 antibodies. A time course analysis revealed significant differences in the expression of 3172 genes and 596 proteins, including protein phosphorylation changes measured by western blot. Integration of these disparate data types showed that each contributed qualitatively different components to the observed cell response to EGF and that varying degrees of concordance in gene expression and protein abundance measurements could be linked to specific biological processes. Networks inferred from individual data types were relatively limited, whereas networks derived from the integrated data recapitulated the known major cellular responses to EGF and exhibited more highly connected signaling nodes than networks derived from any individual dataset. While cell cycle regulatory pathways were altered as anticipated, we found the most robust response to mitogenic concentrations of EGF was induction of matrix metalloprotease cascades, highlighting the importance of the EGFR system as a regulator of the extracellular environment. These results demonstrate the value of integrating multiple levels of biological information to more accurately reconstruct networks of cellular response.	[Waters, Katrina M.; Wiley, H. Steven] Pacific NW Natl Lab, Environm Mol Sci Lab, Richland, WA 99352 USA	United States Department of Energy (DOE); Pacific Northwest National Laboratory	Waters, KM (corresponding author), Pacific NW Natl Lab, Environm Mol Sci Lab, Richland, WA 99352 USA.	katrina.waters@pnl.gov; steven.wiley@pnnl.gov; brian.thrall@pnnl.gov	Liu, Tao/A-9020-2013; Smith, Richard D/J-3664-2012	Liu, Tao/0000-0001-9529-6550; Smith, Richard D/0000-0002-2381-2349; Waters, Katrina/0000-0003-4696-5396; Wiley, Steven/0000-0003-0232-6867	Biomolecular Systems Initiative, Laboratory Directed Research and Development at Pacific Northwest National Laboratory (PNNL); National Institutes of Health (NIH) National Center for Research Resources at PNNL [RR018522]; U. S. Department of Energy; DOE [DE-ACO5-76RLO 1830]; NATIONAL CENTER FOR RESEARCH RESOURCES [P41RR018522] Funding Source: NIH RePORTER	Biomolecular Systems Initiative, Laboratory Directed Research and Development at Pacific Northwest National Laboratory (PNNL); National Institutes of Health (NIH) National Center for Research Resources at PNNL; U. S. Department of Energy(United States Department of Energy (DOE)); DOE(United States Department of Energy (DOE)); NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR))	Support for this research was provided by the Biomolecular Systems Initiative, part of the Laboratory Directed Research and Development Program at Pacific Northwest National Laboratory (PNNL), and the National Institutes of Health (NIH) National Center for Research Resources (RR018522) at PNNL. Portions of this work were conducted at the Environmental Molecular Science Laboratory, a U. S. Department of Energy-funded national user facility. PNNL is operated by Battelle for DOE under contract DE-ACO5-76RLO 1830. The funding agencies had no role in study design, data collection and analysis, decision to publish or preparation of the manuscript.	Aderem A, 2005, CELL, V121, P511, DOI 10.1016/j.cell.2005.04.020; Amit I, 2007, NAT GENET, V39, P503, DOI 10.1038/ng1987; Anastassiou D, 2007, MOL SYST BIOL, V3, DOI 10.1038/msb4100124; Barabasi AL, 2004, NAT REV GENET, V5, P101, DOI 10.1038/nrg1272; Benjamini Y, 1995, J ROY STAT SOC, V57, P289; Bolstad BM, 2003, BIOINFORMATICS, V19, P185, DOI 10.1093/bioinformatics/19.2.185; Bonneau R, 2007, CELL, V131, P1354, DOI 10.1016/j.cell.2007.10.053; Chen GA, 2002, MOL CELL PROTEOMICS, V1, P304, DOI 10.1074/mcp.M200008-MCP200; Chen WNU, 2004, J BIOL CHEM, V279, P18488, DOI 10.1074/jbc.M310874200; Chen WNU, 2003, PROTEOMICS, V3, P1647, DOI 10.1002/pmic.200300468; Cox B, 2005, METHODS, V35, P303, DOI 10.1016/j.ymeth.2004.08.021; Fischer OM, 2003, BIOCHEM SOC T, V31, P1203; Griffin TJ, 2002, MOL CELL PROTEOMICS, V1, P323, DOI 10.1074/mcp.M200001-MCP200; Gygi SP, 1999, MOL CELL BIOL, V19, P1720, DOI 10.1128/mcb.19.3.1720; Gygi SP, 1999, NAT BIOTECHNOL, V17, P994, DOI 10.1038/13690; Hatzimanikatis V, 1999, METAB ENG, V1, P275, DOI 10.1006/mben.1999.0115; Hoheisel JD, 2006, NAT REV GENET, V7, P200, DOI 10.1038/nrg1809; Ideker T, 2001, SCIENCE, V292, P929, DOI 10.1126/science.292.5518.929; Ideker T, 2011, CELL, V144, P860, DOI 10.1016/j.cell.2011.03.007; Irish JM, 2006, NAT REV CANCER, V6, P146, DOI 10.1038/nrc1804; Jacobs JM, 2004, J PROTEOME RES, V3, P68, DOI 10.1021/pr034062a; Jones RB, 2006, NATURE, V439, P168, DOI 10.1038/nature04177; Kitano H, 2002, CURR GENET, V41, P1, DOI 10.1007/s00294-002-0285-z; Lettieri T, 2006, ENVIRON HEALTH PERSP, V114, P4, DOI 10.1289/ehp.8194; Liu T, 2005, PROTEOMICS, V5, P1263, DOI 10.1002/pmic.200401055; Liu T, 2004, ANAL CHEM, V76, P5345, DOI 10.1021/ac049485q; Maheshwari G, 2001, J CELL BIOL, V155, P1123, DOI 10.1083/jcb.200109060; McDermott JE, 2010, DIS MARKERS, V28, P253, DOI [10.1155/2010/708932, 10.3233/DMA-2010-0695]; Monaghan-Benson E, 2006, J BIOL CHEM, V281, P9450, DOI 10.1074/jbc.M501901200; Moro L, 2002, J BIOL CHEM, V277, P9405, DOI 10.1074/jbc.M109101200; Nesvizhskii AI, 2003, ANAL CHEM, V75, P4646, DOI 10.1021/ac0341261; Nicholson JK, 2004, NAT BIOTECHNOL, V22, P1268, DOI 10.1038/nbt1015; Nishizuka S, 2003, P NATL ACAD SCI USA, V100, P14229, DOI 10.1073/pnas.2331323100; Oyama M, 2011, J BIOL CHEM, V286, P818, DOI 10.1074/jbc.M110.156877; Perou CM, 1999, P NATL ACAD SCI USA, V96, P9212, DOI 10.1073/pnas.96.16.9212; Petritis K, 2003, ANAL CHEM, V75, P1039, DOI 10.1021/ac0205154; Pines A, 2011, MOL CELL BIOL, V31, P4964, DOI 10.1128/MCB.05258-11; Pratt JM, 2002, MOL CELL PROTEOMICS, V1, P579, DOI 10.1074/mcp.M200046-MCP200; Qian WJ, 2005, MOL CELL PROTEOMICS, V4, P700, DOI 10.1074/mcp.M500045-MCP200; Saeed AI, 2003, BIOTECHNIQUES, V34, P374, DOI 10.2144/03342mt01; SCHENA M, 1995, SCIENCE, V270, P467, DOI 10.1126/science.270.5235.467; Shah AR, 2007, BIOINFORMATICS, V23, P906, DOI 10.1093/bioinformatics/btm031; Shannon P, 2003, GENOME RES, V13, P2498, DOI 10.1101/gr.1239303; Smith RD, 2002, PROTEOMICS, V2, P513, DOI 10.1002/1615-9861(200205)2:5<513::AID-PROT513>3.0.CO;2-W; STAMPFER MR, 1993, CANCER SURV, V18, P7; STAMPFER MR, 1993, EXP CELL RES, V208, P175, DOI 10.1006/excr.1993.1236; Stelzl U, 2005, CELL, V122, P957, DOI 10.1016/j.cell.2005.08.029; Tian Q, 2004, MOL CELL PROTEOMICS, V3, P960, DOI 10.1074/mcp.M400055-MCP200; Verhoeckx KCM, 2004, PROTEOMICS, V4, P1014, DOI 10.1002/pmic.200300669; Waters Katrina M., 2006, Briefings in Functional Genomics & Proteomics, V5, P261, DOI 10.1093/bfgp/ell019; Wiley HS, 2003, TRENDS CELL BIOL, V13, P43; Yamanishi Y, 2003, BIOINFORMATICS, V19, pi323, DOI 10.1093/bioinformatics/btg1045; Zangar RC, 2006, EXPERT REV PROTEOMIC, V3, P37, DOI 10.1586/14789450.3.1.37; Zhang Y, 2005, MOL CELL PROTEOMICS, V4, P1240, DOI 10.1074/mcp.M500089-MCP200	54	33	33	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 29	2012	7	3							e34515	10.1371/journal.pone.0034515	http://dx.doi.org/10.1371/journal.pone.0034515			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	948SR	22479638	gold, Green Published, Green Submitted			2022-12-25	WOS:000304523400086
J	Jia, Y; Suzuki, N; Yamamoto, M; Gassmann, M; Noguchi, CT				Jia, Yi; Suzuki, Norio; Yamamoto, Masayuki; Gassmann, Max; Noguchi, Constance Tom			Endogenous erythropoietin signaling facilitates skeletal muscle repair and recovery following pharmacologically induced damage	FASEB JOURNAL			English	Article						PI3K/Akt; myoblast; wound healing; transgenic mice	MICE OVEREXPRESSING ERYTHROPOIETIN; STEM-CELLS; EXCESSIVE ERYTHROCYTOSIS; RECEPTOR; ACTIVATION; ANGIOGENESIS; EXPRESSION; GATA-1; DIFFERENTIATION; PROLIFERATION	Erythropoietin acts by binding to its cell surface receptor on erythroid progenitor cells to stimulate erythrocyte production. Erythropoietin receptor expression in nonhematopoietic tissue, including skeletal muscle progenitor cells, raises the possibility of a role for erythropoietin beyond erythropoiesis. Mice with erythropoietin receptor restricted to hematopoietic tissue were used to assess contributions of endogenous erythropoietin to promote skeletal myoblast proliferation and survival and wound healing in a mouse model of cardiotoxin induced muscle injury. Compared with wild-type controls, these mice had fewer skeletal muscle Pax-7(+) satellite cells and myoblasts that do not proliferate in culture, were more susceptible to skeletal muscle injury and reduced maximum load tolerated by isolated muscle. In contrast, mice with chronic elevated circulating erythropoietin had more Pax-7(+) satellite cells and myoblasts with increased proliferation and survival in culture, decreased muscle injury, and accelerated recovery of maximum load tolerated by isolated muscle. Skeletal muscle myoblasts also produced endogenous erythropoietin that increased at low O-2. Erythropoietin promoted proliferation, survival, and wound recovery in myoblasts via the phosphoinositide 3-kinase/AKT pathway. Therefore, endogenous and exogenous erythropoietin contribute to increasing satellite cell number following muscle injury, improve myoblast proliferation and survival, and promote repair and regeneration in this mouse induced muscle injury model independent of its effect on erythrocyte production.-Jia, Y., Suzuki, N., Yamamoto, M., Gassmann, M., Noguchi, C. T. Endogenous erythropoietin signaling facilitates skeletal muscle repair and recovery following pharmacologically induced damage. FASEB J. 26, 2847-2858 (2012). www.fasebj.org	[Jia, Yi; Noguchi, Constance Tom] NIDDK, Mol Med Branch, NIH, Bethesda, MD 20892 USA; [Suzuki, Norio; Yamamoto, Masayuki] Tohoku Univ, Grad Sch Med, Dept Med Biochem, Sendai, Miyagi 980, Japan; [Gassmann, Max] Univ Zurich, Inst Vet Physiol, Vetsuisse Fac, Zurich, Switzerland; [Gassmann, Max] Univ Zurich, Zurich Ctr Integrat Human Physiol ZIHP, Zurich, Switzerland; [Gassmann, Max] UPCH, Lima, Peru	National Institutes of Health (NIH) - USA; NIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK); Tohoku University; University of Zurich; University of Zurich; Zurich Center Integrative Human Physiology (ZIHP); Universidad Peruana Cayetano Heredia	Noguchi, CT (corresponding author), NIDDK, Mol Med Branch, NIH, Bldg 10,Rm 9N319,10 Ctr Dr,MSC 1822, Bethesda, MD 20892 USA.	connien@mail.nih.gov	Yamamoto, Masayuki/A-4873-2010; Suzuki, Norio/F-3456-2010; Suzuki, Norio/AAZ-9458-2021	Yamamoto, Masayuki/0000-0002-9073-9436; Suzuki, Norio/0000-0001-6100-3350; Gassmann, Max/0000-0003-2750-8878	National Institute of Diabetes and Digestive and Kidney Diseases; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [ZIADK025103] Funding Source: NIH RePORTER	National Institute of Diabetes and Digestive and Kidney Diseases(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	The authors thank Li Wang, Heather Rogers, Susan E. Ivie, and Xiaobing Yu for their contributions in studies on transcription regulation and position-holding time. Funding is provided by the Intramural Research Program of the National Institute of Diabetes and Digestive and Kidney Diseases. Author contributions: Y.J. performed conception and design, collection and/or assembly of data, data analysis and interpretation, manuscript writing, and final approval of manuscript; N.S. provided study material and data analysis and interpretation; M.Y. provided study material and data analysis and interpretation; M. G. provided study material and data analysis and interpretation; and C.T.N. provided conception and design, financial support, data analysis and interpretation, manuscript writing, and final approval of manuscript.	Abedi M, 2007, BRIT J HAEMATOL, V138, P792, DOI 10.1111/j.1365-2141.2007.06720.x; Ameln H, 2005, FASEB J, V19, P1009, DOI 10.1096/fj.04-2304fje; ANAGNOSTOU A, 1994, P NATL ACAD SCI USA, V91, P3974, DOI 10.1073/pnas.91.9.3974; Chen ZY, 2007, J BIOL CHEM, V282, P25875, DOI 10.1074/jbc.M701988200; CHIN K, 1995, NUCLEIC ACIDS RES, V23, P3041, DOI 10.1093/nar/23.15.3041; Cosgrove BD, 2009, DIFFERENTIATION, V78, P185, DOI 10.1016/j.diff.2009.08.004; Deng HB, 2011, INT J BIOCHEM CELL B, V43, P409, DOI 10.1016/j.biocel.2010.11.011; Digicaylioglu M, 2001, NATURE, V412, P641, DOI 10.1038/35088074; Fu P, 2007, BIOCHEM BIOPH RES CO, V354, P372, DOI 10.1016/j.bbrc.2007.01.044; Fukada S, 2008, EXP CELL RES, V314, P193, DOI 10.1016/j.yexcr.2007.09.020; Gassmann M, 2008, BIOL REPROD, V78, P1049, DOI 10.1095/biolreprod.107.065532; Hagstrom L, 2010, J BIOMED BIOTECHNOL, DOI 10.1155/2010/137817; Hamer PW, 2002, J ANAT, V200, P69, DOI 10.1046/j.0021-8782.2001.00008.x; Heinicke K, 2006, AM J PHYSIOL-REG I, V291, pR947, DOI 10.1152/ajpregu.00152.2006; Jia Y, 2009, FASEB J, V23, P3089, DOI 10.1096/fj.09-130237; Katz O, 2010, J ENDOCRINOL, V205, P87, DOI 10.1677/JOE-09-0425; Kawamura I, 2010, AM J PHYSIOL-HEART C, V299, pH372, DOI 10.1152/ajpheart.00035.2010; Kuang SH, 2007, CELL, V129, P999, DOI 10.1016/j.cell.2007.03.044; Lepper C, 2009, NATURE, V460, P627, DOI 10.1038/nature08209; Lundby C, 2008, J APPL PHYSIOL, V104, P1154, DOI 10.1152/japplphysiol.01211.2007; Mao WK, 2008, J MOL CELL CARDIOL, V45, P250, DOI 10.1016/j.yjmcc.2008.05.010; Nakano M, 2007, CIRC RES, V100, P662, DOI 10.1161/01.RES.0000260179.43672.fe; Nouette-Gaulain K, 2009, ANESTHESIOLOGY, V110, P648, DOI 10.1097/ALN.0b013e3181974f7a; Ogilvie M, 2000, J BIOL CHEM, V275, P39754, DOI 10.1074/jbc.M004999200; Ohanna M, 2005, NAT CELL BIOL, V7, P286, DOI 10.1038/ncb1231; Pelletier S, 2006, MOL CELL BIOL, V26, P8527, DOI 10.1128/MCB.01035-06; Quaschning T, 2002, FASEB J, V16, P259, DOI 10.1096/fj.02-0296fje; Ren HX, 2010, P NATL ACAD SCI USA, V107, P5857, DOI 10.1073/pnas.0909570107; Rotter R, 2008, J ORTHOP RES, V26, P1618, DOI 10.1002/jor.20692; Rundqvist H, 2009, EUR J ENDOCRINOL, V161, P427, DOI 10.1530/EJE-09-0342; Ruschitzka FT, 2000, P NATL ACAD SCI USA, V97, P11609, DOI 10.1073/pnas.97.21.11609; Schuler B, 2010, P NATL ACAD SCI USA, V107, P419, DOI 10.1073/pnas.0912924107; Suzuki N, 2002, BLOOD, V100, P2279, DOI 10.1182/blood-2002-01-0124; Tedesco FS, 2010, J CLIN INVEST, V120, P11, DOI 10.1172/JCI40373; Teng RF, 2011, NAT COMMUN, V2, DOI 10.1038/ncomms1526; Teng RF, 2011, BASIC RES CARDIOL, V106, P343, DOI 10.1007/s00395-011-0158-z; Tsai PT, 2006, J NEUROSCI, V26, P1269, DOI 10.1523/JNEUROSCI.4480-05.2006; Um M, 2007, CELL SIGNAL, V19, P634, DOI 10.1016/j.cellsig.2006.08.014; Wang KP, 2008, J BIOL CHEM, V283, P34029, DOI 10.1074/jbc.M803012200; Westenbrink BD, 2008, CARDIOVASC DRUG THER, V22, P265, DOI 10.1007/s10557-008-6094-y; Yasuda Y, 1998, J BIOL CHEM, V273, P25381, DOI 10.1074/jbc.273.39.25381; Yu XB, 2002, DEVELOPMENT, V129, P505; Zhao W, 2006, BLOOD, V107, P907, DOI 10.1182/blood-2005-06-2516; ZON LI, 1991, P NATL ACAD SCI USA, V88, P10638, DOI 10.1073/pnas.88.23.10638	44	36	36	0	7	FEDERATION AMER SOC EXP BIOL	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3998 USA	0892-6638	1530-6860		FASEB J	Faseb J.	JUL	2012	26	7					2847	2858		10.1096/fj.11-196618	http://dx.doi.org/10.1096/fj.11-196618			12	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	967MP	22490927	Green Published			2022-12-25	WOS:000305912500013
J	Hager, L; Li, LX; Pun, H; Liu, L; Hossain, MA; Maguire, GF; Naples, M; Baker, C; Magomedova, L; Tam, J; Adeli, K; Cummins, CL; Connelly, PW; Ng, DS				Hager, Lauren; Li, Lixin; Pun, Henry; Liu, Lu; Hossain, Mohammad A.; Maguire, Graham F.; Naples, Mark; Baker, Chris; Magomedova, Lilia; Tam, Jonathan; Adeli, Khosrow; Cummins, Carolyn L.; Connelly, Philip W.; Ng, Dominic S.			Lecithin:Cholesterol Acyltransferase Deficiency Protects against Cholesterol-induced Hepatic Endoplasmic Reticulum Stress in Mice	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							PICK C1-LIKE 1; DIET-INDUCED OBESITY; LCAT-NULL MICE; GLUCOSE-HOMEOSTASIS; GENE-EXPRESSION; LDL RECEPTOR; LECITHIN; ATHEROSCLEROSIS; IDENTIFICATION; ACCUMULATION	We recently reported that lecithin:cholesterol acyltransferase (LCAT) knock-out mice, particularly in the LDL receptor knock-out background, are hypersensitive to insulin and resistant to high fat diet-induced insulin resistance (IR) and obesity. We demonstrated that chow-fed Ldlr-/-xLcat+/+ mice have elevated hepatic endoplasmic reticulum (ER) stress, which promotes IR, compared with wild-type controls, and this effect is normalized in Ldlr-/-xLcat-/- mice. In the present study, we tested the hypothesis that hepatic ER cholesterol metabolism differentially regulates ER stress using these models. We observed that the Ldlr-/-xLcat+/+ mice accumulate excess hepatic total and ER cholesterol primarily attributed to increased reuptake of biliary cholesterol as we observed reduced biliary cholesterol in conjunction with decreased hepatic Abcg5/g8 mRNA, increased Npc1l1 mRNA, and decreased Hmgr mRNA and nuclear SREBP2 protein. Intestinal NPC1L1 protein was induced. Expression of these genes was reversed in the Ldlr-/-xLcat-/- mice, accounting for the normalization of total and ER cholesterol and ER stress. Upon feeding a 2% high cholesterol diet (HCD), Ldlr-/-xLcat-/- mice accumulated a similar amount of total hepatic cholesterol compared with the Ldlr-/-xLcat+/+ mice, but the hepatic ER cholesterol levels remained low in conjunction with being protected from HCD-induced ER stress and IR. Hepatic ER stress correlates strongly with hepatic ER free cholesterol but poorly with hepatic tissue free cholesterol. The unexpectedly low ER cholesterol seen in HCD-fed Ldlr-/-xLcat-/- mice was attributable to a coordinated marked up-regulation of ACAT2 and suppressed SREBP2 processing. Thus, factors influencing the accumulation of ER cholesterol may be important for the development of hepatic insulin resistance.	[Hager, Lauren; Li, Lixin; Pun, Henry; Liu, Lu; Hossain, Mohammad A.; Maguire, Graham F.; Tam, Jonathan; Connelly, Philip W.; Ng, Dominic S.] St Michaels Hosp, Keenan Res Ctr, Dept Med, Li Ka Shing Knowledge Inst, Toronto, ON M5B 1W8, Canada; [Hager, Lauren; Ng, Dominic S.] Univ Toronto, Dept Physiol, Fac Med, Toronto, ON M5S 1A8, Canada; [Adeli, Khosrow; Connelly, Philip W.] Univ Toronto, Dept Lab Med & Pathobiol, Toronto, ON M5S 1A8, Canada; [Naples, Mark; Baker, Chris; Adeli, Khosrow] Hosp Sick Children, Div Biochem, Toronto, ON M5G 1X8, Canada; [Magomedova, Lilia; Cummins, Carolyn L.] Univ Toronto, Fac Pharm, Toronto, ON M5S 3M2, Canada	University of Toronto; Li Ka Shing Knowledge Institute; University Toronto Affiliates; Saint Michaels Hospital Toronto; University of Toronto; University of Toronto; University of Toronto; University Toronto Affiliates; Hospital for Sick Children (SickKids); University of Toronto	Ng, DS (corresponding author), St Michaels Hosp, Keenan Res Ctr, Dept Med, Li Ka Shing Knowledge Inst, 30 Bond St,Shuter 3-041, Toronto, ON M5B 1W8, Canada.	ngd@smh.toronto.on.ca	Connelly, Philip W/B-7583-2012; Li, Lixin/F-3034-2014	Connelly, Philip W/0000-0001-7244-6843; Li, Lixin/0000-0003-3016-4228; Cummins, Carolyn/0000-0001-7603-6577; Adeli, Khosrow/0000-0002-5839-5709	Heart and Stroke Foundation of Ontario [NA6331]; Canadian Institutes of Health Research [MOP-97904]; Natural Science and Engineering Research Council [RGPIN 356873-08]; Canada Foundation for Innovation	Heart and Stroke Foundation of Ontario(Heart & Stroke Foundation of Ontario); Canadian Institutes of Health Research(Canadian Institutes of Health Research (CIHR)); Natural Science and Engineering Research Council(Natural Sciences and Engineering Research Council of Canada (NSERC)); Canada Foundation for Innovation(Canada Foundation for InnovationCGIAR)	This work was supported in part by a Grant-in-aid from the Heart and Stroke Foundation of Ontario to D. S. N. (NA6331), K. A., and P. W. C., Canadian Institutes of Health Research Operating Grant MOP-97904, Natural Science and Engineering Research Council Grant RGPIN 356873-08, and a Canada Foundation for Innovation infrastructure grant (to C. L. C.).	Brown J. Mark, 2009, Immunology Endocrine & Metabolic Agents in Medicinal Chemistry, V9, P18; Calpe-Berdiel L, 2005, ATHEROSCLEROSIS, V181, P75, DOI 10.1016/j.atherosclerosis.2004.11.025; Choi DK, 2011, CELL PHYSIOL BIOCHEM, V28, P933, DOI 10.1159/000335807; Das A, 2008, J BIOL CHEM, V283, P10453, DOI 10.1074/jbc.M709460200; De Marinis E, 2008, J ENDOCRINOL, V198, P635, DOI 10.1677/JOE-08-0242; Dikkers A, 2010, WORLD J GASTROENTERO, V16, P5936, DOI 10.3748/wjg.v16.i47.5936; Elferink RPJO, 2011, EXPERT OPIN THER TAR, V15, P1173, DOI 10.1517/14728222.2011.607163; FOLCH J, 1957, J BIOL CHEM, V226, P497; FROHLICH J, 1988, METABOLISM, V37, P3, DOI 10.1016/0026-0495(88)90021-2; Irisawa M, 2009, J BIOL CHEM, V284, P28995, DOI 10.1074/jbc.M109.041376; Klett EL, 2004, BMC GASTROENTEROL, V4, DOI 10.1186/1471-230X-4-21; Lada AT, 2004, J LIPID RES, V45, P378, DOI 10.1194/jlr.D300037-JLR200; Lambert G, 2001, J BIOL CHEM, V276, P15090, DOI 10.1074/jbc.M008466200; Lee JP, 2010, MOL CANCER RES, V8, P93, DOI 10.1158/1541-7786.MCR-08-0491; Li LX, 2007, AM J PHYSIOL-ENDOC M, V293, pE587, DOI 10.1152/ajpendo.00278.2007; Li LX, 2011, J BIOL CHEM, V286, P17809, DOI 10.1074/jbc.M110.180893; Mari M, 2006, CELL METAB, V4, P185, DOI 10.1016/j.cmet.2006.07.006; Ng DS, 2004, J BIOL CHEM, V279, P7636, DOI 10.1074/jbc.M309439200; Ng DS, 2002, J BIOL CHEM, V277, P11715, DOI 10.1074/jbc.M112320200; Ozcan U, 2006, SCIENCE, V313, P1137, DOI 10.1126/science.1128294; Ohshiro T, 2011, ARTERIOSCL THROM VAS, V31, P1108, DOI 10.1161/ATVBAHA.111.223552; Ozcan U, 2004, SCIENCE, V306, P457, DOI 10.1126/science.1103160; Park SW, 2010, P NATL ACAD SCI USA, V107, P19320, DOI 10.1073/pnas.1012044107; Pramfalk C, 2010, J LIPID RES, V51, P1354, DOI [10.1194/jlr.M900274-JLR200, 10.1194/jlr.M900274]; Pramfalk C, 2011, CURR OPIN LIPIDOL, V22, P225, DOI 10.1097/MOL.0b013e3283468c28; Radhakrishnan A, 2008, CELL METAB, V8, P512, DOI 10.1016/j.cmet.2008.10.008; Rousset X, 2009, CURR OPIN ENDOCRINOL, V16, P163, DOI 10.1097/MED.0b013e328329233b; Rudel LL, 2002, J BIOL CHEM, V277, P31401, DOI 10.1074/jbc.M204106200; Schreyer SA, 2002, AM J PHYSIOL-ENDOC M, V282, pE207, DOI 10.1152/ajpendo.2002.282.1.E207; Song H, 2006, AM J PHYSIOL-ENDOC M, V290, pE17, DOI 10.1152/ajpendo.00597.2004; Subramanian S, 2008, ARTERIOSCL THROM VAS, V28, P685, DOI 10.1161/ATVBAHA.107.157685; Tabas I, 2002, J CLIN INVEST, V110, P905, DOI 10.1172/JCI200216452; Tabas I, 2010, CIRC RES, V107, P839, DOI 10.1161/CIRCRESAHA.110.224766; Taghibiglou C, 2000, J LIPID RES, V41, P499; Temel RE, 2007, J CLIN INVEST, V117, P1968, DOI 10.1172/JCI30060; Van Erpecum KJ, 2011, CLIN RES HEPATOL GAS, V35, P281, DOI 10.1016/j.clinre.2011.01.009; Yamanashi Y, 2012, HEPATOLOGY, V55, P953, DOI 10.1002/hep.24772; Yamanashi Y, 2011, GASTROENTEROLOGY, V140, P1664, DOI 10.1053/j.gastro.2011.01.050; Zhu XH, 2004, AM J PATHOL, V165, P1269, DOI 10.1016/S0002-9440(10)63386-X	39	46	48	0	10	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JUN 8	2012	287	24					20755	20768		10.1074/jbc.M112.340919	http://dx.doi.org/10.1074/jbc.M112.340919			14	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	974FB	22500017	Green Submitted, Green Published, hybrid			2022-12-25	WOS:000306414500094
J	Finnigan, GC; Cronan, GE; Park, HJ; Srinivasan, S; Quiocho, FA; Stevens, TH				Finnigan, Gregory C.; Cronan, Glen E.; Park, Hae J.; Srinivasan, Sankaranarayanan; Quiocho, Florante A.; Stevens, Tom H.			Sorting of the Yeast Vacuolar-type, Proton-translocating ATPase Enzyme Complex (V-ATPase) IDENTIFICATION OF A NECESSARY AND SUFFICIENT GOLGI/ENDOSOMAL RETENTION SIGNAL IN Stv1p	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							N-TERMINAL DOMAIN; H+-ATPASE; CRYSTAL-STRUCTURE; MEMBRANE-PROTEIN; ALKALINE-PHOSPHATASE; GOLGI-APPARATUS; GENE ENCODES; CLUSTAL-W; SUBUNIT; VPH1P	Subunit a of the yeast vacuolar-type, proton-translocating ATPase enzyme complex (V-ATPase) is responsible for both proton translocation and subcellular localization of this highly conserved molecular machine. Inclusion of the Vph1p isoform causes the V-ATPase complex to traffic to the vacuolar membrane, whereas incorporation of Stv1p causes continued cycling between the trans-Golgi and endosome. We previously demonstrated that this targeting information is contained within the cytosolic, N-terminal portion of V-ATPase subunit a (Stv1p). To identify residues responsible for sorting of the Golgi isoform of the V-ATPase, a random mutagenesis was performed on the N terminus of Stv1p. Subsequent characterization of mutant alleles led to the identification of a short peptide sequence, (WKY)-K-83, that is necessary for proper Stv1p localization. Based on three-dimensional homology modeling to the Meiothermus ruber subunit I, we propose a structural model of the intact Stv1p-containing V-ATPase demonstrating the accessibility of the (WKY)-K-83 sequence to retrograde sorting machinery. Finally, we characterized the sorting signal within the context of a reconstructed Stv1p ancestor (Anc.Stv1). This evolutionary intermediate includes an endogenous (WKY)-K-83 sorting motif and is sufficient to compete with sorting of the native yeast Stv1p V-ATPase isoform. These data define a novel sorting signal that is both necessary and sufficient for trafficking of the V-ATPase within the Golgi/endosomal network.	[Stevens, Tom H.] Univ Oregon, Inst Mol Biol, Eugene, OR 97403 USA; [Srinivasan, Sankaranarayanan; Quiocho, Florante A.] Baylor Coll Med, Verna & Marrs McLean Dept Biochem & Mol Biol, Houston, TX 77030 USA	University of Oregon; Baylor College of Medicine	Stevens, TH (corresponding author), Univ Oregon, Inst Mol Biol, 297 Klamath Hall,1229 Univ Oregon, Eugene, OR 97403 USA.	stevens@molbio.uoregon.edu		Cronan, Glen/0000-0001-7092-6595; Stevens, Tom/0000-0001-6427-6848; Finnigan, Gregory/0000-0002-5710-173X	National Institutes of Health [GM38006, GM088803]; American Heart Association Predoctoral Fellowship [0715808Z]; Welch Foundation [Q-581]; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM038006, T32GM007413, R01GM088803] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); American Heart Association Predoctoral Fellowship(American Heart Association); Welch Foundation(The Welch Foundation); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported, in whole or in part, by National Institutes of Health Grants GM38006 (to T. H. S.) and GM088803 (to F. A. Q.). This work was also supported by American Heart Association Predoctoral Fellowship 0715808Z (to G. E. C.) and Welch Foundation Grant Q-581 (to F. A. Q.).	Arighi CN, 2004, J CELL BIOL, V165, P123, DOI 10.1083/jcb.200312055; Bonifacino JS, 2003, ANNU REV BIOCHEM, V72, P395, DOI 10.1146/annurev.biochem.72.121801.161800; Bonifacino JS, 2008, CURR OPIN CELL BIOL, V20, P427, DOI 10.1016/j.ceb.2008.03.009; Bryant NJ, 1997, J CELL BIOL, V136, P287, DOI 10.1083/jcb.136.2.287; Canuel M, 2008, BIOCHEM BIOPH RES CO, V366, P724, DOI 10.1016/j.bbrc.2007.12.015; Collins BM, 2008, TRAFFIC, V9, P1811, DOI 10.1111/j.1600-0854.2008.00777.x; Cooper AA, 1996, J CELL BIOL, V133, P529, DOI 10.1083/jcb.133.3.529; Cowles CR, 1997, CELL, V91, P109, DOI 10.1016/S0092-8674(01)80013-1; Davis-Kaplan SR, 2006, J BIOL CHEM, V281, P32025, DOI 10.1074/jbc.M606451200; Dean AM, 2007, NAT REV GENET, V8, P675, DOI 10.1038/nrg2160; Dettmer J, 2006, PLANT CELL, V18, P715, DOI 10.1105/tpc.105.037978; Diepholz M, 2008, STRUCTURE, V16, P1789, DOI 10.1016/j.str.2008.09.010; Drory O, 2004, EMBO REP, V5, P1148, DOI 10.1038/sj.embor.7400294; Ediger B, 2009, J BIOL CHEM, V284, P19522, DOI 10.1074/jbc.M109.013375; Finnigan GC, 2011, MOL BIOL CELL, V22, P3176, DOI 10.1091/mbc.E11-03-0244; Forgac M, 2007, NAT REV MOL CELL BIO, V8, P917, DOI 10.1038/nrm2272; Frattini A, 2000, NAT GENET, V25, P343, DOI 10.1038/77131; Goldstein AL, 1999, YEAST, V15, P1541, DOI 10.1002/(SICI)1097-0061(199910)15:14<1541::AID-YEA476>3.3.CO;2-B; GOLDSTEIN DJ, 1991, NATURE, V352, P347, DOI 10.1038/352347a0; Graham LA, 2003, J BIOENERG BIOMEMBR, V35, P301, DOI 10.1023/A:1025772730586; HAASS C, 1995, J BIOL CHEM, V270, P6186, DOI 10.1074/jbc.270.11.6186; Harms MJ, 2010, CURR OPIN STRUC BIOL, V20, P360, DOI 10.1016/j.sbi.2010.03.005; Hill K, 2000, EMBO J, V19, P550, DOI 10.1093/emboj/19.4.550; HILL KJ, 1995, J BIOL CHEM, V270, P22329, DOI 10.1074/jbc.270.38.22329; Hinton A, 2009, PFLUG ARCH EUR J PHY, V457, P589, DOI 10.1007/s00424-007-0382-4; HIRATA R, 1993, J BIOL CHEM, V268, P961; Hirata T, 2003, J BIOL CHEM, V278, P23714, DOI 10.1074/jbc.M302756200; Jo WJ, 2009, BMC GENOMICS, V10, DOI 10.1186/1471-2164-10-130; Johnston HD, 2005, MOL BIOL CELL, V16, P1456, DOI 10.1091/mbc.E04-07-0642; Kane PA, 2006, MICROBIOL MOL BIOL R, V70, P177, DOI 10.1128/MMBR.70.1.177-191.2006; Kane PM, 2007, J BIOENERG BIOMEMBR, V39, P415, DOI 10.1007/s10863-007-9112-z; Kawasaki-Nishi S, 2003, J BIOL CHEM, V278, P41908, DOI 10.1074/jbc.M308026200; Kawasaki-Nishi S, 2001, J BIOL CHEM, V276, P47411, DOI 10.1074/jbc.M108310200; Kawasaki-Nishi S, 2001, P NATL ACAD SCI USA, V98, P12397, DOI 10.1073/pnas.221291798; KLIONSKY DJ, 1990, MICROBIOL REV, V54, P266, DOI 10.1128/MMBR.54.3.266-292.1990; Landolt-Marticorena C, 2000, J BIOL CHEM, V275, P15449, DOI 10.1074/jbc.M000207200; Larkin MA, 2007, BIOINFORMATICS, V23, P2947, DOI 10.1093/bioinformatics/btm404; Leng XH, 1998, J BIOL CHEM, V273, P6717, DOI 10.1074/jbc.273.12.6717; Leng XH, 1999, J BIOL CHEM, V274, P14655, DOI 10.1074/jbc.274.21.14655; MacDiarmid CW, 2000, EMBO J, V19, P2845, DOI 10.1093/emboj/19.12.2845; Malkus P, 2004, MOL BIOL CELL, V15, P5075, DOI 10.1091/mbc.E04-06-0514; MANOLSON MF, 1992, J BIOL CHEM, V267, P14294; MANOLSON MF, 1994, J BIOL CHEM, V269, P14064; MARKWELL MAK, 1978, ANAL BIOCHEM, V87, P206, DOI 10.1016/0003-2697(78)90586-9; Marshansky V, 2008, CURR OPIN CELL BIOL, V20, P415, DOI 10.1016/j.ceb.2008.03.015; Mellman I, 1996, ANNU REV CELL DEV BI, V12, P575, DOI 10.1146/annurev.cellbio.12.1.575; Miseta A, 1999, FEBS LETT, V451, P132, DOI 10.1016/S0014-5793(99)00519-0; Misra S, 2002, NATURE, V415, P933, DOI 10.1038/415933a; Muench SP, 2011, Q REV BIOPHYS, V44, P311, DOI 10.1017/S0033583510000338; Nishi T, 2002, NAT REV MOL CELL BIO, V3, P94, DOI 10.1038/nrm729; Nishiguchi M, 2003, NEUROCHEM INT, V42, P493, DOI 10.1016/S0197-0186(02)00139-0; Nothwehr SF, 2000, J CELL BIOL, V151, P297, DOI 10.1083/jcb.151.2.297; NOTHWEHR SF, 1993, J CELL BIOL, V121, P1197, DOI 10.1083/jcb.121.6.1197; Nothwehr SF, 1999, MOL BIOL CELL, V10, P875, DOI 10.1091/mbc.10.4.875; Oestreich AJ, 2007, MOL BIOL CELL, V18, P707, DOI 10.1091/mbc.E06-08-0680; OHNO H, 1995, SCIENCE, V269, P1872, DOI 10.1126/science.7569928; Oka T, 2001, J BIOL CHEM, V276, P33079, DOI 10.1074/jbc.M101652200; Oka T, 2001, J BIOL CHEM, V276, P40050, DOI 10.1074/jbc.M106488200; Otte S, 2002, EMBO J, V21, P6095, DOI 10.1093/emboj/cdf598; Perez-Sayans M, 2010, CANCER LETT, V295, P135, DOI 10.1016/j.canlet.2010.03.019; Perzov N, 2002, J EXP BIOL, V205, P1209; Pettersen EF, 2004, J COMPUT CHEM, V25, P1605, DOI 10.1002/jcc.20084; Piper RC, 1997, J CELL BIOL, V138, P531, DOI 10.1083/jcb.138.3.531; Qi J, 2007, J BIOL CHEM, V282, P24743, DOI 10.1074/jbc.M700663200; Qi J, 2008, J BIOL CHEM, V283, P19274, DOI 10.1074/jbc.M802442200; Rojas JD, 2004, J CELL PHYSIOL, V201, P190, DOI 10.1002/jcp.20059; ROTHMAN JH, 1986, CELL, V47, P1041, DOI 10.1016/0092-8674(86)90819-6; Ryan M, 2008, MOL BIOL CELL, V19, P5131, DOI 10.1091/mbc.E08-06-0629; Sagermann M, 2001, P NATL ACAD SCI USA, V98, P7134, DOI 10.1073/pnas.131192798; Sambrook J, 2001, MOL CLONING LAB MANU; Sandoval Ignacio V., 1994, Trends in Cell Biology, V4, P292, DOI 10.1016/0962-8924(94)90220-8; Schekman R, 1996, SCIENCE, V271, P1526, DOI 10.1126/science.271.5255.1526; Seaman MNJ, 2007, J CELL SCI, V120, P2378, DOI 10.1242/jcs.009654; Sennoune SR, 2004, AM J PHYSIOL-CELL PH, V286, pC1443, DOI 10.1152/ajpcell.00407.2003; Smith AN, 2000, NAT GENET, V26, P71, DOI 10.1038/79208; Srinivasan S, 2011, J MOL BIOL, V412, P14, DOI 10.1016/j.jmb.2011.07.014; Stepp JD, 1997, J CELL BIOL, V139, P1761, DOI 10.1083/jcb.139.7.1761; Strochlic TI, 2007, J CELL BIOL, V177, P115, DOI 10.1083/jcb.200609161; THOMPSON JD, 1994, NUCLEIC ACIDS RES, V22, P4673, DOI 10.1093/nar/22.22.4673; Thornton JW, 2004, NAT REV GENET, V5, P366, DOI 10.1038/nrg1324; Toei M, 2010, BIOCHEMISTRY-US, V49, P4715, DOI 10.1021/bi100397s; Toyomura T, 2003, J BIOL CHEM, V278, P22023, DOI 10.1074/jbc.M302436200; Vowels JJ, 1998, EMBO J, V17, P2482, DOI 10.1093/emboj/17.9.2482; Wang YR, 2004, J BIOL CHEM, V279, P44628, DOI 10.1074/jbc.M407345200; Wassmer T, 2006, MOL BIOL CELL, V17, P917, DOI 10.1091/mbc.E05-06-0511; Xu L, 2010, PLOS PATHOG, V6, DOI 10.1371/journal.ppat.1000822; Yokoyama K, 2003, J BIOL CHEM, V278, P24255, DOI 10.1074/jbc.M303104200; Zhang Y, 2008, BMC BIOINFORMATICS, V9, DOI 10.1186/1471-2105-9-40; Zheng L, 2004, NUCLEIC ACIDS RES, V32, DOI 10.1093/nar/gnh110	89	38	38	0	3	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JUN 1	2012	287	23					19487	19500		10.1074/jbc.M112.343814	http://dx.doi.org/10.1074/jbc.M112.343814			14	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	974EF	22496448	hybrid, Green Published			2022-12-25	WOS:000306411900062
J	Cruys-Bagger, N; Elmerdahl, J; Praestgaard, E; Tatsumi, H; Spodsberg, N; Borch, K; Westh, P				Cruys-Bagger, Nicolaj; Elmerdahl, Jens; Praestgaard, Eigil; Tatsumi, Hirosuke; Spodsberg, Nikolaj; Borch, Kim; Westh, Peter			Pre-steady-state Kinetics for Hydrolysis of Insoluble Cellulose by Cellobiohydrolase Cel7A	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							TRICHODERMA-REESEI; ENZYMATIC-HYDROLYSIS; CELLOBIOSE DEHYDROGENASE; PHANEROCHAETE-CHRYSOSPORIUM; MICROCRYSTALLINE CELLULOSE; CRYSTALLINE CELLULOSE; CELLULASES; SUBSTRATE; ADSORPTION; SYNERGISM	The transient kinetic behavior of enzyme reactions prior to the establishment of steady state is a major source of mechanistic information, yet this approach has not been utilized for cellulases acting on their natural substrate, insoluble cellulose. Here, we elucidate the pre-steady-state regime for the exo-acting cellulase Cel7A using amperometric biosensors and an explicit model for processive hydrolysis of cellulose. This analysis allows the identification of a pseudo-steady-state period and quantification of a processivity number as well as rate constants for the formation of a threaded enzyme complex, processive hydrolysis, and dissociation, respectively. These kinetic parameters elucidate limiting factors in the cellulolytic process. We concluded, for example, that Cel7A cleaves about four glycosidic bonds/s during processive hydrolysis. However, the results suggest that stalling the processive movement and low off-rates result in a specific activity at pseudo-steady state that is 10-25-fold lower. It follows that the dissociation of the enzyme-substrate complex (half-time of similar to 30 s) is rate-limiting for the investigated system. We suggest that this approach can be useful in attempts to unveil fundamental reasons for the distinctive variability in hydrolytic activity found in different cellulase-substrate systems.	[Cruys-Bagger, Nicolaj; Elmerdahl, Jens; Praestgaard, Eigil; Westh, Peter] Roskilde Univ, Dept Sci Syst & Models, Res Unit Funct Biomat, DK-4000 Roskilde, Denmark; [Tatsumi, Hirosuke] Shinshu Univ, Int Young Researchers Empowerment Ctr, Matsumoto, Nagano 3908621, Japan; [Spodsberg, Nikolaj; Borch, Kim] Novozymes AS, DK-2880 Bagsvaerd, Denmark	Roskilde University; Shinshu University; Novozymes	Westh, P (corresponding author), Roskilde Univ, Dept Sci Syst & Models, Res Unit Funct Biomat, Univ Vej 1, DK-4000 Roskilde, Denmark.	pwesth@ruc.dk	Westh, Peter/AAR-9731-2021	Westh, Peter/0000-0002-6185-0637	Danish Agency for Science, Technology and Innovation; Ministry of Education, Culture, Sports, Science and Technology of Japan [23760746]; Programme Commission on Sustainable Energy and Environment [2104-07-0028]	Danish Agency for Science, Technology and Innovation; Ministry of Education, Culture, Sports, Science and Technology of Japan(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)); Programme Commission on Sustainable Energy and Environment	This work was supported by the Danish Agency for Science, Technology and Innovation; Grant 2104-07-0028 from the Programme Commission on Sustainable Energy and Environment (to P. W.); and Grant-in-aid for Young Scientists 23760746 and special coordination funds for promoting science and technology from the Ministry of Education, Culture, Sports, Science and Technology of Japan (to H. T.).	Abel M, 2001, BIOCHEM J, V357, P195, DOI 10.1042/0264-6021:3570195; Baker JO, 2000, APPL BIOCHEM BIOTECH, V84-6, P217, DOI 10.1385/ABAB:84-86:1-9:217; Bansal P, 2009, BIOTECHNOL ADV, V27, P833, DOI 10.1016/j.biotechadv.2009.06.005; Barr BK, 2002, BIOCHEMISTRY-US, V41, P4447, DOI 10.1021/bi015854q; Beckham GT, 2011, J PHYS CHEM B, V115, P4118, DOI 10.1021/jp1106394; Bohlin C, 2010, BIOTECHNOL BIOENG, V107, P943, DOI 10.1002/bit.22885; Eriksson T, 2002, APPL BIOCHEM BIOTECH, V101, P41, DOI 10.1385/ABAB:101:1:41; Fox JM, 2012, BIOCHEMISTRY-US, V51, P442, DOI 10.1021/bi2011543; Gruno M, 2004, BIOTECHNOL BIOENG, V86, P503, DOI 10.1002/bit.10838; Harjunpaa V, 1996, EUR J BIOCHEM, V240, P584, DOI 10.1111/j.1432-1033.1996.0584h.x; Henriksson G, 1998, BBA-PROTEIN STRUCT M, V1383, P48, DOI 10.1016/S0167-4838(97)00180-5; HIGHAM CW, 1994, FEBS LETT, V351, P128, DOI 10.1016/0014-5793(94)00847-7; Hilden L, 2001, ANAL BIOCHEM, V290, P245, DOI 10.1006/abio.2000.4959; Igarashi K, 2011, SCIENCE, V333, P1279, DOI 10.1126/science.1208386; Igarashi K, 2009, J BIOL CHEM, V284, P36186, DOI 10.1074/jbc.M109.034611; Jalak J, 2010, BIOTECHNOL BIOENG, V106, P871, DOI 10.1002/bit.22779; Johnson K. A., 1992, ENZYMES, P1; KABAYAMA MA, 1958, CAN J CHEM, V36, P557, DOI 10.1139/v58-078; Karim N, 2005, THERMOCHIM ACTA, V431, P9, DOI 10.1016/j.tca.2005.01.025; Kim Y. S., 1983, WASEDA DAIGAKU RIKOG, V104, P29; Kostylev M, 2012, BIOTECHNOL BIOENG, V109, P295, DOI 10.1002/bit.23299; Kurasin M, 2011, J BIOL CHEM, V286, P169, DOI 10.1074/jbc.M110.161059; Ludwig R, 2010, CHEMPHYSCHEM, V11, P2674, DOI 10.1002/cphc.201000216; Ma AZ, 2008, ENZYME MICROB TECH, V42, P543, DOI 10.1016/j.enzmictec.2008.02.009; Matulova M, 2008, FEBS J, V275, P3503, DOI 10.1111/j.1742-4658.2008.06497.x; Medve J, 1998, BIOTECHNOL BIOENG, V59, P621, DOI 10.1002/(SICI)1097-0290(19980905)59:5&lt;621::AID-BIT13&gt;3.0.CO;2-C; MEDVE J, 1994, BIOTECHNOL BIOENG, V44, P1064, DOI 10.1002/bit.260440907; Murphy L, 2012, J BIOL CHEM, V287, P1252, DOI 10.1074/jbc.M111.276485; Murphy L, 2010, ANAL BIOCHEM, V404, P140, DOI 10.1016/j.ab.2010.04.020; NIDETZKY B, 1994, BIOCHEM J, V303, P817, DOI 10.1042/bj3030817; Praestgaard E, 2011, FEBS J, V278, P1547, DOI 10.1111/j.1742-4658.2011.08078.x; Quinlan RJ, 2011, P NATL ACAD SCI USA, V108, P15079, DOI 10.1073/pnas.1105776108; Tatsumi H, 2006, ANAL BIOCHEM, V357, P257, DOI 10.1016/j.ab.2006.07.019; TOMME P, 1990, BIOTECHNOL LETT, V12, P525, DOI 10.1007/BF01086347; TULL D, 1994, BIOCHEMISTRY-US, V33, P6363, DOI 10.1021/bi00186a041; Valjamae P, 1998, EUR J BIOCHEM, V253, P469, DOI 10.1046/j.1432-1327.1998.2530469.x; Wilson DB, 2009, CURR OPIN BIOTECH, V20, P295, DOI 10.1016/j.copbio.2009.05.007; Yang B, 2006, BIOTECHNOL BIOENG, V94, P1122, DOI 10.1002/bit.20942; Zhang YHP, 2005, BIOMACROMOLECULES, V6, P1510, DOI 10.1021/bm049235j; Zhang YHP, 2004, BIOTECHNOL BIOENG, V88, P797, DOI 10.1002/bit.20282	40	89	89	1	54	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAY 25	2012	287	22					18451	18458		10.1074/jbc.M111.334946	http://dx.doi.org/10.1074/jbc.M111.334946			8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	974EC	22493488	Green Published, hybrid			2022-12-25	WOS:000306411600051
J	Shen, TH; Gladoun, N; Castillo-Martin, M; Bonal, D; Domingo-Domenech, J; Charytonowicz, D; Cordon-Cardo, C				Shen, Tian Huai; Gladoun, Nataliya; Castillo-Martin, Mireia; Bonal, Dennis; Domingo-Domenech, Josep; Charytonowicz, Daniel; Cordon-Cardo, Carlos			A BAC-Based Transgenic Mouse Specifically Expresses an Inducible Cre in the Urothelium	PLOS ONE			English	Article							GENE-EXPRESSION; MICE; INACTIVATION; GENOME; CELLS; TOOL; RAS	Cre-loxp mediated conditional knockout strategy has played critical roles for revealing functions of many genes essential for development, as well as the causal relationships between gene mutations and diseases in the postnatal adult mice. One key factor of this strategy is the availability of mice with tissue-or cell type-specific Cre expression. However, the success of the traditional molecular cloning approach to generate mice with tissue specific Cre expression often depends on luck. Here we provide a better alternative by using bacterial artificial chromosome (BAC)-based recombineering to insert iCreERT2 cDNA at the ATG start of the Upk2 gene. The BAC-based transgenic mice express the inducible Cre specifically in the urothelium as demonstrated by mRNA expression and staining for LacZ expression after crossing with a Rosa26 reporter mouse. Taking into consideration the size of the gene of interest and neighboring genes included in a BAC, this method should be widely applicable for generation of mice with tissue specific gene expression or deletions in a more specific manner than previously reported.	[Shen, Tian Huai; Gladoun, Nataliya; Castillo-Martin, Mireia; Bonal, Dennis; Domingo-Domenech, Josep; Charytonowicz, Daniel; Cordon-Cardo, Carlos] Columbia Univ, Herbert Irving Comprehens Canc Ctr, Med Ctr, New York, NY USA; [Shen, Tian Huai; Gladoun, Nataliya; Castillo-Martin, Mireia; Bonal, Dennis; Domingo-Domenech, Josep; Cordon-Cardo, Carlos] Columbia Univ, Dept Pathol, Med Ctr, New York, NY USA; [Castillo-Martin, Mireia; Bonal, Dennis; Domingo-Domenech, Josep; Cordon-Cardo, Carlos] Columbia Univ, Dept Urol, Med Ctr, New York, NY USA	Columbia University; Columbia University; Columbia University	Shen, TH (corresponding author), Albert Einstein Coll Med, Ruth L & David S Gottesman Inst Stem Cells & Rege, Dept Med, Bronx, NY 10467 USA.	carlos.cordon-cardo@mssm.edu	Castillo-Martin, Mireia/H-6152-2013		National Institutes of Health [P01 CA087497]; Alexander and Margaret Stewart Trust; NATIONAL CANCER INSTITUTE [P01CA087497] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Alexander and Margaret Stewart Trust; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	This work was supported by National Institutes of Health grant P01 CA087497, and partially supported by an Alexander and Margaret Stewart Trust Award. No additional external funding received for this study. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adams DJ, 2005, GENOMICS, V86, P753, DOI 10.1016/j.ygeno.2005.08.003; Ahmad I, 2011, DIS MODEL MECH, V4, P548, DOI 10.1242/dmm.006874; Blondeau B, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0030210; Copeland NG, 2001, NAT REV GENET, V2, P769, DOI 10.1038/35093556; Cordon-Cardo C, 2008, SCAND J UROL NEPHROL, V42, P154, DOI 10.1080/03008880802291915; Di Cristofano A, 1998, NAT GENET, V19, P348, DOI 10.1038/1235; Erdmann G, 2007, BMC NEUROSCI, V8, DOI 10.1186/1471-2202-8-63; Heiman M, 2008, CELL, V135, P738, DOI 10.1016/j.cell.2008.10.028; Jemal A, 2011, CA-CANCER J CLIN, V61, P134, DOI [10.3322/caac.20115, 10.3322/caac.20107]; Kerr DE, 1998, NAT BIOTECHNOL, V16, P75, DOI 10.1038/nbt0198-75; Kim JE, 2004, AM J PATHOL, V165, P1875, DOI 10.1016/S0002-9440(10)63240-3; LIN JH, 1995, P NATL ACAD SCI USA, V92, P679, DOI 10.1073/pnas.92.3.679; Livak KJ, 2001, METHODS, V25, P402, DOI 10.1006/meth.2001.1262; Marino S, 2000, GENE DEV, V14, P994; Miloud T, 2012, J IMMUNOL, V188, P1125, DOI 10.4049/jimmunol.1003920; Mo L, 2005, AM J PHYSIOL-RENAL, V289, pF562, DOI 10.1152/ajprenal.00368.2004; Soriano P, 1999, NAT GENET, V21, P70, DOI 10.1038/5007; Wallace HAC, 2007, CELL, V128, P197, DOI 10.1016/j.cell.2006.11.044; Warming S, 2005, NUCLEIC ACIDS RES, V33, DOI 10.1093/nar/gni035; Wrann CD, 2012, J CLIN INVEST, V122, P1010, DOI 10.1172/JCI58431; WU XR, 1990, J BIOL CHEM, V265, P19170; Wu XR, 2009, KIDNEY INT, V75, P1153, DOI 10.1038/ki.2009.73; Yang XD, 2011, NAT MED, V17, P87, DOI 10.1038/nm.2278; Zhang ZT, 1999, CANCER RES, V59, P3512; Zhang ZT, 2001, ONCOGENE, V20, P1973, DOI 10.1038/sj.onc.1204315; Zhao SL, 2011, NAT METHODS, V8, P745, DOI 10.1038/nmeth.1668; Zhou HP, 2010, AM J PHYSIOL-RENAL, V299, pF387, DOI 10.1152/ajprenal.00185.2010	27	10	10	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 9	2012	7	4							e35243	10.1371/journal.pone.0035243	http://dx.doi.org/10.1371/journal.pone.0035243			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	955JO	22496911	Green Published, gold, Green Submitted			2022-12-25	WOS:000305014500051
J	Eriksson, N; Tung, JY; Kiefer, AK; Hinds, DA; Francke, U; Mountain, JL; Do, CB				Eriksson, Nicholas; Tung, Joyce Y.; Kiefer, Amy K.; Hinds, David A.; Francke, Uta; Mountain, Joanna L.; Do, Chuong B.			Novel Associations for Hypothyroidism Include Known Autoimmune Risk Loci	PLOS ONE			English	Article							GENOME-WIDE ASSOCIATION; THYROID-DISEASE; GRAVES-DISEASE; HASHIMOTOS-THYROIDITIS; SUSCEPTIBILITY LOCI; R620W POLYMORPHISM; GENE VARIANTS; VAV FAMILY; ALLELE; PHOSPHODIESTERASE	Hypothyroidism is the most common thyroid disorder, affecting about 5% of the general population. Here we present the current largest genome-wide association study of hypothyroidism, in 3,736 cases and 35,546 controls. Hypothyroidism was assessed via web-based questionnaires. We identify five genome-wide significant associations, three of which are well known to be involved in a large spectrum of autoimmune diseases: rs6679677 near PTPN22, rs3184504 in SH2B3, and rs2517532 in the HLA class I region (p-values 2.8.10(-13), 2.6.10(-12), and 1.3.10(-8), respectively). We also report associations with rs4915077 near VAV3 (p-value 7.5.10(-10)) and rs925489 near FOXE1 (p-value 2.4.10(-19)). VAV3 is involved in immune function, and FOXE1 and PTPN22 have previously been associated with hypothyroidism. Although the HLA class I region and SH2B3 have previously been linked with a number of autoimmune diseases, this is the first report of their association with thyroid disease. The VAV3 association is also novel. We also show suggestive evidence of association for hypothyroidism with a SNP in the HLA class II region (independent of the other HLA association) as well as SNPs in CAPZB, PDE8B, and CTLA4. CAPZB and PDE8B have been linked to TSH levels and CTLA4 to a variety of autoimmune diseases. These results suggest heterogeneity in the genetic etiology of hypothyroidism, implicating genes involved in both autoimmune disorders and thyroid function. Using a genetic risk profile score based on the top association from each of the five genome-wide significant regions in our study, the relative risk between the highest and lowest deciles of genetic risk is 2.0.	[Eriksson, Nicholas; Tung, Joyce Y.; Kiefer, Amy K.; Hinds, David A.; Francke, Uta; Mountain, Joanna L.; Do, Chuong B.] 23andMe Inc, Mountain View, CA USA		Eriksson, N (corresponding author), 23andMe Inc, Mountain View, CA USA.	nick@23andme.com		Hinds, David/0000-0002-4911-803X				Alcina A, 2010, GENES IMMUN, V11, P439, DOI 10.1038/gene.2010.30; Arnaud-Lopez L, 2008, AM J HUM GENET, V82, P1270, DOI 10.1016/j.ajhg.2008.04.019; Barrett JC, 2008, NAT GENET, V40, P955, DOI 10.1038/ng.175; Bender AT, 2006, PHARMACOL REV, V58, P488, DOI 10.1124/pr.58.3.5; Betz RC, 2008, BRIT J DERMATOL, V158, P389, DOI 10.1111/j.1365-2133.2007.08312.x; Castanet M, 2010, HORM RES PAEDIAT, V73, P423, DOI 10.1159/000281438; Chen PL, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0016635; Cho JH, 2011, NEW ENGL J MED, V365, P1612, DOI 10.1056/NEJMra1100030; Chu X, 2011, NAT GENET, V43, P897, DOI 10.1038/ng.898; Coenen MJH, 2009, HUM MOL GENET, V18, P4195, DOI 10.1093/hmg/ddp365; Cotsapas C, 2011, PLOS GENET, V7, DOI 10.1371/journal.pgen.1002254; Criswell LA, 2005, AM J HUM GENET, V76, P561, DOI 10.1086/429096; Denny JC, 2011, AM J HUM GENET, V89, P529, DOI 10.1016/j.ajhg.2011.09.008; Do CB, 2011, PLOS GENET, V7, DOI 10.1371/journal.pgen.1002141; Donner H, 1997, J CLIN ENDOCR METAB, V82, P4130, DOI 10.1210/jc.82.12.4130; Eriksson N, 2010, PLOS GENET, V6, DOI 10.1371/journal.pgen.1000993; Falush D, 2003, GENETICS, V164, P1567; Fraser HI, 2010, J IMMUNOL, V184, P5075, DOI 10.4049/jimmunol.0903734; Fujikawa K, 2003, J EXP MED, V198, P1595, DOI 10.1084/jem.20030874; Giordano TJ, 2005, ONCOGENE, V24, P6646, DOI 10.1038/sj.onc.1208822; Gourh P, 2006, ARTHRITIS RHEUM-US, V54, P3945, DOI 10.1002/art.22196; Gregersen PK, 2009, ANNU REV IMMUNOL, V27, P363, DOI 10.1146/annurev.immunol.021908.132653; Gudmundsson J, 2009, NAT GENET, V41, P460, DOI 10.1038/ng.339; Hakonarson H, 2007, NATURE, V448, P591, DOI 10.1038/nature06010; Hayashi M, 1998, BIOCHEM BIOPH RES CO, V250, P751, DOI 10.1006/bbrc.1998.9379; Ikegami H, 2006, J CLIN ENDOCR METAB, V91, P1087, DOI 10.1210/jc.2005-1407; Landa I, 2009, PLOS GENET, V5, DOI 10.1371/journal.pgen.1000637; Lee YH, 2007, RHEUMATOLOGY, V46, P49, DOI 10.1093/rheumatology/kel170; Lettre G, 2008, HUM MOL GENET, V17, pR116, DOI 10.1093/hmg/ddn246; Lowe JK, 2009, PLOS GENET, V5, DOI 10.1371/journal.pgen.1000365; Menconi F, 2008, P NATL ACAD SCI USA, V105, P14034, DOI 10.1073/pnas.0806584105; Movilla N, 1999, MOL CELL BIOL, V19, P7870; Newby PR, 2010, EUR J HUM GENET, V18, P1021, DOI 10.1038/ejhg.2010.55; Newport M, 2007, NAT GENET, V39, P1329, DOI 10.1038/ng.2007.17; Newton-Cheh C, 2009, NAT GENET, V41, P666, DOI 10.1038/ng.361; Panicker V, 2010, AM J HUM GENET, V87, P430, DOI 10.1016/j.ajhg.2010.08.005; Park SM, 2005, J MED GENET, V42, P379, DOI 10.1136/jmg.2004.024158; Petrone A, 2001, THYROID, V11, P171, DOI 10.1089/105072501300042901; Pruim RJ, 2010, BIOINFORMATICS, V26, P2336, DOI 10.1093/bioinformatics/btq419; Simmonds MJ, 2011, BRIEF FUNCT GENOMICS, V10, P77, DOI 10.1093/bfgp/elq036; Sirota M, 2009, PLOS GENET, V5, DOI 10.1371/journal.pgen.1000792; Smyth D, 2004, DIABETES, V53, P3020, DOI 10.2337/diabetes.53.11.3020; TANDON N, 1991, CLIN ENDOCRINOL, V34, P383; Teumer A, 2011, AM J HUM GENET, V88, P664, DOI 10.1016/j.ajhg.2011.04.015; Todd JA, 2007, NAT GENET, V39, P857, DOI 10.1038/ng2068; Tomer Y, 2010, THYROID, V20, P715, DOI 10.1089/thy.2010.1644; Velaga MR, 2004, J CLIN ENDOCR METAB, V89, P5862, DOI 10.1210/jc.2004-1108; Wigginton JE, 2005, AM J HUM GENET, V76, P887, DOI 10.1086/429864; Zeitlin AA, 2008, CLIN ENDOCRINOL, V68, P671, DOI 10.1111/j.1365-2265.2007.03075.x; Zhernakova A, 2010, AM J HUM GENET, V86, P970, DOI 10.1016/j.ajhg.2010.05.004	50	97	97	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 6	2012	7	4							e34442	10.1371/journal.pone.0034442	http://dx.doi.org/10.1371/journal.pone.0034442			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	955JA	22493691	Green Published, gold, Green Submitted			2022-12-25	WOS:000305012700033
J	Lindenmayer, DB; Northrop-Mackie, AR; Montague-Drake, R; Crane, M; Michael, D; Okada, S; Gibbons, P				Lindenmayer, David B.; Northrop-Mackie, Amanda R.; Montague-Drake, Rebecca; Crane, Mason; Michael, Damian; Okada, Sachiko; Gibbons, Philip			Not All Kinds of Revegetation Are Created Equal: Revegetation Type Influences Bird Assemblages in Threatened Australian Woodland Ecosystems	PLOS ONE			English	Article							SOUTH-EASTERN AUSTRALIA; CANONICAL CORRESPONDENCE-ANALYSIS; AGRICULTURAL LANDSCAPES; REMNANT VEGETATION; SPECIES RICHNESS; CONSERVATION; FORESTS; RESTORATION; DIVERSITY; REGROWTH	The value for biodiversity of large intact areas of native vegetation is well established. The biodiversity value of regrowth vegetation is also increasingly recognised worldwide. However, there can be different kinds of revegetation that have different origins. Are there differences in the richness and composition of biotic communities in different kinds of revegetation? The answer remains unknown or poorly known in many ecosystems. We examined the conservation value of different kinds of revegetation through a comparative study of birds in 193 sites surveyed over ten years in four growth types located in semi-cleared agricultural areas of south-eastern Australia. These growth types were resprout regrowth, seedling regrowth, plantings, and old growth. Our investigation produced several key findings: (1) Marked differences in the bird assemblages of plantings, resprout regrowth, seedling regrowth, and old growth. (2) Differences in the number of species detected significantly more often in the different growth types; 29 species for plantings, 25 for seedling regrowth, 20 for resprout regrowth, and 15 for old growth. (3) Many bird species of conservation concern were significantly more often recorded in resprout regrowth, seedling regrowth or plantings but no species of conservation concern were recorded most often in old growth. We suggest that differences in bird occurrence among different growth types are likely to be strongly associated with growth-type differences in stand structural complexity. Our findings suggest a range of vegetation growth types are likely to be required in a given farmland area to support the diverse array of bird species that have the potential to occur in Australian temperate woodland ecosystems. Our results also highlight the inherent conservation value of regrowth woodland and suggest that current policies which allow it to be cleared or thinned need to be carefully re-examined.	[Lindenmayer, David B.] Australian Natl Univ, Fenner Sch Environm & Soc, ARC Ctr Excellence Environm Decis, Canberra, ACT, Australia; Australian Natl Univ, Natl Environm Res Program, Canberra, ACT, Australia	Australian National University; Australian National University	Lindenmayer, DB (corresponding author), Australian Natl Univ, Fenner Sch Environm & Soc, ARC Ctr Excellence Environm Decis, Canberra, ACT, Australia.	david.lindenmayer@anu.edu.au	Crane, Mason/AAQ-1810-2021; Lindenmayer, David B/P-7183-2017; Gibbons, Philip/I-8248-2012	Lindenmayer, David B/0000-0002-4766-4088; 	Murray Catchment Management Authority; Australian Research Council; Australian Government	Murray Catchment Management Authority; Australian Research Council(Australian Research Council); Australian Government(Australian GovernmentCGIAR)	This work was supported by major grants from the Murray Catchment Management Authority, the Australian Research Council and the Australian Government's Caring for our Country Program. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Agresti A., 2013, CATEGORICAL DATA ANA, V3rd; [Anonymous], 2010, TEMPERATE WOODLAND C; Antos MJ, 2008, EMU, V108, P201, DOI 10.1071/MU08005; Barlow J, 2007, BIOL CONSERV, V136, P212, DOI 10.1016/j.biocon.2006.11.021; Bowen ME, 2007, BIOL CONSERV, V140, P273, DOI 10.1016/j.biocon.2007.08.012; Bowen ME, 2009, BIOL CONSERV, V142, P3051, DOI 10.1016/j.biocon.2009.08.005; Briggs SV, 2008, AUST J BOT, V56, P590, DOI 10.1071/BT08046; Broome A, 2011, BIODIVERS CONSERV, V20, P729, DOI 10.1007/s10531-010-9974-y; Bunnell F., 2009, FORESTRY BIODIVERSIT; Chappell MJ, 2011, AGR HUM VALUES, V28, P3, DOI 10.1007/s10460-009-9251-4; Chazdon RL, 2009, CONSERV BIOL, V23, P1406, DOI 10.1111/j.1523-1739.2009.01338.x; Commonwealth of Australia, 2009, ENVL STEW STRAT FRAM; CONNELL JH, 1978, SCIENCE, V199, P1302, DOI 10.1126/science.199.4335.1302; Cribb J, 2010, COM FAM GLOB FOOD; Cunningham RB, 2008, CONSERV BIOL, V22, P742, DOI 10.1111/j.1523-1739.2008.00924.x; Cunningham RB, 2007, ECOL APPL, V17, P609, DOI 10.1890/05-1892; Dent DH, 2009, BIOL CONSERV, V142, P2833, DOI 10.1016/j.biocon.2009.05.035; Department of Environment Climate Change and Water, 2009, NSW ANN REP NAT VEG; Dhondt AA, 2007, BIRD STUDY, V54, P12, DOI 10.1080/00063650709461452; Doerr VAJ, 2006, EMU, V106, P93, DOI 10.1071/MU05020; Dorrough J, 2005, BIOL CONSERV, V123, P55, DOI 10.1016/j.biocon.2004.10.008; Dwass M., 1960, CONTRIBUTIONS PROBAB, P198; Egler FE, 1954, VEGETATIO ACTA GEOBO, V4, P412, DOI DOI 10.1007/BF00275587; Eldridge DJ, 2011, ECOL LETT, V14, P709, DOI 10.1111/j.1461-0248.2011.01630.x; Felton A, 2008, BIOL CONSERV, V141, P545, DOI 10.1016/j.biocon.2007.11.009; Field SA, 2002, AUSTRAL ECOL, V27, P624, DOI 10.1046/j.1442-9993.2002.01223.x; Fischer J, 2008, DIVERS DISTRIB, V14, P38, DOI 10.1111/j.1472-4642.2007.00411.x; Fischer J, 2009, P NATL ACAD SCI USA, V106, P10386, DOI 10.1073/pnas.0900110106; Ford HA, 2001, BIOL CONSERV, V97, P71, DOI 10.1016/S0006-3207(00)00101-4; Ford HA, 2009, BIOL CONSERV, V142, P3182, DOI 10.1016/j.biocon.2009.08.022; Foster DR, 2006, CONSERV BIOL, V20, P959, DOI 10.1111/j.1523-1739.2006.00495.x; Franklin J.F., 2000, CONSERVATION BIOL PR, V1, P9, DOI DOI 10.1111/J.1526-4629.2000.TB00155.X; Fuller RJ, 1998, FORESTRY, V71, P199, DOI 10.1093/forestry/71.3.199; Gibb H, 2010, BIOL CONSERV, V143, P677, DOI 10.1016/j.biocon.2009.12.005; Gibbons P, 2010, FOREST ECOL MANAG, V260, P2125, DOI 10.1016/j.foreco.2010.09.003; Gibson L, 2011, NATURE, V478, P378, DOI 10.1038/nature10425; Hobbs R.J., 2000, TEMPERATE EUCALYPT W; HOLLING CS, 1992, ECOL MONOGR, V62, P447, DOI 10.2307/2937313; Howes AL, 2009, WILDLIFE RES, V36, P617, DOI 10.1071/WR09054; Johnson EA, 2008, ECOL LETT, V11, P419, DOI 10.1111/j.1461-0248.2008.01173.x; Kavanagh RP, 2007, AUSTRAL ECOL, V32, P635, DOI 10.1111/j.1442-9993.2007.01746.x; Keith D.A., 2004, OCEAN SHORES DESERT; Laven NH, 1997, CORELLA, V22, P55; Legendre P., 1998, NUMERICAL ECOLOGY, V24; Leps J, 2003, MULTIVARIATE ANAL EC; Lindenmayer DB, 2010, BIOL CONSERV, V143, P289, DOI 10.1016/j.biocon.2009.10.010; Lindenmayer D.B., 2002, CONSERVING FOREST BI; Lindenmayer D, 2010, CONSERV BIOL, V24, P1459, DOI 10.1111/j.1523-1739.2010.01544.x; Lindenmayer DB, 2008, ECOL MONOGR, V78, P567, DOI 10.1890/07-0945.1; Lindenmayer DB, 2009, EMU, V109, P100, DOI 10.1071/MU08029; Lindenmayer DB, 2008, ECOL APPL, V18, P1967, DOI 10.1890/07-1943.1; Lindenmayer DB, 2010, EFFECTIVE ECOLOGICAL MONITORING, P1; Mac Nally R, 2010, RESTOR ECOL, V18, P85, DOI 10.1111/j.1526-100X.2008.00430.x; MACARTHUR R, 1961, ECOLOGY, V42, P594, DOI 10.2307/1932254; MacFaden SW, 2002, FOREST SCI, V48, P243; Major RE, 2001, BIOL CONSERV, V102, P47, DOI 10.1016/S0006-3207(01)00090-8; Major RE, 1999, J APPL ECOL, V36, P901, DOI 10.1046/j.1365-2664.1999.00457.x; Manning AD, 2006, BIOL CONSERV, V132, P311, DOI 10.1016/j.biocon.2006.04.023; Martin TG, 2005, J APPL ECOL, V42, P400, DOI 10.1111/j.1365-2664.2005.01012.x; Michael DR, 2011, BIOL CONSERV, V144, P407, DOI 10.1016/j.biocon.2010.09.019; Millennium Ecosystem Assessment, 2005, EC HUM WELL BEING BI; Montague-Drake RM, 2009, BIOL CONSERV, V142, P2896, DOI 10.1016/j.biocon.2009.07.009; Montague-Drake RM, 2011, LANDSCAPE ECOL, V26, P1383, DOI 10.1007/s10980-011-9665-4; Munro N, 2011, PLANTING FOR WILDLIFE: A PRACTICAL GUIDE TO RESTORING NATIVE WOODLANDS, P1; Nelson PR, 2005, ANAL MEANS GRAPHICAL; NSW Office of Environment and Heritage, 2011, NAT VEG MAN CLEAR; ODUM E. P, 1959, FUNDAMENTALS ECOLOGY; Oliver D, 2011, WOODLAND WANDERINGS, V8, P8; PALMER MW, 1993, ECOLOGY, V74, P2215, DOI 10.2307/1939575; Paton DC, 2000, TEMPERATE EUCALYPT WOODLANDS IN AUSTRALIA, P57; Pike DA, 2011, ECOL APPL, V21, P274, DOI 10.1890/09-2394.1; Posa MRC, 2006, BIOL CONSERV, V129, P256, DOI 10.1016/j.biocon.2005.10.041; Priday SD, 2010, EMU, V110, P118, DOI 10.1071/MU09051; PROBER SM, 1995, AUST J BOT, V43, P349, DOI 10.1071/BT9950349; Pyke G.H., 1983, METHODS CENSUSING BI, P55; Reid J., 1999, THREATENED DECLINING; Sekercioglu CH, 2006, TRENDS ECOL EVOL, V21, P464, DOI 10.1016/j.tree.2006.05.007; Selwood K, 2009, OECOLOGIA, V159, P435, DOI 10.1007/s00442-008-1221-9; Steel R.G.D., 1960, TECHNOMETRICS, VVol. 2, P197, DOI [DOI 10.1080/00401706.1960.10489894, 10.1080/00401706.1960.10489894]; STEEL RG, 1961, BIOMETRICS, V17, P539, DOI 10.2307/2527854; Swanson ME, 2011, FRONT ECOL ENVIRON, V9, P117, DOI 10.1890/090157; TERBRAAK CJF, 1986, ECOLOGY, V67, P1167; Titeux N, 2004, J BIOGEOGR, V31, P1841, DOI 10.1111/j.1365-2699.2004.01125.x; Tyre AJ, 2003, ECOL APPL, V13, P1790, DOI 10.1890/02-5078; Vesk PA, 2008, BIOL CONSERV, V141, P174, DOI 10.1016/j.biocon.2007.09.010; Watson J, 2001, CONSERV BIOL, V15, P1364, DOI 10.1046/j.1523-1739.2001.00166.x; Weinberg A, 2011, BIOL CONSERV, V144, P227, DOI 10.1016/j.biocon.2010.08.020; Wilkins S, 2003, RESTOR ECOL, V11, P489, DOI 10.1046/j.1526-100X.2003.rec0244.x; Woinarski JCZ, 2009, WILDLIFE RES, V36, P675, DOI 10.1071/WR08128; Zuur F. A., 2007, ANAL ECOLOGICAL DATA	90	50	50	0	46	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 6	2012	7	4							e34527	10.1371/journal.pone.0034527	http://dx.doi.org/10.1371/journal.pone.0034527			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	955JA	22493698	Green Published, Green Submitted, gold			2022-12-25	WOS:000305012700040
J	Chim, SSC; Lee, WS; Ting, YH; Chan, OK; Lee, SWY; Leung, TY				Chim, Stephen S. C.; Lee, Wing S.; Ting, Yuen H.; Chan, Oi K.; Lee, Shara W. Y.; Leung, Tak Y.			Systematic Identification of Spontaneous Preterm Birth-Associated RNA Transcripts in Maternal Plasma	PLOS ONE			English	Article							TUMOR-NECROSIS-FACTOR; GENE POLYMORPHISMS; INTRAAMNIOTIC INFECTION; MESSENGER-RNA; FETAL; QUANTIFICATION; INTERLEUKIN-4; PARTURITION; MICRORNAS; PROTOCOLS	Background: Spontaneous preterm birth (SPB, before 37 gestational weeks) is a major cause of perinatal mortality and morbidity, but its pathogenesis remains unclear. Studies on SPB have been hampered by the limited availability of markers for SPB in predelivery clinical samples that can be easily compared with gestational age-matched normal controls. We hypothesize that SPB involves aberrant placental RNA expression, and that such RNA transcripts can be detected in predelivery maternal plasma samples, which can be compared with gestational age-matched controls. Principal Findings: Using gene expression microarray to profile essentially all human genes, we observed that 426 probe signals were changed by > 2.9-fold in the SPB placentas, compared with the spontaneous term birth (STB) placentas. Among the genes represented by those probes, we observed an over-representation of functions in RNA stabilization, extracellular matrix binding, and acute inflammatory response. Using RT-quantitative PCR, we observed differences in the RNA concentrations of certain genes only between the SPB and STB placentas, but not between the STB and term elective cesarean delivery placentas. Notably, 36 RNA transcripts were observed at placental microarray signals higher than a threshold, which indicated the possibility of their detection in maternal plasma. Among them, the IL1RL1 mRNA was tested in plasma samples taken from 37 women. It was detected in 6 of 10 (60%) plasma samples collected during the presentation of preterm labor (<= 32.9 weeks) in women eventually giving SPB, but was detected in only 1 of 27 (4%) samples collected during matched gestational weeks from women with no preterm labor (Fisher exact test, p = 0.00056). Conclusion: We have identified 36 SPB-associated RNA transcripts, which are possibly detectable in maternal plasma. We have illustrated that the IL1RL1 mRNA was more frequently detected in predelivery maternal plasma samples collected from women resulting in SPB than the gestational-age matched controls.	[Chim, Stephen S. C.; Lee, Wing S.; Ting, Yuen H.; Chan, Oi K.; Leung, Tak Y.] Chinese Univ Hong Kong, Dept Obstet & Gynaecol, Shatin, Hong Kong, Peoples R China; [Chim, Stephen S. C.] Chinese Univ Hong Kong, Li Ka Shing Inst Hlth Sci, Ctr Res Circulating Fetal Nucle Acids, Shatin, Hong Kong, Peoples R China; [Lee, Wing S.; Lee, Shara W. Y.] Chinese Univ Hong Kong, Dept Chem Pathol, Shatin, Hong Kong, Peoples R China	Chinese University of Hong Kong; Chinese University of Hong Kong; Chinese University of Hong Kong	Chim, SSC (corresponding author), Chinese Univ Hong Kong, Dept Obstet & Gynaecol, Shatin, Hong Kong, Peoples R China.	sschim@cuhk.edu.hk	Chim, Stephen SC/O-6271-2016; Lee, Shara WY/G-1874-2014	Chim, Stephen SC/0000-0002-2152-7050; Lee, Shara WY/0000-0001-5257-2076	Research Grants Council of the Hong Kong Special Administrative Region, China [CUHK4484/06M]; University Grants Committee of the Government of the Hong Kong Special Administrative Region, China [AoE/M-04/06]	Research Grants Council of the Hong Kong Special Administrative Region, China(Hong Kong Research Grants Council); University Grants Committee of the Government of the Hong Kong Special Administrative Region, China	This study was supported by a grant from the Research Grants Council of the Hong Kong Special Administrative Region, China (Project No. CUHK4484/06M) and by the University Grants Committee of the Government of the Hong Kong Special Administrative Region, China, under the Areas of Excellence Scheme (AoE/M-04/06). The funders had no role in study design, data collection and analysis, decision to publish or preparation of the manuscript.	Aidoo M, 2001, GENET EPIDEMIOL, V21, P201, DOI 10.1002/gepi.1029; Amory JH, 2004, AM J OBSTET GYNECOL, V191, P1362, DOI 10.1016/j.ajog.2004.05.067; Annells MF, 2004, AM J OBSTET GYNECOL, V191, P2056, DOI 10.1016/j.ajog.2004.04.021; Ashburner M, 2000, NAT GENET, V25, P25, DOI 10.1038/75556; BENJAMINI Y, 1995, J R STAT SOC B, V57, P289, DOI 10.1111/j.2517-6161.1995.tb02031.x; Bustin SA, 2009, CLIN CHEM, V55, P611, DOI 10.1373/clinchem.2008.112797; Carbon S, 2009, BIOINFORMATICS, V25, P288, DOI 10.1093/bioinformatics/btn615; Chen Dafang, 2003, Beijing Da Xue Xue Bao Yi Xue Ban, V35, P377; Chim SSC, 2005, P NATL ACAD SCI USA, V102, P14753, DOI 10.1073/pnas.0503335102; Chim SSC, 2008, CLIN CHEM, V54, P482, DOI 10.1373/clinchem.2007.097972; Chiu RWK, 2001, CLIN CHEM, V47, P1607; Dennis G, 2003, GENOME BIOL, V4, DOI 10.1186/gb-2003-4-9-r60; Esplin S, 2011, AM J OBSTET GYNECOL, V204, DOI 10.1016/j.ajog.2010.09.021; Goldenberg RL, 2008, LANCET, V371, P75, DOI 10.1016/S0140-6736(08)60074-4; Gravett MG, 2004, JAMA-J AM MED ASSOC, V292, P462, DOI 10.1001/jama.292.4.462; Haataja R, 2011, PLOS GENET, V7, DOI 10.1371/journal.pgen.1001293; Haddad R, 2008, AM J OBSTET GYNECOL, V198, DOI 10.1016/j.ajog.2007.11.021; Hartel C, 2004, MOL HUM REPROD, V10, P911, DOI 10.1093/molehr/gah120; Heung MMS, 2009, PRENATAL DIAG, V29, P277, DOI 10.1002/pd.2191; Hitti J, 2010, AM J OBSTET GYNECOL, V203, DOI 10.1016/j.ajog.2010.03.037; Huang DW, 2009, NAT PROTOC, V4, P44, DOI 10.1038/nprot.2008.211; Iams JD, 1996, NEW ENGL J MED, V334, P567, DOI 10.1056/NEJM199602293340904; Irizarry RA, 2003, BIOSTATISTICS, V4, P249, DOI 10.1093/biostatistics/4.2.249; Kalish RB, 2004, AM J OBSTET GYNECOL, V190, P702, DOI 10.1016/j.ajog.2003.09.066; Li YP, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0007489; Lim LP, 2005, NATURE, V433, P769, DOI 10.1038/nature03315; Lo YMD, 2007, NAT MED, V13, P218, DOI 10.1038/nm1530; LOCKWOOD CJ, 1991, NEW ENGL J MED, V325, P669, DOI 10.1056/NEJM199109053251001; Macones GA, 2004, AM J OBSTET GYNECOL, V190, P1504, DOI 10.1016/j.ajog.2004.01.001; Mayor-Lynn K, 2011, REPROD SCI, V18, P46, DOI 10.1177/1933719110374115; Moore S, 2004, BJOG-INT J OBSTET GY, V111, P125, DOI [10.1046/j.1471-0528.2003.00044.x, 10.1046/j.1471-0528.2003.00024.x-i1]; Ng EKO, 2003, P NATL ACAD SCI USA, V100, P4748, DOI 10.1073/pnas.0637450100; Olson PD, 2011, PLOS PATHOG, V7, DOI 10.1371/journal.ppat.1001287; Pereira L, 2010, AM J OBSTET GYNECOL, V202, DOI 10.1016/j.ajog.2010.02.048; Plunkett J, 2008, ANN MED, V40, P167, DOI 10.1080/07853890701806181; Romero R, 2006, BJOG-INT J OBSTET GY, V113, P17, DOI 10.1111/j.1471-0528.2006.01120.x; Shah SJ, 2009, J PROTEOME RES, V8, P2407, DOI 10.1021/pr8010342; Shankar R, 2010, REPROD SCI, V17, P297, DOI 10.1177/1933719109353454; Simhan HN, 2003, OBSTET GYNECOL, V102, P162, DOI 10.1016/S0029-7844(03)00406-X; Slattery MM, 2002, LANCET, V360, P1489, DOI 10.1016/S0140-6736(02)11476-0; Snegovskikh VV, 2009, REPROD SCI, V16, P767, DOI 10.1177/1933719109336623; Tsui NBY, 2004, J MED GENET, V41, P461, DOI 10.1136/jmg.2003.016881; Tsui NBY, 2002, CLIN CHEM, V48, P1647; Wu WX, 1999, ENDOCRINOLOGY, V140, P2364, DOI 10.1210/en.140.5.2364	44	32	36	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 5	2012	7	4							e34328	10.1371/journal.pone.0034328	http://dx.doi.org/10.1371/journal.pone.0034328			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	955IH	22496790	Green Published, Green Submitted, gold			2022-12-25	WOS:000305010500005
J	Bull, ND; Guidi, A; Goedert, M; Martin, KR; Spillantini, MG				Bull, Natalie D.; Guidi, Alessandra; Goedert, Michel; Martin, Keith R.; Spillantini, Maria Grazia			Reduced Axonal Transport and Increased Excitotoxic Retinal Ganglion Cell Degeneration in Mice Transgenic for Human Mutant P301S Tau	PLOS ONE			English	Article							FRONTOTEMPORAL DEMENTIA; NEUROTROPHIC FACTOR; MOUSE MODEL; PROTEIN; PHOSPHORYLATION; TAUOPATHY; FTDP-17; MUTATIONS; GLAUCOMA; BRAIN	The effects of tau hyperphosphorylation and aggregation on axonal transport were investigated in the optic nerve of mice transgenic for human mutant P301S tau. Transport was examined using cholera toxin B tracing. Retrograde transport was reduced in transgenic mice at 3 and 5 months of age, when compared to C57/Bl6 control mice. Anterograde axonal transport was also reduced in 3-month-old transgenic mice. Mild excitotoxic injury of retinal ganglion cells resulted in greater nerve cell loss in retinas from 3- and 5-month old P301S transgenic mice, when compared to controls. In conjunction with the detection of abnormal tau in the optic nerve in human and experimental glaucoma, the present findings suggest that tau hyperphosphorylation and aggregation may constitute targets for neuroprotective therapies in glaucoma as well as tauopathies.	[Bull, Natalie D.; Guidi, Alessandra; Martin, Keith R.; Spillantini, Maria Grazia] Univ Cambridge, Dept Clin Neurosci, Cambridge Ctr Brain Repair, Cambridge, England; [Martin, Keith R.] Univ Cambridge, Dept Ophthalmol, Cambridge, England; [Martin, Keith R.] Univ Cambridge, Biomed Res Ctr, Cambridge Natl Inst Hlth Res, Cambridge, England; [Goedert, Michel] Med Res Council Lab Mol Biol, Cambridge, England	University of Cambridge; University of Cambridge; University of Cambridge; MRC Laboratory Molecular Biology; UK Research & Innovation (UKRI); Medical Research Council UK (MRC)	Bull, ND (corresponding author), Univ Cambridge, Dept Clin Neurosci, Cambridge Ctr Brain Repair, Cambridge, England.	krgm2@cam.ac.uk; mgs11@cam.ac.uk			Fight for Sight United Kingdom; Cambridge University Hospitals' National Health Services Foundation Trust (Addenbrooke's Hospital); Glaucoma Foundation; Medical Research Council; National Institute for Health Research; Addenbrooke's Research Trust; Alzheimer's Research United Kingdom; MRC [MC_U105184291] Funding Source: UKRI; Alzheimers Research UK [ART-PG2011-20] Funding Source: researchfish; Medical Research Council [MC_U105184291] Funding Source: researchfish	Fight for Sight United Kingdom; Cambridge University Hospitals' National Health Services Foundation Trust (Addenbrooke's Hospital); Glaucoma Foundation; Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); National Institute for Health Research(National Institute for Health Research (NIHR)); Addenbrooke's Research Trust; Alzheimer's Research United Kingdom; MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Alzheimers Research UK(Alzheimer&apos;s Research UK (ARUK)); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission)	Fight for Sight United Kingdom; Cambridge University Hospitals' National Health Services Foundation Trust (Addenbrooke's Hospital); the Glaucoma Foundation; Medical Research Council; National Institute for Health Research; Addenbrooke's Research Trust; Alzheimer's Research United Kingdom. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Allen B, 2002, J NEUROSCI, V22, P9340; Arendt T, J NEUROSCI, V23, P6972; Delobel P, 2008, AM J PATHOL, V172, P123, DOI 10.2353/ajpath.2008.070627; Gasparini L, 2011, NEUROBIOL AGING, V32, P419, DOI 10.1016/j.neurobiolaging.2009.03.002; Goedert M, 1999, FEBS LETT, V450, P306, DOI 10.1016/S0014-5793(99)00508-6; GOEDERT M, 1993, P NATL ACAD SCI USA, V90, P5066, DOI 10.1073/pnas.90.11.5066; Goedert M, 2006, SCIENCE, V314, P777, DOI 10.1126/science.1132814; Gupta N, 2008, CAN J OPHTHALMOL, V43, P53, DOI 10.3129/i07-185; Hasegawa M, 1996, FEBS LETT, V384, P25, DOI 10.1016/0014-5793(96)00271-2; Hong M, 1998, SCIENCE, V282, P1914, DOI 10.1126/science.282.5395.1914; Hutton M, 1998, NATURE, V393, P702, DOI 10.1038/31508; Ishihara T, 1999, NEURON, V24, P751, DOI 10.1016/S0896-6273(00)81127-7; Ittner LM, 2008, P NATL ACAD SCI USA, V105, P15997, DOI 10.1073/pnas.0808084105; Kanaan NM, 2011, J NEUROSCI, V31, P9858, DOI 10.1523/JNEUROSCI.0560-11.2011; Ko ML, 2001, NEUROSCI LETT, V305, P139, DOI 10.1016/S0304-3940(01)01830-4; LaPointe NE, 2009, J NEUROSCI RES, V87, P440, DOI 10.1002/jnr.21850; Magnani E, 2007, EMBO J, V26, P4546, DOI 10.1038/sj.emboj.7601878; Mandell JW, 1996, J NEUROSCI, V16, P5727; Martin KRG, 2006, EXP EYE RES, V83, P255, DOI 10.1016/j.exer.2005.11.025; Martin KRG, 2003, INVEST OPHTH VIS SCI, V44, P4357, DOI 10.1167/iovs.02-1332; Morfini G, 2007, J NEUROSCI RES, V85, P2620, DOI 10.1002/jnr.21154; Nacharaju P, 1999, FEBS LETT, V447, P195, DOI 10.1016/S0014-5793(99)00294-X; Nakanishi N, 2009, J NEUROSCI, V29, P5260, DOI 10.1523/JNEUROSCI.1067-09.2009; Pease ME, 2000, INVEST OPHTH VIS SCI, V41, P764; Poorkaj P, 1998, ANN NEUROL, V43, P815, DOI 10.1002/ana.410430617; Probst A, 2000, ACTA NEUROPATHOL, V99, P469, DOI 10.1007/s004010051148; Saxena S, 2011, NEURON, V71, P35, DOI 10.1016/j.neuron.2011.06.031; Spillantini MG, 1998, P NATL ACAD SCI USA, V95, P7737, DOI 10.1073/pnas.95.13.7737; Spittaels K, 1999, AM J PATHOL, V155, P2153, DOI 10.1016/S0002-9440(10)65533-2; Stamer K, 2002, J CELL BIOL, V156, P1051, DOI 10.1083/jcb.200108057; Utton MA, 2002, J NEUROSCI, V22, P6394; Velasco A, 2008, FEBS LETT, V582, P901, DOI 10.1016/j.febslet.2008.02.025; Yuan A, 2008, J NEUROSCI, V28, P1682, DOI 10.1523/JNEUROSCI.5242-07.2008; Zhang B, 2004, J NEUROSCI, V24, P4657, DOI 10.1523/JNEUROSCI.0797-04.2004	34	44	45	0	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 4	2012	7	4							e34724	10.1371/journal.pone.0034724	http://dx.doi.org/10.1371/journal.pone.0034724			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	953GO	22496848	Green Published, gold, Green Submitted			2022-12-25	WOS:000304855200071
J	Garcia-Rodriguez, N; de la Loza, MDD; Andreson, B; Monje-Casas, F; Rothstein, R; Wellinger, RE				Garcia-Rodriguez, Nestor; Diaz de la Loza, Maria del Carmen; Andreson, Bethany; Monje-Casas, Fernando; Rothstein, Rodney; Erik Wellinger, Ralf			Impaired Manganese Metabolism Causes Mitotic Misregulation	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							YEAST SACCHAROMYCES-CEREVISIAE; HAILEY-HAILEY-DISEASE; CELL-CYCLE CONTROL; BUDDING YEAST; SECRETORY PATHWAY; DNA-REPLICATION; S-PHASE; PROTEIN-KINASE; ION-PUMP; GOLGI CA2+/MN2+-ATPASE	Manganese is an essential trace element, whose intracellular levels need to be carefully regulated. Mn2+ acts as a cofactor for many enzymes and excess of Mn2+ is toxic. Alterations in Mn2+ homeostasis affect metabolic functions and mutations in the human Mn2+/Ca2+ transporter ATP2C1 have been linked to Hailey-Hailey disease. By deletion of the yeast orthologue PMR1 we have studied the impact of Mn2+ on cell cycle progression and show that an excess of cytosolic Mn2+ alters S-phase transit, induces transcriptional up-regulation of cell cycle regulators, bypasses the need for S-phase cell cycle checkpoints and predisposes to genomic instability. On the other hand, we find that depletion of the Golgi Mn2+ pool requires a functional morphology checkpoint to avoid the formation of polyploid cells.	[Erik Wellinger, Ralf] Univ Seville, CSIC, Ctr Andaluz Biol Mol & Med Regenerat CABIMER, Dept Mol Biol, Seville 41092, Spain; [Andreson, Bethany] Columbia Univ, Dept Biol Sci, New York, NY 10027 USA; [Rothstein, Rodney] Columbia Univ, Med Ctr, Dept Genet & Dev, New York, NY 10032 USA	Consejo Superior de Investigaciones Cientificas (CSIC); Universidad Pablo de Olavide; University of Sevilla; CSIC - Centro Andaluz de Biologia Molecular y Medicina Regenerativa (CABIMER); Columbia University; Columbia University	Wellinger, RE (corresponding author), Univ Seville, CSIC, Ctr Andaluz Biol Mol & Med Regenerat CABIMER, Dept Mol Biol, Av Amer Vespucio S-N, Seville 41092, Spain.	ralf.wellinger@cabimer.es	Díaz de la Loza, María del Carmen/C-6229-2015; Monje-Casas, Fernando/M-3062-2014; García-Rodríguez, Néstor/AAH-1450-2019; Wellinger, Ralf Erik/L-8463-2014	Díaz de la Loza, María del Carmen/0000-0002-9212-6190; Monje-Casas, Fernando/0000-0002-3587-2373; Garcia Rodriguez, Nestor/0000-0002-4049-1604; Wellinger, Ralf Erik/0000-0002-4421-6618; Rothstein, Rodney/0000-0002-4107-9654	National Institutes of Health [GM50237]; Spanish Ministry of Science and Innovation [BIO2006-08051, BFU2010-21339]; Junta de Andalucia [P08-CTS-04297]; University of Seville/El Monte Foundation; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R37GM050237, R01GM050237] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Spanish Ministry of Science and Innovation(Ministry of Science and Innovation, Spain (MICINN)Spanish Government); Junta de Andalucia(Junta de Andalucia); University of Seville/El Monte Foundation; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported, in whole or in part, by grants from the National Institutes of Health (GM50237) (to R. R.), the Spanish Ministry of Science and Innovation (BIO2006-08051 and BFU2010-21339), and the Junta de Andalucia (P08-CTS-04297) (to R. E. W.).; Recipient of a pre-doctoral training grant from the University of Seville/El Monte Foundation.	ANTEBI A, 1992, MOL BIOL CELL, V3, P633, DOI 10.1091/mbc.3.6.633; Bartholomew CR, 2001, MOL CELL BIOL, V21, P4949, DOI 10.1128/MCB.21.15.4949-4959.2001; BECKMAN RA, 1985, BIOCHEMISTRY-US, V24, P5810, DOI 10.1021/bi00342a019; Bloom J, 2007, NAT REV MOL CELL BIO, V8, P149, DOI 10.1038/nrm2105; Bolton EC, 2002, MOL CELL, V9, P879, DOI 10.1016/S1097-2765(02)00495-1; BOOHER RN, 1993, EMBO J, V12, P3417, DOI 10.1002/j.1460-2075.1993.tb06016.x; Clotet J, 2006, EMBO J, V25, P2338, DOI 10.1038/sj.emboj.7601095; Cope MJTV, 1999, J CELL BIOL, V144, P1203, DOI 10.1083/jcb.144.6.1203; Couper J., 1837, BR ANN MED PHARM, V1, P41, DOI DOI 10.1002/JCP.22692; Crowley JD, 2000, MET IONS BIOL SYST, V37, P209; Desany BA, 1998, GENE DEV, V12, P2956, DOI 10.1101/gad.12.18.2956; Devasahayam G, 2006, P NATL ACAD SCI USA, V103, P17840, DOI 10.1073/pnas.0604303103; Donaldson AD, 1998, MOL CELL, V2, P173, DOI 10.1016/S1097-2765(00)80127-6; Durr G, 1998, MOL BIOL CELL, V9, P1149, DOI 10.1091/mbc.9.5.1149; FOIANI M, 1994, MOL CELL BIOL, V14, P923, DOI 10.1128/MCB.14.2.923; Garcia R, 2004, J BIOL CHEM, V279, P15183, DOI 10.1074/jbc.M312954200; Harvey SL, 2003, CURR BIOL, V13, P264, DOI 10.1016/S0960-9822(03)00049-6; Hu FF, 2005, P NATL ACAD SCI USA, V102, P8910, DOI 10.1073/pnas.0406987102; Hu ZL, 2000, NAT GENET, V24, P61, DOI 10.1038/71701; Jaag HM, 2010, CELL HOST MICROBE, V7, P74, DOI 10.1016/j.chom.2009.12.009; Jordan PW, 2007, PLOS GENET, V3, P2368, DOI 10.1371/journal.pgen.0030222; KAUFMAN RJ, 1994, BIOCHEMISTRY-US, V33, P9813, DOI 10.1021/bi00199a001; Keen CL, 2000, MET IONS BIOL SYST, V37, P89; Kozminski KG, 2003, MOL BIOL CELL, V14, P4958, DOI 10.1091/mbc.E03-06-0426; LAPINSKAS PJ, 1995, MOL CELL BIOL, V15, P1382; Lew DJ, 2000, CURR OPIN GENET DEV, V10, P47, DOI 10.1016/S0959-437X(99)00051-9; LEW DJ, 1995, CURR OPIN GENET DEV, V5, P17, DOI 10.1016/S0959-437X(95)90048-9; LEW DJ, 1995, J CELL BIOL, V129, P739, DOI 10.1083/jcb.129.3.739; Lin SJ, 1996, MOL CELL BIOL, V16, P6303; Lippincott J, 1998, J CELL BIOL, V143, P1947, DOI 10.1083/jcb.143.7.1947; Lisby M, 2001, P NATL ACAD SCI USA, V98, P8276, DOI 10.1073/pnas.121006298; Longtine MS, 1998, YEAST, V14, P953, DOI 10.1002/(SICI)1097-0061(199807)14:10<953::AID-YEA293>3.3.CO;2-L; Lopes M, 2001, NATURE, V412, P557, DOI 10.1038/35087613; Losev E, 2008, MOL CELL BIOL, V28, P3336, DOI 10.1128/MCB.00567-07; LOUKIN S, 1995, J CELL BIOL, V131, P1025, DOI 10.1083/jcb.131.4.1025; Lucchini RG, 2009, NEUROMOL MED, V11, P311, DOI 10.1007/s12017-009-8108-8; Lue NF, 2005, P NATL ACAD SCI USA, V102, P9778, DOI 10.1073/pnas.0502252102; Mandal D, 2000, J BIOL CHEM, V275, P23933, DOI 10.1074/jbc.M002619200; McNulty JJ, 2005, CURR BIOL, V15, P2190, DOI 10.1016/j.cub.2005.11.039; Mendenhall MD, 1998, MICROBIOL MOL BIOL R, V62, P1191, DOI 10.1128/MMBR.62.4.1191-1243.1998; Mohr MR, 2011, ARCH DERMATOL, V147, P211, DOI 10.1001/archdermatol.2010.445; Mondesert G, 1996, J CELL BIOL, V132, P137, DOI 10.1083/jcb.132.1.137; Mondesert G, 1997, GENETICS, V147, P421; Monje-Casas F, 2009, DEV CELL, V16, P132, DOI 10.1016/j.devcel.2008.11.002; Okunade GW, 2007, J BIOL CHEM, V282, DOI 10.1074/jbc.M703029200; Paidhungat M, 1998, GENETICS, V148, P1777; Pan XW, 2006, CELL, V124, P1069, DOI 10.1016/j.cell.2005.12.036; Pellicioli A, 1999, EMBO J, V18, P6561, DOI 10.1093/emboj/18.22.6561; Pittman JK, 2004, MOL MICROBIOL, V54, P1104, DOI 10.1111/j.1365-2958.2004.04332.x; Poletto NP, 2010, ARCH MICROBIOL, V192, P247, DOI 10.1007/s00203-010-0553-0; PRINGLE JR, 1991, METHOD ENZYMOL, V194, P732; Rayner JC, 1998, J BIOL CHEM, V273, P26836, DOI 10.1074/jbc.273.41.26836; Reddi AR, 2009, FREE RADICAL BIO MED, V46, P154, DOI 10.1016/j.freeradbiomed.2008.09.032; Rice LM, 2005, EUKARYOT CELL, V4, P55, DOI 10.1128/EC.4.1.55-62.2005; Ringvoll J, 2007, FEMS YEAST RES, V7, P848, DOI 10.1111/j.1567-1364.2007.00248.x; RUDOLPH HK, 1989, CELL, V58, P133, DOI 10.1016/0092-8674(89)90410-8; Santocanale C, 1998, NATURE, V395, P615, DOI 10.1038/27001; SCHWOB E, 1993, GENE DEV, V7, P1160, DOI 10.1101/gad.7.7a.1160; Sia RAL, 1996, MOL BIOL CELL, V7, P1657, DOI 10.1091/mbc.7.11.1657; Storici F, 2006, METHOD ENZYMOL, V409, P329, DOI 10.1016/S0076-6879(05)09019-1; Suter B, 2004, GENETICS, V167, P579, DOI 10.1534/genetics.103.024851; Ton VK, 2002, J BIOL CHEM, V277, P6422, DOI 10.1074/jbc.M110612200; Valerio-Santiago M, 2011, J CELL BIOL, V192, P599, DOI 10.1083/jcb.201007044; Wei Y, 1999, BIOCHEMISTRY-US, V38, P14534, DOI 10.1021/bi9911233; Wellinger RE, 2003, MOL CELL BIOL, V23, P6363, DOI 10.1128/MCB.23.18.6363-6372.2003; Wiggins CAR, 1998, P NATL ACAD SCI USA, V95, P7945, DOI 10.1073/pnas.95.14.7945; Yaakov G, 2009, MOL BIOL CELL, V20, P3572, DOI 10.1091/mbc.E09-02-0129; Yuen KWY, 2007, P NATL ACAD SCI USA, V104, P3925, DOI 10.1073/pnas.0610642104; Zewail A, 2003, P NATL ACAD SCI USA, V100, P3345, DOI 10.1073/pnas.0530118100; ZHOU Z, 1993, CELL, V75, P1119, DOI 10.1016/0092-8674(93)90321-G; Zou J, 2009, MOL BIOL CELL, V20, P3239, DOI 10.1091/mbc.E08-12-1255	71	9	10	0	4	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAY 25	2012	287	22					18717	18729		10.1074/jbc.M112.358309	http://dx.doi.org/10.1074/jbc.M112.358309			13	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	974EC	22493290	hybrid, Green Published			2022-12-25	WOS:000306411600080
J	Kita, K; Suzuki, T; Ochi, T				Kita, Kayoko; Suzuki, Toshihide; Ochi, Takafumi			Diphenylarsinic Acid Promotes Degradation of Glutaminase C by Mitochondrial Lon Protease	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							ATP-DEPENDENT PROTEASE; PHOSPHATE-ACTIVATED GLUTAMINASE; PARAPLEGIN-RELATED GENE; MISFOLDED PROTEINS; SUBSTRATE PROTEINS; ESCHERICHIA-COLI; PIM1 PROTEASE; IDENTIFICATION; PROTEOLYSIS; EXPRESSION	Glutaminase C (GAC), a splicing variant of the kidney-type glutaminase (KGA) gene, is a vital mitochondrial enzyme protein that catalyzes glutamine to glutamate. Earlier studies have shown that GAC proteins in the human hepatocarcinoma cell line, HepG2, were down-regulated by diphenylarsinic acid (DPAA), but the mechanism by which DPAA induced GAC protein down-regulation remained poorly understood. Here, we showed that DPAA promoted GAC protein degradation without affecting GAC transcription and translation. Moreover, DPAA-induced GAC proteolysis was mediated by mitochondrial Lon protease. DPAA insolubilized 0.5% Triton X-100-soluble GAC protein and promoted the accumulation of insoluble GAC in Lon protease knockdown cells. DPAA destroyed the native tetrameric GAC conformation and promoted an increase in the unassembled form of GAC when DPAA was incubated with cell extracts. Decreases in the tetrameric form of GAC were observed in cells exposed to DPAA, and decreases occurred prior to a decrease in total GAC protein levels. In addition, decreases in the tetrameric form of GAC were observed independently with Lon protease. Mitochondrial heat shock protein 70 is known to be an indispensable protein that can bind to misfolded proteins, thereby supporting degradation of proteins sensitive to Lon protease. When cells were incubated with DPAA, GAC proteins that can bind with mtHsp70 increased. Interestingly, the association of mtHsp70 with GAC protein increased when the tetrameric form of GAC was reduced. These results suggest that degradation of native tetrameric GAC by DPAA may be a trigger in GAC protein degradation by Lon protease.	[Kita, Kayoko; Suzuki, Toshihide; Ochi, Takafumi] Teikyo Univ, Fac Pharmasci, Toxicol Lab, Itabashi Ku, Tokyo 1738605, Japan	Teikyo University	Kita, K (corresponding author), Teikyo Univ, Fac Pharmasci, Toxicol Lab, Itabashi Ku, 2-11-1 Kaga, Tokyo 1738605, Japan.	kkayoko@pharm.teikyo-u.ac.jp			Ministry of Education, Culture, Sports, Science, and Technology (MEXT) of Japan [20790113]	Ministry of Education, Culture, Sports, Science, and Technology (MEXT) of Japan(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT))	This work was supported by Grant-in-aid for Young Scientists (B) 20790113 from the Ministry of Education, Culture, Sports, Science, and Technology (MEXT) of Japan.	Aledo JC, 2000, MAMM GENOME, V11, P1107, DOI 10.1007/s003350010190; Banfi S, 1999, GENOMICS, V59, P51, DOI 10.1006/geno.1999.5818; Bayot A, 2008, BIOCHIMIE, V90, P260, DOI 10.1016/j.biochi.2007.10.010; Bayot A, 2010, J BIOL CHEM, V285, P11445, DOI 10.1074/jbc.M109.065425; Bota DA, 2002, NAT CELL BIOL, V4, P674, DOI 10.1038/ncb836; CHUNG CH, 1981, P NATL ACAD SCI-BIOL, V78, P4931, DOI 10.1073/pnas.78.8.4931; Coppola M, 2000, GENOMICS, V66, P48, DOI 10.1006/geno.2000.6136; CURTHOYS NP, 1995, ANNU REV NUTR, V15, P133, DOI 10.1146/annurev.nu.15.070195.001025; Elgadi KM, 1999, PHYSIOL GENOMICS, V1, P51, DOI 10.1152/physiolgenomics.1999.1.2.51; Frase H, 2006, BIOCHEMISTRY-US, V45, P8264, DOI 10.1021/bi060542e; Fukuda R, 2007, CELL, V129, P111, DOI 10.1016/j.cell.2007.01.047; Gao P, 2009, NATURE, V458, P762, DOI 10.1038/nature07823; Gottesman S, 2003, ANNU REV CELL DEV BI, V19, P565, DOI 10.1146/annurev.cellbio.19.110701.153228; Granot Z, 2003, MOL ENDOCRINOL, V17, P2461, DOI 10.1210/me.2003-0074; Granot Z, 2007, MOL ENDOCRINOL, V21, P2164, DOI 10.1210/me.2005-0458; Guillon B, 2009, FEBS J, V276, P1036, DOI 10.1111/j.1742-4658.2008.06847.x; Gur E, 2008, GENE DEV, V22, P2267, DOI 10.1101/gad.1670908; HASER WG, 1985, BIOCHEM J, V229, P399, DOI 10.1042/bj2290399; Holcomb T, 2000, MOL BRAIN RES, V76, P56, DOI 10.1016/S0169-328X(99)00331-9; Hori O, 2002, J CELL BIOL, V157, P1151, DOI 10.1083/jcb.200108103; Ishii K, 2004, ANN NEUROL, V56, P741, DOI 10.1002/ana.20290; Kang SG, 2005, J BIOL CHEM, V280, P35424, DOI 10.1074/jbc.M507240200; Kang SG, 2002, J BIOL CHEM, V277, P21095, DOI 10.1074/jbc.M201642200; Kita K, 2007, TOXICOL APPL PHARM, V220, P262, DOI 10.1016/j.taap.2007.01.009; KUZELA S, 1994, METHOD ENZYMOL, V244, P376; Lee I, 2008, BBA-PROTEINS PROTEOM, V1784, P727, DOI 10.1016/j.bbapap.2008.02.010; Major T, 2006, MOL CELL BIOL, V26, P762, DOI 10.1128/MCB.26.3.762-776.2006; Masson J, 2006, J NEUROSCI, V26, P4660, DOI 10.1523/JNEUROSCI.4241-05.2006; Ngo JK, 2009, FREE RADICAL BIO MED, V46, P1042, DOI 10.1016/j.freeradbiomed.2008.12.024; Ogura T, 2001, GENES CELLS, V6, P575, DOI 10.1046/j.1365-2443.2001.00447.x; Porter LD, 2002, PHYSIOL GENOMICS, V9, P157, DOI 10.1152/physiolgenomics.00017.2002; Roberg B, 2000, AM J PHYSIOL-CELL PH, V279, pC648, DOI 10.1152/ajpcell.2000.279.3.C648; Rotanova TV, 2004, EUR J BIOCHEM, V271, P4865, DOI 10.1111/j.1432-1033.2004.04452.x; Savel'ev AS, 1998, J BIOL CHEM, V273, P20596, DOI 10.1074/jbc.273.32.20596; SHINEBERG B, 1973, J BACTERIOL, V116, P1469, DOI 10.1128/JB.116.3.1469-1471.1973; SRINIVASAN M, 1995, J BIOL CHEM, V270, P1185, DOI 10.1074/jbc.270.3.1185; SRINIVASAN M, 1995, J BIOL CHEM, V270, P1191, DOI 10.1074/jbc.270.3.1191; Sullivan JM, 2000, LEARN MEMORY, V7, P132, DOI 10.1101/lm.7.3.132; Tsilibaris V, 2006, RES MICROBIOL, V157, P701, DOI 10.1016/j.resmic.2006.05.004; von Janowsky B, 2005, BIOL CHEM, V386, P1307, DOI 10.1515/BC.2005.149; WAGNER I, 1994, EMBO J, V13, P5135, DOI 10.1002/j.1460-2075.1994.tb06843.x; Yu AYH, 2007, FEBS LETT, V581, P3749, DOI 10.1016/j.febslet.2007.04.076; Zhao Q, 2002, EMBO J, V21, P4411, DOI 10.1093/emboj/cdf445	44	32	34	0	22	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAY 25	2012	287	22					18163	18172		10.1074/jbc.M112.362699	http://dx.doi.org/10.1074/jbc.M112.362699			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	974EC	22493432	hybrid, Green Published			2022-12-25	WOS:000306411600024
J	Qi, XJ; Sandmeyer, S				Qi, Xiaojie; Sandmeyer, Suzanne			In Vitro Targeting of Strand Transfer by the Ty3 Retroelement Integrase	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							RNA-POLYMERASE-III; TRANSCRIPTION FACTOR IIIB; TATA-BINDING PROTEIN; POSITION-SPECIFIC INTEGRATION; HIV-1 INTEGRASE; YEAST RETROTRANSPOSON; DNA; INITIATION; ELEMENT; GENES	The Saccharomyces cerevisiae long terminal repeat retrotransposon Ty3 integrates within one or two nucleotides of the transcription initiation sites of genes transcribed by RNA polymerase III. In this study the minimal components required to re-constitute position-specific strand transfer by Ty3 integrase are defined. Ty3 integrase targeted by a synthetic fusion of RNA polymerase III transcription factor IIIB subunits, Brf1 and TBP, mediated position-specific strand transfer of duplex oligonucleotides representing the ends of the Ty3 cDNA. These results further delimit the TFIIIB domains targeted by the Ty3 element and show that IN is the Ty3 component sufficient in vitro to target integration. These results underscore the com-monality of protein interactions that mediate transcription and retrotransposon targeting. Surprisingly, in the presence of MnCl2, strand transfer was TFIIIB-independent and targeted sequences resembling the Ty3 terminal inverted repeat.	[Qi, Xiaojie; Sandmeyer, Suzanne] Univ Calif Irvine, Dept Biol Chem, Irvine, CA 92697 USA; [Sandmeyer, Suzanne] Univ Calif Irvine, Inst Genom & Bioinformat, Irvine, CA 92697 USA	University of California System; University of California Irvine; University of California System; University of California Irvine	Sandmeyer, S (corresponding author), Univ Calif Irvine, Dept Biol Chem, Irvine, CA 92697 USA.	sbsandme@uci.edu			National Institutes of Health Public Service [GM33281]; NSF [0450159]; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM033281] Funding Source: NIH RePORTER	National Institutes of Health Public Service(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NSF(National Science Foundation (NSF)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported, in whole or in part, by funds from the National Institutes of Health Public Service Grant GM33281 and NSF Grant ID 0450159 (to S. S.).	AUSUBEL FM, 2007, CURRENT PROTOCOLS MO; Beauregard A, 2008, ANNU REV GENET, V42, P587, DOI 10.1146/annurev.genet.42.110807.091549; Bushman F, 2005, NAT REV MICROBIOL, V3, P848, DOI 10.1038/nrmicro1263; BUSHMAN FD, 1991, P NATL ACAD SCI USA, V88, P1339, DOI 10.1073/pnas.88.4.1339; CHALKER DL, 1992, GENE DEV, V6, P117, DOI 10.1101/gad.6.1.117; Cherepanov P, 2005, P NATL ACAD SCI USA, V102, P17308, DOI 10.1073/pnas.0506924102; Chung T, 2007, MOL CELL BIOL, V27, P8492, DOI 10.1128/MCB.01173-07; Clemens K, 2011, J VIROL, V85, P3055, DOI 10.1128/JVI.01055-10; Delelis O, 2010, BBA-GENE REGUL MECH, V1799, P207, DOI 10.1016/j.bbagrm.2009.08.005; Devine SE, 1996, GENE DEV, V10, P620, DOI 10.1101/gad.10.5.620; Esposito D, 1998, EMBO J, V17, P5832, DOI 10.1093/emboj/17.19.5832; HANSEN LJ, 1988, MOL CELL BIOL, V8, P5245, DOI 10.1128/MCB.8.12.5245; HICKMAN AB, 1994, J BIOL CHEM, V269, P29279; Hizi A, 2005, J BIOL CHEM, V280, P39086, DOI 10.1074/jbc.M506363200; Kassavetis GA, 2006, BIOCHEM SOC T, V34, P1082, DOI 10.1042/BST0341082; Kassavetis GA, 2005, P NATL ACAD SCI USA, V102, P15406, DOI 10.1073/pnas.0507653102; Kassavetis GA, 1999, EMBO J, V18, P5042, DOI 10.1093/emboj/18.18.5042; Kassavetis GA, 1998, P NATL ACAD SCI USA, V95, P9196, DOI 10.1073/pnas.95.16.9196; Kirchner J, 1996, J VIROL, V70, P4737, DOI 10.1128/JVI.70.7.4737-4747.1996; KIRCHNER J, 1995, SCIENCE, V267, P1488, DOI 10.1126/science.7878467; Lange HC, 2001, BIOTECHNOL BIOENG, V75, P334, DOI 10.1002/bit.10054; Larsen Liza S Z, 2008, Int J Bioinform Res Appl, V4, P324, DOI 10.1504/IJBRA.2008.019578; Leem YE, 2008, MOL CELL, V30, P98, DOI 10.1016/j.molcel.2008.02.016; Llano M, 2006, SCIENCE, V314, P461, DOI 10.1126/science.1132319; Maertens G, 2003, J BIOL CHEM, V278, P33528, DOI 10.1074/jbc.M303594200; Maertens GN, 2010, NATURE, V468, P326, DOI 10.1038/nature09517; Malik HS, 1999, J VIROL, V73, P5186, DOI 10.1128/JVI.73.6.5186-5190.1999; MARGOTTIN F, 1991, SCIENCE, V251, P424, DOI 10.1126/science.1989075; Peterson-Burch BD, 2004, GENOME BIOL, V5, DOI 10.1186/gb-2004-5-10-r78; Qi XJ, 2012, GENOME RES, V22, P681, DOI 10.1101/gr.131219.111; Sandmeyer S.B., 2002, MOBILE DNA-UK, P663; SHARON G, 1994, MOL CELL BIOL, V14, P6540, DOI 10.1128/MCB.14.10.6540; Van Maele B, 2006, TRENDS BIOCHEM SCI, V31, P98, DOI 10.1016/j.tibs.2005.12.002; WHITEHALL SK, 1995, GENE DEV, V9, P2974, DOI 10.1101/gad.9.23.2974; Winckler T, 2005, CYTOGENET GENOME RES, V110, P288, DOI 10.1159/000084961; Xie WW, 2001, MOL CELL BIOL, V21, P6606, DOI 10.1128/MCB.21.19.6606-6614.2001; Yieh L, 2000, J BIOL CHEM, V275, P29800, DOI 10.1074/jbc.M003149200; Yieh L, 2002, J BIOL CHEM, V277, P25920, DOI 10.1074/jbc.M202729200; Zhou HB, 2001, J VIROL, V75, P1359, DOI 10.1128/JVI.75.3.1359-1370.2001; Zhu YX, 2003, P NATL ACAD SCI USA, V100, P5891, DOI 10.1073/pnas.1036705100; ZOU S, 1995, P NATL ACAD SCI USA, V92, P920, DOI 10.1073/pnas.92.3.920	41	17	18	0	0	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258			J BIOL CHEM	J. Biol. Chem.	MAY 25	2012	287	22					18589	18595		10.1074/jbc.M111.326025	http://dx.doi.org/10.1074/jbc.M111.326025			7	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	974EC	22493285	Green Published, hybrid			2022-12-25	WOS:000306411600069
J	Tapken, W; Ravet, K; Pilon, M				Tapken, Wiebke; Ravet, Karl; Pilon, Marinus			Plastocyanin Controls the Stabilization of the Thylakoid Cu-transporting P-type ATPase PAA2/HMA8 in Response to Low Copper in Arabidopsis	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							WILSONS-DISEASE PROTEIN; SUPEROXIDE-DISMUTASE; GENE-EXPRESSION; HOMEOSTASIS; CHLOROPLASTS; THALIANA; DEGRADATION; PHOTOSYNTHESIS; CHLOROPHYLL; TOLERANCE	PAA2/HMA8 (P-type ATPase of Arabidopsis/Heavy-metal-associated 8) is a thylakoid located copper (Cu)-transporter in Arabidopsis thaliana. In tandem with PAA1/HMA6, which is located in the inner chloroplast envelope, it supplies Cu to plastocyanin (PC), an essential cuproenzyme of the photosynthetic machinery. We investigated whether the chloroplast Cu transporters are affected by Cu addition to the growth media. Immu-noblots showed that PAA2 protein abundance decreased significantly and specifically when Cu in the media was increased, while PAA1 remained unaffected. The function of SPL7, the transcriptional regulator of Cu homeostasis, was not required for this regulation of PAA2 protein abundance and Cu addition did not affect PAA2 transcript levels, as determined by qRT-PCR. We used the translational inhibitor cycloheximide to analyze turnover and observed that the stability of the PAA2 protein was decreased in plants grown with elevated Cu. Interestingly, PAA2 protein abundance was significantly increased in paa1 mutants, in which the Cu content in the chloroplast is half of that of the wild-type, due to impaired Cu import into the organ-elle. In contrast in a pc2 insertion mutant, which has strongly reduced plastocyanin expression, the PAA2 protein levels were low regardless of Cu addition to the growth media. Together, these data indicate that plastid Cu levels control PAA2 stability and that plastocyanin, which is the target of PAA2 mediated Cu delivery in thylakoids, is a major determinant of this regulatory mechanism.	[Pilon, Marinus] Colorado State Univ, Dept Biol, Ft Collins, CO 80523 USA; Colorado State Univ, Program Mol Plant Biol, Ft Collins, CO 80523 USA	Colorado State University; Colorado State University	Pilon, M (corresponding author), Colorado State Univ, Dept Biol, 200 W Lake St,1878 Campus Delivery, Ft Collins, CO 80523 USA.	pilon@lamar.colostate.edu	Ravet, Karl/AHD-6431-2022		United States National Science Foundation [IOS-0847442, MCB 0950726]; European-FP7-International Outgoing Fellowship (Marie Curie, IntegrRegulFeSPlast) [PIOF-GA-2010-273586]; Div Of Molecular and Cellular Bioscience [0950726] Funding Source: National Science Foundation	United States National Science Foundation(National Science Foundation (NSF)); European-FP7-International Outgoing Fellowship (Marie Curie, IntegrRegulFeSPlast); Div Of Molecular and Cellular Bioscience(National Science Foundation (NSF)NSF - Directorate for Biological Sciences (BIO))	This work was supported by the United States National Science Foundation (Grant Numbers IOS-0847442 and MCB 0950726).; Supported by a European-FP7-International Outgoing Fellowship (Marie Curie, IntegrRegulFeSPlast; PIOF-GA-2010-273586).	Abdel-Ghany SE, 2008, J BIOL CHEM, V283, P15932, DOI 10.1074/jbc.M801406200; Abdel-Ghany SE, 2009, PLANTA, V229, P767, DOI 10.1007/s00425-008-0869-z; Abdel-Ghany SE, 2005, PLANT PHYSIOL, V138, P161, DOI 10.1104/pp.104.058602; Abdel-Ghany SE, 2005, PLANT CELL, V17, P1233, DOI 10.1105/tpc.104.030452; Adle DJ, 2008, J BIOL CHEM, V283, P31460, DOI 10.1074/jbc.M806054200; Adle DJ, 2009, P NATL ACAD SCI USA, V106, P10189, DOI 10.1073/pnas.0812114106; Arnaud N, 2006, J BIOL CHEM, V281, P23579, DOI 10.1074/jbc.M602135200; Arrivault S, 2006, PLANT J, V46, P861, DOI 10.1111/j.1365-313X.2006.02746.x; BRUINSMA J, 1961, BIOCHIM BIOPHYS ACTA, V52, P576, DOI 10.1016/0006-3002(61)90418-8; Burkhead JL, 2009, NEW PHYTOL, V182, P799, DOI 10.1111/j.1469-8137.2009.02846.x; Catty P, 2011, J BIOL CHEM, V286, P36188, DOI 10.1074/jbc.M111.241034; Chu CC, 2005, PLANT PHYSIOL, V139, P425, DOI 10.1104/pp.105.065284; Cohu CM, 2009, MOL PLANT, V2, P1336, DOI 10.1093/mp/ssp084; Fitzpatrick LM, 2001, PLANT J, V27, P59, DOI 10.1046/j.0960-7412.2001.01061.x; Jarvis P, 2008, NEW PHYTOL, V179, P257, DOI 10.1111/j.1469-8137.2008.02452.x; Kieselbach T, 2000, FEBS LETT, V480, P271, DOI 10.1016/S0014-5793(00)01890-1; Kliebenstein DJ, 1998, PLANT PHYSIOL, V118, P637, DOI 10.1104/pp.118.2.637; Kupper H, 2003, FUNCT PLANT BIOL, V30, P1187, DOI 10.1071/FP03129; La Fontaine S, 2007, ARCH BIOCHEM BIOPHYS, V463, P149, DOI 10.1016/j.abb.2007.04.021; MCCORD JM, 1969, J BIOL CHEM, V244, P6049; MURASHIGE T, 1962, PHYSIOL PLANTARUM, V15, P473, DOI 10.1111/j.1399-3054.1962.tb08052.x; Pesaresi P, 2009, MOL PLANT, V2, P236, DOI 10.1093/mp/ssn041; Ravet K, 2011, PLANT PHYSIOL, V157, P1300, DOI 10.1104/pp.111.183350; Remans T, 2008, PLANTA, V227, P1343, DOI 10.1007/s00425-008-0706-4; Sancenon V, 2003, PLANT MOL BIOL, V51, P577, DOI 10.1023/A:1022345507112; Shikanai T, 2003, PLANT CELL, V15, P1333, DOI 10.1105/tpc.011817; Singleton WCJ, 2010, J BIOL CHEM, V285, P27111, DOI 10.1074/jbc.M110.154468; Vanderwerf SM, 2002, BIOCHEM SOC T, V30, P739, DOI 10.1042/bst0300739; Vanderwerf SM, 2001, J BIOL CHEM, V276, P36289, DOI 10.1074/jbc.M102055200; Varkonyi-Gasic E, 2007, PLANT METHODS, V3, DOI 10.1186/1746-4811-3-12; Wangeline AL, 2004, J ENVIRON QUAL, V33, P54, DOI 10.2134/jeq2004.0054; Weigel M, 2003, J BIOL CHEM, V278, P31286, DOI 10.1074/jbc.M302876200; Yamasaki H, 2007, J BIOL CHEM, V282, P16369, DOI 10.1074/jbc.M700138200; Yamasaki H, 2009, PLANT CELL, V21, P347, DOI 10.1105/tpc.108.060137; Yoo SD, 2007, NAT PROTOC, V2, P1565, DOI 10.1038/nprot.2007.199; Zhang Y, 2009, CHEM REV, V109, P4828, DOI 10.1021/cr800557s	36	33	35	1	21	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAY 25	2012	287	22					18544	18550		10.1074/jbc.M111.318204	http://dx.doi.org/10.1074/jbc.M111.318204			7	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	974EC	22493454	Green Published, hybrid			2022-12-25	WOS:000306411600060
J	Andberg, M; Maaheimo, H; Boer, H; Penttila, M; Koivula, A; Richard, P				Andberg, Martina; Maaheimo, Hannu; Boer, Harry; Penttila, Merja; Koivula, Anu; Richard, Peter			Characterization of a novel Agrobacterium tumefaciens Galactarolactone Cycloisomerase Enzyme for Direct Conversion of D-Galactarolactone to 3-Deoxy-2-keto-L-threo-hexarate	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							D-GLUCARIC ACID; ENOLASE SUPERFAMILY; MANDELATE RACEMASE; ESCHERICHIA-COLI; EVOLUTION; MECHANISM; DEHYDROGENASE; SPECIFICITY; DEHYDRATASE; ALDOLASE	Microorganisms use different pathways for D-galacturonate catabolism. In the known microbial oxidative pathway, D-galacturonate is oxidized to D-galactarolactone, the lactone hydrolyzed to galactarate, which is further converted to 3-deoxy-2-keto-hexarate and alpha-ketoglutarate. We have shown recently that Agrobacterium tumefaciens strain C58 contains an uronate dehydrogenase (At Udh) that oxidizes D-galacturonic acid to D-galactarolactone. Here we report identification of a novel enzyme from the same A. tumefaciens strain, which we named Galactarolactone cycloisomerase (At Gci) (E.C. 5.5.1.-), for the direct conversion of the D-galactarolactone to 3-deoxy-2-keto-hexarate. The At Gci enzyme is 378 amino acids long and belongs to the mandelate racemase subgroup in the enolase superfamily. At Gci was heterologously expressed in Escherichia coli, and the purified enzyme was found to exist as an octameric form. It is active both on D-galactarolactone and D-glucarolactone, but does not work on the corresponding linear hexaric acid forms. The details of the reaction mechanism were further studied by NMR and optical rotation demonstrating that the reaction product of At Gci from D-galactaro-1,4-lactone and D-glucaro-1,4-lactone conversion is in both cases the L-threo form of 3-deoxy-2-keto-hexarate.	[Andberg, Martina; Maaheimo, Hannu; Boer, Harry; Penttila, Merja; Koivula, Anu; Richard, Peter] VTT Tech Res Ctr Finland, FIN-02044 Espoo, Finland	VTT Technical Research Center Finland	Andberg, M (corresponding author), VTT Tech Res Ctr Finland, POB 1000, FIN-02044 Espoo, Finland.	martina.andberg@vtt.fi	Richard, Peter/A-4229-2009; Penttilä, Merja E/A-4710-2013	Richard, Peter/0000-0003-0922-6092; Blomster Andberg, Martina/0000-0002-8021-9947; Penttila, Merja/0000-0002-6929-1032; Boer, Harry/0000-0002-1685-2270; Koivula, Anu/0000-0002-7600-5700	Academy of Finland through the Centre of Excellence in White Biotechnology-Green Chemistry [118573]	Academy of Finland through the Centre of Excellence in White Biotechnology-Green Chemistry(Academy of Finland)	This study was supported by the Academy of Finland through the Centre of Excellence in White Biotechnology-Green Chemistry (decision number 118573).	BERTANI G, 1951, J BACTERIOL, V62, P293, DOI 10.1128/JB.62.3.293-300.1951; Boer H, 2010, APPL MICROBIOL BIOT, V86, P901, DOI 10.1007/s00253-009-2333-9; Brown JM, 2007, J CARBOHYD CHEM, V26, P455, DOI 10.1080/07328300701787172; Buchanan CL, 1999, BIOCHEM J, V343, P563, DOI 10.1042/0264-6021:3430563; CHANG YF, 1970, J BACTERIOL, V102, P85, DOI 10.1128/JB.102.1.85-96.1970; CHANG YF, 1969, J BACTERIOL, V99, P667, DOI 10.1128/JB.99.3.667-673.1969; Gerlt JA, 2005, ARCH BIOCHEM BIOPHYS, V433, P59, DOI 10.1016/j.abb.2004.07.034; Hasson MS, 1998, P NATL ACAD SCI USA, V95, P10396, DOI 10.1073/pnas.95.18.10396; Hubbard BK, 1998, BIOCHEMISTRY-US, V37, P14369, DOI 10.1021/bi981124f; Izard T, 2000, EMBO J, V19, P3849, DOI 10.1093/emboj/19.15.3849; JEFFCOAT R, 1969, BIOCHEM J, V115, P977, DOI 10.1042/bj1150977; Kelly SM, 2005, BBA-PROTEINS PROTEOM, V1751, P119, DOI 10.1016/j.bbapap.2005.06.005; KILGORE WW, 1959, NATURE, V183, P1412, DOI 10.1038/1831412a0; MACGEE J, 1954, J BIOL CHEM, V210, P617; MITRA B, 1995, BIOCHEMISTRY-US, V34, P2777, DOI 10.1021/bi00009a006; Parkkinen T, 2011, J BIOL CHEM, V286, P27294, DOI 10.1074/jbc.M111.254854; Peranen J, 1996, ANAL BIOCHEM, V236, P371, DOI 10.1006/abio.1996.0187; Rakus JF, 2009, BIOCHEMISTRY-US, V48, P11546, DOI 10.1021/bi901731c; Richard P, 2009, APPL MICROBIOL BIOT, V82, P597, DOI 10.1007/s00253-009-1870-6; Schafer SL, 1996, BIOCHEMISTRY-US, V35, P5662, DOI 10.1021/bi960174m; Yew WS, 2007, BIOCHEMISTRY-US, V46, P9564, DOI 10.1021/bi7008882; Yew WS, 2006, BIOCHEMISTRY-US, V45, P14582, DOI 10.1021/bi061687o; ZAJIC JE, 1959, J BACTERIOL, V78, P734, DOI 10.1128/JB.78.5.734-735.1959	23	28	30	1	9	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAY 18	2012	287	21					17662	17671		10.1074/jbc.M111.335240	http://dx.doi.org/10.1074/jbc.M111.335240			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	973PU	22493433	hybrid, Green Published			2022-12-25	WOS:000306373000065
J	Rubin, BER; Ree, RH; Moreau, CS				Rubin, Benjamin E. R.; Ree, Richard H.; Moreau, Corrie S.			Inferring Phylogenies from RAD Sequence Data	PLOS ONE			English	Article							MAXIMUM-LIKELIHOOD; DIVERGENCE TIMES; EVOLUTIONARY; IDENTIFICATION; MAMMALS; MARKERS; GENES; TREES; LOCI	Reduced-representation genome sequencing represents a new source of data for systematics, and its potential utility in interspecific phylogeny reconstruction has not yet been explored. One approach that seems especially promising is the use of inexpensive short-read technologies (e. g., Illumina, SOLiD) to sequence restriction-site associated DNA (RAD) - the regions of the genome that flank the recognition sites of restriction enzymes. In this study, we simulated the collection of RAD sequences from sequenced genomes of different taxa (Drosophila, mammals, and yeasts) and developed a proof-of-concept workflow to test whether informative data could be extracted and used to accurately reconstruct "known" phylogenies of species within each group. The workflow consists of three basic steps: first, sequences are clustered by similarity to estimate orthology; second, clusters are filtered by taxonomic coverage; and third, they are aligned and concatenated for "total evidence" phylogenetic analysis. We evaluated the performance of clustering and filtering parameters by comparing the resulting topologies with well-supported reference trees and we were able to identify conditions under which the reference tree was inferred with high support. For Drosophila, whole genome alignments allowed us to directly evaluate which parameters most consistently recovered orthologous sequences. For the parameter ranges explored, we recovered the best results at the low ends of sequence similarity and taxonomic representation of loci; these generated the largest supermatrices with the highest proportion of missing data. Applications of the method to mammals and yeasts were less successful, which we suggest may be due partly to their much deeper evolutionary divergence times compared to Drosophila (crown ages of approximately 100 and 300 versus 60 Mya, respectively). RAD sequences thus appear to hold promise for reconstructing phylogenetic relationships in younger clades in which sufficient numbers of orthologous restriction sites are retained across species.	[Rubin, Benjamin E. R.] Univ Chicago, Comm Evolutionary Biol, Chicago, IL 60637 USA; [Rubin, Benjamin E. R.; Moreau, Corrie S.] Field Museum Nat Hist, Dept Zool, Chicago, IL 60605 USA; [Ree, Richard H.] Field Museum Nat Hist, Dept Bot, Chicago, IL 60605 USA	University of Chicago; Field Museum of Natural History (Chicago); Field Museum of Natural History (Chicago)	Rubin, BER (corresponding author), Univ Chicago, Comm Evolutionary Biol, Chicago, IL 60637 USA.	brubin@fieldmuseum.org		Moreau, Corrie/0000-0003-1139-5792	U.S. National Science Foundation	U.S. National Science Foundation(National Science Foundation (NSF))	BERR was funded in part by a U.S. National Science Foundation Graduate Research Fellowship. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript. No additional external funding was received for this study.	Adkins RM, 2003, MOL PHYLOGENET EVOL, V26, P409, DOI 10.1016/S1055-7903(02)00304-4; Ane C, 2007, MOL BIOL EVOL, V24, P412; Baird NA, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0003376; Bergsten J, 2005, CLADISTICS, V21, P163, DOI 10.1111/j.1096-0031.2005.00059.x; Bryant D, 2009, ARXIV09104193V1 QBIO; Burleigh JG, 2006, SYST BIOL, V55, P426, DOI 10.1080/10635150500541722; Catchen JM, 2011, G3-GENES GENOM GENET, V1, P171, DOI 10.1534/g3.111.000240; Clark AG, 2007, NATURE, V450, P203, DOI 10.1038/nature06341; Cutter AD, 2008, MOL BIOL EVOL, V25, P778, DOI 10.1093/molbev/msn024; de Villiers EP, 2010, VIROLOGY, V400, P128, DOI 10.1016/j.virol.2010.01.019; Drummond AJ, 2007, BMC EVOL BIOL, V7, DOI 10.1186/1471-2148-7-214; Edgar RC, 2004, NUCLEIC ACIDS RES, V32, P1792, DOI 10.1093/nar/gkh340; Edgar RC, 2010, BIOINFORMATICS, V26, P2460, DOI 10.1093/bioinformatics/btq461; Emerson KJ, 2010, P NATL ACAD SCI USA, V107, P16196, DOI 10.1073/pnas.1006538107; FELSENSTEIN J, 1978, SYST ZOOL, V27, P401, DOI 10.2307/2412923; Foster JT, 2009, J BACTERIOL, V191, P2864, DOI 10.1128/JB.01581-08; Fulton TM, 2002, PLANT CELL, V14, P1457, DOI 10.1105/tpc.010479; Glazko GV, 2003, MOL BIOL EVOL, V20, P424, DOI 10.1093/molbev/msg050; HILLIS DM, 1993, SYST BIOL, V42, P182, DOI 10.2307/2992540; Hohenlohe PA, 2010, PLOS GENET, V6, DOI 10.1371/journal.pgen.1000862; Knowles LL, 2007, SYST BIOL, V56, P887, DOI [10.1080/10635150701405560, 10.1080/10635150701701091]; Kubatko LS, 2009, BIOINFORMATICS, V25, P971, DOI 10.1093/bioinformatics/btp079; Lewis ZA, 2007, GENETICS, V177, P1163, DOI 10.1534/genetics.107.078147; Li H, 2008, GENOME RES, V18, P1851, DOI 10.1101/gr.078212.108; Liu L, 2008, BIOINFORMATICS, V24, P2542, DOI 10.1093/bioinformatics/btn484; Metzker Michael L, 2010, Nat Rev Genet, V11, P31, DOI 10.1038/nrg2626; Miller MR, 2007, GENOME BIOL, V8, DOI 10.1186/gb-2007-8-6-r105; Miller MR, 2007, GENOME RES, V17, P240, DOI 10.1101/gr.5681207; Murphy WJ, 2007, GENOME RES, V17, P413, DOI 10.1101/gr.5918807; Philippe H, 2005, ANNU REV ECOL EVOL S, V36, P541, DOI 10.1146/annurev.ecolsys.35.112202.130205; Philippe H, 2004, MOL BIOL EVOL, V21, P1740, DOI 10.1093/molbev/msh182; Philippe H, 2011, PLOS BIOL, V9, DOI 10.1371/journal.pbio.1000602; Pollard DA, 2006, PLOS GENET, V2, P1634, DOI 10.1371/journal.pgen.0020173; Prasad AB, 2008, MOL BIOL EVOL, V25, P1795, DOI 10.1093/molbev/msn104; Rannala B, 2008, ANNU REV GENOM HUM G, V9, P217, DOI 10.1146/annurev.genom.9.081307.164407; Rokas A, 2003, NATURE, V425, P798, DOI 10.1038/nature02053; RUSSO CAM, 1995, MOL BIOL EVOL, V12, P391; Sims GE, 2009, P NATL ACAD SCI USA, V106, P17077, DOI 10.1073/pnas.0909377106; Stamatakis A, 2006, BIOINFORMATICS, V22, P2688, DOI 10.1093/bioinformatics/btl446; Steppan SJ, 2004, SYST BIOL, V53, P533, DOI 10.1080/10635150490468701; Tamura K, 2004, MOL BIOL EVOL, V21, P36, DOI 10.1093/molbev/msg236; Taylor JW, 2006, MYCOLOGIA, V98, P838, DOI 10.3852/mycologia.98.6.838; Wiens JJ, 2003, SYST BIOL, V52, P528, DOI 10.1080/10635150390218330; Wiens JJ, 2011, SYST BIOL, V60, P719, DOI 10.1093/sysbio/syr025; Wu FN, 2006, GENETICS, V174, P1407, DOI 10.1534/genetics.106.062455	45	233	234	1	119	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 6	2012	7	4							e33394	10.1371/journal.pone.0033394	http://dx.doi.org/10.1371/journal.pone.0033394			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	955JA	22493668	Green Published, Green Submitted, gold			2022-12-25	WOS:000305012700010
J	Yan, CF; Han, SJ; Zhou, YM; Wang, CG; Dai, GH; Xiao, WF; Li, MH				Yan, Cai-Feng; Han, Shi-Jie; Zhou, Yu-Mei; Wang, Cun-Guo; Dai, Guan-Hua; Xiao, Wen-Fa; Li, Mai-He			Needle-Age Related Variability in Nitrogen, Mobile Carbohydrates, and delta C-13 within Pinus koraiensis Tree Crowns	PLOS ONE			English	Article							CARBON-ISOTOPE DISCRIMINATION; LEAF GAS-EXCHANGE; SCOTS PINE; CANOPY POSITION; TROPICAL FOREST; CEMBRA TREES; DOUGLAS-FIR; LIGHT; NUTRIENT; AREA	For both ecologists and physiologists, foliar physioecology as a function of spatially and temporally variable environmental factors such as sunlight exposure within a tree crown is important for understanding whole tree physiology and for predicting ecosystem carbon balance and productivity. Hence, we studied concentrations of nitrogen (N), non-structural carbohydrates (NSC = soluble sugars + starch), and delta C-13 in different-aged needles within Pinus koraiensis tree crowns, to understand the needle age- and crown position-related physiology, in order to test the hypothesis that concentrations of N, NSC, and delta C-13 are needle-age and crown position dependent (more light, more photosynthesis affecting N, NSC, and delta C-13), and to develop an accurate sampling strategy. The present study indicated that the 1-yr-old needles had significantly higher concentration levels of mobile carbohydrates (both on a mass and an area basis) and N-area (on an area basis), as well as NSC-N ratios, but significantly lower levels of N-mass (on a mass basis) concentration and specific leaf area (SLA), compared to the current-year needles. Azimuthal (south-facing vs. north-facing crown side) effects were found to be significant on starch [both on a mass (STmass) and an area basis (STarea)], delta C-13 values, and N-area, with higher levels in needles on the S-facing crown side than the N-facing crown side. Needle N-mass concentrations significantly decreased but needle STmass, STarea, and delta C-13 values significantly increased with increasing vertical crown levels. Our results suggest that the sun-exposed crown position related to photosynthetic activity and water availability affects starch accumulation and carbon isotope discrimination. Needle age associated with physiological activity plays an important role in determining carbon and nitrogen physiology. The present study indicates that across-scale sampling needs to carefully select tissue samples with equal age from a comparable crown position.	[Yan, Cai-Feng; Han, Shi-Jie; Zhou, Yu-Mei; Wang, Cun-Guo; Li, Mai-He] Chinese Acad Sci, Inst Appl Ecol, State Key Lab Forest & Soil Ecol, Shenyang, Peoples R China; [Yan, Cai-Feng; Wang, Cun-Guo] Chinese Acad Sci, Grad Univ, Beijing, Peoples R China; [Dai, Guan-Hua] Chinese Acad Sci, Res Stn Changbai Mt Forest Ecosyst, Erdaobaihe, Peoples R China; [Xiao, Wen-Fa] Chinese Acad Forestry, Key Lab Forest Ecol & Environm, State Forestry Adm, Beijing, Peoples R China; [Li, Mai-He] Swiss Fed Res Inst WSL, Birmensdorf, Switzerland	Chinese Academy of Sciences; Shenyang Institute of Applied Ecology, CAS; Chinese Academy of Sciences; University of Chinese Academy of Sciences, CAS; Chinese Academy of Sciences; Chinese Academy of Forestry; Research Institute of Forest Ecology, Environment and Protection, CAF; Swiss Federal Institutes of Technology Domain; Swiss Federal Institute for Forest, Snow & Landscape Research	Yan, CF (corresponding author), Chinese Acad Sci, Inst Appl Ecol, State Key Lab Forest & Soil Ecol, Shenyang, Peoples R China.	maihe.li@wsl.ch	Zhou, Yu/HHN-3071-2022; Li, Mai-He/L-6390-2013	Li, Mai-He/0000-0002-7029-2841	National Natural Science Foundation of China [40930107]; Key Laboratory of Forest Ecology and Environment, State Forestry Administration, Chinese Academy of Forestry [CAFIFEEPYBB2007001]; Major State Basic Research Development Program [2011CB403200]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Key Laboratory of Forest Ecology and Environment, State Forestry Administration, Chinese Academy of Forestry; Major State Basic Research Development Program(National Basic Research Program of China)	This study was supported by the National Natural Science Foundation of China (Project no. 40930107), Key Laboratory of Forest Ecology and Environment, State Forestry Administration, Chinese Academy of Forestry (CAFIFEEPYBB2007001), and the Major State Basic Research Development Program (2011CB403200). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Attiwill PM, 2005, TREES-STRUCT FUNCT, V20, P79, DOI DOI 10.1007/S00468-005-0015-5; Barszczowska L, 2005, ACTA SOC BOT POL, V74, P93; Bond BJ, 1999, OECOLOGIA, V120, P183, DOI 10.1007/s004420050847; Bond BJ, 2000, TRENDS PLANT SCI, V5, P349, DOI 10.1016/S1360-1385(00)01691-5; Brendel O, 2003, ANN FOREST SCI, V60, P97, DOI 10.1051/forest:2003001; BROADMEADOW MSJ, 1992, OECOLOGIA, V89, P435, DOI 10.1007/BF00317423; Chevillat VS, 2005, BASIC APPL ECOL, V6, P519, DOI 10.1016/j.baae.2005.04.008; Chmura DJ, 2008, TREE PHYSIOL, V28, P729, DOI 10.1093/treephys/28.5.729; CONSTABLE GA, 1980, AUST J PLANT PHYSIOL, V7, P539, DOI 10.1071/PP9800539; CRAIG H, 1957, GEOCHIM COSMOCHIM AC, V12, P133, DOI 10.1016/0016-7037(57)90024-8; DALE MP, 1992, J ECOL, V80, P517, DOI 10.2307/2260695; El-Sharkawy MA, 2007, PHOTOSYNTHETICA, V45, P515, DOI 10.1007/s11099-007-0089-y; FISCHER C, 1991, TREES-STRUCT FUNCT, V5, P187, DOI 10.1007/BF00227524; GEBAUER G, 1994, PLANT SOIL, V164, P267, DOI 10.1007/BF00010079; GEBAUER G, 1991, OECOLOGIA, V87, P198, DOI 10.1007/BF00325257; GEIGER J, 1961, Z PHYS, V161, P243, DOI 10.1007/BF01338932; Gonzalez-Real MM, 2000, PLANT CELL ENVIRON, V23, P351, DOI 10.1046/j.1365-3040.2000.00559.x; Griffin KL, 2002, NEW PHYTOL, V154, P609, DOI 10.1046/j.1469-8137.2002.00410.x; GUTIERREZ MV, 1994, AUST J PLANT PHYSIOL, V21, P207, DOI 10.1071/PP9940207; Han QM, 2003, TREE PHYSIOL, V23, P851, DOI 10.1093/treephys/23.12.851; Hao ZQ, 2002, CHINESE J APPL ECOLO, V13, P785; HATCHER PE, 1990, OECOLOGIA, V85, P200, DOI 10.1007/BF00319402; Helle G, 2004, PLANT CELL ENVIRON, V27, P367, DOI 10.1111/j.0016-8025.2003.01159.x; Helmisaari Helja-Sisko, 1992, Silva Fennica, V26, P145; Hoch G, 2003, OECOLOGIA, V135, P10, DOI 10.1007/s00442-002-1154-7; Hollinger DY, 1996, TREE PHYSIOL, V16, P627; Holtum JAM, 2005, TREES-STRUCT FUNCT, V19, P545, DOI 10.1007/s00468-005-0413-8; Iio A, 2005, TREE PHYSIOL, V25, P533, DOI 10.1093/treephys/25.5.533; Ishii H, 2002, TREE PHYSIOL, V22, P31, DOI 10.1093/treephys/22.1.31; Ishii HT, 2008, OECOLOGIA, V156, P751, DOI 10.1007/s00442-008-1032-z; Jaggi M, 2002, OECOLOGIA, V131, P325, DOI 10.1007/s00442-002-0881-0; Johnson IR, 1996, AGR SYST, V50, P1, DOI 10.1016/0308-521X(95)00010-3; Koch GW, 2004, NATURE, V428, P851, DOI 10.1038/nature02417; Li CY, 2009, TREES-STRUCT FUNCT, V23, P1109, DOI 10.1007/s00468-009-0354-8; Li MH, 2008, PLANT CELL ENVIRON, V31, P1377, DOI 10.1111/j.1365-3040.2008.01848.x; Li MH, 2008, TREE PHYSIOL, V28, P1287, DOI 10.1093/treephys/28.8.1287; Li MH, 2006, TREES-STRUCT FUNCT, V20, P611, DOI 10.1007/s00468-006-0076-0; Li MH, 2002, TREES-STRUCT FUNCT, V16, P331, DOI 10.1007/s00468-002-0172-8; Li MH, 2001, PHYTON-ANN REI BOT A, V41, P203; Li MC, 2009, J FOREST RES-JPN, V14, P229, DOI 10.1007/s10310-009-0132-x; Livingston NJ, 1998, PLANT CELL ENVIRON, V21, P795, DOI 10.1046/j.1365-3040.1998.00314.x; LOWTHER WL, 1980, NEW ZEAL J EXP AGR, V8, P249, DOI 10.1080/03015521.1980.10426267; Ludovici KH, 2002, FOREST ECOL MANAG, V159, P261, DOI 10.1016/S0378-1127(01)00439-X; Maguire DA, 1996, CAN J FOREST RES, V26, P849, DOI 10.1139/x26-093; Marshall JD, 2003, CAN J FOREST RES, V33, P164, DOI 10.1139/X02-158; McGarvey RC, 2004, TREE PHYSIOL, V24, P1209, DOI 10.1093/treephys/24.11.1209; MEINZER FC, 1992, OECOLOGIA, V91, P305, DOI 10.1007/BF00317617; Mickelbart MV, 2010, HORTSCIENCE, V45, P428, DOI 10.21273/HORTSCI.45.3.428; Morecroft MD, 1996, NEW PHYTOL, V134, P471, DOI 10.1111/j.1469-8137.1996.tb04364.x; Niinemets U, 1997, TREE PHYSIOL, V17, P723; Niinemets U, 2003, ACTA OECOL, V24, P209, DOI 10.1016/S1146-609X(03)00094-8; Niinemets U, 2001, TREE PHYSIOL, V21, P1231, DOI 10.1093/treephys/21.17.1231; Nippert JB, 2003, TREE PHYSIOL, V23, P591, DOI 10.1093/treephys/23.9.591; O'Neal ME, 2002, J ECON ENTOMOL, V95, P1190, DOI 10.1603/0022-0493-95.6.1190; Ometto JPHB, 2002, GLOBAL BIOGEOCHEM CY, V16, DOI 10.1029/2001GB001462; Ozanne CMP, 2003, SCIENCE, V301, P183, DOI 10.1126/science.1084507; Perica S, 2001, J PLANT NUTR, V24, P779, DOI 10.1081/PLN-100103670; PERTERER J, 1990, FORSTWISS CENTRALBL, V109, P220, DOI 10.1007/BF02741637; Peters J, 2008, EUR J FOREST RES, V127, P293, DOI 10.1007/s10342-008-0205-y; Roux-Swarthout DL, 2001, PLANT SCI, V160, P563; Ryan MG, 2006, PLANT CELL ENVIRON, V29, P367, DOI 10.1111/j.1365-3040.2005.01478.x; Sabatier S, 1999, ANN BOT-LONDON, V84, P387, DOI 10.1006/anbo.1999.0939; SCHOETTLE AW, 1994, TREE PHYSIOL, V14, P1055, DOI 10.1093/treephys/14.7-8-9.1055; Schoettle AW, 1999, TREE PHYSIOL, V19, P13; SEIFTER S, 1950, P SOC EXP BIOL MED, V75, P46, DOI 10.3181/00379727-75-18095; Shi PL, 2006, BASIC APPL ECOL, V7, P370, DOI 10.1016/j.baae.2005.06.005; Suzuki M, 2003, ANN BOT-LONDON, V92, P339, DOI 10.1093/aob/mcg144; Takeuchi Y, 2001, PLANT CELL ENVIRON, V24, P1257, DOI 10.1046/j.0016-8025.2001.00787.x; Tateno R, 2002, ECOL RES, V17, P695, DOI 10.1046/j.1440-1703.2002.00526.x; Terwilliger VJ, 1997, AM J BOT, V84, P1693; VANHEES AFM, 1993, FOREST ECOL MANAG, V58, P19, DOI 10.1016/0378-1127(93)90128-A; Weiskittel AR, 2007, ANN FOREST SCI, V65, P103; Woodruff DR, 2007, PLANT CELL ENVIRON, V30, P559, DOI 10.1111/j.1365-3040.2007.01652.x; Wu Jing-Lian, 2009, Yingyong Shengtai Xuebao, V20, P235; Wurth MKR, 2005, OECOLOGIA, V143, P11, DOI 10.1007/s00442-004-1773-2; Wurth MKR, 1998, OECOLOGIA, V116, P18, DOI 10.1007/PL00013821; Xiao CW, 2006, TREES-STRUCT FUNCT, V20, P304, DOI 10.1007/s00468-005-0039-x; YODER BJ, 1994, FOREST SCI, V40, P513; Zha TS, 2002, NEW PHYTOL, V156, P33, DOI 10.1046/j.1469-8137.2002.00488.x	79	34	39	1	47	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 6	2012	7	4							e35076	10.1371/journal.pone.0035076	http://dx.doi.org/10.1371/journal.pone.0035076			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	955JA	22493732	Green Published, Green Submitted, gold			2022-12-25	WOS:000305012700074
J	Xing, YZ; Samuvel, DJ; Stevens, SM; Dubno, JR; Schulte, BA; Lang, HN				Xing, Yazhi; Samuvel, Devadoss J.; Stevens, Shawn M.; Dubno, Judy R.; Schulte, Bradley A.; Lang, Hainan			Age-Related Changes of Myelin Basic Protein in Mouse and Human Auditory Nerve	PLOS ONE			English	Article							SPIRAL GANGLION NEURONS; PRODUCT OTOACOUSTIC EMISSIONS; HUMAN INNER-EAR; HUMAN COCHLEA; HEARING-LOSS; GLUTAMATE RECEPTORS; PERIPHERAL-NERVE; CORPUS-CALLOSUM; RHESUS-MONKEY; TEMPORAL BONE	Age-related hearing loss (presbyacusis) is the most common type of hearing impairment. One of the most consistent pathological changes seen in presbyacusis is the loss of spiral ganglion neurons (SGNs). Defining the cellular and molecular basis of SGN degeneration in the human inner ear is critical to gaining a better understanding of the pathophysiology of presbyacusis. However, information on age-related cellular and molecular alterations in the human spiral ganglion remains scant, owing to the very limited availably of human specimens suitable for high resolution morphological and molecular analysis. This study aimed at defining age-related alterations in the auditory nerve in human temporal bones and determining if immunostaining for myelin basic protein (MBP) can be used as an alternative approach to electron microscopy for evaluating myelin degeneration. For comparative purposes, we evaluated ultrastructural alternations and changes in MBP immunostaining in aging CBA/CaJ mice. We then examined 13 temporal bones from 10 human donors, including 4 adults aged 38-46 years (middle-aged group) and 6 adults aged 63-91 years (older group). Similar to the mouse, intense immunostaining of MBP was present throughout the auditory nerve of the middle-aged human donors. Significant declines in MBP immunoreactivity and losses of MBP+ auditory nerve fibers were observed in the spiral ganglia of both the older human and aged mouse ears. This study demonstrates that immunostaining for MBP in combination with confocal microscopy provides a sensitive, reliable, and efficient method for assessing alterations of myelin sheaths in the auditory nerve. The results also suggest that myelin degeneration may play a critical role in the SGN loss and the subsequent decline of the auditory nerve function in presbyacusis.	[Xing, Yazhi; Samuvel, Devadoss J.; Dubno, Judy R.; Schulte, Bradley A.; Lang, Hainan] Med Univ S Carolina, Dept Pathol & Lab Med, Charleston, SC 29425 USA; [Stevens, Shawn M.; Dubno, Judy R.; Schulte, Bradley A.] Med Univ S Carolina, Dept Otolaryngol Head & Neck Surg, Charleston, SC 29425 USA	Medical University of South Carolina; Medical University of South Carolina	Xing, YZ (corresponding author), Med Univ S Carolina, Dept Pathol & Lab Med, Charleston, SC 29425 USA.	langh@musc.edu	Xing, Yazhi/GVU-8191-2022; Xing, Yazhi/HDO-1842-2022	Lang, Hainan/0000-0003-2210-7856; Xing, Yazhi/0000-0001-8975-7242	National Institutes of Health (NIH) [NIH DC00422, NIH DC07506, DC00713]; South Carolina Clinical and Translational Research Institute (SCTR) [NIH/NCRR UL1RR029882]; NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCES [UL1TR000062] Funding Source: NIH RePORTER; NATIONAL CENTER FOR RESEARCH RESOURCES [UL1RR029882] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON DEAFNESS AND OTHER COMMUNICATION DISORDERS [R01DC000713, R03DC007506, P01DC000422, P50DC000422] Funding Source: NIH RePORTER	National Institutes of Health (NIH)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); South Carolina Clinical and Translational Research Institute (SCTR); NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Advancing Translational Sciences (NCATS)); NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL INSTITUTE ON DEAFNESS AND OTHER COMMUNICATION DISORDERS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Deafness & Other Communication Disorders (NIDCD))	This work was supported by National Institutes of Health (NIH); Grant number: NIH DC00422 (HL, JRD, BAS); Grant number: NIH DC07506 (HL); Grant number: DC00713 (BAS); This work also benefitted from the South Carolina Clinical and Translational Research Institute (SCTR) Clinical and Translational Science Award (NIH/NCRR UL1RR029882). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ARNOLD W, 1987, ACTA OTO-LARYNGOL, P76; Bartzokis G, 2011, NEUROBIOL AGING, V32, P1341, DOI 10.1016/j.neurobiolaging.2009.08.007; BERGLUND AM, 1987, J COMP NEUROL, V255, P560, DOI 10.1002/cne.902550408; BLACK JA, 1982, BRAIN RES, V250, P1, DOI 10.1016/0006-8993(82)90948-9; Boggs JM, 2006, CELL MOL LIFE SCI, V63, P1945, DOI 10.1007/s00018-006-6094-7; Bowley MP, 2010, J COMP NEUROL, V518, P3046, DOI 10.1002/cne.22379; Braak H, 2004, NEUROBIOL AGING, V25, P19, DOI 10.1016/j.neurobiolaging.2003.04.001; CHAN KFJ, 1990, J NEUROSCI RES, V25, P535, DOI 10.1002/jnr.490250410; Conforti L, 2007, TRENDS NEUROSCI, V30, P159, DOI 10.1016/j.tins.2007.02.004; Cunningham CD, 2001, LARYNGOSCOPE, V111, P278, DOI 10.1097/00005537-200102000-00017; DOBROWOLSKI Z, 1986, EUR J CELL BIOL, V41, P65; DOBROWOLSKI Z, 1986, EUR J CELL BIOL, V42, P17; Driscoll M, 2003, NAT REV GENET, V4, P181, DOI 10.1038/nrg1018; El-Badry MM, 2007, EUR J NEUROSCI, V25, P1437, DOI 10.1111/j.1460-9568.2007.05401.x; Faddis BT, 1997, J NEUROCYTOL, V26, P625, DOI 10.1023/A:1018593710530; Fields RD, 2008, TRENDS NEUROSCI, V31, P361, DOI 10.1016/j.tins.2008.04.001; Gates GA, 2005, LANCET, V366, P1111, DOI 10.1016/S0140-6736(05)67423-5; GEREN BB, 1953, P NATL ACAD SCI USA, V39, P880, DOI 10.1073/pnas.39.8.880; Griffiths I, 1998, SCIENCE, V280, P1610, DOI 10.1126/science.280.5369.1610; Guimaraes P, 2004, HEARING RES, V192, P83, DOI 10.1016/j.heares.2004.01.013; Guipponi M, 2007, AM J PATHOL, V171, P608, DOI 10.2353/ajpath.2007.070068; Hansen MR, 2001, HEARING RES, V161, P87, DOI 10.1016/S0378-5955(01)00360-4; HENRY KR, 1980, AUDIOLOGY, V19, P369; Hequembourg S, 2001, JARO-J ASSOC RES OTO, V2, P118, DOI 10.1007/s101620010075; Hill CMD, 2005, BIOCHEMISTRY-US, V44, P16672, DOI 10.1021/bi050646+; HOEFFDING V, 1988, J COMP NEUROL, V276, P537, DOI 10.1002/cne.902760408; Hoopfer ED, 2006, NEURON, V50, P883, DOI 10.1016/j.neuron.2006.05.013; Hsu WJ, 1997, ORL J OTO-RHINO-LARY, V59, P258, DOI 10.1159/000276949; Ishiyama A, 2009, HEARING RES, V254, P1, DOI 10.1016/j.heares.2009.03.014; Jagger DJ, 2003, J PHYSIOL-LONDON, V552, P525, DOI 10.1111/j.1469-7793.2003.00525.x; Jimenez AM, 1999, HEARING RES, V138, P91, DOI 10.1016/S0378-5955(99)00154-9; JOHNSSON LG, 1974, ANN OTO RHINOL LARYN, V83, P294, DOI 10.1177/000348947408300303; Jyothi V, 2010, J COMP NEUROL, V518, P3254, DOI 10.1002/cne.22398; KEITHLEY EM, 1979, J COMP NEUROL, V188, P429, DOI 10.1002/cne.901880306; KEITHLEY EM, 1989, HEARING RES, V38, P125, DOI 10.1016/0378-5955(89)90134-2; Khalifa SAM, 2003, HEARING RES, V185, P35, DOI 10.1016/S0378-5955(03)00228-4; Knipper M, 1998, DEVELOPMENT, V125, P3709; Kujawa SG, 2006, J NEUROSCI, V26, P2115, DOI 10.1523/JNEUROSCI.4985-05.2006; Kujawa SG, 2009, J NEUROSCI, V29, P14077, DOI 10.1523/JNEUROSCI.2845-09.2009; Kusunoki T, 2004, OTOLARYNG HEAD NECK, V131, P897, DOI 10.1016/j.otohns.2004.05.022; Lang HN, 2010, JARO-J ASSOC RES OTO, V11, P419, DOI 10.1007/s10162-010-0214-7; Lang HN, 2006, J NEUROSCI, V26, P3541, DOI 10.1523/JNEUROSCI.2488-05.2006; LEE MK, 1994, CURR OPIN CELL BIOL, V6, P34, DOI 10.1016/0955-0674(94)90113-9; LI HS, 1991, ACTA OTO-LARYNGOL, V111, P827, DOI 10.3109/00016489109138418; Linthicum FH, 2009, OTOL NEUROTOL, V30, P418, DOI 10.1097/MAO.0b013e31819a8827; Liu W, 2011, CELL TISSUE RES, V345, P213, DOI 10.1007/s00441-011-1209-3; Liu W, 2010, CELL TISSUE RES, V342, P345, DOI 10.1007/s00441-010-1081-6; Liu W, 2009, HEARING RES, V250, P55, DOI 10.1016/j.heares.2009.01.010; Lopez I, 2005, J NEUROSCI METH, V145, P37, DOI 10.1016/j.jneumeth.2004.11.024; Lopez I, 2003, J NEUROSCI RES, V74, P666, DOI 10.1002/jnr.10813; Lopez IA, 2007, CELL TISSUE RES, V328, P453, DOI 10.1007/s00441-007-0380-z; Makary CA, 2011, JARO-J ASSOC RES OTO, V12, P711, DOI 10.1007/s10162-011-0283-2; Melcangi RC, 1998, NEUROSCIENCE, V85, P569, DOI 10.1016/S0306-4522(97)00628-3; Mills John H., 2006, Seminars in Hearing, V27, P228, DOI 10.1055/s-2006-954849; Mock B, 2011, JARO-J ASSOC RES OTO, V12, P173, DOI 10.1007/s10162-010-0247-y; Moscarello MA, 1997, ALTSCHUL SY, V4, P13; Nadol JB, 1996, OTOLARYNG HEAD NECK, V115, P298, DOI 10.1016/S0194-5998(96)70042-6; NADOL JB, 1990, HEARING RES, V49, P141, DOI 10.1016/0378-5955(90)90101-T; NADOL JB, 1979, OTOLARYNG HEAD NECK, V87, P818, DOI 10.1177/019459987908700617; Nave KA, 2008, ANNU REV NEUROSCI, V31, P535, DOI 10.1146/annurev.neuro.30.051606.094309; Nave KA, 2010, NAT REV NEUROSCI, V11, P275, DOI 10.1038/nrn2797; Newman TA, 2001, BRAIN, V124, P2203, DOI 10.1093/brain/124.11.2203; Ohlemiller KK, 2010, JARO-J ASSOC RES OTO, V11, P605, DOI 10.1007/s10162-010-0228-1; Ohlemiller KK, 2004, J COMP NEUROL, V479, P103, DOI 10.1002/cne.20326; OTA CY, 1980, ACTA OTO-LARYNGOL, V89, P53, DOI 10.3109/00016488009127108; Ouardouz M, 2009, ANN NEUROL, V65, P151, DOI 10.1002/ana.21533; Ouardouz M, 2009, ANN NEUROL, V65, P160, DOI 10.1002/ana.21539; PERKINS RE, 1975, J COMP NEUROL, V163, P129, DOI 10.1002/cne.901630202; Peters A, 2002, J COMP NEUROL, V442, P277, DOI 10.1002/cne.10099; Peters A, 1996, J COMP NEUROL, V371, P153, DOI 10.1002/(SICI)1096-9861(19960715)371:1<153::AID-CNE9>3.0.CO;2-2; Peters A, 2000, J COMP NEUROL, V419, P364, DOI 10.1002/(SICI)1096-9861(20000410)419:3<364::AID-CNE8>3.0.CO;2-R; Peters A, 2002, J NEUROCYTOL, V31, P581, DOI 10.1023/A:1025731309829; Pettingill LN, 2008, NEUROSCIENCE, V152, P821, DOI 10.1016/j.neuroscience.2007.11.057; Polverini E, 2004, J STRUCT BIOL, V148, P353, DOI 10.1016/j.jsb.2004.08.004; Prasad K, 1995, J BIOL CHEM, V270, P30551, DOI 10.1074/jbc.270.51.30551; Pun S, 2006, NAT NEUROSCI, V9, P408, DOI 10.1038/nn1653; Rask-Andersen H, 2000, HEARING RES, V141, P1, DOI 10.1016/S0378-5955(99)00179-3; Reid MA, 2004, J NEUROSCI, V24, P733, DOI 10.1523/JNEUROSCI.3923-03.2004; Robertson NG, 2006, HUM MOL GENET, V15, P1071, DOI 10.1093/hmg/ddl022; ROMAND MR, 1987, ACTA OTO-LARYNGOL, V104, P29, DOI 10.3109/00016488709109044; Romand R, 1984, ULTRASTRUCTURAL ATLA, P165; ROTH GA, 1993, NEUROCHEM INT, V23, P459, DOI 10.1016/0197-0186(93)90130-W; Sandell JH, 2001, J COMP NEUROL, V429, P541, DOI 10.1002/1096-9861(20010122)429:4<541::AID-CNE3>3.0.CO;2-5; Schiffmann R, 2004, CURR OPIN NEUROL, V17, P187, DOI 10.1097/00019052-200404000-00017; Schmiedt RA., 2009, SPRINGER HDB AUDITOR; SCHULNECHT H, 1968, Archives of Otolaryngology, V87, P129; Sekerkova G, 2008, J COMP NEUROL, V509, P661, DOI 10.1002/cne.21755; Sha SH, 2008, HEARING RES, V243, P87, DOI 10.1016/j.heares.2008.06.001; SPOENDLIN H, 1972, ACTA OTO-LARYNGOL, V73, P235, DOI 10.3109/00016487209138937; STORER JB, 1966, J GERONTOL, V21, P404, DOI 10.1093/geronj/21.3.404; Suter U, 2003, NAT REV NEUROSCI, V4, P714, DOI 10.1038/nrn1196; Trapp BD, 2008, ANNU REV NEUROSCI, V31, P247, DOI 10.1146/annurev.neuro.30.051606.094313; Tylstedt S, 1997, ACTA OTO-LARYNGOL, V117, P505, DOI 10.3109/00016489709113429; UCHIDA Y, 1986, J NEUROCHEM, V46, P1376, DOI 10.1111/j.1471-4159.1986.tb01750.x; Varghese GI, 2005, HEARING RES, V209, P60, DOI 10.1016/j.heares.2005.06.006; Verdu E, 2000, J PERIPHER NERV SYST, V5, P191, DOI 10.1046/j.1529-8027.2000.00026.x; Wang DS, 2004, NEUROSCI RES, V48, P93, DOI 10.1016/j.neures.2003.10.002; Wang SJ, 2009, J NEUROSCI RES, V87, P3428, DOI 10.1002/jnr.22164; Wang Y, 2005, J NEUROL SCI, V232, P59, DOI 10.1016/j.jns.2005.01.016; Weber PC, 2001, LARYNGOSCOPE, V111, P1156, DOI 10.1097/00005537-200107000-00006; Weisz C, 2009, NATURE, V461, P1126, DOI 10.1038/nature08487; Wise AK, 2005, J COMP NEUROL, V487, P147, DOI 10.1002/cne.20563; Wu T, 2003, JARO-J ASSOC RES OTO, V4, P353, DOI 10.1007/s10162-002-3026-6; Yin XH, 1998, J NEUROSCI, V18, P1953, DOI 10.1523/jneurosci.18-06-01953.1998; Zheng QY, 1999, HEARING RES, V130, P94, DOI 10.1016/S0378-5955(99)00003-9; ZHOU RZ, 1995, HEARING RES, V88, P87, DOI 10.1016/0378-5955(95)00104-C; ZHOU RZ, 1995, HEARING RES, V88, P98, DOI 10.1016/0378-5955(95)00105-D	107	54	55	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 5	2012	7	4							e34500	10.1371/journal.pone.0034500	http://dx.doi.org/10.1371/journal.pone.0034500			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	955IH	22496821	Green Submitted, Green Published, gold			2022-12-25	WOS:000305010500015
J	Chintapalli, VR; Terhzaz, S; Wang, J; Al Bratty, M; Watson, DG; Herzyk, P; Davies, SA; Dow, JAT				Chintapalli, Venkateswara R.; Terhzaz, Selim; Wang, Jing; Al Bratty, Mohammed; Watson, David G.; Herzyk, Pawel; Davies, Shireen A.; Dow, Julian A. T.			Functional Correlates of Positional and Gender-Specific Renal Asymmetry in Drosophila	PLOS ONE			English	Article							VITELLIFORM MACULAR DYSTROPHY; NEUROPEPTIDE-F RECEPTOR; MULTIPOTENT STEM-CELLS; MALPIGHIAN TUBULES; OXIDATIVE STRESS; FLUID SECRETION; SITUS-INVERSUS; MELANOGASTER; CALCIUM; SEX	Background: In humans and other animals, the internal organs are positioned asymmetrically in the body cavity, and disruption of this body plan can be fatal in humans. The mechanisms by which internal asymmetry are established are presently the subject of intense study; however, the functional significance of internal asymmetry (outside the brain) is largely unexplored. Is internal asymmetry functionally significant, or merely an expedient way of packing organs into a cavity? Methodology/Principal Findings: Like humans, Drosophila shows internal asymmetry, with the gut thrown into stereotyped folds. There is also renal asymmetry, with the rightmost pair of renal (Malpighian) tubules always ramifying anteriorly, and the leftmost pair always sitting posteriorly in the body cavity. Accordingly, transcriptomes of anterior-directed (right-side) and posterior-directed (left-side) Malpighian (renal) tubules were compared in both adult male and female Drosophila. Although genes encoding the basic functions of the tubules (transport, signalling) were uniformly expressed, some functions (like innate immunity) showed positional or gender differences in emphasis; others, like calcium handling or the generation of potentially toxic ammonia, were reserved for just the right-side or left-side tubules, respectively. These findings correlated with the distinct locations of each tubule pair within the body cavity. Well known developmental genes (like dorsocross, dachshund and doublesex) showed continuing, patterned expression in adult tubules, implying that somatic tissues maintain both left-right and gender identities throughout life. Gender asymmetry was also noted, both in defence and in male-specific expression of receptors for neuropeptide F and sex-peptide: NPF elevated calcium only in male tubules. Conclusions/Significance: Accordingly, the physical asymmetry of the tubules in the body cavity is directly adaptive. Now that the detailed machinery underlying internal asymmetry is starting to be delineated, our work invites the investigation, not just of tissues in isolation, but in the context of their unique physical locations and milieux.	[Chintapalli, Venkateswara R.; Terhzaz, Selim; Wang, Jing; Herzyk, Pawel; Davies, Shireen A.; Dow, Julian A. T.] Univ Glasgow, Coll Med Vet & Life Sci, Inst Mol Cell & Syst Biol, Glasgow, Lanark, Scotland; [Al Bratty, Mohammed; Watson, David G.] Strathclyde Inst Pharm & Biomed Sci, Glasgow, Lanark, Scotland	University of Glasgow; University of Strathclyde	Chintapalli, VR (corresponding author), Univ Glasgow, Coll Med Vet & Life Sci, Inst Mol Cell & Syst Biol, Glasgow, Lanark, Scotland.	julian.dow@glasgow.ac.uk	Albratty, Mohammed/AHD-1350-2022; Dow, Julian/M-2371-2019	Dow, Julian/0000-0002-9595-5146; Terhzaz, Selim/0000-0002-6192-6558	United Kingdom (UK) Biotechnology and Biological Sciences Research Council (BBSRC); Universities of Glasgow and Strathclyde; Biotechnology and Biological Sciences Research Council [BB/F010397/1] Funding Source: researchfish; BBSRC [BB/F010397/1] Funding Source: UKRI	United Kingdom (UK) Biotechnology and Biological Sciences Research Council (BBSRC); Universities of Glasgow and Strathclyde; Biotechnology and Biological Sciences Research Council(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); BBSRC(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC))	This work was funded by the United Kingdom (UK) Biotechnology and Biological Sciences Research Council (BBSRC) and by general funds of the Universities of Glasgow and Strathclyde. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aldehni F, 2009, J AM SOC NEPHROL, V20, P1556, DOI 10.1681/ASN.2008090987; Allan AK, 2005, PHYSIOL GENOMICS, V22, P128, DOI 10.1152/physiolgenomics.00233.2004; Beyenbach KW, 2010, ANNU REV ENTOMOL, V55, P351, DOI 10.1146/annurev-ento-112408-085512; Broderick KE, 2003, AM J PHYSIOL-CELL PH, V285, pC1207, DOI 10.1152/ajpcell.00123.2003; Broeck JV, 2001, PEPTIDES, V22, P241, DOI 10.1016/S0196-9781(00)00376-4; Burn SF, 2009, BIOESSAYS, V31, P1026, DOI 10.1002/bies.200900056; Button D, 1996, MOL BIOL CELL, V7, P419, DOI 10.1091/mbc.7.3.419; Caldwell GM, 1999, GENOMICS, V58, P98, DOI 10.1006/geno.1999.5808; Chahine S, 2011, J EXP BIOL, V214, P462, DOI 10.1242/jeb.048884; Chahine S, 2010, ARCH INSECT BIOCHEM, V73, P128, DOI 10.1002/arch.20346; Chahine S, 2009, J INSECT PHYSIOL, V55, P927, DOI 10.1016/j.jinsphys.2009.06.005; Chapman R.F, 2012, INSECTS STRUCTURE FU, V5th; Chen YH, 2011, KIDNEY INT, V80, P369, DOI 10.1038/ki.2011.80; Chien LT, 2007, J GEN PHYSIOL, V130, P513, DOI 10.1085/jgp.200709795; Chintapalli VR, 2007, NAT GENET, V39, P715, DOI 10.1038/ng2049; Coast GM, 2009, J EXP BIOL, V212, P378, DOI 10.1242/jeb.024109; Coast GM, 2005, ANN NY ACAD SCI, V1040, P1, DOI 10.1196/annals.1327.001; Coast GM, 2001, J EXP BIOL, V204, P1795; Coutelis JB, 2008, SEMIN CELL DEV BIOL, V19, P252, DOI 10.1016/j.semcdb.2008.01.006; Davies SA, 1995, AM J PHYSIOL-REG I, V269, pR1321, DOI 10.1152/ajpregu.1995.269.6.R1321; Dow JAT, 2003, PHYSIOL REV, V83, P687, DOI 10.1152/physrev.00035.2002; DOW JAT, 1994, J EXP BIOL, V197, P421; Dow JAT, 2010, AM J PHYSIOL-RENAL, V299, pF1237, DOI 10.1152/ajprenal.00521.2010; Dow JAT, 2009, J EXP BIOL, V212, P435, DOI 10.1242/jeb.024224; Drago I, 2008, J BIOL CHEM, V283, P14384, DOI 10.1074/jbc.M800600200; Drake LL, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0015578; Dube K, 2000, J INSECT PHYSIOL, V46, P1449, DOI 10.1016/S0022-1910(00)00069-X; Eden E, 2009, BMC BIOINFORMATICS, V10, DOI 10.1186/1471-2105-10-48; Evans JM, 2005, J EXP BIOL, V208, P3771, DOI 10.1242/jeb.01829; Feng GP, 2003, EUR J NEUROSCI, V18, P227, DOI 10.1046/j.1460-9568.2003.02719.x; Fujii S, 2002, EMBO J, V21, P5353, DOI 10.1093/emboj/cdf556; Garczynski SF, 2002, PEPTIDES, V23, P773, DOI 10.1016/S0196-9781(01)00647-7; Hatton-Ellis E, 2007, P NATL ACAD SCI USA, V104, P169, DOI 10.1073/pnas.0606933104; Hewes RS, 2001, GENOME RES, V11, P1126, DOI 10.1101/gr.169901; Hofmann T, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0010519; Huang YQ, 2011, PEPTIDES, V32, P483, DOI 10.1016/j.peptides.2010.09.014; Iliadi KG, 2008, P NATL ACAD SCI USA, V105, P19986, DOI 10.1073/pnas.0810698105; Johnson EC, 2003, J BIOL CHEM, V278, P52172, DOI 10.1074/jbc.M306756200; Kahsai L, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0011480; Kamleh MA, 2008, FEBS LETT, V582, P2916, DOI 10.1016/j.febslet.2008.07.029; Kamleh MA, 2009, FEBS LETT IN PRESS; KARTAGENER M, 1962, ARCH PEDIATR, V79, P193; Kaufmann N, 2005, AM J PHYSIOL-CELL PH, V289, pC397, DOI 10.1152/ajpcell.00612.2004; Kim YJ, 2010, P NATL ACAD SCI USA, V107, P6520, DOI 10.1073/pnas.0914764107; Lee GH, 2006, P NATL ACAD SCI USA, V103, P12580, DOI 10.1073/pnas.0601171103; Lee KS, 2004, J BIOL CHEM, V279, P50781, DOI 10.1074/jbc.M407842200; Levin M, 2007, BIOESSAYS, V29, P271, DOI 10.1002/bies.20545; Lopez-Gracia ML, 2007, ADV ANAT EMBRYOL CEL, V188, P1; MacPherson MR, 2001, AM J PHYSIOL-CELL PH, V280, pC394, DOI 10.1152/ajpcell.2001.280.2.C394; Marmorstein AD, 2000, P NATL ACAD SCI USA, V97, P12758, DOI 10.1073/pnas.220402097; Marquez J, 2006, NEUROCHEM INT, V48, P465, DOI 10.1016/j.neuint.2005.10.015; McGettigan J, 2005, INSECT BIOCHEM MOLEC, V35, P741, DOI 10.1016/j.ibmb.2005.02.017; Mellroth P, 2006, BIOCHEM BIOPH RES CO, V350, P994, DOI 10.1016/j.bbrc.2006.09.139; Mertens I, 2002, BIOCHEM BIOPH RES CO, V297, P1140, DOI 10.1016/S0006-291X(02)02351-3; Metaxakis A, 2005, GENETICS, V171, P571, DOI 10.1534/genetics.105.041848; Nassel DR, 2011, PEPTIDES, V32, P1335, DOI 10.1016/j.peptides.2011.03.013; O'Donnell MJ, 1998, AM J PHYSIOL-REG I, V274, pR1039, DOI 10.1152/ajpregu.1998.274.4.R1039; ODonnell MJ, 1996, J EXP BIOL, V199, P1163; Overend G, 2011, PEPTIDES; Pifferi S, 2006, P NATL ACAD SCI USA, V103, P12929, DOI 10.1073/pnas.0604505103; Reim I, 2005, DEVELOPMENT, V132, P4911, DOI 10.1242/dev.02077; Rosay P, 1997, J CELL SCI, V110, P1683; Secca T, 2011, J INSECT PHYSIOL, V57, P521, DOI 10.1016/j.jinsphys.2011.02.002; Sharma N, 2008, CURR TOP DEV BIOL, V85, P371, DOI 10.1016/S0070-2153(08)00813-2; Singh SR, 2008, J AM SOC NEPHROL, V19, P660, DOI 10.1681/ASN.2007121307; Singh SR, 2007, CELL STEM CELL, V1, P191, DOI 10.1016/j.stem.2007.07.003; Singh SR, 2009, J EXP BIOL, V212, P413, DOI 10.1242/jeb.024216; Soderberg JAE, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0019866; Southall TD, 2006, PHYSIOL GENOMICS, V26, P35, DOI 10.1152/physiolgenomics.00038.2006; Sozen MA, 1997, P NATL ACAD SCI USA, V94, P5207, DOI 10.1073/pnas.94.10.5207; Stergiopoulos K, 2008, PHYSL GENOMICS; Sutherland MJ, 2009, AM J MED GENET C, V151C, P307, DOI 10.1002/ajmg.c.30228; Terhzaz S, 1999, J EXP BIOL, V202, P3667; Terhzaz S, 2010, CELL SIGNAL, V22, P737, DOI 10.1016/j.cellsig.2009.12.009; Terhzaz S, 2010, PHYSIOL GENOMICS, V41, P33, DOI 10.1152/physiolgenomics.00147.2009; Torrie LS, 2004, P NATL ACAD SCI USA, V101, P13689, DOI 10.1073/pnas.0403087101; Tzou P, 2002, CURR OPIN MICROBIOL, V5, P102, DOI 10.1016/S1369-5274(02)00294-1; Veenstra JA, 2009, CELL TISSUE RES, V336, P309, DOI 10.1007/s00441-009-0769-y; Wang J, 2004, GENOME BIOL, V5, DOI 10.1186/gb-2004-5-9-r69; Wen TQ, 2005, P NATL ACAD SCI USA, V102, P2141, DOI 10.1073/pnas.0406814102; Wessing A, 1999, J INSECT PHYSIOL, V45, P39, DOI 10.1016/S0022-1910(98)00097-3; Wheat CW, 2007, P NATL ACAD SCI USA, V104, P20427, DOI 10.1073/pnas.0706229104; Winterhalter WE, 2009, P ROY SOC B-BIOL SCI, V276, P1109, DOI 10.1098/rspb.2008.1559; Wolfner MF, 2003, CURR BIOL, V13, pR101, DOI 10.1016/S0960-9822(03)00038-1; Wu Q, 2003, NEURON, V39, P147, DOI 10.1016/S0896-6273(03)00396-9; Yang J, 2007, PHYSIOL GENOMICS, V30, P223, DOI 10.1152/physiolgenomics.00018.2007; Yapici N, 2008, NATURE, V451, P33, DOI 10.1038/nature06483; Zeng XK, 2010, J CELL PHYSIOL, V224, P766, DOI 10.1002/jcp.22179	88	42	42	0	17	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 4	2012	7	4							e32577	10.1371/journal.pone.0032577	http://dx.doi.org/10.1371/journal.pone.0032577			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	953GO	22496733	Green Accepted, gold, Green Published, Green Submitted			2022-12-25	WOS:000304855200004
J	Corti, A; Franzini, M; Cianchetti, S; Bergamini, G; Lorenzini, E; Melotti, P; Paolicchi, A; Paggiaro, P; Pompella, A				Corti, Alessandro; Franzini, Maria; Cianchetti, Silvana; Bergamini, Gabriella; Lorenzini, Evelina; Melotti, Paola; Paolicchi, Aldo; Paggiaro, Pierluigi; Pompella, Alfonso			Contribution by Polymorphonucleate Granulocytes to Elevated Gamma-Glutamyltransferase in Cystic Fibrosis Sputum	PLOS ONE			English	Article							HUMAN NEUTROPHILS; OXIDATIVE STRESS; CELL LINES; TRANSPEPTIDASE; GLUTATHIONE; CFTR; INFLAMMATION; TRANSPORT	Background: Cystic fibrosis (CF) is an autosomal recessive disorder characterized by a chronic neutrophilic airways inflammation, increasing levels of oxidative stress and reduced levels of antioxidants such as glutathione (GSH). Gammaglutamyltransferase (GGT), an enzyme induced by oxidative stress and involved in the catabolism of GSH and its derivatives, is increased in the airways of CF patients with inflammation, but the possible implications of its increase have not yet been investigated in detail. Principal Findings: The present study was aimed to evaluate the origin and the biochemical characteristics of the GGT detectable in CF sputum. We found GGT activity both in neutrophils and in the fluid, the latter significantly correlating with myeloperoxidase expression. In neutrophils, GGT was associated with intracellular granules. In the fluid, gel-filtration chromatography showed the presence of two distinct GGT fractions, the first corresponding to the human plasma b-GGT fraction, the other to the free enzyme. The same fractions were also observed in the supernatant of ionomycin and fMLP-activated neutrophils. Western blot analysis confirmed the presence of a single band of GGT immunoreactive peptide in the CF sputum samples and in isolated neutrophils. Conclusions: In conclusion, our data indicate that neutrophils are able to transport and release GGT, thus increasing GGT activity in CF sputum. The prompt release of GGT may have consequences on all GGT substrates, including major inflammatory mediators such as S-nitrosoglutathione and leukotrienes, and could participate in early modulation of inflammatory response.	[Corti, Alessandro; Lorenzini, Evelina; Paolicchi, Aldo; Pompella, Alfonso] Univ Pisa, Scuola Med, Dipartimento Patol Sperimentale, Pisa, Italy; [Franzini, Maria] Scuola Super Sant Anna, Pisa, Italy; [Franzini, Maria; Paolicchi, Aldo] CNR, Fdn Toscana G Monasterio, I-56100 Pisa, Regione Toscana, Italy; [Cianchetti, Silvana; Paggiaro, Pierluigi] Univ Pisa, Dipartimento Cardio Torac & Vasc, Pisa, Italy; [Bergamini, Gabriella; Melotti, Paola] Azienda Osped Verona, Ctr Fibrosi Cist, Verona, Italy; [Bergamini, Gabriella] Univ Verona, Dipartimento Patol & Diagnost, I-37100 Verona, Italy	University of Pisa; Scuola Superiore Sant'Anna; Consiglio Nazionale delle Ricerche (CNR); University of Pisa; University of Verona; Azienda Ospedaliera Universitaria Integrata Verona; University of Verona	Corti, A (corresponding author), Univ Pisa, Scuola Med, Dipartimento Patol Sperimentale, Pisa, Italy.	alessandro.corti@med.unipi.it	Paolicchi, Aldo/K-3946-2018; Franzini, Maria/L-5650-2013; Melotti, Paola/J-6205-2018; Pompella, Alfonso/G-6785-2012	Paolicchi, Aldo/0000-0002-9940-8481; Franzini, Maria/0000-0001-9496-9370; Melotti, Paola/0000-0002-5276-1595; Pompella, Alfonso/0000-0002-6435-9325	Fondazione per la Ricerca sulla Fibrosi Cistica-Onlus (Verona, Italy) [22/2009]	Fondazione per la Ricerca sulla Fibrosi Cistica-Onlus (Verona, Italy)	The present study was supported by a grant from Fondazione per la Ricerca sulla Fibrosi Cistica-Onlus (Verona, Italy; Project FFC#22/2009). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bergamini G, 2009, AM J RESP CELL MOL, V41, P199, DOI 10.1165/rcmb.2008-0013OC; BROM J, 1984, IMMUNOLOGY, V51, P571; Cantin AM, 2007, FREE RADICAL BIO MED, V42, P15, DOI 10.1016/j.freeradbiomed.2006.09.022; Cianchetti S, 2004, EUR RESPIR J, V24, P1018, DOI 10.1183/09031936.04.00139503; Cocucci E, 2009, TRENDS CELL BIOL, V19, P43, DOI 10.1016/j.tcb.2008.11.003; Corti A, 2005, ANTIOXID REDOX SIGN, V7, P911, DOI 10.1089/ars.2005.7.911; Corti A, 2010, ANTICANCER RES, V30, P1169; Elizur A, 2008, CHEST, V133, P489, DOI 10.1378/chest.07-1631; EVJEN G, 1992, CLIN CHIM ACTA, V209, P27, DOI 10.1016/0009-8981(92)90330-S; Franzini M, 2008, CLIN CHIM ACTA, V395, P188, DOI 10.1016/j.cca.2008.06.005; Franzini M, 2008, ANAL BIOCHEM, V374, P1, DOI 10.1016/j.ab.2007.10.025; Gao L, 1999, AM J PHYSIOL-LUNG C, V277, pL113, DOI 10.1152/ajplung.1999.277.1.L113; Gasser O, 2004, BLOOD, V104, P2543, DOI 10.1182/blood-2004-01-0361; GIARD DJ, 1973, J NATL CANCER I, V51, P1417, DOI 10.1093/jnci/51.5.1417; Hanigan MH, 1996, J HISTOCHEM CYTOCHEM, V44, P1101, DOI 10.1177/44.10.8813074; Hess C, 1999, J IMMUNOL, V163, P4564; Hogg N, 1997, BIOCHEM J, V323, P477, DOI 10.1042/bj3230477; Hudson VM, 2001, FREE RADICAL BIO MED, V30, P1440, DOI 10.1016/S0891-5849(01)00530-5; Hull J, 1997, THORAX, V52, P557, DOI 10.1136/thx.52.6.557; HUSEBY NE, 1974, SCAND J CLIN LAB INV, V34, P357, DOI 10.3109/00365517409049892; Hybertson BM, 2000, INFLAMMATION, V24, P289, DOI 10.1023/A:1007092529261; JOYCEBRADY M, 1994, J BIOL CHEM, V269, P14219; Karp DR, 1999, INT IMMUNOL, V11, P1791, DOI 10.1093/intimm/11.11.1791; KHALAF MR, 1987, HISTOCHEM J, V19, P385, DOI 10.1007/BF01680457; Kjeldsen L, 1999, J IMMUNOL METHODS, V232, P131, DOI 10.1016/S0022-1759(99)00171-4; Klebanoff SJ, 2005, J LEUKOCYTE BIOL, V77, P598, DOI 10.1189/jlb.1204697; KOLLER DY, 1995, AM J RESP CRIT CARE, V152, P629, DOI 10.1164/ajrccm.152.2.7633718; KUGELMAN A, 1994, AM J RESP CELL MOL, V11, P586, DOI 10.1165/ajrcmb.11.5.7946387; Linsdell P, 1998, AM J PHYSIOL-CELL PH, V275, pC323, DOI 10.1152/ajpcell.1998.275.1.C323; MORELL A, 1986, AM J HEMATOL, V21, P289, DOI 10.1002/ajh.2830210308; Paolicchi A, 2004, CIRCULATION, V109, P1440, DOI 10.1161/01.CIR.0000120558.41356.E6; Perez-Vilar J, 2004, FREE RADICAL BIO MED, V37, P1564, DOI 10.1016/j.freeradbiomed.2004.07.027; RAULF M, 1985, IMMUNOLOGY, V55, P135; ROUM JH, 1993, J APPL PHYSIOL, V75, P2419, DOI 10.1152/jappl.1993.75.6.2419; Rubin BK, 2007, PAEDIATR RESPIR REV, V8, P4, DOI 10.1016/j.prrv.2007.02.004; vanKlaveren RJ, 1997, FREE RADICAL BIO MED, V22, P525, DOI 10.1016/S0891-5849(96)00375-9; Witko-Sarsat V, 1999, MEDIAT INFLAMM, V8, P7, DOI 10.1080/09629359990658; ZEITLIN PL, 1991, AM J RESP CELL MOL, V4, P313, DOI 10.1165/ajrcmb/4.4.313	38	27	27	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 4	2012	7	4							e34772	10.1371/journal.pone.0034772	http://dx.doi.org/10.1371/journal.pone.0034772			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	953GO	22496859	Green Published, gold, Green Submitted			2022-12-25	WOS:000304855200080
J	Umezawa, T; Kato, A; Ogoshi, M; Ookata, K; Munakata, K; Yamamoto, Y; Islam, Z; Doi, H; Romero, MF; Hirose, S				Umezawa, Takahiro; Kato, Akira; Ogoshi, Maho; Ookata, Kayoko; Munakata, Keijiro; Yamamoto, Yoko; Islam, Zinia; Doi, Hiroyuki; Romero, Michael F.; Hirose, Shigehisa			O-2-Filled Swimbladder Employs Monocarboxylate Transporters for the Generation of O-2 by Lactate-Induced Root Effect Hemoglobin	PLOS ONE			English	Article							RETE-MIRABILE; MOLECULAR CHARACTERIZATION; PHENOTYPIC HETEROGENEITY; STRUCTURAL BASIS; LACTIC-ACID; EEL; SECRETION; FISH; ULTRASTRUCTURE; COTRANSPORTER	The swimbladder volume is regulated by O-2 transfer between the luminal space and the blood In the swimbladder, lactic acid generation by anaerobic glycolysis in the gas gland epithelial cells and its recycling through the rete mirabile bundles of countercurrent capillaries are essential for local blood acidification and oxygen liberation from hemoglobin by the "Root effect." While O-2 generation is critical for fish flotation, the molecular mechanism of the secretion and recycling of lactic acid in this critical process is not clear. To clarify molecules that are involved in the blood acidification and visualize the route of lactic acid movement, we analyzed the expression of 17 members of the H+/monocarboxylate transporter (MCT) family in the fugu genome and found that only MCT1b and MCT4b are highly expressed in the fugu swimbladder. Electrophysiological analyses demonstrated that MCT1b is a high-affinity lactate transporter whereas MCT4b is a low-affinity/high-conductance lactate transporter. Immunohistochemistry demonstrated that (i) MCT4b expresses in gas gland cells together with the glycolytic enzyme GAPDH at high level and mediate lactic acid secretion by gas gland cells, and (ii) MCT1b expresses in arterial, but not venous, capillary endothelial cells in rete mirabile and mediates recycling of lactic acid in the rete mirabile by solute-specific transcellular transport. These results clarified the mechanism of the blood acidification in the swimbladder by spatially organized two lactic acid transporters MCT4b and MCT1b.	[Umezawa, Takahiro; Kato, Akira; Ogoshi, Maho; Ookata, Kayoko; Munakata, Keijiro; Yamamoto, Yoko; Islam, Zinia; Hirose, Shigehisa] Tokyo Inst Technol, Dept Biol Sci, Yokohama, Kanagawa 227, Japan; [Kato, Akira; Romero, Michael F.] Mayo Clin Coll Med, Dept Physiol & Biomed Engn, Rochester, MN USA; [Ogoshi, Maho] Okayama Univ, Shimonoseki Marine Sci Museum, Ushimado Marine Lab, Setouchi, Japan; [Doi, Hiroyuki] Shimonoseki Acad Marine Sci, Shimonoseki, Yamaguchi, Japan	Tokyo Institute of Technology; Mayo Clinic; Okayama University	Umezawa, T (corresponding author), Tokyo Inst Technol, Dept Biol Sci, Midori Ku, Yokohama, Kanagawa 227, Japan.	akirkato@bio.titech.ac.jp	Kato, Akira/E-6328-2010	Kato, Akira/0000-0002-9083-1443	Ministry of Education, Culture, Sport, Science and Technology of Japan (MEXT) [14104002, 18059010, 22370029, 21770077, 23657054]; MEXT; Global Center of Excellence of MEXT; Grants-in-Aid for Scientific Research [22870020] Funding Source: KAKEN	Ministry of Education, Culture, Sport, Science and Technology of Japan (MEXT)(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)); MEXT(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)); Global Center of Excellence of MEXT; Grants-in-Aid for Scientific Research(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI))	This work was supported by Grants-in-Aid for Scientific Research 14104002, 18059010, 22370029, 21770077, and 23657054 from the Ministry of Education, Culture, Sport, Science and Technology of Japan (MEXT), and the 21st Century and Global Center of Excellence Programs of MEXT. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aird WC, 2007, CIRC RES, V100, P158, DOI 10.1161/01.RES.0000255691.76142.4a; Aird WC, 2007, CIRC RES, V100, P174, DOI 10.1161/01.RES.0000255690.03436.ae; Albers JAA, 1806, GOTTINGEN GELEHRTE A, V2, P681; Aparicio S, 2002, SCIENCE, V297, P1301, DOI 10.1126/science.1072104; Berenbrink M, 2005, SCIENCE, V307, P1752, DOI 10.1126/science.1107793; Brittain T, 2005, J INORG BIOCHEM, V99, P120, DOI 10.1016/j.jinorgbio.2004.09.025; DAOUST BG, 1970, COMP BIOCHEM PHYSIOL, V32, P637, DOI 10.1016/0010-406X(70)90818-2; DENTON EJ, 1961, PROG BIOPHYS MOL BIO, V11, P177, DOI 10.1016/S0096-4174(18)30212-9; FANGE R, 1966, PHYSIOL REV, V46, P299, DOI 10.1152/physrev.1966.46.2.299; FANGE R, 1958, BIOL BULL, V115, P172, DOI 10.2307/1539023; Fox JEM, 2000, J PHYSIOL-LONDON, V529, P285, DOI 10.1111/j.1469-7793.2000.00285.x; GARCIA CK, 1994, CELL, V76, P865, DOI 10.1016/0092-8674(94)90361-1; GREEN SL, 1984, CELL TISSUE RES, V237, P277, DOI 10.1007/BF00217146; Halestrap AP, 2004, PFLUG ARCH EUR J PHY, V447, P619, DOI 10.1007/s00424-003-1067-2; Hall FG, 1924, BIOL BULL-US, V47, P79, DOI 10.2307/1536532; ITO N, 1995, J MOL BIOL, V250, P648, DOI 10.1006/jmbi.1995.0405; Jones TW, 1838, LONDON MED GAS, V21, P650; Kato A, 2011, AM J PHYSIOL-REG I, V300, pR284, DOI 10.1152/ajpregu.00725.2009; KOBAYASHI H, 1990, RESP PHYSIOL, V79, P231, DOI 10.1016/0034-5687(90)90129-M; KOBAYASHI H, 1989, RESP PHYSIOL, V78, P45, DOI 10.1016/0034-5687(89)90141-2; Kurita Y, 2008, AM J PHYSIOL-REG I, V294, pR1402, DOI 10.1152/ajpregu.00759.2007; Mylvaganam SE, 1996, NAT STRUCT BIOL, V3, P275, DOI 10.1038/nsb0396-275; Nakada T, 2007, FASEB J, V21, P1067, DOI 10.1096/fj.06-6834com; Pelster B, 2004, MICRON, V35, P73, DOI 10.1016/j.micron.2003.10.021; PELSTER B, 1995, AM J PHYSIOL-REG I, V269, pR793, DOI 10.1152/ajpregu.1995.269.4.R793; PELSTER B, 1993, J EXP BIOL, V185, P169; PELSTER B, 1991, J EXP BIOL, V156, P207; Plata C, 2007, J BIOL CHEM, V282, P11996, DOI 10.1074/jbc.M609313200; RASIO EA, 1977, CIRC RES, V41, P791, DOI 10.1161/01.RES.41.6.791; Romero MF, 1998, AM J PHYSIOL-RENAL, V274, pF425, DOI 10.1152/ajprenal.1998.274.2.F425; Root RW, 1931, BIOL BULL-US, V61, P427, DOI 10.2307/1536959; SCHOLANDER PF, 1953, BIOL BULL, V104, P75, DOI 10.2307/1538693; Siauve N, 1999, JMRI-J MAGN RESON IM, V9, P353, DOI 10.1002/(SICI)1522-2586(199902)9:2<353::AID-JMRI31>3.3.CO;2-L; Tamura K, 2007, MOL BIOL EVOL, V24, P1596, DOI 10.1093/molbev/msm092; THOMPSON JD, 1994, NUCLEIC ACIDS RES, V22, P4673, DOI 10.1093/nar/22.22.4673; WAGNER RC, 1987, MICROVASC RES, V34, P349, DOI 10.1016/0026-2862(87)90067-7; WAGNER RC, 1982, J ULTRA MOL STRUCT R, V81, P37, DOI 10.1016/S0022-5320(82)90039-9; Xie QH, 2002, AM J PHYSIOL-RENAL, V283, pF826, DOI 10.1152/ajprenal.00079.2002	38	11	11	0	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 4	2012	7	4							e34579	10.1371/journal.pone.0034579	http://dx.doi.org/10.1371/journal.pone.0034579			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	953GO	22496829	Green Published, gold, Green Submitted			2022-12-25	WOS:000304855200062
J	Valderrama, M; Crepon, B; Botella-Soler, V; Martinerie, J; Hasboun, D; Alvarado-Rojas, C; Baulac, M; Adam, C; Navarro, V; Le Van Quyen, M				Valderrama, Mario; Crepon, Benoit; Botella-Soler, Vicente; Martinerie, Jacques; Hasboun, Dominique; Alvarado-Rojas, Catalina; Baulac, Michel; Adam, Claude; Navarro, Vincent; Le Van Quyen, Michel			Human Gamma Oscillations during Slow Wave Sleep	PLOS ONE			English	Article							HIGH-FREQUENCY OSCILLATIONS; NEOCORTICAL NEURONS; HZ OSCILLATIONS; BAND RESPONSE; CORTEX; STATES; EEG; SYNCHRONIZATION; RIPPLES; NETWORK	Neocortical local field potentials have shown that gamma oscillations occur spontaneously during slow-wave sleep (SWS). At the macroscopic EEG level in the human brain, no evidences were reported so far. In this study, by using simultaneous scalp and intracranial EEG recordings in 20 epileptic subjects, we examined gamma oscillations in cerebral cortex during SWS. We report that gamma oscillations in low (30-50 Hz) and high (60-120 Hz) frequency bands recurrently emerged in all investigated regions and their amplitudes coincided with specific phases of the cortical slow wave. In most of the cases, multiple oscillatory bursts in different frequency bands from 30 to 120 Hz were correlated with positive peaks of scalp slow waves ("IN-phase'' pattern), confirming previous animal findings. In addition, we report another gamma pattern that appears preferentially during the negative phase of the slow wave ("ANTI-phase'' pattern). This new pattern presented dominant peaks in the high gamma range and was preferentially expressed in the temporal cortex. Finally, we found that the spatial coherence between cortical sites exhibiting gamma activities was local and fell off quickly when computed between distant sites. Overall, these results provide the first human evidences that gamma oscillations can be observed in macroscopic EEG recordings during sleep. They support the concept that these high-frequency activities might be associated with phasic increases of neural activity during slow oscillations. Such patterned activity in the sleeping brain could play a role in off-line processing of cortical networks.	[Valderrama, Mario; Crepon, Benoit; Martinerie, Jacques; Hasboun, Dominique; Alvarado-Rojas, Catalina; Baulac, Michel; Adam, Claude; Navarro, Vincent; Le Van Quyen, Michel] Univ Paris 06, Ctr Rech Inst Cerveau & Moelle Epiniere CRICM, INSERM,UMRS 975, Hop La Pitie Salpetriere,CNRS,UMR 7225, Paris, France; [Botella-Soler, Vicente] Univ Valencia, Dept Fis Teor, CSIC, Valencia, Spain; [Botella-Soler, Vicente] Univ Valencia, Inst Fis Corpuscular IFIC, CSIC, Valencia, Spain; [Crepon, Benoit; Hasboun, Dominique; Baulac, Michel; Adam, Claude; Navarro, Vincent] Grp Hosp Pitie Salpetriere, AP HP, Epilepsy Unit, F-75634 Paris, France; [Valderrama, Mario] Univ Los Andes, Dept Ingn Elect & Elect, Bogota, Colombia	Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Pitie-Salpetriere - APHP; Centre National de la Recherche Scientifique (CNRS); CNRS - National Institute for Biology (INSB); Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Sorbonne Universite; Consejo Superior de Investigaciones Cientificas (CSIC); CSIC - UAM - Institut de Fisica Teorica (IFT); University of Valencia; Consejo Superior de Investigaciones Cientificas (CSIC); CSIC - Instituto de Fisica Corpuscular (IFIC); University of Valencia; Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Pitie-Salpetriere - APHP; UDICE-French Research Universities; Sorbonne Universite; Universidad de los Andes (Colombia)	Valderrama, M (corresponding author), Univ Paris 06, Ctr Rech Inst Cerveau & Moelle Epiniere CRICM, INSERM,UMRS 975, Hop La Pitie Salpetriere,CNRS,UMR 7225, Paris, France.	quyen@t-online.de	Alvarado-Rojas, Catalina/AAR-8761-2021	Valderrama, Mario/0000-0001-8791-6078; Alvarado-Rojas, Catalina/0000-0002-2315-5692; Botella-Soler, Vicente/0000-0002-8790-1914; Navarro, Vincent/0000-0003-0077-8114	European Union [211713]; University of Los Andes; Administrative Department for Science, Technology and Innovation (COLCIENCIAS), Colombia; Generalitat Valenciana; INSERM	European Union(European Commission); University of Los Andes; Administrative Department for Science, Technology and Innovation (COLCIENCIAS), Colombia(Departamento Administrativo de Ciencia, Tecnologia e Innovacion Colciencias); Generalitat Valenciana(Center for Forestry Research & Experimentation (CIEF)European Commission); INSERM(Institut National de la Sante et de la Recherche Medicale (Inserm)European Commission)	This work was partially supported by the European Union-FP7 Project EPILEPSIAE (Evolving Platform for Improving Living Expectation of Subjects Suffering from IctAl Events, Grant No 211713). Mario Valderrama thanks the University of Los Andes and the Administrative Department for Science, Technology and Innovation (COLCIENCIAS), Colombia, for financial support. Vicente Botella-Soler thanks Generalitat Valenciana for financial support. Vincent Navarro was supported by Contrat d'Interface INSERM. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Achermann P, 1997, NEUROSCIENCE, V81, P213, DOI 10.1016/S0306-4522(97)00186-3; Alarcon G, 1997, BRAIN, V120, P2259, DOI 10.1093/brain/120.12.2259; ALLEN PJ, 1992, ELECTROEN CLIN NEURO, V82, P155, DOI 10.1016/0013-4694(92)90160-J; [Anonymous], 1913, P SOC PSYCHICAL RES; Cantero JL, 2004, NEUROIMAGE, V22, P1271, DOI 10.1016/j.neuroimage.2004.03.014; Cash SS, 2009, SCIENCE, V324, P1084, DOI 10.1126/science.1169626; Clemens Z, 2007, BRAIN, V130, P2868, DOI 10.1093/brain/awm146; Compte A, 2008, J NEUROSCI, V28, P13828, DOI 10.1523/JNEUROSCI.2684-08.2008; Crepon B, 2010, BRAIN, V133, P33, DOI 10.1093/brain/awp277; Crone NE, 2001, CLIN NEUROPHYSIOL, V112, P565, DOI 10.1016/S1388-2457(00)00545-9; Dalal SS, 2010, J NEUROSCI, V30, P14285, DOI 10.1523/JNEUROSCI.4275-10.2010; Dang-Vu TT, 2008, P NATL ACAD SCI USA, V105, P15160, DOI 10.1073/pnas.0801819105; Della Marca G, 2007, SLEEP MED, V8, P96, DOI 10.1016/j.sleep.2006.08.004; Destexhe A, 2007, TRENDS NEUROSCI, V30, P334, DOI 10.1016/j.tins.2007.04.006; Dickson CT, 2003, J NEUROPHYSIOL, V90, P39, DOI 10.1152/jn.01063.2002; Fell J, 2002, INT J NEUROSCI, V112, P893, DOI 10.1080/00207450290025905; Grenier F, 2003, J NEUROPHYSIOL, V89, P841, DOI 10.1152/jn.00420.2002; Grenier FO, 2001, J NEUROPHYSIOL, V86, P1884, DOI 10.1152/jn.2001.86.4.1884; Gross DW, 1999, NEUROSCIENCE, V94, P1005, DOI 10.1016/S0306-4522(99)00343-7; Haider B, 2009, NEURON, V62, P171, DOI 10.1016/j.neuron.2009.04.008; Isomura Y, 2006, NEURON, V52, P871, DOI 10.1016/j.neuron.2006.10.023; Jacobs J, 2009, J NEUROSCI, V29, P10203, DOI 10.1523/JNEUROSCI.2187-09.2009; Jensen O, 2007, TRENDS NEUROSCI, V30, P317, DOI 10.1016/j.tins.2007.05.001; Jerbi K, 2009, BRAIN TOPOGR, V22, P18, DOI 10.1007/s10548-009-0078-5; Jerbi K, 2009, HUM BRAIN MAPP, V30, P1758, DOI 10.1002/hbm.20750; Ji DY, 2007, NAT NEUROSCI, V10, P100, DOI 10.1038/nn1825; Lachaux JP, 2005, NEUROIMAGE, V25, P491, DOI 10.1016/j.neuroimage.2004.11.052; Lachaux JP, 1999, HUM BRAIN MAPP, V8, P194, DOI 10.1002/(SICI)1097-0193(1999)8:4<194::AID-HBM4>3.0.CO;2-C; Le Van Quyen M, 2010, J NEUROSCI, V30, P7770, DOI 10.1523/JNEUROSCI.5049-09.2010; Luczak A, 2007, P NATL ACAD SCI USA, V104, P347, DOI 10.1073/pnas.0605643104; Mallat S., 1999, WAVELET TOUR SIGNAL, DOI 10.1016/B978-012466606-1/50008-8; Maloney KJ, 1997, NEUROSCIENCE, V76, P541, DOI 10.1016/S0306-4522(96)00298-9; Massimini M, 2004, J NEUROSCI, V24, P6862, DOI 10.1523/JNEUROSCI.1318-04.2004; Mena-Segovia J, 2008, J PHYSIOL-LONDON, V586, P2947, DOI 10.1113/jphysiol.2008.153874; Menon V, 1996, ELECTROEN CLIN NEURO, V98, P89, DOI 10.1016/0013-4694(95)00206-5; Molle M, 2004, P NATL ACAD SCI USA, V101, P13963, DOI 10.1073/pnas.0402820101; Molle M, 2002, J NEUROSCI, V22, P10941; Montgomery SM, 2007, P NATL ACAD SCI USA, V104, P14495, DOI 10.1073/pnas.0701826104; Mukovski M, 2007, CEREB CORTEX, V17, P400, DOI 10.1093/cercor/bhj157; Murphy M, 2009, P NATL ACAD SCI USA, V106, P1608, DOI 10.1073/pnas.0807933106; Nichols TE, 2002, HUM BRAIN MAPP, V15, P1, DOI 10.1002/hbm.1058; Ossandon T, 2011, J NEUROSCI, V31, P14521, DOI 10.1523/JNEUROSCI.2483-11.2011; Penttonen M, 2003, THALAMUS RELAT SYST, V48, P1; Sejnowski TJ, 2006, J NEUROSCI, V26, P1673, DOI 10.1523/JNEUROSCI.3737-05d.2006; Sejnowski TJ, 2000, BRAIN RES, V886, P208, DOI 10.1016/S0006-8993(00)03007-9; Siapas AG, 2005, NEURON, V46, P141, DOI 10.1016/j.neuron.2005.02.028; Staba RJ, 2002, J NEUROPHYSIOL, V88, P1743, DOI 10.1152/jn.2002.88.4.1743; Steriade M, 1996, J NEUROSCI, V16, P392, DOI 10.1523/jneurosci.16-01-00392.1996; STERIADE M, 1994, TRENDS NEUROSCI, V17, P199; STERIADE M, 1993, J NEUROSCI, V13, P3252, DOI 10.1523/jneurosci.13-08-03252.1993; TallonBaudry C, 1996, J NEUROSCI, V16, P4240; Trajanovic NN, 2007, SLEEP MED, V8, P111, DOI 10.1016/j.sleep.2006.08.013; Volgushev M, 2006, J NEUROSCI, V26, P5665, DOI 10.1523/JNEUROSCI.0279-06.2006; Wolansky T, 2006, J NEUROSCI, V26, P6213, DOI 10.1523/JNEUROSCI.5594-05.2006; Worrell GA, 2004, BRAIN, V127, P1496, DOI 10.1093/brain/awh149; Yuval-Greenberg S, 2008, NEURON, V58, P429, DOI 10.1016/j.neuron.2008.03.027	56	62	63	0	19	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 4	2012	7	4							e33477	10.1371/journal.pone.0033477	http://dx.doi.org/10.1371/journal.pone.0033477			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	953GO	22496749	Green Published, Green Submitted, gold			2022-12-25	WOS:000304855200013
J	Xiao, F; Wang, HX; Fu, XR; Li, YF; Wu, ZG				Xiao, Fang; Wang, Haixia; Fu, Xinrong; Li, Yanfeng; Wu, Zhenguo			TRAF6 Promotes Myogenic Differentiation via the TAK1/p38 Mitogen-Activated Protein Kinase and Akt Pathways	PLOS ONE			English	Article							I-KAPPA-B; P38-ALPHA/BETA MAPK; SIGNALING PATHWAY; TRANSCRIPTIONAL CONTROL; MOLECULAR REGULATION; P38; INSULIN; BINDING; PHOSPHORYLATION; COMPLEX	p38 mitogen-activated protein kinase (MAPK) is an essential kinase involved in myogenic differentiation. Although many substrates of p38 MAPK have been identified, little is known about its upstream activators during myogenic differentiation. TRAF6 is known to function in cytokine signaling during inflammatory responses. However, not much is known about its role in myogenic differentiation and muscle regeneration. We showed here that TRAF6 and its intrinsic ubiquitin E3 ligase activity are required for myogenic differentiation. In mouse myoblasts, knockdown of TRAF6 compromised the p38 MAPK and Akt pathways, while deliberate activation of either pathway rescued the differentiation defect caused by TRAF6 knockdown. TAK1 acted as a key signal transducer downstream of TRAF6 in myogenic differentiation. In vivo, knockdown of TRAF6 in mouse muscles compromised the injury-induced muscle regeneration without impairing macrophage infiltration and myoblast proliferation. Collectively, we demonstrated that TRAF6 promotes myogenic differentiation and muscle regeneration via the TAK1/p38 MAPK and Akt pathways.	[Xiao, Fang; Wang, Haixia; Fu, Xinrong; Li, Yanfeng; Wu, Zhenguo] Hong Kong Univ Sci & Technol, Div Life Sci, State Key Lab Mol Neurosci, Kowloon, Hong Kong, Peoples R China	Hong Kong University of Science & Technology	Xiao, F (corresponding author), Hong Kong Univ Sci & Technol, Div Life Sci, State Key Lab Mol Neurosci, Kowloon, Hong Kong, Peoples R China.	bczgwu@ust.hk	li, yan/GTI-4638-2022	Wu, Zhenguo/0000-0003-3049-8324	Hong Kong Research Grant Council [HKUST6496/06M, 663308, HKUST1/06C]; University Grants Council [AoE/B-15/01]	Hong Kong Research Grant Council(Hong Kong Research Grants Council); University Grants Council	This work was supported by grants from Hong Kong Research Grant Council (HKUST6496/06M, 663308, and HKUST1/06C to ZW) and an Area of Excellence Scheme (AoE/B-15/01) of the University Grants Council. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adhikari A, 2007, ONCOGENE, V26, P3214, DOI 10.1038/sj.onc.1210413; Alessi DR, 1996, EMBO J, V15, P6541, DOI 10.1002/j.1460-2075.1996.tb01045.x; Arnold L, 2007, J EXP MED, V204, P1057, DOI 10.1084/jem.20070075; Berkes CA, 2005, SEMIN CELL DEV BIOL, V16, P585, DOI 10.1016/j.semcdb.2005.07.006; Bhatnagar S, 2010, J BIOL CHEM, V285, P6401, DOI 10.1074/jbc.M109.064063; Black BL, 1998, ANNU REV CELL DEV BI, V14, P167, DOI 10.1146/annurev.cellbio.14.1.167; Blank JL, 1996, J BIOL CHEM, V271, P5361, DOI 10.1074/jbc.271.10.5361; Bois PRJ, 2003, EMBO J, V22, P1147, DOI 10.1093/emboj/cdg116; Buckingham M, 2001, CURR OPIN GENET DEV, V11, P440, DOI 10.1016/S0959-437X(00)00215-X; Cabane C, 2003, AM J PHYSIOL-CELL PH, V284, pC658, DOI 10.1152/ajpcell.00078.2002; Charge SBP, 2004, PHYSIOL REV, V84, P209, DOI 10.1152/physrev.00019.2003; Chung JY, 2002, J CELL SCI, V115, P679; Deng L, 2000, CELL, V103, P351, DOI 10.1016/S0092-8674(00)00126-4; Florini JR, 1996, ENDOCR REV, V17, P481, DOI 10.1210/edrv-17-5-481; Hribal ML, 2003, J CELL BIOL, V162, P535, DOI 10.1083/jcb.200212107; Jiang BH, 1999, P NATL ACAD SCI USA, V96, P2077, DOI 10.1073/pnas.96.5.2077; Kanayama A, 2004, MOL CELL, V15, P535, DOI 10.1016/j.molcel.2004.08.008; Kang JS, 2008, J CELL BIOL, V182, P497, DOI 10.1083/jcb.200801119; Keren A, 2006, MOL CELL ENDOCRINOL, V252, P224, DOI 10.1016/j.mce.2006.03.017; Landstrom M, 2010, INT J BIOCHEM CELL B, V42, P585, DOI 10.1016/j.biocel.2009.12.023; Liu SQ, 2011, CELL RES, V21, P6, DOI 10.1038/cr.2010.170; Lluis F, 2006, TRENDS CELL BIOL, V16, P36, DOI 10.1016/j.tcb.2005.11.002; Lluis F, 2005, EMBO J, V24, P974, DOI 10.1038/sj.emboj.7600528; Lu M, 2010, P NATL ACAD SCI USA, V107, P4212, DOI 10.1073/pnas.0908883107; Molkentin JD, 1996, CURR OPIN GENET DEV, V6, P445, DOI 10.1016/S0959-437X(96)80066-9; Mueck T, 2011, DIFFERENTIATION, V81, P99, DOI 10.1016/j.diff.2010.11.002; Ninomiya-Tsuji J, 1999, NATURE, V398, P252, DOI 10.1038/18465; Palacios D, 2010, CELL STEM CELL, V7, P455, DOI 10.1016/j.stem.2010.08.013; Paul PK, 2010, J CELL BIOL, V191, P1395, DOI 10.1083/jcb.201006098; Perdiguero E, 2007, EMBO J, V26, P1245, DOI 10.1038/sj.emboj.7601587; Potthoff MJ, 2007, DEVELOPMENT, V134, P4131, DOI 10.1242/dev.008367; Puri PL, 2000, J CELL PHYSIOL, V185, P155, DOI 10.1002/1097-4652(200011)185:2<155::AID-JCP1>3.0.CO;2-Z; Rampalli S, 2007, NAT STRUCT MOL BIOL, V14, P1150, DOI 10.1038/nsmb1316; Sabourin LA, 2000, CLIN GENET, V57, P16, DOI 10.1034/j.1399-0004.2000.570103.x; Simone C, 2004, NAT GENET, V36, P738, DOI 10.1038/ng1378; Singhirunnusorn P, 2005, J BIOL CHEM, V280, P7359, DOI 10.1074/jbc.M407537200; Takaesu G, 2006, J CELL BIOL, V175, P383, DOI 10.1083/jcb.200608031; Takeuchi O, 2010, CELL, V140, P805, DOI 10.1016/j.cell.2010.01.022; Tamir Y, 2000, J BIOL CHEM, V275, P34424, DOI 10.1074/jbc.M005815200; Wan J, 2004, MOL CELL BIOL, V24, P192, DOI 10.1128/MCB.24.1.192-199.2004; Wang HX, 2008, MOL BIOL CELL, V19, P1519, DOI 10.1091/mbc.E07-08-0817; Wu ZG, 2000, MOL CELL BIOL, V20, P3951, DOI 10.1128/MCB.20.11.3951-3964.2000; Xia ZP, 2009, NATURE, V461, P114, DOI 10.1038/nature08247; Xu Q, 2000, J BIOL CHEM, V275, P36750, DOI 10.1074/jbc.M005030200; Xu Q, 2002, MOL BIOL CELL, V13, P1940, DOI 10.1091/mbc.02-02-0016; YAMAGUCHI K, 1995, SCIENCE, V270, P2008, DOI 10.1126/science.270.5244.2008; Yang WL, 2009, SCIENCE, V325, P1134, DOI 10.1126/science.1175065; Zetser A, 1999, J BIOL CHEM, V274, P5193, DOI 10.1074/jbc.274.8.5193	48	21	23	1	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 4	2012	7	4							e34081	10.1371/journal.pone.0034081	http://dx.doi.org/10.1371/journal.pone.0034081			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	953GO	22496778	Green Published, Green Submitted, gold			2022-12-25	WOS:000304855200030
J	Zou, ZX; Denny, E; Brown, CE; Jensen, MC; Li, G; Fujii, T; Neman, J; Jandial, R; Chen, MK				Zou, Zhaoxia; Denny, Erin; Brown, Christine E.; Jensen, Michael C.; Li, Gang; Fujii, Tatsuhiro; Neman, Josh; Jandial, Rahul; Chen, Mike			Cytotoxic T Lymphocyte Trafficking and Survival in an Augmented Fibrin Matrix Carrier	PLOS ONE			English	Article							DELIVERY VEHICLE; INDUCIBLE PROTEIN-10; ADOPTIVE TRANSFER; IN-VIVO; CELLS; GLUE; TRANSPLANTATION; CHEMOTAXIS; CLOTS; INTERLEUKIN-2	Cell-based therapies have intriguing potential for the treatment of a variety of neurological disorders. One such example is genetically engineered cytotoxic T lymphocytes (CTLs) that are being investigated in brain tumor clinical trials. The development of methods for CTL delivery is critical to their use in the laboratory and clinical setting. In our study, we determined whether CTLs can migrate through fibrin matrices and if their migration, survival, and function could be modulated by adding chemokines to the matrix. Our results indicated that CTLs can freely migrate through fibrin matrices. As expected, the addition of the monocyte chemotactic protein-1 (MCP-1), also known as chemokine C-C motif ligand 2 (CCL2), to the surrounding media increased egress of the CTLs out of the fibrin clot. Interleukin (IL) -2 and/or IL-15 embedded in the matrix enhanced T cell survival and further promoted T cell migration. The interleukin-13 receptor alpha 2 specific (IL-13R alpha2) T cells that traveled out of the fibrin clot retained the capacity to kill U251 glioma cells. In summary, CTLs can survive and migrate robustly in fibrin matrices. These processes can be influenced by modification of matrix constituents. We conclude that fibrin matrices may be suitable T cell carriers and can be used to facilitate understanding of T cell interaction with the surrounding microenvironment.	[Zou, Zhaoxia; Denny, Erin; Li, Gang; Fujii, Tatsuhiro; Neman, Josh; Jandial, Rahul; Chen, Mike] City Hope Natl Med Ctr, Div Neurosurg, Duarte, CA 91010 USA; [Brown, Christine E.; Jensen, Michael C.] City Hope Natl Med Ctr, Dept Canc Immunotherapeut & Tumor Immunol, Duarte, CA 91010 USA	City of Hope; City of Hope	Zou, ZX (corresponding author), City Hope Natl Med Ctr, Div Neurosurg, 1500 E Duarte Rd, Duarte, CA 91010 USA.	mchen@coh.org	LI, GANG/O-1409-2016	LI, GANG/0000-0003-3203-8567; Brown, Christine/0000-0003-4915-8207				Andrades P, 2007, TRANSPL P, V39, P1607, DOI 10.1016/j.transproceed.2007.01.078; Blanco-Jerez C, 2002, J NEUROIMMUNOL, V128, P90, DOI 10.1016/S0165-5728(02)00146-7; Brown CE, 2007, J IMMUNOL, V179, P3332, DOI 10.4049/jimmunol.179.5.3332; Brown CE, 2009, CANCER RES, V69, P8886, DOI 10.1158/0008-5472.CAN-09-2687; CARR MW, 1994, P NATL ACAD SCI USA, V91, P3652, DOI 10.1073/pnas.91.9.3652; Chen SJ, 2010, STEM CELLS DEV, V19, P1757, DOI 10.1089/scd.2009.0452; Christman KL, 2004, J AM COLL CARDIOL, V44, P654, DOI 10.1016/j.jacc.2004.04.040; Cox S, 2004, TISSUE ENG, V10, P942, DOI 10.1089/1076327041348392; Currie LJ, 2001, PLAST RECONSTR SURG, V108, P1713, DOI 10.1097/00006534-200111000-00045; Dudley ME, 2001, J IMMUNOTHER, V24, P363, DOI 10.1097/00002371-200107000-00012; Falanga V, 2007, TISSUE ENG, V13, P1299, DOI 10.1089/ten.2006.0278; Gille J, 2005, TISSUE CELL, V37, P339, DOI 10.1016/j.tice.2005.05.004; Hafez AT, 2005, J UROLOGY, V174, P1663, DOI 10.1097/01.ju.0000177727.56790.98; Hanson AJ, 2002, J BIOMED MATER RES, V61, P474, DOI 10.1002/jbm.10196; Jung SN, 2010, J CRANIOFAC SURG, V21, P468, DOI 10.1097/SCS.0b013e3181cfea50; Kahlon KS, 2004, CANCER RES, V64, P9160, DOI 10.1158/0008-5472.CAN-04-0454; Kassam A, 2004, ENT-EAR NOSE THROAT, V83, P52; Kassam A, 2004, ENT-EAR NOSE THROAT, V83, P50; Kassam Amin, 2004, Ear Nose Throat J, V83, P246; Kinter AL, 2008, J IMMUNOL, V181, P6738, DOI 10.4049/jimmunol.181.10.6738; Kruse CA, 1997, CANCER IMMUNOL IMMUN, V45, P77, DOI 10.1007/s002620050405; LEE K-C, 1991, Yonsei Medical Journal, V32, P53; Mana M, 2006, WOUND REPAIR REGEN, V14, P72, DOI 10.1111/j.1524-475X.2005.00091.x; Muhammad AKMG, 1997, NEUROL RES, V19, P84; Nishimura F, 2006, CANCER RES, V66, P4478, DOI 10.1158/0008-5472.CAN-05-3825; Rainer C, 2001, J THORAC CARDIOV SUR, V121, P1187, DOI 10.1067/mtc.2001.113936; Rosenberg SA, 2009, CURR OPIN IMMUNOL, V21, P233, DOI 10.1016/j.coi.2009.03.002; Roth SJ, 1995, EUR J IMMUNOL, V25, P3482, DOI 10.1002/eji.1830251241; Roychowdhury S, 2004, CANCER RES, V64, P8062, DOI 10.1158/0008-5472.CAN-04-1860; Sallusto F, 1999, NATURE, V401, P708, DOI 10.1038/44385; Stastny MJ, 2007, J PEDIAT HEMATOL ONC, V29, P669, DOI 10.1097/MPH.0b013e3181468c68; Wechselberger G, 2002, PLAST RECONSTR SURG, V110, P123, DOI 10.1097/00006534-200207000-00022; Wechselberger G, 1998, J UROLOGY, V160, P583, DOI 10.1016/S0022-5347(01)62962-8; Zheng M, 1999, CHINESE MED J-PEKING, V112, P493	34	5	5	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 4	2012	7	4							e34652	10.1371/journal.pone.0034652	http://dx.doi.org/10.1371/journal.pone.0034652			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	953GO	22496835	Green Published, gold, Green Submitted			2022-12-25	WOS:000304855200065
J	Johnstone, D; Milward, EA; Berretta, R; Moscato, P				Johnstone, Daniel; Milward, Elizabeth A.; Berretta, Regina; Moscato, Pablo		Alzheimer's Dis Neuroimaging Initi	Multivariate Protein Signatures of Pre-Clinical Alzheimer's Disease in the Alzheimer's Disease Neuroimaging Initiative (ADNI) Plasma Proteome Dataset	PLOS ONE			English	Article							APOLIPOPROTEIN-E POLYMORPHISM; E GENOTYPE; CEREBROSPINAL-FLUID; APOE POLYMORPHISM; E GENE; BIOMARKERS; ALLELE; ASSOCIATION; MARKERS; CLASSIFICATION	Background: Recent Alzheimer's disease (AD) research has focused on finding biomarkers to identify disease at the preclinical stage of mild cognitive impairment (MCI), allowing treatment to be initiated before irreversible damage occurs. Many studies have examined brain imaging or cerebrospinal fluid but there is also growing interest in blood biomarkers. The Alzheimer's Disease Neuroimaging Initiative (ADNI) has generated data on 190 plasma analytes in 566 individuals with MCI, AD or normal cognition. We conducted independent analyses of this dataset to identify plasma protein signatures predicting pre-clinical AD. Methods and Findings: We focused on identifying signatures that discriminate cognitively normal controls (n=54) from individuals with MCI who subsequently progress to AD (n=163). Based on p value, apolipoprotein E (APOE) showed the strongest difference between these groups (p=2.3 x 10(-13)). We applied a multivariate approach based on combinatorial optimization ((alpha,beta)-k Feature Set Selection), which retains information about individual participants and maintains the context of interrelationships between different analytes, to identify the optimal set of analytes (signature) to discriminate these two groups. We identified 11-analyte signatures achieving values of sensitivity and specificity between 65% and 86% for both MCI and AD groups, depending on whether APOE was included and other factors. Classification accuracy was improved by considering "meta-features," representing the difference in relative abundance of two analytes, with an 8-meta-feature signature consistently achieving sensitivity and specificity both over 85%. Generating signatures based on longitudinal rather than cross-sectional data further improved classification accuracy, returning sensitivities and specificities of approximately 90%. Conclusions: Applying these novel analysis approaches to the powerful and well-characterized ADNI dataset has identified sets of plasma biomarkers for pre-clinical AD. While studies of independent test sets are required to validate the signatures, these analyses provide a starting point for developing a cost-effective and minimally invasive test capable of diagnosing AD in its pre-clinical stages.	[Johnstone, Daniel; Milward, Elizabeth A.; Berretta, Regina; Moscato, Pablo] Univ Newcastle, Prior Res Ctr Bioinformat Biomarker Discovery & I, Callaghan, NSW 2308, Australia; [Johnstone, Daniel; Berretta, Regina; Moscato, Pablo] Univ Newcastle, Sch Elect Engn & Comp Sci, Callaghan, NSW 2308, Australia; [Milward, Elizabeth A.] Univ Newcastle, Sch Biomed Sci & Pharm, Callaghan, NSW 2308, Australia	University of Newcastle; University of Newcastle; University of Newcastle	Johnstone, D (corresponding author), Univ Newcastle, Prior Res Ctr Bioinformat Biomarker Discovery & I, Callaghan, NSW 2308, Australia.	Pablo.Moscato@newcastle.edu.au	Preda, Adrian/K-8889-2013; Johnstone, Daniel/E-9929-2013; MOSCATO, PABLO ALBERTO/G-7668-2013; Hsiung, Robin/AAT-1661-2021; Levey, Allan/F-2104-2011	Preda, Adrian/0000-0003-3373-2438; Johnstone, Daniel/0000-0003-2876-3299; Hsiung, Robin/0000-0002-8017-0856; Levey, Allan/0000-0002-3153-502X; Berretta, Regina/0000-0002-4420-3446; Moscato, Pablo/0000-0003-2570-5966; Milward, Adrienne/0000-0002-1023-7795	University of Newcastle; Hunter Medical Research Institute; Alzheimer's Disease Neuroimaging Initiative (ADNI) (National Institutes of Health) [U01 AG024904]; National Institute on Aging; National Institute of Biomedical Imaging and Bioengineering; NIH [P30 AG010129, K01 AG030514]; Dana Foundation; NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCES [UL1TR001998, UL1TR000117] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON AGING [P30AG013846, U01AG024904, K01AG030514, P30AG019610, R01AG012101, R01AG022374, U19AG010483, P30AG010129] Funding Source: NIH RePORTER	University of Newcastle; Hunter Medical Research Institute; Alzheimer's Disease Neuroimaging Initiative (ADNI) (National Institutes of Health)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); National Institute on Aging(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA)); National Institute of Biomedical Imaging and Bioengineering(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Biomedical Imaging & Bioengineering (NIBIB)); NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Dana Foundation; NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Advancing Translational Sciences (NCATS)); NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA))	The authors of this study have only been funded by The University of Newcastle and the Hunter Medical Research Institute. Data collection and sharing for this project was funded by the Alzheimer's Disease Neuroimaging Initiative (ADNI) (National Institutes of Health Grant U01 AG024904). ADNI was funded by the National Institute on Aging, the National Institute of Biomedical Imaging and Bioengineering, and through generous contributions from the following: Abbott, AstraZeneca AB, Bayer Schering Pharma AG, Bristol-Myers Squibb, Eisai Global Clinical Development, Elan Corporation, Genentech, GE Healthcare, GlaxoSmithKilne, Innogenetics, Johnson and Johnson, Eli Lilly and Co., Medpace, Inc., Merck and Co., Inc., Novartis AD, Pfizer Inc, F. Hoffman-La Roche, Schering-Plough, Synarc, Inc., as well as non-profit partners the Alzheimer's Association and Alzheimer's Drug Discovery Foundation, with participation from the U.S. Food and Drug Administration. Private sector contributions to ADNI are facilitated by the Foundation for the National Institutes of Health (www.fnih.org). The grantee organization is the Northern California Institute for Research and Education, and the study is coordinated by the Alzheimer's Disease Cooperative Study at the University of California, San Diego. ADNI data are disseminated by the Laboratory for Neuro Imaging at the University of California, Los Angeles. This research was also supported by NIH grants P30 AG010129, K01 AG030514, and the Dana Foundation. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Baldi P, 2000, BIOINFORMATICS, V16, P412, DOI 10.1093/bioinformatics/16.5.412; Berretta Regina, 2008, V453, P363, DOI 10.1007/978-1-60327-429-6_19; Bertram L, 2007, NAT GENET, V39, P17, DOI 10.1038/ng1934; Blennow K, 2010, NAT REV NEUROL, V6, P131, DOI 10.1038/nrneurol.2010.4; BOERWINKLE E, 1988, AM J HUM GENET, V42, P104; Burman D, 2009, ATHEROSCLEROSIS, V203, P192, DOI 10.1016/j.atherosclerosis.2008.06.007; Campos F, 2011, CLIN SCI, V121, P11, DOI 10.1042/CS20100427; Caselli RJ, 2004, NEUROLOGY, V62, P1990, DOI 10.1212/01.WNL.0000129533.26544.BF; Castellano JM, 2011, SCI TRANSL MED, V3, DOI 10.1126/scitranslmed.3002156; Corbo RM, 1999, ANN HUM GENET, V63, P301, DOI 10.1046/j.1469-1809.1999.6340301.x; CORDER EH, 1994, NAT GENET, V7, P180, DOI 10.1038/ng0694-180; Cotta C, 2004, LECT NOTES COMPUT SC, V3005, P21; Craig-Schapiro R, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0018850; de Paula MR, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0017481; Eichner JE, 2002, AM J EPIDEMIOL, V155, P487, DOI 10.1093/aje/155.6.487; Eisenberg DTA, 2010, AM J PHYS ANTHROPOL, V143, P100, DOI 10.1002/ajpa.21298; Farrer LA, 1997, JAMA-J AM MED ASSOC, V278, P1349, DOI 10.1001/jama.278.16.1349; FAYYAD UM, 1993, IJCAI-93, VOLS 1 AND 2, P1022; Fiala M, 2010, EXP GERONTOL, V45, P57, DOI 10.1016/j.exger.2009.08.003; Fischer P, 1997, LIFE SCI, V60, P2273, DOI 10.1016/S0024-3205(97)00282-8; Frikke-Schmidt R, 2000, J LIPID RES, V41, P1812; Gerdes LU, 2000, GENET EPIDEMIOL, V19, P202, DOI 10.1002/1098-2272(200010)19:3<202::AID-GEPI2>3.0.CO;2-Q; Golledge J, 2010, ATHEROSCLEROSIS, V209, P487, DOI 10.1016/j.atherosclerosis.2009.09.027; Ravetti MG, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0010153; Hall M., 2009, SIGKDD EXPLORATIONS, V11; Hampel H, 2010, NAT REV DRUG DISCOV, V9, P560, DOI 10.1038/nrd3115; Hampel Harald, 2009, Dialogues Clin Neurosci, V11, P141; Han SH, 2011, J ALZHEIMERS DIS, V25, P77, DOI 10.3233/JAD-2011-102145; Hofer SM, 2002, PSYCHOL AGING, V17, P194, DOI 10.1037//0882-7974.17.2.194; Hu WT, 2010, ACTA NEUROPATHOL, V120, P385, DOI 10.1007/s00401-010-0723-9; Hubacek JA, 2010, HUM IMMUNOL, V71, P304, DOI 10.1016/j.humimm.2010.01.008; Hye A, 2006, BRAIN, V129, P3042, DOI 10.1093/brain/awl279; Laske C, 2011, INT J NEUROPSYCHOPH, P1; Leon AS, 2004, METABOLISM, V53, P108, DOI 10.1016/j.metabol.2003.08.013; Marksteiner J, 2011, NEUROBIOL AGING, V32, P539, DOI 10.1016/j.neurobiolaging.2009.03.011; Mattsson N, 2009, JAMA-J AM MED ASSOC, V302, P385, DOI 10.1001/jama.2009.1064; Mendes Alexandre, 2008, V141, P131; Morris JC, 2010, ANN NEUROL, V67, P122, DOI 10.1002/ana.21843; Moscato P, 2007, BIOSYSTEMS, V88, P56, DOI 10.1016/j.biosystems.2006.04.005; Neale MC, 2000, GENET EPIDEMIOL, V18, P331, DOI 10.1002/(SICI)1098-2272(200004)18:4<331::AID-GEPI6>3.0.CO;2-V; O'Bryant SE, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0028092; Ravetti MG, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0003111; Ray S, 2007, NAT MED, V13, P1359, DOI 10.1038/nm1653; Reiman EM, 2009, P NATL ACAD SCI USA, V106, P6820, DOI 10.1073/pnas.0900345106; Reitz C, 2011, ARCH NEUROL-CHICAGO, V68, P99, DOI 10.1001/archneurol.2010.346; Rogaeva E, 2007, NAT GENET, V39, P168, DOI 10.1038/ng1943; SCHMECHEL DE, 1993, P NATL ACAD SCI USA, V90, P9649, DOI 10.1073/pnas.90.20.9649; Shaw LM, 2009, ANN NEUROL, V65, P403, DOI 10.1002/ana.21610; SIEST G, 1995, CLIN CHEM, V41, P1068; SING CF, 1985, AM J HUM GENET, V37, P268; Slooter AJC, 1998, NEUROSCI LETT, V248, P21, DOI 10.1016/S0304-3940(98)00339-5; Soares HD, 2009, ANN NY ACAD SCI, V1180, P56, DOI 10.1111/j.1749-6632.2009.05066.x; STRITTMATTER WJ, 1993, P NATL ACAD SCI USA, V90, P1977, DOI 10.1073/pnas.90.5.1977; Swan GE, 2005, J GERIATR PSYCH NEUR, V18, P196, DOI 10.1177/0891988705281864; Tarawneh R, 2009, CNS NEUROL DISORD-DR, V8, P144, DOI 10.2174/187152709787847324; Thambisetty M, 2010, J ALZHEIMERS DIS, V22, P1099, DOI 10.3233/JAD-2010-101350; Tiraboschi P, 2004, NEUROLOGY, V62, P1977, DOI 10.1212/01.WNL.0000128091.92139.0F; Vincent-Viry M, 1998, CLIN CHEM, V44, P957; Williams R, 2011, NATURE, V475, pS5, DOI 10.1038/475S5a; Wilson RS, 2002, ARCH NEUROL-CHICAGO, V59, P1154, DOI 10.1001/archneur.59.7.1154	60	50	51	0	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 2	2012	7	4							e34341	10.1371/journal.pone.0034341	http://dx.doi.org/10.1371/journal.pone.0034341			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	952GU	22485168	Green Published, gold			2022-12-25	WOS:000304780500043
J	Zhu, ML; Zheng, XC; Shu, QY; Li, H; Zhong, PX; Zhang, HJ; Xu, YJ; Wang, LJ; Wang, LS				Zhu, Manlan; Zheng, Xuchen; Shu, Qingyan; Li, Hui; Zhong, Peixing; Zhang, Huijin; Xu, Yanjun; Wang, Lijin; Wang, Liangsheng			Relationship between the Composition of Flavonoids and Flower Colors Variation in Tropical Water Lily (Nymphaea) Cultivars	PLOS ONE			English	Article							PERFORMANCE LIQUID-CHROMATOGRAPHY; PHENOLIC-COMPOUNDS; BLUE FLOWERS; ANTHOCYANINS; LEAVES; PETALS; COPIGMENTATION; DELPHINIDIN; POLYPHENOLS; IONIZATION	Water lily, the member of the Nymphaeaceae family, is the symbol of Buddhism and Brahmanism in India. Despite its limited researches on flower color variations and formation mechanism, water lily has background of blue flowers and displays an exceptionally wide diversity of flower colors from purple, red, blue to yellow, in nature. In this study, 34 flavonoids were identified among 35 tropical cultivars by high-performance liquid chromatography (HPLC) with photodiode array detection (DAD) and electrospray ionization mass spectrometry (ESI-MS). Among them, four anthocyanins: delphinidin 3-O-rhamnosyl-5-O-galactoside (Dp3Rh5Ga), delphinidin 3-O-(2 ''-O-galloyl-6 ''-O-oxalyl-rhamnoside) (Dp3galloyl-oxalylRh), delphinidin 3-O-(6 ''-O-acetyl-beta-glucopyranoside) (Dp3acetylG) and cyanidin 3-O-(2 ''-O-galloyl-galactopyranoside)-5-O-rhamnoside (Cy3galloylGa5Rh), one chalcone: chalcononaringenin 2'-O-galactoside (Chal2'Ga) and twelve flavonols: myricetin 7-O-rhamnosyl-(1 -> 2)-rhamnoside (My7RhRh), quercetin 7-O-galactosyl-(1 -> 2)-rhamnoside (Qu7GaRh), quercetin 7-O-galactoside (Qu7Ga), kaempferol 7-O-galactosyl-(1 -> 2)-rhamnoside (Km7GaRh), myricetin 3-O-galactoside (My3Ga), kaempferol 7-O-galloylgalactosyl-(1 -> 2)-rhamnoside (Km7galloylGaRh), myricetin 3-O-galloylrhamnoside (My3galloylRh), kaempferol 3-O-galactoside (Km3Ga), isorhamnetin 7-O-galactoside (Is7Ga), isorhamnetin 7-O-xyloside (Is7Xy), kaempferol 3-O-(3 ''-acetylrhamnoside) (Km3-3 '' acetylRh) and quercetin 3-O-acetylgalactoside (Qu3acetylGa) were identified in the petals of tropic water lily for the first time. Meanwhile a multivariate analysis was used to explore the relationship between pigments and flower color. By comparing, the cultivars which were detected delphinidin 3-galactoside (Dp3Ga) presented amaranth, and detected delphinidin 3'-galactoside (Dp3'Ga) presented blue. However, the derivatives of delphinidin and cyanidin were more complicated in red group. No anthocyanins were detected within white and yellow group. At the same time a possible flavonoid biosynthesis pathway of tropical water lily was presumed putatively. These studies will help to elucidate the evolution mechanism on the formation of flower colors and provide theoretical basis for outcross breeding and developing health care products from this plant.	[Zhu, Manlan; Zheng, Xuchen; Shu, Qingyan; Li, Hui; Zhong, Peixing; Zhang, Huijin; Wang, Lijin; Wang, Liangsheng] Chinese Acad Sci, Inst Bot, Key Lab Plant Resources, Beijing Bot Garden, Beijing, Peoples R China; [Zhu, Manlan; Zheng, Xuchen; Zhong, Peixing] Nanjing Agr Univ, Coll Hort, Nanjing, Jiangsu, Peoples R China; [Li, Hui; Wang, Lijin] Chinese Acad Sci, Grad Univ, Beijing, Peoples R China; [Xu, Yanjun] China Agr Univ, Dept Appl Chem, Beijing 100094, Peoples R China	Chinese Academy of Sciences; Institute of Botany, CAS; Nanjing Agricultural University; Chinese Academy of Sciences; University of Chinese Academy of Sciences, CAS; China Agricultural University	Zhu, ML (corresponding author), Chinese Acad Sci, Inst Bot, Key Lab Plant Resources, Beijing Bot Garden, Beijing, Peoples R China.	shuqy@ibcas.ac.cn; wanglsh@ibcas.ac.cn			National Natural Science Foundation of China [31071824]; International Science & Technology Cooperation Program of China [2011DFA30560]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); International Science & Technology Cooperation Program of China	The authors appreciate the support of the National Natural Science Foundation of China, No. 31071824, as well as International Science & Technology Cooperation Program of China, no. 2011DFA30560. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abad-Garcia B, 2009, J CHROMATOGR A, V1216, P5398, DOI 10.1016/j.chroma.2009.05.039; Abulajiang Ke yimu, 2006, STUDY MASS SPECTROME; Afaq F, 2007, J INVEST DERMATOL, V127, P222, DOI 10.1038/sj.jid.5700510; Androutsopoulos VP, 2010, PHARMACOL THERAPEUT, V126, P9, DOI 10.1016/j.pharmthera.2010.01.009; Bomser J, 1996, PLANTA MED, V62, P212, DOI 10.1055/s-2006-957862; Bown D., 1995, ENCY HERBS THEIR USE; Bravo L, 1998, NUTR REV, V56, P317, DOI 10.1111/j.1753-4887.1998.tb01670.x; Cuyckens F, 2004, J MASS SPECTROM, V39, P1, DOI [10.1002/jms.585, 10.1002/jms.622]; Du QZ, 2004, J CHROMATOGR A, V1045, P59, DOI 10.1016/j.chroma.2004.06.017; Elegami AA, 2003, PHYTOCHEMISTRY, V63, P727, DOI 10.1016/S0031-9422(03)00238-3; Fossen T, 1998, PHYTOCHEMISTRY, V49, P1997, DOI 10.1016/S0031-9422(98)00420-8; Fossen T, 2001, J HORTIC SCI BIOTECH, V76, P213; Fossen T, 1999, PHYTOCHEMISTRY, V50, P1185, DOI 10.1016/S0031-9422(98)00649-9; Fossen T, 1998, PHYTOCHEMISTRY, V48, P823, DOI 10.1016/S0031-9422(97)00918-7; Fossen T, 1997, PHYTOCHEMISTRY, V46, P353, DOI 10.1016/S0031-9422(97)00293-8; Fossen T, 1999, PHYTOCHEMISTRY, V51, P1133, DOI 10.1016/S0031-9422(99)00049-7; Gonnet JF, 1999, FOOD CHEM, V66, P387, DOI 10.1016/S0308-8146(99)00088-6; Gonnet JF, 1998, FOOD CHEM, V63, P409, DOI 10.1016/S0308-8146(98)00053-3; HARBORNE JB, 1958, BIOCHEM J, V70, P22, DOI 10.1042/bj0700022; HARBORNE JB, 1962, BIOCHEM J, V84, P100, DOI 10.1042/bj0840100; He QL, 2011, PLOS ONE, V6, P1; Hou DX, 2005, BIOCHEM PHARMACOL, V70, P417, DOI 10.1016/j.bcp.2005.05.003; Huang G., 2009, WATER LILY; Jambor J, 1992, ACTA SOC BOT POL, V60, P119; Jambor Jerzy, 1991, Acta Societatis Botanicorum Poloniae, V60, P119, DOI 10.5586/asbp.1991.010; Juranic Z, 2005, BIOFACTORS, V23, P207, DOI 10.1002/biof.5520230405; Li CH, 2009, J AGR FOOD CHEM, V57, P8496, DOI 10.1021/jf902103b; Li QQ, 2005, PRACTICAL FORESTRY T, V10, P45; Lin LZ, 2007, J AGR FOOD CHEM, V55, P1084, DOI 10.1021/jf062431s; Liu RN, 2007, J ASIAN NAT PROD RES, V9, P333, DOI 10.1080/10286020600727665; Ma YL, 2001, PHYTOCHEM ANALYSIS, V12, P159, DOI 10.1002/pca.573; Markham KR, 1982, FLAVONOIDS ADV RES, V5-6, P37; Marquina S, 2005, PHYTOCHEMISTRY, V66, P921, DOI 10.1016/j.phytochem.2005.02.027; Pedreschi R, 2007, FOOD CHEM, V100, P956, DOI 10.1016/j.foodchem.2005.11.004; Shi YF, 2009, CHINA FRUIT VEGETABL, V8, P40; Solomon A, 2006, J AGR FOOD CHEM, V54, P7717, DOI 10.1021/jf060497h; Springob K, 2003, NAT PROD REP, V20, P288, DOI 10.1039/b109542k; Tanaka Y, 2005, PLANT CELL TISS ORG, V80, P1, DOI 10.1007/s11240-004-0739-8; The Chinese Academy of Sciences Flora Reipublicae Popularis Sinicae Editorial Board, 1979, FLOR REIP POP SIN, V27, P8; Wang LS, 2001, J PLANT RES, V114, P33, DOI 10.1007/PL00013966; Yang RZ, 2009, J CHROMATOGR A, V1216, P106, DOI 10.1016/j.chroma.2008.11.046; Yoshida H, 2004, SCI HORTIC-AMSTERDAM, V99, P175, DOI 10.1016/S0304-4238(03)00093-1; Zafra-Stone S, 2007, MOL NUTR FOOD RES, V51, P675, DOI 10.1002/mnfr.200700002; Zhang JJ, 2007, SCI HORTIC-AMSTERDAM, V114, P104, DOI 10.1016/j.scienta.2007.05.009; Zhang ZZ, 2003, J NAT PROD, V66, P548, DOI 10.1021/np020442j	45	36	44	2	90	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 2	2012	7	4							e34335	10.1371/journal.pone.0034335	http://dx.doi.org/10.1371/journal.pone.0034335			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	952GU	22485167	gold, Green Published, Green Submitted			2022-12-25	WOS:000304780500042
J	Dixon, MJ; Gray, A; Schenning, M; Agacan, M; Tempel, W; Tong, YF; Nedyalkova, L; Park, HW; Leslie, NR; van Aalten, DMF; Downes, CP; Batty, IH				Dixon, Miles J.; Gray, Alexander; Schenning, Martijn; Agacan, Mark; Tempel, Wolfram; Tong, Yufeng; Nedyalkova, Lyudmila; Park, Hee-Won; Leslie, Nicholas R.; van Aalten, Daan M. F.; Downes, C. Peter; Batty, Ian H.			IQGAP Proteins Reveal an Atypical Phosphoinositide (aPI) Binding Domain with a Pseudo C2 Domain Fold	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							PLECKSTRIN; CELL; RECEPTOR; 3-KINASE; PHOSPHATASES; RECOGNITION; SECONDARY; ACTIN; TOOL	Class I phosphoinositide (PI) 3-kinases act through effector proteins whose 3-PI selectivity is mediated by a limited repertoire of structurally defined, lipid recognition domains. We describe here the lipid preferences and crystal structure of a new class of PI binding modules exemplified by select IQGAPs (IQ motif containing GTPase-activating proteins) known to coordinate cellular signaling events and cytoskeletal dynamics. This module is defined by a C-terminal 105-107 amino acid region of which IQGAP1 and -2, but not IQGAP3, binds preferentially to phosphatidylinositol 3,4,5-trisphosphate (PtdInsP3). The binding affinity for PtdInsP3, together with other, secondary target-recognition characteristics, are comparable with those of the pleckstrin homology domain of cytohesin-3 (general receptor for phosphoinositides 1), an established PtdInsP3 effector protein. Importantly, the IQGAP1 C-terminal domain and the cytohesin- 3 pleckstrin homology domain, each tagged with enhanced green fluorescent protein, were both re-localized from the cytosol to the cell periphery following the activation of PI 3-kinase in Swiss 3T3 fibroblasts, consistent with their common, selective recognition of endogenous 3-PI(s). The crystal structure of the C-terminal IQGAP2 PI binding module reveals unexpected topological similarity to an integral fold of C2 domains, including a putative basic binding pocket. We propose that this module integrates select IQGAP proteins with PI 3-kinase signaling and constitutes a novel, atypical phosphoinositide binding domain that may represent the first of a larger group, each perhaps structurally unique but collectively dissimilar from the known PI recognition modules.	[Dixon, Miles J.; Gray, Alexander; Schenning, Martijn; Leslie, Nicholas R.; van Aalten, Daan M. F.; Downes, C. Peter; Batty, Ian H.] Univ Dundee, Coll Life Sci, Div Cell Signalling & Immunol, Dundee DD1 5EH, Scotland; [Agacan, Mark] Univ Dundee, Coll Life Sci, Div Biol Chem & Drug Discovery, Dundee DD1 5EH, Scotland; [Tempel, Wolfram; Tong, Yufeng; Nedyalkova, Lyudmila; Park, Hee-Won] Univ Toronto, Struct Genom Consortium, Toronto, ON M5G 1L5, Canada; [Park, Hee-Won] Univ Toronto, Dept Pharmacol, Toronto, ON M5G 1L5, Canada	University of Dundee; University of Dundee; University of Toronto; Structural Genomics Consortium; University of Toronto	Batty, IH (corresponding author), Univ Dundee, Coll Life Sci, Div Cell Signalling & Immunol, Dow St, Dundee DD1 5EH, Scotland.	i.h.batty@dundee.ac.uk	Leslie, Nicholas/D-2699-2009; Tong, Yufeng/D-2785-2011	Tong, Yufeng/0000-0001-7740-1812; van Aalten, Daan/0000-0002-1499-6908; Gray, Alexander/0000-0001-9227-0363; LESLIE, Nicholas/0000-0001-5131-0541	Medical Research Council, United Kingdom Programme [G0801865]; Wellcome Trust [083481, WT087590MA]; MRC [G0900138, G9403619, G0801865] Funding Source: UKRI; Medical Research Council [G9403619, G0900138, G0801865] Funding Source: researchfish	Medical Research Council, United Kingdom Programme(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Wellcome Trust(Wellcome TrustEuropean Commission); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission)	This work was supported in part by Medical Research Council, United Kingdom Programme Grant G0801865 (to M. J. D., A. G., M. S., N. R. L., C. P. D., and I. H. B.).; Supported by Wellcome Trust Grant 083481.; Supported by Wellcome Trust Senior Research Fellowship WT087590MA.	Batty IH, 2007, BIOCHEM J, V407, P255, DOI 10.1042/BJ20070558; BATTY IH, 1994, BIOCHEM J, V297, P529, DOI 10.1042/bj2970529; BATTY IR, 1985, BIOCHEM J, V232, P211, DOI 10.1042/bj2320211; Brandt DT, 2007, EMBO REP, V8, P1019, DOI 10.1038/sj.embor.7401089; Brandt DT, 2007, J CELL BIOL, V178, P193, DOI 10.1083/jcb.200612071; Brown MD, 2006, TRENDS CELL BIOL, V16, P242, DOI 10.1016/j.tcb.2006.03.002; Cain RJ, 2009, BIOL CELL, V101, P13, DOI 10.1042/BC20080079; Cantley LC, 2002, SCIENCE, V296, P1655, DOI 10.1126/science.296.5573.1655; Corbalan-Garcia S, 2007, BIOCHEM SOC T, V35, P1046, DOI 10.1042/BST0351046; Corbalan-Garcia S, 2003, J BIOL CHEM, V278, P4972, DOI 10.1074/jbc.M209385200; Di Paolo G, 2006, NATURE, V443, P651, DOI 10.1038/nature05185; DiNitto Jonathan P, 2003, Sci STKE, V2003, pre16, DOI 10.1126/stke.2132003re16; Dixon MJ, 2011, MOL CELL PROTEOMICS, V10, DOI 10.1074/mcp.M110.003178; Dong AP, 2007, NAT METHODS, V4, P1019, DOI 10.1038/nmeth1118; Downes CP, 2007, BIOCHEM SOC T, V35, P188, DOI 10.1042/BST0350188; Emsley P, 2010, ACTA CRYSTALLOGR D, V66, P486, DOI 10.1107/S0907444910007493; Ferguson KM, 2000, MOL CELL, V6, P373, DOI 10.1016/S1097-2765(00)00037-X; Garcia P, 1995, BIOCHEMISTRY-US, V34, P16228, DOI 10.1021/bi00049a039; Gray A, 1999, BIOCHEM J, V344, P929, DOI 10.1042/0264-6021:3440929; Gray A, 2003, ANAL BIOCHEM, V313, P234, DOI 10.1016/S0003-2697(02)00607-3; Guerrero-Valero M, 2009, P NATL ACAD SCI USA, V106, P6603, DOI 10.1073/pnas.0813099106; Hawkins PT, 2006, BIOCHEM SOC T, V34, P647, DOI 10.1042/BST0340647; HOLM L, 1995, TRENDS BIOCHEM SCI, V20, P478, DOI 10.1016/S0968-0004(00)89105-7; Irvine RF, 2001, NAT REV MOL CELL BIO, V2, P327, DOI 10.1038/35073015; Klarlund JK, 1997, SCIENCE, V275, P1927, DOI 10.1126/science.275.5308.1927; Kok K, 2009, TRENDS BIOCHEM SCI, V34, P115, DOI 10.1016/j.tibs.2009.01.003; Krissinel E, 2004, ACTA CRYSTALLOGR D, V60, P2256, DOI 10.1107/S0907444904026460; Kutateladze TG, 2010, NAT CHEM BIOL, V6, P507, DOI [10.1038/NCHEMBIO.390, 10.1038/nchembio.390]; Lemmon MA, 2003, TRAFFIC, V4, P201, DOI 10.1034/j.1600-0854.2004.00071.x; Lemmon MA, 2008, NAT REV MOL CELL BIO, V9, P99, DOI 10.1038/nrm2328; Leslie NR, 2002, CELL SIGNAL, V14, P285, DOI 10.1016/S0898-6568(01)00234-0; Li ZG, 1999, J BIOL CHEM, V274, P37885, DOI 10.1074/jbc.274.53.37885; Majerus PW, 1999, J BIOL CHEM, V274, P10669, DOI 10.1074/jbc.274.16.10669; Marone R, 2008, BBA-PROTEINS PROTEOM, V1784, P159, DOI 10.1016/j.bbapap.2007.10.003; Moravcevic K, 2012, STRUCTURE, V20, P15, DOI 10.1016/j.str.2011.11.012; Murshudov GN, 1997, ACTA CRYSTALLOGR D, V53, P240, DOI 10.1107/S0907444996012255; Narayan K, 2006, METHODS, V39, P122, DOI 10.1016/j.ymeth.2006.05.006; Noritake J, 2005, J CELL SCI, V118, P2085, DOI 10.1242/jcs.02379; Otwinowski Z, 1997, METHOD ENZYMOL, V276, P307, DOI 10.1016/S0076-6879(97)76066-X; Pape T, 2004, J APPL CRYSTALLOGR, V37, P843, DOI 10.1107/S0021889804018047; Perrakis A, 1999, NAT STRUCT BIOL, V6, P458, DOI 10.1038/8263; Stenmark H, 1999, J CELL SCI, V112, P4175; Stephens L, 2008, CURR BIOL, V18, pR485, DOI 10.1016/j.cub.2008.04.048; STEPHENS LR, 1993, BIOCHIM BIOPHYS ACTA, V1179, P27, DOI 10.1016/0167-4889(93)90072-W; SUTTON RB, 1995, CELL, V80, P929, DOI 10.1016/0092-8674(95)90296-1; Tirnauer JS, 2004, DEV CELL, V7, P778, DOI 10.1016/j.devcel.2004.11.012; Van der Kaay J, 1999, J BIOL CHEM, V274, P35963, DOI 10.1074/jbc.274.50.35963; Vanhaesebroeck B, 2001, ANNU REV BIOCHEM, V70, P535, DOI 10.1146/annurev.biochem.70.1.535; Verdaguer N, 1999, EMBO J, V18, P6329, DOI 10.1093/emboj/18.22.6329; White CD, 2012, CELL SIGNAL, V24, P826, DOI 10.1016/j.cellsig.2011.12.005; White CD, 2009, FEBS LETT, V583, P1817, DOI 10.1016/j.febslet.2009.05.007	51	20	22	0	1	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JUN 29	2012	287	27					22483	22496		10.1074/jbc.M112.352773	http://dx.doi.org/10.1074/jbc.M112.352773			14	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	975GB	22493426	hybrid, Green Published			2022-12-25	WOS:000306495000007
J	Chung, H; Lee, JH; Jeong, D; Han, IO; Oh, ES				Chung, Heesung; Lee, Jung-hyun; Jeong, Dayun; Han, Inn-Oc; Oh, Eok-Soo			Melanocortin 1 Receptor Regulates Melanoma Cell Migration by Controlling Syndecan-2 Expression	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							AGOUTI SIGNAL PROTEIN; FOCAL ADHESION KINASE; NECROSIS-FACTOR-ALPHA; STIMULATING HORMONE; SKIN PIGMENTATION; HEPARAN-SULFATE; RED HAIR; MELANOCYTES; MC1R; KERATINOCYTES	The melanocortin 1 receptor (MC1R), a key regulator of melanogenesis, is known to control inflammation, acting in concert with the MC1R ligand alpha-melanocyte-stimulating hormone. Although cell migration is a key event in inflammation, few studies have addressed the function of MC1R in this context. Using highly motile melanoma cells, we found that the expression level of MC1R was associated with the extent of migration of mouse melanoma cells, suggesting that MC1R plays a functional role in controlling this migration. Overexpression of MC1R enhanced melanoma cell migration, whereas the opposite was true when MC1R levels were knocked down using small inhibitory RNAs. Interestingly, MC1R expression enhanced the synthesis of syndecan-2, a cell surface heparan sulfate proteoglycan known to be involved in melanoma cell migration. Knockdown of syndecan-2 expression decreased MC1R-mediated cell migration. Further, MC1R inhibited the activation of p38 MAPK, subsequently enhancing expression of sydnecan-2, in parallel with an increase in the extent of cell migration. Consistently, activation of p38 by H2O2 inhibited syndecan-2 expression and cell migration, whereas inhibition of p38 activation enhanced syndecan-2 expression and cell migration. Finally, we found that alpha-melanocyte-stimulating hormone inhibited MC1R-mediated cell migration via activation of p38 and inhibition of syndecan-2 expression. Together, the data strongly suggest that MC1R regulates melanoma cell migration via inhibition of syndecan-2 expression.	[Chung, Heesung; Lee, Jung-hyun; Jeong, Dayun; Oh, Eok-Soo] Ewha Womans Univ, Dept Life Sci, Div Life & Pharmaceut Sci, Seoul 120750, South Korea; [Chung, Heesung; Lee, Jung-hyun; Jeong, Dayun; Oh, Eok-Soo] Ewha Womans Univ, Ctr Cell Signaling & Drug Discovery Res, Seoul 120750, South Korea; [Han, Inn-Oc] Inha Univ, Dept Physiol & Biophys, Coll Med, Inchon 402751, South Korea	Ewha Womans University; Ewha Womans University; Inha University	Oh, ES (corresponding author), Ewha Womans Univ, Dept Life Sci, Div Life & Pharmaceut Sci, 52 Ewhayeodae Gil, Seoul 120750, South Korea.	OhES@ewha.ac.kr	Lee, Jung-Hyun/AAL-2954-2021	Lee, Jung-Hyun/0000-0003-1913-0027	National Research Foundation of Korea; Ministry of Education, Science and Technology [2009-0071381, 2010-0028042]	National Research Foundation of Korea(National Research Foundation of Korea); Ministry of Education, Science and Technology(Ministry of Education, Science & Technology (MEST), Republic of Korea)	This work was supported by the Basic Science Research Program through the National Research Foundation of Korea funded by Ministry of Education, Science and Technology Grants 2009-0071381 and 2010-0028042 (to E.-S. O.).	Abdel-Malek ZA, 2001, CELL MOL LIFE SCI, V58, P434, DOI 10.1007/PL00000868; Chen E, 2004, BLOOD, V103, P1710, DOI 10.1182/blood-2003-06-1783; Chluba-de Tapia J, 1996, J CELL SCI, V109, P2023; Choi Y, 2011, MATRIX BIOL, V30, P93, DOI 10.1016/j.matbio.2010.10.006; Choi Y, 2010, BIOCHEM BIOPH RES CO, V391, P921, DOI 10.1016/j.bbrc.2009.11.165; Clasper S, 1999, J BIOL CHEM, V274, P24113, DOI 10.1074/jbc.274.34.24113; Cone RD, 2006, ENDOCR REV, V27, P736, DOI 10.1210/er.2006-0034; DELUCA M, 1993, J CELL SCI, V105, P1079; Eves P, 2003, BRIT J CANCER, V89, P2004, DOI 10.1038/sj.bjc.6601349; Haycock JW, 2000, J BIOL CHEM, V275, P15629, DOI 10.1074/jbc.275.21.15629; Kauser S, 2005, ENDOCRINOLOGY, V146, P532, DOI 10.1210/en.2004-1145; Le Pape E, 2009, P NATL ACAD SCI USA, V106, P1802, DOI 10.1073/pnas.0806753106; Lee H, 2011, BIOCHEM BIOPH RES CO, V409, P148, DOI 10.1016/j.bbrc.2011.04.135; Lee JH, 2009, J BIOL CHEM, V284, P27167, DOI 10.1074/jbc.M109.034678; Lin JY, 2007, NATURE, V445, P843, DOI 10.1038/nature05660; Mahalingam Y, 2007, J BIOL CHEM, V282, P3221, DOI 10.1074/jbc.M604938200; Manceau M, 2011, SCIENCE, V331, P1062, DOI 10.1126/science.1200684; Newton RA, 2007, PEPTIDES, V28, P2387, DOI 10.1016/j.peptides.2007.10.003; Park H, 2005, CANCER RES, V65, P9899, DOI 10.1158/0008-5472.CAN-05-1386; Parsons JT, 2003, J CELL SCI, V116, P1409, DOI 10.1242/jcs.00373; POSTE G, 1982, CANCER RES, V42, P2770; Redondo P, 1998, ARCH DERMATOL RES, V290, P425, DOI 10.1007/s004030050330; Roberts DW, 2008, J CELL PHYSIOL, V215, P344, DOI 10.1002/jcp.21318; Sakai C, 1997, EMBO J, V16, P3544, DOI 10.1093/emboj/16.12.3544; Salazar-Onfray F, 2002, BRIT J CANCER, V87, P414, DOI 10.1038/sj.bjc.6600441; Scott GA, 1998, J INVEST DERMATOL, V111, P243, DOI 10.1046/j.1523-1747.1998.00276.x; SOLCA FF, 1993, FEBS LETT, V322, P177, DOI 10.1016/0014-5793(93)81563-F; VALVERDE P, 1995, NAT GENET, V11, P328, DOI 10.1038/ng1195-328; Wagner EF, 2009, NAT REV CANCER, V9, P537, DOI 10.1038/nrc2694; Yamaguchi Y, 2007, J BIOL CHEM, V282, P27557, DOI 10.1074/jbc.R700026200; Zhu N, 2004, BRIT J CANCER, V90, P1457, DOI 10.1038/sj.bjc.6601698; Zhu NW, 2002, J INVEST DERMATOL, V119, P1165, DOI 10.1046/j.1523-1747.2002.19516.x; Zhuang SG, 2000, J BIOL CHEM, V275, P25939, DOI 10.1074/jbc.M001185200	33	34	36	0	5	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JUN 1	2012	287	23					19326	19335		10.1074/jbc.M111.334730	http://dx.doi.org/10.1074/jbc.M111.334730			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	974EF	22493442	hybrid, Green Published			2022-12-25	WOS:000306411900042
J	Meir, A; Bayer, EA; Livnah, O				Meir, Amit; Bayer, Edward A.; Livnah, Oded			Structural Adaptation of a Thermostable Biotin-binding Protein in a Psychrophilic Environment	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							AVIDIN; STREPTAVIDIN; TRYPTOPHAN; SINGLE; DIMER; PURIFICATION; TECHNOLOGY; EXPRESSION; STABILITY; BACTERIUM	Shwanavidin is an avidin-like protein from the marine proteo-bactrium Shewanella denitrificans, which exhibits an innate dimeric structure while maintaining high affinity toward biotin. A unique residue (Phe-43) from the L3,4 loop and a distinctive disulfide bridge were shown to account for the high affinity toward biotin. Phe-43 emulates the function and position of the critical intermonomeric Trp that characterizes the tetrameric avidins but is lacking in shwanavidin. The 18 copies of the apo-monomer revealed distinctive snapshots of L3,4 and Phe-43, providing rare insight into loop flexibility, binding site accessibility, and psychrophilic adaptation. Nevertheless, as in all avidins, shwanavidin also displays high thermostability properties. The unique features of shwanavidin may provide a platform for the design of a long sought after monovalent form of avidin, which would be ideal for novel types of biotechnological application.	[Meir, Amit; Livnah, Oded] Hebrew Univ Jerusalem, Wolfson Ctr Appl Struct Biol, Alexander Silverman Inst Life Sci, Dept Biol Chem, IL-91904 Jerusalem, Israel; [Bayer, Edward A.] Weizmann Inst Sci, Dept Biol Chem, IL-76100 Rehovot, Israel	Hebrew University of Jerusalem; Weizmann Institute of Science	Livnah, O (corresponding author), Hebrew Univ Jerusalem, Wolfson Ctr Appl Struct Biol, Alexander Silverman Inst Life Sci, Dept Biol Chem, IL-91904 Jerusalem, Israel.	oded.livnah@huji.ac.il		Meir, Amit/0000-0001-9635-1021				Arnold K, 2006, BIOINFORMATICS, V22, P195, DOI 10.1093/bioinformatics/bti770; BAILEY S, 1994, ACTA CRYSTALLOGR D, V50, P760, DOI 10.1107/s0907444994003112; BAYER EA, 1995, BBA-GENE STRUCT EXPR, V1263, P60, DOI 10.1016/0167-4781(95)00077-T; BAYER EA, 1990, J CHROMATOGR, V510, P3, DOI 10.1016/S0021-9673(01)93733-1; Brettar I, 2002, INT J SYST EVOL MICR, V52, P2211, DOI 10.1099/00207713-52-6-2211; Brettar I, 2012, ISME J, V6, P195, DOI 10.1038/ismej.2011.80; Camacho C, 2009, BMC BIOINFORMATICS, V10, DOI 10.1186/1471-2105-10-421; Casanueva A, 2010, TRENDS MICROBIOL, V18, P374, DOI 10.1016/j.tim.2010.05.002; CHILKOTI A, 1995, P NATL ACAD SCI USA, V92, P1754, DOI 10.1073/pnas.92.5.1754; Chivers CE, 2011, BIOCHEM J, V435, P55, DOI 10.1042/BJ20101593; Chivers CE, 2010, NAT METHODS, V7, P391, DOI [10.1038/nmeth.1450, 10.1038/NMETH.1450]; DeLano W. L., 2010, PYMOL MOL GRAPHICS S; Eisenberg-Domovich Y, 2005, ACTA CRYSTALLOGR D, V61, P528, DOI 10.1107/S0907444905003914; Emsley P, 2004, ACTA CRYSTALLOGR D, V60, P2126, DOI 10.1107/S0907444904019158; Feller G, 2003, NAT REV MICROBIOL, V1, P200, DOI 10.1038/nrmicro773; Freitag S, 1998, J MOL BIOL, V279, P211, DOI 10.1006/jmbi.1998.1735; Freitag S, 1997, PROTEIN SCI, V6, P1157, DOI 10.1002/pro.5560060604; Gasteiger E, 2003, NUCLEIC ACIDS RES, V31, P3784, DOI 10.1093/nar/gkg563; Gonzalez M, 1999, BIOMOL ENG, V16, P67, DOI 10.1016/S1050-3862(99)00041-8; Gonzalez V, 2006, P NATL ACAD SCI USA, V103, P3834, DOI 10.1073/pnas.0508502103; Green N M, 1975, Adv Protein Chem, V29, P85, DOI 10.1016/S0065-3233(08)60411-8; Helppolainen SH, 2008, BBA-PROTEINS PROTEOM, V1784, P1002, DOI 10.1016/j.bbapap.2008.04.010; Helppolainen SH, 2007, BIOCHEM J, V405, P397, DOI 10.1042/BJ20070076; Howarth M, 2006, NAT METHODS, V3, P267, DOI 10.1038/NMETH861; Jain E, 2009, BMC BIOINFORMATICS, V10, DOI 10.1186/1471-2105-10-136; Johnson M, 2008, NUCLEIC ACIDS RES, V36, pW5, DOI 10.1093/nar/gkn201; Kiefer Florian, 2009, Nucleic Acids Res, V37, pD387, DOI 10.1093/nar/gkn750; KURZBAN GP, 1991, J BIOL CHEM, V266, P14470; Laitinen OH, 1999, FEBS LETT, V461, P52, DOI 10.1016/S0014-5793(99)01423-4; Lim KH, 2011, BIOCHEMISTRY-US, V50, P8682, DOI 10.1021/bi2010366; LIVNAH O, 1993, P NATL ACAD SCI USA, V90, P5076, DOI 10.1073/pnas.90.11.5076; LIVNAH O, 1993, FEBS LETT, V328, P165, DOI 10.1016/0014-5793(93)80986-5; Mccoy AJ, 2007, J APPL CRYSTALLOGR, V40, P658, DOI 10.1107/S0021889807021206; Meir A, 2009, J MOL BIOL, V386, P379, DOI 10.1016/j.jmb.2008.11.061; Morris RJ, 2003, METHOD ENZYMOL, V374, P229, DOI 10.1016/S0076-6879(03)74011-7; Nordlund HR, 2005, BIOCHEM J, V392, P485, DOI 10.1042/BJ20051038; Nordlund HR, 2005, J BIOL CHEM, V280, P13250, DOI 10.1074/jbc.M414336200; Nordlund HR, 2004, J BIOL CHEM, V279, P36715, DOI 10.1074/jbc.M403496200; Pazy Y, 2003, J BACTERIOL, V185, P4050, DOI 10.1128/JB.185.14.4050-4056.2003; Sano T, 1997, P NATL ACAD SCI USA, V94, P6153, DOI 10.1073/pnas.94.12.6153; Sano T, 1997, Methods Mol Biol, V63, P119; Sardo A, 2011, PROTEIN EXPRES PURIF, V77, P131, DOI 10.1016/j.pep.2011.01.003; Sheffield P, 1999, PROTEIN EXPRES PURIF, V15, P34, DOI 10.1006/prep.1998.1003; Takakura Y, 2009, FEBS J, V276, P1383, DOI 10.1111/j.1742-4658.2009.06879.x; Teulon JM, 2011, J MOL RECOGNIT, V24, P490, DOI 10.1002/jmr.1109; Vagin AA, 2004, ACTA CRYSTALLOGR D, V60, P2184, DOI 10.1107/S0907444904023510; WEBER PC, 1989, SCIENCE, V243, P85, DOI 10.1126/science.2911722; WILCHEK M, 1989, TRENDS BIOCHEM SCI, V14, P408, DOI 10.1016/0968-0004(89)90289-2; Zwart Peter H., 2008, V426, P419, DOI 10.1007/978-1-60327-058-8_28	49	20	20	0	12	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	MAY 25	2012	287	22					17951	17962		10.1074/jbc.M112.357186	http://dx.doi.org/10.1074/jbc.M112.357186			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	974EC	22493427	hybrid, Green Published			2022-12-25	WOS:000306411600005
J	Teichman, S; Qu, SG; Kanner, BI				Teichman, Shlomit; Qu, Shaogang; Kanner, Baruch I.			Conserved Asparagine Residue Located in Binding Pocket Controls Cation Selectivity and Substrate Interactions in Neuronal Glutamate Transporter	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							AMINO-ACID TRANSPORTER; RAT-BRAIN; INDIVIDUAL SUBUNITS; MEMBRANE-VESICLES; CHLORIDE CHANNEL; REENTRANT LOOP; GLT-1; ION; HOMOLOG; SODIUM	Transporters of the major excitatory neurotransmitter glutamate play a crucial role in glutamatergic neurotransmission by removing their substrate from the synaptic cleft. The transport mechanism involves co-transport of glutamic acid with three Na+ ions followed by countertransport of one K+ ion. Structural work on the archeal homologue Glt(Ph) indicates a role of a conserved asparagine in substrate binding. According to a recent proposal, this residue may also participate in a novel Na+ binding site. In this study, we characterize mutants of this residue from the neuronal transporter EAAC1, Asn-451. None of the mutants, except for N451S, were able to exhibit transport. However, the K-m of this mutant for L-aspartate was increased similar to 30-fold. Remarkably, the increase for D-aspartate and L-glutamate was 250- and 400-fold, respectively. Moreover, the cation specificity of N451S was altered because sodium but not lithium could support transport. A similar change in cation specificity was observed with a mutant of a conserved threonine residue, T370S, also implicated to participate in the novel Na+ site together with the bound substrate. In further contrast to the wild type transporter, only L-aspartate was able to activate the uncoupled anion conductance by N451S, but with an almost 1000-fold reduction in apparent affinity. Our results not only provide experimental support for the Na+ site but also suggest a distinct orientation of the substrate in the binding pocket during the activation of the anion conductance.	[Teichman, Shlomit; Qu, Shaogang; Kanner, Baruch I.] Hebrew Univ Jerusalem, Hadassah Med Sch, Dept Biochem & Mol Biol, Inst Med Res Israel Canada, IL-91120 Jerusalem, Israel	Hebrew University of Jerusalem	Kanner, BI (corresponding author), Hebrew Univ Jerusalem, Hadassah Med Sch, Dept Biochem & Mol Biol, Inst Med Res Israel Canada, POB 12272, IL-91120 Jerusalem, Israel.	kannerb@cc.huji.ac.il			National Institutes of Neurological Disorders and Stroke through National Institutes of Health [NS 16708]; United States-Israel Binational Science Foundation [2007051]; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R56NS016708, R01NS016708] Funding Source: NIH RePORTER	National Institutes of Neurological Disorders and Stroke through National Institutes of Health; United States-Israel Binational Science Foundation(US-Israel Binational Science Foundation); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))	This work was supported, in whole or in part, by the National Institutes of Neurological Disorders and Stroke through National Institutes of Health Grant NS 16708 and United States-Israel Binational Science Foundation Grant 2007051.	Arriza JL, 1997, P NATL ACAD SCI USA, V94, P4155, DOI 10.1073/pnas.94.8.4155; Bendahan A, 2000, J BIOL CHEM, V275, P37436, DOI 10.1074/jbc.M006536200; Bergles DE, 2002, J NEUROSCI, V22, P10153; Borre L, 2004, J BIOL CHEM, V279, P2513, DOI 10.1074/jbc.M311446200; Borre L, 2001, J BIOL CHEM, V276, P40396, DOI 10.1074/jbc.M104926200; Boudker O, 2007, NATURE, V445, P387, DOI 10.1038/nature05455; BREW H, 1987, NATURE, V327, P707, DOI 10.1038/327707a0; Crisman TJ, 2009, P NATL ACAD SCI USA, V106, P20752, DOI 10.1073/pnas.0908570106; FAIRMAN WA, 1995, NATURE, V375, P599, DOI 10.1038/375599a0; Grewer C, 2000, P NATL ACAD SCI USA, V97, P9706, DOI 10.1073/pnas.160170397; Grewer C, 2005, BIOCHEMISTRY-US, V44, P11913, DOI 10.1021/bi050987n; Groeneveld M, 2007, J MOL BIOL, V372, P565, DOI 10.1016/j.jmb.2007.06.067; Groeneveld M, 2010, BIOCHEMISTRY-US, V49, P3511, DOI 10.1021/bi100430s; Grunewald M, 1998, NEURON, V21, P623, DOI 10.1016/S0896-6273(00)80572-3; Grunewald M, 2000, J BIOL CHEM, V275, P9684, DOI 10.1074/jbc.275.13.9684; Holmseth S, 2005, NEUROSCIENCE, V136, P649, DOI 10.1016/j.neuroscience.2005.07.022; KANAI Y, 1992, NATURE, V360, P467, DOI 10.1038/360467a0; KANNER BI, 1978, BIOCHEMISTRY-US, V17, P3949, DOI 10.1021/bi00612a011; KANNER BI, 1982, BIOCHEMISTRY-US, V21, P6327, DOI 10.1021/bi00267a044; Kavanaugh MP, 1997, J BIOL CHEM, V272, P1703, DOI 10.1074/jbc.272.3.1703; Koch HP, 2007, J NEUROSCI, V27, P2943, DOI 10.1523/JNEUROSCI.0118-07.2007; Koch HP, 2005, J NEUROSCI, V25, P1730, DOI 10.1523/JNEUROSCI.4138-04.2005; KUNKEL TA, 1987, METHOD ENZYMOL, V154, P367; Larsson HP, 2010, P NATL ACAD SCI USA, V107, P13912, DOI 10.1073/pnas.1006289107; Leary GP, 2007, J NEUROSCI, V27, P2938, DOI 10.1523/JNEUROSCI.4851-06.2007; Levy LM, 1998, J NEUROSCI, V18, P9620, DOI 10.1523/jneurosci.18-23-09620.1998; Menaker D, 2006, J NEUROCHEM, V99, P20, DOI 10.1111/j.1471-4159.2006.04003.x; NELSON PJ, 1983, BIOCHEMISTRY-US, V22, P5459, DOI 10.1021/bi00292a030; Otis TS, 2000, J NEUROSCI, V20, P2749; PINES G, 1995, J BIOL CHEM, V270, P17093, DOI 10.1074/jbc.270.29.17093; PINES G, 1990, BIOCHEMISTRY-US, V29, P11209, DOI 10.1021/bi00503a008; Reyes N, 2009, NATURE, V462, P880, DOI 10.1038/nature08616; Rosental N, 2006, J BIOL CHEM, V281, P27905, DOI 10.1074/jbc.M600331200; Rosental N, 2010, J BIOL CHEM, V285, P21241, DOI 10.1074/jbc.M109.087163; Slotboom DJ, 1999, P NATL ACAD SCI USA, V96, P14282, DOI 10.1073/pnas.96.25.14282; Tao Z, 2010, J BIOL CHEM, V285, P17725, DOI 10.1074/jbc.M110.121798; Teichman S, 2007, J GEN PHYSIOL, V129, P527, DOI 10.1085/jgp.200609707; Teichman S, 2009, P NATL ACAD SCI USA, V106, P14297, DOI 10.1073/pnas.0904625106; WADICHE JI, 1995, NEURON, V14, P1019, DOI 10.1016/0896-6273(95)90340-2; Wadiche JI, 1998, J NEUROSCI, V18, P7650; WADICHE JI, 1995, NEURON, V15, P721, DOI 10.1016/0896-6273(95)90159-0; Watzke N, 2001, J GEN PHYSIOL, V117, P547, DOI 10.1085/jgp.117.6.547; Yamashita A, 2005, NATURE, V437, P215, DOI 10.1038/nature03978; Yernool D, 2004, NATURE, V431, P811, DOI 10.1038/nature03018; Zerangue N, 1996, NATURE, V383, P634, DOI 10.1038/383634a0; Zhang YM, 1999, P NATL ACAD SCI USA, V96, P1710, DOI 10.1073/pnas.96.4.1710; Zhang YM, 1998, P NATL ACAD SCI USA, V95, P751, DOI 10.1073/pnas.95.2.751	47	15	15	0	6	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAY 18	2012	287	21					17198	17205		10.1074/jbc.M112.355040	http://dx.doi.org/10.1074/jbc.M112.355040			8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	973PU	22493292	Green Published, hybrid			2022-12-25	WOS:000306373000019
J	Hernandez-Lemus, E; Nicasio-Collazo, LA; Castaneda-Priego, R				Hernandez-Lemus, Enrique; Adriana Nicasio-Collazo, Luz; Castaneda-Priego, Ramon			Hysteresis in Pressure-Driven DNA Denaturation	PLOS ONE			English	Article							IRREVERSIBLE THERMODYNAMICS; CHARGE RENORMALIZATION; BASE COMPOSITION; STRESS; DYNAMICS; ENTROPY; DAMAGE; HELIX; ACID	In the past, a great deal of attention has been drawn to thermal driven denaturation processes. In recent years, however, the discovery of stress-induced denaturation, observed at the one-molecule level, has revealed new insights into the complex phenomena involved in the thermo-mechanics of DNA function. Understanding the effect of local pressure variations in DNA stability is thus an appealing topic. Such processes as cellular stress, dehydration, and changes in the ionic strength of the medium could explain local pressure changes that will affect the molecular mechanics of DNA and hence its stability. In this work, a theory that accounts for hysteresis in pressure-driven DNA denaturation is proposed. We here combine an irreversible thermodynamic approach with an equation of state based on the Poisson-Boltzmann cell model. The latter one provides a good description of the osmotic pressure over a wide range of DNA concentrations. The resulting theoretical framework predicts, in general, the process of denaturation and, in particular, hysteresis curves for a DNA sequence in terms of system parameters such as salt concentration, density of DNA molecules and temperature in addition to structural and configurational states of DNA. Furthermore, this formalism can be naturally extended to more complex situations, for example, in cases where the host medium is made up of asymmetric salts or in the description of the (helical-like) charge distribution along the DNA molecule. Moreover, since this study incorporates the effect of pressure through a thermodynamic analysis, much of what is known from temperature-driven experiments will shed light on the pressure-induced melting issue.	[Hernandez-Lemus, Enrique] Natl Inst Genom Med, Computat Genom Dept, Mexico City, DF, Mexico; [Hernandez-Lemus, Enrique] Univ Nacl Autonoma Mexico, Ctr Complex Sci, Mexico City 04510, DF, Mexico; [Adriana Nicasio-Collazo, Luz; Castaneda-Priego, Ramon] Univ Guanajuato, Div Sci & Engn, Leon, Guanajuato, Mexico	Instituto Nacional de Medicina Genomica; Universidad Nacional Autonoma de Mexico; Universidad de Guanajuato	Hernandez-Lemus, E (corresponding author), Natl Inst Genom Med, Computat Genom Dept, Mexico City, DF, Mexico.	ehernandez@inmegen.gob.mx; ramoncp@fisica.ugto.mx	Castaneda-Priego, Ramon/D-5043-2009	Hernandez-Lemus, Enrique/0000-0002-1872-1397	(PIFI) of the Secretaria de Educacion Publica (Mexico's Ministry of Education) [3.4]; Mexico's National Council of Science and Technology (CONACyT) [61418/2007, 102339/2008]; National Institute of Genomic Medicine (Mexico)	(PIFI) of the Secretaria de Educacion Publica (Mexico's Ministry of Education); Mexico's National Council of Science and Technology (CONACyT)(Consejo Nacional de Ciencia y Tecnologia (CONACyT)); National Institute of Genomic Medicine (Mexico)	Financial support from the Integral Program for Institutional Strengthening (PIFI for its Spanish acronym) of the Secretaria de Educacion Publica (Mexico's Ministry of Education) 3.4, and Mexico's National Council of Science and Technology (CONACyT for its Spanish acronym) (grant nos. 61418/2007 and 102339/2008), as well as federal funding from the National Institute of Genomic Medicine (Mexico) is acknowledged. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ALEXANDER S, 1984, J CHEM PHYS, V80, P5776, DOI 10.1063/1.446600; Barbi M, 2003, PHYS REV E, V68, DOI 10.1103/PhysRevE.68.061909; Belloni L, 2000, J PHYS-CONDENS MAT, V12, pR549, DOI 10.1088/0953-8984/12/46/201; Benham CJ, 1996, J MOL BIOL, V255, P425, DOI 10.1006/jmbi.1996.0035; Blake RD, 1999, BIOINFORMATICS, V15, P370, DOI 10.1093/bioinformatics/15.5.370; BRESLAUER KJ, 1992, METHOD ENZYMOL, V211, P533; Cattaneo C, 1949, ATT SEM MAT FIS U MO, V3, P83101; CHEN M, 1993, J MATH PHYS, V34, P3012, DOI 10.1063/1.530060; Choi CH, 2004, NUCLEIC ACIDS RES, V32, P1584, DOI 10.1093/nar/gkh335; Cocco S, 2004, PHYS REV E, V70, DOI 10.1103/PhysRevE.70.011910; Cocco S, 2002, CR PHYS, V3, P569, DOI 10.1016/S1631-0705(02)01345-2; Dagdug L, 2004, REV MEX FIS, V50, P594; Daune M., 1999, MOL BIOPHYSICS STRUC; Denton AR, 2010, J PHYS-CONDENS MAT, V22, DOI 10.1088/0953-8984/22/36/364108; Dobnikar J, 2006, NEW J PHYS, V8, DOI 10.1088/1367-2630/8/11/277; Dubins DN, 2001, J AM CHEM SOC, V123, P9254, DOI 10.1021/ja004309u; EssevazRoulet B, 1997, P NATL ACAD SCI USA, V94, P11935, DOI 10.1073/pnas.94.22.11935; Frank-Kamenestskii MD, 2006, SELF ASSEMBLY PATTER; GLASEL JA, 1995, BIOTECHNIQUES, V18, P62; Hansen L., 2001, PHYS REV E, V64, DOI [DOI 10.1103/PHYSREVE.64.021907), 10.1103/PhysRevE.64.021907]; Hennig D, 2006, ARXIVNLINPS0306019V1; Hernandez-Lemus E, 2002, REV MEX FIS, V48, P38; Ichijima Y, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0008821; JOU D, 1985, PHYS REV A, V31, P2502, DOI 10.1103/PhysRevA.31.2502; Jou D, 1998, EXTENDED IRREVERSIBL; Kanduc M, 2009, SOFT MATTER, V5, P868, DOI 10.1039/b811795k; Kleckner N, 2004, P NATL ACAD SCI USA, V101, P12592, DOI 10.1073/pnas.0402724101; Kurki S, 2003, J CELL SCI, V116, P3917, DOI 10.1242/jcs.00714; Kurzynski M, 2000, PHYSICA A, V285, P29, DOI 10.1016/S0378-4371(00)00270-3; MacQuarrie D.A., 1976, STAT MECH; MARMUR J, 1962, J MOL BIOL, V5, P109, DOI 10.1016/S0022-2836(62)80066-7; MAYERGOYZ ID, 1986, PHYS REV LETT, V56, P1518, DOI 10.1103/PhysRevLett.56.1518; Peyrard M, 2004, NONLINEARITY, V17, pR1, DOI 10.1088/0951-7715/17/2/R01; Pianegonda S, 2007, J CHEM PHYS, V126, DOI 10.1063/1.2387168; POLAND D, 1974, BIOPOLYMERS, V13, P1859, DOI 10.1002/bip.1974.360130916; Rayan G, 2005, J PHYS CHEM B, V109, P15558, DOI 10.1021/jp050899c; Reza Amiri A, 2010, THESIS U TORONTO; Rief M, 1999, NAT STRUCT BIOL, V6, P346; Rouzina I, 2001, BIOPHYS J, V80, P882, DOI 10.1016/S0006-3495(01)76067-5; Salim NS, 2009, ISOTHERMAL TITRATION; Smith SB, 1996, SCIENCE, V271, P795, DOI 10.1126/science.271.5250.795; Storm C, 2003, PHYS REV E, V67, DOI 10.1103/PhysRevE.67.051906; Stroock DW, 1982, TATA I FUNDAMENTAL R; Trizac E, 2007, PHYS REV E, V75, DOI 10.1103/PhysRevE.75.011401; Trizac E, 2003, LANGMUIR, V19, P4027, DOI 10.1021/la027056m; Vernotte P, 1958, CR HEBD ACAD SCI, V246; von Zglinicki T, 2001, EXP GERONTOL, V36, P1049, DOI 10.1016/S0531-5565(01)00111-5; Wannier GH, 1987, STAT PHYS; Whitelam S, 2008, BIOPHYS J, V94, P2452, DOI 10.1529/biophysj.107.117036; Williams MC, 2004, SPECTROSC-INT J, V18, P203, DOI 10.1155/2004/403203; Wilton DJ, 2008, NUCLEIC ACIDS RES, V36, P4032, DOI 10.1093/nar/gkn350; Zoli M, 2011, ARXIV11064207	52	3	3	0	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 9	2012	7	4							e33789	10.1371/journal.pone.0033789	http://dx.doi.org/10.1371/journal.pone.0033789			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	955JO	22496765	Green Published, gold, Green Submitted			2022-12-25	WOS:000305014500016
J	Chen, HL; Huang, JY; Chen, CM; Chu, TH; Shih, C				Chen, Hung-Lin; Huang, Jyun-Yuan; Chen, Chun-Ming; Chu, Tien-Hua; Shih, Chiaho			MicroRNA-22 Can Reduce Parathymosin Expression in Transdifferentiated Hepatocytes	PLOS ONE			English	Article							CELL-PROLIFERATION; TRANSCRIPTION FACTORS; ZN2+-BINDING PROTEIN; RAT-TISSUES; IN-VIVO; LIVER; BINDING; VIRUS; DIFFERENTIATION; RECOGNITION	Pancreatic acinar cells AR42J-B13 can transdifferentiate into hepatocyte-like cells permissive for efficient hepatitis B virus (HBV) replication. Here, we profiled miRNAs differentially expressed in AR42J-B13 cells before and after transdifferentiation to hepatocytes, using chip-based microarray. Significant increase of miRNA expression, including miR-21, miR-22, and miR-122a, was confirmed by stem-loop real-time PCR and Northern blot analyses. In contrast, miR-93, miR-130b, and a number of other miRNAs, were significantly reduced after transdifferentiation. To investigate the potential significance of miR-22 in hepatocytes, we generated cell lines stably expressing miR-22. By 2D-DIGE, LC-MS/MS, and Western blot analyses, we identified several potential target genes of miR-22, including parathymosin. In transdifferentiated hepatocytes, miR-22 can inhibit both mRNA and protein expression of parathymosin, probably through a direct and an indirect mechanism. We tested two computer predicted miR-22 target sites at the 3' UTR of parathymosin, by the 3' UTR reporter gene assay. Treatment with anti-miR-22 resulted in significant elevation of the reporter activity. In addition, we observed an in vivo inverse correlation between miR-22 and parathymosin mRNA in their tissue distribution in a rat model. The phenomenon that miR-22 can reduce parathymosin protein was also observed in human hepatoma cell lines Huh7 and HepG2. So far, we detected no major effect on several transdifferentiation markers when AR42J-B13 cells were transfected with miR-22, or anti-miR-22, or a parathymosin expression vector, with or without dexamethasone treatment. Therefore, miR-22 appears to be neither necessary nor sufficient for transdifferentiation. We discussed the possibility that altered expression of some other microRNAs could induce cell cycle arrest leading to transdifferentiation.	[Chen, Hung-Lin; Chen, Chun-Ming; Shih, Chiaho] Acad Sinica, Inst Biomed Sci, Taipei, Taiwan; [Huang, Jyun-Yuan; Chu, Tien-Hua; Shih, Chiaho] Natl Def Med Ctr, Grad Inst Life Sci, Taipei, Taiwan	Academia Sinica - Taiwan; National Defense Medical Center	Chen, HL (corresponding author), Acad Sinica, Inst Biomed Sci, Taipei, Taiwan.	cshih@ibms.sinica.edu.tw	Shih, Chiaho/S-7017-2018	Chen, Hung-Lin/0000-0001-7900-3391	National Science Council; Academia Sinica; National Health Research Institute, Taiwan; Affymetrix Gene Expression Service Lab, Academia Sinica, Taiwan	National Science Council(Ministry of Science and Technology, Taiwan); Academia Sinica(Academia Sinica - Taiwan); National Health Research Institute, Taiwan(National Health Research Institutes - Taiwan); Affymetrix Gene Expression Service Lab, Academia Sinica, Taiwan	The authors acknowledge the funding from National Science Council, Academia Sinica, and National Health Research Institute, Taiwan. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; We thank the support from the Affymetrix Gene Expression Service Lab (http://ipmb.sinica.edu.tw/affy/), Academia Sinica, Taiwan. We thank Dr. Wen-Chang Lin for careful reading and discussion on this manuscript	ADEN DP, 1979, NATURE, V282, P615, DOI 10.1038/282615a0; Ambs S, 2008, CANCER RES, V68, P6162, DOI 10.1158/0008-5472.CAN-08-0144; Bar N, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0010859; Bartel DP, 2009, CELL, V136, P215, DOI 10.1016/j.cell.2009.01.002; Behm-Ansmant I, 2006, GENE DEV, V20, P1885, DOI 10.1101/gad.1424106; BRAND IA, 1991, EUR J CELL BIOL, V54, P157; Chen JF, 2010, J CELL BIOL, V190, P867, DOI 10.1083/jcb.200911036; Esau C, 2006, CELL METAB, V3, P87, DOI 10.1016/j.cmet.2006.01.005; Girard M, 2008, J HEPATOL, V48, P648, DOI 10.1016/j.jhep.2008.01.019; Griffiths-Jones S, 2008, NUCLEIC ACIDS RES, V36, pD154, DOI 10.1093/nar/gkm952; HARITOS AA, 1985, P NATL ACAD SCI USA, V82, P1050, DOI 10.1073/pnas.82.4.1050; Hino K, 2008, RNA, V14, P1433, DOI 10.1261/rna.810208; John B, 2004, PLOS BIOL, V2, P1862, DOI 10.1371/journal.pbio.0020363; Jopling CL, 2005, SCIENCE, V309, P1577, DOI 10.1126/science.1113329; Krutzfeldt J, 2005, NATURE, V438, P685, DOI 10.1038/nature04303; Lagos-Quintana M, 2002, CURR BIOL, V12, P735, DOI 10.1016/S0960-9822(02)00809-6; Lal A, 2009, MOL CELL, V35, P610, DOI 10.1016/j.molcel.2009.08.020; Landgraf P, 2007, CELL, V129, P1401, DOI 10.1016/j.cell.2007.04.040; Lewis AP, 2010, BIOCHEM SOC T, V38, P1553, DOI 10.1042/BST0381553; Martic G, 2005, J BIOL CHEM, V280, P16143, DOI 10.1074/jbc.M410175200; Meng FY, 2007, J BIOL CHEM, V282, P8256, DOI 10.1074/jbc.M607712200; NAKABAYASHI H, 1982, CANCER RES, V42, P3858; Nilsen TW, 2007, TRENDS GENET, V23, P243, DOI 10.1016/j.tig.2007.02.011; Okamoto K, 2005, J BIOL CHEM, V280, P36986, DOI 10.1074/jbc.M506056200; Pandey DP, 2009, MOL CELL BIOL, V29, P3783, DOI 10.1128/MCB.01875-08; Patel JB, 2011, ONCOGENE, V30, P1290, DOI 10.1038/onc.2010.510; RAO MS, 1988, BIOCHEM BIOPH RES CO, V156, P131, DOI 10.1016/S0006-291X(88)80814-3; Rehmsmeier M, 2004, RNA, V10, P1507, DOI 10.1261/rna.5248604; Savkovic V, 2004, DIGEST DIS, V22, P239, DOI 10.1159/000082795; Shen CN, 2000, NAT CELL BIOL, V2, P879, DOI 10.1038/35046522; SHIH CH, 1989, P NATL ACAD SCI USA, V86, P6323, DOI 10.1073/pnas.86.16.6323; Smith SB, 1999, MOL CELL BIOL, V19, P8272; Thomas M, 2010, NAT STRUCT MOL BIOL, V17, P1169, DOI 10.1038/nsmb.1921; Ting Y, 2010, BIOCHEM BIOPH RES CO, V394, P606, DOI 10.1016/j.bbrc.2010.03.030; Tosh D, 2007, BIOL CELL, V99, P37, DOI 10.1042/BC20060050; Wang J, 2011, J CELL BIOCH; Wang RYL, 2005, J VIROL, V79, P13116, DOI 10.1128/JVI.79.20.13116-13128.2005; Wingender E, 1996, NUCLEIC ACIDS RES, V24, P238, DOI 10.1093/nar/24.1.238; Xiong J, 2010, ONCOGENE, V29, P4980, DOI 10.1038/onc.2010.241; Xu H, 2010, HEPATOLOGY, V52, P1431, DOI 10.1002/hep.23818; Yeung ML, 2008, CANCER RES, V68, P8976, DOI 10.1158/0008-5472.CAN-08-0769; Zhang J, 2010, BRIT J CANCER, V103, P1215, DOI 10.1038/sj.bjc.6605895	42	6	7	1	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 6	2012	7	4							e34116	10.1371/journal.pone.0034116	http://dx.doi.org/10.1371/journal.pone.0034116			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	955JA	22493679	Green Submitted, Green Published, gold			2022-12-25	WOS:000305012700021
J	Johns, SE; Hargrave, LA; Newton-Fisher, NE				Johns, Sarah E.; Hargrave, Lucy A.; Newton-Fisher, Nicholas E.			Red Is Not a Proxy Signal for Female Genitalia in Humans	PLOS ONE			English	Article							EXTERNAL GENITALIA; SEXUAL SWELLINGS; COLOR; WOMEN; PERFORMANCE; FERTILITY; EVOLUTION; DOMINANCE; VAGINITIS; PRIMATES	Red is a colour that induces physiological and psychological effects in humans, affecting competitive and sporting success, signalling and enhancing male social dominance. The colour is also associated with increased sexual attractiveness, such that women associated with red objects or contexts are regarded as more desirable. It has been proposed that human males have a biological predisposition towards the colour red such that it is 'sexually salient'. This hypothesis argues that women use the colour red to announce impending ovulation and sexual proceptivity, with this functioning as a proxy signal for genital colour, and that men show increased attraction in consequence. In the first test of this hypothesis, we show that contrary to the hypothesis, heterosexual men did not prefer redder female genitalia and, by extension, that red is not a proxy signal for genital colour. We found a relative preference for pinker genital images with redder genitalia rated significantly less sexually attractive. This effect was independent of raters' prior sexual experience and variation in female genital morphology. Our results refute the hypothesis that men's attraction to red is linked to an implied relationship to genital colour and women's signalling of fertility and sexual proceptivity.	[Johns, Sarah E.; Hargrave, Lucy A.; Newton-Fisher, Nicholas E.] Univ Kent, Sch Anthropol & Conservat, Canterbury, Kent, England	University of Kent	Johns, SE (corresponding author), Univ Kent, Sch Anthropol & Conservat, Canterbury, Kent, England.	s.e.johns@kent.ac.uk		Newton-Fisher, Nicholas/0000-0002-7657-2641; Johns, Sarah/0000-0002-7715-7351				Ackerman D, 1993, NATURAL HIST SENSES; ANDERSON CM, 1994, PRIMATES, V35, P283, DOI 10.1007/BF02382726; Attrill MJ, 2008, J SPORT SCI, V26, P577, DOI 10.1080/02640410701736244; Ayala ES, 2009, J PSYCHIATR RES, V43, P1235, DOI 10.1016/j.jpsychires.2009.04.008; Basaran M, 2008, CLIMACTERIC, V11, P416, DOI 10.1080/13697130802366670; BIELERT C, 1989, J ZOOL, V219, P569, DOI 10.1111/j.1469-7998.1989.tb02601.x; Brewer S, 2004, BLUFFERS GUIDE SEX; Buckley T, BLOOD MAGIC ANTHR ME; Crichton N, 2001, J CLIN NURS, V10, P706; Cuthill IC, 1997, P ROY SOC B-BIOL SCI, V264, P1093, DOI 10.1098/rspb.1997.0151; Edwards Libby, 2004, Dermatol Ther, V17, P102, DOI 10.1111/j.1396-0296.2004.04010.x; Elliot AJ, 2008, J PERS SOC PSYCHOL, V95, P1150, DOI 10.1037/0022-3514.95.5.1150; Farage Miranda, 2006, Archives of Gynecology and Obstetrics, V273, P195, DOI 10.1007/s00404-005-0079-x; Gangestad SW, 2010, EVOL HUM BEHAV, V31, P400, DOI 10.1016/j.evolhumbehav.2010.05.003; Greenfield A.B., 2006, PERFECT RED EMPIRE E; Heffner L.J., 2010, REPROD SYSTEM GLANCE; Hill RA, 2005, NATURE, V435, P293, DOI 10.1038/435293a; Howarth H, 2010, MED HUMANIT, V36, P75, DOI 10.1136/jmh.2009.003707; Huchard E, 2010, BMC EVOL BIOL, V10, DOI 10.1186/1471-2148-10-96; Huchard E, 2009, P ROY SOC B-BIOL SCI, V276, P1889, DOI 10.1098/rspb.2008.1923; Ilie A, 2008, CYBERPSYCHOL BEHAV, V11, P375, DOI 10.1089/cpb.2007.0122; Jung I., 2011, COMMUN COMPUT PHYS, V173, P284, DOI [DOI 10.1007/978-3-642-22098-2_57, 10.1007/978-3-642-22098-2_57]; Kayser DN, 2010, EUR J SOC PSYCHOL, V40, P901, DOI 10.1002/ejsp.757; Kinsey Alfred, 1953, SEXUAL BEHAV HUMAN F; Kissling EA, 2002, SEX ROLES, V46, P5, DOI 10.1023/A:1016029416750; Knight C., 1995, BLOOD RELATIONS MENS; Little A.C., 2007, J EVOLUTIONARY PSYCH, V5, P161, DOI [10. 1556/JEP. 2007. 1008, DOI 10.1556/JEP.2007.1008, https://doi.org/10.1556/JEP.2007.1008]; Lloyd J, 2005, BJOG-INT J OBSTET GY, V112, P643, DOI 10.1111/j.1471-0528.2004.00517.x; Low BS, 1979, EVOLUTIONARY BIOL HU, P462; Maier MA, 2008, PERS SOC PSYCHOL B, V34, P1530, DOI 10.1177/0146167208323104; Masters WH., 1966, HUMAN SEXUAL RESPONS; Morris D, 2005, NAKED WOMAN; Morris D., 1967, NAKED APE; MORTON RS, 1977, P ROY SOC MED, V70, P3, DOI 10.1177/00359157770700S402; Nunn CL, 1999, ANIM BEHAV, V58, P229, DOI 10.1006/anbe.1999.1159; Pallingston J, 1999, LIPSTICK CELEBRATION; Pryke SR, 2006, P ROY SOC B-BIOL SCI, V273, P949, DOI 10.1098/rspb.2005.3362; Roberts SC, 2010, EVOL PSYCHOL-US, V8, P350, DOI 10.1177/147470491000800304; Schick VR, 2011, J SEX RES, V48, P74, DOI 10.1080/00224490903308404; Schienle A, 2003, ANXIETY STRESS COPIN, V16, P185, DOI 10.1080/1061580021000030544; Setchell JM, 2005, ETHOLOGY, V111, P25, DOI 10.1111/j.1439-0310.2004.01054.x; Stephen ID, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0005083; Stika CS, 2010, DERMATOL THER, V23, P514, DOI 10.1111/j.1529-8019.2010.01354.x; Tanfer K, 1996, SEX TRANSM DIS, V23, P395, DOI 10.1097/00007435-199609000-00009; VERKAUF BS, 1992, OBSTET GYNECOL, V80, P41; Waitt C, 2006, AM J PRIMATOL, V68, P738, DOI 10.1002/ajp.20264; WOLNER-HANSSEN P, 1989, Journal of the American Medical Association, V261, P571, DOI 10.1001/jama.261.4.571	47	5	6	0	21	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 6	2012	7	4							e34669	10.1371/journal.pone.0034669	http://dx.doi.org/10.1371/journal.pone.0034669			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	955JA	22493709	Green Published, Green Submitted, Green Accepted, gold			2022-12-25	WOS:000305012700051
J	Azevedo, RVDM; Dias, DBS; Bretas, JAC; Mazzoni, CJ; Souza, NA; Albano, RM; Wagner, G; Davila, AMR; Peixoto, AA				Azevedo, Renata V. D. M.; Dias, Denise B. S.; Bretas, Jorge A. C.; Mazzoni, Camila J.; Souza, Nataly A.; Albano, Rodolpho M.; Wagner, Glauber; Davila, Alberto M. R.; Peixoto, Alexandre A.			The Transcriptome of Lutzomyia longipalpis (Diptera: Psychodidae) Male Reproductive Organs	PLOS ONE			English	Article							ACCESSORY-GLAND-PROTEINS; DENGUE VECTOR MOSQUITO; PHYSIOLOGICAL FUNCTIONS; VISCERAL LEISHMANIASIS; GENETIC-DIVERGENCE; SPECIES COMPLEX; SAND FLIES; DROSOPHILA; FEMALE; EXPRESSION	Background: It has been suggested that genes involved in the reproductive biology of insect disease vectors are potential targets for future alternative methods of control. Little is known about the molecular biology of reproduction in phlebotomine sand flies and there is no information available concerning genes that are expressed in male reproductive organs of Lutzomyia longipalpis, the main vector of American visceral leishmaniasis and a species complex. Methods/Principal Findings: We generated 2678 high quality ESTs ("Expressed Sequence Tags'') of L. longipalpis male reproductive organs that were grouped in 1391 non-redundant sequences (1136 singlets and 255 clusters). BLAST analysis revealed that only 57% of these sequences share similarity with a L. longipalpis female EST database. Although no more than 36% of the non-redundant sequences showed similarity to protein sequences deposited in databases, more than half of them presented the best-match hits with mosquito genes. Gene ontology analysis identified subsets of genes involved in biological processes such as protein biosynthesis and DNA replication, which are probably associated with spermatogenesis. A number of non-redundant sequences were also identified as putative male reproductive gland proteins (mRGPs), also known as male accessory gland protein genes (Acps). Conclusions: The transcriptome analysis of L. longipalpis male reproductive organs is one step further in the study of the molecular basis of the reproductive biology of this important species complex. It has allowed the identification of genes potentially involved in spermatogenesis as well as putative mRGPs sequences, which have been studied in many insect species because of their effects on female post-mating behavior and physiology and their potential role in sexual selection and speciation. These data open a number of new avenues for further research in the molecular and evolutionary reproductive biology of sand flies.	[Azevedo, Renata V. D. M.; Dias, Denise B. S.; Bretas, Jorge A. C.; Souza, Nataly A.; Wagner, Glauber; Davila, Alberto M. R.; Peixoto, Alexandre A.] Fiocruz MS, Inst Oswaldo Cruz, BR-21045900 Rio De Janeiro, Brazil; [Dias, Denise B. S.] Univ Estado Rio de Janeiro, Dept Biol Celular, BR-20550011 Rio De Janeiro, Brazil; [Mazzoni, Camila J.] Inst Zoo & Wildtierforsch, Berlin, Germany; [Mazzoni, Camila J.] Berlin Ctr Genom Biodivers Res, Berlin, Germany; [Albano, Rodolpho M.] Univ Estado Rio de Janeiro, Dept Bioquim, BR-20550011 Rio De Janeiro, Brazil; [Wagner, Glauber] Univ Oeste Santa Catarina, Area Ciencias Biol & Saude, Joacaba, SC, Brazil; [Davila, Alberto M. R.] Fiocruz MS, Polo Biol Computac & Sistemas, BR-21045900 Rio De Janeiro, Brazil	Fundacao Oswaldo Cruz; Universidade do Estado do Rio de Janeiro; Leibniz Institut fur Zoo und Wildtierforschung; Universidade do Estado do Rio de Janeiro; Universidade do Oeste de Santa Catarina; Fundacao Oswaldo Cruz	Azevedo, RVDM (corresponding author), Fiocruz MS, Inst Oswaldo Cruz, BR-21045900 Rio De Janeiro, Brazil.	apeixoto@ioc.fiocruz.br	Wagner, Glauber GW/B-2369-2013; Mazzoni, Camila J/L-3441-2014; Mazzoni, Camila/AAJ-9702-2020; Dávila, Alberto M. R./AAJ-4647-2021	Wagner, Glauber GW/0000-0001-5003-6595; Mazzoni, Camila/0000-0001-6758-5427; Dávila, Alberto M. R./0000-0002-6918-7673; Albano, Rodolpho/0000-0002-0643-901X	Howard Hughes Medical Institute; CNPq; Faperj; FIOCRUZ	Howard Hughes Medical Institute(Howard Hughes Medical Institute); CNPq(Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPQ)); Faperj(Fundacao Carlos Chagas Filho de Amparo a Pesquisa do Estado do Rio De Janeiro (FAPERJ)); FIOCRUZ	This work was supported by grants from the Howard Hughes Medical Institute, CNPq, Faperj, and FIOCRUZ. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Almeida FC, 2009, GENETICS, V181, P235, DOI 10.1534/genetics.108.096263; Anderson JM, 2006, BMC GENOMICS, V7, DOI 10.1186/1471-2164-7-52; Andrews J, 2000, GENOME RES, V10, P2030, DOI 10.1101/gr.10.12.2030; [Anonymous], 1991, BIOL BLOOD SUCKING I; Araki AS, 2009, PLOS NEGLECT TROP D, V3, DOI 10.1371/journal.pntd.0000365; Arner ESJ, 2000, EUR J BIOCHEM, V267, P6102, DOI 10.1046/j.1432-1327.2000.01701.x; Arrivillaga J, 2003, J MED ENTOMOL, V40, P615, DOI 10.1603/0022-2585-40.5.615; Baker DA, 2011, BMC GENOMICS, V12, DOI 10.1186/1471-2164-12-296; Barth R., 1961, Memorias do Instituto Oswaldo Cruz, V59, P23; Bauzer LGSR, 2007, MEM I OSWALDO CRUZ, V102, P1, DOI 10.1590/S0074-02762007000100001; Breugelmans B, 2009, PEPTIDES, V30, P622, DOI 10.1016/j.peptides.2008.07.026; Davies SJ, 2006, INSECT BIOCHEM MOLEC, V36, P846, DOI 10.1016/j.ibmb.2006.08.009; Davila AMR, 2005, BIOINFORMATICS, V21, P4302, DOI 10.1093/bioinformatics/bti705; Dillon RJ, 2006, GENOMICS, V88, P831, DOI 10.1016/j.ygeno.2006.06.011; Dottorini T, 2007, P NATL ACAD SCI USA, V104, P16215, DOI 10.1073/pnas.0703904104; DOWNE AER, 1975, J INSECT PHYSIOL, V21, P1835, DOI 10.1016/0022-1910(75)90250-4; Fausto AM, 2000, TISSUE CELL, V32, P228, DOI 10.1054/tice.2000.0110; Galindo K, 2001, GENETICS, V159, P1059; Gillott C, 2003, ANNU REV ENTOMOL, V48, P163, DOI 10.1146/annurev.ento.48.091801.112657; Guedes SD, 2005, BIOCHEM BIOPH RES CO, V328, P106, DOI 10.1016/j.bbrc.2004.12.135; Jochim RC, 2008, BMC GENOMICS, V9, DOI 10.1186/1471-2164-9-15; Krzywinska E, 2009, BMC GENOMICS, V10, DOI 10.1186/1471-2164-10-300; Lainson R, 2005, MEM I OSWALDO CRUZ, V100, P811, DOI 10.1590/S0074-02762005000800001; LANZARO GC, 1993, AM J TROP MED HYG, V48, P839, DOI 10.4269/ajtmh.1993.48.839; Larkin MA, 2007, BIOINFORMATICS, V23, P2947, DOI 10.1093/bioinformatics/btm404; Lins RMMA, 2008, MEM I OSWALDO CRUZ, V103, P736, DOI 10.1590/S0074-02762008000700019; Lung O, 2001, J INSECT PHYSIOL, V47, P617, DOI 10.1016/S0022-1910(00)00151-7; Maingon RDC, 2008, TRENDS PARASITOL, V24, P12, DOI 10.1016/j.pt.2007.10.003; MEIKLE DB, 1990, J INSECT PHYSIOL, V36, P93, DOI 10.1016/0022-1910(90)90179-J; MONSMA SA, 1990, DEV BIOL, V142, P465, DOI 10.1016/0012-1606(90)90368-S; Mueller JL, 2007, GENETICS, V175, P777, DOI 10.1534/genetics.106.065318; Mueller JL, 2004, P NATL ACAD SCI USA, V101, P13542, DOI 10.1073/pnas.0405579101; Nichol H, 2002, ANNU REV ENTOMOL, V47, P535, DOI 10.1146/annurev.ento.47.091201.145237; ODHIAMBO TR, 1971, TISSUE CELL, V3, P309, DOI 10.1016/S0040-8166(71)80025-3; Oliveira F, 2009, PARASITOL INT, V58, P1, DOI 10.1016/j.parint.2008.07.004; Panhuis TM, 2006, PHILOS T R SOC B, V361, P261, DOI 10.1098/rstb.2005.1793; Pitaluga AN, 2009, MOL GENET GENOMICS, V282, P307, DOI 10.1007/s00438-009-0466-2; Ram KR, 2007, INTEGR COMP BIOL, V47, P427, DOI 10.1093/icb/icm046; Ram KR, 2005, INSECT BIOCHEM MOLEC, V35, P1059, DOI 10.1016/j.ibmb.2005.05.001; Ram KR, 2006, P NATL ACAD SCI USA, V103, P18674, DOI 10.1073/pnas.0606228103; Rogers DW, 2009, PLOS BIOL, V7, DOI 10.1371/journal.pbio.1000272; Rogers DW, 2008, P NATL ACAD SCI USA, V105, P19390, DOI 10.1073/pnas.0809723105; SAMAKOVLIS C, 1991, EMBO J, V10, P163, DOI 10.1002/j.1460-2075.1991.tb07932.x; Simonet G, 2002, COMP BIOCHEM PHYS B, V132, P247, DOI 10.1016/S1096-4959(01)00530-9; Sirot LK, 2008, INSECT BIOCHEM MOLEC, V38, P176, DOI 10.1016/j.ibmb.2007.10.007; Sirot LK, 2011, PLOS NEGLECT TROP D, V5, DOI 10.1371/journal.pntd.0000989; Swanson WJ, 2001, P NATL ACAD SCI USA, V98, P7375, DOI 10.1073/pnas.131568198; Tamura K, 2007, MOL BIOL EVOL, V24, P1596, DOI 10.1093/molbev/msm092; Thailayil J, 2011, P NATL ACAD SCI USA, V108, P13677, DOI 10.1073/pnas.1104738108; Vogt RG, 2002, J EXP BIOL, V205, P719; Walker MJ, 2006, PROTEOME SCI, V4, DOI 10.1186/1477-5956-4-9; Ward PC, 1983, MEM I O CRUZ, V78, P269; Ward RD, 1988, BIOSYSTEMATICS HAEMA, P258; Wolfner MF, 2002, HEREDITY, V88, P85, DOI 10.1038/sj.hdy.6800017; Young David G., 1994, Memoirs of the American Entomological Institute (Gainesville), V54, P1	55	26	26	0	26	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 5	2012	7	4							e34495	10.1371/journal.pone.0034495	http://dx.doi.org/10.1371/journal.pone.0034495			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	955IH	22496818	Green Published, gold, Green Submitted			2022-12-25	WOS:000305010500012
J	Evans, KL; Newton, J; Mallord, JW; Markman, S				Evans, Karl L.; Newton, Jason; Mallord, John W.; Markman, Shai			Stable Isotope Analysis Provides New Information on Winter Habitat Use of Declining Avian Migrants That Is Relevant to Their Conservation	PLOS ONE			English	Article							MIGRATORY CONNECTIVITY; GEOGRAPHICAL-DISTRIBUTION; PHOTOSYNTHETIC PATHWAYS; SOUTHERN-AFRICA; WEST-AFRICA; APUS-APUS; ECOLOGY; CARBON; BIRDS; SURVIVAL	Winter habitat use and the magnitude of migratory connectivity are important parameters when assessing drivers of the marked declines in avian migrants. Such information is unavailable for most species. We use a stable isotope approach to assess these factors for three declining African-Eurasian migrants whose winter ecology is poorly known: wood warbler Phylloscopus sibilatrix, house martin Delichon urbicum and common swift Apus apus. Spatially segregated breeding wood warbler populations (sampled across a 800 km transect), house martins and common swifts (sampled across a 3,500 km transect) exhibited statistically identical intra-specific carbon and nitrogen isotope ratios in winter grown feathers. Such patterns are compatible with a high degree of migratory connectivity, but could arise if species use isotopically similar resources at different locations. Wood warbler carbon isotope ratios are more depleted than typical for African-Eurasian migrants and are compatible with use of moist lowland forest. The very limited variance in these ratios indicates specialisation on isotopically restricted resources, which may drive the similarity in wood warbler populations' stable isotope ratios and increase susceptibility to environmental change within its wintering grounds. House martins were previously considered to primarily use moist montane forest during the winter, but this seems unlikely given the enriched nature of their carbon isotope ratios. House martins use a narrower isotopic range of resources than the common swift, indicative of increased specialisation or a relatively limited wintering range; both factors could increase house martins' vulnerability to environmental change. The marked variance in isotope ratios within each common swift population contributes to the lack of population specific signatures and indicates that the species is less vulnerable to environmental change in sub-Saharan Africa than our other focal species. Our findings demonstrate how stable isotope research can contribute to understanding avian migrants' winter ecology and conservation status.	[Evans, Karl L.] Univ Sheffield, Dept Anim & Plant Sci, Sheffield S10 2TN, S Yorkshire, England; [Newton, Jason] SUERC, UK NERC Life Sci Mass Spectrometry Facil, E Kilbride, Lanark, Scotland; [Mallord, John W.] Royal Soc Protect Birds, Sandy SG19 2DL, Beds, England; [Markman, Shai] Univ Haifa, Dept Biol, Tivon, Israel	University of Sheffield; Scottish Universities Research & Reactor Center; UK Research & Innovation (UKRI); Natural Environment Research Council (NERC); Royal Society for Protection of Birds; University of Haifa	Evans, KL (corresponding author), Univ Sheffield, Dept Anim & Plant Sci, Sheffield S10 2TN, S Yorkshire, England.	karl.evans@sheffield.ac.uk	Newton, Jason/A-9536-2009	Newton, Jason/0000-0001-7594-3693	Natural Environment Research Council [EK-137-20/08]; Leverhulme Trust [ECF/2008/0018]; NERC [lsmsf010002] Funding Source: UKRI; Natural Environment Research Council [lsmsf010002] Funding Source: researchfish	Natural Environment Research Council(UK Research & Innovation (UKRI)Natural Environment Research Council (NERC)); Leverhulme Trust(Leverhulme Trust); NERC(UK Research & Innovation (UKRI)Natural Environment Research Council (NERC)); Natural Environment Research Council(UK Research & Innovation (UKRI)Natural Environment Research Council (NERC))	This work was funded by a Natural Environment Research Council Life Sciences Mass Spectrometry Facilities grant (EK-137-20/08) and the Leverhulme Trust (ECF/2008/0018). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	AMBROSE SH, 1986, OECOLOGIA, V69, P395, DOI 10.1007/BF00377062; Bearhop S, 2004, J ANIM ECOL, V73, P1007, DOI 10.1111/j.0021-8790.2004.00861.x; Bensch S, 2006, J AVIAN BIOL, V37, P323, DOI 10.1111/j.2006.0908-8857.03628.x; BURFIELD IJ, 2004, BIRDS EUROPE POPULAT; Cardillo M, 2008, P ROY SOC B-BIOL SCI, V275, P1441, DOI 10.1098/rspb.2008.0179; Chamberlain CP, 2000, P ROY SOC B-BIOL SCI, V267, P43, DOI 10.1098/rspb.2000.0964; Chantler P., 1995, SWIFTS GUIDE SWIFTS; Cooper N, 2008, GLOBAL ECOL BIOGEOGR, V17, P211, DOI 10.1111/j.1466-8238.2007.00355.x; Coplen TB, 2006, ANAL CHEM, V78, P2439, DOI 10.1021/ac052027c; EHLERINGER JR, 1988, OECOLOGIA, V76, P562, DOI 10.1007/BF00397870; ELLIS RP, 1980, S AFR J SCI, V76, P307; Eraud C, 2009, IBIS, V151, P186, DOI 10.1111/j.1474-919X.2008.00876.x; Evans KL, 2003, BIRD STUDY, V50, P294, DOI 10.1080/00063650309461322; FARQUHAR GD, 1982, AUST J PLANT PHYSIOL, V9, P121, DOI 10.1071/PP9820121; Fry CH., 1988, BIRDS AFRICA, V3; Gory G, 2008, REV ECOL-TERRE VIE, V63, P251; Grey J, 2004, LIMNOL OCEANOGR, V49, P239, DOI 10.4319/lo.2004.49.1.0239; Hernquist MB, 2009, J AVIAN BIOL, V40, P102; Hill LA, 2002, MIGRATION ATLAS, P465; Hobson KA, 2003, CAN J ZOOL, V81, P1630, DOI 10.1139/Z03-140; Inger R, 2008, IBIS, V150, P447, DOI 10.1111/j.1474-919X.2008.00839.x; Jenni L., 1994, BIOL MOULT BIRDS; Kelly JF, 2000, CAN J ZOOL, V78, P1, DOI 10.1139/cjz-78-1-1; Lack D., 1956, SWIFTS TOWER; Marra PP, 1998, SCIENCE, V282, P1884, DOI 10.1126/science.282.5395.1884; MOREL GJ, 1992, IBIS, V134, P83; Neto JM, 2006, J AVIAN BIOL, V37, P117; Newsome SD, 2007, FRONT ECOL ENVIRON, V5, P429, DOI 10.1890/060150.1; Newton I, 2008, MIGRATION ECOLOGY OF BIRDS, P1; Norman D., 2002, MIGRATION ATLAS, P565; Oatley TB, 1999, OSTRICH, V70, P236; Oppel S, 2011, J AVIAN BIOL, V42, P342, DOI 10.1111/j.1600-048X.2011.05252.x; Pain DJ, 2004, OECOLOGIA, V138, P168, DOI 10.1007/s00442-003-1416-z; Peach WJ, 1990, IBIS, V133, P300; PEARSON DJ, 1992, IBIS, V134, P89; Reichlin TS, 2010, DIVERS DISTRIB, V16, P643, DOI 10.1111/j.1472-4642.2010.00664.x; Risely K, 2011, 597 BRIT TRUST ORN; Robinson RA, 2010, ONLINE RINGING REPOR; Saino N, 2004, P ROY SOC B-BIOL SCI, V271, P681, DOI 10.1098/rspb.2003.2656; Sanderson FJ, 2006, BIOL CONSERV, V131, P93, DOI 10.1016/j.biocon.2006.02.008; Schaub M, 2005, J ANIM ECOL, V74, P656, DOI 10.1111/j.1365-2656.2005.00961.x; SEALY JC, 1987, GEOCHIM COSMOCHIM AC, V51, P2707, DOI 10.1016/0016-7037(87)90151-7; Shultz S, 2005, P ROY SOC B-BIOL SCI, V272, P2305, DOI 10.1098/rspb.2005.3250; SMITH BN, 1971, PLANT PHYSIOL, V47, P380, DOI 10.1104/pp.47.3.380; Stutchbury BJM, 2009, SCIENCE, V323, P896, DOI 10.1126/science.1166664; Svensson L., 1992, IDENTIFICATION GUIDE; Szep T, 2009, J ORNITHOL, V150, P621, DOI 10.1007/s10336-009-0382-6; SZEP T, 1995, IBIS, V137, P162, DOI 10.1111/j.1474-919X.1995.tb03235.x; VOGEL JC, 1978, S AFR J SCI, V74, P209; Webster MS, 2002, TRENDS ECOL EVOL, V17, P76, DOI 10.1016/S0169-5347(01)02380-1; WERGER MJA, 1981, FLORA, V171, P64; Wernham C., 2002, MIGRATION ATLAS, P443; Wernham CV, 2002, MIGRATION ATLAS; Wilcove DS, 2008, PLOS BIOL, V6, P1361, DOI 10.1371/journal.pbio.0060188; Yohannes E, 2007, J AVIAN BIOL, V38, P347, DOI 10.1111/j.2007.0908-8857.03927.x; Zwarts L., 2009, LIVING EDGE WETLANDS	56	15	15	0	54	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 5	2012	7	4							e34542	10.1371/journal.pone.0034542	http://dx.doi.org/10.1371/journal.pone.0034542			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	955IH	22496827	Green Published, Green Accepted, gold			2022-12-25	WOS:000305010500017
J	Martinell, J; Kowalewski, M; Domenech, R				Martinell, Jordi; Kowalewski, Michal; Domenech, Rosa			Drilling Predation on Serpulid Polychaetes (Ditrupa arietina) from the Pliocene of the Cope Basin, Murcia Region, Southeastern Spain	PLOS ONE			English	Article							WESTERN MEDITERRANEAN SEA; NATICID GASTROPODS; FOSSIL RECORD; BOTTOM ASSEMBLAGES; BORING PREDATION; MIDDLE MIOCENE; BRACHIOPODS; PREY; HOLES; PALEOECOLOGY	We report quantitative analyses of drilling predation on the free-living, tube-dwelling serpulid polychaete Ditrupa arietina from the Cope Cabo marine succession (Pliocene, Spain). Tubes of D. arietina are abundant in the sampled units: 9 bulk samples from 5 horizons yielded,5925 specimens of D. arietina. Except for fragmentation, tubes were well preserved. Complete specimens ranged from 3.1 to 13.4 mm in length and displayed allometric growth patterns, with larger specimens being relatively slimmer. Drilled Ditrupa tubes were observed in all samples. Drillholes, identified as Oichnus paraboloides, were characterized by circular to elliptical outline (drillhole eccentricity increased with its diameter), parabolic vertical profile, outer diameter larger than inner diameter, penetration of one tube wall only, narrow range of drill-hole sizes, and non-random (anterior) distribution of drillholes. A total of 233 drilled specimens were identified, with drilling frequencies varying across horizons from 2.7% to 21% (3.9% for pooled data). Many tube fragments were broken across a drillhole suggesting that the reported frequencies are conservative and that biologically-facilitated (drill-hole induced) fragmentation hampers fossil preservation of complete serpulid tubes. No failed or repaired holes were observed. Multiple complete drillholes were present (3.9%). Drilled specimens were significantly smaller than undrilled specimens and tube length and drill-hole diameter were weakly correlated. The results suggest that drillholes were produced by a size-selective, sitestereotypic predatory organism of unknown affinity. The qualitative and quantitative patterns reported here are mostly consistent with previous reports on recent and fossil Ditrupa and reveal parallels with drilling patterns documented for scaphopod mollusks, a group that is ecologically and morphologically similar to Ditrupa. Consistent with previous studies, the results suggest that free-dwelling serpulid polychaetes are preyed upon by drilling predators and may provide a viable source of data on biotic interactions in the fossil record.	[Martinell, Jordi; Domenech, Rosa] Univ Barcelona, Inst Recerca Biodiversitat, Barcelona, Spain; [Martinell, Jordi; Domenech, Rosa] Univ Barcelona, Fac Geol, Barcelona, Spain; [Kowalewski, Michal] Virginia Tech, Dept Geosci, Blacksburg, VA USA	University of Barcelona; University of Barcelona; Virginia Polytechnic Institute & State University	Martinell, J (corresponding author), Univ Barcelona, Inst Recerca Biodiversitat, Barcelona, Spain.	michalk@vt.edu	Martinell, Jordi/X-4501-2019; Kowalewski, Michal/B-4263-2008; Martinell, Jordi/K-2981-2014; Domènech, Rosa/M-6195-2013; Domènech, Rosa/X-5080-2019	Martinell, Jordi/0000-0003-2638-8106; Kowalewski, Michal/0000-0002-8575-4711; Martinell, Jordi/0000-0003-2638-8106; Domènech, Rosa/0000-0002-4174-8942; Domènech, Rosa/0000-0002-4174-8942	Spanish government [CGL2007-60507/BTE]; National Science Foundation [OCE-0602375, EAR-0920075, EAR-1053433]	Spanish government(Spanish GovernmentEuropean Commission); National Science Foundation(National Science Foundation (NSF))	This research project is supported by the grant CGL2007-60507/BTE funded by the Spanish government. In addition, MK acknowledges continuous support of his research program by the National Science Foundation grants (OCE-0602375, EAR-0920075, and EAR-1053433). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	BARDAJI T, 1995, GEODIN ACTA, V8, P112, DOI 10.1080/09853111.1995.11105383; Bardaji T, 1999, TEOR IMOV MAT STAT, P1; Baumiller TK, 1999, PALAEOGEOGR PALAEOCL, V147, P283, DOI 10.1016/S0031-0182(98)00165-5; BAUMILLER TK, 1990, PALAEONTOLOGY, V33, P743; Baumiller TK, 1996, PALAEOGEOGR PALAEOCL, V123, P343, DOI 10.1016/0031-0182(95)00124-7; BENGTSON S, 1992, SCIENCE, V257, P367, DOI 10.1126/science.257.5068.367; Berg JC, 1976, NAUTILUS, V90, P1; Bolam SG, 2002, J EXP MAR BIOL ECOL, V269, P197, DOI 10.1016/S0022-0981(02)00003-5; Bromley R.G., 1981, Acta Geologica Hispanica, V16, P55; Bromley RG, 1993, B GEOL SOC DENMARK, V40, P167; Cintra-Buenrostro CE, 2005, PALAIOS, V20, P296, DOI 10.2110/palo-2004.p04-21; Cosentino A, 2006, MAR ECOL-EVOL PERSP, V27, P170, DOI 10.1111/j.1439-0485.2006.00088.x; D'Alessandro A, 2004, SEDIMENT GEOL, V166, P89, DOI 10.1016/j.sedgeo.2003.11.017; Di Geronimo I, 1989, B ACC GIOENIA SC NAT, V20, P129; Di Geronimo Italo, 1992, Rivista Italiana di Paleontologia e Stratigrafia, V98, P229; Dietl GP, 1995, J SHELLFISH RES, V14, P307; Dominici S, 2001, PALAIOS, V16, P336, DOI 10.2307/3515575; EKDALE AA, 1985, PALAEOGEOGR PALAEOCL, V50, P63, DOI 10.1016/S0031-0182(85)80006-7; Gremare A, 1998, ESTUAR COAST SHELF S, V47, P447, DOI 10.1006/ecss.1998.0379; Guizien K, 2010, CONT SHELF RES, V30, P239, DOI 10.1016/j.csr.2009.11.010; Harper EM, 2005, PALAEONTOLOGY, V48, P197, DOI 10.1111/j.1475-4983.2004.00433.x; Harper EM, 2000, PALAEOGEOGR PALAEOCL, V158, P15, DOI 10.1016/S0031-0182(99)00164-9; Hoffman A, 1984, NEUES JB GEOLOGIE PA, P393; Hoffmeister AP, 2003, LETHAIA, V36, P107, DOI 10.1080/00241160310000408; Hua H, 2003, PALAIOS, V18, P454, DOI 10.1669/0883-1351(2003)018<0454:BICSCP>2.0.CO;2; Huntley JW, 2007, P NATL ACAD SCI USA, V104, P15006, DOI 10.1073/pnas.0704960104; Jager M., 1993, Contributions to Tertiary and Quaternary Geology, V29, P73; Jordana E, 2001, J EXP MAR BIOL ECOL, V266, P219, DOI 10.1016/S0022-0981(01)00357-4; KABAT AR, 1990, MALACOLOGIA, V32, P155; Kaplan P, 2000, PALAIOS, V15, P499, DOI 10.2307/3515614; Kelley PH, 1996, PALAIOS, V11, P437, DOI 10.2307/3515211; Kelley PH, 2001, PALAEOGEOGR PALAEOCL, V166, P165, DOI 10.1016/S0031-0182(00)00207-8; KITCHELL JA, 1981, PALEOBIOLOGY, V7, P533, DOI 10.1017/S0094837300025574; KITCHELL JA, 1986, MALACOLOGIA, V27, P291; Klompmaker AA, 2012, PALAEOGEOGR PALAEOCL, V321, P113, DOI 10.1016/j.palaeo.2012.01.024; Klompmaker AA, 2011, LETHAIA, V44, P429, DOI 10.1111/j.1502-3931.2010.00254.x; Kowalewski M, 2005, SCIENCE, V308, P1774, DOI 10.1126/science.1113408; Kowalewski M, 2000, J PALEONTOL, V74, P532, DOI 10.1666/0022-3360(2000)074<0532:DHISOP>2.0.CO;2; Kowalewski M, 2004, J MOLLUS STUD, V70, P359, DOI 10.1093/mollus/70.4.359; Kowalewski M, 1998, GEOLOGY, V26, P1091, DOI 10.1130/0091-7613(1998)026<1091:AFRFOH>2.3.CO;2; Kowalewski Michal, 2002, Paleontological Society Papers, V8, P3; Labrune C, 2007, J SEA RES, V58, P125, DOI 10.1016/j.seares.2007.02.006; Leighton LR, 2001, PALAEOGEOGR PALAEOCL, V165, P53, DOI 10.1016/S0031-0182(00)00153-X; Li Rong-Yu, 2011, Palaeoworld, V20, P296, DOI 10.1016/j.palwor.2011.04.001; Martinell J, 2010, PALAIOS, V25, P221, DOI 10.2110/palo.2009.p09-124r; MCCLINTOCK JB, 1993, B MAR SCI, V52, P1013; MCNAMARA KJ, 1994, ECHINODERMS THROUGH TIME, P785; Medernach L, 2000, MAR ECOL PROG SER, V199, P171, DOI 10.3354/meps199171; Morton B., 2009, ACOREANA S, V6, P157; Morton B., 2009, ACOREANA S, V6, P146; Muller OF, 1776, ZOOLOGIAE DANICAE PR, p[I, 1], DOI DOI 10.5962/BHL.TITLE.13268; Nebelsick JH, 1999, PALAIOS, V14, P127, DOI 10.2307/3515369; Nilsen KSS, 2008, ICHNOS, V8, P99; Picard J, 1965, RECL TRAV STN MAR EN, V52, P1; Pruss SB, 2011, PALAEOGEOGR PALAEOCL, V311, P74, DOI 10.1016/j.palaeo.2011.08.003; RICHARDS R P, 1969, Journal of Paleontology, V43, P838; Rodrigues SC, 2008, ACTA PALAEONTOL POL, V53, P657, DOI 10.4202/app.2008.0410; ROY K, 1994, PALAIOS, V9, P413, DOI 10.2307/3515059; Sanfilippo R, 1999, RIV ITAL PALEONTOL S, V105, P455, DOI 10.13130/2039-4942/5386; Sarda R, 2000, ICES J MAR SCI, V57, P1446, DOI 10.1006/jmsc.2000.0922; Savazzi Enrico, 1995, Palaeontologische Zeitschrift, V69, P73; SMITH SA, 1985, SCIENCE, V230, P1033, DOI 10.1126/science.230.4729.1033; SOHL NF, 1969, AM ZOOL, V9, P725; ten Hove H.A., 1990, Records of the Australian Museum, V42, P101; Ten Hove H.A., 2011, WORLD POLYCHAETA DAT; ten Hove HA, 1994, DEHOREN ZIJN ECHO, P65; Vermeij G.J, 1987, EVOLUTION ESCALATION; VERMEIJ GJ, 1980, PALEOBIOLOGY, V6, P352, DOI 10.1017/S0094837300006850; VERMEIJ GJ, 1983, PALAEONTOLOGY, V26, P455; Viseras C, 2004, CUENCAS NEOGENAS POS, P576; Wijnker E, 2008, NETH J GEOSCI, V87, P165, DOI 10.1017/S0016774600023209; WILSON JB, 1976, J MAR BIOL ASSOC UK, V56, P291, DOI 10.1017/S0025315400018919; Yochelson E.L., 1983, US GEOLOGICAL SURVEY, V1282, P1; Zlotnik M, 2005, ACTA PALAEONTOL POL, V50, P409; Zlotnik M, 2001, ACTA PALAEONTOL POL, V46, P87	75	20	22	0	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 5	2012	7	4							e34576	10.1371/journal.pone.0034576	http://dx.doi.org/10.1371/journal.pone.0034576			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	955IH	22496828	Green Published, gold, Green Submitted			2022-12-25	WOS:000305010500018
J	Turunen, SP; Kummu, O; Harila, K; Veneskoski, M; Soliymani, R; Baumann, M; Pussinen, PJ; Horkko, S				Turunen, S. Pauliina; Kummu, Outi; Harila, Kirsi; Veneskoski, Marja; Soliymani, Rabah; Baumann, Marc; Pussinen, Pirkko J.; Horkko, Sohvi			Recognition of Porphyromonas gingivalis Gingipain Epitopes by Natural IgM Binding to Malondialdehyde Modified Low-Density Lipoprotein	PLOS ONE			English	Article							E-DEFICIENT MICE; OXIDATION-SPECIFIC EPITOPES; CORONARY-ARTERY-DISEASE; LDL RECEPTOR-DEFICIENT; APOLIPOPROTEIN-E; MYOCARDIAL-INFARCTION; MONOCLONAL AUTOANTIBODIES; STREPTOCOCCUS-PNEUMONIAE; OXIDIZED PHOSPHOLIPIDS; PERIODONTITIS PATIENTS	Objective: Increased risk for atherosclerosis is associated with infectious diseases including periodontitis. Natural IgM antibodies recognize pathogen-associated molecular patterns on bacteria, and oxidized lipid and protein epitopes on low-density lipoprotein (LDL) and apoptotic cells. We aimed to identify epitopes on periodontal pathogen Porphyromonas gingivalis recognized by natural IgM binding to malondialdehyde (MDA) modified LDL. Methods and Results: Mouse monoclonal IgM (MDmAb) specific for MDA-LDL recognized epitopes on P. gingivalis on flow cytometry and chemiluminescence immunoassays. Immunization of C57BL/6 mice with P. gingivalis induced IgM, but not IgG, immune response to MDA-LDL and apoptotic cells. Immunization of LDLR-/- mice with P. gingivalis induced IgM, but not IgG, immune response to MDA-LDL and diminished aortic lipid deposition. On Western blot MDmAb bound to P. gingivalis fragments identified as arginine-specific gingipain (Rgp) by mass spectrometry. Recombinant domains of Rgp produced in E. coli were devoid of phosphocholine epitopes but contained epitopes recognized by MDmAb and human serum IgM. Serum IgM levels to P. gingivalis were associated with anti-MDA-LDL levels in humans. Conclusion: Gingipain of P. gingivalis is recognized by natural IgM and shares molecular identity with epitopes on MDA-LDL. These findings suggest a role for natural antibodies in the pathogenesis of two related inflammatory diseases, atherosclerosis and periodontitis.	[Turunen, S. Pauliina; Kummu, Outi; Harila, Kirsi; Veneskoski, Marja; Horkko, Sohvi] Univ Oulu, Inst Diagnost, Dept Med Microbiol & Immunol, Oulu, Finland; [Turunen, S. Pauliina; Kummu, Outi; Harila, Kirsi; Veneskoski, Marja; Horkko, Sohvi] Oulu Univ Hosp, Clin Res Ctr, Oulu, Finland; [Soliymani, Rabah; Baumann, Marc] Biomedicum Helsinki, Inst Biomed Anat, Prot Chem Unit, Helsinki, Finland; [Pussinen, Pirkko J.] Univ Helsinki, Inst Dent, Helsinki, Finland	University of Oulu; University of Oulu; University of Helsinki; University of Helsinki	Turunen, SP (corresponding author), Univ Oulu, Inst Diagnost, Dept Med Microbiol & Immunol, Oulu, Finland.	sohvi.horkko@oulu.fi		Pussinen, Pirkko/0000-0003-3563-1876; Kummu, Outi/0000-0003-0327-3496; Turunen, S. Pauliina/0000-0001-8060-9876; Soliymani, Rabah/0000-0003-0184-3352; Baumann, Marc/0000-0002-2991-889X	Academy of Finland [119012, 134763]; Finnish Foundation for Cardiovascular Research; Sigrid Juselius Foundation; Sohlberg Foundation; Finnish Cultural Foundation; Paavo Nurmi Foundation	Academy of Finland(Academy of Finland); Finnish Foundation for Cardiovascular Research; Sigrid Juselius Foundation(Sigrid Juselius Foundation); Sohlberg Foundation; Finnish Cultural Foundation(Finnish Cultural FoundationFinnish IT center for science); Paavo Nurmi Foundation	The work was supported by Academy of Finland (119012 and 134763), Finnish Foundation for Cardiovascular Research, Sigrid Juselius Foundation, Sohlberg Foundation, Finnish Cultural Foundation, and Paavo Nurmi Foundation. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ait-Oufella H, 2010, J EXP MED, V207, P1579, DOI 10.1084/jem.20100155; Binder CJ, 2010, J CLIN IMMUNOL, V30, pS56, DOI 10.1007/s10875-010-9396-3; Binder CJ, 2003, NAT MED, V9, P736, DOI 10.1038/nm876; Booth V, 1997, J PERIODONTAL RES, V32, P54, DOI 10.1111/j.1600-0765.1997.tb01382.x; BRILES DE, 1992, INFECT IMMUN, V60, P1957, DOI 10.1128/IAI.60.5.1957-1962.1992; Chang MK, 1999, P NATL ACAD SCI USA, V96, P6353, DOI 10.1073/pnas.96.11.6353; Chou MY, 2009, J CLIN INVEST, V119, P1335, DOI 10.1172/JCI36800; Curtis MA, 1999, J PERIODONTAL RES, V34, P464, DOI 10.1111/j.1600-0765.1999.tb02282.x; de Faire U, 2010, J AUTOIMMUN, V34, P73, DOI 10.1016/j.jaut.2009.05.003; de Laat B, 2011, CURR RHEUMATOL REP, V13, P70, DOI 10.1007/s11926-010-0144-8; DESTEFANO F, 1993, BRIT MED J, V306, P688, DOI 10.1136/bmj.306.6879.688; DRAPER HH, 1990, METHOD ENZYMOL, V186, P421; Epstein SE, 2000, ARTERIOSCL THROM VAS, V20, P1417, DOI 10.1161/01.ATV.20.6.1417; ESTERBAUER H, 1991, FREE RADICAL BIO MED, V11, P81, DOI 10.1016/0891-5849(91)90192-6; Freigang S, 1998, ARTERIOSCL THROM VAS, V18, P1972, DOI 10.1161/01.ATV.18.12.1972; FRIEDEWALD WT, 1972, CLIN CHEM, V18, P499; Georges JL, 2003, AM J CARDIOL, V92, P515, DOI 10.1016/S0002-9149(03)00717-3; Gibson FC, 2004, CIRCULATION, V109, P2801, DOI 10.1161/01.CIR.0000129769.17895.F0; Gibson FC, 2001, INFECT IMMUN, V69, P7959, DOI 10.1128/IAI.69.12.7959-7963.2001; Gmur R, 1999, J DENT RES, V78, P77, DOI 10.1177/00220345990780011201; Guo YH, 2010, PERIODONTOL 2000, V54, P15, DOI 10.1111/j.1600-0757.2010.00377.x; HABEEB AFS, 1966, ANAL BIOCHEM, V14, P328, DOI 10.1016/0003-2697(66)90275-2; Hansson GK, 2011, NAT IMMUNOL, V12, P204, DOI 10.1038/ni.2001; HAVEL RJ, 1955, J CLIN INVEST, V34, P1345, DOI 10.1172/JCI103182; Hayashi C, 2011, ATHEROSCLEROSIS, V215, P52, DOI 10.1016/j.atherosclerosis.2010.12.009; Hazen SL, 2008, J BIOL CHEM, V283, P15527, DOI 10.1074/jbc.R700054200; Hill GE, 1998, ATHEROSCLEROSIS, V141, P107, DOI 10.1016/S0021-9150(98)00153-1; Horkko S, 2000, FREE RADICAL BIO MED, V28, P1771, DOI 10.1016/S0891-5849(00)00333-6; Horkko S, 1999, J CLIN INVEST, V103, P117, DOI 10.1172/JCI4533; Inagaki S, 2003, J PERIODONTOL, V74, P1432, DOI 10.1902/jop.2003.74.10.1432; ISHIBASHI S, 1994, J CLIN INVEST, V93, P1885, DOI 10.1172/JCI117179; KADOWAKI T, 1994, J BIOL CHEM, V269, P21371; Kaizuka K, 2003, J PERIODONTOL, V74, P38, DOI 10.1902/jop.2003.74.1.38; Karvonen J, 2003, CIRCULATION, V108, P2107, DOI 10.1161/01.CIR.0000092891.55157.A7; Kellokoski E, 2009, PEPTIDES, V30, P2292, DOI 10.1016/j.peptides.2009.09.008; Lalla E, 2003, ARTERIOSCL THROM VAS, V23, P1405, DOI 10.1161/01.ATV.0000082462.26258.FE; Lewis MJ, 2009, CIRCULATION, V120, P417, DOI 10.1161/CIRCULATIONAHA.109.868158; Li L, 2002, CIRCULATION, V105, P861, DOI 10.1161/hc0702.104178; Maekawa T, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0020240; MATTILA KJ, 1989, BRIT MED J, V298, P779, DOI 10.1136/bmj.298.6676.779; Mayr M, 2006, J AM COLL CARDIOL, V47, P2436, DOI 10.1016/j.jacc.2006.03.024; Miller YI, 2011, CIRC RES, V108, P235, DOI 10.1161/CIRCRESAHA.110.223875; Miyamoto T, 2006, INFECT IMMUN, V74, P1376, DOI 10.1128/IAI.74.2.1376-1380.2006; Palinski W, 1996, J CLIN INVEST, V98, P800, DOI 10.1172/JCI118853; PALINSKI W, 1990, ARTERIOSCLEROSIS, V10, P325, DOI 10.1161/01.ATV.10.3.325; PENGO V, 1995, THROMB HAEMOSTASIS, V73, P29; POTEMPA J, 1995, INFECT IMMUN, V63, P1176, DOI 10.1128/IAI.63.4.1176-1182.1995; Pussinen PJ, 2004, ARTERIOSCL THROM VAS, V24, P2174, DOI 10.1161/01.ATV.0000145979.82184.9f; Pussinen PJ, 2004, EUR J CARDIOV PREV R, V11, P408, DOI 10.1097/00149831-200410000-00008; Pussinen PJ, 2002, J CLIN MICROBIOL, V40, P512, DOI 10.1128/JCM.40.2.512-518.2002; Pussinen PJ, 2003, ARTERIOSCL THROM VAS, V23, P1250, DOI 10.1161/01.ATV.0000072969.71452.87; Ross R, 1999, NEW ENGL J MED, V340, P115, DOI 10.1056/NEJM199901143400207; Schenkein HA, 1999, INFECT IMMUN, V67, P4814, DOI 10.1128/IAI.67.9.4814-4818.1999; Schenkein HA, 2004, J PERIODONTOL, V75, P146, DOI 10.1902/jop.2004.75.1.146; Schenkein HA, 2003, J DENT RES, V82, P919, DOI 10.1177/154405910308201114; Schenkein HA, 2001, INFECT IMMUN, V69, P6612, DOI 10.1128/IAI.69.11.6612-6617.2001; Shaw PX, 2000, J CLIN INVEST, V105, P1731, DOI 10.1172/JCI8472; Shevchenko A, 1996, ANAL CHEM, V68, P850, DOI 10.1021/ac950914h; TANGIRALA RK, 1995, J LIPID RES, V36, P2320; Tsimikas S, 2007, J LIPID RES, V48, P425, DOI 10.1194/jlr.M600361-JLR200; Tuma DJ, 1996, HEPATOLOGY, V23, P872, DOI 10.1002/hep.510230431; Tuominen A, 2006, ARTERIOSCL THROM VAS, V26, P2096, DOI 10.1161/01.ATV.0000233333.07991.4a; Veneskoski M, 2011, FREE RADICAL BIO MED, V51, P834, DOI 10.1016/j.freeradbiomed.2011.05.029; von Nandelstadh P, 2011, BIOCHEM J, V436, P113, DOI 10.1042/BJ20101672; Yasaki-Inagaki Y, 2006, FEMS IMMUNOL MED MIC, V47, P287, DOI 10.1111/j.1574-695X.2006.00091.x; Yusuf S, 2004, LANCET, V364, P937, DOI 10.1016/S0140-6736(04)17018-9; ZHANG SH, 1992, SCIENCE, V258, P468, DOI 10.1126/science.1411543	67	46	46	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 5	2012	7	4							e34910	10.1371/journal.pone.0034910	http://dx.doi.org/10.1371/journal.pone.0034910			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	955IH	22496875	Green Published, Green Submitted, gold			2022-12-25	WOS:000305010500028
J	Chan, YK; Huang, IC; Farzan, M				Chan, Ying Kai; Huang, I-Chueh; Farzan, Michael			IFITM Proteins Restrict Antibody-Dependent Enhancement of Dengue Virus Infection	PLOS ONE			English	Article							WEST NILE VIRUS; HEMORRHAGIC-FEVER; HUMAN-CELLS	Interferon-inducible transmembrane (IFITM) proteins restrict the entry processes of several pathogenic viruses, including the flaviviruses West Nile virus and dengue virus (DENV). DENV infects cells directly or via antibody-dependent enhancement (ADE) in Fc-receptor-bearing cells, a process thought to contribute to severe disease in a secondary infection. Here we investigated whether ADE-mediated DENV infection bypasses IFITM-mediated restriction or whether IFITM proteins can be protective in a secondary infection. We observed that IFITM proteins restricted ADE-mediated and direct infection with comparable efficiencies in a myelogenous leukemia cell line. Our data suggest that IFITM proteins can contribute to control of secondary DENV infections.	[Chan, Ying Kai; Huang, I-Chueh; Farzan, Michael] Harvard Univ, Sch Med, New England Primate Res Ctr, Dept Microbiol & Immunobiol, Southborough, MA 01772 USA	Harvard University	Chan, YK (corresponding author), Harvard Univ, Sch Med, New England Primate Res Ctr, Dept Microbiol & Immunobiol, Southborough, MA 01772 USA.	ykchan@fas.harvard.edu; farzan@hms.harvard.edu		Farzan, Michael/0000-0002-2990-5319	New England Regional Center for Excellence/Biodefense and Emerging Infectious Disease [U54 AI057159]; New England Primate Research Center [RR000168]; Burroughs Wellcome Fund; NATIONAL CENTER FOR RESEARCH RESOURCES [K26RR000168, P51RR000168] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R00AI093679, U54AI057159, K99AI093679] Funding Source: NIH RePORTER	New England Regional Center for Excellence/Biodefense and Emerging Infectious Disease; New England Primate Research Center; Burroughs Wellcome Fund(Burroughs Wellcome Fund); NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	This work was supported by the New England Regional Center for Excellence/Biodefense and Emerging Infectious Disease (U54 AI057159), by the New England Primate Research Center Base Grant (RR000168), and by the Burroughs Wellcome Fund. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Brass AL, 2009, CELL, V139, P1243, DOI 10.1016/j.cell.2009.12.017; Diamond MS, 2000, J VIROL, V74, P7814, DOI 10.1128/JVI.74.17.7814-7823.2000; Dowd KA, 2011, VIROLOGY, V411, P306, DOI 10.1016/j.virol.2010.12.020; FRIEDMAN RL, 1984, CELL, V38, P745, DOI 10.1016/0092-8674(84)90270-8; Gubler DJ, 1998, CLIN MICROBIOL REV, V11, P480, DOI 10.1128/CMR.11.3.480; Guy B, 2004, VACCINE, V22, P3563, DOI 10.1016/j.vaccine.2004.03.042; HALSTEAD SB, 1970, YALE J BIOL MED, V42, P350; Halstead SB, 2007, LANCET, V370, P1644, DOI 10.1016/S0140-6736(07)61687-0; Huang IC, 2008, J VIROL, V82, P4834, DOI 10.1128/JVI.00079-08; Huang IC, 2011, PLOS PATHOG, V7, DOI 10.1371/journal.ppat.1001258; Huang IC, 2006, J BIOL CHEM, V281, P3198, DOI 10.1074/jbc.M508381200; Jessie K, 2004, J INFECT DIS, V189, P1411, DOI 10.1086/383043; Jiang D, 2010, J VIROL, V84, P8332, DOI 10.1128/JVI.02199-09; KLIKS SC, 1988, AM J TROP MED HYG, V38, P411, DOI 10.4269/ajtmh.1988.38.411; LEWIN AR, 1991, EUR J BIOCHEM, V199, P417, DOI 10.1111/j.1432-1033.1991.tb16139.x; LITTAUA R, 1990, J IMMUNOL, V144, P3183; Liu SY, 2011, CURR OPIN IMMUNOL, V23, P57, DOI 10.1016/j.coi.2010.11.003; Lu J, 2011, J VIROL, V85, P2126, DOI 10.1128/JVI.01531-10; Moffatt P, 2008, J BONE MINER RES, V23, P1497, DOI 10.1359/JBMR.080412; Moreno-Altamirano MMB, 2007, INTERVIROLOGY, V50, P237, DOI 10.1159/000100567; Pierson Theodore C., 2008, Expert Reviews in Molecular Medicine, V10, P1, DOI 10.1017/S1462399408000665; Rodenhuis-Zybert IA, 2011, TRENDS MICROBIOL, V19, P248, DOI 10.1016/j.tim.2011.02.002; Rodenhuis-Zybert IA, 2010, PLOS PATHOG, V6, DOI 10.1371/journal.ppat.1000718; Samuel CE, 2001, CLIN MICROBIOL REV, V14, P778, DOI 10.1128/CMR.14.4.778-809.2001; Schoggins JW, 2011, NATURE, V472, P481, DOI 10.1038/nature09907; Tassaneetrithep B, 2003, J EXP MED, V197, P823, DOI 10.1084/jem.20021840; Ubol S, 2010, CLIN VACCINE IMMUNOL, V17, P1829, DOI 10.1128/CVI.00316-10	27	35	46	1	15	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 30	2012	7	3							e34508	10.1371/journal.pone.0034508	http://dx.doi.org/10.1371/journal.pone.0034508			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	959UC	22479637	Green Published, Green Submitted, gold			2022-12-25	WOS:000305339100163
J	Nimlos, MR; Beckham, GT; Matthews, JF; Bu, LT; Himmel, ME; Crowley, MF				Nimlos, Mark R.; Beckham, Gregg T.; Matthews, James F.; Bu, Lintao; Himmel, Michael E.; Crowley, Michael F.			Binding Preferences, Surface Attachment, Diffusivity, and Orientation of a Family 1 Carbohydrate-binding Module on Cellulose	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							FACTORS INFLUENCING GLYCOSYLATION; TRICHODERMA-REESEI CELLULASES; GLYCOSIDE HYDROLASE FAMILY; CRYSTAL-STRUCTURE; CELLOBIOHYDROLASE-I; MOLECULAR-DYNAMICS; HYPOCREA-JECORINA; LIGNOCELLULOSIC BIOMASS; N-GLYCOSYLATION; CATALYTIC CORE	Cellulase enzymes often contain carbohydrate-binding modules (CBMs) for binding to cellulose. The mechanisms by which CBMs recognize specific surfaces of cellulose and aid in deconstruction are essential to understand cellulase action. The Family 1 CBM from the Trichoderma reesei Family 7 cellobiohydrolase, Cel7A, is known to selectively bind to hydrophobic surfaces of native cellulose. It is most commonly suggested that three aromatic residues identify the planar binding face of this CBM, but several recent studies have challenged this hypothesis. Here, we use molecular simulation to study the CBM binding orientation and affinity on hydrophilic and hydrophobic cellulose surfaces. Roughly 43 mu s of molecular dynamics simulations were conducted, which enables statistically significant observations. We quantify the fractions of the CBMs that detach from crystal surfaces or diffuse to other surfaces, the diffusivity along the hydrophobic surface, and the overall orientation of the CBM on both hydrophobic and hydrophilic faces. The simulations demonstrate that there is a thermodynamic driving force for the Cel7A CBM to bind preferentially to the hydrophobic surface of cellulose relative to hydrophilic surfaces. In addition, the simulations demonstrate that the CBM can diffuse from hydrophilic surfaces to the hydrophobic surface, whereas the reverse transition is not observed. Lastly, our simulations suggest that the flat faces of Family 1 CBMs are the preferred binding surfaces. These results enhance our understanding of how Family 1 CBMs interact with and recognize specific cellulose surfaces and provide insights into the initial events of cellulase adsorption and diffusion on cellulose.	[Nimlos, Mark R.; Beckham, Gregg T.; Bu, Lintao] Natl Renewable Energy Ctr, Natl Bioenergy Ctr, Golden, CO 80401 USA; [Matthews, James F.; Himmel, Michael E.; Crowley, Michael F.] Natl Renewable Energy Ctr, Biosci Ctr, Golden, CO 80401 USA; [Beckham, Gregg T.] Colorado Sch Mines, Dept Chem Engn, Golden, CO 80401 USA	United States Department of Energy (DOE); National Renewable Energy Laboratory - USA; Colorado School of Mines	Nimlos, MR (corresponding author), Natl Renewable Energy Ctr, Natl Bioenergy Ctr, 1617 Cole Blvd, Golden, CO 80401 USA.	mark.nimlos@nrel.gov	crowley, michael F/A-4852-2013	crowley, michael F/0000-0001-5163-9398	Department of Energy Office of the Biomass; NSF Teragrid [MCB090159]	Department of Energy Office of the Biomass(United States Department of Energy (DOE)); NSF Teragrid(National Science Foundation (NSF))	This work was supported in part by the Department of Energy Office of the Biomass Program. Computer time was provided by the TACC Ranger cluster and the NICS Athena and Kraken clusters under NSF Teragrid Grant MCB090159.	Arantes V, 2010, BIOTECHNOL BIOFUELS, V3, DOI 10.1186/1754-6834-3-4; Beckham GT, 2011, CURR OPIN BIOTECH, V22, P231, DOI 10.1016/j.copbio.2010.11.005; Beckham GT, 2011, J PHYS CHEM B, V115, P4118, DOI 10.1021/jp1106394; Beckham GT, 2010, BIOPHYS J, V99, P3773, DOI 10.1016/j.bpj.2010.10.032; Beckham GT, 2010, J PHYS CHEM B, V114, P1447, DOI 10.1021/jp908810a; Boraston AB, 2004, BIOCHEM J, V382, P769, DOI 10.1042/BJ20040892; Bu LT, 2011, J BIOL CHEM, V286, P18161, DOI 10.1074/jbc.M110.212076; Bu LT, 2009, J PHYS CHEM B, V113, P10994, DOI 10.1021/jp904003z; Case DA, 2005, J COMPUT CHEM, V26, P1668, DOI 10.1002/jcc.20290; Chundawat SPS, 2011, ANNU REV CHEM BIOMOL, V2, P121, DOI 10.1146/annurev-chembioeng-061010-114205; Chundawat SPS, 2011, J AM CHEM SOC, V133, P11163, DOI 10.1021/ja2011115; Crowley MF, 2009, INT J QUANTUM CHEM, V109, P3767, DOI 10.1002/qua.22372; Deshpande N, 2008, GLYCOBIOLOGY, V18, P626, DOI 10.1093/glycob/cwn044; Divne C, 1998, J MOL BIOL, V275, P309, DOI 10.1006/jmbi.1997.1437; DIVNE C, 1994, SCIENCE, V265, P524, DOI 10.1126/science.8036495; DURELL SR, 1994, J PHYS CHEM-US, V98, P2198, DOI 10.1021/j100059a038; ESSMANN U, 1995, J CHEM PHYS, V103, P8577, DOI 10.1063/1.470117; Fernandes AN, 2011, P NATL ACAD SCI USA, V108, pE1195, DOI 10.1073/pnas.1108942108; Guvench O, 2008, J COMPUT CHEM, V29, P2543, DOI 10.1002/jcc.21004; Guvench O, 2009, J CHEM THEORY COMPUT, V5, P2353, DOI 10.1021/ct900242e; Hall M, 2011, BIORESOURCE TECHNOL, V102, P2910, DOI 10.1016/j.biortech.2010.11.010; Harris PV, 2010, BIOCHEMISTRY-US, V49, P3305, DOI 10.1021/bi100009p; Harrison MJ, 1998, EUR J BIOCHEM, V256, P119, DOI 10.1046/j.1432-1327.1998.2560119.x; Helbert W, 1998, J STRUCT BIOL, V124, P42, DOI 10.1006/jsbi.1998.4045; Himmel ME, 2007, SCIENCE, V315, P804, DOI 10.1126/science.1137016; HOOVER WG, 1985, PHYS REV A, V31, P1695, DOI 10.1103/PhysRevA.31.1695; Horikawa Y, 2006, CELLULOSE, V13, P309, DOI 10.1007/s10570-005-9037-9; Hui JPM, 2001, J CHROMATOGR B, V752, P349, DOI 10.1016/S0378-4347(00)00373-X; Igarashi K, 2009, J BIOL CHEM, V284, P36186, DOI 10.1074/jbc.M109.034611; Jervis EJ, 1997, J BIOL CHEM, V272, P24016, DOI 10.1074/jbc.272.38.24016; JORGENSEN WL, 1983, J CHEM PHYS, V79, P926, DOI 10.1063/1.445869; Karkehabadi S, 2008, J MOL BIOL, V383, P144, DOI 10.1016/j.jmb.2008.08.016; Kleywegt GJ, 1997, J MOL BIOL, V272, P383, DOI 10.1006/jmbi.1997.1243; Koivula A, 1998, FEBS LETT, V429, P341, DOI 10.1016/S0014-5793(98)00596-1; KOTTALAM J, 1988, J AM CHEM SOC, V110, P7690, DOI 10.1021/ja00231a018; Koyama M, 1997, CELLULOSE, V4, P147, DOI 10.1023/A:1018427604670; KRAULIS PJ, 1989, BIOCHEMISTRY-US, V28, P7241, DOI 10.1021/bi00444a016; KUMAR S, 1992, J COMPUT CHEM, V13, P1011, DOI 10.1002/jcc.540130812; Lantz SE, 2010, BIOTECHNOL BIOFUELS, V3, DOI 10.1186/1754-6834-3-20; Lehtio J, 2003, P NATL ACAD SCI USA, V100, P484, DOI 10.1073/pnas.212651999; LINDER M, 1995, PROTEIN SCI, V4, P1056, DOI 10.1002/pro.5560040604; LINDER M, 1995, FEBS LETT, V372, P96, DOI 10.1016/0014-5793(95)00961-8; Mackerell AD, 2004, J COMPUT CHEM, V25, P1400, DOI 10.1002/jcc.20065; MacKerell AD, 1998, J PHYS CHEM B, V102, P3586, DOI 10.1021/jp973084f; Martinez D, 2008, NAT BIOTECHNOL, V26, P553, DOI 10.1038/nbt1403; Matthews JF, 2012, J CHEM THEORY COMPUT, V8, P735, DOI 10.1021/ct2007692; Matthews JF, 2006, CARBOHYD RES, V341, P138, DOI 10.1016/j.carres.2005.09.028; Mulakala C, 2005, PROTEINS, V60, P598, DOI 10.1002/prot.20547; Newman RH, 1998, HOLZFORSCHUNG, V52, P157, DOI 10.1515/hfsg.1998.52.2.157; Nishiyama Y, 2002, J AM CHEM SOC, V124, P9074, DOI 10.1021/ja0257319; Nishiyama Y, 2009, J WOOD SCI, V55, P241, DOI 10.1007/s10086-009-1029-1; NOSE S, 1983, MOL PHYS, V50, P1055, DOI 10.1080/00268978300102851; PARRINELLO M, 1980, PHYS REV LETT, V45, P1196, DOI 10.1103/PhysRevLett.45.1196; Payne CM, 2011, J PHYS CHEM LETT, V2, P1546, DOI 10.1021/jz2005122; Phillips CM, 2011, J PROTEOME RES, V10, P4177, DOI 10.1021/pr200329b; REESE ET, 1976, BIOTECHNOL BIOENG, P9; ROUVINEN J, 1990, SCIENCE, V249, P380, DOI 10.1126/science.2377893; RYCKAERT JP, 1977, J COMPUT PHYS, V23, P327, DOI 10.1016/0021-9991(77)90098-5; Sandgren M, 2001, J MOL BIOL, V308, P295, DOI 10.1006/jmbi.2001.4583; Shao JY, 2007, J CHEM THEORY COMPUT, V3, P2312, DOI 10.1021/ct700119m; SRISODSUK M, 1993, J BIOL CHEM, V268, P20756; Stals I, 2004, GLYCOBIOLOGY, V14, P713, DOI 10.1093/glycob/cwh080; Stals I, 2004, GLYCOBIOLOGY, V14, P725, DOI 10.1093/glycob/cwh081; Stals I, 2010, FEMS MICROBIOL LETT, V303, P9, DOI 10.1111/j.1574-6968.2009.01849.x; Tavagnacco L, 2011, CARBOHYD RES, V346, P839, DOI 10.1016/j.carres.2011.01.019; TORRIE GM, 1977, J COMPUT PHYS, V23, P187, DOI 10.1016/0021-9991(77)90121-8; Wilson DB, 2009, CURR OPIN BIOTECH, V20, P295, DOI 10.1016/j.copbio.2009.05.007	67	67	67	0	81	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	JUN 8	2012	287	24					20603	20612		10.1074/jbc.M112.358184	http://dx.doi.org/10.1074/jbc.M112.358184			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	974FB	22496371	Green Published, hybrid			2022-12-25	WOS:000306414500080
J	Li, ZH; De Gaudenzi, JG; Alvarez, VE; Mendiondo, N; Wang, HM; Kissinger, JC; Frasch, AC; Docampo, R				Li, Zhu-Hong; De Gaudenzi, Javier G.; Alvarez, Vanina E.; Mendiondo, Nicolas; Wang, Haiming; Kissinger, Jessica C.; Frasch, Alberto C.; Docampo, Roberto			A 43-Nucleotide U-rich Element in 3 '-Untranslated Region of Large Number of Trypanosoma cruzi Transcripts Is Important for mRNA Abundance in Intracellular Amastigotess	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							GENE-EXPRESSION; AU-RICH; BINDING PROTEINS; TRANS-SIALIDASE; GENOME; FAMILY; SEQUENCE; LIFE; TRYPOMASTIGOTE; IDENTIFICATION	Trypanosoma cruzi, the agent of Chagas disease, does not seem to control gene expression through regulation of transcription initiation and makes use of post-transcriptional mechanisms. We report here a 43-nt U-rich RNA element located in the 3'-untranslated region (3'-UTR) of a large number of T. cruzi mRNAs that is important for mRNA abundance in the intracellular amastigote stage of the parasite. Whole genome scan analysis, differential display RT-PCR, Northern blot, and RT-PCR analyses were used to determine the transcript levels of more than 900 U-rich-containing mRNAs of large gene families as well as single and low copy number genes. Our results indicate that the 43-nt U-rich mRNA element is preferentially present in amastigotes. The cis-element of a protein kinase 3'-UTR but not its mutated version promoted the expression of the green fluorescent protein reporter gene in amastigotes. The regulatory cis-element, but not its mutated version, was also shown to interact with the trypanosome-specific RNA-binding protein (RBP) TcUBP1 but not with other related RBPs. Co-immunoprecipitation experiments of TcUBP1-containing ribonucleoprotein complexes formed in vivo validated the interaction with representative endogenous RNAs having the element. These results suggest that this 43-nt U-rich element together with other yet unidentified sequences might be involved in the modulation of abundance and/or translation of subsets of transcripts in the amastigote stage.	[Li, Zhu-Hong; Wang, Haiming; Kissinger, Jessica C.; Docampo, Roberto] Univ Georgia, Ctr Trop & Emerging Global Dis, Athens, GA 30602 USA; [Kissinger, Jessica C.] Univ Georgia, Dept Genet, Athens, GA 30602 USA; [Docampo, Roberto] Univ Georgia, Dept Cellular Biol, Athens, GA 30602 USA; [Kissinger, Jessica C.] Univ Georgia, Inst Bioinformat, Athens, GA 30602 USA; [De Gaudenzi, Javier G.; Alvarez, Vanina E.; Mendiondo, Nicolas; Frasch, Alberto C.] Univ Nacl Gen San Martin, Consejo Nacl Invest Cient & Tecn, Inst Tecnol Chascomus, Inst Invest Biotecnol, RA-1650 San Martin, Buenos Aires, Argentina	University System of Georgia; University of Georgia; University System of Georgia; University of Georgia; University System of Georgia; University of Georgia; University System of Georgia; University of Georgia; Consejo Nacional de Investigaciones Cientificas y Tecnicas (CONICET)	Docampo, R (corresponding author), Univ Georgia, Ctr Trop & Emerging Global Dis, 350B Paul D Coverdell Ctr,500 DW Brooks Dr, Athens, GA 30602 USA.	rdocampo@uga.edu	Kissinger, Jessica/M-9920-2019; Kissinger, Jessica C/E-9610-2010	Kissinger, Jessica/0000-0002-6413-1101; Kissinger, Jessica C/0000-0002-6413-1101; Alvarez, Vanina/0000-0002-9890-6980; Frasch, Alberto Carlos/0000-0001-7532-653X	National Institutes of Health [R01AI-068647, D43TW-07888, D43TW-07820]; Howard Hughes Medical Institute; Agencia Nacional de Promocion Cientifica y Tecnologica, Argentina; Consejo Nacional de Investigaciones Clentificas y Tecnicas; FOGARTY INTERNATIONAL CENTER [D43TW007888, R03TW007820] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI068647] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Howard Hughes Medical Institute(Howard Hughes Medical Institute); Agencia Nacional de Promocion Cientifica y Tecnologica, Argentina(ANPCyT); Consejo Nacional de Investigaciones Clentificas y Tecnicas; FOGARTY INTERNATIONAL CENTER(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Fogarty International Center (FIC)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	This work was supported, in whole or in part, by National Institutes of Health Grants R01AI-068647, D43TW-07888, and D43TW-07820 (to R. D.). Work at the Frasch laboratory was supported in part by an international scholarship from the Howard Hughes Medical Institute, Agencia Nacional de Promocion Cientifica y Tecnologica, Argentina (to A. C. F. and J. G. D. G.) and Consejo Nacional de Investigaciones Clentificas y Tecnicas (to J. G. D. G.).	Archer SK, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0018425; Archer SK, 2009, PLOS PATHOG, V5, DOI 10.1371/journal.ppat.1000565; Aslett M, 2010, NUCLEIC ACIDS RES, V38, pD457, DOI 10.1093/nar/gkp851; Atwood JA, 2005, SCIENCE, V309, P473, DOI 10.1126/science.1110289; Bailey T L, 1994, Proc Int Conf Intell Syst Mol Biol, V2, P28; Bailey TL, 1998, BIOINFORMATICS, V14, P48, DOI 10.1093/bioinformatics/14.1.48; Bakheet T, 2001, NUCLEIC ACIDS RES, V29, P246, DOI 10.1093/nar/29.1.246; Barreau C, 2005, NUCLEIC ACIDS RES, V33, P7138, DOI 10.1093/nar/gki1012; Bartholomeu DC, 2009, NUCLEIC ACIDS RES, V37, P3407, DOI 10.1093/nar/gkp172; BONE GJ, 1956, NATURE, V178, P308, DOI 10.1038/178308a0; Boucher N, 2002, J BIOL CHEM, V277, P19511, DOI 10.1074/jbc.M200500200; Bringaud F, 2007, PLOS PATHOG, V3, P1291, DOI 10.1371/journal.ppat.0030136; Caler EV, 1998, EMBO J, V17, P4975, DOI 10.1093/emboj/17.17.4975; Campos PC, 2008, INT J PARASITOL, V38, P1383, DOI 10.1016/j.ijpara.2008.07.001; CAPUT D, 1986, P NATL ACAD SCI USA, V83, P1670, DOI 10.1073/pnas.83.6.1670; Cassola A, 2007, MOL MICROBIOL, V65, P655, DOI 10.1111/j.1365-2958.2007.05833.x; CHEN CYA, 1995, TRENDS BIOCHEM SCI, V20, P465, DOI 10.1016/S0968-0004(00)89102-1; Clayton CE, 2002, EMBO J, V21, P1881, DOI 10.1093/emboj/21.8.1881; D'Orso I, 2003, TRENDS PARASITOL, V19, P151, DOI 10.1016/S1471-4922(03)00035-7; D'Orso I, 2001, J BIOL CHEM, V276, P15783, DOI 10.1074/jbc.M010959200; de Diego JL, 2001, BIOCHEMISTRY-US, V40, P1053, DOI 10.1021/bi001659k; De Gaudenzi J, 2005, EUKARYOT CELL, V4, P2106, DOI 10.1128/EC.4.12.2106-2114.2005; De Gaudenzi JG, 2011, ESSAYS BIOCHEM, V51, P31, DOI [10.1042/bse0510031, 10.1042/BSE0510031]; De Gaudenzi JG, 2003, J BIOL CHEM, V278, P18884, DOI 10.1074/jbc.M301756200; Di Noia JM, 2000, J BIOL CHEM, V275, P10218, DOI 10.1074/jbc.275.14.10218; El-Sayed NM, 2005, SCIENCE, V309, P409, DOI 10.1126/science.1112631; Frasch ACC, 2000, PARASITOL TODAY, V16, P282, DOI 10.1016/S0169-4758(00)01698-7; Haile S, 2007, CURR OPIN MICROBIOL, V10, P569, DOI 10.1016/j.mib.2007.10.001; Hendriks E, 2007, TRYPANOSOMES GENOME, P209; Holetz FB, 2007, BIOCHEM BIOPH RES CO, V356, P1062, DOI 10.1016/j.bbrc.2007.03.104; Jager AV, 2008, FEMS MICROBIOL LETT, V283, P182, DOI 10.1111/j.1574-6968.2008.01170.x; Jager AV, 2007, P NATL ACAD SCI USA, V104, P2035, DOI 10.1073/pnas.0611125104; Keene JD, 2007, NAT REV GENET, V8, P533, DOI 10.1038/nrg2111; Keene JD, 2002, MOL CELL, V9, P1161, DOI 10.1016/S1097-2765(02)00559-2; Keene JD, 2001, P NATL ACAD SCI USA, V98, P7018, DOI 10.1073/pnas.111145598; Khabar KSA, 2005, J INTERF CYTOK RES, V25, P1, DOI 10.1089/jir.2005.25.1; Kramer S, 2011, TRENDS PARASITOL, V27, P23, DOI 10.1016/j.pt.2010.06.011; Li ZH, 2011, J BIOL CHEM, V286, P43959, DOI 10.1074/jbc.M111.311530; LIANG P, 1992, SCIENCE, V257, P967, DOI 10.1126/science.1354393; Mansfield KD, 2009, BIOL CELL, V101, P169, DOI 10.1042/BC20080055; Mao Y, 2009, BMC GENOMICS, V10, DOI 10.1186/1471-2164-10-355; Mayho M, 2006, NUCLEIC ACIDS RES, V34, P5312, DOI 10.1093/nar/gkl598; Minning TA, 2009, BMC GENOMICS, V10, DOI 10.1186/1471-2164-10-370; MORENO SNJ, 1994, J EXP MED, V180, P1535, DOI 10.1084/jem.180.4.1535; Nardelli SC, 2007, EUKARYOT CELL, V6, P337, DOI 10.1128/EC.00279-06; Noe G, 2008, BMC MOL BIOL, V9, DOI 10.1186/1471-2199-9-107; Ouellette Marc, 2009, Journal of Biology (London), V8, P8, DOI 10.1186/jbiol203; Palenchar JB, 2006, MOL BIOCHEM PARASIT, V146, P135, DOI 10.1016/j.molbiopara.2005.12.008; Queiroz R, 2009, BMC GENOMICS, V10, DOI 10.1186/1471-2164-10-495; SCHMATZ DM, 1982, PARASITOLOGY, V85, P115, DOI 10.1017/S0031182000054202; Stern MZ, 2009, RNA, V15, P648, DOI 10.1261/rna.1230209; TOMLINSON S, 1995, PARASITOLOGY, V110, P547, DOI 10.1017/S0031182000065264	52	17	17	0	4	ELSEVIER	AMSTERDAM	RADARWEG 29, 1043 NX AMSTERDAM, NETHERLANDS		1083-351X		J BIOL CHEM	J. Biol. Chem.	JUN 1	2012	287	23					19058	19069		10.1074/jbc.M111.338699	http://dx.doi.org/10.1074/jbc.M111.338699			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	974EF	22500021	Green Published, hybrid			2022-12-25	WOS:000306411900017
J	Shimizu, T; Lin, FQ; Hasegawa, M; Okada, K; Nojiri, H; Yamane, H				Shimizu, Takafumi; Lin, Fengqiu; Hasegawa, Morifumi; Okada, Kazunori; Nojiri, Hideaki; Yamane, Hisakazu			Purification and Identification of Naringenin 7-O-Methyltransferase, a Key Enzyme in Biosynthesis of Flavonoid Phytoalexin Sakuranetin in Rice	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							DITERPENE PHYTOALEXIN; FLAVANONE PHYTOALEXIN; METHYLTRANSFERASE; PROTEINS; LEAVES; CELLS; ACID	Sakuranetin, the major flavonoid phytoalexin in rice, is induced by ultraviolet (UV) irradiation, CuCl2 treatment, jasmonic acid treatment, and infection by phytopathogens. It was recently demonstrated that sakuranetin has anti-inflammatory activity, anti-mutagenic activity, anti-pathogenic activities against Helicobacter pylori, Leishmania, and Trypanosoma and contributes to the maintenance of glucose homeostasis in animals. Thus, sakuranetin is a useful compound as a plant antibiotic and a potential pharmaceutical agent. Sakuranetin is biosynthesized from naringenin by naringenin 7-O-methyltransferase (NOMT). In previous research, rice NOMT (OsNOMT) was purified to apparent homogeneity from UV-treated wild-type rice leaves, but the purified protein, named OsCOMT1, exhibited caffeic acid O-methyltransferase (COMT) activity and not NOMT activity. In this study, we found that OsCOMT1 does not contribute to sakuranetin production in rice in vivo, and we purified OsNOMT using the oscomt1 mutant. A crude protein preparation from UV-treated oscomt1 leaves was subjected to three sequential purification steps, resulting in a 400-fold purification from the crude enzyme preparation. Using SDS-PAGE, the purest enzyme preparation showed a minor band at an apparent molecular mass of 40 kDa. Two O-methyltransferase-like proteins, encoded by Os04g0175900 and Os12g0240900, were identified from the 40-kDa band by MALDI-TOF/TOF analysis. Recombinant Os12g0240900 protein showed NOMT activity, but the recombinant Os04g0175900 protein did not. Os12g0240900 expression was induced by jasmonic acid treatment in rice leaves prior to sakuranetin accumulation, and the Os12g0240900 protein showed reasonable kinetic properties to OsNOMT. On the basis of these results, we conclude that Os12g0240900 encodes an OsNOMT.	[Shimizu, Takafumi; Lin, Fengqiu; Okada, Kazunori; Nojiri, Hideaki; Yamane, Hisakazu] Univ Tokyo, Biotechnol Res Ctr, Bunkyo Ku, Tokyo, Japan; [Hasegawa, Morifumi] Ibaraki Univ, Coll Agr, Ami, Ibaraki 30003, Japan	University of Tokyo; Ibaraki University	Okada, K (corresponding author), Univ Tokyo, Biotechnol Res Ctr, Bunkyo Ku, 1-1-1 Yayoi, Tokyo, Japan.	ukokada@mail.ecc.u-tokyo.ac.jp	Hasegawa, Morifumi/G-6053-2011; Shimizu, Takafumi/C-4123-2017	Hasegawa, Morifumi/0000-0001-9829-2811; Shimizu, Takafumi/0000-0003-4372-1337; Nojiri, Hideaki/0000-0003-3091-8691	Program for Promotion of Basic Research Activities for Innovative Biosciences	Program for Promotion of Basic Research Activities for Innovative Biosciences	This work was supported by the Program for Promotion of Basic Research Activities for Innovative Biosciences.	AKATSUKA T, 1985, AGR BIOL CHEM TOKYO, V49, P1689, DOI 10.1080/00021369.1985.10866951; Asahina Y., 1908, ARCH PHARM, V246, P259, DOI 10.1002/ardp.19082460404.; ATTIEH JM, 1995, J BIOL CHEM, V270, P9250, DOI 10.1074/jbc.270.16.9250; CARTWRIGHT DW, 1981, PHYTOCHEMISTRY, V20, P535, DOI 10.1016/S0031-9422(00)84189-8; Christensen AB, 1998, PLANT MOL BIOL, V36, P219, DOI 10.1023/A:1005985609313; Fernandez J, 1998, ELECTROPHORESIS, V19, P1036, DOI 10.1002/elps.1150190619; Grecco SD, 2012, EXP PARASITOL, V130, P141, DOI 10.1016/j.exppara.2011.11.002; HARBORNE JB, 1999, PHYTOCHEMICAL DICT H, P976; Horinouchi S, 2009, CURR OPIN CHEM BIOL, V13, P197, DOI 10.1016/j.cbpa.2009.02.004; Kanno H, 2012, APPL ENTOMOL ZOOL, V47, P27, DOI 10.1007/s13355-011-0085-3; KATO H, 1993, PHYTOCHEMISTRY, V33, P79, DOI 10.1016/0031-9422(93)85399-C; KATO H, 1994, PHYTOCHEMISTRY, V36, P299, DOI 10.1016/S0031-9422(00)97064-X; KATO T, 1973, TETRAHEDRON LETT, P3861; Kim BG, 2006, J AGR FOOD CHEM, V54, P823, DOI 10.1021/jf0522715; KODAMA O, 1992, PHYTOCHEMISTRY, V31, P3807, DOI 10.1016/S0031-9422(00)97532-0; KOGA H, 1994, CAN J BOT, V72, P1463, DOI 10.1139/b94-180; Koga J, 1997, PHYTOCHEMISTRY, V44, P249, DOI 10.1016/S0031-9422(96)00534-1; KOGA J, 1995, TETRAHEDRON, V51, P7907, DOI 10.1016/0040-4020(95)00423-6; Lin FQ, 2006, J PESTIC SCI, V31, P47, DOI 10.1584/jpestics.31.47; Liu HB, 2012, PLANT METHODS, V8, DOI 10.1186/1746-4811-8-2; Miyazawa M, 2003, J FOOD SCI, V68, P52, DOI 10.1111/j.1365-2621.2003.tb14113.x; Noel JP, 2003, RECENT ADV PHYTOCHEM, V37, P37; Plowright RA, 1996, NEMATOLOGICA, V42, P564, DOI 10.1163/004625996X00063; Rakwal R, 2000, PLANT SCI, V155, P213, DOI 10.1016/S0168-9452(00)00223-5; Rakwal R, 1996, BIOCHEM BIOPH RES CO, V222, P732, DOI 10.1006/bbrc.1996.0812; Saito T, 2008, BIOCHEM BIOPH RES CO, V372, P835, DOI 10.1016/j.bbrc.2008.05.146; Shevchenko A, 1996, ANAL CHEM, V68, P850, DOI 10.1021/ac950914h; Shimizu T, 2008, PHYTOCHEMISTRY, V69, P973, DOI 10.1016/j.phytochem.2007.10.005; TAMOGAMI S, 1993, TETRAHEDRON, V49, P2025, DOI 10.1016/S0040-4020(01)86302-X; VANETTEN HD, 1994, PLANT CELL, V6, P1191; Yajima A, 2000, EUR J ORG CHEM, V2000, P4079; Zhang L, 2008, PROTEIN SCI, V17, P1971, DOI 10.1110/ps.036186.108; Zhang XF, 2006, ARCH PHARM RES, V29, P1102, DOI 10.1007/BF02969299	33	70	76	11	64	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JUN 1	2012	287	23					19315	19325		10.1074/jbc.M112.351270	http://dx.doi.org/10.1074/jbc.M112.351270			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	974EF	22493492	Green Published, hybrid			2022-12-25	WOS:000306411900041
J	Suhasini, AN; Sommers, JA; Yu, S; Wu, YL; Xu, T; Kelman, Z; Kaplan, DL; Brosh, RM				Suhasini, Avvaru N.; Sommers, Joshua A.; Yu, Stephen; Wu, Yuliang; Xu, Ting; Kelman, Zvi; Kaplan, Daniel L.; Brosh, Robert M., Jr.			DNA Repair and Replication Fork Helicases Are Differentially Affected by Alkyl Phosphotriester Lesion	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							VINYLPHOSPHONATE INTERNUCLEOTIDE LINKAGES; WERNER-SYNDROME PROTEIN; ESCHERICHIA-COLI RECQ; MCM HELICASE; BIOCHEMICAL-CHARACTERIZATION; SUBSTRATE-SPECIFICITY; BLOOMS-SYNDROME; FANCJ HELICASE; DAMAGED DNA; UVRD	DNA helicases are directly responsible for catalytically unwinding duplex DNA in an ATP-dependent and directionally specific manner and play essential roles in cellular nucleic acid metabolism. It has been conventionally thought that DNA helicases are inhibited by bulky covalent DNA adducts in a strand-specific manner. However, the effects of highly stable alkyl phosphotriester (PTE) lesions that are induced by chemical mutagens and refractory to DNA repair have not been previously studied for their effects on helicases. In this study, DNA repair and replication helicases were examined for unwinding a forked duplex DNA substrate harboring a single isopropyl PTE specifically positioned in the helicase-translocating or -nontranslocating strand within the double-stranded region. A comparison of SF2 helicases (RecQ, RECQ1, WRN, BLM, FANCJ, and ChlR1) with a SF1 DNA repair helicase (UvrD) and two replicative helicases(MCM and DnaB) demonstrates unique differences in the effect of the PTE on the DNA unwinding reactions catalyzed by these enzymes. All of the SF2 helicases tested were inhibited by the PTE lesion, whereas UvrD and the replication fork helicases were fully tolerant of the isopropyl backbone modification, irrespective of strand. Sequestration studies demonstrated that RECQ1 helicase was trapped by the PTE lesion only when it resided in the helicase-translocating strand. Our results are discussed in light of the current models for DNA unwinding by helicases that are likely to encounter sugar phosphate backbone damage during biological DNA transactions.	[Suhasini, Avvaru N.; Sommers, Joshua A.; Yu, Stephen; Brosh, Robert M., Jr.] NIA, Lab Mol Gerontol, NIH, Biomed Res Ctr, Baltimore, MD 21224 USA; [Wu, Yuliang] Univ Saskatchewan, Dept Biochem, Saskatoon, SK S7N 5E5, Canada; [Xu, Ting] NIDDK, Mol Biol Lab, NIH, Bethesda, MD 20892 USA; [Kelman, Zvi] Univ Maryland, Inst Biosci & Biotechnol Res, Rockville, MD 20850 USA; [Kaplan, Daniel L.] Vanderbilt Univ, Dept Biol Sci, Nashville, TN 37235 USA	National Institutes of Health (NIH) - USA; NIH National Institute on Aging (NIA); University of Saskatchewan; National Institutes of Health (NIH) - USA; NIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK); Vanderbilt University	Brosh, RM (corresponding author), NIA, Lab Mol Gerontol, NIH, Biomed Res Ctr, 251 Bayview Blvd, Baltimore, MD 21224 USA.	broshr@mail.nih.gov	Brosh, Robert/AAR-6124-2020; Xu, Ting/A-3296-2012	Kaplan, Daniel/0000-0003-2760-7745	National Institutes of Health Intramural Research Program of NIA; NIDDK; Fanconi Anemia Research Fund; NATIONAL INSTITUTE ON AGING [ZIAAG000752, ZIAAG000753, ZIAAG000741] Funding Source: NIH RePORTER	National Institutes of Health Intramural Research Program of NIA; NIDDK(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); Fanconi Anemia Research Fund; NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA))	This work was supported in part by the National Institutes of Health Intramural Research Program of NIA and NIDDK. This work was also supported by the Fanconi Anemia Research Fund (to R. M. B.).	Aygun O, 2010, DNA REPAIR, V9, P345, DOI 10.1016/j.dnarep.2009.12.008; Bertram RD, 2002, BIOCHEMISTRY-US, V41, P7725, DOI 10.1021/bi025755s; Bochman ML, 2009, MICROBIOL MOL BIOL R, V73, P652, DOI 10.1128/MMBR.00019-09; Brosh RM, 2002, J BIOL CHEM, V277, P23236, DOI 10.1074/jbc.M111446200; Brosh RM, 2007, NUCLEIC ACIDS RES, V35, P7527, DOI 10.1093/nar/gkm1008; Cadman CJ, 2006, J MOL BIOL, V362, P18, DOI 10.1016/j.jmb.2006.06.032; Cantor S, 2004, P NATL ACAD SCI USA, V101, P2357, DOI 10.1073/pnas.0308717101; Choudhary S, 2004, J BIOL CHEM, V279, P34603, DOI 10.1074/jbc.M401901200; Compton SA, 2008, J BIOL CHEM, V283, P24478, DOI 10.1074/jbc.M803370200; Fan L, 2008, CELL, V133, P789, DOI 10.1016/j.cell.2008.04.030; Fischer CJ, 2004, J MOL BIOL, V344, P1287, DOI 10.1016/j.jmb.2004.10.005; Forsburg SL, 2008, BIOCHEM SOC T, V36, P114, DOI 10.1042/BST0360114; Garcia PL, 2004, NUCLEIC ACIDS RES, V32, P3771, DOI 10.1093/nar/gkh709; GORBALENYA AE, 1989, NUCLEIC ACIDS RES, V17, P4713, DOI 10.1093/nar/17.12.4713; Graham BW, 2011, NUCLEIC ACIDS RES, V39, P6585, DOI 10.1093/nar/gkr345; Guarne A, 2004, EMBO J, V23, P4134, DOI 10.1038/sj.emboj.7600412; Gupta R, 2005, J BIOL CHEM, V280, P25450, DOI 10.1074/jbc.M501995200; Gupta R, 2006, NUCLEIC ACIDS RES, V34, P6673, DOI 10.1093/nar/gkl964; Hickson ID, 2003, NAT REV CANCER, V3, P169, DOI 10.1038/nrc1012; Janscak P, 2003, J MOL BIOL, V330, P29, DOI 10.1016/S0022-2836(03)00534-5; Jones GDD, 2010, MUTAGENESIS, V25, P3, DOI 10.1093/mutage/gep038; Kaplan DL, 2000, J MOL BIOL, V301, P285, DOI 10.1006/jmbi.2000.3965; Kaplan DL, 2002, MOL CELL, V10, P647, DOI 10.1016/S1097-2765(02)00642-1; Karow JK, 1999, CURR BIOL, V9, P597, DOI 10.1016/S0960-9822(99)80264-4; Killoran MP, 2006, NUCLEIC ACIDS RES, V34, P4098, DOI 10.1093/nar/gkl538; Kumari A, 2010, J BIOL CHEM, V285, P21313, DOI 10.1074/jbc.M109.078964; Kuper J, 2012, EMBO J, V31, P494, DOI 10.1038/emboj.2011.374; Lee JY, 2006, CELL, V127, P1349, DOI 10.1016/j.cell.2006.10.049; Lehmann AR, 2001, GENE DEV, V15, P15, DOI 10.1101/gad.859501; Liu H, 2008, CELL, V133, P801, DOI 10.1016/j.cell.2008.04.029; Lu XC, 2011, J MOL CELL BIOL, V3, P31, DOI 10.1093/jmcb/mjq056; Lucic B, 2011, NUCLEIC ACIDS RES, V39, P1703, DOI 10.1093/nar/gkq1031; Maluf NK, 2003, J MOL BIOL, V325, P913, DOI 10.1016/S0022-2836(02)01277-9; MATSON SW, 1991, PROG NUCLEIC ACID RE, V40, P289; Sakakibara N, 2009, MOL MICROBIOL, V72, P286, DOI 10.1111/j.1365-2958.2009.06663.x; Sharma S, 2005, J BIOL CHEM, V280, P28072, DOI 10.1074/jbc.M500264200; Sharma S, 2004, MOL BIOL CELL, V15, P734, DOI 10.1091/mbc.E03-08-0567; Shin JH, 2009, J BIOL CHEM, V284, P540, DOI 10.1074/jbc.M806803200; Sontz PA, 2012, P NATL ACAD SCI USA, V109, P1856, DOI 10.1073/pnas.1120063109; Soultanas P, 2001, TRENDS BIOCHEM SCI, V26, P47, DOI 10.1016/S0968-0004(00)01734-5; Suhasini AN, 2011, EMBO J, V30, P692, DOI 10.1038/emboj.2010.362; Suhasini AN, 2010, CELL CYCLE, V9, P2317, DOI 10.4161/cc.9.12.11902; Suhasini AN, 2009, J BIOL CHEM, V284, P18458, DOI 10.1074/jbc.M109.012229; van der Lelij P, 2010, AM J HUM GENET, V86, P262, DOI 10.1016/j.ajhg.2010.01.008; West SC, 1997, ANNU REV GENET, V31, P213, DOI 10.1146/annurev.genet.31.1.213; White MF, 2009, BIOCHEM SOC T, V37, P547, DOI 10.1042/BST0370547; Wolski SC, 2008, PLOS BIOL, V6, P1332, DOI 10.1371/journal.pbio.0060149; Wu YL, 2012, J BIOL CHEM, V287, P1007, DOI 10.1074/jbc.M111.276022; Wu YL, 2010, DNA REPAIR, V9, P315, DOI 10.1016/j.dnarep.2009.12.010; Xu HQ, 2003, J BIOL CHEM, V278, P34925, DOI 10.1074/jbc.M303581200; Yashiki T, 1992, Nucleic Acids Symp Ser, P197; Zhang XD, 2006, J BIOL CHEM, V281, P12655, DOI 10.1074/jbc.M513089200	52	19	19	0	6	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JUN 1	2012	287	23					19188	19198		10.1074/jbc.M112.352757	http://dx.doi.org/10.1074/jbc.M112.352757			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	974EF	22500020	Green Published, hybrid			2022-12-25	WOS:000306411900029
J	Huang, ZP; Wang, YL; Nayak, PS; Dammann, CE; Sanchez-Esteban, J				Huang, Zheping; Wang, Yulian; Nayak, Pritha S.; Dammann, Christiane E.; Sanchez-Esteban, Juan			Stretch-induced Fetal Type II Cell Differentiation Is Mediated via ErbB1-ErbB4 Interactions	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							GROWTH-FACTOR RECEPTOR; ERBB SIGNALING NETWORK; RAT LUNG FIBROBLASTS; EGF-RECEPTOR; MICE LACKING; NEUREGULIN RECEPTOR; CARDIAC DEVELOPMENT; MECHANICAL FORCES; EPITHELIAL-CELLS; TGF-ALPHA	Stretch-induced differentiation of lung fetal type II epithelial cells is mediated through EGFR (ErbB1) via release of HB-EGF and TGF-alpha ligands. Employing an EGFR knock-out mice model, we further investigated the role of the ErbB family of receptors in mechanotranduction during lung development. Deletion of EGFR prevented endogenous and mechanical stretch-induced type II cell differentiation via the ERK pathway, which was rescued by overexpression of a constitutively active MEK. Interestingly, the expression of ErbB4, the only ErbB receptor that EGFR co-precipitates in wild-type cells, was decreased in EGFR-deficient type II cells. Similar to EGFR, ErbB4 was activated by stretch and participated in ERK phosphorylation and type II cell differentiation. However, neuregulin (NRG) or stretch-induced ErbB4 activation were blunted in EGFR-deficient cells and not rescued after ErbB4 overexpression, suggesting that induction of ErbB4 phosphorylation is EGFR-dependent. Finally, we addressed how shedding of ligands is regulated by EGFR. In knock-out cells, TGF-alpha, a ligand for EGFR, was not released by stretch, while HB-EGF, a ligand for EGFR and ErbB4, was shed by stretch although to a lower magnitude than in normal cells. Release of these ligands was inhibited by blocking EGFR and ERK pathway. In conclusion, our studies show that EGFR and ErbB4 regulate stretch-induced type II cell differentiation via ERK pathway. Interactions between these two receptors are important for mechanical signals in lung fetal type II cells. These studies provide novel insights into the cell signaling mechanisms regulating ErbB family receptors in lung cell differentiation.	[Huang, Zheping; Wang, Yulian; Nayak, Pritha S.; Sanchez-Esteban, Juan] Women & Infants Hosp Rhode Isl, Dept Pediat, Providence, RI 02905 USA; [Huang, Zheping; Wang, Yulian; Nayak, Pritha S.; Sanchez-Esteban, Juan] Brown Univ, Warren Alpert Med Sch, Providence, RI 02905 USA; [Dammann, Christiane E.] Floating Hosp Children, Tufts Med Ctr, Div Newborn Med, Boston, MA 02111 USA	Women & Infants Hospital Rhode Island; Brown University; Floating Hospital For Children; Tufts Medical Center	Sanchez-Esteban, J (corresponding author), Women & Infants Hosp Rhode Isl, Dept Pediat, 101 Dudley Str, Providence, RI 02905 USA.	jsanchezesteban@wihri.org			National Institutes of Health [R01 HD052670, P20 RR018728]; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT [R01HD052670] Funding Source: NIH RePORTER; NATIONAL CENTER FOR RESEARCH RESOURCES [P20RR018728] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR))	This work was supported, in whole or in part, by National Institutes of Health Grants R01 HD052670 (to J. S.-E.) and P20 RR018728.	Alroy I, 1997, FEBS LETT, V410, P83, DOI 10.1016/S0014-5793(97)00412-2; Blobel CP, 2005, NAT REV MOL CELL BIO, V6, P32, DOI 10.1038/nrm1548; Egeblad M, 2001, BIOCHEM BIOPH RES CO, V281, P25, DOI 10.1006/bbrc.2001.4302; Fan HZ, 1999, EMBO J, V18, P6962, DOI 10.1093/emboj/18.24.6962; FOWLER KJ, 1995, P NATL ACAD SCI USA, V92, P1465, DOI 10.1073/pnas.92.5.1465; GASSMANN M, 1995, NATURE, V378, P390, DOI 10.1038/378390a0; Gechtman Z, 1999, J BIOL CHEM, V274, P28828, DOI 10.1074/jbc.274.40.28828; GOLDSTEIN JD, 1980, J PEDIATR-US, V97, P282, DOI 10.1016/S0022-3476(80)80496-3; GrausPorta D, 1997, EMBO J, V16, P1647, DOI 10.1093/emboj/16.7.1647; Harding R., 1997, LUNG SCI FDN, P2093; Joe P, 1997, AM J PHYSIOL-LUNG C, V272, pL95, DOI 10.1152/ajplung.1997.272.1.L95; KHOOR A, 1994, J HISTOCHEM CYTOCHEM, V42, P1187, DOI 10.1177/42.9.8064126; LEE KF, 1995, NATURE, V378, P394, DOI 10.1038/378394a0; Liu MY, 2000, J APPL PHYSIOL, V89, P2078, DOI 10.1152/jappl.2000.89.5.2078; Liu W, 2007, BBA-MOL BASIS DIS, V1772, P737, DOI 10.1016/j.bbadis.2007.04.008; Liu W, 2010, BBA-MOL CELL RES, V1803, P832, DOI 10.1016/j.bbamcr.2010.03.003; MASSAGUE J, 1993, ANNU REV BIOCHEM, V62, P515, DOI 10.1146/annurev.bi.62.070193.002503; MIETTINEN PJ, 1995, NATURE, V376, P337, DOI 10.1038/376337a0; Miettinen PJ, 1997, DEV BIOL, V186, P224, DOI 10.1006/dbio.1997.8593; MOESSINGER AC, 1990, J CLIN INVEST, V86, P1270, DOI 10.1172/JCI114834; Moghal N, 1999, CURR OPIN CELL BIOL, V11, P190, DOI 10.1016/S0955-0674(99)80025-8; Olayioye MA, 2000, EMBO J, V19, P3159, DOI 10.1093/emboj/19.13.3159; Patel NV, 2000, AM J RESP CELL MOL, V22, P432, DOI 10.1165/ajrcmb.22.4.3854; Purevdorj E, 2008, AM J PHYSIOL-LUNG C, V294, pL516, DOI 10.1152/ajplung.00423.2007; Sahin U, 2004, J CELL BIOL, V164, P769, DOI 10.1083/jcb.200307137; Sanchez-Esteban J, 2006, AM J PHYSIOL-LUNG C, V290, pL343, DOI 10.1152/ajplung.00189.2005; Sanchez-Esteban J, 1998, AM J MED SCI, V316, P200, DOI 10.1097/00000441-199809000-00009; Sanchez-Esteban J, 2004, AM J RESP CELL MOL, V30, P76, DOI 10.1165/rcmb.2003-0121OC; Sanchez-Esteban J, 2002, AM J PHYSIOL-LUNG C, V282, pL448, DOI 10.1152/ajplung.00399.2000; Sanchez-Esteban J, 2001, J APPL PHYSIOL, V91, P589, DOI 10.1152/jappl.2001.91.2.589; SCARPELLI EM, 1975, PEDIATR RES, V9, P190, DOI 10.1203/00006450-197504000-00010; Schlessinger J, 2002, CELL, V110, P669, DOI 10.1016/S0092-8674(02)00966-2; Shelly M, 1998, J BIOL CHEM, V273, P10496, DOI 10.1074/jbc.273.17.10496; SIBILIA M, 1995, SCIENCE, V269, P234, DOI 10.1126/science.7618085; Sibilia M, 2007, DIFFERENTIATION, V75, P770, DOI 10.1111/j.1432-0436.2007.00238.x; Singh AB, 2005, CELL SIGNAL, V17, P1183, DOI 10.1016/j.cellsig.2005.03.026; Torday JS, 1998, AM J MED SCI, V316, P205, DOI 10.1097/00000441-199809000-00010; Wang YL, 2006, AM J PHYSIOL-LUNG C, V291, pL820, DOI 10.1152/ajplung.00068.2006; Wang YL, 2009, J PHYSIOL-LONDON, V587, P1739, DOI 10.1113/jphysiol.2008.163899; WIGGLESWORTH JS, 1979, EARLY HUM DEV, V3, P51, DOI 10.1016/0378-3782(79)90020-3; Wirtz HR, 2000, RESP PHYSIOL, V119, P1, DOI 10.1016/S0034-5687(99)00092-4; Zscheppang K, 2007, AM J PHYSIOL-LUNG C, V293, pL429, DOI 10.1152/ajplung.00451.2006; Zscheppang K, 2006, PEDIATR PULM, V41, P1205, DOI 10.1002/ppul.20518; Zscheppang K, 2011, AM J RESP CELL MOL, V45, P761, DOI 10.1165/rcmb.2010-0179OC	44	29	30	0	6	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAY 25	2012	287	22					18091	18102		10.1074/jbc.M111.313163	http://dx.doi.org/10.1074/jbc.M111.313163			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	974EC	22493501	hybrid, Green Published			2022-12-25	WOS:000306411600018
J	Shin, I; Percudani, R; Rhee, S				Shin, Inchul; Percudani, Riccardo; Rhee, Sangkee			Structural and Functional Insights into (S)-Ureidoglycine Aminohydrolase, Key Enzyme of Purine Catabolism in Arabidopsis thaliana	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							PATHWAY; ALLANTOINASE; DEGRADATION; BIOSYNTHESIS; MECHANISM; REVEALS; SYSTEM; SUITE	The ureide pathway has recently been identified as the metabolic route of purine catabolism in plants and some bacteria. In this pathway, uric acid, which is a major product of the early stage of purine catabolism, is degraded into glyoxylate and ammonia via stepwise reactions of seven different enzymes. Therefore, the pathway has a possible physiological role in mobilization of purine ring nitrogen for further assimilation. (S)-Ureidoglycine aminohydrolase enzyme converts (S)-ureidoglycine into (S)-ureidoglycolate and ammonia, providing the final substrate to the pathway. Here, we report a structural and functional analysis of this enzyme from Arabidopsis thaliana (AtUGlyAH). The crystal structure of AtUGlyAH in the ligand-free form shows a monomer structure in the bicupin fold of the beta-barrel and an octameric functional unit as well as a Mn2+ ion binding site. The structure of AtUGlyAH in complex with (S)-ureidoglycine revealed that the Mn2+ ion acts as a molecular anchor to bind (S)-ureidoglycine, and its binding mode dictates the enantioselectivity of the reaction. Further kinetic analysis characterized the functional roles of the active site residues, including the Mn2+ ion binding site and residues in the vicinity of (S)-ureidoglycine. These analyses provide molecular insights into the structure of the enzyme and its possible catalytic mechanism.	[Shin, Inchul; Rhee, Sangkee] Seoul Natl Univ, Dept Agr Biotechnol, Seoul 151921, South Korea; [Rhee, Sangkee] Seoul Natl Univ, Ctr Fungal Pathogenesis, Seoul 151921, South Korea; [Percudani, Riccardo] Univ Parma, Dept Biochem & Mol Biol, I-43100 Parma, Italy	Seoul National University (SNU); Seoul National University (SNU); University of Parma	Rhee, S (corresponding author), Seoul Natl Univ, Dept Agr Biotechnol, Seoul 151921, South Korea.	srheesnu@snu.ac.kr	percudani, riccardo/B-4872-2011	percudani, riccardo/0000-0001-8452-1062	Next-Generation BioGreen 21 Program (Plant Molecular Breeding Center) [PJ008059]; Rural Development Administration; National Research Foundation [R11-2008-062-01002-0, 2010-0025883]; Ministry of Education, Science, and Technology, Republic of Korea	Next-Generation BioGreen 21 Program (Plant Molecular Breeding Center)(Rural Development Administration (RDA), Republic of Korea); Rural Development Administration(Rural Development Administration (RDA), Republic of Korea); National Research Foundation; Ministry of Education, Science, and Technology, Republic of Korea(Ministry of Education, Science & Technology (MEST), Republic of Korea)	This work was supported by grants from the Next-Generation BioGreen 21 Program (Plant Molecular Breeding Center no. PJ008059), Rural Development Administration, and from National Research Foundation (R11-2008-062-01002-0 and 2010-0025883) funded by the Ministry of Education, Science, and Technology, Republic of Korea.	Adams PD, 2010, ACTA CRYSTALLOGR D, V66, P213, DOI 10.1107/S0907444909052925; Agarwal G, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0005736; Agarwal R, 2007, J MOL BIOL, V368, P450, DOI 10.1016/j.jmb.2007.02.028; Atkins C, 2000, PROKARYOTIC NITROGEN FIXATION, P559; Boldt R, 2003, PHYSIOL PLANTARUM, V117, P297, DOI 10.1034/j.1399-3054.2003.00030.x; Brunger AT, 1998, ACTA CRYSTALLOGR D, V54, P905, DOI 10.1107/S0907444998003254; Cendron L, 2007, J BIOL CHEM, V282, P18182, DOI 10.1074/jbc.M701297200; Chen VB, 2010, ACTA CRYSTALLOGR D, V66, P12, DOI 10.1107/S0907444909042073; DeLano W. L., 2010, PYMOL MOL GRAPHICS S; Emsley P, 2010, ACTA CRYSTALLOGR D, V66, P486, DOI 10.1107/S0907444910007493; French JB, 2010, J BIOL CHEM, V285, P35446, DOI 10.1074/jbc.M110.156034; Gouet P, 1999, BIOINFORMATICS, V15, P305, DOI 10.1093/bioinformatics/15.4.305; Hennebry SC, 2009, FEBS J, V276, P5367, DOI 10.1111/j.1742-4658.2009.07246.x; HOLM L, 1993, J MOL BIOL, V233, P123, DOI 10.1006/jmbi.1993.1489; Kamat SS, 2011, BIOCHEMISTRY-US, V50, P1917, DOI 10.1021/bi101788n; Kim KS, 2010, J BACTERIOL, V192, P4089, DOI 10.1128/JB.00201-10; Kim K, 2007, J BIOL CHEM, V282, P23457, DOI 10.1074/jbc.M703211200; Kim K, 2009, J MOL BIOL, V387, P1067, DOI 10.1016/j.jmb.2009.02.041; Lamberto I, 2010, PLANT CELL, V22, P1564, DOI 10.1105/tpc.109.070102; Loh KD, 2006, P NATL ACAD SCI USA, V103, P5114, DOI 10.1073/pnas.0600521103; Muratsubaki H, 2006, ANAL BIOCHEM, V359, P161, DOI 10.1016/j.ab.2006.09.024; Otwinowski Z, 1997, METHOD ENZYMOL, V276, P307, DOI 10.1016/S0076-6879(97)76066-X; Ramazzina I, 2006, NAT CHEM BIOL, V2, P144, DOI 10.1038/nchembio768; Ramazzina I, 2008, J BIOL CHEM, V283, P23295, DOI 10.1074/jbc.M801195200; Reumann S, 2007, PLANT CELL, V19, P3170, DOI 10.1105/tpc.107.050989; Serventi F, 2010, ACS CHEM BIOL, V5, P203, DOI 10.1021/cb900248n; SGRAVENMADE EJ, 1970, BIOCHIM BIOPHYS ACTA, V198, P569, DOI 10.1016/0005-2744(70)90134-8; Smith PMC, 2002, PLANT PHYSIOL, V128, P793, DOI 10.1104/pp.010912; Terwilliger TC, 1999, ACTA CRYSTALLOGR D, V55, P849, DOI 10.1107/S0907444999000839; Terwilliger TC, 2003, ACTA CRYSTALLOGR D, V59, P38, DOI 10.1107/S0907444902018036; Terwilliger TC, 2000, ACTA CRYSTALLOGR D, V56, P965, DOI 10.1107/S0907444900005072; VOGELS GD, 1976, BACTERIOL REV, V40, P403, DOI 10.1128/MMBR.40.2.403-468.1976; Werner AK, 2011, TRENDS PLANT SCI, V16, P381, DOI 10.1016/j.tplants.2011.03.012; Werner AK, 2010, NAT CHEM BIOL, V6, P19, DOI [10.1038/NCHEMBIO.265, 10.1038/nchembio.265]; Winn MD, 2011, ACTA CRYSTALLOGR D, V67, P235, DOI 10.1107/S0907444910045749	35	11	12	0	9	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAY 25	2012	287	22					18796	18805		10.1074/jbc.M111.331819	http://dx.doi.org/10.1074/jbc.M111.331819			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	974EC	22493446	Green Published, hybrid			2022-12-25	WOS:000306411600088
J	Pinhal, D; Shivji, MS; Nachtigall, PG; Chapman, DD; Martins, C				Pinhal, Danillo; Shivji, Mahmood S.; Nachtigall, Pedro G.; Chapman, Demian D.; Martins, Cesar			A Streamlined DNA Tool for Global Identification of Heavily Exploited Coastal Shark Species (Genus Rhizoprionodon)	PLOS ONE			English	Article							MULTIPLEX PCR; GENETIC IDENTIFICATION; BODY PARTS; CONSERVATION; TRADE; CARCHARHINIDAE; LALANDII	Obtaining accurate species-specific landings data is an essential step toward achieving sustainable shark fisheries. Globally distributed sharpnose sharks (genus Rhizoprionodon) exhibit life-history characteristics (rapid growth, early maturity, annual reproduction) that suggests that they could be fished in a sustainable manner assuming an investment in monitoring, assessment and careful management. However, obtaining species-specific landings data for sharpnose sharks is problematic because they are morphologically very similar to one another. Moreover, sharpnose sharks may also be confused with other small sharks (either small species or juveniles of large species) once they are processed (i.e., the head and fins are removed). Here we present a highly streamlined molecular genetics approach based on seven species-specific PCR primers in a multiplex format that can simultaneously discriminate body parts from the seven described sharpnose shark species commonly occurring in coastal fisheries worldwide. The species-specific primers are based on nucleotide sequence differences among species in the nuclear ribosomal internal transcribed spacer 2 locus (ITS2). This approach also distinguishes sharpnose sharks from a wide range of other sharks (52 species) and can therefore assist in the regulation of coastal shark fisheries around the world.	[Pinhal, Danillo; Nachtigall, Pedro G.] UNESP Sao Paulo State Univ, Dept Genet, Sao Paulo, Brazil; [Shivji, Mahmood S.] Nova SE Univ, Save Our Seas Shark Ctr, Dania, FL USA; [Shivji, Mahmood S.] Nova SE Univ, Oceanog Ctr, Guy Harvey Res Inst, Dania, FL USA; [Chapman, Demian D.] SUNY Stony Brook, Sch Marine & Atmospher Sci, Stony Brook, NY 11794 USA; [Chapman, Demian D.] SUNY Stony Brook, Inst Ocean Conservat Sci, Stony Brook, NY 11794 USA; [Martins, Cesar] UNESP Sao Paulo State Univ, Dept Morphol, Sao Paulo, Brazil	Universidade Estadual Paulista; Nova Southeastern University; Nova Southeastern University; State University of New York (SUNY) System; State University of New York (SUNY) Stony Brook; State University of New York (SUNY) System; State University of New York (SUNY) Stony Brook; Universidade Estadual Paulista	Pinhal, D (corresponding author), UNESP Sao Paulo State Univ, Dept Genet, Sao Paulo, Brazil.	dlpinhal@ibb.unesp.br	Pinhal, Danillo/C-5983-2012; Martins, Cesar/A-2594-2008; Adapta, Inct/J-8371-2013; Nachtigall, Pedro Gabriel/M-5424-2017	Pinhal, Danillo/0000-0003-1075-0182; Martins, Cesar/0000-0003-3534-974X; Nachtigall, Pedro Gabriel/0000-0002-3196-0173	Sao Paulo Research Foundation (FAPESP) [07/03067-8, 07/03065-5]; Save Our Seas Foundation; Hai Stiftung/Shark Foundation	Sao Paulo Research Foundation (FAPESP)(Fundacao de Amparo a Pesquisa do Estado de Sao Paulo (FAPESP)); Save Our Seas Foundation; Hai Stiftung/Shark Foundation	This work was supported by grants to DP and CM from the Sao Paulo Research Foundation (FAPESP - grant numbers 07/03067-8 and 07/03065-5) and grants from the Save Our Seas Foundation and Hai Stiftung/Shark Foundation to MSS. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abercrombie DL, 2005, CONSERV GENET, V6, P775, DOI 10.1007/s10592-005-9036-2; AU DW, 2008, SHARKS OPEN OCEAN BI, P298, DOI DOI 10.1002/9781444302516.CH26; Chapman DD, 2003, CONSERV GENET, V4, P415, DOI 10.1023/A:1024771215616; Compagno Leonard, 2005, P1; Dubey B, 2009, CONSERV GENET, V10, P1861, DOI 10.1007/s10592-009-9835-y; FAO Food and Agriculture Organization, 2000, FISH MAN CONS S1; Heist Edward J., 2005, P27; Kibbe WA, 2007, NUCLEIC ACIDS RES, V35, pW43, DOI 10.1093/nar/gkm234; Lessa RPT, 2005, BRAZILIAN NATL PLAN; Lewin, 2004, GENES-BASEL; Magnussen JE, 2007, ANIM CONSERV, V10, P199, DOI 10.1111/j.1469-1795.2006.00088.x; Mendonca FF, 2011, CONSERV GENET, V12, P193, DOI 10.1007/s10592-010-0132-6; Mendonca FF, 2009, MOL ECOL RESOUR, V9, P771, DOI 10.1111/j.1755-0998.2009.02524.x; Motta FS, 2005, FISH RES, V74, P116, DOI 10.1016/j.fishres.2005.03.010; Mukherjee N, 2007, CONSERV GENET, V8, P1465, DOI 10.1007/s10592-007-9289-z; NMFS National Marine Fisheries Service, 2001, BIOL OP ONG KLAM PRO; Ogden Rob, 2010, Endangered Species Research, V9, P179, DOI 10.3354/esr00144; Pank M, 2001, MAR BIOTECHNOL, V3, P231, DOI 10.1007/s101260000071; Rosa RS, 2004, IUCN 2010 IUCN RED L; Shivji M, 2002, CONSERV BIOL, V16, P1036, DOI 10.1046/j.1523-1739.2002.01188.x; Shivji MS, 2010, CRC MAR BIOL SER, P593; Tamura K, 2007, MOL BIOL EVOL, V24, P1596, DOI 10.1093/molbev/msm092; Untergasser A, 2007, NUCLEIC ACIDS RES, V35, pW71, DOI 10.1093/nar/gkm306; Walker TI, 1998, MAR FRESHWATER RES, V49, P553, DOI 10.1071/MF98017; Wong EHK, 2009, MOL ECOL RESOUR, V9, P243, DOI 10.1111/j.1755-0998.2009.02653.x	25	14	14	0	39	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 9	2012	7	4							e34797	10.1371/journal.pone.0034797	http://dx.doi.org/10.1371/journal.pone.0034797			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	955JO	22496864	Green Submitted, gold, Green Published			2022-12-25	WOS:000305014500032
J	Stradalova, V; Blazikova, M; Grossmann, G; Opekarova, M; Tanner, W; Malinsky, J				Stradalova, Vendula; Blazikova, Michaela; Grossmann, Guido; Opekarova, Miroslava; Tanner, Widmar; Malinsky, Jan			Distribution of Cortical Endoplasmic Reticulum Determines Positioning of Endocytic Events in Yeast Plasma Membrane	PLOS ONE			English	Article							NUCLEUS-VACUOLE JUNCTIONS; SACCHAROMYCES-CEREVISIAE; BUDDING YEAST; CELL; ER; COMPARTMENTATION; MICRODOMAINS; ORGANIZATION; PROTEINS; LIPIDS	In many eukaryotes, a significant part of the plasma membrane is closely associated with the dynamic meshwork of cortical endoplasmic reticulum (cortical ER). We mapped temporal variations in the local coverage of the yeast plasma membrane with cortical ER pattern and identified micron-sized plasma membrane domains clearly different in cortical ER persistence. We show that clathrin-mediated endocytosis is initiated outside the cortical ER-covered plasma membrane zones. These cortical ER-covered zones are highly dynamic but do not overlap with the immobile and also endocytosis-inactive membrane compartment of Can1 (MCC) and the subjacent eisosomes. The eisosomal component Pil1 is shown to regulate the distribution of cortical ER and thus the accessibility of the plasma membrane for endocytosis.	[Stradalova, Vendula; Blazikova, Michaela; Malinsky, Jan] Acad Sci Czech Republic, Inst Expt Med, Prague, Czech Republic; [Blazikova, Michaela] Charles Univ Prague, Fac Math & Phys, Prague, Czech Republic; [Grossmann, Guido] Carnegie Inst Sci, Dept Plant Biol, Stanford, CA USA; [Opekarova, Miroslava] Acad Sci Czech Republic, Inst Microbiol, Prague, Czech Republic; [Tanner, Widmar] Univ Regensburg, Inst Cell Biol & Plant Physiol, Regensburg, Germany	Czech Academy of Sciences; Institute of Experimental Medicine of the Czech Academy of Sciences; Charles University Prague; Carnegie Institution for Science; Czech Academy of Sciences; Institute of Microbiology of the Czech Academy of Sciences; University of Regensburg	Stradalova, V (corresponding author), Acad Sci Czech Republic, Inst Expt Med, Prague, Czech Republic.	malinsky@biomed.cas.cz	Malinsky, Jan/H-2484-2014; Efenberkova, Michaela/AAF-9968-2020; Grossmann, Guido/GQA-5985-2022; Stradalova, Vendula/H-2458-2014; Grossmann, Guido/D-3537-2014	Malinsky, Jan/0000-0002-1433-0989; Efenberkova, Michaela/0000-0003-1227-0393; Grossmann, Guido/0000-0001-7529-9244; Grossmann, Guido/0000-0001-7529-9244; Opekarova, Miroslava/0000-0002-2898-6014	Grant Agency of the Czech Republic [204/07/0133, P302/11/0146, 204/09/1924]; Grant Agency of the Academy of Sciences of the Czech Republic [KAN200520801]; Deutsche Forschungsgemeinschaft (DFG) [TA 36/18-1, TH, SFB699 Z2]; EMBO;  [AV0Z50390703];  [AV0Z50200510]	Grant Agency of the Czech Republic(Grant Agency of the Czech Republic); Grant Agency of the Academy of Sciences of the Czech Republic(Czech Academy of SciencesGrant Agency of the Czech Republic); Deutsche Forschungsgemeinschaft (DFG)(German Research Foundation (DFG)); EMBO(European Molecular Biology Organization (EMBO)); ; 	This work was financially supported by the Grant Agency of the Czech Republic (projects 204/07/0133, P302/11/0146 and 204/09/1924), the Grant Agency of the Academy of Sciences of the Czech Republic (KAN200520801), by the institutional grants (AV0Z50390703 and AV0Z50200510), and by the Deutsche Forschungsgemeinschaft (DFG projects TA 36/18-1; TH; SFB699 Z2). GG was supported by a EMBO long-term fellowship. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Berchtold D, 2009, MOL BIOL CELL, V20, P1565, DOI 10.1091/mbc.E08-10-1001; Bevis BJ, 2002, NAT CELL BIOL, V4, P750, DOI 10.1038/ncb852; Brach T, 2011, J CELL SCI, V124, P328, DOI 10.1242/jcs.078519; Engqvist-Goldstein AEY, 2003, ANNU REV CELL DEV BI, V19, P287, DOI 10.1146/annurev.cellbio.19.111401.093127; Frohlich F, 2009, J CELL BIOL, V185, P1227, DOI 10.1083/jcb.200811081; Grossmann G, 2007, EMBO J, V26, P1, DOI 10.1038/sj.emboj.7601466; Grossmann G, 2008, J CELL BIOL, V183, P1075, DOI 10.1083/jcb.200806035; Idrissi FZ, 2008, J CELL BIOL, V180, P1219, DOI 10.1083/jcb.200708060; Kaksonen M, 2005, CELL, V123, P305, DOI 10.1016/j.cell.2005.09.024; Kleine-Vehn J, 2011, MOL SYST BIOL, V7, DOI 10.1038/msb.2011.72; Kukulski W, 2011, J CELL BIOL, V192, P111, DOI 10.1083/jcb.201009037; Kvam E, 2007, AUTOPHAGY, V3, P85, DOI 10.4161/auto.3586; Lingwood D, 2010, SCIENCE, V327, P46, DOI 10.1126/science.1174621; Loewen CJR, 2007, J CELL BIOL, V179, P467, DOI 10.1083/jcb.200708205; Loibl M, 2010, EUKARYOT CELL, V9, P1184, DOI 10.1128/EC.00006-10; Malinska K, 2004, J CELL SCI, V117, P6031, DOI 10.1242/jcs.01493; Malinska K, 2003, MOL BIOL CELL, V14, P4427, DOI 10.1091/mbc.E03-04-0221; Malinsky J, 2010, YEAST, V27, P473, DOI 10.1002/yea.1772; Moreira KE, 2009, MOL BIOL CELL, V20, P809, DOI 10.1091/mbc.E08-03-0313; Olivera-Couto A, 2011, MOL BIOL CELL, V22, P2360, DOI 10.1091/mbc.E10-12-1021; Orci L, 2009, P NATL ACAD SCI USA, V106, P19358, DOI 10.1073/pnas.0911280106; Pan XZ, 2000, MOL BIOL CELL, V11, P2445, DOI 10.1091/mbc.11.7.2445; Perktold A, 2007, FEMS YEAST RES, V7, P629, DOI 10.1111/j.1567-1364.2007.00226.x; Pichler H, 2001, EUR J BIOCHEM, V268, P2351, DOI 10.1046/j.1432-1327.2001.02116.x; Prinz WA, 2000, J CELL BIOL, V150, P461, DOI 10.1083/jcb.150.3.461; Sparkes IA, 2009, BIOCHEM J, V423, P145, DOI 10.1042/BJ20091113; Stimpson HEM, 2009, MOL BIOL CELL, V20, P4640, DOI 10.1091/mbc.E09-05-0429; Stradalova V, 2009, J CELL SCI, V122, P2887, DOI 10.1242/jcs.051227; Toret CP, 2006, J CELL SCI, V119, P4585, DOI 10.1242/jcs.03251; Toshima JY, 2006, P NATL ACAD SCI USA, V103, P5793, DOI 10.1073/pnas.0601042103; Walther TC, 2006, NATURE, V439, P998, DOI 10.1038/nature04472; Walther TC, 2007, EMBO J, V26, P4946, DOI 10.1038/sj.emboj.7601933; West M, 2011, J CELL BIOL, V193, P333, DOI 10.1083/jcb.201011039; Zhang D, 2010, CURR BIOL, V20, P1029, DOI 10.1016/j.cub.2010.04.017; Ziolkowska NE, 2011, NAT STRUCT MOL BIOL, V18, P854, DOI 10.1038/nsmb.2080	35	33	33	2	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 9	2012	7	4							e35132	10.1371/journal.pone.0035132	http://dx.doi.org/10.1371/journal.pone.0035132			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	955JO	22496901	Green Published, Green Submitted, gold			2022-12-25	WOS:000305014500047
J	Zha, DJ; Chen, FY; Ramamoorthy, S; Fridberger, A; Choudhury, N; Jacques, SL; Wang, RKK; Nuttall, AL				Zha, Dingjun; Chen, Fangyi; Ramamoorthy, Sripriya; Fridberger, Anders; Choudhury, Niloy; Jacques, Steven L.; Wang, Ruikang K.; Nuttall, Alfred L.			In Vivo Outer Hair Cell Length Changes Expose the Active Process in the Cochlea	PLOS ONE			English	Article							MECHANICAL WAVE-FORM; BASILAR-MEMBRANE; INNER-EAR; TECTORIAL MEMBRANE; MAMMALIAN COCHLEA; SUPPORTING CELLS; RESPONSES; MODEL; ORGAN; CORTI	In Background: Mammalian hearing is refined by amplification of the sound-evoked vibration of the cochlear partition. This amplification is at least partly due to forces produced by protein motors residing in the cylindrical body of the outer hair cell. To transmit power to the cochlear partition, it is required that the outer hair cells dynamically change their length, in addition to generating force. These length changes, which have not previously been measured in vivo, must be correctly timed with the acoustic stimulus to produce amplification. Methodology/Principal Findings: Using in vivo optical coherence tomography, we demonstrate that outer hair cells in living guinea pigs have length changes with unexpected timing and magnitudes that depend on the stimulus level in the sensitive cochlea. Conclusions/Significance: The level-dependent length change is a necessary condition for directly validating that power is expended by the active process presumed to underlie normal hearing.	[Zha, Dingjun; Chen, Fangyi; Ramamoorthy, Sripriya; Fridberger, Anders; Nuttall, Alfred L.] Oregon Hlth & Sci Univ, Oregon Hearing Res Ctr, Portland, OR 97201 USA; [Zha, Dingjun] Fourth Mil Med Univ, Xijing Hosp, Dept Otolaryngol Head & Neck Surg, Xian, Shaanxi, Peoples R China; [Jacques, Steven L.; Nuttall, Alfred L.] Oregon Hlth & Sci Univ, Dept Biomed Engn, Portland, OR 97201 USA; [Jacques, Steven L.] Oregon Hlth & Sci Univ, Dept Dermatol, Portland, OR 97201 USA; [Wang, Ruikang K.] Univ Washington, Dept Bioengn, Seattle, WA 98195 USA; [Fridberger, Anders] Karolinska Inst, M1 Karolinska Univ Hosp, Ctr Hearing & Commun Res, Dept Clin Sci Intervent & Technol, Stockholm, Sweden; [Choudhury, Niloy] Michigan Technol Univ, Dept Biomed Engn, Houghton, MI 49931 USA; [Nuttall, Alfred L.] Univ Michigan, Kresge Hearing Res Inst, Ann Arbor, MI 48109 USA	Oregon Health & Science University; Air Force Military Medical University; Oregon Health & Science University; Oregon Health & Science University; University of Washington; University of Washington Seattle; Karolinska Institutet; Karolinska University Hospital; Michigan Technological University; University of Michigan System; University of Michigan	Zha, DJ (corresponding author), Oregon Hlth & Sci Univ, Oregon Hearing Res Ctr, Portland, OR 97201 USA.	chenfa@ohsu.edu	Wang, Ruikang/L-3889-2019; Fridberger, Anders/E-8977-2010; Chen, Fangyi/I-3497-2018	Wang, Ruikang/0000-0001-5169-8822; Fridberger, Anders/0000-0002-7960-1559; Chen, Fangyi/0000-0002-5024-6215; Ramamoorthy, Sripriya/0000-0002-0782-1229	National Institute on Deafness and Other Communicable Disorders [R01 DC 000141, DC 010399]; Swedish Research Counctil [K2011-63X-14061-11-3]; Tysta Skolan foundation; Horselskadades Riksforbund; Chinese National Nature Science Foundation [30600702]; NATIONAL INSTITUTE ON DEAFNESS AND OTHER COMMUNICATION DISORDERS [R01DC010399, R01DC000141, P30DC005983] Funding Source: NIH RePORTER	National Institute on Deafness and Other Communicable Disorders; Swedish Research Counctil; Tysta Skolan foundation; Horselskadades Riksforbund; Chinese National Nature Science Foundation(National Natural Science Foundation of China (NSFC)); NATIONAL INSTITUTE ON DEAFNESS AND OTHER COMMUNICATION DISORDERS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Deafness & Other Communication Disorders (NIDCD))	Supported by National Institute on Deafness and Other Communicable Disorders grants R01 DC 000141 (ALN) and DC 010399 (ALN), Swedish Research Counctil grant K2011-63X-14061-11-3 (AF), grants from the Tysta Skolan foundation and Horselskadades Riksforbund (AF) and supported by Chinese National Nature Science Foundation, 30600702 (DZ). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ALLEN JB, 1980, J ACOUST SOC AM, V68, P1660, DOI 10.1121/1.385198; ANGELBORG C, 1972, ACTA OTO-LARYNGOL, P49; ASHMORE JF, 1987, J PHYSIOL-LONDON, V388, P323, DOI 10.1113/jphysiol.1987.sp016617; BROWNELL WE, 1985, SCIENCE, V227, P194, DOI 10.1126/science.3966153; BROWNELL WE, 1990, EAR HEARING, V11, P82, DOI 10.1097/00003446-199004000-00003; Chan DK, 2005, NAT NEUROSCI, V8, P149, DOI 10.1038/nn1385; Chen FY, 2011, NAT NEUROSCI, V14, P770, DOI 10.1038/nn.2827; Chen FY, 2007, J BIOMED OPT, V12, DOI 10.1117/1.2717134; Choudhury N, 2006, HEARING RES, V220, P1, DOI 10.1016/j.heares.2006.06.006; CODY AR, 1987, J PHYSIOL-LONDON, V383, P551; Cooper NP, 1997, J NEUROPHYSIOL, V78, P261, DOI 10.1152/jn.1997.78.1.261; DALLOS P, 1991, NATURE, V350, P155, DOI 10.1038/350155a0; DAVIS H, 1983, HEARING RES, V9, P79, DOI 10.1016/0378-5955(83)90136-3; de Boer E, 2000, J ACOUST SOC AM, V107, P1487, DOI 10.1121/1.428435; de Boer E, 2000, J ACOUST SOC AM, V107, P1497, DOI 10.1121/1.428436; de Boer E., 2001, PHYSL PSYCHOL BASES, P1; Fridberger A, 2004, J NEUROSCI, V24, P10057, DOI 10.1523/JNEUROSCI.2711-04.2004; GEISLER CD, 1995, HEARING RES, V86, P132, DOI 10.1016/0378-5955(95)00064-B; GEISLER CD, 1986, HEARING RES, V24, P125, DOI 10.1016/0378-5955(86)90056-0; Grosh K, 2004, J ACOUST SOC AM, V115, P2178, DOI 10.1121/1.1695431; Gummer AW, 1996, P NATL ACAD SCI USA, V93, P8727, DOI 10.1073/pnas.93.16.8727; Hallworth R, 1995, J NEUROPHYSIOL, V74, P2319, DOI 10.1152/jn.1995.74.6.2319; He DZZ, 1999, P NATL ACAD SCI USA, V96, P8223, DOI 10.1073/pnas.96.14.8223; Jacob S, 2011, BIOPHYS J, V100, P2586, DOI 10.1016/j.bpj.2011.05.002; Kennedy HJ, 2005, NATURE, V433, P880, DOI 10.1038/nature03367; KHANNA SM, 1982, SCIENCE, V215, P305, DOI 10.1126/science.7053580; MAMMANO F, 1993, NATURE, V365, P838, DOI 10.1038/365838a0; MAMMANO F, 1995, PFLUG ARCH EUR J PHY, V430, P745, DOI 10.1007/BF00386170; MARKIN VS, 1995, BIOPHYS J, V69, P138, DOI 10.1016/S0006-3495(95)79883-6; NEELY ST, 1993, J ACOUST SOC AM, V94, P137, DOI 10.1121/1.407091; Nilsen KE, 1999, NAT NEUROSCI, V2, P642, DOI 10.1038/10197; Nobili R, 1996, J ACOUST SOC AM, V99, P2244, DOI 10.1121/1.415412; NUTTALL AL, 1991, HEARING RES, V51, P203, DOI 10.1016/0378-5955(91)90037-A; Ramamoorthy S, 2007, J ACOUST SOC AM, V121, P2758, DOI 10.1121/1.2713725; RHODE WS, 1971, J ACOUST SOC AM, V49, P1218, DOI 10.1121/1.1912485; ROBLES L, 1986, J ACOUST SOC AM, V80, P1364, DOI 10.1121/1.394389; RUGGERO MA, 1991, J NEUROSCI, V11, P1057; SANTOS-SACCHI J, 1988, HEARING RES, V35, P143, DOI 10.1016/0378-5955(88)90113-X; SANTOS-SACCHI J, 1992, J NEUROSCI, V12, P1906; SLEPECKY N, 1983, HEARING RES, V10, P359, DOI 10.1016/0378-5955(83)90098-9; ter Kuile E., 1900, PFLUGERS ARCH GES PH, V79, P146, DOI 10.1007/BF01796105; Tolomeo JA, 1997, BIOPHYS J, V73, P2241, DOI 10.1016/S0006-3495(97)78255-9; Tomo I, 2007, BIOPHYS J, V93, P3279, DOI 10.1529/biophysj.107.105072; ZENNER HP, 1985, HEARING RES, V18, P127, DOI 10.1016/0378-5955(85)90004-8; Zheng J, 2000, NATURE, V405, P149, DOI 10.1038/35012009; ZWISLOCKI JJ, 1979, SCIENCE, V204, P639, DOI 10.1126/science.432671	46	43	43	0	20	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 9	2012	7	4							e32757	10.1371/journal.pone.0032757	http://dx.doi.org/10.1371/journal.pone.0032757			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	955JO	22496736	gold, Green Submitted, Green Published			2022-12-25	WOS:000305014500006
J	Castrezana, S; Bono, JM				Castrezana, Sergio; Bono, Jeremy M.			Host Plant Adaptation in Drosophila mettleri Populations	PLOS ONE			English	Article							SONORAN DESERT; TRADE-OFFS; CACTOPHILIC DROSOPHILA; ECOLOGICAL SPECIATION; LOCAL ADAPTATION; CYTOCHROME P450S; CACTUS ALKALOIDS; SPECIALIZATION; INVOLVEMENT; CACTACEAE	The process of local adaptation creates diversity among allopatric populations, and may eventually lead to speciation. Plant-feeding insect populations that specialize on different host species provide an excellent opportunity to evaluate the causes of ecological specialization and the subsequent consequences for diversity. In this study, we used geographically separated Drosophila mettleri populations that specialize on different host cacti to examine oviposition preference for and larval performance on an array of natural and non-natural hosts (eight total). We found evidence of local adaptation in performance on saguaro cactus (Carnegiea gigantea) for populations that are typically associated with this host, and to chemically divergent prickly pear species (Opuntia spp.) in a genetically isolated population on Santa Catalina Island. Moreover, each population exhibited reduced performance on the alternative host. This finding is consistent with trade-offs associated with adaptation to these chemically divergent hosts, although we also discuss alternative explanations for this pattern. For oviposition preference, Santa Catalina Island flies were more likely to oviposit on some prickly pear species, but all populations readily laid eggs on saguaro. Experiments with non-natural hosts suggest that factors such as ecological opportunity may play a more important role than host plant chemistry in explaining the lack of natural associations with some hosts.	[Castrezana, Sergio] Univ Arizona, Dept Ecol & Evolutionary Biol, Tucson, AZ USA; [Bono, Jeremy M.] Univ Colorado, Dept Biol, Colorado Springs, CO 80907 USA	University of Arizona; University of Colorado System; University of Colorado at Colorado Springs	Castrezana, S (corresponding author), Univ Calif Los Angeles, Ecol & Evolutionary Biol Dept, Los Angeles, CA 90024 USA.	jbono@uccs.edu			National Science Foundation [INT-9402161, BED9510645]	National Science Foundation(National Science Foundation (NSF))	This research was supported by National Science Foundation Grants INT-9402161 and BED9510645. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Agrawal AA, 2000, ECOLOGY, V81, P500, DOI 10.1890/0012-9658(2000)081[0500:HREAAT]2.0.CO;2; Bono JM, 2008, MOL ECOL, V17, P3211, DOI 10.1111/j.1365-294X.2008.03823.x; Castrezana SJ, 2008, BEHAV GENET, V38, P437, DOI 10.1007/s10519-008-9209-0; Coyne JA, 2004, SPECIATION, V37; Danielson PB, 1998, MOL GEN GENET, V259, P54, DOI 10.1007/s004380050788; Danielson PB, 1997, P NATL ACAD SCI USA, V94, P10797, DOI 10.1073/pnas.94.20.10797; FOGLEMAN JC, 1981, AM NAT, V118, P541, DOI 10.1086/283846; FOGLEMAN JC, 1982, COMP BIOCHEM PHYS A, V71, P413, DOI 10.1016/0300-9629(82)90427-3; Fogleman JC, 2001, AM ZOOL, V41, P877, DOI 10.1668/0003-1569(2001)041[0877:CIITCM]2.0.CO;2; Fogleman JC, 1990, ECOLOGICAL EVOLUTION; FOX LR, 1981, SCIENCE, V211, P887, DOI 10.1126/science.211.4485.887; FRANK MR, 1992, P NATL ACAD SCI USA, V89, P11998, DOI 10.1073/pnas.89.24.11998; FRY JD, 1996, AM NAT             S, V148, P84, DOI DOI 10.1086/285904; Funk DJ, 2002, GENETICA, V116, P251, DOI 10.1023/A:1021236510453; FUTUYMA DJ, 1988, ANNU REV ECOL SYST, V19, P207, DOI 10.1146/annurev.es.19.110188.001231; Griffith MP, 2009, INT J PLANT SCI, V170, P107, DOI 10.1086/593048; Hartmann S, 2002, AM J BOT, V89, P1085, DOI 10.3732/ajb.89.7.1085; Hereford J, 2009, AM NAT, V173, P579, DOI 10.1086/597611; Hurtado LA, 2004, MOL ECOL, V13, P1365, DOI 10.1111/j.1365-294X.2004.02169.x; JAENIKE J, 1990, ANNU REV ECOL SYST, V21, P243, DOI 10.1146/annurev.ecolsys.21.1.243; Kawecki TJ, 2004, ECOL LETT, V7, P1225, DOI 10.1111/j.1461-0248.2004.00684.x; Kircher H.W., 1982, P143; Markow TA, 2002, EVOLUTION, V56, P546, DOI 10.1111/j.0014-3820.2002.tb01365.x; Meyer BN, 1980, PHYTOCHEMISTRY, V19; MEYER JM, 1987, J CHEM ECOL, V13, P2069, DOI 10.1007/BF01012872; Newby BD, 1998, J INSECT BEHAV, V11, P691, DOI 10.1023/A:1022398809881; Rundle HD, 2005, ECOL LETT, V8, P336, DOI 10.1111/j.1461-0248.2004.00715.x; Scheirs J, 2005, EVOL ECOL, V19, P551, DOI 10.1007/s10682-005-2004-y; Schluter D, 2009, P NATL ACAD SCI USA, V106, P9955, DOI 10.1073/pnas.0901264106; Starmer W.T., 1982, P159; Starmer WT, 1990, ECOLOGICAL EVOLUTION; Stintzing FC, 2005, MOL NUTR FOOD RES, V49, P175, DOI 10.1002/mnfr.200400071; STROMBOM J, 1978, ACTA PHARM SUEC, V15, P127; VIA S, 1991, EVOLUTION, V45, P827, DOI 10.1111/j.1558-5646.1991.tb04353.x	34	6	6	1	28	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 6	2012	7	4							e34008	10.1371/journal.pone.0034008	http://dx.doi.org/10.1371/journal.pone.0034008			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	955JA	22493678	Green Published, gold, Green Submitted			2022-12-25	WOS:000305012700020
J	Machado, D; Couto, I; Perdigao, J; Rodrigues, L; Portugal, I; Baptista, P; Veigas, B; Amaral, L; Viveiros, M				Machado, Diana; Couto, Isabel; Perdigao, Joao; Rodrigues, Liliana; Portugal, Isabel; Baptista, Pedro; Veigas, Bruno; Amaral, Leonard; Viveiros, Miguel			Contribution of Efflux to the Emergence of Isoniazid and Multidrug Resistance in Mycobacterium tuberculosis	PLOS ONE			English	Article							CATALASE-PEROXIDASE GENE; DRUG-RESISTANCE; SUSCEPTIBILITY; MUTATIONS; MECHANISM; RIFAMPIN; PUMP; SPECIMENS; STRESS	Multidrug resistant (MDR) tuberculosis is caused by Mycobacterium tuberculosis resistant to isoniazid and rifampicin, the two most effective drugs used in tuberculosis therapy. Here, we investigated the mechanism by which resistance towards isoniazid develops and how overexpression of efflux pumps favors accumulation of mutations in isoniazid targets, thus establishing a MDR phenotype. The study was based on the in vitro induction of an isoniazid resistant phenotype by prolonged serial exposure of M. tuberculosis strains to the critical concentration of isoniazid employed for determination of drug susceptibility testing in clinical isolates. Results show that susceptible and rifampicin monoresistant strains exposed to this concentration become resistant to isoniazid after three weeks; and that resistance observed for the majority of these strains could be reduced by means of efflux pumps inhibitors. RT-qPCR assessment of efflux pump genes expression showed overexpression of all tested genes. Enhanced real-time efflux of ethidium bromide, a common efflux pump substrate, was also observed, showing a clear relation between overexpression of the genes and increased efflux pump function. Further exposure to isoniazid resulted in the selection and stabilization of spontaneous mutations and deletions in the katG gene along with sustained increased efflux activity. Together, results demonstrate the relevance of efflux pumps as one of the factors of isoniazid resistance in M. tuberculosis. These results support the hypothesis that activity of efflux pumps allows the maintenance of an isoniazid resistant population in a sub-optimally treated patient from which isoniazid genetically resistant mutants emerge. Therefore, the use of inhibitors of efflux should be considered in the development of new therapeutic strategies for preventing the emergence of MDR-TB during treatment.	[Machado, Diana; Couto, Isabel; Rodrigues, Liliana; Amaral, Leonard; Viveiros, Miguel] Univ Nova Lisboa, Inst Higiene & Med Trop, Unidade Microbiol Med, Grp Micobacterias, P-1200 Lisbon, Portugal; [Couto, Isabel] Univ Nova Lisboa, Fac Ciencias & Tecnol, Ctr Recursos Microbiol CREM, Caparica, Portugal; [Perdigao, Joao; Portugal, Isabel] Univ Lisbon, Fac Farm, Ctr Patogenese Mol URIA, P-1699 Lisbon, Portugal; [Baptista, Pedro; Veigas, Bruno] Univ Nova Lisboa, Fac Ciencias & Tecnol, Dept Ciencias Vida, CIGMH, Caparica, Portugal; [Amaral, Leonard; Viveiros, Miguel] COST ACT BM0701 ATENS, Brusells, Belgium	Universidade Nova de Lisboa; Institute of Hygiene & Tropical Medicine - UNL; Universidade Nova de Lisboa; Universidade de Lisboa; Universidade Nova de Lisboa	Machado, D (corresponding author), Univ Nova Lisboa, Inst Higiene & Med Trop, Unidade Microbiol Med, Grp Micobacterias, P-1200 Lisbon, Portugal.	mviveiros@ihmt.unl.pt	Viveiros, Miguel/A-7326-2008; Couto, Isabel/I-2640-2012; Baptista, Pedro/P-3182-2019; Veigas, Bruno M/I-1253-2012; Amaral, Leonard/I-2112-2012; Machado, Diana/L-7027-2013; Portugal, Isabel/B-1491-2008; Perdigão, João/L-6893-2013; Baptista, Pedro V/A-1237-2009; iMed.ULisboa, M2B/B-5277-2014; Rodrigues, Liliana/N-2463-2014	Viveiros, Miguel/0000-0001-9676-6251; Couto, Isabel/0000-0003-3536-2733; Amaral, Leonard/0000-0003-3127-1295; Machado, Diana/0000-0003-2375-2726; Portugal, Isabel/0000-0002-7843-0006; Perdigão, João/0000-0002-0339-1305; Baptista, Pedro V/0000-0001-5255-7095; iMed.ULisboa, M2B/0000-0002-1245-3715; Rodrigues, Liliana/0000-0002-2094-2666; Veigas, Bruno/0000-0002-9265-4591	Fundacao para a Ciencia e a Tecnologia (FCT), Portugal [EU-FSE/FEDER-PTDC/BIA-MIC/71280/2006, EU-QREN/COMPETE-PTDC/SAU-FCF/102807/2008, SFRH/BD/65060/2009, SFRH/BD/24931/2005]; Fundacao Calouste Gulbenkian (FCG), Portugal	Fundacao para a Ciencia e a Tecnologia (FCT), Portugal(Portuguese Foundation for Science and Technology); Fundacao Calouste Gulbenkian (FCG), Portugal	This work was supported by grant EU-FSE/FEDER-PTDC/BIA-MIC/71280/2006 and EU-QREN/COMPETE-PTDC/SAU-FCF/102807/2008 from Fundacao para a Ciencia e a Tecnologia (FCT), Portugal and Project "Early Molecular Detection of M/XDRTB in the Great Lisbon Healthcare Region", Refa SDH49, from Fundacao Calouste Gulbenkian (FCG), Portugal. Authors DM and LR were supported by grants SFRH/BD/65060/2009 and SFRH/BD/24931/2005 from FCT of Portugal. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	da Silva PEA, 2011, FEMS IMMUNOL MED MIC, V63, P1, DOI 10.1111/j.1574-695X.2011.00831.x; BANERJEE A, 1994, SCIENCE, V263, P227, DOI 10.1126/science.8284673; Bergval IL, 2009, J ANTIMICROB CHEMOTH, V64, P515, DOI 10.1093/jac/dkp237; Bianco MV, 2011, BMC INFECT DIS, V11, DOI 10.1186/1471-2334-11-195; Bottger EC, 2011, CLIN MICROBIOL INFEC, V17, P1128, DOI 10.1111/j.1469-0691.2011.03551.x; Cole ST, 1998, NATURE, V393, P537, DOI 10.1038/31159; Costa SS, 2011, BMC MICROBIOL, V11, DOI 10.1186/1471-2180-11-241; Cox JS, 1999, NATURE, V52, P2503; De Rossi Edda, 2002, Molecular Medicine (Baltimore), V8, P714; de Steenwinkel JEM, 2010, J ANTIMICROB CHEMOTH, V65, P2582, DOI 10.1093/jac/dkq374; DeMarco CE, 2007, ANTIMICROB AGENTS CH, V51, P3235, DOI 10.1128/AAC.00430-07; Doran JL, 1997, CLIN DIAGN LAB IMMUN, V4, P23, DOI 10.1128/CDLI.4.1.23-32.1997; Guo HL, 2006, J MED MICROBIOL, V55, P1527, DOI 10.1099/jmm.0.46718-0; Gupta AK, 2010, INDIAN J MED RES, V132, P176; Gupta AK, 2010, MICROB DRUG RESIST, V16, P21, DOI 10.1089/mdr.2009.0054; Hazbon MH, 2006, ANTIMICROB AGENTS CH, V50, P2640, DOI 10.1128/AAC.00112-06; HEYM B, 1995, MOL MICROBIOL, V15, P235, DOI 10.1111/j.1365-2958.1995.tb02238.x; Inderlied C. B., 1996, ANTIBIOTICS LAB MED, P127; Livak KJ, 2001, METHODS, V25, P402, DOI 10.1006/meth.2001.1262; Louw GE, 2009, ANTIMICROB AGENTS CH, V53, P3181, DOI 10.1128/AAC.01577-08; Louw GE, 2011, AM J RESP CRIT CARE, V184, P269, DOI 10.1164/rccm.201011-1924OC; Martinez JL, 2000, ANTIMICROB AGENTS CH, V44, P1771, DOI 10.1128/AAC.44.7.1771-1777.2000; Martins A, 2009, INT J ANTIMICROB AG, V34, P602, DOI 10.1016/j.ijantimicag.2009.06.029; Paixao Laura, 2009, J Biol Eng, V3, P18, DOI 10.1186/1754-1611-3-18; Pasca MR, 2005, ANTIMICROB AGENTS CH, V49, P4775, DOI 10.1128/AAC.49.11.4775-4777.2005; Pasipanodya JG, 2011, CURR OPIN PHARMACOL, V11, P457, DOI 10.1016/j.coph.2011.07.001; Perdigao J, 2008, MICROB DRUG RESIST, V14, P133, DOI 10.1089/mdr.2008.0798; Portevin D, 2004, P NATL ACAD SCI USA, V101, P314, DOI 10.1073/pnas.0305439101; Rodrigues L, 2008, J ANTIMICROB CHEMOTH, V61, P1076, DOI 10.1093/jac/dkn070; Rodrigues L, 2012, INFECT GENET EVOL, V12, P695, DOI 10.1016/j.meegid.2011.08.009; Rodrigues Liliana, 2011, Recent Pat Antiinfect Drug Discov, V6, P118; Rodrigues L, 2009, INT J ANTIMICROB AG, V34, P529, DOI 10.1016/j.ijantimicag.2009.07.010; Siddiqi S, 2006, MGIT960 PROCEDURE MA; Silva PEA, 2001, ANTIMICROB AGENTS CH, V45, P800, DOI 10.1128/AAC.45.3.800-804.2001; Somoskovi A, 2001, RESP RES, V2, P164, DOI 10.1186/rr54; Springer B, 2009, J CLIN MICROBIOL, V47, P1773, DOI 10.1128/JCM.02501-08; Srivastava S, 2010, J INFECT DIS, V201, P1225, DOI 10.1086/651377; Supply P, 2006, J CLIN MICROBIOL, V44, P4498, DOI 10.1128/JCM.01392-06; TELENTI A, 1993, LANCET, V341, P647, DOI 10.1016/0140-6736(93)90417-F; Vijdea R, 2008, EUR J CLIN MICROBIOL, V27, P1079, DOI 10.1007/s10096-008-0548-9; Vilcheze C, 2007, ANNU REV MICROBIOL, V61, P35, DOI 10.1146/annurev.micro.61.111606.122346; Viveiros M, 2005, J CLIN MICROBIOL, V43, P4880, DOI 10.1128/JCM.43.9.4880-4884.2005; Viveiros M, 2003, INT J ANTIMICROB AG, V22, P274, DOI 10.1016/S0924-8579(03)00208-5; Viveiros M, 2002, ANTIMICROB AGENTS CH, V46, P2804, DOI 10.1128/AAC.46.9.2804-2810.2002; Viveiros M, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0000365; Viveiros M, 2010, METHODS MOL BIOL, V642, P159, DOI 10.1007/978-1-60327-279-7_12; Webber MA, 2003, J ANTIMICROB CHEMOTH, V51, P9, DOI 10.1093/jac/dkg050; *WHO, 2008, WHOHTMTB2008394; Wilson W, 1999, P NATL ACAD SCI USA, V96, P12833, DOI 10.1073/pnas.96.22.12833; World Health Organisation, 2011, WHOHTMTB201116; ZHANG Y, 1992, NATURE, V358, P591, DOI 10.1038/358591a0; Zumla A, 2011, TROP MED INT HEALTH, V16, P79, DOI 10.1111/j.1365-3156.2010.02665.x	52	161	166	0	51	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 6	2012	7	4							e34538	10.1371/journal.pone.0034538	http://dx.doi.org/10.1371/journal.pone.0034538			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	955JA	22493700	Green Submitted, Green Published, gold			2022-12-25	WOS:000305012700042
J	Mulder, AM; Carragher, B; Towne, V; Meng, Y; Wang, Y; Dieter, L; Potter, CS; Washabaugh, MW; Sitrin, RD; Zhao, QJ				Mulder, Anke M.; Carragher, Bridget; Towne, Victoria; Meng, Yuan; Wang, Yang; Dieter, Lance; Potter, Clinton S.; Washabaugh, Michael W.; Sitrin, Robert D.; Zhao, Qinjian			Toolbox for Non-Intrusive Structural and Functional Analysis of Recombinant VLP Based Vaccines: A Case Study with Hepatitis B Vaccine	PLOS ONE			English	Article							VIRUS-LIKE PARTICLES; SURFACE-ANTIGEN PARTICLES; LINKED-IMMUNOSORBENT-ASSAY; AUSTRALIA-ANTIGEN; ENVELOPE PROTEINS; PAPILLOMAVIRUS; VISUALIZATION; ANTIBODIES; YEAST	Background: Fundamental to vaccine development, manufacturing consistency, and product stability is an understanding of the vaccine structure-activity relationship. With the virus-like particle (VLP) approach for recombinant vaccines gaining popularity, there is growing demand for tools that define their key characteristics. We assessed a suite of non-intrusive VLP epitope structure and function characterization tools by application to the Hepatitis B surface antigen (rHBsAg) VLP-based vaccine. Methodology: The epitope-specific immune reactivity of rHBsAg epitopes to a given monoclonal antibody was monitored by surface plasmon resonance (SPR) and quantitatively analyzed on rHBsAg VLPs in-solution or bound to adjuvant with a competitive enzyme-linked immunosorbent assay (ELISA). The structure of recombinant rHBsAg particles was examined by cryo transmission electron microscopy (cryoTEM) and in-solution atomic force microscopy (AFM). Principal Findings: SPR and competitive ELISA determined relative antigenicity in solution, in real time, with rapid turnaround, and without the need of dissolving the particulate aluminum based adjuvant. These methods demonstrated the nature of the clinically relevant epitopes of HBsAg as being responsive to heat and/or redox treatment. In-solution AFM and cryoTEM determined vaccine particle size distribution, shape, and morphology. Redox-treated rHBsAg enabled 3D reconstruction from CryoTEM images - confirming the previously proposed octahedral structure and the established lipid-to-protein ratio of HBsAg particles. Results from these non-intrusive biophysical and immunochemical analyses coalesced into a comprehensive understanding of rHBsAg vaccine epitope structure and function that was important for assuring the desired epitope formation, determinants for vaccine potency, and particle stability during vaccine design, development, and manufacturing. Significance: Together, the methods presented here comprise a novel suite of non-intrusive VLP structural and functional characterization tools for recombinant vaccines. Key VLP structural features were defined and epitope-specific antigenicity was quantified while preserving epitope integrity and particle morphology. These tools should facilitate the development of other VLP-based vaccines.	[Mulder, Anke M.; Carragher, Bridget; Potter, Clinton S.] NanoImaging Serv, Dept Res & Dev, La Jolla, CA USA; [Meng, Yuan; Wang, Yang; Washabaugh, Michael W.; Zhao, Qinjian] Merck Res Labs, Vaccine Analyt R&D, West Point, PA USA; [Dieter, Lance] Merck Res Labs, Vaccine Bioproc R&D, West Point, PA USA; [Towne, Victoria; Sitrin, Robert D.] Merck Mfg Div, Vaccine Mfg Sci & Commercializat, West Point, PA USA	Merck & Company; Merck & Company; Merck & Company	Mulder, AM (corresponding author), NanoImaging Serv, Dept Res & Dev, La Jolla, CA USA.	mulder@nanoimagingservices.com; qinjianzhao@gmail.com		Carragher, Bridget/0000-0002-0624-5020				BAYER ME, 1968, NATURE, V218, P1057, DOI 10.1038/2181057a0; Berkower I, 2011, J VIROL, V85, P2439, DOI 10.1128/JVI.02061-10; BRUSS V, 1991, P NATL ACAD SCI USA, V88, P1059, DOI 10.1073/pnas.88.3.1059; Carragher B, 2008, ADV TRANSMISSION ELE, P104; DANE DS, 1970, LANCET, V1, P695; DUBOCHET J, 2009, HDB CRYOPREPARATION, P1; Frank J, 1996, J STRUCT BIOL, V116, P190, DOI 10.1006/jsbi.1996.0030; GAVILANES F, 1990, BIOCHEM J, V265, P857, DOI 10.1042/bj2650857; Gilbert RJC, 2005, P NATL ACAD SCI USA, V102, P14783, DOI 10.1073/pnas.0505062102; Goddard TD, 2007, J STRUCT BIOL, V157, P281, DOI 10.1016/j.jsb.2006.06.010; GOMEZGUTIERREZ J, 1995, BBA-BIOMEMBRANES, V1233, P205, DOI 10.1016/0005-2736(94)00255-N; Greiner VJ, 2010, BIOCHIMIE, V92, P994, DOI 10.1016/j.biochi.2010.04.014; HARPAZ Y, 1994, STRUCTURE, V2, P641, DOI 10.1016/S0969-2126(00)00065-4; High K, 2005, ANAL BIOCHEM, V347, P159, DOI 10.1016/j.ab.2005.09.007; KIRNBAUER R, 1992, P NATL ACAD SCI USA, V89, P12180, DOI 10.1073/pnas.89.24.12180; Kuznetsov YG, 2011, MICROBIOL MOL BIOL R, V75, P268, DOI 10.1128/MMBR.00041-10; Lander GC, 2009, J STRUCT BIOL, V166, P95, DOI 10.1016/j.jsb.2009.01.002; Le Duff Y, 2009, J VIROL, V83, P12443, DOI 10.1128/JVI.01594-09; Li SW, 2005, VACCINE, V23, P2893, DOI 10.1016/j.vaccine.2004.11.064; Ludtke SJ, 1999, J STRUCT BIOL, V128, P82, DOI 10.1006/jsbi.1999.4174; Mallick SP, 2005, ULTRAMICROSCOPY, V104, P8, DOI 10.1016/j.ultramic.2005.02.004; Mangold CMT, 1997, ARCH VIROL, V142, P2257, DOI 10.1007/s007050050240; MANGOLD CMT, 1995, VIROLOGY, V211, P535, DOI 10.1006/viro.1995.1435; Meng Y, 2005, ANAL BIOCHEM, V345, P227, DOI 10.1016/j.ab.2005.07.026; Milhiet PE, 2011, BIOCHIMIE, V93, P254, DOI 10.1016/j.biochi.2010.09.018; Rappuoli R, 2011, NATURE, V473, P463, DOI 10.1038/nature10124; Roldao A, 2010, EXPERT REV VACCINES, V9, P1149, DOI [10.1586/erv.10.115, 10.1586/ERV.10.115]; Roseman AM, 2004, J STRUCT BIOL, V145, P91, DOI 10.1016/j.jsb.2003.11.007; Salisse J, 2009, J VIROL, V83, P9321, DOI 10.1128/JVI.00678-09; SALUNKE DM, 1989, BIOPHYS J, V56, P887, DOI 10.1016/S0006-3495(89)82735-3; Satoh O, 2000, J BIOCHEM-TOKYO, V127, P543, DOI 10.1093/oxfordjournals.jbchem.a022639; Schofield T, 2002, Dev Biol (Basel), V111, P299; Shearer MH, 1998, MOL IMMUNOL, V35, P1149, DOI 10.1016/S0161-5890(98)00110-2; Short JM, 2009, J MOL BIOL, V390, P135, DOI 10.1016/j.jmb.2009.04.059; STIRK HJ, 1992, INTERVIROLOGY, V33, P148, DOI 10.1159/000150244; VALENZUELA P, 1982, NATURE, V298, P347, DOI 10.1038/298347a0; Voss NR, 2009, J STRUCT BIOL, V166, P205, DOI 10.1016/j.jsb.2009.01.004; WAMPLER DE, 1985, P NATL ACAD SCI USA, V82, P6830, DOI 10.1073/pnas.82.20.6830; WATERS J, 1986, J GEN VIROL, V67, P2467, DOI 10.1099/0022-1317-67-11-2467; Wolf M, 2010, P NATL ACAD SCI USA, V107, P6298, DOI 10.1073/pnas.0914604107; Zhao Q, 2012, VIROLOGY IN PRESS; Zhao QJ, 2011, VACCINE, V29, P7936, DOI 10.1016/j.vaccine.2011.08.070; Zhao QJ, 2011, BIOCHEM BIOPH RES CO, V408, P447, DOI 10.1016/j.bbrc.2011.04.048; Zhao QJ, 2006, HUM VACCINES, V2, P174, DOI 10.4161/hv.2.4.3015; Zhao QJ, 2005, J VIROL METHODS, V127, P133, DOI 10.1016/j.jviromet.2005.03.015; Zhu FC, 2010, LANCET, V376, P895, DOI 10.1016/S0140-6736(10)61030-6	46	42	46	0	32	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 6	2012	7	4							e33235	10.1371/journal.pone.0033235	http://dx.doi.org/10.1371/journal.pone.0033235			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	955JA	22493667	Green Published, gold, Green Submitted			2022-12-25	WOS:000305012700009
J	Sharp, ME; Viswanathan, J; Lanyon, LJ; Barton, JJS				Sharp, Madeleine E.; Viswanathan, Jayalakshmi; Lanyon, Linda J.; Barton, Jason J. S.			Sensitivity and Bias in Decision-Making under Risk: Evaluating the Perception of Reward, Its Probability and Value	PLOS ONE			English	Article							DOPAMINE AGONISTS; PARKINSONS-DISEASE; NOVELTY-SEEKING; PROSPECT-THEORY; EXPECTED VALUE; PERSONALITY; IMPAIRMENT; DISORDERS; AVERSION; DISTINCT	Background: There are few clinical tools that assess decision-making under risk. Tests that characterize sensitivity and bias in decisions between prospects varying in magnitude and probability of gain may provide insights in conditions with anomalous reward-related behaviour. Objective: We designed a simple test of how subjects integrate information about the magnitude and the probability of reward, which can determine discriminative thresholds and choice bias in decisions under risk. Design/Methods: Twenty subjects were required to choose between two explicitly described prospects, one with higher probability but lower magnitude of reward than the other, with the difference in expected value between the two prospects varying from 3 to 23%. Results: Subjects showed a mean threshold sensitivity of 43% difference in expected value. Regarding choice bias, there was a 'risk premium' of 38%, indicating a tendency to choose higher probability over higher reward. An analysis using prospect theory showed that this risk premium is the predicted outcome of hypothesized non-linearities in the subjective perception of reward value and probability. Conclusions: This simple test provides a robust measure of discriminative value thresholds and biases in decisions under risk. Prospect theory can also make predictions about decisions when subjective perception of reward or probability is anomalous, as may occur in populations with dopaminergic or striatal dysfunction, such as Parkinson's disease and schizophrenia.	[Sharp, Madeleine E.; Viswanathan, Jayalakshmi; Lanyon, Linda J.; Barton, Jason J. S.] Univ British Columbia, Dept Med Neurol, Human Vis & Eye Movement Lab, Vancouver, BC V5Z 1M9, Canada; [Viswanathan, Jayalakshmi; Lanyon, Linda J.; Barton, Jason J. S.] Univ British Columbia, Dept Ophthalmol & Visual Sci, Vancouver, BC V5Z 1M9, Canada; [Barton, Jason J. S.] Univ British Columbia, Dept Psychol, Vancouver, BC, Canada	University of British Columbia; University of British Columbia; University of British Columbia	Sharp, ME (corresponding author), Univ British Columbia, Dept Med Neurol, Human Vis & Eye Movement Lab, Vancouver, BC V5Z 1M9, Canada.	madeleinesharp@gmail.com	Barton, Jason JS/A-6362-2012; Viswanathan, Jaya/AAW-1403-2021; Lanyon, Linda/L-9238-2019	Lanyon, Linda/0000-0002-0885-1825; Viswanathan, Jayalakshmi/0000-0001-5338-3170	Canadian Institute of Health Research: CIHR [MOP-81270]	Canadian Institute of Health Research: CIHR(Canadian Institutes of Health Research (CIHR))	This study was funded by the Canadian Institute of Health Research: CIHR grant number MOP-81270. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	BECHARA A, 1994, COGNITION, V50, P7, DOI 10.1016/0010-0277(94)90018-3; Bechara A, 1996, CEREB CORTEX, V6, P215, DOI 10.1093/cercor/6.2.215; Blaukopf CL, 2006, EXP BRAIN RES, V174, P786, DOI 10.1007/s00221-006-0685-2; Bodi N, 2009, BRAIN, V132, P2385, DOI 10.1093/brain/awp094; Camerer C, 2000, NEUROECONOMICS DECIS; Camerer C, 1989, J RISK UNCERTAINTY; CANAVAN AGM, 1989, NEUROPSYCHOLOGIA, V27, P141, DOI 10.1016/0028-3932(89)90167-X; Christopoulos GI, 2009, J NEUROSCI, V29, P12574, DOI 10.1523/JNEUROSCI.2614-09.2009; d'Acremont M, 2008, COGN AFFECT BEHAV NE, V8, P363, DOI 10.3758/CABN.8.4.363; Daw ND, 2006, NATURE, V441, P876, DOI 10.1038/nature04766; Ding L, 2007, J NEUROPHYSIOL, V97, P57, DOI 10.1152/jn.00902.2006; Dodd ML, 2005, ARCH NEUROL-CHICAGO, V62, P1377, DOI 10.1001/archneur.62.9.noc50009; Dunn BD, 2006, NEUROSCI BIOBEHAV R, V30, P239, DOI 10.1016/j.neubiorev.2005.07.001; Fox CR, 2009, NEUROECONOMICS: DECISION MAKING AND THE BRAIN, P145, DOI 10.1016/B978-0-12-374176-9.00011-7; Glimcher PW, 2008, COGN AFFECT BEHAV NE, V8, P348, DOI 10.3758/CABN.8.4.348; Hikosaka O, 2006, J NEUROPHYSIOL, V95, P567, DOI 10.1152/jn.00458.2005; Holt C. A. K., 2002, AM EC REV, V92; Hsu M, 2009, J NEUROSCI, V29, P2231, DOI 10.1523/JNEUROSCI.5296-08.2009; Huettel SA, 2006, NEURON, V49, P765, DOI 10.1016/j.neuron.2006.01.024; KAHNEMAN D, 1979, ECONOMETRICA, V47, P263, DOI 10.2307/1914185; Kobayakawa M, 2008, MOVEMENT DISORD, V23, P547, DOI 10.1002/mds.21865; Lejuez CW, 2002, J EXP PSYCHOL-APPL, V8, P75, DOI 10.1037//1076-898X.8.2.75; LESIEUR HR, 1987, AM J PSYCHIAT, V144, P1184; Levy I, 2010, J NEUROPHYSIOL, V103, P1036, DOI 10.1152/jn.00853.2009; Liston DB, 2008, J NEUROSCI, V28, P13866, DOI 10.1523/JNEUROSCI.3120-08.2008; Markowitz H, 1952, J FINANC, V7, P77, DOI 10.1111/j.1540-6261.1952.tb01525.x; MENZA MA, 1993, NEUROLOGY, V43, P505, DOI 10.1212/WNL.43.3_Part_1.505; Milstein DM, 2007, J NEUROSCI, V27, P4810, DOI 10.1523/JNEUROSCI.0577-07.2007; O'Neill M, 2010, NEURON, V68, P789, DOI 10.1016/j.neuron.2010.09.031; Pagonabarraga J, 2007, MOVEMENT DISORD, V22, P1430, DOI 10.1002/mds.21457; Payzan-LeNestour E, 2011, PLOS COMPUT BIOL, V7, DOI 10.1371/journal.pcbi.1001048; Platt M, 2008, NAT NEUROSCI; Ragonese P, 2003, NEUROEPIDEMIOLOGY, V22, P297, DOI 10.1159/000071193; Roesch MR, 2004, SCIENCE, V304, P307, DOI 10.1126/science.1093223; Rolls ET, 2008, CEREB CORTEX, V18, P652, DOI 10.1093/cercor/bhm097; Ross M, 2011, NEUROSCIENCE, V196, P168, DOI 10.1016/j.neuroscience.2011.08.006; Savage L.J., 1954, FDN STAT; Schonberg T, 2011, TRENDS COGN SCI, V15, P11, DOI 10.1016/j.tics.2010.10.002; Schultz W, 2002, NEURON, V36, P241, DOI 10.1016/S0896-6273(02)00967-4; Schultz W, 2008, PHILOS T R SOC B, V363, P3801, DOI 10.1098/rstb.2008.0152; Shurman B, 2005, SCHIZOPHR RES, V72, P215, DOI 10.1016/j.schres.2004.03.020; SIMPSON TL, 1995, OPTOMETRY VISION SCI, V72, P371, DOI 10.1097/00006324-199506000-00004; Stanton SJ, 2011, PSYCHOL SCI, V22, P447, DOI 10.1177/0956797611401752; Stott HP, 2006, J RISK UNCERTAINTY, V32, P101, DOI 10.1007/s11166-006-8289-6; Stritzke M, 2009, J OPT SOC AM A, V26, P1; Symmonds M, 2010, J NEUROSCI, V30, P14380, DOI 10.1523/JNEUROSCI.1459-10.2010; Tobler PN, 2008, J NEUROSCI, V28, P11703, DOI 10.1523/JNEUROSCI.2870-08.2008; Tobler PN, 2007, J NEUROPHYSIOL, V97, P1621, DOI 10.1152/jn.00745.2006; Tobler PN, 2009, P NATL ACAD SCI USA, V106, P7185, DOI 10.1073/pnas.0809599106; Tomer R, 2004, J NEUROL NEUROSUR PS, V75, P972, DOI 10.1136/jnnp.2003.024885; Toplak ME, 2010, CLIN PSYCHOL REV, V30, P562, DOI 10.1016/j.cpr.2010.04.002; van Eimeren T, 2009, NEUROPSYCHOPHARMACOL, V34, P2758, DOI [10.1038/sj.npp.npp2009124, 10.1038/npp.2009.124]; Voon V, 2011, BRAIN, V134, P1438, DOI 10.1093/brain/awr080; Weber E, 2008, DECISIONS UNCERTAINT; Yechiam E, 2005, PSYCHOL SCI, V16, P973, DOI 10.1111/j.1467-9280.2005.01646.x	55	9	9	0	28	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 6	2012	7	4							e33460	10.1371/journal.pone.0033460	http://dx.doi.org/10.1371/journal.pone.0033460			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	955JA	22493669	Green Submitted, Green Published, gold			2022-12-25	WOS:000305012700011
J	Bate, N; Gingras, AR; Bachir, A; Horwitz, R; Ye, F; Patel, B; Goult, BT; Critchley, DR				Bate, Neil; Gingras, Alexandre R.; Bachir, Alexia; Horwitz, Rick; Ye, Feng; Patel, Bipin; Goult, Benjamin T.; Critchley, David R.			Talin Contains A C-Terminal Calpain2 Cleavage Site Important In Focal Adhesion Dynamics	PLOS ONE			English	Article							CELL-MIGRATION; MEDIATED PROTEOLYSIS; INTEGRIN ACTIVATION; BINDING-SITES; VINCULIN; DOMAIN; HEAD; REVEALS; IDENTIFICATION; CYTOSKELETON	Talin is a large (similar to 2540 residues) dimeric adaptor protein that associates with the integrin family of cell adhesion molecules in cell-extracellular matrix junctions (focal adhesions; FAs), where it both activates integrins and couples them to the actin cytoskeleton. Calpain2-mediated cleavage of talin between the head and rod domains has previously been shown to be important in FA turnover. Here we identify an additional calpain2-cleavage site that removes the dimerisation domain from the C-terminus of the talin rod, and show that an E2492G mutation inhibits calpain cleavage at this site in vitro, and increases the steady state levels of talin1 in vivo. Expression of a GFP-tagged talin1 E2492G mutant in CHO.K1 cells inhibited FA turnover and the persistence of cell protrusion just as effectively as a L432G mutation that inhibits calpain cleavage between the talin head and rod domains. Moreover, incorporation of both mutations into a single talin molecule had an additive effect clearly demonstrating that calpain cleavage at both the N- and C-terminal regions of talin contribute to the regulation of FA dynamics. However, the N-terminal site was more sensitive to calpain cleavage suggesting that lower levels of calpain are required to liberate the talin head and rod fragments than are needed to clip off the C-terminal dimerisation domain. The talin head and rod liberated by calpain2 cleavage have recently been shown to play roles in an integrin activation cycle important in FA turnover and in FAK-dependent cell cycle progression respectively. The half-life of the talin head is tightly regulated by ubiquitination and we suggest that removal of the C-terminal dimerisation domain from the talin rod may provide a mechanism both for terminating the signalling function of the talin rod and indeed for inactivating full-length talin thereby promoting FA turnover at the rear of the cell.	[Bate, Neil; Gingras, Alexandre R.; Patel, Bipin; Goult, Benjamin T.; Critchley, David R.] Univ Leicester, Dept Biochem, Leicester LE1 7RH, Leics, England; [Bachir, Alexia; Horwitz, Rick] Univ Virginia, Sch Med, Dept Cell Biol, Charlottesville, VA 22908 USA; [Ye, Feng] Univ Calif San Diego, Dept Med, La Jolla, CA 92093 USA	University of Leicester; University of Virginia; University of California System; University of California San Diego	Bate, N (corresponding author), Univ Leicester, Dept Biochem, Leicester LE1 7RH, Leics, England.	drc@le.ac.uk	Goult, Benjamin T/B-3127-2009; Gingras, Alexandre R/E-1867-2011	Goult, Benjamin T/0000-0002-3438-2807; Gingras, Alexandre R/0000-0002-5373-0176	Wellcome Trust; Cancer Research United Kingdom; Cell Migration Consortium (National Institutes of Health (NIH)) [U54 GM64346]; NIH [GM23244]; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [U54GM064346, R37GM023244, R01GM023244] Funding Source: NIH RePORTER	Wellcome Trust(Wellcome TrustEuropean Commission); Cancer Research United Kingdom(Cancer Research UK); Cell Migration Consortium (National Institutes of Health (NIH))(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	Funding to DRC for staff and consumables was provided by the Wellcome Trust, Cancer Research United Kingdom and a grant from the Cell Migration Consortium (National Institutes of Health (NIH) Grant U54 GM64346), which also funded the work in RH's lab along with NIH grant GM23244. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Anthis NJ, 2009, EMBO J, V28, P3623, DOI 10.1038/emboj.2009.287; Anthis NJ, 2011, TRENDS BIOCH SCI; Barsukov IL, 2003, J BIOL CHEM, V278, P31202, DOI 10.1074/jbc.M303850200; Bolton SJ, 1997, CELL MOTIL CYTOSKEL, V36, P363; Calderwood DA, 1999, J BIOL CHEM, V274, P28071, DOI 10.1074/jbc.274.40.28071; Carragher NO, 2006, ONCOGENE, V25, P5726, DOI 10.1038/sj.onc.1209582; Chan KT, 2010, J BIOL CHEM, V285, P11418, DOI 10.1074/jbc.M109.090746; Cortesio CL, 2011, J BIOL CHEM, V286, P9998, DOI 10.1074/jbc.M110.187294; Critchley DR, 2008, J CELL SCI, V121, P1345, DOI 10.1242/jcs.018085; Critchley DR, 2009, ANNU REV BIOPHYS, V38, P235, DOI 10.1146/annurev.biophys.050708.133744; Debrand E, 2009, FEBS J, V276, P1610, DOI 10.1111/j.1742-4658.2009.06893.x; Di Paolo G, 2002, NATURE, V420, P85, DOI 10.1038/nature01147; Dourdin N, 2001, J BIOL CHEM, V276, P48382, DOI 10.1074/jbc.M108893200; Elliott PR, 2010, STRUCTURE, V18, P1289, DOI 10.1016/j.str.2010.07.011; Webb Benjamin, 2016, Curr Protoc Bioinformatics, V54, DOI [10.1002/0471140864.ps0209s50, 10.1002/cpps.20, 10.1002/0471250953.bi0506s15, 10.1002/cpbi.3]; Fabrice R, 2006, INT J BIOCHEM CELL B, V38, P404, DOI 10.1016/j.biocel.2005.09.020; Flevaris P, 2007, J CELL BIOL, V179, P553, DOI 10.1083/jcb.200703185; Franco SJ, 2004, NAT CELL BIOL, V6, P977, DOI 10.1038/ncb1175; Gingras AR, 2008, EMBO J, V27, P458, DOI 10.1038/sj.emboj.7601965; Gingras AR, 2010, J BIOL CHEM, V285, P29577, DOI 10.1074/jbc.M109.095455; Gingras AR, 2009, J BIOL CHEM, V284, P8857, DOI 10.1074/jbc.M805937200; Gingras AR, 2005, J BIOL CHEM, V280, P37217, DOI 10.1074/jbc.M508060200; Glading A, 2002, TRENDS CELL BIOL, V12, P46, DOI 10.1016/S0962-8924(01)02179-1; Goult BT, 2010, EMBO J, V29, P1069, DOI 10.1038/emboj.2010.4; Harburger DS, 2009, J CELL SCI, V122, P159, DOI 10.1242/jcs.018093; Hayashi M, 1999, ARCH BIOCHEM BIOPHYS, V371, P133, DOI 10.1006/abbi.1999.1427; Hemmings L, 1996, J CELL SCI, V109, P2715; Huang C, 2009, NAT CELL BIOL, V11, P624, DOI 10.1038/ncb1868; Humphries JD, 2007, J CELL BIOL, V179, P1043, DOI 10.1083/jcb.200703036; Jiang GY, 2003, NATURE, V424, P334, DOI 10.1038/nature01805; Kopp PM, 2010, EUR J CELL BIOL, V89, P661, DOI 10.1016/j.ejcb.2010.05.003; Lebart MC, 2006, FEBS J, V273, P3415, DOI 10.1111/j.1742-4658.2006.05350.x; Lee HS, 2004, J MOL BIOL, V343, P771, DOI 10.1016/j.jmb.2004.08.069; Legate KR, 2006, NAT REV MOL CELL BIO, V7, P20, DOI 10.1038/nrm1789; Legate KR, 2009, J CELL SCI, V122, P187, DOI 10.1242/jcs.041624; Leloup L, 2010, J BIOL CHEM, V285, P33549, DOI 10.1074/jbc.M110.123604; Moes M, 2007, J BIOL CHEM, V282, P17280, DOI 10.1074/jbc.M611846200; NIGGLI V, 1994, EUR J BIOCHEM, V224, P951, DOI 10.1111/j.1432-1033.1994.00951.x; Papagrigoriou E, 2004, EMBO J, V23, P2942, DOI 10.1038/sj.emboj.7600285; Parsons JT, 2010, NAT REV MOL CELL BIO, V11, P633, DOI 10.1038/nrm2957; Priddle H, 1998, J CELL BIOL, V142, P1121, DOI 10.1083/jcb.142.4.1121; REES DJG, 1990, NATURE, V347, P685, DOI 10.1038/347685a0; Ridley AJ, 2003, SCIENCE, V302, P1704, DOI 10.1126/science.1092053; SALI A, 1993, J MOL BIOL, V234, P779, DOI 10.1006/jmbi.1993.1626; Saunders RM, 2006, EUR J CELL BIOL, V85, P487, DOI 10.1016/j.ejcb.2006.01.014; Senetar MA, 2007, CELL MOTIL CYTOSKEL, V64, P157, DOI 10.1002/cm.20173; Shattil SJ, 2010, NAT REV MOL CELL BIO, V11, P288, DOI 10.1038/nrm2871; Stabach PR, 1997, BIOCHEMISTRY-US, V36, P57, DOI 10.1021/bi962034i; Svensson L, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0015090; Swaney KF, 2010, ANNU REV BIOPHYS, V39, P265, DOI 10.1146/annurev.biophys.093008.131228; Vicente-Manzanares M, 2009, J CELL SCI, V122, P199, DOI 10.1242/jcs.018564; Vranken WF, 2005, PROTEINS, V59, P687, DOI 10.1002/prot.20449; Wang PB, 2011, J CELL BIOL, V195, P499, DOI 10.1083/jcb.201104128; Webb DJ, 2004, NAT CELL BIOL, V6, P154, DOI 10.1038/ncb1094; Xu WM, 1998, DEVELOPMENT, V125, P327; Zaidel-Bar R, 2007, NAT CELL BIOL, V9, P858, DOI 10.1038/ncb0807-858; Zhang X, 2008, NAT CELL BIOL, V10, P1062, DOI 10.1038/ncb1765; Ziegler WH, 2006, TRENDS CELL BIOL, V16, P453, DOI 10.1016/j.tcb.2006.07.004	58	47	49	4	17	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 4	2012	7	4							e34461	10.1371/journal.pone.0034461	http://dx.doi.org/10.1371/journal.pone.0034461			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	953GO	22496808	Green Published, Green Accepted, Green Submitted, gold			2022-12-25	WOS:000304855200052
J	Bode, AS; Huberts, W; Bosboom, EMH; Kroon, W; van der Linden, WPM; Planken, RN; van de Vosse, FN; Tordoir, JHM				Bode, Aron S.; Huberts, Wouter; Bosboom, E. Marielle H.; Kroon, Wilco; van der Linden, Wim P. M.; Planken, R. Nils; van de Vosse, Frans N.; Tordoir, Jan H. M.			Patient-Specific Computational Modeling of Upper Extremity Arteriovenous Fistula Creation: Its Feasibility to Support Clinical Decision-Making	PLOS ONE			English	Article							HEMODIALYSIS VASCULAR ACCESS; ABDOMINAL AORTIC-ANEURYSM; CEPHALIC VEIN; RADIAL ARTERY; BLOOD-FLOW; HEMODYNAMICS; FAILURE; SIMULATION; ISCHEMIA; DISEASE	Introduction: Inadequate flow enhancement on the one hand, and excessive flow enhancement on the other hand, remain frequent complications of arteriovenous fistula (AVF) creation, and hamper hemodialysis therapy in patients with end-stage renal disease. In an effort to reduce these, a patient-specific computational model, capable of predicting postoperative flow, has been developed. The purpose of this study was to determine the accuracy of the patient-specific model and to investigate its feasibility to support decision-making in AVF surgery. Methods: Patient-specific pulse wave propagation models were created for 25 patients awaiting AVF creation. Model input parameters were obtained from clinical measurements and literature. For every patient, a radiocephalic AVF, a brachiocephalic AVF, and a brachiobasilic AVF configuration were simulated and analyzed for their postoperative flow. The most distal configuration with a predicted flow between 400 and 1500 ml/min was considered the preferred location for AVF surgery. The suggestion of the model was compared to the choice of an experienced vascular surgeon. Furthermore, predicted flows were compared to measured postoperative flows. Results: Taken into account the confidence interval (25th and 75th percentile interval), overlap between predicted and measured postoperative flows was observed in 70% of the patients. Differentiation between upper and lower arm configuration was similar in 76% of the patients, whereas discrimination between two upper arm AVF configurations was more difficult. In 3 patients the surgeon created an upper arm AVF, while model based predictions allowed for lower arm AVF creation, thereby preserving proximal vessels. In one patient early thrombosis in a radiocephalic AVF was observed which might have been indicated by the low predicted postoperative flow. Conclusions: Postoperative flow can be predicted relatively accurately for multiple AVF configurations by using computational modeling. This model may therefore be considered a valuable additional tool in the preoperative work-up of patients awaiting AVF creation.	[Bode, Aron S.; Tordoir, Jan H. M.] Maastricht Univ, Med Ctr, Dept Surg, Maastricht, Netherlands; [Huberts, Wouter; Bosboom, E. Marielle H.; Kroon, Wilco; van de Vosse, Frans N.] Eindhoven Univ Technol, Dept Biomed Engn, NL-5600 MB Eindhoven, Netherlands; [Huberts, Wouter; Bosboom, E. Marielle H.; Kroon, Wilco; van de Vosse, Frans N.] Maastricht Univ, Med Ctr, Dept Biomed Engn, Maastricht, Netherlands; [van der Linden, Wim P. M.] Philips Res Eindhoven, Healthcare Informat Management Grp, Eindhoven, Netherlands; [Planken, R. Nils] Univ Amsterdam, Acad Med Ctr, Dept Radiol, NL-1105 AZ Amsterdam, Netherlands	Maastricht University; Eindhoven University of Technology; Maastricht University; Philips; Philips Research; University of Amsterdam; Academic Medical Center Amsterdam	Bode, AS (corresponding author), Maastricht Univ, Med Ctr, Dept Surg, Maastricht, Netherlands.	aronbode@gmail.com	Tordoir, Jan/AAE-4083-2020; Planken, RN/GMX-0438-2022; van de Vosse, Frans N/I-4006-2013	van de Vosse, Frans N/0000-0002-4084-2064; Planken, R. Nils/0000-0003-3940-4670; Huberts, Wouter/0000-0002-0779-4785	European Commission [ICT-224390]; Profileringsfonds of the Maastricht University Medical Center	European Commission(European CommissionEuropean Commission Joint Research Centre); Profileringsfonds of the Maastricht University Medical Center	The current study, funded by the European Commission, was performed as part of the 'patient-specific image-based computational modeling for improvement of short-and long-term outcome of vascular access in patients on hemodialysis therapy' (ARCH) project, which is a 7th Framework European collaborative project with the aim to develop predictive tools and methodologies to aid clinical decision-making and to improve the success after AVF creation (ARCH Project, ICT-224390). Furthermore, the authors greatly acknowledge additional funding by the Profileringsfonds of the Maastricht University Medical Center. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Allon M, 2002, KIDNEY INT, V62, P1109, DOI 10.1111/j.1523-1755.2002.kid551.x; [Anonymous], AM J KIDNEY DIS, V48, pS176; Bessems D, 2008, J BIOMECH, V41, P284, DOI 10.1016/j.jbiomech.2007.09.014; Bode A, 2012, MODELING CONTROL DIA; Bode A, J VASC ACCE IN PRESS; Bode AS, 2011, EUR J VASC IN PRESS; Breeuwer M, 2008, MED BIOL ENG COMPUT, V46, P1085, DOI 10.1007/s11517-008-0393-0; Cebral JR, 2005, AM J NEURORADIOL, V26, P2550; David T, 2008, MED ENG PHYS, V30, P1227, DOI 10.1016/j.medengphy.2008.09.008; Gijsen FJH, 2007, J BIOMECH, V40, P2349, DOI 10.1016/j.jbiomech.2006.12.007; Huberts W., 2011, MED ENG PHY IN PRESS; Huberts W, 2011, J BIOMECH UNPUB; Huberts W, 2011, SENSITIVITY ST UNPUB; Hunter PJ, 2003, ANNU REV BIOMED ENG, V5, P147, DOI 10.1146/annurev.bioeng.5.040202.121537; Kaiser DR, 2001, HYPERTENSION, V38, P1440, DOI 10.1161/hy1201.096539; Krueger, 2000, Int J Angiol, V9, P226, DOI 10.1007/s005470000039; Krueger U, 2002, ARTIF ORGANS, V26, P571, DOI 10.1046/j.1525-1594.2002.07078.x; Ku YM, 2006, NEPHROL DIAL TRANSPL, V21, P715, DOI 10.1093/ndt/gfi214; Lee T, CLIN J AM SOC NEPHRO; Malovrh M, 2002, AM J KIDNEY DIS, V39, P1218, DOI 10.1053/ajkd.2002.33394; Marchandise E, 2009, MED ENG PHYS, V31, P131, DOI 10.1016/j.medengphy.2008.04.015; McArdle WD, 1996, EXERCISE PHYSL ENERG; Mihmanli I, 2001, J ULTRAS MED, V20, P217; Mourad JJ, 1997, HYPERTENSION, V30, P1425, DOI 10.1161/01.HYP.30.6.1425; Pisoni RL, 2009, AM J KIDNEY DIS, V53, P475, DOI 10.1053/j.ajkd.2008.10.043; Planken RN, 2008, J VASC ACCESS, V9, P269, DOI 10.1177/112972980800900408; Planken RN, 2006, J VASC SURG, V44, P353, DOI 10.1016/j.jvs.2006.04.038; Reymond P, AM J PHYSL HEART CIR, V301, pH1173; Roy-Chaudhury P, 2007, J NEPHROL, V20, P150; Shemesh D, 2007, ULTRASOUND MED BIOL, V33, P727, DOI 10.1016/j.ultrasmedbio.2006.11.019; Sidawy AN, 2002, J VASC SURG, V35, P603, DOI 10.1067/mva.2002.122025; Silva MB, 1998, J VASC SURG, V27, P302, DOI 10.1016/S0741-5214(98)70360-X; Steele BN, 2003, IEEE T INF TECHNOL B, V7, P123, DOI 10.1109/TITB.2003.811880; STERGIOPULOS N, 1992, J BIOMECH, V25, P1477, DOI 10.1016/0021-9290(92)90060-E; Strandness DES, 1975, HEMODYNAMICS SURGEON; Tordoir J, 2007, NEPHROL DIAL TRANSPL, V22, P88, DOI 10.1093/ndt/gfm021; Tordoir JHM, 2003, NEPHROL DIAL TRANSPL, V18, P378, DOI 10.1093/ndt/18.2.378; Tordoir JHM, 2004, EUR J VASC ENDOVASC, V27, P1, DOI 10.1016/j.ejvs.2003.10.007; Vorp DA, 2007, J BIOMECH, V40, P1887, DOI 10.1016/j.jbiomech.2006.09.003; WESTERHOF N, 1969, J BIOMECH, V2, P121, DOI 10.1016/0021-9290(69)90024-4; Wijnen E, 2005, ARTIF ORGANS, V29, P960, DOI 10.1111/j.1525-1594.2005.00165.x; Zanow J, 2006, J VASC SURG, V44, P1273, DOI 10.1016/j.jvs.2006.08.010; Zanow J, 2008, J VASC SURG, V48, P1559, DOI 10.1016/j.jvs.2008.06.040	43	22	23	1	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 4	2012	7	4							e34491	10.1371/journal.pone.0034491	http://dx.doi.org/10.1371/journal.pone.0034491			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	953GO	22496816	Green Submitted, Green Published, gold			2022-12-25	WOS:000304855200057
J	Chartoumpekis, DV; Zaravinos, A; Ziros, PG; Iskrenova, RP; Psyrogiannis, AI; Kyriazopoulou, VE; Habeos, IG				Chartoumpekis, Dionysios V.; Zaravinos, Apostolos; Ziros, Panos G.; Iskrenova, Ralitsa P.; Psyrogiannis, Agathoklis I.; Kyriazopoulou, Venetsana E.; Habeos, Ioannis G.			Differential Expression of MicroRNAs in Adipose Tissue after Long-Term High-Fat Diet-Induced Obesity in Mice	PLOS ONE			English	Article							ADIPOCYTE DIFFERENTIATION; GENE-EXPRESSION; ABDOMINAL OBESITY; BETA(3)-ADRENOCEPTOR AGONIST; LIPID-METABOLISM; ADIPOGENESIS; IDENTIFICATION; ANTIOBESITY; INDUCTION; PROTEINS	Obesity is a major health concern worldwide which is associated with increased risk of chronic diseases such as metabolic syndrome, cardiovascular disease and cancer. The elucidation of the molecular mechanisms involved in adipogenesis and obesogenesis is of essential importance as it could lead to the identification of novel biomarkers and therapeutic targets for the development of anti-obesity drugs. MicroRNAs (miRNAs) have been shown to play regulatory roles in several biological processes. They have become a growing research field and consist of promising pharmaceutical targets in various fields such as cancer, metabolism, etc. The present study investigated the possible implication of miRNAs in adipose tissue during the development of obesity using as a model the C57BLJ6 mice fed a high-fat diet. C57BLJ6 wild type male mice were fed either a standard (SD) or a high-fat diet (HFD) for 5 months. Total RNA was prepared from white adipose tissue and was used for microRNA profiling and qPCR. Twenty-two of the most differentially expressed miRNAs, as identified by the microRNA profiling were validated using qPCR. The results of the present study confirmed previous results. The up-regulation of mmu-miR-222 and the down-regulation of mmu-miR-200b, mmu-miR-200c, mmu-miR-204, mmu-miR-30a*, mmu-miR-193, mmu-miR-378 and mmu-miR-30e* after HFD feeding has also been previously reported. On the other hand, we show for the first time the up-regulation of mmu-miR-342-3p, mmu-miR-142-3p, mmu-miR-142-5p, mmu-miR-21, mmu-miR-146a, mmu-miR-146b, mmu-miR-379 and the down-regulation of mmu-miR-122, mmu-miR-133b, mmu-miR-1, mmu-miR-30a*, mmu-miR-192 and mmu-miR-203 during the development of obesity. However, future studies are warranted in order to understand the exact role that miRNAs play in adipogenesis and obesity.	[Chartoumpekis, Dionysios V.; Ziros, Panos G.; Iskrenova, Ralitsa P.; Psyrogiannis, Agathoklis I.; Kyriazopoulou, Venetsana E.; Habeos, Ioannis G.] Univ Patras, Sch Med, Dept Internal Med, Div Endocrinol, GR-26110 Patras, Greece; [Zaravinos, Apostolos] Univ Crete, Sch Med, Lab Clin Virol, Iraklion, Greece	University of Patras; University of Crete	Chartoumpekis, DV (corresponding author), Univ Patras, Sch Med, Dept Internal Med, Div Endocrinol, GR-26110 Patras, Greece.	ihabeos@med.upatras.gr	Zaravinos, Apostolos/B-2528-2019; Chartoumpekis, Dionysios/L-8071-2017	Zaravinos, Apostolos/0000-0003-4625-5562; Chartoumpekis, Dionysios/0000-0002-6139-6067				Alexander R, 2011, EXPERT OPIN THER TAR, V15, P623, DOI 10.1517/14728222.2011.561317; Aronne LJ, 2007, AM J MED, V120, pS29, DOI 10.1016/j.amjmed.2006.11.015; Bengestrate L, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0021305; Bergman RN, 2007, AM J MED, V120, pS3, DOI 10.1016/j.amjmed.2006.11.012; Calle EE, 2004, NAT REV CANCER, V4, P579, DOI 10.1038/nrc1408; Chang Jinhong, 2004, RNA Biol, V1, P106, DOI 10.4161/rna.1.2.1066; Chartoumpekis DV, 2011, DIABETES, V60, P2465, DOI 10.2337/db11-0112; Chen Y, 2008, BLOOD, V111, P1217, DOI 10.1182/blood-2007-07-104133; Clarke IJ, 2010, CLIN EXP PHARMACOL P, V37, P121, DOI 10.1111/j.1440-1681.2009.05259.x; COUSIN B, 1992, J CELL SCI, V103, P931; Couzin J, 2008, SCIENCE, V319, P1782, DOI 10.1126/science.319.5871.1782; Day JW, 2009, NAT CHEM BIOL, V5, P749, DOI 10.1038/nchembio.209; Despres JP, 2006, NATURE, V444, P881, DOI 10.1038/nature05488; DESPRES JP, 1993, NUTRITION, V9, P452; Dweep H, 2011, J BIOMED INFORM, V44, P839, DOI 10.1016/j.jbi.2011.05.002; Enomoto H, 2004, J CELL SCI, V117, P417, DOI 10.1242/jcs.00866; Esau C, 2006, CELL METAB, V3, P87, DOI 10.1016/j.cmet.2006.01.005; Feldmann HM, 2009, CELL METAB, V9, P203, DOI 10.1016/j.cmet.2008.12.014; Gerin I, 2010, AM J PHYSIOL-ENDOC M, V299, pE198, DOI 10.1152/ajpendo.00179.2010; GIMBLE JM, 1995, J CELL BIOCHEM, V58, P393, DOI 10.1002/jcb.240580312; Gregory PA, 2008, NAT CELL BIOL, V10, P593, DOI 10.1038/ncb1722; He L, 2004, NAT REV GENET, V5, P522, DOI 10.1038/nrg1379; Heneghan HM, 2010, OBES REV, V11, P354, DOI 10.1111/j.1467-789X.2009.00659.x; Huang J, 2010, STEM CELLS, V28, P357, DOI 10.1002/stem.288; Huang ZH, 2009, AM J PHYSIOL-ENDOC M, V296, pE1110, DOI 10.1152/ajpendo.90964.2008; James P T, 2001, Obes Res, V9 Suppl 4, p228S, DOI 10.1038/oby.2001.123; Keller P, 2011, BMC ENDOCR DISORD, V11, DOI 10.1186/1472-6823-11-7; Kennell JA, 2008, P NATL ACAD SCI USA, V105, P15417, DOI 10.1073/pnas.0807763105; Kershaw EE, 2004, J CLIN ENDOCR METAB, V89, P2548, DOI 10.1210/jc.2004-0395; Kim YJ, 2009, STEM CELLS, V27, P3093, DOI 10.1002/stem.235; Kolfschoten IGM, 2009, DIABETES OBES METAB, V11, P118, DOI 10.1111/j.1463-1326.2009.01118.x; Lagos-Quintana M, 2002, CURR BIOL, V12, P735, DOI 10.1016/S0960-9822(02)00809-6; Lagos-Quintana M, 2001, SCIENCE, V294, P853, DOI 10.1126/science.1064921; Livak KJ, 2001, METHODS, V25, P402, DOI 10.1006/meth.2001.1262; McGregor RA, 2011, CURR MOL MED, V11, P304; Nishimura S, 2007, DIABETES, V56, P1517, DOI 10.2337/db06-1749; Ortega FJ, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0009022; Osada H, 2007, CARCINOGENESIS, V28, P2, DOI 10.1093/carcin/bgl185; Radojicic J, 2011, CELL CYCLE, V10, P507, DOI 10.4161/cc.10.3.14754; Saykally JN, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0008460; Sturn A, 2002, BIOINFORMATICS, V18, P207, DOI 10.1093/bioinformatics/18.1.207; Taganov KD, 2006, P NATL ACAD SCI USA, V103, P12481, DOI 10.1073/pnas.0605298103; Tanaka T, 1997, EMBO J, V16, P7432, DOI 10.1093/emboj/16.24.7432; Umekawa T, 1997, EUR J ENDOCRINOL, V136, P429, DOI 10.1530/eje.0.1360429; Vandesompele J, 2002, GENOME BIOL, V3, DOI 10.1186/gb-2002-3-7-research0034; Wajchenberg BL, 2000, ENDOCR REV, V21, P697, DOI 10.1210/er.21.6.697; Walden TB, 2009, J CELL PHYSIOL, V218, P444, DOI 10.1002/jcp.21621; Xie HM, 2009, DIABETES, V58, P1050, DOI 10.2337/db08-1299; Xu HY, 1999, J BIOL CHEM, V274, P26287, DOI 10.1074/jbc.274.37.26287; Yang BF, 2007, NAT MED, V13, P486, DOI 10.1038/nm1569; YOSHIDA T, 1994, LIFE SCI, V54, P491, DOI 10.1016/0024-3205(94)00408-0; Yun SJ, 2008, BIOCHEM BIOPH RES CO, V371, P138, DOI 10.1016/j.bbrc.2008.04.029; Yun Z, 2002, DEV CELL, V2, P331, DOI 10.1016/S1534-5807(02)00131-4; Zhang B, 2005, NUCLEIC ACIDS RES, V33, pW741, DOI 10.1093/nar/gki475; Zhao EP, 2009, MAMM GENOME, V20, P476, DOI 10.1007/s00335-009-9217-2	55	163	174	0	64	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 4	2012	7	4							e34872	10.1371/journal.pone.0034872	http://dx.doi.org/10.1371/journal.pone.0034872			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	953GO	22496873	Green Submitted, Green Published, gold			2022-12-25	WOS:000304855200087
J	Mdzinarishvili, T; Sherman, S				Mdzinarishvili, Tengiz; Sherman, Simon			A Heuristic Solution of the Identifiability Problem of the Age-Period-Cohort Analysis of Cancer Occurrence: Lung Cancer Example	PLOS ONE			English	Article							TEMPORAL VARIATION; MORTALITY-RATES; OLD-AGE; MODELS; TIME	Background: The Age-Period-Cohort (APC) analysis is aimed at estimating the following effects on disease incidence: (i) the age of the subject at the time of disease diagnosis; (ii) the time period, when the disease occurred; and (iii) the date of birth of the subject. These effects can help in evaluating the biological events leading to the disease, in estimating the influence of distinct risk factors on disease occurrence, and in the development of new strategies for disease prevention and treatment. Methodology/Principal Findings: We developed a novel approach for estimating the APC effects on disease incidence rates in the frame of the Log-Linear Age-Period-Cohort (LLAPC) model. Since the APC effects are linearly interdependent and cannot be uniquely estimated, solving this identifiability problem requires setting four redundant parameters within a set of unknown parameters. By setting three parameters (one of the time-period and the birth-cohort effects and the corresponding age effect) to zero, we reduced this problem to the problem of determining one redundant parameter and, used as such, the effect of the time-period adjacent to the anchored time period. By varying this identification parameter, a family of estimates of the APC effects can be obtained. Using a heuristic assumption that the differences between the adjacent birth-cohort effects are small, we developed a numerical method for determining the optimal value of the identification parameter, by which a unique set of all APC effects is determined and the identifiability problem is solved. Conclusions/Significance: We tested this approach while estimating the APC effects on lung cancer occurrence in white men and women using the SEER data, collected during 1975-2004. We showed that the LLAPC models with the corresponding unique sets of the APC effects estimated by the proposed approach fit very well with the observational data.	[Mdzinarishvili, Tengiz; Sherman, Simon] Univ Nebraska Med Ctr, Eppley Inst, Omaha, NE USA	University of Nebraska System; University of Nebraska Medical Center	Mdzinarishvili, T (corresponding author), Univ Nebraska Med Ctr, Eppley Inst, Omaha, NE USA.	ssherm@unmc.edu			NCI NIH HHS [R01 CA140940] Funding Source: Medline; NATIONAL CANCER INSTITUTE [R01CA140940] Funding Source: NIH RePORTER	NCI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))		[Anonymous], 1973, LTD US DAT 1973 2004; BARRETT JC, 1973, J HYG-CAMBRIDGE, V71, P253, DOI 10.1017/S0022172400022725; BARRETT JC, 1978, J EPIDEMIOL COMMUN H, V32, P314, DOI 10.1136/jech.32.4.314; Chatterjee S., 2015, REGRESSION ANAL EXAM; Chatterjee S., 1986, STAT SCI, V1, P379, DOI [10.1214/ss/1177013622, DOI 10.1214/SS/1177013622]; CLAYTON D, 1987, STAT MED, V6, P449, DOI 10.1002/sim.4780060405; CLAYTON D, 1987, STAT MED, V6, P469, DOI 10.1002/sim.4780060406; COOK PJ, 1969, INT J CANCER, V4, P93, DOI 10.1002/ijc.2910040113; Devore J., 2007, MODERN MATH STAT APP; Fienberg SE, 1978, SOCIOL METHODOL, V8, P1; Fu WJ, 2008, SOCIOL METHOD RES, V36, P327, DOI 10.1177/0049124107310637; Harding C, 2008, CANCER RES, V68, P4465, DOI 10.1158/0008-5472.CAN-07-1670; Harding C, 2012, CANCER-AM CANCER SOC, V118, P1371, DOI 10.1002/cncr.26376; HOLFORD TR, 1991, ANNU REV PUBL HEALTH, V12, P425, DOI 10.1146/annurev.pu.12.050191.002233; Holford TR, 2005, ENCY BIOSTATISTICS, P17; Jemal A, 2006, CA-CANCER J CLIN, V56, P106, DOI 10.3322/canjclin.56.2.106; Luebeck EG, 2002, P NATL ACAD SCI USA, V99, P15095, DOI 10.1073/pnas.222118199; Mdzinarishvili T, 2010, CANCER INFORM, V9, P179; Mdzinarishvili T, 2009, CANCER INFORM, V7, P271; Mdzinarishvili T, 2010, CANCER INFORM, V9, P67; Mdzinarishvili T, 2009, CANCER INFORM, V7, P183; Meza R, 2008, P NATL ACAD SCI USA, V105, P16284, DOI 10.1073/pnas.0801151105; Moolgavkar SH, 1998, MODERN EPIDEMIOLOGY, P482; Moolgavkar SH, 2009, CANCER CAUSE CONTROL, V20, P935, DOI 10.1007/s10552-009-9328-9; Pompei F, 2001, HUM ECOL RISK ASSESS, V7, P1619, DOI 10.1080/20018091095267; Pompei F, 2004, NAT REV CANCER, V3, P1474; Rosenberg PS, 2011, CANCER EPIDEM BIOMAR, V20, P1263, DOI 10.1158/1055-9965.EPI-11-0421; Selvin S, 2004, STORY WALLAH CELEBRA, P1; Tikhonov A.N., 1977, SOLUTION ILL POSED P, V54, P266, DOI 10.1137/1021044; Yang Y, 2004, SOCIOL METHODOL, V34, P75, DOI 10.1111/j.0081-1750.2004.00148.x	30	5	5	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 4	2012	7	4							e34362	10.1371/journal.pone.0034362	http://dx.doi.org/10.1371/journal.pone.0034362			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	953GO	22496795	Green Submitted, gold, Green Published			2022-12-25	WOS:000304855200042
J	Patel, R; Baker, SS; Liu, WS; Desai, S; Alkhouri, R; Kozielski, R; Mastrandrea, L; Sarfraz, A; Cai, WJ; Vlassara, H; Patel, MS; Baker, RD; Zhu, LX				Patel, Raza; Baker, Susan S.; Liu, Wensheng; Desai, Sonal; Alkhouri, Razan; Kozielski, Rafal; Mastrandrea, Lucy; Sarfraz, Adil; Cai, Weijing; Vlassara, Helen; Patel, Mulchand S.; Baker, Robert D.; Zhu, Lixin			Effect of Dietary Advanced Glycation End Products on Mouse Liver	PLOS ONE			English	Article							NONALCOHOLIC STEATOHEPATITIS; OXIDANT STRESS; UNITED-STATES; INSULIN-RESISTANCE; OXIDATIVE STRESS; LIFE-SPAN; DISEASE; MICE; PREVALENCE; RECEPTOR	The exact pathophysiology of non-alcoholic steatohepatitis (NASH) is not known. Previous studies suggest that dietary advanced glycation end products (AGEs) can cause oxidative stress in liver. We aim to study the effects of dietary AGEs on liver health and their possible role in the pathogenesis of NASH. METHODS: Two groups of mice were fed the same diet except the AGE content varied. One group was fed a high AGE diet and the second group was fed a regular AGE diet. Liver histology, alanine aminotransferase, aspartate aminotransferase, fasting glucose, fasting insulin, insulin resistance and glucose tolerance were assessed. RESULTS: Histology revealed that neutrophil infiltration occurred in the livers of the high AGE group at week 26; steatosis did not accompany liver inflammation. At week 39 livers from both groups exhibited macro-or micro-steatosis, yet no inflammation was detected. Higher insulin levels were detected in the regular AGE group at week 26 (P = 0.034), compared to the high AGE group. At week 39, the regular AGE group showed higher levels of alanine aminotransferase (P<0.01) and aspartate aminotransferase (P = 0.02) than those of the high AGE group. CONCLUSIONS: We demonstrate that a high AGE diet can cause liver inflammation in the absence of steatosis. Our results show that dietary AGEs could play a role in initiating liver inflammation contributing to the disease progression of NASH. Our observation that the inflammation caused by high AGE alone did not persist suggests interesting future directions to investigate how AGEs contribute to pro-oxidative and anti-oxidative pathways in the liver.	[Patel, Raza; Baker, Susan S.; Liu, Wensheng; Desai, Sonal; Alkhouri, Razan; Sarfraz, Adil; Baker, Robert D.; Zhu, Lixin] SUNY Buffalo, Digest Dis & Nutr Ctr, Dept Pediat, Women & Childrens Hosp Buffalo, Buffalo, NY 14260 USA; [Kozielski, Rafal] SUNY Buffalo, Women & Childrens Hosp Buffalo, Dept Pathol, Buffalo, NY 14260 USA; [Cai, Weijing; Vlassara, Helen] Mt Sinai Sch Med, Div Nephrol, New York, NY USA; [Patel, Mulchand S.] SUNY Buffalo, Dept Biochem, Buffalo, NY 14214 USA	State University of New York (SUNY) System; State University of New York (SUNY) Buffalo; Women & Children's Hospital of Buffalo; State University of New York (SUNY) System; State University of New York (SUNY) Buffalo; Women & Children's Hospital of Buffalo; Icahn School of Medicine at Mount Sinai; State University of New York (SUNY) System; State University of New York (SUNY) Buffalo	Patel, R (corresponding author), SUNY Buffalo, Digest Dis & Nutr Ctr, Dept Pediat, Women & Childrens Hosp Buffalo, Buffalo, NY 14260 USA.	sbaker@upa.chob.edu; lixinzhu@buffalo.edu	liu, wen/HGE-3071-2022	Zhu, Lixin/0000-0001-7904-1769	Peter and Tommy Fund, Inc., Buffalo, NY	Peter and Tommy Fund, Inc., Buffalo, NY	This work was supported by an unrestricted grant from the Peter and Tommy Fund, Inc., Buffalo, NY http://www.thepeterandtommyfund.org (to Dr. Baker) and a departmental start-up fund (to Dr. Zhu). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abe R, 2004, J INVEST DERMATOL, V122, P461, DOI 10.1046/j.0022-202X.2004.22218.x; Anstee QM, 2006, INT J EXP PATHOL, V87, P1, DOI 10.1111/j.0959-9673.2006.00465.x; Baker SS, 2010, PLOS ONE, V5, pA82, DOI 10.1371/journal.pone.0009570; Birlouez-Aragon I, 2010, AM J CLIN NUTR, V91, P1220, DOI 10.3945/ajcn.2009.28737; Browning JD, 2004, HEPATOLOGY, V40, P1387, DOI 10.1002/hep.20466; Brunt EM, 2004, SEMIN LIVER DIS, V24, P3; Bugianesi Elisabetta, 2007, Curr Diab Rep, V7, P175, DOI 10.1007/s11892-007-0029-z; Cai WJ, 2008, AM J PATHOL, V173, P327, DOI 10.2353/ajpath.2008.080152; Cai WJ, 2007, AM J PATHOL, V170, P1893, DOI 10.2353/ajpath.2007.061281; Cerami C, 1997, P NATL ACAD SCI USA, V94, P13915, DOI 10.1073/pnas.94.25.13915; Charlton MR, 2011, GASTROENTEROLOGY, V141, P1249, DOI 10.1053/j.gastro.2011.06.061; Chuyen NV, 2005, ANN NY ACAD SCI, V1043, P467, DOI 10.1196/annals.1333.053; Clark JM, 2003, AM J GASTROENTEROL, V98, P960, DOI [10.1016/S0002-9270(03)00265-X, 10.1111/j.1572-0241.2003.07486.x]; Cope K, 2000, GASTROENTEROLOGY, V119, P1340, DOI 10.1053/gast.2000.19267; Day CP, 1998, GASTROENTEROLOGY, V114, P842, DOI 10.1016/S0016-5085(98)70599-2; GARCIARUIZ C, 1995, MOL PHARMACOL, V48, P825; Hensley K, 2000, CARCINOGENESIS, V21, P983, DOI 10.1093/carcin/21.5.983; Huttunen HJ, 2002, CANCER RES, V62, P4805; Hyogo H, 2008, CURR PHARM DESIGN, V14, P969, DOI 10.2174/138161208784139701; Hyogo H, 2007, J GASTROEN HEPATOL, V22, P1112, DOI 10.1111/j.1440-1746.2007.04943.x; Iwamoto K, 2008, J GASTROENTEROL, V43, P298, DOI 10.1007/s00535-007-2152-7; Kim CH, 2008, CLEV CLIN J MED, V75, P721, DOI 10.3949/ccjm.75.10.721; Kimura T, 1996, NEUROSCI LETT, V208, P53, DOI 10.1016/0304-3940(96)12537-4; Kojima H, 2007, ALCOHOL CLIN EXP RES, V31, p61S, DOI 10.1111/j.1530-0277.2006.00288.x; Lieber CS, 2004, HEPATOL RES, V28, P1, DOI 10.1016/j.hepres.2003.08.001; Lin HZ, 2000, NAT MED, V6, P998, DOI 10.1038/79697; Lindenmeier M, 2002, J AGR FOOD CHEM, V50, P6997, DOI 10.1021/jf020618n; Lindsey JB, 2009, DIABETES CARE, V32, P1218, DOI 10.2337/dc09-0053; Mannaerts GP, 2000, CELL BIOCHEM BIOPHYS, V32, P73, DOI 10.1385/CBB:32:1-3:73; MATTHEWS DR, 1985, DIABETOLOGIA, V28, P412, DOI 10.1007/BF00280883; Perez-Carreras M, 2003, HEPATOLOGY, V38, P999, DOI 10.1053/jhep.2003.50398; Sandu O, 2005, DIABETES, V54, P2314, DOI 10.2337/diabetes.54.8.2314; Seki S, 2002, J HEPATOL, V37, P56, DOI 10.1016/S0168-8278(02)00073-9; Singh R, 2001, DIABETOLOGIA, V44, P129, DOI 10.1007/s001250051591; Tilg H, 2010, HEPATOLOGY, V52, P1836, DOI 10.1002/hep.24001; Vlassara H, 1997, DIABETES, V46, pS19, DOI 10.2337/diab.46.2.S19; Vlassara H, 2002, P NATL ACAD SCI USA, V99, P15596, DOI 10.1073/pnas.242407999; Wang MY, 2009, ACTA NEUROPATHOL, V118, P381, DOI 10.1007/s00401-009-0513-4; Yang SQ, 2000, ARCH BIOCHEM BIOPHYS, V378, P259, DOI 10.1006/abbi.2000.1829; Younossi ZM, 2011, CLIN GASTROENTEROL H, V9, P524, DOI 10.1016/j.cgh.2011.03.020	40	60	60	2	19	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 4	2012	7	4							e35143	10.1371/journal.pone.0035143	http://dx.doi.org/10.1371/journal.pone.0035143			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	953GO	22496902	Green Published, gold			2022-12-25	WOS:000304855200100
J	Resch, AM; Palakodeti, D; Lu, YC; Horowitz, M; Graveley, BR				Resch, Alissa M.; Palakodeti, Dasaradhi; Lu, Yi-Chien; Horowitz, Michael; Graveley, Brenton R.			Transcriptome Analysis Reveals Strain-Specific and Conserved Stemness Genes in Schmidtea mediterranea	PLOS ONE			English	Article							ALTERNATIVE SPLICING EVENTS; CELL FUNCTION; PLANARIAN; PROTEIN; REGENERATION; DIFFERENTIATION; EXPRESSION; DATABASE; GENOME; MODEL	The planarian Schmidtea mediterranea is a powerful model organism for studying stem cell biology due to its extraordinary regenerative ability mediated by neoblasts, a population of adult somatic stem cells. Elucidation of the S. mediterranea transcriptome and the dynamics of transcript expression will increase our understanding of the gene regulatory programs that regulate stem cell function and differentiation. Here, we have used RNA-Seq to characterize the S. mediterranea transcriptome in sexual and asexual animals and in purified neoblast and differentiated cell populations. Our analysis identified many uncharacterized genes, transcripts, and alternatively spliced isoforms that are differentially expressed in a strain or cell type-specific manner. Transcriptome profiling of purified neoblasts and differentiated cells identified neoblast-enriched transcripts, many of which likely play important roles in regeneration and stem cell function. Strikingly, many of the neoblast-enriched genes are orthologs of genes whose expression is enriched in human embryonic stem cells, suggesting that a core set of genes that regulate stem cell function are conserved across metazoan species.	[Resch, Alissa M.; Horowitz, Michael; Graveley, Brenton R.] Univ Connecticut, Ctr Hlth, Dept Genet & Dev Biol, Stem Cell Inst, Farmington, CT USA; [Palakodeti, Dasaradhi] Natl Ctr Biol Sci, Inst Stem Cell Biol & Regenerat Med, Bangalore, Karnataka, India; [Lu, Yi-Chien] Weill Cornell Med Coll, Dept Pathol & Lab Med, New York, NY USA	University of Connecticut; Department of Biotechnology (DBT) India; Institute for Stem Cell Biology & Regenerative Medicine - inStem; Tata Institute of Fundamental Research (TIFR); National Centre for Biological Sciences (NCBS); Cornell University	Resch, AM (corresponding author), Univ Connecticut, Ctr Hlth, Dept Genet & Dev Biol, Stem Cell Inst, Farmington, CT USA.	graveley@neuron.uchc.edu	Graveley, Brenton R/C-3108-2013	Graveley, Brenton/0000-0001-5777-5892	Raymond and Beverly Sackler Fund for the Arts and Sciences; Connecticut Stem Cell Fund	Raymond and Beverly Sackler Fund for the Arts and Sciences; Connecticut Stem Cell Fund	This work was generously supported by the Raymond and Beverly Sackler Fund for the Arts and Sciences and the State of Connecticut Stem Cell Fund (to Dr. Graveley). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abril JF, 2010, BMC GENOMICS, V11, DOI 10.1186/1471-2164-11-731; Adamidi C, 2011, GENOME RES, V21, P1193, DOI 10.1101/gr.113779.110; Altschul SF, 1997, NUCLEIC ACIDS RES, V25, P3389, DOI 10.1093/nar/25.17.3389; Alvarado AS, 2004, PHILOS T R SOC B, V359, P759, DOI 10.1098/rstb.2004.1465; Alvarado AS, 2002, DEVELOPMENT, V129, P5659, DOI 10.1242/dev.00167; Alvarez-Presas M, 2008, MOL PHYLOGENET EVOL, V47, P555, DOI 10.1016/j.ympev.2008.01.032; Antin PB, 2010, DEV DYNAM, V239, P1879, DOI 10.1002/dvdy.22318; Archer TC, 2011, DEV BIOL, V350, P429, DOI 10.1016/j.ydbio.2010.12.013; Ashburner M, 2000, NAT GENET, V25, P25, DOI 10.1038/75556; Berriman M, 2009, NATURE, V460, P352, DOI 10.1038/nature08160; Besset V, 1999, CELL GROWTH DIFFER, V10, P173; Blekhman R, 2010, GENOME RES, V20, P180, DOI 10.1101/gr.099226.109; Blythe MJ, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0015617; C elegans Sequencing Consortium, 1998, SCIENCE, V282, P2012, DOI 10.1126/science.282.5396.2012; Calvanese V, 2010, P NATL ACAD SCI USA, V107, P13736, DOI 10.1073/pnas.1001399107; Cebria F, 2005, DEVELOPMENT, V132, P3691, DOI 10.1242/dev.01941; Chapman JA, 2010, NATURE, V464, P592, DOI 10.1038/nature08830; Collins FS, 2004, NATURE, V431, P931, DOI 10.1038/nature03001; de Hoon MJL, 2004, BIOINFORMATICS, V20, P1453, DOI 10.1093/bioinformatics/bth078; Eads BD, 2007, BMC GENOMICS, V8, DOI 10.1186/1471-2164-8-464; Eisenhoffer GT, 2008, CELL STEM CELL, V3, P327, DOI 10.1016/j.stem.2008.07.002; Fernandez-Taboada E, 2011, BMC GENOMICS, V12, DOI 10.1186/1471-2164-12-133; FRIEDEN C, 1989, TRENDS BIOCHEM SCI, V14, P283, DOI 10.1016/0968-0004(89)90065-0; Friedlander MR, 2008, NAT BIOTECHNOL, V26, P407, DOI 10.1038/nbt1394; Fu WY, 2011, NEUROSCIENCE, V180, P353, DOI 10.1016/j.neuroscience.2011.02.024; Gerstein MB, 2010, SCIENCE, V330, P1775, DOI 10.1126/science.1196914; Graveley BR, 2011, NATURE, V471, P473, DOI 10.1038/nature09715; Guth SIE, 2008, CELL MOL LIFE SCI, V65, P3000, DOI 10.1007/s00018-008-8138-7; Harris JE, 2006, DEV BIOL, V299, P105, DOI 10.1016/j.ydbio.2006.07.013; Hartmann B, 2011, RNA, V17, P453, DOI 10.1261/rna.2460411; Hayashi T, 2006, DEV GROWTH DIFFER, V48, P371, DOI 10.1111/j.1440-169x.2006.00876.x; Ho TH, 2004, EMBO J, V23, P3103, DOI 10.1038/sj.emboj.7600300; Hollenbach JP, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0021808; Holubcova Z, 2011, STEM CELLS, V29, P46, DOI 10.1002/stem.549; Huggins CE, 2008, J MOL CELL CARDIOL, V44, P270, DOI 10.1016/j.yjmcc.2007.11.020; Kalsotra A, 2008, P NATL ACAD SCI USA, V105, P20333, DOI 10.1073/pnas.0809045105; Kawamura K, 1999, MICROSC RES TECHNIQ, V44, P269, DOI 10.1002/(SICI)1097-0029(19990215)44:4<269::AID-JEMT6>3.0.CO;2-K; Koledova Z, 2010, STEM CELLS DEV, V19, P1663, DOI 10.1089/scd.2010.0136; Kondoh E, 2008, DEV GROWTH DIFFER, V50, P665, DOI 10.1111/j.1440-169X.2008.01064.x; LANGE CS, 1968, INT J RADIAT BIOL RE, V14, P119, DOI 10.1080/09553006814550931; Langmead B, 2009, GENOME BIOL, V10, DOI 10.1186/gb-2009-10-3-r25; Laronda MM, 2011, ENDOCRINOLOGY, V152, P1606, DOI 10.1210/en.2010-1249; Lazaro EM, 2011, BMC EVOL BIOL, V11, DOI 10.1186/1471-2148-11-274; Lechler T, 2005, NATURE, V437, P275, DOI 10.1038/nature03922; Lu YC, 2009, RNA, V15, P1483, DOI 10.1261/rna.1702009; Magen A, 2005, NUCLEIC ACIDS RES, V33, P5574, DOI 10.1093/nar/gki858; Marchler-Bauer A, 2002, NUCLEIC ACIDS RES, V30, P281, DOI 10.1093/nar/30.1.281; Marthiens V, 2010, J CELL SCI, V123, P1613, DOI 10.1242/jcs.054312; Meier-Stiegen F, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0011481; Newmark PA, 2002, NAT REV GENET, V3, P210, DOI 10.1038/nrg759; Ng HH, 2011, NAT CELL BIOL, V13, P490, DOI 10.1038/ncb0511-490; Nilsen TW, 2010, NATURE, V463, P457, DOI 10.1038/nature08909; Orkin SH, 2011, CELL, V145, P835, DOI 10.1016/j.cell.2011.05.019; Palakodeti D, 2008, RNA, V14, P1174, DOI 10.1261/rna.1085008; Phillips K, 2000, J MOL BIOL, V302, P1023, DOI 10.1006/jmbi.2000.4107; Reddien PW, 2005, SCIENCE, V310, P1327, DOI 10.1126/science.1116110; Reddien PW, 2005, DEV CELL, V8, P635, DOI 10.1016/j.devcel.2005.02.014; Resch A, 2004, NUCLEIC ACIDS RES, V32, P1261, DOI 10.1093/nar/gkh284; Ritter AR, 2010, DEV DYNAM, V239, P2685, DOI 10.1002/dvdy.22407; Robb SMC, 2008, NUCLEIC ACIDS RES, V36, pD599, DOI 10.1093/nar/Gkm684; Rossi DJ, 2007, NATURE, V447, P725, DOI 10.1038/nature05862; Saiki Y, 2000, GENOMICS, V70, P387, DOI 10.1006/geno.2000.6385; Saldanha AJ, 2004, BIOINFORMATICS, V20, P3246, DOI 10.1093/bioinformatics/bth349; Sestan N, 1999, SCIENCE, V286, P741, DOI 10.1126/science.286.5440.741; Sundaram P, 2006, MOL BIOL CELL, V17, P3678, DOI 10.1091/mbc.E06-03-0192; Takahashi K, 2007, CELL, V131, P861, DOI 10.1016/j.cell.2007.11.019; Takahashi K, 2006, CELL, V126, P663, DOI 10.1016/j.cell.2006.07.024; Trapnell C, 2010, NAT BIOTECHNOL, V28, P511, DOI 10.1038/nbt.1621; Trapnell C, 2009, BIOINFORMATICS, V25, P1105, DOI 10.1093/bioinformatics/btp120; Vicente M, 2007, DIFFERENTIATION, V75, P427, DOI 10.1111/j.1432-0436.2006.00156.x; Wang YY, 2010, GENE DEV, V24, P2081, DOI 10.1101/gad.1951010; WOLFF ETIENNE, 1948, REV SUISSE ZOOL, V55, P218; Wu DY, 2009, NATURE, V462, P1056, DOI 10.1038/nature08656; Yeo GW, 2005, P NATL ACAD SCI USA, V102, P2850, DOI 10.1073/pnas.0409742102; Zayas RM, 2005, P NATL ACAD SCI USA, V102, P18491, DOI 10.1073/pnas.0509507102; Zerbino DR, 2008, GENOME RES, V18, P821, DOI 10.1101/gr.074492.107; Zhou Y, 2009, NATURE, V460, P345, DOI 10.1038/nature08140	77	42	43	0	13	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 4	2012	7	4							e34447	10.1371/journal.pone.0034447	http://dx.doi.org/10.1371/journal.pone.0034447			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	953GO	22496805	Green Submitted, Green Published, gold			2022-12-25	WOS:000304855200051
J	Weber, AL; Khan, GF; Magwire, MM; Tabor, CL; Mackay, TFC; Anholt, RRH				Weber, Allison L.; Khan, George F.; Magwire, Michael M.; Tabor, Crystal L.; Mackay, Trudy F. C.; Anholt, Robert R. H.			Genome-Wide Association Analysis of Oxidative Stress Resistance in Drosophila melanogaster	PLOS ONE			English	Article							GENE DISRUPTION PROJECT; LIFE-SPAN; SUPEROXIDE-DISMUTASE; ATAXIA-TELANGIECTASIA; TYROSINE KINASE; FREE-RADICALS; NITRIC-OXIDE; EXPRESSION; PROTEIN; ANTIOXIDANTS	Background: Aerobic organisms are susceptible to damage by reactive oxygen species. Oxidative stress resistance is a quantitative trait with population variation attributable to the interplay between genetic and environmental factors. Drosophila melanogaster provides an ideal system to study the genetics of variation for resistance to oxidative stress. Methods and Findings: We used 167 wild-derived inbred lines of the Drosophila Genetic Reference Panel for a genome-wide association study of acute oxidative stress resistance to two oxidizing agents, paraquat and menadione sodium bisulfite. We found significant genetic variation for both stressors. Single nucleotide polymorphisms (SNPs) associated with variation in oxidative stress resistance were often sex-specific and agent-dependent, with a small subset common for both sexes or treatments. Associated SNPs had moderately large effects, with an inverse relationship between effect size and allele frequency. Linear models with up to 12 SNPs explained 67-79% and 56-66% of the phenotypic variance for resistance to paraquat and menadione sodium bisulfite, respectively. Many genes implicated were novel with no known role in oxidative stress resistance. Bioinformatics analyses revealed a cellular network comprising DNA metabolism and neuronal development, consistent with targets of oxidative stress-inducing agents. We confirmed associations of seven candidate genes associated with natural variation in oxidative stress resistance through mutational analysis. Conclusions: We identified novel candidate genes associated with variation in resistance to oxidative stress that have context-dependent effects. These results form the basis for future translational studies to identify oxidative stress susceptibility/resistance genes that are evolutionary conserved and might play a role in human disease.	[Weber, Allison L.; Magwire, Michael M.; Tabor, Crystal L.; Mackay, Trudy F. C.; Anholt, Robert R. H.] N Carolina State Univ, Dept Genet, Raleigh, NC 27695 USA; [Weber, Allison L.; Khan, George F.; Magwire, Michael M.; Tabor, Crystal L.; Mackay, Trudy F. C.; Anholt, Robert R. H.] N Carolina State Univ, WM Keck Ctr Behav Biol, Raleigh, NC 27695 USA; [Khan, George F.; Anholt, Robert R. H.] N Carolina State Univ, Dept Biol, Raleigh, NC 27695 USA	University of North Carolina; North Carolina State University; University of North Carolina; North Carolina State University; University of North Carolina; North Carolina State University	Weber, AL (corresponding author), N Carolina State Univ, Dept Genet, Box 7614, Raleigh, NC 27695 USA.	allisonwebergenetics@gmail.com	Anholt, Robert/S-5977-2019		National Institutes of Health [F32 GM089010, 5RC1ES018255, GM045146]; NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES [RC1ES018255] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM045146, F32GM089010] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Environmental Health Sciences (NIEHS)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported by National Institutes of Health (www.nih.gov) grants F32 GM089010 (to ALW) and 5RC1ES018255 and GM045146 (to RRHA and TFCM). The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Andersen JK, 2004, NAT MED, V10, pS18, DOI 10.1038/nrn1434; Antonov A.V., 2010, NUCLEIC ACIDS RES, V38, pW118; ARKING R, 1991, DEV GENET, V12, P362, DOI 10.1002/dvg.1020120505; Arya GH, 2010, GENETICS, V186, P1475, DOI 10.1534/genetics.110.123166; Azumi H, 2002, ARTERIOSCL THROM VAS, V22, P1838, DOI 10.1161/01.ATV.0000037101.40667.62; Barnham KJ, 2004, NAT REV DRUG DISCOV, V3, P205, DOI 10.1038/nrd1330; Bellen HJ, 2004, GENETICS, V167, P761, DOI 10.1534/genetics.104.026427; Bellen HJ, 2011, GENETICS, V188, P731, DOI 10.1534/genetics.111.126995; BREWER GJ, 1967, AM J HUM GENET, V19, P674; Caceres L, 2011, GENE DEV, V25, P1476, DOI 10.1101/gad.2064111; Calabrese V, 2007, NAT REV NEUROSCI, V8, P766, DOI 10.1038/nrn2214; Chen DR, 2008, MOL BIOL CELL, V19, P308, DOI 10.1091/mbc.E07-08-0735; Dawes-Hoang RE, 2005, DEVELOPMENT, V132, P4165, DOI 10.1242/dev.01938; DeRosse P, 2008, SCHIZOPHRENIA BULL, V34, P1047, DOI 10.1093/schbul/sbn076; Falconer D. S, 1996, INTRO QUANTITATIVE G; Finkel T, 2005, NAT REV MOL CELL BIO, V6, P971, DOI 10.1038/nrm1763; Finkel T, 2003, CURR OPIN CELL BIOL, V15, P247, DOI 10.1016/S0955-0674(03)00002-4; Finkel T, 2000, NATURE, V408, P239, DOI 10.1038/35041687; GERTLER FB, 1995, GENE DEV, V9, P521, DOI 10.1101/gad.9.5.521; Ginsberg SD, 2012, NEUROBIOL DIS, V45, P99, DOI 10.1016/j.nbd.2011.07.013; Giorgio M, 2007, NAT REV MOL CELL BIO, V8, p722A; Girardot F, 2004, BMC GENOMICS, V5, DOI 10.1186/1471-2164-5-74; HARI KL, 1995, CELL, V82, P815, DOI 10.1016/0092-8674(95)90478-6; HARMAN D, 1956, J GERONTOL, V11, P298, DOI 10.1093/geronj/11.3.298; Helmersson J, 2002, CLIN SCI, V102, P39, DOI 10.1042/CS20010179; Holzenberger M, 2003, NATURE, V421, P182, DOI 10.1038/nature01298; Ide T, 2002, ARTERIOSCL THROM VAS, V22, P438, DOI 10.1161/hq0302.104515; Karaczyn A, 2010, NEURAL DEV, V5, DOI 10.1186/1749-8104-5-31; Khazaeli AA, 2007, MECH AGEING DEV, V128, P486, DOI 10.1016/j.mad.2007.06.005; Knowles JW, 2003, HUM GENET, V112, P62, DOI 10.1007/s00439-002-0834-z; Kopp A, 2003, GENETICS, V163, P771; Landis GN, 2004, P NATL ACAD SCI USA, V101, P7663, DOI 10.1073/pnas.0307605101; LARSEN PL, 1993, P NATL ACAD SCI USA, V90, P8905, DOI 10.1073/pnas.90.19.8905; Li WJ, 2005, DEV DYNAM, V234, P512, DOI 10.1002/dvdy.20496; Lin YJ, 1998, SCIENCE, V282, P943, DOI 10.1126/science.282.5390.943; Littleton JT, 2000, NEURON, V26, P35, DOI 10.1016/S0896-6273(00)81135-6; Loew O, 1900, SCIENCE, V11, P701, DOI 10.1126/science.11.279.701; Mackay TFC, 2012, NATURE, V482, P173, DOI 10.1038/nature10811; Madamanchi NR, 2005, ARTERIOSCL THROM VAS, V25, P950, DOI 10.1161/01.ATV.0000161050.77646.68; Magwere T, 2006, MECH AGEING DEV, V127, P356, DOI 10.1016/j.mad.2005.12.009; Maillet M, 2003, NAT CELL BIOL, V5, P633, DOI 10.1038/ncb1007; Manolio TA, 2009, NATURE, V461, P747, DOI 10.1038/nature08494; McGovern VL, 2003, MECH DEVELOP, V120, P1193, DOI 10.1016/s0925-4773(03)00159-X; Monaghan P, 2009, ECOL LETT, V12, P75, DOI 10.1111/j.1461-0248.2008.01258.x; Morton DB, 2004, MOL NEUROBIOL, V29, P97, DOI 10.1385/MN:29:2:097; O'Driscoll M, 2003, NAT GENET, V33, P497, DOI 10.1038/ng1129; O'Neal J, 2009, EXP HEMATOL, V37, P234, DOI 10.1016/j.exphem.2008.10.014; ORR EC, 1990, NUCLEIC ACIDS RES, V18, P3663, DOI 10.1093/nar/18.12.3663; ORR WC, 1994, SCIENCE, V263, P1128, DOI 10.1126/science.8108730; Palu E, 2002, J NEUROSCI RES, V69, P243, DOI 10.1002/jnr.10292; Pandey KN, 2011, FEBS J, V278, P1792, DOI 10.1111/j.1742-4658.2011.08081.x; Parkes TL, 1998, NAT GENET, V19, P171, DOI 10.1038/534; Patterson C, 1999, J BIOL CHEM, V274, P19814, DOI 10.1074/jbc.274.28.19814; Perry T, 2007, INSECT BIOCHEM MOLEC, V37, P184, DOI 10.1016/j.ibmb.2006.11.009; Popa-Nita O, 2008, ARTHRITIS RHEUM-US, V58, P1866, DOI 10.1002/art.23801; RITVO ER, 1988, ARCH GEN PSYCHIAT, V45, P600; Sartori-Valinotti JC, 2007, CLIN EXP PHARMACOL P, V34, P938, DOI 10.1111/j.1440-1681.2007.04643.x; Schwaerzel M, 2007, J NEUROSCI, V27, P1229, DOI 10.1523/JNEUROSCI.4622-06.2007; Sekelsky JJ, 2000, MUTAT RES-DNA REPAIR, V459, P219, DOI 10.1016/S0921-8777(99)00075-0; SETO NOL, 1987, NUCLEIC ACIDS RES, V15, P10601, DOI 10.1093/nar/15.24.10601; Shalaby NA, 2009, GENETICS, V182, P1061, DOI 10.1534/genetics.108.099986; Shamloula HK, 2002, GENETICS, V161, P693; SHIOMI T, 1994, MUTAT RES, V314, P167, DOI 10.1016/0921-8777(94)90080-9; Sun JT, 1999, MOL CELL BIOL, V19, P216; Swan LE, 2004, GENE DEV, V18, P223, DOI 10.1101/gad.287604; Thorpe GW, 2004, P NATL ACAD SCI USA, V101, P6564, DOI 10.1073/pnas.0305888101; Valko M, 2006, CHEM-BIOL INTERACT, V160, P1, DOI 10.1016/j.cbi.2005.12.009; Valko M, 2007, INT J BIOCHEM CELL B, V39, P44, DOI 10.1016/j.biocel.2006.07.001; van Kesteren PJM, 1998, THROMB HAEMOSTASIS, V79, P1029; VANFLETEREN JR, 1993, BIOCHEM J, V292, P605, DOI 10.1042/bj2920605; Volders K, 2011, CURR MOL MED, V11, P204, DOI 10.2174/156652411795243432; Wallace MA, 2005, CHEM RES TOXICOL, V18, P1279, DOI 10.1021/tx050050n; Walldorf U, 2000, MECH DEVELOP, V96, P141, DOI 10.1016/S0925-4773(00)00380-4; Wang Y, 2006, J HERED, V97, P355, DOI 10.1093/jhered/esl009; Wilson RJ, 2008, NUCLEIC ACIDS RES, V36, pD588, DOI 10.1093/nar/gkm930; Zhao HW, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0011701; Zuo H, 2010, CANCER RES, V70, P1389, DOI 10.1158/0008-5472.CAN-09-2812	77	78	80	1	46	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 4	2012	7	4							e34745	10.1371/journal.pone.0034745	http://dx.doi.org/10.1371/journal.pone.0034745			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	953GO	22496853	Green Published, gold, Green Submitted			2022-12-25	WOS:000304855200074
J	Li, ZQ; Cheng, DJ; Mon, H; Tatsuke, T; Zhu, L; Xu, J; Lee, JM; Xia, QY; Kusakabe, T				Li, Zhiqing; Cheng, Daojun; Mon, Hiroaki; Tatsuke, Tsuneyuki; Zhu, Li; Xu, Jian; Lee, Jae Man; Xia, Qingyou; Kusakabe, Takahiro			Genome-Wide Identification of Polycomb Target Genes Reveals a Functional Association of Pho with Scm in Bombyx mori	PLOS ONE			English	Article							METHYL-LYSINE-BINDING; DNA-BINDING; HISTONE METHYLTRANSFERASE; CHROMATIN BINDING; GROUP PROTEINS; CELL-CYCLE; SEX COMB; COMPLEXES; RECRUITMENT; REPRESSION	Polycomb group (PcG) proteins are evolutionarily conserved chromatin modifiers and act together in three multimeric complexes, Polycomb repressive complex 1 (PRC1), Polycomb repressive complex 2 (PRC2), and Pleiohomeotic repressive complex (PhoRC), to repress transcription of the target genes. Here, we identified Polycomb target genes in Bombyx mori with holocentric centromere using genome-wide expression screening based on the knockdown of BmSCE, BmESC, BmPHO, or BmSCM gene, which represent the distinct complexes. As a result, the expressions of 29 genes were up-regulated after knocking down 4 PcG genes. Particularly, there is a significant overlap between targets of BmPho (331 out of 524) and BmScm (331 out of 532), and among these, 190 genes function as regulator factors playing important roles in development. We also found that BmPho, as well as BmScm, can interact with other Polycomb components examined in this study. Further detailed analysis revealed that the C-terminus of BmPho containing zinc finger domain is involved in the interaction between BmPho and BmScm. Moreover, the zinc finger domain in BmPho contributes to its inhibitory function and ectopic overexpression of BmScm is able to promote transcriptional repression by Gal4-Pho fusions including BmScm-interacting domain. Loss of BmPho expression causes relocalization of BmScm into the cytoplasm. Collectively, we provide evidence of a functional link between BmPho and BmScm, and propose two Polycomb-related repression mechanisms requiring only BmPho associated with BmScm or a whole set of PcG complexes.	[Li, Zhiqing; Mon, Hiroaki; Tatsuke, Tsuneyuki; Zhu, Li; Xu, Jian; Lee, Jae Man; Kusakabe, Takahiro] Kyushu Univ, Grad Sch Bioresource & Bioenvironm Sci, Lab Silkworm Sci, Fukuoka 812, Japan; [Cheng, Daojun; Xia, Qingyou] Southwest Univ, State Key Lab Silkworm Genome Biol, Chongqing, Peoples R China	Kyushu University; Southwest University - China	Li, ZQ (corresponding author), Kyushu Univ, Grad Sch Bioresource & Bioenvironm Sci, Lab Silkworm Sci, Fukuoka 812, Japan.	kusakabe@agr.kyushu-u.ac.jp	Tatsuke, Tsuneyuki/I-3714-2019; Xu, Jian/G-6684-2015; Zhu, Li/S-7517-2018	Tatsuke, Tsuneyuki/0000-0003-2322-4528; Xu, Jian/0000-0003-1816-4129; Zhu, Li/0000-0002-4919-1894; Li, Zhiqing/0000-0001-8323-3245	Japan Society for the Promotion of Science [22248004, 23580077]; National Basic Research Program of China [2012CB114600]; Grants-in-Aid for Scientific Research [22248004] Funding Source: KAKEN	Japan Society for the Promotion of Science(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of Science); National Basic Research Program of China(National Basic Research Program of China); Grants-in-Aid for Scientific Research(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI))	This work was supported in part by Grants-in-Aid for Scientific Research (KAKENHI) no. 22248004 and 23580077 from the Japan Society for the Promotion of Science to TK and JML, and also by a grant from the National Basic Research Program of China to QX: 2012CB114600. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Boutros R, 2006, CURR OPIN CELL BIOL, V18, P185, DOI 10.1016/j.ceb.2006.02.003; Boyer LA, 2006, NATURE, V441, P349, DOI 10.1038/nature04733; Bracken AP, 2006, GENE DEV, V20, P1123, DOI 10.1101/gad.381706; Brown JL, 1998, MOL CELL, V1, P1057, DOI 10.1016/S1097-2765(00)80106-9; Buchenau P, 1998, J CELL BIOL, V141, P469, DOI 10.1083/jcb.141.2.469; Cavalli G, 2011, J MOL BIOL, V409, P54, DOI 10.1016/j.jmb.2011.03.001; Chai CL, 2008, INSECT BIOCHEM MOLEC, V38, P1111, DOI 10.1016/j.ibmb.2008.06.008; Cheng D, 2008, INSECT BIOCHEM MOLEC, V38, P1130, DOI 10.1016/j.ibmb.2008.09.013; Finley RL, 1996, P NATL ACAD SCI USA, V93, P3011, DOI 10.1073/pnas.93.7.3011; Francis NJ, 2009, CELL CYCLE, V8, P3521, DOI 10.4161/cc.8.21.9876; Grimm C, 2007, EMBO REP, V8, P1031, DOI 10.1038/sj.embor.7401085; Grimm C, 2009, EMBO J, V28, P1965, DOI 10.1038/emboj.2009.147; Gupta RA, 2010, NATURE, V464, P1071, DOI 10.1038/nature08975; Jacobs JJL, 2002, BBA-REV CANCER, V1602, P151, DOI 10.1016/S0304-419X(02)00052-5; Kanhere A, 2010, MOL CELL, V38, P675, DOI 10.1016/j.molcel.2010.03.019; Klymenko T, 2006, GENE DEV, V20, P1110, DOI 10.1101/gad.377406; Lee JM, 2004, COMP BIOCHEM PHYS B, V139, P35, DOI 10.1016/j.cbpc.2004.06.004; Leeb M, 2010, GENE DEV, V24, P265, DOI 10.1101/gad.544410; LEWIS EB, 1978, NATURE, V276, P565, DOI 10.1038/276565a0; Li ZQ, 2011, MOL BIOL RE IN PRESS; Majewski IJ, 2010, BLOOD, V116, P731, DOI 10.1182/blood-2009-12-260760; MESSMER S, 1992, GENE DEV, V6, P1241, DOI 10.1101/gad.6.7.1241; Mitsunobu H, 2012, INSECT MOL BIOL, V21, P9, DOI 10.1111/j.1365-2583.2011.01115.x; Mohd-Sarip A, 2002, MOL CELL BIOL, V22, P7473, DOI 10.1128/MCB.22.21.7473-7483.2002; Mon H, 2012, RNA BIOL, V9, P40, DOI 10.4161/rna.9.1.18084; Morey L, 2010, TRENDS BIOCHEM SCI, V35, P323, DOI 10.1016/j.tibs.2010.02.009; Muller J, 2002, CELL, V111, P197, DOI 10.1016/S0092-8674(02)00976-5; Oktaba K, 2008, DEV CELL, V15, P877, DOI 10.1016/j.devcel.2008.10.005; Pasini D, 2004, CELL CYCLE, V3, P396; Poux S, 2001, DEVELOPMENT, V128, P75; Prezioso C, 2011, FEBS LETT, V585, P2067, DOI 10.1016/j.febslet.2011.04.062; Roseman RR, 2001, GENETICS, V158, P291; Saurin AJ, 1998, J CELL BIOL, V142, P887, DOI 10.1083/jcb.142.4.887; Schwartz YB, 2006, NAT GENET, V38, P700, DOI 10.1038/ng1817; Shao ZH, 1999, CELL, V98, P37, DOI 10.1016/S0092-8674(00)80604-2; Simon JA, 2009, NAT REV MOL CELL BIO, V10, P697, DOI 10.1038/nrm2763; Simon JA, 2008, MUTAT RES-FUND MOL M, V647, P21, DOI 10.1016/j.mrfmmm.2008.07.010; Sparmann A, 2006, NAT REV CANCER, V6, P846, DOI 10.1038/nrc1991; STRUHL G, 1981, NATURE, V293, P36, DOI 10.1038/293036a0; Tolhuis B, 2006, NAT GENET, V38, P694, DOI 10.1038/ng1792; Wang L, 2004, MOL CELL, V14, P637, DOI 10.1016/j.molcel.2004.05.009; Wang LJ, 2010, MOL CELL BIOL, V30, P2584, DOI 10.1128/MCB.01451-09; Wilkinson FH, 2006, P NATL ACAD SCI USA, V103, P19296, DOI 10.1073/pnas.0603564103; Xia QY, 2007, GENOME BIOL, V8, DOI 10.1186/gb-2007-8-8-r162; Yap KL, 2010, MOL CELL, V38, P662, DOI 10.1016/j.molcel.2010.03.021	45	14	16	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 2	2012	7	4							e34330	10.1371/journal.pone.0034330	http://dx.doi.org/10.1371/journal.pone.0034330			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	952GU	22485166	Green Published, Green Submitted, gold			2022-12-25	WOS:000304780500041
J	Hinerman, JM; Dignam, JD; Mueser, TC				Hinerman, Jennifer M.; Dignam, J. David; Mueser, Timothy C.			Models for the Binary Complex of Bacteriophage T4 Gp59 Helicase Loading Protein GP32 SINGLE-STRANDED DNA-BINDING PROTEIN AND TERNARY COMPLEX WITH PSEUDO-Y JUNCTION DNA	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							DNA-BINDING-PROTEIN; ISOTHERMAL TITRATION CALORIMETRY; REPLICATION FORK; SEDIMENTATION-VELOCITY; CRYSTAL-STRUCTURE; POLYMERASE GP43; GENE-59 PROTEIN; GP32; RECOMBINATION; ARCHITECTURE	Bacteriophage T4 gp59 helicase assembly protein (gp59) is required for loading of gp41 replicative helicase onto DNA protected by gp32 single-stranded DNA-binding protein. The gp59 protein recognizes branched DNA structures found at replication and recombination sites. Binding of gp32 protein (full-length and deletion constructs) to gp59 protein measured by isothermal titration calorimetry demonstrates that the gp32 protein C-terminal A-domain is essential for protein-protein interaction in the absence of DNA. Sedimentation velocity experiments with gp59 protein and gp32 Delta B protein (an N-terminal B-domain deletion) show that these proteins are monomers but form a 1:1 complex with a dissociation constant comparable with that determined by isothermal titration calorimetry. Small angle x-ray scattering (SAXS) studies indicate that the gp59 protein is a prolate monomer, consistent with the crystal structure and hydrodynamic properties determined from sedimentation velocity experiments. SAXS experiments also demonstrate that gp32 Delta B protein is a prolate monomer with an elongated A-domain protruding from the core. Fitting structures of gp59 protein and the gp32 core into the SAXS-derived molecular envelope supports a model for the gp59 protein-gp32 Delta B protein complex. Our earlier work demonstrated that gp59 protein attracts full-length gp32 protein to pseudo-Y junctions. A model of the gp59 protein-DNA complex, modified to accommodate new SAXS data for the binary complex together with mutational analysis of gp59 protein, is presented in the accompanying article (Dolezal, D., Jones, C. E., Lai, X., Brister, J. R., Mueser, T. C., Nossal, N. G., and Hinton, D. M. (2012) J. Biol. Chem. 287, 18596-18607).	[Hinerman, Jennifer M.; Mueser, Timothy C.] Univ Toledo, Coll Nat Sci & Math, Dept Chem, Toledo, OH 43606 USA; [Dignam, J. David] Univ Toledo, Coll Med, Dept Biochem & Canc Biol, Toledo, OH 43614 USA	University of Toledo; University of Toledo	Mueser, TC (corresponding author), Univ Toledo, Coll Nat Sci & Math, Dept Chem, Toledo, OH 43606 USA.	Timothy.Mueser@utoledo.edu			National Science Foundation [0346960]; Division Of Chemistry [0822838] Funding Source: National Science Foundation	National Science Foundation(National Science Foundation (NSF)); Division Of Chemistry(National Science Foundation (NSF)NSF - Directorate for Mathematical & Physical Sciences (MPS))	This work was supported by a grant from the National Science Foundation CAREER Award 0346960 (to T. C. M.).	ALBERTS BM, 1970, NATURE, V227, P1313, DOI 10.1038/2271313a0; Aves Stephen J., 2009, V521, P3, DOI 10.1007/978-1-60327-817-5_1; Barry ER, 2006, MICROBIOL MOL BIOL R, V70, P876, DOI 10.1128/MMBR.00029-06; BARRY J, 1994, J BIOL CHEM, V269, P33049; Chastain PD, 2003, J BIOL CHEM, V278, P21276, DOI 10.1074/jbc.M301573200; Dolezal D, 2012, J BIOL CHEM, V287, P18596, DOI 10.1074/jbc.M111.332080; Huebscher Ulrich, 2009, V521, P19, DOI [10.1007/978-1-60327-817-5_2, 10.1007/978-1-60327-815-7_2]; Ishmael FT, 2002, J BIOL CHEM, V277, P20555, DOI 10.1074/jbc.M111951200; Ishmael FT, 2001, J BIOL CHEM, V276, P25236, DOI 10.1074/jbc.M100783200; Izaac A, 2006, ACTA CRYSTALLOGR D, V62, P833, DOI 10.1107/S0907444906018385; Jelesarov I, 1999, J MOL RECOGNIT, V12, P3, DOI 10.1002/(SICI)1099-1352(199901/02)12:1<3::AID-JMR441>3.0.CO;2-6; Jones CE, 2004, J BIOL CHEM, V279, P25721, DOI 10.1074/jbc.M402128200; Jones CE, 2004, J BIOL CHEM, V279, P12067, DOI 10.1074/jbc.M313840200; Jones CE, 2001, P NATL ACAD SCI USA, V98, P8312, DOI 10.1073/pnas.121009398; Karam J. D., 1994, MOL BIOL BACTERIOPHA; Kong DC, 1997, J BIOL CHEM, V272, P8380; Kreuzer KN, 2000, TRENDS BIOCHEM SCI, V25, P165, DOI 10.1016/S0968-0004(00)01559-0; Lakowicz JR, 1999, PRINCIPLES FLUORESCE; Laue TM, 1999, ANNU REV BIOPH BIOM, V28, P75, DOI 10.1146/annurev.biophys.28.1.75; Leavitt S, 2001, CURR OPIN STRUC BIOL, V11, P560, DOI 10.1016/S0959-440X(00)00248-7; Lefebvre SD, 1999, J BIOL CHEM, V274, P22830, DOI 10.1074/jbc.274.32.22830; Ma YJ, 2004, J BIOL CHEM, V279, P19035, DOI 10.1074/jbc.M311738200; Morrical SW, 1996, J BIOL CHEM, V271, P20198, DOI 10.1074/jbc.271.33.20198; Mueser TC, 2000, J MOL BIOL, V296, P597, DOI 10.1006/jmbi.1999.3438; Mueser TC, 2010, VIROL J, V7, DOI 10.1186/1743-422X-7-359; Nossal NG, 2007, J BIOL CHEM, V282, P1098, DOI 10.1074/jbc.M606772200; PRIGODICH RV, 1986, BIOCHEMISTRY-US, V25, P3666, DOI 10.1021/bi00360a029; Schuck P, 2000, BIOPHYS J, V78, P1606, DOI 10.1016/S0006-3495(00)76713-0; Shah D. B, 1975, J VIROL, V17, P175; SHAMOO Y, 1995, NATURE, V376, P362, DOI 10.1038/376362a0; SPICER EK, 1979, J BIOL CHEM, V254, P6433; Stafford WF, 2000, METHOD ENZYMOL, V323, P302; Waidner LA, 2001, J BIOL CHEM, V276, P2509, DOI 10.1074/jbc.M007778200; Xi J, 2005, BIOCHEMISTRY-US, V44, P7747, DOI 10.1021/bi047296w; Xi J, 2005, BIOCHEMISTRY-US, V44, P2305, DOI 10.1021/bi0479508; Xu H, 2001, BIOCHEMISTRY-US, V40, P7651, DOI 10.1021/bi010116n; YONESAKI T, 1994, J BIOL CHEM, V269, P1284; ZIMMERMAN SB, 1991, J MOL BIOL, V222, P599, DOI 10.1016/0022-2836(91)90499-V	38	4	4	0	4	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAY 25	2012	287	22					18608	18617		10.1074/jbc.M111.333476	http://dx.doi.org/10.1074/jbc.M111.333476			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	974EC	22493434	Green Published, hybrid			2022-12-25	WOS:000306411600071
J	Rius, M; Chillaron, J				Rius, Monica; Chillaron, Josep			Carrier Subunit of Plasma Membrane Transporter Is Required for Oxidative Folding of Its Helper Subunit	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							AMINO-ACID TRANSPORTERS; GENOTYPE-PHENOTYPE CORRELATION; ENDOPLASMIC-RETICULUM; CRYSTAL-STRUCTURE; I CYSTINURIA; PROTEIN; MUTATIONS; MECHANISM; SYSTEM; ALPHA	We study the amino acid transport system b(0,+) as a model for folding, assembly, and early traffic of membrane protein complexes. System b(0,+) is made of two disulfide-linked membrane subunits: the carrier, b(0,+) amino acid transporter (b(0,+) AT), a polytopic protein, and the helper, related to b(0,+) amino acid transporter (rBAT), a type II glycoprotein. rBAT ectodomain mutants display folding/trafficking defects that lead to type I cystinuria. Here we show that, in the presence of b(0,+) AT, three disulfides were formed in the rBAT ectodomain. Disulfides Cys-242-Cys-273 and Cys-571-Cys-666 were essential for biogenesis. Cys-673-Cys-685 was dispensable, but the single mutants C673S, and C685S showed compromised stability and trafficking. Cys-242-Cys-273 likely was the first disulfide to form, and unpaired Cys-242 or Cys-273 disrupted oxidative folding. Strikingly, unassembled rBAT was found as an ensemble of different redox species, mainly monomeric. The ensemble did not change upon inhibition of rBAT degradation. Overall, these results indicated a b(0,+) AT-dependent oxidative folding of the rBAT ectodomain, with the initial and probably cotranslational formation of Cys-242-Cys-273, followed by the oxidation of Cys-571-Cys-666 and Cys-673-Cys-685,that was completed posttranslationally.	[Rius, Monica; Chillaron, Josep] Univ Barcelona, Fac Biol, Dept Physiol & Immunol, E-08028 Barcelona, Spain	University of Barcelona	Chillaron, J (corresponding author), Univ Barcelona, Fac Biol, Dept Physiol & Immunol, Av Diagonal 643, E-08028 Barcelona, Spain.	jchillaron@ub.edu	Chillaron, Josep/ABF-7663-2021	Chillaron, Josep/0000-0003-3068-7598	Spanish Ministerio de Ciencia e Innovacion [BFU2006-06788/BMC, BFU2009-07215/BMC]	Spanish Ministerio de Ciencia e Innovacion(Ministry of Science and Innovation, Spain (MICINN)Instituto de Salud Carlos IIISpanish Government)	This study was supported by Spanish Ministerio de Ciencia e Innovacion Grants BFU2006-06788/BMC and BFU2009-07215/BMC (to J.C.).	Abramson J, 2003, SCIENCE, V301, P610, DOI 10.1126/science.1088196; Arias-Moreno X, 2008, J BIOL CHEM, V283, P13627, DOI 10.1074/jbc.M800755200; Bartoccioni P, 2008, HUM MOL GENET, V17, P1845, DOI 10.1093/hmg/ddn080; Bauch C, 2002, AM J PHYSIOL-RENAL, V283, pF181, DOI 10.1152/ajprenal.00212.2001; Bisceglia L, 2001, KIDNEY INT, V59, P1250, DOI 10.1046/j.1523-1755.2001.0590041250.x; BONIFACINO JS, 1990, CELL, V63, P503, DOI 10.1016/0092-8674(90)90447-M; BRAAKMAN I, 1992, EMBO J, V11, P1717, DOI 10.1002/j.1460-2075.1992.tb05223.x; Broer S, 2011, BIOCHEM J, V436, P193, DOI 10.1042/BJ20101912; Chang JY, 2011, BIOCHEMISTRY-US, V50, P3414, DOI 10.1021/bi200131j; Chapman DC, 2010, SEMIN CELL DEV BIOL, V21, P512, DOI 10.1016/j.semcdb.2009.12.013; Chillaron J, 2001, AM J PHYSIOL-RENAL, V281, pF995, DOI 10.1152/ajprenal.2001.281.6.F995; Chillaron J, 1996, J BIOL CHEM, V271, P17761, DOI 10.1074/jbc.271.30.17761; Chillaron J, 2010, NAT REV NEPHROL, V6, P424, DOI 10.1038/nrneph.2010.69; D'Angelo JA, 2010, J IMMUNOL, V185, P3217, DOI 10.4049/jimmunol.1001199; Deora AB, 1998, J BIOL CHEM, V273, P32980, DOI 10.1074/jbc.273.49.32980; Egoshi K, 2000, KIDNEY INT, V57, P25, DOI 10.1046/j.1523-1755.2000.00821.x; Feige MJ, 2009, MOL CELL, V34, P569, DOI 10.1016/j.molcel.2009.04.028; Fernandez E, 2002, AM J PHYSIOL-RENAL, V283, pF540, DOI 10.1152/ajprenal.00071.2002; Fitter J, 2005, CELL MOL LIFE SCI, V62, P1925, DOI 10.1007/s00018-005-5079-2; Font M, 2001, HUM MOL GENET, V10, P305, DOI 10.1093/hmg/10.4.305; Font-Llitjos M, 2005, J MED GENET, V42, P58, DOI 10.1136/jmg.2004.022244; Fort J, 2007, J BIOL CHEM, V282, P31444, DOI 10.1074/jbc.M704524200; Gajewski C, 2011, P NATL ACAD SCI USA, V108, P3240, DOI 10.1073/pnas.1017097108; Gao X, 2009, SCIENCE, V324, P1565, DOI 10.1126/science.1173654; Guo ZY, 2005, BIOCHEMISTRY-US, V44, P6537, DOI 10.1021/bi047409b; Ishimoto T, 2011, CANCER CELL, V19, P387, DOI 10.1016/j.ccr.2011.01.038; Janecek S, 1997, J MOL EVOL, V45, P322, DOI 10.1007/PL00006236; Jansens A, 2002, SCIENCE, V298, P2401, DOI 10.1126/science.1078376; Kanehara K, 2007, SEMIN CELL DEV BIOL, V18, P743, DOI 10.1016/j.semcdb.2007.09.007; Khushoo A, 2011, MOL CELL, V41, P682, DOI 10.1016/j.molcel.2011.02.027; Kowalczyk L, 2011, P NATL ACAD SCI USA, V108, P3935, DOI 10.1073/pnas.1018081108; Mitchell WB, 2007, BLOOD, V109, P3725, DOI 10.1182/blood-2006-11-058420; Palacin M, 2004, PFLUG ARCH EUR J PHY, V447, P490, DOI 10.1007/s00424-003-1062-7; Penn AC, 2008, EMBO J, V27, P3056, DOI 10.1038/emboj.2008.222; Pineda M, 2004, BIOCHEM J, V377, P665, DOI 10.1042/BJ20030956; Reig N, 2002, EMBO J, V21, P4906, DOI 10.1093/emboj/cdf500; Sakamoto S, 2009, BIOCHEM J, V417, P441, DOI 10.1042/BJ20081798; Shao SC, 2011, CELL, V146, P13, DOI 10.1016/j.cell.2011.06.028; Tansey William P, 2007, CSH Protoc, V2007, DOI 10.1101/pdb.prot4619; TATU U, 1993, EMBO J, V12, P2151, DOI 10.1002/j.1460-2075.1993.tb05863.x; van Lith M, 2006, J IMMUNOL, V177, P5430, DOI 10.4049/jimmunol.177.8.5430; Verrey F, 2004, PFLUG ARCH EUR J PHY, V447, P532, DOI 10.1007/s00424-003-1086-z; von Heijne G, 2011, ANNU REV BIOCHEM, V80, P157, DOI 10.1146/annurev-biochem-111910-091345; Wanamaker CP, 2007, J BIOL CHEM, V282, P31113, DOI 10.1074/jbc.M705369200; Wang N, 2005, MOL BIOL CELL, V16, P3740, DOI 10.1091/mbc.E05-05-0381; Watanabe K, 1997, J MOL BIOL, V269, P142, DOI 10.1006/jmbi.1997.1018; Yamashita A, 2005, NATURE, V437, P215, DOI 10.1038/nature03978	47	10	10	0	2	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAY 25	2012	287	22					18190	18200		10.1074/jbc.M111.321943	http://dx.doi.org/10.1074/jbc.M111.321943			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	974EC	22493502	hybrid, Green Published			2022-12-25	WOS:000306411600027
J	Stampoulis, P; Ueda, T; Matsumoto, M; Terasawa, H; Miyano, K; Sumimoto, H; Shimada, I				Stampoulis, Pavlos; Ueda, Takumi; Matsumoto, Masahiko; Terasawa, Hiroaki; Miyano, Kei; Sumimoto, Hideki; Shimada, Ichio			Atypical Membrane-embedded Phosphatidylinositol 3,4-Bisphosphate (PI(3,4)P-2)-binding Site on p47(phox) Phox Homology (PX) Domain Revealed by NMR	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							PHAGOCYTE NADPH OXIDASE; CROSS-SATURATION EXPERIMENTS; CHRONIC GRANULOMATOUS-DISEASE; COLLAGEN-BINDING MODE; SH3 DOMAIN; STRUCTURAL BASIS; INTRAMOLECULAR INTERACTION; CRYSTAL-STRUCTURE; PROTEIN COMPLEX; ACTIVATION	The Phox homology (PX) domain is a functional module that targets membranes through specific interactions with phosphoinositides. The p47(phox) PX domain preferably binds phosphatidylinositol 3,4-bisphosphate (PI(3,4)P-2) and plays a pivotal role in the assembly of phagocyte NADPH oxidase. We describe the PI(3,4)P-2 binding mode of the p47(phox) PX domain as identified by a transferred cross-saturation experiment. The identified PI(3,4)P-2-binding site, which includes the residues of helices alpha 1 and alpha 1' and the following loop up to the distorted left-handed PPII helix, is located at a unique position, as compared with the phosphoinositide-binding sites of all other PX domains characterized thus far. Mutational analyses corroborated the results of the transferred cross-saturation experiments. Moreover, experiments with intact cells demonstrated the importance of this unique binding site for the function of the NADPH oxidase. The low affinity and selectivity of the atypical phosphoinositide-binding site on the p47(phox) PX domain suggest that different types of phosphoinositides sequentially bind to the p47(phox) PX domain, allowing the regulation of the multiple events that characterize the assembly and activation of phagocyte NADPH oxidase.	[Shimada, Ichio] Univ Tokyo, Grad Sch Pharmaceut Sci, Bunkyo Ku, Tokyo 1130033, Japan; [Stampoulis, Pavlos] Japan Biol Informat Consortium, Tokyo 1040032, Japan; [Miyano, Kei; Sumimoto, Hideki] Kyushu Univ, Grad Sch Med Sci, Fukuoka 8128582, Japan; [Shimada, Ichio] Natl Inst Adv Ind Sci & Technol, Biomed Informat Res Ctr, Tokyo 1350064, Japan	University of Tokyo; Kyushu University; National Institute of Advanced Industrial Science & Technology (AIST)	Shimada, I (corresponding author), Univ Tokyo, Grad Sch Pharmaceut Sci, Bunkyo Ku, Tokyo 1130033, Japan.	shimada@iw-nmr.f.u-tokyo.ac.jp			Japan New Energy and Industrial Development Organization; Ministry of Economy, Trade, and Industry; Grants-in-Aid for Scientific Research [23790338] Funding Source: KAKEN	Japan New Energy and Industrial Development Organization; Ministry of Economy, Trade, and Industry; Grants-in-Aid for Scientific Research(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI))	This work was supported by a grant from the Japan New Energy and Industrial Development Organization and the Ministry of Economy, Trade, and Industry.	Ago T, 1999, J BIOL CHEM, V274, P33644, DOI 10.1074/jbc.274.47.33644; Ago T, 2003, P NATL ACAD SCI USA, V100, P4474, DOI 10.1073/pnas.0735712100; Ago T, 2001, BIOCHEM BIOPH RES CO, V287, P733, DOI 10.1006/bbrc.2001.5629; Babior BM, 1999, BLOOD, V93, P1464, DOI 10.1182/blood.V93.5.1464.405a32_1464_1476; Bai JH, 2004, NAT STRUCT MOL BIOL, V11, P36, DOI 10.1038/nsmb709; Bravo J, 2001, MOL CELL, V8, P829, DOI 10.1016/S1097-2765(01)00372-0; Cheever ML, 2001, NAT CELL BIOL, V3, P613, DOI 10.1038/35083000; Duzgunes N, 2003, METHOD ENZYMOL, V367, P23; Ellson C, 2006, EMBO J, V25, P4468, DOI 10.1038/sj.emboj.7601346; Fratti RA, 2007, J BIOL CHEM, V282, P13133, DOI 10.1074/jbc.M700584200; Frohlich M, 2001, CHEM PHYS LIPIDS, V109, P103, DOI 10.1016/S0009-3084(00)00220-6; Harris BZ, 2001, BIOCHEMISTRY-US, V40, P5921, DOI 10.1021/bi010142l; Heyworth PG, 2003, CURR OPIN IMMUNOL, V15, P578, DOI 10.1016/S0952-7915(03)00109-2; Hiroaki H, 2001, NAT STRUCT BIOL, V8, P526, DOI 10.1038/88591; Ichikawa O, 2007, EMBO J, V26, P4168, DOI 10.1038/sj.emboj.7601833; Johnston RB, 2001, CURR OPIN HEMATOL, V8, P17, DOI 10.1097/00062752-200101000-00004; Kanai F, 2001, NAT CELL BIOL, V3, P675, DOI 10.1038/35083070; Karathanassis D, 2002, EMBO J, V21, P5057, DOI 10.1093/emboj/cdf519; Kofuku Y, 2009, J BIOL CHEM, V284, P35240, DOI 10.1074/jbc.M109.024851; Koharudin LMI, 2009, J BIOL CHEM, V284, P23697, DOI 10.1074/jbc.M109.008995; Lee CS, 2006, NAT CELL BIOL, V8, P477, DOI 10.1038/ncb1401; Lee SA, 2006, J BIOL CHEM, V281, P37091, DOI 10.1074/jbc.M608610200; Lu J, 2002, BIOCHEMISTRY-US, V41, P5956, DOI 10.1021/bi020050b; Matsumoto M, 2010, J MAGN RESON, V205, P114, DOI 10.1016/j.jmr.2010.04.011; Miyano K, 2012, METHODS MOL BIOL, V827, P195, DOI 10.1007/978-1-61779-442-1_14; Nagasawa T, 2003, ARCH BIOCHEM BIOPHYS, V416, P92, DOI 10.1016/S0003-9861(03)00296-0; Nakamura T, 2010, J MED CHEM, V53, P1917, DOI 10.1021/jm901099v; Nakanishi T, 2002, J MOL BIOL, V318, P245, DOI 10.1016/S0022-2836(02)00018-9; Nauseef WM, 2004, HISTOCHEM CELL BIOL, V122, P277, DOI 10.1007/s00418-004-0679-8; Nishida N, 2003, NAT STRUCT BIOL, V10, P53, DOI 10.1038/nsb876; Papayannopoulos V, 2005, MOL CELL, V17, P181, DOI 10.1016/j.molcel.2004.11.054; Pylypenko O, 2007, EMBO J, V26, P4788, DOI 10.1038/sj.emboj.7601889; Riek R, 2002, J AM CHEM SOC, V124, P12144, DOI 10.1021/ja026763z; Sato TK, 2001, SCIENCE, V294, P1881, DOI 10.1126/science.1065763; Shen K, 2008, BIOCHEMISTRY-US, V47, P8855, DOI 10.1021/bi8005847; Shimada I, 2005, METHOD ENZYMOL, V394, P483, DOI 10.1016/S0076-6879(05)94020-2; Shimada I, 2009, PROG NUCL MAG RES SP, V54, P123, DOI 10.1016/j.pnmrs.2008.07.001; Stahelin RV, 2007, J BIOL CHEM, V282, P25737, DOI 10.1074/jbc.M702861200; Stahelin RV, 2003, J BIOL CHEM, V278, P14469, DOI 10.1074/jbc.M212579200; Stroupe C, 2006, EMBO J, V25, P1579, DOI 10.1038/sj.emboj.7601051; Sumimoto H, 2008, FEBS J, V275, P3249, DOI 10.1111/j.1742-4658.2008.06488.x; Takeda M, 2003, J BIOL CHEM, V278, P43550, DOI 10.1074/jbc.M308199200; Takeuchi K, 2004, J BIOL CHEM, V279, P4981, DOI 10.1074/jbc.M307815200; Takeuchi K, 2003, STRUCTURE, V11, P1381, DOI 10.1016/j.str.2003.10.003; Taura M, 2009, BIOCHEM J, V419, P329, DOI 10.1042/BJ20082028; Vignais PV, 2002, CELL MOL LIFE SCI, V59, P1428, DOI 10.1007/s00018-002-8520-9; Xing Y, 2004, J BIOL CHEM, V279, P30662, DOI 10.1074/jbc.M404107200; Xu Y, 2001, BIOCHEM J, V360, P513, DOI 10.1042/0264-6021:3600513; Yan J, 2005, EMBO J, V24, P3985, DOI 10.1038/sj.emboj.7600858; Yokogawa M, 2011, J BIOL CHEM, V286, P2215, DOI 10.1074/jbc.M110.160754; Yoshiura C, 2010, J AM CHEM SOC, V132, P6768, DOI 10.1021/ja100830f; Zhan Y, 2002, J BIOL CHEM, V277, P4512, DOI 10.1074/jbc.M109520200; Zhou CZ, 2003, J BIOL CHEM, V278, P50371, DOI 10.1074/jbc.M304392200	53	16	16	0	8	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAY 18	2012	287	21					17848	17859		10.1074/jbc.M111.332874	http://dx.doi.org/10.1074/jbc.M111.332874			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	973PU	22493288	Green Published, hybrid			2022-12-25	WOS:000306373000082
J	Haspot, F; Lavault, A; Sinzger, C; Sampaio, KL; Stierhof, YD; Pilet, P; Bressolette-Bodin, C; Halary, F				Haspot, Fabienne; Lavault, Amelie; Sinzger, Christian; Sampaio, Kerstin Laib; Stierhof, York-Dieter; Pilet, Paul; Bressolette-Bodin, Celine; Halary, Franck			Human Cytomegalovirus Entry into Dendritic Cells Occurs via a Macropinocytosis-Like Pathway in a pH-Independent and Cholesterol-Dependent Manner	PLOS ONE			English	Article							GROWTH-FACTOR RECEPTOR; EPSTEIN-BARR-VIRUS; HEPATITIS-C VIRUS; DC-SIGN; ENDOTHELIAL-CELLS; TRANS-INFECTION; T-CELLS; ANTIGEN PRESENTATION; EPITHELIAL-CELLS; ANNEXIN-II	Human cytomegalovirus (HCMV) is a ubiquitous herpesvirus that is able to infect fibroblastic, epithelial, endothelial and hematopoietic cells. Over the past ten years, several groups have provided direct evidence that dendritic cells (DCs) fully support the HCMV lytic cycle. We previously demonstrated that the C-type lectin dendritic cell-specific intercellular adhesion molecule-3-grabbing non-integrin (DC-SIGN) has a prominent role in the docking of HCMV on monocyte-derived DCs (MDDCs). The DC-SIGN/HCMV interaction was demonstrated to be a crucial and early event that substantially enhanced infection in trans, i.e., from one CMV-bearing cell to another non-infected cell (or trans-infection), and rendered susceptible cells fully permissive to HCMV infection. Nevertheless, nothing is yet known about how HCMV enters MDDCs. In this study, we demonstrated that VHL/E HCMV virions (an endothelio/dendrotropic strain) are first internalized into MDDCs by a macropinocytosis-like process in an actin-and cholesterol-dependent, but pH-independent, manner. We observed the accumulation of virions in large uncoated vesicles with endosomal features, and the virions remained as intact particles that retained infectious potential for several hours. This trans-infection property was specific to MDDCs because monocyte-derived macrophages or monocytes from the same donor were unable to allow the accumulation of and the subsequent transmission of the virus. Together, these data allowed us to delineate the early mechanisms of the internalization and entry of an endothelio/dendrotropic HCMV strain into human MDDCs and to propose that DCs can serve as a "Trojan horse" to convey CMV from entry sites to other locations that may favor the occurrence of either latency or acute infection.	[Haspot, Fabienne; Lavault, Amelie; Halary, Franck] Inst Transplantat Urol & Nephrol ITUN, Inst Natl Sante & Rech Med, Unite Mixte Rech S 1064 Ex643, Nantes, France; [Haspot, Fabienne; Lavault, Amelie; Pilet, Paul; Bressolette-Bodin, Celine; Halary, Franck] Univ Nantes, Unite Format & Rech Med Pharmacie, Nantes, France; [Haspot, Fabienne; Lavault, Amelie; Bressolette-Bodin, Celine; Halary, Franck] CHU Nantes, F-44035 Nantes 01, France; [Sinzger, Christian; Sampaio, Kerstin Laib] Eberhard Karls Univ Tubingen, Inst Med Virol & Epidemiol Viral Dis, Tubingen, Germany; [Stierhof, York-Dieter] Eberhard Karls Univ Tubingen, Ctr Mol Biol Plants, Tubingen, Germany; [Pilet, Paul] Inst Natl Sante & Rech Med, Unite Mixte Rech 791, Nantes, France; [Bressolette-Bodin, Celine] Univ Nantes, Equipe Accueil 4271, Nantes, France	Institut National de la Sante et de la Recherche Medicale (Inserm); Nantes Universite; Nantes Universite; CHU de Nantes; Eberhard Karls University of Tubingen; Eberhard Karls University Hospital; Eberhard Karls University of Tubingen; Institut National de la Sante et de la Recherche Medicale (Inserm); Nantes Universite	Haspot, F (corresponding author), Inst Transplantat Urol & Nephrol ITUN, Inst Natl Sante & Rech Med, Unite Mixte Rech S 1064 Ex643, Nantes, France.	franck.halary@univ-nantes.fr	HASPOT, Fabienne/AAD-5698-2021; halary, franck/AAR-9437-2020; Halary, Franck/B-3782-2017; Bressollette-Bodin, Celine/C-8780-2012	halary, franck/0000-0003-0336-9615; Halary, Franck/0000-0003-0336-9615; Haspot, Fabienne/0000-0003-0513-1387	Roche Organ Transplantation and Research Foundation (ROTRF, Basel, Switzerland) [705613444]; Region Pays de la Loire Aquitaine	Roche Organ Transplantation and Research Foundation (ROTRF, Basel, Switzerland); Region Pays de la Loire Aquitaine(Region Pays de la Loire)	This work was supported by the Roche Organ Transplantation and Research Foundation (Fabienne Haspot's salary; project no. 705613444, ROTRF, Basel, Switzerland) and by the Region Pays de la Loire Aquitaine (A. Lavault's salary). The funders had no role in the study design, the data collection and analysis, the decision to publish, or the preparation of the manuscript.	BEERSMA MFC, 1992, CURR EYE RES, V11, P141, DOI 10.3109/02713689208999524; BEERSMA MFC, 1991, J GEN VIROL, V72, P2757, DOI 10.1099/0022-1317-72-11-2757; Bodaghi B, 1999, INVEST OPHTH VIS SCI, V40, P2598; Bressollette-Bodin C, 2009, J MED VIROL, V81, P90, DOI 10.1002/jmv.21334; Cambi A, 2004, J CELL BIOL, V164, P145, DOI 10.1083/jcb.200306112; COMPTON T, 1992, VIROLOGY, V191, P387, DOI 10.1016/0042-6822(92)90200-9; COMPTON T, 1993, VIROLOGY, V193, P834, DOI 10.1006/viro.1993.1192; Cormier EG, 2004, P NATL ACAD SCI USA, V101, P14067, DOI 10.1073/pnas.0405695101; Dominguez-Soto A, 2007, BLOOD, V109, P5337, DOI 10.1182/blood-2006-09-048058; DOWRICK P, 1993, EUR J CELL BIOL, V61, P44; Engering A, 2002, J IMMUNOL, V168, P2118, DOI 10.4049/jimmunol.168.5.2118; Falcone S, 2006, J CELL SCI, V119, P4758, DOI 10.1242/jcs.03238; Feire AL, 2004, P NATL ACAD SCI USA, V101, P15470, DOI 10.1073/pnas.0406821101; Fleetwood AJ, 2009, J LEUKOCYTE BIOL, V86, P411, DOI 10.1189/jlb.1108702; Geijtenbeek TBH, 2000, CELL, V100, P587, DOI 10.1016/S0092-8674(00)80694-7; Gerna G, 2005, J GEN VIROL, V86, P275, DOI 10.1099/vir.0.80474-0; Giugni TD, 1996, J INFECT DIS, V173, P1062, DOI 10.1093/infdis/173.5.1062; Halary F, 2002, IMMUNITY, V17, P653, DOI 10.1016/S1074-7613(02)00447-8; HEWLETT LJ, 1994, J CELL BIOL, V124, P689, DOI 10.1083/jcb.124.5.689; Isaacson MK, 2007, J VIROL, V81, P6241, DOI 10.1128/JVI.00169-07; Koopman M, 2004, FEBS LETT, V573, P6, DOI 10.1016/j.febslet.2004.07.035; Lakhan SE, 2009, J BIOMED SCI, V16, DOI 10.1186/1423-0127-16-93; Lim J. P., 2011, IMMUNOL CELL BIOL; Ludwig IS, 2004, J VIROL, V78, P8322, DOI 10.1128/jvi.78.15.8322-8332.2004; Marsh M, 2006, CELL, V124, P729, DOI 10.1016/j.cell.2006.02.007; MCGOOKEY DJ, 1983, J CELL BIOL, V96, P1273, DOI 10.1083/jcb.96.5.1273; MCKEATING JA, 1986, J MED VIROL, V18, P341, DOI 10.1002/jmv.1890180407; Mercer J, 2010, ANNU REV BIOCHEM, V79, P803, DOI 10.1146/annurev-biochem-060208-104626; Mercer J, 2009, NAT CELL BIOL, V11, P510, DOI 10.1038/ncb0509-510; NEMEROW GR, 1984, VIROLOGY, V132, P186, DOI 10.1016/0042-6822(84)90102-8; Neumann AK, 2008, J CELL SCI, V121, P634, DOI 10.1242/jcs.022418; Ogawa-Goto K, 2003, J VIROL, V77, P8541, DOI 10.1128/JVI.77.15.8541-8547.2003; Pietropaolo R, 1999, J GEN VIROL, V80, P1807, DOI 10.1099/0022-1317-80-7-1807; Plazolles N, 2010, J LEUKOC BIOL; Randolph GJ, 2005, NAT REV IMMUNOL, V5, P617, DOI 10.1038/nri1670; Riegler S, 2000, J GEN VIROL, V81, P393, DOI 10.1099/0022-1317-81-2-393; Rodal SK, 1999, MOL BIOL CELL, V10, P961, DOI 10.1091/mbc.10.4.961; Ryckman BJ, 2006, J VIROL, V80, P710, DOI 10.1128/JVI.80.2.710-722.2006; Ryckman BJ, 2008, P NATL ACAD SCI USA, V105, P14118, DOI 10.1073/pnas.0804365105; SALLUSTO F, 1994, J EXP MED, V179, P1109, DOI 10.1084/jem.179.4.1109; Sampaio KL, 2005, J VIROL, V79, P2754, DOI 10.1128/JVI.79.5.2754-2767.2005; Sarkar K, 2005, IMMUNOLOGY, V116, P513, DOI 10.1111/j.1365-2567.2005.02253.x; Sathish N, 2009, PLOS PATHOG, V5, DOI 10.1371/journal.ppat.1000332; Savina A, 2007, IMMUNOL REV, V219, P143, DOI 10.1111/j.1600-065X.2007.00552.x; Savina A, 2006, CELL, V126, P205, DOI 10.1016/j.cell.2006.05.035; Savina A, 2009, IMMUNITY, V30, P544, DOI 10.1016/j.immuni.2009.01.013; Scrivano L, 2011, PLOS PATHOG, V7, DOI 10.1371/journal.ppat.1001256; Segura E, 2009, P NATL ACAD SCI USA, V106, P20377, DOI 10.1073/pnas.0910295106; Singh SK, 2009, MOL IMMUNOL, V47, P164, DOI 10.1016/j.molimm.2009.09.026; Sinzger C, 2008, CURR TOP MICROBIOL, V325, P63; Sinzger C, 2008, J CLIN VIROL, V41, P174, DOI 10.1016/j.jcv.2007.12.002; Sodeik B, 1997, J CELL BIOL, V136, P1007, DOI 10.1083/jcb.136.5.1007; SODERBERG C, 1993, J VIROL, V67, P6576; Straschewski S, 2011, J VIROL, V85, P5150, DOI 10.1128/JVI.02100-10; Tabarani G, 2009, J BIOL CHEM, V284, P21229, DOI 10.1074/jbc.M109.021204; Tacken PJ, 2011, BLOOD, V118, P4111, DOI 10.1182/blood-2011-04-346957; TALBOT P, 1977, J GEN VIROL, V36, P345, DOI 10.1099/0022-1317-36-2-345; Verreck FAW, 2004, P NATL ACAD SCI USA, V101, P4560, DOI 10.1073/pnas.0400983101; WALDMAN WJ, 1989, J MED VIROL, V28, P223; Wang D, 2007, P NATL ACAD SCI USA, V104, P20037, DOI 10.1073/pnas.0709704104; Wang X, 2005, NAT MED, V11, P515, DOI 10.1038/nm1236; Wang X, 2003, NATURE, V424, P456, DOI 10.1038/nature01818; WEST MA, 1989, J CELL BIOL, V109, P2731, DOI 10.1083/jcb.109.6.2731; Wiley RD, 2006, P NATL ACAD SCI USA, V103, P738, DOI 10.1073/pnas.0507995103; Wille PT, 2010, J VIROL, V84, P2585, DOI 10.1128/JVI.02249-09; WRIGHT JF, 1995, J VIROL, V69, P4784, DOI 10.1128/JVI.69.8.4784-4791.1995; Yu HJ, 2008, PLOS PATHOG, V4, DOI 10.1371/journal.ppat.1000134	67	58	61	0	16	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 9	2012	7	4							e34795	10.1371/journal.pone.0034795	http://dx.doi.org/10.1371/journal.pone.0034795			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	955JO	22496863	Green Submitted, Green Published, gold			2022-12-25	WOS:000305014500031
J	Balme, GA; Hunter, L; Braczkowski, AR				Balme, Guy Andrew; Hunter, Luke; Braczkowski, Alex Richard			Applicability of Age-Based Hunting Regulations for African Leopards	PLOS ONE			English	Article							CONSERVATION; RELIABILITY; POPULATION; DYNAMICS; IMPACT; LION	In species in which juvenile survival depends strongly on male tenure, excessive trophy hunting can artificially elevate male turnover and increase infanticide, potentially to unsustainable levels. Simulation models show that the likelihood of safe harvests can be improved by restricting offtakes to males old enough to have reared their first cohort of offspring to independence; in the case of African leopards, males were >= 7 years old. Here, we explore the applicability of an age-based approach for regulating trophy hunting of leopards. We conducted a structured survey comprising photographs of known-age leopards to assess the ability of wildlife practitioners to sex and age leopards. We also evaluated the utility of four phenotypic traits for use by trophy hunters to age male leopards in the field. Our logistic regression models showed that male leopard age affected the likelihood of survey respondents identifying the correct sex; notably, males <2 years were typically misidentified as females, while mature males (>= 4 years) were sexed correctly. Mature male leopards were also more likely to be aged correctly, as were portrait photographs. Aging proficiency was also influenced by the profession of respondents, with hunters recording the lowest scores. A discriminant model including dewlap size, the condition of the ears, and the extent of facial scarring accurately discriminated among male leopard age classes. Model classification rates were considerably higher than the respective scores attained by survey respondents, implying that the aging ability of hunters could theoretically improve with appropriate training. Dewlap size was a particularly reliable indicator of males >= 7 years and a review of online trophy galleries suggested its wider utility as an aging criterion. Our study demonstrated that an age-based hunting approach is practically applicable for leopards. However, implementation would require major reform within the regulatory framework and the hunting industry.	[Balme, Guy Andrew; Hunter, Luke] Panthera, New York, NY USA; [Braczkowski, Alex Richard] Univ Oxford, Dept Zool, Wildlife Conservat Res Unit, Oxford OX1 3PS, England	University of Oxford	Balme, GA (corresponding author), Panthera, New York, NY USA.	gbalme@panthera.org	Hunter, Luke T.B./H-3324-2019	Hunter, Luke T.B./0000-0001-9653-6544; Braczkowski, Alexander/0000-0002-0099-7803				[Anonymous], 2005, AFRICAN LEOPARD ECOL; Balme GA, 2012, S AFR J WIL IN PRESS; Balme GA, 2009, THESIS DURBAN U KWAZ; Balme GA, 2012, MAMM REV IN PRESS; Balme Guy A., 2010, P341; Balme GA, 2009, BIOL CONSERV, V142, P2681, DOI 10.1016/j.biocon.2009.06.020; Balme GA, 2009, J WILDLIFE MANAGE, V73, P433, DOI 10.2193/2007-368; Begg CM, 2007, TROPHY MONITORING NI; Booth V., 2009, COMPARISON PRICES HU; Caro TM, 2009, BIOL CONSERV, V142, P909, DOI 10.1016/j.biocon.2008.12.018; Caro TM, 1998, AFR J ECOL, V36, P321, DOI 10.1046/j.1365-2028.1998.00146.x; Cooley HS, 2009, ECOLOGY, V90, P2913, DOI 10.1890/08-1805.1; Costello CM, 2004, WILDLIFE SOC B, V32, P169, DOI 10.2193/0091-7648(2004)32[169:ROTCAT]2.0.CO;2; Crooks KR, 1998, CONSERV BIOL, V12, P889, DOI 10.1046/j.1523-1739.1998.97054.x; Daly B., 2005, CONSERVATION BREEDIN; Gaona P, 1998, ECOL MONOGR, V68, P349, DOI 10.1890/0012-9615(1998)068[0349:DAVOAM]2.0.CO;2; Garel M, 2005, WILDLIFE BIOL, V11, P229, DOI 10.2981/0909-6396(2005)11[229:ROMAUM]2.0.CO;2; Garel M, 2005, ACTA THERIOL, V50, P109, DOI 10.1007/BF03192623; Grant WM, 2008, INTO THORNS HUNTING; Harshyne WA, 1998, J WILDLIFE MANAGE, V62, P1281, DOI 10.2307/3801992; Henschel P, 2011, J ZOOL, V285, P11, DOI 10.1111/j.1469-7998.2011.00826.x; Henschel P., 2008, IUCN RED LIST THREAT; HOEFS M, 1984, J WILDLIFE MANAGE, V48, P980, DOI 10.2307/3801451; Hunter LTB, 2012, MAMMALS AFR IN PRESS, V5; LESSELLS CM, 1987, AUK, V104, P116, DOI 10.2307/4087240; Lindsey PA, 2007, BIOL CONSERV, V134, P455, DOI 10.1016/j.biocon.2006.09.005; Lindsey PA, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0029332; Logan K.A., 2001, DESERT PUMA EVOLUTIO; Loveridge AJ, 2007, BIOL CONSERV, V134, P548, DOI 10.1016/j.biocon.2006.09.010; Loveridge A.J., 2006, KEY TOPICS CONSERVAT, P224; Milner-Gulland E.J., 2009, RECREATIONAL HUNTING, P75, DOI 10.1002/9781444303179; Olifiers N, 2010, WILDLIFE BIOL, V16, P389, DOI 10.2981/09-104; Packer C, 2011, CONSERV BIOL, V25, P142, DOI 10.1111/j.1523-1739.2010.01576.x; Packer C, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0005941; Purchase G., 2008, STATE KNOWLEDGE REGA; Ray J.C., 2005, 24 WILDL CONS SOC; Smith RJ, 2003, NATURE, V426, P67, DOI 10.1038/nature02025; Soares FS, 2011, ASIAN AUSTRAL J ANIM, V24, P1587, DOI 10.5713/ajas.2011.11070; Spong Goran, 2000, Conservation Genetics, V1, P169, DOI 10.1023/A:1026543308136; Stander PE, 1997, AFR J ECOL, V35, P156, DOI 10.1111/j.1365-2028.1997.068-89068.x; Stein AB, 2011, AFR J ECOL, V49, P383, DOI 10.1111/j.1365-2028.2011.01267.x; Sunquist ME, 2002, WILD CATS WORLD; Whitman K, 2004, NATURE, V428, P175, DOI 10.1038/nature02395; Whitman K. L., 2007, HUNTERS GUIDE AGING; Whitman KL, 2007, CONSERV BIOL, V21, P591, DOI 10.1111/j.1523-1739.2007.00700.x; Zar J.H., 2009, BIOSTATISTICAL ANAL	46	59	59	1	51	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 6	2012	7	4							e35209	10.1371/journal.pone.0035209	http://dx.doi.org/10.1371/journal.pone.0035209			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	955JA	22493739	Green Submitted, Green Published, gold			2022-12-25	WOS:000305012700081
J	Jensen, MA; Jauregui, L; Davis, RW				Jensen, Michael A.; Jauregui, Lauren; Davis, Ronald W.			A Rapid, Cost-Effective Method of Assembly and Purification of Synthetic DNA Probes > 100 bp	PLOS ONE			English	Article							LIGATION	Here we introduce a rapid, cost-effective method of generating molecular DNA probes in just under 15 minutes without the need for expensive, time-consuming gel-extraction steps. As an example, we enzymatically concatenated six variable strands (50 bp) with a common strand sequence (51 bp) in a single pool using Fast-Link DNA ligase to produce 101 bp targets (10 min). Unincorporated species were then filtered out by passing the crude reaction through a size-exclusion column (<5 min). We then compared full-length product yield of crude and purified samples using HPLC analysis; the results of which clearly show our method yields three-quarters that of the crude sample (50% higher than by gel-extraction). And while we substantially reduced the amount of unligated product with our filtration process, higher purity and yield, with an increase in number of stands per reaction (>12) could be achieved with further optimization. Moreover, for large-scale assays, we envision this method to be fully automated with the use of robotics such as the Biomek FX; here, potentially thousands of samples could be pooled, ligated and purified in either a 96, 384 or 1536-well platform in just minutes.	[Jensen, Michael A.; Jauregui, Lauren; Davis, Ronald W.] Stanford Genome Technol Ctr, Palo Alto, CA USA	Stanford University	Jensen, MA (corresponding author), Stanford Genome Technol Ctr, Palo Alto, CA USA.	m.a.jensen@stanford.edu			National Institutes of Health [PO1 HG000205, RC2 HG005570-01]; NATIONAL HUMAN GENOME RESEARCH INSTITUTE [P01HG000205, RC2HG005570] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL HUMAN GENOME RESEARCH INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Human Genome Research Institute (NHGRI))	Research for this manuscript was funded by the following grants from the National Institutes of Health (www.nih.gov): PO1 HG000205 to Michael Jensen and Ronald Davis and RC2 HG005570-01 to Lauren Jauregui and Ronald Davis. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Akhras MS, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0000223; Borodina TA, 2003, ANAL BIOCHEM, V318, P309, DOI 10.1016/S0003-2697(03)00250-1; Dahl F, 2007, P NATL ACAD SCI USA, V104, P9387, DOI 10.1073/pnas.0702165104; Fredriksson S, 2007, NAT METHODS, V4, P327, DOI 10.1038/NMETH1020; Garcia-Canas V, 2011, J SEP SCI, V34, P1011, DOI 10.1002/jssc.201000826; Hardenbol P, 2003, NAT BIOTECHNOL, V21, P673, DOI 10.1038/nbt821; Natsoulis G, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0021088; Ritari Jarmo, 2009, BMC Res Notes, V2, P249, DOI 10.1186/1756-0500-2-249	8	2	2	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 6	2012	7	4							e34373	10.1371/journal.pone.0034373	http://dx.doi.org/10.1371/journal.pone.0034373			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	955JA	22493688	Green Submitted, Green Published, gold			2022-12-25	WOS:000305012700030
J	Levinson, NM; Boxer, SG				Levinson, Nicholas M.; Boxer, Steven G.			Structural and Spectroscopic Analysis of the Kinase Inhibitor Bosutinib and an Isomer of Bosutinib Binding to the Abl Tyrosine Kinase Domain	PLOS ONE			English	Article							CHRONIC MYELOGENOUS LEUKEMIA; C-ABL; CLINICAL RESISTANCE; ELECTRIC-FIELDS; CHRONIC PHASE; ACTIVE-SITE; IMATINIB; SRC; COMPLEX; MUTATION	Chronic myeloid leukemia (CML) is caused by the kinase activity of the BCR-Abl fusion protein. The Abl inhibitors imatinib, nilotinib and dasatinib are currently used to treat CML, but resistance to these inhibitors is a significant clinical problem. The kinase inhibitor bosutinib has shown efficacy in clinical trials for imatinib-resistant CML, but its binding mode is unknown. We present the 2.4 angstrom structure of bosutinib bound to the kinase domain of Abl, which explains the inhibitor's activity against several imatinib-resistant mutants, and reveals that similar inhibitors that lack a nitrile moiety could be effective against the common T315I mutant. We also report that two distinct chemical compounds are currently being sold under the name "bosutinib", and report spectroscopic and structural characterizations of both. We show that the fluorescence properties of these compounds allow inhibitor binding to be measured quantitatively, and that the infrared absorption of the nitrile group reveals a different electrostatic environment in the conserved ATP-binding sites of Abl and Src kinases. Exploiting such differences could lead to inhibitors with improved selectivity.	[Levinson, Nicholas M.; Boxer, Steven G.] Stanford Univ, Dept Chem, Stanford, CA 94305 USA	Stanford University	Levinson, NM (corresponding author), Stanford Univ, Dept Chem, Stanford, CA 94305 USA.	nickl@stanford.edu		Boxer, Steven/0000-0001-9167-4286; Levinson, Nicholas/0000-0003-4338-8087	NIH [F32GM087896, GM27738]; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM027738, F32GM087896, R37GM027738] Funding Source: NIH RePORTER	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported by NIH grants F32GM087896 and GM27738 (http://www.nigms.nih.gov/). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adams PD, 2010, ACTA CRYSTALLOGR D, V66, P213, DOI 10.1107/S0907444909052925; Andrews SS, 2000, REV SCI INSTRUM, V71, P3567, DOI 10.1063/1.1287343; Andrews SS, 2000, J PHYS CHEM A, V104, P11853, DOI 10.1021/jp002242r; BAILEY S, 1994, ACTA CRYSTALLOGR D, V50, P760, DOI 10.1107/s0907444994003112; Boschelli DH, 2001, J MED CHEM, V44, P3965, DOI 10.1021/jm0102250; Boschelli DH, 2001, J MED CHEM, V44, P822, DOI 10.1021/jm000420z; CAMPONE M, 2007, BREAST CANC RES TREA; Cools J, 2003, NEW ENGL J MED, V348, P1201, DOI 10.1056/NEJMoa025217; Cortes JE, 2010, J CLIN ONCOL, V28, P487; Cortes J, 2006, BLOOD, V108, p54A, DOI 10.1182/blood.V108.11.168.168; Dauter Z, 1999, J MOL BIOL, V289, P83, DOI 10.1006/jmbi.1999.2743; Demetri GD, 2002, NEW ENGL J MED, V347, P472, DOI 10.1056/NEJMoa020461; Druker BJ, 2001, NEW ENGL J MED, V344, P1031, DOI 10.1056/NEJM200104053441401; Emsley P, 2010, ACTA CRYSTALLOGR D, V66, P486, DOI 10.1107/S0907444910007493; Golas JM, 2003, CANCER RES, V63, P375; Gorre ME, 2001, SCIENCE, V293, P876, DOI 10.1126/science.1062538; Hubbard SR, 1997, EMBO J, V16, P5572, DOI 10.1093/emboj/16.18.5572; Kantarjian HM, 2007, BLOOD, V110, P3540, DOI 10.1182/blood-2007-03-080689; Karaman MW, 2008, NAT BIOTECHNOL, V26, P127, DOI 10.1038/nbt1358; le Coutre P, 2000, BLOOD, V95, P1758, DOI 10.1182/blood.V95.5.1758.005a41_1758_1766; Leslie AGW, 1992, JOINT CRYSTALLOGRAPH, V26; Levinson NM, 2006, PLOS BIOL, V4, P753, DOI 10.1371/journal.pbio.0040144; Nagar B, 2002, CANCER RES, V62, P4236; Nagar B, 2003, CELL, V112, P859, DOI 10.1016/S0092-8674(03)00194-6; Pao W, 2005, PLOS MED, V2, P225, DOI 10.1371/journal.pmed.0020073; Puttini M, 2006, CANCER RES, V66, P11314, DOI 10.1158/0008-5472.CAN-06-1199; Redaelli S, 2009, J CLIN ONCOL, V27, P469, DOI 10.1200/JCO.2008.19.8853; Roumiantsev S, 2002, P NATL ACAD SCI USA, V99, P10700, DOI 10.1073/pnas.162140299; Sawyers CL, 1999, NEW ENGL J MED, V340, P1330, DOI 10.1056/NEJM199904293401706; Schindler T, 2000, SCIENCE, V289, P1938, DOI 10.1126/science.289.5486.1938; Seeliger MA, 2005, PROTEIN SCI, V14, P3135, DOI 10.1110/ps.051750905; Seeliger MA, 2007, STRUCTURE, V15, P299, DOI 10.1016/j.str.2007.01.015; Seeliger MA, 2009, CANCER RES, V69, P2384, DOI 10.1158/0008-5472.CAN-08-3953; Shah NP, 2007, J CLIN INVEST, V117, P2562, DOI 10.1172/JCI30890; Shah NP, 2002, CANCER CELL, V2, P117, DOI 10.1016/S1535-6108(02)00096-X; Shan YB, 2009, P NATL ACAD SCI USA, V106, P139, DOI 10.1073/pnas.0811223106; Stamos J, 2002, J BIOL CHEM, V277, P46265, DOI 10.1074/jbc.M207135200; Suydam IT, 2006, SCIENCE, V313, P200, DOI 10.1126/science.1127159; Suydam IT, 2003, BIOCHEMISTRY-US, V42, P12050, DOI 10.1021/bi0352926; Talpaz M, 2006, NEW ENGL J MED, V354, P2531, DOI 10.1056/NEJMoa055229; Tokarski JS, 2006, CANCER RES, V66, P5790, DOI 10.1158/0008-5472.CAN-05-4187; Toledo LM, 1999, CURR MED CHEM, V6, P775; Vultur A, 2008, MOL CANCER THER, V7, P1185, DOI 10.1158/1535-7163.MCT-08-0126; Wang WR, 2006, P NATL ACAD SCI USA, V103, P3563, DOI 10.1073/pnas.0600048103; Webb LJ, 2008, BIOCHEMISTRY-US, V47, P1588, DOI 10.1021/bi701708u; Wells SA, 2010, J CLIN ONCOL, V28, P767, DOI 10.1200/JCO.2009.23.6604; Yamaguchi H, 1996, NATURE, V384, P484, DOI 10.1038/384484a0; Yin XJ, 2010, MOLECULES, V15, P4261, DOI 10.3390/molecules15064261; Young MA, 2006, CANCER RES, V66, P1007, DOI 10.1158/0008-5472.CAN-05-2788; Yun CH, 2008, P NATL ACAD SCI USA, V105, P2070, DOI 10.1073/pnas.0709662105; Yun CH, 2007, CANCER CELL, V11, P217, DOI 10.1016/j.ccr.2006.12.017	51	94	97	0	22	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 6	2012	7	4							e29828	10.1371/journal.pone.0029828	http://dx.doi.org/10.1371/journal.pone.0029828			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	955JA	22493660	Green Published, gold, Green Submitted			2022-12-25	WOS:000305012700002
J	Kindermans, PJ; Verstraeten, D; Schrauwen, B				Kindermans, Pieter-Jan; Verstraeten, David; Schrauwen, Benjamin			A Bayesian Model for Exploiting Application Constraints to Enable Unsupervised Training of a P300-based BCI	PLOS ONE			English	Article							BRAIN-COMPUTER-INTERFACE; MENTAL PROSTHESIS; COMPETITION 2003; P300 WAVE; CLASSIFICATION; COMMUNICATION; ALGORITHM; SPELLER	This work introduces a novel classifier for a P300-based speller, which, contrary to common methods, can be trained entirely unsupervisedly using an Expectation Maximization approach, eliminating the need for costly dataset collection or tedious calibration sessions. We use publicly available datasets for validation of our method and show that our unsupervised classifier performs competitively with supervised state-of-the-art spellers. Finally, we demonstrate the added value of our method in different experimental settings which reflect realistic usage situations of increasing difficulty and which would be difficult or impossible to tackle with existing supervised or adaptive methods.	[Kindermans, Pieter-Jan; Verstraeten, David; Schrauwen, Benjamin] Univ Ghent, Ghent, Belgium	Ghent University	Kindermans, PJ (corresponding author), Univ Ghent, Ghent, Belgium.	PieterJan.Kindermans@UGent.be			BOF-GOA; Ghent University	BOF-GOA; Ghent University(Ghent University)	This work was partially funded by the BOF-GOA Project Home-MATE funded by the Ghent University Special Research Fund. http://www.ugent.be. No additional external funding received for this study. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bishop C. M., 2006, J ELECT IMAG, V16, P140; Blankertz B, 2004, IEEE T BIO-MED ENG, V51, P1044, DOI 10.1109/TBME.2004.826692; Blankertz B, 2006, IEEE T NEUR SYS REH, V14, P153, DOI 10.1109/TNSRE.2006.875642; Blankertz B, 2011, NEUROIMAGE, V56, P814, DOI 10.1016/j.neuroimage.2010.06.048; Cecotti H, 2010, IEEE T PATTERN ANAL, V99; Dahne S, 2011, 5 INT BRAIN COMP INT; DEMPSTER AP, 1977, J ROY STAT SOC B MET, V39, P1, DOI 10.1111/j.2517-6161.1977.tb01600.x; Donchin E, 2000, IEEE T REHABIL ENG, V8, P174, DOI 10.1109/86.847808; Dornhege G., 2007, BRAIN COMPUTER INTER; FARWELL LA, 1988, ELECTROEN CLIN NEURO, V70, P510, DOI 10.1016/0013-4694(88)90149-6; Fisher RA, 1936, ANN EUGENIC, V7, P179, DOI 10.1111/j.1469-1809.1936.tb02137.x; Hoffmann U, 2005, I IEEE EMBS C NEUR E, P97; Hoffmann U, 2008, J NEUROSCI METH, V167, P115, DOI 10.1016/j.jneumeth.2007.03.005; Kindermans PJ, 2011, 5 INT BRAIN COMP INT; Krauledat M, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0002967; Li YQ, 2008, PATTERN RECOGN LETT, V29, P1285, DOI 10.1016/j.patrec.2008.01.030; Liu Y, 2005, NEURAL NETWORKS BRAI, V3, P1535; Lu SJ, 2009, IEEE T NEUR SYS REH, V17, P135, DOI 10.1109/TNSRE.2009.2015197; Nijboer F, 2008, CLIN NEUROPHYSIOL, V119, P1909, DOI 10.1016/j.clinph.2008.03.034; Panicker RC, 2010, IEEE T BIO-MED ENG, V57, P2927, DOI 10.1109/TBME.2010.2058804; PICTON TW, 1992, J CLIN NEUROPHYSIOL, V9, P456, DOI 10.1097/00004691-199210000-00002; Rakotomarnonjy A, 2008, IEEE T BIO-MED ENG, V55, P1147, DOI 10.1109/TBME.2008.915728; Toh KA, 2008, NEURAL COMPUT, V20, P1565, DOI 10.1162/neco.2007.04-07-508; Vaughan TM, 2006, IEEE T NEUR SYS REH, V14, P229, DOI 10.1109/TNSRE.2006.875577; VIDAL JJ, 1973, ANNU REV BIOPHYS BIO, V2, P157, DOI 10.1146/annurev.bb.02.060173.001105; Wolpaw JR, 2002, CLIN NEUROPHYSIOL, V113, P767, DOI 10.1016/S1388-2457(02)00057-3; Xu N, 2004, IEEE T BIO-MED ENG, V51, P1067, DOI 10.1109/TBME.2004.826699; Xu P, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0014634; Yanez-Suarez O, P300 SPELLER PUBLICD	29	50	52	3	13	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 4	2012	7	4							e33758	10.1371/journal.pone.0033758	http://dx.doi.org/10.1371/journal.pone.0033758			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	953GO	22496763	Green Published, Green Submitted, gold			2022-12-25	WOS:000304855200022
J	Yu, X; Jiang, YF; Lu, L; Gong, X; Sun, XG; Xuan, ZP; Lu, LJ				Yu, Xin; Jiang, Yanfang; Lu, Lu; Gong, Xu; Sun, Xiguang; Xuan, Zhaopeng; Lu, Laijin			A Crucial Role of IL-17 and IFN-gamma during Acute Rejection of Peripheral Nerve Xenotransplantation in Mice	PLOS ONE			English	Article							T-CELL RESPONSES; TH17 CELLS; ALLOGRAFT-REJECTION; NEUROMA FORMATION; PORCINE ISLETS; EFFECTOR; LINEAGE; INFLAMMATION; DIFFERENTIATION; TRANSPLANTATION	Nerve injuries causing segmental loss require nerve grafting. However, autografts and allografts have limitations for clinical use. Peripheral nerve xenotransplantation has become an area of great interest in clinical surgery research as an alternative graft strategy. However, xenotransplant rejection is severe with cellular immunity, and Th1 cells play an important role in the process. To better understand the process of rejection, we used peripheral nerve xenografts from rats to mice and found that mononuclear cells expressing IFN-gamma and IL-17 infiltrated around the grafts, and IFN-gamma and IL-17 producing CD4+ and CD8+ T cells increased during the process of acute rejection. The changes of IL-4 level had no significant difference between xenotransplanted group and sham control group. The rejection of xenograft was significantly prevented after the treatment of IL-17 and IFN-gamma neutralizing antibodies. These data suggest that Th17 cells contribute to the acute rejection process of peripheral nerve xenotransplant in addition to Th1 cells.	[Yu, Xin; Lu, Lu; Gong, Xu; Sun, Xiguang; Xuan, Zhaopeng; Lu, Laijin] Jilin Univ, Dept Hand Surg, Hosp 1, Changchun 130023, Peoples R China; [Jiang, Yanfang] Jilin Univ, Dept Cent Lab, Second Part Hosp 1, Changchun 130023, Peoples R China	Jilin University; Jilin University	Yu, X (corresponding author), Jilin Univ, Dept Hand Surg, Hosp 1, Changchun 130023, Peoples R China.	lulaijin@yeah.net	lu, lu/HII-7530-2022; lu, lu/HGA-0894-2022		National Natural Science Foundation of China [81171145, 30972610]; Ph.D. Programs Foundation of Ministry of Education of China [20100061110057]; Graduate Innovation Foundation of Jilin University [20101032]; National High Technology Research and Development Program 863 [2011AA02A106]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Ph.D. Programs Foundation of Ministry of Education of China(Ministry of Education, China); Graduate Innovation Foundation of Jilin University; National High Technology Research and Development Program 863(National High Technology Research and Development Program of China)	This study supported by grants from the National Natural Science Foundation of China (No. 81171145 and 30972610), Ph.D. Programs Foundation of Ministry of Education of China (20100061110057), Graduate Innovation Foundation of Jilin University(20101032), and National High Technology Research and Development Program 863 (2011AA02A106). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Antonysamy MA, 1999, J IMMUNOL, V162, P577; Bending D, 2009, J CLIN INVEST, V119, P565, DOI 10.1172/JCI37865; Berger A, 1999, UNFALLCHIRURG, V102, P59, DOI 10.1007/s001130050373; Bettelli E, 2006, NATURE, V441, P235, DOI 10.1038/nature04753; Cardona K, 2006, NAT MED, V12, P304, DOI 10.1038/nm1375; Chen Y, 2008, TRANSPL P, V40, P2691, DOI 10.1016/j.transproceed.2008.08.014; Crome SQ, 2010, CLIN EXP IMMUNOL, V159, P109, DOI 10.1111/j.1365-2249.2009.04037.x; Davila E, 2006, XENOTRANSPLANTATION, V13, P31, DOI 10.1111/j.1399-3089.2005.00258.x; Dorling A, 1996, EUR J IMMUNOL, V26, P1378, DOI 10.1002/eji.1830260630; Fabrega E, 2009, LIVER TRANSPLANT, V15, P629, DOI 10.1002/lt.21724; Faust SM, 2009, J IMMUNOL, V183, P7297, DOI 10.4049/jimmunol.0902446; Fox IK, 2005, MUSCLE NERVE, V31, P59, DOI 10.1002/mus.20231; Galeano M, 2009, MICROSURG, V29, P568, DOI 10.1002/micr.20652; Harrington LE, 2005, NAT IMMUNOL, V6, P1123, DOI 10.1038/ni1254; He D, 2006, J INVEST DERMATOL, V126, P110; Hebebrand D, 1997, J HAND SURG-BRIT EUR, V22B, P304, DOI 10.1016/S0266-7681(97)80391-9; Hering BJ, 2006, NAT MED, V12, P301, DOI 10.1038/nm1369; Honey K, 1999, J IMMUNOL, V163, P4805; Ivanov II, 2006, CELL, V126, P1121, DOI 10.1016/j.cell.2006.07.035; Jones ND, 2006, J IMMUNOL, V176, P2316, DOI 10.4049/jimmunol.176.4.2316; Khader SA, 2007, NAT IMMUNOL, V8, P369, DOI 10.1038/ni1449; Kim OS, 2002, MODERN PATHOL, V15, p133A; Kortylewski M, 2009, CANCER CELL, V15, P114, DOI 10.1016/j.ccr.2008.12.018; Kreisel D, 2002, NAT MED, V8, P233, DOI 10.1038/nm0302-233; Lee YK, 2009, IMMUNITY, V30, P92, DOI 10.1016/j.immuni.2008.11.005; Liang SC, 2006, J EXP MED, V203, P2271, DOI 10.1084/jem.20061308; Lu LJ, 2009, J BIOMED BIOTECHNOL, DOI 10.1155/2009/412598; Luger D, 2008, J EXP MED, V205, P799, DOI 10.1084/jem.20071258; Mangan PR, 2006, NATURE, V441, P231, DOI 10.1038/nature04754; Martin-Orozco N, 2009, EUR J IMMUNOL, V39, P216, DOI 10.1002/eji.200838475; Novak CB, 2009, J HAND SURG-AM, V34A, P281, DOI 10.1016/j.jhsa.2008.11.017; O'Connor RA, 2008, J IMMUNOL, V181, P3750, DOI 10.4049/jimmunol.181.6.3750; Park H, 2005, NAT IMMUNOL, V6, P1133, DOI 10.1038/ni1261; SCHALLER E, 1987, PLAST RECONSTR SURG, V80, P870, DOI 10.1097/00006534-198712000-00043; Sinis N, 2007, PLAST RECONSTR SURG, V119, P960, DOI 10.1097/01.prs.0000242486.70919.82; Su SB, 2007, INVEST OPHTH VIS SCI, V48, P4616, DOI 10.1167/iovs.07-0233; Szabo SJ, 2000, CELL, V100, P655, DOI 10.1016/S0092-8674(00)80702-3; Trambley J, 1999, J CLIN INVEST, V104, P1715, DOI 10.1172/JCI8082; Trumble TE, 2000, HAND CLIN, V16, P105; Veldhoen M, 2006, NAT IMMUNOL, V7, P1151, DOI 10.1038/ni1391; Wei G, 2009, IMMUNITY, V30, P155, DOI 10.1016/j.immuni.2008.12.009; Yang YG, 2007, NAT REV IMMUNOL, V7, P519, DOI 10.1038/nri2099; Yuan XL, 2008, J EXP MED, V205, P3133, DOI 10.1084/jem.20081937	43	41	42	0	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 30	2012	7	3							e34419	10.1371/journal.pone.0034419	http://dx.doi.org/10.1371/journal.pone.0034419			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	959UC	22479627	Green Published, Green Submitted, gold			2022-12-25	WOS:000305339100157
J	Park, JN; Lee, DJ; Kwon, O; Oh, DB; Bahn, YS; Kang, HA				Park, Jeong-Nam; Lee, Dong-Jik; Kwon, Ohsuk; Oh, Doo-Byoung; Bahn, Yong-Sun; Kang, Hyun Ah			Unraveling Unique Structure and Biosynthesis Pathway of N-Linked Glycans in Human Fungal Pathogen Cryptococcus neoformans by Glycomics Analysis	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							OUTER CHAIN ELONGATION; CELL-WALL; CANDIDA-ALBICANS; SACCHAROMYCES-CEREVISIAE; MANNOSYLTRANSFERASE FAMILY; POLYSACCHARIDE CAPSULE; PROTEIN GLYCOSYLATION; PICHIA-PASTORIS; MATING TYPES; IDENTIFICATION	The encapsulated fungal pathogen Cryptococcus neoformans causes cryptococcosis in immunocompromised individuals. Although cell surface mannoproteins have been implicated in C. neoformans pathogenicity, the structure of N-linked glycans assembled on mannoproteins has not yet been elucidated. By analyzing oligosaccharide profiles combined with exoglycosi-dase treatment, we report here that C. neoformans has serotype-specific high mannose-type N-glycans with or without a beta 1,2-xylose residue, which is attached to the trimannosyl core of N-glycans. Interestingly, the neutral N-glycans of serotypes A and D were shown to contain a xylose residue, whereas those of serotype B appeared to be much shorter and devoid of a xylose residue. Moreover, analysis of the C. neoformans uxs1 Delta mutant demonstrated that UDP-xylose is utilized as a donor sugar in N-glycan biosynthesis. We also constructed and analyzed a set of C. neoformans mutant strains lacking genes putatively assigned to the reconstructed N-glycan biosynthesis pathway. It was shown that the outer chain of N-glycan is initiated by CnOch1p with addition of an alpha 1,6-mannose residue and then subsequently extended by CnMnn2p with multiple additions of alpha 1,2-mannose residues. Finally, comparative analysis of acidic N-glycans from wild-type, Cnoch1 Delta, Cnmnn2 Delta, and Cnuxs1 Delta strains strongly indicated the presence of xylose phosphate attached to mannose residues in the core and outer region of N-glycans. Our data present the first report on the unique structure and biosynthesis pathway of N-glycans in C. neoformans.	[Park, Jeong-Nam; Lee, Dong-Jik; Kang, Hyun Ah] Chung Ang Univ, Dept Life Sci, Ctr Fungal Pathogenesis, Seoul 156756, South Korea; [Kwon, Ohsuk; Oh, Doo-Byoung] Korea Res Inst Biosci & Biotechnol, Syst & Synthet Biol Res Ctr, Taejon 305806, South Korea; [Bahn, Yong-Sun] Yonsei Univ, Dept Biotechnol, Ctr Fungal Pathogenesis, Seoul 120749, South Korea	Chung Ang University; Korea Research Institute of Bioscience & Biotechnology (KRIBB); Yonsei University	Kang, HA (corresponding author), Chung Ang Univ, Dept Life Sci, Ctr Fungal Pathogenesis, Seoul 156756, South Korea.	hyunkang@cau.ac.kr	Bahn, Yong-Sun/C-1211-2012	Bahn, Yong-Sun/0000-0001-9573-5752; Oh, Doo-Byoung/0000-0002-4432-0941	Korean Ministry of Education, Science, and Technology [2010-0029117, 2012-0001150]	Korean Ministry of Education, Science, and Technology(Ministry of Education, Science & Technology (MEST), Republic of Korea)	This work was supported in part by the National Research Foundation of cerevisiae are modified by the addition of phosphomannan by Korea Grants 2010-0029117 and 2012-0001150 from the Korean Ministry of Education, Science, and Technology.	Bahn YS, 2004, EUKARYOT CELL, V3, P1476, DOI 10.1128/EC.3.6.1476-1491.2004; Bates S, 2006, J BIOL CHEM, V281, P90, DOI 10.1074/jbc.M510360200; Biondo C, 2005, INFECT IMMUN, V73, P7348, DOI 10.1128/IAI.73.11.7348-7355.2005; Biondo C, 2006, FEMS YEAST RES, V6, P645, DOI 10.1111/j.1567-1364.2006.00043.x; Bovers M, 2008, REV IBEROAM MICOL, V25, pS4, DOI 10.1016/S1130-1406(08)70019-6; Bryan RA, 2005, EUKARYOT CELL, V4, P465, DOI 10.1128/EC.4.2.465-475.2005; Buser R, 2010, J BIOL CHEM, V285, P10715, DOI 10.1074/jbc.M109.076075; Castle SA, 2008, EUKARYOT CELL, V7, P1611, DOI 10.1128/EC.00458-07; Cheon SA, 2011, PLOS PATHOG, V7, DOI 10.1371/journal.ppat.1002177; CHERNIAK R, 1994, INFECT IMMUN, V62, P1507, DOI 10.1128/IAI.62.5.1507-1512.1994; Chiba Y, 1998, J BIOL CHEM, V273, P26298, DOI 10.1074/jbc.273.41.26298; Choi BK, 2003, P NATL ACAD SCI USA, V100, P5022, DOI 10.1073/pnas.0931263100; Dean N, 1999, BBA-GEN SUBJECTS, V1426, P309, DOI 10.1016/S0304-4165(98)00132-9; Deshpande N, 2008, GLYCOBIOLOGY, V18, P626, DOI 10.1093/glycob/cwn044; Doering TL, 2009, ANNU REV MICROBIOL, V63, P223, DOI 10.1146/annurev.micro.62.081307.162753; Franzot SP, 1999, J CLIN MICROBIOL, V37, P838, DOI 10.1128/JCM.37.3.838-840.1999; Fraser JA, 2003, EUKARYOT CELL, V2, P1036, DOI 10.1128/EC.2.5.1036-1045.2003; Gemmill TR, 1999, BBA-GEN SUBJECTS, V1426, P227, DOI 10.1016/S0304-4165(98)00126-3; Helenius A, 2004, ANNU REV BIOCHEM, V73, P1019, DOI 10.1146/annurev.biochem.73.011303.073752; Hobson RP, 2004, J BIOL CHEM, V279, P39628, DOI 10.1074/jbc.M405003200; Jigami Y, 1999, BBA-GEN SUBJECTS, V1426, P335, DOI 10.1016/S0304-4165(98)00134-2; Kim MS, 2009, BIOCHEM BIOPH RES CO, V390, P983, DOI 10.1016/j.bbrc.2009.10.089; Kim MW, 2006, J BIOL CHEM, V281, P6261, DOI 10.1074/jbc.M508507200; Klutts JS, 2006, FEMS YEAST RES, V6, P499, DOI 10.1111/j.1567-1364.2006.00054.x; Kotz A, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0015729; Kwon-Chung Kyung J., 2002, Taxon, V51, P804, DOI 10.2307/1555045; KWONCHUNG KJ, 1978, AM J EPIDEMIOL, V108, P337, DOI 10.1093/oxfordjournals.aje.a112628; KWONCHUNG KJ, 1992, INFECT IMMUN, V60, P602, DOI 10.1128/IAI.60.2.602-605.1992; Leach MD, 2012, EUKARYOT CELL, V11, P98, DOI 10.1128/EC.05238-11; Levitz SM, 2006, FEMS YEAST RES, V6, P513, DOI 10.1111/j.1567-1364.2006.00071.x; Lussier M, 1999, BBA-GEN SUBJECTS, V1426, P323, DOI 10.1016/S0304-4165(98)00133-0; Maddi A, 2010, EUKARYOT CELL, V9, P1766, DOI 10.1128/EC.00134-10; Mansour MK, 2006, J IMMUNOL, V176, P3053, DOI 10.4049/jimmunol.176.5.3053; Mille C, 2008, J BIOL CHEM, V283, P9724, DOI 10.1074/jbc.M708825200; Mora-Montes HM, 2010, J BIOL CHEM, V285, P12087, DOI 10.1074/jbc.M109.081513; Moyrand F, 2002, MOL MICROBIOL, V45, P837, DOI 10.1046/j.1365-2958.2002.03059.x; NAKAYAMA K, 1992, EMBO J, V11, P2511, DOI 10.1002/j.1460-2075.1992.tb05316.x; Nakayama K, 1997, FEBS LETT, V412, P547, DOI 10.1016/S0014-5793(97)00634-0; Park JN, 2011, APPL ENVIRON MICROB, V77, P1187, DOI 10.1128/AEM.02323-10; Perfect JR, 2005, FEMS IMMUNOL MED MIC, V45, P395, DOI 10.1016/j.femsim.2005.06.005; Ram AFJ, 2006, NAT PROTOC, V1, P2253, DOI 10.1038/nprot.2006.397; Reilly MC, 2011, J BIOL CHEM, V286, P26888, DOI 10.1074/jbc.M111.262162; Samuelson J, 2005, P NATL ACAD SCI USA, V102, P1548, DOI 10.1073/pnas.0409460102; Song Y, 2007, APPL ENVIRON MICROB, V73, P4446, DOI 10.1128/AEM.02058-06; Turner KM, 2006, BBA-GEN SUBJECTS, V1760, P1569, DOI 10.1016/j.bbagen.2006.07.002; Uccelletti D, 2006, FEMS YEAST RES, V6, P449, DOI 10.1111/j.1567-1364.2006.00027.x; WILLIAMSON PR, 1994, J BACTERIOL, V176, P656, DOI 10.1128/jb.176.3.656-664.1994; Wozniak Karen L., 2009, V470, P71, DOI 10.1007/978-1-59745-204-5_7; Yoko-o T, 2001, FEBS LETT, V489, P75, DOI 10.1016/S0014-5793(01)02082-8	50	31	31	0	17	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JUN 1	2012	287	23					19501	19515		10.1074/jbc.M112.354209	http://dx.doi.org/10.1074/jbc.M112.354209			15	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	974EF	22500028	hybrid, Green Published			2022-12-25	WOS:000306411900063
J	Richart, AN; Brunner, CIW; Stott, K; Murzina, NV; Thomas, JO				Richart, Alexandria N.; Brunner, Clair I. W.; Stott, Katherine; Murzina, Natalia V.; Thomas, Jean O.			Characterization of Chromoshadow Domain-mediated Binding of Heterochromatin Protein 1 alpha (HP1 alpha) to Histone H3	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							HP1 BINDING; CRYSTAL-STRUCTURE; NMR-SPECTROSCOPY; MAMMALIAN-CELLS; NUCLEOSOMAL DNA; LYSINE 9; CHROMATIN; DYNAMICS; CHROMODOMAIN; RECOGNITION	The chromoshadow domain (CSD) of heterochromatin protein 1 (HP1) was recently shown to contribute to chromatin binding and transcriptional regulation through interaction with histone H3. Here, we demonstrate the structural basis of this interaction for the CSD of HP1 alpha. This mode of H3 binding is dependent on dimerization of the CSD and recognition of a PxVxL-like motif, as for other CSD partners. NMR chemical shift mapping showed that the H3 residues that mediate the CSD interaction occur in and adjacent to the alpha N helix just within the nucleosome core. Access to the binding region would require some degree of unwrapping of the DNA near the nucleosomal DNA entry/exit site.	[Richart, Alexandria N.; Brunner, Clair I. W.; Stott, Katherine; Murzina, Natalia V.; Thomas, Jean O.] Univ Cambridge, Dept Biochem, Cambridge CB2 1GA, England	University of Cambridge	Murzina, NV (corresponding author), Univ Cambridge, Dept Biochem, Cambridge CB2 1GA, England.	nm@mole.bio.cam.ac.uk; jot1@cam.ac.uk		Stott, Katherine/0000-0002-4014-1188	Wellcome Trust [094519/Z/10/Z]; Gates Cambridge Trust	Wellcome Trust(Wellcome TrustEuropean Commission); Gates Cambridge Trust	This work was supported by Project Grant 094519/Z/10/Z from the Wellcome Trust (to J. O. T. and N. V. M.) and by a scholarship from the Gates Cambridge Trust (to A. N. R.).	Ayoub N, 2009, CELL CYCLE, V8, P2945; Ball LJ, 1997, EMBO J, V16, P2473, DOI 10.1093/emboj/16.9.2473; Bannister AJ, 2001, NATURE, V410, P120, DOI 10.1038/35065138; Brasher SV, 2000, EMBO J, V19, P1587, DOI 10.1093/emboj/19.7.1587; Canzio D, 2011, MOL CELL, V41, P67, DOI 10.1016/j.molcel.2010.12.016; Cavanagh J., 1996, PROTEIN NMR SPECTROS; Cheutin T, 2003, SCIENCE, V299, P721, DOI 10.1126/science.1078572; Danzer JR, 2004, DEVELOPMENT, V131, P3571, DOI 10.1242/dev.01223; Dawson MR, 2009, NATURE, V461, pE4, DOI 10.1038/nature08254; Dialynas GK, 2006, J BIOL CHEM, V281, P14350, DOI 10.1074/jbc.M600558200; Eskeland R, 2007, MOL CELL BIOL, V27, P453, DOI 10.1128/MCB.01576-06; Fan JY, 2004, MOL CELL, V16, P655, DOI 10.1016/j.molcel.2004.10.023; Fanti L, 2008, CURR OPIN GENET DEV, V18, P169, DOI 10.1016/j.gde.2008.01.009; Ferreira H, 2007, MOL CELL BIOL, V27, P4037, DOI 10.1128/MCB.02229-06; Festenstein R, 2003, SCIENCE, V299, P719, DOI 10.1126/science.1078694; Fischle W, 2003, NATURE, V425, P475, DOI 10.1038/nature02017; Hediger F, 2006, CURR OPIN GENET DEV, V16, P143, DOI 10.1016/j.gde.2006.02.013; Huang Y, 2006, STRUCTURE, V14, P703, DOI 10.1016/j.str.2006.01.007; Kato H, 2009, J AM CHEM SOC, V131, P15104, DOI 10.1021/ja9070078; KRAULIS PJ, 1991, J APPL CRYSTALLOGR, V24, P946, DOI 10.1107/S0021889891004399; Kwon SH, 2011, BIOESSAYS, V33, P280, DOI 10.1002/bies.201000138; Lachner M, 2001, NATURE, V410, P116, DOI 10.1038/35065132; Lavigne M, 2009, PLOS GENET, V5, DOI 10.1371/journal.pgen.1000769; Li G, 2004, NAT STRUCT MOL BIOL, V11, P763, DOI 10.1038/nsmb801; Li G, 2005, NAT STRUCT MOL BIOL, V12, P46, DOI 10.1038/nsmb869; Lomberk G, 2006, GENOME BIOL, V7, DOI 10.1186/gb-2006-7-7-228; Luger K, 1997, NATURE, V389, P251, DOI 10.1038/38444; Meehan RR, 2003, EMBO J, V22, P3164, DOI 10.1093/emboj/cdg306; Merritt EA, 1997, METHOD ENZYMOL, V277, P505, DOI 10.1016/S0076-6879(97)77028-9; Muller KP, 2009, BIOPHYS J, V97, P2876, DOI 10.1016/j.bpj.2009.08.057; Murzina N, 1999, MOL CELL, V4, P529, DOI 10.1016/S1097-2765(00)80204-X; Poirier MG, 2008, J MOL BIOL, V379, P772, DOI 10.1016/j.jmb.2008.04.025; Schmiedeberg L, 2004, MOL BIOL CELL, V15, P2819, DOI 10.1091/mbc.E03-11-0827; Smothers JF, 2000, CURR BIOL, V10, P27, DOI 10.1016/S0960-9822(99)00260-2; Somers J, 2009, NUCLEIC ACIDS RES, V37, P2504, DOI 10.1093/nar/gkp114; Thiru A, 2004, EMBO J, V23, P489, DOI 10.1038/sj.emboj.7600088; Travers AA, 2003, EMBO REP, V4, P131, DOI 10.1038/sj.embor.embor741; Ueda T, 2004, BIOCHEMISTRY-US, V43, P9901, DOI 10.1021/bi035975l; Verreault A, 1998, CURR BIOL, V8, P96, DOI 10.1016/S0960-9822(98)70040-5; Vranken WF, 2005, PROTEINS, V59, P687, DOI 10.1002/prot.20449; WALLRATH LL, 1995, GENE DEV, V9, P1263, DOI 10.1101/gad.9.10.1263; Zuiderweg ERP, 2002, BIOCHEMISTRY-US, V41, P1, DOI 10.1021/bi011870b	42	21	21	0	6	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAY 25	2012	287	22					18730	18737		10.1074/jbc.M111.337204	http://dx.doi.org/10.1074/jbc.M111.337204			8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	974EC	22493481	Green Published, hybrid			2022-12-25	WOS:000306411600081
J	Scranton, MA; Yee, A; Park, SY; Walling, LL				Scranton, Melissa A.; Yee, Ashley; Park, Sang-Youl; Walling, Linda L.			Plant Leucine Aminopeptidases Moonlight as Molecular Chaperones to Alleviate Stress-induced Damage	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							HEAT-SHOCK PROTEINS; END RULE PATHWAY; ARABIDOPSIS-THALIANA; MANDUCA-SEXTA; LAP-A; NICOTIANA-ATTENUATA; GENE-EXPRESSION; JASMONIC ACID; AMINO-ACID; IN-VITRO	Leucine aminopeptidases (LAPs) are present in animals, plants, and microbes. In plants, there are two classes of LAPs. The neutral LAPs (LAP-N and its orthologs) are constitutively expressed and detected in all plants, whereas the stress-induced acidic LAPs (LAP-A) are expressed only in a subset of the Solanaceae. LAPs have a role in insect defense and act as a regulator of the late branch of wound signaling in Solanum lycopersicum (tomato). Although the mechanism of LAP-A action is unknown, it has been presumed that LAP peptidase activity is essential for regulating wound signaling. Here we show that plant LAPs are bifunctional. Using three assays to monitor protein protection from heat-induced damage, it was shown that the tomato LAP-A and LAP-N and the Arabidopsis thaliana LAP1 and LAP2 are molecular chaperones. Assays using LAP-A catalytic site mutants demonstrated that LAP-A chaperone activity was independent of its peptidase activity. Furthermore, disruption of the LAP-A hexameric structure increased chaperone activity. Together, these data identify a new class of molecular chaperones and a new function for the plant LAPs as well as suggesting new mechanisms for LAP action in the defense of solanaceous plants against stress.	[Walling, Linda L.] Univ Calif Riverside, Dept Bot & Plant Sci, Riverside, CA 92521 USA; Univ Calif Riverside, Ctr Plant Cell Biol, Riverside, CA 92521 USA	University of California System; University of California Riverside; University of California System; University of California Riverside	Walling, LL (corresponding author), Univ Calif Riverside, Dept Bot & Plant Sci, Riverside, CA 92521 USA.	Linda.walling@ucr.edu		Scranton, Melissa/0000-0003-1910-3117	National Science Foundation [IOB 0645230, MCB 0313579, DGE 0504249, IOB 064523]	National Science Foundation(National Science Foundation (NSF))	This work was supported by National Science Foundation Grants IOB 0645230 and MCB 0313579 (to L. L. W.).; Supported in part by the National Science Foundation-funded ChemlGERT program (Grant DGE 0504249) and Grant IOB 064523.	[Anonymous], 2004, HDB PROTEOLYTIC ENZY; Barrett A. J., 1998, HDB PROTEOLYTIC ENZY; BARTLING D, 1992, EUR J BIOCHEM, V205, P425, DOI 10.1111/j.1432-1033.1992.tb16796.x; Basha E, 2010, J BIOL CHEM, V285, P11489, DOI 10.1074/jbc.M109.074088; Bostock RM, 2005, ANNU REV PHYTOPATHOL, V43, P545, DOI 10.1146/annurev.phyto.41.052002.095505; BRYAN JK, 1977, ANAL BIOCHEM, V78, P513, DOI 10.1016/0003-2697(77)90111-7; Chao WS, 1999, PLANT PHYSIOL, V120, P979, DOI 10.1104/pp.120.4.979; Chao WS, 2000, PLANTA, V210, P563, DOI 10.1007/s004250050045; Chen H, 2005, P NATL ACAD SCI USA, V102, P19237, DOI 10.1073/pnas.0509026102; Chen H, 2007, PLANT PHYSIOL, V143, P1954, DOI 10.1104/pp.106.095588; DOW JAT, 1992, J EXP BIOL, V172, P355; FELTON GW, 1989, J CHEM ECOL, V15, P2667, DOI 10.1007/BF01014725; Fowler JH, 2009, PLANT CELL, V21, P1239, DOI 10.1105/tpc.108.065029; FRYDMAN J, 1994, NATURE, V370, P111, DOI 10.1038/370111a0; Giese KC, 2005, P NATL ACAD SCI USA, V102, P18896, DOI 10.1073/pnas.0506169103; Giese KC, 2002, J BIOL CHEM, V277, P46310, DOI 10.1074/jbc.M208926200; Graciet E, 2010, TRENDS PLANT SCI, V15, P447, DOI 10.1016/j.tplants.2010.04.011; Gu YQ, 1999, EUR J BIOCHEM, V263, P726, DOI 10.1046/j.1432-1327.1999.00548.x; Gu YQ, 2000, EUR J BIOCHEM, V267, P1178, DOI 10.1046/j.1432-1327.2000.01116.x; Gu YQ, 1996, PLANT PHYSIOL, V110, P1257, DOI 10.1104/pp.110.4.1257; Gu YQ, 1996, J BIOL CHEM, V271, P25880, DOI 10.1074/jbc.271.42.25880; Gu YQ, 2002, EUR J BIOCHEM, V269, P1630, DOI 10.1046/j.1432-1327.2002.02795.x; Halitschke R, 2003, PLANT PHYSIOL, V131, P1894, DOI 10.1104/pp.102.018184; Hartl M, 2008, NEW PHYTOL, V179, P356, DOI 10.1111/j.1469-8137.2008.02479.x; Haslbeck M, 2005, NAT STRUCT MOL BIOL, V12, P842, DOI 10.1038/nsmb993; Hong WZ, 2005, J BIOL CHEM, V280, P27029, DOI 10.1074/jbc.M503934200; Hotokezaka Y, 2002, J BIOL CHEM, V277, P18545, DOI 10.1074/jbc.M201022200; Huynh KH, 2009, ACTA CRYSTALLOGR F, V65, P952, DOI 10.1107/S1744309109031467; Jang HH, 2004, CELL, V117, P625, DOI 10.1016/j.cell.2004.05.002; JOHNSON R, 1989, P NATL ACAD SCI USA, V86, P9871, DOI 10.1073/pnas.86.24.9871; Kale A, 2010, J MOL BIOL, V398, P703, DOI 10.1016/j.jmb.2010.03.042; Kampinga HH, 2010, NAT REV MOL CELL BIO, V11, P579, DOI 10.1038/nrm2941; Kang JH, 2006, PLANT CELL, V18, P3303, DOI 10.1105/tpc.106.041103; Lawrence SD, 2008, J CHEM ECOL, V34, P1013, DOI 10.1007/s10886-008-9507-2; Lee GJ, 1998, METHOD ENZYMOL, V290, P350, DOI 10.1016/S0076-6879(98)90031-3; Lee JR, 2009, P NATL ACAD SCI USA, V106, P5978, DOI 10.1073/pnas.0811231106; Lee S, 2009, BMB REP, V42, P812, DOI 10.5483/BMBRep.2009.42.12.812; Malki A, 2005, J BIOL CHEM, V280, P14420, DOI 10.1074/jbc.M408296200; McGowan S, 2010, P NATL ACAD SCI USA, V107, P2449, DOI 10.1073/pnas.0911813107; Meinnel T, 2006, BIOL CHEM, V387, P839, DOI 10.1515/BC.2006.107; Narvaez-Vasquez J, 2008, PLANTA, V227, P341, DOI 10.1007/s00425-007-0621-0; Neuwald AF, 1999, GENOME RES, V9, P27; PAUTOT V, 1993, P NATL ACAD SCI USA, V90, P9906, DOI 10.1073/pnas.90.21.9906; Pautot V, 2001, MOL PLANT MICROBE IN, V14, P214, DOI 10.1094/MPMI.2001.14.2.214; Peer WA, 2011, ANN BOT-LONDON, V107, P1171, DOI 10.1093/aob/mcq265; Peer WA, 2009, PLANT CELL, V21, P1693, DOI 10.1105/tpc.108.059634; Reymond P, 2000, PLANT CELL, V12, P707, DOI 10.1105/tpc.12.5.707; Ross S, 2005, PLANT PHYSIOL, V137, P623, DOI 10.1104/pp.104.056861; Sakamoto W, 2006, ANNU REV PLANT BIOL, V57, P599, DOI 10.1146/annurev.arplant.57.032905.105401; Sanchez-Moran E, 2004, PLANT CELL, V16, P2895, DOI 10.1105/tpc.104.024992; Santhoshkumar P, 2001, MOL VIS, V7, P172; Siddique M, 2008, CELL STRESS CHAPERON, V13, P183, DOI 10.1007/s12192-008-0032-6; Spiess C, 1999, CELL, V97, P339, DOI 10.1016/S0092-8674(00)80743-6; Strater N, 1999, P NATL ACAD SCI USA, V96, P11151, DOI 10.1073/pnas.96.20.11151; Sun Y, 2005, CELL MOL LIFE SCI, V62, P2460, DOI 10.1007/s00018-005-5190-4; Suzuki CK, 1997, TRENDS BIOCHEM SCI, V22, P118, DOI 10.1016/S0968-0004(97)01020-7; Tapley TL, 2010, P NATL ACAD SCI USA, V107, P1071, DOI 10.1073/pnas.0911610107; Taylor A, 1985, Prog Clin Biol Res, V180, P299; Tu CJ, 2003, PLANT PHYSIOL, V132, P243, DOI 10.1104/pp.102.013854; Tyedmers J, 2010, NAT REV MOL CELL BIO, V11, P777, DOI 10.1038/nrm2993; van Endert P, 2011, CELL MOL LIFE SCI, V68, P1553, DOI 10.1007/s00018-011-0662-1; Varshavsky A, 2011, PROTEIN SCI, V20, P1298, DOI 10.1002/pro.666; VIERLING E, 1991, ANNU REV PLANT PHYS, V42, P579, DOI 10.1146/annurev.pp.42.060191.003051; Walling LL, 2006, CURR OPIN PLANT BIOL, V9, P227, DOI 10.1016/j.pbi.2006.03.009; WALLING LL, 2004, HDB PROTEOLYTIC ENZY, P901; Wang WX, 2004, TRENDS PLANT SCI, V9, P244, DOI 10.1016/j.tplants.2004.03.006	66	41	43	0	37	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAY 25	2012	287	22					18408	18417		10.1074/jbc.M111.309500	http://dx.doi.org/10.1074/jbc.M111.309500			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	974EC	22493451	Green Published, hybrid			2022-12-25	WOS:000306411600047
J	Feng, CG; Stamatos, NM; Dragan, AI; Medvedev, A; Whitford, M; Zhang, L; Song, C; Rallabhandi, P; Cole, L; Nhu, QM; Vogel, SN; Geddes, CD; Cross, AS				Feng, Chiguang; Stamatos, Nicholas M.; Dragan, Anatoliy I.; Medvedev, Andrei; Whitford, Melissa; Zhang, Lei; Song, Chang; Rallabhandi, Prasad; Cole, Leah; Nhu, Quan M.; Vogel, Stefanie N.; Geddes, Chris D.; Cross, Alan S.			Sialyl Residues Modulate LPS-Mediated Signaling through the Toll-Like Receptor 4 Complex	PLOS ONE			English	Article							RECURRENT BACTERIAL-INFECTIONS; N-LINKED GLYCOSYLATIONS; CELL-SURFACE; SIALIDASE ACTIVITY; TLR4-MD-2 COMPLEX; HUMAN NEUTROPHILS; PLASMA-MEMBRANE; IN-VIVO; MD-2; TLR4	We previously reported that neuraminidase (NA) pretreatment of human PBMCs markedly increased their cytokine response to lipopolysaccharide (LPS). To study the mechanisms by which this occurs, we transfected HEK293T cells with plasmids encoding TLR4, CD14, and MD2 (three components of the LPS receptor complex), as well as a NF-kappa B luciferase reporting system. Both TLR4 and MD2 encoded by the plasmids are alpha-2,6 sialylated. HEK293T cells transfected with TLR4/MD2/CD14 responded robustly to the addition of LPS; however, omission of the MD2 plasmid abrogated this response. Addition of culture supernatants from MD2 (sMD2)-transfected HEK293T cells, but not recombinant, non-glycosylated MD2 reconstituted this response. NA treatment of sMD2 enhanced the LPS response as did NA treatment of the TLR4/CD14-transfected cell supplemented with untreated sMD2, but optimal LPS-initiated responses were observed with NA-treated TLR4/CD14-transfected cells supplemented with NA-treated sMD2. We hypothesized that removal of negatively charged sialyl residues from glycans on the TLR4 complex would hasten the dimerization of TLR4 monomers required for signaling. Co-transfection of HEK293T cells with separate plasmids encoding either YFP- or FLAG-tagged TLR4, followed by treatment with NA and stimulation with LPS, led to an earlier and more robust time-dependent dimerization of TLR4 monomers on co-immunoprecipitation, compared to untreated cells. These findings were confirmed by fluorescence resonance energy transfer (FRET) analysis. Overexpression of human Neu1 increased LPS-initiated TLR4-mediated NF-kappa B activation and a NA inhibitor suppressed its activation. We conclude that (1) sialyl residues on TLR4 modulate LPS responsiveness, perhaps by facilitating clustering of the homodimers, and that (2) sialic acid, and perhaps other glycosyl species, regulate MD2 activity required for LPS-mediated signaling. We speculate that endogenous sialidase activity mobilized during cell activation may play a role in this regulation.	[Feng, Chiguang; Whitford, Melissa; Zhang, Lei; Cross, Alan S.] Univ Maryland, Sch Med, Ctr Vaccine Dev, Baltimore, MD 21201 USA; [Stamatos, Nicholas M.] Univ Maryland, Sch Med, Dept Med, Baltimore, MD 21201 USA; [Stamatos, Nicholas M.] Univ Maryland, Sch Med, Inst Human Virol, Baltimore, MD 21201 USA; [Dragan, Anatoliy I.; Geddes, Chris D.] Univ Maryland, Inst Fluorescence, Baltimore, MD 21201 USA; [Medvedev, Andrei; Song, Chang; Rallabhandi, Prasad; Cole, Leah; Nhu, Quan M.; Vogel, Stefanie N.] Univ Maryland, Sch Med, Dept Microbiol & Immunol, Baltimore, MD 21201 USA	University System of Maryland; University of Maryland Baltimore; University System of Maryland; University of Maryland Baltimore; University System of Maryland; University of Maryland Baltimore; University System of Maryland; University of Maryland Baltimore; University of Maryland Baltimore County; University System of Maryland; University of Maryland Baltimore	Feng, CG (corresponding author), Univ Maryland, Sch Med, Ctr Vaccine Dev, Baltimore, MD 21201 USA.	across@medicine.umaryland.edu			National Institutes of Health (NIH) [HL086933-01A1]; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL086933] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [T32AI007540, R01AI018797] Funding Source: NIH RePORTER	National Institutes of Health (NIH)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	These studies were supported by National Institutes of Health (NIH) grant HL086933-01A1 to ASC. The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Amith SR, 2010, CELL SIGNAL, V22, P314, DOI 10.1016/j.cellsig.2009.09.038; Amith SR, 2009, GLYCOCONJUGATE J, V26, P1197, DOI 10.1007/s10719-009-9239-8; Bagriacik EU, 1999, GLYCOBIOLOGY, V9, P267, DOI 10.1093/glycob/9.3.267; Casanova JL, 2011, ANNU REV IMMUNOL, V29, P447, DOI 10.1146/annurev-immunol-030409-101335; Correia JD, 2002, J BIOL CHEM, V277, P1845, DOI 10.1074/jbc.M109910200; CROSS AS, 1991, J CLIN INVEST, V88, P2067, DOI 10.1172/JCI115536; Cross AS, 2003, J BIOL CHEM, V278, P4112, DOI 10.1074/jbc.M207591200; CROSS AS, 1989, J EXP MED, V169, P2021, DOI 10.1084/jem.169.6.2021; Dragan AI, 2004, J MOL BIOL, V343, P371, DOI 10.1016/j.jmb.2004.08.035; Dragan AI, 2008, METHOD ENZYMOL, V450, P185, DOI 10.1016/S0076-6879(08)03409-5; Feng CG, 2011, J LEUKOCYTE BIOL, V90, P313, DOI 10.1189/jlb.1210708; FOGEL M, 1983, J EXP MED, V157, P371, DOI 10.1084/jem.157.1.371; GALJART NJ, 1991, J BIOL CHEM, V266, P14754; Gioannini TL, 2004, P NATL ACAD SCI USA, V101, P4186, DOI 10.1073/pnas.0306906101; Hinek A, 2008, AM J PATHOL, V173, P1042, DOI 10.2353/ajpath.2008.071081; KEARSE KP, 1988, J IMMUNOL, V140, P1770; Kim HM, 2007, CELL, V130, P906, DOI 10.1016/j.cell.2007.08.002; Kobayashi M, 2006, J IMMUNOL, V176, P6211, DOI 10.4049/jimmunol.176.10.6211; Liang F, 2006, J BIOL CHEM, V281, P27526, DOI 10.1074/jbc.M605633200; Medvedev AE, 2005, J IMMUNOL, V174, P6587, DOI 10.4049/jimmunol.174.11.6587; Medvedev AE, 2003, J EXP MED, V198, P521, DOI 10.1084/jem.20030701; Medvedev AE, 2007, J BIOL CHEM, V282, P16042, DOI 10.1074/jbc.M606781200; Meng J, 2008, J BIOL CHEM, V283, P3376, DOI 10.1074/jbc.M707640200; Miyake K, 2006, J ENDOTOXIN RES, V12, P195, DOI 10.1179/096805106X118807; Monti E, 2002, NEUROCHEM RES, V27, P649, DOI 10.1023/A:1020276000901; Nagai Y, 2002, NAT IMMUNOL, V3, P667, DOI 10.1038/ni809; Nan XL, 2007, J LEUKOCYTE BIOL, V81, P284, DOI 10.1189/jlb.1105692; Nomura S, 2003, PROTEIN EXPRES PURIF, V28, P310, DOI 10.1016/S1046-5928(02)00705-2; OBRIEN AD, 1980, NATURE, V287, P440, DOI 10.1038/287440a0; Ohnishi T, 2003, CLIN DIAGN LAB IMMUN, V10, P405, DOI 10.1128/CDLI.10.3.405-410.2003; Ohnishi T, 2001, J IMMUNOL, V167, P3354, DOI 10.4049/jimmunol.167.6.3354; Overton MC, 2000, CURR BIOL, V10, P341, DOI 10.1016/S0960-9822(00)00386-9; Papini N, 2004, J BIOL CHEM, V279, P16989, DOI 10.1074/jbc.M400881200; Park BS, 2009, NATURE, V458, P1191, DOI 10.1038/nature07830; Patterson GH, 2000, ANAL BIOCHEM, V284, P438, DOI 10.1006/abio.2000.4708; Poltorak A, 1998, SCIENCE, V282, P2085, DOI 10.1126/science.282.5396.2085; Rallabhandi P, 2008, J IMMUNOL, V180, P1139, DOI 10.4049/jimmunol.180.2.1139; Rallabhandi P, 2006, J IMMUNOL, V177, P322, DOI 10.4049/jimmunol.177.1.322; Rifat S, 2008, J LEUKOCYTE BIOL, V84, P1075, DOI 10.1189/jlb.0706462; ROGGENTIN P, 1993, MOL MICROBIOL, V9, P915, DOI 10.1111/j.1365-2958.1993.tb01221.x; Sakarya S, 2004, GLYCOBIOLOGY, V14, P481, DOI 10.1093/glycob/cwh065; SCHAUER R, 1985, TRENDS BIOCHEM SCI, V10, P357, DOI 10.1016/0968-0004(85)90112-4; Schromm AB, 2001, J EXP MED, V194, P79, DOI 10.1084/jem.194.1.79; SETOGUCHI M, 1989, BIOCHIM BIOPHYS ACTA, V1008, P213, DOI 10.1016/0167-4781(80)90012-3; Stamatos NM, 2010, J LEUKOCYTE BIOL, V88, P1227, DOI 10.1189/jlb.1209776; Stamatos NM, 2004, J LEUKOCYTE BIOL, V75, P307, DOI 10.1189/jlb.0503241; Stelter F, 1996, EUR J BIOCHEM, V236, P457, DOI 10.1111/j.1432-1033.1996.00457.x; Teghanemt A, 2008, J BIOL CHEM, V283, P21881, DOI 10.1074/jbc.M800672200; Vasl J, 2008, J IMMUNOL, V180, P6107, DOI 10.4049/jimmunol.180.9.6107; Vasta GR, 2009, NAT REV MICROBIOL, V7, P424, DOI 10.1038/nrmicro2146; Visentin A, 2001, PNAS, V98, P12156; Visintin A, 2006, J LEUKOCYTE BIOL, V80, P1584, DOI 10.1189/jlb.0606388; Wang Y, 2002, J BIOL CHEM, V277, P26252, DOI 10.1074/jbc.M110515200	53	35	35	2	18	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 9	2012	7	4							e32359	10.1371/journal.pone.0032359	http://dx.doi.org/10.1371/journal.pone.0032359			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	955JO	22496731	Green Submitted, gold, Green Published			2022-12-25	WOS:000305014500003
J	Feverati, G; Achoch, M; Zrimi, J; Vuillon, L; Lesieur, C				Feverati, Giovanni; Achoch, Mounia; Zrimi, Jihad; Vuillon, Laurent; Lesieur, Claire			Beta-Strand Interfaces of Non-Dimeric Protein Oligomers Are Characterized by Scattered Charged Residue Patterns	PLOS ONE			English	Article							SIDE-CHAIN; BACTERIOPHAGE-T4 FIBRITIN; ALZHEIMERS-DISEASE; RECOGNITION SITES; CHOLERA-TOXIN; COILED COILS; ALPHA-HELIX; ASSEMBLIES; SEQUENCES; FORMS	Protein oligomers are formed either permanently, transiently or even by default. The protein chains are associated through intermolecular interactions constituting the protein interface. The protein interfaces of 40 soluble protein oligomers of stoechiometries above two are investigated using a quantitative and qualitative methodology, which analyzes the x-ray structures of the protein oligomers and considers their interfaces as interaction networks. The protein oligomers of the dataset share the same geometry of interface, made by the association of two individual beta-strands (beta-interfaces), but are otherwise unrelated. The results show that the beta-interfaces are made of two interdigitated interaction networks. One of them involves interactions between main chain atoms (backbone network) while the other involves interactions between side chain and backbone atoms or between only side chain atoms (side chain network). Each one has its own characteristics which can be associated to a distinct role. The secondary structure of the beta-interfaces is implemented through the backbone networks which are enriched with the hydrophobic amino acids favored in intramolecular beta-sheets (MCWIV). The intermolecular specificity is provided by the side chain networks via positioning different types of charged residues at the extremities (arginine) and in the middle (glutamic acid and histidine) of the interface. Such charge distribution helps discriminating between sequences of intermolecular beta-strands, of intramolecular beta-strands and of beta-strands forming beta-amyloid fibers. This might open new venues for drug designs and predictive tool developments. Moreover, the beta-strands of the cholera toxin B subunit interface, when produced individually as synthetic peptides, are capable of inhibiting the assembly of the toxin into pentamers. Thus, their sequences contain the features necessary for a beta-interface formation. Such beta-strands could be considered as 'assemblons', independent associating units, by homology to the foldons (independent folding unit). Such property would be extremely valuable in term of assembly inhibitory drug development.	[Feverati, Giovanni; Achoch, Mounia; Zrimi, Jihad; Lesieur, Claire] Univ Savoie, Annecy Le Vieux, France; [Achoch, Mounia; Zrimi, Jihad] Univ Cadi Ayyad, LCBM, Fac Sci & Tech Gueliz, Marrakech, Morocco; [Vuillon, Laurent] Univ Savoie, LAMA, Le Bourget Du Lac, France; [Lesieur, Claire] Univ Grenoble 1, AGIM, Archamps, France	Universite de Savoie; Cadi Ayyad University of Marrakech; Centre National de la Recherche Scientifique (CNRS); Universite de Savoie; UDICE-French Research Universities; Communaute Universite Grenoble Alpes; Universite Grenoble Alpes (UGA)	Feverati, G (corresponding author), Univ Savoie, Annecy Le Vieux, France.	lesieur@lapp.in2p3.fr	Vuillon, Laurent/AAR-6864-2020; Feverati, Giovanni/L-8248-2013		The system complex Rhone Alpes IXXI; University of Savoie	The system complex Rhone Alpes IXXI(Region Auvergne-Rhone-Alpes); University of Savoie	This work was supported by The system complex Rhone Alpes IXXI (5000 euros). Supported by the University of Savoie (4000 euros) The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bode C, 2007, FEBS LETT, V581, P2776, DOI 10.1016/j.febslet.2007.05.021; Calladine CR, 2001, J MOL BIOL, V305, P603, DOI 10.1006/jmbi.2000.4320; Cazals F, 2006, PROTEIN SCI, V15, P2082, DOI 10.1110/ps.062245906; Chakrabarti P, 2002, PROTEINS, V47, P334, DOI 10.1002/prot.10085; Conrady DG, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0015153; CRICK FHC, 1953, ACTA CRYSTALLOGR, V6, P689, DOI 10.1107/S0365110X53001964; Dang LT, 2011, J BIOL CHEM; Davis FP, 2005, BIOINFORMATICS, V21, P1901, DOI 10.1093/bioinformatics/bti277; de la Paz ML, 2004, P NATL ACAD SCI USA, V101, P87, DOI 10.1073/pnas.2634884100; de la Paz ML, 2002, P NATL ACAD SCI USA, V99, P16052, DOI 10.1073/pnas.252340199; FarzadFard F, 2008, J STRUCT BIOL, V161, P101, DOI 10.1016/j.jsb.2007.09.024; Gan L, 2003, BIOCHEMISTRY-US, V42, P857, DOI 10.1021/bi0271401; Gao M, 2010, P NATL ACAD SCI USA, V107, P22517, DOI 10.1073/pnas.1012820107; GARRATT RC, 1991, FEBS LETT, V280, P141, DOI 10.1016/0014-5793(91)80223-P; Goodsell DS, 2000, ANNU REV BIOPH BIOM, V29, P105, DOI 10.1146/annurev.biophys.29.1.105; Grigoryan G, 2008, CURR OPIN STRUC BIOL, V18, P477, DOI 10.1016/j.sbi.2008.04.008; Grueninger D, 2008, SCIENCE, V319, P206, DOI 10.1126/science.1150421; Guex N, 1997, ELECTROPHORESIS, V18, P2714, DOI 10.1002/elps.1150181505; Guharoy M, 2007, BIOINFORMATICS, V23, P1909, DOI 10.1093/bioinformatics/btm274; Guidry Jesse J, 2003, BMC Biochem, V4, P14, DOI 10.1186/1471-2091-4-14; Hadley EB, 2008, P NATL ACAD SCI USA, V105, P530, DOI 10.1073/pnas.0709068105; Harrison RS, 2007, REV PHYSIOL BIOCH P, V159, P1, DOI 10.1007/112_2007_0701; Iacovache I, 2008, BIOCH BIOPHYS ACTA; Janin J, 2008, Q REV BIOPHYS, V41, P133, DOI 10.1017/S0033583508004708; Jones S, 1996, P NATL ACAD SCI USA, V93, P13, DOI 10.1073/pnas.93.1.13; Kirkitadze MD, 2002, J NEUROSCI RES, V69, P567, DOI 10.1002/jnr.10328; Klein WL, 2004, NEUROBIOL AGING, V25, P569, DOI 10.1016/j.neurobiolaging.2004.02.010; Krishnan A, 2008, CURR PROTEIN PEPT SC, V9, P28; LAEMMLI UK, 1970, NATURE, V227, P680, DOI 10.1038/227680a0; Larsen TA, 1998, STRUCT FOLD DES, V6, P421, DOI 10.1016/S0969-2126(98)00044-6; Lesieur C, 1997, MOL MEMBR BIOL, V14, P45, DOI 10.3109/09687689709068435; Lesieur C, 2002, J BIOL CHEM, V277, P16697, DOI 10.1074/jbc.M110561200; Lesieur C, 2010, PLOS ONE; Lo Conte L, 1999, J MOL BIOL, V285, P2177; LUPAS A, 1991, SCIENCE, V252, P1162, DOI 10.1126/science.252.5009.1162; Lupas A, 1996, TRENDS BIOCHEM SCI, V21, P375, DOI 10.1016/0968-0004(96)10052-9; Ma B, 2007, CURR TOP MED CHEM, V7, P999, DOI 10.2174/156802607780906717; Ma BY, 2003, P NATL ACAD SCI USA, V100, P5772, DOI 10.1073/pnas.1030237100; Ma BY, 2000, J MOL BIOL, V296, P1091, DOI 10.1006/jmbi.2000.3518; Marshall KE, 2009, BIOCHEM SOC T, V37, P671, DOI 10.1042/BST0370671; Martin AJM, 2011, BIOINFORMATICS, V27, P2003, DOI 10.1093/bioinformatics/btr191; Merkel JS, 1999, STRUCT FOLD DES, V7, P1333, DOI 10.1016/S0969-2126(00)80023-4; Miller Y, 2010, POLYM ALZHEIMER AMYL; MINOR DL, 1994, NATURE, V367, P660, DOI 10.1038/367660a0; Mitraki A, 2005, METH MOL B, V300, P125; Moskaleva O, 2010, ACTA CRYSTALLOGR F, V66, P760, DOI 10.1107/S1744309110017331; MURZIN AG, 1995, J MOL BIOL, V247, P536, DOI 10.1006/jmbi.1995.0159; Nikulin A, 2005, ACTA CRYSTALLOGR D, V61, P141, DOI 10.1107/S0907444904030008; Panchenko AR, 1997, J MOL BIOL, V272, P95, DOI 10.1006/jmbi.1997.1205; Panchenko AR, 1996, P NATL ACAD SCI USA, V93, P2008, DOI 10.1073/pnas.93.5.2008; Papanikolopoulou K, 2004, J MOL BIOL, V342, P219, DOI 10.1016/j.jmb.2004.07.008; Papanikolopoulou K, 2004, J BIOL CHEM, V279, P8991, DOI 10.1074/jbc.M311791200; Penel S, 1999, J MOL BIOL, V287, P127, DOI 10.1006/jmbi.1998.2549; Richardson JS, 2002, P NATL ACAD SCI USA, V99, P2754, DOI 10.1073/pnas.052706099; Ruddock LW, 1996, J BIOL CHEM, V271, P19118, DOI 10.1074/jbc.271.32.19118; Shomura Y, 2004, J MOL BIOL, V335, P1265, DOI 10.1016/j.jmb.2003.11.028; Shulman-Peleg A, 2007, BMC BIOL, V5, DOI 10.1186/1741-7007-5-43; Soto C, 2003, NAT REV NEUROSCI, V4, P49, DOI 10.1038/nrn1007; Stein A, 2011, 3 DIMENSIONAL MODELI; Tacnet P, 2008, BBA-PROTEINS PROTEOM, V1784, P518, DOI 10.1016/j.bbapap.2007.12.005; Tsai CJ, 1996, J MOL BIOL, V260, P604, DOI 10.1006/jmbi.1996.0424; Tsai CJ, 1997, PROTEIN SCI, V6, P53; Tsai CJ, 1996, CRIT REV BIOCHEM MOL, V31, P127, DOI 10.3109/10409239609106582; Tuncbag N, 2009, BRIEF BIOINFORM, V10, P217, DOI 10.1093/bib/bbp001; Walshaw J, 2003, J STRUCT BIOL, V144, P349, DOI 10.1016/j.jsb.2003.10.014; Yan C, 2008, PROTEIN J, V27, P59, DOI 10.1007/s10930-007-9108-x; ZHANG RG, 1995, J MOL BIOL, V251, P563, DOI 10.1006/jmbi.1995.0456; Zrimi J, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0015347	68	9	9	0	14	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 9	2012	7	4							e32558	10.1371/journal.pone.0032558	http://dx.doi.org/10.1371/journal.pone.0032558			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	955JO	22496732	Green Published, Green Submitted, gold			2022-12-25	WOS:000305014500004
J	Pham, KT; Weiss, E; Soto, LFJ; Breithaupt, U; Haas, R; Fischer, W				Kieu Thuy Pham; Weiss, Evelyn; Soto, Luisa F. Jimenez; Breithaupt, Ute; Haas, Rainer; Fischer, Wolfgang			CagI Is an Essential Component of the Helicobacter pylori Cag Type IV Secretion System and Forms a Complex with CagL	PLOS ONE			English	Article							PATHOGENICITY ISLAND; PROTEIN; TRANSLOCATION; SURFACE; STABILIZATION; INDUCTION; SIGNAL; GENES; CELLS; VIRB5	Helicobacter pylori, the causative agent of type B gastritis, peptic ulcers, gastric adenocarcinoma and MALT lymphoma, uses the Cag type IV secretion system to induce a strong proinflammatory response in the gastric mucosa and to inject its effector protein CagA into gastric cells. CagA translocation results in altered host cell gene expression profiles and cytoskeletal rearrangements, and it is considered as a major bacterial virulence trait. Recently, it has been shown that binding of the type IV secretion apparatus to integrin receptors on target cells is a crucial step in the translocation process. Several bacterial proteins, including the Cag-specific components CagL and CagI, have been involved in this interaction. Here, we have examined the localization and interactions of CagI in the bacterial cell. Since the cagI gene overlaps and is co-transcribed with the cagL gene, the role of CagI for type IV secretion system function has been difficult to assess, and conflicting results have been reported regarding its involvement in the proinflammatory response. Using a marker-free gene deletion approach and genetic complementation, we show now that CagI is an essential component of the Cag type IV secretion apparatus for both CagA translocation and interleukin-8 induction. CagI is distributed over soluble and membrane-associated pools and seems to be partly surface-exposed. Deletion of several genes encoding essential Cag components has an impact on protein levels of CagI and CagL, suggesting that both proteins require partial assembly of the secretion apparatus. Finally, we show by co-immunoprecipitation that CagI and CagL interact with each other. Taken together, our results indicate that CagI and CagL form a functional complex which is formed at a late stage of secretion apparatus assembly.	[Kieu Thuy Pham; Weiss, Evelyn; Soto, Luisa F. Jimenez; Breithaupt, Ute; Haas, Rainer; Fischer, Wolfgang] Univ Munich, Max von Pettenkofer Inst Hyg & Med Mikrobiol, Munich, Germany	University of Munich	Pham, KT (corresponding author), Univ Munich, Max von Pettenkofer Inst Hyg & Med Mikrobiol, Munich, Germany.	fischer@mvp.uni-muenchen.de		Jimenez Soto, Luisa Fernanda/0000-0001-8551-5019	Deutsche Forschungsgemeinschaft [Ha2697/15-1]; Ministry of Education and Training of the Socialist Republic of Vietnam	Deutsche Forschungsgemeinschaft(German Research Foundation (DFG)); Ministry of Education and Training of the Socialist Republic of Vietnam	This work was supported by a research grant from the Deutsche Forschungsgemeinschaft (Ha2697/15-1) to RH. KTP received a research scholarship from the Ministry of Education and Training of the Socialist Republic of Vietnam. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alvarez-Martinez CE, 2009, MICROBIOL MOL BIOL R, V73, P775, DOI 10.1128/MMBR.00023-09; Amieva MR, 2008, GASTROENTEROLOGY, V134, P306, DOI 10.1053/j.gastro.2007.11.009; Andrzejewska J, 2006, J BACTERIOL, V188, P5865, DOI 10.1128/JB.00060-06; Backert S, 2008, TRENDS MICROBIOL, V16, P409, DOI 10.1016/j.tim.2008.07.001; Basso D, 2008, GASTROENTEROLOGY, V135, P91, DOI 10.1053/j.gastro.2008.03.041; Busler VJ, 2006, J BACTERIOL, V188, P4787, DOI 10.1128/JB.00066-06; Cascales E, 2003, NAT REV MICROBIOL, V1, P137, DOI 10.1038/nrmicro753; Cendron L, 2009, J MOL BIOL, V386, P204, DOI 10.1016/j.jmb.2008.12.018; Censini S, 1996, P NATL ACAD SCI USA, V93, P14648, DOI 10.1073/pnas.93.25.14648; Dailidiene D, 2006, APPL ENVIRON MICROB, V72, P5908, DOI 10.1128/AEM.01135-06; Fernandez D, 1996, J BACTERIOL, V178, P3168, DOI 10.1128/jb.178.11.3168-3176.1996; Fischer W, 2004, J BACTERIOL, V186, P777, DOI 10.1128/JB.186.3.777-784.2004; Fischer W, 2001, MOL MICROBIOL, V42, P1337, DOI 10.1046/j.1365-2958.2001.02714.x; Fischer W, 2011, FEBS J, V278, P1203, DOI 10.1111/j.1742-4658.2011.08036.x; Fischer W, 2010, NUCLEIC ACIDS RES, V38, P6089, DOI 10.1093/nar/gkq378; HAAS R, 1993, MOL MICROBIOL, V8, P753, DOI 10.1111/j.1365-2958.1993.tb01618.x; Hapfelmeier S, 2000, J BACTERIOL, V182, P4505, DOI 10.1128/JB.182.16.4505-4511.2000; Hatakeyama M, 2008, CURR OPIN MICROBIOL, V11, P30, DOI 10.1016/j.mib.2007.12.003; Hohlfeld S, 2006, MOL MICROBIOL, V59, P1624, DOI 10.1111/j.1365-2958.2006.05050.x; Jimenez-Soto LF, 2009, PLOS PATHOG, V5, DOI 10.1371/journal.ppat.1000684; Jurik A, 2010, INFECT IMMUN, V78, P5244, DOI 10.1128/IAI.00796-10; Kutter S, 2008, J BACTERIOL, V190, P2161, DOI 10.1128/JB.01341-07; Kwok T, 2007, NATURE, V449, P862, DOI 10.1038/nature06187; Odenbreit S, 2000, SCIENCE, V287, P1497, DOI 10.1126/science.287.5457.1497; Ohnishi N, 2008, P NATL ACAD SCI USA, V105, P1003, DOI 10.1073/pnas.0711183105; Pattis I, 2007, MICROBIOL-SGM, V153, P2896, DOI 10.1099/mic.0.2007/007385-0; Peek RM, 2002, NAT REV CANCER, V2, P28, DOI 10.1038/nrc703; Pinto-Santini DM, 2009, J BACTERIOL, V191, P7343, DOI 10.1128/JB.00946-09; Puls J, 2002, MOL MICROBIOL, V43, P961, DOI 10.1046/j.1365-2958.2002.02780.x; Rieder G, 2005, GASTROENTEROLOGY, V128, P1229, DOI 10.1053/j.gastro.2005.02.064; Rohde M, 2003, MOL MICROBIOL, V49, P219, DOI 10.1046/j.1365-2958.2003.03549.x; Sambrook J, 2001, MOL CLONING LAB MANU; Selbach M, 2002, INFECT IMMUN, V70, P665, DOI 10.1128/IAI.70.2.665-671.2002; Shaffer CL, 2011, PLOS PATHOG, V7, DOI 10.1371/journal.ppat.1002237; Sharma CM, 2010, NATURE, V464, P250, DOI 10.1038/nature08756; Suerbaum S, 2002, NEW ENGL J MED, V347, P1175, DOI 10.1056/NEJMra020542; Tanaka J, 2003, CELL MICROBIOL, V5, P395, DOI 10.1046/j.1462-5822.2003.00286.x; Terradot L, 2011, FEBS J, V278, P1213, DOI 10.1111/j.1742-4658.2011.08037.x; WESSEL D, 1984, ANAL BIOCHEM, V138, P141, DOI 10.1016/0003-2697(84)90782-6	39	38	39	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 6	2012	7	4							e35341	10.1371/journal.pone.0035341	http://dx.doi.org/10.1371/journal.pone.0035341			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	955JA	22493745	Green Published, Green Submitted, gold			2022-12-25	WOS:000305012700087
J	Bruder, JT; Semenova, E; Chen, P; Limbach, K; Patterson, NB; Stefaniak, ME; Konovalova, S; Thomas, C; Hamilton, M; King, CR; Richie, TL; Doolan, DL				Bruder, Joseph T.; Semenova, Elena; Chen, Ping; Limbach, Keith; Patterson, Noelle B.; Stefaniak, Maureen E.; Konovalova, Svetlana; Thomas, Charlie; Hamilton, Melissa; King, C. Richter; Richie, Thomas L.; Doolan, Denise L.			Modification of Ad5 Hexon Hypervariable Regions Circumvents Pre-Existing Ad5 Neutralizing Antibodies and Induces Protective Immune Responses	PLOS ONE			English	Article							ADENOVIRUS TYPE 5; CD8(+) T-CELLS; PLASMODIUM-YOELII; VACCINE VECTORS; HIV-1 VACCINE; GENE-TRANSFER; IMMUNOGENICITY; PROTEIN; VIRUS; IMMUNIZATION	The development of an effective malaria vaccine is a high global health priority. Vaccine vectors based on adenovirus type 5 are capable of generating robust and protective T cell and antibody responses in animal models and are currently being evaluated in clinical trials for HIV and malaria. They appear to be more effective in terms of inducing antigen-specific immune responses as compared with non-Ad5 serotype vectors. However, the high prevalence of neutralizing antibodies to Ad5 in the human population, particularly in the developing world, has the potential to limit the effectiveness of Ad5-based vaccines. We have generated novel Ad5-based vectors that precisely replace the hexon hypervariable regions with those derived from Ad43, a subgroup D serotype with low prevalence of neutralizing antibody in humans. We have demonstrated that these hexon-modified adenovectors are not neutralized efficiently by Ad5 neutralizing antibodies in vitro using sera from mice, rabbits and human volunteers. We have also generated hexon-modified adenovectors that express a rodent malaria parasite antigen, PyCSP, and demonstrated that they are as immunogenic as an unmodified vector. Furthermore, in contrast to the unmodified vector, the hexon-modified adenovectors induced robust T cell responses in mice with high levels of Ad5 neutralizing antibody. We also show that the hexon-modified vector can be combined with unmodified Ad5 vector in prime-boost regimens to induce protective responses in mice. Our data establish that these hexon-modified vectors are highly immunogenic even in the presence of pre-existing anti-adenovirus antibodies. These hexon-modified adenovectors may have advantages in sub-Saharan Africa where there is a high prevalence of Ad5 neutralizing antibody in the population.	[Bruder, Joseph T.; Semenova, Elena; Chen, Ping; Konovalova, Svetlana; Thomas, Charlie; Hamilton, Melissa; King, C. Richter] GenVec Inc, Res, Gaithersburg, MD USA; [Limbach, Keith; Patterson, Noelle B.; Stefaniak, Maureen E.; Richie, Thomas L.; Doolan, Denise L.] USN, Med Res Ctr, US Mil Malaria Vaccine Program, Silver Spring, MD USA; [Doolan, Denise L.] Queensland Inst Med Res, Brisbane, Qld 4006, Australia	United States Department of Defense; United States Navy; QIMR Berghofer Medical Research Institute	Bruder, JT (corresponding author), GenVec Inc, Res, Gaithersburg, MD USA.	jbruder@genvec.com	Doolan, Denise L/F-1969-2015	Doolan, Denise/0000-0001-7354-8817; Richie, Thomas/0000-0002-2946-5456	National Institutes of Health (NIH) [1R43AI077309-01]; US Army Medical Research and Material Command (work unit 6000.RAD1.F.A0309); US Army Medical Research and Material Command (work unit 62236N.4127.3696.A0258; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R43AI077309] Funding Source: NIH RePORTER	National Institutes of Health (NIH)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); US Army Medical Research and Material Command (work unit 6000.RAD1.F.A0309); US Army Medical Research and Material Command (work unit 62236N.4127.3696.A0258; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	This work was supported by National Institutes of Health (NIH) grant #1R43AI077309-01 and by funds allocated to NMRC by the US Army Medical Research and Material Command (work units 6000.RAD1.F.A0309 and 62236N.4127.3696.A0258). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abbink P, 2007, J VIROL, V81, P4654, DOI 10.1128/JVI.02696-06; Abel B, 2010, AM J RESP CRIT CARE, V181, P1407, DOI 10.1164/rccm.200910-1484OC; Barouch DH, 2004, J IMMUNOL, V172, P6290, DOI 10.4049/jimmunol.172.10.6290; Brough DE, 1996, J VIROL, V70, P6497, DOI 10.1128/JVI.70.9.6497-6501.1996; Bruder JT, 2010, VACCINE, V28, P3201, DOI 10.1016/j.vaccine.2010.02.024; Bruder JT, 2010, HUM VACCINES, V6, P54, DOI 10.4161/hv.6.1.10463; Buchbinder SP, 2008, LANCET, V372, P1881, DOI 10.1016/S0140-6736(08)61591-3; Casimiro DR, 2003, J VIROL, V77, P6305, DOI 10.1128/JVI.77.11.6305-6313.2003; Catanzaro AT, 2006, J INFECT DIS, V194, P1638, DOI 10.1086/509258; CHAROENVIT Y, 1991, J IMMUNOL, V146, P1020; Cheng C, 2007, PLOS PATHOG, V3, P239, DOI 10.1371/journal.ppat.0030025; Doolan DL, 2006, CURR MOL MED, V6, P169, DOI 10.2174/156652406776055249; EGAN JE, 1987, SCIENCE, V236, P453, DOI 10.1126/science.3551073; Epstein SL, 2005, VACCINE, V23, P5404, DOI 10.1016/j.vaccine.2005.04.047; Farina SF, 2001, J VIROL, V75, P11603, DOI 10.1128/JVI.75.23.11603-11613.2001; Fitzgerald JC, 2003, J IMMUNOL, V170, P1416, DOI 10.4049/jimmunol.170.3.1416; Gall J, 1996, J VIROL, V70, P2116, DOI 10.1128/JVI.70.4.2116-2123.1996; Gall JGD, 1998, J VIROL, V72, P10260, DOI 10.1128/JVI.72.12.10260-10264.1998; Gilbert SC, 2002, VACCINE, V20, P1039, DOI 10.1016/S0264-410X(01)00450-9; Hensley SE, 2007, MOL THER, V15, P393, DOI 10.1038/sj.mt.6300024; HIERHOLZER JC, 1991, ARCH VIROL, V121, P179, DOI 10.1007/BF01316753; Hong SS, 2003, J VIROL, V77, P10366, DOI 10.1128/JVI.77.19.10366-10375.2003; JACOBS SC, 1992, J VIROL, V66, P2086, DOI 10.1128/JVI.66.4.2086-2095.1992; Kostense S, 2004, AIDS, V18, P1213, DOI 10.1097/00002030-200405210-00019; Lasaro MO, 2009, MOL THER, V17, P1333, DOI 10.1038/mt.2009.130; Lemckert AAC, 2005, J VIROL, V79, P9694, DOI 10.1128/JVI.79.15.9694-9701.2005; Lubeck MD, 1997, NAT MED, V3, P651, DOI 10.1038/nm0697-651; McElrath MJ, 2008, LANCET, V372, P1894, DOI 10.1016/S0140-6736(08)61592-5; NORRBY E, 1969, J GEN VIROL, V5, P221, DOI 10.1099/0022-1317-5-2-221; Ophorst OJAE, 2006, INFECT IMMUN, V74, P313, DOI 10.1128/IAI.74.1.313-320.2006; Ophorst OJAE, 2004, VACCINE, V22, P3035, DOI 10.1016/j.vaccine.2004.02.011; Pinto AR, 2003, J IMMUNOL, V171, P6774, DOI 10.4049/jimmunol.171.12.6774; POTOCNJAK P, 1980, J EXP MED, V151, P1504, DOI 10.1084/jem.151.6.1504; Rasmussen H, 2002, CANCER GENE THER, V9, P951, DOI 10.1038/sj.cgt.7700518; Roberts DM, 2006, NATURE, V441, P239, DOI 10.1038/nature04721; ROBERTS MM, 1986, SCIENCE, V232, P1148, DOI 10.1126/science.3704642; Rodrigues EG, 2000, PARASITE IMMUNOL, V22, P157, DOI 10.1046/j.1365-3024.2000.00289.x; Rodrigues EG, 1997, J IMMUNOL, V158, P1268; Roederer M, 2011, CYTOM PART A, V79A, P167, DOI 10.1002/cyto.a.21015; Roy S, 1998, J VIROL, V72, P6875, DOI 10.1128/JVI.72.8.6875-6879.1998; Rux JJ, 2000, MOL THER, V1, P18, DOI 10.1006/mthe.1999.0001; Rux JJ, 2004, HUM GENE THER, V15, P1167, DOI 10.1089/hum.2004.15.1167; Rux JJ, 2003, J VIROL, V77, P9553, DOI 10.1128/JVI.77.17.9553-9566.2003; Sedegah M, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0024586; Sedegah M, 2010, MALARIA J, V9, DOI 10.1186/1475-2875-9-241; Shiver JW, 2004, ANNU REV MED, V55, P355, DOI 10.1146/annurev.med.55.091902.104344; Shiver JW, 2002, NATURE, V415, P331, DOI 10.1038/415331a; Sprangers MC, 2003, J CLIN MICROBIOL, V41, P5046, DOI 10.1128/JCM.41.11.5046-5052.2003; Sridhar S, 2008, J VIROL, V82, P3822, DOI 10.1128/JVI.02568-07; Sullivan NJ, 2003, NATURE, V424, P681, DOI 10.1038/nature01876; Sumida SM, 2005, J IMMUNOL, V174, P7179, DOI 10.4049/jimmunol.174.11.7179; Tamminga C, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0025868; Tan YD, 2003, HUM GENE THER, V14, P1673, DOI 10.1089/104303403322542310; Thorner AR, 2006, J CLIN MICROBIOL, V44, P3781, DOI 10.1128/JCM.01249-06; TOOGOOD CIA, 1992, J GEN VIROL, V73, P1429, DOI 10.1099/0022-1317-73-6-1429; Tsuji M, 2003, TRENDS PARASITOL, V19, P88, DOI 10.1016/S1471-4922(02)00053-3; Vogels R, 2003, J VIROL, V77, P8263, DOI 10.1128/JVI.77.15.8263-8271.2003; Wang J, 2004, J IMMUNOL, V173, P6357, DOI 10.4049/jimmunol.173.10.6357; WANG RB, 1995, J IMMUNOL, V154, P2784; WOHLFART C, 1988, J VIROL, V62, P2321, DOI 10.1128/JVI.62.7.2321-2328.1988; Worgall S, 2005, J CLIN INVEST, V115, P1281, DOI 10.1172/JCI200523135; Xiang ZQ, 1996, VIROLOGY, V219, P220, DOI 10.1006/viro.1996.0239; Xiang ZQ, 2002, J VIROL, V76, P2667, DOI 10.1128/JVI.76.6.2667-2675.2002; Youil R, 2002, HUM GENE THER, V13, P311, DOI 10.1089/10430340252769824	64	24	29	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 5	2012	7	4							e33920	10.1371/journal.pone.0033920	http://dx.doi.org/10.1371/journal.pone.0033920			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	955IH	22496772	Green Published, gold, Green Accepted, Green Submitted			2022-12-25	WOS:000305010500003
J	Harris, GL; Creason, MB; Brulte, GB; Herr, DR				Harris, Greg L.; Creason, Michael B.; Brulte, Greg B.; Herr, Deron R.			In Vitro and In Vivo Antagonism of a G Protein-Coupled Receptor (S1P(3)) with a Novel Blocking Monoclonal Antibody	PLOS ONE			English	Article							SPHINGOSINE 1-PHOSPHATE RECEPTORS; ENDOTHELIAL-CELL MIGRATION; SIGNALING PATHWAYS; GROWTH-FACTOR; SPHINGOSINE-1-PHOSPHATE RECEPTORS; FINGOLIMOD FTY720; CANCER CELLS; EXPRESSION; PROLIFERATION; ANGIOGENESIS	Background: S1P(3) is a lipid-activated G protein-couple receptor (GPCR) that has been implicated in the pathological processes of a number of diseases, including sepsis and cancer. Currently, there are no available high-affinity, subtype-selective drug compounds that can block activation of S1P(3). We have developed a monoclonal antibody (7H9) that specifically recognizes S1P(3) and acts as a functional antagonist. Methodology/Principal Findings: Specific binding of 7H9 was demonstrated by immunocytochemistry using cells that over-express individual members of the S1P receptor family. We show, in vitro, that 7H9 can inhibit the activation of S1P(3)-mediated cellular processes, including arrestin translocation, receptor internalization, adenylate cyclase inhibiton, and calcium mobilization. We also demonstrate that 7H9 blocks activation of S1P(3) in vivo, 1) by preventing lethality due to systemic inflammation, and 2) by altering the progression of breast tumor xenografts. Conclusions/Significance: We have developed the first-reported monoclonal antibody that selectively recognizes a lipid-activated GPCR and blocks functional activity. In addition to serving as a lead drug compound for the treatment of sepsis and breast cancer, it also provides proof of concept for the generation of novel GPCR-specific therapeutic antibodies.	[Harris, Greg L.; Creason, Michael B.; Brulte, Greg B.; Herr, Deron R.] Express Drug Designs LLC, San Marcos, CA USA; [Harris, Greg L.; Herr, Deron R.] San Diego State Univ, Dept Biol, San Diego, CA 92182 USA	California State University System; San Diego State University	Harris, GL (corresponding author), Express Drug Designs LLC, San Marcos, CA USA.	dherr@expressiondrugdesigns.com	Herr, Deron/AAB-7380-2020	Herr, Deron/0000-0001-5755-0896	National Institutes of Health (NIH) [1R43 CA132400, 1R43 CA156892]; NATIONAL CANCER INSTITUTE [R43CA156892, R43CA132400] Funding Source: NIH RePORTER	National Institutes of Health (NIH)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	This work was supported by National Institutes of Health (NIH) grants (1R43 CA132400, 1R43 CA156892) to DRH. The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript. No additional external funding was received for this study.	Arikawa K, 2003, J BIOL CHEM, V278, P32841, DOI 10.1074/jbc.M305024200; Benaud C, 2002, J BIOL CHEM, V277, P10539, DOI 10.1074/jbc.M109064200; Budde K, 2002, J AM SOC NEPHROL, V13, DOI 10.1681/ASN.V1341073; Choi JW, 2010, ANNU REV PHARMACOL, V50, P157, DOI 10.1146/annurev.pharmtox.010909.105753; Chun J, 2011, DISCOV MED, V12, P213; Czeloth N, 2005, J IMMUNOL, V175, P2960, DOI 10.4049/jimmunol.175.5.2960; Dolezalova H, 2003, J CELL BIOCHEM, V88, P732, DOI 10.1002/jcb.10394; Doll F, 2005, BBA-MOL CELL BIOL L, V1738, P72, DOI 10.1016/j.bbalip.2005.12.001; Ferguson Stephen S. G., 2003, V237, P121; Fieber CB, 2006, EXP CELL RES, V312, P1164, DOI 10.1016/j.yexcr.2006.01.022; Goetzl EJ, 1999, CANCER RES, V59, P4732; Hait NC, 2009, SCIENCE, V325, P1254, DOI 10.1126/science.1176709; Heringdorf DMZ, 2003, FEBS LETT, V554, P443, DOI 10.1016/S0014-5793(03)01219-5; Herr DR, 2007, CURR DRUG TARGETS, V8, P155, DOI 10.2174/138945007779315669; Ishii I, 2001, J BIOL CHEM, V276, P33697, DOI 10.1074/jbc.M104441200; Ishii I, 2002, J BIOL CHEM, V277, P25152, DOI 10.1074/jbc.M200137200; Jacobs E, 1999, BRIT J CANCER, V80, P352, DOI 10.1038/sj.bjc.6690362; Kappos L, 2006, NEW ENGL J MED, V355, P1124, DOI 10.1056/NEJMoa052643; Kato Y, 2007, CANCER BIOL THER, V6, P891, DOI 10.4161/cbt.6.6.4096; Kimura T, 2000, BIOCHEM J, V348, P71, DOI 10.1042/0264-6021:3480071; Kon J, 1999, J BIOL CHEM, V274, P23940, DOI 10.1074/jbc.274.34.23940; Kono M, 2004, J BIOL CHEM, V279, P29367, DOI 10.1074/jbc.M403937200; LaMontagne K, 2006, CANCER RES, V66, P221, DOI 10.1158/0008-5472.CAN-05-2001; Langlois S, 2004, BLOOD, V103, P3020, DOI 10.1182/blood-2003-08-2968; Le Stunff H, 2004, J BIOL CHEM, V279, P34290, DOI 10.1074/jbc.M404907200; Lee MJ, 1999, CELL, V99, P301, DOI 10.1016/S0092-8674(00)81661-X; Li ZS, 2009, BREAST CANCER RES TR, V118, P33, DOI 10.1007/s10549-008-0216-x; Licht T, 2003, BLOOD, V102, P2099, DOI 10.1182/blood-2002-12-3634; Liu YJ, 2000, J CLIN INVEST, V106, P951, DOI 10.1172/JCI10905; Maggon K, 2007, CURR MED CHEM, V14, P1978; Martin JL, 2009, J BIOL CHEM; Nava VE, 2002, EXP CELL RES, V281, P115, DOI 10.1006/excr.2002.5658; Niessen F, 2008, NATURE, V452, P654, DOI 10.1038/nature06663; Nixon GF, 2009, BRIT J PHARMACOL, V158, P982, DOI 10.1111/j.1476-5381.2009.00281.x; Oskouian B, 2004, SEMIN CELL DEV BIOL, V15, P529, DOI 10.1016/j.semcdb.2004.05.009; Oz-Arslan D, 2006, J LEUKOCYTE BIOL, V80, P287, DOI 10.1189/jlb.1205751; Paik JH, 2001, J BIOL CHEM, V276, P11830, DOI 10.1074/jbc.M009422200; Pchejetski D, 2010, CANCER RES, V70, P8651, DOI 10.1158/0008-5472.CAN-10-1388; Peters SLM, 2007, CURR OPIN PHARMACOL, V7, P186, DOI 10.1016/j.coph.2006.09.008; Radeff-Huang J, 2004, J CELL BIOCHEM, V92, P949, DOI 10.1002/jcb.20094; Roviezzo F, 2011, J PHARM EXPT THERAPE; Ruf W, 2009, J THROMB HAEMOST, V7, P118, DOI 10.1111/j.1538-7836.2009.03374.x; Sarkar S, 2005, FEBS LETT, V579, P5313, DOI 10.1016/j.febslet.2005.08.055; Singleton PA, 2007, AM J RESP CELL MOL, V37, P222, DOI 10.1165/rcmb.2006-0327OC; Singleton PA, 2006, J BIOL CHEM, V281, P34381, DOI 10.1074/jbc.M603680200; Skoura A, 2007, J CLIN INVEST, V117, P2506, DOI 10.1172/JCI31123; Spiegel S, 2003, NAT REV MOL CELL BIO, V4, P397, DOI 10.1038/nrm1103; Sugimoto N, 2003, MOL CELL BIOL, V23, P1534, DOI 10.1128/MCB.23.5.1534-1545.2003; Sukocheva O, 2006, J CELL BIOL, V173, P301, DOI 10.1083/jcb.200506033; Visentin B, 2006, CANCER CELL, V9, P225, DOI 10.1016/j.ccr.2006.02.023; Wang F, 1999, J BIOL CHEM, V274, P35343, DOI 10.1074/jbc.274.50.35343; Watson C, 2010, AM J PATHOL, V177, P2205, DOI 10.2353/ajpath.2010.100220; Yamashita H, 2006, J SURG RES, V130, P80, DOI 10.1016/j.jss.2005.08.004; Zhang YH, 2006, J PHYSIOL-LONDON, V575, P101, DOI 10.1113/jphysiol.2006.111575	54	34	38	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 5	2012	7	4							e35129	10.1371/journal.pone.0035129	http://dx.doi.org/10.1371/journal.pone.0035129			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	955IH	22496900	Green Published, gold, Green Submitted			2022-12-25	WOS:000305010500031
J	Brouwer, L; Richardson, DS; Komdeur, J				Brouwer, Lyanne; Richardson, David S.; Komdeur, Jan			Helpers at the Nest Improve Late-Life Offspring Performance: Evidence from a Long-Term Study and a Cross-Foster Experiment	PLOS ONE			English	Article							WARBLER ACROCEPHALUS-SECHELLENSIS; COOPERATIVELY BREEDING BIRDS; SEYCHELLES WARBLER; REPRODUCTIVE SUCCESS; NATAL DISPERSAL; FITNESS CONSEQUENCES; GROUP-SIZE; SURVIVAL; SEX; EVOLUTION	Background: Conditions during an individual's rearing period can have far reaching consequences for its survival and reproduction later in life. Conditions typically vary due to variation in parental quality and/or the environment, but in cooperative breeders the presence of helpers adds an important component to this. Determining the causal effect of helpers on offspring fitness is difficult, since high-quality breeders or territories are likely to produce high-quality offspring, but are also more likely to have helpers because of past reproductive success. This problem is best resolved by comparing the effect of both helping and non-helping subordinates on offspring fitness, however species in which both type of subordinates commonly occur are rare. Methodology/Principal Findings: We used multi-state capture-recapture models on 20 years of data to investigate the effect of rearing conditions on survival and recruitment in the cooperatively breeding Seychelles warbler (Acrocephalus sechellensis), with both helping and non-helping subordinates. The number of helpers in the rearing territory, but not territory quality, group-or brood size, was positively associated with survival of offspring in their first year, and later in life. This was not a result of group size itself since the number of non-helpers was not associated with offspring survival. Furthermore, a nestling cross-foster experiment showed that the number of helpers on the pre-foster territory was not associated with offspring survival, indicating that offspring from territories with helpers do not differ in (genetic) quality. Conclusions/Significance: Our results suggest that the presence of helpers not only increase survival of offspring in their first year of life, but also subsequent adult survival, and therefore have important fitness consequences later in life. This means that when calculating the fitness benefits of helping not only short-term but also the late-life benefits have to be taken into account to fully understand the evolution of cooperative breeding.	[Brouwer, Lyanne; Komdeur, Jan] Univ Groningen, Anim Ecol Grp, Ctr Ecol & Evolutionary Studies, Groningen, Netherlands; [Brouwer, Lyanne] Australian Natl Univ, Res Sch Biol, Canberra, ACT, Australia; [Richardson, David S.] Univ E Anglia, Sch Biol Sci, Ctr Ecol Evolut & Conservat, Norwich NR4 7TJ, Norfolk, England; [Richardson, David S.] Nat Seychelles, Mahe, Seychelles	University of Groningen; Australian National University; University of East Anglia	Brouwer, L (corresponding author), Univ Groningen, Anim Ecol Grp, Ctr Ecol & Evolutionary Studies, Groningen, Netherlands.	L.Brouwer@MyScience.eu	Komdeur, Jan/X-1261-2019	Komdeur, Jan/0000-0002-9241-0124; Brouwer, Lyanne/0000-0001-6728-4851	Netherlands Organisation for Scientific Research [825.08.003]; Netherlands Foundation for the Advancement of Tropical Research [WOTRO, 84-519]; Marie Curie Fellowship [HPMF-CT-2000-01074]; NERC [NER/I/S/2002/00712]; Natural Environment Research Council [NER/I/S/2002/00712] Funding Source: researchfish	Netherlands Organisation for Scientific Research(Netherlands Organization for Scientific Research (NWO)); Netherlands Foundation for the Advancement of Tropical Research; Marie Curie Fellowship(European Commission); NERC(UK Research & Innovation (UKRI)Natural Environment Research Council (NERC)); Natural Environment Research Council(UK Research & Innovation (UKRI)Natural Environment Research Council (NERC))	L.B. was supported by Rubicon fellowship of the Netherlands Organisation for Scientific Research (grant no. 825.08.003) and by a Netherlands Foundation for the Advancement of Tropical Research grant (WOTRO, 84-519) awarded to J.K. This work was further supported by a Marie Curie Fellowship (HPMF-CT-2000-01074) and a NERC fellowship (NER/I/S/2002/00712) awarded to D.S.R. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Akaike H, 1973, INT S INF THEOR, P267, DOI DOI 10.2307/2334537; Beckerman AP, 2002, TRENDS ECOL EVOL, V17, P263, DOI 10.1016/S0169-5347(02)02469-2; Bennetts R. E., 2001, METHODS ESTIMATING D, P3; Brouwer L, 2007, MOL ECOL, V16, P3134, DOI 10.1111/j.1365-294X.2007.03370.x; Brouwer L, 2005, BEHAV ECOL, V16, P667, DOI 10.1093/beheco/ari042; Brouwer L, 2006, J ANIM ECOL, V75, P1321, DOI 10.1111/j.1365-2656.2006.01155.x; Brouwer L, 2009, ECOLOGY, V90, P729, DOI 10.1890/07-1437.1; Brown J.L., 1987, HELPING COMMUNAL BRE; BROWN JL, 1982, SCIENCE, V215, P421, DOI 10.1126/science.215.4531.421; Burnham K.P., 2002, MODEL SELECTION MULT, DOI 10.1007/b97636; Cam E, 2000, J ANIM ECOL, V69, P380, DOI 10.1046/j.1365-2656.2000.00400.x; Cam E, 2003, J ANIM ECOL, V72, P411, DOI 10.1046/j.1365-2656.2003.00708.x; Cam E, 2011, J ORNITHOL, V152, P187, DOI 10.1007/s10336-011-0707-0; Caswell H., 2001, MATRIX POPULATION MO, V2nd ed.; Charlesworth B., 1994, EVOLUTION AGE STRUCT, V2nd ed, edited by C. Cannings, F. C. Hoppensteadt, and L. A. Segel.; Clutton-Brock TH, 1988, REPROD SUCCESS STUDI; Cockburn A, 1998, ANNU REV ECOL SYST, V29, P141, DOI 10.1146/annurev.ecolsys.29.1.141; Cockburn A, 2008, J ANIM ECOL, V77, P430, DOI 10.1111/j.1365-2656.2007.01351.x; Cooch EG, WHITE GC PROGRAM MAR; DAVIES NB, 1992, J ANIM ECOL, V61, P259, DOI 10.2307/5319; Dickinson JL, 2004, FITNESS CONSEQUENCES; DRENT RH, 1980, ARDEA, V68, P225; Dugdale H., 2010, FITNESS CONSEQUENCES; Eikenaar C, 2008, J AVIAN BIOL, V39, P73, DOI 10.1111/j.0908-8857.2008.04124.x; Eikenaar C, 2009, BEHAV ECOL, V20, P207, DOI 10.1093/beheco/arn136; Eising CM, 2001, P ROY SOC B-BIOL SCI, V268, P839, DOI 10.1098/rspb.2001.1594; Emlen ST, 1991, EVOLUTION COOPERATIV, P301; Green DJ, 1995, P ROY SOC B-BIOL SCI, V262, P297, DOI 10.1098/rspb.1995.0209; Green DJ, 2001, J ANIM ECOL, V70, P505, DOI 10.1046/j.1365-2656.2001.00503.x; Griffin AS, 2003, SCIENCE, V302, P634, DOI 10.1126/science.1089402; Griffiths R, 1998, MOL ECOL, V7, P1071, DOI 10.1046/j.1365-294x.1998.00389.x; HAKKARAINEN H, 1994, OECOLOGIA, V97, P209, DOI 10.1007/BF00323151; Hatchwell BJ, 2004, BEHAV ECOL, V15, P1, DOI 10.1093/beheco/arg091; Hipfner JM, 2000, J AVIAN BIOL, V31, P112, DOI 10.1034/j.1600-048X.2000.310202.x; Hodge SJ, 2008, J ANIM ECOL, V77, P92, DOI 10.1111/j.1365-2656.2007.01318.x; Hodge SJ, 2005, P ROY SOC B-BIOL SCI, V272, P2479, DOI 10.1098/rspb.2005.3255; Ims RA, 2001, CONDITION DEPENDENT, P203; Kokko H, 2001, P ROY SOC B-BIOL SCI, V268, P187, DOI 10.1098/rspb.2000.1349; Komdeur J, 1996, BEHAV ECOL, V7, P326; Komdeur J, 2004, IBIS, V146, P298, DOI 10.1046/j.1474-919X.2004.00255.x; Komdeur J, 1996, P ROY SOC B-BIOL SCI, V263, P661, DOI 10.1098/rspb.1996.0099; KOMDEUR J, 1994, P ROY SOC B-BIOL SCI, V256, P47, DOI 10.1098/rspb.1994.0047; KOMDEUR J, 1994, BEHAV ECOL SOCIOBIOL, V34, P175, DOI 10.1007/BF00167742; KOMDEUR J, 1992, NATURE, V358, P493, DOI 10.1038/358493a0; Komdeur J, 1996, BEHAV ECOL, V7, P417, DOI 10.1093/beheco/7.4.417; Komdeur J, 1996, J BIOL RHYTHM, V11, P333, DOI 10.1177/074873049601100407; Komdeur J., 1991, THESIS U CAMBRIDGE C; Legge S, 2000, J ANIM ECOL, V69, P714, DOI 10.1046/j.1365-2656.2000.00429.x; Lindstrom J, 1999, TRENDS ECOL EVOL, V14, P343, DOI 10.1016/S0169-5347(99)01639-0; Lummaa V, 2002, TRENDS ECOL EVOL, V17, P141, DOI 10.1016/S0169-5347(01)02414-4; Lusk C, 2003, NATURE, V422, P580, DOI 10.1038/422580b; Magrath R. D., 1997, J ANIM ECOL, V66, P670; MAGRATH RD, 1991, J ANIM ECOL, V60, P335, DOI 10.2307/5464; MCNAMARA JM, 1992, EVOL ECOL, V6, P170, DOI 10.1007/BF02270710; Monaghan P, 2009, ECOL LETT, V12, P75, DOI 10.1111/j.1461-0248.2008.01258.x; Morris DW, 1998, OIKOS, V83, P518, DOI 10.2307/3546679; MUMME RL, 1992, BEHAV ECOL SOCIOBIOL, V31, P319; Newton, 1989, LIFETIME REPROD BIRD; Nichols JD, 1995, J APPL STAT, V22, P835, DOI 10.1080/02664769524658; Reid JM, 2003, J ANIM ECOL, V72, P36, DOI 10.1046/j.1365-2656.2003.00673.x; Richardson DS, 2007, EVOLUTION, V61, P2790, DOI 10.1111/j.1558-5646.2007.00222.x; Richardson DS, 2001, MOL ECOL, V10, P2263, DOI 10.1046/j.0962-1083.2001.01355.x; Richardson DS, 2004, EVOLUTION, V58, P2037, DOI 10.1111/j.0014-3820.2004.tb00488.x; Richardson DS, 2003, J EVOLUTION BIOL, V16, P854, DOI 10.1046/j.1420-9101.2003.00592.x; Richardson DS, 2002, EVOLUTION, V56, P2313; Ridley AR, 2007, J ANIM ECOL, V76, P750, DOI 10.1111/j.1365-2656.2007.01248.x; Russell AF, 2007, SCIENCE, V317, P941, DOI 10.1126/science.1146037; Russell AF, 2007, P R SOC B, V274, P513, DOI 10.1098/rspb.2006.3698; Saino N, 2003, P ROY SOC B-BIOL SCI, V270, P2485, DOI 10.1098/rspb.2003.2534; SEDINGER JS, 1995, ECOLOGY, V76, P2404, DOI 10.2307/2265816; Shreeves G, 2002, AM NAT, V159, P81, DOI 10.1086/324125; Sparkman AM, 2011, P ROY SOC B-BIOL SCI, V278, P1381, DOI 10.1098/rspb.2010.1921; Tinbergen JM, 2005, J ANIM ECOL, V74, P1112, DOI 10.1111/j.1365-2656.2005.01010.x; Van de Pol M, 2006, J ANIM ECOL, V75, P616, DOI 10.1111/j.1365-2656.2006.01079.x; Van der Jeugd HP, 1998, J ANIM ECOL, V67, P953, DOI 10.1046/j.1365-2656.1998.6760953.x; Verhulst S, 1997, ECOLOGY, V78, P864, DOI 10.1890/0012-9658(1997)078[0864:NDOGTI]2.0.CO;2; White GC, 1999, BIRD STUDY, V46, P120, DOI 10.1080/00063659909477239	77	25	27	1	62	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 4	2012	7	4							e33167	10.1371/journal.pone.0033167	http://dx.doi.org/10.1371/journal.pone.0033167			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	953GO	22496744	Green Submitted, Green Published, gold			2022-12-25	WOS:000304855200010
J	Garg, AD; Bose, M; Ahmed, MI; Bonass, WA; Wood, SR				Garg, Abhishek D.; Bose, Muthiah; Ahmed, Mohammed I.; Bonass, William A.; Wood, Simon R.			In Vitro Studies on Erythrosine-Based Photodynamic Therapy of Malignant and Pre-Malignant Oral Epithelial Cells	PLOS ONE			English	Article							SINGLET OXYGEN; CANCER; APOPTOSIS; MECHANISMS; PHOTOSENSITIZERS; DEPOLARIZATION; PATHWAYS; EXPOSURE; NECROSIS; DAMAGE	Photodynamic Therapy (PDT) involves the administration of a tumor localizing photosensitizing agent, which upon activation with light of an appropriate wavelength leads to the destruction of the tumor cells. The aim of the present study was to determine the efficacy of erythrosine as a photosensitizer for the PDT of oral malignancies. The drug uptake kinetics of erythrosine in malignant (H357) and pre-malignant (DOK) oral epithelial cells and their susceptibility to erythrosine-based PDT was studied along with the determination of the subcellular localization of erythrosine. This was followed by initial investigations into the mechanism of cell killing induced following PDT involving both high and low concentrations of erythrosine. The results showed that at 37 degrees C the uptake of erythrosine by both DOK and H357 cells increased in an erythrosine dose dependent manner. However, the percentage of cell killing observed following PDT differed between the 2 cell lines; a maximum of similar to 80% of DOK cell killing was achieved as compared to similar to 60% killing for H357 cells. Both the DOK and H357 cell types exhibited predominantly mitochondrial accumulation of erythrosine, but the mitochondrial transmembrane potential (Delta Psi(m)) studies showed that the H357 cells were far more resistant to the changes in Delta Psi(m). when compared to the DOK cells and this might be a factor in the apparent relative resistance of the H357 cells to PDT. Finally, cell death morphology and caspase activity analysis studies demonstrated the occurrence of extensive necrosis with high dose PDT in DOK cells, whereas apoptosis was observed at lower doses of PDT for both cell lines. For H357 cells, high dose PDT produced both apoptotic as well as necrotic responses. This is the first instance of erythrosine-based PDT's usage for cancer cell killing.	[Garg, Abhishek D.; Bose, Muthiah; Ahmed, Mohammed I.; Bonass, William A.; Wood, Simon R.] Univ Leeds, Fac Med & Hlth, Leeds Dent Inst, Dept Oral Biol, Leeds, W Yorkshire, England; [Garg, Abhishek D.; Bose, Muthiah; Ahmed, Mohammed I.] Univ Leeds, Fac Biol Sci, Leeds, W Yorkshire, England	University of Leeds; University of Leeds	Garg, AD (corresponding author), Univ Leeds, Fac Med & Hlth, Leeds Dent Inst, Dept Oral Biol, Leeds, W Yorkshire, England.	s.r.wood@leeds.ac.uk	Garg, Abhishek/D-5230-2012; Ahmed, Mohammed/AAU-7535-2021; Ahmed, Mohammed/T-5898-2019; Ahmed, Mohamed/N-8174-2019	Garg, Abhishek/0000-0002-9976-9922; Ahmed, Mohammed/0000-0002-9051-7681; Ahmed, Mohamed/0000-0002-1921-0724				Agostinis P, 2004, PHOTOCH PHOTOBIO SCI, V3, P721, DOI 10.1039/b315237e; Agostinis P, 2011, CA-CANCER J CLIN, V61, P250, DOI 10.3322/caac.20114; Alberts B, 2002, MOL BIOL CELL; Allaker RP, 2009, INT J ANTIMICROB AG, V33, P8, DOI 10.1016/j.ijantimicag.2008.07.014; Allison RR, 2004, PHOTODIAGN PHOTODYN, V1, P27, DOI 10.1016/S1572-1000(04)00007-9; Argiris A, 2004, HEAD NECK CANC, P14; Bolte S, 2006, J MICROSC-OXFORD, V224, P213, DOI 10.1111/j.1365-2818.2006.01706.x; British Dental Association, 2000, 6 BRIT DENT ASS; Buytaert E, 2007, BBA-REV CANCER, V1776, P86, DOI 10.1016/j.bbcan.2007.07.001; Castro A, 2005, PLOS MED, V2, P1217, DOI 10.1371/journal.pmed.0020338; Chaloupka R, 1999, FEBS LETT, V462, P295, DOI 10.1016/S0014-5793(99)01538-0; CHANG SE, 1992, INT J CANCER, V52, P896, DOI 10.1002/ijc.2910520612; Chiu SM, 2001, BRIT J CANCER, V84, P1099, DOI 10.1054/bjoc.2000.1714; Dougherty TJ, 1998, JNCI-J NATL CANCER I, V90, P889, DOI 10.1093/jnci/90.12.889; Estevez JP, 2010, PHOTODIAGN PHOTODYN, V7, P251, DOI 10.1016/j.pdpdt.2010.07.007; Friberg EG, 2003, CANCER LETT, V195, P73, DOI 10.1016/S0304-3835(03)00150-2; GANDIN E, 1979, ARCH INT PHYSIOL BIO, V87, P1046; Garg AD, 2011, PHOTOCH PHOTOBIO SCI, V10, P670, DOI 10.1039/c0pp00294a; Garg AD, 2012, EMBO J, V31, P1062, DOI 10.1038/emboj.2011.497; Garg AD, 2012, CANCER IMMUNOL IMMUN, V61, P215, DOI 10.1007/s00262-011-1184-2; Garg AD, 2010, APOPTOSIS, V15, P1050, DOI 10.1007/s10495-010-0479-7; Garg AD, 2010, BBA-REV CANCER, V1805, P53, DOI 10.1016/j.bbcan.2009.08.003; Geserick C, 2006, MECH AGEING DEV, V127, P579, DOI 10.1016/j.mad.2006.01.017; Gottesman MM, 2002, ANNU REV MED, V53, P615, DOI 10.1146/annurev.med.53.082901.103929; Green DR, 1998, SCIENCE, V281, P1309, DOI 10.1126/science.281.5381.1309; He YY, 2008, PHOTOCHEM PHOTOBIOL, V84, P69, DOI 10.1111/j.1751-1097.2007.00199.x; Hengartner MO, 2000, NATURE, V407, P770, DOI 10.1038/35037710; Indran IR, 2011, CANCER RES, V71, P266, DOI 10.1158/0008-5472.CAN-10-1588; Josefsen LB, 2008, BRIT J PHARMACOL, V154, P1, DOI 10.1038/bjp.2008.98; Kim R, 2006, J PATHOL, V208, P319, DOI 10.1002/path.1885; Kobayashi W, 2006, ORAL ONCOL, V42, P46, DOI 10.1016/j.oraloncology.2005.05.009; Konopka K, 2007, J DENT RES, V86, P694, DOI 10.1177/154405910708600803; Loebinger MR, 2010, BRIT J CANCER, V103, P1692, DOI 10.1038/sj.bjc.6605952; Luo Y, 1997, PHOTOCHEM PHOTOBIOL, V66, P479, DOI 10.1111/j.1751-1097.1997.tb03176.x; Moan J, 2003, COMP SER PHOTOCHEM, V2, P1; MOAN J, 1991, PHOTOCHEM PHOTOBIOL, V53, P549, DOI 10.1111/j.1751-1097.1991.tb03669.x; Moor ACE, 2003, COMP SER PHOTOCHEM, V2, P19; Nagel W, 2001, AM J PHYSIOL-CELL PH, V281, pC1223, DOI 10.1152/ajpcell.2001.281.4.C1223; Parkin DM, 2005, CA-CANCER J CLIN, V55, P74, DOI 10.3322/canjclin.55.2.74; Plaetzer K, 2003, MED LASER APPL, V18, P7, DOI DOI 10.1078/1615-1615-00082; PRIME SS, 1994, INT J CANCER, V56, P406, DOI 10.1002/ijc.2910560320; Schuler M, 2000, J BIOL CHEM, V275, P7337, DOI 10.1074/jbc.275.10.7337; Shah GM, 1996, BIOCHEM BIOPH RES CO, V229, P838, DOI 10.1006/bbrc.1996.1889; Sharman WM, 2004, ADV DRUG DELIVER REV, V56, P53, DOI 10.1016/j.addr.2003.08.015; Siboni G, 2002, PHOTOCH PHOTOBIO SCI, V1, P483, DOI 10.1039/b202884k; Usuda J, 2010, LUNG CANCER, V67, P198, DOI 10.1016/j.lungcan.2009.04.002; Vazifeh D, 1999, ANTIMICROB AGENTS CH, V43, P246, DOI 10.1128/AAC.43.2.246; Wood S, 2006, J ANTIMICROB CHEMOTH, V57, P680, DOI 10.1093/jac/dkl021	48	40	40	0	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 2	2012	7	4							e34475	10.1371/journal.pone.0034475	http://dx.doi.org/10.1371/journal.pone.0034475			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	952GU	22485174	Green Submitted, Green Published, gold			2022-12-25	WOS:000304780500049
J	Sato, Y; Kameya, M; Fushinobu, S; Wakagi, T; Arai, H; Ishii, M; Igarashi, Y				Sato, Yuya; Kameya, Masafumi; Fushinobu, Shinya; Wakagi, Takayoshi; Arai, Hiroyuki; Ishii, Masaharu; Igarashi, Yasuo			A Novel Enzymatic System against Oxidative Stress in the Thermophilic Hydrogen-Oxidizing Bacterium Hydrogenobacter thermophilus	PLOS ONE			English	Article							TRICARBOXYLIC-ACID CYCLE; SULFOLOBUS-TOKODAII STRAIN-7; RUBRERYTHRIN-LIKE PROTEIN; DESULFOVIBRIO-VULGARIS; SUPEROXIDE-DISMUTASE; CLOSTRIDIUM-ACETOBUTYLICUM; OBLIGATORY ANAEROBE; PYROCOCCUS-FURIOSUS; PEROXIDASE-ACTIVITY; RUBREDOXIN	Rubrerythrin (Rbr) is a non-heme iron protein composed of two distinctive domains and functions as a peroxidase in anaerobic organisms. A novel Rbr-like protein, ferriperoxin (Fpx), was identified in Hydrogenobacter thermophilus and was found not to possess the rubredoxin-like domain that is present in typical Rbrs. Although this protein is widely distributed among aerobic organisms, its function remains unknown. In this study, Fpx exhibited ferredoxin:NADPH oxidoreductase (FNR)-dependent peroxidase activity and reduced both hydrogen peroxide (H2O2) and organic hydroperoxide in the presence of NADPH and FNR as electron donors. The calculated K-m and V-max values of Fpx for organic hydroperoxides were comparable to that for H2O2, demonstrating a multiple reactivity of Fpx towards hydroperoxides. An fpx gene disruptant was unable to grow under aerobic conditions, whereas its growth profiles were comparable to those of the wild-type strain under anaerobic and microaerobic conditions, clearly indicating the indispensability of Fpx as an antioxidant of H. thermophilus in aerobic environments. Structural analysis suggested that domain-swapping occurs in Fpx, and this domain-swapped structure is well conserved among thermophiles, implying the importance of structural stability of domain-swapped conformation for thermal environments. In addition, Fpx was located on a deep branch of the phylogenetic tree of Rbr and Rbr-like proteins. This finding, taken together with the wide distribution of Fpx among Bacteria and Archaea, suggests that Fpx is an ancestral type of Rbr homolog that functions as an essential antioxidant and may be part of an ancestral peroxide-detoxification system.	[Sato, Yuya; Fushinobu, Shinya; Wakagi, Takayoshi; Arai, Hiroyuki; Ishii, Masaharu; Igarashi, Yasuo] Univ Tokyo, Dept Biotechnol, Bunkyo Ku, Tokyo, Japan; [Kameya, Masafumi] Toyama Prefectural Univ, Biotechnol Res Ctr, Toyama, Japan; [Kameya, Masafumi] Toyama Prefectural Univ, Dept Biotechnol, Toyama, Japan	University of Tokyo; Toyama Prefectural University; Toyama Prefectural University	Sato, Y (corresponding author), Univ Tokyo, Dept Biotechnol, Bunkyo Ku, Tokyo, Japan.	amishii@mail.ecc.u-tokyo.ac.jp	Sato, Yuya/M-4921-2018; Fushinobu, Shinya/E-4987-2011; Wakagi, Takayoshi/AAJ-4145-2021	Sato, Yuya/0000-0003-2959-9603; Fushinobu, Shinya/0000-0003-1346-6435; Kameya, Masafumi/0000-0003-1987-4296	Japan Society for the Promotion of Science [21248010]	Japan Society for the Promotion of Science(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of Science)	Grant-in-Aid for Scientific Research (A) from Japan Society for the Promotion of Science KAKENHI (21248010). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alban PS, 1998, J APPL MICROBIOL, V85, P875, DOI 10.1046/j.1365-2672.1998.00602.x; Andrews SC, 2010, BBA-GEN SUBJECTS, V1800, P691, DOI 10.1016/j.bbagen.2010.05.010; Arai H, 2010, J BACTERIOL, V192, P2651, DOI 10.1128/JB.00158-10; BEH M, 1993, ARCH MICROBIOL, V160, P306, DOI 10.1007/BF00292082; Berg IA, 2011, APPL ENVIRON MICROB, V77, P1925, DOI 10.1128/AEM.02473-10; Bonomi F, 1996, J BIOL INORG CHEM, V1, P67, DOI 10.1007/s007750050024; Cooley RB, 2011, J MOL BIOL; Cooley RB, 2011, SCIENCE, V332, P929, DOI 10.1126/science.1205687; Coulter ED, 1999, BIOCHEM BIOPH RES CO, V255, P317, DOI 10.1006/bbrc.1999.0197; Coulter ED, 2001, ARCH BIOCHEM BIOPHYS, V394, P76, DOI 10.1006/abbi.2001.2531; Das A, 2001, J BACTERIOL, V183, P1560, DOI 10.1128/JB.183.5.1560-1567.2001; Fushinobu S, 2003, BIOCHEMISTRY-US, V42, P11707, DOI 10.1021/bi034220b; Hoseki J, 1999, J BIOCHEM-TOKYO, V126, P951, DOI 10.1093/oxfordjournals.jbchem.a022539; Ikeda T, 2009, FEMS MICROBIOL LETT, V297, P124, DOI 10.1111/j.1574-6968.2009.01667.x; ISHII M, 1987, J BACTERIOL, V169, P2380, DOI 10.1128/jb.169.6.2380-2384.1987; Iyer RB, 2005, J BIOL INORG CHEM, V10, P407, DOI 10.1007/s00775-005-0650-8; JACOB F, 1977, SCIENCE, V196, P1161, DOI 10.1126/science.860134; Kawasaki S, 2004, FEBS LETT, V571, P21, DOI 10.1016/j.febslet.2004.06.047; Kawasaki S, 2007, FEBS LETT, V581, P2460, DOI 10.1016/j.febslet.2007.04.050; Kawasaki S, 2009, APPL ENVIRON MICROB, V75, P1021, DOI 10.1128/AEM.01425-08; KEELE BB, 1970, J BIOL CHEM, V245, P6176; Kurtz DM, 2006, J INORG BIOCHEM, V100, P679, DOI 10.1016/j.jinorgbio.2005.12.017; Lanzilotta WN, 2011, J BIOL INORG CHEM, V16, P949; LEGALL J, 1988, BIOCHEMISTRY-US, V27, P1636, DOI 10.1021/bi00405a037; Lehmann Y, 1996, J BACTERIOL, V178, P7152, DOI 10.1128/jb.178.24.7152-7158.1996; MCCORD JM, 1969, J BIOL CHEM, V244, P6056; PESCHEK GA, 1989, BIOCHEMISTRY-US, V28, P3057, DOI 10.1021/bi00433a048; Picrik AJ, 1993, EUR J BIOCHEM, V212, P237; PITULLE C, 1994, INT J SYST BACTERIOL, V44, P620, DOI 10.1099/00207713-44-4-620; RICHTER OMH, 1994, J BIOL CHEM, V269, P23079; SCHAUDER R, 1987, ARCH MICROBIOL, V148, P218, DOI 10.1007/BF00414815; SHIBA H, 1982, AGR BIOL CHEM TOKYO, V46, P2341, DOI 10.1080/00021369.1982.10865433; SHIBA H, 1985, ARCH MICROBIOL, V141, P198, DOI 10.1007/BF00408058; Sztukowska M, 2002, MOL MICROBIOL, V44, P479, DOI 10.1046/j.1365-2958.2002.02892.x; Tempel W, 2004, PROTEINS, V57, P878, DOI 10.1002/prot.20280; Ukeda H, 1997, ANAL BIOCHEM, V251, P206, DOI 10.1006/abio.1997.2273; Wahlund TM, 1997, J BACTERIOL, V179, P4859, DOI 10.1128/jb.179.15.4859-4867.1997; Wakagi T, 2003, FEMS MICROBIOL LETT, V222, P33, DOI 10.1016/S0378-1097(03)00233-7; Weinberg MV, 2004, J BACTERIOL, V186, P7888, DOI 10.1128/JB.186.23.7888-7895.2004; WOLFF SP, 1994, METHOD ENZYMOL, V233, P182; Yamamoto M, 2006, FEMS MICROBIOL LETT, V263, P189, DOI 10.1111/j.1574-6968.2006.00415.x; Zhao WX, 2007, MOL MICROBIOL, V66, P1219, DOI 10.1111/j.1365-2958.2007.05994.x	42	10	10	1	18	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 2	2012	7	4							e34825	10.1371/journal.pone.0034825	http://dx.doi.org/10.1371/journal.pone.0034825			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	952GU	22485188	Green Published, gold, Green Submitted			2022-12-25	WOS:000304780500062
J	Shen, XF; Ruan, XG; Zhao, H				Shen, Xuefeng; Ruan, Xiaoguo; Zhao, Hua			Stimulation of Midbrain Dopaminergic Structures Modifies Firing Rates of Rat Lateral Habenula Neurons	PLOS ONE			English	Article							VENTRAL TEGMENTAL AREA; PREFRONTAL CORTEX; SUBSTANTIA-NIGRA; NUCLEUS; BRAIN; TRANSMISSION; PATHWAY; ORIGIN; SYSTEM; D1	Ventral tegmental area (VTA) and substantia nigra pars compacta SNpc) are midbrain structures known to be involved in mediating reward in rodents. Lateral habenula (LHb) is considered as a negative reward source and it is reported that stimulation of the LHb rapidly induces inhibition of firing in midbrain dopamine neurons. Interestingly, the phasic fall in LHb neuronal activity may follow the excitation of dopamine neurons in response to reward-predicting stimuli. The VTA and SNpc give rise to dopaminergic projections that innervate the LHb, which is also known to be involved in processing painful stimuli. But it's unclear what physiological effects these inputs have on habenular function. In this study we distinguished the LHb pain activated neurons of the Wistar rats and assessed their electrophysiological responsiveness to the stimulation of the VTA and SNpc with either single-pulse stimulation (300 mu A, 0.5 Hz) or tetanic stimulation (80 mu A, 25 Hz). Single-pulse stimulation that was delivered to either midbrain structure triggered transient inhibition of firing of similar to 90% of the LHb pain-activated neurons. However, tetanic stimulation of the VTA tended to evoke an elevation in neuronal firing rate. W conclude that LHb pain-activated neurons can receive diverse reward-related signals originating from midbrain dopaminergic structures, and thus participate in the regulation of the brain reward system via both positive and negative feedback mechanisms.	[Shen, Xuefeng; Ruan, Xiaoguo; Zhao, Hua] Jilin Univ, Norman Bethune Coll Med, Dept Physiol, Changchun 130023, Jilin, Peoples R China	Jilin University	Shen, XF (corresponding author), Jilin Univ, Norman Bethune Coll Med, Dept Physiol, Changchun 130023, Jilin, Peoples R China.	zhua@jlu.edu.cn		Shen, Xuefeng/0000-0003-4401-3025	National Natural Science Foundation of China [30670670, 30970956]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC))	This study was supported by the National Natural Science Foundation of China (No. 30670670 and No. 30970956). The funders had no role in study design,data collection and analysis,decision to publish,or preparation of the manuscript.	AKISKAL HS, 1973, SCIENCE, V182, P20, DOI 10.1126/science.182.4107.20; ALBIN RL, 1989, TRENDS NEUROSCI, V12, P366, DOI 10.1016/0166-2236(89)90074-X; Carlezon WA, 2009, NEUROPHARMACOLOGY, V56, P122, DOI 10.1016/j.neuropharm.2008.06.075; CHERGUI K, 1994, NEUROSCIENCE, V62, P641, DOI 10.1016/0306-4522(94)90465-0; CHRISTOPH GR, 1986, J NEUROSCI, V6, P613; Ellison G, 2002, EUR NEUROPSYCHOPHARM, V12, P287, DOI 10.1016/S0924-977X(02)00020-2; FREMEAU RT, 1991, P NATL ACAD SCI USA, V88, P3772, DOI 10.1073/pnas.88.9.3772; Gao DM, 1996, EUR J NEUROSCI, V8, P1474, DOI 10.1111/j.1460-9568.1996.tb01609.x; GARRIS PA, 1994, J NEUROSCI, V14, P442; Gruber C, 2007, NEUROSCI LETT, V427, P165, DOI 10.1016/j.neulet.2007.09.016; Gurden H, 1999, NEUROSCIENCE, V94, P1019, DOI 10.1016/S0306-4522(99)00395-4; Hauptman JS, 2008, NEUROSURG FOCUS, V25, DOI 10.3171/FOC/2008/25/7/E3; Ikemoto S, 2007, BRAIN RES REV, V56, P27, DOI 10.1016/j.brainresrev.2007.05.004; Ji HF, 2007, J NEUROSCI, V27, P6923, DOI 10.1523/JNEUROSCI.0958-07.2007; Juckel G, 2009, EUR ARCH PSY CLIN N, V259, P1, DOI 10.1007/s00406-008-0826-7; Kao C Q, 1985, Sheng Li Xue Bao, V37, P24; KAWAGOE KT, 1992, NEUROSCIENCE, V51, P55, DOI 10.1016/0306-4522(92)90470-M; Kowski AB, 2009, NEUROSCIENCE, V161, P1154, DOI 10.1016/j.neuroscience.2009.04.026; Lecourtier L, 2008, EUR J NEUROSCI, V27, P1755, DOI 10.1111/j.1460-9568.2008.06130.x; LI YQ, 1993, J COMP NEUROL, V333, P118, DOI 10.1002/cne.903330110; Matsumoto M, 2007, NATURE, V447, P1111, DOI 10.1038/nature05860; Matsumoto M, 2009, NAT NEUROSCI, V12, P77, DOI 10.1038/nn.2233; Meshul CK, 1998, SYNAPSE, V30, P211, DOI 10.1002/(SICI)1098-2396(199810)30:2<211::AID-SYN11>3.0.CO;2-4; Paxinos G, 1998, RAT BRAIN IN STEREOTAXIC COORDINATES, FOURTH ED., pix; PHILLIPSON OT, 1982, EXP BRAIN RES, V45, P89; REISINE TD, 1984, BRAIN RES, V308, P281, DOI 10.1016/0006-8993(84)91067-9; Sartorius A, 2010, BIOL PSYCHIAT, V67, pE9, DOI 10.1016/j.biopsych.2009.08.027; Schultz W, 1997, SCIENCE, V275, P1593, DOI 10.1126/science.275.5306.1593; Seymour B, 2005, NAT NEUROSCI, V8, P1234, DOI 10.1038/nn1527; SKAGERBERG G, 1984, BRAIN RES, V307, P99, DOI 10.1016/0006-8993(84)90465-7; Smith WJ, 1997, PHYSIOL BEHAV, V61, P717, DOI 10.1016/S0031-9384(96)00524-0; Surmeier DJ, 2007, TRENDS NEUROSCI, V30, P228, DOI 10.1016/j.tins.2007.03.008; Tobler PN, 2005, SCIENCE, V307, P1642, DOI 10.1126/science.1105370; Ullsperger M, 2003, J NEUROSCI, V23, P4308, DOI 10.1523/jneurosci.23-10-04308.2003; Ungless MA, 2004, SCIENCE, V303, P2040, DOI 10.1126/science.1093360; Watanabe Y, 2009, NEUROREPORT, V20, P875, DOI 10.1097/WNR.0b013e32832c5e98; WEINER DM, 1991, P NATL ACAD SCI USA, V88, P1859, DOI 10.1073/pnas.88.5.1859; Yang LM, 2008, BEHAV BRAIN RES, V188, P84, DOI 10.1016/j.bbr.2007.10.022; Zhang Chun-xiao, 2007, Zhongguo Ying Yong Sheng Li Xue Za Zhi, V23, P442; Zhao H, 1995, Sheng Li Xue Bao, V47, P292	40	37	38	1	16	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 2	2012	7	4							e34323	10.1371/journal.pone.0034323	http://dx.doi.org/10.1371/journal.pone.0034323			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	952GU	22485164	Green Published, Green Submitted, gold			2022-12-25	WOS:000304780500039
J	Veleri, S; Bishop, K; Nogare, DED; English, MA; Foskett, TJ; Chitnis, A; Sood, R; Liu, P; Swaroop, A				Veleri, Shobi; Bishop, Kevin; Nogare, Damian E. Dalle; English, Milton A.; Foskett, Trevor J.; Chitnis, Ajay; Sood, Raman; Liu, Paul; Swaroop, Anand			Knockdown of Bardet-Biedl Syndrome Gene BBS9/PTHB1 Leads to Cilia Defects	PLOS ONE			English	Article							PLANAR CELL POLARITY; RESPONSIVE B1 GENE; WPK RAT; DISEASE; PROTEIN; DISSECTION; GENOMICS; COMPLEX; FAMILY; MODEL	Bardet-Biedl Syndrome (BBS, MIM#209900) is a genetically heterogeneous disorder with pleiotropic phenotypes that include retinopathy, mental retardation, obesity and renal abnormalities. Of the 15 genes identified so far, seven encode core proteins that form a stable complex called BBSome, which is implicated in trafficking of proteins to cilia. Though BBS9 (also known as PTHB1) is reportedly a component of BBSome, its direct function has not yet been elucidated. Using zebrafish as a model, we show that knockdown of bbs9 with specific antisense morpholinos leads to developmental abnormalities in retina and brain including hydrocephaly that are consistent with the core phenotypes observed in syndromic ciliopathies. Knockdown of bbs9 also causes reduced number and length of cilia in Kupffer's vesicle. We also demonstrate that an orthologous human BBS9 mRNA, but not one carrying a missense mutation identified in BBS patients, can rescue the bbs9 morphant phenotype. Consistent with these findings, knockdown of Bbs9 in mouse IMCD3 cells results in the absence of cilia. Our studies suggest a key conserved role of BBS9 in biogenesis and/or function of cilia in zebrafish and mammals.	[Veleri, Shobi; English, Milton A.; Foskett, Trevor J.; Swaroop, Anand] NEI, N NRL, NIH, Bethesda, MD 20892 USA; [Bishop, Kevin; English, Milton A.; Sood, Raman; Liu, Paul] NHGRI, NIH, Bethesda, MD 20892 USA; [Nogare, Damian E. Dalle; Chitnis, Ajay] NICHHD, NIH, Bethesda, MD 20892 USA	National Institutes of Health (NIH) - USA; NIH National Eye Institute (NEI); National Institutes of Health (NIH) - USA; NIH National Human Genome Research Institute (NHGRI); National Institutes of Health (NIH) - USA; NIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)	Veleri, S (corresponding author), NEI, N NRL, NIH, Bethesda, MD 20892 USA.	swaroopa@nei.nih.gov	Veleri, Shobi/ABD-9406-2020; Liu, Paul/A-7976-2012; Bishop, Kevin H/C-7816-2012	Liu, Paul/0000-0002-6779-025X; Bishop, Kevin H/0000-0002-8057-1051; Swaroop, Anand/0000-0002-1975-1141	National Eye Institute, National Human Genome Research Institute; National Institute of Child Health and Development, National Institutes of Health; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT [ZIAHD001012] Funding Source: NIH RePORTER; NATIONAL EYE INSTITUTE [ZIAEY000450] Funding Source: NIH RePORTER; NATIONAL HUMAN GENOME RESEARCH INSTITUTE [ZIAHG000102, ZIGHG200351] Funding Source: NIH RePORTER	National Eye Institute, National Human Genome Research Institute; National Institute of Child Health and Development, National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); NATIONAL EYE INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI)); NATIONAL HUMAN GENOME RESEARCH INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Human Genome Research Institute (NHGRI))	The study was supported by intramural funds of the National Eye Institute, National Human Genome Research Institute and National Institute of Child Health and Development, National Institutes of Health. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adams AE, 1999, BONE, V24, P305, DOI 10.1016/S8756-3282(98)00188-4; Ansley SJ, 2003, NATURE, V425, P628, DOI 10.1038/nature02030; Badano JL, 2006, NATURE, V439, P326, DOI 10.1038/nature04370; Banizs B, 2005, DEVELOPMENT, V132, P5329, DOI 10.1242/dev.02153; Beales PL, 1999, J MED GENET, V36, P437; Ciruna B, 2006, NATURE, V439, P220, DOI 10.1038/nature04375; Craige B, J CELL BIOL, V190, P927; Fliegauf M, 2007, NAT REV MOL CELL BIO, V8, P880, DOI 10.1038/nrm2278; Gattone VH, 2004, ANAT REC PART A, V277A, P384, DOI 10.1002/ar.a.20022; Gerdes JM, 2009, CELL, V137, P32, DOI 10.1016/j.cell.2009.03.023; Gherman A, 2006, NAT GENET, V38, P961, DOI 10.1038/ng0906-961; Ghosh AK, HUM MOL GENET, V19, P90; GREEN JS, 1989, NEW ENGL J MED, V321, P1002, DOI 10.1056/NEJM198910123211503; Huangfu DW, 2003, NATURE, V426, P83, DOI 10.1038/nature02061; Hurd TW, NEPHRON EXP NEPHROL, V118, pe9; Jin H, CELL, V141, P1208; Johnson ET, 2008, DEV DYNAM, V237, P2053, DOI 10.1002/dvdy.21612; Kang H, 2008, HUM REPROD, V23, P1457, DOI 10.1093/humrep/den086; Kim JC, 2005, J CELL SCI, V118, P1007, DOI 10.1242/jcs.01676; Kim JC, 2004, NAT GENET, V36, P462, DOI 10.1038/ng1352; Kim SK, SCIENCE, V329, P1337; Li JB, 2004, CELL, V117, P541, DOI 10.1016/S0092-8674(04)00450-7; Loktev AV, 2008, DEV CELL, V15, P854, DOI 10.1016/j.devcel.2008.11.001; Lyons SE, 2001, BLOOD, V97, P2611, DOI 10.1182/blood.V97.9.2611; May-Simera HL, DEV BIOL, V345, P215; Nachury MV, 2007, CELL, V129, P1201, DOI 10.1016/j.cell.2007.03.053; Nishimura DY, 2005, AM J HUM GENET, V77, P1021, DOI 10.1086/498323; Robu ME, 2007, PLOS GENET, V3, P787, DOI 10.1371/journal.pgen.0030078; Ross AJ, 2005, NAT GENET, V37, P1135, DOI 10.1038/ng1644; Seo S, 2010, P NATL ACAD SCI USA, V107, P1488, DOI 10.1073/pnas.0910268107; Shu X, HUM MOL GENET, V19, P657; Simons M, 2005, NAT GENET, V37, P537, DOI 10.1038/ng1552; Smith UM, 2006, NAT GENET, V38, P191, DOI 10.1038/ng1713; Tissir F, NAT NEUROSCI, V13, P700; Torban E, 2004, J BIOL CHEM, V279, P52703, DOI 10.1074/jbc.M408675200; Vernon EG, 2003, ONCOGENE, V22, P1371, DOI 10.1038/sj.onc.1206332; Vieira JP, 2012, J CHILD NEUROLOGY; Wolff C, 2003, CURR BIOL, V13, P1169, DOI 10.1016/S0960-9822(03)00461-5; Yen HJ, 2006, HUM MOL GENET, V15, P667, DOI 10.1093/hmg/ddi468; Zaghloul NA, 2009, J CLIN INVEST, V119, P428, DOI 10.1172/JCI37041; Zhou W, AM J PHYSL RENAL PHY	41	36	37	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 29	2012	7	3							e34389	10.1371/journal.pone.0034389	http://dx.doi.org/10.1371/journal.pone.0034389			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	948SR	22479622	Green Submitted, Green Published, gold			2022-12-25	WOS:000304523400080
J	Wolburg, H; Mogk, S; Acker, S; Frey, C; Meinert, M; Schonfeld, C; Lazarus, M; Urade, Y; Kubata, BK; Duszenko, M				Wolburg, Hartwig; Mogk, Stefan; Acker, Sven; Frey, Claudia; Meinert, Monika; Schoenfeld, Caroline; Lazarus, Michael; Urade, Yoshihiro; Kubata, Bruno Kilunga; Duszenko, Michael			Late Stage Infection in Sleeping Sickness	PLOS ONE			English	Article							TRYPANOSOMA-BRUCEI-BRUCEI; BLOOD-BRAIN-BARRIER; PROGRAMMED CELL-DEATH; VIRCHOW-ROBIN SPACES; CEREBROSPINAL-FLUID; TRANSENDOTHELIAL MIGRATION; AFRICAN TRYPANOSOMIASIS; IMMUNE-COMPLEXES; TIGHT JUNCTIONS; PIA MATER	At the turn of the 19th century, trypanosomes were identified as the causative agent of sleeping sickness and their presence within the cerebrospinal fluid of late stage sleeping sickness patients was described. However, no definitive proof of how the parasites reach the brain has been presented so far. Analyzing electron micrographs prepared from rodent brains more than 20 days after infection, we present here conclusive evidence that the parasites first enter the brain via the choroid plexus from where they penetrate the epithelial cell layer to reach the ventricular system. Adversely, no trypanosomes were observed within the parenchyma outside blood vessels. We also show that brain infection depends on the formation of long slender trypanosomes and that the cerebrospinal fluid as well as the stroma of the choroid plexus is a hostile environment for the survival of trypanosomes, which enter the pial space including the Virchow-Robin space via the subarachnoid space to escape degradation. Our data suggest that trypanosomes do not intend to colonize the brain but reside near or within the glia limitans, from where they can re-populate blood vessels and disrupt the sleep wake cycles.	[Wolburg, Hartwig] Univ Tubingen, Inst Pathol & Neuropathol, Tubingen, Germany; [Mogk, Stefan; Acker, Sven; Frey, Claudia; Schoenfeld, Caroline; Duszenko, Michael] Univ Tubingen, Interfac Inst Biochem, Tubingen, Germany; [Meinert, Monika] Univ Tubingen, Inst Evolut Biol Invertebrates, Tubingen, Germany; [Lazarus, Michael; Urade, Yoshihiro] Osaka Biosci Inst, Dept Mol Behav Biol, Osaka, Japan; [Kubata, Bruno Kilunga] African Union New Partnership Africas Dev Agcy Re, Nairobi, Kenya	Eberhard Karls University of Tubingen; Eberhard Karls University Hospital; Eberhard Karls University of Tubingen; Eberhard Karls University of Tubingen; African Union (AU)	Wolburg, H (corresponding author), Univ Tubingen, Inst Pathol & Neuropathol, Tubingen, Germany.	michael.duszenko@uni-tuebingen.de	Lazarus, Michael/G-3130-2010	Lazarus, Michael/0000-0003-3863-4474; Lazarus, Michael/0000-0003-4700-7894	German Research Foundation [DU 136/15-1]; Takeda Science Foundation; Japan Society for the Progress of Science; Government of Canada provided through the Canadian International Development Agency; Grants-in-Aid for Scientific Research [21300133] Funding Source: KAKEN	German Research Foundation(German Research Foundation (DFG)); Takeda Science Foundation(Takeda Science Foundation (TSF)); Japan Society for the Progress of Science; Government of Canada provided through the Canadian International Development Agency; Grants-in-Aid for Scientific Research(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI))	This work has been supported by the German Research Foundation, grant DU 136/15-1. The authors are grateful to the Takeda Science Foundation for a fellowship to SM and the Japan Society for the Progress of Science for a travel grant to MD. This study received also financial support of the Government of Canada provided through the Canadian International Development Agency to New Partnership for Africa's Development. The funders had no role in study design, data collection and analysis, decision to publish or preparation of the manuscript.	BLACK SJ, 1982, PARASITE IMMUNOL, V4, P233, DOI 10.1111/j.1365-3024.1982.tb00435.x; Bruce D., 1895, PRELIMINARY REPORT T; Brun R, 2010, LANCET, V375, P148, DOI 10.1016/S0140-6736(09)60829-1; Castellant A, 1903, BRIT MED J, V1903, P1431, DOI 10.1136/bmj.1.2216.1431; Claes F, 2009, PLOS NEGLECT TROP D, V3, DOI 10.1371/journal.pntd.0000486; Cox FEG, 2004, INFECT DIS CLIN N AM, V18, P231, DOI 10.1016/j.idc.2004.01.004; Cross GAM, 1998, MOL BIOCHEM PARASIT, V91, P77, DOI 10.1016/S0166-6851(97)00186-2; de Sousa KP, 2010, PROTEIN J, V29, P283, DOI 10.1007/s10930-010-9250-8; Denninger V, 2008, METHOD ENZYMOL, V451, P373, DOI 10.1016/S0076-6879(08)03225-4; Duszenko M, 2006, TRENDS PARASITOL, V22, P536, DOI 10.1016/j.pt.2006.08.010; Engelhardt B, 2004, EUR J IMMUNOL, V34, P2955, DOI 10.1002/eji.200425327; FERGUSON MAJ, 1985, J BIOL CHEM, V260, P4547; Figarella K, 2006, CELL DEATH DIFFER, V13, P1802, DOI 10.1038/sj.cdd.4401862; Figarella K, 2005, CELL DEATH DIFFER, V12, P335, DOI 10.1038/sj.cdd.4401564; Frankmann S, 1987, NEW APPROACH REPEATE; GREENWOOD BM, 1980, T ROY SOC TROP MED H, V74, P716, DOI 10.1016/0035-9203(80)90184-4; Haag J, 1998, MOL BIOCHEM PARASIT, V91, P37, DOI 10.1016/S0166-6851(97)00185-0; Hayaishi O, 2004, ARCH ITAL BIOL, V142, P533; HIRUMI H, 1994, PARASITOL TODAY, V10, P80, DOI 10.1016/0169-4758(94)90402-2; Iadecola C, 2004, NAT REV NEUROSCI, V5, P347, DOI 10.1038/nrn1387; Kibona SN, 2006, TROP MED INT HEALTH, V11, P144, DOI 10.1111/j.1365-3156.2005.01545.x; Kreier J, 1977, PARASITIC PROTOZOA, V1, P205; Kristensson K, 2010, PROG NEUROBIOL, V91, P152, DOI 10.1016/j.pneurobio.2009.12.001; Kubata BK, 2007, TRENDS PARASITOL, V23, P325, DOI 10.1016/j.pt.2007.05.005; Kwee RM, 2007, RADIOGRAPHICS, V27, P1071, DOI 10.1148/rg.274065722; LAMBERT PH, 1981, J CLIN INVEST, V67, P77, DOI 10.1172/JCI110035; LANHAM SM, 1968, NATURE, V218, P1273, DOI 10.1038/2181273a0; Leggat PA, 2001, TRAVEL MED INFECT DI, V1, P137; Lentner C, 1981, GEIGY SCI TABLES, V1; Lyck R, 2003, BLOOD, V102, P3675, DOI 10.1182/blood-2003-02-0358; Masocha W, 2007, PHYSIOL BEHAV, V92, P110, DOI 10.1016/j.physbeh.2007.05.045; MORSE DE, 1972, AM J ANAT, V133, P349, DOI 10.1002/aja.1001330309; Mulenga C, 2001, NEUROPATH APPL NEURO, V27, P77, DOI 10.1046/j.0305-1846.2001.00306.x; ONOE H, 1988, P NATL ACAD SCI USA, V85, P4082, DOI 10.1073/pnas.85.11.4082; ORMEROD WE, 1986, T ROY SOC TROP MED H, V80, P626, DOI 10.1016/0035-9203(86)90161-6; Osterauer R, 2010, EVOL DEV, V12, P474, DOI 10.1111/j.1525-142X.2010.00433.x; PATZOLD U, 1980, J NEUROL, V222, P249, DOI 10.1007/BF00313154; Paxinos G, 1998, RAT BRAIN IN STEREOTAXIC COORDINATES, FOURTH ED., pix; PENTREATH VW, 1990, T ROY SOC TROP MED H, V84, P795, DOI 10.1016/0035-9203(90)90085-S; PENTREATH VW, 1995, T ROY SOC TROP MED H, V89, P9, DOI 10.1016/0035-9203(95)90637-1; PENTREATH VW, 1992, ANN TROP MED PARASIT, V86, P29, DOI 10.1080/00034983.1992.11812627; POLTERA AA, 1980, CLIN EXP IMMUNOL, V40, P496; Ransohoff RM, 2003, NAT REV IMMUNOL, V3, P569, DOI 10.1038/nri1130; Rodgers J, 2011, AM J TROP MED HYG, V84, P344, DOI 10.4269/ajtmh.2011.10-0487; Rubin LL, 1999, ANNU REV NEUROSCI, V22, P11, DOI 10.1146/annurev.neuro.22.1.11; SCHMIDT H, 1985, AM J TROP MED HYG, V34, P64, DOI 10.4269/ajtmh.1985.34.64; SCHMIDT H, 1983, VIRCHOWS ARCH A, V399, P333, DOI 10.1007/BF00612951; Steverding D, 2008, PARASITE VECTOR, V1, DOI 10.1186/1756-3305-1-3; Turner CMR, 1997, FEMS MICROBIOL LETT, V153, P227, DOI 10.1111/j.1574-6968.1997.tb10486.x; Wastling SL, 2011, TRENDS PARASITOL, V27, P394, DOI 10.1016/j.pt.2011.04.005; Wewer C, 2011, J NEUROINFLAMM, V8, DOI 10.1186/1742-2094-8-51; WHO, 2011, AFR TRYP SLEEP SICKN; Wolburg H, 2002, VASC PHARMACOL, V38, P323, DOI 10.1016/S1537-1891(02)00200-8; Wolburg H, 2001, NEUROSCI LETT, V307, P77, DOI 10.1016/S0304-3940(01)01927-9; Wolburg H, 2010, ACTA NEUROPATHOL, V119, P75, DOI 10.1007/s00401-009-0627-8; Yang Y, 2011, PROG MOL BIOL TRANSL, V99, P241, DOI 10.1016/S1877-1173(11)99006-1; ZHANG ET, 1990, J ANAT, V170, P111	57	32	32	0	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 27	2012	7	3							e34304	10.1371/journal.pone.0034304	http://dx.doi.org/10.1371/journal.pone.0034304			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	940MY	22496723	Green Published, Green Submitted, gold			2022-12-25	WOS:000303894900079
J	Rieckmann, T; Kriegs, M; Nitsch, L; Hoffer, K; Rohaly, G; Kocher, S; Petersen, C; Dikomey, E; Dornreiter, I; Dahm-Daphi, J				Rieckmann, T.; Kriegs, M.; Nitsch, L.; Hoffer, K.; Rohaly, G.; Kocher, S.; Petersen, C.; Dikomey, E.; Dornreiter, I.; Dahm-Daphi, J.			p53 modulates homologous recombination at I-SceI-induced double-strand breaks through cell-cycle regulation	ONCOGENE			English	Article						p53; homologous recombination; cell cycle	DNA END RESECTION; MUTANT P53; MAMMALIAN-CELLS; HUMAN RAD51; REPAIR; CTIP; PHOSPHORYLATION; INACTIVATION; DISSOCIATION; SUPPRESSION	Inhibition of homologous recombination (HR) is believed to be a transactivation-independent function of p53 that protects from genetic instability. Misrepair by HR can lead to genetic alterations such as translocations, duplications, insertions and loss of heterozygosity, which all bear the risk of driving oncogenic transformation. Regulation of HR by wild-type p53 (wtp53) should prevent these genomic rearrangements. Mutation of p53 is a frequent event during carcinogenesis. In particular, dominant-negative mutants inhibiting wtp53 expressed from the unperturbed allel can drive oncogenic transformation by disrupting the p53-dependent anticancer barrier. Here, we asked whether the hot spot mutants R175H and R273H relax HR control in p53-proficient cells. Utilizing an I-SceI-based reporter assay, we observed a moderate (1.5 x) stimulation of HR upon expression of the mutant proteins in p53-proficient CV-1, but not in p53-deficient H1299 cells. Importantly, the stimulatory effect was exactly paralleled by an increase in the number of HR competent S- and G2-phase cells, which can well explain the enhanced recombination frequencies. Furthermore, the impact on HR exerted by the transactivation domain double-mutant L22Q/W23S and mutant R273P, both of which were reported to regulate HR independently of G1-arrest execution, is also exactly mirrored by cell-cycle behavior. These results are in contrast to previous concepts stating that the transactivation-independent impact of p53 on HR is a general phenomenon valid for replication-associated and also for directly induced double-strand break. Our data strongly suggest that the latter is largely mediated by cell-cycle regulation, a classical transactivation-dependent function of p53. Oncogene (2013) 32, 968-975; doi:10.1038/onc.2012.123; published online 9 April 2012	[Rieckmann, T.; Kriegs, M.; Nitsch, L.; Hoffer, K.; Kocher, S.; Dikomey, E.; Dahm-Daphi, J.] Univ Med Ctr Hamburg Eppendorf, Lab Radiobiol & Expt Radiooncol, Hamburg, Germany; [Rohaly, G.; Dornreiter, I.] Leibniz Inst Expt Virol, Heinrich Pette Inst, Hamburg, Germany; [Kocher, S.; Dahm-Daphi, J.] Univ Marburg, Particle Therapy Ctr, Inst Radiobiol & Mol Radiat Oncol, D-35043 Marburg, Hessen, Germany; [Petersen, C.] Univ Med Ctr Hamburg Eppendorf, Dept Radiotherapy & Radiooncol, Hamburg, Germany	University of Hamburg; University Medical Center Hamburg-Eppendorf; Heinrich Pette Institute; Philipps University Marburg; University of Hamburg; University Medical Center Hamburg-Eppendorf	Dahm-Daphi, J (corresponding author), Univ Marburg, Particle Therapy Ctr, Inst Radiobiol & Mol Radiat Oncol, D-35043 Marburg, Hessen, Germany.	jochen.dahmdaphi@staff.uni-marburg.de	Petersen, Cordula/AAW-9789-2020; Hoffer, Kenneth J/P-6431-2019	Rieckmann, Thorsten/0000-0001-8426-107X	German Cancer Aid (Deutsche Krebshilfe) [107889, 107980]	German Cancer Aid (Deutsche Krebshilfe)(Deutsche Krebshilfe)	We thank Dr Tom Misteli for the pDsRed-/-Scel-GR vector. This work was supported by a grant from the German Cancer Aid (Deutsche Krebshilfe No. 107889 to JDD and No. 107980 to ID).	Akyuz N, 2002, MOL CELL BIOL, V22, P6306, DOI 10.1128/MCB.22.17.6306-6317.2002; Albertson DG, 2003, NAT GENET, V34, P369, DOI 10.1038/ng1215; Bertrand P, 2004, TRENDS GENET, V20, P235, DOI 10.1016/j.tig.2004.04.003; Bertrand P, 1997, ONCOGENE, V14, P1117, DOI 10.1038/sj.onc.1200931; Boehden GS, 2003, ONCOGENE, V22, P4111, DOI 10.1038/sj.onc.1206632; Bunz F, 2002, CANCER RES, V62, P1129; Dudenhoffer C, 1999, ONCOGENE, V18, P5773, DOI 10.1038/sj.onc.1202964; Dudenhoffer C, 1998, MOL CELL BIOL, V18, P5332, DOI 10.1128/MCB.18.9.5332; Eid W, 2010, EMBO REP, V11, P962, DOI 10.1038/embor.2010.157; Gatz SA, 2006, CELL DEATH DIFFER, V13, P1003, DOI 10.1038/sj.cdd.4401903; Huertas P, 2009, J BIOL CHEM, V284, P9558, DOI 10.1074/jbc.M808906200; Joerger AC, 2008, ANNU REV BIOCHEM, V77, P557, DOI 10.1146/annurev.biochem.77.060806.091238; Johnson TM, 2005, NAT GENET, V37, P145, DOI 10.1038/ng1498; Kaidi A, 2010, SCIENCE, V329, P1348, DOI 10.1126/science.1192049; KERN SE, 1992, SCIENCE, V256, P827, DOI 10.1126/science.1589764; Kriegs M, 2010, DNA REPAIR, V9, P889, DOI 10.1016/j.dnarep.2010.05.005; Lee SM, 1997, J BIOL CHEM, V272, P7532, DOI 10.1074/jbc.272.11.7532; Linke SP, 2003, CANCER RES, V63, P2596; Mansour WY, 2008, NUCLEIC ACIDS RES, V36, P4088, DOI 10.1093/nar/gkn347; Mekeel KL, 1997, ONCOGENE, V14, P1847, DOI 10.1038/sj.onc.1201143; Restle A, 2008, NUCLEIC ACIDS RES, V36, P5362, DOI 10.1093/nar/gkn503; Roemer K, 1996, ONCOGENE, V12, P2069; Romanova LY, 2004, ONCOGENE, V23, P9025, DOI 10.1038/sj.onc.1207982; Saintigny Y, 1999, ONCOGENE, V18, P3553, DOI 10.1038/sj.onc.1202941; Saintigny Y, 2002, ONCOGENE, V21, P488, DOI 10.1038/sj.onc.1205040; Sartori AA, 2007, NATURE, V450, P509, DOI 10.1038/nature06337; Sengupta S, 2003, EMBO J, V22, P1210, DOI 10.1093/emboj/cdg114; Soutoglou E, 2007, NAT CELL BIOL, V9, P675, DOI 10.1038/ncb1591; Sturzbecher NW, 1996, EMBO J, V15, P1992; Susse S, 2000, ONCOGENE, V19, P4500, DOI 10.1038/sj.onc.1203809; Tang M, 2006, NAT GENET, V38, P395, DOI 10.1038/ng0406-395; van Gent DC, 2001, NAT REV GENET, V2, P196, DOI 10.1038/35056049; Wiesmuller L, 1996, J VIROL, V70, P737; Willers H, 2000, ONCOGENE, V19, P632, DOI 10.1038/sj.onc.1203142; Yoon D, 2004, J MOL BIOL, V336, P639, DOI 10.1016/j.jmb.2003.12.050; You ZS, 2009, MOL CELL, V36, P954, DOI 10.1016/j.molcel.2009.12.002; Zhang YP, 2001, SCIENCE, V292, P1910, DOI 10.1126/science.1058637	37	17	17	0	11	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0950-9232			ONCOGENE	Oncogene	FEB 21	2013	32	8					968	975		10.1038/onc.2012.123	http://dx.doi.org/10.1038/onc.2012.123			8	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	111LQ	22484423				2022-12-25	WOS:000316523200004
J	Lim, J; Lee, Y; Kim, HW; Rhyu, IJ; Oh, MS; Youdim, MBH; Yue, ZY; Oh, YJ				Lim, Junghyun; Lee, Yunsu; Kim, Hyun-Wook; Rhyu, Im Joo; Oh, Myung Sook; Youdim, Moussa B. H.; Yue, Zhenyu; Oh, Young J.			Nigericin-induced Impairment of Autophagic Flux in Neuronal Cells Is Inhibited by Overexpression of Bak	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							BCL-2 FAMILY-MEMBERS; MULTIVESICULAR BODIES; CATION COMPLEXES; MAMMALIAN-CELLS; X-L; APOPTOSIS; PROTEIN; DEATH; BECLIN-1; MACROAUTOPHAGY	Bak is a prototypic pro-apoptotic Bcl-2 family protein expressed in a wide variety of tissues and cells. Recent studies have revealed that Bcl-2 family proteins regulate apoptosis as well as autophagy. To investigate whether and how Bak exerts a regulatory role on autophagy-related events, we treated independent cell lines, including MN9D neuronal cells, with nigericin, a K+/H+ ionophore. Treatment of MN9D cells with nigericin led to an increase of LC3-II and p62 levels with concomitant activation of caspase. Ultrastructural examination revealed accumulation of autophagic vacuoles and swollen vacuoles in nigericin-treated cells. We further found that the LC3-II accumulated as a consequence of impaired autophagic flux and the disrupted degradation of LC3-II in nigericin-treated cells. In this cell death paradigm, both transient and stable overexpression of various forms of Bak exerted a protective role, whereas it did not inhibit the extent of nigericin-mediated activation of caspase-3. Subsequent biochemical and electron microscopic studies revealed that overexpressed Bak maintained autophagic flux and reduced the area occupied by swollen vacuoles in nigericin-treated cells. Similar results were obtained in nigericin-treated non-neuronal cells and another proton ionophore-induced cell death paradigm. Taken together, our study indicates that a protective role for Bak during ionophore-induced cell death may be closely associated with its regulatory effect on maintenance of autophagic flux and vacuole homeostasis.	[Lim, Junghyun; Lee, Yunsu; Oh, Young J.] Yonsei Univ, Coll Life Sci & Biotechnol, Dept Biol, Seoul 120749, South Korea; [Kim, Hyun-Wook; Rhyu, Im Joo] Korea Univ, Coll Med, Dept Anat, Seoul 136705, South Korea; [Oh, Myung Sook] Kyung Hee Univ, Dept Life & Nanopharmaceut Sci, Seoul 130701, South Korea; [Youdim, Moussa B. H.] Technion Israel Inst Technol, IL-31096 Haifa, Israel; [Yue, Zhenyu] Mt Sinai Sch Med, Friedman Brain Inst, Dept Neurol & Neurosci, New York, NY 10029 USA	Yonsei University; Korea University; Korea University Medicine (KU Medicine); Kyung Hee University; Technion Israel Institute of Technology; Icahn School of Medicine at Mount Sinai	Oh, YJ (corresponding author), Yonsei Univ, Coll Life Sci & Biotechnol, Dept Biol, 134 Shinchon Dong, Seoul 120749, South Korea.	yjoh@yonsei.ac.kr	Oh, Myung Sook/AAH-9948-2020	Rhyu, Im Joo/0000-0002-5558-6278	Ministry of Science and Technology through BRC; Korea Science and Engineering Foundation (SRC) [2012-0000496]; Mid-Career Research Program through NRF; Ministry of Education, Science, and Technology; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS060123] Funding Source: NIH RePORTER	Ministry of Science and Technology through BRC; Korea Science and Engineering Foundation (SRC)(Korea Science and Engineering Foundation); Mid-Career Research Program through NRF; Ministry of Education, Science, and Technology(Ministry of Education, Science & Technology (MEST), Republic of Korea); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))	This work was supported by grants from the Ministry of Science and Technology through BRC, and in part by the Korea Science and Engineering Foundation (SRC, 2012-0000496) and the Mid-Career Research Program through NRF funded by the Ministry of Education, Science, and Technology (to Y. J. O.).	Boya P, 2005, MOL CELL BIOL, V25, P1025, DOI 10.1128/MCB.25.3.1025-1040.2005; Chipuk JE, 2010, MOL CELL, V37, P299, DOI 10.1016/j.molcel.2010.01.025; Cook NR, 2004, TRAFFIC, V5, P685, DOI 10.1111/j.1600-0854.2004.00212.x; Eisenberg-Lerner A, 2009, CELL DEATH DIFFER, V16, P966, DOI 10.1038/cdd.2009.33; Erlich S, 2007, AUTOPHAGY, V3, P561, DOI 10.4161/auto.4713; Eskelinen EL, 2005, AUTOPHAGY, V1, P1, DOI 10.4161/auto.1.1.1270; Fader CM, 2009, CELL DEATH DIFFER, V16, P70, DOI 10.1038/cdd.2008.168; Filimonenko M, 2007, J CELL BIOL, V179, P485, DOI 10.1083/jcb.200702115; Galluzzi L, 2009, CELL DEATH DIFFER, V16, P1093, DOI 10.1038/cdd.2009.44; GRINDE B, 1983, EXP CELL RES, V149, P27, DOI 10.1016/0014-4827(83)90377-4; Gross A, 1999, GENE DEV, V13, P1899, DOI 10.1101/gad.13.15.1899; HANSEN MB, 1989, J IMMUNOL METHODS, V119, P203, DOI 10.1016/0022-1759(89)90397-9; He CC, 2009, ANNU REV GENET, V43, P67, DOI 10.1146/annurev-genet-102808-114910; Hoyer-Hansen M, 2007, CELL DEATH DIFFER, V14, P1576, DOI 10.1038/sj.cdd.4402200; Hoyer-Hansen M, 2007, MOL CELL, V25, P193, DOI 10.1016/j.molcel.2006.12.009; Iwai-Kanai E, 2008, AUTOPHAGY, V4, P322, DOI 10.4161/auto.5603; Jager S, 2004, J CELL SCI, V117, P4837, DOI 10.1242/jcs.01370; Kabeya Y, 2000, EMBO J, V19, P5720, DOI 10.1093/emboj/19.21.5720; Kawai A, 2007, AUTOPHAGY, V3, P154, DOI 10.4161/auto.3634; Kim H, 2009, MOL CELL, V36, P487, DOI 10.1016/j.molcel.2009.09.030; Kim JE, 1999, J NEUROCHEM, V72, P2456, DOI 10.1046/j.1471-4159.1999.0722456.x; Komatsu M, 2007, CELL, V131, P1149, DOI 10.1016/j.cell.2007.10.035; Kroemer G, 2009, CELL DEATH DIFFER, V16, P3, DOI 10.1038/cdd.2008.150; Kroemer G, 2010, MOL CELL, V40, P280, DOI 10.1016/j.molcel.2010.09.023; Kroemer G, 2008, NAT REV MOL CELL BIO, V9, P1004, DOI 10.1038/nrm2529; Lee JA, 2007, CURR BIOL, V17, P1561, DOI 10.1016/j.cub.2007.07.029; Lee YM, 2008, J BIOL CHEM, V283, P9986, DOI 10.1074/jbc.M800426200; Liang XH, 1998, J VIROL, V72, P8586, DOI 10.1128/JVI.72.11.8586-8596.1998; Lim J, 2011, AUTOPHAGY, V7, P51, DOI 10.4161/auto.7.1.13909; Luo S, 2010, CELL DEATH DIFFER, V17, P268, DOI 10.1038/cdd.2009.121; Luzio JP, 2003, MOL MEMBR BIOL, V20, P141, DOI 10.1080/0968768031000089546; Maiuri MC, 2007, NAT REV MOL CELL BIO, V8, P741, DOI 10.1038/nrm2239; Maiuri MC, 2007, EMBO J, V26, P2527, DOI 10.1038/sj.emboj.7601689; Maiuri MC, 2007, AUTOPHAGY, V3, P374, DOI 10.4161/auto.4237; Malik SA, 2011, ONCOGENE, V30, P3918, DOI 10.1038/onc.2011.104; Oh JH, 1997, NEUROREPORT, V8, P1851, DOI 10.1097/00001756-199705260-00012; PINKERTO.M, 1970, J MOL BIOL, V49, P533, DOI 10.1016/0022-2836(70)90279-2; Scarlatti F, 2009, CELL DEATH DIFFER, V16, P12, DOI 10.1038/cdd.2008.101; STEINRAUF LK, 1971, BIOCHEM BIOPH RES CO, V45, P1279, DOI 10.1016/0006-291X(71)90156-2; Strappazzon F, 2011, EMBO J, V30, P1195, DOI 10.1038/emboj.2011.49; Tait SWG, 2010, NAT REV MOL CELL BIO, V11, P621, DOI 10.1038/nrm2952; Tanida I, 2005, AUTOPHAGY, V1, P84, DOI 10.4161/auto.1.2.1697; Thorens B, 1996, J CELL SCI, V109, P1311; Wong E, 2010, NAT NEUROSCI, V13, P805, DOI 10.1038/nn.2575; Yee KS, 2009, CELL DEATH DIFFER, V16, P1135, DOI 10.1038/cdd.2009.28; Yla-Anttila P, 2009, METHOD ENZYMOL, V452, P143, DOI 10.1016/S0076-6879(08)03610-0; Zhang LH, 2007, P NATL ACAD SCI USA, V104, P19023, DOI 10.1073/pnas.0709695104	47	20	21	0	6	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JUL 6	2012	287	28					23271	23282		10.1074/jbc.M112.364281	http://dx.doi.org/10.1074/jbc.M112.364281			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	975KX	22493436	Green Published, hybrid			2022-12-25	WOS:000306511300002
J	Aussignargues, C; Giuliani, MC; Infossi, P; Lojou, E; Guiral, M; Giudici-Orticoni, MT; Ilbert, M				Aussignargues, Clement; Giuliani, Marie-Cecile; Infossi, Pascale; Lojou, Elisabeth; Guiral, Marianne; Giudici-Orticoni, Marie-Therese; Ilbert, Marianne			Rhodanese Functions as Sulfur Supplier for Key Enzymes in Sulfur Energy Metabolism	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							BACTERIUM AQUIFEX-AEOLICUS; MOLYBDENUM COFACTOR; OXYGENASE-REDUCTASE; ELEMENTAL SULFUR; SUD PROTEIN; SULFURTRANSFERASE; BIOSYNTHESIS; MEMBRANE; IDENTIFICATION; LOCALIZATION	How microorganisms obtain energy is a challenging topic, and there have been numerous studies on the mechanisms involved. Here, we focus on the energy substrate traffic in the hyperthermophilic bacterium Aquifex aeolicus. This bacterium can use insoluble sulfur as an energy substrate and has an intricate sulfur energy metabolism involving several sulfur-reducing and -oxidizing supercomplexes and enzymes. We demonstrate that the cytoplasmic rhodanese SbdP participates in this sulfur energy metabolism. Rhodaneses are a widespread family of proteins known to transfer sulfur atoms. We show that SbdP has also some unusual characteristics compared with other rhodaneses; it can load a long sulfur chain, and it can interact with more than one partner. Its partners (sulfur reductase and sulfur oxygenase reductase) are key enzymes of the sulfur energy metabolism of A. aeolicus and share the capacity to use long sulfur chains as substrate. We demonstrate a positive effect of SbdP, once loaded with sulfur chains, on sulfur reductase activity, most likely by optimizing substrate uptake. Taken together, these results lead us to propose a physiological role for SbdP as a carrier and sulfur chain donor to these key enzymes, therefore enabling channeling of sulfur substrate in the cell as well as greater efficiency of the sulfur energy metabolism of A. aeolicus.	[Aussignargues, Clement; Giuliani, Marie-Cecile; Infossi, Pascale; Lojou, Elisabeth; Guiral, Marianne; Giudici-Orticoni, Marie-Therese; Ilbert, Marianne] Aix Marseille Univ, Unite Bioenerget & Ingn Prot, Inst Microbiol Mediterranee, CNRS, F-13402 Marseille 20, France	Centre National de la Recherche Scientifique (CNRS); UDICE-French Research Universities; Aix-Marseille Universite	Ilbert, M (corresponding author), Aix Marseille Univ, Unite Bioenerget & Ingn Prot, Inst Microbiol Mediterranee, CNRS, 31 Chemin Joseph Aiguier, F-13402 Marseille 20, France.	milbert@imm.cnrs.fr	Ilbert, marianne/ABG-5015-2021	ilbert, marianne/0000-0002-9070-2334	Ministere de l'Enseignement Superieur et de la Recherche; Collectivite Territoriale Corse	Ministere de l'Enseignement Superieur et de la Recherche(Estonian Research Council); Collectivite Territoriale Corse(Region Corse)	Recipient of a fellowship from the Ministere de l'Enseignement Superieur et de la Recherche.; Supported by the "Collectivite Territoriale Corse." Present address: Laboratoire de Biochimie et Biologie Moleculaire du Vegetal, UMR-CNRS 6134 SPE, Universite de Corse, Campus Grimaldi, 20250 Corte, France.	Acosta M, 2005, OMICS, V9, P13, DOI 10.1089/omi.2005.9.13; Amend JP, 2001, FEMS MICROBIOL REV, V25, P175, DOI 10.1111/j.1574-6976.2001.tb00576.x; Baymann F, 2001, BIOCHEMISTRY-US, V40, P13681, DOI 10.1021/bi011201y; Bonch-Osmolovskaya E., 2007, ELS, DOI [10.1002/9780470015902.a0000405.pub2, DOI 10.1002/9780470015902.A0000405.PUB2]; Brito JA, 2009, BIOCHEMISTRY-US, V48, P5613, DOI 10.1021/bi9003827; Brugna-Guiral M, 2003, EXTREMOPHILES, V7, P145, DOI 10.1007/s00792-002-0306-3; BUKAU B, 1993, J GEN MICROBIOL, V139, P95, DOI 10.1099/00221287-139-1-95; CANNELLA C, 1984, ANAL BIOCHEM, V142, P159, DOI 10.1016/0003-2697(84)90531-1; Chen ZW, 2005, APPL ENVIRON MICROB, V71, P621, DOI 10.1128/AEM.71.2.621-628.2005; Cheng Hui, 2008, Open Microbiol J, V2, P18, DOI 10.2174/1874285800802010018; Cipollone R, 2007, IUBMB LIFE, V59, P51, DOI 10.1080/15216540701206859; Cipollone R, 2007, APPL ENVIRON MICROB, V73, P390, DOI 10.1128/AEM.02143-06; Dahl Christiane, 2006, V1, P21, DOI 10.1007/7171_002; Dahl JU, 2011, J BIOL CHEM, V286, P35801, DOI 10.1074/jbc.M111.282368; Forlani F, 2005, FEBS LETT, V579, P6786, DOI 10.1016/j.febslet.2005.11.013; Frigaard Niels-Ulrik, 2008, V27, P337; George GN, 2008, J BACTERIOL, V190, P6376, DOI 10.1128/JB.00539-08; Giuliani MC, 2007, FEBS J, V274, P4572, DOI 10.1111/j.1742-4658.2007.05985.x; Giuliani MC, 2010, BIOCHIMIE, V92, P388, DOI 10.1016/j.biochi.2009.12.013; Guiral M, 2005, J BIOL CHEM, V280, P42004, DOI 10.1074/jbc.M508034200; Guiral M, 2009, J PROTEOME RES, V8, P1717, DOI 10.1021/pr8007946; Hedderich R, 1998, FEMS MICROBIOL REV, V22, P353, DOI 10.1111/j.1574-6976.1998.tb00376.x; HUBER R, 1992, SYST APPL MICROBIOL, V15, P340, DOI 10.1016/S0723-2020(11)80206-7; Huber R., 2002, ELS, DOI [10.1038/npg.els.0000442, DOI 10.1038/NPG.ELS.0000442]; Jormakka M, 2008, NAT STRUCT MOL BIOL, V15, P730, DOI 10.1038/nsmb.1434; Kessler D, 2006, FEMS MICROBIOL REV, V30, P825, DOI 10.1111/j.1574-6976.2006.00036.x; Kletzin A, 2004, J BIOENERG BIOMEMBR, V36, P77, DOI 10.1023/B:JOBB.0000019600.36757.8c; Klimmek O, 1998, EUR J BIOCHEM, V253, P263, DOI 10.1046/j.1432-1327.1998.2530263.x; Klimmek O, 1999, EUR J BIOCHEM, V263, P79, DOI 10.1046/j.1432-1327.1999.00461.x; Klimmek O, 2005, MET IONS BIOL SYST, V43, P105; Lin YJ, 2004, BIOCHEMISTRY-US, V43, P1418, DOI 10.1021/bi0356597; Marcia M, 2009, P NATL ACAD SCI USA, V106, P9625, DOI 10.1073/pnas.0904165106; MARKWELL MAK, 1978, ANAL BIOCHEM, V87, P206, DOI 10.1016/0003-2697(78)90586-9; Matthies A, 2004, P NATL ACAD SCI USA, V101, P5946, DOI 10.1073/pnas.0308191101; Montegrossi G, 2001, ANAL CHEM, V73, P3709, DOI 10.1021/ac001429b; OLSEN GJ, 1994, J BACTERIOL, V176, P1, DOI 10.1128/JB.176.1.1-6.1994; Palenchar PM, 2000, J BIOL CHEM, V275, P8283, DOI 10.1074/jbc.275.12.8283; Papenbrock J, 2011, AMINO ACIDS, V41, P43, DOI 10.1007/s00726-010-0478-6; Pelletier N, 2008, EXTREMOPHILES, V12, P205, DOI 10.1007/s00792-007-0119-5; Philippot P, 2007, SCIENCE, V317, P1534, DOI 10.1126/science.1145861; Prunetti L, 2010, J BIOL CHEM, V285, P41815, DOI 10.1074/jbc.M110.167841; Remelli W, 2010, BIOL CHEM, V391, P777, DOI 10.1515/BC.2010.073; Robinson NJ, 2010, ANNU REV BIOCHEM, V79, P537, DOI 10.1146/annurev-biochem-030409-143539; Rothery RA, 2008, BBA-BIOMEMBRANES, V1778, P1897, DOI 10.1016/j.bbamem.2007.09.002; Tanaka Y, 2004, J BIOL CHEM, V279, P32957, DOI 10.1074/jbc.M404405200; Urich T, 2006, SCIENCE, V311, P996, DOI 10.1126/science.1120306; Vieille C, 2001, MICROBIOL MOL BIOL R, V65, P1, DOI 10.1128/MMBR.65.1.1-43.2001; Wachtershauser G, 2000, SCIENCE, V289, P1307, DOI 10.1126/science.289.5483.1307	48	21	23	1	19	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	JUN 8	2012	287	24					19936	19948		10.1074/jbc.M111.324863	http://dx.doi.org/10.1074/jbc.M111.324863			13	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	974FB	22496367	Green Published, hybrid			2022-12-25	WOS:000306414500016
J	Bae, EJ; Xu, JF; Oh, DY; Bandyopadhyay, G; Lagakos, WS; Keshwani, M; Olefsky, JM				Bae, Eun Ju; Xu, Jianfeng; Oh, Da Young; Bandyopadhyay, Gautam; Lagakos, William S.; Keshwani, Malik; Olefsky, Jerrold M.			Liver-specific p70 S6 Kinase Depletion Protects against Hepatic Steatosis and Systemic Insulin Resistance	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							DIET-INDUCED OBESITY; MAMMALIAN TARGET; AMINO-ACIDS; RAPAMYCIN PATHWAY; RAT HEPATOCYTES; LIPOGENESIS; ACTIVATION; MICE; AKT; SENSITIVITY	Obesity-associated hepatic steatosis is a manifestation of selective insulin resistance whereby lipogenesis remains sensitive to insulin but the ability of insulin to suppress glucose production is impaired. We created a mouse model of liver-specific knockdown of p70 S6 kinase (S6K) (L-S6K-KD) by systemic delivery of an adeno-associated virus carrying a shRNA for S6K and examined the effects on steatosis and insulin resistance. High fat diet (HFD) fed L-S6K-KD mice showed improved glucose tolerance and systemic insulin sensitivity compared with controls, with no changes in food intake or body weight. The induction of lipogenic gene expression was attenuated in the L-S6K-KD mice with decreased sterol regulatory element-binding protein (SREBP)-1c expression and mature SREBP-1c protein, as well as decreased steatosis on HFD. Our results demonstrate the importance of S6K: 1) as a modulator of the hepatic response to fasting/refeeding, 2) in the development of steatosis, and 3) as a key node in selective hepatic insulin resistance in obese mice.	[Olefsky, Jerrold M.] Univ Calif San Diego, Dept Med, Div Endocrinol & Metab, La Jolla, CA 92093 USA; [Keshwani, Malik] Univ Calif San Diego, Dept Pharmacol, La Jolla, CA 92093 USA	University of California System; University of California San Diego; University of California System; University of California San Diego	Olefsky, JM (corresponding author), Univ Calif San Diego, Dept Med, Div Endocrinol & Metab, 9500 Gilman Dr, La Jolla, CA 92093 USA.	jolefsky@ucsd.edu			National Institutes of Health [DK033651, DK074868, T32 DK 007494, DK063491]; Eunice Kennedy Shriver NICHD/National Institutes of Health [U54 HD 012303-25]; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT [P50HD012303, U54HD012303] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK033651, T32DK007494, P01DK074868, P30DK063491, R37DK033651] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Eunice Kennedy Shriver NICHD/National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	This work was supported, in whole or in part, by Grants DK033651, DK074868, T32 DK 007494, and DK063491 from the National Institutes of Health. This work was also supported by the Eunice Kennedy Shriver NICHD/National Institutes of Health through cooperative agreement U54 HD 012303-25 as part of the specialized Cooperative Centers Program in Reproduction and Infertility Research.	Aguilar V, 2007, CELL METAB, V5, P476, DOI 10.1016/j.cmet.2007.05.006; BAQUET A, 1991, BIOCHEM J, V273, P57, DOI 10.1042/bj2730057; Biddinger SB, 2008, CELL METAB, V7, P125, DOI 10.1016/j.cmet.2007.11.013; Brown MS, 2008, CELL METAB, V7, P95, DOI 10.1016/j.cmet.2007.12.009; Brown NF, 2007, METABOLISM, V56, P1500, DOI 10.1016/j.metabol.2007.06.016; Harrington LS, 2005, TRENDS BIOCHEM SCI, V30, P35, DOI 10.1016/j.tibs.2004.11.003; Hegarty BD, 2005, P NATL ACAD SCI USA, V102, P791, DOI 10.1073/pnas.0405067102; Jiang GQ, 2005, J CLIN INVEST, V115, P1030, DOI 10.1172/JCI200523962; Keshwani MM, 2008, J BIOL CHEM, V283, P11972, DOI 10.1074/jbc.M800114200; Khamzina L, 2005, ENDOCRINOLOGY, V146, P1473, DOI 10.1210/en.2004-0921; Krebs M, 2003, DIABETOLOGIA, V46, P917, DOI 10.1007/s00125-003-1129-1; Le Bacquer O, 2007, J CLIN INVEST, V117, P387, DOI 10.1172/JCI29528; Leavens KF, 2009, CELL METAB, V10, P405, DOI 10.1016/j.cmet.2009.10.004; Li SJ, 2010, P NATL ACAD SCI USA, V107, P3441, DOI 10.1073/pnas.0914798107; Ma XJM, 2009, NAT REV MOL CELL BIO, V10, P307, DOI 10.1038/nrm2672; Nobukuni T, 2005, P NATL ACAD SCI USA, V102, P14238, DOI 10.1073/pnas.0506925102; Oh DY, 2010, CELL, V142, P687, DOI 10.1016/j.cell.2010.07.041; Peterson TR, 2011, CELL, V146, P408, DOI 10.1016/j.cell.2011.06.034; Porstmann T, 2008, CELL METAB, V8, P224, DOI 10.1016/j.cmet.2008.07.007; Radimerski T, 2002, GENE DEV, V16, P2627, DOI 10.1101/gad.239102; Snyder RO, 1997, NAT GENET, V16, P270, DOI 10.1038/ng0797-270; Tremblay F, 2005, ENDOCRINOLOGY, V146, P1328, DOI 10.1210/en.2004-0777; Um SH, 2004, NATURE, V431, P200, DOI 10.1038/nature02866; Yecies JL, 2011, CELL METAB, V14, P21, DOI 10.1016/j.cmet.2011.06.002; Yoshizaki T, 2009, MOL CELL BIOL, V29, P1363, DOI 10.1128/MCB.00705-08; Zick Y, 2004, BIOCHEM SOC T, V32, P812, DOI 10.1042/BST0320812	26	43	44	0	1	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAY 25	2012	287	22					18769	18780		10.1074/jbc.M112.365544	http://dx.doi.org/10.1074/jbc.M112.365544			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	974EC	22493495	Green Published, hybrid			2022-12-25	WOS:000306411600085
J	Ma, CY; Wang, NH; Detre, C; Wang, GX; O'Keeffe, M; Terhorst, C				Ma, Chunyan; Wang, Ninghai; Detre, Cynthia; Wang, Guoxing; O'Keeffe, Michael; Terhorst, Cox			Receptor Signaling Lymphocyte-activation Molecule Family 1 (Slamf1) Regulates Membrane Fusion and NADPH Oxidase 2 (NOX2) Activity by Recruiting a Beclin-1/Vps34/Ultraviolet Radiation Resistance-associated Gene (UVRAG) Complex	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							IMMUNE-RESPONSES; INNATE IMMUNITY; AUTOPHAGY GENE; ROLES; MACROPHAGES; BECLIN-1; PATHWAY; SENSOR; VPS34; CELL	Phagocytosis is a pivotal process by which macrophages eliminate microorganisms upon recognition by pathogen sensors. Surprisingly, the self-ligand cell surface receptor Slamf1 functions not only as a co-stimulatory molecule but also as a microbial sensor of several Gram-negative bacteria. Upon entering the phagosome of macrophages Slamf1 induces production of phosphatidylinositol 3-phosphate, which positively regulates the activity of the NOX2 enzyme and phagolysosomal maturation. Here, we report that in Escherichia coli-containing phagosomes of mouse macrophages, Slamf1 interacts with the class III PI3K Vps34 in a complex with Beclin-1 and UVRAG. Upon phagocytosis of bacteria the NOX2 activity was reduced in macrophages isolated from Beclin-1(+/-) mice compared with wild-type mice. This Slamf1/Beclin-1/Vps34/UVRAG protein complex is formed in intracellular membrane compartments as it is found without inducing phagocytosis in macrophages, human chronic lymphocytic leukemia cells, and transfectant HEK293 cells. Elimination of its cytoplasmic tail abolished the interaction of Slamf1 with the complex, but deletion or mutation of the two ITAM motifs did not. Both the BD and CCD domains of Beclin-1 were required for efficient binding to Slamf1. Because Slamf1 did not interact with Atg14L or Rubicon, which can also form a complex with Vps34 and Beclin-1, we conclude that Slamf1 recruits a subset of Vps34-associated proteins, which is involved in membrane fusion and NOX2 regulation.	[Ma, Chunyan; Wang, Ninghai; Detre, Cynthia; Wang, Guoxing; O'Keeffe, Michael; Terhorst, Cox] Harvard Univ, Sch Med, Beth Israel Deaconess Med Ctr, Div Immunol, Boston, MA 02115 USA	Harvard University; Beth Israel Deaconess Medical Center; Harvard Medical School	Ma, CY (corresponding author), Harvard Univ, Sch Med, Beth Israel Deaconess Med Ctr, Div Immunol, Boston, MA 02115 USA.	cma@bidmc.harvard.edu; cterhors@bidmc.harvard.edu	Wang, Guoxing/G-6586-2013		National Institutes of Health [AI-15066]; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R56AI015066, R01AI015066] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [P30DK043351] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	The work was supported, in whole or in part, by National Institutes of Health Grant AI-15066 (to C. T.).	Backer JM, 2008, BIOCHEM J, V410, P1, DOI 10.1042/BJ20071427; Berger SB, 2010, NAT IMMUNOL, V11, P920, DOI 10.1038/ni.1931; Calpe S, 2008, ADV IMMUNOL, V97, P177, DOI 10.1016/S0065-2776(08)00004-7; Cheson B. D, 2001, CHRONIC LYMPHOCYTIC, P33; Deretic V, 2012, CURR OPIN IMMUNOL, V24, P21, DOI 10.1016/j.coi.2011.10.006; Joubert PE, 2009, CELL HOST MICROBE, V6, P354, DOI 10.1016/j.chom.2009.09.006; Lam GY, 2010, SEMIN IMMUNOPATHOL, V32, P415, DOI 10.1007/s00281-010-0221-0; Levine B, 2011, NATURE, V469, P323, DOI 10.1038/nature09782; Lonnbro P, 2008, BMC CELL BIOL, V9, DOI 10.1186/1471-2121-9-35; Mantegazza AR, 2008, BLOOD, V112, P4712, DOI 10.1182/blood-2008-01-134791; Qu XP, 2003, J CLIN INVEST, V112, P1809, DOI 10.1172/JCI200320039; Saitoh T, 2008, NATURE, V456, P264, DOI 10.1038/nature07383; Saitoh T, 2010, J CELL BIOL, V189, P925, DOI 10.1083/jcb.201002021; Sanjuan MA, 2007, NATURE, V450, P1253, DOI 10.1038/nature06421; Shin HW, 2005, J CELL BIOL, V170, P607, DOI 10.1083/jcb.200505128; Thoresen SB, 2010, EXP CELL RES, V316, P3368, DOI 10.1016/j.yexcr.2010.07.008; Vieira OV, 2001, J CELL BIOL, V155, P19, DOI 10.1083/jcb.200107069; Wang NH, 2004, J EXP MED, V199, P1255, DOI 10.1084/jem.20031835; Wang NH, 2010, J IMMUNOL, V185, P5683, DOI 10.4049/jimmunol.1001974; Wirawan E, 2012, AUTOPHAGY, V8, P6, DOI 10.4161/auto.8.1.16645; Xu Y, 2007, IMMUNITY, V27, P135, DOI 10.1016/j.immuni.2007.05.022; Yue ZY, 2003, P NATL ACAD SCI USA, V100, P15077, DOI 10.1073/pnas.2436255100; Zhong Y, 2009, NAT CELL BIOL, V11, P468, DOI 10.1038/ncb1854	23	33	41	1	4	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258			J BIOL CHEM	J. Biol. Chem.	MAY 25	2012	287	22					18359	18365		10.1074/jbc.M112.367060	http://dx.doi.org/10.1074/jbc.M112.367060			7	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	974EC	22493499	Green Published, hybrid			2022-12-25	WOS:000306411600042
J	Melo, FR; Grujic, M; Spirkoski, J; Calounova, G; Pejler, G				Melo, Fabio R.; Grujic, Mirjana; Spirkoski, Jane; Calounova, Gabriela; Pejler, Gunnar			Serglycin Proteoglycan Promotes Apoptotic versus Necrotic Cell Death in Mast Cells	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							GRANZYME-B; POLY(ADP-RIBOSE) POLYMERASE; SECRETORY GRANULE; T-LYMPHOCYTES; PROTEASES; ACTIVATION; EXPRESSION; MATURATION; INHIBITORS; CLEAVAGE	The mechanisms that govern whether a cell dies by apoptosis or necrosis are not fully understood. Here we show that serglycin, a secretory granule proteoglycan of hematopoietic cells, can have a major impact on this decision. Wild type and serglycin(-/-) mast cells were equally sensitive to a range of cell death-inducing regimens. However, whereas wild type mast cells underwent apoptotic cell death, serglycin(-/-) cells died predominantly by necrosis. Investigations of the underlying mechanism revealed that cell death was accompanied by leakage of secretory granule compounds into the cytosol and that the necrotic phenotype of serglycin(-/-) mast cells was linked to defective degradation of poly(ADP-ribose) polymerase-1. Cells lacking mouse mast cell protease 6, a major serglycin-associated protease, exhibited similar defects in apoptosis as observed in serglycin(-/-) cells, indicating that the pro-apoptotic function of serglycin is due to downstream effects of proteases that are complex-bound to serglycin. Together, these findings implicate serglycin in promoting apoptotic versus necrotic cell death.	[Melo, Fabio R.] Swedish Univ Agr Sci, Dept Anat Physiol & Biochem, BMC, S-75123 Uppsala, Sweden	Swedish University of Agricultural Sciences	Melo, FR (corresponding author), Swedish Univ Agr Sci, Dept Anat Physiol & Biochem, BMC, Box 575, S-75123 Uppsala, Sweden.	Fabio.Melo@slu.se; Gunnar.Pejler@slu.se	Melo, Fabio Rabelo/GQP-0844-2022		King Gustaf V's 80-year Anniversary Fund; Swedish Research Council; Swedish Cancer Foundation	King Gustaf V's 80-year Anniversary Fund; Swedish Research Council(Swedish Research CouncilEuropean Commission); Swedish Cancer Foundation	This work was supported by grants from King Gustaf V's 80-year Anniversary Fund, The Swedish Research Council, and The Swedish Cancer Foundation.	Abrink M, 2004, J BIOL CHEM, V279, P40897, DOI 10.1074/jbc.M405856200; Berent-Maoz B, 2011, ANN ALLERG ASTHMA IM, V106, P239, DOI 10.1016/j.anai.2010.12.001; Bird PI, 2009, NAT REV IMMUNOL, V9, P871, DOI 10.1038/nri2671; Bishop JR, 2007, NATURE, V446, P1030, DOI 10.1038/nature05817; Braga T, 2007, BIOCHEM J, V403, P49, DOI 10.1042/BJ20061257; Chaitanya GV, 2010, CELL COMMUN SIGNAL, V8, DOI 10.1186/1478-811X-8-31; Duelli A, 2009, J IMMUNOL, V183, P7073, DOI 10.4049/jimmunol.0900309; Edinger AL, 2004, CURR OPIN CELL BIOL, V16, P663, DOI 10.1016/j.ceb.2004.09.011; Elmore S, 2007, TOXICOL PATHOL, V35, P495, DOI 10.1080/01926230701320337; Glenthoj A, 2011, BLOOD, V118, P4440, DOI 10.1182/blood-2011-06-362947; Gonzalez VM, 2001, MOL PHARMACOL, V59, P657, DOI 10.1124/mol.59.4.657; Grujic M, 2005, J BIOL CHEM, V280, P33411, DOI 10.1074/jbc.M501708200; Ha HC, 1999, P NATL ACAD SCI USA, V96, P13978, DOI 10.1073/pnas.96.24.13978; Hartmann K, 1997, J IMMUNOL, V159, P4006; Ida H, 2003, EUR J IMMUNOL, V33, P3284, DOI 10.1002/eji.200324376; Kaiserman D, 2010, CELL DEATH DIFFER, V17, P586, DOI 10.1038/cdd.2009.169; Kar P, 2010, ARCH BIOCHEM BIOPHYS, V495, P1, DOI 10.1016/j.abb.2009.12.020; Kolset SO, 2011, J IMMUNOL, V187, P4927, DOI 10.4049/jimmunol.1100806; Laforge M, 2006, J IMMUNOL, V176, P3966, DOI 10.4049/jimmunol.176.7.3966; LAZEBNIK YA, 1994, NATURE, V371, P346, DOI 10.1038/371346a0; Malbec O, 2007, J IMMUNOL, V178, P6465, DOI 10.4049/jimmunol.178.10.6465; Meen AJ, 2011, J BIOL CHEM, V286, P2636, DOI 10.1074/jbc.M110.151944; Melo FR, 2011, J BIOL CHEM, V286, P5423, DOI 10.1074/jbc.M110.176461; Metkar SS, 2002, IMMUNITY, V16, P417, DOI 10.1016/S1074-7613(02)00286-8; Michallet MC, 2004, J IMMUNOL, V172, P5405, DOI 10.4049/jimmunol.172.9.5405; Niemann CU, 2007, BLOOD, V109, P4478, DOI 10.1182/blood-2006-02-001719; Norberg E, 2010, BIOCHEM BIOPH RES CO, V396, P95, DOI 10.1016/j.bbrc.2010.02.163; Pejler G, 2010, BLOOD, V115, P4981, DOI 10.1182/blood-2010-01-257287; Pereira PJB, 1998, NATURE, V392, P306, DOI 10.1038/32703; Ringvall M, 2008, J ALLERGY CLIN IMMUN, V121, P1020, DOI 10.1016/j.jaci.2007.11.031; Shin K, 2008, J IMMUNOL, V180, P4885, DOI 10.4049/jimmunol.180.7.4885; Taylor RC, 2008, NAT REV MOL CELL BIO, V9, P231, DOI 10.1038/nrm2312; Tchougounova E, 2003, J EXP MED, V198, P423, DOI 10.1084/jem.20030671; Tran TM, 2009, APOPTOSIS, V14, P320, DOI 10.1007/s10495-009-0311-4; van Nierop K, 2006, J HISTOCHEM CYTOCHEM, V54, P1425, DOI 10.1369/jhc.6A6967.2006; Virag L, 2002, PHARMACOL REV, V54, P375, DOI 10.1124/pr.54.3.375; Woulfe DS, 2008, BLOOD, V111, P3458, DOI 10.1182/blood-2007-07-104703; Zernichow L, 2006, FEBS J, V273, P536, DOI 10.1111/j.1742-4658.2005.05085.x	38	15	17	0	1	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAY 25	2012	287	22					18142	18152		10.1074/jbc.M112.344796	http://dx.doi.org/10.1074/jbc.M112.344796			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	974EC	22493512	hybrid, Green Published			2022-12-25	WOS:000306411600022
J	Shen, X; Zeng, H; Xie, L; He, J; Li, J; Xie, XJ; Luo, CL; Xu, HP; Zhou, M; Nie, QH; Zhang, XQ				Shen, Xu; Zeng, Hua; Xie, Liang; He, Jun; Li, Jian; Xie, Xiujuan; Luo, Chenglong; Xu, Haiping; Zhou, Min; Nie, Qinghua; Zhang, Xiquan			The GTPase Activating Rap/RanGAP Domain-Like 1 Gene Is Associated with Chicken Reproductive Traits	PLOS ONE			English	Article							VASOACTIVE-INTESTINAL-PEPTIDE; GENOME-WIDE ASSOCIATION; HORMONE BETA-SUBUNIT; HIGH EGG-PRODUCTION; PITUITARY-GLAND; DOMESTIC HEN; BODY-WEIGHT; INCUBATION BEHAVIOR; PROLACTIN SECRETION; CANDIDATE GENES	Background: Abundant evidence indicates that chicken reproduction is strictly regulated by the hypothalamic-pituitary-gonad (HPG) axis, and the genes included in the HPG axis have been studied extensively. However, the question remains as to whether any other genes outside of the HPG system are involved in regulating chicken reproduction. The present study was aimed to identify, on a genome-wide level, novel genes associated with chicken reproductive traits. Methodology/Principal Finding: Suppressive subtractive hybridization (SSH), genome-wide association study (GWAS), and gene-centric GWAS were used to identify novel genes underlying chicken reproduction. Single marker-trait association analysis with a large population and allelic frequency spectrum analysis were used to confirm the effects of candidate genes. Using two full-sib Ningdu Sanhuang (NDH) chickens, GARNL1 was identified as a candidate gene involved in chicken broodiness by SSH analysis. Its expression levels in the hypothalamus and pituitary were significantly higher in brooding chickens than in non-brooding chickens. GWAS analysis with a NDH two tail sample showed that 2802 SNPs were significantly associated with egg number at 300 d of age (EN300). Among the 2802 SNPs, 2 SNPs composed a block overlapping the GARNL1 gene. The gene-centric GWAS analysis with another two tail sample of NDH showed that GARNL1 was strongly associated with EN300 and age at first egg (AFE). Single marker-trait association analysis in 1301 female NDH chickens confirmed that variation in this gene was related to EN300 and AFE. The allelic frequency spectrum of the SNP rs15700989 among 5 different populations supported the above associations. Western blotting, RT-PCR, and qPCR were used to analyze alternative splicing of the GARNL1 gene. RT-PCR detected 5 transcripts and revealed that the transcript, which has a 141 bp insertion, was expressed in a tissue-specific manner. Conclusions/Significance: Our findings demonstrate that the GARNL1 gene contributes to chicken reproductive traits.	[Shen, Xu; Zeng, Hua; Xie, Liang; He, Jun; Li, Jian; Xie, Xiujuan; Xu, Haiping; Nie, Qinghua; Zhang, Xiquan] S China Agr Univ, Coll Anim Sci, Dept Anim Genet Breeding & Reprod, Guangzhou, Guangdong, Peoples R China; [Shen, Xu; He, Jun; Li, Jian; Xie, Xiujuan; Xu, Haiping; Nie, Qinghua; Zhang, Xiquan] Guangdong Prov Key Lab Agroanim Genom & Mol Breed, Guangzhou, Guangdong, Peoples R China; [Xie, Liang] Hainan Acad Agr Sci, Inst Anim Sci & Vet, Haikou, Hainan, Peoples R China; [Luo, Chenglong] Guangdong Acad Agr Sci, Inst Anim Sci, Guangzhou, Guangdong, Peoples R China; [Zhou, Min] Jiang Xi Educ Coll, Inst Biotechnol, Nanchang, Jiangxi, Peoples R China	South China Agricultural University; Guangdong Academy of Agricultural Sciences	Shen, X (corresponding author), S China Agr Univ, Coll Anim Sci, Dept Anim Genet Breeding & Reprod, Guangzhou, Guangdong, Peoples R China.	xqzhang@scau.edu.cn	xu, haiping/GSJ-1374-2022		China Agriculture Research System [CARS-42-G05]; National Natural Scientific Foundation of China [31000544]	China Agriculture Research System; National Natural Scientific Foundation of China(National Natural Science Foundation of China (NSFC))	This work was supported by China Agriculture Research System (CARS-42-G05) and the National Natural Scientific Foundation of China, project (No. 31000544). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abasht B, 2007, ANIM GENET, V38, P491, DOI 10.1111/j.1365-2052.2007.01642.x; Ahn JS, 2010, STEM CELLS DEV, V19, P1249, DOI 10.1089/scd.2009.0265; Bao B, 2011, BMC GENOMICS, V12, DOI 10.1186/1471-2164-12-224; Barrett JC, 2005, BIOINFORMATICS, V21, P263, DOI 10.1093/bioinformatics/bth457; Basheer A, 2010, 32 C INT SOC AN GEN; Bhatt R, 2003, GEN COMP ENDOCR, V130, P41, DOI 10.1016/S0016-6480(02)00533-6; Bouatia-Naji N, 2009, NAT GENET, V41, P89, DOI 10.1038/ng.277; BUNTIN JD, 1988, J ENDOCRINOL, V118, P33, DOI 10.1677/joe.0.1180033; Chaiseha Y, 2003, NEUROENDOCRINOLOGY, V77, P105, DOI 10.1159/000068649; Chen CF, 2007, THERIOGENOLOGY, V68, P1305, DOI 10.1016/j.theriogenology.2007.08.032; Chen LR, 2007, ANIM REPROD SCI, V100, P172, DOI 10.1016/j.anireprosci.2006.07.005; Ciccone NA, 2004, J NEUROENDOCRINOL, V16, P999, DOI 10.1111/j.1365-2826.2005.01260.x; Cui JX, 2006, POULTRY SCI, V85, P26, DOI 10.1093/ps/85.1.26; Dunn IC, 2009, ANIM GENET, V40, P110, DOI 10.1111/j.1365-2052.2008.01794.x; Dunn IC, 1999, J NEUROENDOCRINOL, V11, P371; Dunn IC, 2004, HEREDITY, V92, P128, DOI 10.1038/sj.hdy.6800396; El Halawani ME, 2000, POULTRY SCI, V79, P349, DOI 10.1093/ps/79.3.349; ELHALAWANI ME, 1993, POULTRY SCI, V72, P906, DOI 10.3382/ps.0720906; Elkin RG, 2003, POULTRY SCI, V82, P517, DOI 10.1093/ps/82.4.517; GARWOOD VA, 1975, POULTRY SCI, V54, P1765; Gorni C, 2011, ANIM GENET, V42, P161, DOI 10.1111/j.1365-2052.2010.02098.x; HALAWANI ME, 1980, BIOL REPROD, V23, P118, DOI 10.1095/biolreprod23.1.118; Han B, 2009, PLOS GENET, V5, DOI 10.1371/journal.pgen.1000456; Hansen C, 2005, ANIM BIOTECHNOL, V16, P67, DOI 10.1081/ABIO-200055016; Hasenstein JR, 2008, DEV BIOLOGICALS, V132, P213, DOI 10.1159/000317162; HATTORI M, 1995, MOL CELL BIOL, V15, P552, DOI 10.1128/MCB.15.1.552; Hemminger BM, 2006, BIOINFORMATICS, V22, P626, DOI 10.1093/bioinformatics/btk025; Heng JIT, 2002, J BIOL CHEM, V277, P43152, DOI 10.1074/jbc.M204858200; Jiang RS, 2005, POULTRY SCI, V84, P839, DOI 10.1093/ps/84.6.839; Jiang RunShen, 2007, Journal of China Agricultural University, V12, P46; Jorgenson E, 2006, NAT REV GENET, V7, P885, DOI 10.1038/nrg1962; Klenke U, 2010, ENDOCRINOLOGY, V151, P2736, DOI 10.1210/en.2009-1198; Kuo YM, 2005, THERIOGENOLOGY, V64, P1490, DOI 10.1016/j.theriogenology.2005.03.020; Liang Y, 2006, DOMEST ANIM ENDOCRIN, V30, P1, DOI 10.1016/j.domaniend.2005.05.006; LIU G, 1995, POULTRY SCI, V74, P1259, DOI 10.3382/ps.0741259; MAURO LJ, 1989, ENDOCRINOLOGY, V125, P1795, DOI 10.1210/endo-125-4-1795; Mochizuki N, 1999, NATURE, V400, P891, DOI 10.1038/23738; Onagbesan OM, 2006, POULTRY SCI, V85, P1245, DOI 10.1093/ps/85.7.1245; Richard-Yris MA, 1998, BRIT POULTRY SCI, V39, P309, DOI 10.1080/00071669888836; Rioux JD, 2007, NAT GENET, V39, P596, DOI 10.1038/ng2032; Romanov MN, 2002, POULTRY SCI, V81, P928, DOI 10.1093/ps/81.7.928; Sasaki O, 2004, ANIM GENET, V35, P188, DOI 10.1111/j.1365-2052.2004.01133.x; Schreiweis MA, 2006, ANIM GENET, V37, P106, DOI 10.1111/j.1365-2052.2005.01394.x; Schulze TG, 2009, MOL PSYCHIATR, V14, P487, DOI 10.1038/mp.2008.134; Schutz K, 2002, BEHAV GENET, V32, P423, DOI 10.1023/A:1020880211144; Schwarzbraun T, 2004, GENOMICS, V84, P577, DOI 10.1016/j.ygeno.2004.04.013; Sharp PJ, 2005, ANN NY ACAD SCI, V1040, P189, DOI 10.1196/annals.1327.024; SHARP PJ, 1993, POULTRY SCI, V72, P897, DOI 10.3382/ps.0720897; SHARP PJ, 1989, J ENDOCRINOL, V122, P5, DOI 10.1677/joe.0.1220005; SHARP PJ, 1984, J EXP ZOOL, V232, P475, DOI 10.1002/jez.1402320314; SHARP PJ, 2004, GENES PERSISTENCY EG, P38; Shimojima K, 2009, GENOMICS, V94, P414, DOI 10.1016/j.ygeno.2009.08.015; Shiue YL, 2006, THERIOGENOLOGY, V66, P1274, DOI 10.1016/j.theriogenology.2006.03.037; Tuiskula-Haavisto M, 2004, GENET RES, V84, P57, DOI 10.1017/S0016672304006950; Tuiskula-Haavisto M, 2002, POULTRY SCI, V81, P919, DOI 10.1093/ps/81.7.919; Uemoto Y, 2009, POULTRY SCI, V88, P2512, DOI 10.3382/ps.2009-00331; Wardecka Barbara, 2002, Journal of Applied Genetics, V43, P319; Xu HP, 2010, POULTRY SCI, V89, P428, DOI 10.3382/ps.2009-00428; Xu HP, 2011, BMC GENET, V12, DOI 10.1186/1471-2156-12-33; Xu HP, 2010, BMC GENET, V11, DOI 10.1186/1471-2156-11-17; Yang N, 2005, WORLD POULTRY SCI J, V61, P373, DOI [10.1079/WPS200463, 10.1079/WPS200563]; Youngren OM, 1998, NEUROENDOCRINOLOGY, V68, P319, DOI 10.1159/000054380; ZHANG K, 1991, SCIENCE, V254, P1630, DOI 10.1126/science.1749934; Zhou M, 2008, POULTRY SCI, V87, P893, DOI 10.3382/ps.2007-00495; Zhou M, 2010, BRIT POULTRY SCI, V51, P195, DOI 10.1080/00071661003745786	65	19	24	0	23	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 9	2012	7	4							e33851	10.1371/journal.pone.0033851	http://dx.doi.org/10.1371/journal.pone.0033851			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	955JO	22496769	Green Published, Green Submitted, gold			2022-12-25	WOS:000305014500018
J	Buchi, L; Vuilleumier, S				Buechi, Lucie; Vuilleumier, Severine			Dispersal Strategies, Few Dominating or Many Coexisting: The Effect of Environmental Spatial Structure and Multiple Sources of Mortality	PLOS ONE			English	Article							METAPOPULATION PERSISTENCE; PATCHY ENVIRONMENTS; LOCAL ADAPTATION; SEED DISPERSAL; EVOLUTION; COMPETITION; LANDSCAPES; DISTANCE; POPULATIONS; HABITATS	Interspecific competition, life history traits, environmental heterogeneity and spatial structure as well as disturbance are known to impact the successful dispersal strategies in metacommunities. However, studies on the direction of impact of those factors on dispersal have yielded contradictory results and often considered only few competing dispersal strategies at the same time. We used a unifying modeling approach to contrast the combined effects of species traits (adult survival, specialization), environmental heterogeneity and structure (spatial autocorrelation, habitat availability) and disturbance on the selected, maintained and coexisting dispersal strategies in heterogeneous metacommunities. Using a negative exponential dispersal kernel, we allowed for variation of both species dispersal distance and dispersal rate. We showed that strong disturbance promotes species with high dispersal abilities, while low local adult survival and habitat availability select against them. Spatial autocorrelation favors species with higher dispersal ability when adult survival and disturbance rate are low, and selects against them in the opposite situation. Interestingly, several dispersal strategies coexist when disturbance and adult survival act in opposition, as for example when strong disturbance regime favors species with high dispersal abilities while low adult survival selects species with low dispersal. Our results unify apparently contradictory previous results and demonstrate that spatial structure, disturbance and adult survival determine the success and diversity of coexisting dispersal strategies in competing metacommunities.	[Buechi, Lucie; Vuilleumier, Severine] Univ Lausanne, Dept Ecol & Evolut, Lausanne, Switzerland; [Buechi, Lucie] Agroscope Changins Wadenswil Res Stn ACW, Nyon, Switzerland	University of Lausanne; Swiss Federal Research Station Agroscope	Buchi, L (corresponding author), Univ Lausanne, Dept Ecol & Evolut, Lausanne, Switzerland.	Lucie.Buchi@gmail.com	; Buchi, Lucie/E-5677-2012	Vuilleumier, Severine/0000-0002-0131-3186; Buchi, Lucie/0000-0002-1935-6176	Swiss National Science Foundation [31003A-112511/2, PZ00P3-121702, PZ00P3_139421 / 1, 31003A-130065]	Swiss National Science Foundation(Swiss National Science Foundation (SNSF)European Commission)	This work was funded by the Swiss National Science Foundation, grant #31003A-112511/2 and for SV, grants #PZ00P3-121702, #PZ00P3_139421 / 1 and #31003A-130065. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Achter JD, 2006, EVOL ECOL RES, V8, P1377; ASMUSSEN MA, 1983, THEOR POPUL BIOL, V23, P281, DOI 10.1016/0040-5809(83)90019-9; BALKAU BJ, 1973, GENETICS, V74, P171; BENGTSSON BO, 1978, J THEOR BIOL, V73, P439, DOI 10.1016/0022-5193(78)90151-0; Blanquart F, 2011, AM NAT, V177, P188, DOI 10.1086/657953; Bonte D, 2010, OIKOS, V119, P560, DOI 10.1111/j.1600-0706.2009.17943.x; Buchi L, 2009, ECOL MODEL, V220, P2857, DOI 10.1016/j.ecolmodel.2009.08.005; Cadotte MW, 2006, AM NAT, V167, P913, DOI 10.1086/504850; Chase JM, 2005, FUNCT ECOL, V19, P182, DOI 10.1111/j.0269-8463.2005.00937.x; Clark JS, 1999, ECOLOGY, V80, P1475, DOI 10.2307/176541; COHEN D, 1991, THEOR POPUL BIOL, V39, P63, DOI 10.1016/0040-5809(91)90041-D; COMINS HN, 1980, J THEOR BIOL, V82, P205, DOI 10.1016/0022-5193(80)90099-5; CONNELL JH, 1978, SCIENCE, V199, P1302, DOI 10.1126/science.199.4335.1302; Conrad KF, 1999, ECOGRAPHY, V22, P524, DOI 10.1111/j.1600-0587.1999.tb00541.x; Devictor V, 2009, DIVERS DISTRIB, V15, P122, DOI 10.1111/j.1472-4642.2008.00510.x; Doebeli M, 1997, EVOLUTION, V51, P1730, DOI 10.1111/j.1558-5646.1997.tb05097.x; FRANK SA, 1986, J THEOR BIOL, V122, P303, DOI 10.1016/S0022-5193(86)80122-9; GADGIL M, 1971, ECOLOGY, V52, P253, DOI 10.2307/1934583; Gandon S, 1999, J THEOR BIOL, V199, P275, DOI 10.1006/jtbi.1999.0960; Goodnight CJ, 2011, PHILOS T R SOC B, V366, P1401, DOI 10.1098/rstb.2010.0290; Gros A, 2006, OIKOS, V114, P544, DOI 10.1111/j.2006.0030-1299.14909.x; HAMILTON WD, 1977, NATURE, V269, P578, DOI 10.1038/269578a0; Hanski I, 2004, ECOL LETT, V7, P958, DOI 10.1111/j.1461-0248.2004.00654.x; HASTINGS A, 1983, THEOR POPUL BIOL, V24, P244, DOI 10.1016/0040-5809(83)90027-8; Heino M, 2001, AM NAT, V157, P495, DOI 10.1086/319927; Hiebeler D, 2004, THEOR POPUL BIOL, V66, P205, DOI 10.1016/j.tpb.2004.06.004; Hiebeler DE, 2007, J MATH BIOL, V54, P337, DOI 10.1007/s00285-006-0054-6; Higgins SI, 2002, J ECOL, V90, P616, DOI 10.1046/j.1365-2745.2002.00694.x; Hovestadt T, 2001, P ROY SOC B-BIOL SCI, V268, P385, DOI 10.1098/rspb.2000.1379; Hubbell Stephen P., 2001, V32, pi; Jansen VAA, 2007, EVOLUTION, V61, P2386, DOI 10.1111/j.1558-5646.2007.00201.x; JOHNSON ML, 1990, ANNU REV ECOL SYST, V21, P449, DOI 10.1146/annurev.ecolsys.21.1.449; Johst K, 2002, OIKOS, V98, P263, DOI 10.1034/j.1600-0706.2002.980208.x; Kallimanis AS, 2006, EVOL ECOL RES, V8, P529; Kisdi E, 2002, AM NAT, V159, P579, DOI 10.1086/339989; Kneitel JM, 2004, ECOL LETT, V7, P69, DOI 10.1046/j.1461-0248.2003.00551.x; LEVIN SA, 1984, THEOR POPUL BIOL, V26, P165, DOI 10.1016/0040-5809(84)90028-5; Levin SA, 2003, ANNU REV ECOL EVOL S, V34, P575, DOI 10.1146/annurev.ecolsys.34.011802.132428; Massol F, 2011, EVOLUTION, V65, P490, DOI 10.1111/j.1558-5646.2010.01143.x; Mathias A, 2001, EVOLUTION, V55, P246; MCPEEK MA, 1992, AM NAT, V140, P1010, DOI 10.1086/285453; MORRIS DW, 1991, AM NAT, V137, P907, DOI 10.1086/285200; Mouquet N., 2005, METACOMMUNITIES SPAT, P237; Muneepeerakul R, 2011, J THEOR BIOL, V269, P256, DOI 10.1016/j.jtbi.2010.11.003; Murrell DJ, 2002, OIKOS, V97, P229, DOI 10.1034/j.1600-0706.2002.970209.x; Nichols J., 2001, DISPERSAL; North A, 2007, OIKOS, V116, P1106, DOI 10.1111/j.2007.0030-1299.15366.x; OLIVIERI I, 1995, AM NAT, V146, P202, DOI 10.1086/285795; Paradis E, 1998, EVOL ECOL, V12, P235, DOI 10.1023/A:1006539930788; Parvinen K, 2003, J EVOLUTION BIOL, V16, P143, DOI 10.1046/j.1420-9101.2003.00478.x; Parvinen K, 2006, B MATH BIOL, V68, P655, DOI 10.1007/s11538-005-9040-1; Payne JL, 2011, J THEOR BIOL, V273, P147, DOI 10.1016/j.jtbi.2010.12.036; Perrin N, 1999, AM NAT, V154, P282, DOI 10.1086/303236; Poethke HJ, 2003, AM NAT, V161, P631, DOI 10.1086/368224; R Development Core Team, 2009, R FDN STAT COMP; Ronce O, 2000, AM NAT, V155, P485, DOI 10.1086/303341; Ronce O, 2007, ANNU REV ECOL EVOL S, V38, P231, DOI 10.1146/annurev.ecolsys.38.091206.095611; Rousset F, 2002, J EVOLUTION BIOL, V15, P515, DOI 10.1046/j.1420-9101.2002.00430.x; Snyder RE, 2011, P ROY SOC B-BIOL SCI, V278, P739, DOI 10.1098/rspb.2010.1549; Streiff R, 1999, MOL ECOL, V8, P831, DOI 10.1046/j.1365-294X.1999.00637.x; TILMAN D, 1994, ECOLOGY, V75, P2, DOI 10.2307/1939377; Travis JMJ, 1999, P ROY SOC B-BIOL SCI, V266, P723, DOI 10.1098/rspb.1999.0696; Travis JMJ, 2001, ECOL RES, V16, P157, DOI 10.1046/j.1440-1703.2001.00381.x; Urban MC, 2008, TRENDS ECOL EVOL, V23, P311, DOI 10.1016/j.tree.2008.02.007; Van Valen Leigh, 1971, Evolution, V25, P591, DOI [10.1111/j.1558-5646.1971.tb01919.x, 10.2307/2406942]; Vuilleumier S, 2007, THEOR POPUL BIOL, V72, P77, DOI 10.1016/j.tpb.2006.11.001; WASER PM, 1986, AM NAT, V128, P529, DOI 10.1086/284585; With KA, 1999, LANDSCAPE ECOL, V14, P73, DOI 10.1023/A:1008030215600	68	13	13	0	30	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 6	2012	7	4							e34733	10.1371/journal.pone.0034733	http://dx.doi.org/10.1371/journal.pone.0034733			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	955JA	22493712	Green Published, Green Submitted, gold, Green Accepted			2022-12-25	WOS:000305012700054
J	Cheng, WY; Kandel, JJ; Yamashiro, DJ; Canoll, P; Anastassiou, D				Cheng, Wei-Yi; Kandel, Jessica J.; Yamashiro, Darrell J.; Canoll, Peter; Anastassiou, Dimitris			A Multi-Cancer Mesenchymal Transition Gene Expression Signature Is Associated with Prolonged Time to Recurrence in Glioblastoma	PLOS ONE			English	Article							TUMOR PROGRESSION; STEM-CELLS; INVASION; DISEASE; GROWTH	A stage-associated gene expression signature of coordinately expressed genes, including the transcription factor Slug (SNAI2) and other epithelial-mesenchymal transition (EMT) markers has been found present in samples from publicly available gene expression datasets in multiple cancer types, including nonepithelial cancers. The expression levels of the co-expressed genes vary in a continuous and coordinate manner across the samples, ranging from absence of expression to strong co-expression of all genes. These data suggest that tumor cells may pass through an EMT-like process of mesenchymal transition to varying degrees. Here we show that, in glioblastoma multiforme (GBM), this signature is associated with time to recurrence following initial treatment. By analyzing data from The Cancer Genome Atlas (TCGA), we found that GBM patients who responded to therapy and had long time to recurrence had low levels of the signature in their tumor samples (P = 3 x 10(-7)). We also found that the signature is strongly correlated in gliomas with the putative stem cell marker CD44, and is highly enriched among the differentially expressed genes in glioblastomas vs. lower grade gliomas. Our results suggest that long delay before tumor recurrence is associated with absence of the mesenchymal transition signature, raising the possibility that inhibiting this transition might improve the durability of therapy in glioma patients.	[Cheng, Wei-Yi; Anastassiou, Dimitris] Columbia Univ, Ctr Computat Biol & Bioinformat, New York, NY 10027 USA; [Kandel, Jessica J.; Yamashiro, Darrell J.] Columbia Univ, Inst Canc Genet, New York, NY USA; [Kandel, Jessica J.] Columbia Univ, Dept Surg, New York, NY USA; [Kandel, Jessica J.; Yamashiro, Darrell J.] Columbia Univ, Dept Pediat, New York, NY 10027 USA; [Yamashiro, Darrell J.; Canoll, Peter] Columbia Univ, Dept Pathol & Cell Biol, New York, NY USA; [Canoll, Peter] Columbia Univ, Columbia Stem Cell Initiat, New York, NY USA; [Cheng, Wei-Yi; Anastassiou, Dimitris] Columbia Univ, Dept Elect Engn, New York, NY 10027 USA	Columbia University; Columbia University; Columbia University; Columbia University; Columbia University; Columbia University; Columbia University	Cheng, WY (corresponding author), Columbia Univ, Ctr Computat Biol & Bioinformat, New York, NY 10027 USA.	da8@columbia.edu			Columbia University; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS066955] Funding Source: NIH RePORTER	Columbia University; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))	This research was funded from Columbia University's inventor's patent royalty proceeds. The patent is unrelated to the research described in the paper. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alison MR, 2011, J PATHOL, V223, P147, DOI 10.1002/path.2793; Anastassiou D, 2011, BMC CANCER, V11, DOI 10.1186/1471-2407-11-529; Anido J, 2010, CANCER CELL, V18, P655, DOI 10.1016/j.ccr.2010.10.023; Buck E, 2007, MOL CANCER THER, V6, P532, DOI 10.1158/1535-7163.MCT-06-0462; Cooper LAD, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0012548; Cover T. M., 2006, ELEMENTS INFORM THEO, p[xxiii, 74]; Creighton CJ, 2009, P NATL ACAD SCI USA, V106, P13820, DOI 10.1073/pnas.0905718106; Dabney AR, 2005, BIOINFORMATICS, V21, P4148, DOI 10.1093/bioinformatics/bti681; Jechlinger M, 2003, ONCOGENE, V22, P7155, DOI 10.1038/sj.onc.1206887; Kim H, 2010, BMC MED GENOMICS, V3, DOI 10.1186/1755-8794-3-51; Mani SA, 2008, CELL, V133, P704, DOI 10.1016/j.cell.2008.03.027; Mikheeva SA, 2010, MOL CANCER, V9, DOI 10.1186/1476-4598-9-194; Morel AP, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0002888; Peinado H, 2007, NAT REV CANCER, V7, P415, DOI 10.1038/nrc2131; Phillips HS, 2006, CANCER CELL, V9, P157, DOI 10.1016/j.ccr.2006.02.019; Scheel C, 2011, INT J CANCER, V129, P2310, DOI 10.1002/ijc.26311; Singh A, 2010, ONCOGENE, V29, P4741, DOI 10.1038/onc.2010.215; Subramanian A, 2005, P NATL ACAD SCI USA, V102, P15545, DOI 10.1073/pnas.0506580102; Taube JH, 2010, P NATL ACAD SCI USA, V107, P15449, DOI 10.1073/pnas.1004900107; Thiery JP, 2009, CELL, V139, P871, DOI 10.1016/j.cell.2009.11.007; Thiery JP, 2002, NAT REV CANCER, V2, P442, DOI 10.1038/nrc822; Verhaak RGW, 2010, CANCER CELL, V17, P98, DOI 10.1016/j.ccr.2009.12.020; Xu Y, 2010, CANCER RES, V70, P2455, DOI 10.1158/0008-5472.CAN-09-2505; Yang HW, 2010, BMC CANCER, V10, DOI 10.1186/1471-2407-10-301; Zoller M, 2011, NAT REV CANCER, V11, P254, DOI 10.1038/nrc3023	25	89	94	0	13	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 6	2012	7	4							e34705	10.1371/journal.pone.0034705	http://dx.doi.org/10.1371/journal.pone.0034705			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	955JA	22493711	gold, Green Submitted, Green Published			2022-12-25	WOS:000305012700053
J	Ma, Y; Zhang, L; Edwards, JN; Launikonis, BS; Chen, C				Ma, Yi; Zhang, Lin; Edwards, Joshua N.; Launikonis, Bradley S.; Chen, Chen			Growth Hormone Secretagogues Protect Mouse Cardiomyocytes from in vitro Ischemia/Reperfusion Injury through Regulation of Intracellular Calcium	PLOS ONE			English	Article							SARCOPLASMIC-RETICULUM; RAT-HEART; VENTRICULAR MYOCYTES; ISCHEMIA-REPERFUSION; NA+-CA2+ EXCHANGER; CARDIAC ISCHEMIA; GH-SECRETAGOGUES; GHRELIN; RECEPTOR; EXPRESSION	Background: Ischemic heart disease is a leading cause of mortality. To study this disease, ischemia/reperfusion (I/R) models are widely used to mimic the process of transient blockage and subsequent recovery of cardiac coronary blood supply. We aimed to determine whether the presence of the growth hormone secretagogues, ghrelin and hexarelin, would protect/improve the function of heart from I/R injury and to examine the underlying mechanisms. Methodology/Principal Findings: Isolated hearts from adult male mice underwent 20 min global ischemia and 30 min reperfusion using a Langendorff apparatus. Ghrelin (10 nM) or hexarelin (1 nM) was introduced into the perfusion system either 10 min before or after ischemia, termed pre- and post-treatments. In freshly isolated cardiomyocytes from these hearts, single cell shortening, intracellular calcium ([Ca2+](i)) transients and caffeine-releasable sarcoplasmic reticulum (SR) Ca2+ were measured. In addition, RT-PCR and Western blots were used to examine the expression level of GHS receptor type 1a (GHS-R1a), and phosphorylated phospholamban (p-PLB), respectively. Ghrelin and hexarelin pre- or post-treatments prevented the significant reduction in the cell shortening, [Ca2+](i) transient amplitude and caffeine-releasable SR Ca2+ content after I/R through recovery of p-PLB. GHS-R1a antagonists, [D-Lys3]-GHRP-6 (200 nM) and BIM28163 (100 nM), completely blocked the effects of GHS on both cell shortening and [Ca2+](i) transients. Conclusion/Significance: Through activation of GHS-R1a, ghrelin and hexarelin produced a positive inotropic effect on ischemic cardiomyocytes and protected them from I/R injury probably by protecting or recovering p-PLB (and therefore SR Ca2+ content) to allow the maintenance or recovery of normal cardiac contractility. These observations provide supporting evidence for the potential therapeutic application of ghrelin and hexarelin in patients with cardiac I/R injury.	[Ma, Yi; Edwards, Joshua N.; Launikonis, Bradley S.; Chen, Chen] Univ Queensland, Sch Biomed Sci, Brisbane, Qld, Australia; [Zhang, Lin] Univ Auckland, Sch Biol Sci, Auckland 1, New Zealand	University of Queensland; University of Auckland	Ma, Y (corresponding author), Univ Queensland, Sch Biomed Sci, Brisbane, Qld, Australia.	chen.chen@uq.edu.au	Launikonis, Bradley/K-6256-2015; CHEN, CHEN/HDM-6657-2022; Chen, Chen/B-4284-2010; chen, chen/GRY-7085-2022	Launikonis, Bradley/0000-0003-0700-4867; Chen, Chen/0000-0003-2104-534X; Ma, Yi/0000-0002-7226-8327	Australian National Health and Medical Research Council; University of Queensland	Australian National Health and Medical Research Council(National Health and Medical Research Council (NHMRC) of Australia); University of Queensland(University of Queensland)	This work was supported by funding from the Australian National Health and Medical Research Council and the University of Queensland. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Asakawa A, 2003, GUT, V52, P947, DOI 10.1136/gut.52.7.947; Baldanzi G, 2002, J CELL BIOL, V159, P1029, DOI 10.1083/jcb.200207165; Bers DM, 2002, NATURE, V415, P198, DOI 10.1038/415198a; Berti F, 1998, GROWTH HORM IGF RES, V8, P149, DOI 10.1016/S1096-6374(98)80041-5; Bodart V, 2002, CIRC RES, V90, P844, DOI 10.1161/01.RES.0000016164.02525.B4; Bulgarelli I, 2009, J NEUROSCI RES, V87, P2718, DOI 10.1002/jnr.22088; Cassoni P, 2001, J CLIN ENDOCR METAB, V86, P1738, DOI 10.1210/jc.86.4.1738; Ceylan-Isik AF, 2011, J MOL CELL CARDIOL, V50, P107, DOI 10.1016/j.yjmcc.2010.10.023; Chambers DJ, 2010, PHARMACOL THERAPEUT, V127, P41, DOI 10.1016/j.pharmthera.2010.04.001; Chang L, 2004, J CARDIOVASC PHARM, V43, P165, DOI 10.1097/00005344-200402000-00001; del Monte F, 2004, P NATL ACAD SCI USA, V101, P5622, DOI 10.1073/pnas.0305778101; Feng DD, 2011, EUR J NEUROSCI, V34, P732, DOI 10.1111/j.1460-9568.2011.07787.x; Frascarelli S, 2003, BASIC RES CARDIOL, V98, P401, DOI 10.1007/s00395-003-0434-7; Fung Jenny N. T., 2010, Hormones & Cancer, V1, P245, DOI 10.1007/s12672-010-0047-1; FURMAN E, 1985, CARDIOVASC RES, V19, P606, DOI 10.1093/cvr/19.10.606; Gnanapavan S, 2002, J CLIN ENDOCR METAB, V87, P2988, DOI 10.1210/jc.87.6.2988; Halem HA, 2004, EUR J ENDOCRINOL, V151, pS71, DOI 10.1530/eje.0.151S071; Headrick JP, 2001, EXP PHYSIOL, V86, P703, DOI 10.1111/j.1469-445X.2001.tb00035.x; Iwasaki E, 2011, DIG DIS SCI; Kawamura K, 2003, ENDOCRINOLOGY, V144, P2623, DOI 10.1210/en.2003-0033; Kojima M, 1999, NATURE, V402, P656, DOI 10.1038/45230; Kuster GM, 2010, FREE RADICAL BIO MED, V48, P1182, DOI 10.1016/j.freeradbiomed.2010.01.038; Launikonis BS, 1997, J PHYSIOL-LONDON, V504, P425, DOI 10.1111/j.1469-7793.1997.425be.x; McDonough JL, 1999, CIRC RES, V84, P9; Murphy E, 2008, PHYSIOL REV, V88, P581, DOI 10.1152/physrev.00024.2007; Ogawa A, 2011, AM J PHYSL REGUL INT; OSTADAL B, 1999, CARDIAC ISCHEMIA INJ; Santiago DJ, 2010, BIOPHYS J, V98, P2111, DOI 10.1016/j.bpj.2010.01.042; Sax B, 2011, PEPTIDES, V32, P362, DOI 10.1016/j.peptides.2010.11.020; Seehase M, 2006, BIOL NEONATE, V90, P174, DOI 10.1159/000092888; Sun Q, 2010, ENDOCRINOLOGY, V151, P4446, DOI 10.1210/en.2009-1432; Sun YX, 2007, ENDOCRINOLOGY, V148, P1323, DOI 10.1210/en.2006-0782; Torsello A, 2003, ENDOCRINOLOGY, V144, P1787, DOI 10.1210/en.2002-221048; Xu XB, 2003, ENDOCRINOLOGY, V144, P5050, DOI 10.1210/en.2003-0025; Xu XL, 2008, PHARMACOLOGY, V81, P325, DOI 10.1159/000121335; Yang CG, 2011, MOL MED REP, V4, P1061, DOI 10.3892/mmr.2011.571; Yu Wei, 2010, Zhonghua Xin Xue Guan Bing Za Zhi, V38, P225; Zhang GG, 2009, PEPTIDES, V30, P1109, DOI 10.1016/j.peptides.2009.03.024; Zima AV, 2010, J PHYSIOL-LONDON, V588, P4743, DOI 10.1113/jphysiol.2010.197913	39	26	27	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 6	2012	7	4							e35265	10.1371/journal.pone.0035265	http://dx.doi.org/10.1371/journal.pone.0035265			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	955JA	22493744	Green Published, Green Submitted, gold			2022-12-25	WOS:000305012700086
J	Sousa-Figueiredo, JC; Gamboa, D; Pedro, JM; Fancony, C; Langa, AJ; Magalhaes, RJS; Stothard, JR; Nery, SV				Sousa-Figueiredo, Jose Carlos; Gamboa, Dina; Pedro, Joao Mario; Fancony, Claudia; Langa, Antonio Justino; Magalhaes, Ricardo J. Soares; Stothard, J. Russell; Nery, Susana Vaz			Epidemiology of Malaria, Schistosomiasis, Geohelminths, Anemia and Malnutrition in the Context of a Demographic Surveillance System in Northern Angola	PLOS ONE			English	Article							NUTRITIONAL-STATUS; CHILDREN; HEALTH; MORBIDITY; INFECTION; COUNTRIES; DISEASES; ASCARIS; IMPACT; RISK	Background: Malaria, schistosomiasis and geohelminth infection are linked to maternal and child morbidity and mortality in sub-Saharan Africa. Knowing the prevalence levels of these infections is vital to guide governments towards the implementation of successful and cost-effective disease control initiatives. Methodology/Principal Findings: A cross-sectional study of 1,237 preschool children (0-5 year olds), 1,142 school-aged children (6-15 year olds) and 960 women (>15 year olds) was conducted to understand the distribution of malnutrition, anemia, malaria, schistosomiasis (intestinal and urinary) and geohelminths in a north-western province of Angola. We used a recent demographic surveillance system (DSS) database to select and recruit suitable households. Malnutrition was common among children (23.3% under-weight, 9.9% wasting and 32.2% stunting), and anemia was found to be a severe public health problem (i.e., >40%). Malaria prevalence was highest among preschool children reaching 20.2%. Micro-hematuria prevalence levels reached 10.0% of preschool children, 16.6% of school-aged children and 21.7% of mothers. Geohelminth infections were common, affecting 22.3% of preschool children, 31.6% of school-aged children and 28.0% of mothers. Conclusions: Here we report prevalence levels of malaria, schistosomiasis and geohelminths; all endemic in this poorly described area where a DSS has been recently established. Furthermore we found evidence that the studied infections are associated with the observed levels of anemia and malnutrition, which can justify the implementation of integrated interventions for the control of these diseases and morbidities.	[Sousa-Figueiredo, Jose Carlos; Stothard, J. Russell] Univ Liverpool, Liverpool Sch Trop Med, Ctr Trop & Infect Dis, Liverpool L3 5QA, Merseyside, England; [Sousa-Figueiredo, Jose Carlos] Univ London London Sch Hyg & Trop Med, Dept Infect & Trop Dis, London WC1E 7HT, England; [Gamboa, Dina; Pedro, Joao Mario; Fancony, Claudia; Langa, Antonio Justino; Nery, Susana Vaz] Hlth Res Ctr Angola, CISA Project, Caxito, Bengo, Angola; [Pedro, Joao Mario] Escola Super Tecnol Saude Lisboa, Lisbon, Portugal; [Magalhaes, Ricardo J. Soares] Univ Queensland, Sch Populat Hlth, Herston, Qld, Australia	Liverpool School of Tropical Medicine; University of Liverpool; University of London; London School of Hygiene & Tropical Medicine; Universidade de Lisboa; University of Queensland	Sousa-Figueiredo, JC (corresponding author), Univ Liverpool, Liverpool Sch Trop Med, Ctr Trop & Infect Dis, Liverpool L3 5QA, Merseyside, England.	susana.nery@cisacaxito.org	Pedro, Joao M/A-6556-2013; Magalhaes, Ricardo J. Soares/A-5316-2010; Nery, Susana Vaz/P-4518-2014; Stothard, John Russell/AAK-4829-2021	Pedro, Joao M/0000-0003-2405-521X; Magalhaes, Ricardo J. Soares/0000-0001-9157-8470; Stothard, John Russell/0000-0002-9370-3420; Fancony, Claudia/0000-0003-4421-1769; Vaz Nery, Susana/0000-0002-2399-7785	Portuguese Institute for Development Assistance (Ministry of Foreign Affairs); Calouste Gulbenkian Foundation; Angolan Ministry of Health; Bengo Provincial Government	Portuguese Institute for Development Assistance (Ministry of Foreign Affairs); Calouste Gulbenkian Foundation; Angolan Ministry of Health; Bengo Provincial Government	This work has been funded by the Portuguese Institute for Development Assistance (Ministry of Foreign Affairs) and the Calouste Gulbenkian Foundation, and was supported by the Angolan Ministry of Health and the Bengo Provincial Government. The funders had no role in study design, data collection and analysis, decision to publish or preparation of the manuscript.	Agadjanian V, 2003, SOC SCI MED, V56, P2515, DOI 10.1016/S0277-9536(02)00286-1; Akaike H., 1973, 2 INT S INF THEOR, P267, DOI DOI 10.1007/978-1-4612-1694-0_15; [Anonymous], 2001, IRON DEFICIENCY ANAE; Armitage P., 2001, STAT METHODS MED RES; Avogo WA, 2010, SOC SCI MED, V70, P53, DOI 10.1016/j.socscimed.2009.09.057; Bejon P, 2008, PLOS NEGLECT TROP D, V2, DOI 10.1371/journal.pntd.0000164; BRESLOW NE, 1993, J AM STAT ASSOC, V88, P9, DOI 10.1080/01621459.1993.10594284; CHOPRA J G, 1965, J Trop Pediatr Afr Child Health, V11, P18; COSEP, 2006, ANG MAL IND SURV; Costa MJ, SETTING DEMOGR UNPUB; deOnis M, 1996, AM J CLIN NUTR, V64, P650, DOI 10.1093/ajcn/64.4.650; DIRREN H, 1994, EUR J CLIN NUTR, V48, P625; Filippi V, 2006, LANCET, V368, P1535, DOI 10.1016/S0140-6736(06)69384-7; Fleischer B, 2004, TROP MED INT HEALTH, V9, P755, DOI 10.1111/j.1365-3156.2004.01278.x; Giugliani C, 2010, ARCH DIS CHILD, V95, P198, DOI 10.1136/adc.2009.169227; Glinz D, 2010, PLOS NEGLECT TROP D, V4, DOI 10.1371/journal.pntd.0000754; Goodman D, 2007, AM J TROP MED HYG, V76, P725, DOI 10.4269/ajtmh.2007.76.725; Hall A, 2007, LANCET INFECT DIS, V7, P297, DOI 10.1016/S1473-3099(07)70084-1; Hotez PJ, 2008, PLOS NEGLECT TROP D, V2, DOI 10.1371/journal.pntd.0000270; Katz N, 1972, Rev Inst Med Trop Sao Paulo, V14, P397; Kennedy G, 2006, PUBLIC HEALTH NUTR, V9, P187, DOI 10.1079/PHN2005835; Kirkwood BR, 2003, ESSENTIAL MED STAT; Lwambo NJS, 1997, B WORLD HEALTH ORGAN, V75, P247; Lwanga SK, 1991, SAMPLE SIZE DETERMIN; Magalhaes RJS, 2011, PLOS MED, V8, DOI 10.1371/journal.pmed.1000438; Martin-Prevel Y, 2000, B WORLD HEALTH ORGAN, V78, P108; MINSA WFP WHO UNICEF, 2005, BAS SURV HELM CONTR; Molyneux DH, 2009, LANCET, V373, P296, DOI 10.1016/S0140-6736(09)60089-1; Muller O, 2003, LANCET, V361, P86, DOI 10.1016/S0140-6736(03)12154-X; Petney TN, 1998, INT J PARASITOL, V28, P377, DOI 10.1016/S0020-7519(97)00189-6; PMI, 2011, COUNTR PROF ANG; Richter J, 2003, ACTA TROP, V86, P161, DOI 10.1016/S0001-706X(03)00032-9; Rollinson D, 2005, J HELMINTHOL, V79, P199, DOI 10.1079/JOH2005305; Sacko M, 2010, ACTA TROP, DOI [10.1016/j.actatropica.2010.1012.1009, DOI 10.1016/J.ACTATROPICA.2010.1012.1009]; Savioli L., 1998, GUIDELINES EVALUATIO; Shapiro AE, 2005, T ROY SOC TROP MED H, V99, P18, DOI 10.1016/j.trstmh.2004.02.006; STEPHENSON LS, 1980, PARASITOLOGY, V81, P221, DOI 10.1017/S0031182000055177; THEINHLAING, 1991, T ROY SOC TROP MED H, V85, P523, DOI 10.1016/0035-9203(91)90242-Q; Tohon ZB, 2008, PLOS NEGLECT TROP D, V2, DOI 10.1371/journal.pntd.0000241; UNICEF, 2011, CHILDINFO MON SIT CH; Walker SP, 2007, LANCET, V369, P145, DOI 10.1016/S0140-6736(07)60076-2; *WHO, 2002, WHO TRAD MED STRAT 2; WHO, 2006, WHO GLOB DAT AN; World Health Organization, 2008, COMM DIR INT MAJ HLT; World Health Organization, 2008, WORLD MAL REP; Yamey G, 2002, BRIT MED J, V325, P176, DOI 10.1136/bmj.325.7357.176	46	66	69	0	17	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 6	2012	7	4							e33189	10.1371/journal.pone.0033189	http://dx.doi.org/10.1371/journal.pone.0033189			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	955JA	22493664	Green Submitted, gold, Green Published, Green Accepted			2022-12-25	WOS:000305012700006
J	Walker, SI; Grover, MA; Hud, NV				Walker, Sara Imari; Grover, Martha A.; Hud, Nicholas V.			Universal Sequence Replication, Reversible Polymerization and Early Functional Biopolymers: A Model for the Initiation of Prebiotic Sequence Evolution	PLOS ONE			English	Article							TEMPLATE-DIRECTED SYNTHESIS; MOLECULAR EVOLUTION; EUTECTIC PHASE; ORIGIN; EMERGENCE; SELECTION; DNA; OLIGONUCLEOTIDES; INTERCALATION; AMPLIFICATION	Many models for the origin of life have focused on understanding how evolution can drive the refinement of a preexisting enzyme, such as the evolution of efficient replicase activity. Here we present a model for what was, arguably, an even earlier stage of chemical evolution, when polymer sequence diversity was generated and sustained before, and during, the onset of functional selection. The model includes regular environmental cycles (e.g. hydration-dehydration cycles) that drive polymers between times of replication and functional activity, which coincide with times of different monomer and polymer diffusivity. Template-directed replication of informational polymers, which takes place during the dehydration stage of each cycle, is considered to be sequence-independent. New sequences are generated by spontaneous polymer formation, and all sequences compete for a finite monomer resource that is recycled via reversible polymerization. Kinetic Monte Carlo simulations demonstrate that this proposed prebiotic scenario provides a robust mechanism for the exploration of sequence space. Introduction of a polymer sequence with monomer synthetase activity illustrates that functional sequences can become established in a preexisting pool of otherwise non-functional sequences. Functional selection does not dominate system dynamics and sequence diversity remains high, permitting the emergence and spread of more than one functional sequence. It is also observed that polymers spontaneously form clusters in simulations where polymers diffuse more slowly than monomers, a feature that is reminiscent of a previous proposal that the earliest stages of life could have been defined by the collective evolution of a system-wide cooperation of polymer aggregates. Overall, the results presented demonstrate the merits of considering plausible prebiotic polymer chemistries and environments that would have allowed for the rapid turnover of monomer resources and for regularly varying monomer/polymer diffusivities.	[Walker, Sara Imari; Grover, Martha A.; Hud, Nicholas V.] Georgia Inst Technol, NSF NASA Ctr Chem Evolut, Atlanta, GA 30332 USA; [Walker, Sara Imari; Grover, Martha A.] Georgia Inst Technol, Sch Chem & Biomol Engn, Atlanta, GA 30332 USA; [Walker, Sara Imari; Hud, Nicholas V.] Georgia Inst Technol, Sch Chem & Biochem, Atlanta, GA 30332 USA	National Aeronautics & Space Administration (NASA); University System of Georgia; Georgia Institute of Technology; University System of Georgia; Georgia Institute of Technology; University System of Georgia; Georgia Institute of Technology	Walker, SI (corresponding author), Arizona State Univ, BEYOND Ctr Fundamental Concepts Sci, Tempe, AZ 85287 USA.	hud@chemistry.gatech.edu	Walker, Sara/J-5829-2015; Hud, Nicholas V/T-7017-2017	Walker, Sara/0000-0001-5779-2772; Hud, Nicholas/0000-0001-7711-6472	NSF [CHE-1004570]; NASA under the NSF Center for Chemical Evolution [CHE-1004570]; NASA Astrobiology Institute through the NASA	NSF(National Science Foundation (NSF)); NASA under the NSF Center for Chemical Evolution; NASA Astrobiology Institute through the NASA	This work was jointly supported by NSF and the NASA Astrobiology Program, under the NSF Center for Chemical Evolution, CHE-1004570. SIW additionally acknowledges support from the NASA Astrobiology Institute through the NASA Postdoctoral Fellowship Program. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alfonsi A, 2004, RR5435 INRIA; Apel CL, 2005, ORIGINS LIFE EVOL B, V35, P323, DOI 10.1007/s11084-005-2046-8; Bean HD, 2006, ORIGINS LIFE EVOL B, V36, P39, DOI 10.1007/s11084-005-2082-4; Bernstein D, 2005, PHYS REV E, V71, DOI 10.1103/PhysRevE.71.041103; BOERLIJST MC, 1991, PHYSICA D, V48, P17, DOI 10.1016/0167-2789(91)90049-F; Cairns-Smith A.G., 1982, GENETIC TAKEOVER MIN; CHACON P, 1995, PHYSICA D, V81, P398, DOI 10.1016/0167-2789(94)00214-B; Chatterjee A, 2007, J COMPUT-AIDED MATER, V14, P253, DOI 10.1007/s10820-006-9042-9; Commeyras A, 2002, POLYM INT, V51, P661, DOI 10.1002/pi.1027; Corliss J. B., 1981, Oceanologica Acta, V4, P59; Czaran T, 2000, GEOMETRY SPATIAL INT; Deck C, 2011, NAT CHEM, V3, P603, DOI [10.1038/NCHEM.1086, 10.1038/nchem.1086]; Dobson CM, 2000, P NATL ACAD SCI USA, V97, P11864, DOI 10.1073/pnas.200366897; EIGEN M, 1977, NATURWISSENSCHAFTEN, V64, P541, DOI 10.1007/BF00450633; EIGEN M, 1971, NATURWISSENSCHAFTEN, V58, P465, DOI 10.1007/BF00623322; EIGEN M, 1988, J PHYS CHEM-US, V92, P6881, DOI 10.1021/j100335a010; ELLINGTON AD, 1990, NATURE, V346, P818, DOI 10.1038/346818a0; Engelhart AE, 2010, COLD SPRING HARB PER, V2; Eschenmoser A, 2007, TETRAHEDRON, V63, P12821, DOI 10.1016/j.tet.2007.10.012; Fishkis M, 2011, ORIGINS LIFE EVOL B, V41, P261, DOI 10.1007/s11084-010-9220-3; Gesteland R, 2006, RNA WORLD COLD SPRIN; GILLESPIE DT, 1976, J COMPUT PHYS, V22, P403, DOI 10.1016/0021-9991(76)90041-3; Hazen R. M., 2010, COLD SPRING HARB PER, V2; Hazen RM, 2007, P NATL ACAD SCI USA, V104, P8574, DOI 10.1073/pnas.0701744104; Hazen RM, 2009, INT J DEV BIOL, V53, P683, DOI 10.1387/ijdb.092936rh; Hogeweg P, 2003, ORIGINS LIFE EVOL B, V33, P375, DOI 10.1023/A:1025754907141; Horowitz ED, 2010, P NATL ACAD SCI USA, V107, P5288, DOI 10.1073/pnas.0914172107; Huber C, 1998, SCIENCE, V281, P670, DOI 10.1126/science.281.5377.670; Hud NV, 2007, CHEM BIODIVERS, V4, P768, DOI 10.1002/cbdv.200790063; Hud NV, 2000, J THEOR BIOL, V205, P543, DOI 10.1006/jtbi.2000.2084; Jain SS, 2004, ANGEW CHEM INT EDIT, V43, P2004, DOI 10.1002/anie.200353155; Joyce GF, 2002, NATURE, V420, P278, DOI 10.1038/420278a; Joyce GF, 2002, NATURE, V418, P214, DOI 10.1038/418214a; KACIAN DL, 1972, P NATL ACAD SCI USA, V69, P3038, DOI 10.1073/pnas.69.10.3038; Kauffman S.A., 1993, ORIGINS ORDER; KING GAM, 1986, J THEOR BIOL, V123, P493, DOI 10.1016/S0022-5193(86)80216-8; KING GAM, 1982, BIOSYSTEMS, V15, P89, DOI 10.1016/0303-2647(82)90022-3; Konnyu B, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0020931; Konnyu B, 2008, BMC EVOL BIOL, V8, DOI 10.1186/1471-2148-8-267; LAHAV N, 1978, SCIENCE, V201, P67, DOI 10.1126/science.663639; Lee DH, 1996, NATURE, V382, P525, DOI 10.1038/382525a0; Lehman N, 2011, ENTROPY-SWITZ, V13, P17, DOI 10.3390/e13010017; Leitzel JC, 2001, CHEM REC, V1, P53; Li XY, 2011, HETEROCYCLES, V82, P1477, DOI 10.3987/COM-10-S(E)99; Luther A, 1998, NATURE, V396, P245, DOI 10.1038/24343; Ma W, 2007, RNA, V13, P2012, DOI 10.1261/rna.658507; Ma WT, 2007, BIOSYSTEMS, V90, P28, DOI 10.1016/j.biosystems.2006.06.005; Ma WT, 2010, ASTROBIOLOGY, V10, P437, DOI 10.1089/ast.2009.0385; Manapat ML, 2010, J THEOR BIOL, V263, P317, DOI 10.1016/j.jtbi.2009.12.020; Monnard PA, 2003, J AM CHEM SOC, V125, P13734, DOI 10.1021/ja036465h; Monnard PA, 2008, CHEM BIODIVERS, V5, P1521, DOI 10.1002/cbdv.200890141; NIELSEN PE, 1993, ORIGINS LIFE EVOL B, V23, P323, DOI 10.1007/BF01582083; Pedersen K, 2000, FEMS MICROBIOL LETT, V185, P9, DOI 10.1016/S0378-1097(00)00061-6; Pross A, 2005, ORIGINS LIFE EVOL B, V35, P151, DOI 10.1007/s11084-005-5272-1; Pross A, 2003, J THEOR BIOL, V220, P393, DOI 10.1006/jtbi.2003.3178; ROBERTSON MP, 1995, NATURE, V375, P772, DOI 10.1038/375772a0; SHANNON CE, 1948, BELL SYST TECH J, V27, P623, DOI 10.1002/j.1538-7305.1948.tb00917.x; STRIBLING R, 1991, J MOL EVOL, V32, P289, DOI 10.1007/BF02102186; Szabo P, 2002, NATURE, V420, P340, DOI 10.1038/nature01187; SZATHMARY E, 1987, J THEOR BIOL, V128, P463, DOI 10.1016/S0022-5193(87)80191-1; SZATHMARY E, 1989, TRENDS ECOL EVOL, V4, P200, DOI 10.1016/0169-5347(89)90073-6; SZATHMARY E, 1997, MAJOR TRANSITIONS EV; Takeuchi N, 2009, PLOS COMPUT BIOL, V5, DOI 10.1371/journal.pcbi.1000542; TUERK C, 1990, SCIENCE, V249, P505, DOI 10.1126/science.2200121; Turk RM, 2010, P NATL ACAD SCI USA, V107, P4585, DOI 10.1073/pnas.0912895107; Ura Y, 2009, SCIENCE, V325, P73, DOI 10.1126/science.1174577; Vetsigian K, 2006, P NATL ACAD SCI USA, V103, P10696, DOI 10.1073/pnas.0603780103; WACHTERSHAUSER G, 1992, PROG BIOPHYS MOL BIO, V58, P85, DOI 10.1016/0079-6107(92)90022-X; Wochner A, 2011, SCIENCE, V332, P209, DOI 10.1126/science.1200752; Woese CR, 2002, P NATL ACAD SCI USA, V99, P8742, DOI 10.1073/pnas.132266999; Wu M, 2011, ASTROBIOLOGY, V11, P895, DOI 10.1089/ast.2011.0679; Wu M, 2009, J MOL EVOL, V69, P541, DOI 10.1007/s00239-009-9276-8; Zhan ZYJ, 1997, J AM CHEM SOC, V119, P12420, DOI 10.1021/ja972870v	73	45	48	0	54	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 6	2012	7	4							e34166	10.1371/journal.pone.0034166	http://dx.doi.org/10.1371/journal.pone.0034166			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	955JA	22493682	Green Published, Green Submitted, gold			2022-12-25	WOS:000305012700024
J	Cheng, Y; Sk, UH; Zhang, Y; Ren, XC; Zhang, L; Huber-Keener, KJ; Sun, YW; Liao, J; Amin, S; Sharma, AK; Yang, JM				Cheng, Yan; Sk, Ugir Hossain; Zhang, Yi; Ren, Xingcong; Zhang, Li; Huber-Keener, Kathryn J.; Sun, Yuan-Wan; Liao, Jason; Amin, Shantu; Sharma, Arun K.; Yang, Jin-Ming			Rational Incorporation of Selenium into Temozolomide Elicits Superior Antitumor Activity Associated with Both Apoptotic and Autophagic Cell Death	PLOS ONE			English	Article							MALIGNANT GLIOMA; CANCER; MELANOMA; ISOSELENOCYANATES; SENSITIVITY; BECLIN; AGENTS; MGMT	Background: The DNA alkylating agent temozolomide (TMZ) is widely used in the treatment of human malignancies such as glioma and melanoma. On the basis of previous structure-activity studies, we recently synthesized a new TMZ selenium analog by rationally introducing an N-ethylselenocyanate extension to the amide functionality in TMZ structure. Principal Findings: This TMZ-Se analog showed a superior cytotoxicity to TMZ in human glioma and melanoma cells and a more potent tumor-inhibiting activity than TMZ in mouse glioma and melanoma xenograft model. TMZ-Se was also effective against a TMZ-resistant glioma cell line. To explore the mechanism underlying the superior antitumor activity of TMZ-Se, we compared the effects of TMZ and TMZ-Se on apoptosis and autophagy. Apoptosis was significantly increased in tumor cells treated with TMZ-Se in comparison to those treated with TMZ. TMZ-Se also triggered greater autophagic response, as compared with TMZ, and suppressing autophagy partly rescued cell death induced by TMZ-Se, indicating that TMZ-Se-triggered autophagy contributed to cell death. Although mRNA level of the key autophagy gene, Beclin 1, was increased, Beclin 1 protein was down-regulated in the cells treated with TMZ-Se. The decrease in Beclin 1 following TMZ-Se treatment were rescued by the calpain inhibitors and the calpain-mediated degradation of Beclin1 had no effect on autophagy but promoted apoptosis in cells treated with TMZ-Se. Conclusions: Our study indicates that incorporation of Se into TMZ can render greater potency to this chemotherapeutic drug.	[Cheng, Yan] Penn State Univ, Coll Med, Dept Pharmacol, Hershey, PA 17033 USA; Penn State Univ, Coll Med, Penn State Hershey Canc Inst, Hershey, PA USA; Milton S Hershey Med Ctr, Hershey, PA USA	Pennsylvania Commonwealth System of Higher Education (PCSHE); Pennsylvania State University; Penn State Health; Pennsylvania Commonwealth System of Higher Education (PCSHE); Pennsylvania State University; Penn State Health; Pennsylvania Commonwealth System of Higher Education (PCSHE); Pennsylvania State University; Penn State Health	Cheng, Y (corresponding author), Penn State Univ, Coll Med, Dept Pharmacol, Hershey, PA 17033 USA.	aks14@psu.edu; juy16@psu.edu		Sharma, Arun/0000-0002-7679-7779; Huber-Keener, Kathryn/0000-0002-1981-7251	US Public Health Service [R01CA135038, R03CA143999]; NATIONAL CANCER INSTITUTE [R01CA135038, R03CA143999] Funding Source: NIH RePORTER	US Public Health Service(United States Department of Health & Human ServicesUnited States Public Health Service); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	This work was supported by grants from the US Public Health Service R01CA135038 (Yang) and R03CA143999 (Sharma). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript	Bael TE, 2008, MELANOMA RES, V18, P147, DOI 10.1097/CMR.0b013e3282f2a7ae; Combs GF, 1998, PHARMACOL THERAPEUT, V79, P179, DOI 10.1016/S0163-7258(98)00014-X; Dalby KN, 2010, AUTOPHAGY, V6, P322, DOI 10.4161/auto.6.3.11625; Daniel F, 2006, WORLD J GASTROENTERO, V12, P2895, DOI 10.3748/wjg.v12.i18.2895; Desai D, 2010, CHEM-BIOL INTERACT, V188, P446, DOI 10.1016/j.cbi.2010.09.021; Desai D, 2010, INT J CANCER, V127, P230, DOI 10.1002/ijc.25033; Desai D, 2010, BIOORG MED CHEM LETT, V20, P2044, DOI 10.1016/j.bmcl.2009.07.068; Friedman HS, 2000, CLIN CANCER RES, V6, P2585; Gasparian AV, 2002, MOL CANCER THER, V1, P1079; Hoyer-Hansen M, 2008, AUTOPHAGY, V4, P574, DOI 10.4161/auto.5921; Jariwalla RJ, 2009, BRIT J NUTR, V101, P182, DOI 10.1017/S0007114508998305; Kaina B, 2007, DNA REPAIR, V6, P1079, DOI 10.1016/j.dnarep.2007.03.008; Kanzawa T, 2004, CELL DEATH DIFFER, V11, P448, DOI 10.1038/sj.cdd.4401359; Kim T, 2001, CARCINOGENESIS, V22, P559, DOI 10.1093/carcin/22.4.559; Liang XH, 1998, J VIROL, V72, P8586, DOI 10.1128/JVI.72.11.8586-8596.1998; Natsumeda M, 2011, NEUROPATHOLOGY, V31, P486, DOI 10.1111/j.1440-1789.2010.01197.x; Naumann SC, 2009, BRIT J CANCER, V100, P322, DOI 10.1038/sj.bjc.6604856; Nguyen N, 2011, CANCER PREV RES, V4, P248, DOI 10.1158/1940-6207.CAPR-10-0106; Niu TK, 2010, FEBS LETT, V584, P3519, DOI 10.1016/j.febslet.2010.07.018; Ochs K, 2000, CANCER RES, V60, P5815; Rayman MP, 2005, P NUTR SOC, V64, P527, DOI 10.1079/PNS2005467; Reiling JH, 2006, ONCOGENE, V25, P6373, DOI 10.1038/sj.onc.1209889; Sharma A, 2009, CLIN CANCER RES, V15, P1674, DOI 10.1158/1078-0432.CCR-08-2214; Sharma AK, 2011, CLIN CANCER RES, V17, P4474, DOI 10.1158/1078-0432.CCR-10-2370; Sharma AK, 2008, J MED CHEM, V51, P7820, DOI 10.1021/jm800993r; Yoo BH, 2010, J BIOL CHEM, V285, P5438, DOI 10.1074/jbc.M109.046789; Zhang WB, 2010, J BIOL CHEM, V285, P40461, DOI 10.1074/jbc.M110.164046; Zhou N, 2003, J BIOL CHEM, V278, P29532, DOI 10.1074/jbc.M301877200	28	24	24	0	13	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 5	2012	7	4							e35104	10.1371/journal.pone.0035104	http://dx.doi.org/10.1371/journal.pone.0035104			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	955IH	22496897	Green Published, gold, Green Submitted			2022-12-25	WOS:000305010500029
J	Orton, E; Kendrick, D; West, J; Tata, LJ				Orton, Elizabeth; Kendrick, Denise; West, Joe; Tata, Laila J.			Independent Risk Factors for Injury in Pre-School Children: Three Population-Based Nested Case-Control Studies Using Routine Primary Care Data	PLOS ONE			English	Article							ALCOHOL-USE DISORDERS; CHILDHOOD FRACTURES; GENERAL-PRACTICE; YOUNG-CHILDREN; SOCIAL-CLASS; ACCIDENTS; FAMILY; AGE; DRINKING; ENGLAND	Background: Injuries in childhood are largely preventable yet an estimated 2,400 children die every day because of injury and violence. Despite this, the factors that contribute to injury occurrence have not been quantified at the population scale using primary care data. We used The Health Improvement Network (THIN) database to identify risk factors for thermal injury, fractures and poisoning in pre-school children in order to inform the optimal delivery of preventative strategies. Methods: We used a matched, nested case-control study design. Cases were children under 5 with a first medically recorded injury, comprising 3,649 thermal injury cases, 4,050 fracture cases and 2,193 poisoning cases, matched on general practice to 94,620 control children. Results: Younger maternal age and higher birth order increased the odds of all injuries. Children's age of highest injury risk varied by injury type; compared with children under 1 year, thermal injuries were highest in those age 1-2 (OR = 2.43, 95%CI 2.23-2.65), poisonings in those age 2-3 (OR = 7.32, 95%CI 6.26-8.58) and fractures in those age 3-5 (OR = 3.80, 95%CI 3.42-4.23). Increasing deprivation was an important modifiable risk factor for poisonings and thermal injuries (tests for trend p <= 0.001) as were hazardous/harmful alcohol consumption by a household adult (OR = 1.73, 95%CI 1.26-2.38 and OR = 1.39, 95%CI 1.07-1.81 respectively) and maternal diagnosis of depression (OR = 1.45, 95%CI 1.24-1.70 and OR = 1.16, 95%CI 1.02-1.32 respectively). Fracture was not associated with these factors, however, not living in single-adult household reduced the odds of fracture (OR = 0.88, 95%CI 0.82-0.95). Conclusions: Maternal depression, hazardous/harmful adult alcohol consumption and socioeconomic deprivation represent important modifiable risk factors for thermal injury and poisoning but not fractures in preschool children. Since these risk factors can be ascertained from routine primary care records, pre-school children's frequent visits to primary care present an opportunity to reduce injury risk by implementing effective preventative interventions from existing national guidelines.	[Orton, Elizabeth; Kendrick, Denise] Univ Nottingham, Div Primary Care, Nottingham NG7 2RD, England; [West, Joe; Tata, Laila J.] Univ Nottingham, City Hosp Nottingham, Div Epidemiol & Publ Hlth, Nottingham NG7 2RD, England	University of Nottingham; Nottingham University Hospital NHS Trust; Nottingham City Hospital; University of Nottingham	Orton, E (corresponding author), Univ Nottingham, Div Primary Care, Univ Pk, Nottingham NG7 2RD, England.	elizabeth.orton@nottingham.ac.uk	Orton, Elizabeth/AAI-1377-2021; Orton, Elizabeth/J-6550-2013; West, Joe/M-3867-2019; West, Joe/I-6637-2012; Tata, Laila/J-5227-2012	Orton, Elizabeth/0000-0002-2531-8846; West, Joe/0000-0002-1135-9356; West, Joe/0000-0002-1135-9356; Kendrick, Denise/0000-0003-3603-6542; Tata, Laila/0000-0002-6404-8658				Agran PF, 2003, PEDIATRICS, V111, pE683, DOI 10.1542/peds.111.6.e683; Audit Commission, 2007, BETT SAF SORR PREV U; BEAUTRAIS AL, 1981, AUST PAEDIATR J, V17, P104; BIJUR PE, 1992, JAMA-J AM MED ASSOC, V267, P3166, DOI 10.1001/jama.267.23.3166; Bourke Alison, 2004, Inform Prim Care, V12, P171; Branche C., 2008, WORLD REPORT CHILD I; BROWN GW, 1978, LANCET, V1, P378; Centre TI, 2009, HOSP EP STAT EXT CAU; Cheeta S, 2008, ADDICTION, V103, P766, DOI 10.1111/j.1360-0443.2008.02198.x; Collett D, 2003, MODELLING SURVIVAL D; Cooper C, 2004, J BONE MINER RES, V19, P1976, DOI 10.1359/JBMR.040902; Crandall M, 2006, J SURG RES, V133, P7, DOI 10.1016/j.jss.2006.02.027; Damashek A, 2009, J PEDIATR PSYCHOL, V34, P344, DOI 10.1093/jpepsy/jsn097; Dawson DA, 2005, DRUG ALCOHOL DEPEN, V77, P139, DOI 10.1016/j.drugalcdep.2004.07.012; Flavin MP, 2006, BMC PUBLIC HEALTH, V6, DOI 10.1186/1471-2458-6-187; Groom L, 2006, INJURY PREV, V12, P166, DOI 10.1136/ip.2005.011254; Haynes R, 2003, SOC SCI MED, V57, P625, DOI 10.1016/S0277-9536(02)00446-X; Hippisley-Cox J, 2002, BRIT MED J, V324, P1132, DOI 10.1136/bmj.324.7346.1132; Joffe Ari R, 2006, J Intensive Care Med, V21, P227, DOI 10.1177/0885066606288944; JOLLY DL, 1993, J PAEDIATR CHILD H, V29, P438; Kendrick D, 2005, SOC SCI MED, V61, P1905, DOI 10.1016/j.socscimed.2005.04.003; Kendrick D, 2001, PUBLIC HEALTH, V115, P103, DOI 10.1016/S0033-3506(01)00427-9; Kendrick D, 2012, BRIT J GEN PRACT, V62, P62, DOI 10.3399/bjgp12X625012; Lalloo R, 2003, INJURY, V34, P261, DOI 10.1016/S0020-1383(02)00277-2; LANDIN LA, 1983, ACTA ORTHOP SCAND, V54, P1; Laursen B, 2008, EUR J PUBLIC HEALTH, V18, P366, DOI 10.1093/eurpub/ckn034; Lyons RA, 2000, BRIT MED J, V320, P149, DOI 10.1136/bmj.320.7228.149; MacInnes K, 2008, BMC PUBLIC HEALTH, V8, DOI 10.1186/1471-2458-8-120; NICE, 2010, STRAT PREV UN INJ 15; NICE, 2007, AN POSTN MENT HLTH; NICE, 2009, DEPR TREATM MAN DEPR; NICE, 2010, ALC US DIS PREV DEV, P1; O'Connor TG, 2000, PEDIATRICS, V106, DOI 10.1542/peds.106.5.e68; ONS, 2009, MORT STAT DEATHS REG; Pomerantz WJ, 2001, J URBAN HEALTH, V78, P141, DOI 10.1093/jurban/78.1.141; Reading R, 1999, SOC SCI MED, V48, P321, DOI 10.1016/S0277-9536(98)00311-6; Reading R, 2008, SOC SCI MED, V67, P915, DOI 10.1016/j.socscimed.2008.05.018; Reid MC, 1999, ARCH INTERN MED, V159, P1681, DOI 10.1001/archinte.159.15.1681; Rewers A, 2005, PEDIATRICS, V115, pE543, DOI 10.1542/peds.2004-1064; Roberts I, 1997, J EPIDEMIOL COMMUN H, V51, P334, DOI 10.1136/jech.51.3.334; ROSPA, 2002, HOM LEIS ACC SURV SY; Ruckinger S, 2009, BMC MED RES METHODOL, V9, DOI 10.1186/1471-2288-9-7; Russell K M, 1998, J Community Health Nurs, V15, P179, DOI 10.1207/s15327655jchn1503_5; Schmertmann M, 2008, INJURY PREV, V14, P30, DOI 10.1136/ip.2007.016253; Schwebel DC, 2008, J PEDIATR PSYCHOL, V33, P1108, DOI 10.1093/jpepsy/jsn046; Shenassa ED, 2004, AM J PUBLIC HEALTH, V94, P633, DOI 10.2105/AJPH.94.4.633; Smith L, 2009, DRINKING UK EXPLORAT; Stark AD, 2002, BRIT MED J, V324, P457, DOI 10.1136/bmj.324.7335.457; Tata LJ, 2008, THORAX, V63, P981, DOI 10.1136/thx.2008.098244; Townsend PP., 1988, HLTH DEPRIVATION INE; UNICEF, 2001, LEAG TABL CHILD DEAT; Villalba-Cota J, 2004, ANN TROP PAEDIATR, V24, P53, DOI 10.1179/027249304225013259; Winqvist S, 2007, BRAIN INJURY, V21, P1079, DOI 10.1080/02699050701553221	53	45	47	0	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 5	2012	7	4							e35193	10.1371/journal.pone.0035193	http://dx.doi.org/10.1371/journal.pone.0035193			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	955IH	22496906	Green Published, gold			2022-12-25	WOS:000305010500033
J	John, S; Thiebach, L; Frie, C; Mokkapati, S; Bechtel, M; Nischt, R; Rosser-Davies, S; Paulsson, M; Smyth, N				John, Susan; Thiebach, Lars; Frie, Christian; Mokkapati, Sharada; Bechtel, Manuela; Nischt, Roswitha; Rosser-Davies, Sally; Paulsson, Mats; Smyth, Neil			Epidermal Transglutaminase (TGase 3) Is Required for Proper Hair Development, but Not the Formation of the Epidermal Barrier	PLOS ONE			English	Article							CORNIFIED CELL-ENVELOPE; PROTEIN CROSS-LINKING; PROLINE-RICH PROTEINS; TISSUE TRANSGLUTAMINASE; LAMELLAR ICHTHYOSIS; KERATINOCYTE TRANSGLUTAMINASE; PACHYONYCHIA-CONGENITA; BINDING-PROTEIN; MICE LACKING; SKIN	Transglutaminases (TGase), a family of cross-linking enzymes present in most cell types, are important in events as diverse as cell-signaling and matrix stabilization. Transglutaminase 1 is crucial in developing the epidermal barrier, however the skin also contains other family members, in particular TGase 3. This isoform is highly expressed in the cornified layer, where it is believed to stabilize the epidermis and its reduction is implicated in psoriasis. To understand the importance of TGase 3 in vivo we have generated and analyzed mice lacking this protein. Surprisingly, these animals display no obvious defect in skin development, no overt changes in barrier function or ability to heal wounds. In contrast, hair lacking TGase 3 is thinner, has major alterations in the cuticle cells and hair protein cross-linking is markedly decreased. Apparently, while TGase 3 is of unique functional importance in hair, in the epidermis loss of TGase 3 can be compensated for by other family members.	[John, Susan; Thiebach, Lars; Frie, Christian; Paulsson, Mats; Smyth, Neil] Univ Cologne, Ctr Biochem, D-50931 Cologne, North Rhine Wes, Germany; [John, Susan] Univ Cologne, Ctr Mol Med CMMC, D-50931 Cologne, North Rhine Wes, Germany; [Mokkapati, Sharada; Bechtel, Manuela; Nischt, Roswitha] Univ Cologne, Dept Dermatol, D-50931 Cologne, North Rhine Wes, Germany; [Rosser-Davies, Sally; Smyth, Neil] Univ Southampton, Sch Biol Sci, Southampton, Hants, England; [Paulsson, Mats] Cologne Excellence Cluster Cellular Stress Respon, Cologne, North Rhine Wes, Germany	University of Cologne; University of Cologne; University of Cologne; University of Southampton; University of Cologne	John, S (corresponding author), Univ Cologne, Ctr Biochem, D-50931 Cologne, North Rhine Wes, Germany.	susan.john@uni-koeln.de		Smyth, Neil/0000-0002-3734-2149	Deutsche Forschungsgemeinschaft [SFB 589, SFB 829]; MRC [G0501515]; Medical Research Council [G0501515] Funding Source: researchfish	Deutsche Forschungsgemeinschaft(German Research Foundation (DFG)); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission)	The authors acknowledge the financial support by the Deutsche Forschungsgemeinschaft (SFB 589, SFB 829) and the MRC by grant number G0501515. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aeschlimann D, 2000, CONNECT TISSUE RES, V41, P1, DOI 10.3109/03008200009005638; AESCHLIMANN D, 1994, THROMB HAEMOSTASIS, V71, P402; Aeschlimann Daniel, 1996, Seminars in Thrombosis and Hemostasis, V22, P437; Ahvazi B, 2003, EXP MOL MED, V35, P228, DOI 10.1038/emm.2003.31; Akimov SS, 2000, J CELL BIOL, V148, P825, DOI 10.1083/jcb.148.4.825; Appel B, 1942, NEW ENGL J MED, V226, P912, DOI 10.1056/NEJM194206042262303; BOWNESS JM, 1988, BIOCHIM BIOPHYS ACTA, V967, P234; BUXMAN MM, 1975, J INVEST DERMATOL, V65, P107, DOI 10.1111/1523-1747.ep12598072; Candi E, 2005, NAT REV MOL CELL BIO, V6, P328, DOI 10.1038/nrm1619; Candi E, 1998, P NATL ACAD SCI USA, V95, P2067, DOI 10.1073/pnas.95.5.2067; CANDI E, 1995, J BIOL CHEM, V270, P26382, DOI 10.1074/jbc.270.44.26382; Candi E, 2001, J BIOL CHEM, V276, P35014, DOI 10.1074/jbc.M010157200; Cheng T, 2006, J BIOL CHEM, V281, P15893, DOI 10.1074/jbc.M600694200; CLEMENTI M, 1986, BRIT J DERMATOL, V114, P367, DOI 10.1111/j.1365-2133.1986.tb02829.x; Djian P, 2000, J CELL BIOL, V151, P381, DOI 10.1083/jcb.151.2.381; FOLK JE, 1965, J BIOL CHEM, V240, P2951; Grenard P, 2001, J BIOL CHEM, V276, P33066, DOI 10.1074/jbc.M102553200; Hardman MJ, 1998, DEVELOPMENT, V125, P1541; Haroon ZA, 1999, FASEB J, V13, P1787, DOI 10.1096/fasebj.13.13.1787; Hitomi K, 2001, INT J BIOCHEM CELL B, V33, P491, DOI 10.1016/S1357-2725(01)00033-4; HUBER M, 1995, SCIENCE, V267, P525, DOI 10.1126/science.7824952; Inada R, 2000, AM J PATHOL, V157, P1875, DOI 10.1016/S0002-9440(10)64826-2; Kalinin AE, 2002, BIOESSAYS, V24, P789, DOI 10.1002/bies.10144; KIM HC, 1990, J BIOL CHEM, V265, P21971; Koch PJ, 2000, J CELL BIOL, V151, P389, DOI 10.1083/jcb.151.2.389; Kuramoto N, 2002, J CLIN INVEST, V109, P243, DOI 10.1172/JCI200213563; LEE SC, 1993, J BIOL CHEM, V268, P12164; Lee YJ, 2006, MOL CELL PROTEOMICS, V5, P789, DOI 10.1074/mcp.M500278-MCP200; Matsuki M, 1998, P NATL ACAD SCI USA, V95, P1044, DOI 10.1073/pnas.95.3.1044; McGowan KM, 1998, J CELL BIOL, V143, P469, DOI 10.1083/jcb.143.2.469; McGowan KM, 2002, GENE DEV, V16, P1412, DOI 10.1101/gad.979502; MCLEAN WHI, 1995, NAT GENET, V9, P273, DOI 10.1038/ng0395-273; Medland SE, 2009, AM J HUM GENET, V85, P750, DOI 10.1016/j.ajhg.2009.10.009; MYCEK MJ, 1959, ARCH BIOCHEM BIOPHYS, V84, P528, DOI 10.1016/0003-9861(59)90613-7; Nunes I, 1997, J CELL BIOL, V136, P1151, DOI 10.1083/jcb.136.5.1151; OKEEFE EJ, 1993, J INVEST DERMATOL, V101, pS65, DOI 10.1111/1523-1747.ep12362866; Pinkas DM, 2007, PLOS BIOL, V5, P2788, DOI 10.1371/journal.pbio.0050327; Raghunath M, 1996, J CLIN INVEST, V98, P1174, DOI 10.1172/JCI118901; Rice RH, 1996, ANAT RECORD, V246, P433, DOI 10.1002/(SICI)1097-0185(199612)246:4<433::AID-AR2>3.0.CO;2-W; RUSSELL LJ, 1995, NAT GENET, V9, P279, DOI 10.1038/ng0395-279; Sardy M, 2002, J EXP MED, V195, P747, DOI 10.1084/jem.20011299; Sevilla LM, 2007, J CELL BIOL, V179, P1599, DOI 10.1083/jcb.200706187; Siegel M, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0001861; Steinert PM, 2003, J BIOL CHEM, V278, P41409, DOI 10.1074/jbc.M302037200; Steinert PM, 1998, J BIOL CHEM, V273, P11758, DOI 10.1074/jbc.273.19.11758; Stephens P, 2004, J CELL SCI, V117, P3389, DOI 10.1242/jcs.01188; Tarcsa E, 1997, J BIOL CHEM, V272, P27893, DOI 10.1074/jbc.272.44.27893; Thibaut S, 2005, J INVEST DERMATOL, V125, P581, DOI 10.1111/j.0022-202X.2005.23868.x; Vader LW, 2002, J EXP MED, V195, P643, DOI 10.1084/jem.20012028; Verderio EAM, 2005, PROG EXP TUMOR RES, V38, P89; Wang ZL, 2003, J INVEST DERMATOL, V121, P1276, DOI 10.1111/j.1523-1747.2003.12644.x; Yamada K, 1997, HUM MOL GENET, V6, P2223, DOI 10.1093/hmg/6.13.2223; Yamane A, 2010, FEBS J, V277, P3564, DOI 10.1111/j.1742-4658.2010.07765.x; Zhang H, 2005, CELL RES, V15, P105, DOI 10.1038/sj.cr.7290274	54	34	35	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 4	2012	7	4							e34252	10.1371/journal.pone.0034252	http://dx.doi.org/10.1371/journal.pone.0034252			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	953GO	22496784	Green Submitted, gold, Green Published, Green Accepted			2022-12-25	WOS:000304855200035
J	Skopelitou, K; Dhavala, P; Papageorgiou, AC; Labrou, NE				Skopelitou, Katholiki; Dhavala, Prathusha; Papageorgiou, Anastassios C.; Labrou, Nikolaos E.			A Glutathione Transferase from Agrobacterium tumefaciens Reveals a Novel Class of Bacterial GST Superfamily	PLOS ONE			English	Article							HYDROPHOBIC STAPLE MOTIF; CATALYTIC MECHANISM; S-TRANSFERASE; SECONDARY-STRUCTURE; DISULFIDE BOND; H-SITE; ENZYMES; BINDING; P1-1; STABILITY	In the present work, we report a novel class of glutathione transferases (GSTs) originated from the pathogenic soil bacterium Agrobacterium tumefaciens C58, with structural and catalytic properties not observed previously in prokaryotic and eukaryotic GST isoenzymes. A GST-like sequence from A. tumefaciens C58 (Atu3701) with low similarity to other characterized GST family of enzymes was identified. Phylogenetic analysis showed that it belongs to a distinct GST class not previously described and restricted only in soil bacteria, called the Eta class (H). This enzyme (designated as AtuGSTH1-1) was cloned and expressed in E. coli and its structural and catalytic properties were investigated. Functional analysis showed that AtuGSTH1-1 exhibits significant transferase activity against the common substrates aryl halides, as well as very high peroxidase activity towards organic hydroperoxides. The crystal structure of AtuGSTH1-1 was determined at 1.4 angstrom resolution in complex with S-(p-nitrobenzyl)-glutathione (Nb-GSH). Although AtuGSTH1-1 adopts the canonical GST fold, sequence and structural characteristics distinct from previously characterized GSTs were identified. The absence of the classic catalytic essential residues (Tyr, Ser, Cys) distinguishes AtuGSTH1-1 from all other cytosolic GSTs of known structure and function. Site-directed mutagenesis showed that instead of the classic catalytic residues, an Arg residue (Arg34), an electron-sharing network, and a bridge of a network of water molecules may form the basis of the catalytic mechanism. Comparative sequence analysis, structural information, and site-directed mutagenesis in combination with kinetic analysis showed that Phe22, Ser25, and Arg187 are additional important residues for the enzyme's catalytic efficiency and specificity.	[Skopelitou, Katholiki; Labrou, Nikolaos E.] Agr Univ Athens, Dept Agr Biotechnol, Lab Enzyme Technol, Athens, Greece; [Dhavala, Prathusha; Papageorgiou, Anastassios C.] Abo Akad Univ, Univ Turku, Turku Ctr Biotechnol, Turku, Finland	Agricultural University of Athens; Abo Akademi University; University of Turku	Skopelitou, K (corresponding author), Agr Univ Athens, Dept Agr Biotechnol, Lab Enzyme Technol, Athens, Greece.	lambrou@aua.gr	Labrou, Nikolaos/B-1089-2011; Papageorgiou, Anastassios C./AAL-5274-2020	Labrou, Nikolaos/0000-0003-1925-9867; Papageorgiou, Anastassios C./0000-0002-7980-1120	grant THALES; European Social Fund; Academy of Finland [121278]; European Community [226716]	grant THALES(Thales Group); European Social Fund(European Social Fund (ESF)); Academy of Finland(Academy of Finland); European Community(European Commission)	This work was partially supported by the grant THALES. The grant THALES falls under the Operational Programme "Education and Lifelong Learning" and is co-financed by the European Social Fund and National Resources. Dr. Papageorgiou thanks the Academy of Finland for financial support (grant number 121278). Access to EMBL Hamburg (c/o DESY) was provided by the European Community's Seventh Framework Programme (FP7/2007-2012) under grant agreement no. 226716. No additional external funding received for this study. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adams PD, 2002, ACTA CRYSTALLOGR D, V58, P1948, DOI 10.1107/S0907444902016657; Allocati N, 2006, BIOCHEM J, V394, P11, DOI 10.1042/BJ20051367; Allocati N, 2008, PROTEINS, V71, P16, DOI 10.1002/prot.21835; Allocati N, 2009, FEBS J, V276, P58, DOI 10.1111/j.1742-4658.2008.06743.x; Armstrong RN, 1997, CHEM RES TOXICOL, V10, P2, DOI 10.1021/tx960072x; Axarli IA, 2004, BIOCHEM J, V382, P885, DOI 10.1042/BJ20040298; Axarli I, 2009, J MOL BIOL, V385, P984, DOI 10.1016/j.jmb.2008.10.084; Axarli I, 2010, BBA-PROTEINS PROTEOM, V1804, P662, DOI 10.1016/j.bbapap.2009.10.016; Axarli I, 2009, BIOCHEM J, V422, P247, DOI 10.1042/BJ20090224; Balogh LM, 2010, BIOCHEMISTRY-US, V49, P1541, DOI 10.1021/bi902038u; Cocco R, 2001, J BIOL CHEM, V276, P32177, DOI 10.1074/jbc.M104057200; Diederichs K, 1997, NAT STRUCT BIOL, V4, P269, DOI 10.1038/nsb0497-269; Dixon DP, 2010, PHYTOCHEMISTRY, V71, P338, DOI 10.1016/j.phytochem.2009.12.012; Dourado DFAR, 2008, CHEM-EUR J, V14, P9591, DOI 10.1002/chem.200800946; Emsley P, 2004, ACTA CRYSTALLOGR D, V60, P2126, DOI 10.1107/S0907444904019158; Federici L, 2010, PROTEIN ENG DES SEL, V23, P743, DOI 10.1093/protein/gzq048; Grahn E, 2006, ACTA CRYSTALLOGR D, V62, P197, DOI 10.1107/S0907444905039296; Gupta MN, 2011, CURR SCI INDIA, V100, P1152; Hayes JD, 1999, FREE RADICAL RES, V31, P273, DOI 10.1080/10715769900300851; Hayes JD, 2005, ANNU REV PHARMACOL, V45, P51, DOI 10.1146/annurev.pharmtox.45.120403.095857; Hegazy UM, 2006, CHEM BIOL, V13, P929, DOI 10.1016/j.chembiol.2006.07.005; HO SN, 1989, GENE, V77, P51, DOI 10.1016/0378-1119(89)90358-2; Holm L, 1997, NUCLEIC ACIDS RES, V25, P231, DOI 10.1093/nar/25.1.231; Honaker MT, 2011, J BIOL CHEM, V286, P42770, DOI 10.1074/jbc.M111.304386; Hurd TR, 2005, ANTIOXID REDOX SIGN, V7, P999, DOI 10.1089/ars.2005.7.999; JOHNSON WW, 1993, J BIOL CHEM, V268, P11508; KABSCH W, 1983, BIOPOLYMERS, V22, P2577, DOI 10.1002/bip.360221211; Kabsch W, 2010, ACTA CRYSTALLOGR D, V66, P125, DOI 10.1107/S0907444909047337; Krissinel E, 2004, ACTA CRYSTALLOGR D, V60, P2256, DOI 10.1107/S0907444904026460; Krissinel E, 2007, J MOL BIOL, V372, P774, DOI 10.1016/j.jmb.2007.05.022; LASKOWSKI RA, 1993, J APPL CRYSTALLOGR, V26, P283, DOI 10.1107/S0021889892009944; Lovell SC, 2003, PROTEINS, V50, P437, DOI 10.1002/prot.10286; Mannervik B, 1996, BIOCHEM SOC T, V24, P878, DOI 10.1042/bst0240878; MATTHEWS BW, 1968, J MOL BIOL, V33, P491, DOI 10.1016/0022-2836(68)90205-2; Mccoy AJ, 2007, J APPL CRYSTALLOGR, V40, P658, DOI 10.1107/S0021889807021206; Micaloni C, 2003, J MOL BIOL, V325, P111, DOI 10.1016/S0022-2836(02)01178-6; Morris RJ, 2003, METHOD ENZYMOL, V374, P229, DOI 10.1016/S0076-6879(03)74011-7; Murshudov GN, 1997, ACTA CRYSTALLOGR D, V53, P240, DOI 10.1107/S0907444996012255; Norrgard MA, 2011, J BIOL CHEM, V286, P16871, DOI 10.1074/jbc.M111.230078; Otwinowski Z, 1997, METHOD ENZYMOL, V276, P307, DOI 10.1016/S0076-6879(97)76066-X; Pemble SE, 1996, BIOCHEM J, V319, P749, DOI 10.1042/bj3190749; Pitzschke A, 2010, EMBO J, V29, P1021, DOI 10.1038/emboj.2010.8; Potterton L, 2004, ACTA CRYSTALLOGR D, V60, P2288, DOI 10.1107/S0907444904023716; Ricci G, 1996, J BIOL CHEM, V271, P16187, DOI 10.1074/jbc.271.27.16187; Rossjohn J, 1998, STRUCT FOLD DES, V6, P721, DOI 10.1016/S0969-2126(98)00074-4; SAMPSON NS, 1992, BIOCHEMISTRY-US, V31, P8488, DOI 10.1021/bi00151a015; Sheldrick GM, 2008, ACTA CRYSTALLOGR A, V64, P112, DOI 10.1107/S0108767307043930; Sies H, 1998, CHEM-BIOL INTERACT, V112, P177, DOI 10.1016/S0009-2797(97)00160-9; Skopelitou K, 2012, FUNCT INTEGR GENOMIC, V12, P157, DOI 10.1007/s10142-011-0248-x; Stenberg G, 2000, J BIOL CHEM, V275, P10421, DOI 10.1074/jbc.275.14.10421; Vonrhein Clemens, 2007, Methods Mol Biol, V364, P215, DOI 10.1385/1-59745-266-1:215; Wadington MC, 2009, BIOCHEMISTRY-US, V48, P6559, DOI 10.1021/bi9008825; Wiktelius E, 2007, BIOCHEM J, V406, P115, DOI 10.1042/BJ20070328; Winayanuwattikun P, 2005, J BIOL CHEM, V280, P31776, DOI 10.1074/jbc.M502612200; Wolf AV, HDB CHEM PHYS, pD; Wood DW, 2001, SCIENCE, V294, P2317, DOI 10.1126/science.1066804	56	22	22	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 4	2012	7	4							e34263	10.1371/journal.pone.0034263	http://dx.doi.org/10.1371/journal.pone.0034263			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	953GO	22496785	Green Published, gold, Green Submitted			2022-12-25	WOS:000304855200036
J	Hogan, L; Bhuju, S; Jones, DC; Laing, K; Trowsdale, J; Butcher, P; Singh, M; Vordermeier, M; Allen, RL				Hogan, Louise; Bhuju, Sabin; Jones, Des C.; Laing, Ken; Trowsdale, John; Butcher, Philip; Singh, Mahavir; Vordermeier, Martin; Allen, Rachel L.			Characterisation of Bovine Leukocyte Ig-like Receptors	PLOS ONE			English	Article							IMMUNOGLOBULIN-LIKE RECEPTORS; DENDRITIC CELLS; KILLER-CELL; MULTIPLE-SCLEROSIS; INHIBITION MOTIFS; FC-RECEPTOR; KIR GENES; SUPERFAMILY; ACTIVATION; EVOLUTION	Leukocyte Immunoglobulin-like receptors (LILR) are innate immune receptors involved in regulating both innate and adaptive immune functions. LILR show more interspecies conservation than the closely related Killer Ig-like receptors, and homologues have been identified in rodents, primates, seals and chickens. The murine equivalents, paired Ig-like receptors PIR), contain two additional immunoglobulin domains, but show strong sequence and functional similarities to human LILR. The bovine genome was recently sequenced, with preliminary annotations indicating that LILR were present in this species. We therefore sought to identify and characterize novel LILR within the Bos taurus genome, compare these phylogenetically with LILR from other species and determine whether they were expressed in vivo. Twenty six potential bovine LILR were initially identified using BLAST and BLAT software. Phylogenetic analysis constructed using the neighbour joining method, incorporating pairwise deletion and confidence limits estimated from 1000 replicates using bootstrapping, indicated that 16 of these represent novel bovine LILR. Protein structures defined using protein BLAST predict that the bovine LILR family comprises seven putative inhibitory, four activating and five soluble receptors. Preliminary expression analysis was performed by mapping the predicted sequences with raw data from total transcript sequence generated using Genome Analyzer Ilx (Illumina) to provide evidence that all 16 of these receptors are expressed in vivo. The bovine receptor family appears to contain receptors which resemble the six domain rodent PIR as well as the four domain LILR found in other species.	[Hogan, Louise; Laing, Ken; Butcher, Philip; Allen, Rachel L.] Univ London, Div Clin Sci, Ctr Infect, London, England; [Hogan, Louise; Vordermeier, Martin] AHVLA, TB Res Grp, Weybridge, New Haw, England; [Bhuju, Sabin; Singh, Mahavir] Helmholtz Zentrum Infekt Forsch, Dept Gene Regulat & Differentiat, Braunschweig, Germany; [Jones, Des C.; Trowsdale, John] Univ Cambridge, Dept Pathol, Div Immunol, Cambridge CB2 1QP, England; [Bhuju, Sabin; Singh, Mahavir] LIONEX Diagnost & Therapeut, Braunschweig, Germany	University of London; Helmholtz Association; Helmholtz-Center for Infection Research; University of Cambridge; Lionex Diagnostics & Therapeutics GmbH	Hogan, L (corresponding author), Univ London, Div Clin Sci, Ctr Infect, Cranmer Terrace, London, England.	p0904768@sgul.ac.uk		Hogan, Louise/0000-0001-5526-954X; Laing, Ken/0000-0003-1883-3433; Allen, Rachel/0000-0001-9834-8475; Butcher, Philip/0000-0003-1223-9097	St George's University of London; Animal Health and Veterinary Laboratories Agency; MRC [G0901682] Funding Source: UKRI; Medical Research Council [G0901682] Funding Source: researchfish	St George's University of London; Animal Health and Veterinary Laboratories Agency; MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission)	This project was funded by St George's University of London and the Animal Health and Veterinary Laboratories Agency. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Anderson KJ, 2009, IMMUNOLOGY, V127, P8, DOI 10.1111/j.1365-2567.2009.03097.x; Barrow AD, 2006, EUR J IMMUNOL, V36, P1646, DOI 10.1002/eji.200636195; Beinhauer BG, 2004, EUR J IMMUNOL, V34, P74, DOI 10.1002/eji.200324550; Bentley DR, 2008, NATURE, V456, P53, DOI 10.1038/nature07517; Bleharski JR, 2003, SCIENCE, V301, P1527, DOI 10.1126/science.1087785; Burge C, 1997, J MOL BIOL, V268, P78, DOI 10.1006/jmbi.1997.0951; Burshtyn DN, 1997, J BIOL CHEM, V272, P13066, DOI 10.1074/jbc.272.20.13066; Canavez F, 2001, J IMMUNOL, V167, P5786, DOI 10.4049/jimmunol.167.10.5786; CASTELLS MC, 1994, J BIOL CHEM, V269, P8393; Cella M, 1997, J EXP MED, V185, P1743, DOI 10.1084/jem.185.10.1743; Chang CC, 2002, NAT IMMUNOL, V3, P237, DOI 10.1038/ni760; Chenna R, 2003, NUCLEIC ACIDS RES, V31, P3497, DOI 10.1093/nar/gkg500; Cosman D, 1997, IMMUNITY, V7, P273, DOI 10.1016/S1074-7613(00)80529-4; Daeron M, 2008, IMMUNOL REV, V224, P11, DOI 10.1111/j.1600-065X.2008.00666.x; Elsik CG, 2009, SCIENCE, V324, P522, DOI 10.1126/science.1169588; FELSENSTEIN J, 1985, EVOLUTION, V39, P783, DOI 10.1111/j.1558-5646.1985.tb00420.x; Guethlein LA, 2007, IMMUNOGENETICS, V59, P517, DOI 10.1007/s00251-007-0214-x; Hammond JA, 2009, J IMMUNOL, V182, P3618, DOI 10.4049/jimmunol.0803026; HARPAZ Y, 1994, J MOL BIOL, V238, P528, DOI 10.1006/jmbi.1994.1312; Hayami K, 1997, J BIOL CHEM, V272, P7320, DOI 10.1074/jbc.272.11.7320; Hirayasu K, 2008, AM J HUM GENET, V82, P1075, DOI 10.1016/j.ajhg.2008.03.012; Huang J, 2010, J VIROL; Huang JH, 2009, J EXP MED, V206, P2959, DOI 10.1084/jem.20091386; Jones DC, 2009, EUR J IMMUNOL; Jones DC, 2011, J IMMUNOL, V186, P2990, DOI 10.4049/jimmunol.1003078; Kabalak G, 2009, ARTHRITIS RHEUM-US, V60, P2923, DOI 10.1002/art.24804; Katz HR, 1996, P NATL ACAD SCI USA, V93, P10809, DOI 10.1073/pnas.93.20.10809; Kent WJ, 2002, GENOME RES, V12, P656, DOI 10.1101/gr.229202; Koch S, 2005, GENES IMMUN, V6, P445, DOI 10.1038/sj.gene.6364187; Kollnberger S, 2004, J IMMUNOL, V173, P1699, DOI 10.4049/jimmunol.173.3.1699; Kubagawa H, 1997, P NATL ACAD SCI USA, V94, P5261, DOI 10.1073/pnas.94.10.5261; Lee DJ, 2007, J IMMUNOL, V179, P8128, DOI 10.4049/jimmunol.179.12.8128; Liang SY, 2002, EUR J IMMUNOL, V32, P2418, DOI 10.1002/1521-4141(200209)32:9<2418::AID-IMMU2418>3.0.CO;2-L; Lomsadze A, 2005, NUCLEIC ACIDS RES, V33, P6494, DOI 10.1093/nar/gki937; Martin AM, 2002, TRENDS IMMUNOL, V23, P81, DOI 10.1016/S1471-4906(01)02155-X; McQueen KL, 2002, EUR J IMMUNOL, V32, P810, DOI 10.1002/1521-4141(200203)32:3<810::AID-IMMU810>3.0.CO;2-P; Nakajima H, 1999, J IMMUNOL, V162, P5; Nikolaidis N, 2005, P NATL ACAD SCI USA, V102, P4057, DOI 10.1073/pnas.0501040102; Nikolaidis N, 2005, IMMUNOGENETICS, V57, P151, DOI 10.1007/s00251-004-0764-0; Olcese L, 1996, J IMMUNOL, V156, P4531; Ordonez D, 2009, GENES IMMUN, V10, P579, DOI 10.1038/gene.2009.34; Pilsbury LE, 2010, MEDIAT INFLAMM, V2010, DOI 10.1155/2010/536478; Rutherford K, 2000, BIOINFORMATICS, V16, P944, DOI 10.1093/bioinformatics/16.10.944; SAITOU N, 1987, MOL BIOL EVOL, V4, P406, DOI 10.1093/oxfordjournals.molbev.a040454; Samaridis J, 1997, EUR J IMMUNOL, V27, P660, DOI 10.1002/eji.1830270313; Sloane DE, 2004, BLOOD, V104, P2832, DOI 10.1182/blood-2004-01-0268; Storset AK, 2003, EUR J IMMUNOL, V33, P980, DOI 10.1002/eji.200323710; Takai T, 2001, IMMUNOL REV, V181, P215, DOI 10.1034/j.1600-065X.2001.1810118.x; Tamura K, 2007, MOL BIOL EVOL, V24, P1596, DOI 10.1093/molbev/msm092; Torkar M, 2000, EUR J IMMUNOL, V30, P3655, DOI 10.1002/1521-4141(200012)30:12<3655::AID-IMMU3655>3.0.CO;2-Y; Tun T, 2003, TISSUE ANTIGENS, V61, P220, DOI 10.1034/j.1399-0039.2003.00042.x; Vely F, 1997, EUR J IMMUNOL, V27, P1994, DOI 10.1002/eji.1830270825; Viertlboeck BC, 2005, J IMMUNOL, V175, P385, DOI 10.4049/jimmunol.175.1.385; Vivier E, 1997, IMMUNOL TODAY, V18, P286, DOI 10.1016/S0167-5699(97)80025-4; Willcox BE, 2003, NAT IMMUNOL, V4, P913, DOI 10.1038/ni961; Willcox Benjamin E, 2002, BMC Struct Biol, V2, P6, DOI 10.1186/1472-6807-2-6; Wilson MJ, 2000, P NATL ACAD SCI USA, V97, P4778, DOI 10.1073/pnas.080588597; Young NT, 2008, BLOOD, V111, P3090, DOI 10.1182/blood-2007-05-089771	58	16	16	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 2	2012	7	4							e34291	10.1371/journal.pone.0034291	http://dx.doi.org/10.1371/journal.pone.0034291			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	952GU	22485161	Green Published, Green Submitted, Green Accepted, gold			2022-12-25	WOS:000304780500036
J	Lim, EJ; Hong, DY; Park, JH; Joung, YH; Darvin, P; Kim, SY; Na, YM; Hwang, TS; Ye, SK; Moon, ES; Cho, BW; Park, KD; Lee, HK; Park, T; Yang, YM				Lim, Eun Joung; Hong, Dae Young; Park, Jin Hee; Joung, Youn Hee; Darvin, Pramod; Kim, Sang Yoon; Na, Yoon Mi; Hwang, Tae Sook; Ye, Sang-Kyu; Moon, Eon-Soo; Cho, Byung Wook; Park, Kyung Do; Lee, Hak Kyo; Park, Taekyu; Yang, Young Mok			Methylsulfonylmethane Suppresses Breast Cancer Growth by Down-Regulating STAT3 and STAT5b Pathways	PLOS ONE			English	Article							DIMETHYL SULFONE; SIGNAL TRANSDUCER; ESTROGEN-RECEPTORS; IGF-1 EXPRESSION; TRANSCRIPTION 5B; VEGF EXPRESSION; CYCLIN D1; IN-VIVO; CELLS; PROGESTERONE	Breast cancer is the most aggressive form of all cancers, with high incidence and mortality rates. The purpose of the present study was to investigate the molecular mechanism by which methylsulfonylmethane (MSM) inhibits breast cancer growth in mice xenografts. MSM is an organic sulfur-containing natural compound without any toxicity. In this study, we demonstrated that MSM substantially decreased the viability of human breast cancer cells in a dose-dependent manner. MSM also suppressed the phosphorylation of STAT3, STAT5b, expression of IGF-1R, HIF-1 alpha, VEGF, BrK and p-IGF-1R and inhibited triple-negative receptor expression in receptor-positive cell lines. Moreover, expression in receptor-positive cell-lines. Moreover, MSM decreased the DNA-binding activities of STAT5b and STAT3, to the target gene promoters in MDA-MB 231 or co-transfected COS-7 cells. We confirmed that MSM significantly decreased the relative luciferase activities indicating crosstalk between STAT5b/IGF-1R, STAT5b/HSP90 alpha, and STAT3/VEGF. To confirm these findings in vivo, xenografts were established in Balb/c athymic nude mice with MDA-MB 231 cells and MSM was administered for 30 days. Concurring to our in vitro analysis, these xenografts showed decreased expression of STAT3, STAT5b, IGF-1R and VEGF. Through in vitro and in vivo analysis, we confirmed that MSM can effectively regulate multiple targets including STAT3/VEGF and STAT5b/IGF-1R. These are the major molecules involved in tumor development, progression, and metastasis: Thus, we strongly recommend the use of MSM as a trial drug for treating all types of breast cancers including triple-negative cancers.	[Lim, Eun Joung; Park, Jin Hee; Joung, Youn Hee; Darvin, Pramod; Kim, Sang Yoon; Na, Yoon Mi; Hwang, Tae Sook; Yang, Young Mok] Konkuk Univ, Dept Pathol, Sch Med, Seoul, South Korea; [Lim, Eun Joung; Park, Jin Hee; Joung, Youn Hee; Darvin, Pramod; Kim, Sang Yoon; Na, Yoon Mi; Hwang, Tae Sook; Yang, Young Mok] Konkuk Univ, Inst Biomed Sci & Technol, Seoul, South Korea; [Hong, Dae Young] Konkuk Univ Hosp, Dept Emergency Med, Seoul, South Korea; [Ye, Sang-Kyu] Seoul Natl Univ, Coll Med, Dept Pharmacol, Seoul, South Korea; [Moon, Eon-Soo] Konkuk Univ, Sch Med, Dept Internal Med, Chungju, South Korea; [Cho, Byung Wook] Pusan Natl Univ, Coll Life Sci, Dept Anim Sci, Pusan, South Korea; [Park, Kyung Do; Lee, Hak Kyo] Hankyong Natl Univ, Genom Informat Ctr, Anseong, South Korea; [Park, Taekyu] Konkuk Univ, Coll Biomed & Hlth Sci, Dept Biotechnol, Chungju, South Korea	Konkuk University; Konkuk University Medical Center; Konkuk University; Konkuk University; Konkuk University Medical Center; Seoul National University (SNU); Konkuk University; Konkuk University Medical Center; Pusan National University; Hankyong National University; Konkuk University	Lim, EJ (corresponding author), Konkuk Univ, Dept Pathol, Sch Med, Glocal Campus, Seoul, South Korea.	ymyang@kku.ac.kr	Ye, Sang Kyu/J-2768-2012; Darvin, Pramod/M-1730-2019	Darvin, Pramod/0000-0003-3746-109X	Next generation BioGreen 21 Program [PJ0081062011]; Rural Development Administration; Ministry of Commerce, Industry and Energy through the Bio-Food and Drug Research Center at Konkuk University, Glocal Campus, South Korea	Next generation BioGreen 21 Program(Rural Development Administration (RDA), Republic of Korea); Rural Development Administration(Rural Development Administration (RDA), Republic of Korea); Ministry of Commerce, Industry and Energy through the Bio-Food and Drug Research Center at Konkuk University, Glocal Campus, South Korea	This work was supported by a grant from the Next generation BioGreen 21 Program (No. PJ0081062011), by the Rural Development Administration, and partially supported by the Ministry of Commerce, Industry and Energy through the Bio-Food and Drug Research Center at Konkuk University, Glocal Campus, South Korea. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Anders CK, 2009, CLIN BREAST CANCER, V9, pS73, DOI 10.3816/CBC.2009.s.008; Arpino G, 2005, JNCI-J NATL CANCER I, V97, P1254, DOI 10.1093/jnci/dji249; Barrager E, 2002, J ALTERN COMPLEM MED, V8, P167, DOI 10.1089/107555302317371451; Battle T. E., 2002, Current Molecular Medicine (Hilversum), V2, P381, DOI 10.2174/1566524023362456; BEILKE MA, 1987, J LAB CLIN MED, V110, P91; Bernaciak TM, 2009, BREAST CANCER RES, V11, DOI 10.1186/bcr2341; BLACK R, 1983, CLIN ONCOL, V9, P311; Buettner R, 2002, CLIN CANCER RES, V8, P945; Caron JM, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0011788; Chapman RS, 2000, ADV EXP MED BIOL, V480, P129; Chen JQ, 2009, BBA-REV CANCER, V1796, P162, DOI 10.1016/j.bbcan.2009.06.003; CHILDS SJ, 1994, UROL CLIN N AM, V21, P85; Dabrosin C, 2003, INT J CANCER, V107, P535, DOI 10.1002/ijc.11398; Dolled-Filhart M, 2003, CLIN CANCER RES, V9, P594; Engelke UFH, 2005, NMR BIOMED, V18, P331, DOI 10.1002/nbm.966; Ferrara N, 2003, NAT MED, V9, P669, DOI 10.1038/nm0603-669; Ferreira ACS, 2003, J AGR FOOD CHEM, V51, P727, DOI 10.1021/jf025934g; Fisher BJ, 1998, INT J RADIAT ONCOL, V42, P117, DOI 10.1016/S0360-3016(98)00177-1; Fowler AM, 2007, BREAST CANCER RES, V9, DOI 10.1186/bcr1748; Gluz O, 2009, ANN ONCOL, V20, P1913, DOI 10.1093/annonc/mdp492; Graham JD, 2000, J STEROID BIOCHEM, V74, P255, DOI 10.1016/S0960-0760(00)00101-1; Hopp TA, 2004, CLIN CANCER RES, V10, P2751, DOI 10.1158/1078-0432.CCR-03-0141; Horvath K, 2002, FOOD CHEM TOXICOL, V40, P1459, DOI 10.1016/S0278-6915(02)00086-8; Hwang PH, 2005, EXP MOL MED, V37, P391, DOI 10.1038/emm.2005.49; Ismail-Khan R, 2010, CANCER CONTROL, V17, P173, DOI 10.1177/107327481001700305; Jacob SW, 2003, MSM DEFINITIVE GUIDE, P107; Joung YH, 2005, EXP MOL MED, V37, P353, DOI 10.1038/emm.2005.45; Joung YH, 2008, INT J ONCOL, V33, P477, DOI 10.3892/ijo_00000030; Joung YH, 2007, BIOCHEM BIOPH RES CO, V358, P733, DOI 10.1016/j.bbrc.2007.04.201; Jung JE, 2005, FASEB J, V19, P1296, DOI 10.1096/fj.04-3099fje; KASTNER P, 1990, EMBO J, V9, P1603, DOI 10.1002/j.1460-2075.1990.tb08280.x; Kim LS, 2006, OSTEOARTHR CARTILAGE, V14, P286, DOI 10.1016/j.joca.2005.10.003; Kimura H, 2001, J BIOL CHEM, V276, P2292, DOI 10.1074/jbc.M008398200; Klagsbrun Michael, 1996, Cytokine and Growth Factor Reviews, V7, P259, DOI 10.1016/S1359-6101(96)00027-5; KRAUS WL, 1993, ENDOCRINOLOGY, V132, P2371, DOI 10.1210/en.132.6.2371; Lim EJ, 2010, INT J ONCOL, V36, P1243, DOI 10.3892/ijo_00000608; Liu XW, 1997, GENE DEV, V11, P179, DOI 10.1101/gad.11.2.179; LYDON JP, 1995, GENE DEV, V9, P2266, DOI 10.1101/gad.9.18.2266; Matsumoto T, 2001, Sci STKE, V2001, pre21, DOI 10.1126/stke.2001.112.re21; Mitsiades CS, 2004, CANCER CELL, V5, P221, DOI 10.1016/S1535-6108(04)00050-9; Moasser MM, 2007, ONCOGENE, V26, P6469, DOI 10.1038/sj.onc.1210477; MORTON JI, 1986, P SOC EXP BIOL MED, V183, P227; Nahta R, 2005, CANCER RES, V65, P11118, DOI 10.1158/0008-5472.CAN-04-3841; Niu GL, 2002, ONCOGENE, V21, P2000, DOI 10.1038/sj.onc.1205260; Park SH, 2001, MOL ENDOCRINOL, V15, P2157, DOI 10.1210/me.15.12.2157; Podo F, 2010, MOL ONCOL, V4, P209, DOI 10.1016/j.molonc.2010.04.006; RAVDIN PM, 1992, J CLIN ONCOL, V10, P1284, DOI 10.1200/JCO.1992.10.8.1284; Rose SE, 2000, MAGN RESON IMAGING, V18, P95, DOI 10.1016/S0730-725X(99)00110-1; SLAMON DJ, 1987, SCIENCE, V235, P177, DOI 10.1126/science.3798106; Tian XB, 2007, J NUCL MED, V48, P1699, DOI 10.2967/jnumed.107.042499; Tweardy D, 2011, J CLIN ONCOL, V29, P2443, DOI 10.1200/JCO.2010.34.2014; Weaver AM, 2007, BREAST CANCER RES, V9, DOI 10.1186/bcr1794; Werner H, 1996, P NATL ACAD SCI USA, V93, P8318, DOI 10.1073/pnas.93.16.8318; Yamashita H, 2004, CANCER SCI, V95, P662, DOI 10.1111/j.1349-7006.2004.tb03326.x; Yarden Y, 2001, NAT REV MOL CELL BIO, V2, P127, DOI 10.1038/35052073; Yi HK, 2001, EUR J CANCER, V37, P2257, DOI 10.1016/S0959-8049(01)00269-6; ZHANG HJ, 1984, BREAST CANCER RES TR, V4, P221, DOI 10.1007/BF01806488	57	53	54	0	17	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 2	2012	7	4							e33361	10.1371/journal.pone.0033361	http://dx.doi.org/10.1371/journal.pone.0033361			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	952GU	22485142	Green Published, Green Submitted, gold			2022-12-25	WOS:000304780500018
J	Martin, LJ; Kissebah, AH; Olivier, M				Martin, Lisa J.; Kissebah, Ahmed H.; Olivier, Michael			Accounting for a Quantitative Trait Locus for Plasma Triglyceride Levels: Utilization of Variants in Multiple Genes	PLOS ONE			English	Article							HOLT-ORAM-SYNDROME; GENOME-WIDE SCAN; CHOLESTEROL LEVELS; NUCLEAR FAMILIES; COMBINED LINKAGE; TBX5 MUTATIONS; ASSOCIATION; OBESITY; PHENOTYPES; GENETICS	Background: For decades, research efforts have tried to uncover the underlying genetic basis of human susceptibility to a variety of diseases. Linkage studies have resulted in highly replicated findings and helped identify quantitative trait loci (QTL) for many complex traits; however identification of specific alleles accounting for linkage remains elusive. The purpose of this study was to determine whether with a sufficient number of variants a linkage signal can be fully explained. Method: We used comprehensive fine-mapping using a dense set of single nucleotide polymorphisms (SNPs) across the entire quantitative trait locus (QTL) on human chromosome 7q36 linked to plasma triglyceride levels. Analyses included measured genotype and combined linkage association analyses. Results: Screening this linkage region, we found an over representation of nominally significant associations in five genes (MLL3, DPP6, PAXIP1, HTR5A, INSIG1). However, no single genetic variant was sufficient to account for the linkage. On the other hand, multiple variants capturing the variation in these five genes did account for the linkage at this locus. Permutation analyses suggested that this reduction in LOD score was unlikely to have occurred by chance (p=0.008). Discussion: With recent findings, it has become clear that most complex traits are influenced by a large number of genetic variants each contributing only a small percentage to the overall phenotype. We found that with a sufficient number of variants, the linkage can be fully explained. The results from this analysis suggest that perhaps the failure to identify causal variants for linkage peaks may be due to multiple variants under the linkage peak with small individual effect, rather than a single variant of large effect.	[Martin, Lisa J.] Cincinnati Childrens Hosp Med Ctr, Div Human Genet, Cincinnati, OH USA; [Martin, Lisa J.] Univ Cincinnati, Dept Pediat, Sch Med, Cincinnati, OH 45221 USA; [Martin, Lisa J.] Cincinnati Childrens Hosp Med Ctr, Div Biostat & Epidemiol, Cincinnati, OH USA; [Kissebah, Ahmed H.; Olivier, Michael] Med Coll Wisconsin, Human & Mol Genet Ctr, Milwaukee, WI 53226 USA; [Kissebah, Ahmed H.] Med Coll Wisconsin, Dept Med, Milwaukee, WI 53226 USA; [Olivier, Michael] Med Coll Wisconsin, Biotechnol & Bioengn Ctr, Milwaukee, WI 53226 USA; [Olivier, Michael] Med Coll Wisconsin, Dept Physiol, Milwaukee, WI 53226 USA	Cincinnati Children's Hospital Medical Center; University of Cincinnati; Cincinnati Children's Hospital Medical Center; Medical College of Wisconsin; Medical College of Wisconsin; Medical College of Wisconsin; Medical College of Wisconsin	Martin, LJ (corresponding author), Cincinnati Childrens Hosp Med Ctr, Div Human Genet, Cincinnati, OH USA.	Lisa.martin@cchmc.org	Martin, Lisa/E-2425-2016	Martin, Lisa/0000-0001-8702-9946	Take Off Pounds Sensibly organization;  [R01 HL74168];  [R01 DK071895]; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL074168] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK071895] Funding Source: NIH RePORTER	Take Off Pounds Sensibly organization; ; ; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	The Take Off Pounds Sensibly organization provided financial support. This work was supported in part by R01 HL74168 (MO) and R01 DK071895 (AHK). No additional external funding was received for this study. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Almasy L, 2004, BEHAV GENET, V34, P173, DOI 10.1023/B:BEGE.0000013731.03827.69; Almasy L, 1998, AM J HUM GENET, V62, P1198, DOI 10.1086/301844; Banas SM, 2009, CELL MOL NEUROBIOL, V29, P157, DOI 10.1007/s10571-008-9307-9; Barrett JC, 2005, BIOINFORMATICS, V21, P263, DOI 10.1093/bioinformatics/bth457; Boes E, 2009, EXP GERONTOL, V44, P136, DOI 10.1016/j.exger.2008.11.003; Carlton VEH, 2005, AM J HUM GENET, V77, P567, DOI 10.1086/468189; Cecil JE, 2005, DIABETOLOGIA, V48, P1496, DOI 10.1007/s00125-005-1817-0; Chen DL, 1999, J LIPID RES, V40, P1735; Chen MH, 2010, HUM HERED, V69, P104, DOI 10.1159/000264448; Cho YW, 2009, CELL METAB, V10, P27, DOI 10.1016/j.cmet.2009.05.010; Chung RH, 2007, GENET EPIDEMIOL, V31, P134, DOI 10.1002/gepi.20196; Das SK, 2004, DIABETES, V53, P3300, DOI 10.2337/diabetes.53.12.3300; Debeer P, 2007, CLIN ORTHOP RELAT R, P20, DOI 10.1097/BLO.0b013e3181123ffe; Dehghan A, 2011, CIRCULATION, V123, P731, DOI 10.1161/CIRCULATIONAHA.110.948570; Dong XY, 2010, PEPTIDES, V31, P2145, DOI 10.1016/j.peptides.2010.07.020; Duggirala R, 2000, AM J HUM GENET, V66, P1237, DOI 10.1086/302849; Ehret GB, 2009, EUR J HUM GENET, V17, P1650, DOI 10.1038/ejhg.2009.94; Elbein SC, 2009, DIABETES, V58, P268, DOI 10.2337/db08-0931; Falconer D. S., 1989, Introduction to quantitative genetics.; Fan RZ, 2003, EUR J HUM GENET, V11, P125, DOI 10.1038/sj.ejhg.5200941; Florez JC, 2008, J CLIN ENDOCR METAB, V93, P4633, DOI 10.1210/jc.2008-1345; Frazer KA, 2009, NAT REV GENET, V10, P241, DOI 10.1038/nrg2554; Fulker DW, 1999, AM J HUM GENET, V64, P259, DOI 10.1086/302193; Hebebrand J, 2010, OBESITY FACTS, V3, P294, DOI 10.1159/000321537; Hinney A, 2010, EUR CHILD ADOLES PSY, V19, P297, DOI 10.1007/s00787-010-0096-6; Kaulin YA, 2009, J NEUROSCI, V29, P3242, DOI 10.1523/JNEUROSCI.4767-08.2009; Kissebah AH, 2000, P NATL ACAD SCI USA, V97, P14478, DOI 10.1073/pnas.97.26.14478; Lee J, 2008, P NATL ACAD SCI USA, V105, P19229, DOI 10.1073/pnas.0810100105; Levin AM, 2008, CANCER RES, V68, P6492, DOI 10.1158/0008-5472.CAN-08-0348; Li WD, 2005, J LIPID RES, V46, P432, DOI 10.1194/jlr.M400391-JLR200; Lillioja S, 2009, DIABETOLOGIA, V52, P1061, DOI 10.1007/s00125-009-1324-9; Lin JP, 2003, BMC GENET, V4, DOI 10.1186/1471-2156-4-S1-S47; Lommatzsch ST, 2009, SEMIN RESP CRIT CARE, V30, P531, DOI 10.1055/s-0029-1238911; Love-Gregory L, 2007, CURR OPIN CLIN NUTR, V10, P397, DOI 10.1097/MCO.0b013e3281e3888d; Marx J, 2002, SCIENCE, V296, P686, DOI 10.1126/science.296.5568.686; McCarthy S, 2005, HUM GENET, V117, P545, DOI 10.1007/s00439-005-1328-6; Mori AD, 2004, CURR OPIN CARDIOL, V19, P211, DOI 10.1097/00001573-200405000-00004; Nadin BM, 2010, J NEUROSCI, V30, P8551, DOI 10.1523/JNEUROSCI.5489-09.2010; Pullinger Clive R, 2003, Expert Rev Cardiovasc Ther, V1, P107, DOI 10.1586/14779072.1.1.107; Shearman AM, 2000, HUM MOL GENET, V9, P1315, DOI 10.1093/hmg/9.9.1315; Siegmund KD, 2001, GENET EPIDEMIOL, V21, pS358, DOI 10.1002/gepi.2001.21.s1.s358; Smith EM, 2010, J LIPID RES, V51, P701, DOI 10.1194/jlr.M001404; Sonnenberg GE, 2004, J LIPID RES, V45, P610, DOI 10.1194/jlr.M300474-JLR200; Sun X, 2011, AM J PHYSL GASTROINT; Teslovich TM, 2010, NATURE, V466, P707, DOI 10.1038/nature09270; The International HapMap Consortium, 2005, NATURE, V437, P1299, DOI DOI 10.1038/NATURE04226; Zhang Y, 2010, PHYSL GENOMICS	47	2	2	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 2	2012	7	4							e34614	10.1371/journal.pone.0034614	http://dx.doi.org/10.1371/journal.pone.0034614			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	952GU	22485179	Green Published, Green Submitted, gold			2022-12-25	WOS:000304780500054
J	Sandoval-Comte, A; Pineda, E; Aguilar-Lopez, JL				Sandoval-Comte, Adriana; Pineda, Eduardo; Aguilar-Lopez, Jose L.			In Search of Critically Endangered Species: The Current Situation of Two Tiny Salamander Species in the Neotropical Mountains of Mexico	PLOS ONE			English	Article							PLETHODONTID SALAMANDERS; POPULATIONS; DECLINES; CONSERVATION; TRENDS; TOOL	Worldwide, one in every three species of amphibian is endangered, 39 species have gone extinct in the last 500 years and another 130 species are suspected to have gone extinct in recent decades. Of the amphibians, salamanders have the highest portion of their species in one of the risk categories, even higher than the frogs. To date there have been few studies that have used recent field data to examine the status of populations of endangered salamanders. In this study we evaluate the current situation of two tiny salamanders, Parvimolge townsendi and Thorius pennatulus, both of which are distributed at intermediate elevations in the mountains of the northern Neotropics and are considered to be critically endangered; the first has been proposed as possibly extinct. By carrying out exhaustive surveys in both historical and potentially suitable sites for these two species, we evaluated their abundance and the characteristics of their habitats, and estimated their potential geographic distribution. We visited 22 sites, investing 672 person-hours of sampling effort in he surveys, and found 201 P. townsendi salamanders in 11 sites and only 13 T. pennatulus salamanders in 5 sites. Both species were preferentially found in cloud forest fragments that were well conserved or only moderately transformed, and some of the salamanders were found in shade coffee plantations. The potential distribution area of both species is markedly fragmented and we estimate that it has decreased by more than 48%. The results of this study highlight the importance of carrying out exhaustive, systematic field surveys to obtain accurate information about the current situation of critically endangered species, and help us better understand the crisis that amphibians are facing worldwide.	[Sandoval-Comte, Adriana; Pineda, Eduardo; Aguilar-Lopez, Jose L.] AC, Inst Ecol, Xalapa, Veracruz, Mexico	Instituto de Ecologia - Mexico	Sandoval-Comte, A (corresponding author), AC, Inst Ecol, Xalapa, Veracruz, Mexico.	eduardo.pineda@inecol.edu.mx	Pineda, Eduardo/N-5254-2014; Sandoval-Comte, Adriana/R-4575-2018	Pineda, Eduardo/0000-0002-1997-9576; Sandoval-Comte, Adriana/0000-0002-2265-465X	CONACyT (Consejo Nacional de Ciencia y Tecnologia) [336197, 23588]; CONABIO (Comision Nacional para el Conocimiento y Uso de la Biodiversidad) [HK006]; INECOL	CONACyT (Consejo Nacional de Ciencia y Tecnologia)(Consejo Nacional de Ciencia y Tecnologia (CONACyT)); CONABIO (Comision Nacional para el Conocimiento y Uso de la Biodiversidad); INECOL	Adriana Sandoval-Comte was supported by CONACyT (Consejo Nacional de Ciencia y Tecnologia) (grant 336197). Fondo SEMARNAT-CONACyT (project 23588) and CONABIO (Comision Nacional para el Conocimiento y Uso de la Biodiversidad) (project HK006) provided support for this research. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; We gratefully acknowledge the contributions of Octavio Rojas-Soto, Luis Canseco-Marquez and Sean M. Rovito who made valuable comments on this study. Rene. Murrieta, Matthias Ros and Jose Manuel Serrano provided the geographic references for some of the specimens collected. Flor Vazquez, Carolina Madero, Antonio Vazquez, Policarpo Ronzon, Luis Carrillo, Nelson Ceron, Ricardo Luria and all who helped with the field work. Roberto Monroy provided advice on editing the maps. Bianca Delfosse translated the text of the manuscript from the original in Spanish and offered valuable suggestions, and one anonymous reviewer offered comments that improved the manuscript. The owners of several properties (Finca Kassandra, Rancho Alamor, Rancho San Gabriel, Granja Avicola Los Naranjos and Rancho La Mesa) kindly allowed us to sample on their land. To the Graduate Studies program of the INECOL for support provided.	[Anonymous], 2004, STATISTICA VERS 7 DA; Ash AN, 1997, CONSERV BIOL, V11, P983, DOI 10.1046/j.1523-1739.1997.96172.x; Bailey LL, 2004, ECOL APPL, V14, P692, DOI 10.1890/03-5012; Canseco-MuYrquez L., 2006, INVENTARIOS HERPETOF, P180; Castillo-Campos G, 2011, BIODIVERSIDAD ESTADO, P159; Cheng TL, 2011, P NATL ACAD SCI USA, V108, P9502, DOI 10.1073/pnas.1105538108; Conservation International, 2011, GLOB SEARCH LOST FRO; COPE ED, 1869, P ACAD NAT SCI PHILA, V21, P93; Dunn E. R., 1922, Proceedings of the Biological Society of Washington, V35, P5; ESRI, 1998, AREVIEW GIS VERS 3 2; Frias-Alvarez P, 2010, BIODIVERS CONSERV, V19, P3699, DOI 10.1007/s10531-010-9923-9; Frost DR, 2011, AMPHIBIAN SPECIES WO; Hanken J, 1998, COPEIA, P312; Herbeck LA, 1999, CONSERV BIOL, V13, P623, DOI 10.1046/j.1523-1739.1999.98097.x; Hijmans R.J., WORLDCLIM; IUCN, 2019, IUCN RED LIST THREAT; Korhonen L, 2006, SILVA FENN, V40, P577, DOI 10.14214/sf.315; Lips KR, 2006, P NATL ACAD SCI USA, V103, P3165, DOI 10.1073/pnas.0506889103; Martinez-Gordillo D, 2010, J EVOLUTION BIOL, V23, P259, DOI 10.1111/j.1420-9101.2009.01897.x; Murrieta-Galindo R, 2007, DIVERSIDAD ANFIBIOS; Ochoa-Ochoa L, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0006878; Ochoa-Ochoa LM, 2011, BIOL CONSERV, V144, P2710, DOI 10.1016/j.biocon.2011.07.032; Papenfuss TJ, 2010, FROGLOG, V93, P1; Parra-Olea G, 1999, REV BIOL TROP, V47, P217; Parra-Olea G, 2008, THORIUS PENNATULUS, V2008; Parra-Olea G, 2008, PARVIMOLGE TOWNSENDI; PECHMANN JHK, 1991, SCIENCE, V253, P892, DOI 10.1126/science.253.5022.892; Phillips S.J., 2004, P 21 INT C MACH LEAR, P655, DOI [DOI 10.1145/1015330.1015412, 10.1145/1015330.1015412]; Raffaclli J, 2007, URODELES MONDE; Rasband W., 2006, IMAGEJ; Rojas-Soto OR, 2008, J FIELD ORNITHOL, V79, P245, DOI 10.1111/j.1557-9263.2008.00170.x; Rovito SM, 2009, P NATL ACAD SCI USA, V106, P3231, DOI 10.1073/pnas.0813051106; Scheffers BR, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0022531; SEDESMA, 2006, PROGR MAN AR NAT MAR; SEMARNAT (Secretaria del Medio Ambiente y Recursos Naturales), 2010, NORM OF MEX NOM 059; Stuart S. N., 2008, THREATENED AMPHIBIAN; Stuart SN, 2004, SCIENCE, V306, P1783, DOI 10.1126/science.1103538; Wake D.B., 1976, NAT HIST MUS LOS ANG, V25, P1; Wake David B., 1992, Tulane Studies in Zoology and Botany Supplementary Publication, V1, P303; WAKE DB, 1987, ANN MO BOT GARD, V74, P242, DOI 10.2307/2399397; Welsh HH, 2001, CONSERV BIOL, V15, P558, DOI 10.1046/j.1523-1739.2001.015003558.x; Whitfield SM, 2007, P NATL ACAD SCI USA, V104, P8352, DOI 10.1073/pnas.0611256104; Zar JH., 1999, BIOL STAT	43	11	13	0	15	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 2	2012	7	4							e34023	10.1371/journal.pone.0034023	http://dx.doi.org/10.1371/journal.pone.0034023			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	952GU	22485155	Green Published, Green Submitted, gold			2022-12-25	WOS:000304780500031
J	Kossenkov, AV; Dawany, N; Evans, TL; Kucharczuk, JC; Albelda, SM; Showe, LC; Showe, MK; Vachani, A				Kossenkov, Andrew V.; Dawany, Noor; Evans, Tracey L.; Kucharczuk, John C.; Albelda, Steven M.; Showe, Louise C.; Showe, Michael K.; Vachani, Anil			Peripheral Immune Cell Gene Expression Predicts Survival of Patients with Non-Small Cell Lung Cancer	PLOS ONE			English	Article							MICRORNA SIGNATURES; CXCR4 EXPRESSION; SUPPRESSOR-CELLS; BLOOD; NEUTROPHILS; SYSTEM; STAGE	Prediction of cancer recurrence in patients with non-small cell lung cancer (NSCLC) currently relies on the assessment of clinical characteristics including age, tumor stage, and smoking history. A better prediction of early stage cancer patients with poorer survival and late stage patients with better survival is needed to design patient-tailored treatment protocols. We analyzed gene expression in RNA from peripheral blood mononuclear cells (PBMC) of NSCLC patients to identify signatures predictive of overall patient survival. We find that PBMC gene expression patterns from NSCLC patients, like patterns from tumors, have information predictive of patient outcomes. We identify and validate a 26 gene prognostic panel that is independent of clinical stage. Many additional prognostic genes are specific to myeloid cells and are more highly expressed in patients with shorter survival. We also observe that significant numbers of prognostic genes change expression levels in PBMC collected after tumor resection. These post-surgery gene expression profiles may provide a means to re-evaluate prognosis over time. These studies further suggest that patient outcomes are not solely determined by tumor gene expression profiles but can also be influenced by the immune response as reflected in peripheral immune cells.	[Kossenkov, Andrew V.; Dawany, Noor; Showe, Louise C.; Showe, Michael K.] Wistar Inst Anat & Biol, Philadelphia, PA USA; [Evans, Tracey L.] Univ Penn, Sch Med, Dept Med, Div Hematol Oncol, Philadelphia, PA 19104 USA; [Kucharczuk, John C.] Univ Penn, Sch Med, Dept Surg, Div Thorac Surg, Philadelphia, PA 19104 USA; [Albelda, Steven M.; Vachani, Anil] Univ Penn, Sch Med, Dept Med, Div Pulm Allergy & Crit Care Med, Philadelphia, PA 19104 USA	The Wistar Institute; University of Pennsylvania; University of Pennsylvania; University of Pennsylvania	Kossenkov, AV (corresponding author), Wistar Inst Anat & Biol, Philadelphia, PA USA.	lshowe@wistar.org			Pennsylvania Department of Health [SAP 4100020718]; Wistar Cancer Center [P30 CA010815]; National Institutes of Health [K07 CA111952, T32 CA 09171]; NATIONAL CANCER INSTITUTE [T32CA009171, K07CA111952, P30CA010815] Funding Source: NIH RePORTER; NATIONAL CENTER FOR RESEARCH RESOURCES [S10RR024693] Funding Source: NIH RePORTER	Pennsylvania Department of Health; Wistar Cancer Center; National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR))	This work was supported by Pennsylvania Department of Health Tobacco Settlement grant (SAP 4100020718); the Pennsylvania Department of Health Commonwealth Universal Research Enhancement Program; the Wistar Cancer Center Support Grant (P30 CA010815); National Institutes of Health (K07 CA111952) to A. V. and (T32 CA 09171) to A. V. K. The project used the Wistar Institute Genomics and Bioinformatics facilities supported by the Wistar Cancer Center Support Grant (P30 CA010815). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abbas AR, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0006098; Abbas AR, 2005, GENES IMMUN, V6, P319, DOI 10.1038/sj.gene.6364173; ACS, 2010, CANC FACTS FIG 2010; Boeri M, 2011, P NATL ACAD SCI USA, V108, P3713, DOI 10.1073/pnas.1100048108; Chen AL, 2008, BIOTECHNOL LETT, V30, P2045, DOI 10.1007/s10529-008-9800-8; Chen G, 2011, WORLD J SURG, V35, P56, DOI 10.1007/s00268-010-0784-x; Diaz-Montero CM, 2009, CANCER IMMUNOL IMMUN, V58, P49, DOI 10.1007/s00262-008-0523-4; Dubey S, 2008, AM J RESP CRIT CARE, V177, P941, DOI 10.1164/rccm.200801-107UP; Gabrilovich DI, 2009, NAT REV IMMUNOL, V9, P162, DOI 10.1038/nri2506; Goeman JJ, 2010, BIOMETRICAL J, V52, P70, DOI 10.1002/bimj.200900028; GONEN M, 2005, CONCORDANCE PROBABIL; Gregory AD, 2011, CANCER RES, V71, P2411, DOI 10.1158/0008-5472.CAN-10-2583; Hu ZB, 2010, J CLIN ONCOL, V28, P1721, DOI 10.1200/JCO.2009.24.9342; Huang DW, 2009, NUCLEIC ACIDS RES, V37, P1, DOI 10.1093/nar/gkn923; Jemal A, 2005, JAMA-J AM MED ASSOC, V294, P1255, DOI 10.1001/jama.294.10.1255; Kadara H, 2011, CLIN CANCER RES, V17, P1490, DOI 10.1158/1078-0432.CCR-10-2703; Kossenkov AV, 2011, CLIN CANC RES; Le QT, 2006, CLIN CANCER RES, V12, P1507, DOI 10.1158/1078-0432.CCR-05-2049; Leone V, 2011, J CLIN ENDOCRINOL ME; Mootha VK, 2003, NAT GENET, V34, P267, DOI 10.1038/ng1180; Pardoll D, 2003, ANNU REV IMMUNOL, V21, P807, DOI 10.1146/annurev.immunol.21.120601.141135; Schmielau J, 2001, CANCER RES, V61, P4756; Shen J, 2011, LAB INVEST, V91, P579, DOI 10.1038/labinvest.2010.194; Showe MK, 2009, CANCER RES, V69, P9202, DOI 10.1158/0008-5472.CAN-09-1378; Stachon A, 2001, CLIN CHEM LAB MED, V39, P239, DOI 10.1515/CCLM.2001.038; Storey John D, 2003, Methods Mol Biol, V224, P149; Subramanian A, 2005, P NATL ACAD SCI USA, V102, P15545, DOI 10.1073/pnas.0506580102; Subramanian J, 2010, JNCI-J NATL CANCER I, V102, P464, DOI 10.1093/jnci/djq025; Trellakis S, 2011, INT J CA; van den Akker E, 2010, HAEMATOL-HEMATOL J, V95, P1594, DOI 10.3324/haematol.2009.019828; Varlotto J, 2005, INT J RADIAT ONCOL, V63, P25, DOI 10.1016/j.ijrobp.2005.04.049; Yamada M, 2011, CELL MOL IMMUNOL, V8, P305, DOI 10.1038/cmi.2011.8	32	20	21	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 29	2012	7	3							e34392	10.1371/journal.pone.0034392	http://dx.doi.org/10.1371/journal.pone.0034392			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	948SR	22479623	gold, Green Submitted, Green Published			2022-12-25	WOS:000304523400081
J	Thornton, E; Vink, R				Thornton, Emma; Vink, Robert			Treatment with a Substance P Receptor Antagonist Is Neuroprotective in the Intrastriatal 6-Hydroxydopamine Model of Early Parkinson's Disease	PLOS ONE			English	Article							NEUROKININ-3 RECEPTORS; BASAL GANGLIA; IN-VIVO; MICROGLIAL ACTIVATION; FUNCTIONAL DEFICITS; OXIDATIVE STRESS; DOPAMINE; DEGENERATION; ASTROCYTES; NIGRA	Neuroinflammation and blood brain barrier (BBB) dysfunction have been implicated in the pathogenesis of Parkinson's disease (PD). The neuropeptide substance P (SP) is an important mediator of both neuroinflammation and BBB dysfunction through its NK1 receptor in a process known as neurogenic inflammation. Increased SP content has previously been reported following 6-OHDA treatment in vitro, with the levels of SP correlating with cell death. The present study used an in vivo 6-OHDA lesion model to determine if dopaminergic degeneration was associated with increased SP in the substantia nigra and whether this degeneration could be prevented by using a SP, NK1 receptor antagonist Unilateral, intrastriatal 6-OHDA lesions were induced and SP (10 mu g/2 mu L) or the NK1 receptor antagonists, N-acetyl-L-tryptophan (2 mu L at 50 nM) or L-333,060 (2 mu L at 100 nM), administered immediately after the neurotoxin. Nigral SP content was then determined using immunohistochemical and ELISA methods, neuroinflammation and barrier integrity was assessed using Iba-1, ED-1, GFAP and albumin immunohistochemistry, while dopaminergic cell loss was assessed with tyrosine hydroxylase immunohistochemistry. Motor function in all animals was assessed using the rotarod task. Intrastriatal 6-OHDA lesioning produced an early and sustained increase in ipsilateral nigral SP content, along with a breakdown of the BBB and activation of microglia and astrocytes. Further exacerbation of SP levels accelerated disease progression, whereas NK1 receptor antagonist treatment protected dopaminergic neurons, preserved barrier integrity, reduced neuroinflammation and significantly improved motor function. We propose that neurogenic inflammation contributes to dopaminergic degeneration in early experimental PD and demonstrate that an NK1 receptor antagonist may represent a novel neuroprotective therapy.	[Thornton, Emma; Vink, Robert] Univ Adelaide, Sch Med Sci, Adelaide Ctr Neurosci Res, Adelaide, SA, Australia	University of Adelaide	Thornton, E (corresponding author), Univ Adelaide, Sch Med Sci, Adelaide Ctr Neurosci Res, Adelaide, SA, Australia.	Robert.Vink@adelaide.edu.au	Vink, Robert/S-5616-2019; Vink, Robert/J-7351-2012; Emery, Kitty/B-5850-2011; Speller, Camilla/D-2830-2014	Vink, Robert/0000-0002-4885-0667; Vink, Robert/0000-0002-4885-0667; Emery, Kitty/0000-0002-4031-1968; Speller, Camilla/0000-0001-7128-9903	Neurosurgical Research Foundation, Adelaide, Australia	Neurosurgical Research Foundation, Adelaide, Australia	This study was funded, in part, by the Neurosurgical Research Foundation, Adelaide, Australia. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript. No additional external funding received for this study.	Alves G, 2008, J NEUROL, V255, P18, DOI 10.1007/s00415-008-5004-3; BANNON MJ, 1995, BRAIN RES, V695, P19, DOI 10.1016/0006-8993(95)00791-N; Bartels AL, 2008, J NEURAL TRANSM, V115, P1001, DOI 10.1007/s00702-008-0030-y; BEAL MF, 1992, FASEB J, V6, P3338, DOI 10.1096/fasebj.6.15.1464368; Bevan MD, 1996, NEUROSCIENCE, V75, P5, DOI 10.1016/0306-4522(96)00377-6; Bishop C, 2004, BRAIN RES, V1023, P126, DOI 10.1016/j.brainres.2004.07.039; Block ML, 2006, FASEB J, V20, P251, DOI 10.1096/fj.05-4553com; Blum D, 2001, PROG NEUROBIOL, V65, P135, DOI 10.1016/S0301-0082(01)00003-X; Brahmachari S, 2006, J NEUROSCI, V26, P4930, DOI 10.1523/JNEUROSCI.5480-05.2006; Brochard V, 2009, J CLIN INVEST, V119, P182, DOI 10.1172/JCI36470; Carson MJ, 2006, CLIN NEUROSCI RES, V6, P237, DOI 10.1016/j.cnr.2006.09.004; Chen LW, 2004, CURR DRUG TARGETS, V5, P197, DOI 10.2174/1389450043490596; Chung YC, 2010, BMB REP, V43, P225, DOI 10.5483/BMBRep.2010.43.4.225; De Ceballos ML, 1999, PEPTIDES, V20, P249, DOI 10.1016/S0196-9781(98)00177-6; Depino AM, 2003, EUR J NEUROSCI, V18, P2731, DOI 10.1111/j.1460-9568.2003.03014.x; Deumens R, 2002, EXP NEUROL, V175, P303, DOI 10.1006/exnr.2002.7891; Donkin JJ, 2009, J CEREBR BLOOD F MET, V29, P1388, DOI 10.1038/jcbfm.2009.63; FERNANDEZ A, 1994, NEUROSCIENCE, V61, P73, DOI 10.1016/0306-4522(94)90061-2; Gao HM, 2002, J NEUROCHEM, V81, P1285, DOI 10.1046/j.1471-4159.2002.00928.x; HAMM RJ, 1994, J NEUROTRAUM, V11, P187, DOI 10.1089/neu.1994.11.187; Harrison S, 2001, INT J BIOCHEM CELL B, V33, P555, DOI 10.1016/S1357-2725(01)00031-0; Helps SC, 2012, APPL IMMUNOHISTO M M, V20, P82, DOI 10.1097/PAI.0b013e31821fc8cd; Hirsch EC, 2000, J NEUROL, V247, P58, DOI 10.1007/PL00007762; Ionov ID, 2008, INT J NEUROSCI, V118, P1763, DOI 10.1080/00207450802330561; Ji KA, 2008, GLIA, V56, P1039, DOI 10.1002/glia.20677; Kortekaas R, 2005, ANN NEUROL, V57, P176, DOI 10.1002/ana.20369; Lee CS, 1996, NEUROSCIENCE, V72, P641, DOI 10.1016/0306-4522(95)00571-4; Levesque M, 2007, NEUROSCI RES, V57, P362, DOI 10.1016/j.neures.2006.11.002; Lin RCS, 1995, NEUROREPORT, V7, P310, DOI 10.1097/00001756-199512000-00074; Liu B, 2003, J PHARMACOL EXP THER, V304, P1, DOI 10.1124/jpet.102.035048; MANTYH PW, 1989, P NATL ACAD SCI USA, V86, P5193, DOI 10.1073/pnas.86.13.5193; Marriott I, 2004, FRONT BIOSCI-LANDMRK, V9, P2153, DOI 10.2741/1377; Marti M, 2005, J NEUROCHEM, V93, P195, DOI 10.1111/j.1471-4159.2005.03015.x; MAUBORGNE A, 1983, BRAIN RES, V268, P167, DOI 10.1016/0006-8993(83)90403-1; McGeer PL, 2008, MOVEMENT DISORD, V23, P474, DOI 10.1002/mds.21751; Mosley RL, 2006, CLIN NEUROSCI RES, V6, P261, DOI 10.1016/j.cnr.2006.09.006; Nimmo AJ, 2004, NEUROPEPTIDES, V38, P40, DOI 10.1016/j.npep.2003.12.003; NISBET AP, 1995, NEUROSCIENCE, V66, P361, DOI 10.1016/0306-4522(94)00606-6; Ogura T, 2005, NEUROSCI RES, V51, P299, DOI 10.1016/j.neures.2004.12.006; Paxinos G, 1998, RAT BRAIN IN STEREOTAXIC COORDINATES, FOURTH ED., pix; REID MS, 1990, EXP BRAIN RES, V82, P293; Rite I, 2007, J NEUROCHEM, V101, P1567, DOI 10.1111/j.1471-4159.2007.04567.x; Rock RB, 2006, J NEUROIMMUNE PHARM, V1, P117, DOI 10.1007/s11481-006-9012-8; Rodriguez MC, 1998, ANN NEUROL, V44, pS175, DOI 10.1002/ana.410440726; Schwarting RKW, 1996, PROG NEUROBIOL, V49, P215, DOI 10.1016/S0301-0082(96)00015-9; Shults CW, 2004, MITOCHONDRION, V4, P641, DOI 10.1016/j.mito.2004.07.028; SIVAM SP, 1991, NEUROPEPTIDES, V18, P201, DOI 10.1016/0143-4179(91)90148-C; Takagi S, 2007, J NEURAL TRANSM, V114, P1553, DOI 10.1007/s00702-007-0790-9; Teismann P, 2004, CELL TISSUE RES, V318, P149, DOI 10.1007/s00441-004-0944-0; TENOVUO O, 1984, BRAIN RES, V303, P113, DOI 10.1016/0006-8993(84)90217-8; Thornton E, 2010, NEUROSCI LETT, V481, P64, DOI 10.1016/j.neulet.2010.06.057; Turner RJ, 2011, BRAIN RES, V1393, P84, DOI 10.1016/j.brainres.2011.03.066; UKAI M, 1995, PHARMACOL BIOCHEM BE, V51, P705, DOI 10.1016/0091-3057(95)00010-T; Vink R, 2010, NEUROTHERAPEUTICS, V7, P74, DOI 10.1016/j.nurt.2009.10.018; Wojtera M, 2005, FOLIA NEUROPATHOL, V43, P311	56	67	71	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 2	2012	7	4							e34138	10.1371/journal.pone.0034138	http://dx.doi.org/10.1371/journal.pone.0034138			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	952GU	22905156	Green Published, Green Submitted, gold, Green Accepted			2022-12-25	WOS:000304780500034
J	Savory, EA; Zou, C; Adhikari, BN; Hamilton, JP; Buell, CR; Shiu, SH; Day, B				Savory, Elizabeth A.; Zou, Cheng; Adhikari, Bishwo N.; Hamilton, John P.; Buell, C. Robin; Shiu, Shin-Han; Day, Brad			Alternative Splicing of a Multi-Drug Transporter from Pseudoperonospora cubensis Generates an RXLR Effector Protein That Elicits a Rapid Cell Death	PLOS ONE			English	Review							PHYTOPHTHORA-SOJAE; GENOME SEQUENCE; AVIRULENCE; ARABIDOPSIS; EXPRESSION; EVOLUTION; GENES; LOCUS; POLYMORPHISMS; MECHANISMS	Pseudoperonospora cubensis, an obligate oomycete pathogen, is the causal agent of cucurbit downy mildew, a foliar disease of global economic importance. Similar to other oomycete plant pathogens, Ps. cubensis has a suite of RXLR and RXLR-like effector proteins, which likely function as virulence or avirulence determinants during the course of host infection. Using in silico analyses, we identified 271 candidate effector proteins within the Ps. cubensis genome with variable RXLR motifs. In extending this analysis, we present the functional characterization of one Ps. cubensis effector protein, RXLR protein 1 (PscRXLR1), and its closest Phytophthora infestans ortholog, PITG_17484, a member of the Drug/Metabolite Transporter (DMT) superfamily. To assess if such effector-non-effector pairs are common among oomycete plant pathogens, we examined the relationship(s) among putative ortholog pairs in Ps. cubensis and P. infestans. Of 271 predicted Ps. cubensis effector proteins, only 109 (41%) had a putative ortholog in P. infestans and evolutionary rate analysis of these orthologs shows that they are evolving significantly faster than most other genes. We found that PscRXLR1 was up-regulated during the early stages of infection of plants, and, moreover, that heterologous expression of PscRXLR1 in Nicotiana benthamiana elicits a rapid necrosis. More interestingly, we also demonstrate that PscRXLR1 arises as a product of alternative splicing, making this the first example of an alternative splicing event in plant pathogenic oomycetes transforming a non-effector gene to a functional effector protein. Taken together, these data suggest a role for PscRXLR1 in pathogenicity, and, in total, our data provide a basis for comparative analysis of candidate effector proteins and their non-effector orthologs as a means of understanding function and evolutionary history of pathogen effectors.	[Savory, Elizabeth A.; Day, Brad] Michigan State Univ, Dept Plant Pathol, E Lansing, MI 48824 USA; [Zou, Cheng; Adhikari, Bishwo N.; Hamilton, John P.; Buell, C. Robin; Shiu, Shin-Han] Michigan State Univ, Dept Plant Biol, E Lansing, MI 48824 USA	Michigan State University; Michigan State University	Savory, EA (corresponding author), Michigan State Univ, Dept Plant Pathol, E Lansing, MI 48824 USA.	bday@msu.edu	Shiu, Shin-Han/R-6117-2016; Hamilton, John P/G-1379-2016	Shiu, Shin-Han/0000-0001-6470-235X; Hamilton, John P/0000-0002-8682-5526; Buell, C Robin/0000-0002-6727-4677; Adhikari, Bishwo/0000-0003-4840-9609; Savory, Elizabeth/0000-0002-6016-9962; zou, cheng/0000-0001-9325-9465; Day, Brad/0000-0002-9880-4319; Vaillancourt, Brieanne/0000-0002-6795-5173	National Science Foundation [IOS-0641319]; United States Department of Agriculture Agriculture and Food Research Initiative (AFRI)	National Science Foundation(National Science Foundation (NSF)); United States Department of Agriculture Agriculture and Food Research Initiative (AFRI)	Work in the laboratory of BD is supported by a grant from the National Science Foundation (IOS-0641319). EAS is supported by a United States Department of Agriculture Agriculture and Food Research Initiative (AFRI) pre-doctoral fellowship. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Allen RL, 2004, SCIENCE, V306, P1957, DOI 10.1126/science.1104022; Altschul SF, 1997, NUCLEIC ACIDS RES, V25, P3389, DOI 10.1093/nar/25.17.3389; Armstrong MR, 2005, P NATL ACAD SCI USA, V102, P7766, DOI 10.1073/pnas.0500113102; Baxter L, 2010, SCIENCE, V330, P1549, DOI 10.1126/science.1195203; Bendtsen JD, 2004, J MOL BIOL, V340, P783, DOI 10.1016/j.jmb.2004.05.028; Bos JIB, 2006, PLANT J, V48, P165, DOI 10.1111/j.1365-313X.2006.02866.x; Cantarel BL, 2008, GENOME RES, V18, P188, DOI 10.1101/gr.6743907; Chandran D, 2009, PLANT PHYSIOL, V149, P1435, DOI 10.1104/pp.108.132985; Chaparro-Garcia A, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0016608; Chisholm ST, 2006, CELL, V124, P803, DOI 10.1016/j.cell.2006.02.008; Costanzo S, 2007, CURR GENET, V52, P115, DOI 10.1007/s00294-007-0144-z; de Wit PJGM, 2009, MOL PLANT PATHOL, V10, P735, DOI 10.1111/j.1364-3703.2009.00591.x; Dong SM, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0005556; Edgar RC, 2004, NUCLEIC ACIDS RES, V32, P1792, DOI 10.1093/nar/gkh340; Emanuelsson O, 2007, NAT PROTOC, V2, P953, DOI 10.1038/nprot.2007.131; Franke I, 2003, J BACTERIOL, V185, P1161, DOI 10.1128/JB.185.4.1161-1166.2003; Gurlebeck D, 2009, MOL PLANT PATHOL, V10, P175, DOI 10.1111/j.1364-3703.2008.00519.x; Haas BJ, 2009, NATURE, V461, P393, DOI 10.1038/nature08358; Halterman DA, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0010536; Huang SW, 2009, NAT GENET, V41, P1275, DOI 10.1038/ng.475; Jack DL, 2001, EUR J BIOCHEM, V268, P3620, DOI 10.1046/j.1432-1327.2001.02265.x; Jacobs KA, 1997, GENE, V198, P289, DOI 10.1016/S0378-1119(97)00330-2; Jiang RHY, 2008, P NATL ACAD SCI USA, V105, P4874, DOI 10.1073/pnas.0709303105; Jin P, 2003, PLANT PHYSIOL, V133, P1072, DOI 10.1104/pp.103.025999; JONES DT, 1992, COMPUT APPL BIOSCI, V8, P275, DOI 10.1093/bioinformatics/8.3.275; Jones JDG, 2006, NATURE, V444, P323, DOI 10.1038/nature05286; Kamoun S, 2006, ANNU REV PHYTOPATHOL, V44, P41, DOI 10.1146/annurev.phyto.44.070505.143436; Keren H, 2010, NAT REV GENET, V11, P345, DOI 10.1038/nrg2776; Knepper C, 2011, PLANT PHYSIOL, V156, P286, DOI 10.1104/pp.110.169656; Langmead B, 2009, GENOME BIOL, V10, DOI 10.1186/gb-2009-10-3-r25; Larkin MA, 2007, BIOINFORMATICS, V23, P2947, DOI 10.1093/bioinformatics/btm404; Levesque CA, 2010, GENOME BIOL, V11, DOI 10.1186/gb-2010-11-7-r73; Liu TL, 2011, PLANT PHYSIOL, V155, P490, DOI 10.1104/pp.110.166470; Lynch M, 2000, SCIENCE, V290, P1151, DOI 10.1126/science.290.5494.1151; Mansfield JW, 2009, MOL PLANT PATHOL, V10, P721, DOI 10.1111/j.1364-3703.2009.00576.x; Matlin AJ, 2005, NAT REV MOL CELL BIO, V6, P386, DOI 10.1038/nrm1645; Nelson BK, 2007, PLANT J, V51, P1126, DOI 10.1111/j.1365-313X.2007.03212.x; Oh SK, 2009, PLANT CELL, V21, P2928, DOI 10.1105/tpc.109.068247; Quevillon E, 2005, NUCLEIC ACIDS RES, V33, pW116, DOI 10.1093/nar/gki442; Qutob D, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0005066; Rafiqi M, 2010, PLANT CELL, V22, P2017, DOI 10.1105/tpc.109.072983; Rehmany AP, 2005, PLANT CELL, V17, P1839, DOI 10.1105/tpc.105.031807; Salamov AA, 2000, GENOME RES, V10, P516, DOI 10.1101/gr.10.4.516; Savory EA, 2011, MOL PLANT PATHOL, V12, P217, DOI 10.1111/j.1364-3703.2010.00670.x; Schornack S, 2010, P NATL ACAD SCI USA, V107, P17421, DOI 10.1073/pnas.1008491107; Schornack S, 2009, MOL PLANT PATHOL, V10, P795, DOI 10.1111/j.1364-3703.2009.00593.x; Shan LB, 2000, PLANT CELL, V12, P2323, DOI 10.1105/tpc.12.12.2323; Shan WX, 2004, MOL PLANT MICROBE IN, V17, P394, DOI 10.1094/MPMI.2004.17.4.394; Shen DY, 2011, CAN J MICROBIOL, V57, P84, DOI [10.1139/W10-103, 10.1139/w10-103]; Tamura K, 2011, MOL BIOL EVOL, V28, P2731, DOI 10.1093/molbev/msr121; Tang HB, 2008, GENOME RES, V18, P1944, DOI 10.1101/gr.080978.108; Tian MY, 2011, MOL PLANT MICROBE IN, V24, P543, DOI 10.1094/MPMI-08-10-0185; Torto TA, 2003, GENOME RES, V13, P1675, DOI 10.1101/gr.910003; Tyler BM, 2006, SCIENCE, V313, P1261, DOI 10.1126/science.1128796; Whisson SC, 2007, NATURE, V450, P115, DOI 10.1038/nature06203; Win J, 2006, FUNGAL GENET BIOL, V43, P20, DOI 10.1016/j.fgb.2005.10.003; Win J, 2007, PLANT CELL, V19, P2349, DOI 10.1105/tpc.107.051037; Win J, 2011, METHODS MOL BIOL, V712, P181, DOI 10.1007/978-1-61737-998-7_15; Yang ZH, 1997, COMPUT APPL BIOSCI, V13, P555; Zerbino DR, 2008, GENOME RES, V18, P821, DOI 10.1101/gr.074492.107	60	45	46	2	28	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 5	2012	7	4							e34701	10.1371/journal.pone.0034701	http://dx.doi.org/10.1371/journal.pone.0034701			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	955IH	22545137	Green Published, gold, Green Submitted			2022-12-25	WOS:000305010500024
J	Xu, JY; Qi, X; Gong, JF; Yu, MY; Zhang, FX; Sha, HB; Gao, X				Xu, Jingyue; Qi, Xin; Gong, Jianfeng; Yu, Mingyan; Zhang, Fangxiong; Sha, Haibo; Gao, Xiang			Fstl1 Antagonizes BMP Signaling and Regulates Ureter Development	PLOS ONE			English	Article							BONE MORPHOGENETIC PROTEIN-4; URINARY-TRACT DEVELOPMENT; SONIC-HEDGEHOG; CONGENITAL-ANOMALIES; MOUSE URETER; BRANCHING MORPHOGENESIS; PERISTALTIC MACHINERY; VESICOURETERAL REFLUX; KIDNEY DEVELOPMENT; EXPRESSION	Bone morphogenetic protein (BMP) signaling pathway plays important roles in urinary tract development although the detailed regulation of its activity in this process remains unclear. Here we report that follistatiri-like 1 (Fstl1), encoding a secreted extracellular glycoprotein, is expressed in developing ureter and antagonizes BMP signaling activity. Mouse embryos carrying disrupted Fstl1 gene displayed prominent hydroureter arising from proximal segment and tireterovesical junction defects. These defects were associated with significant reduction in ureteric epithelial cell proliferation at E15.5 and E16.5 as well as absence of subepithelial ureteral mesenchymal cells in the urinary tract at E16.5 and E18.5. At the molecular level, increased BMP signaling was found in Fstl1 deficient ureters, indicated by elevated pSmad1/5/8 activity. in vitro study also indicated that Fstl1 can directly bind to ALK6 which is specifically expressed in ureteric epithelial cells in developing ureter. Furthermore, Sonic hedgehog (SHH) signaling, which is crucial for differentiation of ureteral subepithelial cell proliferation, was also impaired in Fstl1(-/-) ureter. Altogether, our data suggest that Fstl1 is essential in maintaining normal ureter development by antagonizing BMP signaling.	[Xu, Jingyue; Qi, Xin; Gong, Jianfeng; Yu, Mingyan; Sha, Haibo; Gao, Xiang] Nanjing Univ, Model Anim Res Ctr, MOE Key Lab Model Anim Dis Study, Nanjing, Jiangsu, Peoples R China; [Gao, Xiang] Wenzhou Med Coll, Sch Life Sci, Zhejiang Prov Key Lab Technol & Applicat Model Or, Wenzhou, Peoples R China; [Zhang, Fangxiong] Chinese Acad Sci, Inst Neurosci, Shanghai Inst Life Sci, Shanghai, Peoples R China	Nanjing University; Wenzhou Medical University; Chinese Academy of Sciences; Shanghai Institutes for Biological Sciences, CAS	Xu, JY (corresponding author), Nanjing Univ, Model Anim Res Ctr, MOE Key Lab Model Anim Dis Study, Nanjing, Jiangsu, Peoples R China.	gaoxiang@nju.edu.cn			MOST (The Ministry of Science and Technology) [2011CB944104, 2011BAI15B02, 2011ZX09307-302-02]; NSFC (The National Science Foundation of China) [30825024]	MOST (The Ministry of Science and Technology); NSFC (The National Science Foundation of China)	This work is supported in part by grants from MOST (The Ministry of Science and Technology) (2011CB944104, 2011BAI15B02, 2011ZX09307-302-02) and NSFC (The National Science Foundation of China) (30825024). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adams D, 2007, GENE EXPR PATTERNS, V7, P491, DOI 10.1016/j.modgep.2006.10.009; Airik R, 2006, J CLIN INVEST, V116, P663, DOI 10.1172/JCI26027; Batourina E, 2005, NAT GENET, V37, P1082, DOI 10.1038/ng1645; Bellusci S, 1996, DEVELOPMENT, V122, P1693; BLESSING M, 1993, GENE DEV, V7, P204, DOI 10.1101/gad.7.2.204; BOBER E, 1994, DEVELOPMENT, V120, P603; Botchkarev VA, 2001, FASEB J, V15, P2205, DOI 10.1096/fj.01-0207com; Bush KT, 2006, DEV BIOL, V298, P571, DOI 10.1016/j.ydbio.2006.07.006; Chang CP, 2004, J CLIN INVEST, V113, P1051, DOI 10.1172/JCI200420049; Chia I, 2011, DEVELOPMENT, V138, P2089, DOI 10.1242/dev.056838; Dal-Pra S, 2006, DEV BIOL, V298, P514, DOI 10.1016/j.ydbio.2006.07.002; Ding J, 2009, ENDOCRINOLOGY, V150, P2136, DOI 10.1210/en.2008-1006; DRESSLER GR, 1990, DEVELOPMENT, V109, P787; DUDLEY AT, 1995, GENE DEV, V9, P2795, DOI 10.1101/gad.9.22.2795; Dudley AT, 1997, DEV DYNAM, V208, P349; Geng Y, 2011, P NATL ACAD SCI USA, V108, P7058, DOI 10.1073/pnas.1007293108; Goodrich LV, 1997, SCIENCE, V277, P1109, DOI 10.1126/science.277.5329.1109; Hambrock HO, 2004, J BIOL CHEM, V279, P11727, DOI 10.1074/jbc.M309318200; Hoshino T, 2008, GENES CELLS, V13, P159, DOI 10.1111/j.1365-2443.2007.01158.x; Hu P, 2000, J CELL BIOL, V151, P961, DOI 10.1083/jcb.151.5.961; Lakso M, 1996, P NATL ACAD SCI USA, V93, P5860, DOI 10.1073/pnas.93.12.5860; Lamm MLG, 2001, DEV BIOL, V232, P301, DOI 10.1006/dbio.2001.0187; Li KC, 2011, NEURON, V69, P974, DOI 10.1016/j.neuron.2011.01.022; Liem KF, 2000, DEVELOPMENT, V127, P4855; LUO G, 1995, GENE DEV, V9, P2808, DOI 10.1101/gad.9.22.2808; Mahoney ZX, 2006, P NATL ACAD SCI USA, V103, P19872, DOI 10.1073/pnas.0609326103; MAURER P, 1995, J MOL BIOL, V253, P347, DOI 10.1006/jmbi.1995.0557; Mendelsohn C, 2004, J CLIN INVEST, V113, P957, DOI 10.1172/JCI21402; Mendelsohn C, 2009, ORGANOGENESIS, V5, P306; Michos O, 2004, DEVELOPMENT, V131, P3401, DOI 10.1242/dev.01251; Michos O, 2007, DEVELOPMENT, V134, P2397, DOI 10.1242/dev.02861; Mitchell EKL, 2006, GENE EXPR PATTERNS, V6, P519, DOI 10.1016/j.modgep.2005.10.008; Miyazaki Y, 1998, J CLIN INVEST, V102, P1489, DOI 10.1172/JCI4401; Miyazaki Y, 2003, PEDIATR INT, V45, P598, DOI 10.1046/j.1442-200X.2003.01777.x; Miyazaki Y, 2003, KIDNEY INT, V63, P835, DOI 10.1046/j.1523-1755.2003.00834.x; Miyazaki Y, 2000, J CLIN INVEST, V105, P863, DOI 10.1172/JCI8256; Monsoro-Burq AH, 2001, MOL CELL, V7, P789, DOI 10.1016/S1097-2765(01)00223-4; Murawski IJ, 2007, AM J PHYSIOL-RENAL, V293, pF1736, DOI 10.1152/ajprenal.00221.2007; Nishimura H, 1999, MOL CELL, V3, P1, DOI 10.1016/S1097-2765(00)80169-0; Okabayashi K, 1999, BIOCHEM BIOPH RES CO, V254, P42, DOI 10.1006/bbrc.1998.9892; Oshima Y, 2008, CIRCULATION, V117, P3099, DOI 10.1161/CIRCULATIONAHA.108.767673; Ouchi N, 2008, J BIOL CHEM, V283, P32802, DOI 10.1074/jbc.M803440200; Pope JC, 1999, J AM SOC NEPHROL, V10, P2018; Roberts DJ, 1998, DEVELOPMENT, V125, P2791; ROBERTS DJ, 1995, DEVELOPMENT, V121, P3163; Schedl A, 2000, CURR OPIN GENET DEV, V10, P543, DOI 10.1016/S0959-437X(00)00125-8; Schilling TF, 1999, DEV BIOL, V210, P277, DOI 10.1006/dbio.1999.9214; Sylva M, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0022616; Tanaka M, 2010, FEBS J, V277, P4278, DOI 10.1111/j.1742-4658.2010.07816.x; Towers P, 1999, DEV BIOL, V214, P298, DOI 10.1006/dbio.1999.9421; Uetani N, 2009, CLIN GENET, V75, P307, DOI 10.1111/j.1399-0004.2009.01175.x; Uetani N, 2009, J CLIN INVEST, V119, P924, DOI 10.1172/JCI37196; Umezu T, 2010, P NATL ACAD SCI USA, V107, P4601, DOI 10.1073/pnas.0909501107; Vainio S, 2002, NAT REV GENET, V3, P533, DOI 10.1038/nrg842; Yu J, 2002, DEVELOPMENT, V129, P5301; Zhang YD, 2000, DEVELOPMENT, V127, P1431; Zhao J, 2009, HUM MOL GENET, V18, P3090, DOI 10.1093/hmg/ddp250; Zhou YH, 1998, EMBO J, V17, P6689, DOI 10.1093/emboj/17.22.6689	58	56	60	0	16	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 2	2012	7	4							e32554	10.1371/journal.pone.0032554	http://dx.doi.org/10.1371/journal.pone.0032554			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	952GU	22808012	Green Submitted, Green Published, gold			2022-12-25	WOS:000304780500008
J	Lin, ZJ; Lu, J; Zhou, WH; Shen, YQ				Lin, Zhijie; Lu, Jing; Zhou, Weihong; Shen, Yuequan			Structural Insights into TIR Domain Specificity of the Bridging Adaptor Mal in TLR4 Signaling	PLOS ONE			English	Article							KAPPA-B ACTIVATION; CRYSTAL-STRUCTURE; RECEPTOR DOMAIN; GENETIC-VARIATIONS; TRANSDUCTION; REVEALS; MOLECULE; SEPSIS; DIMERIZATION; TUBERCULOSIS	MyD88 adaptor-like protein (Mal) is a crucial adaptor that acts as a bridge to recruit the MyD88 molecule to activated TLR4 receptors in response to invading pathogens. The specific assembly of the Toll/interleukin-1 receptor (TIR) domains of TLR4, Mal and MyD88 is responsible for proper signal transduction in the TLR4 signaling pathway. However, the molecular mechanism for the specificity of these TIR domains remains unclear. Here, we present the crystal structure of the TIR domain of the human Mal molecule (Mal-TIR) at a resolution of 2.4 angstrom. Unexpectedly, Mal-TIR exhibits an extraordinarily long AB loop, but no alpha B helix or BB loop, distinguishing it from other TIR domains. More importantly, the Mal-TIR AB loop is capable of mediating direct binding to the TIR domains of TLR4 and MyD88 simultaneously. We also found that Mal-TIR can form a back-to-back dimer that may resemble the dimeric assembly of the entire Mal molecule. Our data demonstrate the bridge role of the Mal-TIR domain and provide important information about TIR domain specificity.	[Lin, Zhijie; Lu, Jing; Zhou, Weihong; Shen, Yuequan] Nankai Univ, State Key Lab Med Chem Biol, Tianjin 300071, Peoples R China; [Lin, Zhijie; Lu, Jing; Zhou, Weihong; Shen, Yuequan] Nankai Univ, Coll Life Sci, Tianjin 300071, Peoples R China	Nankai University; Nankai University	Shen, YQ (corresponding author), Nankai Univ, State Key Lab Med Chem Biol, Tianjin 300071, Peoples R China.	yuequan74@yahoo.com	Shen, Yuequan/C-8950-2013; Lin, Zhijie/Y-4836-2019	Shen, Yuequan/0000-0002-3775-0900; LU, JINJIAN/0000-0001-6703-3120; yuanjia, Hu/0000-0001-5244-8577	973 Program [2007CB914301, 2009CB825504]; NSFC [31170684]; TBR [08QTPTJC28200, 08SYSYTC00200]	973 Program(National Basic Research Program of China); NSFC(National Natural Science Foundation of China (NSFC)); TBR	This work was funded by the 973 Program (grants 2007CB914301 and 2009CB825504), NSFC (grant 31170684) and the TBR program (grants 08QTPTJC28200 and 08SYSYTC00200). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Akira S, 2006, CELL, V124, P783, DOI 10.1016/j.cell.2006.02.015; An Y, 2011, INT J MOL MED, V27, P795, DOI 10.3892/ijmm.2011.645; [Anonymous], ACTA CRYSTALLOGR D, V50, P760; Barton GM, 2009, NAT REV IMMUNOL, V9, P535, DOI 10.1038/nri2587; Bernoux M, 2011, CELL HOST MICROBE, V9, P200, DOI 10.1016/j.chom.2011.02.009; Brunger AT, 1998, ACTA CRYSTALLOGR D, V54, P905, DOI 10.1107/S0907444998003254; Castiblanco J, 2008, INFECT GENET EVOL, V8, P541, DOI 10.1016/j.meegid.2008.03.001; Chan SL, 2010, PROTEIN SCI, V19, P155, DOI 10.1002/pro.275; Chan SL, 2009, J BIOL CHEM, V284, P21386, DOI 10.1074/jbc.C109.007591; Choe J, 2005, SCIENCE, V309, P581, DOI 10.1126/science.1115253; Dissanayeke SR, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0006698; Dunne A, 2003, J BIOL CHEM, V278, P41443, DOI 10.1074/jbc.M301742200; Durrani O, 2011, RHEUMATOLOGY, V50, P1760, DOI 10.1093/rheumatology/ker200; Emsley P, 2004, ACTA CRYSTALLOGR D, V60, P2126, DOI 10.1107/S0907444904019158; Ferwerda B, 2009, P NATL ACAD SCI USA, V106, P10272, DOI 10.1073/pnas.0811273106; Fitzgerald KA, 2001, NATURE, V413, P78, DOI 10.1038/35092578; George J, 2010, J IMMUNOL, V184, P3025, DOI 10.4049/jimmunol.0901156; Gray P, 2006, J BIOL CHEM, V281, P10489, DOI 10.1074/jbc.M508892200; Horng T, 2002, NATURE, V420, P329, DOI 10.1038/nature01180; Horng T, 2001, NAT IMMUNOL, V2, P835, DOI 10.1038/ni0901-835; Jiang ZF, 2006, P NATL ACAD SCI USA, V103, P10961, DOI 10.1073/pnas.0603804103; Jin MS, 2007, CELL, V130, P1071, DOI 10.1016/j.cell.2007.09.008; Kagan JC, 2006, CELL, V125, P943, DOI 10.1016/j.cell.2006.03.047; Kawamoto T, 2008, EUR J PHARMACOL, V584, P40, DOI 10.1016/j.ejphar.2008.01.026; Khan JA, 2004, J BIOL CHEM, V279, P31664, DOI 10.1074/jbc.M403434200; Khor CC, 2007, NAT GENET, V39, P523, DOI 10.1038/ng1976; Kumpf O, 2010, CRIT CARE, V14, DOI 10.1186/cc9047; Li CS, 2005, J BIOL CHEM, V280, P26152, DOI 10.1074/jbc.M503262200; Liu L, 2008, SCIENCE, V320, P379, DOI 10.1126/science.1155406; Loiarro M, 2005, J BIOL CHEM, V280, P15809, DOI 10.1074/jbc.C400613200; Mansell A, 2004, J BIOL CHEM, V279, P37227, DOI 10.1074/jbc.C400289200; Matsunaga N, 2011, MOL PHARMACOL, V79, P34, DOI 10.1124/mol.110.068064; McCoy AJ, 2007, ACTA CRYSTALLOGR D, V63, P32, DOI 10.1107/S0907444906045975; Miggin SM, 2007, P NATL ACAD SCI USA, V104, P3372, DOI 10.1073/pnas.0608100104; Miguel RN, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0000788; Nagpal K, 2009, J BIOL CHEM, V284, P25742, DOI 10.1074/jbc.M109.014886; Nejentsev S, 2008, NAT GENET, V40, P261, DOI 10.1038/ng0308-261; Nyman T, 2008, J BIOL CHEM, V283, P11861, DOI 10.1074/jbc.C800001200; O'Neill LAJ, 2007, NAT REV IMMUNOL, V7, P353, DOI 10.1038/nri2079; Ohnishi H, 2009, P NATL ACAD SCI USA, V106, P10260, DOI 10.1073/pnas.0812956106; Otwinowski Z, 1997, METHOD ENZYMOL, V276, P307, DOI 10.1016/S0076-6879(97)76066-X; Pape T, 2004, J APPL CRYSTALLOGR, V37, P843, DOI 10.1107/S0021889804018047; Piao W, 2008, J BIOL CHEM, V283, P3109, DOI 10.1074/jbc.M707400200; Song ZJ, 2010, BMC MED GENET, V11, DOI 10.1186/1471-2350-11-168; Takashima K, 2009, BRIT J PHARMACOL, V157, P1250, DOI 10.1111/j.1476-5381.2009.00297.x; Toshchakov VY, 2011, J IMMUNOL, V186, P4819, DOI 10.4049/jimmunol.1002424; Toshchakov VU, 2005, J IMMUNOL, V175, P494, DOI 10.4049/jimmunol.175.1.494; Valkov E, 2011, P NATL ACAD SCI USA, V108, P14879, DOI 10.1073/pnas.1104780108; Watters TM, 2007, IMMUNOL CELL BIOL, V85, P411, DOI 10.1038/sj.icb.7100095; Xu YW, 2000, NATURE, V408, P111, DOI 10.1038/35040600; Yamamoto M, 2002, NATURE, V420, P324, DOI 10.1038/nature01182; Zwart Peter H., 2008, V426, P419, DOI 10.1007/978-1-60327-058-8_28	52	129	129	1	14	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 2	2012	7	4							e34202	10.1371/journal.pone.0034202	http://dx.doi.org/10.1371/journal.pone.0034202			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	087PX	22485159	Green Published, gold, Green Submitted			2022-12-25	WOS:000314775500001
J	Zhang, L; Li, YG; Li, YH; Qi, L; Liu, XG; Yuan, CZ; Hus, NW; Ma, DX; Li, ZF; Yang, Q; Li, W; Li, JM				Zhang, Lei; Li, Yong-gang; Li, Yu-hua; Qi, Lei; Liu, Xin-guang; Yuan, Cun-zhong; Hus, Nai-wen; Ma, Dao-xin; Li, Zhen-feng; Yang, Qiang; Li, Wei; Li, Jian-min			Increased Frequencies of Th22 Cells as well as Th17 Cells in the Peripheral Blood of Patients with Ankylosing Spondylitis and Rheumatoid Arthritis	PLOS ONE			English	Article							COLLAGEN-INDUCED ARTHRITIS; GROWTH-FACTOR-BETA; MEMORY T-CELLS; DISEASE-ACTIVITY; PROINFLAMMATORY CYTOKINE; AUTOIMMUNE INFLAMMATION; INFLAMED JOINTS; CROHNS-DISEASE; INTERLEUKIN 22; DISTINCT	Background: T-helper (Th) 22 is involved in the pathogenesis of inflammatory diseases. The roles of Th22 cells in the pathophysiological of ankylosing spondylitis (AS) and rheumatoid arthritis (RA) remain unsettled. So we examined the frequencies of Th22 cells, Th17 cells and Th1 cells in peripheral blood (PB) from patients with AS and patients with RA compared with both healthy controls as well as patients with osteoarthritis. Design and Methods: We studied 32 AS patients, 20 RA patients, 10 OA patients and 20 healthy controls. The expression of IL-22, IL-17 and IFN-gamma were examined in AS, RA, OA patients and healthy controls by flow cytometry. Plasma IL-22 and IL-17 levels were examined by enzyme-linked immunosorbent assay. Results: Th22 cells, Th17 cells and interleukin-22 were significantly elevated in AS and RA patients compared with OA patients and healthy controls. Moreover, Th22 cells showed positive correlation with Th17 cells as well as interleukin-22 in AS and RA patients. However, positive correlation between IL-22 and Th17 cells was only found in AS patients not in RA patients. In addition, the percentages of both Th22 cells and Th17 cells correlated positively with disease activity only in RA patients not in AS patients. Conclusions:The frequencies of both Th22 cells and Th17 cells were elevated in PB from patients with AS and patients with RA. These findings suggest that Th22 cells and Th17 cells may be implicated in the pathogenesis of AS and RA, and Th22 cells and Th17 cells may be reasonable cellular targets for therapeutic intervention.	[Zhang, Lei; Li, Yong-gang; Qi, Lei; Li, Zhen-feng; Yang, Qiang; Li, Jian-min] Shandong Univ, Dept Orthoped, Qilu Hosp, Jinan 250100, Peoples R China; [Li, Yu-hua] Shandong Univ, Dept Emergency, Qilu Hosp, Jinan 250100, Peoples R China; [Liu, Xin-guang; Ma, Dao-xin] Shandong Univ, Qilu Hosp, Dept Hematol, Jinan 250100, Peoples R China; [Yuan, Cun-zhong] Shandong Univ, Dept Obstet & Gynecol, Qilu Hosp, Jinan 250100, Peoples R China; [Hus, Nai-wen] Shandong Univ, Prov Hosp, Dept Rheumatol, Jinan 250100, Peoples R China; [Li, Wei] Shandong Univ, Qilu Hosp, Dept Clin Lab, Jinan 250100, Peoples R China	Shandong University; Shandong University; Shandong University; Shandong University; Shandong University; Shandong University	Zhang, L (corresponding author), Shandong Univ, Dept Orthoped, Qilu Hosp, Jinan 250100, Peoples R China.	daoxinma@hotmail.com; jianminli123456@163.com	Li, yu/HHZ-5236-2022	Zhang, Lurong/0000-0002-0829-4942; Liang, Guoqiang/0000-0002-2355-444X; Liu, Haiyan/0000-0002-4652-469X; Liu, Xin Guang/0000-0001-9033-9099; Yao, Fei/0000-0002-6936-4553; Li, Yonggang/0000-0001-8280-4827	National Natural Science Foundation [30600680, 81070407, 30973018]; Shandong Technological Development Project [2005BS03022, Q2008C07, BS2009SW014]; Graduate Independent Innovation Foundation of Shandong University, GIIFSDU [yzc21300071613082, yzc10147]	National Natural Science Foundation(National Natural Science Foundation of China (NSFC)); Shandong Technological Development Project; Graduate Independent Innovation Foundation of Shandong University, GIIFSDU	This study was partially supported by research funding from the National Natural Science Foundation (30600680, 81070407 and 30973018), the Shandong Technological Development Project (2005BS03022, Q2008C07, and BS2009SW014), and Graduate Independent Innovation Foundation of Shandong University, GIIFSDU (yzc21300071613082, yzc10147). (http://www.nsfc.gov.cn/Portal0/default152.htm) (http://www.art.sdu.edu.cn/2011/0321/931.html). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ARNETT FC, 1988, ARTHRITIS RHEUM, V31, P315, DOI 10.1002/art.1780310302; Bettelli E, 2008, NATURE, V453, P1051, DOI 10.1038/nature07036; Bettelli E, 2007, NAT IMMUNOL, V8, P345, DOI 10.1038/ni0407-345; Brand S, 2006, AM J PHYSIOL-GASTR L, V290, pG827, DOI 10.1152/ajpgi.00513.2005; Chabaud M, 1999, ARTHRITIS RHEUM-US, V42, P963, DOI 10.1002/1529-0131(199905)42:5<963::AID-ANR15>3.0.CO;2-E; Cheng F, 2009, ANN RHEUM DIS, V68, P604, DOI 10.1136/ard.2008.097089; Colin EM, 2010, ARTHRITIS RHEUM-US, V62, P132, DOI 10.1002/art.25043; Cua DJ, 2003, NATURE, V421, P744, DOI 10.1038/nature01355; Dolhain RJEM, 1996, ARTHRITIS RHEUM-US, V39, P1961, DOI 10.1002/art.1780391204; Duhen T, 2009, NAT IMMUNOL, V10, P857, DOI 10.1038/ni.1767; Eyerich S, 2009, J CLIN INVEST, V119, P3573, DOI 10.1172/JCI40202; Fitch Erin, 2007, Curr Rheumatol Rep, V9, P461, DOI 10.1007/s11926-007-0075-1; Flytlie HA, 2010, CYTOKINE, V49, P24, DOI 10.1016/j.cyto.2009.10.005; GARRETT S, 1994, J RHEUMATOL, V21, P2286; Gaston JSH, 2008, RHEUMATOLOGY, V47, P8, DOI 10.1093/rheumatology/kem203; Harrington LE, 2005, NAT IMMUNOL, V6, P1123, DOI 10.1038/ni1254; Hirota K, 2007, J EXP MED, V204, P2803, DOI 10.1084/jem.20071397; Hirota K, 2007, J EXP MED, V204, P41, DOI 10.1084/jem.20062259; Ikeuchi H, 2005, ARTHRITIS RHEUM-US, V52, P1037, DOI 10.1002/art.20965; Kagami S, 2010, J INVEST DERMATOL, V130, P1373, DOI 10.1038/jid.2009.399; Kebir H, 2007, NAT MED, V13, P1173, DOI 10.1038/nm1651; Leipe J, 2011, ANN RHEUM DIS, V70, P1453, DOI 10.1136/ard.2011.152074; Leipe J, 2010, ARTHRITIS RHEUM-US, V62, P2876, DOI 10.1002/art.27622; Lejeune D, 2002, J BIOL CHEM, V277, P33676, DOI 10.1074/jbc.M204204200; Lo YH, 2010, J DERMATOL SCI, V58, P225, DOI 10.1016/j.jdermsci.2010.03.018; Lubberts E, 2004, ARTHRITIS RHEUM-US, V50, P650, DOI 10.1002/art.20001; Lubberts E, 2001, J IMMUNOL, V167, P1004, DOI 10.4049/jimmunol.167.2.1004; Mangan PR, 2006, NATURE, V441, P231, DOI 10.1038/nature04754; Mei Y, 2011, CLIN RHEUMATOL, V30, P269, DOI 10.1007/s10067-010-1647-4; Miossec P, 2003, ARTHRITIS RHEUM-US, V48, P594, DOI 10.1002/art.10816; Miossec P, 2007, ARTHRITIS RHEUM-US, V56, P2111, DOI 10.1002/art.22733; MOSMANN TR, 1989, ANNU REV IMMUNOL, V7, P145, DOI 10.1146/annurev.immunol.7.1.145; Murphy CA, 2003, J EXP MED, V198, P1951, DOI 10.1084/jem.20030896; Okey Allan B, 2005, Toxicol Appl Pharmacol, V207, P43, DOI 10.1016/j.taap.2004.12.028; Park H, 2005, NAT IMMUNOL, V6, P1133, DOI 10.1038/ni1261; Parsonage G, 2008, ARTHRITIS RES THER, V10, DOI 10.1186/ar2406; PREVOO MLL, 1995, ARTHRITIS RHEUM, V38, P44, DOI 10.1002/art.1780380107; Renauld JC, 2003, NAT REV IMMUNOL, V3, P667, DOI 10.1038/nri1153; Schmechel S, 2008, INFLAMM BOWEL DIS, V14, P204, DOI 10.1002/ibd.20315; Shahrara S, 2008, ARTHRITIS RES THER, V10, DOI 10.1186/ar2477; Shen H, 2009, ARTHRITIS RHEUM-US, V60, P1647, DOI 10.1002/art.24568; Trifari S, 2009, NAT IMMUNOL, V10, P864, DOI 10.1038/ni.1770; VANDERLINDEN S, 1984, ARTHRITIS RHEUM, V27, P361; Volpe E, 2008, NAT IMMUNOL, V9, P650, DOI 10.1038/ni.1613; Wedderburn LR, 2000, ARTHRITIS RHEUM-US, V43, P765, DOI 10.1002/1529-0131(200004)43:4<765::AID-ANR7>3.0.CO;2-B; Wolk K, 2002, J IMMUNOL, V168, P5397, DOI 10.4049/jimmunol.168.11.5397; Zenewicz LA, 2007, IMMUNITY, V27, P647, DOI 10.1016/j.immuni.2007.07.023; Zhang L, 2011, J CLIN IMMUNOL, V31, P606, DOI 10.1007/s10875-011-9540-8; Zheng Y, 2007, NATURE, V445, P648, DOI 10.1038/nature05505	49	187	202	0	14	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 2	2012	7	4							e31000	10.1371/journal.pone.0031000	http://dx.doi.org/10.1371/journal.pone.0031000			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	952GU	22485125	gold, Green Published, Green Submitted			2022-12-25	WOS:000304780500001
J	Anderson, AM; Carter, KW; Anderson, D; Wise, MJ				Anderson, Alison M.; Carter, Kim W.; Anderson, Denise; Wise, Michael J.			Coexpression of Nuclear Receptors and Histone Methylation Modifying Genes in the Testis: Implications for Endocrine Disruptor Modes of Action	PLOS ONE			English	Article							NEONATAL EXPOSURE; MECHANISMS; DNA; METHYLTRANSFERASES; NOMENCLATURE; ACTIVATION; EXPRESSION; CHEMICALS; MLL3; MARK	Background: Endocrine disruptor chemicals elicit adverse health effects by perturbing nuclear receptor signalling systems. It has been speculated that these compounds may also perturb epigenetic mechanisms and thus contribute to the early origin of adult onset disease. We hypothesised that histone methylation may be a component of the epigenome that is susceptible to perturbation. We used coexpression analysis of publicly available data to investigate the combinatorial actions of nuclear receptors and genes involved in histone methylation in normal testis and when faced with endocrine disruptor compounds. Methodology/Principal Findings: The expression patterns of a set of genes were profiled across testis tissue in human, rat and mouse, plus control and exposed samples from four toxicity experiments in the rat. Our results indicate that histone methylation events are a more general component of nuclear receptor mediated transcriptional regulation in the testis than previously appreciated. Coexpression patterns support the role of a gatekeeper mechanism involving the histone methylation modifiers Kdm1, Prdm2, and Ehmt1 and indicate that this mechanism is a common determinant of transcriptional integrity for genes critical to diverse physiological endpoints relevant to endocrine disruption. Coexpression patterns following exposure to vinclozolin and dibutyl phthalate suggest that coactivity of the demethylase Kdm1 in particular warrants further investigation in relation to endocrine disruptor mode of action. Conclusions/Significance: This study provides proof of concept that a bioinformatics approach that profiles genes related to a specific hypothesis across multiple biological settings can provide powerful insight into coregulatory activity that would be difficult to discern at an individual experiment level or by traditional differential expression analysis methods.	[Anderson, Alison M.; Carter, Kim W.; Anderson, Denise] Univ Western Australia, Telethon Inst Child Hlth Res, Ctr Child Hlth Res, Perth, WA 6009, Australia	Telethon Kids Institute; University of Western Australia	Anderson, AM (corresponding author), Univ Western Australia, Telethon Inst Child Hlth Res, Ctr Child Hlth Res, Perth, WA 6009, Australia.	alisona@ichr.uwa.edu.au	Anderson, Alison/J-6786-2014; Wise, Michael/B-5676-2012	Anderson, Alison/0000-0002-1490-2262; Wise, Michael/0000-0001-6559-4303; Anderson, Denise/0000-0003-0643-4136	William and Marlene Schrader Trust [F6787]	William and Marlene Schrader Trust	AA was supported by a William and Marlene Schrader Postgraduate Scholarship [F6787] awarded by the William and Marlene Schrader Trust. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Allis CD, 2007, CELL, V131, P633, DOI 10.1016/j.cell.2007.10.039; Allocco DJ, 2004, BMC BIOINFORMATICS, V5, DOI 10.1186/1471-2105-5-18; Ansari KI, 2011, BIOCHEMISTRY-US, V50, P3517, DOI 10.1021/bi102037t; BENJAMINI Y, 1995, J R STAT SOC B, V57, P289, DOI 10.1111/j.2517-6161.1995.tb02031.x; Bjornstrom L, 2005, MOL ENDOCRINOL, V19, P833, DOI 10.1210/me.2004-0486; Brykczynska U, 2010, NAT STRUCT MOL BIOL, V17, P679, DOI 10.1038/nsmb.1821; Bulynko YA, 2011, BIOCHEMISTRY-US, V50, P313, DOI 10.1021/bi101762x; Cloos PAC, 2008, GENE DEV, V22, P1115, DOI 10.1101/gad.1652908; Crawford BD, 2006, ACS CHEM BIOL, V1, P495, DOI 10.1021/cb600367v; De Santa F, 2007, CELL, V130, P1083, DOI 10.1016/j.cell.2007.08.019; Diamanti-Kandarakis E, 2009, ENDOCR REV, V30, P293, DOI 10.1210/er.2009-0002; Dreijerink KMA, 2006, CANCER RES, V66, P4929, DOI 10.1158/0008-5472.CAN-05-4461; Dreijerink KMA, 2009, MOL CELL BIOL, V29, P5060, DOI 10.1128/MCB.01001-08; Foster PMD, 2006, INT J ANDROL, V29, P140, DOI 10.1111/j.1365-2605.2005.00563.x; Garcia-Bassets I, 2007, CELL, V128, P505, DOI 10.1016/j.cell.2006.12.038; Gentleman RC, 2004, GENOME BIOL, V5, DOI 10.1186/gb-2004-5-10-r80; Germain P, 2006, PHARMACOL REV, V58, P685, DOI 10.1124/pr.58.4.2; Hemberger M, 2009, NAT REV MOL CELL BIO, V10, P526, DOI 10.1038/nrm2727; Hiroi H, 2004, MOL ENDOCRINOL, V18, P791, DOI 10.1210/me.2003-0305; Hotchkiss AK, 2010, REPROD TOXICOL, V30, P261, DOI 10.1016/j.reprotox.2010.06.001; Hublitz P, 2009, INT J DEV BIOL, V53, P335, DOI 10.1387/ijdb.082717ph; Issaeva I, 2007, MOL CELL BIOL, V27, P1889, DOI 10.1128/MCB.01506-06; Kim SM, 2010, NUCLEIC ACIDS RES, V38, P6389, DOI 10.1093/nar/gkq491; LeBaron MJ, 2010, MUTAT RES-REV MUTAT, V705, P83, DOI 10.1016/j.mrrev.2010.04.003; Lee S, 2008, MOL ENDOCRINOL, V22, P1312, DOI 10.1210/me.2008-0012; Lee S, 2009, MOL ENDOCRINOL, V23, P610, DOI 10.1210/me.2008-0455; Metzger E, 2005, NATURE, V437, P436, DOI 10.1038/nature04020; Mo R, 2006, J BIOL CHEM, V281, P15714, DOI 10.1074/jbc.M513245200; Narita M, 2007, ADDICT BIOL, V12, P167, DOI 10.1111/j.1369-1600.2007.00048.x; Newbold RR, 2011, AM J CLIN NUTR, V94, p1939S, DOI 10.3945/ajcn.110.001057; Newbold RR, 2009, MOL CELL ENDOCRINOL, V304, P84, DOI 10.1016/j.mce.2009.02.024; Okada Y, 2010, J ANDROL, V31, P75, DOI 10.2164/jandrol.109.008052; Vicent GP, 2011, GENE DEV, V25, P845, DOI 10.1101/gad.621811; Sato K, 2009, ENDOCR J, V56, P131, DOI 10.1507/endocrj.K08E-239; Smyth G.K., 2004, STAT APPL GENET MOL, V3, DOI DOI 10.2202/1544-6115.1027; Sun LC, 2008, CANCER RES, V68, P2726, DOI 10.1158/0008-5472.CAN-07-6654; Viswakarma N, 2010, PPAR RES; Wang J, 2009, NAT GENET, V41, P125, DOI 10.1038/ng.268; Wilson VS, 2008, INT J ANDROL, V31, P178, DOI 10.1111/j.1365-2605.2007.00861.x; Wysocka J, 2005, CELL, V121, P859, DOI 10.1016/j.cell.2005.03.036; Yang J, 2010, CANCER RES, V70, P6456, DOI 10.1158/0008-5472.CAN-10-0413; Zhang XA, 2011, J MOL ENDOCRINOL, V46, pR11, DOI 10.1677/JME-10-0053	42	24	26	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 4	2012	7	4							e34158	10.1371/journal.pone.0034158	http://dx.doi.org/10.1371/journal.pone.0034158			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	953GO	22496781	Green Published, Green Submitted, gold			2022-12-25	WOS:000304855200033
